"","Collection","Gene_set","Size","NES_b_cell","PValue_b_cell","FDR_b_cell","SLE>Control","NES_t_cell","PValue_t_cell","FDR_t_cell","SLE>Control"
"1","C7_Immunologic_signatures","C7_ALL_48_GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN",200,-3.2808,0,0,"No",-1.2062,0.096,0.82,"No"
"2","C7_Immunologic_signatures","C7_ALL_1282_GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN",200,-3.2684,0,0,"No",-1.2796,0.046,0.51,"No"
"3","C7_Immunologic_signatures","C7_ALL_1286_GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN",200,-3.2638,0,0,"No",-1.1312,0.15,1,"No"
"4","C7_Immunologic_signatures","C7_ALL_42_GSE10325_BCELL_VS_MYELOID_DN",198,-3.2374,0,0,"No",-1.2865,0.035,0.51,"No"
"5","C7_Immunologic_signatures","C7_ALL_1270_GSE29618_BCELL_VS_MONOCYTE_DN",200,-3.1681,0,0,"No",-0.6744,1,1,"No"
"6","C7_Immunologic_signatures","C7_ALL_1274_GSE29618_BCELL_VS_MDC_DN",200,-3.1517,0,0,"No",0.5847,1,1,"Yes"
"7","C7_Immunologic_signatures","C7_ALL_46_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN",200,-3.0641,0,0,"No",-1.3557,0.014,0.35,"No"
"8","C4_Cancer_gene_neighborhoods","C4_CGN_324_GNF2_CASP1",111,-3.0356,0,0,"No",-0.8515,0.81,1,"No"
"9","C7_Immunologic_signatures","C7_ALL_1287_GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP",200,-3.0355,0,0,"No",-1.0826,0.25,1,"No"
"10","C7_Immunologic_signatures","C7_ALL_984_GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN",199,-3.0326,0,0,"No",-0.8211,0.91,1,"No"
"11","C4_Cancer_gene_neighborhoods","C4_CGN_356_GNF2_HCK",93,-3.0275,0,0,"No",-0.7242,0.96,1,"No"
"12","C7_Immunologic_signatures","C7_ALL_1277_GSE29618_MONOCYTE_VS_MDC_UP",199,-3.02,0,0,"No",-1.0467,0.35,1,"No"
"13","C7_Immunologic_signatures","C7_ALL_1275_GSE29618_MONOCYTE_VS_PDC_UP",199,-3.0197,0,0,"No",-0.8571,0.84,1,"No"
"14","C7_Immunologic_signatures","C7_ALL_1292_GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN",200,-2.9646,0,0,"No",-0.8254,0.92,1,"No"
"15","C7_Immunologic_signatures","C7_ALL_980_GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN",198,-2.9478,0,0,"No",0.8599,0.84,1,"Yes"
"16","C4_Cancer_gene_neighborhoods","C4_CGN_287_GNF2_CARD15",69,-2.9444,0,0,"No",-1.5063,0.0076,0.27,"No"
"17","C7_Immunologic_signatures","C7_ALL_990_GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN",199,-2.9344,0,0,"No",-1.0544,0.33,1,"No"
"18","C7_Immunologic_signatures","C7_ALL_1886_GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN",196,-2.9266,0,0,"No",-2.1014,0,0,"No"
"19","C7_Immunologic_signatures","C7_ALL_978_GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN",200,-2.923,0,0,"No",-1.1719,0.12,0.95,"No"
"20","C7_Immunologic_signatures","C7_ALL_1289_GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP",200,-2.9229,0,0,"No",-0.7431,0.99,1,"No"
"21","C7_Immunologic_signatures","C7_ALL_1280_GSE29618_PDC_VS_MDC_DN",199,-2.9146,0,0,"No",-0.6721,1,1,"No"
"22","C2_Chemical_and_genetic_perturbations","C2_CGP_1446_BROWN_MYELOID_CELL_DEVELOPMENT_UP",162,-2.8998,0,0,"No",-0.8597,0.8,1,"No"
"23","C7_Immunologic_signatures","C7_ALL_996_GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN",200,-2.8966,0,0,"No",-0.9948,0.45,1,"No"
"24","C7_Immunologic_signatures","C7_ALL_1899_GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP",192,-2.8879,0,0,"No",-1.9496,0,0,"No"
"25","C4_Cancer_gene_neighborhoods","C4_CGN_419_GNF2_TNFRSF1B",64,-2.8873,0,0,"No",-0.7386,0.94,1,"No"
"26","C4_Cancer_gene_neighborhoods","C4_CGN_330_GNF2_CD33",51,-2.8853,0,0,"No",-2.0468,0,0.0049,"No"
"27","C7_Immunologic_signatures","C7_ALL_73_GSE11057_PBMC_VS_MEM_CD4_TCELL_UP",193,-2.8696,0,0,"No",-0.9716,0.55,1,"No"
"28","C7_Immunologic_signatures","C7_ALL_1746_GSE6269_HEALTHY_VS_STREP_AUREUS_INF_PBMC_DN",167,-2.863,0,0,"No",0.6097,1,1,"Yes"
"29","C7_Immunologic_signatures","C7_ALL_1905_GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP",192,-2.8612,0,0,"No",-1.9707,0,0,"No"
"30","C7_Immunologic_signatures","C7_ALL_37_GSE10325_CD4_TCELL_VS_BCELL_UP",195,-2.8543,0,0,"No",1.2236,0.051,0.19,"Yes"
"31","C4_Cancer_gene_neighborhoods","C4_CGN_329_GNF2_CD1D",44,-2.8498,0,0,"No",-1.9237,0,0.0073,"No"
"32","C7_Immunologic_signatures","C7_ALL_1884_GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN",197,-2.8366,0,0,"No",-1.7935,0,0.00052,"No"
"33","C4_Cancer_gene_neighborhoods","C4_CGN_392_GNF2_PECAM1",56,-2.8354,0,0,"No",-0.7885,0.84,1,"No"
"34","C7_Immunologic_signatures","C7_ALL_1888_GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN",191,-2.8171,0,0,"No",-2.0907,0,0,"No"
"35","C7_Immunologic_signatures","C7_ALL_1062_GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN",199,-2.8108,0,0,"No",-0.9525,0.59,1,"No"
"36","C7_Immunologic_signatures","C7_ALL_1903_GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP",193,-2.8016,0,0,"No",-2.0208,0,0,"No"
"37","C7_Immunologic_signatures","C7_ALL_70_GSE11057_CD4_CENT_MEM_VS_PBMC_DN",191,-2.8004,0,0,"No",-1.042,0.35,1,"No"
"38","C7_Immunologic_signatures","C7_ALL_68_GSE11057_CD4_EFF_MEM_VS_PBMC_DN",196,-2.7957,0,0,"No",-0.9305,0.64,1,"No"
"39","C7_Immunologic_signatures","C7_ALL_1897_GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP",191,-2.7895,0,0,"No",-1.853,0,7.6e-05,"No"
"40","C4_Cancer_gene_neighborhoods","C4_CGN_404_GNF2_S100A4",47,-2.7652,0,0,"No",-0.8093,0.79,1,"No"
"41","C7_Immunologic_signatures","C7_ALL_1284_GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN",199,-2.7441,0,0,"No",-0.8712,0.81,1,"No"
"42","C4_Cancer_gene_neighborhoods","C4_CGN_353_GNF2_FOS",41,-2.7107,0,0,"No",-1.9897,0,0.0039,"No"
"43","C4_Cancer_gene_neighborhoods","C4_CGN_328_GNF2_CD14",34,-2.7103,0,0,"No",-1.6445,0.0057,0.098,"No"
"44","C2_Chemical_and_genetic_perturbations","C2_CGP_3357_ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION",127,-2.6846,0,0,"No",-1.1916,0.13,0.81,"No"
"45","C2_Chemical_and_genetic_perturbations","C2_CGP_1522_VERHAAK_AML_WITH_NPM1_MUTATED_UP",182,-2.6803,0,0,"No",0.9557,0.58,0.86,"Yes"
"46","C4_Cancer_gene_neighborhoods","C4_CGN_376_GNF2_MCL1",57,-2.6763,0,0,"No",0.6816,0.98,1,"Yes"
"47","C2_Chemical_and_genetic_perturbations","C2_CGP_2547_RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN",313,-2.6729,0,0,"No",-0.8232,0.95,1,"No"
"48","C7_Immunologic_signatures","C7_ALL_43_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP",195,-2.6647,0,0,"No",1.1236,0.15,0.38,"Yes"
"49","C7_Immunologic_signatures","C7_ALL_1909_GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP",190,-2.6559,0,0,"No",-1.7713,0,7e-04,"No"
"50","C2_Chemical_and_genetic_perturbations","C2_CGP_321_JAATINEN_HEMATOPOIETIC_STEM_CELL_DN",223,-2.6502,0,0,"No",1.769,0,0.054,"Yes"
"51","C2_Chemical_and_genetic_perturbations","C2_CGP_1455_GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN",85,-2.6482,0,0,"No",-1.5701,0,0.44,"No"
"52","C7_Immunologic_signatures","C7_ALL_1907_GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP",193,-2.6424,0,0,"No",-1.8862,0,8.8e-05,"No"
"53","C7_Immunologic_signatures","C7_ALL_40_GSE10325_CD4_TCELL_VS_MYELOID_DN",199,-2.6298,0,0,"No",-1.0852,0.27,1,"No"
"54","C2_Chemical_and_genetic_perturbations","C2_CGP_3035_KAMIKUBO_MYELOID_CEBPA_NETWORK",27,-2.6119,0,0,"No",-0.5732,0.98,1,"No"
"55","C7_Immunologic_signatures","C7_ALL_1070_GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN",200,-2.6084,0,0,"No",-1.0335,0.35,1,"No"
"56","C2_Chemical_and_genetic_perturbations","C2_CGP_1554_HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN",62,-2.6063,0,0,"No",-1.0161,0.43,0.99,"No"
"57","C2_Chemical_and_genetic_perturbations","C2_CGP_1493_HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN",76,-2.6041,0,0,"No",0.8666,0.76,0.96,"Yes"
"58","C7_Immunologic_signatures","C7_ALL_64_GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN",197,-2.6037,0,0,"No",0.548,1,1,"Yes"
"59","C7_Immunologic_signatures","C7_ALL_1748_GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_DN",169,-2.5953,0,0,"No",-0.6937,1,1,"No"
"60","C2_Chemical_and_genetic_perturbations","C2_CGP_3030_LI_INDUCED_T_TO_NATURAL_KILLER_UP",305,-2.5816,0,0,"No",-0.6567,1,1,"No"
"61","C0_Hallmark","H_ALL_1_HALLMARK_TNFA_SIGNALING_VIA_NFKB",200,-2.5575,0,0,"No",-1.7409,0,0.015,"No"
"62","C7_Immunologic_signatures","C7_ALL_1272_GSE29618_BCELL_VS_PDC_DN",197,-2.5557,0,0,"No",0.7606,0.98,1,"Yes"
"63","C4_Cancer_modules","C4_CM_156_MODULE_165",76,-2.5547,0,0,"No",-0.9183,0.62,0.88,"No"
"64","C2_Chemical_and_genetic_perturbations","C2_CGP_1984_MCLACHLAN_DENTAL_CARIES_UP",239,-2.5544,0,0,"No",0.9099,0.75,0.91,"Yes"
"65","C7_Immunologic_signatures","C7_ALL_1064_GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN",199,-2.5503,0,0,"No",-0.6924,1,1,"No"
"66","C0_Hallmark","H_ALL_31_HALLMARK_INFLAMMATORY_RESPONSE",196,-2.55,0,0,"No",0.8484,0.9,1,"Yes"
"67","C4_Cancer_gene_neighborhoods","C4_CGN_352_GNF2_FGR",32,-2.5392,0,0,"No",-0.3997,1,1,"No"
"68","C7_Immunologic_signatures","C7_ALL_1631_GSE3982_DC_VS_BCELL_UP",196,-2.5256,0,0,"No",0.7754,0.98,1,"Yes"
"69","C7_Immunologic_signatures","C7_ALL_961_GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP",200,-2.5233,0,0,"No",1.1998,0.086,0.23,"Yes"
"70","C2_Chemical_and_genetic_perturbations","C2_CGP_160_GAL_LEUKEMIC_STEM_CELL_DN",234,-2.5231,0,0,"No",-1.0513,0.31,0.97,"No"
"71","C7_Immunologic_signatures","C7_ALL_4_KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN",198,-2.5211,0,0,"No",0.938,0.64,0.94,"Yes"
"72","C4_Cancer_gene_neighborhoods","C4_CGN_420_GNF2_TNFSF10",30,-2.5206,0,0,"No",0.6218,0.97,1,"Yes"
"73","C2_Chemical_and_genetic_perturbations","C2_CGP_3056_VERHAAK_GLIOBLASTOMA_MESENCHYMAL",216,-2.5186,0,0,"No",0.8439,0.9,0.97,"Yes"
"74","GO_BP","511686_GO_0050715_POSITIVE_REGULATION_OF_CYTOKINE_SECRETION",72,-2.513,0,0,"No",-1.1769,0.2,0.9,"No"
"75","C4_Cancer_gene_neighborhoods","C4_CGN_366_GNF2_ITGB2",57,-2.5111,0,0,"No",-0.4994,1,1,"No"
"76","C2_Chemical_and_genetic_perturbations","C2_CGP_3375_GHANDHI_BYSTANDER_IRRADIATION_UP",83,-2.5092,0,0,"No",-1.6594,0.0018,0.38,"No"
"77","C7_Immunologic_signatures","C7_ALL_1090_GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN",199,-2.5081,0,0,"No",-0.8276,0.89,1,"No"
"78","C4_Cancer_modules","C4_CM_70_MODULE_75",381,-2.5031,0,0,"No",1.1802,0.05,0.41,"Yes"
"79","C7_Immunologic_signatures","C7_ALL_1114_GSE2706_UNSTIM_VS_2H_R848_DC_DN",189,-2.4972,0,0,"No",-1.6907,0,0.0031,"No"
"80","C2_Chemical_and_genetic_perturbations","C2_CGP_1510_LENAOUR_DENDRITIC_CELL_MATURATION_DN",128,-2.4972,0,0,"No",-0.8547,0.82,1,"No"
"81","C2_Chemical_and_genetic_perturbations","C2_CGP_2550_RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP",406,-2.4942,0,0,"No",0.6886,1,1,"Yes"
"82","C7_Immunologic_signatures","C7_ALL_941_GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP",198,-2.4925,0,0,"No",1.0673,0.28,0.53,"Yes"
"83","C7_Immunologic_signatures","C7_ALL_992_GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN",193,-2.4891,0,0,"No",-0.8635,0.81,1,"No"
"84","C7_Immunologic_signatures","C7_ALL_16_GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN",199,-2.4862,0,0,"No",-0.7341,0.99,1,"No"
"85","C7_Immunologic_signatures","C7_ALL_1637_GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP",199,-2.4857,0,0,"No",-0.8296,0.92,1,"No"
"86","C2_Chemical_and_genetic_perturbations","C2_CGP_1832_MCLACHLAN_DENTAL_CARIES_DN",234,-2.4851,0,0,"No",0.9588,0.58,0.86,"Yes"
"87","C7_Immunologic_signatures","C7_ALL_1060_GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN",197,-2.4828,0,0,"No",-0.8194,0.91,1,"No"
"88","C7_Immunologic_signatures","C7_ALL_986_GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN",186,-2.4811,0,0,"No",-0.8321,0.88,1,"No"
"89","C4_Cancer_modules","C4_CM_42_MODULE_46",374,-2.4701,0,0,"No",1.1663,0.083,0.44,"Yes"
"90","GO_BP","516145_GO_0071219_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN",120,-2.4697,0,0,"No",-1.0506,0.35,0.97,"No"
"91","C2_Chemical_and_genetic_perturbations","C2_CGP_2513_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP",130,-2.4679,0,0,"No",1.0797,0.25,0.67,"Yes"
"92","C2_Chemical_and_genetic_perturbations","C2_CGP_1491_NEMETH_INFLAMMATORY_RESPONSE_LPS_UP",88,-2.4663,0,0,"No",-1.2303,0.14,0.77,"No"
"93","GO_BP","516148_GO_0071222_CELLULAR_RESPONSE_TO_LIPOPOLYSACCHARIDE",113,-2.4509,0,0,"No",-0.9965,0.46,0.99,"No"
"94","C2_Chemical_and_genetic_perturbations","C2_CGP_360_HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP",62,-2.4508,0,0,"No",-1.3845,0.054,0.61,"No"
"95","C7_Immunologic_signatures","C7_ALL_6_KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN",198,-2.4481,0,0,"No",0.7683,0.99,1,"Yes"
"96","GO_BP","501901_GO_0032675_REGULATION_OF_INTERLEUKIN_6_PRODUCTION",87,-2.4407,0,0,"No",-1.1039,0.26,0.94,"No"
"97","C2_Chemical_and_genetic_perturbations","C2_CGP_219_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN",204,-2.4405,0,0,"No",0.9367,0.68,0.88,"Yes"
"98","WikiPathways","198912_WP98_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION",30,-2.4397,0,0,"No",-0.9298,0.55,1,"No"
"99","GO_BP","516142_GO_0071216_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS",139,-2.4392,0,0,"No",-1.1246,0.2,0.94,"No"
"100","C2_Chemical_and_genetic_perturbations","C2_CGP_1284_ROSS_AML_WITH_CBFB_MYH11_FUSION",51,-2.4371,0,0,"No",-0.9599,0.52,1,"No"
"101","C7_Immunologic_signatures","C7_ALL_14_GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN",198,-2.4332,0,0,"No",1.0079,0.44,0.71,"Yes"
"102","C7_Immunologic_signatures","C7_ALL_982_GSE22886_NAIVE_BCELL_VS_DC_DN",199,-2.4272,0,0,"No",-0.5703,1,1,"No"
"103","KEGG_pathway","HSA05134_LEGIONELLOSIS",55,-2.4262,0,0,"No",-1.397,0.048,0.38,"No"
"104","C4_Cancer_modules","C4_CM_5_MODULE_5",426,-2.4241,0,0,"No",1.0123,0.4,0.71,"Yes"
"105","C7_Immunologic_signatures","C7_ALL_976_GSE22886_NAIVE_TCELL_VS_DC_DN",200,-2.4224,0,0,"No",-0.6838,1,1,"No"
"106","C7_Immunologic_signatures","C7_ALL_1901_GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP",195,-2.4217,0,0,"No",-1.2809,0.048,0.51,"No"
"107","C4_Cancer_gene_neighborhoods","C4_CGN_394_GNF2_PTPN4",49,-2.4197,0,0,"No",0.8396,0.75,0.94,"Yes"
"108","C7_Immunologic_signatures","C7_ALL_1068_GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN",200,-2.4176,0,0,"No",-1.1837,0.12,0.88,"No"
"109","C4_Cancer_gene_neighborhoods","C4_CGN_333_GNF2_CD7",38,-2.417,0,0,"No",0.9625,0.51,0.67,"Yes"
"110","C7_Immunologic_signatures","C7_ALL_1078_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN",199,-2.4145,0,0,"No",-0.6617,1,1,"No"
"111","C7_Immunologic_signatures","C7_ALL_334_GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN",199,-2.4141,0,0,"No",-1.7053,0,0.0028,"No"
"112","C7_Immunologic_signatures","C7_ALL_1056_GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN",200,-2.4135,0,0,"No",0.8463,0.89,1,"Yes"
"113","C7_Immunologic_signatures","C7_ALL_1647_GSE3982_MAC_VS_BCELL_UP",197,-2.4062,0,0,"No",-0.7665,0.98,1,"No"
"114","C7_Immunologic_signatures","C7_ALL_1577_GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP",194,-2.405,0,0,"No",0.9744,0.52,0.82,"Yes"
"115","C2_Chemical_and_genetic_perturbations","C2_CGP_2904_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP",71,-2.4044,0,0,"No",-0.8186,0.81,1,"No"
"116","C7_Immunologic_signatures","C7_ALL_336_GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN",198,-2.4016,0,0,"No",-1.5881,0,0.02,"No"
"117","C2_Chemical_and_genetic_perturbations","C2_CGP_1652_RAMALHO_STEMNESS_DN",74,-2.4009,0,0,"No",-1.1733,0.18,0.82,"No"
"118","C7_Immunologic_signatures","C7_ALL_1137_GSE2706_2H_VS_8H_R848_STIM_DC_UP",193,-2.4009,0,0,"No",-1.2584,0.065,0.59,"No"
"119","C4_Cancer_gene_neighborhoods","C4_CGN_363_GNF2_IL2RB",45,-2.3994,0,0,"No",0.8842,0.69,0.86,"Yes"
"120","C7_Immunologic_signatures","C7_ALL_1635_GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP",199,-2.397,0,0,"No",0.6528,1,1,"Yes"
"121","REACTOME","106413_REACT_11152_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL",67,-2.396,0,0,"No",1.1322,0.23,0.54,"Yes"
"122","C7_Immunologic_signatures","C7_ALL_60_GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN",195,-2.3959,0,0,"No",-0.7093,1,1,"No"
"123","C7_Immunologic_signatures","C7_ALL_1025_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP",195,-2.3947,0,0,"No",-1.021,0.4,1,"No"
"124","GO_BP","501981_GO_0032755_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION",55,-2.3875,0,0,"No",-1.1156,0.26,0.94,"No"
"125","C2_Chemical_and_genetic_perturbations","C2_CGP_1349_WIELAND_UP_BY_HBV_INFECTION",100,-2.3861,0,0,"No",0.9035,0.68,0.92,"Yes"
"126","C7_Immunologic_signatures","C7_ALL_1073_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP",197,-2.3768,0,0,"No",-0.8424,0.86,1,"No"
"127","C2_Chemical_and_genetic_perturbations","C2_CGP_2410_QI_PLASMACYTOMA_UP",258,-2.3755,0,0,"No",1.0259,0.37,0.76,"Yes"
"128","C2_Chemical_and_genetic_perturbations","C2_CGP_334_GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP",65,-2.3747,0,0,"No",-1.0093,0.43,0.99,"No"
"129","C2_Chemical_and_genetic_perturbations","C2_CGP_1564_TAVOR_CEBPA_TARGETS_UP",48,-2.373,0,0,"No",-0.6367,0.98,1,"No"
"130","C7_Immunologic_signatures","C7_ALL_1023_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP",196,-2.372,0,0,"No",-0.7558,0.99,1,"No"
"131","C7_Immunologic_signatures","C7_ALL_1870_GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN",198,-2.3713,0,0,"No",1.2168,0.073,0.2,"Yes"
"132","C2_Chemical_and_genetic_perturbations","C2_CGP_2528_PARK_APL_PATHOGENESIS_DN",49,-2.3669,0,0,"No",-0.6645,0.97,1,"No"
"133","C4_Cancer_modules","C4_CM_59_MODULE_63",207,-2.3618,0,0,"No",-1.2681,0.041,0.57,"No"
"134","C2_Chemical_and_genetic_perturbations","C2_CGP_2515_LINDSTEDT_DENDRITIC_CELL_MATURATION_A",66,-2.3584,0,0,"No",-1.036,0.4,0.97,"No"
"135","C2_Chemical_and_genetic_perturbations","C2_CGP_1787_LIAN_LIPA_TARGETS_3M",59,-2.3497,0,0,"No",1.0253,0.4,0.76,"Yes"
"136","C2_Chemical_and_genetic_perturbations","C2_CGP_1172_ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP",219,-2.3455,0,0,"No",-1.0107,0.43,0.99,"No"
"137","C2_Chemical_and_genetic_perturbations","C2_CGP_1341_FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP",86,-2.3421,0,0,"No",1.3679,0.027,0.32,"Yes"
"138","GO_BP","491964_GO_0007159_LEUKOCYTE_CELL_CELL_ADHESION",258,-2.3412,0,0,"No",-0.7505,1,1,"No"
"139","KEGG_compound","C07645_ALDOPHOSPHAMIDE",27,-2.3376,0,0,"No",-1.8616,0.0018,0.011,"No"
"140","C2_Chemical_and_genetic_perturbations","C2_CGP_214_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP",85,-2.3336,0,0,"No",0.9382,0.6,0.88,"Yes"
"141","C2_Chemical_and_genetic_perturbations","C2_CGP_423_MARKEY_RB1_ACUTE_LOF_UP",214,-2.3334,0,0,"No",1.1222,0.17,0.6,"Yes"
"142","C7_Immunologic_signatures","C7_ALL_988_GSE22886_NAIVE_CD8_TCELL_VS_DC_DN",199,-2.3321,0,0,"No",0.6525,1,1,"Yes"
"143","C7_Immunologic_signatures","C7_ALL_1874_GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN",199,-2.3318,0,0,"No",0.8235,0.92,1,"Yes"
"144","GO_BP","511678_GO_0050707_REGULATION_OF_CYTOKINE_SECRETION",112,-2.3303,0,0.00015,"No",-0.8554,0.79,1,"No"
"145","C7_Immunologic_signatures","C7_ALL_994_GSE22886_NAIVE_CD4_TCELL_VS_DC_DN",200,-2.3268,0,0,"No",0.9753,0.51,0.82,"Yes"
"146","C2_Chemical_and_genetic_perturbations","C2_CGP_2174_WALLACE_PROSTATE_CANCER_RACE_UP",285,-2.326,0,0,"No",1.1873,0.076,0.51,"Yes"
"147","C7_Immunologic_signatures","C7_ALL_1122_GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN",190,-2.3225,0,0,"No",-1.262,0.056,0.58,"No"
"148","C2_Chemical_and_genetic_perturbations","C2_CGP_508_DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP",50,-2.3213,0,0,"No",1.1436,0.25,0.56,"Yes"
"149","C7_Immunologic_signatures","C7_ALL_2_KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN",200,-2.319,0,0,"No",1.3848,0.012,0.043,"Yes"
"150","C2_Chemical_and_genetic_perturbations","C2_CGP_1504_HALMOS_CEBPA_TARGETS_UP",51,-2.3189,0,0,"No",-1.0589,0.35,0.97,"No"
"151","C2_Chemical_and_genetic_perturbations","C2_CGP_1447_NADLER_OBESITY_UP",59,-2.315,0,0,"No",0.8776,0.71,0.94,"Yes"
"152","C2_Chemical_and_genetic_perturbations","C2_CGP_2472_BOYLAN_MULTIPLE_MYELOMA_C_D_DN",249,-2.3128,0,0,"No",1.0627,0.27,0.69,"Yes"
"153","C7_Immunologic_signatures","C7_ALL_1758_GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN",162,-2.3122,0,0,"No",0.8407,0.88,1,"Yes"
"154","C7_Immunologic_signatures","C7_ALL_1118_GSE2706_UNSTIM_VS_2H_LPS_DC_DN",190,-2.31,0,0,"No",-1.4021,0.016,0.23,"No"
"155","C2_Chemical_and_genetic_perturbations","C2_CGP_221_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN",140,-2.3075,0,0,"No",1.1283,0.2,0.59,"Yes"
"156","C7_Immunologic_signatures","C7_ALL_1088_GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN",197,-2.3065,0,0,"No",-0.8045,0.93,1,"No"
"157","C2_Chemical_and_genetic_perturbations","C2_CGP_2699_POOLA_INVASIVE_BREAST_CANCER_UP",273,-2.3027,0,0,"No",1.1008,0.19,0.63,"Yes"
"158","C4_Cancer_gene_neighborhoods","C4_CGN_334_GNF2_CD97",38,-2.2985,0,0,"No",-0.6695,0.96,1,"No"
"159","C7_Immunologic_signatures","C7_ALL_1553_GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP",196,-2.297,0,0,"No",-0.9578,0.54,1,"No"
"160","C2_Chemical_and_genetic_perturbations","C2_CGP_222_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP",171,-2.2963,0,0,"No",1.3417,0.015,0.35,"Yes"
"161","C7_Immunologic_signatures","C7_ALL_1889_GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP",198,-2.2959,0,0,"No",-1.0349,0.35,1,"No"
"162","KEGG_compound","C14786__1R_2S_NAPHTHALENE_1_2_OXIDE_1R_2S_NAPHTHALENE_EPOXIDE",25,-2.2953,0,0,"No",-2.0603,0,0.012,"No"
"163","GO_BP","491808_GO_0006968_CELLULAR_DEFENSE_RESPONSE",55,-2.295,0,0.00013,"No",0.85,0.76,1,"Yes"
"164","GO_BP","515418_GO_0070486_LEUKOCYTE_AGGREGATION",225,-2.2897,0,0.00012,"No",-0.7954,0.96,1,"No"
"165","C4_Cancer_modules","C4_CM_160_MODULE_170",98,-2.2889,0,0,"No",1.2847,0.066,0.3,"Yes"
"166","GO_BP","507785_GO_0045428_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",47,-2.2858,0,0.00011,"No",-1.2547,0.14,0.91,"No"
"167","C2_Chemical_and_genetic_perturbations","C2_CGP_2510_GOLDRATH_ANTIGEN_RESPONSE",344,-2.2846,0,0,"No",1.2193,0.034,0.47,"Yes"
"168","C7_Immunologic_signatures","C7_ALL_72_GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN",197,-2.2823,0,0,"No",0.6563,1,1,"Yes"
"169","GO_BP","491798_GO_0006954_INFLAMMATORY_RESPONSE",413,-2.2823,0,1e-04,"No",-1.1551,0.097,0.92,"No"
"170","GO_BP","754528_GO_1901568_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS",94,-2.2793,0,9.3e-05,"No",-1.0232,0.39,0.97,"No"
"171","C2_Chemical_and_genetic_perturbations","C2_CGP_1521_GERY_CEBP_TARGETS",125,-2.2789,0,0,"No",-1.3678,0.022,0.64,"No"
"172","C7_Immunologic_signatures","C7_ALL_1895_GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP",195,-2.277,0,0,"No",-0.8982,0.75,1,"No"
"173","C2_BioCarta_Pathways","C2_CP_BIOCARTA_6_BIOCARTA_GRANULOCYTES_PATHWAY",14,-2.2766,0,0,"No",-1.2011,0.24,1,"No"
"174","GO_BP","499914_GO_0030593_NEUTROPHIL_CHEMOTAXIS",42,-2.2763,0,8.6e-05,"No",-1.0824,0.34,0.95,"No"
"175","C7_Immunologic_signatures","C7_ALL_1822_GSE7852_LN_VS_FAT_TCONV_DN",200,-2.2758,0,0,"No",-0.7704,0.96,1,"No"
"176","GO_BP","505284_GO_0042108_POSITIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS",58,-2.2751,0,8.1e-05,"No",-1.2102,0.15,0.88,"No"
"177","C4_Cancer_modules","C4_CM_71_MODULE_76",76,-2.2742,0,0,"No",1.2035,0.14,0.39,"Yes"
"178","KEGG_compound","C14802_1_NITRONAPHTHALENE_7_8_OXIDE",19,-2.2734,0,0,"No",-1.9333,0,0.0045,"No"
"179","C7_Immunologic_signatures","C7_ALL_1676_GSE3982_BCELL_VS_BASOPHIL_DN",197,-2.2728,0,0,"No",0.9517,0.6,0.89,"Yes"
"180","C2_Chemical_and_genetic_perturbations","C2_CGP_2549_RUTELLA_RESPONSE_TO_HGF_DN",234,-2.2712,0,2.7e-05,"No",-0.997,0.45,1,"No"
"181","C4_Cancer_gene_neighborhoods","C4_CGN_409_GNF2_SPI1",34,-2.2706,0,0,"No",0.6357,0.96,1,"Yes"
"182","C2_BioCarta_Pathways","C2_CP_BIOCARTA_47_BIOCARTA_CTL_PATHWAY",13,-2.2706,0,0,"No",1.3466,0.12,0.52,"Yes"
"183","C2_Chemical_and_genetic_perturbations","C2_CGP_2548_RUTELLA_RESPONSE_TO_HGF_UP",413,-2.2701,0,2.6e-05,"No",0.7779,1,1,"Yes"
"184","C4_Cancer_gene_neighborhoods","C4_CGN_384_GNF2_MYD88",60,-2.2689,0,0,"No",1.1115,0.26,0.35,"Yes"
"185","C2_Chemical_and_genetic_perturbations","C2_CGP_304_NAGASHIMA_EGF_SIGNALING_UP",58,-2.2686,0,2.6e-05,"No",-2.0267,0,0.075,"No"
"186","C7_Immunologic_signatures","C7_ALL_972_GSE22886_DC_VS_MONOCYTE_DN",199,-2.2661,0,0,"No",0.8456,0.89,1,"Yes"
"187","C2_Chemical_and_genetic_perturbations","C2_CGP_3063_WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP",376,-2.2655,0,2.5e-05,"No",-0.9387,0.65,1,"No"
"188","KEGG_pathway","HSA04640_HEMATOPOIETIC_CELL_LINEAGE",85,-2.2636,0,0,"No",1.018,0.42,0.85,"Yes"
"189","C2_Chemical_and_genetic_perturbations","C2_CGP_1146_AMIT_SERUM_RESPONSE_40_MCF10A",32,-2.2612,0,2.5e-05,"No",-1.7411,0.008,0.35,"No"
"190","C2_Chemical_and_genetic_perturbations","C2_CGP_2983_DAZARD_UV_RESPONSE_CLUSTER_G28",20,-2.2612,0,2.4e-05,"No",-1.9245,0.002,0.1,"No"
"191","GO_BP","946597_GO_1990266_NEUTROPHIL_MIGRATION",44,-2.2604,0,7.6e-05,"No",-0.9868,0.47,1,"No"
"192","C1_Positional","C1_ALL_235_CHR11Q11",46,-2.2592,0,0.00097,"No",2.2543,0,0,"Yes"
"193","REACTOME","1127556_REACT_264075_ATTENUATION_PHASE",14,-2.259,0,0,"No",-2.0208,0,0.025,"No"
"194","C7_Immunologic_signatures","C7_ALL_1267_GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP",187,-2.2563,0,0,"No",0.8872,0.81,1,"Yes"
"195","GO_BP","516517_GO_0071593_LYMPHOCYTE_AGGREGATION",219,-2.2559,0,7.1e-05,"No",-0.7694,0.99,1,"No"
"196","GO_BP","489292_GO_0042026_PROTEIN_REFOLDING",22,-2.254,0,6.7e-05,"No",-1.8117,0,0.43,"No"
"197","C7_Immunologic_signatures","C7_ALL_17_GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP",200,-2.2529,0,0,"No",0.9556,0.57,0.88,"Yes"
"198","C2_Chemical_and_genetic_perturbations","C2_CGP_3269_HUANG_GATA2_TARGETS_UP",147,-2.252,0,2.4e-05,"No",0.9688,0.54,0.84,"Yes"
"199","C4_Cancer_modules","C4_CM_116_MODULE_121",93,-2.2505,0,0,"No",-0.937,0.59,0.89,"No"
"200","KEGG_compound","C06790_TRICHLOROETHENE_TRICHLOROETHYLENE_TCE",19,-2.2503,0,0,"No",-1.9838,0.0019,0.0019,"No"
"201","GO_BP","503315_GO_0034109_HOMOTYPIC_CELL_CELL_ADHESION",275,-2.2489,0,6.4e-05,"No",0.9337,0.69,1,"Yes"
"202","C7_Immunologic_signatures","C7_ALL_62_GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN",198,-2.2487,0,0,"No",-0.5612,1,1,"No"
"203","C2_Chemical_and_genetic_perturbations","C2_CGP_2518_LINDSTEDT_DENDRITIC_CELL_MATURATION_D",67,-2.2482,0,4.6e-05,"No",0.8078,0.85,0.99,"Yes"
"204","KEGG_compound","C14787__1S_2R_NAPHTHALENE_1_2_OXIDE_1S_2R_NAPHTHALENE_EPOXIDE",24,-2.2467,0,0,"No",-2.0279,0,0.0034,"No"
"205","C7_Immunologic_signatures","C7_ALL_944_GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN",195,-2.2427,0,0,"No",0.7947,0.96,1,"Yes"
"206","GO_BP","505286_GO_0042110_T_CELL_ACTIVATION",217,-2.2424,0,0.00018,"No",-0.7584,0.99,1,"No"
"207","GO_BP","515421_GO_0070489_T_CELL_AGGREGATION",217,-2.2394,0,0.00017,"No",-0.7625,0.98,1,"No"
"208","C2_Chemical_and_genetic_perturbations","C2_CGP_357_HAHTOLA_SEZARY_SYNDROM_DN",39,-2.2384,0,4.5e-05,"No",0.7448,0.89,1,"Yes"
"209","C2_BioCarta_Pathways","C2_CP_BIOCARTA_192_BIOCARTA_THELPER_PATHWAY",12,-2.2376,0,0,"No",1.4928,0.064,0.37,"Yes"
"210","GO_BP","491578_GO_0006690_ICOSANOID_METABOLIC_PROCESS",93,-2.2368,0,0.00016,"No",-1.041,0.37,0.98,"No"
"211","C6_Oncogenic_signatures","C6_ALL_132_RPS14_DN_V1_UP",186,-2.2323,0,0,"No",0.9318,0.64,0.91,"Yes"
"212","C7_Immunologic_signatures","C7_ALL_939_GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP",199,-2.2323,0,0,"No",1.0582,0.29,0.56,"Yes"
"213","REACTOME","105721_REACT_6959_PHASE_II_CONJUGATION",89,-2.2302,0,0,"No",-1.0309,0.39,0.97,"No"
"214","C7_Immunologic_signatures","C7_ALL_946_GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN",196,-2.2292,0,0,"No",0.8678,0.83,1,"Yes"
"215","C6_Oncogenic_signatures","C6_ALL_70_RAF_UP_V1_UP",188,-2.228,0,0,"No",-0.7488,0.99,1,"No"
"216","C4_Cancer_modules","C4_CM_208_MODULE_223",136,-2.2274,0,0,"No",0.9338,0.63,0.81,"Yes"
"217","C2_Chemical_and_genetic_perturbations","C2_CGP_1657_LIAN_LIPA_TARGETS_6M",74,-2.2274,0,6.7e-05,"No",1.0147,0.41,0.78,"Yes"
"218","C7_Immunologic_signatures","C7_ALL_332_GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN",199,-2.2274,0,0,"No",-1.731,0,0.0018,"No"
"219","GO_BP","513882_GO_0060326_CELL_CHEMOTAXIS",146,-2.2271,0,0.00026,"No",1.0248,0.38,0.97,"Yes"
"220","GO_BP","505226_GO_0042035_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS",93,-2.2271,0,0.00025,"No",-1.0257,0.41,0.97,"No"
"221","GO_BP","493740_GO_0009620_RESPONSE_TO_FUNGUS",37,-2.2271,0,0.00024,"No",1.3832,0.048,0.57,"Yes"
"222","KEGG_pathway","HSA05162_MEASLES",130,-2.2256,0,0,"No",-0.8625,0.79,1,"No"
"223","C2_Chemical_and_genetic_perturbations","C2_CGP_2681_VALK_AML_CLUSTER_5",33,-2.2237,0,6.6e-05,"No",-0.7412,0.86,1,"No"
"224","KEGG_compound","C14839_BROMOBENZENE_3_4_OXIDE_BROMOBENZENE_3_4_EPOXIDE",18,-2.2234,0,0,"No",-1.8811,0,0.0087,"No"
"225","C4_Cancer_modules","C4_CM_123_MODULE_128",95,-2.2229,0,0,"No",1.3117,0.056,0.26,"Yes"
"226","C7_Immunologic_signatures","C7_ALL_937_GSE22886_TCELL_VS_BCELL_NAIVE_UP",198,-2.2211,0,0,"No",1.3752,0.0096,0.048,"Yes"
"227","C0_Hallmark","H_ALL_23_HALLMARK_COMPLEMENT",199,-2.2206,0,0,"No",0.6704,1,0.99,"Yes"
"228","C2_Chemical_and_genetic_perturbations","C2_CGP_2847_HOSHIDA_LIVER_CANCER_SUBCLASS_S1",234,-2.2203,0,6.5e-05,"No",0.9939,0.46,0.81,"Yes"
"229","C7_Immunologic_signatures","C7_ALL_1669_GSE3982_NEUTROPHIL_VS_NKCELL_UP",199,-2.2201,0,0,"No",0.8858,0.8,1,"Yes"
"230","C2_Chemical_and_genetic_perturbations","C2_CGP_263_PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP",52,-2.2187,0,6.4e-05,"No",0.8209,0.79,0.98,"Yes"
"231","C2_Chemical_and_genetic_perturbations","C2_CGP_2223_WORSCHECH_TUMOR_REJECTION_UP",53,-2.2181,0,8.3e-05,"No",-1.0149,0.4,0.98,"No"
"232","C2_Chemical_and_genetic_perturbations","C2_CGP_2500_SEKI_INFLAMMATORY_RESPONSE_LPS_UP",77,-2.2178,0,8.2e-05,"No",-1.2911,0.083,0.7,"No"
"233","KEGG_compound","C14870_2_BROMOACETALDEHYDE",17,-2.2171,0,0,"No",-1.9519,0,0.0033,"No"
"234","GO_BP","511700_GO_0050729_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE",88,-2.2146,0,0.00023,"No",-0.9662,0.53,1,"No"
"235","C7_Immunologic_signatures","C7_ALL_1756_GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN",172,-2.2138,0,0,"No",-0.807,0.92,1,"No"
"236","C2_Chemical_and_genetic_perturbations","C2_CGP_3328_BOSCO_TH1_CYTOTOXIC_MODULE",112,-2.2129,0,1e-04,"No",0.9301,0.62,0.89,"Yes"
"237","GO_BP","494734_GO_2000379_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",74,-2.2128,0,0.00022,"No",-0.9402,0.58,1,"No"
"238","C7_Immunologic_signatures","C7_ALL_1891_GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP",194,-2.2126,0,0,"No",0.8912,0.79,1,"Yes"
"239","GO_BP","751072_GO_0036152_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING",22,-2.2111,0,0.00022,"No",-0.9257,0.58,1,"No"
"240","GO_BP","501728_GO_0032496_RESPONSE_TO_LIPOPOLYSACCHARIDE",250,-2.2107,0,0.00021,"No",-0.8291,0.93,1,"No"
"241","GO_BP","502776_GO_0033559_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS",105,-2.2101,0,2e-04,"No",-1.0782,0.29,0.95,"No"
"242","C2_Chemical_and_genetic_perturbations","C2_CGP_251_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN",183,-2.2092,0,9.9e-05,"No",0.862,0.85,0.96,"Yes"
"243","GO_MF","489730_GO_0004364_GLUTATHIONE_TRANSFERASE_ACTIVITY",21,-2.2088,0,0.0023,"No",-1.844,0.0038,0.15,"No"
"244","C2_Chemical_and_genetic_perturbations","C2_CGP_3304_GUILLAUMOND_KLF10_TARGETS_DN",30,-2.2081,0,9.8e-05,"No",-1.0169,0.43,0.99,"No"
"245","GO_BP","1047426_GO_1903426_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",54,-2.2065,0,0.00019,"No",-1.1911,0.19,0.9,"No"
"246","C7_Immunologic_signatures","C7_ALL_974_GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN",193,-2.2044,0,0,"No",0.959,0.57,0.87,"Yes"
"247","GO_BP","516545_GO_0071621_GRANULOCYTE_CHEMOTAXIS",49,-2.2043,0,0.00019,"No",-0.7349,0.91,1,"No"
"248","C2_Chemical_and_genetic_perturbations","C2_CGP_1979_DAZARD_UV_RESPONSE_CLUSTER_G2",30,-2.2036,0,9.6e-05,"No",-1.5571,0.023,0.43,"No"
"249","GO_BP","487587_GO_0001676_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS",96,-2.203,0,0.00018,"No",-1.0385,0.37,0.98,"No"
"250","KEGG_compound","C14857_1_1_DICHLOROETHYLENE_EPOXIDE_2_2_DICHLOROOXIRANE",17,-2.2027,0,0,"No",-2.0077,0.0018,0.0025,"No"
"251","C2_BioCarta_Pathways","C2_CP_BIOCARTA_191_BIOCARTA_TCYTOTOXIC_PATHWAY",12,-2.2017,0,0,"No",1.6755,0.01,0.26,"Yes"
"252","C2_Chemical_and_genetic_perturbations","C2_CGP_302_NAGASHIMA_NRG1_SIGNALING_UP",174,-2.2011,0,9.5e-05,"No",-1.7127,0,0.34,"No"
"253","C2_Chemical_and_genetic_perturbations","C2_CGP_1833_BURTON_ADIPOGENESIS_PEAK_AT_2HR",51,-2.2009,0,9.3e-05,"No",-1.578,0.011,0.46,"No"
"254","GO_BP","488111_GO_0002237_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN",263,-2.1988,0,0.00018,"No",-0.8595,0.89,1,"No"
"255","C2_Chemical_and_genetic_perturbations","C2_CGP_2572_HINATA_NFKB_TARGETS_KERATINOCYTE_UP",89,-2.1988,0,9.2e-05,"No",-0.9678,0.52,1,"No"
"256","C7_Immunologic_signatures","C7_ALL_1555_GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP",193,-2.198,0,0,"No",-0.9319,0.63,1,"No"
"257","GO_BP","507786_GO_0045429_POSITIVE_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",36,-2.1975,0,0.00017,"No",-0.8271,0.76,1,"No"
"258","KEGG_compound","C14858_2_2_DICHLOROACETALDEHYDE",17,-2.1964,0,0,"No",-1.9844,0,0.002,"No"
"259","C2_Chemical_and_genetic_perturbations","C2_CGP_1520_THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP",77,-2.1936,0,9.1e-05,"No",0.8752,0.73,0.95,"Yes"
"260","KEGG_compound","C13645_HYDROBROMIC_ACID_HBR",17,-2.1932,0,0.00014,"No",-1.9748,0,0.0024,"No"
"261","C4_Cancer_modules","C4_CM_87_MODULE_92",138,-2.1928,0,0.00011,"No",-1.3598,0.02,0.53,"No"
"262","KEGG_pathway","HSA00980_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450",70,-2.1924,0,0,"No",-1.3416,0.049,0.34,"No"
"263","C7_Immunologic_signatures","C7_ALL_1027_GSE24142_DN2_VS_DN3_THYMOCYTE_UP",197,-2.1922,0,0,"No",-0.7221,0.99,1,"No"
"264","KEGG_pathway","HSA04650_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",123,-2.1907,0,0,"No",-0.7641,0.96,1,"No"
"265","C4_Cancer_modules","C4_CM_103_MODULE_108",49,-2.1883,0,2e-04,"No",1.6302,0.0066,0.063,"Yes"
"266","C2_Chemical_and_genetic_perturbations","C2_CGP_3313_PHONG_TNF_RESPONSE_VIA_P38_PARTIAL",160,-2.188,0,8.9e-05,"No",-1.5104,0.0018,0.45,"No"
"267","GO_BP","911357_GO_0097530_GRANULOCYTE_MIGRATION",53,-2.1876,0,0.00017,"No",0.8487,0.76,1,"Yes"
"268","C2_Chemical_and_genetic_perturbations","C2_CGP_2805_KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS",44,-2.1866,0,8.8e-05,"No",1.2716,0.12,0.42,"Yes"
"269","GO_BP","496376_GO_0016337_SINGLE_ORGANISMAL_CELL_CELL_ADHESION",437,-2.1864,0,2e-04,"No",-0.8683,0.91,1,"No"
"270","C0_Hallmark","H_ALL_10_HALLMARK_APOPTOSIS",160,-2.1858,0,0,"No",-1.0532,0.34,0.86,"No"
"271","KEGG_pathway","HSA05133_PERTUSSIS",73,-2.1849,0,0,"No",-1.3821,0.044,0.34,"No"
"272","KEGG_compound","C14859_CHLOROACETYL_CHLORIDE",17,-2.184,0,0.00013,"No",-2.0259,0,0.0028,"No"
"273","C4_Cancer_modules","C4_CM_162_MODULE_172",93,-2.1837,0,0.00018,"No",1.0103,0.45,0.7,"Yes"
"274","GO_BP","511698_GO_0050727_REGULATION_OF_INFLAMMATORY_RESPONSE",251,-2.1837,0,0.00022,"No",-0.8095,0.95,1,"No"
"275","C2_Chemical_and_genetic_perturbations","C2_CGP_519_MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN",61,-2.1833,0,8.7e-05,"No",1.0582,0.31,0.7,"Yes"
"276","C2_Chemical_and_genetic_perturbations","C2_CGP_1339_YAGI_AML_RELAPSE_PROGNOSIS",35,-2.1824,0,8.6e-05,"No",-0.6402,0.95,1,"No"
"277","GO_BP","498212_GO_0019369_ARACHIDONIC_ACID_METABOLIC_PROCESS",62,-2.1822,0,0.00022,"No",-1.1249,0.24,0.94,"No"
"278","KEGG_pathway","HSA05204_CHEMICAL_CARCINOGENESIS",77,-2.182,0,0,"No",-1.2055,0.16,0.53,"No"
"279","GO_BP","754690_GO_1901739_REGULATION_OF_MYOBLAST_FUSION",17,-2.1819,0,0.00021,"No",1.1493,0.26,0.84,"Yes"
"280","C2_Chemical_and_genetic_perturbations","C2_CGP_97_FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN",454,-2.1806,0,8.4e-05,"No",-0.6357,1,1,"No"
"281","KEGG_compound","C14800_1_NITRONAPHTHALENE_5_6_OXIDE",20,-2.1801,0,0.00012,"No",-1.8882,0,0.008,"No"
"282","C7_Immunologic_signatures","C7_ALL_389_GSE15767_MED_VS_SCS_MAC_LN_UP",200,-2.18,0,0,"No",-0.9504,0.59,1,"No"
"283","GO_BP","982307_GO_0098602_SINGLE_ORGANISM_CELL_ADHESION",486,-2.1794,0,0.00021,"No",-0.9686,0.58,1,"No"
"284","GO_BP","517936_GO_2000377_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",129,-2.1783,0,0.00026,"No",-1.0632,0.35,0.96,"No"
"285","C4_Cancer_modules","C4_CM_256_MODULE_291",65,-2.1774,0,0.00017,"No",1.0431,0.34,0.64,"Yes"
"286","GO_BP","501340_GO_0032103_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS",221,-2.1773,0,0.00028,"No",-0.9434,0.62,1,"No"
"287","KEGG_compound","C11088_1_2_DIBROMOETHANE_ETHYLENE_DIBROMIDE",17,-2.1771,0,0.00011,"No",-2.0382,0,0.011,"No"
"288","GO_BP","493739_GO_0009617_RESPONSE_TO_BACTERIUM",404,-2.1768,0,3e-04,"No",0.9107,0.81,1,"Yes"
"289","KEGG_compound","C00162_FATTY_ACID",49,-2.1751,0,1e-04,"No",-0.9373,0.56,1,"No"
"290","GO_BP","489314_GO_0042742_DEFENSE_RESPONSE_TO_BACTERIUM",161,-2.1736,0,3e-04,"No",1.0252,0.38,0.97,"Yes"
"291","C7_Immunologic_signatures","C7_ALL_194_GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN",200,-2.173,0,0,"No",0.9944,0.48,0.76,"Yes"
"292","GO_BP","501948_GO_0032722_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION",40,-2.1719,0,0.00029,"No",-1.0063,0.45,0.98,"No"
"293","C2_Chemical_and_genetic_perturbations","C2_CGP_114_CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP",173,-2.1698,0,8.3e-05,"No",0.8379,0.89,0.98,"Yes"
"294","REACTOME","645317_REACT_121369_ACYL_CHAIN_REMODELLING_OF_PE",21,-2.1695,0,0.00025,"No",-0.9143,0.58,1,"No"
"295","REACTOME","771578_REACT_160274_FCGR_ACTIVATION",13,-2.1694,0,2e-04,"No",-0.6234,0.93,1,"No"
"296","C7_Immunologic_signatures","C7_ALL_1742_GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN",160,-2.1683,0,0,"No",0.6809,1,1,"Yes"
"297","GO_BP","987837_GO_1903036_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING",134,-2.1682,0,0.00031,"No",0.8501,0.84,1,"Yes"
"298","C2_Chemical_and_genetic_perturbations","C2_CGP_1351_GOLUB_ALL_VS_AML_DN",24,-2.1679,0,8.2e-05,"No",-0.9896,0.45,1,"No"
"299","GO_BP","511837_GO_0050900_LEUKOCYTE_MIGRATION",234,-2.1676,0,0.00033,"No",0.995,0.45,0.98,"Yes"
"300","KEGG_reaction","R07084_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE_HYDROLASE_BENZO_A_PYRENE_7_8_DIOL_GLUTATHIONE_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE_H2O",16,-2.1676,0,0,"No",-2.0319,0.0019,0.0035,"No"
"301","GO_CC","507297_GO_0044291_CELL_CELL_CONTACT_ZONE",59,-2.1673,0,0.00098,"No",-1.2901,0.1,0.66,"No"
"302","C2_Chemical_and_genetic_perturbations","C2_CGP_3373_GHANDHI_DIRECT_IRRADIATION_UP",106,-2.1666,0,8.1e-05,"No",-1.3192,0.04,0.7,"No"
"303","C7_Immunologic_signatures","C7_ALL_1058_GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN",197,-2.1662,0,0,"No",-0.7294,1,1,"No"
"304","KEGG_compound","C14863_2_S_GLUTATHIONYL_ACETYL_GLUTATHIONE",16,-2.1654,0,9.6e-05,"No",-2.0129,0,0.0026,"No"
"305","C2_Chemical_and_genetic_perturbations","C2_CGP_532_KAN_RESPONSE_TO_ARSENIC_TRIOXIDE",117,-2.1652,0,9.6e-05,"No",0.8822,0.75,0.94,"Yes"
"306","C4_Cancer_modules","C4_CM_334_MODULE_399",51,-2.1649,0,0.00016,"No",0.9315,0.59,0.81,"Yes"
"307","KEGG_pathway","HSA04978_MINERAL_ABSORPTION",49,-2.1646,0,0,"No",-0.8268,0.79,1,"No"
"308","C2_Chemical_and_genetic_perturbations","C2_CGP_1976_MAHAJAN_RESPONSE_TO_IL1A_UP",77,-2.164,0,0.00011,"No",-0.9918,0.48,1,"No"
"309","C4_Cancer_modules","C4_CM_280_MODULE_321",111,-2.1637,0,0.00015,"No",0.6772,0.99,1,"Yes"
"310","KEGG_compound","C14793__1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE",16,-2.1637,0,9e-05,"No",-2.0002,0,0.0022,"No"
"311","C4_Cancer_gene_neighborhoods","C4_CGN_288_GNF2_CDC20",56,-2.163,0,3.5e-05,"No",-0.9816,0.49,0.87,"No"
"312","GO_BP","1047428_GO_1903428_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",38,-2.1622,0,0.00035,"No",-0.8028,0.82,1,"No"
"313","C2_Chemical_and_genetic_perturbations","C2_CGP_232_PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP",32,-2.1616,0,0.00011,"No",-0.8661,0.69,1,"No"
"314","C4_Cancer_modules","C4_CM_364_MODULE_444",15,-2.1593,0,0.00014,"No",0.774,0.77,0.98,"Yes"
"315","C4_Cancer_modules","C4_CM_74_MODULE_79",97,-2.1573,0,0.00013,"No",1.3492,0.051,0.23,"Yes"
"316","GO_BP","511685_GO_0050714_POSITIVE_REGULATION_OF_PROTEIN_SECRETION",162,-2.1552,0,0.00039,"No",-0.8826,0.77,1,"No"
"317","C7_Immunologic_signatures","C7_ALL_1682_GSE3982_BCELL_VS_NKCELL_DN",193,-2.1534,0,0,"No",-0.9209,0.65,1,"No"
"318","GO_CC","495152_GO_0014704_INTERCALATED_DISC",49,-2.1523,0,0.00049,"No",-1.3735,0.048,0.62,"No"
"319","GO_BP","502880_GO_0044126_REGULATION_OF_GROWTH_OF_SYMBIONT_IN_HOST",15,-2.1522,0,4e-04,"No",-0.8022,0.72,1,"No"
"320","GO_BP","493583_GO_0009410_RESPONSE_TO_XENOBIOTIC_STIMULUS",174,-2.1505,0,4e-04,"No",-1.2979,0.023,0.89,"No"
"321","KEGG_compound","C14791__1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1489,0,0.00025,"No",-2.0075,0.0018,0.0024,"No"
"322","KEGG_compound","C14874_GLUTATHIONE_EPISULFONIUM_ION",16,-2.1487,0,0.00024,"No",-1.9887,0,0.0021,"No"
"323","C2_Chemical_and_genetic_perturbations","C2_CGP_1780_ZHANG_PROLIFERATING_VS_QUIESCENT",51,-2.1469,0,0.00012,"No",-0.7498,0.89,1,"No"
"324","KEGG_compound","C11278_AFLATOXIN_B1EXO_8_9_EPOXIDE_GSH_8_9_DIHYDRO_8_S_GLUTATHIONYL_9_HYDROXYAFLATOXIN_B1",16,-2.146,0,0.00023,"No",-2.0361,0,0.0044,"No"
"325","KEGG_compound","C14840_BROMOBENZENE_2_3_OXIDE_BROMOBENZENE_2_3_EPOXIDE",18,-2.1458,0,0.00021,"No",-1.9057,0.0018,0.0065,"No"
"326","C7_Immunologic_signatures","C7_ALL_1667_GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP",199,-2.1456,0,0,"No",0.8197,0.92,1,"Yes"
"327","GO_BP","516390_GO_0071466_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS",168,-2.1452,0,0.00041,"No",-1.2867,0.047,0.89,"No"
"328","C4_Cancer_modules","C4_CM_26_MODULE_27",351,-2.1451,0,0.00013,"No",0.9123,0.81,0.82,"Yes"
"329","KEGG_compound","C14792__1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1441,0,2e-04,"No",-2.0072,0,0.0023,"No"
"330","KEGG_reaction","R07026_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_5_6_OXIDE_GLUTATHIONE_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE",16,-2.1439,0,0,"No",-2.0083,0,0.0019,"No"
"331","KEGG_compound","C14864_S_2_CHLOROACETYL_GLUTATHIONE",16,-2.1425,0,0.00019,"No",-1.9957,0,0.0021,"No"
"332","C2_Chemical_and_genetic_perturbations","C2_CGP_3372_SMIRNOV_RESPONSE_TO_IR_6HR_DN",114,-2.1422,0,0.00012,"No",-1.3218,0.047,0.69,"No"
"333","C2_Chemical_and_genetic_perturbations","C2_CGP_1385_SANA_TNF_SIGNALING_UP",81,-2.141,0,0.00012,"No",0.7435,0.93,1,"Yes"
"334","KEGG_pathway","HSA00982_DRUG_METABOLISM",64,-2.1391,0,0,"No",-1.3374,0.055,0.34,"No"
"335","C4_Cancer_gene_neighborhoods","C4_CGN_379_GNF2_MKI67",28,-2.1388,0,6.6e-05,"No",-0.9774,0.46,0.86,"No"
"336","GO_CC","499715_GO_0030315_T_TUBULE",39,-2.1382,0,0.00064,"No",-1.4085,0.069,0.65,"No"
"337","GO_BP","499915_GO_0030595_LEUKOCYTE_CHEMOTAXIS",94,-2.138,0,0.00054,"No",1.1634,0.17,0.82,"Yes"
"338","C7_Immunologic_signatures","C7_ALL_1689_GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP",198,-2.1368,0,0,"No",0.9373,0.63,0.94,"Yes"
"339","KEGG_reaction","R07025_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_5_6_OXIDE_GLUTATHIONE_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE",16,-2.1364,0,0,"No",-1.9902,0.002,0.0016,"No"
"340","KEGG_reaction","R07116_2_BROMOACETALDEHYDE_GLUTATHIONE_S_FORMYLMETHYL_TRANSFERASE_2_BROMOACETALDEHYDE_GLUTATHIONE_S_FORMYLMETHYL_GLUTATHIONE_HYDROBROMIC_ACID",16,-2.1354,0,0,"No",-2.0022,0,0.0016,"No"
"341","C2_Chemical_and_genetic_perturbations","C2_CGP_1840_RODWELL_AGING_KIDNEY_UP",476,-2.1352,0,0.00012,"No",1.2652,0.018,0.42,"Yes"
"342","C2_Chemical_and_genetic_perturbations","C2_CGP_2589_LEE_EARLY_T_LYMPHOCYTE_UP",104,-2.135,0,0.00012,"No",-0.787,0.9,1,"No"
"343","KEGG_reaction","R03522_RX_GLUTATHIONE_R_TRANSFERASE_RX_GLUTATHIONE_HALIDE_R_S_GLUTATHIONE",16,-2.1337,0,0,"No",-2.0117,0,0.0021,"No"
"344","C7_Immunologic_signatures","C7_ALL_118_GSE12366_NAIVE_VS_MEMORY_BCELL_DN",190,-2.1333,0,0,"No",-0.9053,0.73,1,"No"
"345","GO_BP","507155_GO_0044146_NEGATIVE_REGULATION_OF_GROWTH_OF_SYMBIONT_INVOLVED_IN_INTERACTION_WITH_HOST",15,-2.1331,0,0.00059,"No",-0.7974,0.75,1,"No"
"346","C2_BioCarta_Pathways","C2_CP_BIOCARTA_83_BIOCARTA_TCAPOPTOSIS_PATHWAY",9,-2.1328,0,0.00056,"No",1.6453,0.027,0.28,"Yes"
"347","KEGG_enzyme","2.5.1.18_GLUTATHIONE_TRANSFERASE_GLUTATHIONE_S_TRANSFERASE_GLUTATHIONE_S_ALKYLTRANSFERASE_GLUTATHIONE_S_ARYLTRANSFERASE_S_HYDROXYALKYL_GLUTATHIONE_LYASE_GLUTATHIONE_S_ARALKYLTRANSFERASE_GLUTATHIONE_S_ALKYL_TRANSFERASE_GST",16,-2.1324,0,0,"No",-2.0309,0.0018,0.003,"No"
"348","GO_BP","987835_GO_1903034_REGULATION_OF_RESPONSE_TO_WOUNDING",359,-2.1324,0,0.00058,"No",0.8836,0.89,1,"Yes"
"349","GO_CC","507512_GO_0045121_MEMBRANE_RAFT",234,-2.1323,0,0.00048,"No",-1.0391,0.36,0.84,"No"
"350","KEGG_pathway","HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION",247,-2.1322,0,0,"No",1.0012,0.44,0.89,"Yes"
"351","C4_Cancer_gene_neighborhoods","C4_CGN_326_GNF2_CASP8",27,-2.1318,0,6.3e-05,"No",-0.8524,0.68,1,"No"
"352","KEGG_compound","C01327_HYDROCHLORIC_ACID_HCL_HYDROGEN_CHLORIDE_HYDROCHLORIDE",16,-2.1318,0,0.00024,"No",-2.0261,0,0.0031,"No"
"353","REACTOME","105698_REACT_13433_BIOLOGICAL_OXIDATIONS",174,-2.1317,0,0.00099,"No",-1.1782,0.13,0.86,"No"
"354","KEGG_compound","C14804_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE",16,-2.1316,0,0.00023,"No",-1.9989,0,0.0022,"No"
"355","GO_CC","487668_GO_0001772_IMMUNOLOGICAL_SYNAPSE",30,-2.1311,0,0.00039,"No",-0.6748,0.93,1,"No"
"356","C4_Cancer_modules","C4_CM_102_MODULE_107",77,-2.1305,0,0.00018,"No",0.958,0.53,0.77,"Yes"
"357","KEGG_reaction","R07093_CHLOROACETYL_CHLORIDE_GLUTATHIONE_S_CHLOROACETYLTRANSFERASE_CHLOROACETYL_CHLORIDE_GLUTATHIONE_S_2_CHLOROACETYL_GLUTATHIONE_HYDROCHLORIC_ACID",16,-2.1302,0,0,"No",-2.0058,0.002,0.0017,"No"
"358","KEGG_compound","C14803_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE",16,-2.1295,0,0.00023,"No",-1.9691,0,0.0026,"No"
"359","C7_Immunologic_signatures","C7_ALL_1502_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN",194,-2.1295,0,0,"No",-0.8885,0.78,1,"No"
"360","GO_CC","493991_GO_0009897_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",224,-2.1291,0,0.00032,"No",0.9746,0.55,0.82,"Yes"
"361","KEGG_reaction","R09409_GLUTATHIONE_S_TRANSFERASE_AFLATOXIN_B1_EXO_8_9_EPOXIDE_GLUTATHIONE_AFLATOXIN_B1EXO_8_9_EPOXIDE_GSH",16,-2.1285,0,0,"No",-1.9803,0,0.0014,"No"
"362","KEGG_compound","C14861_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE",16,-2.1285,0,0.00022,"No",-1.9552,0,0.003,"No"
"363","KEGG_reaction","R07100_TRICHLOROETHENE_GLUTATHIONE_S_1_2_DICHLOROVINYL_TRANSFERASE_TRICHLOROETHENE_GLUTATHIONE_S_1_2_DICHLOROVINYL_GLUTATHIONE_HYDROCHLORIC_ACID",16,-2.1282,0,0,"No",-2.041,0,0.012,"No"
"364","C7_Immunologic_signatures","C7_ALL_237_GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP",193,-2.1278,0,0,"No",0.829,0.91,1,"Yes"
"365","KEGG_reaction","R07023_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_7_8_OXIDE_GLUTATHIONE_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE",16,-2.1274,0,0,"No",-2.0236,0.0038,0.0022,"No"
"366","GO_BP","492024_GO_0007229_INTEGRIN_MEDIATED_SIGNALING_PATHWAY",79,-2.1271,0,0.00068,"No",-1.0688,0.33,0.96,"No"
"367","KEGG_compound","C14847_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE",16,-2.1264,0,0.00021,"No",-2.0375,0,0.0068,"No"
"368","WikiPathways","198794_WP530_CYTOKINES_AND_INFLAMMATORY_RESPONSE",23,-2.1259,0,0,"No",-1.4274,0.07,1,"No"
"369","KEGG_compound","C14851_BENZO_A_PYRENE_4_5_OXIDE_BENZO_A_PYRENE_4_5_EPOXIDE",20,-2.1257,0,2e-04,"No",-2.0606,0,0.024,"No"
"370","C2_Chemical_and_genetic_perturbations","C2_CGP_1497_WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP",31,-2.1243,0,0.00014,"No",-0.7693,0.85,1,"No"
"371","C2_Chemical_and_genetic_perturbations","C2_CGP_207_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP",134,-2.1229,0,0.00014,"No",-1.5047,0.0072,0.45,"No"
"372","REACTOME","105727_REACT_6926_GLUTATHIONE_CONJUGATION",29,-2.1228,0,0.0013,"No",-1.9468,0.0019,0.044,"No"
"373","GO_BP","491109_GO_0006749_GLUTATHIONE_METABOLIC_PROCESS",43,-2.1223,0,0.00071,"No",-1.3393,0.08,0.91,"No"
"374","GO_MF","496916_GO_0030414_PEPTIDASE_INHIBITOR_ACTIVITY",158,-2.1221,0,0.004,"No",-1.0524,0.33,0.86,"No"
"375","KEGG_reaction","R07004__1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1S_2R_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1219,0,0.00011,"No",-2.0336,0,0.0044,"No"
"376","C7_Immunologic_signatures","C7_ALL_1653_GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP",199,-2.1212,0,0,"No",0.814,0.94,1,"Yes"
"377","C0_Hallmark","H_ALL_46_HALLMARK_ALLOGRAFT_REJECTION",195,-2.1212,0,0,"No",1.6206,0.0024,0.011,"Yes"
"378","KEGG_reaction","R07003__1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1S_2R_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE",16,-2.1211,0,9.9e-05,"No",-1.9785,0,0.0013,"No"
"379","GO_BP","501958_GO_0032732_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION",28,-2.1211,0,7e-04,"No",-1.2345,0.16,0.9,"No"
"380","KEGG_reaction","R07094_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYLTRANSFERASE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYL_GLUTATHIONE_HYDROCHLORIC_ACID",16,-2.1209,0,9.1e-05,"No",-1.9855,0.0019,0.0015,"No"
"381","KEGG_reaction","R07024_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_7_8_OXIDE_GLUTATHIONE_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE",16,-2.1208,0,8.4e-05,"No",-1.9598,0,0.0017,"No"
"382","KEGG_reaction","R07083_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BENZO_A_PYRENE_4_5_OXIDE_GLUTATHIONE_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE",16,-2.1205,0,7.8e-05,"No",-2.0004,0,0.0016,"No"
"383","C2_Chemical_and_genetic_perturbations","C2_CGP_2685_VALK_AML_CLUSTER_9",35,-2.1204,0,0.00016,"No",-0.7239,0.9,1,"No"
"384","C2_Chemical_and_genetic_perturbations","C2_CGP_1372_ROSS_AML_WITH_MLL_FUSIONS",78,-2.1203,0,0.00015,"No",0.9983,0.47,0.8,"Yes"
"385","C2_Chemical_and_genetic_perturbations","C2_CGP_3072_DEMAGALHAES_AGING_UP",53,-2.1203,0,0.00015,"No",1.1347,0.26,0.57,"Yes"
"386","C7_Immunologic_signatures","C7_ALL_1418_GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN",196,-2.1199,0,0,"No",0.8389,0.89,1,"Yes"
"387","C2_Chemical_and_genetic_perturbations","C2_CGP_1445_NAKAJIMA_EOSINOPHIL",30,-2.1197,0,0.00015,"No",-0.6617,0.94,1,"No"
"388","C4_Cancer_modules","C4_CM_376_MODULE_462",15,-2.1197,0,0.00017,"No",1.1817,0.24,0.42,"Yes"
"389","C2_Chemical_and_genetic_perturbations","C2_CGP_1142_AMIT_EGF_RESPONSE_120_MCF10A",43,-2.1196,0,0.00015,"No",-1.1738,0.19,0.82,"No"
"390","KEGG_reaction","R08280_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE_HYDROLASE_ALDOPHOSPHAMIDE_GLUTATHIONE_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE_H2O",16,-2.119,0,7.3e-05,"No",-1.9843,0,0.0014,"No"
"391","GO_BP","507677_GO_0045321_LEUKOCYTE_ACTIVATION",412,-2.1189,0,0.00072,"No",-0.7659,1,1,"No"
"392","KEGG_compound","C14805_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE",16,-2.1184,0,0.00029,"No",-1.9602,0,0.0028,"No"
"393","C2_Chemical_and_genetic_perturbations","C2_CGP_389_DELYS_THYROID_CANCER_UP",431,-2.1181,0,0.00016,"No",-0.9652,0.57,1,"No"
"394","C2_Chemical_and_genetic_perturbations","C2_CGP_766_DIRMEIER_LMP1_RESPONSE_EARLY",66,-2.1177,0,0.00016,"No",-1.5039,0.014,0.45,"No"
"395","C7_Immunologic_signatures","C7_ALL_1639_GSE3982_DC_VS_NKCELL_UP",198,-2.1164,0,0,"No",-0.8741,0.81,1,"No"
"396","C2_Chemical_and_genetic_perturbations","C2_CGP_100_ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP",458,-2.1153,0,0.00016,"No",-1.6643,0,0.4,"No"
"397","C7_Immunologic_signatures","C7_ALL_1613_GSE3982_MAST_CELL_VS_BCELL_UP",200,-2.1151,0,0,"No",1.2079,0.075,0.21,"Yes"
"398","GO_BP","911356_GO_0097529_MYELOID_LEUKOCYTE_MIGRATION",74,-2.1149,0,0.00081,"No",0.9356,0.58,1,"Yes"
"399","GO_BP","507987_GO_0045639_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION",78,-2.1144,0,8e-04,"No",-1.23,0.14,0.89,"No"
"400","KEGG_compound","C14855_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE",16,-2.1142,0,0.00028,"No",-2.0035,0,0.0023,"No"
"401","GO_BP","491675_GO_0006805_XENOBIOTIC_METABOLIC_PROCESS",167,-2.1137,0,8e-04,"No",-1.3145,0.046,0.87,"No"
"402","GO_BP","1129383_GO_1903557_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION",46,-2.1131,0,0.00079,"No",1.2026,0.18,0.78,"Yes"
"403","C2_Chemical_and_genetic_perturbations","C2_CGP_483_MISSIAGLIA_REGULATED_BY_METHYLATION_UP",121,-2.1129,0,0.00016,"No",0.8927,0.7,0.93,"Yes"
"404","C7_Immunologic_signatures","C7_ALL_1599_GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP",197,-2.1129,0,0,"No",0.8741,0.82,1,"Yes"
"405","GO_BP","501959_GO_0032733_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION",24,-2.1126,0,8e-04,"No",-1.5834,0.021,0.72,"No"
"406","KEGG_compound","C14852_BENZO_A_PYRENE_7_8_DIOL_BENZO_A_PYRENE_7_8_DIHYDRODIOL",21,-2.1121,0,0.00031,"No",-1.9859,0,0.0021,"No"
"407","KEGG_reaction","R07069_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BROMOBENZENE_3_4_OXIDE_GLUTATHIONE_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE",16,-2.1116,0,6.8e-05,"No",-2.0305,0,0.0025,"No"
"408","C4_Cancer_modules","C4_CM_220_MODULE_241",73,-2.1113,0,0.00016,"No",1.0353,0.4,0.66,"Yes"
"409","KEGG_compound","C14856_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE",16,-2.1113,0,3e-04,"No",-2.0351,0.0019,0.0039,"No"
"410","KEGG_compound","C14865_2_S_GLUTATHIONYL_ACETYL_CHLORIDE",16,-2.1113,0,0.00029,"No",-1.9683,0,0.0026,"No"
"411","KEGG_compound","C14871_S_FORMYLMETHYL_GLUTATHIONE",16,-2.1099,0,0.00028,"No",-2.0238,0,0.0028,"No"
"412","C2_Chemical_and_genetic_perturbations","C2_CGP_3107_CHYLA_CBFA2T3_TARGETS_UP",378,-2.1099,0,0.00017,"No",-1.0519,0.31,0.97,"No"
"413","KEGG_compound","C14806_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE",16,-2.1096,0.0015,0.00028,"No",-2.0372,0,0.0057,"No"
"414","C4_Cancer_modules","C4_CM_382_MODULE_478",19,-2.1094,0,0.00016,"No",-1.385,0.085,0.5,"No"
"415","C2_Chemical_and_genetic_perturbations","C2_CGP_1649_BROWNE_HCMV_INFECTION_16HR_DN",84,-2.1064,0,0.00018,"No",0.9129,0.62,0.91,"Yes"
"416","C2_Chemical_and_genetic_perturbations","C2_CGP_2952_NAKAMURA_ADIPOGENESIS_EARLY_UP",64,-2.1064,0,0.00018,"No",0.9318,0.57,0.89,"Yes"
"417","GO_BP","513511_GO_0055078_SODIUM_ION_HOMEOSTASIS",25,-2.1058,0,9e-04,"No",-1.3865,0.077,1,"No"
"418","KEGG_compound","C11583_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE",16,-2.1056,0,0.00031,"No",-2.0211,0,0.0027,"No"
"419","C7_Immunologic_signatures","C7_ALL_192_GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN",198,-2.1054,0,0,"No",0.8851,0.79,1,"Yes"
"420","KEGG_reaction","R07091_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE_2_2_DICHLOROACETALDEHYDE_LYASE_GLUTATHIONE_FORMING_2_2_DICHLOROACETALDEHYDE_GLUTATHIONE_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE",16,-2.105,0,6.4e-05,"No",-2.0306,0.0019,0.003,"No"
"421","C7_Immunologic_signatures","C7_ALL_1451_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP",196,-2.1047,0,0,"No",0.7704,0.98,1,"Yes"
"422","KEGG_compound","C14848_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE",16,-2.1042,0,3e-04,"No",-2.0382,0,0.0085,"No"
"423","C7_Immunologic_signatures","C7_ALL_1641_GSE3982_DC_VS_TH1_UP",198,-2.1033,0,0,"No",-0.7629,0.98,1,"No"
"424","KEGG_reaction","R07113_1_2_DIBROMOETHANE_GLUTATHIONE_ETHYLENETRANSFERASE_EPISULFONIUM_FORMING_1_2_DIBROMOETHANE_GLUTATHIONE_H_GLUTATHIONE_EPISULFONIUM_ION_2_HYDROBROMIC_ACID",16,-2.1031,0,6.1e-05,"No",-2.0351,0,0.0058,"No"
"425","GO_BP","491591_GO_0006704_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS",10,-2.1022,0,9e-04,"No",0.6679,0.88,1,"Yes"
"426","KEGG_reaction","R07002__1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1R_2S_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1021,0,5.7e-05,"No",-1.9887,0,0.0014,"No"
"427","C2_Chemical_and_genetic_perturbations","C2_CGP_3207_WINZEN_DEGRADED_VIA_KHSRP",100,-2.102,0,0.00017,"No",-1.2548,0.1,0.74,"No"
"428","KEGG_compound","C00462_HALIDE_HYDROGEN_HALIDE_HX_HALO_ACID",16,-2.1011,0,0.00029,"No",-2.0151,0,0.0027,"No"
"429","C2_Chemical_and_genetic_perturbations","C2_CGP_2511_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP",105,-2.1009,0,0.00018,"No",1.3386,0.043,0.35,"Yes"
"430","GO_BP","518997_GO_2000351_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS",37,-2.0991,0,9e-04,"No",0.765,0.87,1,"Yes"
"431","C4_Cancer_modules","C4_CM_155_MODULE_164",59,-2.0991,0,2e-04,"No",1.1812,0.18,0.42,"Yes"
"432","C2_Chemical_and_genetic_perturbations","C2_CGP_1384_SANA_RESPONSE_TO_IFNG_UP",74,-2.0988,0,0.00022,"No",0.5789,1,1,"Yes"
"433","KEGG_compound","C14868_S_1_2_DICHLOROVINYL_GLUTATHIONE_DCVG",16,-2.0979,0,0.00032,"No",-2.0343,0,0.0036,"No"
"434","GO_BP","488576_GO_0002703_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY",147,-2.097,0,0.00098,"No",-1.1467,0.16,0.93,"No"
"435","C2_Chemical_and_genetic_perturbations","C2_CGP_186_JAEGER_METASTASIS_DN",242,-2.0963,0,0.00024,"No",-0.9646,0.56,1,"No"
"436","GO_BP","502227_GO_0033005_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION",15,-2.0959,0,0.001,"No",-0.8434,0.68,1,"No"
"437","C4_Cancer_modules","C4_CM_237_MODULE_263",37,-2.0959,0,0.00019,"No",1.7335,0.013,0.038,"Yes"
"438","C7_Immunologic_signatures","C7_ALL_1334_GSE30083_SP2_VS_SP4_THYMOCYTE_DN",200,-2.0952,0,0,"No",-0.9266,0.66,1,"No"
"439","GO_BP","487712_GO_0001816_CYTOKINE_PRODUCTION",117,-2.0944,0,0.001,"No",-0.8045,0.9,1,"No"
"440","GO_BP","508897_GO_0046649_LYMPHOCYTE_ACTIVATION",330,-2.0936,0,0.001,"No",-0.823,0.96,1,"No"
"441","GO_BP","501986_GO_0032760_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION",43,-2.0928,0,0.001,"No",1.1898,0.18,0.79,"Yes"
"442","C7_Immunologic_signatures","C7_ALL_379_GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP",191,-2.0926,0,0,"No",-1.1324,0.17,1,"No"
"443","KEGG_compound","C01322_RX_ORGANIC_HALIDE",16,-2.0921,0,0.00031,"No",-2.0088,0,0.0026,"No"
"444","C2_Chemical_and_genetic_perturbations","C2_CGP_182_SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP",158,-2.0917,0,0.00026,"No",1.2393,0.064,0.45,"Yes"
"445","REACTOME","685553_REACT_147851_ARACHIDONIC_ACID_METABOLISM",51,-2.0914,0,0.0019,"No",-0.9481,0.55,1,"No"
"446","C7_Immunologic_signatures","C7_ALL_1130_GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN",185,-2.0911,0,0,"No",-1.0262,0.4,1,"No"
"447","GO_BP","488394_GO_0002521_LEUKOCYTE_DIFFERENTIATION",284,-2.0908,0,0.0011,"No",-1.0971,0.19,0.95,"No"
"448","C2_Chemical_and_genetic_perturbations","C2_CGP_256_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP",157,-2.0908,0,0.00026,"No",1.0014,0.43,0.8,"Yes"
"449","GO_BP","754692_GO_1901741_POSITIVE_REGULATION_OF_MYOBLAST_FUSION",14,-2.0908,0,0.001,"No",1.546,0.041,0.35,"Yes"
"450","C2_Chemical_and_genetic_perturbations","C2_CGP_371_KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP",126,-2.0907,0,0.00026,"No",0.7956,0.92,0.99,"Yes"
"451","C2_Chemical_and_genetic_perturbations","C2_CGP_1033_CAFFAREL_RESPONSE_TO_THC_8HR_5_DN",11,-2.0905,0,0.00027,"No",-1.4484,0.078,0.53,"No"
"452","GO_BP","507153_GO_0044144_MODULATION_OF_GROWTH_OF_SYMBIONT_INVOLVED_IN_INTERACTION_WITH_HOST",15,-2.09,0,0.001,"No",-0.8144,0.73,1,"No"
"453","C0_Hallmark","H_ALL_20_HALLMARK_APICAL_JUNCTION",198,-2.0897,0,0,"No",-1.1158,0.19,0.86,"No"
"454","C7_Immunologic_signatures","C7_ALL_182_GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN",197,-2.0895,0,0,"No",-0.6521,1,1,"No"
"455","KEGG_reaction","R07092_1_1_DICHLOROETHYLENE_EPOXIDE_GLUTATHIONE_S_CHLOROEPOXYETHYL_TRANSFERASE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_FORMING_1_1_DICHLOROETHYLENE_EPOXIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_HYDROCHLORIC_ACID",16,-2.0895,0,5.5e-05,"No",-1.99,0,0.0015,"No"
"456","KEGG_reaction","R07070_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BROMOBENZENE_2_3_OXIDE_GLUTATHIONE_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE",16,-2.0894,0,5.2e-05,"No",-2.0177,0,0.002,"No"
"457","C2_Chemical_and_genetic_perturbations","C2_CGP_1966_ZHU_CMV_8_HR_UP",47,-2.0887,0,0.00028,"No",-0.9065,0.6,1,"No"
"458","C2_Chemical_and_genetic_perturbations","C2_CGP_1473_ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP",65,-2.0883,0,0.00027,"No",-0.7722,0.89,1,"No"
"459","GO_BP","499534_GO_0030098_LYMPHOCYTE_DIFFERENTIATION",197,-2.0875,0,0.0011,"No",-1.0496,0.35,0.97,"No"
"460","GO_BP","499537_GO_0030101_NATURAL_KILLER_CELL_ACTIVATION",48,-2.0873,0,0.0011,"No",-0.9969,0.46,0.99,"No"
"461","REACTOME","366238_REACT_75925_AMYLOIDS",79,-2.0868,0,0.0018,"No",-1.808,0,0.079,"No"
"462","GO_BP","501941_GO_0032715_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION",31,-2.0868,0,0.0011,"No",-1.4839,0.042,0.83,"No"
"463","C2_BioCarta_Pathways","C2_CP_BIOCARTA_38_BIOCARTA_LAIR_PATHWAY",17,-2.0863,0,0.0012,"No",-0.9971,0.46,1,"No"
"464","GO_MF","490167_GO_0004866_ENDOPEPTIDASE_INHIBITOR_ACTIVITY",152,-2.0862,0,0.0042,"No",-1.058,0.31,0.87,"No"
"465","C7_Immunologic_signatures","C7_ALL_39_GSE10325_CD4_TCELL_VS_MYELOID_UP",195,-2.0849,0,0,"No",1.4807,0,0.016,"Yes"
"466","GO_BP","499627_GO_0030217_T_CELL_DIFFERENTIATION",123,-2.0846,0,0.0011,"No",-0.9626,0.53,1,"No"
"467","C0_Hallmark","H_ALL_26_HALLMARK_MTORC1_SIGNALING",200,-2.0839,0,0,"No",0.7496,1,1,"Yes"
"468","C4_Cancer_modules","C4_CM_196_MODULE_209",87,-2.0837,0,0.00023,"No",0.8422,0.81,0.93,"Yes"
"469","C2_Chemical_and_genetic_perturbations","C2_CGP_2530_PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION",30,-2.0816,0,0.00033,"No",0.7355,0.88,1,"Yes"
"470","GO_BP","1184559_GO_1904035_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS",50,-2.0816,0,0.0012,"No",0.8855,0.69,1,"Yes"
"471","C4_Cancer_gene_neighborhoods","C4_CGN_298_GNF2_H2AFX",31,-2.0805,0,0.00012,"No",-1.1035,0.31,0.72,"No"
"472","C2_Chemical_and_genetic_perturbations","C2_CGP_2900_TIAN_TNF_SIGNALING_VIA_NFKB",28,-2.0805,0,0.00034,"No",-1.9437,0,0.092,"No"
"473","C2_Chemical_and_genetic_perturbations","C2_CGP_1932_BURTON_ADIPOGENESIS_PEAK_AT_8HR",39,-2.0804,0,0.00033,"No",-0.9027,0.63,1,"No"
"474","REACTOME","1127555_REACT_264164_HSF1_DEPENDENT_TRANSACTIVATION",22,-2.0801,0,0.0017,"No",-1.8349,0.0038,0.065,"No"
"475","C4_Cancer_modules","C4_CM_271_MODULE_310",20,-2.0778,0,0.00022,"No",-1.6149,0.018,0.22,"No"
"476","C4_Cancer_gene_neighborhoods","C4_CGN_367_GNF2_JAK1",32,-2.0778,0,0.00012,"No",0.9788,0.49,0.63,"Yes"
"477","C2_Chemical_and_genetic_perturbations","C2_CGP_1174_MORI_PRE_BI_LYMPHOCYTE_UP",79,-2.0777,0,0.00033,"No",0.8211,0.82,0.98,"Yes"
"478","C2_Chemical_and_genetic_perturbations","C2_CGP_2488_VILIMAS_NOTCH1_TARGETS_UP",51,-2.0776,0,0.00033,"No",-0.8256,0.77,1,"No"
"479","C4_Cancer_modules","C4_CM_40_MODULE_44",314,-2.0768,0,0.00021,"No",1.2388,0.021,0.34,"Yes"
"480","C2_Chemical_and_genetic_perturbations","C2_CGP_1974_VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN",14,-2.0762,0,0.00033,"No",-1.1379,0.32,0.86,"No"
"481","C2_Chemical_and_genetic_perturbations","C2_CGP_2319_WILENSKY_RESPONSE_TO_DARAPLADIB",29,-2.0756,0,0.00034,"No",0.8371,0.72,0.98,"Yes"
"482","C6_Oncogenic_signatures","C6_ALL_51_P53_DN_V1_DN",183,-2.0753,0,0,"No",-1.1668,0.12,0.48,"No"
"483","KEGG_compound","C02320_R_S_GLUTATHIONE",20,-2.0728,0,0.00041,"No",-2.037,0,0.0049,"No"
"484","GO_BP","512059_GO_0051149_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION",71,-2.0725,0,0.0014,"No",-0.8773,0.7,1,"No"
"485","C2_Chemical_and_genetic_perturbations","C2_CGP_3130_JOHNSTONE_PARVB_TARGETS_3_UP",426,-2.0723,0,0.00037,"No",-0.5611,1,1,"No"
"486","C4_Cancer_gene_neighborhoods","C4_CGN_374_GNF2_MATK",24,-2.0722,0,0.00011,"No",1.0522,0.37,0.46,"Yes"
"487","GO_BP","500608_GO_0031349_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE",273,-2.0707,0,0.0014,"No",-0.7238,1,1,"No"
"488","C2_Chemical_and_genetic_perturbations","C2_CGP_121_DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN",114,-2.0706,0,0.00037,"No",1.4161,0.0092,0.28,"Yes"
"489","C2_Chemical_and_genetic_perturbations","C2_CGP_2177_SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN",146,-2.0702,0,0.00036,"No",0.9275,0.65,0.9,"Yes"
"490","GO_BP","1129381_GO_1903555_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION",86,-2.0695,0,0.0014,"No",0.9244,0.64,1,"Yes"
"491","C7_Immunologic_signatures","C7_ALL_1824_GSE7852_THYMUS_VS_FAT_TCONV_DN",200,-2.069,0,0,"No",-0.9082,0.69,1,"No"
"492","GO_MF","492393_GO_0008329_SIGNALING_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY",15,-2.069,0,0.0058,"No",-0.8919,0.61,1,"No"
"493","C2_Chemical_and_genetic_perturbations","C2_CGP_1060_RICKMAN_METASTASIS_DN",256,-2.0688,0,0.00037,"No",-1.2892,0.028,0.7,"No"
"494","C7_Immunologic_signatures","C7_ALL_210_GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN",199,-2.0683,0,0,"No",0.984,0.46,0.79,"Yes"
"495","GO_BP","501903_GO_0032677_REGULATION_OF_INTERLEUKIN_8_PRODUCTION",49,-2.0669,0,0.0014,"No",1.2063,0.16,0.78,"Yes"
"496","C2_Chemical_and_genetic_perturbations","C2_CGP_2475_WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER",55,-2.0669,0,0.00037,"No",-0.9173,0.61,1,"No"
"497","C2_BioCarta_Pathways","C2_CP_BIOCARTA_91_BIOCARTA_IL17_PATHWAY",15,-2.0668,0,0.0018,"No",1.625,0.034,0.25,"Yes"
"498","C2_Chemical_and_genetic_perturbations","C2_CGP_1147_AMIT_SERUM_RESPONSE_60_MCF10A",57,-2.0667,0,0.00037,"No",-1.5734,0.011,0.43,"No"
"499","GO_BP","508891_GO_0046643_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION",12,-2.0659,0,0.0014,"No",-1.5172,0.054,0.8,"No"
"500","C2_Chemical_and_genetic_perturbations","C2_CGP_396_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN",151,-2.0655,0,0.00039,"No",-0.8602,0.8,1,"No"
"501","GO_BP","1026079_GO_1903307_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY",22,-2.0647,0,0.0015,"No",0.9793,0.49,1,"Yes"
"502","C2_Chemical_and_genetic_perturbations","C2_CGP_250_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP",182,-2.0643,0,0.00039,"No",-0.9845,0.49,1,"No"
"503","C4_Cancer_modules","C4_CM_352_MODULE_424",18,-2.0643,0,0.00025,"No",-1.3947,0.079,0.53,"No"
"504","C2_BioCarta_Pathways","C2_CP_BIOCARTA_7_BIOCARTA_LYM_PATHWAY",11,-2.0641,0,0.0017,"No",-0.8412,0.68,1,"No"
"505","C2_Chemical_and_genetic_perturbations","C2_CGP_2340_CHUNG_BLISTER_CYTOTOXICITY_DN",44,-2.0624,0,0.00041,"No",0.8604,0.69,0.96,"Yes"
"506","REACTOME","645321_REACT_120829_ACYL_CHAIN_REMODELLING_OF_PC",23,-2.0624,0,0.0019,"No",-0.8242,0.73,1,"No"
"507","C7_Immunologic_signatures","C7_ALL_421_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP",198,-2.0621,0,0,"No",1.1384,0.14,0.34,"Yes"
"508","C7_Immunologic_signatures","C7_ALL_239_GSE14000_4H_VS_16H_LPS_DC_UP",192,-2.0619,0,0,"No",1.1333,0.17,0.35,"Yes"
"509","C2_Chemical_and_genetic_perturbations","C2_CGP_2383_PODAR_RESPONSE_TO_ADAPHOSTIN_UP",146,-2.0619,0,4e-04,"No",-1.3141,0.054,0.69,"No"
"510","GO_BP","508015_GO_0045667_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION",105,-2.0616,0,0.0016,"No",-0.9615,0.53,1,"No"
"511","GO_BP","754638_GO_1901687_GLUTATHIONE_DERIVATIVE_BIOSYNTHETIC_PROCESS",24,-2.0612,0,0.0016,"No",-1.8504,0,0.42,"No"
"512","GO_BP","751071_GO_0036151_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING",25,-2.0605,0,0.0016,"No",-0.7181,0.9,1,"No"
"513","C4_Cancer_modules","C4_CM_225_MODULE_247",32,-2.0605,0,0.00028,"No",-0.957,0.53,0.86,"No"
"514","KEGG_pathway","HSA05132_SALMONELLA_INFECTION",82,-2.0597,0,0,"No",-0.9592,0.53,0.94,"No"
"515","C2_Chemical_and_genetic_perturbations","C2_CGP_3310_PHONG_TNF_TARGETS_UP",63,-2.0594,0,0.00044,"No",-1.847,0,0.23,"No"
"516","GO_BP","488634_GO_0002761_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION",107,-2.0589,0,0.0016,"No",-0.9236,0.61,1,"No"
"517","REACTOME","105654_REACT_1503_LIGAND_DEPENDENT_CASPASE_ACTIVATION",17,-2.0588,0,0.0017,"No",-0.5739,0.98,1,"No"
"518","C2_Chemical_and_genetic_perturbations","C2_CGP_2095_FOSTER_TOLERANT_MACROPHAGE_UP",156,-2.0585,0,0.00044,"No",0.7948,0.93,0.99,"Yes"
"519","C2_Chemical_and_genetic_perturbations","C2_CGP_794_YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN",84,-2.0579,0,0.00044,"No",0.9431,0.55,0.87,"Yes"
"520","C2_Chemical_and_genetic_perturbations","C2_CGP_1392_SMITH_TERT_TARGETS_DN",87,-2.0571,0,0.00044,"No",-0.8324,0.81,1,"No"
"521","C3_TF_targets","C3_TFT_109_V_SRF_01",50,-2.0546,0,0,"No",-1.4056,0.046,0.16,"No"
"522","GO_BP","518224_GO_0090084_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY",10,-2.0545,0,0.0017,"No",-1.8433,0.0077,0.43,"No"
"523","C2_Chemical_and_genetic_perturbations","C2_CGP_2349_BOQUEST_STEM_CELL_UP",252,-2.0542,0,0.00044,"No",-1.2367,0.052,0.76,"No"
"524","GO_BP","501878_GO_0032652_REGULATION_OF_INTERLEUKIN_1_PRODUCTION",45,-2.0537,0,0.0017,"No",-1.1968,0.18,0.9,"No"
"525","C7_Immunologic_signatures","C7_ALL_963_GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP",199,-2.0536,0,0,"No",-1.1408,0.15,1,"No"
"526","C7_Immunologic_signatures","C7_ALL_1809_GSE7852_TREG_VS_TCONV_THYMUS_UP",200,-2.0531,0,0,"No",0.8403,0.89,1,"Yes"
"527","C7_Immunologic_signatures","C7_ALL_1039_GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP",197,-2.0527,0,0,"No",-0.8246,0.9,1,"No"
"528","C2_Chemical_and_genetic_perturbations","C2_CGP_2016_YANG_MUC2_TARGETS_DUODENUM_3MO_DN",21,-2.0524,0,0.00044,"No",-1.5643,0.026,0.42,"No"
"529","C4_Cancer_modules","C4_CM_286_MODULE_327",21,-2.0518,0,0.00035,"No",0.8378,0.71,0.94,"Yes"
"530","C2_Chemical_and_genetic_perturbations","C2_CGP_1866_BURTON_ADIPOGENESIS_1",33,-2.0511,0,0.00044,"No",-1.1619,0.23,0.83,"No"
"531","GO_BP","515323_GO_0070391_RESPONSE_TO_LIPOTEICHOIC_ACID",8,-2.051,0,0.0017,"No",-1.6376,0.025,0.69,"No"
"532","KEGG_pathway","HSA04261_ADRENERGIC_SIGNALING_IN_CARDIOMYOCYTES",147,-2.051,0,0,"No",-1.5277,0.0052,0.65,"No"
"533","GO_BP","488126_GO_0002253_ACTIVATION_OF_IMMUNE_RESPONSE",347,-2.0509,0,0.0017,"No",-0.69,1,1,"No"
"534","GO_BP","506366_GO_0043306_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION",13,-2.0506,0.0016,0.0017,"No",-0.8898,0.6,1,"No"
"535","C4_Cancer_modules","C4_CM_140_MODULE_148",13,-2.0495,0,0.00037,"No",1.4447,0.086,0.15,"Yes"
"536","C2_Chemical_and_genetic_perturbations","C2_CGP_1953_SESTO_RESPONSE_TO_UV_C3",20,-2.0493,0,0.00047,"No",-1.4261,0.069,0.55,"No"
"537","C2_Chemical_and_genetic_perturbations","C2_CGP_1609_REN_ALVEOLAR_RHABDOMYOSARCOMA_DN",408,-2.0493,0,0.00047,"No",1.0263,0.33,0.76,"Yes"
"538","C2_Chemical_and_genetic_perturbations","C2_CGP_2574_HINATA_NFKB_TARGETS_FIBROBLAST_UP",82,-2.0491,0,0.00046,"No",-0.919,0.62,1,"No"
"539","GO_CC","490903_GO_0005901_CAVEOLA",69,-2.049,0,0.0025,"No",0.8936,0.67,0.9,"Yes"
"540","KEGG_pathway","HSA04970_SALIVARY_SECRETION",83,-2.0489,0,0,"No",-1.5175,0.014,0.57,"No"
"541","C2_Chemical_and_genetic_perturbations","C2_CGP_1871_KEEN_RESPONSE_TO_ROSIGLITAZONE_DN",104,-2.0487,0,0.00046,"No",1.2237,0.1,0.46,"Yes"
"542","C7_Immunologic_signatures","C7_ALL_174_GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN",188,-2.0486,0,0,"No",-1.0509,0.34,1,"No"
"543","C2_Chemical_and_genetic_perturbations","C2_CGP_2142_HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP",442,-2.0483,0,0.00047,"No",-1.4347,0.0017,0.54,"No"
"544","C2_Chemical_and_genetic_perturbations","C2_CGP_1659_NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN",20,-2.048,0,0.00046,"No",-0.7198,0.87,1,"No"
"545","REACTOME","1127552_REACT_264249_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES",28,-2.0471,0,0.0021,"No",-0.642,0.97,1,"No"
"546","C2_Chemical_and_genetic_perturbations","C2_CGP_1556_LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS",25,-2.0463,0,0.00048,"No",1.5444,0.025,0.17,"Yes"
"547","GO_BP","491579_GO_0006691_LEUKOTRIENE_METABOLIC_PROCESS",32,-2.046,0,0.0019,"No",-0.6436,0.97,1,"No"
"548","C2_Chemical_and_genetic_perturbations","C2_CGP_2444_JIANG_TIP30_TARGETS_UP",45,-2.0459,0,0.00047,"No",0.6221,0.98,1,"Yes"
"549","KEGG_compound","C19586_AFLATOXIN_B1_EXO_8_9_EPOXIDE_2_3_EPOXYAFLATOXIN_B1",22,-2.0449,0,0.00049,"No",-1.9389,0.0038,0.0041,"No"
"550","KEGG_pathway","HSA04971_GASTRIC_ACID_SECRETION",74,-2.0447,0,0,"No",-1.4219,0.02,0.39,"No"
"551","GO_BP","508717_GO_0046456_ICOSANOID_BIOSYNTHETIC_PROCESS",45,-2.0442,0,0.0019,"No",-0.9312,0.55,1,"No"
"552","GO_BP","488579_GO_0002706_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY",110,-2.044,0,0.0019,"No",-1.4416,0.017,0.91,"No"
"553","C7_Immunologic_signatures","C7_ALL_894_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN",197,-2.0437,0,0,"No",-0.895,0.74,1,"No"
"554","GO_BP","502230_GO_0033008_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",13,-2.0436,0.0015,0.0019,"No",-0.9035,0.59,1,"No"
"555","KEGG_pathway","HSA04380_OSTEOCLAST_DIFFERENTIATION",128,-2.0432,0,0,"No",-1.0701,0.3,0.71,"No"
"556","GO_BP","501906_GO_0032680_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION",82,-2.042,0,0.002,"No",0.9594,0.57,1,"Yes"
"557","GO_BP","511687_GO_0050716_POSITIVE_REGULATION_OF_INTERLEUKIN_1_SECRETION",19,-2.0416,0,0.002,"No",-1.0879,0.35,0.95,"No"
"558","C2_Chemical_and_genetic_perturbations","C2_CGP_2139_HELLER_SILENCED_BY_METHYLATION_DN",102,-2.0412,0,0.00051,"No",-1.1096,0.25,0.9,"No"
"559","C2_Chemical_and_genetic_perturbations","C2_CGP_2590_LEE_EARLY_T_LYMPHOCYTE_DN",56,-2.0411,0,0.00051,"No",1.2512,0.13,0.43,"Yes"
"560","KEGG_compound","C00118_D_GLYCERALDEHYDE_3_PHOSPHATE_2R_2_HYDROXY_3_PHOSPHONOOXY_PROPANAL_GLYCERALDEHYDE_3_PHOSPHATE",11,-2.0406,0.0016,0.00051,"No",-1.1885,0.26,0.8,"No"
"561","C7_Immunologic_signatures","C7_ALL_1706_GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN",195,-2.0406,0,0,"No",0.9279,0.64,0.96,"Yes"
"562","REACTOME","1183606_REACT_355336_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALIG_PATHWAY",27,-2.0401,0,0.0023,"No",-0.6507,0.94,1,"No"
"563","C7_Immunologic_signatures","C7_ALL_1665_GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP",199,-2.04,0,0,"No",0.7415,1,1,"Yes"
"564","C7_Immunologic_signatures","C7_ALL_1643_GSE3982_DC_VS_TH2_UP",195,-2.0399,0,0,"No",-0.9034,0.72,1,"No"
"565","GO_BP","506085_GO_0042993_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS",43,-2.0399,0,0.002,"No",-1.2832,0.13,0.89,"No"
"566","C2_Chemical_and_genetic_perturbations","C2_CGP_216_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP",178,-2.0398,0,0.00052,"No",1.0329,0.35,0.75,"Yes"
"567","WikiPathways","198899_WP692_SULFATION_BIOTRANSFORMATION_REACTION",16,-2.0397,0,0.0036,"No",1.084,0.32,1,"Yes"
"568","C0_Hallmark","H_ALL_43_HALLMARK_IL2_STAT5_SIGNALING",199,-2.0393,0,0,"No",0.7434,1,1,"Yes"
"569","GO_MF","490388_GO_0005125_CYTOKINE_ACTIVITY",197,-2.0385,0,0.01,"No",1.1329,0.15,0.75,"Yes"
"570","C6_Oncogenic_signatures","C6_ALL_150_HOXA9_DN_V1_UP",192,-2.0377,0,0,"No",0.8164,0.94,0.98,"Yes"
"571","C2_Chemical_and_genetic_perturbations","C2_CGP_37_SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP",343,-2.0374,0,0.00053,"No",0.8526,0.95,0.97,"Yes"
"572","C0_Hallmark","H_ALL_2_HALLMARK_HYPOXIA",197,-2.0371,0,0,"No",-0.946,0.6,0.95,"No"
"573","C0_Hallmark","H_ALL_3_HALLMARK_CHOLESTEROL_HOMEOSTASIS",72,-2.037,0,0,"No",-1.0407,0.37,0.82,"No"
"574","C4_Cancer_gene_neighborhoods","C4_CGN_427_GNF2_ZAP70",26,-2.0369,0,0.00011,"No",1.2704,0.15,0.15,"Yes"
"575","WikiPathways","198902_WP237_GLUCOCORTICOID_AMP_MINERALCORTICOID_METABOLISM",8,-2.0365,0,0.0027,"No",0.8087,0.72,1,"Yes"
"576","GO_BP","754530_GO_1901570_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS",45,-2.036,0,0.0021,"No",-0.9319,0.57,1,"No"
"577","C7_Immunologic_signatures","C7_ALL_1076_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN",200,-2.0359,0,0,"No",-0.9747,0.51,1,"No"
"578","C2_Chemical_and_genetic_perturbations","C2_CGP_1092_WU_CELL_MIGRATION",178,-2.0359,0,0.00054,"No",1.4047,0.0044,0.29,"Yes"
"579","GO_BP","755342_GO_2001236_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",159,-2.0357,0,0.0021,"No",-0.6643,1,1,"No"
"580","C2_Chemical_and_genetic_perturbations","C2_CGP_2868_UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN",37,-2.0353,0,0.00055,"No",-1.7779,0.0038,0.34,"No"
"581","GO_CC","752590_GO_0090533_CATION_TRANSPORTING_ATPASE_COMPLEX",16,-2.0352,0,0.0023,"No",-1.6563,0.013,0.31,"No"
"582","C2_Chemical_and_genetic_perturbations","C2_CGP_715_MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS",36,-2.0352,0,0.00054,"No",-0.6773,0.96,1,"No"
"583","C2_BioCarta_Pathways","C2_CP_BIOCARTA_54_BIOCARTA_DC_PATHWAY",22,-2.0347,0,0.0025,"No",0.7899,0.78,0.97,"Yes"
"584","GO_BP","488125_GO_0002252_IMMUNE_EFFECTOR_PROCESS",430,-2.0345,0,0.0021,"No",1.0512,0.27,0.95,"Yes"
"585","C7_Immunologic_signatures","C7_ALL_234_GSE14000_UNSTIM_VS_4H_LPS_DC_DN",197,-2.0338,0,0,"No",0.7634,0.99,1,"Yes"
"586","C7_Immunologic_signatures","C7_ALL_1474_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN",197,-2.0335,0,0,"No",0.8515,0.89,1,"Yes"
"587","C2_Chemical_and_genetic_perturbations","C2_CGP_1449_ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN",73,-2.0327,0,0.00055,"No",1.0555,0.34,0.7,"Yes"
"588","GO_MF","494924_GO_0061135_ENDOPEPTIDASE_REGULATOR_ACTIVITY",161,-2.0327,0,0.0099,"No",-0.9744,0.52,0.94,"No"
"589","GO_BP","515304_GO_0070372_REGULATION_OF_ERK1_AND_ERK2_CASCADE",166,-2.0322,0,0.0021,"No",-0.9209,0.67,1,"No"
"590","GO_MF","849756_GO_0038187_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY",15,-2.0318,0,0.0089,"No",-0.8556,0.64,1,"No"
"591","C7_Immunologic_signatures","C7_ALL_1242_GSE2826_WT_VS_BTK_KO_BCELL_DN",194,-2.0305,0,0,"No",0.7587,0.99,1,"Yes"
"592","C7_Immunologic_signatures","C7_ALL_773_GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP",191,-2.0301,0,0,"No",-0.993,0.48,1,"No"
"593","WikiPathways","672459_WP2272_PATHOGENIC_ESCHERICHIA_COLI_INFECTION",55,-2.0296,0,0.0024,"No",0.9895,0.45,1,"Yes"
"594","GO_BP","512175_GO_0051290_PROTEIN_HETEROTETRAMERIZATION",35,-2.0295,0,0.0023,"No",-1.6905,0.0038,0.58,"No"
"595","C7_Immunologic_signatures","C7_ALL_1035_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP",195,-2.0293,0,0,"No",0.8792,0.82,1,"Yes"
"596","GO_BP","513700_GO_0060142_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",25,-2.0291,0,0.0022,"No",1.1761,0.23,0.81,"Yes"
"597","GO_BP","508880_GO_0046632_ALPHA_BETA_T_CELL_DIFFERENTIATION",45,-2.0285,0,0.0022,"No",0.7267,0.92,1,"Yes"
"598","GO_BP","503309_GO_0034103_REGULATION_OF_TISSUE_REMODELING",59,-2.0282,0,0.0022,"No",-1.0334,0.38,0.98,"No"
"599","KEGG_pathway","HSA04915_ESTROGEN_SIGNALING_PATHWAY",99,-2.0281,0,0.00015,"No",-1.4766,0.0073,0.44,"No"
"600","C7_Immunologic_signatures","C7_ALL_230_GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN",193,-2.0279,0,0,"No",-0.9342,0.65,1,"No"
"601","C2_Chemical_and_genetic_perturbations","C2_CGP_1791_DELLA_RESPONSE_TO_TSA_AND_BUTYRATE",20,-2.0275,0,0.00059,"No",-1.5451,0.037,0.43,"No"
"602","C6_Oncogenic_signatures","C6_ALL_102_ALK_DN_V1_UP",130,-2.0274,0,0,"No",-0.8401,0.83,0.98,"No"
"603","GO_MF","498649_GO_0019865_IMMUNOGLOBULIN_BINDING",22,-2.027,0,0.0081,"No",-1.171,0.26,0.79,"No"
"604","C2_Chemical_and_genetic_perturbations","C2_CGP_3033_NOUSHMEHR_GBM_GERMLINE_MUTATED",8,-2.0264,0,0.00061,"No",-1.4511,0.097,0.52,"No"
"605","GO_BP","508889_GO_0046641_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION",18,-2.0259,0,0.0023,"No",-0.6374,0.92,1,"No"
"606","C2_Chemical_and_genetic_perturbations","C2_CGP_1448_SANSOM_APC_TARGETS_DN",356,-2.0249,0,0.00064,"No",-1.0635,0.25,0.96,"No"
"607","GO_BP","501875_GO_0032649_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION",82,-2.0248,0,0.0023,"No",-1.0208,0.43,0.97,"No"
"608","GO_BP","511735_GO_0050764_REGULATION_OF_PHAGOCYTOSIS",54,-2.0242,0,0.0023,"No",-1.0297,0.4,0.97,"No"
"609","C2_Chemical_and_genetic_perturbations","C2_CGP_661_LINDGREN_BLADDER_CANCER_CLUSTER_2B",384,-2.0234,0,0.00064,"No",0.8819,0.9,0.94,"Yes"
"610","GO_BP","488159_GO_0002286_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",50,-2.0228,0,0.0023,"No",-0.8739,0.68,1,"No"
"611","GO_BP","501868_GO_0032642_REGULATION_OF_CHEMOKINE_PRODUCTION",55,-2.0224,0,0.0023,"No",1.018,0.42,0.97,"Yes"
"612","C2_Chemical_and_genetic_perturbations","C2_CGP_244_MULLIGHAN_MLL_SIGNATURE_2_UP",417,-2.0223,0,0.00065,"No",-0.6059,1,1,"No"
"613","C2_Chemical_and_genetic_perturbations","C2_CGP_716_FARMER_BREAST_CANCER_CLUSTER_1",41,-2.0218,0,0.00066,"No",2.0458,0,0.0037,"Yes"
"614","KEGG_pathway","HSA04913_OVARIAN_STEROIDOGENESIS",50,-2.021,0,0.00021,"No",-0.8091,0.81,1,"No"
"615","C4_Cancer_modules","C4_CM_199_MODULE_212",321,-2.0209,0,4e-04,"No",1.1262,0.13,0.49,"Yes"
"616","C7_Immunologic_signatures","C7_ALL_1851_GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP",197,-2.0207,0,0,"No",0.68,1,1,"Yes"
"617","GO_BP","489316_GO_0050832_DEFENSE_RESPONSE_TO_FUNGUS",24,-2.0205,0,0.0024,"No",1.5919,0.019,0.3,"Yes"
"618","KEGG_compound","C04438_1_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_2_LYSOPHOSPHATIDYLETHANOLAMINE",25,-2.0205,0,0.00081,"No",-0.8123,0.73,1,"No"
"619","GO_BP","1129359_GO_1903532_POSITIVE_REGULATION_OF_SECRETION_BY_CELL",268,-2.0204,0,0.0024,"No",0.8544,0.92,1,"Yes"
"620","C2_Chemical_and_genetic_perturbations","C2_CGP_325_GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN",11,-2.0199,0.0017,0.00071,"No",-0.6177,0.94,1,"No"
"621","C2_Chemical_and_genetic_perturbations","C2_CGP_3276_PLASARI_TGFB1_TARGETS_10HR_UP",193,-2.0198,0,0.00071,"No",-1.3914,0.014,0.59,"No"
"622","C2_Chemical_and_genetic_perturbations","C2_CGP_2321_MATZUK_CUMULUS_EXPANSION",9,-2.0197,0,0.00071,"No",-1.4245,0.087,0.55,"No"
"623","C7_Immunologic_signatures","C7_ALL_1072_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN",199,-2.0192,0,0,"No",0.9272,0.65,0.96,"Yes"
"624","GO_CC","1025319_GO_0044853_PLASMA_MEMBRANE_RAFT",70,-2.0186,0,0.0025,"No",-0.9001,0.64,0.96,"No"
"625","KEGG_pathway","HSA00591_LINOLEIC_ACID_METABOLISM",26,-2.0186,0,2e-04,"No",-0.9191,0.56,0.96,"No"
"626","C2_Chemical_and_genetic_perturbations","C2_CGP_1590_BRUNO_HEMATOPOIESIS",64,-2.0183,0,0.00072,"No",0.8399,0.8,0.98,"Yes"
"627","C4_Cancer_modules","C4_CM_34_MODULE_38",449,-2.0182,0,0.00042,"No",-1.3408,0.0049,0.49,"No"
"628","C7_Immunologic_signatures","C7_ALL_962_GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN",198,-2.0171,0,0,"No",0.8638,0.84,1,"Yes"
"629","C2_Chemical_and_genetic_perturbations","C2_CGP_385_GESERICK_TERT_TARGETS_DN",21,-2.0168,0,0.00073,"No",-1.7228,0.011,0.34,"No"
"630","C2_Chemical_and_genetic_perturbations","C2_CGP_1999_KRIGE_AMINO_ACID_DEPRIVATION",28,-2.0158,0,0.00073,"No",-1.5461,0.025,0.44,"No"
"631","C2_Chemical_and_genetic_perturbations","C2_CGP_1619_SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A",22,-2.0154,0,0.00073,"No",-1.4323,0.085,0.54,"No"
"632","GO_BP","502884_GO_0044130_NEGATIVE_REGULATION_OF_GROWTH_OF_SYMBIONT_IN_HOST",14,-2.0153,0,0.0026,"No",-0.8067,0.74,1,"No"
"633","C7_Immunologic_signatures","C7_ALL_54_GSE10325_MYELOID_VS_LUPUS_MYELOID_DN",199,-2.0152,0,0,"No",1.4891,0,0.014,"Yes"
"634","C7_Immunologic_signatures","C7_ALL_338_GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN",198,-2.0149,0,0,"No",-0.9938,0.46,1,"No"
"635","C2_Chemical_and_genetic_perturbations","C2_CGP_3141_MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP",254,-2.0148,0,0.00073,"No",-1.1005,0.2,0.91,"No"
"636","C4_Cancer_modules","C4_CM_283_MODULE_324",130,-2.014,0,0.00048,"No",0.8569,0.81,0.91,"Yes"
"637","C7_Immunologic_signatures","C7_ALL_1551_GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP",198,-2.0139,0,0,"No",-0.911,0.7,1,"No"
"638","GO_BP","511689_GO_0050718_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_SECRETION",18,-2.0136,0,0.0026,"No",-1.0833,0.34,0.96,"No"
"639","GO_BP","499536_GO_0030100_REGULATION_OF_ENDOCYTOSIS",171,-2.0122,0,0.0027,"No",-0.8056,0.92,1,"No"
"640","C2_Chemical_and_genetic_perturbations","C2_CGP_3385_ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF",216,-2.0118,0,0.00075,"No",-0.9392,0.62,1,"No"
"641","C2_Chemical_and_genetic_perturbations","C2_CGP_1342_LEE_LIVER_CANCER_ACOX1_UP",63,-2.0118,0,0.00076,"No",1.3701,0.057,0.32,"Yes"
"642","GO_CC","505527_GO_0042383_SARCOLEMMA",99,-2.0117,0,0.0028,"No",-1.2873,0.068,0.66,"No"
"643","C4_Cancer_modules","C4_CM_164_MODULE_174",95,-2.0116,0,5e-04,"No",0.9857,0.49,0.72,"Yes"
"644","GO_BP","507985_GO_0045637_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION",179,-2.0105,0,0.0027,"No",-1.0443,0.35,0.97,"No"
"645","C2_Chemical_and_genetic_perturbations","C2_CGP_2272_SMID_BREAST_CANCER_NORMAL_LIKE_UP",455,-2.0099,0,0.00079,"No",0.9913,0.45,0.81,"Yes"
"646","C7_Immunologic_signatures","C7_ALL_1141_GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP",197,-2.009,0,0,"No",1.2436,0.073,0.16,"Yes"
"647","C7_Immunologic_signatures","C7_ALL_1092_GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN",177,-2.0082,0,0,"No",-0.9235,0.67,1,"No"
"648","C2_Chemical_and_genetic_perturbations","C2_CGP_1579_IGLESIAS_E2F_TARGETS_UP",149,-2.0081,0,0.00079,"No",1.3064,0.042,0.39,"Yes"
"649","C7_Immunologic_signatures","C7_ALL_1787_GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP",198,-2.0077,0,0,"No",-0.6827,1,1,"No"
"650","GO_BP","494695_GO_0010631_EPITHELIAL_CELL_MIGRATION",69,-2.0073,0,0.0029,"No",-1.063,0.34,0.96,"No"
"651","C2_Chemical_and_genetic_perturbations","C2_CGP_1555_NAKAJIMA_MAST_CELL",46,-2.0067,0,0.00081,"No",-0.8474,0.73,1,"No"
"652","WikiPathways","739007_WP2431_SPINAL_CORD_INJURY",109,-2.0066,0,0.0027,"No",-1.2019,0.14,0.81,"No"
"653","C4_Cancer_modules","C4_CM_205_MODULE_220",317,-2.0064,0,0.00048,"No",-1.0779,0.24,0.68,"No"
"654","GO_BP","488692_GO_0002819_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE",120,-2.0064,0,0.003,"No",-1.3314,0.044,0.9,"No"
"655","GO_BP","751069_GO_0036149_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING",14,-2.0062,0,0.003,"No",0.7728,0.76,1,"Yes"
"656","KEGG_pathway","HSA05140_LEISHMANIASIS",70,-2.0059,0,0.00019,"No",-1.4353,0.02,0.38,"No"
"657","KEGG_compound","C00735_CORTISOL_HYDROCORTISONE_11BETA_17ALPHA_21_TRIHYDROXY_4_PREGNENE_3_20_DIONE_KENDALL_S_COMPOUND_F_REICHSTEIN_S_SUBSTANCE_M",8,-2.0057,0,0.00094,"No",0.5818,0.95,1,"Yes"
"658","GO_BP","511749_GO_0050778_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE",481,-2.0052,0,0.003,"No",-0.8057,0.99,1,"No"
"659","C2_Chemical_and_genetic_perturbations","C2_CGP_1251_ROZANOV_MMP14_TARGETS_DN",35,-2.0049,0,0.00085,"No",1.2782,0.12,0.42,"Yes"
"660","KEGG_pathway","HSA04540_GAP_JUNCTION",88,-2.0047,0,0.00018,"No",-0.852,0.75,1,"No"
"661","C4_Cancer_modules","C4_CM_14_MODULE_15",354,-2.0045,0,0.00047,"No",1.104,0.19,0.54,"Yes"
"662","C6_Oncogenic_signatures","C6_ALL_156_STK33_SKM_UP",275,-2.0043,0,0.00019,"No",-1.1018,0.21,0.57,"No"
"663","C2_Chemical_and_genetic_perturbations","C2_CGP_1790_BURTON_ADIPOGENESIS_8",86,-2.0041,0,0.00088,"No",1.2265,0.13,0.46,"Yes"
"664","GO_BP","488630_GO_0002757_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION",300,-2.0041,0,0.003,"No",-0.708,1,1,"No"
"665","C2_Chemical_and_genetic_perturbations","C2_CGP_774_DAUER_STAT3_TARGETS_UP",47,-2.004,0,0.00088,"No",-0.8293,0.75,1,"No"
"666","GO_BP","487572_GO_0001659_TEMPERATURE_HOMEOSTASIS",26,-2.0038,0,0.003,"No",-1.2139,0.21,0.88,"No"
"667","GO_BP","488123_GO_0002250_ADAPTIVE_IMMUNE_RESPONSE",148,-2.0038,0,0.003,"No",-0.7149,0.99,1,"No"
"668","C2_BioCarta_Pathways","C2_CP_BIOCARTA_98_BIOCARTA_IL12_PATHWAY",21,-2.0037,0.0016,0.0031,"No",-0.8099,0.75,1,"No"
"669","C4_Cancer_modules","C4_CM_230_MODULE_254",58,-2.0036,0,0.00052,"No",1.0799,0.32,0.58,"Yes"
"670","GO_BP","515306_GO_0070374_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE",117,-2.0035,0,0.003,"No",-1.0814,0.31,0.95,"No"
"671","C2_Chemical_and_genetic_perturbations","C2_CGP_307_KIM_WT1_TARGETS_8HR_UP",161,-2.0035,0,0.00088,"No",-1.1921,0.12,0.81,"No"
"672","REACTOME","1183554_REACT_355442_DECTIN_2_FAMILY",10,-2.0031,0,0.0048,"No",-1.0009,0.48,0.99,"No"
"673","C2_Chemical_and_genetic_perturbations","C2_CGP_979_GROSS_HYPOXIA_VIA_ELK3_DN",156,-2.0031,0,0.00088,"No",-0.8146,0.89,1,"No"
"674","GO_BP","511699_GO_0050728_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE",87,-2.0025,0,0.003,"No",0.813,0.85,1,"Yes"
"675","GO_MF","499638_GO_0030228_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY",14,-2.0024,0,0.01,"No",0.7396,0.84,1,"Yes"
"676","C2_Chemical_and_genetic_perturbations","C2_CGP_2664_CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP",39,-2.0023,0,0.00088,"No",-0.797,0.79,1,"No"
"677","GO_BP","754636_GO_1901685_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS",24,-2.0022,0,0.003,"No",-1.8708,0,0.43,"No"
"678","GO_MF","490289_GO_0005003_EPHRIN_RECEPTOR_ACTIVITY",17,-2.002,0,0.0094,"No",-1.2212,0.22,0.85,"No"
"679","GO_BP","808776_GO_1902105_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION",223,-2.0019,0,0.003,"No",-1.069,0.3,0.96,"No"
"680","C2_Chemical_and_genetic_perturbations","C2_CGP_1375_LEE_LIVER_CANCER_MYC_E2F1_UP",53,-2.0011,0,0.00088,"No",1.0565,0.37,0.7,"Yes"
"681","GO_BP","511972_GO_0051047_POSITIVE_REGULATION_OF_SECRETION",298,-2.0009,0,0.003,"No",0.9192,0.76,1,"Yes"
"682","GO_BP","487464_GO_0001525_ANGIOGENESIS",281,-2.0003,0,0.0031,"No",-1.1336,0.18,0.93,"No"
"683","C2_Chemical_and_genetic_perturbations","C2_CGP_1435_LEE_LIVER_CANCER_E2F1_UP",60,-2.0001,0,0.00091,"No",1.2889,0.072,0.4,"Yes"
"684","C6_Oncogenic_signatures","C6_ALL_157_STK33_UP",280,-1.9999,0,0.00016,"No",-0.9089,0.74,0.86,"No"
"685","C2_Chemical_and_genetic_perturbations","C2_CGP_2423_ALONSO_METASTASIS_EMT_UP",36,-1.9995,0,0.00092,"No",1.1728,0.22,0.53,"Yes"
"686","GO_BP","1184542_GO_1904018_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT",119,-1.999,0,0.0031,"No",1.0922,0.28,0.91,"Yes"
"687","C4_Cancer_modules","C4_CM_403_MODULE_516",14,-1.9979,0,0.00053,"No",-0.5061,0.99,1,"No"
"688","C4_Cancer_gene_neighborhoods","C4_CGN_294_GNF2_CCNB2",57,-1.9978,0,0.00029,"No",-0.92,0.62,0.99,"No"
"689","C7_Immunologic_signatures","C7_ALL_1818_GSE7852_THYMUS_VS_FAT_TREG_DN",200,-1.9977,0,0,"No",-1.2884,0.033,0.51,"No"
"690","C7_Immunologic_signatures","C7_ALL_892_GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN",195,-1.9976,0,0,"No",-0.9515,0.6,1,"No"
"691","GO_BP","514551_GO_0060996_DENDRITIC_SPINE_DEVELOPMENT",11,-1.9971,0,0.0033,"No",-1.2029,0.25,0.89,"No"
"692","GO_BP","506362_GO_0043302_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION",17,-1.9971,0,0.0032,"No",0.9989,0.43,0.98,"Yes"
"693","KEGG_pathway","HSA05130_PATHOGENIC_ESCHERICHIA_COLI_INFECTION",55,-1.9968,0,0.00017,"No",0.9893,0.45,0.91,"Yes"
"694","C2_Chemical_and_genetic_perturbations","C2_CGP_3016_BROWNE_HCMV_INFECTION_2HR_DN",47,-1.9964,0,0.00097,"No",-1.2263,0.17,0.78,"No"
"695","C2_Chemical_and_genetic_perturbations","C2_CGP_1389_CHEOK_RESPONSE_TO_HD_MTX_UP",22,-1.9963,0,0.00097,"No",0.7988,0.76,0.99,"Yes"
"696","GO_BP","1129532_GO_1903708_POSITIVE_REGULATION_OF_HEMOPOIESIS",153,-1.996,0,0.0032,"No",-1.1713,0.15,0.91,"No"
"697","C7_Immunologic_signatures","C7_ALL_1686_GSE3982_BCELL_VS_TH2_DN",194,-1.9956,0,0,"No",0.8948,0.78,1,"Yes"
"698","C7_Immunologic_signatures","C7_ALL_1037_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP",198,-1.9946,0,0,"No",0.8195,0.95,1,"Yes"
"699","C7_Immunologic_signatures","C7_ALL_1661_GSE3982_NEUTROPHIL_VS_BCELL_UP",191,-1.9942,0,0,"No",1.2183,0.092,0.2,"Yes"
"700","C4_Cancer_gene_neighborhoods","C4_CGN_383_GNF2_MSN",24,-1.9942,0,0.00028,"No",0.7175,0.9,1,"Yes"
"701","GO_MF","490168_GO_0004867_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY",88,-1.9936,0,0.011,"No",-1.2558,0.096,0.84,"No"
"702","C2_Chemical_and_genetic_perturbations","C2_CGP_2356_LABBE_TGFB1_TARGETS_DN",98,-1.9933,0,0.001,"No",-0.961,0.52,1,"No"
"703","C4_Cancer_gene_neighborhoods","C4_CGN_399_GNF2_RAB7L1",33,-1.9922,0,0.00027,"No",0.9854,0.47,0.61,"Yes"
"704","C2_Chemical_and_genetic_perturbations","C2_CGP_1239_ONDER_CDH1_TARGETS_2_DN",452,-1.9914,0,0.001,"No",-1.2289,0.03,0.77,"No"
"705","C2_Chemical_and_genetic_perturbations","C2_CGP_422_MARKEY_RB1_CHRONIC_LOF_DN",116,-1.9914,0,0.001,"No",-0.9256,0.63,1,"No"
"706","C2_Chemical_and_genetic_perturbations","C2_CGP_2062_GAVIN_FOXP3_TARGETS_CLUSTER_P4",99,-1.9909,0,0.001,"No",-0.4976,1,1,"No"
"707","C2_Chemical_and_genetic_perturbations","C2_CGP_3249_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1",46,-1.9902,0,0.0011,"No",-1.6973,0.011,0.33,"No"
"708","GO_BP","511815_GO_0050873_BROWN_FAT_CELL_DIFFERENTIATION",32,-1.99,0,0.0037,"No",-0.806,0.79,1,"No"
"709","C2_Chemical_and_genetic_perturbations","C2_CGP_1462_ALCALAY_AML_BY_NPM1_LOCALIZATION_UP",138,-1.9894,0,0.0011,"No",0.9853,0.48,0.81,"Yes"
"710","KEGG_pathway","HSA05412_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_",74,-1.9891,0,0.00027,"No",-1.375,0.045,0.35,"No"
"711","KEGG_pathway","HSA00592_ALPHA_LINOLENIC_ACID_METABOLISM",22,-1.9891,0,0.00026,"No",-0.8956,0.61,0.96,"No"
"712","GO_BP","911400_GO_0098542_DEFENSE_RESPONSE_TO_OTHER_ORGANISM",307,-1.9887,0,0.0038,"No",1.2866,0.0074,0.69,"Yes"
"713","C6_Oncogenic_signatures","C6_ALL_161_KRAS_DF_V1_UP",188,-1.9887,0,0.00014,"No",-1.1812,0.12,0.48,"No"
"714","C2_Chemical_and_genetic_perturbations","C2_CGP_2843_BOYLAN_MULTIPLE_MYELOMA_PCA1_UP",98,-1.9882,0,0.0011,"No",1.0659,0.32,0.68,"Yes"
"715","GO_CC","487622_GO_0005882_INTERMEDIATE_FILAMENT",136,-1.9881,0,0.0046,"No",1.265,0.063,0.45,"Yes"
"716","REACTOME","160140_REACT_22232_SIGNALING_BY_INTERLEUKINS",111,-1.9876,0,0.0063,"No",-0.632,0.99,1,"No"
"717","C2_BioCarta_Pathways","C2_CP_BIOCARTA_57_BIOCARTA_MTA3_PATHWAY",19,-1.9876,0,0.0038,"No",-0.8741,0.62,1,"No"
"718","GO_BP","487715_GO_0001819_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION",336,-1.9876,0,0.0038,"No",-0.8145,0.95,1,"No"
"719","GO_BP","508018_GO_0045670_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION",57,-1.9874,0,0.0038,"No",-1.2763,0.12,0.89,"No"
"720","C2_Chemical_and_genetic_perturbations","C2_CGP_242_MULLIGHAN_MLL_SIGNATURE_1_UP",380,-1.9874,0,0.0011,"No",0.6634,1,1,"Yes"
"721","C2_Chemical_and_genetic_perturbations","C2_CGP_2707_BOYAULT_LIVER_CANCER_SUBCLASS_G2",27,-1.9873,0,0.0011,"No",-0.6454,0.95,1,"No"
"722","GO_BP","516149_GO_0071223_CELLULAR_RESPONSE_TO_LIPOTEICHOIC_ACID",8,-1.9871,0,0.0038,"No",-1.6326,0.025,0.7,"No"
"723","WikiPathways","920975_WP2447_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS_",34,-1.9865,0.0014,0.0033,"No",-0.8332,0.71,1,"No"
"724","GO_CC","490923_GO_0005924_CELL_SUBSTRATE_ADHERENS_JUNCTION",388,-1.9862,0,0.0044,"No",1.6639,0,0.081,"Yes"
"725","GO_BP","491744_GO_0006883_CELLULAR_SODIUM_ION_HOMEOSTASIS",14,-1.9854,0,0.0039,"No",-1.452,0.081,0.9,"No"
"726","C2_Chemical_and_genetic_perturbations","C2_CGP_132_CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN",449,-1.9854,0,0.0011,"No",0.9975,0.47,0.8,"Yes"
"727","GO_BP","500540_GO_0031281_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY",68,-1.985,0,0.0039,"No",-0.9754,0.51,1,"No"
"728","GO_CC","490892_GO_0005890_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX",11,-1.9848,0,0.0043,"No",-1.3965,0.1,0.63,"No"
"729","WikiPathways","198770_WP127_IL_5_SIGNALING_PATHWAY",69,-1.9847,0,0.0029,"No",-0.56,1,1,"No"
"730","C7_Immunologic_signatures","C7_ALL_1892_GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN",199,-1.9846,0,0,"No",-0.946,0.61,1,"No"
"731","GO_BP","488635_GO_0002762_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION",41,-1.9844,0,0.0039,"No",-0.9161,0.56,1,"No"
"732","C2_Chemical_and_genetic_perturbations","C2_CGP_2406_HUANG_DASATINIB_RESISTANCE_UP",80,-1.9843,0,0.0011,"No",1.0166,0.42,0.78,"Yes"
"733","C7_Immunologic_signatures","C7_ALL_1601_GSE3982_EOSINOPHIL_VS_NKCELL_UP",193,-1.9842,0,0,"No",0.8378,0.89,1,"Yes"
"734","GO_MF","490169_GO_0004869_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY",47,-1.984,0,0.012,"No",0.9777,0.47,0.9,"Yes"
"735","GO_BP","487713_GO_0001817_REGULATION_OF_CYTOKINE_PRODUCTION",498,-1.9836,0,0.0039,"No",0.9049,0.87,1,"Yes"
"736","KEGG_pathway","HSA05164_INFLUENZA_A",167,-1.9836,0,0.00029,"No",-1.133,0.18,0.65,"No"
"737","GO_BP","507476_GO_0045076_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS",18,-1.9835,0.0015,0.0039,"No",-1.0122,0.47,0.98,"No"
"738","GO_BP","1129530_GO_1903706_REGULATION_OF_HEMOPOIESIS",301,-1.9834,0,0.0039,"No",-1.1184,0.18,0.94,"No"
"739","GO_BP","488329_GO_0002456_T_CELL_MEDIATED_IMMUNITY",25,-1.9833,0,0.0038,"No",-0.8617,0.65,1,"No"
"740","C2_Chemical_and_genetic_perturbations","C2_CGP_2785_MARSON_FOXP3_TARGETS_UP",66,-1.9827,0,0.0011,"No",0.7464,0.95,1,"Yes"
"741","C4_Cancer_modules","C4_CM_23_MODULE_24",438,-1.9822,0,0.00067,"No",-1.1606,0.095,0.63,"No"
"742","GO_BP","514224_GO_0060669_EMBRYONIC_PLACENTA_MORPHOGENESIS",24,-1.9822,0.0014,0.0039,"No",-1.4842,0.035,0.83,"No"
"743","C4_Cancer_modules","C4_CM_6_MODULE_6",397,-1.982,0,0.00065,"No",-1.1512,0.097,0.63,"No"
"744","GO_BP","754304_GO_1901342_REGULATION_OF_VASCULATURE_DEVELOPMENT",207,-1.9814,0,0.0039,"No",0.9416,0.62,1,"Yes"
"745","GO_BP","501661_GO_0032429_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY",10,-1.9814,0,0.0039,"No",-0.9803,0.49,1,"No"
"746","GO_BP","504902_GO_0035725_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",83,-1.9801,0,0.004,"No",-1.6176,0,0.7,"No"
"747","GO_CC","495323_GO_0031225_ANCHORED_COMPONENT_OF_MEMBRANE",141,-1.9794,0,0.0044,"No",1.2709,0.063,0.44,"Yes"
"748","C6_Oncogenic_signatures","C6_ALL_6_EGFR_UP_V1_UP",192,-1.9777,0,0.00013,"No",-0.8592,0.83,0.95,"No"
"749","C2_Chemical_and_genetic_perturbations","C2_CGP_1983_JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP",31,-1.9777,0,0.0012,"No",0.9915,0.47,0.81,"Yes"
"750","GO_BP","496142_GO_0016042_LIPID_CATABOLIC_PROCESS",229,-1.9773,0,0.0041,"No",0.9602,0.58,1,"Yes"
"751","GO_CC","490924_GO_0005925_FOCAL_ADHESION",384,-1.9773,0,0.0041,"No",1.6646,0,0.082,"Yes"
"752","GO_BP","505489_GO_0042345_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS",40,-1.9771,0,0.0041,"No",-0.9818,0.48,1,"No"
"753","GO_BP","751341_GO_0038083_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION",38,-1.9765,0,0.0041,"No",-1.0473,0.38,0.97,"No"
"754","C7_Immunologic_signatures","C7_ALL_1449_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP",196,-1.9764,0,0,"No",0.7923,0.96,1,"Yes"
"755","C7_Immunologic_signatures","C7_ALL_1029_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP",196,-1.9762,0,0,"No",-0.6954,0.99,1,"No"
"756","REACTOME","1127695_REACT_264198_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS",48,-1.9754,0.0013,0.0071,"No",-0.83,0.78,1,"No"
"757","C2_Chemical_and_genetic_perturbations","C2_CGP_2662_CROONQUIST_NRAS_SIGNALING_UP",40,-1.9751,0,0.0013,"No",0.9889,0.47,0.81,"Yes"
"758","C7_Immunologic_signatures","C7_ALL_1816_GSE7852_LN_VS_FAT_TREG_DN",198,-1.9748,0,0,"No",-1.1442,0.16,1,"No"
"759","C7_Immunologic_signatures","C7_ALL_1910_GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN",199,-1.9746,0,0,"No",-0.7395,0.99,1,"No"
"760","C4_Cancer_modules","C4_CM_36_MODULE_40",80,-1.9737,0,0.00088,"No",0.9191,0.63,0.82,"Yes"
"761","GO_BP","488588_GO_0002715_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",29,-1.9734,0,0.0043,"No",-0.721,0.88,1,"No"
"762","C2_Chemical_and_genetic_perturbations","C2_CGP_2857_CAIRO_LIVER_DEVELOPMENT_DN",214,-1.9727,0,0.0014,"No",-1.0745,0.27,0.95,"No"
"763","GO_BP","503898_GO_0034698_RESPONSE_TO_GONADOTROPIN",27,-1.9725,0,0.0043,"No",-1.3444,0.11,0.92,"No"
"764","GO_BP","751849_GO_0044706_MULTI_MULTICELLULAR_ORGANISM_PROCESS",220,-1.9725,0,0.0043,"No",-1.2755,0.049,0.89,"No"
"765","GO_BP","491581_GO_0006693_PROSTAGLANDIN_METABOLIC_PROCESS",27,-1.9723,0,0.0043,"No",-0.715,0.88,1,"No"
"766","C4_Cancer_modules","C4_CM_13_MODULE_14",12,-1.9719,0.0016,0.00086,"No",-0.5178,0.99,1,"No"
"767","C2_Chemical_and_genetic_perturbations","C2_CGP_2351_BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP",420,-1.9718,0,0.0014,"No",0.9906,0.49,0.81,"Yes"
"768","C2_Chemical_and_genetic_perturbations","C2_CGP_328_GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP",55,-1.9715,0,0.0014,"No",-1.0396,0.38,0.97,"No"
"769","C2_Chemical_and_genetic_perturbations","C2_CGP_367_LIU_CDX2_TARGETS_UP",35,-1.9712,0,0.0014,"No",-1.1591,0.23,0.83,"No"
"770","C6_Oncogenic_signatures","C6_ALL_108_MEL18_DN_V1_UP",139,-1.971,0,0.00011,"No",-1.1913,0.14,0.47,"No"
"771","C7_Immunologic_signatures","C7_ALL_1593_GSE3982_EOSINOPHIL_VS_BCELL_UP",196,-1.9709,0,0,"No",0.8199,0.9,1,"Yes"
"772","GO_BP","512752_GO_0051897_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING",76,-1.9708,0,0.0044,"No",-0.9719,0.5,1,"No"
"773","C4_Cancer_modules","C4_CM_312_MODULE_362",18,-1.9705,0,0.00087,"No",0.5664,0.98,1,"Yes"
"774","C2_Chemical_and_genetic_perturbations","C2_CGP_73_DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN",180,-1.9705,0,0.0014,"No",-1.2404,0.088,0.75,"No"
"775","C2_Chemical_and_genetic_perturbations","C2_CGP_1994_BILD_HRAS_ONCOGENIC_SIGNATURE",257,-1.9702,0,0.0014,"No",-1.2781,0.028,0.71,"No"
"776","C2_Chemical_and_genetic_perturbations","C2_CGP_2806_KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD",20,-1.9701,0,0.0014,"No",1.7476,0.0021,0.061,"Yes"
"777","GO_BP","491764_GO_0006909_PHAGOCYTOSIS",155,-1.9695,0,0.0044,"No",0.699,0.99,1,"Yes"
"778","C2_BioCarta_Pathways","C2_CP_BIOCARTA_176_BIOCARTA_TOB1_PATHWAY",19,-1.9692,0,0.0045,"No",-0.7891,0.77,1,"No"
"779","REACTOME","645322_REACT_120977_HYDROLYSIS_OF_LPC",8,-1.9691,0,0.0075,"No",0.8974,0.59,0.91,"Yes"
"780","KEGG_pathway","HSA00590_ARACHIDONIC_ACID_METABOLISM",58,-1.9688,0,0.00028,"No",-0.8566,0.75,1,"No"
"781","C7_Immunologic_signatures","C7_ALL_1691_GSE3982_BASOPHIL_VS_NKCELL_UP",192,-1.9685,0,0,"No",1.3161,0.017,0.088,"Yes"
"782","GO_BP","518270_GO_0090130_TISSUE_MIGRATION",79,-1.9684,0,0.0045,"No",-1.2304,0.13,0.89,"No"
"783","C2_BioCarta_Pathways","C2_CP_BIOCARTA_128_BIOCARTA_NO2IL12_PATHWAY",17,-1.9683,0,0.0042,"No",0.9827,0.49,0.81,"Yes"
"784","C7_Immunologic_signatures","C7_ALL_1336_GSE30083_SP3_VS_SP4_THYMOCYTE_DN",199,-1.9683,0,0,"No",-0.573,1,1,"No"
"785","C2_Chemical_and_genetic_perturbations","C2_CGP_1398_LEE_LIVER_CANCER_CIPROFIBRATE_UP",58,-1.9682,0,0.0014,"No",0.9097,0.62,0.91,"Yes"
"786","C6_Oncogenic_signatures","C6_ALL_104_BMI1_DN_MEL18_DN_V1_UP",143,-1.9681,0,1e-04,"No",-1.1133,0.23,0.55,"No"
"787","C7_Immunologic_signatures","C7_ALL_1020_GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN",191,-1.968,0,0,"No",-0.7812,0.97,1,"No"
"788","C4_Cancer_modules","C4_CM_1_MODULE_1",358,-1.9679,0,9e-04,"No",-1.1959,0.065,0.61,"No"
"789","GO_BP","508073_GO_0045730_RESPIRATORY_BURST",14,-1.9676,0,0.0045,"No",0.75,0.81,1,"Yes"
"790","C2_Chemical_and_genetic_perturbations","C2_CGP_2867_HAHTOLA_CTCL_PATHOGENESIS",16,-1.9673,0.0032,0.0014,"No",1.6749,0.023,0.097,"Yes"
"791","C2_Chemical_and_genetic_perturbations","C2_CGP_1508_LENAOUR_DENDRITIC_CELL_MATURATION_UP",110,-1.967,0,0.0014,"No",-0.6974,0.99,1,"No"
"792","C4_Cancer_gene_neighborhoods","C4_CGN_290_GNF2_CENPE",41,-1.9668,0,0.00038,"No",-1.1273,0.28,0.7,"No"
"793","GO_BP","518272_GO_0090132_EPITHELIUM_MIGRATION",71,-1.9664,0,0.0046,"No",-1.1515,0.2,0.93,"No"
"794","GO_CC","499503_GO_0030055_CELL_SUBSTRATE_JUNCTION",392,-1.9663,0,0.0046,"No",1.6483,0,0.088,"Yes"
"795","C2_Chemical_and_genetic_perturbations","C2_CGP_1287_FERRANDO_TAL1_NEIGHBORS",20,-1.9662,0,0.0014,"No",0.9328,0.55,0.89,"Yes"
"796","GO_BP","512223_GO_0051339_REGULATION_OF_LYASE_ACTIVITY",141,-1.9661,0,0.0046,"No",1.1095,0.2,0.89,"Yes"
"797","C2_Chemical_and_genetic_perturbations","C2_CGP_2695_VALK_AML_WITH_CEBPA",35,-1.966,0,0.0014,"No",0.9889,0.46,0.81,"Yes"
"798","GO_BP","491580_GO_0006692_PROSTANOID_METABOLIC_PROCESS",27,-1.9655,0,0.0046,"No",-0.7109,0.89,1,"No"
"799","C4_Cancer_gene_neighborhoods","C4_CGN_365_GNF2_ITGAL",55,-1.9652,0,0.00037,"No",0.6756,0.97,1,"Yes"
"800","C7_Immunologic_signatures","C7_ALL_1612_GSE3982_MAST_CELL_VS_NEUTROPHIL_DN",196,-1.9633,0,0,"No",-0.695,1,1,"No"
"801","C2_Chemical_and_genetic_perturbations","C2_CGP_2381_BRUECKNER_TARGETS_OF_MIRLET7A3_UP",108,-1.9633,0,0.0015,"No",-0.8452,0.82,1,"No"
"802","GO_MF","514681_GO_0061134_PEPTIDASE_REGULATOR_ACTIVITY",204,-1.9632,0,0.014,"No",1.0076,0.42,0.87,"Yes"
"803","WikiPathways","672454_WP2118_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY",74,-1.963,0,0.003,"No",-1.3823,0.044,0.92,"No"
"804","GO_BP","488316_GO_0002443_LEUKOCYTE_MEDIATED_IMMUNITY",164,-1.9621,0,0.0049,"No",0.9421,0.62,1,"Yes"
"805","C2_Chemical_and_genetic_perturbations","C2_CGP_2544_RUIZ_TNC_TARGETS_UP",153,-1.9615,0,0.0015,"No",0.9905,0.49,0.81,"Yes"
"806","C2_BioCarta_Pathways","C2_CP_BIOCARTA_110_BIOCARTA_TCRA_PATHWAY",11,-1.961,0,0.0047,"No",1.1417,0.28,0.67,"Yes"
"807","KEGG_pathway","HSA05146_AMOEBIASIS",108,-1.9609,0,0.00032,"No",-1.2522,0.1,0.49,"No"
"808","GO_BP","511702_GO_0050731_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION",139,-1.9607,0,0.005,"No",-1.2215,0.085,0.88,"No"
"809","C2_Chemical_and_genetic_perturbations","C2_CGP_1714_BROWNE_INTERFERON_RESPONSIVE_GENES",68,-1.9606,0,0.0015,"No",1.1979,0.16,0.49,"Yes"
"810","C2_Chemical_and_genetic_perturbations","C2_CGP_106_PRAMOONJAGO_SOX4_TARGETS_UP",52,-1.9594,0,0.0016,"No",-0.9873,0.47,1,"No"
"811","KEGG_pathway","HSA05152_TUBERCULOSIS",169,-1.9594,0,0.00035,"No",-1.1079,0.22,0.69,"No"
"812","REACTOME","105707_REACT_13645_EICOSANOIDS",12,-1.9593,0,0.008,"No",-1.0594,0.38,0.93,"No"
"813","C2_Chemical_and_genetic_perturbations","C2_CGP_2569_SWEET_LUNG_CANCER_KRAS_UP",483,-1.9591,0,0.0016,"No",1.2632,0.012,0.42,"Yes"
"814","GO_BP","503320_GO_0034114_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION",16,-1.9588,0,0.0052,"No",-1.1886,0.22,0.9,"No"
"815","C7_Immunologic_signatures","C7_ALL_1466_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN",198,-1.958,0,0,"No",0.8223,0.92,1,"Yes"
"816","C2_Chemical_and_genetic_perturbations","C2_CGP_3209_VANLOO_SP3_TARGETS_DN",88,-1.9579,0,0.0016,"No",-0.6963,0.99,1,"No"
"817","GO_BP","488695_GO_0002822_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",111,-1.9579,0,0.0053,"No",-1.3695,0.029,0.98,"No"
"818","GO_BP","488399_GO_0002526_ACUTE_INFLAMMATORY_RESPONSE",64,-1.9577,0,0.0053,"No",-1.1807,0.18,0.91,"No"
"819","C2_Chemical_and_genetic_perturbations","C2_CGP_1599_LIANG_SILENCED_BY_METHYLATION_2",51,-1.9577,0,0.0016,"No",1.2171,0.15,0.47,"Yes"
"820","WikiPathways","198862_WP69_TCR_SIGNALING_PATHWAY",89,-1.9575,0,0.0033,"No",-0.8447,0.78,1,"No"
"821","GO_BP","1026077_GO_1903305_REGULATION_OF_REGULATED_SECRETORY_PATHWAY",40,-1.957,0,0.0053,"No",0.8501,0.72,1,"Yes"
"822","C7_Immunologic_signatures","C7_ALL_1592_GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN",191,-1.9568,0,0,"No",-0.6092,1,1,"No"
"823","KEGG_pathway","HSA00480_GLUTATHIONE_METABOLISM",46,-1.9562,0,0.00034,"No",-1.4646,0.031,0.39,"No"
"824","C0_Hallmark","H_ALL_32_HALLMARK_XENOBIOTIC_METABOLISM",195,-1.9561,0,0,"No",-0.9348,0.64,0.88,"No"
"825","GO_BP","752430_GO_0086064_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION",13,-1.956,0,0.0053,"No",-1.2181,0.2,0.88,"No"
"826","REACTOME","645326_REACT_120722_ACYL_CHAIN_REMODELLING_OF_PI",14,-1.9558,0.0016,0.0082,"No",0.7712,0.77,1,"Yes"
"827","GO_BP","505490_GO_0042346_POSITIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS",23,-1.9557,0,0.0053,"No",-1.3543,0.11,0.96,"No"
"828","C2_Chemical_and_genetic_perturbations","C2_CGP_984_GROSS_HYPOXIA_VIA_ELK3_ONLY_UP",33,-1.9555,0,0.0017,"No",0.828,0.75,0.98,"Yes"
"829","GO_BP","517581_GO_0072678_T_CELL_MIGRATION",16,-1.9544,0,0.0054,"No",1.1447,0.27,0.84,"Yes"
"830","WikiPathways","700638_WP2359_PARKIN_UBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY",75,-1.954,0,0.003,"No",-1.1227,0.26,0.96,"No"
"831","GO_BP","488567_GO_0002694_REGULATION_OF_LEUKOCYTE_ACTIVATION",407,-1.9536,0,0.0054,"No",0.9143,0.78,1,"Yes"
"832","C7_Immunologic_signatures","C7_ALL_1588_GSE3982_EOSINOPHIL_VS_DC_DN",199,-1.9536,0,0,"No",1.1768,0.11,0.27,"Yes"
"833","GO_BP","511748_GO_0050777_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE",105,-1.9536,0,0.0054,"No",0.6914,0.99,1,"Yes"
"834","GO_BP","488578_GO_0002705_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY",94,-1.9532,0,0.0054,"No",-1.3161,0.077,0.88,"No"
"835","GO_BP","505421_GO_0042269_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",26,-1.9525,0,0.0054,"No",-0.557,0.99,1,"No"
"836","C2_BioCarta_Pathways","C2_CP_BIOCARTA_22_BIOCARTA_BLYMPHOCYTE_PATHWAY",11,-1.9521,0,0.0047,"No",-1.3021,0.16,1,"No"
"837","GO_BP","503244_GO_0034035_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",18,-1.952,0,0.0054,"No",0.7767,0.8,1,"Yes"
"838","GO_BP","502225_GO_0033003_REGULATION_OF_MAST_CELL_ACTIVATION",36,-1.9518,0,0.0054,"No",0.8477,0.71,1,"Yes"
"839","GO_BP","488636_GO_0002763_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION",49,-1.9517,0,0.0054,"No",-1.2755,0.11,0.89,"No"
"840","GO_BP","506573_GO_0043542_ENDOTHELIAL_CELL_MIGRATION",54,-1.9517,0,0.0054,"No",-1.1304,0.24,0.93,"No"
"841","C7_Immunologic_signatures","C7_ALL_1472_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN",198,-1.9511,0,0,"No",1.1936,0.091,0.24,"Yes"
"842","C7_Immunologic_signatures","C7_ALL_222_GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN",192,-1.9509,0,0,"No",-0.8091,0.95,1,"No"
"843","C2_Chemical_and_genetic_perturbations","C2_CGP_313_ELVIDGE_HYPOXIA_BY_DMOG_UP",131,-1.9507,0,0.0018,"No",-0.7743,0.93,1,"No"
"844","C2_Chemical_and_genetic_perturbations","C2_CGP_2324_MATZUK_IMPLANTATION_AND_UTERINE",21,-1.9506,0,0.0018,"No",-0.9019,0.59,1,"No"
"845","GO_BP","508099_GO_0045762_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY",56,-1.9503,0,0.0054,"No",0.9099,0.61,1,"Yes"
"846","C2_Chemical_and_genetic_perturbations","C2_CGP_373_KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP",115,-1.9502,0,0.0018,"No",-0.7535,0.96,1,"No"
"847","C4_Cancer_modules","C4_CM_15_MODULE_16",498,-1.9499,0,0.0013,"No",1.1588,0.066,0.45,"Yes"
"848","KEGG_pathway","HSA04015_RAP1_SIGNALING_PATHWAY",199,-1.9498,0,0.00045,"No",0.9681,0.52,0.96,"Yes"
"849","KEGG_pathway","HSA04961_ENDOCRINE_AND_OTHER_FACTOR_REGULATED_CALCIUM_REABSORPTION",48,-1.9492,0,0.00043,"No",-1.0189,0.4,0.85,"No"
"850","C2_Chemical_and_genetic_perturbations","C2_CGP_2799_WINNEPENNINCKX_MELANOMA_METASTASIS_DN",42,-1.9488,0,0.0018,"No",-0.8875,0.64,1,"No"
"851","WikiPathways","198916_WP408_OXIDATIVE_STRESS",31,-1.9488,0,0.003,"No",-1.2135,0.18,0.91,"No"
"852","C7_Immunologic_signatures","C7_ALL_1265_GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP",187,-1.9484,0,0,"No",-0.9531,0.56,1,"No"
"853","GO_BP","751070_GO_0036150_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING",16,-1.9484,0,0.0056,"No",-0.9426,0.53,1,"No"
"854","KEGG_pathway","HSA05414_DILATED_CARDIOMYOPATHY",89,-1.9482,0,0.00042,"No",-1.5755,0.0072,0.58,"No"
"855","GO_BP","506364_GO_0043304_REGULATION_OF_MAST_CELL_DEGRANULATION",27,-1.9478,0,0.0056,"No",0.8695,0.67,1,"Yes"
"856","GO_BP","502360_GO_0033139_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN",14,-1.9476,0,0.0056,"No",-1.1103,0.34,0.94,"No"
"857","GO_BP","487800_GO_0001909_LEUKOCYTE_MEDIATED_CYTOTOXICITY",35,-1.9474,0,0.0056,"No",0.9847,0.47,1,"Yes"
"858","GO_BP","507948_GO_0045600_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION",40,-1.9473,0,0.0056,"No",-1.0712,0.31,0.96,"No"
"859","REACTOME","730334_REACT_150420_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX_",22,-1.947,0.0015,0.0088,"No",0.9131,0.6,0.89,"Yes"
"860","C2_Chemical_and_genetic_perturbations","C2_CGP_1863_GEISS_RESPONSE_TO_DSRNA_UP",37,-1.9469,0,0.0019,"No",-0.8595,0.7,1,"No"
"861","GO_BP","511411_GO_0050427_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS",18,-1.9468,0,0.0056,"No",0.7581,0.8,1,"Yes"
"862","GO_BP","519046_GO_2000406_POSITIVE_REGULATION_OF_T_CELL_MIGRATION",19,-1.9461,0.0015,0.0056,"No",-0.7081,0.89,1,"No"
"863","WikiPathways","198915_WP206_FATTY_ACID_OMEGA_OXIDATION",15,-1.9454,0.0015,0.0028,"No",-1.7988,0.0019,0.25,"No"
"864","C2_Chemical_and_genetic_perturbations","C2_CGP_2214_RIGGI_EWING_SARCOMA_PROGENITOR_UP",422,-1.945,0,0.002,"No",0.9288,0.75,0.89,"Yes"
"865","C2_Chemical_and_genetic_perturbations","C2_CGP_2315_ZHENG_IL22_SIGNALING_UP",55,-1.9449,0,0.002,"No",0.8532,0.74,0.97,"Yes"
"866","C2_Chemical_and_genetic_perturbations","C2_CGP_748_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",63,-1.9442,0,0.002,"No",-0.9016,0.66,1,"No"
"867","REACTOME","187094_REACT_23837_INTERLEUKIN_3_5_AND_GM_CSF_SIGNALING",44,-1.9438,0,0.0088,"No",-0.7636,0.87,1,"No"
"868","C4_Cancer_modules","C4_CM_49_MODULE_53",394,-1.9433,0,0.0014,"No",0.9553,0.63,0.77,"Yes"
"869","GO_BP","501871_GO_0032645_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION",12,-1.943,0,0.0057,"No",-1.9503,0.0019,0.37,"No"
"870","GO_BP","518223_GO_0090083_REGULATION_OF_INCLUSION_BODY_ASSEMBLY",16,-1.9429,0,0.0057,"No",-1.6156,0.017,0.7,"No"
"871","GO_BP","506360_GO_0043300_REGULATION_OF_LEUKOCYTE_DEGRANULATION",35,-1.9425,0,0.0058,"No",0.9153,0.59,1,"Yes"
"872","GO_BP","511856_GO_0050921_POSITIVE_REGULATION_OF_CHEMOTAXIS",103,-1.9422,0,0.0058,"No",1.0478,0.34,0.95,"Yes"
"873","GO_BP","511701_GO_0050730_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION",190,-1.9417,0,0.0058,"No",-1.0556,0.33,0.97,"No"
"874","GO_BP","494536_GO_0010466_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY",217,-1.9416,0,0.0057,"No",0.9879,0.47,0.99,"Yes"
"875","C2_Chemical_and_genetic_perturbations","C2_CGP_2464_DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN",28,-1.9413,0,0.0021,"No",1.6339,0.013,0.12,"Yes"
"876","GO_BP","519043_GO_2000403_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION",25,-1.9412,0,0.0057,"No",0.983,0.47,1,"Yes"
"877","C7_Immunologic_signatures","C7_ALL_1545_GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP",191,-1.9409,0,0,"No",1.1814,0.12,0.26,"Yes"
"878","C2_Chemical_and_genetic_perturbations","C2_CGP_1794_VERRECCHIA_EARLY_RESPONSE_TO_TGFB1",58,-1.9408,0,0.0021,"No",-0.7844,0.87,1,"No"
"879","GO_BP","508102_GO_0045765_REGULATION_OF_ANGIOGENESIS",190,-1.9407,0,0.0058,"No",0.9365,0.66,1,"Yes"
"880","C6_Oncogenic_signatures","C6_ALL_128_CAHOY_ASTROGLIAL",98,-1.9402,0,9.4e-05,"No",-0.9372,0.56,0.84,"No"
"881","GO_BP","508103_GO_0045766_POSITIVE_REGULATION_OF_ANGIOGENESIS",110,-1.9397,0.0012,0.0059,"No",1.1005,0.24,0.9,"Yes"
"882","GO_BP","514268_GO_0060713_LABYRINTHINE_LAYER_MORPHOGENESIS",21,-1.9395,0,0.0059,"No",-1.4937,0.041,0.82,"No"
"883","GO_BP","508888_GO_0046640_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION",25,-1.9394,0,0.0058,"No",0.6573,0.94,1,"Yes"
"884","GO_BP","516320_GO_0071396_CELLULAR_RESPONSE_TO_LIPID",320,-1.9392,0,0.0059,"No",-1.0279,0.37,0.97,"No"
"885","GO_BP","488147_GO_0002274_MYELOID_LEUKOCYTE_ACTIVATION",103,-1.9382,0,0.0059,"No",0.9752,0.51,1,"Yes"
"886","GO_BP","495016_GO_0010951_NEGATIVE_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY",210,-1.9381,0,0.0059,"No",0.99,0.48,0.99,"Yes"
"887","C2_Chemical_and_genetic_perturbations","C2_CGP_871_SIMBULAN_UV_RESPONSE_NORMAL_UP",9,-1.9378,0,0.0021,"No",-1.613,0.026,0.4,"No"
"888","C2_Chemical_and_genetic_perturbations","C2_CGP_2140_HELLER_HDAC_TARGETS_UP",310,-1.9378,0,0.0021,"No",-1.6337,0,0.37,"No"
"889","C7_Immunologic_signatures","C7_ALL_965_GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP",200,-1.9378,0,0,"No",-1.002,0.43,1,"No"
"890","WikiPathways","198918_WP619_TYPE_II_INTERFERON_SIGNALING_IFNG_",48,-1.9374,0,0.003,"No",-1.2083,0.17,0.89,"No"
"891","C7_Immunologic_signatures","C7_ALL_137_GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP",194,-1.9373,0,0,"No",-0.769,0.97,1,"No"
"892","GO_BP","512642_GO_0051770_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS",15,-1.9371,0,0.0059,"No",-0.8072,0.75,1,"No"
"893","GO_BP","491526_GO_0006636_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS",54,-1.9368,0,0.0059,"No",-0.9981,0.47,0.99,"No"
"894","GO_CC","490911_GO_0005912_ADHERENS_JUNCTION",452,-1.9367,0,0.0071,"No",1.5419,0,0.16,"Yes"
"895","GO_BP","508161_GO_0045840_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION",39,-1.9367,0,0.0059,"No",-1.1559,0.25,0.92,"No"
"896","GO_BP","507486_GO_0045086_POSITIVE_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS",13,-1.9361,0,0.0059,"No",-0.8434,0.67,1,"No"
"897","GO_BP","503800_GO_0034599_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",153,-1.9361,0,0.0059,"No",-0.8714,0.81,1,"No"
"898","GO_BP","492390_GO_0008015_BLOOD_CIRCULATION",286,-1.9359,0,0.0059,"No",-1.1678,0.11,0.91,"No"
"899","GO_BP","505564_GO_0042423_CATECHOLAMINE_BIOSYNTHETIC_PROCESS",18,-1.9356,0.0015,0.0059,"No",-0.998,0.44,0.99,"No"
"900","GO_BP","501886_GO_0032660_REGULATION_OF_INTERLEUKIN_17_PRODUCTION",21,-1.9353,0.0015,0.0059,"No",-1.5721,0.03,0.72,"No"
"901","C7_Immunologic_signatures","C7_ALL_1404_GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN",200,-1.9351,0,0,"No",1.5609,0,0.0053,"Yes"
"902","C7_Immunologic_signatures","C7_ALL_1341_GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP",200,-1.9348,0,0,"No",-1.0338,0.39,1,"No"
"903","C2_Chemical_and_genetic_perturbations","C2_CGP_220_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP",190,-1.9348,0,0.0022,"No",1.3433,0.023,0.35,"Yes"
"904","C2_Chemical_and_genetic_perturbations","C2_CGP_2901_TIAN_TNF_SIGNALING_NOT_VIA_NFKB",22,-1.9346,0,0.0022,"No",-1.9598,0.0019,0.094,"No"
"905","C4_Cancer_modules","C4_CM_96_MODULE_101",9,-1.9338,0,0.0016,"No",-1.442,0.08,0.48,"No"
"906","GO_BP","507946_GO_0045598_REGULATION_OF_FAT_CELL_DIFFERENTIATION",93,-1.9338,0,0.0059,"No",-1.1225,0.24,0.94,"No"
"907","C2_Chemical_and_genetic_perturbations","C2_CGP_822_WEINMANN_ADAPTATION_TO_HYPOXIA_DN",40,-1.9336,0,0.0022,"No",-0.9371,0.55,1,"No"
"908","C2_Chemical_and_genetic_perturbations","C2_CGP_1569_APPEL_IMATINIB_RESPONSE",33,-1.9336,0,0.0022,"No",0.6894,0.94,1,"Yes"
"909","WikiPathways","198898_WP697_ESTROGEN_METABOLISM",16,-1.9336,0.0015,0.0028,"No",-1.0977,0.32,0.94,"No"
"910","REACTOME","1183588_REACT_355391_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3",63,-1.9332,0,0.0099,"No",-1.8895,0.0018,0.062,"No"
"911","C2_Chemical_and_genetic_perturbations","C2_CGP_1597_KIM_HYPOXIA",25,-1.9327,0,0.0022,"No",-1.2441,0.16,0.75,"No"
"912","C2_Chemical_and_genetic_perturbations","C2_CGP_1697_BROWNE_HCMV_INFECTION_24HR_DN",146,-1.9316,0,0.0022,"No",0.8478,0.86,0.97,"Yes"
"913","C2_Chemical_and_genetic_perturbations","C2_CGP_1054_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN",373,-1.9315,0,0.0022,"No",-1.028,0.35,0.98,"No"
"914","C2_Chemical_and_genetic_perturbations","C2_CGP_319_ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN",104,-1.9315,0,0.0022,"No",-0.9044,0.65,1,"No"
"915","GO_BP","488581_GO_0002708_POSITIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY",79,-1.9311,0,0.0062,"No",-1.4876,0.013,0.83,"No"
"916","GO_BP","510613_GO_0048545_RESPONSE_TO_STEROID_HORMONE",358,-1.9309,0,0.0062,"No",-0.9973,0.46,0.99,"No"
"917","C4_Cancer_modules","C4_CM_168_MODULE_178",14,-1.9308,0,0.0017,"No",0.4985,0.99,1,"Yes"
"918","C2_Chemical_and_genetic_perturbations","C2_CGP_1266_ZUCCHI_METASTASIS_DN",43,-1.9308,0,0.0022,"No",-1.1009,0.28,0.91,"No"
"919","GO_BP","508874_GO_0046626_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY",40,-1.9305,0,0.0062,"No",-0.991,0.48,1,"No"
"920","C7_Immunologic_signatures","C7_ALL_1619_GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP",199,-1.9301,0,0,"No",0.7523,0.99,1,"Yes"
"921","GO_BP","488239_GO_0002366_LEUKOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",119,-1.9301,0,0.0062,"No",-0.6096,1,1,"No"
"922","C6_Oncogenic_signatures","C6_ALL_57_MYC_UP_V1_DN",160,-1.9291,0,8.7e-05,"No",-1.3446,0.04,0.44,"No"
"923","GO_BP","508898_GO_0046651_LYMPHOCYTE_PROLIFERATION",81,-1.9284,0,0.0064,"No",0.6648,1,1,"Yes"
"924","GO_BP","491990_GO_0007190_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY",35,-1.9281,0,0.0064,"No",0.9455,0.54,1,"Yes"
"925","GO_MF","752611_GO_0097110_SCAFFOLD_PROTEIN_BINDING",38,-1.928,0,0.021,"No",-0.9169,0.6,0.97,"No"
"926","GO_MF","506579_GO_0043548_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING",27,-1.928,0,0.02,"No",-0.7152,0.9,1,"No"
"927","GO_BP","488546_GO_0002673_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE",65,-1.9277,0,0.0064,"No",-1.3332,0.068,0.91,"No"
"928","GO_BP","494640_GO_0010575_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION",25,-1.9274,0.0029,0.0064,"No",-1.1511,0.26,0.93,"No"
"929","C4_Cancer_modules","C4_CM_273_MODULE_312",46,-1.927,0.0014,0.0017,"No",1.0613,0.34,0.61,"Yes"
"930","C2_Chemical_and_genetic_perturbations","C2_CGP_781_WANG_METHYLATED_IN_BREAST_CANCER",35,-1.927,0,0.0024,"No",-1.002,0.44,1,"No"
"931","C6_Oncogenic_signatures","C6_ALL_62_SNF5_DN_V1_UP",149,-1.9268,0,8.1e-05,"No",1.0414,0.35,0.72,"Yes"
"932","GO_BP","501877_GO_0032651_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION",37,-1.9268,0.0014,0.0065,"No",-0.9048,0.6,1,"No"
"933","GO_MF","490159_GO_0004857_ENZYME_INHIBITOR_ACTIVITY",323,-1.9267,0,0.019,"No",-0.8646,0.89,1,"No"
"934","C4_Cancer_modules","C4_CM_108_MODULE_113",100,-1.9264,0,0.0017,"No",-1.0799,0.29,0.68,"No"
"935","GO_BP","488570_GO_0002697_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS",290,-1.9262,0,0.0065,"No",-0.8038,0.97,1,"No"
"936","C7_Immunologic_signatures","C7_ALL_1597_GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP",198,-1.9262,0,0,"No",0.8696,0.87,1,"Yes"
"937","GO_BP","488759_GO_0002886_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",36,-1.9261,0,0.0065,"No",0.7034,0.94,1,"Yes"
"938","GO_BP","506197_GO_0043123_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",177,-1.9259,0,0.0065,"No",-0.7752,0.96,1,"No"
"939","C2_Chemical_and_genetic_perturbations","C2_CGP_505_MCBRYAN_PUBERTAL_BREAST_6_7WK_DN",77,-1.9258,0,0.0024,"No",1.0979,0.29,0.64,"Yes"
"940","GO_CC","501145_GO_0031904_ENDOSOME_LUMEN",13,-1.9257,0,0.0077,"No",-0.5798,0.96,1,"No"
"941","C2_Chemical_and_genetic_perturbations","C2_CGP_2138_HELLER_SILENCED_BY_METHYLATION_UP",267,-1.9256,0,0.0024,"No",-0.9681,0.54,1,"No"
"942","C6_Oncogenic_signatures","C6_ALL_107_MEL18_DN_V1_DN",144,-1.9255,0,7.6e-05,"No",0.8886,0.76,0.96,"Yes"
"943","KEGG_pathway","HSA05014_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS_",51,-1.9255,0,0.00055,"No",-0.8225,0.8,1,"No"
"944","C2_Chemical_and_genetic_perturbations","C2_CGP_2660_CROONQUIST_STROMAL_STIMULATION_UP",58,-1.9255,0,0.0024,"No",-1.2428,0.13,0.75,"No"
"945","KEGG_compound","C00157_PHOSPHATIDYLCHOLINE_LECITHIN_PHOSPHATIDYL_N_TRIMETHYLETHANOLAMINE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_CHOLINE_PHOSPHATIDE_3_SN_PHOSPHATIDYLCHOLINE",34,-1.9254,0.0014,0.0032,"No",-0.6424,0.97,1,"No"
"946","GO_BP","500118_GO_0030819_POSITIVE_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS",82,-1.9253,0,0.0065,"No",-0.9577,0.53,1,"No"
"947","C7_Immunologic_signatures","C7_ALL_1768_GSE7460_TCONV_VS_TREG_THYMUS_DN",200,-1.9251,0,0,"No",0.6961,1,1,"Yes"
"948","C2_Chemical_and_genetic_perturbations","C2_CGP_324_GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP",22,-1.9249,0,0.0024,"No",-1.3373,0.1,0.69,"No"
"949","C2_Chemical_and_genetic_perturbations","C2_CGP_1518_ABBUD_LIF_SIGNALING_1_UP",43,-1.9249,0,0.0024,"No",1.3042,0.096,0.39,"Yes"
"950","GO_BP","507514_GO_0045123_CELLULAR_EXTRAVASATION",26,-1.9248,0,0.0065,"No",-0.8707,0.67,1,"No"
"951","GO_BP","489009_GO_0003215_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS",16,-1.9247,0,0.0065,"No",-0.9766,0.48,1,"No"
"952","GO_BP","511807_GO_0050865_REGULATION_OF_CELL_ACTIVATION",437,-1.9243,0,0.0065,"No",0.9238,0.8,1,"Yes"
"953","C4_Cancer_modules","C4_CM_91_MODULE_96",35,-1.9241,0,0.0017,"No",-1.2478,0.15,0.58,"No"
"954","C4_Cancer_modules","C4_CM_342_MODULE_410",34,-1.924,0,0.0016,"No",-1.1669,0.21,0.63,"No"
"955","C7_Immunologic_signatures","C7_ALL_989_GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP",198,-1.924,0,0,"No",0.8862,0.81,1,"Yes"
"956","C2_Chemical_and_genetic_perturbations","C2_CGP_155_NEWMAN_ERCC6_TARGETS_UP",26,-1.9232,0,0.0024,"No",0.9545,0.53,0.86,"Yes"
"957","C2_Chemical_and_genetic_perturbations","C2_CGP_2352_BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN",30,-1.9227,0,0.0024,"No",-1.1606,0.25,0.83,"No"
"958","C2_Chemical_and_genetic_perturbations","C2_CGP_2725_CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP",24,-1.9224,0,0.0025,"No",0.7264,0.87,1,"Yes"
"959","C2_Chemical_and_genetic_perturbations","C2_CGP_1321_SANA_TNF_SIGNALING_DN",89,-1.9223,0,0.0024,"No",1.0486,0.35,0.71,"Yes"
"960","GO_BP","488811_GO_0003013_CIRCULATORY_SYSTEM_PROCESS",307,-1.9218,0,0.0067,"No",-1.1322,0.15,0.93,"No"
"961","GO_BP","501915_GO_0032689_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION",27,-1.9218,0,0.0067,"No",-0.9492,0.53,1,"No"
"962","GO_BP","751866_GO_0044724_SINGLE_ORGANISM_CARBOHYDRATE_CATABOLIC_PROCESS",118,-1.9211,0,0.0067,"No",-0.816,0.88,1,"No"
"963","GO_CC","921100_GO_0098552_SIDE_OF_MEMBRANE",315,-1.921,0,0.0077,"No",0.9723,0.58,0.82,"Yes"
"964","C7_Immunologic_signatures","C7_ALL_905_GSE20715_0H_VS_24H_OZONE_LUNG_UP",198,-1.9208,0,0,"No",0.8238,0.93,1,"Yes"
"965","GO_BP","508879_GO_0046631_ALPHA_BETA_T_CELL_ACTIVATION",52,-1.9207,0,0.0068,"No",-0.7721,0.85,1,"No"
"966","C2_Chemical_and_genetic_perturbations","C2_CGP_3092_WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG",25,-1.9207,0,0.0025,"No",-0.9932,0.47,1,"No"
"967","C4_Cancer_gene_neighborhoods","C4_CGN_408_GNF2_SNRK",28,-1.92,0,0.00058,"No",0.5179,1,1,"Yes"
"968","GO_CC","490373_GO_0046658_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE",37,-1.9196,0,0.0074,"No",1.2641,0.12,0.45,"Yes"
"969","REACTOME","1183540_REACT_355210_MYD88_DEFICIENCY_TLR2_4_",10,-1.9195,0,0.012,"No",-0.8262,0.68,1,"No"
"970","GO_BP","505458_GO_0042312_REGULATION_OF_VASODILATION",40,-1.9195,0,0.0069,"No",1.2551,0.14,0.73,"Yes"
"971","C7_Immunologic_signatures","C7_ALL_302_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN",198,-1.9191,0,0,"No",0.6491,1,1,"Yes"
"972","GO_BP","508017_GO_0045669_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION",58,-1.9189,0,0.0069,"No",-0.8115,0.81,1,"No"
"973","C2_Chemical_and_genetic_perturbations","C2_CGP_1488_LEI_MYB_TARGETS",313,-1.9185,0,0.0026,"No",0.8966,0.83,0.93,"Yes"
"974","C7_Immunologic_signatures","C7_ALL_1332_GSE30083_SP2_VS_SP3_THYMOCYTE_DN",196,-1.9185,0,0,"No",-1.1506,0.14,1,"No"
"975","C2_Chemical_and_genetic_perturbations","C2_CGP_2906_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP",83,-1.9185,0,0.0025,"No",0.8449,0.81,0.97,"Yes"
"976","C1_Positional","C1_ALL_102_CHR1Q23",92,-1.9181,0,0.021,"No",1.0592,0.31,0.66,"Yes"
"977","GO_BP","501957_GO_0032731_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION",24,-1.9177,0,0.007,"No",-1.0926,0.33,0.95,"No"
"978","C2_Chemical_and_genetic_perturbations","C2_CGP_2609_ZHANG_TLX_TARGETS_DN",108,-1.9174,0,0.0026,"No",-0.9576,0.56,1,"No"
"979","WikiPathways","198792_WP1433_NOD_PATHWAY",38,-1.9162,0,0.0033,"No",-0.8925,0.63,1,"No"
"980","C2_Chemical_and_genetic_perturbations","C2_CGP_2166_FINETTI_BREAST_CANCER_KINOME_GREEN",16,-1.9157,0,0.0026,"No",-0.9497,0.5,1,"No"
"981","GO_BP","507488_GO_0045088_REGULATION_OF_INNATE_IMMUNE_RESPONSE",255,-1.9155,0,0.0071,"No",0.624,1,1,"Yes"
"982","REACTOME","161021_REACT_21264_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS",8,-1.9151,0,0.012,"No",0.909,0.54,0.9,"Yes"
"983","KEGG_compound","C00051_GLUTATHIONE_5_L_GLUTAMYL_L_CYSTEINYLGLYCINE_N_N_GAMMA_L_GLUTAMYL_L_CYSTEINYL_GLYCINE_GAMMA_L_GLUTAMYL_L_CYSTEINYL_GLYCINE_GSH_REDUCED_GLUTATHIONE",35,-1.9151,0,0.004,"No",-1.5728,0.015,0.18,"No"
"984","GO_BP","496151_GO_0016052_CARBOHYDRATE_CATABOLIC_PROCESS",125,-1.9143,0,0.0073,"No",0.8221,0.88,1,"Yes"
"985","KEGG_pathway","HSA05150_STAPHYLOCOCCUS_AUREUS_INFECTION",52,-1.9141,0,0.00075,"No",-0.906,0.63,0.97,"No"
"986","GO_BP","500538_GO_0031279_REGULATION_OF_CYCLASE_ACTIVITY",115,-1.9136,0,0.0073,"No",0.9549,0.57,1,"Yes"
"987","C7_Immunologic_signatures","C7_ALL_1801_GSE7764_NKCELL_VS_SPLENOCYTE_UP",199,-1.9132,0,0,"No",-0.726,0.99,1,"No"
"988","C7_Immunologic_signatures","C7_ALL_160_GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN",197,-1.9124,0,0,"No",-1.0248,0.38,1,"No"
"989","C7_Immunologic_signatures","C7_ALL_290_GSE14350_IL2RB_KO_VS_WT_TREG_DN",199,-1.9123,0,0,"No",-0.8897,0.75,1,"No"
"990","C7_Immunologic_signatures","C7_ALL_1026_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN",200,-1.9122,0,0,"No",0.9266,0.68,0.96,"Yes"
"991","GO_MF","498648_GO_0019864_IGG_BINDING",12,-1.9122,0,0.023,"No",-1.0731,0.35,0.85,"No"
"992","C7_Immunologic_signatures","C7_ALL_1764_GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN",191,-1.9121,0,0,"No",1.211,0.085,0.21,"Yes"
"993","GO_BP","487714_GO_0001818_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION",189,-1.9119,0,0.0075,"No",0.957,0.57,1,"Yes"
"994","C7_Immunologic_signatures","C7_ALL_1680_GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN",191,-1.9118,0,0,"No",-1.0455,0.33,1,"No"
"995","GO_MF","487838_GO_0001948_GLYCOPROTEIN_BINDING",77,-1.9113,0,0.022,"No",-0.9886,0.48,0.92,"No"
"996","C4_Cancer_modules","C4_CM_117_MODULE_122",132,-1.9107,0,0.0019,"No",1.0544,0.32,0.62,"Yes"
"997","GO_BP","502165_GO_0032943_MONONUCLEAR_CELL_PROLIFERATION",83,-1.9106,0,0.0076,"No",0.6197,1,1,"Yes"
"998","GO_BP","487801_GO_0001910_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY",51,-1.9105,0,0.0076,"No",-0.7699,0.87,1,"No"
"999","C4_Cancer_modules","C4_CM_327_MODULE_387",49,-1.9105,0,0.0019,"No",-1.1854,0.18,0.61,"No"
"1000","C2_Chemical_and_genetic_perturbations","C2_CGP_141_DOANE_BREAST_CANCER_ESR1_UP",111,-1.9103,0,0.0028,"No",-1.2184,0.11,0.79,"No"
"1001","REACTOME","730333_REACT_150149_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX_",14,-1.9102,0,0.013,"No",-0.8269,0.7,1,"No"
"1002","GO_CC","983697_GO_0098636_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION",30,-1.9099,0.0015,0.0081,"No",-0.8833,0.65,0.96,"No"
"1003","C2_Chemical_and_genetic_perturbations","C2_CGP_2086_RIGGINS_TAMOXIFEN_RESISTANCE_UP",64,-1.9099,0,0.0028,"No",1.0509,0.36,0.71,"Yes"
"1004","C3_TF_targets","C3_TFT_457_V_AP1_Q6_01",255,-1.9097,0,0.0033,"No",-1.0932,0.23,0.56,"No"
"1005","C2_Chemical_and_genetic_perturbations","C2_CGP_2877_CHIARETTI_T_ALL_RELAPSE_PROGNOSIS",19,-1.9095,0,0.0028,"No",0.872,0.66,0.95,"Yes"
"1006","C2_Chemical_and_genetic_perturbations","C2_CGP_122_CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP",39,-1.9093,0,0.0028,"No",-0.7156,0.91,1,"No"
"1007","KEGG_pathway","HSA04972_PANCREATIC_SECRETION",89,-1.9092,0,0.00087,"No",-1.23,0.12,0.53,"No"
"1008","C2_Chemical_and_genetic_perturbations","C2_CGP_3117_ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN",115,-1.9091,0,0.0028,"No",0.7982,0.93,0.99,"Yes"
"1009","C2_Chemical_and_genetic_perturbations","C2_CGP_1067_SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN",55,-1.9089,0,0.0028,"No",-1.1803,0.21,0.82,"No"
"1010","C7_Immunologic_signatures","C7_ALL_1487_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP",195,-1.9089,0,0,"No",-1.0678,0.26,1,"No"
"1011","GO_BP","753073_GO_1900077_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",32,-1.9089,0,0.0077,"No",-1.2363,0.18,0.9,"No"
"1012","C7_Immunologic_signatures","C7_ALL_1410_GSE360_CTRL_VS_L_MAJOR_DC_DN",198,-1.9084,0,0,"No",-0.9064,0.69,1,"No"
"1013","GO_BP","502228_GO_0033006_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",28,-1.9083,0,0.0077,"No",0.8464,0.7,1,"Yes"
"1014","C7_Immunologic_signatures","C7_ALL_1036_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN",193,-1.908,0,0,"No",-1.2168,0.08,0.8,"No"
"1015","C2_Chemical_and_genetic_perturbations","C2_CGP_3179_DELPUECH_FOXO3_TARGETS_UP",67,-1.9077,0,0.0028,"No",-0.7569,0.91,1,"No"
"1016","C2_Chemical_and_genetic_perturbations","C2_CGP_2181_MARZEC_IL2_SIGNALING_UP",114,-1.9074,0,0.0028,"No",-0.7802,0.92,1,"No"
"1017","GO_BP","494639_GO_0010574_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION",29,-1.9072,0.0015,0.0078,"No",-1.1029,0.31,0.94,"No"
"1018","C2_Chemical_and_genetic_perturbations","C2_CGP_2990_NIELSEN_SYNOVIAL_SARCOMA_DN",20,-1.907,0,0.0028,"No",0.865,0.66,0.96,"Yes"
"1019","GO_BP","498214_GO_0019371_CYCLOOXYGENASE_PATHWAY",14,-1.9069,0,0.0078,"No",0.781,0.76,1,"Yes"
"1020","GO_BP","508228_GO_0045921_POSITIVE_REGULATION_OF_EXOCYTOSIS",66,-1.9068,0,0.0078,"No",0.9969,0.43,0.98,"Yes"
"1021","GO_BP","507994_GO_0045646_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION",35,-1.9063,0,0.0078,"No",-0.9726,0.48,1,"No"
"1022","GO_BP","488761_GO_0002888_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",17,-1.9061,0,0.0078,"No",-0.7529,0.83,1,"No"
"1023","GO_BP","491471_GO_0006575_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS",195,-1.9061,0,0.0078,"No",-1.1365,0.16,0.93,"No"
"1024","GO_BP","487507_GO_0001569_PATTERNING_OF_BLOOD_VESSELS",36,-1.9057,0,0.0078,"No",-0.8055,0.78,1,"No"
"1025","C7_Immunologic_signatures","C7_ALL_1204_GSE27786_CD8_TCELL_VS_NKCELL_DN",200,-1.9056,0,0,"No",0.8223,0.95,1,"Yes"
"1026","C2_Chemical_and_genetic_perturbations","C2_CGP_723_ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER",140,-1.9051,0,0.0029,"No",0.625,1,1,"Yes"
"1027","C2_Chemical_and_genetic_perturbations","C2_CGP_2679_VALK_AML_CLUSTER_3",32,-1.9049,0.0014,0.0029,"No",1.308,0.11,0.39,"Yes"
"1028","GO_BP","501951_GO_0032725_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION",12,-1.9047,0,0.0078,"No",-1.9138,0,0.31,"No"
"1029","C7_Immunologic_signatures","C7_ALL_1357_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP",194,-1.9046,0,0,"No",-1.2147,0.083,0.81,"No"
"1030","C2_Chemical_and_genetic_perturbations","C2_CGP_2150_AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G",95,-1.9044,0,0.0029,"No",0.8177,0.87,0.98,"Yes"
"1031","GO_BP","488302_GO_0002429_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",186,-1.9042,0,0.0079,"No",-0.6312,1,1,"No"
"1032","GO_MF","489324_GO_0003823_ANTIGEN_BINDING",74,-1.9041,0,0.023,"No",-1.045,0.36,0.86,"No"
"1033","KEGG_pathway","HSA04666_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS",91,-1.9036,0,0.00095,"No",-0.8338,0.81,1,"No"
"1034","GO_BP","494895_GO_0010831_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION",23,-1.9035,0.0015,0.008,"No",1.4246,0.074,0.52,"Yes"
"1035","GO_BP","508629_GO_0046365_MONOSACCHARIDE_CATABOLIC_PROCESS",84,-1.9034,0,0.0079,"No",-0.8259,0.81,1,"No"
"1036","GO_BP","502414_GO_0033194_RESPONSE_TO_HYDROPEROXIDE",15,-1.9032,0,0.008,"No",-1.1896,0.23,0.9,"No"
"1037","C7_Immunologic_signatures","C7_ALL_789_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP",192,-1.9025,0,0,"No",-0.9226,0.68,1,"No"
"1038","C2_Chemical_and_genetic_perturbations","C2_CGP_2693_VALK_AML_WITH_11Q23_REARRANGED",22,-1.9025,0,0.003,"No",0.981,0.48,0.81,"Yes"
"1039","GO_MF","490191_GO_0030246_CARBOHYDRATE_BINDING",266,-1.9017,0,0.023,"No",-1.1558,0.12,0.81,"No"
"1040","REACTOME","105688_REACT_18266_AXON_GUIDANCE",325,-1.901,0,0.014,"No",-1.1738,0.083,0.86,"No"
"1041","GO_BP","513701_GO_0060143_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",20,-1.9007,0.0015,0.0082,"No",1.5361,0.044,0.36,"Yes"
"1042","KEGG_pathway","HSA04612_ANTIGEN_PROCESSING_AND_PRESENTATION",69,-1.9007,0,0.00095,"No",-1.0925,0.3,0.7,"No"
"1043","GO_MF","498054_GO_0019199_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY",80,-1.9007,0,0.022,"No",-1.1345,0.24,0.81,"No"
"1044","C7_Immunologic_signatures","C7_ALL_450_GSE17721_CTRL_VS_LPS_1H_BMDM_DN",194,-1.9001,0,0,"No",-1.2731,0.044,0.53,"No"
"1045","GO_BP","500549_GO_0031290_RETINAL_GANGLION_CELL_AXON_GUIDANCE",18,-1.9,0,0.0083,"No",-1.0057,0.44,0.98,"No"
"1046","GO_CC","500511_GO_0031252_CELL_LEADING_EDGE",326,-1.8998,0,0.0092,"No",-0.9648,0.58,0.89,"No"
"1047","C2_Chemical_and_genetic_perturbations","C2_CGP_118_HUTTMANN_B_CLL_POOR_SURVIVAL_UP",270,-1.8998,0,0.0031,"No",-1.1068,0.21,0.92,"No"
"1048","C2_Chemical_and_genetic_perturbations","C2_CGP_848_WOOD_EBV_EBNA1_TARGETS_UP",110,-1.8998,0,0.0031,"No",0.7925,0.93,0.99,"Yes"
"1049","C2_Chemical_and_genetic_perturbations","C2_CGP_201_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP",28,-1.8997,0,0.0031,"No",-1.5643,0.015,0.43,"No"
"1050","REACTOME","576262_REACT_118779_EXTRACELLULAR_MATRIX_ORGANIZATION",262,-1.8996,0,0.014,"No",-0.9468,0.63,1,"No"
"1051","GO_BP","488706_GO_0002833_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS",27,-1.8995,0,0.0083,"No",0.555,0.98,1,"Yes"
"1052","GO_BP","488637_GO_0002764_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY",402,-1.8994,0,0.0083,"No",-0.8184,0.97,1,"No"
"1053","KEGG_pathway","HSA04071_SPHINGOLIPID_SIGNALING_PATHWAY",120,-1.8993,0,0.00096,"No",-1.0879,0.26,0.7,"No"
"1054","GO_BP","499462_GO_0071260_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS",69,-1.8988,0,0.0083,"No",-0.7207,0.95,1,"No"
"1055","KEGG_compound","C04230_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ACYL_SN_GLYCEROL_3_PHOSPHOCHOLINE_ALPHA_ACYLGLYCEROPHOSPHOCHOLINE_2_LYSOLECITHIN_2_LYSOPHOSPHATIDYLCHOLINE_1_ACYLGLYCEROPHOSPHOCHOLINE",27,-1.8988,0,0.0047,"No",-1.003,0.44,1,"No"
"1056","C7_Immunologic_signatures","C7_ALL_1131_GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP",183,-1.8986,0,0,"No",-0.7035,0.99,1,"No"
"1057","GO_BP","512066_GO_0051156_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS",22,-1.8986,0,0.0083,"No",-0.8612,0.64,1,"No"
"1058","C2_Chemical_and_genetic_perturbations","C2_CGP_1868_MOREIRA_RESPONSE_TO_TSA_DN",18,-1.8985,0,0.0031,"No",0.9143,0.59,0.91,"Yes"
"1059","GO_BP","488136_GO_0002263_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",120,-1.8981,0,0.0083,"No",-0.6414,1,1,"No"
"1060","C2_Chemical_and_genetic_perturbations","C2_CGP_229_BILBAN_B_CLL_LPL_DN",42,-1.8978,0.0014,0.0031,"No",-1.3187,0.11,0.7,"No"
"1061","C2_Chemical_and_genetic_perturbations","C2_CGP_2270_SMID_BREAST_CANCER_ERBB2_UP",133,-1.8978,0,0.0031,"No",-0.7908,0.92,1,"No"
"1062","C2_Chemical_and_genetic_perturbations","C2_CGP_639_HUMMERICH_SKIN_CANCER_PROGRESSION_UP",85,-1.8976,0,0.0031,"No",0.9203,0.64,0.9,"Yes"
"1063","REACTOME","366167_REACT_75808_THE_NLRP3_INFLAMMASOME",12,-1.8969,0,0.014,"No",-0.9582,0.5,1,"No"
"1064","C2_Chemical_and_genetic_perturbations","C2_CGP_2672_ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP",32,-1.8968,0.0015,0.0032,"No",0.9567,0.51,0.86,"Yes"
"1065","C7_Immunologic_signatures","C7_ALL_651_GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDM_UP",195,-1.8968,0,0,"No",1.5186,0.0023,0.0094,"Yes"
"1066","C2_Chemical_and_genetic_perturbations","C2_CGP_544_DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP",141,-1.8961,0,0.0032,"No",1.0588,0.35,0.7,"Yes"
"1067","C2_Chemical_and_genetic_perturbations","C2_CGP_1454_MA_MYELOID_DIFFERENTIATION_DN",44,-1.8959,0,0.0032,"No",-0.8484,0.71,1,"No"
"1068","C7_Immunologic_signatures","C7_ALL_860_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN",191,-1.8958,0,0,"No",-0.7947,0.94,1,"No"
"1069","WikiPathways","198864_WP364_IL_6_SIGNALING_PATHWAY",98,-1.8955,0,0.0042,"No",-1.0268,0.38,0.98,"No"
"1070","C2_Chemical_and_genetic_perturbations","C2_CGP_2855_CAIRO_HEPATOBLASTOMA_CLASSES_DN",206,-1.8954,0,0.0032,"No",-0.8761,0.8,1,"No"
"1071","KEGG_pathway","HSA05020_PRION_DISEASES",36,-1.895,0,0.00099,"No",-0.9777,0.49,0.9,"No"
"1072","C2_Chemical_and_genetic_perturbations","C2_CGP_1927_KAAB_FAILED_HEART_VENTRICLE_DN",41,-1.8946,0,0.0032,"No",0.9344,0.58,0.88,"Yes"
"1073","C2_Chemical_and_genetic_perturbations","C2_CGP_2415_HUPER_BREAST_BASAL_VS_LUMINAL_UP",53,-1.8945,0.0014,0.0032,"No",1.1643,0.19,0.53,"Yes"
"1074","C2_Chemical_and_genetic_perturbations","C2_CGP_3327_BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE",150,-1.8945,0,0.0032,"No",1.5854,0,0.15,"Yes"
"1075","GO_BP","512233_GO_0051349_POSITIVE_REGULATION_OF_LYASE_ACTIVITY",68,-1.8944,0,0.0088,"No",-0.9194,0.62,1,"No"
"1076","C4_Cancer_modules","C4_CM_69_MODULE_73",23,-1.8942,0,0.0024,"No",1.6137,0.014,0.071,"Yes"
"1077","C2_Chemical_and_genetic_perturbations","C2_CGP_2571_SWEET_KRAS_ONCOGENIC_SIGNATURE",89,-1.8942,0,0.0032,"No",1.5669,0.0089,0.16,"Yes"
"1078","C4_Cancer_modules","C4_CM_226_MODULE_248",129,-1.8941,0,0.0023,"No",-1.1735,0.16,0.62,"No"
"1079","GO_BP","510586_GO_0048514_BLOOD_VESSEL_MORPHOGENESIS",359,-1.8941,0,0.0088,"No",-1.0744,0.25,0.96,"No"
"1080","REACTOME","160967_REACT_20649_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS",17,-1.8939,0,0.014,"No",-0.9951,0.47,0.99,"No"
"1081","C7_Immunologic_signatures","C7_ALL_1406_GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN",195,-1.8936,0,0,"No",1.0158,0.38,0.69,"Yes"
"1082","GO_BP","1184560_GO_1904036_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS",32,-1.8933,0,0.0089,"No",0.9542,0.5,1,"Yes"
"1083","GO_BP","513296_GO_0052548_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY",352,-1.893,0,0.0089,"No",0.99,0.5,0.99,"Yes"
"1084","KEGG_pathway","HSA04810_REGULATION_OF_ACTIN_CYTOSKELETON",202,-1.8928,0,0.0011,"No",-0.9425,0.6,0.97,"No"
"1085","GO_BP","501983_GO_0032757_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION",34,-1.8926,0.0015,0.0089,"No",1.2389,0.13,0.75,"Yes"
"1086","C2_Chemical_and_genetic_perturbations","C2_CGP_2723_CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP",176,-1.8925,0,0.0033,"No",-0.9397,0.61,1,"No"
"1087","GO_BP","488869_GO_0003071_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",23,-1.8924,0,0.0089,"No",1.4615,0.045,0.48,"Yes"
"1088","GO_BP","487930_GO_0002040_SPROUTING_ANGIOGENESIS",42,-1.892,0,0.0089,"No",-1.4214,0.042,0.94,"No"
"1089","KEGG_pathway","HSA04664_FC_EPSILON_RI_SIGNALING_PATHWAY",70,-1.8919,0,0.001,"No",-1.2767,0.079,0.46,"No"
"1090","C4_Cancer_modules","C4_CM_396_MODULE_501",15,-1.8916,0.0016,0.0024,"No",-1.5621,0.034,0.3,"No"
"1091","GO_BP","488558_GO_0002685_REGULATION_OF_LEUKOCYTE_MIGRATION",126,-1.8909,0,0.009,"No",1.0045,0.47,0.98,"Yes"
"1092","C2_Chemical_and_genetic_perturbations","C2_CGP_1243_ONDER_CDH1_TARGETS_3_DN",53,-1.8909,0,0.0034,"No",-1.0792,0.34,0.95,"No"
"1093","C2_Chemical_and_genetic_perturbations","C2_CGP_2454_VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP",160,-1.8908,0,0.0034,"No",0.9809,0.52,0.81,"Yes"
"1094","GO_BP","512065_GO_0051155_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION",41,-1.8908,0,0.009,"No",1.1493,0.22,0.84,"Yes"
"1095","C2_Chemical_and_genetic_perturbations","C2_CGP_2182_MARZEC_IL2_SIGNALING_DN",36,-1.8907,0,0.0033,"No",-0.7937,0.82,1,"No"
"1096","C4_Cancer_modules","C4_CM_288_MODULE_329",51,-1.8907,0,0.0024,"No",-1.0337,0.4,0.76,"No"
"1097","GO_BP","488577_GO_0002704_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY",37,-1.8904,0,0.0091,"No",-0.6165,0.98,1,"No"
"1098","KEGG_compound","C04635_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_1_ALKENYLGLYCEROPHOSPHOETHANOLAMINE",22,-1.8901,0,0.0053,"No",-0.8815,0.61,1,"No"
"1099","C4_Cancer_gene_neighborhoods","C4_CGN_293_GNF2_CCNA2",68,-1.8895,0,0.00091,"No",0.9036,0.67,0.83,"Yes"
"1100","GO_BP","502362_GO_0033141_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN",14,-1.8887,0.0015,0.0093,"No",-1.1441,0.28,0.93,"No"
"1101","C2_Chemical_and_genetic_perturbations","C2_CGP_2551_RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN",241,-1.8885,0,0.0034,"No",-0.9125,0.71,1,"No"
"1102","GO_CC","490685_GO_0008305_INTEGRIN_COMPLEX",30,-1.8885,0.0014,0.01,"No",-0.8992,0.6,0.96,"No"
"1103","C3_TF_targets","C3_TFT_316_V_AP1_01",261,-1.8884,0,0.0033,"No",-1.2574,0.035,0.27,"No"
"1104","C7_Immunologic_signatures","C7_ALL_1744_GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN",161,-1.888,0,0,"No",1.0428,0.35,0.61,"Yes"
"1105","GO_BP","505454_GO_0042307_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS",85,-1.8879,0,0.0094,"No",-1.1237,0.25,0.94,"No"
"1106","GO_BP","506082_GO_0042990_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS",82,-1.8878,0,0.0094,"No",-0.9782,0.49,1,"No"
"1107","C2_Chemical_and_genetic_perturbations","C2_CGP_2065_GAVIN_PDE3B_TARGETS",22,-1.8878,0.0015,0.0035,"No",-0.6799,0.92,1,"No"
"1108","C2_Chemical_and_genetic_perturbations","C2_CGP_438_CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",171,-1.8878,0,0.0034,"No",-0.9245,0.66,1,"No"
"1109","GO_BP","489005_GO_0003211_CARDIAC_VENTRICLE_FORMATION",10,-1.8876,0.0016,0.0094,"No",-1.1,0.35,0.94,"No"
"1110","C7_Immunologic_signatures","C7_ALL_1030_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN",195,-1.8874,0,0,"No",-0.749,0.98,1,"No"
"1111","GO_BP","519041_GO_2000401_REGULATION_OF_LYMPHOCYTE_MIGRATION",36,-1.8874,0,0.0094,"No",1.1472,0.25,0.84,"Yes"
"1112","GO_CC","506270_GO_0043202_LYSOSOMAL_LUMEN",71,-1.8867,0,0.01,"No",-0.9475,0.55,0.89,"No"
"1113","C2_Chemical_and_genetic_perturbations","C2_CGP_2750_YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP",10,-1.8866,0.0017,0.0035,"No",-1.5556,0.03,0.43,"No"
"1114","REACTOME","645324_REACT_121384_ACYL_CHAIN_REMODELLING_OF_PS",15,-1.8865,0,0.015,"No",-0.9145,0.56,1,"No"
"1115","C7_Immunologic_signatures","C7_ALL_1031_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP",195,-1.8865,0,0,"No",-0.7349,0.98,1,"No"
"1116","C2_Chemical_and_genetic_perturbations","C2_CGP_1022_SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP",11,-1.8862,0,0.0035,"No",-0.8497,0.66,1,"No"
"1117","GO_BP","500912_GO_0031663_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",27,-1.8862,0.003,0.0095,"No",-1.054,0.37,0.97,"No"
"1118","C2_Chemical_and_genetic_perturbations","C2_CGP_495_ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN",26,-1.8861,0,0.0035,"No",-0.9352,0.57,1,"No"
"1119","GO_BP","488568_GO_0002695_NEGATIVE_REGULATION_OF_LEUKOCYTE_ACTIVATION",121,-1.8858,0,0.0095,"No",-0.791,0.91,1,"No"
"1120","C7_Immunologic_signatures","C7_ALL_310_GSE1460_DP_VS_CD4_THYMOCYTE_DN",200,-1.8858,0,0,"No",1.2786,0.034,0.12,"Yes"
"1121","C2_Chemical_and_genetic_perturbations","C2_CGP_193_OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP",232,-1.8857,0,0.0035,"No",-1.0872,0.23,0.94,"No"
"1122","C2_Chemical_and_genetic_perturbations","C2_CGP_2697_JISON_SICKLE_CELL_DISEASE_UP",180,-1.8856,0,0.0035,"No",1.3784,0.012,0.31,"Yes"
"1123","GO_BP","512140_GO_0051249_REGULATION_OF_LYMPHOCYTE_ACTIVATION",351,-1.8856,0,0.0095,"No",0.7758,0.99,1,"Yes"
"1124","GO_BP","507925_GO_0045577_REGULATION_OF_B_CELL_DIFFERENTIATION",23,-1.8856,0,0.0095,"No",-0.8383,0.69,1,"No"
"1125","GO_BP","514552_GO_0060997_DENDRITIC_SPINE_MORPHOGENESIS",8,-1.8852,0,0.0095,"No",-1.3731,0.13,0.98,"No"
"1126","C3_TF_targets","C3_TFT_117_ARGGGTTAA_UNKNOWN",119,-1.8852,0,0.0025,"No",-1.1967,0.12,0.35,"No"
"1127","GO_BP","491051_GO_0006066_ALCOHOL_METABOLIC_PROCESS",341,-1.8846,0,0.0095,"No",-1.0007,0.47,0.99,"No"
"1128","C7_Immunologic_signatures","C7_ALL_1616_GSE3982_MAST_CELL_VS_BASOPHIL_DN",197,-1.8846,0,0,"No",1.0075,0.43,0.71,"Yes"
"1129","C2_Chemical_and_genetic_perturbations","C2_CGP_2297_BASSO_HAIRY_CELL_LEUKEMIA_DN",80,-1.8844,0.0013,0.0035,"No",0.7513,0.94,1,"Yes"
"1130","C2_Chemical_and_genetic_perturbations","C2_CGP_2607_ZHANG_TLX_TARGETS_60HR_UP",292,-1.8844,0,0.0035,"No",-0.8696,0.85,1,"No"
"1131","GO_BP","501590_GO_0032355_RESPONSE_TO_ESTRADIOL",95,-1.8841,0,0.0096,"No",-0.9991,0.45,0.99,"No"
"1132","C4_Cancer_modules","C4_CM_30_MODULE_33",370,-1.8838,0,0.0025,"No",-0.981,0.54,0.83,"No"
"1133","C3_MicroRNA_targets","C3_MIR_134_TCTCTCC_MIR_185",123,-1.8837,0,0.024,"No",-1.0881,0.27,1,"No"
"1134","C2_BioCarta_Pathways","C2_CP_BIOCARTA_118_BIOCARTA_MONOCYTE_PATHWAY",11,-1.8834,0,0.012,"No",-0.5484,0.97,1,"No"
"1135","GO_BP","488590_GO_0002717_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",19,-1.8833,0.0016,0.0097,"No",-0.4308,1,1,"No"
"1136","GO_BP","808778_GO_1902107_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION",121,-1.8833,0,0.0096,"No",-1.1786,0.13,0.91,"No"
"1137","GO_BP","487506_GO_0001568_BLOOD_VESSEL_DEVELOPMENT",428,-1.8832,0,0.0096,"No",-1.0441,0.32,0.97,"No"
"1138","GO_BP","488160_GO_0002287_ALPHA_BETA_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",23,-1.8829,0.0015,0.0096,"No",-1.0893,0.31,0.95,"No"
"1139","C2_Chemical_and_genetic_perturbations","C2_CGP_2064_GAVIN_FOXP3_TARGETS_CLUSTER_P7",89,-1.8827,0,0.0036,"No",-0.5603,1,1,"No"
"1140","REACTOME","205110_REACT_27283_INTERLEUKIN_2_SIGNALING",49,-1.8826,0,0.015,"No",-0.7366,0.92,1,"No"
"1141","C2_Chemical_and_genetic_perturbations","C2_CGP_293_ZHOU_INFLAMMATORY_RESPONSE_LPS_UP",402,-1.8825,0,0.0036,"No",-1.1822,0.069,0.82,"No"
"1142","GO_BP","506448_GO_0043410_POSITIVE_REGULATION_OF_MAPK_CASCADE",404,-1.8821,0,0.0098,"No",-0.9721,0.54,1,"No"
"1143","KEGG_compound","C01595_LINOLEATE_LINOLEIC_ACID_9Z_12Z_OCTADECADIENOIC_ACID_9_CIS_12_CIS_OCTADECADIENOATE_9_CIS_12_CIS_OCTADECADIENOIC_ACID",30,-1.8816,0.0014,0.0058,"No",-0.8957,0.65,1,"No"
"1144","C2_Chemical_and_genetic_perturbations","C2_CGP_3244_SERVITJA_LIVER_HNF1A_TARGETS_UP",130,-1.8815,0,0.0036,"No",-0.7464,0.97,1,"No"
"1145","GO_BP","497083_GO_0018108_PEPTIDYL_TYROSINE_PHOSPHORYLATION",149,-1.8815,0,0.0098,"No",-1.2505,0.068,0.91,"No"
"1146","GO_CC","499487_GO_0030027_LAMELLIPODIUM",155,-1.8815,0,0.011,"No",-0.8825,0.76,0.95,"No"
"1147","GO_BP","808777_GO_1902106_NEGATIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION",74,-1.8814,0,0.0098,"No",-1.079,0.31,0.95,"No"
"1148","C2_Chemical_and_genetic_perturbations","C2_CGP_223_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN",139,-1.8813,0,0.0036,"No",1.4205,0.016,0.28,"Yes"
"1149","C2_Chemical_and_genetic_perturbations","C2_CGP_1827_GEORGANTAS_HSC_MARKERS",70,-1.8812,0,0.0036,"No",0.89,0.69,0.94,"Yes"
"1150","GO_BP","505665_GO_0042534_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS",15,-1.881,0,0.0098,"No",-0.7263,0.84,1,"No"
"1151","C2_Chemical_and_genetic_perturbations","C2_CGP_642_KLEIN_TARGETS_OF_BCR_ABL1_FUSION",45,-1.8809,0,0.0036,"No",-1.092,0.32,0.93,"No"
"1152","C7_Immunologic_signatures","C7_ALL_885_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP",196,-1.8809,0,0,"No",-0.9206,0.68,1,"No"
"1153","C2_Chemical_and_genetic_perturbations","C2_CGP_906_HOWLIN_PUBERTAL_MAMMARY_GLAND",63,-1.8804,0,0.0036,"No",0.8953,0.67,0.93,"Yes"
"1154","GO_BP","492564_GO_0050830_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM",62,-1.8802,0,0.0099,"No",0.8656,0.71,1,"Yes"
"1155","C2_Chemical_and_genetic_perturbations","C2_CGP_2600_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4",193,-1.88,0,0.0037,"No",-1.3888,0.0089,0.6,"No"
"1156","GO_MF","515779_GO_0070851_GROWTH_FACTOR_RECEPTOR_BINDING",112,-1.8798,0,0.029,"No",-1.021,0.42,0.89,"No"
"1157","GO_BP","489312_GO_0006953_ACUTE_PHASE_RESPONSE",36,-1.8794,0,0.0099,"No",-1.1621,0.22,0.92,"No"
"1158","KEGG_pathway","HSA04260_CARDIAC_MUSCLE_CONTRACTION",70,-1.8792,0,0.0011,"No",1.0228,0.4,0.87,"Yes"
"1159","KEGG_pathway","HSA04064_NF_KAPPA_B_SIGNALING_PATHWAY",87,-1.8792,0,0.0011,"No",-1.08,0.34,0.7,"No"
"1160","C7_Immunologic_signatures","C7_ALL_9_KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP",199,-1.8789,0,0,"No",1.6456,0,0.0012,"Yes"
"1161","GO_BP","753175_GO_1900182_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS",92,-1.8787,0,0.01,"No",-1.013,0.4,0.98,"No"
"1162","REACTOME","106062_REACT_12051_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL",99,-1.8785,0,0.015,"No",0.8451,0.82,0.96,"Yes"
"1163","C2_Chemical_and_genetic_perturbations","C2_CGP_2031_SINGH_NFE2L2_TARGETS",15,-1.8784,0,0.0037,"No",-1.4631,0.07,0.52,"No"
"1164","GO_BP","511855_GO_0050920_REGULATION_OF_CHEMOTAXIS",138,-1.8783,0,0.01,"No",0.8571,0.84,1,"Yes"
"1165","GO_BP","514882_GO_0061337_CARDIAC_CONDUCTION",50,-1.8781,0,0.01,"No",-1.4433,0.036,0.91,"No"
"1166","GO_CC","515098_GO_0070161_ANCHORING_JUNCTION",490,-1.8781,0,0.011,"No",1.5082,0,0.19,"Yes"
"1167","GO_BP","488166_GO_0002293_ALPHA_BETA_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",23,-1.878,0,0.01,"No",-1.1193,0.3,0.94,"No"
"1168","GO_BP","508875_GO_0046627_NEGATIVE_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY",28,-1.8779,0.0015,0.01,"No",-1.1239,0.29,0.94,"No"
"1169","GO_BP","511795_GO_0050850_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING",27,-1.8778,0.0031,0.0099,"No",-0.8695,0.67,1,"No"
"1170","C2_Chemical_and_genetic_perturbations","C2_CGP_863_GRUETZMANN_PANCREATIC_CANCER_UP",357,-1.8778,0,0.0037,"No",1.1757,0.058,0.52,"Yes"
"1171","GO_BP","752806_GO_0097305_RESPONSE_TO_ALCOHOL",275,-1.8773,0,0.01,"No",0.9562,0.61,1,"Yes"
"1172","GO_BP","505171_GO_0040013_NEGATIVE_REGULATION_OF_LOCOMOTION",220,-1.8771,0,0.01,"No",-0.771,0.97,1,"No"
"1173","C2_Chemical_and_genetic_perturbations","C2_CGP_1422_KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP",51,-1.8771,0.0013,0.0037,"No",0.8148,0.81,0.98,"Yes"
"1174","C4_Cancer_modules","C4_CM_424_MODULE_562",21,-1.8771,0,0.0028,"No",-0.8622,0.66,0.94,"No"
"1175","GO_BP","516360_GO_0071436_SODIUM_ION_EXPORT",9,-1.8769,0,0.01,"No",-1.6944,0.018,0.59,"No"
"1176","GO_BP","506196_GO_0043122_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",225,-1.8766,0,0.01,"No",-0.8133,0.92,1,"No"
"1177","GO_CC","496363_GO_0016323_BASOLATERAL_PLASMA_MEMBRANE",188,-1.8764,0,0.011,"No",-1.2129,0.067,0.67,"No"
"1178","REACTOME","106359_REACT_15344_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES",50,-1.8764,0,0.015,"No",1.7255,0.0043,0.039,"Yes"
"1179","GO_BP","487834_GO_0001944_VASCULATURE_DEVELOPMENT",449,-1.8756,0,0.01,"No",-1.0786,0.21,0.95,"No"
"1180","C2_Chemical_and_genetic_perturbations","C2_CGP_3162_PASINI_SUZ12_TARGETS_DN",313,-1.8756,0,0.0038,"No",-0.8779,0.86,1,"No"
"1181","REACTOME","105924_REACT_18405_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION",10,-1.8755,0,0.015,"No",-1.4636,0.064,0.46,"No"
"1182","C7_Immunologic_signatures","C7_ALL_874_GSE20366_TREG_VS_TCONV_DN",198,-1.8754,0,0,"No",-0.9397,0.62,1,"No"
"1183","GO_BP","512141_GO_0051250_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION",104,-1.8752,0,0.01,"No",-0.8192,0.86,1,"No"
"1184","GO_BP","512641_GO_0051769_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS",19,-1.875,0,0.01,"No",0.6969,0.89,1,"Yes"
"1185","C2_Chemical_and_genetic_perturbations","C2_CGP_1585_HANSON_HRAS_SIGNALING_VIA_NFKB",21,-1.8749,0,0.0038,"No",-0.9429,0.53,1,"No"
"1186","C7_Immunologic_signatures","C7_ALL_1071_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP",198,-1.8749,0,0,"No",-0.8534,0.86,1,"No"
"1187","C0_Hallmark","H_ALL_38_HALLMARK_UV_RESPONSE_UP",158,-1.8746,0,0.00019,"No",-1.4887,0.0053,0.073,"No"
"1188","C2_Chemical_and_genetic_perturbations","C2_CGP_333_GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN",93,-1.8744,0,0.0039,"No",0.8935,0.71,0.93,"Yes"
"1189","C4_Cancer_modules","C4_CM_206_MODULE_221",30,-1.8744,0,0.0028,"No",0.7148,0.9,1,"Yes"
"1190","REACTOME","1183538_REACT_355462_IRAK4_DEFICIENCY_TLR2_4_",10,-1.8743,0.0034,0.015,"No",-0.829,0.68,1,"No"
"1191","C2_Chemical_and_genetic_perturbations","C2_CGP_2012_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM",63,-1.8742,0,0.0039,"No",1.2771,0.086,0.42,"Yes"
"1192","WikiPathways","672448_WP2059_ALZHEIMERS_DISEASE",77,-1.8742,0,0.0054,"No",-0.7947,0.86,1,"No"
"1193","C4_Cancer_modules","C4_CM_336_MODULE_401",13,-1.8736,0,0.0028,"No",-0.7009,0.88,1,"No"
"1194","C2_Chemical_and_genetic_perturbations","C2_CGP_311_ELVIDGE_HYPOXIA_UP",171,-1.8736,0,0.0039,"No",-0.8828,0.77,1,"No"
"1195","GO_MF","490244_GO_0004953_ICOSANOID_RECEPTOR_ACTIVITY",16,-1.8732,0.0031,0.031,"No",1.349,0.13,0.53,"Yes"
"1196","C7_Immunologic_signatures","C7_ALL_1479_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP",196,-1.8732,0,0,"No",0.8084,0.96,1,"Yes"
"1197","C2_Chemical_and_genetic_perturbations","C2_CGP_1582_ZHAN_MULTIPLE_MYELOMA_DN",41,-1.8731,0,0.0039,"No",1.2802,0.12,0.41,"Yes"
"1198","GO_BP","488591_GO_0002718_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",50,-1.8723,0,0.011,"No",-1.1523,0.24,0.92,"No"
"1199","C2_Chemical_and_genetic_perturbations","C2_CGP_2303_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN",22,-1.8722,0,0.0039,"No",-1.0768,0.34,0.95,"No"
"1200","GO_BP","503310_GO_0034104_NEGATIVE_REGULATION_OF_TISSUE_REMODELING",15,-1.8722,0,0.011,"No",0.7929,0.73,1,"Yes"
"1201","GO_BP","500601_GO_0031342_NEGATIVE_REGULATION_OF_CELL_KILLING",13,-1.8721,0.0016,0.01,"No",-0.5608,0.98,1,"No"
"1202","C7_Immunologic_signatures","C7_ALL_1523_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP",196,-1.8717,0,0,"No",-0.8137,0.92,1,"No"
"1203","C7_Immunologic_signatures","C7_ALL_1043_GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP",196,-1.8716,0,0,"No",-0.9992,0.47,1,"No"
"1204","GO_BP","488165_GO_0002292_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",23,-1.8715,0,0.011,"No",-1.1081,0.28,0.94,"No"
"1205","WikiPathways","198880_WP558_COMPLEMENT_AND_COAGULATION_CASCADES",51,-1.8714,0,0.0052,"No",0.9695,0.52,1,"Yes"
"1206","C6_Oncogenic_signatures","C6_ALL_154_STK33_NOMO_UP",284,-1.8713,0,0.00035,"No",0.7961,0.99,0.98,"Yes"
"1207","C7_Immunologic_signatures","C7_ALL_1687_GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP",200,-1.8712,0,0,"No",1.2737,0.041,0.13,"Yes"
"1208","GO_BP","488561_GO_0002688_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS",82,-1.8708,0,0.011,"No",1.1024,0.26,0.9,"Yes"
"1209","KEGG_compound","C01176_17ALPHA_HYDROXYPROGESTERONE_17ALPHA_HYDROXY_4_PREGNENE_3_20_DIONE_PREGN_4_ENE_3_20_DIONE_17_OL_17ALPHA_HYDROXY_PROGESTERONE",6,-1.8708,0.0034,0.0066,"No",1.275,0.2,0.79,"Yes"
"1210","C2_Chemical_and_genetic_perturbations","C2_CGP_2628_SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE",101,-1.8707,0,0.004,"No",0.6419,1,1,"Yes"
"1211","C7_Immunologic_signatures","C7_ALL_1340_GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN",196,-1.8707,0,0,"No",-1.2842,0.034,0.5,"No"
"1212","GO_MF","490372_GO_0046875_EPHRIN_RECEPTOR_BINDING",29,-1.8703,0,0.03,"No",-1.2851,0.13,0.81,"No"
"1213","C7_Immunologic_signatures","C7_ALL_637_GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_UP",192,-1.8695,0,0,"No",-1.1977,0.091,0.82,"No"
"1214","C2_Chemical_and_genetic_perturbations","C2_CGP_3111_WIERENGA_STAT5A_TARGETS_UP",216,-1.8693,0,0.0041,"No",-1.0344,0.38,0.97,"No"
"1215","GO_BP","487515_GO_0007157_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES",32,-1.8692,0,0.011,"No",-0.9211,0.57,1,"No"
"1216","GO_CC","499432_GO_0042101_T_CELL_RECEPTOR_COMPLEX",14,-1.8689,0.003,0.012,"No",1.4064,0.07,0.29,"Yes"
"1217","KEGG_pathway","HSA04145_PHAGOSOME",146,-1.8688,0,0.0013,"No",0.7662,0.95,1,"Yes"
"1218","C4_Cancer_modules","C4_CM_417_MODULE_543",14,-1.8688,0.0031,0.003,"No",-0.9324,0.55,0.88,"No"
"1219","WikiPathways","198795_WP306_FOCAL_ADHESION",181,-1.8687,0,0.0051,"No",0.7486,0.99,1,"Yes"
"1220","C2_Chemical_and_genetic_perturbations","C2_CGP_1442_ZHAN_MULTIPLE_MYELOMA_CD1_UP",45,-1.8685,0,0.0041,"No",-0.9644,0.51,1,"No"
"1221","C4_Cancer_modules","C4_CM_264_MODULE_300",33,-1.8682,0,0.0029,"No",-0.6491,0.95,1,"No"
"1222","GO_BP","488322_GO_0002449_LYMPHOCYTE_MEDIATED_IMMUNITY",120,-1.8677,0,0.011,"No",0.6908,1,1,"Yes"
"1223","GO_BP","512159_GO_0051271_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT",199,-1.8677,0,0.011,"No",-0.8401,0.89,1,"No"
"1224","GO_BP","508019_GO_0045671_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION",21,-1.8675,0.0016,0.011,"No",-0.8362,0.71,1,"No"
"1225","GO_BP","488572_GO_0002699_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS",152,-1.867,0,0.011,"No",-1.043,0.35,0.98,"No"
"1226","GO_BP","500607_GO_0031348_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE",124,-1.8669,0,0.011,"No",0.7886,0.95,1,"Yes"
"1227","GO_BP","488694_GO_0002821_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE",81,-1.8668,0,0.011,"No",-1.4638,0.016,0.87,"No"
"1228","REACTOME","106036_REACT_1695_GPVI_MEDIATED_ACTIVATION_CASCADE",49,-1.8668,0.0014,0.016,"No",-0.6574,0.97,1,"No"
"1229","GO_BP","501835_GO_0032609_INTERFERON_GAMMA_PRODUCTION",18,-1.8666,0,0.011,"No",-0.9439,0.54,1,"No"
"1230","C2_Chemical_and_genetic_perturbations","C2_CGP_488_WANG_BARRETTS_ESOPHAGUS_DN",22,-1.8663,0,0.0042,"No",0.729,0.86,1,"Yes"
"1231","REACTOME","106503_REACT_11051_RHO_GTPASE_CYCLE",123,-1.8663,0,0.015,"No",-1.1608,0.19,0.84,"No"
"1232","C7_Immunologic_signatures","C7_ALL_1840_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN",189,-1.8662,0,0,"No",0.9937,0.47,0.76,"Yes"
"1233","C2_Chemical_and_genetic_perturbations","C2_CGP_480_WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN",34,-1.8661,0,0.0042,"No",-1.3935,0.058,0.59,"No"
"1234","GO_BP","501889_GO_0032663_REGULATION_OF_INTERLEUKIN_2_PRODUCTION",46,-1.8656,0,0.011,"No",-0.9607,0.51,1,"No"
"1235","REACTOME","106153_REACT_11047_MINERALOCORTICOID_BIOSYNTHESIS",6,-1.8652,0.0017,0.015,"No",0.9309,0.54,0.86,"Yes"
"1236","REACTOME","730312_REACT_150361_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH",10,-1.865,0,0.015,"No",-0.568,0.96,1,"No"
"1237","C7_Immunologic_signatures","C7_ALL_1377_GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP",197,-1.8644,0,0,"No",-0.8549,0.85,1,"No"
"1238","C7_Immunologic_signatures","C7_ALL_175_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP",191,-1.8641,0,0,"No",-1.1696,0.11,0.93,"No"
"1239","GO_BP","516724_GO_0071801_REGULATION_OF_PODOSOME_ASSEMBLY",10,-1.864,0.0033,0.011,"No",-1.0792,0.35,0.95,"No"
"1240","C6_Oncogenic_signatures","C6_ALL_63_CAMP_UP_V1_DN",199,-1.8638,0,4e-04,"No",-0.9048,0.74,0.87,"No"
"1241","GO_BP","507765_GO_0045408_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS",14,-1.8631,0.0016,0.012,"No",-1.5682,0.029,0.72,"No"
"1242","C2_Chemical_and_genetic_perturbations","C2_CGP_1415_SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP",45,-1.8631,0,0.0044,"No",0.4651,1,1,"Yes"
"1243","GO_BP","506657_GO_0043627_RESPONSE_TO_ESTROGEN",157,-1.8629,0,0.012,"No",-0.9425,0.6,1,"No"
"1244","KEGG_compound","C00060_CARBOXYLATE_R_COOH_MONOCARBOXYLATE_CARBOXYLIC_ACID",18,-1.8628,0,0.0072,"No",0.8154,0.74,1,"Yes"
"1245","REACTOME","106061_REACT_641_DISSOLUTION_OF_FIBRIN_CLOT",13,-1.8627,0.0015,0.015,"No",0.6966,0.88,1,"Yes"
"1246","C2_Chemical_and_genetic_perturbations","C2_CGP_3114_WIERENGA_STAT5A_TARGETS_GROUP2",60,-1.8626,0,0.0044,"No",-0.7381,0.92,1,"No"
"1247","GO_MF","487469_GO_0001530_LIPOPOLYSACCHARIDE_BINDING",16,-1.8616,0,0.033,"No",-0.8067,0.72,1,"No"
"1248","C2_Chemical_and_genetic_perturbations","C2_CGP_401_CASTELLANO_NRAS_TARGETS_UP",65,-1.8616,0,0.0045,"No",-0.9351,0.58,1,"No"
"1249","GO_MF","490030_GO_0004714_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY",64,-1.8614,0,0.031,"No",-1.2178,0.15,0.83,"No"
"1250","C2_Chemical_and_genetic_perturbations","C2_CGP_518_MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP",168,-1.8613,0,0.0045,"No",-0.8248,0.89,1,"No"
"1251","C7_Immunologic_signatures","C7_ALL_1580_GSE3982_DC_VS_MAC_LPS_STIM_DN",197,-1.8611,0,0,"No",-0.8825,0.76,1,"No"
"1252","C2_Chemical_and_genetic_perturbations","C2_CGP_897_WANG_RESPONSE_TO_BEXAROTENE_DN",29,-1.8611,0.0014,0.0045,"No",0.9834,0.44,0.81,"Yes"
"1253","GO_BP","518998_GO_2000352_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS",25,-1.8611,0,0.012,"No",0.6802,0.91,1,"Yes"
"1254","C7_Immunologic_signatures","C7_ALL_1139_GSE2706_2H_VS_8H_LPS_STIM_DC_UP",194,-1.8611,0,0,"No",-1.0301,0.38,1,"No"
"1255","REACTOME","105724_REACT_6913_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES",19,-1.8607,0,0.015,"No",0.9839,0.47,0.78,"Yes"
"1256","C1_Positional","C1_ALL_197_CHR13Q21",9,-1.8605,0,0.035,"No",0.6138,0.94,1,"Yes"
"1257","REACTOME","1127692_REACT_264548_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE",34,-1.8604,0,0.015,"No",0.9448,0.54,0.84,"Yes"
"1258","GO_BP","491989_GO_0007189_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",69,-1.8601,0,0.012,"No",0.8997,0.67,1,"Yes"
"1259","GO_BP","500386_GO_0031099_REGENERATION",110,-1.86,0,0.012,"No",-0.978,0.5,1,"No"
"1260","C2_Chemical_and_genetic_perturbations","C2_CGP_2853_CAIRO_HEPATOBLASTOMA_DN",259,-1.8599,0,0.0045,"No",-0.8945,0.79,1,"No"
"1261","GO_BP","502066_GO_0032844_REGULATION_OF_HOMEOSTATIC_PROCESS",337,-1.8599,0,0.012,"No",0.9248,0.73,1,"Yes"
"1262","C2_Chemical_and_genetic_perturbations","C2_CGP_1155_LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT",101,-1.8595,0,0.0045,"No",0.808,0.9,0.99,"Yes"
"1263","C3_TF_targets","C3_TFT_456_V_AP1_Q2_01",270,-1.8595,0,0.004,"No",-1.5085,0,0.13,"No"
"1264","C2_Chemical_and_genetic_perturbations","C2_CGP_1708_YAMAZAKI_TCEB3_TARGETS_UP",174,-1.8594,0,0.0045,"No",-0.8587,0.84,1,"No"
"1265","GO_BP","487444_GO_0001505_REGULATION_OF_NEUROTRANSMITTER_LEVELS",151,-1.8593,0,0.012,"No",-1.0948,0.25,0.95,"No"
"1266","C6_Oncogenic_signatures","C6_ALL_15_HINATA_NFKB_IMMU_INF",14,-1.8593,0.0016,0.00043,"No",-1.2697,0.17,0.35,"No"
"1267","GO_BP","507489_GO_0045089_POSITIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE",189,-1.8593,0,0.012,"No",0.616,1,1,"Yes"
"1268","C2_Chemical_and_genetic_perturbations","C2_CGP_1481_HSIAO_LIVER_SPECIFIC_GENES",236,-1.8592,0,0.0045,"No",-1.1491,0.14,0.85,"No"
"1269","GO_BP","500115_GO_0030816_POSITIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS",90,-1.8588,0,0.012,"No",0.9985,0.46,0.98,"Yes"
"1270","C4_Cancer_modules","C4_CM_127_MODULE_132",13,-1.8588,0,0.0033,"No",-1.3171,0.14,0.52,"No"
"1271","C4_Cancer_modules","C4_CM_359_MODULE_433",58,-1.8588,0,0.0033,"No",-1.1799,0.18,0.62,"No"
"1272","GO_BP","752381_GO_0086009_MEMBRANE_REPOLARIZATION",15,-1.8585,0,0.012,"No",-1.4907,0.067,0.82,"No"
"1273","GO_MF","496892_GO_0031072_HEAT_SHOCK_PROTEIN_BINDING",69,-1.8584,0.0013,0.032,"No",-0.9764,0.5,0.94,"No"
"1274","GO_BP","488556_GO_0002683_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS",332,-1.858,0,0.012,"No",0.8567,0.93,1,"Yes"
"1275","GO_BP","509070_GO_0046850_REGULATION_OF_BONE_REMODELING",38,-1.8576,0,0.012,"No",-0.5825,0.99,1,"No"
"1276","C7_Immunologic_signatures","C7_ALL_1328_GSE30083_SP1_VS_SP3_THYMOCYTE_DN",196,-1.8575,0,0,"No",-0.813,0.92,1,"No"
"1277","C6_Oncogenic_signatures","C6_ALL_3_E2F1_UP_V1_DN",190,-1.8575,0,0.00047,"No",-1.2498,0.064,0.38,"No"
"1278","GO_BP","501969_GO_0032743_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION",31,-1.8572,0.0014,0.012,"No",-0.7724,0.8,1,"No"
"1279","C2_Chemical_and_genetic_perturbations","C2_CGP_1929_ZAMORA_NOS2_TARGETS_DN",92,-1.8571,0,0.0046,"No",0.9538,0.53,0.86,"Yes"
"1280","C4_Cancer_gene_neighborhoods","C4_CGN_313_GNF2_RRM2",40,-1.8569,0,0.0014,"No",-0.769,0.85,1,"No"
"1281","GO_BP","487864_GO_0001974_BLOOD_VESSEL_REMODELING",32,-1.8569,0,0.012,"No",0.8093,0.8,1,"Yes"
"1282","C7_Immunologic_signatures","C7_ALL_1452_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN",200,-1.8568,0,4.6e-06,"No",-0.8348,0.89,1,"No"
"1283","C4_Cancer_gene_neighborhoods","C4_CGN_295_GNF2_ESPL1",35,-1.8565,0.0015,0.0014,"No",0.8279,0.76,0.96,"Yes"
"1284","WikiPathways","755436_WP2100_AHR_PATHWAY",26,-1.8564,0,0.0055,"No",-1.2892,0.13,1,"No"
"1285","C2_BioCarta_Pathways","C2_CP_BIOCARTA_40_BIOCARTA_TID_PATHWAY",19,-1.8562,0.0031,0.014,"No",-1.0749,0.36,1,"No"
"1286","GO_BP","511766_GO_0050798_ACTIVATED_T_CELL_PROLIFERATION",10,-1.8561,0.0017,0.012,"No",0.5455,0.96,1,"Yes"
"1287","REACTOME","1183587_REACT_355542_RHO_GTPASES_ACTIVATE_PKNS",89,-1.8558,0,0.015,"No",-1.5311,0.0071,0.41,"No"
"1288","GO_BP","491546_GO_0006658_PHOSPHATIDYLSERINE_METABOLIC_PROCESS",26,-1.8558,0.0015,0.012,"No",0.9321,0.56,1,"Yes"
"1289","GO_BP","492325_GO_0042267_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",24,-1.8555,0.0045,0.012,"No",-0.5849,0.97,1,"No"
"1290","C7_Immunologic_signatures","C7_ALL_1608_GSE3982_MAST_CELL_VS_DC_DN",198,-1.8555,0,4.6e-06,"No",-1.0522,0.33,1,"No"
"1291","GO_BP","500116_GO_0030817_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS",112,-1.8552,0,0.012,"No",-0.9449,0.55,1,"No"
"1292","REACTOME","771577_REACT_160123_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS",84,-1.855,0,0.015,"No",-0.6678,0.99,1,"No"
"1293","GO_BP","755343_GO_2001237_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",93,-1.8549,0,0.012,"No",-0.8201,0.83,1,"No"
"1294","C4_Cancer_gene_neighborhoods","C4_CGN_401_GNF2_RAP1B",36,-1.8549,0.0014,0.0014,"No",0.7329,0.91,1,"Yes"
"1295","KEGG_pathway","HSA05144_MALARIA",48,-1.8548,0,0.0015,"No",1.2398,0.15,0.48,"Yes"
"1296","GO_CC","490805_GO_0005775_VACUOLAR_LUMEN",76,-1.8547,0,0.014,"No",-0.8757,0.75,0.95,"No"
"1297","GO_BP","518794_GO_2000146_NEGATIVE_REGULATION_OF_CELL_MOTILITY",186,-1.8541,0,0.012,"No",-0.8133,0.91,1,"No"
"1298","C6_Oncogenic_signatures","C6_ALL_8_ERB2_UP_V1_UP",190,-1.8536,0,5e-04,"No",0.9488,0.61,0.95,"Yes"
"1299","C2_Chemical_and_genetic_perturbations","C2_CGP_260_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP",44,-1.8535,0,0.0048,"No",-0.7367,0.9,1,"No"
"1300","C2_Chemical_and_genetic_perturbations","C2_CGP_498_MCBRYAN_PUBERTAL_BREAST_3_4WK_UP",206,-1.8534,0,0.0048,"No",0.8373,0.91,0.98,"Yes"
"1301","C2_Chemical_and_genetic_perturbations","C2_CGP_1136_AMIT_EGF_RESPONSE_120_HELA",69,-1.8528,0,0.0048,"No",-1.2106,0.16,0.79,"No"
"1302","GO_BP","507773_GO_0045416_POSITIVE_REGULATION_OF_INTERLEUKIN_8_BIOSYNTHETIC_PROCESS",8,-1.8528,0.0033,0.012,"No",-0.8393,0.67,1,"No"
"1303","GO_BP","516173_GO_0071248_CELLULAR_RESPONSE_TO_METAL_ION",101,-1.8523,0,0.013,"No",1.1204,0.23,0.88,"Yes"
"1304","GO_BP","513749_GO_0060193_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY",93,-1.8522,0,0.012,"No",-1.0646,0.33,0.96,"No"
"1305","GO_BP","516548_GO_0071624_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS",20,-1.852,0,0.012,"No",-0.8651,0.66,1,"No"
"1306","C7_Immunologic_signatures","C7_ALL_281_GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP",199,-1.8518,0,4.5e-06,"No",1.0253,0.41,0.66,"Yes"
"1307","C2_Chemical_and_genetic_perturbations","C2_CGP_986_GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP",140,-1.8517,0,0.0049,"No",-1.0277,0.38,0.98,"No"
"1308","C2_Chemical_and_genetic_perturbations","C2_CGP_2527_PARK_APL_PATHOGENESIS_UP",14,-1.8517,0.0031,0.0049,"No",1.1736,0.24,0.53,"Yes"
"1309","GO_MF","490417_GO_0005154_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING",28,-1.8516,0.0015,0.034,"No",-0.6212,0.96,1,"No"
"1310","WikiPathways","198785_WP716_VITAMIN_A_AND_CAROTENOID_METABOLISM",39,-1.8512,0,0.0059,"No",-1.4969,0.027,0.87,"No"
"1311","GO_BP","488560_GO_0002687_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION",90,-1.851,0,0.013,"No",1.1763,0.16,0.81,"Yes"
"1312","C2_Chemical_and_genetic_perturbations","C2_CGP_2422_WINTER_HYPOXIA_METAGENE",235,-1.8504,0,0.0049,"No",-0.9717,0.54,1,"No"
"1313","GO_BP","497183_GO_0018212_PEPTIDYL_TYROSINE_MODIFICATION",171,-1.8504,0,0.013,"No",-1.2379,0.07,0.91,"No"
"1314","C2_Chemical_and_genetic_perturbations","C2_CGP_56_SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP",151,-1.8504,0,0.0049,"No",1.0641,0.28,0.69,"Yes"
"1315","C4_Cancer_gene_neighborhoods","C4_CGN_358_GNF2_HMMR",47,-1.8502,0,0.0014,"No",-0.6791,0.94,1,"No"
"1316","GO_BP","492048_GO_0007269_NEUROTRANSMITTER_SECRETION",119,-1.8493,0,0.013,"No",-1.0869,0.3,0.95,"No"
"1317","KEGG_pathway","HSA05142_CHAGAS_DISEASE_AMERICAN_TRYPANOSOMIASIS_",103,-1.8492,0,0.0015,"No",-0.9066,0.69,0.97,"No"
"1318","GO_MF","490029_GO_0004713_PROTEIN_TYROSINE_KINASE_ACTIVITY",141,-1.8492,0,0.035,"No",-1.4181,0.012,0.66,"No"
"1319","C2_Chemical_and_genetic_perturbations","C2_CGP_1602_MARTINEZ_RESPONSE_TO_TRABECTEDIN",50,-1.8488,0,0.005,"No",-1.2142,0.17,0.8,"No"
"1320","GO_BP","491592_GO_0006705_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS",6,-1.8486,0,0.013,"No",0.7715,0.75,1,"Yes"
"1321","KEGG_pathway","HSA04610_COMPLEMENT_AND_COAGULATION_CASCADES",68,-1.8486,0,0.0015,"No",-0.8806,0.71,0.99,"No"
"1322","C4_Cancer_modules","C4_CM_113_MODULE_118",399,-1.8485,0,0.0036,"No",1.0286,0.35,0.68,"Yes"
"1323","REACTOME","105715_REACT_34_ETHANOL_OXIDATION",10,-1.8481,0,0.016,"No",-1.8726,0.0036,0.061,"No"
"1324","GO_BP","511771_GO_0050805_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION",46,-1.8479,0,0.013,"No",-1.2818,0.1,0.89,"No"
"1325","C2_BioCarta_Pathways","C2_CP_BIOCARTA_178_BIOCARTA_NKT_PATHWAY",29,-1.8478,0.0044,0.016,"No",0.9186,0.57,0.9,"Yes"
"1326","GO_CC","490888_GO_0005883_NEUROFILAMENT",9,-1.8478,0,0.015,"No",0.7578,0.77,0.98,"Yes"
"1327","C7_Immunologic_signatures","C7_ALL_1440_GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN",199,-1.8477,0,4.5e-06,"No",0.8651,0.86,1,"Yes"
"1328","KEGG_pathway","HSA04142_LYSOSOME",123,-1.8475,0,0.0015,"No",-0.5549,1,1,"No"
"1329","GO_BP","492025_GO_0019722_CALCIUM_MEDIATED_SIGNALING",81,-1.8472,0,0.013,"No",-1.0285,0.39,0.97,"No"
"1330","GO_BP","511778_GO_0050818_REGULATION_OF_COAGULATION",84,-1.8472,0,0.013,"No",1.1482,0.18,0.84,"Yes"
"1331","GO_BP","500898_GO_0031649_HEAT_GENERATION",7,-1.8471,0.0016,0.013,"No",-1.7361,0.0057,0.63,"No"
"1332","GO_BP","510591_GO_0048520_POSITIVE_REGULATION_OF_BEHAVIOR",120,-1.847,0,0.013,"No",1.1693,0.14,0.81,"Yes"
"1333","C7_Immunologic_signatures","C7_ALL_1054_GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN",200,-1.8469,0,4.5e-06,"No",1.0756,0.28,0.51,"Yes"
"1334","GO_BP","491529_GO_0006639_ACYLGLYCEROL_METABOLIC_PROCESS",95,-1.8469,0,0.013,"No",-0.7771,0.92,1,"No"
"1335","C2_Chemical_and_genetic_perturbations","C2_CGP_636_DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS",22,-1.8468,0,0.0051,"No",-1.6502,0.014,0.37,"No"
"1336","GO_BP","495140_GO_0014068_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",55,-1.8464,0,0.013,"No",0.8568,0.76,1,"Yes"
"1337","KEGG_reaction","R07064_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_LINOLEATE",18,-1.8463,0.0015,0.0063,"No",0.8227,0.72,1,"Yes"
"1338","C0_Hallmark","H_ALL_48_HALLMARK_KRAS_SIGNALING_UP",198,-1.8461,0,0.00026,"No",-0.872,0.81,0.98,"No"
"1339","C2_Chemical_and_genetic_perturbations","C2_CGP_600_PEREZ_TP63_TARGETS",344,-1.846,0,0.0052,"No",-1.693,0,0.33,"No"
"1340","GO_BP","507934_GO_0045586_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION",8,-1.8457,0,0.013,"No",-1.419,0.096,0.94,"No"
"1341","C0_Hallmark","H_ALL_21_HALLMARK_APICAL_SURFACE",43,-1.8456,0,0.00024,"No",0.8331,0.76,1,"Yes"
"1342","C7_Immunologic_signatures","C7_ALL_661_GSE17721_LPS_VS_CPG_6H_BMDM_UP",196,-1.8456,0,8.9e-06,"No",0.8318,0.92,1,"Yes"
"1343","GO_BP","753357_GO_1900373_POSITIVE_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",102,-1.845,0,0.013,"No",-1.0969,0.27,0.94,"No"
"1344","GO_BP","501881_GO_0032655_REGULATION_OF_INTERLEUKIN_12_PRODUCTION",45,-1.845,0,0.013,"No",-1.2163,0.19,0.88,"No"
"1345","GO_BP","508136_GO_0045807_POSITIVE_REGULATION_OF_ENDOCYTOSIS",91,-1.845,0,0.013,"No",-1.1396,0.21,0.93,"No"
"1346","C2_Chemical_and_genetic_perturbations","C2_CGP_1304_JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP",71,-1.8449,0,0.0053,"No",1.4308,0.03,0.27,"Yes"
"1347","GO_BP","488582_GO_0002709_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY",53,-1.8448,0,0.013,"No",-1.1989,0.17,0.9,"No"
"1348","GO_MF","490245_GO_0004954_PROSTANOID_RECEPTOR_ACTIVITY",12,-1.8444,0,0.036,"No",1.3965,0.091,0.49,"Yes"
"1349","GO_BP","513295_GO_0052547_REGULATION_OF_PEPTIDASE_ACTIVITY",369,-1.8444,0,0.013,"No",0.9744,0.55,1,"Yes"
"1350","GO_BP","488571_GO_0002698_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS",83,-1.8444,0,0.013,"No",0.8481,0.79,1,"Yes"
"1351","GO_BP","496324_GO_0016264_GAP_JUNCTION_ASSEMBLY",8,-1.8441,0.0049,0.013,"No",-0.9694,0.49,1,"No"
"1352","C4_Cancer_modules","C4_CM_39_MODULE_43",98,-1.8441,0,0.0038,"No",1.4192,0.022,0.17,"Yes"
"1353","KEGG_pathway","HSA05145_TOXOPLASMOSIS",116,-1.8438,0,0.0015,"No",-1.2914,0.057,0.42,"No"
"1354","C7_Immunologic_signatures","C7_ALL_1900_GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN",200,-1.8438,0,8.9e-06,"No",-0.6469,1,1,"No"
"1355","C2_Chemical_and_genetic_perturbations","C2_CGP_3198_DALESSIO_TSA_RESPONSE",21,-1.8434,0.0029,0.0054,"No",-1.7599,0.0056,0.34,"No"
"1356","GO_BP","513308_GO_0052564_RESPONSE_TO_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",13,-1.8433,0,0.013,"No",1.0949,0.34,0.91,"Yes"
"1357","GO_BP","508101_GO_0045764_POSITIVE_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",234,-1.8432,0,0.013,"No",-1.0294,0.38,0.97,"No"
"1358","GO_BP","494586_GO_0010517_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY",93,-1.8432,0,0.013,"No",-1.0146,0.42,0.98,"No"
"1359","GO_BP","500600_GO_0031341_REGULATION_OF_CELL_KILLING",66,-1.8429,0,0.013,"No",-1.0064,0.44,0.98,"No"
"1360","C2_Chemical_and_genetic_perturbations","C2_CGP_275_SENESE_HDAC1_AND_HDAC2_TARGETS_UP",229,-1.8428,0,0.0054,"No",-0.838,0.92,1,"No"
"1361","GO_BP","487788_GO_0001892_EMBRYONIC_PLACENTA_DEVELOPMENT",89,-1.8425,0,0.013,"No",-1.4178,0.037,0.94,"No"
"1362","GO_BP","504542_GO_0035358_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY",11,-1.8424,0,0.013,"No",-1.0695,0.38,0.96,"No"
"1363","KEGG_compound","C04317_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_RADYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ALKYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE",26,-1.8423,0,0.0094,"No",0.5374,0.99,1,"Yes"
"1364","C4_Cancer_gene_neighborhoods","C4_CGN_405_GNF2_SELL",47,-1.8419,0,0.0016,"No",1.2361,0.14,0.18,"Yes"
"1365","C2_Chemical_and_genetic_perturbations","C2_CGP_1048_FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN",8,-1.8418,0,0.0054,"No",-1.2106,0.24,0.8,"No"
"1366","GO_BP","518183_GO_0090036_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING",15,-1.8408,0,0.014,"No",-0.9637,0.51,1,"No"
"1367","C2_Chemical_and_genetic_perturbations","C2_CGP_1545_PETROVA_PROX1_TARGETS_DN",64,-1.8407,0,0.0055,"No",1.1544,0.2,0.55,"Yes"
"1368","C2_Chemical_and_genetic_perturbations","C2_CGP_2096_FOSTER_TOLERANT_MACROPHAGE_DN",409,-1.8405,0,0.0055,"No",-0.8389,0.94,1,"No"
"1369","GO_BP","503532_GO_0034329_CELL_JUNCTION_ASSEMBLY",157,-1.8401,0,0.014,"No",-1.2252,0.083,0.88,"No"
"1370","C7_Immunologic_signatures","C7_ALL_1775_GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP",198,-1.84,0,8.8e-06,"No",-0.8518,0.85,1,"No"
"1371","C2_Chemical_and_genetic_perturbations","C2_CGP_1786_DAZARD_RESPONSE_TO_UV_NHEK_UP",240,-1.84,0,0.0055,"No",1.0924,0.22,0.64,"Yes"
"1372","C3_TF_targets","C3_TFT_143_V_AP1_C",268,-1.8399,0,0.0041,"No",-1.3543,0.013,0.19,"No"
"1373","C7_Immunologic_signatures","C7_ALL_1116_GSE2706_UNSTIM_VS_8H_R848_DC_DN",196,-1.8399,0,8.8e-06,"No",0.8431,0.88,1,"Yes"
"1374","GO_BP","511809_GO_0050867_POSITIVE_REGULATION_OF_CELL_ACTIVATION",280,-1.8398,0,0.014,"No",0.8129,0.96,1,"Yes"
"1375","C4_Cancer_modules","C4_CM_285_MODULE_326",13,-1.8397,0,0.0039,"No",1.3927,0.089,0.2,"Yes"
"1376","C6_Oncogenic_signatures","C6_ALL_105_BMI1_DN_V1_DN",137,-1.8395,0,0.00059,"No",1.1723,0.16,0.39,"Yes"
"1377","C2_Chemical_and_genetic_perturbations","C2_CGP_2503_HUNSBERGER_EXERCISE_REGULATED_GENES",31,-1.8394,0.0044,0.0055,"No",-0.8142,0.75,1,"No"
"1378","GO_BP","515593_GO_0070663_REGULATION_OF_LEUKOCYTE_PROLIFERATION",183,-1.8388,0,0.014,"No",-0.7769,0.96,1,"No"
"1379","C2_Chemical_and_genetic_perturbations","C2_CGP_2470_BOYLAN_MULTIPLE_MYELOMA_D_DN",78,-1.8386,0,0.0056,"No",-0.827,0.81,1,"No"
"1380","REACTOME","119536_REACT_19375_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION",8,-1.8386,0.0017,0.018,"No",-1.4862,0.063,0.45,"No"
"1381","GO_BP","754839_GO_1901888_REGULATION_OF_CELL_JUNCTION_ASSEMBLY",57,-1.8385,0,0.014,"No",-1.2278,0.13,0.88,"No"
"1382","KEGG_compound","C05345_BETA_D_FRUCTOSE_6_PHOSPHATE",17,-1.8385,0.0031,0.0097,"No",0.5511,0.97,1,"Yes"
"1383","GO_MF","489953_GO_0004622_LYSOPHOSPHOLIPASE_ACTIVITY",16,-1.8383,0,0.038,"No",-0.7003,0.88,1,"No"
"1384","C7_Immunologic_signatures","C7_ALL_1684_GSE3982_BCELL_VS_TH1_DN",196,-1.8383,0,8.7e-06,"No",0.8556,0.87,1,"Yes"
"1385","C2_Chemical_and_genetic_perturbations","C2_CGP_515_OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN",32,-1.8381,0,0.0056,"No",-0.7744,0.81,1,"No"
"1386","GO_BP","502178_GO_0032956_REGULATION_OF_ACTIN_CYTOSKELETON_ORGANIZATION",251,-1.8378,0,0.014,"No",-1.0653,0.29,0.96,"No"
"1387","GO_BP","753015_GO_1900017_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",7,-1.8378,0,0.014,"No",-1.5143,0.047,0.81,"No"
"1388","GO_BP","488333_GO_0002460_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",117,-1.8374,0,0.014,"No",-0.7041,0.99,1,"No"
"1389","C2_Chemical_and_genetic_perturbations","C2_CGP_1594_KUMAR_TARGETS_OF_MLL_AF9_FUSION",399,-1.8373,0,0.0057,"No",1.2038,0.053,0.48,"Yes"
"1390","C2_Chemical_and_genetic_perturbations","C2_CGP_394_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN",141,-1.8373,0,0.0056,"No",0.8572,0.84,0.96,"Yes"
"1391","C7_Immunologic_signatures","C7_ALL_769_GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP",198,-1.8368,0,8.7e-06,"No",-1.1047,0.23,1,"No"
"1392","GO_MF","486561_GO_0015036_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",30,-1.8368,0,0.037,"No",-0.6995,0.91,1,"No"
"1393","C2_Chemical_and_genetic_perturbations","C2_CGP_2993_DASU_IL6_SIGNALING_UP",59,-1.8366,0,0.0057,"No",-1.1193,0.26,0.9,"No"
"1394","C2_Chemical_and_genetic_perturbations","C2_CGP_1715_MCCLUNG_DELTA_FOSB_TARGETS_2WK",47,-1.8366,0,0.0057,"No",-1.1853,0.19,0.81,"No"
"1395","KEGG_pathway","HSA00380_TRYPTOPHAN_METABOLISM",40,-1.8364,0,0.0018,"No",-1.1639,0.22,0.59,"No"
"1396","WikiPathways","198850_WP465_TRYPTOPHAN_METABOLISM",46,-1.8363,0,0.0069,"No",0.7673,0.89,1,"Yes"
"1397","C7_Immunologic_signatures","C7_ALL_1398_GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN",198,-1.8363,0,8.7e-06,"No",-0.8875,0.78,1,"No"
"1398","C2_Chemical_and_genetic_perturbations","C2_CGP_2011_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE",75,-1.8358,0,0.0057,"No",1.2009,0.13,0.49,"Yes"
"1399","GO_BP","501955_GO_0032729_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION",55,-1.8357,0,0.014,"No",-0.9823,0.47,1,"No"
"1400","GO_BP","507249_GO_0044242_CELLULAR_LIPID_CATABOLIC_PROCESS",136,-1.8357,0,0.014,"No",0.9648,0.57,1,"Yes"
"1401","C2_Chemical_and_genetic_perturbations","C2_CGP_467_LANDIS_ERBB2_BREAST_TUMORS_324_UP",148,-1.8357,0,0.0057,"No",0.7428,0.98,1,"Yes"
"1402","KEGG_compound","C00053_3_PHOSPHOADENYLYL_SULFATE_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_3_PHOSPHO_5_ADENYLYL_SULFATE_PAPS",20,-1.8354,0.0015,0.0098,"No",0.7973,0.74,1,"Yes"
"1403","GO_MF","498635_GO_0019855_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY",10,-1.8354,0,0.036,"No",-0.9135,0.58,0.97,"No"
"1404","C4_Cancer_modules","C4_CM_88_MODULE_93",181,-1.8353,0,0.0041,"No",1.3912,0.007,0.2,"Yes"
"1405","GO_BP","511793_GO_0050848_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING",44,-1.835,0,0.014,"No",-0.8518,0.73,1,"No"
"1406","GO_BP","491066_GO_0006081_CELLULAR_ALDEHYDE_METABOLIC_PROCESS",55,-1.835,0,0.014,"No",0.9193,0.61,1,"Yes"
"1407","C2_Chemical_and_genetic_perturbations","C2_CGP_231_HOEBEKE_LYMPHOID_STEM_CELL_DN",86,-1.8349,0,0.0058,"No",1.4434,0.0065,0.26,"Yes"
"1408","C4_Cancer_gene_neighborhoods","C4_CGN_289_GNF2_CDC2",62,-1.8349,0,0.0017,"No",0.8172,0.83,0.98,"Yes"
"1409","GO_BP","494708_GO_0010644_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING",15,-1.8347,0,0.014,"No",-1.1876,0.26,0.9,"No"
"1410","C2_Chemical_and_genetic_perturbations","C2_CGP_903_HASINA_NOL7_TARGETS_UP",13,-1.8345,0,0.0058,"No",-0.7304,0.85,1,"No"
"1411","GO_BP","515485_GO_0070555_RESPONSE_TO_INTERLEUKIN_1",72,-1.8344,0.0013,0.014,"No",1.3209,0.069,0.64,"Yes"
"1412","C3_TF_targets","C3_TFT_302_V_BACH1_01",259,-1.8344,0,0.0036,"No",-1.4347,0.0017,0.15,"No"
"1413","C4_Cancer_modules","C4_CM_166_MODULE_176",220,-1.8342,0,0.0041,"No",-1.2181,0.078,0.62,"No"
"1414","KEGG_reaction","R02053_PHOSPHATIDYLETHANOLAMINE_2_ACYLHYDROLASE_PHOSPHATIDYLETHANOLAMINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_FATTY_ACID",18,-1.8341,0.0015,0.0076,"No",0.8059,0.74,1,"Yes"
"1415","C2_Chemical_and_genetic_perturbations","C2_CGP_3277_PLASARI_TGFB1_TARGETS_10HR_DN",241,-1.8336,0,0.0058,"No",1.2235,0.062,0.46,"Yes"
"1416","C2_Chemical_and_genetic_perturbations","C2_CGP_410_LINDGREN_BLADDER_CANCER_CLUSTER_1_DN",375,-1.8331,0,0.0059,"No",-1.0196,0.39,0.98,"No"
"1417","C4_Cancer_modules","C4_CM_320_MODULE_375",85,-1.833,0,0.0041,"No",1.1063,0.26,0.53,"Yes"
"1418","GO_BP","501384_GO_0032148_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY",20,-1.8327,0.0015,0.015,"No",-0.9371,0.56,1,"No"
"1419","KEGG_reaction","R07379_PLASMENYLETHANOLAMINE_2_ACYLHYDROLASE_O_1_ALK_1_ENYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_H2O_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_CARBOXYLATE",18,-1.8324,0,0.0074,"No",0.8168,0.72,1,"Yes"
"1420","C7_Immunologic_signatures","C7_ALL_1330_GSE30083_SP1_VS_SP4_THYMOCYTE_DN",200,-1.8323,0,1.3e-05,"No",0.7922,0.97,1,"Yes"
"1421","C4_Cancer_modules","C4_CM_347_MODULE_416",22,-1.8323,0.003,0.0041,"No",-0.9049,0.58,0.88,"No"
"1422","GO_BP","488196_GO_0002323_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",19,-1.8322,0.0016,0.015,"No",0.8789,0.66,1,"Yes"
"1423","REACTOME","530759_REACT_115897_BETA_DEFENSINS",14,-1.8319,0,0.019,"No",-1.3402,0.13,0.6,"No"
"1424","REACTOME","187093_REACT_23950_INTERLEUKIN_1_PROCESSING",7,-1.8317,0.0017,0.018,"No",-1.4716,0.077,0.46,"No"
"1425","GO_MF","511756_GO_0050786_RAGE_RECEPTOR_BINDING",11,-1.8316,0,0.037,"No",1.473,0.065,0.4,"Yes"
"1426","C2_Chemical_and_genetic_perturbations","C2_CGP_41_FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP",21,-1.8316,0.0045,0.0059,"No",-1.051,0.38,0.97,"No"
"1427","C2_Chemical_and_genetic_perturbations","C2_CGP_2540_WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP",57,-1.8316,0,0.0059,"No",0.7673,0.89,1,"Yes"
"1428","GO_BP","511823_GO_0050885_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE",55,-1.8315,0,0.015,"No",-0.9729,0.52,1,"No"
"1429","C2_Chemical_and_genetic_perturbations","C2_CGP_2954_NAKAMURA_ADIPOGENESIS_LATE_UP",102,-1.8314,0,0.0059,"No",0.8772,0.77,0.95,"Yes"
"1430","KEGG_pathway","HSA04062_CHEMOKINE_SIGNALING_PATHWAY",178,-1.8312,0,0.0018,"No",1.055,0.3,0.83,"Yes"
"1431","GO_BP","488096_GO_0002221_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY",140,-1.8312,0,0.015,"No",-0.6283,1,1,"No"
"1432","GO_BP","492315_GO_0007565_FEMALE_PREGNANCY",163,-1.831,0,0.015,"No",-1.2403,0.062,0.91,"No"
"1433","C6_Oncogenic_signatures","C6_ALL_66_LTE2_UP_V1_UP",184,-1.831,0,0.00071,"No",-0.7059,1,0.99,"No"
"1434","C2_Chemical_and_genetic_perturbations","C2_CGP_2539_CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL",12,-1.8309,0.0015,0.0059,"No",-0.6669,0.88,1,"No"
"1435","GO_BP","501876_GO_0032650_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION",6,-1.8308,0,0.015,"No",-1.182,0.3,0.91,"No"
"1436","GO_BP","498167_GO_0019322_PENTOSE_BIOSYNTHETIC_PROCESS",6,-1.8305,0,0.015,"No",-0.7254,0.8,1,"No"
"1437","C2_Chemical_and_genetic_perturbations","C2_CGP_1465_XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP",17,-1.8301,0.0031,0.006,"No",0.863,0.65,0.96,"Yes"
"1438","C7_Immunologic_signatures","C7_ALL_1473_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP",199,-1.8296,0,1.3e-05,"No",1.3553,0.02,0.059,"Yes"
"1439","KEGG_reaction","R01317_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ARACHIDONATE",18,-1.8296,0,0.0073,"No",0.8092,0.74,1,"Yes"
"1440","GO_BP","493461_GO_0009268_RESPONSE_TO_PH",31,-1.8292,0.0044,0.015,"No",-1.3235,0.1,0.89,"No"
"1441","GO_BP","505288_GO_0042116_MACROPHAGE_ACTIVATION",27,-1.8292,0,0.015,"No",0.7489,0.86,1,"Yes"
"1442","C2_Chemical_and_genetic_perturbations","C2_CGP_1788_ZHU_CMV_ALL_UP",120,-1.8284,0,0.0061,"No",-0.9049,0.69,1,"No"
"1443","C2_Chemical_and_genetic_perturbations","C2_CGP_234_AKL_HTLV1_INFECTION_UP",27,-1.8283,0.0014,0.0061,"No",0.5239,1,1,"Yes"
"1444","C4_Cancer_gene_neighborhoods","C4_CGN_360_GNF2_ICAM3",39,-1.8282,0.0014,0.0018,"No",1.0607,0.34,0.44,"Yes"
"1445","GO_BP","501956_GO_0032730_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION",6,-1.8279,0,0.015,"No",-1.1877,0.29,0.9,"No"
"1446","GO_BP","505339_GO_0042178_XENOBIOTIC_CATABOLIC_PROCESS",10,-1.8279,0.0017,0.015,"No",-1.9749,0,0.35,"No"
"1447","GO_BP","488631_GO_0002758_INNATE_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION",145,-1.8278,0,0.015,"No",-0.7228,0.98,1,"No"
"1448","GO_BP","508098_GO_0045761_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY",78,-1.8272,0,0.015,"No",0.9488,0.56,1,"Yes"
"1449","C7_Immunologic_signatures","C7_ALL_1655_GSE3982_MAC_VS_NKCELL_UP",200,-1.8272,0,1.7e-05,"No",0.9325,0.64,0.95,"Yes"
"1450","C2_Chemical_and_genetic_perturbations","C2_CGP_2152_COATES_MACROPHAGE_M1_VS_M2_UP",81,-1.8269,0,0.0062,"No",-1.1502,0.24,0.85,"No"
"1451","GO_CC","490910_GO_0005911_CELL_CELL_JUNCTION",360,-1.8268,0,0.019,"No",-1.2451,0.024,0.64,"No"
"1452","KEGG_pathway","HSA04750_INFLAMMATORY_MEDIATOR_REGULATION_OF_TRP_CHANNELS",97,-1.8267,0,0.0019,"No",-1.2609,0.088,0.48,"No"
"1453","GO_MF","513558_GO_0055131_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING",6,-1.8266,0.0017,0.039,"No",-1.8361,0,0.15,"No"
"1454","C2_Chemical_and_genetic_perturbations","C2_CGP_2656_LIU_VAV3_PROSTATE_CARCINOGENESIS_UP",86,-1.8266,0,0.0062,"No",1.0501,0.35,0.71,"Yes"
"1455","C2_Chemical_and_genetic_perturbations","C2_CGP_3364_LIM_MAMMARY_LUMINAL_PROGENITOR_DN",13,-1.8261,0.0016,0.0063,"No",-0.8258,0.7,1,"No"
"1456","GO_BP","513302_GO_0052555_POSITIVE_REGULATION_BY_ORGANISM_OF_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",7,-1.8258,0,0.015,"No",0.7972,0.73,1,"Yes"
"1457","C3_TF_targets","C3_TFT_20_V_NFE2_01",262,-1.8258,0,0.0035,"No",-1.1509,0.13,0.45,"No"
"1458","C3_TF_targets","C3_TFT_396_V_ELF1_Q6",243,-1.8255,0,0.0031,"No",-0.9838,0.5,0.8,"No"
"1459","GO_BP","508755_GO_0046496_NICOTINAMIDE_NUCLEOTIDE_METABOLIC_PROCESS",91,-1.8254,0,0.016,"No",-0.7607,0.94,1,"No"
"1460","GO_MF","487546_GO_0001618_VIRUS_RECEPTOR_ACTIVITY",33,-1.8253,0.0027,0.038,"No",-1.1275,0.27,0.81,"No"
"1461","C7_Immunologic_signatures","C7_ALL_1700_GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN",196,-1.8252,0,1.7e-05,"No",-0.7194,0.99,1,"No"
"1462","GO_BP","494927_GO_0010863_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY",69,-1.8252,0,0.016,"No",-0.8589,0.71,1,"No"
"1463","WikiPathways","198781_WP334_GPCRS_CLASS_B_SECRETIN_LIKE",23,-1.8251,0,0.0076,"No",1.0234,0.42,1,"Yes"
"1464","GO_MF","489499_GO_0004030_ALDEHYDE_DEHYDROGENASE_NAD_P_ACTIVITY",7,-1.8249,0.0033,0.037,"No",-1.1314,0.31,0.81,"No"
"1465","C7_Immunologic_signatures","C7_ALL_1610_GSE3982_MAST_CELL_VS_MAC_DN",195,-1.8247,0,1.7e-05,"No",-0.9832,0.47,1,"No"
"1466","GO_BP","494882_GO_0010818_T_CELL_CHEMOTAXIS",9,-1.8247,0,0.016,"No",0.9826,0.47,1,"Yes"
"1467","C7_Immunologic_signatures","C7_ALL_1124_GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN",193,-1.8246,0,1.7e-05,"No",0.8558,0.88,1,"Yes"
"1468","KEGG_reaction","R01315_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_FATTY_ACID",18,-1.8245,0.0016,0.0072,"No",0.8054,0.75,1,"Yes"
"1469","GO_CC","506302_GO_0043235_RECEPTOR_COMPLEX",293,-1.8245,0,0.019,"No",-1.2205,0.06,0.66,"No"
"1470","GO_BP","755345_GO_2001239_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",58,-1.8241,0.0013,0.016,"No",-1.114,0.27,0.94,"No"
"1471","C4_Cancer_modules","C4_CM_197_MODULE_210",27,-1.8239,0.0015,0.0045,"No",-1.316,0.12,0.51,"No"
"1472","C2_BioCarta_Pathways","C2_CP_BIOCARTA_52_BIOCARTA_INFLAM_PATHWAY",29,-1.8239,0.003,0.019,"No",-1.5165,0.034,1,"No"
"1473","GO_BP","516161_GO_0071236_CELLULAR_RESPONSE_TO_ANTIBIOTIC",14,-1.8236,0.0016,0.016,"No",-1.0731,0.35,0.96,"No"
"1474","WikiPathways","198816_WP185_INTEGRIN_MEDIATED_CELL_ADHESION",98,-1.8235,0,0.0074,"No",-0.881,0.72,1,"No"
"1475","C2_Chemical_and_genetic_perturbations","C2_CGP_1685_CUI_TCF21_TARGETS_UP",35,-1.8233,0.0014,0.0064,"No",0.8697,0.67,0.95,"Yes"
"1476","GO_BP","507497_GO_0045104_INTERMEDIATE_FILAMENT_CYTOSKELETON_ORGANIZATION",35,-1.8232,0,0.016,"No",1.0047,0.43,0.98,"Yes"
"1477","GO_BP","488094_GO_0002218_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE",152,-1.8231,0,0.016,"No",-0.7279,0.99,1,"No"
"1478","GO_BP","507967_GO_0045619_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION",127,-1.8229,0,0.016,"No",-1.2392,0.1,0.91,"No"
"1479","KEGG_pathway","HSA05410_HYPERTROPHIC_CARDIOMYOPATHY_HCM_",82,-1.8228,0,0.002,"No",-1.4801,0.013,0.54,"No"
"1480","GO_CC","911391_GO_0098533_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX",24,-1.8227,0.0014,0.019,"No",-1.8282,0.002,0.35,"No"
"1481","GO_BP","753258_GO_1900274_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY",71,-1.8223,0,0.016,"No",-0.941,0.55,1,"No"
"1482","C7_Immunologic_signatures","C7_ALL_1849_GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP",198,-1.8223,0,1.7e-05,"No",0.8144,0.94,1,"Yes"
"1483","C3_TF_targets","C3_TFT_594_TGASTMAGC_V_NFE2_01",192,-1.8223,0,0.003,"No",-1.0153,0.41,0.73,"No"
"1484","GO_BP","488697_GO_0002824_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",78,-1.8222,0,0.016,"No",-1.4854,0.0092,0.84,"No"
"1485","C6_Oncogenic_signatures","C6_ALL_68_MEK_UP_V1_UP",194,-1.822,0,0.00068,"No",0.8596,0.86,0.99,"Yes"
"1486","C3_TF_targets","C3_TFT_421_V_HNF1_Q6",245,-1.822,0,0.0027,"No",-0.8825,0.8,0.99,"No"
"1487","KEGG_reaction","R07859_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_9Z_12Z_15Z_OCTADECATRIENOIC_ACID",18,-1.8217,0.0016,0.0071,"No",0.8252,0.74,1,"Yes"
"1488","GO_BP","513385_GO_0052646_ALDITOL_PHOSPHATE_METABOLIC_PROCESS",33,-1.8217,0,0.016,"No",1.0592,0.36,0.94,"Yes"
"1489","C4_Cancer_modules","C4_CM_107_MODULE_112",250,-1.8216,0,0.0045,"No",-1.2483,0.042,0.6,"No"
"1490","C7_Immunologic_signatures","C7_ALL_438_GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN",196,-1.8214,0,1.7e-05,"No",1.088,0.23,0.48,"Yes"
"1491","C7_Immunologic_signatures","C7_ALL_1835_GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP",200,-1.8212,0,1.7e-05,"No",-0.9505,0.59,1,"No"
"1492","KEGG_pathway","HSA04360_AXON_GUIDANCE",124,-1.821,0.0012,0.002,"No",-1.2436,0.09,0.51,"No"
"1493","C2_Chemical_and_genetic_perturbations","C2_CGP_2279_ITO_PTTG1_TARGETS_DN",9,-1.8209,0.0017,0.0066,"No",-0.6147,0.92,1,"No"
"1494","C2_Chemical_and_genetic_perturbations","C2_CGP_2355_LABBE_TGFB1_TARGETS_UP",100,-1.8204,0,0.0066,"No",-0.8562,0.76,1,"No"
"1495","C7_Immunologic_signatures","C7_ALL_1630_GSE3982_DC_VS_NEUTROPHIL_DN",196,-1.8203,0,1.7e-05,"No",0.8176,0.94,1,"Yes"
"1496","C7_Immunologic_signatures","C7_ALL_1896_GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN",195,-1.8202,0,1.6e-05,"No",-0.8291,0.88,1,"No"
"1497","C7_Immunologic_signatures","C7_ALL_1877_GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP",198,-1.8198,0,1.6e-05,"No",1.4629,0.0047,0.019,"Yes"
"1498","GO_BP","502254_GO_0033032_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS",24,-1.8197,0,0.016,"No",0.8564,0.68,1,"Yes"
"1499","GO_MF","490322_GO_0005041_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY",10,-1.8196,0,0.039,"No",0.8329,0.68,1,"Yes"
"1500","GO_BP","494893_GO_0010829_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSPORT",15,-1.8195,0.0016,0.016,"No",-1.3111,0.13,0.87,"No"
"1501","GO_BP","946750_GO_1990267_RESPONSE_TO_TRANSITION_METAL_NANOPARTICLE",112,-1.8195,0,0.016,"No",1.174,0.14,0.81,"Yes"
"1502","C7_Immunologic_signatures","C7_ALL_1678_GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN",185,-1.819,0,1.6e-05,"No",-1.0667,0.28,1,"No"
"1503","GO_BP","503319_GO_0034113_HETEROTYPIC_CELL_CELL_ADHESION",27,-1.8189,0.0015,0.016,"No",0.8642,0.7,1,"Yes"
"1504","C7_Immunologic_signatures","C7_ALL_787_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP",190,-1.8188,0,1.6e-05,"No",-1.1089,0.21,1,"No"
"1505","GO_BP","492415_GO_0008037_CELL_RECOGNITION",107,-1.8186,0,0.016,"No",-1.1802,0.15,0.91,"No"
"1506","GO_BP","513098_GO_0052255_MODULATION_BY_ORGANISM_OF_DEFENSE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",9,-1.8185,0,0.016,"No",0.6257,0.93,1,"Yes"
"1507","GO_BP","507427_GO_0045019_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",11,-1.8179,0.0047,0.016,"No",-1.5711,0.037,0.71,"No"
"1508","C2_Chemical_and_genetic_perturbations","C2_CGP_1570_YAGI_AML_FAB_MARKERS",190,-1.8179,0,0.0068,"No",0.9644,0.56,0.84,"Yes"
"1509","KEGG_reaction","R07000_NAPHTHALENE_NADPH_OXYGEN_OXIDOREDUCTASE_RH_HYDROXYLATING_OR_EPOXIDIZING_NAPHTHALENE_NADPH_OXYGEN_H_1R_2S_NAPHTHALENE_1_2_OXIDE_NADP_H2O",8,-1.8177,0.0016,0.007,"No",-1.4207,0.079,0.26,"No"
"1510","GO_BP","488587_GO_0002714_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY",28,-1.8176,0,0.017,"No",-1.751,0.0078,0.6,"No"
"1511","GO_BP","753355_GO_1900371_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",139,-1.8176,0,0.016,"No",-0.9483,0.56,1,"No"
"1512","GO_BP","506406_GO_0043367_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",29,-1.8172,0.0043,0.017,"No",-0.9608,0.52,1,"No"
"1513","KEGG_compound","C05138_17ALPHA_HYDROXYPREGNENOLONE",5,-1.8171,0.0018,0.013,"No",1.0762,0.37,1,"Yes"
"1514","KEGG_module","HSA_M00109_C21_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_CORTISOL_CORTISONE",6,-1.8171,0,0.15,"No",0.9411,0.52,0.88,"Yes"
"1515","GO_BP","502166_GO_0032944_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION",177,-1.817,0,0.017,"No",-0.815,0.9,1,"No"
"1516","C2_Chemical_and_genetic_perturbations","C2_CGP_3026_KARLSSON_TGFB1_TARGETS_DN",207,-1.8168,0,0.0069,"No",-0.7737,0.97,1,"No"
"1517","C2_Chemical_and_genetic_perturbations","C2_CGP_253_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN",17,-1.8167,0.0048,0.0069,"No",-1.224,0.19,0.78,"No"
"1518","C2_Chemical_and_genetic_perturbations","C2_CGP_635_DUTTA_APOPTOSIS_VIA_NFKB",33,-1.8166,0.0028,0.0069,"No",-0.9596,0.47,1,"No"
"1519","GO_BP","987836_GO_1903035_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING",141,-1.8165,0,0.017,"No",0.8378,0.85,1,"Yes"
"1520","GO_BP","487675_GO_0001779_NATURAL_KILLER_CELL_DIFFERENTIATION",13,-1.8164,0.0031,0.017,"No",-0.92,0.57,1,"No"
"1521","GO_BP","503533_GO_0034330_CELL_JUNCTION_ORGANIZATION",188,-1.816,0,0.017,"No",-1.3333,0.0089,0.91,"No"
"1522","REACTOME","106552_REACT_2232_RNA_POLYMERASE_I_PROMOTER_OPENING",59,-1.8153,0.0014,0.023,"No",-1.9591,0,0.045,"No"
"1523","C7_Immunologic_signatures","C7_ALL_1657_GSE3982_MAC_VS_TH1_UP",197,-1.815,0,1.6e-05,"No",0.7538,0.99,1,"Yes"
"1524","C2_Chemical_and_genetic_perturbations","C2_CGP_356_HAHTOLA_SEZARY_SYNDROM_UP",97,-1.8149,0,0.007,"No",1.6996,0,0.083,"Yes"
"1525","KEGG_pathway","HSA04911_INSULIN_SECRETION",83,-1.8147,0,0.0021,"No",-1.2978,0.068,0.42,"No"
"1526","GO_BP","512006_GO_0051092_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY",128,-1.8146,0,0.017,"No",0.8725,0.78,1,"Yes"
"1527","C7_Immunologic_signatures","C7_ALL_771_GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP",186,-1.8146,0,1.6e-05,"No",-0.9908,0.46,1,"No"
"1528","GO_BP","492172_GO_0007411_AXON_GUIDANCE",399,-1.8145,0,0.017,"No",-1.2512,0.029,0.91,"No"
"1529","C2_Chemical_and_genetic_perturbations","C2_CGP_1583_BASSO_CD40_SIGNALING_UP",100,-1.8142,0,0.007,"No",-1.152,0.2,0.85,"No"
"1530","C2_Chemical_and_genetic_perturbations","C2_CGP_1813_DAZARD_UV_RESPONSE_CLUSTER_G4",20,-1.8142,0.0031,0.007,"No",-1.4048,0.092,0.58,"No"
"1531","GO_BP","517429_GO_0072524_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",105,-1.8142,0,0.017,"No",-0.7198,0.98,1,"No"
"1532","C4_Cancer_modules","C4_CM_174_MODULE_184",29,-1.8141,0.0014,0.0051,"No",0.6792,0.94,1,"Yes"
"1533","REACTOME","105701_REACT_13812_ENDOGENOUS_STEROLS",22,-1.8139,0.003,0.023,"No",1.1205,0.3,0.56,"Yes"
"1534","GO_CC","486839_GO_0000323_LYTIC_VACUOLE",473,-1.8139,0,0.021,"No",0.8902,0.91,0.91,"Yes"
"1535","C2_Chemical_and_genetic_perturbations","C2_CGP_1044_SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP",18,-1.8139,0.0015,0.007,"No",-1.4074,0.07,0.58,"No"
"1536","WikiPathways","920957_WP2355_CORTICOTROPIN_RELEASING_HORMONE",89,-1.8138,0.0013,0.0083,"No",-1.2875,0.065,1,"No"
"1537","GO_BP","488102_GO_0002228_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",26,-1.8138,0.0016,0.017,"No",-0.7361,0.85,1,"No"
"1538","C7_Immunologic_signatures","C7_ALL_1085_GSE25087_TREG_VS_TCONV_ADULT_UP",198,-1.8138,0,1.6e-05,"No",-0.7299,0.99,1,"No"
"1539","GO_BP","1022094_GO_0098657_IMPORT_INTO_CELL",18,-1.8131,0,0.017,"No",-1.3586,0.1,0.96,"No"
"1540","GO_BP","507705_GO_0045348_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS",8,-1.813,0.0017,0.017,"No",-1.3261,0.15,0.89,"No"
"1541","GO_BP","503348_GO_0034142_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",99,-1.8128,0,0.017,"No",-0.8238,0.87,1,"No"
"1542","C2_BioCarta_Pathways","C2_CP_BIOCARTA_18_BIOCARTA_SPPA_PATHWAY",21,-1.8123,0.0015,0.021,"No",-0.8479,0.66,1,"No"
"1543","GO_BP","511675_GO_0050704_REGULATION_OF_INTERLEUKIN_1_SECRETION",23,-1.812,0.0015,0.017,"No",-1.095,0.32,0.95,"No"
"1544","C7_Immunologic_signatures","C7_ALL_120_GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN",188,-1.812,0,1.6e-05,"No",1.6222,0.0023,0.0021,"Yes"
"1545","GO_BP","505283_GO_0042107_CYTOKINE_METABOLIC_PROCESS",21,-1.8119,0.0046,0.017,"No",-0.9683,0.48,1,"No"
"1546","WikiPathways","198888_WP167_EICOSANOID_SYNTHESIS",20,-1.8118,0.0016,0.0081,"No",1.0842,0.34,1,"Yes"
"1547","GO_CC","489651_GO_0005764_LYSOSOME",473,-1.8117,0,0.021,"No",0.8853,0.9,0.91,"Yes"
"1548","C2_Chemical_and_genetic_perturbations","C2_CGP_1915_SEMENZA_HIF1_TARGETS",35,-1.8117,0.0014,0.0072,"No",-1.0732,0.33,0.95,"No"
"1549","GO_BP","505276_GO_0042098_T_CELL_PROLIFERATION",44,-1.8117,0,0.017,"No",0.7828,0.82,1,"Yes"
"1550","GO_BP","502298_GO_0033077_T_CELL_DIFFERENTIATION_IN_THYMUS",51,-1.8116,0,0.017,"No",-1.0319,0.4,0.98,"No"
"1551","GO_BP","516518_GO_0071594_THYMOCYTE_AGGREGATION",51,-1.8116,0,0.017,"No",-1.0144,0.44,0.98,"No"
"1552","GO_MF","490031_GO_0004715_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY",45,-1.8113,0.0014,0.043,"No",-1.2207,0.15,0.84,"No"
"1553","C2_BioCarta_Pathways","C2_CP_BIOCARTA_162_BIOCARTA_RHO_PATHWAY",31,-1.8112,0.0015,0.02,"No",0.909,0.58,0.91,"Yes"
"1554","GO_BP","513508_GO_0055075_POTASSIUM_ION_HOMEOSTASIS",16,-1.811,0.0032,0.017,"No",-1.3327,0.14,0.91,"No"
"1555","GO_BP","507947_GO_0045599_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION",40,-1.8109,0.0028,0.017,"No",-0.8095,0.8,1,"No"
"1556","C2_Chemical_and_genetic_perturbations","C2_CGP_1088_RICKMAN_HEAD_AND_NECK_CANCER_C",99,-1.8107,0,0.0073,"No",1.0361,0.38,0.74,"Yes"
"1557","C7_Immunologic_signatures","C7_ALL_220_GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN",198,-1.8105,0,1.6e-05,"No",0.799,0.95,1,"Yes"
"1558","C7_Immunologic_signatures","C7_ALL_1718_GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN",197,-1.8105,0,1.6e-05,"No",0.9461,0.62,0.91,"Yes"
"1559","C7_Immunologic_signatures","C7_ALL_1468_GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN",195,-1.8103,0,1.6e-05,"No",1.0933,0.22,0.46,"Yes"
"1560","WikiPathways","198837_WP702_METAPATHWAY_BIOTRANSFORMATION",175,-1.8103,0,0.0079,"No",1.0187,0.4,1,"Yes"
"1561","GO_BP","487456_GO_0001516_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS",21,-1.81,0.003,0.017,"No",-0.7379,0.88,1,"No"
"1562","C3_TF_targets","C3_TFT_153_V_SRF_C",207,-1.81,0,0.0031,"No",-1.2618,0.045,0.26,"No"
"1563","C2_BioCarta_Pathways","C2_CP_BIOCARTA_3_BIOCARTA_CSK_PATHWAY",21,-1.8099,0.0059,0.019,"No",1.367,0.082,0.54,"Yes"
"1564","C2_Chemical_and_genetic_perturbations","C2_CGP_354_GOZGIT_ESR1_TARGETS_UP",144,-1.8098,0,0.0074,"No",-1.3014,0.055,0.69,"No"
"1565","C4_Cancer_modules","C4_CM_18_MODULE_19",306,-1.8098,0,0.0052,"No",-0.9031,0.75,0.88,"No"
"1566","GO_BP","488348_GO_0002475_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB",11,-1.8092,0.0063,0.018,"No",-1.0035,0.44,0.99,"No"
"1567","C7_Immunologic_signatures","C7_ALL_1621_GSE3982_MAST_CELL_VS_NKCELL_UP",199,-1.8092,0,1.6e-05,"No",1.2004,0.093,0.23,"Yes"
"1568","C2_Chemical_and_genetic_perturbations","C2_CGP_3338_GENTLES_LEUKEMIC_STEM_CELL_DN",19,-1.8091,0.003,0.0074,"No",1.2407,0.18,0.45,"Yes"
"1569","GO_BP","502068_GO_0032846_POSITIVE_REGULATION_OF_HOMEOSTATIC_PROCESS",147,-1.809,0,0.018,"No",-0.9348,0.61,1,"No"
"1570","GO_BP","507496_GO_0045103_INTERMEDIATE_FILAMENT_BASED_PROCESS",36,-1.809,0.0014,0.018,"No",0.9272,0.57,1,"Yes"
"1571","GO_BP","509047_GO_0046824_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT",100,-1.8088,0,0.018,"No",-1.0569,0.33,0.96,"No"
"1572","C2_Chemical_and_genetic_perturbations","C2_CGP_1102_DEN_INTERACT_WITH_LCA5",26,-1.8088,0.0015,0.0074,"No",1.0873,0.32,0.65,"Yes"
"1573","C2_Chemical_and_genetic_perturbations","C2_CGP_134_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN",458,-1.8087,0,0.0074,"No",1.0673,0.19,0.68,"Yes"
"1574","C2_Chemical_and_genetic_perturbations","C2_CGP_1181_MORI_IMMATURE_B_LYMPHOCYTE_DN",90,-1.8086,0,0.0074,"No",0.7415,0.94,1,"Yes"
"1575","REACTOME","1127693_REACT_263952_EPHB_MEDIATED_FORWARD_SIGNALING",41,-1.8086,0,0.024,"No",0.7394,0.91,1,"Yes"
"1576","C2_Chemical_and_genetic_perturbations","C2_CGP_1347_CHEN_LUNG_CANCER_SURVIVAL",26,-1.8085,0,0.0074,"No",-0.9196,0.58,1,"No"
"1577","GO_BP","499232_GO_0021953_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION",163,-1.8085,0,0.018,"No",-1.1968,0.12,0.9,"No"
"1578","C2_Chemical_and_genetic_perturbations","C2_CGP_1742_RUAN_RESPONSE_TO_TNF_DN",82,-1.8084,0,0.0073,"No",0.8749,0.71,0.95,"Yes"
"1579","GO_MF","504223_GO_0035035_HISTONE_ACETYLTRANSFERASE_BINDING",21,-1.8082,0.003,0.043,"No",-0.944,0.53,0.95,"No"
"1580","C2_Chemical_and_genetic_perturbations","C2_CGP_3008_SASSON_RESPONSE_TO_FORSKOLIN_DN",88,-1.8078,0,0.0074,"No",0.6197,1,1,"Yes"
"1581","GO_BP","492437_GO_0008064_REGULATION_OF_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION",129,-1.8074,0,0.018,"No",-0.8029,0.9,1,"No"
"1582","GO_BP","502192_GO_0032970_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS",298,-1.8072,0,0.018,"No",-0.9942,0.47,1,"No"
"1583","C2_Chemical_and_genetic_perturbations","C2_CGP_2063_GAVIN_FOXP3_TARGETS_CLUSTER_P6",91,-1.8071,0,0.0074,"No",0.6987,0.98,1,"Yes"
"1584","GO_BP","508746_GO_0046486_GLYCEROLIPID_METABOLIC_PROCESS",297,-1.8069,0,0.018,"No",-0.8336,0.94,1,"No"
"1585","C2_Chemical_and_genetic_perturbations","C2_CGP_528_STREICHER_LSM1_TARGETS_UP",44,-1.8069,0,0.0074,"No",-1.0235,0.41,0.98,"No"
"1586","KEGG_pathway","HSA04611_PLATELET_ACTIVATION",131,-1.8069,0,0.0024,"No",1.2167,0.1,0.53,"Yes"
"1587","GO_BP","500107_GO_0030808_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",141,-1.8067,0,0.018,"No",-0.9456,0.6,1,"No"
"1588","C2_Chemical_and_genetic_perturbations","C2_CGP_1803_SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER",45,-1.8062,0,0.0075,"No",-0.8484,0.72,1,"No"
"1589","GO_BP","516546_GO_0071622_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS",31,-1.806,0,0.018,"No",1.0029,0.45,0.98,"Yes"
"1590","GO_BP","486819_GO_0000302_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",156,-1.8059,0,0.018,"No",-0.8192,0.89,1,"No"
"1591","REACTOME","119537_REACT_19193_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION",8,-1.8058,0.0034,0.024,"No",-1.4812,0.058,0.46,"No"
"1592","C2_Chemical_and_genetic_perturbations","C2_CGP_3093_WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1",27,-1.8056,0.003,0.0075,"No",-1.1186,0.28,0.89,"No"
"1593","GO_BP","491054_GO_0006069_ETHANOL_OXIDATION",11,-1.8056,0.0048,0.018,"No",-1.3461,0.13,0.92,"No"
"1594","C2_Chemical_and_genetic_perturbations","C2_CGP_164_NOJIMA_SFRP2_TARGETS_UP",31,-1.8055,0.003,0.0075,"No",-1.3304,0.1,0.69,"No"
"1595","GO_BP","498206_GO_0019362_PYRIDINE_NUCLEOTIDE_METABOLIC_PROCESS",97,-1.8054,0,0.018,"No",-0.7116,0.97,1,"No"
"1596","GO_BP","508016_GO_0045668_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION",37,-1.8052,0,0.018,"No",-1.2245,0.15,0.88,"No"
"1597","KEGG_pathway","HSA04930_TYPE_II_DIABETES_MELLITUS",47,-1.8052,0,0.0024,"No",-1.3848,0.056,0.35,"No"
"1598","GO_BP","491528_GO_0006638_NEUTRAL_LIPID_METABOLIC_PROCESS",96,-1.8051,0,0.018,"No",-0.7151,0.97,1,"No"
"1599","GO_MF","492830_GO_0008556_POTASSIUM_TRANSPORTING_ATPASE_ACTIVITY",11,-1.8049,0.0017,0.044,"No",-1.3896,0.11,0.65,"No"
"1600","GO_BP","506202_GO_0043129_SURFACTANT_HOMEOSTASIS",10,-1.8049,0,0.018,"No",0.6487,0.92,1,"Yes"
"1601","GO_BP","515591_GO_0070661_LEUKOCYTE_PROLIFERATION",89,-1.8048,0,0.018,"No",0.7416,0.96,1,"Yes"
"1602","GO_BP","517579_GO_0072676_LYMPHOCYTE_MIGRATION",28,-1.8048,0.0015,0.018,"No",0.8623,0.66,1,"Yes"
"1603","C7_Immunologic_signatures","C7_ALL_884_GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN",199,-1.8045,0,2e-05,"No",-0.7834,0.97,1,"No"
"1604","GO_BP","491758_GO_0006897_ENDOCYTOSIS",482,-1.8039,0,0.018,"No",-0.8626,0.93,1,"No"
"1605","GO_BP","752431_GO_0086065_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION",36,-1.8039,0,0.018,"No",-1.2744,0.13,0.89,"No"
"1606","C2_Chemical_and_genetic_perturbations","C2_CGP_1471_FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP",86,-1.8038,0.0013,0.0077,"No",0.9694,0.51,0.84,"Yes"
"1607","GO_BP","491702_GO_0006837_SEROTONIN_TRANSPORT",7,-1.8038,0,0.018,"No",-1.3114,0.16,0.87,"No"
"1608","GO_BP","492553_GO_0008212_MINERALOCORTICOID_METABOLIC_PROCESS",6,-1.8037,0.0017,0.018,"No",0.7599,0.76,1,"Yes"
"1609","C7_Immunologic_signatures","C7_ALL_795_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP",193,-1.8036,0,2e-05,"No",-0.8434,0.88,1,"No"
"1610","C2_Chemical_and_genetic_perturbations","C2_CGP_2546_RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP",334,-1.8033,0,0.0077,"No",0.7454,1,1,"Yes"
"1611","GO_BP","519044_GO_2000404_REGULATION_OF_T_CELL_MIGRATION",22,-1.8033,0.0015,0.018,"No",-0.8987,0.63,1,"No"
"1612","GO_BP","510176_GO_0048008_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",34,-1.8031,0,0.018,"No",0.536,0.99,1,"Yes"
"1613","GO_BP","492171_GO_0007409_AXONOGENESIS",486,-1.8028,0,0.018,"No",-1.2159,0.04,0.88,"No"
"1614","C2_Chemical_and_genetic_perturbations","C2_CGP_21_KORKOLA_CHORIOCARCINOMA_UP",6,-1.8027,0.0035,0.0077,"No",-0.7753,0.73,1,"No"
"1615","REACTOME","1127677_REACT_268237_DNA_METHYLATION",61,-1.8026,0,0.025,"No",-2.0866,0,0.042,"No"
"1616","C2_Chemical_and_genetic_perturbations","C2_CGP_1746_LEONARD_HYPOXIA",47,-1.8026,0.0014,0.0077,"No",-1.1521,0.21,0.85,"No"
"1617","GO_BP","511679_GO_0050708_REGULATION_OF_PROTEIN_SECRETION",333,-1.8025,0,0.018,"No",0.8212,0.98,1,"Yes"
"1618","C7_Immunologic_signatures","C7_ALL_613_GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_UP",198,-1.8025,0,2e-05,"No",0.8647,0.86,1,"Yes"
"1619","GO_MF","496634_GO_0016713_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",8,-1.8025,0.0048,0.045,"No",0.7004,0.83,1,"Yes"
"1620","C2_Chemical_and_genetic_perturbations","C2_CGP_1699_CHIBA_RESPONSE_TO_TSA_UP",49,-1.8025,0.0027,0.0077,"No",-0.9107,0.6,1,"No"
"1621","GO_BP","508893_GO_0046645_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION",8,-1.8023,0.0017,0.018,"No",-1.0811,0.34,0.95,"No"
"1622","GO_BP","491988_GO_0007188_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",138,-1.8022,0,0.018,"No",-1.0003,0.44,0.99,"No"
"1623","C2_Chemical_and_genetic_perturbations","C2_CGP_1727_NATSUME_RESPONSE_TO_INTERFERON_BETA_DN",52,-1.802,0,0.0078,"No",1.6026,0.0065,0.14,"Yes"
"1624","KEGG_reaction","R07387_PLASMANYLCHOLINE_2_ACYLHYDROLASE_1_RADYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_CARBOXYLATE",18,-1.8019,0,0.0086,"No",0.8091,0.74,1,"Yes"
"1625","GO_BP","503814_GO_0034614_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",82,-1.8017,0,0.018,"No",0.6037,1,1,"Yes"
"1626","GO_BP","499586_GO_0030168_PLATELET_ACTIVATION",229,-1.8016,0,0.018,"No",1.2635,0.033,0.72,"Yes"
"1627","GO_BP","511764_GO_0050795_REGULATION_OF_BEHAVIOR",186,-1.8015,0,0.018,"No",0.9621,0.57,1,"Yes"
"1628","C4_Cancer_gene_neighborhoods","C4_CGN_396_GNF2_PTPRC",68,-1.8015,0.0013,0.0028,"No",0.6338,1,1,"Yes"
"1629","C2_Chemical_and_genetic_perturbations","C2_CGP_1261_TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP",76,-1.8013,0.0013,0.0078,"No",1.0728,0.32,0.67,"Yes"
"1630","GO_BP","508011_GO_0045663_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION",16,-1.8012,0.003,0.018,"No",0.67,0.9,1,"Yes"
"1631","C7_Immunologic_signatures","C7_ALL_278_GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN",199,-1.8012,0,1.9e-05,"No",1.0053,0.45,0.72,"Yes"
"1632","GO_BP","494874_GO_0010810_REGULATION_OF_CELL_SUBSTRATE_ADHESION",155,-1.8011,0,0.018,"No",-1.0236,0.41,0.97,"No"
"1633","GO_MF","489754_GO_0050839_CELL_ADHESION_MOLECULE_BINDING",171,-1.801,0,0.045,"No",0.7528,0.98,1,"Yes"
"1634","C7_Immunologic_signatures","C7_ALL_1291_GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP",196,-1.801,0,1.9e-05,"No",0.7166,1,1,"Yes"
"1635","GO_MF","492411_GO_0071723_LIPOPEPTIDE_BINDING",7,-1.8009,0.0017,0.044,"No",-1.1323,0.32,0.81,"No"
"1636","GO_BP","488569_GO_0002696_POSITIVE_REGULATION_OF_LEUKOCYTE_ACTIVATION",269,-1.8008,0,0.018,"No",0.8274,0.94,1,"Yes"
"1637","GO_BP","488563_GO_0002690_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS",67,-1.8006,0.0013,0.018,"No",1.2557,0.11,0.72,"Yes"
"1638","GO_BP","753115_GO_1900120_REGULATION_OF_RECEPTOR_BINDING",15,-1.8005,0.0016,0.018,"No",1.1512,0.26,0.83,"Yes"
"1639","C7_Immunologic_signatures","C7_ALL_89_GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP",199,-1.8005,0,1.9e-05,"No",-0.6845,1,1,"No"
"1640","GO_CC","487625_GO_0001726_RUFFLE",154,-1.8005,0,0.023,"No",-0.6693,0.99,1,"No"
"1641","KEGG_module","HSA_M00353_SPLICEOSOME_PRP19_CDC5L_COMPLEX",14,-1.7997,0.0047,0.09,"No",-1.6627,0.024,0.35,"No"
"1642","GO_BP","510733_GO_0048678_RESPONSE_TO_AXON_INJURY",40,-1.7996,0.0041,0.018,"No",-1.3399,0.087,0.91,"No"
"1643","GO_BP","1129382_GO_1903556_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION",38,-1.7996,0.003,0.018,"No",-0.9451,0.54,1,"No"
"1644","C2_Chemical_and_genetic_perturbations","C2_CGP_326_GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP",86,-1.7996,0,0.008,"No",1.2094,0.15,0.48,"Yes"
"1645","GO_MF","490389_GO_0005126_CYTOKINE_RECEPTOR_BINDING",237,-1.7993,0,0.044,"No",-0.9898,0.47,0.92,"No"
"1646","C7_Immunologic_signatures","C7_ALL_1697_GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP",192,-1.7993,0,1.9e-05,"No",-0.8636,0.82,1,"No"
"1647","KEGG_pathway","HSA04620_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",99,-1.7989,0,0.0026,"No",-0.9435,0.58,0.97,"No"
"1648","GO_BP","488167_GO_0002294_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",21,-1.7987,0.003,0.019,"No",-1.0836,0.33,0.96,"No"
"1649","GO_BP","491052_GO_0006067_ETHANOL_METABOLIC_PROCESS",14,-1.7987,0.003,0.019,"No",-1.212,0.24,0.88,"No"
"1650","GO_BP","493825_GO_0009713_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",20,-1.7982,0.0016,0.019,"No",-1.0576,0.39,0.96,"No"
"1651","KEGG_pathway","HSA04921_OXYTOCIN_SIGNALING_PATHWAY",157,-1.7982,0,0.0026,"No",-1.1799,0.14,0.55,"No"
"1652","C2_Chemical_and_genetic_perturbations","C2_CGP_2732_COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN",134,-1.798,0,0.0082,"No",-0.9877,0.48,1,"No"
"1653","C7_Immunologic_signatures","C7_ALL_925_GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP",195,-1.7977,0,2.3e-05,"No",1.0866,0.25,0.48,"Yes"
"1654","C2_Chemical_and_genetic_perturbations","C2_CGP_1971_BURTON_ADIPOGENESIS_9",91,-1.7977,0,0.0082,"No",-0.8306,0.83,1,"No"
"1655","GO_BP","488449_GO_0002576_PLATELET_DEGRANULATION",85,-1.7977,0.0013,0.019,"No",1.5049,0.014,0.4,"Yes"
"1656","GO_BP","506565_GO_0043534_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",25,-1.7975,0.0045,0.019,"No",-1.3884,0.06,1,"No"
"1657","KEGG_compound","C00350_PHOSPHATIDYLETHANOLAMINE_3_PHOSPHATIDYL_ETHANOLAMINE_3_PHOSPHATIDYL_ETHANOLAMINE_CEPHALIN_O_1_BETA_ACYL_2_ACYL_SN_GLYCERO_3_PHOSPHO_ETHANOLAMINE_1_ACYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_1_PHOSPHATIDYLETHANOLAMINE",35,-1.7973,0,0.017,"No",-0.7982,0.79,1,"No"
"1658","C7_Immunologic_signatures","C7_ALL_184_GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN",197,-1.7972,0,2.3e-05,"No",-0.9474,0.61,1,"No"
"1659","C4_Cancer_gene_neighborhoods","C4_CGN_291_GNF2_CENPF",62,-1.7966,0.0014,0.003,"No",0.9417,0.55,0.73,"Yes"
"1660","GO_BP","508773_GO_0046514_CERAMIDE_CATABOLIC_PROCESS",12,-1.7965,0.0031,0.019,"No",-0.9132,0.57,1,"No"
"1661","C2_Chemical_and_genetic_perturbations","C2_CGP_1738_KUNINGER_IGF1_VS_PDGFB_TARGETS_DN",45,-1.7965,0.0014,0.0083,"No",0.9513,0.52,0.86,"Yes"
"1662","C2_Chemical_and_genetic_perturbations","C2_CGP_1899_DAZARD_RESPONSE_TO_UV_SCC_UP",122,-1.7963,0,0.0083,"No",1.3978,0.028,0.29,"Yes"
"1663","C2_Chemical_and_genetic_perturbations","C2_CGP_2596_LEE_DIFFERENTIATING_T_LYMPHOCYTE",197,-1.7962,0,0.0082,"No",0.9211,0.72,0.9,"Yes"
"1664","C4_Cancer_modules","C4_CM_2_MODULE_2",370,-1.7962,0,0.006,"No",1.0067,0.43,0.7,"Yes"
"1665","GO_BP","500101_GO_0030802_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",137,-1.7961,0,0.019,"No",-0.9194,0.65,1,"No"
"1666","C2_Chemical_and_genetic_perturbations","C2_CGP_2665_CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN",98,-1.796,0,0.0082,"No",-1.425,0.029,0.55,"No"
"1667","GO_BP","511677_GO_0050706_REGULATION_OF_INTERLEUKIN_1_BETA_SECRETION",21,-1.7959,0.0017,0.019,"No",-0.9531,0.52,1,"No"
"1668","C4_Cancer_modules","C4_CM_306_MODULE_355",29,-1.7959,0.0028,0.006,"No",-1.4262,0.056,0.46,"No"
"1669","REACTOME","106248_REACT_16967_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY",19,-1.7958,0.0015,0.027,"No",-1.0296,0.41,0.97,"No"
"1670","GO_BP","499736_GO_0030336_NEGATIVE_REGULATION_OF_CELL_MIGRATION",179,-1.7956,0,0.019,"No",-0.8682,0.82,1,"No"
"1671","C7_Immunologic_signatures","C7_ALL_548_GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN",197,-1.7955,0,2.3e-05,"No",-0.8225,0.92,1,"No"
"1672","GO_BP","512781_GO_0051931_REGULATION_OF_SENSORY_PERCEPTION",30,-1.7955,0.0015,0.019,"No",1.1387,0.26,0.85,"Yes"
"1673","GO_BP","503585_GO_0034383_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE",10,-1.7953,0.0032,0.019,"No",-1.1284,0.33,0.93,"No"
"1674","GO_BP","492874_GO_0008625_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",35,-1.7951,0.0014,0.019,"No",0.617,0.98,1,"Yes"
"1675","C7_Immunologic_signatures","C7_ALL_1828_GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN",197,-1.7951,0,2.3e-05,"No",-1.0679,0.29,1,"No"
"1676","C6_Oncogenic_signatures","C6_ALL_181_KRAS_KIDNEY_UP_V1_UP",136,-1.7951,0,0.00084,"No",1.0283,0.4,0.74,"Yes"
"1677","C2_Chemical_and_genetic_perturbations","C2_CGP_1278_HOUSTIS_ROS",36,-1.795,0,0.0083,"No",1.0557,0.37,0.7,"Yes"
"1678","GO_BP","752383_GO_0086011_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL",11,-1.7949,0.0033,0.019,"No",-0.9537,0.5,1,"No"
"1679","GO_BP","500109_GO_0030810_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",103,-1.7946,0,0.019,"No",-1.0729,0.33,0.96,"No"
"1680","C2_Chemical_and_genetic_perturbations","C2_CGP_1567_VERHAAK_AML_WITH_NPM1_MUTATED_DN",242,-1.7942,0,0.0084,"No",1.1448,0.13,0.56,"Yes"
"1681","GO_MF","490192_GO_0004896_CYTOKINE_RECEPTOR_ACTIVITY",87,-1.7941,0,0.046,"No",1.0322,0.37,0.84,"Yes"
"1682","GO_BP","511999_GO_0051084_DE_NOVO_POSTTRANSLATIONAL_PROTEIN_FOLDING",49,-1.7941,0.0013,0.019,"No",1.0541,0.35,0.94,"Yes"
"1683","C2_Chemical_and_genetic_perturbations","C2_CGP_2788_ONO_AML1_TARGETS_DN",40,-1.7935,0,0.0084,"No",0.9545,0.54,0.86,"Yes"
"1684","C7_Immunologic_signatures","C7_ALL_1028_GSE24142_DN2_VS_DN3_THYMOCYTE_DN",200,-1.7935,0,2.3e-05,"No",-0.6501,1,1,"No"
"1685","GO_BP","506148_GO_0043062_EXTRACELLULAR_STRUCTURE_ORGANIZATION",369,-1.7934,0,0.019,"No",-1.1131,0.17,0.94,"No"
"1686","C7_Immunologic_signatures","C7_ALL_793_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP",190,-1.7931,0,2.3e-05,"No",-1.0576,0.32,1,"No"
"1687","GO_MF","489530_GO_0004062_ARYL_SULFOTRANSFERASE_ACTIVITY",6,-1.7928,0,0.045,"No",-1.0876,0.38,0.85,"No"
"1688","GO_BP","511737_GO_0050766_POSITIVE_REGULATION_OF_PHAGOCYTOSIS",36,-1.7926,0.0028,0.019,"No",-1.3335,0.094,0.92,"No"
"1689","REACTOME","106363_REACT_16983_AMINE_LIGAND_BINDING_RECEPTORS",40,-1.7926,0.0014,0.027,"No",1.0171,0.43,0.72,"Yes"
"1690","GO_MF","491980_GO_0050431_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING",16,-1.7925,0.0062,0.045,"No",0.8926,0.61,0.98,"Yes"
"1691","C2_Chemical_and_genetic_perturbations","C2_CGP_1526_PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN",160,-1.7925,0,0.0086,"No",-0.7987,0.92,1,"No"
"1692","REACTOME","106506_REACT_12529_SIGNALING_BY_VEGF",116,-1.7921,0,0.027,"No",-0.7114,0.98,1,"No"
"1693","C2_Chemical_and_genetic_perturbations","C2_CGP_1515_NGUYEN_NOTCH1_TARGETS_UP",29,-1.7918,0.0014,0.0086,"No",-0.996,0.45,1,"No"
"1694","GO_BP","501966_GO_0032740_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION",11,-1.7917,0.0031,0.02,"No",-1.564,0.034,0.72,"No"
"1695","C2_Chemical_and_genetic_perturbations","C2_CGP_332_GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP",180,-1.7915,0,0.0086,"No",1.4184,0.0072,0.28,"Yes"
"1696","C2_BioCarta_Pathways","C2_CP_BIOCARTA_53_BIOCARTA_D4GDI_PATHWAY",13,-1.7912,0.0065,0.024,"No",-0.6064,0.95,1,"No"
"1697","C4_Cancer_modules","C4_CM_94_MODULE_99",341,-1.7905,0,0.0062,"No",-1.3116,0.01,0.5,"No"
"1698","GO_BP","514182_GO_0060627_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT",373,-1.7903,0,0.02,"No",0.9812,0.55,1,"Yes"
"1699","C4_Cancer_gene_neighborhoods","C4_CGN_370_GNF2_LCAT",121,-1.7902,0,0.0032,"No",-1.1653,0.15,0.65,"No"
"1700","GO_BP","487670_GO_0001774_MICROGLIAL_CELL_ACTIVATION",12,-1.7901,0.0046,0.02,"No",1.1283,0.29,0.87,"Yes"
"1701","REACTOME","576263_REACT_118572_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX",87,-1.79,0,0.027,"No",-0.8479,0.79,1,"No"
"1702","KEGG_pathway","HSA04960_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION",38,-1.79,0.0015,0.0028,"No",-1.3546,0.083,0.32,"No"
"1703","GO_BP","499325_GO_0022407_REGULATION_OF_CELL_CELL_ADHESION",340,-1.7899,0,0.02,"No",0.9361,0.66,1,"Yes"
"1704","GO_BP","501961_GO_0032735_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION",29,-1.7896,0.0015,0.02,"No",-1.486,0.038,0.84,"No"
"1705","GO_BP","511635_GO_0050663_CYTOKINE_SECRETION",32,-1.7896,0.0029,0.02,"No",0.9556,0.54,1,"Yes"
"1706","GO_BP","512118_GO_0051222_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT",358,-1.7894,0,0.02,"No",0.8263,0.99,1,"Yes"
"1707","GO_BP","491674_GO_0006801_SUPEROXIDE_METABOLIC_PROCESS",31,-1.7892,0.0043,0.02,"No",-1.1584,0.25,0.92,"No"
"1708","C2_Chemical_and_genetic_perturbations","C2_CGP_1665_HENDRICKS_SMARCA4_TARGETS_UP",54,-1.7892,0.0014,0.0088,"No",0.8552,0.73,0.97,"Yes"
"1709","GO_MF","496348_GO_0016298_LIPASE_ACTIVITY",105,-1.7891,0.0012,0.046,"No",0.8003,0.91,1,"Yes"
"1710","C2_Chemical_and_genetic_perturbations","C2_CGP_1978_KYNG_RESPONSE_TO_H2O2",71,-1.789,0,0.0088,"No",1.4446,0.031,0.26,"Yes"
"1711","C2_Chemical_and_genetic_perturbations","C2_CGP_1427_LEE_LIVER_CANCER_DENA_UP",58,-1.7888,0,0.0088,"No",1.3515,0.048,0.34,"Yes"
"1712","C6_Oncogenic_signatures","C6_ALL_85_PKCA_DN_V1_DN",141,-1.7882,0,0.00085,"No",-1.0511,0.34,0.57,"No"
"1713","KEGG_pathway","HSA04668_TNF_SIGNALING_PATHWAY",109,-1.7879,0,0.0028,"No",-1.1505,0.2,0.61,"No"
"1714","GO_BP","511805_GO_0050863_REGULATION_OF_T_CELL_ACTIVATION",258,-1.7877,0,0.02,"No",0.8477,0.93,1,"Yes"
"1715","GO_BP","487916_GO_0002026_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION",27,-1.7876,0.0015,0.02,"No",-1.3139,0.13,0.87,"No"
"1716","GO_BP","849823_GO_0097485_NEURON_PROJECTION_GUIDANCE",413,-1.7876,0,0.02,"No",-1.2312,0.029,0.9,"No"
"1717","KEGG_pathway","HSA04514_CELL_ADHESION_MOLECULES_CAMS_",137,-1.7873,0,0.0028,"No",-0.909,0.66,0.98,"No"
"1718","C2_BioCarta_Pathways","C2_CP_BIOCARTA_199_BIOCARTA_CTLA4_PATHWAY",19,-1.7872,0.0015,0.024,"No",1.5702,0.019,0.3,"Yes"
"1719","GO_MF","487680_GO_0001784_PHOSPHOTYROSINE_BINDING",13,-1.7871,0.0016,0.046,"No",-0.72,0.82,1,"No"
"1720","C2_Chemical_and_genetic_perturbations","C2_CGP_1973_TRACEY_RESISTANCE_TO_IFNA2_DN",31,-1.787,0.0015,0.009,"No",0.7242,0.89,1,"Yes"
"1721","GO_BP","496384_GO_0016358_DENDRITE_DEVELOPMENT",76,-1.7866,0,0.02,"No",-1.0386,0.38,0.98,"No"
"1722","KEGG_pathway","HSA05321_INFLAMMATORY_BOWEL_DISEASE_IBD_",62,-1.7866,0.0013,0.0028,"No",-1.4048,0.042,0.39,"No"
"1723","C4_Cancer_modules","C4_CM_183_MODULE_196",23,-1.7863,0.0015,0.0064,"No",-1.1441,0.26,0.61,"No"
"1724","REACTOME","106050_REACT_318_PLATELET_DEGRANULATION",79,-1.7863,0,0.028,"No",1.5104,0,0.14,"Yes"
"1725","KEGG_pathway","HSA04510_FOCAL_ADHESION",202,-1.7862,0,0.0028,"No",-0.8618,0.83,1,"No"
"1726","GO_BP","498817_GO_0021533_CELL_DIFFERENTIATION_IN_HINDBRAIN",24,-1.7862,0.0029,0.021,"No",-0.8403,0.72,1,"No"
"1727","GO_BP","492001_GO_0007202_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY",61,-1.7861,0,0.021,"No",-0.9379,0.58,1,"No"
"1728","C2_Chemical_and_genetic_perturbations","C2_CGP_2036_HARRIS_BRAIN_CANCER_PROGENITORS",43,-1.786,0,0.0091,"No",0.9533,0.51,0.86,"Yes"
"1729","GO_BP","508120_GO_0045785_POSITIVE_REGULATION_OF_CELL_ADHESION",338,-1.7858,0,0.021,"No",0.91,0.78,1,"Yes"
"1730","GO_BP","510716_GO_0048661_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION",49,-1.7853,0.0028,0.021,"No",-0.9405,0.57,1,"No"
"1731","C2_Chemical_and_genetic_perturbations","C2_CGP_601_PEREZ_TP53_AND_TP63_TARGETS",200,-1.785,0,0.0092,"No",-1.7062,0,0.34,"No"
"1732","GO_BP","1047427_GO_1903427_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",14,-1.785,0.0016,0.021,"No",-1.5627,0.04,0.72,"No"
"1733","C2_Chemical_and_genetic_perturbations","C2_CGP_1720_BROWNE_HCMV_INFECTION_8HR_UP",102,-1.7849,0,0.0092,"No",-1.6455,0,0.36,"No"
"1734","C2_Chemical_and_genetic_perturbations","C2_CGP_2395_CADWELL_ATG16L1_TARGETS_UP",88,-1.7846,0,0.0092,"No",-0.9062,0.68,1,"No"
"1735","C2_Chemical_and_genetic_perturbations","C2_CGP_217_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN",31,-1.7844,0,0.0092,"No",1.0376,0.39,0.74,"Yes"
"1736","GO_BP","513500_GO_0055067_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS",95,-1.7843,0,0.021,"No",-1.0068,0.44,0.98,"No"
"1737","GO_BP","502460_GO_0033240_POSITIVE_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS",242,-1.7843,0,0.021,"No",-1.01,0.42,0.98,"No"
"1738","GO_CC","500513_GO_0031254_CELL_TRAILING_EDGE",9,-1.7841,0.0048,0.028,"No",-1.0432,0.4,0.84,"No"
"1739","C7_Immunologic_signatures","C7_ALL_1673_GSE3982_NEUTROPHIL_VS_TH2_UP",197,-1.784,0,3e-05,"No",-0.6919,1,1,"No"
"1740","GO_BP","493575_GO_0009636_RESPONSE_TO_TOXIC_SUBSTANCE",150,-1.7839,0,0.021,"No",-1.1363,0.17,0.93,"No"
"1741","GO_MF","500176_GO_0030881_BETA_2_MICROGLOBULIN_BINDING",11,-1.7839,0.0032,0.047,"No",-1.1992,0.23,0.81,"No"
"1742","GO_BP","1041581_GO_1903409_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",25,-1.7838,0.0045,0.021,"No",-1.0619,0.37,0.96,"No"
"1743","GO_BP","503966_GO_0034767_POSITIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT",78,-1.7838,0.0013,0.021,"No",-1.1709,0.19,0.91,"No"
"1744","GO_BP","488549_GO_0002676_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE",9,-1.7836,0.0048,0.021,"No",-1.1158,0.33,0.94,"No"
"1745","REACTOME","106034_REACT_798_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION",220,-1.7836,0,0.029,"No",1.0921,0.22,0.59,"Yes"
"1746","GO_MF","506432_GO_0043394_PROTEOGLYCAN_BINDING",26,-1.7836,0.0015,0.046,"No",-1.1085,0.32,0.83,"No"
"1747","GO_BP","496036_GO_0015914_PHOSPHOLIPID_TRANSPORT",51,-1.7835,0,0.021,"No",-1.1822,0.18,0.91,"No"
"1748","C7_Immunologic_signatures","C7_ALL_1522_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN",200,-1.7834,0,3e-05,"No",0.8295,0.92,1,"Yes"
"1749","C7_Immunologic_signatures","C7_ALL_1128_GSE2706_R848_VS_LPS_8H_STIM_DC_DN",185,-1.7833,0,3e-05,"No",-0.7231,1,1,"No"
"1750","REACTOME","106357_REACT_14828_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS_",295,-1.7831,0,0.028,"No",1.4951,0,0.15,"Yes"
"1751","GO_BP","513273_GO_0052510_POSITIVE_REGULATION_BY_ORGANISM_OF_DEFENSE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",9,-1.7831,0.0032,0.021,"No",0.6308,0.94,1,"Yes"
"1752","C2_Chemical_and_genetic_perturbations","C2_CGP_2137_STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN",60,-1.7829,0,0.0093,"No",0.9042,0.64,0.92,"Yes"
"1753","GO_BP","491701_GO_0006836_NEUROTRANSMITTER_TRANSPORT",158,-1.7828,0,0.021,"No",-1.0328,0.37,0.98,"No"
"1754","REACTOME","106370_REACT_18352_EICOSANOID_LIGAND_BINDING_RECEPTORS",15,-1.7828,0.0094,0.028,"No",-1.0254,0.42,0.97,"No"
"1755","GO_BP","505562_GO_0042421_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS",6,-1.7827,0.0018,0.021,"No",-0.6195,0.93,1,"No"
"1756","C2_Chemical_and_genetic_perturbations","C2_CGP_1160_JEON_SMAD6_TARGETS_DN",19,-1.7826,0.0016,0.0094,"No",-1.3286,0.11,0.69,"No"
"1757","KEGG_compound","C01953_PREGNENOLONE_5_PREGNEN_3BETA_OL_20_ONE_3BETA_HYDROXYPREGN_5_EN_20_ONE",8,-1.7825,0.0033,0.02,"No",1.3443,0.14,0.64,"Yes"
"1758","C0_Hallmark","H_ALL_14_HALLMARK_ESTROGEN_RESPONSE_LATE",194,-1.7824,0,0.00075,"No",-1.1185,0.21,1,"No"
"1759","GO_BP","494587_GO_0010518_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY",82,-1.7822,0.0013,0.021,"No",-0.9561,0.55,1,"No"
"1760","GO_BP","487789_GO_0001893_MATERNAL_PLACENTA_DEVELOPMENT",27,-1.782,0.0015,0.021,"No",-1.074,0.36,0.95,"No"
"1761","GO_BP","491365_GO_0006458_DE_NOVO_PROTEIN_FOLDING",54,-1.7817,0.0027,0.021,"No",1.0023,0.47,0.98,"Yes"
"1762","GO_BP","511642_GO_0050670_REGULATION_OF_LYMPHOCYTE_PROLIFERATION",172,-1.7816,0,0.021,"No",-0.871,0.79,1,"No"
"1763","GO_BP","515601_GO_0070671_RESPONSE_TO_INTERLEUKIN_12",6,-1.7815,0.0034,0.021,"No",-1.3215,0.16,0.89,"No"
"1764","C7_Immunologic_signatures","C7_ALL_1557_GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP",198,-1.7815,0,3e-05,"No",0.833,0.91,1,"Yes"
"1765","GO_MF","490567_GO_0005391_SODIUM_POTASSIUM_EXCHANGING_ATPASE_ACTIVITY",10,-1.7812,0.012,0.047,"No",-1.4005,0.093,0.62,"No"
"1766","REACTOME","106148_REACT_11048_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL",15,-1.781,0.0044,0.028,"No",-0.7773,0.8,1,"No"
"1767","GO_BP","489301_GO_0051017_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",42,-1.7809,0,0.021,"No",-1.0703,0.35,0.96,"No"
"1768","GO_BP","752692_GO_0097191_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",95,-1.7807,0,0.021,"No",-1.0485,0.37,0.97,"No"
"1769","C7_Immunologic_signatures","C7_ALL_1033_GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP",196,-1.7804,0,3e-05,"No",-1.1327,0.19,1,"No"
"1770","C2_Chemical_and_genetic_perturbations","C2_CGP_2849_HOSHIDA_LIVER_CANCER_SUBCLASS_S3",261,-1.7804,0,0.0096,"No",1.1022,0.16,0.63,"Yes"
"1771","C4_Cancer_modules","C4_CM_159_MODULE_169",96,-1.7801,0,0.0069,"No",0.9673,0.54,0.76,"Yes"
"1772","C7_Immunologic_signatures","C7_ALL_797_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP",186,-1.7801,0,2.9e-05,"No",0.7425,0.99,1,"Yes"
"1773","C2_Chemical_and_genetic_perturbations","C2_CGP_615_MAHADEVAN_RESPONSE_TO_MP470_UP",19,-1.78,0.0046,0.0096,"No",0.749,0.81,1,"Yes"
"1774","REACTOME","1127512_REACT_264464_VEGFA_VEGFR2_PATHWAY",109,-1.7799,0,0.028,"No",0.7301,0.97,1,"Yes"
"1775","REACTOME","106048_REACT_1280_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_",84,-1.7798,0,0.028,"No",1.5017,0.011,0.15,"Yes"
"1776","GO_BP","487798_GO_0001906_CELL_KILLING",51,-1.7798,0,0.021,"No",1.2102,0.17,0.78,"Yes"
"1777","GO_BP","498983_GO_0021700_DEVELOPMENTAL_MATURATION",205,-1.7798,0,0.021,"No",-1.3032,0.044,0.89,"No"
"1778","GO_BP","495963_GO_0015837_AMINE_TRANSPORT",6,-1.7797,0.0018,0.021,"No",0.646,0.89,1,"Yes"
"1779","GO_MF","489497_GO_0004028_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY",7,-1.7797,0.0017,0.047,"No",1.0438,0.39,0.83,"Yes"
"1780","GO_BP","494896_GO_0010832_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION",15,-1.7795,0.0031,0.021,"No",-1.171,0.26,0.91,"No"
"1781","C4_Cancer_gene_neighborhoods","C4_CGN_297_GNF2_GSTM1",108,-1.7794,0,0.0036,"No",-1.1158,0.24,0.72,"No"
"1782","GO_MF","492495_GO_0008142_OXYSTEROL_BINDING",5,-1.7794,0.0017,0.046,"No",-0.5762,0.94,1,"No"
"1783","GO_CC","487822_GO_0001931_UROPOD",9,-1.7792,0.0031,0.029,"No",-1.0458,0.41,0.84,"No"
"1784","GO_BP","755346_GO_2001240_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",34,-1.7789,0,0.021,"No",-1.3497,0.071,0.93,"No"
"1785","GO_BP","506634_GO_0043603_CELLULAR_AMIDE_METABOLIC_PROCESS",259,-1.7785,0,0.022,"No",-0.81,0.94,1,"No"
"1786","GO_BP","1184561_GO_1904037_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS",18,-1.7785,0,0.021,"No",0.7462,0.85,1,"Yes"
"1787","GO_BP","507771_GO_0045414_REGULATION_OF_INTERLEUKIN_8_BIOSYNTHETIC_PROCESS",11,-1.7782,0.0016,0.022,"No",-0.8503,0.65,1,"No"
"1788","GO_BP","516820_GO_0071900_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",449,-1.7781,0,0.022,"No",0.7548,1,1,"Yes"
"1789","C2_Chemical_and_genetic_perturbations","C2_CGP_3037_MARTENS_BOUND_BY_PML_RARA_FUSION",449,-1.7779,0,0.0099,"No",-0.9675,0.61,1,"No"
"1790","C2_Chemical_and_genetic_perturbations","C2_CGP_365_PROVENZANI_METASTASIS_DN",132,-1.7778,0,0.0099,"No",1.6248,0,0.12,"Yes"
"1791","C4_Cancer_modules","C4_CM_56_MODULE_60",412,-1.7776,0,0.007,"No",-1.0531,0.29,0.72,"No"
"1792","C2_Chemical_and_genetic_perturbations","C2_CGP_2845_BOYLAN_MULTIPLE_MYELOMA_PCA3_UP",79,-1.7776,0,0.0099,"No",-0.9716,0.51,1,"No"
"1793","GO_BP","489310_GO_0030832_REGULATION_OF_ACTIN_FILAMENT_LENGTH",130,-1.7773,0,0.022,"No",-0.8045,0.9,1,"No"
"1794","REACTOME","1127547_REACT_264303_CONDENSATION_OF_PROPHASE_CHROMOSOMES",70,-1.7771,0.0013,0.028,"No",-1.9232,0,0.047,"No"
"1795","GO_BP","511991_GO_0051262_PROTEIN_TETRAMERIZATION",115,-1.7768,0.0013,0.022,"No",-1.1819,0.15,0.91,"No"
"1796","C2_Chemical_and_genetic_perturbations","C2_CGP_112_THUM_SYSTOLIC_HEART_FAILURE_UP",412,-1.7768,0,0.01,"No",1.2751,0.017,0.42,"Yes"
"1797","C2_Chemical_and_genetic_perturbations","C2_CGP_1926_SESTO_RESPONSE_TO_UV_C7",67,-1.7765,0,0.01,"No",1.0608,0.33,0.69,"Yes"
"1798","GO_BP","487579_GO_0001667_AMEBOIDAL_TYPE_CELL_MIGRATION",132,-1.7764,0,0.022,"No",-0.8263,0.87,1,"No"
"1799","GO_BP","500103_GO_0030804_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",100,-1.7763,0,0.022,"No",-1.0532,0.34,0.97,"No"
"1800","KEGG_compound","C00080_H_HYDRON",260,-1.7763,0,0.021,"No",-1.0695,0.28,0.98,"No"
"1801","GO_MF","489299_GO_0030674_PROTEIN_BINDING_BRIDGING",138,-1.7763,0,0.047,"No",1.0664,0.28,0.82,"Yes"
"1802","GO_BP","491792_GO_0009612_RESPONSE_TO_MECHANICAL_STIMULUS",182,-1.7761,0,0.022,"No",-1.0627,0.28,0.96,"No"
"1803","C2_Chemical_and_genetic_perturbations","C2_CGP_920_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1",224,-1.7759,0,0.01,"No",0.7877,0.98,1,"Yes"
"1804","GO_BP","499608_GO_0030198_EXTRACELLULAR_MATRIX_ORGANIZATION",363,-1.7757,0,0.022,"No",-1.0544,0.3,0.97,"No"
"1805","GO_CC","506110_GO_0043020_NADPH_OXIDASE_COMPLEX",9,-1.7752,0.005,0.029,"No",-1.328,0.14,0.64,"No"
"1806","C3_TF_targets","C3_TFT_78_V_CEBPB_02",254,-1.7752,0,0.0051,"No",-1.0241,0.38,0.71,"No"
"1807","C2_Chemical_and_genetic_perturbations","C2_CGP_489_WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP",119,-1.7752,0,0.01,"No",0.7963,0.94,0.99,"Yes"
"1808","C2_BioCarta_Pathways","C2_CP_BIOCARTA_95_BIOCARTA_IL5_PATHWAY",9,-1.775,0.0067,0.026,"No",-1.1885,0.27,1,"No"
"1809","C7_Immunologic_signatures","C7_ALL_1434_GSE360_DC_VS_MAC_L_DONOVANI_DN",200,-1.7748,0,3.3e-05,"No",1.1597,0.11,0.3,"Yes"
"1810","C7_Immunologic_signatures","C7_ALL_1651_GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP",199,-1.7748,0,3.3e-05,"No",1.2837,0.031,0.12,"Yes"
"1811","C2_Chemical_and_genetic_perturbations","C2_CGP_2931_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5",26,-1.7747,0,0.01,"No",0.8732,0.67,0.95,"Yes"
"1812","GO_BP","487733_GO_0001837_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",53,-1.7746,0.0013,0.022,"No",-1.1104,0.28,0.94,"No"
"1813","GO_BP","518905_GO_2000258_NEGATIVE_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE",11,-1.7746,0.0064,0.022,"No",0.7611,0.77,1,"Yes"
"1814","GO_BP","488583_GO_0002710_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY",11,-1.7745,0.0017,0.022,"No",-0.5959,0.95,1,"No"
"1815","GO_BP","510822_GO_0048771_TISSUE_REMODELING",89,-1.7745,0,0.022,"No",-1.2213,0.12,0.88,"No"
"1816","GO_BP","512230_GO_0051346_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY",351,-1.7745,0,0.022,"No",-1.0113,0.42,0.98,"No"
"1817","C2_Chemical_and_genetic_perturbations","C2_CGP_491_WANG_ESOPHAGUS_CANCER_PROGRESSION_UP",8,-1.7743,0,0.01,"No",-1.5748,0.033,0.45,"No"
"1818","C2_Chemical_and_genetic_perturbations","C2_CGP_2888_DANG_REGULATED_BY_MYC_DN",252,-1.7743,0,0.01,"No",0.9424,0.66,0.88,"Yes"
"1819","GO_BP","507473_GO_0045073_REGULATION_OF_CHEMOKINE_BIOSYNTHETIC_PROCESS",13,-1.774,0,0.022,"No",-1.1511,0.29,0.93,"No"
"1820","GO_BP","987838_GO_1903037_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION",263,-1.7738,0,0.022,"No",0.8701,0.88,1,"Yes"
"1821","C4_Cancer_modules","C4_CM_261_MODULE_297",73,-1.7736,0,0.0072,"No",-1.0421,0.39,0.74,"No"
"1822","GO_BP","508945_GO_0046717_ACID_SECRETION",55,-1.7734,0.0027,0.022,"No",-1.0855,0.33,0.95,"No"
"1823","C2_Chemical_and_genetic_perturbations","C2_CGP_3236_KATSANOU_ELAVL1_TARGETS_UP",167,-1.7734,0,0.01,"No",-1.0848,0.25,0.94,"No"
"1824","C3_TF_targets","C3_TFT_459_V_AP1_Q4_01",259,-1.7734,0,0.005,"No",-1.2845,0.022,0.25,"No"
"1825","GO_BP","512881_GO_0052031_MODULATION_BY_SYMBIONT_OF_HOST_DEFENSE_RESPONSE",9,-1.7732,0.0033,0.022,"No",0.6428,0.91,1,"Yes"
"1826","C4_Cancer_modules","C4_CM_370_MODULE_454",10,-1.773,0.0097,0.0072,"No",0.6626,0.91,1,"Yes"
"1827","GO_BP","499603_GO_0030193_REGULATION_OF_BLOOD_COAGULATION",77,-1.7729,0,0.022,"No",1.1836,0.17,0.8,"Yes"
"1828","C2_Chemical_and_genetic_perturbations","C2_CGP_2668_ZHAN_LATE_DIFFERENTIATION_GENES_UP",33,-1.7729,0,0.01,"No",0.8998,0.63,0.93,"Yes"
"1829","C7_Immunologic_signatures","C7_ALL_1766_GSE7460_TCONV_VS_TREG_LN_DN",199,-1.7728,0,3.6e-05,"No",-0.8426,0.84,1,"No"
"1830","REACTOME","1183596_REACT_355141_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES",10,-1.7728,0.0047,0.029,"No",-1.1197,0.33,0.87,"No"
"1831","GO_BP","494894_GO_0010830_REGULATION_OF_MYOTUBE_DIFFERENTIATION",46,-1.7725,0.0014,0.022,"No",1.1707,0.19,0.81,"Yes"
"1832","REACTOME","106518_REACT_13723_NEUROTRANSMITTER_RELEASE_CYCLE",48,-1.7722,0.0014,0.029,"No",-1.3725,0.067,0.57,"No"
"1833","GO_BP","506968_GO_0043950_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING",12,-1.7722,0.0045,0.022,"No",0.7901,0.76,1,"Yes"
"1834","C3_TF_targets","C3_TFT_610_CCAWWNAAGG_V_SRF_Q4",82,-1.7719,0,0.0047,"No",-1.2846,0.095,0.25,"No"
"1835","C0_Hallmark","H_ALL_7_HALLMARK_IL6_JAK_STAT3_SIGNALING",85,-1.7719,0,0.00084,"No",1.1175,0.23,0.34,"Yes"
"1836","C2_Chemical_and_genetic_perturbations","C2_CGP_1247_CERVERA_SDHB_TARGETS_2",109,-1.7719,0,0.01,"No",-0.8657,0.8,1,"No"
"1837","KEGG_pathway","HSA04976_BILE_SECRETION",72,-1.7716,0,0.0033,"No",-1.2149,0.15,0.51,"No"
"1838","C7_Immunologic_signatures","C7_ALL_777_GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP",193,-1.7712,0,3.6e-05,"No",-1.1005,0.23,1,"No"
"1839","C2_Chemical_and_genetic_perturbations","C2_CGP_30_LIU_PROSTATE_CANCER_DN",466,-1.7711,0,0.01,"No",-0.9567,0.61,1,"No"
"1840","GO_BP","518904_GO_2000257_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE",30,-1.7711,0.0028,0.023,"No",0.996,0.44,0.98,"Yes"
"1841","GO_BP","488764_GO_0002891_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",26,-1.7707,0,0.023,"No",-1.708,0.0097,0.71,"No"
"1842","C7_Immunologic_signatures","C7_ALL_418_GSE15930_STIM_VS_STIM_AND_IL_12_48H_CD8_T_CELL_DN",198,-1.7707,0,3.6e-05,"No",1.1785,0.1,0.26,"Yes"
"1843","GO_BP","515594_GO_0070664_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION",58,-1.7706,0.004,0.023,"No",-0.6118,0.99,1,"No"
"1844","KEGG_pathway","HSA04520_ADHERENS_JUNCTION",73,-1.7704,0,0.0033,"No",1.2476,0.13,0.47,"Yes"
"1845","C2_Chemical_and_genetic_perturbations","C2_CGP_849_WOOD_EBV_EBNA1_TARGETS_DN",47,-1.7704,0.0014,0.01,"No",0.9461,0.56,0.87,"Yes"
"1846","GO_BP","503963_GO_0034764_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT",84,-1.7703,0,0.023,"No",-1.0522,0.34,0.97,"No"
"1847","GO_BP","488793_GO_0002920_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE",42,-1.7702,0.0015,0.023,"No",-1.2466,0.13,0.91,"No"
"1848","GO_BP","508590_GO_0046325_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT",12,-1.7701,0.0031,0.023,"No",-1.2308,0.21,0.89,"No"
"1849","C7_Immunologic_signatures","C7_ALL_11_KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP",195,-1.7699,0,3.6e-05,"No",0.8927,0.78,1,"Yes"
"1850","GO_MF","495364_GO_0015081_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",130,-1.7698,0,0.05,"No",-1.7467,0,0.25,"No"
"1851","GO_BP","504456_GO_0035272_EXOCRINE_SYSTEM_DEVELOPMENT",42,-1.7697,0,0.023,"No",-1.1731,0.21,0.91,"No"
"1852","C2_Chemical_and_genetic_perturbations","C2_CGP_3369_SMIRNOV_RESPONSE_TO_IR_2HR_UP",52,-1.7696,0,0.011,"No",-1.3176,0.086,0.69,"No"
"1853","C2_Chemical_and_genetic_perturbations","C2_CGP_1244_ONDER_CDH1_SIGNALING_VIA_CTNNB1",79,-1.7695,0,0.011,"No",0.8829,0.7,0.94,"Yes"
"1854","GO_BP","488573_GO_0002700_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",84,-1.7695,0.0013,0.023,"No",-1.1429,0.22,0.93,"No"
"1855","GO_BP","488734_GO_0002861_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",22,-1.7694,0.0047,0.023,"No",-0.9647,0.5,1,"No"
"1856","C1_Positional","C1_ALL_299_CHR12P13",195,-1.7694,0,0.084,"No",-1.232,0.067,1,"No"
"1857","GO_BP","858521_GO_0061572_ACTIN_FILAMENT_BUNDLE_ORGANIZATION",42,-1.7694,0.0014,0.023,"No",-1.0813,0.32,0.95,"No"
"1858","C2_Chemical_and_genetic_perturbations","C2_CGP_1910_BROWNE_HCMV_INFECTION_6HR_UP",69,-1.7693,0.0013,0.011,"No",-0.8637,0.75,1,"No"
"1859","C2_Chemical_and_genetic_perturbations","C2_CGP_1721_MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP",69,-1.7692,0.0013,0.011,"No",1.7429,0,0.063,"Yes"
"1860","GO_BP","488158_GO_0002285_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",84,-1.7692,0,0.023,"No",0.5689,1,1,"Yes"
"1861","GO_BP","511808_GO_0050866_NEGATIVE_REGULATION_OF_CELL_ACTIVATION",140,-1.769,0,0.023,"No",-0.8137,0.9,1,"No"
"1862","GO_BP","495040_GO_0010975_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT",291,-1.7688,0,0.023,"No",-1.2827,0.037,0.89,"No"
"1863","KEGG_compound","C00410_PROGESTERONE_4_PREGNENE_3_20_DIONE",10,-1.7688,0.005,0.023,"No",1.2018,0.24,0.86,"Yes"
"1864","GO_BP","754002_GO_1901032_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",13,-1.7686,0.0049,0.023,"No",1.4873,0.061,0.43,"Yes"
"1865","C2_Chemical_and_genetic_perturbations","C2_CGP_2862_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN",9,-1.7684,0.0087,0.011,"No",-1.3734,0.12,0.63,"No"
"1866","GO_BP","514255_GO_0060700_REGULATION_OF_RIBONUCLEASE_ACTIVITY",6,-1.7684,0.0033,0.023,"No",-1.4015,0.094,0.98,"No"
"1867","C2_Chemical_and_genetic_perturbations","C2_CGP_1463_FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP",48,-1.7681,0,0.011,"No",-1.2298,0.15,0.77,"No"
"1868","GO_BP","1184586_GO_1904062_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT",139,-1.7681,0,0.023,"No",-1.3158,0.029,0.88,"No"
"1869","GO_BP","499467_GO_0023061_SIGNAL_RELEASE",191,-1.768,0,0.023,"No",0.8822,0.8,1,"Yes"
"1870","GO_BP","515543_GO_0070613_REGULATION_OF_PROTEIN_PROCESSING",346,-1.768,0,0.023,"No",0.8933,0.86,1,"Yes"
"1871","C2_Chemical_and_genetic_perturbations","C2_CGP_1334_RADAEVA_RESPONSE_TO_IFNA1_UP",52,-1.7679,0,0.011,"No",1.1304,0.23,0.58,"Yes"
"1872","GO_MF","490606_GO_0005496_STEROID_BINDING",80,-1.7676,0,0.051,"No",-1.0633,0.32,0.86,"No"
"1873","WikiPathways","198886_WP455_GPCRS_CLASS_A_RHODOPSIN_LIKE",244,-1.7676,0,0.014,"No",1.4316,0.0025,0.43,"Yes"
"1874","GO_BP","510924_GO_0048875_CHEMICAL_HOMEOSTASIS_WITHIN_A_TISSUE",12,-1.7675,0.0049,0.023,"No",-1.3943,0.095,1,"No"
"1875","C7_Immunologic_signatures","C7_ALL_204_GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN",193,-1.7675,0,3.6e-05,"No",1.2432,0.055,0.16,"Yes"
"1876","C2_Chemical_and_genetic_perturbations","C2_CGP_1603_WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2",36,-1.7675,0.0014,0.011,"No",0.6349,0.97,1,"Yes"
"1877","C2_Chemical_and_genetic_perturbations","C2_CGP_2306_GAURNIER_PSMD4_TARGETS",69,-1.7675,0.0013,0.011,"No",0.8831,0.71,0.94,"Yes"
"1878","C7_Immunologic_signatures","C7_ALL_1804_GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN",194,-1.767,0,3.6e-05,"No",-0.8052,0.94,1,"No"
"1879","GO_BP","754832_GO_1901881_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION",14,-1.767,0.0046,0.023,"No",-0.5929,0.96,1,"No"
"1880","C7_Immunologic_signatures","C7_ALL_629_GSE17721_POLYIC_VS_CPG_12H_BMDM_UP",197,-1.767,0,3.6e-05,"No",0.8541,0.83,1,"Yes"
"1881","C7_Immunologic_signatures","C7_ALL_1454_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN",199,-1.7669,0,3.6e-05,"No",1.0558,0.32,0.57,"Yes"
"1882","C7_Immunologic_signatures","C7_ALL_94_GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",191,-1.7668,0,3.5e-05,"No",-0.7667,0.96,1,"No"
"1883","REACTOME","187194_REACT_25149_ION_TRANSPORT_BY_P_TYPE_ATPASES",47,-1.7667,0,0.031,"No",-1.4551,0.04,0.48,"No"
"1884","GO_BP","500913_GO_0031664_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",19,-1.7663,0.003,0.023,"No",-1.1566,0.27,0.92,"No"
"1885","C6_Oncogenic_signatures","C6_ALL_48_P53_DN_V2_UP",141,-1.7661,0,0.00099,"No",-1.1636,0.14,0.48,"No"
"1886","KEGG_pathway","HSA04621_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY",57,-1.7659,0.0026,0.0035,"No",-1.2242,0.14,0.52,"No"
"1887","C2_Chemical_and_genetic_perturbations","C2_CGP_640_HUMMERICH_SKIN_CANCER_PROGRESSION_DN",100,-1.7659,0,0.011,"No",-0.8574,0.8,1,"No"
"1888","GO_BP","512657_GO_0051785_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION",52,-1.7659,0.0013,0.023,"No",-1.1354,0.26,0.93,"No"
"1889","C2_Chemical_and_genetic_perturbations","C2_CGP_2534_WU_ALZHEIMER_DISEASE_DN",18,-1.7658,0.0015,0.011,"No",-1.0159,0.43,0.99,"No"
"1890","C7_Immunologic_signatures","C7_ALL_172_GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN",191,-1.7657,0,3.9e-05,"No",-1.0603,0.3,1,"No"
"1891","GO_MF","490395_GO_0005132_TYPE_I_INTERFERON_RECEPTOR_BINDING",12,-1.7656,0.0016,0.052,"No",-0.8288,0.71,1,"No"
"1892","C2_Chemical_and_genetic_perturbations","C2_CGP_847_LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN",110,-1.7655,0.0012,0.011,"No",-1.1375,0.19,0.86,"No"
"1893","KEGG_pathway","HSA04670_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION",113,-1.7654,0,0.0035,"No",0.8092,0.89,1,"Yes"
"1894","REACTOME","160998_REACT_21402_CDO_IN_MYOGENESIS",30,-1.7653,0.0045,0.031,"No",-1.1831,0.22,0.85,"No"
"1895","C2_Chemical_and_genetic_perturbations","C2_CGP_476_BERENJENO_TRANSFORMED_BY_RHOA_DN",390,-1.7651,0,0.011,"No",0.887,0.9,0.94,"Yes"
"1896","GO_BP","511806_GO_0050864_REGULATION_OF_B_CELL_ACTIVATION",101,-1.7651,0,0.023,"No",-0.7721,0.92,1,"No"
"1897","WikiPathways","198855_WP75_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",98,-1.765,0.0012,0.014,"No",-0.9383,0.62,1,"No"
"1898","GO_BP","508718_GO_0046457_PROSTANOID_BIOSYNTHETIC_PROCESS",21,-1.7649,0,0.023,"No",-0.7233,0.85,1,"No"
"1899","C2_Chemical_and_genetic_perturbations","C2_CGP_430_VANHARANTA_UTERINE_FIBROID_DN",67,-1.7648,0.004,0.011,"No",-1.4152,0.036,0.57,"No"
"1900","C2_Chemical_and_genetic_perturbations","C2_CGP_2485_BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN",40,-1.7648,0.0044,0.011,"No",-0.5847,0.99,1,"No"
"1901","C7_Immunologic_signatures","C7_ALL_1520_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN",199,-1.7646,0,3.9e-05,"No",0.8626,0.82,1,"Yes"
"1902","GO_BP","498215_GO_0019372_LIPOXYGENASE_PATHWAY",13,-1.7643,0.0048,0.024,"No",0.8738,0.64,1,"Yes"
"1903","C4_Cancer_modules","C4_CM_47_MODULE_51",36,-1.7642,0.0014,0.0078,"No",-0.8415,0.72,0.96,"No"
"1904","C2_Chemical_and_genetic_perturbations","C2_CGP_2743_BUDHU_LIVER_CANCER_METASTASIS_UP",10,-1.764,0.0082,0.011,"No",0.5394,0.97,1,"Yes"
"1905","C7_Immunologic_signatures","C7_ALL_912_GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN",196,-1.7637,0,3.9e-05,"No",-0.7062,1,1,"No"
"1906","REACTOME","1127691_REACT_264068_EPH_EPHRIN_SIGNALING",94,-1.7634,0.0012,0.031,"No",0.9254,0.63,0.87,"Yes"
"1907","GO_BP","513272_GO_0052509_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_DEFENSE_RESPONSE",9,-1.7632,0.0049,0.024,"No",0.6238,0.92,1,"Yes"
"1908","REACTOME","187196_REACT_24970_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION",131,-1.7631,0,0.031,"No",-0.8823,0.75,1,"No"
"1909","C2_Chemical_and_genetic_perturbations","C2_CGP_1668_CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN",42,-1.7631,0.0014,0.011,"No",1.0659,0.33,0.69,"Yes"
"1910","GO_BP","491372_GO_0006469_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY",199,-1.763,0,0.024,"No",-0.7033,1,1,"No"
"1911","C7_Immunologic_signatures","C7_ALL_908_GSE20715_0H_VS_48H_OZONE_LUNG_DN",200,-1.763,0,3.8e-05,"No",-1.025,0.39,1,"No"
"1912","GO_BP","491766_GO_0006911_PHAGOCYTOSIS_ENGULFMENT",15,-1.7628,0.0081,0.024,"No",1.1438,0.27,0.84,"Yes"
"1913","C6_Oncogenic_signatures","C6_ALL_36_BCAT_GDS748_UP",47,-1.7628,0.0027,0.001,"No",-1.0522,0.35,0.59,"No"
"1914","WikiPathways","198881_WP286_IL_3_SIGNALING_PATHWAY",100,-1.7627,0,0.014,"No",0.8069,0.89,1,"Yes"
"1915","C2_Chemical_and_genetic_perturbations","C2_CGP_1345_UEDA_PERIFERAL_CLOCK",168,-1.7625,0,0.011,"No",-0.9227,0.65,1,"No"
"1916","GO_BP","487466_GO_0006790_SULFUR_COMPOUND_METABOLIC_PROCESS",322,-1.7624,0,0.024,"No",-1.0244,0.4,0.97,"No"
"1917","GO_BP","513747_GO_0060191_REGULATION_OF_LIPASE_ACTIVITY",173,-1.7622,0,0.024,"No",1.1719,0.097,0.81,"Yes"
"1918","C7_Immunologic_signatures","C7_ALL_188_GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN",197,-1.7621,0,3.8e-05,"No",1.2521,0.051,0.15,"Yes"
"1919","KEGG_pathway","HSA04974_PROTEIN_DIGESTION_AND_ABSORPTION",85,-1.762,0,0.0036,"No",-1.586,0.0018,0.8,"No"
"1920","GO_BP","491684_GO_0006814_SODIUM_ION_TRANSPORT",139,-1.762,0,0.024,"No",-1.7528,0,0.61,"No"
"1921","C7_Immunologic_signatures","C7_ALL_895_GSE20715_WT_VS_TLR4_KO_LUNG_UP",196,-1.7616,0,3.8e-05,"No",1.4805,0.0023,0.016,"Yes"
"1922","C4_Cancer_modules","C4_CM_146_MODULE_154",69,-1.7613,0,0.008,"No",-1.1458,0.22,0.63,"No"
"1923","GO_BP","508687_GO_0046425_REGULATION_OF_JAK_STAT_CASCADE",94,-1.761,0,0.024,"No",-1.3614,0.044,0.97,"No"
"1924","C2_Chemical_and_genetic_perturbations","C2_CGP_2669_ZHAN_LATE_DIFFERENTIATION_GENES_DN",16,-1.761,0.0032,0.011,"No",-1.0885,0.33,0.93,"No"
"1925","C2_Chemical_and_genetic_perturbations","C2_CGP_1671_MCDOWELL_ACUTE_LUNG_INJURY_UP",44,-1.7608,0.0041,0.011,"No",1.1633,0.22,0.53,"Yes"
"1926","KEGG_module","HSA_M00042_CATECHOLAMINE_BIOSYNTHESIS_TYROSINE_DOPAMINE_NORADRENALINE_ADRENALINE",5,-1.7607,0,0.099,"No",0.8074,0.69,0.94,"Yes"
"1927","GO_BP","512160_GO_0051272_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT",326,-1.7605,0,0.024,"No",1.0674,0.25,0.93,"Yes"
"1928","GO_BP","518522_GO_0090382_PHAGOSOME_MATURATION",49,-1.7604,0.0014,0.024,"No",-0.6827,0.96,1,"No"
"1929","C2_Chemical_and_genetic_perturbations","C2_CGP_1548_XU_RESPONSE_TO_TRETINOIN_UP",16,-1.7604,0.0047,0.011,"No",-1.0058,0.45,1,"No"
"1930","GO_MF","496555_GO_0016614_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS",129,-1.7604,0,0.054,"No",0.9425,0.6,0.94,"Yes"
"1931","GO_MF","487576_GO_0001664_G_PROTEIN_COUPLED_RECEPTOR_BINDING",223,-1.7604,0,0.053,"No",-1.234,0.068,0.84,"No"
"1932","GO_BP","513300_GO_0052552_MODULATION_BY_ORGANISM_OF_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",9,-1.7602,0.0048,0.024,"No",0.6329,0.92,1,"Yes"
"1933","C4_Cancer_modules","C4_CM_308_MODULE_357",72,-1.7598,0,0.008,"No",-0.9815,0.49,0.83,"No"
"1934","C2_Chemical_and_genetic_perturbations","C2_CGP_1459_ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN",51,-1.7598,0,0.011,"No",1.0788,0.31,0.67,"Yes"
"1935","GO_MF","505523_GO_0042379_CHEMOKINE_RECEPTOR_BINDING",49,-1.7598,0,0.053,"No",1.4035,0.054,0.48,"Yes"
"1936","C4_Cancer_gene_neighborhoods","C4_CGN_285_GNF2_BUB1",26,-1.7597,0.003,0.0045,"No",-0.529,0.99,1,"No"
"1937","C2_Chemical_and_genetic_perturbations","C2_CGP_1090_RICKMAN_HEAD_AND_NECK_CANCER_E",84,-1.7597,0,0.011,"No",1.109,0.27,0.62,"Yes"
"1938","GO_BP","505453_GO_0042306_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS",150,-1.7595,0,0.024,"No",-1.1038,0.23,0.94,"No"
"1939","GO_BP","754068_GO_1901099_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND",34,-1.7595,0.0045,0.024,"No",-1.3419,0.099,0.91,"No"
"1940","C2_Chemical_and_genetic_perturbations","C2_CGP_1683_HU_GENOTOXIC_DAMAGE_24HR",35,-1.7595,0.0057,0.011,"No",1.224,0.15,0.47,"Yes"
"1941","C7_Immunologic_signatures","C7_ALL_1552_GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN",196,-1.7592,0,4.5e-05,"No",-0.9355,0.64,1,"No"
"1942","C7_Immunologic_signatures","C7_ALL_934_GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN",198,-1.7592,0,4.5e-05,"No",0.5943,1,1,"Yes"
"1943","KEGG_pathway","HSA00562_INOSITOL_PHOSPHATE_METABOLISM",63,-1.7591,0,0.0036,"No",-1.5167,0.01,0.48,"No"
"1944","REACTOME","106199_REACT_723_GLUCOSE_METABOLISM",76,-1.7591,0,0.032,"No",0.7347,0.93,1,"Yes"
"1945","C2_Chemical_and_genetic_perturbations","C2_CGP_2541_WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN",11,-1.759,0,0.011,"No",-1.0749,0.36,0.95,"No"
"1946","KEGG_pathway","HSA00340_HISTIDINE_METABOLISM",23,-1.7589,0.0046,0.0036,"No",0.9337,0.56,1,"Yes"
"1947","GO_MF","507654_GO_0045295_GAMMA_CATENIN_BINDING",12,-1.7586,0.0096,0.052,"No",0.9066,0.59,0.98,"Yes"
"1948","GO_BP","498270_GO_0019430_REMOVAL_OF_SUPEROXIDE_RADICALS",12,-1.7586,0.0032,0.025,"No",0.5827,0.96,1,"Yes"
"1949","C2_Chemical_and_genetic_perturbations","C2_CGP_2143_HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN",276,-1.7583,0,0.011,"No",0.7408,1,1,"Yes"
"1950","GO_MF","490638_GO_0005543_PHOSPHOLIPID_BINDING",325,-1.7582,0,0.052,"No",-0.9919,0.48,0.92,"No"
"1951","KEGG_compound","C00219_ARACHIDONATE_ARACHIDONIC_ACID_5Z_8Z_11Z_14Z_ICOSATETRAENOIC_ACID_CIS_5_8_11_14_EICOSATETRAENOIC_ACID",39,-1.7581,0.0014,0.025,"No",0.9148,0.58,1,"Yes"
"1952","GO_BP","505666_GO_0042535_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS",9,-1.7579,0.0032,0.025,"No",0.732,0.81,1,"Yes"
"1953","C2_Chemical_and_genetic_perturbations","C2_CGP_1876_DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN",287,-1.7572,0,0.012,"No",-1.7361,0,0.34,"No"
"1954","C4_Cancer_gene_neighborhoods","C4_CGN_348_GNF2_EGFR",27,-1.7572,0.0015,0.0045,"No",1.2369,0.14,0.18,"Yes"
"1955","REACTOME","106388_REACT_6966_TOLL_LIKE_RECEPTORS_CASCADES",141,-1.7571,0,0.032,"No",-0.7765,0.95,1,"No"
"1956","C3_TF_targets","C3_TFT_121_V_AP1_Q6",255,-1.7571,0,0.0054,"No",-1.2568,0.03,0.27,"No"
"1957","GO_BP","502162_GO_0032940_SECRETION_BY_CELL",478,-1.757,0,0.025,"No",1.1214,0.12,0.88,"Yes"
"1958","C2_BioCarta_Pathways","C2_CP_BIOCARTA_116_BIOCARTA_PPARA_PATHWAY",55,-1.757,0,0.03,"No",-0.882,0.69,1,"No"
"1959","C0_Hallmark","H_ALL_42_HALLMARK_COAGULATION",135,-1.7567,0,0.00092,"No",1.0348,0.37,0.55,"Yes"
"1960","GO_CC","490798_GO_0005766_PRIMARY_LYSOSOME",14,-1.7565,0.0016,0.037,"No",0.9486,0.51,0.84,"Yes"
"1961","REACTOME","187209_REACT_23916_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS",13,-1.7565,0.0049,0.032,"No",-0.5175,0.99,1,"No"
"1962","C7_Immunologic_signatures","C7_ALL_85_GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP",195,-1.7563,0,4.8e-05,"No",-1.0476,0.34,1,"No"
"1963","REACTOME","1127694_REACT_264047_EPHRIN_SIGNALING",19,-1.7562,0.0063,0.031,"No",-1.0659,0.36,0.91,"No"
"1964","GO_BP","498213_GO_0019370_LEUKOTRIENE_BIOSYNTHETIC_PROCESS",20,-1.756,0.0062,0.025,"No",-0.7761,0.8,1,"No"
"1965","WikiPathways","198832_WP236_ADIPOGENESIS",129,-1.756,0,0.014,"No",-0.7361,0.96,1,"No"
"1966","GO_BP","489308_GO_0030036_ACTIN_CYTOSKELETON_ORGANIZATION",375,-1.7558,0,0.025,"No",-1.1055,0.18,0.94,"No"
"1967","GO_BP","751039_GO_0036119_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR",10,-1.7557,0.0081,0.025,"No",1.3319,0.14,0.63,"Yes"
"1968","C2_Chemical_and_genetic_perturbations","C2_CGP_2128_LEE_LIVER_CANCER",48,-1.7556,0,0.012,"No",-0.957,0.52,1,"No"
"1969","C4_Cancer_gene_neighborhoods","C4_CGN_299_GNF2_HPX",132,-1.7554,0,0.0045,"No",-1.2195,0.1,0.67,"No"
"1970","KEGG_compound","C05488_11_DEOXYCORTISOL_CORTODOXONE",5,-1.7549,0.0018,0.026,"No",1.0936,0.34,1,"Yes"
"1971","GO_BP","753042_GO_1900046_REGULATION_OF_HEMOSTASIS",77,-1.7549,0,0.025,"No",1.1736,0.19,0.81,"Yes"
"1972","C2_Chemical_and_genetic_perturbations","C2_CGP_2358_LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN",102,-1.7547,0,0.012,"No",-1.0731,0.3,0.95,"No"
"1973","C2_Chemical_and_genetic_perturbations","C2_CGP_2061_GAVIN_FOXP3_TARGETS_CLUSTER_P3",159,-1.7543,0,0.012,"No",-1.2555,0.063,0.74,"No"
"1974","GO_CC","505709_GO_0042582_AZUROPHIL_GRANULE",14,-1.7543,0.0063,0.037,"No",0.9358,0.55,0.86,"Yes"
"1975","C7_Immunologic_signatures","C7_ALL_1032_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN",198,-1.7542,0,5.1e-05,"No",0.9799,0.53,0.8,"Yes"
"1976","REACTOME","160997_REACT_21303_MYOGENESIS",30,-1.754,0.0042,0.032,"No",-1.1933,0.21,0.84,"No"
"1977","GO_BP","500593_GO_0031334_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY",141,-1.7537,0,0.026,"No",-0.7779,0.93,1,"No"
"1978","WikiPathways","198825_WP15_SELENIUM_PATHWAY",83,-1.7536,0.0026,0.014,"No",1.155,0.2,0.89,"Yes"
"1979","C2_Chemical_and_genetic_perturbations","C2_CGP_1547_BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS",31,-1.7535,0.0015,0.012,"No",1.61,0.019,0.13,"Yes"
"1980","C4_Cancer_modules","C4_CM_297_MODULE_341",82,-1.7534,0.0013,0.0085,"No",-1.2038,0.14,0.64,"No"
"1981","C4_Cancer_modules","C4_CM_11_MODULE_12",348,-1.7533,0,0.0084,"No",-1.0077,0.4,0.8,"No"
"1982","C7_Immunologic_signatures","C7_ALL_1695_GSE3982_BASOPHIL_VS_TH2_UP",197,-1.7533,0,5.1e-05,"No",0.7343,1,1,"Yes"
"1983","C4_Cancer_gene_neighborhoods","C4_CGN_338_GNF2_CDKN1C",22,-1.7533,0.0015,0.0045,"No",1.0399,0.38,0.48,"Yes"
"1984","C2_Chemical_and_genetic_perturbations","C2_CGP_269_ODONNELL_TFRC_TARGETS_UP",417,-1.7533,0,0.012,"No",-1.0434,0.33,0.98,"No"
"1985","GO_BP","494517_GO_0010447_RESPONSE_TO_ACIDIC_PH",13,-1.7531,0.0098,0.026,"No",-1.3423,0.13,0.92,"No"
"1986","GO_BP","505662_GO_0042531_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",49,-1.7531,0.0084,0.026,"No",-1.6026,0.0073,0.69,"No"
"1987","C7_Immunologic_signatures","C7_ALL_1115_GSE2706_UNSTIM_VS_8H_R848_DC_UP",189,-1.7527,0,5.1e-05,"No",-0.9252,0.66,1,"No"
"1988","C2_Chemical_and_genetic_perturbations","C2_CGP_2354_LABBE_WNT3A_TARGETS_DN",93,-1.7526,0,0.012,"No",1.4486,0.021,0.26,"Yes"
"1989","C2_Chemical_and_genetic_perturbations","C2_CGP_2696_VALK_AML_WITH_FLT3_ITD",40,-1.7525,0,0.012,"No",1.175,0.21,0.52,"Yes"
"1990","GO_BP","500098_GO_0030799_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",200,-1.7518,0,0.026,"No",1.1899,0.081,0.79,"Yes"
"1991","C7_Immunologic_signatures","C7_ALL_1716_GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN",199,-1.7517,0,5.4e-05,"No",-0.7446,0.98,1,"No"
"1992","GO_BP","515600_GO_0070670_RESPONSE_TO_INTERLEUKIN_4",30,-1.7517,0.0044,0.026,"No",0.927,0.58,1,"Yes"
"1993","C2_Chemical_and_genetic_perturbations","C2_CGP_1031_CAFFAREL_RESPONSE_TO_THC_DN",31,-1.7516,0.0029,0.012,"No",1.0507,0.39,0.71,"Yes"
"1994","C1_Positional","C1_ALL_207_CHRXQ25",20,-1.7515,0.0045,0.086,"No",-1.1282,0.3,1,"No"
"1995","C2_Chemical_and_genetic_perturbations","C2_CGP_2135_STEARMAN_TUMOR_FIELD_EFFECT_UP",36,-1.7515,0.0029,0.012,"No",1.2321,0.17,0.46,"Yes"
"1996","C7_Immunologic_signatures","C7_ALL_1582_GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN",191,-1.7515,0,5.4e-05,"No",-0.8404,0.85,1,"No"
"1997","C7_Immunologic_signatures","C7_ALL_1261_GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP",184,-1.7513,0,5.4e-05,"No",-1.3996,0.0081,0.23,"No"
"1998","C3_TF_targets","C3_TFT_498_KRCTCNNNNMANAGC_UNKNOWN",64,-1.7508,0.0013,0.0056,"No",-1.7545,0,0.1,"No"
"1999","GO_BP","503511_GO_0034308_PRIMARY_ALCOHOL_METABOLIC_PROCESS",41,-1.7508,0.0014,0.027,"No",1.2852,0.11,0.7,"Yes"
"2000","GO_BP","494946_GO_0010882_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING",23,-1.7508,0.0061,0.026,"No",-1.2139,0.19,0.88,"No"
"2001","C1_Positional","C1_ALL_261_CHR12Q",16,-1.7508,0.0016,0.073,"No",-0.81,0.72,0.96,"No"
"2002","KEGG_compound","C04637_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_PHOSPHATIDYL_MYO_INOSITOL_4_5_BISPHOSPHATE_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_4_5_BISPHOSPHATE_",36,-1.7507,0.0058,0.027,"No",-1.4718,0.042,0.34,"No"
"2003","GO_BP","511811_GO_0050869_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION",32,-1.7503,0.0058,0.027,"No",0.8824,0.66,1,"Yes"
"2004","C7_Immunologic_signatures","C7_ALL_1279_GSE29618_PDC_VS_MDC_UP",195,-1.7501,0,5.7e-05,"No",-0.8511,0.87,1,"No"
"2005","GO_MF","496567_GO_0016903_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS",41,-1.7501,0.0043,0.056,"No",0.9799,0.43,0.9,"Yes"
"2006","REACTOME","477123_REACT_111174_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES_",8,-1.75,0.0048,0.033,"No",-1.0006,0.45,0.98,"No"
"2007","C2_Chemical_and_genetic_perturbations","C2_CGP_931_TOMLINS_METASTASIS_DN",20,-1.75,0.003,0.012,"No",-1.168,0.23,0.83,"No"
"2008","C7_Immunologic_signatures","C7_ALL_1571_GSE3982_CTRL_VS_LPS_48H_DC_UP",198,-1.7498,0,5.7e-05,"No",0.7717,0.98,1,"Yes"
"2009","GO_BP","488641_GO_0002768_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",301,-1.7497,0,0.027,"No",-0.7772,0.98,1,"No"
"2010","KEGG_pathway","HSA05143_AFRICAN_TRYPANOSOMIASIS",34,-1.7497,0.0014,0.0041,"No",-1.3637,0.074,0.32,"No"
"2011","GO_BP","507502_GO_0045109_INTERMEDIATE_FILAMENT_ORGANIZATION",16,-1.7495,0.0079,0.027,"No",1.0576,0.37,0.94,"Yes"
"2012","REACTOME","477121_REACT_111225_REGULATION_OF_KIT_SIGNALING",16,-1.7493,0.0015,0.033,"No",0.4891,0.99,1,"Yes"
"2013","GO_MF","493634_GO_0015038_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",5,-1.7492,0.0054,0.056,"No",-1.2328,0.26,0.84,"No"
"2014","GO_BP","510623_GO_0048557_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS",18,-1.7491,0.0047,0.027,"No",1.1129,0.31,0.89,"Yes"
"2015","C2_Chemical_and_genetic_perturbations","C2_CGP_258_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP",21,-1.749,0,0.012,"No",1.1619,0.24,0.54,"Yes"
"2016","C7_Immunologic_signatures","C7_ALL_1765_GSE7460_TCONV_VS_TREG_LN_UP",199,-1.749,0,5.7e-05,"No",-0.7907,0.95,1,"No"
"2017","GO_BP","516166_GO_0071241_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE",114,-1.7489,0,0.027,"No",1.1476,0.19,0.84,"Yes"
"2018","GO_BP","488417_GO_0002544_CHRONIC_INFLAMMATORY_RESPONSE",13,-1.7489,0,0.027,"No",0.801,0.72,1,"Yes"
"2019","GO_BP","511812_GO_0050870_POSITIVE_REGULATION_OF_T_CELL_ACTIVATION",183,-1.7487,0,0.027,"No",0.8677,0.83,1,"Yes"
"2020","GO_BP","518999_GO_2000353_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS",12,-1.7486,0.0016,0.027,"No",0.7182,0.86,1,"Yes"
"2021","C0_Hallmark","H_ALL_19_HALLMARK_INTERFERON_GAMMA_RESPONSE",200,-1.7485,0,0.00087,"No",1.4296,0.0023,0.046,"Yes"
"2022","C3_TF_targets","C3_TFT_214_V_ETS2_B",273,-1.7484,0,0.0053,"No",-0.9089,0.74,0.95,"No"
"2023","GO_BP","500100_GO_0030801_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",110,-1.7482,0,0.027,"No",0.9739,0.48,1,"Yes"
"2024","GO_BP","507700_GO_0045343_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS",18,-1.7478,0.0092,0.027,"No",0.9502,0.51,1,"Yes"
"2025","GO_BP","518249_GO_0090109_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ASSEMBLY",40,-1.7477,0.0043,0.027,"No",-1.3561,0.072,0.97,"No"
"2026","C2_Chemical_and_genetic_perturbations","C2_CGP_650_RASHI_RESPONSE_TO_IONIZING_RADIATION_6",82,-1.7476,0,0.013,"No",1.4231,0.017,0.28,"Yes"
"2027","GO_BP","488304_GO_0002431_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY",72,-1.7475,0.0013,0.027,"No",0.6149,0.99,1,"Yes"
"2028","C2_Chemical_and_genetic_perturbations","C2_CGP_2153_COATES_MACROPHAGE_M1_VS_M2_DN",76,-1.7474,0,0.013,"No",-1.0224,0.4,0.98,"No"
"2029","C7_Immunologic_signatures","C7_ALL_1438_GSE360_DC_VS_MAC_T_GONDII_DN",198,-1.7473,0,6.3e-05,"No",-1.0562,0.3,1,"No"
"2030","GO_BP","499819_GO_0030449_REGULATION_OF_COMPLEMENT_ACTIVATION",28,-1.7472,0.0015,0.027,"No",0.8774,0.65,1,"Yes"
"2031","C7_Immunologic_signatures","C7_ALL_1811_GSE7852_TREG_VS_TCONV_FAT_UP",199,-1.747,0,6.3e-05,"No",-0.8193,0.92,1,"No"
"2032","C7_Immunologic_signatures","C7_ALL_1559_GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP",199,-1.7469,0,6.6e-05,"No",0.5679,1,1,"Yes"
"2033","GO_MF","489663_GO_0008236_SERINE_TYPE_PEPTIDASE_ACTIVITY",165,-1.7469,0,0.056,"No",1.107,0.21,0.78,"Yes"
"2034","GO_BP","503316_GO_0034110_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION",273,-1.7468,0,0.027,"No",0.9054,0.79,1,"Yes"
"2035","REACTOME","106157_REACT_6841_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT",17,-1.7468,0.0094,0.033,"No",-1.3368,0.12,0.59,"No"
"2036","C2_Chemical_and_genetic_perturbations","C2_CGP_1577_SCHURINGA_STAT5A_TARGETS_DN",16,-1.7466,0.0015,0.013,"No",1.152,0.29,0.55,"Yes"
"2037","GO_BP","510864_GO_0048813_DENDRITE_MORPHOGENESIS",43,-1.7465,0,0.027,"No",-0.5718,1,1,"No"
"2038","C2_Chemical_and_genetic_perturbations","C2_CGP_2476_FERRARI_RESPONSE_TO_FENRETINIDE_UP",22,-1.7463,0.0015,0.013,"No",-1.5097,0.034,0.45,"No"
"2039","C3_TF_targets","C3_TFT_140_V_NFKB_Q6",251,-1.7462,0,0.0051,"No",-1.4031,0.0052,0.16,"No"
"2040","GO_BP","753391_GO_1900407_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",45,-1.7461,0.0013,0.027,"No",1.0529,0.36,0.95,"Yes"
"2041","GO_BP","516331_GO_0071407_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND",318,-1.7459,0,0.027,"No",-0.8653,0.86,1,"No"
"2042","C2_Chemical_and_genetic_perturbations","C2_CGP_1646_MARCHINI_TRABECTEDIN_RESISTANCE_UP",21,-1.7459,0.003,0.013,"No",1.1726,0.22,0.53,"Yes"
"2043","C2_Chemical_and_genetic_perturbations","C2_CGP_1783_GERHOLD_ADIPOGENESIS_DN",64,-1.7459,0.0026,0.013,"No",0.6949,0.95,1,"Yes"
"2044","C2_Chemical_and_genetic_perturbations","C2_CGP_3075_DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN",91,-1.7459,0.0013,0.013,"No",-0.9927,0.47,1,"No"
"2045","C2_Chemical_and_genetic_perturbations","C2_CGP_1371_JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN",65,-1.7458,0.0013,0.013,"No",-1.5693,0.0037,0.43,"No"
"2046","C2_Chemical_and_genetic_perturbations","C2_CGP_3006_SASSON_RESPONSE_TO_GONADOTROPHINS_DN",87,-1.7458,0.0013,0.013,"No",-0.657,1,1,"No"
"2047","GO_MF","505929_GO_0042834_PEPTIDOGLYCAN_BINDING",9,-1.7457,0.0088,0.056,"No",-1.0822,0.36,0.85,"No"
"2048","GO_MF","495329_GO_0015037_PEPTIDE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",6,-1.7456,0.0052,0.056,"No",-1.1111,0.35,0.83,"No"
"2049","C2_Chemical_and_genetic_perturbations","C2_CGP_3251_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4",108,-1.7455,0,0.013,"No",-1.1467,0.19,0.85,"No"
"2050","GO_BP","752691_GO_0097190_APOPTOTIC_SIGNALING_PATHWAY",347,-1.7455,0,0.027,"No",-0.7977,0.98,1,"No"
"2051","GO_BP","512325_GO_0051447_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE",16,-1.7454,0.0065,0.027,"No",-1.2704,0.2,0.89,"No"
"2052","C2_Chemical_and_genetic_perturbations","C2_CGP_2333_MATZUK_MALE_REPRODUCTION_SERTOLI",28,-1.7452,0.0029,0.013,"No",0.8621,0.7,0.96,"Yes"
"2053","C7_Immunologic_signatures","C7_ALL_446_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN",197,-1.7449,0,6.9e-05,"No",1.488,0.0024,0.014,"Yes"
"2054","GO_BP","509071_GO_0046851_NEGATIVE_REGULATION_OF_BONE_REMODELING",10,-1.7447,0.0016,0.028,"No",-0.6529,0.9,1,"No"
"2055","GO_BP","499735_GO_0030335_POSITIVE_REGULATION_OF_CELL_MIGRATION",310,-1.7447,0,0.027,"No",1.08,0.2,0.92,"Yes"
"2056","GO_BP","508256_GO_0045954_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",17,-1.7446,0.0096,0.027,"No",-0.4809,0.99,1,"No"
"2057","KEGG_compound","C05582_HOMOVANILLATE_HOMOVANILLIC_ACID_3_METHOXY_4_HYDROXYPHENYLACETATE",5,-1.7446,0.0036,0.028,"No",0.7846,0.73,1,"Yes"
"2058","GO_BP","491415_GO_0006518_PEPTIDE_METABOLIC_PROCESS",109,-1.7444,0,0.027,"No",0.8564,0.8,1,"Yes"
"2059","C2_Chemical_and_genetic_perturbations","C2_CGP_1959_ABE_VEGFA_TARGETS_30MIN",29,-1.7443,0.0029,0.013,"No",-1.3788,0.076,0.62,"No"
"2060","C7_Immunologic_signatures","C7_ALL_1004_GSE22886_CTRL_VS_LPS_24H_DC_DN",199,-1.7442,0,6.9e-05,"No",1.0782,0.25,0.51,"Yes"
"2061","GO_BP","1129349_GO_1903522_REGULATION_OF_BLOOD_CIRCULATION",217,-1.7442,0,0.028,"No",-1.1582,0.13,0.92,"No"
"2062","C2_Chemical_and_genetic_perturbations","C2_CGP_3017_BROWNE_HCMV_INFECTION_4HR_UP",54,-1.7441,0,0.013,"No",-1.2924,0.096,0.7,"No"
"2063","C2_Chemical_and_genetic_perturbations","C2_CGP_3_WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP",21,-1.7441,0.0087,0.013,"No",-0.7509,0.82,1,"No"
"2064","C2_Chemical_and_genetic_perturbations","C2_CGP_2361_NAKAMURA_METASTASIS_MODEL_DN",42,-1.7438,0.0056,0.013,"No",0.9487,0.54,0.87,"Yes"
"2065","C7_Immunologic_signatures","C7_ALL_1572_GSE3982_CTRL_VS_LPS_48H_DC_DN",196,-1.7438,0,6.9e-05,"No",1.0013,0.45,0.73,"Yes"
"2066","C2_Chemical_and_genetic_perturbations","C2_CGP_1618_ABE_VEGFA_TARGETS_2HR",34,-1.7437,0.0073,0.013,"No",-0.7823,0.82,1,"No"
"2067","GO_BP","491531_GO_0006641_TRIGLYCERIDE_METABOLIC_PROCESS",86,-1.7436,0.0013,0.028,"No",-0.6387,1,1,"No"
"2068","GO_MF","495324_GO_0015026_CORECEPTOR_ACTIVITY",27,-1.7435,0.0043,0.056,"No",1.6721,0.0022,0.18,"Yes"
"2069","C2_Chemical_and_genetic_perturbations","C2_CGP_1812_ZHENG_RESPONSE_TO_ARSENITE_UP",17,-1.7434,0.0046,0.013,"No",0.8822,0.66,0.94,"Yes"
"2070","KEGG_compound","C00829_NAPHTHALENE",8,-1.7433,0.0033,0.028,"No",-1.4146,0.086,0.41,"No"
"2071","GO_BP","510920_GO_0048871_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS",196,-1.7432,0,0.028,"No",-1.0833,0.26,0.96,"No"
"2072","GO_BP","494123_GO_0010043_RESPONSE_TO_ZINC_ION",38,-1.7431,0,0.028,"No",1.2815,0.1,0.7,"Yes"
"2073","C6_Oncogenic_signatures","C6_ALL_103_BMI1_DN_MEL18_DN_V1_DN",144,-1.7431,0,0.0014,"No",1.0913,0.23,0.57,"Yes"
"2074","C2_Chemical_and_genetic_perturbations","C2_CGP_1180_MORI_IMMATURE_B_LYMPHOCYTE_UP",52,-1.743,0.0013,0.013,"No",-0.6934,0.95,1,"No"
"2075","C0_Hallmark","H_ALL_15_HALLMARK_ANDROGEN_RESPONSE",100,-1.743,0.0025,0.00082,"No",0.9949,0.49,0.66,"Yes"
"2076","C0_Hallmark","H_ALL_33_HALLMARK_FATTY_ACID_METABOLISM",155,-1.7429,0,0.00078,"No",1.2186,0.084,0.2,"Yes"
"2077","GO_BP","516599_GO_0071675_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION",13,-1.7427,0.0077,0.028,"No",-0.8208,0.69,1,"No"
"2078","REACTOME","106259_REACT_11213_NICOTINAMIDE_SALVAGING",5,-1.7425,0,0.035,"No",-1.4344,0.06,0.5,"No"
"2079","GO_BP","505267_GO_0042088_T_HELPER_1_TYPE_IMMUNE_RESPONSE",16,-1.7424,0.006,0.028,"No",-1.1222,0.3,0.93,"No"
"2080","KEGG_pathway","HSA04210_APOPTOSIS",86,-1.7424,0.0025,0.0045,"No",-0.8489,0.78,0.99,"No"
"2081","C2_Chemical_and_genetic_perturbations","C2_CGP_2058_GAVIN_FOXP3_TARGETS_CLUSTER_T4",94,-1.7423,0,0.013,"No",1.41,0.018,0.29,"Yes"
"2082","C7_Immunologic_signatures","C7_ALL_906_GSE20715_0H_VS_24H_OZONE_LUNG_DN",199,-1.7421,0,7.2e-05,"No",-1.106,0.23,1,"No"
"2083","C2_Chemical_and_genetic_perturbations","C2_CGP_2049_LEIN_ASTROCYTE_MARKERS",42,-1.7419,0.0014,0.013,"No",1.2906,0.12,0.4,"Yes"
"2084","C3_TF_targets","C3_TFT_72_V_CEBPB_01",255,-1.7418,0,0.0054,"No",-1.0599,0.29,0.63,"No"
"2085","REACTOME","187095_REACT_23891_INTERLEUKIN_RECEPTOR_SHC_SIGNALING",28,-1.7418,0.0014,0.035,"No",-0.8823,0.64,1,"No"
"2086","GO_BP","812220_GO_0036376_SODIUM_ION_EXPORT_FROM_CELL",7,-1.7417,0.0017,0.028,"No",-1.5842,0.024,0.72,"No"
"2087","GO_BP","507996_GO_0045648_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION",21,-1.7417,0.0029,0.028,"No",-1.1181,0.3,0.94,"No"
"2088","C2_Chemical_and_genetic_perturbations","C2_CGP_2899_DORN_ADENOVIRUS_INFECTION_48HR_DN",37,-1.7416,0.0043,0.013,"No",-1.4399,0.043,0.53,"No"
"2089","GO_BP","495138_GO_0014066_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",72,-1.7416,0.0026,0.028,"No",0.7603,0.95,1,"Yes"
"2090","WikiPathways","920955_WP1449_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",97,-1.7415,0.0013,0.016,"No",-0.9486,0.56,1,"No"
"2091","C2_Chemical_and_genetic_perturbations","C2_CGP_1850_GENTILE_UV_HIGH_DOSE_UP",25,-1.7414,0.0015,0.013,"No",-1.028,0.44,0.98,"No"
"2092","C2_Chemical_and_genetic_perturbations","C2_CGP_977_GROSS_ELK3_TARGETS_DN",31,-1.7413,0.0045,0.013,"No",1.2294,0.17,0.46,"Yes"
"2093","KEGG_pathway","HSA04740_OLFACTORY_TRANSDUCTION",336,-1.7411,0,0.0045,"No",2.4514,0,0,"Yes"
"2094","C7_Immunologic_signatures","C7_ALL_1646_GSE3982_MAC_VS_NEUTROPHIL_DN",186,-1.741,0,7.8e-05,"No",0.5955,1,1,"Yes"
"2095","GO_BP","751352_GO_0038094_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY",72,-1.741,0,0.028,"No",0.5805,1,1,"Yes"
"2096","C6_Oncogenic_signatures","C6_ALL_134_IL15_UP_V1_UP",182,-1.7408,0,0.0014,"No",-1.0477,0.35,0.57,"No"
"2097","C3_TF_targets","C3_TFT_221_V_PAX4_02",229,-1.7407,0,0.0051,"No",-1.1296,0.18,0.48,"No"
"2098","C2_BioCarta_Pathways","C2_CP_BIOCARTA_51_BIOCARTA_CYTOKINE_PATHWAY",21,-1.7407,0.003,0.035,"No",-1.5202,0.054,1,"No"
"2099","C2_Chemical_and_genetic_perturbations","C2_CGP_753_XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN",20,-1.7407,0.006,0.013,"No",-1.2201,0.2,0.79,"No"
"2100","KEGG_pathway","HSA00500_STARCH_AND_SUCROSE_METABOLISM",54,-1.7405,0.0027,0.0045,"No",0.7733,0.88,1,"Yes"
"2101","C2_Chemical_and_genetic_perturbations","C2_CGP_2722_CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN",165,-1.7405,0,0.013,"No",0.8686,0.81,0.96,"Yes"
"2102","C2_Chemical_and_genetic_perturbations","C2_CGP_1793_BURTON_ADIPOGENESIS_2",71,-1.7403,0.0027,0.013,"No",-0.8414,0.8,1,"No"
"2103","GO_BP","488735_GO_0002862_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",10,-1.7403,0.0017,0.028,"No",-1.0028,0.46,0.99,"No"
"2104","GO_BP","505272_GO_0042093_T_HELPER_CELL_DIFFERENTIATION",20,-1.7403,0.0015,0.028,"No",-0.8455,0.71,1,"No"
"2105","KEGG_pathway","HSA04010_MAPK_SIGNALING_PATHWAY",248,-1.7399,0,0.0044,"No",-1.5945,0,1,"No"
"2106","C7_Immunologic_signatures","C7_ALL_1194_GSE27786_CD4_TCELL_VS_NKCELL_DN",200,-1.7396,0,7.8e-05,"No",0.9215,0.69,0.97,"Yes"
"2107","REACTOME","119519_REACT_19271_SEMAPHORIN_INTERACTIONS",66,-1.7395,0,0.035,"No",-0.8296,0.84,1,"No"
"2108","GO_BP","754571_GO_1901615_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS",491,-1.7395,0,0.028,"No",-0.9487,0.64,1,"No"
"2109","C2_Chemical_and_genetic_perturbations","C2_CGP_309_KIM_WT1_TARGETS_12HR_UP",159,-1.7391,0,0.013,"No",-1.1021,0.25,0.91,"No"
"2110","GO_MF","496869_GO_0017048_RHO_GTPASE_BINDING",71,-1.7389,0.0013,0.059,"No",-1.5923,0.0056,0.46,"No"
"2111","GO_MF","504443_GO_0035259_GLUCOCORTICOID_RECEPTOR_BINDING",10,-1.7388,0.0016,0.058,"No",-0.9902,0.45,0.92,"No"
"2112","GO_BP","505585_GO_0042445_HORMONE_METABOLIC_PROCESS",161,-1.7388,0,0.029,"No",0.9513,0.61,1,"Yes"
"2113","KEGG_pathway","HSA04923_REGULATION_OF_LIPOLYSIS_IN_ADIPOCYTES",55,-1.7387,0,0.0045,"No",-0.9825,0.49,0.9,"No"
"2114","KEGG_compound","C02140_CORTICOSTERONE_11BETA_21_DIHYDROXY_4_PREGNENE_3_20_DIONE_KENDALL_S_COMPOUND_B_REICHSTEIN_S_SUBSTANCE_H",5,-1.7386,0,0.029,"No",0.6985,0.82,1,"Yes"
"2115","GO_BP","503805_GO_0034605_CELLULAR_RESPONSE_TO_HEAT",64,-1.7385,0,0.029,"No",-1.183,0.18,0.91,"No"
"2116","C2_Chemical_and_genetic_perturbations","C2_CGP_218_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP",153,-1.7384,0,0.013,"No",1.591,0,0.14,"Yes"
"2117","GO_BP","487716_GO_0001820_SEROTONIN_SECRETION",5,-1.7383,0.0035,0.029,"No",-1.2557,0.21,0.91,"No"
"2118","GO_BP","753072_GO_1900076_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",52,-1.7382,0,0.029,"No",-1.0167,0.43,0.98,"No"
"2119","GO_BP","502010_GO_0032787_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS",477,-1.7381,0,0.029,"No",0.9871,0.48,0.99,"Yes"
"2120","REACTOME","905994_REACT_169185_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE",76,-1.7381,0.0013,0.035,"No",-1.4335,0.022,0.49,"No"
"2121","GO_MF","490246_GO_0004955_PROSTAGLANDIN_RECEPTOR_ACTIVITY",9,-1.738,0.0016,0.058,"No",1.5024,0.056,0.38,"Yes"
"2122","C2_Chemical_and_genetic_perturbations","C2_CGP_486_TANG_SENESCENCE_TP53_TARGETS_DN",57,-1.7379,0.0013,0.013,"No",0.8057,0.83,0.99,"Yes"
"2123","GO_BP","505278_GO_0042102_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION",84,-1.7378,0,0.029,"No",-0.7277,0.94,1,"No"
"2124","GO_MF","500177_GO_0030882_LIPID_ANTIGEN_BINDING",5,-1.7378,0.0051,0.057,"No",-1.4098,0.094,0.66,"No"
"2125","C2_Chemical_and_genetic_perturbations","C2_CGP_2357_LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP",108,-1.7378,0,0.013,"No",-1.0514,0.35,0.97,"No"
"2126","GO_BP","751354_GO_0038096_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS",71,-1.7375,0,0.029,"No",0.605,1,1,"Yes"
"2127","C7_Immunologic_signatures","C7_ALL_1244_GSE2826_XID_VS_BTK_KO_BCELL_DN",197,-1.7375,0,7.8e-05,"No",1.1885,0.095,0.25,"Yes"
"2128","GO_MF","507666_GO_0045309_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING",19,-1.7373,0.0075,0.057,"No",0.6914,0.9,1,"Yes"
"2129","REACTOME","106019_REACT_6835_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS",28,-1.737,0.0087,0.035,"No",1.038,0.38,0.69,"Yes"
"2130","REACTOME","106548_REACT_7963_PACKAGING_OF_TELOMERE_ENDS",49,-1.7369,0.0041,0.035,"No",-1.707,0.0018,0.16,"No"
"2131","C1_Positional","C1_ALL_176_CHR2Q23",20,-1.7368,0.0047,0.077,"No",-1.3324,0.12,0.97,"No"
"2132","GO_BP","507480_GO_0045080_POSITIVE_REGULATION_OF_CHEMOKINE_BIOSYNTHETIC_PROCESS",9,-1.7365,0.0064,0.029,"No",-1.2111,0.22,0.88,"No"
"2133","GO_BP","508762_GO_0046503_GLYCEROLIPID_CATABOLIC_PROCESS",31,-1.7364,0.0029,0.029,"No",1.0227,0.41,0.97,"Yes"
"2134","GO_BP","488628_GO_0002755_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",82,-1.7364,0,0.029,"No",-0.6931,0.98,1,"No"
"2135","C7_Immunologic_signatures","C7_ALL_1516_GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN",193,-1.7364,0,8.1e-05,"No",0.925,0.66,0.96,"Yes"
"2136","C7_Immunologic_signatures","C7_ALL_620_GSE17721_POLYIC_VS_CPG_1H_BMDM_DN",196,-1.7364,0,8e-05,"No",-1.4251,0.0081,0.18,"No"
"2137","C2_BioCarta_Pathways","C2_CP_BIOCARTA_189_BIOCARTA_HSP27_PATHWAY",15,-1.7364,0.0094,0.035,"No",-1.3178,0.13,1,"No"
"2138","GO_BP","491765_GO_0006910_PHAGOCYTOSIS_RECOGNITION",11,-1.7363,0.0033,0.029,"No",1.0241,0.42,0.97,"Yes"
"2139","GO_BP","946741_GO_1902622_REGULATION_OF_NEUTROPHIL_MIGRATION",24,-1.7363,0.0044,0.029,"No",0.6719,0.93,1,"Yes"
"2140","GO_BP","516307_GO_0071383_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS",125,-1.7363,0,0.029,"No",-1.1206,0.21,0.94,"No"
"2141","GO_CC","503904_GO_0034704_CALCIUM_CHANNEL_COMPLEX",63,-1.7362,0.0013,0.044,"No",-1.3158,0.081,0.63,"No"
"2142","GO_BP","491076_GO_0006096_GLYCOLYTIC_PROCESS",40,-1.7361,0.0057,0.029,"No",-0.9465,0.56,1,"No"
"2143","C2_Chemical_and_genetic_perturbations","C2_CGP_2478_HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS",79,-1.7361,0,0.014,"No",-1.2356,0.14,0.76,"No"
"2144","KEGG_pathway","HSA03320_PPAR_SIGNALING_PATHWAY",67,-1.7359,0,0.0046,"No",-0.7192,0.94,1,"No"
"2145","GO_BP","491846_GO_0007015_ACTIN_FILAMENT_ORGANIZATION",163,-1.7358,0,0.029,"No",-1.0772,0.3,0.95,"No"
"2146","C7_Immunologic_signatures","C7_ALL_1381_GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP",191,-1.7357,0,8e-05,"No",-0.9501,0.56,1,"No"
"2147","GO_MF","505438_GO_0042287_MHC_PROTEIN_BINDING",22,-1.7356,0.0062,0.057,"No",1.1784,0.25,0.73,"Yes"
"2148","C7_Immunologic_signatures","C7_ALL_1659_GSE3982_MAC_VS_TH2_UP",199,-1.7351,0,8e-05,"No",0.8033,0.97,1,"Yes"
"2149","GO_MF","495539_GO_0015295_SOLUTE_PROTON_SYMPORTER_ACTIVITY",17,-1.7347,0.0031,0.057,"No",-1.0345,0.41,0.87,"No"
"2150","WikiPathways","198819_WP26_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR",24,-1.7347,0.006,0.016,"No",-1.0512,0.38,0.98,"No"
"2151","GO_BP","987840_GO_1903039_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION",185,-1.7347,0,0.029,"No",0.9039,0.73,1,"Yes"
"2152","GO_BP","507997_GO_0045649_REGULATION_OF_MACROPHAGE_DIFFERENTIATION",20,-1.7346,0.0044,0.029,"No",-0.6105,0.96,1,"No"
"2153","C3_TF_targets","C3_TFT_300_V_STAT5A_03",250,-1.7345,0,0.0052,"No",-1.0062,0.42,0.75,"No"
"2154","GO_BP","499327_GO_0022409_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION",217,-1.7344,0,0.029,"No",1.0194,0.4,0.97,"Yes"
"2155","GO_BP","516150_GO_0071224_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN",5,-1.7344,0.0036,0.029,"No",-0.8888,0.6,1,"No"
"2156","GO_BP","753356_GO_1900372_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",40,-1.7343,0.0056,0.029,"No",0.9277,0.6,1,"Yes"
"2157","WikiPathways","198765_WP117_GPCRS_OTHER",88,-1.734,0,0.016,"No",1.3711,0.04,0.54,"Yes"
"2158","C2_Chemical_and_genetic_perturbations","C2_CGP_3205_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP",269,-1.734,0.0011,0.014,"No",-1.1762,0.098,0.82,"No"
"2159","GO_BP","502418_GO_0033198_RESPONSE_TO_ATP",25,-1.7339,0.0015,0.029,"No",-0.7086,0.9,1,"No"
"2160","C7_Immunologic_signatures","C7_ALL_1182_GSE27786_BCELL_VS_NKCELL_DN",198,-1.7339,0,9.2e-05,"No",0.6509,1,1,"Yes"
"2161","C2_Chemical_and_genetic_perturbations","C2_CGP_3242_SERVITJA_ISLET_HNF1A_TARGETS_UP",153,-1.7337,0,0.014,"No",1.2035,0.12,0.48,"Yes"
"2162","C2_Chemical_and_genetic_perturbations","C2_CGP_2798_SEIKE_LUNG_CANCER_POOR_SURVIVAL",10,-1.7337,0.0048,0.014,"No",-1.4605,0.089,0.52,"No"
"2163","REACTOME","106065_REACT_12560_BASIGIN_INTERACTIONS",25,-1.7337,0.0046,0.036,"No",-1.4643,0.042,0.47,"No"
"2164","GO_MF","500179_GO_0030884_EXOGENOUS_LIPID_ANTIGEN_BINDING",5,-1.7336,0.0018,0.057,"No",-1.4285,0.078,0.65,"No"
"2165","REACTOME","106152_REACT_11036_GLUCOCORTICOID_BIOSYNTHESIS",8,-1.7336,0.014,0.036,"No",0.8022,0.73,0.99,"Yes"
"2166","KEGG_pathway","HSA04144_ENDOCYTOSIS",213,-1.7335,0,0.0046,"No",-0.9629,0.54,0.93,"No"
"2167","C2_Chemical_and_genetic_perturbations","C2_CGP_1884_BURTON_ADIPOGENESIS_PEAK_AT_0HR",62,-1.7335,0.0013,0.014,"No",-0.7405,0.92,1,"No"
"2168","C4_Cancer_modules","C4_CM_405_MODULE_521",35,-1.7333,0.0015,0.01,"No",-1.0812,0.33,0.69,"No"
"2169","GO_BP","499618_GO_0030208_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS",11,-1.7332,0.0097,0.03,"No",-1.2053,0.24,0.89,"No"
"2170","C3_TF_targets","C3_TFT_603_RGAGGAARY_V_PU1_Q6",497,-1.7332,0,0.0051,"No",-0.9954,0.48,0.76,"No"
"2171","C6_Oncogenic_signatures","C6_ALL_28_AKT_UP_V1_UP",154,-1.7332,0,0.0016,"No",-0.9249,0.65,0.84,"No"
"2172","GO_BP","1129450_GO_1903624_REGULATION_OF_DNA_CATABOLIC_PROCESS",11,-1.733,0.0068,0.03,"No",0.8398,0.69,1,"Yes"
"2173","C2_Chemical_and_genetic_perturbations","C2_CGP_2268_SMID_BREAST_CANCER_LUMINAL_A_UP",82,-1.7328,0.0013,0.014,"No",0.936,0.59,0.89,"Yes"
"2174","GO_BP","750851_GO_0035924_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS",27,-1.7326,0.003,0.03,"No",-1.3642,0.083,0.98,"No"
"2175","C2_Chemical_and_genetic_perturbations","C2_CGP_3284_WANG_MLL_TARGETS",279,-1.7323,0,0.014,"No",0.9751,0.52,0.83,"Yes"
"2176","C2_Chemical_and_genetic_perturbations","C2_CGP_211_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP",18,-1.7322,0.0044,0.014,"No",-1.1376,0.29,0.86,"No"
"2177","C2_Chemical_and_genetic_perturbations","C2_CGP_2144_CLAUS_PGR_POSITIVE_MENINGIOMA_UP",10,-1.7319,0.0065,0.014,"No",1.3547,0.12,0.34,"Yes"
"2178","GO_BP","495830_GO_0015695_ORGANIC_CATION_TRANSPORT",15,-1.7317,0.0094,0.03,"No",-1.2155,0.25,0.88,"No"
"2179","GO_BP","491987_GO_0007187_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER",164,-1.7314,0,0.03,"No",1.2091,0.083,0.78,"Yes"
"2180","C1_Positional","C1_ALL_276_CHR6P22",105,-1.7314,0,0.074,"No",-1.6311,0.0018,0.55,"No"
"2181","REACTOME","1127684_REACT_263923_HDACS_DEACETYLATE_HISTONES",91,-1.7313,0.0013,0.036,"No",-2.0256,0,0.033,"No"
"2182","C2_Chemical_and_genetic_perturbations","C2_CGP_2203_POS_RESPONSE_TO_HISTAMINE_UP",13,-1.7311,0.012,0.014,"No",-1.0482,0.37,0.97,"No"
"2183","GO_BP","499434_GO_0050852_T_CELL_RECEPTOR_SIGNALING_PATHWAY",93,-1.731,0,0.03,"No",0.8955,0.73,1,"Yes"
"2184","GO_BP","512748_GO_0051893_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY",40,-1.731,0.0014,0.03,"No",-1.3645,0.081,0.98,"No"
"2185","GO_BP","512751_GO_0051896_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING",116,-1.731,0,0.03,"No",-0.7638,0.94,1,"No"
"2186","C4_Cancer_modules","C4_CM_357_MODULE_431",14,-1.731,0.011,0.011,"No",-0.9353,0.55,0.89,"No"
"2187","REACTOME","106398_REACT_6894_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE",122,-1.7309,0,0.036,"No",-0.6786,0.99,1,"No"
"2188","C2_Chemical_and_genetic_perturbations","C2_CGP_1170_SHIN_B_CELL_LYMPHOMA_CLUSTER_8",35,-1.7308,0.0043,0.014,"No",-0.7724,0.82,1,"No"
"2189","C2_Chemical_and_genetic_perturbations","C2_CGP_522_LUCAS_HNF4A_TARGETS_UP",57,-1.7304,0.0014,0.014,"No",-0.8225,0.79,1,"No"
"2190","REACTOME","161003_REACT_22205_L1CAM_INTERACTIONS",97,-1.7302,0,0.036,"No",-1.1274,0.22,0.89,"No"
"2191","KEGG_pathway","HSA04918_THYROID_HORMONE_SYNTHESIS",71,-1.7301,0.0013,0.0047,"No",-1.3688,0.05,0.34,"No"
"2192","GO_BP","492558_GO_0008217_REGULATION_OF_BLOOD_PRESSURE",159,-1.7301,0,0.03,"No",-1.0314,0.36,0.98,"No"
"2193","KEGG_compound","C16453_4_N_NITROSOMETHYLAMINO_1_3_PYRIDYL_1_BUTANONE_NNK",12,-1.7298,0.0048,0.032,"No",-1.3319,0.13,0.58,"No"
"2194","C2_Chemical_and_genetic_perturbations","C2_CGP_3361_LIM_MAMMARY_STEM_CELL_UP",481,-1.7296,0,0.014,"No",-1.0849,0.2,0.94,"No"
"2195","C4_Cancer_modules","C4_CM_89_MODULE_94",358,-1.7296,0,0.011,"No",-1.0605,0.27,0.72,"No"
"2196","C2_Chemical_and_genetic_perturbations","C2_CGP_2141_HELLER_HDAC_TARGETS_DN",284,-1.7295,0,0.014,"No",0.795,0.99,0.99,"Yes"
"2197","C2_Chemical_and_genetic_perturbations","C2_CGP_1733_BROWNE_HCMV_INFECTION_20HR_DN",99,-1.7293,0,0.014,"No",-0.8864,0.71,1,"No"
"2198","GO_BP","500108_GO_0030809_NEGATIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",40,-1.7293,0.0014,0.03,"No",0.9189,0.57,1,"Yes"
"2199","C2_Chemical_and_genetic_perturbations","C2_CGP_1474_MATSUDA_NATURAL_KILLER_DIFFERENTIATION",471,-1.7293,0,0.014,"No",1.0804,0.2,0.66,"Yes"
"2200","GO_BP","508689_GO_0046427_POSITIVE_REGULATION_OF_JAK_STAT_CASCADE",63,-1.7292,0.0026,0.03,"No",-1.5422,0.0055,0.74,"No"
"2201","C7_Immunologic_signatures","C7_ALL_1509_GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP",199,-1.7291,0,9.5e-05,"No",-0.9313,0.67,1,"No"
"2202","GO_BP","519122_GO_2000482_REGULATION_OF_INTERLEUKIN_8_SECRETION",13,-1.729,0.0062,0.03,"No",1.3152,0.15,0.65,"Yes"
"2203","C2_Chemical_and_genetic_perturbations","C2_CGP_593_MUELLER_METHYLATED_IN_GLIOBLASTOMA",36,-1.7289,0,0.014,"No",1.009,0.41,0.78,"Yes"
"2204","C2_Chemical_and_genetic_perturbations","C2_CGP_1772_RHODES_UNDIFFERENTIATED_CANCER",69,-1.7289,0,0.014,"No",1.5713,0,0.16,"Yes"
"2205","C7_Immunologic_signatures","C7_ALL_1484_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN",197,-1.7288,0,9.8e-05,"No",0.827,0.91,1,"Yes"
"2206","C2_Chemical_and_genetic_perturbations","C2_CGP_3314_PHONG_TNF_RESPONSE_NOT_VIA_P38",336,-1.7288,0,0.014,"No",-1.0032,0.45,1,"No"
"2207","WikiPathways","198851_WP727_MONOAMINE_TRANSPORT",32,-1.7285,0.0045,0.017,"No",-0.8268,0.78,1,"No"
"2208","C2_Chemical_and_genetic_perturbations","C2_CGP_490_WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN",101,-1.7285,0,0.014,"No",0.9475,0.57,0.87,"Yes"
"2209","C4_Cancer_modules","C4_CM_381_MODULE_474",16,-1.7285,0.0015,0.011,"No",1.1003,0.31,0.54,"Yes"
"2210","GO_BP","751040_GO_0036120_CELLULAR_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR_STIMULUS",9,-1.7285,0.0016,0.031,"No",1.4317,0.1,0.52,"Yes"
"2211","C2_Chemical_and_genetic_perturbations","C2_CGP_167_WIKMAN_ASBESTOS_LUNG_CANCER_DN",27,-1.7285,0,0.014,"No",0.6804,0.94,1,"Yes"
"2212","C2_Chemical_and_genetic_perturbations","C2_CGP_1912_LY_AGING_OLD_DN",56,-1.7284,0.0027,0.014,"No",1.342,0.063,0.35,"Yes"
"2213","C7_Immunologic_signatures","C7_ALL_1337_GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP",197,-1.7284,0,9.8e-05,"No",0.7875,0.97,1,"Yes"
"2214","C2_Chemical_and_genetic_perturbations","C2_CGP_1056_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN",101,-1.7283,0.0012,0.014,"No",-1.1192,0.24,0.89,"No"
"2215","GO_MF","490271_GO_0004984_OLFACTORY_RECEPTOR_ACTIVITY",311,-1.7278,0,0.061,"No",2.4604,0,0.00036,"Yes"
"2216","C7_Immunologic_signatures","C7_ALL_1083_GSE25087_TREG_VS_TCONV_FETUS_UP",197,-1.7276,0,9.8e-05,"No",0.7781,0.98,1,"Yes"
"2217","GO_BP","508012_GO_0045664_REGULATION_OF_NEURON_DIFFERENTIATION",420,-1.7275,0,0.031,"No",-1.1849,0.065,0.91,"No"
"2218","C4_Cancer_modules","C4_CM_391_MODULE_492",16,-1.7274,0.0079,0.011,"No",-0.6461,0.93,1,"No"
"2219","REACTOME","119559_REACT_19397_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES",95,-1.7274,0,0.037,"No",-1.0909,0.3,0.91,"No"
"2220","C6_Oncogenic_signatures","C6_ALL_106_BMI1_DN_V1_UP",144,-1.7269,0,0.0018,"No",-1.3246,0.037,0.4,"No"
"2221","C6_Oncogenic_signatures","C6_ALL_97_ESC_V6_5_UP_EARLY_V1_DN",150,-1.7267,0,0.0017,"No",-1.0098,0.43,0.66,"No"
"2222","GO_BP","491968_GO_0007163_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY",128,-1.7266,0,0.031,"No",-0.9461,0.59,1,"No"
"2223","WikiPathways","198845_WP481_INSULIN_SIGNALING",162,-1.7265,0,0.016,"No",-1.0441,0.36,0.96,"No"
"2224","C2_Chemical_and_genetic_perturbations","C2_CGP_2385_LU_TUMOR_ENDOTHELIAL_MARKERS_UP",22,-1.7265,0.0015,0.014,"No",1.3103,0.12,0.38,"Yes"
"2225","GO_MF","500178_GO_0030883_ENDOGENOUS_LIPID_ANTIGEN_BINDING",5,-1.7263,0.0034,0.061,"No",-1.4099,0.11,0.66,"No"
"2226","GO_BP","1022134_GO_0099587_INORGANIC_ION_IMPORT_INTO_CELL",12,-1.7262,0.0081,0.031,"No",-1.2249,0.2,0.88,"No"
"2227","C2_Chemical_and_genetic_perturbations","C2_CGP_1443_ABBUD_LIF_SIGNALING_1_DN",26,-1.7261,0.0044,0.015,"No",-0.9872,0.47,1,"No"
"2228","C4_Cancer_modules","C4_CM_343_MODULE_411",78,-1.7261,0,0.011,"No",-1.1457,0.22,0.62,"No"
"2229","C2_Chemical_and_genetic_perturbations","C2_CGP_126_LIU_CMYB_TARGETS_UP",163,-1.7259,0,0.015,"No",-0.7162,0.99,1,"No"
"2230","GO_BP","512149_GO_0051258_PROTEIN_POLYMERIZATION",84,-1.7258,0,0.031,"No",0.8353,0.83,1,"Yes"
"2231","GO_CC","507495_GO_0045095_KERATIN_FILAMENT",56,-1.7258,0.0013,0.049,"No",0.9682,0.52,0.82,"Yes"
"2232","GO_BP","755339_GO_2001233_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY",369,-1.7257,0,0.031,"No",0.8635,0.92,1,"Yes"
"2233","GO_BP","498798_GO_0021514_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION",15,-1.7252,0.0077,0.031,"No",-1.6011,0.029,0.7,"No"
"2234","GO_BP","518795_GO_2000147_POSITIVE_REGULATION_OF_CELL_MOTILITY",317,-1.7251,0,0.031,"No",1.0653,0.23,0.93,"Yes"
"2235","C4_Cancer_modules","C4_CM_75_MODULE_80",32,-1.725,0.0028,0.011,"No",-0.8397,0.7,0.96,"No"
"2236","GO_BP","501893_GO_0032667_REGULATION_OF_INTERLEUKIN_23_PRODUCTION",7,-1.725,0.007,0.031,"No",-1.0807,0.36,0.95,"No"
"2237","GO_BP","500113_GO_0030814_REGULATION_OF_CAMP_METABOLIC_PROCESS",128,-1.7249,0,0.031,"No",0.9512,0.56,1,"Yes"
"2238","GO_BP","498220_GO_0019377_GLYCOLIPID_CATABOLIC_PROCESS",11,-1.7248,0.0033,0.031,"No",-0.9103,0.58,1,"No"
"2239","GO_BP","518578_GO_0097028_DENDRITIC_CELL_DIFFERENTIATION",32,-1.7247,0,0.031,"No",-1.4813,0.041,0.84,"No"
"2240","C0_Hallmark","H_ALL_16_HALLMARK_MYOGENESIS",197,-1.7247,0,0.00097,"No",-1.6186,0,0.028,"No"
"2241","C2_Chemical_and_genetic_perturbations","C2_CGP_646_RASHI_RESPONSE_TO_IONIZING_RADIATION_2",125,-1.7246,0,0.015,"No",-0.9917,0.44,1,"No"
"2242","REACTOME","477132_REACT_111155_CELL_CELL_COMMUNICATION",129,-1.7246,0,0.038,"No",-1.0924,0.26,0.91,"No"
"2243","GO_BP","511662_GO_0050690_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS",29,-1.7241,0.0088,0.032,"No",1.1393,0.27,0.85,"Yes"
"2244","C7_Immunologic_signatures","C7_ALL_775_GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP",194,-1.7241,0,1e-04,"No",-0.9135,0.72,1,"No"
"2245","REACTOME","106371_REACT_18425_PROSTANOID_LIGAND_RECEPTORS",9,-1.724,0.0068,0.037,"No",-0.9849,0.46,1,"No"
"2246","C7_Immunologic_signatures","C7_ALL_1419_GSE360_CTRL_VS_L_DONOVANI_MAC_UP",199,-1.7238,0,0.00011,"No",0.7839,0.96,1,"Yes"
"2247","C2_Chemical_and_genetic_perturbations","C2_CGP_2649_ZHAN_EARLY_DIFFERENTIATION_GENES_UP",7,-1.7236,0.0069,0.015,"No",0.9192,0.55,0.9,"Yes"
"2248","C2_Chemical_and_genetic_perturbations","C2_CGP_1980_VERRECCHIA_RESPONSE_TO_TGFB1_C3",14,-1.7235,0.0063,0.015,"No",0.7385,0.81,1,"Yes"
"2249","GO_BP","491817_GO_0006979_RESPONSE_TO_OXIDATIVE_STRESS",312,-1.7234,0,0.032,"No",-0.9034,0.76,1,"No"
"2250","C2_Chemical_and_genetic_perturbations","C2_CGP_255_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN",54,-1.7232,0.0013,0.015,"No",1.0065,0.46,0.79,"Yes"
"2251","C2_Chemical_and_genetic_perturbations","C2_CGP_846_LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP",81,-1.7231,0,0.015,"No",0.6105,1,1,"Yes"
"2252","GO_BP","491480_GO_0006584_CATECHOLAMINE_METABOLIC_PROCESS",42,-1.7229,0.0028,0.032,"No",-0.9457,0.55,1,"No"
"2253","GO_BP","508739_GO_0046479_GLYCOSPHINGOLIPID_CATABOLIC_PROCESS",11,-1.7229,0.0098,0.032,"No",-0.8787,0.59,1,"No"
"2254","GO_BP","500839_GO_0031589_CELL_SUBSTRATE_ADHESION",158,-1.7228,0,0.032,"No",-1.0304,0.38,0.98,"No"
"2255","REACTOME","105911_REACT_1383_GLYCOLYSIS",31,-1.7228,0.0029,0.038,"No",-1.0571,0.38,0.93,"No"
"2256","GO_BP","499488_GO_0030029_ACTIN_FILAMENT_BASED_PROCESS",417,-1.7228,0,0.032,"No",-1.0941,0.18,0.95,"No"
"2257","GO_MF","489956_GO_0047498_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY",8,-1.7226,0.01,0.062,"No",-1.081,0.35,0.85,"No"
"2258","C7_Immunologic_signatures","C7_ALL_836_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN",175,-1.7225,0,0.00011,"No",-1.3182,0.037,0.42,"No"
"2259","GO_BP","518889_GO_2000242_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS",95,-1.7223,0.0013,0.032,"No",1.2671,0.075,0.71,"Yes"
"2260","C2_Chemical_and_genetic_perturbations","C2_CGP_2201_BIERIE_INFLAMMATORY_RESPONSE_TGFB1",5,-1.7223,0.0018,0.015,"No",-1.1977,0.27,0.8,"No"
"2261","REACTOME","160966_REACT_20676_CELL_JUNCTION_ORGANIZATION",84,-1.722,0.0013,0.038,"No",-1.0446,0.36,0.95,"No"
"2262","C3_TF_targets","C3_TFT_4_V_E47_01",249,-1.7218,0,0.0061,"No",-1.6287,0,0.15,"No"
"2263","C7_Immunologic_signatures","C7_ALL_1807_GSE7852_TREG_VS_TCONV_LN_UP",200,-1.7218,0,0.00011,"No",-0.9227,0.69,1,"No"
"2264","GO_BP","500136_GO_0030838_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION",63,-1.7218,0.0013,0.032,"No",-0.7944,0.84,1,"No"
"2265","GO_BP","1129311_GO_0098754_DETOXIFICATION",12,-1.7215,0.011,0.032,"No",-1.0499,0.39,0.97,"No"
"2266","GO_CC","498675_GO_0019897_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE",130,-1.7215,0,0.05,"No",-1.1982,0.11,0.7,"No"
"2267","GO_BP","516277_GO_0071353_CELLULAR_RESPONSE_TO_INTERLEUKIN_4",26,-1.7214,0.0044,0.032,"No",0.9521,0.56,1,"Yes"
"2268","C4_Cancer_modules","C4_CM_239_MODULE_265",29,-1.7214,0.012,0.011,"No",1.3818,0.075,0.2,"Yes"
"2269","C7_Immunologic_signatures","C7_ALL_956_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN",187,-1.7214,0,0.00012,"No",-0.7411,0.98,1,"No"
"2270","C2_Chemical_and_genetic_perturbations","C2_CGP_1534_THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN",225,-1.7213,0,0.015,"No",0.8399,0.94,0.98,"Yes"
"2271","GO_BP","494687_GO_0010623_DEVELOPMENTAL_PROGRAMMED_CELL_DEATH",28,-1.7212,0.0072,0.032,"No",-1.4075,0.053,0.97,"No"
"2272","C0_Hallmark","H_ALL_36_HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY",49,-1.721,0.0014,0.00097,"No",0.8031,0.8,1,"Yes"
"2273","C7_Immunologic_signatures","C7_ALL_1833_GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP",198,-1.7209,0,0.00012,"No",-0.9975,0.45,1,"No"
"2274","GO_MF","492384_GO_0008009_CHEMOKINE_ACTIVITY",39,-1.7209,0.0028,0.063,"No",1.5587,0.0067,0.33,"Yes"
"2275","GO_BP","501837_GO_0032611_INTERLEUKIN_1_BETA_PRODUCTION",11,-1.7208,0.013,0.032,"No",-0.6814,0.86,1,"No"
"2276","GO_CC","501813_GO_0032587_RUFFLE_MEMBRANE",76,-1.7207,0,0.049,"No",0.6211,1,1,"Yes"
"2277","C2_Chemical_and_genetic_perturbations","C2_CGP_2520_MARSHALL_VIRAL_INFECTION_RESPONSE_DN",29,-1.7206,0.0015,0.015,"No",0.7219,0.89,1,"Yes"
"2278","GO_BP","491553_GO_0006665_SPHINGOLIPID_METABOLIC_PROCESS",125,-1.7206,0,0.032,"No",-0.8079,0.89,1,"No"
"2279","GO_BP","504544_GO_0035360_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY",6,-1.7205,0.0034,0.032,"No",-1.5042,0.06,0.82,"No"
"2280","GO_BP","507279_GO_0044272_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS",166,-1.7204,0,0.032,"No",-0.9786,0.51,1,"No"
"2281","C2_Chemical_and_genetic_perturbations","C2_CGP_1162_SUNG_METASTASIS_STROMA_UP",108,-1.7204,0,0.015,"No",-1.2571,0.086,0.74,"No"
"2282","C2_Chemical_and_genetic_perturbations","C2_CGP_614_MAHADEVAN_RESPONSE_TO_MP470_DN",19,-1.7204,0.011,0.015,"No",-1.4032,0.085,0.58,"No"
"2283","GO_BP","755344_GO_2001238_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",57,-1.7203,0.0014,0.032,"No",0.6521,0.99,1,"Yes"
"2284","C2_Chemical_and_genetic_perturbations","C2_CGP_1785_BURTON_ADIPOGENESIS_3",100,-1.7202,0,0.015,"No",0.7716,0.93,1,"Yes"
"2285","C2_Chemical_and_genetic_perturbations","C2_CGP_2516_LINDSTEDT_DENDRITIC_CELL_MATURATION_B",53,-1.7201,0.0014,0.015,"No",-0.6454,0.96,1,"No"
"2286","GO_BP","511847_GO_0050911_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SMELL",311,-1.72,0,0.032,"No",2.4734,0,0,"Yes"
"2287","GO_BP","492273_GO_0007520_MYOBLAST_FUSION",18,-1.7198,0.011,0.032,"No",-1.6302,0.014,0.7,"No"
"2288","GO_BP","500153_GO_0030855_EPITHELIAL_CELL_DIFFERENTIATION",481,-1.7198,0,0.032,"No",0.9952,0.48,0.98,"Yes"
"2289","KEGG_pathway","HSA05202_TRANSCRIPTIONAL_MISREGULATION_IN_CANCER",174,-1.7197,0,0.0054,"No",-0.9137,0.68,0.97,"No"
"2290","C2_Chemical_and_genetic_perturbations","C2_CGP_2846_BOYLAN_MULTIPLE_MYELOMA_PCA3_DN",69,-1.7196,0,0.015,"No",0.9183,0.59,0.9,"Yes"
"2291","GO_BP","508725_GO_0046464_ACYLGLYCEROL_CATABOLIC_PROCESS",24,-1.7194,0.0063,0.032,"No",1.1294,0.29,0.87,"Yes"
"2292","GO_BP","494881_GO_0010817_REGULATION_OF_HORMONE_LEVELS",237,-1.719,0,0.033,"No",1.0514,0.31,0.95,"Yes"
"2293","C4_Cancer_gene_neighborhoods","C4_CGN_415_GNF2_STAT6",79,-1.7189,0.0026,0.0067,"No",1.6484,0.0022,0.0099,"Yes"
"2294","GO_BP","488693_GO_0002820_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE",30,-1.7188,0.0058,0.033,"No",-0.7745,0.83,1,"No"
"2295","GO_BP","501383_GO_0032147_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY",260,-1.7188,0,0.032,"No",0.8222,0.95,1,"Yes"
"2296","KEGG_module","HSA_M00087_BETA_OXIDATION",12,-1.7186,0.0065,0.12,"No",0.5872,0.95,1,"Yes"
"2297","GO_BP","505668_GO_0042537_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS",26,-1.7185,0.0058,0.033,"No",-1.4775,0.038,0.84,"No"
"2298","GO_BP","518170_GO_0090023_POSITIVE_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS",17,-1.7183,0.0091,0.033,"No",0.8102,0.77,1,"Yes"
"2299","C7_Immunologic_signatures","C7_ALL_32_GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN",198,-1.7181,0,0.00012,"No",0.8193,0.94,1,"Yes"
"2300","GO_BP","507515_GO_0045124_REGULATION_OF_BONE_RESORPTION",31,-1.7178,0.0015,0.033,"No",0.6628,0.95,1,"Yes"
"2301","C7_Immunologic_signatures","C7_ALL_406_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN",199,-1.7177,0,0.00012,"No",1.2879,0.029,0.11,"Yes"
"2302","C7_Immunologic_signatures","C7_ALL_65_GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP",195,-1.7174,0,0.00012,"No",-1.2509,0.05,0.62,"No"
"2303","C2_Chemical_and_genetic_perturbations","C2_CGP_437_CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",235,-1.7174,0,0.016,"No",-1.1066,0.21,0.91,"No"
"2304","C3_TF_targets","C3_TFT_91_V_HNF3B_01",208,-1.7171,0,0.006,"No",-1.2456,0.053,0.29,"No"
"2305","GO_BP","494883_GO_0010819_REGULATION_OF_T_CELL_CHEMOTAXIS",11,-1.7171,0.0064,0.033,"No",0.7889,0.77,1,"Yes"
"2306","GO_BP","488446_GO_0002573_MYELOID_LEUKOCYTE_DIFFERENTIATION",98,-1.7171,0,0.033,"No",-0.8541,0.8,1,"No"
"2307","GO_BP","488871_GO_0003073_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",85,-1.7168,0.0013,0.033,"No",-1.1185,0.25,0.94,"No"
"2308","C2_Chemical_and_genetic_perturbations","C2_CGP_1467_YU_MYC_TARGETS_UP",42,-1.7168,0.0029,0.016,"No",0.9728,0.5,0.83,"Yes"
"2309","GO_BP","507358_GO_0044406_ADHESION_OF_SYMBIONT_TO_HOST",11,-1.7167,0,0.033,"No",-0.6623,0.9,1,"No"
"2310","C2_Chemical_and_genetic_perturbations","C2_CGP_2618_MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP",26,-1.7163,0.0059,0.016,"No",-0.6309,0.96,1,"No"
"2311","KEGG_compound","C05487_17ALPHA_21_DIHYDROXYPREGNENOLONE",5,-1.7163,0.0055,0.037,"No",1.1417,0.32,0.97,"Yes"
"2312","C2_Chemical_and_genetic_perturbations","C2_CGP_2280_LE_SKI_TARGETS_UP",16,-1.7162,0.0031,0.016,"No",0.7508,0.83,1,"Yes"
"2313","C7_Immunologic_signatures","C7_ALL_1526_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN",200,-1.7162,0.0011,0.00012,"No",1.0767,0.25,0.51,"Yes"
"2314","GO_BP","982451_GO_1902883_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS",28,-1.7161,0.0075,0.033,"No",1.2756,0.14,0.7,"Yes"
"2315","C6_Oncogenic_signatures","C6_ALL_177_KRAS_600_LUNG_BREAST_UP_V1_UP",262,-1.7161,0,0.0019,"No",-0.9235,0.7,0.84,"No"
"2316","C2_Chemical_and_genetic_perturbations","C2_CGP_2691_VALK_AML_CLUSTER_16",26,-1.716,0.0075,0.016,"No",0.5853,0.97,1,"Yes"
"2317","C7_Immunologic_signatures","C7_ALL_1107_GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP",185,-1.716,0,0.00012,"No",-0.9928,0.48,1,"No"
"2318","GO_BP","516635_GO_0071711_BASEMENT_MEMBRANE_ORGANIZATION",10,-1.7158,0.0049,0.033,"No",-1.2082,0.25,0.88,"No"
"2319","GO_BP","503648_GO_0034446_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",39,-1.7158,0.0028,0.033,"No",-1.1424,0.25,0.93,"No"
"2320","C2_Chemical_and_genetic_perturbations","C2_CGP_1942_WENG_POR_TARGETS_LIVER_UP",39,-1.7156,0.0014,0.016,"No",-1.1833,0.21,0.82,"No"
"2321","GO_MF","496961_GO_0017171_SERINE_HYDROLASE_ACTIVITY",167,-1.7156,0,0.066,"No",1.093,0.23,0.8,"Yes"
"2322","C4_Cancer_modules","C4_CM_341_MODULE_408",18,-1.7154,0.0093,0.012,"No",-0.5701,0.97,1,"No"
"2323","GO_BP","512142_GO_0051251_POSITIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION",241,-1.7153,0,0.033,"No",0.662,1,1,"Yes"
"2324","C2_Chemical_and_genetic_perturbations","C2_CGP_1796_ZHU_CMV_8_HR_DN",53,-1.7153,0.0014,0.016,"No",-0.6573,0.97,1,"No"
"2325","C2_Chemical_and_genetic_perturbations","C2_CGP_1614_MODY_HIPPOCAMPUS_POSTNATAL",62,-1.715,0.0013,0.016,"No",1.013,0.4,0.78,"Yes"
"2326","GO_BP","751382_GO_0038124_TOLL_LIKE_RECEPTOR_TLR6_TLR2_SIGNALING_PATHWAY",72,-1.715,0,0.033,"No",-0.6754,0.98,1,"No"
"2327","GO_BP","510562_GO_0048488_SYNAPTIC_VESICLE_ENDOCYTOSIS",28,-1.7148,0.0029,0.033,"No",-1.2911,0.11,0.88,"No"
"2328","GO_BP","513546_GO_0055117_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION",77,-1.7146,0.0026,0.033,"No",-1.196,0.14,0.89,"No"
"2329","KEGG_compound","C00084_ACETALDEHYDE_ETHANAL",19,-1.7146,0.011,0.037,"No",1.2167,0.18,0.86,"Yes"
"2330","GO_BP","487867_GO_0001977_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME",17,-1.7145,0.013,0.033,"No",1.5617,0.043,0.34,"Yes"
"2331","GO_BP","506431_GO_0043393_REGULATION_OF_PROTEIN_BINDING",141,-1.7145,0,0.033,"No",-0.6749,1,1,"No"
"2332","GO_BP","498705_GO_0019932_SECOND_MESSENGER_MEDIATED_SIGNALING",137,-1.7144,0,0.033,"No",-0.7755,0.94,1,"No"
"2333","REACTOME","530757_REACT_115846_DEFENSINS",23,-1.7142,0.0045,0.041,"No",1.0396,0.4,0.68,"Yes"
"2334","C3_TF_targets","C3_TFT_352_V_PU1_Q6",226,-1.7142,0,0.0061,"No",0.8958,0.79,1,"Yes"
"2335","KEGG_module","HSA_M00004_PENTOSE_PHOSPHATE_PATHWAY_PENTOSE_PHOSPHATE_CYCLE_",12,-1.7142,0.0063,0.098,"No",0.5606,0.99,0.98,"Yes"
"2336","GO_BP","505640_GO_0042509_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",57,-1.714,0.004,0.033,"No",-1.5729,0.016,0.73,"No"
"2337","GO_BP","508731_GO_0046470_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS",61,-1.7139,0.004,0.033,"No",-1.089,0.32,0.95,"No"
"2338","REACTOME","106383_REACT_15488_OLFACTORY_SIGNALING_PATHWAY",313,-1.7138,0,0.041,"No",2.4373,0,0,"Yes"
"2339","KEGG_pathway","HSA04370_VEGF_SIGNALING_PATHWAY",61,-1.7138,0.0013,0.0057,"No",-0.9423,0.55,0.96,"No"
"2340","C2_Chemical_and_genetic_perturbations","C2_CGP_2864_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2",13,-1.7134,0.011,0.016,"No",0.578,0.96,1,"Yes"
"2341","C2_Chemical_and_genetic_perturbations","C2_CGP_2612_MELLMAN_TUT1_TARGETS_DN",46,-1.7134,0.0028,0.016,"No",-0.7981,0.83,1,"No"
"2342","C2_Chemical_and_genetic_perturbations","C2_CGP_1364_BROCKE_APOPTOSIS_REVERSED_BY_IL6",144,-1.7131,0,0.016,"No",0.9833,0.49,0.81,"Yes"
"2343","GO_BP","510178_GO_0048010_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",108,-1.7131,0,0.034,"No",0.7967,0.91,1,"Yes"
"2344","C2_Chemical_and_genetic_perturbations","C2_CGP_1361_NELSON_RESPONSE_TO_ANDROGEN_UP",85,-1.7131,0.0026,0.016,"No",0.7798,0.87,1,"Yes"
"2345","GO_MF","496557_GO_0016616_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",114,-1.7128,0,0.066,"No",1.025,0.41,0.86,"Yes"
"2346","C7_Immunologic_signatures","C7_ALL_1411_GSE360_CTRL_VS_T_GONDII_DC_UP",198,-1.7127,0,0.00014,"No",1.2176,0.064,0.2,"Yes"
"2347","C7_Immunologic_signatures","C7_ALL_779_GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP",192,-1.7125,0,0.00014,"No",-0.7041,1,1,"No"
"2348","C2_Chemical_and_genetic_perturbations","C2_CGP_2129_ZHANG_GATA6_TARGETS_UP",15,-1.7125,0.012,0.016,"No",1.1856,0.24,0.51,"Yes"
"2349","GO_BP","499604_GO_0030194_POSITIVE_REGULATION_OF_BLOOD_COAGULATION",25,-1.7125,0.0076,0.034,"No",1.0391,0.41,0.96,"Yes"
"2350","C2_Chemical_and_genetic_perturbations","C2_CGP_1797_ZHU_CMV_24_HR_DN",89,-1.7123,0.0013,0.016,"No",0.9888,0.5,0.81,"Yes"
"2351","GO_BP","501838_GO_0032612_INTERLEUKIN_1_PRODUCTION",12,-1.7123,0.0096,0.034,"No",-0.6788,0.87,1,"No"
"2352","GO_BP","494830_GO_0010765_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT",31,-1.7119,0.0043,0.034,"No",-1.608,0.016,0.71,"No"
"2353","C7_Immunologic_signatures","C7_ALL_747_GSE17721_0_5H_VS_24H_CPG_BMDM_UP",199,-1.7118,0,0.00014,"No",1.2048,0.1,0.22,"Yes"
"2354","GO_MF","499642_GO_0030235_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY",10,-1.7118,0,0.066,"No",0.6821,0.88,1,"Yes"
"2355","GO_BP","751381_GO_0038123_TOLL_LIKE_RECEPTOR_TLR1_TLR2_SIGNALING_PATHWAY",72,-1.7118,0.0026,0.034,"No",-0.6752,0.99,1,"No"
"2356","GO_BP","501200_GO_0031960_RESPONSE_TO_CORTICOSTEROID",139,-1.7116,0,0.034,"No",0.821,0.89,1,"Yes"
"2357","GO_BP","507969_GO_0045621_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION",75,-1.7113,0,0.034,"No",-1.0848,0.29,0.96,"No"
"2358","GO_BP","505301_GO_0042129_REGULATION_OF_T_CELL_PROLIFERATION",129,-1.7112,0,0.034,"No",-0.7456,0.96,1,"No"
"2359","KEGG_compound","C02336_BETA_D_FRUCTOSE_BETA_FRUIT_SUGAR_BETA_D_ARABINO_HEXULOSE_BETA_LEVULOSE_FRUCTOSE",8,-1.7109,0.0081,0.038,"No",-1.1401,0.29,0.86,"No"
"2360","C2_Chemical_and_genetic_perturbations","C2_CGP_3360_ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE",61,-1.7108,0,0.016,"No",0.9262,0.61,0.89,"Yes"
"2361","C2_Chemical_and_genetic_perturbations","C2_CGP_1046_WOTTON_RUNX_TARGETS_DN",28,-1.7107,0.0074,0.016,"No",-1.0473,0.39,0.97,"No"
"2362","C2_Chemical_and_genetic_perturbations","C2_CGP_1310_LEE_LIVER_CANCER_MYC_TGFA_UP",58,-1.7106,0.0027,0.016,"No",0.9375,0.58,0.88,"Yes"
"2363","C4_Cancer_modules","C4_CM_255_MODULE_289",119,-1.7106,0,0.012,"No",1.1576,0.18,0.45,"Yes"
"2364","GO_BP","488580_GO_0002707_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY",28,-1.7103,0.0028,0.034,"No",-0.6512,0.94,1,"No"
"2365","GO_BP","1039945_GO_1903391_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION",41,-1.7103,0.0042,0.034,"No",-1.3209,0.088,0.89,"No"
"2366","C2_Chemical_and_genetic_perturbations","C2_CGP_1525_ZHAN_MULTIPLE_MYELOMA_MF_UP",44,-1.7103,0.0014,0.016,"No",-0.7551,0.89,1,"No"
"2367","GO_BP","495020_GO_0010955_NEGATIVE_REGULATION_OF_PROTEIN_PROCESSING",310,-1.7103,0,0.034,"No",0.9431,0.67,1,"Yes"
"2368","REACTOME","106417_REACT_12623_GENERATION_OF_SECOND_MESSENGER_MOLECULES",30,-1.7102,0.0014,0.042,"No",1.0051,0.44,0.75,"Yes"
"2369","GO_BP","500604_GO_0031345_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION",110,-1.7102,0,0.034,"No",-0.9433,0.58,1,"No"
"2370","C2_Chemical_and_genetic_perturbations","C2_CGP_74_DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP",254,-1.7101,0,0.016,"No",1.0635,0.28,0.69,"Yes"
"2371","GO_CC","492527_GO_0008180_COP9_SIGNALOSOME",36,-1.7099,0.0029,0.054,"No",-1.109,0.29,0.76,"No"
"2372","GO_BP","498163_GO_0019318_HEXOSE_METABOLIC_PROCESS",176,-1.7099,0,0.034,"No",-0.8698,0.8,1,"No"
"2373","C2_Chemical_and_genetic_perturbations","C2_CGP_1183_MORI_MATURE_B_LYMPHOCYTE_DN",75,-1.7096,0,0.016,"No",1.4656,0.015,0.24,"Yes"
"2374","GO_BP","488952_GO_0003158_ENDOTHELIUM_DEVELOPMENT",85,-1.7095,0.0013,0.034,"No",0.819,0.86,1,"Yes"
"2375","C2_Chemical_and_genetic_perturbations","C2_CGP_1141_AMIT_EGF_RESPONSE_60_MCF10A",39,-1.7094,0.0043,0.016,"No",-1.4599,0.044,0.52,"No"
"2376","REACTOME","366166_REACT_75900_INFLAMMASOMES",17,-1.7094,0.011,0.042,"No",-0.7707,0.79,1,"No"
"2377","GO_BP","498166_GO_0019321_PENTOSE_METABOLIC_PROCESS",14,-1.7094,0.0047,0.034,"No",0.6653,0.93,1,"Yes"
"2378","C2_Chemical_and_genetic_perturbations","C2_CGP_537_NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN",13,-1.7091,0.013,0.016,"No",-1.581,0.039,0.46,"No"
"2379","GO_BP","503340_GO_0034134_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY",74,-1.7088,0,0.035,"No",-0.6088,1,1,"No"
"2380","GO_BP","501918_GO_0032692_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION",11,-1.7087,0.0048,0.035,"No",-1.5255,0.043,0.77,"No"
"2381","C2_Chemical_and_genetic_perturbations","C2_CGP_2559_ROSS_LEUKEMIA_WITH_MLL_FUSIONS",78,-1.7085,0.0013,0.017,"No",1.2746,0.09,0.42,"Yes"
"2382","GO_MF","496677_GO_0016765_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS",51,-1.7085,0.0013,0.068,"No",-1.1414,0.24,0.81,"No"
"2383","GO_BP","515457_GO_0070527_PLATELET_AGGREGATION",39,-1.7082,0.0042,0.035,"No",1.5943,0.013,0.3,"Yes"
"2384","GO_BP","517431_GO_0072526_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",46,-1.7082,0.0041,0.035,"No",-0.8818,0.65,1,"No"
"2385","C4_Cancer_gene_neighborhoods","C4_CGN_317_GNF2_TST",102,-1.708,0,0.0075,"No",-1.1906,0.14,0.69,"No"
"2386","C2_BioCarta_Pathways","C2_CP_BIOCARTA_156_BIOCARTA_STEM_PATHWAY",15,-1.708,0.008,0.047,"No",-1.2979,0.14,1,"No"
"2387","C2_BioCarta_Pathways","C2_CP_BIOCARTA_78_BIOCARTA_GATA3_PATHWAY",16,-1.7079,0.0094,0.046,"No",0.8113,0.71,0.97,"Yes"
"2388","C7_Immunologic_signatures","C7_ALL_791_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP",192,-1.7079,0,0.00017,"No",-0.7675,0.97,1,"No"
"2389","C7_Immunologic_signatures","C7_ALL_276_GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN",200,-1.7078,0,0.00017,"No",1.2237,0.055,0.19,"Yes"
"2390","GO_MF","506250_GO_0043178_ALCOHOL_BINDING",94,-1.7077,0.0012,0.068,"No",-1.298,0.068,0.78,"No"
"2391","C7_Immunologic_signatures","C7_ALL_844_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN",198,-1.7073,0,0.00017,"No",0.8382,0.9,1,"Yes"
"2392","GO_BP","511796_GO_0050851_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",119,-1.7073,0,0.035,"No",0.8255,0.88,1,"Yes"
"2393","REACTOME","906029_REACT_169262_LAMININ_INTERACTIONS",23,-1.7073,0.0042,0.042,"No",-0.4618,1,1,"No"
"2394","C3_TF_targets","C3_TFT_417_V_SREBP_Q3",252,-1.7071,0,0.0062,"No",-1.1932,0.11,0.36,"No"
"2395","C2_Chemical_and_genetic_perturbations","C2_CGP_1412_DORSAM_HOXA9_TARGETS_DN",32,-1.7071,0.0059,0.017,"No",-0.9253,0.6,1,"No"
"2396","GO_MF","498070_GO_0019215_INTERMEDIATE_FILAMENT_BINDING",10,-1.7071,0.0062,0.067,"No",-0.5628,0.97,1,"No"
"2397","C2_BioCarta_Pathways","C2_CP_BIOCARTA_15_BIOCARTA_ASBCELL_PATHWAY",12,-1.7071,0.0049,0.045,"No",0.6762,0.89,1,"Yes"
"2398","GO_BP","488306_GO_0002433_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS",71,-1.7071,0.0013,0.035,"No",0.6027,1,1,"Yes"
"2399","KEGG_pathway","HSA05323_RHEUMATOID_ARTHRITIS",85,-1.7068,0,0.0063,"No",-1.1122,0.25,0.68,"No"
"2400","C7_Immunologic_signatures","C7_ALL_1506_GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN",198,-1.7068,0,0.00018,"No",-0.9337,0.65,1,"No"
"2401","GO_BP","500603_GO_0031344_REGULATION_OF_CELL_PROJECTION_ORGANIZATION",419,-1.7068,0,0.035,"No",-1.1929,0.056,0.9,"No"
"2402","GO_BP","512057_GO_0051147_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION",135,-1.7066,0,0.035,"No",-0.9969,0.47,0.99,"No"
"2403","GO_BP","510715_GO_0048660_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION",80,-1.7065,0,0.035,"No",-0.9773,0.5,1,"No"
"2404","C2_Chemical_and_genetic_perturbations","C2_CGP_1529_PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP",129,-1.7065,0,0.017,"No",0.9414,0.58,0.88,"Yes"
"2405","GO_MF","490364_GO_0005096_GTPASE_ACTIVATOR_ACTIVITY",240,-1.7065,0,0.067,"No",-1.4091,0.0034,0.65,"No"
"2406","C2_Chemical_and_genetic_perturbations","C2_CGP_2605_ZHANG_TLX_TARGETS_36HR_UP",221,-1.7062,0,0.017,"No",-0.897,0.75,1,"No"
"2407","C7_Immunologic_signatures","C7_ALL_1350_GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN",198,-1.706,0,0.00018,"No",-1.3419,0.014,0.37,"No"
"2408","WikiPathways","198900_WP129_MATRIX_METALLOPROTEINASES",29,-1.7057,0.0029,0.02,"No",-0.9496,0.54,1,"No"
"2409","GO_BP","511779_GO_0050820_POSITIVE_REGULATION_OF_COAGULATION",27,-1.7056,0.0029,0.035,"No",1.0007,0.44,0.98,"Yes"
"2410","C2_Chemical_and_genetic_perturbations","C2_CGP_2309_ZHENG_GLIOBLASTOMA_PLASTICITY_UP",249,-1.7055,0,0.017,"No",0.8825,0.83,0.94,"Yes"
"2411","KEGG_compound","C00159_D_MANNOSE_MANNOSE_SEMINOSE_CARUBINOSE",13,-1.7054,0.0092,0.04,"No",-1.2846,0.17,0.65,"No"
"2412","GO_BP","506334_GO_0043268_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT",28,-1.7054,0.0044,0.035,"No",-1.6657,0.0058,0.64,"No"
"2413","GO_BP","495137_GO_0014065_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",25,-1.7053,0.0091,0.035,"No",-1.1601,0.25,0.92,"No"
"2414","KEGG_compound","C06427__9Z_12Z_15Z_OCTADECATRIENOIC_ACID_ALPHA_LINOLENIC_ACID_9_12_15_OCTADECATRIENOIC_ACID_LINOLENATE_ALPHA_LINOLENATE",23,-1.7053,0.0029,0.039,"No",-0.7382,0.84,1,"No"
"2415","GO_BP","515235_GO_0070302_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",176,-1.7048,0,0.036,"No",-1.1498,0.15,0.93,"No"
"2416","GO_BP","502722_GO_0033504_FLOOR_PLATE_DEVELOPMENT",7,-1.7048,0.0085,0.036,"No",1.1485,0.29,0.84,"Yes"
"2417","C2_Chemical_and_genetic_perturbations","C2_CGP_2897_DORN_ADENOVIRUS_INFECTION_32HR_DN",36,-1.7047,0.0029,0.017,"No",-1.5188,0.019,0.44,"No"
"2418","C2_Chemical_and_genetic_perturbations","C2_CGP_2577_HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP",162,-1.7044,0,0.017,"No",0.8336,0.88,0.98,"Yes"
"2419","C2_Chemical_and_genetic_perturbations","C2_CGP_1610_TRAYNOR_RETT_SYNDROM_UP",42,-1.7043,0.0026,0.017,"No",-0.9862,0.48,1,"No"
"2420","C2_Chemical_and_genetic_perturbations","C2_CGP_542_DARWICHE_PAPILLOMA_RISK_HIGH_UP",139,-1.7043,0,0.017,"No",1.1733,0.15,0.53,"Yes"
"2421","GO_BP","514625_GO_0061077_CHAPERONE_MEDIATED_PROTEIN_FOLDING",46,-1.7042,0.0027,0.036,"No",0.8045,0.79,1,"Yes"
"2422","GO_BP","516822_GO_0071902_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",270,-1.7041,0,0.036,"No",0.7435,1,1,"Yes"
"2423","C2_Chemical_and_genetic_perturbations","C2_CGP_2007_DURCHDEWALD_SKIN_CARCINOGENESIS_DN",258,-1.7039,0,0.017,"No",0.7296,1,1,"Yes"
"2424","KEGG_compound","C05580_3_4_DIHYDROXYMANDELATE_3_4_DIHYDROXYMANDELIC_ACID_DIHYDROXYMANDELIC_ACID",5,-1.7038,0.0035,0.04,"No",0.7882,0.72,1,"Yes"
"2425","GO_BP","490998_GO_0006012_GALACTOSE_METABOLIC_PROCESS",14,-1.7038,0.0094,0.036,"No",-1.4536,0.065,0.9,"No"
"2426","C2_Chemical_and_genetic_perturbations","C2_CGP_1691_VARELA_ZMPSTE24_TARGETS_DN",37,-1.7032,0.0057,0.017,"No",-0.8573,0.7,1,"No"
"2427","C2_Chemical_and_genetic_perturbations","C2_CGP_1530_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP",179,-1.7031,0,0.017,"No",1.2041,0.1,0.49,"Yes"
"2428","C2_Chemical_and_genetic_perturbations","C2_CGP_1939_LY_AGING_MIDDLE_DN",16,-1.7029,0.0082,0.017,"No",-1.2097,0.19,0.79,"No"
"2429","GO_BP","508180_GO_0045861_NEGATIVE_REGULATION_OF_PROTEOLYSIS",295,-1.7028,0,0.036,"No",0.937,0.68,1,"Yes"
"2430","REACTOME","905996_REACT_169168_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP_",104,-1.7026,0,0.044,"No",-1.4224,0.016,0.5,"No"
"2431","GO_BP","505470_GO_0042326_NEGATIVE_REGULATION_OF_PHOSPHORYLATION",353,-1.7026,0,0.036,"No",0.9287,0.73,1,"Yes"
"2432","KEGG_pathway","HSA04070_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM",81,-1.7025,0,0.0064,"No",-1.4784,0.015,0.48,"No"
"2433","GO_BP","495942_GO_0015812_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT",8,-1.7023,0.01,0.036,"No",-0.9108,0.58,1,"No"
"2434","GO_MF","490470_GO_0005229_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY",14,-1.7019,0.016,0.069,"No",1.3198,0.14,0.57,"Yes"
"2435","GO_BP","508233_GO_0045926_NEGATIVE_REGULATION_OF_GROWTH",216,-1.7017,0,0.037,"No",-1.3257,0.019,0.89,"No"
"2436","C4_Cancer_gene_neighborhoods","C4_CGN_359_GNF2_HPN",129,-1.7016,0,0.0082,"No",-1.169,0.15,0.68,"No"
"2437","GO_BP","488099_GO_0002224_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",123,-1.7016,0,0.036,"No",-0.7007,0.99,1,"No"
"2438","C2_Chemical_and_genetic_perturbations","C2_CGP_2468_BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN",40,-1.7016,0.0028,0.018,"No",-0.7207,0.91,1,"No"
"2439","GO_BP","508722_GO_0046461_NEUTRAL_LIPID_CATABOLIC_PROCESS",24,-1.7016,0.0093,0.036,"No",1.1212,0.28,0.88,"Yes"
"2440","GO_BP","491560_GO_0006672_CERAMIDE_METABOLIC_PROCESS",61,-1.7015,0.0026,0.036,"No",-0.811,0.83,1,"No"
"2441","GO_BP","502379_GO_0033158_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION",17,-1.7015,0.0078,0.036,"No",-0.9776,0.5,1,"No"
"2442","GO_BP","488794_GO_0002921_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE",12,-1.7015,0.0093,0.036,"No",-0.8534,0.64,1,"No"
"2443","WikiPathways","672458_WP2261_SIGNALING_PATHWAYS_IN_GLIOBLASTOMA",80,-1.7014,0.0013,0.02,"No",-1.1443,0.23,0.93,"No"
"2444","GO_BP","517292_GO_0072376_PROTEIN_ACTIVATION_CASCADE",64,-1.7014,0.0013,0.036,"No",1.0871,0.29,0.92,"Yes"
"2445","C2_Chemical_and_genetic_perturbations","C2_CGP_281_LEE_NEURAL_CREST_STEM_CELL_UP",142,-1.7013,0,0.018,"No",0.955,0.56,0.86,"Yes"
"2446","C2_Chemical_and_genetic_perturbations","C2_CGP_197_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP",78,-1.7011,0.0026,0.018,"No",-0.725,0.96,1,"No"
"2447","GO_BP","489002_GO_0003208_CARDIAC_VENTRICLE_MORPHOGENESIS",62,-1.701,0.0013,0.036,"No",0.8552,0.75,1,"Yes"
"2448","C2_Chemical_and_genetic_perturbations","C2_CGP_2629_SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE",67,-1.7009,0,0.018,"No",-0.7043,0.95,1,"No"
"2449","C7_Immunologic_signatures","C7_ALL_277_GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP",199,-1.7008,0,0.00021,"No",-0.8297,0.9,1,"No"
"2450","C2_Chemical_and_genetic_perturbations","C2_CGP_3250_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3",19,-1.7008,0.0044,0.018,"No",-1.3111,0.15,0.68,"No"
"2451","GO_BP","492863_GO_0008610_LIPID_BIOSYNTHETIC_PROCESS",491,-1.7007,0,0.037,"No",-0.7818,1,1,"No"
"2452","GO_CC","911483_GO_1902495_TRANSMEMBRANE_TRANSPORTER_COMPLEX",301,-1.7007,0,0.058,"No",-1.5937,0,0.45,"No"
"2453","GO_BP","1184588_GO_1904064_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT",55,-1.7006,0.0055,0.037,"No",-1.2303,0.15,0.89,"No"
"2454","GO_BP","507589_GO_0045216_CELL_CELL_JUNCTION_ORGANIZATION",162,-1.7004,0,0.037,"No",-1.3016,0.046,0.89,"No"
"2455","C3_MicroRNA_targets","C3_MIR_116_ATGAAGG_MIR_205",157,-1.7004,0,0.13,"No",-0.9831,0.49,1,"No"
"2456","GO_BP","508927_GO_0046697_DECIDUALIZATION",17,-1.7004,0.015,0.037,"No",-1.692,0.017,0.59,"No"
"2457","C4_Cancer_modules","C4_CM_229_MODULE_253",21,-1.7003,0.0016,0.013,"No",-1.1544,0.27,0.64,"No"
"2458","KEGG_compound","C05584_3_METHOXY_4_HYDROXYMANDELATE_VANILLYLMANDELIC_ACID",5,-1.7,0,0.041,"No",0.7891,0.73,1,"Yes"
"2459","GO_BP","505579_GO_0042439_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",80,-1.6999,0,0.037,"No",-0.9614,0.54,1,"No"
"2460","C2_Chemical_and_genetic_perturbations","C2_CGP_151_ROY_WOUND_BLOOD_VESSEL_UP",49,-1.6997,0.0028,0.018,"No",0.9705,0.5,0.83,"Yes"
"2461","GO_BP","508238_GO_0045931_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE",106,-1.6996,0,0.037,"No",-0.7868,0.89,1,"No"
"2462","C2_Chemical_and_genetic_perturbations","C2_CGP_3274_PLASARI_TGFB1_TARGETS_1HR_UP",34,-1.6996,0,0.018,"No",-2.2407,0,0.0054,"No"
"2463","REACTOME","160135_REACT_21308_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE",56,-1.6995,0.0039,0.045,"No",-1.0308,0.38,0.97,"No"
"2464","GO_BP","487786_GO_0001890_PLACENTA_DEVELOPMENT",144,-1.6994,0,0.037,"No",-1.1182,0.2,0.94,"No"
"2465","C2_Chemical_and_genetic_perturbations","C2_CGP_2299_IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP",125,-1.6994,0,0.018,"No",0.8001,0.92,0.99,"Yes"
"2466","C2_Chemical_and_genetic_perturbations","C2_CGP_3202_FARDIN_HYPOXIA_11",32,-1.6992,0.0028,0.018,"No",0.6418,0.95,1,"Yes"
"2467","GO_BP","498216_GO_0019373_EPOXYGENASE_P450_PATHWAY",19,-1.6987,0.009,0.037,"No",-1.7141,0.011,0.74,"No"
"2468","C2_Chemical_and_genetic_perturbations","C2_CGP_1848_ZHU_CMV_ALL_DN",126,-1.6986,0,0.018,"No",0.8147,0.9,0.98,"Yes"
"2469","C3_TF_targets","C3_TFT_443_V_NRF2_Q4",249,-1.6986,0,0.0067,"No",-1.1708,0.12,0.41,"No"
"2470","KEGG_pathway","HSA04919_THYROID_HORMONE_SIGNALING_PATHWAY",118,-1.6985,0,0.0067,"No",-1.4036,0.021,0.38,"No"
"2471","C2_Chemical_and_genetic_perturbations","C2_CGP_792_SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP",68,-1.6984,0.0025,0.018,"No",1.6302,0.0065,0.12,"Yes"
"2472","REACTOME","771579_REACT_160086_REGULATION_OF_ACTIN_DYNAMICS_FOR_PHAGOCYTIC_CUP_FORMATION",59,-1.6983,0.0013,0.045,"No",0.6347,0.99,1,"Yes"
"2473","C7_Immunologic_signatures","C7_ALL_419_GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP",198,-1.6977,0,0.00022,"No",1.6423,0,0.0014,"Yes"
"2474","GO_MF","496561_GO_0016620_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",29,-1.6975,0.0044,0.072,"No",-0.9082,0.63,0.98,"No"
"2475","GO_BP","507798_GO_0045444_FAT_CELL_DIFFERENTIATION",93,-1.6972,0.0013,0.038,"No",-0.899,0.68,1,"No"
"2476","OMIM_gene","OMIM188370_THYMOCYTE_ANTIGEN_CD1A_CD1A",5,-1.697,0.0018,0.33,"No",-1.4344,0.082,0.66,"No"
"2477","C6_Oncogenic_signatures","C6_ALL_183_KRAS_LUNG_UP_V1_UP",130,-1.6968,0.0012,0.0024,"No",-1.0668,0.33,0.6,"No"
"2478","GO_CC","505607_GO_0042470_MELANOSOME",103,-1.6968,0,0.059,"No",0.9636,0.53,0.82,"Yes"
"2479","GO_BP","499475_GO_0030007_CELLULAR_POTASSIUM_ION_HOMEOSTASIS",9,-1.6967,0.0081,0.038,"No",-1.4585,0.079,0.88,"No"
"2480","REACTOME","645336_REACT_121025_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE",33,-1.6967,0.0058,0.045,"No",-0.8331,0.69,1,"No"
"2481","KEGG_compound","C01161_3_4_DIHYDROXYPHENYLACETATE_3_4_DIHYDROXYPHENYLACETIC_ACID_HOMOPROTOCATECHUATE",5,-1.6966,0.0018,0.042,"No",0.7822,0.74,1,"Yes"
"2482","C2_Chemical_and_genetic_perturbations","C2_CGP_2220_HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN",47,-1.6966,0.0043,0.018,"No",-0.9411,0.56,1,"No"
"2483","GO_BP","495154_GO_0014706_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",254,-1.6965,0,0.038,"No",-1.036,0.35,0.98,"No"
"2484","GO_BP","489321_GO_0006956_COMPLEMENT_ACTIVATION",43,-1.6964,0.0028,0.038,"No",1.0669,0.36,0.94,"Yes"
"2485","GO_BP","753044_GO_1900048_POSITIVE_REGULATION_OF_HEMOSTASIS",25,-1.6963,0.01,0.038,"No",1.0599,0.35,0.94,"Yes"
"2486","C2_Chemical_and_genetic_perturbations","C2_CGP_1711_MACLACHLAN_BRCA1_TARGETS_DN",16,-1.6961,0.0078,0.018,"No",-0.985,0.44,1,"No"
"2487","KEGG_module","HSA_M00001_GLYCOLYSIS_EMBDEN_MEYERHOF_PATHWAY_GLUCOSE_PYRUVATE",25,-1.6961,0.0061,0.094,"No",-1.2243,0.21,1,"No"
"2488","GO_BP","754343_GO_1901381_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",20,-1.6961,0.0079,0.038,"No",-1.6585,0.019,0.67,"No"
"2489","REACTOME","1183536_REACT_355047_DISEASES_OF_IMMUNE_SYSTEM",23,-1.696,0.0061,0.045,"No",-0.4777,1,1,"No"
"2490","GO_BP","500131_GO_0030833_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION",112,-1.6957,0.0012,0.038,"No",-0.8153,0.86,1,"No"
"2491","C3_MicroRNA_targets","C3_MIR_59_CTAGGAA_MIR_384",62,-1.6956,0.0013,0.087,"No",-0.9725,0.5,1,"No"
"2492","GO_BP","502890_GO_0033673_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY",213,-1.6955,0,0.038,"No",-0.7371,1,1,"No"
"2493","REACTOME","105699_REACT_13705_PHASE_1_FUNCTIONALIZATION_OF_COMPOUNDS",78,-1.6955,0.0013,0.045,"No",-1.236,0.12,0.78,"No"
"2494","C2_Chemical_and_genetic_perturbations","C2_CGP_826_MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP",172,-1.6955,0,0.018,"No",1.1133,0.2,0.61,"Yes"
"2495","GO_BP","752703_GO_0097202_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",96,-1.6955,0,0.038,"No",0.8043,0.9,1,"Yes"
"2496","GO_BP","514111_GO_0060556_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS",9,-1.6954,0.018,0.038,"No",-1.6244,0.024,0.69,"No"
"2497","GO_BP","499158_GO_0021879_FOREBRAIN_NEURON_DIFFERENTIATION",52,-1.6953,0.0027,0.038,"No",-1.3506,0.069,0.93,"No"
"2498","C2_Chemical_and_genetic_perturbations","C2_CGP_2350_BOQUEST_STEM_CELL_DN",215,-1.6952,0,0.018,"No",-1.042,0.37,0.98,"No"
"2499","C2_Chemical_and_genetic_perturbations","C2_CGP_2384_PODAR_RESPONSE_TO_ADAPHOSTIN_DN",18,-1.6952,0.011,0.018,"No",0.9845,0.45,0.81,"Yes"
"2500","GO_BP","517721_GO_0075136_RESPONSE_TO_HOST",14,-1.6951,0.0031,0.038,"No",1.0598,0.39,0.94,"Yes"
"2501","GO_BP","501508_GO_0032273_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION",76,-1.695,0,0.038,"No",-0.74,0.94,1,"No"
"2502","C3_TF_targets","C3_TFT_178_V_CHOP_01",230,-1.695,0,0.0067,"No",-0.9215,0.69,0.93,"No"
"2503","REACTOME","105650_REACT_1619_DEATH_RECEPTOR_SIGNALLING",21,-1.695,0.01,0.045,"No",-0.9364,0.53,1,"No"
"2504","GO_BP","501887_GO_0032661_REGULATION_OF_INTERLEUKIN_18_PRODUCTION",5,-1.6948,0,0.038,"No",-1.5637,0.024,0.72,"No"
"2505","GO_BP","504887_GO_0035710_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",31,-1.6948,0.009,0.038,"No",-0.8686,0.67,1,"No"
"2506","GO_MF","490412_GO_0005149_INTERLEUKIN_1_RECEPTOR_BINDING",16,-1.6947,0.011,0.074,"No",-1.5255,0.038,0.53,"No"
"2507","C2_Chemical_and_genetic_perturbations","C2_CGP_745_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",37,-1.6946,0.0056,0.018,"No",-0.9134,0.59,1,"No"
"2508","KEGG_reaction","R07001_NAPHTHALENE_NADPH_OXYGEN_OXIDOREDUCTASE_RH_HYDROXYLATING_OR_EPOXIDIZING_NAPHTHALENE_NADPH_OXYGEN_H_1S_2R_NAPHTHALENE_1_2_OXIDE_NADP_H2O",7,-1.6945,0.0069,0.032,"No",-1.3523,0.15,0.34,"No"
"2509","C3_TF_targets","C3_TFT_131_V_SRF_Q6",234,-1.6944,0,0.0065,"No",-0.8941,0.77,0.97,"No"
"2510","C2_Chemical_and_genetic_perturbations","C2_CGP_832_BORLAK_LIVER_CANCER_EGF_UP",54,-1.6944,0.0013,0.018,"No",-0.8534,0.74,1,"No"
"2511","GO_BP","489317_GO_0009615_RESPONSE_TO_VIRUS",225,-1.6943,0,0.038,"No",1.4041,0.0067,0.55,"Yes"
"2512","C2_Chemical_and_genetic_perturbations","C2_CGP_3094_PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP",131,-1.6943,0,0.018,"No",0.964,0.53,0.85,"Yes"
"2513","GO_BP","500899_GO_0031650_REGULATION_OF_HEAT_GENERATION",13,-1.6941,0.013,0.038,"No",-1.0423,0.39,0.98,"No"
"2514","GO_BP","488700_GO_0002827_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE",12,-1.6941,0.014,0.038,"No",-1.4022,0.096,0.99,"No"
"2515","GO_BP","488548_GO_0002675_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE",25,-1.6938,0.013,0.038,"No",-1.4339,0.06,0.92,"No"
"2516","C7_Immunologic_signatures","C7_ALL_1528_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN",200,-1.6938,0,0.00024,"No",0.935,0.64,0.94,"Yes"
"2517","GO_MF","496396_GO_0016408_C_ACYLTRANSFERASE_ACTIVITY",14,-1.6937,0.0063,0.074,"No",-0.7588,0.82,1,"No"
"2518","GO_BP","491870_GO_0007043_CELL_CELL_JUNCTION_ASSEMBLY",75,-1.6937,0,0.038,"No",-1.2255,0.12,0.88,"No"
"2519","GO_MF","487582_GO_0001671_ATPASE_ACTIVATOR_ACTIVITY",14,-1.6936,0.0066,0.073,"No",-1.2397,0.2,0.84,"No"
"2520","GO_BP","491472_GO_0006576_CELLULAR_BIOGENIC_AMINE_METABOLIC_PROCESS",142,-1.6936,0,0.038,"No",-1.0901,0.27,0.95,"No"
"2521","GO_MF","495439_GO_0015166_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",11,-1.6936,0.008,0.072,"No",-1.2102,0.24,0.81,"No"
"2522","GO_BP","994747_GO_0036465_SYNAPTIC_VESICLE_RECYCLING",30,-1.6935,0.0042,0.038,"No",-1.2855,0.12,0.89,"No"
"2523","C3_TF_targets","C3_TFT_580_TTCNRGNNNNTTC_V_HSF_Q6",148,-1.6934,0.0012,0.0065,"No",-1.0054,0.44,0.74,"No"
"2524","C7_Immunologic_signatures","C7_ALL_876_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN",199,-1.6934,0,0.00025,"No",0.809,0.93,1,"Yes"
"2525","C2_Chemical_and_genetic_perturbations","C2_CGP_1892_ZHU_CMV_24_HR_UP",93,-1.6934,0,0.018,"No",0.9328,0.61,0.89,"Yes"
"2526","GO_CC","516361_GO_0071437_INVADOPODIUM",10,-1.6932,0.0065,0.06,"No",-1.1391,0.3,0.72,"No"
"2527","GO_BP","518169_GO_0090022_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS",22,-1.6931,0.0074,0.038,"No",0.7145,0.88,1,"Yes"
"2528","GO_BP","514266_GO_0060711_LABYRINTHINE_LAYER_DEVELOPMENT",48,-1.6931,0.0014,0.038,"No",-1.2124,0.18,0.88,"No"
"2529","C2_Chemical_and_genetic_perturbations","C2_CGP_2772_MIKKELSEN_MEF_LCP_WITH_H3K4ME3",127,-1.693,0,0.019,"No",-0.944,0.61,1,"No"
"2530","C2_Chemical_and_genetic_perturbations","C2_CGP_1265_ROSS_AML_WITH_PML_RARA_FUSION",76,-1.693,0.0013,0.018,"No",-1.0259,0.39,0.98,"No"
"2531","C7_Immunologic_signatures","C7_ALL_1355_GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP",199,-1.693,0,0.00025,"No",-0.6472,1,1,"No"
"2532","GO_MF","513648_GO_0060090_BINDING_BRIDGING",153,-1.6929,0,0.072,"No",0.9903,0.48,0.88,"Yes"
"2533","GO_CC","510821_GO_0048770_PIGMENT_GRANULE",104,-1.6929,0.0013,0.059,"No",0.9903,0.5,0.8,"Yes"
"2534","GO_BP","512653_GO_0051781_POSITIVE_REGULATION_OF_CELL_DIVISION",116,-1.6928,0.0024,0.038,"No",0.8954,0.67,1,"Yes"
"2535","GO_BP","508462_GO_0046164_ALCOHOL_CATABOLIC_PROCESS",52,-1.6927,0,0.038,"No",-0.7169,0.93,1,"No"
"2536","GO_BP","509004_GO_0046777_PROTEIN_AUTOPHOSPHORYLATION",187,-1.6927,0,0.038,"No",-1.3513,0.024,0.94,"No"
"2537","GO_BP","511797_GO_0050853_B_CELL_RECEPTOR_SIGNALING_PATHWAY",34,-1.6925,0.0014,0.038,"No",-0.9338,0.58,1,"No"
"2538","GO_BP","1022096_GO_0098659_INORGANIC_CATION_IMPORT_INTO_CELL",12,-1.6924,0.0051,0.038,"No",-1.2281,0.21,0.88,"No"
"2539","C2_Chemical_and_genetic_perturbations","C2_CGP_3174_WANG_NFKB_TARGETS",25,-1.6924,0.0015,0.019,"No",-1.0235,0.42,0.98,"No"
"2540","GO_BP","510173_GO_0048003_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB",7,-1.6923,0.017,0.038,"No",-1.3304,0.15,0.9,"No"
"2541","GO_BP","752201_GO_0061458_REPRODUCTIVE_SYSTEM_DEVELOPMENT",395,-1.6922,0,0.038,"No",-0.9201,0.73,1,"No"
"2542","C2_Chemical_and_genetic_perturbations","C2_CGP_1767_VERRECCHIA_RESPONSE_TO_TGFB1_C2",25,-1.6922,0.0045,0.019,"No",-1.0714,0.35,0.95,"No"
"2543","C7_Immunologic_signatures","C7_ALL_744_GSE17721_0_5H_VS_4H_CPG_BMDM_DN",200,-1.6918,0,0.00025,"No",0.8152,0.94,1,"Yes"
"2544","GO_BP","492272_GO_0007519_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",114,-1.6917,0.0024,0.038,"No",-1.1098,0.25,0.94,"No"
"2545","C7_Immunologic_signatures","C7_ALL_1786_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN",198,-1.6915,0,0.00025,"No",-0.7605,0.98,1,"No"
"2546","C6_Oncogenic_signatures","C6_ALL_174_KRAS_600_UP_V1_DN",260,-1.6914,0,0.0025,"No",-1.3983,0,0.38,"No"
"2547","GO_BP","508223_GO_0045916_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION",10,-1.6913,0.011,0.039,"No",0.5098,0.99,1,"Yes"
"2548","GO_BP","491967_GO_0007162_NEGATIVE_REGULATION_OF_CELL_ADHESION",189,-1.6912,0,0.038,"No",-1.0486,0.36,0.97,"No"
"2549","GO_BP","510631_GO_0048566_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT",34,-1.6911,0.0043,0.038,"No",1.0157,0.46,0.97,"Yes"
"2550","KEGG_pathway","HSA04014_RAS_SIGNALING_PATHWAY",212,-1.6909,0,0.0073,"No",-0.877,0.81,0.99,"No"
"2551","GO_BP","513043_GO_0052200_RESPONSE_TO_HOST_DEFENSES",14,-1.6907,0.014,0.039,"No",1.0764,0.35,0.93,"Yes"
"2552","C2_Chemical_and_genetic_perturbations","C2_CGP_2766_MIKKELSEN_MCV6_ICP_WITH_H3K27ME3",70,-1.6907,0,0.019,"No",-1.4462,0.023,0.53,"No"
"2553","GO_BP","508594_GO_0046330_POSITIVE_REGULATION_OF_JNK_CASCADE",104,-1.6905,0.0013,0.039,"No",-1.4498,0.017,0.9,"No"
"2554","GO_BP","752385_GO_0086013_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",9,-1.6905,0.012,0.039,"No",-1.1676,0.27,0.91,"No"
"2555","REACTOME","106516_REACT_13477_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES",206,-1.6903,0,0.047,"No",-1.5995,0,0.34,"No"
"2556","GO_BP","514261_GO_0060706_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT",23,-1.6903,0.0031,0.039,"No",-1.2726,0.17,0.89,"No"
"2557","GO_BP","754916_GO_2000810_REGULATION_OF_TIGHT_JUNCTION_ASSEMBLY",9,-1.6903,0.0099,0.039,"No",-1.1114,0.32,0.94,"No"
"2558","GO_BP","753173_GO_1900180_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS",166,-1.6902,0,0.039,"No",-1.0364,0.37,0.98,"No"
"2559","GO_BP","504753_GO_0035574_HISTONE_H4_K20_DEMETHYLATION",15,-1.6902,0.013,0.039,"No",-1.6059,0.031,0.71,"No"
"2560","GO_BP","495024_GO_0010959_REGULATION_OF_METAL_ION_TRANSPORT",277,-1.6902,0,0.039,"No",-1.2305,0.052,0.89,"No"
"2561","C3_TF_targets","C3_TFT_442_V_SRF_Q4",216,-1.6901,0,0.0065,"No",-1.0078,0.43,0.75,"No"
"2562","C7_Immunologic_signatures","C7_ALL_566_GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_DN",195,-1.6901,0,0.00026,"No",-1.0624,0.32,1,"No"
"2563","KEGG_pathway","HSA05161_HEPATITIS_B",142,-1.6897,0,0.0072,"No",-0.8998,0.71,0.97,"No"
"2564","C2_Chemical_and_genetic_perturbations","C2_CGP_1660_HARRIS_HYPOXIA",79,-1.6895,0.0025,0.019,"No",-0.9952,0.44,1,"No"
"2565","WikiPathways","920993_WP585_INTERFERON_TYPE_I",49,-1.6895,0.0042,0.023,"No",0.6454,0.99,1,"Yes"
"2566","C7_Immunologic_signatures","C7_ALL_715_GSE17721_12H_VS_24H_LPS_BMDM_UP",199,-1.6893,0,0.00026,"No",-0.6219,1,1,"No"
"2567","REACTOME","161070_REACT_20506_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS",18,-1.6892,0.0089,0.047,"No",-1.0863,0.33,0.9,"No"
"2568","C7_Immunologic_signatures","C7_ALL_1120_GSE2706_UNSTIM_VS_8H_LPS_DC_DN",196,-1.6892,0,0.00026,"No",-0.7347,0.99,1,"No"
"2569","GO_BP","488613_GO_0002740_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION_INVOLVED_IN_IMMUNE_RESPONSE",6,-1.6891,0,0.039,"No",-1.1028,0.33,0.94,"No"
"2570","WikiPathways","198824_WP100_GLUTATHIONE_METABOLISM",19,-1.689,0.0095,0.022,"No",-1.0141,0.44,1,"No"
"2571","REACTOME","645310_REACT_120800_DERMATAN_SULFATE_BIOSYNTHESIS",10,-1.6889,0.018,0.046,"No",-1.2387,0.2,0.78,"No"
"2572","GO_CC","506263_GO_0043195_TERMINAL_BOUTON",41,-1.6888,0.0043,0.061,"No",-0.968,0.49,0.89,"No"
"2573","KEGG_pathway","HSA04320_DORSO_VENTRAL_AXIS_FORMATION",26,-1.6888,0.0029,0.0072,"No",-1.1322,0.27,0.64,"No"
"2574","GO_BP","508135_GO_0045806_NEGATIVE_REGULATION_OF_ENDOCYTOSIS",38,-1.6886,0.0042,0.039,"No",0.7435,0.88,1,"Yes"
"2575","GO_BP","492043_GO_0007264_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION",425,-1.6885,0,0.039,"No",-0.9923,0.48,1,"No"
"2576","GO_BP","512366_GO_0051488_ACTIVATION_OF_ANAPHASE_PROMOTING_COMPLEX_ACTIVITY",7,-1.6884,0.0086,0.039,"No",-1.5043,0.06,0.82,"No"
"2577","GO_CC","506271_GO_0043203_AXON_HILLOCK",7,-1.6883,0.0082,0.06,"No",-1.3017,0.18,0.65,"No"
"2578","GO_BP","516371_GO_0071447_CELLULAR_RESPONSE_TO_HYDROPEROXIDE",6,-1.6883,0.009,0.039,"No",-1.0827,0.37,0.96,"No"
"2579","GO_BP","505175_GO_0040017_POSITIVE_REGULATION_OF_LOCOMOTION",334,-1.6881,0,0.039,"No",1.1148,0.16,0.88,"Yes"
"2580","KEGG_compound","C01172_BETA_D_GLUCOSE_6_PHOSPHATE",9,-1.6881,0.0099,0.045,"No",-1.1053,0.34,0.93,"No"
"2581","GO_BP","494731_GO_0010668_ECTODERMAL_CELL_DIFFERENTIATION",5,-1.6881,0.0053,0.039,"No",-1.3084,0.16,0.88,"No"
"2582","C7_Immunologic_signatures","C7_ALL_915_GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP",199,-1.688,0,0.00026,"No",0.9514,0.61,0.89,"Yes"
"2583","GO_BP","487802_GO_0001911_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY",11,-1.6878,0.013,0.039,"No",0.7658,0.78,1,"Yes"
"2584","GO_MF","506303_GO_0043236_LAMININ_BINDING",27,-1.6878,0.0044,0.076,"No",0.7329,0.88,1,"Yes"
"2585","GO_BP","518755_GO_2000106_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS",81,-1.6876,0,0.039,"No",0.726,0.97,1,"Yes"
"2586","GO_BP","496218_GO_0016125_STEROL_METABOLIC_PROCESS",119,-1.6874,0,0.039,"No",-0.7203,0.98,1,"No"
"2587","GO_BP","505029_GO_0035860_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY",5,-1.6874,0.01,0.039,"No",-1.5805,0.029,0.72,"No"
"2588","KEGG_pathway","HSA00140_STEROID_HORMONE_BIOSYNTHESIS",57,-1.6874,0.0053,0.0072,"No",1.6647,0.0043,0.038,"Yes"
"2589","GO_BP","491618_GO_0006733_OXIDOREDUCTION_COENZYME_METABOLIC_PROCESS",109,-1.6873,0,0.039,"No",0.8093,0.9,1,"Yes"
"2590","GO_BP","512773_GO_0051923_SULFATION",15,-1.6873,0.0063,0.039,"No",1.0293,0.4,0.97,"Yes"
"2591","C2_Chemical_and_genetic_perturbations","C2_CGP_1069_SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN",414,-1.6872,0,0.019,"No",-1.1997,0.054,0.79,"No"
"2592","C2_Chemical_and_genetic_perturbations","C2_CGP_1061_FRIDMAN_SENESCENCE_UP",76,-1.6871,0.0013,0.019,"No",-0.8666,0.73,1,"No"
"2593","GO_BP","499635_GO_0030225_MACROPHAGE_DIFFERENTIATION",17,-1.687,0.0078,0.039,"No",-0.7397,0.83,1,"No"
"2594","C2_Chemical_and_genetic_perturbations","C2_CGP_3156_ISSAEVA_MLL2_TARGETS",59,-1.687,0.0027,0.019,"No",0.7245,0.93,1,"Yes"
"2595","GO_BP","487804_GO_0001913_T_CELL_MEDIATED_CYTOTOXICITY",9,-1.687,0.0035,0.039,"No",-0.6346,0.93,1,"No"
"2596","GO_BP","503513_GO_0034310_PRIMARY_ALCOHOL_CATABOLIC_PROCESS",9,-1.687,0.0097,0.039,"No",1.2679,0.19,0.71,"Yes"
"2597","C2_Chemical_and_genetic_perturbations","C2_CGP_1568_RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN",28,-1.6868,0.0015,0.019,"No",-1.6022,0.02,0.41,"No"
"2598","GO_BP","488810_GO_0003012_MUSCLE_SYSTEM_PROCESS",253,-1.6862,0,0.039,"No",-1.3389,0.007,0.9,"No"
"2599","KEGG_compound","C03205_11_DEOXYCORTICOSTERONE_DEOXYCORTICOSTERONE_CORTEXONE_21_HYDROXY_4_PREGNENE_3_20_DIONE_DESOXYCORTONE_DOC",8,-1.6861,0.0066,0.045,"No",0.9143,0.56,1,"Yes"
"2600","GO_BP","510667_GO_0048608_REPRODUCTIVE_STRUCTURE_DEVELOPMENT",391,-1.6861,0,0.039,"No",-0.891,0.82,1,"No"
"2601","C4_Cancer_gene_neighborhoods","C4_CGN_373_GNF2_MAPT",40,-1.686,0.007,0.0095,"No",-1.3507,0.085,0.51,"No"
"2602","GO_BP","508155_GO_0045834_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS",104,-1.686,0,0.039,"No",-0.9853,0.48,1,"No"
"2603","GO_BP","505648_GO_0042517_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",29,-1.6859,0.0087,0.039,"No",-1.6888,0.0075,0.58,"No"
"2604","KEGG_pathway","HSA04630_JAK_STAT_SIGNALING_PATHWAY",148,-1.6857,0,0.0072,"No",-1.3119,0.026,0.39,"No"
"2605","REACTOME","106146_REACT_11041_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL",24,-1.6857,0.011,0.047,"No",1.1547,0.25,0.5,"Yes"
"2606","GO_BP","493824_GO_0009712_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS",44,-1.6856,0.0028,0.039,"No",-0.953,0.53,1,"No"
"2607","GO_BP","516201_GO_0071277_CELLULAR_RESPONSE_TO_CALCIUM_ION",37,-1.6856,0.0042,0.039,"No",-0.7186,0.91,1,"No"
"2608","REACTOME","106415_REACT_12582_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS",18,-1.6855,0.0095,0.047,"No",1.1422,0.26,0.52,"Yes"
"2609","WikiPathways","198847_WP399_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY",101,-1.6854,0.0012,0.023,"No",-1.2077,0.13,0.86,"No"
"2610","C2_Chemical_and_genetic_perturbations","C2_CGP_2073_MARSON_FOXP3_TARGETS_STIMULATED_DN",10,-1.6851,0.011,0.02,"No",-1.47,0.069,0.51,"No"
"2611","GO_BP","488585_GO_0002712_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY",43,-1.6851,0.0041,0.04,"No",-1.5764,0.014,0.74,"No"
"2612","C7_Immunologic_signatures","C7_ALL_681_GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_UP",195,-1.6851,0,0.00027,"No",-0.7635,0.98,1,"No"
"2613","C6_Oncogenic_signatures","C6_ALL_171_KRAS_300_UP_V1_UP",133,-1.6851,0,0.0025,"No",-0.863,0.77,0.96,"No"
"2614","GO_MF","510193_GO_0048029_MONOSACCHARIDE_BINDING",64,-1.685,0.004,0.077,"No",-0.832,0.77,1,"No"
"2615","GO_MF","490178_GO_0004879_LIGAND_ACTIVATED_SEQUENCE_SPECIFIC_DNA_BINDING_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY",48,-1.6849,0.0027,0.076,"No",-1.056,0.35,0.87,"No"
"2616","GO_BP","495015_GO_0010950_POSITIVE_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY",139,-1.6849,0,0.04,"No",0.9313,0.66,1,"Yes"
"2617","C4_Cancer_modules","C4_CM_276_MODULE_316",69,-1.6849,0.0013,0.015,"No",-1.5148,0.0076,0.35,"No"
"2618","C2_Chemical_and_genetic_perturbations","C2_CGP_2752_MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP",12,-1.6848,0.0083,0.02,"No",-0.5996,0.95,1,"No"
"2619","GO_BP","499961_GO_0030656_REGULATION_OF_VITAMIN_METABOLIC_PROCESS",11,-1.6848,0.0066,0.04,"No",-1.6006,0.025,0.69,"No"
"2620","C2_Chemical_and_genetic_perturbations","C2_CGP_3384_ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF",46,-1.6847,0.0055,0.02,"No",-1.5077,0.015,0.45,"No"
"2621","GO_BP","500102_GO_0030803_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",38,-1.6846,0,0.04,"No",0.9885,0.47,0.99,"Yes"
"2622","REACTOME","730332_REACT_150352_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL",11,-1.6845,0.013,0.047,"No",-1.4399,0.072,0.51,"No"
"2623","C7_Immunologic_signatures","C7_ALL_1494_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN",197,-1.6844,0,0.00027,"No",-1.2245,0.067,0.75,"No"
"2624","C2_Chemical_and_genetic_perturbations","C2_CGP_316_ELVIDGE_HIF1A_TARGETS_DN",91,-1.6842,0.0012,0.02,"No",-0.7966,0.9,1,"No"
"2625","WikiPathways","198826_WP304_KIT_RECEPTOR_SIGNALING_PATHWAY",66,-1.6841,0.0013,0.022,"No",-0.8033,0.84,1,"No"
"2626","C4_Cancer_gene_neighborhoods","C4_CGN_411_GNF2_SPRR1B",17,-1.6839,0.0078,0.0097,"No",-1.0424,0.39,0.82,"No"
"2627","REACTOME","106401_REACT_6809_MYD88_INDEPENDENT_TLR3_TLR4_CASCADE",100,-1.6839,0.0013,0.047,"No",-0.7586,0.93,1,"No"
"2628","C2_Chemical_and_genetic_perturbations","C2_CGP_2553_SCHRAETS_MLL_TARGETS_DN",33,-1.6838,0.0099,0.02,"No",1.547,0.032,0.17,"Yes"
"2629","GO_BP","499472_GO_0030004_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS",63,-1.6836,0.0013,0.04,"No",-1.3409,0.06,0.91,"No"
"2630","C7_Immunologic_signatures","C7_ALL_852_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN",188,-1.6834,0,0.00027,"No",-1.314,0.026,0.43,"No"
"2631","GO_CC","517467_GO_0072562_BLOOD_MICROPARTICLE",111,-1.6833,0.0013,0.062,"No",1.1861,0.14,0.54,"Yes"
"2632","GO_BP","490984_GO_0005996_MONOSACCHARIDE_METABOLIC_PROCESS",242,-1.6831,0,0.04,"No",0.7842,0.99,1,"Yes"
"2633","C2_Chemical_and_genetic_perturbations","C2_CGP_576_WONG_ENDOMETRIAL_CANCER_LATE",9,-1.6831,0.01,0.02,"No",-0.9615,0.51,1,"No"
"2634","C2_Chemical_and_genetic_perturbations","C2_CGP_3358_ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP",280,-1.6831,0,0.02,"No",1.0057,0.47,0.79,"Yes"
"2635","GO_MF","517257_GO_0072341_MODIFIED_AMINO_ACID_BINDING",51,-1.683,0.0053,0.077,"No",-1.2186,0.16,0.84,"No"
"2636","GO_BP","501879_GO_0032653_REGULATION_OF_INTERLEUKIN_10_PRODUCTION",39,-1.683,0.01,0.04,"No",-1.2072,0.18,0.88,"No"
"2637","C7_Immunologic_signatures","C7_ALL_1761_GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP",177,-1.6829,0,0.00027,"No",1.0978,0.22,0.45,"Yes"
"2638","C7_Immunologic_signatures","C7_ALL_1393_GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP",197,-1.6829,0,0.00027,"No",1.3285,0.017,0.078,"Yes"
"2639","C3_TF_targets","C3_TFT_455_V_SRF_Q5_01",217,-1.6828,0,0.0072,"No",-0.8775,0.8,0.99,"No"
"2640","C2_Chemical_and_genetic_perturbations","C2_CGP_2050_LEIN_OLIGODENDROCYTE_MARKERS",71,-1.6827,0.0013,0.02,"No",-1.0681,0.33,0.96,"No"
"2641","C2_Chemical_and_genetic_perturbations","C2_CGP_2927_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1",68,-1.6826,0.0027,0.02,"No",-0.9077,0.64,1,"No"
"2642","GO_BP","511745_GO_0050774_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS",9,-1.6825,0.0081,0.04,"No",-0.7562,0.79,1,"No"
"2643","GO_BP","508592_GO_0046328_REGULATION_OF_JNK_CASCADE",146,-1.6824,0,0.04,"No",-1.3017,0.043,0.89,"No"
"2644","GO_BP","496230_GO_0016137_GLYCOSIDE_METABOLIC_PROCESS",16,-1.6822,0.011,0.04,"No",-0.9962,0.46,0.99,"No"
"2645","REACTOME","106390_REACT_6788_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE",95,-1.6817,0,0.048,"No",-0.6291,1,1,"No"
"2646","C0_Hallmark","H_ALL_44_HALLMARK_BILE_ACID_METABOLISM",109,-1.6817,0,0.0017,"No",-0.9414,0.6,0.91,"No"
"2647","REACTOME","106400_REACT_6890_ACTIVATED_TLR4_SIGNALLING",114,-1.6817,0.0012,0.047,"No",-0.702,0.98,1,"No"
"2648","C7_Immunologic_signatures","C7_ALL_656_GSE17721_LPS_VS_CPG_1H_BMDM_DN",197,-1.6817,0.0011,0.00027,"No",-1.5748,0,0.024,"No"
"2649","C2_Chemical_and_genetic_perturbations","C2_CGP_2595_LEE_NAIVE_T_LYMPHOCYTE",19,-1.6817,0.011,0.02,"No",-0.7558,0.83,1,"No"
"2650","C7_Immunologic_signatures","C7_ALL_150_GSE13306_TREG_VS_TCONV_SPLEEN_DN",196,-1.6816,0,0.00027,"No",0.8581,0.87,1,"Yes"
"2651","C2_Chemical_and_genetic_perturbations","C2_CGP_2709_BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN",50,-1.6814,0.004,0.02,"No",0.8852,0.68,0.94,"Yes"
"2652","C4_Cancer_modules","C4_CM_80_MODULE_85",51,-1.6814,0.0054,0.016,"No",-0.8677,0.7,0.93,"No"
"2653","KEGG_pathway","HSA04730_LONG_TERM_DEPRESSION",60,-1.6813,0,0.0075,"No",-0.7887,0.87,1,"No"
"2654","C4_Cancer_gene_neighborhoods","C4_CGN_339_GNF2_CEBPA",64,-1.6813,0.0038,0.0098,"No",-1.1601,0.19,0.65,"No"
"2655","GO_BP","491679_GO_0006809_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",14,-1.6813,0.02,0.041,"No",-1.3118,0.14,0.87,"No"
"2656","REACTOME","106402_REACT_7980_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE",95,-1.6812,0,0.047,"No",-0.6375,0.99,1,"No"
"2657","GO_BP","517246_GO_0072330_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS",166,-1.681,0,0.041,"No",1.0526,0.31,0.95,"Yes"
"2658","C4_Cancer_modules","C4_CM_161_MODULE_171",133,-1.6809,0,0.016,"No",1.6363,0.0023,0.065,"Yes"
"2659","GO_BP","518765_GO_2000116_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",216,-1.6807,0,0.041,"No",0.9336,0.66,1,"Yes"
"2660","GO_BP","513011_GO_0052166_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE",6,-1.6807,0.0052,0.041,"No",0.7939,0.73,1,"Yes"
"2661","GO_BP","510559_GO_0048485_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT",22,-1.6807,0.0077,0.041,"No",-1.1419,0.29,0.93,"No"
"2662","GO_BP","513151_GO_0052308_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_MODULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6807,0.012,0.041,"No",0.7961,0.72,1,"Yes"
"2663","GO_BP","488156_GO_0002283_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",11,-1.6806,0.0063,0.041,"No",1.1622,0.27,0.82,"Yes"
"2664","C7_Immunologic_signatures","C7_ALL_1543_GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.6806,0,0.00027,"No",1.0164,0.39,0.69,"Yes"
"2665","GO_BP","516726_GO_0071803_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY",7,-1.6804,0.012,0.041,"No",-1.1784,0.27,0.91,"No"
"2666","C2_Chemical_and_genetic_perturbations","C2_CGP_2614_HAN_SATB1_TARGETS_DN",440,-1.68,0,0.021,"No",0.8632,0.95,0.96,"Yes"
"2667","C7_Immunologic_signatures","C7_ALL_903_GSE20715_0H_VS_6H_OZONE_LUNG_UP",200,-1.68,0,0.00027,"No",0.7712,0.98,1,"Yes"
"2668","GO_BP","510181_GO_0048013_EPHRIN_RECEPTOR_SIGNALING_PATHWAY",91,-1.68,0,0.041,"No",0.9389,0.59,1,"Yes"
"2669","GO_BP","516821_GO_0071901_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",124,-1.6799,0,0.041,"No",-0.6634,1,1,"No"
"2670","GO_BP","510175_GO_0048007_ANTIGEN_PROCESSING_AND_PRESENTATION_EXOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB",7,-1.6799,0.01,0.041,"No",-1.3655,0.14,0.99,"No"
"2671","C2_Chemical_and_genetic_perturbations","C2_CGP_1952_WANG_SMARCE1_TARGETS_UP",277,-1.6799,0,0.021,"No",1.2666,0.032,0.42,"Yes"
"2672","C4_Cancer_modules","C4_CM_268_MODULE_306",26,-1.6799,0.0045,0.016,"No",1.2545,0.14,0.32,"Yes"
"2673","C2_Chemical_and_genetic_perturbations","C2_CGP_1986_WENG_POR_TARGETS_LIVER_DN",19,-1.6799,0.0093,0.021,"No",-0.8884,0.61,1,"No"
"2674","GO_BP","752000_GO_0052803_IMIDAZOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS",9,-1.6799,0.0098,0.041,"No",0.5491,0.99,1,"Yes"
"2675","C2_Chemical_and_genetic_perturbations","C2_CGP_513_HAMAI_APOPTOSIS_VIA_TRAIL_DN",175,-1.6797,0,0.021,"No",-1.0124,0.42,0.99,"No"
"2676","GO_BP","492544_GO_0008203_CHOLESTEROL_METABOLIC_PROCESS",106,-1.6796,0,0.041,"No",-0.8768,0.74,1,"No"
"2677","GO_BP","754572_GO_1901616_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS",66,-1.6794,0.0013,0.041,"No",0.9005,0.67,1,"Yes"
"2678","KEGG_compound","C00029_UDP_GLUCOSE_UDPGLUCOSE_UDP_D_GLUCOSE_URIDINE_DIPHOSPHATE_GLUCOSE_UDP_ALPHA_D_GLUCOSE",11,-1.6794,0.013,0.048,"No",-1.0439,0.4,0.99,"No"
"2679","C4_Cancer_modules","C4_CM_121_MODULE_126",181,-1.6794,0,0.016,"No",0.7234,1,1,"Yes"
"2680","C2_Chemical_and_genetic_perturbations","C2_CGP_2895_DORN_ADENOVIRUS_INFECTION_24HR_DN",41,-1.6793,0.0014,0.021,"No",-1.1884,0.19,0.81,"No"
"2681","GO_BP","488405_GO_0002532_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE",19,-1.6792,0.012,0.041,"No",1.0281,0.41,0.97,"Yes"
"2682","C2_Chemical_and_genetic_perturbations","C2_CGP_384_LANDIS_BREAST_CANCER_PROGRESSION_DN",70,-1.6791,0.0039,0.021,"No",0.89,0.69,0.94,"Yes"
"2683","C2_Chemical_and_genetic_perturbations","C2_CGP_13_PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP",203,-1.6791,0,0.021,"No",1.0678,0.29,0.68,"Yes"
"2684","C2_BioCarta_Pathways","C2_CP_BIOCARTA_49_BIOCARTA_CELLCYCLE_PATHWAY",23,-1.6791,0.0029,0.058,"No",-0.5662,0.98,1,"No"
"2685","GO_BP","508882_GO_0046634_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION",69,-1.679,0.0013,0.041,"No",-0.8499,0.75,1,"No"
"2686","GO_BP","513149_GO_0052306_MODULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6789,0.0053,0.041,"No",0.8018,0.71,1,"Yes"
"2687","GO_MF","504754_GO_0035575_HISTONE_DEMETHYLASE_ACTIVITY_H4_K20_SPECIFIC_",15,-1.6788,0.017,0.079,"No",-1.5842,0.039,0.47,"No"
"2688","GO_BP","501722_GO_0032490_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN",10,-1.6787,0.011,0.041,"No",-1.1228,0.31,0.94,"No"
"2689","GO_BP","512483_GO_0051607_DEFENSE_RESPONSE_TO_VIRUS",148,-1.6787,0,0.041,"No",1.2345,0.074,0.75,"Yes"
"2690","REACTOME","106391_REACT_6783_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE",100,-1.6787,0,0.048,"No",-0.7671,0.91,1,"No"
"2691","C2_Chemical_and_genetic_perturbations","C2_CGP_3144_KIM_GLIS2_TARGETS_UP",82,-1.6787,0.0026,0.021,"No",0.9837,0.49,0.81,"Yes"
"2692","C2_Chemical_and_genetic_perturbations","C2_CGP_2950_MOOTHA_GLYCOLYSIS",21,-1.6786,0.0076,0.021,"No",-0.9799,0.47,1,"No"
"2693","C2_Chemical_and_genetic_perturbations","C2_CGP_874_CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP",21,-1.6786,0.012,0.021,"No",-0.8805,0.62,1,"No"
"2694","C2_Chemical_and_genetic_perturbations","C2_CGP_2985_NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN",20,-1.6785,0.009,0.021,"No",-1.1915,0.22,0.8,"No"
"2695","GO_BP","498794_GO_0021510_SPINAL_CORD_DEVELOPMENT",86,-1.6785,0.0013,0.041,"No",-1.2933,0.067,0.88,"No"
"2696","C2_Chemical_and_genetic_perturbations","C2_CGP_1049_FUJIWARA_PARK2_IN_LIVER_CANCER_UP",8,-1.6783,0.0087,0.021,"No",-1.783,0.0059,0.36,"No"
"2697","C2_Chemical_and_genetic_perturbations","C2_CGP_2507_CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN",100,-1.6782,0,0.021,"No",1.6584,0,0.11,"Yes"
"2698","KEGG_compound","C00427_PROSTAGLANDIN_H2_5Z_13E_15S_9ALPHA_11ALPHA_EPIDIOXY_15_HYDROXYPROSTA_5_13_DIENOATE_5Z_13E_15S_9ALPHA_11ALPHA_EPIDIOXY_15_HYDROXYPROSTA_5_13_DIENOATE_PGH2_5Z_9ALPHA_11ALPHA_13E_15S_9_11_EPIDIOXY_15_HYDROXY_PROSTA_5_13_DIENOATE",10,-1.6781,0.0033,0.048,"No",-0.9863,0.47,1,"No"
"2699","GO_BP","491771_GO_0006919_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",90,-1.678,0.0013,0.041,"No",0.7734,0.92,1,"Yes"
"2700","C2_Chemical_and_genetic_perturbations","C2_CGP_2884_ZHAN_MULTIPLE_MYELOMA_MF_DN",40,-1.6778,0.01,0.021,"No",0.8374,0.76,0.98,"Yes"
"2701","GO_BP","511644_GO_0050672_NEGATIVE_REGULATION_OF_LYMPHOCYTE_PROLIFERATION",55,-1.6777,0.0041,0.041,"No",-0.6376,0.99,1,"No"
"2702","GO_MF","514145_GO_0060590_ATPASE_REGULATOR_ACTIVITY",20,-1.6777,0.0059,0.08,"No",-1.1855,0.22,0.79,"No"
"2703","C3_TF_targets","C3_TFT_541_YATTNATC_UNKNOWN",363,-1.6777,0,0.0073,"No",-1.2263,0.048,0.3,"No"
"2704","C2_Chemical_and_genetic_perturbations","C2_CGP_273_SENESE_HDAC1_TARGETS_UP",447,-1.6777,0,0.021,"No",0.9269,0.8,0.89,"Yes"
"2705","C7_Immunologic_signatures","C7_ALL_1303_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP",189,-1.6776,0,0.00029,"No",-1.263,0.044,0.58,"No"
"2706","KEGG_pathway","HSA00062_FATTY_ACID_ELONGATION",25,-1.6775,0.0029,0.0077,"No",0.4765,0.99,1,"Yes"
"2707","GO_BP","507243_GO_0044236_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",94,-1.6773,0.0025,0.041,"No",-1.1486,0.2,0.93,"No"
"2708","C7_Immunologic_signatures","C7_ALL_846_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN",193,-1.6772,0,0.00029,"No",-0.8319,0.91,1,"No"
"2709","GO_BP","502059_GO_0032836_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT",10,-1.6772,0.0098,0.041,"No",-0.7897,0.74,1,"No"
"2710","GO_BP","505291_GO_0042119_NEUTROPHIL_ACTIVATION",21,-1.6772,0.012,0.041,"No",1.3757,0.083,0.58,"Yes"
"2711","GO_BP","503318_GO_0034112_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION",187,-1.6771,0,0.041,"No",0.9372,0.64,1,"Yes"
"2712","C2_Chemical_and_genetic_perturbations","C2_CGP_1025_GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN",26,-1.6771,0.003,0.021,"No",0.6095,0.97,1,"Yes"
"2713","C2_Chemical_and_genetic_perturbations","C2_CGP_1784_LU_AGING_BRAIN_UP",256,-1.6769,0,0.021,"No",1.0098,0.39,0.78,"Yes"
"2714","GO_MF","496569_GO_0016628_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",23,-1.6767,0.0072,0.08,"No",-0.7131,0.89,1,"No"
"2715","GO_BP","489296_GO_0006936_MUSCLE_CONTRACTION",208,-1.6764,0,0.042,"No",-1.3685,0.0086,0.99,"No"
"2716","GO_BP","508116_GO_0045779_NEGATIVE_REGULATION_OF_BONE_RESORPTION",8,-1.6763,0.0053,0.042,"No",0.666,0.87,1,"Yes"
"2717","GO_BP","487824_GO_0001933_NEGATIVE_REGULATION_OF_PROTEIN_PHOSPHORYLATION",285,-1.6762,0,0.042,"No",0.8374,0.94,1,"Yes"
"2718","KEGG_module","HSA_M00002_GLYCOLYSIS_CORE_MODULE_INVOLVING_THREE_CARBON_COMPOUNDS",12,-1.6762,0.0063,0.098,"No",-1.1212,0.33,1,"No"
"2719","GO_MF","490451_GO_0005200_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON",97,-1.6761,0.0038,0.079,"No",1.2076,0.12,0.7,"Yes"
"2720","KEGG_pathway","HSA04022_CGMP_PKG_SIGNALING_PATHWAY",164,-1.6761,0,0.0078,"No",-1.1611,0.14,0.59,"No"
"2721","C7_Immunologic_signatures","C7_ALL_930_GSE22886_NAIVE_TCELL_VS_NKCELL_DN",198,-1.676,0,3e-04,"No",-0.6551,1,1,"No"
"2722","GO_MF","499583_GO_0030165_PDZ_DOMAIN_BINDING",86,-1.676,0.0013,0.079,"No",-0.8688,0.74,1,"No"
"2723","GO_BP","491802_GO_0006959_HUMORAL_IMMUNE_RESPONSE",135,-1.676,0,0.042,"No",1.1113,0.22,0.89,"Yes"
"2724","C0_Hallmark","H_ALL_25_HALLMARK_PI3K_AKT_MTOR_SIGNALING",102,-1.6758,0.0013,0.0018,"No",-0.8458,0.78,1,"No"
"2725","REACTOME","106403_REACT_8005_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE",95,-1.6758,0,0.049,"No",-0.6349,0.99,1,"No"
"2726","GO_MF","911389_GO_0098531_DIRECT_LIGAND_REGULATED_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",48,-1.6758,0.0068,0.078,"No",-1.0419,0.36,0.87,"No"
"2727","GO_BP","989119_GO_1903054_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION",5,-1.6758,0.0035,0.042,"No",-0.9975,0.47,0.99,"No"
"2728","GO_BP","516167_GO_0071242_CELLULAR_RESPONSE_TO_AMMONIUM_ION",19,-1.6757,0.0045,0.042,"No",-1.0969,0.33,0.94,"No"
"2729","GO_MF","490259_GO_0004969_HISTAMINE_RECEPTOR_ACTIVITY",6,-1.6757,0.0034,0.077,"No",-1.3663,0.14,0.68,"No"
"2730","GO_BP","502094_GO_0032872_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE",172,-1.6757,0,0.042,"No",-1.128,0.2,0.93,"No"
"2731","GO_BP","511681_GO_0050710_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION",34,-1.6756,0,0.042,"No",-0.5346,1,1,"No"
"2732","GO_BP","488712_GO_0002839_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE_TO_TUMOR_CELL",9,-1.6756,0.013,0.042,"No",0.71,0.86,1,"Yes"
"2733","GO_MF","492790_GO_0008510_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY",6,-1.6756,0.0034,0.077,"No",-1.5818,0.055,0.46,"No"
"2734","C2_Chemical_and_genetic_perturbations","C2_CGP_2767_MIKKELSEN_MCV6_LCP_WITH_H3K27ME3",25,-1.6753,0.011,0.021,"No",-1.0745,0.35,0.95,"No"
"2735","GO_BP","505647_GO_0042516_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",35,-1.6752,0.0028,0.042,"No",-1.6785,0.0059,0.59,"No"
"2736","C4_Cancer_modules","C4_CM_48_MODULE_52",422,-1.6752,0,0.016,"No",1.0953,0.18,0.54,"Yes"
"2737","GO_BP","489001_GO_0003207_CARDIAC_CHAMBER_FORMATION",11,-1.6748,0.017,0.042,"No",-1.2164,0.23,0.88,"No"
"2738","C4_Cancer_modules","C4_CM_191_MODULE_204",84,-1.6747,0.0013,0.016,"No",-1.0841,0.3,0.7,"No"
"2739","GO_MF","753721_GO_1900750_OLIGOPEPTIDE_BINDING",11,-1.6746,0.011,0.077,"No",-1.5335,0.04,0.55,"No"
"2740","C6_Oncogenic_signatures","C6_ALL_26_AKT_UP_MTOR_DN_V1_UP",163,-1.6744,0.0012,0.0028,"No",-0.8403,0.86,0.98,"No"
"2741","GO_MF","489951_GO_0004620_PHOSPHOLIPASE_ACTIVITY",87,-1.6744,0.0013,0.076,"No",0.9419,0.58,0.93,"Yes"
"2742","GO_BP","755162_GO_2001056_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",129,-1.6744,0,0.042,"No",0.8743,0.8,1,"Yes"
"2743","C2_Chemical_and_genetic_perturbations","C2_CGP_659_LI_LUNG_CANCER",40,-1.6744,0.011,0.021,"No",0.8398,0.74,0.98,"Yes"
"2744","C7_Immunologic_signatures","C7_ALL_1457_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP",195,-1.6744,0.0011,3e-04,"No",0.6519,1,1,"Yes"
"2745","GO_BP","513012_GO_0052167_MODULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE",6,-1.6743,0.0066,0.042,"No",0.8377,0.68,1,"Yes"
"2746","C2_Chemical_and_genetic_perturbations","C2_CGP_3123_BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN",88,-1.6743,0.0013,0.021,"No",-1.1508,0.2,0.85,"No"
"2747","C2_Chemical_and_genetic_perturbations","C2_CGP_729_OHASHI_AURKB_TARGETS",9,-1.6741,0.01,0.021,"No",0.4771,1,1,"Yes"
"2748","C2_Chemical_and_genetic_perturbations","C2_CGP_935_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN",32,-1.6741,0.0043,0.021,"No",-0.8478,0.69,1,"No"
"2749","GO_BP","488762_GO_0002889_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",42,-1.6738,0.0081,0.042,"No",-1.5435,0.0074,0.75,"No"
"2750","C3_TF_targets","C3_TFT_409_V_AML_Q6",262,-1.6738,0,0.0075,"No",-1.2861,0.029,0.25,"No"
"2751","GO_BP","511643_GO_0050671_POSITIVE_REGULATION_OF_LYMPHOCYTE_PROLIFERATION",115,-1.6737,0,0.042,"No",-0.7847,0.9,1,"No"
"2752","GO_CC","502486_GO_0033267_AXON_PART",152,-1.6736,0,0.067,"No",-1.1273,0.19,0.73,"No"
"2753","REACTOME","106110_REACT_13552_INTEGRIN_CELL_SURFACE_INTERACTIONS",66,-1.6736,0.004,0.05,"No",0.7785,0.9,1,"Yes"
"2754","C2_Chemical_and_genetic_perturbations","C2_CGP_2259_SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN",286,-1.6736,0,0.021,"No",1.0202,0.39,0.77,"Yes"
"2755","GO_BP","514589_GO_0061041_REGULATION_OF_WOUND_HEALING",109,-1.6735,0,0.042,"No",1.06,0.31,0.94,"Yes"
"2756","C7_Immunologic_signatures","C7_ALL_1338_GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN",194,-1.6734,0,3e-04,"No",-0.9632,0.56,1,"No"
"2757","C7_Immunologic_signatures","C7_ALL_1459_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP",196,-1.6732,0,3e-04,"No",-0.7039,0.99,1,"No"
"2758","GO_BP","784765_GO_1902041_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",45,-1.6732,0.0028,0.042,"No",0.9248,0.6,1,"Yes"
"2759","C7_Immunologic_signatures","C7_ALL_911_GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP",195,-1.6728,0,3e-04,"No",0.9772,0.5,0.82,"Yes"
"2760","GO_BP","498799_GO_0021515_CELL_DIFFERENTIATION_IN_SPINAL_CORD",51,-1.6728,0.0027,0.042,"No",-1.3103,0.087,0.87,"No"
"2761","GO_BP","510177_GO_0048009_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",14,-1.6728,0.011,0.042,"No",-0.7265,0.86,1,"No"
"2762","GO_BP","510683_GO_0048625_MYOBLAST_FATE_COMMITMENT",5,-1.6727,0.01,0.042,"No",-1.4999,0.048,0.82,"No"
"2763","WikiPathways","920995_WP2436_DOPAMINE_METABOLISM",13,-1.6726,0.013,0.025,"No",0.8127,0.73,1,"Yes"
"2764","REACTOME","106496_REACT_15426_PLC_BETA_MEDIATED_EVENTS",46,-1.6726,0.0041,0.05,"No",-1.3022,0.12,0.66,"No"
"2765","GO_BP","502167_GO_0032945_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION",55,-1.6725,0.0042,0.042,"No",-0.6413,0.98,1,"No"
"2766","C3_TF_targets","C3_TFT_297_V_BACH2_01",264,-1.6722,0,0.0075,"No",-1.2394,0.047,0.29,"No"
"2767","C3_TF_targets","C3_TFT_462_V_OCT1_Q5_01",257,-1.6721,0,0.0073,"No",-1.1779,0.12,0.4,"No"
"2768","C7_Immunologic_signatures","C7_ALL_1407_GSE360_CTRL_VS_L_DONOVANI_DC_UP",198,-1.672,0,3e-04,"No",1.1078,0.21,0.42,"Yes"
"2769","GO_CC","517464_GO_0072559_NLRP3_INFLAMMASOME_COMPLEX",7,-1.6719,0.007,0.068,"No",-1.2526,0.19,0.66,"No"
"2770","C7_Immunologic_signatures","C7_ALL_1024_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN",198,-1.6718,0,3e-04,"No",0.8173,0.95,1,"Yes"
"2771","GO_BP","983729_GO_1903010_REGULATION_OF_BONE_DEVELOPMENT",11,-1.6717,0.0096,0.043,"No",-0.8326,0.69,1,"No"
"2772","GO_MF","490241_GO_0004950_CHEMOKINE_RECEPTOR_ACTIVITY",25,-1.6716,0.0076,0.078,"No",1.6561,0.011,0.2,"Yes"
"2773","C7_Immunologic_signatures","C7_ALL_811_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP",194,-1.6716,0,3e-04,"No",0.6137,1,1,"Yes"
"2774","GO_BP","501917_GO_0032691_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION",9,-1.6715,0.011,0.043,"No",-1.3305,0.15,0.9,"No"
"2775","C7_Immunologic_signatures","C7_ALL_232_GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN",194,-1.6714,0,3e-04,"No",0.831,0.9,1,"Yes"
"2776","C7_Immunologic_signatures","C7_ALL_1860_GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN",194,-1.6714,0,3e-04,"No",-0.9148,0.68,1,"No"
"2777","GO_BP","499615_GO_0030205_DERMATAN_SULFATE_METABOLIC_PROCESS",12,-1.6711,0.013,0.043,"No",-1.2837,0.15,0.9,"No"
"2778","C6_Oncogenic_signatures","C6_ALL_90_PTEN_DN_V2_UP",135,-1.6711,0,0.003,"No",-1.056,0.33,0.59,"No"
"2779","GO_BP","494116_GO_0010035_RESPONSE_TO_INORGANIC_SUBSTANCE",372,-1.6711,0,0.043,"No",0.9599,0.62,1,"Yes"
"2780","GO_BP","496951_GO_0017157_REGULATION_OF_EXOCYTOSIS",167,-1.671,0,0.043,"No",1.155,0.14,0.83,"Yes"
"2781","GO_BP","493490_GO_0009306_PROTEIN_SECRETION",125,-1.6709,0.0012,0.043,"No",1.1892,0.12,0.79,"Yes"
"2782","GO_BP","499231_GO_0021952_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS",22,-1.6708,0.011,0.043,"No",-1.0478,0.38,0.97,"No"
"2783","C7_Immunologic_signatures","C7_ALL_1380_GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN",195,-1.6708,0,0.00031,"No",-0.6671,1,1,"No"
"2784","GO_BP","507689_GO_0045332_PHOSPHOLIPID_TRANSLOCATION",19,-1.6707,0.009,0.043,"No",-1.2636,0.17,0.9,"No"
"2785","GO_MF","492421_GO_0008046_AXON_GUIDANCE_RECEPTOR_ACTIVITY",8,-1.6705,0.021,0.078,"No",-1.0162,0.44,0.89,"No"
"2786","GO_BP","510805_GO_0048754_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE",148,-1.6704,0,0.043,"No",1.2844,0.048,0.7,"Yes"
"2787","GO_BP","754181_GO_1901214_REGULATION_OF_NEURON_DEATH",226,-1.6703,0,0.043,"No",-1.0742,0.27,0.95,"No"
"2788","C2_Chemical_and_genetic_perturbations","C2_CGP_3112_WIERENGA_STAT5A_TARGETS_DN",212,-1.6702,0,0.022,"No",0.9833,0.49,0.81,"Yes"
"2789","GO_BP","513716_GO_0060158_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",9,-1.6701,0.012,0.043,"No",-0.8882,0.59,1,"No"
"2790","GO_BP","502168_GO_0032946_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION",116,-1.6699,0,0.043,"No",-0.7686,0.94,1,"No"
"2791","C2_Chemical_and_genetic_perturbations","C2_CGP_983_GROSS_HYPOXIA_VIA_HIF1A_DN",109,-1.6696,0,0.022,"No",-1.0597,0.33,0.97,"No"
"2792","C3_TF_targets","C3_TFT_427_V_OCT_Q6",251,-1.6694,0,0.0075,"No",-1.2535,0.039,0.27,"No"
"2793","C2_Chemical_and_genetic_perturbations","C2_CGP_1401_LU_IL4_SIGNALING",94,-1.6693,0,0.022,"No",1.277,0.077,0.42,"Yes"
"2794","REACTOME","106404_REACT_8006_TOLL_LIKE_RECEPTOR_TLR6_TLR2_CASCADE",95,-1.6693,0,0.052,"No",-0.6411,1,1,"No"
"2795","GO_BP","504843_GO_0035666_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",78,-1.6691,0.0038,0.043,"No",-0.8057,0.86,1,"No"
"2796","C7_Immunologic_signatures","C7_ALL_1464_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN",198,-1.669,0,0.00031,"No",1.0177,0.41,0.69,"Yes"
"2797","GO_BP","507463_GO_0045063_T_HELPER_1_CELL_DIFFERENTIATION",6,-1.6688,0.0085,0.043,"No",-1.1445,0.3,0.93,"No"
"2798","C2_Chemical_and_genetic_perturbations","C2_CGP_1101_AMIT_DELAYED_EARLY_GENES",18,-1.6686,0.0076,0.022,"No",-1.3778,0.11,0.62,"No"
"2799","C2_Chemical_and_genetic_perturbations","C2_CGP_2555_CHANG_CORE_SERUM_RESPONSE_DN",209,-1.6685,0,0.022,"No",-0.9769,0.51,1,"No"
"2800","C2_Chemical_and_genetic_perturbations","C2_CGP_770_NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF",8,-1.6685,0.0017,0.022,"No",1.4567,0.094,0.25,"Yes"
"2801","C4_Cancer_modules","C4_CM_300_MODULE_345",122,-1.6685,0,0.017,"No",1.327,0.031,0.25,"Yes"
"2802","GO_BP","755150_GO_2001044_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY",12,-1.6684,0.011,0.044,"No",0.9531,0.52,1,"Yes"
"2803","C1_Positional","C1_ALL_104_CHR11Q14",41,-1.6683,0.0028,0.13,"No",-1.1078,0.29,1,"No"
"2804","GO_CC","507692_GO_0045335_PHAGOCYTIC_VESICLE",80,-1.6679,0.0026,0.069,"No",0.9282,0.6,0.86,"Yes"
"2805","GO_MF","490424_GO_0005159_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING",14,-1.6678,0.013,0.08,"No",0.6385,0.93,1,"Yes"
"2806","GO_BP","1026090_GO_1903318_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION",299,-1.6677,0,0.044,"No",0.94,0.65,1,"Yes"
"2807","C4_Cancer_modules","C4_CM_372_MODULE_456",111,-1.6677,0,0.017,"No",-0.9319,0.61,0.88,"No"
"2808","C2_Chemical_and_genetic_perturbations","C2_CGP_2314_AUJLA_IL22_AND_IL17A_SIGNALING",10,-1.6676,0.0033,0.022,"No",-0.7941,0.73,1,"No"
"2809","REACTOME","119543_REACT_19323_SPHINGOLIPID_METABOLISM",72,-1.6675,0.004,0.052,"No",-0.9136,0.62,1,"No"
"2810","C2_Chemical_and_genetic_perturbations","C2_CGP_2005_GHO_ATF5_TARGETS_DN",16,-1.6675,0.016,0.022,"No",0.6213,0.95,1,"Yes"
"2811","C2_Chemical_and_genetic_perturbations","C2_CGP_2170_MASSARWEH_TAMOXIFEN_RESISTANCE_DN",244,-1.6673,0,0.022,"No",-0.942,0.6,1,"No"
"2812","C2_Chemical_and_genetic_perturbations","C2_CGP_1179_MORI_SMALL_PRE_BII_LYMPHOCYTE_DN",76,-1.6672,0.0026,0.022,"No",0.9046,0.66,0.92,"Yes"
"2813","GO_BP","513303_GO_0052556_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_IMMUNE_RESPONSE",6,-1.667,0.0087,0.044,"No",0.8382,0.64,1,"Yes"
"2814","GO_MF","492413_GO_0008035_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING",8,-1.6669,0.0099,0.08,"No",-0.7976,0.73,1,"No"
"2815","C2_Chemical_and_genetic_perturbations","C2_CGP_2783_OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP",24,-1.6668,0.012,0.022,"No",1.0348,0.39,0.74,"Yes"
"2816","C7_Immunologic_signatures","C7_ALL_1067_GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP",200,-1.6666,0,0.00033,"No",1.2187,0.057,0.2,"Yes"
"2817","C6_Oncogenic_signatures","C6_ALL_30_MTOR_UP_V1_UP",154,-1.6665,0,0.0032,"No",-1.0559,0.31,0.58,"No"
"2818","C2_Chemical_and_genetic_perturbations","C2_CGP_3309_PEDRIOLI_MIR31_TARGETS_DN",401,-1.6664,0,0.022,"No",-1.0049,0.44,1,"No"
"2819","REACTOME","187096_REACT_23787_REGULATION_OF_SIGNALING_BY_CBL",18,-1.6664,0.011,0.052,"No",-0.8003,0.75,1,"No"
"2820","C7_Immunologic_signatures","C7_ALL_296_GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN",196,-1.6664,0,0.00033,"No",0.9492,0.62,0.9,"Yes"
"2821","C2_Chemical_and_genetic_perturbations","C2_CGP_391_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP",57,-1.6663,0.0054,0.022,"No",1.3541,0.077,0.34,"Yes"
"2822","GO_MF","496709_GO_0016810_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS",119,-1.6663,0,0.079,"No",-1.0103,0.42,0.89,"No"
"2823","REACTOME","105653_REACT_402_TRAIL_SIGNALING",7,-1.6662,0.017,0.052,"No",-0.9812,0.48,1,"No"
"2824","C3_TF_targets","C3_TFT_3_V_MYOD_01",261,-1.6661,0,0.0077,"No",-1.344,0.013,0.2,"No"
"2825","C7_Immunologic_signatures","C7_ALL_1202_GSE27786_CD4_TCELL_VS_MONO_MAC_DN",197,-1.6661,0,0.00033,"No",-1.0182,0.4,1,"No"
"2826","C7_Immunologic_signatures","C7_ALL_824_GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN",198,-1.6658,0,0.00033,"No",0.7215,1,1,"Yes"
"2827","GO_BP","491791_GO_0006942_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION",87,-1.6657,0,0.045,"No",-1.1982,0.15,0.9,"No"
"2828","C7_Immunologic_signatures","C7_ALL_1343_GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP",198,-1.6656,0,0.00033,"No",-0.8246,0.9,1,"No"
"2829","REACTOME","106495_REACT_15526_G_PROTEIN_MEDIATED_EVENTS",47,-1.6656,0,0.052,"No",-1.2852,0.1,0.67,"No"
"2830","GO_BP","496362_GO_0016322_NEURON_REMODELING",9,-1.6656,0.014,0.045,"No",-1.5875,0.031,0.71,"No"
"2831","GO_BP","505865_GO_0042759_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS",10,-1.6655,0.0095,0.045,"No",-0.5466,0.96,1,"No"
"2832","C2_Chemical_and_genetic_perturbations","C2_CGP_1134_AMIT_EGF_RESPONSE_40_HELA",42,-1.6655,0.011,0.022,"No",-1.5755,0.0077,0.46,"No"
"2833","REACTOME","187089_REACT_25281_TRIF_MEDIATED_TLR3_TLR4_SIGNALING",100,-1.6655,0.0012,0.052,"No",-0.759,0.94,1,"No"
"2834","C7_Immunologic_signatures","C7_ALL_1038_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN",198,-1.6652,0,0.00033,"No",-0.8799,0.78,1,"No"
"2835","GO_BP","516721_GO_0071798_RESPONSE_TO_PROSTAGLANDIN_D",5,-1.6652,0.0054,0.045,"No",1.0086,0.47,0.98,"Yes"
"2836","GO_BP","514092_GO_0060537_MUSCLE_TISSUE_DEVELOPMENT",269,-1.6652,0,0.045,"No",-1.0833,0.24,0.95,"No"
"2837","C2_Chemical_and_genetic_perturbations","C2_CGP_2907_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN",77,-1.6649,0,0.023,"No",1.078,0.29,0.67,"Yes"
"2838","GO_BP","507926_GO_0045578_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION",6,-1.6649,0.011,0.045,"No",-0.9593,0.51,1,"No"
"2839","GO_BP","506422_GO_0043383_NEGATIVE_T_CELL_SELECTION",11,-1.6648,0.0064,0.045,"No",0.6879,0.88,1,"Yes"
"2840","GO_BP","487826_GO_0001935_ENDOTHELIAL_CELL_PROLIFERATION",21,-1.6648,0.014,0.045,"No",-1.1538,0.26,0.92,"No"
"2841","KEGG_compound","C11150_TRICHLOROACETATE_TRICHLOROACETIC_ACID_TCA",5,-1.6648,0.0054,0.055,"No",0.7674,0.73,1,"Yes"
"2842","C2_Chemical_and_genetic_perturbations","C2_CGP_3015_BROWNE_HCMV_INFECTION_2HR_UP",39,-1.6647,0.012,0.023,"No",-1.7648,0,0.35,"No"
"2843","GO_BP","501921_GO_0032695_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION",15,-1.6643,0.012,0.045,"No",0.7001,0.88,1,"Yes"
"2844","C7_Immunologic_signatures","C7_ALL_830_GSE17974_2_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN",195,-1.6642,0,0.00034,"No",0.7534,0.99,1,"Yes"
"2845","C2_BioCarta_Pathways","C2_CP_BIOCARTA_115_BIOCARTA_MCALPAIN_PATHWAY",24,-1.6642,0.0028,0.066,"No",0.9627,0.51,0.84,"Yes"
"2846","GO_BP","493585_GO_0010038_RESPONSE_TO_METAL_ION",262,-1.664,0,0.045,"No",1.1132,0.16,0.89,"Yes"
"2847","GO_BP","503311_GO_0034105_POSITIVE_REGULATION_OF_TISSUE_REMODELING",26,-1.6638,0.0043,0.045,"No",-1.2971,0.13,0.88,"No"
"2848","GO_BP","518770_GO_2000121_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS",6,-1.6636,0.0052,0.045,"No",0.9434,0.51,1,"Yes"
"2849","C7_Immunologic_signatures","C7_ALL_1387_GSE339_CD8POS_VS_CD4CD8DN_DC_UP",197,-1.6635,0,0.00034,"No",1.3128,0.018,0.091,"Yes"
"2850","GO_MF","750963_GO_0036041_LONG_CHAIN_FATTY_ACID_BINDING",10,-1.6633,0.015,0.081,"No",1.2216,0.2,0.71,"Yes"
"2851","GO_BP","488101_GO_0002227_INNATE_IMMUNE_RESPONSE_IN_MUCOSA",25,-1.6633,0.006,0.045,"No",1.1752,0.23,0.81,"Yes"
"2852","C2_Chemical_and_genetic_perturbations","C2_CGP_2956_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN",10,-1.6632,0.0095,0.023,"No",0.5369,0.97,1,"Yes"
"2853","REACTOME","161004_REACT_22365_RECYCLING_PATHWAY_OF_L1",28,-1.663,0.014,0.053,"No",-0.5393,0.99,1,"No"
"2854","GO_BP","488148_GO_0002275_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",37,-1.663,0.0085,0.045,"No",0.9072,0.63,1,"Yes"
"2855","GO_CC","490838_GO_0005811_LIPID_PARTICLE",55,-1.663,0.004,0.072,"No",0.7311,0.93,0.99,"Yes"
"2856","GO_MF","506356_GO_0043295_GLUTATHIONE_BINDING",11,-1.6629,0.0098,0.081,"No",-1.5242,0.043,0.53,"No"
"2857","GO_MF","496705_GO_0016801_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS",11,-1.6627,0.013,0.081,"No",-1.6144,0.02,0.45,"No"
"2858","GO_MF","492388_GO_0008013_BETA_CATENIN_BINDING",64,-1.6627,0.004,0.08,"No",-1.1967,0.16,0.8,"No"
"2859","GO_MF","492422_GO_0008047_ENZYME_ACTIVATOR_ACTIVITY",424,-1.6626,0,0.079,"No",-1.0177,0.4,0.89,"No"
"2860","GO_CC","982594_GO_1990351_TRANSPORTER_COMPLEX",310,-1.6625,0,0.071,"No",-1.5297,0,0.61,"No"
"2861","GO_BP","505247_GO_0042063_GLIOGENESIS",168,-1.6623,0,0.045,"No",0.9833,0.5,1,"Yes"
"2862","GO_BP","503322_GO_0034116_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION",9,-1.6623,0.0095,0.045,"No",-1.0146,0.44,0.98,"No"
"2863","GO_BP","492350_GO_0007608_SENSORY_PERCEPTION_OF_SMELL",338,-1.6623,0,0.045,"No",2.3531,0,6.8e-05,"Yes"
"2864","C2_Chemical_and_genetic_perturbations","C2_CGP_337_BIDUS_METASTASIS_DN",155,-1.6623,0,0.023,"No",-0.6767,0.99,1,"No"
"2865","C7_Immunologic_signatures","C7_ALL_1781_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP",195,-1.6622,0,0.00034,"No",1.0075,0.45,0.71,"Yes"
"2866","C2_Chemical_and_genetic_perturbations","C2_CGP_1781_GAJATE_RESPONSE_TO_TRABECTEDIN_UP",66,-1.662,0.0066,0.023,"No",1.2894,0.089,0.4,"Yes"
"2867","GO_BP","494876_GO_0010812_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION",43,-1.662,0.0042,0.045,"No",-0.9461,0.51,1,"No"
"2868","GO_MF","490643_GO_0005548_PHOSPHOLIPID_TRANSPORTER_ACTIVITY",44,-1.662,0.0042,0.079,"No",-1.043,0.36,0.87,"No"
"2869","C7_Immunologic_signatures","C7_ALL_869_GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP",192,-1.662,0,0.00034,"No",-1.1767,0.12,0.92,"No"
"2870","C2_Chemical_and_genetic_perturbations","C2_CGP_1167_SHIN_B_CELL_LYMPHOMA_CLUSTER_5",16,-1.6619,0.0089,0.023,"No",-1.1488,0.28,0.85,"No"
"2871","C7_Immunologic_signatures","C7_ALL_156_GSE13306_RA_VS_UNTREATED_TREG_DN",194,-1.6619,0.0011,0.00034,"No",-0.9555,0.57,1,"No"
"2872","GO_MF","489318_GO_0004252_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY",144,-1.6618,0,0.078,"No",1.2646,0.056,0.65,"Yes"
"2873","WikiPathways","198901_WP706_SIDS_SUSCEPTIBILITY_PATHWAYS",156,-1.6617,0,0.027,"No",-1.1366,0.18,0.93,"No"
"2874","C6_Oncogenic_signatures","C6_ALL_61_SNF5_DN_V1_DN",133,-1.6616,0,0.0034,"No",-1.0594,0.34,0.59,"No"
"2875","C7_Immunologic_signatures","C7_ALL_1767_GSE7460_TCONV_VS_TREG_THYMUS_UP",198,-1.6616,0,0.00034,"No",-0.8601,0.85,1,"No"
"2876","C2_Chemical_and_genetic_perturbations","C2_CGP_2744_BUDHU_LIVER_CANCER_METASTASIS_DN",7,-1.6615,0.013,0.023,"No",-1.7165,0.0098,0.34,"No"
"2877","C3_TF_targets","C3_TFT_466_V_NFAT_Q4_01",258,-1.6613,0.0011,0.0078,"No",-0.8497,0.88,1,"No"
"2878","C2_Chemical_and_genetic_perturbations","C2_CGP_1917_WANG_CISPLATIN_RESPONSE_AND_XPC_UP",195,-1.6613,0.0012,0.023,"No",-0.9032,0.72,1,"No"
"2879","GO_MF","487744_GO_0001848_COMPLEMENT_BINDING",17,-1.6612,0.0092,0.078,"No",-1.2534,0.17,0.84,"No"
"2880","GO_BP","753031_GO_1900034_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT",35,-1.6612,0.0086,0.046,"No",-1.3394,0.084,0.91,"No"
"2881","KEGG_pathway","HSA00010_GLYCOLYSIS_GLUCONEOGENESIS",67,-1.6611,0.0026,0.0093,"No",0.9981,0.44,0.89,"Yes"
"2882","C4_Cancer_modules","C4_CM_414_MODULE_537",17,-1.6611,0.011,0.018,"No",-0.9254,0.55,0.88,"No"
"2883","GO_BP","508883_GO_0046635_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION",46,-1.6611,0.0054,0.046,"No",-0.6337,0.99,1,"No"
"2884","C4_Cancer_modules","C4_CM_348_MODULE_417",20,-1.661,0.01,0.018,"No",1.4769,0.051,0.13,"Yes"
"2885","GO_BP","1129531_GO_1903707_NEGATIVE_REGULATION_OF_HEMOPOIESIS",119,-1.6609,0,0.046,"No",-1.1785,0.13,0.91,"No"
"2886","C4_Cancer_modules","C4_CM_301_MODULE_346",17,-1.6608,0.011,0.017,"No",-0.5626,0.98,1,"No"
"2887","REACTOME","106159_REACT_6934_LDL_MEDIATED_LIPID_TRANSPORT",6,-1.6607,0.0086,0.053,"No",-0.631,0.91,1,"No"
"2888","C7_Immunologic_signatures","C7_ALL_952_GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN",195,-1.6607,0,0.00035,"No",0.7078,1,1,"Yes"
"2889","C1_Positional","C1_ALL_163_CHR16Q12",42,-1.6607,0.0041,0.13,"No",-0.7986,0.81,0.96,"No"
"2890","GO_BP","506346_GO_0043281_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",202,-1.6606,0,0.046,"No",0.8963,0.76,1,"Yes"
"2891","GO_BP","498690_GO_0019915_LIPID_STORAGE",25,-1.6605,0.016,0.046,"No",-1.2298,0.18,0.89,"No"
"2892","C7_Immunologic_signatures","C7_ALL_360_GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN",187,-1.6605,0,0.00035,"No",0.8661,0.83,1,"Yes"
"2893","C6_Oncogenic_signatures","C6_ALL_189_LEF1_UP_V1_UP",183,-1.6604,0,0.0033,"No",-0.9929,0.47,0.68,"No"
"2894","GO_BP","501946_GO_0032720_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION",36,-1.6603,0.011,0.046,"No",-1.039,0.41,0.98,"No"
"2895","C2_Chemical_and_genetic_perturbations","C2_CGP_2576_HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN",73,-1.6602,0.0013,0.023,"No",0.8013,0.87,0.99,"Yes"
"2896","GO_BP","511651_GO_0050679_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION",142,-1.6601,0,0.046,"No",-0.9845,0.5,1,"No"
"2897","GO_BP","513848_GO_0060292_LONG_TERM_SYNAPTIC_DEPRESSION",15,-1.6599,0.0064,0.046,"No",-0.9776,0.48,1,"No"
"2898","REACTOME","161020_REACT_21340_GPCR_LIGAND_BINDING",412,-1.6599,0,0.054,"No",1.3061,0.0077,0.32,"Yes"
"2899","C7_Immunologic_signatures","C7_ALL_22_GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN",191,-1.6599,0.0011,0.00036,"No",1.3875,0.0095,0.041,"Yes"
"2900","GO_BP","493723_GO_0009595_DETECTION_OF_BIOTIC_STIMULUS",24,-1.6598,0.0077,0.046,"No",-0.614,0.97,1,"No"
"2901","GO_MF","489298_GO_0003779_ACTIN_BINDING",381,-1.6597,0,0.079,"No",-1.0419,0.31,0.86,"No"
"2902","GO_BP","752384_GO_0086012_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",10,-1.6596,0.018,0.046,"No",-1.3797,0.12,0.99,"No"
"2903","C7_Immunologic_signatures","C7_ALL_1596_GSE3982_EOSINOPHIL_VS_BASOPHIL_DN",195,-1.6596,0,0.00036,"No",1.6398,0,0.0014,"Yes"
"2904","C2_Chemical_and_genetic_perturbations","C2_CGP_1218_NIKOLSKY_BREAST_CANCER_19Q13_4_AMPLICON",7,-1.6595,0.0098,0.023,"No",-0.8922,0.6,1,"No"
"2905","GO_MF","507895_GO_0045545_SYNDECAN_BINDING",5,-1.6595,0.0035,0.078,"No",0.9012,0.57,0.98,"Yes"
"2906","C2_Chemical_and_genetic_perturbations","C2_CGP_2244_ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP",267,-1.6595,0,0.023,"No",1.3899,0.0071,0.3,"Yes"
"2907","C4_Cancer_gene_neighborhoods","C4_CGN_368_GNF2_KISS1",42,-1.6592,0.0014,0.012,"No",0.9318,0.56,0.75,"Yes"
"2908","GO_BP","499721_GO_0030320_CELLULAR_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS",13,-1.6592,0.014,0.046,"No",-0.7939,0.75,1,"No"
"2909","GO_BP","507503_GO_0045110_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY",5,-1.6591,0.0088,0.046,"No",-0.4742,0.99,1,"No"
"2910","C2_Chemical_and_genetic_perturbations","C2_CGP_1312_DORSAM_HOXA9_TARGETS_UP",35,-1.659,0.01,0.024,"No",-0.9391,0.54,1,"No"
"2911","GO_BP","487568_GO_0001655_UROGENITAL_SYSTEM_DEVELOPMENT",295,-1.6589,0,0.046,"No",-1.0664,0.28,0.96,"No"
"2912","GO_BP","499810_GO_0030432_PERISTALSIS",9,-1.6588,0.0087,0.046,"No",-1.1936,0.25,0.9,"No"
"2913","C7_Immunologic_signatures","C7_ALL_1000_GSE22886_TH1_VS_TH2_48H_ACT_DN",199,-1.6587,0,0.00037,"No",0.9424,0.61,0.92,"Yes"
"2914","C7_Immunologic_signatures","C7_ALL_815_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP",185,-1.6586,0,0.00037,"No",0.999,0.45,0.74,"Yes"
"2915","GO_BP","502344_GO_0033123_POSITIVE_REGULATION_OF_PURINE_NUCLEOTIDE_CATABOLIC_PROCESS",497,-1.6586,0,0.046,"No",-1.3876,0,1,"No"
"2916","C3_TF_targets","C3_TFT_539_YAATNANRNNNCAG_UNKNOWN",65,-1.6585,0.0051,0.008,"No",-1.0951,0.3,0.56,"No"
"2917","C2_Chemical_and_genetic_perturbations","C2_CGP_15_LU_TUMOR_VASCULATURE_UP",29,-1.6584,0.012,0.024,"No",1.1993,0.2,0.49,"Yes"
"2918","C0_Hallmark","H_ALL_12_HALLMARK_ADIPOGENESIS",199,-1.6584,0,0.0021,"No",1.4017,0.012,0.053,"Yes"
"2919","C2_Chemical_and_genetic_perturbations","C2_CGP_1158_SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",33,-1.6584,0.0058,0.024,"No",-0.9586,0.53,1,"No"
"2920","C2_Chemical_and_genetic_perturbations","C2_CGP_3206_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN",318,-1.6583,0,0.024,"No",-0.8205,0.96,1,"No"
"2921","C2_Chemical_and_genetic_perturbations","C2_CGP_1693_ZHANG_RESPONSE_TO_CANTHARIDIN_UP",19,-1.6582,0.012,0.024,"No",0.8502,0.71,0.97,"Yes"
"2922","GO_BP","492896_GO_0030041_ACTIN_FILAMENT_POLYMERIZATION",26,-1.658,0.012,0.046,"No",1.0422,0.38,0.96,"Yes"
"2923","GO_BP","499470_GO_0030002_CELLULAR_ANION_HOMEOSTASIS",13,-1.658,0.016,0.046,"No",-0.8027,0.69,1,"No"
"2924","REACTOME","106414_REACT_12526_TCR_SIGNALING",58,-1.6576,0.0013,0.054,"No",0.9393,0.57,0.85,"Yes"
"2925","GO_BP","755340_GO_2001234_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY",195,-1.6575,0,0.047,"No",0.9394,0.65,1,"Yes"
"2926","GO_BP","516236_GO_0071312_CELLULAR_RESPONSE_TO_ALKALOID",32,-1.6574,0.0029,0.047,"No",-1.3641,0.08,0.98,"No"
"2927","C2_Chemical_and_genetic_perturbations","C2_CGP_340_WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP",136,-1.6574,0,0.024,"No",-0.8224,0.9,1,"No"
"2928","GO_BP","502256_GO_0033034_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS",6,-1.6573,0.0054,0.047,"No",-0.6567,0.89,1,"No"
"2929","C0_Hallmark","H_ALL_30_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION",198,-1.6572,0,0.0021,"No",0.9636,0.52,0.73,"Yes"
"2930","C2_Chemical_and_genetic_perturbations","C2_CGP_2522_MARTINELLI_IMMATURE_NEUTROPHIL_DN",13,-1.6572,0.014,0.024,"No",1.3148,0.16,0.38,"Yes"
"2931","GO_MF","489300_GO_0051015_ACTIN_FILAMENT_BINDING",114,-1.657,0,0.08,"No",-1.1144,0.22,0.83,"No"
"2932","C2_Chemical_and_genetic_perturbations","C2_CGP_406_BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN",48,-1.657,0.0043,0.024,"No",-0.8012,0.81,1,"No"
"2933","GO_CC","507397_GO_0044449_CONTRACTILE_FIBER_PART",197,-1.657,0,0.074,"No",-0.9765,0.5,0.88,"No"
"2934","REACTOME","106245_REACT_16956_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC",21,-1.6569,0.017,0.054,"No",0.7938,0.75,1,"Yes"
"2935","C7_Immunologic_signatures","C7_ALL_1517_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP",198,-1.6568,0,0.00039,"No",1.1456,0.13,0.33,"Yes"
"2936","C7_Immunologic_signatures","C7_ALL_763_GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_UP",198,-1.6567,0,0.00039,"No",1.0765,0.25,0.51,"Yes"
"2937","REACTOME","106111_REACT_602_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT",53,-1.6566,0.0027,0.054,"No",-1.2941,0.097,0.66,"No"
"2938","GO_BP","489102_GO_0003310_PANCREATIC_A_CELL_DIFFERENTIATION",6,-1.6566,0.01,0.047,"No",-0.6718,0.85,1,"No"
"2939","KEGG_compound","C00068_THIAMIN_DIPHOSPHATE_THIAMINE_DIPHOSPHATE_THIAMIN_PYROPHOSPHATE_TPP_THPP",10,-1.6566,0.017,0.059,"No",0.8761,0.62,1,"Yes"
"2940","GO_MF","505439_GO_0042288_MHC_CLASS_I_PROTEIN_BINDING",13,-1.6564,0.0093,0.08,"No",1.1065,0.33,0.78,"Yes"
"2941","C2_Chemical_and_genetic_perturbations","C2_CGP_598_EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP",199,-1.6562,0,0.024,"No",-1.4281,0.0017,0.55,"No"
"2942","GO_BP","515036_GO_0070098_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY",45,-1.6561,0.0041,0.047,"No",1.7319,0.0089,0.16,"Yes"
"2943","GO_BP","489281_GO_0006457_PROTEIN_FOLDING",220,-1.656,0,0.047,"No",0.9709,0.55,1,"Yes"
"2944","GO_BP","494948_GO_0010884_POSITIVE_REGULATION_OF_LIPID_STORAGE",20,-1.656,0.0063,0.047,"No",-1.0133,0.44,0.98,"No"
"2945","C2_Chemical_and_genetic_perturbations","C2_CGP_2784_OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN",6,-1.6559,0.012,0.024,"No",-0.9587,0.5,1,"No"
"2946","GO_BP","488704_GO_0002831_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS",117,-1.6557,0,0.047,"No",0.6802,1,1,"Yes"
"2947","KEGG_pathway","HSA04151_PI3K_AKT_SIGNALING_PATHWAY",329,-1.6556,0,0.0097,"No",-0.8943,0.79,0.96,"No"
"2948","GO_BP","507986_GO_0045638_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION",82,-1.6555,0.0013,0.047,"No",-1.0592,0.33,0.96,"No"
"2949","GO_BP","495042_GO_0010977_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT",91,-1.6554,0.0025,0.047,"No",-1.0264,0.41,0.98,"No"
"2950","GO_BP","487803_GO_0001912_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY",39,-1.6554,0.0041,0.047,"No",0.6546,0.96,1,"Yes"
"2951","C2_Chemical_and_genetic_perturbations","C2_CGP_1255_LE_EGR2_TARGETS_DN",106,-1.6554,0,0.024,"No",-1.1021,0.27,0.92,"No"
"2952","GO_BP","850008_GO_1902307_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",15,-1.6554,0.016,0.047,"No",-1.1962,0.23,0.89,"No"
"2953","KEGG_compound","C00116_GLYCEROL_GLYCERIN_1_2_3_TRIHYDROXYPROPANE_1_2_3_PROPANETRIOL",11,-1.6553,0.0098,0.059,"No",-0.7709,0.75,1,"No"
"2954","GO_BP","513035_GO_0052192_MOVEMENT_IN_ENVIRONMENT_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",56,-1.6552,0.0027,0.047,"No",-1.0369,0.39,0.98,"No"
"2955","C2_Chemical_and_genetic_perturbations","C2_CGP_1900_KAYO_CALORIE_RESTRICTION_MUSCLE_UP",92,-1.655,0.0012,0.024,"No",0.8307,0.8,0.98,"Yes"
"2956","C7_Immunologic_signatures","C7_ALL_1715_GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP",197,-1.655,0,4e-04,"No",0.9935,0.45,0.76,"Yes"
"2957","C2_Chemical_and_genetic_perturbations","C2_CGP_2859_GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP",12,-1.655,0.0081,0.024,"No",-0.736,0.8,1,"No"
"2958","GO_BP","492316_GO_0007566_EMBRYO_IMPLANTATION",39,-1.6549,0.0028,0.047,"No",-0.882,0.67,1,"No"
"2959","C4_Cancer_gene_neighborhoods","C4_CGN_403_GNF2_RTN1",50,-1.6549,0.004,0.013,"No",-1.6693,0,0.092,"No"
"2960","C7_Immunologic_signatures","C7_ALL_536_GSE17721_LPS_VS_POLYIC_6H_BMDM_DN",198,-1.6549,0,4e-04,"No",0.9249,0.7,0.96,"Yes"
"2961","GO_BP","488547_GO_0002674_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE",11,-1.6547,0.016,0.047,"No",-1.1406,0.28,0.93,"No"
"2962","C2_Chemical_and_genetic_perturbations","C2_CGP_2111_KYNG_DNA_DAMAGE_BY_4NQO_OR_UV",61,-1.6546,0.0013,0.024,"No",0.862,0.72,0.96,"Yes"
"2963","GO_BP","512268_GO_0051384_RESPONSE_TO_GLUCOCORTICOID",127,-1.6546,0.0012,0.047,"No",0.8907,0.76,1,"Yes"
"2964","C7_Immunologic_signatures","C7_ALL_299_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP",197,-1.6545,0,4e-04,"No",1.1711,0.098,0.28,"Yes"
"2965","GO_BP","510563_GO_0048489_SYNAPTIC_VESICLE_TRANSPORT",113,-1.6543,0.0012,0.047,"No",0.8309,0.87,1,"Yes"
"2966","GO_BP","504944_GO_0035767_ENDOTHELIAL_CELL_CHEMOTAXIS",8,-1.6543,0.014,0.047,"No",-1.2145,0.25,0.88,"No"
"2967","GO_BP","507928_GO_0045580_REGULATION_OF_T_CELL_DIFFERENTIATION",100,-1.6541,0,0.047,"No",-1.3606,0.045,0.97,"No"
"2968","C2_Chemical_and_genetic_perturbations","C2_CGP_814_AMUNDSON_RESPONSE_TO_ARSENITE",214,-1.6541,0,0.024,"No",0.7181,1,1,"Yes"
"2969","C7_Immunologic_signatures","C7_ALL_57_GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP",188,-1.6541,0,4e-04,"No",-1.1006,0.23,1,"No"
"2970","GO_BP","751150_GO_0036230_GRANULOCYTE_ACTIVATION",24,-1.654,0.011,0.047,"No",1.4586,0.053,0.48,"Yes"
"2971","GO_MF","500671_GO_0031420_ALKALI_METAL_ION_BINDING",12,-1.654,0.012,0.081,"No",-1.6413,0.011,0.41,"No"
"2972","C2_Chemical_and_genetic_perturbations","C2_CGP_2768_MIKKELSEN_MCV6_LCP_WITH_H3K4ME3",156,-1.6539,0,0.024,"No",-1.4413,0.0052,0.53,"No"
"2973","GO_BP","494940_GO_0010876_LIPID_LOCALIZATION",244,-1.6539,0,0.047,"No",-1.037,0.37,0.98,"No"
"2974","C2_Chemical_and_genetic_perturbations","C2_CGP_500_MCBRYAN_PUBERTAL_BREAST_4_5WK_UP",261,-1.6539,0,0.024,"No",0.9767,0.51,0.82,"Yes"
"2975","KEGG_reaction","R00904_3_AMINOPROPANAL_NAD_OXIDOREDUCTASE_3_AMINOPROPANAL_NAD_H2O_BETA_ALANINE_NADH_H_",9,-1.6538,0.015,0.049,"No",0.8307,0.67,1,"Yes"
"2976","KEGG_compound","C00106_URACIL",6,-1.6538,0.013,0.059,"No",-0.8456,0.62,1,"No"
"2977","C3_TF_targets","C3_TFT_581_RGAANNTTC_V_HSF1_01",436,-1.6536,0,0.0086,"No",-1.4113,0.0034,0.16,"No"
"2978","C7_Immunologic_signatures","C7_ALL_1375_GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP",195,-1.6536,0,4e-04,"No",-0.6655,1,1,"No"
"2979","REACTOME","771580_REACT_160158_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS",26,-1.6535,0.0073,0.055,"No",-0.9658,0.52,1,"No"
"2980","C2_Chemical_and_genetic_perturbations","C2_CGP_1524_BASSO_CD40_SIGNALING_DN",66,-1.6535,0.0027,0.024,"No",-0.5856,1,1,"No"
"2981","C4_Cancer_modules","C4_CM_195_MODULE_208",119,-1.6534,0,0.019,"No",1.634,0,0.065,"Yes"
"2982","C2_Chemical_and_genetic_perturbations","C2_CGP_305_KIM_WT1_TARGETS_UP",211,-1.6534,0,0.024,"No",-1.0369,0.39,0.98,"No"
"2983","GO_MF","490639_GO_0005544_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING",54,-1.6534,0.0041,0.081,"No",0.9632,0.52,0.91,"Yes"
"2984","WikiPathways","672462_WP2037_PROLACTIN_SIGNALING_PATHWAY",74,-1.6533,0.0026,0.029,"No",-0.6474,0.99,1,"No"
"2985","GO_BP","500887_GO_0031638_ZYMOGEN_ACTIVATION",110,-1.6533,0,0.048,"No",-0.6851,0.98,1,"No"
"2986","GO_BP","512289_GO_0051410_DETOXIFICATION_OF_NITROGEN_COMPOUND",5,-1.6532,0.012,0.048,"No",-1.4607,0.057,0.88,"No"
"2987","GO_BP","508009_GO_0045661_REGULATION_OF_MYOBLAST_DIFFERENTIATION",40,-1.6532,0.0071,0.047,"No",-1.2581,0.13,0.91,"No"
"2988","C6_Oncogenic_signatures","C6_ALL_163_TBK1_DF_UP",288,-1.6531,0,0.0035,"No",-0.7262,1,1,"No"
"2989","C7_Immunologic_signatures","C7_ALL_1568_GSE3982_CTRL_VS_LPS_4H_MAC_DN",198,-1.6531,0.0011,4e-04,"No",1.1387,0.15,0.34,"Yes"
"2990","GO_BP","518962_GO_2000316_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE",7,-1.653,0.0052,0.047,"No",-1.5123,0.065,0.81,"No"
"2991","GO_BP","514683_GO_0061138_MORPHOGENESIS_OF_A_BRANCHING_EPITHELIUM",179,-1.6529,0,0.048,"No",1.0836,0.23,0.92,"Yes"
"2992","C2_Chemical_and_genetic_perturbations","C2_CGP_1320_CHANG_POU5F1_TARGETS_DN",8,-1.6527,0.011,0.024,"No",-1.0373,0.4,0.98,"No"
"2993","C2_Chemical_and_genetic_perturbations","C2_CGP_1941_SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1",392,-1.6526,0,0.024,"No",-1.0955,0.21,0.92,"No"
"2994","GO_BP","488592_GO_0002719_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",18,-1.6526,0.013,0.048,"No",-1.0804,0.35,0.95,"No"
"2995","C2_Chemical_and_genetic_perturbations","C2_CGP_6_WINTER_HYPOXIA_DN",50,-1.6525,0.0041,0.024,"No",0.6685,0.96,1,"Yes"
"2996","C2_Chemical_and_genetic_perturbations","C2_CGP_3057_HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP",242,-1.6525,0,0.024,"No",1.2041,0.068,0.48,"Yes"
"2997","C2_Chemical_and_genetic_perturbations","C2_CGP_1482_GILDEA_METASTASIS",29,-1.6524,0.01,0.024,"No",1.2372,0.16,0.45,"Yes"
"2998","C2_Chemical_and_genetic_perturbations","C2_CGP_3279_PLASARI_NFIC_TARGETS_BASAL_DN",18,-1.6522,0.014,0.024,"No",0.7134,0.84,1,"Yes"
"2999","GO_BP","511896_GO_0050962_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",16,-1.6522,0.015,0.048,"No",-1.6848,0.014,0.59,"No"
"3000","GO_BP","513610_GO_0060052_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION",10,-1.6522,0.019,0.048,"No",0.5697,0.96,1,"Yes"
"3001","WikiPathways","198779_WP382_MAPK_SIGNALING_PATHWAY",164,-1.6521,0,0.029,"No",-1.2611,0.071,0.88,"No"
"3002","C2_BioCarta_Pathways","C2_CP_BIOCARTA_93_BIOCARTA_IL3_PATHWAY",15,-1.652,0.014,0.071,"No",-1.2093,0.22,1,"No"
"3003","C2_Chemical_and_genetic_perturbations","C2_CGP_3065_QI_HYPOXIA",138,-1.652,0,0.024,"No",-1.0312,0.37,0.98,"No"
"3004","GO_BP","500389_GO_0031102_NEURON_PROJECTION_REGENERATION",25,-1.6519,0.017,0.048,"No",-1.4996,0.044,0.82,"No"
"3005","GO_BP","499181_GO_0021902_COMMITMENT_OF_NEURONAL_CELL_TO_SPECIFIC_NEURON_TYPE_IN_FOREBRAIN",6,-1.6516,0.01,0.048,"No",-1.7077,0.006,0.7,"No"
"3006","C2_BioCarta_Pathways","C2_CP_BIOCARTA_75_BIOCARTA_FMLP_PATHWAY",35,-1.6516,0.01,0.07,"No",0.5574,1,1,"Yes"
"3007","GO_BP","1129485_GO_1903659_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY",5,-1.6515,0.007,0.048,"No",-1.3749,0.11,0.99,"No"
"3008","GO_BP","514896_GO_0061351_NEURAL_PRECURSOR_CELL_PROLIFERATION",64,-1.6515,0.0066,0.048,"No",-0.8754,0.68,1,"No"
"3009","GO_BP","512973_GO_0052126_MOVEMENT_IN_HOST_ENVIRONMENT",56,-1.6514,0.0027,0.048,"No",-1.0309,0.4,0.98,"No"
"3010","GO_BP","508113_GO_0045776_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE",41,-1.6514,0.0072,0.048,"No",-1.3007,0.11,0.89,"No"
"3011","GO_BP","507799_GO_0045445_MYOBLAST_DIFFERENTIATION",33,-1.6512,0.0042,0.048,"No",-0.822,0.75,1,"No"
"3012","C2_Chemical_and_genetic_perturbations","C2_CGP_295_KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN",322,-1.6511,0,0.025,"No",-0.9184,0.72,1,"No"
"3013","GO_BP","511845_GO_0050908_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_VISUAL_PERCEPTION",16,-1.6511,0.0093,0.048,"No",-1.7026,0.006,0.69,"No"
"3014","GO_BP","501973_GO_0032747_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION",5,-1.651,0.007,0.048,"No",-1.3283,0.14,0.89,"No"
"3015","GO_MF","490348_GO_0051019_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING",21,-1.6509,0.006,0.082,"No",-0.6736,0.91,1,"No"
"3016","C2_BioCarta_Pathways","C2_CP_BIOCARTA_67_BIOCARTA_ERYTH_PATHWAY",15,-1.6508,0.016,0.068,"No",-1.5139,0.054,1,"No"
"3017","GO_BP","516295_GO_0071371_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS",18,-1.6507,0.013,0.048,"No",-1.0069,0.44,0.98,"No"
"3018","C7_Immunologic_signatures","C7_ALL_1808_GSE7852_TREG_VS_TCONV_LN_DN",199,-1.6505,0,0.00042,"No",-0.791,0.95,1,"No"
"3019","GO_BP","513148_GO_0052305_POSITIVE_REGULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6503,0.012,0.048,"No",0.8203,0.67,1,"Yes"
"3020","KEGG_module","HSA_M00684_JAK_STAT_SIGNALING",19,-1.6502,0.016,0.11,"No",-0.9,0.57,1,"No"
"3021","C3_TF_targets","C3_TFT_472_V_CP2_02",243,-1.6502,0,0.0088,"No",-1.2703,0.034,0.26,"No"
"3022","GO_BP","505305_GO_0042133_NEUROTRANSMITTER_METABOLIC_PROCESS",24,-1.65,0.015,0.048,"No",-0.8527,0.66,1,"No"
"3023","GO_BP","488629_GO_0002756_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",81,-1.6497,0,0.048,"No",-0.9062,0.62,1,"No"
"3024","GO_MF","490291_GO_0005005_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY",9,-1.6496,0.013,0.083,"No",-1.2821,0.19,0.81,"No"
"3025","C2_Chemical_and_genetic_perturbations","C2_CGP_2197_OSADA_ASCL1_TARGETS_DN",24,-1.6495,0.011,0.025,"No",-0.7381,0.84,1,"No"
"3026","REACTOME","106461_REACT_12033_SIGNALLING_TO_RAS",34,-1.6492,0.0045,0.057,"No",-0.5291,1,1,"No"
"3027","GO_BP","506345_GO_0043280_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",120,-1.6488,0.0012,0.049,"No",0.8505,0.83,1,"Yes"
"3028","C2_BioCarta_Pathways","C2_CP_BIOCARTA_177_BIOCARTA_BARRESTIN_SRC_PATHWAY",14,-1.6487,0.013,0.068,"No",-1.0998,0.32,1,"No"
"3029","C2_Chemical_and_genetic_perturbations","C2_CGP_2965_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1",9,-1.6486,0.013,0.025,"No",0.8331,0.67,0.97,"Yes"
"3030","GO_BP","487589_GO_0001678_CELLULAR_GLUCOSE_HOMEOSTASIS",61,-1.6485,0.0013,0.049,"No",0.8143,0.82,1,"Yes"
"3031","C2_Chemical_and_genetic_perturbations","C2_CGP_1076_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP",11,-1.6484,0.016,0.025,"No",-1.2135,0.23,0.79,"No"
"3032","GO_BP","921131_GO_1902532_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION",376,-1.6483,0,0.049,"No",0.7209,1,1,"Yes"
"3033","GO_MF","490442_GO_0005178_INTEGRIN_BINDING",103,-1.6483,0.0012,0.083,"No",-0.7263,0.96,1,"No"
"3034","C2_Chemical_and_genetic_perturbations","C2_CGP_1176_MORI_LARGE_PRE_BII_LYMPHOCYTE_UP",86,-1.648,0.0038,0.025,"No",0.8846,0.74,0.94,"Yes"
"3035","GO_MF","490428_GO_0005164_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING",31,-1.648,0.015,0.083,"No",-1.0496,0.36,0.86,"No"
"3036","GO_MF","489645_GO_0004180_CARBOXYPEPTIDASE_ACTIVITY",37,-1.6479,0.0099,0.082,"No",-0.5442,0.99,1,"No"
"3037","C2_Chemical_and_genetic_perturbations","C2_CGP_3370_SMIRNOV_RESPONSE_TO_IR_2HR_DN",55,-1.6479,0.0039,0.025,"No",-1.2929,0.11,0.71,"No"
"3038","REACTOME","685549_REACT_147694_DAP12_INTERACTIONS",172,-1.6476,0,0.058,"No",-1.0505,0.34,0.94,"No"
"3039","C2_Chemical_and_genetic_perturbations","C2_CGP_3048_KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN",80,-1.6476,0.0026,0.025,"No",-0.8753,0.72,1,"No"
"3040","C2_Chemical_and_genetic_perturbations","C2_CGP_3070_HOELZEL_NF1_TARGETS_UP",135,-1.6474,0.0012,0.025,"No",1.1936,0.1,0.5,"Yes"
"3041","C2_Chemical_and_genetic_perturbations","C2_CGP_2060_GAVIN_FOXP3_TARGETS_CLUSTER_P2",78,-1.6474,0.0038,0.025,"No",0.9581,0.54,0.86,"Yes"
"3042","GO_BP","500307_GO_0031017_EXOCRINE_PANCREAS_DEVELOPMENT",8,-1.6474,0.017,0.049,"No",1.0075,0.47,0.98,"Yes"
"3043","GO_BP","507425_GO_0045017_GLYCEROLIPID_BIOSYNTHETIC_PROCESS",209,-1.6469,0,0.049,"No",-0.6786,0.99,1,"No"
"3044","GO_BP","506443_GO_0043405_REGULATION_OF_MAP_KINASE_ACTIVITY",283,-1.6469,0,0.049,"No",-0.6909,1,1,"No"
"3045","C4_Cancer_gene_neighborhoods","C4_CGN_323_GNF2_BUB1B",49,-1.6469,0.0068,0.014,"No",-0.6937,0.95,1,"No"
"3046","C3_TF_targets","C3_TFT_151_V_OCT_C",250,-1.6467,0,0.0089,"No",-1.4689,0.0035,0.13,"No"
"3047","GO_BP","513017_GO_0052173_RESPONSE_TO_DEFENSES_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",14,-1.6467,0.016,0.049,"No",1.064,0.35,0.94,"Yes"
"3048","GO_BP","518462_GO_0090322_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS",18,-1.6467,0.0078,0.049,"No",0.7969,0.78,1,"Yes"
"3049","GO_CC","850015_GO_1990104_DNA_BENDING_COMPLEX",93,-1.6466,0,0.08,"No",-1.7534,0,0.18,"No"
"3050","C2_Chemical_and_genetic_perturbations","C2_CGP_1543_MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP",401,-1.6465,0,0.026,"No",-1.3423,0.0065,0.7,"No"
"3051","GO_BP","487578_GO_0001666_RESPONSE_TO_HYPOXIA",243,-1.6464,0,0.049,"No",0.8318,0.94,1,"Yes"
"3052","GO_CC","506272_GO_0043204_PERIKARYON",64,-1.6464,0.0027,0.079,"No",-0.9655,0.52,0.89,"No"
"3053","GO_BP","514910_GO_0061365_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY",11,-1.6464,0.016,0.049,"No",-1.4086,0.1,0.97,"No"
"3054","GO_BP","513312_GO_0052572_RESPONSE_TO_HOST_IMMUNE_RESPONSE",12,-1.6464,0.0096,0.049,"No",1.1084,0.32,0.89,"Yes"
"3055","GO_BP","488552_GO_0002679_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE",5,-1.6462,0.0086,0.049,"No",-0.5461,0.96,1,"No"
"3056","GO_BP","513014_GO_0052169_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_MODULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE",6,-1.6461,0.012,0.049,"No",0.799,0.71,1,"Yes"
"3057","C7_Immunologic_signatures","C7_ALL_1017_GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP",197,-1.646,0,0.00048,"No",1.7164,0,0.00044,"Yes"
"3058","GO_BP","518836_GO_2000188_REGULATION_OF_CHOLESTEROL_HOMEOSTASIS",11,-1.6459,0.021,0.049,"No",-1.2362,0.21,0.9,"No"
"3059","GO_BP","513100_GO_0052257_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_INDUCTION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6458,0.0085,0.049,"No",0.8109,0.71,1,"Yes"
"3060","GO_BP","519154_GO_2000514_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",33,-1.6458,0.013,0.049,"No",-1.5212,0.028,0.79,"No"
"3061","C2_Chemical_and_genetic_perturbations","C2_CGP_390_DELYS_THYROID_CANCER_DN",224,-1.6457,0,0.026,"No",-0.9848,0.51,1,"No"
"3062","GO_BP","500197_GO_0030902_HINDBRAIN_DEVELOPMENT",128,-1.6457,0.0012,0.049,"No",-1.1042,0.24,0.94,"No"
"3063","GO_BP","504643_GO_0035459_CARGO_LOADING_INTO_VESICLE",6,-1.6457,0.0069,0.049,"No",1.2188,0.26,0.76,"Yes"
"3064","KEGG_compound","C00279_D_ERYTHROSE_4_PHOSPHATE",7,-1.6455,0.0051,0.064,"No",-0.7808,0.77,1,"No"
"3065","GO_BP","753392_GO_1900408_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",27,-1.6454,0.0042,0.049,"No",1.2724,0.13,0.71,"Yes"
"3066","C2_Chemical_and_genetic_perturbations","C2_CGP_3295_TIAN_BHLHA15_TARGETS",16,-1.6453,0.014,0.026,"No",-1.1273,0.31,0.89,"No"
"3067","C3_TF_targets","C3_TFT_563_TTGCWCAAY_V_CEBPB_02",63,-1.6453,0.0079,0.0088,"No",-0.756,0.92,1,"No"
"3068","C2_Chemical_and_genetic_perturbations","C2_CGP_412_LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN",140,-1.6452,0,0.026,"No",1.1488,0.15,0.56,"Yes"
"3069","GO_MF","490634_GO_0005536_GLUCOSE_BINDING",8,-1.6452,0.0067,0.084,"No",-1.3245,0.16,0.73,"No"
"3070","C2_Chemical_and_genetic_perturbations","C2_CGP_2067_GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN",5,-1.6451,0.012,0.026,"No",-0.8071,0.72,1,"No"
"3071","C2_Chemical_and_genetic_perturbations","C2_CGP_2941_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15",34,-1.645,0.0044,0.026,"No",0.8391,0.73,0.98,"Yes"
"3072","GO_BP","499623_GO_0030213_HYALURONAN_BIOSYNTHETIC_PROCESS",6,-1.6449,0.012,0.05,"No",-0.88,0.62,1,"No"
"3073","REACTOME","1183537_REACT_355585_DISEASES_ASSOCIATED_WITH_THE_TLR_SIGNALING_CASCADE",23,-1.6449,0.013,0.059,"No",-0.4802,1,1,"No"
"3074","GO_BP","504618_GO_0035434_COPPER_ION_TRANSMEMBRANE_TRANSPORT",7,-1.6448,0.0066,0.05,"No",-0.8903,0.57,1,"No"
"3075","GO_MF","490310_GO_0005021_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",7,-1.6448,0.0035,0.084,"No",0.584,0.94,1,"Yes"
"3076","GO_BP","516722_GO_0071799_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_D_STIMULUS",5,-1.6447,0.013,0.05,"No",0.9876,0.48,0.99,"Yes"
"3077","GO_BP","752738_GO_0097237_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE",19,-1.6446,0.011,0.05,"No",-0.9,0.57,1,"No"
"3078","GO_BP","1022187_GO_1903201_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH",39,-1.6445,0.013,0.05,"No",1.0058,0.45,0.98,"Yes"
"3079","GO_BP","1053346_GO_0098739_IMPORT_ACROSS_PLASMA_MEMBRANE",6,-1.6442,0.0098,0.05,"No",-1.6848,0.025,0.58,"No"
"3080","C2_Chemical_and_genetic_perturbations","C2_CGP_1985_GERHOLD_ADIPOGENESIS_UP",49,-1.6441,0.0067,0.026,"No",1.2995,0.093,0.39,"Yes"
"3081","GO_BP","498627_GO_0046686_RESPONSE_TO_CADMIUM_ION",38,-1.6439,0.0073,0.05,"No",0.815,0.79,1,"Yes"
"3082","GO_BP","518896_GO_2000249_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION",26,-1.6439,0.015,0.05,"No",-1.2017,0.22,0.89,"No"
"3083","C6_Oncogenic_signatures","C6_ALL_101_ALK_DN_V1_DN",134,-1.6439,0,0.0038,"No",-0.9998,0.45,0.68,"No"
"3084","C6_Oncogenic_signatures","C6_ALL_180_KRAS_KIDNEY_UP_V1_DN",126,-1.6438,0.0025,0.0037,"No",-1.2814,0.056,0.34,"No"
"3085","GO_BP","505634_GO_0042503_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",6,-1.6437,0.012,0.05,"No",-1.2939,0.18,0.88,"No"
"3086","GO_BP","488816_GO_0003018_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM",99,-1.6437,0.0025,0.05,"No",1.2119,0.12,0.77,"Yes"
"3087","C2_Chemical_and_genetic_perturbations","C2_CGP_1506_NUMATA_CSF3_SIGNALING_VIA_STAT3",22,-1.6436,0.0077,0.026,"No",-1.0436,0.38,0.98,"No"
"3088","GO_MF","502036_GO_0032813_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING",44,-1.6436,0.0028,0.084,"No",-0.8525,0.72,1,"No"
"3089","GO_BP","498208_GO_0019364_PYRIDINE_NUCLEOTIDE_CATABOLIC_PROCESS",42,-1.6435,0.01,0.05,"No",-1.0321,0.41,0.98,"No"
"3090","C6_Oncogenic_signatures","C6_ALL_42_ATF2_UP_V1_UP",178,-1.6435,0,0.0037,"No",-1.0596,0.31,0.6,"No"
"3091","C2_Chemical_and_genetic_perturbations","C2_CGP_2013_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST",128,-1.6434,0.0024,0.026,"No",1.4537,0.0094,0.25,"Yes"
"3092","C2_Chemical_and_genetic_perturbations","C2_CGP_2018_YANG_MUC2_TARGETS_DUODENUM_6MO_DN",19,-1.6434,0.012,0.026,"No",-1.5593,0.051,0.43,"No"
"3093","C6_Oncogenic_signatures","C6_ALL_50_RELA_DN_V1_UP",146,-1.6433,0.0012,0.0036,"No",-1.4662,0.015,0.28,"No"
"3094","C2_Chemical_and_genetic_perturbations","C2_CGP_130_LIU_TARGETS_OF_VMYB_VS_CMYB_DN",43,-1.6427,0.0057,0.026,"No",0.8282,0.79,0.98,"Yes"
"3095","KEGG_pathway","HSA00071_FATTY_ACID_DEGRADATION",44,-1.6426,0.0096,0.011,"No",0.5509,1,1,"Yes"
"3096","GO_BP","516316_GO_0071392_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS",21,-1.6426,0.021,0.05,"No",-1.0963,0.31,0.94,"No"
"3097","GO_BP","514609_GO_0061061_MUSCLE_STRUCTURE_DEVELOPMENT",434,-1.6425,0,0.05,"No",-1.1248,0.13,0.94,"No"
"3098","C7_Immunologic_signatures","C7_ALL_1806_GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN",199,-1.6425,0,0.00053,"No",0.7338,1,1,"Yes"
"3099","C2_Chemical_and_genetic_perturbations","C2_CGP_1729_LINDVALL_IMMORTALIZED_BY_TERT_UP",75,-1.6424,0.0039,0.026,"No",-0.9709,0.5,1,"No"
"3100","C2_Chemical_and_genetic_perturbations","C2_CGP_974_WILLIAMS_ESR2_TARGETS_UP",27,-1.6424,0.014,0.026,"No",-1.2832,0.13,0.69,"No"
"3101","GO_BP","753518_GO_1900543_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_METABOLIC_PROCESS",88,-1.6424,0.0012,0.05,"No",1.1175,0.23,0.88,"Yes"
"3102","GO_BP","502096_GO_0032874_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE",118,-1.6424,0,0.05,"No",-1.3791,0.02,0.98,"No"
"3103","GO_MF","487771_GO_0001875_LIPOPOLYSACCHARIDE_RECEPTOR_ACTIVITY",5,-1.6423,0.009,0.085,"No",-0.8195,0.67,1,"No"
"3104","C3_TF_targets","C3_TFT_356_V_TEF_Q6",246,-1.6421,0,0.0089,"No",-1.0563,0.31,0.64,"No"
"3105","GO_BP","501506_GO_0032271_REGULATION_OF_PROTEIN_POLYMERIZATION",137,-1.642,0.0012,0.05,"No",-0.8957,0.7,1,"No"
"3106","C2_Chemical_and_genetic_perturbations","C2_CGP_569_OLSSON_E2F3_TARGETS_DN",47,-1.642,0.0055,0.026,"No",1.0405,0.36,0.73,"Yes"
"3107","GO_MF","490644_GO_0005549_ODORANT_BINDING",62,-1.6419,0.0026,0.084,"No",1.8602,0,0.043,"Yes"
"3108","C6_Oncogenic_signatures","C6_ALL_41_ATF2_UP_V1_DN",176,-1.6417,0,0.0036,"No",-1.1789,0.11,0.47,"No"
"3109","GO_CC","500494_GO_0031233_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",23,-1.6417,0.015,0.081,"No",1.1812,0.22,0.55,"Yes"
"3110","C6_Oncogenic_signatures","C6_ALL_75_PRC2_EZH2_UP_V1_DN",187,-1.6416,0,0.0036,"No",-1.063,0.29,0.61,"No"
"3111","C6_Oncogenic_signatures","C6_ALL_17_CYCLIN_D1_KE_V1_DN",183,-1.6412,0,0.0035,"No",1.3397,0.016,0.32,"Yes"
"3112","GO_CC","500495_GO_0031234_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE",95,-1.6411,0.0038,0.08,"No",-0.9567,0.55,0.9,"No"
"3113","C2_Chemical_and_genetic_perturbations","C2_CGP_3252_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5",11,-1.641,0.019,0.027,"No",-1.531,0.045,0.45,"No"
"3114","GO_BP","507800_GO_0045446_ENDOTHELIAL_CELL_DIFFERENTIATION",72,-1.6407,0.0026,0.051,"No",0.7496,0.93,1,"Yes"
"3115","GO_BP","507458_GO_0045058_T_CELL_SELECTION",33,-1.6406,0.0074,0.051,"No",-0.7828,0.81,1,"No"
"3116","GO_BP","500390_GO_0031103_AXON_REGENERATION",18,-1.6405,0.018,0.051,"No",-1.1757,0.26,0.9,"No"
"3117","GO_BP","1129337_GO_1903510_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS",120,-1.6404,0,0.051,"No",-0.776,0.95,1,"No"
"3118","KEGG_compound","C05382_SEDOHEPTULOSE_7_PHOSPHATE_D_SEDOHEPTULOSE_7_PHOSPHATE_D_ALTRO_HEPTULOSE_7_PHOSPHATE_ALTRO_HEPTULOSE_7_PHOSPHATE",5,-1.6404,0.013,0.066,"No",-0.5355,0.97,1,"No"
"3119","KEGG_module","HSA_M00131_INOSITOL_PHOSPHATE_METABOLISM_INS_1_3_4_5_P4_INS_1_3_4_P3_MYO_INOSITOL",9,-1.6404,0.015,0.11,"No",-0.9161,0.57,1,"No"
"3120","GO_BP","487918_GO_0002028_REGULATION_OF_SODIUM_ION_TRANSPORT",67,-1.6403,0.0026,0.051,"No",-1.6093,0.0038,0.71,"No"
"3121","GO_BP","507930_GO_0045582_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION",63,-1.6402,0.0026,0.051,"No",-1.0105,0.45,0.98,"No"
"3122","C3_TF_targets","C3_TFT_244_V_FOXJ2_01",178,-1.6402,0,0.009,"No",-1.0187,0.41,0.72,"No"
"3123","KEGG_pathway","HSA04066_HIF_1_SIGNALING_PATHWAY",101,-1.6401,0.0024,0.011,"No",-0.8303,0.84,1,"No"
"3124","C2_Chemical_and_genetic_perturbations","C2_CGP_1843_WELCSH_BRCA1_TARGETS_UP",197,-1.64,0,0.027,"No",1.5399,0,0.18,"Yes"
"3125","C2_Chemical_and_genetic_perturbations","C2_CGP_2918_MIKKELSEN_NPC_HCP_WITH_H3K27ME3",314,-1.6399,0,0.027,"No",-1.1706,0.092,0.82,"No"
"3126","C6_Oncogenic_signatures","C6_ALL_111_NOTCH_DN_V1_DN",173,-1.6398,0,0.0035,"No",-1.0824,0.28,0.58,"No"
"3127","GO_MF","499587_GO_0030169_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING",15,-1.6398,0.017,0.086,"No",0.8934,0.58,0.99,"Yes"
"3128","C3_TF_targets","C3_TFT_350_V_PEA3_Q6",256,-1.6396,0,0.0088,"No",0.8469,0.93,1,"Yes"
"3129","C2_Chemical_and_genetic_perturbations","C2_CGP_1836_LEE_AGING_CEREBELLUM_UP",82,-1.6395,0.0013,0.027,"No",-0.8234,0.82,1,"No"
"3130","GO_BP","518227_GO_0090087_REGULATION_OF_PEPTIDE_TRANSPORT",242,-1.6394,0,0.051,"No",-0.8933,0.79,1,"No"
"3131","GO_MF","495521_GO_0015267_CHANNEL_ACTIVITY",425,-1.6393,0,0.085,"No",-1.5309,0,0.54,"No"
"3132","C2_Chemical_and_genetic_perturbations","C2_CGP_1294_GNATENKO_PLATELET_SIGNATURE",47,-1.6391,0.0042,0.027,"No",1.8722,0,0.025,"Yes"
"3133","GO_BP","753116_GO_1900121_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING",10,-1.639,0.012,0.051,"No",1.0163,0.42,0.97,"Yes"
"3134","C2_Chemical_and_genetic_perturbations","C2_CGP_2804_UROSEVIC_RESPONSE_TO_IMIQUIMOD",23,-1.6389,0.01,0.027,"No",1.4326,0.07,0.27,"Yes"
"3135","C2_Chemical_and_genetic_perturbations","C2_CGP_788_TERAMOTO_OPN_TARGETS_CLUSTER_7",19,-1.6389,0.014,0.027,"No",-1.4988,0.045,0.46,"No"
"3136","KEGG_pathway","HSA01212_FATTY_ACID_METABOLISM",49,-1.6388,0.0041,0.012,"No",-0.8073,0.81,0.99,"No"
"3137","C2_Chemical_and_genetic_perturbations","C2_CGP_3302_REICHERT_MITOSIS_LIN9_TARGETS",28,-1.6387,0.0072,0.027,"No",-0.8655,0.67,1,"No"
"3138","REACTOME","187221_REACT_25210_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI",5,-1.6386,0.0069,0.063,"No",-0.567,0.95,1,"No"
"3139","GO_BP","488666_GO_0002793_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION",68,-1.6385,0.0052,0.052,"No",0.7369,0.94,1,"Yes"
"3140","GO_BP","512677_GO_0051806_ENTRY_INTO_CELL_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",56,-1.6384,0.0041,0.052,"No",-1.0312,0.39,0.98,"No"
"3141","C2_Chemical_and_genetic_perturbations","C2_CGP_298_SABATES_COLORECTAL_ADENOMA_UP",128,-1.6384,0,0.027,"No",-0.9882,0.47,1,"No"
"3142","GO_BP","782511_GO_0038179_NEUROTROPHIN_SIGNALING_PATHWAY",272,-1.6383,0,0.052,"No",-0.9333,0.67,1,"No"
"3143","C2_Chemical_and_genetic_perturbations","C2_CGP_1792_RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP",17,-1.6382,0.011,0.027,"No",0.8429,0.68,0.97,"Yes"
"3144","REACTOME","685555_REACT_147707_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS",15,-1.6382,0.021,0.063,"No",1.5323,0.039,0.13,"Yes"
"3145","GO_BP","499598_GO_0030183_B_CELL_DIFFERENTIATION",85,-1.6382,0.0026,0.052,"No",-1.0859,0.3,0.96,"No"
"3146","KEGG_module","HSA_M00549_NUCLEOTIDE_SUGAR_BIOSYNTHESIS_GLUCOSE_UDP_GLUCOSE",7,-1.6381,0.01,0.1,"No",-0.9262,0.53,1,"No"
"3147","GO_BP","516200_GO_0071276_CELLULAR_RESPONSE_TO_CADMIUM_ION",15,-1.638,0.015,0.052,"No",1.1632,0.25,0.82,"Yes"
"3148","C7_Immunologic_signatures","C7_ALL_842_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN",193,-1.6379,0,0.00059,"No",0.9514,0.58,0.89,"Yes"
"3149","C4_Cancer_modules","C4_CM_124_MODULE_129",216,-1.6379,0,0.022,"No",-1.0827,0.25,0.69,"No"
"3150","C2_Chemical_and_genetic_perturbations","C2_CGP_2474_BOYLAN_MULTIPLE_MYELOMA_C_DN",56,-1.6378,0.0066,0.027,"No",-0.8194,0.81,1,"No"
"3151","GO_BP","503961_GO_0034762_REGULATION_OF_TRANSMEMBRANE_TRANSPORT",350,-1.6378,0,0.052,"No",-1.3131,0.013,0.87,"No"
"3152","GO_BP","492551_GO_0008210_ESTROGEN_METABOLIC_PROCESS",20,-1.6376,0.017,0.052,"No",0.9127,0.6,1,"Yes"
"3153","GO_BP","512698_GO_0051828_ENTRY_INTO_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",56,-1.6376,0.0054,0.052,"No",-1.0321,0.39,0.98,"No"
"3154","GO_BP","492391_GO_0008016_REGULATION_OF_HEART_CONTRACTION",155,-1.6376,0.0012,0.052,"No",-1.2317,0.094,0.9,"No"
"3155","GO_BP","505271_GO_0042092_TYPE_2_IMMUNE_RESPONSE",8,-1.6375,0.018,0.052,"No",-1.5571,0.04,0.72,"No"
"3156","GO_BP","512371_GO_0051493_REGULATION_OF_CYTOSKELETON_ORGANIZATION",378,-1.6374,0,0.052,"No",-1.0362,0.35,0.98,"No"
"3157","GO_BP","519040_GO_2000400_POSITIVE_REGULATION_OF_THYMOCYTE_AGGREGATION",11,-1.6373,0.015,0.052,"No",0.6668,0.9,1,"Yes"
"3158","GO_CC","503903_GO_0034703_CATION_CHANNEL_COMPLEX",161,-1.6372,0.0023,0.082,"No",-1.4568,0.0068,0.62,"No"
"3159","GO_BP","505535_GO_0042391_REGULATION_OF_MEMBRANE_POTENTIAL",281,-1.637,0,0.052,"No",-1.3788,0.0052,0.98,"No"
"3160","C3_TF_targets","C3_TFT_120_V_AP1_Q2",256,-1.637,0,0.0089,"No",-1.2022,0.087,0.35,"No"
"3161","GO_BP","503410_GO_0034204_LIPID_TRANSLOCATION",20,-1.6369,0.018,0.052,"No",-1.1323,0.28,0.93,"No"
"3162","KEGG_compound","C04756_O_1_ALK_1_ENYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_PHOSPHATIDALETHANOLAMINE_PLASMENYLETHANOLAMINE_ETHANOLAMINEPLASMALOGEN_2_ACYL_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_1_ALKENYL_2_ACYLGLYCEROPHOSPHOETHANOLAMINE",25,-1.6369,0.014,0.068,"No",0.6713,0.92,1,"Yes"
"3163","C2_Chemical_and_genetic_perturbations","C2_CGP_31_LIU_SOX4_TARGETS_UP",136,-1.6369,0,0.027,"No",0.8128,0.9,0.98,"Yes"
"3164","C2_Chemical_and_genetic_perturbations","C2_CGP_898_STANHILL_HRAS_TRANSFROMATION_UP",8,-1.6369,0.012,0.027,"No",-1.6034,0.021,0.42,"No"
"3165","C2_Chemical_and_genetic_perturbations","C2_CGP_645_RASHI_RESPONSE_TO_IONIZING_RADIATION_1",43,-1.6366,0.013,0.027,"No",-1.1444,0.25,0.85,"No"
"3166","C2_Chemical_and_genetic_perturbations","C2_CGP_327_GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN",46,-1.6366,0.015,0.027,"No",0.959,0.51,0.86,"Yes"
"3167","KEGG_pathway","HSA04270_VASCULAR_SMOOTH_MUSCLE_CONTRACTION",116,-1.6363,0.0012,0.012,"No",-1.0443,0.34,0.77,"No"
"3168","C3_TF_targets","C3_TFT_133_V_AP1_Q4",266,-1.6363,0,0.0088,"No",-1.243,0.064,0.29,"No"
"3169","C2_Chemical_and_genetic_perturbations","C2_CGP_3142_MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN",221,-1.6362,0.0011,0.027,"No",0.955,0.61,0.86,"Yes"
"3170","GO_BP","511810_GO_0050868_NEGATIVE_REGULATION_OF_T_CELL_ACTIVATION",74,-1.6361,0,0.052,"No",-0.8525,0.78,1,"No"
"3171","WikiPathways","198869_WP80_NUCLEOTIDE_GPCRS",11,-1.6361,0.019,0.034,"No",1.1798,0.24,0.97,"Yes"
"3172","GO_MF","495362_GO_0015079_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",137,-1.6361,0,0.088,"No",-1.1863,0.15,0.79,"No"
"3173","C7_Immunologic_signatures","C7_ALL_1713_GSE3982_NKCELL_VS_TH2_UP",192,-1.636,0.0022,0.00063,"No",-0.9677,0.54,1,"No"
"3174","C7_Immunologic_signatures","C7_ALL_1773_GSE7460_CD8_TCELL_VS_TREG_ACT_UP",194,-1.6359,0,0.00063,"No",-0.8855,0.75,1,"No"
"3175","C2_Chemical_and_genetic_perturbations","C2_CGP_235_AKL_HTLV1_INFECTION_DN",67,-1.6359,0.0026,0.027,"No",1.2503,0.12,0.44,"Yes"
"3176","C2_Chemical_and_genetic_perturbations","C2_CGP_2084_SANSOM_WNT_PATHWAY_REQUIRE_MYC",57,-1.6359,0.004,0.027,"No",-1.3042,0.075,0.69,"No"
"3177","C4_Cancer_modules","C4_CM_200_MODULE_213",79,-1.6356,0.0038,0.022,"No",1.0034,0.45,0.7,"Yes"
"3178","GO_BP","499682_GO_0030278_REGULATION_OF_OSSIFICATION",170,-1.6356,0.0023,0.052,"No",-1.0988,0.24,0.95,"No"
"3179","GO_BP","751211_GO_0036293_RESPONSE_TO_DECREASED_OXYGEN_LEVELS",260,-1.6354,0,0.052,"No",-0.8028,0.96,1,"No"
"3180","WikiPathways","198873_WP357_FATTY_ACID_BIOSYNTHESIS",22,-1.6353,0.013,0.033,"No",0.6469,0.95,1,"Yes"
"3181","GO_BP","505268_GO_0042089_CYTOKINE_BIOSYNTHETIC_PROCESS",17,-1.6353,0.022,0.052,"No",-0.9293,0.55,1,"No"
"3182","C2_Chemical_and_genetic_perturbations","C2_CGP_395_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP",118,-1.6353,0,0.027,"No",1.1834,0.13,0.51,"Yes"
"3183","GO_BP","515595_GO_0070665_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION",120,-1.6352,0,0.052,"No",-0.7161,0.98,1,"No"
"3184","REACTOME","187223_REACT_25208_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI",20,-1.6348,0.013,0.064,"No",-0.6042,0.97,1,"No"
"3185","C7_Immunologic_signatures","C7_ALL_1401_GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP",192,-1.634,0.0011,0.00065,"No",1.6416,0,0.0014,"Yes"
"3186","GO_BP","500029_GO_0030728_OVULATION",18,-1.634,0.011,0.053,"No",1.1034,0.33,0.9,"Yes"
"3187","GO_BP","512058_GO_0051148_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION",49,-1.6338,0.007,0.053,"No",-1.211,0.15,0.88,"No"
"3188","GO_BP","511800_GO_0050857_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",13,-1.6338,0.016,0.053,"No",0.5055,0.99,1,"Yes"
"3189","GO_MF","498721_GO_0019955_CYTOKINE_BINDING",83,-1.6338,0.0025,0.089,"No",1.3959,0.038,0.48,"Yes"
"3190","GO_MF","487910_GO_0002020_PROTEASE_BINDING",90,-1.6338,0.0013,0.089,"No",0.9504,0.59,0.93,"Yes"
"3191","C2_Chemical_and_genetic_perturbations","C2_CGP_2489_VILIMAS_NOTCH1_TARGETS_DN",19,-1.6337,0.016,0.028,"No",0.8402,0.69,0.98,"Yes"
"3192","GO_MF","486557_GO_0051082_UNFOLDED_PROTEIN_BINDING",94,-1.6336,0.0013,0.088,"No",-1.0069,0.4,0.89,"No"
"3193","REACTOME","106513_REACT_13685_NEURONAL_SYSTEM",284,-1.6335,0,0.065,"No",-1.5692,0,0.36,"No"
"3194","C7_Immunologic_signatures","C7_ALL_727_GSE17721_12H_VS_24H_POLYIC_BMDM_UP",199,-1.6335,0,0.00065,"No",0.8609,0.88,1,"Yes"
"3195","GO_BP","946743_GO_1902624_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION",18,-1.6334,0.016,0.053,"No",0.7731,0.8,1,"Yes"
"3196","GO_BP","493281_GO_0009080_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",5,-1.6333,0.007,0.053,"No",-1.3661,0.12,0.99,"No"
"3197","GO_BP","751794_GO_0044650_ADHESION_OF_SYMBIONT_TO_HOST_CELL",9,-1.6331,0.019,0.053,"No",-0.7635,0.76,1,"No"
"3198","REACTOME","105709_REACT_13425_MISCELLANEOUS_SUBSTRATES",12,-1.633,0.014,0.065,"No",-1.1646,0.26,0.85,"No"
"3199","C7_Immunologic_signatures","C7_ALL_1396_GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN",200,-1.6329,0,0.00067,"No",1.106,0.22,0.43,"Yes"
"3200","GO_MF","490563_GO_0005375_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-1.6328,0.017,0.088,"No",-0.8966,0.57,0.99,"No"
"3201","GO_BP","509045_GO_0046822_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT",188,-1.6328,0,0.053,"No",-0.9877,0.47,1,"No"
"3202","C7_Immunologic_signatures","C7_ALL_507_GSE17721_CTRL_VS_CPG_12H_BMDM_UP",197,-1.6327,0,0.00068,"No",1.1054,0.22,0.43,"Yes"
"3203","GO_BP","495248_GO_0014854_RESPONSE_TO_INACTIVITY",8,-1.6326,0.0099,0.053,"No",-1.1842,0.27,0.91,"No"
"3204","WikiPathways","712094_WP2406_CARDIAC_PROGENITOR_DIFFERENTIATION",51,-1.6326,0.0054,0.033,"No",-1.2552,0.13,0.86,"No"
"3205","GO_MF","492826_GO_0015662_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_PHOSPHORYLATIVE_MECHANISM",31,-1.6326,0.013,0.088,"No",-1.1451,0.25,0.81,"No"
"3206","C2_Chemical_and_genetic_perturbations","C2_CGP_804_DACOSTA_UV_RESPONSE_VIA_ERCC3_UP",307,-1.6324,0,0.028,"No",-1.2259,0.054,0.77,"No"
"3207","C2_Chemical_and_genetic_perturbations","C2_CGP_2748_WOO_LIVER_CANCER_RECURRENCE_UP",105,-1.6322,0,0.028,"No",-0.7487,0.97,1,"No"
"3208","C2_Chemical_and_genetic_perturbations","C2_CGP_2581_HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP",42,-1.6322,0.0057,0.028,"No",0.849,0.72,0.97,"Yes"
"3209","C7_Immunologic_signatures","C7_ALL_1789_GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP",198,-1.6321,0,0.00069,"No",1.1369,0.15,0.35,"Yes"
"3210","REACTOME","106481_REACT_12433_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION_",24,-1.632,0.0088,0.065,"No",-0.9319,0.57,1,"No"
"3211","C2_Chemical_and_genetic_perturbations","C2_CGP_1301_LEE_LIVER_CANCER_MYC_UP",53,-1.6319,0.007,0.028,"No",1.6357,0.0022,0.12,"Yes"
"3212","GO_MF","495511_GO_0015250_WATER_CHANNEL_ACTIVITY",11,-1.6318,0.011,0.088,"No",-0.6045,0.95,1,"No"
"3213","GO_MF","505331_GO_0042169_SH2_DOMAIN_BINDING",30,-1.6318,0.0043,0.087,"No",-0.8156,0.76,1,"No"
"3214","C2_Chemical_and_genetic_perturbations","C2_CGP_2231_MCCABE_HOXC6_TARGETS_DN",21,-1.6317,0.018,0.028,"No",-0.8876,0.62,1,"No"
"3215","GO_BP","501719_GO_0032487_REGULATION_OF_RAP_PROTEIN_SIGNAL_TRANSDUCTION",480,-1.6316,0,0.054,"No",-1.3401,0.0016,0.91,"No"
"3216","GO_BP","849817_GO_0097479_SYNAPTIC_VESICLE_LOCALIZATION",118,-1.6315,0,0.054,"No",0.8479,0.84,1,"Yes"
"3217","GO_BP","500149_GO_0030851_GRANULOCYTE_DIFFERENTIATION",16,-1.6315,0.026,0.054,"No",0.7634,0.78,1,"Yes"
"3218","C2_Chemical_and_genetic_perturbations","C2_CGP_2428_CROMER_TUMORIGENESIS_UP",59,-1.6315,0.004,0.028,"No",1.1766,0.17,0.52,"Yes"
"3219","C2_Chemical_and_genetic_perturbations","C2_CGP_1920_SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER",41,-1.6311,0.0084,0.028,"No",-1.3588,0.067,0.66,"No"
"3220","GO_CC","911320_GO_0044815_DNA_PACKAGING_COMPLEX",99,-1.6311,0.0026,0.086,"No",-1.7298,0,0.19,"No"
"3221","C2_Chemical_and_genetic_perturbations","C2_CGP_393_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP",125,-1.631,0,0.028,"No",1.1101,0.25,0.61,"Yes"
"3222","REACTOME","106154_REACT_11059_ANDROGEN_BIOSYNTHESIS",11,-1.6309,0.022,0.065,"No",0.7236,0.81,1,"Yes"
"3223","GO_BP","494719_GO_0010656_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS",23,-1.6309,0.012,0.054,"No",0.7596,0.8,1,"Yes"
"3224","GO_BP","753999_GO_1901029_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",7,-1.6307,0.022,0.054,"No",-1.5,0.064,0.83,"No"
"3225","C2_Chemical_and_genetic_perturbations","C2_CGP_1587_GREENBAUM_E2A_TARGETS_UP",33,-1.6305,0.0043,0.028,"No",1.0866,0.33,0.65,"Yes"
"3226","C2_Chemical_and_genetic_perturbations","C2_CGP_2914_MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3",129,-1.6303,0,0.028,"No",-1.0084,0.46,0.99,"No"
"3227","C6_Oncogenic_signatures","C6_ALL_136_IL2_UP_V1_UP",182,-1.6303,0,0.0039,"No",-0.9971,0.46,0.68,"No"
"3228","C2_Chemical_and_genetic_perturbations","C2_CGP_1822_BURTON_ADIPOGENESIS_PEAK_AT_24HR",42,-1.6301,0.0041,0.028,"No",-0.9578,0.51,1,"No"
"3229","C7_Immunologic_signatures","C7_ALL_280_GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN",200,-1.63,0,0.00071,"No",1.2367,0.051,0.17,"Yes"
"3230","REACTOME","106243_REACT_17029_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING",28,-1.63,0.022,0.065,"No",1.1779,0.21,0.47,"Yes"
"3231","C2_Chemical_and_genetic_perturbations","C2_CGP_1408_COLLER_MYC_TARGETS_UP",25,-1.6298,0.012,0.028,"No",0.6992,0.91,1,"Yes"
"3232","C2_Chemical_and_genetic_perturbations","C2_CGP_461_BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP",19,-1.6298,0.011,0.028,"No",1.0065,0.45,0.79,"Yes"
"3233","GO_BP","501249_GO_0032012_REGULATION_OF_ARF_PROTEIN_SIGNAL_TRANSDUCTION",477,-1.6298,0,0.055,"No",-1.3243,0.0067,0.89,"No"
"3234","REACTOME","530751_REACT_116105_GLYCOSPHINGOLIPID_METABOLISM",39,-1.6297,0.009,0.065,"No",-0.9059,0.6,1,"No"
"3235","WikiPathways","198877_WP384_APOPTOSIS_MODULATION_BY_HSP70",19,-1.6297,0.013,0.034,"No",-1.0379,0.41,0.96,"No"
"3236","GO_BP","494084_GO_0010001_GLIAL_CELL_DIFFERENTIATION",137,-1.6295,0.0023,0.055,"No",1.048,0.33,0.95,"Yes"
"3237","GO_CC","500515_GO_0031256_LEADING_EDGE_MEMBRANE",124,-1.6291,0.0012,0.086,"No",-0.8438,0.82,0.98,"No"
"3238","C4_Cancer_modules","C4_CM_360_MODULE_436",132,-1.629,0,0.023,"No",1.2933,0.054,0.29,"Yes"
"3239","GO_BP","506554_GO_0043523_REGULATION_OF_NEURON_APOPTOTIC_PROCESS",185,-1.6289,0,0.055,"No",-1.1535,0.16,0.92,"No"
"3240","GO_BP","513606_GO_0060048_CARDIAC_MUSCLE_CONTRACTION",43,-1.6289,0.0085,0.055,"No",-1.3332,0.077,0.91,"No"
"3241","GO_BP","504520_GO_0035336_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS",23,-1.6288,0.011,0.055,"No",-1.2257,0.16,0.88,"No"
"3242","GO_BP","492326_GO_0007584_RESPONSE_TO_NUTRIENT",180,-1.6288,0,0.055,"No",-0.823,0.91,1,"No"
"3243","C6_Oncogenic_signatures","C6_ALL_153_STK33_NOMO_DN",271,-1.6288,0,0.0039,"No",0.8346,0.94,1,"Yes"
"3244","GO_MF","751693_GO_0044548_S100_PROTEIN_BINDING",10,-1.6287,0.02,0.089,"No",-1.0349,0.4,0.88,"No"
"3245","GO_BP","499211_GO_0021932_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION",9,-1.6285,0.018,0.055,"No",0.6447,0.91,1,"Yes"
"3246","GO_MF","495441_GO_0015168_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",10,-1.6284,0.017,0.089,"No",-0.7672,0.78,1,"No"
"3247","GO_BP","497941_GO_0019062_VIRION_ATTACHMENT_TO_HOST_CELL",9,-1.6283,0.02,0.055,"No",-0.7636,0.79,1,"No"
"3248","C2_Chemical_and_genetic_perturbations","C2_CGP_405_BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP",27,-1.6282,0.015,0.029,"No",0.9857,0.47,0.81,"Yes"
"3249","GO_BP","500183_GO_0030888_REGULATION_OF_B_CELL_PROLIFERATION",57,-1.6282,0.0081,0.055,"No",-0.6935,0.96,1,"No"
"3250","C2_Chemical_and_genetic_perturbations","C2_CGP_1647_GENTILE_UV_LOW_DOSE_UP",27,-1.628,0.016,0.029,"No",-1.1015,0.31,0.91,"No"
"3251","C2_Chemical_and_genetic_perturbations","C2_CGP_117_CORRE_MULTIPLE_MYELOMA_DN",59,-1.628,0.0054,0.029,"No",0.7717,0.9,1,"Yes"
"3252","C2_Chemical_and_genetic_perturbations","C2_CGP_176_VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP",171,-1.6279,0,0.029,"No",0.9741,0.53,0.83,"Yes"
"3253","C2_Chemical_and_genetic_perturbations","C2_CGP_1913_WENG_POR_DOSAGE",19,-1.6278,0.017,0.029,"No",-1.3115,0.13,0.69,"No"
"3254","GO_BP","513301_GO_0052553_MODULATION_BY_SYMBIONT_OF_HOST_IMMUNE_RESPONSE",8,-1.6277,0.023,0.055,"No",0.6327,0.92,1,"Yes"
"3255","REACTOME","205111_REACT_27307_INTERLEUKIN_6_SIGNALING",11,-1.6276,0.015,0.066,"No",-0.7327,0.83,1,"No"
"3256","GO_BP","502113_GO_0032891_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT",19,-1.6275,0.022,0.055,"No",-1.1252,0.28,0.94,"No"
"3257","REACTOME","530735_REACT_115993_SHC1_EVENTS_IN_ERBB2_SIGNALING",32,-1.6273,0.0072,0.066,"No",-0.8176,0.75,1,"No"
"3258","GO_BP","495147_GO_0014075_RESPONSE_TO_AMINE",41,-1.6272,0.0043,0.055,"No",0.7087,0.92,1,"Yes"
"3259","GO_BP","491844_GO_0007009_PLASMA_MEMBRANE_ORGANIZATION",179,-1.6272,0,0.055,"No",0.8486,0.87,1,"Yes"
"3260","C7_Immunologic_signatures","C7_ALL_1819_GSE7852_LN_VS_THYMUS_TCONV_UP",197,-1.6271,0,0.00076,"No",0.8289,0.93,1,"Yes"
"3261","C6_Oncogenic_signatures","C6_ALL_188_LEF1_UP_V1_DN",186,-1.6271,0.0023,0.0039,"No",0.8208,0.94,0.99,"Yes"
"3262","WikiPathways","198814_WP534_GLYCOLYSIS_AND_GLUCONEOGENESIS",49,-1.627,0.0013,0.034,"No",0.9013,0.65,1,"Yes"
"3263","GO_BP","514723_GO_0061178_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",37,-1.6269,0.013,0.055,"No",0.9423,0.55,1,"Yes"
"3264","C2_Chemical_and_genetic_perturbations","C2_CGP_2737_KAPOSI_LIVER_CANCER_MET_UP",18,-1.6268,0.018,0.029,"No",-1.2458,0.19,0.75,"No"
"3265","C2_Chemical_and_genetic_perturbations","C2_CGP_2621_MIKKELSEN_PLURIPOTENT_STATE_DN",8,-1.6268,0.018,0.029,"No",-0.8505,0.67,1,"No"
"3266","GO_BP","508727_GO_0046466_MEMBRANE_LIPID_CATABOLIC_PROCESS",23,-1.6267,0.02,0.055,"No",-0.6612,0.93,1,"No"
"3267","REACTOME","905993_REACT_169436_OXIDATIVE_STRESS_INDUCED_SENESCENCE",118,-1.6266,0.0024,0.065,"No",-1.547,0.0035,0.39,"No"
"3268","C2_Chemical_and_genetic_perturbations","C2_CGP_2074_MARSON_FOXP3_CORE_DIRECT_TARGETS",19,-1.6266,0.012,0.029,"No",0.9295,0.55,0.89,"Yes"
"3269","GO_BP","752665_GO_0097164_AMMONIUM_ION_METABOLIC_PROCESS",159,-1.6264,0,0.056,"No",-1.0581,0.32,0.96,"No"
"3270","REACTOME","645297_REACT_121315_GLYCOSAMINOGLYCAN_METABOLISM",119,-1.6263,0,0.065,"No",0.9695,0.53,0.8,"Yes"
"3271","C2_BioCarta_Pathways","C2_CP_BIOCARTA_97_BIOCARTA_IL10_PATHWAY",17,-1.6263,0.012,0.079,"No",-1.119,0.31,1,"No"
"3272","GO_BP","504497_GO_0035313_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS",11,-1.6262,0.016,0.056,"No",-1.2304,0.21,0.89,"No"
"3273","C3_TF_targets","C3_TFT_377_V_COREBINDINGFACTOR_Q6",269,-1.6261,0,0.0094,"No",0.7828,0.99,1,"Yes"
"3274","C2_BioCarta_Pathways","C2_CP_BIOCARTA_107_BIOCARTA_INTEGRIN_PATHWAY",38,-1.626,0.013,0.077,"No",-0.8094,0.78,1,"No"
"3275","C3_TF_targets","C3_TFT_351_V_PTF1BETA_Q6",238,-1.626,0,0.0093,"No",-1.2791,0.043,0.25,"No"
"3276","C2_Chemical_and_genetic_perturbations","C2_CGP_1560_CROMER_METASTASIS_DN",79,-1.6259,0.0025,0.029,"No",-0.9354,0.59,1,"No"
"3277","GO_BP","494303_GO_0010226_RESPONSE_TO_LITHIUM_ION",25,-1.6258,0.018,0.056,"No",-0.9084,0.6,1,"No"
"3278","GO_BP","506336_GO_0043270_POSITIVE_REGULATION_OF_ION_TRANSPORT",201,-1.6258,0,0.056,"No",-1.0986,0.23,0.95,"No"
"3279","C2_Chemical_and_genetic_perturbations","C2_CGP_2573_HINATA_NFKB_TARGETS_KERATINOCYTE_DN",20,-1.6257,0.014,0.029,"No",1.1437,0.28,0.56,"Yes"
"3280","C7_Immunologic_signatures","C7_ALL_1795_GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP",199,-1.6257,0.0011,0.00078,"No",-0.9024,0.73,1,"No"
"3281","C2_Chemical_and_genetic_perturbations","C2_CGP_2149_AMUNDSON_GAMMA_RADIATION_RESPONSE",40,-1.6256,0.0098,0.029,"No",-0.9363,0.57,1,"No"
"3282","GO_BP","491733_GO_0006869_LIPID_TRANSPORT",224,-1.6256,0,0.056,"No",-0.9792,0.5,1,"No"
"3283","REACTOME","106145_REACT_11054_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS",26,-1.6255,0.015,0.065,"No",1.2008,0.19,0.44,"Yes"
"3284","GO_BP","487659_GO_0001763_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE",187,-1.6255,0,0.056,"No",1.0157,0.39,0.97,"Yes"
"3285","C2_Chemical_and_genetic_perturbations","C2_CGP_902_SHANK_TAL1_TARGETS_DN",10,-1.6255,0.017,0.029,"No",0.9518,0.51,0.86,"Yes"
"3286","REACTOME","119526_REACT_19200_OTHER_SEMAPHORIN_INTERACTIONS",19,-1.6255,0.014,0.065,"No",-0.8564,0.65,1,"No"
"3287","GO_BP","508281_GO_0045980_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS",91,-1.6255,0.0013,0.056,"No",1.1118,0.23,0.89,"Yes"
"3288","C7_Immunologic_signatures","C7_ALL_529_GSE17721_LPS_VS_POLYIC_1H_BMDM_UP",197,-1.6253,0,0.00078,"No",0.9569,0.6,0.88,"Yes"
"3289","GO_BP","516375_GO_0071451_CELLULAR_RESPONSE_TO_SUPEROXIDE",14,-1.6253,0.019,0.056,"No",0.641,0.92,1,"Yes"
"3290","GO_BP","506444_GO_0043406_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY",205,-1.6253,0,0.056,"No",-0.6773,1,1,"No"
"3291","C7_Immunologic_signatures","C7_ALL_1906_GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN",200,-1.6252,0,0.00078,"No",0.9074,0.74,1,"Yes"
"3292","C3_TF_targets","C3_TFT_461_V_MYOD_Q6_01",251,-1.6252,0,0.0091,"No",-1.5712,0,0.12,"No"
"3293","GO_CC","487079_GO_0000786_NUCLEOSOME",93,-1.6251,0.0013,0.088,"No",-1.7745,0.0018,0.18,"No"
"3294","C2_Chemical_and_genetic_perturbations","C2_CGP_747_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",24,-1.625,0.015,0.029,"No",-1.0564,0.37,0.96,"No"
"3295","REACTOME","105728_REACT_6960_GLUTATHIONE_SYNTHESIS_AND_RECYCLING",12,-1.625,0.013,0.065,"No",0.4013,1,1,"Yes"
"3296","GO_BP","491787_GO_0006937_REGULATION_OF_MUSCLE_CONTRACTION",147,-1.6248,0,0.056,"No",-1.1683,0.15,0.91,"No"
"3297","C2_Chemical_and_genetic_perturbations","C2_CGP_1368_TENEDINI_MEGAKARYOCYTE_MARKERS",66,-1.6248,0.0052,0.029,"No",0.9489,0.53,0.87,"Yes"
"3298","C2_Chemical_and_genetic_perturbations","C2_CGP_1931_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN",157,-1.6246,0,0.029,"No",-1.3382,0.033,0.7,"No"
"3299","C2_Chemical_and_genetic_perturbations","C2_CGP_2637_MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3",138,-1.6245,0.0024,0.029,"No",-1.3695,0.02,0.63,"No"
"3300","GO_BP","506578_GO_0043547_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY",447,-1.6243,0,0.056,"No",-1.3892,0,1,"No"
"3301","GO_MF","490341_GO_0005070_SH3_SH2_ADAPTOR_ACTIVITY",52,-1.6242,0.0053,0.092,"No",0.9013,0.67,0.98,"Yes"
"3302","C7_Immunologic_signatures","C7_ALL_166_GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN",191,-1.6242,0,8e-04,"No",-1.093,0.25,1,"No"
"3303","KEGG_pathway","HSA00040_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS",36,-1.6241,0.0088,0.013,"No",1.5078,0.029,0.097,"Yes"
"3304","GO_BP","507104_GO_0044089_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS",277,-1.6241,0.0011,0.056,"No",-0.912,0.74,1,"No"
"3305","GO_CC","505755_GO_0042641_ACTOMYOSIN",67,-1.624,0.0026,0.088,"No",-0.9183,0.64,0.94,"No"
"3306","GO_BP","510362_GO_0048247_LYMPHOCYTE_CHEMOTAXIS",16,-1.6239,0.016,0.056,"No",1.0359,0.39,0.96,"Yes"
"3307","C2_Chemical_and_genetic_perturbations","C2_CGP_921_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2",150,-1.6239,0.0012,0.03,"No",0.9157,0.67,0.9,"Yes"
"3308","GO_BP","511769_GO_0050803_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY",63,-1.6235,0.0027,0.056,"No",-1.4139,0.056,0.95,"No"
"3309","C2_Chemical_and_genetic_perturbations","C2_CGP_2790_ONO_FOXP3_TARGETS_DN",41,-1.6234,0.0014,0.03,"No",1.2058,0.16,0.48,"Yes"
"3310","KEGG_compound","C05212_1_RADYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ORGANYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_2_ACYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE",22,-1.6233,0.024,0.078,"No",0.6965,0.87,1,"Yes"
"3311","GO_BP","506921_GO_0043901_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS",141,-1.6233,0.0012,0.057,"No",1.1596,0.16,0.83,"Yes"
"3312","GO_BP","492543_GO_0008202_STEROID_METABOLIC_PROCESS",234,-1.6231,0.0011,0.057,"No",0.8269,0.95,1,"Yes"
"3313","GO_BP","751214_GO_0036296_RESPONSE_TO_INCREASED_OXYGEN_LEVELS",23,-1.623,0.015,0.057,"No",-0.7688,0.81,1,"No"
"3314","C2_Chemical_and_genetic_perturbations","C2_CGP_1250_ROZANOV_MMP14_TARGETS_UP",264,-1.623,0,0.03,"No",1.1786,0.077,0.52,"Yes"
"3315","GO_BP","491418_GO_0006522_ALANINE_METABOLIC_PROCESS",5,-1.623,0.016,0.057,"No",-1.3815,0.11,1,"No"
"3316","C3_TF_targets","C3_TFT_177_V_OCT1_07",154,-1.6229,0,0.0092,"No",-1.2268,0.086,0.31,"No"
"3317","GO_CC","490893_GO_0005891_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX",41,-1.6228,0.0057,0.088,"No",-1.7816,0.0055,0.2,"No"
"3318","GO_BP","504418_GO_0035234_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH",8,-1.6228,0.013,0.057,"No",-0.9097,0.57,1,"No"
"3319","GO_BP","849818_GO_0097480_ESTABLISHMENT_OF_SYNAPTIC_VESICLE_LOCALIZATION",116,-1.6227,0,0.057,"No",0.8163,0.89,1,"Yes"
"3320","GO_BP","516209_GO_0071285_CELLULAR_RESPONSE_TO_LITHIUM_ION",15,-1.6227,0.017,0.057,"No",0.9796,0.46,1,"Yes"
"3321","C7_Immunologic_signatures","C7_ALL_737_GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_UP",198,-1.6227,0.0011,0.00084,"No",0.8711,0.83,1,"Yes"
"3322","REACTOME","106439_REACT_11061_SIGNALLING_BY_NGF",281,-1.6227,0,0.066,"No",-0.9437,0.63,1,"No"
"3323","GO_BP","501721_GO_0032489_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION",481,-1.6226,0,0.057,"No",-1.3247,0.0048,0.89,"No"
"3324","GO_BP","502310_GO_0033089_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS",11,-1.6226,0.011,0.056,"No",0.6766,0.88,1,"Yes"
"3325","GO_BP","501717_GO_0032485_REGULATION_OF_RAL_PROTEIN_SIGNAL_TRANSDUCTION",478,-1.6226,0,0.056,"No",-1.3145,0.0093,0.87,"No"
"3326","C2_Chemical_and_genetic_perturbations","C2_CGP_795_YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP",25,-1.6224,0.015,0.03,"No",-1.0202,0.42,0.98,"No"
"3327","GO_MF","499383_GO_0022838_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY",406,-1.6223,0,0.093,"No",-1.5481,0,0.52,"No"
"3328","C2_Chemical_and_genetic_perturbations","C2_CGP_594_RIZ_ERYTHROID_DIFFERENTIATION_HEMGN",30,-1.6222,0.018,0.03,"No",-0.9028,0.62,1,"No"
"3329","GO_BP","488317_GO_0002444_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",48,-1.6222,0.0042,0.057,"No",1.2562,0.11,0.73,"Yes"
"3330","C3_TF_targets","C3_TFT_89_V_HFH1_01",237,-1.6218,0,0.0092,"No",-0.7628,0.99,1,"No"
"3331","GO_BP","502841_GO_0033625_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION",5,-1.6218,0.011,0.057,"No",-0.827,0.67,1,"No"
"3332","GO_CC","505281_GO_0042105_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX",5,-1.6218,0.01,0.087,"No",1.4858,0.058,0.21,"Yes"
"3333","GO_BP","488380_GO_0002507_TOLERANCE_INDUCTION",8,-1.6217,0.022,0.057,"No",-1.1046,0.35,0.94,"No"
"3334","GO_BP","500164_GO_0030866_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION",20,-1.6216,0.016,0.057,"No",-1.0649,0.35,0.96,"No"
"3335","C2_Chemical_and_genetic_perturbations","C2_CGP_1882_BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN",46,-1.6215,0.0028,0.03,"No",1.425,0.036,0.28,"Yes"
"3336","C7_Immunologic_signatures","C7_ALL_1447_GSE360_L_DONOVANI_VS_T_GONDII_DC_UP",197,-1.6215,0.0012,0.00086,"No",-0.9735,0.56,1,"No"
"3337","GO_MF","490561_GO_0005372_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,-1.6215,0.018,0.093,"No",-0.6586,0.91,1,"No"
"3338","KEGG_compound","C03024_REDUCED_FLAVOPROTEIN",9,-1.6212,0.02,0.078,"No",-1.2121,0.23,0.75,"No"
"3339","C2_Chemical_and_genetic_perturbations","C2_CGP_2764_MIKKELSEN_MCV6_HCP_WITH_H3K27ME3",400,-1.6212,0,0.03,"No",-1.5453,0,0.43,"No"
"3340","GO_BP","492352_GO_0007611_LEARNING_OR_MEMORY",195,-1.6212,0.0011,0.057,"No",-1.2361,0.057,0.9,"No"
"3341","GO_BP","512005_GO_0051091_POSITIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",215,-1.6209,0.0011,0.057,"No",0.8562,0.9,1,"Yes"
"3342","C2_Chemical_and_genetic_perturbations","C2_CGP_374_KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN",75,-1.6208,0.0039,0.03,"No",-0.8155,0.83,1,"No"
"3343","C2_Chemical_and_genetic_perturbations","C2_CGP_1452_SCHURINGA_STAT5A_TARGETS_UP",21,-1.6208,0.018,0.03,"No",-0.6933,0.9,1,"No"
"3344","GO_BP","781987_GO_1901998_TOXIN_TRANSPORT",33,-1.6207,0.019,0.057,"No",-0.7328,0.88,1,"No"
"3345","GO_BP","501339_GO_0032102_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS",233,-1.6207,0,0.057,"No",1.0524,0.3,0.95,"Yes"
"3346","GO_BP","494736_GO_2000378_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",32,-1.6205,0.01,0.057,"No",-1.2389,0.16,0.91,"No"
"3347","C7_Immunologic_signatures","C7_ALL_886_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN",196,-1.6205,0,0.00087,"No",0.9853,0.48,0.79,"Yes"
"3348","C2_Chemical_and_genetic_perturbations","C2_CGP_2999_WHITFIELD_CELL_CYCLE_LITERATURE",44,-1.6204,0.0098,0.03,"No",-0.9478,0.55,1,"No"
"3349","GO_BP","510718_GO_0048663_NEURON_FATE_COMMITMENT",66,-1.6204,0.0025,0.057,"No",-1.2131,0.15,0.88,"No"
"3350","GO_BP","508179_GO_0045860_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY",477,-1.6203,0,0.057,"No",0.8551,0.96,1,"Yes"
"3351","REACTOME","106204_REACT_1520_GLUCONEOGENESIS",31,-1.6203,0.013,0.067,"No",0.8966,0.61,0.91,"Yes"
"3352","GO_BP","507927_GO_0045579_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION",12,-1.6203,0.026,0.057,"No",-0.5628,0.97,1,"No"
"3353","C2_Chemical_and_genetic_perturbations","C2_CGP_1081_SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN",45,-1.6199,0.0098,0.03,"No",1.5574,0.013,0.17,"Yes"
"3354","C2_Chemical_and_genetic_perturbations","C2_CGP_1947_GENTILE_UV_LOW_DOSE_DN",67,-1.6198,0.0026,0.03,"No",-1.0282,0.37,0.98,"No"
"3355","GO_BP","501715_GO_0032483_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION",477,-1.6198,0,0.057,"No",-1.3276,0.0016,0.89,"No"
"3356","GO_BP","777642_GO_1901985_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION",26,-1.6198,0.015,0.057,"No",-1.1157,0.3,0.94,"No"
"3357","GO_BP","494785_GO_0010720_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT",385,-1.6195,0,0.058,"No",-1.0433,0.3,0.98,"No"
"3358","C2_Chemical_and_genetic_perturbations","C2_CGP_3317_ABDELMOHSEN_ELAVL4_TARGETS",16,-1.6192,0.017,0.03,"No",-0.635,0.94,1,"No"
"3359","REACTOME","187091_REACT_25351_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX",16,-1.6192,0.018,0.067,"No",1.2021,0.2,0.44,"Yes"
"3360","C2_Chemical_and_genetic_perturbations","C2_CGP_2341_WHITEFORD_PEDIATRIC_CANCER_MARKERS",116,-1.6192,0.0012,0.03,"No",-0.8933,0.73,1,"No"
"3361","GO_BP","494187_GO_0010107_POTASSIUM_ION_IMPORT",25,-1.6191,0.015,0.058,"No",-1.1537,0.24,0.92,"No"
"3362","GO_BP","490994_GO_0006006_GLUCOSE_METABOLIC_PROCESS",138,-1.6191,0,0.058,"No",-0.8087,0.91,1,"No"
"3363","C3_TF_targets","C3_TFT_444_V_CEBP_Q2_01",264,-1.6191,0,0.0093,"No",-1.0509,0.3,0.64,"No"
"3364","GO_MF","496710_GO_0016811_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES",59,-1.619,0.0066,0.095,"No",-0.8963,0.64,0.99,"No"
"3365","GO_BP","510276_GO_0048146_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION",48,-1.6188,0.007,0.058,"No",1.3862,0.064,0.57,"Yes"
"3366","C7_Immunologic_signatures","C7_ALL_544_GSE17721_LPS_VS_POLYIC_24H_BMDM_DN",198,-1.6186,0,0.00091,"No",1.165,0.11,0.29,"Yes"
"3367","GO_BP","515237_GO_0070304_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",119,-1.6185,0,0.058,"No",-1.3736,0.024,0.98,"No"
"3368","C2_Chemical_and_genetic_perturbations","C2_CGP_48_KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP",121,-1.6185,0,0.031,"No",-0.9077,0.69,1,"No"
"3369","GO_BP","491420_GO_0006524_ALANINE_CATABOLIC_PROCESS",5,-1.6183,0.011,0.058,"No",-1.3937,0.11,1,"No"
"3370","KEGG_compound","C00059_SULFATE_SULFURIC_ACID",13,-1.6183,0.022,0.079,"No",-1.3235,0.15,0.59,"No"
"3371","C7_Immunologic_signatures","C7_ALL_881_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP",198,-1.6183,0,0.00092,"No",0.7708,0.98,1,"Yes"
"3372","C2_Chemical_and_genetic_perturbations","C2_CGP_548_TOMIDA_METASTASIS_UP",26,-1.618,0.011,0.031,"No",1.0757,0.34,0.67,"Yes"
"3373","C2_Chemical_and_genetic_perturbations","C2_CGP_2265_SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN",25,-1.6179,0.015,0.031,"No",-0.7653,0.83,1,"No"
"3374","C3_TF_targets","C3_TFT_159_V_STAT_01",247,-1.6179,0,0.0092,"No",-0.9392,0.61,0.89,"No"
"3375","GO_MF","487767_GO_0001871_PATTERN_BINDING",168,-1.6179,0.0012,0.095,"No",-1.0389,0.35,0.87,"No"
"3376","GO_BP","491078_GO_0006098_PENTOSE_PHOSPHATE_SHUNT",13,-1.6179,0.023,0.058,"No",-0.8714,0.63,1,"No"
"3377","C6_Oncogenic_signatures","C6_ALL_112_NOTCH_DN_V1_UP",177,-1.6178,0.0023,0.0045,"No",0.948,0.6,0.93,"Yes"
"3378","REACTOME","106405_REACT_6932_COMPLEMENT_CASCADE",36,-1.6178,0.013,0.067,"No",1.157,0.23,0.5,"Yes"
"3379","C2_Chemical_and_genetic_perturbations","C2_CGP_2039_BAFNA_MUC4_TARGETS_UP",6,-1.6178,0.014,0.031,"No",-1.1034,0.35,0.91,"No"
"3380","C2_Chemical_and_genetic_perturbations","C2_CGP_3058_HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN",103,-1.6177,0,0.031,"No",0.8473,0.83,0.97,"Yes"
"3381","C6_Oncogenic_signatures","C6_ALL_166_NFE2L2_V2",425,-1.6176,0,0.0044,"No",0.9396,0.67,0.92,"Yes"
"3382","C2_Chemical_and_genetic_perturbations","C2_CGP_3106_PHESSE_TARGETS_OF_APC_AND_MBD2_DN",12,-1.6173,0.029,0.031,"No",-0.9043,0.59,1,"No"
"3383","C7_Immunologic_signatures","C7_ALL_502_GSE17721_CTRL_VS_CPG_4H_BMDM_DN",194,-1.6173,0,0.00093,"No",0.8367,0.9,1,"Yes"
"3384","C2_Chemical_and_genetic_perturbations","C2_CGP_474_BARIS_THYROID_CANCER_DN",58,-1.6173,0.01,0.031,"No",0.9275,0.6,0.9,"Yes"
"3385","C2_BioCarta_Pathways","C2_CP_BIOCARTA_65_BIOCARTA_ECM_PATHWAY",23,-1.6173,0.016,0.081,"No",1.0596,0.35,0.77,"Yes"
"3386","C2_Chemical_and_genetic_perturbations","C2_CGP_2015_CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN",35,-1.6172,0.0044,0.031,"No",0.8019,0.78,0.99,"Yes"
"3387","C6_Oncogenic_signatures","C6_ALL_40_ATF2_S_UP_V1_UP",187,-1.6172,0.0011,0.0043,"No",-0.9974,0.45,0.68,"No"
"3388","KEGG_pathway","HSA05200_PATHWAYS_IN_CANCER",387,-1.6172,0,0.014,"No",-0.8517,0.93,0.99,"No"
"3389","GO_BP","499138_GO_0021859_PYRAMIDAL_NEURON_DIFFERENTIATION",7,-1.6172,0.013,0.058,"No",-1.0622,0.4,0.96,"No"
"3390","GO_CC","487472_GO_0001533_CORNIFIED_ENVELOPE",16,-1.6172,0.015,0.09,"No",1.0855,0.37,0.67,"Yes"
"3391","GO_BP","506310_GO_0043243_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY",21,-1.6168,0.023,0.059,"No",-0.8281,0.71,1,"No"
"3392","C4_Cancer_gene_neighborhoods","C4_CGN_276_CAR_HPX",69,-1.6167,0.0065,0.019,"No",1.5564,0.01,0.021,"Yes"
"3393","GO_BP","519366_GO_2000727_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",10,-1.6166,0.023,0.059,"No",-0.9888,0.45,1,"No"
"3394","C2_Chemical_and_genetic_perturbations","C2_CGP_2521_MARTINELLI_IMMATURE_NEUTROPHIL_UP",11,-1.6166,0.015,0.031,"No",1.6845,0.018,0.092,"Yes"
"3395","C2_Chemical_and_genetic_perturbations","C2_CGP_1066_SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP",112,-1.6165,0.0025,0.031,"No",-1.1044,0.24,0.91,"No"
"3396","GO_MF","502156_GO_0032934_STEROL_BINDING",41,-1.6165,0.0069,0.096,"No",-1.2131,0.17,0.82,"No"
"3397","C7_Immunologic_signatures","C7_ALL_1872_GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN",200,-1.6165,0,0.00094,"No",0.8731,0.8,1,"Yes"
"3398","GO_BP","494696_GO_0010632_REGULATION_OF_EPITHELIAL_CELL_MIGRATION",143,-1.6165,0.0023,0.059,"No",-1.0297,0.4,0.97,"No"
"3399","GO_BP","487842_GO_0001952_REGULATION_OF_CELL_MATRIX_ADHESION",80,-1.6164,0.0025,0.059,"No",-1.2995,0.064,0.89,"No"
"3400","C2_Chemical_and_genetic_perturbations","C2_CGP_815_FUNG_IL2_SIGNALING_2",12,-1.6163,0.022,0.031,"No",0.9251,0.54,0.89,"Yes"
"3401","GO_BP","501252_GO_0032015_REGULATION_OF_RAN_PROTEIN_SIGNAL_TRANSDUCTION",477,-1.6163,0,0.059,"No",-1.316,0.0063,0.88,"No"
"3402","GO_BP","755304_GO_2001198_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION",7,-1.6162,0.012,0.059,"No",-0.5125,0.98,1,"No"
"3403","C2_Chemical_and_genetic_perturbations","C2_CGP_858_JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN",45,-1.6162,0.014,0.031,"No",1.116,0.25,0.61,"Yes"
"3404","C0_Hallmark","H_ALL_37_HALLMARK_P53_PATHWAY",199,-1.6162,0,0.0033,"No",-0.8811,0.77,1,"No"
"3405","GO_MF","495680_GO_0015491_CATION_CATION_ANTIPORTER_ACTIVITY",22,-1.6161,0.015,0.096,"No",-0.8136,0.74,1,"No"
"3406","C7_Immunologic_signatures","C7_ALL_550_GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_DN",196,-1.616,0,0.00094,"No",-1.0114,0.44,1,"No"
"3407","GO_BP","487610_GO_0001707_MESODERM_FORMATION",62,-1.616,0.0069,0.059,"No",-1.3562,0.054,0.97,"No"
"3408","GO_BP","752457_GO_0086091_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION",26,-1.6159,0.017,0.059,"No",-0.954,0.51,1,"No"
"3409","GO_MF","496599_GO_0016667_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS",49,-1.6159,0.0054,0.095,"No",1.0153,0.43,0.87,"Yes"
"3410","C2_Chemical_and_genetic_perturbations","C2_CGP_335_GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN",86,-1.6158,0.005,0.031,"No",1.4023,0.021,0.29,"Yes"
"3411","C7_Immunologic_signatures","C7_ALL_1135_GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP",197,-1.6156,0,0.00095,"No",0.9199,0.7,0.98,"Yes"
"3412","GO_BP","502058_GO_0032835_GLOMERULUS_DEVELOPMENT",48,-1.6156,0.0098,0.059,"No",-1.3062,0.1,0.88,"No"
"3413","GO_CC","499480_GO_0030016_MYOFIBRIL",201,-1.6156,0,0.09,"No",-0.9171,0.7,0.94,"No"
"3414","GO_BP","487496_GO_0016049_CELL_GROWTH",120,-1.6156,0.0037,0.059,"No",-1.148,0.17,0.93,"No"
"3415","KEGG_pathway","HSA04020_CALCIUM_SIGNALING_PATHWAY",178,-1.6155,0.0011,0.014,"No",-1.3663,0.02,0.33,"No"
"3416","GO_BP","503964_GO_0034765_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT",334,-1.6155,0,0.059,"No",-1.3657,0.0068,0.99,"No"
"3417","C6_Oncogenic_signatures","C6_ALL_185_KRAS_LUNG_BREAST_UP_V1_UP",127,-1.6153,0,0.0044,"No",0.9621,0.56,0.94,"Yes"
"3418","GO_MF","510618_GO_0048551_METALLOENZYME_INHIBITOR_ACTIVITY",14,-1.6152,0.022,0.095,"No",-1.3244,0.12,0.72,"No"
"3419","GO_BP","500148_GO_0030850_PROSTATE_GLAND_DEVELOPMENT",40,-1.6152,0.0083,0.059,"No",0.9836,0.46,1,"Yes"
"3420","GO_BP","514629_GO_0061081_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",11,-1.6151,0.023,0.059,"No",0.7787,0.75,1,"Yes"
"3421","GO_CC","506265_GO_0043197_DENDRITIC_SPINE",97,-1.6151,0,0.089,"No",-1.3774,0.028,0.63,"No"
"3422","GO_MF","490248_GO_0004957_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY",5,-1.615,0.021,0.095,"No",0.8508,0.63,1,"Yes"
"3423","REACTOME","106406_REACT_8024_INITIAL_TRIGGERING_OF_COMPLEMENT",18,-1.615,0.021,0.069,"No",-0.8635,0.64,1,"No"
"3424","GO_BP","518443_GO_0090303_POSITIVE_REGULATION_OF_WOUND_HEALING",44,-1.6148,0.011,0.059,"No",1.1001,0.3,0.9,"Yes"
"3425","KEGG_compound","C00022_PYRUVATE_PYRUVIC_ACID_2_OXOPROPANOATE_2_OXOPROPANOIC_ACID_PYRORACEMIC_ACID",29,-1.6147,0.0061,0.082,"No",0.734,0.87,1,"Yes"
"3426","GO_BP","754110_GO_1901142_INSULIN_METABOLIC_PROCESS",7,-1.6147,0.012,0.059,"No",-1.9371,0.0019,0.3,"No"
"3427","GO_BP","513605_GO_0060047_HEART_CONTRACTION",53,-1.6146,0.0056,0.059,"No",-1.2948,0.093,0.88,"No"
"3428","GO_BP","489000_GO_0003206_CARDIAC_CHAMBER_MORPHOGENESIS",104,-1.6146,0.0025,0.059,"No",-0.8993,0.68,1,"No"
"3429","GO_BP","495066_GO_0012502_INDUCTION_OF_PROGRAMMED_CELL_DEATH",141,-1.6145,0,0.059,"No",-0.647,1,1,"No"
"3430","C3_TF_targets","C3_TFT_492_GTGGGTGK_UNKNOWN",285,-1.6144,0,0.0094,"No",-1.164,0.11,0.41,"No"
"3431","GO_BP","508115_GO_0045778_POSITIVE_REGULATION_OF_OSSIFICATION",82,-1.6144,0.0026,0.059,"No",-1.1138,0.26,0.94,"No"
"3432","GO_MF","492691_GO_0008391_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY",16,-1.6144,0.033,0.095,"No",-1.9428,0,0.11,"No"
"3433","GO_BP","509069_GO_0046849_BONE_REMODELING",41,-1.6144,0.0042,0.059,"No",-1.5481,0.039,0.74,"No"
"3434","C2_Chemical_and_genetic_perturbations","C2_CGP_1682_KAAB_HEART_ATRIUM_VS_VENTRICLE_UP",245,-1.6144,0,0.031,"No",1.0478,0.3,0.72,"Yes"
"3435","REACTOME","106156_REACT_6823_LIPOPROTEIN_METABOLISM",30,-1.614,0.012,0.069,"No",-1.4521,0.05,0.48,"No"
"3436","GO_BP","495103_GO_0014031_MESENCHYMAL_CELL_DEVELOPMENT",101,-1.6138,0,0.059,"No",0.9461,0.57,1,"Yes"
"3437","C2_Chemical_and_genetic_perturbations","C2_CGP_1149_AMIT_SERUM_RESPONSE_240_MCF10A",57,-1.6138,0.0069,0.031,"No",1.1314,0.23,0.58,"Yes"
"3438","C4_Cancer_modules","C4_CM_85_MODULE_90",17,-1.6137,0.027,0.027,"No",-1.1951,0.23,0.6,"No"
"3439","GO_MF","751289_GO_0038024_CARGO_RECEPTOR_ACTIVITY",63,-1.6134,0.0066,0.095,"No",-1.4372,0.033,0.63,"No"
"3440","GO_BP","506167_GO_0043087_REGULATION_OF_GTPASE_ACTIVITY",477,-1.6134,0,0.059,"No",-1.3252,0.0033,0.89,"No"
"3441","GO_CC","496301_GO_0016234_INCLUSION_BODY",60,-1.6133,0.0027,0.089,"No",-0.9672,0.51,0.89,"No"
"3442","GO_BP","495879_GO_0015748_ORGANOPHOSPHATE_ESTER_TRANSPORT",76,-1.6133,0.0026,0.059,"No",-1.1049,0.26,0.94,"No"
"3443","C7_Immunologic_signatures","C7_ALL_1376_GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN",199,-1.6133,0,0.001,"No",1.0964,0.22,0.45,"Yes"
"3444","GO_BP","510179_GO_0048011_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY",268,-1.6132,0,0.059,"No",-0.9205,0.7,1,"No"
"3445","GO_CC","503902_GO_0034702_ION_CHANNEL_COMPLEX",270,-1.6132,0,0.088,"No",-1.4793,0.0017,0.64,"No"
"3446","GO_BP","501544_GO_0032309_ICOSANOID_SECRETION",13,-1.6131,0.019,0.059,"No",-0.6456,0.93,1,"No"
"3447","GO_BP","500893_GO_0031644_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS",109,-1.6131,0.0013,0.059,"No",-1.0449,0.34,0.97,"No"
"3448","C2_Chemical_and_genetic_perturbations","C2_CGP_778_KORKOLA_TERATOMA",39,-1.6131,0.013,0.032,"No",-1.2198,0.15,0.78,"No"
"3449","C7_Immunologic_signatures","C7_ALL_131_GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP",189,-1.613,0,0.001,"No",0.7686,0.99,1,"Yes"
"3450","KEGG_compound","C02700_L_FORMYLKYNURENINE_N_FORMYL_L_KYNURENINE_N_FORMYLKYNURENINE",5,-1.6128,0.0052,0.082,"No",-1.4258,0.099,0.41,"No"
"3451","WikiPathways","198913_WP1545_MIRNAS_INVOLVED_IN_DDR",23,-1.6127,0.009,0.039,"No",-1.4215,0.081,0.96,"No"
"3452","C2_Chemical_and_genetic_perturbations","C2_CGP_2731_COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP",107,-1.6127,0.0012,0.032,"No",0.8428,0.82,0.97,"Yes"
"3453","C2_Chemical_and_genetic_perturbations","C2_CGP_3288_DELACROIX_RAR_TARGETS_UP",47,-1.6126,0.018,0.032,"No",-1.1125,0.28,0.9,"No"
"3454","C2_Chemical_and_genetic_perturbations","C2_CGP_868_JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN",65,-1.6126,0.004,0.032,"No",-0.6626,0.98,1,"No"
"3455","GO_BP","493499_GO_0042493_RESPONSE_TO_DRUG",390,-1.6125,0,0.06,"No",-1.1379,0.12,0.93,"No"
"3456","GO_BP","514262_GO_0060707_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION",13,-1.6124,0.023,0.06,"No",-1.3013,0.16,0.89,"No"
"3457","C2_Chemical_and_genetic_perturbations","C2_CGP_20_KORKOLA_YOLK_SAC_TUMOR_UP",20,-1.6123,0.014,0.032,"No",0.7727,0.79,1,"Yes"
"3458","C2_Chemical_and_genetic_perturbations","C2_CGP_1844_JACKSON_DNMT1_TARGETS_UP",77,-1.6122,0.0013,0.032,"No",1.1148,0.24,0.61,"Yes"
"3459","C7_Immunologic_signatures","C7_ALL_1432_GSE360_DC_VS_MAC_DN",193,-1.6122,0,0.001,"No",-0.7161,0.99,1,"No"
"3460","C2_Chemical_and_genetic_perturbations","C2_CGP_1138_AMIT_EGF_RESPONSE_480_HELA",161,-1.6122,0.0012,0.032,"No",0.6878,1,1,"Yes"
"3461","GO_BP","512174_GO_0051289_PROTEIN_HOMOTETRAMERIZATION",55,-1.6119,0.012,0.06,"No",-0.7821,0.85,1,"No"
"3462","GO_MF","504765_GO_0035586_PURINERGIC_RECEPTOR_ACTIVITY",38,-1.6117,0.0085,0.096,"No",1.2855,0.11,0.63,"Yes"
"3463","WikiPathways","198894_WP314_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION",38,-1.6117,0.014,0.038,"No",-1.0549,0.36,0.99,"No"
"3464","C4_Cancer_modules","C4_CM_353_MODULE_426",85,-1.6117,0.0025,0.027,"No",-0.958,0.54,0.87,"No"
"3465","GO_BP","1039947_GO_1903393_POSITIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION",20,-1.6116,0.02,0.06,"No",-1.1456,0.26,0.93,"No"
"3466","GO_MF","511515_GO_0050542_ICOSANOID_BINDING",6,-1.6115,0.015,0.096,"No",1.492,0.07,0.39,"Yes"
"3467","GO_BP","501644_GO_0032412_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",154,-1.611,0.0023,0.06,"No",-1.4808,0.0069,0.83,"No"
"3468","GO_BP","494950_GO_0010886_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE",7,-1.611,0.018,0.06,"No",-0.7063,0.85,1,"No"
"3469","C7_Immunologic_signatures","C7_ALL_1276_GSE29618_MONOCYTE_VS_PDC_DN",194,-1.611,0,0.0011,"No",-0.7223,0.99,1,"No"
"3470","GO_BP","516246_GO_0071322_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS",63,-1.6108,0.011,0.06,"No",-0.6972,0.97,1,"No"
"3471","GO_CC","489297_GO_0043292_CONTRACTILE_FIBER",214,-1.6107,0,0.089,"No",-0.8745,0.79,0.95,"No"
"3472","GO_MF","750773_GO_0001221_TRANSCRIPTION_COFACTOR_BINDING",16,-1.6106,0.016,0.096,"No",-0.9001,0.61,0.99,"No"
"3473","C7_Immunologic_signatures","C7_ALL_570_GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_DN",198,-1.6106,0.0034,0.0011,"No",0.8699,0.85,1,"Yes"
"3474","GO_BP","510373_GO_0048259_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS",62,-1.6105,0.0039,0.06,"No",-0.6913,0.96,1,"No"
"3475","REACTOME","106220_REACT_1859_PENTOSE_PHOSPHATE_PATHWAY_HEXOSE_MONOPHOSPHATE_SHUNT_",7,-1.6105,0.0098,0.071,"No",-0.7334,0.79,1,"No"
"3476","C2_Chemical_and_genetic_perturbations","C2_CGP_38_SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN",82,-1.6105,0.0026,0.032,"No",-0.7937,0.87,1,"No"
"3477","GO_BP","494884_GO_0010820_POSITIVE_REGULATION_OF_T_CELL_CHEMOTAXIS",10,-1.6105,0.024,0.06,"No",0.89,0.58,1,"Yes"
"3478","C2_Chemical_and_genetic_perturbations","C2_CGP_526_ZIRN_TRETINOIN_RESPONSE_UP",21,-1.6105,0.019,0.032,"No",-1.4748,0.052,0.51,"No"
"3479","C2_Chemical_and_genetic_perturbations","C2_CGP_407_BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP",8,-1.6104,0.034,0.032,"No",1.3038,0.16,0.39,"Yes"
"3480","GO_BP","511843_GO_0050906_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",397,-1.6104,0,0.06,"No",2.0789,0,0.0047,"Yes"
"3481","C2_Chemical_and_genetic_perturbations","C2_CGP_746_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",81,-1.6101,0,0.032,"No",0.8185,0.85,0.98,"Yes"
"3482","REACTOME","1127675_REACT_264541_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION",64,-1.61,0.0052,0.071,"No",-1.8557,0,0.059,"No"
"3483","C2_Chemical_and_genetic_perturbations","C2_CGP_2556_CHANG_CYCLING_GENES",148,-1.6099,0,0.032,"No",1.0192,0.37,0.77,"Yes"
"3484","REACTOME","106502_REACT_11044_SIGNALING_BY_RHO_GTPASES",395,-1.6099,0,0.07,"No",-0.9829,0.5,1,"No"
"3485","C2_Chemical_and_genetic_perturbations","C2_CGP_162_BASAKI_YBX1_TARGETS_UP",287,-1.6098,0,0.032,"No",1.0509,0.31,0.71,"Yes"
"3486","REACTOME","1127514_REACT_264273_VEGFR2_MEDIATED_CELL_PROLIFERATION",35,-1.6097,0.015,0.07,"No",-0.8938,0.64,1,"No"
"3487","REACTOME","833815_REACT_163679_SCAVENGING_BY_CLASS_B_RECEPTORS",5,-1.6097,0.012,0.07,"No",-1.2058,0.27,0.83,"No"
"3488","GO_BP","494957_GO_0010893_POSITIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS",13,-1.6096,0.027,0.061,"No",-1.402,0.082,0.98,"No"
"3489","REACTOME","530742_REACT_116005_SHC1_EVENTS_IN_ERBB4_SIGNALING",28,-1.6095,0.017,0.069,"No",-0.5869,0.98,1,"No"
"3490","C2_Chemical_and_genetic_perturbations","C2_CGP_434_LANDIS_ERBB2_BREAST_TUMORS_65_DN",35,-1.6095,0.0055,0.032,"No",1.1549,0.27,0.55,"Yes"
"3491","C2_Chemical_and_genetic_perturbations","C2_CGP_171_RODRIGUES_NTN1_TARGETS_DN",155,-1.6094,0.0012,0.032,"No",-1.0933,0.27,0.93,"No"
"3492","C2_Chemical_and_genetic_perturbations","C2_CGP_993_INGRAM_SHH_TARGETS_DN",60,-1.6093,0.011,0.032,"No",-1.1258,0.27,0.89,"No"
"3493","C0_Hallmark","H_ALL_13_HALLMARK_ESTROGEN_RESPONSE_EARLY",195,-1.6093,0,0.0035,"No",-1.1791,0.12,0.83,"No"
"3494","GO_BP","492351_GO_0007610_BEHAVIOR",470,-1.6092,0,0.061,"No",-1.2312,0.034,0.9,"No"
"3495","GO_MF","499996_GO_0030695_GTPASE_REGULATOR_ACTIVITY",268,-1.6091,0,0.097,"No",-1.4027,0,0.63,"No"
"3496","GO_BP","500872_GO_0031622_POSITIVE_REGULATION_OF_FEVER_GENERATION",7,-1.6091,0.017,0.061,"No",-1.2578,0.19,0.91,"No"
"3497","C4_Cancer_modules","C4_CM_3_MODULE_3",383,-1.609,0,0.027,"No",1.4991,0,0.12,"Yes"
"3498","GO_BP","499468_GO_0045056_TRANSCYTOSIS",11,-1.6089,0.026,0.061,"No",-1.0892,0.34,0.95,"No"
"3499","GO_BP","498506_GO_0019682_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS",13,-1.6088,0.025,0.061,"No",-0.8577,0.67,1,"No"
"3500","C7_Immunologic_signatures","C7_ALL_1184_GSE27786_BCELL_VS_NKTCELL_DN",199,-1.6087,0.0023,0.0011,"No",-0.9555,0.56,1,"No"
"3501","GO_MF","496565_GO_0016624_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR",8,-1.6087,0.027,0.097,"No",1.0185,0.43,0.87,"Yes"
"3502","C2_Chemical_and_genetic_perturbations","C2_CGP_2563_VANTVEER_BREAST_CANCER_ESR1_DN",238,-1.6086,0,0.032,"No",0.9728,0.54,0.83,"Yes"
"3503","GO_BP","510592_GO_0048521_NEGATIVE_REGULATION_OF_BEHAVIOR",44,-1.6086,0.01,0.061,"No",0.8782,0.68,1,"Yes"
"3504","GO_BP","488813_GO_0003015_HEART_PROCESS",60,-1.6083,0.0068,0.061,"No",-1.3292,0.063,0.9,"No"
"3505","C2_BioCarta_Pathways","C2_CP_BIOCARTA_149_BIOCARTA_NKCELLS_PATHWAY",20,-1.6082,0.016,0.085,"No",-0.6994,0.88,1,"No"
"3506","GO_CC","495775_GO_0015629_ACTIN_CYTOSKELETON",429,-1.6082,0,0.09,"No",-0.9432,0.65,0.89,"No"
"3507","GO_BP","507714_GO_0045357_REGULATION_OF_INTERFERON_BETA_BIOSYNTHETIC_PROCESS",8,-1.6082,0.021,0.061,"No",-0.6651,0.91,1,"No"
"3508","GO_BP","518323_GO_0090183_REGULATION_OF_KIDNEY_DEVELOPMENT",59,-1.6082,0.0039,0.061,"No",-0.8702,0.71,1,"No"
"3509","GO_MF","496461_GO_0016493_C_C_CHEMOKINE_RECEPTOR_ACTIVITY",12,-1.6082,0.011,0.096,"No",1.2819,0.16,0.63,"Yes"
"3510","GO_MF","492573_GO_0008242_OMEGA_PEPTIDASE_ACTIVITY",19,-1.6081,0.013,0.096,"No",-0.7621,0.83,1,"No"
"3511","C7_Immunologic_signatures","C7_ALL_1365_GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP",198,-1.6081,0,0.0011,"No",0.8773,0.83,1,"Yes"
"3512","C3_TF_targets","C3_TFT_122_V_AP4_Q5",268,-1.6081,0,0.01,"No",-1.3012,0.027,0.24,"No"
"3513","WikiPathways","198874_WP51_REGULATION_OF_ACTIN_CYTOSKELETON",137,-1.608,0,0.039,"No",-1.0467,0.35,0.97,"No"
"3514","GO_BP","488696_GO_0002823_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",27,-1.6079,0.013,0.061,"No",-0.8472,0.68,1,"No"
"3515","GO_BP","512000_GO_0051085_CHAPERONE_MEDIATED_PROTEIN_FOLDING_REQUIRING_COFACTOR",11,-1.6079,0.026,0.061,"No",-0.6454,0.92,1,"No"
"3516","GO_BP","493459_GO_0009266_RESPONSE_TO_TEMPERATURE_STIMULUS",157,-1.6078,0,0.061,"No",-0.9858,0.48,1,"No"
"3517","GO_MF","492533_GO_0008191_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY",14,-1.6078,0.029,0.096,"No",-1.3611,0.13,0.69,"No"
"3518","C2_Chemical_and_genetic_perturbations","C2_CGP_1943_HU_GENOTOXIC_DAMAGE_4HR",35,-1.6078,0.0086,0.033,"No",-1.1187,0.29,0.89,"No"
"3519","GO_BP","514251_GO_0060696_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS",5,-1.6078,0.007,0.061,"No",-0.6376,0.9,1,"No"
"3520","C7_Immunologic_signatures","C7_ALL_159_GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP",198,-1.6077,0,0.0011,"No",0.6276,1,1,"Yes"
"3521","WikiPathways","711361_WP2374_ONCOSTATIN_M_SIGNALING_PATHWAY",63,-1.6076,0.0078,0.038,"No",-0.6944,0.97,1,"No"
"3522","GO_BP","515414_GO_0070482_RESPONSE_TO_OXYGEN_LEVELS",278,-1.6076,0,0.061,"No",0.8155,0.97,1,"Yes"
"3523","GO_BP","501467_GO_0032232_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",13,-1.6075,0.022,0.061,"No",0.5886,0.96,1,"Yes"
"3524","GO_BP","503583_GO_0034381_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE",21,-1.6074,0.017,0.061,"No",0.646,0.95,1,"Yes"
"3525","GO_BP","493279_GO_0009078_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",5,-1.6074,0.0088,0.061,"No",-1.3915,0.11,1,"No"
"3526","C2_Chemical_and_genetic_perturbations","C2_CGP_2588_HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN",21,-1.6071,0.018,0.033,"No",0.944,0.55,0.87,"Yes"
"3527","C3_TF_targets","C3_TFT_63_V_PBX1_01",239,-1.607,0,0.01,"No",-1.0323,0.37,0.69,"No"
"3528","KEGG_pathway","HSA01200_CARBON_METABOLISM",113,-1.607,0.0025,0.015,"No",1.0886,0.25,0.81,"Yes"
"3529","GO_BP","510606_GO_0048537_MUCOSAL_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT",12,-1.6069,0.021,0.061,"No",-0.8552,0.63,1,"No"
"3530","C2_Chemical_and_genetic_perturbations","C2_CGP_887_KIM_MYCL1_AMPLIFICATION_TARGETS_UP",12,-1.6068,0.023,0.033,"No",-1.3377,0.15,0.7,"No"
"3531","GO_BP","499535_GO_0030099_MYELOID_CELL_DIFFERENTIATION",198,-1.6068,0,0.062,"No",1.0293,0.36,0.97,"Yes"
"3532","GO_BP","505684_GO_0042554_SUPEROXIDE_ANION_GENERATION",13,-1.6068,0.016,0.061,"No",-1.1706,0.27,0.91,"No"
"3533","REACTOME","833827_REACT_163834_FCERI_MEDIATED_CA_2_MOBILIZATION",29,-1.6067,0.0086,0.071,"No",-0.7416,0.85,1,"No"
"3534","GO_MF","507653_GO_0045294_ALPHA_CATENIN_BINDING",10,-1.6066,0.016,0.096,"No",-1.6404,0.027,0.4,"No"
"3535","GO_MF","750780_GO_0001228_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",246,-1.6064,0,0.096,"No",-0.9324,0.67,0.97,"No"
"3536","GO_BP","502492_GO_0033273_RESPONSE_TO_VITAMIN",97,-1.6064,0,0.062,"No",-0.8319,0.83,1,"No"
"3537","KEGG_compound","C00003_NAD_NAD_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_DPN_DIPHOSPHOPYRIDINE_NUCLEOTIDE_NADIDE_BETA_NAD_",118,-1.6063,0.0012,0.086,"No",0.9561,0.54,1,"Yes"
"3538","C2_Chemical_and_genetic_perturbations","C2_CGP_435_LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP",20,-1.6063,0.022,0.033,"No",0.9515,0.55,0.86,"Yes"
"3539","GO_BP","486718_GO_0000187_ACTIVATION_OF_MAPK_ACTIVITY",139,-1.6062,0.0012,0.062,"No",-0.6509,1,1,"No"
"3540","C2_Chemical_and_genetic_perturbations","C2_CGP_2570_SWEET_LUNG_CANCER_KRAS_DN",426,-1.606,0,0.033,"No",1.0252,0.33,0.76,"Yes"
"3541","KEGG_compound","C00092_D_GLUCOSE_6_PHOSPHATE_GLUCOSE_6_PHOSPHATE_ROBISON_ESTER",9,-1.606,0.027,0.085,"No",-1.0965,0.36,0.94,"No"
"3542","C2_Chemical_and_genetic_perturbations","C2_CGP_436_LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN",55,-1.606,0.0081,0.033,"No",0.8391,0.78,0.98,"Yes"
"3543","C2_Chemical_and_genetic_perturbations","C2_CGP_2926_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0",74,-1.6059,0.0051,0.033,"No",0.8906,0.64,0.94,"Yes"
"3544","C2_Chemical_and_genetic_perturbations","C2_CGP_502_MCBRYAN_PUBERTAL_BREAST_5_6WK_UP",113,-1.6059,0.0025,0.033,"No",0.969,0.53,0.84,"Yes"
"3545","WikiPathways","198782_WP437_EGFR1_SIGNALING_PATHWAY",177,-1.6058,0,0.038,"No",-0.8007,0.93,1,"No"
"3546","C7_Immunologic_signatures","C7_ALL_1540_GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN",188,-1.6058,0,0.0012,"No",-1.3468,0.022,0.36,"No"
"3547","GO_BP","491575_GO_0006687_GLYCOSPHINGOLIPID_METABOLIC_PROCESS",59,-1.6058,0.0052,0.062,"No",-0.6599,0.97,1,"No"
"3548","C1_Positional","C1_ALL_282_CHR4Q23",21,-1.6055,0.024,0.2,"No",-1.3282,0.12,0.77,"No"
"3549","C3_TF_targets","C3_TFT_484_V_PXR_Q2",251,-1.6055,0,0.01,"No",-1.3455,0.012,0.2,"No"
"3550","C7_Immunologic_signatures","C7_ALL_1561_GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.6055,0,0.0012,"No",0.9143,0.7,0.99,"Yes"
"3551","C2_Chemical_and_genetic_perturbations","C2_CGP_2912_MIKKELSEN_ES_ICP_WITH_H3K27ME3",41,-1.6054,0.015,0.033,"No",-1.5464,0.028,0.44,"No"
"3552","GO_MF","489236_GO_0005521_LAMIN_BINDING",12,-1.6053,0.018,0.096,"No",-1.1913,0.25,0.79,"No"
"3553","GO_BP","505654_GO_0042523_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN",17,-1.6049,0.025,0.062,"No",-1.6047,0.021,0.7,"No"
"3554","C2_Chemical_and_genetic_perturbations","C2_CGP_468_LANDIS_ERBB2_BREAST_TUMORS_324_DN",145,-1.6049,0,0.033,"No",1.1065,0.21,0.62,"Yes"
"3555","GO_BP","510651_GO_0048588_DEVELOPMENTAL_CELL_GROWTH",62,-1.6048,0.0052,0.062,"No",-1.0075,0.46,0.98,"No"
"3556","C2_Chemical_and_genetic_perturbations","C2_CGP_2745_LEE_LIVER_CANCER_HEPATOBLAST",15,-1.6048,0.016,0.033,"No",-1.2135,0.21,0.8,"No"
"3557","C3_MicroRNA_targets","C3_MIR_212_GTAAACC_MIR_299_5P",48,-1.6048,0.0069,0.19,"No",-1.2133,0.18,1,"No"
"3558","C7_Immunologic_signatures","C7_ALL_531_GSE17721_LPS_VS_POLYIC_2H_BMDM_UP",195,-1.6047,0,0.0012,"No",0.8998,0.76,1,"Yes"
"3559","GO_BP","492550_GO_0008209_ANDROGEN_METABOLIC_PROCESS",30,-1.6046,0.014,0.062,"No",0.9109,0.6,1,"Yes"
"3560","GO_BP","501328_GO_0032091_NEGATIVE_REGULATION_OF_PROTEIN_BINDING",61,-1.6044,0.0066,0.062,"No",0.8766,0.72,1,"Yes"
"3561","WikiPathways","198882_WP581_EPO_RECEPTOR_SIGNALING",26,-1.6043,0.017,0.038,"No",-0.9011,0.63,1,"No"
"3562","GO_BP","1184361_GO_0090630_ACTIVATION_OF_GTPASE_ACTIVITY",27,-1.6043,0.012,0.063,"No",-1.2484,0.15,0.91,"No"
"3563","GO_CC","501664_GO_0032432_ACTIN_FILAMENT_BUNDLE",59,-1.6042,0.011,0.092,"No",-0.8183,0.78,1,"No"
"3564","REACTOME","106459_REACT_12056_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE",199,-1.6042,0,0.072,"No",-0.947,0.58,1,"No"
"3565","GO_BP","518585_GO_0097035_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION",33,-1.604,0.013,0.063,"No",-0.9219,0.58,1,"No"
"3566","GO_BP","487061_GO_0000768_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",22,-1.6039,0.0077,0.063,"No",-1.3518,0.096,0.95,"No"
"3567","GO_CC","490879_GO_0005871_KINESIN_COMPLEX",51,-1.6039,0.017,0.091,"No",-0.979,0.5,0.87,"No"
"3568","GO_BP","508730_GO_0046469_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS",5,-1.6039,0.0073,0.063,"No",-0.9385,0.55,1,"No"
"3569","C2_Chemical_and_genetic_perturbations","C2_CGP_2826_WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP",28,-1.6038,0.0088,0.033,"No",-0.7854,0.8,1,"No"
"3570","C2_Chemical_and_genetic_perturbations","C2_CGP_1550_MENSE_HYPOXIA_UP",98,-1.6038,0.0062,0.033,"No",-1.023,0.4,0.98,"No"
"3571","GO_BP","513862_GO_0060306_REGULATION_OF_MEMBRANE_REPOLARIZATION",27,-1.6037,0.015,0.063,"No",-0.8496,0.72,1,"No"
"3572","REACTOME","161046_REACT_21346_ACTIVATION_OF_CA_PERMEABLE_KAINATE_RECEPTOR",12,-1.6037,0.022,0.072,"No",-0.8455,0.66,1,"No"
"3573","GO_MF","490641_GO_0005546_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING",45,-1.6036,0.0085,0.097,"No",-0.9521,0.52,0.95,"No"
"3574","GO_BP","498980_GO_0021697_CEREBELLAR_CORTEX_FORMATION",21,-1.6036,0.015,0.063,"No",0.8364,0.72,1,"Yes"
"3575","GO_BP","513623_GO_0060065_UTERUS_DEVELOPMENT",18,-1.6036,0.024,0.063,"No",-0.7639,0.82,1,"No"
"3576","GO_BP","498073_GO_0019218_REGULATION_OF_STEROID_METABOLIC_PROCESS",75,-1.6035,0.0039,0.063,"No",0.8208,0.82,1,"Yes"
"3577","GO_BP","507460_GO_0045060_NEGATIVE_THYMIC_T_CELL_SELECTION",10,-1.6035,0.024,0.063,"No",0.8193,0.69,1,"Yes"
"3578","GO_BP","510544_GO_0048469_CELL_MATURATION",130,-1.6034,0,0.063,"No",-1.3632,0.023,0.97,"No"
"3579","GO_BP","753716_GO_1900745_POSITIVE_REGULATION_OF_P38MAPK_CASCADE",9,-1.6033,0.024,0.063,"No",-1.1316,0.31,0.93,"No"
"3580","C2_Chemical_and_genetic_perturbations","C2_CGP_1538_ALCALAY_AML_BY_NPM1_LOCALIZATION_DN",184,-1.6033,0,0.033,"No",1.0432,0.33,0.73,"Yes"
"3581","GO_MF","490162_GO_0004860_PROTEIN_KINASE_INHIBITOR_ACTIVITY",61,-1.6033,0.0093,0.097,"No",0.7768,0.9,1,"Yes"
"3582","C4_Cancer_modules","C4_CM_367_MODULE_448",45,-1.6032,0.0042,0.029,"No",0.7662,0.89,0.99,"Yes"
"3583","C7_Immunologic_signatures","C7_ALL_387_GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP",199,-1.6032,0.0011,0.0012,"No",1.0437,0.35,0.61,"Yes"
"3584","C2_Chemical_and_genetic_perturbations","C2_CGP_827_MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN",161,-1.6031,0,0.033,"No",0.9153,0.7,0.9,"Yes"
"3585","C7_Immunologic_signatures","C7_ALL_231_GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP",195,-1.603,0,0.0012,"No",0.7428,1,1,"Yes"
"3586","GO_BP","508082_GO_0045742_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",22,-1.603,0.015,0.063,"No",-0.804,0.76,1,"No"
"3587","C7_Immunologic_signatures","C7_ALL_609_GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_UP",199,-1.603,0,0.0012,"No",0.9571,0.56,0.88,"Yes"
"3588","C7_Immunologic_signatures","C7_ALL_748_GSE17721_0_5H_VS_24H_CPG_BMDM_DN",199,-1.603,0,0.0012,"No",0.8776,0.79,1,"Yes"
"3589","C7_Immunologic_signatures","C7_ALL_347_GSE15215_CD2_POS_VS_NEG_PDC_UP",193,-1.603,0,0.0012,"No",-1.3358,0.014,0.37,"No"
"3590","KEGG_pathway","HSA04024_CAMP_SIGNALING_PATHWAY",198,-1.6029,0,0.016,"No",-1.0926,0.23,0.71,"No"
"3591","GO_MF","752654_GO_0097153_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",15,-1.6029,0.023,0.096,"No",-1.0235,0.42,0.89,"No"
"3592","C7_Immunologic_signatures","C7_ALL_710_GSE17721_0_5H_VS_4H_LPS_BMDM_DN",194,-1.6029,0.0011,0.0012,"No",-0.8643,0.83,1,"No"
"3593","C3_TF_targets","C3_TFT_344_V_MAF_Q6",251,-1.6028,0,0.01,"No",-1.0386,0.35,0.67,"No"
"3594","C2_Chemical_and_genetic_perturbations","C2_CGP_3100_OHGUCHI_LIVER_HNF4A_TARGETS_UP",40,-1.6028,0.013,0.034,"No",-1.3137,0.11,0.69,"No"
"3595","GO_BP","753013_GO_1900015_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",11,-1.6026,0.019,0.063,"No",-1.6959,0.02,0.61,"No"
"3596","GO_BP","512812_GO_0051962_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT",331,-1.6024,0,0.063,"No",-1.0463,0.29,0.97,"No"
"3597","KEGG_compound","C03161_OXIDIZED_FLAVOPROTEIN",9,-1.6021,0.017,0.087,"No",-1.2212,0.25,0.77,"No"
"3598","C7_Immunologic_signatures","C7_ALL_1176_GSE27786_LIN_NEG_VS_MONO_MAC_DN",199,-1.602,0.0011,0.0012,"No",-1.2111,0.071,0.79,"No"
"3599","C3_TF_targets","C3_TFT_204_V_HFH8_01",196,-1.6019,0,0.01,"No",0.7888,0.96,1,"Yes"
"3600","GO_BP","512749_GO_0051894_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY",19,-1.6019,0.022,0.063,"No",-1.1622,0.25,0.92,"No"
"3601","C2_Chemical_and_genetic_perturbations","C2_CGP_128_LIU_VMYB_TARGETS_UP",126,-1.6019,0.0036,0.034,"No",0.6653,1,1,"Yes"
"3602","KEGG_pathway","HSA05100_BACTERIAL_INVASION_OF_EPITHELIAL_CELLS",78,-1.6019,0.005,0.016,"No",0.9555,0.58,0.97,"Yes"
"3603","REACTOME","187105_REACT_25216_REGULATION_OF_IFNA_SIGNALING",22,-1.6018,0.026,0.072,"No",-0.6513,0.94,1,"No"
"3604","GO_BP","498833_GO_0021549_CEREBELLUM_DEVELOPMENT",84,-1.6018,0.0026,0.063,"No",-1.1646,0.19,0.92,"No"
"3605","GO_BP","495075_GO_0014002_ASTROCYTE_DEVELOPMENT",14,-1.6018,0.014,0.063,"No",-0.9255,0.55,1,"No"
"3606","C7_Immunologic_signatures","C7_ALL_1702_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN",200,-1.6016,0.0011,0.0012,"No",1.1691,0.11,0.28,"Yes"
"3607","GO_BP","487954_GO_0002064_EPITHELIAL_CELL_DEVELOPMENT",188,-1.6015,0.0011,0.063,"No",-0.9845,0.49,1,"No"
"3608","GO_MF","495515_GO_0015254_GLYCEROL_CHANNEL_ACTIVITY",10,-1.6015,0.013,0.097,"No",-0.7595,0.79,1,"No"
"3609","GO_BP","751014_GO_0036092_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS",15,-1.6014,0.022,0.063,"No",-1.1565,0.26,0.92,"No"
"3610","KEGG_pathway","HSA04916_MELANOGENESIS",100,-1.6012,0.0037,0.016,"No",-1.0832,0.3,0.69,"No"
"3611","REACTOME","106144_REACT_11040_BILE_ACID_AND_BILE_SALT_METABOLISM",34,-1.6012,0.013,0.072,"No",0.8902,0.65,0.91,"Yes"
"3612","C2_Chemical_and_genetic_perturbations","C2_CGP_2490_SPIRA_SMOKERS_LUNG_CANCER_UP",37,-1.6011,0.013,0.034,"No",1.8141,0.0022,0.039,"Yes"
"3613","C7_Immunologic_signatures","C7_ALL_1902_GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN",196,-1.601,0,0.0012,"No",1.0605,0.28,0.56,"Yes"
"3614","GO_BP","508246_GO_0045940_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS",23,-1.6008,0.025,0.064,"No",-1.2416,0.16,0.91,"No"
"3615","C3_TF_targets","C3_TFT_217_V_OCT1_B",252,-1.6008,0,0.01,"No",-1.1527,0.15,0.45,"No"
"3616","REACTOME","645311_REACT_120888_CS_DS_DEGRADATION",13,-1.6008,0.013,0.072,"No",-0.9444,0.54,1,"No"
"3617","GO_CC","499802_GO_0030424_AXON",323,-1.6007,0,0.093,"No",-0.9717,0.53,0.88,"No"
"3618","GO_BP","518899_GO_2000252_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR",6,-1.6006,0.021,0.064,"No",0.8495,0.64,1,"Yes"
"3619","C2_Chemical_and_genetic_perturbations","C2_CGP_2176_SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP",179,-1.6004,0,0.034,"No",0.768,0.98,1,"Yes"
"3620","GO_BP","496184_GO_0046889_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS",53,-1.6003,0.0067,0.064,"No",-1.1737,0.2,0.91,"No"
"3621","GO_BP","499861_GO_0030522_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY",191,-1.6003,0,0.064,"No",-0.6724,1,1,"No"
"3622","REACTOME","106186_REACT_1249_HISTIDINE_CATABOLISM",5,-1.6002,0.024,0.072,"No",-0.6111,0.91,1,"No"
"3623","GO_BP","499151_GO_0021872_FOREBRAIN_GENERATION_OF_NEURONS",64,-1.6,0.0079,0.064,"No",-1.247,0.11,0.91,"No"
"3624","GO_MF","487554_GO_0001637_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY",26,-1.6,0.017,0.098,"No",1.7431,0,0.11,"Yes"
"3625","GO_BP","492192_GO_0007431_SALIVARY_GLAND_DEVELOPMENT",31,-1.5999,0.0099,0.064,"No",-1.1335,0.29,0.93,"No"
"3626","KEGG_pathway","HSA04080_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION",266,-1.5996,0,0.016,"No",1.3145,0.014,0.34,"Yes"
"3627","GO_BP","513868_GO_0060312_REGULATION_OF_BLOOD_VESSEL_REMODELING",5,-1.5996,0.023,0.064,"No",-0.7333,0.77,1,"No"
"3628","GO_MF","499363_GO_0022803_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",462,-1.5996,0,0.098,"No",-1.5038,0,0.55,"No"
"3629","GO_MF","489954_GO_0004623_PHOSPHOLIPASE_A2_ACTIVITY",27,-1.5995,0.016,0.097,"No",1.0387,0.39,0.83,"Yes"
"3630","GO_BP","511623_GO_0050651_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",14,-1.5995,0.034,0.064,"No",-1.0448,0.41,0.97,"No"
"3631","C2_BioCarta_Pathways","C2_CP_BIOCARTA_89_BIOCARTA_HIF_PATHWAY",15,-1.5994,0.022,0.09,"No",-0.6317,0.93,1,"No"
"3632","GO_BP","751208_GO_0036289_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION",6,-1.5994,0.01,0.064,"No",-0.722,0.81,1,"No"
"3633","GO_BP","491279_GO_0006335_DNA_REPLICATION_DEPENDENT_NUCLEOSOME_ASSEMBLY",31,-1.5994,0.013,0.064,"No",-1.8179,0.0095,0.42,"No"
"3634","C2_Chemical_and_genetic_perturbations","C2_CGP_3268_GUO_TARGETS_OF_IRS1_AND_IRS2",97,-1.5993,0.0025,0.035,"No",-0.7902,0.89,1,"No"
"3635","GO_BP","492504_GO_0008154_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION",42,-1.5992,0.0083,0.064,"No",-0.9416,0.58,1,"No"
"3636","C2_Chemical_and_genetic_perturbations","C2_CGP_1805_BROWNE_HCMV_INFECTION_18HR_DN",173,-1.5992,0.0012,0.035,"No",-0.9798,0.52,1,"No"
"3637","C3_TF_targets","C3_TFT_96_V_OCT1_01",249,-1.5992,0,0.01,"No",-1.225,0.051,0.3,"No"
"3638","GO_BP","492042_GO_0007263_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION",18,-1.5988,0.018,0.064,"No",0.7404,0.83,1,"Yes"
"3639","C7_Immunologic_signatures","C7_ALL_1493_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP",196,-1.5987,0,0.0013,"No",0.7642,0.99,1,"Yes"
"3640","GO_BP","502772_GO_0033555_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS",66,-1.5987,0.012,0.064,"No",-1.3888,0.04,1,"No"
"3641","GO_MF","502438_GO_0033218_AMIDE_BINDING",225,-1.5987,0,0.097,"No",0.8666,0.85,1,"Yes"
"3642","C2_Chemical_and_genetic_perturbations","C2_CGP_1869_WENG_POR_TARGETS_GLOBAL_DN",22,-1.5987,0.012,0.035,"No",0.6599,0.95,1,"Yes"
"3643","GO_MF","487235_GO_0001012_RNA_POLYMERASE_II_REGULATORY_REGION_DNA_BINDING",375,-1.5986,0,0.097,"No",-1.1971,0.057,0.8,"No"
"3644","GO_BP","492002_GO_0007204_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION",154,-1.5984,0.0012,0.064,"No",1.1522,0.16,0.84,"Yes"
"3645","GO_BP","751351_GO_0038093_FC_RECEPTOR_SIGNALING_PATHWAY",215,-1.5984,0,0.064,"No",-0.7539,0.99,1,"No"
"3646","REACTOME","905991_REACT_169274_CELLULAR_SENESCENCE",185,-1.5983,0,0.073,"No",-1.2503,0.052,0.75,"No"
"3647","GO_MF","499388_GO_0022843_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY",147,-1.5983,0,0.097,"No",-1.5495,0.0018,0.54,"No"
"3648","GO_BP","488575_GO_0002702_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",57,-1.5983,0.0094,0.064,"No",-1.245,0.13,0.91,"No"
"3649","GO_BP","491734_GO_0006873_CELLULAR_ION_HOMEOSTASIS",447,-1.5982,0,0.064,"No",1.0891,0.19,0.92,"Yes"
"3650","C7_Immunologic_signatures","C7_ALL_1213_GSE27786_NKCELL_VS_NKTCELL_UP",199,-1.5981,0,0.0013,"No",0.8506,0.89,1,"Yes"
"3651","KEGG_pathway","HSA05203_VIRAL_CARCINOGENESIS",202,-1.598,0,0.016,"No",-0.8759,0.81,0.99,"No"
"3652","C7_Immunologic_signatures","C7_ALL_1402_GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN",198,-1.5979,0,0.0013,"No",1.6844,0,0.00081,"Yes"
"3653","C7_Immunologic_signatures","C7_ALL_1109_GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP",185,-1.5978,0.0012,0.0013,"No",-0.9356,0.64,1,"No"
"3654","KEGG_pathway","HSA04660_T_CELL_RECEPTOR_SIGNALING_PATHWAY",102,-1.5977,0.007,0.016,"No",0.7405,0.97,1,"Yes"
"3655","C2_Chemical_and_genetic_perturbations","C2_CGP_957_KHETCHOUMIAN_TRIM24_TARGETS_UP",46,-1.5977,0.013,0.035,"No",0.7818,0.85,1,"Yes"
"3656","C2_Chemical_and_genetic_perturbations","C2_CGP_2455_VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN",134,-1.5977,0.0012,0.035,"No",-0.9249,0.65,1,"No"
"3657","C2_Chemical_and_genetic_perturbations","C2_CGP_1707_DELASERNA_MYOD_TARGETS_DN",55,-1.5976,0.0069,0.035,"No",0.7681,0.9,1,"Yes"
"3658","GO_BP","504210_GO_0035020_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION",483,-1.5976,0,0.065,"No",-1.2968,0.011,0.88,"No"
"3659","C2_Chemical_and_genetic_perturbations","C2_CGP_1935_WU_HBX_TARGETS_2_UP",23,-1.5975,0.015,0.035,"No",0.8984,0.62,0.93,"Yes"
"3660","GO_BP","499584_GO_0030166_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",53,-1.5975,0.0053,0.065,"No",0.7771,0.86,1,"Yes"
"3661","GO_BP","507250_GO_0044243_MULTICELLULAR_ORGANISMAL_CATABOLIC_PROCESS",80,-1.5973,0.0013,0.065,"No",-1.0564,0.34,0.97,"No"
"3662","GO_MF","495417_GO_0015144_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",32,-1.5972,0.017,0.097,"No",-1.1195,0.27,0.82,"No"
"3663","C2_Chemical_and_genetic_perturbations","C2_CGP_3127_JOHNSTONE_PARVB_TARGETS_1_DN",61,-1.5972,0.0027,0.035,"No",-0.7003,0.95,1,"No"
"3664","GO_BP","516344_GO_0071420_CELLULAR_RESPONSE_TO_HISTAMINE",8,-1.5972,0.018,0.065,"No",0.7965,0.72,1,"Yes"
"3665","GO_BP","496191_GO_0016098_MONOTERPENOID_METABOLIC_PROCESS",6,-1.5972,0.018,0.065,"No",-0.9275,0.57,1,"No"
"3666","GO_BP","510610_GO_0048541_PEYER_S_PATCH_DEVELOPMENT",12,-1.597,0.025,0.065,"No",-0.8598,0.64,1,"No"
"3667","C7_Immunologic_signatures","C7_ALL_1617_GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP",199,-1.597,0.0011,0.0013,"No",1.305,0.017,0.097,"Yes"
"3668","GO_BP","488795_GO_0002922_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE",10,-1.5967,0.034,0.065,"No",-1.3162,0.13,0.89,"No"
"3669","C2_Chemical_and_genetic_perturbations","C2_CGP_3022_WHITFIELD_CELL_CYCLE_G2_M",215,-1.5964,0,0.035,"No",-1.0361,0.34,0.98,"No"
"3670","GO_BP","511937_GO_0051004_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY",35,-1.5964,0.013,0.065,"No",0.8944,0.6,1,"Yes"
"3671","GO_BP","506522_GO_0043491_PROTEIN_KINASE_B_SIGNALING",33,-1.5962,0.012,0.065,"No",-0.8588,0.7,1,"No"
"3672","GO_BP","510787_GO_0048732_GLAND_DEVELOPMENT",373,-1.5962,0,0.065,"No",-0.8172,0.97,1,"No"
"3673","GO_BP","512004_GO_0051090_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",342,-1.5962,0,0.065,"No",-0.8083,0.97,1,"No"
"3674","C2_Chemical_and_genetic_perturbations","C2_CGP_965_GROSS_HYPOXIA_VIA_HIF1A_ONLY",8,-1.596,0.027,0.035,"No",-1.0124,0.46,0.99,"No"
"3675","GO_BP","503953_GO_0034754_CELLULAR_HORMONE_METABOLIC_PROCESS",103,-1.5959,0.005,0.065,"No",-1.0387,0.37,0.98,"No"
"3676","GO_BP","513958_GO_0060402_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",44,-1.5959,0.014,0.065,"No",-0.8025,0.82,1,"No"
"3677","GO_BP","500901_GO_0031652_POSITIVE_REGULATION_OF_HEAT_GENERATION",8,-1.5959,0.032,0.065,"No",-1.2129,0.23,0.88,"No"
"3678","C7_Immunologic_signatures","C7_ALL_207_GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP",198,-1.5959,0,0.0013,"No",0.8774,0.82,1,"Yes"
"3679","C6_Oncogenic_signatures","C6_ALL_176_KRAS_600_LUNG_BREAST_UP_V1_DN",268,-1.5958,0,0.0052,"No",-1.1327,0.15,0.52,"No"
"3680","GO_BP","752807_GO_0097306_CELLULAR_RESPONSE_TO_ALCOHOL",77,-1.5956,0.0064,0.065,"No",0.8497,0.79,1,"Yes"
"3681","GO_BP","499233_GO_0021954_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT",68,-1.5956,0.01,0.065,"No",-1.3412,0.067,0.92,"No"
"3682","GO_BP","512093_GO_0051187_COFACTOR_CATABOLIC_PROCESS",81,-1.5956,0.0054,0.065,"No",1.0021,0.43,0.98,"Yes"
"3683","C7_Immunologic_signatures","C7_ALL_1513_GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP",197,-1.5955,0,0.0013,"No",-1.1371,0.16,1,"No"
"3684","C4_Cancer_modules","C4_CM_262_MODULE_298",21,-1.5954,0.012,0.03,"No",0.9507,0.51,0.78,"Yes"
"3685","GO_BP","491790_GO_0006941_STRIATED_MUSCLE_CONTRACTION",73,-1.5953,0.0039,0.065,"No",-1.5346,0.015,0.77,"No"
"3686","C7_Immunologic_signatures","C7_ALL_1708_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN",199,-1.5953,0,0.0013,"No",1.103,0.21,0.44,"Yes"
"3687","GO_BP","486645_GO_0000103_SULFATE_ASSIMILATION",8,-1.5952,0.027,0.065,"No",-0.5683,0.96,1,"No"
"3688","GO_BP","500163_GO_0030865_CORTICAL_CYTOSKELETON_ORGANIZATION",23,-1.5951,0.013,0.065,"No",-0.8626,0.66,1,"No"
"3689","KEGG_pathway","HSA05230_CENTRAL_CARBON_METABOLISM_IN_CANCER",67,-1.5951,0.0065,0.017,"No",-1.0921,0.3,0.69,"No"
"3690","GO_BP","503329_GO_0034123_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",14,-1.595,0.023,0.065,"No",1.2072,0.22,0.78,"Yes"
"3691","GO_BP","499569_GO_0030149_SPHINGOLIPID_CATABOLIC_PROCESS",22,-1.5949,0.022,0.065,"No",0.6853,0.92,1,"Yes"
"3692","C4_Cancer_modules","C4_CM_129_MODULE_134",29,-1.5947,0.015,0.03,"No",1.665,0.0063,0.056,"Yes"
"3693","C2_Chemical_and_genetic_perturbations","C2_CGP_1317_SHEPARD_BMYB_TARGETS",71,-1.5946,0.0052,0.036,"No",-0.9337,0.6,1,"No"
"3694","GO_BP","505019_GO_0035850_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",23,-1.5945,0.024,0.065,"No",-0.8768,0.66,1,"No"
"3695","C2_Chemical_and_genetic_perturbations","C2_CGP_1325_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1",9,-1.5944,0.012,0.036,"No",1.1502,0.3,0.56,"Yes"
"3696","WikiPathways","198812_WP474_ENDOCHONDRAL_OSSIFICATION",64,-1.5942,0.0079,0.041,"No",-1.246,0.12,0.85,"No"
"3697","C2_Chemical_and_genetic_perturbations","C2_CGP_855_MURATA_VIRULENCE_OF_H_PILORI",23,-1.5942,0.017,0.036,"No",-1.1178,0.29,0.89,"No"
"3698","C3_TF_targets","C3_TFT_340_V_HSF_Q6",199,-1.5942,0.0011,0.011,"No",-1.2086,0.085,0.34,"No"
"3699","GO_BP","508020_GO_0045672_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION",22,-1.5941,0.024,0.066,"No",-1.7108,0.0038,0.72,"No"
"3700","KEGG_pathway","HSA04912_GNRH_SIGNALING_PATHWAY",91,-1.5941,0.0026,0.017,"No",-1.018,0.4,0.84,"No"
"3701","GO_BP","514093_GO_0060538_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT",122,-1.594,0.0024,0.066,"No",-1.0542,0.32,0.97,"No"
"3702","GO_BP","499426_GO_0022898_REGULATION_OF_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",157,-1.5939,0.0012,0.066,"No",-1.4408,0.0069,0.91,"No"
"3703","GO_CC","490837_GO_0030139_ENDOCYTIC_VESICLE",223,-1.5939,0,0.098,"No",1.0146,0.44,0.76,"Yes"
"3704","KEGG_compound","C05665_3_AMINOPROPANAL_BETA_AMINOPROPION_ALDEHYDE",12,-1.5939,0.018,0.093,"No",-0.9626,0.5,1,"No"
"3705","REACTOME","366164_REACT_75913_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS",48,-1.5938,0.0096,0.076,"No",-0.79,0.82,1,"No"
"3706","GO_BP","494836_GO_0010771_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION",89,-1.5936,0.0049,0.066,"No",-1.1359,0.23,0.93,"No"
"3707","GO_BP","505801_GO_0042692_MUSCLE_CELL_DIFFERENTIATION",250,-1.5935,0,0.066,"No",-1.1067,0.21,0.94,"No"
"3708","C2_Chemical_and_genetic_perturbations","C2_CGP_2047_DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP",77,-1.5934,0.0039,0.036,"No",-1.7271,0,0.35,"No"
"3709","C4_Cancer_modules","C4_CM_170_MODULE_180",114,-1.5934,0.0024,0.03,"No",-1.3423,0.054,0.51,"No"
"3710","GO_BP","849963_GO_1902262_APOPTOTIC_PROCESS_INVOLVED_IN_PATTERNING_OF_BLOOD_VESSELS",6,-1.5933,0.031,0.066,"No",0.9066,0.58,1,"Yes"
"3711","C2_Chemical_and_genetic_perturbations","C2_CGP_1502_RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP",30,-1.5932,0.025,0.036,"No",0.7235,0.89,1,"Yes"
"3712","C2_Chemical_and_genetic_perturbations","C2_CGP_88_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP",66,-1.593,0.0013,0.036,"No",0.9392,0.56,0.88,"Yes"
"3713","KEGG_pathway","HSA00052_GALACTOSE_METABOLISM",29,-1.5927,0.022,0.017,"No",-1.3623,0.082,0.31,"No"
"3714","GO_BP","754153_GO_1901186_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY",23,-1.5926,0.022,0.066,"No",-0.7727,0.8,1,"No"
"3715","GO_BP","495017_GO_0010952_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY",150,-1.5926,0,0.066,"No",0.9225,0.64,1,"Yes"
"3716","C2_Chemical_and_genetic_perturbations","C2_CGP_79_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN",153,-1.5925,0.0034,0.036,"No",-1.1896,0.13,0.81,"No"
"3717","GO_CC","505708_GO_0042581_SPECIFIC_GRANULE",14,-1.5925,0.031,0.098,"No",1.1243,0.31,0.61,"Yes"
"3718","GO_MF","499378_GO_0022832_VOLTAGE_GATED_CHANNEL_ACTIVITY",185,-1.5925,0.0012,0.1,"No",-1.4465,0.0035,0.63,"No"
"3719","GO_BP","751848_GO_0044705_MULTI_ORGANISM_REPRODUCTIVE_BEHAVIOR",31,-1.5923,0.0087,0.066,"No",0.7731,0.82,1,"Yes"
"3720","C7_Immunologic_signatures","C7_ALL_642_GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_DN",199,-1.5919,0,0.0014,"No",0.8847,0.78,1,"Yes"
"3721","C7_Immunologic_signatures","C7_ALL_66_GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN",187,-1.5919,0,0.0014,"No",-0.9443,0.61,1,"No"
"3722","C2_Chemical_and_genetic_perturbations","C2_CGP_169_RODRIGUES_DCC_TARGETS_DN",121,-1.5919,0.0024,0.036,"No",0.776,0.94,1,"Yes"
"3723","GO_BP","507290_GO_0044283_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS",410,-1.5918,0,0.066,"No",-0.7982,0.98,1,"No"
"3724","C2_Chemical_and_genetic_perturbations","C2_CGP_1879_ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN",51,-1.5917,0.0055,0.036,"No",-0.8946,0.67,1,"No"
"3725","C2_Chemical_and_genetic_perturbations","C2_CGP_1360_CHESLER_BRAIN_D6MIT150_QTL_TRANS",8,-1.5917,0.03,0.036,"No",-1.1449,0.31,0.85,"No"
"3726","GO_MF","490478_GO_0005244_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY",185,-1.5917,0,0.1,"No",-1.4349,0.0068,0.64,"No"
"3727","C2_Chemical_and_genetic_perturbations","C2_CGP_1544_CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70",67,-1.5916,0.012,0.036,"No",-1.1946,0.16,0.8,"No"
"3728","C2_Chemical_and_genetic_perturbations","C2_CGP_75_DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN",68,-1.5914,0.0065,0.036,"No",-0.8657,0.73,1,"No"
"3729","GO_BP","512806_GO_0051956_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT",9,-1.5914,0.02,0.067,"No",-1.3552,0.12,0.96,"No"
"3730","GO_CC","500923_GO_0031674_I_BAND",122,-1.5914,0,0.098,"No",-1.0196,0.4,0.84,"No"
"3731","GO_CC","499970_GO_0030666_ENDOCYTIC_VESICLE_MEMBRANE",128,-1.5913,0,0.096,"No",0.8747,0.78,0.91,"Yes"
"3732","GO_BP","512061_GO_0051151_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",6,-1.5913,0.016,0.067,"No",-1.0941,0.36,0.95,"No"
"3733","C3_TF_targets","C3_TFT_30_V_NFKAPPAB_01",247,-1.591,0,0.011,"No",-1.1943,0.1,0.36,"No"
"3734","C2_Chemical_and_genetic_perturbations","C2_CGP_3266_VERNOCHET_ADIPOGENESIS",18,-1.5909,0.019,0.036,"No",1.3876,0.09,0.3,"Yes"
"3735","C3_TF_targets","C3_TFT_512_RYTAAWNNNTGAY_UNKNOWN",60,-1.5908,0.0053,0.011,"No",-1.3328,0.065,0.19,"No"
"3736","GO_BP","516420_GO_0071496_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS",285,-1.5907,0,0.067,"No",-0.7654,0.99,1,"No"
"3737","C2_Chemical_and_genetic_perturbations","C2_CGP_1829_HAN_JNK_SINGALING_UP",35,-1.5905,0.013,0.036,"No",1.0133,0.4,0.78,"Yes"
"3738","C7_Immunologic_signatures","C7_ALL_81_GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",196,-1.5905,0.0011,0.0015,"No",1.0098,0.42,0.72,"Yes"
"3739","C2_Chemical_and_genetic_perturbations","C2_CGP_1023_SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN",29,-1.5904,0.019,0.036,"No",-0.9869,0.48,1,"No"
"3740","GO_BP","1184489_GO_1903963_ARACHIDONATE_TRANSPORT",13,-1.5904,0.027,0.067,"No",-0.6311,0.94,1,"No"
"3741","C6_Oncogenic_signatures","C6_ALL_47_P53_DN_V2_DN",139,-1.5902,0.0023,0.0055,"No",-0.9353,0.61,0.84,"No"
"3742","REACTOME","119523_REACT_19279_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION",14,-1.59,0.028,0.078,"No",-1.2325,0.2,0.79,"No"
"3743","KEGG_pathway","HSA04724_GLUTAMATERGIC_SYNAPSE",115,-1.5897,0.0024,0.017,"No",-1.227,0.1,0.52,"No"
"3744","C2_Chemical_and_genetic_perturbations","C2_CGP_694_FARMER_BREAST_CANCER_BASAL_VS_LULMINAL",327,-1.5897,0,0.037,"No",0.78,1,1,"Yes"
"3745","GO_MF","506117_GO_0043028_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",44,-1.5897,0.0096,0.1,"No",0.8073,0.82,1,"Yes"
"3746","C7_Immunologic_signatures","C7_ALL_663_GSE17721_LPS_VS_CPG_8H_BMDM_UP",196,-1.5896,0,0.0015,"No",-0.7447,0.99,1,"No"
"3747","C4_Cancer_modules","C4_CM_400_MODULE_511",38,-1.5895,0.015,0.031,"No",-1.0538,0.38,0.72,"No"
"3748","GO_MF","490458_GO_0005216_ION_CHANNEL_ACTIVITY",388,-1.5895,0,0.1,"No",-1.572,0,0.48,"No"
"3749","GO_BP","505083_GO_0035914_SKELETAL_MUSCLE_CELL_DIFFERENTIATION",50,-1.5895,0.012,0.068,"No",-1.0937,0.31,0.95,"No"
"3750","GO_MF","504770_GO_0035591_SIGNALING_ADAPTOR_ACTIVITY",72,-1.5895,0.0064,0.1,"No",1.0582,0.37,0.83,"Yes"
"3751","GO_BP","512234_GO_0051350_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY",27,-1.5889,0.0089,0.068,"No",0.756,0.88,1,"Yes"
"3752","C4_Cancer_modules","C4_CM_362_MODULE_439",21,-1.5888,0.011,0.031,"No",1.2149,0.2,0.38,"Yes"
"3753","GO_BP","491688_GO_0006820_ANION_TRANSPORT",484,-1.5888,0,0.068,"No",-1.2808,0.013,0.89,"No"
"3754","GO_BP","500117_GO_0030818_NEGATIVE_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS",33,-1.5886,0.01,0.068,"No",-0.7843,0.81,1,"No"
"3755","WikiPathways","755439_WP2038_REGULATION_OF_MICROTUBULE_CYTOSKELETON",44,-1.5885,0.013,0.043,"No",-0.6265,0.97,1,"No"
"3756","GO_BP","502498_GO_0033280_RESPONSE_TO_VITAMIN_D",21,-1.5885,0.024,0.068,"No",-0.7552,0.83,1,"No"
"3757","C7_Immunologic_signatures","C7_ALL_919_GSE22045_TREG_VS_TCONV_UP",180,-1.5885,0.0023,0.0015,"No",-0.9424,0.61,1,"No"
"3758","C2_Chemical_and_genetic_perturbations","C2_CGP_3148_STEGER_ADIPOGENESIS_UP",20,-1.5882,0.017,0.037,"No",0.9504,0.52,0.86,"Yes"
"3759","C3_TF_targets","C3_TFT_141_V_OCT1_Q6",256,-1.5881,0,0.011,"No",-1.0793,0.25,0.6,"No"
"3760","C7_Immunologic_signatures","C7_ALL_588_GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_DN",198,-1.5881,0.0011,0.0016,"No",-0.8101,0.92,1,"No"
"3761","C2_Chemical_and_genetic_perturbations","C2_CGP_2823_GYORFFY_DOXORUBICIN_RESISTANCE",52,-1.588,0.0081,0.037,"No",-1.2122,0.15,0.8,"No"
"3762","C2_Chemical_and_genetic_perturbations","C2_CGP_736_BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX",17,-1.588,0.022,0.037,"No",1.6379,0.023,0.12,"Yes"
"3763","GO_BP","500533_GO_0031274_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY",12,-1.5878,0.024,0.068,"No",-1.0059,0.43,0.98,"No"
"3764","GO_CC","496364_GO_0016324_APICAL_PLASMA_MEMBRANE",255,-1.5877,0,0.099,"No",-1.1588,0.11,0.68,"No"
"3765","REACTOME","160969_REACT_20580_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS",9,-1.5877,0.025,0.079,"No",-0.4545,1,1,"No"
"3766","C7_Immunologic_signatures","C7_ALL_52_GSE10325_BCELL_VS_LUPUS_BCELL_DN",199,-1.5876,0.0011,0.0016,"No",1.7784,0,0.00022,"Yes"
"3767","C2_Chemical_and_genetic_perturbations","C2_CGP_851_MOHANKUMAR_TLX1_TARGETS_DN",185,-1.5873,0.0012,0.037,"No",0.9909,0.48,0.81,"Yes"
"3768","GO_MF","487205_GO_0000981_SEQUENCE_SPECIFIC_DNA_BINDING_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY",496,-1.5872,0,0.1,"No",-1.128,0.13,0.81,"No"
"3769","GO_BP","511461_GO_0050482_ARACHIDONIC_ACID_SECRETION",13,-1.5871,0.027,0.069,"No",-0.6478,0.91,1,"No"
"3770","GO_MF","496861_GO_0017040_CERAMIDASE_ACTIVITY",5,-1.5871,0.022,0.1,"No",-0.7681,0.75,1,"No"
"3771","C3_TF_targets","C3_TFT_284_V_FOXO1_01",241,-1.587,0,0.011,"No",-0.902,0.75,0.96,"No"
"3772","WikiPathways","198789_WP428_WNT_SIGNALING_PATHWAY",60,-1.5869,0.0067,0.042,"No",-1.2071,0.17,0.82,"No"
"3773","C2_Chemical_and_genetic_perturbations","C2_CGP_1469_ABBUD_LIF_SIGNALING_2_UP",13,-1.5869,0.027,0.037,"No",-0.882,0.61,1,"No"
"3774","GO_MF","499384_GO_0022839_ION_GATED_CHANNEL_ACTIVITY",41,-1.5868,0.019,0.1,"No",1.1685,0.21,0.73,"Yes"
"3775","C7_Immunologic_signatures","C7_ALL_966_GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN",200,-1.5868,0,0.0016,"No",1.7055,0,6e-04,"Yes"
"3776","REACTOME","366171_REACT_75790_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM",301,-1.5868,0,0.079,"No",1.1115,0.14,0.56,"Yes"
"3777","GO_BP","499234_GO_0021955_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS",29,-1.5866,0.015,0.069,"No",-0.9102,0.6,1,"No"
"3778","REACTOME","645258_REACT_120956_CELLULAR_RESPONSES_TO_STRESS",312,-1.5866,0,0.079,"No",-0.9947,0.45,0.98,"No"
"3779","GO_BP","488193_GO_0002320_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION",11,-1.5864,0.031,0.069,"No",-1.0612,0.38,0.96,"No"
"3780","GO_BP","491522_GO_0006631_FATTY_ACID_METABOLIC_PROCESS",284,-1.5863,0,0.069,"No",0.9226,0.72,1,"Yes"
"3781","C4_Cancer_modules","C4_CM_187_MODULE_200",27,-1.5863,0.016,0.031,"No",-0.8565,0.71,0.94,"No"
"3782","GO_BP","511744_GO_0050773_REGULATION_OF_DENDRITE_DEVELOPMENT",88,-1.5862,0.0025,0.069,"No",-1.4576,0.0073,0.88,"No"
"3783","GO_BP","506517_GO_0043485_ENDOSOME_TO_PIGMENT_GRANULE_TRANSPORT",9,-1.5862,0.021,0.069,"No",0.5208,0.98,1,"Yes"
"3784","C2_Chemical_and_genetic_perturbations","C2_CGP_1460_GUO_HEX_TARGETS_UP",81,-1.5859,0.0091,0.038,"No",-0.885,0.69,1,"No"
"3785","C2_Chemical_and_genetic_perturbations","C2_CGP_50_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP",294,-1.5858,0,0.038,"No",1.112,0.16,0.61,"Yes"
"3786","C2_Chemical_and_genetic_perturbations","C2_CGP_224_LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP",14,-1.5853,0.03,0.038,"No",-1.0658,0.37,0.96,"No"
"3787","WikiPathways","198813_WP410_DIURNALLY_REGULATED_GENES_WITH_CIRCADIAN_ORTHOLOGS",50,-1.5852,0.0083,0.042,"No",0.7047,0.96,1,"Yes"
"3788","GO_MF","490426_GO_0005161_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING",14,-1.5849,0.03,0.1,"No",1.3725,0.11,0.49,"Yes"
"3789","REACTOME","119571_REACT_19305_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS",96,-1.5847,0.0038,0.08,"No",-1.5324,0.0072,0.42,"No"
"3790","GO_MF","752380_GO_0086008_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION",7,-1.5846,0.028,0.1,"No",0.721,0.82,1,"Yes"
"3791","GO_BP","515502_GO_0070572_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION",5,-1.5845,0.016,0.07,"No",-0.8654,0.6,1,"No"
"3792","C2_Chemical_and_genetic_perturbations","C2_CGP_458_GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN",31,-1.5844,0.016,0.038,"No",0.8916,0.66,0.93,"Yes"
"3793","GO_BP","504214_GO_0035024_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION",15,-1.5844,0.034,0.07,"No",-1.0297,0.4,0.97,"No"
"3794","C2_Chemical_and_genetic_perturbations","C2_CGP_807_DIRMEIER_LMP1_RESPONSE_LATE_UP",57,-1.5844,0.0056,0.038,"No",-0.588,0.99,1,"No"
"3795","C7_Immunologic_signatures","C7_ALL_1881_GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP",195,-1.5842,0,0.0016,"No",-0.8367,0.88,1,"No"
"3796","C4_Cancer_gene_neighborhoods","C4_CGN_390_GNF2_PAK2",28,-1.5842,0.021,0.026,"No",1.1795,0.25,0.24,"Yes"
"3797","GO_BP","494122_GO_0010042_RESPONSE_TO_MANGANESE_ION",12,-1.5842,0.024,0.07,"No",-0.8769,0.62,1,"No"
"3798","GO_BP","504823_GO_0035646_ENDOSOME_TO_MELANOSOME_TRANSPORT",9,-1.5842,0.022,0.07,"No",0.5398,0.98,1,"Yes"
"3799","C7_Immunologic_signatures","C7_ALL_850_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN",193,-1.5841,0,0.0016,"No",-1.0683,0.3,1,"No"
"3800","C2_Chemical_and_genetic_perturbations","C2_CGP_2034_LOPES_METHYLATED_IN_COLON_CANCER_UP",27,-1.5841,0.015,0.038,"No",0.893,0.6,0.93,"Yes"
"3801","GO_BP","987839_GO_1903038_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION",78,-1.584,0.0052,0.07,"No",-0.8405,0.81,1,"No"
"3802","GO_BP","508287_GO_0045986_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION",14,-1.584,0.021,0.07,"No",-0.675,0.89,1,"No"
"3803","GO_BP","500553_GO_0031294_LYMPHOCYTE_COSTIMULATION",77,-1.584,0.0026,0.07,"No",0.9623,0.54,1,"Yes"
"3804","GO_MF","492451_GO_0008083_GROWTH_FACTOR_ACTIVITY",147,-1.584,0.0011,0.1,"No",1.0098,0.44,0.87,"Yes"
"3805","GO_CC","499973_GO_0030670_PHAGOCYTIC_VESICLE_MEMBRANE",53,-1.5839,0.0095,0.1,"No",1.1063,0.26,0.64,"Yes"
"3806","C6_Oncogenic_signatures","C6_ALL_141_PDGF_UP_V1_DN",125,-1.5839,0.0012,0.0059,"No",1.0177,0.41,0.76,"Yes"
"3807","GO_BP","850006_GO_1902305_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",45,-1.5839,0.015,0.07,"No",-1.3518,0.07,0.95,"No"
"3808","GO_BP","494612_GO_0010543_REGULATION_OF_PLATELET_ACTIVATION",27,-1.5838,0.023,0.07,"No",1.2502,0.17,0.73,"Yes"
"3809","GO_BP","501538_GO_0032303_REGULATION_OF_ICOSANOID_SECRETION",18,-1.5838,0.029,0.07,"No",0.7537,0.8,1,"Yes"
"3810","C2_Chemical_and_genetic_perturbations","C2_CGP_462_BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN",31,-1.5838,0.02,0.038,"No",1.0327,0.4,0.75,"Yes"
"3811","KEGG_compound","C00103_D_GLUCOSE_1_PHOSPHATE_ALPHA_D_GLUCOSE_1_PHOSPHATE_CORI_ESTER_D_GLUCOSE_ALPHA_1_PHOSPHATE",10,-1.5835,0.021,0.1,"No",-1.2241,0.2,0.78,"No"
"3812","C7_Immunologic_signatures","C7_ALL_330_GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN",196,-1.5832,0.0011,0.0017,"No",-1.1308,0.19,1,"No"
"3813","GO_BP","488812_GO_0003014_RENAL_SYSTEM_PROCESS",99,-1.5831,0.0013,0.07,"No",1.2336,0.077,0.75,"Yes"
"3814","GO_BP","784766_GO_1902042_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",25,-1.5831,0.027,0.07,"No",0.9513,0.54,1,"Yes"
"3815","GO_BP","499326_GO_0022408_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION",117,-1.5831,0.0025,0.07,"No",-0.8065,0.86,1,"No"
"3816","GO_MF","489477_GO_0046873_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",398,-1.583,0,0.1,"No",-1.5929,0,0.47,"No"
"3817","C2_Chemical_and_genetic_perturbations","C2_CGP_1005_ROPERO_HDAC2_TARGETS",107,-1.5829,0.0037,0.039,"No",0.778,0.93,1,"Yes"
"3818","GO_BP","499617_GO_0030207_CHONDROITIN_SULFATE_CATABOLIC_PROCESS",13,-1.5828,0.025,0.07,"No",-0.9319,0.56,1,"No"
"3819","GO_BP","507289_GO_0044282_SMALL_MOLECULE_CATABOLIC_PROCESS",271,-1.5827,0,0.07,"No",0.9917,0.45,0.99,"Yes"
"3820","C7_Immunologic_signatures","C7_ALL_1784_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN",199,-1.5827,0.0011,0.0017,"No",-0.8657,0.83,1,"No"
"3821","C2_Chemical_and_genetic_perturbations","C2_CGP_2948_MOOTHA_GLUCONEOGENESIS",32,-1.5826,0.013,0.039,"No",-0.8735,0.69,1,"No"
"3822","C7_Immunologic_signatures","C7_ALL_1511_GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP",191,-1.5825,0,0.0017,"No",-1.2049,0.1,0.81,"No"
"3823","GO_BP","514396_GO_0060841_VENOUS_BLOOD_VESSEL_DEVELOPMENT",15,-1.5825,0.023,0.071,"No",-0.8791,0.65,1,"No"
"3824","C2_Chemical_and_genetic_perturbations","C2_CGP_1230_JI_METASTASIS_REPRESSED_BY_STK11",27,-1.5825,0.025,0.039,"No",1.1696,0.24,0.53,"Yes"
"3825","C2_Chemical_and_genetic_perturbations","C2_CGP_1441_YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP",78,-1.5825,0.0052,0.039,"No",-0.9999,0.44,1,"No"
"3826","C7_Immunologic_signatures","C7_ALL_200_GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN",198,-1.5824,0,0.0017,"No",1.6725,0.0023,0.00096,"Yes"
"3827","C6_Oncogenic_signatures","C6_ALL_184_KRAS_LUNG_BREAST_UP_V1_DN",134,-1.5824,0.0024,0.006,"No",-1.3156,0.043,0.37,"No"
"3828","C7_Immunologic_signatures","C7_ALL_1240_GSE2826_WT_VS_XID_BCELL_DN",196,-1.5823,0,0.0017,"No",0.9889,0.49,0.77,"Yes"
"3829","GO_BP","516374_GO_0071450_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL",14,-1.5823,0.02,0.071,"No",0.6372,0.93,1,"Yes"
"3830","C7_Immunologic_signatures","C7_ALL_1485_GSE360_L_MAJOR_VS_T_GONDII_MAC_UP",187,-1.5821,0.0011,0.0017,"No",-0.7698,0.97,1,"No"
"3831","C7_Immunologic_signatures","C7_ALL_1564_GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN",189,-1.582,0,0.0017,"No",-1.0673,0.29,1,"No"
"3832","GO_BP","518333_GO_0090193_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT",8,-1.5819,0.025,0.071,"No",0.8411,0.66,1,"Yes"
"3833","REACTOME","685550_REACT_147814_DAP12_SIGNALING",158,-1.5819,0,0.082,"No",-1.1701,0.13,0.86,"No"
"3834","GO_BP","507548_GO_0045165_CELL_FATE_COMMITMENT",223,-1.5818,0,0.071,"No",-1.032,0.36,0.98,"No"
"3835","GO_MF","489481_GO_0004012_PHOSPHOLIPID_TRANSLOCATING_ATPASE_ACTIVITY",15,-1.5818,0.025,0.1,"No",-1.5201,0.055,0.54,"No"
"3836","C2_Chemical_and_genetic_perturbations","C2_CGP_1293_LAMB_CCND1_TARGETS",19,-1.5818,0.018,0.039,"No",-1.1607,0.26,0.83,"No"
"3837","C7_Immunologic_signatures","C7_ALL_783_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0_5H_CD4_TCELL_UP",173,-1.5816,0,0.0017,"No",-1.6916,0,0.0033,"No"
"3838","GO_BP","948741_GO_1902713_REGULATION_OF_INTERFERON_GAMMA_SECRETION",5,-1.5816,0.016,0.071,"No",1.0756,0.37,0.93,"Yes"
"3839","GO_BP","850044_GO_1990138_NEURON_PROJECTION_EXTENSION",44,-1.5816,0.0098,0.071,"No",-1.2425,0.14,0.91,"No"
"3840","KEGG_pathway","HSA04973_CARBOHYDRATE_DIGESTION_AND_ABSORPTION",44,-1.5813,0.011,0.018,"No",-1.2388,0.14,0.51,"No"
"3841","C2_Chemical_and_genetic_perturbations","C2_CGP_1909_BAELDE_DIABETIC_NEPHROPATHY_DN",431,-1.5812,0,0.039,"No",1.2858,0.01,0.4,"Yes"
"3842","C2_Chemical_and_genetic_perturbations","C2_CGP_55_KOBAYASHI_EGFR_SIGNALING_6HR_DN",17,-1.5811,0.02,0.039,"No",-1.6115,0.024,0.4,"No"
"3843","C7_Immunologic_signatures","C7_ALL_1754_GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN",170,-1.5811,0.0012,0.0017,"No",1.3488,0.02,0.063,"Yes"
"3844","REACTOME","161044_REACT_21322_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS",12,-1.5809,0.029,0.082,"No",-0.8374,0.68,1,"No"
"3845","GO_BP","495813_GO_0015677_COPPER_ION_IMPORT",9,-1.5808,0.021,0.071,"No",0.5869,0.95,1,"Yes"
"3846","C2_Chemical_and_genetic_perturbations","C2_CGP_1557_ZHAN_MULTIPLE_MYELOMA_MS_UP",46,-1.5808,0.0097,0.039,"No",-0.8071,0.8,1,"No"
"3847","C7_Immunologic_signatures","C7_ALL_542_GSE17721_LPS_VS_POLYIC_16H_BMDM_DN",199,-1.5808,0,0.0017,"No",0.9396,0.62,0.93,"Yes"
"3848","C7_Immunologic_signatures","C7_ALL_124_GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN",200,-1.5807,0.0011,0.0017,"No",0.795,0.97,1,"Yes"
"3849","KEGG_pathway","HSA00600_SPHINGOLIPID_METABOLISM",47,-1.5806,0.019,0.018,"No",-0.9288,0.59,0.97,"No"
"3850","C2_Chemical_and_genetic_perturbations","C2_CGP_3021_WHITFIELD_CELL_CYCLE_G2",180,-1.5806,0,0.039,"No",-0.9321,0.65,1,"No"
"3851","REACTOME","1127575_REACT_268571_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN",6,-1.5805,0.019,0.082,"No",0.8793,0.61,0.92,"Yes"
"3852","GO_MF","487654_GO_0001758_RETINAL_DEHYDROGENASE_ACTIVITY",7,-1.5805,0.025,0.11,"No",-1.0202,0.44,0.89,"No"
"3853","GO_BP","505041_GO_0035872_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY",47,-1.5804,0.013,0.072,"No",0.6729,0.98,1,"Yes"
"3854","C0_Hallmark","H_ALL_35_HALLMARK_GLYCOLYSIS",199,-1.5803,0.0012,0.0046,"No",-0.745,0.99,1,"No"
"3855","REACTOME","119533_REACT_19195_ADHERENS_JUNCTIONS_INTERACTIONS",29,-1.5803,0.019,0.082,"No",0.8999,0.62,0.91,"Yes"
"3856","C2_Chemical_and_genetic_perturbations","C2_CGP_672_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27",10,-1.5803,0.031,0.039,"No",0.7609,0.77,1,"Yes"
"3857","GO_BP","982450_GO_1902882_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS",49,-1.5802,0.016,0.072,"No",1.3049,0.11,0.66,"Yes"
"3858","GO_BP","499613_GO_0030203_GLYCOSAMINOGLYCAN_METABOLIC_PROCESS",160,-1.58,0.0012,0.072,"No",-0.7303,0.99,1,"No"
"3859","GO_BP","488709_GO_0002836_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL",11,-1.58,0.021,0.072,"No",0.7931,0.74,1,"Yes"
"3860","C4_Cancer_modules","C4_CM_214_MODULE_235",79,-1.5799,0.0025,0.033,"No",-1.1028,0.26,0.69,"No"
"3861","GO_MF","487201_GO_0000977_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",371,-1.5799,0,0.11,"No",-1.2301,0.036,0.84,"No"
"3862","C7_Immunologic_signatures","C7_ALL_1172_GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN",193,-1.5799,0,0.0018,"No",-1.3276,0.017,0.4,"No"
"3863","C7_Immunologic_signatures","C7_ALL_611_GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_UP",197,-1.5797,0,0.0018,"No",-0.9703,0.55,1,"No"
"3864","C2_Chemical_and_genetic_perturbations","C2_CGP_1632_WEIGEL_OXIDATIVE_STRESS_RESPONSE",35,-1.5797,0.019,0.039,"No",-1.239,0.16,0.75,"No"
"3865","GO_BP","494786_GO_0010721_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT",240,-1.5797,0,0.072,"No",-1.0821,0.23,0.95,"No"
"3866","C2_Chemical_and_genetic_perturbations","C2_CGP_2841_KOBAYASHI_EGFR_SIGNALING_24HR_DN",250,-1.5795,0,0.039,"No",1.01,0.41,0.78,"Yes"
"3867","GO_BP","492183_GO_0007422_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT",70,-1.5795,0.0039,0.072,"No",-1.1238,0.24,0.94,"No"
"3868","C2_Chemical_and_genetic_perturbations","C2_CGP_1988_BURTON_ADIPOGENESIS_6",188,-1.5794,0.0011,0.039,"No",1.3696,0.0043,0.32,"Yes"
"3869","C7_Immunologic_signatures","C7_ALL_1663_GSE3982_NEUTROPHIL_VS_BASOPHIL_UP",190,-1.5791,0.0011,0.0018,"No",-0.9549,0.59,1,"No"
"3870","C0_Hallmark","H_ALL_4_HALLMARK_MITOTIC_SPINDLE",200,-1.579,0,0.0045,"No",-0.752,0.97,1,"No"
"3871","C7_Immunologic_signatures","C7_ALL_579_GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_UP",198,-1.579,0,0.0018,"No",1.4884,0,0.014,"Yes"
"3872","C3_TF_targets","C3_TFT_604_CTAWWWATA_V_RSRFC4_Q2",347,-1.5789,0,0.012,"No",-1.3583,0.0016,0.19,"No"
"3873","GO_BP","491683_GO_0006813_POTASSIUM_ION_TRANSPORT",150,-1.5789,0.0024,0.072,"No",-1.1263,0.18,0.94,"No"
"3874","C2_Chemical_and_genetic_perturbations","C2_CGP_724_SCHEIDEREIT_IKK_INTERACTING_PROTEINS",58,-1.5788,0.0068,0.039,"No",-0.9996,0.43,1,"No"
"3875","GO_MF","502169_GO_0032947_PROTEIN_COMPLEX_SCAFFOLD",63,-1.5788,0.015,0.11,"No",-0.9577,0.55,0.95,"No"
"3876","GO_BP","512576_GO_0051701_INTERACTION_WITH_HOST",126,-1.5786,0.0047,0.072,"No",0.81,0.92,1,"Yes"
"3877","GO_BP","518420_GO_0090280_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT",14,-1.5786,0.023,0.072,"No",0.8011,0.73,1,"Yes"
"3878","GO_MF","754527_GO_1901567_FATTY_ACID_DERIVATIVE_BINDING",6,-1.5786,0.023,0.11,"No",1.5464,0.048,0.34,"Yes"
"3879","C7_Immunologic_signatures","C7_ALL_924_GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN",199,-1.5785,0.0011,0.0018,"No",1.2799,0.039,0.12,"Yes"
"3880","GO_BP","513972_GO_0060416_RESPONSE_TO_GROWTH_HORMONE",36,-1.5784,0.018,0.072,"No",-0.824,0.76,1,"No"
"3881","GO_BP","499471_GO_0030003_CELLULAR_CATION_HOMEOSTASIS",435,-1.5784,0,0.072,"No",1.0974,0.18,0.9,"Yes"
"3882","GO_BP","491759_GO_0006898_RECEPTOR_MEDIATED_ENDOCYTOSIS",192,-1.5784,0.0011,0.072,"No",-0.8384,0.87,1,"No"
"3883","C7_Immunologic_signatures","C7_ALL_1550_GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN",195,-1.5784,0.0011,0.0018,"No",-0.7159,0.99,1,"No"
"3884","GO_BP","498811_GO_0021527_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION",13,-1.5784,0.022,0.072,"No",0.9267,0.56,1,"Yes"
"3885","GO_BP","511828_GO_0050890_COGNITION",223,-1.5783,0,0.072,"No",-1.1777,0.11,0.9,"No"
"3886","GO_BP","513952_GO_0060396_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY",26,-1.5781,0.018,0.072,"No",0.5052,1,1,"Yes"
"3887","C7_Immunologic_signatures","C7_ALL_605_GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_UP",198,-1.578,0,0.0018,"No",-0.6446,1,1,"No"
"3888","GO_MF","777638_GO_1901981_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING",99,-1.578,0.0074,0.11,"No",-0.7429,0.95,1,"No"
"3889","KEGG_compound","C00040_ACYL_COA_ACYL_COENZYME_A",43,-1.578,0.011,0.11,"No",-1.0476,0.35,0.99,"No"
"3890","GO_BP","511740_GO_0050769_POSITIVE_REGULATION_OF_NEUROGENESIS",299,-1.578,0,0.072,"No",-0.9928,0.46,1,"No"
"3891","C2_Chemical_and_genetic_perturbations","C2_CGP_1514_GREENBAUM_E2A_TARGETS_DN",21,-1.5779,0.026,0.04,"No",1.4979,0.042,0.21,"Yes"
"3892","GO_MF","490479_GO_0005245_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",44,-1.5778,0.0042,0.11,"No",-1.7853,0.0056,0.2,"No"
"3893","C2_Chemical_and_genetic_perturbations","C2_CGP_2982_DAZARD_UV_RESPONSE_CLUSTER_G24",28,-1.5777,0.018,0.04,"No",-1.411,0.058,0.58,"No"
"3894","GO_CC","507303_GO_0044297_CELL_BODY",389,-1.5776,0,0.11,"No",-1.2184,0.038,0.66,"No"
"3895","GO_BP","510813_GO_0048762_MESENCHYMAL_CELL_DIFFERENTIATION",114,-1.5776,0.0024,0.072,"No",-0.9019,0.7,1,"No"
"3896","GO_BP","754341_GO_1901379_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",46,-1.5775,0.0098,0.073,"No",-1.1416,0.24,0.93,"No"
"3897","GO_BP","488589_GO_0002716_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",9,-1.5774,0.021,0.072,"No",0.5566,0.97,1,"Yes"
"3898","C2_Chemical_and_genetic_perturbations","C2_CGP_775_DAUER_STAT3_TARGETS_DN",50,-1.5774,0.015,0.04,"No",1.4931,0.021,0.21,"Yes"
"3899","GO_BP","501758_GO_0032528_MICROVILLUS_ORGANIZATION",18,-1.5774,0.028,0.072,"No",0.701,0.88,1,"Yes"
"3900","C2_Chemical_and_genetic_perturbations","C2_CGP_1140_AMIT_EGF_RESPONSE_40_MCF10A",19,-1.5773,0.028,0.04,"No",-1.3432,0.13,0.7,"No"
"3901","GO_MF","489934_GO_0004602_GLUTATHIONE_PEROXIDASE_ACTIVITY",16,-1.5773,0.032,0.11,"No",-0.7979,0.74,1,"No"
"3902","GO_MF","494641_GO_0010576_METALLOENZYME_REGULATOR_ACTIVITY",15,-1.5772,0.025,0.1,"No",-1.3605,0.12,0.69,"No"
"3903","KEGG_compound","C00095_D_FRUCTOSE_LEVULOSE_FRUIT_SUGAR_D_ARABINO_HEXULOSE",10,-1.5772,0.02,0.11,"No",-1.1547,0.27,0.84,"No"
"3904","C2_Chemical_and_genetic_perturbations","C2_CGP_249_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN",7,-1.5772,0.024,0.04,"No",-0.8068,0.69,1,"No"
"3905","REACTOME","530736_REACT_115854_GRB2_EVENTS_IN_ERBB2_SIGNALING",30,-1.5771,0.02,0.083,"No",0.6386,0.96,1,"Yes"
"3906","C2_Chemical_and_genetic_perturbations","C2_CGP_1878_SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN",18,-1.577,0.032,0.04,"No",-0.5623,0.97,1,"No"
"3907","GO_BP","754182_GO_1901215_NEGATIVE_REGULATION_OF_NEURON_DEATH",153,-1.577,0.0012,0.073,"No",-1.0258,0.38,0.98,"No"
"3908","C2_Chemical_and_genetic_perturbations","C2_CGP_2331_MATZUK_LUTEAL_GENES",8,-1.577,0.027,0.04,"No",0.6068,0.93,1,"Yes"
"3909","GO_BP","494875_GO_0010811_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION",95,-1.5769,0.0051,0.073,"No",0.8926,0.7,1,"Yes"
"3910","GO_MF","492692_GO_0008392_ARACHIDONIC_ACID_EPOXYGENASE_ACTIVITY",16,-1.5769,0.022,0.1,"No",-1.9439,0,0.14,"No"
"3911","C3_TF_targets","C3_TFT_327_V_CEBPDELTA_Q6",234,-1.5768,0.0011,0.012,"No",-1.0547,0.31,0.64,"No"
"3912","GO_BP","508014_GO_0045666_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION",234,-1.5768,0,0.073,"No",-1.0448,0.34,0.97,"No"
"3913","C7_Immunologic_signatures","C7_ALL_1813_GSE7852_LN_VS_THYMUS_TREG_UP",199,-1.5768,0.0023,0.0018,"No",-0.882,0.8,1,"No"
"3914","C7_Immunologic_signatures","C7_ALL_1126_GSE2706_R848_VS_LPS_2H_STIM_DC_DN",179,-1.5767,0,0.0018,"No",-1.1936,0.1,0.84,"No"
"3915","C7_Immunologic_signatures","C7_ALL_766_GSE17974_0H_VS_0_5H_IN_VITRO_ACT_CD4_TCELL_DN",183,-1.5767,0,0.0018,"No",-1.4587,0.0037,0.12,"No"
"3916","GO_CC","506115_GO_0043025_NEURONAL_CELL_BODY",341,-1.5767,0,0.11,"No",-1.3465,0.01,0.63,"No"
"3917","C2_Chemical_and_genetic_perturbations","C2_CGP_1987_SU_PLACENTA",26,-1.5766,0.018,0.04,"No",-0.8163,0.76,1,"No"
"3918","C3_TF_targets","C3_TFT_135_V_CEBP_Q2",226,-1.5765,0,0.012,"No",-1.2678,0.039,0.26,"No"
"3919","REACTOME","106358_REACT_14819_PEPTIDE_LIGAND_BINDING_RECEPTORS",175,-1.5765,0.0012,0.083,"No",1.6685,0,0.061,"Yes"
"3920","GO_BP","488710_GO_0002837_REGULATION_OF_IMMUNE_RESPONSE_TO_TUMOR_CELL",11,-1.5764,0.036,0.073,"No",0.8122,0.72,1,"Yes"
"3921","GO_MF","490300_GO_0019838_GROWTH_FACTOR_BINDING",121,-1.5763,0.0036,0.1,"No",-0.8005,0.9,1,"No"
"3922","GO_BP","498080_GO_0019228_NEURONAL_ACTION_POTENTIAL",29,-1.5762,0.022,0.073,"No",-1.0491,0.38,0.97,"No"
"3923","C3_TF_targets","C3_TFT_288_V_CDC5_01",243,-1.5761,0,0.012,"No",1.0065,0.41,1,"Yes"
"3924","GO_MF","498574_GO_0019763_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY",7,-1.5761,0.024,0.1,"No",-1.5318,0.05,0.54,"No"
"3925","C1_Positional","C1_ALL_63_CHR4Q21",82,-1.5761,0.0089,0.25,"No",1.1595,0.18,0.63,"Yes"
"3926","GO_BP","518991_GO_2000345_REGULATION_OF_HEPATOCYTE_PROLIFERATION",8,-1.5761,0.032,0.073,"No",-0.741,0.81,1,"No"
"3927","GO_BP","488319_GO_0002446_NEUTROPHIL_MEDIATED_IMMUNITY",23,-1.576,0.018,0.073,"No",1.6175,0.015,0.28,"Yes"
"3928","C1_Positional","C1_ALL_9_CHR1P13",104,-1.576,0.0038,0.23,"No",-1.1393,0.19,1,"No"
"3929","C2_Chemical_and_genetic_perturbations","C2_CGP_3319_FOSTER_KDM1A_TARGETS_UP",252,-1.5759,0,0.04,"No",1.0767,0.24,0.67,"Yes"
"3930","C3_MicroRNA_targets","C3_MIR_164_CCCAGAG_MIR_326",152,-1.5758,0.0023,0.22,"No",-1.2566,0.073,1,"No"
"3931","GO_BP","492328_GO_0007586_DIGESTION",112,-1.5757,0.0062,0.073,"No",-1.0393,0.38,0.98,"No"
"3932","GO_BP","492669_GO_0008360_REGULATION_OF_CELL_SHAPE",124,-1.5757,0.0024,0.073,"No",1.0981,0.25,0.91,"Yes"
"3933","C2_Chemical_and_genetic_perturbations","C2_CGP_2619_MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN",65,-1.5756,0.0093,0.04,"No",-1.1262,0.23,0.89,"No"
"3934","GO_MF","492567_GO_0008227_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY",49,-1.5754,0.011,0.1,"No",-1.1042,0.31,0.84,"No"
"3935","C3_TF_targets","C3_TFT_483_V_T3R_Q6",240,-1.5753,0,0.012,"No",-1.1316,0.17,0.48,"No"
"3936","C2_Chemical_and_genetic_perturbations","C2_CGP_2575_HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP",35,-1.5753,0.012,0.04,"No",-0.9533,0.51,1,"No"
"3937","C2_Chemical_and_genetic_perturbations","C2_CGP_534_MCBRYAN_TERMINAL_END_BUD_UP",11,-1.5752,0.027,0.04,"No",-1.0682,0.38,0.96,"No"
"3938","GO_MF","505429_GO_0042277_PEPTIDE_BINDING",204,-1.5751,0,0.1,"No",0.9508,0.62,0.93,"Yes"
"3939","C2_Chemical_and_genetic_perturbations","C2_CGP_550_SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN",12,-1.5751,0.026,0.04,"No",0.8751,0.6,0.95,"Yes"
"3940","C2_Chemical_and_genetic_perturbations","C2_CGP_1168_SHIN_B_CELL_LYMPHOMA_CLUSTER_6",11,-1.575,0.017,0.04,"No",-0.9399,0.55,1,"No"
"3941","C4_Cancer_modules","C4_CM_407_MODULE_524",30,-1.575,0.018,0.034,"No",0.9278,0.58,0.8,"Yes"
"3942","C2_Chemical_and_genetic_perturbations","C2_CGP_2932_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6",73,-1.575,0.0038,0.04,"No",1.3378,0.058,0.35,"Yes"
"3943","GO_BP","494539_GO_0010469_REGULATION_OF_RECEPTOR_ACTIVITY",88,-1.575,0.0064,0.073,"No",-1.2704,0.097,0.89,"No"
"3944","GO_BP","506494_GO_0043462_REGULATION_OF_ATPASE_ACTIVITY",44,-1.5748,0.0099,0.073,"No",-1.2162,0.17,0.88,"No"
"3945","C2_Chemical_and_genetic_perturbations","C2_CGP_928_TOMLINS_PROSTATE_CANCER_UP",40,-1.5748,0.017,0.04,"No",1.4144,0.055,0.28,"Yes"
"3946","GO_BP","510808_GO_0048757_PIGMENT_GRANULE_MATURATION",9,-1.5745,0.035,0.074,"No",0.5481,0.96,1,"Yes"
"3947","GO_BP","1129477_GO_1903651_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT",218,-1.5745,0,0.074,"No",0.9644,0.57,1,"Yes"
"3948","C7_Immunologic_signatures","C7_ALL_1040_GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN",199,-1.5744,0.0023,0.0019,"No",0.6432,1,1,"Yes"
"3949","GO_BP","500554_GO_0031295_T_CELL_COSTIMULATION",69,-1.5744,0.0013,0.074,"No",1.1835,0.14,0.8,"Yes"
"3950","C2_Chemical_and_genetic_perturbations","C2_CGP_308_KIM_WT1_TARGETS_8HR_DN",126,-1.5744,0.0024,0.04,"No",-0.8495,0.86,1,"No"
"3951","GO_BP","492358_GO_0007617_MATING_BEHAVIOR",22,-1.5743,0.016,0.074,"No",0.9124,0.57,1,"Yes"
"3952","GO_BP","497101_GO_0018126_PROTEIN_HYDROXYLATION",16,-1.5743,0.027,0.074,"No",-1.0981,0.33,0.95,"No"
"3953","GO_BP","510891_GO_0048841_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",15,-1.5742,0.031,0.073,"No",-0.9769,0.48,1,"No"
"3954","GO_MF","490628_GO_0005527_MACROLIDE_BINDING",16,-1.5741,0.031,0.1,"No",-0.9166,0.59,0.97,"No"
"3955","GO_MF","513534_GO_0055102_LIPASE_INHIBITOR_ACTIVITY",17,-1.574,0.024,0.1,"No",1.0682,0.35,0.82,"Yes"
"3956","C4_Cancer_modules","C4_CM_181_MODULE_194",15,-1.5736,0.033,0.034,"No",0.8737,0.64,0.89,"Yes"
"3957","GO_BP","511650_GO_0050678_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION",264,-1.5735,0.0011,0.074,"No",-0.9932,0.47,1,"No"
"3958","C2_Chemical_and_genetic_perturbations","C2_CGP_2749_WOO_LIVER_CANCER_RECURRENCE_DN",80,-1.5732,0.0038,0.041,"No",-1.0207,0.4,0.98,"No"
"3959","KEGG_pathway","HSA05205_PROTEOGLYCANS_IN_CANCER",201,-1.5729,0.0034,0.019,"No",1.1535,0.15,0.65,"Yes"
"3960","C2_Chemical_and_genetic_perturbations","C2_CGP_1296_SHEPARD_BMYB_MORPHOLINO_DN",195,-1.5729,0.0023,0.041,"No",-0.9624,0.58,1,"No"
"3961","GO_BP","491730_GO_0006865_AMINO_ACID_TRANSPORT",120,-1.5728,0.005,0.074,"No",-1.2043,0.1,0.89,"No"
"3962","GO_CC","490707_GO_0005641_NUCLEAR_ENVELOPE_LUMEN",9,-1.5728,0.018,0.11,"No",0.9646,0.51,0.83,"Yes"
"3963","C7_Immunologic_signatures","C7_ALL_596_GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_DN",195,-1.5727,0.0011,0.002,"No",0.9258,0.67,0.96,"Yes"
"3964","C2_Chemical_and_genetic_perturbations","C2_CGP_1311_FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN",41,-1.5726,0.0055,0.041,"No",-0.5118,1,1,"No"
"3965","C6_Oncogenic_signatures","C6_ALL_170_KRAS_300_UP_V1_DN",131,-1.5726,0,0.0065,"No",-1.0952,0.27,0.57,"No"
"3966","C2_Chemical_and_genetic_perturbations","C2_CGP_2973_ZEMBUTSU_SENSITIVITY_TO_CISPLATIN",20,-1.5725,0.013,0.041,"No",0.6301,0.95,1,"Yes"
"3967","KEGG_pathway","HSA00410_BETA_ALANINE_METABOLISM",30,-1.5724,0.025,0.019,"No",-0.862,0.71,1,"No"
"3968","WikiPathways","198911_WP696_BENZO_A_PYRENE_METABOLISM",9,-1.5724,0.036,0.046,"No",-1.098,0.35,0.97,"No"
"3969","WikiPathways","198865_WP143_FATTY_ACID_BETA_OXIDATION",34,-1.5722,0.014,0.046,"No",0.5648,0.98,1,"Yes"
"3970","C2_Chemical_and_genetic_perturbations","C2_CGP_2916_MIKKELSEN_ES_LCP_WITH_H3K4ME3",135,-1.5722,0.0012,0.041,"No",-1.4082,0.013,0.58,"No"
"3971","C2_BioCarta_Pathways","C2_CP_BIOCARTA_4_BIOCARTA_SRCRPTP_PATHWAY",11,-1.5722,0.034,0.11,"No",-0.7233,0.82,1,"No"
"3972","GO_BP","511853_GO_0050918_POSITIVE_CHEMOTAXIS",31,-1.572,0.026,0.075,"No",1.4012,0.062,0.55,"Yes"
"3973","GO_CC","507559_GO_0045177_APICAL_PART_OF_CELL",332,-1.572,0,0.11,"No",-1.1483,0.13,0.7,"No"
"3974","GO_BP","512373_GO_0051495_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION",153,-1.572,0,0.075,"No",-1.0414,0.34,0.98,"No"
"3975","GO_BP","495041_GO_0010976_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT",161,-1.5718,0,0.075,"No",-1.0477,0.31,0.97,"No"
"3976","REACTOME","105678_REACT_107_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS",38,-1.5716,0.01,0.087,"No",-0.6322,0.96,1,"No"
"3977","GO_BP","912527_GO_0044818_MITOTIC_G2_M_TRANSITION_CHECKPOINT",20,-1.5715,0.028,0.075,"No",0.7174,0.87,1,"Yes"
"3978","C2_Chemical_and_genetic_perturbations","C2_CGP_1677_MCCLUNG_CREB1_TARGETS_DN",55,-1.5715,0.0069,0.041,"No",-0.8415,0.75,1,"No"
"3979","GO_BP","496938_GO_0046685_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE",23,-1.5715,0.016,0.075,"No",-1.0082,0.47,0.98,"No"
"3980","C2_Chemical_and_genetic_perturbations","C2_CGP_1835_MCCLUNG_CREB1_TARGETS_UP",98,-1.5715,0.005,0.041,"No",-0.8857,0.7,1,"No"
"3981","C4_Cancer_modules","C4_CM_275_MODULE_315",16,-1.5714,0.029,0.035,"No",0.7961,0.75,0.97,"Yes"
"3982","C2_Chemical_and_genetic_perturbations","C2_CGP_2579_HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP",67,-1.5712,0.0093,0.041,"No",-0.5225,1,1,"No"
"3983","KEGG_compound","C00100_PROPANOYL_COA_PROPIONYL_COA_PROPIONYL_COENZYME_A",12,-1.5711,0.025,0.11,"No",-0.6265,0.93,1,"No"
"3984","GO_BP","754579_GO_1901623_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS",20,-1.5711,0.015,0.075,"No",1.1727,0.24,0.81,"Yes"
"3985","GO_BP","487607_GO_0001704_FORMATION_OF_PRIMARY_GERM_LAYER",108,-1.571,0.0049,0.075,"No",-1.097,0.26,0.94,"No"
"3986","C7_Immunologic_signatures","C7_ALL_1220_GSE27786_NKCELL_VS_MONO_MAC_DN",196,-1.571,0,0.002,"No",0.8277,0.93,1,"Yes"
"3987","GO_CC","487787_GO_0001891_PHAGOCYTIC_CUP",17,-1.5709,0.031,0.11,"No",1.0469,0.39,0.72,"Yes"
"3988","GO_BP","516341_GO_0071417_CELLULAR_RESPONSE_TO_ORGANONITROGEN_COMPOUND",438,-1.5709,0,0.075,"No",-0.8396,0.95,1,"No"
"3989","GO_BP","501585_GO_0032350_REGULATION_OF_HORMONE_METABOLIC_PROCESS",30,-1.5708,0.013,0.075,"No",-0.89,0.62,1,"No"
"3990","GO_BP","493721_GO_0009593_DETECTION_OF_CHEMICAL_STIMULUS",388,-1.5708,0,0.075,"No",2.1565,0,0.0014,"Yes"
"3991","GO_BP","487432_GO_0044409_ENTRY_INTO_HOST",54,-1.5708,0.0066,0.075,"No",-1.0374,0.38,0.98,"No"
"3992","GO_MF","499382_GO_0022836_GATED_CHANNEL_ACTIVITY",323,-1.5708,0,0.11,"No",-1.461,0.0017,0.61,"No"
"3993","GO_BP","513548_GO_0055119_RELAXATION_OF_CARDIAC_MUSCLE",12,-1.5707,0.027,0.075,"No",-1.5024,0.048,0.82,"No"
"3994","GO_BP","755318_GO_2001212_REGULATION_OF_VASCULOGENESIS",12,-1.5707,0.021,0.075,"No",1.4405,0.078,0.51,"Yes"
"3995","KEGG_pathway","HSA00640_PROPANOATE_METABOLISM",28,-1.5707,0.023,0.02,"No",-0.837,0.71,1,"No"
"3996","REACTOME","1183610_REACT_355311_CASP8_ACTIVITY_IS_INHIBITED",11,-1.5704,0.039,0.087,"No",0.5728,0.95,1,"Yes"
"3997","C7_Immunologic_signatures","C7_ALL_1322_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN",196,-1.5703,0,0.0021,"No",-0.9744,0.52,1,"No"
"3998","GO_BP","510973_GO_0048925_LATERAL_LINE_SYSTEM_DEVELOPMENT",10,-1.5703,0.027,0.075,"No",-1.3591,0.12,0.96,"No"
"3999","C2_Chemical_and_genetic_perturbations","C2_CGP_1450_ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION",86,-1.5701,0.0062,0.041,"No",-0.7488,0.93,1,"No"
"4000","C4_Cancer_gene_neighborhoods","C4_CGN_256_GCM_PTPRD",56,-1.5701,0.012,0.03,"No",-1.1742,0.21,0.68,"No"
"4001","C7_Immunologic_signatures","C7_ALL_749_GSE17721_4_VS_24H_CPG_BMDM_UP",199,-1.5701,0.0011,0.0021,"No",-0.8385,0.87,1,"No"
"4002","KEGG_module","HSA_M00678_HEDGEHOG_SIGNALING",10,-1.5701,0.028,0.17,"No",-1.1349,0.33,1,"No"
"4003","REACTOME","187088_REACT_25148_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON",18,-1.5701,0.034,0.087,"No",1.11,0.32,0.56,"Yes"
"4004","GO_CC","507404_GO_0044456_SYNAPSE_PART",432,-1.57,0,0.11,"No",-1.1983,0.064,0.71,"No"
"4005","GO_BP","508851_GO_0046597_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL",18,-1.5698,0.021,0.075,"No",1.284,0.16,0.7,"Yes"
"4006","C3_TF_targets","C3_TFT_199_V_HFH3_01",185,-1.5697,0.0023,0.013,"No",-0.9867,0.51,0.79,"No"
"4007","GO_BP","849937_GO_1902236_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",17,-1.5697,0.024,0.076,"No",-1.1789,0.23,0.91,"No"
"4008","GO_BP","511645_GO_0050673_EPITHELIAL_CELL_PROLIFERATION",79,-1.5696,0.0076,0.075,"No",-0.9359,0.59,1,"No"
"4009","GO_MF","495537_GO_0015293_SYMPORTER_ACTIVITY",134,-1.5695,0,0.11,"No",-1.6598,0.0018,0.41,"No"
"4010","GO_MF","487203_GO_0000979_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING",49,-1.5694,0.012,0.11,"No",-1.0083,0.46,0.89,"No"
"4011","C2_Chemical_and_genetic_perturbations","C2_CGP_392_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN",50,-1.5693,0.0069,0.042,"No",1.1037,0.29,0.62,"Yes"
"4012","C2_Chemical_and_genetic_perturbations","C2_CGP_2273_SMID_BREAST_CANCER_NORMAL_LIKE_DN",6,-1.5692,0.023,0.042,"No",0.7531,0.78,1,"Yes"
"4013","C2_Chemical_and_genetic_perturbations","C2_CGP_1249_ROZANOV_MMP14_CORRELATED",11,-1.5692,0.038,0.042,"No",1.0762,0.34,0.67,"Yes"
"4014","C3_TF_targets","C3_TFT_148_V_NFKB_C",260,-1.5691,0.0011,0.013,"No",-1.1356,0.15,0.47,"No"
"4015","GO_BP","519397_GO_2000758_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION",21,-1.5691,0.015,0.076,"No",-1.1943,0.21,0.9,"No"
"4016","GO_BP","513953_GO_0060397_JAK_STAT_CASCADE_INVOLVED_IN_GROWTH_HORMONE_SIGNALING_PATHWAY",23,-1.5691,0.02,0.076,"No",-0.6443,0.95,1,"No"
"4017","C4_Cancer_modules","C4_CM_339_MODULE_404",22,-1.569,0.03,0.035,"No",-1.5549,0.031,0.29,"No"
"4018","KEGG_compound","C00031_D_GLUCOSE_GRAPE_SUGAR_DEXTROSE_GLUCOSE_D_GLUCOPYRANOSE",20,-1.569,0.03,0.11,"No",-1.174,0.24,0.81,"No"
"4019","GO_BP","493581_GO_0009408_RESPONSE_TO_HEAT",106,-1.569,0.0051,0.076,"No",-1.0744,0.32,0.96,"No"
"4020","C7_Immunologic_signatures","C7_ALL_1785_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP",196,-1.5689,0.0012,0.0021,"No",0.7604,0.97,1,"Yes"
"4021","GO_BP","501641_GO_0032409_REGULATION_OF_TRANSPORTER_ACTIVITY",190,-1.5689,0,0.076,"No",-1.2529,0.056,0.91,"No"
"4022","GO_BP","511622_GO_0050650_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",27,-1.5689,0.026,0.076,"No",-0.5612,0.99,1,"No"
"4023","C2_Chemical_and_genetic_perturbations","C2_CGP_3263_YANG_BCL3_TARGETS_UP",357,-1.5688,0,0.042,"No",0.9199,0.78,0.9,"Yes"
"4024","GO_MF","490617_GO_0046870_CADMIUM_ION_BINDING",6,-1.5686,0.03,0.11,"No",-1.7114,0.0098,0.32,"No"
"4025","KEGG_compound","C00153_NICOTINAMIDE_NICOTINIC_ACID_AMIDE_NIACINAMIDE_VITAMIN_PP",5,-1.5685,0.011,0.11,"No",0.3923,1,1,"Yes"
"4026","GO_MF","490161_GO_0004859_PHOSPHOLIPASE_INHIBITOR_ACTIVITY",12,-1.5684,0.021,0.11,"No",0.9543,0.52,0.92,"Yes"
"4027","REACTOME","477136_REACT_111176_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION",12,-1.5684,0.028,0.088,"No",0.9745,0.45,0.79,"Yes"
"4028","C2_Chemical_and_genetic_perturbations","C2_CGP_575_WONG_ENDMETRIUM_CANCER_DN",80,-1.5684,0.0078,0.042,"No",1.1581,0.18,0.54,"Yes"
"4029","GO_BP","491443_GO_0006547_HISTIDINE_METABOLIC_PROCESS",7,-1.5683,0.028,0.076,"No",-0.6228,0.91,1,"No"
"4030","GO_BP","496152_GO_0016053_ORGANIC_ACID_BIOSYNTHETIC_PROCESS",284,-1.5683,0,0.076,"No",0.8996,0.81,1,"Yes"
"4031","C3_TF_targets","C3_TFT_92_V_HNF1_01",236,-1.5681,0,0.013,"No",-0.9965,0.48,0.76,"No"
"4032","GO_BP","1022188_GO_1903202_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH",26,-1.5681,0.026,0.076,"No",1.2393,0.16,0.75,"Yes"
"4033","GO_BP","501192_GO_0031952_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION",32,-1.5681,0.02,0.076,"No",0.9417,0.54,1,"Yes"
"4034","C2_Chemical_and_genetic_perturbations","C2_CGP_237_RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN",361,-1.5681,0,0.042,"No",1.7483,0,0.061,"Yes"
"4035","C2_Chemical_and_genetic_perturbations","C2_CGP_890_YANG_BREAST_CANCER_ESR1_UP",36,-1.5679,0.013,0.042,"No",-1.4951,0.048,0.46,"No"
"4036","GO_BP","492347_GO_0007606_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS",416,-1.5678,0,0.076,"No",2.0179,0,0.01,"Yes"
"4037","GO_BP","500605_GO_0031346_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION",215,-1.5678,0,0.076,"No",-1.0081,0.41,0.98,"No"
"4038","C2_Chemical_and_genetic_perturbations","C2_CGP_1591_MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP",89,-1.5677,0.0063,0.042,"No",-1.7998,0,0.33,"No"
"4039","C7_Immunologic_signatures","C7_ALL_304_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN",193,-1.5676,0,0.0022,"No",-0.6668,1,1,"No"
"4040","C2_Chemical_and_genetic_perturbations","C2_CGP_3272_LE_NEURONAL_DIFFERENTIATION_DN",19,-1.5675,0.027,0.042,"No",-1.1422,0.28,0.86,"No"
"4041","GO_BP","499626_GO_0030216_KERATINOCYTE_DIFFERENTIATION",82,-1.5673,0.0078,0.076,"No",1.1929,0.14,0.79,"Yes"
"4042","C2_Chemical_and_genetic_perturbations","C2_CGP_1580_MUNSHI_MULTIPLE_MYELOMA_UP",80,-1.5672,0.0013,0.042,"No",1.139,0.2,0.57,"Yes"
"4043","C7_Immunologic_signatures","C7_ALL_50_GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN",195,-1.567,0,0.0022,"No",1.5485,0,0.0063,"Yes"
"4044","C7_Immunologic_signatures","C7_ALL_1395_GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP",198,-1.567,0,0.0022,"No",0.8177,0.93,1,"Yes"
"4045","GO_BP","500099_GO_0030800_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",48,-1.5669,0.018,0.077,"No",1.263,0.12,0.72,"Yes"
"4046","REACTOME","576264_REACT_118682_ACTIVATION_OF_MATRIX_METALLOPROTEINASES",31,-1.5668,0.012,0.088,"No",0.9806,0.45,0.78,"Yes"
"4047","GO_BP","505307_GO_0042135_NEUROTRANSMITTER_CATABOLIC_PROCESS",8,-1.5667,0.033,0.077,"No",-1.1538,0.28,0.93,"No"
"4048","GO_BP","499340_GO_0022604_REGULATION_OF_CELL_MORPHOGENESIS",437,-1.5667,0,0.077,"No",-1.1343,0.13,0.93,"No"
"4049","C2_Chemical_and_genetic_perturbations","C2_CGP_1148_AMIT_SERUM_RESPONSE_120_MCF10A",65,-1.5667,0.01,0.042,"No",-0.9647,0.5,1,"No"
"4050","GO_BP","491444_GO_0006548_HISTIDINE_CATABOLIC_PROCESS",5,-1.5665,0.028,0.077,"No",-0.6222,0.91,1,"No"
"4051","REACTOME","833813_REACT_164011_REGULATION_BY_C_FLIP",11,-1.5664,0.036,0.088,"No",0.5741,0.95,1,"Yes"
"4052","C2_Chemical_and_genetic_perturbations","C2_CGP_533_LANG_MYB_FAMILY_TARGETS",29,-1.5664,0.023,0.042,"No",0.6173,0.97,1,"Yes"
"4053","C7_Immunologic_signatures","C7_ALL_1132_GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN",190,-1.5663,0.0011,0.0022,"No",-0.9814,0.5,1,"No"
"4054","C2_Chemical_and_genetic_perturbations","C2_CGP_2119_KYNG_DNA_DAMAGE_DN",192,-1.5663,0.0012,0.042,"No",0.9878,0.49,0.81,"Yes"
"4055","GO_BP","501623_GO_0032388_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT",297,-1.5662,0,0.077,"No",0.9381,0.69,1,"Yes"
"4056","GO_BP","983731_GO_1903012_POSITIVE_REGULATION_OF_BONE_DEVELOPMENT",5,-1.5661,0.019,0.077,"No",-1.0214,0.47,0.97,"No"
"4057","C3_TF_targets","C3_TFT_415_V_NFKB_Q6_01",228,-1.5658,0,0.013,"No",-1.4374,0.005,0.15,"No"
"4058","C2_Chemical_and_genetic_perturbations","C2_CGP_70_ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP",178,-1.5658,0,0.042,"No",-1.1647,0.14,0.83,"No"
"4059","C2_Chemical_and_genetic_perturbations","C2_CGP_448_GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN",89,-1.5658,0.0063,0.042,"No",-1.349,0.039,0.68,"No"
"4060","REACTOME","161001_REACT_22384_NETRIN_MEDIATED_REPULSION_SIGNALS",10,-1.5658,0.033,0.088,"No",0.6553,0.89,1,"Yes"
"4061","C2_Chemical_and_genetic_perturbations","C2_CGP_146_TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN",16,-1.5658,0.028,0.042,"No",-0.5974,0.96,1,"No"
"4062","GO_BP","509146_GO_0046949_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS",19,-1.5657,0.02,0.077,"No",-0.9391,0.51,1,"No"
"4063","C2_Chemical_and_genetic_perturbations","C2_CGP_3083_FIGUEROA_AML_METHYLATION_CLUSTER_3_DN",39,-1.5657,0.011,0.042,"No",-0.7771,0.83,1,"No"
"4064","GO_BP","518337_GO_0090197_POSITIVE_REGULATION_OF_CHEMOKINE_SECRETION",8,-1.5656,0.028,0.077,"No",-0.7149,0.82,1,"No"
"4065","GO_BP","947899_GO_0098581_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS",21,-1.5654,0.017,0.077,"No",-0.7126,0.88,1,"No"
"4066","GO_BP","512754_GO_0051899_MEMBRANE_DEPOLARIZATION",107,-1.5651,0.0074,0.077,"No",-1.3619,0.028,0.97,"No"
"4067","C6_Oncogenic_signatures","C6_ALL_18_CYCLIN_D1_KE_V1_UP",184,-1.5651,0,0.007,"No",-0.8705,0.8,0.96,"No"
"4068","GO_MF","516736_GO_0071814_PROTEIN_LIPID_COMPLEX_BINDING",24,-1.565,0.021,0.11,"No",1.0118,0.45,0.87,"Yes"
"4069","C3_TF_targets","C3_TFT_242_V_MEIS1AHOXA9_01",106,-1.5647,0.0037,0.013,"No",-1.0227,0.43,0.71,"No"
"4070","GO_BP","507266_GO_0044259_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS",89,-1.5645,0.0038,0.078,"No",-1.133,0.19,0.93,"No"
"4071","WikiPathways","198856_WP500_GLYCOGEN_METABOLISM",37,-1.5645,0.013,0.048,"No",-0.8461,0.73,1,"No"
"4072","GO_BP","502037_GO_0032814_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION",26,-1.5644,0.016,0.078,"No",-1.2179,0.17,0.88,"No"
"4073","C2_Chemical_and_genetic_perturbations","C2_CGP_1774_YAMAZAKI_TCEB3_TARGETS_DN",212,-1.5644,0.0022,0.043,"No",0.9443,0.62,0.87,"Yes"
"4074","GO_CC","499482_GO_0030018_Z_DISC",108,-1.5643,0.0072,0.11,"No",-1.0067,0.43,0.85,"No"
"4075","GO_BP","508156_GO_0045835_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION",10,-1.5642,0.041,0.078,"No",-1.2185,0.23,0.88,"No"
"4076","GO_BP","491523_GO_0006633_FATTY_ACID_BIOSYNTHETIC_PROCESS",113,-1.5641,0,0.078,"No",0.8561,0.84,1,"Yes"
"4077","C2_Chemical_and_genetic_perturbations","C2_CGP_1764_CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP",102,-1.5641,0.0064,0.043,"No",-0.8511,0.77,1,"No"
"4078","C2_Chemical_and_genetic_perturbations","C2_CGP_1115_BENPORATH_MYC_TARGETS_WITH_EBOX",225,-1.5641,0,0.043,"No",1,0.46,0.8,"Yes"
"4079","REACTOME","119561_REACT_19320_SODIUM_CALCIUM_EXCHANGERS",9,-1.564,0.018,0.089,"No",-0.6831,0.88,1,"No"
"4080","GO_BP","516561_GO_0071637_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION",6,-1.564,0.031,0.078,"No",-1.0078,0.45,0.98,"No"
"4081","C2_Chemical_and_genetic_perturbations","C2_CGP_1405_FERRANDO_LYL1_NEIGHBORS",15,-1.5639,0.032,0.043,"No",0.6117,0.96,1,"Yes"
"4082","C2_Chemical_and_genetic_perturbations","C2_CGP_3280_PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP",33,-1.5639,0.017,0.043,"No",0.9134,0.61,0.91,"Yes"
"4083","C7_Immunologic_signatures","C7_ALL_812_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN",184,-1.5639,0,0.0024,"No",1.0252,0.37,0.66,"Yes"
"4084","C7_Immunologic_signatures","C7_ALL_1477_GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP",192,-1.5638,0.0011,0.0024,"No",1.1387,0.16,0.34,"Yes"
"4085","C7_Immunologic_signatures","C7_ALL_742_GSE17721_0_5H_VS_12H_CPG_BMDM_DN",200,-1.5636,0.0011,0.0024,"No",-0.9172,0.69,1,"No"
"4086","C2_Chemical_and_genetic_perturbations","C2_CGP_1818_VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1",38,-1.5635,0.017,0.043,"No",1.2082,0.17,0.48,"Yes"
"4087","GO_CC","507315_GO_0044309_NEURON_SPINE",99,-1.5633,0.0026,0.11,"No",-1.3176,0.053,0.65,"No"
"4088","C7_Immunologic_signatures","C7_ALL_1443_GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP",192,-1.5633,0,0.0024,"No",0.8453,0.85,1,"Yes"
"4089","GO_CC","508926_GO_0046696_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX",5,-1.5633,0.013,0.11,"No",0.8502,0.66,0.92,"Yes"
"4090","C2_BioCarta_Pathways","C2_CP_BIOCARTA_140_BIOCARTA_MYOSIN_PATHWAY",29,-1.5632,0.026,0.12,"No",-0.8921,0.64,1,"No"
"4091","GO_BP","508657_GO_0046394_CARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS",284,-1.5632,0,0.078,"No",0.8938,0.8,1,"Yes"
"4092","C2_Chemical_and_genetic_perturbations","C2_CGP_2584_HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN",28,-1.5631,0.015,0.043,"No",-0.5577,0.99,1,"No"
"4093","C2_Chemical_and_genetic_perturbations","C2_CGP_2795_NGO_MALIGNANT_GLIOMA_1P_LOH",16,-1.5631,0.021,0.043,"No",1.3209,0.14,0.37,"Yes"
"4094","C2_Chemical_and_genetic_perturbations","C2_CGP_3166_VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP",14,-1.563,0.038,0.043,"No",-0.5882,0.97,1,"No"
"4095","KEGG_reaction","R01786_ATP_ALPHA_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_ALPHA_D_GLUCOSE_ADP_ALPHA_D_GLUCOSE_6_PHOSPHATE",5,-1.5629,0.018,0.11,"No",-1.1927,0.28,0.54,"No"
"4096","GO_BP","752382_GO_0086010_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL",38,-1.5628,0.0086,0.078,"No",-1.3514,0.072,0.94,"No"
"4097","GO_BP","502031_GO_0032808_LACRIMAL_GLAND_DEVELOPMENT",5,-1.5628,0.023,0.078,"No",-1.3801,0.12,1,"No"
"4098","REACTOME","105700_REACT_13567_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE",60,-1.5627,0.011,0.089,"No",-1.1186,0.27,0.87,"No"
"4099","GO_BP","504766_GO_0035587_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY",28,-1.5627,0.021,0.078,"No",1.4203,0.05,0.53,"Yes"
"4100","GO_CC","517462_GO_0072557_IPAF_INFLAMMASOME_COMPLEX",5,-1.5626,0.021,0.11,"No",-0.4178,1,1,"No"
"4101","GO_MF","498065_GO_0019210_KINASE_INHIBITOR_ACTIVITY",63,-1.5625,0.0054,0.11,"No",0.7586,0.9,1,"Yes"
"4102","GO_BP","512756_GO_0051901_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION",8,-1.5625,0.035,0.078,"No",-1.0242,0.45,0.97,"No"
"4103","C3_TF_targets","C3_TFT_301_V_STAT6_01",250,-1.5623,0.0011,0.013,"No",-1.0149,0.39,0.73,"No"
"4104","GO_MF","982504_GO_1902936_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING",64,-1.5623,0.012,0.11,"No",-0.7646,0.88,1,"No"
"4105","C7_Immunologic_signatures","C7_ALL_907_GSE20715_0H_VS_48H_OZONE_LUNG_UP",199,-1.5623,0,0.0024,"No",0.8775,0.81,1,"Yes"
"4106","GO_BP","499850_GO_0030511_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",23,-1.5623,0.022,0.079,"No",0.5248,0.99,1,"Yes"
"4107","C2_Chemical_and_genetic_perturbations","C2_CGP_2394_LIN_NPAS4_TARGETS_DN",67,-1.5622,0.008,0.043,"No",-1.5219,0.028,0.44,"No"
"4108","C7_Immunologic_signatures","C7_ALL_1046_GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN",197,-1.5621,0,0.0024,"No",-0.7767,0.98,1,"No"
"4109","GO_BP","506447_GO_0043409_NEGATIVE_REGULATION_OF_MAPK_CASCADE",133,-1.5621,0.0024,0.079,"No",0.7756,0.95,1,"Yes"
"4110","GO_BP","513632_GO_0060074_SYNAPSE_MATURATION",6,-1.5621,0.02,0.079,"No",-0.9491,0.49,1,"No"
"4111","C7_Immunologic_signatures","C7_ALL_1890_GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN",200,-1.5621,0.0011,0.0024,"No",-0.5325,1,1,"No"
"4112","GO_BP","512375_GO_0051497_NEGATIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY",10,-1.5619,0.036,0.079,"No",0.6697,0.89,1,"Yes"
"4113","GO_MF","512720_GO_0051861_GLYCOLIPID_BINDING",24,-1.5618,0.016,0.11,"No",-1.0279,0.39,0.88,"No"
"4114","GO_MF","487206_GO_0000982_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",267,-1.5617,0,0.11,"No",-0.9714,0.5,0.94,"No"
"4115","GO_CC","500844_GO_0031594_NEUROMUSCULAR_JUNCTION",50,-1.5617,0.021,0.11,"No",-1.3492,0.076,0.63,"No"
"4116","REACTOME","645312_REACT_120870_PHOSPHOLIPID_METABOLISM",140,-1.5616,0,0.09,"No",0.6251,1,1,"Yes"
"4117","GO_BP","513927_GO_0060371_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION",8,-1.5616,0.025,0.079,"No",-0.8261,0.68,1,"No"
"4118","C7_Immunologic_signatures","C7_ALL_1605_GSE3982_EOSINOPHIL_VS_TH2_UP",192,-1.5615,0.0012,0.0025,"No",-0.8493,0.86,1,"No"
"4119","C2_Chemical_and_genetic_perturbations","C2_CGP_2433_YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP",144,-1.5613,0.0046,0.043,"No",0.9346,0.63,0.88,"Yes"
"4120","C2_Chemical_and_genetic_perturbations","C2_CGP_2911_MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED",57,-1.5612,0.011,0.043,"No",-1.1341,0.25,0.87,"No"
"4121","GO_MF","490629_GO_0005528_FK506_BINDING",16,-1.561,0.035,0.11,"No",-0.9253,0.53,0.97,"No"
"4122","C7_Immunologic_signatures","C7_ALL_1546_GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN",199,-1.5609,0,0.0025,"No",-0.7244,0.99,1,"No"
"4123","GO_BP","512169_GO_0051283_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION",32,-1.5608,0.02,0.079,"No",-0.6238,0.96,1,"No"
"4124","C2_Chemical_and_genetic_perturbations","C2_CGP_3256_WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR",152,-1.5608,0.0024,0.044,"No",-0.749,0.98,1,"No"
"4125","GO_BP","493606_GO_0009435_NAD_BIOSYNTHETIC_PROCESS",15,-1.5607,0.031,0.079,"No",-1.0921,0.34,0.95,"No"
"4126","GO_BP","488202_GO_0002329_PRE_B_CELL_DIFFERENTIATION",6,-1.5607,0.015,0.079,"No",-0.9062,0.56,1,"No"
"4127","GO_BP","512151_GO_0051261_PROTEIN_DEPOLYMERIZATION",26,-1.5607,0.013,0.079,"No",-0.9527,0.53,1,"No"
"4128","GO_BP","495974_GO_0015849_ORGANIC_ACID_TRANSPORT",233,-1.5607,0.0022,0.079,"No",-1.2275,0.051,0.88,"No"
"4129","GO_CC","751048_GO_0036128_CATSPER_COMPLEX",9,-1.5606,0.029,0.11,"No",-1.7604,0.002,0.19,"No"
"4130","GO_BP","755291_GO_2001185_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",7,-1.5606,0.032,0.079,"No",-1.315,0.17,0.88,"No"
"4131","GO_BP","499665_GO_0030260_ENTRY_INTO_HOST_CELL",54,-1.5604,0.019,0.079,"No",-1.022,0.4,0.97,"No"
"4132","GO_MF","490487_GO_0005253_ANION_CHANNEL_ACTIVITY",77,-1.5604,0.013,0.11,"No",1.0427,0.36,0.84,"Yes"
"4133","GO_BP","752435_GO_0086069_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION",12,-1.5604,0.033,0.079,"No",1.1174,0.31,0.88,"Yes"
"4134","GO_BP","515260_GO_0070328_TRIGLYCERIDE_HOMEOSTASIS",29,-1.5601,0.015,0.079,"No",0.6477,0.96,1,"Yes"
"4135","GO_BP","513748_GO_0060192_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY",16,-1.5601,0.026,0.079,"No",-0.7686,0.8,1,"No"
"4136","C2_Chemical_and_genetic_perturbations","C2_CGP_1495_NADLER_OBESITY_DN",48,-1.56,0.016,0.044,"No",1.2664,0.12,0.42,"Yes"
"4137","GO_CC","490676_GO_0005604_BASEMENT_MEMBRANE",95,-1.56,0.0062,0.11,"No",-0.9982,0.43,0.86,"No"
"4138","GO_BP","491533_GO_0006643_MEMBRANE_LIPID_METABOLIC_PROCESS",166,-1.56,0,0.079,"No",-0.7738,0.95,1,"No"
"4139","C2_Chemical_and_genetic_perturbations","C2_CGP_1409_MANALO_HYPOXIA_UP",204,-1.5599,0.0023,0.044,"No",-0.862,0.85,1,"No"
"4140","GO_MF","490281_GO_0004994_SOMATOSTATIN_RECEPTOR_ACTIVITY",5,-1.5599,0.026,0.11,"No",0.6941,0.85,1,"Yes"
"4141","GO_BP","512811_GO_0051961_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT",213,-1.5598,0.0011,0.079,"No",-1.0706,0.29,0.96,"No"
"4142","GO_BP","502458_GO_0033238_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS",406,-1.5598,0,0.079,"No",1.0661,0.25,0.93,"Yes"
"4143","C1_Positional","C1_ALL_228_CHR7Q36",73,-1.5598,0.0052,0.24,"No",-1.034,0.38,1,"No"
"4144","GO_MF","490015_GO_0004697_PROTEIN_KINASE_C_ACTIVITY",16,-1.5597,0.032,0.11,"No",-1.456,0.058,0.61,"No"
"4145","KEGG_pathway","HSA00053_ASCORBATE_AND_ALDARATE_METABOLISM",27,-1.5597,0.022,0.022,"No",1.5306,0.037,0.097,"Yes"
"4146","C2_Chemical_and_genetic_perturbations","C2_CGP_2770_MIKKELSEN_MEF_ICP_WITH_H3K27ME3",193,-1.5595,0,0.044,"No",-1.5744,0,0.44,"No"
"4147","REACTOME","105689_REACT_18334_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH",70,-1.5595,0.004,0.091,"No",-1.3529,0.053,0.59,"No"
"4148","GO_BP","488756_GO_0002883_REGULATION_OF_HYPERSENSITIVITY",8,-1.5594,0.029,0.079,"No",-1.1417,0.31,0.93,"No"
"4149","C4_Cancer_modules","C4_CM_350_MODULE_419",34,-1.5593,0.02,0.038,"No",1.0264,0.4,0.68,"Yes"
"4150","GO_BP","499473_GO_0072503_CELLULAR_DIVALENT_INORGANIC_CATION_HOMEOSTASIS",306,-1.5593,0.0011,0.079,"No",1.1439,0.11,0.84,"Yes"
"4151","GO_BP","1022192_GO_1903206_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH",11,-1.5591,0.026,0.08,"No",1.4944,0.06,0.42,"Yes"
"4152","C2_Chemical_and_genetic_perturbations","C2_CGP_2506_CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP",49,-1.5591,0.011,0.044,"No",-1.2926,0.096,0.7,"No"
"4153","GO_BP","511973_GO_0051048_NEGATIVE_REGULATION_OF_SECRETION",161,-1.5589,0.0012,0.08,"No",0.9187,0.67,1,"Yes"
"4154","C2_Chemical_and_genetic_perturbations","C2_CGP_1676_SESTO_RESPONSE_TO_UV_C6",39,-1.5589,0.01,0.044,"No",0.8665,0.68,0.96,"Yes"
"4155","GO_BP","515305_GO_0070373_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE",38,-1.5589,0.024,0.08,"No",0.8229,0.74,1,"Yes"
"4156","KEGG_module","HSA_M00003_GLUCONEOGENESIS_OXALOACETATE_FRUCTOSE_6P",17,-1.5589,0.017,0.17,"No",-1.1545,0.26,1,"No"
"4157","KEGG_pathway","HSA04115_P53_SIGNALING_PATHWAY",68,-1.5588,0.0092,0.022,"No",-0.733,0.95,1,"No"
"4158","C2_Chemical_and_genetic_perturbations","C2_CGP_3170_VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN",15,-1.5585,0.028,0.044,"No",0.791,0.76,0.99,"Yes"
"4159","C2_Chemical_and_genetic_perturbations","C2_CGP_1893_NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP",20,-1.5585,0.028,0.044,"No",-0.9753,0.5,1,"No"
"4160","C2_Chemical_and_genetic_perturbations","C2_CGP_741_LI_CISPLATIN_RESISTANCE_UP",27,-1.5584,0.012,0.044,"No",-1.0346,0.4,0.97,"No"
"4161","C1_Positional","C1_ALL_142_CHR7P12",19,-1.5582,0.031,0.23,"No",1.1924,0.23,0.61,"Yes"
"4162","C2_Chemical_and_genetic_perturbations","C2_CGP_603_RODRIGUES_NTN1_AND_DCC_TARGETS",34,-1.5581,0.02,0.044,"No",-1.1728,0.22,0.82,"No"
"4163","GO_CC","498676_GO_0019898_EXTRINSIC_COMPONENT_OF_MEMBRANE",243,-1.5579,0,0.11,"No",-0.9964,0.46,0.86,"No"
"4164","GO_BP","512176_GO_0051291_PROTEIN_HETEROOLIGOMERIZATION",109,-1.5579,0.0049,0.08,"No",-1.3312,0.068,0.9,"No"
"4165","GO_MF","492412_GO_0071813_LIPOPROTEIN_PARTICLE_BINDING",24,-1.5579,0.021,0.11,"No",1.0108,0.45,0.87,"Yes"
"4166","C7_Immunologic_signatures","C7_ALL_904_GSE20715_0H_VS_6H_OZONE_LUNG_DN",195,-1.5578,0,0.0026,"No",-0.8028,0.92,1,"No"
"4167","GO_BP","501926_GO_0032700_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION",11,-1.5576,0.027,0.08,"No",-1.0201,0.44,0.97,"No"
"4168","GO_MF","750779_GO_0001227_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",120,-1.5575,0.0061,0.11,"No",-1.2847,0.057,0.81,"No"
"4169","C2_Chemical_and_genetic_perturbations","C2_CGP_2883_ZHAN_MULTIPLE_MYELOMA_HP_DN",45,-1.5574,0.021,0.044,"No",0.8283,0.78,0.98,"Yes"
"4170","GO_BP","491008_GO_0006022_AMINOGLYCAN_METABOLIC_PROCESS",169,-1.5572,0.0012,0.081,"No",0.9185,0.68,1,"Yes"
"4171","C2_Chemical_and_genetic_perturbations","C2_CGP_1565_YAGI_AML_SURVIVAL",128,-1.5572,0,0.045,"No",-0.825,0.85,1,"No"
"4172","GO_CC","487624_GO_0001725_STRESS_FIBER",57,-1.5572,0.011,0.11,"No",-0.8338,0.78,0.99,"No"
"4173","C2_Chemical_and_genetic_perturbations","C2_CGP_859_WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP",8,-1.5572,0.015,0.044,"No",-0.7823,0.72,1,"No"
"4174","WikiPathways","198817_WP368_MITOCHONDRIAL_LC_FATTY_ACID_BETA_OXIDATION",16,-1.5571,0.025,0.05,"No",1.0231,0.42,1,"Yes"
"4175","GO_BP","754674_GO_1901723_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",5,-1.5571,0.026,0.081,"No",-0.7632,0.74,1,"No"
"4176","REACTOME","105680_REACT_13579_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS",11,-1.5571,0.03,0.092,"No",1.2792,0.17,0.35,"Yes"
"4177","GO_BP","504521_GO_0035337_FATTY_ACYL_COA_METABOLIC_PROCESS",31,-1.557,0.023,0.081,"No",-0.9655,0.52,1,"No"
"4178","GO_BP","496456_GO_0016486_PEPTIDE_HORMONE_PROCESSING",34,-1.5569,0.011,0.081,"No",1.1222,0.25,0.88,"Yes"
"4179","WikiPathways","198822_WP1772_APOPTOSIS_MODULATION_AND_SIGNALING",79,-1.5568,0.0026,0.05,"No",-0.859,0.75,1,"No"
"4180","C4_Cancer_modules","C4_CM_430_MODULE_575",12,-1.5568,0.036,0.039,"No",1.7139,0.019,0.043,"Yes"
"4181","GO_BP","505702_GO_0042574_RETINAL_METABOLIC_PROCESS",13,-1.5566,0.032,0.081,"No",-1.4446,0.068,0.91,"No"
"4182","C7_Immunologic_signatures","C7_ALL_1326_GSE30083_SP1_VS_SP2_THYMOCYTE_DN",195,-1.5563,0.0011,0.0027,"No",-0.9333,0.62,1,"No"
"4183","C2_Chemical_and_genetic_perturbations","C2_CGP_1369_TARTE_PLASMA_CELL_VS_PLASMABLAST_DN",307,-1.5561,0,0.045,"No",1.7916,0,0.045,"Yes"
"4184","GO_BP","508588_GO_0046323_GLUCOSE_IMPORT",8,-1.556,0.033,0.081,"No",-1.5193,0.058,0.79,"No"
"4185","GO_BP","513957_GO_0060401_CYTOSOLIC_CALCIUM_ION_TRANSPORT",45,-1.5559,0.0044,0.081,"No",-0.787,0.84,1,"No"
"4186","C2_BioCarta_Pathways","C2_CP_BIOCARTA_112_BIOCARTA_PYK2_PATHWAY",28,-1.5559,0.022,0.12,"No",-0.8522,0.68,1,"No"
"4187","GO_BP","510275_GO_0048145_REGULATION_OF_FIBROBLAST_PROLIFERATION",76,-1.5557,0.012,0.081,"No",1.3317,0.073,0.63,"Yes"
"4188","REACTOME","106482_REACT_12599_ERK_MAPK_TARGETS",21,-1.5557,0.02,0.093,"No",-0.87,0.63,1,"No"
"4189","GO_BP","751425_GO_0038169_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY",5,-1.5556,0.026,0.081,"No",0.6991,0.83,1,"Yes"
"4190","C7_Immunologic_signatures","C7_ALL_404_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN",199,-1.5555,0.0011,0.0027,"No",1.4335,0.0074,0.027,"Yes"
"4191","C2_Chemical_and_genetic_perturbations","C2_CGP_3203_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP",20,-1.5554,0.033,0.045,"No",-0.711,0.85,1,"No"
"4192","C2_Chemical_and_genetic_perturbations","C2_CGP_2977_ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN",18,-1.5553,0.043,0.045,"No",0.8792,0.61,0.94,"Yes"
"4193","GO_BP","500387_GO_0031100_ORGAN_REGENERATION",54,-1.5553,0.0071,0.081,"No",-0.7355,0.92,1,"No"
"4194","C2_Chemical_and_genetic_perturbations","C2_CGP_2734_HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN",68,-1.5553,0.0053,0.045,"No",-0.7677,0.89,1,"No"
"4195","GO_BP","512105_GO_0051209_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",32,-1.5551,0.021,0.081,"No",-0.6444,0.97,1,"No"
"4196","C2_Chemical_and_genetic_perturbations","C2_CGP_3299_ALFANO_MYC_TARGETS",235,-1.555,0,0.045,"No",1.1433,0.14,0.56,"Yes"
"4197","C2_BioCarta_Pathways","C2_CP_BIOCARTA_62_BIOCARTA_NDKDYNAMIN_PATHWAY",18,-1.5549,0.023,0.12,"No",0.7249,0.86,1,"Yes"
"4198","GO_BP","753098_GO_1900103_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",11,-1.5547,0.036,0.082,"No",-1.116,0.32,0.94,"No"
"4199","C2_Chemical_and_genetic_perturbations","C2_CGP_2934_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8",49,-1.5547,0.0097,0.045,"No",-0.7205,0.94,1,"No"
"4200","GO_BP","513919_GO_0060363_CRANIAL_SUTURE_MORPHOGENESIS",10,-1.5546,0.035,0.082,"No",-1.0993,0.36,0.95,"No"
"4201","C7_Immunologic_signatures","C7_ALL_1465_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP",189,-1.5546,0,0.0027,"No",-0.8415,0.87,1,"No"
"4202","WikiPathways","198821_WP698_GLUCURONIDATION",26,-1.5546,0.025,0.05,"No",1.749,0.01,0.081,"Yes"
"4203","REACTOME","187174_REACT_23947_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION",17,-1.5546,0.028,0.094,"No",-1.0959,0.34,0.91,"No"
"4204","C7_Immunologic_signatures","C7_ALL_1481_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP",198,-1.5544,0,0.0027,"No",1.2574,0.034,0.15,"Yes"
"4205","GO_BP","516218_GO_0071294_CELLULAR_RESPONSE_TO_ZINC_ION",12,-1.5543,0.044,0.082,"No",1.4479,0.06,0.5,"Yes"
"4206","C2_BioCarta_Pathways","C2_CP_BIOCARTA_31_BIOCARTA_CBL_PATHWAY",13,-1.5543,0.026,0.12,"No",0.9024,0.61,0.9,"Yes"
"4207","C7_Immunologic_signatures","C7_ALL_1507_GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP",197,-1.5543,0.0023,0.0027,"No",1.2964,0.022,0.11,"Yes"
"4208","GO_MF","490018_GO_0004702_RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",83,-1.5542,0.0078,0.11,"No",-1.3332,0.059,0.72,"No"
"4209","GO_BP","753021_GO_1900024_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",33,-1.5542,0.017,0.082,"No",1.1405,0.26,0.85,"Yes"
"4210","C6_Oncogenic_signatures","C6_ALL_100_ESC_V6_5_UP_LATE_V1_UP",173,-1.5542,0.0011,0.0081,"No",-0.825,0.88,0.95,"No"
"4211","GO_BP","488303_GO_0002430_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",5,-1.5542,0.018,0.082,"No",-0.6985,0.85,1,"No"
"4212","REACTOME","645309_REACT_120989_CHONDROITIN_SULFATE_BIOSYNTHESIS",19,-1.554,0.023,0.094,"No",-0.5865,0.98,1,"No"
"4213","GO_BP","1184427_GO_1903901_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE",83,-1.5539,0.01,0.082,"No",1.3856,0.03,0.57,"Yes"
"4214","C2_Chemical_and_genetic_perturbations","C2_CGP_199_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP",17,-1.5539,0.032,0.045,"No",0.4945,0.99,1,"Yes"
"4215","GO_MF","487742_GO_0001846_OPSONIN_BINDING",12,-1.5539,0.038,0.11,"No",-1.2771,0.16,0.82,"No"
"4216","GO_BP","499041_GO_0021761_LIMBIC_SYSTEM_DEVELOPMENT",81,-1.5539,0,0.082,"No",-1.0358,0.39,0.98,"No"
"4217","C7_Immunologic_signatures","C7_ALL_890_GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN",197,-1.5538,0,0.0028,"No",-0.9037,0.74,1,"No"
"4218","REACTOME","106170_REACT_13796_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE",31,-1.5537,0.024,0.093,"No",-1.0843,0.32,0.91,"No"
"4219","GO_BP","487805_GO_0001914_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY",27,-1.5537,0.025,0.082,"No",-0.6619,0.95,1,"No"
"4220","GO_BP","508306_GO_0046006_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION",35,-1.5537,0.026,0.082,"No",-1.0249,0.4,0.97,"No"
"4221","GO_BP","1184553_GO_1904029_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",90,-1.5533,0.0089,0.082,"No",-0.8268,0.81,1,"No"
"4222","C2_Chemical_and_genetic_perturbations","C2_CGP_2644_TAVAZOIE_METASTASIS",101,-1.5533,0.0075,0.046,"No",-1.3554,0.034,0.66,"No"
"4223","C2_Chemical_and_genetic_perturbations","C2_CGP_2613_HAN_SATB1_TARGETS_UP",393,-1.5532,0,0.046,"No",0.8675,0.92,0.96,"Yes"
"4224","C6_Oncogenic_signatures","C6_ALL_31_PIGF_UP_V1_DN",183,-1.5531,0.0012,0.008,"No",-1.2426,0.058,0.36,"No"
"4225","C7_Immunologic_signatures","C7_ALL_1791_GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP",192,-1.5528,0,0.0028,"No",0.7837,0.98,1,"Yes"
"4226","C2_Chemical_and_genetic_perturbations","C2_CGP_2742_YAMASHITA_LIVER_CANCER_STEM_CELL_DN",75,-1.5528,0.005,0.046,"No",-1.0159,0.44,0.99,"No"
"4227","GO_BP","502039_GO_0032816_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION",20,-1.5527,0.03,0.083,"No",-1.4742,0.065,0.85,"No"
"4228","C6_Oncogenic_signatures","C6_ALL_167_CORDENONSI_YAP_CONSERVED_SIGNATURE",57,-1.5526,0.01,0.0079,"No",-1.4432,0.027,0.29,"No"
"4229","REACTOME","106526_REACT_13583_NEUROTRANSMITTER_CLEARANCE_IN_THE_SYNAPTIC_CLEFT",8,-1.5525,0.024,0.094,"No",-0.9322,0.53,1,"No"
"4230","GO_BP","911401_GO_0098543_DETECTION_OF_OTHER_ORGANISM",17,-1.5524,0.036,0.083,"No",0.8787,0.63,1,"Yes"
"4231","GO_BP","1144984_GO_1903846_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",23,-1.5522,0.033,0.083,"No",0.5346,1,1,"Yes"
"4232","C2_Chemical_and_genetic_perturbations","C2_CGP_1864_ABE_VEGFA_TARGETS",20,-1.5522,0.024,0.046,"No",0.9198,0.54,0.9,"Yes"
"4233","GO_BP","513507_GO_0055074_CALCIUM_ION_HOMEOSTASIS",284,-1.5521,0,0.083,"No",1.2053,0.057,0.78,"Yes"
"4234","GO_BP","512358_GO_0051480_CYTOSOLIC_CALCIUM_ION_HOMEOSTASIS",181,-1.552,0.0012,0.083,"No",1.1791,0.11,0.8,"Yes"
"4235","C2_Chemical_and_genetic_perturbations","C2_CGP_570_MARKS_HDAC_TARGETS_UP",23,-1.552,0.028,0.046,"No",0.7265,0.88,1,"Yes"
"4236","GO_MF","490570_GO_0005402_CATION_SUGAR_SYMPORTER_ACTIVITY",8,-1.552,0.035,0.12,"No",-0.7829,0.73,1,"No"
"4237","GO_BP","504522_GO_0035338_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS",17,-1.5519,0.023,0.083,"No",-0.7459,0.82,1,"No"
"4238","C7_Immunologic_signatures","C7_ALL_1471_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP",199,-1.5518,0,0.0029,"No",1.2497,0.064,0.15,"Yes"
"4239","GO_BP","513498_GO_0072507_DIVALENT_INORGANIC_CATION_HOMEOSTASIS",328,-1.5517,0,0.083,"No",1.101,0.18,0.9,"Yes"
"4240","GO_BP","752002_GO_0052805_IMIDAZOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",5,-1.5516,0.019,0.083,"No",-0.6006,0.94,1,"No"
"4241","GO_MF","506116_GO_0043027_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",25,-1.5515,0.02,0.12,"No",-0.7085,0.87,1,"No"
"4242","GO_BP","514000_GO_0060445_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS",16,-1.5513,0.038,0.083,"No",-0.9067,0.58,1,"No"
"4243","GO_BP","1129406_GO_1903580_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS",33,-1.5512,0.022,0.083,"No",-1.0001,0.46,0.99,"No"
"4244","GO_BP","491748_GO_0006887_EXOCYTOSIS",304,-1.5511,0.0011,0.083,"No",1.3031,0.0097,0.66,"Yes"
"4245","C2_Chemical_and_genetic_perturbations","C2_CGP_320_JAATINEN_HEMATOPOIETIC_STEM_CELL_UP",310,-1.551,0,0.046,"No",-0.7745,0.99,1,"No"
"4246","C2_BioCarta_Pathways","C2_CP_BIOCARTA_73_BIOCARTA_FEEDER_PATHWAY",9,-1.5509,0.023,0.12,"No",-1.3542,0.13,1,"No"
"4247","GO_CC","505841_GO_0042734_PRESYNAPTIC_MEMBRANE",55,-1.5508,0.012,0.11,"No",-1.2857,0.1,0.66,"No"
"4248","C2_Chemical_and_genetic_perturbations","C2_CGP_2377_RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP",100,-1.5508,0.0074,0.046,"No",-0.9783,0.51,1,"No"
"4249","GO_BP","506514_GO_0043482_CELLULAR_PIGMENT_ACCUMULATION",11,-1.5508,0.028,0.083,"No",-0.6334,0.91,1,"No"
"4250","GO_BP","494986_GO_0010922_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY",23,-1.5507,0.028,0.083,"No",0.6501,0.95,1,"Yes"
"4251","C2_Chemical_and_genetic_perturbations","C2_CGP_2601_BRUNEAU_SEPTATION_ATRIAL",5,-1.5506,0.016,0.046,"No",-0.9975,0.45,1,"No"
"4252","C7_Immunologic_signatures","C7_ALL_1383_GSE339_CD4POS_VS_CD8POS_DC_UP",198,-1.5505,0,0.003,"No",0.8548,0.88,1,"Yes"
"4253","GO_BP","517430_GO_0072525_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",22,-1.5504,0.025,0.083,"No",-1.0139,0.45,0.98,"No"
"4254","GO_MF","490468_GO_0005227_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY",30,-1.5504,0.019,0.12,"No",-0.9569,0.52,0.95,"No"
"4255","GO_MF","492572_GO_0008238_EXOPEPTIDASE_ACTIVITY",106,-1.5503,0.0088,0.12,"No",0.677,1,1,"Yes"
"4256","GO_MF","496264_GO_0016175_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVITY",9,-1.5503,0.049,0.12,"No",-0.8997,0.59,0.99,"No"
"4257","REACTOME","106196_REACT_474_METABOLISM_OF_CARBOHYDRATES",262,-1.5503,0,0.095,"No",0.8944,0.81,0.91,"Yes"
"4258","C3_TF_targets","C3_TFT_208_V_PAX3_B",87,-1.5502,0.0038,0.015,"No",0.7217,0.96,1,"Yes"
"4259","C2_Chemical_and_genetic_perturbations","C2_CGP_882_SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION",49,-1.5501,0.014,0.046,"No",0.8857,0.65,0.94,"Yes"
"4260","C3_TF_targets","C3_TFT_329_V_CRX_Q4",262,-1.5499,0,0.015,"No",-1.0461,0.33,0.65,"No"
"4261","GO_MF","493089_GO_0008865_FRUCTOKINASE_ACTIVITY",5,-1.5499,0.028,0.12,"No",-1.2122,0.27,0.82,"No"
"4262","C2_Chemical_and_genetic_perturbations","C2_CGP_64_CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP",145,-1.5498,0.0059,0.047,"No",0.6978,1,1,"Yes"
"4263","GO_BP","517562_GO_0072659_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",126,-1.5498,0,0.084,"No",0.836,0.86,1,"Yes"
"4264","C2_Chemical_and_genetic_perturbations","C2_CGP_540_DARWICHE_PAPILLOMA_RISK_LOW_UP",154,-1.5497,0,0.047,"No",1.1537,0.14,0.55,"Yes"
"4265","C6_Oncogenic_signatures","C6_ALL_23_CSR_LATE_UP_V1_DN",141,-1.5497,0.0012,0.0081,"No",0.9493,0.57,0.97,"Yes"
"4266","GO_BP","507998_GO_0045650_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION",8,-1.5497,0.035,0.084,"No",-0.7572,0.79,1,"No"
"4267","C2_BioCarta_Pathways","C2_CP_BIOCARTA_30_BIOCARTA_CASPASE_PATHWAY",23,-1.5496,0.018,0.12,"No",-0.6984,0.9,1,"No"
"4268","C2_Chemical_and_genetic_perturbations","C2_CGP_850_MOHANKUMAR_TLX1_TARGETS_UP",409,-1.5496,0,0.047,"No",0.9603,0.61,0.85,"Yes"
"4269","C2_Chemical_and_genetic_perturbations","C2_CGP_2353_LABBE_WNT3A_TARGETS_UP",111,-1.5496,0.0025,0.047,"No",-0.8542,0.81,1,"No"
"4270","GO_CC","752843_GO_0097342_RIPOPTOSOME",7,-1.5495,0.02,0.11,"No",-1.0224,0.43,0.84,"No"
"4271","GO_BP","502185_GO_0032963_COLLAGEN_METABOLIC_PROCESS",83,-1.5495,0.0065,0.084,"No",-1.1712,0.18,0.91,"No"
"4272","GO_BP","487448_GO_0001508_ACTION_POTENTIAL",88,-1.5494,0.0085,0.084,"No",-1.3318,0.05,0.9,"No"
"4273","GO_BP","753986_GO_1901016_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",31,-1.5493,0.024,0.084,"No",-1.1158,0.3,0.94,"No"
"4274","GO_BP","518766_GO_2000117_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",78,-1.5493,0.011,0.084,"No",0.906,0.67,1,"Yes"
"4275","C2_Chemical_and_genetic_perturbations","C2_CGP_1275_UEDA_CENTRAL_CLOCK",88,-1.5492,0.0026,0.047,"No",-0.9329,0.59,1,"No"
"4276","GO_BP","486620_GO_0000079_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",90,-1.5492,0.0063,0.084,"No",-0.839,0.82,1,"No"
"4277","C2_BioCarta_Pathways","C2_CP_BIOCARTA_169_BIOCARTA_MEF2D_PATHWAY",18,-1.5492,0.027,0.11,"No",-0.607,0.95,1,"No"
"4278","GO_BP","513458_GO_0055025_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",26,-1.5491,0.018,0.084,"No",-0.7749,0.82,1,"No"
"4279","GO_CC","499481_GO_0030017_SARCOMERE",178,-1.549,0,0.11,"No",-0.9883,0.49,0.85,"No"
"4280","C2_Chemical_and_genetic_perturbations","C2_CGP_1539_KANG_IMMORTALIZED_BY_TERT_DN",100,-1.549,0.0025,0.047,"No",0.8825,0.73,0.94,"Yes"
"4281","GO_BP","511939_GO_0051006_POSITIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY",10,-1.5489,0.022,0.084,"No",-1.4189,0.099,0.94,"No"
"4282","KEGG_pathway","HSA04614_RENIN_ANGIOTENSIN_SYSTEM",17,-1.5488,0.031,0.024,"No",1.5297,0.027,0.094,"Yes"
"4283","C4_Cancer_modules","C4_CM_377_MODULE_464",14,-1.5488,0.04,0.041,"No",0.8368,0.7,0.93,"Yes"
"4284","GO_BP","505719_GO_0042593_GLUCOSE_HOMEOSTASIS",153,-1.5487,0.0036,0.084,"No",0.9926,0.44,0.99,"Yes"
"4285","GO_MF","507655_GO_0045296_CADHERIN_BINDING",27,-1.5487,0.023,0.12,"No",-0.7551,0.85,1,"No"
"4286","GO_BP","499139_GO_0021860_PYRAMIDAL_NEURON_DEVELOPMENT",6,-1.5486,0.018,0.084,"No",-1.2297,0.24,0.89,"No"
"4287","GO_MF","489788_GO_0016308_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY",7,-1.5486,0.041,0.12,"No",-1.2411,0.23,0.85,"No"
"4288","GO_BP","751426_GO_0038170_SOMATOSTATIN_SIGNALING_PATHWAY",5,-1.5485,0.02,0.084,"No",0.6942,0.82,1,"Yes"
"4289","C2_BioCarta_Pathways","C2_CP_BIOCARTA_125_BIOCARTA_NTHI_PATHWAY",24,-1.5484,0.034,0.11,"No",-0.685,0.92,1,"No"
"4290","GO_BP","518324_GO_0090184_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT",38,-1.5484,0.02,0.084,"No",0.986,0.48,1,"Yes"
"4291","GO_BP","500134_GO_0030836_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION",8,-1.5483,0.04,0.084,"No",-0.6462,0.89,1,"No"
"4292","GO_CC","750942_GO_0036019_ENDOLYSOSOME",9,-1.5482,0.031,0.11,"No",0.8534,0.62,0.91,"Yes"
"4293","C2_Chemical_and_genetic_perturbations","C2_CGP_538_DARWICHE_SKIN_TUMOR_PROMOTER_UP",137,-1.5482,0.0012,0.047,"No",0.8933,0.76,0.93,"Yes"
"4294","GO_BP","511842_GO_0050905_NEUROMUSCULAR_PROCESS",101,-1.5478,0.0037,0.084,"No",-0.9442,0.58,1,"No"
"4295","GO_BP","492070_GO_0007292_FEMALE_GAMETE_GENERATION",89,-1.5478,0.01,0.084,"No",-1.209,0.16,0.88,"No"
"4296","REACTOME","106507_REACT_12380_VEGF_LIGAND_RECEPTOR_INTERACTIONS",7,-1.5478,0.039,0.097,"No",0.5196,0.98,1,"Yes"
"4297","C2_Chemical_and_genetic_perturbations","C2_CGP_2733_HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP",62,-1.5477,0.0093,0.047,"No",1.074,0.32,0.67,"Yes"
"4298","KEGG_pathway","HSA00920_SULFUR_METABOLISM",10,-1.5477,0.033,0.024,"No",-0.4444,0.99,1,"No"
"4299","C2_BioCarta_Pathways","C2_CP_BIOCARTA_213_BIOCARTA_UCALPAIN_PATHWAY",18,-1.5474,0.043,0.11,"No",-0.7821,0.8,1,"No"
"4300","GO_BP","494076_GO_0009991_RESPONSE_TO_EXTRACELLULAR_STIMULUS",418,-1.5474,0,0.085,"No",-0.928,0.73,1,"No"
"4301","C7_Immunologic_signatures","C7_ALL_180_GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN",199,-1.5472,0,0.0031,"No",0.8072,0.95,1,"Yes"
"4302","GO_MF","489958_GO_0047499_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY",5,-1.547,0.019,0.12,"No",-0.5862,0.91,1,"No"
"4303","C3_TF_targets","C3_TFT_435_V_E2A_Q2",237,-1.5468,0,0.016,"No",-1.5728,0,0.14,"No"
"4304","KEGG_module","HSA_M00014_GLUCURONATE_PATHWAY_URONATE_PATHWAY_",27,-1.5467,0.029,0.18,"No",1.6115,0.0067,0.12,"Yes"
"4305","C2_Chemical_and_genetic_perturbations","C2_CGP_2199_DE_YY1_TARGETS_UP",20,-1.5463,0.03,0.048,"No",0.7288,0.88,1,"Yes"
"4306","C2_Chemical_and_genetic_perturbations","C2_CGP_1322_TARTE_PLASMA_CELL_VS_PLASMABLAST_UP",374,-1.5463,0.0011,0.048,"No",1.5699,0,0.16,"Yes"
"4307","KEGG_pathway","HSA00524_BUTIROSIN_AND_NEOMYCIN_BIOSYNTHESIS",5,-1.5462,0.03,0.024,"No",-1.1977,0.29,0.52,"No"
"4308","C7_Immunologic_signatures","C7_ALL_729_GSE17721_0_5H_VS_12H_PAM3CSK4_BMDM_UP",197,-1.5461,0,0.0032,"No",1.2851,0.026,0.12,"Yes"
"4309","GO_MF","495514_GO_0051119_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",22,-1.546,0.035,0.12,"No",-1.0983,0.3,0.84,"No"
"4310","GO_BP","512203_GO_0051319_G2_PHASE",9,-1.5456,0.027,0.086,"No",-0.91,0.6,1,"No"
"4311","GO_MF","490163_GO_0004861_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY",12,-1.5456,0.041,0.12,"No",-1.222,0.22,0.85,"No"
"4312","C2_BioCarta_Pathways","C2_CP_BIOCARTA_103_BIOCARTA_DEATH_PATHWAY",33,-1.5456,0.019,0.11,"No",-1.0439,0.39,1,"No"
"4313","C7_Immunologic_signatures","C7_ALL_162_GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN",193,-1.5453,0.0034,0.0033,"No",1.2811,0.031,0.12,"Yes"
"4314","GO_MF","487531_GO_0001594_TRACE_AMINE_RECEPTOR_ACTIVITY",6,-1.5453,0.037,0.12,"No",0.8724,0.61,1,"Yes"
"4315","C2_Chemical_and_genetic_perturbations","C2_CGP_3312_PHONG_TNF_RESPONSE_VIA_P38_COMPLETE",226,-1.5453,0,0.048,"No",-1.0636,0.29,0.96,"No"
"4316","C3_TF_targets","C3_TFT_166_V_AHRARNT_01",140,-1.5453,0,0.016,"No",-1.0757,0.28,0.61,"No"
"4317","C2_Chemical_and_genetic_perturbations","C2_CGP_1701_MODY_HIPPOCAMPUS_NEONATAL",35,-1.5453,0.019,0.048,"No",1.2471,0.15,0.44,"Yes"
"4318","GO_BP","500111_GO_0030812_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS",38,-1.5451,0.02,0.086,"No",-0.8515,0.74,1,"No"
"4319","C7_Immunologic_signatures","C7_ALL_809_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP",178,-1.5451,0,0.0033,"No",-0.8448,0.88,1,"No"
"4320","GO_BP","513497_GO_0055065_METAL_ION_HOMEOSTASIS",442,-1.545,0,0.086,"No",1.2236,0.026,0.76,"Yes"
"4321","GO_BP","512012_GO_0051098_REGULATION_OF_BINDING",233,-1.545,0,0.086,"No",0.9333,0.66,1,"Yes"
"4322","C2_Chemical_and_genetic_perturbations","C2_CGP_2592_LEE_DOUBLE_POLAR_THYMOCYTE",25,-1.545,0.02,0.048,"No",-1.0263,0.42,0.98,"No"
"4323","WikiPathways","198784_WP1544_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY",84,-1.5448,0.005,0.054,"No",-0.7679,0.93,1,"No"
"4324","C2_Chemical_and_genetic_perturbations","C2_CGP_1177_MORI_LARGE_PRE_BII_LYMPHOCYTE_DN",58,-1.5447,0.018,0.048,"No",-0.771,0.89,1,"No"
"4325","C6_Oncogenic_signatures","C6_ALL_121_RB_DN_V1_DN",114,-1.5447,0.0024,0.0085,"No",1.2243,0.095,0.38,"Yes"
"4326","GO_BP","1129358_GO_1903531_NEGATIVE_REGULATION_OF_SECRETION_BY_CELL",144,-1.5446,0.0036,0.087,"No",0.9298,0.63,1,"Yes"
"4327","C7_Immunologic_signatures","C7_ALL_1480_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN",199,-1.5444,0.0023,0.0033,"No",-0.8297,0.88,1,"No"
"4328","GO_BP","511844_GO_0050907_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",350,-1.5443,0,0.087,"No",2.2908,0,0.00013,"Yes"
"4329","C7_Immunologic_signatures","C7_ALL_805_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP",183,-1.5443,0.0034,0.0033,"No",0.961,0.58,0.86,"Yes"
"4330","GO_BP","494834_GO_0010769_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION",266,-1.5443,0,0.087,"No",-1.2424,0.059,0.91,"No"
"4331","GO_MF","495328_GO_0015035_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",24,-1.5442,0.033,0.12,"No",0.8301,0.72,1,"Yes"
"4332","C3_TF_targets","C3_TFT_557_RACCACAR_V_AML_Q6",258,-1.5442,0,0.016,"No",-0.8004,0.97,1,"No"
"4333","GO_BP","494172_GO_0010092_SPECIFICATION_OF_ORGAN_IDENTITY",14,-1.5441,0.04,0.087,"No",-1.0204,0.41,0.97,"No"
"4334","GO_BP","752373_GO_0086001_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",33,-1.544,0.013,0.087,"No",-1.0032,0.45,0.99,"No"
"4335","GO_BP","513873_GO_0060317_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",21,-1.5438,0.043,0.087,"No",0.7975,0.77,1,"Yes"
"4336","GO_BP","506508_GO_0043476_PIGMENT_ACCUMULATION",11,-1.5438,0.022,0.087,"No",-0.6473,0.91,1,"No"
"4337","C7_Immunologic_signatures","C7_ALL_1102_GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN",188,-1.5437,0.0023,0.0033,"No",0.7482,0.99,1,"Yes"
"4338","C7_Immunologic_signatures","C7_ALL_1453_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP",196,-1.5436,0.0045,0.0033,"No",1.088,0.23,0.47,"Yes"
"4339","C2_Chemical_and_genetic_perturbations","C2_CGP_2688_VALK_AML_CLUSTER_12",29,-1.5436,0.016,0.048,"No",0.9073,0.61,0.91,"Yes"
"4340","C2_Chemical_and_genetic_perturbations","C2_CGP_1238_ONDER_CDH1_TARGETS_2_UP",252,-1.5435,0,0.048,"No",1.2974,0.021,0.39,"Yes"
"4341","C3_TF_targets","C3_TFT_257_V_CHX10_01",212,-1.5435,0,0.016,"No",-1.0824,0.25,0.59,"No"
"4342","C2_Chemical_and_genetic_perturbations","C2_CGP_1453_HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP",77,-1.5433,0.0078,0.048,"No",-0.885,0.71,1,"No"
"4343","GO_BP","499352_GO_0022617_EXTRACELLULAR_MATRIX_DISASSEMBLY",119,-1.5433,0.0025,0.087,"No",-0.8358,0.84,1,"No"
"4344","GO_BP","488893_GO_0003097_RENAL_WATER_TRANSPORT",6,-1.5432,0.042,0.087,"No",-0.7501,0.76,1,"No"
"4345","GO_CC","500380_GO_0031093_PLATELET_ALPHA_GRANULE_LUMEN",47,-1.543,0.02,0.12,"No",1.6345,0.0043,0.094,"Yes"
"4346","REACTOME","477128_REACT_111133_GROWTH_HORMONE_RECEPTOR_SIGNALING",23,-1.5426,0.025,0.1,"No",-0.679,0.92,1,"No"
"4347","REACTOME","730320_REACT_150154_INOSITOL_PHOSPHATE_METABOLISM",46,-1.5426,0.011,0.1,"No",-1.1574,0.19,0.85,"No"
"4348","C0_Hallmark","H_ALL_22_HALLMARK_HEDGEHOG_SIGNALING",33,-1.5426,0.013,0.0065,"No",-0.7743,0.83,1,"No"
"4349","GO_BP","511627_GO_0050655_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS",15,-1.5425,0.037,0.088,"No",-1.1765,0.26,0.9,"No"
"4350","GO_BP","754673_GO_1901722_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",11,-1.5423,0.033,0.088,"No",-0.8631,0.61,1,"No"
"4351","GO_BP","512013_GO_0051099_POSITIVE_REGULATION_OF_BINDING",99,-1.5422,0.0065,0.088,"No",-0.5994,1,1,"No"
"4352","GO_MF","498023_GO_0019158_MANNOKINASE_ACTIVITY",5,-1.542,0.019,0.12,"No",-1.216,0.26,0.82,"No"
"4353","GO_BP","516146_GO_0071220_CELLULAR_RESPONSE_TO_BACTERIAL_LIPOPROTEIN",5,-1.542,0.029,0.088,"No",0.8171,0.67,1,"Yes"
"4354","GO_BP","516929_GO_0072010_GLOMERULAR_EPITHELIUM_DEVELOPMENT",19,-1.5419,0.031,0.088,"No",-0.9626,0.5,1,"No"
"4355","C2_Chemical_and_genetic_perturbations","C2_CGP_3128_JOHNSTONE_PARVB_TARGETS_2_UP",135,-1.5419,0.0059,0.049,"No",1.1051,0.23,0.62,"Yes"
"4356","C2_Chemical_and_genetic_perturbations","C2_CGP_2466_BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN",32,-1.5418,0.029,0.049,"No",0.8288,0.72,0.98,"Yes"
"4357","GO_BP","948898_GO_1902743_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION",31,-1.5417,0.017,0.088,"No",0.839,0.74,1,"Yes"
"4358","GO_BP","494234_GO_0010155_REGULATION_OF_PROTON_TRANSPORT",14,-1.5416,0.028,0.088,"No",1.2386,0.2,0.75,"Yes"
"4359","KEGG_compound","C18040_5ALPHA_DIHYDRODEOXYCORTICOSTERONE_5ALPHA_PREGNAN_21_OL_3_20_DIONE_ALLOPREGNANE_21_OL_3_20_DIONE",7,-1.5416,0.026,0.14,"No",-0.6942,0.83,1,"No"
"4360","GO_BP","507936_GO_0045588_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION",5,-1.5416,0.039,0.088,"No",-0.7101,0.82,1,"No"
"4361","GO_BP","493578_GO_0009405_PATHOGENESIS",264,-1.5416,0,0.088,"No",0.8956,0.81,1,"Yes"
"4362","GO_BP","491735_GO_0006874_CELLULAR_CALCIUM_ION_HOMEOSTASIS",271,-1.5414,0,0.088,"No",1.2319,0.049,0.75,"Yes"
"4363","C2_Chemical_and_genetic_perturbations","C2_CGP_3158_CHENG_TAF7L_TARGETS",6,-1.5413,0.034,0.049,"No",-1.3309,0.15,0.69,"No"
"4364","GO_BP","509139_GO_0046942_CARBOXYLIC_ACID_TRANSPORT",231,-1.541,0,0.088,"No",-1.2278,0.06,0.88,"No"
"4365","GO_MF","489959_GO_0004629_PHOSPHOLIPASE_C_ACTIVITY",30,-1.541,0.019,0.12,"No",-1.0552,0.36,0.87,"No"
"4366","C2_Chemical_and_genetic_perturbations","C2_CGP_2480_GU_PDEF_TARGETS_UP",71,-1.5409,0.0065,0.049,"No",0.9831,0.49,0.81,"Yes"
"4367","GO_MF","496630_GO_0016709_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",37,-1.5409,0.018,0.12,"No",-0.6738,0.94,1,"No"
"4368","GO_BP","502046_GO_0032823_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION",11,-1.5409,0.037,0.088,"No",-1.3023,0.15,0.89,"No"
"4369","GO_MF","490542_GO_0005351_SUGAR_PROTON_SYMPORTER_ACTIVITY",8,-1.5407,0.039,0.12,"No",-0.809,0.72,1,"No"
"4370","GO_CC","503973_GO_0034774_SECRETORY_GRANULE_LUMEN",58,-1.5407,0.008,0.12,"No",1.5201,0.016,0.18,"Yes"
"4371","GO_BP","514219_GO_0060664_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS",5,-1.5407,0.022,0.088,"No",-0.8125,0.7,1,"No"
"4372","GO_BP","501621_GO_0032386_REGULATION_OF_INTRACELLULAR_TRANSPORT",495,-1.5406,0,0.088,"No",0.9002,0.87,1,"Yes"
"4373","KEGG_pathway","HSA04390_HIPPO_SIGNALING_PATHWAY",150,-1.5405,0.0012,0.025,"No",-0.8962,0.74,0.97,"No"
"4374","GO_BP","494658_GO_0010594_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION",99,-1.5403,0.0051,0.088,"No",-0.9607,0.56,1,"No"
"4375","C7_Immunologic_signatures","C7_ALL_691_GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_UP",195,-1.5402,0,0.0035,"No",-1.01,0.42,1,"No"
"4376","KEGG_reaction","R01600_ATP_BETA_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_BETA_D_GLUCOSE_ADP_BETA_D_GLUCOSE_6_PHOSPHATE",5,-1.54,0.029,0.13,"No",-1.1971,0.27,0.55,"No"
"4377","C4_Cancer_modules","C4_CM_425_MODULE_563",14,-1.5399,0.038,0.044,"No",1.0108,0.44,0.71,"Yes"
"4378","C2_Chemical_and_genetic_perturbations","C2_CGP_669_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24",13,-1.5399,0.045,0.05,"No",-1.2731,0.17,0.71,"No"
"4379","C1_Positional","C1_ALL_179_CHR9Q13",17,-1.5395,0.037,0.26,"No",-0.886,0.63,1,"No"
"4380","GO_BP","503317_GO_0034111_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION",84,-1.5395,0.012,0.089,"No",-0.8654,0.72,1,"No"
"4381","GO_BP","750893_GO_0035966_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN",158,-1.5395,0.0012,0.089,"No",-0.8859,0.76,1,"No"
"4382","KEGG_compound","C00004_NADH_DPNH_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE",106,-1.5393,0.0086,0.14,"No",0.9941,0.46,1,"Yes"
"4383","GO_BP","518397_GO_0090257_REGULATION_OF_MUSCLE_SYSTEM_PROCESS",190,-1.5393,0.0012,0.089,"No",-1.046,0.34,0.97,"No"
"4384","C2_Chemical_and_genetic_perturbations","C2_CGP_1191_LEE_TARGETS_OF_PTCH1_AND_SUFU_UP",53,-1.5392,0.018,0.05,"No",1.0076,0.42,0.79,"Yes"
"4385","GO_BP","753096_GO_1900101_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",18,-1.5392,0.049,0.089,"No",-1.1717,0.26,0.91,"No"
"4386","C2_Chemical_and_genetic_perturbations","C2_CGP_236_RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP",77,-1.539,0.0038,0.05,"No",1.2261,0.11,0.46,"Yes"
"4387","C2_Chemical_and_genetic_perturbations","C2_CGP_2793_SCHOEN_NFKB_SIGNALING",34,-1.539,0.013,0.05,"No",-1.4284,0.04,0.55,"No"
"4388","C2_Chemical_and_genetic_perturbations","C2_CGP_1535_AFFAR_YY1_TARGETS_DN",230,-1.539,0.0011,0.05,"No",1.1495,0.15,0.56,"Yes"
"4389","GO_BP","511813_GO_0050871_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION",63,-1.5389,0.0082,0.089,"No",-0.9259,0.58,1,"No"
"4390","GO_BP","518826_GO_2000178_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION",20,-1.5388,0.028,0.089,"No",-1.4692,0.04,0.86,"No"
"4391","GO_BP","500915_GO_0031666_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",7,-1.5387,0.031,0.089,"No",-0.7354,0.79,1,"No"
"4392","KEGG_pathway","HSA04723_RETROGRADE_ENDOCANNABINOID_SIGNALING",100,-1.5386,0.0038,0.025,"No",-1.095,0.29,0.71,"No"
"4393","GO_BP","507248_GO_0044241_LIPID_DIGESTION",12,-1.5384,0.035,0.089,"No",-1.6976,0.0084,0.61,"No"
"4394","C3_MicroRNA_targets","C3_MIR_105_GAGCCTG_MIR_484",104,-1.5384,0.0063,0.27,"No",-1.2791,0.082,1,"No"
"4395","GO_BP","508834_GO_0046580_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION",41,-1.5384,0.022,0.089,"No",-0.8878,0.64,1,"No"
"4396","C6_Oncogenic_signatures","C6_ALL_155_STK33_SKM_DN",265,-1.5382,0.0011,0.0092,"No",1.0371,0.34,0.72,"Yes"
"4397","REACTOME","187104_REACT_25162_INTERFERON_ALPHA_BETA_SIGNALING",64,-1.5381,0.016,0.1,"No",1.2298,0.12,0.42,"Yes"
"4398","C7_Immunologic_signatures","C7_ALL_679_GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDM_UP",200,-1.5381,0.0023,0.0037,"No",0.9062,0.73,1,"Yes"
"4399","C2_Chemical_and_genetic_perturbations","C2_CGP_1641_JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN",63,-1.538,0.019,0.05,"No",-0.945,0.54,1,"No"
"4400","C7_Immunologic_signatures","C7_ALL_15_GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP",200,-1.5378,0.0011,0.0037,"No",0.7333,0.99,1,"Yes"
"4401","C2_Chemical_and_genetic_perturbations","C2_CGP_2687_VALK_AML_CLUSTER_11",36,-1.5377,0.013,0.05,"No",0.7113,0.92,1,"Yes"
"4402","GO_BP","503344_GO_0034138_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY",82,-1.5376,0.0078,0.09,"No",-0.7534,0.94,1,"No"
"4403","C2_Chemical_and_genetic_perturbations","C2_CGP_1732_MURAKAMI_UV_RESPONSE_6HR_UP",36,-1.5376,0.025,0.05,"No",0.8113,0.79,0.98,"Yes"
"4404","C2_Chemical_and_genetic_perturbations","C2_CGP_3307_BRIDEAU_IMPRINTED_GENES",60,-1.5376,0.014,0.05,"No",-1.0387,0.39,0.97,"No"
"4405","C2_Chemical_and_genetic_perturbations","C2_CGP_1377_LE_EGR2_TARGETS_UP",108,-1.5375,0.0062,0.05,"No",1.1396,0.19,0.57,"Yes"
"4406","GO_MF","502767_GO_0033549_MAP_KINASE_PHOSPHATASE_ACTIVITY",13,-1.5374,0.033,0.12,"No",-0.7114,0.83,1,"No"
"4407","C3_TF_targets","C3_TFT_599_CCCNNGGGAR_V_OLF1_01",315,-1.5374,0,0.017,"No",-1.3729,0.0085,0.18,"No"
"4408","C7_Immunologic_signatures","C7_ALL_1482_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN",197,-1.5373,0,0.0037,"No",0.931,0.68,0.95,"Yes"
"4409","GO_BP","488537_GO_0002664_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION",11,-1.5373,0.048,0.09,"No",0.7828,0.76,1,"Yes"
"4410","C7_Immunologic_signatures","C7_ALL_432_GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN",197,-1.5371,0.0023,0.0037,"No",0.8327,0.9,1,"Yes"
"4411","GO_BP","510940_GO_0048892_LATERAL_LINE_NERVE_DEVELOPMENT",10,-1.5371,0.031,0.09,"No",-1.3394,0.15,0.91,"No"
"4412","C7_Immunologic_signatures","C7_ALL_294_GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN",196,-1.5371,0.0011,0.0037,"No",1.093,0.22,0.46,"Yes"
"4413","GO_BP","488881_GO_0003085_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",15,-1.5371,0.034,0.09,"No",-1.2026,0.23,0.89,"No"
"4414","GO_BP","505541_GO_0042398_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS",50,-1.537,0.012,0.09,"No",-0.7572,0.87,1,"No"
"4415","GO_MF","505448_GO_0042301_PHOSPHATE_ION_BINDING",12,-1.5368,0.039,0.12,"No",0.6145,0.95,1,"Yes"
"4416","GO_MF","504441_GO_0035257_NUCLEAR_HORMONE_RECEPTOR_BINDING",127,-1.5368,0.0048,0.12,"No",0.7878,0.93,1,"Yes"
"4417","GO_BP","499438_GO_0023014_SIGNAL_TRANSDUCTION_BY_PHOSPHORYLATION",238,-1.5368,0.0011,0.09,"No",-0.7871,0.96,1,"No"
"4418","GO_BP","507076_GO_0044060_REGULATION_OF_ENDOCRINE_PROCESS",41,-1.5368,0.016,0.09,"No",1.0212,0.41,0.97,"Yes"
"4419","C2_Chemical_and_genetic_perturbations","C2_CGP_662_LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE",49,-1.5367,0.0096,0.051,"No",0.8502,0.74,0.97,"Yes"
"4420","WikiPathways","698753_WP2332_INTERLEUKIN_11_SIGNALING_PATHWAY",40,-1.5367,0.02,0.057,"No",0.7077,0.94,1,"Yes"
"4421","GO_BP","754840_GO_1901889_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY",13,-1.5366,0.034,0.09,"No",0.9432,0.52,1,"Yes"
"4422","REACTOME","105776_REACT_683_G1_S_SPECIFIC_TRANSCRIPTION",17,-1.5365,0.036,0.1,"No",-0.6317,0.92,1,"No"
"4423","C4_Cancer_modules","C4_CM_189_MODULE_202",28,-1.5365,0.028,0.045,"No",-1.0051,0.44,0.8,"No"
"4424","GO_BP","513516_GO_0055083_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS",19,-1.5364,0.037,0.09,"No",-1.2917,0.15,0.88,"No"
"4425","GO_MF","496472_GO_0016505_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",21,-1.5362,0.037,0.12,"No",1.1801,0.21,0.73,"Yes"
"4426","GO_BP","488707_GO_0002834_REGULATION_OF_RESPONSE_TO_TUMOR_CELL",11,-1.5361,0.042,0.09,"No",0.7957,0.71,1,"Yes"
"4427","KEGG_pathway","HSA04964_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION",23,-1.536,0.022,0.026,"No",-1.2032,0.22,0.52,"No"
"4428","GO_BP","510928_GO_0048880_SENSORY_SYSTEM_DEVELOPMENT",13,-1.5359,0.04,0.09,"No",-1.1872,0.26,0.9,"No"
"4429","GO_BP","503327_GO_0034121_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",36,-1.5358,0.03,0.09,"No",-0.7624,0.85,1,"No"
"4430","C7_Immunologic_signatures","C7_ALL_300_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN",190,-1.5358,0.0023,0.0038,"No",-1.2965,0.037,0.49,"No"
"4431","GO_BP","499046_GO_0021766_HIPPOCAMPUS_DEVELOPMENT",55,-1.5357,0.015,0.09,"No",-0.8076,0.84,1,"No"
"4432","GO_BP","507716_GO_0045359_POSITIVE_REGULATION_OF_INTERFERON_BETA_BIOSYNTHETIC_PROCESS",7,-1.5357,0.03,0.09,"No",-0.7148,0.83,1,"No"
"4433","C7_Immunologic_signatures","C7_ALL_1883_GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP",199,-1.5356,0,0.0038,"No",1.376,0.017,0.047,"Yes"
"4434","GO_BP","488516_GO_0002643_REGULATION_OF_TOLERANCE_INDUCTION",13,-1.5355,0.025,0.09,"No",-0.7739,0.75,1,"No"
"4435","GO_CC","490677_GO_0005605_BASAL_LAMINA",23,-1.5354,0.038,0.12,"No",-0.6747,0.92,1,"No"
"4436","C3_TF_targets","C3_TFT_577_AAAYWAACM_V_HFH4_01",248,-1.5354,0.0011,0.017,"No",-0.9121,0.72,0.95,"No"
"4437","GO_CC","490915_GO_0005916_FASCIA_ADHERENS",13,-1.5353,0.032,0.12,"No",-1.0501,0.37,0.83,"No"
"4438","GO_CC","752670_GO_0097169_AIM2_INFLAMMASOME_COMPLEX",6,-1.5351,0.036,0.12,"No",-0.9367,0.55,0.91,"No"
"4439","REACTOME","106508_REACT_12583_VEGF_BINDS_TO_VEGFR_LEADING_TO_RECEPTOR_DIMERIZATION",7,-1.5351,0.048,0.1,"No",0.5235,0.98,1,"Yes"
"4440","GO_BP","501765_GO_0032535_REGULATION_OF_CELLULAR_COMPONENT_SIZE",242,-1.535,0,0.091,"No",-0.9446,0.63,1,"No"
"4441","GO_BP","505406_GO_0042246_TISSUE_REGENERATION",37,-1.5349,0.027,0.091,"No",-1.1087,0.3,0.94,"No"
"4442","C2_Chemical_and_genetic_perturbations","C2_CGP_3031_LI_INDUCED_T_TO_NATURAL_KILLER_DN",110,-1.5348,0.0072,0.051,"No",-1.0363,0.39,0.98,"No"
"4443","C4_Cancer_modules","C4_CM_43_MODULE_47",219,-1.5348,0.0023,0.045,"No",1.2521,0.048,0.32,"Yes"
"4444","C2_Chemical_and_genetic_perturbations","C2_CGP_2836_LOPEZ_MESOTHELIOMA_SURVIVAL_DN",12,-1.5347,0.037,0.051,"No",-1.2581,0.18,0.74,"No"
"4445","GO_MF","490635_GO_0005539_GLYCOSAMINOGLYCAN_BINDING",181,-1.5345,0,0.12,"No",1.1198,0.17,0.77,"Yes"
"4446","C7_Immunologic_signatures","C7_ALL_540_GSE17721_LPS_VS_POLYIC_12H_BMDM_DN",197,-1.5344,0.0011,0.0039,"No",0.7875,0.98,1,"Yes"
"4447","WikiPathways","198793_WP550_BIOGENIC_AMINE_SYNTHESIS",14,-1.5344,0.039,0.057,"No",0.8073,0.74,1,"Yes"
"4448","C6_Oncogenic_signatures","C6_ALL_144_TGFB_UP_V1_UP",186,-1.5343,0,0.0095,"No",-1.3394,0.017,0.42,"No"
"4449","WikiPathways","198829_WP134_PENTOSE_PHOSPHATE_PATHWAY",8,-1.5343,0.027,0.057,"No",0.7361,0.8,1,"Yes"
"4450","C7_Immunologic_signatures","C7_ALL_1810_GSE7852_TREG_VS_TCONV_THYMUS_DN",198,-1.5343,0.0034,0.0039,"No",-0.8743,0.8,1,"No"
"4451","KEGG_compound","C00024_ACETYL_COA_ACETYL_COENZYME_A",35,-1.5342,0.022,0.14,"No",0.5165,1,1,"Yes"
"4452","GO_BP","492196_GO_0007435_SALIVARY_GLAND_MORPHOGENESIS",28,-1.534,0.025,0.091,"No",-1.1223,0.28,0.93,"No"
"4453","GO_BP","751253_GO_0036336_DENDRITIC_CELL_MIGRATION",19,-1.5339,0.032,0.091,"No",1.4714,0.049,0.46,"Yes"
"4454","KEGG_pathway","HSA00983_DRUG_METABOLISM",46,-1.5339,0.014,0.026,"No",1.1095,0.27,0.78,"Yes"
"4455","GO_CC","490799_GO_0005767_SECONDARY_LYSOSOME",7,-1.5339,0.03,0.12,"No",0.9645,0.49,0.82,"Yes"
"4456","GO_BP","506445_GO_0043407_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY",73,-1.5338,0.013,0.091,"No",-0.8558,0.75,1,"No"
"4457","GO_CC","507386_GO_0044437_VACUOLAR_PART",369,-1.5337,0.001,0.12,"No",0.8626,0.92,0.91,"Yes"
"4458","GO_BP","513523_GO_0055090_ACYLGLYCEROL_HOMEOSTASIS",29,-1.5336,0.025,0.092,"No",0.6451,0.96,1,"Yes"
"4459","GO_BP","491780_GO_0006929_SUBSTRATE_DEPENDENT_CELL_MIGRATION",26,-1.5335,0.022,0.092,"No",-0.6172,0.97,1,"No"
"4460","WikiPathways","920963_WP2328_ALLOGRAFT_REJECTION",36,-1.5334,0.026,0.056,"No",-0.7412,0.88,1,"No"
"4461","C3_MicroRNA_targets","C3_MIR_150_AACTGAC_MIR_223",96,-1.5334,0.0076,0.24,"No",-0.8896,0.68,1,"No"
"4462","C7_Immunologic_signatures","C7_ALL_500_GSE17721_CTRL_VS_CPG_2H_BMDM_DN",196,-1.5333,0,0.0039,"No",-0.8117,0.92,1,"No"
"4463","C7_Immunologic_signatures","C7_ALL_308_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN",198,-1.5333,0.0011,0.0039,"No",0.9366,0.64,0.94,"Yes"
"4464","GO_BP","515271_GO_0070339_RESPONSE_TO_BACTERIAL_LIPOPEPTIDE",5,-1.5333,0.043,0.092,"No",0.8218,0.68,1,"Yes"
"4465","C3_TF_targets","C3_TFT_324_V_AFP1_Q6",258,-1.5333,0,0.017,"No",1.0055,0.44,1,"Yes"
"4466","C4_Cancer_gene_neighborhoods","C4_CGN_417_GNF2_TIMP2",39,-1.5332,0.02,0.043,"No",0.9868,0.46,0.61,"Yes"
"4467","GO_BP","498247_GO_0019405_ALDITOL_CATABOLIC_PROCESS",5,-1.5331,0.031,0.092,"No",0.8539,0.63,1,"Yes"
"4468","C6_Oncogenic_signatures","C6_ALL_27_AKT_UP_V1_DN",173,-1.5329,0.0023,0.0095,"No",-0.9582,0.57,0.79,"No"
"4469","GO_BP","502839_GO_0033623_REGULATION_OF_INTEGRIN_ACTIVATION",10,-1.5327,0.04,0.092,"No",-0.7682,0.77,1,"No"
"4470","GO_BP","514225_GO_0060670_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS",9,-1.5327,0.035,0.092,"No",-1.1097,0.34,0.94,"No"
"4471","GO_CC","499505_GO_0030057_DESMOSOME",23,-1.5327,0.035,0.12,"No",1.0279,0.42,0.74,"Yes"
"4472","C3_TF_targets","C3_TFT_90_V_FOXD3_01",189,-1.5325,0.0023,0.017,"No",-0.9714,0.53,0.82,"No"
"4473","C2_Chemical_and_genetic_perturbations","C2_CGP_2542_RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP",15,-1.5325,0.047,0.052,"No",-1.196,0.23,0.8,"No"
"4474","GO_BP","488593_GO_0002720_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",27,-1.5325,0.024,0.092,"No",-0.73,0.9,1,"No"
"4475","C2_Chemical_and_genetic_perturbations","C2_CGP_797_KANG_GIST_WITH_PDGFRA_DN",5,-1.5325,0.014,0.052,"No",0.5339,0.96,1,"Yes"
"4476","GO_BP","511976_GO_0051051_NEGATIVE_REGULATION_OF_TRANSPORT",397,-1.5325,0,0.092,"No",0.8873,0.87,1,"Yes"
"4477","GO_BP","754001_GO_1901031_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",24,-1.5325,0.03,0.092,"No",1.7299,0.0066,0.16,"Yes"
"4478","C2_Chemical_and_genetic_perturbations","C2_CGP_1399_IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP",24,-1.5324,0.019,0.052,"No",1.0683,0.38,0.68,"Yes"
"4479","GO_BP","496148_GO_0016048_DETECTION_OF_TEMPERATURE_STIMULUS",14,-1.5324,0.028,0.092,"No",-0.7697,0.79,1,"No"
"4480","C4_Cancer_modules","C4_CM_190_MODULE_203",16,-1.5324,0.033,0.046,"No",-1.1305,0.28,0.64,"No"
"4481","C6_Oncogenic_signatures","C6_ALL_110_PTEN_DN_V1_UP",172,-1.5323,0.0023,0.0095,"No",-0.9455,0.59,0.83,"No"
"4482","GO_BP","491739_GO_0006878_CELLULAR_COPPER_ION_HOMEOSTASIS",14,-1.5323,0.042,0.092,"No",0.6605,0.91,1,"Yes"
"4483","GO_BP","495846_GO_0015711_ORGANIC_ANION_TRANSPORT",340,-1.5323,0,0.092,"No",-1.3034,0.012,0.89,"No"
"4484","KEGG_reaction","R00299_ATP_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_D_GLUCOSE_ADP_D_GLUCOSE_6_PHOSPHATE",5,-1.5323,0.026,0.13,"No",-1.2116,0.26,0.53,"No"
"4485","REACTOME","105655_REACT_832_DIMERIZATION_OF_PROCASPASE_8",11,-1.5322,0.036,0.11,"No",0.5599,0.97,1,"Yes"
"4486","C2_Chemical_and_genetic_perturbations","C2_CGP_2483_TOOKER_GEMCITABINE_RESISTANCE_DN",122,-1.5322,0.0012,0.052,"No",1.093,0.25,0.64,"Yes"
"4487","C7_Immunologic_signatures","C7_ALL_971_GSE22886_DC_VS_MONOCYTE_UP",198,-1.5321,0.0012,0.004,"No",0.899,0.76,1,"Yes"
"4488","GO_BP","506227_GO_0043154_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",76,-1.5321,0.0079,0.092,"No",0.9404,0.57,1,"Yes"
"4489","C7_Immunologic_signatures","C7_ALL_578_GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_DN",197,-1.5321,0.0023,0.004,"No",1.2827,0.038,0.12,"Yes"
"4490","C2_Chemical_and_genetic_perturbations","C2_CGP_2813_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL",17,-1.5319,0.044,0.052,"No",-0.7259,0.84,1,"No"
"4491","GO_BP","514646_GO_0061098_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY",35,-1.5319,0.027,0.092,"No",-0.9373,0.56,1,"No"
"4492","GO_MF","489759_GO_0004396_HEXOKINASE_ACTIVITY",5,-1.5318,0.024,0.12,"No",-1.1942,0.29,0.8,"No"
"4493","GO_BP","515441_GO_0070509_CALCIUM_ION_IMPORT",33,-1.5317,0.033,0.092,"No",-1.2589,0.16,0.91,"No"
"4494","C7_Immunologic_signatures","C7_ALL_848_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN",184,-1.5316,0,0.004,"No",-1.1884,0.12,0.85,"No"
"4495","C2_Chemical_and_genetic_perturbations","C2_CGP_2838_KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP",22,-1.5316,0.035,0.052,"No",1.0909,0.3,0.64,"Yes"
"4496","C2_BioCarta_Pathways","C2_CP_BIOCARTA_37_BIOCARTA_CELL2CELL_PATHWAY",14,-1.5314,0.034,0.12,"No",-0.72,0.84,1,"No"
"4497","OMIM_gene","OMIM603335_DYNEIN_AXONEMAL_HEAVY_CHAIN_5_DNAH5",5,-1.5312,0.028,0.95,"No",-0.744,0.78,0.98,"No"
"4498","GO_MF","487328_GO_0001105_RNA_POLYMERASE_II_TRANSCRIPTION_COACTIVATOR_ACTIVITY",24,-1.5312,0.029,0.12,"No",-0.9765,0.49,0.94,"No"
"4499","C2_Chemical_and_genetic_perturbations","C2_CGP_3091_FIGUEROA_AML_METHYLATION_CLUSTER_7_DN",5,-1.531,0.027,0.053,"No",-0.8585,0.65,1,"No"
"4500","C2_Chemical_and_genetic_perturbations","C2_CGP_154_GRABARCZYK_BCL11B_TARGETS_DN",55,-1.5308,0.025,0.053,"No",0.8673,0.75,0.96,"Yes"
"4501","C7_Immunologic_signatures","C7_ALL_354_GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN",193,-1.5307,0,0.0041,"No",-1.5903,0,0.02,"No"
"4502","C4_Cancer_modules","C4_CM_64_MODULE_68",21,-1.5307,0.038,0.046,"No",0.9658,0.48,0.76,"Yes"
"4503","C2_BioCarta_Pathways","C2_CP_BIOCARTA_76_BIOCARTA_FREE_PATHWAY",10,-1.5307,0.046,0.12,"No",-1.2344,0.23,1,"No"
"4504","GO_BP","487932_GO_0002042_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",15,-1.5306,0.04,0.093,"No",-1.4674,0.069,0.87,"No"
"4505","C7_Immunologic_signatures","C7_ALL_1827_GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP",198,-1.5305,0.0034,0.0041,"No",0.8736,0.83,1,"Yes"
"4506","GO_BP","514155_GO_0060600_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT",17,-1.5304,0.033,0.093,"No",-1.1625,0.26,0.92,"No"
"4507","GO_BP","512817_GO_0051967_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",10,-1.5304,0.038,0.093,"No",-0.9836,0.48,1,"No"
"4508","GO_BP","496455_GO_0016485_PROTEIN_PROCESSING",213,-1.5304,0,0.093,"No",0.9487,0.61,1,"Yes"
"4509","C6_Oncogenic_signatures","C6_ALL_173_KRAS_50_UP_V1_UP",48,-1.5304,0.0097,0.0095,"No",0.7487,0.89,0.99,"Yes"
"4510","C2_Chemical_and_genetic_perturbations","C2_CGP_722_FARMER_BREAST_CANCER_CLUSTER_2",33,-1.5304,0.021,0.053,"No",1.2184,0.18,0.47,"Yes"
"4511","REACTOME","477134_REACT_75792_MEIOTIC_SYNAPSIS",75,-1.5304,0.01,0.11,"No",-1.6197,0.0037,0.32,"No"
"4512","C2_Chemical_and_genetic_perturbations","C2_CGP_2729_CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP",85,-1.5301,0.017,0.053,"No",-1.2878,0.093,0.69,"No"
"4513","C2_Chemical_and_genetic_perturbations","C2_CGP_2779_MIKKELSEN_IPS_LCP_WITH_H3K4ME3",166,-1.5301,0.0023,0.053,"No",-1.4544,0.0089,0.53,"No"
"4514","GO_BP","506333_GO_0043266_REGULATION_OF_POTASSIUM_ION_TRANSPORT",62,-1.53,0.015,0.093,"No",-1.324,0.062,0.89,"No"
"4515","C2_Chemical_and_genetic_perturbations","C2_CGP_905_KONDO_HYPOXIA",8,-1.5298,0.04,0.053,"No",-0.5785,0.95,1,"No"
"4516","C2_Chemical_and_genetic_perturbations","C2_CGP_2810_FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN",26,-1.5298,0.019,0.053,"No",1.2541,0.15,0.43,"Yes"
"4517","GO_MF","499540_GO_0032393_MHC_CLASS_I_RECEPTOR_ACTIVITY",7,-1.5297,0.046,0.13,"No",-0.5253,0.98,1,"No"
"4518","C3_TF_targets","C3_TFT_426_V_TTF1_Q6",253,-1.5296,0,0.018,"No",-1.4757,0,0.14,"No"
"4519","C2_Chemical_and_genetic_perturbations","C2_CGP_3125_BHAT_ESR1_TARGETS_VIA_AKT1_DN",82,-1.5296,0.0087,0.053,"No",-0.8814,0.72,1,"No"
"4520","GO_BP","750939_GO_0036016_CELLULAR_RESPONSE_TO_INTERLEUKIN_3",5,-1.5295,0.027,0.093,"No",0.6421,0.91,1,"Yes"
"4521","REACTOME","106449_REACT_13415_P75NTR_RECRUITS_SIGNALLING_COMPLEXES",13,-1.5294,0.027,0.11,"No",1.1734,0.24,0.47,"Yes"
"4522","C7_Immunologic_signatures","C7_ALL_1081_GSE25087_FETAL_VS_ADULT_TCONV_UP",199,-1.5293,0.0011,0.0041,"No",0.8861,0.81,1,"Yes"
"4523","C2_Chemical_and_genetic_perturbations","C2_CGP_179_VECCHI_GASTRIC_CANCER_EARLY_DN",344,-1.5292,0,0.053,"No",1.3522,0,0.34,"Yes"
"4524","C2_Chemical_and_genetic_perturbations","C2_CGP_487_WANG_BARRETTS_ESOPHAGUS_UP",47,-1.5292,0.028,0.053,"No",-0.9381,0.54,1,"No"
"4525","C7_Immunologic_signatures","C7_ALL_817_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP",176,-1.5292,0.0023,0.0042,"No",1.0654,0.3,0.54,"Yes"
"4526","GO_MF","497601_GO_0018685_ALKANE_1_MONOOXYGENASE_ACTIVITY",5,-1.5291,0.032,0.13,"No",-1.2362,0.23,0.85,"No"
"4527","GO_BP","491539_GO_0006650_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS",231,-1.5291,0,0.094,"No",-0.7746,0.98,1,"No"
"4528","C3_TF_targets","C3_TFT_555_YWATTWNNRGCT_UNKNOWN",65,-1.5291,0.017,0.018,"No",-1.5217,0.016,0.13,"No"
"4529","C2_Chemical_and_genetic_perturbations","C2_CGP_3011_BROWNE_HCMV_INFECTION_30MIN_UP",51,-1.5289,0.028,0.053,"No",-1.2844,0.1,0.7,"No"
"4530","GO_BP","495122_GO_0014050_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION",7,-1.5289,0.024,0.094,"No",1.4457,0.093,0.5,"Yes"
"4531","C7_Immunologic_signatures","C7_ALL_880_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN",192,-1.5288,0.0033,0.0042,"No",1.0903,0.24,0.47,"Yes"
"4532","GO_CC","507369_GO_0044420_EXTRACELLULAR_MATRIX_COMPONENT",132,-1.5288,0.0037,0.12,"No",-1.0616,0.33,0.81,"No"
"4533","GO_BP","518670_GO_2000021_REGULATION_OF_ION_HOMEOSTASIS",167,-1.5287,0,0.094,"No",0.9702,0.49,1,"Yes"
"4534","C7_Immunologic_signatures","C7_ALL_967_GSE22886_NEUTROPHIL_VS_DC_UP",189,-1.5287,0.0011,0.0042,"No",1.3466,0.017,0.065,"Yes"
"4535","GO_BP","516281_GO_0071357_CELLULAR_RESPONSE_TO_TYPE_I_INTERFERON",65,-1.5286,0.0052,0.094,"No",1.1989,0.15,0.78,"Yes"
"4536","C7_Immunologic_signatures","C7_ALL_482_GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_DN",193,-1.5286,0.0035,0.0042,"No",-1.2033,0.1,0.81,"No"
"4537","C2_BioCarta_Pathways","C2_CP_BIOCARTA_28_BIOCARTA_CDMAC_PATHWAY",16,-1.5285,0.049,0.12,"No",-1.3393,0.12,1,"No"
"4538","C2_Chemical_and_genetic_perturbations","C2_CGP_3113_WIERENGA_STAT5A_TARGETS_GROUP1",135,-1.5283,0.0037,0.053,"No",-1.2029,0.11,0.8,"No"
"4539","GO_BP","514528_GO_0060973_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT",9,-1.5283,0.043,0.094,"No",0.902,0.57,1,"Yes"
"4540","C1_Positional","C1_ALL_272_CHR6Q24",41,-1.5282,0.019,0.27,"No",0.9379,0.58,0.84,"Yes"
"4541","C3_TF_targets","C3_TFT_398_V_SREBP1_Q6",238,-1.5281,0.0034,0.018,"No",-1.5324,0.0017,0.14,"No"
"4542","REACTOME","187193_REACT_25300_ION_CHANNEL_TRANSPORT",191,-1.5281,0.0023,0.11,"No",-1.2863,0.045,0.67,"No"
"4543","C2_Chemical_and_genetic_perturbations","C2_CGP_1098_GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN",202,-1.528,0.0011,0.053,"No",1.401,0.01,0.29,"Yes"
"4544","C7_Immunologic_signatures","C7_ALL_914_GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN",198,-1.528,0.0011,0.0042,"No",1.1727,0.089,0.27,"Yes"
"4545","KEGG_compound","C00319_SPHINGOSINE_SPHINGENINE_SPHINGOID_SPHING_4_ENINE",15,-1.5279,0.043,0.15,"No",-0.8445,0.68,1,"No"
"4546","GO_BP","518336_GO_0090196_REGULATION_OF_CHEMOKINE_SECRETION",9,-1.5279,0.037,0.094,"No",0.5936,0.94,1,"Yes"
"4547","C7_Immunologic_signatures","C7_ALL_484_GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN",196,-1.5278,0,0.0042,"No",-1.0304,0.39,1,"No"
"4548","KEGG_pathway","HSA00565_ETHER_LIPID_METABOLISM",42,-1.5277,0.023,0.027,"No",0.7133,0.95,1,"Yes"
"4549","GO_BP","491736_GO_0006875_CELLULAR_METAL_ION_HOMEOSTASIS",377,-1.5277,0,0.094,"No",1.2364,0.031,0.75,"Yes"
"4550","C3_TF_targets","C3_TFT_176_V_EGR2_01",196,-1.5276,0.0011,0.018,"No",-1.129,0.18,0.48,"No"
"4551","GO_CC","501247_GO_0032010_PHAGOLYSOSOME",6,-1.5276,0.048,0.12,"No",1.1632,0.28,0.57,"Yes"
"4552","C7_Immunologic_signatures","C7_ALL_1693_GSE3982_BASOPHIL_VS_TH1_UP",196,-1.5276,0.0023,0.0042,"No",1.2807,0.039,0.12,"Yes"
"4553","C7_Immunologic_signatures","C7_ALL_158_GSE13306_RA_VS_UNTREATED_TCONV_DN",196,-1.5274,0.0023,0.0042,"No",1.1507,0.15,0.32,"Yes"
"4554","C2_Chemical_and_genetic_perturbations","C2_CGP_1262_BYSTROEM_CORRELATED_WITH_IL5_DN",64,-1.5273,0.019,0.054,"No",0.8575,0.77,0.96,"Yes"
"4555","GO_BP","512755_GO_0051900_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION",16,-1.5272,0.039,0.095,"No",-0.9362,0.55,1,"No"
"4556","GO_BP","511857_GO_0050922_NEGATIVE_REGULATION_OF_CHEMOTAXIS",31,-1.5272,0.032,0.095,"No",0.9563,0.52,1,"Yes"
"4557","C2_Chemical_and_genetic_perturbations","C2_CGP_2390_CHEN_HOXA5_TARGETS_6HR_DN",6,-1.527,0.041,0.054,"No",-0.5374,0.98,1,"No"
"4558","GO_BP","507269_GO_0044262_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",170,-1.527,0.0011,0.095,"No",0.8661,0.85,1,"Yes"
"4559","GO_BP","752377_GO_0086005_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",15,-1.527,0.034,0.095,"No",0.6086,0.96,1,"Yes"
"4560","C6_Oncogenic_signatures","C6_ALL_179_KRAS_BREAST_UP_V1_UP",122,-1.5267,0.0049,0.0099,"No",1.2857,0.047,0.41,"Yes"
"4561","C6_Oncogenic_signatures","C6_ALL_45_ATM_DN_V1_DN",141,-1.5267,0.0059,0.0098,"No",-1.3836,0.019,0.34,"No"
"4562","GO_BP","497076_GO_0018101_PROTEIN_CITRULLINATION",5,-1.5267,0.021,0.095,"No",-1.2902,0.17,0.88,"No"
"4563","GO_BP","492620_GO_0008299_ISOPRENOID_BIOSYNTHETIC_PROCESS",25,-1.5265,0.038,0.095,"No",-1.0955,0.31,0.95,"No"
"4564","C2_Chemical_and_genetic_perturbations","C2_CGP_299_SABATES_COLORECTAL_ADENOMA_DN",266,-1.5265,0,0.054,"No",1.3276,0.0077,0.36,"Yes"
"4565","GO_BP","514040_GO_0060485_MESENCHYME_DEVELOPMENT",160,-1.5265,0,0.095,"No",-0.9387,0.61,1,"No"
"4566","GO_BP","492013_GO_0007215_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",39,-1.5264,0.016,0.095,"No",-1.2811,0.13,0.89,"No"
"4567","GO_BP","518348_GO_0090208_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS",18,-1.5263,0.047,0.095,"No",-0.8939,0.6,1,"No"
"4568","GO_BP","948899_GO_1902744_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION",5,-1.5263,0.031,0.095,"No",0.8071,0.7,1,"Yes"
"4569","GO_BP","509094_GO_0046883_REGULATION_OF_HORMONE_SECRETION",237,-1.5261,0.0011,0.095,"No",0.9333,0.69,1,"Yes"
"4570","GO_MF","490537_GO_0005342_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",118,-1.5261,0.0037,0.13,"No",-1.1852,0.13,0.78,"No"
"4571","C6_Oncogenic_signatures","C6_ALL_88_MTOR_UP_N4_V1_UP",194,-1.526,0.0011,0.0097,"No",-0.7112,0.99,1,"No"
"4572","C2_Chemical_and_genetic_perturbations","C2_CGP_1842_ZHOU_TNF_SIGNALING_30MIN",53,-1.526,0.015,0.054,"No",0.8545,0.73,0.97,"Yes"
"4573","C7_Immunologic_signatures","C7_ALL_1041_GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP",198,-1.5259,0.0011,0.0043,"No",-1.1466,0.15,1,"No"
"4574","C2_BioCarta_Pathways","C2_CP_BIOCARTA_32_BIOCARTA_CCR3_PATHWAY",20,-1.5258,0.033,0.12,"No",-1.0182,0.43,1,"No"
"4575","GO_MF","489706_GO_0004340_GLUCOKINASE_ACTIVITY",5,-1.5258,0.03,0.13,"No",-1.1936,0.27,0.8,"No"
"4576","C7_Immunologic_signatures","C7_ALL_442_GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN",199,-1.5257,0,0.0043,"No",0.8164,0.94,1,"Yes"
"4577","GO_BP","511739_GO_0050768_NEGATIVE_REGULATION_OF_NEUROGENESIS",191,-1.5257,0,0.095,"No",-1.0726,0.29,0.96,"No"
"4578","C7_Immunologic_signatures","C7_ALL_901_GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP",197,-1.5253,0.0011,0.0044,"No",0.8133,0.95,1,"Yes"
"4579","C2_Chemical_and_genetic_perturbations","C2_CGP_1119_PETRETTO_CARDIAC_HYPERTROPHY",34,-1.5252,0.031,0.054,"No",-0.6864,0.94,1,"No"
"4580","WikiPathways","198790_WP262_EBV_LMP1_SIGNALING",22,-1.5251,0.032,0.06,"No",-0.8986,0.62,1,"No"
"4581","GO_BP","491914_GO_0007095_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT",15,-1.525,0.038,0.096,"No",-0.794,0.76,1,"No"
"4582","GO_BP","495294_GO_0014902_MYOTUBE_DIFFERENTIATION",49,-1.525,0.018,0.096,"No",-1.2347,0.15,0.9,"No"
"4583","GO_MF","489533_GO_0004065_ARYLSULFATASE_ACTIVITY",12,-1.525,0.046,0.13,"No",-0.9708,0.49,0.94,"No"
"4584","GO_BP","505341_GO_0042180_CELLULAR_KETONE_METABOLIC_PROCESS",64,-1.525,0.019,0.096,"No",-0.7645,0.87,1,"No"
"4585","GO_BP","487445_GO_0042136_NEUROTRANSMITTER_BIOSYNTHETIC_PROCESS",16,-1.5249,0.033,0.096,"No",-0.8096,0.72,1,"No"
"4586","C2_Chemical_and_genetic_perturbations","C2_CGP_5_WINTER_HYPOXIA_UP",92,-1.5248,0.0051,0.055,"No",-0.9695,0.53,1,"No"
"4587","GO_BP","500184_GO_0030889_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION",15,-1.5247,0.049,0.096,"No",1.0286,0.43,0.97,"Yes"
"4588","C6_Oncogenic_signatures","C6_ALL_96_ESC_J1_UP_LATE_V1_UP",176,-1.5247,0.0023,0.0098,"No",-1.2737,0.059,0.35,"No"
"4589","GO_BP","517546_GO_0072643_INTERFERON_GAMMA_SECRETION",8,-1.5247,0.051,0.096,"No",-0.7875,0.71,1,"No"
"4590","C7_Immunologic_signatures","C7_ALL_12_KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN",199,-1.5246,0.0011,0.0044,"No",1.418,0.0049,0.032,"Yes"
"4591","REACTOME","1127530_REACT_263890_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4",15,-1.5244,0.032,0.11,"No",0.7116,0.88,1,"Yes"
"4592","GO_BP","516727_GO_0071804_CELLULAR_POTASSIUM_ION_TRANSPORT",129,-1.5244,0.0036,0.096,"No",-1.2259,0.11,0.88,"No"
"4593","GO_BP","500870_GO_0031620_REGULATION_OF_FEVER_GENERATION",8,-1.5242,0.046,0.096,"No",-1.0559,0.39,0.97,"No"
"4594","C2_Chemical_and_genetic_perturbations","C2_CGP_2221_ENGELMANN_CANCER_PROGENITORS_UP",46,-1.524,0.014,0.055,"No",-0.8441,0.73,1,"No"
"4595","C2_Chemical_and_genetic_perturbations","C2_CGP_3151_ZHU_SKIL_TARGETS_DN",9,-1.524,0.031,0.055,"No",0.8325,0.67,0.97,"Yes"
"4596","C4_Cancer_modules","C4_CM_257_MODULE_292",132,-1.5238,0.0061,0.048,"No",1.5517,0.007,0.094,"Yes"
"4597","REACTOME","1183607_REACT_355027_REGULATED_NECROSIS",16,-1.5237,0.028,0.11,"No",0.4936,1,1,"Yes"
"4598","GO_BP","492891_GO_0045909_POSITIVE_REGULATION_OF_VASODILATION",26,-1.5236,0.041,0.096,"No",1.3294,0.12,0.63,"Yes"
"4599","GO_BP","518215_GO_0090075_RELAXATION_OF_MUSCLE",20,-1.5236,0.047,0.096,"No",-1.0825,0.33,0.95,"No"
"4600","C2_BioCarta_Pathways","C2_CP_BIOCARTA_102_BIOCARTA_GSK3_PATHWAY",26,-1.5235,0.031,0.12,"No",0.9052,0.6,0.91,"Yes"
"4601","KEGG_pathway","HSA05131_SHIGELLOSIS",64,-1.5235,0.017,0.028,"No",0.9738,0.5,0.96,"Yes"
"4602","GO_MF","490488_GO_0005254_CHLORIDE_CHANNEL_ACTIVITY",68,-1.5235,0.012,0.13,"No",-0.9582,0.53,0.95,"No"
"4603","C2_Chemical_and_genetic_perturbations","C2_CGP_2040_BAFNA_MUC4_TARGETS_DN",5,-1.5234,0.024,0.055,"No",-1.2014,0.28,0.8,"No"
"4604","C3_MicroRNA_targets","C3_MIR_83_GTGACTT_MIR_224",156,-1.5234,0.0024,0.24,"No",-0.9983,0.46,1,"No"
"4605","KEGG_compound","C00114_CHOLINE_BILINEURINE",12,-1.5234,0.048,0.15,"No",-0.6319,0.92,1,"No"
"4606","C3_MicroRNA_targets","C3_MIR_219_AGTGCGT_MIR_521",6,-1.5234,0.03,0.21,"No",-1.3742,0.12,0.66,"No"
"4607","GO_MF","499364_GO_0022804_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",328,-1.5233,0,0.13,"No",-1.1885,0.076,0.79,"No"
"4608","C2_Chemical_and_genetic_perturbations","C2_CGP_3363_LIM_MAMMARY_LUMINAL_PROGENITOR_UP",54,-1.5233,0.013,0.055,"No",-0.8792,0.69,1,"No"
"4609","GO_MF","490356_GO_0005088_RAS_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",127,-1.5233,0.0036,0.13,"No",-1.4675,0.0089,0.59,"No"
"4610","GO_BP","911354_GO_0097527_NECROPTOTIC_SIGNALING_PATHWAY",6,-1.5233,0.046,0.096,"No",0.7802,0.73,1,"Yes"
"4611","C6_Oncogenic_signatures","C6_ALL_159_KRAS_AMP_LUNG_UP_V1_UP",128,-1.5232,0.0035,0.01,"No",-1.096,0.26,0.57,"No"
"4612","GO_MF","504276_GO_0035091_PHOSPHATIDYLINOSITOL_BINDING",184,-1.523,0.0023,0.13,"No",-0.8464,0.87,1,"No"
"4613","KEGG_compound","C00054_ADENOSINE_3_5_BISPHOSPHATE_PAP_3_PHOSPHOADENYLATE_PHOSPHOADENOSINE_PHOSPHATE",18,-1.523,0.04,0.15,"No",1.3039,0.12,0.73,"Yes"
"4614","C2_Chemical_and_genetic_perturbations","C2_CGP_889_TSAI_RESPONSE_TO_IONIZING_RADIATION",145,-1.5229,0.0023,0.055,"No",0.8993,0.71,0.93,"Yes"
"4615","C7_Immunologic_signatures","C7_ALL_178_GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN",197,-1.5227,0.0023,0.0046,"No",1.1505,0.13,0.32,"Yes"
"4616","GO_MF","507608_GO_0045236_CXCR_CHEMOKINE_RECEPTOR_BINDING",16,-1.5226,0.039,0.13,"No",1.232,0.18,0.7,"Yes"
"4617","C2_Chemical_and_genetic_perturbations","C2_CGP_590_CHASSOT_SKIN_WOUND",10,-1.5225,0.044,0.055,"No",-1.5276,0.04,0.45,"No"
"4618","KEGG_compound","C00535_TESTOSTERONE_17BETA_HYDROXY_4_ANDROSTEN_3_ONE",31,-1.5225,0.023,0.15,"No",1.7619,0,0.049,"Yes"
"4619","C3_TF_targets","C3_TFT_341_V_LBP1_Q6",219,-1.5224,0,0.019,"No",-1.1123,0.19,0.51,"No"
"4620","C7_Immunologic_signatures","C7_ALL_807_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP",191,-1.5222,0.0011,0.0046,"No",-1.051,0.31,1,"No"
"4621","C2_Chemical_and_genetic_perturbations","C2_CGP_3230_IKEDA_MIR30_TARGETS_UP",116,-1.5221,0.0087,0.055,"No",0.7892,0.94,1,"Yes"
"4622","GO_BP","750856_GO_0035929_STEROID_HORMONE_SECRETION",5,-1.5221,0.026,0.097,"No",0.8087,0.68,1,"Yes"
"4623","C3_TF_targets","C3_TFT_175_V_EGR3_01",85,-1.5219,0.0099,0.019,"No",-1.0702,0.32,0.61,"No"
"4624","C7_Immunologic_signatures","C7_ALL_384_GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN",183,-1.5219,0.0011,0.0046,"No",-1.5031,0.0051,0.065,"No"
"4625","C2_Chemical_and_genetic_perturbations","C2_CGP_3289_DELACROIX_RAR_TARGETS_DN",24,-1.5218,0.045,0.056,"No",-0.921,0.59,1,"No"
"4626","GO_BP","511899_GO_0050965_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN",10,-1.5217,0.052,0.097,"No",-1.1022,0.32,0.94,"No"
"4627","C3_TF_targets","C3_TFT_77_V_CEBPA_01",240,-1.5217,0.0011,0.018,"No",-1.0126,0.43,0.73,"No"
"4628","GO_BP","503535_GO_0034332_ADHERENS_JUNCTION_ORGANIZATION",70,-1.5216,0.012,0.097,"No",-0.9031,0.65,1,"No"
"4629","C7_Immunologic_signatures","C7_ALL_1190_GSE27786_BCELL_VS_MONO_MAC_DN",196,-1.5216,0.0011,0.0046,"No",-1.025,0.4,1,"No"
"4630","GO_BP","498076_GO_0019221_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",372,-1.5215,0,0.098,"No",1.2183,0.041,0.76,"Yes"
"4631","C2_Chemical_and_genetic_perturbations","C2_CGP_44_FOURNIER_ACINAR_DEVELOPMENT_LATE_DN",21,-1.5215,0.04,0.056,"No",1.069,0.37,0.68,"Yes"
"4632","GO_BP","503923_GO_0034723_DNA_REPLICATION_DEPENDENT_NUCLEOSOME_ORGANIZATION",32,-1.5215,0.023,0.098,"No",-1.8271,0.0038,0.4,"No"
"4633","C2_Chemical_and_genetic_perturbations","C2_CGP_2824_GYORFFY_MITOXANTRONE_RESISTANCE",54,-1.5213,0.019,0.056,"No",0.7778,0.87,1,"Yes"
"4634","C3_TF_targets","C3_TFT_200_V_FREAC2_01",248,-1.5212,0,0.018,"No",-0.797,0.95,1,"No"
"4635","GO_CC","499504_GO_0030056_HEMIDESMOSOME",9,-1.5211,0.052,0.13,"No",-1.0208,0.43,0.84,"No"
"4636","GO_MF","496495_GO_0016538_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY",20,-1.5211,0.027,0.13,"No",-1.3843,0.086,0.65,"No"
"4637","GO_BP","755305_GO_2001199_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION",5,-1.5208,0.023,0.098,"No",-0.9059,0.57,1,"No"
"4638","KEGG_pathway","HSA00030_PENTOSE_PHOSPHATE_PATHWAY",29,-1.5208,0.04,0.029,"No",0.9062,0.61,1,"Yes"
"4639","GO_MF","490337_GO_0005057_RECEPTOR_SIGNALING_PROTEIN_ACTIVITY",149,-1.5208,0.0048,0.13,"No",-1.0485,0.33,0.86,"No"
"4640","C3_TF_targets","C3_TFT_613_TGANNYRGCA_V_TCF11MAFG_01",294,-1.5207,0,0.018,"No",-0.969,0.54,0.82,"No"
"4641","GO_BP","511814_GO_0050872_WHITE_FAT_CELL_DIFFERENTIATION",12,-1.5206,0.045,0.098,"No",0.9443,0.53,1,"Yes"
"4642","C2_Chemical_and_genetic_perturbations","C2_CGP_1333_KIM_GERMINAL_CENTER_T_HELPER_DN",24,-1.5205,0.024,0.056,"No",0.7039,0.9,1,"Yes"
"4643","GO_BP","511983_GO_0051058_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION",42,-1.5205,0.021,0.098,"No",-0.8851,0.66,1,"No"
"4644","KEGG_pathway","HSA05322_SYSTEMIC_LUPUS_ERYTHEMATOSUS",125,-1.5205,0.0036,0.029,"No",-1.4093,0.019,0.41,"No"
"4645","GO_MF","500248_GO_0030955_POTASSIUM_ION_BINDING",8,-1.5203,0.039,0.13,"No",-1.4687,0.056,0.6,"No"
"4646","C2_BioCarta_Pathways","C2_CP_BIOCARTA_159_BIOCARTA_PML_PATHWAY",17,-1.5202,0.055,0.12,"No",-0.5996,0.96,1,"No"
"4647","C7_Immunologic_signatures","C7_ALL_1390_GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN",197,-1.5201,0.0011,0.0048,"No",1.326,0.024,0.08,"Yes"
"4648","C7_Immunologic_signatures","C7_ALL_922_GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN",193,-1.5201,0.0023,0.0048,"No",-1.1656,0.12,0.94,"No"
"4649","GO_CC","490889_GO_0005884_ACTIN_FILAMENT",77,-1.5199,0.01,0.13,"No",-0.7878,0.87,1,"No"
"4650","C7_Immunologic_signatures","C7_ALL_498_GSE17721_CTRL_VS_CPG_1H_BMDM_DN",197,-1.5199,0.0011,0.0048,"No",-1.1358,0.18,1,"No"
"4651","C2_Chemical_and_genetic_perturbations","C2_CGP_62_GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP",39,-1.5197,0.026,0.056,"No",0.8422,0.74,0.97,"Yes"
"4652","GO_BP","491689_GO_0006821_CHLORIDE_TRANSPORT",89,-1.5197,0.009,0.099,"No",-1.0146,0.4,0.98,"No"
"4653","C2_Chemical_and_genetic_perturbations","C2_CGP_2151_AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G",171,-1.5196,0.0023,0.056,"No",0.9726,0.56,0.83,"Yes"
"4654","GO_MF","490002_GO_0004675_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",16,-1.5195,0.057,0.13,"No",-0.6385,0.93,1,"No"
"4655","GO_BP","496153_GO_0016054_ORGANIC_ACID_CATABOLIC_PROCESS",196,-1.5193,0,0.099,"No",0.9035,0.75,1,"Yes"
"4656","C2_Chemical_and_genetic_perturbations","C2_CGP_3368_DURAND_STROMA_NS_UP",161,-1.5193,0.0048,0.056,"No",-1.0257,0.37,0.98,"No"
"4657","GO_BP","513566_GO_0060008_SERTOLI_CELL_DIFFERENTIATION",21,-1.5192,0.037,0.099,"No",-1.9331,0.0019,0.27,"No"
"4658","C7_Immunologic_signatures","C7_ALL_576_GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN",197,-1.5191,0,0.0048,"No",-0.9697,0.52,1,"No"
"4659","C2_Chemical_and_genetic_perturbations","C2_CGP_3007_SASSON_RESPONSE_TO_FORSKOLIN_UP",90,-1.5191,0.013,0.056,"No",0.9775,0.49,0.82,"Yes"
"4660","C2_Chemical_and_genetic_perturbations","C2_CGP_2215_RIGGI_EWING_SARCOMA_PROGENITOR_DN",185,-1.5191,0.0035,0.056,"No",1.1996,0.096,0.49,"Yes"
"4661","KEGG_compound","C03681_5ALPHA_PREGNANE_3_20_DIONE_5ALPHA_DIHYDROPROGESTERONE",7,-1.519,0.027,0.15,"No",-0.7048,0.82,1,"No"
"4662","C4_Cancer_modules","C4_CM_138_MODULE_146",100,-1.519,0.0073,0.05,"No",1.1485,0.2,0.46,"Yes"
"4663","C2_Chemical_and_genetic_perturbations","C2_CGP_271_ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP",82,-1.519,0.0078,0.056,"No",1.0157,0.41,0.78,"Yes"
"4664","C7_Immunologic_signatures","C7_ALL_1178_GSE27786_BCELL_VS_CD4_TCELL_DN",194,-1.5189,0.0035,0.0048,"No",0.8697,0.83,1,"Yes"
"4665","C3_TF_targets","C3_TFT_123_V_AP4_Q6",219,-1.5187,0,0.019,"No",-1.4386,0.0074,0.15,"No"
"4666","GO_MF","498750_GO_0019992_DIACYLGLYCEROL_BINDING",10,-1.5187,0.042,0.13,"No",0.8632,0.62,1,"Yes"
"4667","C7_Immunologic_signatures","C7_ALL_659_GSE17721_LPS_VS_CPG_4H_BMDM_UP",196,-1.5186,0.0022,0.0049,"No",0.8946,0.77,1,"Yes"
"4668","GO_BP","516147_GO_0071221_CELLULAR_RESPONSE_TO_BACTERIAL_LIPOPEPTIDE",5,-1.5185,0.027,0.099,"No",0.8111,0.69,1,"Yes"
"4669","GO_BP","751342_GO_0038084_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY",14,-1.5185,0.049,0.099,"No",-0.8937,0.58,1,"No"
"4670","C2_Chemical_and_genetic_perturbations","C2_CGP_1573_ABBUD_LIF_SIGNALING_2_DN",7,-1.5184,0.049,0.056,"No",1.2766,0.19,0.42,"Yes"
"4671","GO_MF","494614_GO_0051879_HSP90_PROTEIN_BINDING",19,-1.5184,0.052,0.13,"No",0.8117,0.73,1,"Yes"
"4672","GO_BP","494659_GO_0010595_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION",59,-1.5183,0.021,0.099,"No",-0.915,0.62,1,"No"
"4673","GO_MF","490490_GO_0005261_CATION_CHANNEL_ACTIVITY",287,-1.5183,0,0.13,"No",-1.5817,0,0.45,"No"
"4674","C2_Chemical_and_genetic_perturbations","C2_CGP_821_WEINMANN_ADAPTATION_TO_HYPOXIA_UP",28,-1.5182,0.034,0.057,"No",-0.8215,0.77,1,"No"
"4675","GO_BP","498819_GO_0021535_CELL_MIGRATION_IN_HINDBRAIN",13,-1.5182,0.05,0.099,"No",0.5374,0.98,1,"Yes"
"4676","GO_MF","754436_GO_1901476_CARBOHYDRATE_TRANSPORTER_ACTIVITY",33,-1.5182,0.03,0.13,"No",-1.0668,0.34,0.86,"No"
"4677","C7_Immunologic_signatures","C7_ALL_401_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP",193,-1.5182,0.0011,0.0049,"No",-1.0067,0.42,1,"No"
"4678","GO_BP","512774_GO_0051924_REGULATION_OF_CALCIUM_ION_TRANSPORT",183,-1.5181,0.0011,0.1,"No",-1.1286,0.19,0.93,"No"
"4679","C2_Chemical_and_genetic_perturbations","C2_CGP_3255_PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2",76,-1.518,0.011,0.057,"No",0.691,0.99,1,"Yes"
"4680","C7_Immunologic_signatures","C7_ALL_1633_GSE3982_DC_VS_BASOPHIL_UP",196,-1.518,0.0024,0.0049,"No",-0.7662,0.97,1,"No"
"4681","GO_BP","492281_GO_0007528_NEUROMUSCULAR_JUNCTION_DEVELOPMENT",42,-1.5178,0.028,0.1,"No",-1.0238,0.4,0.97,"No"
"4682","C2_Chemical_and_genetic_perturbations","C2_CGP_2646_FERRANDO_HOX11_NEIGHBORS",23,-1.5178,0.036,0.057,"No",0.7994,0.77,0.99,"Yes"
"4683","GO_BP","515563_GO_0070633_TRANSEPITHELIAL_TRANSPORT",13,-1.5177,0.035,0.1,"No",-0.7744,0.78,1,"No"
"4684","GO_BP","518417_GO_0090277_POSITIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION",64,-1.5176,0.017,0.1,"No",0.7461,0.92,1,"Yes"
"4685","GO_BP","495833_GO_0015698_INORGANIC_ANION_TRANSPORT",171,-1.5176,0.0023,0.1,"No",-1.0244,0.38,0.97,"No"
"4686","GO_BP","500531_GO_0031272_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY",13,-1.5176,0.051,0.1,"No",-1.0867,0.38,0.95,"No"
"4687","C4_Cancer_modules","C4_CM_163_MODULE_173",16,-1.5175,0.042,0.05,"No",0.7889,0.74,0.98,"Yes"
"4688","C2_Chemical_and_genetic_perturbations","C2_CGP_869_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP",29,-1.5174,0.033,0.057,"No",0.9902,0.5,0.81,"Yes"
"4689","GO_BP","500829_GO_0031579_MEMBRANE_RAFT_ORGANIZATION",15,-1.5173,0.047,0.1,"No",0.9838,0.49,1,"Yes"
"4690","GO_MF","489789_GO_0004435_PHOSPHATIDYLINOSITOL_PHOSPHOLIPASE_C_ACTIVITY",28,-1.5172,0.029,0.13,"No",-1.0875,0.34,0.85,"No"
"4691","KEGG_pathway","HSA04068_FOXO_SIGNALING_PATHWAY",132,-1.5172,0.0086,0.029,"No",-0.8145,0.87,1,"No"
"4692","C1_Positional","C1_ALL_103_CHR6Q23",51,-1.5171,0.015,0.28,"No",1.0873,0.32,0.63,"Yes"
"4693","GO_BP","491800_GO_0006957_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY",13,-1.5171,0.027,0.1,"No",-1.0371,0.4,0.98,"No"
"4694","REACTOME","106396_REACT_9020_TOLL_LIKE_RECEPTOR_7_8_TLR7_8_CASCADE",89,-1.517,0.0076,0.12,"No",-0.5606,1,1,"No"
"4695","REACTOME","645332_REACT_121175_PI_METABOLISM",51,-1.517,0.018,0.12,"No",-0.7999,0.84,1,"No"
"4696","GO_BP","514462_GO_0060907_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION",8,-1.517,0.029,0.1,"No",0.993,0.45,0.99,"Yes"
"4697","C7_Immunologic_signatures","C7_ALL_1880_GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN",199,-1.5169,0.0011,0.005,"No",1.5542,0,0.0058,"Yes"
"4698","GO_BP","513612_GO_0060054_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING",5,-1.5168,0.028,0.1,"No",-1.6069,0.014,0.71,"No"
"4699","C2_Chemical_and_genetic_perturbations","C2_CGP_3329_BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE",78,-1.5167,0.016,0.057,"No",1.3583,0.036,0.33,"Yes"
"4700","C2_BioCarta_Pathways","C2_CP_BIOCARTA_55_BIOCARTA_P35ALZHEIMERS_PATHWAY",11,-1.5167,0.048,0.12,"No",-1.0868,0.35,1,"No"
"4701","C3_TF_targets","C3_TFT_514_SMTTTTGT_UNKNOWN",394,-1.5166,0,0.019,"No",-1.1155,0.16,0.5,"No"
"4702","C4_Cancer_modules","C4_CM_259_MODULE_294",18,-1.5165,0.036,0.05,"No",-0.4326,1,1,"No"
"4703","C7_Immunologic_signatures","C7_ALL_1361_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP",185,-1.5164,0.0058,0.005,"No",-1.1292,0.19,1,"No"
"4704","GO_MF","490311_GO_0005024_TRANSFORMING_GROWTH_FACTOR_BETA_ACTIVATED_RECEPTOR_ACTIVITY",16,-1.5164,0.041,0.13,"No",-0.6461,0.92,1,"No"
"4705","C6_Oncogenic_signatures","C6_ALL_20_CYCLIN_D1_UP_V1_UP",184,-1.5164,0.0057,0.011,"No",-1.0727,0.28,0.6,"No"
"4706","C3_TF_targets","C3_TFT_268_V_STAT5A_01",246,-1.5164,0,0.019,"No",-0.8869,0.78,0.98,"No"
"4707","GO_BP","492900_GO_0008654_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS",213,-1.5163,0.0011,0.1,"No",-0.6968,1,1,"No"
"4708","C3_TF_targets","C3_TFT_105_V_HSF1_01",260,-1.5163,0,0.019,"No",-1.3943,0.0066,0.17,"No"
"4709","GO_BP","514859_GO_0061314_NOTCH_SIGNALING_INVOLVED_IN_HEART_DEVELOPMENT",9,-1.5163,0.046,0.1,"No",-1.2421,0.2,0.91,"No"
"4710","KEGG_compound","C06002__S_METHYLMALONATE_SEMIALDEHYDE",11,-1.5161,0.047,0.15,"No",0.6509,0.92,1,"Yes"
"4711","GO_BP","755310_GO_2001204_REGULATION_OF_OSTEOCLAST_DEVELOPMENT",7,-1.5161,0.033,0.1,"No",-0.7123,0.84,1,"No"
"4712","C2_Chemical_and_genetic_perturbations","C2_CGP_266_DITTMER_PTHLH_TARGETS_DN",72,-1.5161,0.012,0.057,"No",1.2214,0.13,0.47,"Yes"
"4713","C2_Chemical_and_genetic_perturbations","C2_CGP_955_GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS",12,-1.516,0.051,0.057,"No",1.1649,0.26,0.54,"Yes"
"4714","C7_Immunologic_signatures","C7_ALL_1408_GSE360_CTRL_VS_L_DONOVANI_DC_DN",195,-1.516,0,0.0051,"No",0.8411,0.88,1,"Yes"
"4715","C2_Chemical_and_genetic_perturbations","C2_CGP_1816_KAAB_HEART_ATRIUM_VS_VENTRICLE_DN",257,-1.516,0.0011,0.057,"No",1.4155,0.005,0.28,"Yes"
"4716","GO_MF","503440_GO_0034235_GPI_ANCHOR_BINDING",8,-1.5159,0.031,0.13,"No",-0.6109,0.94,1,"No"
"4717","C2_BioCarta_Pathways","C2_CP_BIOCARTA_135_BIOCARTA_CCR5_PATHWAY",17,-1.5158,0.023,0.12,"No",0.7117,0.85,1,"Yes"
"4718","GO_BP","505287_GO_0042113_B_CELL_ACTIVATION",132,-1.5157,0.0037,0.1,"No",-0.7689,0.95,1,"No"
"4719","GO_BP","503349_GO_0034143_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",14,-1.5156,0.046,0.1,"No",-0.9835,0.45,1,"No"
"4720","GO_BP","506555_GO_0043524_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS",129,-1.5156,0.007,0.1,"No",-1.0983,0.26,0.95,"No"
"4721","GO_MF","492768_GO_0008484_SULFURIC_ESTER_HYDROLASE_ACTIVITY",17,-1.5155,0.041,0.13,"No",-1.0881,0.34,0.85,"No"
"4722","GO_CC","487081_GO_0000788_NUCLEAR_NUCLEOSOME",37,-1.5155,0.034,0.13,"No",-1.8062,0,0.22,"No"
"4723","GO_MF","490562_GO_0015291_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",191,-1.5155,0.0023,0.13,"No",-1.4828,0.0051,0.59,"No"
"4724","REACTOME","905992_REACT_169325_ONCOGENE_INDUCED_SENESCENCE",30,-1.5154,0.032,0.12,"No",0.6841,0.94,1,"Yes"
"4725","GO_BP","491631_GO_0006750_GLUTATHIONE_BIOSYNTHETIC_PROCESS",16,-1.5153,0.041,0.1,"No",0.5121,0.99,1,"Yes"
"4726","GO_BP","489025_GO_0003231_CARDIAC_VENTRICLE_DEVELOPMENT",93,-1.5152,0.0074,0.1,"No",0.9031,0.7,1,"Yes"
"4727","GO_BP","750938_GO_0036015_RESPONSE_TO_INTERLEUKIN_3",5,-1.5151,0.022,0.1,"No",0.6348,0.89,1,"Yes"
"4728","C7_Immunologic_signatures","C7_ALL_1790_GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN",198,-1.5151,0.0022,0.0051,"No",-0.5914,1,1,"No"
"4729","GO_BP","493923_GO_0009820_ALKALOID_METABOLIC_PROCESS",11,-1.515,0.039,0.1,"No",-1.1935,0.24,0.9,"No"
"4730","C2_Chemical_and_genetic_perturbations","C2_CGP_779_KORKOLA_YOLK_SAC_TUMOR",61,-1.515,0.018,0.058,"No",-0.9659,0.51,1,"No"
"4731","C0_Hallmark","H_ALL_39_HALLMARK_UV_RESPONSE_DN",144,-1.515,0.0036,0.0088,"No",1.245,0.075,0.17,"Yes"
"4732","GO_BP","511798_GO_0050854_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",35,-1.5149,0.032,0.1,"No",0.7853,0.83,1,"Yes"
"4733","GO_MF","490525_GO_0005319_LIPID_TRANSPORTER_ACTIVITY",91,-1.5149,0.014,0.13,"No",-1.2602,0.11,0.84,"No"
"4734","GO_BP","499492_GO_0030033_MICROVILLUS_ASSEMBLY",17,-1.5149,0.043,0.1,"No",0.7034,0.88,1,"Yes"
"4735","GO_BP","754650_GO_1901699_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND",493,-1.5148,0,0.1,"No",-0.8063,1,1,"No"
"4736","GO_BP","491606_GO_0006720_ISOPRENOID_METABOLIC_PROCESS",117,-1.5148,0.0061,0.1,"No",-1.1151,0.24,0.94,"No"
"4737","C2_Chemical_and_genetic_perturbations","C2_CGP_2811_FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP",62,-1.5146,0.017,0.058,"No",0.7492,0.92,1,"Yes"
"4738","GO_BP","512323_GO_0051445_REGULATION_OF_MEIOTIC_CELL_CYCLE",36,-1.5145,0.027,0.1,"No",-1.2288,0.17,0.89,"No"
"4739","GO_BP","492270_GO_0007517_MUSCLE_ORGAN_DEVELOPMENT",262,-1.5145,0.0011,0.1,"No",-1.0978,0.2,0.95,"No"
"4740","C4_Cancer_gene_neighborhoods","C4_CGN_422_GNF2_TTK",39,-1.5145,0.022,0.052,"No",0.8131,0.78,0.98,"Yes"
"4741","C2_Chemical_and_genetic_perturbations","C2_CGP_3316_KINNEY_DNMT1_METHYLATION_TARGETS",13,-1.5144,0.05,0.058,"No",-0.8354,0.69,1,"No"
"4742","GO_BP","512165_GO_0051279_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",62,-1.5144,0.02,0.1,"No",1.1191,0.26,0.88,"Yes"
"4743","GO_BP","508658_GO_0046395_CARBOXYLIC_ACID_CATABOLIC_PROCESS",196,-1.5143,0.0011,0.1,"No",0.8878,0.76,1,"Yes"
"4744","GO_BP","499134_GO_0021854_HYPOTHALAMUS_DEVELOPMENT",24,-1.5141,0.044,0.1,"No",0.774,0.82,1,"Yes"
"4745","GO_BP","502067_GO_0032845_NEGATIVE_REGULATION_OF_HOMEOSTATIC_PROCESS",90,-1.514,0.01,0.1,"No",0.9172,0.66,1,"Yes"
"4746","GO_MF","504358_GO_0035173_HISTONE_KINASE_ACTIVITY",20,-1.5139,0.037,0.13,"No",-0.8032,0.77,1,"No"
"4747","C2_Chemical_and_genetic_perturbations","C2_CGP_447_GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP",186,-1.5139,0.0011,0.058,"No",0.7241,1,1,"Yes"
"4748","C7_Immunologic_signatures","C7_ALL_818_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN",196,-1.5138,0,0.0053,"No",0.7809,0.98,1,"Yes"
"4749","GO_BP","1184555_GO_1904031_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",20,-1.5135,0.04,0.1,"No",-0.9587,0.52,1,"No"
"4750","C2_Chemical_and_genetic_perturbations","C2_CGP_574_WONG_ENDMETRIUM_CANCER_UP",25,-1.5135,0.026,0.058,"No",-1.0851,0.31,0.94,"No"
"4751","C2_Chemical_and_genetic_perturbations","C2_CGP_1169_SHIN_B_CELL_LYMPHOMA_CLUSTER_7",27,-1.5134,0.032,0.058,"No",-1.7019,0.0074,0.34,"No"
"4752","C4_Cancer_modules","C4_CM_158_MODULE_168",22,-1.5133,0.037,0.051,"No",-0.8324,0.72,0.97,"No"
"4753","GO_BP","491700_GO_0006835_DICARBOXYLIC_ACID_TRANSPORT",63,-1.5133,0.016,0.1,"No",-1.1881,0.19,0.9,"No"
"4754","GO_MF","500653_GO_0031402_SODIUM_ION_BINDING",6,-1.5132,0.037,0.13,"No",-1.5092,0.052,0.55,"No"
"4755","C7_Immunologic_signatures","C7_ALL_1075_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP",195,-1.513,0,0.0053,"No",0.9488,0.61,0.9,"Yes"
"4756","GO_BP","513893_GO_0060337_TYPE_I_INTERFERON_SIGNALING_PATHWAY",65,-1.513,0.0093,0.1,"No",1.1939,0.16,0.79,"Yes"
"4757","C7_Immunologic_signatures","C7_ALL_800_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN",200,-1.5129,0,0.0053,"No",0.695,1,1,"Yes"
"4758","GO_BP","506359_GO_0043299_LEUKOCYTE_DEGRANULATION",31,-1.5129,0.022,0.1,"No",0.9779,0.49,1,"Yes"
"4759","GO_BP","518898_GO_2000251_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION",12,-1.5128,0.039,0.1,"No",-1.0692,0.38,0.96,"No"
"4760","C7_Immunologic_signatures","C7_ALL_1826_GSE7852_TREG_VS_TCONV_DN",200,-1.5128,0,0.0053,"No",0.7298,1,1,"Yes"
"4761","C2_Chemical_and_genetic_perturbations","C2_CGP_2659_CROONQUIST_IL6_DEPRIVATION_DN",98,-1.5128,0.009,0.058,"No",-0.762,0.93,1,"No"
"4762","C7_Immunologic_signatures","C7_ALL_1288_GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN",197,-1.5127,0,0.0053,"No",0.9323,0.7,0.95,"Yes"
"4763","GO_BP","502007_GO_0032781_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY",29,-1.5127,0.036,0.1,"No",-1.1366,0.25,0.93,"No"
"4764","GO_BP","512184_GO_0051299_CENTROSOME_SEPARATION",7,-1.5127,0.049,0.1,"No",-1.0528,0.4,0.97,"No"
"4765","GO_MF","495592_GO_0015368_CALCIUM_CATION_ANTIPORTER_ACTIVITY",10,-1.5126,0.027,0.13,"No",-0.6667,0.86,1,"No"
"4766","C2_Chemical_and_genetic_perturbations","C2_CGP_140_DOANE_RESPONSE_TO_ANDROGEN_DN",237,-1.5126,0.0022,0.058,"No",-0.7735,0.98,1,"No"
"4767","GO_BP","500602_GO_0031343_POSITIVE_REGULATION_OF_CELL_KILLING",50,-1.5125,0.026,0.1,"No",-0.8114,0.77,1,"No"
"4768","GO_BP","488612_GO_0002739_REGULATION_OF_CYTOKINE_SECRETION_INVOLVED_IN_IMMUNE_RESPONSE",11,-1.5124,0.036,0.1,"No",-0.731,0.81,1,"No"
"4769","GO_BP","491534_GO_0006644_PHOSPHOLIPID_METABOLIC_PROCESS",288,-1.5123,0.0011,0.1,"No",-0.8231,0.94,1,"No"
"4770","WikiPathways","198827_WP710_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT_",91,-1.5122,0.012,0.066,"No",-0.9116,0.64,1,"No"
"4771","C4_Cancer_modules","C4_CM_55_MODULE_59",26,-1.5121,0.037,0.051,"No",-1.3514,0.095,0.5,"No"
"4772","C2_Chemical_and_genetic_perturbations","C2_CGP_637_ROVERSI_GLIOMA_COPY_NUMBER_DN",51,-1.5121,0.018,0.059,"No",0.8753,0.69,0.95,"Yes"
"4773","GO_BP","513693_GO_0060135_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY",52,-1.512,0.02,0.1,"No",-0.971,0.52,1,"No"
"4774","C2_Chemical_and_genetic_perturbations","C2_CGP_1801_PAL_PRMT5_TARGETS_DN",28,-1.512,0.017,0.059,"No",-1.2053,0.19,0.8,"No"
"4775","C2_Chemical_and_genetic_perturbations","C2_CGP_1306_KANNAN_TP53_TARGETS_UP",58,-1.512,0.015,0.058,"No",0.7714,0.91,1,"Yes"
"4776","C7_Immunologic_signatures","C7_ALL_34_GSE10239_NAIVE_VS_DAY4_5_EFF_CD8_TCELL_DN",199,-1.5118,0.0023,0.0054,"No",1.2697,0.038,0.13,"Yes"
"4777","GO_BP","500539_GO_0031280_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY",26,-1.5118,0.03,0.1,"No",0.7379,0.86,1,"Yes"
"4778","GO_MF","495360_GO_0015077_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",342,-1.5116,0.0011,0.13,"No",-1.0512,0.3,0.86,"No"
"4779","C2_Chemical_and_genetic_perturbations","C2_CGP_962_ALCALA_APOPTOSIS",87,-1.5115,0.01,0.059,"No",1.4979,0.017,0.21,"Yes"
"4780","WikiPathways","672455_WP2035_FSH_SIGNALING_PATHWAY",27,-1.5115,0.03,0.066,"No",1.0538,0.37,1,"Yes"
"4781","REACTOME","645301_REACT_121288_KERATAN_SULFATE_KERATIN_METABOLISM",33,-1.5115,0.029,0.12,"No",0.5917,0.98,1,"Yes"
"4782","C3_TF_targets","C3_TFT_546_YGTCCTTGR_UNKNOWN",94,-1.5115,0.012,0.019,"No",-1.3086,0.064,0.23,"No"
"4783","GO_BP","517132_GO_0072216_POSITIVE_REGULATION_OF_METANEPHROS_DEVELOPMENT",14,-1.5115,0.039,0.1,"No",1.057,0.38,0.94,"Yes"
"4784","C2_Chemical_and_genetic_perturbations","C2_CGP_1270_ASTON_MAJOR_DEPRESSIVE_DISORDER_DN",157,-1.5114,0.0024,0.059,"No",-1.0708,0.29,0.95,"No"
"4785","C3_MicroRNA_targets","C3_MIR_194_GTACAGG_MIR_486",58,-1.5112,0.029,0.21,"No",-0.8873,0.67,1,"No"
"4786","C3_TF_targets","C3_TFT_262_V_ZIC1_01",255,-1.5111,0.0011,0.019,"No",-1.3669,0.0088,0.19,"No"
"4787","C2_Chemical_and_genetic_perturbations","C2_CGP_997_MANTOVANI_VIRAL_GPCR_SIGNALING_DN",49,-1.5111,0.02,0.059,"No",-0.7963,0.82,1,"No"
"4788","C7_Immunologic_signatures","C7_ALL_1236_GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN",198,-1.5111,0.0034,0.0055,"No",0.8703,0.84,1,"Yes"
"4789","C2_Chemical_and_genetic_perturbations","C2_CGP_1737_IVANOVA_HEMATOPOIESIS_STEM_CELL",245,-1.5111,0.0011,0.059,"No",-1.2893,0.026,0.71,"No"
"4790","KEGG_pathway","HSA05416_VIRAL_MYOCARDITIS",56,-1.511,0.015,0.031,"No",0.6297,0.99,1,"Yes"
"4791","GO_BP","518841_GO_2000194_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT",10,-1.5106,0.05,0.1,"No",-0.9103,0.56,1,"No"
"4792","GO_BP","491692_GO_0006825_COPPER_ION_TRANSPORT",20,-1.5106,0.036,0.1,"No",0.5632,0.97,1,"Yes"
"4793","GO_BP","491743_GO_0006882_CELLULAR_ZINC_ION_HOMEOSTASIS",14,-1.5106,0.059,0.1,"No",-0.8955,0.63,1,"No"
"4794","GO_MF","512305_GO_0051427_HORMONE_RECEPTOR_BINDING",150,-1.5105,0.0036,0.13,"No",-0.669,1,1,"No"
"4795","C2_BioCarta_Pathways","C2_CP_BIOCARTA_217_BIOCARTA_ACTINY_PATHWAY",20,-1.5104,0.052,0.12,"No",1.24,0.19,0.66,"Yes"
"4796","GO_BP","508085_GO_0045746_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY",22,-1.5104,0.043,0.1,"No",-1.5615,0.015,0.71,"No"
"4797","C3_MicroRNA_targets","C3_MIR_106_GTAAGAT_MIR_200A",54,-1.5102,0.025,0.2,"No",1.1069,0.27,1,"Yes"
"4798","C2_Chemical_and_genetic_perturbations","C2_CGP_1839_RODWELL_AGING_KIDNEY_NO_BLOOD_UP",217,-1.5102,0.0011,0.059,"No",1.153,0.13,0.55,"Yes"
"4799","KEGG_compound","C12126_DIHYDROCERAMIDE_N_ACYLSPHINGANINE",11,-1.5101,0.047,0.16,"No",-1.1438,0.28,0.85,"No"
"4800","C3_TF_targets","C3_TFT_116_V_OCT1_05",239,-1.5101,0.0022,0.019,"No",-1.3335,0.016,0.2,"No"
"4801","GO_BP","516728_GO_0071805_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",129,-1.51,0.0024,0.1,"No",-1.2321,0.089,0.9,"No"
"4802","C2_Chemical_and_genetic_perturbations","C2_CGP_1760_BROWNE_HCMV_INFECTION_48HR_UP",177,-1.5095,0,0.059,"No",-0.9214,0.66,1,"No"
"4803","C2_Chemical_and_genetic_perturbations","C2_CGP_2054_LEIN_MEDULLA_MARKERS",80,-1.5095,0.0078,0.059,"No",-0.7206,0.96,1,"No"
"4804","GO_BP","508078_GO_0045737_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",20,-1.5093,0.039,0.1,"No",-0.9562,0.51,1,"No"
"4805","GO_BP","491073_GO_0006090_PYRUVATE_METABOLIC_PROCESS",69,-1.5091,0.012,0.1,"No",0.8164,0.84,1,"Yes"
"4806","GO_BP","516271_GO_0071347_CELLULAR_RESPONSE_TO_INTERLEUKIN_1",47,-1.5089,0.026,0.1,"No",1.0108,0.43,0.98,"Yes"
"4807","GO_BP","505342_GO_0042181_KETONE_BIOSYNTHETIC_PROCESS",28,-1.5089,0.047,0.1,"No",-0.6538,0.95,1,"No"
"4808","GO_BP","502112_GO_0032890_REGULATION_OF_ORGANIC_ACID_TRANSPORT",52,-1.5088,0.018,0.1,"No",-0.7202,0.93,1,"No"
"4809","WikiPathways","198777_WP3_KEAP1_NRF2_PATHWAY",13,-1.5088,0.063,0.066,"No",-0.5832,0.96,1,"No"
"4810","C7_Immunologic_signatures","C7_ALL_1622_GSE3982_MAST_CELL_VS_NKCELL_DN",195,-1.5086,0.0068,0.0057,"No",-0.8914,0.77,1,"No"
"4811","GO_BP","491776_GO_0006925_INFLAMMATORY_CELL_APOPTOTIC_PROCESS",7,-1.5084,0.053,0.1,"No",0.7144,0.82,1,"Yes"
"4812","KEGG_reaction","R03435_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_INOSITOLTRISPHOSPHOHYDROLASE_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_H2O_D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_1_2_DIACYL_SN_GLYCEROL",13,-1.5084,0.044,0.16,"No",-1.6693,0.021,0.048,"No"
"4813","C7_Immunologic_signatures","C7_ALL_1061_GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP",199,-1.5083,0,0.0057,"No",1.1137,0.18,0.41,"Yes"
"4814","C7_Immunologic_signatures","C7_ALL_441_GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP",198,-1.5083,0,0.0057,"No",0.7295,1,1,"Yes"
"4815","GO_BP","508013_GO_0045665_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION",146,-1.5081,0.0024,0.1,"No",-0.9907,0.47,1,"No"
"4816","GO_CC","513761_GO_0060205_CYTOPLASMIC_MEMBRANE_BOUNDED_VESICLE_LUMEN",75,-1.508,0.012,0.14,"No",1.741,0.0023,0.044,"Yes"
"4817","C2_Chemical_and_genetic_perturbations","C2_CGP_2109_KYNG_DNA_DAMAGE_BY_UV",61,-1.5079,0.012,0.06,"No",-0.6698,0.98,1,"No"
"4818","GO_BP","519103_GO_2000463_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",19,-1.5079,0.038,0.1,"No",-0.9826,0.46,1,"No"
"4819","C7_Immunologic_signatures","C7_ALL_810_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN",191,-1.5078,0,0.0057,"No",1.1545,0.13,0.31,"Yes"
"4820","C2_Chemical_and_genetic_perturbations","C2_CGP_1608_REN_ALVEOLAR_RHABDOMYOSARCOMA_UP",96,-1.5078,0.005,0.06,"No",-0.9532,0.57,1,"No"
"4821","GO_BP","501726_GO_0032494_RESPONSE_TO_PEPTIDOGLYCAN",11,-1.5075,0.042,0.1,"No",-0.6964,0.84,1,"No"
"4822","C3_TF_targets","C3_TFT_129_V_MYOD_Q6",239,-1.5075,0,0.02,"No",-1.6085,0,0.11,"No"
"4823","GO_MF","492859_GO_0019887_PROTEIN_KINASE_REGULATOR_ACTIVITY",128,-1.5073,0.0071,0.14,"No",0.7547,0.97,1,"Yes"
"4824","C7_Immunologic_signatures","C7_ALL_1195_GSE27786_CD4_TCELL_VS_NKTCELL_UP",198,-1.5073,0.0023,0.0058,"No",-0.9895,0.5,1,"No"
"4825","GO_BP","516925_GO_0072006_NEPHRON_DEVELOPMENT",115,-1.5073,0.0085,0.1,"No",-1.1102,0.25,0.94,"No"
"4826","C2_Chemical_and_genetic_perturbations","C2_CGP_1886_JACKSON_DNMT1_TARGETS_DN",23,-1.5073,0.031,0.06,"No",-1.6329,0.016,0.36,"No"
"4827","GO_BP","514576_GO_0061028_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER",29,-1.5072,0.025,0.1,"No",0.9846,0.49,1,"Yes"
"4828","C7_Immunologic_signatures","C7_ALL_899_GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP",198,-1.5072,0,0.0058,"No",0.9108,0.7,1,"Yes"
"4829","GO_BP","754675_GO_1901724_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",5,-1.5072,0.047,0.1,"No",-0.9366,0.53,1,"No"
"4830","GO_BP","499164_GO_0021885_FOREBRAIN_CELL_MIGRATION",57,-1.5071,0.015,0.1,"No",-1.3794,0.055,0.99,"No"
"4831","GO_BP","512168_GO_0051282_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION",34,-1.5071,0.034,0.1,"No",-0.6034,0.97,1,"No"
"4832","GO_BP","508239_GO_0045932_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION",20,-1.507,0.043,0.1,"No",0.8839,0.63,1,"Yes"
"4833","C2_Chemical_and_genetic_perturbations","C2_CGP_2775_MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3",115,-1.507,0.0061,0.06,"No",-1.0666,0.31,0.96,"No"
"4834","C7_Immunologic_signatures","C7_ALL_806_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN",173,-1.5069,0.0047,0.0058,"No",-1.0557,0.32,1,"No"
"4835","GO_BP","505807_GO_0042698_OVULATION_CYCLE",81,-1.5068,0.0093,0.1,"No",0.7928,0.89,1,"Yes"
"4836","C2_Chemical_and_genetic_perturbations","C2_CGP_3175_WANG_TNF_TARGETS",22,-1.5068,0.025,0.06,"No",-1.4225,0.073,0.55,"No"
"4837","C2_Chemical_and_genetic_perturbations","C2_CGP_157_HORIUCHI_WTAP_TARGETS_UP",300,-1.5065,0.0011,0.06,"No",1.1376,0.12,0.57,"Yes"
"4838","GO_BP","493855_GO_0009743_RESPONSE_TO_CARBOHYDRATE",154,-1.5064,0.0023,0.11,"No",0.8178,0.91,1,"Yes"
"4839","C3_TF_targets","C3_TFT_286_V_FOXO4_02",249,-1.5064,0.0011,0.02,"No",-1.0552,0.3,0.64,"No"
"4840","C7_Immunologic_signatures","C7_ALL_513_GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_UP",198,-1.5064,0.0023,0.0058,"No",-0.8728,0.82,1,"No"
"4841","C2_Chemical_and_genetic_perturbations","C2_CGP_2222_ENGELMANN_CANCER_PROGENITORS_DN",63,-1.5063,0.017,0.06,"No",-1.3229,0.084,0.7,"No"
"4842","C2_BioCarta_Pathways","C2_CP_BIOCARTA_81_BIOCARTA_GH_PATHWAY",27,-1.5063,0.038,0.12,"No",-0.8437,0.73,1,"No"
"4843","KEGG_compound","C00555_4_AMINOBUTYRALDEHYDE_4_AMINOBUTANAL",6,-1.5063,0.043,0.16,"No",0.75,0.76,1,"Yes"
"4844","GO_MF","515609_GO_0070679_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING",10,-1.5063,0.037,0.14,"No",-1.5695,0.053,0.48,"No"
"4845","C4_Cancer_modules","C4_CM_344_MODULE_412",13,-1.5063,0.048,0.054,"No",0.524,0.98,1,"Yes"
"4846","C2_Chemical_and_genetic_perturbations","C2_CGP_1703_KAYO_AGING_MUSCLE_UP",236,-1.5061,0,0.061,"No",1.1451,0.13,0.56,"Yes"
"4847","GO_MF","495563_GO_0015321_SODIUM_DEPENDENT_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.506,0.028,0.14,"No",-0.7782,0.72,1,"No"
"4848","KEGG_compound","C00016_FAD_FLAVIN_ADENINE_DINUCLEOTIDE",17,-1.5058,0.031,0.16,"No",-0.5304,0.99,1,"No"
"4849","C2_Chemical_and_genetic_perturbations","C2_CGP_1601_LY_AGING_PREMATURE_DN",30,-1.5058,0.025,0.061,"No",0.8333,0.73,0.98,"Yes"
"4850","GO_CC","501221_GO_0031983_VESICLE_LUMEN",76,-1.5057,0.014,0.14,"No",1.7228,0,0.052,"Yes"
"4851","C2_Chemical_and_genetic_perturbations","C2_CGP_279_SENESE_HDAC3_TARGETS_UP",492,-1.5057,0,0.061,"No",1.0092,0.43,0.78,"Yes"
"4852","GO_BP","509057_GO_0046834_LIPID_PHOSPHORYLATION",40,-1.5056,0.016,0.11,"No",-0.8122,0.79,1,"No"
"4853","GO_MF","487301_GO_0001078_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",88,-1.5055,0.01,0.14,"No",-1.3417,0.041,0.7,"No"
"4854","GO_BP","503542_GO_0034340_RESPONSE_TO_TYPE_I_INTERFERON",66,-1.5055,0.017,0.11,"No",1.2405,0.12,0.75,"Yes"
"4855","GO_BP","488201_GO_0002328_PRO_B_CELL_DIFFERENTIATION",5,-1.5055,0.042,0.11,"No",-1.1829,0.28,0.91,"No"
"4856","GO_MF","487300_GO_0001077_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",187,-1.5054,0.0035,0.14,"No",0.905,0.75,0.98,"Yes"
"4857","REACTOME","1127511_REACT_264461_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION",21,-1.5054,0.037,0.13,"No",-0.7517,0.84,1,"No"
"4858","GO_BP","511838_GO_0050901_LEUKOCYTE_TETHERING_OR_ROLLING",15,-1.5053,0.041,0.11,"No",-0.7573,0.81,1,"No"
"4859","GO_CC","499839_GO_0030496_MIDBODY",123,-1.5051,0.0061,0.14,"No",0.842,0.84,0.92,"Yes"
"4860","GO_BP","513567_GO_0060009_SERTOLI_CELL_DEVELOPMENT",15,-1.5049,0.045,0.11,"No",-1.9038,0,0.31,"No"
"4861","C7_Immunologic_signatures","C7_ALL_1875_GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP",197,-1.5048,0.0012,0.006,"No",1.2249,0.075,0.19,"Yes"
"4862","C2_Chemical_and_genetic_perturbations","C2_CGP_23_KORKOLA_SEMINOMA_UP",44,-1.5048,0.027,0.061,"No",-1.1742,0.22,0.82,"No"
"4863","C2_Chemical_and_genetic_perturbations","C2_CGP_1934_SAFFORD_T_LYMPHOCYTE_ANERGY",87,-1.5047,0.0051,0.061,"No",0.8938,0.7,0.93,"Yes"
"4864","GO_BP","506342_GO_0043277_APOPTOTIC_CELL_CLEARANCE",25,-1.5047,0.037,0.11,"No",0.7306,0.86,1,"Yes"
"4865","REACTOME","730321_REACT_150312_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL",27,-1.5046,0.04,0.13,"No",-1.2192,0.18,0.79,"No"
"4866","C7_Immunologic_signatures","C7_ALL_1417_GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP",199,-1.5045,0.0023,0.006,"No",1.2119,0.083,0.21,"Yes"
"4867","C7_Immunologic_signatures","C7_ALL_1868_GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN",197,-1.5045,0.0034,0.006,"No",0.971,0.54,0.83,"Yes"
"4868","C6_Oncogenic_signatures","C6_ALL_39_ATF2_S_UP_V1_DN",178,-1.5045,0.0023,0.012,"No",-0.8601,0.83,0.95,"No"
"4869","C2_Chemical_and_genetic_perturbations","C2_CGP_1804_CHEN_ETV5_TARGETS_SERTOLI",19,-1.5045,0.037,0.061,"No",0.8515,0.67,0.97,"Yes"
"4870","GO_BP","516303_GO_0071379_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS",15,-1.5044,0.046,0.11,"No",1.1204,0.3,0.88,"Yes"
"4871","GO_BP","488518_GO_0002645_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION",10,-1.5044,0.058,0.11,"No",0.7552,0.76,1,"Yes"
"4872","GO_BP","497131_GO_0018158_PROTEIN_OXIDATION",7,-1.5044,0.053,0.11,"No",0.8467,0.66,1,"Yes"
"4873","C4_Cancer_modules","C4_CM_331_MODULE_395",14,-1.5043,0.051,0.054,"No",0.605,0.96,1,"Yes"
"4874","GO_BP","495124_GO_0014052_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION",6,-1.5043,0.064,0.11,"No",-1.139,0.3,0.93,"No"
"4875","GO_BP","506120_GO_0043031_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION",5,-1.5043,0.025,0.11,"No",-0.9725,0.5,1,"No"
"4876","KEGG_compound","C05130_IMIDAZOLE_4_ACETALDEHYDE_IMIDAZOLE_ACETALDEHYDE",6,-1.5043,0.037,0.16,"No",0.7522,0.77,1,"Yes"
"4877","C3_TF_targets","C3_TFT_234_V_AREB6_01",262,-1.5041,0.0011,0.02,"No",-1.393,0.0034,0.16,"No"
"4878","C2_Chemical_and_genetic_perturbations","C2_CGP_187_OSMAN_BLADDER_CANCER_UP",403,-1.5041,0,0.061,"No",1.3725,0.0024,0.32,"Yes"
"4879","GO_BP","514113_GO_0060558_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY",7,-1.504,0.051,0.11,"No",-1.6266,0.028,0.7,"No"
"4880","C2_Chemical_and_genetic_perturbations","C2_CGP_433_LANDIS_ERBB2_BREAST_TUMORS_65_UP",22,-1.5038,0.041,0.061,"No",0.8838,0.64,0.94,"Yes"
"4881","C7_Immunologic_signatures","C7_ALL_1727_GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP",198,-1.5036,0.0011,0.0061,"No",-1.0021,0.46,1,"No"
"4882","C4_Cancer_modules","C4_CM_207_MODULE_222",22,-1.5035,0.034,0.054,"No",-0.7837,0.77,0.99,"No"
"4883","C2_Chemical_and_genetic_perturbations","C2_CGP_1431_MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP",41,-1.5035,0.039,0.061,"No",-1.1658,0.21,0.83,"No"
"4884","C2_Chemical_and_genetic_perturbations","C2_CGP_558_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN",45,-1.5034,0.02,0.061,"No",-1.473,0.025,0.5,"No"
"4885","GO_BP","508159_GO_0045838_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL",25,-1.5034,0.032,0.11,"No",-1.2575,0.16,0.91,"No"
"4886","C7_Immunologic_signatures","C7_ALL_1498_GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN",191,-1.5034,0.0011,0.0061,"No",0.8724,0.8,1,"Yes"
"4887","GO_BP","498499_GO_0019674_NAD_METABOLIC_PROCESS",30,-1.5032,0.033,0.11,"No",-0.863,0.71,1,"No"
"4888","GO_BP","508123_GO_0045792_NEGATIVE_REGULATION_OF_CELL_SIZE",10,-1.5031,0.044,0.11,"No",-1.3007,0.17,0.89,"No"
"4889","GO_BP","495809_GO_0015672_MONOVALENT_INORGANIC_CATION_TRANSPORT",411,-1.503,0,0.11,"No",-1.0426,0.33,0.98,"No"
"4890","C3_TF_targets","C3_TFT_119_V_AP1FJ_Q2",260,-1.5029,0,0.02,"No",-1.1352,0.16,0.47,"No"
"4891","C2_Chemical_and_genetic_perturbations","C2_CGP_1885_JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP",49,-1.5029,0.029,0.062,"No",-0.7282,0.93,1,"No"
"4892","C4_Cancer_gene_neighborhoods","C4_CGN_255_GCM_PTK2",143,-1.5029,0.0072,0.057,"No",-0.9634,0.52,0.88,"No"
"4893","GO_MF","489997_GO_0004668_PROTEIN_ARGININE_DEIMINASE_ACTIVITY",5,-1.5028,0.03,0.14,"No",-1.3068,0.17,0.76,"No"
"4894","C3_TF_targets","C3_TFT_383_V_CDX2_Q5",241,-1.5027,0.0011,0.02,"No",-0.8819,0.8,0.98,"No"
"4895","GO_BP","491495_GO_0006600_CREATINE_METABOLIC_PROCESS",11,-1.5025,0.059,0.11,"No",-1.1956,0.25,0.89,"No"
"4896","C7_Immunologic_signatures","C7_ALL_425_GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP",192,-1.5024,0.0023,0.0062,"No",-0.9764,0.51,1,"No"
"4897","GO_BP","516315_GO_0071391_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS",29,-1.5024,0.032,0.11,"No",-1.0093,0.45,0.98,"No"
"4898","GO_CC","499563_GO_0030136_CLATHRIN_COATED_VESICLE",132,-1.5023,0.006,0.14,"No",1.1312,0.18,0.6,"Yes"
"4899","GO_MF","496603_GO_0016671_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR",13,-1.5023,0.063,0.14,"No",-0.6345,0.94,1,"No"
"4900","GO_CC","517589_GO_0072686_MITOTIC_SPINDLE",41,-1.5022,0.023,0.14,"No",-1.1141,0.27,0.75,"No"
"4901","C7_Immunologic_signatures","C7_ALL_1711_GSE3982_NKCELL_VS_TH1_UP",190,-1.5021,0.0011,0.0062,"No",-1.0691,0.28,1,"No"
"4902","GO_BP","496232_GO_0016139_GLYCOSIDE_CATABOLIC_PROCESS",6,-1.5018,0.037,0.11,"No",-0.9288,0.56,1,"No"
"4903","C2_Chemical_and_genetic_perturbations","C2_CGP_1037_CAFFAREL_RESPONSE_TO_THC_24HR_3_DN",13,-1.5018,0.033,0.062,"No",0.9835,0.47,0.81,"Yes"
"4904","C7_Immunologic_signatures","C7_ALL_1097_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP",198,-1.5018,0.0023,0.0062,"No",0.7923,0.96,1,"Yes"
"4905","REACTOME","106192_REACT_813_CREATINE_METABOLISM",11,-1.5017,0.041,0.13,"No",-1.3985,0.11,0.53,"No"
"4906","REACTOME","477120_REACT_111040_SIGNALING_BY_SCF_KIT",134,-1.5017,0.0048,0.13,"No",-1.0108,0.41,0.99,"No"
"4907","C2_Chemical_and_genetic_perturbations","C2_CGP_1795_XU_GH1_EXOGENOUS_TARGETS_UP",82,-1.5016,0.01,0.062,"No",0.9816,0.49,0.81,"Yes"
"4908","C7_Immunologic_signatures","C7_ALL_1623_GSE3982_MAST_CELL_VS_TH1_UP",196,-1.5016,0.0011,0.0063,"No",0.8862,0.8,1,"Yes"
"4909","REACTOME","119550_REACT_19231_G_ALPHA_I_SIGNALLING_EVENTS",221,-1.5016,0.0011,0.13,"No",1.3985,0.0024,0.23,"Yes"
"4910","GO_BP","507347_GO_0044341_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT",5,-1.5015,0.034,0.11,"No",-0.7671,0.75,1,"No"
"4911","C2_Chemical_and_genetic_perturbations","C2_CGP_2787_ONO_AML1_TARGETS_UP",24,-1.5015,0.043,0.062,"No",-0.914,0.59,1,"No"
"4912","GO_CC","500302_GO_0031012_EXTRACELLULAR_MATRIX",403,-1.5015,0,0.14,"No",-1.1941,0.054,0.69,"No"
"4913","GO_BP","501929_GO_0032703_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION",15,-1.5014,0.033,0.11,"No",-0.9409,0.54,1,"No"
"4914","GO_MF","500936_GO_0031690_ADRENERGIC_RECEPTOR_BINDING",17,-1.5013,0.039,0.14,"No",-0.5792,0.97,1,"No"
"4915","C4_Cancer_gene_neighborhoods","C4_CGN_377_GNF2_MCM4",53,-1.5013,0.026,0.056,"No",1.0949,0.3,0.38,"Yes"
"4916","GO_BP","488154_GO_0002281_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",7,-1.5011,0.033,0.11,"No",0.6692,0.86,1,"Yes"
"4917","GO_BP","488220_GO_0002347_RESPONSE_TO_TUMOR_CELL",6,-1.501,0.052,0.11,"No",1.0602,0.4,0.94,"Yes"
"4918","GO_BP","754531_GO_1901571_FATTY_ACID_DERIVATIVE_TRANSPORT",16,-1.501,0.035,0.11,"No",-0.804,0.73,1,"No"
"4919","C2_Chemical_and_genetic_perturbations","C2_CGP_3228_IKEDA_MIR133_TARGETS_UP",43,-1.5009,0.035,0.062,"No",-0.5109,1,1,"No"
"4920","GO_BP","491417_GO_0006521_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",351,-1.5009,0.0011,0.11,"No",1.0171,0.37,0.97,"Yes"
"4921","C2_Chemical_and_genetic_perturbations","C2_CGP_2840_KOBAYASHI_EGFR_SIGNALING_24HR_UP",96,-1.5009,0.0077,0.062,"No",-0.8675,0.76,1,"No"
"4922","C7_Immunologic_signatures","C7_ALL_612_GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_DN",197,-1.5008,0,0.0063,"No",1.3585,0.0025,0.057,"Yes"
"4923","C2_Chemical_and_genetic_perturbations","C2_CGP_2359_NAKAMURA_METASTASIS",46,-1.5007,0.025,0.062,"No",0.6519,0.98,1,"Yes"
"4924","KEGG_compound","C19574_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_NNAL",27,-1.5007,0.03,0.17,"No",1.4346,0.051,0.42,"Yes"
"4925","GO_BP","494704_GO_0010640_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",14,-1.5006,0.053,0.11,"No",-1.2235,0.2,0.88,"No"
"4926","GO_BP","499616_GO_0030206_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS",23,-1.5006,0.034,0.11,"No",-0.54,0.99,1,"No"
"4927","GO_BP","502718_GO_0033500_CARBOHYDRATE_HOMEOSTASIS",157,-1.5006,0.0012,0.11,"No",0.975,0.53,1,"Yes"
"4928","C2_Chemical_and_genetic_perturbations","C2_CGP_1612_BRACHAT_RESPONSE_TO_METHOTREXATE_DN",27,-1.5005,0.035,0.062,"No",1.0587,0.36,0.7,"Yes"
"4929","GO_BP","508603_GO_0046339_DIACYLGLYCEROL_METABOLIC_PROCESS",13,-1.5004,0.058,0.11,"No",-1.4309,0.08,0.92,"No"
"4930","GO_BP","488584_GO_0002711_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY",37,-1.5003,0.023,0.11,"No",-1.0982,0.3,0.95,"No"
"4931","GO_BP","498203_GO_0019359_NICOTINAMIDE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",18,-1.5002,0.043,0.11,"No",-1.0015,0.46,0.99,"No"
"4932","GO_BP","516257_GO_0071333_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",45,-1.5,0.029,0.11,"No",0.786,0.85,1,"Yes"
"4933","KEGG_pathway","HSA04917_PROLACTIN_SIGNALING_PATHWAY",70,-1.5,0.01,0.034,"No",-0.9246,0.6,0.97,"No"
"4934","GO_MF","498678_GO_0019901_PROTEIN_KINASE_BINDING",448,-1.4996,0,0.14,"No",0.7515,1,1,"Yes"
"4935","REACTOME","1127672_REACT_264352_PRC2_METHYLATES_HISTONES_AND_DNA",69,-1.4996,0.01,0.13,"No",-2.0464,0,0.037,"No"
"4936","C3_TF_targets","C3_TFT_107_V_HSF2_01",243,-1.4995,0,0.021,"No",-1.3513,0.017,0.19,"No"
"4937","C7_Immunologic_signatures","C7_ALL_395_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP",198,-1.4995,0.0011,0.0065,"No",-1.0207,0.41,1,"No"
"4938","REACTOME","187220_REACT_25046_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION",36,-1.4994,0.027,0.13,"No",0.6149,0.99,1,"Yes"
"4939","GO_BP","498975_GO_0021692_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS",13,-1.4993,0.046,0.11,"No",-1.3402,0.13,0.91,"No"
"4940","GO_BP","496865_GO_0046887_POSITIVE_REGULATION_OF_HORMONE_SECRETION",92,-1.4993,0.014,0.11,"No",1.229,0.1,0.76,"Yes"
"4941","C2_Chemical_and_genetic_perturbations","C2_CGP_3366_LIM_MAMMARY_LUMINAL_MATURE_DN",96,-1.4993,0.014,0.063,"No",1.164,0.17,0.53,"Yes"
"4942","C2_BioCarta_Pathways","C2_CP_BIOCARTA_190_BIOCARTA_TCR_PATHWAY",44,-1.4992,0.016,0.13,"No",0.8634,0.72,0.9,"Yes"
"4943","GO_BP","494077_GO_0009992_CELLULAR_WATER_HOMEOSTASIS",12,-1.4991,0.053,0.11,"No",-0.6987,0.88,1,"No"
"4944","C2_Chemical_and_genetic_perturbations","C2_CGP_2765_MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3",33,-1.4991,0.034,0.063,"No",-1.1853,0.2,0.81,"No"
"4945","GO_BP","488728_GO_0002855_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL",6,-1.4991,0.054,0.11,"No",-0.5007,0.99,1,"No"
"4946","C4_Cancer_modules","C4_CM_298_MODULE_342",205,-1.4987,0,0.056,"No",-1.1207,0.2,0.67,"No"
"4947","GO_BP","512359_GO_0051481_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION",8,-1.4986,0.036,0.11,"No",1.004,0.45,0.98,"Yes"
"4948","C2_Chemical_and_genetic_perturbations","C2_CGP_147_LAIHO_COLORECTAL_CANCER_SERRATED_UP",111,-1.4986,0.011,0.063,"No",1.7577,0,0.058,"Yes"
"4949","GO_MF","754632_GO_1901681_SULFUR_COMPOUND_BINDING",204,-1.4985,0.0023,0.14,"No",-1.0552,0.3,0.87,"No"
"4950","C4_Cancer_gene_neighborhoods","C4_CGN_332_GNF2_CD53",58,-1.4985,0.015,0.057,"No",1.2204,0.16,0.19,"Yes"
"4951","GO_BP","503543_GO_0034341_RESPONSE_TO_INTERFERON_GAMMA",121,-1.4984,0.0082,0.11,"No",1.077,0.31,0.93,"Yes"
"4952","C4_Cancer_modules","C4_CM_263_MODULE_299",35,-1.4984,0.037,0.056,"No",-1.0654,0.35,0.71,"No"
"4953","GO_BP","494947_GO_0010883_REGULATION_OF_LIPID_STORAGE",39,-1.4984,0.022,0.11,"No",-0.8807,0.67,1,"No"
"4954","GO_BP","496150_GO_0016051_CARBOHYDRATE_BIOSYNTHETIC_PROCESS",135,-1.4983,0.0047,0.11,"No",1.0667,0.29,0.93,"Yes"
"4955","WikiPathways","672449_WP2012_MIRS_IN_MUSCLE_CELL_DIFFERENTIATION",32,-1.4982,0.037,0.072,"No",-1.0791,0.32,0.97,"No"
"4956","C7_Immunologic_signatures","C7_ALL_1710_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN",198,-1.4981,0.0023,0.0066,"No",1.3379,0.019,0.071,"Yes"
"4957","GO_MF","504791_GO_0035612_AP_2_ADAPTOR_COMPLEX_BINDING",8,-1.4978,0.038,0.14,"No",-0.6584,0.89,1,"No"
"4958","GO_BP","494931_GO_0010867_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS",11,-1.4978,0.035,0.11,"No",0.9305,0.55,1,"Yes"
"4959","C2_Chemical_and_genetic_perturbations","C2_CGP_46_FRASOR_TAMOXIFEN_RESPONSE_UP",50,-1.4977,0.013,0.064,"No",-0.6727,0.96,1,"No"
"4960","GO_BP","755406_GO_2001300_LIPOXIN_METABOLIC_PROCESS",7,-1.4976,0.038,0.11,"No",1.1126,0.34,0.89,"Yes"
"4961","C3_TF_targets","C3_TFT_25_V_E4BP4_01",221,-1.4975,0.0068,0.021,"No",-1.1931,0.11,0.36,"No"
"4962","GO_BP","504767_GO_0035588_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY",21,-1.4975,0.049,0.11,"No",1.64,0.014,0.25,"Yes"
"4963","C2_Chemical_and_genetic_perturbations","C2_CGP_516_HUMMERICH_BENIGN_SKIN_TUMOR_UP",16,-1.4975,0.048,0.064,"No",1.2521,0.18,0.44,"Yes"
"4964","C3_TF_targets","C3_TFT_394_V_POU1F1_Q6",225,-1.4975,0.0044,0.021,"No",-1.0437,0.35,0.66,"No"
"4965","C4_Cancer_modules","C4_CM_130_MODULE_135",25,-1.4972,0.041,0.056,"No",-1.3258,0.12,0.52,"No"
"4966","GO_BP","496272_GO_0016198_AXON_CHOICE_POINT_RECOGNITION",6,-1.4972,0.054,0.11,"No",-1.1361,0.31,0.93,"No"
"4967","GO_BP","500114_GO_0030815_NEGATIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS",37,-1.497,0.027,0.11,"No",0.8281,0.75,1,"Yes"
"4968","C3_TF_targets","C3_TFT_232_V_SOX9_B1",230,-1.4969,0.0011,0.021,"No",0.8736,0.86,1,"Yes"
"4969","GO_BP","487835_GO_0001945_LYMPH_VESSEL_DEVELOPMENT",19,-1.4967,0.039,0.11,"No",-0.9976,0.47,0.99,"No"
"4970","GO_BP","488731_GO_0002858_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_DIRECTED_AGAINST_TUMOR_CELL_TARGET",6,-1.4966,0.054,0.11,"No",-0.5121,0.97,1,"No"
"4971","C7_Immunologic_signatures","C7_ALL_997_GSE22886_TH1_VS_TH2_12H_ACT_UP",196,-1.4966,0,0.0068,"No",-1.0406,0.35,1,"No"
"4972","C7_Immunologic_signatures","C7_ALL_555_GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_UP",199,-1.4965,0.0034,0.0068,"No",0.9578,0.56,0.88,"Yes"
"4973","GO_BP","501859_GO_0032633_INTERLEUKIN_4_PRODUCTION",7,-1.4965,0.052,0.11,"No",-0.6204,0.9,1,"No"
"4974","GO_BP","1053349_GO_0098742_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES",187,-1.4964,0.0023,0.11,"No",1.3766,0.0098,0.58,"Yes"
"4975","GO_BP","514560_GO_0061005_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",35,-1.4964,0.038,0.11,"No",-1.1105,0.3,0.94,"No"
"4976","C2_Chemical_and_genetic_perturbations","C2_CGP_3005_SASSON_RESPONSE_TO_GONADOTROPHINS_UP",91,-1.4962,0.011,0.064,"No",0.9944,0.47,0.81,"Yes"
"4977","C3_TF_targets","C3_TFT_412_V_IRF_Q6",236,-1.4962,0,0.021,"No",0.8094,0.96,1,"Yes"
"4978","GO_BP","1022081_GO_0036473_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS",19,-1.4962,0.044,0.11,"No",-0.8662,0.64,1,"No"
"4979","C2_Chemical_and_genetic_perturbations","C2_CGP_1851_SU_LIVER",54,-1.4961,0.025,0.064,"No",0.7112,0.94,1,"Yes"
"4980","C2_BioCarta_Pathways","C2_CP_BIOCARTA_109_BIOCARTA_KERATINOCYTE_PATHWAY",46,-1.4961,0.017,0.13,"No",-0.8532,0.74,1,"No"
"4981","GO_BP","508628_GO_0046364_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS",59,-1.496,0.011,0.11,"No",0.8872,0.69,1,"Yes"
"4982","C7_Immunologic_signatures","C7_ALL_1728_GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN",196,-1.496,0.0023,0.0068,"No",-0.8143,0.93,1,"No"
"4983","KEGG_compound","C05269_3_OXOHEXANOYL_COA_3_KETOHEXANOYL_COA",8,-1.496,0.047,0.17,"No",0.5544,0.96,1,"Yes"
"4984","C3_MicroRNA_targets","C3_MIR_43_CTCTGGA_MIR_520A_MIR_525",155,-1.4959,0.0047,0.2,"No",-1.1047,0.22,1,"No"
"4985","GO_BP","911402_GO_1902414_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION",6,-1.4959,0.048,0.11,"No",0.5495,0.96,1,"Yes"
"4986","REACTOME","1183608_REACT_355409_RIPK1_MEDIATED_REGULATED_NECROSIS",16,-1.4958,0.036,0.13,"No",0.4905,0.99,1,"Yes"
"4987","C2_Chemical_and_genetic_perturbations","C2_CGP_3330_BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE",58,-1.4958,0.024,0.064,"No",1.3991,0.031,0.3,"Yes"
"4988","GO_BP","508255_GO_0045953_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",7,-1.4958,0.052,0.11,"No",0.6701,0.86,1,"Yes"
"4989","C7_Immunologic_signatures","C7_ALL_814_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN",191,-1.4958,0.0023,0.0068,"No",-0.8808,0.79,1,"No"
"4990","C2_Chemical_and_genetic_perturbations","C2_CGP_1182_MORI_MATURE_B_LYMPHOCYTE_UP",89,-1.4958,0.013,0.064,"No",0.7195,0.98,1,"Yes"
"4991","GO_BP","496173_GO_0016079_SYNAPTIC_VESICLE_EXOCYTOSIS",72,-1.4957,0.016,0.11,"No",0.956,0.53,1,"Yes"
"4992","GO_BP","512150_GO_0051259_PROTEIN_OLIGOMERIZATION",400,-1.4957,0,0.11,"No",-1.0265,0.33,0.98,"No"
"4993","GO_BP","948112_GO_1902669_POSITIVE_REGULATION_OF_AXON_GUIDANCE",7,-1.4956,0.062,0.11,"No",0.6147,0.92,1,"Yes"
"4994","C2_Chemical_and_genetic_perturbations","C2_CGP_170_RODRIGUES_NTN1_TARGETS_UP",17,-1.4956,0.042,0.064,"No",1.2358,0.17,0.45,"Yes"
"4995","C7_Immunologic_signatures","C7_ALL_236_GSE14000_UNSTIM_VS_16H_LPS_DC_DN",197,-1.4956,0.0034,0.0068,"No",-0.7149,0.99,1,"No"
"4996","GO_BP","982314_GO_0098609_CELL_CELL_ADHESION",188,-1.4955,0.0023,0.11,"No",1.3599,0.011,0.6,"Yes"
"4997","GO_MF","490357_GO_0005089_RHO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",77,-1.4951,0.012,0.14,"No",-1.59,0.0071,0.46,"No"
"4998","C7_Immunologic_signatures","C7_ALL_1488_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN",193,-1.4951,0.0023,0.0069,"No",-0.9063,0.73,1,"No"
"4999","C2_BioCarta_Pathways","C2_CP_BIOCARTA_66_BIOCARTA_ERK_PATHWAY",27,-1.495,0.042,0.13,"No",-0.7588,0.82,1,"No"
"5000","C2_Chemical_and_genetic_perturbations","C2_CGP_1021_SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN",22,-1.4949,0.042,0.065,"No",-1.0664,0.35,0.96,"No"
"5001","GO_CC","500921_GO_0031672_A_BAND",29,-1.4948,0.037,0.15,"No",-1.4114,0.073,0.68,"No"
"5002","REACTOME","645298_REACT_121083_HYALURONAN_METABOLISM",16,-1.4948,0.054,0.13,"No",-1.0202,0.43,0.98,"No"
"5003","C3_TF_targets","C3_TFT_385_V_SMAD4_Q6",237,-1.4947,0.0011,0.021,"No",-1.1188,0.18,0.5,"No"
"5004","REACTOME","187226_REACT_25085_N_GLYCAN_ANTENNAE_ELONGATION",15,-1.4946,0.05,0.13,"No",0.6211,0.95,1,"Yes"
"5005","C7_Immunologic_signatures","C7_ALL_995_GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP",195,-1.4946,0.0022,0.0069,"No",1.0149,0.39,0.7,"Yes"
"5006","C2_Chemical_and_genetic_perturbations","C2_CGP_2876_CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY",29,-1.4945,0.025,0.065,"No",0.6459,0.96,1,"Yes"
"5007","REACTOME","205242_REACT_27271_MEIOTIC_RECOMBINATION",82,-1.4945,0.011,0.13,"No",-1.5803,0.0054,0.35,"No"
"5008","C2_Chemical_and_genetic_perturbations","C2_CGP_3359_ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN",297,-1.4945,0,0.065,"No",-1.0282,0.35,0.98,"No"
"5009","GO_BP","510793_GO_0048738_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",146,-1.4945,0.0047,0.11,"No",0.8663,0.8,1,"Yes"
"5010","WikiPathways","198807_WP244_ALPHA6_BETA4_INTEGRIN_SIGNALING_PATHWAY",69,-1.4944,0.031,0.073,"No",1.0663,0.32,1,"Yes"
"5011","GO_BP","493495_GO_0009311_OLIGOSACCHARIDE_METABOLIC_PROCESS",44,-1.4944,0.025,0.11,"No",-0.8225,0.77,1,"No"
"5012","GO_MF","495366_GO_0015085_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",126,-1.4944,0.0024,0.14,"No",-1.6235,0.0018,0.44,"No"
"5013","GO_BP","511895_GO_0050961_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",10,-1.4943,0.056,0.11,"No",-1.1028,0.34,0.94,"No"
"5014","GO_BP","491763_GO_0006907_PINOCYTOSIS",10,-1.4943,0.055,0.11,"No",-0.781,0.76,1,"No"
"5015","GO_BP","494809_GO_0010744_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION",14,-1.4942,0.046,0.11,"No",1.2256,0.21,0.76,"Yes"
"5016","C7_Immunologic_signatures","C7_ALL_1386_GSE339_CD4POS_VS_CD4CD8DN_DC_DN",198,-1.4939,0.0045,0.007,"No",0.8181,0.93,1,"Yes"
"5017","REACTOME","106058_REACT_1573_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION",5,-1.4938,0.045,0.13,"No",-0.9297,0.54,1,"No"
"5018","GO_MF","501289_GO_0032052_BILE_ACID_BINDING",7,-1.4938,0.048,0.14,"No",-0.7492,0.77,1,"No"
"5019","C3_TF_targets","C3_TFT_338_V_HNF6_Q6",226,-1.4938,0.0022,0.021,"No",0.9252,0.74,1,"Yes"
"5020","GO_BP","492339_GO_0007598_BLOOD_COAGULATION_EXTRINSIC_PATHWAY",5,-1.4937,0.042,0.11,"No",-0.9077,0.58,1,"No"
"5021","GO_BP","517027_GO_0072111_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",10,-1.4937,0.047,0.11,"No",-1.022,0.45,0.97,"No"
"5022","GO_BP","754606_GO_1901654_RESPONSE_TO_KETONE",118,-1.4937,0.0073,0.11,"No",0.9294,0.64,1,"Yes"
"5023","C7_Immunologic_signatures","C7_ALL_461_GSE17721_CTRL_VS_LPS_24H_BMDM_UP",198,-1.4937,0.0045,0.007,"No",1.044,0.34,0.61,"Yes"
"5024","C6_Oncogenic_signatures","C6_ALL_73_PRC2_EDD_UP_V1_DN",182,-1.4936,0.0023,0.014,"No",-0.9935,0.48,0.68,"No"
"5025","GO_CC","501391_GO_0032155_CELL_DIVISION_SITE_PART",48,-1.4936,0.027,0.15,"No",0.8599,0.7,0.91,"Yes"
"5026","GO_BP","490997_GO_0006011_UDP_GLUCOSE_METABOLIC_PROCESS",5,-1.4935,0.035,0.11,"No",-0.7425,0.78,1,"No"
"5027","C2_Chemical_and_genetic_perturbations","C2_CGP_1439_DER_IFN_GAMMA_RESPONSE_UP",71,-1.4934,0.014,0.065,"No",1.3526,0.03,0.34,"Yes"
"5028","C7_Immunologic_signatures","C7_ALL_1168_GSE27786_LIN_NEG_VS_NKCELL_DN",200,-1.4934,0,0.0071,"No",-0.8694,0.83,1,"No"
"5029","GO_MF","495342_GO_0016918_RETINAL_BINDING",13,-1.4934,0.051,0.14,"No",0.9428,0.51,0.94,"Yes"
"5030","C2_Chemical_and_genetic_perturbations","C2_CGP_728_OHASHI_AURKA_TARGETS",6,-1.4933,0.052,0.065,"No",-1.452,0.093,0.52,"No"
"5031","C7_Immunologic_signatures","C7_ALL_1525_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP",195,-1.4932,0.0022,0.0071,"No",0.7846,0.98,1,"Yes"
"5032","GO_BP","752363_GO_0080184_RESPONSE_TO_PHENYLPROPANOID",8,-1.4932,0.051,0.11,"No",-1.0249,0.42,0.97,"No"
"5033","C3_TF_targets","C3_TFT_370_GCCNNNWTAAR_UNKNOWN",145,-1.4932,0.0095,0.021,"No",-1.2755,0.059,0.25,"No"
"5034","C7_Immunologic_signatures","C7_ALL_623_GSE17721_POLYIC_VS_CPG_4H_BMDM_UP",199,-1.493,0.0034,0.0071,"No",1.3487,0.017,0.063,"Yes"
"5035","C6_Oncogenic_signatures","C6_ALL_49_RELA_DN_V1_DN",133,-1.493,0.006,0.014,"No",-1.1947,0.13,0.47,"No"
"5036","C7_Immunologic_signatures","C7_ALL_1740_GSE5960_TH1_VS_ANERGIC_TH1_DN",196,-1.493,0.0034,0.0071,"No",0.684,1,1,"Yes"
"5037","GO_BP","492852_GO_0008593_REGULATION_OF_NOTCH_SIGNALING_PATHWAY",53,-1.493,0.02,0.11,"No",-0.8654,0.72,1,"No"
"5038","C7_Immunologic_signatures","C7_ALL_1191_GSE27786_CD4_VS_CD8_TCELL_UP",199,-1.4929,0.0011,0.0071,"No",-0.753,0.98,1,"No"
"5039","C2_Chemical_and_genetic_perturbations","C2_CGP_3180_DELPUECH_FOXO3_TARGETS_DN",41,-1.4929,0.032,0.065,"No",-0.7395,0.9,1,"No"
"5040","GO_BP","499052_GO_0021772_OLFACTORY_BULB_DEVELOPMENT",36,-1.4927,0.032,0.11,"No",-1.3843,0.064,0.99,"No"
"5041","KEGG_pathway","HSA05332_GRAFT_VERSUS_HOST_DISEASE",37,-1.4926,0.034,0.036,"No",-0.7244,0.89,1,"No"
"5042","GO_BP","1129351_GO_1903524_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION",74,-1.4925,0.01,0.11,"No",1.0908,0.28,0.91,"Yes"
"5043","REACTOME","161007_REACT_22292_CHL1_INTERACTIONS",9,-1.4925,0.05,0.13,"No",-1.1684,0.28,0.85,"No"
"5044","GO_BP","486820_GO_0000303_RESPONSE_TO_SUPEROXIDE",17,-1.4924,0.057,0.11,"No",-0.5724,0.97,1,"No"
"5045","C6_Oncogenic_signatures","C6_ALL_86_PKCA_DN_V1_UP",144,-1.4924,0.0048,0.014,"No",-1.3325,0.042,0.41,"No"
"5046","C7_Immunologic_signatures","C7_ALL_816_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN",187,-1.4924,0.0011,0.0071,"No",0.9387,0.63,0.93,"Yes"
"5047","GO_BP","498230_GO_0019388_GALACTOSE_CATABOLIC_PROCESS",8,-1.4924,0.055,0.11,"No",-1.1289,0.3,0.93,"No"
"5048","GO_BP","518956_GO_2000310_REGULATION_OF_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",15,-1.4924,0.056,0.11,"No",-1.2317,0.19,0.9,"No"
"5049","C7_Immunologic_signatures","C7_ALL_292_GSE14350_IL2RB_KO_VS_WT_TEFF_DN",198,-1.4922,0.0035,0.0071,"No",1.0201,0.38,0.68,"Yes"
"5050","GO_BP","1022191_GO_1903205_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH",13,-1.492,0.055,0.11,"No",1.4578,0.093,0.48,"Yes"
"5051","GO_BP","499717_GO_0030317_SPERM_MOTILITY",41,-1.492,0.038,0.11,"No",-1.3458,0.079,0.92,"No"
"5052","C6_Oncogenic_signatures","C6_ALL_83_CTIP_DN_V1_DN",129,-1.492,0.0084,0.014,"No",-1.1314,0.22,0.52,"No"
"5053","C2_Chemical_and_genetic_perturbations","C2_CGP_2893_DORN_ADENOVIRUS_INFECTION_12HR_DN",33,-1.4918,0.045,0.066,"No",-1.3343,0.092,0.69,"No"
"5054","KEGG_compound","C00074_PHOSPHOENOLPYRUVATE_PHOSPHOENOLPYRUVIC_ACID_PEP",8,-1.4918,0.05,0.18,"No",-0.7384,0.82,1,"No"
"5055","GO_BP","508748_GO_0046488_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS",130,-1.4917,0.0061,0.11,"No",-0.8076,0.87,1,"No"
"5056","C2_Chemical_and_genetic_perturbations","C2_CGP_2778_MIKKELSEN_IPS_LCP_WITH_H3K27ME3",10,-1.4916,0.049,0.066,"No",-0.9403,0.52,1,"No"
"5057","GO_MF","489647_GO_0004185_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY",5,-1.4916,0.051,0.15,"No",0.5947,0.92,1,"Yes"
"5058","GO_BP","502002_GO_0032776_DNA_METHYLATION_ON_CYTOSINE",35,-1.4915,0.026,0.11,"No",-2.1128,0,0.11,"No"
"5059","C7_Immunologic_signatures","C7_ALL_474_GSE17721_CTRL_VS_POLYIC_8H_BMDM_DN",197,-1.4915,0.0033,0.0072,"No",-0.948,0.58,1,"No"
"5060","GO_BP","496520_GO_0016572_HISTONE_PHOSPHORYLATION",25,-1.4915,0.037,0.11,"No",-0.9416,0.55,1,"No"
"5061","C2_Chemical_and_genetic_perturbations","C2_CGP_2103_JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN",17,-1.4914,0.045,0.066,"No",1.0904,0.33,0.64,"Yes"
"5062","GO_BP","506583_GO_0043552_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",26,-1.4914,0.043,0.11,"No",-0.8906,0.61,1,"No"
"5063","GO_BP","489302_GO_0051016_BARBED_END_ACTIN_FILAMENT_CAPPING",11,-1.4913,0.044,0.11,"No",0.8044,0.74,1,"Yes"
"5064","GO_BP","513580_GO_0060022_HARD_PALATE_DEVELOPMENT",6,-1.4912,0.036,0.11,"No",-0.7761,0.75,1,"No"
"5065","C2_BioCarta_Pathways","C2_CP_BIOCARTA_153_BIOCARTA_CK1_PATHWAY",17,-1.491,0.053,0.13,"No",0.9775,0.49,0.81,"Yes"
"5066","C2_Chemical_and_genetic_perturbations","C2_CGP_2266_SMID_BREAST_CANCER_LUMINAL_B_UP",170,-1.491,0.0024,0.066,"No",-1.3035,0.03,0.69,"No"
"5067","GO_BP","519212_GO_2000573_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS",18,-1.4909,0.054,0.11,"No",-0.9256,0.55,1,"No"
"5068","C7_Immunologic_signatures","C7_ALL_954_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN",196,-1.4908,0.0012,0.0073,"No",0.7064,1,1,"Yes"
"5069","C2_Chemical_and_genetic_perturbations","C2_CGP_1175_MORI_PRE_BI_LYMPHOCYTE_DN",77,-1.4908,0.013,0.066,"No",0.8329,0.83,0.97,"Yes"
"5070","C2_Chemical_and_genetic_perturbations","C2_CGP_3285_SANDERSON_PPARA_TARGETS",14,-1.4906,0.052,0.066,"No",-0.6487,0.92,1,"No"
"5071","GO_BP","751851_GO_0044708_SINGLE_ORGANISM_BEHAVIOR",352,-1.4906,0,0.11,"No",-1.2796,0.02,0.89,"No"
"5072","C7_Immunologic_signatures","C7_ALL_1152_GSE27786_LSK_VS_NKCELL_DN",200,-1.4906,0.0012,0.0073,"No",0.7363,1,1,"Yes"
"5073","C2_Chemical_and_genetic_perturbations","C2_CGP_36_BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN",165,-1.4906,0.0047,0.066,"No",-1.024,0.39,0.98,"No"
"5074","GO_BP","506321_GO_0043254_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY",283,-1.4905,0.0011,0.11,"No",0.7732,0.99,1,"Yes"
"5075","GO_MF","1053355_GO_0098748_ENDOCYTIC_ADAPTOR_ACTIVITY",9,-1.4905,0.058,0.15,"No",0.8383,0.65,1,"Yes"
"5076","C7_Immunologic_signatures","C7_ALL_1476_GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN",197,-1.4905,0.0011,0.0073,"No",-1.0989,0.25,1,"No"
"5077","C2_Chemical_and_genetic_perturbations","C2_CGP_1873_LIU_SMARCA4_TARGETS",61,-1.4905,0.018,0.066,"No",-1.1121,0.25,0.9,"No"
"5078","REACTOME","187081_REACT_25222_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME",89,-1.4903,0.0078,0.14,"No",-0.572,1,1,"No"
"5079","REACTOME","106021_REACT_11149_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS",21,-1.4903,0.038,0.13,"No",1.1833,0.23,0.46,"Yes"
"5080","GO_BP","507968_GO_0045620_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION",35,-1.4902,0.032,0.11,"No",-1.2488,0.15,0.91,"No"
"5081","C1_Positional","C1_ALL_95_CHR1Q21",246,-1.4901,0.0011,0.33,"No",-1.2688,0.038,1,"No"
"5082","GO_BP","519319_GO_2000680_REGULATION_OF_RUBIDIUM_ION_TRANSPORT",5,-1.49,0.035,0.11,"No",-0.534,0.98,1,"No"
"5083","GO_BP","503368_GO_0034162_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY",73,-1.4899,0.015,0.11,"No",-0.599,0.99,1,"No"
"5084","GO_BP","488411_GO_0002538_ARACHIDONIC_ACID_METABOLITE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",5,-1.4899,0.034,0.11,"No",0.6709,0.86,1,"Yes"
"5085","C2_Chemical_and_genetic_perturbations","C2_CGP_2068_ZHENG_BOUND_BY_FOXP3",483,-1.4899,0,0.066,"No",1.2122,0.03,0.48,"Yes"
"5086","C7_Immunologic_signatures","C7_ALL_616_GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_DN",198,-1.4898,0.0035,0.0073,"No",1.1611,0.12,0.3,"Yes"
"5087","C2_Chemical_and_genetic_perturbations","C2_CGP_3287_DELACROIX_RARG_BOUND_MEF",361,-1.4898,0,0.066,"No",-1.1047,0.19,0.92,"No"
"5088","C7_Immunologic_signatures","C7_ALL_1752_GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_DN",170,-1.4897,0.0034,0.0074,"No",1.0462,0.31,0.6,"Yes"
"5089","GO_BP","494702_GO_0010638_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION",439,-1.4896,0,0.11,"No",0.7445,1,1,"Yes"
"5090","C7_Immunologic_signatures","C7_ALL_115_GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP",186,-1.4895,0.0045,0.0074,"No",0.7636,0.99,1,"Yes"
"5091","GO_BP","507259_GO_0044252_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",8,-1.4894,0.048,0.11,"No",0.8132,0.7,1,"Yes"
"5092","GO_BP","488730_GO_0002857_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL",6,-1.4893,0.039,0.11,"No",-0.4995,0.96,1,"No"
"5093","GO_MF","496312_GO_0016248_CHANNEL_INHIBITOR_ACTIVITY",37,-1.4891,0.038,0.15,"No",0.6991,0.95,1,"Yes"
"5094","C7_Immunologic_signatures","C7_ALL_121_GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP",193,-1.489,0.0034,0.0074,"No",0.7213,1,1,"Yes"
"5095","C3_TF_targets","C3_TFT_241_V_MEIS1_01",236,-1.489,0.0022,0.022,"No",-0.9683,0.54,0.82,"No"
"5096","WikiPathways","198804_WP691_TAMOXIFEN_METABOLISM",18,-1.4889,0.045,0.075,"No",0.8765,0.62,1,"Yes"
"5097","GO_BP","491919_GO_0007100_MITOTIC_CENTROSOME_SEPARATION",5,-1.4889,0.037,0.11,"No",-0.9267,0.54,1,"No"
"5098","GO_BP","501943_GO_0032717_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION",13,-1.4888,0.051,0.11,"No",1.0258,0.4,0.97,"Yes"
"5099","C3_TF_targets","C3_TFT_411_V_ETS_Q4",248,-1.4887,0.0022,0.022,"No",-0.9258,0.69,0.92,"No"
"5100","GO_BP","488733_GO_0002860_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_DIRECTED_AGAINST_TUMOR_CELL_TARGET",6,-1.4887,0.05,0.11,"No",-0.5175,0.98,1,"No"
"5101","REACTOME","105694_REACT_1482_ERK_ACTIVATION",12,-1.4887,0.053,0.14,"No",-0.8641,0.64,1,"No"
"5102","GO_BP","512063_GO_0051153_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION",75,-1.4886,0.014,0.11,"No",1.1726,0.18,0.81,"Yes"
"5103","GO_BP","492552_GO_0008211_GLUCOCORTICOID_METABOLIC_PROCESS",16,-1.4886,0.044,0.11,"No",-1.0517,0.37,0.97,"No"
"5104","REACTOME","106020_REACT_11068_NEF_AND_SIGNAL_TRANSDUCTION",8,-1.4885,0.057,0.14,"No",-0.6187,0.92,1,"No"
"5105","GO_BP","1129399_GO_1903573_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",26,-1.4884,0.038,0.11,"No",-1.0056,0.43,0.98,"No"
"5106","KEGG_compound","C00027_HYDROGEN_PEROXIDE_H2O2_OXYDOL",28,-1.4882,0.034,0.18,"No",-1.396,0.073,0.45,"No"
"5107","C3_TF_targets","C3_TFT_440_V_PAX_Q6",251,-1.4882,0.0011,0.022,"No",-1.3043,0.02,0.23,"No"
"5108","KEGG_compound","C00577_D_GLYCERALDEHYDE",11,-1.4882,0.05,0.18,"No",-0.7105,0.85,1,"No"
"5109","GO_BP","492318_GO_0007568_AGING",210,-1.488,0.0033,0.11,"No",0.8975,0.81,1,"Yes"
"5110","C2_Chemical_and_genetic_perturbations","C2_CGP_923_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4",256,-1.4879,0.0011,0.067,"No",-1.0483,0.33,0.97,"No"
"5111","GO_BP","501507_GO_0032272_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION",56,-1.4879,0.027,0.11,"No",-0.982,0.51,1,"No"
"5112","GO_BP","489303_GO_0051014_ACTIN_FILAMENT_SEVERING",7,-1.4879,0.065,0.11,"No",-0.4947,0.97,1,"No"
"5113","C7_Immunologic_signatures","C7_ALL_1770_GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN",199,-1.4878,0.0045,0.0076,"No",0.7701,0.99,1,"Yes"
"5114","WikiPathways","198861_WP58_MONOAMINE_GPCRS",33,-1.4877,0.034,0.075,"No",0.9941,0.45,1,"Yes"
"5115","C2_Chemical_and_genetic_perturbations","C2_CGP_1269_LEE_LIVER_CANCER_CIPROFIBRATE_DN",61,-1.4877,0.016,0.067,"No",-1.2661,0.11,0.72,"No"
"5116","GO_BP","506619_GO_0043588_SKIN_DEVELOPMENT",190,-1.4877,0.0022,0.11,"No",0.972,0.53,1,"Yes"
"5117","GO_BP","510380_GO_0048266_BEHAVIORAL_RESPONSE_TO_PAIN",15,-1.4876,0.054,0.11,"No",-1.5321,0.053,0.77,"No"
"5118","GO_BP","510892_GO_0048842_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",7,-1.4876,0.06,0.11,"No",0.6153,0.94,1,"Yes"
"5119","C7_Immunologic_signatures","C7_ALL_625_GSE17721_POLYIC_VS_CPG_6H_BMDM_UP",197,-1.4876,0.0023,0.0076,"No",0.7241,0.99,1,"Yes"
"5120","GO_BP","511773_GO_0050807_REGULATION_OF_SYNAPSE_ORGANIZATION",60,-1.4876,0.022,0.11,"No",-1.3707,0.052,0.98,"No"
"5121","GO_BP","499945_GO_0030638_POLYKETIDE_METABOLIC_PROCESS",9,-1.4876,0.048,0.11,"No",-0.7089,0.83,1,"No"
"5122","GO_BP","498711_GO_0048017_INOSITOL_LIPID_MEDIATED_SIGNALING",129,-1.4875,0.0097,0.11,"No",-1.1154,0.23,0.94,"No"
"5123","GO_MF","754574_GO_1901618_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",43,-1.4875,0.027,0.15,"No",-1.8916,0,0.17,"No"
"5124","REACTOME","1127591_REACT_267917_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE",6,-1.4874,0.048,0.14,"No",-0.8616,0.63,1,"No"
"5125","C2_Chemical_and_genetic_perturbations","C2_CGP_19_KORKOLA_TERATOMA_UP",16,-1.4872,0.054,0.068,"No",0.9911,0.43,0.81,"Yes"
"5126","GO_CC","496302_GO_0016235_AGGRESOME",28,-1.4872,0.035,0.15,"No",-0.9024,0.6,0.96,"No"
"5127","C7_Immunologic_signatures","C7_ALL_1812_GSE7852_TREG_VS_TCONV_FAT_DN",200,-1.4872,0.0035,0.0076,"No",0.8453,0.92,1,"Yes"
"5128","GO_BP","518332_GO_0090192_REGULATION_OF_GLOMERULUS_DEVELOPMENT",12,-1.4871,0.058,0.11,"No",1.0765,0.34,0.93,"Yes"
"5129","GO_BP","494821_GO_0010756_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION",5,-1.4871,0.048,0.11,"No",-0.8749,0.62,1,"No"
"5130","GO_BP","499347_GO_0022612_GLAND_MORPHOGENESIS",101,-1.4871,0.017,0.11,"No",-0.8805,0.72,1,"No"
"5131","GO_MF","489502_GO_0004033_ALDO_KETO_REDUCTASE_NADP_ACTIVITY",20,-1.4871,0.037,0.15,"No",-0.8206,0.74,1,"No"
"5132","GO_BP","503321_GO_0034115_NEGATIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION",7,-1.4871,0.054,0.11,"No",-1.363,0.15,0.97,"No"
"5133","GO_BP","498829_GO_0021545_CRANIAL_NERVE_DEVELOPMENT",51,-1.4871,0.014,0.11,"No",-1.0855,0.31,0.96,"No"
"5134","C2_Chemical_and_genetic_perturbations","C2_CGP_3009_BAE_BRCA1_TARGETS_UP",74,-1.4869,0.0051,0.068,"No",1.2898,0.075,0.4,"Yes"
"5135","C7_Immunologic_signatures","C7_ALL_463_GSE17721_CTRL_VS_POLYIC_0_5H_BMDM_UP",196,-1.4868,0.0045,0.0077,"No",1.0218,0.4,0.68,"Yes"
"5136","REACTOME","105697_REACT_18312_NCAM1_INTERACTIONS",37,-1.4868,0.036,0.14,"No",-1.4872,0.028,0.47,"No"
"5137","C3_TF_targets","C3_TFT_438_V_NF1_Q6_01",262,-1.4867,0,0.022,"No",-0.9052,0.75,0.95,"No"
"5138","C2_Chemical_and_genetic_perturbations","C2_CGP_178_VECCHI_GASTRIC_CANCER_EARLY_UP",415,-1.4866,0.001,0.068,"No",1.0125,0.41,0.78,"Yes"
"5139","C2_Chemical_and_genetic_perturbations","C2_CGP_86_TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP",20,-1.4865,0.051,0.068,"No",-1.0793,0.35,0.95,"No"
"5140","WikiPathways","198772_WP1539_ANGIOGENESIS",23,-1.4865,0.038,0.075,"No",0.64,0.94,1,"Yes"
"5141","C2_Chemical_and_genetic_perturbations","C2_CGP_3342_HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN",12,-1.4865,0.049,0.068,"No",-0.9327,0.56,1,"No"
"5142","C3_TF_targets","C3_TFT_45_V_CP2_01",256,-1.4865,0.0022,0.022,"No",-1.3487,0.0069,0.19,"No"
"5143","GO_BP","516168_GO_0071243_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE",11,-1.4865,0.044,0.11,"No",-1.2536,0.2,0.91,"No"
"5144","C4_Cancer_modules","C4_CM_234_MODULE_259",46,-1.4863,0.018,0.06,"No",-0.9417,0.56,0.89,"No"
"5145","GO_BP","493862_GO_0009750_RESPONSE_TO_FRUCTOSE",6,-1.4862,0.062,0.12,"No",-0.9622,0.48,1,"No"
"5146","GO_BP","494965_GO_0010901_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",5,-1.4861,0.052,0.12,"No",-1.4668,0.08,0.87,"No"
"5147","C2_Chemical_and_genetic_perturbations","C2_CGP_2108_KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION",77,-1.4861,0.016,0.068,"No",-0.6431,0.99,1,"No"
"5148","C4_Cancer_gene_neighborhoods","C4_CGN_325_GNF2_CASP4",24,-1.486,0.034,0.063,"No",1.3924,0.08,0.064,"Yes"
"5149","C2_Chemical_and_genetic_perturbations","C2_CGP_1937_LI_ADIPOGENESIS_BY_ACTIVATED_PPARG",17,-1.4859,0.053,0.068,"No",0.8209,0.74,0.98,"Yes"
"5150","C2_Chemical_and_genetic_perturbations","C2_CGP_153_GRABARCZYK_BCL11B_TARGETS_UP",80,-1.4858,0.02,0.068,"No",1.2094,0.13,0.48,"Yes"
"5151","GO_BP","515229_GO_0070296_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT",10,-1.4857,0.079,0.12,"No",0.4523,1,1,"Yes"
"5152","GO_BP","499709_GO_0030309_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS",6,-1.4856,0.055,0.12,"No",0.5135,0.97,1,"Yes"
"5153","C2_Chemical_and_genetic_perturbations","C2_CGP_98_GARY_CD5_TARGETS_UP",470,-1.4856,0,0.068,"No",-0.696,1,1,"No"
"5154","GO_CC","495068_GO_0012506_VESICLE_MEMBRANE",453,-1.4854,0,0.15,"No",1.1406,0.07,0.6,"Yes"
"5155","KEGG_pathway","HSA01040_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS",23,-1.4853,0.037,0.038,"No",-0.8563,0.7,1,"No"
"5156","C4_Cancer_modules","C4_CM_118_MODULE_123",242,-1.4853,0,0.061,"No",-1.1524,0.14,0.64,"No"
"5157","GO_MF","509140_GO_0046943_CARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",111,-1.4852,0.0087,0.15,"No",-1.2229,0.13,0.85,"No"
"5158","C2_Chemical_and_genetic_perturbations","C2_CGP_767_EINAV_INTERFERON_SIGNATURE_IN_CANCER",27,-1.4851,0.031,0.068,"No",1.502,0.038,0.21,"Yes"
"5159","GO_BP","508734_GO_0046474_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS",184,-1.4849,0.0023,0.12,"No",0.6878,1,1,"Yes"
"5160","C2_Chemical_and_genetic_perturbations","C2_CGP_2653_MILI_PSEUDOPODIA_CHEMOTAXIS_DN",456,-1.4848,0,0.068,"No",-0.9879,0.52,1,"No"
"5161","GO_BP","1022099_GO_0098662_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORT",446,-1.4847,0,0.12,"No",-1.1388,0.11,0.93,"No"
"5162","GO_BP","492353_GO_0007612_LEARNING",116,-1.4847,0.0097,0.12,"No",-1.1963,0.14,0.9,"No"
"5163","C6_Oncogenic_signatures","C6_ALL_19_CYCLIN_D1_UP_V1_DN",185,-1.4845,0.0023,0.015,"No",0.8583,0.85,0.98,"Yes"
"5164","C7_Immunologic_signatures","C7_ALL_1861_GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP",196,-1.4844,0.0023,0.008,"No",0.6061,1,1,"Yes"
"5165","GO_BP","501798_GO_0032570_RESPONSE_TO_PROGESTERONE",34,-1.4844,0.04,0.12,"No",-0.7795,0.84,1,"No"
"5166","GO_BP","492010_GO_0007212_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",26,-1.4844,0.032,0.12,"No",0.7165,0.89,1,"Yes"
"5167","GO_BP","492000_GO_0007200_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",65,-1.4841,0.027,0.12,"No",1.3325,0.055,0.63,"Yes"
"5168","GO_MF","495528_GO_0015277_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",5,-1.4841,0.052,0.15,"No",-1.1851,0.3,0.78,"No"
"5169","C7_Immunologic_signatures","C7_ALL_1649_GSE3982_MAC_VS_BASOPHIL_UP",200,-1.484,0.0023,0.008,"No",-1.0224,0.38,1,"No"
"5170","C2_Chemical_and_genetic_perturbations","C2_CGP_2758_MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3",319,-1.484,0,0.069,"No",-1.3279,0.023,0.68,"No"
"5171","C3_TF_targets","C3_TFT_190_V_LMO2COM_01",258,-1.4839,0.0011,0.023,"No",-1.6633,0,0.14,"No"
"5172","C2_Chemical_and_genetic_perturbations","C2_CGP_667_GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION",22,-1.4839,0.036,0.069,"No",-0.8435,0.71,1,"No"
"5173","C6_Oncogenic_signatures","C6_ALL_143_TGFB_UP_V1_DN",186,-1.4838,0.0034,0.015,"No",-1.1703,0.14,0.48,"No"
"5174","C2_Chemical_and_genetic_perturbations","C2_CGP_3013_BROWNE_HCMV_INFECTION_1HR_UP",58,-1.4838,0.024,0.069,"No",-0.9646,0.5,1,"No"
"5175","GO_MF","495403_GO_0015129_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-1.4838,0.051,0.15,"No",-1.3518,0.13,0.69,"No"
"5176","C2_Chemical_and_genetic_perturbations","C2_CGP_83_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN",189,-1.4837,0.0023,0.069,"No",-1.2537,0.056,0.74,"No"
"5177","C2_Chemical_and_genetic_perturbations","C2_CGP_514_OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP",67,-1.4836,0.016,0.069,"No",1.0926,0.3,0.64,"Yes"
"5178","GO_BP","512372_GO_0051494_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION",111,-1.4836,0.014,0.12,"No",-0.9183,0.65,1,"No"
"5179","WikiPathways","198908_WP195_IL_1_SIGNALING_PATHWAY",12,-1.4835,0.057,0.076,"No",0.944,0.5,1,"Yes"
"5180","C2_Chemical_and_genetic_perturbations","C2_CGP_66_ZERBINI_RESPONSE_TO_SULINDAC_UP",9,-1.4835,0.054,0.069,"No",-0.5532,0.95,1,"No"
"5181","WikiPathways","198830_WP694_ARYLAMINE_METABOLISM",7,-1.4834,0.05,0.075,"No",0.5844,0.95,1,"Yes"
"5182","C2_Chemical_and_genetic_perturbations","C2_CGP_1219_NIKOLSKY_BREAST_CANCER_20P13_AMPLICON",8,-1.4832,0.057,0.069,"No",-0.8803,0.61,1,"No"
"5183","C2_Chemical_and_genetic_perturbations","C2_CGP_2536_MIZUKAMI_HYPOXIA_DN",6,-1.4832,0.049,0.069,"No",0.7874,0.73,1,"Yes"
"5184","GO_BP","487865_GO_0001975_RESPONSE_TO_AMPHETAMINE",29,-1.4831,0.044,0.12,"No",-0.7785,0.79,1,"No"
"5185","C2_Chemical_and_genetic_perturbations","C2_CGP_3395_HECKER_IFNB1_TARGETS",91,-1.4829,0.016,0.069,"No",2.0388,0,0.004,"Yes"
"5186","WikiPathways","760636_WP1422_SPHINGOLIPID_METABOLISM",21,-1.4829,0.058,0.075,"No",-0.7747,0.8,1,"No"
"5187","GO_MF","496353_GO_0016307_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY",16,-1.4829,0.057,0.15,"No",-0.9059,0.57,0.98,"No"
"5188","GO_BP","506684_GO_0043654_RECOGNITION_OF_APOPTOTIC_CELL",7,-1.4826,0.057,0.12,"No",1.0869,0.37,0.92,"Yes"
"5189","GO_BP","515458_GO_0070528_PROTEIN_KINASE_C_SIGNALING",12,-1.4824,0.044,0.12,"No",-0.8703,0.62,1,"No"
"5190","GO_BP","510596_GO_0048525_NEGATIVE_REGULATION_OF_VIRAL_PROCESS",84,-1.4823,0.01,0.12,"No",1.3668,0.035,0.59,"Yes"
"5191","C2_Chemical_and_genetic_perturbations","C2_CGP_2680_VALK_AML_CLUSTER_4",30,-1.4822,0.036,0.069,"No",0.7799,0.83,1,"Yes"
"5192","C1_Positional","C1_ALL_319_CHR1Q12",14,-1.4822,0.065,0.33,"No",-1.3542,0.12,0.95,"No"
"5193","GO_BP","505483_GO_0042339_KERATAN_SULFATE_METABOLIC_PROCESS",33,-1.4822,0.037,0.12,"No",0.6516,0.96,1,"Yes"
"5194","GO_BP","501193_GO_0031953_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION",10,-1.4822,0.07,0.12,"No",-1.245,0.22,0.91,"No"
"5195","GO_CC","507396_GO_0044448_CELL_CORTEX_PART",119,-1.482,0.011,0.16,"No",-0.8718,0.76,0.94,"No"
"5196","GO_BP","507526_GO_0045137_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS",193,-1.4818,0.0057,0.12,"No",-0.9044,0.71,1,"No"
"5197","C2_Chemical_and_genetic_perturbations","C2_CGP_2225_HUANG_FOXA2_TARGETS_UP",45,-1.4816,0.026,0.069,"No",-0.9323,0.59,1,"No"
"5198","C3_TF_targets","C3_TFT_267_V_FAC1_01",214,-1.4816,0.0011,0.023,"No",-0.9451,0.63,0.88,"No"
"5199","GO_BP","755341_GO_2001235_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY",174,-1.4815,0.0045,0.12,"No",0.8351,0.9,1,"Yes"
"5200","GO_BP","488539_GO_0002666_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION",8,-1.4815,0.053,0.12,"No",1.1114,0.33,0.89,"Yes"
"5201","GO_BP","494723_GO_0010660_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS",39,-1.4814,0.032,0.12,"No",0.8051,0.78,1,"Yes"
"5202","GO_BP","491965_GO_0007160_CELL_MATRIX_ADHESION",116,-1.4814,0.0098,0.12,"No",0.8814,0.73,1,"Yes"
"5203","GO_BP","518419_GO_0090279_REGULATION_OF_CALCIUM_ION_IMPORT",24,-1.4814,0.037,0.12,"No",0.9575,0.51,1,"Yes"
"5204","GO_BP","499719_GO_0072501_CELLULAR_DIVALENT_INORGANIC_ANION_HOMEOSTASIS",7,-1.4814,0.056,0.12,"No",0.5144,0.98,1,"Yes"
"5205","GO_BP","516308_GO_0071384_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS",39,-1.4813,0.029,0.12,"No",0.9098,0.64,1,"Yes"
"5206","REACTOME","187082_REACT_25024_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION",87,-1.4813,0.021,0.14,"No",0.5807,1,1,"Yes"
"5207","GO_CC","501390_GO_0032154_CLEAVAGE_FURROW",45,-1.4812,0.029,0.16,"No",0.8625,0.73,0.91,"Yes"
"5208","GO_MF","489846_GO_0004497_MONOOXYGENASE_ACTIVITY",95,-1.4809,0.02,0.15,"No",-1.0149,0.44,0.89,"No"
"5209","C2_Chemical_and_genetic_perturbations","C2_CGP_2578_HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN",71,-1.4809,0.023,0.07,"No",-0.9245,0.6,1,"No"
"5210","GO_MF","506249_GO_0043177_ORGANIC_ACID_BINDING",219,-1.4808,0.0011,0.15,"No",0.9643,0.58,0.91,"Yes"
"5211","C4_Cancer_modules","C4_CM_84_MODULE_89",14,-1.4808,0.052,0.063,"No",-1.0009,0.45,0.79,"No"
"5212","GO_BP","510717_GO_0048662_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION",28,-1.4807,0.039,0.12,"No",-0.8889,0.64,1,"No"
"5213","C6_Oncogenic_signatures","C6_ALL_127_CAHOY_ASTROCYTIC",95,-1.4806,0.01,0.015,"No",-1.1624,0.16,0.47,"No"
"5214","C2_Chemical_and_genetic_perturbations","C2_CGP_329_GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN",11,-1.4806,0.06,0.07,"No",0.7547,0.8,1,"Yes"
"5215","C7_Immunologic_signatures","C7_ALL_1587_GSE3982_EOSINOPHIL_VS_DC_UP",195,-1.4805,0,0.0085,"No",0.7298,0.99,1,"Yes"
"5216","C2_Chemical_and_genetic_perturbations","C2_CGP_2484_BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP",47,-1.4804,0.027,0.07,"No",1.1851,0.18,0.51,"Yes"
"5217","C3_TF_targets","C3_TFT_362_V_E12_Q6",259,-1.4804,0,0.023,"No",-1.426,0.0017,0.16,"No"
"5218","C6_Oncogenic_signatures","C6_ALL_135_IL2_UP_V1_DN",184,-1.4803,0.0023,0.015,"No",0.9909,0.46,0.85,"Yes"
"5219","GO_BP","512480_GO_0051602_RESPONSE_TO_ELECTRICAL_STIMULUS",38,-1.4803,0.043,0.12,"No",-0.9246,0.6,1,"No"
"5220","C2_Chemical_and_genetic_perturbations","C2_CGP_2666_IRITANI_MAD1_TARGETS_UP",13,-1.4803,0.049,0.07,"No",1.0837,0.35,0.66,"Yes"
"5221","C3_TF_targets","C3_TFT_86_V_GATA1_02",236,-1.4803,0.0011,0.023,"No",-1.0307,0.36,0.69,"No"
"5222","GO_BP","751029_GO_0036109_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS",11,-1.4802,0.053,0.12,"No",-1.0396,0.39,0.98,"No"
"5223","C3_TF_targets","C3_TFT_1_AAANWWTGC_UNKNOWN",185,-1.4801,0,0.023,"No",-0.8029,0.94,1,"No"
"5224","C2_Chemical_and_genetic_perturbations","C2_CGP_1820_LEE_AGING_NEOCORTEX_UP",88,-1.48,0.015,0.07,"No",-0.7389,0.94,1,"No"
"5225","GO_BP","498709_GO_0048015_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING",129,-1.4798,0.0049,0.12,"No",-1.1234,0.22,0.94,"No"
"5226","C7_Immunologic_signatures","C7_ALL_704_GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_DN",198,-1.4798,0.0034,0.0086,"No",1.4519,0.0025,0.022,"Yes"
"5227","GO_MF","492541_GO_0008200_ION_CHANNEL_INHIBITOR_ACTIVITY",36,-1.4797,0.043,0.15,"No",0.7379,0.9,1,"Yes"
"5228","GO_BP","490964_GO_0005976_POLYSACCHARIDE_METABOLIC_PROCESS",90,-1.4795,0.02,0.12,"No",1.1286,0.21,0.87,"Yes"
"5229","C2_Chemical_and_genetic_perturbations","C2_CGP_2133_KANG_CISPLATIN_RESISTANCE_UP",19,-1.4795,0.055,0.07,"No",-0.9078,0.57,1,"No"
"5230","C2_Chemical_and_genetic_perturbations","C2_CGP_185_JAEGER_METASTASIS_UP",39,-1.4794,0.051,0.07,"No",-0.7857,0.83,1,"No"
"5231","C2_Chemical_and_genetic_perturbations","C2_CGP_1954_HAN_JNK_SINGALING_DN",37,-1.4794,0.028,0.07,"No",1.3221,0.09,0.37,"Yes"
"5232","GO_BP","505830_GO_0042723_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",6,-1.4793,0.053,0.12,"No",-1.0751,0.39,0.96,"No"
"5233","C7_Immunologic_signatures","C7_ALL_1574_GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN",199,-1.4792,0.0022,0.0087,"No",1.1718,0.11,0.28,"Yes"
"5234","C2_Chemical_and_genetic_perturbations","C2_CGP_353_RODRIGUES_THYROID_CARCINOMA_DN",77,-1.4792,0.025,0.07,"No",0.7456,0.94,1,"Yes"
"5235","C2_Chemical_and_genetic_perturbations","C2_CGP_1639_WHITESIDE_CISPLATIN_RESISTANCE_UP",11,-1.4792,0.068,0.07,"No",0.9359,0.56,0.89,"Yes"
"5236","GO_BP","1129549_GO_1903725_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS",54,-1.4791,0.026,0.12,"No",-0.715,0.93,1,"No"
"5237","GO_BP","518556_GO_0097006_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS",43,-1.479,0.033,0.12,"No",-0.7618,0.86,1,"No"
"5238","C6_Oncogenic_signatures","C6_ALL_172_KRAS_50_UP_V1_DN",43,-1.4789,0.034,0.015,"No",0.9341,0.58,0.92,"Yes"
"5239","WikiPathways","198909_WP23_B_CELL_RECEPTOR_SIGNALING_PATHWAY",157,-1.4787,0.0081,0.076,"No",0.7481,0.98,1,"Yes"
"5240","C2_Chemical_and_genetic_perturbations","C2_CGP_1933_SIMBULAN_PARP1_TARGETS_DN",16,-1.4787,0.059,0.07,"No",-1.1213,0.29,0.89,"No"
"5241","C3_TF_targets","C3_TFT_245_V_FOXJ2_02",230,-1.4787,0.0023,0.023,"No",-0.8865,0.79,0.98,"No"
"5242","WikiPathways","198808_WP699_AFLATOXIN_B1_METABOLISM",7,-1.4786,0.044,0.075,"No",-1.1055,0.34,1,"No"
"5243","GO_BP","506358_GO_0043297_APICAL_JUNCTION_ASSEMBLY",45,-1.4786,0.03,0.12,"No",-1.112,0.28,0.94,"No"
"5244","C7_Immunologic_signatures","C7_ALL_858_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN",196,-1.4785,0.0034,0.0087,"No",0.7878,0.98,1,"Yes"
"5245","GO_MF","752701_GO_0097200_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS",7,-1.4785,0.054,0.15,"No",-0.5434,0.97,1,"No"
"5246","C2_BioCarta_Pathways","C2_CP_BIOCARTA_17_BIOCARTA_CHEMICAL_PATHWAY",22,-1.4782,0.042,0.14,"No",-0.7887,0.76,1,"No"
"5247","GO_BP","502907_GO_0033690_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION",10,-1.4782,0.049,0.12,"No",-0.7039,0.85,1,"No"
"5248","GO_MF","492839_GO_0008574_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY_PLUS_END_DIRECTED",18,-1.4782,0.064,0.15,"No",-1.3834,0.11,0.65,"No"
"5249","GO_BP","487899_GO_0002009_MORPHOGENESIS_OF_AN_EPITHELIUM",428,-1.4781,0.0011,0.12,"No",-0.8337,0.97,1,"No"
"5250","GO_BP","502237_GO_0033015_TETRAPYRROLE_CATABOLIC_PROCESS",7,-1.4781,0.06,0.12,"No",-0.6439,0.9,1,"No"
"5251","C7_Immunologic_signatures","C7_ALL_1830_GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN",192,-1.4779,0.0012,0.0088,"No",-1.0171,0.4,1,"No"
"5252","REACTOME","105753_REACT_1846_G2_M_DNA_REPLICATION_CHECKPOINT",5,-1.4778,0.04,0.14,"No",-0.6631,0.86,1,"No"
"5253","C2_Chemical_and_genetic_perturbations","C2_CGP_803_DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN",9,-1.4778,0.068,0.071,"No",-0.502,0.99,1,"No"
"5254","GO_BP","505457_GO_0042311_VASODILATION",29,-1.4777,0.041,0.12,"No",1.4465,0.043,0.5,"Yes"
"5255","GO_BP","505673_GO_0042542_RESPONSE_TO_HYDROGEN_PEROXIDE",87,-1.4777,0.015,0.12,"No",-0.7642,0.91,1,"No"
"5256","GO_BP","493712_GO_0009581_DETECTION_OF_EXTERNAL_STIMULUS",177,-1.4775,0.0035,0.12,"No",-1.2808,0.028,0.89,"No"
"5257","GO_BP","501261_GO_0032024_POSITIVE_REGULATION_OF_INSULIN_SECRETION",51,-1.4775,0.026,0.12,"No",0.6954,0.96,1,"Yes"
"5258","C4_Cancer_modules","C4_CM_167_MODULE_177",100,-1.4775,0.014,0.064,"No",1.3651,0.033,0.21,"Yes"
"5259","C2_Chemical_and_genetic_perturbations","C2_CGP_2038_TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN",15,-1.4774,0.06,0.071,"No",-1.0231,0.44,0.98,"No"
"5260","C7_Immunologic_signatures","C7_ALL_1003_GSE22886_CTRL_VS_LPS_24H_DC_UP",200,-1.4774,0.0034,0.0089,"No",2.1009,0,0,"Yes"
"5261","GO_BP","512014_GO_0051100_NEGATIVE_REGULATION_OF_BINDING",108,-1.4773,0.0061,0.12,"No",1.0615,0.32,0.94,"Yes"
"5262","GO_BP","507420_GO_0045010_ACTIN_NUCLEATION",24,-1.4772,0.048,0.12,"No",0.8434,0.72,1,"Yes"
"5263","REACTOME","106147_REACT_11053_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL",13,-1.4772,0.066,0.14,"No",0.9025,0.58,0.9,"Yes"
"5264","C2_Chemical_and_genetic_perturbations","C2_CGP_2277_KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN",10,-1.4769,0.067,0.071,"No",-1.163,0.26,0.83,"No"
"5265","GO_BP","518616_GO_0097066_RESPONSE_TO_THYROID_HORMONE",15,-1.4767,0.047,0.12,"No",0.5974,0.97,1,"Yes"
"5266","REACTOME","1127590_REACT_267648_DEFECTIVE_CHST3_CAUSES_SEDCJD",6,-1.4767,0.063,0.14,"No",-0.8617,0.63,1,"No"
"5267","GO_MF","490394_GO_0005131_GROWTH_HORMONE_RECEPTOR_BINDING",5,-1.4767,0.051,0.16,"No",-0.9248,0.55,0.96,"No"
"5268","GO_MF","496047_GO_0015925_GALACTOSIDASE_ACTIVITY",6,-1.4766,0.048,0.16,"No",-1.4079,0.1,0.64,"No"
"5269","C7_Immunologic_signatures","C7_ALL_932_GSE22886_NAIVE_VS_MEMORY_TCELL_DN",199,-1.4765,0.0034,0.009,"No",1.4063,0.0069,0.035,"Yes"
"5270","C2_Chemical_and_genetic_perturbations","C2_CGP_17_KORKOLA_EMBRYONAL_CARCINOMA_UP",41,-1.4764,0.042,0.072,"No",1.1231,0.26,0.6,"Yes"
"5271","GO_BP","488104_GO_0002230_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST",19,-1.4763,0.037,0.12,"No",-1.4258,0.077,0.93,"No"
"5272","GO_BP","502359_GO_0033138_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION",83,-1.4763,0.012,0.12,"No",-0.7394,0.95,1,"No"
"5273","REACTOME","1127589_REACT_268113_DEFECTIVE_CHSY1_CAUSES_TPBS",6,-1.4763,0.065,0.14,"No",-0.8618,0.61,1,"No"
"5274","C2_Chemical_and_genetic_perturbations","C2_CGP_457_GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP",182,-1.4762,0.0083,0.072,"No",0.9976,0.44,0.8,"Yes"
"5275","GO_BP","510943_GO_0048895_LATERAL_LINE_NERVE_GLIAL_CELL_DIFFERENTIATION",9,-1.4762,0.057,0.12,"No",-1.3182,0.15,0.89,"No"
"5276","GO_BP","492011_GO_0007213_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY",12,-1.476,0.05,0.12,"No",-0.9166,0.57,1,"No"
"5277","KEGG_pathway","HSA04977_VITAMIN_DIGESTION_AND_ABSORPTION",23,-1.476,0.045,0.041,"No",-1.2214,0.19,0.5,"No"
"5278","C2_BioCarta_Pathways","C2_CP_BIOCARTA_145_BIOCARTA_PTEN_PATHWAY",18,-1.476,0.055,0.14,"No",0.6864,0.9,1,"Yes"
"5279","GO_BP","495263_GO_0014870_RESPONSE_TO_MUSCLE_INACTIVITY",6,-1.4759,0.052,0.12,"No",-1.0293,0.41,0.97,"No"
"5280","C2_Chemical_and_genetic_perturbations","C2_CGP_2320_MATZUK_OVULATION",13,-1.4759,0.052,0.072,"No",0.6422,0.91,1,"Yes"
"5281","GO_BP","501587_GO_0032352_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS",13,-1.4758,0.052,0.12,"No",0.8837,0.6,1,"Yes"
"5282","GO_BP","489291_GO_0006986_RESPONSE_TO_UNFOLDED_PROTEIN",146,-1.4757,0.0093,0.12,"No",-0.9745,0.51,1,"No"
"5283","C2_Chemical_and_genetic_perturbations","C2_CGP_419_NADERI_BREAST_CANCER_PROGNOSIS_UP",49,-1.4756,0.023,0.072,"No",-0.7352,0.9,1,"No"
"5284","GO_MF","499485_GO_0050840_EXTRACELLULAR_MATRIX_BINDING",47,-1.4756,0.031,0.16,"No",0.9749,0.52,0.9,"Yes"
"5285","C7_Immunologic_signatures","C7_ALL_477_GSE17721_CTRL_VS_POLYIC_24H_BMDM_UP",198,-1.4755,0.0046,0.0092,"No",1.4469,0.0023,0.023,"Yes"
"5286","GO_MF","514949_GO_0070008_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY",11,-1.4755,0.055,0.16,"No",-1.084,0.36,0.85,"No"
"5287","GO_BP","488564_GO_0002691_REGULATION_OF_CELLULAR_EXTRAVASATION",13,-1.4754,0.062,0.12,"No",0.7216,0.86,1,"Yes"
"5288","GO_BP","494778_GO_0010713_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS",7,-1.4754,0.061,0.12,"No",0.8442,0.68,1,"Yes"
"5289","GO_CC","499964_GO_0030659_CYTOPLASMIC_VESICLE_MEMBRANE",439,-1.4753,0.001,0.16,"No",1.1585,0.05,0.57,"Yes"
"5290","C2_Chemical_and_genetic_perturbations","C2_CGP_549_TOMIDA_METASTASIS_DN",18,-1.4753,0.043,0.072,"No",0.8014,0.74,0.99,"Yes"
"5291","GO_BP","495203_GO_0014807_REGULATION_OF_SOMITOGENESIS",8,-1.4752,0.06,0.12,"No",-1.5824,0.036,0.71,"No"
"5292","C2_Chemical_and_genetic_perturbations","C2_CGP_2557_MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP",14,-1.4752,0.053,0.072,"No",-0.7933,0.76,1,"No"
"5293","C7_Immunologic_signatures","C7_ALL_1862_GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN",199,-1.4752,0.0023,0.0092,"No",0.7753,0.98,1,"Yes"
"5294","KEGG_compound","C00836_SPHINGANINE_DIHYDROSPHINGOSINE_2_AMINO_1_3_DIHYDROXYOCTADECANE",17,-1.4752,0.059,0.19,"No",-0.9556,0.5,1,"No"
"5295","C2_Chemical_and_genetic_perturbations","C2_CGP_2834_LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN",16,-1.4751,0.057,0.072,"No",-1.1346,0.29,0.87,"No"
"5296","GO_MF","490493_GO_0005272_SODIUM_CHANNEL_ACTIVITY",34,-1.4749,0.039,0.16,"No",-1.386,0.066,0.65,"No"
"5297","REACTOME","106244_REACT_16936_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC",27,-1.4748,0.043,0.15,"No",1.2226,0.19,0.42,"Yes"
"5298","GO_BP","493916_GO_0009812_FLAVONOID_METABOLIC_PROCESS",28,-1.4747,0.04,0.12,"No",1.5151,0.045,0.39,"Yes"
"5299","C2_Chemical_and_genetic_perturbations","C2_CGP_2502_RAY_ALZHEIMERS_DISEASE",12,-1.4747,0.052,0.072,"No",1.0374,0.39,0.74,"Yes"
"5300","GO_BP","511637_GO_0050665_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS",9,-1.4747,0.04,0.12,"No",0.7678,0.78,1,"Yes"
"5301","GO_MF","492468_GO_0008106_ALCOHOL_DEHYDROGENASE_NADP_ACTIVITY",12,-1.4746,0.046,0.16,"No",0.8229,0.72,1,"Yes"
"5302","GO_MF","498062_GO_0019207_KINASE_REGULATOR_ACTIVITY",146,-1.4746,0.0072,0.15,"No",0.7797,0.97,1,"Yes"
"5303","GO_CC","501389_GO_0032153_CELL_DIVISION_SITE",48,-1.4746,0.03,0.16,"No",0.8679,0.73,0.91,"Yes"
"5304","GO_BP","948110_GO_1902667_REGULATION_OF_AXON_GUIDANCE",17,-1.4745,0.048,0.12,"No",-0.9505,0.54,1,"No"
"5305","C7_Immunologic_signatures","C7_ALL_1384_GSE339_CD4POS_VS_CD8POS_DC_DN",198,-1.4744,0.0034,0.0093,"No",1.1406,0.15,0.34,"Yes"
"5306","GO_BP","492300_GO_0007548_SEX_DIFFERENTIATION",247,-1.4743,0,0.12,"No",-0.8916,0.76,1,"No"
"5307","C4_Cancer_modules","C4_CM_244_MODULE_275",16,-1.4742,0.055,0.065,"No",-1.0566,0.37,0.72,"No"
"5308","GO_MF","499870_GO_0030544_HSP70_PROTEIN_BINDING",24,-1.4741,0.069,0.15,"No",-0.8208,0.74,1,"No"
"5309","C2_Chemical_and_genetic_perturbations","C2_CGP_261_LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP",14,-1.4741,0.064,0.072,"No",-1.3605,0.12,0.66,"No"
"5310","C2_Chemical_and_genetic_perturbations","C2_CGP_2378_RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN",155,-1.4741,0.0059,0.072,"No",-0.8434,0.85,1,"No"
"5311","C2_Chemical_and_genetic_perturbations","C2_CGP_125_DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN",312,-1.4739,0.0021,0.072,"No",1.5656,0,0.16,"Yes"
"5312","C2_Chemical_and_genetic_perturbations","C2_CGP_3389_ZWANG_EGF_INTERVAL_UP",91,-1.4738,0.016,0.072,"No",-1.1743,0.17,0.83,"No"
"5313","C3_TF_targets","C3_TFT_58_V_IK1_01",269,-1.4737,0,0.025,"No",-1.4249,0.005,0.15,"No"
"5314","GO_BP","503837_GO_0034637_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS",58,-1.4737,0.025,0.12,"No",0.9871,0.47,0.99,"Yes"
"5315","GO_BP","518358_GO_0090218_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY",28,-1.4737,0.047,0.12,"No",-0.6882,0.93,1,"No"
"5316","REACTOME","1127519_REACT_264242_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX",86,-1.4735,0.021,0.15,"No",-1.689,0.0019,0.18,"No"
"5317","REACTOME","530734_REACT_115755_SIGNALING_BY_ERBB2",157,-1.4735,0.0012,0.15,"No",-1.0078,0.42,0.99,"No"
"5318","GO_BP","518965_GO_2000319_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION",6,-1.4735,0.055,0.12,"No",-1.5386,0.051,0.76,"No"
"5319","GO_BP","488452_GO_0002579_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION",10,-1.4735,0.054,0.12,"No",-0.9774,0.5,1,"No"
"5320","GO_MF","501784_GO_0032554_PURINE_DEOXYRIBONUCLEOTIDE_BINDING",7,-1.4734,0.047,0.16,"No",1.343,0.15,0.53,"Yes"
"5321","C0_Hallmark","H_ALL_40_HALLMARK_ANGIOGENESIS",36,-1.4733,0.032,0.015,"No",1.5673,0.011,0.013,"Yes"
"5322","C7_Immunologic_signatures","C7_ALL_440_GSE17580_TREG_VS_TEFF_DN",197,-1.4732,0.0045,0.0095,"No",0.8033,0.96,1,"Yes"
"5323","C3_TF_targets","C3_TFT_164_V_MEF2_03",231,-1.4732,0.0022,0.025,"No",-1.4999,0,0.13,"No"
"5324","C2_Chemical_and_genetic_perturbations","C2_CGP_441_GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP",205,-1.4732,0.0023,0.073,"No",1.3914,0.012,0.3,"Yes"
"5325","GO_MF","487381_GO_0001159_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING",253,-1.4731,0,0.16,"No",-0.9293,0.65,0.97,"No"
"5326","C7_Immunologic_signatures","C7_ALL_454_GSE17721_CTRL_VS_LPS_4H_BMDM_DN",195,-1.4728,0.0046,0.0096,"No",-0.9322,0.63,1,"No"
"5327","KEGG_compound","C00486_BILIRUBIN",21,-1.4727,0.052,0.2,"No",1.739,0.0062,0.06,"Yes"
"5328","C3_TF_targets","C3_TFT_283_V_FOXO4_01",238,-1.4726,0,0.025,"No",-0.8678,0.83,0.99,"No"
"5329","C3_TF_targets","C3_TFT_202_V_FREAC4_01",146,-1.4726,0.007,0.025,"No",-0.8188,0.9,1,"No"
"5330","C2_Chemical_and_genetic_perturbations","C2_CGP_2246_ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP",124,-1.4726,0.0074,0.073,"No",0.8993,0.71,0.93,"Yes"
"5331","C7_Immunologic_signatures","C7_ALL_649_GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_UP",193,-1.4726,0.0034,0.0096,"No",1.4093,0.007,0.035,"Yes"
"5332","C7_Immunologic_signatures","C7_ALL_665_GSE17721_LPS_VS_CPG_12H_BMDM_UP",196,-1.4725,0.0023,0.0096,"No",1.5665,0,0.005,"Yes"
"5333","C2_Chemical_and_genetic_perturbations","C2_CGP_616_APPIERTO_RESPONSE_TO_FENRETINIDE_UP",37,-1.4725,0.028,0.073,"No",-0.9318,0.57,1,"No"
"5334","C7_Immunologic_signatures","C7_ALL_415_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP",192,-1.4724,0.0033,0.0096,"No",1.0938,0.21,0.46,"Yes"
"5335","GO_BP","750799_GO_0002934_DESMOSOME_ORGANIZATION",9,-1.4723,0.049,0.12,"No",0.6096,0.94,1,"Yes"
"5336","GO_BP","515517_GO_0070587_REGULATION_OF_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION",7,-1.4723,0.071,0.12,"No",-1.3649,0.13,0.98,"No"
"5337","KEGG_reaction","R07055_LINOLEATE_OXYGEN_NADPH_H_9_10_EPOME_NADP_H2O",7,-1.4723,0.061,0.2,"No",-0.9562,0.51,0.83,"No"
"5338","GO_BP","502278_GO_0033057_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_BEHAVIOR",23,-1.4723,0.042,0.12,"No",0.5044,1,1,"Yes"
"5339","C3_TF_targets","C3_TFT_365_V_HEB_Q6",261,-1.4723,0.0011,0.024,"No",-1.2221,0.057,0.31,"No"
"5340","C2_Chemical_and_genetic_perturbations","C2_CGP_3229_IKEDA_MIR133_TARGETS_DN",8,-1.4723,0.066,0.073,"No",1.0018,0.44,0.8,"Yes"
"5341","GO_CC","490653_GO_0005578_PROTEINACEOUS_EXTRACELLULAR_MATRIX",331,-1.4723,0,0.16,"No",-1.1779,0.078,0.68,"No"
"5342","GO_BP","499663_GO_0030258_LIPID_MODIFICATION",136,-1.4723,0.0084,0.12,"No",0.7094,0.99,1,"Yes"
"5343","GO_CC","507561_GO_0045179_APICAL_CORTEX",6,-1.4722,0.073,0.16,"No",-0.876,0.63,0.96,"No"
"5344","C3_TF_targets","C3_TFT_436_GGARNTKYCCA_UNKNOWN",74,-1.4721,0.016,0.024,"No",-0.8822,0.7,0.98,"No"
"5345","KEGG_compound","C05827_METHYLIMIDAZOLE_ACETALDEHYDE_1_METHYLIMIDAZOLE_4_ACETALDEHYDE_METHYLIMIDAZOLEACETALDEHYDE",7,-1.4721,0.048,0.2,"No",0.9407,0.52,1,"Yes"
"5346","GO_BP","500916_GO_0031667_RESPONSE_TO_NUTRIENT_LEVELS",390,-1.4721,0,0.12,"No",-0.8643,0.9,1,"No"
"5347","C2_Chemical_and_genetic_perturbations","C2_CGP_485_TANG_SENESCENCE_TP53_TARGETS_UP",32,-1.472,0.047,0.073,"No",0.9581,0.52,0.86,"Yes"
"5348","GO_BP","498207_GO_0019363_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",18,-1.4719,0.048,0.12,"No",-1.026,0.41,0.98,"No"
"5349","C2_Chemical_and_genetic_perturbations","C2_CGP_1438_OSAWA_TNF_TARGETS",10,-1.4719,0.071,0.073,"No",-1.2868,0.18,0.69,"No"
"5350","GO_BP","492880_GO_0008631_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS",19,-1.4718,0.062,0.12,"No",-0.8519,0.68,1,"No"
"5351","GO_BP","514229_GO_0060674_PLACENTA_BLOOD_VESSEL_DEVELOPMENT",31,-1.4718,0.041,0.12,"No",-1.1346,0.26,0.93,"No"
"5352","C2_Chemical_and_genetic_perturbations","C2_CGP_641_CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN",29,-1.4717,0.039,0.073,"No",1.5435,0.021,0.17,"Yes"
"5353","GO_BP","487781_GO_0001885_ENDOTHELIAL_CELL_DEVELOPMENT",46,-1.4717,0.033,0.12,"No",0.6858,0.95,1,"Yes"
"5354","C7_Immunologic_signatures","C7_ALL_1500_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN",200,-1.4717,0.0022,0.0097,"No",-0.7502,0.98,1,"No"
"5355","GO_BP","754604_GO_1901652_RESPONSE_TO_PEPTIDE",416,-1.4717,0,0.12,"No",-0.7796,0.99,1,"No"
"5356","GO_BP","498564_GO_0019751_POLYOL_METABOLIC_PROCESS",100,-1.4716,0.016,0.12,"No",-1.1533,0.21,0.92,"No"
"5357","C6_Oncogenic_signatures","C6_ALL_52_P53_DN_V1_UP",183,-1.4716,0.007,0.016,"No",0.9001,0.76,0.96,"Yes"
"5358","C2_Chemical_and_genetic_perturbations","C2_CGP_2519_MARSHALL_VIRAL_INFECTION_RESPONSE_UP",7,-1.4716,0.061,0.073,"No",0.9912,0.46,0.81,"Yes"
"5359","GO_BP","493264_GO_0009063_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS",111,-1.4713,0.0086,0.12,"No",-0.7817,0.9,1,"No"
"5360","C2_BioCarta_Pathways","C2_CP_BIOCARTA_42_BIOCARTA_COMP_PATHWAY",18,-1.4712,0.047,0.14,"No",-0.9618,0.5,1,"No"
"5361","GO_BP","499316_GO_0022037_METENCEPHALON_DEVELOPMENT",96,-1.4711,0.01,0.12,"No",-1.233,0.12,0.9,"No"
"5362","C2_Chemical_and_genetic_perturbations","C2_CGP_285_TIEN_INTESTINE_PROBIOTICS_2HR_UP",27,-1.4711,0.034,0.073,"No",1.6654,0.013,0.1,"Yes"
"5363","GO_BP","487571_GO_0001658_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS",45,-1.4711,0.033,0.12,"No",0.8537,0.75,1,"Yes"
"5364","GO_BP","498518_GO_0019695_CHOLINE_METABOLIC_PROCESS",6,-1.4711,0.061,0.12,"No",-1.2494,0.2,0.91,"No"
"5365","GO_MF","487200_GO_0000976_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",439,-1.471,0,0.16,"No",-1.1927,0.051,0.79,"No"
"5366","C7_Immunologic_signatures","C7_ALL_1290_GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN",198,-1.471,0.0011,0.0098,"No",1.9032,0,0,"Yes"
"5367","GO_BP","493308_GO_0009109_COENZYME_CATABOLIC_PROCESS",73,-1.4709,0.021,0.12,"No",1.0914,0.28,0.92,"Yes"
"5368","GO_BP","514230_GO_0060675_URETERIC_BUD_MORPHOGENESIS",52,-1.4708,0.03,0.12,"No",0.7615,0.87,1,"Yes"
"5369","GO_BP","492168_GO_0007405_NEUROBLAST_PROLIFERATION",27,-1.4707,0.058,0.12,"No",-0.8071,0.77,1,"No"
"5370","GO_BP","486790_GO_0000271_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS",52,-1.4705,0.029,0.12,"No",1.0837,0.31,0.92,"Yes"
"5371","OMIM_gene","OMIM602940_MARCKS_LIKE_PROTEIN_1_MARCKSL1",5,-1.4705,0.056,1,"No",-1.4066,0.11,0.66,"No"
"5372","C2_Chemical_and_genetic_perturbations","C2_CGP_2880_ZHAN_MULTIPLE_MYELOMA_CD1_DN",44,-1.4705,0.045,0.074,"No",-1.0569,0.37,0.97,"No"
"5373","REACTOME","160138_REACT_21328_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES",30,-1.4704,0.035,0.15,"No",-1.1695,0.23,0.85,"No"
"5374","KEGG_compound","C00006_NADP_NADP_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE_BETA_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE_TPN_TRIPHOSPHOPYRIDINE_NUCLEOTIDE_BETA_NADP_",145,-1.4704,0.0082,0.2,"No",-0.7079,0.99,1,"No"
"5375","C2_Chemical_and_genetic_perturbations","C2_CGP_1028_GOUYER_TATI_TARGETS_UP",10,-1.4704,0.07,0.074,"No",0.763,0.82,1,"Yes"
"5376","C2_Chemical_and_genetic_perturbations","C2_CGP_2757_YAGI_AML_WITH_11Q23_REARRANGED",347,-1.4704,0.0011,0.074,"No",0.8162,0.98,0.98,"Yes"
"5377","REACTOME","160978_REACT_380_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS",19,-1.4704,0.056,0.15,"No",0.6523,0.94,1,"Yes"
"5378","C3_TF_targets","C3_TFT_99_V_OCT1_04",227,-1.4703,0.0011,0.025,"No",-1.0737,0.29,0.61,"No"
"5379","GO_BP","518547_GO_0090407_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS",456,-1.4703,0,0.12,"No",-0.7833,1,1,"No"
"5380","C7_Immunologic_signatures","C7_ALL_466_GSE17721_CTRL_VS_POLYIC_1H_BMDM_DN",195,-1.4703,0.0023,0.0099,"No",-1.1011,0.23,1,"No"
"5381","C2_Chemical_and_genetic_perturbations","C2_CGP_2171_MASSARWEH_RESPONSE_TO_ESTRADIOL",61,-1.4703,0.023,0.073,"No",-0.8519,0.76,1,"No"
"5382","GO_BP","504251_GO_0035066_POSITIVE_REGULATION_OF_HISTONE_ACETYLATION",19,-1.4703,0.042,0.12,"No",-1.2021,0.22,0.89,"No"
"5383","C3_MicroRNA_targets","C3_MIR_118_GGCAGCT_MIR_22",231,-1.4702,0.0044,0.24,"No",-1.2264,0.073,1,"No"
"5384","C2_Chemical_and_genetic_perturbations","C2_CGP_3197_DUAN_PRDM5_TARGETS",78,-1.47,0.027,0.074,"No",-1.4117,0.031,0.58,"No"
"5385","REACTOME","730336_REACT_150422_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES",6,-1.47,0.053,0.15,"No",-0.7029,0.83,1,"No"
"5386","C7_Immunologic_signatures","C7_ALL_1879_GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP",198,-1.47,0.0045,0.0099,"No",0.8776,0.82,1,"Yes"
"5387","REACTOME","1183556_REACT_355289_SIGNALING_BY_FGFR1",157,-1.4699,0.0036,0.15,"No",-0.9397,0.62,1,"No"
"5388","C2_Chemical_and_genetic_perturbations","C2_CGP_2264_SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP",6,-1.4698,0.047,0.074,"No",1.4748,0.065,0.23,"Yes"
"5389","C4_Cancer_modules","C4_CM_390_MODULE_491",78,-1.4698,0.024,0.067,"No",-0.769,0.92,1,"No"
"5390","GO_BP","498549_GO_0019730_ANTIMICROBIAL_HUMORAL_RESPONSE",33,-1.4697,0.038,0.12,"No",1.6232,0.013,0.27,"Yes"
"5391","GO_BP","508885_GO_0046637_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION",42,-1.4697,0.029,0.12,"No",-1.1979,0.19,0.9,"No"
"5392","GO_BP","753998_GO_1901028_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",42,-1.4696,0.032,0.12,"No",-0.7548,0.87,1,"No"
"5393","GO_BP","812240_GO_1902117_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY",29,-1.4695,0.048,0.12,"No",-0.5889,0.98,1,"No"
"5394","GO_CC","506709_GO_0043679_AXON_TERMINUS",76,-1.4694,0.022,0.17,"No",1.0881,0.3,0.67,"Yes"
"5395","GO_BP","516302_GO_0071378_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS",27,-1.4694,0.041,0.12,"No",-0.4385,1,1,"No"
"5396","C2_Chemical_and_genetic_perturbations","C2_CGP_987_GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN",103,-1.4693,0.01,0.074,"No",-0.8556,0.79,1,"No"
"5397","GO_BP","505329_GO_0042167_HEME_CATABOLIC_PROCESS",7,-1.4692,0.062,0.12,"No",-0.6512,0.91,1,"No"
"5398","C2_Chemical_and_genetic_perturbations","C2_CGP_2670_ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP",15,-1.4692,0.056,0.074,"No",0.9666,0.48,0.84,"Yes"
"5399","GO_MF","511517_GO_0050544_ARACHIDONIC_ACID_BINDING",5,-1.4692,0.05,0.16,"No",1.5859,0.027,0.3,"Yes"
"5400","C2_Chemical_and_genetic_perturbations","C2_CGP_306_KIM_WT1_TARGETS_DN",457,-1.4692,0,0.074,"No",0.8759,0.93,0.95,"Yes"
"5401","C2_Chemical_and_genetic_perturbations","C2_CGP_107_PRAMOONJAGO_SOX4_TARGETS_DN",51,-1.469,0.023,0.074,"No",1.2239,0.15,0.46,"Yes"
"5402","GO_MF","509171_GO_0046982_PROTEIN_HETERODIMERIZATION_ACTIVITY",437,-1.469,0,0.16,"No",-0.9736,0.54,0.94,"No"
"5403","GO_BP","518757_GO_2000108_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS",28,-1.469,0.04,0.12,"No",-0.6896,0.93,1,"No"
"5404","GO_BP","488698_GO_0002825_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE",20,-1.4689,0.048,0.12,"No",-1.1251,0.28,0.94,"No"
"5405","C2_Chemical_and_genetic_perturbations","C2_CGP_1799_SU_KIDNEY",15,-1.4689,0.056,0.074,"No",-1.3531,0.091,0.67,"No"
"5406","GO_BP","513636_GO_0060078_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL",58,-1.4688,0.028,0.12,"No",-1.1619,0.19,0.91,"No"
"5407","GO_BP","487718_GO_0001822_KIDNEY_DEVELOPMENT",243,-1.4688,0.0022,0.12,"No",-1.1096,0.18,0.94,"No"
"5408","REACTOME","105695_REACT_1391_ERK1_ACTIVATION",10,-1.4688,0.061,0.15,"No",-0.9432,0.54,1,"No"
"5409","GO_BP","752693_GO_0097192_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",37,-1.4686,0.04,0.12,"No",-0.8584,0.68,1,"No"
"5410","GO_BP","518059_GO_0080135_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS",473,-1.4686,0,0.12,"No",0.8704,0.95,1,"Yes"
"5411","C4_Cancer_modules","C4_CM_404_MODULE_519",15,-1.4686,0.064,0.067,"No",-0.6571,0.91,1,"No"
"5412","C2_Chemical_and_genetic_perturbations","C2_CGP_994_MANTOVANI_NFKB_TARGETS_UP",43,-1.4685,0.036,0.074,"No",0.7773,0.84,1,"Yes"
"5413","GO_BP","488124_GO_0002251_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE",37,-1.4684,0.022,0.13,"No",0.9502,0.52,1,"Yes"
"5414","C2_Chemical_and_genetic_perturbations","C2_CGP_27_HOLLMANN_APOPTOSIS_VIA_CD40_UP",199,-1.4684,0.0034,0.074,"No",1.2915,0.03,0.4,"Yes"
"5415","C7_Immunologic_signatures","C7_ALL_283_GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP",200,-1.4684,0.0011,0.01,"No",1.1414,0.15,0.34,"Yes"
"5416","GO_BP","508077_GO_0045736_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",27,-1.4684,0.048,0.13,"No",-0.6019,0.98,1,"No"
"5417","GO_BP","518377_GO_0090237_REGULATION_OF_ARACHIDONIC_ACID_SECRETION",5,-1.4682,0.052,0.13,"No",-0.6752,0.84,1,"No"
"5418","C2_Chemical_and_genetic_perturbations","C2_CGP_2830_STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA",18,-1.4682,0.055,0.074,"No",0.6937,0.88,1,"Yes"
"5419","GO_BP","518925_GO_2000278_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS",39,-1.4682,0.037,0.13,"No",0.548,1,1,"Yes"
"5420","C2_Chemical_and_genetic_perturbations","C2_CGP_692_FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL",324,-1.4681,0,0.074,"No",1.0234,0.38,0.77,"Yes"
"5421","C7_Immunologic_signatures","C7_ALL_670_GSE17721_LPS_VS_CPG_24H_BMDM_DN",200,-1.4681,0.0023,0.01,"No",1.6513,0,0.0012,"Yes"
"5422","KEGG_compound","C11554_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_BISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_4_BISPHOSPHATE_",12,-1.468,0.066,0.2,"No",-0.9912,0.46,1,"No"
"5423","KEGG_pathway","HSA05310_ASTHMA",27,-1.4679,0.033,0.044,"No",-1.1322,0.29,0.65,"No"
"5424","GO_BP","492162_GO_0007398_ECTODERM_DEVELOPMENT",20,-1.4679,0.064,0.13,"No",-1.4267,0.067,0.93,"No"
"5425","C6_Oncogenic_signatures","C6_ALL_9_GCNP_SHH_UP_EARLY_V1_DN",157,-1.4678,0.0058,0.017,"No",-1.039,0.35,0.58,"No"
"5426","C2_Chemical_and_genetic_perturbations","C2_CGP_60_GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP",30,-1.4677,0.044,0.074,"No",-0.606,0.99,1,"No"
"5427","GO_BP","492367_GO_0007626_LOCOMOTORY_BEHAVIOR",173,-1.4676,0.0058,0.13,"No",-1.0275,0.38,0.97,"No"
"5428","C3_MicroRNA_targets","C3_MIR_132_GGCAGTG_MIR_324_3P",96,-1.4676,0.013,0.23,"No",-0.9437,0.58,1,"No"
"5429","C3_TF_targets","C3_TFT_10_V_SP1_01",231,-1.4676,0.0022,0.025,"No",-1.5232,0.0016,0.14,"No"
"5430","KEGG_reaction","R09420_CARBONYL_REDUCTASE_4_N_NITROSOMETHYLAMINO_1_3_PYRIDYL_1_BUTANONE_NADPH_H_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_NADP_",6,-1.4675,0.058,0.2,"No",-0.5553,0.96,1,"No"
"5431","C2_Chemical_and_genetic_perturbations","C2_CGP_756_XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP",10,-1.4674,0.068,0.074,"No",0.8545,0.63,0.97,"Yes"
"5432","C3_TF_targets","C3_TFT_50_V_EVI1_02",128,-1.4673,0.0024,0.025,"No",-1.0024,0.45,0.75,"No"
"5433","GO_BP","512186_GO_0051302_REGULATION_OF_CELL_DIVISION",248,-1.4672,0,0.13,"No",0.8483,0.92,1,"Yes"
"5434","C7_Immunologic_signatures","C7_ALL_987_GSE22886_NAIVE_CD8_TCELL_VS_DC_UP",198,-1.4671,0.0023,0.01,"No",1.7624,0,0.00026,"Yes"
"5435","GO_BP","754482_GO_1901522_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS",23,-1.467,0.049,0.13,"No",0.951,0.53,1,"Yes"
"5436","REACTOME","106523_REACT_15293_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE",23,-1.467,0.047,0.15,"No",-1.1135,0.28,0.88,"No"
"5437","C3_TF_targets","C3_TFT_191_V_LMO2COM_02",235,-1.4669,0.0022,0.025,"No",-1.0589,0.31,0.64,"No"
"5438","GO_BP","506441_GO_0043403_SKELETAL_MUSCLE_TISSUE_REGENERATION",22,-1.4667,0.052,0.13,"No",-0.9891,0.47,1,"No"
"5439","GO_CC","513754_GO_0060198_CLATHRIN_SCULPTED_VESICLE",11,-1.4666,0.066,0.17,"No",-0.7646,0.76,1,"No"
"5440","KEGG_compound","C00137_MYO_INOSITOL_D_MYO_INOSITOL_1D_MYO_INOSITOL_L_MYO_INOSITOL_1L_MYO_INOSITOL_MESO_INOSITOL_INOSITOL_DAMBOSE_CYCLOHEXITOL_MEAT_SUGAR_BIOS_I",6,-1.4665,0.048,0.2,"No",-1.2582,0.22,0.7,"No"
"5441","C7_Immunologic_signatures","C7_ALL_385_GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP",200,-1.4664,0.0045,0.01,"No",1.2503,0.045,0.15,"Yes"
"5442","GO_BP","506949_GO_0043931_OSSIFICATION_INVOLVED_IN_BONE_MATURATION",12,-1.4663,0.059,0.13,"No",-0.661,0.89,1,"No"
"5443","GO_BP","505048_GO_0035879_PLASMA_MEMBRANE_LACTATE_TRANSPORT",7,-1.4663,0.055,0.13,"No",-1.0545,0.38,0.97,"No"
"5444","GO_BP","503593_GO_0034391_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS",12,-1.4662,0.064,0.13,"No",-0.7566,0.8,1,"No"
"5445","GO_BP","508447_GO_0046149_PIGMENT_CATABOLIC_PROCESS",7,-1.4661,0.045,0.13,"No",-0.6267,0.91,1,"No"
"5446","GO_BP","491796_GO_0006949_SYNCYTIUM_FORMATION",26,-1.4659,0.05,0.13,"No",-1.2317,0.17,0.9,"No"
"5447","GO_BP","499683_GO_0030279_NEGATIVE_REGULATION_OF_OSSIFICATION",63,-1.4656,0.025,0.13,"No",-1.0401,0.38,0.98,"No"
"5448","C2_Chemical_and_genetic_perturbations","C2_CGP_3371_SMIRNOV_RESPONSE_TO_IR_6HR_UP",165,-1.4656,0.0046,0.075,"No",0.7426,0.98,1,"Yes"
"5449","GO_MF","487211_GO_0000987_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",252,-1.4655,0.0011,0.16,"No",-0.9276,0.67,0.97,"No"
"5450","GO_BP","511792_GO_0050847_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY",6,-1.4655,0.06,0.13,"No",0.7364,0.77,1,"Yes"
"5451","C3_TF_targets","C3_TFT_486_V_DR3_Q4",143,-1.4654,0.0085,0.025,"No",-1.3845,0.022,0.17,"No"
"5452","GO_BP","494591_GO_0010522_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",78,-1.4654,0.021,0.13,"No",0.9501,0.59,1,"Yes"
"5453","C2_Chemical_and_genetic_perturbations","C2_CGP_421_MARKEY_RB1_CHRONIC_LOF_UP",111,-1.4653,0.0099,0.075,"No",0.7701,0.94,1,"Yes"
"5454","GO_MF","487270_GO_0001047_CORE_PROMOTER_BINDING",130,-1.4653,0.0083,0.16,"No",-0.766,0.95,1,"No"
"5455","C2_Chemical_and_genetic_perturbations","C2_CGP_1806_MOREIRA_RESPONSE_TO_TSA_UP",28,-1.4652,0.053,0.075,"No",0.8687,0.68,0.96,"Yes"
"5456","GO_CC","487593_GO_0005858_AXONEMAL_DYNEIN_COMPLEX",12,-1.4651,0.055,0.17,"No",-1.7461,0.0057,0.17,"No"
"5457","GO_BP","496543_GO_0016601_RAC_PROTEIN_SIGNAL_TRANSDUCTION",18,-1.4649,0.061,0.13,"No",0.7294,0.85,1,"Yes"
"5458","GO_CC","490912_GO_0005913_CELL_CELL_ADHERENS_JUNCTION",46,-1.4649,0.046,0.17,"No",-0.9557,0.53,0.89,"No"
"5459","C2_Chemical_and_genetic_perturbations","C2_CGP_1870_BURTON_ADIPOGENESIS_7",51,-1.4648,0.028,0.076,"No",1.1987,0.15,0.49,"Yes"
"5460","GO_MF","496265_GO_0016176_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY",5,-1.4647,0.04,0.16,"No",0.7721,0.73,1,"Yes"
"5461","GO_BP","755163_GO_2001057_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS",34,-1.4647,0.042,0.13,"No",-0.7128,0.92,1,"No"
"5462","GO_BP","501646_GO_0032414_POSITIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",52,-1.4645,0.037,0.13,"No",-1.1321,0.24,0.93,"No"
"5463","C2_Chemical_and_genetic_perturbations","C2_CGP_2429_CROMER_TUMORIGENESIS_DN",44,-1.4644,0.034,0.076,"No",1.1139,0.27,0.61,"Yes"
"5464","GO_BP","491801_GO_0006958_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY",30,-1.4644,0.043,0.13,"No",1.0258,0.4,0.97,"Yes"
"5465","GO_BP","512655_GO_0051783_REGULATION_OF_NUCLEAR_DIVISION",150,-1.4644,0.0048,0.13,"No",-0.8982,0.72,1,"No"
"5466","GO_BP","491660_GO_0006787_PORPHYRIN_CONTAINING_COMPOUND_CATABOLIC_PROCESS",7,-1.4644,0.057,0.13,"No",-0.6337,0.91,1,"No"
"5467","C2_Chemical_and_genetic_perturbations","C2_CGP_3283_PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN",30,-1.4644,0.041,0.076,"No",0.716,0.92,1,"Yes"
"5468","KEGG_compound","C00637_INDOLE_3_ACETALDEHYDE_2_INDOL_3_YL_ACETALDEHYDE_INDOLEACETALDEHYDE",8,-1.4644,0.06,0.2,"No",0.8144,0.69,1,"Yes"
"5469","C7_Immunologic_signatures","C7_ALL_1585_GSE3982_EOSINOPHIL_VS_MAST_CELL_UP",196,-1.4643,0.0045,0.011,"No",0.7195,1,1,"Yes"
"5470","KEGG_pathway","HSA01130_BIOSYNTHESIS_OF_ANTIBIOTICS",208,-1.464,0.0011,0.045,"No",1.0587,0.3,0.85,"Yes"
"5471","GO_BP","506651_GO_0043620_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS",57,-1.464,0.017,0.13,"No",0.7046,0.95,1,"Yes"
"5472","GO_BP","511927_GO_0050994_REGULATION_OF_LIPID_CATABOLIC_PROCESS",42,-1.4638,0.025,0.13,"No",-1.2382,0.18,0.91,"No"
"5473","GO_MF","490203_GO_0004908_INTERLEUKIN_1_RECEPTOR_ACTIVITY",7,-1.4635,0.048,0.16,"No",1.4721,0.067,0.4,"Yes"
"5474","GO_BP","514844_GO_0061299_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",11,-1.4635,0.082,0.13,"No",0.8191,0.7,1,"Yes"
"5475","GO_BP","507767_GO_0045410_POSITIVE_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS",7,-1.4634,0.047,0.13,"No",-1.135,0.32,0.93,"No"
"5476","C2_Chemical_and_genetic_perturbations","C2_CGP_1414_YE_METASTATIC_LIVER_CANCER",26,-1.4634,0.05,0.076,"No",0.6009,0.99,1,"Yes"
"5477","GO_MF","496470_GO_0016502_NUCLEOTIDE_RECEPTOR_ACTIVITY",33,-1.4633,0.035,0.16,"No",1.2807,0.14,0.63,"Yes"
"5478","WikiPathways","198823_WP545_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY",17,-1.4632,0.057,0.084,"No",0.8649,0.66,1,"Yes"
"5479","C2_Chemical_and_genetic_perturbations","C2_CGP_873_SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN",31,-1.4632,0.045,0.076,"No",1.1193,0.29,0.6,"Yes"
"5480","KEGG_pathway","HSA00603_GLYCOSPHINGOLIPID_BIOSYNTHESIS",14,-1.4632,0.063,0.045,"No",-0.7767,0.76,1,"No"
"5481","C7_Immunologic_signatures","C7_ALL_1138_GSE2706_2H_VS_8H_R848_STIM_DC_DN",189,-1.4631,0.0023,0.011,"No",1.1617,0.1,0.3,"Yes"
"5482","C4_Cancer_modules","C4_CM_319_MODULE_373",22,-1.463,0.058,0.069,"No",-1.3866,0.095,0.52,"No"
"5483","C2_Chemical_and_genetic_perturbations","C2_CGP_496_JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP",57,-1.463,0.027,0.076,"No",1.4549,0.02,0.25,"Yes"
"5484","C3_TF_targets","C3_TFT_48_V_GATA3_01",234,-1.463,0.0022,0.026,"No",-0.9978,0.48,0.76,"No"
"5485","GO_BP","752785_GO_0097284_HEPATOCYTE_APOPTOTIC_PROCESS",13,-1.463,0.062,0.13,"No",0.8943,0.59,1,"Yes"
"5486","GO_BP","494602_GO_0010533_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY",8,-1.4629,0.085,0.13,"No",-1.1187,0.34,0.94,"No"
"5487","C2_Chemical_and_genetic_perturbations","C2_CGP_2404_THUM_MIR21_TARGETS_HEART_DISEASE_DN",8,-1.4628,0.065,0.076,"No",-1.091,0.37,0.93,"No"
"5488","GO_BP","754605_GO_1901653_CELLULAR_RESPONSE_TO_PEPTIDE",296,-1.4628,0.0022,0.13,"No",-0.7546,0.99,1,"No"
"5489","C2_Chemical_and_genetic_perturbations","C2_CGP_2477_FERRARI_RESPONSE_TO_FENRETINIDE_DN",5,-1.4626,0.06,0.076,"No",-1.5554,0.029,0.42,"No"
"5490","GO_BP","491582_GO_0006694_STEROID_BIOSYNTHETIC_PROCESS",109,-1.4626,0.015,0.13,"No",0.9312,0.61,1,"Yes"
"5491","GO_BP","495146_GO_0014074_RESPONSE_TO_PURINE_CONTAINING_COMPOUND",141,-1.4625,0.0083,0.13,"No",1.0811,0.27,0.92,"Yes"
"5492","C2_Chemical_and_genetic_perturbations","C2_CGP_567_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN",8,-1.4624,0.075,0.077,"No",-1.1867,0.24,0.81,"No"
"5493","C7_Immunologic_signatures","C7_ALL_693_GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_UP",195,-1.4624,0.0035,0.011,"No",0.8751,0.8,1,"Yes"
"5494","C3_TF_targets","C3_TFT_186_V_HLF_01",246,-1.4624,0.0033,0.026,"No",-1.3007,0.029,0.23,"No"
"5495","C3_MicroRNA_targets","C3_MIR_158_ACAACCT_MIR_453",42,-1.4623,0.039,0.22,"No",-0.9132,0.63,1,"No"
"5496","GO_BP","498366_GO_0019532_OXALATE_TRANSPORT",5,-1.4621,0.043,0.13,"No",0.7553,0.77,1,"Yes"
"5497","C2_Chemical_and_genetic_perturbations","C2_CGP_3081_FIGUEROA_AML_METHYLATION_CLUSTER_2_DN",9,-1.462,0.075,0.077,"No",1.4639,0.064,0.24,"Yes"
"5498","C2_Chemical_and_genetic_perturbations","C2_CGP_660_LI_AMPLIFIED_IN_LUNG_CANCER",175,-1.4619,0.008,0.077,"No",2.1551,0,0.0011,"Yes"
"5499","GO_CC","507304_GO_0044298_CELL_BODY_MEMBRANE",11,-1.4619,0.079,0.17,"No",-1.4767,0.07,0.63,"No"
"5500","GO_BP","513492_GO_0072505_DIVALENT_INORGANIC_ANION_HOMEOSTASIS",12,-1.4619,0.074,0.13,"No",-0.7593,0.8,1,"No"
"5501","C4_Cancer_modules","C4_CM_209_MODULE_226",27,-1.4617,0.055,0.069,"No",1.0991,0.31,0.54,"Yes"
"5502","C7_Immunologic_signatures","C7_ALL_147_GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP",197,-1.4617,0.0034,0.011,"No",-0.8026,0.94,1,"No"
"5503","C2_Chemical_and_genetic_perturbations","C2_CGP_2586_HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN",20,-1.4616,0.048,0.077,"No",-0.9295,0.54,1,"No"
"5504","GO_BP","509067_GO_0046847_FILOPODIUM_ASSEMBLY",17,-1.4615,0.055,0.13,"No",-0.6896,0.9,1,"No"
"5505","C6_Oncogenic_signatures","C6_ALL_14_RAPA_EARLY_UP_V1_UP",163,-1.4615,0.0035,0.018,"No",-1.5627,0,0.13,"No"
"5506","C2_Chemical_and_genetic_perturbations","C2_CGP_1766_APRELIKOVA_BRCA1_TARGETS",49,-1.4615,0.038,0.077,"No",1.0238,0.41,0.77,"Yes"
"5507","C2_Chemical_and_genetic_perturbations","C2_CGP_2789_ONO_FOXP3_TARGETS_UP",23,-1.4615,0.046,0.077,"No",-0.9919,0.44,1,"No"
"5508","GO_BP","503514_GO_0034311_DIOL_METABOLIC_PROCESS",11,-1.4614,0.059,0.13,"No",-0.5921,0.94,1,"No"
"5509","C7_Immunologic_signatures","C7_ALL_1717_GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP",196,-1.4614,0.0058,0.011,"No",1.1748,0.14,0.27,"Yes"
"5510","GO_BP","513637_GO_0060079_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",51,-1.4613,0.016,0.13,"No",-1.0775,0.32,0.95,"No"
"5511","WikiPathways","198871_WP53_ID_SIGNALING_PATHWAY",52,-1.4612,0.04,0.084,"No",0.9065,0.61,1,"Yes"
"5512","C2_Chemical_and_genetic_perturbations","C2_CGP_342_MAYBURD_RESPONSE_TO_L663536_UP",28,-1.4609,0.065,0.077,"No",0.6643,0.95,1,"Yes"
"5513","GO_BP","505588_GO_0042448_PROGESTERONE_METABOLIC_PROCESS",14,-1.4608,0.056,0.13,"No",0.8862,0.61,1,"Yes"
"5514","REACTOME","730347_REACT_150139_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R",25,-1.4608,0.049,0.16,"No",0.5567,0.99,1,"Yes"
"5515","C2_Chemical_and_genetic_perturbations","C2_CGP_881_WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN",54,-1.4607,0.028,0.077,"No",-1.3305,0.069,0.69,"No"
"5516","C4_Cancer_modules","C4_CM_427_MODULE_568",72,-1.4606,0.018,0.069,"No",-0.8229,0.79,0.96,"No"
"5517","GO_BP","487501_GO_0001562_RESPONSE_TO_PROTOZOAN",20,-1.4605,0.057,0.13,"No",-1.1818,0.23,0.91,"No"
"5518","GO_BP","754573_GO_1901617_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS",172,-1.4604,0.0093,0.13,"No",-0.8357,0.86,1,"No"
"5519","REACTOME","105706_REACT_13814_FATTY_ACIDS",15,-1.4603,0.055,0.16,"No",-1.5668,0.03,0.35,"No"
"5520","C2_Chemical_and_genetic_perturbations","C2_CGP_678_EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN",48,-1.4602,0.033,0.077,"No",-0.9169,0.6,1,"No"
"5521","GO_BP","494757_GO_0010692_REGULATION_OF_ALKALINE_PHOSPHATASE_ACTIVITY",10,-1.4602,0.066,0.13,"No",-1.3558,0.11,0.97,"No"
"5522","C6_Oncogenic_signatures","C6_ALL_175_KRAS_600_UP_V1_UP",260,-1.4601,0,0.018,"No",1.1826,0.08,0.43,"Yes"
"5523","C3_TF_targets","C3_TFT_118_V_OCT1_06",247,-1.46,0.0011,0.026,"No",-1.0016,0.46,0.75,"No"
"5524","GO_BP","507456_GO_0045055_REGULATED_SECRETORY_PATHWAY",45,-1.46,0.04,0.13,"No",1.1386,0.25,0.85,"Yes"
"5525","KEGG_pathway","HSA05215_PROSTATE_CANCER",88,-1.46,0.017,0.046,"No",0.5955,1,1,"Yes"
"5526","GO_BP","512477_GO_0051599_RESPONSE_TO_HYDROSTATIC_PRESSURE",7,-1.4599,0.071,0.13,"No",-1.3794,0.12,0.98,"No"
"5527","GO_BP","502144_GO_0032922_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION",58,-1.4598,0.029,0.13,"No",-1.0516,0.38,0.97,"No"
"5528","GO_MF","487202_GO_0000978_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",237,-1.4598,0.0022,0.17,"No",-0.9582,0.57,0.95,"No"
"5529","KEGG_compound","C05299_2_METHOXYESTRONE",20,-1.4598,0.049,0.2,"No",1.8652,0.0021,0.018,"Yes"
"5530","C7_Immunologic_signatures","C7_ALL_468_GSE17721_CTRL_VS_POLYIC_2H_BMDM_DN",199,-1.4597,0.0011,0.012,"No",-1.2506,0.057,0.61,"No"
"5531","GO_MF","499447_GO_0023026_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING",16,-1.4595,0.066,0.17,"No",-1.1526,0.29,0.81,"No"
"5532","GO_MF","502511_GO_0033293_MONOCARBOXYLIC_ACID_BINDING",56,-1.4594,0.027,0.17,"No",1.2106,0.13,0.7,"Yes"
"5533","REACTOME","119549_REACT_19327_G_ALPHA_S_SIGNALLING_EVENTS",119,-1.4594,0.0097,0.16,"No",-1.2244,0.11,0.79,"No"
"5534","GO_BP","512225_GO_0051341_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY",81,-1.4593,0.022,0.13,"No",0.8695,0.75,1,"Yes"
"5535","GO_BP","492044_GO_0007265_RAS_PROTEIN_SIGNAL_TRANSDUCTION",217,-1.4592,0.0022,0.13,"No",1.006,0.43,0.98,"Yes"
"5536","REACTOME","187090_REACT_25374_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1",25,-1.4591,0.041,0.16,"No",0.9948,0.45,0.76,"Yes"
"5537","GO_BP","499349_GO_0022614_MEMBRANE_TO_MEMBRANE_DOCKING",5,-1.459,0.048,0.13,"No",-0.609,0.92,1,"No"
"5538","GO_MF","510308_GO_0048185_ACTIVIN_BINDING",12,-1.4588,0.071,0.17,"No",-0.8086,0.72,1,"No"
"5539","GO_BP","491993_GO_0007193_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",63,-1.4588,0.028,0.13,"No",-0.9019,0.66,1,"No"
"5540","GO_MF","492693_GO_0008395_STEROID_HYDROXYLASE_ACTIVITY",29,-1.4587,0.026,0.17,"No",-1.1782,0.22,0.78,"No"
"5541","C2_BioCarta_Pathways","C2_CP_BIOCARTA_131_BIOCARTA_ARENRF2_PATHWAY",13,-1.4587,0.066,0.15,"No",-1.6033,0.035,1,"No"
"5542","KEGG_pathway","HSA05031_AMPHETAMINE_ADDICTION",67,-1.4586,0.034,0.047,"No",-0.9209,0.61,0.96,"No"
"5543","C2_Chemical_and_genetic_perturbations","C2_CGP_742_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",21,-1.4586,0.053,0.078,"No",1.2397,0.2,0.45,"Yes"
"5544","GO_BP","488240_GO_0002367_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",13,-1.4585,0.06,0.13,"No",-0.8679,0.67,1,"No"
"5545","C2_Chemical_and_genetic_perturbations","C2_CGP_1335_PEART_HDAC_PROLIFERATION_CLUSTER_UP",57,-1.4585,0.032,0.078,"No",-0.8125,0.82,1,"No"
"5546","GO_BP","491962_GO_0007156_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES",140,-1.4585,0.0084,0.13,"No",1.5048,0.0023,0.4,"Yes"
"5547","GO_BP","499267_GO_0021988_OLFACTORY_LOBE_DEVELOPMENT",38,-1.4584,0.04,0.13,"No",-1.3726,0.078,0.98,"No"
"5548","GO_MF","490631_GO_0005534_GALACTOSE_BINDING",5,-1.4584,0.048,0.17,"No",-0.8882,0.61,1,"No"
"5549","GO_BP","487917_GO_0002027_REGULATION_OF_HEART_RATE",81,-1.4584,0.021,0.13,"No",1.1203,0.25,0.88,"Yes"
"5550","GO_BP","507703_GO_0045346_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS",14,-1.4583,0.058,0.13,"No",0.9755,0.5,1,"Yes"
"5551","GO_BP","513863_GO_0060307_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION",15,-1.4582,0.058,0.13,"No",-0.8691,0.63,1,"No"
"5552","C7_Immunologic_signatures","C7_ALL_923_GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP",195,-1.4581,0.0023,0.012,"No",-0.6947,1,1,"No"
"5553","GO_BP","751297_GO_0038034_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND",37,-1.4581,0.038,0.13,"No",-0.867,0.69,1,"No"
"5554","C7_Immunologic_signatures","C7_ALL_74_GSE11057_PBMC_VS_MEM_CD4_TCELL_DN",196,-1.4579,0.0011,0.012,"No",1.2882,0.036,0.11,"Yes"
"5555","GO_BP","518825_GO_2000177_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION",70,-1.4579,0.032,0.13,"No",-0.8791,0.71,1,"No"
"5556","C2_Chemical_and_genetic_perturbations","C2_CGP_2234_MCCABE_HOXC6_TARGETS_CANCER_UP",31,-1.4578,0.046,0.079,"No",-1.0145,0.44,0.98,"No"
"5557","GO_BP","488574_GO_0002701_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",21,-1.4578,0.055,0.13,"No",-0.8771,0.64,1,"No"
"5558","C7_Immunologic_signatures","C7_ALL_666_GSE17721_LPS_VS_CPG_12H_BMDM_DN",198,-1.4578,0.0023,0.012,"No",1.3025,0.024,0.1,"Yes"
"5559","C2_Chemical_and_genetic_perturbations","C2_CGP_870_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN",50,-1.4578,0.025,0.079,"No",1.572,0.014,0.16,"Yes"
"5560","GO_BP","495270_GO_0014877_RESPONSE_TO_MUSCLE_INACTIVITY_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION",6,-1.4577,0.065,0.13,"No",-1.0332,0.43,0.98,"No"
"5561","GO_BP","492565_GO_0050829_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM",32,-1.4577,0.057,0.13,"No",-0.9417,0.54,1,"No"
"5562","C2_Chemical_and_genetic_perturbations","C2_CGP_2754_YAGI_AML_WITH_T_8_21_TRANSLOCATION",362,-1.4575,0,0.079,"No",1.0766,0.2,0.67,"Yes"
"5563","C3_MicroRNA_targets","C3_MIR_87_TCGATGG_MIR_213",6,-1.4574,0.063,0.22,"No",-0.9307,0.54,1,"No"
"5564","GO_BP","921109_GO_1902510_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION",7,-1.4574,0.087,0.13,"No",0.4536,0.99,1,"Yes"
"5565","GO_BP","488664_GO_0002791_REGULATION_OF_PEPTIDE_SECRETION",197,-1.4573,0.007,0.13,"No",-0.8192,0.93,1,"No"
"5566","GO_BP","488736_GO_0002863_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",11,-1.4573,0.068,0.13,"No",-0.9733,0.48,1,"No"
"5567","C2_Chemical_and_genetic_perturbations","C2_CGP_2247_ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN",115,-1.4572,0.013,0.079,"No",-1.4061,0.016,0.58,"No"
"5568","KEGG_compound","C00899_11_CIS_RETINOL",5,-1.4571,0.05,0.21,"No",-1.219,0.24,0.75,"No"
"5569","GO_MF","487455_GO_0001515_OPIOID_PEPTIDE_ACTIVITY",5,-1.4568,0.057,0.17,"No",-1.1461,0.33,0.82,"No"
"5570","GO_BP","510375_GO_0048261_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS",15,-1.4567,0.062,0.13,"No",0.6417,0.94,1,"Yes"
"5571","GO_BP","514265_GO_0060710_CHORIO_ALLANTOIC_FUSION",7,-1.4567,0.076,0.13,"No",-1.4118,0.1,0.95,"No"
"5572","C3_TF_targets","C3_TFT_203_V_FREAC7_01",188,-1.4567,0.0067,0.027,"No",0.9673,0.55,1,"Yes"
"5573","C2_Chemical_and_genetic_perturbations","C2_CGP_924_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5",89,-1.4566,0.018,0.079,"No",1.0909,0.27,0.64,"Yes"
"5574","REACTOME","905997_REACT_169118_SIGNALING_BY_LEPTIN",26,-1.4565,0.064,0.16,"No",0.5523,0.98,1,"Yes"
"5575","GO_BP","517227_GO_0072311_GLOMERULAR_EPITHELIAL_CELL_DIFFERENTIATION",16,-1.4565,0.049,0.13,"No",-1.0059,0.44,0.98,"No"
"5576","C2_Chemical_and_genetic_perturbations","C2_CGP_158_HORIUCHI_WTAP_TARGETS_DN",308,-1.4563,0,0.079,"No",1.3003,0.012,0.39,"Yes"
"5577","REACTOME","106460_REACT_12058_SIGNALLING_TO_ERKS",43,-1.4562,0.036,0.16,"No",0.7047,0.96,1,"Yes"
"5578","C4_Cancer_modules","C4_CM_401_MODULE_512",37,-1.4561,0.028,0.072,"No",-1.2167,0.18,0.61,"No"
"5579","KEGG_module","HSA_M00135_GABA_BIOSYNTHESIS_EUKARYOTES_PUTRESCINE_GABA",9,-1.4561,0.064,0.33,"No",-0.7058,0.83,1,"No"
"5580","GO_BP","492626_GO_0008306_ASSOCIATIVE_LEARNING",66,-1.4561,0.02,0.13,"No",-1.1872,0.18,0.9,"No"
"5581","GO_BP","498801_GO_0021517_VENTRAL_SPINAL_CORD_DEVELOPMENT",43,-1.4561,0.023,0.13,"No",-1.4513,0.032,0.9,"No"
"5582","C2_BioCarta_Pathways","C2_CP_BIOCARTA_188_BIOCARTA_STATHMIN_PATHWAY",19,-1.4558,0.047,0.15,"No",1.9093,0.0043,0.082,"Yes"
"5583","C2_Chemical_and_genetic_perturbations","C2_CGP_1607_LEE_AGING_NEOCORTEX_DN",75,-1.4558,0.016,0.079,"No",-0.9458,0.58,1,"No"
"5584","C7_Immunologic_signatures","C7_ALL_1876_GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN",197,-1.4558,0.0023,0.012,"No",-0.7374,0.99,1,"No"
"5585","GO_CC","993476_GO_0097610_CELL_SURFACE_FURROW",45,-1.4558,0.031,0.18,"No",0.8637,0.7,0.91,"Yes"
"5586","C2_Chemical_and_genetic_perturbations","C2_CGP_2582_HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN",50,-1.4557,0.031,0.079,"No",0.727,0.94,1,"Yes"
"5587","GO_BP","503241_GO_0034032_PURINE_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",36,-1.4557,0.029,0.13,"No",0.8485,0.71,1,"Yes"
"5588","REACTOME","1183577_REACT_355408_SIGNALING_BY_FGFR4",156,-1.4557,0.0058,0.16,"No",-0.952,0.58,1,"No"
"5589","GO_BP","491075_GO_0006094_GLUCONEOGENESIS",45,-1.4557,0.03,0.13,"No",0.9378,0.56,1,"Yes"
"5590","REACTOME","105651_REACT_900_FASL_CD95L_SIGNALING",5,-1.4555,0.049,0.16,"No",-0.7568,0.76,1,"No"
"5591","REACTOME","1127687_REACT_264545_RMTS_METHYLATE_HISTONE_ARGININES",71,-1.4555,0.02,0.16,"No",-1.9396,0,0.042,"No"
"5592","GO_BP","495286_GO_0014894_RESPONSE_TO_DENERVATION_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION",6,-1.4554,0.055,0.13,"No",-1.0529,0.39,0.97,"No"
"5593","GO_BP","491994_GO_0007194_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY",25,-1.4554,0.042,0.13,"No",-0.6832,0.94,1,"No"
"5594","GO_BP","518758_GO_2000109_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS",8,-1.4551,0.067,0.13,"No",0.778,0.73,1,"Yes"
"5595","C3_TF_targets","C3_TFT_256_V_IPF1_Q4",243,-1.455,0.0022,0.028,"No",-0.8775,0.83,0.99,"No"
"5596","GO_BP","487741_GO_0001845_PHAGOLYSOSOME_ASSEMBLY",11,-1.455,0.069,0.13,"No",0.5262,0.98,1,"Yes"
"5597","GO_MF","489294_GO_0003777_MICROTUBULE_MOTOR_ACTIVITY",75,-1.4549,0.028,0.17,"No",-1.1503,0.21,0.81,"No"
"5598","C2_Chemical_and_genetic_perturbations","C2_CGP_1195_NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON",38,-1.4549,0.055,0.08,"No",-1.3386,0.095,0.71,"No"
"5599","GO_BP","498914_GO_0021631_OPTIC_NERVE_MORPHOGENESIS",6,-1.4548,0.059,0.13,"No",-0.9564,0.5,1,"No"
"5600","C3_TF_targets","C3_TFT_287_V_FOXO3_01",240,-1.4548,0.0033,0.027,"No",-0.9433,0.64,0.89,"No"
"5601","C2_Chemical_and_genetic_perturbations","C2_CGP_1628_RUAN_RESPONSE_TO_TROGLITAZONE_UP",24,-1.4547,0.053,0.08,"No",-1.0567,0.38,0.97,"No"
"5602","GO_BP","500195_GO_0030900_FOREBRAIN_DEVELOPMENT",331,-1.4547,0.0021,0.13,"No",-1.1189,0.16,0.94,"No"
"5603","C2_Chemical_and_genetic_perturbations","C2_CGP_1828_HENDRICKS_SMARCA4_TARGETS_DN",49,-1.4547,0.026,0.08,"No",-0.9006,0.63,1,"No"
"5604","GO_BP","506566_GO_0043535_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",46,-1.4547,0.035,0.13,"No",-1.0094,0.44,0.98,"No"
"5605","GO_BP","519417_GO_2000778_POSITIVE_REGULATION_OF_INTERLEUKIN_6_SECRETION",7,-1.4547,0.064,0.13,"No",1.0174,0.44,0.97,"Yes"
"5606","C7_Immunologic_signatures","C7_ALL_577_GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_UP",192,-1.4546,0.0067,0.012,"No",0.8385,0.92,1,"Yes"
"5607","C2_Chemical_and_genetic_perturbations","C2_CGP_3238_WANG_THOC1_TARGETS_UP",5,-1.4545,0.059,0.08,"No",-0.7379,0.78,1,"No"
"5608","C2_Chemical_and_genetic_perturbations","C2_CGP_1378_FERNANDEZ_BOUND_BY_MYC",177,-1.4544,0.008,0.08,"No",1.0082,0.43,0.78,"Yes"
"5609","REACTOME","119547_REACT_19287_LYSOSOME_VESICLE_BIOGENESIS",35,-1.4544,0.038,0.16,"No",0.9244,0.56,0.87,"Yes"
"5610","GO_BP","492400_GO_0050796_REGULATION_OF_INSULIN_SECRETION",168,-1.4543,0.0081,0.13,"No",-0.8639,0.82,1,"No"
"5611","C2_Chemical_and_genetic_perturbations","C2_CGP_1241_ONDER_CDH1_TARGETS_1_DN",161,-1.4543,0.0035,0.08,"No",1.023,0.36,0.77,"Yes"
"5612","GO_BP","492702_GO_0008406_GONAD_DEVELOPMENT",185,-1.4542,0.0068,0.13,"No",-0.9113,0.69,1,"No"
"5613","GO_BP","504335_GO_0035150_REGULATION_OF_TUBE_SIZE",70,-1.454,0.02,0.13,"No",1.2732,0.093,0.71,"Yes"
"5614","C2_Chemical_and_genetic_perturbations","C2_CGP_439_ODONNELL_METASTASIS_UP",77,-1.4539,0.02,0.08,"No",-1.0854,0.3,0.94,"No"
"5615","C4_Cancer_modules","C4_CM_361_MODULE_438",65,-1.4539,0.029,0.072,"No",-1.0934,0.31,0.68,"No"
"5616","C2_Chemical_and_genetic_perturbations","C2_CGP_3296_LIU_IL13_MEMORY_MODEL_UP",17,-1.4538,0.067,0.08,"No",-0.7742,0.8,1,"No"
"5617","GO_BP","494937_GO_0010873_POSITIVE_REGULATION_OF_CHOLESTEROL_ESTERIFICATION",8,-1.4537,0.068,0.13,"No",0.6236,0.91,1,"Yes"
"5618","GO_BP","492354_GO_0007613_MEMORY",89,-1.4537,0.013,0.13,"No",-0.9815,0.51,1,"No"
"5619","GO_BP","502847_GO_0033631_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN",5,-1.4535,0.047,0.13,"No",0.6407,0.9,1,"Yes"
"5620","C2_Chemical_and_genetic_perturbations","C2_CGP_2724_CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN",177,-1.4534,0.0012,0.08,"No",-0.8982,0.72,1,"No"
"5621","GO_BP","491464_GO_0006568_TRYPTOPHAN_METABOLIC_PROCESS",13,-1.4533,0.057,0.13,"No",-1.2765,0.16,0.89,"No"
"5622","C2_BioCarta_Pathways","C2_CP_BIOCARTA_70_BIOCARTA_EXTRINSIC_PATHWAY",13,-1.4532,0.068,0.16,"No",1.6239,0.033,0.23,"Yes"
"5623","C7_Immunologic_signatures","C7_ALL_964_GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN",200,-1.4532,0.0045,0.013,"No",1.2551,0.052,0.15,"Yes"
"5624","C2_Chemical_and_genetic_perturbations","C2_CGP_1741_MAHAJAN_RESPONSE_TO_IL1A_DN",76,-1.4532,0.024,0.08,"No",-0.6906,0.98,1,"No"
"5625","C3_TF_targets","C3_TFT_196_V_TCF11MAFG_01",205,-1.4532,0.0033,0.028,"No",-0.784,0.97,1,"No"
"5626","WikiPathways","698754_WP2324_AGE_RAGE_PATHWAY",65,-1.4531,0.042,0.089,"No",0.9207,0.61,1,"Yes"
"5627","KEGG_compound","C00005_NADPH_TPNH_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE",141,-1.4531,0.013,0.21,"No",-0.7097,0.99,1,"No"
"5628","GO_BP","812223_GO_0038180_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY",9,-1.4531,0.076,0.13,"No",-0.657,0.9,1,"No"
"5629","GO_MF","490500_GO_0015171_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",69,-1.4531,0.026,0.17,"No",-1.0641,0.34,0.86,"No"
"5630","C7_Immunologic_signatures","C7_ALL_431_GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP",200,-1.453,0.0045,0.013,"No",1.0506,0.32,0.59,"Yes"
"5631","KEGG_pathway","HSA05330_ALLOGRAFT_REJECTION",35,-1.4528,0.038,0.049,"No",-0.5708,0.99,1,"No"
"5632","REACTOME","106416_REACT_12596_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE",16,-1.4528,0.066,0.16,"No",1.1631,0.24,0.49,"Yes"
"5633","C3_TF_targets","C3_TFT_235_V_AREB6_02",251,-1.4527,0.0022,0.028,"No",-1.2399,0.048,0.29,"No"
"5634","GO_BP","508503_GO_0046209_NITRIC_OXIDE_METABOLIC_PROCESS",31,-1.4526,0.05,0.13,"No",-0.7201,0.9,1,"No"
"5635","C2_Chemical_and_genetic_perturbations","C2_CGP_2561_VANASSE_BCL2_TARGETS_DN",74,-1.4525,0.033,0.081,"No",0.674,0.99,1,"Yes"
"5636","GO_BP","1184554_GO_1904030_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",27,-1.4525,0.047,0.13,"No",-0.5966,0.98,1,"No"
"5637","KEGG_pathway","HSA05340_PRIMARY_IMMUNODEFICIENCY",36,-1.4524,0.039,0.048,"No",0.9143,0.61,1,"Yes"
"5638","C7_Immunologic_signatures","C7_ALL_1504_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN",194,-1.4524,0.0046,0.013,"No",1.3962,0.0098,0.038,"Yes"
"5639","WikiPathways","198791_WP1584_TYPE_II_DIABETES_MELLITUS",21,-1.4524,0.062,0.089,"No",-1.5254,0.035,0.93,"No"
"5640","KEGG_pathway","HSA05034_ALCOHOLISM",171,-1.4524,0.013,0.048,"No",-1.4641,0.0071,0.36,"No"
"5641","C7_Immunologic_signatures","C7_ALL_674_GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDM_DN",197,-1.4523,0.0089,0.013,"No",1.2284,0.067,0.18,"Yes"
"5642","C2_Chemical_and_genetic_perturbations","C2_CGP_418_CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN",23,-1.4522,0.058,0.081,"No",-0.6671,0.92,1,"No"
"5643","C7_Immunologic_signatures","C7_ALL_1441_GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP",195,-1.4522,0.0056,0.013,"No",1.2178,0.063,0.2,"Yes"
"5644","GO_BP","512815_GO_0051965_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY",23,-1.4522,0.046,0.13,"No",-0.9602,0.5,1,"No"
"5645","C2_Chemical_and_genetic_perturbations","C2_CGP_39_DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP",57,-1.4521,0.027,0.081,"No",1.1705,0.21,0.53,"Yes"
"5646","GO_MF","503795_GO_0034594_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY",5,-1.452,0.047,0.17,"No",-1.1747,0.3,0.78,"No"
"5647","C2_Chemical_and_genetic_perturbations","C2_CGP_737_BOWIE_RESPONSE_TO_TAMOXIFEN",18,-1.452,0.048,0.081,"No",1.4737,0.039,0.23,"Yes"
"5648","C2_Chemical_and_genetic_perturbations","C2_CGP_1423_SASAKI_ADULT_T_CELL_LEUKEMIA",175,-1.4519,0.0081,0.081,"No",1.2659,0.043,0.42,"Yes"
"5649","GO_BP","506471_GO_0043434_RESPONSE_TO_PEPTIDE_HORMONE",387,-1.4519,0.0011,0.13,"No",-0.7884,1,1,"No"
"5650","KEGG_compound","C05576_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL",8,-1.4518,0.07,0.21,"No",0.9806,0.44,1,"Yes"
"5651","GO_BP","516639_GO_0071715_ICOSANOID_TRANSPORT",16,-1.4518,0.052,0.13,"No",-0.8121,0.71,1,"No"
"5652","GO_BP","755285_GO_2001179_REGULATION_OF_INTERLEUKIN_10_SECRETION",8,-1.4516,0.079,0.13,"No",-1.0079,0.45,0.98,"No"
"5653","C7_Immunologic_signatures","C7_ALL_1140_GSE2706_2H_VS_8H_LPS_STIM_DC_DN",189,-1.4515,0.0057,0.013,"No",1.0583,0.29,0.56,"Yes"
"5654","C7_Immunologic_signatures","C7_ALL_602_GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_DN",198,-1.4515,0.0056,0.013,"No",-0.9034,0.72,1,"No"
"5655","GO_BP","512778_GO_0051928_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT",94,-1.4515,0.014,0.14,"No",-0.9283,0.61,1,"No"
"5656","C7_Immunologic_signatures","C7_ALL_627_GSE17721_POLYIC_VS_CPG_8H_BMDM_UP",197,-1.4514,0.0022,0.013,"No",-0.8285,0.91,1,"No"
"5657","REACTOME","106385_REACT_17025_DOWNSTREAM_SIGNAL_TRANSDUCTION",155,-1.4513,0.0058,0.16,"No",-1.0913,0.24,0.91,"No"
"5658","C2_BioCarta_Pathways","C2_CP_BIOCARTA_45_BIOCARTA_GCR_PATHWAY",18,-1.4511,0.056,0.16,"No",0.8734,0.63,0.92,"Yes"
"5659","C7_Immunologic_signatures","C7_ALL_49_GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP",195,-1.4509,0.0034,0.013,"No",1.2968,0.03,0.11,"Yes"
"5660","KEGG_compound","C14826_12_13_EPOME_12R_13S_9Z_12_13_EPOXYOCTADECENOIC_ACID",7,-1.4509,0.064,0.21,"No",-0.9797,0.51,1,"No"
"5661","GO_MF","498633_GO_0019842_VITAMIN_BINDING",76,-1.4508,0.02,0.17,"No",-0.9821,0.47,0.93,"No"
"5662","GO_CC","490833_GO_0030141_SECRETORY_GRANULE",297,-1.4507,0.0011,0.18,"No",1.3658,0.005,0.33,"Yes"
"5663","C2_Chemical_and_genetic_perturbations","C2_CGP_942_THEODOROU_MAMMARY_TUMORIGENESIS",27,-1.4506,0.047,0.082,"No",-1.3071,0.13,0.69,"No"
"5664","GO_BP","849877_GO_1902175_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",26,-1.4506,0.048,0.14,"No",0.7664,0.85,1,"Yes"
"5665","GO_CC","496379_GO_0016342_CATENIN_COMPLEX",9,-1.4506,0.075,0.18,"No",-1.2698,0.2,0.66,"No"
"5666","GO_BP","510180_GO_0048012_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",6,-1.4505,0.072,0.14,"No",0.7633,0.77,1,"Yes"
"5667","C6_Oncogenic_signatures","C6_ALL_46_ATM_DN_V1_UP",139,-1.4504,0.0083,0.02,"No",-1.2204,0.1,0.41,"No"
"5668","C2_Chemical_and_genetic_perturbations","C2_CGP_1496_FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN",87,-1.4504,0.014,0.082,"No",1.6208,0.0022,0.13,"Yes"
"5669","C2_Chemical_and_genetic_perturbations","C2_CGP_1891_VERRECCHIA_RESPONSE_TO_TGFB1_C4",13,-1.4504,0.061,0.082,"No",-0.7254,0.85,1,"No"
"5670","C7_Immunologic_signatures","C7_ALL_79_GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP",197,-1.4503,0.0045,0.013,"No",0.8095,0.95,1,"Yes"
"5671","GO_BP","493619_GO_0009448_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS",5,-1.4503,0.073,0.14,"No",0.879,0.59,1,"Yes"
"5672","GO_MF","495674_GO_0015485_CHOLESTEROL_BINDING",37,-1.4503,0.038,0.17,"No",-1.2054,0.19,0.81,"No"
"5673","GO_BP","505042_GO_0035873_LACTATE_TRANSMEMBRANE_TRANSPORT",7,-1.4502,0.059,0.14,"No",-1.0407,0.41,0.98,"No"
"5674","GO_BP","487844_GO_0001954_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION",38,-1.4502,0.037,0.14,"No",-1.0618,0.35,0.96,"No"
"5675","GO_BP","755152_GO_2001046_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY",7,-1.4502,0.06,0.14,"No",1.1923,0.23,0.79,"Yes"
"5676","GO_MF","487269_GO_0001046_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING",84,-1.4501,0.021,0.17,"No",-0.9234,0.62,0.96,"No"
"5677","KEGG_compound","C02737_PHOSPHATIDYLSERINE_PHOSPHATIDYL_L_SERINE_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHO_L_SERINE_3_O_SN_PHOSPHATIDYL_L_SERINE_O3_PHOSPHATIDYL_L_SERINE_L_1_PHOSPHATIDYLSERINE",8,-1.4499,0.084,0.21,"No",-0.7124,0.83,1,"No"
"5678","GO_BP","516995_GO_0072078_NEPHRON_TUBULE_MORPHOGENESIS",62,-1.4498,0.029,0.14,"No",-1.0136,0.4,0.98,"No"
"5679","GO_BP","488943_GO_0003149_MEMBRANOUS_SEPTUM_MORPHOGENESIS",6,-1.4498,0.063,0.14,"No",-0.9278,0.56,1,"No"
"5680","C3_TF_targets","C3_TFT_55_V_MZF1_01",233,-1.4498,0.0034,0.029,"No",-1.2552,0.065,0.27,"No"
"5681","C6_Oncogenic_signatures","C6_ALL_139_PDGF_ERK_DN_V1_DN",146,-1.4496,0.0096,0.02,"No",-1.2955,0.042,0.35,"No"
"5682","WikiPathways","198885_WP49_IL_2_SIGNALING_PATHWAY",42,-1.4496,0.031,0.09,"No",0.834,0.75,1,"Yes"
"5683","GO_BP","503074_GO_0033865_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",36,-1.4496,0.044,0.14,"No",0.8542,0.7,1,"Yes"
"5684","REACTOME","1127565_REACT_264041_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS",29,-1.4496,0.046,0.16,"No",0.804,0.77,1,"Yes"
"5685","C2_Chemical_and_genetic_perturbations","C2_CGP_1302_MENSSEN_MYC_TARGETS",53,-1.4494,0.033,0.082,"No",1.3939,0.048,0.3,"Yes"
"5686","C2_Chemical_and_genetic_perturbations","C2_CGP_322_MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP",20,-1.4492,0.06,0.082,"No",-1.1693,0.24,0.82,"No"
"5687","C7_Immunologic_signatures","C7_ALL_553_GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDM_UP",197,-1.4492,0.0023,0.014,"No",0.7909,0.96,1,"Yes"
"5688","GO_BP","508122_GO_0045787_POSITIVE_REGULATION_OF_CELL_CYCLE",289,-1.4491,0,0.14,"No",1.0223,0.37,0.97,"Yes"
"5689","C2_Chemical_and_genetic_perturbations","C2_CGP_1330_IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP",12,-1.4491,0.081,0.082,"No",1.378,0.11,0.31,"Yes"
"5690","GO_BP","1134004_GO_1903829_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION",268,-1.449,0.0033,0.14,"No",0.8201,0.95,1,"Yes"
"5691","C2_Chemical_and_genetic_perturbations","C2_CGP_813_AMUNDSON_GENOTOXIC_SIGNATURE",103,-1.4489,0.011,0.082,"No",-1.2448,0.093,0.75,"No"
"5692","GO_BP","1129551_GO_1903727_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS",37,-1.4489,0.042,0.14,"No",-0.6897,0.93,1,"No"
"5693","GO_BP","501543_GO_0032308_POSITIVE_REGULATION_OF_PROSTAGLANDIN_SECRETION",11,-1.4489,0.083,0.14,"No",0.643,0.92,1,"Yes"
"5694","GO_BP","752694_GO_0097193_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",172,-1.4488,0.01,0.14,"No",0.599,1,1,"Yes"
"5695","C7_Immunologic_signatures","C7_ALL_603_GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_UP",197,-1.4488,0.0067,0.014,"No",1.05,0.32,0.59,"Yes"
"5696","C4_Cancer_gene_neighborhoods","C4_CGN_99_MORF_ETV3",62,-1.4488,0.025,0.088,"No",-1.3874,0.053,0.47,"No"
"5697","C7_Immunologic_signatures","C7_ALL_1226_GSE27786_NKTCELL_VS_MONO_MAC_DN",199,-1.4487,0.014,0.014,"No",0.9808,0.52,0.8,"Yes"
"5698","REACTOME","1183564_REACT_355265_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2",143,-1.4486,0.0083,0.16,"No",-1.0792,0.27,0.91,"No"
"5699","GO_BP","513967_GO_0060411_CARDIAC_SEPTUM_MORPHOGENESIS",49,-1.4486,0.051,0.14,"No",-1.0115,0.42,0.98,"No"
"5700","C2_Chemical_and_genetic_perturbations","C2_CGP_2827_WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN",14,-1.4482,0.061,0.083,"No",0.6374,0.94,1,"Yes"
"5701","C4_Cancer_modules","C4_CM_419_MODULE_545",18,-1.4481,0.068,0.075,"No",1.1678,0.25,0.44,"Yes"
"5702","KEGG_compound","C01352_FADH2",14,-1.4481,0.071,0.21,"No",-0.6381,0.94,1,"No"
"5703","GO_BP","752376_GO_0086004_REGULATION_OF_CARDIAC_MUSCLE_CELL_CONTRACTION",41,-1.4481,0.038,0.14,"No",-0.9536,0.53,1,"No"
"5704","C3_TF_targets","C3_TFT_395_V_LEF1_Q6",252,-1.4481,0.0022,0.029,"No",-1.0948,0.24,0.56,"No"
"5705","C7_Immunologic_signatures","C7_ALL_1671_GSE3982_NEUTROPHIL_VS_TH1_UP",193,-1.4481,0.01,0.014,"No",0.6522,1,1,"Yes"
"5706","C2_Chemical_and_genetic_perturbations","C2_CGP_888_KIM_MYCL1_AMPLIFICATION_TARGETS_DN",20,-1.448,0.063,0.083,"No",-1.5369,0.035,0.44,"No"
"5707","GO_BP","511680_GO_0050709_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION",81,-1.4479,0.027,0.14,"No",0.7532,0.93,1,"Yes"
"5708","REACTOME","1183593_REACT_355372_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES",34,-1.4479,0.041,0.16,"No",0.8621,0.66,0.94,"Yes"
"5709","C2_Chemical_and_genetic_perturbations","C2_CGP_1638_RUAN_RESPONSE_TO_TNF_UP",12,-1.4478,0.062,0.083,"No",0.6604,0.9,1,"Yes"
"5710","C2_Chemical_and_genetic_perturbations","C2_CGP_3237_KATSANOU_ELAVL1_TARGETS_DN",144,-1.4478,0.011,0.083,"No",-1.0205,0.41,0.98,"No"
"5711","GO_BP","498307_GO_0019471_4_HYDROXYPROLINE_METABOLIC_PROCESS",12,-1.4478,0.072,0.14,"No",-0.7466,0.81,1,"No"
"5712","C3_TF_targets","C3_TFT_213_V_ETS1_B",260,-1.4478,0.0044,0.029,"No",-1.0959,0.21,0.56,"No"
"5713","GO_BP","508292_GO_0045992_NEGATIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT",26,-1.4476,0.04,0.14,"No",-1.3261,0.11,0.89,"No"
"5714","GO_BP","518964_GO_2000318_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE",5,-1.4476,0.06,0.14,"No",-1.3581,0.16,0.96,"No"
"5715","C2_Chemical_and_genetic_perturbations","C2_CGP_3260_WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK",145,-1.4474,0.0058,0.083,"No",0.7666,0.97,1,"Yes"
"5716","GO_BP","518611_GO_0097061_DENDRITIC_SPINE_ORGANIZATION",16,-1.4474,0.062,0.14,"No",-0.9884,0.46,1,"No"
"5717","C0_Hallmark","H_ALL_11_HALLMARK_NOTCH_SIGNALING",32,-1.4473,0.043,0.019,"No",-1.0903,0.34,0.88,"No"
"5718","REACTOME","106373_REACT_18342_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS",16,-1.4473,0.074,0.16,"No",1.8233,0.006,0.018,"Yes"
"5719","C2_Chemical_and_genetic_perturbations","C2_CGP_1831_SESTO_RESPONSE_TO_UV_C0",105,-1.4472,0.025,0.083,"No",1.2233,0.11,0.46,"Yes"
"5720","C7_Immunologic_signatures","C7_ALL_785_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP",190,-1.4472,0.0068,0.014,"No",-1.0036,0.43,1,"No"
"5721","GO_BP","512098_GO_0051195_NEGATIVE_REGULATION_OF_COFACTOR_METABOLIC_PROCESS",7,-1.4471,0.055,0.14,"No",-0.725,0.81,1,"No"
"5722","C7_Immunologic_signatures","C7_ALL_494_GSE17721_CTRL_VS_PAM3CSK4_24H_BMDM_DN",195,-1.4468,0.0023,0.014,"No",1.1886,0.093,0.25,"Yes"
"5723","GO_BP","491053_GO_0006068_ETHANOL_CATABOLIC_PROCESS",6,-1.4468,0.078,0.14,"No",1.2675,0.21,0.71,"Yes"
"5724","GO_BP","507924_GO_0045576_MAST_CELL_ACTIVATION",22,-1.4468,0.053,0.14,"No",-0.7608,0.81,1,"No"
"5725","GO_BP","492003_GO_0007205_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",37,-1.4467,0.049,0.14,"No",-1.393,0.056,1,"No"
"5726","GO_MF","490624_GO_0005522_PROFILIN_BINDING",8,-1.4467,0.065,0.18,"No",-0.8645,0.63,1,"No"
"5727","C2_Chemical_and_genetic_perturbations","C2_CGP_3185_KASLER_HDAC7_TARGETS_2_DN",32,-1.4467,0.052,0.083,"No",-0.8499,0.68,1,"No"
"5728","GO_BP","503352_GO_0034146_TOLL_LIKE_RECEPTOR_5_SIGNALING_PATHWAY",66,-1.4467,0.026,0.14,"No",-0.6128,0.99,1,"No"
"5729","GO_BP","501325_GO_0032088_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY",66,-1.4467,0.024,0.14,"No",-0.8669,0.71,1,"No"
"5730","GO_BP","495000_GO_0010935_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION",12,-1.4466,0.077,0.14,"No",-0.7883,0.75,1,"No"
"5731","C3_TF_targets","C3_TFT_138_V_NF1_Q6",256,-1.4466,0.0011,0.029,"No",-1.177,0.11,0.39,"No"
"5732","GO_MF","495378_GO_0015103_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",132,-1.4464,0.013,0.18,"No",-1.1016,0.26,0.83,"No"
"5733","REACTOME","119560_REACT_19298_BICARBONATE_TRANSPORTERS",9,-1.4463,0.078,0.16,"No",-1.1853,0.27,0.86,"No"
"5734","C2_Chemical_and_genetic_perturbations","C2_CGP_2938_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12",77,-1.4462,0.027,0.083,"No",1.2039,0.14,0.48,"Yes"
"5735","C2_Chemical_and_genetic_perturbations","C2_CGP_102_SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP",8,-1.4462,0.07,0.083,"No",0.8494,0.66,0.97,"Yes"
"5736","C3_TF_targets","C3_TFT_108_V_SRY_01",220,-1.4461,0.0078,0.029,"No",0.9649,0.57,1,"Yes"
"5737","REACTOME","530762_REACT_115529_INTERLEUKIN_7_SIGNALING",11,-1.4461,0.085,0.16,"No",0.6244,0.92,1,"Yes"
"5738","GO_BP","503084_GO_0033875_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",36,-1.446,0.039,0.14,"No",0.8609,0.73,1,"Yes"
"5739","KEGG_enzyme","2.7.1.68_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_DIPHOSPHOINOSITIDE_KINASE_PIP_KINASE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_KINASE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_TYPE_I_PIP_KINASE",5,-1.4459,0.078,0.56,"No",-1.139,0.32,0.57,"No"
"5740","C6_Oncogenic_signatures","C6_ALL_152_STK33_DN",271,-1.4458,0.0011,0.021,"No",0.91,0.73,0.96,"Yes"
"5741","GO_BP","751068_GO_0036148_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING",16,-1.4457,0.078,0.14,"No",-0.9723,0.5,1,"No"
"5742","GO_BP","500132_GO_0030834_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION",45,-1.4457,0.039,0.14,"No",-1.0772,0.33,0.95,"No"
"5743","GO_MF","500473_GO_0031210_PHOSPHATIDYLCHOLINE_BINDING",17,-1.4457,0.069,0.18,"No",-1.221,0.21,0.84,"No"
"5744","GO_BP","487790_GO_0001894_TISSUE_HOMEOSTASIS",154,-1.4456,0.0083,0.14,"No",-0.9877,0.48,1,"No"
"5745","GO_BP","503534_GO_0034331_CELL_JUNCTION_MAINTENANCE",11,-1.4454,0.068,0.14,"No",-1.7504,0.0038,0.56,"No"
"5746","REACTOME","1183570_REACT_252852_SIGNALING_BY_FGFR3",156,-1.4454,0.0058,0.16,"No",-0.9513,0.58,1,"No"
"5747","C6_Oncogenic_signatures","C6_ALL_29_MTOR_UP_V1_DN",168,-1.4454,0.0035,0.021,"No",-1.0603,0.31,0.61,"No"
"5748","C2_Chemical_and_genetic_perturbations","C2_CGP_2_NAKAMURA_CANCER_MICROENVIRONMENT_DN",46,-1.4453,0.038,0.084,"No",-0.9663,0.52,1,"No"
"5749","REACTOME","576253_REACT_118632_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR",13,-1.4453,0.074,0.16,"No",-0.8903,0.6,1,"No"
"5750","GO_BP","506607_GO_0043576_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE",21,-1.4451,0.061,0.14,"No",-1.5429,0.026,0.74,"No"
"5751","C4_Cancer_modules","C4_CM_101_MODULE_106",14,-1.4451,0.068,0.076,"No",-1.4305,0.09,0.48,"No"
"5752","C2_BioCarta_Pathways","C2_CP_BIOCARTA_166_BIOCARTA_HER2_PATHWAY",22,-1.445,0.056,0.16,"No",-0.8696,0.63,1,"No"
"5753","GO_BP","505749_GO_0042635_POSITIVE_REGULATION_OF_HAIR_CYCLE",9,-1.4449,0.088,0.14,"No",-1.2208,0.21,0.88,"No"
"5754","GO_BP","518837_GO_2000189_POSITIVE_REGULATION_OF_CHOLESTEROL_HOMEOSTASIS",6,-1.4449,0.08,0.14,"No",-1.4226,0.093,0.94,"No"
"5755","GO_BP","501589_GO_0032354_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE",11,-1.4449,0.078,0.14,"No",-1.3616,0.12,0.97,"No"
"5756","C4_Cancer_modules","C4_CM_388_MODULE_488",29,-1.4448,0.06,0.076,"No",0.672,0.95,1,"Yes"
"5757","C2_Chemical_and_genetic_perturbations","C2_CGP_2417_MALONEY_RESPONSE_TO_17AAG_UP",40,-1.4448,0.047,0.084,"No",-1.2148,0.18,0.8,"No"
"5758","C3_TF_targets","C3_TFT_170_V_NKX25_02",247,-1.4447,0.0033,0.029,"No",-0.9702,0.54,0.82,"No"
"5759","C4_Cancer_modules","C4_CM_165_MODULE_175",53,-1.4447,0.036,0.076,"No",0.9339,0.59,0.81,"Yes"
"5760","C7_Immunologic_signatures","C7_ALL_913_GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP",194,-1.4446,0.0034,0.014,"No",0.9641,0.54,0.85,"Yes"
"5761","C7_Immunologic_signatures","C7_ALL_585_GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_UP",193,-1.4446,0.008,0.014,"No",-1.142,0.18,1,"No"
"5762","GO_BP","503607_GO_0034405_RESPONSE_TO_FLUID_SHEAR_STRESS",31,-1.4443,0.052,0.14,"No",-0.5209,0.99,1,"No"
"5763","C7_Immunologic_signatures","C7_ALL_1724_GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN",199,-1.4443,0.008,0.014,"No",0.7642,0.98,1,"Yes"
"5764","C6_Oncogenic_signatures","C6_ALL_113_EIF4E_DN",99,-1.4443,0.022,0.021,"No",-0.828,0.84,0.96,"No"
"5765","C4_Cancer_modules","C4_CM_340_MODULE_407",13,-1.4441,0.076,0.076,"No",0.7861,0.77,0.98,"Yes"
"5766","KEGG_pathway","HSA04146_PEROXISOME",82,-1.4441,0.028,0.051,"No",1.2012,0.14,0.56,"Yes"
"5767","REACTOME","1183578_REACT_252869_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4",143,-1.444,0.014,0.16,"No",-1.0731,0.31,0.9,"No"
"5768","GO_MF","492526_GO_0008179_ADENYLATE_CYCLASE_BINDING",10,-1.444,0.083,0.18,"No",-0.7183,0.83,1,"No"
"5769","C2_BioCarta_Pathways","C2_CP_BIOCARTA_200_BIOCARTA_LONGEVITY_PATHWAY",15,-1.444,0.071,0.16,"No",1.5398,0.038,0.34,"Yes"
"5770","C2_Chemical_and_genetic_perturbations","C2_CGP_872_SIMBULAN_UV_RESPONSE_NORMAL_DN",33,-1.444,0.054,0.084,"No",-1.0096,0.44,0.99,"No"
"5771","GO_CC","490909_GO_0030122_AP_2_ADAPTOR_COMPLEX",11,-1.4438,0.087,0.19,"No",0.94,0.53,0.85,"Yes"
"5772","GO_BP","516380_GO_0071456_CELLULAR_RESPONSE_TO_HYPOXIA",107,-1.4437,0.014,0.14,"No",-0.748,0.96,1,"No"
"5773","C2_Chemical_and_genetic_perturbations","C2_CGP_341_WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN",65,-1.4437,0.021,0.085,"No",1.5033,0.025,0.21,"Yes"
"5774","KEGG_compound","C00089_SUCROSE_CANE_SUGAR_SACCHAROSE_1_ALPHA_D_GLUCOPYRANOSYL_2_BETA_D_FRUCTOFURANOSIDE",5,-1.4436,0.062,0.22,"No",-1.3322,0.15,0.6,"No"
"5775","GO_BP","508193_GO_0045879_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY",29,-1.4436,0.065,0.14,"No",-1.0801,0.33,0.95,"No"
"5776","C4_Cancer_gene_neighborhoods","C4_CGN_406_GNF2_SERPINB5",27,-1.4435,0.06,0.09,"No",0.8077,0.77,0.98,"Yes"
"5777","C3_TF_targets","C3_TFT_334_V_GATA4_Q3",242,-1.4434,0.0011,0.03,"No",-0.8682,0.85,0.99,"No"
"5778","C3_TF_targets","C3_TFT_375_V_CACBINDINGPROTEIN_Q6",236,-1.4434,0.0056,0.029,"No",-1.0527,0.32,0.64,"No"
"5779","GO_BP","911464_GO_1902476_CHLORIDE_TRANSMEMBRANE_TRANSPORT",81,-1.4433,0.011,0.14,"No",-0.98,0.5,1,"No"
"5780","GO_BP","487957_GO_0002067_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION",34,-1.4433,0.047,0.14,"No",-1.0247,0.41,0.97,"No"
"5781","C2_Chemical_and_genetic_perturbations","C2_CGP_3001_WU_APOPTOSIS_BY_CDKN1A_VIA_TP53",55,-1.4432,0.031,0.085,"No",0.7774,0.88,1,"Yes"
"5782","GO_BP","500306_GO_0031016_PANCREAS_DEVELOPMENT",73,-1.443,0.03,0.14,"No",0.978,0.48,1,"Yes"
"5783","C7_Immunologic_signatures","C7_ALL_340_GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN",198,-1.443,0.0035,0.015,"No",-0.7227,0.99,1,"No"
"5784","GO_BP","510439_GO_0048332_MESODERM_MORPHOGENESIS",66,-1.443,0.031,0.14,"No",-1.338,0.064,0.91,"No"
"5785","C2_BioCarta_Pathways","C2_CP_BIOCARTA_187_BIOCARTA_BARRESTIN_PATHWAY",9,-1.4429,0.087,0.16,"No",-1.2667,0.19,1,"No"
"5786","GO_CC","500162_GO_0030864_CORTICAL_ACTIN_CYTOSKELETON",50,-1.4429,0.032,0.19,"No",-1.0356,0.4,0.84,"No"
"5787","GO_BP","486719_GO_0000188_INACTIVATION_OF_MAPK_ACTIVITY",28,-1.4428,0.061,0.14,"No",0.6143,0.98,1,"Yes"
"5788","GO_MF","499680_GO_0030276_CLATHRIN_BINDING",58,-1.4426,0.028,0.18,"No",0.7745,0.9,1,"Yes"
"5789","GO_CC","492395_GO_0008021_SYNAPTIC_VESICLE",125,-1.4426,0.011,0.19,"No",1.0788,0.29,0.68,"Yes"
"5790","GO_BP","515276_GO_0070344_REGULATION_OF_FAT_CELL_PROLIFERATION",7,-1.4425,0.064,0.14,"No",-1.1834,0.26,0.91,"No"
"5791","GO_BP","499622_GO_0030212_HYALURONAN_METABOLIC_PROCESS",29,-1.4425,0.043,0.14,"No",-1.3447,0.097,0.92,"No"
"5792","C7_Immunologic_signatures","C7_ALL_1278_GSE29618_MONOCYTE_VS_MDC_DN",198,-1.4423,0.0069,0.015,"No",1.5937,0,0.0034,"Yes"
"5793","REACTOME","1183584_REACT_355474_RHO_GTPASE_EFFECTORS",281,-1.4421,0.0011,0.17,"No",-0.8696,0.85,1,"No"
"5794","C3_TF_targets","C3_TFT_495_GTTRYCATRR_UNKNOWN",169,-1.4419,0.0057,0.03,"No",-1.2031,0.095,0.35,"No"
"5795","C3_TF_targets","C3_TFT_59_V_IK2_01",262,-1.4415,0.0011,0.03,"No",-1.1454,0.15,0.45,"No"
"5796","GO_BP","517025_GO_0072109_GLOMERULAR_MESANGIUM_DEVELOPMENT",7,-1.4413,0.076,0.14,"No",-0.7068,0.83,1,"No"
"5797","C2_Chemical_and_genetic_perturbations","C2_CGP_383_LANDIS_BREAST_CANCER_PROGRESSION_UP",42,-1.4413,0.041,0.086,"No",1.3589,0.072,0.33,"Yes"
"5798","C2_Chemical_and_genetic_perturbations","C2_CGP_1358_BYSTROEM_CORRELATED_WITH_IL5_UP",51,-1.4411,0.037,0.086,"No",1.0751,0.32,0.67,"Yes"
"5799","GO_BP","516322_GO_0071398_CELLULAR_RESPONSE_TO_FATTY_ACID",33,-1.4411,0.048,0.14,"No",0.722,0.92,1,"Yes"
"5800","C3_TF_targets","C3_TFT_47_V_GATA2_01",103,-1.4409,0.022,0.03,"No",-0.7263,0.97,1,"No"
"5801","C2_Chemical_and_genetic_perturbations","C2_CGP_2923_MIKKELSEN_NPC_LCP_WITH_H3K4ME3",56,-1.4409,0.029,0.086,"No",-0.9454,0.51,1,"No"
"5802","C2_Chemical_and_genetic_perturbations","C2_CGP_2531_PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION",22,-1.4408,0.059,0.086,"No",1.0932,0.32,0.64,"Yes"
"5803","REACTOME","106448_REACT_13537_P75NTR_SIGNALS_VIA_NF_KB",16,-1.4404,0.066,0.17,"No",1.0773,0.35,0.62,"Yes"
"5804","GO_BP","503069_GO_0033860_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY",6,-1.4403,0.07,0.14,"No",0.9062,0.58,1,"Yes"
"5805","C2_Chemical_and_genetic_perturbations","C2_CGP_2700_POOLA_INVASIVE_BREAST_CANCER_DN",130,-1.4403,0.0097,0.086,"No",-0.9965,0.46,1,"No"
"5806","C2_Chemical_and_genetic_perturbations","C2_CGP_783_TERAMOTO_OPN_TARGETS_CLUSTER_1",12,-1.4403,0.073,0.086,"No",-1.2032,0.24,0.8,"No"
"5807","REACTOME","106395_REACT_9061_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE",86,-1.4403,0.025,0.17,"No",0.6004,1,1,"Yes"
"5808","GO_CC","502032_GO_0032809_NEURONAL_CELL_BODY_MEMBRANE",11,-1.4403,0.067,0.19,"No",-1.5024,0.05,0.6,"No"
"5809","GO_BP","508946_GO_0046718_VIRAL_ENTRY_INTO_HOST_CELL",51,-1.4402,0.035,0.14,"No",-1.0688,0.34,0.96,"No"
"5810","C2_Chemical_and_genetic_perturbations","C2_CGP_1178_MORI_SMALL_PRE_BII_LYMPHOCYTE_UP",86,-1.4401,0.038,0.086,"No",-0.5957,1,1,"No"
"5811","C2_Chemical_and_genetic_perturbations","C2_CGP_1624_SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP",39,-1.4401,0.034,0.086,"No",0.927,0.58,0.89,"Yes"
"5812","C2_Chemical_and_genetic_perturbations","C2_CGP_1039_CAFFAREL_RESPONSE_TO_THC_24HR_5_DN",59,-1.4401,0.033,0.086,"No",1.1437,0.21,0.56,"Yes"
"5813","GO_CC","500378_GO_0031091_PLATELET_ALPHA_GRANULE",62,-1.44,0.027,0.19,"No",1.8728,0,0.013,"Yes"
"5814","GO_BP","492260_GO_0007507_HEART_DEVELOPMENT",423,-1.44,0.001,0.14,"No",-1.0982,0.19,0.95,"No"
"5815","C2_Chemical_and_genetic_perturbations","C2_CGP_1758_KANG_DOXORUBICIN_RESISTANCE_UP",54,-1.4399,0.037,0.086,"No",-1.0117,0.43,0.99,"No"
"5816","C2_Chemical_and_genetic_perturbations","C2_CGP_26_WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN",91,-1.4395,0.022,0.086,"No",0.7657,0.93,1,"Yes"
"5817","C2_Chemical_and_genetic_perturbations","C2_CGP_2409_MATTHEWS_AP1_TARGETS",17,-1.4395,0.075,0.086,"No",-1.4638,0.061,0.52,"No"
"5818","GO_BP","516920_GO_0072001_RENAL_SYSTEM_DEVELOPMENT",260,-1.4395,0.0011,0.14,"No",-1.1051,0.22,0.94,"No"
"5819","GO_BP","1022093_GO_0098656_ANION_TRANSMEMBRANE_TRANSPORT",210,-1.4395,0.0023,0.14,"No",-1.221,0.068,0.88,"No"
"5820","GO_BP","515500_GO_0070570_REGULATION_OF_NEURON_PROJECTION_REGENERATION",10,-1.4393,0.053,0.14,"No",-1.3183,0.15,0.89,"No"
"5821","GO_BP","494824_GO_0010759_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS",7,-1.4392,0.066,0.14,"No",1.3392,0.15,0.62,"Yes"
"5822","GO_BP","503372_GO_0034166_TOLL_LIKE_RECEPTOR_10_SIGNALING_PATHWAY",66,-1.4391,0.032,0.14,"No",-0.6048,1,1,"No"
"5823","GO_BP","499952_GO_0030647_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS",9,-1.4391,0.076,0.14,"No",-0.8648,0.64,1,"No"
"5824","REACTOME","1183557_REACT_355063_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1",143,-1.439,0.013,0.17,"No",-1.0766,0.27,0.9,"No"
"5825","GO_BP","493263_GO_0009062_FATTY_ACID_CATABOLIC_PROCESS",66,-1.439,0.031,0.14,"No",1.0305,0.4,0.97,"Yes"
"5826","C3_TF_targets","C3_TFT_479_V_PR_Q2",254,-1.4387,0.0022,0.03,"No",-1.241,0.051,0.29,"No"
"5827","GO_BP","489149_GO_0003357_NORADRENERGIC_NEURON_DIFFERENTIATION",7,-1.4387,0.063,0.14,"No",-1.2606,0.2,0.91,"No"
"5828","C7_Immunologic_signatures","C7_ALL_1497_GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP",196,-1.4387,0.0092,0.016,"No",-0.8366,0.89,1,"No"
"5829","REACTOME","106343_REACT_9470_SIGNALING_BY_FGFR",160,-1.4387,0.0081,0.17,"No",-0.8947,0.72,1,"No"
"5830","C7_Immunologic_signatures","C7_ALL_1433_GSE360_DC_VS_MAC_L_DONOVANI_UP",197,-1.4386,0.0045,0.016,"No",1.1266,0.18,0.37,"Yes"
"5831","REACTOME","1183609_REACT_355361_REGULATION_OF_NECROPTOTIC_CELL_DEATH",14,-1.4385,0.072,0.17,"No",-0.3979,1,1,"No"
"5832","REACTOME","187208_REACT_24968_RETINOID_METABOLISM_AND_TRANSPORT",42,-1.4385,0.05,0.17,"No",0.8482,0.73,0.96,"Yes"
"5833","C7_Immunologic_signatures","C7_ALL_364_GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN",189,-1.4384,0.0056,0.016,"No",-0.8033,0.93,1,"No"
"5834","GO_BP","754830_GO_1901879_REGULATION_OF_PROTEIN_DEPOLYMERIZATION",73,-1.4383,0.028,0.14,"No",-0.9127,0.64,1,"No"
"5835","C7_Immunologic_signatures","C7_ALL_104_GSE11924_TH1_VS_TH17_CD4_TCELL_DN",197,-1.4382,0.0056,0.016,"No",-0.8171,0.91,1,"No"
"5836","C2_Chemical_and_genetic_perturbations","C2_CGP_2219_HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP",34,-1.4382,0.044,0.087,"No",1.4052,0.056,0.29,"Yes"
"5837","GO_BP","494887_GO_0010823_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION",38,-1.4382,0.038,0.14,"No",0.7484,0.89,1,"Yes"
"5838","C2_Chemical_and_genetic_perturbations","C2_CGP_2243_ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN",268,-1.4382,0.0044,0.087,"No",-0.9116,0.73,1,"No"
"5839","C7_Immunologic_signatures","C7_ALL_587_GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_UP",198,-1.438,0.0011,0.016,"No",1.041,0.33,0.61,"Yes"
"5840","GO_BP","502843_GO_0033627_CELL_ADHESION_MEDIATED_BY_INTEGRIN",12,-1.438,0.083,0.14,"No",-0.6619,0.89,1,"No"
"5841","C2_Chemical_and_genetic_perturbations","C2_CGP_2090_STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN",41,-1.438,0.036,0.087,"No",1.1618,0.22,0.54,"Yes"
"5842","GO_BP","507253_GO_0044246_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",45,-1.438,0.053,0.14,"No",-0.8928,0.66,1,"No"
"5843","C6_Oncogenic_signatures","C6_ALL_182_KRAS_LUNG_UP_V1_DN",124,-1.4379,0.012,0.022,"No",-1.2147,0.13,0.41,"No"
"5844","GO_BP","491589_GO_0006702_ANDROGEN_BIOSYNTHETIC_PROCESS",15,-1.4378,0.062,0.14,"No",0.6617,0.92,1,"Yes"
"5845","GO_CC","507585_GO_0045211_POSTSYNAPTIC_MEMBRANE",195,-1.4377,0.0046,0.19,"No",-1.3686,0.021,0.62,"No"
"5846","C2_BioCarta_Pathways","C2_CP_BIOCARTA_86_BIOCARTA_MPR_PATHWAY",33,-1.4377,0.051,0.16,"No",1.276,0.11,0.63,"Yes"
"5847","GO_BP","518456_GO_0090316_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT",205,-1.4377,0.0068,0.14,"No",0.8773,0.83,1,"Yes"
"5848","C4_Cancer_gene_neighborhoods","C4_CGN_319_GNF2_AF1Q",24,-1.4377,0.066,0.093,"No",-1.4369,0.05,0.38,"No"
"5849","GO_BP","498280_GO_0019441_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE",7,-1.4373,0.096,0.14,"No",-1.6729,0.017,0.61,"No"
"5850","C2_Chemical_and_genetic_perturbations","C2_CGP_1728_BAELDE_DIABETIC_NEPHROPATHY_UP",85,-1.4373,0.02,0.088,"No",-0.8537,0.75,1,"No"
"5851","C2_Chemical_and_genetic_perturbations","C2_CGP_268_UDAYAKUMAR_MED1_TARGETS_DN",237,-1.4372,0,0.088,"No",-0.9525,0.59,1,"No"
"5852","C2_Chemical_and_genetic_perturbations","C2_CGP_1348_POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP",61,-1.4372,0.038,0.088,"No",-0.8271,0.79,1,"No"
"5853","GO_BP","487511_GO_0001573_GANGLIOSIDE_METABOLIC_PROCESS",14,-1.4372,0.076,0.14,"No",0.8611,0.67,1,"Yes"
"5854","C7_Immunologic_signatures","C7_ALL_493_GSE17721_CTRL_VS_PAM3CSK4_24H_BMDM_UP",199,-1.4372,0.0045,0.016,"No",1.5504,0,0.0061,"Yes"
"5855","KEGG_reaction","R07056_LINOLEATE_OXYGEN_NADPH_H_12_13_EPOME_NADP_H2O",7,-1.4372,0.068,0.24,"No",-1.0086,0.44,0.8,"No"
"5856","GO_MF","492794_GO_0008514_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",143,-1.4371,0.012,0.18,"No",-1.1311,0.21,0.81,"No"
"5857","C7_Immunologic_signatures","C7_ALL_767_GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP",190,-1.437,0.0099,0.016,"No",-1.1643,0.14,0.94,"No"
"5858","GO_BP","499840_GO_0030497_FATTY_ACID_ELONGATION",12,-1.437,0.084,0.14,"No",-0.6378,0.92,1,"No"
"5859","GO_BP","494820_GO_0010755_REGULATION_OF_PLASMINOGEN_ACTIVATION",10,-1.4369,0.065,0.14,"No",-0.9135,0.58,1,"No"
"5860","REACTOME","106484_REACT_12524_CREB_PHOSPHORYLATION",7,-1.4369,0.065,0.17,"No",-1.1459,0.3,0.87,"No"
"5861","GO_BP","494706_GO_0010642_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",10,-1.4368,0.066,0.14,"No",-1.2734,0.19,0.89,"No"
"5862","C7_Immunologic_signatures","C7_ALL_1325_GSE30083_SP1_VS_SP2_THYMOCYTE_UP",197,-1.4368,0.0056,0.016,"No",-0.8688,0.82,1,"No"
"5863","C3_TF_targets","C3_TFT_44_V_E47_02",244,-1.4366,0.0022,0.031,"No",-1.3224,0.024,0.21,"No"
"5864","REACTOME","106258_REACT_11088_NICOTINATE_METABOLISM",11,-1.4366,0.076,0.17,"No",-0.7649,0.8,1,"No"
"5865","GO_BP","508147_GO_0045824_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE",32,-1.4366,0.059,0.15,"No",0.787,0.8,1,"Yes"
"5866","GO_CC","506264_GO_0043196_VARICOSITY",7,-1.4365,0.066,0.19,"No",0.6537,0.87,0.99,"Yes"
"5867","WikiPathways","198896_WP1742_TP53_NETWORK",19,-1.4365,0.079,0.097,"No",-0.5686,0.98,1,"No"
"5868","KEGG_compound","C03758_DOPAMINE_4_2_AMINOETHYL_1_2_BENZENEDIOL_4_2_AMINOETHYL_BENZENE_1_2_DIOL_3_4_DIHYDROXYPHENETHYLAMINE_2_3_4_DIHYDROXYPHENYL_ETHYLAMINE",8,-1.4364,0.078,0.22,"No",-1.1319,0.34,0.87,"No"
"5869","C2_Chemical_and_genetic_perturbations","C2_CGP_680_SCHAVOLT_TARGETS_OF_TP53_AND_TP63",16,-1.4364,0.06,0.088,"No",-1.2725,0.17,0.71,"No"
"5870","GO_BP","491009_GO_0006023_AMINOGLYCAN_BIOSYNTHETIC_PROCESS",102,-1.4364,0.018,0.15,"No",1.0935,0.27,0.91,"Yes"
"5871","GO_CC","490816_GO_0005788_ENDOPLASMIC_RETICULUM_LUMEN",187,-1.4363,0.011,0.19,"No",-0.905,0.71,0.96,"No"
"5872","GO_BP","1129475_GO_1903649_REGULATION_OF_CYTOPLASMIC_TRANSPORT",374,-1.4361,0.0011,0.15,"No",0.9131,0.8,1,"Yes"
"5873","GO_CC","490804_GO_0005774_VACUOLAR_MEMBRANE",290,-1.436,0.0022,0.19,"No",0.7498,1,0.98,"Yes"
"5874","GO_BP","993490_GO_1903115_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT",44,-1.436,0.04,0.15,"No",-0.9128,0.64,1,"No"
"5875","GO_MF","513785_GO_0060229_LIPASE_ACTIVATOR_ACTIVITY",12,-1.4359,0.056,0.19,"No",1.0218,0.46,0.87,"Yes"
"5876","GO_BP","507964_GO_0045616_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION",27,-1.4359,0.067,0.15,"No",-1.1671,0.23,0.91,"No"
"5877","KEGG_compound","C04006_1D_MYO_INOSITOL_3_PHOSPHATE_D_MYO_INOSITOL_3_PHOSPHATE_MYO_INOSITOL_3_PHOSPHATE_INOSITOL_3_PHOSPHATE_1D_MYO_INOSITOL_3_MONOPHOSPHATE_D_MYO_INOSITOL_3_MONOPHOSPHATE_MYO_INOSITOL_3_MONOPHOSPHATE_INOSITOL_3_MONOPHOSPHATE_1L_MYO_INOSITOL_1_PHOSPHATE_L_MYO_INOSITOL_1_PHOSPHATE",6,-1.4359,0.077,0.22,"No",-1.0536,0.42,0.99,"No"
"5878","GO_MF","496707_GO_0016803_ETHER_HYDROLASE_ACTIVITY",8,-1.4359,0.076,0.19,"No",-1.3329,0.15,0.71,"No"
"5879","GO_BP","519124_GO_2000484_POSITIVE_REGULATION_OF_INTERLEUKIN_8_SECRETION",8,-1.4358,0.077,0.15,"No",1.301,0.18,0.67,"Yes"
"5880","GO_BP","499156_GO_0021877_FOREBRAIN_NEURON_FATE_COMMITMENT",14,-1.4358,0.069,0.15,"No",-1.6426,0.018,0.69,"No"
"5881","C3_TF_targets","C3_TFT_34_V_HEN1_02",193,-1.4358,0.01,0.031,"No",-1.0254,0.41,0.71,"No"
"5882","KEGG_compound","C00547_L_NORADRENALINE_NORADRENALINE_NOREPINEPHRINE_ARTERENOL_4_1R_2_AMINO_1_HYDROXYETHYL_1_2_BENZENEDIOL",5,-1.4357,0.073,0.22,"No",0.5412,0.97,1,"Yes"
"5883","GO_BP","512232_GO_0051348_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY",303,-1.4356,0.0022,0.15,"No",1.2068,0.052,0.78,"Yes"
"5884","GO_BP","925912_GO_1902563_REGULATION_OF_NEUTROPHIL_ACTIVATION",5,-1.4356,0.078,0.15,"No",-1.265,0.19,0.9,"No"
"5885","C3_TF_targets","C3_TFT_94_V_HNF4_01",263,-1.4355,0.0011,0.031,"No",-1.2682,0.034,0.26,"No"
"5886","GO_BP","500643_GO_0031392_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS",6,-1.4354,0.068,0.15,"No",-0.6506,0.88,1,"No"
"5887","WikiPathways","198906_WP536_CALCIUM_REGULATION_IN_THE_CARDIAC_CELL",147,-1.4353,0.011,0.097,"No",-0.9247,0.64,1,"No"
"5888","C3_TF_targets","C3_TFT_410_V_CEBP_Q3",246,-1.4353,0.0055,0.031,"No",-0.9976,0.43,0.76,"No"
"5889","C2_BioCarta_Pathways","C2_CP_BIOCARTA_157_BIOCARTA_P27_PATHWAY",13,-1.4352,0.085,0.16,"No",-0.559,0.96,1,"No"
"5890","GO_MF","490320_GO_0005123_DEATH_RECEPTOR_BINDING",16,-1.4352,0.058,0.19,"No",0.8135,0.74,1,"Yes"
"5891","GO_BP","517416_GO_0072511_DIVALENT_INORGANIC_CATION_TRANSPORT",257,-1.435,0.0032,0.15,"No",-1.2148,0.072,0.88,"No"
"5892","C2_Chemical_and_genetic_perturbations","C2_CGP_2627_SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM",36,-1.4349,0.054,0.089,"No",-0.9806,0.49,1,"No"
"5893","GO_BP","509074_GO_0046854_PHOSPHATIDYLINOSITOL_PHOSPHORYLATION",35,-1.4348,0.062,0.15,"No",-0.7629,0.85,1,"No"
"5894","GO_BP","488842_GO_0003044_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL",46,-1.4347,0.039,0.15,"No",-1.0431,0.41,0.98,"No"
"5895","GO_BP","487651_GO_0001755_NEURAL_CREST_CELL_MIGRATION",33,-1.4346,0.048,0.15,"No",1.4574,0.037,0.48,"Yes"
"5896","KEGG_pathway","HSA05217_BASAL_CELL_CARCINOMA",54,-1.4346,0.047,0.056,"No",-1.4386,0.056,0.4,"No"
"5897","GO_BP","507280_GO_0044273_SULFUR_COMPOUND_CATABOLIC_PROCESS",42,-1.4345,0.061,0.15,"No",0.687,0.96,1,"Yes"
"5898","GO_MF","496283_GO_0016209_ANTIOXIDANT_ACTIVITY",66,-1.4345,0.018,0.19,"No",1.2077,0.16,0.7,"Yes"
"5899","C2_BioCarta_Pathways","C2_CP_BIOCARTA_50_BIOCARTA_CFTR_PATHWAY",12,-1.4344,0.08,0.16,"No",1.0817,0.34,0.74,"Yes"
"5900","REACTOME","833825_REACT_163936_FC_EPSILON_RECEPTOR_FCERI_SIGNALING",171,-1.4343,0.01,0.17,"No",-1.0985,0.24,0.9,"No"
"5901","KEGG_pathway","HSA00280_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION",47,-1.4343,0.042,0.055,"No",1.0522,0.36,0.81,"Yes"
"5902","C2_Chemical_and_genetic_perturbations","C2_CGP_1240_ONDER_CDH1_TARGETS_1_UP",139,-1.4343,0.012,0.089,"No",-0.7383,0.97,1,"No"
"5903","WikiPathways","198797_WP254_APOPTOSIS",83,-1.4342,0.022,0.097,"No",-0.6929,0.98,1,"No"
"5904","C7_Immunologic_signatures","C7_ALL_1045_GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP",197,-1.4342,0.0023,0.017,"No",0.7613,0.98,1,"Yes"
"5905","KEGG_compound","C05302_2_METHOXY_17BETA_ESTRADIOL_2_METHOXYESTRADIOL_17BETA",20,-1.4341,0.053,0.22,"No",1.8759,0.002,0.017,"Yes"
"5906","C2_Chemical_and_genetic_perturbations","C2_CGP_3167_VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP",87,-1.4341,0.023,0.089,"No",-0.9984,0.46,1,"No"
"5907","C2_Chemical_and_genetic_perturbations","C2_CGP_2312_BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN",24,-1.434,0.056,0.089,"No",1.0712,0.35,0.68,"Yes"
"5908","REACTOME","119557_REACT_19324_PD_1_SIGNALING",21,-1.4339,0.063,0.17,"No",1.2299,0.19,0.42,"Yes"
"5909","C2_Chemical_and_genetic_perturbations","C2_CGP_2741_YAMASHITA_LIVER_CANCER_STEM_CELL_UP",47,-1.4339,0.031,0.089,"No",-0.6901,0.94,1,"No"
"5910","GO_BP","488999_GO_0003205_CARDIAC_CHAMBER_DEVELOPMENT",123,-1.4339,0.014,0.15,"No",-0.9719,0.5,1,"No"
"5911","GO_BP","500914_GO_0031665_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",9,-1.4338,0.073,0.15,"No",-1.2329,0.21,0.9,"No"
"5912","GO_BP","501540_GO_0032305_POSITIVE_REGULATION_OF_ICOSANOID_SECRETION",15,-1.4338,0.064,0.15,"No",-0.7593,0.82,1,"No"
"5913","GO_BP","517235_GO_0072319_VESICLE_UNCOATING",5,-1.4337,0.079,0.15,"No",-0.8054,0.7,1,"No"
"5914","GO_BP","510865_GO_0048814_REGULATION_OF_DENDRITE_MORPHOGENESIS",57,-1.4337,0.03,0.15,"No",-1.4731,0.025,0.85,"No"
"5915","GO_MF","492789_GO_0008509_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",263,-1.4336,0.0044,0.19,"No",-1.1855,0.092,0.79,"No"
"5916","GO_BP","515228_GO_0070295_RENAL_WATER_ABSORPTION",5,-1.4335,0.072,0.15,"No",0.7226,0.8,1,"Yes"
"5917","GO_BP","1039946_GO_1903392_NEGATIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION",12,-1.4333,0.07,0.15,"No",0.9803,0.46,1,"Yes"
"5918","GO_BP","488328_GO_0002455_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",36,-1.433,0.053,0.15,"No",0.8626,0.71,1,"Yes"
"5919","GO_BP","753715_GO_1900744_REGULATION_OF_P38MAPK_CASCADE",13,-1.433,0.067,0.15,"No",-1.2173,0.22,0.88,"No"
"5920","C3_TF_targets","C3_TFT_595_GGGNNTTTCC_V_NFKB_Q6_01",130,-1.433,0.017,0.032,"No",-1.0263,0.41,0.7,"No"
"5921","GO_BP","514117_GO_0060562_EPITHELIAL_TUBE_MORPHOGENESIS",299,-1.4329,0.0022,0.15,"No",0.95,0.65,1,"Yes"
"5922","C6_Oncogenic_signatures","C6_ALL_56_E2F3_UP_V1_UP",188,-1.4329,0.0058,0.023,"No",-1.049,0.31,0.57,"No"
"5923","C2_Chemical_and_genetic_perturbations","C2_CGP_504_MCBRYAN_PUBERTAL_BREAST_6_7WK_UP",192,-1.4329,0.0035,0.09,"No",0.7526,0.99,1,"Yes"
"5924","GO_BP","498078_GO_0019226_TRANSMISSION_OF_NERVE_IMPULSE",52,-1.4329,0.036,0.15,"No",-1.2306,0.15,0.89,"No"
"5925","GO_BP","505700_GO_0042572_RETINOL_METABOLIC_PROCESS",23,-1.4329,0.059,0.15,"No",1.047,0.39,0.95,"Yes"
"5926","C2_Chemical_and_genetic_perturbations","C2_CGP_3226_IKEDA_MIR1_TARGETS_UP",53,-1.4329,0.033,0.09,"No",0.7868,0.88,1,"Yes"
"5927","C3_TF_targets","C3_TFT_434_V_E2F_Q2",173,-1.4328,0.0093,0.032,"No",1.0869,0.25,1,"Yes"
"5928","GO_MF","515223_GO_0070290_N_ACYLPHOSPHATIDYLETHANOLAMINE_SPECIFIC_PHOSPHOLIPASE_D_ACTIVITY",5,-1.4327,0.067,0.19,"No",-0.8328,0.66,1,"No"
"5929","GO_BP","849878_GO_1902176_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",17,-1.4327,0.072,0.15,"No",0.933,0.55,1,"Yes"
"5930","GO_BP","515126_GO_0070189_KYNURENINE_METABOLIC_PROCESS",10,-1.4325,0.087,0.15,"No",-1.3223,0.15,0.89,"No"
"5931","C2_Chemical_and_genetic_perturbations","C2_CGP_1143_AMIT_EGF_RESPONSE_240_MCF10A",20,-1.4325,0.076,0.09,"No",1.0168,0.42,0.78,"Yes"
"5932","C3_MicroRNA_targets","C3_MIR_28_CAGTGTT_MIR_141_MIR_200A",309,-1.4324,0.0011,0.26,"No",-1.2069,0.06,1,"No"
"5933","C3_TF_targets","C3_TFT_13_V_HOX13_01",44,-1.4324,0.041,0.032,"No",0.8537,0.73,1,"Yes"
"5934","GO_MF","495542_GO_0015298_SOLUTE_CATION_ANTIPORTER_ACTIVITY",27,-1.4323,0.048,0.19,"No",-0.9394,0.55,0.95,"No"
"5935","C2_Chemical_and_genetic_perturbations","C2_CGP_3052_KIM_ALL_DISORDERS_DURATION_CORR_DN",142,-1.4323,0.012,0.09,"No",1.5425,0,0.17,"Yes"
"5936","KEGG_compound","C04549_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_PHOSPHATE_",9,-1.4321,0.084,0.22,"No",-1.096,0.34,0.93,"No"
"5937","C7_Immunologic_signatures","C7_ALL_594_GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN",199,-1.4321,0.0058,0.017,"No",0.8604,0.86,1,"Yes"
"5938","C1_Positional","C1_ALL_156_CHR9Q32",33,-1.432,0.045,0.46,"No",1.0719,0.33,0.67,"Yes"
"5939","GO_BP","1026078_GO_1903306_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY",7,-1.432,0.073,0.15,"No",-0.8914,0.6,1,"No"
"5940","GO_BP","499895_GO_0030574_COLLAGEN_CATABOLIC_PROCESS",73,-1.432,0.029,0.15,"No",-1.0103,0.45,0.98,"No"
"5941","GO_BP","513657_GO_0060099_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT",8,-1.4318,0.089,0.15,"No",-0.6093,0.94,1,"No"
"5942","C2_Chemical_and_genetic_perturbations","C2_CGP_916_FURUKAWA_DUSP6_TARGETS_PCI35_DN",73,-1.4318,0.031,0.09,"No",0.8503,0.78,0.97,"Yes"
"5943","C2_Chemical_and_genetic_perturbations","C2_CGP_1068_SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP",473,-1.4317,0.001,0.09,"No",1.0163,0.4,0.78,"Yes"
"5944","GO_MF","504848_GO_0035671_ENONE_REDUCTASE_ACTIVITY",5,-1.4317,0.066,0.19,"No",-0.7554,0.76,1,"No"
"5945","GO_BP","507999_GO_0045651_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION",12,-1.4316,0.056,0.15,"No",0.4995,0.99,1,"Yes"
"5946","GO_BP","495970_GO_0015844_MONOAMINE_TRANSPORT",23,-1.4316,0.051,0.15,"No",-0.8517,0.7,1,"No"
"5947","GO_CC","518610_GO_0097060_SYNAPTIC_MEMBRANE",239,-1.4316,0.0022,0.19,"No",-1.3644,0.016,0.6,"No"
"5948","REACTOME","1127680_REACT_264269_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS",39,-1.4315,0.042,0.17,"No",-1.0076,0.45,0.99,"No"
"5949","GO_CC","507560_GO_0045178_BASAL_PART_OF_CELL",42,-1.4315,0.043,0.19,"No",-1.4727,0.022,0.6,"No"
"5950","C7_Immunologic_signatures","C7_ALL_1111_GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP",180,-1.4314,0.0092,0.017,"No",1.1058,0.22,0.43,"Yes"
"5951","C4_Cancer_modules","C4_CM_252_MODULE_286",37,-1.4313,0.055,0.083,"No",0.6727,0.95,1,"Yes"
"5952","C7_Immunologic_signatures","C7_ALL_1143_GSE27786_LSK_VS_LIN_NEG_CELL_UP",200,-1.4313,0.0068,0.017,"No",-0.7441,0.98,1,"No"
"5953","C2_Chemical_and_genetic_perturbations","C2_CGP_996_MANTOVANI_VIRAL_GPCR_SIGNALING_UP",83,-1.4313,0.026,0.09,"No",-0.8122,0.84,1,"No"
"5954","C7_Immunologic_signatures","C7_ALL_706_GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_DN",198,-1.4312,0.0068,0.017,"No",1.13,0.17,0.36,"Yes"
"5955","GO_BP","492875_GO_0008626_GRANZYME_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY",5,-1.4311,0.084,0.15,"No",1.1888,0.29,0.79,"Yes"
"5956","GO_CC","499969_GO_0030665_CLATHRIN_COATED_VESICLE_MEMBRANE",73,-1.4311,0.028,0.19,"No",0.8622,0.76,0.91,"Yes"
"5957","GO_BP","516140_GO_0071214_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS",242,-1.431,0.011,0.15,"No",-0.7197,1,1,"No"
"5958","REACTOME","106115_REACT_1319_FATTY_ACYL_COA_BIOSYNTHESIS",24,-1.4309,0.054,0.17,"No",0.4697,1,1,"Yes"
"5959","GO_BP","518416_GO_0090276_REGULATION_OF_PEPTIDE_HORMONE_SECRETION",188,-1.4309,0.0059,0.15,"No",-0.8636,0.84,1,"No"
"5960","REACTOME","1183571_REACT_97307_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3",143,-1.4308,0.012,0.17,"No",-1.072,0.32,0.9,"No"
"5961","C2_Chemical_and_genetic_perturbations","C2_CGP_135_CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP",118,-1.4307,0.02,0.091,"No",0.879,0.74,0.94,"Yes"
"5962","GO_BP","752801_GO_0097300_PROGRAMMED_NECROTIC_CELL_DEATH",25,-1.4306,0.061,0.15,"No",-0.6898,0.9,1,"No"
"5963","C7_Immunologic_signatures","C7_ALL_1496_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN",199,-1.4305,0.012,0.018,"No",-0.6751,1,1,"No"
"5964","REACTOME","106389_REACT_9027_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE",86,-1.4304,0.024,0.17,"No",0.6128,1,1,"Yes"
"5965","GO_BP","487933_GO_0002043_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",6,-1.4304,0.073,0.15,"No",-1.0472,0.43,0.97,"No"
"5966","C2_Chemical_and_genetic_perturbations","C2_CGP_2717_BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP",11,-1.4303,0.083,0.091,"No",-0.5493,0.97,1,"No"
"5967","GO_CC","503560_GO_0034358_PLASMA_LIPOPROTEIN_PARTICLE",37,-1.4301,0.052,0.19,"No",1.1252,0.29,0.61,"Yes"
"5968","GO_CC","495141_GO_0014069_POSTSYNAPTIC_DENSITY",129,-1.4299,0.0083,0.19,"No",-1.0796,0.28,0.81,"No"
"5969","GO_BP","511818_GO_0050880_REGULATION_OF_BLOOD_VESSEL_SIZE",69,-1.4298,0.026,0.15,"No",1.2521,0.1,0.73,"Yes"
"5970","GO_MF","498647_GO_0019863_IGE_BINDING",5,-1.4298,0.066,0.19,"No",-1.4581,0.075,0.61,"No"
"5971","C3_TF_targets","C3_TFT_275_V_POU6F1_01",226,-1.4298,0.0057,0.032,"No",0.9646,0.57,1,"Yes"
"5972","C2_Chemical_and_genetic_perturbations","C2_CGP_3181_WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2",55,-1.4298,0.035,0.091,"No",-1.0325,0.41,0.98,"No"
"5973","GO_BP","491010_GO_0006024_GLYCOSAMINOGLYCAN_BIOSYNTHETIC_PROCESS",101,-1.4298,0.016,0.15,"No",1.078,0.29,0.93,"Yes"
"5974","C2_Chemical_and_genetic_perturbations","C2_CGP_1340_SHIPP_DLBCL_CURED_VS_FATAL_UP",39,-1.4298,0.053,0.091,"No",-0.9443,0.55,1,"No"
"5975","C7_Immunologic_signatures","C7_ALL_882_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN",191,-1.4297,0.008,0.018,"No",-1.073,0.28,1,"No"
"5976","GO_BP","508850_GO_0046596_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL",24,-1.4296,0.088,0.15,"No",1.4251,0.058,0.52,"Yes"
"5977","GO_BP","507711_GO_0045354_REGULATION_OF_INTERFERON_ALPHA_BIOSYNTHETIC_PROCESS",5,-1.4296,0.065,0.15,"No",-0.6555,0.87,1,"No"
"5978","GO_BP","509096_GO_0046885_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS",21,-1.4296,0.059,0.15,"No",0.7445,0.84,1,"Yes"
"5979","C3_TF_targets","C3_TFT_188_V_AML1_01",261,-1.4295,0.0044,0.032,"No",-1.1348,0.15,0.47,"No"
"5980","GO_BP","494823_GO_0010758_REGULATION_OF_MACROPHAGE_CHEMOTAXIS",11,-1.4294,0.071,0.15,"No",1.1503,0.27,0.84,"Yes"
"5981","KEGG_compound","C00154_PALMITOYL_COA_HEXADECANOYL_COA",30,-1.4294,0.055,0.23,"No",-0.7117,0.89,1,"No"
"5982","C4_Cancer_modules","C4_CM_186_MODULE_199",57,-1.4294,0.028,0.083,"No",-0.9053,0.63,0.89,"No"
"5983","GO_BP","491907_GO_0007088_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION",125,-1.4294,0.0085,0.15,"No",-0.9416,0.59,1,"No"
"5984","C4_Cancer_modules","C4_CM_399_MODULE_509",14,-1.4293,0.075,0.083,"No",0.6116,0.94,1,"Yes"
"5985","C7_Immunologic_signatures","C7_ALL_832_GSE18148_CBFB_KO_VS_WT_TREG_DN",195,-1.4292,0.0068,0.018,"No",0.7988,0.96,1,"Yes"
"5986","GO_BP","518149_GO_0090002_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",67,-1.4291,0.028,0.15,"No",-0.7664,0.9,1,"No"
"5987","C7_Immunologic_signatures","C7_ALL_1249_GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP",166,-1.4287,0.012,0.018,"No",-1.0965,0.24,1,"No"
"5988","REACTOME","106397_REACT_9047_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE",93,-1.4287,0.019,0.17,"No",-0.5369,1,1,"No"
"5989","C2_Chemical_and_genetic_perturbations","C2_CGP_1662_SU_SALIVARY_GLAND",15,-1.4286,0.059,0.092,"No",-0.8346,0.7,1,"No"
"5990","GO_BP","501980_GO_0032754_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION",7,-1.4285,0.083,0.15,"No",-1.0613,0.39,0.96,"No"
"5991","C2_Chemical_and_genetic_perturbations","C2_CGP_1135_AMIT_EGF_RESPONSE_60_HELA",45,-1.4285,0.041,0.092,"No",-0.9113,0.62,1,"No"
"5992","GO_BP","753433_GO_1900449_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",29,-1.4285,0.057,0.15,"No",-1.5338,0.036,0.77,"No"
"5993","GO_BP","751564_GO_0044351_MACROPINOCYTOSIS",6,-1.4284,0.083,0.15,"No",-1.3062,0.17,0.88,"No"
"5994","C2_Chemical_and_genetic_perturbations","C2_CGP_2949_MOOTHA_GLYCOGEN_METABOLISM",21,-1.4284,0.067,0.092,"No",1.0009,0.41,0.8,"Yes"
"5995","C3_TF_targets","C3_TFT_400_V_AML1_Q6",261,-1.4284,0.0033,0.033,"No",-1.1403,0.14,0.45,"No"
"5996","REACTOME","119569_REACT_19372_ORGANIC_ANION_TRANSPORTERS",8,-1.4283,0.086,0.17,"No",0.9658,0.52,0.8,"Yes"
"5997","GO_BP","510696_GO_0048640_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH",71,-1.4282,0.029,0.15,"No",-1.3372,0.06,0.9,"No"
"5998","GO_BP","752561_GO_0090504_EPIBOLY",20,-1.4282,0.067,0.15,"No",-0.7478,0.83,1,"No"
"5999","C2_Chemical_and_genetic_perturbations","C2_CGP_95_WILCOX_RESPONSE_TO_PROGESTERONE_DN",64,-1.4281,0.035,0.092,"No",-1.1494,0.2,0.85,"No"
"6000","GO_BP","498821_GO_0021537_TELENCEPHALON_DEVELOPMENT",200,-1.4281,0.0079,0.15,"No",-1.1413,0.16,0.93,"No"
"6001","C2_Chemical_and_genetic_perturbations","C2_CGP_408_BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN",29,-1.4279,0.056,0.092,"No",-1.0559,0.37,0.96,"No"
"6002","C7_Immunologic_signatures","C7_ALL_705_GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_UP",198,-1.4279,0.0034,0.018,"No",-0.7612,0.98,1,"No"
"6003","GO_BP","488702_GO_0002829_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE",9,-1.4278,0.086,0.15,"No",1.0676,0.38,0.93,"Yes"
"6004","C2_Chemical_and_genetic_perturbations","C2_CGP_2251_HOQUE_METHYLATED_IN_CANCER",55,-1.4278,0.039,0.092,"No",1.1693,0.19,0.53,"Yes"
"6005","REACTOME","576254_REACT_118707_REGULATION_OF_COMPLEMENT_CASCADE",23,-1.4277,0.07,0.17,"No",-0.835,0.71,1,"No"
"6006","GO_BP","495860_GO_0015727_LACTATE_TRANSPORT",7,-1.4277,0.069,0.15,"No",-1.032,0.43,0.98,"No"
"6007","C4_Cancer_gene_neighborhoods","C4_CGN_307_GNF2_PCNA",68,-1.4276,0.039,0.1,"No",1.2214,0.13,0.19,"Yes"
"6008","GO_BP","506967_GO_0043949_REGULATION_OF_CAMP_MEDIATED_SIGNALING",22,-1.4276,0.067,0.15,"No",-0.7479,0.84,1,"No"
"6009","GO_BP","489048_GO_0003254_REGULATION_OF_MEMBRANE_DEPOLARIZATION",36,-1.4276,0.052,0.15,"No",-0.9748,0.49,1,"No"
"6010","GO_MF","495383_GO_0015108_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",82,-1.4274,0.033,0.19,"No",-0.9734,0.51,0.94,"No"
"6011","GO_BP","511660_GO_0050688_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS",83,-1.4274,0.02,0.15,"No",0.7629,0.94,1,"Yes"
"6012","REACTOME","205107_REACT_27215_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE",86,-1.4273,0.03,0.17,"No",0.6062,1,1,"Yes"
"6013","GO_MF","505729_GO_0042609_CD4_RECEPTOR_BINDING",5,-1.4273,0.066,0.19,"No",-0.5793,0.94,1,"No"
"6014","C2_Chemical_and_genetic_perturbations","C2_CGP_2919_MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3",202,-1.4272,0.0079,0.092,"No",-1.3142,0.029,0.7,"No"
"6015","GO_BP","516400_GO_0071476_CELLULAR_HYPOTONIC_RESPONSE",7,-1.4272,0.075,0.15,"No",0.485,0.99,1,"Yes"
"6016","REACTOME","106276_REACT_2086_PURINE_CATABOLISM",10,-1.4272,0.078,0.17,"No",-0.9621,0.49,1,"No"
"6017","GO_BP","492548_GO_0008207_C21_STEROID_HORMONE_METABOLIC_PROCESS",25,-1.4272,0.056,0.15,"No",-0.8211,0.74,1,"No"
"6018","C3_TF_targets","C3_TFT_531_TTTNNANAGCYR_UNKNOWN",132,-1.4271,0.0098,0.033,"No",-1.2073,0.13,0.34,"No"
"6019","C2_Chemical_and_genetic_perturbations","C2_CGP_853_DAIRKEE_TERT_TARGETS_DN",122,-1.427,0.016,0.093,"No",0.9185,0.67,0.9,"Yes"
"6020","GO_MF","492498_GO_0008146_SULFOTRANSFERASE_ACTIVITY",48,-1.427,0.039,0.19,"No",2.0062,0,0.013,"Yes"
"6021","GO_BP","501725_GO_0032493_RESPONSE_TO_BACTERIAL_LIPOPROTEIN",6,-1.4268,0.084,0.15,"No",0.7148,0.81,1,"Yes"
"6022","GO_BP","508438_GO_0051198_NEGATIVE_REGULATION_OF_COENZYME_METABOLIC_PROCESS",7,-1.4267,0.068,0.15,"No",-0.7278,0.83,1,"No"
"6023","C4_Cancer_gene_neighborhoods","C4_CGN_27_MORF_NF1",162,-1.4267,0.016,0.1,"No",-1.2661,0.051,0.55,"No"
"6024","KEGG_pathway","HSA05320_AUTOIMMUNE_THYROID_DISEASE",46,-1.4266,0.05,0.059,"No",-0.6316,0.97,1,"No"
"6025","C3_TF_targets","C3_TFT_306_V_STAT4_01",255,-1.4265,0.0044,0.033,"No",0.832,0.95,1,"Yes"
"6026","GO_BP","506198_GO_0043124_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",47,-1.4265,0.048,0.15,"No",-0.538,1,1,"No"
"6027","GO_BP","487807_GO_0001916_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY",22,-1.4265,0.06,0.15,"No",-0.752,0.85,1,"No"
"6028","C2_Chemical_and_genetic_perturbations","C2_CGP_3239_WANG_THOC1_TARGETS_DN",20,-1.4265,0.069,0.093,"No",1.335,0.11,0.36,"Yes"
"6029","REACTOME","106337_REACT_9417_SIGNALING_BY_EGFR",173,-1.4265,0.015,0.17,"No",-0.9486,0.61,1,"No"
"6030","KEGG_compound","C13747_1_7_DIMETHYLXANTHINE_PARAXANTHINE",5,-1.4264,0.08,0.23,"No",-0.708,0.82,1,"No"
"6031","GO_BP","487485_GO_0001547_ANTRAL_OVARIAN_FOLLICLE_GROWTH",5,-1.4263,0.072,0.15,"No",-1.3421,0.14,0.92,"No"
"6032","OMIM_gene","OMIM606945_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_LDLR",5,-1.4263,0.078,1,"No",-0.7454,0.79,1,"No"
"6033","GO_BP","518644_GO_0097094_CRANIOFACIAL_SUTURE_MORPHOGENESIS",15,-1.4262,0.062,0.15,"No",-1.022,0.44,0.97,"No"
"6034","C7_Immunologic_signatures","C7_ALL_1100_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN",199,-1.4261,0.012,0.019,"No",0.7609,1,1,"Yes"
"6035","C2_Chemical_and_genetic_perturbations","C2_CGP_730_KOBAYASHI_RESPONSE_TO_ROMIDEPSIN",19,-1.4261,0.073,0.093,"No",-1.5226,0.031,0.45,"No"
"6036","GO_BP","516309_GO_0071385_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS",37,-1.426,0.058,0.15,"No",0.9289,0.57,1,"Yes"
"6037","C2_Chemical_and_genetic_perturbations","C2_CGP_2419_CUI_GLUCOSE_DEPRIVATION",60,-1.426,0.041,0.093,"No",0.7495,0.92,1,"Yes"
"6038","C7_Immunologic_signatures","C7_ALL_519_GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_UP",196,-1.4257,0.0046,0.019,"No",1.1556,0.13,0.31,"Yes"
"6039","C2_Chemical_and_genetic_perturbations","C2_CGP_1716_CUI_TCF21_TARGETS_DN",31,-1.4257,0.056,0.093,"No",-1.2519,0.16,0.74,"No"
"6040","GO_BP","514645_GO_0061097_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY",58,-1.4255,0.043,0.15,"No",-0.7247,0.94,1,"No"
"6041","GO_BP","518172_GO_0090025_REGULATION_OF_MONOCYTE_CHEMOTAXIS",17,-1.4254,0.062,0.15,"No",1.3505,0.11,0.61,"Yes"
"6042","GO_BP","487893_GO_0002003_ANGIOTENSIN_MATURATION",12,-1.4254,0.083,0.15,"No",1.4827,0.063,0.44,"Yes"
"6043","C3_TF_targets","C3_TFT_401_V_P53_DECAMER_Q2",254,-1.4253,0.0033,0.033,"No",-1.1229,0.18,0.49,"No"
"6044","KEGG_compound","C14825_9_10_EPOME_9R_10S_12Z_9_10_EPOXYOCTADECENOIC_ACID",7,-1.4253,0.079,0.23,"No",-0.9821,0.48,1,"No"
"6045","C7_Immunologic_signatures","C7_ALL_1558_GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN",194,-1.4252,0.0069,0.019,"No",-0.758,0.99,1,"No"
"6046","C7_Immunologic_signatures","C7_ALL_391_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP",197,-1.4252,0.008,0.019,"No",-1.0344,0.37,1,"No"
"6047","GO_BP","508483_GO_0046185_ALDEHYDE_CATABOLIC_PROCESS",10,-1.4251,0.073,0.15,"No",1.6734,0.02,0.22,"Yes"
"6048","REACTOME","106555_REACT_2204_RNA_POLYMERASE_I_CHAIN_ELONGATION",86,-1.425,0.031,0.17,"No",-1.4778,0.0092,0.45,"No"
"6049","C2_Chemical_and_genetic_perturbations","C2_CGP_2706_BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN",40,-1.4249,0.056,0.094,"No",1.358,0.079,0.33,"Yes"
"6050","GO_BP","493713_GO_0009582_DETECTION_OF_ABIOTIC_STIMULUS",180,-1.4248,0.011,0.15,"No",-1.2527,0.072,0.91,"No"
"6051","KEGG_compound","C00071_ALDEHYDE_RCHO",13,-1.4247,0.075,0.23,"No",-0.9083,0.58,1,"No"
"6052","GO_BP","504347_GO_0035162_EMBRYONIC_HEMOPOIESIS",25,-1.4246,0.065,0.15,"No",1.1817,0.22,0.8,"Yes"
"6053","KEGG_compound","C00221_BETA_D_GLUCOSE",7,-1.4244,0.088,0.23,"No",-0.9395,0.53,1,"No"
"6054","GO_BP","1134002_GO_1903827_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION",422,-1.4244,0.001,0.15,"No",0.765,1,1,"Yes"
"6055","C2_Chemical_and_genetic_perturbations","C2_CGP_205_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP",23,-1.4243,0.06,0.094,"No",-0.7234,0.89,1,"No"
"6056","GO_BP","512776_GO_0051926_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT",40,-1.4243,0.047,0.15,"No",-0.7468,0.87,1,"No"
"6057","C7_Immunologic_signatures","C7_ALL_1087_GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP",193,-1.4243,0.0093,0.019,"No",0.7161,1,1,"Yes"
"6058","GO_BP","503812_GO_0034612_RESPONSE_TO_TUMOR_NECROSIS_FACTOR",117,-1.4242,0.012,0.15,"No",0.9639,0.55,1,"Yes"
"6059","REACTOME","645343_REACT_121284_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM",13,-1.424,0.093,0.17,"No",-1.2262,0.23,0.79,"No"
"6060","GO_BP","491593_GO_0006706_STEROID_CATABOLIC_PROCESS",23,-1.424,0.062,0.15,"No",1.0652,0.35,0.93,"Yes"
"6061","C1_Positional","C1_ALL_80_CHR16Q13",40,-1.4239,0.041,0.47,"No",1.5124,0.02,0.28,"Yes"
"6062","GO_BP","751212_GO_0036294_CELLULAR_RESPONSE_TO_DECREASED_OXYGEN_LEVELS",109,-1.4239,0.019,0.15,"No",-0.7299,0.97,1,"No"
"6063","GO_CC","487198_GO_0000974_PRP19_COMPLEX",6,-1.4239,0.09,0.2,"No",-1.193,0.28,0.68,"No"
"6064","GO_BP","502042_GO_0032819_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION",6,-1.4238,0.095,0.15,"No",-1.4924,0.056,0.82,"No"
"6065","GO_MF","505908_GO_0042805_ACTININ_BINDING",27,-1.4238,0.065,0.2,"No",1.074,0.36,0.83,"Yes"
"6066","GO_BP","499716_GO_0030316_OSTEOCLAST_DIFFERENTIATION",34,-1.4237,0.061,0.15,"No",0.7898,0.81,1,"Yes"
"6067","GO_BP","488968_GO_0003174_MITRAL_VALVE_DEVELOPMENT",7,-1.4237,0.097,0.15,"No",0.7945,0.74,1,"Yes"
"6068","C3_TF_targets","C3_TFT_70_V_CDPCR3HD_01",230,-1.4236,0.0056,0.034,"No",-1.2895,0.034,0.25,"No"
"6069","GO_BP","508143_GO_0045820_NEGATIVE_REGULATION_OF_GLYCOLYTIC_PROCESS",7,-1.4236,0.078,0.15,"No",-0.7169,0.83,1,"No"
"6070","C7_Immunologic_signatures","C7_ALL_803_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP",170,-1.4236,0.018,0.019,"No",-1.1893,0.11,0.86,"No"
"6071","GO_BP","1129404_GO_1903578_REGULATION_OF_ATP_METABOLIC_PROCESS",48,-1.4235,0.056,0.15,"No",-0.7312,0.9,1,"No"
"6072","KEGG_pathway","HSA04713_CIRCADIAN_ENTRAINMENT",95,-1.4235,0.024,0.06,"No",-1.0081,0.44,0.87,"No"
"6073","GO_BP","494630_GO_0010565_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS",455,-1.4235,0.001,0.15,"No",1.0338,0.32,0.96,"Yes"
"6074","REACTOME","119558_REACT_19118_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT",257,-1.4235,0.0066,0.17,"No",-1.1761,0.089,0.87,"No"
"6075","GO_BP","502250_GO_0033028_MYELOID_CELL_APOPTOTIC_PROCESS",6,-1.4233,0.079,0.15,"No",-0.6103,0.92,1,"No"
"6076","GO_MF","490303_GO_0048406_NERVE_GROWTH_FACTOR_BINDING",6,-1.4233,0.072,0.2,"No",0.6619,0.87,1,"Yes"
"6077","GO_BP","505173_GO_0040015_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH",13,-1.4233,0.067,0.15,"No",-1.1103,0.33,0.94,"No"
"6078","GO_MF","504442_GO_0035258_STEROID_HORMONE_RECEPTOR_BINDING",71,-1.4231,0.032,0.2,"No",0.8034,0.85,1,"Yes"
"6079","C2_Chemical_and_genetic_perturbations","C2_CGP_209_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP",35,-1.4229,0.062,0.095,"No",-1.2754,0.14,0.72,"No"
"6080","C3_TF_targets","C3_TFT_104_V_BRN2_01",229,-1.4228,0.0034,0.034,"No",-0.9103,0.73,0.95,"No"
"6081","GO_BP","518888_GO_2000241_REGULATION_OF_REPRODUCTIVE_PROCESS",240,-1.4228,0.0034,0.15,"No",1.3014,0.012,0.67,"Yes"
"6082","GO_BP","491594_GO_0006707_CHOLESTEROL_CATABOLIC_PROCESS",10,-1.4226,0.093,0.15,"No",-1.3176,0.16,0.89,"No"
"6083","C3_MicroRNA_targets","C3_MIR_142_ATGCAGT_MIR_217",115,-1.4225,0.019,0.27,"No",0.6782,1,1,"Yes"
"6084","GO_BP","513639_GO_0060081_MEMBRANE_HYPERPOLARIZATION",24,-1.4224,0.049,0.15,"No",-1.1778,0.23,0.91,"No"
"6085","GO_BP","506101_GO_0043010_CAMERA_TYPE_EYE_DEVELOPMENT",278,-1.4224,0.0044,0.15,"No",-1.149,0.13,0.93,"No"
"6086","C3_TF_targets","C3_TFT_39_V_TAL1ALPHAE47_01",243,-1.4223,0.0033,0.034,"No",-1.1514,0.15,0.45,"No"
"6087","C2_Chemical_and_genetic_perturbations","C2_CGP_1675_TRAYNOR_RETT_SYNDROM_DN",18,-1.4223,0.084,0.095,"No",1.0079,0.45,0.79,"Yes"
"6088","C2_Chemical_and_genetic_perturbations","C2_CGP_3394_HORTON_SREBF_TARGETS",25,-1.4222,0.07,0.095,"No",-1.027,0.44,0.98,"No"
"6089","C2_Chemical_and_genetic_perturbations","C2_CGP_2028_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5",473,-1.4222,0.0031,0.095,"No",0.9082,0.83,0.91,"Yes"
"6090","C3_TF_targets","C3_TFT_93_V_TST1_01",244,-1.4221,0.0055,0.034,"No",-0.8726,0.82,0.99,"No"
"6091","C2_Chemical_and_genetic_perturbations","C2_CGP_893_YANG_BREAST_CANCER_ESR1_LASER_DN",49,-1.4221,0.055,0.095,"No",0.8588,0.75,0.96,"Yes"
"6092","GO_BP","518763_GO_2000114_REGULATION_OF_ESTABLISHMENT_OF_CELL_POLARITY",16,-1.422,0.083,0.15,"No",0.6276,0.93,1,"Yes"
"6093","GO_BP","506439_GO_0043401_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY",55,-1.4219,0.043,0.15,"No",-1.0867,0.3,0.95,"No"
"6094","C2_Chemical_and_genetic_perturbations","C2_CGP_613_MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH",15,-1.4218,0.086,0.095,"No",0.991,0.45,0.81,"Yes"
"6095","C2_Chemical_and_genetic_perturbations","C2_CGP_3298_LIU_IL13_PRIMING_MODEL",15,-1.4217,0.057,0.095,"No",-1.5429,0.042,0.43,"No"
"6096","C2_Chemical_and_genetic_perturbations","C2_CGP_1038_CAFFAREL_RESPONSE_TO_THC_24HR_5_UP",34,-1.4217,0.053,0.095,"No",1.2157,0.17,0.47,"Yes"
"6097","GO_BP","498550_GO_0019731_ANTIBACTERIAL_HUMORAL_RESPONSE",31,-1.4216,0.056,0.15,"No",1.5763,0.018,0.32,"Yes"
"6098","C7_Immunologic_signatures","C7_ALL_1066_GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN",195,-1.4216,0.0068,0.02,"No",0.824,0.93,1,"Yes"
"6099","C3_TF_targets","C3_TFT_598_YATGNWAAT_V_OCT_C",348,-1.4215,0,0.034,"No",-1.409,0.0034,0.16,"No"
"6100","GO_BP","492819_GO_0008544_EPIDERMIS_DEVELOPMENT",236,-1.4215,0.0066,0.15,"No",0.8561,0.9,1,"Yes"
"6101","C7_Immunologic_signatures","C7_ALL_1259_GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP",183,-1.4214,0.012,0.02,"No",1.3716,0.018,0.05,"Yes"
"6102","GO_BP","505277_GO_0042100_B_CELL_PROLIFERATION",33,-1.4213,0.061,0.15,"No",0.5052,1,1,"Yes"
"6103","GO_BP","516250_GO_0071326_CELLULAR_RESPONSE_TO_MONOSACCHARIDE_STIMULUS",54,-1.4213,0.047,0.15,"No",-0.6651,0.97,1,"No"
"6104","GO_BP","493497_GO_0009313_OLIGOSACCHARIDE_CATABOLIC_PROCESS",8,-1.4211,0.096,0.15,"No",1.0223,0.45,0.97,"Yes"
"6105","C4_Cancer_modules","C4_CM_147_MODULE_155",25,-1.421,0.048,0.087,"No",0.9767,0.48,0.74,"Yes"
"6106","GO_BP","512092_GO_0051186_COFACTOR_METABOLIC_PROCESS",319,-1.4208,0.0021,0.15,"No",0.9783,0.52,1,"Yes"
"6107","C7_Immunologic_signatures","C7_ALL_1825_GSE7852_TREG_VS_TCONV_UP",198,-1.4208,0.017,0.02,"No",0.7183,1,1,"Yes"
"6108","GO_BP","500831_GO_0031581_HEMIDESMOSOME_ASSEMBLY",11,-1.4208,0.072,0.15,"No",-0.9707,0.48,1,"No"
"6109","GO_BP","510763_GO_0048708_ASTROCYTE_DIFFERENTIATION",29,-1.4207,0.065,0.15,"No",1.2282,0.17,0.76,"Yes"
"6110","C2_Chemical_and_genetic_perturbations","C2_CGP_499_MCBRYAN_PUBERTAL_BREAST_3_4WK_DN",36,-1.4206,0.045,0.096,"No",1.1484,0.23,0.56,"Yes"
"6111","GO_BP","499720_GO_0072502_CELLULAR_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS",6,-1.4204,0.087,0.15,"No",0.4826,0.99,1,"Yes"
"6112","GO_BP","512669_GO_0051798_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT",9,-1.4203,0.092,0.15,"No",-1.2474,0.21,0.91,"No"
"6113","KEGG_pathway","HSA04310_WNT_SIGNALING_PATHWAY",137,-1.4202,0.016,0.061,"No",-0.9915,0.47,0.9,"No"
"6114","REACTOME","106123_REACT_1541_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS",8,-1.4202,0.089,0.18,"No",0.9424,0.53,0.84,"Yes"
"6115","GO_MF","490301_GO_0043121_NEUROTROPHIN_BINDING",9,-1.4201,0.066,0.2,"No",0.8091,0.71,1,"Yes"
"6116","C3_TF_targets","C3_TFT_197_V_TCF11_01",247,-1.42,0.0011,0.035,"No",-0.8284,0.92,1,"No"
"6117","C3_TF_targets","C3_TFT_185_V_ISRE_01",241,-1.42,0.0077,0.034,"No",1.127,0.15,0.97,"Yes"
"6118","C4_Cancer_modules","C4_CM_238_MODULE_264",11,-1.4199,0.1,0.088,"No",0.9811,0.47,0.73,"Yes"
"6119","GO_BP","486822_GO_0000305_RESPONSE_TO_OXYGEN_RADICAL",18,-1.4195,0.086,0.16,"No",-0.554,0.98,1,"No"
"6120","GO_CC","518575_GO_0097025_MPP7_DLG1_LIN7_COMPLEX",5,-1.4195,0.08,0.2,"No",0.9824,0.45,0.81,"Yes"
"6121","GO_BP","488760_GO_0002887_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",7,-1.4193,0.08,0.16,"No",-0.8862,0.6,1,"No"
"6122","C2_Chemical_and_genetic_perturbations","C2_CGP_2616_COLINA_TARGETS_OF_4EBP1_AND_4EBP2",351,-1.4193,0.0032,0.097,"No",1.3807,0.0078,0.31,"Yes"
"6123","GO_BP","512037_GO_0051126_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION",6,-1.4193,0.079,0.16,"No",0.7283,0.81,1,"Yes"
"6124","C6_Oncogenic_signatures","C6_ALL_44_WNT_UP_V1_UP",158,-1.4192,0.013,0.027,"No",-0.913,0.67,0.87,"No"
"6125","GO_BP","489077_GO_0003284_SEPTUM_PRIMUM_DEVELOPMENT",5,-1.4191,0.063,0.16,"No",0.745,0.78,1,"Yes"
"6126","C7_Immunologic_signatures","C7_ALL_140_GSE13229_IMM_VS_MATURE_NKCELL_DN",198,-1.4191,0.0092,0.02,"No",-0.7243,1,1,"No"
"6127","GO_BP","511824_GO_0050886_ENDOCRINE_PROCESS",48,-1.419,0.048,0.16,"No",-0.9331,0.57,1,"No"
"6128","KEGG_pathway","HSA00561_GLYCEROLIPID_METABOLISM",56,-1.419,0.04,0.062,"No",-0.983,0.49,0.91,"No"
"6129","GO_BP","752562_GO_0090505_EPIBOLY_INVOLVED_IN_WOUND_HEALING",19,-1.419,0.083,0.16,"No",-0.6518,0.9,1,"No"
"6130","C3_TF_targets","C3_TFT_147_V_HNF1_C",233,-1.419,0.0056,0.035,"No",-0.9835,0.5,0.8,"No"
"6131","KEGG_pathway","HSA00520_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM",48,-1.419,0.054,0.061,"No",-0.6111,1,1,"No"
"6132","REACTOME","645328_REACT_121324_ACYL_CHAIN_REMODELLING_OF_PG",15,-1.4188,0.089,0.18,"No",-0.9538,0.51,1,"No"
"6133","C7_Immunologic_signatures","C7_ALL_1324_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN",192,-1.4188,0.008,0.021,"No",-0.8518,0.84,1,"No"
"6134","GO_BP","518920_GO_2000273_POSITIVE_REGULATION_OF_RECEPTOR_ACTIVITY",31,-1.4188,0.065,0.16,"No",-1.077,0.33,0.95,"No"
"6135","GO_BP","513903_GO_0060347_HEART_TRABECULA_FORMATION",15,-1.4187,0.085,0.16,"No",-1.38,0.087,1,"No"
"6136","C2_Chemical_and_genetic_perturbations","C2_CGP_2437_FIRESTEIN_PROLIFERATION",173,-1.4187,0.0046,0.097,"No",-0.7836,0.96,1,"No"
"6137","REACTOME","1183563_REACT_355200_SIGNALING_BY_FGFR2",159,-1.4186,0.015,0.18,"No",-0.9049,0.73,1,"No"
"6138","C3_TF_targets","C3_TFT_393_V_HFH4_01",189,-1.4186,0.011,0.034,"No",1.0707,0.26,1,"Yes"
"6139","GO_BP","487674_GO_0001778_PLASMA_MEMBRANE_REPAIR",8,-1.4185,0.089,0.16,"No",-1.6212,0.023,0.69,"No"
"6140","C2_Chemical_and_genetic_perturbations","C2_CGP_527_ZIRN_TRETINOIN_RESPONSE_DN",6,-1.4183,0.088,0.097,"No",0.6383,0.9,1,"Yes"
"6141","C2_Chemical_and_genetic_perturbations","C2_CGP_1519_ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP",26,-1.4183,0.07,0.097,"No",-0.8075,0.77,1,"No"
"6142","GO_BP","492402_GO_0050810_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS",50,-1.4183,0.05,0.16,"No",-0.9821,0.45,1,"No"
"6143","KEGG_pathway","HSA00564_GLYCEROPHOSPHOLIPID_METABOLISM",91,-1.4182,0.022,0.061,"No",-0.6071,1,1,"No"
"6144","C1_Positional","C1_ALL_286_CHR12Q13",236,-1.4182,0.013,0.47,"No",-1.3292,0.025,0.83,"No"
"6145","GO_BP","516270_GO_0071346_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA",101,-1.4181,0.017,0.16,"No",0.8802,0.74,1,"Yes"
"6146","GO_MF","496296_GO_0016229_STEROID_DEHYDROGENASE_ACTIVITY",26,-1.4181,0.062,0.2,"No",1.4118,0.078,0.48,"Yes"
"6147","GO_BP","487849_GO_0001959_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",98,-1.4181,0.025,0.16,"No",0.7539,0.96,1,"Yes"
"6148","KEGG_pathway","HSA00232_CAFFEINE_METABOLISM",5,-1.4179,0.077,0.061,"No",-0.6978,0.81,1,"No"
"6149","GO_BP","492818_GO_0008543_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",159,-1.4179,0.018,0.16,"No",-0.8923,0.73,1,"No"
"6150","C7_Immunologic_signatures","C7_ALL_853_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP",166,-1.4179,0.0093,0.021,"No",-1.0701,0.3,1,"No"
"6151","GO_BP","492355_GO_0007614_SHORT_TERM_MEMORY",8,-1.4178,0.078,0.16,"No",0.9425,0.52,1,"Yes"
"6152","C2_Chemical_and_genetic_perturbations","C2_CGP_2583_HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP",22,-1.4178,0.074,0.098,"No",-1.1742,0.24,0.82,"No"
"6153","C7_Immunologic_signatures","C7_ALL_802_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0_5H_ACT_CD4_TCELL_DN",171,-1.4178,0.017,0.021,"No",-1.2862,0.048,0.5,"No"
"6154","GO_BP","495104_GO_0014032_NEURAL_CREST_CELL_DEVELOPMENT",50,-1.4178,0.04,0.16,"No",1.4273,0.033,0.52,"Yes"
"6155","C2_Chemical_and_genetic_perturbations","C2_CGP_1026_SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP",13,-1.4177,0.074,0.098,"No",-1.3555,0.13,0.67,"No"
"6156","C7_Immunologic_signatures","C7_ALL_1084_GSE25087_TREG_VS_TCONV_FETUS_DN",191,-1.4177,0.011,0.021,"No",1.0399,0.37,0.62,"Yes"
"6157","C7_Immunologic_signatures","C7_ALL_408_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN",200,-1.4177,0.0069,0.021,"No",1.6373,0,0.0015,"Yes"
"6158","GO_BP","494945_GO_0010881_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION",19,-1.4176,0.072,0.16,"No",1.0317,0.41,0.96,"Yes"
"6159","KEGG_pathway","HSA04914_PROGESTERONE_MEDIATED_OOCYTE_MATURATION",87,-1.4174,0.029,0.061,"No",0.9112,0.65,1,"Yes"
"6160","GO_BP","755385_GO_2001279_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS",6,-1.4173,0.069,0.16,"No",-0.6515,0.88,1,"No"
"6161","C7_Immunologic_signatures","C7_ALL_20_GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN",187,-1.4173,0.0069,0.021,"No",0.8843,0.78,1,"Yes"
"6162","GO_BP","751383_GO_0038127_ERBB_SIGNALING_PATHWAY",195,-1.4173,0.0068,0.16,"No",-1.0523,0.32,0.97,"No"
"6163","C3_TF_targets","C3_TFT_24_V_SOX5_01",260,-1.4173,0.0033,0.035,"No",-0.8538,0.87,1,"No"
"6164","KEGG_compound","C02232_3_OXOADIPYL_COA_BETA_KETOADIPYL_COA",5,-1.4172,0.087,0.24,"No",0.5708,0.94,1,"Yes"
"6165","GO_MF","499745_GO_0030346_PROTEIN_PHOSPHATASE_2B_BINDING",6,-1.4172,0.072,0.2,"No",-1.1973,0.29,0.81,"No"
"6166","GO_BP","500152_GO_0030854_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION",9,-1.4171,0.072,0.16,"No",0.832,0.67,1,"Yes"
"6167","C7_Immunologic_signatures","C7_ALL_314_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN",194,-1.4171,0.013,0.021,"No",1.5769,0,0.0043,"Yes"
"6168","C2_Chemical_and_genetic_perturbations","C2_CGP_2966_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2",8,-1.417,0.09,0.098,"No",-1.296,0.17,0.7,"No"
"6169","C2_Chemical_and_genetic_perturbations","C2_CGP_1380_ROSS_AML_OF_FAB_M7_TYPE",68,-1.4169,0.037,0.098,"No",1.7969,0,0.044,"Yes"
"6170","C2_Chemical_and_genetic_perturbations","C2_CGP_929_TOMLINS_PROSTATE_CANCER_DN",39,-1.4169,0.051,0.098,"No",0.7281,0.92,1,"Yes"
"6171","GO_BP","492416_GO_0008038_NEURON_RECOGNITION",33,-1.4168,0.055,0.16,"No",-1.5009,0.038,0.83,"No"
"6172","C7_Immunologic_signatures","C7_ALL_1628_GSE3982_DC_VS_MAC_DN",199,-1.4168,0.008,0.021,"No",1.1443,0.13,0.33,"Yes"
"6173","GO_BP","506361_GO_0043301_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION",7,-1.4168,0.073,0.16,"No",-0.89,0.62,1,"No"
"6174","GO_BP","506647_GO_0043616_KERATINOCYTE_PROLIFERATION",11,-1.4167,0.082,0.16,"No",-1.064,0.39,0.96,"No"
"6175","C7_Immunologic_signatures","C7_ALL_320_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN",199,-1.4165,0.0069,0.021,"No",1.3144,0.021,0.09,"Yes"
"6176","C7_Immunologic_signatures","C7_ALL_1820_GSE7852_LN_VS_THYMUS_TCONV_DN",200,-1.4165,0.0046,0.021,"No",-0.6418,1,1,"No"
"6177","GO_MF","487745_GO_0001849_COMPLEMENT_COMPONENT_C1Q_BINDING",8,-1.4165,0.092,0.2,"No",-1.3627,0.14,0.69,"No"
"6178","C2_Chemical_and_genetic_perturbations","C2_CGP_3231_IKEDA_MIR30_TARGETS_DN",27,-1.4164,0.069,0.098,"No",1.423,0.06,0.28,"Yes"
"6179","C3_TF_targets","C3_TFT_552_YTAAYNGCT_UNKNOWN",144,-1.4164,0.011,0.035,"No",1.0057,0.44,1,"Yes"
"6180","C0_Hallmark","H_ALL_45_HALLMARK_PEROXISOME",103,-1.4163,0.024,0.025,"No",-0.9524,0.55,1,"No"
"6181","GO_MF","499695_GO_0030291_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY",28,-1.4162,0.06,0.2,"No",-0.6148,0.97,1,"No"
"6182","GO_MF","499444_GO_0023023_MHC_PROTEIN_COMPLEX_BINDING",19,-1.4162,0.071,0.2,"No",-1.1048,0.32,0.84,"No"
"6183","REACTOME","119539_REACT_19388_G_PROTEIN_BETA_GAMMA_SIGNALLING",50,-1.416,0.03,0.18,"No",-0.7774,0.86,1,"No"
"6184","C2_Chemical_and_genetic_perturbations","C2_CGP_2104_JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP",12,-1.4159,0.065,0.098,"No",1.0142,0.41,0.78,"Yes"
"6185","GO_BP","506191_GO_0043113_RECEPTOR_CLUSTERING",40,-1.4159,0.063,0.16,"No",-1.0346,0.4,0.98,"No"
"6186","GO_BP","516299_GO_0071375_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS",285,-1.4158,0.0043,0.16,"No",-0.768,0.98,1,"No"
"6187","REACTOME","161011_REACT_22128_LIGAND_INDEPENDENT_CASPASE_ACTIVATION_VIA_DCC",10,-1.4158,0.082,0.18,"No",-0.6197,0.92,1,"No"
"6188","GO_BP","502100_GO_0032878_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY",19,-1.4157,0.07,0.16,"No",0.6794,0.91,1,"Yes"
"6189","GO_BP","491558_GO_0006670_SPHINGOSINE_METABOLIC_PROCESS",10,-1.4156,0.11,0.16,"No",-0.6176,0.94,1,"No"
"6190","C2_Chemical_and_genetic_perturbations","C2_CGP_2828_STEIN_ESR1_TARGETS",85,-1.4156,0.028,0.099,"No",1.1013,0.26,0.63,"Yes"
"6191","C2_Chemical_and_genetic_perturbations","C2_CGP_1298_LEE_LIVER_CANCER_ACOX1_DN",63,-1.4156,0.034,0.099,"No",-0.9186,0.6,1,"No"
"6192","GO_BP","500135_GO_0030837_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION",46,-1.4156,0.043,0.16,"No",-0.7962,0.82,1,"No"
"6193","C2_Chemical_and_genetic_perturbations","C2_CGP_2598_FINAK_BREAST_CANCER_SDPP_SIGNATURE",25,-1.4156,0.061,0.099,"No",1.3761,0.077,0.31,"Yes"
"6194","GO_MF","504195_GO_0035004_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",12,-1.4155,0.083,0.2,"No",-0.9248,0.58,0.96,"No"
"6195","C2_Chemical_and_genetic_perturbations","C2_CGP_2640_MEISSNER_BRAIN_HCP_WITH_H3K27ME3",245,-1.4155,0.0033,0.098,"No",-1.208,0.084,0.8,"No"
"6196","GO_BP","507325_GO_0044319_WOUND_HEALING_SPREADING_OF_CELLS",19,-1.4155,0.071,0.16,"No",-0.6625,0.94,1,"No"
"6197","KEGG_pathway","HSA00051_FRUCTOSE_AND_MANNOSE_METABOLISM",32,-1.4154,0.051,0.061,"No",-0.5944,0.98,1,"No"
"6198","C3_TF_targets","C3_TFT_209_V_PAX8_B",101,-1.4154,0.019,0.035,"No",-0.9505,0.57,0.88,"No"
"6199","C2_Chemical_and_genetic_perturbations","C2_CGP_124_DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP",359,-1.4153,0.0053,0.099,"No",-0.9608,0.61,1,"No"
"6200","GO_MF","506017_GO_0042923_NEUROPEPTIDE_BINDING",20,-1.4153,0.088,0.2,"No",1.153,0.25,0.74,"Yes"
"6201","C7_Immunologic_signatures","C7_ALL_1777_GSE7460_TREG_VS_TCONV_ACT_UP",196,-1.4152,0.0068,0.021,"No",0.6977,1,1,"Yes"
"6202","GO_BP","510652_GO_0048589_DEVELOPMENTAL_GROWTH",214,-1.4152,0.008,0.16,"No",-1.0743,0.28,0.95,"No"
"6203","C2_Chemical_and_genetic_perturbations","C2_CGP_465_OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP",117,-1.4151,0.014,0.099,"No",1.9993,0,0.0063,"Yes"
"6204","GO_BP","510895_GO_0048845_VENOUS_BLOOD_VESSEL_MORPHOGENESIS",9,-1.4151,0.076,0.16,"No",-0.4603,1,1,"No"
"6205","C2_Chemical_and_genetic_perturbations","C2_CGP_1253_CERVERA_SDHB_TARGETS_1_UP",113,-1.4151,0.012,0.099,"No",1.0207,0.43,0.77,"Yes"
"6206","C2_Chemical_and_genetic_perturbations","C2_CGP_1623_DAZARD_UV_RESPONSE_CLUSTER_G3",15,-1.4149,0.078,0.099,"No",-0.9747,0.48,1,"No"
"6207","GO_BP","506192_GO_0043114_REGULATION_OF_VASCULAR_PERMEABILITY",26,-1.4149,0.07,0.16,"No",-0.6725,0.94,1,"No"
"6208","C2_Chemical_and_genetic_perturbations","C2_CGP_2173_WALLACE_PROSTATE_CANCER_DN",6,-1.4147,0.088,0.099,"No",-0.9186,0.55,1,"No"
"6209","GO_CC","505741_GO_0042627_CHYLOMICRON",13,-1.4147,0.087,0.21,"No",-1.1097,0.31,0.76,"No"
"6210","C3_TF_targets","C3_TFT_399_V_HMGIY_Q6",241,-1.4147,0.0055,0.035,"No",-1.2755,0.04,0.25,"No"
"6211","C7_Immunologic_signatures","C7_ALL_1344_GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN",198,-1.4146,0.01,0.022,"No",1.156,0.13,0.31,"Yes"
"6212","C3_TF_targets","C3_TFT_179_V_GFI1_01",255,-1.4146,0.0033,0.035,"No",-1.1745,0.11,0.4,"No"
"6213","C7_Immunologic_signatures","C7_ALL_738_GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_DN",199,-1.4144,0.011,0.022,"No",1.1595,0.13,0.3,"Yes"
"6214","C2_Chemical_and_genetic_perturbations","C2_CGP_52_WATANABE_COLON_CANCER_MSI_VS_MSS_UP",29,-1.4144,0.069,0.099,"No",1.0273,0.42,0.76,"Yes"
"6215","GO_BP","514314_GO_0060759_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS",105,-1.4143,0.034,0.16,"No",0.8482,0.84,1,"Yes"
"6216","GO_BP","500754_GO_0031503_PROTEIN_COMPLEX_LOCALIZATION",20,-1.4143,0.072,0.16,"No",-0.9712,0.5,1,"No"
"6217","REACTOME","771603_REACT_160078_PEPTIDE_HORMONE_METABOLISM",80,-1.4143,0.033,0.18,"No",1.1817,0.15,0.46,"Yes"
"6218","GO_BP","491616_GO_0006732_COENZYME_METABOLIC_PROCESS",256,-1.4143,0.0033,0.16,"No",0.9517,0.63,1,"Yes"
"6219","C7_Immunologic_signatures","C7_ALL_491_GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_UP",199,-1.4142,0.0069,0.022,"No",1.159,0.11,0.3,"Yes"
"6220","C2_Chemical_and_genetic_perturbations","C2_CGP_3383_ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF",495,-1.4141,0,0.099,"No",-1.0896,0.22,0.93,"No"
"6221","GO_BP","751231_GO_0036314_RESPONSE_TO_STEROL",23,-1.414,0.079,0.16,"No",-0.6281,0.96,1,"No"
"6222","GO_BP","755328_GO_2001222_REGULATION_OF_NEURON_MIGRATION",25,-1.4139,0.065,0.16,"No",-0.7502,0.83,1,"No"
"6223","GO_MF","510413_GO_0048306_CALCIUM_DEPENDENT_PROTEIN_BINDING",57,-1.4139,0.046,0.2,"No",1.1188,0.25,0.77,"Yes"
"6224","GO_BP","495853_GO_0015718_MONOCARBOXYLIC_ACID_TRANSPORT",106,-1.4138,0.02,0.16,"No",-1.0824,0.28,0.95,"No"
"6225","C2_Chemical_and_genetic_perturbations","C2_CGP_944_SCHLESINGER_METHYLATED_IN_COLON_CANCER",10,-1.4137,0.08,0.099,"No",1.1453,0.3,0.56,"Yes"
"6226","GO_BP","487881_GO_0001991_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN",16,-1.4137,0.078,0.16,"No",1.6342,0.016,0.25,"Yes"
"6227","GO_BP","486717_GO_0000186_ACTIVATION_OF_MAPKK_ACTIVITY",63,-1.4135,0.054,0.16,"No",-0.8166,0.83,1,"No"
"6228","GO_CC","499829_GO_0030485_SMOOTH_MUSCLE_CONTRACTILE_FIBER",5,-1.4135,0.089,0.21,"No",-0.7804,0.72,1,"No"
"6229","C7_Immunologic_signatures","C7_ALL_83_GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP",193,-1.4134,0.011,0.022,"No",-0.9343,0.63,1,"No"
"6230","GO_BP","491931_GO_0030010_ESTABLISHMENT_OF_CELL_POLARITY",72,-1.4133,0.049,0.16,"No",-0.8931,0.65,1,"No"
"6231","WikiPathways","198914_WP1600_NICOTINE_METABOLISM",6,-1.4133,0.083,0.11,"No",-1.2954,0.19,1,"No"
"6232","GO_BP","499065_GO_0021785_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE",6,-1.4132,0.081,0.16,"No",-1.3374,0.14,0.9,"No"
"6233","GO_BP","501900_GO_0032674_REGULATION_OF_INTERLEUKIN_5_PRODUCTION",14,-1.4132,0.09,0.16,"No",-0.8686,0.66,1,"No"
"6234","GO_BP","491676_GO_0017085_RESPONSE_TO_INSECTICIDE",12,-1.4132,0.076,0.16,"No",-0.9047,0.59,1,"No"
"6235","GO_BP","517131_GO_0072215_REGULATION_OF_METANEPHROS_DEVELOPMENT",23,-1.4132,0.07,0.16,"No",0.9812,0.47,1,"Yes"
"6236","C7_Immunologic_signatures","C7_ALL_1423_GSE360_CTRL_VS_T_GONDII_MAC_UP",199,-1.4131,0.013,0.022,"No",1.1924,0.09,0.24,"Yes"
"6237","KEGG_compound","C00010_COA_COENZYME_A_COA_SH",120,-1.4131,0.026,0.24,"No",-0.828,0.87,1,"No"
"6238","GO_BP","505280_GO_0042104_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION",24,-1.413,0.058,0.16,"No",-1.088,0.35,0.95,"No"
"6239","C3_MicroRNA_targets","C3_MIR_15_TGCACTT_MIR_519C_MIR_519B_MIR_519A",444,-1.4129,0,0.28,"No",-0.7983,0.99,1,"No"
"6240","GO_BP","505322_GO_0042159_LIPOPROTEIN_CATABOLIC_PROCESS",7,-1.4128,0.093,0.16,"No",-0.7326,0.81,1,"No"
"6241","GO_BP","498417_GO_0019585_GLUCURONATE_METABOLIC_PROCESS",25,-1.4128,0.072,0.16,"No",1.5578,0.013,0.34,"Yes"
"6242","GO_BP","753988_GO_1901018_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.4126,0.082,0.16,"No",-1.3797,0.085,1,"No"
"6243","REACTOME","645344_REACT_121147_ALPHA_LINOLENIC_ACID_ALA_METABOLISM",13,-1.4125,0.09,0.18,"No",-1.2081,0.24,0.83,"No"
"6244","C3_TF_targets","C3_TFT_134_V_AP2_Q6",255,-1.4124,0.0044,0.036,"No",-1.2503,0.045,0.28,"No"
"6245","GO_BP","492513_GO_0046683_RESPONSE_TO_ORGANOPHOSPHORUS",124,-1.4123,0.012,0.16,"No",1.0218,0.4,0.97,"Yes"
"6246","REACTOME","645300_REACT_120996_HYALURONAN_UPTAKE_AND_DEGRADATION",12,-1.4123,0.068,0.18,"No",-1.2683,0.2,0.7,"No"
"6247","GO_BP","502184_GO_0032962_POSITIVE_REGULATION_OF_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS",5,-1.4123,0.064,0.16,"No",0.9365,0.55,1,"Yes"
"6248","KEGG_pathway","HSA04726_SEROTONERGIC_SYNAPSE",113,-1.4122,0.028,0.063,"No",-1.0192,0.39,0.86,"No"
"6249","GO_MF","496870_GO_0017049_GTP_RHO_BINDING",13,-1.4121,0.099,0.2,"No",-1.1427,0.31,0.82,"No"
"6250","GO_BP","499436_GO_0050856_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY",25,-1.4121,0.073,0.16,"No",1.0142,0.41,0.97,"Yes"
"6251","GO_BP","498071_GO_0019216_REGULATION_OF_LIPID_METABOLIC_PROCESS",254,-1.4121,0.0056,0.16,"No",0.8149,0.97,1,"Yes"
"6252","GO_BP","516603_GO_0071679_COMMISSURAL_NEURON_AXON_GUIDANCE",7,-1.412,0.082,0.16,"No",-0.7596,0.77,1,"No"
"6253","C3_TF_targets","C3_TFT_471_V_MEF2_Q6_01",238,-1.4119,0.0078,0.036,"No",-1.3598,0.0066,0.19,"No"
"6254","GO_BP","506243_GO_0043171_PEPTIDE_CATABOLIC_PROCESS",13,-1.4119,0.087,0.16,"No",0.4371,1,1,"Yes"
"6255","C2_Chemical_and_genetic_perturbations","C2_CGP_2185_IWANAGA_CARCINOGENESIS_BY_KRAS_UP",168,-1.4118,0.013,0.1,"No",0.9203,0.69,0.9,"Yes"
"6256","KEGG_pathway","HSA04910_INSULIN_SIGNALING_PATHWAY",138,-1.4118,0.015,0.063,"No",0.7298,0.98,1,"Yes"
"6257","C2_Chemical_and_genetic_perturbations","C2_CGP_937_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN",20,-1.4118,0.081,0.1,"No",1.0097,0.43,0.78,"Yes"
"6258","KEGG_pathway","HSA04512_ECM_RECEPTOR_INTERACTION",86,-1.4118,0.025,0.062,"No",-1.0854,0.3,0.7,"No"
"6259","C2_Chemical_and_genetic_perturbations","C2_CGP_1404_MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN",23,-1.4117,0.076,0.1,"No",0.8529,0.68,0.97,"Yes"
"6260","WikiPathways","672446_WP2032_TSH_SIGNALING_PATHWAY",63,-1.4116,0.042,0.11,"No",1.0273,0.39,1,"Yes"
"6261","GO_BP","505302_GO_0042130_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION",45,-1.4115,0.051,0.16,"No",0.7467,0.9,1,"Yes"
"6262","C7_Immunologic_signatures","C7_ALL_1319_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP",191,-1.4115,0.0068,0.022,"No",0.9311,0.67,0.95,"Yes"
"6263","GO_BP","502048_GO_0032825_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION",8,-1.4114,0.098,0.16,"No",-1.6318,0.024,0.7,"No"
"6264","GO_MF","511516_GO_0050543_ICOSATETRAENOIC_ACID_BINDING",6,-1.4114,0.074,0.2,"No",1.5141,0.053,0.36,"Yes"
"6265","GO_BP","497336_GO_0018401_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE",6,-1.4111,0.078,0.16,"No",-0.8395,0.68,1,"No"
"6266","C4_Cancer_modules","C4_CM_50_MODULE_54",261,-1.411,0.0076,0.093,"No",1.3347,0.014,0.24,"Yes"
"6267","GO_CC","490882_GO_0005874_MICROTUBULE",378,-1.4109,0.0032,0.21,"No",-0.9756,0.54,0.88,"No"
"6268","GO_MF","499846_GO_0030506_ANKYRIN_BINDING",20,-1.4107,0.073,0.21,"No",-1.0887,0.36,0.85,"No"
"6269","C7_Immunologic_signatures","C7_ALL_1460_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN",194,-1.4107,0.014,0.023,"No",0.7603,0.98,1,"Yes"
"6270","GO_BP","514843_GO_0061298_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE",18,-1.4106,0.084,0.16,"No",0.9331,0.55,1,"Yes"
"6271","REACTOME","106483_REACT_12436_ERKS_ARE_INACTIVATED",12,-1.4106,0.092,0.18,"No",-0.5253,0.98,1,"No"
"6272","GO_BP","516229_GO_0071305_CELLULAR_RESPONSE_TO_VITAMIN_D",8,-1.4106,0.11,0.16,"No",0.8224,0.68,1,"Yes"
"6273","C7_Immunologic_signatures","C7_ALL_1542_GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN",188,-1.4106,0.016,0.023,"No",-1.0075,0.43,1,"No"
"6274","C2_Chemical_and_genetic_perturbations","C2_CGP_1391_OKUMURA_INFLAMMATORY_RESPONSE_LPS",182,-1.4104,0.0048,0.1,"No",0.8974,0.75,0.93,"Yes"
"6275","GO_BP","519288_GO_2000649_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",37,-1.4103,0.059,0.16,"No",-1.0169,0.41,0.98,"No"
"6276","GO_BP","516463_GO_0071539_PROTEIN_LOCALIZATION_TO_CENTROSOME",8,-1.4103,0.097,0.16,"No",-1.3145,0.15,0.88,"No"
"6277","GO_BP","508737_GO_0046477_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS",5,-1.4102,0.078,0.16,"No",-1.2811,0.23,0.89,"No"
"6278","REACTOME","161073_REACT_22357_ORGANIC_CATION_TRANSPORT",9,-1.41,0.093,0.18,"No",-0.9947,0.47,0.99,"No"
"6279","GO_MF","498055_GO_0019200_CARBOHYDRATE_KINASE_ACTIVITY",20,-1.4098,0.081,0.21,"No",-0.8497,0.69,1,"No"
"6280","GO_BP","515363_GO_0070431_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY",5,-1.4097,0.083,0.16,"No",-0.7441,0.77,1,"No"
"6281","C2_Chemical_and_genetic_perturbations","C2_CGP_1906_SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP",19,-1.4097,0.078,0.1,"No",0.9217,0.58,0.9,"Yes"
"6282","C2_Chemical_and_genetic_perturbations","C2_CGP_241_MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN",75,-1.4096,0.041,0.1,"No",1.499,0.02,0.21,"Yes"
"6283","GO_BP","487785_GO_0001889_LIVER_DEVELOPMENT",105,-1.4096,0.028,0.16,"No",-0.5567,1,1,"No"
"6284","GO_MF","499578_GO_0030159_RECEPTOR_SIGNALING_COMPLEX_SCAFFOLD_ACTIVITY",23,-1.4096,0.069,0.21,"No",-0.8785,0.65,1,"No"
"6285","GO_MF","492597_GO_0008273_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY",5,-1.4096,0.066,0.21,"No",0.5665,0.96,1,"Yes"
"6286","C1_Positional","C1_ALL_253_CHR9P22",32,-1.4094,0.06,0.48,"No",1.0886,0.33,0.64,"Yes"
"6287","C2_Chemical_and_genetic_perturbations","C2_CGP_817_FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1",9,-1.4094,0.082,0.1,"No",1.0936,0.35,0.64,"Yes"
"6288","C7_Immunologic_signatures","C7_ALL_622_GSE17721_POLYIC_VS_CPG_2H_BMDM_DN",195,-1.4093,0.015,0.023,"No",0.9201,0.68,0.98,"Yes"
"6289","GO_CC","499561_GO_0030132_CLATHRIN_COAT_OF_COATED_PIT",16,-1.4093,0.075,0.21,"No",0.884,0.62,0.91,"Yes"
"6290","C2_Chemical_and_genetic_perturbations","C2_CGP_674_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29",7,-1.4093,0.09,0.1,"No",0.8822,0.61,0.94,"Yes"
"6291","C6_Oncogenic_signatures","C6_ALL_142_PDGF_UP_V1_UP",141,-1.4092,0.018,0.03,"No",-1.052,0.33,0.58,"No"
"6292","GO_BP","498085_GO_0019233_SENSORY_PERCEPTION_OF_PAIN",66,-1.4092,0.042,0.16,"No",-1.0329,0.41,0.98,"No"
"6293","GO_BP","516280_GO_0071356_CELLULAR_RESPONSE_TO_TUMOR_NECROSIS_FACTOR",94,-1.4092,0.032,0.16,"No",0.96,0.52,1,"Yes"
"6294","GO_BP","498843_GO_0021559_TRIGEMINAL_NERVE_DEVELOPMENT",9,-1.4091,0.11,0.16,"No",-1.0306,0.42,0.98,"No"
"6295","GO_BP","487667_GO_0001771_IMMUNOLOGICAL_SYNAPSE_FORMATION",6,-1.4091,0.091,0.16,"No",-0.9923,0.48,1,"No"
"6296","REACTOME","119525_REACT_19199_CRMPS_IN_SEMA3A_SIGNALING",15,-1.4091,0.091,0.18,"No",-0.8244,0.69,1,"No"
"6297","GO_BP","494727_GO_0010664_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS",12,-1.4089,0.089,0.16,"No",0.6745,0.89,1,"Yes"
"6298","GO_BP","502229_GO_0033007_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",5,-1.4089,0.074,0.16,"No",-0.5569,0.94,1,"No"
"6299","GO_BP","515766_GO_0070838_DIVALENT_METAL_ION_TRANSPORT",254,-1.4088,0.0022,0.16,"No",-1.2295,0.05,0.89,"No"
"6300","GO_BP","755320_GO_2001214_POSITIVE_REGULATION_OF_VASCULOGENESIS",8,-1.4088,0.084,0.16,"No",1.0571,0.39,0.94,"Yes"
"6301","C7_Immunologic_signatures","C7_ALL_1188_GSE27786_BCELL_VS_NEUTROPHIL_DN",193,-1.4088,0.0056,0.023,"No",0.8703,0.85,1,"Yes"
"6302","REACTOME","530739_REACT_115896_GRB7_EVENTS_IN_ERBB2_SIGNALING",5,-1.4088,0.099,0.18,"No",-1.4357,0.086,0.5,"No"
"6303","C2_Chemical_and_genetic_perturbations","C2_CGP_588_RIZ_ERYTHROID_DIFFERENTIATION_CCNE1",40,-1.4087,0.059,0.1,"No",0.6778,0.95,1,"Yes"
"6304","C2_Chemical_and_genetic_perturbations","C2_CGP_1002_NAKAYAMA_FRA2_TARGETS",42,-1.4087,0.045,0.1,"No",1.0742,0.33,0.67,"Yes"
"6305","C2_Chemical_and_genetic_perturbations","C2_CGP_1093_TAGHAVI_NEOPLASTIC_TRANSFORMATION",12,-1.4086,0.089,0.1,"No",-1.4521,0.065,0.53,"No"
"6306","C2_Chemical_and_genetic_perturbations","C2_CGP_2323_MATZUK_MATERNAL_EFFECT",9,-1.4086,0.091,0.1,"No",-0.665,0.88,1,"No"
"6307","GO_BP","498977_GO_0021694_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION",11,-1.4086,0.082,0.16,"No",-0.9752,0.48,1,"No"
"6308","GO_BP","488559_GO_0002686_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION",27,-1.4082,0.071,0.16,"No",-0.8407,0.72,1,"No"
"6309","C2_Chemical_and_genetic_perturbations","C2_CGP_1403_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1",9,-1.4082,0.087,0.1,"No",-0.9403,0.53,1,"No"
"6310","GO_MF","490491_GO_0005262_CALCIUM_CHANNEL_ACTIVITY",107,-1.4082,0.026,0.21,"No",-1.6754,0.0054,0.37,"No"
"6311","GO_BP","497854_GO_0018958_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS",81,-1.4082,0.045,0.16,"No",-0.9131,0.63,1,"No"
"6312","REACTOME","833816_REACT_163813_SCAVENGING_BY_CLASS_F_RECEPTORS",6,-1.4082,0.083,0.18,"No",0.4979,0.98,1,"Yes"
"6313","C4_Cancer_gene_neighborhoods","C4_CGN_98_MORF_ESR1",165,-1.4081,0.0095,0.12,"No",-1.0674,0.29,0.75,"No"
"6314","GO_MF","495422_GO_0015149_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.4081,0.081,0.21,"No",-1.0906,0.34,0.85,"No"
"6315","GO_BP","982378_GO_1902808_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION",22,-1.408,0.062,0.16,"No",-0.8667,0.66,1,"No"
"6316","C3_TF_targets","C3_TFT_366_V_ICSBP_Q6",241,-1.4079,0.0089,0.038,"No",0.864,0.85,1,"Yes"
"6317","GO_BP","491810_GO_0006971_HYPOTONIC_RESPONSE",8,-1.4078,0.1,0.16,"No",-0.4349,1,1,"No"
"6318","C2_Chemical_and_genetic_perturbations","C2_CGP_1645_ZHOU_TNF_SIGNALING_4HR",54,-1.4077,0.059,0.1,"No",1.6053,0.011,0.14,"Yes"
"6319","GO_BP","508117_GO_0045780_POSITIVE_REGULATION_OF_BONE_RESORPTION",14,-1.4077,0.09,0.16,"No",-0.8319,0.68,1,"No"
"6320","C6_Oncogenic_signatures","C6_ALL_72_PRC1_BMI_UP_V1_UP",186,-1.4076,0.0046,0.03,"No",-1.155,0.13,0.49,"No"
"6321","REACTOME","106384_REACT_16888_SIGNALING_BY_PDGF",178,-1.4076,0.012,0.18,"No",-1.033,0.38,0.97,"No"
"6322","GO_BP","499308_GO_0022029_TELENCEPHALON_CELL_MIGRATION",54,-1.4076,0.048,0.16,"No",-1.33,0.078,0.9,"No"
"6323","GO_BP","491685_GO_0006816_CALCIUM_ION_TRANSPORT",212,-1.4076,0.01,0.16,"No",-1.2595,0.043,0.91,"No"
"6324","C6_Oncogenic_signatures","C6_ALL_99_ESC_V6_5_UP_LATE_V1_DN",164,-1.4075,0.015,0.03,"No",-0.8653,0.82,0.97,"No"
"6325","C3_TF_targets","C3_TFT_372_V_MYOGENIN_Q6",248,-1.4075,0.0099,0.038,"No",-1.2836,0.034,0.25,"No"
"6326","GO_BP","490419_GO_0045741_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",11,-1.4074,0.086,0.16,"No",-0.9597,0.48,1,"No"
"6327","C3_MicroRNA_targets","C3_MIR_46_GCACCTT_MIR_18A_MIR_18B",117,-1.4072,0.026,0.28,"No",-1.0219,0.4,1,"No"
"6328","GO_BP","491089_GO_0006110_REGULATION_OF_GLYCOLYTIC_PROCESS",26,-1.4072,0.073,0.16,"No",0.9295,0.57,1,"Yes"
"6329","C7_Immunologic_signatures","C7_ALL_1044_GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN",197,-1.4071,0.008,0.024,"No",1.132,0.19,0.36,"Yes"
"6330","C3_TF_targets","C3_TFT_611_TTCYNRGAA_V_STAT5B_01",328,-1.407,0.0021,0.038,"No",0.8929,0.84,1,"Yes"
"6331","C2_Chemical_and_genetic_perturbations","C2_CGP_765_NEBEN_AML_WITH_FLT3_OR_NRAS_DN",12,-1.4069,0.095,0.1,"No",1.4633,0.087,0.24,"Yes"
"6332","GO_BP","505499_GO_0042355_L_FUCOSE_CATABOLIC_PROCESS",9,-1.4069,0.088,0.16,"No",0.684,0.86,1,"Yes"
"6333","GO_BP","491976_GO_0007173_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",192,-1.4069,0.008,0.16,"No",-1.0337,0.36,0.98,"No"
"6334","KEGG_module","HSA_M00099_SPHINGOSINE_BIOSYNTHESIS",16,-1.4067,0.09,0.42,"No",-1.145,0.3,1,"No"
"6335","GO_BP","501297_GO_0032060_BLEB_ASSEMBLY",9,-1.4066,0.088,0.16,"No",1.2968,0.18,0.67,"Yes"
"6336","C2_Chemical_and_genetic_perturbations","C2_CGP_492_SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP",15,-1.4066,0.096,0.1,"No",-0.7033,0.86,1,"No"
"6337","GO_CC","500621_GO_0031362_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",18,-1.4066,0.079,0.21,"No",1.384,0.08,0.3,"Yes"
"6338","GO_BP","517119_GO_0072203_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT",7,-1.4064,0.1,0.16,"No",0.6115,0.92,1,"Yes"
"6339","C3_TF_targets","C3_TFT_62_ACAWYAAAG_UNKNOWN",96,-1.4064,0.03,0.038,"No",0.9967,0.48,1,"Yes"
"6340","C2_Chemical_and_genetic_perturbations","C2_CGP_2674_ISHIDA_E2F_TARGETS",52,-1.4063,0.056,0.1,"No",0.8191,0.77,0.98,"Yes"
"6341","C1_Positional","C1_ALL_227_CHR10P12",44,-1.4063,0.047,0.47,"No",0.9728,0.5,0.79,"Yes"
"6342","GO_MF","501782_GO_0032552_DEOXYRIBONUCLEOTIDE_BINDING",9,-1.4063,0.086,0.21,"No",1.489,0.07,0.39,"Yes"
"6343","C4_Cancer_modules","C4_CM_188_MODULE_201",50,-1.4063,0.044,0.096,"No",-1.1735,0.19,0.63,"No"
"6344","KEGG_reaction","R01274_PALMITOYL_COA_HYDROLASE_PALMITOYL_COA_H2O_COA_HEXADECANOIC_ACID",6,-1.4062,0.1,0.29,"No",-0.6529,0.9,0.98,"No"
"6345","C2_Chemical_and_genetic_perturbations","C2_CGP_1299_PENG_GLUCOSE_DEPRIVATION_UP",46,-1.4059,0.059,0.1,"No",-0.8413,0.75,1,"No"
"6346","GO_BP","502152_GO_0032930_POSITIVE_REGULATION_OF_SUPEROXIDE_ANION_GENERATION",8,-1.4059,0.095,0.16,"No",1.1301,0.31,0.87,"Yes"
"6347","GO_CC","500524_GO_0031265_CD95_DEATH_INDUCING_SIGNALING_COMPLEX",6,-1.4057,0.088,0.21,"No",-0.8987,0.58,0.95,"No"
"6348","GO_MF","511636_GO_0050664_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR",14,-1.4057,0.09,0.21,"No",-0.9398,0.54,0.95,"No"
"6349","C2_Chemical_and_genetic_perturbations","C2_CGP_2735_HOSHIDA_LIVER_CANCER_SURVIVAL_UP",72,-1.4057,0.041,0.1,"No",0.8984,0.65,0.93,"Yes"
"6350","GO_BP","508067_GO_0045723_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS",14,-1.4056,0.091,0.16,"No",0.9516,0.49,1,"Yes"
"6351","GO_CC","507312_GO_0044306_NEURON_PROJECTION_TERMINUS",86,-1.4055,0.036,0.21,"No",1.0448,0.37,0.72,"Yes"
"6352","C2_Chemical_and_genetic_perturbations","C2_CGP_2721_CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP",170,-1.4054,0.014,0.1,"No",-0.8276,0.89,1,"No"
"6353","GO_BP","514221_GO_0060666_DICHOTOMOUS_SUBDIVISION_OF_TERMINAL_UNITS_INVOLVED_IN_SALIVARY_GLAND_BRANCHING",5,-1.4054,0.075,0.16,"No",-0.954,0.51,1,"No"
"6354","C7_Immunologic_signatures","C7_ALL_213_GSE13493_DP_VS_CD8POS_THYMOCYTE_UP",196,-1.4053,0.0091,0.024,"No",-0.9263,0.64,1,"No"
"6355","C3_TF_targets","C3_TFT_270_V_STAT5A_02",135,-1.4053,0.013,0.038,"No",-0.7284,0.98,1,"No"
"6356","C3_TF_targets","C3_TFT_272_V_GATA6_01",254,-1.4052,0.0087,0.038,"No",-0.9543,0.58,0.86,"No"
"6357","GO_BP","487955_GO_0002065_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION",118,-1.4052,0.023,0.16,"No",1.0838,0.28,0.92,"Yes"
"6358","REACTOME","1127553_REACT_263897_CELLULAR_RESPONSE_TO_HEAT_STRESS",86,-1.4051,0.036,0.19,"No",0.8477,0.81,0.96,"Yes"
"6359","C2_Chemical_and_genetic_perturbations","C2_CGP_2833_LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP",7,-1.405,0.11,0.1,"No",-1.0983,0.35,0.92,"No"
"6360","GO_BP","498273_GO_0019433_TRIGLYCERIDE_CATABOLIC_PROCESS",20,-1.405,0.082,0.16,"No",1.21,0.2,0.78,"Yes"
"6361","GO_MF","489476_GO_0019829_CATION_TRANSPORTING_ATPASE_ACTIVITY",52,-1.405,0.046,0.21,"No",0.9439,0.52,0.94,"Yes"
"6362","C2_Chemical_and_genetic_perturbations","C2_CGP_3308_PEDRIOLI_MIR31_TARGETS_UP",210,-1.4049,0.0089,0.1,"No",-0.8964,0.74,1,"No"
"6363","C4_Cancer_gene_neighborhoods","C4_CGN_386_GNF2_MYL3",30,-1.4049,0.078,0.12,"No",-1.4533,0.034,0.38,"No"
"6364","GO_BP","491673_GO_0072593_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",114,-1.4048,0.024,0.16,"No",0.8981,0.73,1,"Yes"
"6365","C2_Chemical_and_genetic_perturbations","C2_CGP_54_KOBAYASHI_EGFR_SIGNALING_6HR_UP",7,-1.4048,0.089,0.1,"No",0.7973,0.72,0.99,"Yes"
"6366","REACTOME","106219_REACT_532_GALACTOSE_CATABOLISM",5,-1.4048,0.08,0.19,"No",-1.1526,0.31,0.85,"No"
"6367","C2_BioCarta_Pathways","C2_CP_BIOCARTA_194_BIOCARTA_TEL_PATHWAY",18,-1.4048,0.091,0.19,"No",0.5587,0.98,1,"Yes"
"6368","GO_BP","514243_GO_0060688_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE",51,-1.4047,0.043,0.16,"No",1.3996,0.036,0.55,"Yes"
"6369","GO_BP","519290_GO_2000651_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",11,-1.4045,0.087,0.17,"No",-0.9678,0.51,1,"No"
"6370","GO_BP","506649_GO_0043618_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS",53,-1.4045,0.038,0.17,"No",0.813,0.82,1,"Yes"
"6371","C7_Immunologic_signatures","C7_ALL_301_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP",198,-1.4044,0.0078,0.025,"No",1.3672,0.013,0.052,"Yes"
"6372","GO_BP","505052_GO_0035883_ENTEROENDOCRINE_CELL_DIFFERENTIATION",16,-1.4043,0.082,0.17,"No",1.042,0.4,0.96,"Yes"
"6373","C2_Chemical_and_genetic_perturbations","C2_CGP_1419_BECKER_TAMOXIFEN_RESISTANCE_DN",52,-1.4043,0.052,0.1,"No",1.3733,0.035,0.32,"Yes"
"6374","GO_BP","511830_GO_0050892_INTESTINAL_ABSORPTION",18,-1.4042,0.08,0.17,"No",-1.2308,0.21,0.9,"No"
"6375","C4_Cancer_gene_neighborhoods","C4_CGN_395_GNF2_PTPN6",47,-1.4039,0.046,0.12,"No",1.4008,0.062,0.061,"Yes"
"6376","C2_BioCarta_Pathways","C2_CP_BIOCARTA_2_BIOCARTA_NO1_PATHWAY",30,-1.4037,0.071,0.19,"No",1.4933,0.042,0.4,"Yes"
"6377","C2_Chemical_and_genetic_perturbations","C2_CGP_111_PIEPOLI_LGI1_TARGETS_DN",14,-1.4037,0.095,0.1,"No",-0.8368,0.66,1,"No"
"6378","C2_Chemical_and_genetic_perturbations","C2_CGP_844_OXFORD_RALA_OR_RALB_TARGETS_UP",48,-1.4037,0.044,0.1,"No",-0.9363,0.55,1,"No"
"6379","GO_BP","488889_GO_0003093_REGULATION_OF_GLOMERULAR_FILTRATION",12,-1.4037,0.097,0.17,"No",1.6119,0.019,0.28,"Yes"
"6380","C2_Chemical_and_genetic_perturbations","C2_CGP_2382_BRUECKNER_TARGETS_OF_MIRLET7A3_DN",75,-1.4035,0.029,0.1,"No",1.1558,0.2,0.55,"Yes"
"6381","GO_MF","490620_GO_0005516_CALMODULIN_BINDING",173,-1.4035,0.011,0.21,"No",-1.3518,0.019,0.69,"No"
"6382","C2_Chemical_and_genetic_perturbations","C2_CGP_2800_TSAI_DNAJB4_TARGETS_UP",13,-1.4032,0.088,0.1,"No",1.5931,0.016,0.14,"Yes"
"6383","C7_Immunologic_signatures","C7_ALL_888_GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN",197,-1.4032,0.01,0.025,"No",-1.0526,0.33,1,"No"
"6384","GO_BP","489023_GO_0003229_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",46,-1.4031,0.059,0.17,"No",0.8562,0.73,1,"Yes"
"6385","GO_BP","506193_GO_0043116_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY",9,-1.4029,0.1,0.17,"No",0.9244,0.57,1,"Yes"
"6386","C2_Chemical_and_genetic_perturbations","C2_CGP_3168_VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN",35,-1.4028,0.078,0.11,"No",-1.1259,0.3,0.89,"No"
"6387","C2_BioCarta_Pathways","C2_CP_BIOCARTA_77_BIOCARTA_GABA_PATHWAY",9,-1.4028,0.087,0.19,"No",-0.6974,0.86,1,"No"
"6388","GO_BP","498985_GO_0021702_CEREBELLAR_PURKINJE_CELL_DIFFERENTIATION",11,-1.4027,0.095,0.17,"No",-0.9476,0.51,1,"No"
"6389","C7_Immunologic_signatures","C7_ALL_1547_GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP",187,-1.4026,0.0094,0.025,"No",1.4156,0.0048,0.033,"Yes"
"6390","C7_Immunologic_signatures","C7_ALL_492_GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_DN",192,-1.4025,0.016,0.025,"No",0.7716,0.97,1,"Yes"
"6391","C2_Chemical_and_genetic_perturbations","C2_CGP_2226_HUANG_FOXA2_TARGETS_DN",35,-1.4024,0.062,0.11,"No",0.8055,0.8,0.99,"Yes"
"6392","KEGG_compound","C03344_2_METHYLACETOACETYL_COA_2_METHYL_3_ACETOACETYL_COA",6,-1.4024,0.092,0.26,"No",0.7931,0.72,1,"Yes"
"6393","GO_BP","506470_GO_0043433_NEGATIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",128,-1.4024,0.018,0.17,"No",-0.9779,0.5,1,"No"
"6394","GO_MF","505740_GO_0042625_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS",55,-1.4024,0.066,0.21,"No",0.9808,0.5,0.9,"Yes"
"6395","C7_Immunologic_signatures","C7_ALL_935_GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP",192,-1.4024,0.013,0.025,"No",1.0388,0.32,0.62,"Yes"
"6396","REACTOME","160975_REACT_508_SIGNAL_ATTENUATION",13,-1.4024,0.088,0.19,"No",-0.7943,0.73,1,"No"
"6397","GO_BP","516560_GO_0071636_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION",12,-1.4024,0.089,0.17,"No",-0.9529,0.52,1,"No"
"6398","GO_BP","754561_GO_1901605_ALPHA_AMINO_ACID_METABOLIC_PROCESS",245,-1.4023,0.0022,0.17,"No",-1.0077,0.42,0.98,"No"
"6399","C7_Immunologic_signatures","C7_ALL_75_GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP",194,-1.4022,0.011,0.025,"No",1.2189,0.087,0.2,"Yes"
"6400","C3_MicroRNA_targets","C3_MIR_6_GTGCAAT_MIR_25_MIR_32_MIR_92_MIR_363_MIR_367",307,-1.4021,0.0022,0.28,"No",-0.8995,0.81,1,"No"
"6401","C4_Cancer_gene_neighborhoods","C4_CGN_407_GNF2_SERPINI2",20,-1.4021,0.095,0.12,"No",1.29,0.15,0.13,"Yes"
"6402","GO_BP","512750_GO_0051895_NEGATIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY",12,-1.402,0.093,0.17,"No",0.9584,0.5,1,"Yes"
"6403","GO_BP","502040_GO_0032817_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION",7,-1.4018,0.097,0.17,"No",-1.3192,0.14,0.89,"No"
"6404","GO_MF","499625_GO_0030215_SEMAPHORIN_RECEPTOR_BINDING",10,-1.4017,0.087,0.21,"No",0.8147,0.7,1,"Yes"
"6405","C2_Chemical_and_genetic_perturbations","C2_CGP_1406_PENG_GLUCOSE_DEPRIVATION_DN",165,-1.4017,0.014,0.11,"No",1.101,0.22,0.63,"Yes"
"6406","C2_Chemical_and_genetic_perturbations","C2_CGP_904_HASINA_NOL7_TARGETS_DN",13,-1.4016,0.084,0.11,"No",1.6074,0.023,0.13,"Yes"
"6407","GO_BP","751911_GO_0052695_CELLULAR_GLUCURONIDATION",24,-1.4016,0.076,0.17,"No",1.609,0.02,0.28,"Yes"
"6408","GO_BP","507982_GO_0045634_REGULATION_OF_MELANOCYTE_DIFFERENTIATION",7,-1.4016,0.095,0.17,"No",1.0503,0.38,0.95,"Yes"
"6409","C2_Chemical_and_genetic_perturbations","C2_CGP_28_HOLLMANN_APOPTOSIS_VIA_CD40_DN",262,-1.4015,0.0088,0.11,"No",1.2567,0.03,0.43,"Yes"
"6410","GO_BP","508905_GO_0046661_MALE_SEX_DIFFERENTIATION",144,-1.4015,0.015,0.17,"No",-0.943,0.6,1,"No"
"6411","C7_Immunologic_signatures","C7_ALL_1584_GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN",193,-1.4015,0.011,0.026,"No",-1.0032,0.44,1,"No"
"6412","GO_BP","514699_GO_0061154_ENDOTHELIAL_TUBE_MORPHOGENESIS",8,-1.4014,0.089,0.17,"No",-1.0483,0.4,0.97,"No"
"6413","C2_Chemical_and_genetic_perturbations","C2_CGP_1749_NIELSEN_LIPOSARCOMA_UP",18,-1.4014,0.083,0.11,"No",-1.2562,0.18,0.74,"No"
"6414","C2_Chemical_and_genetic_perturbations","C2_CGP_755_XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN",27,-1.4013,0.073,0.11,"No",-0.7084,0.91,1,"No"
"6415","C2_Chemical_and_genetic_perturbations","C2_CGP_2591_LEE_INTRATHYMIC_T_PROGENITOR",21,-1.4013,0.088,0.11,"No",-0.6105,0.96,1,"No"
"6416","GO_BP","486696_GO_0000165_MAPK_CASCADE",196,-1.4012,0.011,0.17,"No",-0.7209,0.99,1,"No"
"6417","GO_MF","490492_GO_0005267_POTASSIUM_CHANNEL_ACTIVITY",117,-1.4011,0.024,0.21,"No",-1.1293,0.19,0.82,"No"
"6418","C2_Chemical_and_genetic_perturbations","C2_CGP_1100_HE_PTEN_TARGETS_DN",6,-1.4011,0.1,0.11,"No",-1.2745,0.19,0.71,"No"
"6419","GO_BP","513493_GO_0072506_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS",11,-1.401,0.082,0.17,"No",-0.9599,0.51,1,"No"
"6420","GO_BP","501828_GO_0032602_CHEMOKINE_PRODUCTION",9,-1.401,0.11,0.17,"No",0.7258,0.83,1,"Yes"
"6421","GO_BP","499437_GO_0050862_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY",7,-1.4009,0.1,0.17,"No",0.7083,0.81,1,"Yes"
"6422","C7_Immunologic_signatures","C7_ALL_1544_GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN",197,-1.4008,0.0057,0.026,"No",-0.9538,0.56,1,"No"
"6423","C2_BioCarta_Pathways","C2_CP_BIOCARTA_48_BIOCARTA_CXCR4_PATHWAY",23,-1.4008,0.072,0.19,"No",0.5412,0.99,1,"Yes"
"6424","C2_Chemical_and_genetic_perturbations","C2_CGP_520_HUMMERICH_MALIGNANT_SKIN_TUMOR_UP",15,-1.4007,0.099,0.11,"No",1.2701,0.15,0.42,"Yes"
"6425","GO_MF","492805_GO_0008526_PHOSPHATIDYLINOSITOL_TRANSPORTER_ACTIVITY",5,-1.4007,0.097,0.21,"No",-1.1574,0.3,0.81,"No"
"6426","C7_Immunologic_signatures","C7_ALL_1394_GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN",200,-1.4007,0.014,0.026,"No",0.8958,0.76,1,"Yes"
"6427","C3_TF_targets","C3_TFT_198_V_NFY_01",250,-1.4007,0.0078,0.04,"No",-1.1423,0.14,0.45,"No"
"6428","GO_BP","516423_GO_0071499_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS",8,-1.4004,0.095,0.17,"No",-0.5933,0.93,1,"No"
"6429","REACTOME","645313_REACT_121401_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS",90,-1.4004,0.026,0.19,"No",0.8007,0.9,0.99,"Yes"
"6430","C2_Chemical_and_genetic_perturbations","C2_CGP_2594_LEE_RECENT_THYMIC_EMIGRANT",223,-1.4003,0.009,0.11,"No",1.1455,0.14,0.56,"Yes"
"6431","C3_TF_targets","C3_TFT_614_WGGAATGY_V_TEF1_Q6",367,-1.4003,0.0032,0.04,"No",-1.376,0.0066,0.18,"No"
"6432","GO_MF","487532_GO_0001595_ANGIOTENSIN_RECEPTOR_ACTIVITY",5,-1.4002,0.1,0.21,"No",0.7801,0.73,1,"Yes"
"6433","C3_MicroRNA_targets","C3_MIR_123_AAGCACA_MIR_218",396,-1.4002,0.001,0.27,"No",1.0428,0.32,1,"Yes"
"6434","GO_BP","506311_GO_0043244_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY",87,-1.4001,0.027,0.17,"No",-0.9531,0.55,1,"No"
"6435","KEGG_pathway","HSA05231_CHOLINE_METABOLISM_IN_CANCER",101,-1.4,0.035,0.068,"No",-0.922,0.63,0.97,"No"
"6436","C2_Chemical_and_genetic_perturbations","C2_CGP_1642_IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM",294,-1.3997,0.0076,0.11,"No",-0.9981,0.45,1,"No"
"6437","KEGG_compound","C00099_BETA_ALANINE_3_AMINOPROPIONIC_ACID_3_AMINOPROPANOATE",16,-1.3996,0.086,0.26,"No",0.713,0.88,1,"Yes"
"6438","GO_BP","514017_GO_0060462_LUNG_LOBE_DEVELOPMENT",8,-1.3996,0.096,0.17,"No",0.879,0.65,1,"Yes"
"6439","C3_TF_targets","C3_TFT_298_V_MAZR_01",217,-1.3996,0.0068,0.04,"No",-1.6205,0,0.12,"No"
"6440","KEGG_compound","C00672_2_DEOXY_D_RIBOSE_1_PHOSPHATE_2_DEOXY_ALPHA_D_RIBOSE_1_PHOSPHATE",5,-1.3996,0.098,0.26,"No",-0.7036,0.83,1,"No"
"6441","REACTOME","160137_REACT_21399_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION",17,-1.3995,0.075,0.19,"No",-0.6421,0.93,1,"No"
"6442","C2_Chemical_and_genetic_perturbations","C2_CGP_2346_GRADE_COLON_AND_RECTAL_CANCER_DN",99,-1.3995,0.034,0.11,"No",0.8438,0.84,0.97,"Yes"
"6443","C7_Immunologic_signatures","C7_ALL_183_GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP",199,-1.3995,0.015,0.026,"No",1.3824,0.012,0.044,"Yes"
"6444","GO_MF","489501_GO_0004032_ALDITOL_NADP_1_OXIDOREDUCTASE_ACTIVITY",7,-1.3995,0.088,0.21,"No",-0.8669,0.61,1,"No"
"6445","C2_Chemical_and_genetic_perturbations","C2_CGP_2447_WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC",20,-1.3994,0.07,0.11,"No",-1.0531,0.36,0.97,"No"
"6446","GO_BP","499075_GO_0021795_CEREBRAL_CORTEX_CELL_MIGRATION",42,-1.3994,0.052,0.17,"No",-0.7799,0.83,1,"No"
"6447","C2_Chemical_and_genetic_perturbations","C2_CGP_1696_CHANG_IMMORTALIZED_BY_HPV31_DN",61,-1.3993,0.04,0.11,"No",1.3146,0.084,0.38,"Yes"
"6448","GO_BP","488200_GO_0002327_IMMATURE_B_CELL_DIFFERENTIATION",9,-1.3993,0.085,0.17,"No",-0.747,0.77,1,"No"
"6449","C4_Cancer_gene_neighborhoods","C4_CGN_312_GNF2_RRM1",88,-1.3992,0.036,0.12,"No",1.4553,0.016,0.042,"Yes"
"6450","GO_BP","514147_GO_0060592_MAMMARY_GLAND_FORMATION",8,-1.3991,0.093,0.17,"No",-0.9953,0.49,0.99,"No"
"6451","C7_Immunologic_signatures","C7_ALL_505_GSE17721_CTRL_VS_CPG_8H_BMDM_UP",199,-1.3989,0.018,0.026,"No",0.7938,0.98,1,"Yes"
"6452","C2_Chemical_and_genetic_perturbations","C2_CGP_1692_SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2",43,-1.3989,0.06,0.11,"No",-1.3046,0.11,0.69,"No"
"6453","C2_Chemical_and_genetic_perturbations","C2_CGP_14_PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN",134,-1.3986,0.021,0.11,"No",-0.7627,0.95,1,"No"
"6454","C2_Chemical_and_genetic_perturbations","C2_CGP_2462_MOOTHA_ROS",7,-1.3985,0.09,0.11,"No",0.761,0.77,1,"Yes"
"6455","REACTOME","730338_REACT_150320_SYNTHESIS_OF_LIPOXINS_LX_",6,-1.3985,0.094,0.19,"No",1.0725,0.39,0.63,"Yes"
"6456","C7_Immunologic_signatures","C7_ALL_434_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN",200,-1.3985,0.011,0.027,"No",1.2258,0.048,0.19,"Yes"
"6457","C2_Chemical_and_genetic_perturbations","C2_CGP_2305_BERNARD_PPAPDC1B_TARGETS_DN",55,-1.3984,0.033,0.11,"No",-1.0722,0.34,0.95,"No"
"6458","GO_BP","517087_GO_0072171_MESONEPHRIC_TUBULE_MORPHOGENESIS",53,-1.3984,0.05,0.17,"No",0.7411,0.9,1,"Yes"
"6459","GO_BP","491120_GO_0006144_PURINE_NUCLEOBASE_METABOLIC_PROCESS",41,-1.3984,0.063,0.17,"No",0.5192,1,1,"Yes"
"6460","GO_BP","491474_GO_0006578_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS",7,-1.3984,0.11,0.17,"No",-0.6577,0.89,1,"No"
"6461","GO_BP","509037_GO_0046813_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL",5,-1.3983,0.09,0.17,"No",-0.8488,0.66,1,"No"
"6462","GO_BP","502909_GO_0033692_CELLULAR_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS",50,-1.3983,0.042,0.17,"No",1.13,0.24,0.87,"Yes"
"6463","GO_MF","495538_GO_0015294_SOLUTE_CATION_SYMPORTER_ACTIVITY",89,-1.3983,0.023,0.21,"No",-1.6003,0.0035,0.49,"No"
"6464","GO_CC","490935_GO_0005938_CELL_CORTEX",222,-1.3981,0.009,0.22,"No",-0.6911,1,1,"No"
"6465","C2_Chemical_and_genetic_perturbations","C2_CGP_359_HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN",25,-1.3981,0.077,0.11,"No",0.9594,0.52,0.86,"Yes"
"6466","GO_BP","515602_GO_0070672_RESPONSE_TO_INTERLEUKIN_15",13,-1.3981,0.083,0.17,"No",1.2759,0.17,0.7,"Yes"
"6467","C2_Chemical_and_genetic_perturbations","C2_CGP_1658_WU_HBX_TARGETS_1_DN",22,-1.3981,0.079,0.11,"No",-0.9594,0.53,1,"No"
"6468","C2_Chemical_and_genetic_perturbations","C2_CGP_535_MCBRYAN_TERMINAL_END_BUD_DN",6,-1.398,0.087,0.11,"No",0.9114,0.55,0.91,"Yes"
"6469","C2_Chemical_and_genetic_perturbations","C2_CGP_2808_FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN",65,-1.3979,0.037,0.11,"No",0.9989,0.45,0.8,"Yes"
"6470","GO_BP","508027_GO_0045682_REGULATION_OF_EPIDERMIS_DEVELOPMENT",58,-1.3979,0.04,0.17,"No",-1.3102,0.071,0.87,"No"
"6471","C3_TF_targets","C3_TFT_454_V_GR_Q6_01",268,-1.3979,0.0055,0.041,"No",-1.0568,0.3,0.64,"No"
"6472","GO_BP","1129336_GO_1903509_LIPOSACCHARIDE_METABOLIC_PROCESS",99,-1.3978,0.025,0.17,"No",0.717,0.98,1,"Yes"
"6473","C2_Chemical_and_genetic_perturbations","C2_CGP_3224_GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION",39,-1.3977,0.063,0.11,"No",-0.9385,0.54,1,"No"
"6474","GO_CC","496366_GO_0016327_APICOLATERAL_PLASMA_MEMBRANE",12,-1.3977,0.11,0.22,"No",0.8083,0.71,0.95,"Yes"
"6475","GO_MF","509370_GO_0047184_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY",5,-1.3977,0.089,0.21,"No",-1.0351,0.45,0.88,"No"
"6476","GO_CC","490797_GO_0005765_LYSOSOMAL_MEMBRANE",246,-1.3976,0.0033,0.22,"No",0.8291,0.95,0.94,"Yes"
"6477","C7_Immunologic_signatures","C7_ALL_927_GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP",192,-1.3976,0.01,0.027,"No",-1.1167,0.21,1,"No"
"6478","C3_TF_targets","C3_TFT_423_V_SMAD_Q6",250,-1.3976,0.0065,0.041,"No",0.9086,0.78,1,"Yes"
"6479","C6_Oncogenic_signatures","C6_ALL_130_CAHOY_OLIGODENDROCUTIC",97,-1.3974,0.04,0.033,"No",-0.7725,0.92,1,"No"
"6480","GO_BP","508463_GO_0046165_ALCOHOL_BIOSYNTHETIC_PROCESS",107,-1.3973,0.023,0.17,"No",-0.771,0.94,1,"No"
"6481","GO_BP","493867_GO_0009755_HORMONE_MEDIATED_SIGNALING_PATHWAY",92,-1.3973,0.035,0.17,"No",-1.0328,0.37,0.98,"No"
"6482","GO_BP","487829_GO_0001938_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION",64,-1.3972,0.045,0.17,"No",1.122,0.24,0.88,"Yes"
"6483","C4_Cancer_modules","C4_CM_349_MODULE_418",57,-1.3972,0.043,0.1,"No",-1.0081,0.45,0.81,"No"
"6484","C2_Chemical_and_genetic_perturbations","C2_CGP_3254_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7",393,-1.3971,0.0011,0.11,"No",-0.84,0.95,1,"No"
"6485","GO_BP","514018_GO_0060463_LUNG_LOBE_MORPHOGENESIS",8,-1.397,0.096,0.17,"No",0.8834,0.61,1,"Yes"
"6486","GO_BP","518523_GO_0090383_PHAGOSOME_ACIDIFICATION",5,-1.3969,0.086,0.17,"No",-0.8673,0.62,1,"No"
"6487","C3_TF_targets","C3_TFT_114_V_CEBP_01",262,-1.3969,0.0089,0.041,"No",0.9727,0.53,1,"Yes"
"6488","C3_TF_targets","C3_TFT_369_V_TFIII_Q6",201,-1.3969,0.013,0.04,"No",-1.3433,0.012,0.19,"No"
"6489","KEGG_compound","C05634_5_HYDROXYINDOLEACETALDEHYDE",8,-1.3968,0.084,0.26,"No",0.8124,0.68,1,"Yes"
"6490","GO_BP","488942_GO_0003148_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS",14,-1.3968,0.11,0.17,"No",-1.1227,0.31,0.94,"No"
"6491","GO_BP","506681_GO_0043651_LINOLEIC_ACID_METABOLIC_PROCESS",12,-1.3968,0.091,0.17,"No",-1.1328,0.3,0.93,"No"
"6492","C2_Chemical_and_genetic_perturbations","C2_CGP_801_DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN",34,-1.3968,0.065,0.11,"No",-1.0023,0.44,1,"No"
"6493","GO_BP","511412_GO_0050428_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BIOSYNTHETIC_PROCESS",6,-1.3967,0.077,0.17,"No",-0.926,0.52,1,"No"
"6494","KEGG_compound","C00831_PANTETHEINE_R_PANTETHEINE",6,-1.3966,0.12,0.26,"No",-1.1704,0.28,0.81,"No"
"6495","C7_Immunologic_signatures","C7_ALL_1399_GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP",200,-1.3965,0.014,0.027,"No",0.9957,0.46,0.75,"Yes"
"6496","C2_Chemical_and_genetic_perturbations","C2_CGP_2087_RIGGINS_TAMOXIFEN_RESISTANCE_DN",220,-1.3965,0.0089,0.11,"No",0.9662,0.55,0.84,"Yes"
"6497","KEGG_pathway","HSA04940_TYPE_I_DIABETES_MELLITUS",39,-1.3965,0.064,0.069,"No",0.6433,0.98,1,"Yes"
"6498","OMIM_gene","OMIM614216_ACTIVATING_SIGNAL_COINTEGRATOR_1_COMPLEX_SUBUNIT_2_ASCC2",6,-1.3965,0.097,1,"No",0.5706,0.95,1,"Yes"
"6499","C7_Immunologic_signatures","C7_ALL_977_GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP",197,-1.3964,0.011,0.027,"No",0.9185,0.7,0.98,"Yes"
"6500","KEGG_reaction","R01279_PALMITOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_PALMITOYL_COA_FAD_TRANS_HEXADEC_2_ENOYL_COA_FADH2",5,-1.3962,0.082,0.3,"No",-0.6331,0.9,0.99,"No"
"6501","C4_Cancer_modules","C4_CM_111_MODULE_116",29,-1.3962,0.083,0.1,"No",1.9415,0.0041,0.0058,"Yes"
"6502","KEGG_compound","C05272_TRANS_HEXADEC_2_ENOYL_COA_TRANS_2_HEXADECENOYL_COA_2E_HEXADECENOYL_COA",9,-1.3961,0.11,0.26,"No",0.5406,0.96,1,"Yes"
"6503","GO_BP","498827_GO_0021543_PALLIUM_DEVELOPMENT",127,-1.3961,0.023,0.17,"No",-0.7177,0.98,1,"No"
"6504","GO_BP","498830_GO_0021546_RHOMBOMERE_DEVELOPMENT",8,-1.396,0.1,0.17,"No",-0.7341,0.81,1,"No"
"6505","GO_BP","496939_GO_0046677_RESPONSE_TO_ANTIBIOTIC",47,-1.396,0.044,0.17,"No",0.899,0.62,1,"Yes"
"6506","C2_Chemical_and_genetic_perturbations","C2_CGP_3291_KRIEG_HYPOXIA_VIA_KDM3A",53,-1.3957,0.033,0.11,"No",0.8622,0.7,0.96,"Yes"
"6507","GO_BP","514167_GO_0060612_ADIPOSE_TISSUE_DEVELOPMENT",29,-1.3957,0.071,0.17,"No",-1.0455,0.36,0.97,"No"
"6508","C2_Chemical_and_genetic_perturbations","C2_CGP_2714_BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN",15,-1.3957,0.081,0.11,"No",0.7324,0.83,1,"Yes"
"6509","GO_BP","1129360_GO_1903533_REGULATION_OF_PROTEIN_TARGETING",247,-1.3956,0.011,0.17,"No",0.9349,0.67,1,"Yes"
"6510","GO_BP","1129341_GO_1903514_CALCIUM_ION_TRANSPORT_FROM_ENDOPLASMIC_RETICULUM_TO_CYTOSOL",7,-1.3956,0.085,0.17,"No",0.6249,0.92,1,"Yes"
"6511","GO_BP","513731_GO_0060174_LIMB_BUD_FORMATION",8,-1.3955,0.099,0.17,"No",-0.8207,0.68,1,"No"
"6512","GO_BP","491978_GO_0007176_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",24,-1.3955,0.071,0.17,"No",-0.8395,0.7,1,"No"
"6513","C7_Immunologic_signatures","C7_ALL_1802_GSE7764_NKCELL_VS_SPLENOCYTE_DN",199,-1.3955,0.0067,0.027,"No",1.0636,0.27,0.55,"Yes"
"6514","GO_BP","501643_GO_0032411_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY",58,-1.3954,0.037,0.17,"No",-1.0133,0.44,0.98,"No"
"6515","REACTOME","161010_REACT_6840_TRANSPORT_AND_SYNTHESIS_OF_PAPS",6,-1.3954,0.1,0.2,"No",-0.9192,0.57,1,"No"
"6516","GO_CC","507691_GO_0045334_CLATHRIN_COATED_ENDOCYTIC_VESICLE",44,-1.3953,0.076,0.22,"No",0.6814,0.94,0.98,"Yes"
"6517","GO_BP","752652_GO_0097151_POSITIVE_REGULATION_OF_INHIBITORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",5,-1.3952,0.097,0.17,"No",-1.0186,0.44,0.98,"No"
"6518","C2_Chemical_and_genetic_perturbations","C2_CGP_94_WILCOX_RESPONSE_TO_PROGESTERONE_UP",151,-1.3952,0.013,0.11,"No",0.9887,0.49,0.81,"Yes"
"6519","GO_BP","516945_GO_0072028_NEPHRON_MORPHOGENESIS",65,-1.3952,0.045,0.17,"No",-0.868,0.72,1,"No"
"6520","C2_Chemical_and_genetic_perturbations","C2_CGP_2611_MELLMAN_TUT1_TARGETS_UP",19,-1.3952,0.076,0.11,"No",1.256,0.15,0.43,"Yes"
"6521","C2_BioCarta_Pathways","C2_CP_BIOCARTA_99_BIOCARTA_IL2RB_PATHWAY",38,-1.3952,0.049,0.19,"No",0.9862,0.48,0.82,"Yes"
"6522","GO_BP","508010_GO_0045662_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION",22,-1.3952,0.086,0.17,"No",-1.5761,0.025,0.73,"No"
"6523","GO_BP","491850_GO_0007019_MICROTUBULE_DEPOLYMERIZATION",12,-1.395,0.089,0.17,"No",-0.7739,0.76,1,"No"
"6524","KEGG_compound","C00620_ALPHA_D_RIBOSE_1_PHOSPHATE_RIBOSE_1_PHOSPHATE_D_RIBOSE_1_PHOSPHATE",5,-1.3949,0.073,0.26,"No",0.761,0.74,1,"Yes"
"6525","GO_BP","499079_GO_0021799_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION",27,-1.3949,0.074,0.17,"No",-1.175,0.21,0.9,"No"
"6526","C4_Cancer_modules","C4_CM_224_MODULE_245",26,-1.3948,0.066,0.1,"No",0.9222,0.57,0.81,"Yes"
"6527","C3_MicroRNA_targets","C3_MIR_29_AGTTCTC_MIR_146A_MIR_146B",58,-1.3948,0.057,0.27,"No",-1.2458,0.13,1,"No"
"6528","C2_Chemical_and_genetic_perturbations","C2_CGP_2387_LU_TUMOR_ANGIOGENESIS_UP",25,-1.3948,0.073,0.11,"No",-0.962,0.51,1,"No"
"6529","GO_BP","508295_GO_0045995_REGULATION_OF_EMBRYONIC_DEVELOPMENT",103,-1.3947,0.029,0.17,"No",-1.2279,0.12,0.88,"No"
"6530","C2_Chemical_and_genetic_perturbations","C2_CGP_735_PATTERSON_DOCETAXEL_RESISTANCE",28,-1.3947,0.07,0.11,"No",-1.18,0.22,0.82,"No"
"6531","GO_BP","510557_GO_0048483_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT",42,-1.3947,0.059,0.17,"No",0.9631,0.51,1,"Yes"
"6532","GO_BP","514878_GO_0061333_RENAL_TUBULE_MORPHOGENESIS",65,-1.3946,0.041,0.17,"No",-0.9281,0.6,1,"No"
"6533","C7_Immunologic_signatures","C7_ALL_221_GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP",197,-1.3946,0.017,0.028,"No",0.9083,0.74,1,"Yes"
"6534","GO_BP","491691_GO_0006824_COBALT_ION_TRANSPORT",5,-1.3945,0.097,0.17,"No",0.927,0.54,1,"Yes"
"6535","C7_Immunologic_signatures","C7_ALL_1435_GSE360_DC_VS_MAC_L_MAJOR_UP",196,-1.3945,0.009,0.028,"No",1.1478,0.15,0.32,"Yes"
"6536","GO_BP","513509_GO_0055076_TRANSITION_METAL_ION_HOMEOSTASIS",129,-1.3945,0.028,0.17,"No",1.268,0.06,0.71,"Yes"
"6537","C7_Immunologic_signatures","C7_ALL_862_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN",181,-1.3945,0.011,0.028,"No",-0.9097,0.72,1,"No"
"6538","C2_Chemical_and_genetic_perturbations","C2_CGP_2255_SAGIV_CD24_TARGETS_DN",45,-1.3945,0.054,0.11,"No",0.9415,0.56,0.88,"Yes"
"6539","REACTOME","119574_REACT_19165_NA_DEPENDENT_GLUCOSE_TRANSPORTERS",6,-1.3944,0.1,0.2,"No",-1.1653,0.3,0.85,"No"
"6540","GO_BP","501329_GO_0032092_POSITIVE_REGULATION_OF_PROTEIN_BINDING",57,-1.3944,0.049,0.17,"No",-0.9421,0.56,1,"No"
"6541","GO_BP","754305_GO_1901343_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT",69,-1.3944,0.044,0.17,"No",-1.0273,0.4,0.97,"No"
"6542","C7_Immunologic_signatures","C7_ALL_960_GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN",195,-1.3944,0.007,0.028,"No",-0.7725,0.98,1,"No"
"6543","C2_Chemical_and_genetic_perturbations","C2_CGP_239_MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN",124,-1.3942,0.04,0.11,"No",1.262,0.062,0.43,"Yes"
"6544","GO_MF","489876_GO_0004528_PHOSPHODIESTERASE_I_ACTIVITY",5,-1.3941,0.094,0.22,"No",-0.7914,0.72,1,"No"
"6545","GO_BP","989118_GO_1903053_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION",22,-1.3941,0.094,0.17,"No",0.8491,0.69,1,"Yes"
"6546","GO_BP","516928_GO_0072009_NEPHRON_EPITHELIUM_DEVELOPMENT",94,-1.394,0.025,0.17,"No",-0.8751,0.71,1,"No"
"6547","C7_Immunologic_signatures","C7_ALL_1640_GSE3982_DC_VS_NKCELL_DN",191,-1.394,0.012,0.028,"No",0.8973,0.77,1,"Yes"
"6548","GO_BP","494656_GO_0010592_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY",12,-1.3939,0.076,0.17,"No",1.1164,0.3,0.88,"Yes"
"6549","GO_BP","499949_GO_0030643_CELLULAR_PHOSPHATE_ION_HOMEOSTASIS",6,-1.3939,0.099,0.17,"No",0.4765,0.99,1,"Yes"
"6550","GO_BP","486587_GO_0000038_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS",29,-1.3938,0.072,0.17,"No",0.7114,0.91,1,"Yes"
"6551","GO_BP","516182_GO_0071257_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS",11,-1.3937,0.094,0.17,"No",-1.0225,0.39,0.97,"No"
"6552","KEGG_compound","C00189_ETHANOLAMINE_AMINOETHANOL_2_HYDROXYETHYLAMINE",12,-1.3937,0.093,0.26,"No",-0.5611,0.97,1,"No"
"6553","C1_Positional","C1_ALL_53_CHRXQ28",88,-1.3937,0.033,0.5,"No",0.9849,0.48,0.79,"Yes"
"6554","C2_Chemical_and_genetic_perturbations","C2_CGP_1166_SHIN_B_CELL_LYMPHOMA_CLUSTER_3",28,-1.3936,0.064,0.11,"No",-0.6602,0.94,1,"No"
"6555","GO_CC","495072_GO_0012510_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE",12,-1.3935,0.11,0.22,"No",-0.5659,0.96,1,"No"
"6556","GO_CC","499972_GO_0030669_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE",38,-1.3935,0.077,0.22,"No",0.7908,0.81,0.96,"Yes"
"6557","GO_BP","503487_GO_0034284_RESPONSE_TO_MONOSACCHARIDE",132,-1.3935,0.02,0.17,"No",0.8256,0.9,1,"Yes"
"6558","GO_BP","511742_GO_0050771_NEGATIVE_REGULATION_OF_AXONOGENESIS",49,-1.3934,0.056,0.17,"No",-1.1364,0.24,0.93,"No"
"6559","C7_Immunologic_signatures","C7_ALL_1437_GSE360_DC_VS_MAC_T_GONDII_UP",192,-1.3933,0.012,0.028,"No",0.7646,0.99,1,"Yes"
"6560","C4_Cancer_modules","C4_CM_321_MODULE_377",10,-1.3932,0.1,0.1,"No",-1.0998,0.35,0.69,"No"
"6561","C2_Chemical_and_genetic_perturbations","C2_CGP_583_CROSBY_E2F4_TARGETS",6,-1.3932,0.09,0.11,"No",0.6285,0.91,1,"Yes"
"6562","GO_BP","516274_GO_0071350_CELLULAR_RESPONSE_TO_INTERLEUKIN_15",10,-1.3932,0.11,0.17,"No",1.0979,0.34,0.9,"Yes"
"6563","C2_Chemical_and_genetic_perturbations","C2_CGP_2909_CHANDRAN_METASTASIS_DN",298,-1.393,0.0043,0.11,"No",-1.0805,0.25,0.95,"No"
"6564","GO_BP","509136_GO_0046939_NUCLEOTIDE_PHOSPHORYLATION",34,-1.393,0.062,0.17,"No",-1.2407,0.15,0.91,"No"
"6565","GO_BP","502381_GO_0033160_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION",10,-1.393,0.11,0.17,"No",0.5337,0.98,1,"Yes"
"6566","GO_BP","496220_GO_0016127_STEROL_CATABOLIC_PROCESS",10,-1.3929,0.099,0.17,"No",-1.2934,0.18,0.88,"No"
"6567","C7_Immunologic_signatures","C7_ALL_1293_GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP",189,-1.3928,0.0057,0.028,"No",-1.1718,0.14,0.93,"No"
"6568","C4_Cancer_gene_neighborhoods","C4_CGN_381_GNF2_MMP1",32,-1.3927,0.067,0.12,"No",-1.0388,0.36,0.79,"No"
"6569","WikiPathways","198780_WP615_SENESCENCE_AND_AUTOPHAGY",105,-1.3927,0.025,0.13,"No",0.6534,1,1,"Yes"
"6570","GO_BP","517028_GO_0072112_GLOMERULAR_VISCERAL_EPITHELIAL_CELL_DIFFERENTIATION",15,-1.3927,0.087,0.17,"No",0.7164,0.85,1,"Yes"
"6571","KEGG_compound","C02170_METHYLMALONATE_METHYLMALONIC_ACID",7,-1.3926,0.1,0.26,"No",-0.7323,0.8,1,"No"
"6572","GO_BP","512484_GO_0051608_HISTAMINE_TRANSPORT",11,-1.3926,0.12,0.17,"No",0.8124,0.71,1,"Yes"
"6573","GO_BP","492039_GO_0007260_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",10,-1.3925,0.082,0.17,"No",-0.5675,0.96,1,"No"
"6574","GO_BP","499724_GO_0030323_RESPIRATORY_TUBE_DEVELOPMENT",181,-1.3924,0.014,0.17,"No",0.8956,0.74,1,"Yes"
"6575","KEGG_compound","C20876_VERY_LONG_CHAIN_ACYL_COA",8,-1.3922,0.098,0.26,"No",-0.9482,0.5,1,"No"
"6576","GO_BP","754577_GO_1901621_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",6,-1.3921,0.087,0.17,"No",-0.8234,0.68,1,"No"
"6577","GO_MF","490353_GO_0005085_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",193,-1.3917,0.027,0.22,"No",-1.2477,0.065,0.84,"No"
"6578","C2_Chemical_and_genetic_perturbations","C2_CGP_1718_KANG_FLUOROURACIL_RESISTANCE_DN",16,-1.3916,0.095,0.11,"No",-1.2765,0.16,0.72,"No"
"6579","C7_Immunologic_signatures","C7_ALL_113_GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP",189,-1.3915,0.019,0.029,"No",0.7693,0.97,1,"Yes"
"6580","C7_Immunologic_signatures","C7_ALL_1483_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP",198,-1.3915,0.01,0.029,"No",1.0091,0.42,0.71,"Yes"
"6581","KEGG_compound","C06174_CODEINE_5ALPHA_6ALPHA_7_8_DIDEHYDRO_4_5_EPOXY_3_METHOXY_17_METHYLMORPHINAN_6_OL",21,-1.3914,0.08,0.26,"No",1.6642,0.01,0.1,"Yes"
"6582","KEGG_compound","C00401_CHONDROITIN_CHONDROITIN_D_GLUCURONATE",6,-1.3914,0.093,0.26,"No",0.7305,0.79,1,"Yes"
"6583","GO_MF","505692_GO_0042562_HORMONE_BINDING",66,-1.3912,0.039,0.22,"No",1.1106,0.26,0.77,"Yes"
"6584","C7_Immunologic_signatures","C7_ALL_452_GSE17721_CTRL_VS_LPS_2H_BMDM_DN",193,-1.3911,0.013,0.029,"No",-0.8609,0.83,1,"No"
"6585","GO_BP","514136_GO_0060581_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION",13,-1.3908,0.098,0.17,"No",-1.5061,0.042,0.82,"No"
"6586","WikiPathways","198841_WP521_AMINO_ACID_CONJUGATION_OF_BENZOIC_ACID",5,-1.3907,0.11,0.13,"No",-1.6001,0.025,0.78,"No"
"6587","C2_Chemical_and_genetic_perturbations","C2_CGP_1503_ZHAN_MULTIPLE_MYELOMA_PR_UP",42,-1.3907,0.056,0.11,"No",0.9135,0.6,0.91,"Yes"
"6588","C2_Chemical_and_genetic_perturbations","C2_CGP_1552_ZHAN_V2_LATE_DIFFERENTIATION_GENES",44,-1.3906,0.056,0.11,"No",0.7899,0.85,1,"Yes"
"6589","GO_BP","503245_GO_0034036_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-1.3906,0.097,0.17,"No",-0.9217,0.55,1,"No"
"6590","C7_Immunologic_signatures","C7_ALL_1521_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP",198,-1.3906,0.018,0.029,"No",1.0172,0.41,0.69,"Yes"
"6591","GO_BP","753360_GO_1900376_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS",5,-1.3905,0.099,0.17,"No",1.0347,0.42,0.96,"Yes"
"6592","C3_TF_targets","C3_TFT_524_TGGNNNNNNKCCAR_UNKNOWN",414,-1.3902,0.0052,0.044,"No",-1.1259,0.14,0.49,"No"
"6593","C2_Chemical_and_genetic_perturbations","C2_CGP_2072_MARSON_FOXP3_TARGETS_STIMULATED_UP",29,-1.3901,0.06,0.11,"No",1.4393,0.045,0.26,"Yes"
"6594","GO_BP","515518_GO_0070588_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT",127,-1.3901,0.037,0.18,"No",-1.5757,0,0.73,"No"
"6595","KEGG_compound","C00280_ANDROSTENEDIONE_ANDROST_4_ENE_3_17_DIONE_4_ANDROSTENE_3_17_DIONE",15,-1.3898,0.085,0.26,"No",1.1581,0.25,0.95,"Yes"
"6596","GO_BP","491000_GO_0006014_D_RIBOSE_METABOLIC_PROCESS",6,-1.3898,0.087,0.18,"No",0.8505,0.64,1,"Yes"
"6597","OMIM_gene","OMIM601985_COILED_COIL_DOMAIN_CONTAINING_PROTEIN_6_CCDC6",8,-1.3898,0.094,0.94,"No",-1.0657,0.37,0.84,"No"
"6598","KEGG_compound","C00864_PANTOTHENATE_PANTOTHENIC_ACID_R_PANTOTHENATE",6,-1.3898,0.09,0.26,"No",-1.1217,0.34,0.89,"No"
"6599","GO_BP","508005_GO_0045657_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION",6,-1.3895,0.096,0.18,"No",-1.0434,0.4,0.98,"No"
"6600","GO_BP","491699_GO_0006833_WATER_TRANSPORT",40,-1.3895,0.065,0.18,"No",0.9493,0.55,1,"Yes"
"6601","GO_BP","515199_GO_0070266_NECROPTOTIC_PROCESS",18,-1.3895,0.088,0.18,"No",0.5743,0.98,1,"Yes"
"6602","GO_BP","518184_GO_0090037_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING",8,-1.3894,0.11,0.18,"No",-0.6729,0.91,1,"No"
"6603","GO_BP","512805_GO_0051955_REGULATION_OF_AMINO_ACID_TRANSPORT",22,-1.3893,0.084,0.18,"No",-0.8877,0.62,1,"No"
"6604","C4_Cancer_modules","C4_CM_379_MODULE_470",16,-1.3892,0.088,0.1,"No",-1.0039,0.46,0.79,"No"
"6605","C7_Immunologic_signatures","C7_ALL_1309_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP",186,-1.3892,0.016,0.03,"No",-1.2,0.11,0.82,"No"
"6606","C3_TF_targets","C3_TFT_110_V_ARP1_01",160,-1.3892,0.016,0.044,"No",-1.1526,0.17,0.45,"No"
"6607","GO_BP","494007_GO_0009913_EPIDERMAL_CELL_DIFFERENTIATION",124,-1.3891,0.026,0.18,"No",1.0216,0.41,0.97,"Yes"
"6608","C3_MicroRNA_targets","C3_MIR_173_AACTGGA_MIR_145",228,-1.3891,0.0078,0.27,"No",-0.7243,1,1,"No"
"6609","REACTOME","187204_REACT_23879_PLATELET_SENSITIZATION_BY_LDL",17,-1.3889,0.088,0.2,"No",0.5686,0.97,1,"Yes"
"6610","C2_Chemical_and_genetic_perturbations","C2_CGP_2971_VISALA_AGING_LYMPHOCYTE_UP",10,-1.3889,0.099,0.11,"No",-0.6495,0.91,1,"No"
"6611","KEGG_module","HSA_M00689_MAPK_P38_SIGNALING",22,-1.3887,0.089,0.44,"No",-1.6186,0.024,0.34,"No"
"6612","C7_Immunologic_signatures","C7_ALL_689_GSE17721_LPS_VS_GARDIQUIMOD_0_5H_BMDM_UP",192,-1.3886,0.0092,0.03,"No",1.109,0.18,0.42,"Yes"
"6613","GO_BP","498162_GO_0019317_FUCOSE_CATABOLIC_PROCESS",9,-1.3886,0.1,0.18,"No",0.6986,0.83,1,"Yes"
"6614","GO_BP","517040_GO_0072124_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION",7,-1.3885,0.098,0.18,"No",-0.872,0.62,1,"No"
"6615","GO_BP","487567_GO_0001654_EYE_DEVELOPMENT",316,-1.3885,0.0032,0.18,"No",-1.1448,0.14,0.93,"No"
"6616","C2_BioCarta_Pathways","C2_CP_BIOCARTA_59_BIOCARTA_CALCINEURIN_PATHWAY",18,-1.3882,0.092,0.2,"No",-0.4146,1,1,"No"
"6617","GO_BP","511982_GO_0051057_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION",35,-1.3881,0.068,0.18,"No",-0.806,0.77,1,"No"
"6618","C2_Chemical_and_genetic_perturbations","C2_CGP_2124_KONDO_PROSTATE_CANCER_WITH_H3K27ME3",180,-1.3881,0.019,0.11,"No",1.2612,0.053,0.43,"Yes"
"6619","C2_Chemical_and_genetic_perturbations","C2_CGP_284_HUMMEL_BURKITTS_LYMPHOMA_DN",15,-1.388,0.1,0.11,"No",-1.0573,0.38,0.97,"No"
"6620","GO_MF","487478_GO_0001540_BETA_AMYLOID_BINDING",32,-1.388,0.072,0.23,"No",-0.8856,0.67,1,"No"
"6621","REACTOME","105827_REACT_6875_PHOSPHORYLATION_OF_EMI1",6,-1.3879,0.094,0.2,"No",-1.1871,0.25,0.86,"No"
"6622","GO_MF","490480_GO_0005246_CALCIUM_CHANNEL_REGULATOR_ACTIVITY",34,-1.3879,0.063,0.23,"No",-1.0508,0.39,0.86,"No"
"6623","C7_Immunologic_signatures","C7_ALL_572_GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_DN",196,-1.3878,0.018,0.03,"No",0.7598,0.99,1,"Yes"
"6624","REACTOME","106418_REACT_12555_DOWNSTREAM_TCR_SIGNALING",40,-1.3878,0.06,0.2,"No",1.0713,0.34,0.63,"Yes"
"6625","GO_BP","507271_GO_0044264_CELLULAR_POLYSACCHARIDE_METABOLIC_PROCESS",84,-1.3878,0.044,0.18,"No",1.072,0.31,0.93,"Yes"
"6626","GO_BP","499152_GO_0021873_FOREBRAIN_NEUROBLAST_DIVISION",9,-1.3878,0.11,0.18,"No",-0.7332,0.79,1,"No"
"6627","GO_BP","514863_GO_0061318_RENAL_FILTRATION_CELL_DIFFERENTIATION",15,-1.3877,0.087,0.18,"No",0.7299,0.84,1,"Yes"
"6628","GO_BP","487604_GO_0001701_IN_UTERO_EMBRYONIC_DEVELOPMENT",363,-1.3877,0,0.18,"No",-0.7194,1,1,"No"
"6629","GO_MF","487855_GO_0001965_G_PROTEIN_ALPHA_SUBUNIT_BINDING",15,-1.3877,0.1,0.22,"No",0.6506,0.94,1,"Yes"
"6630","REACTOME","771599_REACT_160300_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS",40,-1.3877,0.059,0.2,"No",1.351,0.059,0.26,"Yes"
"6631","C7_Immunologic_signatures","C7_ALL_1590_GSE3982_EOSINOPHIL_VS_MAC_DN",195,-1.3877,0.014,0.03,"No",1.5304,0.0023,0.0083,"Yes"
"6632","REACTOME","160971_REACT_22297_HEME_DEGRADATION",6,-1.3876,0.096,0.2,"No",-0.6025,0.93,1,"No"
"6633","REACTOME","187100_REACT_24938_TRAF6_MEDIATED_IRF7_ACTIVATION",29,-1.3876,0.081,0.2,"No",-0.7353,0.87,1,"No"
"6634","C2_Chemical_and_genetic_perturbations","C2_CGP_246_MULLIGHAN_NPM1_SIGNATURE_3_UP",334,-1.3875,0.0032,0.11,"No",1.0926,0.19,0.64,"Yes"
"6635","GO_BP","500308_GO_0031018_ENDOCRINE_PANCREAS_DEVELOPMENT",43,-1.3875,0.061,0.18,"No",1.0454,0.39,0.95,"Yes"
"6636","GO_BP","496194_GO_0016101_DITERPENOID_METABOLIC_PROCESS",87,-1.3875,0.034,0.18,"No",-1.0685,0.32,0.96,"No"
"6637","C3_TF_targets","C3_TFT_296_V_NKX62_Q2",231,-1.3875,0.012,0.045,"No",0.9977,0.45,1,"Yes"
"6638","GO_BP","503328_GO_0034122_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",22,-1.3874,0.085,0.18,"No",-1.1594,0.27,0.92,"No"
"6639","C7_Immunologic_signatures","C7_ALL_1519_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP",196,-1.3873,0.023,0.03,"No",1.1323,0.17,0.36,"Yes"
"6640","GO_BP","495975_GO_0015850_ORGANIC_HYDROXY_COMPOUND_TRANSPORT",138,-1.3873,0.022,0.18,"No",-1.2771,0.066,0.89,"No"
"6641","GO_MF","495447_GO_0015175_NEUTRAL_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",26,-1.3872,0.083,0.22,"No",0.8411,0.72,1,"Yes"
"6642","C3_TF_targets","C3_TFT_346_V_MTF1_Q4",247,-1.3872,0.01,0.044,"No",-1.0886,0.23,0.58,"No"
"6643","C7_Immunologic_signatures","C7_ALL_92_GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",187,-1.3872,0.013,0.03,"No",-0.6808,1,1,"No"
"6644","REACTOME","105767_REACT_821_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1",38,-1.3871,0.07,0.2,"No",1.0108,0.45,0.73,"Yes"
"6645","GO_BP","491693_GO_0006826_IRON_ION_TRANSPORT",56,-1.387,0.059,0.18,"No",0.9967,0.47,0.98,"Yes"
"6646","GO_BP","754576_GO_1901620_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",6,-1.387,0.11,0.18,"No",-0.8427,0.68,1,"No"
"6647","C7_Immunologic_signatures","C7_ALL_91_GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",197,-1.3869,0.0081,0.03,"No",1.0189,0.38,0.68,"Yes"
"6648","C7_Immunologic_signatures","C7_ALL_722_GSE17721_0_5H_VS_8H_POLYIC_BMDM_DN",198,-1.3869,0.015,0.03,"No",0.9551,0.59,0.88,"Yes"
"6649","GO_BP","503894_GO_0034694_RESPONSE_TO_PROSTAGLANDIN",23,-1.3869,0.076,0.18,"No",1.062,0.35,0.94,"Yes"
"6650","GO_MF","509552_GO_0047372_ACYLGLYCEROL_LIPASE_ACTIVITY",5,-1.3868,0.094,0.23,"No",-0.6013,0.93,1,"No"
"6651","C7_Immunologic_signatures","C7_ALL_322_GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN",199,-1.3867,0.015,0.03,"No",-0.7747,0.98,1,"No"
"6652","GO_MF","512281_GO_0051400_BH_DOMAIN_BINDING",10,-1.3867,0.11,0.22,"No",-0.7051,0.86,1,"No"
"6653","C2_Chemical_and_genetic_perturbations","C2_CGP_2239_ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN",346,-1.3866,0.0043,0.11,"No",0.9811,0.54,0.81,"Yes"
"6654","GO_BP","500780_GO_0031529_RUFFLE_ORGANIZATION",23,-1.3866,0.089,0.18,"No",-1.0069,0.43,0.98,"No"
"6655","REACTOME","645302_REACT_121120_KERATAN_SULFATE_BIOSYNTHESIS",28,-1.3866,0.074,0.2,"No",0.7498,0.85,1,"Yes"
"6656","C7_Immunologic_signatures","C7_ALL_87_GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",193,-1.3865,0.011,0.03,"No",-0.8834,0.79,1,"No"
"6657","C2_Chemical_and_genetic_perturbations","C2_CGP_2964_GERHOLD_RESPONSE_TO_TZD_DN",13,-1.3864,0.074,0.11,"No",1.2404,0.19,0.45,"Yes"
"6658","GO_BP","498806_GO_0021522_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION",31,-1.3862,0.079,0.18,"No",-1.1022,0.33,0.94,"No"
"6659","GO_MF","490621_GO_0005518_COLLAGEN_BINDING",61,-1.3861,0.053,0.22,"No",-0.818,0.8,1,"No"
"6660","GO_MF","503794_GO_0034593_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY",16,-1.3861,0.086,0.22,"No",-0.7376,0.82,1,"No"
"6661","GO_MF","492902_GO_0008656_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",18,-1.386,0.086,0.22,"No",0.8088,0.76,1,"Yes"
"6662","GO_MF","495584_GO_0015355_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.3859,0.089,0.22,"No",-1.0742,0.39,0.86,"No"
"6663","C7_Immunologic_signatures","C7_ALL_1174_GSE27786_LIN_NEG_VS_NEUTROPHIL_DN",199,-1.3859,0.015,0.031,"No",-1.1217,0.22,1,"No"
"6664","GO_BP","513503_GO_0055070_COPPER_ION_HOMEOSTASIS",17,-1.3859,0.098,0.18,"No",0.7691,0.79,1,"Yes"
"6665","GO_BP","499711_GO_0030311_POLY_N_ACETYLLACTOSAMINE_BIOSYNTHETIC_PROCESS",5,-1.3859,0.093,0.18,"No",0.4796,0.99,1,"Yes"
"6666","C4_Cancer_gene_neighborhoods","C4_CGN_123_MORF_LMO1",47,-1.3859,0.069,0.13,"No",-1.5781,0.0057,0.16,"No"
"6667","GO_BP","510734_GO_0048679_REGULATION_OF_AXON_REGENERATION",9,-1.3858,0.13,0.18,"No",-1.2397,0.21,0.91,"No"
"6668","GO_BP","487843_GO_0001953_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION",26,-1.3858,0.09,0.18,"No",0.9453,0.52,1,"Yes"
"6669","REACTOME","187182_REACT_25282_INHIBITION_OF_ADENYLATE_CYCLASE_PATHWAY",14,-1.3857,0.095,0.2,"No",-1.0937,0.35,0.91,"No"
"6670","GO_BP","509072_GO_0046852_POSITIVE_REGULATION_OF_BONE_REMODELING",14,-1.3856,0.095,0.18,"No",-0.835,0.68,1,"No"
"6671","C2_Chemical_and_genetic_perturbations","C2_CGP_3183_KASLER_HDAC7_TARGETS_1_DN",17,-1.3856,0.11,0.11,"No",-0.6717,0.91,1,"No"
"6672","C4_Cancer_modules","C4_CM_125_MODULE_130",23,-1.3856,0.074,0.11,"No",-1.016,0.44,0.8,"No"
"6673","C2_Chemical_and_genetic_perturbations","C2_CGP_108_PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP",81,-1.3856,0.048,0.11,"No",0.933,0.62,0.89,"Yes"
"6674","C3_MicroRNA_targets","C3_MIR_78_GGGCATT_MIR_365",108,-1.3855,0.027,0.27,"No",-1.0755,0.29,1,"No"
"6675","WikiPathways","920992_WP1981_THYROXINE_THYROID_HORMONE_PRODUCTION",6,-1.3855,0.11,0.13,"No",0.8845,0.58,1,"Yes"
"6676","C2_Chemical_and_genetic_perturbations","C2_CGP_1357_LEE_LIVER_CANCER_MYC_E2F1_DN",62,-1.3854,0.049,0.11,"No",-0.9711,0.5,1,"No"
"6677","KEGG_pathway","HSA00760_NICOTINATE_AND_NICOTINAMIDE_METABOLISM",29,-1.3853,0.074,0.075,"No",0.7623,0.81,1,"Yes"
"6678","REACTOME","477125_REACT_111168_ENDOSOMAL_VACUOLAR_PATHWAY",11,-1.3851,0.11,0.2,"No",0.8303,0.68,0.97,"Yes"
"6679","GO_BP","519156_GO_2000516_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",22,-1.385,0.096,0.18,"No",-1.3157,0.12,0.88,"No"
"6680","C7_Immunologic_signatures","C7_ALL_1814_GSE7852_LN_VS_THYMUS_TREG_DN",200,-1.385,0.013,0.031,"No",1.2137,0.087,0.2,"Yes"
"6681","GO_MF","515335_GO_0070403_NAD_BINDING",13,-1.385,0.077,0.22,"No",-0.7733,0.76,1,"No"
"6682","C2_Chemical_and_genetic_perturbations","C2_CGP_2718_BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN",17,-1.3849,0.093,0.12,"No",0.683,0.89,1,"Yes"
"6683","GO_BP","508279_GO_0045978_NEGATIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS",40,-1.3847,0.064,0.18,"No",0.9177,0.62,1,"Yes"
"6684","C2_Chemical_and_genetic_perturbations","C2_CGP_1362_LIN_APC_TARGETS",77,-1.3847,0.047,0.12,"No",-0.7436,0.95,1,"No"
"6685","C3_TF_targets","C3_TFT_269_V_STAT5B_01",243,-1.3847,0.0045,0.046,"No",0.9669,0.58,1,"Yes"
"6686","C7_Immunologic_signatures","C7_ALL_1698_GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN",191,-1.3847,0.019,0.031,"No",-0.7327,0.99,1,"No"
"6687","GO_BP","511968_GO_0051043_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",21,-1.3846,0.088,0.18,"No",-0.9697,0.5,1,"No"
"6688","GO_BP","493858_GO_0009746_RESPONSE_TO_HEXOSE",127,-1.3846,0.028,0.18,"No",0.7933,0.93,1,"Yes"
"6689","C3_TF_targets","C3_TFT_239_V_CART1_01",216,-1.3844,0.012,0.046,"No",-1.0062,0.42,0.74,"No"
"6690","C2_Chemical_and_genetic_perturbations","C2_CGP_497_JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN",21,-1.3843,0.098,0.12,"No",-1.3108,0.15,0.68,"No"
"6691","C2_Chemical_and_genetic_perturbations","C2_CGP_565_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN",8,-1.3843,0.089,0.12,"No",0.6801,0.86,1,"Yes"
"6692","GO_BP","754841_GO_1901890_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY",22,-1.3841,0.089,0.18,"No",-0.9076,0.61,1,"No"
"6693","GO_BP","514563_GO_0061008_HEPATICOBILIARY_SYSTEM_DEVELOPMENT",107,-1.3841,0.039,0.18,"No",-0.6089,1,1,"No"
"6694","C2_Chemical_and_genetic_perturbations","C2_CGP_3390_ZWANG_EGF_INTERVAL_DN",205,-1.3841,0.0088,0.12,"No",-0.8779,0.78,1,"No"
"6695","C2_Chemical_and_genetic_perturbations","C2_CGP_1702_MCCLUNG_COCAINE_REWARD_5D",78,-1.384,0.048,0.12,"No",-0.9201,0.62,1,"No"
"6696","GO_BP","512036_GO_0051125_REGULATION_OF_ACTIN_NUCLEATION",21,-1.3839,0.097,0.18,"No",-0.5138,0.99,1,"No"
"6697","C3_MicroRNA_targets","C3_MIR_88_GTCTTCC_MIR_7",168,-1.3839,0.015,0.26,"No",-1.02,0.41,1,"No"
"6698","C2_Chemical_and_genetic_perturbations","C2_CGP_1260_NELSON_RESPONSE_TO_ANDROGEN_DN",19,-1.3838,0.096,0.12,"No",-0.8717,0.66,1,"No"
"6699","GO_BP","497119_GO_0018146_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS",28,-1.3836,0.082,0.18,"No",0.7557,0.86,1,"Yes"
"6700","GO_BP","491746_GO_0006885_REGULATION_OF_PH",64,-1.3836,0.058,0.18,"No",-0.892,0.67,1,"No"
"6701","C2_Chemical_and_genetic_perturbations","C2_CGP_3176_AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP",121,-1.3835,0.033,0.12,"No",1.3078,0.047,0.39,"Yes"
"6702","C2_Chemical_and_genetic_perturbations","C2_CGP_270_ODONNELL_TFRC_TARGETS_DN",129,-1.3835,0.029,0.12,"No",0.7673,0.96,1,"Yes"
"6703","C3_TF_targets","C3_TFT_158_V_HAND1E47_01",267,-1.3834,0.0086,0.046,"No",-1.2339,0.053,0.29,"No"
"6704","C2_Chemical_and_genetic_perturbations","C2_CGP_330_GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP",13,-1.3834,0.1,0.12,"No",1.6183,0.026,0.13,"Yes"
"6705","KEGG_compound","C01181_4_TRIMETHYLAMMONIOBUTANOATE_BUTYRO_BETAINE_GAMMA_BUTYROBETAINE",6,-1.3834,0.092,0.26,"No",0.9588,0.52,1,"Yes"
"6706","GO_BP","495126_GO_0014054_POSITIVE_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION",5,-1.3833,0.1,0.18,"No",-1.0675,0.4,0.96,"No"
"6707","C2_Chemical_and_genetic_perturbations","C2_CGP_247_MULLIGHAN_NPM1_SIGNATURE_3_DN",160,-1.3833,0.023,0.12,"No",1.2936,0.034,0.4,"Yes"
"6708","C2_Chemical_and_genetic_perturbations","C2_CGP_2630_SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE",81,-1.383,0.048,0.12,"No",1.2594,0.088,0.43,"Yes"
"6709","GO_BP","507020_GO_0044003_MODIFICATION_BY_SYMBIONT_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY",34,-1.383,0.074,0.18,"No",0.8067,0.79,1,"Yes"
"6710","GO_BP","499539_GO_0030104_WATER_HOMEOSTASIS",68,-1.3829,0.049,0.18,"No",1.5125,0.021,0.39,"Yes"
"6711","GO_MF","495456_GO_0015187_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-1.3828,0.097,0.23,"No",-0.8565,0.64,1,"No"
"6712","C2_Chemical_and_genetic_perturbations","C2_CGP_568_OLSSON_E2F3_TARGETS_UP",28,-1.3828,0.077,0.12,"No",-1.1297,0.29,0.89,"No"
"6713","GO_BP","515472_GO_0070542_RESPONSE_TO_FATTY_ACID",56,-1.3828,0.058,0.18,"No",0.6766,0.97,1,"Yes"
"6714","GO_BP","505641_GO_0042510_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT1_PROTEIN",13,-1.3827,0.11,0.18,"No",-1.6455,0.028,0.71,"No"
"6715","C7_Immunologic_signatures","C7_ALL_1382_GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN",194,-1.3827,0.014,0.032,"No",-0.7368,0.99,1,"No"
"6716","C4_Cancer_gene_neighborhoods","C4_CGN_63_MORF_ARL3",298,-1.3827,0.0066,0.13,"No",-1.2708,0.019,0.56,"No"
"6717","WikiPathways","198910_WP1425_BMP_SIGNALLING_AND_REGULATION",12,-1.3825,0.12,0.13,"No",-1.1687,0.27,0.88,"No"
"6718","GO_BP","510256_GO_0048103_SOMATIC_STEM_CELL_DIVISION",23,-1.3825,0.08,0.18,"No",0.6569,0.95,1,"Yes"
"6719","GO_CC","499803_GO_0030425_DENDRITE",373,-1.3824,0.0032,0.24,"No",-1.0744,0.24,0.81,"No"
"6720","C7_Immunologic_signatures","C7_ALL_1224_GSE27786_NKTCELL_VS_NEUTROPHIL_DN",195,-1.3824,0.0069,0.032,"No",0.8666,0.85,1,"Yes"
"6721","C0_Hallmark","H_ALL_49_HALLMARK_KRAS_SIGNALING_DN",182,-1.3824,0.027,0.034,"No",-1.0337,0.38,0.78,"No"
"6722","C7_Immunologic_signatures","C7_ALL_834_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN",177,-1.3822,0.02,0.032,"No",-1.2054,0.11,0.82,"No"
"6723","REACTOME","106534_REACT_15370_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL",140,-1.3822,0.026,0.21,"No",-1.4219,0.015,0.49,"No"
"6724","C3_MicroRNA_targets","C3_MIR_218_TTCCGTT_MIR_191",29,-1.3821,0.074,0.26,"No",-0.9385,0.56,1,"No"
"6725","GO_BP","493275_GO_0009074_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS",19,-1.3821,0.078,0.18,"No",-1.1939,0.22,0.9,"No"
"6726","GO_BP","515106_GO_0070169_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT",36,-1.3819,0.083,0.18,"No",-1.6568,0.0037,0.67,"No"
"6727","KEGG_module","HSA_M00013_MALONATE_SEMIALDEHYDE_PATHWAY_PROPANOYL_COA_ACETYL_COA",6,-1.3818,0.1,0.43,"No",-0.5875,0.94,1,"No"
"6728","C2_Chemical_and_genetic_perturbations","C2_CGP_455_GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP",96,-1.3818,0.043,0.12,"No",0.9864,0.47,0.81,"Yes"
"6729","GO_BP","511703_GO_0050732_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION",36,-1.3817,0.073,0.18,"No",-0.7723,0.86,1,"No"
"6730","C2_Chemical_and_genetic_perturbations","C2_CGP_3134_BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C",89,-1.3817,0.033,0.12,"No",1.0085,0.41,0.79,"Yes"
"6731","GO_CC","487580_GO_0001669_ACROSOMAL_VESICLE",87,-1.3816,0.032,0.24,"No",-0.936,0.6,0.9,"No"
"6732","C2_BioCarta_Pathways","C2_CP_BIOCARTA_13_BIOCARTA_AT1R_PATHWAY",33,-1.3813,0.076,0.2,"No",-0.509,1,1,"No"
"6733","REACTOME","645295_REACT_120966_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK",209,-1.3813,0.014,0.21,"No",1.0178,0.4,0.72,"Yes"
"6734","REACTOME","105722_REACT_6784_GLUCURONIDATION",20,-1.3811,0.094,0.21,"No",1.7475,0.0042,0.033,"Yes"
"6735","GO_BP","494960_GO_0010896_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS",11,-1.3811,0.088,0.18,"No",-1.1023,0.32,0.94,"No"
"6736","C2_Chemical_and_genetic_perturbations","C2_CGP_2443_WANG_TUMOR_INVASIVENESS_DN",209,-1.3811,0.01,0.12,"No",1.1145,0.19,0.61,"Yes"
"6737","C2_BioCarta_Pathways","C2_CP_BIOCARTA_79_BIOCARTA_GLYCOLYSIS_PATHWAY",10,-1.3811,0.096,0.2,"No",-0.8715,0.62,1,"No"
"6738","GO_BP","509092_GO_0046879_HORMONE_SECRETION",74,-1.381,0.052,0.18,"No",1.1363,0.25,0.85,"Yes"
"6739","KEGG_pathway","HSA05166_HTLV_I_INFECTION",256,-1.3808,0.015,0.077,"No",0.6836,1,1,"Yes"
"6740","C3_TF_targets","C3_TFT_285_V_FOXO1_02",235,-1.3807,0.01,0.047,"No",0.8178,0.97,1,"Yes"
"6741","C3_TF_targets","C3_TFT_266_V_IRF7_01",243,-1.3806,0.0099,0.047,"No",0.8734,0.87,1,"Yes"
"6742","C3_MicroRNA_targets","C3_MIR_131_ATACCTC_MIR_202",178,-1.3805,0.013,0.25,"No",-0.9551,0.57,1,"No"
"6743","C7_Immunologic_signatures","C7_ALL_1299_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP",188,-1.3805,0.015,0.033,"No",-0.7465,0.99,1,"No"
"6744","GO_BP","508802_GO_0046546_DEVELOPMENT_OF_PRIMARY_MALE_SEXUAL_CHARACTERISTICS",120,-1.3803,0.022,0.18,"No",-0.9015,0.68,1,"No"
"6745","KEGG_compound","C00275_D_MANNOSE_6_PHOSPHATE",7,-1.3803,0.11,0.27,"No",0.5449,0.96,1,"Yes"
"6746","GO_BP","510551_GO_0048477_OOGENESIS",58,-1.3802,0.044,0.18,"No",-1.1452,0.23,0.93,"No"
"6747","GO_BP","518829_GO_2000181_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_MORPHOGENESIS",65,-1.3801,0.063,0.18,"No",-1.0124,0.42,0.98,"No"
"6748","REACTOME","771601_REACT_160131_FIBRONECTIN_MATRIX_FORMATION",6,-1.38,0.1,0.21,"No",1.0523,0.42,0.66,"Yes"
"6749","C3_TF_targets","C3_TFT_437_V_LEF1_Q2",216,-1.38,0.017,0.047,"No",-0.9599,0.54,0.85,"No"
"6750","C3_TF_targets","C3_TFT_67_V_CDP_02",101,-1.3799,0.037,0.047,"No",-1.3391,0.043,0.19,"No"
"6751","C3_TF_targets","C3_TFT_439_V_EGR_Q6",267,-1.3799,0.011,0.047,"No",-1.2217,0.059,0.3,"No"
"6752","GO_BP","493588_GO_0009415_RESPONSE_TO_WATER",12,-1.3798,0.087,0.18,"No",-0.9716,0.49,1,"No"
"6753","GO_CC","502216_GO_0032994_PROTEIN_LIPID_COMPLEX",39,-1.3798,0.062,0.24,"No",1.1233,0.26,0.61,"Yes"
"6754","GO_BP","510558_GO_0048484_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT",12,-1.3797,0.094,0.18,"No",1.703,0.018,0.19,"Yes"
"6755","C2_Chemical_and_genetic_perturbations","C2_CGP_1695_JIANG_AGING_HYPOTHALAMUS_DN",40,-1.3796,0.07,0.12,"No",0.9094,0.6,0.91,"Yes"
"6756","GO_BP","510185_GO_0048021_REGULATION_OF_MELANIN_BIOSYNTHETIC_PROCESS",5,-1.3794,0.083,0.18,"No",1.0312,0.41,0.97,"Yes"
"6757","C2_Chemical_and_genetic_perturbations","C2_CGP_509_DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN",19,-1.3794,0.09,0.12,"No",0.5619,0.98,1,"Yes"
"6758","C2_Chemical_and_genetic_perturbations","C2_CGP_1295_KIM_GERMINAL_CENTER_T_HELPER_UP",66,-1.3793,0.057,0.12,"No",0.7714,0.89,1,"Yes"
"6759","GO_BP","511772_GO_0050806_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION",86,-1.3792,0.039,0.18,"No",-1.4211,0.035,0.94,"No"
"6760","GO_BP","1129377_GO_1903551_REGULATION_OF_EXTRACELLULAR_EXOSOME_ASSEMBLY",6,-1.3791,0.11,0.18,"No",1.025,0.44,0.97,"Yes"
"6761","C7_Immunologic_signatures","C7_ALL_517_GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_UP",199,-1.3791,0.01,0.033,"No",-0.894,0.74,1,"No"
"6762","KEGG_compound","C05577_3_4_DIHYDROXYMANDELALDEHYDE_3_4_DIHYDROXYPHENYLGLYCOLALDEHYDE",13,-1.3791,0.11,0.27,"No",1.172,0.24,0.92,"Yes"
"6763","KEGG_compound","C00264_3_OXOACYL_COA",11,-1.379,0.094,0.27,"No",-0.7162,0.84,1,"No"
"6764","C2_Chemical_and_genetic_perturbations","C2_CGP_1777_VERRECCHIA_RESPONSE_TO_TGFB1_C1",19,-1.3789,0.092,0.12,"No",0.8269,0.72,0.98,"Yes"
"6765","C2_Chemical_and_genetic_perturbations","C2_CGP_843_OXFORD_RALA_AND_RALB_TARGETS_DN",9,-1.3788,0.11,0.12,"No",1.0394,0.38,0.74,"Yes"
"6766","GO_BP","516255_GO_0071331_CELLULAR_RESPONSE_TO_HEXOSE_STIMULUS",53,-1.3788,0.056,0.18,"No",0.69,0.98,1,"Yes"
"6767","KEGG_pathway","HSA05030_COCAINE_ADDICTION",50,-1.3788,0.053,0.078,"No",-1.1361,0.24,0.65,"No"
"6768","GO_BP","505227_GO_0042036_NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS",27,-1.3788,0.083,0.18,"No",-0.7249,0.89,1,"No"
"6769","C2_Chemical_and_genetic_perturbations","C2_CGP_1773_BROWNE_HCMV_INFECTION_14HR_UP",156,-1.3787,0.022,0.12,"No",-1.2884,0.053,0.7,"No"
"6770","C2_Chemical_and_genetic_perturbations","C2_CGP_2661_CROONQUIST_STROMAL_STIMULATION_DN",12,-1.3786,0.087,0.12,"No",-0.6793,0.88,1,"No"
"6771","C4_Cancer_modules","C4_CM_106_MODULE_111",147,-1.3784,0.022,0.11,"No",-1.1472,0.18,0.63,"No"
"6772","GO_BP","514555_GO_0061000_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT",6,-1.3784,0.11,0.18,"No",-1.3761,0.13,0.99,"No"
"6773","C2_Chemical_and_genetic_perturbations","C2_CGP_978_GROSS_HYPOXIA_VIA_ELK3_UP",206,-1.3782,0.012,0.12,"No",-0.904,0.72,1,"No"
"6774","GO_MF","489341_GO_0003840_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY",7,-1.3782,0.1,0.23,"No",0.6514,0.89,1,"Yes"
"6775","REACTOME","530741_REACT_115596_SIGNALING_BY_ERBB4",143,-1.3782,0.02,0.21,"No",-0.7876,0.93,1,"No"
"6776","KEGG_compound","C00195_N_ACYLSPHINGOSINE_CERAMIDE",28,-1.3782,0.082,0.26,"No",-0.7412,0.87,1,"No"
"6777","C2_BioCarta_Pathways","C2_CP_BIOCARTA_175_BIOCARTA_BARR_MAPK_PATHWAY",11,-1.3782,0.096,0.2,"No",-1.1083,0.33,1,"No"
"6778","REACTOME","106251_REACT_11202_VITAMIN_C_ASCORBATE_METABOLISM",8,-1.3781,0.11,0.21,"No",-1.4012,0.11,0.53,"No"
"6779","GO_BP","502090_GO_0032868_RESPONSE_TO_INSULIN",244,-1.3781,0.013,0.18,"No",-0.8418,0.9,1,"No"
"6780","GO_BP","488805_GO_0003007_HEART_MORPHOGENESIS",206,-1.3781,0.011,0.18,"No",-0.9463,0.59,1,"No"
"6781","GO_BP","515142_GO_0070207_PROTEIN_HOMOTRIMERIZATION",18,-1.378,0.1,0.18,"No",1.2683,0.16,0.71,"Yes"
"6782","GO_BP","513591_GO_0060033_ANATOMICAL_STRUCTURE_REGRESSION",13,-1.3779,0.097,0.18,"No",-1.1878,0.25,0.9,"No"
"6783","GO_BP","514790_GO_0061245_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY",32,-1.3779,0.075,0.18,"No",0.9537,0.55,1,"Yes"
"6784","GO_BP","509098_GO_0046890_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS",116,-1.3778,0.036,0.18,"No",-0.7534,0.96,1,"No"
"6785","REACTOME","1183553_REACT_355550_CLEC7A_INFLAMMASOME_PATHWAY",6,-1.3778,0.11,0.21,"No",-0.52,0.97,1,"No"
"6786","GO_MF","504794_GO_0035615_CLATHRIN_ADAPTOR_ACTIVITY",8,-1.3777,0.11,0.23,"No",0.9584,0.49,0.92,"Yes"
"6787","GO_BP","511770_GO_0050804_REGULATION_OF_SYNAPTIC_TRANSMISSION",245,-1.3775,0.0078,0.18,"No",-1.2475,0.047,0.91,"No"
"6788","C7_Immunologic_signatures","C7_ALL_1501_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP",197,-1.3775,0.013,0.034,"No",0.841,0.89,1,"Yes"
"6789","C3_MicroRNA_targets","C3_MIR_117_CTCAAGA_MIR_526B",68,-1.3774,0.06,0.25,"No",-0.7075,0.96,1,"No"
"6790","GO_BP","507590_GO_0045217_CELL_CELL_JUNCTION_MAINTENANCE",9,-1.3773,0.1,0.19,"No",-1.8338,0.0038,0.42,"No"
"6791","GO_BP","502348_GO_0033127_REGULATION_OF_HISTONE_PHOSPHORYLATION",9,-1.3773,0.092,0.19,"No",-0.6147,0.91,1,"No"
"6792","GO_BP","498164_GO_0019319_HEXOSE_BIOSYNTHETIC_PROCESS",51,-1.3773,0.081,0.18,"No",0.9001,0.63,1,"Yes"
"6793","GO_BP","514405_GO_0060850_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_CELL_FATE_COMMITMENT",17,-1.3772,0.088,0.18,"No",-1.1032,0.32,0.94,"No"
"6794","GO_BP","512064_GO_0051154_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION",24,-1.3771,0.09,0.18,"No",-0.7706,0.8,1,"No"
"6795","C2_Chemical_and_genetic_perturbations","C2_CGP_1192_LEE_TARGETS_OF_PTCH1_AND_SUFU_DN",79,-1.3771,0.036,0.12,"No",-1.0411,0.36,0.97,"No"
"6796","KEGG_module","HSA_M00677_WNT_SIGNALING",37,-1.377,0.084,0.42,"No",-1.1196,0.28,1,"No"
"6797","GO_BP","488758_GO_0002885_POSITIVE_REGULATION_OF_HYPERSENSITIVITY",6,-1.3768,0.12,0.19,"No",-0.9116,0.57,1,"No"
"6798","C2_Chemical_and_genetic_perturbations","C2_CGP_215_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN",41,-1.3767,0.081,0.12,"No",-0.8536,0.72,1,"No"
"6799","GO_MF","853109_GO_0097493_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY",6,-1.3766,0.11,0.23,"No",-1.1144,0.35,0.83,"No"
"6800","GO_BP","510366_GO_0048251_ELASTIC_FIBER_ASSEMBLY",7,-1.3765,0.11,0.19,"No",-1.2002,0.29,0.9,"No"
"6801","GO_BP","515226_GO_0070293_RENAL_ABSORPTION",14,-1.3764,0.098,0.19,"No",-0.7165,0.84,1,"No"
"6802","GO_BP","495301_GO_0014911_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION",19,-1.3762,0.1,0.19,"No",1.2161,0.19,0.76,"Yes"
"6803","GO_BP","504640_GO_0035456_RESPONSE_TO_INTERFERON_BETA",19,-1.3762,0.11,0.19,"No",1.2443,0.18,0.74,"Yes"
"6804","GO_BP","512284_GO_0051403_STRESS_ACTIVATED_MAPK_CASCADE",117,-1.376,0.026,0.19,"No",-0.7511,0.95,1,"No"
"6805","C7_Immunologic_signatures","C7_ALL_1541_GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.376,0.011,0.035,"No",0.9188,0.69,0.98,"Yes"
"6806","C3_TF_targets","C3_TFT_206_V_NFAT_Q6",234,-1.3757,0.0077,0.049,"No",-0.9896,0.46,0.78,"No"
"6807","C3_MicroRNA_targets","C3_MIR_31_ATGTAGC_MIR_221_MIR_222",139,-1.3757,0.022,0.25,"No",0.9721,0.48,1,"Yes"
"6808","GO_BP","511736_GO_0050765_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS",10,-1.3756,0.12,0.19,"No",1.0709,0.38,0.93,"Yes"
"6809","C2_Chemical_and_genetic_perturbations","C2_CGP_2078_ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN",37,-1.3755,0.071,0.12,"No",-0.7992,0.79,1,"No"
"6810","C2_Chemical_and_genetic_perturbations","C2_CGP_1350_SHEPARD_BMYB_MORPHOLINO_UP",202,-1.3755,0.017,0.12,"No",1.0937,0.22,0.64,"Yes"
"6811","GO_BP","498964_GO_0021681_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT",15,-1.3754,0.1,0.19,"No",1.0217,0.41,0.97,"Yes"
"6812","C2_BioCarta_Pathways","C2_CP_BIOCARTA_133_BIOCARTA_P53_PATHWAY",16,-1.3754,0.081,0.21,"No",-1.3386,0.14,1,"No"
"6813","C3_TF_targets","C3_TFT_342_V_LFA1_Q6",243,-1.3754,0.015,0.049,"No",-1.4569,0,0.13,"No"
"6814","C4_Cancer_modules","C4_CM_289_MODULE_330",28,-1.3753,0.089,0.11,"No",1.2154,0.2,0.38,"Yes"
"6815","C7_Immunologic_signatures","C7_ALL_56_GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN",176,-1.3752,0.016,0.035,"No",-1.3134,0.033,0.42,"No"
"6816","KEGG_module","HSA_M00049_ADENINE_RIBONUCLEOTIDE_BIOSYNTHESIS_IMP_ADP_ATP",21,-1.3752,0.086,0.4,"No",-0.9423,0.55,1,"No"
"6817","GO_BP","488280_GO_0002407_DENDRITIC_CELL_CHEMOTAXIS",15,-1.3752,0.11,0.19,"No",1.5392,0.045,0.36,"Yes"
"6818","KEGG_compound","C00007_OXYGEN_O2",128,-1.3751,0.031,0.27,"No",-1.2003,0.12,0.77,"No"
"6819","C7_Immunologic_signatures","C7_ALL_1206_GSE27786_CD8_TCELL_VS_NKTCELL_DN",198,-1.3751,0.011,0.035,"No",0.8981,0.76,1,"Yes"
"6820","C7_Immunologic_signatures","C7_ALL_1149_GSE27786_LSK_VS_CD8_TCELL_UP",199,-1.3751,0.016,0.035,"No",-0.8797,0.79,1,"No"
"6821","C7_Immunologic_signatures","C7_ALL_1136_GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN",186,-1.375,0.015,0.035,"No",-1.1565,0.16,0.96,"No"
"6822","C3_MicroRNA_targets","C3_MIR_155_ACTTTAT_MIR_142_5P",282,-1.375,0.0055,0.24,"No",-0.8332,0.92,1,"No"
"6823","GO_BP","496175_GO_0016082_SYNAPTIC_VESICLE_PRIMING",8,-1.375,0.11,0.19,"No",0.9125,0.56,1,"Yes"
"6824","GO_BP","491574_GO_0006686_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS",5,-1.3749,0.1,0.19,"No",-0.7267,0.81,1,"No"
"6825","GO_BP","499194_GO_0021915_NEURAL_TUBE_DEVELOPMENT",153,-1.3748,0.019,0.19,"No",-0.7885,0.93,1,"No"
"6826","C7_Immunologic_signatures","C7_ALL_804_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN",170,-1.3748,0.024,0.035,"No",-0.9987,0.46,1,"No"
"6827","C3_TF_targets","C3_TFT_111_V_RORA1_01",234,-1.3746,0.015,0.049,"No",-0.9333,0.65,0.9,"No"
"6828","C3_TF_targets","C3_TFT_475_V_GR_01",193,-1.3746,0.011,0.049,"No",0.7689,0.99,1,"Yes"
"6829","GO_BP","518840_GO_2000193_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT",17,-1.3746,0.1,0.19,"No",-0.664,0.91,1,"No"
"6830","GO_BP","505981_GO_0042886_AMIDE_TRANSPORT",96,-1.3746,0.042,0.19,"No",0.6583,0.99,1,"Yes"
"6831","C4_Cancer_gene_neighborhoods","C4_CGN_126_MORF_MAGEA9",409,-1.3745,0,0.14,"No",-1.0735,0.23,0.77,"No"
"6832","KEGG_compound","C00167_UDP_GLUCURONATE_UDPGLUCURONATE_UDP_D_GLUCURONATE_UDP_ALPHA_D_GLUCURONATE",25,-1.3744,0.081,0.27,"No",1.7049,0.013,0.075,"Yes"
"6833","GO_BP","505498_GO_0042354_L_FUCOSE_METABOLIC_PROCESS",11,-1.3743,0.093,0.19,"No",-0.8095,0.69,1,"No"
"6834","C3_TF_targets","C3_TFT_88_V_GATA1_04",230,-1.3743,0.012,0.049,"No",-0.9637,0.55,0.84,"No"
"6835","KEGG_reaction","R10825_VERY_LONG_CHAIN_ACYL_COA_MALONYL_COA_C_ACYLTRANSFERASE_DECARBOXYLATING_VERY_LONG_CHAIN_ACYL_COA_MALONYL_COA_VERY_LONG_CHAIN_3_OXOACYL_COA_CO2_COA",7,-1.3743,0.11,0.33,"No",-1.1157,0.33,0.66,"No"
"6836","GO_BP","508876_GO_0046628_POSITIVE_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY",10,-1.3743,0.1,0.19,"No",-0.6776,0.84,1,"No"
"6837","GO_BP","499163_GO_0021884_FOREBRAIN_NEURON_DEVELOPMENT",28,-1.3743,0.086,0.19,"No",-1.3469,0.11,0.93,"No"
"6838","C2_Chemical_and_genetic_perturbations","C2_CGP_2425_ALONSO_METASTASIS_NEURAL_UP",17,-1.374,0.087,0.12,"No",1.1088,0.3,0.61,"Yes"
"6839","GO_MF","500657_GO_0031406_CARBOXYLIC_ACID_BINDING",180,-1.374,0.017,0.24,"No",1.0919,0.23,0.8,"Yes"
"6840","C7_Immunologic_signatures","C7_ALL_900_GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN",200,-1.3738,0.014,0.035,"No",-1.0031,0.43,1,"No"
"6841","GO_BP","492052_GO_0007274_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION",21,-1.3738,0.097,0.19,"No",-1.5681,0.032,0.72,"No"
"6842","REACTOME","645267_REACT_121237_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS",33,-1.3738,0.082,0.21,"No",0.8353,0.76,0.97,"Yes"
"6843","C2_Chemical_and_genetic_perturbations","C2_CGP_1596_SESTO_RESPONSE_TO_UV_C8",72,-1.3737,0.043,0.12,"No",1.2688,0.11,0.42,"Yes"
"6844","C2_Chemical_and_genetic_perturbations","C2_CGP_557_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP",60,-1.3736,0.06,0.12,"No",0.8863,0.69,0.94,"Yes"
"6845","GO_BP","504990_GO_0035821_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM",406,-1.3736,0.0021,0.19,"No",1.2494,0.019,0.73,"Yes"
"6846","C2_Chemical_and_genetic_perturbations","C2_CGP_378_CHOW_RASSF1_TARGETS_DN",29,-1.3736,0.1,0.12,"No",1.6101,0.013,0.13,"Yes"
"6847","C2_Chemical_and_genetic_perturbations","C2_CGP_1950_GENTILE_UV_RESPONSE_CLUSTER_D8",40,-1.3736,0.073,0.12,"No",0.6712,0.95,1,"Yes"
"6848","GO_MF","499733_GO_0030332_CYCLIN_BINDING",20,-1.3736,0.11,0.24,"No",-1.3568,0.11,0.69,"No"
"6849","C2_Chemical_and_genetic_perturbations","C2_CGP_2252_NADELLA_PRKAR1A_TARGETS_UP",9,-1.3735,0.11,0.12,"No",0.8437,0.69,0.97,"Yes"
"6850","C7_Immunologic_signatures","C7_ALL_910_GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN",197,-1.3733,0.015,0.036,"No",-0.7073,0.99,1,"No"
"6851","GO_BP","508904_GO_0046660_FEMALE_SEX_DIFFERENTIATION",102,-1.3732,0.031,0.19,"No",-0.8642,0.75,1,"No"
"6852","GO_MF","489486_GO_0004017_ADENYLATE_KINASE_ACTIVITY",8,-1.3732,0.12,0.24,"No",-1.0489,0.42,0.86,"No"
"6853","KEGG_compound","C00641_1_2_DIACYL_SN_GLYCEROL_1_2_DIACYLGLYCEROL_L_1_2_DIACYLGLYCEROL",46,-1.3731,0.062,0.27,"No",-1.5679,0.013,0.19,"No"
"6854","GO_BP","506344_GO_0043279_RESPONSE_TO_ALKALOID",115,-1.373,0.02,0.19,"No",-1.0704,0.31,0.96,"No"
"6855","GO_CC","499593_GO_0030175_FILOPODIUM",78,-1.3729,0.054,0.25,"No",-1.1243,0.24,0.73,"No"
"6856","GO_MF","510363_GO_0048248_CXCR3_CHEMOKINE_RECEPTOR_BINDING",5,-1.3729,0.12,0.24,"No",1.4159,0.11,0.48,"Yes"
"6857","C2_Chemical_and_genetic_perturbations","C2_CGP_1274_GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3",14,-1.3728,0.093,0.12,"No",0.7241,0.86,1,"Yes"
"6858","C2_Chemical_and_genetic_perturbations","C2_CGP_1042_BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP",24,-1.3728,0.085,0.12,"No",0.9198,0.59,0.9,"Yes"
"6859","REACTOME","106341_REACT_12578_GAB1_SIGNALOSOME",95,-1.3728,0.025,0.21,"No",-1.0808,0.28,0.92,"No"
"6860","GO_BP","512518_GO_0051642_CENTROSOME_LOCALIZATION",16,-1.3727,0.1,0.19,"No",-0.8489,0.68,1,"No"
"6861","GO_BP","501605_GO_0032370_POSITIVE_REGULATION_OF_LIPID_TRANSPORT",49,-1.3726,0.069,0.19,"No",1.0074,0.44,0.98,"Yes"
"6862","GO_BP","518173_GO_0090026_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS",12,-1.3726,0.12,0.19,"No",1.2626,0.18,0.72,"Yes"
"6863","C2_Chemical_and_genetic_perturbations","C2_CGP_3147_MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN",6,-1.3725,0.11,0.12,"No",0.8658,0.6,0.96,"Yes"
"6864","GO_BP","507804_GO_0045453_BONE_RESORPTION",21,-1.3725,0.082,0.19,"No",-0.9396,0.52,1,"No"
"6865","GO_BP","500242_GO_0030949_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",15,-1.3725,0.11,0.19,"No",-0.8581,0.66,1,"No"
"6866","GO_BP","493444_GO_0009251_GLUCAN_CATABOLIC_PROCESS",21,-1.3724,0.077,0.19,"No",-0.9595,0.48,1,"No"
"6867","C3_TF_targets","C3_TFT_433_V_PIT1_Q6",223,-1.3723,0.015,0.05,"No",-1.067,0.29,0.62,"No"
"6868","GO_BP","494698_GO_0010634_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION",87,-1.3723,0.042,0.19,"No",-1.0032,0.44,0.99,"No"
"6869","REACTOME","1127557_REACT_264487_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE",68,-1.3723,0.056,0.21,"No",0.8811,0.72,0.92,"Yes"
"6870","REACTOME","106024_REACT_11166_NEF_MEDIATED_CD4_DOWN_REGULATION",9,-1.3723,0.11,0.21,"No",0.7767,0.77,1,"Yes"
"6871","REACTOME","106497_REACT_15307_CA_DEPENDENT_EVENTS",30,-1.3722,0.074,0.21,"No",0.7429,0.87,1,"Yes"
"6872","C7_Immunologic_signatures","C7_ALL_253_GSE14308_TH1_VS_TH17_UP",197,-1.3722,0.014,0.036,"No",0.9978,0.44,0.74,"Yes"
"6873","C2_Chemical_and_genetic_perturbations","C2_CGP_1823_SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP",34,-1.3721,0.073,0.12,"No",1.1871,0.2,0.51,"Yes"
"6874","GO_BP","494523_GO_0010453_REGULATION_OF_CELL_FATE_COMMITMENT",31,-1.3721,0.078,0.19,"No",-1.5741,0.021,0.73,"No"
"6875","GO_BP","508777_GO_0046519_SPHINGOID_METABOLIC_PROCESS",13,-1.3721,0.1,0.19,"No",-0.6436,0.92,1,"No"
"6876","GO_BP","751743_GO_0044598_DOXORUBICIN_METABOLIC_PROCESS",8,-1.3721,0.12,0.19,"No",-0.7398,0.78,1,"No"
"6877","KEGG_enzyme","2.7.4.3_ADENYLATE_KINASE_MYOKINASE_5_AMP_KINASE_ADENYLIC_KINASE_ADENYLOKINASE",8,-1.372,0.12,0.63,"No",-1.2683,0.2,0.64,"No"
"6878","C7_Immunologic_signatures","C7_ALL_375_GSE15659_RESTING_VS_ACTIVATED_TREG_UP",182,-1.372,0.019,0.036,"No",0.9507,0.59,0.89,"Yes"
"6879","C7_Immunologic_signatures","C7_ALL_319_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP",198,-1.372,0.017,0.036,"No",1.2232,0.084,0.19,"Yes"
"6880","KEGG_compound","C07490_TRICHLOROETHANOL_2_2_2_TRICHLOROETHANOL",27,-1.372,0.079,0.27,"No",1.8409,0,0.024,"Yes"
"6881","C7_Immunologic_signatures","C7_ALL_1364_GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN",190,-1.372,0.016,0.036,"No",0.928,0.67,0.96,"Yes"
"6882","GO_BP","506102_GO_0043011_MYELOID_DENDRITIC_CELL_DIFFERENTIATION",20,-1.3719,0.1,0.19,"No",-0.9191,0.58,1,"No"
"6883","GO_BP","513808_GO_0060252_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION",8,-1.3719,0.12,0.19,"No",-1.0797,0.34,0.95,"No"
"6884","GO_BP","517245_GO_0072329_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS",84,-1.3719,0.04,0.19,"No",1.0437,0.36,0.95,"Yes"
"6885","C3_TF_targets","C3_TFT_97_V_OCT1_02",202,-1.3719,0.017,0.05,"No",0.9519,0.57,1,"Yes"
"6886","C2_Chemical_and_genetic_perturbations","C2_CGP_956_GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS",14,-1.3718,0.091,0.12,"No",-0.6724,0.88,1,"No"
"6887","C4_Cancer_gene_neighborhoods","C4_CGN_278_CAR_MLANA",42,-1.3718,0.084,0.14,"No",-1.4143,0.048,0.42,"No"
"6888","KEGG_compound","C05274_DECANOYL_COA",8,-1.3716,0.1,0.27,"No",-0.5723,0.94,1,"No"
"6889","GO_BP","514394_GO_0060839_ENDOTHELIAL_CELL_FATE_COMMITMENT",5,-1.3716,0.098,0.19,"No",0.9256,0.53,1,"Yes"
"6890","GO_BP","503350_GO_0034144_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",9,-1.3715,0.1,0.19,"No",-1.4497,0.081,0.9,"No"
"6891","C2_Chemical_and_genetic_perturbations","C2_CGP_1429_PENG_RAPAMYCIN_RESPONSE_UP",194,-1.3715,0.022,0.12,"No",0.8452,0.9,0.97,"Yes"
"6892","C2_Chemical_and_genetic_perturbations","C2_CGP_1630_ZAMORA_NOS2_TARGETS_UP",68,-1.3715,0.044,0.12,"No",1.39,0.046,0.3,"Yes"
"6893","GO_BP","491640_GO_0006766_VITAMIN_METABOLIC_PROCESS",144,-1.3715,0.03,0.19,"No",-0.9885,0.49,1,"No"
"6894","GO_BP","488540_GO_0002667_REGULATION_OF_T_CELL_ANERGY",7,-1.3715,0.095,0.19,"No",0.6706,0.86,1,"Yes"
"6895","C7_Immunologic_signatures","C7_ALL_24_GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN",200,-1.3714,0.013,0.036,"No",1.2899,0.028,0.11,"Yes"
"6896","C3_TF_targets","C3_TFT_309_V_LHX3_01",212,-1.3714,0.013,0.05,"No",-1.1201,0.2,0.5,"No"
"6897","C3_TF_targets","C3_TFT_308_V_STAT6_02",252,-1.3714,0.0099,0.049,"No",-0.9724,0.55,0.82,"No"
"6898","C2_Chemical_and_genetic_perturbations","C2_CGP_1593_HOEGERKORP_CD44_TARGETS_DIRECT_UP",27,-1.3713,0.093,0.12,"No",-0.6973,0.9,1,"No"
"6899","GO_BP","491565_GO_0006677_GLYCOSYLCERAMIDE_METABOLIC_PROCESS",12,-1.3712,0.12,0.19,"No",-1.0084,0.45,0.98,"No"
"6900","GO_BP","501699_GO_0032467_POSITIVE_REGULATION_OF_CYTOKINESIS",35,-1.3711,0.071,0.19,"No",0.8116,0.77,1,"Yes"
"6901","GO_BP","491960_GO_0040007_GROWTH",381,-1.3711,0.0032,0.19,"No",-1.075,0.25,0.96,"No"
"6902","C3_TF_targets","C3_TFT_115_V_SRY_02",244,-1.371,0.0067,0.05,"No",-0.8671,0.82,0.99,"No"
"6903","C3_TF_targets","C3_TFT_295_V_PAX2_02",251,-1.371,0.0077,0.049,"No",0.8856,0.84,1,"Yes"
"6904","C2_Chemical_and_genetic_perturbations","C2_CGP_793_SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN",30,-1.371,0.091,0.12,"No",-1.1184,0.29,0.89,"No"
"6905","C7_Immunologic_signatures","C7_ALL_657_GSE17721_LPS_VS_CPG_2H_BMDM_UP",198,-1.3708,0.021,0.037,"No",0.8891,0.76,1,"Yes"
"6906","GO_MF","489644_GO_0008235_METALLOEXOPEPTIDASE_ACTIVITY",38,-1.3707,0.057,0.24,"No",0.867,0.68,1,"Yes"
"6907","GO_BP","752180_GO_0061437_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT",20,-1.3707,0.09,0.19,"No",-1.1568,0.26,0.92,"No"
"6908","REACTOME","106421_REACT_999_SHC_RELATED_EVENTS",24,-1.3707,0.086,0.21,"No",-0.5927,0.98,1,"No"
"6909","GO_CC","510837_GO_0048786_PRESYNAPTIC_ACTIVE_ZONE",24,-1.3706,0.1,0.25,"No",0.7168,0.89,0.99,"Yes"
"6910","C1_Positional","C1_ALL_70_CHR10P13",24,-1.3706,0.086,0.56,"No",-0.8438,0.69,0.97,"No"
"6911","GO_BP","504175_GO_0034983_PEPTIDYL_LYSINE_DEACETYLATION",7,-1.3705,0.13,0.19,"No",-1.4161,0.089,0.95,"No"
"6912","GO_BP","513494_GO_0055062_PHOSPHATE_ION_HOMEOSTASIS",11,-1.3704,0.11,0.19,"No",-0.9469,0.53,1,"No"
"6913","GO_BP","511979_GO_0051054_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS",126,-1.3703,0.034,0.19,"No",-0.8412,0.82,1,"No"
"6914","GO_BP","753114_GO_1900119_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS",7,-1.3702,0.1,0.19,"No",-0.4563,1,1,"No"
"6915","C2_Chemical_and_genetic_perturbations","C2_CGP_2408_MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN",17,-1.3702,0.1,0.12,"No",0.7109,0.86,1,"Yes"
"6916","C3_TF_targets","C3_TFT_530_TTCYRGAA_UNKNOWN",324,-1.3702,0.0075,0.05,"No",-1.2019,0.077,0.34,"No"
"6917","GO_BP","510785_GO_0048730_EPIDERMIS_MORPHOGENESIS",34,-1.3702,0.083,0.19,"No",-1.2406,0.16,0.91,"No"
"6918","C2_Chemical_and_genetic_perturbations","C2_CGP_163_BASAKI_YBX1_TARGETS_DN",375,-1.3701,0.0042,0.12,"No",1.1461,0.1,0.56,"Yes"
"6919","C6_Oncogenic_signatures","C6_ALL_133_IL15_UP_V1_DN",172,-1.3701,0.022,0.045,"No",-1.1186,0.21,0.54,"No"
"6920","C4_Cancer_modules","C4_CM_310_MODULE_360",14,-1.3701,0.1,0.12,"No",1.5973,0.027,0.075,"Yes"
"6921","C2_Chemical_and_genetic_perturbations","C2_CGP_501_MCBRYAN_PUBERTAL_BREAST_4_5WK_DN",193,-1.3701,0.019,0.12,"No",0.9951,0.47,0.81,"Yes"
"6922","C7_Immunologic_signatures","C7_ALL_1719_GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP",197,-1.37,0.018,0.037,"No",1.2989,0.029,0.1,"Yes"
"6923","C2_Chemical_and_genetic_perturbations","C2_CGP_138_DOANE_BREAST_CANCER_CLASSES_DN",34,-1.37,0.081,0.12,"No",-0.7443,0.87,1,"No"
"6924","GO_BP","498920_GO_0021637_TRIGEMINAL_NERVE_STRUCTURAL_ORGANIZATION",5,-1.3699,0.11,0.19,"No",-1.1896,0.29,0.9,"No"
"6925","GO_CC","512127_GO_0051233_SPINDLE_MIDZONE",25,-1.3699,0.09,0.25,"No",0.6354,0.96,1,"Yes"
"6926","KEGG_pathway","HSA04720_LONG_TERM_POTENTIATION",66,-1.3697,0.038,0.083,"No",1.1125,0.26,0.79,"Yes"
"6927","C7_Immunologic_signatures","C7_ALL_353_GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP",195,-1.3697,0.016,0.037,"No",-1.1214,0.23,1,"No"
"6928","GO_MF","506523_GO_0043492_ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES",116,-1.3697,0.043,0.24,"No",-0.817,0.87,1,"No"
"6929","GO_BP","491607_GO_0006721_TERPENOID_METABOLIC_PROCESS",99,-1.3697,0.055,0.19,"No",-1.0173,0.43,0.98,"No"
"6930","C2_Chemical_and_genetic_perturbations","C2_CGP_344_WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP",18,-1.3697,0.087,0.12,"No",0.9995,0.47,0.8,"Yes"
"6931","GO_BP","750889_GO_0035962_RESPONSE_TO_INTERLEUKIN_13",6,-1.3697,0.13,0.19,"No",-1.2575,0.21,0.91,"No"
"6932","GO_BP","510379_GO_0048265_RESPONSE_TO_PAIN",30,-1.3696,0.083,0.19,"No",-1.6981,0.0059,0.63,"No"
"6933","GO_BP","911329_GO_0090557_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER",10,-1.3696,0.12,0.19,"No",1.036,0.39,0.96,"Yes"
"6934","C2_Chemical_and_genetic_perturbations","C2_CGP_1765_BROWNE_HCMV_INFECTION_8HR_DN",45,-1.3696,0.068,0.12,"No",1.0136,0.45,0.78,"Yes"
"6935","GO_BP","752787_GO_0097286_IRON_ION_IMPORT",10,-1.3695,0.12,0.19,"No",-0.759,0.77,1,"No"
"6936","C3_TF_targets","C3_TFT_222_V_PAX4_03",247,-1.3695,0.011,0.05,"No",-1.4799,0.0035,0.14,"No"
"6937","GO_BP","514248_GO_0060693_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS",10,-1.3694,0.13,0.19,"No",1.0102,0.42,0.98,"Yes"
"6938","GO_BP","492467_GO_0008105_ASYMMETRIC_PROTEIN_LOCALIZATION",22,-1.3694,0.099,0.19,"No",1.2831,0.15,0.7,"Yes"
"6939","KEGG_reaction","R01177_BUTANOYL_COA_ACETYL_COA_C_BUTANOYLTRANSFERASE_ACETYL_COA_BUTANOYL_COA_COA_3_OXOHEXANOYL_COA",5,-1.3694,0.1,0.33,"No",-0.4839,0.99,0.99,"No"
"6940","GO_BP","504423_GO_0035239_TUBE_MORPHOGENESIS",339,-1.3691,0.0074,0.19,"No",1.0074,0.44,0.98,"Yes"
"6941","C7_Immunologic_signatures","C7_ALL_312_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN",190,-1.3688,0.019,0.037,"No",0.9917,0.49,0.76,"Yes"
"6942","GO_MF","489313_GO_0003796_LYSOZYME_ACTIVITY",8,-1.3688,0.12,0.24,"No",-1.3421,0.15,0.71,"No"
"6943","C4_Cancer_modules","C4_CM_35_MODULE_39",10,-1.3687,0.12,0.12,"No",0.9968,0.46,0.71,"Yes"
"6944","GO_BP","494605_GO_0010536_POSITIVE_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY",7,-1.3687,0.11,0.19,"No",-1.0926,0.35,0.95,"No"
"6945","GO_BP","754257_GO_1901293_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS",218,-1.3686,0.015,0.19,"No",0.8466,0.91,1,"Yes"
"6946","C7_Immunologic_signatures","C7_ALL_1705_GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP",195,-1.3686,0.016,0.037,"No",1.2546,0.036,0.15,"Yes"
"6947","C7_Immunologic_signatures","C7_ALL_306_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN",195,-1.3684,0.022,0.037,"No",0.6653,1,1,"Yes"
"6948","C2_BioCarta_Pathways","C2_CP_BIOCARTA_44_BIOCARTA_HDAC_PATHWAY",28,-1.3682,0.082,0.21,"No",1.0291,0.41,0.84,"Yes"
"6949","GO_MF","492496_GO_0008144_DRUG_BINDING",94,-1.3682,0.047,0.24,"No",0.8567,0.78,1,"Yes"
"6950","C2_Chemical_and_genetic_perturbations","C2_CGP_1862_WU_HBX_TARGETS_1_UP",15,-1.368,0.1,0.13,"No",1.2463,0.18,0.44,"Yes"
"6951","GO_CC","500523_GO_0031264_DEATH_INDUCING_SIGNALING_COMPLEX",8,-1.3679,0.11,0.25,"No",-0.8,0.72,1,"No"
"6952","GO_BP","503351_GO_0034145_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",7,-1.3678,0.13,0.19,"No",1.0603,0.39,0.94,"Yes"
"6953","GO_MF","487542_GO_0001608_G_PROTEIN_COUPLED_NUCLEOTIDE_RECEPTOR_ACTIVITY",26,-1.3678,0.094,0.24,"No",1.526,0.033,0.36,"Yes"
"6954","GO_MF","490482_GO_0005248_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY",19,-1.3678,0.1,0.24,"No",-1.0133,0.43,0.89,"No"
"6955","GO_BP","498165_GO_0019320_HEXOSE_CATABOLIC_PROCESS",23,-1.3678,0.088,0.19,"No",-0.9531,0.53,1,"No"
"6956","GO_BP","502781_GO_0033564_ANTERIOR_POSTERIOR_AXON_GUIDANCE",5,-1.3676,0.092,0.19,"No",-0.6752,0.85,1,"No"
"6957","C7_Immunologic_signatures","C7_ALL_1625_GSE3982_MAST_CELL_VS_TH2_UP",196,-1.3674,0.015,0.038,"No",0.7748,0.97,1,"Yes"
"6958","C2_Chemical_and_genetic_perturbations","C2_CGP_2538_YOSHIMURA_MAPK8_TARGETS_DN",359,-1.3674,0.0021,0.13,"No",1.3028,0.0078,0.39,"Yes"
"6959","KEGG_compound","C05445_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL",6,-1.3674,0.13,0.27,"No",0.6209,0.91,1,"Yes"
"6960","C7_Immunologic_signatures","C7_ALL_1699_GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP",190,-1.3673,0.012,0.038,"No",1.4233,0,0.031,"Yes"
"6961","GO_BP","516618_GO_0071694_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION",5,-1.3673,0.13,0.19,"No",1.2237,0.24,0.76,"Yes"
"6962","GO_BP","514856_GO_0061311_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",21,-1.3673,0.1,0.19,"No",-0.8855,0.59,1,"No"
"6963","C2_Chemical_and_genetic_perturbations","C2_CGP_2051_LEIN_CHOROID_PLEXUS_MARKERS",99,-1.3673,0.035,0.13,"No",0.7429,0.96,1,"Yes"
"6964","GO_BP","493457_GO_0009264_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS",19,-1.3672,0.096,0.19,"No",1.3528,0.12,0.61,"Yes"
"6965","GO_BP","498919_GO_0021636_TRIGEMINAL_NERVE_MORPHOGENESIS",5,-1.3672,0.096,0.19,"No",-1.1676,0.29,0.91,"No"
"6966","C4_Cancer_modules","C4_CM_114_MODULE_119",140,-1.367,0.025,0.12,"No",0.8588,0.84,0.91,"Yes"
"6967","C2_Chemical_and_genetic_perturbations","C2_CGP_203_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP",11,-1.367,0.11,0.13,"No",-0.6574,0.9,1,"No"
"6968","REACTOME","106441_REACT_13776_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING",84,-1.367,0.041,0.22,"No",-0.815,0.85,1,"No"
"6969","GO_BP","1129340_GO_1903513_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT",7,-1.3669,0.12,0.19,"No",0.6003,0.93,1,"Yes"
"6970","GO_BP","512056_GO_0051146_STRIATED_MUSCLE_CELL_DIFFERENTIATION",177,-1.3669,0.028,0.19,"No",-1.1396,0.18,0.93,"No"
"6971","GO_MF","489253_GO_0003707_STEROID_HORMONE_RECEPTOR_ACTIVITY",53,-1.3669,0.074,0.24,"No",-1.0316,0.39,0.88,"No"
"6972","KEGG_reaction","R00127_ATP_AMP_PHOSPHOTRANSFERASE_ATP_AMP_2_ADP",8,-1.3667,0.11,0.33,"No",-1.2657,0.19,0.44,"No"
"6973","GO_BP","499708_GO_0030308_NEGATIVE_REGULATION_OF_CELL_GROWTH",149,-1.3667,0.029,0.19,"No",-1.3439,0.033,0.92,"No"
"6974","GO_BP","752182_GO_0061439_KIDNEY_VASCULATURE_MORPHOGENESIS",7,-1.3666,0.13,0.19,"No",-1.2283,0.23,0.89,"No"
"6975","C2_Chemical_and_genetic_perturbations","C2_CGP_1775_LEE_CALORIE_RESTRICTION_MUSCLE_UP",41,-1.3666,0.072,0.13,"No",1.5316,0.023,0.18,"Yes"
"6976","C7_Immunologic_signatures","C7_ALL_291_GSE14350_IL2RB_KO_VS_WT_TEFF_UP",198,-1.3666,0.019,0.038,"No",-0.7524,0.98,1,"No"
"6977","GO_BP","510633_GO_0048568_EMBRYONIC_ORGAN_DEVELOPMENT",412,-1.3665,0.0031,0.19,"No",-1.1168,0.15,0.94,"No"
"6978","REACTOME","106122_REACT_1473_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION",15,-1.3663,0.096,0.22,"No",1.0374,0.41,0.68,"Yes"
"6979","C2_Chemical_and_genetic_perturbations","C2_CGP_3201_FARDIN_HYPOXIA_9",7,-1.3663,0.096,0.13,"No",0.8297,0.68,0.98,"Yes"
"6980","GO_BP","498260_GO_0019418_SULFIDE_OXIDATION",5,-1.3663,0.11,0.19,"No",-0.6354,0.88,1,"No"
"6981","C2_Chemical_and_genetic_perturbations","C2_CGP_3003_ONGUSAHA_BRCA1_TARGETS_UP",12,-1.3663,0.092,0.13,"No",1.036,0.4,0.74,"Yes"
"6982","GO_BP","505556_GO_0042415_NOREPINEPHRINE_METABOLIC_PROCESS",12,-1.3662,0.11,0.19,"No",-0.4702,0.99,1,"No"
"6983","GO_BP","517004_GO_0072088_NEPHRON_EPITHELIUM_MORPHOGENESIS",64,-1.3662,0.063,0.19,"No",-0.8828,0.68,1,"No"
"6984","C3_MicroRNA_targets","C3_MIR_136_GCAAAAA_MIR_129",183,-1.3661,0.021,0.25,"No",-1.1623,0.13,1,"No"
"6985","REACTOME","106412_REACT_7972_ACTIVATION_OF_C3_AND_C5",6,-1.366,0.12,0.22,"No",-1.5955,0.025,0.34,"No"
"6986","GO_BP","489168_GO_0003376_SPHINGOSINE_1_PHOSPHATE_SIGNALING_PATHWAY",8,-1.366,0.12,0.19,"No",0.9065,0.59,1,"Yes"
"6987","REACTOME","106519_REACT_15418_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE",18,-1.366,0.1,0.22,"No",-1.2616,0.17,0.72,"No"
"6988","GO_BP","513871_GO_0060315_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",12,-1.3659,0.11,0.19,"No",1.2531,0.19,0.73,"Yes"
"6989","GO_BP","514242_GO_0060687_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS",7,-1.3659,0.11,0.19,"No",-1.1933,0.25,0.9,"No"
"6990","C2_Chemical_and_genetic_perturbations","C2_CGP_3378_WARTERS_IR_RESPONSE_5GY",46,-1.3659,0.068,0.13,"No",0.9827,0.48,0.81,"Yes"
"6991","GO_BP","1133968_GO_1903793_POSITIVE_REGULATION_OF_ANION_TRANSPORT",49,-1.3658,0.065,0.19,"No",-0.759,0.86,1,"No"
"6992","C3_MicroRNA_targets","C3_MIR_186_ACCAATC_MIR_509",48,-1.3658,0.064,0.24,"No",1.457,0.03,0.57,"Yes"
"6993","GO_MF","490483_GO_0005249_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY",86,-1.3658,0.051,0.24,"No",-1.1988,0.14,0.81,"No"
"6994","C7_Immunologic_signatures","C7_ALL_1430_GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN",195,-1.3655,0.01,0.039,"No",-0.9065,0.69,1,"No"
"6995","C7_Immunologic_signatures","C7_ALL_105_GSE11924_TH2_VS_TH17_CD4_TCELL_UP",197,-1.3655,0.017,0.039,"No",-0.988,0.47,1,"No"
"6996","GO_BP","492317_GO_0007567_PARTURITION",18,-1.3653,0.1,0.19,"No",1.4542,0.062,0.49,"Yes"
"6997","C3_MicroRNA_targets","C3_MIR_95_TTGCCAA_MIR_182",323,-1.3653,0.0075,0.24,"No",-0.7052,1,1,"No"
"6998","C3_TF_targets","C3_TFT_333_V_FXR_Q3",111,-1.3651,0.042,0.052,"No",-0.7581,0.95,1,"No"
"6999","C3_TF_targets","C3_TFT_487_V_HNF4_Q6",257,-1.3651,0.016,0.052,"No",-1.0723,0.26,0.61,"No"
"7000","GO_BP","487440_GO_0001501_SKELETAL_SYSTEM_DEVELOPMENT",452,-1.3651,0.001,0.19,"No",-1.1675,0.082,0.91,"No"
"7001","GO_BP","506489_GO_0043455_REGULATION_OF_SECONDARY_METABOLIC_PROCESS",6,-1.3651,0.13,0.19,"No",1.1754,0.29,0.81,"Yes"
"7002","C4_Cancer_modules","C4_CM_368_MODULE_451",33,-1.3651,0.088,0.12,"No",0.7208,0.9,1,"Yes"
"7003","C4_Cancer_modules","C4_CM_17_MODULE_18",444,-1.3649,0.0021,0.12,"No",1.1832,0.045,0.42,"Yes"
"7004","GO_BP","514134_GO_0060579_VENTRAL_SPINAL_CORD_INTERNEURON_FATE_COMMITMENT",13,-1.3649,0.11,0.19,"No",-1.5226,0.044,0.79,"No"
"7005","GO_BP","510730_GO_0048675_AXON_EXTENSION",28,-1.3648,0.097,0.19,"No",-0.7168,0.89,1,"No"
"7006","C0_Hallmark","H_ALL_18_HALLMARK_INTERFERON_ALPHA_RESPONSE",97,-1.3648,0.03,0.04,"No",1.6761,0,0.0052,"Yes"
"7007","GO_BP","488310_GO_0002437_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",22,-1.3647,0.085,0.19,"No",-0.9777,0.48,1,"No"
"7008","C3_TF_targets","C3_TFT_585_YTAATTAA_V_LHX3_01",178,-1.3646,0.014,0.052,"No",-1.0326,0.37,0.69,"No"
"7009","C2_BioCarta_Pathways","C2_CP_BIOCARTA_146_BIOCARTA_RAB_PATHWAY",12,-1.3646,0.11,0.21,"No",0.994,0.46,0.84,"Yes"
"7010","C3_MicroRNA_targets","C3_MIR_200_ACCGAGC_MIR_423",8,-1.3645,0.12,0.23,"No",-1.16,0.27,1,"No"
"7011","C2_Chemical_and_genetic_perturbations","C2_CGP_668_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17",19,-1.3644,0.11,0.13,"No",-1.1282,0.29,0.89,"No"
"7012","REACTOME","161072_REACT_22345_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT",14,-1.3643,0.11,0.22,"No",-0.875,0.64,1,"No"
"7013","C2_Chemical_and_genetic_perturbations","C2_CGP_1991_MARCHINI_TRABECTEDIN_RESISTANCE_DN",49,-1.3642,0.066,0.13,"No",0.9857,0.47,0.81,"Yes"
"7014","REACTOME","105766_REACT_1590_G1_PHASE",38,-1.3641,0.075,0.22,"No",0.9829,0.49,0.78,"Yes"
"7015","GO_BP","510411_GO_0048304_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES",6,-1.3641,0.13,0.19,"No",-1.333,0.15,0.91,"No"
"7016","GO_MF","511633_GO_0050661_NADP_BINDING",46,-1.364,0.064,0.25,"No",-1.0516,0.39,0.86,"No"
"7017","GO_BP","500185_GO_0030890_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION",39,-1.364,0.079,0.19,"No",-0.7087,0.92,1,"No"
"7018","GO_MF","490613_GO_0005504_FATTY_ACID_BINDING",23,-1.364,0.1,0.24,"No",1.6842,0.015,0.17,"Yes"
"7019","C7_Immunologic_signatures","C7_ALL_998_GSE22886_TH1_VS_TH2_12H_ACT_DN",187,-1.3639,0.026,0.039,"No",-0.8499,0.84,1,"No"
"7020","C4_Cancer_modules","C4_CM_169_MODULE_179",456,-1.3639,0.0041,0.12,"No",0.9886,0.53,0.72,"Yes"
"7021","REACTOME","106500_REACT_15333_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY",14,-1.3638,0.1,0.22,"No",-1.0988,0.35,0.91,"No"
"7022","KEGG_module","HSA_M00355_SPLICEOSOME_35S_U5_SNRNP",37,-1.3638,0.08,0.41,"No",1.4212,0.045,0.26,"Yes"
"7023","GO_BP","516697_GO_0071774_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR",184,-1.3636,0.023,0.19,"No",-0.947,0.6,1,"No"
"7024","C2_Chemical_and_genetic_perturbations","C2_CGP_1154_SHEN_SMARCA2_TARGETS_DN",332,-1.3635,0.0075,0.13,"No",-1.2334,0.046,0.76,"No"
"7025","GO_BP","516377_GO_0071453_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS",120,-1.3635,0.043,0.19,"No",-0.7037,0.99,1,"No"
"7026","C7_Immunologic_signatures","C7_ALL_897_GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP",197,-1.3635,0.014,0.04,"No",1.0271,0.39,0.66,"Yes"
"7027","C2_Chemical_and_genetic_perturbations","C2_CGP_1165_SHIN_B_CELL_LYMPHOMA_CLUSTER_2",29,-1.3634,0.078,0.13,"No",0.6215,0.98,1,"Yes"
"7028","C6_Oncogenic_signatures","C6_ALL_34_VEGF_A_UP_V1_UP",190,-1.3633,0.017,0.048,"No",-1.069,0.28,0.61,"No"
"7029","GO_BP","500651_GO_0031400_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS",439,-1.3633,0.0031,0.19,"No",1.1463,0.081,0.84,"Yes"
"7030","KEGG_pathway","HSA05206_MICRORNAS_IN_CANCER",166,-1.3632,0.02,0.087,"No",-0.9326,0.64,0.96,"No"
"7031","GO_BP","753023_GO_1900026_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",26,-1.3631,0.099,0.2,"No",1.3684,0.072,0.59,"Yes"
"7032","C7_Immunologic_signatures","C7_ALL_1210_GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN",198,-1.3631,0.018,0.04,"No",0.7795,0.99,1,"Yes"
"7033","C2_BioCarta_Pathways","C2_CP_BIOCARTA_117_BIOCARTA_ETS_PATHWAY",18,-1.363,0.094,0.21,"No",-0.8945,0.61,1,"No"
"7034","C3_MicroRNA_targets","C3_MIR_85_CAGGGTC_MIR_504",82,-1.363,0.049,0.23,"No",0.6424,1,1,"Yes"
"7035","C7_Immunologic_signatures","C7_ALL_10_KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN",199,-1.3629,0.017,0.04,"No",0.993,0.46,0.76,"Yes"
"7036","WikiPathways","198810_WP560_TGF_BETA_SIGNALING_PATHWAY",54,-1.3628,0.066,0.15,"No",-0.8299,0.79,1,"No"
"7037","C6_Oncogenic_signatures","C6_ALL_11_GCNP_SHH_UP_LATE_V1_DN",159,-1.3628,0.026,0.048,"No",0.7629,0.99,0.99,"Yes"
"7038","GO_BP","498895_GO_0021612_FACIAL_NERVE_STRUCTURAL_ORGANIZATION",10,-1.3627,0.13,0.2,"No",-0.8613,0.63,1,"No"
"7039","C3_MicroRNA_targets","C3_MIR_196_GTCAGGA_MIR_378",59,-1.3627,0.071,0.22,"No",0.9033,0.64,1,"Yes"
"7040","KEGG_compound","C05259_3_OXOPALMITOYL_COA_3_KETOPALMITOYL_COA_3_OXOHEXADECANOYL_COA",6,-1.3627,0.12,0.28,"No",0.8206,0.67,1,"Yes"
"7041","GO_BP","488953_GO_0003159_MORPHOGENESIS_OF_AN_ENDOTHELIUM",8,-1.3627,0.14,0.2,"No",-1.0754,0.37,0.96,"No"
"7042","C2_BioCarta_Pathways","C2_CP_BIOCARTA_206_BIOCARTA_TOLL_PATHWAY",37,-1.3626,0.068,0.21,"No",-0.5619,1,1,"No"
"7043","C4_Cancer_modules","C4_CM_277_MODULE_317",431,-1.3626,0.0032,0.12,"No",0.9347,0.72,0.81,"Yes"
"7044","C6_Oncogenic_signatures","C6_ALL_125_RB_P130_DN_V1_DN",121,-1.3626,0.036,0.047,"No",1.26,0.061,0.41,"Yes"
"7045","GO_BP","487737_GO_0001841_NEURAL_TUBE_FORMATION",99,-1.3624,0.038,0.2,"No",-0.6847,0.98,1,"No"
"7046","GO_BP","518659_GO_2000010_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",8,-1.3624,0.13,0.2,"No",-1.0846,0.36,0.96,"No"
"7047","GO_BP","510850_GO_0048799_ORGAN_MATURATION",18,-1.3623,0.11,0.2,"No",0.8424,0.69,1,"Yes"
"7048","GO_BP","754562_GO_1901606_ALPHA_AMINO_ACID_CATABOLIC_PROCESS",91,-1.3623,0.046,0.2,"No",-0.895,0.7,1,"No"
"7049","GO_CC","504925_GO_0035748_MYELIN_SHEATH_ABAXONAL_REGION",7,-1.3622,0.13,0.26,"No",-1.4352,0.12,0.64,"No"
"7050","GO_BP","507282_GO_0044275_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS",32,-1.3622,0.082,0.2,"No",-0.7849,0.79,1,"No"
"7051","C7_Immunologic_signatures","C7_ALL_1455_GSE360_L_MAJOR_VS_T_GONDII_DC_UP",193,-1.3621,0.021,0.04,"No",-1.2129,0.11,0.79,"No"
"7052","C7_Immunologic_signatures","C7_ALL_447_GSE17721_CTRL_VS_LPS_0_5H_BMDM_UP",198,-1.3621,0.018,0.04,"No",1.1506,0.13,0.32,"Yes"
"7053","GO_BP","755348_GO_2001242_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",142,-1.362,0.029,0.2,"No",0.8061,0.91,1,"Yes"
"7054","KEGG_reaction","R01547_ATP_DAMP_PHOSPHOTRANSFERASE_ATP_DAMP_ADP_DADP",8,-1.362,0.12,0.33,"No",-1.2736,0.2,0.44,"No"
"7055","C2_Chemical_and_genetic_perturbations","C2_CGP_1981_WESTON_VEGFA_TARGETS_3HR",70,-1.3619,0.062,0.13,"No",1.1969,0.15,0.49,"Yes"
"7056","C3_TF_targets","C3_TFT_548_YNGTTNNNATT_UNKNOWN",356,-1.3618,0.0053,0.053,"No",0.9474,0.66,1,"Yes"
"7057","C2_Chemical_and_genetic_perturbations","C2_CGP_1103_PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP",283,-1.3617,0.012,0.13,"No",0.8209,0.97,0.98,"Yes"
"7058","GO_MF","499376_GO_0022829_WIDE_PORE_CHANNEL_ACTIVITY",21,-1.3617,0.1,0.25,"No",0.9445,0.53,0.94,"Yes"
"7059","C7_Immunologic_signatures","C7_ALL_470_GSE17721_CTRL_VS_POLYIC_4H_BMDM_DN",198,-1.3617,0.016,0.04,"No",-0.85,0.87,1,"No"
"7060","GO_CC","500512_GO_0031253_CELL_PROJECTION_MEMBRANE",265,-1.3617,0.018,0.26,"No",-1.0304,0.38,0.84,"No"
"7061","C3_TF_targets","C3_TFT_465_V_SP1_Q2_01",241,-1.3616,0.0098,0.053,"No",-1.5085,0,0.14,"No"
"7062","C4_Cancer_gene_neighborhoods","C4_CGN_204_GCM_SIRT2",43,-1.3614,0.07,0.15,"No",-0.7933,0.82,1,"No"
"7063","C2_Chemical_and_genetic_perturbations","C2_CGP_1420_PEART_HDAC_PROLIFERATION_CLUSTER_DN",76,-1.3613,0.045,0.13,"No",1.2367,0.13,0.45,"Yes"
"7064","REACTOME","119524_REACT_19236_SEMA3A_PAK_DEPENDENT_AXON_REPULSION",16,-1.3612,0.1,0.22,"No",-0.7193,0.85,1,"No"
"7065","GO_BP","507766_GO_0045409_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS",5,-1.3612,0.1,0.2,"No",-1.5527,0.026,0.73,"No"
"7066","GO_BP","519056_GO_2000416_REGULATION_OF_EOSINOPHIL_MIGRATION",5,-1.3611,0.11,0.2,"No",-1.082,0.39,0.95,"No"
"7067","GO_BP","516616_GO_0071692_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION",5,-1.3611,0.12,0.2,"No",1.2023,0.26,0.78,"Yes"
"7068","KEGG_compound","C02946_4_ACETAMIDOBUTANOATE_N4_ACETYLAMINOBUTANOATE",5,-1.3611,0.15,0.28,"No",0.7038,0.83,1,"Yes"
"7069","GO_BP","751742_GO_0044597_DAUNORUBICIN_METABOLIC_PROCESS",8,-1.3611,0.1,0.2,"No",-0.7509,0.78,1,"No"
"7070","GO_BP","506582_GO_0043551_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",36,-1.3611,0.078,0.2,"No",-0.7972,0.79,1,"No"
"7071","GO_BP","500150_GO_0030852_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION",17,-1.3609,0.11,0.2,"No",1.073,0.34,0.93,"Yes"
"7072","GO_MF","489290_GO_0051087_CHAPERONE_BINDING",71,-1.3608,0.066,0.25,"No",0.726,0.93,1,"Yes"
"7073","GO_BP","487570_GO_0001657_URETERIC_BUD_DEVELOPMENT",86,-1.3608,0.061,0.2,"No",-0.8736,0.72,1,"No"
"7074","GO_MF","516759_GO_0071837_HMG_BOX_DOMAIN_BINDING",17,-1.3608,0.091,0.25,"No",-0.7404,0.85,1,"No"
"7075","KEGG_reaction","R00710_ACETALDEHYDE_NAD_OXIDOREDUCTASE_ACETALDEHYDE_NAD_H2O_ACETATE_NADH_H_",5,-1.3608,0.12,0.33,"No",0.6934,0.86,1,"Yes"
"7076","C2_Chemical_and_genetic_perturbations","C2_CGP_2113_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD",13,-1.3607,0.11,0.13,"No",0.7486,0.81,1,"Yes"
"7077","C2_Chemical_and_genetic_perturbations","C2_CGP_2796_YANAGISAWA_LUNG_CANCER_RECURRENCE",8,-1.3606,0.096,0.13,"No",1.4278,0.097,0.28,"Yes"
"7078","GO_BP","492658_GO_0008347_GLIAL_CELL_MIGRATION",31,-1.3606,0.077,0.2,"No",0.6237,0.98,1,"Yes"
"7079","KEGG_module","HSA_M00388_ECS_COMPLEX",12,-1.3606,0.12,0.39,"No",0.7809,0.74,0.92,"Yes"
"7080","GO_BP","494742_GO_0010677_NEGATIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",42,-1.3605,0.084,0.2,"No",0.5199,1,1,"Yes"
"7081","REACTOME","106096_REACT_1505_INTEGRATION_OF_ENERGY_METABOLISM",103,-1.3604,0.04,0.22,"No",-0.9795,0.52,1,"No"
"7082","KEGG_compound","C00187_CHOLESTEROL_CHOLEST_5_EN_3BETA_OL",13,-1.3604,0.11,0.28,"No",-1.0618,0.36,1,"No"
"7083","C2_Chemical_and_genetic_perturbations","C2_CGP_1755_CHIBA_RESPONSE_TO_TSA",49,-1.3604,0.075,0.13,"No",-0.7604,0.87,1,"No"
"7084","GO_CC","501819_GO_0032593_INSULIN_RESPONSIVE_COMPARTMENT",8,-1.3604,0.13,0.26,"No",-1.081,0.35,0.81,"No"
"7085","KEGG_enzyme","2.3.1.199_VERY_LONG_CHAIN_3_OXOACYL_COA_SYNTHASE_VERY_LONG_CHAIN_3_KETOACYL_COA_SYNTHASE_VERY_LONG_CHAIN_BETA_KETOACYL_COA_SYNTHASE_CONDENSING_ENZYME_CUT1_GENE_NAME_CER6_GENE_NAME_FAE1_GENE_NAME_KCS_GENE_NAME_ELO_GENE_NAME_",7,-1.3603,0.12,0.51,"No",-1.1426,0.31,0.64,"No"
"7086","GO_BP","500873_GO_0031623_RECEPTOR_INTERNALIZATION",44,-1.3601,0.078,0.2,"No",0.9985,0.44,0.98,"Yes"
"7087","GO_BP","492030_GO_0007249_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",58,-1.36,0.063,0.2,"No",0.6308,1,1,"Yes"
"7088","C7_Immunologic_signatures","C7_ALL_522_GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN",197,-1.36,0.017,0.041,"No",-0.6751,1,1,"No"
"7089","GO_BP","518756_GO_2000107_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS",45,-1.3599,0.06,0.2,"No",1.015,0.45,0.97,"Yes"
"7090","WikiPathways","198892_WP247_SMALL_LIGAND_GPCRS",19,-1.3599,0.11,0.15,"No",0.7914,0.77,1,"Yes"
"7091","C7_Immunologic_signatures","C7_ALL_646_GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_DN",199,-1.3598,0.017,0.041,"No",1.052,0.31,0.58,"Yes"
"7092","GO_CC","516362_GO_0071438_INVADOPODIUM_MEMBRANE",6,-1.3597,0.11,0.26,"No",-0.8664,0.64,0.95,"No"
"7093","GO_BP","507471_GO_0045071_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION",45,-1.3597,0.074,0.2,"No",1.6093,0.0084,0.28,"Yes"
"7094","C2_Chemical_and_genetic_perturbations","C2_CGP_2663_CROONQUIST_NRAS_SIGNALING_DN",72,-1.3597,0.058,0.13,"No",-0.8709,0.72,1,"No"
"7095","GO_BP","514115_GO_0060560_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS",106,-1.3597,0.056,0.2,"No",-1.1986,0.13,0.9,"No"
"7096","GO_CC","503907_GO_0034707_CHLORIDE_CHANNEL_COMPLEX",47,-1.3595,0.082,0.26,"No",-1.1641,0.23,0.68,"No"
"7097","GO_BP","513928_GO_0060372_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION",6,-1.3594,0.12,0.2,"No",-0.9114,0.58,1,"No"
"7098","C3_TF_targets","C3_TFT_315_CTGYNNCTYTAA_UNKNOWN",85,-1.3594,0.058,0.054,"No",-0.9881,0.45,0.79,"No"
"7099","GO_MF","490236_GO_0004945_ANGIOTENSIN_TYPE_II_RECEPTOR_ACTIVITY",5,-1.3594,0.12,0.25,"No",0.807,0.7,1,"Yes"
"7100","GO_MF","500940_GO_0031694_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING",5,-1.3593,0.13,0.25,"No",-0.7907,0.74,1,"No"
"7101","GO_MF","489293_GO_0003774_MOTOR_ACTIVITY",128,-1.3593,0.033,0.25,"No",-1.1393,0.19,0.81,"No"
"7102","GO_BP","501466_GO_0032231_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",63,-1.3593,0.062,0.2,"No",-1.2347,0.13,0.9,"No"
"7103","GO_BP","1129308_GO_0098751_BONE_CELL_DEVELOPMENT",21,-1.3592,0.11,0.2,"No",0.9686,0.49,1,"Yes"
"7104","GO_BP","512780_GO_0051930_REGULATION_OF_SENSORY_PERCEPTION_OF_PAIN",25,-1.3592,0.097,0.2,"No",1.4989,0.035,0.41,"Yes"
"7105","C2_BioCarta_Pathways","C2_CP_BIOCARTA_126_BIOCARTA_NFKB_PATHWAY",23,-1.3592,0.095,0.21,"No",-0.8628,0.67,1,"No"
"7106","GO_BP","754494_GO_1901534_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",11,-1.3591,0.12,0.2,"No",-1.0112,0.44,0.98,"No"
"7107","REACTOME","645268_REACT_121256_PHAGOSOMAL_MATURATION_EARLY_ENDOSOMAL_STAGE_",33,-1.3591,0.084,0.22,"No",0.8453,0.76,0.96,"Yes"
"7108","GO_BP","488977_GO_0003183_MITRAL_VALVE_MORPHOGENESIS",6,-1.3591,0.13,0.2,"No",-0.858,0.64,1,"No"
"7109","C2_Chemical_and_genetic_perturbations","C2_CGP_1605_TAKAO_RESPONSE_TO_UVB_RADIATION_UP",86,-1.359,0.056,0.13,"No",1.9284,0,0.014,"Yes"
"7110","GO_BP","491552_GO_0006664_GLYCOLIPID_METABOLIC_PROCESS",97,-1.359,0.047,0.2,"No",0.6227,1,1,"Yes"
"7111","C7_Immunologic_signatures","C7_ALL_574_GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_DN",199,-1.3589,0.014,0.042,"No",0.9562,0.57,0.88,"Yes"
"7112","GO_BP","498805_GO_0021521_VENTRAL_SPINAL_CORD_INTERNEURON_SPECIFICATION",9,-1.3588,0.099,0.2,"No",-0.9477,0.52,1,"No"
"7113","GO_CC","504555_GO_0035371_MICROTUBULE_PLUS_END",15,-1.3587,0.1,0.26,"No",0.6078,0.96,0.99,"Yes"
"7114","GO_BP","496941_GO_0017144_DRUG_METABOLIC_PROCESS",48,-1.3587,0.064,0.2,"No",-1.2707,0.12,0.89,"No"
"7115","GO_BP","487569_GO_0001656_METANEPHROS_DEVELOPMENT",83,-1.3586,0.053,0.2,"No",-1.0159,0.41,0.98,"No"
"7116","GO_MF","489607_GO_0004143_DIACYLGLYCEROL_KINASE_ACTIVITY",15,-1.3585,0.11,0.25,"No",-1.6472,0.018,0.42,"No"
"7117","GO_BP","490972_GO_0005984_DISACCHARIDE_METABOLIC_PROCESS",6,-1.3585,0.15,0.2,"No",-0.9688,0.48,1,"No"
"7118","GO_MF","496685_GO_0016775_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR",16,-1.3585,0.11,0.25,"No",-0.8554,0.66,1,"No"
"7119","GO_BP","494902_GO_0010838_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION",6,-1.3584,0.12,0.2,"No",-1.2614,0.21,0.91,"No"
"7120","C4_Cancer_modules","C4_CM_231_MODULE_255",441,-1.3583,0.0042,0.12,"No",0.9985,0.47,0.71,"Yes"
"7121","C2_Chemical_and_genetic_perturbations","C2_CGP_2022_MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP",10,-1.3582,0.13,0.13,"No",0.5717,0.96,1,"Yes"
"7122","GO_BP","502008_GO_0032782_BILE_ACID_SECRETION",6,-1.358,0.12,0.2,"No",-0.8077,0.72,1,"No"
"7123","C3_MicroRNA_targets","C3_MIR_209_AAGGGAT_MIR_188",75,-1.358,0.066,0.23,"No",0.5584,1,1,"Yes"
"7124","GO_BP","515156_GO_0070221_SULFIDE_OXIDATION_USING_SULFIDE_QUINONE_OXIDOREDUCTASE",5,-1.358,0.12,0.2,"No",-0.6451,0.88,1,"No"
"7125","C2_Chemical_and_genetic_perturbations","C2_CGP_2253_NADELLA_PRKAR1A_TARGETS_DN",8,-1.3577,0.12,0.13,"No",1.0857,0.37,0.65,"Yes"
"7126","C2_Chemical_and_genetic_perturbations","C2_CGP_2925_MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED",212,-1.3577,0.018,0.13,"No",-1.0579,0.3,0.97,"No"
"7127","C1_Positional","C1_ALL_315_CHR4Q13",50,-1.3577,0.07,0.59,"No",1.7351,0.0021,0.13,"Yes"
"7128","GO_BP","516619_GO_0071695_ANATOMICAL_STRUCTURE_MATURATION",51,-1.3577,0.076,0.2,"No",-0.8061,0.81,1,"No"
"7129","C2_Chemical_and_genetic_perturbations","C2_CGP_1798_WU_HBX_TARGETS_3_DN",13,-1.3576,0.11,0.13,"No",-1.2071,0.23,0.8,"No"
"7130","C2_BioCarta_Pathways","C2_CP_BIOCARTA_202_BIOCARTA_PAR1_PATHWAY",36,-1.3576,0.085,0.21,"No",-0.7771,0.84,1,"No"
"7131","C3_TF_targets","C3_TFT_106_AGCYRWTTC_UNKNOWN",117,-1.3576,0.044,0.055,"No",-1.0705,0.31,0.61,"No"
"7132","KEGG_reaction","R09381_ACYL_ACP_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_O_ACYLTRANSFERASE_ACYL_ACYL_CARRIER_PROTEIN_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYL_CARRIER_PROTEIN_PHOSPHATIDATE",8,-1.3574,0.14,0.33,"No",-1.1267,0.32,0.65,"No"
"7133","GO_BP","508409_GO_0046113_NUCLEOBASE_CATABOLIC_PROCESS",9,-1.3574,0.13,0.2,"No",1.0486,0.4,0.95,"Yes"
"7134","GO_BP","509121_GO_0046916_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS",96,-1.3573,0.035,0.2,"No",1.1363,0.18,0.85,"Yes"
"7135","GO_BP","504273_GO_0035088_ESTABLISHMENT_OR_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY",32,-1.3572,0.077,0.2,"No",0.9553,0.54,1,"Yes"
"7136","GO_CC","507301_GO_0044295_AXONAL_GROWTH_CONE",13,-1.3572,0.095,0.26,"No",-1.0965,0.33,0.79,"No"
"7137","GO_BP","498665_GO_0019882_ANTIGEN_PROCESSING_AND_PRESENTATION",221,-1.3571,0.018,0.2,"No",1.5001,0,0.41,"Yes"
"7138","GO_BP","491877_GO_0007052_MITOTIC_SPINDLE_ORGANIZATION",51,-1.3571,0.055,0.2,"No",-0.9628,0.52,1,"No"
"7139","GO_BP","502343_GO_0033122_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_CATABOLIC_PROCESS",30,-1.357,0.074,0.2,"No",-0.7938,0.77,1,"No"
"7140","C3_TF_targets","C3_TFT_258_V_VDR_Q3",216,-1.357,0.014,0.055,"No",-1.3186,0.021,0.21,"No"
"7141","GO_BP","506372_GO_0043312_NEUTROPHIL_DEGRANULATION",8,-1.3569,0.14,0.2,"No",1.3097,0.18,0.66,"Yes"
"7142","GO_MF","510472_GO_0048365_RAC_GTPASE_BINDING",33,-1.3569,0.082,0.25,"No",-1.4194,0.071,0.67,"No"
"7143","GO_BP","505907_GO_0051260_PROTEIN_HOMOOLIGOMERIZATION",233,-1.3566,0.017,0.2,"No",-1.0301,0.36,0.98,"No"
"7144","GO_BP","501766_GO_0032536_REGULATION_OF_CELL_PROJECTION_SIZE",8,-1.3566,0.13,0.2,"No",-0.7824,0.76,1,"No"
"7145","GO_BP","499725_GO_0030324_LUNG_DEVELOPMENT",177,-1.3565,0.017,0.2,"No",0.8937,0.73,1,"Yes"
"7146","GO_MF","492784_GO_0008503_BENZODIAZEPINE_RECEPTOR_ACTIVITY",5,-1.3564,0.12,0.25,"No",-0.9424,0.56,0.96,"No"
"7147","C7_Immunologic_signatures","C7_ALL_77_GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP",193,-1.3563,0.017,0.043,"No",1.2896,0.046,0.11,"Yes"
"7148","GO_BP","508003_GO_0045655_REGULATION_OF_MONOCYTE_DIFFERENTIATION",13,-1.3563,0.13,0.2,"No",-1.0885,0.36,0.95,"No"
"7149","C2_Chemical_and_genetic_perturbations","C2_CGP_2881_ZHAN_MULTIPLE_MYELOMA_CD2_DN",46,-1.3561,0.067,0.13,"No",0.8073,0.8,0.99,"Yes"
"7150","GO_BP","487462_GO_0001523_RETINOID_METABOLIC_PROCESS",81,-1.356,0.064,0.2,"No",-1.0451,0.34,0.97,"No"
"7151","C2_Chemical_and_genetic_perturbations","C2_CGP_2286_GALI_TP53_TARGETS_APOPTOTIC_UP",8,-1.3559,0.13,0.13,"No",-0.9514,0.5,1,"No"
"7152","C6_Oncogenic_signatures","C6_ALL_80_JNK_DN_V1_UP",181,-1.3559,0.027,0.051,"No",-1.284,0.054,0.35,"No"
"7153","GO_BP","514548_GO_0060993_KIDNEY_MORPHOGENESIS",81,-1.3559,0.057,0.2,"No",0.7878,0.91,1,"Yes"
"7154","KEGG_compound","C05985_2_PROPYNAL_2_PROPYN_1_AL_PROPIOLALDEHYDE",5,-1.3558,0.12,0.28,"No",0.7004,0.81,1,"Yes"
"7155","KEGG_module","HSA_M00415_FATTY_ACID_BIOSYNTHESIS_ELONGATION_ENDOPLASMIC_RETICULUM",13,-1.3556,0.12,0.39,"No",-0.6109,0.95,1,"No"
"7156","GO_BP","512269_GO_0051385_RESPONSE_TO_MINERALOCORTICOID",30,-1.3555,0.085,0.2,"No",-0.8693,0.66,1,"No"
"7157","C7_Immunologic_signatures","C7_ALL_393_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP",196,-1.3555,0.017,0.044,"No",-1.0095,0.44,1,"No"
"7158","GO_BP","849988_GO_1902287_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_AXON_GUIDANCE",5,-1.3555,0.12,0.2,"No",-1.1927,0.27,0.9,"No"
"7159","C7_Immunologic_signatures","C7_ALL_279_GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP",197,-1.3554,0.022,0.044,"No",0.8944,0.74,1,"Yes"
"7160","C7_Immunologic_signatures","C7_ALL_516_GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_DN",198,-1.3553,0.02,0.044,"No",-0.8167,0.93,1,"No"
"7161","GO_MF","496114_GO_0016004_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY",10,-1.3551,0.14,0.25,"No",1.2176,0.22,0.7,"Yes"
"7162","GO_BP","506920_GO_0043900_REGULATION_OF_MULTI_ORGANISM_PROCESS",345,-1.355,0.0022,0.2,"No",1.322,0.0025,0.64,"Yes"
"7163","GO_BP","499336_GO_0022600_DIGESTIVE_SYSTEM_PROCESS",55,-1.355,0.063,0.2,"No",-0.9259,0.57,1,"No"
"7164","GO_BP","488798_GO_0002925_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",5,-1.3549,0.12,0.2,"No",-1.3516,0.15,0.94,"No"
"7165","GO_BP","911272_GO_0036445_NEURONAL_STEM_CELL_DIVISION",12,-1.3548,0.12,0.2,"No",-0.5359,0.98,1,"No"
"7166","GO_BP","499477_GO_0030011_MAINTENANCE_OF_CELL_POLARITY",12,-1.3548,0.12,0.2,"No",-1.0335,0.43,0.98,"No"
"7167","WikiPathways","198778_WP1601_FLUOROPYRIMIDINE_ACTIVITY",33,-1.3548,0.086,0.15,"No",-0.9433,0.56,1,"No"
"7168","REACTOME","685535_REACT_147727_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER",54,-1.3547,0.053,0.23,"No",-1.0148,0.43,0.99,"No"
"7169","GO_BP","514553_GO_0060998_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT",37,-1.3546,0.085,0.2,"No",-1.2579,0.15,0.91,"No"
"7170","GO_BP","799419_GO_0061515_MYELOID_CELL_DEVELOPMENT",47,-1.3546,0.072,0.2,"No",1.2483,0.15,0.73,"Yes"
"7171","C2_Chemical_and_genetic_perturbations","C2_CGP_1356_MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN",24,-1.3546,0.088,0.13,"No",1.5529,0.037,0.17,"Yes"
"7172","C2_Chemical_and_genetic_perturbations","C2_CGP_1872_BROWNE_HCMV_INFECTION_10HR_UP",100,-1.3545,0.039,0.13,"No",-1.5689,0.0037,0.42,"No"
"7173","GO_BP","514391_GO_0060836_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION",6,-1.3544,0.13,0.2,"No",0.7294,0.79,1,"Yes"
"7174","C4_Cancer_modules","C4_CM_337_MODULE_402",11,-1.3544,0.13,0.12,"No",1.0772,0.37,0.58,"Yes"
"7175","KEGG_module","HSA_M00692_CELL_CYCLE",13,-1.3542,0.11,0.37,"No",-0.9617,0.5,1,"No"
"7176","KEGG_compound","C01944_OCTANOYL_COA",8,-1.3541,0.12,0.29,"No",-0.5675,0.95,1,"No"
"7177","GO_BP","751913_GO_0052697_XENOBIOTIC_GLUCURONIDATION",9,-1.3541,0.11,0.2,"No",1.1549,0.28,0.83,"Yes"
"7178","GO_BP","515240_GO_0070307_LENS_FIBER_CELL_DEVELOPMENT",14,-1.3541,0.13,0.2,"No",0.7608,0.79,1,"Yes"
"7179","GO_BP","752183_GO_0061440_KIDNEY_VASCULATURE_DEVELOPMENT",19,-1.3541,0.11,0.2,"No",-1.0562,0.4,0.97,"No"
"7180","C4_Cancer_gene_neighborhoods","C4_CGN_277_CAR_IGFBP1",53,-1.3539,0.058,0.16,"No",1.1913,0.15,0.23,"Yes"
"7181","GO_BP","505837_GO_0042730_FIBRINOLYSIS",18,-1.3538,0.11,0.2,"No",0.9399,0.55,1,"Yes"
"7182","GO_BP","501697_GO_0032465_REGULATION_OF_CYTOKINESIS",58,-1.3537,0.069,0.2,"No",0.6316,1,1,"Yes"
"7183","C2_Chemical_and_genetic_perturbations","C2_CGP_985_GROSS_HYPOXIA_VIA_ELK3_ONLY_DN",43,-1.3537,0.081,0.14,"No",-1.0977,0.31,0.91,"No"
"7184","KEGG_compound","C05263_3_OXODODECANOYL_COA",6,-1.3536,0.13,0.29,"No",0.8321,0.67,1,"Yes"
"7185","GO_BP","784767_GO_1902043_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",16,-1.3534,0.13,0.2,"No",0.6338,0.95,1,"Yes"
"7186","C1_Positional","C1_ALL_225_CHR17Q25",176,-1.3534,0.022,0.59,"No",-0.9861,0.48,1,"No"
"7187","C2_Chemical_and_genetic_perturbations","C2_CGP_1280_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS",126,-1.3532,0.031,0.14,"No",1.5249,0.0045,0.19,"Yes"
"7188","REACTOME","106452_REACT_13620_P75NTR_REGULATES_AXONOGENESIS",11,-1.3532,0.12,0.23,"No",-1.0119,0.42,0.99,"No"
"7189","GO_BP","503341_GO_0034135_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY",6,-1.3532,0.13,0.2,"No",-1.0867,0.37,0.95,"No"
"7190","C7_Immunologic_signatures","C7_ALL_708_GSE17721_0_5H_VS_12H_LPS_BMDM_DN",198,-1.3531,0.025,0.045,"No",0.917,0.66,0.98,"Yes"
"7191","GO_BP","498543_GO_0019724_B_CELL_MEDIATED_IMMUNITY",70,-1.3531,0.068,0.2,"No",0.7915,0.87,1,"Yes"
"7192","GO_BP","500597_GO_0031338_REGULATION_OF_VESICLE_FUSION",22,-1.353,0.1,0.2,"No",0.8216,0.75,1,"Yes"
"7193","GO_BP","755349_GO_2001243_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",87,-1.3528,0.046,0.2,"No",0.7557,0.94,1,"Yes"
"7194","GO_BP","505178_GO_0040020_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION",30,-1.3528,0.082,0.2,"No",-1.0256,0.41,0.97,"No"
"7195","GO_MF","490000_GO_0004673_PROTEIN_HISTIDINE_KINASE_ACTIVITY",10,-1.3527,0.11,0.26,"No",-0.7106,0.83,1,"No"
"7196","GO_BP","488095_GO_0002220_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",6,-1.3527,0.11,0.2,"No",-1.269,0.21,0.89,"No"
"7197","C3_TF_targets","C3_TFT_343_V_LXR_Q3",75,-1.3527,0.063,0.058,"No",-1.0882,0.28,0.57,"No"
"7198","C7_Immunologic_signatures","C7_ALL_444_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN",196,-1.3526,0.021,0.045,"No",1.4095,0.014,0.035,"Yes"
"7199","GO_CC","490826_GO_0005798_GOLGI_ASSOCIATED_VESICLE",72,-1.3525,0.058,0.27,"No",1.1053,0.28,0.64,"Yes"
"7200","GO_MF","983692_GO_0098631_PROTEIN_BINDING_INVOLVED_IN_CELL_ADHESION",16,-1.3524,0.13,0.26,"No",-1.0013,0.46,0.9,"No"
"7201","C4_Cancer_gene_neighborhoods","C4_CGN_37_MORF_RAD51L3",375,-1.3524,0.0043,0.16,"No",-1.0308,0.35,0.81,"No"
"7202","GO_MF","495377_GO_0015101_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",29,-1.3522,0.098,0.25,"No",-1.1458,0.27,0.82,"No"
"7203","GO_BP","507821_GO_0045471_RESPONSE_TO_ETHANOL",106,-1.3522,0.047,0.2,"No",0.9587,0.57,1,"Yes"
"7204","GO_CC","752709_GO_0097208_ALVEOLAR_LAMELLAR_BODY",7,-1.3522,0.13,0.27,"No",-0.7953,0.71,1,"No"
"7205","GO_BP","494949_GO_0010885_REGULATION_OF_CHOLESTEROL_STORAGE",13,-1.3521,0.12,0.2,"No",1.1109,0.31,0.89,"Yes"
"7206","C7_Immunologic_signatures","C7_ALL_186_GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN",199,-1.3521,0.023,0.045,"No",1.6017,0,0.003,"Yes"
"7207","GO_BP","487892_GO_0002002_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD",13,-1.352,0.13,0.2,"No",1.5405,0.046,0.36,"Yes"
"7208","C3_TF_targets","C3_TFT_582_STTTCRNTTT_V_IRF_Q6",183,-1.352,0.024,0.058,"No",1.0193,0.41,1,"Yes"
"7209","GO_BP","501832_GO_0032606_TYPE_I_INTERFERON_PRODUCTION",9,-1.352,0.15,0.2,"No",-0.5745,0.95,1,"No"
"7210","KEGG_compound","C00818_D_GLUCARATE_D_GLUCARIC_ACID_L_GULARIC_ACID_D_SACCHARIC_ACID_D_GLUCOSACCHARIC_ACID_GLUCARIC_ACID_GLUCARATE",5,-1.3519,0.12,0.29,"No",0.6972,0.85,1,"Yes"
"7211","C3_TF_targets","C3_TFT_335_V_GCM_Q2",231,-1.3519,0.015,0.058,"No",-1.4805,0.0052,0.15,"No"
"7212","C2_Chemical_and_genetic_perturbations","C2_CGP_1902_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN",32,-1.3518,0.085,0.14,"No",-0.7256,0.91,1,"No"
"7213","C2_Chemical_and_genetic_perturbations","C2_CGP_740_LI_CISPLATIN_RESISTANCE_DN",34,-1.3518,0.076,0.14,"No",-0.7952,0.8,1,"No"
"7214","C2_Chemical_and_genetic_perturbations","C2_CGP_481_KERLEY_RESPONSE_TO_CISPLATIN_UP",44,-1.3518,0.086,0.14,"No",-0.9263,0.57,1,"No"
"7215","GO_CC","503563_GO_0034361_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE",20,-1.3518,0.12,0.27,"No",0.7724,0.8,0.97,"Yes"
"7216","GO_BP","506567_GO_0043536_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",23,-1.3518,0.1,0.2,"No",-1.1299,0.27,0.94,"No"
"7217","REACTOME","477139_REACT_111214_G0_AND_EARLY_G1",25,-1.3518,0.092,0.23,"No",-0.6413,0.97,1,"No"
"7218","GO_MF","497890_GO_0019001_GUANYL_NUCLEOTIDE_BINDING",381,-1.3518,0.0074,0.25,"No",0.9354,0.72,0.94,"Yes"
"7219","GO_BP","753097_GO_1900102_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",9,-1.3518,0.13,0.2,"No",-0.7759,0.75,1,"No"
"7220","C2_Chemical_and_genetic_perturbations","C2_CGP_85_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN",64,-1.3517,0.077,0.14,"No",-1.4983,0.017,0.45,"No"
"7221","C7_Immunologic_signatures","C7_ALL_1450_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN",199,-1.3517,0.022,0.046,"No",0.9535,0.6,0.89,"Yes"
"7222","C3_TF_targets","C3_TFT_305_V_STAT3_02",143,-1.3517,0.027,0.058,"No",-1.4713,0.0052,0.14,"No"
"7223","C1_Positional","C1_ALL_147_CHR1Q32",145,-1.3517,0.037,0.58,"No",-1.2104,0.1,1,"No"
"7224","GO_BP","1025448_GO_1990440_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",10,-1.3517,0.13,0.2,"No",-0.6845,0.87,1,"No"
"7225","C7_Immunologic_signatures","C7_ALL_768_GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN",196,-1.3517,0.023,0.045,"No",-1.1598,0.14,0.97,"No"
"7226","GO_BP","518819_GO_2000171_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT",16,-1.3515,0.12,0.2,"No",-1.3112,0.16,0.87,"No"
"7227","C3_TF_targets","C3_TFT_460_V_AP4_Q6_01",255,-1.3515,0.0089,0.058,"No",-1.2013,0.077,0.34,"No"
"7228","C2_BioCarta_Pathways","C2_CP_BIOCARTA_20_BIOCARTA_AGPCR_PATHWAY",12,-1.3512,0.12,0.22,"No",1.0614,0.39,0.78,"Yes"
"7229","C3_TF_targets","C3_TFT_575_GATAAGR_V_GATA_C",287,-1.3511,0.0022,0.058,"No",-1.0198,0.41,0.72,"No"
"7230","GO_BP","488421_GO_0002548_MONOCYTE_CHEMOTAXIS",17,-1.3511,0.1,0.2,"No",1.5377,0.041,0.36,"Yes"
"7231","GO_BP","510374_GO_0048260_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS",37,-1.3508,0.079,0.2,"No",0.7119,0.9,1,"Yes"
"7232","C2_Chemical_and_genetic_perturbations","C2_CGP_966_FALVELLA_SMOKERS_WITH_LUNG_CANCER",78,-1.3508,0.049,0.14,"No",0.8349,0.85,0.98,"Yes"
"7233","GO_CC","501516_GO_0032281_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLEPROPIONIC_ACID_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX",27,-1.3507,0.12,0.27,"No",-1.131,0.27,0.72,"No"
"7234","GO_BP","500895_GO_0031646_POSITIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS",71,-1.3506,0.063,0.2,"No",-1.2272,0.15,0.88,"No"
"7235","KEGG_reaction","R00631_ALDEHYDE_NAD_OXIDOREDUCTASE_ALDEHYDE_NAD_H2O_FATTY_ACID_NADH_H_",5,-1.3505,0.12,0.33,"No",0.6987,0.84,1,"Yes"
"7236","GO_BP","508487_GO_0046189_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",35,-1.3504,0.095,0.2,"No",-1.0315,0.4,0.98,"No"
"7237","KEGG_compound","C05270_HEXANOYL_COA",10,-1.3503,0.12,0.29,"No",-0.6155,0.9,1,"No"
"7238","GO_MF","489269_GO_0003725_DOUBLE_STRANDED_RNA_BINDING",59,-1.3503,0.067,0.26,"No",0.8338,0.78,1,"Yes"
"7239","C2_Chemical_and_genetic_perturbations","C2_CGP_2809_FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP",35,-1.3503,0.087,0.14,"No",0.9888,0.47,0.81,"Yes"
"7240","C2_BioCarta_Pathways","C2_CP_BIOCARTA_10_BIOCARTA_AKAP95_PATHWAY",12,-1.3502,0.12,0.22,"No",0.9965,0.43,0.84,"Yes"
"7241","C2_Chemical_and_genetic_perturbations","C2_CGP_856_WANG_HCP_PROSTATE_CANCER",109,-1.3502,0.036,0.14,"No",0.842,0.85,0.97,"Yes"
"7242","KEGG_reaction","R01752_D_GLYCERALDEHYDE_NAD_OXIDOREDUCTASE_D_GLYCERALDEHYDE_NAD_H2O_D_GLYCERATE_NADH_H_",5,-1.3501,0.11,0.33,"No",0.7084,0.82,1,"Yes"
"7243","REACTOME","645330_REACT_121006_ACYL_CHAIN_REMODELING_OF_CL",6,-1.3501,0.12,0.23,"No",-0.5707,0.95,1,"No"
"7244","GO_BP","507528_GO_0046688_RESPONSE_TO_COPPER_ION",21,-1.3501,0.1,0.2,"No",0.7171,0.88,1,"Yes"
"7245","GO_BP","512411_GO_0051533_POSITIVE_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS",7,-1.3501,0.13,0.2,"No",-1.6476,0.016,0.71,"No"
"7246","GO_BP","495204_GO_0014808_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM",7,-1.3501,0.12,0.2,"No",0.6067,0.93,1,"Yes"
"7247","C2_Chemical_and_genetic_perturbations","C2_CGP_553_HWANG_PROSTATE_CANCER_MARKERS",27,-1.3495,0.096,0.14,"No",1.109,0.3,0.62,"Yes"
"7248","C2_Chemical_and_genetic_perturbations","C2_CGP_2258_SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP",93,-1.3495,0.034,0.14,"No",-1.5251,0.011,0.45,"No"
"7249","C7_Immunologic_signatures","C7_ALL_148_GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN",198,-1.3495,0.021,0.047,"No",-0.8422,0.85,1,"No"
"7250","GO_CC","507504_GO_0045111_INTERMEDIATE_FILAMENT_CYTOSKELETON",187,-1.3495,0.016,0.27,"No",1.211,0.076,0.51,"Yes"
"7251","GO_BP","492844_GO_0008584_MALE_GONAD_DEVELOPMENT",120,-1.3494,0.033,0.21,"No",-0.9052,0.68,1,"No"
"7252","C2_Chemical_and_genetic_perturbations","C2_CGP_1782_VERRECCHIA_RESPONSE_TO_TGFB1_C5",20,-1.3494,0.11,0.14,"No",1.5696,0.041,0.16,"Yes"
"7253","GO_BP","508801_GO_0046545_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS",85,-1.3494,0.055,0.21,"No",-0.8849,0.72,1,"No"
"7254","GO_BP","849936_GO_1902235_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",25,-1.3493,0.095,0.21,"No",-0.8831,0.65,1,"No"
"7255","GO_MF","492542_GO_0008201_HEPARIN_BINDING",137,-1.3492,0.04,0.26,"No",1.1367,0.19,0.75,"Yes"
"7256","GO_BP","506222_GO_0043149_STRESS_FIBER_ASSEMBLY",14,-1.3492,0.12,0.21,"No",-0.773,0.79,1,"No"
"7257","GO_MF","496957_GO_0017166_VINCULIN_BINDING",10,-1.3492,0.12,0.26,"No",0.6313,0.91,1,"Yes"
"7258","GO_MF","517414_GO_0072509_DIVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",162,-1.3491,0.027,0.26,"No",-1.5994,0,0.48,"No"
"7259","C2_Chemical_and_genetic_perturbations","C2_CGP_1190_TOMIDA_LUNG_CANCER_POOR_SURVIVAL",5,-1.3491,0.13,0.14,"No",0.6893,0.84,1,"Yes"
"7260","KEGG_reaction","R04065_IMIDAZOLE_ACETALDEHYDE_NAD_OXIDOREDUCTASE_IMIDAZOLE_4_ACETALDEHYDE_NAD_H2O_IMIDAZOLE_4_ACETATE_NADH_H_",5,-1.3489,0.12,0.32,"No",0.6924,0.83,1,"Yes"
"7261","GO_BP","511928_GO_0050995_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS",18,-1.3487,0.11,0.21,"No",-0.932,0.55,1,"No"
"7262","C2_Chemical_and_genetic_perturbations","C2_CGP_2517_LINDSTEDT_DENDRITIC_CELL_MATURATION_C",67,-1.3486,0.058,0.14,"No",1.3984,0.045,0.29,"Yes"
"7263","C2_Chemical_and_genetic_perturbations","C2_CGP_2397_BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP",60,-1.3486,0.066,0.14,"No",0.6155,0.99,1,"Yes"
"7264","C3_TF_targets","C3_TFT_237_V_AREB6_04",246,-1.3485,0.016,0.059,"No",-1.1444,0.13,0.45,"No"
"7265","REACTOME","106232_REACT_1132_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS",11,-1.3484,0.13,0.24,"No",-0.9737,0.48,1,"No"
"7266","C2_Chemical_and_genetic_perturbations","C2_CGP_2747_WANG_RECURRENT_LIVER_CANCER_DN",16,-1.3483,0.12,0.14,"No",1.3338,0.13,0.35,"Yes"
"7267","GO_BP","488877_GO_0035814_NEGATIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION",6,-1.3483,0.13,0.21,"No",0.9966,0.47,0.98,"Yes"
"7268","GO_BP","500890_GO_0031641_REGULATION_OF_MYELINATION",28,-1.3483,0.09,0.21,"No",-0.9152,0.61,1,"No"
"7269","C3_TF_targets","C3_TFT_249_CCTNTMAGA_UNKNOWN",125,-1.3483,0.04,0.059,"No",-0.9003,0.71,0.95,"No"
"7270","C7_Immunologic_signatures","C7_ALL_397_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP",196,-1.3482,0.015,0.048,"No",-1.0055,0.44,1,"No"
"7271","C3_TF_targets","C3_TFT_478_V_ER_Q6_02",248,-1.3481,0.014,0.059,"No",-0.9473,0.62,0.88,"No"
"7272","C2_Chemical_and_genetic_perturbations","C2_CGP_1616_JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN",41,-1.3481,0.076,0.14,"No",0.7478,0.88,1,"Yes"
"7273","C2_Chemical_and_genetic_perturbations","C2_CGP_195_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP",32,-1.348,0.095,0.14,"No",0.4553,1,1,"Yes"
"7274","C3_TF_targets","C3_TFT_259_V_SPZ1_01",226,-1.348,0.024,0.059,"No",-1.2971,0.021,0.24,"No"
"7275","GO_CC","492644_GO_0008328_IONOTROPIC_GLUTAMATE_RECEPTOR_COMPLEX",50,-1.348,0.087,0.27,"No",-0.9641,0.52,0.89,"No"
"7276","GO_BP","518347_GO_0090207_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS",29,-1.3479,0.11,0.21,"No",-0.6279,0.96,1,"No"
"7277","KEGG_compound","C02670_D_GLUCURONOLACTONE_GLUCURONE_D_GLUCURONO_3_6_LACTONE_D_GLUCURONE",5,-1.3479,0.14,0.29,"No",0.6934,0.82,1,"Yes"
"7278","GO_BP","491048_GO_0006063_URONIC_ACID_METABOLIC_PROCESS",26,-1.3479,0.096,0.21,"No",1.5544,0.027,0.34,"Yes"
"7279","GO_MF","496834_GO_0017002_ACTIVIN_ACTIVATED_RECEPTOR_ACTIVITY",7,-1.3478,0.11,0.26,"No",-0.7432,0.79,1,"No"
"7280","C2_Chemical_and_genetic_perturbations","C2_CGP_551_OZANNE_AP1_TARGETS_UP",17,-1.3478,0.11,0.14,"No",0.9411,0.55,0.88,"Yes"
"7281","C7_Immunologic_signatures","C7_ALL_376_GSE15659_RESTING_VS_ACTIVATED_TREG_DN",195,-1.3477,0.024,0.048,"No",1.095,0.23,0.46,"Yes"
"7282","C2_Chemical_and_genetic_perturbations","C2_CGP_3177_AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN",16,-1.3477,0.13,0.14,"No",-0.9368,0.55,1,"No"
"7283","GO_BP","512129_GO_0051235_MAINTENANCE_OF_LOCATION",163,-1.3477,0.035,0.21,"No",-0.66,1,1,"No"
"7284","C3_MicroRNA_targets","C3_MIR_100_AAACCAC_MIR_140",109,-1.3477,0.043,0.24,"No",-0.8505,0.81,1,"No"
"7285","C7_Immunologic_signatures","C7_ALL_509_GSE17721_CTRL_VS_CPG_24H_BMDM_UP",195,-1.3476,0.019,0.048,"No",-0.8277,0.87,1,"No"
"7286","KEGG_compound","C05981_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_5_TRISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_4_5_BISPHOSPHATE_",11,-1.3476,0.13,0.29,"No",-0.7402,0.8,1,"No"
"7287","GO_BP","493697_GO_0009566_FERTILIZATION",134,-1.3475,0.028,0.21,"No",-0.8344,0.86,1,"No"
"7288","C3_TF_targets","C3_TFT_18_AACWWCAANK_UNKNOWN",139,-1.3475,0.034,0.059,"No",-0.8186,0.88,1,"No"
"7289","C2_Chemical_and_genetic_perturbations","C2_CGP_1012_FREDERICK_PRKCI_TARGETS",9,-1.3475,0.11,0.14,"No",-0.8279,0.69,1,"No"
"7290","WikiPathways","198760_WP395_IL_4_SIGNALING_PATHWAY",62,-1.3474,0.068,0.16,"No",-0.8329,0.77,1,"No"
"7291","GO_BP","514128_GO_0060573_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION",9,-1.3474,0.14,0.21,"No",-0.9612,0.5,1,"No"
"7292","C2_Chemical_and_genetic_perturbations","C2_CGP_2120_KYNG_DNA_DAMAGE_UP",219,-1.3474,0.016,0.14,"No",-0.7844,0.96,1,"No"
"7293","C1_Positional","C1_ALL_300_CHR7P15",75,-1.3474,0.059,0.57,"No",1.2345,0.12,0.59,"Yes"
"7294","GO_BP","488135_GO_0002262_MYELOID_CELL_HOMEOSTASIS",96,-1.3473,0.056,0.21,"No",1.3523,0.046,0.61,"Yes"
"7295","GO_BP","513488_GO_0055057_NEUROBLAST_DIVISION",12,-1.3473,0.12,0.21,"No",-0.5462,0.96,1,"No"
"7296","GO_CC","490883_GO_0005875_MICROTUBULE_ASSOCIATED_COMPLEX",134,-1.3472,0.045,0.27,"No",-1.0093,0.41,0.85,"No"
"7297","GO_BP","501622_GO_0032387_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT",108,-1.3472,0.042,0.21,"No",-0.8548,0.81,1,"No"
"7298","GO_BP","493361_GO_0009165_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",216,-1.3472,0.017,0.21,"No",0.8614,0.9,1,"Yes"
"7299","WikiPathways","198800_WP524_G13_SIGNALING_PATHWAY",38,-1.347,0.086,0.16,"No",0.9415,0.56,1,"Yes"
"7300","GO_BP","504610_GO_0035426_EXTRACELLULAR_MATRIX_CELL_SIGNALING",5,-1.347,0.12,0.21,"No",-0.8206,0.7,1,"No"
"7301","C4_Cancer_gene_neighborhoods","C4_CGN_340_GNF2_CKS1B",37,-1.3468,0.094,0.16,"No",1.5418,0.019,0.023,"Yes"
"7302","C7_Immunologic_signatures","C7_ALL_1688_GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN",193,-1.3468,0.022,0.048,"No",-0.6616,1,1,"No"
"7303","C7_Immunologic_signatures","C7_ALL_683_GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDM_UP",197,-1.3466,0.019,0.048,"No",-0.9,0.7,1,"No"
"7304","GO_BP","514141_GO_0060586_MULTICELLULAR_ORGANISMAL_IRON_ION_HOMEOSTASIS",7,-1.3466,0.13,0.21,"No",0.8242,0.68,1,"Yes"
"7305","C2_Chemical_and_genetic_perturbations","C2_CGP_411_LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP",8,-1.3465,0.12,0.14,"No",1.4078,0.12,0.29,"Yes"
"7306","C2_Chemical_and_genetic_perturbations","C2_CGP_3282_PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP",54,-1.3464,0.086,0.14,"No",0.8903,0.68,0.94,"Yes"
"7307","GO_BP","489101_GO_0003309_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION",15,-1.3462,0.14,0.21,"No",0.9237,0.56,1,"Yes"
"7308","GO_BP","513734_GO_0060177_REGULATION_OF_ANGIOTENSIN_METABOLIC_PROCESS",13,-1.346,0.11,0.21,"No",1.53,0.055,0.37,"Yes"
"7309","KEGG_reaction","R01986_4_AMINOBUTYRALDEHYDE_NAD_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NADP_H2O_4_AMINOBUTANOATE_NADPH_H_",5,-1.3459,0.14,0.32,"No",0.6899,0.84,1,"Yes"
"7310","GO_BP","518934_GO_2000288_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION",6,-1.3458,0.12,0.21,"No",0.8131,0.7,1,"Yes"
"7311","C2_BioCarta_Pathways","C2_CP_BIOCARTA_196_BIOCARTA_TH1TH2_PATHWAY",19,-1.3458,0.093,0.22,"No",0.7621,0.81,1,"Yes"
"7312","C2_Chemical_and_genetic_perturbations","C2_CGP_2262_SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP",6,-1.3456,0.12,0.14,"No",1.0791,0.37,0.67,"Yes"
"7313","C7_Immunologic_signatures","C7_ALL_282_GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN",200,-1.3456,0.025,0.049,"No",1.1037,0.21,0.43,"Yes"
"7314","KEGG_pathway","HSA04975_FAT_DIGESTION_AND_ABSORPTION",34,-1.3455,0.088,0.099,"No",-1.2216,0.17,0.52,"No"
"7315","C2_Chemical_and_genetic_perturbations","C2_CGP_2010_KIM_LRRC3B_TARGETS",30,-1.3455,0.093,0.14,"No",1.6592,0.013,0.11,"Yes"
"7316","GO_CC","515618_GO_0070688_MLL5_L_COMPLEX",8,-1.3455,0.15,0.27,"No",1.0756,0.37,0.68,"Yes"
"7317","GO_BP","502350_GO_0033129_POSITIVE_REGULATION_OF_HISTONE_PHOSPHORYLATION",6,-1.3454,0.13,0.21,"No",-1.3289,0.14,0.9,"No"
"7318","GO_BP","501541_GO_0032306_REGULATION_OF_PROSTAGLANDIN_SECRETION",12,-1.3453,0.13,0.21,"No",0.7653,0.81,1,"Yes"
"7319","GO_BP","502006_GO_0032780_NEGATIVE_REGULATION_OF_ATPASE_ACTIVITY",11,-1.3452,0.13,0.21,"No",-1.2907,0.17,0.88,"No"
"7320","C2_Chemical_and_genetic_perturbations","C2_CGP_1187_MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN",17,-1.3449,0.11,0.14,"No",-0.6951,0.87,1,"No"
"7321","KEGG_reaction","R03869__S_METHYLMALONATE_SEMIALDEHYDE_NAD_OXIDOREDUCTASE_S_METHYLMALONATE_SEMIALDEHYDE_NAD_H2O_METHYLMALONATE_NADH_H_",5,-1.3449,0.12,0.32,"No",0.6917,0.84,1,"Yes"
"7322","GO_BP","488784_GO_0002911_REGULATION_OF_LYMPHOCYTE_ANERGY",7,-1.3448,0.14,0.21,"No",0.6869,0.87,1,"Yes"
"7323","GO_BP","506390_GO_0043330_RESPONSE_TO_EXOGENOUS_DSRNA",37,-1.3447,0.082,0.21,"No",1.1501,0.22,0.84,"Yes"
"7324","GO_BP","505653_GO_0042522_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN",21,-1.3446,0.097,0.21,"No",-1.4376,0.083,0.92,"No"
"7325","C6_Oncogenic_signatures","C6_ALL_117_CRX_NRL_DN_V1_DN",112,-1.3446,0.036,0.056,"No",-1.0916,0.3,0.55,"No"
"7326","C2_Chemical_and_genetic_perturbations","C2_CGP_1487_HASLINGER_B_CLL_WITH_11Q23_DELETION",23,-1.3445,0.097,0.14,"No",-1.0618,0.34,0.97,"No"
"7327","GO_BP","507823_GO_0048149_BEHAVIORAL_RESPONSE_TO_ETHANOL",9,-1.3444,0.13,0.21,"No",-1.1372,0.3,0.93,"No"
"7328","GO_BP","500385_GO_0031098_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",119,-1.3444,0.05,0.21,"No",-0.7438,0.96,1,"No"
"7329","GO_BP","493400_GO_0009204_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS",7,-1.3443,0.13,0.21,"No",0.7525,0.77,1,"Yes"
"7330","C2_Chemical_and_genetic_perturbations","C2_CGP_1256_ROSS_ACUTE_MYELOID_LEUKEMIA_CBF",82,-1.3443,0.058,0.14,"No",-0.9495,0.55,1,"No"
"7331","WikiPathways","198766_WP453_INFLAMMATORY_RESPONSE_PATHWAY",30,-1.3443,0.1,0.16,"No",0.9063,0.61,1,"Yes"
"7332","C2_Chemical_and_genetic_perturbations","C2_CGP_3253_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6",29,-1.3442,0.095,0.14,"No",1.1423,0.26,0.56,"Yes"
"7333","C2_Chemical_and_genetic_perturbations","C2_CGP_2416_HUPER_BREAST_BASAL_VS_LUMINAL_DN",57,-1.3442,0.065,0.14,"No",0.8993,0.65,0.93,"Yes"
"7334","C2_Chemical_and_genetic_perturbations","C2_CGP_1706_BROWNE_HCMV_INFECTION_14HR_DN",294,-1.3442,0.0088,0.14,"No",0.9532,0.62,0.86,"Yes"
"7335","GO_BP","499609_GO_0030199_COLLAGEN_FIBRIL_ORGANIZATION",41,-1.344,0.093,0.21,"No",-1.5465,0.02,0.74,"No"
"7336","C3_TF_targets","C3_TFT_28_V_CREL_01",251,-1.344,0.02,0.061,"No",-1.2801,0.028,0.25,"No"
"7337","GO_BP","494677_GO_0010613_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY",15,-1.3437,0.13,0.21,"No",-0.6286,0.92,1,"No"
"7338","GO_MF","750852_GO_0035925_MRNA_3_UTR_AU_RICH_REGION_BINDING",6,-1.3437,0.11,0.26,"No",-1.1219,0.34,0.81,"No"
"7339","GO_CC","490453_GO_0005581_COLLAGEN_TRIMER",86,-1.3437,0.057,0.27,"No",-1.1741,0.18,0.69,"No"
"7340","GO_MF","486556_GO_0044183_PROTEIN_BINDING_INVOLVED_IN_PROTEIN_FOLDING",11,-1.3437,0.14,0.26,"No",-1.139,0.29,0.8,"No"
"7341","GO_BP","494603_GO_0010534_REGULATION_OF_ACTIVATION_OF_JAK2_KINASE_ACTIVITY",7,-1.3436,0.12,0.21,"No",-1.1015,0.33,0.94,"No"
"7342","C7_Immunologic_signatures","C7_ALL_1439_GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP",197,-1.3436,0.028,0.05,"No",1.3271,0.012,0.079,"Yes"
"7343","GO_BP","502378_GO_0033157_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT",303,-1.3436,0.0087,0.21,"No",0.8674,0.9,1,"Yes"
"7344","C2_BioCarta_Pathways","C2_CP_BIOCARTA_152_BIOCARTA_BAD_PATHWAY",26,-1.3435,0.12,0.22,"No",1.3519,0.1,0.53,"Yes"
"7345","GO_BP","508181_GO_0045862_POSITIVE_REGULATION_OF_PROTEOLYSIS",315,-1.3435,0.0095,0.21,"No",1.2106,0.057,0.78,"Yes"
"7346","C3_TF_targets","C3_TFT_291_V_ATF6_01",121,-1.3435,0.042,0.061,"No",-0.9141,0.65,0.94,"No"
"7347","C2_Chemical_and_genetic_perturbations","C2_CGP_3159_CHANGOLKAR_H2AFY_TARGETS_UP",48,-1.3434,0.073,0.14,"No",1.315,0.099,0.38,"Yes"
"7348","REACTOME","771568_REACT_160189_STIMULI_SENSING_CHANNELS",97,-1.3434,0.047,0.24,"No",-1.1717,0.18,0.86,"No"
"7349","GO_BP","511801_GO_0050858_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",17,-1.3433,0.12,0.21,"No",0.5646,0.99,1,"Yes"
"7350","C2_Chemical_and_genetic_perturbations","C2_CGP_1606_URS_ADIPOCYTE_DIFFERENTIATION_UP",73,-1.3433,0.078,0.14,"No",1.1355,0.21,0.57,"Yes"
"7351","GO_BP","488512_GO_0002639_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION",30,-1.3432,0.093,0.21,"No",-1.3212,0.085,0.89,"No"
"7352","GO_BP","498963_GO_0021680_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT",23,-1.3432,0.11,0.21,"No",-1.2164,0.19,0.88,"No"
"7353","KEGG_reaction","R02940_2_PROPYN_1_AL_NAD_OXIDOREDUCTASE_2_PROPYNAL_NAD_H2O_PROPYNOATE_NADH_H_",5,-1.3431,0.13,0.31,"No",0.6866,0.84,1,"Yes"
"7354","C7_Immunologic_signatures","C7_ALL_700_GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_DN",199,-1.3431,0.025,0.05,"No",0.9344,0.67,0.94,"Yes"
"7355","C3_TF_targets","C3_TFT_43_V_TAL1BETAITF2_01",246,-1.343,0.012,0.061,"No",-1.2864,0.034,0.26,"No"
"7356","C3_TF_targets","C3_TFT_481_V_VDR_Q6",258,-1.3429,0.0098,0.061,"No",-1.2767,0.034,0.25,"No"
"7357","C7_Immunologic_signatures","C7_ALL_1757_GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP",166,-1.3428,0.027,0.05,"No",1.0436,0.37,0.61,"Yes"
"7358","C7_Immunologic_signatures","C7_ALL_349_GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP",196,-1.3428,0.028,0.05,"No",-1.1673,0.14,0.94,"No"
"7359","KEGG_reaction","R09419_ACYL_COA_MALONYL_COA_C_ACYLTRANSFERASE_DECARBOXYLATING_MALONYL_COA_ACYL_COA_3_OXOACYL_COA_COA_CO2",7,-1.3427,0.13,0.31,"No",-1.1275,0.31,0.66,"No"
"7360","C7_Immunologic_signatures","C7_ALL_464_GSE17721_CTRL_VS_POLYIC_0_5H_BMDM_DN",191,-1.3427,0.033,0.05,"No",-0.8848,0.77,1,"No"
"7361","C2_Chemical_and_genetic_perturbations","C2_CGP_838_OXFORD_RALA_TARGETS_UP",9,-1.3427,0.14,0.14,"No",-0.6423,0.93,1,"No"
"7362","GO_BP","514158_GO_0060603_MAMMARY_GLAND_DUCT_MORPHOGENESIS",34,-1.3427,0.088,0.21,"No",-0.9319,0.55,1,"No"
"7363","GO_BP","499842_GO_0030501_POSITIVE_REGULATION_OF_BONE_MINERALIZATION",33,-1.3427,0.083,0.21,"No",-1.6054,0.016,0.7,"No"
"7364","GO_BP","496370_GO_0016331_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM",141,-1.3426,0.044,0.21,"No",-0.7761,0.95,1,"No"
"7365","KEGG_reaction","R00086_ATP_PHOSPHOHYDROLASE_ATP_H2O_ADP_ORTHOPHOSPHATE",6,-1.3426,0.12,0.3,"No",0.5209,0.96,0.98,"Yes"
"7366","C3_TF_targets","C3_TFT_386_V_CIZ_01",233,-1.3426,0.016,0.061,"No",-0.7691,0.98,1,"No"
"7367","KEGG_pathway","HSA05110_VIBRIO_CHOLERAE_INFECTION",53,-1.3426,0.079,0.1,"No",1.034,0.38,0.84,"Yes"
"7368","GO_MF","490637_GO_0005542_FOLIC_ACID_BINDING",11,-1.3423,0.11,0.26,"No",0.6779,0.85,1,"Yes"
"7369","GO_BP","518427_GO_0090287_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS",173,-1.3423,0.039,0.21,"No",1.0598,0.31,0.94,"Yes"
"7370","GO_BP","983737_GO_1903018_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS",34,-1.3421,0.089,0.21,"No",-0.772,0.83,1,"No"
"7371","GO_MF","507542_GO_0045159_MYOSIN_II_BINDING",5,-1.342,0.14,0.26,"No",1.3213,0.17,0.58,"Yes"
"7372","C1_Positional","C1_ALL_110_CHR1Q25",73,-1.342,0.062,0.58,"No",-0.8536,0.76,0.97,"No"
"7373","KEGG_reaction","R02678_INDOLE_3_ACETALDEHYDE_NAD_OXIDOREDUCTASE_INDOLE_3_ACETALDEHYDE_NAD_H2O_INDOLE_3_ACETATE_NADH_H_",5,-1.3419,0.13,0.3,"No",0.6976,0.82,1,"Yes"
"7374","C2_Chemical_and_genetic_perturbations","C2_CGP_693_FARMER_BREAST_CANCER_APOCRINE_VS_BASAL",326,-1.3418,0.011,0.14,"No",1.2503,0.036,0.44,"Yes"
"7375","GO_BP","495922_GO_0015791_POLYOL_TRANSPORT",14,-1.3418,0.13,0.21,"No",-1.076,0.34,0.95,"No"
"7376","GO_BP","500592_GO_0031333_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY",100,-1.3418,0.063,0.21,"No",-0.7312,0.95,1,"No"
"7377","GO_BP","507275_GO_0044268_MULTICELLULAR_ORGANISMAL_PROTEIN_METABOLIC_PROCESS",5,-1.3418,0.1,0.21,"No",0.5778,0.94,1,"Yes"
"7378","C7_Immunologic_signatures","C7_ALL_456_GSE17721_CTRL_VS_LPS_6H_BMDM_DN",195,-1.3417,0.026,0.051,"No",0.6993,1,1,"Yes"
"7379","C7_Immunologic_signatures","C7_ALL_1603_GSE3982_EOSINOPHIL_VS_TH1_UP",194,-1.3416,0.023,0.051,"No",0.9242,0.7,0.96,"Yes"
"7380","GO_BP","508886_GO_0046638_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION",32,-1.3416,0.099,0.21,"No",-0.8666,0.67,1,"No"
"7381","GO_BP","505618_GO_0042482_POSITIVE_REGULATION_OF_ODONTOGENESIS",10,-1.3415,0.13,0.21,"No",0.718,0.84,1,"Yes"
"7382","GO_BP","488186_GO_0002313_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",9,-1.3415,0.14,0.21,"No",-0.7148,0.81,1,"No"
"7383","C7_Immunologic_signatures","C7_ALL_1712_GSE3982_NKCELL_VS_TH1_DN",197,-1.3415,0.025,0.051,"No",1.0041,0.43,0.72,"Yes"
"7384","C2_Chemical_and_genetic_perturbations","C2_CGP_1860_LY_AGING_MIDDLE_UP",13,-1.3415,0.13,0.14,"No",1.0473,0.39,0.72,"Yes"
"7385","GO_BP","499950_GO_0030644_CELLULAR_CHLORIDE_ION_HOMEOSTASIS",5,-1.3414,0.12,0.21,"No",-1.0243,0.43,0.97,"No"
"7386","KEGG_enzyme","1.2.1.3_ALDEHYDE_DEHYDROGENASE_NAD_COA_INDEPENDENT_ALDEHYDE_DEHYDROGENASE_M_METHYLBENZALDEHYDE_DEHYDROGENASE_NAD_ALDEHYDE_DEHYDROGENASE_NAD_DEPENDENT_4_HYDROXYNONENAL_DEHYDROGENASE_NAD_DEPENDENT_ALDEHYDE_DEHYDROGENASE_NAD_LINKED_ALDEHYDE_DEHYDROGENASE_PROPIONALDEHYDE_DEHYDROGENASE_ALDEHYDE_DEHYDROGENASE_NAD_",5,-1.3414,0.12,0.45,"No",0.6817,0.87,0.93,"Yes"
"7387","GO_BP","496013_GO_0015889_COBALAMIN_TRANSPORT",5,-1.3413,0.14,0.21,"No",-1.1687,0.3,0.91,"No"
"7388","C3_TF_targets","C3_TFT_8_V_MEF2_01",138,-1.3413,0.033,0.061,"No",0.941,0.6,1,"Yes"
"7389","C2_BioCarta_Pathways","C2_CP_BIOCARTA_24_BIOCARTA_BIOPEPTIDES_PATHWAY",41,-1.3413,0.08,0.22,"No",0.881,0.67,0.92,"Yes"
"7390","C2_Chemical_and_genetic_perturbations","C2_CGP_8_PARENT_MTOR_SIGNALING_DN",45,-1.3413,0.084,0.14,"No",-0.9057,0.62,1,"No"
"7391","GO_MF","490632_GO_0005537_MANNOSE_BINDING",16,-1.3412,0.11,0.27,"No",1.3108,0.14,0.59,"Yes"
"7392","C2_Chemical_and_genetic_perturbations","C2_CGP_1643_WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2",39,-1.341,0.075,0.14,"No",0.9314,0.56,0.89,"Yes"
"7393","GO_BP","512580_GO_0051705_MULTI_ORGANISM_BEHAVIOR",79,-1.341,0.069,0.21,"No",-0.8055,0.86,1,"No"
"7394","GO_BP","494953_GO_0010889_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE",12,-1.341,0.13,0.21,"No",0.7635,0.78,1,"Yes"
"7395","REACTOME","106365_REACT_16927_ADRENOCEPTORS",9,-1.3409,0.15,0.25,"No",-1.3485,0.14,0.59,"No"
"7396","GO_BP","488945_GO_0003151_OUTFLOW_TRACT_MORPHOGENESIS",56,-1.3409,0.067,0.21,"No",-0.8968,0.64,1,"No"
"7397","GO_BP","518240_GO_0090100_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",101,-1.3408,0.041,0.21,"No",-0.8765,0.74,1,"No"
"7398","GO_BP","512688_GO_0051817_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",395,-1.3408,0.0095,0.21,"No",1.2033,0.026,0.78,"Yes"
"7399","REACTOME","106466_REACT_12002_ARMS_MEDIATED_ACTIVATION",23,-1.3407,0.11,0.25,"No",0.6491,0.94,1,"Yes"
"7400","C1_Positional","C1_ALL_243_CHRXQ27",18,-1.3406,0.12,0.56,"No",1.1904,0.23,0.61,"Yes"
"7401","GO_BP","505894_GO_0042789_MRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",13,-1.3406,0.13,0.21,"No",-1.1291,0.29,0.93,"No"
"7402","REACTOME","1183591_REACT_355469_RHO_GTPASES_ACTIVATE_IQGAPS",13,-1.3406,0.11,0.24,"No",1.1855,0.25,0.46,"Yes"
"7403","GO_BP","501873_GO_0032647_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION",16,-1.3403,0.12,0.21,"No",0.7941,0.75,1,"Yes"
"7404","GO_BP","753082_GO_1900087_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",20,-1.3403,0.13,0.21,"No",-0.7877,0.76,1,"No"
"7405","REACTOME","105804_REACT_2101_CYCLIN_B2_MEDIATED_EVENTS",5,-1.3403,0.14,0.24,"No",-0.5552,0.97,1,"No"
"7406","REACTOME","187197_REACT_25201_KINESINS",26,-1.3403,0.1,0.24,"No",0.8756,0.63,0.93,"Yes"
"7407","C6_Oncogenic_signatures","C6_ALL_79_JNK_DN_V1_DN",180,-1.3401,0.032,0.059,"No",-1.1777,0.13,0.46,"No"
"7408","C3_MicroRNA_targets","C3_MIR_148_TTTGTAG_MIR_520D",329,-1.3401,0.0053,0.25,"No",-0.7468,1,1,"No"
"7409","C7_Immunologic_signatures","C7_ALL_305_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP",199,-1.3401,0.024,0.052,"No",1.0106,0.44,0.71,"Yes"
"7410","C7_Immunologic_signatures","C7_ALL_557_GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_UP",198,-1.34,0.028,0.052,"No",0.655,1,1,"Yes"
"7411","C7_Immunologic_signatures","C7_ALL_863_GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP",190,-1.34,0.033,0.052,"No",1.2312,0.062,0.18,"Yes"
"7412","GO_MF","489809_GO_0004457_LACTATE_DEHYDROGENASE_ACTIVITY",6,-1.3399,0.14,0.27,"No",-1.082,0.36,0.85,"No"
"7413","GO_BP","518134_GO_0085029_EXTRACELLULAR_MATRIX_ASSEMBLY",16,-1.3399,0.14,0.21,"No",-1.566,0.023,0.72,"No"
"7414","C2_Chemical_and_genetic_perturbations","C2_CGP_110_PIEPOLI_LGI1_TARGETS_UP",15,-1.3398,0.12,0.15,"No",1.6088,0.014,0.13,"Yes"
"7415","GO_BP","513552_GO_0055123_DIGESTIVE_SYSTEM_DEVELOPMENT",138,-1.3398,0.035,0.21,"No",-1.0286,0.4,0.97,"No"
"7416","GO_BP","499319_GO_0022401_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY",18,-1.3397,0.11,0.21,"No",-1.2879,0.15,0.88,"No"
"7417","C7_Immunologic_signatures","C7_ALL_1059_GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP",196,-1.3396,0.029,0.052,"No",0.8037,0.95,1,"Yes"
"7418","C2_Chemical_and_genetic_perturbations","C2_CGP_510_LUI_THYROID_CANCER_PAX8_PPARG_UP",44,-1.3395,0.087,0.15,"No",-1.3145,0.1,0.7,"No"
"7419","GO_BP","506581_GO_0043550_REGULATION_OF_LIPID_KINASE_ACTIVITY",43,-1.3394,0.085,0.21,"No",-0.5861,0.99,1,"No"
"7420","GO_BP","506677_GO_0043647_INOSITOL_PHOSPHATE_METABOLIC_PROCESS",55,-1.3394,0.086,0.21,"No",-0.9848,0.48,1,"No"
"7421","GO_BP","495105_GO_0014033_NEURAL_CREST_CELL_DIFFERENTIATION",59,-1.3393,0.08,0.21,"No",1.2592,0.12,0.72,"Yes"
"7422","GO_BP","515236_GO_0070303_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",40,-1.3393,0.094,0.21,"No",1.0054,0.44,0.98,"Yes"
"7423","KEGG_reaction","R04506_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL_NAD_OXIDOREDUCTASE_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL_NAD_H2O_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANATE_NADH_H_",5,-1.3392,0.12,0.3,"No",0.6784,0.86,1,"Yes"
"7424","GO_BP","487863_GO_0001973_ADENOSINE_RECEPTOR_SIGNALING_PATHWAY",9,-1.3392,0.13,0.21,"No",1.3955,0.11,0.56,"Yes"
"7425","REACTOME","1183589_REACT_355303_RHO_GTPASES_ACTIVATE_CIT",16,-1.3391,0.11,0.25,"No",0.8186,0.73,0.99,"Yes"
"7426","GO_MF","750774_GO_0001222_TRANSCRIPTION_COREPRESSOR_BINDING",8,-1.3389,0.12,0.27,"No",-1.0808,0.33,0.85,"No"
"7427","C7_Immunologic_signatures","C7_ALL_631_GSE17721_POLYIC_VS_CPG_16H_BMDM_UP",197,-1.3387,0.017,0.053,"No",-0.6467,1,1,"No"
"7428","C2_Chemical_and_genetic_perturbations","C2_CGP_414_LINDGREN_BLADDER_CANCER_CLUSTER_3_DN",224,-1.3386,0.025,0.15,"No",0.8127,0.96,0.98,"Yes"
"7429","KEGG_compound","C14869_TRICHLOROETHANOL_GLUCURONIDE_UROCHLORALIC_ACID_2_2_2_TRICHLOROETHYL_BETA_D_GLUCOPYRANOSIDURONIC_ACID",19,-1.3386,0.14,0.3,"No",1.9686,0.002,0.059,"Yes"
"7430","KEGG_compound","C05261_3_OXOTETRADECANOYL_COA",6,-1.3386,0.13,0.3,"No",0.8103,0.7,1,"Yes"
"7431","C2_Chemical_and_genetic_perturbations","C2_CGP_2310_ZHENG_GLIOBLASTOMA_PLASTICITY_DN",57,-1.3386,0.084,0.15,"No",0.8333,0.79,0.98,"Yes"
"7432","GO_BP","501603_GO_0032368_REGULATION_OF_LIPID_TRANSPORT",87,-1.3384,0.06,0.21,"No",1.0517,0.34,0.95,"Yes"
"7433","GO_MF","505705_GO_0042578_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY",349,-1.3383,0.013,0.27,"No",0.8911,0.89,0.98,"Yes"
"7434","GO_BP","491566_GO_0006678_GLUCOSYLCERAMIDE_METABOLIC_PROCESS",5,-1.3383,0.13,0.21,"No",-0.4575,0.99,1,"No"
"7435","KEGG_compound","C04554_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANATE_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANOATE",7,-1.3383,0.14,0.3,"No",0.7358,0.82,1,"Yes"
"7436","GO_BP","515100_GO_0070163_REGULATION_OF_ADIPONECTIN_SECRETION",6,-1.3381,0.14,0.21,"No",-1.3637,0.13,0.97,"No"
"7437","REACTOME","645288_REACT_120729_COLLAGEN_FORMATION",86,-1.3381,0.069,0.25,"No",-1.4376,0.024,0.51,"No"
"7438","GO_BP","503975_GO_0034776_RESPONSE_TO_HISTAMINE",11,-1.3381,0.13,0.21,"No",0.9101,0.57,1,"Yes"
"7439","REACTOME","530750_REACT_115810_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS",33,-1.338,0.11,0.25,"No",-0.7509,0.85,1,"No"
"7440","KEGG_reaction","R02549_4_AMINOBUTANAL_NAD_1_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NAD_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NAD_H2O_4_AMINOBUTANOATE_NADH_H_",5,-1.338,0.12,0.29,"No",0.7095,0.82,1,"Yes"
"7441","GO_BP","499722_GO_0030321_TRANSEPITHELIAL_CHLORIDE_TRANSPORT",6,-1.338,0.14,0.21,"No",1.034,0.44,0.96,"Yes"
"7442","KEGG_module","HSA_M00007_PENTOSE_PHOSPHATE_PATHWAY_NON_OXIDATIVE_PHASE_FRUCTOSE_6P_RIBOSE_5P",7,-1.3378,0.14,0.39,"No",0.9499,0.52,0.94,"Yes"
"7443","GO_BP","488321_GO_0002448_MAST_CELL_MEDIATED_IMMUNITY",19,-1.3377,0.13,0.21,"No",-0.9206,0.56,1,"No"
"7444","C2_Chemical_and_genetic_perturbations","C2_CGP_2677_VALK_AML_CLUSTER_1",27,-1.3375,0.11,0.15,"No",0.8169,0.74,0.98,"Yes"
"7445","GO_BP","488887_GO_0003091_RENAL_WATER_HOMEOSTASIS",34,-1.3374,0.1,0.21,"No",0.904,0.63,1,"Yes"
"7446","KEGG_pathway","HSA04725_CHOLINERGIC_SYNAPSE",112,-1.3373,0.042,0.1,"No",-1.3695,0.033,0.35,"No"
"7447","GO_BP","752577_GO_0090520_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY",8,-1.3372,0.12,0.21,"No",0.9204,0.55,1,"Yes"
"7448","C7_Immunologic_signatures","C7_ALL_108_GSE12366_GC_BCELL_VS_PLASMA_CELL_DN",188,-1.3372,0.035,0.054,"No",0.7748,0.98,1,"Yes"
"7449","GO_BP","513968_GO_0060412_VENTRICULAR_SEPTUM_MORPHOGENESIS",28,-1.3372,0.1,0.21,"No",-0.8425,0.7,1,"No"
"7450","C7_Immunologic_signatures","C7_ALL_1864_GSE9037_WT_VS_IRAK4_KO_BMDM_DN",194,-1.3371,0.032,0.054,"No",1.0491,0.34,0.59,"Yes"
"7451","GO_BP","486640_GO_0000098_SULFUR_AMINO_ACID_CATABOLIC_PROCESS",12,-1.3371,0.13,0.21,"No",0.7869,0.76,1,"Yes"
"7452","GO_BP","752181_GO_0061438_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS",7,-1.3371,0.13,0.21,"No",-1.224,0.21,0.88,"No"
"7453","GO_MF","490226_GO_0004935_ADRENERGIC_RECEPTOR_ACTIVITY",9,-1.337,0.13,0.27,"No",-1.3561,0.12,0.68,"No"
"7454","GO_BP","493483_GO_0009299_MRNA_TRANSCRIPTION",19,-1.337,0.1,0.21,"No",-1.0043,0.44,0.99,"No"
"7455","C2_Chemical_and_genetic_perturbations","C2_CGP_1859_SESTO_RESPONSE_TO_UV_C1",70,-1.3368,0.071,0.15,"No",1.2726,0.083,0.42,"Yes"
"7456","C2_Chemical_and_genetic_perturbations","C2_CGP_252_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP",55,-1.3368,0.075,0.15,"No",0.8607,0.74,0.96,"Yes"
"7457","GO_CC","499564_GO_0030140_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE",26,-1.3367,0.089,0.28,"No",1.1794,0.22,0.55,"Yes"
"7458","C2_Chemical_and_genetic_perturbations","C2_CGP_1666_ZHENG_RESPONSE_TO_ARSENITE_DN",17,-1.3367,0.12,0.15,"No",0.7972,0.74,0.99,"Yes"
"7459","GO_BP","516339_GO_0071415_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND",7,-1.3366,0.14,0.22,"No",0.7722,0.74,1,"Yes"
"7460","GO_BP","494637_GO_0010572_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION",6,-1.3366,0.14,0.22,"No",1.3526,0.14,0.61,"Yes"
"7461","KEGG_compound","C00668_ALPHA_D_GLUCOSE_6_PHOSPHATE",12,-1.3365,0.12,0.3,"No",-0.6566,0.89,1,"No"
"7462","GO_BP","491465_GO_0006569_TRYPTOPHAN_CATABOLIC_PROCESS",11,-1.3365,0.13,0.22,"No",-1.315,0.14,0.88,"No"
"7463","C2_Chemical_and_genetic_perturbations","C2_CGP_3367_DURAND_STROMA_S_UP",290,-1.3365,0.016,0.15,"No",1.3137,0.023,0.38,"Yes"
"7464","GO_BP","513993_GO_0060438_TRACHEA_DEVELOPMENT",14,-1.3365,0.12,0.22,"No",-0.9088,0.59,1,"No"
"7465","C2_Chemical_and_genetic_perturbations","C2_CGP_366_PACHER_TARGETS_OF_IGF1_AND_IGF2_UP",34,-1.3364,0.11,0.15,"No",-0.7851,0.82,1,"No"
"7466","REACTOME","106493_REACT_15295_OPIOID_SIGNALLING",83,-1.3363,0.06,0.25,"No",-1.2013,0.14,0.83,"No"
"7467","GO_BP","518919_GO_2000272_NEGATIVE_REGULATION_OF_RECEPTOR_ACTIVITY",14,-1.3362,0.13,0.22,"No",-1.2653,0.2,0.9,"No"
"7468","GO_BP","498859_GO_0021575_HINDBRAIN_MORPHOGENESIS",43,-1.3362,0.072,0.22,"No",-1.02,0.42,0.97,"No"
"7469","KEGG_compound","C05936_N4_ACETYLAMINOBUTANAL_4_ACETAMIDOBUTANAL",7,-1.3359,0.14,0.3,"No",0.8072,0.71,1,"Yes"
"7470","GO_BP","499947_GO_0030641_REGULATION_OF_CELLULAR_PH",46,-1.3359,0.084,0.22,"No",-1.0902,0.31,0.95,"No"
"7471","C2_Chemical_and_genetic_perturbations","C2_CGP_1578_HOEGERKORP_CD44_TARGETS_TEMPORAL_DN",24,-1.3359,0.11,0.15,"No",0.8219,0.72,0.98,"Yes"
"7472","GO_BP","487660_GO_0001764_NEURON_MIGRATION",111,-1.3357,0.04,0.22,"No",-1.3556,0.024,0.96,"No"
"7473","GO_BP","513502_GO_0055069_ZINC_ION_HOMEOSTASIS",17,-1.3356,0.15,0.22,"No",-0.9435,0.52,1,"No"
"7474","GO_MF","496729_GO_0016832_ALDEHYDE_LYASE_ACTIVITY",9,-1.3356,0.12,0.27,"No",0.64,0.9,1,"Yes"
"7475","GO_CC","500161_GO_0030863_CORTICAL_CYTOSKELETON",76,-1.3356,0.066,0.28,"No",1.033,0.4,0.74,"Yes"
"7476","KEGG_compound","C05267_3_OXOOCTANOYL_COA",6,-1.3355,0.14,0.3,"No",0.8223,0.68,1,"Yes"
"7477","KEGG_reaction","R02957_D_GLUCURONOLACTONE_NAD_OXIDOREDUCTASE_D_GLUCURONOLACTONE_NAD_2_H2O_D_GLUCARATE_NADH_H_",5,-1.3355,0.14,0.29,"No",0.6896,0.84,1,"Yes"
"7478","GO_BP","506419_GO_0043380_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION",8,-1.3353,0.13,0.22,"No",-1.2642,0.2,0.9,"No"
"7479","GO_MF","500975_GO_0031730_CCR5_CHEMOKINE_RECEPTOR_BINDING",8,-1.3353,0.14,0.27,"No",0.7943,0.75,1,"Yes"
"7480","GO_CC","500866_GO_0031616_SPINDLE_POLE_CENTROSOME",11,-1.3353,0.15,0.28,"No",-0.6291,0.92,1,"No"
"7481","GO_BP","510292_GO_0048167_REGULATION_OF_SYNAPTIC_PLASTICITY",122,-1.3352,0.043,0.22,"No",-1.2496,0.068,0.91,"No"
"7482","C4_Cancer_modules","C4_CM_53_MODULE_57",56,-1.3352,0.064,0.14,"No",0.7437,0.92,1,"Yes"
"7483","C7_Immunologic_signatures","C7_ALL_1554_GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN",198,-1.3351,0.026,0.055,"No",0.6047,1,1,"Yes"
"7484","GO_BP","517434_GO_0072529_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",35,-1.335,0.1,0.22,"No",1.1023,0.29,0.9,"Yes"
"7485","C2_Chemical_and_genetic_perturbations","C2_CGP_3374_GHANDHI_DIRECT_IRRADIATION_DN",33,-1.3348,0.12,0.15,"No",-1.2435,0.16,0.75,"No"
"7486","KEGG_compound","C02593_TETRADECANOYL_COA_MYRISTOYL_COA",8,-1.3348,0.13,0.3,"No",-0.5635,0.95,1,"No"
"7487","C7_Immunologic_signatures","C7_ALL_1086_GSE25087_TREG_VS_TCONV_ADULT_DN",193,-1.3348,0.033,0.055,"No",1.1831,0.12,0.25,"Yes"
"7488","GO_BP","488353_GO_0002480_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_TAP_INDEPENDENT",9,-1.3348,0.14,0.22,"No",1.0039,0.45,0.98,"Yes"
"7489","KEGG_compound","C01832_LAUROYL_COA_LAUROYL_COENZYME_A_DODECANOYL_COA",8,-1.3348,0.12,0.3,"No",-0.5577,0.97,1,"No"
"7490","GO_BP","487732_GO_0001836_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",24,-1.3347,0.11,0.22,"No",0.5686,0.99,1,"Yes"
"7491","C2_Chemical_and_genetic_perturbations","C2_CGP_2308_EHLERS_ANEUPLOIDY_DN",12,-1.3347,0.13,0.15,"No",0.7839,0.73,1,"Yes"
"7492","C7_Immunologic_signatures","C7_ALL_1123_GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP",196,-1.3346,0.022,0.055,"No",0.7735,0.98,1,"Yes"
"7493","C3_TF_targets","C3_TFT_2_AAAYRNCTG_UNKNOWN",362,-1.3346,0.0095,0.066,"No",1.0264,0.37,1,"Yes"
"7494","GO_BP","505451_GO_0042304_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS",30,-1.3346,0.1,0.22,"No",0.769,0.84,1,"Yes"
"7495","C7_Immunologic_signatures","C7_ALL_1368_GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN",198,-1.3346,0.023,0.055,"No",1.017,0.37,0.69,"Yes"
"7496","GO_MF","754300_GO_1901338_CATECHOLAMINE_BINDING",15,-1.3345,0.13,0.27,"No",-0.9818,0.48,0.93,"No"
"7497","GO_BP","514046_GO_0060491_REGULATION_OF_CELL_PROJECTION_ASSEMBLY",128,-1.3345,0.045,0.22,"No",-0.7484,0.96,1,"No"
"7498","GO_MF","489668_GO_0004301_EPOXIDE_HYDROLASE_ACTIVITY",5,-1.3344,0.14,0.27,"No",-0.987,0.5,0.92,"No"
"7499","C2_Chemical_and_genetic_perturbations","C2_CGP_150_BORCZUK_MALIGNANT_MESOTHELIOMA_DN",97,-1.3343,0.05,0.15,"No",-1.4841,0.011,0.48,"No"
"7500","GO_BP","490968_GO_0005980_GLYCOGEN_CATABOLIC_PROCESS",20,-1.3342,0.093,0.22,"No",-0.989,0.47,1,"No"
"7501","GO_CC","490802_GO_0005770_LATE_ENDOSOME",197,-1.3341,0.029,0.28,"No",1.2458,0.057,0.47,"Yes"
"7502","GO_BP","1051071_GO_1903431_POSITIVE_REGULATION_OF_CELL_MATURATION",5,-1.334,0.14,0.22,"No",-1.1999,0.29,0.9,"No"
"7503","C6_Oncogenic_signatures","C6_ALL_1_GLI1_UP_V1_DN",28,-1.334,0.11,0.062,"No",0.8617,0.69,1,"Yes"
"7504","KEGG_pathway","HSA05222_SMALL_CELL_LUNG_CANCER",86,-1.3338,0.06,0.11,"No",-0.8069,0.84,0.99,"No"
"7505","GO_MF","496924_GO_0017124_SH3_DOMAIN_BINDING",113,-1.3338,0.056,0.27,"No",-0.7742,0.95,1,"No"
"7506","GO_MF","487682_GO_0001786_PHOSPHATIDYLSERINE_BINDING",22,-1.3337,0.1,0.27,"No",-0.8847,0.65,1,"No"
"7507","C4_Cancer_gene_neighborhoods","C4_CGN_337_GNF2_CDH3",26,-1.3337,0.11,0.18,"No",0.8547,0.68,0.93,"Yes"
"7508","C2_Chemical_and_genetic_perturbations","C2_CGP_773_SILIGAN_BOUND_BY_EWS_FLT1_FUSION",46,-1.3337,0.11,0.15,"No",0.6922,0.95,1,"Yes"
"7509","KEGG_pathway","HSA00770_PANTOTHENATE_AND_COA_BIOSYNTHESIS",18,-1.3336,0.13,0.11,"No",-0.9784,0.5,0.91,"No"
"7510","GO_BP","492364_GO_0007623_CIRCADIAN_RHYTHM",140,-1.3336,0.04,0.22,"No",-1.041,0.35,0.98,"No"
"7511","KEGG_compound","C01277_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_4_PHOSPHATE_",21,-1.3336,0.1,0.3,"No",-1.0564,0.39,0.99,"No"
"7512","C2_Chemical_and_genetic_perturbations","C2_CGP_1466_STOSSI_RESPONSE_TO_ESTRADIOL",47,-1.3336,0.077,0.15,"No",-0.9692,0.47,1,"No"
"7513","C3_TF_targets","C3_TFT_504_RNCTGNYNRNCTGNY_UNKNOWN",79,-1.3335,0.08,0.067,"No",-1.1416,0.23,0.45,"No"
"7514","C3_MicroRNA_targets","C3_MIR_54_CATTTCA_MIR_203",282,-1.3335,0.014,0.26,"No",-0.7184,1,1,"No"
"7515","GO_BP","493413_GO_0009217_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS",5,-1.3335,0.15,0.22,"No",0.6059,0.91,1,"Yes"
"7516","REACTOME","106131_REACT_160_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS",6,-1.3335,0.12,0.25,"No",1.1221,0.34,0.55,"Yes"
"7517","GO_CC","501817_GO_0032591_DENDRITIC_SPINE_MEMBRANE",7,-1.3334,0.14,0.28,"No",-1.0257,0.44,0.84,"No"
"7518","C2_Chemical_and_genetic_perturbations","C2_CGP_1461_WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN",24,-1.3333,0.11,0.15,"No",1.0499,0.37,0.71,"Yes"
"7519","C3_TF_targets","C3_TFT_16_V_RSRFC4_01",240,-1.333,0.014,0.067,"No",-1.239,0.059,0.29,"No"
"7520","GO_BP","516237_GO_0071313_CELLULAR_RESPONSE_TO_CAFFEINE",7,-1.333,0.14,0.22,"No",0.7685,0.74,1,"Yes"
"7521","C3_MicroRNA_targets","C3_MIR_126_CCTGCTG_MIR_214",239,-1.333,0.019,0.25,"No",-0.9169,0.7,1,"No"
"7522","GO_BP","510412_GO_0048305_IMMUNOGLOBULIN_SECRETION",5,-1.3328,0.13,0.22,"No",0.9653,0.5,1,"Yes"
"7523","REACTOME","576268_REACT_118798_PRE_NOTCH_PROCESSING_IN_GOLGI",18,-1.3327,0.11,0.25,"No",-0.9061,0.63,1,"No"
"7524","WikiPathways","920962_WP1455_SEROTONIN_TRANSPORTER_ACTIVITY",10,-1.3326,0.13,0.17,"No",-0.975,0.48,1,"No"
"7525","C7_Immunologic_signatures","C7_ALL_1238_GSE28237_EARLY_VS_LATE_GC_BCELL_DN",197,-1.3326,0.02,0.056,"No",0.8674,0.81,1,"Yes"
"7526","GO_CC","507388_GO_0044440_ENDOSOMAL_PART",388,-1.3325,0.0095,0.28,"No",1.0803,0.17,0.67,"Yes"
"7527","C2_Chemical_and_genetic_perturbations","C2_CGP_825_MAINA_HYPOXIA_VHL_TARGETS_UP",6,-1.3324,0.15,0.15,"No",-0.9542,0.53,1,"No"
"7528","C3_TF_targets","C3_TFT_567_TTAYRTAA_V_E4BP4_01",260,-1.3322,0.021,0.067,"No",-1.3011,0.0087,0.24,"No"
"7529","C7_Immunologic_signatures","C7_ALL_909_GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP",195,-1.3322,0.025,0.057,"No",0.8624,0.86,1,"Yes"
"7530","GO_MF","496311_GO_0016247_CHANNEL_REGULATOR_ACTIVITY",119,-1.3322,0.049,0.27,"No",-1.1378,0.19,0.8,"No"
"7531","KEGG_pathway","HSA04150_MTOR_SIGNALING_PATHWAY",59,-1.3322,0.067,0.11,"No",0.804,0.82,1,"Yes"
"7532","GO_BP","492038_GO_0007259_JAK_STAT_CASCADE",53,-1.3322,0.078,0.22,"No",0.7241,0.93,1,"Yes"
"7533","GO_BP","487734_GO_0001838_EMBRYONIC_EPITHELIAL_TUBE_FORMATION",117,-1.3322,0.043,0.22,"No",-0.7388,0.97,1,"No"
"7534","C7_Immunologic_signatures","C7_ALL_993_GSE22886_NAIVE_CD4_TCELL_VS_DC_UP",196,-1.3321,0.036,0.057,"No",1.3248,0.021,0.081,"Yes"
"7535","GO_BP","514096_GO_0060541_RESPIRATORY_SYSTEM_DEVELOPMENT",206,-1.332,0.034,0.22,"No",-0.8484,0.88,1,"No"
"7536","GO_MF","489641_GO_0004175_ENDOPEPTIDASE_ACTIVITY",395,-1.3319,0.011,0.27,"No",0.9031,0.84,0.98,"Yes"
"7537","C2_Chemical_and_genetic_perturbations","C2_CGP_2465_BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP",38,-1.3319,0.1,0.15,"No",0.773,0.85,1,"Yes"
"7538","GO_BP","507575_GO_0045197_ESTABLISHMENT_OR_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY",25,-1.3319,0.11,0.22,"No",1.1574,0.24,0.83,"Yes"
"7539","C2_Chemical_and_genetic_perturbations","C2_CGP_2728_CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN",24,-1.3317,0.12,0.15,"No",-1.1789,0.21,0.82,"No"
"7540","KEGG_compound","C00954_INDOLE_3_ACETATE_INDOLE_3_ACETIC_ACID_INDOL_3_YL_ACETATE_INDOLEACETATE_INDOLEACETIC_ACID_IAA",5,-1.3317,0.14,0.3,"No",0.7121,0.84,1,"Yes"
"7541","C7_Immunologic_signatures","C7_ALL_1388_GSE339_CD8POS_VS_CD4CD8DN_DC_DN",198,-1.3315,0.018,0.057,"No",0.6536,1,1,"Yes"
"7542","KEGG_compound","C00877_CROTONOYL_COA_CROTONYL_COA_2_BUTENOYL_COA_TRANS_BUT_2_ENOYL_COA_BUT_2_ENOYL_COA_E_BUT_2_ENOYL_COA",9,-1.3313,0.15,0.3,"No",0.5261,0.99,1,"Yes"
"7543","GO_MF","490184_GO_0004887_THYROID_HORMONE_RECEPTOR_ACTIVITY",7,-1.3312,0.14,0.27,"No",-1.0856,0.37,0.85,"No"
"7544","GO_BP","487883_GO_0001993_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE",9,-1.3312,0.15,0.22,"No",0.893,0.59,1,"Yes"
"7545","C2_Chemical_and_genetic_perturbations","C2_CGP_2369_BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP",119,-1.3312,0.043,0.15,"No",-0.8123,0.89,1,"No"
"7546","C2_Chemical_and_genetic_perturbations","C2_CGP_912_CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN",5,-1.3311,0.16,0.15,"No",-0.8156,0.68,1,"No"
"7547","GO_BP","755329_GO_2001223_NEGATIVE_REGULATION_OF_NEURON_MIGRATION",7,-1.3311,0.13,0.22,"No",-1.0599,0.38,0.96,"No"
"7548","GO_BP","507702_GO_0045345_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS",5,-1.331,0.16,0.22,"No",1.0634,0.4,0.94,"Yes"
"7549","KEGG_compound","C05581_3_METHOXY_4_HYDROXYPHENYLACETALDEHYDE_4_HYDROXY_3_METHOXYPHENYL_ACETALDEHYDE_HOMOVANILLIN",6,-1.331,0.14,0.3,"No",0.911,0.56,1,"Yes"
"7550","GO_MF","510201_GO_0048037_COFACTOR_BINDING",255,-1.331,0.021,0.27,"No",-0.7883,0.97,1,"No"
"7551","GO_CC","502062_GO_0032839_DENDRITE_CYTOPLASM",16,-1.331,0.12,0.28,"No",0.974,0.49,0.82,"Yes"
"7552","GO_CC","487149_GO_0000922_SPINDLE_POLE",118,-1.331,0.058,0.28,"No",0.7244,0.99,0.99,"Yes"
"7553","GO_CC","500430_GO_0031143_PSEUDOPODIUM",16,-1.331,0.13,0.28,"No",0.963,0.51,0.82,"Yes"
"7554","GO_MF","489498_GO_0004029_ALDEHYDE_DEHYDROGENASE_NAD_ACTIVITY",18,-1.331,0.12,0.27,"No",0.9108,0.58,0.98,"Yes"
"7555","WikiPathways","198836_WP313_SIGNALING_OF_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR",33,-1.331,0.1,0.17,"No",0.6522,0.96,1,"Yes"
"7556","GO_BP","501747_GO_0032516_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",13,-1.3309,0.15,0.22,"No",0.8544,0.65,1,"Yes"
"7557","C4_Cancer_gene_neighborhoods","C4_CGN_382_GNF2_MMP11",35,-1.3308,0.091,0.18,"No",1.1253,0.26,0.33,"Yes"
"7558","C7_Immunologic_signatures","C7_ALL_533_GSE17721_LPS_VS_POLYIC_4H_BMDM_UP",198,-1.3307,0.019,0.057,"No",1.4539,0,0.021,"Yes"
"7559","REACTOME","576260_REACT_118659_RORA_ACTIVATES_GENE_EXPRESSION",27,-1.3307,0.1,0.25,"No",-0.9611,0.52,1,"No"
"7560","C2_Chemical_and_genetic_perturbations","C2_CGP_2643_MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED",34,-1.3307,0.11,0.15,"No",0.8899,0.62,0.94,"Yes"
"7561","C6_Oncogenic_signatures","C6_ALL_109_PTEN_DN_V1_DN",178,-1.3306,0.035,0.064,"No",1.2587,0.045,0.38,"Yes"
"7562","C7_Immunologic_signatures","C7_ALL_1534_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN",199,-1.3306,0.019,0.057,"No",0.8686,0.85,1,"Yes"
"7563","GO_BP","517018_GO_0072102_GLOMERULUS_MORPHOGENESIS",8,-1.3304,0.14,0.22,"No",-1.2369,0.19,0.9,"No"
"7564","C7_Immunologic_signatures","C7_ALL_487_GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_UP",198,-1.3304,0.028,0.058,"No",1.3893,0,0.041,"Yes"
"7565","C1_Positional","C1_ALL_222_CHR21Q11",15,-1.3303,0.12,0.59,"No",0.9833,0.47,0.78,"Yes"
"7566","C7_Immunologic_signatures","C7_ALL_486_GSE17721_CTRL_VS_PAM3CSK4_4H_BMDM_DN",196,-1.3303,0.036,0.058,"No",-0.9093,0.71,1,"No"
"7567","GO_BP","754749_GO_1901798_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",19,-1.3301,0.15,0.22,"No",-0.6875,0.9,1,"No"
"7568","C1_Positional","C1_ALL_162_CHR2P13",73,-1.33,0.072,0.57,"No",-1.1106,0.26,1,"No"
"7569","C2_Chemical_and_genetic_perturbations","C2_CGP_586_TAKAYAMA_BOUND_BY_AR",10,-1.3299,0.14,0.15,"No",0.9757,0.48,0.82,"Yes"
"7570","REACTOME","106407_REACT_8012_CREATION_OF_C4_AND_C2_ACTIVATORS",11,-1.3299,0.15,0.25,"No",1.3738,0.14,0.25,"Yes"
"7571","C2_Chemical_and_genetic_perturbations","C2_CGP_1533_AFFAR_YY1_TARGETS_UP",209,-1.3299,0.025,0.15,"No",1.0796,0.27,0.66,"Yes"
"7572","C7_Immunologic_signatures","C7_ALL_535_GSE17721_LPS_VS_POLYIC_6H_BMDM_UP",198,-1.3298,0.031,0.058,"No",1.32,0.026,0.085,"Yes"
"7573","GO_BP","507350_GO_0044344_CELLULAR_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR_STIMULUS",181,-1.3298,0.024,0.22,"No",-0.9489,0.61,1,"No"
"7574","C2_Chemical_and_genetic_perturbations","C2_CGP_2632_HSIAO_HOUSEKEEPING_GENES",389,-1.3295,0.0074,0.15,"No",3.0159,0,0,"Yes"
"7575","GO_BP","493861_GO_0009749_RESPONSE_TO_GLUCOSE",107,-1.3295,0.053,0.22,"No",0.8964,0.71,1,"Yes"
"7576","GO_BP","487774_GO_0001878_RESPONSE_TO_YEAST",5,-1.3294,0.14,0.22,"No",0.8427,0.66,1,"Yes"
"7577","C6_Oncogenic_signatures","C6_ALL_84_CTIP_DN_V1_UP",122,-1.3293,0.042,0.064,"No",-1.1516,0.2,0.48,"No"
"7578","GO_BP","505612_GO_0042475_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH",72,-1.3292,0.074,0.22,"No",-1.007,0.46,0.98,"No"
"7579","C7_Immunologic_signatures","C7_ALL_784_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0_5H_CD4_TCELL_DN",188,-1.329,0.029,0.058,"No",-0.9343,0.64,1,"No"
"7580","GO_MF","489960_GO_0004630_PHOSPHOLIPASE_D_ACTIVITY",6,-1.3289,0.16,0.28,"No",-0.4786,0.99,1,"No"
"7581","C4_Cancer_modules","C4_CM_375_MODULE_459",422,-1.3288,0.0063,0.15,"No",0.9656,0.6,0.76,"Yes"
"7582","C2_Chemical_and_genetic_perturbations","C2_CGP_1043_BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN",46,-1.3287,0.09,0.15,"No",1.0224,0.41,0.77,"Yes"
"7583","GO_BP","518658_GO_2000009_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",9,-1.3287,0.16,0.22,"No",-1.3331,0.14,0.91,"No"
"7584","GO_BP","508869_GO_0046621_NEGATIVE_REGULATION_OF_ORGAN_GROWTH",23,-1.3287,0.1,0.22,"No",-0.788,0.81,1,"No"
"7585","GO_BP","495019_GO_0010954_POSITIVE_REGULATION_OF_PROTEIN_PROCESSING",17,-1.3286,0.13,0.22,"No",-1.4109,0.073,0.96,"No"
"7586","GO_BP","508029_GO_0045684_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT",29,-1.3286,0.1,0.22,"No",-1.2496,0.16,0.91,"No"
"7587","C4_Cancer_modules","C4_CM_406_MODULE_522",33,-1.3286,0.097,0.15,"No",-0.7837,0.83,0.98,"No"
"7588","C1_Positional","C1_ALL_124_CHR12Q12",58,-1.3285,0.075,0.56,"No",-0.9524,0.53,1,"No"
"7589","KEGG_compound","C05265_3_OXODECANOYL_COA",6,-1.3285,0.15,0.3,"No",0.82,0.66,1,"Yes"
"7590","C2_Chemical_and_genetic_perturbations","C2_CGP_1196_NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON",13,-1.3284,0.14,0.15,"No",-0.9984,0.46,1,"No"
"7591","GO_BP","496145_GO_0016045_DETECTION_OF_BACTERIUM",15,-1.3282,0.13,0.22,"No",0.9233,0.56,1,"Yes"
"7592","GO_MF","498056_GO_0019201_NUCLEOTIDE_KINASE_ACTIVITY",24,-1.3281,0.12,0.28,"No",-1.1563,0.24,0.81,"No"
"7593","GO_MF","752378_GO_0086006_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",5,-1.3281,0.13,0.28,"No",-1.4825,0.063,0.59,"No"
"7594","C3_TF_targets","C3_TFT_38_V_TAL1BETAE47_01",241,-1.328,0.021,0.07,"No",-1.2266,0.053,0.3,"No"
"7595","GO_CC","503587_GO_0034385_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE",20,-1.328,0.12,0.28,"No",0.7956,0.78,0.96,"Yes"
"7596","GO_MF","502975_GO_0033764_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",23,-1.3279,0.11,0.28,"No",1.4521,0.059,0.43,"Yes"
"7597","GO_BP","498346_GO_0019511_PEPTIDYL_PROLINE_HYDROXYLATION",13,-1.3279,0.15,0.22,"No",-0.9828,0.47,1,"No"
"7598","GO_BP","499491_GO_0030032_LAMELLIPODIUM_ASSEMBLY",33,-1.3278,0.1,0.22,"No",0.8264,0.75,1,"Yes"
"7599","GO_BP","486733_GO_0000212_MEIOTIC_SPINDLE_ORGANIZATION",7,-1.3278,0.12,0.22,"No",-0.9787,0.47,1,"No"
"7600","GO_CC","490906_GO_0005905_COATED_PIT",64,-1.3278,0.074,0.28,"No",0.7153,0.95,0.99,"Yes"
"7601","GO_CC","506122_GO_0043034_COSTAMERE",19,-1.3276,0.12,0.28,"No",-1.3402,0.12,0.62,"No"
"7602","C2_Chemical_and_genetic_perturbations","C2_CGP_1553_DORSEY_GAB2_TARGETS",30,-1.3276,0.12,0.15,"No",1.0728,0.35,0.67,"Yes"
"7603","C2_Chemical_and_genetic_perturbations","C2_CGP_1661_RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN",40,-1.3275,0.097,0.15,"No",1.14,0.25,0.57,"Yes"
"7604","KEGG_compound","C00206_DADP_2_DEOXYADENOSINE_5_DIPHOSPHATE",23,-1.3274,0.11,0.3,"No",-0.7992,0.78,1,"No"
"7605","GO_BP","502429_GO_0033209_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY",29,-1.3274,0.12,0.22,"No",-0.5774,0.99,1,"No"
"7606","C2_Chemical_and_genetic_perturbations","C2_CGP_759_XU_AKT1_TARGETS_48HR",9,-1.3274,0.14,0.15,"No",0.5812,0.94,1,"Yes"
"7607","C2_Chemical_and_genetic_perturbations","C2_CGP_2288_MOSERLE_IFNA_RESPONSE",31,-1.3273,0.12,0.15,"No",2.1962,0,0.00059,"Yes"
"7608","REACTOME","106474_REACT_12464_PI3K_AKT_ACTIVATION",94,-1.3273,0.06,0.26,"No",-1.1548,0.19,0.85,"No"
"7609","C7_Immunologic_signatures","C7_ALL_718_GSE17721_0_5H_VS_12H_POLYIC_BMDM_DN",199,-1.3271,0.019,0.06,"No",-0.9165,0.69,1,"No"
"7610","C2_Chemical_and_genetic_perturbations","C2_CGP_649_RASHI_RESPONSE_TO_IONIZING_RADIATION_5",146,-1.3271,0.039,0.15,"No",0.7812,0.97,1,"Yes"
"7611","C3_MicroRNA_targets","C3_MIR_204_CTTTGCA_MIR_527",231,-1.327,0.02,0.26,"No",-1.1152,0.19,1,"No"
"7612","C2_Chemical_and_genetic_perturbations","C2_CGP_2042_HOWLIN_CITED1_TARGETS_1_DN",37,-1.327,0.096,0.15,"No",1.2757,0.12,0.42,"Yes"
"7613","C7_Immunologic_signatures","C7_ALL_1463_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP",193,-1.3269,0.03,0.06,"No",-0.6515,1,1,"No"
"7614","C3_MicroRNA_targets","C3_MIR_25_TACTTGA_MIR_26A_MIR_26B",299,-1.3268,0.014,0.25,"No",0.8287,0.95,1,"Yes"
"7615","C7_Immunologic_signatures","C7_ALL_1446_GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN",193,-1.3264,0.031,0.06,"No",-1.0901,0.26,1,"No"
"7616","C2_Chemical_and_genetic_perturbations","C2_CGP_2235_MCCABE_HOXC6_TARGETS_CANCER_DN",20,-1.3264,0.1,0.16,"No",-0.7884,0.78,1,"No"
"7617","C4_Cancer_modules","C4_CM_322_MODULE_378",426,-1.3264,0.011,0.15,"No",0.9632,0.58,0.76,"Yes"
"7618","C6_Oncogenic_signatures","C6_ALL_25_AKT_UP_MTOR_DN_V1_DN",174,-1.3263,0.033,0.065,"No",0.9027,0.77,0.97,"Yes"
"7619","GO_BP","494835_GO_0010770_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION",136,-1.3263,0.054,0.23,"No",-1.0821,0.28,0.95,"No"
"7620","C2_Chemical_and_genetic_perturbations","C2_CGP_3087_FIGUEROA_AML_METHYLATION_CLUSTER_5_DN",48,-1.3262,0.085,0.16,"No",1.3612,0.058,0.33,"Yes"
"7621","GO_BP","508721_GO_0046460_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS",45,-1.3262,0.077,0.23,"No",-0.5779,0.99,1,"No"
"7622","GO_MF","490187_GO_0004890_GABA_A_RECEPTOR_ACTIVITY",17,-1.3261,0.13,0.28,"No",-1.2184,0.21,0.83,"No"
"7623","KEGG_compound","C11132_2_METHOXYESTRONE_3_GLUCURONIDE",19,-1.3261,0.13,0.3,"No",1.929,0,0.018,"Yes"
"7624","GO_BP","500359_GO_0031069_HAIR_FOLLICLE_MORPHOGENESIS",29,-1.3261,0.1,0.23,"No",-1.1441,0.26,0.93,"No"
"7625","GO_BP","517080_GO_0072164_MESONEPHRIC_TUBULE_DEVELOPMENT",87,-1.326,0.064,0.23,"No",-0.8954,0.7,1,"No"
"7626","GO_MF","511634_GO_0050662_COENZYME_BINDING",180,-1.326,0.026,0.28,"No",0.7269,1,1,"Yes"
"7627","C7_Immunologic_signatures","C7_ALL_1885_GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP",198,-1.326,0.025,0.06,"No",1.4762,0.0048,0.016,"Yes"
"7628","C2_Chemical_and_genetic_perturbations","C2_CGP_960_OHM_EMBRYONIC_CARCINOMA_UP",6,-1.326,0.15,0.16,"No",-0.6029,0.92,1,"No"
"7629","GO_MF","499652_GO_0030247_POLYSACCHARIDE_BINDING",19,-1.3259,0.11,0.28,"No",-0.9493,0.5,0.94,"No"
"7630","KEGG_pathway","HSA00601_GLYCOSPHINGOLIPID_BIOSYNTHESIS",26,-1.3259,0.11,0.11,"No",0.7464,0.87,1,"Yes"
"7631","C2_Chemical_and_genetic_perturbations","C2_CGP_1024_GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP",21,-1.3258,0.14,0.16,"No",1.2133,0.18,0.48,"Yes"
"7632","WikiPathways","198897_WP24_PEPTIDE_GPCRS",72,-1.3258,0.084,0.17,"No",1.3176,0.051,0.65,"Yes"
"7633","C2_Chemical_and_genetic_perturbations","C2_CGP_459_GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP",227,-1.3258,0.039,0.16,"No",-1.0139,0.41,0.98,"No"
"7634","GO_BP","490965_GO_0005977_GLYCOGEN_METABOLIC_PROCESS",58,-1.3258,0.085,0.23,"No",0.8715,0.71,1,"Yes"
"7635","C2_Chemical_and_genetic_perturbations","C2_CGP_2762_MEISSNER_NPC_HCP_WITH_H3K4ME2",473,-1.3257,0.0073,0.16,"No",-1.2565,0.015,0.74,"No"
"7636","C4_Cancer_gene_neighborhoods","C4_CGN_210_GCM_AQP4",44,-1.3254,0.09,0.19,"No",-0.8383,0.74,1,"No"
"7637","GO_BP","513521_GO_0055088_LIPID_HOMEOSTASIS",99,-1.3253,0.075,0.23,"No",-0.7166,0.98,1,"No"
"7638","REACTOME","187191_REACT_25060_IRON_UPTAKE_AND_TRANSPORT",42,-1.3253,0.096,0.26,"No",0.862,0.69,0.94,"Yes"
"7639","C2_Chemical_and_genetic_perturbations","C2_CGP_2658_CROONQUIST_IL6_DEPRIVATION_UP",20,-1.3252,0.12,0.16,"No",1.0855,0.33,0.65,"Yes"
"7640","KEGG_compound","C15972_ENZYME_N6_LIPOYL_LYSINE_LIPOAMIDE_E",8,-1.3252,0.15,0.3,"No",1.316,0.17,0.71,"Yes"
"7641","C4_Cancer_gene_neighborhoods","C4_CGN_103_MORF_FOSL1",395,-1.3251,0.0094,0.18,"No",-1.1547,0.11,0.66,"No"
"7642","C3_MicroRNA_targets","C3_MIR_61_AGGGCAG_MIR_18A",135,-1.3249,0.041,0.25,"No",-1.0267,0.39,1,"No"
"7643","C2_Chemical_and_genetic_perturbations","C2_CGP_2736_HOSHIDA_LIVER_CANCER_SURVIVAL_DN",113,-1.3248,0.05,0.16,"No",1.1502,0.16,0.56,"Yes"
"7644","C2_Chemical_and_genetic_perturbations","C2_CGP_35_BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP",201,-1.3248,0.025,0.16,"No",0.8309,0.93,0.98,"Yes"
"7645","C3_TF_targets","C3_TFT_281_V_TBP_01",229,-1.3246,0.023,0.073,"No",-1.0191,0.38,0.72,"No"
"7646","GO_BP","492363_GO_0007622_RHYTHMIC_BEHAVIOR",17,-1.3245,0.13,0.23,"No",-0.9913,0.45,1,"No"
"7647","C3_MicroRNA_targets","C3_MIR_60_CTATGCA_MIR_153",215,-1.3245,0.03,0.25,"No",-0.9459,0.6,1,"No"
"7648","C3_MicroRNA_targets","C3_MIR_51_ACAACTT_MIR_382",71,-1.3245,0.077,0.24,"No",-0.6243,1,1,"No"
"7649","KEGG_reaction","R05050_N4_ACETYLAMINOBUTANAL_NAD_OXIDOREDUCTASE_N4_ACETYLAMINOBUTANAL_NAD_H2O_4_ACETAMIDOBUTANOATE_NADH_H_",5,-1.3244,0.14,0.3,"No",0.7031,0.84,1,"Yes"
"7650","C7_Immunologic_signatures","C7_ALL_685_GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_UP",198,-1.3243,0.021,0.062,"No",0.9068,0.76,1,"Yes"
"7651","WikiPathways","198788_WP707_DNA_DAMAGE_RESPONSE",67,-1.3242,0.072,0.17,"No",-0.8621,0.73,1,"No"
"7652","C3_TF_targets","C3_TFT_319_V_NERF_Q2",247,-1.3241,0.021,0.073,"No",-0.9997,0.44,0.76,"No"
"7653","GO_BP","491622_GO_0006739_NADP_METABOLIC_PROCESS",29,-1.3241,0.093,0.23,"No",-0.9619,0.5,1,"No"
"7654","C2_Chemical_and_genetic_perturbations","C2_CGP_226_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP",30,-1.324,0.11,0.16,"No",-1.0324,0.37,0.97,"No"
"7655","GO_BP","495295_GO_0014904_MYOTUBE_CELL_DEVELOPMENT",21,-1.324,0.13,0.23,"No",-1.2523,0.18,0.91,"No"
"7656","C3_MicroRNA_targets","C3_MIR_197_ACACTAC_MIR_142_3P",130,-1.324,0.05,0.24,"No",-0.7758,0.95,1,"No"
"7657","GO_BP","504490_GO_0035306_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION",40,-1.3239,0.09,0.23,"No",0.7458,0.89,1,"Yes"
"7658","C2_Chemical_and_genetic_perturbations","C2_CGP_282_LEE_NEURAL_CREST_STEM_CELL_DN",114,-1.3237,0.067,0.16,"No",-1.0361,0.37,0.98,"No"
"7659","GO_BP","512736_GO_0051881_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL",35,-1.3237,0.1,0.23,"No",1.0555,0.34,0.94,"Yes"
"7660","REACTOME","106139_REACT_17062_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS",6,-1.3236,0.15,0.26,"No",0.4703,0.99,1,"Yes"
"7661","C2_Chemical_and_genetic_perturbations","C2_CGP_2407_HUANG_DASATINIB_RESISTANCE_DN",67,-1.3236,0.078,0.16,"No",-0.6719,0.98,1,"No"
"7662","GO_MF","501791_GO_0032561_GUANYL_RIBONUCLEOTIDE_BINDING",380,-1.3236,0.012,0.28,"No",0.9372,0.75,0.94,"Yes"
"7663","C2_Chemical_and_genetic_perturbations","C2_CGP_1248_ROZANOV_MMP14_TARGETS_SUBSET",33,-1.3236,0.085,0.16,"No",0.7472,0.89,1,"Yes"
"7664","GO_MF","490642_GO_0005547_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING",34,-1.3235,0.099,0.28,"No",-0.95,0.54,0.95,"No"
"7665","KEGG_module","HSA_M00695_CAMP_SIGNALING",14,-1.3233,0.14,0.41,"No",-0.598,0.98,1,"No"
"7666","C3_TF_targets","C3_TFT_500_MCAATNNNNNGCG_UNKNOWN",82,-1.3233,0.067,0.073,"No",-0.8368,0.79,1,"No"
"7667","C2_Chemical_and_genetic_perturbations","C2_CGP_1908_XU_GH1_EXOGENOUS_TARGETS_DN",113,-1.3232,0.058,0.16,"No",1.1717,0.16,0.53,"Yes"
"7668","GO_BP","499701_GO_0030299_INTESTINAL_CHOLESTEROL_ABSORPTION",8,-1.3232,0.13,0.23,"No",-1.8271,0.004,0.42,"No"
"7669","C2_Chemical_and_genetic_perturbations","C2_CGP_2882_ZHAN_MULTIPLE_MYELOMA_LB_DN",41,-1.3231,0.091,0.16,"No",0.8103,0.8,0.98,"Yes"
"7670","C7_Immunologic_signatures","C7_ALL_1352_GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN",200,-1.3231,0.03,0.062,"No",0.8316,0.93,1,"Yes"
"7671","REACTOME","106242_REACT_17004_CHAPERONIN_MEDIATED_PROTEIN_FOLDING",49,-1.323,0.098,0.26,"No",1.115,0.25,0.56,"Yes"
"7672","C2_Chemical_and_genetic_perturbations","C2_CGP_1592_PETROVA_PROX1_TARGETS_UP",28,-1.323,0.11,0.16,"No",-0.7755,0.82,1,"No"
"7673","GO_BP","508219_GO_0045912_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS",49,-1.3226,0.083,0.23,"No",-0.5548,1,1,"No"
"7674","OMIM_gene","OMIM609916_5_AZACYTIDINE_INDUCED_GENE_2_MOUSE_HOMOLOG_OF_AZI2",10,-1.3226,0.13,1,"No",-0.6922,0.86,0.94,"No"
"7675","GO_BP","516990_GO_0072073_KIDNEY_EPITHELIUM_DEVELOPMENT",125,-1.3224,0.047,0.23,"No",-0.9298,0.61,1,"No"
"7676","C7_Immunologic_signatures","C7_ALL_412_GSE15930_STIM_VS_STIM_AND_IL_12_24H_CD8_T_CELL_DN",193,-1.3224,0.037,0.063,"No",1.0175,0.4,0.69,"Yes"
"7677","GO_BP","750930_GO_0036005_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR",7,-1.3223,0.14,0.23,"No",0.8481,0.65,1,"Yes"
"7678","C2_Chemical_and_genetic_perturbations","C2_CGP_3076_DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP",319,-1.3223,0.02,0.16,"No",-0.6841,1,1,"No"
"7679","C7_Immunologic_signatures","C7_ALL_7_KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP",199,-1.3223,0.044,0.063,"No",2.2816,0,0,"Yes"
"7680","C2_BioCarta_Pathways","C2_CP_BIOCARTA_100_BIOCARTA_IL22BP_PATHWAY",16,-1.3222,0.13,0.24,"No",-0.8007,0.74,1,"No"
"7681","GO_BP","511969_GO_0051044_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",15,-1.3222,0.14,0.23,"No",-1.0491,0.4,0.97,"No"
"7682","C2_Chemical_and_genetic_perturbations","C2_CGP_546_MAHADEVAN_IMATINIB_RESISTANCE_UP",19,-1.3221,0.13,0.16,"No",-1.2007,0.22,0.8,"No"
"7683","C7_Immunologic_signatures","C7_ALL_1180_GSE27786_BCELL_VS_CD8_TCELL_DN",195,-1.322,0.026,0.063,"No",0.8674,0.85,1,"Yes"
"7684","GO_BP","508084_GO_0045745_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",18,-1.3219,0.13,0.23,"No",-1.0308,0.42,0.98,"No"
"7685","REACTOME","105705_REACT_13797_CYP2E1_REACTIONS",11,-1.3218,0.14,0.26,"No",-1.8731,0.0019,0.067,"No"
"7686","C7_Immunologic_signatures","C7_ALL_758_GSE17721_0_5H_VS_8H_GARDIQUIMOD_BMDM_DN",198,-1.3218,0.03,0.063,"No",1.076,0.26,0.51,"Yes"
"7687","C7_Immunologic_signatures","C7_ALL_1726_GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN",197,-1.3218,0.039,0.063,"No",0.7816,0.98,1,"Yes"
"7688","REACTOME","530756_REACT_116010_SULFIDE_OXIDATION_TO_SULFATE",5,-1.3218,0.15,0.26,"No",-0.6369,0.9,1,"No"
"7689","GO_MF","492406_GO_0008028_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",34,-1.3218,0.1,0.28,"No",-1.5039,0.032,0.56,"No"
"7690","GO_BP","495831_GO_0015696_AMMONIUM_TRANSPORT",54,-1.3216,0.089,0.23,"No",-0.7596,0.9,1,"No"
"7691","KEGG_compound","C02835_IMIDAZOLE_4_ACETATE_IMIDAZOLEACETIC_ACID_4_IMIDAZOLEACETATE",5,-1.3216,0.13,0.3,"No",0.6847,0.82,1,"Yes"
"7692","C7_Immunologic_signatures","C7_ALL_1491_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP",189,-1.3216,0.038,0.063,"No",0.8601,0.88,1,"Yes"
"7693","GO_BP","494394_GO_0010324_MEMBRANE_INVAGINATION",36,-1.3215,0.1,0.23,"No",1.1883,0.22,0.79,"Yes"
"7694","GO_CC","502205_GO_0032983_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX",7,-1.3215,0.16,0.29,"No",-1.071,0.36,0.8,"No"
"7695","C7_Immunologic_signatures","C7_ALL_270_GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN",200,-1.3214,0.04,0.063,"No",0.8453,0.91,1,"Yes"
"7696","C7_Immunologic_signatures","C7_ALL_672_GSE17721_POLYIC_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-1.3213,0.033,0.063,"No",0.9516,0.58,0.89,"Yes"
"7697","C2_Chemical_and_genetic_perturbations","C2_CGP_29_LIU_PROSTATE_CANCER_UP",94,-1.3213,0.063,0.16,"No",-0.9372,0.58,1,"No"
"7698","C2_Chemical_and_genetic_perturbations","C2_CGP_2774_MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED",73,-1.3213,0.077,0.16,"No",0.9026,0.64,0.92,"Yes"
"7699","GO_BP","495190_GO_0014742_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY",16,-1.3212,0.14,0.23,"No",-0.6395,0.95,1,"No"
"7700","REACTOME","161043_REACT_21312_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING",31,-1.3211,0.12,0.26,"No",-0.9689,0.47,1,"No"
"7701","GO_BP","513929_GO_0060373_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION",7,-1.3211,0.14,0.23,"No",0.798,0.71,1,"Yes"
"7702","KEGG_compound","C00191_D_GLUCURONATE_GLUCURONIC_ACID_GLUCURONATE",23,-1.3211,0.12,0.3,"No",1.6225,0.01,0.14,"Yes"
"7703","GO_MF","487858_GO_0001968_FIBRONECTIN_BINDING",24,-1.321,0.13,0.28,"No",1.0739,0.36,0.82,"Yes"
"7704","GO_BP","510912_GO_0048863_STEM_CELL_DIFFERENTIATION",277,-1.3209,0.023,0.23,"No",-0.9518,0.59,1,"No"
"7705","C2_Chemical_and_genetic_perturbations","C2_CGP_403_CHEBOTAEV_GR_TARGETS_UP",77,-1.3209,0.07,0.16,"No",1.0217,0.4,0.77,"Yes"
"7706","GO_BP","508884_GO_0046636_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION",19,-1.3208,0.14,0.23,"No",0.7359,0.88,1,"Yes"
"7707","REACTOME","833812_REACT_163906_ECM_PROTEOGLYCANS",54,-1.3208,0.085,0.26,"No",1.0568,0.36,0.65,"Yes"
"7708","GO_BP","495004_GO_0010939_REGULATION_OF_NECROTIC_CELL_DEATH",18,-1.3207,0.12,0.23,"No",-0.8704,0.64,1,"No"
"7709","C2_Chemical_and_genetic_perturbations","C2_CGP_2165_FINETTI_BREAST_CANCER_KINOME_RED",16,-1.3205,0.13,0.16,"No",0.8887,0.61,0.94,"Yes"
"7710","C2_Chemical_and_genetic_perturbations","C2_CGP_2249_MITSIADES_RESPONSE_TO_APLIDIN_UP",433,-1.3205,0.0073,0.16,"No",-0.9063,0.81,1,"No"
"7711","C2_Chemical_and_genetic_perturbations","C2_CGP_379_ENK_UV_RESPONSE_EPIDERMIS_UP",290,-1.3204,0.022,0.16,"No",0.9143,0.78,0.91,"Yes"
"7712","C3_TF_targets","C3_TFT_379_V_HP1SITEFACTOR_Q6",222,-1.3204,0.024,0.075,"No",-0.7819,0.97,1,"No"
"7713","GO_BP","517091_GO_0072175_EPITHELIAL_TUBE_FORMATION",118,-1.3204,0.05,0.23,"No",-0.7656,0.95,1,"No"
"7714","C3_TF_targets","C3_TFT_518_TAAYNRNNTCC_UNKNOWN",165,-1.3204,0.04,0.075,"No",-1.2187,0.096,0.31,"No"
"7715","GO_BP","508511_GO_0046218_INDOLALKYLAMINE_CATABOLIC_PROCESS",11,-1.3204,0.15,0.23,"No",-1.3183,0.13,0.89,"No"
"7716","GO_BP","755386_GO_2001280_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS",5,-1.3203,0.14,0.23,"No",-0.767,0.76,1,"No"
"7717","GO_BP","510448_GO_0048341_PARAXIAL_MESODERM_FORMATION",5,-1.3203,0.13,0.23,"No",1.0875,0.38,0.92,"Yes"
"7718","C7_Immunologic_signatures","C7_ALL_1788_GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN",198,-1.3202,0.03,0.064,"No",-0.729,0.99,1,"No"
"7719","KEGG_pathway","HSA00830_RETINOL_METABOLISM",65,-1.3202,0.084,0.12,"No",1.5716,0.016,0.079,"Yes"
"7720","GO_MF","495541_GO_0015297_ANTIPORTER_ACTIVITY",61,-1.3201,0.072,0.28,"No",-0.9907,0.46,0.92,"No"
"7721","C7_Immunologic_signatures","C7_ALL_399_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP",197,-1.32,0.035,0.064,"No",0.9935,0.43,0.76,"Yes"
"7722","GO_BP","510913_GO_0048864_STEM_CELL_DEVELOPMENT",223,-1.3199,0.031,0.23,"No",-0.8352,0.89,1,"No"
"7723","C2_Chemical_and_genetic_perturbations","C2_CGP_3150_ZHU_SKIL_TARGETS_UP",19,-1.3199,0.13,0.16,"No",-1.0507,0.4,0.97,"No"
"7724","C2_Chemical_and_genetic_perturbations","C2_CGP_69_IGARASHI_ATF4_TARGETS_DN",89,-1.3199,0.079,0.16,"No",0.8642,0.76,0.96,"Yes"
"7725","KEGG_reaction","R03283_4_TRIMETHYLAMMONIOBUTANAL_NAD_1_OXIDOREDUCTASE_4_TRIMETHYLAMMONIOBUTANAL_NAD_OXIDOREDUCTASE_4_TRIMETHYLAMMONIOBUTANAL_NAD_H2O_4_TRIMETHYLAMMONIOBUTANOATE_NADH_H_",5,-1.3199,0.13,0.31,"No",0.694,0.83,1,"Yes"
"7726","C2_Chemical_and_genetic_perturbations","C2_CGP_651_RASHI_NFKB1_TARGETS",19,-1.3199,0.12,0.16,"No",-0.6927,0.91,1,"No"
"7727","C2_Chemical_and_genetic_perturbations","C2_CGP_1332_SHEPARD_CRUSH_AND_BURN_MUTANT_DN",178,-1.3199,0.039,0.16,"No",-0.7529,0.97,1,"No"
"7728","GO_BP","750931_GO_0036006_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS",7,-1.3197,0.15,0.23,"No",0.8632,0.59,1,"Yes"
"7729","GO_MF","496849_GO_0017017_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",12,-1.3197,0.16,0.28,"No",-0.6298,0.93,1,"No"
"7730","KEGG_compound","C11173_SN_38",22,-1.3197,0.13,0.3,"No",1.8772,0,0.018,"Yes"
"7731","GO_CC","487096_GO_0000805_X_CHROMOSOME",6,-1.3196,0.16,0.29,"No",-1.0876,0.35,0.81,"No"
"7732","C3_TF_targets","C3_TFT_228_V_AMEF2_Q6",251,-1.3196,0.02,0.075,"No",-1.0412,0.34,0.67,"No"
"7733","C3_MicroRNA_targets","C3_MIR_146_AAGCAAT_MIR_137",218,-1.3196,0.031,0.24,"No",-0.9631,0.54,1,"No"
"7734","C7_Immunologic_signatures","C7_ALL_865_GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP",188,-1.3195,0.035,0.064,"No",-1.1208,0.19,1,"No"
"7735","GO_BP","514849_GO_0061304_RETINAL_BLOOD_VESSEL_MORPHOGENESIS",5,-1.3195,0.15,0.23,"No",0.9833,0.5,1,"Yes"
"7736","KEGG_compound","C01419_CYS_GLY_L_CYSTEINYLGLYCINE",6,-1.3194,0.13,0.3,"No",-0.7582,0.74,1,"No"
"7737","GO_BP","506190_GO_0043112_RECEPTOR_METABOLIC_PROCESS",71,-1.3194,0.088,0.23,"No",0.6964,0.96,1,"Yes"
"7738","C2_Chemical_and_genetic_perturbations","C2_CGP_3337_GENTLES_LEUKEMIC_STEM_CELL_UP",29,-1.3193,0.11,0.16,"No",-0.6783,0.95,1,"No"
"7739","GO_BP","515234_GO_0070301_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE",44,-1.3192,0.11,0.23,"No",-0.6284,0.99,1,"No"
"7740","GO_BP","497179_GO_0018208_PEPTIDYL_PROLINE_MODIFICATION",55,-1.3192,0.091,0.23,"No",1.0655,0.32,0.93,"Yes"
"7741","C3_TF_targets","C3_TFT_502_RAAGNYNNCTTY_UNKNOWN",141,-1.3192,0.053,0.075,"No",-0.7694,0.96,1,"No"
"7742","GO_BP","512189_GO_0051305_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE",6,-1.3191,0.17,0.23,"No",0.8573,0.65,1,"Yes"
"7743","C4_Cancer_modules","C4_CM_243_MODULE_274",80,-1.3191,0.081,0.15,"No",-1.3519,0.055,0.53,"No"
"7744","C7_Immunologic_signatures","C7_ALL_582_GSE17721_CPG_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-1.3191,0.026,0.065,"No",0.6617,1,1,"Yes"
"7745","REACTOME","119572_REACT_19343_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS",12,-1.319,0.13,0.26,"No",-1.2897,0.17,0.66,"No"
"7746","REACTOME","106378_REACT_18372_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS_",81,-1.319,0.063,0.26,"No",-1.0871,0.29,0.91,"No"
"7747","C7_Immunologic_signatures","C7_ALL_1104_GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN",189,-1.319,0.046,0.065,"No",0.7795,0.97,1,"Yes"
"7748","C7_Immunologic_signatures","C7_ALL_1731_GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP",197,-1.319,0.027,0.065,"No",-0.7893,0.95,1,"No"
"7749","GO_BP","508433_GO_0046137_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS",6,-1.3189,0.15,0.23,"No",-1.1633,0.31,0.91,"No"
"7750","C2_Chemical_and_genetic_perturbations","C2_CGP_2740_YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN",15,-1.3187,0.15,0.16,"No",1.6878,0.015,0.09,"Yes"
"7751","GO_MF","750815_GO_0052742_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY",15,-1.3186,0.13,0.28,"No",-1.0624,0.38,0.86,"No"
"7752","GO_BP","500541_GO_0031282_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY",11,-1.3185,0.16,0.23,"No",-1.191,0.24,0.9,"No"
"7753","KEGG_compound","C00804_PROPYNOATE_PROPIOLIC_ACID_ACETYLENECARBOXYLIC_ACID_ACETYLENEMONOCARBOXYLATE",5,-1.3185,0.15,0.3,"No",0.7303,0.78,1,"Yes"
"7754","GO_BP","488796_GO_0002923_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",11,-1.3185,0.14,0.23,"No",-1.2476,0.21,0.91,"No"
"7755","GO_BP","494643_GO_0010578_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY_INVOLVED_IN_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",24,-1.3185,0.11,0.23,"No",-0.9724,0.5,1,"No"
"7756","C2_Chemical_and_genetic_perturbations","C2_CGP_3042_STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN",49,-1.3185,0.099,0.16,"No",1.2676,0.1,0.42,"Yes"
"7757","REACTOME","1127543_REACT_268573_LIGAND_RECEPTOR_INTERACTIONS",7,-1.3184,0.17,0.26,"No",-1.5691,0.026,0.35,"No"
"7758","GO_BP","751221_GO_0036303_LYMPH_VESSEL_MORPHOGENESIS",11,-1.3184,0.15,0.23,"No",-0.7683,0.79,1,"No"
"7759","C2_Chemical_and_genetic_perturbations","C2_CGP_1388_SWEET_KRAS_TARGETS_UP",82,-1.3182,0.078,0.16,"No",0.9253,0.64,0.89,"Yes"
"7760","KEGG_compound","C11131_2_METHOXY_ESTRADIOL_17BETA_3_GLUCURONIDE",19,-1.3181,0.12,0.3,"No",1.9235,0,0.017,"Yes"
"7761","GO_BP","494777_GO_0010712_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS",36,-1.3181,0.12,0.23,"No",0.9079,0.58,1,"Yes"
"7762","GO_MF","495418_GO_0015145_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",15,-1.318,0.14,0.28,"No",-1.1784,0.24,0.79,"No"
"7763","C2_Chemical_and_genetic_perturbations","C2_CGP_1004_LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED",16,-1.318,0.14,0.16,"No",0.9443,0.52,0.87,"Yes"
"7764","GO_MF","752058_GO_0052866_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY",21,-1.3177,0.12,0.28,"No",-0.777,0.78,1,"No"
"7765","KEGG_compound","C01149_4_TRIMETHYLAMMONIOBUTANAL",5,-1.3177,0.14,0.3,"No",0.6904,0.85,1,"Yes"
"7766","GO_MF","486689_GO_0000155_PHOSPHORELAY_SENSOR_KINASE_ACTIVITY",8,-1.3176,0.14,0.28,"No",-0.7388,0.79,1,"No"
"7767","GO_BP","486591_GO_0000041_TRANSITION_METAL_ION_TRANSPORT",105,-1.3174,0.059,0.23,"No",0.9428,0.6,1,"Yes"
"7768","GO_BP","515904_GO_0070977_BONE_MATURATION",14,-1.3174,0.13,0.23,"No",-0.8255,0.67,1,"No"
"7769","GO_MF","495354_GO_0016303_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",11,-1.3173,0.13,0.28,"No",-0.9543,0.52,0.95,"No"
"7770","GO_CC","506277_GO_0043209_MYELIN_SHEATH",42,-1.3173,0.11,0.29,"No",-1.5704,0.0097,0.5,"No"
"7771","GO_MF","500929_GO_0031683_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING",22,-1.3172,0.12,0.28,"No",-0.8023,0.78,1,"No"
"7772","GO_BP","496486_GO_0016525_NEGATIVE_REGULATION_OF_ANGIOGENESIS",63,-1.3171,0.083,0.23,"No",-0.9257,0.59,1,"No"
"7773","GO_BP","506119_GO_0043030_REGULATION_OF_MACROPHAGE_ACTIVATION",22,-1.3171,0.12,0.23,"No",1.534,0.036,0.36,"Yes"
"7774","GO_MF","512403_GO_0051525_NFAT_PROTEIN_BINDING",5,-1.317,0.14,0.28,"No",0.4427,1,1,"Yes"
"7775","GO_BP","502544_GO_0033326_CEREBROSPINAL_FLUID_SECRETION",5,-1.317,0.15,0.23,"No",-1.3205,0.17,0.89,"No"
"7776","C7_Immunologic_signatures","C7_ALL_1077_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP",193,-1.3169,0.05,0.066,"No",1.2537,0.054,0.15,"Yes"
"7777","GO_MF","487543_GO_0001609_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY",7,-1.3169,0.15,0.28,"No",1.4888,0.076,0.39,"Yes"
"7778","GO_BP","487953_GO_0002063_CHONDROCYTE_DEVELOPMENT",23,-1.3168,0.13,0.23,"No",-1.4309,0.07,0.93,"No"
"7779","GO_CC","505743_GO_0042629_MAST_CELL_GRANULE",21,-1.3168,0.15,0.29,"No",0.8424,0.69,0.93,"Yes"
"7780","GO_BP","752695_GO_0097194_EXECUTION_PHASE_OF_APOPTOSIS",84,-1.3167,0.066,0.23,"No",-0.6291,0.99,1,"No"
"7781","REACTOME","106064_REACT_12519_PECAM1_INTERACTIONS",12,-1.3167,0.14,0.27,"No",0.5908,0.96,1,"Yes"
"7782","C3_TF_targets","C3_TFT_61_V_CDP_01",85,-1.3167,0.073,0.077,"No",-1.4152,0.031,0.16,"No"
"7783","GO_MF","495619_GO_0015405_P_P_BOND_HYDROLYSIS_DRIVEN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",130,-1.3166,0.052,0.28,"No",0.8396,0.87,1,"Yes"
"7784","KEGG_reaction","R07106_UDP_GLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_TRICHLOROETHANOL_UDP_GLUCURONATE_TRICHLOROETHANOL_GLUCURONIDE_UDP",19,-1.3166,0.12,0.31,"No",1.8971,0.0044,0.008,"Yes"
"7785","GO_BP","498958_GO_0021675_NERVE_DEVELOPMENT",76,-1.3165,0.085,0.23,"No",-1.1232,0.26,0.94,"No"
"7786","KEGG_compound","C01190_BETA_D_GLUCOSYL_1_1_CERAMIDE_GLUCOSYLCERAMIDE_GLUCOCEREBROSIDE_D_GLUCOSYL_N_ACYLSPHINGOSINE",5,-1.3164,0.15,0.3,"No",-0.4609,1,1,"No"
"7787","C2_Chemical_and_genetic_perturbations","C2_CGP_3184_KASLER_HDAC7_TARGETS_2_UP",6,-1.3164,0.16,0.16,"No",1.2371,0.23,0.45,"Yes"
"7788","C2_Chemical_and_genetic_perturbations","C2_CGP_144_WANG_RESPONSE_TO_FORSKOLIN_UP",23,-1.3164,0.13,0.16,"No",1.0493,0.38,0.71,"Yes"
"7789","C2_Chemical_and_genetic_perturbations","C2_CGP_992_INGRAM_SHH_TARGETS_UP",125,-1.3164,0.051,0.16,"No",-0.6968,0.99,1,"No"
"7790","GO_BP","493494_GO_0009310_AMINE_CATABOLIC_PROCESS",16,-1.3164,0.14,0.23,"No",-1.4649,0.068,0.87,"No"
"7791","GO_BP","500240_GO_0030947_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",26,-1.3164,0.12,0.23,"No",-0.8977,0.59,1,"No"
"7792","C2_Chemical_and_genetic_perturbations","C2_CGP_230_HOEBEKE_LYMPHOID_STEM_CELL_UP",92,-1.3161,0.063,0.16,"No",-1.0416,0.35,0.98,"No"
"7793","GO_BP","490420_GO_0007175_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",8,-1.3161,0.14,0.23,"No",-0.7586,0.77,1,"No"
"7794","GO_BP","491233_GO_0006269_DNA_REPLICATION_SYNTHESIS_OF_RNA_PRIMER",5,-1.3161,0.15,0.23,"No",-0.452,0.99,1,"No"
"7795","KEGG_reaction","R04903_5_HYDROXYINDOLEACETALDEHYDE_NAD_OXIDOREDUCTASE_5_HYDROXYINDOLEACETALDEHYDE_NAD_H2O_5_HYDROXYINDOLEACETATE_H_NADH",5,-1.316,0.14,0.3,"No",0.7139,0.8,1,"Yes"
"7796","C7_Immunologic_signatures","C7_ALL_676_GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDM_DN",199,-1.316,0.021,0.067,"No",0.9764,0.51,0.82,"Yes"
"7797","REACTOME","477133_REACT_111183_MEIOSIS",113,-1.3158,0.065,0.27,"No",-1.4661,0.0092,0.47,"No"
"7798","C2_Chemical_and_genetic_perturbations","C2_CGP_277_SENESE_HDAC2_TARGETS_UP",113,-1.3158,0.064,0.16,"No",1.3168,0.027,0.38,"Yes"
"7799","KEGG_compound","C19645_ACCEPTOR_AGLYCON",19,-1.3158,0.13,0.3,"No",1.9948,0.0021,0.078,"Yes"
"7800","GO_BP","508218_GO_0045911_POSITIVE_REGULATION_OF_DNA_RECOMBINATION",17,-1.3157,0.13,0.24,"No",-1.3131,0.13,0.87,"No"
"7801","REACTOME","530755_REACT_115654_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE",8,-1.3157,0.16,0.27,"No",0.7488,0.79,1,"Yes"
"7802","REACTOME","106551_REACT_1974_RNA_POLYMERASE_I_PROMOTER_CLEARANCE",105,-1.3157,0.062,0.27,"No",-1.5127,0.012,0.43,"No"
"7803","GO_BP","487919_GO_0002029_DESENSITIZATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",18,-1.3155,0.15,0.24,"No",-1.2676,0.19,0.89,"No"
"7804","KEGG_reaction","R04352_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ETIOCHOLANOLONE_UDP_GLUCURONATE_ETIOCHOLAN_3ALPHA_OL_17_ONE_3_GLUCURONIDE_UDP",19,-1.315,0.12,0.3,"No",1.9307,0.0021,0.0074,"Yes"
"7805","C2_Chemical_and_genetic_perturbations","C2_CGP_413_LINDGREN_BLADDER_CANCER_CLUSTER_3_UP",325,-1.315,0.015,0.16,"No",1.2388,0.034,0.45,"Yes"
"7806","GO_BP","516794_GO_0071873_RESPONSE_TO_NOREPINEPHRINE",6,-1.315,0.14,0.24,"No",-1.342,0.15,0.92,"No"
"7807","GO_BP","502814_GO_0033598_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",14,-1.3149,0.14,0.24,"No",0.6699,0.91,1,"Yes"
"7808","C2_Chemical_and_genetic_perturbations","C2_CGP_2981_DAZARD_UV_RESPONSE_CLUSTER_G5",11,-1.3147,0.17,0.16,"No",0.9679,0.51,0.84,"Yes"
"7809","C4_Cancer_gene_neighborhoods","C4_CGN_115_MORF_IL4",185,-1.3145,0.029,0.2,"No",-0.9461,0.58,0.91,"No"
"7810","GO_BP","498272_GO_0019432_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS",42,-1.3145,0.1,0.24,"No",0.5721,0.99,1,"Yes"
"7811","GO_BP","504568_GO_0035384_THIOESTER_BIOSYNTHETIC_PROCESS",27,-1.3145,0.12,0.24,"No",0.637,0.96,1,"Yes"
"7812","WikiPathways","198848_WP170_NUCLEAR_RECEPTORS",38,-1.3144,0.1,0.18,"No",-1.2768,0.12,1,"No"
"7813","KEGG_compound","C05729_R_S_CYSTEINYLGLYCINE",6,-1.3144,0.15,0.3,"No",-0.7457,0.79,1,"No"
"7814","C3_MicroRNA_targets","C3_MIR_161_GAGCTGG_MIR_337",157,-1.3144,0.038,0.25,"No",-1.804,0,0.077,"No"
"7815","KEGG_compound","C11134_TESTOSTERONE_GLUCURONIDE_TESTOSTERONE_17BETA_BETA_D_GLUCURONIDE_",19,-1.3144,0.14,0.3,"No",1.9269,0,0.018,"Yes"
"7816","KEGG_compound","C00231_D_XYLULOSE_5_PHOSPHATE",6,-1.3143,0.14,0.3,"No",0.8144,0.72,1,"Yes"
"7817","C3_TF_targets","C3_TFT_180_V_XBP1_01",130,-1.3143,0.054,0.079,"No",0.932,0.6,1,"Yes"
"7818","KEGG_pathway","HSA04530_TIGHT_JUNCTION",134,-1.3142,0.048,0.12,"No",-0.7921,0.93,1,"No"
"7819","C2_Chemical_and_genetic_perturbations","C2_CGP_276_SENESE_HDAC1_AND_HDAC2_TARGETS_DN",222,-1.3142,0.029,0.16,"No",1.0844,0.22,0.66,"Yes"
"7820","C2_Chemical_and_genetic_perturbations","C2_CGP_656_MARTIN_INTERACT_WITH_HDAC",44,-1.3142,0.1,0.16,"No",0.7608,0.88,1,"Yes"
"7821","GO_BP","508650_GO_0046386_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS",20,-1.3142,0.13,0.24,"No",1.3528,0.087,0.61,"Yes"
"7822","C7_Immunologic_signatures","C7_ALL_1772_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN",195,-1.3141,0.037,0.068,"No",-0.773,0.98,1,"No"
"7823","GO_BP","1134000_GO_1903825_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT",84,-1.314,0.062,0.24,"No",-1.0179,0.43,0.98,"No"
"7824","GO_CC","490801_GO_0005769_EARLY_ENDOSOME",266,-1.314,0.024,0.3,"No",0.998,0.45,0.79,"Yes"
"7825","GO_BP","516540_GO_0071616_ACYL_COA_BIOSYNTHETIC_PROCESS",27,-1.3139,0.11,0.24,"No",0.6554,0.96,1,"Yes"
"7826","C2_Chemical_and_genetic_perturbations","C2_CGP_3053_VERHAAK_GLIOBLASTOMA_PRONEURAL",173,-1.3139,0.037,0.16,"No",-0.8068,0.92,1,"No"
"7827","C7_Immunologic_signatures","C7_ALL_828_GSE17974_1_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN",199,-1.3139,0.034,0.068,"No",-0.7865,0.95,1,"No"
"7828","KEGG_compound","C07649_5_FU_FLUOROURACIL_5_FLUOROURACIL",6,-1.3138,0.15,0.3,"No",-1.0577,0.4,0.99,"No"
"7829","GO_MF","512173_GO_0051287_NAD_BINDING",49,-1.3137,0.089,0.29,"No",1.0545,0.37,0.83,"Yes"
"7830","GO_BP","505071_GO_0035902_RESPONSE_TO_IMMOBILIZATION_STRESS",16,-1.3137,0.13,0.24,"No",0.8844,0.61,1,"Yes"
"7831","GO_MF","490032_GO_0004716_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVITY",9,-1.3136,0.14,0.29,"No",0.4318,0.99,1,"Yes"
"7832","C3_TF_targets","C3_TFT_6_V_AP4_01",255,-1.3136,0.028,0.079,"No",-0.9747,0.53,0.82,"No"
"7833","GO_BP","502459_GO_0033239_NEGATIVE_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS",82,-1.3135,0.074,0.24,"No",1.0891,0.28,0.92,"Yes"
"7834","C2_Chemical_and_genetic_perturbations","C2_CGP_539_DARWICHE_SKIN_TUMOR_PROMOTER_DN",174,-1.3135,0.056,0.16,"No",-0.7867,0.94,1,"No"
"7835","GO_BP","508678_GO_0046415_URATE_METABOLIC_PROCESS",13,-1.3134,0.12,0.24,"No",0.8239,0.71,1,"Yes"
"7836","WikiPathways","698757_WP2291_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER",16,-1.3134,0.13,0.18,"No",0.8848,0.62,1,"Yes"
"7837","GO_BP","505576_GO_0042436_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",11,-1.3133,0.16,0.24,"No",-1.3159,0.12,0.88,"No"
"7838","GO_MF","495540_GO_0015296_ANION_CATION_SYMPORTER_ACTIVITY",49,-1.3133,0.092,0.29,"No",-1.8827,0,0.15,"No"
"7839","C2_Chemical_and_genetic_perturbations","C2_CGP_1198_NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON",21,-1.3132,0.12,0.16,"No",0.5502,0.99,1,"Yes"
"7840","GO_BP","488477_GO_0002604_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION",7,-1.3132,0.15,0.24,"No",0.8777,0.62,1,"Yes"
"7841","GO_BP","752374_GO_0086002_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION",24,-1.3131,0.13,0.24,"No",-1.0539,0.39,0.97,"No"
"7842","C2_Chemical_and_genetic_perturbations","C2_CGP_2532_ZHANG_INTERFERON_RESPONSE",23,-1.3131,0.13,0.16,"No",1.4621,0.044,0.24,"Yes"
"7843","C3_MicroRNA_targets","C3_MIR_65_TATTATA_MIR_374",280,-1.3131,0.016,0.24,"No",0.7618,0.99,1,"Yes"
"7844","GO_BP","507952_GO_0045604_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION",40,-1.313,0.1,0.24,"No",-1.1896,0.2,0.9,"No"
"7845","GO_BP","501908_GO_0032682_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION",13,-1.313,0.13,0.24,"No",-0.8842,0.6,1,"No"
"7846","GO_BP","503816_GO_0034616_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS",16,-1.3129,0.13,0.24,"No",-0.4954,1,1,"No"
"7847","GO_BP","751353_GO_0038095_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY",161,-1.3129,0.041,0.24,"No",-0.8896,0.74,1,"No"
"7848","GO_MF","490627_GO_0005525_GTP_BINDING",360,-1.3128,0.02,0.29,"No",0.9068,0.83,0.98,"Yes"
"7849","GO_BP","511877_GO_0050942_POSITIVE_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION",7,-1.3126,0.15,0.24,"No",1.1001,0.33,0.9,"Yes"
"7850","GO_BP","494962_GO_0010898_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS",7,-1.3126,0.16,0.24,"No",-1.6355,0.016,0.7,"No"
"7851","GO_BP","507121_GO_0044106_CELLULAR_AMINE_METABOLIC_PROCESS",457,-1.3126,0.014,0.24,"No",-0.8515,0.94,1,"No"
"7852","C7_Immunologic_signatures","C7_ALL_167_GSE13411_NAIVE_VS_MEMORY_BCELL_UP",181,-1.3125,0.036,0.07,"No",1.0831,0.26,0.49,"Yes"
"7853","GO_BP","1022156_GO_1903169_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT",56,-1.3124,0.088,0.24,"No",-1.2363,0.15,0.9,"No"
"7854","C2_Chemical_and_genetic_perturbations","C2_CGP_626_SANCHEZ_MDM2_TARGETS",15,-1.3124,0.14,0.17,"No",-0.7514,0.8,1,"No"
"7855","GO_BP","495088_GO_0014015_POSITIVE_REGULATION_OF_GLIOGENESIS",35,-1.3124,0.11,0.24,"No",0.8253,0.76,1,"Yes"
"7856","C7_Immunologic_signatures","C7_ALL_1421_GSE360_CTRL_VS_L_MAJOR_MAC_UP",198,-1.3124,0.027,0.07,"No",1.0516,0.31,0.58,"Yes"
"7857","C3_MicroRNA_targets","C3_MIR_135_AGCATTA_MIR_155",133,-1.3123,0.048,0.24,"No",0.8035,0.92,1,"Yes"
"7858","GO_BP","493492_GO_0009308_AMINE_METABOLIC_PROCESS",463,-1.3123,0.0073,0.24,"No",-0.8665,0.94,1,"No"
"7859","GO_BP","513439_GO_0055006_CARDIAC_CELL_DEVELOPMENT",51,-1.3121,0.098,0.24,"No",-1.2643,0.12,0.9,"No"
"7860","GO_BP","512816_GO_0051966_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",46,-1.312,0.1,0.24,"No",-0.9283,0.58,1,"No"
"7861","C2_BioCarta_Pathways","C2_CP_BIOCARTA_201_BIOCARTA_SARS_PATHWAY",10,-1.3119,0.14,0.26,"No",1.2376,0.21,0.65,"Yes"
"7862","GO_BP","500322_GO_0031032_ACTOMYOSIN_STRUCTURE_ORGANIZATION",76,-1.3119,0.078,0.24,"No",-1.2894,0.095,0.88,"No"
"7863","KEGG_compound","C05583_3_METHOXY_4_HYDROXYPHENYLGLYCOLALDEHYDE",6,-1.3118,0.14,0.3,"No",0.8874,0.61,1,"Yes"
"7864","GO_MF","496686_GO_0016776_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR",40,-1.3117,0.11,0.29,"No",-1.1945,0.18,0.8,"No"
"7865","C2_Chemical_and_genetic_perturbations","C2_CGP_2363_WEST_ADRENOCORTICAL_TUMOR_UP",293,-1.3116,0.016,0.17,"No",1.4207,0,0.28,"Yes"
"7866","KEGG_reaction","R02502_17BETA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_TESTOSTERONE_UDP_GLUCURONATE_TESTOSTERONE_GLUCURONIDE_UDP",19,-1.3116,0.13,0.3,"No",1.9269,0.004,0.0072,"Yes"
"7867","GO_BP","488441_GO_0002568_SOMATIC_DIVERSIFICATION_OF_T_CELL_RECEPTOR_GENES",5,-1.3115,0.15,0.24,"No",0.6732,0.83,1,"Yes"
"7868","GO_MF","495356_GO_0046934_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY",5,-1.3115,0.15,0.29,"No",0.718,0.81,1,"Yes"
"7869","C2_BioCarta_Pathways","C2_CP_BIOCARTA_139_BIOCARTA_CDK5_PATHWAY",11,-1.3114,0.14,0.25,"No",-1.1288,0.3,1,"No"
"7870","KEGG_reaction","R08615_UDP_GLUCURONATE_GLUCURONOHYDROLASE_UDP_GLUCURONATE_H2O_UDP_D_GLUCURONATE",19,-1.3112,0.14,0.3,"No",1.9251,0,0.0069,"Yes"
"7871","C2_Chemical_and_genetic_perturbations","C2_CGP_1370_SMITH_LIVER_CANCER",45,-1.3112,0.11,0.17,"No",1.0716,0.32,0.68,"Yes"
"7872","GO_BP","501962_GO_0032736_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION",9,-1.3112,0.16,0.24,"No",-1.3526,0.15,0.95,"No"
"7873","KEGG_reaction","R08262_MORPHINE_UDP_GLUCURONATE_MORPHINE_3_GLUCURONIDE_UDP",19,-1.311,0.13,0.29,"No",1.9333,0,0.0081,"Yes"
"7874","KEGG_reaction","R02478_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ANDROSTERONE_UDP_GLUCURONATE_ANDROSTERONE_GLUCURONIDE_UDP",19,-1.3109,0.14,0.29,"No",1.9372,0.002,0.012,"Yes"
"7875","REACTOME","160141_REACT_22442_INTERLEUKIN_1_SIGNALING",41,-1.3109,0.097,0.27,"No",0.8632,0.71,0.94,"Yes"
"7876","GO_MF","498679_GO_0019902_PHOSPHATASE_BINDING",141,-1.3109,0.065,0.29,"No",-0.8972,0.73,0.99,"No"
"7877","C7_Immunologic_signatures","C7_ALL_71_GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP",191,-1.3107,0.036,0.071,"No",0.6655,1,1,"Yes"
"7878","C3_MicroRNA_targets","C3_MIR_156_TTTGCAG_MIR_518A_2",208,-1.3107,0.03,0.24,"No",0.6889,1,1,"Yes"
"7879","GO_BP","513998_GO_0060443_MAMMARY_GLAND_MORPHOGENESIS",45,-1.3107,0.11,0.24,"No",-0.8495,0.71,1,"No"
"7880","C7_Immunologic_signatures","C7_ALL_635_GSE17721_PAM3CSK4_VS_GADIQUIMOD_0_5H_BMDM_UP",196,-1.3107,0.036,0.071,"No",0.8996,0.78,1,"Yes"
"7881","C3_TF_targets","C3_TFT_19_V_P300_01",241,-1.3107,0.023,0.082,"No",-1.1492,0.15,0.45,"No"
"7882","GO_MF","495615_GO_0015399_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",130,-1.3106,0.057,0.29,"No",0.8545,0.83,1,"Yes"
"7883","GO_BP","752433_GO_0086067_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION",5,-1.3105,0.14,0.24,"No",-1.2285,0.27,0.89,"No"
"7884","GO_BP","488737_GO_0002864_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",11,-1.3105,0.15,0.24,"No",-0.8498,0.66,1,"No"
"7885","C3_TF_targets","C3_TFT_201_V_FREAC3_01",236,-1.3105,0.033,0.081,"No",-0.7872,0.97,1,"No"
"7886","KEGG_compound","C19646_ACCEPTOR_BETA_D_GLUCURONOSIDE",19,-1.3105,0.098,0.3,"No",1.9514,0.002,0.031,"Yes"
"7887","GO_BP","491430_GO_0006534_CYSTEINE_METABOLIC_PROCESS",7,-1.3105,0.16,0.24,"No",0.9023,0.59,1,"Yes"
"7888","GO_BP","491916_GO_0007097_NUCLEAR_MIGRATION",8,-1.3104,0.16,0.24,"No",-1.0213,0.44,0.97,"No"
"7889","C2_Chemical_and_genetic_perturbations","C2_CGP_2370_BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN",126,-1.3104,0.038,0.17,"No",1.7391,0,0.063,"Yes"
"7890","GO_BP","487663_GO_0001767_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY",5,-1.3104,0.17,0.24,"No",-0.7316,0.78,1,"No"
"7891","GO_BP","487324_GO_0001101_RESPONSE_TO_ACID_CHEMICAL",267,-1.3104,0.03,0.24,"No",0.9235,0.72,1,"Yes"
"7892","GO_BP","495959_GO_0015833_PEPTIDE_TRANSPORT",74,-1.3103,0.077,0.24,"No",0.7553,0.93,1,"Yes"
"7893","C3_TF_targets","C3_TFT_33_V_COMP1_01",110,-1.3103,0.066,0.081,"No",-1.1485,0.18,0.45,"No"
"7894","C1_Positional","C1_ALL_216_CHR22Q12",106,-1.3102,0.066,0.61,"No",-0.7726,0.92,0.96,"No"
"7895","C7_Immunologic_signatures","C7_ALL_808_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN",168,-1.3102,0.036,0.071,"No",-1.0144,0.42,1,"No"
"7896","C2_Chemical_and_genetic_perturbations","C2_CGP_596_RIZ_ERYTHROID_DIFFERENTIATION_6HR",36,-1.3102,0.1,0.17,"No",0.6145,0.98,1,"Yes"
"7897","GO_BP","489131_GO_0003339_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS",8,-1.3102,0.15,0.24,"No",-1.2949,0.18,0.88,"No"
"7898","KEGG_compound","C16578_MORPHINE_6_GLUCURONIDE",19,-1.3102,0.15,0.3,"No",1.9305,0,0.022,"Yes"
"7899","KEGG_compound","C16577_CODEINE_6_GLUCURONIDE",19,-1.3101,0.14,0.3,"No",1.9361,0,0.022,"Yes"
"7900","GO_BP","507461_GO_0045061_THYMIC_T_CELL_SELECTION",18,-1.3101,0.12,0.24,"No",0.7163,0.88,1,"Yes"
"7901","GO_BP","501994_GO_0032768_REGULATION_OF_MONOOXYGENASE_ACTIVITY",53,-1.3101,0.088,0.24,"No",0.8827,0.69,1,"Yes"
"7902","GO_BP","506556_GO_0043525_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS",48,-1.3098,0.1,0.24,"No",-1.1645,0.21,0.91,"No"
"7903","KEGG_reaction","R08259_SN_38_UDP_GLUCURONATE_SN38_GLUCURONIDE_UDP",19,-1.3098,0.13,0.28,"No",1.9822,0,0.028,"Yes"
"7904","C2_BioCarta_Pathways","C2_CP_BIOCARTA_124_BIOCARTA_NFAT_PATHWAY",53,-1.3098,0.089,0.25,"No",0.987,0.47,0.83,"Yes"
"7905","KEGG_compound","C05273_TRANS_TETRADEC_2_ENOYL_COA_2E_TETRADECENOYL_COA",8,-1.3098,0.17,0.3,"No",0.6127,0.92,1,"Yes"
"7906","C2_Chemical_and_genetic_perturbations","C2_CGP_2690_VALK_AML_CLUSTER_15",30,-1.3097,0.14,0.17,"No",0.9912,0.5,0.81,"Yes"
"7907","KEGG_compound","C01335_ROH",19,-1.3097,0.14,0.3,"No",1.9204,0,0.016,"Yes"
"7908","C2_BioCarta_Pathways","C2_CP_BIOCARTA_179_BIOCARTA_IL1R_PATHWAY",33,-1.3095,0.12,0.25,"No",-0.9388,0.55,1,"No"
"7909","GO_BP","487669_GO_0001773_MYELOID_DENDRITIC_CELL_ACTIVATION",23,-1.3094,0.14,0.24,"No",-0.8482,0.69,1,"No"
"7910","C2_Chemical_and_genetic_perturbations","C2_CGP_1118_BENPORATH_PROLIFERATION",147,-1.3094,0.06,0.17,"No",1.2528,0.062,0.43,"Yes"
"7911","GO_BP","505243_GO_0042058_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",73,-1.3094,0.071,0.24,"No",0.922,0.61,1,"Yes"
"7912","GO_BP","488450_GO_0002577_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION",18,-1.3093,0.16,0.24,"No",-0.8922,0.61,1,"No"
"7913","KEGG_reaction","R09426_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_UDP_GLUCURONATE_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_GLUCURONIDE_UDP",19,-1.3093,0.13,0.28,"No",1.977,0.0021,0.021,"Yes"
"7914","C2_Chemical_and_genetic_perturbations","C2_CGP_3163_BAKKER_FOXO3_TARGETS_UP",61,-1.3093,0.091,0.17,"No",1.1137,0.25,0.61,"Yes"
"7915","GO_BP","508772_GO_0046513_CERAMIDE_BIOSYNTHETIC_PROCESS",30,-1.3091,0.13,0.24,"No",-0.5851,0.99,1,"No"
"7916","KEGG_compound","C00416_PHOSPHATIDATE_PHOSPHATIDIC_ACID_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHATE_3_SN_PHOSPHATIDATE",32,-1.3089,0.11,0.3,"No",-1.1784,0.2,0.82,"No"
"7917","GO_BP","505545_GO_0042402_CELLULAR_BIOGENIC_AMINE_CATABOLIC_PROCESS",16,-1.3089,0.14,0.24,"No",-1.4342,0.068,0.93,"No"
"7918","GO_MF","489646_GO_0004181_METALLOCARBOXYPEPTIDASE_ACTIVITY",23,-1.3089,0.14,0.29,"No",-0.6504,0.94,1,"No"
"7919","GO_BP","496976_GO_0017187_PEPTIDYL_GLUTAMIC_ACID_CARBOXYLATION",12,-1.3089,0.16,0.24,"No",-0.9278,0.56,1,"No"
"7920","GO_BP","493307_GO_0009108_COENZYME_BIOSYNTHETIC_PROCESS",100,-1.3088,0.063,0.24,"No",0.8863,0.74,1,"Yes"
"7921","C2_BioCarta_Pathways","C2_CP_BIOCARTA_180_BIOCARTA_MET_PATHWAY",37,-1.3087,0.11,0.25,"No",1.0019,0.44,0.84,"Yes"
"7922","C3_MicroRNA_targets","C3_MIR_178_AGGTGCA_MIR_500",96,-1.3087,0.074,0.24,"No",0.7036,0.99,1,"Yes"
"7923","GO_BP","510409_GO_0048302_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES",9,-1.3087,0.16,0.24,"No",-0.7508,0.79,1,"No"
"7924","GO_BP","487976_GO_0002087_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NEUROLOGICAL_SYSTEM_PROCESS",13,-1.3087,0.14,0.24,"No",-1.3128,0.14,0.87,"No"
"7925","GO_BP","508145_GO_0045822_NEGATIVE_REGULATION_OF_HEART_CONTRACTION",21,-1.3086,0.13,0.24,"No",0.9566,0.49,1,"Yes"
"7926","C2_Chemical_and_genetic_perturbations","C2_CGP_2545_RUIZ_TNC_TARGETS_DN",141,-1.3085,0.058,0.17,"No",1.2732,0.038,0.42,"Yes"
"7927","C3_TF_targets","C3_TFT_441_V_FOX_Q2",206,-1.3084,0.033,0.083,"No",-0.9351,0.62,0.9,"No"
"7928","GO_CC","502859_GO_0033643_HOST_CELL_PART",8,-1.3084,0.16,0.31,"No",-1.2349,0.22,0.63,"No"
"7929","KEGG_compound","C00043_UDP_N_ACETYL_ALPHA_D_GLUCOSAMINE_UDP_N_ACETYL_D_GLUCOSAMINE_UDP_N_ACETYLGLUCOSAMINE",6,-1.3084,0.19,0.3,"No",-1.0214,0.45,1,"No"
"7930","REACTOME","1127598_REACT_264366_SIALIC_ACID_METABOLISM",33,-1.3082,0.11,0.28,"No",0.8073,0.76,0.99,"Yes"
"7931","C3_TF_targets","C3_TFT_360_V_AP3_Q6",237,-1.308,0.029,0.083,"No",0.8865,0.81,1,"Yes"
"7932","GO_BP","505682_GO_0042551_NEURON_MATURATION",30,-1.308,0.11,0.24,"No",-1.6999,0.0056,0.63,"No"
"7933","C2_Chemical_and_genetic_perturbations","C2_CGP_1640_LEE_CALORIE_RESTRICTION_NEOCORTEX_UP",83,-1.3079,0.081,0.17,"No",-0.6437,1,1,"No"
"7934","C4_Cancer_modules","C4_CM_429_MODULE_573",25,-1.3078,0.13,0.16,"No",1.3165,0.12,0.26,"Yes"
"7935","GO_BP","508724_GO_0046463_ACYLGLYCEROL_BIOSYNTHETIC_PROCESS",45,-1.3078,0.099,0.24,"No",-0.5645,1,1,"No"
"7936","KEGG_compound","C00523_ANDROSTERONE_3ALPHA_HYDROXY_5ALPHA_ANDROSTAN_17_ONE",20,-1.3078,0.14,0.3,"No",1.9304,0.0042,0.02,"Yes"
"7937","GO_BP","518669_GO_2000020_POSITIVE_REGULATION_OF_MALE_GONAD_DEVELOPMENT",8,-1.3077,0.16,0.24,"No",-1.0553,0.39,0.97,"No"
"7938","GO_BP","812249_GO_1990089_RESPONSE_TO_NERVE_GROWTH_FACTOR",18,-1.3077,0.13,0.24,"No",0.5635,0.98,1,"Yes"
"7939","GO_BP","499568_GO_0030148_SPHINGOLIPID_BIOSYNTHETIC_PROCESS",63,-1.3076,0.092,0.24,"No",-0.7491,0.92,1,"No"
"7940","KEGG_pathway","HSA04623_CYTOSOLIC_DNA_SENSING_PATHWAY",58,-1.3076,0.092,0.12,"No",-0.6132,0.99,1,"No"
"7941","C2_Chemical_and_genetic_perturbations","C2_CGP_580_KONG_E2F3_TARGETS",97,-1.3075,0.065,0.17,"No",1.116,0.23,0.6,"Yes"
"7942","GO_BP","511867_GO_0050932_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION",9,-1.3075,0.18,0.24,"No",0.9941,0.45,0.98,"Yes"
"7943","GO_MF","496568_GO_0016627_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS",54,-1.3074,0.11,0.29,"No",0.8356,0.77,1,"Yes"
"7944","GO_BP","514762_GO_0061217_REGULATION_OF_MESONEPHROS_DEVELOPMENT",26,-1.3074,0.14,0.24,"No",1.2729,0.14,0.7,"Yes"
"7945","C7_Immunologic_signatures","C7_ALL_1333_GSE30083_SP2_VS_SP4_THYMOCYTE_UP",192,-1.3074,0.045,0.073,"No",-0.9658,0.52,1,"No"
"7946","GO_CC","501246_GO_0032009_EARLY_PHAGOSOME",5,-1.3073,0.16,0.31,"No",-0.8028,0.7,1,"No"
"7947","C2_Chemical_and_genetic_perturbations","C2_CGP_1444_SANSOM_APC_TARGETS_UP",124,-1.3073,0.053,0.17,"No",-0.8577,0.78,1,"No"
"7948","C2_Chemical_and_genetic_perturbations","C2_CGP_1094_COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP",34,-1.3072,0.1,0.17,"No",0.8659,0.7,0.96,"Yes"
"7949","KEGG_reaction","R09427_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_UDP_GLUCURONATE_NNAL_N_GLUCURONIDE_UDP",19,-1.3071,0.13,0.28,"No",1.9359,0,0.0096,"Yes"
"7950","C2_Chemical_and_genetic_perturbations","C2_CGP_2777_MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3",5,-1.307,0.16,0.17,"No",-1.0577,0.41,0.97,"No"
"7951","C2_Chemical_and_genetic_perturbations","C2_CGP_3028_WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN",29,-1.307,0.11,0.17,"No",-0.7705,0.79,1,"No"
"7952","KEGG_compound","C00398_TRYPTAMINE_3_2_AMINOETHYL_INDOLE",5,-1.3069,0.17,0.3,"No",0.9519,0.52,1,"Yes"
"7953","C2_Chemical_and_genetic_perturbations","C2_CGP_2041_HOWLIN_CITED1_TARGETS_1_UP",35,-1.3066,0.12,0.17,"No",1.2907,0.1,0.4,"Yes"
"7954","GO_BP","500180_GO_0030885_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION",5,-1.3066,0.12,0.24,"No",1.3824,0.11,0.57,"Yes"
"7955","C2_Chemical_and_genetic_perturbations","C2_CGP_3193_BILANGES_SERUM_SENSITIVE_VIA_TSC1",23,-1.3066,0.15,0.17,"No",1.0178,0.39,0.78,"Yes"
"7956","C2_Chemical_and_genetic_perturbations","C2_CGP_265_DITTMER_PTHLH_TARGETS_UP",111,-1.3065,0.058,0.17,"No",1.2107,0.12,0.48,"Yes"
"7957","KEGG_compound","C00777_RETINOATE_RETINOIC_ACID_VITAMIN_A_ACID_ALL_TRANS_RETINOATE_ACIDE_RETINOIQUE_FRENCH_DSL_TRETINOINE_FRENCH_EINECS_3_7_DIMETHYL_9_2_6_6_TRIMETHYL_1_CYCLOHEXENE_1_YL_2_4_6_8_NONATETRAENOIC_ACID_ECL_ALL_E_3_7_DIMETHYL_9_2_6_6_TRIMETHYL_1_CYCLOHEXEN_1_YL_2_4_6_8_NONATETRAENOIC_ACID_BETA_RETINOIC_ACID_AGN_100335_ALL_E_RETINOIC_ACID_ALL_TRANS_BETA_RETINOIC_ACID_ALL_TRANS_RETINOIC_ACID_ALL_TRANS_TRETINOIN_ALL_TRANS_VITAMIN_A_ACID_RO_1_5488_TRANS_RETINOIC_ACID_TRETIN_M_ALL_TRANS_VITAMIN_A1_ACID",38,-1.3065,0.096,0.3,"No",1.4659,0.052,0.38,"Yes"
"7958","KEGG_pathway","HSA04727_GABAERGIC_SYNAPSE",85,-1.3065,0.069,0.12,"No",-0.9668,0.55,0.93,"No"
"7959","C6_Oncogenic_signatures","C6_ALL_65_LTE2_UP_V1_DN",194,-1.3063,0.028,0.08,"No",1.1437,0.12,0.43,"Yes"
"7960","C2_Chemical_and_genetic_perturbations","C2_CGP_3043_STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP",81,-1.3062,0.07,0.17,"No",0.8657,0.76,0.96,"Yes"
"7961","KEGG_reaction","R03091_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ESTRADIOL_17BETA_UDP_GLUCURONATE_ESTRADIOL_17BETA_3_GLUCURONIDE_UDP",19,-1.3061,0.15,0.28,"No",1.922,0.0021,0.0064,"Yes"
"7962","GO_BP","512055_GO_0051145_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",35,-1.3061,0.12,0.24,"No",0.804,0.77,1,"Yes"
"7963","GO_BP","501464_GO_0032229_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC",7,-1.306,0.17,0.24,"No",-1.5107,0.04,0.82,"No"
"7964","GO_CC","497888_GO_0018995_HOST",8,-1.306,0.15,0.31,"No",-1.2198,0.23,0.66,"No"
"7965","C2_Chemical_and_genetic_perturbations","C2_CGP_3232_KUWANO_RNA_STABILIZED_BY_NO",7,-1.3059,0.18,0.17,"No",-1.3319,0.13,0.69,"No"
"7966","C2_BioCarta_Pathways","C2_CP_BIOCARTA_41_BIOCARTA_CLASSIC_PATHWAY",14,-1.3059,0.15,0.25,"No",-0.8983,0.6,1,"No"
"7967","C4_Cancer_gene_neighborhoods","C4_CGN_342_GNF2_CYP2B6",49,-1.3057,0.12,0.21,"No",-1.1205,0.26,0.72,"No"
"7968","C2_Chemical_and_genetic_perturbations","C2_CGP_541_DARWICHE_PAPILLOMA_RISK_LOW_DN",157,-1.3057,0.052,0.17,"No",-1.0228,0.37,0.98,"No"
"7969","GO_BP","506537_GO_0043506_REGULATION_OF_JUN_KINASE_ACTIVITY",75,-1.3056,0.09,0.24,"No",-0.9933,0.45,1,"No"
"7970","GO_MF","812218_GO_0036374_GLUTATHIONE_HYDROLASE_ACTIVITY",6,-1.3056,0.16,0.29,"No",-1.0535,0.41,0.86,"No"
"7971","GO_BP","505667_GO_0042536_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS",5,-1.3054,0.16,0.24,"No",-1.1774,0.31,0.9,"No"
"7972","GO_BP","487465_GO_0006029_PROTEOGLYCAN_METABOLIC_PROCESS",93,-1.3054,0.074,0.24,"No",0.8461,0.81,1,"Yes"
"7973","GO_BP","487717_GO_0001821_HISTAMINE_SECRETION",9,-1.3053,0.17,0.24,"No",0.9749,0.46,1,"Yes"
"7974","WikiPathways","672456_WP2034_LEPTIN_SIGNALING_PATHWAY",60,-1.3052,0.081,0.19,"No",0.6772,0.99,1,"Yes"
"7975","GO_BP","502844_GO_0033628_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN",41,-1.3052,0.1,0.24,"No",1.1011,0.29,0.9,"Yes"
"7976","GO_CC","501816_GO_0032590_DENDRITE_MEMBRANE",15,-1.3052,0.17,0.31,"No",1.0546,0.38,0.71,"Yes"
"7977","KEGG_reaction","R09428_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ACCEPTOR_UDP_ACCEPTOR_BETA_D_GLUCURONOSIDE",19,-1.3052,0.11,0.27,"No",1.9353,0.002,0.0088,"Yes"
"7978","C3_TF_targets","C3_TFT_64_V_PAX6_01",98,-1.3051,0.078,0.085,"No",-0.9822,0.48,0.8,"No"
"7979","GO_BP","517079_GO_0072163_MESONEPHRIC_EPITHELIUM_DEVELOPMENT",87,-1.3051,0.062,0.24,"No",-0.8875,0.69,1,"No"
"7980","C2_Chemical_and_genetic_perturbations","C2_CGP_1955_KRASNOSELSKAYA_ILF3_TARGETS_DN",46,-1.3049,0.1,0.17,"No",-1.0989,0.3,0.92,"No"
"7981","GO_CC","487458_GO_0001518_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX",14,-1.3048,0.18,0.31,"No",-1.007,0.44,0.85,"No"
"7982","GO_BP","513526_GO_0055093_RESPONSE_TO_HYPEROXIA",20,-1.3048,0.14,0.24,"No",-0.6703,0.93,1,"No"
"7983","GO_BP","517488_GO_0072583_CLATHRIN_MEDIATED_ENDOCYTOSIS",16,-1.3048,0.14,0.24,"No",0.4363,0.99,1,"Yes"
"7984","C7_Immunologic_signatures","C7_ALL_170_GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN",197,-1.3047,0.042,0.076,"No",1.0327,0.35,0.64,"Yes"
"7985","GO_BP","505380_GO_0042219_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS",15,-1.3047,0.14,0.24,"No",0.7751,0.77,1,"Yes"
"7986","C2_Chemical_and_genetic_perturbations","C2_CGP_1763_WESTON_VEGFA_TARGETS",104,-1.3046,0.07,0.17,"No",1.2338,0.11,0.45,"Yes"
"7987","KEGG_reaction","R08263_MORPHINE_UDP_GLUCURONATE_MORPHINE_6_GLUCURONIDE_UDP",19,-1.3044,0.14,0.27,"No",1.9435,0,0.015,"Yes"
"7988","C2_Chemical_and_genetic_perturbations","C2_CGP_2098_TESAR_ALK_TARGETS_EPISC_4D_UP",6,-1.3044,0.15,0.17,"No",-0.8181,0.69,1,"No"
"7989","REACTOME","106261_REACT_17044_MUSCLE_CONTRACTION",60,-1.3042,0.1,0.28,"No",1.2199,0.14,0.42,"Yes"
"7990","C3_TF_targets","C3_TFT_368_V_TEF1_Q6",218,-1.3042,0.036,0.086,"No",-1.2631,0.044,0.26,"No"
"7991","GO_BP","512033_GO_0051122_HEPOXILIN_BIOSYNTHETIC_PROCESS",5,-1.3041,0.15,0.25,"No",0.9296,0.53,1,"Yes"
"7992","C7_Immunologic_signatures","C7_ALL_658_GSE17721_LPS_VS_CPG_2H_BMDM_DN",195,-1.304,0.035,0.076,"No",1.3222,0.024,0.083,"Yes"
"7993","GO_BP","491809_GO_0006970_RESPONSE_TO_OSMOTIC_STRESS",67,-1.3039,0.083,0.25,"No",-0.9541,0.51,1,"No"
"7994","GO_BP","518268_GO_0090128_REGULATION_OF_SYNAPSE_MATURATION",12,-1.3039,0.17,0.25,"No",-1.3193,0.14,0.89,"No"
"7995","KEGG_reaction","R04354_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_METHOXY_17BETA_ESTRADIOL_UDP_GLUCURONATE_2_METHOXY_ESTRADIOL_17BETA_3_GLUCURONIDE_UDP",19,-1.3039,0.13,0.27,"No",1.9839,0.0021,0.055,"Yes"
"7996","C2_Chemical_and_genetic_perturbations","C2_CGP_1337_KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN",41,-1.3038,0.12,0.17,"No",1.223,0.18,0.46,"Yes"
"7997","C2_Chemical_and_genetic_perturbations","C2_CGP_3339_ROESSLER_LIVER_CANCER_METASTASIS_UP",105,-1.3037,0.059,0.17,"No",0.8883,0.71,0.93,"Yes"
"7998","GO_BP","508833_GO_0046579_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION",30,-1.3037,0.11,0.25,"No",-0.799,0.81,1,"No"
"7999","C7_Immunologic_signatures","C7_ALL_152_GSE13306_TREG_RA_VS_TCONV_RA_DN",196,-1.3037,0.04,0.077,"No",-1.4839,0,0.084,"No"
"8000","GO_BP","502023_GO_0032800_RECEPTOR_BIOSYNTHETIC_PROCESS",5,-1.3036,0.15,0.25,"No",-0.7873,0.73,1,"No"
"8001","C2_BioCarta_Pathways","C2_CP_BIOCARTA_9_BIOCARTA_AGR_PATHWAY",35,-1.3036,0.15,0.25,"No",0.8817,0.67,0.93,"Yes"
"8002","C7_Immunologic_signatures","C7_ALL_598_GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_DN",198,-1.3035,0.041,0.077,"No",1.4132,0.011,0.034,"Yes"
"8003","REACTOME","685534_REACT_147723_PI3K_AKT_SIGNALING_IN_CANCER",78,-1.3034,0.084,0.28,"No",-1.1028,0.28,0.9,"No"
"8004","REACTOME","106190_REACT_916_TRYPTOPHAN_CATABOLISM",11,-1.3034,0.16,0.28,"No",-1.2945,0.16,0.67,"No"
"8005","KEGG_compound","C05504_16_GLUCURONIDE_ESTRIOL_16ALPHA_17BETA_ESTRIOL_16_BETA_D_GLUCURONIDE_",19,-1.3034,0.14,0.3,"No",1.9523,0,0.039,"Yes"
"8006","GO_BP","509097_GO_0046888_NEGATIVE_REGULATION_OF_HORMONE_SECRETION",60,-1.3032,0.081,0.25,"No",-1.3939,0.041,1,"No"
"8007","C2_Chemical_and_genetic_perturbations","C2_CGP_981_GROSS_HIF1A_TARGETS_DN",24,-1.3032,0.14,0.17,"No",1.2715,0.13,0.42,"Yes"
"8008","GO_BP","498210_GO_0019367_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID",5,-1.3032,0.16,0.25,"No",-0.8029,0.71,1,"No"
"8009","C2_Chemical_and_genetic_perturbations","C2_CGP_1072_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP",6,-1.3032,0.17,0.17,"No",-1.226,0.24,0.78,"No"
"8010","GO_BP","493582_GO_0009409_RESPONSE_TO_COLD",37,-1.3031,0.11,0.25,"No",1.1857,0.21,0.8,"Yes"
"8011","GO_MF","486783_GO_0003924_GTPASE_ACTIVITY",240,-1.3031,0.032,0.3,"No",1.039,0.34,0.83,"Yes"
"8012","C3_TF_targets","C3_TFT_66_V_S8_01",233,-1.3031,0.027,0.086,"No",-0.9171,0.69,0.93,"No"
"8013","GO_MF","492678_GO_0008375_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY",44,-1.3031,0.1,0.3,"No",0.7102,0.95,1,"Yes"
"8014","REACTOME","105814_REACT_1100_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION",14,-1.3031,0.14,0.28,"No",0.7482,0.81,1,"Yes"
"8015","GO_BP","505181_GO_0040023_ESTABLISHMENT_OF_NUCLEUS_LOCALIZATION",12,-1.303,0.15,0.25,"No",-1.2964,0.15,0.88,"No"
"8016","C7_Immunologic_signatures","C7_ALL_26_GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN",198,-1.303,0.037,0.077,"No",1.3644,0.014,0.054,"Yes"
"8017","GO_BP","511862_GO_0050927_POSITIVE_REGULATION_OF_POSITIVE_CHEMOTAXIS",23,-1.303,0.13,0.25,"No",0.814,0.76,1,"Yes"
"8018","KEGG_compound","C05635_5_HYDROXYINDOLEACETATE",7,-1.303,0.14,0.3,"No",0.7556,0.8,1,"Yes"
"8019","C3_MicroRNA_targets","C3_MIR_110_AGGAAGC_MIR_516_3P",120,-1.3029,0.074,0.25,"No",-0.8483,0.81,1,"No"
"8020","C3_MicroRNA_targets","C3_MIR_14_TTGCACT_MIR_130A_MIR_301_MIR_130B",400,-1.3029,0.0084,0.24,"No",-0.8344,0.96,1,"No"
"8021","GO_BP","517226_GO_0072310_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT",9,-1.3029,0.17,0.25,"No",-1.1094,0.34,0.94,"No"
"8022","GO_BP","494703_GO_0010639_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION",274,-1.3029,0.023,0.25,"No",0.8356,0.95,1,"Yes"
"8023","KEGG_compound","C11136_ETIOCHOLAN_3ALPHA_OL_17_ONE_3_GLUCURONIDE",19,-1.3028,0.14,0.3,"No",1.9151,0.0061,0.015,"Yes"
"8024","GO_BP","511891_GO_0050957_EQUILIBRIOCEPTION",8,-1.3028,0.16,0.25,"No",1.3759,0.14,0.58,"Yes"
"8025","C4_Cancer_modules","C4_CM_126_MODULE_131",32,-1.3027,0.11,0.17,"No",1.1294,0.25,0.49,"Yes"
"8026","REACTOME","833832_REACT_163710_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING",26,-1.3027,0.12,0.28,"No",0.8997,0.61,0.9,"Yes"
"8027","C7_Immunologic_signatures","C7_ALL_1153_GSE27786_LSK_VS_NKTCELL_UP",199,-1.3026,0.034,0.077,"No",-0.9012,0.73,1,"No"
"8028","KEGG_compound","C11135_ANDROSTERONE_GLUCURONIDE_ANDROSTERONE_3_GLUCURONIDE",19,-1.3026,0.16,0.3,"No",1.9177,0.0043,0.015,"Yes"
"8029","C7_Immunologic_signatures","C7_ALL_163_GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP",187,-1.3025,0.053,0.077,"No",-1.3249,0.015,0.4,"No"
"8030","REACTOME","106454_REACT_13815_AXONAL_GROWTH_INHIBITION_RHOA_ACTIVATION_",10,-1.3025,0.15,0.28,"No",-0.9656,0.51,1,"No"
"8031","GO_BP","491392_GO_0006491_N_GLYCAN_PROCESSING",10,-1.3024,0.16,0.25,"No",0.716,0.84,1,"Yes"
"8032","C7_Immunologic_signatures","C7_ALL_1142_GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN",196,-1.3024,0.044,0.077,"No",1.223,0.067,0.19,"Yes"
"8033","C7_Immunologic_signatures","C7_ALL_437_GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP",198,-1.3024,0.053,0.077,"No",-0.6268,1,1,"No"
"8034","KEGG_reaction","R04353_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_METHOXYESTRONE_UDP_GLUCURONATE_2_METHOXYESTRONE_3_GLUCURONIDE_UDP",19,-1.3023,0.16,0.27,"No",1.9382,0,0.013,"Yes"
"8035","C2_Chemical_and_genetic_perturbations","C2_CGP_90_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP",90,-1.3023,0.083,0.17,"No",1.1901,0.16,0.5,"Yes"
"8036","GO_BP","505722_GO_0042596_FEAR_RESPONSE",31,-1.3023,0.13,0.25,"No",1.021,0.42,0.97,"Yes"
"8037","GO_BP","505558_GO_0042417_DOPAMINE_METABOLIC_PROCESS",26,-1.3023,0.13,0.25,"No",-0.8606,0.67,1,"No"
"8038","GO_BP","499628_GO_0030218_ERYTHROCYTE_DIFFERENTIATION",75,-1.3023,0.093,0.25,"No",1.2881,0.086,0.69,"Yes"
"8039","GO_BP","491180_GO_0006208_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS",7,-1.3022,0.17,0.25,"No",1.1792,0.27,0.8,"Yes"
"8040","GO_CC","501815_GO_0032589_NEURON_PROJECTION_MEMBRANE",31,-1.3022,0.13,0.31,"No",-0.8829,0.65,0.96,"No"
"8041","C4_Cancer_gene_neighborhoods","C4_CGN_105_MORF_FSHR",269,-1.3022,0.028,0.21,"No",-1.1418,0.16,0.68,"No"
"8042","GO_BP","502374_GO_0033153_T_CELL_RECEPTOR_V_D_J_RECOMBINATION",5,-1.3022,0.15,0.25,"No",0.6828,0.84,1,"Yes"
"8043","GO_BP","492817_GO_0008542_VISUAL_LEARNING",47,-1.3022,0.096,0.25,"No",-1.1419,0.24,0.93,"No"
"8044","C2_Chemical_and_genetic_perturbations","C2_CGP_503_MCBRYAN_PUBERTAL_BREAST_5_6WK_DN",135,-1.3021,0.057,0.17,"No",0.7243,0.98,1,"Yes"
"8045","REACTOME","833829_REACT_163769_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION",97,-1.302,0.063,0.28,"No",-1.1123,0.25,0.88,"No"
"8046","C2_Chemical_and_genetic_perturbations","C2_CGP_2088_NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER",22,-1.302,0.14,0.17,"No",-1.2114,0.18,0.8,"No"
"8047","GO_BP","488258_GO_0002385_MUCOSAL_IMMUNE_RESPONSE",34,-1.302,0.13,0.25,"No",0.9691,0.49,1,"Yes"
"8048","C3_TF_targets","C3_TFT_274_V_POU3F2_02",252,-1.3019,0.03,0.087,"No",-1.0095,0.44,0.74,"No"
"8049","C4_Cancer_gene_neighborhoods","C4_CGN_282_GNF2_ATM",30,-1.3019,0.12,0.21,"No",0.8059,0.77,0.98,"Yes"
"8050","KEGG_reaction","R02358_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ESTRONE_UDP_GLUCURONATE_ESTRONE_GLUCURONIDE_UDP",19,-1.3018,0.15,0.26,"No",1.9367,0.0019,0.01,"Yes"
"8051","WikiPathways","198828_WP516_HYPERTROPHY_MODEL",20,-1.3018,0.14,0.19,"No",-1.0799,0.35,0.99,"No"
"8052","GO_MF","499732_GO_0030331_ESTROGEN_RECEPTOR_BINDING",30,-1.3018,0.12,0.3,"No",1.0275,0.42,0.85,"Yes"
"8053","GO_BP","504763_GO_0035584_CALCIUM_MEDIATED_SIGNALING_USING_INTRACELLULAR_CALCIUM_SOURCE",13,-1.3017,0.15,0.25,"No",0.8573,0.64,1,"Yes"
"8054","KEGG_reaction","R08261_UDP_GLUCURONATE_CODEINE_UDP_CODEINE_6_GLUCURONIDE",19,-1.3016,0.13,0.26,"No",1.9749,0.0041,0.017,"Yes"
"8055","GO_MF","495522_GO_0015269_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY",17,-1.3016,0.14,0.3,"No",1.4803,0.061,0.39,"Yes"
"8056","C2_Chemical_and_genetic_perturbations","C2_CGP_1343_IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN",9,-1.3016,0.17,0.17,"No",0.6748,0.88,1,"Yes"
"8057","C4_Cancer_gene_neighborhoods","C4_CGN_136_MORF_NOS2A",281,-1.3016,0.021,0.21,"No",-1.2925,0.015,0.57,"No"
"8058","C4_Cancer_modules","C4_CM_411_MODULE_532",399,-1.3015,0.015,0.17,"No",0.9281,0.74,0.8,"Yes"
"8059","C2_Chemical_and_genetic_perturbations","C2_CGP_1127_PETRETTO_BLOOD_PRESSURE_UP",12,-1.3014,0.15,0.17,"No",-0.9569,0.52,1,"No"
"8060","GO_MF","512277_GO_0051393_ALPHA_ACTININ_BINDING",23,-1.3012,0.12,0.3,"No",1.2406,0.16,0.69,"Yes"
"8061","OMIM_gene","OMIM613170_TETRASPANIN_1_TSPAN1",5,-1.3012,0.18,1,"No",-0.8039,0.7,0.98,"No"
"8062","GO_BP","502114_GO_0032892_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT",26,-1.3012,0.14,0.25,"No",-0.7015,0.89,1,"No"
"8063","GO_BP","488554_GO_0002681_SOMATIC_RECOMBINATION_OF_T_CELL_RECEPTOR_GENE_SEGMENTS",5,-1.3012,0.17,0.25,"No",0.676,0.85,1,"Yes"
"8064","C2_Chemical_and_genetic_perturbations","C2_CGP_1213_NIKOLSKY_BREAST_CANCER_17P11_AMPLICON",10,-1.3012,0.15,0.17,"No",0.5688,0.95,1,"Yes"
"8065","C6_Oncogenic_signatures","C6_ALL_119_NRL_DN_V1_DN",125,-1.3012,0.071,0.083,"No",-0.9295,0.59,0.85,"No"
"8066","GO_BP","515163_GO_0070228_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS",56,-1.3012,0.079,0.25,"No",0.7131,0.96,1,"Yes"
"8067","KEGG_compound","C19606_NNAL_N_GLUCURONIDE",19,-1.3009,0.15,0.3,"No",1.938,0,0.028,"Yes"
"8068","GO_BP","494588_GO_0010519_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY",8,-1.3009,0.19,0.25,"No",-1.2985,0.17,0.89,"No"
"8069","C7_Immunologic_signatures","C7_ALL_648_GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_DN",199,-1.3009,0.049,0.079,"No",-0.6794,1,1,"No"
"8070","GO_BP","504433_GO_0035249_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",35,-1.3008,0.12,0.25,"No",-1.1235,0.27,0.94,"No"
"8071","C7_Immunologic_signatures","C7_ALL_1127_GSE2706_R848_VS_LPS_8H_STIM_DC_UP",169,-1.3008,0.037,0.079,"No",-0.9169,0.68,1,"No"
"8072","GO_BP","503829_GO_0034629_CELLULAR_PROTEIN_COMPLEX_LOCALIZATION",16,-1.3007,0.13,0.25,"No",-0.771,0.8,1,"No"
"8073","C3_TF_targets","C3_TFT_607_CATTGTYY_V_SOX9_B1",350,-1.3004,0.012,0.088,"No",0.8927,0.84,1,"Yes"
"8074","REACTOME","106444_REACT_13638_NRAGE_SIGNALS_DEATH_THROUGH_JNK",45,-1.3004,0.11,0.28,"No",-1.2722,0.13,0.7,"No"
"8075","KEGG_compound","C16643_MORPHINE_3_GLUCURONIDE",19,-1.3003,0.15,0.3,"No",1.9369,0,0.025,"Yes"
"8076","GO_BP","515277_GO_0070345_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION",5,-1.3003,0.16,0.25,"No",-1.0976,0.37,0.95,"No"
"8077","GO_BP","508778_GO_0046520_SPHINGOID_BIOSYNTHETIC_PROCESS",7,-1.3002,0.16,0.25,"No",0.6541,0.9,1,"Yes"
"8078","C3_MicroRNA_targets","C3_MIR_10_TGCACTG_MIR_148A_MIR_152_MIR_148B",304,-1.3001,0.019,0.24,"No",-0.7898,0.98,1,"No"
"8079","GO_BP","518657_GO_2000008_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",24,-1.3001,0.15,0.25,"No",-0.8857,0.65,1,"No"
"8080","C2_Chemical_and_genetic_perturbations","C2_CGP_854_DAWSON_METHYLATED_IN_LYMPHOMA_TCL1",56,-1.3001,0.091,0.18,"No",1.3322,0.073,0.36,"Yes"
"8081","KEGG_pathway","HSA04922_GLUCAGON_SIGNALING_PATHWAY",100,-1.2999,0.066,0.13,"No",-1.1144,0.29,0.69,"No"
"8082","GO_BP","507477_GO_0045077_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS",5,-1.2998,0.16,0.25,"No",0.5187,0.98,1,"Yes"
"8083","GO_BP","754151_GO_1901184_REGULATION_OF_ERBB_SIGNALING_PATHWAY",76,-1.2997,0.08,0.25,"No",0.8966,0.7,1,"Yes"
"8084","GO_BP","487612_GO_0001709_CELL_FATE_DETERMINATION",39,-1.2996,0.11,0.25,"No",-1.3817,0.077,1,"No"
"8085","C3_TF_targets","C3_TFT_446_V_ER_Q6_01",265,-1.2994,0.025,0.089,"No",-1.0001,0.44,0.76,"No"
"8086","C1_Positional","C1_ALL_81_CHR1P22",80,-1.2989,0.079,0.64,"No",0.8182,0.85,0.93,"Yes"
"8087","C3_TF_targets","C3_TFT_174_V_NGFIC_01",249,-1.2988,0.032,0.089,"No",-1.0875,0.23,0.57,"No"
"8088","C2_Chemical_and_genetic_perturbations","C2_CGP_2769_MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3",35,-1.2984,0.13,0.18,"No",1.2225,0.16,0.46,"Yes"
"8089","C1_Positional","C1_ALL_265_CHR17Q24",41,-1.2984,0.12,0.63,"No",-1.2068,0.19,1,"No"
"8090","GO_BP","501564_GO_0032329_SERINE_TRANSPORT",9,-1.2984,0.16,0.25,"No",0.8175,0.71,1,"Yes"
"8091","GO_BP","508081_GO_0045740_POSITIVE_REGULATION_OF_DNA_REPLICATION",59,-1.2981,0.082,0.25,"No",-0.7512,0.9,1,"No"
"8092","GO_MF","506570_GO_0043539_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY",17,-1.2979,0.16,0.3,"No",0.6262,0.93,1,"Yes"
"8093","C7_Immunologic_signatures","C7_ALL_508_GSE17721_CTRL_VS_CPG_12H_BMDM_DN",196,-1.2978,0.049,0.081,"No",-0.8612,0.84,1,"No"
"8094","GO_MF","492450_GO_0008081_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY",87,-1.2978,0.073,0.3,"No",-0.8684,0.73,1,"No"
"8095","GO_MF","489358_GO_0003857_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY",8,-1.2976,0.18,0.3,"No",0.9173,0.56,0.96,"Yes"
"8096","C2_Chemical_and_genetic_perturbations","C2_CGP_3099_SUBTIL_PROGESTIN_TARGETS",36,-1.2976,0.11,0.18,"No",-1.1654,0.21,0.83,"No"
"8097","C3_MicroRNA_targets","C3_MIR_176_GTGTCAA_MIR_514",61,-1.2976,0.1,0.24,"No",0.859,0.77,1,"Yes"
"8098","C4_Cancer_modules","C4_CM_267_MODULE_305",19,-1.2974,0.15,0.17,"No",1.0692,0.36,0.59,"Yes"
"8099","KEGG_module","HSA_M00361_NUCLEOTIDE_SUGAR_BIOSYNTHESIS_EUKARYOTES",8,-1.2973,0.17,0.44,"No",-0.8941,0.58,1,"No"
"8100","GO_BP","487914_GO_0002024_DIET_INDUCED_THERMOGENESIS",7,-1.2973,0.17,0.25,"No",-0.8226,0.7,1,"No"
"8101","GO_BP","493273_GO_0009072_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS",28,-1.2973,0.13,0.25,"No",-1.1054,0.31,0.94,"No"
"8102","GO_BP","498979_GO_0021696_CEREBELLAR_CORTEX_MORPHOGENESIS",31,-1.2973,0.14,0.25,"No",-1.1711,0.25,0.91,"No"
"8103","GO_CC","506323_GO_0043256_LAMININ_COMPLEX",10,-1.2972,0.16,0.32,"No",1.2625,0.16,0.45,"Yes"
"8104","KEGG_compound","C04373_ETIOCHOLANOLONE_3ALPHA_HYDROXY_5BETA_ANDROSTAN_17_ONE_ETIOCHOLAN_3ALPHA_OL_17_ONE_3ALPHA_HYDROXYETIOCHOLAN_17_ONE",20,-1.2971,0.15,0.3,"No",1.9237,0,0.018,"Yes"
"8105","C2_Chemical_and_genetic_perturbations","C2_CGP_2285_BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING",497,-1.2969,0.0072,0.18,"No",-0.8003,1,1,"No"
"8106","GO_BP","510893_GO_0048843_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",9,-1.2969,0.17,0.25,"No",-1.0018,0.46,0.99,"No"
"8107","GO_BP","518525_GO_0090385_PHAGOSOME_LYSOSOME_FUSION",6,-1.2969,0.16,0.25,"No",0.5677,0.96,1,"Yes"
"8108","C3_TF_targets","C3_TFT_98_V_OCT1_03",220,-1.2968,0.04,0.091,"No",0.9791,0.51,1,"Yes"
"8109","WikiPathways","198759_WP289_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS",151,-1.2968,0.062,0.2,"No",0.9217,0.68,1,"Yes"
"8110","GO_BP","508002_GO_0045654_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION",9,-1.2967,0.18,0.25,"No",-0.7643,0.73,1,"No"
"8111","C3_MicroRNA_targets","C3_MIR_71_GTGTTGA_MIR_505",104,-1.2963,0.077,0.24,"No",-1.1465,0.18,1,"No"
"8112","GO_BP","513456_GO_0055023_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH",21,-1.2962,0.13,0.25,"No",-0.5915,0.96,1,"No"
"8113","GO_BP","511774_GO_0050808_SYNAPSE_ORGANIZATION",124,-1.2961,0.064,0.25,"No",-1.1173,0.22,0.94,"No"
"8114","GO_BP","494644_GO_0010579_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY_INVOLVED_IN_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",24,-1.2961,0.12,0.25,"No",-0.986,0.47,1,"No"
"8115","KEGG_reaction","R02902_RETINOATE_UDP_GLUCURONATE_ALL_TRANS_RETINOYL_BETA_GLUCURONIDE_UDP",19,-1.296,0.14,0.27,"No",1.9564,0,0.017,"Yes"
"8116","REACTOME","106550_REACT_1309_RNA_POLYMERASE_I_TRANSCRIPTION",107,-1.2959,0.073,0.29,"No",-1.5286,0.0054,0.41,"No"
"8117","C2_Chemical_and_genetic_perturbations","C2_CGP_1838_TSENG_IRS1_TARGETS_DN",131,-1.2958,0.059,0.18,"No",1.4855,0.0068,0.22,"Yes"
"8118","C2_Chemical_and_genetic_perturbations","C2_CGP_3350_HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN",11,-1.2958,0.16,0.18,"No",-0.7534,0.78,1,"No"
"8119","GO_MF","496752_GO_0016860_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY",54,-1.2956,0.099,0.31,"No",-0.6855,0.98,1,"No"
"8120","GO_CC","500517_GO_0031258_LAMELLIPODIUM_MEMBRANE",18,-1.2956,0.16,0.32,"No",-0.6716,0.9,1,"No"
"8121","GO_BP","496162_GO_0016064_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",67,-1.2956,0.1,0.25,"No",0.638,0.99,1,"Yes"
"8122","GO_BP","487901_GO_0002011_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET",43,-1.2956,0.11,0.25,"No",0.8675,0.7,1,"Yes"
"8123","GO_BP","513924_GO_0060368_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY",5,-1.2955,0.15,0.25,"No",0.5448,0.95,1,"Yes"
"8124","GO_BP","752702_GO_0097201_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS",6,-1.2954,0.18,0.25,"No",-1.1612,0.3,0.92,"No"
"8125","C7_Immunologic_signatures","C7_ALL_1714_GSE3982_NKCELL_VS_TH2_DN",199,-1.2953,0.044,0.084,"No",1.5762,0,0.0044,"Yes"
"8126","C4_Cancer_gene_neighborhoods","C4_CGN_140_MORF_PAX7",260,-1.2953,0.029,0.22,"No",-1.2805,0.029,0.54,"No"
"8127","C7_Immunologic_signatures","C7_ALL_1462_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN",193,-1.2952,0.044,0.084,"No",1.0425,0.32,0.61,"Yes"
"8128","GO_BP","504951_GO_0035774_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",17,-1.2951,0.15,0.25,"No",1.0368,0.38,0.96,"Yes"
"8129","C2_Chemical_and_genetic_perturbations","C2_CGP_2560_VANASSE_BCL2_TARGETS_UP",38,-1.2948,0.13,0.18,"No",1.0502,0.38,0.71,"Yes"
"8130","REACTOME","106057_REACT_2051_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE_",39,-1.2946,0.13,0.29,"No",1.4946,0.01,0.15,"Yes"
"8131","C2_Chemical_and_genetic_perturbations","C2_CGP_2756_YAGI_AML_WITH_T_9_11_TRANSLOCATION",129,-1.2946,0.055,0.18,"No",-0.7105,0.99,1,"No"
"8132","GO_BP","496008_GO_0015884_FOLIC_ACID_TRANSPORT",8,-1.2946,0.15,0.25,"No",-0.974,0.48,1,"No"
"8133","C7_Immunologic_signatures","C7_ALL_1863_GSE9037_WT_VS_IRAK4_KO_BMDM_UP",198,-1.2945,0.049,0.084,"No",1.1219,0.16,0.38,"Yes"
"8134","C2_Chemical_and_genetic_perturbations","C2_CGP_1653_ONGUSAHA_TP53_TARGETS",36,-1.2945,0.14,0.18,"No",-1.2467,0.16,0.75,"No"
"8135","REACTOME","106467_REACT_12079_PLC_GAMMA1_SIGNALLING",36,-1.2944,0.12,0.29,"No",-1.1105,0.28,0.88,"No"
"8136","C7_Immunologic_signatures","C7_ALL_109_GSE12366_GC_VS_NAIVE_BCELL_UP",198,-1.2943,0.042,0.084,"No",1.2138,0.069,0.2,"Yes"
"8137","GO_MF","509016_GO_0046790_VIRION_BINDING",10,-1.2942,0.16,0.31,"No",0.8698,0.62,1,"Yes"
"8138","C2_Chemical_and_genetic_perturbations","C2_CGP_2318_HONMA_DOCETAXEL_RESISTANCE",34,-1.294,0.14,0.18,"No",1.6318,0.0087,0.12,"Yes"
"8139","GO_BP","500645_GO_0031394_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS",5,-1.294,0.15,0.26,"No",-0.7606,0.77,1,"No"
"8140","C2_Chemical_and_genetic_perturbations","C2_CGP_2338_BONCI_TARGETS_OF_MIR15A_AND_MIR16_1",91,-1.2939,0.093,0.18,"No",-1.0061,0.44,1,"No"
"8141","C7_Immunologic_signatures","C7_ALL_169_GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP",185,-1.2939,0.056,0.085,"No",1.0203,0.39,0.68,"Yes"
"8142","GO_BP","508482_GO_0046184_ALDEHYDE_BIOSYNTHETIC_PROCESS",5,-1.2939,0.17,0.26,"No",-0.9896,0.46,1,"No"
"8143","GO_CC","499562_GO_0030135_COATED_VESICLE",236,-1.2939,0.05,0.32,"No",1.147,0.15,0.59,"Yes"
"8144","C7_Immunologic_signatures","C7_ALL_185_GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP",197,-1.2937,0.041,0.085,"No",0.9953,0.46,0.75,"Yes"
"8145","GO_BP","504274_GO_0035089_ESTABLISHMENT_OF_APICAL_BASAL_CELL_POLARITY",9,-1.2937,0.16,0.26,"No",-0.7267,0.83,1,"No"
"8146","REACTOME","119552_REACT_19344_COSTIMULATION_BY_THE_CD28_FAMILY",67,-1.2936,0.096,0.29,"No",1.0956,0.27,0.59,"Yes"
"8147","GO_BP","1129350_GO_1903523_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION",28,-1.2936,0.13,0.26,"No",0.8845,0.63,1,"Yes"
"8148","GO_BP","514541_GO_0060986_ENDOCRINE_HORMONE_SECRETION",12,-1.2936,0.16,0.26,"No",0.7551,0.81,1,"Yes"
"8149","C2_Chemical_and_genetic_perturbations","C2_CGP_67_ZERBINI_RESPONSE_TO_SULINDAC_DN",6,-1.2936,0.19,0.18,"No",-0.6509,0.89,1,"No"
"8150","C7_Immunologic_signatures","C7_ALL_29_GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP",194,-1.2936,0.048,0.085,"No",-0.9995,0.45,1,"No"
"8151","GO_BP","505544_GO_0042401_CELLULAR_BIOGENIC_AMINE_BIOSYNTHETIC_PROCESS",38,-1.2935,0.11,0.26,"No",-0.8341,0.74,1,"No"
"8152","GO_CC","515865_GO_0070938_CONTRACTILE_RING",9,-1.2935,0.16,0.32,"No",-1.1089,0.34,0.75,"No"
"8153","REACTOME","105939_REACT_14835_NOTCH_HLH_TRANSCRIPTION_PATHWAY",13,-1.2935,0.14,0.29,"No",-1.1986,0.23,0.83,"No"
"8154","GO_BP","983738_GO_1903019_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS",13,-1.2935,0.17,0.26,"No",-0.9505,0.51,1,"No"
"8155","GO_MF","489933_GO_0004601_PEROXIDASE_ACTIVITY",39,-1.2934,0.12,0.31,"No",1.1422,0.24,0.76,"Yes"
"8156","GO_BP","755132_GO_2001026_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS",13,-1.2934,0.16,0.26,"No",-0.7154,0.82,1,"No"
"8157","GO_BP","513736_GO_0060179_MALE_MATING_BEHAVIOR",6,-1.2933,0.17,0.26,"No",0.9114,0.57,1,"Yes"
"8158","GO_MF","489890_GO_0004553_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS",94,-1.2932,0.082,0.31,"No",-0.9177,0.64,0.97,"No"
"8159","GO_BP","517427_GO_0072522_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",161,-1.2932,0.07,0.26,"No",0.9176,0.68,1,"Yes"
"8160","KEGG_compound","C19605_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_GLUCURONIDE_NNAL_O_GLUCURONIDE",19,-1.2932,0.13,0.31,"No",1.9027,0,0.014,"Yes"
"8161","GO_BP","514291_GO_0060736_PROSTATE_GLAND_GROWTH",10,-1.2932,0.16,0.26,"No",1.2771,0.16,0.7,"Yes"
"8162","C2_Chemical_and_genetic_perturbations","C2_CGP_1373_GRANDVAUX_IRF3_TARGETS_UP",15,-1.2931,0.15,0.18,"No",1.954,0,0.011,"Yes"
"8163","C2_Chemical_and_genetic_perturbations","C2_CGP_1735_ULE_SPLICING_VIA_NOVA2",43,-1.2931,0.12,0.18,"No",0.8104,0.82,0.98,"Yes"
"8164","GO_CC","499559_GO_0030130_CLATHRIN_COAT_OF_TRANS_GOLGI_NETWORK_VESICLE",11,-1.293,0.17,0.32,"No",-0.7381,0.82,1,"No"
"8165","GO_BP","754037_GO_1901068_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",286,-1.293,0.024,0.26,"No",0.9958,0.48,0.98,"Yes"
"8166","C2_Chemical_and_genetic_perturbations","C2_CGP_1055_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP",107,-1.2929,0.061,0.18,"No",-1.0922,0.27,0.93,"No"
"8167","GO_BP","513434_GO_0055001_MUSCLE_CELL_DEVELOPMENT",123,-1.2926,0.059,0.26,"No",-1.2377,0.11,0.9,"No"
"8168","GO_BP","495192_GO_0014744_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION",5,-1.2925,0.17,0.26,"No",0.9266,0.56,1,"Yes"
"8169","GO_BP","751593_GO_0044380_PROTEIN_LOCALIZATION_TO_CYTOSKELETON",18,-1.2925,0.16,0.26,"No",-1.1159,0.31,0.94,"No"
"8170","GO_BP","506337_GO_0043271_NEGATIVE_REGULATION_OF_ION_TRANSPORT",101,-1.2925,0.076,0.26,"No",0.9687,0.53,1,"Yes"
"8171","GO_BP","511799_GO_0050855_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY",12,-1.2924,0.17,0.26,"No",0.7897,0.74,1,"Yes"
"8172","GO_BP","753025_GO_1900028_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY",5,-1.2923,0.17,0.26,"No",-0.9518,0.54,1,"No"
"8173","GO_BP","513899_GO_0060343_TRABECULA_FORMATION",24,-1.2923,0.16,0.26,"No",-1.1103,0.31,0.94,"No"
"8174","C7_Immunologic_signatures","C7_ALL_255_GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP",198,-1.2922,0.047,0.086,"No",1.1767,0.1,0.27,"Yes"
"8175","C7_Immunologic_signatures","C7_ALL_1492_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN",191,-1.2922,0.041,0.086,"No",-0.8779,0.79,1,"No"
"8176","C2_Chemical_and_genetic_perturbations","C2_CGP_375_PASTURAL_RIZ1_TARGETS_UP",10,-1.292,0.16,0.18,"No",1.3402,0.14,0.35,"Yes"
"8177","KEGG_pathway","HSA04141_PROTEIN_PROCESSING_IN_ENDOPLASMIC_RETICULUM",167,-1.292,0.055,0.14,"No",0.93,0.66,1,"Yes"
"8178","WikiPathways","920958_WP2525_TRANS_SULFURATION_AND_ONE_CARBON_METABOLISM",30,-1.2919,0.13,0.2,"No",-1.3462,0.099,1,"No"
"8179","GO_CC","487585_GO_0001674_FEMALE_GERM_CELL_NUCLEUS",5,-1.2919,0.16,0.32,"No",-1.0234,0.45,0.85,"No"
"8180","C2_Chemical_and_genetic_perturbations","C2_CGP_1382_FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN",50,-1.2919,0.1,0.18,"No",1.3526,0.074,0.34,"Yes"
"8181","GO_CC","504926_GO_0035749_MYELIN_SHEATH_ADAXONAL_REGION",5,-1.2918,0.14,0.32,"No",-0.9094,0.57,0.96,"No"
"8182","GO_BP","516605_GO_0071681_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL",5,-1.2918,0.16,0.26,"No",-0.6505,0.85,1,"No"
"8183","C7_Immunologic_signatures","C7_ALL_538_GSE17721_LPS_VS_POLYIC_8H_BMDM_DN",198,-1.2918,0.055,0.086,"No",1.1318,0.17,0.36,"Yes"
"8184","C2_Chemical_and_genetic_perturbations","C2_CGP_2803_LI_PROSTATE_CANCER_EPIGENETIC",30,-1.2918,0.15,0.18,"No",0.7508,0.88,1,"Yes"
"8185","GO_BP","512291_GO_0051412_RESPONSE_TO_CORTICOSTERONE",23,-1.2916,0.14,0.26,"No",-0.8872,0.63,1,"No"
"8186","GO_BP","500156_GO_0030858_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION",53,-1.2916,0.1,0.26,"No",-1.0171,0.4,0.98,"No"
"8187","GO_BP","493714_GO_0009583_DETECTION_OF_LIGHT_STIMULUS",123,-1.2916,0.072,0.26,"No",-1.0697,0.3,0.96,"No"
"8188","C7_Immunologic_signatures","C7_ALL_740_GSE17721_12H_VS_24H_PAM3CSK4_BMDM_DN",198,-1.2913,0.052,0.087,"No",1.1277,0.16,0.37,"Yes"
"8189","GO_BP","754038_GO_1901069_GUANOSINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",261,-1.2913,0.04,0.26,"No",1.0002,0.48,0.98,"Yes"
"8190","KEGG_reaction","R02389_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_UDP_GLUCURONATE_BILIRUBIN_2_UDP_BILIRUBIN_BETA_DIGLUCURONIDE",19,-1.2912,0.14,0.27,"No",1.9344,0.0021,0.0083,"Yes"
"8191","KEGG_enzyme","2.4.1.17_GLUCURONOSYLTRANSFERASE_1_NAPHTHOL_GLUCURONYLTRANSFERASE_1_NAPHTHOL_UDP_GLUCURONOSYLTRANSFERASE_17BETA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_3ALPHA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_4_HYDROXYBIPHENYL_UDP_GLUCURONOSYLTRANSFERASE_4_METHYLUMBELLIFERONE_UDP_GLUCURONOSYLTRANSFERASE_4_NITROPHENOL_UDP_GLUCURONYLTRANSFERASE_4_NITROPHENOL_UDPGT_17_OH_STEROID_UDPGT_3_OH_ANDROGENIC_UDPGT_BILIRUBIN_URIDINE_DIPHOSPHOGLUCURONYLTRANSFERASE_BILIRUBIN_UDP_GLUCURONOSYLTRANSFERASE_BILIRUBIN_MONOGLUCURONIDE_GLUCURONYLTRANSFERASE_BILIRUBIN_UDPGT_BILIRUBIN_GLUCURONYLTRANSFERASE_CIRAMADOL_UDP_GLUCURONYLTRANSFERASE_ESTRIOL_UDP_GLUCURONOSYLTRANSFERASE_ESTRONE_UDP_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSIDE_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRIOL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRADIOL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_4_HYDROXYBIPHENYL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_1_2_DIACYLGLYCEROL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRIOL_16ALPHA_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE_GT_MORPHINE_GLUCURONYLTRANSFERASE_P_HYDROXYBIPHENYL_UDP_GLUCURONYLTRANSFERASE_P_NITROPHENOL_UDP_GLUCURONOSYLTRANSFERASE_P_NITROPHENOL_UDP_GLUCURONYLTRANSFERASE_P_NITROPHENYLGLUCURONOSYLTRANSFERASE_P_PHENYLPHENOL_GLUCURONYLTRANSFERASE_PHENYL_UDP_GLUCURONOSYLTRANSFERASE_PNP_UDPGT_UDP_GLUCURONATE_ESTRADIOL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONATE_ESTRIOL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONIC_ACID_TRANSFERASE_UDP_GLUCURONYLTRANSFERASE_UDP_GLUCURONATE_4_HYDROXYBIPHENYL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONATE_BILIRUBIN_GLUCURONYLTRANSFERASE_UDP_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONYLTRANSFERASE_UDPGA_TRANSFERASE_UDPGA_GLUCURONYLTRANSFERASE_UDPGT_URIDINE_DIPHOSPHOGLUCURONYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHATE_GLUCURONYLTRANSFERASE_URIDINE_5_DIPHOSPHOGLUCURONYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE",19,-1.2912,0.15,0.49,"No",1.9313,0,0.015,"Yes"
"8192","C7_Immunologic_signatures","C7_ALL_430_GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN",194,-1.2912,0.046,0.087,"No",-1.123,0.18,1,"No"
"8193","REACTOME","645308_REACT_121206_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM",49,-1.2911,0.12,0.29,"No",0.9841,0.49,0.78,"Yes"
"8194","GO_BP","750892_GO_0035965_CARDIOLIPIN_ACYL_CHAIN_REMODELING",7,-1.291,0.16,0.26,"No",-0.9242,0.55,1,"No"
"8195","C7_Immunologic_signatures","C7_ALL_153_GSE13306_TREG_VS_TCONV_UP",195,-1.291,0.045,0.087,"No",-1.0334,0.36,1,"No"
"8196","GO_BP","753989_GO_1901019_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",56,-1.291,0.1,0.26,"No",-1.228,0.16,0.88,"No"
"8197","C2_BioCarta_Pathways","C2_CP_BIOCARTA_160_BIOCARTA_DREAM_PATHWAY",13,-1.291,0.16,0.27,"No",-0.8807,0.64,1,"No"
"8198","C7_Immunologic_signatures","C7_ALL_1378_GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN",199,-1.291,0.055,0.087,"No",0.7032,1,1,"Yes"
"8199","C2_Chemical_and_genetic_perturbations","C2_CGP_3182_KASLER_HDAC7_TARGETS_1_UP",192,-1.2907,0.028,0.18,"No",0.738,0.99,1,"Yes"
"8200","GO_CC","490904_GO_0005902_MICROVILLUS",85,-1.2907,0.098,0.32,"No",-1.031,0.4,0.84,"No"
"8201","GO_CC","487991_GO_0002102_PODOSOME",22,-1.2907,0.14,0.32,"No",0.8694,0.67,0.91,"Yes"
"8202","GO_MF","490476_GO_0005242_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",22,-1.2907,0.14,0.31,"No",-0.8022,0.74,1,"No"
"8203","C2_BioCarta_Pathways","C2_CP_BIOCARTA_25_BIOCARTA_NEUROTRANSMITTERS_PATHWAY",6,-1.2906,0.16,0.26,"No",1.1659,0.29,0.7,"Yes"
"8204","GO_MF","516541_GO_0071617_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY",13,-1.2906,0.15,0.31,"No",0.5848,0.95,1,"Yes"
"8205","REACTOME","106212_REACT_1008_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS_",17,-1.2906,0.15,0.29,"No",-1.124,0.29,0.89,"No"
"8206","C7_Immunologic_signatures","C7_ALL_1530_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN",190,-1.2906,0.047,0.087,"No",-1.0327,0.37,1,"No"
"8207","C7_Immunologic_signatures","C7_ALL_1359_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP",192,-1.2906,0.043,0.087,"No",-0.8033,0.93,1,"No"
"8208","GO_BP","514301_GO_0060746_PARENTAL_BEHAVIOR",13,-1.2905,0.16,0.26,"No",0.7266,0.85,1,"Yes"
"8209","C1_Positional","C1_ALL_5_CHR7P21",34,-1.2904,0.13,0.64,"No",-0.869,0.66,0.99,"No"
"8210","REACTOME","187107_REACT_24980_REGULATION_OF_IFNG_SIGNALING",14,-1.2904,0.15,0.29,"No",0.7178,0.84,1,"Yes"
"8211","C3_TF_targets","C3_TFT_549_YNTTTNNNANGCARM_UNKNOWN",62,-1.2903,0.086,0.097,"No",-0.7379,0.91,1,"No"
"8212","GO_CC","500779_GO_0031528_MICROVILLUS_MEMBRANE",22,-1.2903,0.15,0.32,"No",-0.8229,0.74,1,"No"
"8213","C2_Chemical_and_genetic_perturbations","C2_CGP_415_KOINUMA_COLON_CANCER_MSI_UP",16,-1.2903,0.16,0.18,"No",0.8672,0.67,0.96,"Yes"
"8214","KEGG_compound","C18126_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL",5,-1.2903,0.17,0.31,"No",-0.5433,0.95,1,"No"
"8215","C4_Cancer_gene_neighborhoods","C4_CGN_341_GNF2_CKS2",50,-1.2902,0.11,0.22,"No",1.5099,0.022,0.029,"Yes"
"8216","C2_Chemical_and_genetic_perturbations","C2_CGP_3186_DORMOY_ELAVL1_TARGETS",17,-1.2902,0.14,0.18,"No",0.6339,0.94,1,"Yes"
"8217","KEGG_compound","C03221_2_TRANS_DODECENOYL_COA_2E_DODEC_2_ENOYL_COA_2E_DODECENOYL_COA",8,-1.2901,0.17,0.31,"No",0.6075,0.92,1,"Yes"
"8218","C2_Chemical_and_genetic_perturbations","C2_CGP_1437_BHATTACHARYA_EMBRYONIC_STEM_CELL",88,-1.2901,0.075,0.18,"No",1.5003,0.0045,0.21,"Yes"
"8219","KEGG_pathway","HSA04114_OOCYTE_MEIOSIS",111,-1.29,0.083,0.14,"No",0.8712,0.77,1,"Yes"
"8220","GO_BP","512032_GO_0051121_HEPOXILIN_METABOLIC_PROCESS",5,-1.2898,0.16,0.26,"No",0.9135,0.55,1,"Yes"
"8221","C4_Cancer_modules","C4_CM_104_MODULE_109",37,-1.2897,0.14,0.18,"No",1.0016,0.43,0.71,"Yes"
"8222","GO_BP","511741_GO_0050770_REGULATION_OF_AXONOGENESIS",124,-1.2897,0.063,0.26,"No",-1.1755,0.16,0.9,"No"
"8223","C3_MicroRNA_targets","C3_MIR_84_GAGACTG_MIR_452",92,-1.2893,0.068,0.25,"No",0.6194,1,1,"Yes"
"8224","REACTOME","366239_REACT_75829_PIP3_ACTIVATES_AKT_SIGNALING",91,-1.2892,0.09,0.29,"No",-1.1237,0.24,0.89,"No"
"8225","GO_MF","490640_GO_0005545_1_PHOSPHATIDYLINOSITOL_BINDING",20,-1.2892,0.16,0.31,"No",-0.6778,0.9,1,"No"
"8226","C7_Immunologic_signatures","C7_ALL_1642_GSE3982_DC_VS_TH1_DN",196,-1.2892,0.048,0.088,"No",1.028,0.38,0.65,"Yes"
"8227","GO_BP","750957_GO_0036035_OSTEOCLAST_DEVELOPMENT",6,-1.2891,0.18,0.26,"No",0.7616,0.77,1,"Yes"
"8228","C2_Chemical_and_genetic_perturbations","C2_CGP_2689_VALK_AML_CLUSTER_13",30,-1.289,0.13,0.19,"No",-0.6202,0.97,1,"No"
"8229","C2_Chemical_and_genetic_perturbations","C2_CGP_2837_KORKOLA_CORRELATED_WITH_POU5F1",33,-1.2889,0.13,0.19,"No",-1.3222,0.11,0.69,"No"
"8230","C3_MicroRNA_targets","C3_MIR_20_AAAGGGA_MIR_204_MIR_211",222,-1.2889,0.039,0.25,"No",-0.7557,0.98,1,"No"
"8231","KEGG_compound","C05503_ESTRADIOL_17BETA_3_GLUCURONIDE_17BETA_ESTRADIOL_3_BETA_D_GLUCURONIDE_",19,-1.2889,0.16,0.31,"No",1.9559,0,0.049,"Yes"
"8232","WikiPathways","198811_WP179_CELL_CYCLE",101,-1.2888,0.08,0.21,"No",0.8294,0.86,1,"Yes"
"8233","C3_MicroRNA_targets","C3_MIR_1_AGCACTT_MIR_93_MIR_302A_MIR_302B_MIR_302C_MIR_302D_MIR_372_MIR_373_MIR_520E_MIR_520A_MIR_526B_MIR_520B_MIR_520C_MIR_520D",339,-1.2888,0.021,0.24,"No",-0.6936,1,1,"No"
"8234","C2_Chemical_and_genetic_perturbations","C2_CGP_2075_ZHENG_FOXP3_TARGETS_IN_THYMUS_UP",194,-1.2887,0.057,0.19,"No",1.1089,0.2,0.61,"Yes"
"8235","KEGG_compound","C05276_TRANS_OCT_2_ENOYL_COA_2E_OCTENOYL_COA",8,-1.2886,0.15,0.31,"No",0.6001,0.93,1,"Yes"
"8236","GO_MF","495533_GO_0015288_PORIN_ACTIVITY",7,-1.2886,0.17,0.31,"No",1.4601,0.085,0.41,"Yes"
"8237","GO_BP","494008_GO_0009914_HORMONE_TRANSPORT",81,-1.2885,0.095,0.26,"No",1.1698,0.15,0.81,"Yes"
"8238","GO_BP","518325_GO_0090185_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT",16,-1.2885,0.17,0.26,"No",-0.7576,0.8,1,"No"
"8239","GO_BP","516558_GO_0071634_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION",21,-1.2885,0.15,0.26,"No",0.8357,0.72,1,"Yes"
"8240","C2_BioCarta_Pathways","C2_CP_BIOCARTA_35_BIOCARTA_G1_PATHWAY",28,-1.2884,0.14,0.26,"No",-0.8862,0.64,1,"No"
"8241","C4_Cancer_gene_neighborhoods","C4_CGN_315_GNF2_SMC2L1",33,-1.2884,0.14,0.22,"No",1.0899,0.33,0.39,"Yes"
"8242","GO_BP","513941_GO_0060385_AXONOGENESIS_INVOLVED_IN_INNERVATION",5,-1.2884,0.18,0.26,"No",-1.4237,0.085,0.94,"No"
"8243","C2_Chemical_and_genetic_perturbations","C2_CGP_1541_YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN",17,-1.2884,0.15,0.19,"No",1.5245,0.054,0.19,"Yes"
"8244","C7_Immunologic_signatures","C7_ALL_782_GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN",200,-1.2884,0.054,0.089,"No",0.8686,0.85,1,"Yes"
"8245","REACTOME","161006_REACT_22272_SIGNAL_TRANSDUCTION_BY_L1",21,-1.2883,0.13,0.3,"No",1.1502,0.25,0.51,"Yes"
"8246","C7_Immunologic_signatures","C7_ALL_8_KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN",195,-1.2883,0.04,0.089,"No",0.9281,0.69,0.96,"Yes"
"8247","KEGG_compound","C04043_3_4_DIHYDROXYPHENYLACETALDEHYDE_PROTOCATECHUATEALDEHYDE",8,-1.2882,0.18,0.31,"No",-0.9901,0.5,1,"No"
"8248","GO_BP","488311_GO_0002438_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",7,-1.288,0.17,0.26,"No",1.1082,0.33,0.89,"Yes"
"8249","GO_BP","501306_GO_0032069_REGULATION_OF_NUCLEASE_ACTIVITY",81,-1.288,0.098,0.26,"No",-0.6379,0.99,1,"No"
"8250","KEGG_compound","C01516_MORPHINE",20,-1.288,0.17,0.31,"No",1.7378,0.0083,0.059,"Yes"
"8251","GO_BP","503307_GO_0034101_ERYTHROCYTE_HOMEOSTASIS",82,-1.2879,0.094,0.26,"No",1.4661,0.0044,0.47,"Yes"
"8252","GO_CC","513469_GO_0055038_RECYCLING_ENDOSOME_MEMBRANE",40,-1.2877,0.11,0.32,"No",0.6931,0.94,0.99,"Yes"
"8253","GO_BP","516604_GO_0071680_RESPONSE_TO_INDOLE_3_METHANOL",5,-1.2876,0.19,0.26,"No",-0.6535,0.88,1,"No"
"8254","C3_MicroRNA_targets","C3_MIR_68_GGGGCCC_MIR_296",69,-1.2876,0.11,0.24,"No",-1.7097,0.0035,0.11,"No"
"8255","KEGG_module","HSA_M00047_CREATINE_PATHWAY",7,-1.2874,0.17,0.45,"No",-1.264,0.22,1,"No"
"8256","C1_Positional","C1_ALL_111_CHRXQ11",10,-1.2873,0.17,0.64,"No",-0.9594,0.49,1,"No"
"8257","C7_Immunologic_signatures","C7_ALL_1397_GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP",200,-1.2872,0.053,0.09,"No",1.0125,0.43,0.71,"Yes"
"8258","GO_BP","495119_GO_0014047_GLUTAMATE_SECRETION",24,-1.2871,0.15,0.26,"No",-1.3595,0.11,0.97,"No"
"8259","GO_BP","511916_GO_0050982_DETECTION_OF_MECHANICAL_STIMULUS",40,-1.2871,0.12,0.26,"No",-1.5049,0.022,0.82,"No"
"8260","C3_TF_targets","C3_TFT_476_V_AR_03",56,-1.2869,0.1,0.1,"No",-1.12,0.28,0.5,"No"
"8261","REACTOME","160970_REACT_20537_TYPE_I_HEMIDESMOSOME_ASSEMBLY",9,-1.2869,0.16,0.3,"No",-0.9672,0.5,1,"No"
"8262","C7_Immunologic_signatures","C7_ALL_786_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN",192,-1.2869,0.044,0.09,"No",-1.2947,0.044,0.49,"No"
"8263","C2_Chemical_and_genetic_perturbations","C2_CGP_1395_SANA_RESPONSE_TO_IFNG_DN",85,-1.2869,0.095,0.19,"No",1.6073,0.0046,0.13,"Yes"
"8264","REACTOME","1127510_REACT_268456_PROGRAMMED_CELL_DEATH",163,-1.2868,0.059,0.3,"No",1.4761,0.0048,0.16,"Yes"
"8265","GO_MF","489431_GO_0003951_NAD_KINASE_ACTIVITY",17,-1.2868,0.14,0.32,"No",-1.5442,0.037,0.53,"No"
"8266","C2_Chemical_and_genetic_perturbations","C2_CGP_3218_PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP",85,-1.2866,0.079,0.19,"No",1.5466,0.012,0.17,"Yes"
"8267","GO_BP","504419_GO_0035235_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",24,-1.2866,0.16,0.26,"No",-0.9879,0.48,1,"No"
"8268","GO_BP","504513_GO_0035329_HIPPO_SIGNALING",26,-1.2866,0.14,0.26,"No",0.5786,0.98,1,"Yes"
"8269","GO_BP","507995_GO_0045647_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION",8,-1.2866,0.18,0.26,"No",1.1753,0.26,0.81,"Yes"
"8270","C2_Chemical_and_genetic_perturbations","C2_CGP_1390_MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP",20,-1.2866,0.16,0.19,"No",-1.1746,0.23,0.83,"No"
"8271","C2_Chemical_and_genetic_perturbations","C2_CGP_2130_ZHANG_GATA6_TARGETS_DN",63,-1.2866,0.097,0.19,"No",0.7176,0.94,1,"Yes"
"8272","C2_Chemical_and_genetic_perturbations","C2_CGP_2080_ZHENG_FOXP3_TARGETS_DN",5,-1.2865,0.19,0.19,"No",1.1679,0.29,0.53,"Yes"
"8273","C3_TF_targets","C3_TFT_330_V_DBP_Q6",244,-1.2865,0.041,0.1,"No",-0.9208,0.7,0.93,"No"
"8274","GO_BP","500400_GO_0031113_REGULATION_OF_MICROTUBULE_POLYMERIZATION",22,-1.2863,0.14,0.26,"No",-1.1127,0.29,0.94,"No"
"8275","C7_Immunologic_signatures","C7_ALL_274_GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN",195,-1.2863,0.046,0.091,"No",1.1618,0.15,0.3,"Yes"
"8276","KEGG_compound","C00136_BUTANOYL_COA_BUTYRYL_COA",16,-1.2863,0.17,0.31,"No",-0.582,0.97,1,"No"
"8277","GO_BP","491974_GO_0007171_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY",11,-1.2863,0.19,0.26,"No",-0.9334,0.58,1,"No"
"8278","GO_BP","516927_GO_0072008_GLOMERULAR_MESANGIAL_CELL_DIFFERENTIATION",5,-1.2862,0.18,0.26,"No",0.5012,0.97,1,"Yes"
"8279","GO_CC","506687_GO_0043657_HOST_CELL",8,-1.2862,0.17,0.32,"No",-1.2427,0.22,0.63,"No"
"8280","GO_BP","511652_GO_0050680_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION",111,-1.2861,0.077,0.26,"No",-1.0145,0.43,0.98,"No"
"8281","GO_MF","507849_GO_0045499_CHEMOREPELLENT_ACTIVITY",8,-1.286,0.16,0.32,"No",1.4074,0.11,0.48,"Yes"
"8282","C2_Chemical_and_genetic_perturbations","C2_CGP_2389_CHEN_HOXA5_TARGETS_6HR_UP",9,-1.286,0.18,0.19,"No",-1.2054,0.23,0.8,"No"
"8283","GO_BP","501953_GO_0032727_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION",15,-1.2859,0.15,0.26,"No",0.8138,0.71,1,"Yes"
"8284","GO_BP","753112_GO_1900117_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS",20,-1.2859,0.14,0.26,"No",0.9841,0.49,1,"Yes"
"8285","GO_BP","487827_GO_0001936_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION",91,-1.2857,0.076,0.26,"No",1.2186,0.11,0.76,"Yes"
"8286","C7_Immunologic_signatures","C7_ALL_366_GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN",192,-1.2857,0.055,0.091,"No",0.8747,0.85,1,"Yes"
"8287","KEGG_compound","C11133_ESTRONE_GLUCURONIDE_ESTRONE_3_GLUCURONIDE_ESTRONE_BETA_D_GLUCURONIDE",19,-1.2855,0.15,0.31,"No",1.9465,0.0043,0.028,"Yes"
"8288","C7_Immunologic_signatures","C7_ALL_139_GSE13229_IMM_VS_MATURE_NKCELL_UP",196,-1.2853,0.045,0.091,"No",0.8574,0.86,1,"Yes"
"8289","GO_BP","510635_GO_0048570_NOTOCHORD_MORPHOGENESIS",9,-1.2851,0.18,0.26,"No",-1.2329,0.22,0.9,"No"
"8290","GO_BP","494784_GO_0010719_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",22,-1.2849,0.13,0.26,"No",-0.981,0.48,1,"No"
"8291","C7_Immunologic_signatures","C7_ALL_1119_GSE2706_UNSTIM_VS_8H_LPS_DC_UP",195,-1.2848,0.045,0.092,"No",1.3429,0.0094,0.067,"Yes"
"8292","GO_MF","490092_GO_0004784_SUPEROXIDE_DISMUTASE_ACTIVITY",5,-1.2847,0.17,0.32,"No",-0.619,0.92,1,"No"
"8293","OMIM_gene","OMIM603850_DYNAMIN_1_LIKE_DNM1L",5,-1.2847,0.17,1,"No",0.8082,0.71,1,"Yes"
"8294","GO_BP","498885_GO_0021602_CRANIAL_NERVE_MORPHOGENESIS",24,-1.2847,0.14,0.26,"No",-0.6754,0.93,1,"No"
"8295","C3_MicroRNA_targets","C3_MIR_24_CTCAGGG_MIR_125B_MIR_125A",327,-1.2847,0.028,0.24,"No",-1.0696,0.25,1,"No"
"8296","C3_MicroRNA_targets","C3_MIR_99_TTGGGAG_MIR_150",90,-1.2846,0.093,0.24,"No",-0.7658,0.93,1,"No"
"8297","C2_BioCarta_Pathways","C2_CP_BIOCARTA_72_BIOCARTA_FCER1_PATHWAY",38,-1.2846,0.14,0.27,"No",0.6002,0.99,1,"Yes"
"8298","GO_BP","508653_GO_0046390_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS",155,-1.2846,0.051,0.26,"No",0.8621,0.82,1,"Yes"
"8299","C2_Chemical_and_genetic_perturbations","C2_CGP_1940_BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP",25,-1.2845,0.15,0.19,"No",0.9812,0.45,0.81,"Yes"
"8300","C2_Chemical_and_genetic_perturbations","C2_CGP_2525_NUTT_GBM_VS_AO_GLIOMA_UP",46,-1.2843,0.12,0.19,"No",1.4878,0.016,0.22,"Yes"
"8301","GO_BP","507342_GO_0044336_CANONICAL_WNT_SIGNALING_PATHWAY_INVOLVED_IN_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS",5,-1.2843,0.17,0.26,"No",-0.6674,0.87,1,"No"
"8302","GO_BP","486714_GO_0000183_CHROMATIN_SILENCING_AT_RDNA",38,-1.2843,0.16,0.26,"No",-1.6283,0.0072,0.7,"No"
"8303","GO_BP","519119_GO_2000479_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY",13,-1.2842,0.16,0.26,"No",1.037,0.37,0.96,"Yes"
"8304","REACTOME","187186_REACT_23988_TRANSPORT_OF_ORGANIC_ANIONS",11,-1.2842,0.17,0.3,"No",-1.1295,0.31,0.9,"No"
"8305","C2_Chemical_and_genetic_perturbations","C2_CGP_750_XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR",26,-1.2842,0.14,0.19,"No",0.908,0.62,0.91,"Yes"
"8306","C7_Immunologic_signatures","C7_ALL_1634_GSE3982_DC_VS_BASOPHIL_DN",199,-1.2841,0.056,0.093,"No",1.1819,0.092,0.26,"Yes"
"8307","C7_Immunologic_signatures","C7_ALL_1412_GSE360_CTRL_VS_T_GONDII_DC_DN",192,-1.284,0.057,0.093,"No",0.8479,0.9,1,"Yes"
"8308","KEGG_compound","C01211_PROCOLLAGEN_5_HYDROXY_L_LYSINE_PROCOLLAGEN_L_ERYTHRO_5_HYDROXYLYSINE",5,-1.2837,0.16,0.31,"No",-1.032,0.43,1,"No"
"8309","KEGG_compound","C11061_ALL_TRANS_RETINOYL_BETA_GLUCURONIDE_RETINOYL_GLUCURONIDE",19,-1.2837,0.16,0.31,"No",1.9076,0,0.015,"Yes"
"8310","C4_Cancer_modules","C4_CM_393_MODULE_495",15,-1.2837,0.15,0.19,"No",0.6421,0.95,1,"Yes"
"8311","C2_Chemical_and_genetic_perturbations","C2_CGP_1769_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN",30,-1.2836,0.13,0.19,"No",-0.9102,0.58,1,"No"
"8312","REACTOME","106128_REACT_1697_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA",5,-1.2836,0.18,0.3,"No",0.9932,0.49,0.76,"Yes"
"8313","C3_MicroRNA_targets","C3_MIR_220_CAATGCA_MIR_33",91,-1.2835,0.084,0.24,"No",-0.9755,0.52,1,"No"
"8314","GO_CC","499713_GO_0030313_CELL_ENVELOPE",6,-1.2834,0.17,0.33,"No",0.9321,0.52,0.85,"Yes"
"8315","GO_CC","752724_GO_0097223_SPERM_PART",119,-1.2834,0.078,0.32,"No",-1.1811,0.14,0.68,"No"
"8316","GO_BP","812250_GO_1990090_CELLULAR_RESPONSE_TO_NERVE_GROWTH_FACTOR_STIMULUS",18,-1.2833,0.16,0.27,"No",0.5827,0.98,1,"Yes"
"8317","C3_TF_targets","C3_TFT_229_V_MMEF2_Q6",261,-1.2831,0.035,0.1,"No",-0.942,0.63,0.88,"No"
"8318","KEGG_compound","C00601_PHENYLACETALDEHYDE_ALPHA_TOLUALDEHYDE",8,-1.2831,0.18,0.31,"No",-0.9994,0.45,1,"No"
"8319","C7_Immunologic_signatures","C7_ALL_1134_GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN",170,-1.283,0.062,0.094,"No",-1.241,0.088,0.66,"No"
"8320","C3_MicroRNA_targets","C3_MIR_181_TGCTTTG_MIR_330",325,-1.2829,0.017,0.24,"No",0.9545,0.6,1,"Yes"
"8321","C2_Chemical_and_genetic_perturbations","C2_CGP_2430_KRISHNAN_FURIN_TARGETS_UP",11,-1.2829,0.16,0.19,"No",-1.4856,0.069,0.48,"No"
"8322","C3_MicroRNA_targets","C3_MIR_157_AACATTC_MIR_409_3P",141,-1.2829,0.067,0.23,"No",1.0076,0.41,1,"Yes"
"8323","KEGG_compound","C05275_TRANS_DEC_2_ENOYL_COA_2E_DECENOYL_COA",8,-1.2828,0.18,0.31,"No",0.6114,0.93,1,"Yes"
"8324","REACTOME","106136_REACT_16957_PEROXISOMAL_LIPID_METABOLISM",21,-1.2827,0.14,0.3,"No",1.2983,0.12,0.32,"Yes"
"8325","KEGG_reaction","R01383_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ROH_UDP_BETA_D_GLUCURONOSIDE",19,-1.2826,0.17,0.28,"No",1.9313,0.0022,0.0079,"Yes"
"8326","REACTOME","105778_REACT_471_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION",33,-1.2826,0.13,0.3,"No",0.6921,0.93,1,"Yes"
"8327","C7_Immunologic_signatures","C7_ALL_413_GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP",196,-1.2826,0.057,0.094,"No",1.4227,0.0045,0.031,"Yes"
"8328","C7_Immunologic_signatures","C7_ALL_59_GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP",197,-1.2826,0.042,0.094,"No",-0.6943,0.99,1,"No"
"8329","REACTOME","119534_REACT_19268_NECTIN_NECL_TRANS_HETERODIMERIZATION",6,-1.2825,0.17,0.3,"No",0.9566,0.5,0.82,"Yes"
"8330","GO_MF","495545_GO_0015301_ANION_ANION_ANTIPORTER_ACTIVITY",24,-1.2825,0.16,0.32,"No",-0.8734,0.67,1,"No"
"8331","GO_BP","510764_GO_0048709_OLIGODENDROCYTE_DIFFERENTIATION",57,-1.2825,0.11,0.27,"No",1.0149,0.43,0.97,"Yes"
"8332","C7_Immunologic_signatures","C7_ALL_1736_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN",192,-1.2824,0.05,0.094,"No",0.8066,0.94,1,"Yes"
"8333","GO_BP","508688_GO_0046426_NEGATIVE_REGULATION_OF_JAK_STAT_CASCADE",20,-1.2824,0.16,0.27,"No",0.4939,0.99,1,"Yes"
"8334","KEGG_compound","C07108_TAMOXIFEN",8,-1.2823,0.19,0.31,"No",-0.6707,0.88,1,"No"
"8335","GO_MF","496711_GO_0016812_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES",9,-1.2823,0.18,0.32,"No",1.1155,0.33,0.77,"Yes"
"8336","C3_MicroRNA_targets","C3_MIR_7_TGAATGT_MIR_181A_MIR_181B_MIR_181C_MIR_181D",476,-1.2822,0.015,0.23,"No",-0.7667,1,1,"No"
"8337","C7_Immunologic_signatures","C7_ALL_1313_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP",194,-1.2821,0.053,0.094,"No",-0.679,1,1,"No"
"8338","C2_Chemical_and_genetic_perturbations","C2_CGP_3050_KIM_ALL_DISORDERS_CALB1_CORR_DN",33,-1.2819,0.14,0.19,"No",0.9267,0.59,0.89,"Yes"
"8339","GO_MF","500206_GO_0030911_TPR_DOMAIN_BINDING",5,-1.2819,0.17,0.32,"No",0.6518,0.9,1,"Yes"
"8340","C3_TF_targets","C3_TFT_56_V_MZF1_02",226,-1.2818,0.05,0.1,"No",-1.2647,0.058,0.26,"No"
"8341","KEGG_reaction","R01881_ATP_CREATINE_N_PHOSPHOTRANSFERASE_ATP_CREATINE_ADP_PHOSPHOCREATINE",5,-1.2817,0.16,0.27,"No",-1.083,0.37,0.69,"No"
"8342","C3_TF_targets","C3_TFT_144_V_CEBP_C",198,-1.2815,0.034,0.1,"No",0.9631,0.55,1,"Yes"
"8343","GO_BP","495219_GO_0014823_RESPONSE_TO_ACTIVITY",46,-1.2815,0.12,0.27,"No",-0.7719,0.87,1,"No"
"8344","C7_Immunologic_signatures","C7_ALL_1549_GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.2815,0.056,0.095,"No",0.8503,0.86,1,"Yes"
"8345","REACTOME","1183575_REACT_355160_PI_3K_CASCADE_FGFR3",91,-1.2814,0.091,0.3,"No",-1.1347,0.22,0.9,"No"
"8346","GO_BP","499062_GO_0021782_GLIAL_CELL_DEVELOPMENT",69,-1.2813,0.092,0.27,"No",0.8076,0.84,1,"Yes"
"8347","GO_BP","492845_GO_0008585_FEMALE_GONAD_DEVELOPMENT",81,-1.2813,0.08,0.27,"No",-0.9017,0.66,1,"No"
"8348","REACTOME","106437_REACT_524_SOS_MEDIATED_SIGNALLING",21,-1.2813,0.16,0.3,"No",0.5178,0.99,1,"Yes"
"8349","C2_Chemical_and_genetic_perturbations","C2_CGP_679_EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION",49,-1.2813,0.12,0.19,"No",1.0455,0.37,0.72,"Yes"
"8350","C2_Chemical_and_genetic_perturbations","C2_CGP_1622_IVANOVA_HEMATOPOIESIS_MATURE_CELL",293,-1.2812,0.024,0.19,"No",1.4601,0.0026,0.25,"Yes"
"8351","GO_BP","508472_GO_0046174_POLYOL_CATABOLIC_PROCESS",19,-1.2812,0.15,0.27,"No",0.5775,0.96,1,"Yes"
"8352","GO_BP","512813_GO_0051963_REGULATION_OF_SYNAPSE_ASSEMBLY",38,-1.2812,0.14,0.27,"No",-1.1112,0.28,0.94,"No"
"8353","C2_Chemical_and_genetic_perturbations","C2_CGP_3064_WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN",362,-1.2811,0.029,0.19,"No",1.2022,0.035,0.48,"Yes"
"8354","GO_MF","490010_GO_0004690_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY",9,-1.2811,0.17,0.32,"No",1.3539,0.13,0.52,"Yes"
"8355","C6_Oncogenic_signatures","C6_ALL_92_DCA_UP_V1_UP",171,-1.2811,0.053,0.1,"No",-1.1908,0.11,0.46,"No"
"8356","GO_BP","512745_GO_0051890_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION",9,-1.2811,0.17,0.27,"No",-0.9896,0.47,1,"No"
"8357","C2_Chemical_and_genetic_perturbations","C2_CGP_3324_RAO_BOUND_BY_SALL4",224,-1.2811,0.046,0.19,"No",-0.8484,0.88,1,"No"
"8358","GO_BP","497185_GO_0018214_PROTEIN_CARBOXYLATION",12,-1.281,0.17,0.27,"No",-0.9143,0.59,1,"No"
"8359","C2_Chemical_and_genetic_perturbations","C2_CGP_1944_MCDOWELL_ACUTE_LUNG_INJURY_DN",46,-1.281,0.12,0.19,"No",0.7974,0.85,0.99,"Yes"
"8360","GO_BP","491788_GO_0006939_SMOOTH_MUSCLE_CONTRACTION",47,-1.281,0.12,0.27,"No",0.8039,0.83,1,"Yes"
"8361","GO_BP","982376_GO_1902806_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION",139,-1.281,0.081,0.27,"No",1.2595,0.082,0.72,"Yes"
"8362","KEGG_compound","C00028_ACCEPTOR_HYDROGEN_ACCEPTOR_A_OXIDIZED_DONOR",21,-1.281,0.15,0.31,"No",1.1913,0.22,0.87,"Yes"
"8363","GO_BP","925920_GO_1902571_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY",7,-1.2808,0.2,0.27,"No",1.2904,0.17,0.69,"Yes"
"8364","C2_Chemical_and_genetic_perturbations","C2_CGP_2509_FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN",50,-1.2807,0.12,0.19,"No",-1.0565,0.37,0.96,"No"
"8365","KEGG_compound","C00300_CREATINE_ALPHA_METHYLGUANIDINO_ACETIC_ACID_METHYLGLYCOCYAMINE",6,-1.2807,0.17,0.3,"No",-0.9815,0.5,1,"No"
"8366","C3_TF_targets","C3_TFT_145_V_GATA_C",258,-1.2806,0.041,0.11,"No",-0.9266,0.68,0.92,"No"
"8367","C7_Immunologic_signatures","C7_ALL_840_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN",198,-1.2806,0.05,0.096,"No",0.9848,0.49,0.79,"Yes"
"8368","C2_Chemical_and_genetic_perturbations","C2_CGP_1752_DASU_IL6_SIGNALING_SCAR_UP",30,-1.2806,0.15,0.19,"No",-0.6737,0.94,1,"No"
"8369","GO_CC","490652_GO_0005577_FIBRINOGEN_COMPLEX",7,-1.2805,0.18,0.33,"No",0.9318,0.52,0.85,"Yes"
"8370","GO_CC","490821_GO_0005793_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT",78,-1.2805,0.095,0.33,"No",0.9427,0.57,0.85,"Yes"
"8371","GO_BP","492563_GO_0070265_NECROTIC_CELL_DEATH",27,-1.2804,0.16,0.27,"No",-0.6339,0.96,1,"No"
"8372","C4_Cancer_gene_neighborhoods","C4_CGN_113_MORF_IL13",225,-1.2804,0.04,0.23,"No",-1.2032,0.083,0.65,"No"
"8373","C2_Chemical_and_genetic_perturbations","C2_CGP_2892_DORN_ADENOVIRUS_INFECTION_12HR_UP",26,-1.2802,0.14,0.19,"No",0.885,0.66,0.94,"Yes"
"8374","GO_BP","510982_GO_0048934_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION",12,-1.2801,0.17,0.27,"No",0.9548,0.48,1,"Yes"
"8375","GO_BP","516394_GO_0071470_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS",22,-1.28,0.16,0.27,"No",-0.608,0.98,1,"No"
"8376","C2_Chemical_and_genetic_perturbations","C2_CGP_1407_VANTVEER_BREAST_CANCER_METASTASIS_UP",55,-1.28,0.12,0.19,"No",-1.1401,0.25,0.86,"No"
"8377","KEGG_pathway","HSA01230_BIOSYNTHESIS_OF_AMINO_ACIDS",72,-1.28,0.096,0.15,"No",0.8936,0.68,0.99,"Yes"
"8378","C2_BioCarta_Pathways","C2_CP_BIOCARTA_68_BIOCARTA_EPONFKB_PATHWAY",11,-1.28,0.18,0.27,"No",-0.8957,0.58,1,"No"
"8379","GO_BP","499664_GO_0030259_LIPID_GLYCOSYLATION",5,-1.2797,0.18,0.27,"No",-1.2304,0.23,0.89,"No"
"8380","GO_BP","501468_GO_0032233_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",44,-1.2796,0.12,0.27,"No",-1.2552,0.12,0.91,"No"
"8381","C7_Immunologic_signatures","C7_ALL_433_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP",197,-1.2796,0.052,0.096,"No",-1.0388,0.34,1,"No"
"8382","GO_BP","499527_GO_0030091_PROTEIN_REPAIR",5,-1.2795,0.19,0.27,"No",0.8541,0.65,1,"Yes"
"8383","REACTOME","366231_REACT_75897_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS",12,-1.2795,0.18,0.3,"No",1.2056,0.22,0.44,"Yes"
"8384","GO_CC","500472_GO_0031209_SCAR_COMPLEX",8,-1.2794,0.18,0.33,"No",-0.6911,0.86,1,"No"
"8385","C7_Immunologic_signatures","C7_ALL_1052_GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN",200,-1.2793,0.055,0.097,"No",1.1852,0.097,0.25,"Yes"
"8386","C7_Immunologic_signatures","C7_ALL_723_GSE17721_0_5H_VS_24H_POLYIC_BMDM_UP",194,-1.2793,0.059,0.096,"No",1.645,0,0.0013,"Yes"
"8387","C2_Chemical_and_genetic_perturbations","C2_CGP_1946_MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6",51,-1.2793,0.12,0.19,"No",-0.6971,0.94,1,"No"
"8388","C3_TF_targets","C3_TFT_65_V_PAX2_01",57,-1.2793,0.11,0.11,"No",-1.2238,0.14,0.3,"No"
"8389","C7_Immunologic_signatures","C7_ALL_746_GSE17721_0_5H_VS_8H_CPG_BMDM_DN",200,-1.2792,0.048,0.096,"No",1.0086,0.45,0.71,"Yes"
"8390","GO_MF","489653_GO_0008239_DIPEPTIDYL_PEPTIDASE_ACTIVITY",11,-1.2792,0.19,0.32,"No",0.723,0.84,1,"Yes"
"8391","C7_Immunologic_signatures","C7_ALL_1532_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN",191,-1.2792,0.057,0.096,"No",0.7888,0.96,1,"Yes"
"8392","GO_CC","492446_GO_0008076_VOLTAGE_GATED_POTASSIUM_CHANNEL_COMPLEX",78,-1.2791,0.09,0.33,"No",-1.2465,0.11,0.64,"No"
"8393","C7_Immunologic_signatures","C7_ALL_1709_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP",194,-1.279,0.059,0.096,"No",-0.7882,0.96,1,"No"
"8394","C2_Chemical_and_genetic_perturbations","C2_CGP_2307_EHLERS_ANEUPLOIDY_UP",40,-1.279,0.12,0.19,"No",1.7664,0.0021,0.055,"Yes"
"8395","GO_BP","511803_GO_0050860_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY",13,-1.2789,0.17,0.27,"No",0.9476,0.51,1,"Yes"
"8396","GO_BP","516296_GO_0071372_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS",8,-1.2788,0.17,0.27,"No",-1.2566,0.19,0.91,"No"
"8397","GO_BP","510355_GO_0048240_SPERM_CAPACITATION",13,-1.2788,0.17,0.27,"No",-1.2379,0.19,0.91,"No"
"8398","C7_Immunologic_signatures","C7_ALL_298_GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN",198,-1.2786,0.065,0.097,"No",0.8086,0.94,1,"Yes"
"8399","C2_Chemical_and_genetic_perturbations","C2_CGP_507_VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",14,-1.2786,0.16,0.19,"No",1.175,0.24,0.53,"Yes"
"8400","C2_Chemical_and_genetic_perturbations","C2_CGP_1318_KANNAN_TP53_TARGETS_DN",21,-1.2785,0.15,0.19,"No",-0.6047,0.97,1,"No"
"8401","C3_MicroRNA_targets","C3_MIR_17_CAGTATT_MIR_200B_MIR_200C_MIR_429",466,-1.2785,0.017,0.23,"No",1.0228,0.37,1,"Yes"
"8402","C7_Immunologic_signatures","C7_ALL_205_GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP",198,-1.2783,0.046,0.097,"No",-0.5605,1,1,"No"
"8403","C7_Immunologic_signatures","C7_ALL_590_GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_DN",198,-1.2783,0.053,0.097,"No",0.9353,0.65,0.94,"Yes"
"8404","GO_BP","492601_GO_0008277_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",144,-1.2782,0.058,0.27,"No",-1.0649,0.31,0.96,"No"
"8405","GO_BP","518208_GO_0090068_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS",227,-1.2782,0.043,0.27,"No",1.1712,0.1,0.81,"Yes"
"8406","KEGG_reaction","R04683_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ESTRIOL_UDP_16_GLUCURONIDE_ESTRIOL",19,-1.2781,0.14,0.28,"No",1.9237,0,0.0066,"Yes"
"8407","C7_Immunologic_signatures","C7_ALL_1524_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN",199,-1.2781,0.053,0.097,"No",1.0756,0.28,0.51,"Yes"
"8408","C2_Chemical_and_genetic_perturbations","C2_CGP_248_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP",15,-1.278,0.16,0.2,"No",-1.1555,0.28,0.84,"No"
"8409","C3_TF_targets","C3_TFT_101_V_LYF1_01",254,-1.2779,0.039,0.11,"No",-1.1668,0.12,0.41,"No"
"8410","C7_Immunologic_signatures","C7_ALL_750_GSE17721_4_VS_24H_CPG_BMDM_DN",198,-1.2778,0.056,0.097,"No",-0.7467,0.99,1,"No"
"8411","GO_BP","513496_GO_0055064_CHLORIDE_ION_HOMEOSTASIS",6,-1.2778,0.18,0.27,"No",-1.2956,0.18,0.88,"No"
"8412","GO_BP","498045_GO_0019184_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS",17,-1.2778,0.14,0.27,"No",0.7978,0.77,1,"Yes"
"8413","GO_BP","495302_GO_0014912_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION",13,-1.2777,0.17,0.27,"No",0.7145,0.85,1,"Yes"
"8414","KEGG_compound","C00052_UDP_ALPHA_D_GALACTOSE_UDP_D_GALACTOSE_UDP_GALACTOSE_UDP_D_GALACTOPYRANOSE_UDP_ALPHA_D_GALACTOPYRANOSE",10,-1.2777,0.19,0.31,"No",-0.9962,0.49,1,"No"
"8415","C2_BioCarta_Pathways","C2_CP_BIOCARTA_85_BIOCARTA_SALMONELLA_PATHWAY",13,-1.2777,0.17,0.27,"No",1.1611,0.26,0.66,"Yes"
"8416","GO_BP","513435_GO_0055002_STRIATED_MUSCLE_CELL_DEVELOPMENT",112,-1.2776,0.083,0.27,"No",-1.2834,0.078,0.89,"No"
"8417","GO_MF","509120_GO_0046915_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",28,-1.2776,0.16,0.33,"No",-0.6466,0.95,1,"No"
"8418","GO_BP","493386_GO_0009190_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",33,-1.2776,0.13,0.27,"No",-1.2341,0.16,0.9,"No"
"8419","GO_BP","514556_GO_0061001_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS",23,-1.2775,0.15,0.27,"No",-1.2374,0.2,0.9,"No"
"8420","C2_Chemical_and_genetic_perturbations","C2_CGP_1397_LEE_LIVER_CANCER_MYC_DN",61,-1.2774,0.1,0.2,"No",0.9896,0.46,0.81,"Yes"
"8421","C2_Chemical_and_genetic_perturbations","C2_CGP_243_MULLIGHAN_MLL_SIGNATURE_1_DN",238,-1.2772,0.048,0.2,"No",1.0067,0.45,0.79,"Yes"
"8422","C2_Chemical_and_genetic_perturbations","C2_CGP_2781_KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP",12,-1.2772,0.17,0.2,"No",-0.8916,0.58,1,"No"
"8423","C4_Cancer_gene_neighborhoods","C4_CGN_3_MORF_BCL2",215,-1.277,0.048,0.24,"No",-1.1669,0.13,0.66,"No"
"8424","GO_BP","487480_GO_0001542_OVULATION_FROM_OVARIAN_FOLLICLE",10,-1.277,0.16,0.27,"No",1.0542,0.39,0.94,"Yes"
"8425","GO_BP","510394_GO_0048286_LUNG_ALVEOLUS_DEVELOPMENT",44,-1.2769,0.098,0.27,"No",-1.125,0.27,0.94,"No"
"8426","C3_TF_targets","C3_TFT_292_V_NCX_01",166,-1.2768,0.05,0.11,"No",-0.944,0.62,0.89,"No"
"8427","C2_Chemical_and_genetic_perturbations","C2_CGP_2580_HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN",49,-1.2766,0.12,0.2,"No",-0.6133,0.98,1,"No"
"8428","C2_Chemical_and_genetic_perturbations","C2_CGP_2457_MOOTHA_PGC",416,-1.2766,0.017,0.2,"No",1.7419,0,0.063,"Yes"
"8429","C2_BioCarta_Pathways","C2_CP_BIOCARTA_181_BIOCARTA_GPCR_PATHWAY",33,-1.2765,0.13,0.27,"No",0.7002,0.94,1,"Yes"
"8430","C2_Chemical_and_genetic_perturbations","C2_CGP_2505_PIONTEK_PKD1_TARGETS_DN",17,-1.2765,0.16,0.2,"No",1.0129,0.45,0.78,"Yes"
"8431","REACTOME","106517_REACT_13606_DEPOLARIZATION_OF_THE_PRESYNAPTIC_TERMINAL_TRIGGERS_THE_OPENING_OF_CALCIUM_CHANNELS",13,-1.2763,0.18,0.31,"No",-1.6148,0.025,0.32,"No"
"8432","GO_BP","514267_GO_0060712_SPONGIOTROPHOBLAST_LAYER_DEVELOPMENT",13,-1.2763,0.15,0.27,"No",-1.3601,0.12,0.97,"No"
"8433","GO_BP","750928_GO_0036003_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS",19,-1.2761,0.16,0.27,"No",-0.6035,0.96,1,"No"
"8434","OMIM_gene","OMIM602462_COLLAPSIN_RESPONSE_MEDIATOR_PROTEIN_1_CRMP1",5,-1.2761,0.14,1,"No",0.8205,0.66,1,"Yes"
"8435","REACTOME","106233_REACT_1050_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS",9,-1.2759,0.18,0.31,"No",-1.2021,0.23,0.83,"No"
"8436","GO_BP","752191_GO_0061448_CONNECTIVE_TISSUE_DEVELOPMENT",196,-1.2758,0.059,0.27,"No",-1.1437,0.14,0.93,"No"
"8437","REACTOME","187170_REACT_23974_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION",21,-1.2758,0.15,0.31,"No",1.2978,0.14,0.32,"Yes"
"8438","GO_BP","499338_GO_0022602_OVULATION_CYCLE_PROCESS",72,-1.2757,0.12,0.27,"No",0.9273,0.6,1,"Yes"
"8439","GO_BP","498978_GO_0021695_CEREBELLAR_CORTEX_DEVELOPMENT",47,-1.2757,0.12,0.27,"No",-1.0672,0.36,0.96,"No"
"8440","C2_Chemical_and_genetic_perturbations","C2_CGP_2053_LEIN_PONS_MARKERS",89,-1.2756,0.096,0.2,"No",1.3981,0.026,0.29,"Yes"
"8441","C2_Chemical_and_genetic_perturbations","C2_CGP_1907_XU_GH1_AUTOCRINE_TARGETS_UP",255,-1.2756,0.033,0.2,"No",1.069,0.27,0.68,"Yes"
"8442","GO_MF","490474_GO_0005234_EXTRACELLULAR_GLUTAMATE_GATED_ION_CHANNEL_ACTIVITY",18,-1.2755,0.14,0.33,"No",1.0002,0.44,0.87,"Yes"
"8443","C3_TF_targets","C3_TFT_358_V_ALPHACP1_01",256,-1.2755,0.038,0.11,"No",-1.0649,0.29,0.63,"No"
"8444","C6_Oncogenic_signatures","C6_ALL_115_CRX_DN_V1_DN",129,-1.2755,0.067,0.11,"No",-1.0579,0.3,0.59,"No"
"8445","GO_BP","515669_GO_0070741_RESPONSE_TO_INTERLEUKIN_6",24,-1.2755,0.15,0.27,"No",1.209,0.21,0.78,"Yes"
"8446","C7_Immunologic_signatures","C7_ALL_1231_GSE27786_NEUTROPHIL_VS_MONO_MAC_UP",197,-1.2754,0.055,0.1,"No",0.8957,0.76,1,"Yes"
"8447","GO_MF","496613_GO_0016684_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR",40,-1.2754,0.12,0.33,"No",1.2787,0.12,0.63,"Yes"
"8448","C7_Immunologic_signatures","C7_ALL_1415_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP",192,-1.2754,0.051,0.1,"No",0.9983,0.46,0.74,"Yes"
"8449","GO_BP","491745_GO_0006884_CELL_VOLUME_HOMEOSTASIS",26,-1.2753,0.13,0.27,"No",-0.882,0.62,1,"No"
"8450","REACTOME","105679_REACT_13541_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS",12,-1.2753,0.18,0.31,"No",-1.1209,0.3,0.87,"No"
"8451","GO_BP","496185_GO_0016090_PRENOL_METABOLIC_PROCESS",6,-1.2752,0.2,0.27,"No",-0.7924,0.7,1,"No"
"8452","C7_Immunologic_signatures","C7_ALL_1444_GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN",199,-1.2752,0.054,0.1,"No",1.3081,0.031,0.095,"Yes"
"8453","C7_Immunologic_signatures","C7_ALL_1427_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP",196,-1.2751,0.053,0.1,"No",0.9727,0.55,0.83,"Yes"
"8454","GO_BP","513441_GO_0055008_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS",53,-1.2751,0.11,0.27,"No",1.083,0.33,0.92,"Yes"
"8455","KEGG_compound","C11376_SN38_GLUCURONIDE_SN_38G",20,-1.2751,0.16,0.31,"No",1.9178,0.0022,0.016,"Yes"
"8456","GO_CC","487071_GO_0000778_CONDENSED_NUCLEAR_CHROMOSOME_KINETOCHORE",8,-1.2751,0.19,0.33,"No",0.4702,1,1,"Yes"
"8457","GO_BP","516278_GO_0071354_CELLULAR_RESPONSE_TO_INTERLEUKIN_6",20,-1.2751,0.16,0.27,"No",0.9028,0.58,1,"Yes"
"8458","GO_CC","486691_GO_0000159_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX",20,-1.275,0.16,0.33,"No",-0.6514,0.94,1,"No"
"8459","GO_BP","487609_GO_0001706_ENDODERM_FORMATION",52,-1.275,0.11,0.27,"No",0.7541,0.91,1,"Yes"
"8460","C2_Chemical_and_genetic_perturbations","C2_CGP_76_DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP",62,-1.2749,0.11,0.2,"No",1.1363,0.23,0.57,"Yes"
"8461","C7_Immunologic_signatures","C7_ALL_583_GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDM_UP",197,-1.2749,0.054,0.1,"No",-1.3033,0.033,0.46,"No"
"8462","C3_MicroRNA_targets","C3_MIR_75_TCCCCAC_MIR_491",57,-1.2747,0.1,0.24,"No",-1.0167,0.41,1,"No"
"8463","REACTOME","1183582_REACT_355304_PI_3K_CASCADE_FGFR4",91,-1.2746,0.087,0.31,"No",-1.1286,0.22,0.9,"No"
"8464","C2_Chemical_and_genetic_perturbations","C2_CGP_1810_ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP",29,-1.2746,0.15,0.2,"No",1.2367,0.16,0.45,"Yes"
"8465","C2_Chemical_and_genetic_perturbations","C2_CGP_2786_MARSON_FOXP3_TARGETS_DN",53,-1.2746,0.13,0.2,"No",1.1426,0.21,0.56,"Yes"
"8466","OMIM_gene","OMIM128240_UTROPHIN_UTRN",5,-1.2745,0.19,1,"No",0.7982,0.7,1,"Yes"
"8467","C7_Immunologic_signatures","C7_ALL_614_GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_DN",198,-1.2743,0.05,0.1,"No",1.2923,0.026,0.11,"Yes"
"8468","C7_Immunologic_signatures","C7_ALL_45_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP",195,-1.2743,0.056,0.1,"No",1.4538,0.0025,0.021,"Yes"
"8469","GO_BP","511866_GO_0050931_PIGMENT_CELL_DIFFERENTIATION",30,-1.2742,0.16,0.27,"No",1.1721,0.23,0.81,"Yes"
"8470","C7_Immunologic_signatures","C7_ALL_1112_GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN",184,-1.2741,0.062,0.1,"No",-1.171,0.13,0.93,"No"
"8471","REACTOME","1183561_REACT_355552_PI_3K_CASCADE_FGFR1",91,-1.274,0.082,0.31,"No",-1.1212,0.26,0.88,"No"
"8472","C6_Oncogenic_signatures","C6_ALL_77_PRC2_SUZ12_UP_V1_DN",173,-1.2739,0.064,0.11,"No",-0.8305,0.89,0.97,"No"
"8473","GO_BP","493493_GO_0009309_AMINE_BIOSYNTHETIC_PROCESS",39,-1.2738,0.13,0.28,"No",-0.8885,0.64,1,"No"
"8474","GO_BP","498800_GO_0021516_DORSAL_SPINAL_CORD_DEVELOPMENT",19,-1.2736,0.17,0.28,"No",1.1198,0.3,0.88,"Yes"
"8475","GO_BP","491917_GO_0007098_CENTROSOME_CYCLE",36,-1.2735,0.14,0.28,"No",-0.7131,0.91,1,"No"
"8476","REACTOME","105677_REACT_995_APOPTOTIC_EXECUTION_PHASE",52,-1.2734,0.14,0.31,"No",0.9848,0.48,0.78,"Yes"
"8477","REACTOME","530743_REACT_115961_PI3K_EVENTS_IN_ERBB4_SIGNALING",91,-1.2733,0.11,0.31,"No",-1.1216,0.23,0.88,"No"
"8478","KEGG_enzyme","2.7.3.2_CREATINE_KINASE_ATP_CREATINE_PHOSPHOTRANSFERASE_CK_MM_CK_MB_CK_BB_CK_CREATINE_PHOSPHOKINASE_CREATINE_PHOSPHOTRANSFERASE_PHOSPHOCREATINE_KINASE_ADENOSINE_TRIPHOSPHATE_CREATINE_TRANSPHOSPHORYLASE_MI_CK_CK_BB_CK_MM_CK_MB_CKMIMI_MIMI_CK",5,-1.2732,0.18,0.46,"No",-1.0388,0.45,0.7,"No"
"8479","C2_Chemical_and_genetic_perturbations","C2_CGP_2878_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA",8,-1.2732,0.19,0.2,"No",-0.6464,0.9,1,"No"
"8480","C2_Chemical_and_genetic_perturbations","C2_CGP_3243_SERVITJA_ISLET_HNF1A_TARGETS_DN",103,-1.2731,0.099,0.2,"No",-1.1385,0.22,0.86,"No"
"8481","C7_Immunologic_signatures","C7_ALL_1769_GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP",197,-1.2731,0.063,0.1,"No",1.1364,0.18,0.35,"Yes"
"8482","GO_BP","492251_GO_0007498_MESODERM_DEVELOPMENT",108,-1.2731,0.084,0.28,"No",-1.2195,0.11,0.88,"No"
"8483","C4_Cancer_gene_neighborhoods","C4_CGN_153_MORF_PRKACA",109,-1.273,0.089,0.24,"No",-1.1103,0.25,0.73,"No"
"8484","GO_BP","510983_GO_0048935_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT",12,-1.2729,0.18,0.28,"No",0.9529,0.53,1,"Yes"
"8485","C2_Chemical_and_genetic_perturbations","C2_CGP_860_WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN",5,-1.2728,0.19,0.2,"No",-0.7668,0.74,1,"No"
"8486","C3_TF_targets","C3_TFT_68_V_CDPCR1_01",125,-1.2728,0.093,0.11,"No",-1.1786,0.13,0.4,"No"
"8487","C7_Immunologic_signatures","C7_ALL_5_KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP",198,-1.2727,0.056,0.1,"No",0.7748,0.98,1,"Yes"
"8488","C2_Chemical_and_genetic_perturbations","C2_CGP_3270_HUANG_GATA2_TARGETS_DN",71,-1.2727,0.12,0.2,"No",0.87,0.73,0.95,"Yes"
"8489","GO_BP","512121_GO_0051225_SPINDLE_ASSEMBLY",59,-1.2726,0.12,0.28,"No",-1.0009,0.45,0.99,"No"
"8490","GO_BP","514056_GO_0060501_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS",5,-1.2726,0.21,0.28,"No",-1.0069,0.46,0.98,"No"
"8491","GO_BP","488974_GO_0003180_AORTIC_VALVE_MORPHOGENESIS",5,-1.2726,0.17,0.28,"No",-0.8235,0.69,1,"No"
"8492","GO_BP","508215_GO_0045907_POSITIVE_REGULATION_OF_VASOCONSTRICTION",29,-1.2726,0.14,0.28,"No",1.3401,0.1,0.62,"Yes"
"8493","GO_CC","500763_GO_0031512_MOTILE_PRIMARY_CILIUM",8,-1.2725,0.18,0.33,"No",0.5176,0.99,1,"Yes"
"8494","GO_BP","487719_GO_0001823_MESONEPHROS_DEVELOPMENT",90,-1.2725,0.11,0.28,"No",-0.9183,0.63,1,"No"
"8495","C2_Chemical_and_genetic_perturbations","C2_CGP_2869_VANTVEER_BREAST_CANCER_POOR_PROGNOSIS",53,-1.2724,0.14,0.2,"No",-0.7952,0.83,1,"No"
"8496","GO_BP","491577_GO_0006689_GANGLIOSIDE_CATABOLIC_PROCESS",5,-1.2724,0.17,0.28,"No",1.0431,0.4,0.96,"Yes"
"8497","C7_Immunologic_signatures","C7_ALL_472_GSE17721_CTRL_VS_POLYIC_6H_BMDM_DN",196,-1.2724,0.058,0.1,"No",0.8302,0.93,1,"Yes"
"8498","KEGG_reaction","R09036_ACYL_COA_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL_O_ACYLTRANSFERASE_ACYL_COA_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL_COA_PHOSPHATIDYLGLYCEROL",5,-1.2724,0.16,0.28,"No",-0.5507,0.95,0.99,"No"
"8499","GO_BP","516931_GO_0072012_GLOMERULUS_VASCULATURE_DEVELOPMENT",17,-1.2723,0.17,0.28,"No",-1.1585,0.26,0.92,"No"
"8500","GO_BP","512370_GO_0051492_REGULATION_OF_STRESS_FIBER_ASSEMBLY",57,-1.2722,0.13,0.28,"No",-1.2644,0.11,0.9,"No"
"8501","C1_Positional","C1_ALL_198_CHR15Q23",32,-1.2721,0.15,0.69,"No",-0.8125,0.75,0.98,"No"
"8502","REACTOME","530737_REACT_116008_PI3K_EVENTS_IN_ERBB2_SIGNALING",91,-1.2721,0.099,0.31,"No",-1.1221,0.26,0.89,"No"
"8503","C2_Chemical_and_genetic_perturbations","C2_CGP_1936_SESTO_RESPONSE_TO_UV_C5",46,-1.2721,0.13,0.2,"No",-0.5076,1,1,"No"
"8504","GO_MF","750816_GO_0052813_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_KINASE_ACTIVITY",5,-1.272,0.17,0.33,"No",0.7435,0.78,1,"Yes"
"8505","GO_MF","511063_GO_0050072_M7G_5_PPPN_DIPHOSPHATASE_ACTIVITY",8,-1.272,0.18,0.33,"No",1.1411,0.28,0.75,"Yes"
"8506","GO_BP","491615_GO_0006730_ONE_CARBON_METABOLIC_PROCESS",32,-1.2719,0.13,0.28,"No",-1.0118,0.42,0.98,"No"
"8507","GO_BP","500420_GO_0031133_REGULATION_OF_AXON_DIAMETER",6,-1.2719,0.18,0.28,"No",-0.7825,0.72,1,"No"
"8508","KEGG_compound","C03765_4_HYDROXYPHENYLACETALDEHYDE_2_4_HYDROXYPHENYL_ACETALDEHYDE",8,-1.2718,0.19,0.31,"No",-0.9686,0.5,1,"No"
"8509","GO_BP","503579_GO_0034377_PLASMA_LIPOPROTEIN_PARTICLE_ASSEMBLY",17,-1.2718,0.16,0.28,"No",-1.1538,0.28,0.92,"No"
"8510","GO_BP","510297_GO_0048172_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY",10,-1.2716,0.19,0.28,"No",0.7094,0.81,1,"Yes"
"8511","GO_BP","502255_GO_0033033_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS",14,-1.2716,0.17,0.28,"No",1.2185,0.21,0.76,"Yes"
"8512","KEGG_compound","C04233_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_2_ACYLGLYCERO_3_PHOSPHOCHOLINE_1_LYSOPHOSPHATIDYLCHOLINE_1_LYSOLECITHIN_3_LYSOLECITHIN",6,-1.2716,0.18,0.31,"No",-0.8062,0.73,1,"No"
"8513","REACTOME","1183568_REACT_355450_PI_3K_CASCADE_FGFR2",91,-1.2714,0.1,0.31,"No",-1.1142,0.26,0.88,"No"
"8514","C3_TF_targets","C3_TFT_230_V_HMEF2_Q6",129,-1.2714,0.079,0.11,"No",0.9803,0.51,1,"Yes"
"8515","REACTOME","106121_REACT_494_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS",17,-1.2713,0.15,0.31,"No",1.1595,0.26,0.5,"Yes"
"8516","GO_BP","516796_GO_0071875_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY",14,-1.2713,0.18,0.28,"No",-1.1972,0.24,0.9,"No"
"8517","OMIM_gene","OMIM601896_TNF_RECEPTOR_ASSOCIATED_FACTOR_3_TRAF3",6,-1.2712,0.21,0.93,"No",-0.9485,0.5,0.85,"No"
"8518","C2_Chemical_and_genetic_perturbations","C2_CGP_1272_CHESLER_BRAIN_D6MIT150_QTL_CIS",7,-1.2712,0.19,0.2,"No",-1.65,0.014,0.36,"No"
"8519","C2_Chemical_and_genetic_perturbations","C2_CGP_133_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP",442,-1.2712,0.024,0.2,"No",-1.1002,0.18,0.91,"No"
"8520","C2_Chemical_and_genetic_perturbations","C2_CGP_43_FOURNIER_ACINAR_DEVELOPMENT_LATE_UP",11,-1.271,0.18,0.2,"No",-0.6681,0.89,1,"No"
"8521","KEGG_pathway","HSA00350_TYROSINE_METABOLISM",35,-1.2709,0.15,0.16,"No",-0.9015,0.62,0.97,"No"
"8522","GO_BP","507466_GO_0045066_REGULATORY_T_CELL_DIFFERENTIATION",5,-1.2708,0.19,0.28,"No",-1.3165,0.13,0.89,"No"
"8523","GO_MF","499380_GO_0022834_LIGAND_GATED_CHANNEL_ACTIVITY",146,-1.2708,0.078,0.34,"No",-1.2431,0.075,0.84,"No"
"8524","C7_Immunologic_signatures","C7_ALL_1837_GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP",199,-1.2708,0.055,0.1,"No",-0.6098,1,1,"No"
"8525","GO_BP","493898_GO_0009791_POST_EMBRYONIC_DEVELOPMENT",98,-1.2706,0.087,0.28,"No",0.7328,0.98,1,"Yes"
"8526","GO_MF","509609_GO_0047429_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY",8,-1.2706,0.19,0.33,"No",0.6168,0.93,1,"Yes"
"8527","GO_BP","492555_GO_0008214_PROTEIN_DEALKYLATION",39,-1.2705,0.13,0.28,"No",-1.5382,0.027,0.75,"No"
"8528","C2_Chemical_and_genetic_perturbations","C2_CGP_1925_XU_GH1_AUTOCRINE_TARGETS_DN",137,-1.2705,0.067,0.2,"No",-0.7468,0.96,1,"No"
"8529","C4_Cancer_gene_neighborhoods","C4_CGN_156_MORF_PRKCA",172,-1.2704,0.057,0.24,"No",-1.0771,0.28,0.77,"No"
"8530","WikiPathways","712093_WP2380_BDNF_SIGNALING_PATHWAY",142,-1.2704,0.075,0.23,"No",1.0664,0.29,1,"Yes"
"8531","C7_Immunologic_signatures","C7_ALL_626_GSE17721_POLYIC_VS_CPG_6H_BMDM_DN",199,-1.2703,0.07,0.1,"No",1.0048,0.44,0.72,"Yes"
"8532","C2_Chemical_and_genetic_perturbations","C2_CGP_1921_CHENG_RESPONSE_TO_NICKEL_ACETATE",44,-1.2703,0.13,0.2,"No",0.9712,0.5,0.83,"Yes"
"8533","REACTOME","119527_REACT_19351_SIGNALING_BY_ROBO_RECEPTOR",31,-1.2702,0.16,0.31,"No",-0.7071,0.92,1,"No"
"8534","C2_Chemical_and_genetic_perturbations","C2_CGP_1546_HOEGERKORP_CD44_TARGETS_DIRECT_DN",14,-1.2701,0.16,0.2,"No",0.7612,0.79,1,"Yes"
"8535","GO_BP","499431_GO_0071230_CELLULAR_RESPONSE_TO_AMINO_ACID_STIMULUS",46,-1.2701,0.14,0.28,"No",1.1638,0.22,0.82,"Yes"
"8536","GO_BP","513446_GO_0055013_CARDIAC_MUSCLE_CELL_DEVELOPMENT",49,-1.2701,0.12,0.28,"No",-1.2817,0.11,0.89,"No"
"8537","KEGG_pathway","HSA00460_CYANOAMINO_ACID_METABOLISM",6,-1.27,0.17,0.16,"No",-0.9375,0.52,0.95,"No"
"8538","C2_Chemical_and_genetic_perturbations","C2_CGP_571_MARKS_HDAC_TARGETS_DN",15,-1.27,0.16,0.2,"No",-0.9064,0.58,1,"No"
"8539","GO_BP","513771_GO_0060215_PRIMITIVE_HEMOPOIESIS",6,-1.2698,0.19,0.28,"No",-0.6006,0.92,1,"No"
"8540","C2_Chemical_and_genetic_perturbations","C2_CGP_895_YANG_BREAST_CANCER_ESR1_BULK_DN",23,-1.2698,0.15,0.2,"No",0.6461,0.96,1,"Yes"
"8541","C2_Chemical_and_genetic_perturbations","C2_CGP_3247_KOHOUTEK_CCNT1_TARGETS",49,-1.2696,0.11,0.2,"No",-0.7026,0.93,1,"No"
"8542","GO_CC","505706_GO_0042579_MICROBODY",130,-1.2696,0.091,0.34,"No",0.8724,0.78,0.91,"Yes"
"8543","GO_BP","516838_GO_0071918_UREA_TRANSMEMBRANE_TRANSPORT",5,-1.2695,0.18,0.28,"No",-0.553,0.96,1,"No"
"8544","C2_Chemical_and_genetic_perturbations","C2_CGP_3154_ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS",6,-1.2695,0.2,0.2,"No",0.6879,0.83,1,"Yes"
"8545","GO_MF","503911_GO_0034711_INHIBIN_BINDING",5,-1.2694,0.18,0.34,"No",0.6697,0.86,1,"Yes"
"8546","GO_MF","490001_GO_0004674_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",438,-1.2694,0.016,0.34,"No",-1.1842,0.064,0.78,"No"
"8547","C2_Chemical_and_genetic_perturbations","C2_CGP_2448_TSAI_RESPONSE_TO_RADIATION_THERAPY",32,-1.2694,0.16,0.2,"No",1.0114,0.43,0.78,"Yes"
"8548","C2_Chemical_and_genetic_perturbations","C2_CGP_2366_WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN",24,-1.2693,0.16,0.2,"No",0.8692,0.64,0.96,"Yes"
"8549","GO_BP","513391_GO_0052652_CYCLIC_PURINE_NUCLEOTIDE_METABOLIC_PROCESS",32,-1.2693,0.16,0.28,"No",-1.1638,0.21,0.91,"No"
"8550","C2_Chemical_and_genetic_perturbations","C2_CGP_301_SCIBETTA_KDM5B_TARGETS_DN",79,-1.2692,0.087,0.2,"No",1.205,0.12,0.48,"Yes"
"8551","C3_TF_targets","C3_TFT_136_V_ER_Q6",267,-1.2691,0.042,0.12,"No",-1.1694,0.11,0.41,"No"
"8552","KEGG_module","HSA_M00059_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_BACKBONE",10,-1.2691,0.19,0.47,"No",-0.9017,0.58,1,"No"
"8553","C3_MicroRNA_targets","C3_MIR_73_TGTATGA_MIR_485_3P",149,-1.269,0.079,0.24,"No",1.0361,0.38,1,"Yes"
"8554","C2_Chemical_and_genetic_perturbations","C2_CGP_1509_TAVOR_CEBPA_TARGETS_DN",30,-1.269,0.16,0.2,"No",-1.0551,0.37,0.96,"No"
"8555","C7_Immunologic_signatures","C7_ALL_870_GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN",200,-1.2688,0.069,0.11,"No",1.2949,0.033,0.11,"Yes"
"8556","GO_BP","517564_GO_0072661_PROTEIN_TARGETING_TO_PLASMA_MEMBRANE",20,-1.2688,0.17,0.28,"No",-0.6951,0.87,1,"No"
"8557","GO_BP","506421_GO_0043382_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION",6,-1.2687,0.2,0.28,"No",-1.2852,0.18,0.89,"No"
"8558","GO_BP","513889_GO_0060333_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY",75,-1.2687,0.11,0.28,"No",0.6701,0.99,1,"Yes"
"8559","REACTOME","106189_REACT_1786_PHENYLALANINE_AND_TYROSINE_CATABOLISM",10,-1.2687,0.19,0.31,"No",-1.0504,0.4,0.94,"No"
"8560","GO_BP","511794_GO_0050849_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING",7,-1.2686,0.2,0.28,"No",0.6033,0.93,1,"Yes"
"8561","C2_Chemical_and_genetic_perturbations","C2_CGP_2344_GRADE_COLON_CANCER_DN",33,-1.2686,0.13,0.2,"No",-0.6397,0.97,1,"No"
"8562","GO_BP","514526_GO_0060971_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION",5,-1.2683,0.19,0.28,"No",-1.4597,0.079,0.88,"No"
"8563","KEGG_compound","C00332_ACETOACETYL_COA_ACETOACETYL_COENZYME_A_3_ACETOACETYL_COA",9,-1.2683,0.18,0.32,"No",-0.7536,0.8,1,"No"
"8564","GO_BP","516749_GO_0071827_PLASMA_LIPOPROTEIN_PARTICLE_ORGANIZATION",31,-1.2683,0.15,0.28,"No",-0.8462,0.71,1,"No"
"8565","REACTOME","106522_REACT_12591_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE",24,-1.2683,0.18,0.31,"No",-1.3389,0.12,0.6,"No"
"8566","C2_Chemical_and_genetic_perturbations","C2_CGP_2615_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12",285,-1.2682,0.048,0.2,"No",-0.8919,0.77,1,"No"
"8567","C2_Chemical_and_genetic_perturbations","C2_CGP_1315_NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN",119,-1.2681,0.092,0.2,"No",1.5056,0.0048,0.21,"Yes"
"8568","C7_Immunologic_signatures","C7_ALL_1832_GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN",179,-1.268,0.065,0.11,"No",-1.0147,0.42,1,"No"
"8569","KEGG_compound","C05787_BILIRUBIN_BETA_DIGLUCURONIDE_BILIRUBIN_BISGLUCURONOSIDE",20,-1.268,0.18,0.32,"No",1.9075,0.0021,0.014,"Yes"
"8570","C0_Hallmark","H_ALL_17_HALLMARK_PROTEIN_SECRETION",96,-1.268,0.096,0.097,"No",1.3807,0.029,0.06,"Yes"
"8571","GO_BP","491058_GO_0006073_CELLULAR_GLUCAN_METABOLIC_PROCESS",59,-1.268,0.14,0.28,"No",0.907,0.64,1,"Yes"
"8572","C7_Immunologic_signatures","C7_ALL_420_GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN",199,-1.268,0.049,0.11,"No",1.1833,0.11,0.25,"Yes"
"8573","GO_MF","490035_GO_0004721_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",167,-1.2679,0.08,0.34,"No",1.0483,0.34,0.83,"Yes"
"8574","C3_TF_targets","C3_TFT_137_V_GR_Q6",255,-1.2679,0.051,0.12,"No",-0.8355,0.92,1,"No"
"8575","GO_BP","495120_GO_0014048_REGULATION_OF_GLUTAMATE_SECRETION",13,-1.2679,0.18,0.28,"No",0.8988,0.59,1,"Yes"
"8576","C7_Immunologic_signatures","C7_ALL_1251_GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP",161,-1.2679,0.078,0.11,"No",1.3436,0.035,0.067,"Yes"
"8577","GO_BP","498966_GO_0021683_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS",12,-1.2679,0.18,0.28,"No",1.0364,0.39,0.96,"Yes"
"8578","C7_Immunologic_signatures","C7_ALL_551_GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_UP",199,-1.2678,0.043,0.11,"No",1.2024,0.083,0.22,"Yes"
"8579","C2_Chemical_and_genetic_perturbations","C2_CGP_1854_BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN",164,-1.2677,0.068,0.2,"No",1.307,0.041,0.39,"Yes"
"8580","C3_TF_targets","C3_TFT_27_V_NFKAPPAB65_01",232,-1.2677,0.054,0.12,"No",-1.2978,0.034,0.24,"No"
"8581","GO_BP","507058_GO_0044042_GLUCAN_METABOLIC_PROCESS",59,-1.2676,0.13,0.28,"No",0.8914,0.68,1,"Yes"
"8582","GO_BP","500122_GO_0030823_REGULATION_OF_CGMP_METABOLIC_PROCESS",26,-1.2676,0.18,0.28,"No",0.8694,0.68,1,"Yes"
"8583","C2_Chemical_and_genetic_perturbations","C2_CGP_116_CORRE_MULTIPLE_MYELOMA_UP",70,-1.2676,0.11,0.2,"No",0.8885,0.69,0.93,"Yes"
"8584","GO_BP","489073_GO_0003279_CARDIAC_SEPTUM_DEVELOPMENT",66,-1.2675,0.13,0.28,"No",-1.128,0.24,0.93,"No"
"8585","C7_Immunologic_signatures","C7_ALL_458_GSE17721_CTRL_VS_LPS_8H_BMDM_DN",195,-1.2674,0.064,0.11,"No",-0.9378,0.62,1,"No"
"8586","GO_BP","503447_GO_0034242_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",6,-1.2674,0.2,0.28,"No",-1.2836,0.19,0.89,"No"
"8587","GO_MF","492807_GO_0008528_G_PROTEIN_COUPLED_PEPTIDE_RECEPTOR_ACTIVITY",120,-1.2673,0.098,0.34,"No",1.6837,0,0.17,"Yes"
"8588","C7_Immunologic_signatures","C7_ALL_799_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP",194,-1.2672,0.053,0.11,"No",0.8041,0.95,1,"Yes"
"8589","C2_Chemical_and_genetic_perturbations","C2_CGP_2375_SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN",6,-1.2672,0.19,0.2,"No",0.7047,0.83,1,"Yes"
"8590","GO_MF","511671_GO_0050700_CARD_DOMAIN_BINDING",8,-1.2672,0.2,0.34,"No",-0.8518,0.66,1,"No"
"8591","GO_BP","502356_GO_0033135_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION",106,-1.2671,0.11,0.28,"No",0.9276,0.61,1,"Yes"
"8592","C7_Immunologic_signatures","C7_ALL_1679_GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP",193,-1.2671,0.068,0.11,"No",0.7902,0.96,1,"Yes"
"8593","C3_TF_targets","C3_TFT_130_V_NFY_Q6",255,-1.267,0.053,0.12,"No",-0.8481,0.88,1,"No"
"8594","C7_Immunologic_signatures","C7_ALL_1331_GSE30083_SP2_VS_SP3_THYMOCYTE_UP",192,-1.267,0.071,0.11,"No",-1.0218,0.39,1,"No"
"8595","C4_Cancer_gene_neighborhoods","C4_CGN_102_MORF_FLT1",120,-1.2668,0.069,0.25,"No",-1.3619,0.039,0.5,"No"
"8596","KEGG_module","HSA_M00035_METHIONINE_DEGRADATION",9,-1.2666,0.19,0.46,"No",-1.4787,0.063,0.55,"No"
"8597","REACTOME","106149_REACT_11042_RECYCLING_OF_BILE_ACIDS_AND_SALTS",15,-1.2666,0.17,0.31,"No",-0.88,0.62,1,"No"
"8598","REACTOME","106423_REACT_661_SHC_MEDIATED_SIGNALLING",22,-1.2666,0.17,0.31,"No",-0.5078,1,1,"No"
"8599","KEGG_compound","C00008_ADP_ADENOSINE_5_DIPHOSPHATE",173,-1.2665,0.079,0.32,"No",-0.7209,0.99,1,"No"
"8600","GO_BP","515130_GO_0070193_SYNAPTONEMAL_COMPLEX_ORGANIZATION",19,-1.2664,0.16,0.28,"No",-0.9135,0.57,1,"No"
"8601","GO_BP","488510_GO_0002637_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION",42,-1.2662,0.12,0.28,"No",-1.2236,0.18,0.88,"No"
"8602","GO_MF","499484_GO_0030021_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE",5,-1.2662,0.2,0.34,"No",-1.3665,0.13,0.69,"No"
"8603","C7_Immunologic_signatures","C7_ALL_518_GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_DN",195,-1.2662,0.062,0.11,"No",0.9693,0.53,0.84,"Yes"
"8604","REACTOME","106469_REACT_9000_CALMODULIN_INDUCED_EVENTS",28,-1.2662,0.14,0.31,"No",0.8104,0.78,0.99,"Yes"
"8605","GO_MF","490325_GO_0005044_SCAVENGER_RECEPTOR_ACTIVITY",46,-1.2661,0.13,0.34,"No",-1.1979,0.17,0.81,"No"
"8606","C7_Immunologic_signatures","C7_ALL_61_GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP",192,-1.2661,0.067,0.11,"No",-0.7356,0.99,1,"No"
"8607","KEGG_compound","C05966_15_S_HPETE_5Z_8Z_11Z_13E_15S_15_HYDROPEROXYICOSA_5_8_11_13_TETRAENOIC_ACID_15_HYDROPEROXYEICOSATETRAENOATE_15_HYDROPEROXYICOSATETRAENOATE_15_HYDROPEROXYEICOSATETRAENOIC_ACID_15_HYDROPEROXYICOSATETRAENOIC_ACID_5Z_8Z_11Z_13E_15S_15_HYDROPEROXYICOSA_5_8_11_13_TETRAENOATE",10,-1.2661,0.19,0.32,"No",-0.8125,0.72,1,"No"
"8608","GO_BP","753024_GO_1900027_REGULATION_OF_RUFFLE_ASSEMBLY",16,-1.2661,0.17,0.28,"No",-0.449,1,1,"No"
"8609","OMIM_gene","OMIM162151_PROPROTEIN_CONVERTASE_SUBTILISIN_KEXIN_TYPE_2_PCSK2",5,-1.266,0.18,0.88,"No",0.5855,0.94,1,"Yes"
"8610","GO_BP","491469_GO_0006573_VALINE_METABOLIC_PROCESS",8,-1.266,0.2,0.28,"No",0.6948,0.85,1,"Yes"
"8611","GO_MF","490290_GO_0005004_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY",5,-1.2659,0.17,0.34,"No",0.7407,0.78,1,"Yes"
"8612","C7_Immunologic_signatures","C7_ALL_781_GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP",191,-1.2659,0.062,0.11,"No",0.9564,0.61,0.88,"Yes"
"8613","GO_BP","518475_GO_0090335_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION",5,-1.2658,0.18,0.28,"No",-1.1476,0.34,0.93,"No"
"8614","GO_BP","507081_GO_0044065_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS",16,-1.2658,0.16,0.28,"No",-1.2171,0.2,0.88,"No"
"8615","C3_TF_targets","C3_TFT_318_V_GNCF_01",74,-1.2656,0.11,0.12,"No",0.9536,0.55,1,"Yes"
"8616","C7_Immunologic_signatures","C7_ALL_235_GSE14000_UNSTIM_VS_16H_LPS_DC_UP",195,-1.2656,0.062,0.11,"No",1.5286,0.0023,0.0084,"Yes"
"8617","GO_MF","495469_GO_0015204_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.2655,0.19,0.34,"No",-0.5661,0.97,1,"No"
"8618","GO_BP","491525_GO_0006635_FATTY_ACID_BETA_OXIDATION",47,-1.2655,0.15,0.28,"No",1.2185,0.15,0.76,"Yes"
"8619","C1_Positional","C1_ALL_144_CHRXQ21",38,-1.2654,0.15,0.7,"No",1.1411,0.27,0.63,"Yes"
"8620","GO_BP","514392_GO_0060837_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION",7,-1.2652,0.2,0.28,"No",1.1458,0.32,0.84,"Yes"
"8621","C7_Immunologic_signatures","C7_ALL_1854_GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN",200,-1.2651,0.05,0.11,"No",1.365,0.014,0.053,"Yes"
"8622","C3_TF_targets","C3_TFT_233_V_HNF4_01_B",245,-1.2651,0.055,0.12,"No",-1.144,0.15,0.45,"No"
"8623","C2_Chemical_and_genetic_perturbations","C2_CGP_714_MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS",11,-1.2649,0.18,0.21,"No",1.1203,0.29,0.6,"Yes"
"8624","GO_BP","491454_GO_0006558_L_PHENYLALANINE_METABOLIC_PROCESS",10,-1.2648,0.19,0.28,"No",-0.8569,0.65,1,"No"
"8625","C2_Chemical_and_genetic_perturbations","C2_CGP_1654_GENTILE_UV_RESPONSE_CLUSTER_D4",55,-1.2646,0.13,0.21,"No",-0.8777,0.67,1,"No"
"8626","C7_Immunologic_signatures","C7_ALL_1436_GSE360_DC_VS_MAC_L_MAJOR_DN",196,-1.2646,0.069,0.11,"No",-0.8257,0.91,1,"No"
"8627","GO_BP","517214_GO_0072298_REGULATION_OF_METANEPHRIC_GLOMERULUS_DEVELOPMENT",6,-1.2646,0.2,0.29,"No",0.9665,0.48,1,"Yes"
"8628","REACTOME","105802_REACT_1857_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION",22,-1.2645,0.17,0.31,"No",0.5901,0.97,1,"Yes"
"8629","C7_Immunologic_signatures","C7_ALL_525_GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_UP",199,-1.2645,0.068,0.11,"No",0.8493,0.88,1,"Yes"
"8630","C2_Chemical_and_genetic_perturbations","C2_CGP_2194_FUJII_YBX1_TARGETS_UP",43,-1.2643,0.14,0.21,"No",-0.7496,0.91,1,"No"
"8631","GO_MF","498064_GO_0019209_KINASE_ACTIVATOR_ACTIVITY",58,-1.2643,0.12,0.34,"No",0.8212,0.82,1,"Yes"
"8632","C7_Immunologic_signatures","C7_ALL_1366_GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN",196,-1.2642,0.065,0.11,"No",0.7793,0.98,1,"Yes"
"8633","GO_CC","499975_GO_0030672_SYNAPTIC_VESICLE_MEMBRANE",57,-1.2642,0.13,0.35,"No",-1.1947,0.19,0.7,"No"
"8634","REACTOME","1127544_REACT_267753_ACTIVATION_OF_SMO",17,-1.2642,0.17,0.31,"No",-0.9316,0.54,1,"No"
"8635","GO_BP","510701_GO_0048645_ORGAN_FORMATION",28,-1.2642,0.17,0.29,"No",-0.9517,0.53,1,"No"
"8636","GO_BP","502426_GO_0033206_MEIOTIC_CYTOKINESIS",6,-1.2642,0.2,0.29,"No",1.2221,0.26,0.76,"Yes"
"8637","GO_BP","500917_GO_0031668_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS",217,-1.2642,0.047,0.29,"No",-0.7221,1,1,"No"
"8638","C4_Cancer_gene_neighborhoods","C4_CGN_64_MORF_ATF2",318,-1.2641,0.038,0.25,"No",-1.0966,0.2,0.73,"No"
"8639","REACTOME","106127_REACT_1708_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA",5,-1.2639,0.19,0.31,"No",0.9989,0.46,0.76,"Yes"
"8640","GO_BP","504540_GO_0035356_CELLULAR_TRIGLYCERIDE_HOMEOSTASIS",6,-1.2638,0.2,0.29,"No",-0.5864,0.92,1,"No"
"8641","C2_Chemical_and_genetic_perturbations","C2_CGP_2107_KYNG_DNA_DAMAGE_BY_4NQO",38,-1.2637,0.14,0.21,"No",0.9926,0.46,0.81,"Yes"
"8642","GO_MF","498089_GO_0019238_CYCLOHYDROLASE_ACTIVITY",7,-1.2635,0.18,0.34,"No",-0.8101,0.7,1,"No"
"8643","GO_BP","506502_GO_0043470_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS",34,-1.2634,0.13,0.29,"No",1.0097,0.42,0.98,"Yes"
"8644","C2_Chemical_and_genetic_perturbations","C2_CGP_900_SEMBA_FHIT_TARGETS_UP",11,-1.2634,0.18,0.21,"No",-1.1251,0.31,0.89,"No"
"8645","C2_Chemical_and_genetic_perturbations","C2_CGP_941_DIERICK_SEROTONIN_FUNCTION_GENES",6,-1.2634,0.19,0.21,"No",-1.3127,0.16,0.69,"No"
"8646","C2_Chemical_and_genetic_perturbations","C2_CGP_559_DARWICHE_PAPILLOMA_PROGRESSION_RISK",69,-1.2632,0.12,0.21,"No",-1.0118,0.42,0.99,"No"
"8647","C7_Immunologic_signatures","C7_ALL_1391_GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP",198,-1.2631,0.06,0.11,"No",1.0047,0.45,0.72,"Yes"
"8648","C3_MicroRNA_targets","C3_MIR_55_TCCAGAT_MIR_516_5P",109,-1.2631,0.095,0.25,"No",-1.0945,0.27,1,"No"
"8649","C2_Chemical_and_genetic_perturbations","C2_CGP_1363_VANTVEER_BREAST_CANCER_METASTASIS_DN",119,-1.2631,0.095,0.21,"No",0.9103,0.68,0.91,"Yes"
"8650","GO_BP","495085_GO_0014012_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION",6,-1.263,0.19,0.29,"No",-0.967,0.51,1,"No"
"8651","GO_MF","508872_GO_0046624_SPHINGOLIPID_TRANSPORTER_ACTIVITY",5,-1.2628,0.19,0.34,"No",0.8135,0.69,1,"Yes"
"8652","GO_BP","500125_GO_0030826_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS",19,-1.2628,0.18,0.29,"No",-0.9602,0.55,1,"No"
"8653","GO_BP","494577_GO_0010508_POSITIVE_REGULATION_OF_AUTOPHAGY",43,-1.2628,0.15,0.29,"No",1.0012,0.42,0.98,"Yes"
"8654","GO_BP","488562_GO_0002689_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS",11,-1.2627,0.17,0.29,"No",0.8086,0.74,1,"Yes"
"8655","GO_BP","499514_GO_0030072_PEPTIDE_HORMONE_SECRETION",57,-1.2627,0.12,0.29,"No",0.9154,0.63,1,"Yes"
"8656","C2_Chemical_and_genetic_perturbations","C2_CGP_1901_JIANG_HYPOXIA_NORMAL",306,-1.2626,0.041,0.21,"No",1.4968,0,0.21,"Yes"
"8657","C2_Chemical_and_genetic_perturbations","C2_CGP_2529_PARK_TRETINOIN_RESPONSE",12,-1.2626,0.18,0.21,"No",1.4809,0.067,0.23,"Yes"
"8658","GO_BP","508000_GO_0045652_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION",28,-1.2625,0.15,0.29,"No",-1.2048,0.19,0.89,"No"
"8659","GO_BP","508887_GO_0046639_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION",11,-1.2625,0.21,0.29,"No",-0.9952,0.46,0.99,"No"
"8660","GO_BP","506635_GO_0043604_AMIDE_BIOSYNTHETIC_PROCESS",88,-1.2624,0.095,0.29,"No",0.6448,0.99,1,"Yes"
"8661","C2_Chemical_and_genetic_perturbations","C2_CGP_1222_NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON",16,-1.262,0.18,0.21,"No",-0.8122,0.72,1,"No"
"8662","GO_BP","505864_GO_0042758_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS",7,-1.262,0.19,0.29,"No",1.131,0.31,0.87,"Yes"
"8663","C2_Chemical_and_genetic_perturbations","C2_CGP_1214_NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON",125,-1.2619,0.089,0.21,"No",-1.1054,0.25,0.91,"No"
"8664","KEGG_pathway","HSA04728_DOPAMINERGIC_SYNAPSE",129,-1.2619,0.092,0.16,"No",-0.8335,0.86,1,"No"
"8665","GO_BP","508230_GO_0045923_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS",28,-1.2614,0.16,0.29,"No",1.115,0.28,0.88,"Yes"
"8666","C3_TF_targets","C3_TFT_304_CTGRYYYNATT_UNKNOWN",68,-1.2614,0.12,0.12,"No",-1.0105,0.45,0.74,"No"
"8667","KEGG_compound","C00030_REDUCED_ACCEPTOR_AH2_HYDROGEN_DONOR_DONOR",21,-1.2613,0.16,0.32,"No",1.2082,0.21,0.87,"Yes"
"8668","GO_BP","491847_GO_0007016_CYTOSKELETAL_ANCHORING_AT_PLASMA_MEMBRANE",12,-1.2613,0.19,0.29,"No",-0.9258,0.55,1,"No"
"8669","C3_TF_targets","C3_TFT_155_V_USF_C",275,-1.2613,0.052,0.12,"No",0.8884,0.83,1,"Yes"
"8670","GO_MF","504510_GO_0035326_ENHANCER_BINDING",86,-1.2612,0.12,0.34,"No",-1.2163,0.14,0.83,"No"
"8671","REACTOME","161057_REACT_21330_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES",19,-1.2611,0.17,0.32,"No",0.8904,0.64,0.91,"Yes"
"8672","GO_BP","503453_GO_0034248_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS",18,-1.261,0.16,0.29,"No",0.8458,0.67,1,"Yes"
"8673","C2_Chemical_and_genetic_perturbations","C2_CGP_1305_DER_IFN_ALPHA_RESPONSE_UP",74,-1.2609,0.11,0.21,"No",1.4701,0.022,0.24,"Yes"
"8674","GO_BP","506454_GO_0043416_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION",6,-1.2609,0.19,0.29,"No",-0.9039,0.56,1,"No"
"8675","GO_BP","498081_GO_0019229_REGULATION_OF_VASOCONSTRICTION",54,-1.2609,0.14,0.29,"No",1.0156,0.41,0.97,"Yes"
"8676","REACTOME","106241_REACT_16952_PROTEIN_FOLDING",55,-1.2609,0.15,0.32,"No",0.998,0.46,0.76,"Yes"
"8677","C2_BioCarta_Pathways","C2_CP_BIOCARTA_96_BIOCARTA_IL6_PATHWAY",22,-1.2608,0.17,0.29,"No",-0.7536,0.86,1,"No"
"8678","C3_TF_targets","C3_TFT_246_V_NKX61_01",224,-1.2606,0.062,0.12,"No",-0.9186,0.69,0.93,"No"
"8679","GO_BP","500896_GO_0031647_REGULATION_OF_PROTEIN_STABILITY",156,-1.2606,0.073,0.29,"No",0.8645,0.82,1,"Yes"
"8680","C3_TF_targets","C3_TFT_231_V_RSRFC4_Q2",207,-1.2605,0.067,0.12,"No",-1.1218,0.19,0.49,"No"
"8681","C2_Chemical_and_genetic_perturbations","C2_CGP_143_WANG_RESPONSE_TO_ANDROGEN_UP",29,-1.2605,0.15,0.21,"No",0.8813,0.63,0.94,"Yes"
"8682","REACTOME","645338_REACT_120756_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE",13,-1.2605,0.17,0.32,"No",-0.6745,0.86,1,"No"
"8683","GO_MF","515258_GO_0070325_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING",20,-1.2604,0.15,0.34,"No",-1.3168,0.12,0.74,"No"
"8684","C2_Chemical_and_genetic_perturbations","C2_CGP_3381_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR",128,-1.2602,0.091,0.21,"No",0.904,0.73,0.92,"Yes"
"8685","C2_Chemical_and_genetic_perturbations","C2_CGP_2093_WANG_LSD1_TARGETS_UP",24,-1.2601,0.15,0.21,"No",-1.3383,0.097,0.7,"No"
"8686","C7_Immunologic_signatures","C7_ALL_501_GSE17721_CTRL_VS_CPG_4H_BMDM_UP",200,-1.2601,0.059,0.11,"No",1.4281,0,0.029,"Yes"
"8687","KEGG_pathway","HSA05219_BLADDER_CANCER",38,-1.2597,0.16,0.16,"No",0.7326,0.9,1,"Yes"
"8688","GO_MF","487566_GO_0001653_PEPTIDE_RECEPTOR_ACTIVITY",122,-1.2596,0.11,0.35,"No",1.6305,0,0.23,"Yes"
"8689","C7_Immunologic_signatures","C7_ALL_1595_GSE3982_EOSINOPHIL_VS_BASOPHIL_UP",190,-1.2595,0.076,0.11,"No",-0.73,0.99,1,"No"
"8690","C4_Cancer_modules","C4_CM_198_MODULE_211",11,-1.2595,0.18,0.22,"No",1.5757,0.024,0.082,"Yes"
"8691","C7_Immunologic_signatures","C7_ALL_917_GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP",197,-1.2594,0.058,0.11,"No",0.8194,0.94,1,"Yes"
"8692","C7_Immunologic_signatures","C7_ALL_1607_GSE3982_MAST_CELL_VS_DC_UP",199,-1.2594,0.065,0.11,"No",1.1202,0.16,0.39,"Yes"
"8693","C2_Chemical_and_genetic_perturbations","C2_CGP_3054_VERHAAK_GLIOBLASTOMA_NEURAL",125,-1.2594,0.075,0.21,"No",1.8149,0,0.039,"Yes"
"8694","GO_BP","492389_GO_0016339_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES",28,-1.2593,0.14,0.29,"No",1.211,0.2,0.77,"Yes"
"8695","GO_BP","491091_GO_0006112_ENERGY_RESERVE_METABOLIC_PROCESS",152,-1.2592,0.07,0.29,"No",-0.734,0.99,1,"No"
"8696","REACTOME","645290_REACT_121399_MHC_CLASS_II_ANTIGEN_PRESENTATION",100,-1.2591,0.11,0.32,"No",1.0511,0.34,0.66,"Yes"
"8697","GO_BP","514186_GO_0060631_REGULATION_OF_MEIOSIS_I",8,-1.2591,0.19,0.29,"No",0.8703,0.64,1,"Yes"
"8698","GO_BP","494944_GO_0010880_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM",25,-1.259,0.18,0.29,"No",1.1676,0.25,0.82,"Yes"
"8699","GO_MF","499698_GO_0030295_PROTEIN_KINASE_ACTIVATOR_ACTIVITY",52,-1.259,0.16,0.35,"No",0.9069,0.65,0.98,"Yes"
"8700","C2_Chemical_and_genetic_perturbations","C2_CGP_973_WILLIAMS_ESR1_TARGETS_DN",6,-1.259,0.19,0.21,"No",-1.2663,0.2,0.72,"No"
"8701","GO_BP","502848_GO_0033632_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN",11,-1.2589,0.18,0.29,"No",0.9628,0.51,1,"Yes"
"8702","KEGG_compound","C02686_GALACTOSYLCERAMIDE_GALACTOCEREBROSIDE_D_GALACTOSYL_N_ACYLSPHINGOSINE_CEREBROSIDE_D_GALACTOSYLCERAMIDE",9,-1.2589,0.19,0.32,"No",-1.1576,0.26,0.84,"No"
"8703","KEGG_module","HSA_M00071_GLYCOSPHINGOLIPID_BIOSYNTHESIS_NEOLACTO_SERIES_LACCER_NLC4CER",5,-1.2589,0.19,0.46,"No",0.79,0.74,0.93,"Yes"
"8704","WikiPathways","198872_WP734_SEROTONIN_RECEPTOR_4_6_7_AND_NR3C_SIGNALING",19,-1.2589,0.17,0.24,"No",-0.9869,0.47,1,"No"
"8705","C2_BioCarta_Pathways","C2_CP_BIOCARTA_138_BIOCARTA_EDG1_PATHWAY",26,-1.2589,0.16,0.29,"No",1.0108,0.44,0.83,"Yes"
"8706","GO_BP","486746_GO_0000226_MICROTUBULE_CYTOSKELETON_ORGANIZATION",306,-1.2587,0.045,0.29,"No",-0.8414,0.95,1,"No"
"8707","GO_BP","506503_GO_0043471_REGULATION_OF_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS",34,-1.2587,0.14,0.29,"No",1.0612,0.36,0.94,"Yes"
"8708","C3_TF_targets","C3_TFT_236_V_AREB6_03",253,-1.2587,0.05,0.12,"No",-1.459,0,0.13,"No"
"8709","C7_Immunologic_signatures","C7_ALL_1793_GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP",197,-1.2587,0.068,0.12,"No",-1.1358,0.17,1,"No"
"8710","C2_BioCarta_Pathways","C2_CP_BIOCARTA_58_BIOCARTA_SKP2E2F_PATHWAY",10,-1.2586,0.18,0.29,"No",-0.7652,0.78,1,"No"
"8711","GO_MF","492540_GO_0008199_FERRIC_IRON_BINDING",10,-1.2586,0.18,0.35,"No",0.9918,0.44,0.89,"Yes"
"8712","GO_BP","513505_GO_0055072_IRON_ION_HOMEOSTASIS",91,-1.2585,0.099,0.29,"No",1.4051,0.026,0.55,"Yes"
"8713","GO_BP","493715_GO_0009584_DETECTION_OF_VISIBLE_LIGHT",110,-1.2585,0.1,0.29,"No",-1.0703,0.3,0.96,"No"
"8714","GO_BP","516559_GO_0071635_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION",6,-1.2583,0.2,0.29,"No",1.3829,0.12,0.57,"Yes"
"8715","C2_Chemical_and_genetic_perturbations","C2_CGP_303_NAGASHIMA_NRG1_SIGNALING_DN",55,-1.2582,0.14,0.21,"No",0.8102,0.81,0.98,"Yes"
"8716","C7_Immunologic_signatures","C7_ALL_355_GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP",199,-1.2582,0.075,0.12,"No",0.8176,0.94,1,"Yes"
"8717","C7_Immunologic_signatures","C7_ALL_489_GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_UP",200,-1.2582,0.058,0.12,"No",1.2906,0.039,0.11,"Yes"
"8718","GO_BP","493311_GO_0009112_NUCLEOBASE_METABOLIC_PROCESS",69,-1.2582,0.12,0.29,"No",0.8981,0.67,1,"Yes"
"8719","REACTOME","105780_REACT_329_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1",12,-1.2581,0.19,0.32,"No",0.6052,0.95,1,"Yes"
"8720","C2_Chemical_and_genetic_perturbations","C2_CGP_3204_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN",18,-1.2581,0.18,0.21,"No",0.6981,0.9,1,"Yes"
"8721","GO_BP","488991_GO_0003197_ENDOCARDIAL_CUSHION_DEVELOPMENT",27,-1.258,0.17,0.29,"No",-1.1466,0.25,0.93,"No"
"8722","GO_BP","505867_GO_0042761_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS",11,-1.258,0.17,0.29,"No",0.593,0.96,1,"Yes"
"8723","GO_CC","490331_GO_0005777_PEROXISOME",128,-1.2579,0.087,0.36,"No",0.8846,0.73,0.91,"Yes"
"8724","GO_BP","498990_GO_0021707_CEREBELLAR_GRANULE_CELL_DIFFERENTIATION",10,-1.2579,0.17,0.29,"No",1.2358,0.2,0.75,"Yes"
"8725","C2_Chemical_and_genetic_perturbations","C2_CGP_2873_KYNG_NORMAL_AGING_DN",30,-1.2579,0.16,0.21,"No",-0.6884,0.93,1,"No"
"8726","KEGG_compound","C00173_ACYL_ACYL_CARRIER_PROTEIN_",13,-1.2579,0.19,0.33,"No",-0.659,0.92,1,"No"
"8727","C2_Chemical_and_genetic_perturbations","C2_CGP_643_ROVERSI_GLIOMA_LOH_REGIONS",43,-1.2578,0.14,0.21,"No",0.9496,0.54,0.87,"Yes"
"8728","GO_BP","518698_GO_2000049_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN",6,-1.2578,0.21,0.29,"No",1.1939,0.25,0.79,"Yes"
"8729","C6_Oncogenic_signatures","C6_ALL_137_IL21_UP_V1_DN",168,-1.2577,0.088,0.12,"No",1.1777,0.1,0.41,"Yes"
"8730","REACTOME","160999_REACT_22237_NETRIN_1_SIGNALING",42,-1.2577,0.17,0.32,"No",-1.2218,0.16,0.8,"No"
"8731","GO_BP","750934_GO_0036010_PROTEIN_LOCALIZATION_TO_ENDOSOME",8,-1.2577,0.2,0.29,"No",0.7327,0.78,1,"Yes"
"8732","C2_Chemical_and_genetic_perturbations","C2_CGP_103_SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN",62,-1.2576,0.12,0.21,"No",1.2782,0.094,0.42,"Yes"
"8733","C6_Oncogenic_signatures","C6_ALL_22_CSR_EARLY_UP_V1_UP",146,-1.2576,0.08,0.12,"No",0.8269,0.89,0.99,"Yes"
"8734","C2_Chemical_and_genetic_perturbations","C2_CGP_768_AMUNDSON_DNA_DAMAGE_RESPONSE_TP53",16,-1.2576,0.19,0.21,"No",-0.6552,0.92,1,"No"
"8735","GO_BP","492049_GO_0007270_NEURON_NEURON_SYNAPTIC_TRANSMISSION",59,-1.2574,0.12,0.29,"No",1.0358,0.38,0.96,"Yes"
"8736","GO_MF","492994_GO_0008762_UDP_N_ACETYLMURAMATE_DEHYDROGENASE_ACTIVITY",6,-1.2573,0.21,0.35,"No",-1.0928,0.36,0.85,"No"
"8737","GO_MF","496703_GO_0016798_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS",120,-1.2573,0.092,0.35,"No",0.7676,0.97,1,"Yes"
"8738","GO_MF","490351_GO_0005080_PROTEIN_KINASE_C_BINDING",47,-1.2572,0.14,0.35,"No",1.0837,0.33,0.81,"Yes"
"8739","GO_BP","498871_GO_0021587_CEREBELLUM_MORPHOGENESIS",40,-1.2572,0.15,0.29,"No",-1.0895,0.3,0.95,"No"
"8740","GO_BP","510583_GO_0048511_RHYTHMIC_PROCESS",270,-1.2572,0.042,0.29,"No",-0.8606,0.89,1,"No"
"8741","GO_MF","498680_GO_0019903_PROTEIN_PHOSPHATASE_BINDING",99,-1.2571,0.096,0.35,"No",0.8291,0.83,1,"Yes"
"8742","GO_MF","492392_GO_0008017_MICROTUBULE_BINDING",177,-1.2571,0.064,0.35,"No",-0.7016,1,1,"No"
"8743","C7_Immunologic_signatures","C7_ALL_55_GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP",187,-1.2571,0.072,0.12,"No",0.851,0.86,1,"Yes"
"8744","KEGG_pathway","HSA05169_EPSTEIN_BARR_VIRUS_INFECTION",197,-1.257,0.061,0.17,"No",0.8939,0.78,1,"Yes"
"8745","C2_Chemical_and_genetic_perturbations","C2_CGP_2497_PALOMERO_GSI_SENSITIVITY_UP",7,-1.2568,0.22,0.21,"No",-1.2424,0.21,0.75,"No"
"8746","REACTOME","1127670_REACT_267790_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS",28,-1.2565,0.16,0.32,"No",1.1095,0.3,0.56,"Yes"
"8747","GO_BP","486772_GO_0000255_ALLANTOIN_METABOLIC_PROCESS",5,-1.2564,0.19,0.29,"No",1.2305,0.24,0.75,"Yes"
"8748","GO_BP","506969_GO_0043951_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING",8,-1.2563,0.18,0.29,"No",0.5475,0.96,1,"Yes"
"8749","C6_Oncogenic_signatures","C6_ALL_138_IL21_UP_V1_UP",178,-1.2563,0.07,0.12,"No",-1.1206,0.22,0.54,"No"
"8750","GO_BP","516450_GO_0071526_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY",20,-1.2562,0.17,0.29,"No",-0.8748,0.67,1,"No"
"8751","GO_MF","490517_GO_0005310_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",24,-1.2561,0.16,0.35,"No",0.7553,0.81,1,"Yes"
"8752","C7_Immunologic_signatures","C7_ALL_149_GSE13306_TREG_VS_TCONV_SPLEEN_UP",194,-1.2561,0.06,0.12,"No",-0.829,0.9,1,"No"
"8753","C2_Chemical_and_genetic_perturbations","C2_CGP_2558_MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN",31,-1.2561,0.16,0.22,"No",-0.9387,0.54,1,"No"
"8754","C3_TF_targets","C3_TFT_538_WYAAANNRNNNGCG_UNKNOWN",65,-1.256,0.15,0.13,"No",-1.1089,0.28,0.52,"No"
"8755","GO_MF","506073_GO_0042979_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY",6,-1.2557,0.18,0.35,"No",0.6804,0.87,1,"Yes"
"8756","GO_BP","491614_GO_0006729_TETRAHYDROBIOPTERIN_BIOSYNTHETIC_PROCESS",6,-1.2557,0.19,0.29,"No",0.8556,0.66,1,"Yes"
"8757","C2_Chemical_and_genetic_perturbations","C2_CGP_995_MANTOVANI_NFKB_TARGETS_DN",11,-1.2557,0.18,0.22,"No",-0.9169,0.56,1,"No"
"8758","GO_BP","750912_GO_0035987_ENDODERMAL_CELL_DIFFERENTIATION",40,-1.2553,0.15,0.3,"No",-0.6376,0.97,1,"No"
"8759","C2_Chemical_and_genetic_perturbations","C2_CGP_1574_XU_CREBBP_TARGETS_DN",42,-1.2553,0.14,0.22,"No",0.7379,0.9,1,"Yes"
"8760","C2_Chemical_and_genetic_perturbations","C2_CGP_1215_NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON",330,-1.2553,0.047,0.22,"No",-0.9201,0.7,1,"No"
"8761","C7_Immunologic_signatures","C7_ALL_1099_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP",200,-1.2553,0.073,0.12,"No",0.7997,0.96,1,"Yes"
"8762","GO_BP","499081_GO_0021801_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION",17,-1.2552,0.18,0.3,"No",-0.5962,0.96,1,"No"
"8763","C2_Chemical_and_genetic_perturbations","C2_CGP_2460_LEE_LIVER_CANCER_SURVIVAL_UP",177,-1.2552,0.07,0.22,"No",-0.8179,0.91,1,"No"
"8764","GO_BP","491814_GO_0006975_DNA_DAMAGE_INDUCED_PROTEIN_PHOSPHORYLATION",8,-1.2552,0.19,0.3,"No",-1.2986,0.18,0.89,"No"
"8765","GO_MF","499420_GO_0022889_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-1.2551,0.2,0.35,"No",0.9721,0.49,0.9,"Yes"
"8766","GO_BP","494593_GO_0010524_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",39,-1.2551,0.15,0.3,"No",0.993,0.46,0.99,"Yes"
"8767","C4_Cancer_modules","C4_CM_313_MODULE_363",49,-1.2551,0.15,0.22,"No",1.9127,0,0.0074,"Yes"
"8768","C2_Chemical_and_genetic_perturbations","C2_CGP_2218_AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53",109,-1.255,0.089,0.22,"No",-1.18,0.17,0.82,"No"
"8769","GO_BP","512237_GO_0051353_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY",42,-1.255,0.15,0.3,"No",0.8977,0.63,1,"Yes"
"8770","C7_Immunologic_signatures","C7_ALL_356_GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN",193,-1.2549,0.091,0.12,"No",0.8774,0.84,1,"Yes"
"8771","C7_Immunologic_signatures","C7_ALL_595_GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_UP",197,-1.2549,0.073,0.12,"No",-0.8848,0.77,1,"No"
"8772","C2_Chemical_and_genetic_perturbations","C2_CGP_2599_SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6",453,-1.2549,0.026,0.22,"No",1.3771,0,0.31,"Yes"
"8773","C3_TF_targets","C3_TFT_336_V_HNF4ALPHA_Q6",264,-1.2549,0.054,0.13,"No",-0.973,0.53,0.82,"No"
"8774","GO_BP","486692_GO_0000160_PHOSPHORELAY_SIGNAL_TRANSDUCTION_SYSTEM",11,-1.2548,0.19,0.3,"No",-0.81,0.71,1,"No"
"8775","WikiPathways","198852_WP430_STATIN_PATHWAY",30,-1.2547,0.16,0.24,"No",-1.1551,0.23,0.91,"No"
"8776","C7_Immunologic_signatures","C7_ALL_589_GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_UP",198,-1.2547,0.072,0.12,"No",1.1111,0.2,0.41,"Yes"
"8777","GO_BP","513443_GO_0055010_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS",39,-1.2547,0.14,0.3,"No",1.0453,0.38,0.95,"Yes"
"8778","GO_BP","510693_GO_0048636_POSITIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT",44,-1.2547,0.15,0.3,"No",0.7898,0.85,1,"Yes"
"8779","GO_BP","491423_GO_0006527_ARGININE_CATABOLIC_PROCESS",8,-1.2546,0.2,0.3,"No",-1.3246,0.16,0.89,"No"
"8780","GO_MF","490580_GO_0005452_INORGANIC_ANION_EXCHANGER_ACTIVITY",13,-1.2546,0.18,0.35,"No",-1.2038,0.23,0.81,"No"
"8781","C2_Chemical_and_genetic_perturbations","C2_CGP_780_KORKOLA_CHORIOCARCINOMA",5,-1.2546,0.2,0.22,"No",0.975,0.48,0.82,"Yes"
"8782","GO_BP","488965_GO_0003171_ATRIOVENTRICULAR_VALVE_DEVELOPMENT",18,-1.2545,0.18,0.3,"No",-0.8444,0.68,1,"No"
"8783","C7_Immunologic_signatures","C7_ALL_559_GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_UP",198,-1.2544,0.081,0.12,"No",0.9694,0.53,0.84,"Yes"
"8784","GO_BP","487836_GO_0001946_LYMPHANGIOGENESIS",10,-1.2544,0.18,0.3,"No",-0.823,0.67,1,"No"
"8785","C2_Chemical_and_genetic_perturbations","C2_CGP_1047_FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP",9,-1.2543,0.19,0.22,"No",-1.622,0.023,0.39,"No"
"8786","GO_MF","500875_GO_0031625_UBIQUITIN_PROTEIN_LIGASE_BINDING",216,-1.2543,0.071,0.35,"No",0.8183,0.95,1,"Yes"
"8787","REACTOME","106043_REACT_18283_G_ALPHA_Q_SIGNALLING_EVENTS",181,-1.2543,0.076,0.33,"No",1.0987,0.23,0.58,"Yes"
"8788","GO_BP","501606_GO_0032371_REGULATION_OF_STEROL_TRANSPORT",34,-1.2543,0.15,0.3,"No",0.9805,0.5,1,"Yes"
"8789","WikiPathways","672457_WP2267_SYNAPTIC_VESICLE_PATHWAY",51,-1.2542,0.14,0.24,"No",-0.6984,0.95,1,"No"
"8790","GO_BP","505194_GO_0040036_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",29,-1.2542,0.17,0.3,"No",0.991,0.47,0.99,"Yes"
"8791","C6_Oncogenic_signatures","C6_ALL_178_KRAS_BREAST_UP_V1_DN",139,-1.2541,0.092,0.12,"No",-1.2439,0.078,0.37,"No"
"8792","REACTOME","105648_REACT_578_APOPTOSIS",160,-1.2541,0.071,0.33,"No",1.5202,0.0048,0.14,"Yes"
"8793","GO_BP","494804_GO_0010739_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING",5,-1.254,0.21,0.3,"No",-0.7195,0.81,1,"No"
"8794","C7_Immunologic_signatures","C7_ALL_739_GSE17721_12H_VS_24H_PAM3CSK4_BMDM_UP",198,-1.2538,0.065,0.12,"No",1.1767,0.11,0.27,"Yes"
"8795","GO_BP","508240_GO_0045933_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION",34,-1.2538,0.14,0.3,"No",-0.8601,0.68,1,"No"
"8796","GO_MF","512263_GO_0051379_EPINEPHRINE_BINDING",5,-1.2538,0.2,0.35,"No",-1.0689,0.38,0.86,"No"
"8797","GO_BP","517505_GO_0072602_INTERLEUKIN_4_SECRETION",5,-1.2538,0.19,0.3,"No",-1.0664,0.39,0.96,"No"
"8798","C2_Chemical_and_genetic_perturbations","C2_CGP_2281_LE_SKI_TARGETS_DN",8,-1.2538,0.21,0.22,"No",0.9672,0.48,0.84,"Yes"
"8799","C7_Immunologic_signatures","C7_ALL_1300_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN",195,-1.2537,0.072,0.12,"No",-1.0614,0.29,1,"No"
"8800","C2_Chemical_and_genetic_perturbations","C2_CGP_254_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP",202,-1.2536,0.071,0.22,"No",1.3087,0.035,0.39,"Yes"
"8801","GO_MF","500526_GO_0031267_SMALL_GTPASE_BINDING",226,-1.2535,0.074,0.35,"No",-1.1536,0.14,0.81,"No"
"8802","GO_BP","495093_GO_0014020_PRIMARY_NEURAL_TUBE_FORMATION",87,-1.2535,0.11,0.3,"No",-0.7203,0.97,1,"No"
"8803","C2_Chemical_and_genetic_perturbations","C2_CGP_3036_KAMIKUBO_MYELOID_MN1_NETWORK",19,-1.2534,0.19,0.22,"No",1.5381,0.029,0.18,"Yes"
"8804","GO_BP","504333_GO_0035148_TUBE_FORMATION",130,-1.2534,0.093,0.3,"No",0.7363,0.98,1,"Yes"
"8805","GO_BP","517140_GO_0072224_METANEPHRIC_GLOMERULUS_DEVELOPMENT",11,-1.2534,0.18,0.3,"No",0.421,1,1,"Yes"
"8806","GO_BP","501194_GO_0031954_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION",19,-1.2533,0.2,0.3,"No",1.4194,0.08,0.53,"Yes"
"8807","C3_MicroRNA_targets","C3_MIR_195_GTTATAT_MIR_410",91,-1.2533,0.11,0.27,"No",-1.0407,0.36,1,"No"
"8808","WikiPathways","198889_WP259_NIFEDIPINE_ACTIVITY",5,-1.2531,0.19,0.24,"No",-1.1938,0.29,0.81,"No"
"8809","GO_BP","513440_GO_0055007_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",78,-1.2528,0.11,0.3,"No",-1.126,0.25,0.94,"No"
"8810","C3_TF_targets","C3_TFT_36_V_IRF1_01",241,-1.2528,0.054,0.13,"No",0.9227,0.72,1,"Yes"
"8811","GO_BP","500365_GO_0031077_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT",7,-1.2527,0.21,0.3,"No",-0.8968,0.58,1,"No"
"8812","GO_CC","752885_GO_0097386_GLIAL_CELL_PROJECTION",10,-1.2527,0.2,0.37,"No",-0.6877,0.87,1,"No"
"8813","GO_CC","513468_GO_0055037_RECYCLING_ENDOSOME",122,-1.2526,0.1,0.36,"No",0.8788,0.79,0.91,"Yes"
"8814","KEGG_compound","C00249_HEXADECANOIC_ACID_HEXADECANOATE_HEXADECYLIC_ACID_PALMITIC_ACID_PALMITATE_CETYLIC_ACID",15,-1.2526,0.18,0.33,"No",0.4591,1,1,"Yes"
"8815","C7_Immunologic_signatures","C7_ALL_1720_GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN",199,-1.2526,0.078,0.12,"No",1.0919,0.24,0.47,"Yes"
"8816","C2_Chemical_and_genetic_perturbations","C2_CGP_579_KONG_E2F1_TARGETS",10,-1.2525,0.2,0.22,"No",-1.371,0.093,0.63,"No"
"8817","WikiPathways","711360_WP2377_INTEGRATED_PANCREATIC_CANCER_PATHWAY",191,-1.2524,0.086,0.24,"No",-0.7487,0.98,1,"No"
"8818","GO_BP","493352_GO_0009155_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS",9,-1.2524,0.19,0.3,"No",0.6947,0.85,1,"Yes"
"8819","C2_Chemical_and_genetic_perturbations","C2_CGP_2792_SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN",19,-1.2523,0.17,0.22,"No",-0.9253,0.59,1,"No"
"8820","GO_MF","496626_GO_0016705_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN",157,-1.2523,0.09,0.35,"No",-0.9649,0.53,0.95,"No"
"8821","GO_BP","492184_GO_0007423_SENSORY_ORGAN_DEVELOPMENT",484,-1.2523,0.022,0.3,"No",-0.9007,0.82,1,"No"
"8822","GO_BP","491876_GO_0007051_SPINDLE_ORGANIZATION",95,-1.2522,0.12,0.3,"No",-0.9961,0.46,0.99,"No"
"8823","GO_CC","490905_GO_0005903_BRUSH_BORDER",70,-1.2522,0.14,0.36,"No",-1.1736,0.17,0.68,"No"
"8824","GO_BP","495267_GO_0014874_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION",9,-1.2521,0.21,0.3,"No",-0.7262,0.81,1,"No"
"8825","GO_BP","494525_GO_0010455_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT",12,-1.252,0.2,0.3,"No",-1.1638,0.27,0.91,"No"
"8826","C6_Oncogenic_signatures","C6_ALL_12_GCNP_SHH_UP_LATE_V1_UP",170,-1.252,0.075,0.12,"No",-0.7062,1,1,"No"
"8827","C7_Immunologic_signatures","C7_ALL_1160_GSE27786_LSK_VS_MONO_MAC_DN",198,-1.2518,0.076,0.12,"No",-0.896,0.74,1,"No"
"8828","C2_BioCarta_Pathways","C2_CP_BIOCARTA_84_BIOCARTA_HIVNEF_PATHWAY",58,-1.2518,0.14,0.29,"No",-0.4968,1,1,"No"
"8829","GO_MF","490610_GO_0005501_RETINOID_BINDING",37,-1.2518,0.13,0.35,"No",1.2409,0.14,0.69,"Yes"
"8830","GO_BP","499317_GO_0022038_CORPUS_CALLOSUM_DEVELOPMENT",12,-1.2517,0.19,0.3,"No",-1.1027,0.31,0.94,"No"
"8831","GO_BP","925921_GO_1902572_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY",7,-1.2516,0.2,0.3,"No",1.2487,0.21,0.73,"Yes"
"8832","REACTOME","833826_REACT_163701_FCERI_MEDIATED_MAPK_ACTIVATION",42,-1.2516,0.16,0.33,"No",-0.8191,0.78,1,"No"
"8833","C2_Chemical_and_genetic_perturbations","C2_CGP_1626_KAAB_FAILED_HEART_ATRIUM_DN",141,-1.2515,0.096,0.22,"No",1.4838,0.007,0.23,"Yes"
"8834","C7_Immunologic_signatures","C7_ALL_1576_GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN",199,-1.2514,0.08,0.12,"No",1.3877,0.005,0.042,"Yes"
"8835","GO_BP","516797_GO_0071877_REGULATION_OF_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY",6,-1.2514,0.2,0.3,"No",-1.0422,0.41,0.98,"No"
"8836","C2_Chemical_and_genetic_perturbations","C2_CGP_131_CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP",372,-1.2513,0.032,0.22,"No",-1.517,0,0.44,"No"
"8837","GO_BP","849922_GO_1902221_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",10,-1.2512,0.21,0.3,"No",-0.856,0.65,1,"No"
"8838","C7_Immunologic_signatures","C7_ALL_197_GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP",170,-1.2512,0.086,0.12,"No",-1.2139,0.081,0.8,"No"
"8839","GO_BP","506176_GO_0043096_PURINE_NUCLEOBASE_SALVAGE",6,-1.2511,0.21,0.3,"No",0.8347,0.64,1,"Yes"
"8840","GO_MF","502351_GO_0033130_ACETYLCHOLINE_RECEPTOR_BINDING",8,-1.2511,0.18,0.35,"No",-0.9855,0.46,0.92,"No"
"8841","KEGG_compound","C16587_3_CARBAMOYL_2_PHENYLPROPIONALDEHYDE",11,-1.2511,0.2,0.33,"No",1.2193,0.23,0.86,"Yes"
"8842","GO_MF","496641_GO_0016721_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SUPEROXIDE_RADICALS_AS_ACCEPTOR",5,-1.251,0.19,0.35,"No",-0.6214,0.91,1,"No"
"8843","C2_Chemical_and_genetic_perturbations","C2_CGP_460_GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN",34,-1.251,0.18,0.22,"No",-1.1115,0.31,0.9,"No"
"8844","GO_BP","505620_GO_0042487_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH",12,-1.2509,0.19,0.3,"No",0.7668,0.78,1,"Yes"
"8845","GO_BP","488970_GO_0003176_AORTIC_VALVE_DEVELOPMENT",5,-1.2508,0.19,0.3,"No",-0.8298,0.67,1,"No"
"8846","GO_MF","490401_GO_0005138_INTERLEUKIN_6_RECEPTOR_BINDING",6,-1.2507,0.19,0.35,"No",-0.8685,0.62,1,"No"
"8847","C3_MicroRNA_targets","C3_MIR_103_GTACTGT_MIR_101",257,-1.2505,0.055,0.27,"No",-1.0355,0.36,1,"No"
"8848","C2_Chemical_and_genetic_perturbations","C2_CGP_589_RIZ_ERYTHROID_DIFFERENTIATION_HBZ",40,-1.2505,0.15,0.22,"No",0.9949,0.46,0.81,"Yes"
"8849","GO_BP","488597_GO_0002724_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION",15,-1.2504,0.19,0.3,"No",-0.9904,0.44,1,"No"
"8850","WikiPathways","198838_WP678_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE",7,-1.2503,0.21,0.24,"No",-0.5901,0.93,1,"No"
"8851","GO_BP","754814_GO_1901863_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT",45,-1.2503,0.15,0.3,"No",0.8334,0.76,1,"Yes"
"8852","C2_Chemical_and_genetic_perturbations","C2_CGP_2890_DANG_MYC_TARGETS_DN",31,-1.2502,0.17,0.22,"No",1.1555,0.25,0.55,"Yes"
"8853","C4_Cancer_gene_neighborhoods","C4_CGN_180_MORF_SUPT3H",316,-1.2502,0.049,0.27,"No",-1.0727,0.28,0.76,"No"
"8854","C4_Cancer_modules","C4_CM_351_MODULE_421",28,-1.2502,0.14,0.23,"No",-0.6454,0.96,1,"No"
"8855","GO_MF","495802_GO_0015665_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",17,-1.2502,0.17,0.35,"No",-1.4521,0.062,0.62,"No"
"8856","GO_BP","494528_GO_0010458_EXIT_FROM_MITOSIS",7,-1.2501,0.19,0.3,"No",-1.1065,0.35,0.94,"No"
"8857","GO_BP","502819_GO_0033603_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION",6,-1.2501,0.23,0.3,"No",0.7178,0.82,1,"Yes"
"8858","GO_BP","514386_GO_0060831_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",7,-1.2501,0.22,0.3,"No",-0.7212,0.8,1,"No"
"8859","GO_CC","494090_GO_0010008_ENDOSOME_MEMBRANE",369,-1.25,0.04,0.37,"No",1.0695,0.26,0.69,"Yes"
"8860","GO_BP","515141_GO_0070206_PROTEIN_TRIMERIZATION",36,-1.2499,0.16,0.3,"No",1.0997,0.28,0.9,"Yes"
"8861","GO_BP","751422_GO_0038166_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY",9,-1.2497,0.18,0.3,"No",0.8216,0.69,1,"Yes"
"8862","GO_MF","496697_GO_0016791_PHOSPHATASE_ACTIVITY",258,-1.2497,0.057,0.35,"No",0.9242,0.7,0.95,"Yes"
"8863","GO_MF","489667_GO_0004300_ENOYL_COA_HYDRATASE_ACTIVITY",5,-1.2496,0.2,0.35,"No",0.7973,0.74,1,"Yes"
"8864","C7_Immunologic_signatures","C7_ALL_1069_GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP",199,-1.2495,0.063,0.13,"No",1.1024,0.21,0.44,"Yes"
"8865","GO_MF","489576_GO_0004111_CREATINE_KINASE_ACTIVITY",6,-1.2495,0.21,0.35,"No",-1.1023,0.34,0.83,"No"
"8866","GO_BP","512753_GO_0051898_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING",32,-1.2494,0.2,0.3,"No",0.6565,0.96,1,"Yes"
"8867","GO_BP","499576_GO_0030157_PANCREATIC_JUICE_SECRETION",7,-1.2493,0.2,0.3,"No",-1.4748,0.084,0.85,"No"
"8868","REACTOME","106468_REACT_9053_CAM_PATHWAY",28,-1.2493,0.17,0.33,"No",0.8132,0.78,0.99,"Yes"
"8869","C4_Cancer_gene_neighborhoods","C4_CGN_125_MORF_MAGEA8",249,-1.2493,0.066,0.27,"No",-0.9934,0.47,0.87,"No"
"8870","GO_BP","513983_GO_0060428_LUNG_EPITHELIUM_DEVELOPMENT",35,-1.2492,0.18,0.3,"No",-1.1061,0.3,0.94,"No"
"8871","GO_BP","518723_GO_2000074_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT",7,-1.2492,0.21,0.3,"No",-1.3829,0.12,1,"No"
"8872","GO_BP","505586_GO_0042446_HORMONE_BIOSYNTHETIC_PROCESS",44,-1.2492,0.15,0.3,"No",0.9219,0.6,1,"Yes"
"8873","C7_Immunologic_signatures","C7_ALL_514_GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_DN",196,-1.249,0.076,0.13,"No",1.1796,0.096,0.26,"Yes"
"8874","C4_Cancer_gene_neighborhoods","C4_CGN_183_MORF_TNFRSF25",254,-1.249,0.06,0.27,"No",-1.2904,0.026,0.55,"No"
"8875","C4_Cancer_modules","C4_CM_269_MODULE_307",25,-1.2489,0.17,0.23,"No",1.7566,0.0043,0.034,"Yes"
"8876","C2_Chemical_and_genetic_perturbations","C2_CGP_3066_QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2",37,-1.2489,0.17,0.22,"No",-0.587,0.99,1,"No"
"8877","GO_BP","514411_GO_0060856_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER",6,-1.2488,0.21,0.3,"No",-1.2418,0.22,0.91,"No"
"8878","GO_BP","500402_GO_0031115_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION",10,-1.2488,0.21,0.3,"No",-1.1498,0.28,0.93,"No"
"8879","KEGG_compound","C02166_LEUKOTRIENE_C4_LTC4",5,-1.2488,0.21,0.34,"No",-1.2857,0.18,0.66,"No"
"8880","GO_BP","502905_GO_0033688_REGULATION_OF_OSTEOBLAST_PROLIFERATION",21,-1.2487,0.19,0.3,"No",-0.9234,0.57,1,"No"
"8881","C3_MicroRNA_targets","C3_MIR_104_CAGGTCC_MIR_492",62,-1.2487,0.14,0.27,"No",-1.4418,0.042,0.54,"No"
"8882","REACTOME","106443_REACT_13720_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE",61,-1.2486,0.12,0.33,"No",-0.8122,0.8,1,"No"
"8883","C7_Immunologic_signatures","C7_ALL_1470_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN",196,-1.2486,0.068,0.13,"No",0.9683,0.57,0.84,"Yes"
"8884","GO_BP","500598_GO_0031339_NEGATIVE_REGULATION_OF_VESICLE_FUSION",5,-1.2486,0.21,0.3,"No",-0.8018,0.68,1,"No"
"8885","C7_Immunologic_signatures","C7_ALL_1264_GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN",199,-1.2484,0.07,0.13,"No",2.0289,0,0,"Yes"
"8886","GO_BP","502182_GO_0032960_REGULATION_OF_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-1.2483,0.21,0.3,"No",0.7384,0.79,1,"Yes"
"8887","REACTOME","730309_REACT_150401_COLLAGEN_DEGRADATION",38,-1.2483,0.16,0.33,"No",1.1268,0.27,0.55,"Yes"
"8888","C7_Immunologic_signatures","C7_ALL_111_GSE12366_GC_VS_MEMORY_BCELL_UP",199,-1.2481,0.073,0.13,"No",1.1595,0.14,0.3,"Yes"
"8889","GO_BP","514067_GO_0060512_PROSTATE_GLAND_MORPHOGENESIS",25,-1.2481,0.16,0.3,"No",0.988,0.45,0.99,"Yes"
"8890","GO_BP","948863_GO_0097581_LAMELLIPODIUM_ORGANIZATION",38,-1.2481,0.15,0.3,"No",0.9593,0.49,1,"Yes"
"8891","REACTOME","1127676_REACT_263965_NORC_NEGATIVELY_REGULATES_RRNA_EXPRESSION",102,-1.2481,0.1,0.33,"No",-1.4121,0.03,0.5,"No"
"8892","C2_Chemical_and_genetic_perturbations","C2_CGP_1386_POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP",46,-1.2481,0.16,0.22,"No",-0.9357,0.57,1,"No"
"8893","GO_BP","499611_GO_0030201_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS",25,-1.2481,0.17,0.3,"No",0.7162,0.88,1,"Yes"
"8894","GO_BP","513807_GO_0060251_REGULATION_OF_GLIAL_CELL_PROLIFERATION",17,-1.248,0.18,0.3,"No",-0.7955,0.78,1,"No"
"8895","GO_BP","487965_GO_0002076_OSTEOBLAST_DEVELOPMENT",18,-1.248,0.18,0.3,"No",0.5558,0.98,1,"Yes"
"8896","C4_Cancer_modules","C4_CM_395_MODULE_500",27,-1.248,0.16,0.23,"No",-0.5392,0.99,1,"No"
"8897","C2_Chemical_and_genetic_perturbations","C2_CGP_370_COLDREN_GEFITINIB_RESISTANCE_DN",225,-1.2479,0.058,0.22,"No",0.9509,0.61,0.86,"Yes"
"8898","GO_BP","489143_GO_0003351_EPITHELIAL_CILIUM_MOVEMENT",18,-1.2477,0.19,0.3,"No",-1.702,0.013,0.66,"No"
"8899","C7_Immunologic_signatures","C7_ALL_1778_GSE7460_TREG_VS_TCONV_ACT_DN",193,-1.2477,0.077,0.13,"No",0.8469,0.88,1,"Yes"
"8900","GO_BP","517152_GO_0072236_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT",5,-1.2477,0.2,0.3,"No",-1.2541,0.19,0.91,"No"
"8901","C2_Chemical_and_genetic_perturbations","C2_CGP_1558_MA_MYELOID_DIFFERENTIATION_UP",38,-1.2476,0.17,0.22,"No",0.6269,0.99,1,"Yes"
"8902","KEGG_reaction","R01496_ACYL_COA_SPHINGOSINE_N_ACYLTRANSFERASE_ACYL_COA_SPHINGOSINE_COA_N_ACYLSPHINGOSINE",6,-1.2475,0.22,0.31,"No",-1.3428,0.14,0.34,"No"
"8903","C7_Immunologic_signatures","C7_ALL_664_GSE17721_LPS_VS_CPG_8H_BMDM_DN",199,-1.2475,0.079,0.13,"No",1.2565,0.054,0.15,"Yes"
"8904","C7_Immunologic_signatures","C7_ALL_1843_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP",200,-1.2475,0.072,0.13,"No",1.5818,0,0.0041,"Yes"
"8905","GO_CC","499967_GO_0030662_COATED_VESICLE_MEMBRANE",164,-1.2475,0.093,0.37,"No",0.9279,0.66,0.86,"Yes"
"8906","GO_BP","509675_GO_0047496_VESICLE_TRANSPORT_ALONG_MICROTUBULE",17,-1.2474,0.19,0.3,"No",0.7617,0.82,1,"Yes"
"8907","C6_Oncogenic_signatures","C6_ALL_38_BCAT_100_UP_V1_UP",45,-1.2474,0.13,0.13,"No",-0.8356,0.77,0.98,"No"
"8908","GO_MF","489543_GO_0004075_BIOTIN_CARBOXYLASE_ACTIVITY",6,-1.2473,0.19,0.35,"No",-1.4924,0.057,0.57,"No"
"8909","C3_TF_targets","C3_TFT_146_V_GRE_C",121,-1.2472,0.12,0.14,"No",0.8742,0.76,1,"Yes"
"8910","GO_BP","515168_GO_0070233_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS",17,-1.2472,0.18,0.3,"No",1.2022,0.2,0.78,"Yes"
"8911","GO_MF","489887_GO_0004550_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY",18,-1.2471,0.17,0.35,"No",-0.8315,0.66,1,"No"
"8912","C2_Chemical_and_genetic_perturbations","C2_CGP_2316_ZHENG_IL22_SIGNALING_DN",37,-1.2469,0.16,0.22,"No",-0.6316,0.98,1,"No"
"8913","GO_BP","515165_GO_0070230_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS",19,-1.2469,0.18,0.3,"No",-0.6185,0.95,1,"No"
"8914","GO_BP","499335_GO_0022417_PROTEIN_MATURATION_BY_PROTEIN_FOLDING",9,-1.2468,0.21,0.3,"No",-0.7005,0.85,1,"No"
"8915","GO_CC","486673_GO_0000137_GOLGI_CIS_CISTERNA",6,-1.2468,0.2,0.37,"No",0.684,0.86,0.98,"Yes"
"8916","C7_Immunologic_signatures","C7_ALL_929_GSE22886_NAIVE_TCELL_VS_NKCELL_UP",195,-1.2467,0.08,0.13,"No",2.0404,0,0,"Yes"
"8917","GO_BP","497082_GO_0018107_PEPTIDYL_THREONINE_PHOSPHORYLATION",42,-1.2466,0.16,0.3,"No",-0.8244,0.77,1,"No"
"8918","C7_Immunologic_signatures","C7_ALL_1560_GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN",196,-1.2466,0.084,0.13,"No",0.8642,0.86,1,"Yes"
"8919","GO_BP","513626_GO_0060068_VAGINA_DEVELOPMENT",11,-1.2466,0.19,0.3,"No",-0.7564,0.81,1,"No"
"8920","GO_MF","489469_GO_0003997_ACYL_COA_OXIDASE_ACTIVITY",6,-1.2465,0.21,0.35,"No",0.9165,0.58,0.97,"Yes"
"8921","C2_BioCarta_Pathways","C2_CP_BIOCARTA_88_BIOCARTA_P53HYPOXIA_PATHWAY",22,-1.2465,0.18,0.3,"No",-0.8677,0.64,1,"No"
"8922","C2_BioCarta_Pathways","C2_CP_BIOCARTA_121_BIOCARTA_PITX2_PATHWAY",15,-1.2464,0.19,0.3,"No",-0.7027,0.88,1,"No"
"8923","GO_BP","515758_GO_0070830_TIGHT_JUNCTION_ASSEMBLY",37,-1.2462,0.16,0.3,"No",-1.2082,0.18,0.88,"No"
"8924","GO_BP","492102_GO_0007338_SINGLE_FERTILIZATION",99,-1.2461,0.12,0.3,"No",-0.9471,0.58,1,"No"
"8925","C2_Chemical_and_genetic_perturbations","C2_CGP_1523_KANG_IMMORTALIZED_BY_TERT_UP",86,-1.2461,0.13,0.23,"No",-0.7229,0.94,1,"No"
"8926","C3_TF_targets","C3_TFT_163_V_MEF2_02",223,-1.2459,0.074,0.14,"No",-1.5459,0,0.14,"No"
"8927","REACTOME","530758_REACT_115574_ALPHA_DEFENSINS",9,-1.2459,0.2,0.34,"No",1.503,0.055,0.15,"Yes"
"8928","GO_MF","499879_GO_0030553_CGMP_BINDING",17,-1.2457,0.17,0.35,"No",0.9111,0.57,0.98,"Yes"
"8929","GO_BP","488701_GO_0002828_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE",22,-1.2457,0.18,0.3,"No",1.1838,0.24,0.8,"Yes"
"8930","C3_TF_targets","C3_TFT_218_V_GATA1_05",269,-1.2456,0.051,0.14,"No",0.945,0.64,1,"Yes"
"8931","GO_BP","506941_GO_0043921_MODULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION",22,-1.2456,0.18,0.3,"No",0.8544,0.68,1,"Yes"
"8932","C3_TF_targets","C3_TFT_75_V_TAXCREB_01",136,-1.2456,0.11,0.14,"No",0.7442,0.97,1,"Yes"
"8933","C7_Immunologic_signatures","C7_ALL_1461_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP",194,-1.2455,0.077,0.13,"No",0.9436,0.6,0.92,"Yes"
"8934","C2_BioCarta_Pathways","C2_CP_BIOCARTA_185_BIOCARTA_PTC1_PATHWAY",10,-1.2455,0.2,0.3,"No",-0.5666,0.97,1,"No"
"8935","REACTOME","771571_REACT_160122_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7",7,-1.2454,0.22,0.34,"No",-1.0772,0.37,0.9,"No"
"8936","C7_Immunologic_signatures","C7_ALL_757_GSE17721_0_5H_VS_8H_GARDIQUIMOD_BMDM_UP",200,-1.2453,0.071,0.13,"No",1.3207,0.029,0.084,"Yes"
"8937","C4_Cancer_gene_neighborhoods","C4_CGN_426_GNF2_VAV1",36,-1.2453,0.16,0.28,"No",1.0831,0.31,0.4,"Yes"
"8938","GO_BP","512524_GO_0051648_VESICLE_LOCALIZATION",197,-1.2453,0.064,0.3,"No",1.1601,0.12,0.83,"Yes"
"8939","GO_BP","492106_GO_0007342_FUSION_OF_SPERM_TO_EGG_PLASMA_MEMBRANE",10,-1.2452,0.19,0.3,"No",0.9661,0.49,1,"Yes"
"8940","C2_Chemical_and_genetic_perturbations","C2_CGP_1394_LEE_LIVER_CANCER_DENA_DN",70,-1.2451,0.12,0.23,"No",-0.8171,0.8,1,"No"
"8941","GO_BP","755347_GO_2001241_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",15,-1.2451,0.18,0.3,"No",-0.851,0.69,1,"No"
"8942","KEGG_compound","C00328_L_KYNURENINE_3_ANTHRANILOYL_L_ALANINE",6,-1.2451,0.24,0.34,"No",-1.4692,0.069,0.34,"No"
"8943","C7_Immunologic_signatures","C7_ALL_1780_GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN",191,-1.2451,0.086,0.13,"No",1.0526,0.31,0.58,"Yes"
"8944","GO_BP","514871_GO_0061326_RENAL_TUBULE_DEVELOPMENT",78,-1.245,0.13,0.3,"No",-1.0081,0.48,0.98,"No"
"8945","GO_BP","498826_GO_0021542_DENTATE_GYRUS_DEVELOPMENT",13,-1.245,0.18,0.3,"No",-0.6771,0.9,1,"No"
"8946","C4_Cancer_gene_neighborhoods","C4_CGN_114_MORF_IL16",232,-1.245,0.066,0.27,"No",-1.0671,0.31,0.74,"No"
"8947","GO_MF","491973_GO_0030971_RECEPTOR_TYROSINE_KINASE_BINDING",44,-1.2449,0.15,0.35,"No",-0.9903,0.46,0.92,"No"
"8948","C3_MicroRNA_targets","C3_MIR_125_ATGTCAC_MIR_489",87,-1.2447,0.12,0.28,"No",-1.0001,0.45,1,"No"
"8949","GO_BP","506678_GO_0043648_DICARBOXYLIC_ACID_METABOLIC_PROCESS",86,-1.2447,0.12,0.31,"No",1.1159,0.22,0.88,"Yes"
"8950","GO_BP","505233_GO_0042044_FLUID_TRANSPORT",45,-1.2447,0.15,0.31,"No",1.004,0.45,0.98,"Yes"
"8951","REACTOME","106512_REACT_11065_BETA_CATENIN_PHOSPHORYLATION_CASCADE",17,-1.2447,0.17,0.34,"No",0.6891,0.89,1,"Yes"
"8952","KEGG_compound","C06205_1_2_DIHYDRONAPHTHALENE_1_2_DIOL",5,-1.2446,0.19,0.34,"No",-0.7732,0.75,1,"No"
"8953","GO_BP","513798_GO_0060242_CONTACT_INHIBITION",8,-1.2445,0.21,0.31,"No",0.6924,0.87,1,"Yes"
"8954","C7_Immunologic_signatures","C7_ALL_35_GSE10239_MEMORY_VS_DAY4_5_EFF_CD8_TCELL_UP",197,-1.2445,0.077,0.13,"No",-0.7975,0.94,1,"No"
"8955","GO_BP","754957_GO_2000851_POSITIVE_REGULATION_OF_GLUCOCORTICOID_SECRETION",5,-1.2445,0.2,0.31,"No",1.3027,0.19,0.66,"Yes"
"8956","C2_Chemical_and_genetic_perturbations","C2_CGP_718_FARMER_BREAST_CANCER_CLUSTER_7",20,-1.2444,0.19,0.23,"No",-1.0823,0.35,0.94,"No"
"8957","GO_BP","519395_GO_2000756_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION",46,-1.2443,0.16,0.31,"No",-0.7812,0.84,1,"No"
"8958","C3_TF_targets","C3_TFT_225_V_HOXA3_01",13,-1.2442,0.19,0.14,"No",-0.8242,0.69,1,"No"
"8959","GO_BP","512577_GO_0051702_INTERACTION_WITH_SYMBIONT",44,-1.2442,0.17,0.31,"No",1.1767,0.2,0.81,"Yes"
"8960","C6_Oncogenic_signatures","C6_ALL_149_HOXA9_DN_V1_DN",188,-1.2441,0.082,0.13,"No",0.7428,0.98,0.97,"Yes"
"8961","C2_Chemical_and_genetic_perturbations","C2_CGP_2021_MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN",370,-1.2441,0.047,0.23,"No",0.9184,0.79,0.9,"Yes"
"8962","REACTOME","119532_REACT_19331_CELL_CELL_JUNCTION_ORGANIZATION",58,-1.2441,0.16,0.34,"No",-0.9726,0.51,1,"No"
"8963","GO_BP","501609_GO_0032374_REGULATION_OF_CHOLESTEROL_TRANSPORT",34,-1.244,0.16,0.31,"No",0.9823,0.46,1,"Yes"
"8964","C2_Chemical_and_genetic_perturbations","C2_CGP_3101_OHGUCHI_LIVER_HNF4A_TARGETS_DN",145,-1.244,0.096,0.23,"No",-1.285,0.061,0.7,"No"
"8965","C2_Chemical_and_genetic_perturbations","C2_CGP_2237_MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN",58,-1.244,0.13,0.23,"No",0.7453,0.92,1,"Yes"
"8966","REACTOME","645289_REACT_121139_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES",64,-1.244,0.13,0.34,"No",-1.391,0.05,0.54,"No"
"8967","GO_BP","496525_GO_0016577_HISTONE_DEMETHYLATION",35,-1.2439,0.15,0.31,"No",-1.598,0.013,0.69,"No"
"8968","C2_Chemical_and_genetic_perturbations","C2_CGP_2091_STEIN_ESRRA_TARGETS_UP",387,-1.2439,0.044,0.23,"No",1.2123,0.026,0.48,"Yes"
"8969","C2_Chemical_and_genetic_perturbations","C2_CGP_751_XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR",19,-1.2437,0.18,0.23,"No",-1.0834,0.35,0.94,"No"
"8970","GO_BP","492283_GO_0007530_SEX_DETERMINATION",22,-1.2436,0.19,0.31,"No",-1.7006,0.0075,0.66,"No"
"8971","GO_BP","510791_GO_0048736_APPENDAGE_DEVELOPMENT",168,-1.2436,0.087,0.31,"No",-1.0298,0.38,0.97,"No"
"8972","C2_Chemical_and_genetic_perturbations","C2_CGP_2997_HOFFMAN_CLOCK_TARGETS_UP",11,-1.2434,0.19,0.23,"No",0.781,0.76,1,"Yes"
"8973","KEGG_pathway","HSA05010_ALZHEIMER_S_DISEASE",158,-1.2433,0.1,0.18,"No",2.0308,0,0.0013,"Yes"
"8974","OMIM_gene","OMIM148069_KERATIN_17_KRT17",5,-1.2432,0.21,0.91,"No",0.563,0.94,1,"Yes"
"8975","GO_BP","510615_GO_0048548_REGULATION_OF_PINOCYTOSIS",8,-1.243,0.22,0.31,"No",-0.6093,0.93,1,"No"
"8976","GO_BP","517020_GO_0072104_GLOMERULAR_CAPILLARY_FORMATION",5,-1.243,0.2,0.31,"No",-1.2973,0.18,0.89,"No"
"8977","C1_Positional","C1_ALL_304_CHR12Q11",8,-1.243,0.22,0.77,"No",1.0946,0.36,0.64,"Yes"
"8978","KEGG_compound","C02305_PHOSPHOCREATINE_N_PHOSPHOCREATINE_CREATINE_PHOSPHATE",5,-1.243,0.22,0.34,"No",-1.0219,0.47,1,"No"
"8979","REACTOME","105726_REACT_6946_METHYLATION",10,-1.2429,0.2,0.34,"No",0.7902,0.74,1,"Yes"
"8980","REACTOME","106340_REACT_12579_SHC1_EVENTS_IN_EGFR_SIGNALING",22,-1.2429,0.16,0.34,"No",0.7042,0.93,1,"Yes"
"8981","C4_Cancer_gene_neighborhoods","C4_CGN_410_GNF2_SPINK1",21,-1.2429,0.18,0.28,"No",1.5518,0.042,0.022,"Yes"
"8982","GO_BP","510222_GO_0048066_DEVELOPMENTAL_PIGMENTATION",41,-1.2428,0.18,0.31,"No",1.1617,0.2,0.82,"Yes"
"8983","GO_BP","488830_GO_0003032_DETECTION_OF_OXYGEN",5,-1.2428,0.21,0.31,"No",-0.5831,0.93,1,"No"
"8984","C7_Immunologic_signatures","C7_ALL_1255_GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP",177,-1.2428,0.073,0.13,"No",1.4942,0,0.014,"Yes"
"8985","C7_Immunologic_signatures","C7_ALL_1091_GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP",181,-1.2428,0.086,0.13,"No",-1.0167,0.4,1,"No"
"8986","GO_BP","505819_GO_0042711_MATERNAL_BEHAVIOR",13,-1.2428,0.21,0.31,"No",0.7319,0.8,1,"Yes"
"8987","C7_Immunologic_signatures","C7_ALL_745_GSE17721_0_5H_VS_8H_CPG_BMDM_UP",200,-1.2427,0.087,0.13,"No",1.0986,0.22,0.45,"Yes"
"8988","C3_TF_targets","C3_TFT_355_V_TCF4_Q5",231,-1.2426,0.05,0.14,"No",0.9582,0.59,1,"Yes"
"8989","KEGG_compound","C00267_ALPHA_D_GLUCOSE",19,-1.2426,0.18,0.34,"No",-0.9624,0.51,1,"No"
"8990","WikiPathways","198801_WP34_OVARIAN_INFERTILITY_GENES",32,-1.2424,0.16,0.25,"No",-0.8693,0.68,1,"No"
"8991","KEGG_compound","C06899_CHLORAL_HYDRATE",11,-1.2423,0.2,0.34,"No",1.2245,0.21,0.86,"Yes"
"8992","C7_Immunologic_signatures","C7_ALL_650_GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_DN",198,-1.2423,0.083,0.13,"No",1.5445,0,0.0066,"Yes"
"8993","C7_Immunologic_signatures","C7_ALL_639_GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_UP",193,-1.2423,0.07,0.13,"No",-0.993,0.48,1,"No"
"8994","C7_Immunologic_signatures","C7_ALL_1755_GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_UP",157,-1.2423,0.076,0.13,"No",0.9294,0.68,0.96,"Yes"
"8995","C2_Chemical_and_genetic_perturbations","C2_CGP_1719_NIELSEN_LIPOSARCOMA_DN",19,-1.2422,0.2,0.23,"No",-1.1788,0.23,0.82,"No"
"8996","C4_Cancer_modules","C4_CM_299_MODULE_343",24,-1.242,0.19,0.23,"No",1.1407,0.28,0.47,"Yes"
"8997","C4_Cancer_modules","C4_CM_266_MODULE_303",28,-1.242,0.19,0.23,"No",-0.6504,0.93,1,"No"
"8998","C2_Chemical_and_genetic_perturbations","C2_CGP_1776_MACLACHLAN_BRCA1_TARGETS_UP",21,-1.2419,0.19,0.23,"No",1.2073,0.21,0.48,"Yes"
"8999","C2_Chemical_and_genetic_perturbations","C2_CGP_81_TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN",7,-1.2419,0.22,0.23,"No",-0.8674,0.63,1,"No"
"9000","REACTOME","105733_REACT_6812_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE",8,-1.2419,0.21,0.34,"No",-1.3708,0.11,0.56,"No"
"9001","GO_BP","500133_GO_0030835_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION",35,-1.2418,0.17,0.31,"No",-1.0963,0.3,0.95,"No"
"9002","C7_Immunologic_signatures","C7_ALL_1379_GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP",199,-1.2416,0.081,0.13,"No",1.4189,0.0094,0.032,"Yes"
"9003","GO_BP","753022_GO_1900025_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",7,-1.2416,0.22,0.31,"No",-0.6515,0.89,1,"No"
"9004","GO_CC","505725_GO_0042599_LAMELLAR_BODY",11,-1.2415,0.21,0.38,"No",0.8196,0.69,0.94,"Yes"
"9005","GO_BP","508100_GO_0045763_NEGATIVE_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",79,-1.2414,0.13,0.31,"No",1.0419,0.4,0.96,"Yes"
"9006","GO_BP","508757_GO_0046498_S_ADENOSYLHOMOCYSTEINE_METABOLIC_PROCESS",9,-1.2414,0.19,0.31,"No",-1.348,0.15,0.92,"No"
"9007","GO_MF","498782_GO_0020037_HEME_BINDING",130,-1.2413,0.12,0.36,"No",1.2011,0.13,0.7,"Yes"
"9008","C7_Immunologic_signatures","C7_ALL_733_GSE17721_0_5H_VS_8H_PAM3CSK4_BMDM_UP",198,-1.2413,0.084,0.13,"No",1.4205,0.0049,0.031,"Yes"
"9009","GO_BP","513977_GO_0060421_POSITIVE_REGULATION_OF_HEART_GROWTH",25,-1.2413,0.17,0.31,"No",0.6955,0.92,1,"Yes"
"9010","C2_Chemical_and_genetic_perturbations","C2_CGP_2974_ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE",17,-1.2413,0.19,0.23,"No",-1.27,0.18,0.71,"No"
"9011","REACTOME","105979_REACT_15525_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY",50,-1.2413,0.15,0.34,"No",-1.124,0.27,0.9,"No"
"9012","C7_Immunologic_signatures","C7_ALL_1602_GSE3982_EOSINOPHIL_VS_NKCELL_DN",196,-1.2412,0.08,0.13,"No",1.3806,0.0066,0.045,"Yes"
"9013","C2_Chemical_and_genetic_perturbations","C2_CGP_1464_HEDVAT_ELF4_TARGETS_UP",12,-1.2412,0.21,0.23,"No",-0.4471,0.99,1,"No"
"9014","GO_BP","509090_GO_0046874_QUINOLINATE_METABOLIC_PROCESS",6,-1.2411,0.23,0.31,"No",1.0669,0.4,0.93,"Yes"
"9015","OMIM_gene","OMIM605126_FOUR_AND_A_HALF_LIM_DOMAINS_5_FHL5",8,-1.241,0.21,0.85,"No",1.3121,0.15,0.79,"Yes"
"9016","GO_MF","495462_GO_0015194_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-1.241,0.2,0.36,"No",0.9905,0.46,0.88,"Yes"
"9017","GO_BP","496030_GO_0015908_FATTY_ACID_TRANSPORT",48,-1.2409,0.14,0.31,"No",0.7257,0.93,1,"Yes"
"9018","REACTOME","187217_REACT_23878_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE",13,-1.2409,0.2,0.34,"No",0.6105,0.94,1,"Yes"
"9019","GO_BP","511804_GO_0050861_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY",5,-1.2408,0.2,0.31,"No",-0.8226,0.68,1,"No"
"9020","C2_Chemical_and_genetic_perturbations","C2_CGP_1748_KAAB_FAILED_HEART_ATRIUM_UP",38,-1.2408,0.16,0.23,"No",-0.9097,0.59,1,"No"
"9021","GO_CC","502337_GO_0033116_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE",37,-1.2407,0.17,0.38,"No",1.2422,0.15,0.47,"Yes"
"9022","WikiPathways","198891_WP268_NOTCH_SIGNALING_PATHWAY",46,-1.2407,0.15,0.25,"No",-1.263,0.12,0.93,"No"
"9023","REACTOME","1127537_REACT_264256_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL",7,-1.2407,0.21,0.34,"No",-1.0501,0.38,0.94,"No"
"9024","C2_Chemical_and_genetic_perturbations","C2_CGP_2780_GLINSKY_CANCER_DEATH_UP",6,-1.2407,0.22,0.23,"No",-0.4198,1,1,"No"
"9025","C2_Chemical_and_genetic_perturbations","C2_CGP_1918_VARELA_ZMPSTE24_TARGETS_UP",40,-1.2406,0.18,0.23,"No",-1.0254,0.42,0.98,"No"
"9026","REACTOME","106126_REACT_735_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA",5,-1.2405,0.2,0.34,"No",0.9564,0.52,0.82,"Yes"
"9027","C4_Cancer_modules","C4_CM_272_MODULE_311",18,-1.2404,0.18,0.23,"No",1.9164,0.0041,0.0074,"Yes"
"9028","GO_BP","504454_GO_0035270_ENDOCRINE_SYSTEM_DEVELOPMENT",122,-1.2404,0.11,0.31,"No",1.098,0.25,0.9,"Yes"
"9029","C7_Immunologic_signatures","C7_ALL_374_GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN",194,-1.2403,0.073,0.13,"No",1.2381,0.047,0.17,"Yes"
"9030","C4_Cancer_gene_neighborhoods","C4_CGN_68_MORF_CAMK4",281,-1.2402,0.061,0.28,"No",-0.9573,0.59,0.9,"No"
"9031","GO_CC","504184_GO_0034993_LINC_COMPLEX",7,-1.2402,0.2,0.38,"No",-0.9439,0.53,0.9,"No"
"9032","GO_BP","513981_GO_0060426_LUNG_VASCULATURE_DEVELOPMENT",8,-1.2401,0.2,0.31,"No",-1.2724,0.18,0.89,"No"
"9033","GO_BP","510620_GO_0048553_NEGATIVE_REGULATION_OF_METALLOENZYME_ACTIVITY",6,-1.2401,0.21,0.31,"No",-0.6437,0.88,1,"No"
"9034","GO_BP","754183_GO_1901216_POSITIVE_REGULATION_OF_NEURON_DEATH",58,-1.24,0.15,0.31,"No",-0.976,0.48,1,"No"
"9035","C7_Immunologic_signatures","C7_ALL_1469_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP",195,-1.2399,0.078,0.13,"No",0.9069,0.74,1,"Yes"
"9036","C2_Chemical_and_genetic_perturbations","C2_CGP_1282_LEI_HOXC8_TARGETS_DN",16,-1.2399,0.2,0.23,"No",-0.7943,0.75,1,"No"
"9037","GO_BP","516790_GO_0071869_RESPONSE_TO_CATECHOLAMINE",26,-1.2397,0.19,0.31,"No",-0.799,0.79,1,"No"
"9038","C2_Chemical_and_genetic_perturbations","C2_CGP_2426_ALONSO_METASTASIS_UP",196,-1.2397,0.084,0.23,"No",2.1399,0,0.0013,"Yes"
"9039","C2_Chemical_and_genetic_perturbations","C2_CGP_2066_GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP",19,-1.2397,0.2,0.23,"No",0.5585,0.98,1,"Yes"
"9040","GO_BP","499859_GO_0030520_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",22,-1.2397,0.19,0.31,"No",-0.7462,0.84,1,"No"
"9041","GO_BP","502758_GO_0033540_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE",11,-1.2396,0.19,0.31,"No",1.0325,0.39,0.96,"Yes"
"9042","C2_Chemical_and_genetic_perturbations","C2_CGP_835_YAN_ESCAPE_FROM_ANOIKIS",23,-1.2394,0.18,0.23,"No",0.9656,0.51,0.84,"Yes"
"9043","GO_BP","496307_GO_0016241_REGULATION_OF_MACROAUTOPHAGY",39,-1.2394,0.17,0.31,"No",0.6626,0.97,1,"Yes"
"9044","C7_Immunologic_signatures","C7_ALL_460_GSE17721_CTRL_VS_LPS_12H_BMDM_DN",197,-1.2394,0.082,0.14,"No",1.0753,0.26,0.51,"Yes"
"9045","GO_BP","516422_GO_0071498_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS",14,-1.2393,0.22,0.31,"No",0.3678,1,1,"Yes"
"9046","KEGG_compound","C14850_BENZO_A_PYRENE_7_8_OXIDE_BENZO_A_PYRENE_7_8_EPOXIDE",5,-1.2393,0.22,0.34,"No",-1.4937,0.046,0.3,"No"
"9047","C2_Chemical_and_genetic_perturbations","C2_CGP_2421_BLUM_RESPONSE_TO_SALIRASIB_DN",341,-1.2393,0.041,0.23,"No",0.9233,0.74,0.9,"Yes"
"9048","REACTOME","906028_REACT_169333_TRP_CHANNELS",25,-1.2393,0.17,0.34,"No",-1.5181,0.026,0.43,"No"
"9049","C4_Cancer_gene_neighborhoods","C4_CGN_96_MORF_ERCC4",312,-1.2392,0.05,0.28,"No",-1.0392,0.35,0.8,"No"
"9050","GO_BP","504905_GO_0035728_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR",7,-1.2391,0.22,0.31,"No",-0.5965,0.92,1,"No"
"9051","GO_BP","517019_GO_0072103_GLOMERULUS_VASCULATURE_MORPHOGENESIS",5,-1.2391,0.22,0.31,"No",-1.3266,0.16,0.9,"No"
"9052","GO_MF","498631_GO_0019840_ISOPRENOID_BINDING",40,-1.2391,0.16,0.36,"No",1.2671,0.12,0.64,"Yes"
"9053","C2_Chemical_and_genetic_perturbations","C2_CGP_907_KREPPEL_CD99_TARGETS_UP",5,-1.2391,0.22,0.23,"No",0.544,0.98,1,"Yes"
"9054","REACTOME","1127674_REACT_264000_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION",105,-1.239,0.11,0.34,"No",-1.3906,0.033,0.53,"No"
"9055","C2_Chemical_and_genetic_perturbations","C2_CGP_2947_MOOTHA_FFA_OXYDATION",22,-1.2389,0.18,0.23,"No",1.1183,0.31,0.6,"Yes"
"9056","GO_BP","510630_GO_0048565_DIGESTIVE_TRACT_DEVELOPMENT",127,-1.2388,0.099,0.31,"No",-1.0515,0.34,0.97,"No"
"9057","C7_Immunologic_signatures","C7_ALL_1012_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN",198,-1.2387,0.079,0.14,"No",1.5506,0,0.0061,"Yes"
"9058","C7_Immunologic_signatures","C7_ALL_1620_GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN",190,-1.2387,0.085,0.14,"No",-0.9487,0.59,1,"No"
"9059","OMIM_gene","OMIM603079_CHROMOBOX_HOMOLOG_4_DROSOPHILA_POLYCOMB_CLASS_CBX4",5,-1.2386,0.23,0.81,"No",0.5712,0.95,1,"Yes"
"9060","C1_Positional","C1_ALL_8_CHR10Q21",42,-1.2385,0.16,0.77,"No",0.9332,0.57,0.82,"Yes"
"9061","C2_Chemical_and_genetic_perturbations","C2_CGP_1470_PARK_HSC_MARKERS",44,-1.2385,0.16,0.23,"No",0.8251,0.8,0.98,"Yes"
"9062","GO_BP","513915_GO_0060359_RESPONSE_TO_AMMONIUM_ION",67,-1.2384,0.14,0.31,"No",-1.0696,0.34,0.96,"No"
"9063","C7_Immunologic_signatures","C7_ALL_568_GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_DN",194,-1.2384,0.087,0.14,"No",0.9271,0.69,0.96,"Yes"
"9064","GO_BP","504642_GO_0035458_CELLULAR_RESPONSE_TO_INTERFERON_BETA",13,-1.2384,0.2,0.31,"No",-0.9134,0.58,1,"No"
"9065","GO_BP","510795_GO_0048741_SKELETAL_MUSCLE_FIBER_DEVELOPMENT",19,-1.2383,0.18,0.31,"No",-1.3513,0.11,0.94,"No"
"9066","C3_TF_targets","C3_TFT_278_V_AP2REP_01",176,-1.2383,0.091,0.15,"No",-1.0991,0.26,0.55,"No"
"9067","GO_BP","508431_GO_0046135_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS",22,-1.238,0.18,0.31,"No",-0.4267,1,1,"No"
"9068","KEGG_compound","C00124_D_GALACTOSE_D_GALACTOPYRANOSE",7,-1.238,0.2,0.34,"No",-1.5893,0.024,0.17,"No"
"9069","GO_MF","506577_GO_0043546_MOLYBDOPTERIN_COFACTOR_BINDING",5,-1.238,0.22,0.36,"No",-1.1729,0.28,0.78,"No"
"9070","GO_BP","492105_GO_0007341_PENETRATION_OF_ZONA_PELLUCIDA",5,-1.2379,0.2,0.31,"No",-0.5986,0.93,1,"No"
"9071","GO_BP","498667_GO_0019884_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN",175,-1.2379,0.085,0.31,"No",1.5766,0.0023,0.32,"Yes"
"9072","GO_BP","504769_GO_0035590_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY",21,-1.2378,0.18,0.31,"No",1.4609,0.051,0.48,"Yes"
"9073","KEGG_compound","C00151_L_AMINO_ACID_L_2_AMINO_ACID",5,-1.2378,0.22,0.34,"No",-0.673,0.88,1,"No"
"9074","GO_BP","487497_GO_0001558_REGULATION_OF_CELL_GROWTH",328,-1.2378,0.053,0.31,"No",-0.9719,0.55,1,"No"
"9075","GO_BP","518521_GO_0090381_REGULATION_OF_HEART_INDUCTION",6,-1.2377,0.22,0.31,"No",0.9033,0.6,1,"Yes"
"9076","C2_Chemical_and_genetic_perturbations","C2_CGP_771_WHITE_NEUROBLASTOMA_WITH_1P36_3_DELETION",21,-1.2376,0.19,0.23,"No",-0.975,0.48,1,"No"
"9077","GO_BP","491641_GO_0006767_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS",90,-1.2376,0.13,0.31,"No",-0.7375,0.95,1,"No"
"9078","GO_BP","496355_GO_0016311_DEPHOSPHORYLATION",270,-1.2376,0.062,0.31,"No",0.8774,0.84,1,"Yes"
"9079","GO_BP","492344_GO_0007603_PHOTOTRANSDUCTION_VISIBLE_LIGHT",95,-1.2375,0.13,0.31,"No",-0.9016,0.69,1,"No"
"9080","GO_CC","499555_GO_0030125_CLATHRIN_VESICLE_COAT",23,-1.2375,0.18,0.38,"No",0.7123,0.88,0.99,"Yes"
"9081","C4_Cancer_modules","C4_CM_81_MODULE_86",43,-1.2374,0.16,0.24,"No",1.6797,0.0021,0.051,"Yes"
"9082","REACTOME","105811_REACT_15364_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES",62,-1.2374,0.14,0.34,"No",-0.8557,0.73,1,"No"
"9083","GO_BP","777640_GO_1901983_REGULATION_OF_PROTEIN_ACETYLATION",52,-1.2374,0.14,0.31,"No",0.8849,0.69,1,"Yes"
"9084","GO_BP","507074_GO_0044058_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS",26,-1.2374,0.17,0.31,"No",-1.2418,0.17,0.91,"No"
"9085","GO_BP","488878_GO_0003081_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN",23,-1.2374,0.18,0.31,"No",1.0613,0.34,0.94,"Yes"
"9086","GO_BP","514395_GO_0060840_ARTERY_DEVELOPMENT",56,-1.2374,0.14,0.31,"No",-0.653,0.98,1,"No"
"9087","C7_Immunologic_signatures","C7_ALL_218_GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN",200,-1.2371,0.079,0.14,"No",1.369,0.012,0.051,"Yes"
"9088","GO_BP","498566_GO_0019755_ONE_CARBON_COMPOUND_TRANSPORT",12,-1.2371,0.21,0.31,"No",0.5896,0.96,1,"Yes"
"9089","C7_Immunologic_signatures","C7_ALL_1389_GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP",199,-1.237,0.079,0.14,"No",1.4671,0,0.018,"Yes"
"9090","GO_BP","492359_GO_0007618_MATING",38,-1.237,0.18,0.31,"No",1.0051,0.46,0.98,"Yes"
"9091","C7_Immunologic_signatures","C7_ALL_1799_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP",192,-1.2369,0.09,0.14,"No",0.7966,0.97,1,"Yes"
"9092","C2_Chemical_and_genetic_perturbations","C2_CGP_2535_MIZUKAMI_HYPOXIA_UP",12,-1.2368,0.2,0.24,"No",0.707,0.83,1,"Yes"
"9093","C6_Oncogenic_signatures","C6_ALL_122_RB_DN_V1_UP",127,-1.2368,0.12,0.14,"No",-1.2308,0.092,0.39,"No"
"9094","C2_Chemical_and_genetic_perturbations","C2_CGP_2368_CHO_NR4A1_TARGETS",31,-1.2368,0.18,0.24,"No",-1.0251,0.42,0.98,"No"
"9095","C2_Chemical_and_genetic_perturbations","C2_CGP_362_HAHTOLA_MYCOSIS_FUNGOIDES_UP",18,-1.2367,0.21,0.24,"No",0.8351,0.7,0.98,"Yes"
"9096","GO_BP","494901_GO_0010837_REGULATION_OF_KERATINOCYTE_PROLIFERATION",23,-1.2366,0.19,0.31,"No",-1.1767,0.22,0.9,"No"
"9097","C2_Chemical_and_genetic_perturbations","C2_CGP_819_SASAKI_TARGETS_OF_TP73_AND_TP63",11,-1.2366,0.18,0.24,"No",0.7999,0.71,0.99,"Yes"
"9098","C2_Chemical_and_genetic_perturbations","C2_CGP_954_SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER",86,-1.2365,0.13,0.24,"No",-1.1728,0.17,0.82,"No"
"9099","KEGG_module","HSA_M00130_INOSITOL_PHOSPHATE_METABOLISM_PI_PIP2_INS_1_4_5_P3_INS_1_3_4_5_P4",22,-1.2365,0.17,0.49,"No",-1.734,0,0.38,"No"
"9100","GO_BP","512469_GO_0051591_RESPONSE_TO_CAMP",94,-1.2364,0.12,0.31,"No",1.084,0.3,0.92,"Yes"
"9101","C2_Chemical_and_genetic_perturbations","C2_CGP_1246_ZEILSTRA_CD44_TARGETS_DN",7,-1.2364,0.23,0.24,"No",-1.2709,0.19,0.71,"No"
"9102","GO_BP","489307_GO_0042989_SEQUESTERING_OF_ACTIN_MONOMERS",9,-1.2364,0.18,0.31,"No",1.4754,0.064,0.45,"Yes"
"9103","GO_BP","515923_GO_0070997_NEURON_DEATH",46,-1.2363,0.16,0.31,"No",0.9323,0.57,1,"Yes"
"9104","C7_Immunologic_signatures","C7_ALL_1847_GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP",198,-1.2363,0.079,0.14,"No",1.0504,0.31,0.59,"Yes"
"9105","GO_BP","491549_GO_0006661_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS",90,-1.2362,0.13,0.31,"No",0.5837,1,1,"Yes"
"9106","GO_BP","487880_GO_0001990_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE",36,-1.2362,0.18,0.31,"No",-1.0141,0.43,0.98,"No"
"9107","C2_Chemical_and_genetic_perturbations","C2_CGP_1133_AMIT_EGF_RESPONSE_20_HELA",11,-1.2361,0.2,0.24,"No",-1.2034,0.23,0.8,"No"
"9108","GO_BP","488479_GO_0002606_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION",6,-1.2361,0.23,0.31,"No",0.5402,0.97,1,"Yes"
"9109","GO_MF","489460_GO_0003988_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY",6,-1.236,0.21,0.37,"No",0.5675,0.95,1,"Yes"
"9110","GO_BP","494530_GO_0010460_POSITIVE_REGULATION_OF_HEART_RATE",20,-1.236,0.21,0.31,"No",0.944,0.53,1,"Yes"
"9111","C2_Chemical_and_genetic_perturbations","C2_CGP_581_TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA",98,-1.236,0.12,0.24,"No",0.9008,0.69,0.92,"Yes"
"9112","GO_BP","513787_GO_0060231_MESENCHYMAL_TO_EPITHELIAL_TRANSITION",15,-1.2359,0.21,0.31,"No",-1.2218,0.19,0.88,"No"
"9113","GO_MF","751602_GO_0044389_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING",218,-1.2359,0.079,0.37,"No",0.8267,0.93,1,"Yes"
"9114","C1_Positional","C1_ALL_24_CHR10Q25",44,-1.2357,0.16,0.77,"No",1.1341,0.25,0.65,"Yes"
"9115","GO_BP","503515_GO_0034312_DIOL_BIOSYNTHETIC_PROCESS",6,-1.2356,0.21,0.31,"No",0.7216,0.8,1,"Yes"
"9116","KEGG_enzyme","2.3.1.24_SPHINGOSINE_N_ACYLTRANSFERASE_CERAMIDE_SYNTHETASE_SPHINGOSINE_ACYLTRANSFERASE",6,-1.2355,0.21,0.48,"No",-1.4,0.12,0.42,"No"
"9117","GO_MF","487544_GO_0001614_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY",21,-1.2354,0.18,0.37,"No",1.4149,0.075,0.48,"Yes"
"9118","C1_Positional","C1_ALL_152_CHR17P13",233,-1.2353,0.077,0.76,"No",-1.5717,0,0.6,"No"
"9119","GO_BP","506680_GO_0043650_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS",11,-1.2353,0.2,0.31,"No",-0.9426,0.52,1,"No"
"9120","C2_Chemical_and_genetic_perturbations","C2_CGP_290_TIEN_INTESTINE_PROBIOTICS_24HR_DN",213,-1.2353,0.082,0.24,"No",2.0307,0,0.0044,"Yes"
"9121","GO_MF","496848_GO_0017016_RAS_GTPASE_BINDING",209,-1.2352,0.078,0.37,"No",-1.1703,0.13,0.79,"No"
"9122","C7_Immunologic_signatures","C7_ALL_480_GSE17721_CTRL_VS_PAM3CSK4_0_5H_BMDM_DN",194,-1.2351,0.082,0.14,"No",0.7534,0.99,1,"Yes"
"9123","GO_BP","495134_GO_0014062_REGULATION_OF_SEROTONIN_SECRETION",6,-1.2351,0.22,0.31,"No",1.2474,0.22,0.73,"Yes"
"9124","C7_Immunologic_signatures","C7_ALL_102_GSE11924_TH1_VS_TH2_CD4_TCELL_DN",199,-1.2351,0.1,0.14,"No",1.2669,0.037,0.13,"Yes"
"9125","GO_BP","512526_GO_0051650_ESTABLISHMENT_OF_VESICLE_LOCALIZATION",188,-1.2351,0.091,0.31,"No",1.0973,0.19,0.9,"Yes"
"9126","C7_Immunologic_signatures","C7_ALL_597_GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_UP",197,-1.2351,0.072,0.14,"No",0.7454,0.99,1,"Yes"
"9127","C7_Immunologic_signatures","C7_ALL_593_GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP",194,-1.2351,0.089,0.14,"No",0.9283,0.67,0.96,"Yes"
"9128","C2_Chemical_and_genetic_perturbations","C2_CGP_2048_LEIN_NEURON_MARKERS",68,-1.235,0.15,0.24,"No",0.9837,0.48,0.81,"Yes"
"9129","GO_BP","500396_GO_0031109_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",34,-1.235,0.19,0.31,"No",-0.5833,0.99,1,"No"
"9130","GO_BP","515321_GO_0070389_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING",5,-1.2349,0.22,0.31,"No",0.9682,0.53,1,"Yes"
"9131","C2_Chemical_and_genetic_perturbations","C2_CGP_2565_VANTVEER_BREAST_CANCER_BRCA1_DN",43,-1.2349,0.15,0.24,"No",-1.0541,0.38,0.96,"No"
"9132","C2_Chemical_and_genetic_perturbations","C2_CGP_2101_TESAR_JAK_TARGETS_MOUSE_ES_D3_UP",6,-1.2347,0.23,0.24,"No",-1.1013,0.34,0.91,"No"
"9133","GO_MF","490111_GO_0004806_TRIGLYCERIDE_LIPASE_ACTIVITY",14,-1.2346,0.19,0.37,"No",-0.998,0.46,0.91,"No"
"9134","C7_Immunologic_signatures","C7_ALL_1535_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP",190,-1.2345,0.086,0.14,"No",-0.9846,0.51,1,"No"
"9135","GO_MF","750818_GO_0052745_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY",16,-1.2345,0.2,0.37,"No",-0.6838,0.88,1,"No"
"9136","C7_Immunologic_signatures","C7_ALL_1873_GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP",198,-1.2344,0.074,0.14,"No",0.7954,0.97,1,"Yes"
"9137","GO_BP","753039_GO_1900042_POSITIVE_REGULATION_OF_INTERLEUKIN_2_SECRETION",5,-1.2344,0.21,0.32,"No",-1.3167,0.16,0.89,"No"
"9138","REACTOME","105810_REACT_15451_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATIONFROM_THE_CENTROSOME",62,-1.2343,0.14,0.34,"No",-0.855,0.76,1,"No"
"9139","GO_BP","487442_GO_0001503_OSSIFICATION",245,-1.2342,0.076,0.32,"No",1.1086,0.18,0.89,"Yes"
"9140","C7_Immunologic_signatures","C7_ALL_1794_GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN",195,-1.2342,0.094,0.14,"No",1.3173,0.012,0.087,"Yes"
"9141","C3_TF_targets","C3_TFT_290_V_PITX2_Q2",244,-1.2341,0.072,0.15,"No",-0.9463,0.65,0.88,"No"
"9142","REACTOME","106025_REACT_11200_NEF_MEDIATED_CD8_DOWN_REGULATION",7,-1.2341,0.23,0.34,"No",0.7654,0.75,1,"Yes"
"9143","C2_Chemical_and_genetic_perturbations","C2_CGP_2692_VALK_AML_WITH_T_8_21_TRANSLOCATION",5,-1.2341,0.21,0.24,"No",-0.659,0.88,1,"No"
"9144","C7_Immunologic_signatures","C7_ALL_151_GSE13306_TREG_RA_VS_TCONV_RA_UP",198,-1.234,0.092,0.14,"No",-0.7626,0.97,1,"No"
"9145","GO_BP","518838_GO_2000191_REGULATION_OF_FATTY_ACID_TRANSPORT",26,-1.234,0.18,0.32,"No",0.822,0.76,1,"Yes"
"9146","C2_Chemical_and_genetic_perturbations","C2_CGP_338_WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP",262,-1.2339,0.064,0.24,"No",0.7827,0.99,1,"Yes"
"9147","C2_Chemical_and_genetic_perturbations","C2_CGP_376_PASTURAL_RIZ1_TARGETS_DN",5,-1.2339,0.23,0.24,"No",1.0971,0.37,0.64,"Yes"
"9148","GO_BP","502091_GO_0032869_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",195,-1.2339,0.085,0.32,"No",-0.8558,0.86,1,"No"
"9149","GO_MF","490577_GO_0005432_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY",5,-1.2338,0.22,0.37,"No",-1.0007,0.48,0.9,"No"
"9150","C4_Cancer_gene_neighborhoods","C4_CGN_385_GNF2_MYL2",30,-1.2338,0.18,0.28,"No",-1.7136,0.0038,0.074,"No"
"9151","C3_TF_targets","C3_TFT_320_V_RP58_01",197,-1.2338,0.081,0.15,"No",-0.9427,0.6,0.88,"No"
"9152","KEGG_enzyme","1.11.1.15_PEROXIREDOXIN_THIOREDOXIN_PEROXIDASE_TRYPAREDOXIN_PEROXIDASE_ALKYL_HYDROPEROXIDE_REDUCTASE_C22_AHPC_TRXPX_TXNPX_PRX_PRDX",6,-1.2333,0.23,0.43,"No",1.3116,0.18,0.5,"Yes"
"9153","GO_BP","493266_GO_0009065_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",21,-1.2332,0.17,0.32,"No",-1.0359,0.41,0.98,"No"
"9154","GO_BP","513613_GO_0060055_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING",9,-1.2332,0.22,0.32,"No",0.9824,0.48,1,"Yes"
"9155","REACTOME","119555_REACT_19238_CD28_DEPENDENT_VAV1_PATHWAY",12,-1.2331,0.21,0.35,"No",0.5981,0.95,1,"Yes"
"9156","GO_BP","513730_GO_0060173_LIMB_DEVELOPMENT",162,-1.2331,0.092,0.32,"No",-1.0375,0.35,0.98,"No"
"9157","GO_BP","500151_GO_0030853_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION",7,-1.233,0.21,0.32,"No",0.6861,0.88,1,"Yes"
"9158","GO_BP","508165_GO_0045844_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",44,-1.233,0.17,0.32,"No",0.7782,0.86,1,"Yes"
"9159","GO_BP","495998_GO_0051180_VITAMIN_TRANSPORT",28,-1.2329,0.17,0.32,"No",-1.5515,0.024,0.73,"No"
"9160","GO_MF","495777_GO_0015631_TUBULIN_BINDING",246,-1.2329,0.075,0.37,"No",-0.7136,1,1,"No"
"9161","GO_BP","493402_GO_0009206_PURINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",64,-1.2329,0.15,0.32,"No",1.2651,0.097,0.71,"Yes"
"9162","C3_MicroRNA_targets","C3_MIR_97_TAGCTTT_MIR_9",233,-1.2329,0.07,0.3,"No",-0.7583,0.99,1,"No"
"9163","GO_MF","509113_GO_0046906_TETRAPYRROLE_BINDING",139,-1.2328,0.095,0.37,"No",1.1732,0.14,0.73,"Yes"
"9164","GO_MF","496575_GO_0016634_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",11,-1.2327,0.19,0.37,"No",0.529,0.98,1,"Yes"
"9165","C2_Chemical_and_genetic_perturbations","C2_CGP_701_LUI_THYROID_CANCER_CLUSTER_5",12,-1.2327,0.21,0.24,"No",-0.5538,0.97,1,"No"
"9166","C2_Chemical_and_genetic_perturbations","C2_CGP_1366_FRASOR_RESPONSE_TO_ESTRADIOL_DN",82,-1.2326,0.14,0.24,"No",-0.9292,0.59,1,"No"
"9167","WikiPathways","198849_WP35_G_PROTEIN_SIGNALING_PATHWAYS",94,-1.2326,0.13,0.26,"No",-1.098,0.28,1,"No"
"9168","C2_Chemical_and_genetic_perturbations","C2_CGP_2322_MATZUK_FERTILIZATION",8,-1.2325,0.21,0.24,"No",0.9192,0.58,0.9,"Yes"
"9169","C2_Chemical_and_genetic_perturbations","C2_CGP_3010_BAE_BRCA1_TARGETS_DN",32,-1.2325,0.18,0.24,"No",1.0897,0.31,0.65,"Yes"
"9170","C3_TF_targets","C3_TFT_240_V_TGIF_01",240,-1.2324,0.071,0.15,"No",0.977,0.51,1,"Yes"
"9171","GO_MF","499872_GO_0030546_RECEPTOR_ACTIVATOR_ACTIVITY",29,-1.2324,0.18,0.37,"No",-0.7284,0.88,1,"No"
"9172","C3_TF_targets","C3_TFT_416_V_NFY_Q6_01",256,-1.2324,0.081,0.15,"No",-1.0809,0.25,0.59,"No"
"9173","KEGG_compound","C00111_GLYCERONE_PHOSPHATE_DIHYDROXYACETONE_PHOSPHATE_3_HYDROXY_2_OXOPROPYL_PHOSPHATE",9,-1.2324,0.23,0.35,"No",-1.1451,0.29,0.86,"No"
"9174","GO_BP","982481_GO_1902913_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION",6,-1.2322,0.22,0.32,"No",1.1828,0.27,0.8,"Yes"
"9175","GO_BP","515812_GO_0070884_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE",13,-1.232,0.2,0.32,"No",0.6603,0.9,1,"Yes"
"9176","GO_BP","517300_GO_0072384_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE",35,-1.232,0.17,0.32,"No",0.811,0.76,1,"Yes"
"9177","C4_Cancer_modules","C4_CM_33_MODULE_37",464,-1.232,0.033,0.24,"No",0.8024,0.99,0.97,"Yes"
"9178","C4_Cancer_gene_neighborhoods","C4_CGN_118_MORF_JAG1",91,-1.2319,0.12,0.29,"No",-0.8557,0.81,1,"No"
"9179","REACTOME","106288_REACT_1023_PYRIMIDINE_CATABOLISM",12,-1.2319,0.21,0.35,"No",-0.6135,0.94,1,"No"
"9180","GO_BP","501882_GO_0032656_REGULATION_OF_INTERLEUKIN_13_PRODUCTION",13,-1.2317,0.19,0.32,"No",-0.8293,0.69,1,"No"
"9181","GO_BP","494655_GO_0010591_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY",23,-1.2317,0.2,0.32,"No",1.2836,0.13,0.7,"Yes"
"9182","GO_BP","487956_GO_0002066_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT",47,-1.2315,0.14,0.32,"No",-0.8431,0.72,1,"No"
"9183","GO_BP","488396_GO_0002523_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE",11,-1.2314,0.21,0.32,"No",1.2226,0.21,0.76,"Yes"
"9184","GO_MF","508931_GO_0046703_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING",8,-1.2313,0.21,0.37,"No",0.6777,0.88,1,"Yes"
"9185","C3_MicroRNA_targets","C3_MIR_205_GGTGTGT_MIR_329",113,-1.2312,0.11,0.3,"No",1.0452,0.33,1,"Yes"
"9186","GO_BP","494675_GO_0010611_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY",27,-1.2311,0.19,0.32,"No",-0.5524,0.99,1,"No"
"9187","GO_BP","499309_GO_0022030_TELENCEPHALON_GLIAL_CELL_MIGRATION",17,-1.2311,0.19,0.32,"No",-0.5956,0.96,1,"No"
"9188","GO_BP","508444_GO_0046146_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS",6,-1.2311,0.22,0.32,"No",0.85,0.65,1,"Yes"
"9189","C7_Immunologic_signatures","C7_ALL_813_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP",172,-1.2311,0.1,0.15,"No",1.1955,0.11,0.23,"Yes"
"9190","C3_TF_targets","C3_TFT_600_CGTSACG_V_PAX3_B",147,-1.231,0.1,0.16,"No",-1.0485,0.33,0.65,"No"
"9191","C2_Chemical_and_genetic_perturbations","C2_CGP_2514_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN",48,-1.2309,0.16,0.24,"No",0.8473,0.74,0.97,"Yes"
"9192","GO_CC","507298_GO_0044292_DENDRITE_TERMINUS",10,-1.2308,0.21,0.39,"No",0.8431,0.66,0.93,"Yes"
"9193","GO_BP","493765_GO_0009650_UV_PROTECTION",12,-1.2308,0.22,0.32,"No",0.6124,0.93,1,"Yes"
"9194","C3_TF_targets","C3_TFT_367_V_SMAD3_Q6",233,-1.2307,0.083,0.16,"No",-1.4123,0.0035,0.16,"No"
"9195","C7_Immunologic_signatures","C7_ALL_662_GSE17721_LPS_VS_CPG_6H_BMDM_DN",197,-1.2306,0.089,0.15,"No",1.2325,0.054,0.18,"Yes"
"9196","GO_BP","515239_GO_0070306_LENS_FIBER_CELL_DIFFERENTIATION",25,-1.2306,0.18,0.32,"No",-0.4806,0.99,1,"No"
"9197","GO_BP","514297_GO_0060742_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT",12,-1.2306,0.21,0.32,"No",-0.5355,0.97,1,"No"
"9198","GO_BP","508004_GO_0045656_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION",5,-1.2305,0.22,0.32,"No",-1.191,0.3,0.9,"No"
"9199","C2_Chemical_and_genetic_perturbations","C2_CGP_1472_HOFMANN_CELL_LYMPHOMA_DN",38,-1.2305,0.18,0.24,"No",0.9517,0.54,0.86,"Yes"
"9200","C2_Chemical_and_genetic_perturbations","C2_CGP_2635_MEISSNER_NPC_HCP_WITH_H3K27ME3",73,-1.2305,0.14,0.24,"No",1.4467,0.023,0.26,"Yes"
"9201","GO_BP","752389_GO_0086018_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALLING",7,-1.2303,0.24,0.32,"No",0.8542,0.62,1,"Yes"
"9202","GO_MF","489657_GO_0016805_DIPEPTIDASE_ACTIVITY",14,-1.2303,0.19,0.37,"No",-0.6861,0.9,1,"No"
"9203","GO_BP","755136_GO_2001030_NEGATIVE_REGULATION_OF_CELLULAR_GLUCURONIDATION",8,-1.2303,0.21,0.32,"No",0.8647,0.61,1,"Yes"
"9204","GO_BP","511822_GO_0050884_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE",13,-1.2303,0.21,0.32,"No",-1.5106,0.061,0.81,"No"
"9205","C2_Chemical_and_genetic_perturbations","C2_CGP_1289_PENG_LEUCINE_DEPRIVATION_UP",138,-1.2303,0.11,0.24,"No",0.9777,0.52,0.82,"Yes"
"9206","C4_Cancer_modules","C4_CM_171_MODULE_181",293,-1.2302,0.058,0.25,"No",-1.2863,0.028,0.54,"No"
"9207","GO_BP","499341_GO_0022605_OOGENESIS_STAGE",5,-1.2302,0.23,0.32,"No",0.8386,0.67,1,"Yes"
"9208","C2_Chemical_and_genetic_perturbations","C2_CGP_1969_JIANG_AGING_CEREBRAL_CORTEX_DN",54,-1.2302,0.15,0.24,"No",1.4383,0.036,0.26,"Yes"
"9209","GO_BP","502226_GO_0033004_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION",8,-1.2301,0.2,0.32,"No",0.6944,0.84,1,"Yes"
"9210","KEGG_reaction","R06517_ACYL_COA_SPHINGOSINE_N_ACYLTRANSFERASE_ACYL_COA_SPHINGANINE_COA_DIHYDROCERAMIDE",6,-1.23,0.22,0.33,"No",-1.3531,0.15,0.35,"No"
"9211","GO_BP","499140_GO_0021861_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION",5,-1.2299,0.22,0.32,"No",-0.7805,0.73,1,"No"
"9212","C2_Chemical_and_genetic_perturbations","C2_CGP_152_ROY_WOUND_BLOOD_VESSEL_DN",21,-1.2299,0.2,0.24,"No",-1.2006,0.22,0.79,"No"
"9213","C1_Positional","C1_ALL_113_CHR4Q28",32,-1.2299,0.16,0.76,"No",1.2388,0.16,0.58,"Yes"
"9214","GO_BP","512038_GO_0051127_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION",10,-1.2299,0.22,0.32,"No",-0.7254,0.81,1,"No"
"9215","C7_Immunologic_signatures","C7_ALL_734_GSE17721_0_5H_VS_8H_PAM3CSK4_BMDM_DN",199,-1.2299,0.084,0.15,"No",1.3132,0.021,0.091,"Yes"
"9216","C2_Chemical_and_genetic_perturbations","C2_CGP_2148_AMUNDSON_GAMMA_RADIATION_RESISTANCE",20,-1.2298,0.22,0.24,"No",1.2286,0.16,0.46,"Yes"
"9217","C2_Chemical_and_genetic_perturbations","C2_CGP_3118_KANG_AR_TARGETS_UP",16,-1.2298,0.19,0.24,"No",-0.9644,0.53,1,"No"
"9218","C3_MicroRNA_targets","C3_MIR_201_TGTGTGA_MIR_377",197,-1.2298,0.1,0.3,"No",-0.9277,0.66,1,"No"
"9219","REACTOME","530744_REACT_116022_NUCLEAR_SIGNALING_BY_ERBB4",37,-1.2297,0.18,0.35,"No",0.8929,0.64,0.91,"Yes"
"9220","C7_Immunologic_signatures","C7_ALL_707_GSE17721_0_5H_VS_12H_LPS_BMDM_UP",195,-1.2297,0.088,0.15,"No",1.3977,0.012,0.038,"Yes"
"9221","C7_Immunologic_signatures","C7_ALL_459_GSE17721_CTRL_VS_LPS_12H_BMDM_UP",198,-1.2296,0.099,0.15,"No",1.1983,0.087,0.23,"Yes"
"9222","GO_MF","492724_GO_0008429_PHOSPHATIDYLETHANOLAMINE_BINDING",7,-1.2295,0.22,0.37,"No",0.9763,0.49,0.9,"Yes"
"9223","GO_CC","500681_GO_0031430_M_BAND",18,-1.2295,0.21,0.4,"No",-1.403,0.085,0.64,"No"
"9224","C2_Chemical_and_genetic_perturbations","C2_CGP_959_OHM_METHYLATED_IN_ADULT_CANCERS",27,-1.2294,0.2,0.24,"No",0.9013,0.62,0.92,"Yes"
"9225","C1_Positional","C1_ALL_123_CHR13Q32",26,-1.2293,0.2,0.75,"No",0.8617,0.69,0.89,"Yes"
"9226","C2_Chemical_and_genetic_perturbations","C2_CGP_2228_MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN",19,-1.2292,0.18,0.24,"No",1.0139,0.43,0.78,"Yes"
"9227","REACTOME","771569_REACT_160315_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION",80,-1.2292,0.13,0.35,"No",-0.7186,0.97,1,"No"
"9228","REACTOME","576270_REACT_118614_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS",31,-1.2292,0.18,0.35,"No",-0.7605,0.83,1,"No"
"9229","C2_Chemical_and_genetic_perturbations","C2_CGP_963_OKAWA_NEUROBLASTOMA_1P36_31_DELETION",21,-1.2291,0.18,0.24,"No",-0.9685,0.48,1,"No"
"9230","C2_Chemical_and_genetic_perturbations","C2_CGP_2245_ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN",205,-1.2291,0.077,0.24,"No",0.8893,0.8,0.94,"Yes"
"9231","GO_BP","513577_GO_0060019_RADIAL_GLIAL_CELL_DIFFERENTIATION",6,-1.2291,0.24,0.32,"No",0.487,0.99,1,"Yes"
"9232","C3_TF_targets","C3_TFT_187_V_OLF1_01",266,-1.2291,0.061,0.16,"No",-1.3231,0.02,0.21,"No"
"9233","GO_BP","504293_GO_0035108_LIMB_MORPHOGENESIS",144,-1.229,0.11,0.32,"No",-0.9397,0.6,1,"No"
"9234","C7_Immunologic_signatures","C7_ALL_1373_GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP",193,-1.2289,0.091,0.15,"No",-0.9203,0.7,1,"No"
"9235","C7_Immunologic_signatures","C7_ALL_318_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN",186,-1.2289,0.067,0.15,"No",1.2904,0.037,0.11,"Yes"
"9236","GO_BP","494985_GO_0010921_REGULATION_OF_PHOSPHATASE_ACTIVITY",99,-1.2289,0.13,0.32,"No",-0.8226,0.86,1,"No"
"9237","KEGG_compound","C01598_MELATONIN_N_ACETYL_5_METHOXYTRYPTAMINE",6,-1.2288,0.24,0.35,"No",-0.9798,0.48,1,"No"
"9238","GO_BP","498845_GO_0021561_FACIAL_NERVE_DEVELOPMENT",11,-1.2287,0.19,0.32,"No",-0.8705,0.64,1,"No"
"9239","GO_BP","494073_GO_0009988_CELL_CELL_RECOGNITION",53,-1.2286,0.15,0.32,"No",-1.067,0.36,0.96,"No"
"9240","GO_BP","751912_GO_0052696_FLAVONOID_GLUCURONIDATION",21,-1.2286,0.2,0.32,"No",1.8046,0.002,0.097,"Yes"
"9241","GO_BP","517216_GO_0072300_POSITIVE_REGULATION_OF_METANEPHRIC_GLOMERULUS_DEVELOPMENT",5,-1.2286,0.23,0.32,"No",-0.8128,0.69,1,"No"
"9242","C7_Immunologic_signatures","C7_ALL_141_GSE13229_IMM_VS_INTMATURE_NKCELL_UP",193,-1.2285,0.11,0.15,"No",-1.0077,0.41,1,"No"
"9243","GO_BP","502571_GO_0033353_S_ADENOSYLMETHIONINE_CYCLE",5,-1.2285,0.21,0.32,"No",-0.9435,0.54,1,"No"
"9244","GO_BP","492568_GO_0008228_OPSONIZATION",6,-1.2285,0.23,0.32,"No",-1.1795,0.28,0.91,"No"
"9245","C2_Chemical_and_genetic_perturbations","C2_CGP_857_JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP",7,-1.2284,0.22,0.24,"No",-0.8605,0.64,1,"No"
"9246","GO_MF","499759_GO_0030368_INTERLEUKIN_17_RECEPTOR_ACTIVITY",7,-1.2284,0.23,0.37,"No",-0.9495,0.52,0.95,"No"
"9247","C7_Immunologic_signatures","C7_ALL_1074_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN",196,-1.2281,0.1,0.15,"No",1.5557,0,0.0057,"Yes"
"9248","C7_Immunologic_signatures","C7_ALL_873_GSE20366_TREG_VS_TCONV_UP",189,-1.228,0.1,0.15,"No",-0.9083,0.71,1,"No"
"9249","GO_MF","490518_GO_0005343_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY",31,-1.228,0.17,0.37,"No",-1.8358,0.0058,0.13,"No"
"9250","GO_BP","512713_GO_0051851_MODIFICATION_BY_HOST_OF_SYMBIONT_MORPHOLOGY_OR_PHYSIOLOGY",41,-1.2278,0.17,0.32,"No",1.1973,0.19,0.78,"Yes"
"9251","C2_Chemical_and_genetic_perturbations","C2_CGP_867_JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP",106,-1.2278,0.13,0.24,"No",0.9136,0.66,0.91,"Yes"
"9252","GO_BP","516997_GO_0072080_NEPHRON_TUBULE_DEVELOPMENT",75,-1.2276,0.15,0.32,"No",-0.9979,0.46,0.99,"No"
"9253","GO_BP","755134_GO_2001028_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS",8,-1.2276,0.21,0.32,"No",-0.7516,0.8,1,"No"
"9254","C7_Immunologic_signatures","C7_ALL_125_GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP",191,-1.2276,0.095,0.15,"No",0.9317,0.65,0.95,"Yes"
"9255","GO_BP","503596_GO_0034394_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",19,-1.2275,0.21,0.32,"No",-0.7323,0.89,1,"No"
"9256","C2_Chemical_and_genetic_perturbations","C2_CGP_1303_IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN",21,-1.2275,0.2,0.24,"No",1.6518,0.017,0.11,"Yes"
"9257","GO_BP","850035_GO_1990126_RETROGRADE_TRANSPORT_ENDOSOME_TO_PLASMA_MEMBRANE",11,-1.2273,0.22,0.32,"No",0.6709,0.88,1,"Yes"
"9258","C2_Chemical_and_genetic_perturbations","C2_CGP_653_AIGNER_ZEB1_TARGETS",34,-1.2272,0.17,0.24,"No",-0.9912,0.46,1,"No"
"9259","C7_Immunologic_signatures","C7_ALL_1053_GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP",192,-1.2272,0.082,0.15,"No",1.1057,0.23,0.43,"Yes"
"9260","GO_BP","501727_GO_0032495_RESPONSE_TO_MURAMYL_DIPEPTIDE",12,-1.2272,0.22,0.32,"No",-1.0281,0.41,0.97,"No"
"9261","C3_MicroRNA_targets","C3_MIR_37_CACTTTG_MIR_520G_MIR_520H",236,-1.2271,0.083,0.3,"No",0.8009,0.95,1,"Yes"
"9262","GO_BP","496070_GO_0015949_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION",19,-1.2271,0.2,0.32,"No",0.8991,0.61,1,"Yes"
"9263","GO_BP","489125_GO_0003333_AMINO_ACID_TRANSMEMBRANE_TRANSPORT",58,-1.2269,0.15,0.32,"No",-1.0843,0.32,0.96,"No"
"9264","C2_Chemical_and_genetic_perturbations","C2_CGP_1501_NADLER_HYPERGLYCEMIA_AT_OBESITY",57,-1.2268,0.17,0.24,"No",-0.916,0.61,1,"No"
"9265","GO_BP","516345_GO_0071421_MANGANESE_ION_TRANSMEMBRANE_TRANSPORT",5,-1.2268,0.23,0.32,"No",-0.6896,0.84,1,"No"
"9266","GO_MF","506105_GO_0043014_ALPHA_TUBULIN_BINDING",24,-1.2267,0.18,0.37,"No",-0.6449,0.95,1,"No"
"9267","WikiPathways","198840_WP272_BLOOD_CLOTTING_CASCADE",23,-1.2267,0.19,0.27,"No",-1.0064,0.44,0.99,"No"
"9268","GO_CC","514747_GO_0061202_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE_MEMBRANE",7,-1.2265,0.23,0.4,"No",-0.7976,0.7,1,"No"
"9269","C2_Chemical_and_genetic_perturbations","C2_CGP_1128_PETRETTO_BLOOD_PRESSURE_DN",7,-1.2263,0.22,0.25,"No",-0.9531,0.53,1,"No"
"9270","GO_BP","496856_GO_0050821_PROTEIN_STABILIZATION",101,-1.2261,0.12,0.32,"No",0.9074,0.67,1,"Yes"
"9271","GO_BP","753991_GO_1901021_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",22,-1.226,0.19,0.32,"No",-1.1146,0.3,0.94,"No"
"9272","GO_BP","491283_GO_0006342_CHROMATIN_SILENCING",57,-1.226,0.18,0.32,"No",-1.7906,0,0.49,"No"
"9273","C2_Chemical_and_genetic_perturbations","C2_CGP_1750_INGA_TP53_TARGETS",17,-1.2258,0.2,0.25,"No",-0.6424,0.92,1,"No"
"9274","C2_Chemical_and_genetic_perturbations","C2_CGP_2229_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP",24,-1.2258,0.22,0.25,"No",0.8459,0.69,0.97,"Yes"
"9275","GO_BP","512060_GO_0051150_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",15,-1.2258,0.21,0.32,"No",-1.1663,0.27,0.91,"No"
"9276","GO_BP","948498_GO_1902692_REGULATION_OF_NEUROBLAST_PROLIFERATION",28,-1.2258,0.17,0.32,"No",-0.8756,0.64,1,"No"
"9277","KEGG_pathway","HSA00531_GLYCOSAMINOGLYCAN_DEGRADATION",19,-1.2258,0.2,0.2,"No",-0.7561,0.81,1,"No"
"9278","GO_BP","490992_GO_0006004_FUCOSE_METABOLIC_PROCESS",18,-1.2257,0.21,0.32,"No",0.6815,0.89,1,"Yes"
"9279","C7_Immunologic_signatures","C7_ALL_1650_GSE3982_MAC_VS_BASOPHIL_DN",197,-1.2257,0.096,0.15,"No",1.1445,0.15,0.33,"Yes"
"9280","KEGG_compound","C03740__5_L_GLUTAMYL_L_AMINO_ACID_L_GAMMA_GLUTAMYL_L_AMINO_ACID",5,-1.2257,0.21,0.36,"No",-0.6552,0.89,1,"No"
"9281","GO_BP","755129_GO_2001023_REGULATION_OF_RESPONSE_TO_DRUG",5,-1.2257,0.21,0.32,"No",0.6517,0.88,1,"Yes"
"9282","GO_BP","507937_GO_0045589_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION",11,-1.2256,0.2,0.32,"No",-1.0639,0.38,0.96,"No"
"9283","C6_Oncogenic_signatures","C6_ALL_82_BRCA1_DN_V1_UP",125,-1.2255,0.11,0.15,"No",-1.2492,0.088,0.37,"No"
"9284","C2_BioCarta_Pathways","C2_CP_BIOCARTA_207_BIOCARTA_TPO_PATHWAY",24,-1.2255,0.19,0.32,"No",0.864,0.67,0.91,"Yes"
"9285","GO_BP","502368_GO_0033147_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",11,-1.2254,0.21,0.32,"No",0.7637,0.78,1,"Yes"
"9286","C3_TF_targets","C3_TFT_408_V_FXR_IR1_Q6",109,-1.2253,0.13,0.16,"No",-1.0162,0.41,0.73,"No"
"9287","GO_MF","511942_GO_0051010_MICROTUBULE_PLUS_END_BINDING",11,-1.2253,0.21,0.38,"No",0.6862,0.86,1,"Yes"
"9288","KEGG_compound","C04405__2S_3S_3_HYDROXY_2_METHYLBUTANOYL_COA_S_3_HYDROXY_2_METHYLBUTYRYL_COA",5,-1.2252,0.24,0.36,"No",1.1173,0.34,1,"Yes"
"9289","C1_Positional","C1_ALL_64_CHR10P15",43,-1.2251,0.16,0.75,"No",-0.4131,1,1,"No"
"9290","GO_BP","512834_GO_0051984_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION",13,-1.2251,0.22,0.32,"No",0.5598,0.96,1,"Yes"
"9291","C2_Chemical_and_genetic_perturbations","C2_CGP_1309_FRASOR_RESPONSE_TO_ESTRADIOL_UP",37,-1.2249,0.19,0.25,"No",-1.0607,0.33,0.97,"No"
"9292","GO_BP","752436_GO_0086070_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION",7,-1.2249,0.22,0.32,"No",0.8584,0.61,1,"Yes"
"9293","KEGG_pathway","HSA04721_SYNAPTIC_VESICLE_CYCLE",62,-1.2248,0.15,0.2,"No",1.0386,0.38,0.83,"Yes"
"9294","C2_Chemical_and_genetic_perturbations","C2_CGP_2650_ZHAN_EARLY_DIFFERENTIATION_GENES_DN",42,-1.2248,0.16,0.25,"No",-0.7707,0.86,1,"No"
"9295","C7_Immunologic_signatures","C7_ALL_677_GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_UP",198,-1.2247,0.078,0.15,"No",0.8134,0.93,1,"Yes"
"9296","GO_CC","504183_GO_0034992_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE",7,-1.2246,0.25,0.4,"No",-0.9552,0.49,0.89,"No"
"9297","C2_Chemical_and_genetic_perturbations","C2_CGP_3392_CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP",33,-1.2246,0.18,0.25,"No",-1.2714,0.13,0.71,"No"
"9298","GO_BP","486623_GO_0000083_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",26,-1.2246,0.19,0.33,"No",-0.5232,0.99,1,"No"
"9299","GO_CC","490850_GO_0005826_ACTOMYOSIN_CONTRACTILE_RING",5,-1.2246,0.25,0.4,"No",-0.9991,0.47,0.87,"No"
"9300","C7_Immunologic_signatures","C7_ALL_732_GSE17721_0_5H_VS_4H_PAM3CSK4_BMDM_DN",197,-1.2245,0.088,0.15,"No",1.0363,0.36,0.63,"Yes"
"9301","GO_BP","499330_GO_0022412_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM",231,-1.2244,0.076,0.33,"No",-1.1107,0.19,0.94,"No"
"9302","C1_Positional","C1_ALL_262_CHR4Q25",34,-1.2243,0.2,0.74,"No",0.7448,0.9,0.98,"Yes"
"9303","C7_Immunologic_signatures","C7_ALL_504_GSE17721_CTRL_VS_CPG_6H_BMDM_DN",199,-1.2243,0.086,0.15,"No",0.9221,0.67,0.97,"Yes"
"9304","GO_BP","505613_GO_0042476_ODONTOGENESIS",101,-1.2241,0.14,0.33,"No",-1.21,0.14,0.88,"No"
"9305","GO_BP","494780_GO_0010715_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY",9,-1.2241,0.21,0.33,"No",-0.7426,0.79,1,"No"
"9306","C2_Chemical_and_genetic_perturbations","C2_CGP_25_WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP",107,-1.2241,0.13,0.25,"No",1.3872,0.013,0.3,"Yes"
"9307","C3_TF_targets","C3_TFT_313_V_ATF4_Q2",255,-1.2241,0.088,0.16,"No",-1.1457,0.14,0.45,"No"
"9308","GO_BP","486626_GO_0000086_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",141,-1.224,0.12,0.33,"No",-0.7692,0.95,1,"No"
"9309","GO_BP","502304_GO_0033083_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION",8,-1.2237,0.25,0.33,"No",0.7224,0.82,1,"Yes"
"9310","C2_Chemical_and_genetic_perturbations","C2_CGP_1586_FAELT_B_CLL_WITH_VH3_21_DN",49,-1.2237,0.16,0.25,"No",0.9433,0.57,0.87,"Yes"
"9311","C3_TF_targets","C3_TFT_485_V_DR4_Q2",255,-1.2237,0.072,0.16,"No",-1.2365,0.053,0.29,"No"
"9312","C7_Immunologic_signatures","C7_ALL_712_GSE17721_0_5H_VS_8H_LPS_BMDM_DN",196,-1.2235,0.1,0.15,"No",0.6777,1,1,"Yes"
"9313","C7_Immunologic_signatures","C7_ALL_1800_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN",197,-1.2234,0.083,0.15,"No",-0.6259,1,1,"No"
"9314","C1_Positional","C1_ALL_27_CHR15Q26",73,-1.2233,0.14,0.73,"No",1.0705,0.32,0.66,"Yes"
"9315","GO_BP","491772_GO_0006921_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS",69,-1.2232,0.15,0.33,"No",-0.649,0.99,1,"No"
"9316","C3_TF_targets","C3_TFT_420_V_GATA_Q6",191,-1.2232,0.08,0.16,"No",-0.9465,0.62,0.88,"No"
"9317","GO_MF","510184_GO_0048020_CCR_CHEMOKINE_RECEPTOR_BINDING",16,-1.223,0.21,0.38,"No",1.4667,0.075,0.4,"Yes"
"9318","GO_CC","503905_GO_0034705_POTASSIUM_CHANNEL_COMPLEX",80,-1.223,0.14,0.4,"No",-1.2477,0.079,0.65,"No"
"9319","C6_Oncogenic_signatures","C6_ALL_116_CRX_DN_V1_UP",123,-1.223,0.13,0.15,"No",-1.6689,0,0.06,"No"
"9320","GO_BP","495249_GO_0014855_STRIATED_MUSCLE_CELL_PROLIFERATION",16,-1.2229,0.23,0.33,"No",-0.9183,0.57,1,"No"
"9321","C2_Chemical_and_genetic_perturbations","C2_CGP_1717_SU_THYMUS",20,-1.2229,0.18,0.25,"No",1.2976,0.14,0.4,"Yes"
"9322","GO_BP","499857_GO_0030518_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",77,-1.2228,0.15,0.33,"No",-0.6319,0.99,1,"No"
"9323","GO_BP","754613_GO_1901661_QUINONE_METABOLIC_PROCESS",30,-1.2227,0.18,0.33,"No",-0.6651,0.94,1,"No"
"9324","KEGG_compound","C03033_BETA_D_GLUCURONOSIDE_O_BETA_D_GLUCURONOSIDE_GLUCURONIDE_BETA_D_GLUCURONIDE",21,-1.2226,0.2,0.36,"No",1.8246,0,0.028,"Yes"
"9325","C7_Immunologic_signatures","C7_ALL_1518_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN",199,-1.2226,0.092,0.16,"No",1.0283,0.4,0.65,"Yes"
"9326","GO_BP","504906_GO_0035729_CELLULAR_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR_STIMULUS",7,-1.2225,0.25,0.33,"No",-0.6097,0.93,1,"No"
"9327","C2_Chemical_and_genetic_perturbations","C2_CGP_2988_NIELSEN_LEIOMYOSARCOMA_DN",18,-1.2224,0.2,0.25,"No",0.8529,0.67,0.97,"Yes"
"9328","C7_Immunologic_signatures","C7_ALL_1442_GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN",197,-1.2224,0.084,0.16,"No",0.7247,1,1,"Yes"
"9329","GO_BP","493766_GO_0009651_RESPONSE_TO_SALT_STRESS",24,-1.2224,0.19,0.33,"No",0.9593,0.53,1,"Yes"
"9330","GO_BP","495086_GO_0014013_REGULATION_OF_GLIOGENESIS",73,-1.2222,0.15,0.33,"No",0.8318,0.79,1,"Yes"
"9331","REACTOME","105696_REACT_1183_ERK2_ACTIVATION",9,-1.2222,0.21,0.36,"No",-0.5043,0.98,1,"No"
"9332","C7_Immunologic_signatures","C7_ALL_510_GSE17721_CTRL_VS_CPG_24H_BMDM_DN",195,-1.2221,0.09,0.16,"No",1.033,0.34,0.64,"Yes"
"9333","C2_Chemical_and_genetic_perturbations","C2_CGP_1426_LEE_LIVER_CANCER_E2F1_DN",61,-1.222,0.16,0.25,"No",-0.9593,0.51,1,"No"
"9334","GO_BP","491136_GO_0006164_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",123,-1.222,0.12,0.33,"No",0.984,0.49,1,"Yes"
"9335","C6_Oncogenic_signatures","C6_ALL_33_VEGF_A_UP_V1_DN",192,-1.2219,0.1,0.15,"No",1.3792,0.0091,0.26,"Yes"
"9336","GO_BP","501169_GO_0031929_TOR_SIGNALING",16,-1.2217,0.21,0.33,"No",0.6791,0.9,1,"Yes"
"9337","GO_CC","501652_GO_0032420_STEREOCILIUM",28,-1.2217,0.19,0.4,"No",-1.4098,0.08,0.67,"No"
"9338","GO_BP","849968_GO_1902267_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT",5,-1.2217,0.24,0.33,"No",-0.5765,0.93,1,"No"
"9339","GO_BP","754812_GO_1901861_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT",134,-1.2217,0.12,0.33,"No",-0.883,0.73,1,"No"
"9340","GO_MF","495662_GO_0015467_G_PROTEIN_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",6,-1.2216,0.26,0.38,"No",1.0133,0.43,0.87,"Yes"
"9341","WikiPathways","198883_WP22_IL_9_SIGNALING_PATHWAY",24,-1.2216,0.2,0.27,"No",0.9402,0.54,1,"Yes"
"9342","GO_BP","493989_GO_0009895_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS",205,-1.2216,0.088,0.33,"No",0.8106,0.93,1,"Yes"
"9343","C7_Immunologic_signatures","C7_ALL_448_GSE17721_CTRL_VS_LPS_0_5H_BMDM_DN",191,-1.2216,0.1,0.16,"No",-0.7877,0.94,1,"No"
"9344","C4_Cancer_gene_neighborhoods","C4_CGN_45_MORF_STK17A",165,-1.2215,0.1,0.3,"No",-1.0812,0.27,0.76,"No"
"9345","C2_Chemical_and_genetic_perturbations","C2_CGP_824_TSUNODA_CISPLATIN_RESISTANCE_DN",48,-1.2215,0.18,0.25,"No",0.775,0.87,1,"Yes"
"9346","GO_MF","489348_GO_0003847_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY",5,-1.2213,0.21,0.38,"No",1.2637,0.22,0.64,"Yes"
"9347","C3_MicroRNA_targets","C3_MIR_67_AAAGGAT_MIR_501",123,-1.2213,0.13,0.31,"No",-0.7793,0.94,1,"No"
"9348","GO_BP","495953_GO_0015825_L_SERINE_TRANSPORT",8,-1.2212,0.23,0.33,"No",0.9784,0.49,1,"Yes"
"9349","GO_BP","491648_GO_0006775_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS",54,-1.2211,0.17,0.33,"No",-1.3554,0.069,0.96,"No"
"9350","C1_Positional","C1_ALL_117_CHR8Q12",30,-1.221,0.18,0.73,"No",1.498,0.027,0.29,"Yes"
"9351","GO_BP","504867_GO_0035690_CELLULAR_RESPONSE_TO_DRUG",54,-1.2209,0.17,0.33,"No",-0.7529,0.9,1,"No"
"9352","GO_BP","507970_GO_0045622_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION",22,-1.2209,0.19,0.33,"No",-1.4849,0.044,0.83,"No"
"9353","GO_BP","514131_GO_0060576_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT",13,-1.2209,0.21,0.33,"No",0.8966,0.62,1,"Yes"
"9354","GO_BP","495121_GO_0014049_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION",5,-1.2208,0.21,0.33,"No",-0.7726,0.75,1,"No"
"9355","C7_Immunologic_signatures","C7_ALL_1257_GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP",174,-1.2205,0.093,0.16,"No",1.0381,0.34,0.62,"Yes"
"9356","GO_BP","505720_GO_0042594_RESPONSE_TO_STARVATION",165,-1.2205,0.11,0.33,"No",0.6615,1,1,"Yes"
"9357","GO_BP","1129328_GO_0098801_REGULATION_OF_RENAL_SYSTEM_PROCESS",35,-1.2204,0.2,0.33,"No",1.7371,0.0041,0.15,"Yes"
"9358","GO_BP","506923_GO_0043903_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM",204,-1.2204,0.093,0.33,"No",1.6546,0,0.24,"Yes"
"9359","GO_BP","492111_GO_0007346_REGULATION_OF_MITOTIC_CELL_CYCLE",413,-1.2203,0.055,0.33,"No",1.1223,0.12,0.88,"Yes"
"9360","C3_TF_targets","C3_TFT_353_V_SP3_Q3",240,-1.2202,0.07,0.17,"No",-1.4243,0.0034,0.15,"No"
"9361","C2_Chemical_and_genetic_perturbations","C2_CGP_2217_VICENT_METASTASIS_UP",14,-1.2202,0.23,0.25,"No",0.6791,0.88,1,"Yes"
"9362","REACTOME","105670_REACT_831_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE",5,-1.2202,0.25,0.36,"No",0.6701,0.87,1,"Yes"
"9363","GO_BP","513935_GO_0060379_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION",10,-1.2201,0.23,0.33,"No",-0.6532,0.91,1,"No"
"9364","C2_Chemical_and_genetic_perturbations","C2_CGP_139_DOANE_RESPONSE_TO_ANDROGEN_UP",180,-1.2201,0.1,0.25,"No",-0.9815,0.49,1,"No"
"9365","GO_BP","501996_GO_0032770_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY",25,-1.2201,0.2,0.33,"No",0.8939,0.64,1,"Yes"
"9366","GO_BP","502917_GO_0033700_PHOSPHOLIPID_EFFLUX",14,-1.2201,0.21,0.33,"No",-0.8584,0.67,1,"No"
"9367","GO_BP","516788_GO_0071867_RESPONSE_TO_MONOAMINE",26,-1.22,0.21,0.33,"No",-0.788,0.78,1,"No"
"9368","C4_Cancer_gene_neighborhoods","C4_CGN_160_MORF_PTPRB",243,-1.22,0.083,0.3,"No",-1.0195,0.4,0.82,"No"
"9369","GO_MF","490636_GO_0005540_HYALURONIC_ACID_BINDING",22,-1.2199,0.2,0.38,"No",-1.0535,0.38,0.86,"No"
"9370","C7_Immunologic_signatures","C7_ALL_644_GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_DN",196,-1.2199,0.084,0.16,"No",1.3335,0.012,0.074,"Yes"
"9371","GO_BP","513904_GO_0060348_BONE_DEVELOPMENT",162,-1.2198,0.11,0.33,"No",-1.2563,0.051,0.91,"No"
"9372","GO_BP","495935_GO_0015804_NEUTRAL_AMINO_ACID_TRANSPORT",30,-1.2198,0.21,0.33,"No",0.8893,0.63,1,"Yes"
"9373","C2_Chemical_and_genetic_perturbations","C2_CGP_2250_MITSIADES_RESPONSE_TO_APLIDIN_DN",249,-1.2198,0.085,0.25,"No",0.9446,0.63,0.87,"Yes"
"9374","GO_MF","752446_GO_0086080_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION",9,-1.2198,0.22,0.38,"No",-0.77,0.77,1,"No"
"9375","C7_Immunologic_signatures","C7_ALL_546_GSE17721_POLYIC_VS_PAM3CSK4_0_5H_BMDM_DN",197,-1.2196,0.094,0.16,"No",1.0494,0.34,0.59,"Yes"
"9376","GO_BP","497975_GO_0019098_REPRODUCTIVE_BEHAVIOR",78,-1.2195,0.16,0.33,"No",0.8262,0.81,1,"Yes"
"9377","GO_BP","491137_GO_0006165_NUCLEOSIDE_DIPHOSPHATE_PHOSPHORYLATION",18,-1.2193,0.22,0.33,"No",-0.82,0.7,1,"No"
"9378","GO_CC","494018_GO_0009925_BASAL_PLASMA_MEMBRANE",29,-1.2193,0.19,0.41,"No",-1.1862,0.23,0.68,"No"
"9379","REACTOME","105909_REACT_18325_REGULATION_OF_INSULIN_SECRETION",76,-1.2192,0.13,0.36,"No",-0.9608,0.53,1,"No"
"9380","GO_MF","489304_GO_0003785_ACTIN_MONOMER_BINDING",19,-1.2191,0.2,0.38,"No",0.7656,0.8,1,"Yes"
"9381","C4_Cancer_gene_neighborhoods","C4_CGN_70_MORF_CASP2",100,-1.2189,0.13,0.3,"No",-0.8165,0.87,1,"No"
"9382","C7_Immunologic_signatures","C7_ALL_503_GSE17721_CTRL_VS_CPG_6H_BMDM_UP",198,-1.2188,0.088,0.16,"No",0.938,0.67,0.94,"Yes"
"9383","REACTOME","106379_REACT_18290_CALCITONIN_LIKE_LIGAND_RECEPTORS",9,-1.2188,0.23,0.36,"No",-1.2058,0.24,0.82,"No"
"9384","GO_BP","948853_GO_0044839_CELL_CYCLE_G2_M_PHASE_TRANSITION",141,-1.2187,0.11,0.33,"No",-0.7746,0.95,1,"No"
"9385","GO_MF","490578_GO_0005436_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY",8,-1.2186,0.24,0.38,"No",0.7393,0.8,1,"Yes"
"9386","GO_CC","496367_GO_0016328_LATERAL_PLASMA_MEMBRANE",47,-1.2186,0.18,0.41,"No",-1.276,0.11,0.66,"No"
"9387","GO_BP","499061_GO_0021781_GLIAL_CELL_FATE_COMMITMENT",15,-1.2184,0.21,0.33,"No",1.0436,0.39,0.95,"Yes"
"9388","C2_Chemical_and_genetic_perturbations","C2_CGP_1800_GENTILE_UV_RESPONSE_CLUSTER_D2",41,-1.2184,0.18,0.25,"No",1.132,0.25,0.58,"Yes"
"9389","REACTOME","119553_REACT_19183_CD28_CO_STIMULATION",32,-1.2184,0.19,0.36,"No",0.6013,0.98,1,"Yes"
"9390","GO_BP","494604_GO_0010535_POSITIVE_REGULATION_OF_ACTIVATION_OF_JAK2_KINASE_ACTIVITY",6,-1.2182,0.22,0.33,"No",-1.0915,0.38,0.95,"No"
"9391","GO_BP","513259_GO_0052472_MODULATION_BY_HOST_OF_SYMBIONT_TRANSCRIPTION",22,-1.2182,0.22,0.33,"No",0.8575,0.68,1,"Yes"
"9392","C2_Chemical_and_genetic_perturbations","C2_CGP_2420_BLUM_RESPONSE_TO_SALIRASIB_UP",243,-1.2182,0.094,0.26,"No",1.3056,0.017,0.39,"Yes"
"9393","C4_Cancer_modules","C4_CM_241_MODULE_272",12,-1.2181,0.22,0.26,"No",-0.6735,0.88,1,"No"
"9394","GO_BP","505590_GO_0042451_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS",112,-1.2181,0.15,0.33,"No",1.0608,0.32,0.94,"Yes"
"9395","GO_MF","511945_GO_0051020_GTPASE_BINDING",239,-1.2181,0.077,0.38,"No",-1.1503,0.15,0.81,"No"
"9396","C3_TF_targets","C3_TFT_294_V_NKX22_01",183,-1.2181,0.11,0.17,"No",-1.1811,0.13,0.39,"No"
"9397","KEGG_pathway","HSA04622_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY",65,-1.2181,0.17,0.21,"No",-0.7411,0.93,1,"No"
"9398","GO_BP","518926_GO_2000279_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS",17,-1.2179,0.22,0.33,"No",0.791,0.78,1,"Yes"
"9399","C2_Chemical_and_genetic_perturbations","C2_CGP_2029_MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP",10,-1.2179,0.23,0.26,"No",0.5427,0.98,1,"Yes"
"9400","C2_Chemical_and_genetic_perturbations","C2_CGP_1837_WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH",60,-1.2178,0.17,0.26,"No",0.7982,0.85,0.99,"Yes"
"9401","C3_MicroRNA_targets","C3_MIR_11_CACTGCC_MIR_34A_MIR_34C_MIR_449",274,-1.2178,0.087,0.31,"No",-1.0247,0.38,1,"No"
"9402","GO_BP","514325_GO_0060770_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT",7,-1.2176,0.23,0.33,"No",0.6574,0.89,1,"Yes"
"9403","C2_Chemical_and_genetic_perturbations","C2_CGP_3212_RAFFEL_VEGFA_TARGETS_UP",9,-1.2176,0.22,0.26,"No",1.122,0.3,0.6,"Yes"
"9404","KEGG_compound","C00957_MERCAPTOPYRUVATE_3_MERCAPTOPYRUVIC_ACID_3_MERCAPTOPYRUVATE",9,-1.2175,0.23,0.37,"No",-0.8153,0.71,1,"No"
"9405","C6_Oncogenic_signatures","C6_ALL_158_KRAS_AMP_LUNG_UP_V1_DN",132,-1.2174,0.13,0.16,"No",-0.7948,0.92,0.99,"No"
"9406","GO_MF","496401_GO_0016413_O_ACETYLTRANSFERASE_ACTIVITY",6,-1.2173,0.25,0.39,"No",0.614,0.92,1,"Yes"
"9407","KEGG_compound","C00078_L_TRYPTOPHAN_TRYPTOPHAN_S_ALPHA_AMINO_BETA_3_INDOLYL_PROPIONIC_ACID",9,-1.2173,0.22,0.37,"No",-1.4803,0.072,0.33,"No"
"9408","C3_TF_targets","C3_TFT_103_V_PAX5_02",17,-1.2173,0.19,0.17,"No",0.773,0.8,1,"Yes"
"9409","GO_BP","517294_GO_0072378_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION",22,-1.2172,0.22,0.33,"No",0.9851,0.46,1,"Yes"
"9410","C3_TF_targets","C3_TFT_544_YGCANTGCR_UNKNOWN",123,-1.2171,0.13,0.17,"No",0.8054,0.9,1,"Yes"
"9411","GO_BP","517444_GO_0072539_T_HELPER_17_CELL_DIFFERENTIATION",5,-1.2169,0.25,0.33,"No",-0.7624,0.75,1,"No"
"9412","REACTOME","106114_REACT_1190_TRIGLYCERIDE_BIOSYNTHESIS",45,-1.2168,0.19,0.37,"No",0.7729,0.86,1,"Yes"
"9413","GO_CC","502215_GO_0032993_PROTEIN_DNA_COMPLEX",153,-1.2167,0.11,0.41,"No",-1.3043,0.051,0.65,"No"
"9414","GO_MF","490260_GO_0004970_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY",19,-1.2167,0.2,0.39,"No",0.9236,0.57,0.95,"Yes"
"9415","GO_CC","499965_GO_0030660_GOLGI_ASSOCIATED_VESICLE_MEMBRANE",45,-1.2167,0.17,0.41,"No",0.9507,0.54,0.83,"Yes"
"9416","GO_MF","490546_GO_0005355_GLUCOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,-1.2165,0.2,0.39,"No",-1.095,0.35,0.84,"No"
"9417","C7_Immunologic_signatures","C7_ALL_208_GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN",161,-1.2165,0.1,0.16,"No",-1.1011,0.23,1,"No"
"9418","C7_Immunologic_signatures","C7_ALL_417_GSE15930_STIM_VS_STIM_AND_IL_12_48H_CD8_T_CELL_UP",197,-1.2165,0.11,0.16,"No",1.2419,0.051,0.16,"Yes"
"9419","GO_BP","492883_GO_0008635_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C",8,-1.2165,0.24,0.33,"No",0.7962,0.74,1,"Yes"
"9420","C7_Immunologic_signatures","C7_ALL_751_GSE17721_12H_VS_24H_CPG_BMDM_UP",194,-1.2164,0.11,0.16,"No",1.1325,0.16,0.36,"Yes"
"9421","C2_Chemical_and_genetic_perturbations","C2_CGP_471_BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP",16,-1.2164,0.22,0.26,"No",1.5782,0.04,0.16,"Yes"
"9422","KEGG_reaction","R02746_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ACYLHYDROLASE_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_SN_GLYCERO_3_PHOSPHOCHOLINE_FATTY_ACID",5,-1.2163,0.24,0.35,"No",-1.0104,0.46,0.81,"No"
"9423","GO_BP","500174_GO_0030879_MAMMARY_GLAND_DEVELOPMENT",122,-1.2163,0.15,0.33,"No",0.9369,0.63,1,"Yes"
"9424","REACTOME","730341_REACT_150417_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET_",8,-1.2162,0.25,0.37,"No",-1.239,0.24,0.78,"No"
"9425","GO_BP","491587_GO_0006700_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",15,-1.2162,0.22,0.33,"No",-1.0399,0.4,0.98,"No"
"9426","GO_BP","492012_GO_0007214_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY",23,-1.2162,0.21,0.33,"No",-1.3863,0.091,1,"No"
"9427","GO_BP","498967_GO_0021684_CEREBELLAR_GRANULAR_LAYER_FORMATION",10,-1.2161,0.24,0.33,"No",1.2185,0.23,0.76,"Yes"
"9428","GO_BP","516934_GO_0072015_GLOMERULAR_VISCERAL_EPITHELIAL_CELL_DEVELOPMENT",8,-1.2161,0.24,0.33,"No",-0.8447,0.67,1,"No"
"9429","C3_TF_targets","C3_TFT_376_V_CACCCBINDINGFACTOR_Q6",263,-1.2161,0.083,0.17,"No",-1.3385,0.016,0.19,"No"
"9430","C3_TF_targets","C3_TFT_373_V_ZF5_01",231,-1.216,0.081,0.17,"No",-0.8126,0.96,1,"No"
"9431","C2_Chemical_and_genetic_perturbations","C2_CGP_477_TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP",7,-1.2159,0.24,0.26,"No",1.1368,0.31,0.57,"Yes"
"9432","GO_BP","507509_GO_0045117_AZOLE_TRANSPORT",18,-1.2159,0.22,0.33,"No",0.7663,0.8,1,"Yes"
"9433","KEGG_compound","C05271_TRANS_HEX_2_ENOYL_COA_2E_HEXENOYL_COA",10,-1.2158,0.22,0.37,"No",0.5491,0.97,1,"Yes"
"9434","C1_Positional","C1_ALL_212_CHR15Q",8,-1.2157,0.23,0.73,"No",1.2459,0.21,0.59,"Yes"
"9435","GO_BP","513603_GO_0060045_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION",19,-1.2157,0.21,0.33,"No",-0.6791,0.9,1,"No"
"9436","C2_Chemical_and_genetic_perturbations","C2_CGP_909_HATADA_METHYLATED_IN_LUNG_CANCER_UP",384,-1.2157,0.057,0.26,"No",-1.125,0.13,0.89,"No"
"9437","GO_BP","505747_GO_0042633_HAIR_CYCLE",82,-1.2156,0.14,0.33,"No",0.8694,0.75,1,"Yes"
"9438","GO_BP","500823_GO_0031572_G2_DNA_DAMAGE_CHECKPOINT",35,-1.2156,0.18,0.33,"No",-0.615,0.99,1,"No"
"9439","C6_Oncogenic_signatures","C6_ALL_13_RAPA_EARLY_UP_V1_DN",177,-1.2156,0.13,0.16,"No",-1.0928,0.26,0.57,"No"
"9440","GO_BP","489050_GO_0003256_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_MYOCARDIAL_PRECURSOR_CELL_DIFFERENTIATION",7,-1.2156,0.24,0.33,"No",-0.9348,0.55,1,"No"
"9441","WikiPathways","198763_WP554_ACE_INHIBITOR_PATHWAY",17,-1.2156,0.22,0.28,"No",1.4711,0.069,0.36,"Yes"
"9442","GO_BP","506538_GO_0043507_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY",60,-1.2155,0.17,0.33,"No",-0.9509,0.54,1,"No"
"9443","GO_BP","508732_GO_0046471_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS",33,-1.2154,0.19,0.33,"No",-0.8203,0.73,1,"No"
"9444","GO_BP","491088_GO_0006109_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS",157,-1.2154,0.11,0.33,"No",0.9695,0.54,1,"Yes"
"9445","GO_MF","511281_GO_0050291_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY",6,-1.2154,0.24,0.39,"No",-1.3378,0.15,0.7,"No"
"9446","GO_MF","511834_GO_0050897_COBALT_ION_BINDING",5,-1.2154,0.25,0.39,"No",-0.6988,0.85,1,"No"
"9447","GO_MF","500794_GO_0031543_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY",13,-1.2152,0.23,0.39,"No",-1.0538,0.39,0.87,"No"
"9448","KEGG_pathway","HSA00120_PRIMARY_BILE_ACID_BIOSYNTHESIS",16,-1.2152,0.21,0.21,"No",1.0615,0.37,0.85,"Yes"
"9449","C4_Cancer_gene_neighborhoods","C4_CGN_23_MORF_MDM2",271,-1.2152,0.075,0.31,"No",-1.2214,0.066,0.69,"No"
"9450","GO_BP","497171_GO_0018200_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION",29,-1.2151,0.19,0.34,"No",-0.8664,0.66,1,"No"
"9451","GO_BP","493453_GO_0009260_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",152,-1.2151,0.13,0.34,"No",0.9064,0.73,1,"Yes"
"9452","GO_BP","515430_GO_0070498_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY",12,-1.2151,0.23,0.34,"No",-0.9358,0.52,1,"No"
"9453","GO_BP","504641_GO_0035457_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA",8,-1.215,0.22,0.34,"No",1.2122,0.26,0.77,"Yes"
"9454","C2_Chemical_and_genetic_perturbations","C2_CGP_799_MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN",20,-1.215,0.21,0.26,"No",1.5127,0.035,0.2,"Yes"
"9455","GO_BP","753003_GO_1900003_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY",6,-1.2149,0.22,0.34,"No",1.2199,0.23,0.77,"Yes"
"9456","C2_Chemical_and_genetic_perturbations","C2_CGP_2812_FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN",76,-1.2148,0.14,0.26,"No",-1.0579,0.35,0.98,"No"
"9457","GO_BP","1184356_GO_0061687_DETOXIFICATION_OF_INORGANIC_COMPOUND",7,-1.2148,0.23,0.34,"No",1.1941,0.25,0.79,"Yes"
"9458","GO_CC","487451_GO_0001527_MICROFIBRIL",9,-1.2146,0.23,0.41,"No",0.6082,0.93,0.99,"Yes"
"9459","GO_BP","513715_GO_0060157_URINARY_BLADDER_DEVELOPMENT",5,-1.2146,0.25,0.34,"No",0.8933,0.58,1,"Yes"
"9460","GO_MF","490616_GO_0005507_COPPER_ION_BINDING",53,-1.2145,0.18,0.39,"No",-0.6539,0.98,1,"No"
"9461","GO_BP","513940_GO_0060384_INNERVATION",21,-1.2145,0.18,0.34,"No",-1.1812,0.24,0.91,"No"
"9462","GO_BP","499686_GO_0030282_BONE_MINERALIZATION",37,-1.2143,0.21,0.34,"No",-1.2915,0.12,0.88,"No"
"9463","C1_Positional","C1_ALL_38_CHR3P22",59,-1.2143,0.15,0.73,"No",-0.862,0.71,0.97,"No"
"9464","GO_BP","500348_GO_0031058_POSITIVE_REGULATION_OF_HISTONE_MODIFICATION",61,-1.2142,0.18,0.34,"No",-1.2337,0.13,0.9,"No"
"9465","GO_BP","503552_GO_0034350_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS",7,-1.2141,0.25,0.34,"No",0.9236,0.54,1,"Yes"
"9466","GO_BP","504292_GO_0035107_APPENDAGE_MORPHOGENESIS",147,-1.2141,0.13,0.34,"No",-0.9224,0.66,1,"No"
"9467","C2_Chemical_and_genetic_perturbations","C2_CGP_3315_RATTENBACHER_BOUND_BY_CELF1",438,-1.2141,0.048,0.26,"No",-0.8102,0.99,1,"No"
"9468","C2_Chemical_and_genetic_perturbations","C2_CGP_758_XU_AKT1_TARGETS_6HR",27,-1.214,0.21,0.26,"No",1.3445,0.075,0.35,"Yes"
"9469","C3_TF_targets","C3_TFT_210_V_WHN_B",249,-1.214,0.096,0.17,"No",-0.8408,0.92,1,"No"
"9470","C4_Cancer_modules","C4_CM_356_MODULE_430",55,-1.214,0.17,0.27,"No",-0.7964,0.84,0.98,"No"
"9471","REACTOME","477115_REACT_111064_DAG_AND_IP3_SIGNALING",34,-1.2138,0.19,0.37,"No",-0.9736,0.51,1,"No"
"9472","GO_BP","506409_GO_0043370_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",26,-1.2138,0.19,0.34,"No",-1.4474,0.062,0.9,"No"
"9473","C2_Chemical_and_genetic_perturbations","C2_CGP_1905_TSENG_IRS1_TARGETS_UP",111,-1.2137,0.14,0.26,"No",1.5152,0.0021,0.2,"Yes"
"9474","GO_BP","492379_GO_0007638_MECHANOSENSORY_BEHAVIOR",11,-1.2137,0.23,0.34,"No",-0.7885,0.78,1,"No"
"9475","C2_Chemical_and_genetic_perturbations","C2_CGP_2145_CLAUS_PGR_POSITIVE_MENINGIOMA_DN",12,-1.2136,0.21,0.26,"No",0.681,0.88,1,"Yes"
"9476","GO_BP","492343_GO_0007602_PHOTOTRANSDUCTION",111,-1.2136,0.13,0.34,"No",-1.1039,0.24,0.94,"No"
"9477","C7_Immunologic_signatures","C7_ALL_457_GSE17721_CTRL_VS_LPS_8H_BMDM_UP",199,-1.2135,0.097,0.17,"No",1.1224,0.17,0.38,"Yes"
"9478","REACTOME","105672_REACT_607_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE",5,-1.2134,0.27,0.37,"No",0.6809,0.85,1,"Yes"
"9479","GO_BP","753987_GO_1901017_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",10,-1.2134,0.22,0.34,"No",-0.8965,0.6,1,"No"
"9480","GO_MF","516178_GO_0071253_CONNEXIN_BINDING",5,-1.2134,0.25,0.39,"No",1.1706,0.3,0.73,"Yes"
"9481","GO_BP","1022098_GO_0098661_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT",120,-1.2134,0.13,0.34,"No",-0.9175,0.67,1,"No"
"9482","GO_MF","492716_GO_0008420_CTD_PHOSPHATASE_ACTIVITY",6,-1.2134,0.24,0.39,"No",0.5879,0.94,1,"Yes"
"9483","C2_Chemical_and_genetic_perturbations","C2_CGP_3061_CHICAS_RB1_TARGETS_GROWING",238,-1.2133,0.1,0.26,"No",0.9123,0.73,0.91,"Yes"
"9484","GO_CC","487594_GO_0005868_CYTOPLASMIC_DYNEIN_COMPLEX",26,-1.2132,0.21,0.41,"No",-0.9957,0.46,0.85,"No"
"9485","C4_Cancer_gene_neighborhoods","C4_CGN_51_MORF_TFDP2",223,-1.2132,0.1,0.31,"No",-1.2113,0.1,0.69,"No"
"9486","GO_MF","489513_GO_0004046_AMINOACYLASE_ACTIVITY",5,-1.2132,0.24,0.39,"No",1.4848,0.053,0.39,"Yes"
"9487","C1_Positional","C1_ALL_67_CHR11Q12",143,-1.2131,0.12,0.72,"No",-0.8892,0.74,1,"No"
"9488","GO_MF","490564_GO_0005384_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.213,0.24,0.39,"No",-0.6902,0.85,1,"No"
"9489","C3_TF_targets","C3_TFT_54_V_EVI1_05",168,-1.2128,0.13,0.18,"No",1.2683,0.053,0.51,"Yes"
"9490","C2_Chemical_and_genetic_perturbations","C2_CGP_3071_HOELZEL_NF1_TARGETS_DN",109,-1.2127,0.14,0.26,"No",0.9764,0.52,0.82,"Yes"
"9491","GO_MF","490418_GO_0030297_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY",5,-1.2127,0.22,0.39,"No",1.1142,0.37,0.77,"Yes"
"9492","REACTOME","833830_REACT_163910_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION",12,-1.2126,0.23,0.37,"No",-1.0094,0.43,0.99,"No"
"9493","GO_BP","516240_GO_0071316_CELLULAR_RESPONSE_TO_NICOTINE",8,-1.2126,0.22,0.34,"No",-1.093,0.35,0.95,"No"
"9494","REACTOME","187218_REACT_23810_CALNEXIN_CALRETICULIN_CYCLE",11,-1.2126,0.23,0.37,"No",0.7283,0.84,1,"Yes"
"9495","C4_Cancer_modules","C4_CM_233_MODULE_257",156,-1.2125,0.12,0.27,"No",-1.095,0.26,0.7,"No"
"9496","GO_BP","752387_GO_0086015_SA_NODE_CELL_ACTION_POTENTIAL",7,-1.2124,0.24,0.34,"No",0.8577,0.62,1,"Yes"
"9497","GO_BP","488872_GO_0035809_REGULATION_OF_URINE_VOLUME",19,-1.2124,0.19,0.34,"No",1.3112,0.14,0.66,"Yes"
"9498","GO_BP","487979_GO_0002090_REGULATION_OF_RECEPTOR_INTERNALIZATION",29,-1.2123,0.19,0.34,"No",-0.7418,0.87,1,"No"
"9499","C7_Immunologic_signatures","C7_ALL_1019_GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP",193,-1.2123,0.12,0.17,"No",1.1221,0.19,0.38,"Yes"
"9500","C3_TF_targets","C3_TFT_328_V_CEBPGAMMA_Q6",250,-1.2122,0.085,0.18,"No",1.193,0.065,0.71,"Yes"
"9501","GO_BP","488208_GO_0002335_MATURE_B_CELL_DIFFERENTIATION",13,-1.2122,0.21,0.34,"No",-0.5064,0.99,1,"No"
"9502","GO_BP","508771_GO_0046512_SPHINGOSINE_BIOSYNTHETIC_PROCESS",6,-1.2121,0.22,0.34,"No",0.719,0.83,1,"Yes"
"9503","GO_BP","507825_GO_0045475_LOCOMOTOR_RHYTHM",7,-1.2121,0.25,0.34,"No",-0.6751,0.89,1,"No"
"9504","C7_Immunologic_signatures","C7_ALL_1015_GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP",192,-1.212,0.11,0.17,"No",-0.9267,0.66,1,"No"
"9505","C7_Immunologic_signatures","C7_ALL_439_GSE17580_TREG_VS_TEFF_UP",200,-1.2119,0.11,0.17,"No",0.9388,0.63,0.93,"Yes"
"9506","C4_Cancer_modules","C4_CM_369_MODULE_453",43,-1.2119,0.18,0.27,"No",0.8797,0.67,0.89,"Yes"
"9507","GO_MF","496282_GO_0016208_AMP_BINDING",9,-1.2118,0.24,0.39,"No",0.7058,0.85,1,"Yes"
"9508","C2_Chemical_and_genetic_perturbations","C2_CGP_3346_HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN",14,-1.2117,0.23,0.26,"No",-0.6433,0.94,1,"No"
"9509","GO_MF","513784_GO_0060228_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY",6,-1.2116,0.24,0.39,"No",-1.0309,0.44,0.88,"No"
"9510","C2_Chemical_and_genetic_perturbations","C2_CGP_274_SENESE_HDAC1_TARGETS_DN",255,-1.2115,0.085,0.26,"No",-1.1578,0.12,0.84,"No"
"9511","GO_BP","755363_GO_2001257_REGULATION_OF_CATION_CHANNEL_ACTIVITY",73,-1.2115,0.17,0.34,"No",-1.2485,0.11,0.91,"No"
"9512","C7_Immunologic_signatures","C7_ALL_112_GSE12366_GC_VS_MEMORY_BCELL_DN",194,-1.2115,0.1,0.17,"No",0.9569,0.6,0.88,"Yes"
"9513","GO_BP","510607_GO_0048538_THYMUS_DEVELOPMENT",38,-1.2114,0.17,0.34,"No",-0.735,0.89,1,"No"
"9514","KEGG_pathway","HSA00900_TERPENOID_BACKBONE_BIOSYNTHESIS",22,-1.2112,0.22,0.22,"No",0.592,0.97,1,"Yes"
"9515","C6_Oncogenic_signatures","C6_ALL_43_WNT_UP_V1_DN",155,-1.2111,0.12,0.16,"No",1.1892,0.09,0.43,"Yes"
"9516","REACTOME","730316_REACT_150260_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES",11,-1.2111,0.23,0.37,"No",1.0527,0.38,0.66,"Yes"
"9517","C2_Chemical_and_genetic_perturbations","C2_CGP_2434_YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN",257,-1.211,0.087,0.26,"No",-1.2513,0.045,0.74,"No"
"9518","GO_MF","496680_GO_0016769_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS",22,-1.2109,0.21,0.39,"No",-1.0671,0.4,0.87,"No"
"9519","C3_TF_targets","C3_TFT_482_V_AR_Q6",246,-1.2109,0.085,0.18,"No",-1.0617,0.29,0.64,"No"
"9520","REACTOME","576267_REACT_118722_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM",6,-1.2109,0.23,0.37,"No",-1.2589,0.19,0.72,"No"
"9521","C2_Chemical_and_genetic_perturbations","C2_CGP_288_TIEN_INTESTINE_PROBIOTICS_6HR_DN",167,-1.2109,0.11,0.26,"No",1.3473,0.016,0.35,"Yes"
"9522","C3_TF_targets","C3_TFT_35_V_YY1_01",240,-1.2107,0.096,0.18,"No",-0.8286,0.93,1,"No"
"9523","C2_Chemical_and_genetic_perturbations","C2_CGP_1559_RADMACHER_AML_PROGNOSIS",78,-1.2107,0.16,0.26,"No",1.0026,0.44,0.79,"Yes"
"9524","GO_BP","487977_GO_0002088_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE",65,-1.2106,0.16,0.34,"No",1.1404,0.23,0.85,"Yes"
"9525","C2_Chemical_and_genetic_perturbations","C2_CGP_3220_PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP",332,-1.2106,0.082,0.26,"No",-0.7839,0.98,1,"No"
"9526","C7_Immunologic_signatures","C7_ALL_69_GSE11057_CD4_CENT_MEM_VS_PBMC_UP",198,-1.2106,0.11,0.17,"No",-0.9144,0.7,1,"No"
"9527","C3_MicroRNA_targets","C3_MIR_93_ATAGGAA_MIR_202",102,-1.2106,0.15,0.33,"No",-0.6608,1,1,"No"
"9528","C2_Chemical_and_genetic_perturbations","C2_CGP_2232_TING_SILENCED_BY_DICER",30,-1.2106,0.19,0.26,"No",1.0117,0.44,0.78,"Yes"
"9529","GO_BP","503405_GO_0034199_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY",17,-1.2105,0.22,0.34,"No",0.8485,0.67,1,"Yes"
"9530","C7_Immunologic_signatures","C7_ALL_1409_GSE360_CTRL_VS_L_MAJOR_DC_UP",196,-1.2103,0.093,0.17,"No",0.9428,0.64,0.92,"Yes"
"9531","C2_Chemical_and_genetic_perturbations","C2_CGP_2860_GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN",55,-1.2103,0.17,0.26,"No",-0.7722,0.88,1,"No"
"9532","C1_Positional","C1_ALL_18_CHR20P12",35,-1.2102,0.2,0.72,"No",0.904,0.62,0.85,"Yes"
"9533","OMIM_gene","OMIM176884_PROTEIN_TYROSINE_PHOSPHATASE_RECEPTOR_TYPE_ALPHA_PTPRA",5,-1.2102,0.26,0.86,"No",1.1516,0.31,1,"Yes"
"9534","GO_BP","514126_GO_0060571_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD",18,-1.2102,0.23,0.34,"No",-0.8277,0.72,1,"No"
"9535","GO_CC","490706_GO_0005640_NUCLEAR_OUTER_MEMBRANE",23,-1.2102,0.2,0.42,"No",0.8967,0.6,0.9,"Yes"
"9536","GO_BP","498091_GO_0019240_CITRULLINE_BIOSYNTHETIC_PROCESS",8,-1.2102,0.24,0.34,"No",0.8722,0.6,1,"Yes"
"9537","C7_Immunologic_signatures","C7_ALL_405_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP",198,-1.2102,0.12,0.17,"No",-0.7621,0.98,1,"No"
"9538","C2_Chemical_and_genetic_perturbations","C2_CGP_363_HAHTOLA_MYCOSIS_FUNGOIDES_DN",15,-1.21,0.22,0.26,"No",1.2409,0.19,0.45,"Yes"
"9539","REACTOME","106150_REACT_11057_METABOLISM_OF_STEROID_HORMONES_AND_VITAMIN_D",32,-1.21,0.2,0.37,"No",-0.9106,0.6,1,"No"
"9540","GO_BP","1039894_GO_0061640_CYTOSKELETON_DEPENDENT_CYTOKINESIS",39,-1.2099,0.2,0.34,"No",1.0539,0.34,0.94,"Yes"
"9541","GO_BP","517443_GO_0072538_T_HELPER_17_TYPE_IMMUNE_RESPONSE",5,-1.2098,0.26,0.34,"No",-0.7874,0.74,1,"No"
"9542","C2_Chemical_and_genetic_perturbations","C2_CGP_3221_PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN",425,-1.2097,0.061,0.26,"No",1.0819,0.19,0.66,"Yes"
"9543","GO_BP","504602_GO_0035418_PROTEIN_LOCALIZATION_TO_SYNAPSE",15,-1.2096,0.22,0.34,"No",-1.2319,0.22,0.9,"No"
"9544","GO_MF","508785_GO_0046527_GLUCOSYLTRANSFERASE_ACTIVITY",12,-1.2096,0.24,0.39,"No",0.794,0.74,1,"Yes"
"9545","C1_Positional","C1_ALL_270_CHR5Q32",31,-1.2095,0.2,0.71,"No",1.1341,0.26,0.64,"Yes"
"9546","GO_BP","493917_GO_0009813_FLAVONOID_BIOSYNTHETIC_PROCESS",21,-1.2095,0.22,0.34,"No",1.7536,0.011,0.14,"Yes"
"9547","GO_BP","516575_GO_0071651_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION",5,-1.2094,0.27,0.34,"No",-1.1179,0.35,0.94,"No"
"9548","C7_Immunologic_signatures","C7_ALL_90_GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN",193,-1.2094,0.11,0.17,"No",0.7501,1,1,"Yes"
"9549","GO_MF","515337_GO_0070405_AMMONIUM_ION_BINDING",58,-1.2093,0.17,0.39,"No",-1.2252,0.15,0.85,"No"
"9550","GO_BP","512180_GO_0051295_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION",5,-1.2093,0.26,0.34,"No",1.0424,0.44,0.96,"Yes"
"9551","C2_BioCarta_Pathways","C2_CP_BIOCARTA_184_BIOCARTA_SHH_PATHWAY",15,-1.2089,0.22,0.34,"No",1.2246,0.2,0.67,"Yes"
"9552","C7_Immunologic_signatures","C7_ALL_130_GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN",195,-1.2089,0.097,0.17,"No",0.9259,0.66,0.96,"Yes"
"9553","GO_MF","487380_GO_0001158_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING",73,-1.2088,0.17,0.39,"No",-1.2738,0.1,0.81,"No"
"9554","C7_Immunologic_signatures","C7_ALL_730_GSE17721_0_5H_VS_12H_PAM3CSK4_BMDM_DN",197,-1.2087,0.11,0.17,"No",1.6462,0,0.0013,"Yes"
"9555","GO_BP","498838_GO_0021554_OPTIC_NERVE_DEVELOPMENT",11,-1.2085,0.24,0.34,"No",-0.7093,0.83,1,"No"
"9556","GO_BP","495931_GO_0015800_ACIDIC_AMINO_ACID_TRANSPORT",20,-1.2085,0.21,0.34,"No",0.7489,0.83,1,"Yes"
"9557","GO_BP","861226_GO_0097501_STRESS_RESPONSE_TO_METAL_ION",5,-1.2084,0.25,0.34,"No",-0.7226,0.8,1,"No"
"9558","C1_Positional","C1_ALL_88_CHR17Q23",78,-1.2084,0.16,0.7,"No",-0.8308,0.8,0.97,"No"
"9559","GO_BP","514928_GO_0061383_TRABECULA_MORPHOGENESIS",38,-1.2084,0.19,0.34,"No",-1.0113,0.41,0.98,"No"
"9560","C2_Chemical_and_genetic_perturbations","C2_CGP_2958_TRACEY_RESISTANCE_TO_IFNA2_UP",6,-1.2083,0.24,0.27,"No",1.5388,0.033,0.18,"Yes"
"9561","GO_MF","489479_GO_0042626_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_SUBSTANCES",97,-1.2082,0.18,0.39,"No",0.8441,0.8,1,"Yes"
"9562","GO_BP","515038_GO_0070100_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY",5,-1.2082,0.25,0.34,"No",-0.7124,0.81,1,"No"
"9563","C7_Immunologic_signatures","C7_ALL_1527_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP",195,-1.2079,0.12,0.18,"No",0.899,0.75,1,"Yes"
"9564","C2_Chemical_and_genetic_perturbations","C2_CGP_2254_SAGIV_CD24_TARGETS_UP",21,-1.2079,0.22,0.27,"No",-1.1103,0.3,0.9,"No"
"9565","C7_Immunologic_signatures","C7_ALL_465_GSE17721_CTRL_VS_POLYIC_1H_BMDM_UP",198,-1.2078,0.1,0.18,"No",1.1276,0.17,0.37,"Yes"
"9566","GO_MF","503683_GO_0034481_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY",5,-1.2078,0.24,0.39,"No",0.6853,0.86,1,"Yes"
"9567","C7_Immunologic_signatures","C7_ALL_725_GSE17721_4H_VS_24H_POLYIC_BMDM_UP",198,-1.2078,0.1,0.18,"No",1.5956,0,0.0032,"Yes"
"9568","KEGG_compound","C00334_4_AMINOBUTANOATE_4_AMINOBUTANOIC_ACID_4_AMINOBUTYRATE_4_AMINOBUTYRIC_ACID_GAMMA_AMINOBUTYRIC_ACID_GABA",11,-1.2077,0.23,0.38,"No",0.6739,0.87,1,"Yes"
"9569","C7_Immunologic_signatures","C7_ALL_950_GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN",194,-1.2077,0.11,0.18,"No",1.1788,0.086,0.26,"Yes"
"9570","C7_Immunologic_signatures","C7_ALL_668_GSE17721_LPS_VS_CPG_16H_BMDM_DN",198,-1.2076,0.12,0.18,"No",1.296,0.024,0.11,"Yes"
"9571","C2_BioCarta_Pathways","C2_CP_BIOCARTA_167_BIOCARTA_ERK5_PATHWAY",18,-1.2075,0.2,0.34,"No",-0.8431,0.7,1,"No"
"9572","GO_BP","495924_GO_0015793_GLYCEROL_TRANSPORT",11,-1.2073,0.24,0.34,"No",-0.6564,0.89,1,"No"
"9573","GO_BP","492729_GO_0050819_NEGATIVE_REGULATION_OF_COAGULATION",46,-1.2073,0.18,0.34,"No",1.3451,0.074,0.61,"Yes"
"9574","C7_Immunologic_signatures","C7_ALL_1834_GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN",187,-1.2073,0.12,0.18,"No",-1.5593,0,0.029,"No"
"9575","GO_BP","518827_GO_2000179_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION",40,-1.2073,0.19,0.34,"No",0.879,0.67,1,"Yes"
"9576","GO_BP","512729_GO_0051873_KILLING_BY_HOST_OF_SYMBIONT_CELLS",6,-1.2071,0.24,0.34,"No",1.5577,0.041,0.34,"Yes"
"9577","GO_BP","508154_GO_0045833_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS",71,-1.2071,0.17,0.34,"No",-0.8481,0.76,1,"No"
"9578","GO_BP","491713_GO_0015813_L_GLUTAMATE_TRANSPORT",19,-1.207,0.22,0.34,"No",0.7493,0.82,1,"Yes"
"9579","C2_Chemical_and_genetic_perturbations","C2_CGP_721_FARMER_BREAST_CANCER_CLUSTER_4",16,-1.207,0.23,0.27,"No",0.9865,0.47,0.81,"Yes"
"9580","KEGG_reaction","R04751_HEXANOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_HEXANOYL_COA_FAD_TRANS_HEX_2_ENOYL_COA_FADH2",6,-1.207,0.23,0.36,"No",-0.5618,0.95,1,"No"
"9581","GO_BP","492174_GO_0007413_AXONAL_FASCICULATION",19,-1.2069,0.23,0.34,"No",-1.4048,0.081,0.98,"No"
"9582","C7_Immunologic_signatures","C7_ALL_1400_GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN",199,-1.2069,0.095,0.18,"No",1.1677,0.099,0.28,"Yes"
"9583","REACTOME","187171_REACT_24019_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1_",19,-1.2069,0.22,0.38,"No",1.2082,0.19,0.44,"Yes"
"9584","C2_Chemical_and_genetic_perturbations","C2_CGP_1125_BENPORATH_ES_CORE_NINE",9,-1.2069,0.24,0.27,"No",-1.1047,0.35,0.91,"No"
"9585","GO_BP","512804_GO_0051954_POSITIVE_REGULATION_OF_AMINE_TRANSPORT",27,-1.2067,0.22,0.34,"No",-0.8148,0.75,1,"No"
"9586","GO_BP","508425_GO_0046129_PURINE_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS",112,-1.2067,0.14,0.34,"No",1.09,0.26,0.92,"Yes"
"9587","REACTOME","477119_REACT_111080_SPRY_REGULATION_OF_FGF_SIGNALING",16,-1.2065,0.23,0.38,"No",1.0619,0.36,0.64,"Yes"
"9588","GO_BP","751702_GO_0044557_RELAXATION_OF_SMOOTH_MUSCLE",8,-1.2065,0.24,0.34,"No",1.1947,0.25,0.79,"Yes"
"9589","GO_BP","491789_GO_0006940_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION",49,-1.2065,0.18,0.34,"No",-1.0194,0.43,0.97,"No"
"9590","GO_MF","752449_GO_0086083_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION",6,-1.2064,0.27,0.39,"No",-0.5903,0.92,1,"No"
"9591","C6_Oncogenic_signatures","C6_ALL_160_KRAS_DF_V1_DN",182,-1.2064,0.12,0.17,"No",-1.0198,0.4,0.63,"No"
"9592","GO_BP","513638_GO_0060080_REGULATION_OF_INHIBITORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",12,-1.2062,0.26,0.35,"No",-1.257,0.19,0.91,"No"
"9593","C7_Immunologic_signatures","C7_ALL_1636_GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN",194,-1.2062,0.12,0.18,"No",1.1077,0.2,0.42,"Yes"
"9594","C2_Chemical_and_genetic_perturbations","C2_CGP_1998_DOUGLAS_BMI1_TARGETS_DN",312,-1.2062,0.075,0.27,"No",1.4185,0,0.28,"Yes"
"9595","GO_MF","490011_GO_0004691_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY",7,-1.2061,0.24,0.39,"No",1.0984,0.36,0.79,"Yes"
"9596","GO_BP","511970_GO_0051045_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",6,-1.2059,0.26,0.35,"No",0.6658,0.85,1,"Yes"
"9597","C2_Chemical_and_genetic_perturbations","C2_CGP_3351_HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP",27,-1.2059,0.21,0.27,"No",0.5133,0.99,1,"Yes"
"9598","C2_Chemical_and_genetic_perturbations","C2_CGP_1826_GENTILE_UV_HIGH_DOSE_DN",312,-1.2058,0.076,0.27,"No",1.2351,0.031,0.45,"Yes"
"9599","GO_BP","507260_GO_0044253_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",34,-1.2058,0.2,0.35,"No",-1.1375,0.26,0.93,"No"
"9600","C7_Immunologic_signatures","C7_ALL_699_GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_UP",197,-1.2058,0.1,0.18,"No",1.3596,0.012,0.057,"Yes"
"9601","GO_BP","505177_GO_0040019_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT",25,-1.2058,0.21,0.35,"No",-1.2712,0.15,0.89,"No"
"9602","C3_TF_targets","C3_TFT_509_RTTTNNNYTGGM_UNKNOWN",150,-1.2056,0.13,0.19,"No",0.9411,0.62,1,"Yes"
"9603","C7_Immunologic_signatures","C7_ALL_190_GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN",160,-1.2055,0.13,0.18,"No",-1.3943,0.019,0.23,"No"
"9604","GO_BP","508870_GO_0046622_POSITIVE_REGULATION_OF_ORGAN_GROWTH",35,-1.2055,0.2,0.35,"No",0.7764,0.82,1,"Yes"
"9605","C7_Immunologic_signatures","C7_ALL_607_GSE17721_LPS_VS_PAM3CSK4_6H_BMDM_UP",199,-1.2055,0.12,0.18,"No",1.0082,0.41,0.71,"Yes"
"9606","GO_BP","508336_GO_0046039_GTP_METABOLIC_PROCESS",12,-1.2055,0.23,0.35,"No",-0.8091,0.72,1,"No"
"9607","C3_TF_targets","C3_TFT_41_V_HEN1_01",193,-1.2054,0.094,0.19,"No",-0.8233,0.93,1,"No"
"9608","C2_Chemical_and_genetic_perturbations","C2_CGP_3074_DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP",226,-1.2054,0.11,0.27,"No",0.9349,0.67,0.89,"Yes"
"9609","GO_BP","504239_GO_0035051_CARDIOCYTE_DIFFERENTIATION",101,-1.2052,0.15,0.35,"No",-1.0735,0.3,0.95,"No"
"9610","C2_Chemical_and_genetic_perturbations","C2_CGP_1961_LEE_AGING_MUSCLE_UP",44,-1.2052,0.2,0.27,"No",0.8729,0.72,0.95,"Yes"
"9611","C4_Cancer_modules","C4_CM_412_MODULE_533",43,-1.205,0.21,0.28,"No",-1.4527,0.036,0.49,"No"
"9612","GO_MF","489233_GO_0003680_AT_DNA_BINDING",8,-1.205,0.25,0.39,"No",-1.444,0.077,0.63,"No"
"9613","C4_Cancer_modules","C4_CM_254_MODULE_288",36,-1.2049,0.18,0.28,"No",1.4769,0.037,0.13,"Yes"
"9614","C2_Chemical_and_genetic_perturbations","C2_CGP_761_SHI_SPARC_TARGETS_DN",11,-1.2049,0.26,0.27,"No",-1.293,0.15,0.71,"No"
"9615","GO_BP","948900_GO_1902745_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION",16,-1.2048,0.23,0.35,"No",0.8578,0.68,1,"Yes"
"9616","C2_Chemical_and_genetic_perturbations","C2_CGP_1857_LEE_CALORIE_RESTRICTION_NEOCORTEX_DN",86,-1.2048,0.15,0.27,"No",-1.0466,0.38,0.97,"No"
"9617","GO_MF","496399_GO_0016411_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY",16,-1.2048,0.21,0.39,"No",-0.8079,0.74,1,"No"
"9618","GO_BP","501565_GO_0032330_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION",42,-1.2047,0.19,0.35,"No",-1.0468,0.38,0.97,"No"
"9619","GO_BP","498893_GO_0021610_FACIAL_NERVE_MORPHOGENESIS",11,-1.2045,0.23,0.35,"No",-0.8757,0.63,1,"No"
"9620","GO_MF","490485_GO_0005251_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",35,-1.2044,0.2,0.39,"No",-1.3105,0.11,0.75,"No"
"9621","C2_Chemical_and_genetic_perturbations","C2_CGP_3023_WHITFIELD_CELL_CYCLE_M_G1",146,-1.2042,0.13,0.27,"No",1.1826,0.11,0.51,"Yes"
"9622","GO_BP","517095_GO_0072179_NEPHRIC_DUCT_FORMATION",5,-1.2041,0.25,0.35,"No",-0.8175,0.7,1,"No"
"9623","GO_BP","512043_GO_0051133_REGULATION_OF_NK_T_CELL_ACTIVATION",6,-1.204,0.27,0.35,"No",-1.2406,0.2,0.91,"No"
"9624","GO_BP","512424_GO_0051546_KERATINOCYTE_MIGRATION",5,-1.2039,0.26,0.35,"No",0.9676,0.5,1,"Yes"
"9625","C4_Cancer_modules","C4_CM_99_MODULE_104",337,-1.2039,0.081,0.28,"No",-1.2216,0.054,0.62,"No"
"9626","KEGG_compound","C00033_ACETATE_ACETIC_ACID_ETHANOIC_ACID",29,-1.2038,0.21,0.38,"No",1.0223,0.42,1,"Yes"
"9627","GO_BP","501312_GO_0032075_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY",74,-1.2038,0.16,0.35,"No",-0.7419,0.92,1,"No"
"9628","C3_MicroRNA_targets","C3_MIR_169_ACTGCCT_MIR_34B",216,-1.2037,0.097,0.34,"No",-0.8847,0.8,1,"No"
"9629","GO_BP","755375_GO_2001269_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",6,-1.2037,0.25,0.35,"No",0.7255,0.82,1,"Yes"
"9630","GO_BP","507972_GO_0045624_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION",15,-1.2037,0.23,0.35,"No",-1.3597,0.11,0.97,"No"
"9631","C7_Immunologic_signatures","C7_ALL_948_GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN",196,-1.2034,0.11,0.18,"No",-1.043,0.36,1,"No"
"9632","GO_BP","512714_GO_0051852_DISRUPTION_BY_HOST_OF_SYMBIONT_CELLS",6,-1.2034,0.25,0.35,"No",1.5566,0.046,0.34,"Yes"
"9633","GO_BP","518617_GO_0097067_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS",11,-1.2034,0.25,0.35,"No",0.9013,0.6,1,"Yes"
"9634","GO_BP","503642_GO_0034440_LIPID_OXIDATION",65,-1.2034,0.17,0.35,"No",1.3384,0.067,0.62,"Yes"
"9635","C4_Cancer_gene_neighborhoods","C4_CGN_182_MORF_THRA",51,-1.2033,0.17,0.33,"No",-1.1438,0.24,0.68,"No"
"9636","C2_Chemical_and_genetic_perturbations","C2_CGP_259_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN",8,-1.2032,0.24,0.27,"No",0.8956,0.58,0.93,"Yes"
"9637","C3_MicroRNA_targets","C3_MIR_76_GCTTGAA_MIR_498",111,-1.203,0.17,0.34,"No",1.0053,0.45,1,"Yes"
"9638","KEGG_compound","C03345_2_METHYLBUT_2_ENOYL_COA_TRANS_2_METHYLBUT_2_ENOYL_COA_TIGLYL_COA_E_2_METHYLCROTONOYL_COA_METHYLCROTONOYL_COA_METHYLCROTONYL_COA_TIGLOYL_COA_2_METHYLCROTANOYL_COA",6,-1.2027,0.25,0.38,"No",0.8476,0.64,1,"Yes"
"9639","GO_BP","495828_GO_0015693_MAGNESIUM_ION_TRANSPORT",15,-1.2027,0.23,0.35,"No",-0.8754,0.64,1,"No"
"9640","C2_Chemical_and_genetic_perturbations","C2_CGP_726_HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER",13,-1.2026,0.24,0.27,"No",0.5853,0.96,1,"Yes"
"9641","REACTOME","576272_REACT_118721_SIGNALING_BY_NOTCH2",32,-1.2026,0.18,0.38,"No",-0.7788,0.84,1,"No"
"9642","GO_BP","948111_GO_1902668_NEGATIVE_REGULATION_OF_AXON_GUIDANCE",11,-1.2024,0.24,0.35,"No",-1.0403,0.42,0.98,"No"
"9643","GO_CC","490908_GO_0030121_AP_1_ADAPTOR_COMPLEX",5,-1.2023,0.26,0.43,"No",-0.8141,0.69,1,"No"
"9644","GO_BP","513155_GO_0052312_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",23,-1.2023,0.22,0.35,"No",0.8673,0.66,1,"Yes"
"9645","C3_TF_targets","C3_TFT_52_V_EVI1_03",55,-1.2023,0.18,0.19,"No",0.7767,0.88,1,"Yes"
"9646","GO_BP","495966_GO_0015840_UREA_TRANSPORT",7,-1.2022,0.28,0.35,"No",-0.8286,0.69,1,"No"
"9647","C4_Cancer_modules","C4_CM_8_MODULE_8",415,-1.2022,0.069,0.28,"No",1.5777,0,0.083,"Yes"
"9648","C7_Immunologic_signatures","C7_ALL_896_GSE20715_WT_VS_TLR4_KO_LUNG_DN",196,-1.2022,0.11,0.18,"No",-1.1429,0.18,1,"No"
"9649","GO_MF","496432_GO_0016454_C_PALMITOYLTRANSFERASE_ACTIVITY",5,-1.2021,0.26,0.4,"No",-1.4038,0.1,0.65,"No"
"9650","GO_BP","514725_GO_0061180_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT",60,-1.2021,0.18,0.35,"No",-0.7544,0.9,1,"No"
"9651","C7_Immunologic_signatures","C7_ALL_453_GSE17721_CTRL_VS_LPS_4H_BMDM_UP",200,-1.2021,0.11,0.18,"No",1.0332,0.37,0.64,"Yes"
"9652","GO_BP","493342_GO_0009145_PURINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",65,-1.202,0.17,0.35,"No",1.2444,0.1,0.74,"Yes"
"9653","C4_Cancer_gene_neighborhoods","C4_CGN_261_GCM_RAP2A",34,-1.202,0.2,0.33,"No",-0.8485,0.72,1,"No"
"9654","GO_BP","506533_GO_0043502_REGULATION_OF_MUSCLE_ADAPTATION",46,-1.2019,0.18,0.35,"No",-0.8784,0.68,1,"No"
"9655","GO_BP","752439_GO_0086073_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_ADHESION_INVOLVED_IN_CELL_COMMUNICATION",6,-1.2019,0.25,0.35,"No",-0.5962,0.92,1,"No"
"9656","GO_BP","487952_GO_0002062_CHONDROCYTE_DIFFERENTIATION",62,-1.2019,0.17,0.35,"No",-1.5452,0.022,0.74,"No"
"9657","C3_TF_targets","C3_TFT_32_V_MYOGNF1_01",48,-1.2017,0.17,0.19,"No",-0.7809,0.83,1,"No"
"9658","KEGG_compound","C00671__S_3_METHYL_2_OXOPENTANOIC_ACID_S_3_METHYL_2_OXOPENTANOATE_3S_3_METHYL_2_OXOPENTANOIC_ACID_3S_3_METHYL_2_OXOPENTANOATE",5,-1.2014,0.26,0.38,"No",-0.6357,0.92,1,"No"
"9659","C2_Chemical_and_genetic_perturbations","C2_CGP_1841_MCCLUNG_COCAIN_REWARD_4WK",72,-1.2014,0.17,0.28,"No",-0.9542,0.53,1,"No"
"9660","C7_Immunologic_signatures","C7_ALL_372_GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN",195,-1.2013,0.13,0.18,"No",1.0605,0.29,0.56,"Yes"
"9661","C3_MicroRNA_targets","C3_MIR_188_ATGTACA_MIR_493",311,-1.2013,0.081,0.34,"No",0.7992,0.99,1,"Yes"
"9662","GO_BP","849768_GO_0044793_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS",7,-1.2013,0.26,0.35,"No",0.8543,0.64,1,"Yes"
"9663","C2_Chemical_and_genetic_perturbations","C2_CGP_2121_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP",55,-1.2012,0.19,0.28,"No",1.013,0.39,0.78,"Yes"
"9664","GO_BP","921146_GO_1902547_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS",9,-1.2012,0.25,0.35,"No",-0.9924,0.47,1,"No"
"9665","GO_BP","1025360_GO_1903224_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION",6,-1.2011,0.28,0.35,"No",1.4018,0.12,0.55,"Yes"
"9666","C2_Chemical_and_genetic_perturbations","C2_CGP_283_HUMMEL_BURKITTS_LYMPHOMA_UP",42,-1.2011,0.2,0.28,"No",0.7504,0.88,1,"Yes"
"9667","REACTOME","771584_REACT_160125_VISUAL_PHOTOTRANSDUCTION",93,-1.2011,0.16,0.39,"No",0.8936,0.67,0.91,"Yes"
"9668","C2_Chemical_and_genetic_perturbations","C2_CGP_1057_RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP",121,-1.201,0.16,0.28,"No",0.7727,0.96,1,"Yes"
"9669","C4_Cancer_gene_neighborhoods","C4_CGN_24_MORF_MT4",240,-1.2009,0.11,0.33,"No",-1.1295,0.17,0.71,"No"
"9670","KEGG_pathway","HSA04012_ERBB_SIGNALING_PATHWAY",86,-1.2009,0.18,0.23,"No",-0.8232,0.81,1,"No"
"9671","C1_Positional","C1_ALL_258_CHR2Q12",41,-1.2007,0.2,0.72,"No",1.1337,0.26,0.63,"Yes"
"9672","GO_BP","505928_GO_0042832_DEFENSE_RESPONSE_TO_PROTOZOAN",17,-1.2006,0.22,0.35,"No",-0.8516,0.67,1,"No"
"9673","C7_Immunologic_signatures","C7_ALL_761_GSE17721_4_VS_24H_GARDIQUIMOD_BMDM_UP",198,-1.2006,0.12,0.18,"No",1.414,0.0072,0.034,"Yes"
"9674","GO_BP","514583_GO_0061035_REGULATION_OF_CARTILAGE_DEVELOPMENT",58,-1.2006,0.19,0.35,"No",-1.2744,0.1,0.89,"No"
"9675","GO_BP","508720_GO_0046459_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS",18,-1.2006,0.24,0.35,"No",0.6978,0.89,1,"Yes"
"9676","WikiPathways","672460_WP2064_NEURAL_CREST_DIFFERENTIATION",96,-1.2005,0.16,0.3,"No",-1.0788,0.3,0.94,"No"
"9677","KEGG_pathway","HSA00620_PYRUVATE_METABOLISM",40,-1.2005,0.21,0.23,"No",1.0199,0.45,0.86,"Yes"
"9678","C7_Immunologic_signatures","C7_ALL_1_KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP",199,-1.2004,0.12,0.19,"No",0.9854,0.47,0.79,"Yes"
"9679","OMIM_gene","OMIM300822_OPSIN_1_LONG_WAVE_SENSITIVE_OPN1LW",8,-1.2003,0.24,0.85,"No",0.558,0.97,0.99,"Yes"
"9680","C6_Oncogenic_signatures","C6_ALL_94_ESC_J1_UP_EARLY_V1_UP",168,-1.2002,0.14,0.18,"No",-1.1534,0.17,0.48,"No"
"9681","GO_BP","513579_GO_0060021_PALATE_DEVELOPMENT",84,-1.2002,0.17,0.35,"No",-1.051,0.35,0.97,"No"
"9682","KEGG_compound","C04646_6_THIOINOSINE_5_MONOPHOSPHATE_9_5_PHOSPHO_1_RIBOFURANOSYL_6_MERCAPTOPURINE",5,-1.2,0.24,0.38,"No",-0.8383,0.65,1,"No"
"9683","C7_Immunologic_signatures","C7_ALL_1878_GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN",199,-1.2,0.13,0.19,"No",1.1893,0.088,0.25,"Yes"
"9684","C7_Immunologic_signatures","C7_ALL_1311_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP",192,-1.2,0.13,0.19,"No",-0.9099,0.71,1,"No"
"9685","KEGG_compound","C00468_ESTRONE_3_HYDROXY_1_3_5_10_ESTRATRIEN_17_ONE",29,-1.2,0.21,0.38,"No",1.807,0.0022,0.031,"Yes"
"9686","GO_BP","508356_GO_0046060_DATP_METABOLIC_PROCESS",7,-1.2,0.27,0.35,"No",0.8178,0.69,1,"Yes"
"9687","GO_BP","492327_GO_0007585_RESPIRATORY_GASEOUS_EXCHANGE",44,-1.1999,0.18,0.35,"No",0.7664,0.85,1,"Yes"
"9688","C2_Chemical_and_genetic_perturbations","C2_CGP_3281_PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN",105,-1.1999,0.15,0.28,"No",1.1156,0.22,0.6,"Yes"
"9689","GO_BP","513658_GO_0060100_POSITIVE_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT",6,-1.1999,0.25,0.35,"No",-0.6078,0.93,1,"No"
"9690","GO_CC","500716_GO_0031465_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX",5,-1.1999,0.25,0.44,"No",0.9383,0.53,0.85,"Yes"
"9691","C2_Chemical_and_genetic_perturbations","C2_CGP_119_HUTTMANN_B_CLL_POOR_SURVIVAL_DN",59,-1.1998,0.19,0.28,"No",-0.9457,0.56,1,"No"
"9692","C2_Chemical_and_genetic_perturbations","C2_CGP_2399_BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP",49,-1.1997,0.18,0.28,"No",0.6817,0.96,1,"Yes"
"9693","GO_CC","501148_GO_0031907_MICROBODY_LUMEN",36,-1.1996,0.19,0.43,"No",0.8726,0.65,0.91,"Yes"
"9694","C4_Cancer_modules","C4_CM_242_MODULE_273",52,-1.1996,0.2,0.28,"No",1.6041,0.0022,0.074,"Yes"
"9695","C7_Immunologic_signatures","C7_ALL_377_GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP",189,-1.1996,0.12,0.19,"No",0.9565,0.6,0.88,"Yes"
"9696","C7_Immunologic_signatures","C7_ALL_697_GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_UP",198,-1.1995,0.13,0.19,"No",0.9258,0.69,0.96,"Yes"
"9697","C2_Chemical_and_genetic_perturbations","C2_CGP_1620_NATSUME_RESPONSE_TO_INTERFERON_BETA_UP",70,-1.1994,0.18,0.28,"No",0.8808,0.72,0.94,"Yes"
"9698","REACTOME","187179_REACT_24987_GABA_A_RECEPTOR_ACTIVATION",12,-1.1994,0.25,0.39,"No",-0.9303,0.52,1,"No"
"9699","C2_BioCarta_Pathways","C2_CP_BIOCARTA_63_BIOCARTA_EPHA4_PATHWAY",10,-1.1994,0.25,0.35,"No",0.7949,0.73,0.99,"Yes"
"9700","C7_Immunologic_signatures","C7_ALL_1320_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN",192,-1.1993,0.1,0.19,"No",-0.715,1,1,"No"
"9701","C3_MicroRNA_targets","C3_MIR_140_CTTTGTA_MIR_524",430,-1.1993,0.057,0.34,"No",0.8734,0.94,1,"Yes"
"9702","GO_BP","506268_GO_0043200_RESPONSE_TO_AMINO_ACID",85,-1.1992,0.18,0.35,"No",0.9189,0.65,1,"Yes"
"9703","GO_MF","500043_GO_0030742_GTP_DEPENDENT_PROTEIN_BINDING",17,-1.1992,0.24,0.4,"No",0.7137,0.87,1,"Yes"
"9704","GO_CC","490828_GO_0030137_COPI_COATED_VESICLE",20,-1.1992,0.24,0.43,"No",1.588,0.031,0.13,"Yes"
"9705","GO_MF","496718_GO_0016820_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES_CATALYZING_TRANSMEMBRANE_MOVEMENT_OF_SUBSTANCES",98,-1.1991,0.16,0.4,"No",0.8421,0.83,1,"Yes"
"9706","C2_Chemical_and_genetic_perturbations","C2_CGP_702_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22",11,-1.1991,0.27,0.28,"No",-0.9204,0.57,1,"No"
"9707","GO_MF","506590_GO_0043559_INSULIN_BINDING",5,-1.1991,0.25,0.4,"No",1.1121,0.36,0.77,"Yes"
"9708","KEGG_compound","C20877_VERY_LONG_CHAIN_3_OXOACYL_COA",8,-1.199,0.26,0.38,"No",-1.0793,0.38,0.96,"No"
"9709","C7_Immunologic_signatures","C7_ALL_701_GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_UP",196,-1.199,0.12,0.19,"No",1.0318,0.35,0.64,"Yes"
"9710","C3_TF_targets","C3_TFT_477_V_PR_02",129,-1.199,0.14,0.19,"No",-0.775,0.94,1,"No"
"9711","GO_BP","513994_GO_0060439_TRACHEA_MORPHOGENESIS",7,-1.1989,0.26,0.35,"No",0.8379,0.64,1,"Yes"
"9712","C7_Immunologic_signatures","C7_ALL_211_GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP",197,-1.1988,0.14,0.19,"No",-1.1579,0.14,0.96,"No"
"9713","GO_BP","512636_GO_0051764_ACTIN_CROSSLINK_FORMATION",5,-1.1988,0.24,0.35,"No",-0.7538,0.75,1,"No"
"9714","GO_BP","751232_GO_0036315_CELLULAR_RESPONSE_TO_STEROL",16,-1.1988,0.23,0.35,"No",-0.6027,0.97,1,"No"
"9715","C2_Chemical_and_genetic_perturbations","C2_CGP_2184_IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN",347,-1.1987,0.082,0.28,"No",0.8039,0.99,0.99,"Yes"
"9716","GO_BP","511829_GO_0050891_MULTICELLULAR_ORGANISMAL_WATER_HOMEOSTASIS",57,-1.1986,0.19,0.35,"No",1.5042,0.016,0.4,"Yes"
"9717","GO_CC","490851_GO_0005827_POLAR_MICROTUBULE",5,-1.1986,0.24,0.43,"No",-1.0536,0.41,0.83,"No"
"9718","KEGG_pathway","HSA05160_HEPATITIS_C",127,-1.1985,0.14,0.23,"No",0.7554,0.97,1,"Yes"
"9719","C7_Immunologic_signatures","C7_ALL_122_GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN",198,-1.1984,0.11,0.19,"No",-0.7635,0.98,1,"No"
"9720","GO_BP","512470_GO_0051592_RESPONSE_TO_CALCIUM_ION",101,-1.1983,0.17,0.35,"No",0.995,0.45,0.98,"Yes"
"9721","C2_Chemical_and_genetic_perturbations","C2_CGP_1858_CUI_TCF21_TARGETS_2_UP",419,-1.1982,0.071,0.28,"No",1.2598,0.018,0.43,"Yes"
"9722","C3_MicroRNA_targets","C3_MIR_198_ATTCTTT_MIR_186",268,-1.1982,0.097,0.34,"No",1.1962,0.066,1,"Yes"
"9723","C3_TF_targets","C3_TFT_173_V_EGR1_01",266,-1.1982,0.12,0.2,"No",-0.9405,0.64,0.89,"No"
"9724","C2_Chemical_and_genetic_perturbations","C2_CGP_1759_BROWNE_HCMV_INFECTION_48HR_DN",495,-1.1981,0.055,0.28,"No",0.9083,0.88,0.91,"Yes"
"9725","C2_Chemical_and_genetic_perturbations","C2_CGP_968_GALIE_TUMOR_ANGIOGENESIS",8,-1.1981,0.24,0.28,"No",0.6877,0.85,1,"Yes"
"9726","C7_Immunologic_signatures","C7_ALL_673_GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDM_UP",194,-1.198,0.12,0.19,"No",0.831,0.92,1,"Yes"
"9727","C7_Immunologic_signatures","C7_ALL_495_GSE17721_CTRL_VS_CPG_0_5H_BMDM_UP",198,-1.198,0.12,0.19,"No",0.6935,1,1,"Yes"
"9728","KEGG_compound","C00041_L_ALANINE_L_2_AMINOPROPIONIC_ACID_L_ALPHA_ALANINE",11,-1.1977,0.25,0.38,"No",-0.9169,0.56,1,"No"
"9729","C2_Chemical_and_genetic_perturbations","C2_CGP_1095_COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN",28,-1.1977,0.21,0.28,"No",1.3179,0.11,0.38,"Yes"
"9730","GO_BP","493498_GO_0009314_RESPONSE_TO_RADIATION",447,-1.1977,0.061,0.36,"No",-0.9009,0.82,1,"No"
"9731","GO_BP","516791_GO_0071870_CELLULAR_RESPONSE_TO_CATECHOLAMINE_STIMULUS",23,-1.1976,0.23,0.36,"No",0.7148,0.9,1,"Yes"
"9732","C3_TF_targets","C3_TFT_142_V_SP1_Q6",254,-1.1975,0.12,0.2,"No",-1.2342,0.057,0.3,"No"
"9733","GO_MF","490023_GO_0004707_MAP_KINASE_ACTIVITY",13,-1.1973,0.24,0.4,"No",-1.0973,0.34,0.84,"No"
"9734","C7_Immunologic_signatures","C7_ALL_687_GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_UP",197,-1.1973,0.13,0.19,"No",0.9024,0.75,1,"Yes"
"9735","C7_Immunologic_signatures","C7_ALL_358_GSE15659_TREG_VS_TCONV_DN",179,-1.1971,0.12,0.19,"No",0.9638,0.56,0.86,"Yes"
"9736","REACTOME","161025_REACT_20558_SMOOTH_MUSCLE_CONTRACTION",28,-1.197,0.22,0.39,"No",1.364,0.084,0.25,"Yes"
"9737","C2_Chemical_and_genetic_perturbations","C2_CGP_2979_ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE",18,-1.197,0.24,0.28,"No",-1.098,0.32,0.91,"No"
"9738","C2_BioCarta_Pathways","C2_CP_BIOCARTA_80_BIOCARTA_SET_PATHWAY",11,-1.197,0.24,0.35,"No",1.2778,0.19,0.65,"Yes"
"9739","C7_Immunologic_signatures","C7_ALL_1414_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN",196,-1.1969,0.12,0.19,"No",-0.9411,0.62,1,"No"
"9740","C2_Chemical_and_genetic_perturbations","C2_CGP_1104_PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN",165,-1.1969,0.14,0.28,"No",1.1409,0.15,0.57,"Yes"
"9741","GO_BP","511929_GO_0050996_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS",20,-1.1969,0.26,0.36,"No",-1.2271,0.2,0.88,"No"
"9742","C2_Chemical_and_genetic_perturbations","C2_CGP_372_KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN",64,-1.1969,0.18,0.28,"No",-0.7681,0.88,1,"No"
"9743","GO_BP","502224_GO_0033002_MUSCLE_CELL_PROLIFERATION",19,-1.1968,0.22,0.36,"No",-0.6561,0.92,1,"No"
"9744","GO_MF","504359_GO_0035174_HISTONE_SERINE_KINASE_ACTIVITY",9,-1.1968,0.23,0.4,"No",-0.814,0.69,1,"No"
"9745","C7_Immunologic_signatures","C7_ALL_328_GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN",198,-1.1968,0.12,0.19,"No",1.4784,0,0.016,"Yes"
"9746","GO_MF","496727_GO_0016830_CARBON_CARBON_LYASE_ACTIVITY",48,-1.1968,0.19,0.4,"No",-0.8497,0.73,1,"No"
"9747","REACTOME","833810_REACT_163874_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS",42,-1.1968,0.2,0.39,"No",1.3207,0.08,0.3,"Yes"
"9748","GO_MF","513428_GO_0052689_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY",117,-1.1966,0.14,0.4,"No",1.1389,0.18,0.75,"Yes"
"9749","GO_BP","1184393_GO_1903867_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT",5,-1.1966,0.26,0.36,"No",-1.0593,0.43,0.96,"No"
"9750","C7_Immunologic_signatures","C7_ALL_717_GSE17721_0_5H_VS_12H_POLYIC_BMDM_UP",198,-1.1964,0.12,0.19,"No",1.4672,0.0051,0.018,"Yes"
"9751","GO_BP","488663_GO_0002790_PEPTIDE_SECRETION",59,-1.1964,0.17,0.36,"No",0.956,0.51,1,"Yes"
"9752","GO_BP","752408_GO_0086042_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION",6,-1.1961,0.27,0.36,"No",-0.5969,0.95,1,"No"
"9753","C1_Positional","C1_ALL_231_CHRXP22",124,-1.1961,0.15,0.72,"No",1.1615,0.16,0.63,"Yes"
"9754","KEGG_pathway","HSA04340_HEDGEHOG_SIGNALING_PATHWAY",50,-1.1961,0.19,0.23,"No",-0.9395,0.59,0.96,"No"
"9755","C2_Chemical_and_genetic_perturbations","C2_CGP_3095_PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN",155,-1.196,0.13,0.28,"No",0.8858,0.76,0.94,"Yes"
"9756","C4_Cancer_gene_neighborhoods","C4_CGN_26_MORF_MSH3",239,-1.196,0.11,0.33,"No",-1.3495,0.022,0.48,"No"
"9757","REACTOME","187098_REACT_25026_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY",14,-1.1959,0.25,0.39,"No",1.0359,0.38,0.69,"Yes"
"9758","C3_TF_targets","C3_TFT_317_V_PPARA_02",126,-1.1959,0.15,0.2,"No",-1.368,0.026,0.19,"No"
"9759","C2_Chemical_and_genetic_perturbations","C2_CGP_84_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP",72,-1.1958,0.17,0.28,"No",0.9865,0.45,0.81,"Yes"
"9760","REACTOME","187188_REACT_23826_PASSIVE_TRANSPORT_BY_AQUAPORINS",11,-1.1958,0.24,0.39,"No",-0.6459,0.93,1,"No"
"9761","GO_BP","512838_GO_0051988_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE",11,-1.1957,0.25,0.36,"No",-0.6486,0.91,1,"No"
"9762","GO_MF","495527_GO_0015276_LIGAND_GATED_ION_CHANNEL_ACTIVITY",141,-1.1957,0.14,0.4,"No",-1.2264,0.089,0.85,"No"
"9763","GO_BP","494575_GO_0010506_REGULATION_OF_AUTOPHAGY",235,-1.1957,0.11,0.36,"No",1.0729,0.24,0.93,"Yes"
"9764","GO_BP","498669_GO_0019886_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II",91,-1.1954,0.18,0.36,"No",1.0389,0.37,0.96,"Yes"
"9765","GO_BP","488892_GO_0003096_RENAL_SODIUM_ION_TRANSPORT",5,-1.1954,0.25,0.36,"No",-1.3857,0.081,0.99,"No"
"9766","C4_Cancer_gene_neighborhoods","C4_CGN_424_GNF2_TYK2",33,-1.1954,0.23,0.33,"No",1.1353,0.28,0.31,"Yes"
"9767","C2_Chemical_and_genetic_perturbations","C2_CGP_2284_BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING",244,-1.1954,0.12,0.28,"No",-0.8673,0.86,1,"No"
"9768","GO_BP","501714_GO_0032482_RAB_PROTEIN_SIGNAL_TRANSDUCTION",70,-1.1953,0.18,0.36,"No",0.8721,0.72,1,"Yes"
"9769","C7_Immunologic_signatures","C7_ALL_1200_GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN",195,-1.1953,0.13,0.19,"No",0.9976,0.44,0.74,"Yes"
"9770","GO_BP","496195_GO_0016102_DITERPENOID_BIOSYNTHETIC_PROCESS",7,-1.1953,0.24,0.36,"No",-0.9663,0.49,1,"No"
"9771","GO_BP","502095_GO_0032873_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE",38,-1.1953,0.22,0.36,"No",1.1493,0.25,0.84,"Yes"
"9772","GO_BP","508899_GO_0046653_TETRAHYDROFOLATE_METABOLIC_PROCESS",18,-1.1953,0.23,0.36,"No",-0.8787,0.63,1,"No"
"9773","C1_Positional","C1_ALL_206_CHR21Q22",159,-1.1952,0.13,0.71,"No",0.6898,1,1,"Yes"
"9774","GO_MF","501287_GO_0032050_CLATHRIN_HEAVY_CHAIN_BINDING",5,-1.1951,0.26,0.41,"No",-0.73,0.79,1,"No"
"9775","GO_BP","516417_GO_0071493_CELLULAR_RESPONSE_TO_UV_B",8,-1.195,0.27,0.36,"No",-0.8928,0.56,1,"No"
"9776","C2_Chemical_and_genetic_perturbations","C2_CGP_1085_RICKMAN_HEAD_AND_NECK_CANCER_A",96,-1.1948,0.15,0.28,"No",1.1166,0.22,0.6,"Yes"
"9777","C3_MicroRNA_targets","C3_MIR_179_ACTGTAG_MIR_139",121,-1.1947,0.17,0.34,"No",1.1507,0.16,1,"Yes"
"9778","C7_Immunologic_signatures","C7_ALL_1776_GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN",199,-1.1947,0.14,0.19,"No",0.9163,0.73,0.99,"Yes"
"9779","GO_BP","519032_GO_2000392_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS",6,-1.1946,0.26,0.36,"No",-0.8216,0.69,1,"No"
"9780","GO_BP","491384_GO_0006482_PROTEIN_DEMETHYLATION",37,-1.1945,0.21,0.36,"No",-1.6435,0.0092,0.7,"No"
"9781","C3_MicroRNA_targets","C3_MIR_32_ACTGTGA_MIR_27A_MIR_27B",466,-1.1945,0.066,0.34,"No",-0.869,0.88,1,"No"
"9782","C7_Immunologic_signatures","C7_ALL_164_GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN",197,-1.1944,0.14,0.19,"No",1.2387,0.05,0.17,"Yes"
"9783","GO_BP","513628_GO_0060070_CANONICAL_WNT_SIGNALING_PATHWAY",84,-1.1942,0.17,0.36,"No",-1.0611,0.35,0.96,"No"
"9784","C7_Immunologic_signatures","C7_ALL_743_GSE17721_0_5H_VS_4H_CPG_BMDM_UP",200,-1.194,0.12,0.19,"No",0.643,1,1,"Yes"
"9785","GO_MF","498654_GO_0019871_SODIUM_CHANNEL_INHIBITOR_ACTIVITY",5,-1.194,0.25,0.41,"No",-1.0559,0.41,0.87,"No"
"9786","C7_Immunologic_signatures","C7_ALL_386_GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN",198,-1.1939,0.13,0.19,"No",-1.0318,0.37,1,"No"
"9787","C2_BioCarta_Pathways","C2_CP_BIOCARTA_23_BIOCARTA_BCR_PATHWAY",34,-1.1939,0.21,0.35,"No",-0.6453,0.96,1,"No"
"9788","GO_BP","501611_GO_0032376_POSITIVE_REGULATION_OF_CHOLESTEROL_TRANSPORT",15,-1.1938,0.23,0.36,"No",0.6874,0.89,1,"Yes"
"9789","GO_BP","512331_GO_0051453_REGULATION_OF_INTRACELLULAR_PH",44,-1.1938,0.21,0.36,"No",-1.0203,0.42,0.97,"No"
"9790","GO_MF","495448_GO_0015179_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",43,-1.1936,0.22,0.41,"No",1.0042,0.45,0.87,"Yes"
"9791","KEGG_pathway","HSA05211_RENAL_CELL_CARCINOMA",65,-1.1935,0.19,0.24,"No",1.0839,0.31,0.81,"Yes"
"9792","C2_Chemical_and_genetic_perturbations","C2_CGP_3079_FIGUEROA_AML_METHYLATION_CLUSTER_1_DN",46,-1.1935,0.2,0.28,"No",0.7828,0.84,1,"Yes"
"9793","GO_CC","499557_GO_0030128_CLATHRIN_COAT_OF_ENDOCYTIC_VESICLE",12,-1.1935,0.26,0.44,"No",0.9345,0.53,0.85,"Yes"
"9794","C2_Chemical_and_genetic_perturbations","C2_CGP_3068_LU_EZH2_TARGETS_UP",281,-1.1934,0.092,0.28,"No",0.8643,0.91,0.96,"Yes"
"9795","GO_BP","506453_GO_0043415_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION",5,-1.1933,0.26,0.36,"No",-0.9615,0.5,1,"No"
"9796","REACTOME","106471_REACT_15530_PKA_ACTIVATION",16,-1.1933,0.24,0.4,"No",0.9935,0.45,0.77,"Yes"
"9797","GO_BP","512668_GO_0051797_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT",14,-1.1933,0.22,0.36,"No",-1.0361,0.4,0.98,"No"
"9798","C7_Immunologic_signatures","C7_ALL_146_GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN",199,-1.1932,0.13,0.19,"No",0.9977,0.48,0.74,"Yes"
"9799","C4_Cancer_modules","C4_CM_386_MODULE_485",52,-1.1932,0.2,0.29,"No",-1.0145,0.44,0.79,"No"
"9800","C2_Chemical_and_genetic_perturbations","C2_CGP_2727_CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP",73,-1.1931,0.19,0.28,"No",-1.3341,0.066,0.69,"No"
"9801","C7_Immunologic_signatures","C7_ALL_1095_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP",200,-1.193,0.12,0.19,"No",1.6867,0,0.00082,"Yes"
"9802","GO_BP","491723_GO_0006857_OLIGOPEPTIDE_TRANSPORT",6,-1.193,0.28,0.36,"No",-1.2117,0.26,0.88,"No"
"9803","C2_Chemical_and_genetic_perturbations","C2_CGP_399_CASTELLANO_HRAS_AND_NRAS_TARGETS_UP",5,-1.193,0.26,0.28,"No",-0.9222,0.56,1,"No"
"9804","GO_MF","489660_GO_0008237_METALLOPEPTIDASE_ACTIVITY",180,-1.1928,0.14,0.41,"No",0.8168,0.94,1,"Yes"
"9805","GO_BP","499702_GO_0030300_REGULATION_OF_INTESTINAL_CHOLESTEROL_ABSORPTION",7,-1.1926,0.27,0.36,"No",-1.5276,0.051,0.77,"No"
"9806","C2_Chemical_and_genetic_perturbations","C2_CGP_1078_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP",8,-1.1926,0.26,0.29,"No",-1.1467,0.29,0.85,"No"
"9807","C6_Oncogenic_signatures","C6_ALL_148_SIRNA_EIF4GI_UP",93,-1.1926,0.17,0.19,"No",1.2571,0.082,0.36,"Yes"
"9808","GO_BP","496031_GO_0015909_LONG_CHAIN_FATTY_ACID_TRANSPORT",37,-1.1926,0.2,0.36,"No",0.7475,0.88,1,"Yes"
"9809","GO_BP","518745_GO_2000096_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY",7,-1.1925,0.26,0.36,"No",0.6678,0.87,1,"Yes"
"9810","C2_Chemical_and_genetic_perturbations","C2_CGP_2755_YAGI_AML_WITH_INV_16_TRANSLOCATION",414,-1.1924,0.072,0.29,"No",1.3872,0,0.3,"Yes"
"9811","C2_Chemical_and_genetic_perturbations","C2_CGP_2367_DONATO_CELL_CYCLE_TRETINOIN",6,-1.1924,0.28,0.29,"No",-0.6951,0.85,1,"No"
"9812","GO_MF","983695_GO_0098634_PROTEIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION",6,-1.1924,0.24,0.41,"No",-1.156,0.29,0.81,"No"
"9813","C7_Immunologic_signatures","C7_ALL_191_GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP",180,-1.1923,0.13,0.19,"No",1.1467,0.15,0.33,"Yes"
"9814","GO_BP","510921_GO_0048872_HOMEOSTASIS_OF_NUMBER_OF_CELLS",177,-1.1923,0.13,0.36,"No",1.2289,0.066,0.75,"Yes"
"9815","C2_Chemical_and_genetic_perturbations","C2_CGP_1490_ROETH_TERT_TARGETS_DN",8,-1.1923,0.26,0.29,"No",0.8308,0.65,0.98,"Yes"
"9816","C7_Immunologic_signatures","C7_ALL_569_GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_UP",200,-1.1923,0.12,0.19,"No",-0.9611,0.57,1,"No"
"9817","C3_TF_targets","C3_TFT_53_V_EVI1_04",231,-1.1922,0.12,0.2,"No",1.1291,0.14,0.98,"Yes"
"9818","C7_Immunologic_signatures","C7_ALL_3_KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP",196,-1.1922,0.13,0.19,"No",1.3297,0.012,0.077,"Yes"
"9819","C2_BioCarta_Pathways","C2_CP_BIOCARTA_211_BIOCARTA_TRKA_PATHWAY",12,-1.1921,0.25,0.35,"No",-0.7786,0.77,1,"No"
"9820","C2_Chemical_and_genetic_perturbations","C2_CGP_386_YEMELYANOV_GR_TARGETS_DN",10,-1.1919,0.26,0.29,"No",-1.3368,0.14,0.69,"No"
"9821","KEGG_reaction","R07046_ARACHIDONATE_OXYGEN_NADPH_H_19_S_HETE_NADP_H2O",6,-1.1919,0.26,0.38,"No",-1.4555,0.072,0.24,"No"
"9822","GO_BP","519314_GO_2000675_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS",6,-1.1918,0.26,0.36,"No",1.3104,0.16,0.66,"Yes"
"9823","C2_Chemical_and_genetic_perturbations","C2_CGP_3290_DELACROIX_RAR_BOUND_ES",450,-1.1918,0.072,0.29,"No",-0.9388,0.67,1,"No"
"9824","GO_BP","507929_GO_0045581_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION",26,-1.1918,0.22,0.36,"No",-1.4524,0.066,0.9,"No"
"9825","GO_BP","487672_GO_0001776_LEUKOCYTE_HOMEOSTASIS",62,-1.1917,0.19,0.36,"No",0.7476,0.92,1,"Yes"
"9826","C3_TF_targets","C3_TFT_384_V_OSF2_Q6",258,-1.1917,0.1,0.2,"No",-0.8829,0.81,0.99,"No"
"9827","C2_Chemical_and_genetic_perturbations","C2_CGP_1712_LEE_AGING_CEREBELLUM_DN",82,-1.1917,0.18,0.29,"No",0.9382,0.59,0.88,"Yes"
"9828","GO_MF","490071_GO_0004758_SERINE_C_PALMITOYLTRANSFERASE_ACTIVITY",5,-1.1916,0.26,0.41,"No",-1.4036,0.098,0.64,"No"
"9829","GO_BP","508170_GO_0045851_PH_REDUCTION",27,-1.1916,0.23,0.36,"No",-0.6374,0.96,1,"No"
"9830","C2_Chemical_and_genetic_perturbations","C2_CGP_2676_ROME_INSULIN_TARGETS_IN_MUSCLE_DN",193,-1.1915,0.12,0.29,"No",-1.3995,0.0084,0.59,"No"
"9831","GO_BP","491848_GO_0007017_MICROTUBULE_BASED_PROCESS",478,-1.1914,0.072,0.36,"No",-0.8842,0.89,1,"No"
"9832","GO_BP","491482_GO_0006586_INDOLALKYLAMINE_METABOLIC_PROCESS",23,-1.1914,0.23,0.36,"No",-1.1473,0.28,0.93,"No"
"9833","C3_MicroRNA_targets","C3_MIR_40_AAGCCAT_MIR_135A_MIR_135B",330,-1.1912,0.11,0.34,"No",-0.6971,1,1,"No"
"9834","C4_Cancer_modules","C4_CM_333_MODULE_397",120,-1.1911,0.15,0.3,"No",-0.9799,0.51,0.82,"No"
"9835","REACTOME","119540_REACT_19290_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA",47,-1.191,0.2,0.4,"No",0.7876,0.82,1,"Yes"
"9836","KEGG_pathway","HSA04550_SIGNALING_PATHWAYS_REGULATING_PLURIPOTENCY_OF_STEM_CELLS",140,-1.1909,0.17,0.24,"No",-1.1973,0.12,0.51,"No"
"9837","C1_Positional","C1_ALL_249_CHR3Q25",53,-1.1908,0.19,0.72,"No",-1.056,0.35,1,"No"
"9838","C2_Chemical_and_genetic_perturbations","C2_CGP_225_LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN",7,-1.1908,0.25,0.29,"No",-1.2744,0.19,0.71,"No"
"9839","C4_Cancer_gene_neighborhoods","C4_CGN_237_GCM_LTK",43,-1.1908,0.21,0.34,"No",-0.9854,0.47,0.86,"No"
"9840","C2_BioCarta_Pathways","C2_CP_BIOCARTA_64_BIOCARTA_EPO_PATHWAY",19,-1.1907,0.23,0.35,"No",-1.2749,0.16,1,"No"
"9841","GO_BP","503553_GO_0034351_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS",7,-1.1906,0.26,0.36,"No",0.9353,0.56,1,"Yes"
"9842","GO_BP","495005_GO_0010940_POSITIVE_REGULATION_OF_NECROTIC_CELL_DEATH",5,-1.1906,0.28,0.36,"No",0.6475,0.89,1,"Yes"
"9843","GO_BP","512094_GO_0051188_COFACTOR_BIOSYNTHETIC_PROCESS",129,-1.1905,0.15,0.36,"No",1.1058,0.23,0.9,"Yes"
"9844","C2_Chemical_and_genetic_perturbations","C2_CGP_1757_YIH_RESPONSE_TO_ARSENITE_C2",18,-1.1904,0.25,0.29,"No",0.7428,0.87,1,"Yes"
"9845","C1_Positional","C1_ALL_121_CHR8P21",76,-1.1902,0.18,0.71,"No",-0.7879,0.88,0.96,"No"
"9846","GO_CC","499591_GO_0030173_INTEGRAL_COMPONENT_OF_GOLGI_MEMBRANE",44,-1.1902,0.22,0.45,"No",0.6679,0.98,0.99,"Yes"
"9847","C7_Immunologic_signatures","C7_ALL_429_GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP",199,-1.1901,0.14,0.2,"No",1.3163,0.024,0.088,"Yes"
"9848","REACTOME","530738_REACT_115720_PLCG1_EVENTS_IN_ERBB2_SIGNALING",37,-1.19,0.21,0.4,"No",-0.9225,0.6,1,"No"
"9849","REACTOME","105806_REACT_1006_POLO_LIKE_KINASE_MEDIATED_EVENTS",16,-1.1899,0.23,0.4,"No",-0.4978,0.99,1,"No"
"9850","GO_BP","501198_GO_0031958_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY",12,-1.1898,0.27,0.37,"No",-0.8572,0.66,1,"No"
"9851","OMIM_gene","OMIM600140_CREB_BINDING_PROTEIN_CREBBP",5,-1.1897,0.25,0.84,"No",0.4993,0.98,0.98,"Yes"
"9852","GO_BP","508868_GO_0046620_REGULATION_OF_ORGAN_GROWTH",74,-1.1897,0.18,0.37,"No",0.7736,0.92,1,"Yes"
"9853","GO_BP","491407_GO_0006509_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",22,-1.1897,0.22,0.37,"No",0.4569,1,1,"Yes"
"9854","C7_Immunologic_signatures","C7_ALL_1431_GSE360_DC_VS_MAC_UP",198,-1.1896,0.14,0.2,"No",0.7319,1,1,"Yes"
"9855","C2_Chemical_and_genetic_perturbations","C2_CGP_2167_FINETTI_BREAST_CANCERS_KINOME_BLUE",20,-1.1896,0.23,0.29,"No",-1.4811,0.051,0.49,"No"
"9856","C2_Chemical_and_genetic_perturbations","C2_CGP_2759_MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3",56,-1.1896,0.2,0.29,"No",1.0938,0.25,0.64,"Yes"
"9857","C2_Chemical_and_genetic_perturbations","C2_CGP_1635_BRACHAT_RESPONSE_TO_CISPLATIN",22,-1.1894,0.22,0.29,"No",0.8925,0.62,0.93,"Yes"
"9858","GO_BP","516789_GO_0071868_CELLULAR_RESPONSE_TO_MONOAMINE_STIMULUS",23,-1.1894,0.23,0.37,"No",0.7227,0.89,1,"Yes"
"9859","GO_BP","492169_GO_0007406_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION",7,-1.1893,0.26,0.37,"No",-1.1438,0.29,0.93,"No"
"9860","GO_BP","498637_GO_0019852_L_ASCORBIC_ACID_METABOLIC_PROCESS",11,-1.1892,0.25,0.37,"No",-1.3529,0.13,0.95,"No"
"9861","OMIM_gene","OMIM600947_HUNTINGTIN_ASSOCIATED_PROTEIN_1_HAP1",6,-1.1892,0.29,0.8,"No",0.5288,0.97,0.99,"Yes"
"9862","GO_BP","519404_GO_2000765_REGULATION_OF_CYTOPLASMIC_TRANSLATION",6,-1.1892,0.26,0.37,"No",-1.0653,0.4,0.96,"No"
"9863","GO_BP","506341_GO_0043276_ANOIKIS",5,-1.1892,0.29,0.37,"No",-0.6908,0.83,1,"No"
"9864","GO_BP","753004_GO_1900004_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY",6,-1.189,0.28,0.37,"No",1.2078,0.25,0.78,"Yes"
"9865","GO_BP","494330_GO_0010256_ENDOMEMBRANE_SYSTEM_ORGANIZATION",404,-1.1889,0.09,0.37,"No",0.9854,0.5,1,"Yes"
"9866","GO_BP","497777_GO_0018879_BIPHENYL_METABOLIC_PROCESS",6,-1.1888,0.26,0.37,"No",1.0189,0.44,0.97,"Yes"
"9867","C6_Oncogenic_signatures","C6_ALL_87_MTOR_UP_N4_V1_DN",185,-1.1887,0.13,0.19,"No",-0.7387,0.99,1,"No"
"9868","GO_BP","488797_GO_0002924_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",6,-1.1886,0.26,0.37,"No",-0.8657,0.62,1,"No"
"9869","GO_MF","499460_GO_0045125_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY",9,-1.1886,0.26,0.41,"No",1.0602,0.37,0.83,"Yes"
"9870","GO_BP","512532_GO_0051656_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION",291,-1.1885,0.097,0.37,"No",1.2457,0.045,0.74,"Yes"
"9871","C2_Chemical_and_genetic_perturbations","C2_CGP_3353_HOLLEMAN_DAUNORUBICIN_ALL_UP",7,-1.1884,0.26,0.29,"No",-1.0666,0.37,0.96,"No"
"9872","C3_TF_targets","C3_TFT_312_V_ATF3_Q6",244,-1.1881,0.14,0.21,"No",-0.9381,0.65,0.89,"No"
"9873","GO_BP","849985_GO_1902284_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE",17,-1.188,0.23,0.37,"No",-1.193,0.25,0.9,"No"
"9874","GO_BP","497792_GO_0018894_DIBENZO_P_DIOXIN_METABOLIC_PROCESS",6,-1.1879,0.27,0.37,"No",0.7632,0.77,1,"Yes"
"9875","GO_BP","513599_GO_0060041_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE",131,-1.1879,0.14,0.37,"No",-1.1671,0.14,0.91,"No"
"9876","GO_CC","487083_GO_0000790_NUCLEAR_CHROMATIN",253,-1.1878,0.12,0.45,"No",-1.5093,0,0.63,"No"
"9877","C2_Chemical_and_genetic_perturbations","C2_CGP_1768_KIM_GASTRIC_CANCER_CHEMOSENSITIVITY",97,-1.1876,0.17,0.29,"No",-0.9125,0.64,1,"No"
"9878","C7_Immunologic_signatures","C7_ALL_1424_GSE360_CTRL_VS_T_GONDII_MAC_DN",197,-1.1871,0.12,0.2,"No",-0.8519,0.83,1,"No"
"9879","C7_Immunologic_signatures","C7_ALL_1503_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP",198,-1.1869,0.15,0.2,"No",0.8502,0.87,1,"Yes"
"9880","OMIM_gene","OMIM603344_USO1_VESICLE_DOCKING_PROTEIN_S_CEREVISIAE_HOMOLOG_OF_USO1",5,-1.1868,0.29,0.77,"No",-1.086,0.4,1,"No"
"9881","C7_Immunologic_signatures","C7_ALL_877_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP",200,-1.1866,0.12,0.2,"No",0.6968,1,1,"Yes"
"9882","C7_Immunologic_signatures","C7_ALL_780_GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN",198,-1.1864,0.14,0.2,"No",-0.6994,1,1,"No"
"9883","C2_Chemical_and_genetic_perturbations","C2_CGP_1324_PENG_LEUCINE_DEPRIVATION_DN",186,-1.1863,0.14,0.29,"No",1.3021,0.037,0.39,"Yes"
"9884","GO_BP","514272_GO_0060717_CHORION_DEVELOPMENT",5,-1.1863,0.26,0.37,"No",-1.0843,0.36,0.96,"No"
"9885","GO_BP","494085_GO_0010002_CARDIOBLAST_DIFFERENTIATION",13,-1.1861,0.24,0.37,"No",-0.6804,0.9,1,"No"
"9886","GO_BP","993419_GO_1903077_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",18,-1.1861,0.23,0.37,"No",0.9418,0.51,1,"Yes"
"9887","REACTOME","205243_REACT_27161_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION",78,-1.1861,0.2,0.41,"No",-0.7584,0.92,1,"No"
"9888","C7_Immunologic_signatures","C7_ALL_1385_GSE339_CD4POS_VS_CD4CD8DN_DC_UP",199,-1.1861,0.14,0.2,"No",0.9261,0.7,0.96,"Yes"
"9889","C1_Positional","C1_ALL_194_CHR1P12",16,-1.1861,0.26,0.71,"No",-1.0664,0.36,1,"No"
"9890","GO_BP","497080_GO_0018105_PEPTIDYL_SERINE_PHOSPHORYLATION",103,-1.186,0.16,0.37,"No",-1.1551,0.2,0.92,"No"
"9891","C3_MicroRNA_targets","C3_MIR_165_GCTGAGT_MIR_512_5P",50,-1.1858,0.21,0.35,"No",0.8141,0.82,1,"Yes"
"9892","GO_MF","492396_GO_0008022_PROTEIN_C_TERMINUS_BINDING",166,-1.1856,0.15,0.42,"No",1.0013,0.45,0.87,"Yes"
"9893","GO_BP","516392_GO_0071468_CELLULAR_RESPONSE_TO_ACIDIC_PH",7,-1.1856,0.26,0.37,"No",-1.252,0.22,0.91,"No"
"9894","C7_Immunologic_signatures","C7_ALL_215_GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP",199,-1.1855,0.14,0.21,"No",1.1378,0.16,0.34,"Yes"
"9895","GO_BP","494740_GO_0010675_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",149,-1.1855,0.16,0.37,"No",0.9802,0.5,1,"Yes"
"9896","GO_BP","514763_GO_0061218_NEGATIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT",6,-1.1855,0.3,0.37,"No",-0.6772,0.86,1,"No"
"9897","GO_BP","505746_GO_0042632_CHOLESTEROL_HOMEOSTASIS",62,-1.1853,0.2,0.37,"No",-0.9973,0.44,0.99,"No"
"9898","C3_MicroRNA_targets","C3_MIR_98_CTGAGCC_MIR_24",228,-1.1851,0.13,0.35,"No",-1.1845,0.088,1,"No"
"9899","GO_BP","489074_GO_0003281_VENTRICULAR_SEPTUM_DEVELOPMENT",43,-1.1851,0.21,0.37,"No",-0.9984,0.46,0.99,"No"
"9900","C2_BioCarta_Pathways","C2_CP_BIOCARTA_92_BIOCARTA_IL2_PATHWAY",22,-1.1849,0.22,0.36,"No",0.5406,0.99,0.99,"Yes"
"9901","GO_BP","510426_GO_0048319_AXIAL_MESODERM_MORPHOGENESIS",5,-1.1849,0.26,0.37,"No",-1.2914,0.2,0.88,"No"
"9902","C4_Cancer_modules","C4_CM_7_MODULE_7",229,-1.1848,0.12,0.3,"No",1.0756,0.25,0.58,"Yes"
"9903","GO_MF","499386_GO_0022841_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY",15,-1.1848,0.25,0.42,"No",1.1828,0.23,0.73,"Yes"
"9904","C3_MicroRNA_targets","C3_MIR_189_GCATTTG_MIR_105",173,-1.1848,0.13,0.35,"No",-0.6877,1,1,"No"
"9905","C2_Chemical_and_genetic_perturbations","C2_CGP_1271_STANELLE_E2F1_TARGETS",28,-1.1847,0.23,0.3,"No",-1.289,0.15,0.7,"No"
"9906","GO_BP","498237_GO_0019395_FATTY_ACID_OXIDATION",64,-1.1846,0.19,0.37,"No",1.3374,0.068,0.62,"Yes"
"9907","GO_BP","518987_GO_2000341_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION",6,-1.1845,0.26,0.37,"No",-1.3052,0.18,0.88,"No"
"9908","C2_Chemical_and_genetic_perturbations","C2_CGP_1930_YIH_RESPONSE_TO_ARSENITE_C1",24,-1.1844,0.25,0.3,"No",-0.8825,0.64,1,"No"
"9909","C7_Immunologic_signatures","C7_ALL_562_GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_DN",199,-1.1844,0.14,0.21,"No",1.4475,0,0.023,"Yes"
"9910","REACTOME","105691_REACT_634_RAF_MAP_KINASE_CASCADE",17,-1.1842,0.24,0.41,"No",0.6107,0.97,1,"Yes"
"9911","C3_TF_targets","C3_TFT_132_V_USF_Q6",255,-1.1842,0.13,0.22,"No",0.9016,0.77,1,"Yes"
"9912","GO_BP","496497_GO_0016540_PROTEIN_AUTOPROCESSING",10,-1.1841,0.24,0.37,"No",-1.2969,0.15,0.88,"No"
"9913","GO_BP","982498_GO_1902930_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS",40,-1.1841,0.21,0.37,"No",-0.8577,0.7,1,"No"
"9914","GO_BP","501155_GO_0031915_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY",6,-1.1841,0.26,0.37,"No",-1.2939,0.18,0.88,"No"
"9915","GO_BP","510440_GO_0048333_MESODERMAL_CELL_DIFFERENTIATION",27,-1.1841,0.23,0.37,"No",-0.8124,0.76,1,"No"
"9916","C3_TF_targets","C3_TFT_519_TCCATTKW_UNKNOWN",234,-1.184,0.13,0.22,"No",-0.9594,0.57,0.85,"No"
"9917","GO_BP","506598_GO_0043567_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",22,-1.1838,0.24,0.37,"No",-0.7773,0.81,1,"No"
"9918","C7_Immunologic_signatures","C7_ALL_427_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP",199,-1.1837,0.13,0.21,"No",1.1118,0.18,0.41,"Yes"
"9919","GO_BP","505517_GO_0042373_VITAMIN_K_METABOLIC_PROCESS",7,-1.1836,0.26,0.37,"No",0.765,0.75,1,"Yes"
"9920","GO_BP","491416_GO_0006520_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",348,-1.1836,0.1,0.37,"No",-0.8132,0.98,1,"No"
"9921","GO_BP","982500_GO_1902932_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS",19,-1.1835,0.24,0.37,"No",-0.8881,0.61,1,"No"
"9922","C7_Immunologic_signatures","C7_ALL_1866_GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN",195,-1.1835,0.13,0.21,"No",-1.0593,0.31,1,"No"
"9923","C2_Chemical_and_genetic_perturbations","C2_CGP_607_DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN",84,-1.1834,0.19,0.3,"No",-1.1932,0.13,0.8,"No"
"9924","C4_Cancer_modules","C4_CM_176_MODULE_188",134,-1.1833,0.16,0.31,"No",1.0276,0.4,0.68,"Yes"
"9925","GO_BP","518340_GO_0090200_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",28,-1.1831,0.23,0.37,"No",0.6207,0.98,1,"Yes"
"9926","GO_BP","512410_GO_0051532_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS",12,-1.1831,0.26,0.37,"No",-1.5895,0.019,0.72,"No"
"9927","C3_MicroRNA_targets","C3_MIR_143_ATGCTGG_MIR_338",114,-1.183,0.18,0.35,"No",-0.8727,0.76,1,"No"
"9928","GO_BP","494782_GO_0010717_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",56,-1.183,0.19,0.37,"No",-1.186,0.18,0.9,"No"
"9929","GO_BP","510691_GO_0048634_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT",136,-1.183,0.17,0.37,"No",-0.874,0.77,1,"No"
"9930","GO_MF","490527_GO_0005326_NEUROTRANSMITTER_TRANSPORTER_ACTIVITY",23,-1.1829,0.25,0.42,"No",-1.2079,0.19,0.81,"No"
"9931","GO_BP","515015_GO_0070076_HISTONE_LYSINE_DEMETHYLATION",34,-1.1827,0.22,0.37,"No",-1.5608,0.015,0.7,"No"
"9932","C2_Chemical_and_genetic_perturbations","C2_CGP_1290_LEE_LIVER_CANCER_MYC_TGFA_DN",64,-1.1827,0.21,0.3,"No",-0.8803,0.7,1,"No"
"9933","C2_Chemical_and_genetic_perturbations","C2_CGP_2097_TESAR_ALK_TARGETS_EPISC_3D_UP",5,-1.1826,0.28,0.3,"No",0.9216,0.58,0.9,"Yes"
"9934","GO_BP","508593_GO_0046329_NEGATIVE_REGULATION_OF_JNK_CASCADE",33,-1.1826,0.23,0.37,"No",0.7155,0.93,1,"Yes"
"9935","KEGG_reaction","R04545_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_ADP_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE",8,-1.1826,0.26,0.39,"No",-0.7934,0.73,1,"No"
"9936","C7_Immunologic_signatures","C7_ALL_1212_GSE27786_CD8_TCELL_VS_MONO_MAC_DN",197,-1.1824,0.14,0.21,"No",-0.8264,0.92,1,"No"
"9937","C2_Chemical_and_genetic_perturbations","C2_CGP_2183_IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP",173,-1.1822,0.14,0.3,"No",1.1345,0.17,0.57,"Yes"
"9938","REACTOME","106470_REACT_15497_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB",17,-1.1821,0.25,0.41,"No",0.8959,0.6,0.91,"Yes"
"9939","C2_Chemical_and_genetic_perturbations","C2_CGP_1122_STARK_HYPPOCAMPUS_22Q11_DELETION_UP",51,-1.1821,0.2,0.3,"No",-1.2882,0.11,0.69,"No"
"9940","GO_BP","516155_GO_0071229_CELLULAR_RESPONSE_TO_ACID_CHEMICAL",147,-1.1821,0.15,0.37,"No",1.0344,0.34,0.96,"Yes"
"9941","C3_MicroRNA_targets","C3_MIR_144_ACATATC_MIR_190",60,-1.1821,0.22,0.35,"No",-0.8112,0.79,1,"No"
"9942","GO_BP","506650_GO_0043619_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_OXIDATIVE_STRESS",10,-1.1821,0.27,0.37,"No",0.9253,0.56,1,"Yes"
"9943","GO_BP","515167_GO_0070232_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS",33,-1.1821,0.23,0.37,"No",0.9515,0.55,1,"Yes"
"9944","C3_MicroRNA_targets","C3_MIR_147_ACCAAAG_MIR_9",494,-1.1819,0.079,0.34,"No",-0.9909,0.49,1,"No"
"9945","GO_BP","506380_GO_0043320_NATURAL_KILLER_CELL_DEGRANULATION",6,-1.1819,0.26,0.37,"No",1.0741,0.37,0.93,"Yes"
"9946","C2_Chemical_and_genetic_perturbations","C2_CGP_2261_SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN",35,-1.1818,0.23,0.3,"No",1.0185,0.4,0.77,"Yes"
"9947","GO_CC","500474_GO_0031211_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX",6,-1.1817,0.27,0.46,"No",-1.3428,0.16,0.63,"No"
"9948","GO_BP","491975_GO_0007172_SIGNAL_COMPLEX_ASSEMBLY",8,-1.1817,0.26,0.37,"No",1.3184,0.14,0.65,"Yes"
"9949","C2_Chemical_and_genetic_perturbations","C2_CGP_820_YANAGIHARA_ESX1_TARGETS",30,-1.1817,0.23,0.3,"No",0.7886,0.79,1,"Yes"
"9950","GO_MF","499588_GO_0030170_PYRIDOXAL_PHOSPHATE_BINDING",53,-1.1816,0.22,0.42,"No",-0.9519,0.52,0.95,"No"
"9951","REACTOME","106263_REACT_1698_METABOLISM_OF_NUCLEOTIDES",79,-1.1816,0.18,0.41,"No",0.7489,0.97,1,"Yes"
"9952","GO_CC","490811_GO_0005782_PEROXISOMAL_MATRIX",34,-1.1816,0.22,0.46,"No",0.7937,0.79,0.96,"Yes"
"9953","GO_BP","507954_GO_0045606_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION",18,-1.1815,0.25,0.38,"No",-1.1376,0.27,0.93,"No"
"9954","GO_MF","511632_GO_0050660_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING",69,-1.1814,0.2,0.42,"No",0.6906,0.98,1,"Yes"
"9955","C2_BioCarta_Pathways","C2_CP_BIOCARTA_43_BIOCARTA_VDR_PATHWAY",12,-1.1814,0.27,0.36,"No",-0.9845,0.49,1,"No"
"9956","C4_Cancer_gene_neighborhoods","C4_CGN_239_GCM_MAP4K4",169,-1.1813,0.15,0.36,"No",-0.9938,0.47,0.88,"No"
"9957","C2_Chemical_and_genetic_perturbations","C2_CGP_1855_LIANG_SILENCED_BY_METHYLATION_UP",29,-1.1813,0.22,0.3,"No",-0.9312,0.57,1,"No"
"9958","C4_Cancer_modules","C4_CM_213_MODULE_234",51,-1.1812,0.21,0.31,"No",1.0514,0.36,0.62,"Yes"
"9959","KEGG_compound","C00550_SPHINGOMYELIN",7,-1.1812,0.27,0.41,"No",0.7594,0.77,1,"Yes"
"9960","GO_CC","496879_GO_0017059_SERINE_C_PALMITOYLTRANSFERASE_COMPLEX",6,-1.1808,0.29,0.46,"No",-1.3101,0.15,0.64,"No"
"9961","GO_BP","506047_GO_0042953_LIPOPROTEIN_TRANSPORT",13,-1.1808,0.26,0.38,"No",0.8305,0.71,1,"Yes"
"9962","GO_BP","506499_GO_0043467_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY",75,-1.1806,0.18,0.38,"No",1.029,0.39,0.97,"Yes"
"9963","GO_CC","486674_GO_0000138_GOLGI_TRANS_CISTERNA",5,-1.1805,0.27,0.46,"No",0.6704,0.87,0.99,"Yes"
"9964","GO_BP","491013_GO_0006027_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS",58,-1.1805,0.19,0.38,"No",-0.754,0.9,1,"No"
"9965","C3_TF_targets","C3_TFT_87_V_GATA1_03",234,-1.1803,0.14,0.22,"No",1.1629,0.12,0.86,"Yes"
"9966","GO_BP","494955_GO_0010891_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE",5,-1.1803,0.27,0.38,"No",-0.6764,0.87,1,"No"
"9967","C3_MicroRNA_targets","C3_MIR_163_AGTCTTA_MIR_499",74,-1.1802,0.19,0.34,"No",0.7627,0.92,1,"Yes"
"9968","C2_Chemical_and_genetic_perturbations","C2_CGP_802_DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP",18,-1.1801,0.24,0.3,"No",0.61,0.97,1,"Yes"
"9969","C7_Immunologic_signatures","C7_ALL_1556_GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN",196,-1.1801,0.15,0.21,"No",0.7201,1,1,"Yes"
"9970","KEGG_compound","C00584_PROSTAGLANDIN_E2_5Z_13E_15S_11ALPHA_15_DIHYDROXY_9_OXOPROSTA_5_13_DIENOATE_5Z_13E_15S_11ALPHA_15_DIHYDROXY_9_OXOPROST_13_ENOATE_DINOPROSTONE_PGE2",5,-1.1801,0.27,0.41,"No",0.6527,0.87,1,"Yes"
"9971","GO_MF","499435_GO_0048018_RECEPTOR_AGONIST_ACTIVITY",15,-1.1801,0.26,0.43,"No",-0.7877,0.78,1,"No"
"9972","GO_CC","506156_GO_0043073_GERM_CELL_NUCLEUS",22,-1.18,0.26,0.46,"No",-1.2443,0.16,0.63,"No"
"9973","C2_Chemical_and_genetic_perturbations","C2_CGP_331_GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN",10,-1.1799,0.27,0.3,"No",0.7258,0.82,1,"Yes"
"9974","C4_Cancer_gene_neighborhoods","C4_CGN_80_MORF_CTSB",180,-1.1799,0.15,0.36,"No",1.063,0.27,0.44,"Yes"
"9975","C3_MicroRNA_targets","C3_MIR_58_GTGTGAG_MIR_342",65,-1.1799,0.2,0.34,"No",-0.7618,0.89,1,"No"
"9976","C2_Chemical_and_genetic_perturbations","C2_CGP_3245_SERVITJA_LIVER_HNF1A_TARGETS_DN",153,-1.1799,0.16,0.3,"No",1.2485,0.057,0.44,"Yes"
"9977","GO_CC","492611_GO_0008290_F_ACTIN_CAPPING_PROTEIN_COMPLEX",9,-1.1798,0.25,0.46,"No",0.9161,0.56,0.87,"Yes"
"9978","C7_Immunologic_signatures","C7_ALL_388_GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN",198,-1.1795,0.15,0.22,"No",-1.3982,0.0017,0.22,"No"
"9979","C7_Immunologic_signatures","C7_ALL_575_GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_UP",200,-1.1794,0.13,0.22,"No",1.3977,0.0046,0.038,"Yes"
"9980","GO_BP","505561_GO_0042420_DOPAMINE_CATABOLIC_PROCESS",5,-1.1793,0.29,0.38,"No",0.7994,0.74,1,"Yes"
"9981","C4_Cancer_modules","C4_CM_251_MODULE_285",49,-1.1792,0.21,0.31,"No",-0.998,0.45,0.79,"No"
"9982","C3_TF_targets","C3_TFT_525_TGTYNNNNNRGCARM_UNKNOWN",83,-1.1791,0.2,0.22,"No",0.7812,0.9,1,"Yes"
"9983","GO_MF","750742_GO_0001190_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",40,-1.179,0.22,0.43,"No",-1.326,0.096,0.73,"No"
"9984","REACTOME","187203_REACT_23765_REDUCTION_OF_CYTOSOLIC_CA_LEVELS",10,-1.179,0.25,0.42,"No",-1.2983,0.16,0.67,"No"
"9985","C2_Chemical_and_genetic_perturbations","C2_CGP_181_BARRIER_COLON_CANCER_RECURRENCE_DN",20,-1.179,0.26,0.3,"No",-1.0025,0.44,1,"No"
"9986","C3_TF_targets","C3_TFT_216_CCAWYNNGAAR_UNKNOWN",143,-1.1789,0.17,0.22,"No",0.8101,0.89,1,"Yes"
"9987","C2_Chemical_and_genetic_perturbations","C2_CGP_2760_YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP",39,-1.1789,0.22,0.3,"No",0.6546,0.97,1,"Yes"
"9988","C7_Immunologic_signatures","C7_ALL_1323_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP",195,-1.1788,0.15,0.22,"No",1.0137,0.43,0.7,"Yes"
"9989","C7_Immunologic_signatures","C7_ALL_608_GSE17721_LPS_VS_PAM3CSK4_6H_BMDM_DN",198,-1.1788,0.16,0.22,"No",1.2432,0.033,0.16,"Yes"
"9990","C2_Chemical_and_genetic_perturbations","C2_CGP_3085_FIGUEROA_AML_METHYLATION_CLUSTER_4_DN",13,-1.1787,0.26,0.3,"No",-0.6066,0.96,1,"No"
"9991","GO_BP","486621_GO_0000080_MITOTIC_G1_PHASE",30,-1.1785,0.22,0.38,"No",1.049,0.4,0.95,"Yes"
"9992","GO_CC","499805_GO_0030427_SITE_OF_POLARIZED_GROWTH",129,-1.1785,0.18,0.46,"No",0.7007,0.99,0.99,"Yes"
"9993","GO_MF","496743_GO_0016849_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY",22,-1.1784,0.24,0.43,"No",-0.5875,0.97,1,"No"
"9994","WikiPathways","198802_WP1591_HEART_DEVELOPMENT",42,-1.1784,0.23,0.33,"No",-1.3983,0.064,0.95,"No"
"9995","GO_BP","500891_GO_0031642_NEGATIVE_REGULATION_OF_MYELINATION",6,-1.1782,0.28,0.38,"No",0.9546,0.5,1,"Yes"
"9996","GO_MF","499871_GO_0030545_RECEPTOR_REGULATOR_ACTIVITY",43,-1.178,0.22,0.43,"No",-0.9967,0.48,0.91,"No"
"9997","C4_Cancer_modules","C4_CM_100_MODULE_105",198,-1.1778,0.16,0.31,"No",1.4522,0,0.15,"Yes"
"9998","C7_Immunologic_signatures","C7_ALL_640_GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_DN",199,-1.1777,0.14,0.22,"No",0.9559,0.58,0.88,"Yes"
"9999","C2_Chemical_and_genetic_perturbations","C2_CGP_2278_ITO_PTTG1_TARGETS_UP",12,-1.1777,0.26,0.3,"No",1.5421,0.042,0.17,"Yes"
"10000","C3_TF_targets","C3_TFT_506_RNTCANNRNNYNATTW_UNKNOWN",60,-1.1776,0.2,0.23,"No",-1.1583,0.21,0.43,"No"
"10001","C3_MicroRNA_targets","C3_MIR_193_CAGCACT_MIR_512_3P",155,-1.1776,0.15,0.34,"No",-0.758,0.98,1,"No"
"10002","C2_Chemical_and_genetic_perturbations","C2_CGP_2191_RIZKI_TUMOR_INVASIVENESS_3D_DN",267,-1.1776,0.13,0.3,"No",1.1054,0.19,0.62,"Yes"
"10003","KEGG_compound","C00058_FORMATE_METHANOIC_ACID_FORMIC_ACID",9,-1.1775,0.28,0.41,"No",-0.8739,0.62,1,"No"
"10004","C2_Chemical_and_genetic_perturbations","C2_CGP_2342_GRADE_METASTASIS_DN",45,-1.1774,0.21,0.3,"No",1.4117,0.049,0.28,"Yes"
"10005","REACTOME","645296_REACT_121096_EGFR_TRANSACTIVATION_BY_GASTRIN",9,-1.1774,0.27,0.42,"No",0.5972,0.94,1,"Yes"
"10006","GO_BP","487599_GO_0001696_GASTRIC_ACID_SECRETION",6,-1.1774,0.28,0.38,"No",-0.6429,0.9,1,"No"
"10007","C2_Chemical_and_genetic_perturbations","C2_CGP_2773_MIKKELSEN_IPS_WITH_HCP_H3K27ME3",95,-1.1773,0.18,0.3,"No",1.7858,0,0.047,"Yes"
"10008","C2_Chemical_and_genetic_perturbations","C2_CGP_1762_BURTON_ADIPOGENESIS_5",126,-1.1773,0.16,0.3,"No",1.6928,0,0.087,"Yes"
"10009","C2_Chemical_and_genetic_perturbations","C2_CGP_655_HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3",7,-1.1773,0.27,0.3,"No",-1.3951,0.096,0.59,"No"
"10010","GO_BP","513578_GO_0060020_BERGMANN_GLIAL_CELL_DIFFERENTIATION",5,-1.1772,0.28,0.38,"No",0.9111,0.55,1,"Yes"
"10011","C7_Immunologic_signatures","C7_ALL_1762_GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN",186,-1.1772,0.14,0.22,"No",0.8917,0.8,1,"Yes"
"10012","C3_MicroRNA_targets","C3_MIR_160_TCATCTC_MIR_143",146,-1.1771,0.17,0.34,"No",-1.2772,0.053,1,"No"
"10013","C3_TF_targets","C3_TFT_445_V_MYB_Q5_01",263,-1.177,0.12,0.23,"No",0.9118,0.74,1,"Yes"
"10014","GO_BP","518694_GO_2000045_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",134,-1.177,0.17,0.38,"No",1.372,0.024,0.58,"Yes"
"10015","GO_BP","519155_GO_2000515_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",11,-1.1768,0.28,0.38,"No",-1.0099,0.42,0.98,"No"
"10016","REACTOME","161000_REACT_22351_DCC_MEDIATED_ATTRACTIVE_SIGNALING",14,-1.1767,0.26,0.42,"No",0.7529,0.79,1,"Yes"
"10017","C4_Cancer_modules","C4_CM_223_MODULE_244",187,-1.1767,0.14,0.31,"No",0.8796,0.82,0.88,"Yes"
"10018","GO_BP","982276_GO_0090559_REGULATION_OF_MEMBRANE_PERMEABILITY",32,-1.1767,0.22,0.38,"No",1.1756,0.22,0.81,"Yes"
"10019","C3_TF_targets","C3_TFT_397_V_IRF1_Q6",250,-1.1767,0.12,0.23,"No",0.8128,0.96,1,"Yes"
"10020","GO_BP","504449_GO_0035265_ORGAN_GROWTH",64,-1.1766,0.2,0.38,"No",0.9308,0.6,1,"Yes"
"10021","C3_MicroRNA_targets","C3_MIR_38_GGGACCA_MIR_133A_MIR_133B",199,-1.1765,0.17,0.34,"No",-0.9708,0.51,1,"No"
"10022","C7_Immunologic_signatures","C7_ALL_1348_GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN",200,-1.1765,0.15,0.22,"No",-0.8847,0.76,1,"No"
"10023","C2_Chemical_and_genetic_perturbations","C2_CGP_2858_CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL",16,-1.1765,0.24,0.31,"No",1.1192,0.3,0.6,"Yes"
"10024","C2_Chemical_and_genetic_perturbations","C2_CGP_278_SENESE_HDAC2_TARGETS_DN",125,-1.1764,0.18,0.31,"No",1.3849,0.018,0.31,"Yes"
"10025","GO_BP","751079_GO_0036159_INNER_DYNEIN_ARM_ASSEMBLY",7,-1.1764,0.29,0.38,"No",-1.3326,0.16,0.9,"No"
"10026","KEGG_pathway","HSA04920_ADIPOCYTOKINE_SIGNALING_PATHWAY",70,-1.1764,0.21,0.26,"No",-0.8076,0.87,1,"No"
"10027","C7_Immunologic_signatures","C7_ALL_1505_GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP",200,-1.1763,0.14,0.22,"No",1.1162,0.2,0.4,"Yes"
"10028","GO_BP","511672_GO_0050701_INTERLEUKIN_1_SECRETION",6,-1.1763,0.27,0.38,"No",0.8811,0.64,1,"Yes"
"10029","GO_BP","494402_GO_0010332_RESPONSE_TO_GAMMA_RADIATION",44,-1.1762,0.2,0.38,"No",0.8176,0.8,1,"Yes"
"10030","C7_Immunologic_signatures","C7_ALL_1796_GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN",193,-1.1762,0.15,0.22,"No",1.3055,0.024,0.097,"Yes"
"10031","C2_Chemical_and_genetic_perturbations","C2_CGP_690_MATTIOLI_MGUS_VS_PCL",102,-1.1761,0.18,0.31,"No",1.6937,0,0.087,"Yes"
"10032","GO_BP","487851_GO_0001961_POSITIVE_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",26,-1.176,0.24,0.38,"No",-0.824,0.74,1,"No"
"10033","C4_Cancer_modules","C4_CM_54_MODULE_58",21,-1.1759,0.25,0.31,"No",-0.9218,0.56,0.88,"No"
"10034","KEGG_pathway","HSA05218_MELANOMA",63,-1.1758,0.23,0.26,"No",0.9187,0.62,1,"Yes"
"10035","WikiPathways","198835_WP47_HEDGEHOG_SIGNALING_PATHWAY",21,-1.1758,0.25,0.33,"No",-1.276,0.15,0.99,"No"
"10036","GO_MF","487626_GO_0001727_LIPID_KINASE_ACTIVITY",6,-1.1758,0.29,0.43,"No",-0.87,0.62,1,"No"
"10037","C2_Chemical_and_genetic_perturbations","C2_CGP_610_TURJANSKI_MAPK7_TARGETS",8,-1.1756,0.28,0.31,"No",-0.5991,0.95,1,"No"
"10038","C3_MicroRNA_targets","C3_MIR_167_AGCTCCT_MIR_28",89,-1.1756,0.18,0.34,"No",-1.1782,0.15,1,"No"
"10039","C2_Chemical_and_genetic_perturbations","C2_CGP_1120_STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP",193,-1.1756,0.15,0.31,"No",-0.6689,1,1,"No"
"10040","KEGG_compound","C05973_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_1_LYSOPHOSPHATIDYLETHANOLAMINE_O_2_ACYL_SN_GLYCERO_3_PHOSPHO_ETHANOLAMINE",5,-1.1753,0.29,0.41,"No",-0.6765,0.83,1,"No"
"10041","C2_Chemical_and_genetic_perturbations","C2_CGP_1739_MEDINA_SMARCA4_TARGETS",44,-1.1753,0.21,0.31,"No",-1.4022,0.046,0.58,"No"
"10042","GO_MF","514955_GO_0070016_ARMADILLO_REPEAT_DOMAIN_BINDING",11,-1.1753,0.27,0.43,"No",-0.7091,0.84,1,"No"
"10043","GO_BP","492648_GO_0008333_ENDOSOME_TO_LYSOSOME_TRANSPORT",30,-1.1753,0.23,0.38,"No",-0.5611,0.99,1,"No"
"10044","GO_BP","754607_GO_1901655_CELLULAR_RESPONSE_TO_KETONE",36,-1.1753,0.23,0.38,"No",1.0745,0.36,0.93,"Yes"
"10045","C3_TF_targets","C3_TFT_361_V_ATF1_Q6",229,-1.1753,0.15,0.23,"No",0.9322,0.68,1,"Yes"
"10046","GO_MF","507852_GO_0045502_DYNEIN_BINDING",18,-1.1751,0.24,0.43,"No",-0.9556,0.51,0.95,"No"
"10047","C3_MicroRNA_targets","C3_MIR_182_TTTTGAG_MIR_373",223,-1.1751,0.14,0.33,"No",0.9088,0.74,1,"Yes"
"10048","GO_BP","488191_GO_0002318_MYELOID_PROGENITOR_CELL_DIFFERENTIATION",7,-1.1751,0.28,0.38,"No",-1.0704,0.38,0.96,"No"
"10049","OMIM_gene","OMIM611266_POTE_ANKYRIN_DOMAIN_FAMILY_MEMBER_K_PSEUDOGENE_POTEKP",7,-1.1751,0.28,0.76,"No",1.4165,0.11,0.85,"Yes"
"10050","GO_BP","506411_GO_0043372_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",19,-1.1751,0.25,0.38,"No",-1.3482,0.11,0.93,"No"
"10051","GO_BP","516244_GO_0071320_CELLULAR_RESPONSE_TO_CAMP",44,-1.175,0.22,0.38,"No",-0.8776,0.67,1,"No"
"10052","C6_Oncogenic_signatures","C6_ALL_123_RB_P107_DN_V1_DN",116,-1.175,0.19,0.21,"No",1.1738,0.15,0.4,"Yes"
"10053","GO_BP","506319_GO_0043252_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT",13,-1.175,0.26,0.38,"No",-1.1785,0.28,0.91,"No"
"10054","C2_Chemical_and_genetic_perturbations","C2_CGP_2210_YAMASHITA_METHYLATED_IN_PROSTATE_CANCER",53,-1.1749,0.22,0.31,"No",-1.1278,0.25,0.89,"No"
"10055","GO_BP","501608_GO_0032373_POSITIVE_REGULATION_OF_STEROL_TRANSPORT",15,-1.1749,0.24,0.38,"No",0.7029,0.89,1,"Yes"
"10056","REACTOME","1127574_REACT_264618_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS",13,-1.1748,0.23,0.42,"No",1.1004,0.31,0.58,"Yes"
"10057","GO_BP","501331_GO_0032094_RESPONSE_TO_FOOD",16,-1.1748,0.25,0.38,"No",-1.1781,0.23,0.91,"No"
"10058","GO_BP","753159_GO_1900165_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_SECRETION",5,-1.1748,0.26,0.38,"No",-0.9978,0.5,0.99,"No"
"10059","GO_BP","503595_GO_0034393_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS",5,-1.1748,0.31,0.38,"No",-0.7432,0.77,1,"No"
"10060","C1_Positional","C1_ALL_29_CHR4P12",19,-1.1747,0.25,0.75,"No",-0.9763,0.5,1,"No"
"10061","GO_BP","512120_GO_0051224_NEGATIVE_REGULATION_OF_PROTEIN_TRANSPORT",169,-1.1746,0.16,0.38,"No",0.7529,0.99,1,"Yes"
"10062","C3_TF_targets","C3_TFT_149_V_NFY_C",241,-1.1746,0.15,0.23,"No",-0.9094,0.71,0.95,"No"
"10063","GO_BP","516747_GO_0071825_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION",33,-1.1745,0.24,0.38,"No",0.811,0.74,1,"Yes"
"10064","KEGG_pathway","HSA00533_GLYCOSAMINOGLYCAN_BIOSYNTHESIS",15,-1.1744,0.26,0.26,"No",-0.6087,0.96,1,"No"
"10065","C7_Immunologic_signatures","C7_ALL_1158_GSE27786_LSK_VS_NEUTROPHIL_DN",198,-1.1743,0.15,0.22,"No",0.9093,0.73,1,"Yes"
"10066","C7_Immunologic_signatures","C7_ALL_295_GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP",198,-1.1742,0.16,0.22,"No",1.3173,0.023,0.087,"Yes"
"10067","GO_BP","490569_GO_0043267_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT",22,-1.1742,0.25,0.38,"No",-0.8225,0.74,1,"No"
"10068","C7_Immunologic_signatures","C7_ALL_735_GSE17721_0_5H_VS_24H_PAM3CSK4_BMDM_UP",198,-1.1741,0.14,0.22,"No",1.6125,0,0.0024,"Yes"
"10069","REACTOME","105669_REACT_963_APOPTOTIC_FACTOR_MEDIATED_RESPONSE",7,-1.1741,0.27,0.42,"No",0.9346,0.53,0.85,"Yes"
"10070","GO_BP","511938_GO_0051005_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY",5,-1.1741,0.29,0.39,"No",0.5968,0.91,1,"Yes"
"10071","C3_TF_targets","C3_TFT_112_V_RORA2_01",144,-1.174,0.16,0.23,"No",-1.061,0.34,0.63,"No"
"10072","C2_Chemical_and_genetic_perturbations","C2_CGP_1753_LINDVALL_IMMORTALIZED_BY_TERT_DN",78,-1.174,0.21,0.31,"No",-1.168,0.18,0.83,"No"
"10073","C2_Chemical_and_genetic_perturbations","C2_CGP_1164_SHIN_B_CELL_LYMPHOMA_CLUSTER_1",13,-1.174,0.25,0.31,"No",-1.167,0.26,0.83,"No"
"10074","C2_Chemical_and_genetic_perturbations","C2_CGP_1542_NGUYEN_NOTCH1_TARGETS_DN",86,-1.1739,0.19,0.31,"No",-0.9686,0.5,1,"No"
"10075","GO_BP","496040_GO_0015918_STEROL_TRANSPORT",49,-1.1738,0.21,0.39,"No",0.9391,0.58,1,"Yes"
"10076","GO_BP","500599_GO_0031340_POSITIVE_REGULATION_OF_VESICLE_FUSION",8,-1.1738,0.27,0.39,"No",0.9655,0.51,1,"Yes"
"10077","GO_MF","490459_GO_0005217_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",23,-1.1738,0.27,0.43,"No",0.7833,0.76,1,"Yes"
"10078","C7_Immunologic_signatures","C7_ALL_947_GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP",189,-1.1737,0.16,0.22,"No",0.7482,0.99,1,"Yes"
"10079","GO_BP","487477_GO_0001539_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY",11,-1.1736,0.28,0.39,"No",-1.6954,0.016,0.6,"No"
"10080","C7_Immunologic_signatures","C7_ALL_1856_GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN",192,-1.1733,0.15,0.22,"No",-0.8376,0.86,1,"No"
"10081","GO_MF","501232_GO_0031994_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING",8,-1.1733,0.29,0.43,"No",0.767,0.75,1,"Yes"
"10082","C2_Chemical_and_genetic_perturbations","C2_CGP_3173_SUMI_HNF4A_TARGETS",31,-1.173,0.24,0.31,"No",-1.032,0.38,0.97,"No"
"10083","GO_BP","514527_GO_0060972_LEFT_RIGHT_PATTERN_FORMATION",24,-1.1729,0.24,0.39,"No",-1.9804,0,0.48,"No"
"10084","C7_Immunologic_signatures","C7_ALL_523_GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_UP",200,-1.1729,0.15,0.22,"No",1.4522,0.0045,0.022,"Yes"
"10085","REACTOME","106463_REACT_12077_SIGNALLING_TO_P38_VIA_RIT_AND_RIN",21,-1.1729,0.26,0.43,"No",-0.545,0.99,1,"No"
"10086","GO_BP","507475_GO_0045075_REGULATION_OF_INTERLEUKIN_12_BIOSYNTHETIC_PROCESS",9,-1.1728,0.27,0.39,"No",-1.2066,0.23,0.88,"No"
"10087","GO_MF","499372_GO_0022821_POTASSIUM_ION_ANTIPORTER_ACTIVITY",7,-1.1728,0.29,0.43,"No",0.7274,0.82,1,"Yes"
"10088","C7_Immunologic_signatures","C7_ALL_1489_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP",190,-1.1727,0.16,0.23,"No",1.2805,0.026,0.12,"Yes"
"10089","REACTOME","187172_REACT_23824_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP_",12,-1.1726,0.25,0.43,"No",1.3098,0.14,0.31,"Yes"
"10090","GO_BP","514116_GO_0060561_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS",17,-1.1725,0.26,0.39,"No",-1.2316,0.19,0.9,"No"
"10091","C4_Cancer_modules","C4_CM_315_MODULE_367",29,-1.1725,0.22,0.32,"No",0.8355,0.75,0.93,"Yes"
"10092","GO_CC","514745_GO_0061200_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE",7,-1.1724,0.27,0.47,"No",-0.8207,0.69,1,"No"
"10093","GO_BP","495109_GO_0014037_SCHWANN_CELL_DIFFERENTIATION",31,-1.1724,0.24,0.39,"No",-1.0685,0.35,0.96,"No"
"10094","KEGG_compound","C16218__2E_OCTADECENOYL_COA_TRANS_OCTADEC_2_ENOYL_COA",6,-1.1723,0.28,0.42,"No",1.0965,0.36,1,"Yes"
"10095","C2_Chemical_and_genetic_perturbations","C2_CGP_623_BAKER_HEMATOPOESIS_STAT5_TARGETS",7,-1.1723,0.29,0.31,"No",-0.855,0.63,1,"No"
"10096","GO_BP","517005_GO_0072089_STEM_CELL_PROLIFERATION",59,-1.1722,0.22,0.39,"No",-0.7612,0.89,1,"No"
"10097","GO_BP","501512_GO_0032277_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION",7,-1.1721,0.26,0.39,"No",0.9297,0.53,1,"Yes"
"10098","C2_Chemical_and_genetic_perturbations","C2_CGP_3303_GUILLAUMOND_KLF10_TARGETS_UP",49,-1.1721,0.2,0.31,"No",0.8738,0.71,0.95,"Yes"
"10099","GO_BP","508151_GO_0045830_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING",14,-1.1718,0.27,0.39,"No",-1.6399,0.023,0.69,"No"
"10100","GO_BP","498242_GO_0019400_ALDITOL_METABOLIC_PROCESS",25,-1.1717,0.24,0.39,"No",0.8151,0.75,1,"Yes"
"10101","C7_Immunologic_signatures","C7_ALL_44_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN",186,-1.1716,0.15,0.23,"No",-0.7029,1,1,"No"
"10102","REACTOME","366221_REACT_75908_POTASSIUM_CHANNELS",98,-1.1714,0.19,0.43,"No",-1.1151,0.26,0.88,"No"
"10103","GO_BP","488118_GO_0002244_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",113,-1.1713,0.19,0.39,"No",0.9139,0.68,1,"Yes"
"10104","C7_Immunologic_signatures","C7_ALL_741_GSE17721_0_5H_VS_12H_CPG_BMDM_UP",200,-1.1713,0.14,0.23,"No",1.4629,0.0024,0.019,"Yes"
"10105","GO_BP","498181_GO_0019336_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS",7,-1.1712,0.28,0.39,"No",1.0414,0.43,0.96,"Yes"
"10106","GO_BP","1129209_GO_0044872_LIPOPROTEIN_LOCALIZATION",13,-1.171,0.25,0.39,"No",0.8337,0.67,1,"Yes"
"10107","C3_TF_targets","C3_TFT_100_V_AHR_01",64,-1.1709,0.21,0.24,"No",-1.0614,0.33,0.63,"No"
"10108","WikiPathways","198762_WP1471_TOR_SIGNALING",34,-1.1709,0.24,0.34,"No",0.5997,0.98,1,"Yes"
"10109","C3_MicroRNA_targets","C3_MIR_18_ACATTCC_MIR_1_MIR_206",296,-1.1708,0.12,0.34,"No",0.9448,0.65,1,"Yes"
"10110","C2_Chemical_and_genetic_perturbations","C2_CGP_685_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21",6,-1.1708,0.27,0.31,"No",0.7013,0.83,1,"Yes"
"10111","C2_Chemical_and_genetic_perturbations","C2_CGP_752_XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP",35,-1.1707,0.25,0.31,"No",-0.5888,0.98,1,"No"
"10112","GO_BP","505565_GO_0042424_CATECHOLAMINE_CATABOLIC_PROCESS",6,-1.1705,0.29,0.39,"No",0.7024,0.84,1,"Yes"
"10113","C2_Chemical_and_genetic_perturbations","C2_CGP_3103_THILLAINADESAN_ZNF217_TARGETS_UP",44,-1.1705,0.23,0.31,"No",1.0127,0.42,0.78,"Yes"
"10114","GO_BP","498745_GO_0019985_TRANSLESION_SYNTHESIS",12,-1.1704,0.26,0.39,"No",-1.1417,0.29,0.93,"No"
"10115","GO_BP","518339_GO_0090199_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",45,-1.1704,0.23,0.39,"No",1.0892,0.32,0.92,"Yes"
"10116","C7_Immunologic_signatures","C7_ALL_1305_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP",194,-1.1704,0.17,0.23,"No",0.7833,0.96,1,"Yes"
"10117","C2_Chemical_and_genetic_perturbations","C2_CGP_1681_SESTO_RESPONSE_TO_UV_C2",54,-1.1704,0.2,0.31,"No",1.1209,0.23,0.6,"Yes"
"10118","C4_Cancer_modules","C4_CM_134_MODULE_139",75,-1.1703,0.2,0.32,"No",-1.2032,0.18,0.62,"No"
"10119","C2_Chemical_and_genetic_perturbations","C2_CGP_1432_FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP",63,-1.1702,0.23,0.31,"No",1.3345,0.055,0.36,"Yes"
"10120","C2_Chemical_and_genetic_perturbations","C2_CGP_3382_ZWANG_EGF_PERSISTENTLY_UP",32,-1.1701,0.24,0.31,"No",0.8896,0.65,0.94,"Yes"
"10121","GO_CC","499804_GO_0030426_GROWTH_CONE",126,-1.1701,0.18,0.48,"No",0.6601,1,0.99,"Yes"
"10122","GO_BP","499465_GO_0023058_ADAPTATION_OF_SIGNALING_PATHWAY",20,-1.17,0.25,0.39,"No",-1.2481,0.19,0.91,"No"
"10123","C2_Chemical_and_genetic_perturbations","C2_CGP_972_WILLIAMS_ESR1_TARGETS_UP",26,-1.17,0.25,0.31,"No",0.8952,0.63,0.93,"Yes"
"10124","KEGG_compound","C14749_19_S_HETE_19S_HYDROXYEICOSATETRAENOIC_ACID_19S_HYDROXYICOSATETRAENOIC_ACID_19S_HYDROXY_ARACHIDONIC_ACID",6,-1.17,0.27,0.42,"No",-1.448,0.11,0.37,"No"
"10125","REACTOME","160977_REACT_22279_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM",184,-1.17,0.15,0.43,"No",-0.5441,1,1,"No"
"10126","C2_Chemical_and_genetic_perturbations","C2_CGP_886_KIM_MYCN_AMPLIFICATION_TARGETS_DN",100,-1.1699,0.19,0.31,"No",-0.734,0.95,1,"No"
"10127","C2_Chemical_and_genetic_perturbations","C2_CGP_861_MAINA_VHL_TARGETS_UP",10,-1.1698,0.28,0.31,"No",-1.2965,0.18,0.7,"No"
"10128","C2_Chemical_and_genetic_perturbations","C2_CGP_2905_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN",70,-1.1697,0.2,0.31,"No",-1.2406,0.13,0.75,"No"
"10129","C7_Immunologic_signatures","C7_ALL_1374_GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN",199,-1.1697,0.16,0.23,"No",-0.755,0.98,1,"No"
"10130","GO_BP","516793_GO_0071872_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS",11,-1.1695,0.25,0.39,"No",-0.7471,0.8,1,"No"
"10131","GO_BP","495022_GO_0010957_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS",5,-1.1695,0.31,0.39,"No",-1.1641,0.31,0.91,"No"
"10132","C2_Chemical_and_genetic_perturbations","C2_CGP_1744_DELASERNA_MYOD_TARGETS_UP",89,-1.1694,0.19,0.31,"No",-0.9619,0.53,1,"No"
"10133","GO_BP","508747_GO_0046487_GLYOXYLATE_METABOLIC_PROCESS",8,-1.1692,0.29,0.39,"No",1.1043,0.34,0.9,"Yes"
"10134","C3_MicroRNA_targets","C3_MIR_133_GAGCCAG_MIR_149",143,-1.1692,0.17,0.34,"No",-1.0745,0.3,1,"No"
"10135","GO_BP","514064_GO_0060509_TYPE_I_PNEUMOCYTE_DIFFERENTIATION",7,-1.1689,0.3,0.39,"No",0.7683,0.76,1,"Yes"
"10136","GO_BP","490988_GO_0006000_FRUCTOSE_METABOLIC_PROCESS",11,-1.1688,0.27,0.39,"No",0.4691,0.99,1,"Yes"
"10137","C2_Chemical_and_genetic_perturbations","C2_CGP_1655_RHODES_CANCER_META_SIGNATURE",64,-1.1688,0.2,0.31,"No",1.0747,0.32,0.67,"Yes"
"10138","GO_CC","490705_GO_0005639_INTEGRAL_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE",13,-1.1686,0.27,0.48,"No",-0.8775,0.61,0.96,"No"
"10139","GO_BP","501647_GO_0032415_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY",6,-1.1685,0.3,0.39,"No",0.8601,0.64,1,"Yes"
"10140","C2_Chemical_and_genetic_perturbations","C2_CGP_1367_CHEOK_RESPONSE_TO_HD_MTX_DN",24,-1.1684,0.25,0.32,"No",-0.8855,0.63,1,"No"
"10141","C2_Chemical_and_genetic_perturbations","C2_CGP_1009_LIU_NASOPHARYNGEAL_CARCINOMA",67,-1.1684,0.23,0.31,"No",1.5626,0.011,0.16,"Yes"
"10142","GO_BP","519307_GO_2000668_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS",6,-1.1684,0.28,0.39,"No",-1.3148,0.18,0.88,"No"
"10143","GO_MF","496893_GO_0017080_SODIUM_CHANNEL_REGULATOR_ACTIVITY",34,-1.1683,0.23,0.44,"No",-0.9078,0.62,0.98,"No"
"10144","C2_Chemical_and_genetic_perturbations","C2_CGP_2326_MATZUK_STEROIDOGENESIS",7,-1.1683,0.3,0.31,"No",0.6178,0.91,1,"Yes"
"10145","C4_Cancer_modules","C4_CM_16_MODULE_17",358,-1.1683,0.11,0.32,"No",1.6628,0,0.055,"Yes"
"10146","C7_Immunologic_signatures","C7_ALL_1722_GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN",198,-1.1683,0.14,0.23,"No",0.8754,0.8,1,"Yes"
"10147","C3_TF_targets","C3_TFT_69_V_CDPCR3_01",51,-1.1683,0.22,0.24,"No",-0.869,0.7,0.99,"No"
"10148","C7_Immunologic_signatures","C7_ALL_485_GSE17721_CTRL_VS_PAM3CSK4_4H_BMDM_UP",198,-1.1682,0.15,0.23,"No",1.2468,0.071,0.16,"Yes"
"10149","GO_BP","498820_GO_0021536_DIENCEPHALON_DEVELOPMENT",74,-1.1681,0.21,0.39,"No",-1.0123,0.42,0.98,"No"
"10150","GO_BP","487479_GO_0001541_OVARIAN_FOLLICLE_DEVELOPMENT",46,-1.1679,0.23,0.39,"No",0.841,0.72,1,"Yes"
"10151","GO_BP","498443_GO_0019614_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS",6,-1.1679,0.28,0.39,"No",0.7356,0.78,1,"Yes"
"10152","GO_BP","500198_GO_0030903_NOTOCHORD_DEVELOPMENT",18,-1.1678,0.26,0.39,"No",-0.8567,0.67,1,"No"
"10153","GO_BP","491373_GO_0006470_PROTEIN_DEPHOSPHORYLATION",155,-1.1678,0.17,0.39,"No",1.0003,0.44,0.98,"Yes"
"10154","GO_BP","505748_GO_0042634_REGULATION_OF_HAIR_CYCLE",20,-1.1676,0.26,0.39,"No",-1.2854,0.16,0.89,"No"
"10155","GO_BP","496942_GO_0017145_STEM_CELL_DIVISION",33,-1.1676,0.25,0.39,"No",-0.7337,0.87,1,"No"
"10156","GO_BP","514161_GO_0060606_TUBE_CLOSURE",81,-1.1676,0.21,0.39,"No",-0.7499,0.93,1,"No"
"10157","GO_BP","513976_GO_0060420_REGULATION_OF_HEART_GROWTH",42,-1.1674,0.22,0.39,"No",0.871,0.69,1,"Yes"
"10158","C4_Cancer_gene_neighborhoods","C4_CGN_131_MORF_MLLT10",290,-1.1674,0.14,0.38,"No",-1.0271,0.38,0.82,"No"
"10159","GO_CC","490844_GO_0005819_SPINDLE",283,-1.167,0.14,0.48,"No",0.9635,0.57,0.82,"Yes"
"10160","C3_TF_targets","C3_TFT_354_V_TCF1P_Q6",256,-1.167,0.13,0.24,"No",-0.8697,0.82,1,"No"
"10161","C4_Cancer_modules","C4_CM_394_MODULE_497",28,-1.1669,0.26,0.32,"No",-1.6951,0.0039,0.18,"No"
"10162","C7_Immunologic_signatures","C7_ALL_309_GSE1460_DP_VS_CD4_THYMOCYTE_UP",196,-1.1668,0.16,0.24,"No",0.9618,0.57,0.86,"Yes"
"10163","C2_Chemical_and_genetic_perturbations","C2_CGP_32_LIU_SOX4_TARGETS_DN",307,-1.1668,0.14,0.32,"No",0.9646,0.59,0.84,"Yes"
"10164","C3_MicroRNA_targets","C3_MIR_23_ACTGAAA_MIR_30A_3P_MIR_30E_3P",199,-1.1666,0.15,0.34,"No",-0.9231,0.67,1,"No"
"10165","GO_BP","510907_GO_0048857_NEURAL_NUCLEUS_DEVELOPMENT",66,-1.1663,0.2,0.4,"No",0.8863,0.68,1,"Yes"
"10166","GO_BP","495215_GO_0014819_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION",9,-1.1663,0.29,0.4,"No",-1.0372,0.41,0.98,"No"
"10167","GO_BP","507966_GO_0045618_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION",13,-1.1662,0.27,0.4,"No",-1.0254,0.42,0.97,"No"
"10168","KEGG_pathway","HSA00511_OTHER_GLYCAN_DEGRADATION",18,-1.1661,0.28,0.27,"No",0.6576,0.92,1,"Yes"
"10169","GO_BP","501979_GO_0032753_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION",17,-1.166,0.27,0.4,"No",-0.9121,0.58,1,"No"
"10170","C7_Immunologic_signatures","C7_ALL_1011_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP",198,-1.166,0.16,0.24,"No",1.2871,0.037,0.11,"Yes"
"10171","GO_BP","505450_GO_0042303_MOLTING_CYCLE",89,-1.1659,0.23,0.4,"No",0.7601,0.93,1,"Yes"
"10172","C2_Chemical_and_genetic_perturbations","C2_CGP_543_DARWICHE_PAPILLOMA_RISK_HIGH_DN",172,-1.1659,0.18,0.32,"No",-0.9332,0.64,1,"No"
"10173","GO_BP","516298_GO_0071374_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS",5,-1.1659,0.3,0.4,"No",-1.2428,0.21,0.91,"No"
"10174","C3_TF_targets","C3_TFT_547_YKACATTT_UNKNOWN",270,-1.1658,0.14,0.24,"No",0.955,0.63,1,"Yes"
"10175","GO_BP","512818_GO_0051968_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",18,-1.1658,0.25,0.4,"No",-1.091,0.32,0.95,"No"
"10176","C2_Chemical_and_genetic_perturbations","C2_CGP_2504_PIONTEK_PKD1_TARGETS_UP",35,-1.1658,0.25,0.32,"No",1.1641,0.23,0.53,"Yes"
"10177","GO_BP","501670_GO_0032438_MELANOSOME_ORGANIZATION",22,-1.1656,0.25,0.4,"No",-0.6682,0.91,1,"No"
"10178","GO_BP","504808_GO_0035630_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION",5,-1.1656,0.29,0.4,"No",0.8383,0.68,1,"Yes"
"10179","C6_Oncogenic_signatures","C6_ALL_69_RAF_UP_V1_DN",191,-1.1656,0.16,0.22,"No",0.8853,0.76,0.95,"Yes"
"10180","GO_BP","506181_GO_0043101_PURINE_CONTAINING_COMPOUND_SALVAGE",16,-1.1656,0.27,0.4,"No",0.7669,0.78,1,"Yes"
"10181","WikiPathways","755438_WP2011_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS",16,-1.1656,0.29,0.34,"No",-0.5321,0.98,1,"No"
"10182","C7_Immunologic_signatures","C7_ALL_478_GSE17721_CTRL_VS_POLYIC_24H_BMDM_DN",196,-1.1655,0.16,0.24,"No",-0.7675,0.98,1,"No"
"10183","C2_Chemical_and_genetic_perturbations","C2_CGP_2856_CAIRO_LIVER_DEVELOPMENT_UP",162,-1.1652,0.17,0.32,"No",-0.9422,0.59,1,"No"
"10184","GO_BP","492457_GO_0008090_RETROGRADE_AXON_CARGO_TRANSPORT",6,-1.1652,0.28,0.4,"No",-0.7214,0.81,1,"No"
"10185","GO_MF","506591_GO_0043560_INSULIN_RECEPTOR_SUBSTRATE_BINDING",12,-1.1652,0.28,0.45,"No",-0.8101,0.73,1,"No"
"10186","C2_Chemical_and_genetic_perturbations","C2_CGP_2079_ZHENG_FOXP3_TARGETS_UP",26,-1.1652,0.26,0.32,"No",1.182,0.22,0.51,"Yes"
"10187","GO_BP","491793_GO_0050954_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS",153,-1.1652,0.18,0.4,"No",0.9376,0.62,1,"Yes"
"10188","C2_Chemical_and_genetic_perturbations","C2_CGP_523_LUCAS_HNF4A_TARGETS_DN",8,-1.1651,0.29,0.32,"No",-0.72,0.82,1,"No"
"10189","GO_BP","1026091_GO_1903319_POSITIVE_REGULATION_OF_PROTEIN_MATURATION",14,-1.1651,0.27,0.4,"No",-1.4135,0.084,0.95,"No"
"10190","GO_BP","504812_GO_0035634_RESPONSE_TO_STILBENOID",5,-1.1649,0.28,0.4,"No",-0.9909,0.49,1,"No"
"10191","C2_Chemical_and_genetic_perturbations","C2_CGP_2797_KESHELAVA_MULTIPLE_DRUG_RESISTANCE",87,-1.1649,0.2,0.32,"No",-0.8712,0.73,1,"No"
"10192","C2_Chemical_and_genetic_perturbations","C2_CGP_442_GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN",81,-1.1647,0.21,0.32,"No",-0.7556,0.92,1,"No"
"10193","GO_BP","491012_GO_0006026_AMINOGLYCAN_CATABOLIC_PROCESS",65,-1.1647,0.23,0.4,"No",1.0401,0.37,0.96,"Yes"
"10194","C6_Oncogenic_signatures","C6_ALL_71_PRC1_BMI_UP_V1_DN",174,-1.1646,0.17,0.22,"No",-1.0918,0.26,0.56,"No"
"10195","GO_BP","487661_GO_0001765_MEMBRANE_RAFT_ASSEMBLY",8,-1.1645,0.27,0.4,"No",0.8216,0.69,1,"Yes"
"10196","GO_CC","500490_GO_0031229_INTRINSIC_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE",13,-1.1645,0.27,0.48,"No",-0.8756,0.62,0.95,"No"
"10197","C2_BioCarta_Pathways","C2_CP_BIOCARTA_183_BIOCARTA_SODD_PATHWAY",10,-1.1644,0.28,0.39,"No",-0.8664,0.62,1,"No"
"10198","C2_Chemical_and_genetic_perturbations","C2_CGP_1157_SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",27,-1.1644,0.25,0.32,"No",-0.8858,0.64,1,"No"
"10199","GO_BP","493421_GO_0009225_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS",31,-1.1643,0.24,0.4,"No",-0.6931,0.92,1,"No"
"10200","C4_Cancer_modules","C4_CM_270_MODULE_308",71,-1.1643,0.23,0.33,"No",0.6984,0.97,1,"Yes"
"10201","GO_MF","493551_GO_0009374_BIOTIN_BINDING",5,-1.1641,0.28,0.45,"No",-1.3006,0.18,0.77,"No"
"10202","GO_BP","510603_GO_0048532_ANATOMICAL_STRUCTURE_ARRANGEMENT",20,-1.164,0.26,0.4,"No",-0.9589,0.52,1,"No"
"10203","REACTOME","106339_REACT_12606_GRB2_EVENTS_IN_EGFR_SIGNALING",21,-1.1639,0.26,0.44,"No",0.7411,0.87,1,"Yes"
"10204","C3_MicroRNA_targets","C3_MIR_180_GTGCAAA_MIR_507",128,-1.1639,0.18,0.35,"No",-0.9225,0.66,1,"No"
"10205","GO_CC","490914_GO_0005915_ZONULA_ADHERENS",8,-1.1638,0.28,0.48,"No",-1.3606,0.12,0.6,"No"
"10206","GO_BP","498629_GO_0046689_RESPONSE_TO_MERCURY_ION",15,-1.1637,0.24,0.4,"No",-1.1207,0.31,0.94,"No"
"10207","WikiPathways","760635_WP2361_GASTRIC_CANCER_NETWORK_1",41,-1.1637,0.23,0.34,"No",-1.2151,0.15,0.95,"No"
"10208","C3_TF_targets","C3_TFT_22_V_CREBP1_01",180,-1.1637,0.17,0.25,"No",-1.1838,0.12,0.39,"No"
"10209","C3_TF_targets","C3_TFT_184_V_RREB1_01",201,-1.1637,0.16,0.25,"No",-1.2332,0.064,0.29,"No"
"10210","KEGG_reaction","R01175_BUTANOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_BUTANOYL_COA_FAD_FADH2_CROTONOYL_COA",5,-1.1636,0.27,0.41,"No",-0.5252,0.96,0.99,"No"
"10211","KEGG_module","HSA_M00693_CELL_CYCLE",10,-1.1635,0.29,0.64,"No",0.5775,0.97,1,"Yes"
"10212","GO_BP","486716_GO_0000185_ACTIVATION_OF_MAPKKK_ACTIVITY",9,-1.1635,0.29,0.4,"No",-1.5722,0.049,0.73,"No"
"10213","C2_Chemical_and_genetic_perturbations","C2_CGP_1110_BENPORATH_NOS_TARGETS",178,-1.1634,0.17,0.32,"No",0.9209,0.69,0.9,"Yes"
"10214","GO_BP","497180_GO_0018209_PEPTIDYL_SERINE_MODIFICATION",122,-1.1634,0.19,0.4,"No",-1.2163,0.096,0.88,"No"
"10215","REACTOME","106374_REACT_18289_P2Y_RECEPTORS",12,-1.1634,0.28,0.44,"No",1.8152,0.002,0.019,"Yes"
"10216","GO_BP","499848_GO_0030509_BMP_SIGNALING_PATHWAY",76,-1.1633,0.21,0.4,"No",-0.9014,0.66,1,"No"
"10217","C2_BioCarta_Pathways","C2_CP_BIOCARTA_36_BIOCARTA_G2_PATHWAY",24,-1.1631,0.27,0.38,"No",-0.7116,0.88,1,"No"
"10218","KEGG_pathway","HSA04152_AMPK_SIGNALING_PATHWAY",122,-1.1631,0.18,0.27,"No",0.8291,0.86,1,"Yes"
"10219","GO_BP","849932_GO_1902231_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",7,-1.163,0.28,0.4,"No",-1.0161,0.44,0.98,"No"
"10220","GO_BP","501511_GO_0032276_REGULATION_OF_GONADOTROPIN_SECRETION",9,-1.1629,0.29,0.4,"No",0.8403,0.66,1,"Yes"
"10221","GO_BP","518329_GO_0090189_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS",23,-1.1629,0.25,0.4,"No",1.1853,0.21,0.8,"Yes"
"10222","C3_TF_targets","C3_TFT_511_RYCACNNRNNRNCAG_UNKNOWN",74,-1.1629,0.22,0.25,"No",-1.3593,0.042,0.19,"No"
"10223","C3_TF_targets","C3_TFT_273_V_POU3F2_01",94,-1.1629,0.19,0.25,"No",1.309,0.067,0.5,"Yes"
"10224","GO_MF","496779_GO_0016892_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS",8,-1.1629,0.29,0.45,"No",1.4237,0.082,0.47,"Yes"
"10225","C4_Cancer_modules","C4_CM_325_MODULE_382",22,-1.1628,0.25,0.33,"No",-0.8602,0.68,0.93,"No"
"10226","C1_Positional","C1_ALL_108_CHR9P11",12,-1.1626,0.28,0.78,"No",-1.1613,0.28,1,"No"
"10227","GO_BP","500675_GO_0031424_KERATINIZATION",34,-1.1626,0.23,0.4,"No",1.4133,0.061,0.54,"Yes"
"10228","GO_BP","513596_GO_0060038_CARDIAC_MUSCLE_CELL_PROLIFERATION",13,-1.1625,0.28,0.4,"No",-0.9816,0.51,1,"No"
"10229","C7_Immunologic_signatures","C7_ALL_1148_GSE27786_LSK_VS_CD4_TCELL_DN",197,-1.1623,0.16,0.24,"No",0.7794,0.97,1,"Yes"
"10230","GO_MF","501063_GO_0031821_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_BINDING",7,-1.1622,0.3,0.45,"No",0.6394,0.91,1,"Yes"
"10231","C7_Immunologic_signatures","C7_ALL_969_GSE22886_NEUTROPHIL_VS_MONOCYTE_UP",184,-1.1621,0.16,0.24,"No",1.4418,0.0065,0.024,"Yes"
"10232","C7_Immunologic_signatures","C7_ALL_1782_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN",198,-1.1621,0.17,0.24,"No",0.7552,1,1,"Yes"
"10233","C2_Chemical_and_genetic_perturbations","C2_CGP_524_ZIRN_TRETINOIN_RESPONSE_WT1_UP",23,-1.162,0.26,0.32,"No",1.0956,0.33,0.64,"Yes"
"10234","C3_TF_targets","C3_TFT_276_V_HIF1_Q5",239,-1.1619,0.15,0.25,"No",-0.94,0.64,0.89,"No"
"10235","REACTOME","106173_REACT_238_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION_",16,-1.1617,0.24,0.44,"No",-1.1332,0.29,0.89,"No"
"10236","GO_BP","499900_GO_0030579_UBIQUITIN_DEPENDENT_SMAD_PROTEIN_CATABOLIC_PROCESS",6,-1.1617,0.29,0.4,"No",-0.6032,0.94,1,"No"
"10237","C3_TF_targets","C3_TFT_332_V_FOXM1_01",239,-1.1616,0.15,0.25,"No",-1.091,0.24,0.57,"No"
"10238","GO_CC","501810_GO_0032584_GROWTH_CONE_MEMBRANE",8,-1.1615,0.27,0.49,"No",-1.2366,0.2,0.63,"No"
"10239","GO_BP","509058_GO_0046835_CARBOHYDRATE_PHOSPHORYLATION",24,-1.1615,0.26,0.4,"No",-0.7138,0.89,1,"No"
"10240","C1_Positional","C1_ALL_264_CHR5Q34",24,-1.1615,0.25,0.77,"No",-1.3607,0.11,1,"No"
"10241","GO_BP","504250_GO_0035065_REGULATION_OF_HISTONE_ACETYLATION",43,-1.1614,0.23,0.4,"No",-0.7691,0.88,1,"No"
"10242","GO_BP","494342_GO_0010269_RESPONSE_TO_SELENIUM_ION",5,-1.1614,0.29,0.4,"No",0.7356,0.8,1,"Yes"
"10243","GO_BP","518152_GO_0090005_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",13,-1.1614,0.28,0.4,"No",0.7115,0.84,1,"Yes"
"10244","GO_BP","1184420_GO_1903894_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE",10,-1.1614,0.28,0.4,"No",-1.2361,0.19,0.9,"No"
"10245","C7_Immunologic_signatures","C7_ALL_703_GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_UP",198,-1.1613,0.17,0.24,"No",1.4557,0.0047,0.021,"Yes"
"10246","REACTOME","106234_REACT_1906_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS",8,-1.1612,0.28,0.44,"No",-1.0227,0.42,0.98,"No"
"10247","C1_Positional","C1_ALL_139_CHR3P26",20,-1.1611,0.27,0.76,"No",-1.0095,0.44,1,"No"
"10248","GO_CC","503564_GO_0034362_LOW_DENSITY_LIPOPROTEIN_PARTICLE",14,-1.1611,0.28,0.49,"No",0.6187,0.94,0.99,"Yes"
"10249","C2_Chemical_and_genetic_perturbations","C2_CGP_72_DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP",326,-1.1611,0.13,0.33,"No",0.837,0.95,0.97,"Yes"
"10250","GO_BP","499645_GO_0030239_MYOFIBRIL_ASSEMBLY",48,-1.1611,0.23,0.4,"No",-1.562,0.0056,0.71,"No"
"10251","GO_MF","496713_GO_0016814_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES",35,-1.1611,0.25,0.45,"No",-1.0493,0.38,0.86,"No"
"10252","C7_Immunologic_signatures","C7_ALL_410_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN",199,-1.1611,0.15,0.25,"No",1.4947,0.0023,0.014,"Yes"
"10253","GO_BP","512452_GO_0051574_POSITIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION",6,-1.161,0.3,0.4,"No",0.9745,0.49,1,"Yes"
"10254","C2_Chemical_and_genetic_perturbations","C2_CGP_749_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",19,-1.161,0.26,0.33,"No",-1.2278,0.2,0.77,"No"
"10255","KEGG_pathway","HSA05032_MORPHINE_ADDICTION",90,-1.161,0.2,0.27,"No",-1.0581,0.33,0.74,"No"
"10256","GO_BP","505849_GO_0042743_HYDROGEN_PEROXIDE_METABOLIC_PROCESS",34,-1.1607,0.24,0.4,"No",1.3055,0.089,0.66,"Yes"
"10257","GO_BP","499126_GO_0021846_CELL_PROLIFERATION_IN_FOREBRAIN",29,-1.1607,0.25,0.4,"No",-1.013,0.44,0.98,"No"
"10258","GO_BP","512202_GO_0051318_G1_PHASE",34,-1.1607,0.25,0.4,"No",1.0676,0.32,0.94,"Yes"
"10259","C7_Immunologic_signatures","C7_ALL_1079_GSE25087_FETAL_VS_ADULT_TREG_UP",197,-1.1606,0.16,0.25,"No",1.2648,0.038,0.14,"Yes"
"10260","GO_MF","495659_GO_0015459_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY",43,-1.1605,0.23,0.45,"No",-1.1405,0.24,0.81,"No"
"10261","GO_BP","494765_GO_0010700_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION",8,-1.1605,0.28,0.4,"No",0.9736,0.49,1,"Yes"
"10262","GO_MF","505333_GO_0042171_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE_ACTIVITY",11,-1.1605,0.29,0.45,"No",-0.5722,0.94,1,"No"
"10263","GO_BP","508396_GO_0046100_HYPOXANTHINE_METABOLIC_PROCESS",6,-1.1603,0.3,0.4,"No",0.9384,0.55,1,"Yes"
"10264","C4_Cancer_modules","C4_CM_345_MODULE_414",17,-1.1603,0.26,0.33,"No",2.053,0,0.0018,"Yes"
"10265","REACTOME","106129_REACT_1887_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA",5,-1.1603,0.3,0.44,"No",0.9721,0.51,0.8,"Yes"
"10266","C2_Chemical_and_genetic_perturbations","C2_CGP_77_DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN",15,-1.1602,0.26,0.33,"No",0.8333,0.71,0.98,"Yes"
"10267","KEGG_compound","C00951_ESTRADIOL_17BETA_ESTRADIOL_BETA_ESTRADIOL",28,-1.1602,0.27,0.43,"No",1.8089,0,0.032,"Yes"
"10268","C2_Chemical_and_genetic_perturbations","C2_CGP_1919_YIH_RESPONSE_TO_ARSENITE_C3",36,-1.1602,0.25,0.33,"No",1.1715,0.19,0.53,"Yes"
"10269","GO_BP","511626_GO_0050654_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS",59,-1.1601,0.22,0.4,"No",0.8492,0.77,1,"Yes"
"10270","GO_BP","488027_GO_0002138_RETINOIC_ACID_BIOSYNTHETIC_PROCESS",6,-1.1601,0.29,0.4,"No",-0.9467,0.52,1,"No"
"10271","GO_BP","504968_GO_0035791_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY",5,-1.1601,0.31,0.4,"No",1.1551,0.33,0.83,"Yes"
"10272","C2_Chemical_and_genetic_perturbations","C2_CGP_426_CHIN_BREAST_CANCER_COPY_NUMBER_DN",13,-1.1599,0.28,0.33,"No",-1.0417,0.38,0.98,"No"
"10273","C3_TF_targets","C3_TFT_605_TAAWWATAG_V_RSRFC4_Q2",165,-1.1598,0.18,0.25,"No",-0.9008,0.72,0.96,"No"
"10274","GO_BP","506654_GO_0043623_CELLULAR_PROTEIN_COMPLEX_ASSEMBLY",285,-1.1598,0.16,0.4,"No",1.0762,0.25,0.93,"Yes"
"10275","C2_Chemical_and_genetic_perturbations","C2_CGP_627_BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER",22,-1.1598,0.26,0.33,"No",-0.8643,0.66,1,"No"
"10276","C2_Chemical_and_genetic_perturbations","C2_CGP_2479_REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS",8,-1.1597,0.3,0.33,"No",0.669,0.87,1,"Yes"
"10277","C2_Chemical_and_genetic_perturbations","C2_CGP_556_HU_ANGIOGENESIS_DN",37,-1.1597,0.23,0.33,"No",1.6486,0.0022,0.11,"Yes"
"10278","GO_MF","495517_GO_0042887_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",14,-1.1596,0.28,0.45,"No",-1.0734,0.36,0.86,"No"
"10279","C7_Immunologic_signatures","C7_ALL_1260_GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN",166,-1.1596,0.19,0.25,"No",-1.0519,0.35,1,"No"
"10280","GO_BP","506121_GO_0043032_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION",9,-1.1596,0.28,0.4,"No",1.7146,0.018,0.18,"Yes"
"10281","C2_Chemical_and_genetic_perturbations","C2_CGP_2962_HO_LIVER_CANCER_VASCULAR_INVASION",12,-1.1596,0.29,0.33,"No",-0.7367,0.8,1,"No"
"10282","GO_BP","495938_GO_0015807_L_AMINO_ACID_TRANSPORT",52,-1.1595,0.23,0.4,"No",0.8635,0.71,1,"Yes"
"10283","C2_Chemical_and_genetic_perturbations","C2_CGP_1581_KAMMINGA_EZH2_TARGETS",41,-1.1595,0.26,0.33,"No",1.2246,0.16,0.46,"Yes"
"10284","GO_BP","752958_GO_0097459_IRON_ION_IMPORT_INTO_CELL",7,-1.1594,0.3,0.4,"No",-0.5931,0.93,1,"No"
"10285","GO_BP","508589_GO_0046324_REGULATION_OF_GLUCOSE_IMPORT",49,-1.1593,0.22,0.4,"No",-0.7538,0.9,1,"No"
"10286","GO_BP","491868_GO_0007041_LYSOSOMAL_TRANSPORT",49,-1.1591,0.22,0.4,"No",-0.7026,0.95,1,"No"
"10287","GO_BP","493324_GO_0009127_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",68,-1.159,0.22,0.4,"No",1.3871,0.037,0.57,"Yes"
"10288","GO_BP","504723_GO_0035542_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY",8,-1.1589,0.32,0.4,"No",-0.9476,0.51,1,"No"
"10289","C2_Chemical_and_genetic_perturbations","C2_CGP_1498_NEMETH_INFLAMMATORY_RESPONSE_LPS_DN",32,-1.1589,0.25,0.33,"No",1.0512,0.38,0.71,"Yes"
"10290","GO_BP","514929_GO_0061384_HEART_TRABECULA_MORPHOGENESIS",25,-1.1589,0.25,0.4,"No",-1.0349,0.39,0.98,"No"
"10291","GO_BP","508146_GO_0045823_POSITIVE_REGULATION_OF_HEART_CONTRACTION",27,-1.1589,0.26,0.4,"No",-0.8545,0.66,1,"No"
"10292","GO_BP","490342_GO_0007178_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",217,-1.1588,0.16,0.4,"No",0.8186,0.94,1,"Yes"
"10293","C7_Immunologic_signatures","C7_ALL_471_GSE17721_CTRL_VS_POLYIC_6H_BMDM_UP",198,-1.1588,0.16,0.25,"No",1.492,0.0024,0.014,"Yes"
"10294","GO_BP","502807_GO_0033591_RESPONSE_TO_L_ASCORBIC_ACID",5,-1.1587,0.29,0.4,"No",1.0177,0.46,0.97,"Yes"
"10295","GO_BP","513971_GO_0060415_MUSCLE_TISSUE_MORPHOGENESIS",63,-1.1586,0.23,0.4,"No",1.2183,0.14,0.76,"Yes"
"10296","GO_BP","518484_GO_0090344_NEGATIVE_REGULATION_OF_CELL_AGING",16,-1.1586,0.27,0.4,"No",-0.565,0.98,1,"No"
"10297","GO_BP","499703_GO_0030301_CHOLESTEROL_TRANSPORT",49,-1.1585,0.24,0.4,"No",0.9598,0.52,1,"Yes"
"10298","GO_BP","507984_GO_0045636_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION",5,-1.1585,0.29,0.4,"No",1.1096,0.37,0.89,"Yes"
"10299","C1_Positional","C1_ALL_84_CHR9P21",32,-1.1584,0.24,0.76,"No",0.8414,0.73,0.92,"Yes"
"10300","C2_Chemical_and_genetic_perturbations","C2_CGP_3192_BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2",72,-1.1584,0.23,0.33,"No",2.2813,0,0.00017,"Yes"
"10301","GO_BP","489225_GO_0003433_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS",5,-1.1583,0.3,0.4,"No",-1.497,0.035,0.82,"No"
"10302","C3_TF_targets","C3_TFT_448_V_AP2_Q6_01",267,-1.1583,0.14,0.25,"No",-1.2855,0.031,0.25,"No"
"10303","C3_TF_targets","C3_TFT_169_V_NKX25_01",118,-1.1583,0.19,0.25,"No",-1.3342,0.047,0.2,"No"
"10304","C2_Chemical_and_genetic_perturbations","C2_CGP_1440_HASLINGER_B_CLL_WITH_17P13_DELETION",21,-1.1583,0.28,0.33,"No",0.7392,0.84,1,"Yes"
"10305","GO_BP","512530_GO_0051654_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION",12,-1.1582,0.28,0.4,"No",-0.7706,0.77,1,"No"
"10306","C2_Chemical_and_genetic_perturbations","C2_CGP_404_CHEBOTAEV_GR_TARGETS_DN",117,-1.1582,0.2,0.33,"No",-1.0043,0.47,1,"No"
"10307","C2_Chemical_and_genetic_perturbations","C2_CGP_3379_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR",8,-1.1581,0.29,0.33,"No",-0.7175,0.81,1,"No"
"10308","C3_TF_targets","C3_TFT_224_V_MSX1_01",167,-1.1581,0.18,0.25,"No",1.0047,0.46,1,"Yes"
"10309","GO_CC","516470_GO_0071546_PI_BODY",5,-1.1581,0.33,0.49,"No",-0.9953,0.46,0.84,"No"
"10310","C2_Chemical_and_genetic_perturbations","C2_CGP_2991_NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN",18,-1.1579,0.26,0.33,"No",-1.063,0.38,0.96,"No"
"10311","GO_BP","491103_GO_0006122_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C",7,-1.1579,0.3,0.4,"No",0.8019,0.7,1,"Yes"
"10312","GO_CC","921157_GO_1990246_UNIPLEX_COMPLEX",5,-1.1579,0.29,0.49,"No",1.363,0.1,0.33,"Yes"
"10313","GO_BP","487886_GO_0001996_POSITIVE_REGULATION_OF_HEART_RATE_BY_EPINEPHRINE_NOREPINEPHRINE",5,-1.1578,0.29,0.4,"No",1.4497,0.086,0.49,"Yes"
"10314","C7_Immunologic_signatures","C7_ALL_1499_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP",198,-1.1578,0.17,0.25,"No",0.7829,0.97,1,"Yes"
"10315","C7_Immunologic_signatures","C7_ALL_1420_GSE360_CTRL_VS_L_DONOVANI_MAC_DN",199,-1.1577,0.17,0.25,"No",0.9687,0.54,0.84,"Yes"
"10316","KEGG_compound","C03460_2_METHYLPROP_2_ENOYL_COA_METHACRYLYL_COA_METHYLACRYLYL_COA",7,-1.1577,0.29,0.44,"No",0.8199,0.7,1,"Yes"
"10317","C3_TF_targets","C3_TFT_413_V_MYB_Q3",246,-1.1576,0.14,0.25,"No",-1.0546,0.31,0.64,"No"
"10318","C2_Chemical_and_genetic_perturbations","C2_CGP_2332_MATZUK_PREOVULATORY_FOLLICLE",10,-1.1575,0.29,0.33,"No",-1.1309,0.3,0.88,"No"
"10319","C2_Chemical_and_genetic_perturbations","C2_CGP_1656_NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP",18,-1.1575,0.26,0.33,"No",1.6117,0.023,0.13,"Yes"
"10320","C7_Immunologic_signatures","C7_ALL_1737_GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP",199,-1.1574,0.17,0.25,"No",0.748,0.99,1,"Yes"
"10321","C3_MicroRNA_targets","C3_MIR_120_CAGCTTT_MIR_320",252,-1.1573,0.14,0.36,"No",1.0962,0.22,1,"Yes"
"10322","C2_BioCarta_Pathways","C2_CP_BIOCARTA_203_BIOCARTA_STRESS_PATHWAY",25,-1.1573,0.25,0.39,"No",-0.8805,0.63,1,"No"
"10323","GO_BP","491821_GO_0006984_ER_NUCLEUS_SIGNALING_PATHWAY",21,-1.1573,0.25,0.41,"No",-1.1664,0.25,0.91,"No"
"10324","GO_BP","753717_GO_1900746_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY",8,-1.1573,0.31,0.41,"No",-0.9323,0.56,1,"No"
"10325","C2_Chemical_and_genetic_perturbations","C2_CGP_1478_HASLINGER_B_CLL_WITH_13Q14_DELETION",24,-1.1572,0.29,0.33,"No",-1.1597,0.26,0.83,"No"
"10326","C2_Chemical_and_genetic_perturbations","C2_CGP_961_OHM_EMBRYONIC_CARCINOMA_DN",8,-1.1572,0.3,0.33,"No",-0.4866,0.98,1,"No"
"10327","WikiPathways","198879_WP61_DELTA_NOTCH_SIGNALING_PATHWAY",83,-1.1571,0.23,0.35,"No",-0.8037,0.86,1,"No"
"10328","GO_BP","492838_GO_0030048_ACTIN_FILAMENT_BASED_MOVEMENT",63,-1.1571,0.23,0.41,"No",-1.0128,0.45,0.98,"No"
"10329","GO_BP","512283_GO_0051402_NEURON_APOPTOTIC_PROCESS",38,-1.1571,0.25,0.41,"No",0.9218,0.6,1,"Yes"
"10330","C4_Cancer_modules","C4_CM_212_MODULE_233",22,-1.157,0.26,0.33,"No",0.554,0.99,1,"Yes"
"10331","C7_Immunologic_signatures","C7_ALL_1245_GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP",167,-1.157,0.19,0.25,"No",1.1222,0.18,0.38,"Yes"
"10332","OMIM_gene","OMIM107280_SERPIN_PEPTIDASE_INHIBITOR_CLADE_A_MEMBER_3_SERPINA3",7,-1.157,0.27,0.78,"No",1.4334,0.093,1,"Yes"
"10333","REACTOME","106464_REACT_12005_PROLONGED_ERK_ACTIVATION_EVENTS",27,-1.1568,0.24,0.45,"No",0.6561,0.95,1,"Yes"
"10334","REACTOME","106060_REACT_1439_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION",22,-1.1568,0.25,0.45,"No",1.7484,0.0061,0.033,"Yes"
"10335","REACTOME","1127505_REACT_268299_VXPX_CARGO_TARGETING_TO_CILIUM",21,-1.1568,0.26,0.45,"No",-1.0477,0.38,0.94,"No"
"10336","GO_BP","504487_GO_0035303_REGULATION_OF_DEPHOSPHORYLATION",125,-1.1566,0.21,0.41,"No",-0.8112,0.9,1,"No"
"10337","GO_MF","499385_GO_0022840_LEAK_CHANNEL_ACTIVITY",16,-1.1566,0.28,0.46,"No",1.1908,0.23,0.72,"Yes"
"10338","GO_MF","490025_GO_0004709_MAP_KINASE_KINASE_KINASE_ACTIVITY",25,-1.1565,0.26,0.46,"No",-1.5489,0.027,0.53,"No"
"10339","GO_BP","512471_GO_0051593_RESPONSE_TO_FOLIC_ACID",10,-1.1564,0.27,0.41,"No",-0.6385,0.9,1,"No"
"10340","GO_BP","508733_GO_0046473_PHOSPHATIDIC_ACID_METABOLIC_PROCESS",29,-1.1563,0.25,0.41,"No",0.7993,0.8,1,"Yes"
"10341","C6_Oncogenic_signatures","C6_ALL_126_RB_P130_DN_V1_UP",119,-1.1563,0.2,0.24,"No",-0.9427,0.6,0.83,"No"
"10342","GO_MF","496712_GO_0016813_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES",12,-1.1562,0.28,0.46,"No",-1.4151,0.1,0.66,"No"
"10343","GO_BP","514193_GO_0060638_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING",8,-1.1562,0.31,0.41,"No",1.2795,0.2,0.7,"Yes"
"10344","GO_MF","499387_GO_0022842_NARROW_PORE_CHANNEL_ACTIVITY",16,-1.1562,0.28,0.46,"No",1.1559,0.28,0.74,"Yes"
"10345","C2_Chemical_and_genetic_perturbations","C2_CGP_1_NAKAMURA_CANCER_MICROENVIRONMENT_UP",22,-1.1562,0.26,0.33,"No",-0.6722,0.93,1,"No"
"10346","GO_MF","502775_GO_0033558_PROTEIN_DEACETYLASE_ACTIVITY",26,-1.156,0.25,0.46,"No",-1.4169,0.073,0.66,"No"
"10347","GO_BP","487676_GO_0001780_NEUTROPHIL_HOMEOSTASIS",7,-1.156,0.29,0.41,"No",-0.7742,0.75,1,"No"
"10348","C2_Chemical_and_genetic_perturbations","C2_CGP_1875_GENTILE_UV_RESPONSE_CLUSTER_D1",18,-1.156,0.27,0.33,"No",1.0345,0.4,0.74,"Yes"
"10349","KEGG_compound","C00445_5_10_METHENYLTETRAHYDROFOLATE",8,-1.1559,0.27,0.44,"No",0.6004,0.93,1,"Yes"
"10350","GO_BP","518562_GO_0097012_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR",6,-1.1558,0.31,0.41,"No",-1.422,0.1,0.94,"No"
"10351","KEGG_compound","C00186__S_LACTATE_L_LACTATE_L_LACTIC_ACID",5,-1.1558,0.32,0.44,"No",-0.8821,0.6,1,"No"
"10352","C3_TF_targets","C3_TFT_226_V_EN1_01",107,-1.1557,0.22,0.26,"No",-0.7969,0.89,1,"No"
"10353","C7_Immunologic_signatures","C7_ALL_999_GSE22886_TH1_VS_TH2_48H_ACT_UP",192,-1.1556,0.18,0.25,"No",-1.0618,0.32,1,"No"
"10354","GO_BP","513525_GO_0055092_STEROL_HOMEOSTASIS",63,-1.1556,0.24,0.41,"No",-0.9456,0.56,1,"No"
"10355","C2_Chemical_and_genetic_perturbations","C2_CGP_2944_SENGUPTA_EBNA1_ANTICORRELATED",161,-1.1556,0.19,0.33,"No",-1.6772,0,0.37,"No"
"10356","KEGG_pathway","HSA05214_GLIOMA",64,-1.1556,0.22,0.28,"No",0.8028,0.83,1,"Yes"
"10357","KEGG_module","HSA_M00032_LYSINE_DEGRADATION_LYSINE_SACCHAROPINE_ACETOACETYL_COA",11,-1.1556,0.29,0.64,"No",-0.7484,0.8,1,"No"
"10358","C3_MicroRNA_targets","C3_MIR_174_AAGCACT_MIR_520F",235,-1.1555,0.15,0.36,"No",0.7526,1,1,"Yes"
"10359","C1_Positional","C1_ALL_74_CHR15Q11",48,-1.1553,0.23,0.76,"No",0.9268,0.59,0.82,"Yes"
"10360","C2_Chemical_and_genetic_perturbations","C2_CGP_2317_BOCHKIS_FOXA2_TARGETS",419,-1.1553,0.12,0.33,"No",0.9772,0.54,0.82,"Yes"
"10361","C3_MicroRNA_targets","C3_MIR_66_CTTGTAT_MIR_381",204,-1.1552,0.17,0.36,"No",0.9133,0.74,1,"Yes"
"10362","REACTOME","161013_REACT_22426_ASPARAGINE_N_LINKED_GLYCOSYLATION",118,-1.1552,0.19,0.45,"No",0.837,0.87,0.97,"Yes"
"10363","KEGG_module","HSA_M00079_KERATAN_SULFATE_DEGRADATION",5,-1.1552,0.32,0.62,"No",-0.7998,0.71,1,"No"
"10364","C4_Cancer_modules","C4_CM_314_MODULE_366",33,-1.1551,0.26,0.34,"No",-1.0939,0.32,0.69,"No"
"10365","GO_CC","487073_GO_0000780_CONDENSED_NUCLEAR_CHROMOSOME_CENTROMERIC_REGION",16,-1.1551,0.28,0.5,"No",-0.9561,0.53,0.9,"No"
"10366","C2_Chemical_and_genetic_perturbations","C2_CGP_1365_POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN",58,-1.1551,0.25,0.33,"No",2.1387,0,0.0013,"Yes"
"10367","C3_TF_targets","C3_TFT_556_YYCATTCAWW_UNKNOWN",186,-1.155,0.18,0.26,"No",-0.9194,0.67,0.93,"No"
"10368","C2_Chemical_and_genetic_perturbations","C2_CGP_1258_KENNY_CTNNB1_TARGETS_UP",50,-1.155,0.23,0.33,"No",0.9957,0.47,0.81,"Yes"
"10369","KEGG_compound","C05141_ESTRIOL_1_3_5_10_ESTRATRIENE_3_16_ALPHA_17BETA_TRIOL",26,-1.155,0.26,0.44,"No",1.8502,0.0021,0.022,"Yes"
"10370","GO_CC","486914_GO_0000421_AUTOPHAGIC_VACUOLE_MEMBRANE",23,-1.1548,0.26,0.49,"No",-0.9048,0.61,0.96,"No"
"10371","C4_Cancer_modules","C4_CM_385_MODULE_484",42,-1.1547,0.27,0.34,"No",1.3884,0.053,0.2,"Yes"
"10372","C2_Chemical_and_genetic_perturbations","C2_CGP_1673_WANG_SMARCE1_TARGETS_DN",364,-1.1547,0.12,0.33,"No",1.5576,0,0.17,"Yes"
"10373","WikiPathways","198799_WP363_WNT_SIGNALING_PATHWAY_NETPATH",114,-1.1546,0.21,0.35,"No",-0.8169,0.89,1,"No"
"10374","C2_Chemical_and_genetic_perturbations","C2_CGP_1621_BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP",388,-1.1546,0.13,0.33,"No",0.9191,0.77,0.9,"Yes"
"10375","REACTOME","105908_REACT_15428_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS_",20,-1.1544,0.28,0.45,"No",2.005,0,0.0022,"Yes"
"10376","GO_BP","496349_GO_0034260_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY",22,-1.1543,0.27,0.41,"No",-0.834,0.7,1,"No"
"10377","GO_MF","495461_GO_0015193_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.1543,0.31,0.46,"No",-1.2056,0.25,0.82,"No"
"10378","GO_BP","488898_GO_0035810_POSITIVE_REGULATION_OF_URINE_VOLUME",13,-1.1542,0.27,0.41,"No",1.1488,0.3,0.84,"Yes"
"10379","GO_BP","495132_GO_0014060_REGULATION_OF_EPINEPHRINE_SECRETION",7,-1.1542,0.3,0.41,"No",-1.232,0.24,0.9,"No"
"10380","REACTOME","161059_REACT_20524_SIGNAL_AMPLIFICATION",31,-1.154,0.24,0.45,"No",0.9921,0.45,0.76,"Yes"
"10381","WikiPathways","198805_WP45_G1_TO_S_CELL_CYCLE_CONTROL",68,-1.1539,0.23,0.35,"No",0.8423,0.78,1,"Yes"
"10382","GO_BP","515297_GO_0070365_HEPATOCYTE_DIFFERENTIATION",9,-1.1539,0.29,0.41,"No",-0.404,1,1,"No"
"10383","GO_MF","490190_GO_0042605_PEPTIDE_ANTIGEN_BINDING",31,-1.1538,0.25,0.46,"No",-0.4617,1,1,"No"
"10384","C3_TF_targets","C3_TFT_264_V_ZIC3_01",247,-1.1538,0.17,0.26,"No",-1.1497,0.13,0.45,"No"
"10385","C2_Chemical_and_genetic_perturbations","C2_CGP_1865_MMS_MOUSE_LYMPH_HIGH_4HRS_UP",36,-1.1538,0.25,0.33,"No",1.3249,0.11,0.37,"Yes"
"10386","C2_Chemical_and_genetic_perturbations","C2_CGP_212_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN",72,-1.1538,0.22,0.33,"No",1.6219,0.002,0.13,"Yes"
"10387","REACTOME","187085_REACT_25120_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING",12,-1.1536,0.3,0.45,"No",-0.883,0.61,1,"No"
"10388","C3_MicroRNA_targets","C3_MIR_74_GTATTAT_MIR_369_3P",206,-1.1535,0.18,0.36,"No",0.8255,0.94,1,"Yes"
"10389","GO_BP","496105_GO_0015988_ENERGY_COUPLED_PROTON_TRANSMEMBRANE_TRANSPORT_AGAINST_ELECTROCHEMICAL_GRADIENT",29,-1.1531,0.25,0.41,"No",1.6423,0.021,0.25,"Yes"
"10390","KEGG_compound","C00352_D_GLUCOSAMINE_6_PHOSPHATE_D_GLUCOSAMINE_PHOSPHATE",10,-1.1529,0.29,0.44,"No",-0.7069,0.86,1,"No"
"10391","C7_Immunologic_signatures","C7_ALL_1694_GSE3982_BASOPHIL_VS_TH1_DN",199,-1.1529,0.18,0.26,"No",0.9156,0.72,0.99,"Yes"
"10392","GO_BP","503571_GO_0034369_PLASMA_LIPOPROTEIN_PARTICLE_REMODELING",23,-1.1529,0.27,0.41,"No",-0.4968,0.99,1,"No"
"10393","C3_TF_targets","C3_TFT_126_V_CREBP1_Q2",251,-1.1528,0.17,0.26,"No",-0.8883,0.79,0.98,"No"
"10394","REACTOME","119545_REACT_19187_CLATHRIN_DERIVED_VESICLE_BUDDING",70,-1.152,0.23,0.45,"No",0.9647,0.52,0.8,"Yes"
"10395","C2_Chemical_and_genetic_perturbations","C2_CGP_51_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN",327,-1.1519,0.15,0.34,"No",-1.1631,0.1,0.83,"No"
"10396","C2_Chemical_and_genetic_perturbations","C2_CGP_1889_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6",17,-1.1519,0.28,0.34,"No",1.2302,0.16,0.46,"Yes"
"10397","C0_Hallmark","H_ALL_5_HALLMARK_WNT_BETA_CATENIN_SIGNALING",42,-1.1519,0.25,0.24,"No",-0.9869,0.45,0.92,"No"
"10398","GO_BP","499849_GO_0030510_REGULATION_OF_BMP_SIGNALING_PATHWAY",72,-1.1519,0.23,0.41,"No",0.8064,0.83,1,"Yes"
"10399","GO_BP","753006_GO_1900006_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT",43,-1.1518,0.25,0.41,"No",-1.2201,0.17,0.88,"No"
"10400","GO_BP","511657_GO_0050685_POSITIVE_REGULATION_OF_MRNA_PROCESSING",34,-1.1518,0.27,0.41,"No",-1.2258,0.18,0.88,"No"
"10401","GO_BP","502150_GO_0032928_REGULATION_OF_SUPEROXIDE_ANION_GENERATION",11,-1.1517,0.31,0.41,"No",1.0372,0.39,0.96,"Yes"
"10402","GO_MF","490423_GO_0005158_INSULIN_RECEPTOR_BINDING",32,-1.1515,0.25,0.47,"No",0.9424,0.56,0.94,"Yes"
"10403","C3_MicroRNA_targets","C3_MIR_72_ATACTGT_MIR_144",198,-1.1514,0.17,0.36,"No",0.7296,1,1,"Yes"
"10404","GO_BP","500918_GO_0031669_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS",191,-1.1513,0.2,0.41,"No",0.7365,0.99,1,"Yes"
"10405","GO_BP","493589_GO_0009416_RESPONSE_TO_LIGHT_STIMULUS",332,-1.151,0.15,0.41,"No",-0.9421,0.65,1,"No"
"10406","GO_BP","494533_GO_0010463_MESENCHYMAL_CELL_PROLIFERATION",12,-1.151,0.29,0.41,"No",-1.0674,0.38,0.96,"No"
"10407","GO_CC","849819_GO_0097481_NEURONAL_POSTSYNAPTIC_DENSITY",20,-1.1509,0.27,0.5,"No",-1.1178,0.32,0.75,"No"
"10408","GO_MF","496937_GO_0017137_RAB_GTPASE_BINDING",87,-1.1508,0.21,0.47,"No",-0.9258,0.63,0.97,"No"
"10409","GO_BP","983710_GO_1902991_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",12,-1.1507,0.29,0.41,"No",0.9496,0.52,1,"Yes"
"10410","C7_Immunologic_signatures","C7_ALL_1569_GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP",197,-1.1505,0.19,0.26,"No",1.4009,0.0048,0.037,"Yes"
"10411","C2_Chemical_and_genetic_perturbations","C2_CGP_1097_GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP",69,-1.1505,0.24,0.34,"No",1.4245,0.031,0.28,"Yes"
"10412","GO_BP","495854_GO_0015721_BILE_ACID_AND_BILE_SALT_TRANSPORT",26,-1.1505,0.26,0.42,"No",-1.23,0.18,0.89,"No"
"10413","C1_Positional","C1_ALL_141_CHR11P12",13,-1.1504,0.27,0.77,"No",0.4275,1,1,"Yes"
"10414","C4_Cancer_gene_neighborhoods","C4_CGN_347_GNF2_DNM1",72,-1.1504,0.24,0.42,"No",-1.2108,0.15,0.66,"No"
"10415","GO_BP","1184422_GO_1903896_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE",8,-1.1502,0.31,0.42,"No",-1.2528,0.19,0.91,"No"
"10416","KEGG_compound","C06754_CHLOROACETALDEHYDE_2_CHLOROETHANAL",6,-1.1502,0.32,0.44,"No",-0.7784,0.71,1,"No"
"10417","C2_Chemical_and_genetic_perturbations","C2_CGP_1951_BROWNE_HCMV_INFECTION_24HR_UP",147,-1.1501,0.22,0.34,"No",-0.9883,0.47,1,"No"
"10418","C4_Cancer_modules","C4_CM_236_MODULE_262",14,-1.1501,0.29,0.34,"No",1.4104,0.093,0.18,"Yes"
"10419","GO_BP","502562_GO_0033344_CHOLESTEROL_EFFLUX",26,-1.1501,0.26,0.42,"No",-1.179,0.23,0.91,"No"
"10420","C2_Chemical_and_genetic_perturbations","C2_CGP_2155_LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP",74,-1.15,0.23,0.34,"No",-0.8631,0.72,1,"No"
"10421","REACTOME","645291_REACT_121036_THE_ACTIVATION_OF_ARYLSULFATASES",13,-1.15,0.28,0.46,"No",-0.6203,0.92,1,"No"
"10422","C4_Cancer_gene_neighborhoods","C4_CGN_32_MORF_PSMF1",163,-1.15,0.19,0.42,"No",-1.188,0.14,0.68,"No"
"10423","C2_BioCarta_Pathways","C2_CP_BIOCARTA_14_BIOCARTA_ACE2_PATHWAY",13,-1.15,0.29,0.4,"No",1.1468,0.27,0.67,"Yes"
"10424","GO_CC","490884_GO_0005876_SPINDLE_MICROTUBULE",55,-1.15,0.24,0.5,"No",0.7317,0.92,0.99,"Yes"
"10425","C6_Oncogenic_signatures","C6_ALL_98_ESC_V6_5_UP_EARLY_V1_UP",156,-1.1499,0.2,0.25,"No",-1.3167,0.041,0.4,"No"
"10426","C7_Immunologic_signatures","C7_ALL_316_GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN",200,-1.1498,0.19,0.27,"No",1.2865,0.029,0.11,"Yes"
"10427","C2_Chemical_and_genetic_perturbations","C2_CGP_3155_MAEKAWA_ATF2_TARGETS",24,-1.1497,0.27,0.34,"No",-1.0399,0.38,0.97,"No"
"10428","C3_MicroRNA_targets","C3_MIR_42_ACAGGGT_MIR_10A_MIR_10B",122,-1.1494,0.21,0.36,"No",-1.0637,0.34,1,"No"
"10429","C3_TF_targets","C3_TFT_171_V_PPARA_01",37,-1.1494,0.24,0.27,"No",0.7891,0.83,1,"Yes"
"10430","GO_BP","495227_GO_0014831_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION",5,-1.1493,0.31,0.42,"No",-0.9973,0.49,0.99,"No"
"10431","GO_BP","491056_GO_0006071_GLYCEROL_METABOLIC_PROCESS",20,-1.1491,0.28,0.42,"No",0.6534,0.94,1,"Yes"
"10432","C4_Cancer_gene_neighborhoods","C4_CGN_128_MORF_MAP2K7",175,-1.1489,0.18,0.42,"No",-1.1096,0.22,0.72,"No"
"10433","C6_Oncogenic_signatures","C6_ALL_59_SRC_UP_V1_DN",164,-1.1489,0.19,0.25,"No",0.9726,0.52,0.91,"Yes"
"10434","GO_BP","516709_GO_0071786_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION",9,-1.1487,0.29,0.42,"No",0.621,0.92,1,"Yes"
"10435","C4_Cancer_modules","C4_CM_296_MODULE_340",26,-1.1485,0.28,0.34,"No",-0.9715,0.49,0.84,"No"
"10436","GO_BP","503569_GO_0034367_MACROMOLECULAR_COMPLEX_REMODELING",23,-1.1485,0.27,0.42,"No",-0.4855,1,1,"No"
"10437","KEGG_reaction","R00703__S_LACTATE_NAD_OXIDOREDUCTASE_S_LACTATE_NAD_PYRUVATE_NADH_H_",5,-1.1484,0.31,0.43,"No",-0.8767,0.61,0.96,"No"
"10438","GO_MF","515424_GO_0070492_OLIGOSACCHARIDE_BINDING",8,-1.1483,0.29,0.47,"No",-0.902,0.59,0.99,"No"
"10439","REACTOME","161039_REACT_20625_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE",7,-1.1483,0.31,0.46,"No",0.6836,0.87,1,"Yes"
"10440","GO_MF","515815_GO_0070888_E_BOX_BINDING",32,-1.1483,0.26,0.47,"No",0.8073,0.78,1,"Yes"
"10441","KEGG_enzyme","2.7.1.107_DIACYLGLYCEROL_KINASE_ATP_DIGLYCERIDE_KINASE_AMBIGUOUS_1_2_DIACYLGLYCEROL_KINASE_PHOSPHORYLATING_AMBIGUOUS_1_2_DIACYLGLYCEROL_KINASE_AMBIGUOUS_SN_1_2_DIACYLGLYCEROL_KINASE_AMBIGUOUS_DG_KINASE_AMBIGUOUS_DGK_AMBIGUOUS_ATP_DIACYLGLYCEROL_PHOSPHOTRANSFERASE_ARACHIDONOYL_SPECIFIC_DIACYLGLYCEROL_KINASE_DIACYLGLYCEROL_ATP_KINASE_ATP_1_2_DIACYLGLYCEROL_3_PHOSPHOTRANSFERASE_DIACYLGLYCEROL_KINASE_ATP_DEPENDENT_",10,-1.1482,0.3,0.54,"No",-1.7115,0.013,0.078,"No"
"10442","GO_BP","518990_GO_2000344_POSITIVE_REGULATION_OF_ACROSOME_REACTION",5,-1.1482,0.3,0.42,"No",-1.3483,0.12,0.93,"No"
"10443","GO_BP","1025340_GO_0098732_MACROMOLECULE_DEACYLATION",47,-1.1481,0.26,0.42,"No",-1.205,0.18,0.89,"No"
"10444","GO_MF","489342_GO_0003841_1_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY",11,-1.1481,0.29,0.47,"No",-0.5894,0.95,1,"No"
"10445","GO_CC","503906_GO_0034706_SODIUM_CHANNEL_COMPLEX",17,-1.1481,0.29,0.51,"No",-0.9538,0.51,0.88,"No"
"10446","GO_BP","512374_GO_0051496_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY",40,-1.148,0.27,0.42,"No",-1.2901,0.11,0.88,"No"
"10447","GO_BP","752262_GO_0072698_PROTEIN_LOCALIZATION_TO_MICROTUBULE_CYTOSKELETON",16,-1.1479,0.29,0.42,"No",-0.8339,0.73,1,"No"
"10448","C3_TF_targets","C3_TFT_139_ATGGYGGA_UNKNOWN",101,-1.1478,0.23,0.27,"No",-0.7867,0.9,1,"No"
"10449","GO_BP","518561_GO_0097011_CELLULAR_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS",6,-1.1477,0.31,0.42,"No",-1.4143,0.096,0.95,"No"
"10450","GO_BP","507449_GO_0045048_PROTEIN_INSERTION_INTO_ER_MEMBRANE",5,-1.1476,0.3,0.42,"No",0.8397,0.66,1,"Yes"
"10451","C2_Chemical_and_genetic_perturbations","C2_CGP_137_DOANE_BREAST_CANCER_CLASSES_UP",71,-1.1475,0.25,0.34,"No",0.9094,0.65,0.91,"Yes"
"10452","C7_Immunologic_signatures","C7_ALL_350_GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN",200,-1.1475,0.16,0.27,"No",0.8391,0.89,1,"Yes"
"10453","GO_BP","849986_GO_1902285_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE",6,-1.1475,0.32,0.42,"No",-1.0222,0.43,0.97,"No"
"10454","GO_BP","812238_GO_1902115_REGULATION_OF_ORGANELLE_ASSEMBLY",111,-1.1474,0.23,0.42,"No",0.6082,1,1,"Yes"
"10455","GO_MF","489796_GO_0046030_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY",8,-1.1474,0.32,0.47,"No",-1.0044,0.44,0.9,"No"
"10456","GO_BP","752846_GO_0097345_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION",10,-1.1473,0.3,0.42,"No",1.1201,0.35,0.88,"Yes"
"10457","C3_TF_targets","C3_TFT_162_V_STAT3_01",21,-1.1473,0.28,0.27,"No",0.9647,0.52,1,"Yes"
"10458","C4_Cancer_modules","C4_CM_410_MODULE_530",16,-1.1472,0.28,0.35,"No",1.141,0.3,0.47,"Yes"
"10459","GO_MF","500796_GO_0031545_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY",9,-1.1471,0.29,0.47,"No",-1.0266,0.45,0.88,"No"
"10460","GO_BP","491032_GO_0006047_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS",10,-1.147,0.29,0.42,"No",-0.7332,0.84,1,"No"
"10461","GO_BP","500783_GO_0031532_ACTIN_CYTOSKELETON_REORGANIZATION",47,-1.147,0.24,0.42,"No",-1.0803,0.32,0.95,"No"
"10462","C2_Chemical_and_genetic_perturbations","C2_CGP_1137_AMIT_EGF_RESPONSE_240_HELA",60,-1.147,0.23,0.34,"No",-0.891,0.66,1,"No"
"10463","C2_Chemical_and_genetic_perturbations","C2_CGP_2720_BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN",50,-1.1469,0.24,0.34,"No",0.7554,0.89,1,"Yes"
"10464","GO_MF","501366_GO_0032129_HISTONE_DEACETYLASE_ACTIVITY_H3_K9_SPECIFIC_",13,-1.1468,0.29,0.47,"No",-1.2659,0.18,0.83,"No"
"10465","GO_MF","486804_GO_0000287_MAGNESIUM_ION_BINDING",191,-1.1467,0.19,0.47,"No",-0.7291,0.99,1,"No"
"10466","GO_MF","983693_GO_0098632_PROTEIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION",10,-1.1466,0.29,0.47,"No",-0.7772,0.76,1,"No"
"10467","GO_BP","506539_GO_0043508_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY",14,-1.1465,0.31,0.42,"No",0.8415,0.69,1,"Yes"
"10468","GO_MF","490406_GO_0005143_INTERLEUKIN_12_RECEPTOR_BINDING",5,-1.1464,0.32,0.47,"No",-1.253,0.2,0.84,"No"
"10469","C3_MicroRNA_targets","C3_MIR_170_GTTAAAG_MIR_302B",69,-1.1464,0.24,0.37,"No",0.975,0.53,1,"Yes"
"10470","GO_BP","507484_GO_0045084_POSITIVE_REGULATION_OF_INTERLEUKIN_12_BIOSYNTHETIC_PROCESS",7,-1.1463,0.29,0.42,"No",-1.1507,0.3,0.92,"No"
"10471","GO_BP","1129553_GO_1903729_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION",62,-1.1463,0.23,0.42,"No",0.8982,0.66,1,"Yes"
"10472","C4_Cancer_gene_neighborhoods","C4_CGN_149_MORF_PPP2R5B",169,-1.1463,0.2,0.42,"No",-1.3083,0.042,0.54,"No"
"10473","C2_Chemical_and_genetic_perturbations","C2_CGP_700_LUI_THYROID_CANCER_CLUSTER_4",12,-1.1462,0.29,0.35,"No",-1.3265,0.13,0.69,"No"
"10474","C2_Chemical_and_genetic_perturbations","C2_CGP_1808_TAKAO_RESPONSE_TO_UVB_RADIATION_DN",98,-1.1462,0.23,0.34,"No",1.569,0,0.16,"Yes"
"10475","REACTOME","106099_REACT_1946_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING",17,-1.1462,0.27,0.46,"No",1.0028,0.46,0.75,"Yes"
"10476","C2_BioCarta_Pathways","C2_CP_BIOCARTA_71_BIOCARTA_FAS_PATHWAY",30,-1.146,0.25,0.4,"No",-0.9086,0.63,1,"No"
"10477","C7_Immunologic_signatures","C7_ALL_731_GSE17721_0_5H_VS_4H_PAM3CSK4_BMDM_UP",199,-1.146,0.19,0.27,"No",1.3784,0.0045,0.046,"Yes"
"10478","C6_Oncogenic_signatures","C6_ALL_164_TBK1_DN_48HRS_DN",50,-1.1458,0.25,0.25,"No",1.3121,0.083,0.36,"Yes"
"10479","GO_BP","504467_GO_0035283_CENTRAL_NERVOUS_SYSTEM_SEGMENTATION",5,-1.1458,0.31,0.42,"No",-0.7351,0.79,1,"No"
"10480","KEGG_compound","C05337_CHENODEOXYCHOLOYL_COA_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLANOYL_COA",7,-1.1456,0.31,0.45,"No",1.0516,0.41,1,"Yes"
"10481","C7_Immunologic_signatures","C7_ALL_1575_GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP",197,-1.1456,0.18,0.27,"No",-0.8008,0.93,1,"No"
"10482","GO_BP","491542_GO_0006654_PHOSPHATIDIC_ACID_BIOSYNTHETIC_PROCESS",29,-1.1455,0.27,0.42,"No",0.7896,0.79,1,"Yes"
"10483","C7_Immunologic_signatures","C7_ALL_891_GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP",197,-1.1454,0.19,0.27,"No",-0.7438,0.99,1,"No"
"10484","GO_BP","506391_GO_0043331_RESPONSE_TO_DSRNA",61,-1.1454,0.24,0.42,"No",1.0247,0.39,0.97,"Yes"
"10485","C3_TF_targets","C3_TFT_371_V_TFIIA_Q6",243,-1.1452,0.17,0.27,"No",-1.3107,0.016,0.23,"No"
"10486","GO_BP","492032_GO_0007252_I_KAPPAB_PHOSPHORYLATION",12,-1.1452,0.31,0.42,"No",-0.7299,0.82,1,"No"
"10487","C2_Chemical_and_genetic_perturbations","C2_CGP_3213_RAFFEL_VEGFA_TARGETS_DN",5,-1.1451,0.32,0.35,"No",-0.6435,0.87,1,"No"
"10488","C7_Immunologic_signatures","C7_ALL_135_GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP",191,-1.1451,0.19,0.28,"No",-0.6641,1,1,"No"
"10489","KEGG_reaction","R03104_3_MERCAPTOLACTATE_NAD_OXIDOREDUCTASE_3_MERCAPTOLACTATE_NAD_MERCAPTOPYRUVATE_NADH_H_",5,-1.1449,0.33,0.43,"No",-0.8652,0.63,0.97,"No"
"10490","KEGG_module","HSA_M00073_N_GLYCAN_PRECURSOR_TRIMMING",6,-1.1449,0.3,0.62,"No",-1.0229,0.45,1,"No"
"10491","C7_Immunologic_signatures","C7_ALL_403_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP",197,-1.1448,0.19,0.28,"No",-0.9194,0.68,1,"No"
"10492","C2_Chemical_and_genetic_perturbations","C2_CGP_1458_CROMER_METASTASIS_UP",79,-1.1447,0.24,0.35,"No",0.8401,0.82,0.98,"Yes"
"10493","C1_Positional","C1_ALL_122_CHR5Q35",114,-1.1447,0.23,0.78,"No",-0.8638,0.76,0.98,"No"
"10494","KEGG_module","HSA_M00147_NADH_DEHYDROGENASE_UBIQUINONE_1_BETA_SUBCOMPLEX",14,-1.1446,0.3,0.61,"No",1.9713,0.002,0.0064,"Yes"
"10495","C7_Immunologic_signatures","C7_ALL_883_GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP",195,-1.1446,0.18,0.28,"No",0.8785,0.83,1,"Yes"
"10496","KEGG_compound","C00780_SEROTONIN_3_2_AMINOETHYL_1H_INDOL_5_OL_5_HYDROXYTRYPTAMINE_ENTERAMINE",8,-1.1446,0.31,0.45,"No",-0.8195,0.71,1,"No"
"10497","C2_Chemical_and_genetic_perturbations","C2_CGP_969_GALIE_TUMOR_STEMNESS_GENES",5,-1.1446,0.32,0.35,"No",-0.6855,0.82,1,"No"
"10498","GO_BP","518676_GO_2000027_REGULATION_OF_ORGAN_MORPHOGENESIS",151,-1.1446,0.2,0.42,"No",1.0283,0.38,0.97,"Yes"
"10499","C2_Chemical_and_genetic_perturbations","C2_CGP_1236_DING_LUNG_CANCER_MUTATED_FREQUENTLY",12,-1.1445,0.29,0.35,"No",-1.3019,0.15,0.69,"No"
"10500","REACTOME","106265_REACT_522_PURINE_METABOLISM",33,-1.1444,0.27,0.47,"No",0.4125,1,1,"Yes"
"10501","GO_MF","490024_GO_0004708_MAP_KINASE_KINASE_ACTIVITY",22,-1.1444,0.27,0.47,"No",-1.0801,0.34,0.85,"No"
"10502","C1_Positional","C1_ALL_92_CHR3Q26",62,-1.1443,0.24,0.77,"No",-0.8713,0.73,1,"No"
"10503","C2_Chemical_and_genetic_perturbations","C2_CGP_113_THUM_SYSTOLIC_HEART_FAILURE_DN",234,-1.1442,0.17,0.35,"No",-0.7992,0.96,1,"No"
"10504","GO_BP","504567_GO_0035383_THIOESTER_METABOLIC_PROCESS",63,-1.1442,0.24,0.42,"No",-0.8385,0.77,1,"No"
"10505","GO_BP","494871_GO_0010807_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING",5,-1.144,0.32,0.42,"No",-1.3638,0.12,0.97,"No"
"10506","GO_BP","752161_GO_0061418_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA",29,-1.1439,0.27,0.42,"No",1.2065,0.2,0.78,"Yes"
"10507","C3_TF_targets","C3_TFT_73_ACCTGTTG_UNKNOWN",149,-1.1439,0.2,0.28,"No",-1.0502,0.34,0.64,"No"
"10508","GO_BP","508397_GO_0046101_HYPOXANTHINE_BIOSYNTHETIC_PROCESS",5,-1.1438,0.34,0.42,"No",0.6938,0.87,1,"Yes"
"10509","GO_BP","514915_GO_0061370_TESTOSTERONE_BIOSYNTHETIC_PROCESS",5,-1.1437,0.32,0.42,"No",-0.7449,0.76,1,"No"
"10510","C3_MicroRNA_targets","C3_MIR_137_GGCACAT_MIR_455",57,-1.1437,0.26,0.37,"No",-0.9216,0.61,1,"No"
"10511","C2_Chemical_and_genetic_perturbations","C2_CGP_2328_MATZUK_CENTRAL_FOR_FEMALE_FERTILITY",28,-1.1437,0.27,0.35,"No",-1.6574,0.013,0.36,"No"
"10512","C7_Immunologic_signatures","C7_ALL_424_GSE15930_STIM_VS_STIM_AND_IL_12_72H_CD8_T_CELL_DN",195,-1.1436,0.2,0.28,"No",1.2706,0.032,0.13,"Yes"
"10513","REACTOME","119520_REACT_19259_SEMA4D_IN_SEMAPHORIN_SIGNALING",27,-1.1435,0.27,0.47,"No",-0.7845,0.8,1,"No"
"10514","C2_Chemical_and_genetic_perturbations","C2_CGP_484_MISSIAGLIA_REGULATED_BY_METHYLATION_DN",120,-1.1435,0.23,0.35,"No",0.9486,0.57,0.87,"Yes"
"10515","C7_Immunologic_signatures","C7_ALL_1426_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN",200,-1.1432,0.18,0.28,"No",-0.776,0.98,1,"No"
"10516","C2_Chemical_and_genetic_perturbations","C2_CGP_2339_CHUNG_BLISTER_CYTOTOXICITY_UP",133,-1.1431,0.21,0.35,"No",1.6684,0,0.1,"Yes"
"10517","GO_BP","504639_GO_0035455_RESPONSE_TO_INTERFERON_ALPHA",17,-1.1431,0.28,0.43,"No",1.5605,0.032,0.34,"Yes"
"10518","C2_Chemical_and_genetic_perturbations","C2_CGP_3119_KANG_AR_TARGETS_DN",18,-1.1431,0.29,0.35,"No",0.6973,0.89,1,"Yes"
"10519","C7_Immunologic_signatures","C7_ALL_1239_GSE2826_WT_VS_XID_BCELL_UP",193,-1.143,0.18,0.28,"No",1.141,0.16,0.34,"Yes"
"10520","REACTOME","106165_REACT_11235_TRANS_GOLGI_NETWORK_VESICLE_BUDDING",70,-1.143,0.23,0.47,"No",0.9569,0.53,0.82,"Yes"
"10521","GO_MF","496051_GO_0015929_HEXOSAMINIDASE_ACTIVITY",15,-1.1429,0.29,0.47,"No",-0.6648,0.89,1,"No"
"10522","C2_Chemical_and_genetic_perturbations","C2_CGP_3012_BROWNE_HCMV_INFECTION_30MIN_DN",150,-1.1429,0.22,0.35,"No",0.9456,0.62,0.87,"Yes"
"10523","GO_BP","505773_GO_0042659_REGULATION_OF_CELL_FATE_SPECIFICATION",18,-1.1429,0.27,0.43,"No",-1.0839,0.34,0.96,"No"
"10524","GO_MF","499877_GO_0030551_CYCLIC_NUCLEOTIDE_BINDING",38,-1.1428,0.27,0.47,"No",0.9762,0.49,0.9,"Yes"
"10525","GO_BP","491527_GO_0006637_ACYL_COA_METABOLIC_PROCESS",63,-1.1428,0.24,0.43,"No",-0.8301,0.79,1,"No"
"10526","GO_MF","499433_GO_0042608_T_CELL_RECEPTOR_BINDING",7,-1.1428,0.32,0.47,"No",1.1567,0.31,0.74,"Yes"
"10527","GO_MF","490528_GO_0005328_NEUROTRANSMITTER_SODIUM_SYMPORTER_ACTIVITY",18,-1.1427,0.29,0.47,"No",-1.4436,0.075,0.63,"No"
"10528","C7_Immunologic_signatures","C7_ALL_1392_GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN",194,-1.1426,0.2,0.28,"No",1.2588,0.038,0.14,"Yes"
"10529","REACTOME","366165_REACT_75776_NOD1_2_SIGNALING_PATHWAY",32,-1.1425,0.29,0.47,"No",-0.8678,0.68,1,"No"
"10530","C2_Chemical_and_genetic_perturbations","C2_CGP_1922_TSENG_ADIPOGENIC_POTENTIAL_DN",43,-1.1424,0.26,0.35,"No",1.293,0.099,0.4,"Yes"
"10531","GO_BP","781978_GO_1901989_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION",48,-1.1424,0.26,0.43,"No",0.6455,0.98,1,"Yes"
"10532","GO_MF","496732_GO_0016836_HYDRO_LYASE_ACTIVITY",47,-1.1423,0.25,0.47,"No",0.9874,0.45,0.89,"Yes"
"10533","GO_MF","490028_GO_0004712_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY",49,-1.1423,0.26,0.47,"No",-1.1881,0.19,0.79,"No"
"10534","KEGG_reaction","R01000_2_HYDROXYBUTYRATE_NAD_OXIDOREDUCTASE_2_HYDROXYBUTANOIC_ACID_NAD_2_OXOBUTANOATE_NADH_H_",5,-1.1421,0.34,0.43,"No",-0.8802,0.59,0.97,"No"
"10535","C3_TF_targets","C3_TFT_212_V_ATF_B",183,-1.142,0.2,0.28,"No",-1.0357,0.39,0.68,"No"
"10536","GO_BP","514758_GO_0061213_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT",22,-1.142,0.28,0.43,"No",1.1653,0.25,0.82,"Yes"
"10537","GO_BP","512807_GO_0051957_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT",10,-1.1419,0.29,0.43,"No",-0.7298,0.84,1,"No"
"10538","C2_Chemical_and_genetic_perturbations","C2_CGP_1421_NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP",152,-1.1418,0.22,0.35,"No",1.575,0.0024,0.16,"Yes"
"10539","C2_Chemical_and_genetic_perturbations","C2_CGP_345_WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN",14,-1.1418,0.29,0.35,"No",1.5629,0.04,0.16,"Yes"
"10540","C3_MicroRNA_targets","C3_MIR_52_ATGTTAA_MIR_302C",238,-1.1418,0.18,0.37,"No",0.919,0.72,1,"Yes"
"10541","C2_Chemical_and_genetic_perturbations","C2_CGP_772_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3",7,-1.1417,0.32,0.35,"No",-1.251,0.21,0.74,"No"
"10542","C2_Chemical_and_genetic_perturbations","C2_CGP_1563_XU_RESPONSE_TO_TRETINOIN_DN",12,-1.1416,0.3,0.35,"No",1.016,0.43,0.78,"Yes"
"10543","GO_BP","491586_GO_0006699_BILE_ACID_BIOSYNTHETIC_PROCESS",20,-1.1416,0.29,0.43,"No",1.2493,0.17,0.73,"Yes"
"10544","GO_BP","513969_GO_0060413_ATRIAL_SEPTUM_MORPHOGENESIS",14,-1.1414,0.3,0.43,"No",-0.9942,0.47,1,"No"
"10545","REACTOME","187106_REACT_25078_INTERFERON_GAMMA_SIGNALING",89,-1.1414,0.24,0.47,"No",0.7269,0.97,1,"Yes"
"10546","GO_BP","494930_GO_0010866_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS",17,-1.1413,0.28,0.43,"No",1.0679,0.35,0.94,"Yes"
"10547","C2_Chemical_and_genetic_perturbations","C2_CGP_2657_LIU_VAV3_PROSTATE_CARCINOGENESIS_DN",15,-1.1411,0.3,0.35,"No",1.3234,0.14,0.37,"Yes"
"10548","C2_Chemical_and_genetic_perturbations","C2_CGP_3135_BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D",272,-1.1411,0.18,0.35,"No",0.9395,0.63,0.88,"Yes"
"10549","GO_BP","753111_GO_1900116_EXTRACELLULAR_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION",14,-1.141,0.28,0.43,"No",1.0509,0.36,0.95,"Yes"
"10550","REACTOME","119556_REACT_19405_CTLA4_INHIBITORY_SIGNALING",22,-1.1409,0.27,0.47,"No",0.6368,0.95,1,"Yes"
"10551","GO_BP","491143_GO_0006171_CAMP_BIOSYNTHETIC_PROCESS",16,-1.1409,0.29,0.43,"No",-0.9191,0.56,1,"No"
"10552","C7_Immunologic_signatures","C7_ALL_1416_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN",195,-1.1409,0.19,0.28,"No",-0.9807,0.5,1,"No"
"10553","C7_Immunologic_signatures","C7_ALL_1798_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN",196,-1.1409,0.2,0.28,"No",0.6629,1,1,"Yes"
"10554","GO_BP","512467_GO_0051589_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT",12,-1.1408,0.31,0.43,"No",0.8436,0.63,1,"Yes"
"10555","C7_Immunologic_signatures","C7_ALL_245_GSE14308_TH2_VS_TH17_UP",198,-1.1406,0.2,0.28,"No",1.4397,0.0069,0.025,"Yes"
"10556","C2_Chemical_and_genetic_perturbations","C2_CGP_464_CAIRO_PML_TARGETS_BOUND_BY_MYC_DN",14,-1.1406,0.29,0.35,"No",-0.7104,0.85,1,"No"
"10557","C4_Cancer_modules","C4_CM_221_MODULE_242",204,-1.1406,0.19,0.36,"No",-1.1031,0.22,0.71,"No"
"10558","GO_BP","492849_GO_0008589_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY",65,-1.1405,0.26,0.43,"No",-1.0052,0.45,0.98,"No"
"10559","C2_Chemical_and_genetic_perturbations","C2_CGP_2587_HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP",21,-1.1405,0.29,0.35,"No",-0.6936,0.91,1,"No"
"10560","KEGG_pathway","HSA04932_NON_ALCOHOLIC_FATTY_LIVER_DISEASE_NAFLD_",143,-1.1404,0.23,0.3,"No",1.7708,0,0.017,"Yes"
"10561","C7_Immunologic_signatures","C7_ALL_1297_GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP",195,-1.1404,0.19,0.28,"No",-1.3379,0.017,0.37,"No"
"10562","C2_Chemical_and_genetic_perturbations","C2_CGP_3189_BILANGES_SERUM_SENSITIVE_GENES",84,-1.1402,0.24,0.35,"No",1.4817,0.023,0.23,"Yes"
"10563","GO_BP","500543_GO_0031284_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY",10,-1.1401,0.29,0.43,"No",-1.3571,0.13,0.97,"No"
"10564","GO_BP","510653_GO_0048592_EYE_MORPHOGENESIS",139,-1.1401,0.23,0.43,"No",-1.0131,0.43,0.98,"No"
"10565","KEGG_reaction","R04452_1_ALKYL_2_ACETYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ACETOHYDROLASE_2_ACETYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_ACETATE",5,-1.14,0.32,0.43,"No",1.2768,0.2,0.69,"Yes"
"10566","GO_BP","510894_GO_0048844_ARTERY_MORPHOGENESIS",49,-1.14,0.25,0.43,"No",0.6498,0.98,1,"Yes"
"10567","GO_BP","515651_GO_0070723_RESPONSE_TO_CHOLESTEROL",20,-1.1399,0.29,0.43,"No",-0.6443,0.94,1,"No"
"10568","C7_Immunologic_signatures","C7_ALL_27_GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP",196,-1.1399,0.18,0.28,"No",-1.1591,0.15,0.96,"No"
"10569","C2_Chemical_and_genetic_perturbations","C2_CGP_470_BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN",31,-1.1398,0.29,0.35,"No",-1.7431,0.0038,0.37,"No"
"10570","C2_Chemical_and_genetic_perturbations","C2_CGP_65_CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN",375,-1.1398,0.14,0.35,"No",-0.9165,0.76,1,"No"
"10571","GO_BP","500154_GO_0030856_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION",111,-1.1398,0.21,0.43,"No",-1.0246,0.41,0.97,"No"
"10572","C2_Chemical_and_genetic_perturbations","C2_CGP_910_HATADA_METHYLATED_IN_LUNG_CANCER_DN",35,-1.1398,0.27,0.35,"No",1.2986,0.12,0.39,"Yes"
"10573","GO_CC","490819_GO_0005791_ROUGH_ENDOPLASMIC_RETICULUM",60,-1.1398,0.26,0.52,"No",0.9207,0.6,0.87,"Yes"
"10574","KEGG_reaction","R02240_ATP_1_2_DIACYLGLYCEROL_3_PHOSPHOTRANSFERASE_ATP_1_2_DIACYL_SN_GLYCEROL_ADP_PHOSPHATIDATE",10,-1.1397,0.31,0.42,"No",-1.6891,0.011,0.041,"No"
"10575","KEGG_module","HSA_M00078_HEPARAN_SULFATE_DEGRADATION",9,-1.1396,0.29,0.6,"No",-0.614,0.93,1,"No"
"10576","C7_Immunologic_signatures","C7_ALL_624_GSE17721_POLYIC_VS_CPG_4H_BMDM_DN",196,-1.1395,0.2,0.28,"No",1.2431,0.059,0.16,"Yes"
"10577","GO_BP","513582_GO_0060024_RHYTHMIC_SYNAPTIC_TRANSMISSION",6,-1.1395,0.33,0.43,"No",-1.1783,0.27,0.91,"No"
"10578","GO_BP","499852_GO_0030513_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY",27,-1.1395,0.29,0.43,"No",0.8493,0.7,1,"Yes"
"10579","C3_TF_targets","C3_TFT_11_V_EVI1_06",20,-1.1394,0.27,0.28,"No",-1.1774,0.23,0.39,"No"
"10580","REACTOME","106376_REACT_18365_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS",9,-1.1393,0.31,0.47,"No",0.8036,0.73,1,"Yes"
"10581","REACTOME","105703_REACT_13543_XENOBIOTICS",21,-1.1392,0.27,0.47,"No",-1.5186,0.037,0.43,"No"
"10582","GO_MF","490360_GO_0005092_GDP_DISSOCIATION_INHIBITOR_ACTIVITY",10,-1.1391,0.29,0.48,"No",-0.6118,0.94,1,"No"
"10583","C7_Immunologic_signatures","C7_ALL_1730_GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN",196,-1.139,0.2,0.29,"No",1.8265,0,3.3e-05,"Yes"
"10584","GO_BP","516633_GO_0071709_MEMBRANE_ASSEMBLY",20,-1.1389,0.3,0.43,"No",0.8599,0.7,1,"Yes"
"10585","C2_Chemical_and_genetic_perturbations","C2_CGP_828_MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP",223,-1.1389,0.19,0.35,"No",1.0351,0.34,0.74,"Yes"
"10586","REACTOME","106368_REACT_17064_SEROTONIN_RECEPTORS",12,-1.1388,0.32,0.47,"No",1.0569,0.39,0.65,"Yes"
"10587","GO_BP","508728_GO_0046467_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS",97,-1.1387,0.24,0.43,"No",0.6482,1,1,"Yes"
"10588","GO_BP","494043_GO_0009954_PROXIMAL_DISTAL_PATTERN_FORMATION",30,-1.1387,0.28,0.43,"No",1.3084,0.11,0.66,"Yes"
"10589","GO_BP","500835_GO_0031585_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",5,-1.1386,0.32,0.43,"No",-0.8055,0.72,1,"No"
"10590","GO_BP","504705_GO_0035524_PROLINE_TRANSMEMBRANE_TRANSPORT",5,-1.1386,0.33,0.43,"No",-1.199,0.28,0.9,"No"
"10591","REACTOME","105985_REACT_6266_EARLY_PHASE_OF_HIV_LIFE_CYCLE",14,-1.1385,0.31,0.47,"No",1.2121,0.19,0.43,"Yes"
"10592","REACTOME","106338_REACT_12478_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA",36,-1.1383,0.3,0.47,"No",-0.8562,0.69,1,"No"
"10593","GO_CC","925904_GO_1902555_ENDORIBONUCLEASE_COMPLEX",6,-1.1383,0.32,0.52,"No",-0.8973,0.59,0.95,"No"
"10594","KEGG_compound","C00857_DEAMINO_NAD_DEAMIDO_NAD_DEAMIDO_NAD",7,-1.1382,0.31,0.46,"No",-0.57,0.95,1,"No"
"10595","GO_BP","491081_GO_0006103_2_OXOGLUTARATE_METABOLIC_PROCESS",16,-1.1382,0.29,0.43,"No",-0.7493,0.82,1,"No"
"10596","GO_BP","494732_GO_0010669_EPITHELIAL_STRUCTURE_MAINTENANCE",19,-1.1381,0.28,0.43,"No",-1.0939,0.32,0.95,"No"
"10597","GO_MF","489750_GO_0004385_GUANYLATE_KINASE_ACTIVITY",12,-1.1381,0.31,0.48,"No",-1.1877,0.24,0.79,"No"
"10598","C2_Chemical_and_genetic_perturbations","C2_CGP_2436_FIRESTEIN_CTNNB1_PATHWAY",32,-1.1381,0.28,0.36,"No",-0.8856,0.63,1,"No"
"10599","C7_Immunologic_signatures","C7_ALL_1829_GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP",197,-1.138,0.2,0.29,"No",0.8942,0.77,1,"Yes"
"10600","REACTOME","106485_REACT_299_SIGNALING_BY_NOTCH",111,-1.1379,0.23,0.47,"No",-0.9125,0.67,1,"No"
"10601","GO_BP","495313_GO_0015012_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",21,-1.1379,0.3,0.43,"No",0.8147,0.77,1,"Yes"
"10602","GO_BP","512527_GO_0051651_MAINTENANCE_OF_LOCATION_IN_CELL",118,-1.1379,0.22,0.43,"No",0.7749,0.93,1,"Yes"
"10603","C7_Immunologic_signatures","C7_ALL_543_GSE17721_LPS_VS_POLYIC_24H_BMDM_UP",197,-1.1379,0.19,0.29,"No",1.2494,0.053,0.15,"Yes"
"10604","GO_BP","493301_GO_0009101_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",341,-1.1378,0.17,0.43,"No",0.9073,0.83,1,"Yes"
"10605","C2_Chemical_and_genetic_perturbations","C2_CGP_2865_WINNEPENNINCKX_MELANOMA_METASTASIS_UP",161,-1.1377,0.21,0.36,"No",0.9472,0.61,0.87,"Yes"
"10606","GO_BP","501820_GO_0032594_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER",7,-1.1376,0.31,0.43,"No",-0.7492,0.79,1,"No"
"10607","C2_Chemical_and_genetic_perturbations","C2_CGP_2190_RIZKI_TUMOR_INVASIVENESS_3D_UP",205,-1.1376,0.2,0.36,"No",-0.9203,0.7,1,"No"
"10608","GO_BP","506505_GO_0043473_PIGMENTATION",89,-1.1375,0.24,0.43,"No",1.2487,0.095,0.73,"Yes"
"10609","GO_BP","503844_GO_0034644_CELLULAR_RESPONSE_TO_UV",52,-1.1375,0.24,0.43,"No",0.7453,0.89,1,"Yes"
"10610","KEGG_compound","C11557_1_PHOSPHATIDYL_1D_MYO_INOSITOL_5_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_5_PHOSPHATE_",5,-1.1374,0.34,0.46,"No",-0.8952,0.57,1,"No"
"10611","C3_TF_targets","C3_TFT_430_V_MYC_Q2",180,-1.1374,0.21,0.29,"No",0.8783,0.82,1,"Yes"
"10612","C3_TF_targets","C3_TFT_405_V_HNF4_DR1_Q3",250,-1.1374,0.18,0.29,"No",-1.0747,0.26,0.61,"No"
"10613","GO_BP","507949_GO_0045601_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION",14,-1.1373,0.3,0.43,"No",-0.7897,0.75,1,"No"
"10614","GO_CC","498616_GO_0019814_IMMUNOGLOBULIN_COMPLEX",5,-1.1372,0.33,0.53,"No",0.8538,0.65,0.91,"Yes"
"10615","GO_BP","487921_GO_0002031_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION",12,-1.1371,0.29,0.43,"No",-0.8256,0.7,1,"No"
"10616","C7_Immunologic_signatures","C7_ALL_1413_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP",192,-1.137,0.21,0.29,"No",0.8913,0.77,1,"Yes"
"10617","GO_BP","512568_GO_0051693_ACTIN_FILAMENT_CAPPING",31,-1.1369,0.25,0.43,"No",-1.0011,0.44,0.99,"No"
"10618","GO_BP","505571_GO_0042430_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS",28,-1.1369,0.29,0.43,"No",-1.1879,0.23,0.9,"No"
"10619","GO_BP","496108_GO_0015991_ATP_HYDROLYSIS_COUPLED_PROTON_TRANSPORT",29,-1.1368,0.27,0.43,"No",1.629,0.011,0.26,"Yes"
"10620","C3_MicroRNA_targets","C3_MIR_177_GCAAGGA_MIR_502",70,-1.1368,0.26,0.38,"No",-0.8346,0.81,1,"No"
"10621","GO_BP","493751_GO_0009635_RESPONSE_TO_HERBICIDE",8,-1.1368,0.32,0.43,"No",0.8944,0.6,1,"Yes"
"10622","C2_Chemical_and_genetic_perturbations","C2_CGP_1254_CERVERA_SDHB_TARGETS_1_DN",35,-1.1367,0.28,0.36,"No",-0.9811,0.48,1,"No"
"10623","GO_BP","512324_GO_0051446_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE",14,-1.1367,0.29,0.43,"No",-1.01,0.43,0.98,"No"
"10624","C7_Immunologic_signatures","C7_ALL_1573_GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP",193,-1.1367,0.2,0.29,"No",0.7541,0.99,1,"Yes"
"10625","REACTOME","106520_REACT_15425_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE",18,-1.1367,0.3,0.47,"No",-1.1617,0.25,0.85,"No"
"10626","C7_Immunologic_signatures","C7_ALL_1779_GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP",196,-1.1363,0.2,0.29,"No",0.893,0.77,1,"Yes"
"10627","GO_BP","513954_GO_0060398_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY",5,-1.1362,0.34,0.43,"No",-0.8913,0.59,1,"No"
"10628","C7_Immunologic_signatures","C7_ALL_1425_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP",196,-1.1362,0.2,0.29,"No",0.7579,0.99,1,"Yes"
"10629","REACTOME","1183566_REACT_355146_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2",45,-1.1362,0.27,0.47,"No",-1.2296,0.15,0.79,"No"
"10630","C4_Cancer_modules","C4_CM_66_MODULE_70",41,-1.1361,0.27,0.36,"No",-0.9146,0.59,0.88,"No"
"10631","C3_MicroRNA_targets","C3_MIR_21_AATGTGA_MIR_23A_MIR_23B",412,-1.136,0.16,0.38,"No",1.0584,0.28,1,"Yes"
"10632","GO_BP","508097_GO_0045760_POSITIVE_REGULATION_OF_ACTION_POTENTIAL",11,-1.136,0.33,0.43,"No",-1.6908,0.013,0.59,"No"
"10633","GO_BP","506430_GO_0043392_NEGATIVE_REGULATION_OF_DNA_BINDING",45,-1.1359,0.29,0.43,"No",1.399,0.049,0.55,"Yes"
"10634","C7_Immunologic_signatures","C7_ALL_287_GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP",200,-1.1359,0.19,0.29,"No",-0.9536,0.58,1,"No"
"10635","C2_Chemical_and_genetic_perturbations","C2_CGP_2686_VALK_AML_CLUSTER_10",31,-1.1358,0.28,0.36,"No",-1.0191,0.43,0.98,"No"
"10636","C4_Cancer_gene_neighborhoods","C4_CGN_77_MORF_CNTN1",106,-1.1358,0.24,0.45,"No",-0.9109,0.66,1,"No"
"10637","GO_BP","491590_GO_0006703_ESTROGEN_BIOSYNTHETIC_PROCESS",9,-1.1357,0.3,0.43,"No",1.125,0.3,0.87,"Yes"
"10638","C7_Immunologic_signatures","C7_ALL_654_GSE17721_LPS_VS_CPG_0_5H_BMDM_DN",197,-1.1356,0.22,0.29,"No",0.9715,0.57,0.83,"Yes"
"10639","GO_MF","496623_GO_0016701_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN",26,-1.1355,0.28,0.48,"No",-0.9475,0.51,0.94,"No"
"10640","OMIM_gene","OMIM600503_SUB1_S_CEREVISIAE_HOMOLOG_OF_SUB1",5,-1.1354,0.34,0.81,"No",-0.7354,0.77,0.96,"No"
"10641","C2_Chemical_and_genetic_perturbations","C2_CGP_61_GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN",36,-1.1354,0.26,0.36,"No",1.5944,0.017,0.14,"Yes"
"10642","KEGG_compound","C00011_CO2_CARBON_DIOXIDE",95,-1.1353,0.23,0.46,"No",-0.9587,0.53,1,"No"
"10643","GO_BP","777522_GO_1901970_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION",8,-1.1352,0.3,0.44,"No",0.751,0.77,1,"Yes"
"10644","REACTOME","1127671_REACT_264098_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION",122,-1.1351,0.24,0.47,"No",-1.3987,0.02,0.53,"No"
"10645","C2_Chemical_and_genetic_perturbations","C2_CGP_3055_VERHAAK_GLIOBLASTOMA_CLASSICAL",161,-1.135,0.2,0.36,"No",-0.9513,0.59,1,"No"
"10646","GO_BP","486791_GO_0000272_POLYSACCHARIDE_CATABOLIC_PROCESS",24,-1.135,0.3,0.44,"No",-0.8428,0.71,1,"No"
"10647","C2_Chemical_and_genetic_perturbations","C2_CGP_2205_POS_HISTAMINE_RESPONSE_NETWORK",31,-1.1348,0.26,0.36,"No",0.6508,0.95,1,"Yes"
"10648","GO_BP","491849_GO_0007018_MICROTUBULE_BASED_MOVEMENT",184,-1.1348,0.22,0.44,"No",-0.9771,0.51,1,"No"
"10649","C2_Chemical_and_genetic_perturbations","C2_CGP_2263_SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN",9,-1.1347,0.3,0.36,"No",-1.5014,0.077,0.45,"No"
"10650","C3_TF_targets","C3_TFT_380_V_USF2_Q6",245,-1.1347,0.18,0.29,"No",0.9364,0.63,1,"Yes"
"10651","C2_Chemical_and_genetic_perturbations","C2_CGP_1307_PENG_GLUTAMINE_DEPRIVATION_UP",37,-1.1345,0.29,0.36,"No",-0.9892,0.46,1,"No"
"10652","GO_MF","489811_GO_0004459_L_LACTATE_DEHYDROGENASE_ACTIVITY",5,-1.1345,0.34,0.49,"No",-0.8915,0.61,1,"No"
"10653","C2_Chemical_and_genetic_perturbations","C2_CGP_2373_SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM",5,-1.1343,0.32,0.36,"No",1.3233,0.15,0.37,"Yes"
"10654","REACTOME","187103_REACT_25229_INTERFERON_SIGNALING",189,-1.1342,0.19,0.47,"No",1.3447,0.008,0.27,"Yes"
"10655","C4_Cancer_modules","C4_CM_284_MODULE_325",53,-1.1342,0.26,0.37,"No",-0.9068,0.63,0.9,"No"
"10656","C4_Cancer_modules","C4_CM_179_MODULE_191",15,-1.1341,0.29,0.36,"No",1.5197,0.047,0.11,"Yes"
"10657","C2_Chemical_and_genetic_perturbations","C2_CGP_1492_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN",163,-1.1341,0.19,0.36,"No",0.9887,0.48,0.81,"Yes"
"10658","C2_Chemical_and_genetic_perturbations","C2_CGP_2257_SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN",85,-1.1341,0.25,0.36,"No",-0.8868,0.69,1,"No"
"10659","GO_BP","503455_GO_0034250_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS",9,-1.134,0.34,0.44,"No",0.9365,0.5,1,"Yes"
"10660","C7_Immunologic_signatures","C7_ALL_754_GSE17721_0_5H_VS_12H_GARDIQUIMOD_BMDM_DN",198,-1.134,0.21,0.29,"No",0.7745,0.99,1,"Yes"
"10661","GO_MF","496645_GO_0016725_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS",10,-1.134,0.34,0.49,"No",1.3655,0.12,0.5,"Yes"
"10662","OMIM_gene","OMIM608749_BROMODOMAIN_CONTAINING_PROTEIN_4_BRD4",6,-1.1338,0.34,0.78,"No",0.7244,0.79,1,"Yes"
"10663","C7_Immunologic_signatures","C7_ALL_893_GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP",196,-1.1337,0.21,0.29,"No",1.0011,0.47,0.73,"Yes"
"10664","GO_MF","509160_GO_0046969_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K9_SPECIFIC_",13,-1.1337,0.31,0.49,"No",-1.2564,0.16,0.84,"No"
"10665","C3_TF_targets","C3_TFT_378_V_HNF3ALPHA_Q6",199,-1.1337,0.21,0.29,"No",-0.9479,0.58,0.89,"No"
"10666","GO_BP","499723_GO_0030322_STABILIZATION_OF_MEMBRANE_POTENTIAL",16,-1.1335,0.3,0.44,"No",1.1976,0.23,0.78,"Yes"
"10667","GO_BP","505172_GO_0040014_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH",69,-1.1334,0.26,0.44,"No",0.9894,0.48,0.99,"Yes"
"10668","C2_Chemical_and_genetic_perturbations","C2_CGP_2131_MCGOWAN_RSP6_TARGETS_UP",17,-1.1334,0.29,0.36,"No",0.881,0.62,0.94,"Yes"
"10669","GO_BP","513886_GO_0060330_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA",25,-1.1334,0.27,0.44,"No",0.883,0.62,1,"Yes"
"10670","GO_BP","494970_GO_0010906_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS",95,-1.1334,0.24,0.44,"No",0.7239,0.97,1,"Yes"
"10671","GO_MF","489251_GO_0003705_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",89,-1.1333,0.25,0.49,"No",0.9408,0.59,0.94,"Yes"
"10672","C7_Immunologic_signatures","C7_ALL_573_GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_UP",197,-1.1333,0.2,0.3,"No",0.9131,0.75,0.99,"Yes"
"10673","GO_BP","515599_GO_0070669_RESPONSE_TO_INTERLEUKIN_2",7,-1.1333,0.33,0.44,"No",1.5001,0.062,0.41,"Yes"
"10674","C2_Chemical_and_genetic_perturbations","C2_CGP_78_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP",401,-1.1333,0.15,0.36,"No",1.2424,0.025,0.45,"Yes"
"10675","GO_MF","495480_GO_0015216_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-1.1332,0.33,0.49,"No",-0.778,0.74,1,"No"
"10676","GO_BP","808772_GO_1902101_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",8,-1.1332,0.32,0.44,"No",0.7379,0.79,1,"Yes"
"10677","REACTOME","106235_REACT_733_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS",9,-1.1332,0.31,0.47,"No",0.864,0.66,0.95,"Yes"
"10678","C2_Chemical_and_genetic_perturbations","C2_CGP_2337_MATZUK_SPERMATOZOA",109,-1.1331,0.23,0.36,"No",0.7227,0.98,1,"Yes"
"10679","GO_BP","517118_GO_0072202_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT",10,-1.1331,0.31,0.44,"No",-0.9506,0.51,1,"No"
"10680","C2_Chemical_and_genetic_perturbations","C2_CGP_2094_WANG_LSD1_TARGETS_DN",38,-1.1331,0.27,0.36,"No",-1.0155,0.42,0.99,"No"
"10681","C2_Chemical_and_genetic_perturbations","C2_CGP_3196_KIM_TIAL1_TARGETS",31,-1.1331,0.29,0.36,"No",1.2574,0.15,0.43,"Yes"
"10682","C7_Immunologic_signatures","C7_ALL_1850_GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN",191,-1.133,0.21,0.3,"No",1.5778,0,0.0043,"Yes"
"10683","GO_BP","505343_GO_0042182_KETONE_CATABOLIC_PROCESS",7,-1.133,0.32,0.44,"No",0.8411,0.68,1,"Yes"
"10684","GO_BP","517318_GO_0072402_RESPONSE_TO_DNA_INTEGRITY_CHECKPOINT_SIGNALING",5,-1.133,0.34,0.44,"No",-0.9447,0.53,1,"No"
"10685","C4_Cancer_modules","C4_CM_378_MODULE_465",15,-1.1329,0.3,0.36,"No",0.7979,0.76,0.98,"Yes"
"10686","C7_Immunologic_signatures","C7_ALL_871_GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP",193,-1.1329,0.21,0.3,"No",0.8096,0.94,1,"Yes"
"10687","GO_MF","507331_GO_0044325_ION_CHANNEL_BINDING",85,-1.1329,0.26,0.49,"No",0.7272,0.96,1,"Yes"
"10688","GO_BP","518379_GO_0090239_REGULATION_OF_HISTONE_H4_ACETYLATION",9,-1.1329,0.3,0.44,"No",-0.7328,0.8,1,"No"
"10689","GO_CC","490824_GO_0005796_GOLGI_LUMEN",81,-1.1328,0.24,0.53,"No",1.4051,0.023,0.29,"Yes"
"10690","C3_TF_targets","C3_TFT_207_V_MYCMAX_B",258,-1.1328,0.2,0.29,"No",-0.71,1,1,"No"
"10691","C2_Chemical_and_genetic_perturbations","C2_CGP_2942_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16",75,-1.1328,0.26,0.36,"No",-0.9155,0.64,1,"No"
"10692","GO_BP","498455_GO_0019626_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS",7,-1.1328,0.33,0.44,"No",-0.7898,0.75,1,"No"
"10693","C2_Chemical_and_genetic_perturbations","C2_CGP_2710_BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN",27,-1.1327,0.29,0.36,"No",1.494,0.047,0.21,"Yes"
"10694","C2_Chemical_and_genetic_perturbations","C2_CGP_240_MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP",137,-1.1327,0.22,0.36,"No",0.8172,0.89,0.98,"Yes"
"10695","GO_BP","513772_GO_0060216_DEFINITIVE_HEMOPOIESIS",20,-1.1327,0.3,0.44,"No",-0.8553,0.69,1,"No"
"10696","REACTOME","106030_REACT_1230_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN",13,-1.1327,0.31,0.47,"No",-0.681,0.89,1,"No"
"10697","GO_BP","519286_GO_2000647_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION",15,-1.1327,0.32,0.44,"No",-0.7566,0.78,1,"No"
"10698","GO_BP","492134_GO_0007369_GASTRULATION",150,-1.1326,0.21,0.44,"No",0.9164,0.7,1,"Yes"
"10699","C7_Immunologic_signatures","C7_ALL_527_GSE17721_LPS_VS_POLYIC_0_5H_BMDM_UP",195,-1.1324,0.22,0.3,"No",0.8406,0.92,1,"Yes"
"10700","C2_Chemical_and_genetic_perturbations","C2_CGP_2678_VALK_AML_CLUSTER_2",29,-1.1324,0.28,0.36,"No",1.1558,0.22,0.55,"Yes"
"10701","C2_Chemical_and_genetic_perturbations","C2_CGP_2682_VALK_AML_CLUSTER_6",33,-1.1324,0.27,0.36,"No",1.738,0.0064,0.064,"Yes"
"10702","GO_BP","507254_GO_0044247_CELLULAR_POLYSACCHARIDE_CATABOLIC_PROCESS",22,-1.1324,0.3,0.44,"No",-0.9162,0.57,1,"No"
"10703","WikiPathways","672450_WP1971_INTEGRATED_CANCER_PATHWAY",35,-1.1322,0.29,0.39,"No",-0.9192,0.58,1,"No"
"10704","C7_Immunologic_signatures","C7_ALL_407_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP",196,-1.1322,0.22,0.3,"No",-0.8041,0.95,1,"No"
"10705","GO_MF","490371_GO_0005105_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING",5,-1.1322,0.34,0.49,"No",-1.5146,0.038,0.55,"No"
"10706","REACTOME","106408_REACT_7964_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION",5,-1.1322,0.33,0.47,"No",0.9711,0.5,0.8,"Yes"
"10707","C2_Chemical_and_genetic_perturbations","C2_CGP_922_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3",65,-1.1321,0.26,0.36,"No",1.4181,0.033,0.28,"Yes"
"10708","GO_BP","518192_GO_0090051_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",8,-1.1321,0.33,0.44,"No",-1.2788,0.19,0.89,"No"
"10709","GO_BP","510922_GO_0048873_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE",24,-1.1319,0.3,0.44,"No",-0.7137,0.89,1,"No"
"10710","GO_BP","754492_GO_1901532_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",39,-1.1319,0.28,0.44,"No",-1.3242,0.093,0.89,"No"
"10711","C3_TF_targets","C3_TFT_609_TCANNTGAY_V_SREBP1_01",466,-1.1318,0.15,0.3,"No",0.8085,1,1,"Yes"
"10712","KEGG_compound","C05984_2_HYDROXYBUTANOIC_ACID_2_HYDROXYBUTYRATE_2_HYDROXYBUTYRIC_ACID",5,-1.1317,0.33,0.46,"No",-0.8882,0.58,1,"No"
"10713","C7_Immunologic_signatures","C7_ALL_867_GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP",200,-1.1316,0.21,0.3,"No",0.7926,0.97,1,"Yes"
"10714","C7_Immunologic_signatures","C7_ALL_341_GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP",200,-1.1314,0.2,0.3,"No",1.5194,0,0.0094,"Yes"
"10715","WikiPathways","755440_WP2263_PROSTATE_CANCER",108,-1.1314,0.23,0.39,"No",0.6558,1,1,"Yes"
"10716","C7_Immunologic_signatures","C7_ALL_1749_GSE6269_FLU_VS_E_COLI_INF_PBMC_UP",161,-1.1314,0.23,0.3,"No",0.8724,0.79,1,"Yes"
"10717","GO_BP","518701_GO_2000052_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY",8,-1.1313,0.31,0.44,"No",-0.8678,0.63,1,"No"
"10718","KEGG_pathway","HSA04330_NOTCH_SIGNALING_PATHWAY",48,-1.1313,0.26,0.32,"No",-1.1987,0.16,0.52,"No"
"10719","GO_CC","506273_GO_0043205_FIBRIL",13,-1.1311,0.29,0.54,"No",1.0262,0.45,0.74,"Yes"
"10720","C7_Immunologic_signatures","C7_ALL_1218_GSE27786_NKCELL_VS_NEUTROPHIL_DN",191,-1.131,0.21,0.3,"No",0.8477,0.88,1,"Yes"
"10721","GO_MF","490573_GO_0005416_CATION_AMINO_ACID_SYMPORTER_ACTIVITY",13,-1.1306,0.31,0.49,"No",-1.3693,0.11,0.7,"No"
"10722","C7_Immunologic_signatures","C7_ALL_1838_GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN",196,-1.1305,0.2,0.3,"No",0.8465,0.92,1,"Yes"
"10723","GO_BP","513805_GO_0060249_ANATOMICAL_STRUCTURE_HOMEOSTASIS",350,-1.1305,0.18,0.44,"No",-0.9447,0.63,1,"No"
"10724","GO_BP","504768_GO_0035589_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY",14,-1.1305,0.32,0.44,"No",1.7769,0.008,0.12,"Yes"
"10725","C7_Immunologic_signatures","C7_ALL_95_GSE11924_TFH_VS_TH1_CD4_TCELL_UP",199,-1.1304,0.23,0.3,"No",-0.7052,1,1,"No"
"10726","C2_BioCarta_Pathways","C2_CP_BIOCARTA_127_BIOCARTA_NOS1_PATHWAY",21,-1.1304,0.31,0.42,"No",1.628,0.009,0.28,"Yes"
"10727","GO_BP","493349_GO_0009152_PURINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",117,-1.1304,0.24,0.44,"No",0.9659,0.55,1,"Yes"
"10728","C2_Chemical_and_genetic_perturbations","C2_CGP_1963_MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN",13,-1.1303,0.31,0.37,"No",0.9073,0.57,0.91,"Yes"
"10729","C2_Chemical_and_genetic_perturbations","C2_CGP_757_XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN",88,-1.1302,0.26,0.37,"No",-0.836,0.79,1,"No"
"10730","GO_BP","508471_GO_0046173_POLYOL_BIOSYNTHETIC_PROCESS",23,-1.1302,0.29,0.44,"No",-0.9302,0.56,1,"No"
"10731","C2_Chemical_and_genetic_perturbations","C2_CGP_238_MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP",271,-1.1301,0.19,0.37,"No",1.0327,0.34,0.75,"Yes"
"10732","GO_BP","495300_GO_0014910_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION",36,-1.13,0.29,0.44,"No",1.0247,0.41,0.97,"Yes"
"10733","KEGG_compound","C01245_D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_1D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_INOSITOL_1_4_5_TRISPHOSPHATE_INS_1_4_5_P3",21,-1.13,0.3,0.47,"No",-1.3321,0.13,0.59,"No"
"10734","C4_Cancer_modules","C4_CM_422_MODULE_557",11,-1.13,0.32,0.37,"No",-1.0498,0.38,0.72,"No"
"10735","C7_Immunologic_signatures","C7_ALL_343_GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP",199,-1.1299,0.23,0.3,"No",1.4134,0.0025,0.034,"Yes"
"10736","KEGG_compound","C00083_MALONYL_COA_MALONYL_COENZYME_A",12,-1.1299,0.3,0.46,"No",-1.0493,0.39,0.99,"No"
"10737","GO_BP","499726_GO_0030325_ADRENAL_GLAND_DEVELOPMENT",27,-1.1299,0.29,0.44,"No",0.9046,0.61,1,"Yes"
"10738","GO_BP","494983_GO_0010919_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS",11,-1.1297,0.31,0.44,"No",1.4209,0.079,0.53,"Yes"
"10739","GO_MF","496751_GO_0016859_CIS_TRANS_ISOMERASE_ACTIVITY",43,-1.1297,0.28,0.49,"No",1.1587,0.23,0.74,"Yes"
"10740","GO_BP","515869_GO_0070942_NEUTROPHIL_MEDIATED_CYTOTOXICITY",5,-1.1297,0.34,0.44,"No",1.4368,0.073,0.51,"Yes"
"10741","C1_Positional","C1_ALL_208_CHR4Q34",15,-1.1297,0.32,0.82,"No",1.2302,0.19,0.59,"Yes"
"10742","C2_Chemical_and_genetic_perturbations","C2_CGP_1551_MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP",25,-1.1296,0.29,0.37,"No",0.8642,0.64,0.96,"Yes"
"10743","GO_BP","515179_GO_0070244_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS",7,-1.1295,0.32,0.44,"No",0.8116,0.67,1,"Yes"
"10744","KEGG_compound","C00344_PHOSPHATIDYLGLYCEROL_3_3_SN_PHOSPHATIDYL_GLYCEROL_3_3_PHOSPHATIDYL_GLYCEROL_PTDGRO",6,-1.1295,0.35,0.46,"No",-0.5809,0.95,1,"No"
"10745","C2_Chemical_and_genetic_perturbations","C2_CGP_1279_BASSO_B_LYMPHOCYTE_NETWORK",143,-1.1294,0.24,0.37,"No",1.5507,0,0.17,"Yes"
"10746","GO_BP","1026085_GO_1903313_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS",41,-1.1294,0.29,0.44,"No",-1.1385,0.24,0.93,"No"
"10747","GO_BP","754611_GO_1901659_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS",134,-1.1293,0.23,0.44,"No",1.0767,0.3,0.93,"Yes"
"10748","REACTOME","161076_REACT_22151_TRANSPORT_OF_NUCLEOTIDE_SUGARS",9,-1.1293,0.33,0.48,"No",-1.2217,0.21,0.79,"No"
"10749","C7_Immunologic_signatures","C7_ALL_634_GSE17721_POLYIC_VS_CPG_24H_BMDM_DN",198,-1.1292,0.23,0.3,"No",1.4224,0.0024,0.031,"Yes"
"10750","C7_Immunologic_signatures","C7_ALL_826_GSE17974_0_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN",194,-1.129,0.22,0.3,"No",1.0743,0.27,0.51,"Yes"
"10751","REACTOME","161049_REACT_22344_NUCLEOSOME_ASSEMBLY",71,-1.129,0.25,0.48,"No",-1.3222,0.064,0.62,"No"
"10752","C3_MicroRNA_targets","C3_MIR_63_ACTGCAG_MIR_17_3P",109,-1.1287,0.23,0.39,"No",0.9711,0.5,1,"Yes"
"10753","C4_Cancer_gene_neighborhoods","C4_CGN_71_MORF_CD8A",120,-1.1287,0.25,0.46,"No",-1.0641,0.32,0.74,"No"
"10754","C7_Immunologic_signatures","C7_ALL_798_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN",199,-1.1286,0.21,0.3,"No",0.7636,0.99,1,"Yes"
"10755","GO_BP","993418_GO_1903076_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",56,-1.1286,0.28,0.44,"No",1.083,0.31,0.92,"Yes"
"10756","GO_BP","510770_GO_0048715_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION",12,-1.1285,0.3,0.44,"No",-0.67,0.9,1,"No"
"10757","KEGG_pathway","HSA00650_BUTANOATE_METABOLISM",26,-1.1285,0.29,0.32,"No",0.8529,0.71,1,"Yes"
"10758","GO_BP","502850_GO_0033634_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN",5,-1.1284,0.33,0.44,"No",-0.6271,0.89,1,"No"
"10759","GO_BP","510377_GO_0048263_DETERMINATION_OF_DORSAL_IDENTITY",5,-1.1282,0.34,0.44,"No",1.5459,0.041,0.35,"Yes"
"10760","C7_Immunologic_signatures","C7_ALL_709_GSE17721_0_5H_VS_4H_LPS_BMDM_UP",197,-1.1282,0.23,0.3,"No",1.5296,0,0.0084,"Yes"
"10761","KEGG_compound","C00085_D_FRUCTOSE_6_PHOSPHATE_D_FRUCTOSE_6_PHOSPHORIC_ACID_NEUBERG_ESTER",9,-1.1282,0.32,0.46,"No",0.6618,0.89,1,"Yes"
"10762","GO_BP","849770_GO_0061525_HINDGUT_DEVELOPMENT",8,-1.1282,0.3,0.44,"No",1.2007,0.26,0.78,"Yes"
"10763","GO_BP","752786_GO_0097285_CELL_TYPE_SPECIFIC_APOPTOTIC_PROCESS",94,-1.1281,0.26,0.44,"No",1.0831,0.29,0.92,"Yes"
"10764","C2_Chemical_and_genetic_perturbations","C2_CGP_964_COWLING_MYCN_TARGETS",43,-1.1281,0.28,0.37,"No",-1.2232,0.16,0.78,"No"
"10765","GO_BP","518708_GO_2000059_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",8,-1.1281,0.32,0.44,"No",-0.9348,0.53,1,"No"
"10766","C7_Immunologic_signatures","C7_ALL_1846_GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN",196,-1.128,0.21,0.3,"No",1.1913,0.1,0.24,"Yes"
"10767","GO_MF","498068_GO_0019213_DEACETYLASE_ACTIVITY",38,-1.128,0.27,0.49,"No",-1.021,0.4,0.89,"No"
"10768","GO_BP","492879_GO_0008630_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",78,-1.1279,0.25,0.45,"No",-0.6413,0.99,1,"No"
"10769","C2_Chemical_and_genetic_perturbations","C2_CGP_2156_LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN",45,-1.1278,0.28,0.37,"No",-0.7634,0.88,1,"No"
"10770","GO_BP","500313_GO_0031023_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION",69,-1.1278,0.26,0.45,"No",0.5728,1,1,"Yes"
"10771","GO_BP","753186_GO_1900193_REGULATION_OF_OOCYTE_MATURATION",5,-1.1277,0.34,0.45,"No",-1.5875,0.024,0.71,"No"
"10772","GO_MF","515262_GO_0070330_AROMATASE_ACTIVITY",22,-1.1277,0.32,0.49,"No",-1.4778,0.045,0.59,"No"
"10773","GO_BP","488368_GO_0002495_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II",93,-1.1276,0.24,0.45,"No",1.126,0.21,0.87,"Yes"
"10774","C3_TF_targets","C3_TFT_113_V_COUP_01",258,-1.1275,0.18,0.31,"No",-1.1132,0.22,0.51,"No"
"10775","REACTOME","833818_REACT_163810_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE",5,-1.1275,0.34,0.48,"No",0.9768,0.51,0.79,"Yes"
"10776","C2_BioCarta_Pathways","C2_CP_BIOCARTA_123_BIOCARTA_VIP_PATHWAY",25,-1.1274,0.27,0.43,"No",1.1537,0.23,0.67,"Yes"
"10777","C3_TF_targets","C3_TFT_404_V_PPAR_DR1_Q2",250,-1.1273,0.21,0.3,"No",-1.117,0.19,0.5,"No"
"10778","C2_Chemical_and_genetic_perturbations","C2_CGP_732_KOMMAGANI_TP63_GAMMA_TARGETS",9,-1.1272,0.31,0.37,"No",-0.8021,0.7,1,"No"
"10779","C7_Immunologic_signatures","C7_ALL_695_GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_UP",197,-1.1271,0.21,0.31,"No",0.8123,0.94,1,"Yes"
"10780","C2_BioCarta_Pathways","C2_CP_BIOCARTA_210_BIOCARTA_TFF_PATHWAY",21,-1.1271,0.29,0.42,"No",0.9938,0.46,0.82,"Yes"
"10781","C7_Immunologic_signatures","C7_ALL_1701_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP",189,-1.127,0.23,0.31,"No",-1.0756,0.28,1,"No"
"10782","C7_Immunologic_signatures","C7_ALL_435_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP",193,-1.127,0.24,0.31,"No",1.5249,0,0.0088,"Yes"
"10783","REACTOME","1127625_REACT_264295_S45_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.127,0.31,0.48,"No",0.693,0.87,1,"Yes"
"10784","C2_Chemical_and_genetic_perturbations","C2_CGP_2935_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9",75,-1.1269,0.25,0.37,"No",1.2633,0.095,0.42,"Yes"
"10785","C2_Chemical_and_genetic_perturbations","C2_CGP_3161_PASINI_SUZ12_TARGETS_UP",110,-1.1269,0.24,0.37,"No",0.7783,0.94,1,"Yes"
"10786","C7_Immunologic_signatures","C7_ALL_558_GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_DN",199,-1.1269,0.23,0.31,"No",1.5005,0,0.012,"Yes"
"10787","GO_BP","510694_GO_0048638_REGULATION_OF_DEVELOPMENTAL_GROWTH",236,-1.1268,0.2,0.45,"No",-0.8855,0.8,1,"No"
"10788","GO_BP","517133_GO_0072217_NEGATIVE_REGULATION_OF_METANEPHROS_DEVELOPMENT",9,-1.1267,0.33,0.45,"No",-0.8212,0.69,1,"No"
"10789","C1_Positional","C1_ALL_326_CHR2P14",29,-1.1266,0.29,0.82,"No",1.4418,0.064,0.31,"Yes"
"10790","GO_BP","497167_GO_0018196_PEPTIDYL_ASPARAGINE_MODIFICATION",125,-1.1266,0.25,0.45,"No",0.9712,0.54,1,"Yes"
"10791","GO_BP","491740_GO_0006879_CELLULAR_IRON_ION_HOMEOSTASIS",65,-1.1264,0.27,0.45,"No",1.2874,0.075,0.69,"Yes"
"10792","C2_Chemical_and_genetic_perturbations","C2_CGP_3069_LU_EZH2_TARGETS_DN",394,-1.1264,0.17,0.37,"No",0.9307,0.73,0.89,"Yes"
"10793","GO_BP","752842_GO_0097341_ZYMOGEN_INHIBITION",10,-1.1262,0.34,0.45,"No",-0.976,0.49,1,"No"
"10794","GO_MF","496540_GO_0016597_AMINO_ACID_BINDING",89,-1.1262,0.26,0.49,"No",1.1556,0.19,0.74,"Yes"
"10795","C2_Chemical_and_genetic_perturbations","C2_CGP_2597_LI_WILMS_TUMOR",27,-1.1261,0.26,0.37,"No",0.9453,0.55,0.87,"Yes"
"10796","C2_Chemical_and_genetic_perturbations","C2_CGP_2889_DANG_MYC_TARGETS_UP",141,-1.126,0.25,0.37,"No",1.8791,0,0.023,"Yes"
"10797","GO_BP","492203_GO_0007442_HINDGUT_MORPHOGENESIS",7,-1.126,0.32,0.45,"No",1.5565,0.046,0.33,"Yes"
"10798","C7_Immunologic_signatures","C7_ALL_241_GSE14026_TH1_VS_TH17_UP",190,-1.1259,0.21,0.31,"No",1.0678,0.28,0.53,"Yes"
"10799","C7_Immunologic_signatures","C7_ALL_1848_GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN",194,-1.1259,0.22,0.31,"No",1.3908,0.0067,0.041,"Yes"
"10800","GO_BP","511949_GO_0051024_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_SECRETION",11,-1.1257,0.31,0.45,"No",0.7572,0.81,1,"Yes"
"10801","GO_MF","500266_GO_0030976_THIAMINE_PYROPHOSPHATE_BINDING",5,-1.1256,0.34,0.5,"No",-0.9249,0.54,0.96,"No"
"10802","C3_TF_targets","C3_TFT_551_YRTCANNRCGC_UNKNOWN",64,-1.1256,0.27,0.31,"No",-1.1674,0.2,0.41,"No"
"10803","GO_MF","509118_GO_0046912_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER",5,-1.1255,0.33,0.49,"No",0.6501,0.87,1,"Yes"
"10804","C2_Chemical_and_genetic_perturbations","C2_CGP_919_KARAKAS_TGFB1_SIGNALING",17,-1.1255,0.29,0.37,"No",1.1401,0.28,0.57,"Yes"
"10805","GO_BP","506617_GO_0043586_TONGUE_DEVELOPMENT",20,-1.1255,0.28,0.45,"No",0.7371,0.86,1,"Yes"
"10806","KEGG_enzyme","1.1.1.27_L_LACTATE_DEHYDROGENASE_LACTIC_ACID_DEHYDROGENASE_L_NLDH_L_LACTATE_DEHYDROGENASE_L_LACTIC_DEHYDROGENASE_L_LACTIC_ACID_DEHYDROGENASE_LACTATE_DEHYDROGENASE_LACTATE_DEHYDROGENASE_NAD_DEPENDENT_LACTIC_DEHYDROGENASE_NAD_LACTATE_DEHYDROGENASE",5,-1.1255,0.31,0.53,"No",-0.8767,0.63,0.81,"No"
"10807","GO_BP","498875_GO_0021591_VENTRICULAR_SYSTEM_DEVELOPMENT",26,-1.1255,0.29,0.45,"No",0.6915,0.92,1,"Yes"
"10808","GO_MF","492797_GO_0008517_FOLIC_ACID_TRANSPORTER_ACTIVITY",7,-1.1254,0.35,0.49,"No",-1.0527,0.41,0.86,"No"
"10809","C2_Chemical_and_genetic_perturbations","C2_CGP_1731_WANG_CISPLATIN_RESPONSE_AND_XPC_DN",224,-1.1252,0.2,0.37,"No",0.8458,0.93,0.97,"Yes"
"10810","GO_MF","486680_GO_0000146_MICROFILAMENT_MOTOR_ACTIVITY",21,-1.1252,0.29,0.49,"No",-0.8805,0.64,1,"No"
"10811","GO_BP","499614_GO_0030204_CHONDROITIN_SULFATE_METABOLIC_PROCESS",56,-1.1251,0.27,0.45,"No",0.7933,0.86,1,"Yes"
"10812","GO_BP","505237_GO_0042048_OLFACTORY_BEHAVIOR",7,-1.1251,0.33,0.45,"No",-0.9257,0.55,1,"No"
"10813","GO_BP","1026082_GO_1903310_POSITIVE_REGULATION_OF_CHROMATIN_MODIFICATION",65,-1.1251,0.26,0.45,"No",-1.0952,0.28,0.95,"No"
"10814","GO_BP","487575_GO_0001662_BEHAVIORAL_FEAR_RESPONSE",27,-1.125,0.32,0.45,"No",1.0164,0.42,0.97,"Yes"
"10815","GO_BP","514848_GO_0061303_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE",10,-1.1249,0.31,0.45,"No",-0.9948,0.47,0.99,"No"
"10816","C7_Immunologic_signatures","C7_ALL_920_GSE22045_TREG_VS_TCONV_DN",185,-1.1249,0.22,0.31,"No",0.8295,0.9,1,"Yes"
"10817","GO_MF","495355_GO_0035005_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY",7,-1.1249,0.32,0.49,"No",0.9274,0.54,0.95,"Yes"
"10818","REACTOME","576249_REACT_118700_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS",34,-1.1249,0.3,0.49,"No",-0.7523,0.86,1,"No"
"10819","GO_BP","493359_GO_0009163_NUCLEOSIDE_BIOSYNTHETIC_PROCESS",134,-1.1248,0.25,0.45,"No",1.0743,0.28,0.93,"Yes"
"10820","GO_BP","781981_GO_1901992_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",45,-1.1248,0.27,0.45,"No",0.6184,0.99,1,"Yes"
"10821","C3_TF_targets","C3_TFT_543_YGACNNYACAR_UNKNOWN",90,-1.1247,0.26,0.31,"No",1.0478,0.34,1,"Yes"
"10822","C4_Cancer_gene_neighborhoods","C4_CGN_75_MORF_CDH4",131,-1.1247,0.24,0.47,"No",-1.1688,0.17,0.67,"No"
"10823","GO_BP","512096_GO_0051193_REGULATION_OF_COFACTOR_METABOLIC_PROCESS",41,-1.1246,0.28,0.45,"No",1.2619,0.12,0.72,"Yes"
"10824","GO_MF","486595_GO_0009055_ELECTRON_CARRIER_ACTIVITY",95,-1.1246,0.23,0.49,"No",2.0904,0,0.0053,"Yes"
"10825","GO_BP","508163_GO_0045842_POSITIVE_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION",8,-1.1246,0.32,0.45,"No",0.746,0.8,1,"Yes"
"10826","C2_Chemical_and_genetic_perturbations","C2_CGP_3321_YU_BAP1_TARGETS",29,-1.1245,0.31,0.37,"No",1.0224,0.4,0.77,"Yes"
"10827","GO_BP","502789_GO_0033572_TRANSFERRIN_TRANSPORT",33,-1.1242,0.31,0.45,"No",0.7775,0.88,1,"Yes"
"10828","GO_BP","514998_GO_0070059_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",28,-1.1242,0.29,0.45,"No",-1.189,0.21,0.9,"No"
"10829","GO_CC","490703_GO_0005637_NUCLEAR_INNER_MEMBRANE",44,-1.1241,0.28,0.55,"No",0.7028,0.95,0.99,"Yes"
"10830","GO_BP","500196_GO_0030901_MIDBRAIN_DEVELOPMENT",77,-1.1241,0.25,0.45,"No",1.1286,0.21,0.87,"Yes"
"10831","GO_MF","490579_GO_0005451_MONOVALENT_CATION_PROTON_ANTIPORTER_ACTIVITY",10,-1.1241,0.32,0.49,"No",-0.7537,0.79,1,"No"
"10832","GO_BP","494697_GO_0010633_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION",46,-1.124,0.29,0.45,"No",0.6971,0.96,1,"Yes"
"10833","C3_TF_targets","C3_TFT_403_GCTNWTTGK_UNKNOWN",295,-1.1239,0.19,0.31,"No",1.0226,0.37,1,"Yes"
"10834","C2_Chemical_and_genetic_perturbations","C2_CGP_1916_BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN",60,-1.1239,0.27,0.37,"No",-0.9725,0.51,1,"No"
"10835","C2_Chemical_and_genetic_perturbations","C2_CGP_547_MAHADEVAN_IMATINIB_RESISTANCE_DN",19,-1.1238,0.29,0.37,"No",1.1197,0.29,0.6,"Yes"
"10836","KEGG_compound","C00718_AMYLOSE_AMYLOSE_CHAIN_1_4_ALPHA_D_GLUCOSYL_N_1_4_ALPHA_D_GLUCOSYL_N_1_1_4_ALPHA_D_GLUCOSYL_N_1_4_1_4_ALPHA_D_GLUCOSYL_N_1_D_GLUCOSE_1_4_ALPHA_D_GLUCAN",7,-1.1237,0.32,0.47,"No",-1.3176,0.17,0.6,"No"
"10837","C7_Immunologic_signatures","C7_ALL_86_GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN",190,-1.1236,0.22,0.31,"No",0.9905,0.47,0.77,"Yes"
"10838","GO_MF","496746_GO_0016853_ISOMERASE_ACTIVITY",156,-1.1236,0.22,0.49,"No",1.0032,0.47,0.87,"Yes"
"10839","GO_BP","1129497_GO_1903671_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS",8,-1.1235,0.34,0.45,"No",-1.2417,0.22,0.91,"No"
"10840","C2_Chemical_and_genetic_perturbations","C2_CGP_57_SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN",51,-1.1235,0.27,0.37,"No",-0.7662,0.87,1,"No"
"10841","GO_BP","513894_GO_0060338_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY",36,-1.1234,0.3,0.45,"No",0.878,0.66,1,"Yes"
"10842","C7_Immunologic_signatures","C7_ALL_1536_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN",198,-1.1232,0.21,0.31,"No",-0.8165,0.93,1,"No"
"10843","C4_Cancer_gene_neighborhoods","C4_CGN_138_MORF_ORC1L",69,-1.1232,0.27,0.47,"No",0.6892,0.98,1,"Yes"
"10844","C2_Chemical_and_genetic_perturbations","C2_CGP_1802_VISALA_AGING_LYMPHOCYTE_DN",19,-1.1232,0.3,0.38,"No",1.1189,0.29,0.6,"Yes"
"10845","GO_BP","507086_GO_0044070_REGULATION_OF_ANION_TRANSPORT",123,-1.1232,0.25,0.45,"No",0.8502,0.82,1,"Yes"
"10846","GO_BP","497245_GO_0018279_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE",124,-1.1232,0.23,0.45,"No",0.9799,0.5,1,"Yes"
"10847","GO_MF","500741_GO_0031490_CHROMATIN_DNA_BINDING",70,-1.1232,0.27,0.49,"No",0.8584,0.76,1,"Yes"
"10848","GO_BP","514323_GO_0060768_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT",9,-1.1231,0.32,0.45,"No",0.5891,0.96,1,"Yes"
"10849","C3_TF_targets","C3_TFT_310_V_ERR1_Q2",256,-1.1231,0.21,0.31,"No",-0.8629,0.85,1,"No"
"10850","GO_BP","504760_GO_0035581_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR",8,-1.123,0.34,0.45,"No",1.0019,0.44,0.98,"Yes"
"10851","GO_CC","502862_GO_0033646_HOST_INTRACELLULAR_PART",6,-1.123,0.36,0.55,"No",-0.9558,0.53,0.89,"No"
"10852","C4_Cancer_gene_neighborhoods","C4_CGN_60_MORF_AP2M1",219,-1.123,0.2,0.46,"No",2.2562,0,0,"Yes"
"10853","C2_Chemical_and_genetic_perturbations","C2_CGP_2463_DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP",12,-1.123,0.3,0.38,"No",-0.4892,0.99,1,"No"
"10854","GO_MF","497892_GO_0019003_GDP_BINDING",50,-1.123,0.29,0.49,"No",1.493,0.022,0.39,"Yes"
"10855","C2_Chemical_and_genetic_perturbations","C2_CGP_1962_CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB",17,-1.123,0.33,0.38,"No",1.0796,0.33,0.66,"Yes"
"10856","GO_MF","505242_GO_0042056_CHEMOATTRACTANT_ACTIVITY",22,-1.1227,0.3,0.49,"No",1.2081,0.2,0.7,"Yes"
"10857","GO_BP","494954_GO_0010890_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE",7,-1.1227,0.33,0.45,"No",0.6807,0.86,1,"Yes"
"10858","C7_Immunologic_signatures","C7_ALL_878_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN",198,-1.1225,0.21,0.31,"No",-0.9707,0.51,1,"No"
"10859","C2_Chemical_and_genetic_perturbations","C2_CGP_1096_BALDWIN_PRKCI_TARGETS_UP",35,-1.1225,0.29,0.38,"No",1.2778,0.11,0.42,"Yes"
"10860","C7_Immunologic_signatures","C7_ALL_1049_GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP",198,-1.1225,0.23,0.31,"No",1.0011,0.43,0.73,"Yes"
"10861","GO_BP","755373_GO_2001267_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",10,-1.1225,0.31,0.45,"No",1.3546,0.13,0.61,"Yes"
"10862","GO_BP","510293_GO_0048168_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY",48,-1.1224,0.28,0.45,"No",-1.1245,0.27,0.94,"No"
"10863","C2_Chemical_and_genetic_perturbations","C2_CGP_1977_JIANG_AGING_HYPOTHALAMUS_UP",47,-1.1223,0.3,0.38,"No",1.796,0,0.044,"Yes"
"10864","KEGG_compound","C00361_DGDP_2_DEOXYGUANOSINE_5_DIPHOSPHATE",17,-1.1223,0.3,0.47,"No",0.4722,1,1,"Yes"
"10865","C2_Chemical_and_genetic_perturbations","C2_CGP_1690_PAL_PRMT5_TARGETS_UP",202,-1.122,0.22,0.38,"No",1.3649,0.01,0.33,"Yes"
"10866","GO_BP","751684_GO_0044539_LONG_CHAIN_FATTY_ACID_IMPORT",7,-1.122,0.34,0.45,"No",0.8201,0.67,1,"Yes"
"10867","GO_BP","504588_GO_0035404_HISTONE_SERINE_PHOSPHORYLATION",11,-1.1219,0.33,0.45,"No",-0.8018,0.74,1,"No"
"10868","GO_BP","488566_GO_0002693_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION",6,-1.1218,0.34,0.45,"No",0.966,0.5,1,"Yes"
"10869","C2_BioCarta_Pathways","C2_CP_BIOCARTA_108_BIOCARTA_INTRINSIC_PATHWAY",23,-1.1218,0.31,0.43,"No",1.0999,0.31,0.72,"Yes"
"10870","C2_Chemical_and_genetic_perturbations","C2_CGP_1680_SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B",23,-1.1216,0.29,0.38,"No",1.1904,0.24,0.5,"Yes"
"10871","GO_BP","510654_GO_0048593_CAMERA_TYPE_EYE_MORPHOGENESIS",107,-1.1216,0.26,0.45,"No",1.0535,0.32,0.95,"Yes"
"10872","WikiPathways","198833_WP176_FOLATE_METABOLISM",22,-1.1215,0.29,0.4,"No",1.1751,0.22,0.91,"Yes"
"10873","GO_MF","496696_GO_0016790_THIOLESTER_HYDROLASE_ACTIVITY",29,-1.1214,0.3,0.5,"No",-0.8981,0.59,0.99,"No"
"10874","GO_BP","513988_GO_0060433_BRONCHUS_DEVELOPMENT",7,-1.121,0.34,0.45,"No",0.9906,0.45,0.99,"Yes"
"10875","GO_MF","490452_GO_0005201_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT",74,-1.121,0.26,0.5,"No",-1.292,0.079,0.8,"No"
"10876","C4_Cancer_modules","C4_CM_203_MODULE_218",19,-1.1209,0.3,0.39,"No",-1.8512,0,0.1,"No"
"10877","C2_Chemical_and_genetic_perturbations","C2_CGP_1584_HASLINGER_B_CLL_WITH_6Q21_DELETION",20,-1.1209,0.29,0.38,"No",-0.9883,0.46,1,"No"
"10878","GO_MF","496728_GO_0016831_CARBOXY_LYASE_ACTIVITY",33,-1.1208,0.3,0.5,"No",-0.9401,0.55,0.96,"No"
"10879","GO_BP","510376_GO_0048262_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY",5,-1.1208,0.35,0.45,"No",1.5182,0.055,0.38,"Yes"
"10880","GO_BP","517339_GO_0072423_RESPONSE_TO_DNA_DAMAGE_CHECKPOINT_SIGNALING",5,-1.1207,0.35,0.45,"No",-0.9429,0.54,1,"No"
"10881","GO_BP","513531_GO_0055098_RESPONSE_TO_LOW_DENSITY_LIPOPROTEIN_PARTICLE",6,-1.1205,0.35,0.45,"No",1.0592,0.39,0.94,"Yes"
"10882","GO_MF","489254_GO_0003708_RETINOIC_ACID_RECEPTOR_ACTIVITY",7,-1.1204,0.33,0.5,"No",-0.9487,0.51,0.94,"No"
"10883","GO_MF","496691_GO_0016782_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS",60,-1.1204,0.26,0.5,"No",1.9063,0,0.031,"Yes"
"10884","C7_Immunologic_signatures","C7_ALL_496_GSE17721_CTRL_VS_CPG_0_5H_BMDM_DN",192,-1.1204,0.22,0.32,"No",0.9067,0.72,1,"Yes"
"10885","C2_Chemical_and_genetic_perturbations","C2_CGP_2835_LOPEZ_MESOTHELIOMA_SURVIVAL_UP",11,-1.1204,0.33,0.38,"No",0.6165,0.95,1,"Yes"
"10886","GO_BP","512238_GO_0051354_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY",23,-1.1202,0.3,0.45,"No",0.7428,0.83,1,"Yes"
"10887","GO_BP","514295_GO_0060740_PROSTATE_GLAND_EPITHELIUM_MORPHOGENESIS",23,-1.1201,0.3,0.46,"No",1.0192,0.42,0.97,"Yes"
"10888","C2_Chemical_and_genetic_perturbations","C2_CGP_2771_MIKKELSEN_MEF_LCP_WITH_H3K27ME3",63,-1.12,0.27,0.38,"No",-1.1139,0.26,0.9,"No"
"10889","GO_BP","487562_GO_0001649_OSTEOBLAST_DIFFERENTIATION",118,-1.1197,0.24,0.46,"No",1.3375,0.039,0.62,"Yes"
"10890","GO_BP","488377_GO_0002504_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II",93,-1.1197,0.27,0.46,"No",1.1343,0.21,0.86,"Yes"
"10891","GO_BP","508258_GO_0045956_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",15,-1.1197,0.34,0.46,"No",-1.625,0.026,0.69,"No"
"10892","GO_BP","492420_GO_0008045_MOTOR_NEURON_AXON_GUIDANCE",26,-1.1196,0.3,0.46,"No",-1.1153,0.27,0.94,"No"
"10893","C2_Chemical_and_genetic_perturbations","C2_CGP_1393_SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN",43,-1.1195,0.29,0.38,"No",1.3947,0.057,0.3,"Yes"
"10894","C7_Immunologic_signatures","C7_ALL_198_GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN",197,-1.1195,0.24,0.32,"No",1.5499,0,0.0061,"Yes"
"10895","GO_BP","753040_GO_1900044_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION",6,-1.1195,0.35,0.46,"No",-0.8082,0.69,1,"No"
"10896","C7_Immunologic_signatures","C7_ALL_765_GSE17974_0H_VS_0_5H_IN_VITRO_ACT_CD4_TCELL_UP",183,-1.1194,0.24,0.32,"No",-0.9751,0.52,1,"No"
"10897","GO_BP","514502_GO_0060947_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",6,-1.1192,0.34,0.46,"No",0.7047,0.84,1,"Yes"
"10898","C2_Chemical_and_genetic_perturbations","C2_CGP_1993_BILD_E2F3_ONCOGENIC_SIGNATURE",242,-1.1191,0.22,0.38,"No",-0.8015,0.96,1,"No"
"10899","GO_BP","513890_GO_0060334_REGULATION_OF_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY",24,-1.119,0.3,0.46,"No",0.9373,0.53,1,"Yes"
"10900","C7_Immunologic_signatures","C7_ALL_1316_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN",196,-1.119,0.23,0.32,"No",0.9105,0.72,1,"Yes"
"10901","KEGG_pathway","HSA05120_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION",67,-1.119,0.27,0.34,"No",0.9267,0.57,1,"Yes"
"10902","C1_Positional","C1_ALL_69_CHR1P31",80,-1.1188,0.28,0.84,"No",1.2489,0.095,0.59,"Yes"
"10903","C2_Chemical_and_genetic_perturbations","C2_CGP_1664_KAYO_CALORIE_RESTRICTION_MUSCLE_DN",83,-1.1188,0.28,0.38,"No",1.5767,0.0046,0.16,"Yes"
"10904","C2_Chemical_and_genetic_perturbations","C2_CGP_1376_ASTON_MAJOR_DEPRESSIVE_DISORDER_UP",48,-1.1188,0.28,0.38,"No",-0.8473,0.75,1,"No"
"10905","GO_BP","505642_GO_0042511_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT1_PROTEIN",9,-1.1187,0.3,0.46,"No",-1.2401,0.21,0.91,"No"
"10906","GO_CC","500489_GO_0031228_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE",49,-1.1187,0.29,0.56,"No",0.8205,0.79,0.94,"Yes"
"10907","GO_MF","512770_GO_0051920_PEROXIREDOXIN_ACTIVITY",7,-1.1187,0.33,0.5,"No",1.3549,0.16,0.52,"Yes"
"10908","C4_Cancer_gene_neighborhoods","C4_CGN_121_MORF_KDR",89,-1.1187,0.28,0.47,"No",1.1038,0.25,0.36,"Yes"
"10909","GO_BP","503570_GO_0034368_PROTEIN_LIPID_COMPLEX_REMODELING",23,-1.1187,0.3,0.46,"No",-0.4996,1,1,"No"
"10910","C2_BioCarta_Pathways","C2_CP_BIOCARTA_74_BIOCARTA_FIBRINOLYSIS_PATHWAY",12,-1.1187,0.32,0.43,"No",1.4285,0.086,0.48,"Yes"
"10911","C7_Immunologic_signatures","C7_ALL_866_GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN",200,-1.1186,0.22,0.32,"No",0.7262,0.99,1,"Yes"
"10912","GO_BP","503581_GO_0034379_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY",8,-1.1185,0.32,0.46,"No",-0.8561,0.64,1,"No"
"10913","GO_CC","921094_GO_0097539_CILIARY_TRANSITION_FIBER",5,-1.1185,0.35,0.56,"No",-1.2502,0.23,0.66,"No"
"10914","GO_BP","503594_GO_0034392_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS",5,-1.1184,0.35,0.46,"No",0.6121,0.92,1,"Yes"
"10915","C7_Immunologic_signatures","C7_ALL_51_GSE10325_BCELL_VS_LUPUS_BCELL_UP",187,-1.1184,0.23,0.32,"No",-1.0795,0.29,1,"No"
"10916","GO_BP","517299_GO_0072383_PLUS_END_DIRECTED_VESICLE_TRANSPORT_ALONG_MICROTUBULE",6,-1.1182,0.34,0.46,"No",0.8646,0.62,1,"Yes"
"10917","GO_BP","517248_GO_0072332_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR",48,-1.118,0.29,0.46,"No",-0.5294,1,1,"No"
"10918","C3_TF_targets","C3_TFT_418_V_STAT_Q6",257,-1.118,0.2,0.32,"No",-0.7614,0.98,1,"No"
"10919","GO_BP","518150_GO_0090003_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",44,-1.1179,0.27,0.46,"No",0.957,0.55,1,"Yes"
"10920","C4_Cancer_modules","C4_CM_184_MODULE_197",172,-1.1178,0.23,0.39,"No",1.0089,0.41,0.7,"Yes"
"10921","C7_Immunologic_signatures","C7_ALL_1371_GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP",199,-1.1177,0.23,0.32,"No",0.6048,1,1,"Yes"
"10922","C2_Chemical_and_genetic_perturbations","C2_CGP_3139_CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY",34,-1.1177,0.28,0.38,"No",1.4401,0.052,0.26,"Yes"
"10923","REACTOME","1127679_REACT_263902_O_LINKED_GLYCOSYLATION",102,-1.1176,0.27,0.5,"No",-0.8774,0.72,1,"No"
"10924","C2_Chemical_and_genetic_perturbations","C2_CGP_1126_BENPORATH_ES_CORE_NINE_CORRELATED",99,-1.1173,0.25,0.38,"No",-0.7651,0.93,1,"No"
"10925","GO_BP","514451_GO_0060896_NEURAL_PLATE_PATTERN_SPECIFICATION",9,-1.1172,0.32,0.46,"No",-1.2774,0.19,0.89,"No"
"10926","C2_Chemical_and_genetic_perturbations","C2_CGP_1379_FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP",150,-1.1172,0.23,0.38,"No",1.9318,0,0.014,"Yes"
"10927","GO_BP","513436_GO_0055003_CARDIAC_MYOFIBRIL_ASSEMBLY",15,-1.1171,0.32,0.46,"No",-1.7145,0.011,0.76,"No"
"10928","C4_Cancer_gene_neighborhoods","C4_CGN_175_MORF_RUNX1",146,-1.1171,0.24,0.47,"No",-0.9735,0.52,0.86,"No"
"10929","C7_Immunologic_signatures","C7_ALL_1510_GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN",198,-1.1171,0.23,0.32,"No",1.3968,0.013,0.038,"Yes"
"10930","KEGG_compound","C00258_D_GLYCERATE_GLYCERATE_R_GLYCERATE_GLYCERIC_ACID",7,-1.1171,0.33,0.48,"No",0.6421,0.9,1,"Yes"
"10931","C3_TF_targets","C3_TFT_220_V_PAX4_01",253,-1.117,0.22,0.32,"No",-0.7818,0.98,1,"No"
"10932","GO_BP","500906_GO_0031657_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",8,-1.117,0.32,0.46,"No",-0.7724,0.78,1,"No"
"10933","GO_BP","508381_GO_0046085_ADENOSINE_METABOLIC_PROCESS",15,-1.1169,0.33,0.46,"No",-0.6613,0.92,1,"No"
"10934","GO_BP","514080_GO_0060525_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT",12,-1.1168,0.33,0.46,"No",1.1035,0.33,0.9,"Yes"
"10935","GO_BP","500589_GO_0031330_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS",167,-1.1167,0.25,0.46,"No",1.0334,0.37,0.96,"Yes"
"10936","GO_BP","491388_GO_0006487_PROTEIN_N_LINKED_GLYCOSYLATION",132,-1.1167,0.28,0.46,"No",0.9356,0.63,1,"Yes"
"10937","C2_Chemical_and_genetic_perturbations","C2_CGP_53_WATANABE_COLON_CANCER_MSI_VS_MSS_DN",77,-1.1167,0.29,0.38,"No",1.291,0.062,0.4,"Yes"
"10938","GO_BP","512182_GO_0051297_CENTROSOME_ORGANIZATION",63,-1.1166,0.29,0.46,"No",0.6086,0.99,1,"Yes"
"10939","C4_Cancer_modules","C4_CM_144_MODULE_152",124,-1.1166,0.25,0.39,"No",2.4118,0,0,"Yes"
"10940","C2_Chemical_and_genetic_perturbations","C2_CGP_89_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN",85,-1.1166,0.27,0.38,"No",0.9429,0.59,0.87,"Yes"
"10941","GO_CC","506686_GO_0043656_INTRACELLULAR_REGION_OF_HOST",6,-1.1165,0.32,0.56,"No",-0.9502,0.54,0.89,"No"
"10942","GO_BP","517302_GO_0072386_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE",6,-1.1165,0.34,0.46,"No",0.8605,0.65,1,"Yes"
"10943","C3_MicroRNA_targets","C3_MIR_171_GACAATC_MIR_219",143,-1.1164,0.24,0.42,"No",-1.1408,0.18,1,"No"
"10944","GO_BP","514452_GO_0060897_NEURAL_PLATE_REGIONALIZATION",7,-1.1164,0.32,0.46,"No",-1.0278,0.42,0.97,"No"
"10945","GO_MF","752700_GO_0097199_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",7,-1.1163,0.35,0.5,"No",-0.9337,0.55,0.96,"No"
"10946","GO_BP","506527_GO_0043496_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY",18,-1.1161,0.31,0.46,"No",1.0554,0.38,0.94,"Yes"
"10947","REACTOME","161050_REACT_22186_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE",71,-1.116,0.28,0.5,"No",-1.3065,0.084,0.66,"No"
"10948","C4_Cancer_gene_neighborhoods","C4_CGN_181_MORF_THPO",122,-1.1159,0.27,0.47,"No",1.2228,0.091,0.19,"Yes"
"10949","GO_BP","508612_GO_0046348_AMINO_SUGAR_CATABOLIC_PROCESS",13,-1.1159,0.34,0.46,"No",1.2335,0.2,0.75,"Yes"
"10950","GO_BP","519143_GO_2000503_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS",6,-1.1159,0.32,0.46,"No",1.271,0.19,0.71,"Yes"
"10951","GO_BP","512802_GO_0051952_REGULATION_OF_AMINE_TRANSPORT",76,-1.1159,0.28,0.46,"No",1.0143,0.4,0.97,"Yes"
"10952","REACTOME","1127629_REACT_264092_MISSPLICED_GSK3BETA_MUTANTS_STABILIZE_BETA_CATENIN",15,-1.1158,0.33,0.5,"No",0.7077,0.86,1,"Yes"
"10953","GO_BP","516792_GO_0071871_RESPONSE_TO_EPINEPHRINE",13,-1.1157,0.32,0.46,"No",-0.6536,0.92,1,"No"
"10954","KEGG_compound","C05823_3_MERCAPTOLACTATE_L_3_MERCAPTOLACTATE_R_3_MERCAPTOLACTATE",5,-1.1157,0.37,0.48,"No",-0.8667,0.66,1,"No"
"10955","C7_Immunologic_signatures","C7_ALL_968_GSE22886_NEUTROPHIL_VS_DC_DN",200,-1.1156,0.23,0.33,"No",2.2421,0,0,"Yes"
"10956","C3_TF_targets","C3_TFT_154_V_TATA_C",264,-1.1155,0.23,0.33,"No",1.1549,0.11,0.85,"Yes"
"10957","C7_Immunologic_signatures","C7_ALL_1704_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN",200,-1.1154,0.25,0.33,"No",1.3365,0.012,0.072,"Yes"
"10958","C3_TF_targets","C3_TFT_431_V_AP2_Q3",247,-1.1153,0.25,0.33,"No",-0.9701,0.56,0.82,"No"
"10959","C7_Immunologic_signatures","C7_ALL_713_GSE17721_0_5H_VS_24H_LPS_BMDM_UP",195,-1.1152,0.24,0.33,"No",1.5642,0,0.0051,"Yes"
"10960","GO_BP","513457_GO_0055024_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",47,-1.1152,0.29,0.46,"No",-0.8004,0.81,1,"No"
"10961","C7_Immunologic_signatures","C7_ALL_617_GSE17721_POLYIC_VS_CPG_0_5H_BMDM_UP",195,-1.1152,0.23,0.33,"No",-0.8956,0.74,1,"No"
"10962","GO_BP","506600_GO_0043569_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",7,-1.1151,0.35,0.46,"No",0.6876,0.86,1,"Yes"
"10963","GO_BP","501919_GO_0032693_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION",15,-1.1151,0.33,0.46,"No",-0.8363,0.69,1,"No"
"10964","C2_Chemical_and_genetic_perturbations","C2_CGP_1235_DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY",26,-1.115,0.34,0.39,"No",-1.1239,0.29,0.89,"No"
"10965","C7_Immunologic_signatures","C7_ALL_753_GSE17721_0_5H_VS_12H_GARDIQUIMOD_BMDM_UP",199,-1.115,0.24,0.33,"No",1.4497,0.0024,0.022,"Yes"
"10966","GO_MF","512255_GO_0051371_MUSCLE_ALPHA_ACTININ_BINDING",9,-1.1149,0.34,0.51,"No",-1.0753,0.39,0.86,"No"
"10967","GO_BP","513819_GO_0060263_REGULATION_OF_RESPIRATORY_BURST",9,-1.1148,0.34,0.46,"No",0.6635,0.89,1,"Yes"
"10968","GO_MF","507434_GO_0045028_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY",14,-1.1147,0.33,0.5,"No",1.7436,0.015,0.12,"Yes"
"10969","C7_Immunologic_signatures","C7_ALL_25_GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP",196,-1.1147,0.24,0.33,"No",1.7883,0,0.00017,"Yes"
"10970","C7_Immunologic_signatures","C7_ALL_1150_GSE27786_LSK_VS_CD8_TCELL_DN",198,-1.1146,0.25,0.33,"No",1.045,0.34,0.6,"Yes"
"10971","C3_TF_targets","C3_TFT_345_V_MAZ_Q6",189,-1.1145,0.25,0.33,"No",-0.9755,0.53,0.82,"No"
"10972","WikiPathways","672451_WP2203_TSLP_SIGNALING_PATHWAY",37,-1.1144,0.29,0.41,"No",0.8619,0.67,1,"Yes"
"10973","C3_MicroRNA_targets","C3_MIR_94_CCAGGTT_MIR_490",65,-1.1144,0.28,0.42,"No",-0.7818,0.9,1,"No"
"10974","GO_BP","516359_GO_0071435_POTASSIUM_ION_EXPORT",10,-1.1143,0.33,0.46,"No",-0.8513,0.65,1,"No"
"10975","GO_BP","508086_GO_0045747_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY",24,-1.1143,0.32,0.46,"No",0.6901,0.92,1,"Yes"
"10976","WikiPathways","672447_WP2018_RANKL_RANK_SIGNALING_PATHWAY",54,-1.114,0.3,0.41,"No",-0.8192,0.78,1,"No"
"10977","GO_BP","499962_GO_0051196_REGULATION_OF_COENZYME_METABOLIC_PROCESS",41,-1.1139,0.3,0.46,"No",1.2683,0.12,0.71,"Yes"
"10978","C2_Chemical_and_genetic_perturbations","C2_CGP_1911_DAZARD_UV_RESPONSE_CLUSTER_G1",67,-1.1138,0.27,0.39,"No",1.8486,0,0.028,"Yes"
"10979","GO_BP","755358_GO_2001252_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION",82,-1.1137,0.29,0.46,"No",-0.8947,0.7,1,"No"
"10980","C2_Chemical_and_genetic_perturbations","C2_CGP_91_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN",72,-1.1135,0.27,0.39,"No",-0.8485,0.75,1,"No"
"10981","GO_BP","491082_GO_0006104_SUCCINYL_COA_METABOLIC_PROCESS",5,-1.1135,0.38,0.46,"No",-0.4393,1,1,"No"
"10982","GO_BP","491588_GO_0006701_PROGESTERONE_BIOSYNTHETIC_PROCESS",7,-1.1135,0.32,0.46,"No",-1.1179,0.32,0.94,"No"
"10983","KEGG_pathway","HSA04672_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION",44,-1.1134,0.3,0.34,"No",-0.9503,0.52,0.96,"No"
"10984","GO_BP","488152_GO_0002279_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",17,-1.1134,0.32,0.46,"No",-0.7702,0.78,1,"No"
"10985","GO_BP","511948_GO_0051023_REGULATION_OF_IMMUNOGLOBULIN_SECRETION",16,-1.1134,0.31,0.46,"No",-0.8406,0.68,1,"No"
"10986","C2_Chemical_and_genetic_perturbations","C2_CGP_2842_FOURNIER_ACINAR_DEVELOPMENT_LATE_2",276,-1.1133,0.23,0.39,"No",1.426,0,0.28,"Yes"
"10987","GO_MF","506433_GO_0043395_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING",15,-1.1133,0.33,0.51,"No",-0.9586,0.51,0.96,"No"
"10988","GO_BP","488975_GO_0003181_ATRIOVENTRICULAR_VALVE_MORPHOGENESIS",15,-1.1133,0.32,0.46,"No",-0.8199,0.72,1,"No"
"10989","GO_CC","507231_GO_0044224_JUXTAPARANODE_REGION_OF_AXON",9,-1.1132,0.33,0.57,"No",-1.2493,0.21,0.66,"No"
"10990","C7_Immunologic_signatures","C7_ALL_93_GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",191,-1.1131,0.24,0.33,"No",1.6105,0,0.0025,"Yes"
"10991","C2_Chemical_and_genetic_perturbations","C2_CGP_2562_VANTVEER_BREAST_CANCER_ESR1_UP",165,-1.113,0.26,0.39,"No",-1.3757,0.025,0.63,"No"
"10992","GO_BP","498887_GO_0021604_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION",13,-1.113,0.33,0.46,"No",-0.7054,0.86,1,"No"
"10993","GO_MF","489819_GO_0004467_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY",13,-1.1128,0.31,0.51,"No",0.8971,0.57,0.98,"Yes"
"10994","C2_Chemical_and_genetic_perturbations","C2_CGP_1725_CHUANG_OXIDATIVE_STRESS_RESPONSE_UP",27,-1.1128,0.32,0.39,"No",-0.9611,0.5,1,"No"
"10995","GO_BP","518232_GO_0090092_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",211,-1.1125,0.23,0.46,"No",1.0545,0.29,0.94,"Yes"
"10996","GO_BP","500006_GO_0030705_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT",105,-1.1125,0.26,0.46,"No",0.7936,0.92,1,"Yes"
"10997","GO_BP","498828_GO_0021544_SUBPALLIUM_DEVELOPMENT",21,-1.1124,0.33,0.46,"No",-1.0412,0.38,0.98,"No"
"10998","REACTOME","106023_REACT_11103_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION",10,-1.1124,0.34,0.51,"No",1.0741,0.36,0.62,"Yes"
"10999","GO_BP","752841_GO_0097340_INHIBITION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",10,-1.1121,0.34,0.47,"No",-0.9706,0.47,1,"No"
"11000","GO_BP","512167_GO_0051281_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",27,-1.112,0.33,0.47,"No",1.3102,0.11,0.66,"Yes"
"11001","C6_Oncogenic_signatures","C6_ALL_118_CRX_NRL_DN_V1_UP",134,-1.1119,0.26,0.31,"No",-1.6743,0,0.11,"No"
"11002","C1_Positional","C1_ALL_233_CHR12Q21",45,-1.1119,0.3,0.85,"No",1.0943,0.32,0.63,"Yes"
"11003","C7_Immunologic_signatures","C7_ALL_1165_GSE27786_LIN_NEG_VS_CD8_TCELL_UP",199,-1.1118,0.23,0.33,"No",0.9524,0.6,0.89,"Yes"
"11004","GO_BP","754342_GO_1901380_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",14,-1.1114,0.33,0.47,"No",-0.7349,0.84,1,"No"
"11005","C1_Positional","C1_ALL_151_CHR18Q12",46,-1.1114,0.3,0.85,"No",1.1191,0.26,0.63,"Yes"
"11006","C2_Chemical_and_genetic_perturbations","C2_CGP_2929_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3",14,-1.1113,0.33,0.39,"No",1.3159,0.14,0.38,"Yes"
"11007","GO_BP","492107_GO_0007343_EGG_ACTIVATION",7,-1.1112,0.35,0.47,"No",-1.6129,0.023,0.7,"No"
"11008","C3_TF_targets","C3_TFT_223_V_PAX4_04",212,-1.1112,0.24,0.33,"No",-0.9006,0.73,0.95,"No"
"11009","GO_BP","505784_GO_0042670_RETINAL_CONE_CELL_DIFFERENTIATION",9,-1.1112,0.33,0.47,"No",1.2623,0.2,0.72,"Yes"
"11010","C2_Chemical_and_genetic_perturbations","C2_CGP_2992_NIELSEN_SCHWANNOMA_DN",17,-1.1111,0.33,0.39,"No",0.9219,0.57,0.9,"Yes"
"11011","REACTOME","833798_REACT_163875_SPERM_MOTILITY_AND_TAXES",9,-1.1109,0.32,0.51,"No",-1.7285,0.0041,0.13,"No"
"11012","C2_Chemical_and_genetic_perturbations","C2_CGP_398_CASTELLANO_HRAS_TARGETS_DN",6,-1.1107,0.36,0.39,"No",0.9839,0.5,0.81,"Yes"
"11013","C2_Chemical_and_genetic_perturbations","C2_CGP_976_GROSS_ELK3_TARGETS_UP",26,-1.1107,0.31,0.39,"No",-0.9952,0.48,1,"No"
"11014","REACTOME","160942_REACT_21391_MITOTIC_G2_G2_M_PHASES",116,-1.1107,0.27,0.51,"No",-0.6103,1,1,"No"
"11015","GO_BP","510804_GO_0048753_PIGMENT_GRANULE_ORGANIZATION",23,-1.1106,0.31,0.47,"No",-0.7553,0.82,1,"No"
"11016","GO_BP","502026_GO_0032803_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_CATABOLIC_PROCESS",5,-1.1104,0.34,0.47,"No",-0.9463,0.54,1,"No"
"11017","GO_BP","508805_GO_0046549_RETINAL_CONE_CELL_DEVELOPMENT",9,-1.1104,0.35,0.47,"No",1.2432,0.2,0.74,"Yes"
"11018","OMIM_gene","OMIM603025_PHOSPHATIDYLINOSITOL_BINDING_CLATHRIN_ASSEMBLY_PROTEIN_PICALM",6,-1.1104,0.34,0.81,"No",-0.922,0.55,0.86,"No"
"11019","C2_Chemical_and_genetic_perturbations","C2_CGP_2192_RIZKI_TUMOR_INVASIVENESS_2D_UP",69,-1.1103,0.28,0.39,"No",-0.8381,0.74,1,"No"
"11020","C4_Cancer_modules","C4_CM_250_MODULE_284",45,-1.1102,0.28,0.4,"No",0.8377,0.76,0.94,"Yes"
"11021","C2_Chemical_and_genetic_perturbations","C2_CGP_2180_YOKOE_CANCER_TESTIS_ANTIGENS",37,-1.1101,0.3,0.39,"No",-1.3818,0.071,0.62,"No"
"11022","C2_Chemical_and_genetic_perturbations","C2_CGP_1571_ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN",51,-1.1101,0.31,0.39,"No",0.7341,0.91,1,"Yes"
"11023","C2_Chemical_and_genetic_perturbations","C2_CGP_3241_JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN",92,-1.11,0.27,0.39,"No",1.1171,0.23,0.6,"Yes"
"11024","GO_CC","493992_GO_0009898_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE",54,-1.1099,0.3,0.57,"No",0.8858,0.67,0.91,"Yes"
"11025","C2_Chemical_and_genetic_perturbations","C2_CGP_2552_SCHRAETS_MLL_TARGETS_UP",35,-1.1099,0.3,0.39,"No",1.0862,0.31,0.65,"Yes"
"11026","GO_BP","487650_GO_0001754_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION",42,-1.1099,0.29,0.47,"No",-1.3652,0.071,0.98,"No"
"11027","REACTOME","161047_REACT_21254_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS",20,-1.1097,0.31,0.51,"No",-0.7869,0.77,1,"No"
"11028","GO_BP","499042_GO_0021762_SUBSTANTIA_NIGRA_DEVELOPMENT",46,-1.1097,0.31,0.47,"No",1.1002,0.29,0.9,"Yes"
"11029","C2_Chemical_and_genetic_perturbations","C2_CGP_2236_MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP",66,-1.1094,0.28,0.4,"No",-0.9867,0.48,1,"No"
"11030","GO_BP","493270_GO_0009069_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",34,-1.1094,0.32,0.47,"No",0.7801,0.84,1,"Yes"
"11031","GO_BP","506363_GO_0043303_MAST_CELL_DEGRANULATION",17,-1.1094,0.34,0.47,"No",-0.7711,0.77,1,"No"
"11032","REACTOME","106425_REACT_570_IRS_ACTIVATION",5,-1.1092,0.39,0.51,"No",0.678,0.86,1,"Yes"
"11033","GO_BP","491721_GO_0006855_DRUG_TRANSMEMBRANE_TRANSPORT",17,-1.1092,0.33,0.47,"No",-0.9845,0.46,1,"No"
"11034","KEGG_module","HSA_M00050_GUANINE_RIBONUCLEOTIDE_BIOSYNTHESIS_IMP_GDP_GTP",13,-1.1092,0.33,0.65,"No",-0.7635,0.78,1,"No"
"11035","C7_Immunologic_signatures","C7_ALL_161_GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP",192,-1.109,0.27,0.34,"No",-0.9684,0.51,1,"No"
"11036","C6_Oncogenic_signatures","C6_ALL_24_CSR_LATE_UP_V1_UP",160,-1.109,0.26,0.32,"No",1.6706,0,0.071,"Yes"
"11037","C2_Chemical_and_genetic_perturbations","C2_CGP_932_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP",43,-1.1088,0.32,0.4,"No",1.2961,0.1,0.4,"Yes"
"11038","C2_Chemical_and_genetic_perturbations","C2_CGP_3362_LIM_MAMMARY_STEM_CELL_DN",424,-1.1088,0.21,0.4,"No",1.2129,0.02,0.48,"Yes"
"11039","KEGG_compound","C00236_3_PHOSPHO_D_GLYCEROYL_PHOSPHATE_1_3_BISPHOSPHO_D_GLYCERATE_R_2_HYDROXY_3_PHOSPHONOOXY_1_MONOANHYDRIDE_WITH_PHOSPHORIC_PROPANOIC_ACID_D_GLYCERATE_1_3_DIPHOSPHATE",8,-1.1088,0.34,0.49,"No",1.2987,0.19,0.74,"Yes"
"11040","C4_Cancer_gene_neighborhoods","C4_CGN_124_MORF_LTK",142,-1.1086,0.28,0.49,"No",-1.2096,0.091,0.65,"No"
"11041","GO_BP","499078_GO_0021798_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION",7,-1.1085,0.34,0.47,"No",-1.037,0.4,0.98,"No"
"11042","C2_Chemical_and_genetic_perturbations","C2_CGP_1957_JI_RESPONSE_TO_FSH_UP",74,-1.1085,0.27,0.4,"No",0.9189,0.61,0.9,"Yes"
"11043","C3_TF_targets","C3_TFT_263_V_ZIC2_01",243,-1.1084,0.24,0.34,"No",-1.3436,0.0067,0.19,"No"
"11044","GO_BP","510172_GO_0048002_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN",192,-1.1084,0.25,0.47,"No",1.6475,0,0.24,"Yes"
"11045","REACTOME","106462_REACT_12065_P38MAPK_EVENTS",13,-1.1083,0.33,0.51,"No",0.8056,0.74,1,"Yes"
"11046","GO_BP","501712_GO_0032480_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION",41,-1.1082,0.32,0.47,"No",1.5071,0.04,0.4,"Yes"
"11047","GO_BP","511861_GO_0050926_REGULATION_OF_POSITIVE_CHEMOTAXIS",25,-1.1081,0.33,0.47,"No",0.7191,0.9,1,"Yes"
"11048","GO_BP","495082_GO_0014009_GLIAL_CELL_PROLIFERATION",8,-1.1079,0.35,0.47,"No",0.8145,0.68,1,"Yes"
"11049","GO_BP","502034_GO_0032811_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION",6,-1.1077,0.36,0.47,"No",-1.2011,0.23,0.89,"No"
"11050","C7_Immunologic_signatures","C7_ALL_759_GSE17721_0_5H_VS_24H_GARDIQUIMOD_BMDM_UP",199,-1.1076,0.26,0.34,"No",1.2074,0.075,0.21,"Yes"
"11051","GO_BP","506309_GO_0043242_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY",62,-1.1076,0.3,0.47,"No",-1.0825,0.32,0.95,"No"
"11052","GO_BP","517417_GO_0072512_TRIVALENT_INORGANIC_CATION_TRANSPORT",37,-1.1076,0.31,0.47,"No",0.9077,0.63,1,"Yes"
"11053","GO_BP","510700_GO_0048644_MUSCLE_ORGAN_MORPHOGENESIS",69,-1.1075,0.28,0.47,"No",1.1859,0.17,0.8,"Yes"
"11054","GO_BP","514118_GO_0060563_NEUROEPITHELIAL_CELL_DIFFERENTIATION",64,-1.1075,0.3,0.47,"No",1.0523,0.35,0.95,"Yes"
"11055","GO_MF","496642_GO_0016722_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS",19,-1.1074,0.32,0.52,"No",1.071,0.34,0.82,"Yes"
"11056","GO_BP","488088_GO_0002209_BEHAVIORAL_DEFENSE_RESPONSE",28,-1.1073,0.32,0.47,"No",1.1646,0.26,0.82,"Yes"
"11057","KEGG_compound","C00127_GLUTATHIONE_DISULFIDE_GSSG_OXIGLUTATIONE_OXIDIZED_GLUTATHIONE",9,-1.1072,0.34,0.49,"No",0.8155,0.71,1,"Yes"
"11058","GO_MF","496894_GO_0017081_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY",16,-1.1072,0.34,0.52,"No",0.7967,0.75,1,"Yes"
"11059","REACTOME","105813_REACT_765_MITOTIC_PROPHASE",135,-1.1072,0.27,0.51,"No",-1.0775,0.29,0.91,"No"
"11060","GO_BP","515104_GO_0070167_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT",72,-1.1071,0.28,0.47,"No",-1.3679,0.044,0.99,"No"
"11061","GO_BP","487980_GO_0002091_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION",6,-1.107,0.38,0.47,"No",-0.8657,0.61,1,"No"
"11062","C0_Hallmark","H_ALL_27_HALLMARK_E2F_TARGETS",200,-1.107,0.24,0.31,"No",1.1298,0.15,0.33,"Yes"
"11063","GO_MF","506099_GO_0043008_ATP_DEPENDENT_PROTEIN_BINDING",7,-1.1069,0.37,0.52,"No",-0.7478,0.79,1,"No"
"11064","GO_BP","501245_GO_0032008_POSITIVE_REGULATION_OF_TOR_SIGNALING",21,-1.1068,0.32,0.47,"No",1.0462,0.39,0.95,"Yes"
"11065","GO_MF","506068_GO_0042974_RETINOIC_ACID_RECEPTOR_BINDING",30,-1.1067,0.32,0.52,"No",-0.8257,0.73,1,"No"
"11066","GO_BP","514852_GO_0061307_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT",8,-1.1067,0.35,0.47,"No",-0.8246,0.68,1,"No"
"11067","C2_Chemical_and_genetic_perturbations","C2_CGP_424_MARKEY_RB1_ACUTE_LOF_DN",226,-1.1066,0.25,0.4,"No",1.4106,0.0024,0.29,"Yes"
"11068","C1_Positional","C1_ALL_223_CHR11Q13",268,-1.1065,0.24,0.85,"No",-1.1724,0.13,1,"No"
"11069","GO_BP","492373_GO_0007632_VISUAL_BEHAVIOR",52,-1.1065,0.31,0.47,"No",-1.0043,0.42,0.99,"No"
"11070","C2_Chemical_and_genetic_perturbations","C2_CGP_227_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN",32,-1.1064,0.3,0.4,"No",-1.0457,0.38,0.97,"No"
"11071","GO_BP","505599_GO_0042462_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT",31,-1.1063,0.32,0.47,"No",-1.0303,0.39,0.98,"No"
"11072","GO_MF","500990_GO_0031748_D1_DOPAMINE_RECEPTOR_BINDING",8,-1.1063,0.32,0.52,"No",-1.4081,0.1,0.65,"No"
"11073","C0_Hallmark","H_ALL_50_HALLMARK_PANCREAS_BETA_CELLS",34,-1.1062,0.33,0.31,"No",1.1315,0.25,0.35,"Yes"
"11074","GO_BP","510768_GO_0048713_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION",27,-1.1061,0.33,0.47,"No",1.3158,0.12,0.65,"Yes"
"11075","REACTOME","1127627_REACT_264636_S37_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.1059,0.33,0.52,"No",0.6785,0.88,1,"Yes"
"11076","GO_MF","500250_GO_0030957_TAT_PROTEIN_BINDING",7,-1.1059,0.33,0.52,"No",1.0574,0.39,0.83,"Yes"
"11077","REACTOME","477138_REACT_111118_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION",42,-1.1058,0.3,0.51,"No",-0.5759,0.99,1,"No"
"11078","C4_Cancer_modules","C4_CM_265_MODULE_301",153,-1.1058,0.27,0.41,"No",1.1644,0.13,0.44,"Yes"
"11079","C7_Immunologic_signatures","C7_ALL_342_GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN",198,-1.1057,0.26,0.35,"No",0.6215,1,1,"Yes"
"11080","C1_Positional","C1_ALL_298_CHR16P11",109,-1.1057,0.28,0.85,"No",-1.6328,0,1,"No"
"11081","GO_MF","489975_GO_0004645_PHOSPHORYLASE_ACTIVITY",6,-1.1056,0.36,0.52,"No",-1.2094,0.23,0.81,"No"
"11082","GO_BP","499322_GO_0022404_MOLTING_CYCLE_PROCESS",81,-1.1055,0.29,0.47,"No",-0.7211,0.94,1,"No"
"11083","GO_BP","513601_GO_0060043_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION",28,-1.1055,0.32,0.47,"No",0.6885,0.91,1,"Yes"
"11084","C3_TF_targets","C3_TFT_60_V_IK3_01",216,-1.1054,0.25,0.35,"No",-0.8878,0.77,0.98,"No"
"11085","GO_BP","514315_GO_0060760_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS",27,-1.1053,0.32,0.47,"No",0.8163,0.74,1,"Yes"
"11086","GO_CC","505715_GO_0042588_ZYMOGEN_GRANULE",12,-1.1052,0.36,0.58,"No",1.5237,0.044,0.17,"Yes"
"11087","KEGG_compound","C16545_TAMOXIFEN_N_OXIDE",5,-1.105,0.38,0.49,"No",0.6838,0.85,1,"Yes"
"11088","GO_BP","515037_GO_0070099_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY",8,-1.1049,0.34,0.48,"No",-0.8262,0.68,1,"No"
"11089","C7_Immunologic_signatures","C7_ALL_1166_GSE27786_LIN_NEG_VS_CD8_TCELL_DN",199,-1.1049,0.25,0.35,"No",1.0439,0.32,0.61,"Yes"
"11090","GO_BP","512654_GO_0051782_NEGATIVE_REGULATION_OF_CELL_DIVISION",71,-1.1047,0.3,0.48,"No",0.6843,0.98,1,"Yes"
"11091","GO_MF","486780_GO_0046961_PROTON_TRANSPORTING_ATPASE_ACTIVITY_ROTATIONAL_MECHANISM",22,-1.1047,0.33,0.52,"No",1.6848,0.011,0.18,"Yes"
"11092","GO_MF","496755_GO_0016863_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS",14,-1.1047,0.34,0.52,"No",0.6954,0.86,1,"Yes"
"11093","C1_Positional","C1_ALL_281_CHR1Q24",49,-1.1046,0.31,0.84,"No",1.0048,0.43,0.75,"Yes"
"11094","GO_BP","501244_GO_0032007_NEGATIVE_REGULATION_OF_TOR_SIGNALING",23,-1.1045,0.32,0.48,"No",-0.8251,0.72,1,"No"
"11095","C2_Chemical_and_genetic_perturbations","C2_CGP_3208_VANLOO_SP3_TARGETS_UP",8,-1.1045,0.32,0.4,"No",0.8345,0.68,0.98,"Yes"
"11096","C7_Immunologic_signatures","C7_ALL_1170_GSE27786_LIN_NEG_VS_NKTCELL_DN",198,-1.1044,0.25,0.35,"No",0.7455,0.99,1,"Yes"
"11097","KEGG_pathway","HSA04962_VASOPRESSIN_REGULATED_WATER_REABSORPTION",44,-1.1041,0.32,0.36,"No",0.7294,0.92,1,"Yes"
"11098","C7_Immunologic_signatures","C7_ALL_1317_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP",184,-1.1041,0.24,0.35,"No",-1.3478,0.019,0.37,"No"
"11099","GO_BP","517436_GO_0072531_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT",11,-1.1041,0.35,0.48,"No",-1.212,0.25,0.88,"No"
"11100","C3_TF_targets","C3_TFT_402_V_DR1_Q3",247,-1.104,0.24,0.35,"No",-1.1142,0.2,0.51,"No"
"11101","C4_Cancer_gene_neighborhoods","C4_CGN_89_MORF_DMPK",168,-1.1039,0.27,0.5,"No",-0.8813,0.77,1,"No"
"11102","C3_MicroRNA_targets","C3_MIR_159_GTGCCAA_MIR_96",300,-1.1038,0.24,0.44,"No",-0.9274,0.68,1,"No"
"11103","REACTOME","1127534_REACT_268561_RA_BIOSYNTHESIS_PATHWAY",20,-1.1038,0.33,0.52,"No",-1.279,0.15,0.68,"No"
"11104","C2_Chemical_and_genetic_perturbations","C2_CGP_1486_ZHAN_MULTIPLE_MYELOMA_LB_UP",44,-1.1037,0.32,0.4,"No",-0.8562,0.74,1,"No"
"11105","C2_Chemical_and_genetic_perturbations","C2_CGP_864_GRUETZMANN_PANCREATIC_CANCER_DN",198,-1.1037,0.26,0.4,"No",1.5067,0,0.21,"Yes"
"11106","GO_BP","508229_GO_0045922_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS",23,-1.1037,0.32,0.48,"No",0.8864,0.64,1,"Yes"
"11107","GO_BP","519240_GO_2000601_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION",7,-1.1036,0.36,0.48,"No",-0.817,0.7,1,"No"
"11108","GO_MF","504565_GO_0035381_ATP_GATED_ION_CHANNEL_ACTIVITY",7,-1.1036,0.34,0.52,"No",-0.8054,0.71,1,"No"
"11109","KEGG_compound","C00109_2_OXOBUTANOATE_2_KETOBUTYRIC_ACID_2_OXOBUTYRIC_ACID_2_OXOBUTYRATE_2_OXOBUTANOIC_ACID_ALPHA_KETOBUTYRIC_ACID_ALPHA_KETOBUTYRATE",8,-1.1036,0.35,0.49,"No",0.7955,0.71,1,"Yes"
"11110","REACTOME","106465_REACT_12076_FRS2_MEDIATED_ACTIVATION",25,-1.1035,0.31,0.52,"No",0.6794,0.93,1,"Yes"
"11111","C3_TF_targets","C3_TFT_124_V_CREB_Q2",261,-1.1034,0.23,0.35,"No",-0.9273,0.69,0.92,"No"
"11112","C3_MicroRNA_targets","C3_MIR_22_CACTGTG_MIR_128A_MIR_128B",333,-1.1034,0.23,0.44,"No",0.9708,0.56,1,"Yes"
"11113","C2_Chemical_and_genetic_perturbations","C2_CGP_2398_BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN",57,-1.1032,0.28,0.41,"No",0.8886,0.68,0.94,"Yes"
"11114","KEGG_module","HSA_M00094_CERAMIDE_BIOSYNTHESIS",12,-1.1031,0.32,0.65,"No",-1.1893,0.26,1,"No"
"11115","WikiPathways","198904_WP688_CATALYTIC_CYCLE_OF_MAMMALIAN_FMOS",5,-1.1031,0.36,0.43,"No",0.672,0.85,1,"Yes"
"11116","C7_Immunologic_signatures","C7_ALL_179_GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP",199,-1.103,0.25,0.35,"No",1.1025,0.19,0.44,"Yes"
"11117","GO_BP","501243_GO_0032006_REGULATION_OF_TOR_SIGNALING",52,-1.103,0.31,0.48,"No",0.7172,0.94,1,"Yes"
"11118","GO_MF","489656_GO_0004222_METALLOENDOPEPTIDASE_ACTIVITY",102,-1.1029,0.3,0.52,"No",-0.963,0.54,0.95,"No"
"11119","GO_BP","500290_GO_0031000_RESPONSE_TO_CAFFEINE",15,-1.1027,0.34,0.48,"No",1.2191,0.21,0.77,"Yes"
"11120","C2_Chemical_and_genetic_perturbations","C2_CGP_2037_TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP",17,-1.1027,0.33,0.41,"No",1.0428,0.39,0.73,"Yes"
"11121","GO_BP","500919_GO_0031670_CELLULAR_RESPONSE_TO_NUTRIENT",54,-1.1026,0.28,0.48,"No",0.8091,0.82,1,"Yes"
"11122","GO_BP","486599_GO_0000052_CITRULLINE_METABOLIC_PROCESS",12,-1.1025,0.34,0.48,"No",0.7071,0.85,1,"Yes"
"11123","GO_MF","496928_GO_0017128_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY",9,-1.1025,0.34,0.52,"No",1.0558,0.39,0.83,"Yes"
"11124","GO_CC","513743_GO_0060187_CELL_POLE",9,-1.1025,0.35,0.59,"No",1.1384,0.3,0.6,"Yes"
"11125","C2_BioCarta_Pathways","C2_CP_BIOCARTA_21_BIOCARTA_BCELLSURVIVAL_PATHWAY",16,-1.1024,0.33,0.45,"No",1.098,0.34,0.71,"Yes"
"11126","C2_Chemical_and_genetic_perturbations","C2_CGP_1156_SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",81,-1.1023,0.31,0.41,"No",1.2355,0.12,0.45,"Yes"
"11127","REACTOME","119521_REACT_19266_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION",8,-1.1023,0.36,0.52,"No",-0.8298,0.65,1,"No"
"11128","GO_BP","505689_GO_0042559_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",16,-1.1021,0.33,0.48,"No",0.8555,0.66,1,"Yes"
"11129","GO_BP","487832_GO_0001941_POSTSYNAPTIC_MEMBRANE_ORGANIZATION",21,-1.1021,0.34,0.48,"No",-1.434,0.067,0.93,"No"
"11130","GO_BP","488890_GO_0003094_GLOMERULAR_FILTRATION",9,-1.102,0.34,0.48,"No",0.5351,0.98,1,"Yes"
"11131","C2_Chemical_and_genetic_perturbations","C2_CGP_3377_WARTERS_RESPONSE_TO_IR_SKIN",79,-1.102,0.28,0.41,"No",0.7402,0.94,1,"Yes"
"11132","C4_Cancer_gene_neighborhoods","C4_CGN_6_MORF_BCL2L11",179,-1.102,0.27,0.5,"No",1.1565,0.14,0.27,"Yes"
"11133","GO_MF","489417_GO_0046933_PROTON_TRANSPORTING_ATP_SYNTHASE_ACTIVITY_ROTATIONAL_MECHANISM",11,-1.102,0.35,0.52,"No",1.7694,0.0083,0.1,"Yes"
"11134","C4_Cancer_modules","C4_CM_323_MODULE_379",194,-1.1019,0.27,0.42,"No",-1.0938,0.23,0.68,"No"
"11135","GO_MF","489848_GO_0004499_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY",5,-1.1018,0.36,0.52,"No",0.6971,0.85,1,"Yes"
"11136","C3_MicroRNA_targets","C3_MIR_2_CTACCTC_LET_7A_LET_7B_LET_7C_LET_7D_LET_7E_LET_7F_MIR_98_LET_7G_LET_7I",387,-1.1017,0.22,0.44,"No",-0.8615,0.92,1,"No"
"11137","GO_BP","500211_GO_0030916_OTIC_VESICLE_FORMATION",8,-1.1016,0.37,0.48,"No",-0.9518,0.52,1,"No"
"11138","GO_MF","496343_GO_0016290_PALMITOYL_COA_HYDROLASE_ACTIVITY",11,-1.1014,0.35,0.52,"No",0.6419,0.9,1,"Yes"
"11139","GO_BP","493265_GO_0009064_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",60,-1.1013,0.3,0.48,"No",-1.1238,0.24,0.94,"No"
"11140","GO_CC","507679_GO_0045323_INTERLEUKIN_1_RECEPTOR_COMPLEX",5,-1.1013,0.37,0.59,"No",-0.6655,0.85,1,"No"
"11141","GO_CC","515780_GO_0070852_CELL_BODY_FIBER",6,-1.1012,0.37,0.59,"No",-1.2485,0.2,0.65,"No"
"11142","C7_Immunologic_signatures","C7_ALL_530_GSE17721_LPS_VS_POLYIC_1H_BMDM_DN",195,-1.1011,0.25,0.36,"No",0.6915,1,1,"Yes"
"11143","GO_BP","488964_GO_0003170_HEART_VALVE_DEVELOPMENT",28,-1.101,0.31,0.48,"No",-0.9639,0.5,1,"No"
"11144","C2_Chemical_and_genetic_perturbations","C2_CGP_1353_DER_IFN_BETA_RESPONSE_UP",102,-1.1009,0.28,0.41,"No",1.7039,0,0.081,"Yes"
"11145","C7_Immunologic_signatures","C7_ALL_1106_GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN",188,-1.1009,0.26,0.36,"No",0.8635,0.85,1,"Yes"
"11146","GO_BP","983739_GO_1903020_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS",14,-1.1009,0.35,0.48,"No",-0.8009,0.74,1,"No"
"11147","REACTOME","161005_REACT_22266_INTERACTION_BETWEEN_L1_AND_ANKYRINS",29,-1.1009,0.33,0.52,"No",-1.4783,0.041,0.46,"No"
"11148","GO_MF","505440_GO_0042289_MHC_CLASS_II_PROTEIN_BINDING",5,-1.1008,0.37,0.52,"No",0.9521,0.52,0.93,"Yes"
"11149","KEGG_pathway","HSA04722_NEUROTROPHIN_SIGNALING_PATHWAY",117,-1.1007,0.29,0.36,"No",0.739,0.98,1,"Yes"
"11150","C2_Chemical_and_genetic_perturbations","C2_CGP_606_DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP",62,-1.1007,0.29,0.41,"No",-0.9519,0.57,1,"No"
"11151","GO_BP","517576_GO_0072673_LAMELLIPODIUM_MORPHOGENESIS",5,-1.1007,0.36,0.48,"No",0.7566,0.75,1,"Yes"
"11152","GO_MF","492799_GO_0008519_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",22,-1.1006,0.34,0.52,"No",-0.7201,0.89,1,"No"
"11153","C4_Cancer_gene_neighborhoods","C4_CGN_362_GNF2_IGFBP1",29,-1.1006,0.34,0.5,"No",1.655,0.0062,0.0094,"Yes"
"11154","GO_BP","499266_GO_0021987_CEREBRAL_CORTEX_DEVELOPMENT",93,-1.1004,0.29,0.48,"No",0.6231,1,1,"Yes"
"11155","C2_Chemical_and_genetic_perturbations","C2_CGP_166_WIKMAN_ASBESTOS_LUNG_CANCER_UP",17,-1.1,0.32,0.41,"No",0.9978,0.44,0.8,"Yes"
"11156","C4_Cancer_modules","C4_CM_194_MODULE_207",220,-1.1,0.26,0.42,"No",-0.9242,0.66,0.88,"No"
"11157","GO_CC","501181_GO_0031941_FILAMENTOUS_ACTIN",25,-1.0998,0.32,0.59,"No",-1.0655,0.36,0.82,"No"
"11158","KEGG_module","HSA_M00085_FATTY_ACID_BIOSYNTHESIS_ELONGATION_MITOCHONDRIA",6,-1.0998,0.37,0.64,"No",0.8911,0.59,0.89,"Yes"
"11159","C3_TF_targets","C3_TFT_189_V_P53_02",249,-1.0997,0.26,0.36,"No",-0.8776,0.82,0.99,"No"
"11160","GO_BP","499148_GO_0021869_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION",5,-1.0996,0.37,0.48,"No",-1.0314,0.46,0.98,"No"
"11161","C2_Chemical_and_genetic_perturbations","C2_CGP_830_LI_WILMS_TUMOR_ANAPLASTIC_UP",19,-1.0996,0.35,0.41,"No",1.1918,0.23,0.5,"Yes"
"11162","C2_Chemical_and_genetic_perturbations","C2_CGP_2006_DURCHDEWALD_SKIN_CARCINOGENESIS_UP",87,-1.0995,0.3,0.41,"No",1.1227,0.22,0.6,"Yes"
"11163","GO_BP","754868_GO_1990001_INHIBITION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",10,-1.0994,0.33,0.48,"No",-0.9734,0.48,1,"No"
"11164","C3_MicroRNA_targets","C3_MIR_102_ATGTTTC_MIR_494",160,-1.0994,0.29,0.44,"No",-1.0644,0.33,1,"No"
"11165","GO_BP","490596_GO_0006906_VESICLE_FUSION",87,-1.0993,0.29,0.48,"No",0.938,0.6,1,"Yes"
"11166","C4_Cancer_modules","C4_CM_217_MODULE_238",159,-1.0993,0.29,0.42,"No",1.097,0.23,0.54,"Yes"
"11167","C2_Chemical_and_genetic_perturbations","C2_CGP_833_MANN_RESPONSE_TO_AMIFOSTINE_UP",20,-1.0992,0.35,0.41,"No",1.0548,0.37,0.7,"Yes"
"11168","GO_BP","508062_GO_0045717_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS",10,-1.099,0.34,0.48,"No",0.6415,0.9,1,"Yes"
"11169","GO_BP","519065_GO_2000425_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE",10,-1.099,0.36,0.48,"No",-1.0432,0.41,0.98,"No"
"11170","GO_BP","504519_GO_0035335_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION",97,-1.0989,0.29,0.48,"No",1.0846,0.28,0.92,"Yes"
"11171","C7_Immunologic_signatures","C7_ALL_1034_GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN",197,-1.0989,0.27,0.36,"No",1.0096,0.44,0.71,"Yes"
"11172","GO_MF","500971_GO_0031726_CCR1_CHEMOKINE_RECEPTOR_BINDING",7,-1.0989,0.35,0.52,"No",1.2491,0.22,0.68,"Yes"
"11173","KEGG_compound","C00354_D_FRUCTOSE_1_6_BISPHOSPHATE",5,-1.0988,0.38,0.5,"No",-0.6724,0.87,1,"No"
"11174","C2_Chemical_and_genetic_perturbations","C2_CGP_2110_KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION",15,-1.0987,0.34,0.41,"No",-0.4783,0.99,1,"No"
"11175","GO_BP","501263_GO_0032026_RESPONSE_TO_MAGNESIUM_ION",16,-1.0984,0.33,0.49,"No",1.2817,0.15,0.7,"Yes"
"11176","C2_Chemical_and_genetic_perturbations","C2_CGP_3194_BILANGES_SERUM_SENSITIVE_VIA_TSC2",39,-1.0983,0.32,0.41,"No",-1.3078,0.1,0.69,"No"
"11177","REACTOME","730340_REACT_150134_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE_",9,-1.0982,0.34,0.53,"No",-1.0183,0.45,0.98,"No"
"11178","C2_Chemical_and_genetic_perturbations","C2_CGP_2427_ALONSO_METASTASIS_DN",24,-1.0982,0.34,0.41,"No",0.6933,0.9,1,"Yes"
"11179","GO_BP","515870_GO_0070943_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL",5,-1.0982,0.36,0.49,"No",1.4122,0.088,0.54,"Yes"
"11180","GO_CC","502204_GO_0032982_MYOSIN_FILAMENT",21,-1.0982,0.34,0.59,"No",-1.3843,0.08,0.63,"No"
"11181","GO_BP","500124_GO_0030825_POSITIVE_REGULATION_OF_CGMP_METABOLIC_PROCESS",19,-1.0981,0.34,0.49,"No",-0.7221,0.86,1,"No"
"11182","C2_Chemical_and_genetic_perturbations","C2_CGP_1853_KUNINGER_IGF1_VS_PDGFB_TARGETS_UP",78,-1.0981,0.31,0.41,"No",-1.9903,0,0.083,"No"
"11183","C2_Chemical_and_genetic_perturbations","C2_CGP_1629_WU_HBX_TARGETS_2_DN",14,-1.0981,0.34,0.41,"No",-0.7582,0.78,1,"No"
"11184","GO_BP","506696_GO_0043666_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",33,-1.0979,0.32,0.49,"No",0.7296,0.9,1,"Yes"
"11185","GO_MF","501273_GO_0032036_MYOSIN_HEAVY_CHAIN_BINDING",9,-1.0978,0.34,0.52,"No",-1.4071,0.098,0.64,"No"
"11186","C6_Oncogenic_signatures","C6_ALL_55_E2F3_UP_V1_DN",152,-1.0976,0.26,0.34,"No",-1.0155,0.41,0.64,"No"
"11187","GO_MF","512306_GO_0051428_PEPTIDE_HORMONE_RECEPTOR_BINDING",16,-1.0976,0.34,0.52,"No",-1.1427,0.27,0.81,"No"
"11188","GO_MF","496454_GO_0016504_PEPTIDASE_ACTIVATOR_ACTIVITY",37,-1.0975,0.32,0.52,"No",1.2067,0.18,0.69,"Yes"
"11189","GO_BP","1134003_GO_1903828_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION",108,-1.0975,0.29,0.49,"No",-0.6282,1,1,"No"
"11190","C1_Positional","C1_ALL_325_CHR14Q31",23,-1.0975,0.35,0.86,"No",-0.8798,0.65,1,"No"
"11191","C7_Immunologic_signatures","C7_ALL_698_GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_DN",198,-1.0974,0.27,0.37,"No",0.9988,0.48,0.74,"Yes"
"11192","KEGG_pathway","HSA04662_B_CELL_RECEPTOR_SIGNALING_PATHWAY",72,-1.0974,0.31,0.37,"No",-0.5315,1,1,"No"
"11193","REACTOME","645345_REACT_121100_LINOLEIC_ACID_LA_METABOLISM",8,-1.0974,0.36,0.53,"No",-1.4905,0.049,0.47,"No"
"11194","GO_BP","516033_GO_0071107_RESPONSE_TO_PARATHYROID_HORMONE",8,-1.0974,0.37,0.49,"No",-1.0465,0.41,0.97,"No"
"11195","C3_TF_targets","C3_TFT_271_CRGAARNNNNCGA_UNKNOWN",47,-1.0974,0.3,0.36,"No",0.8299,0.76,1,"Yes"
"11196","C2_BioCarta_Pathways","C2_CP_BIOCARTA_171_BIOCARTA_ACH_PATHWAY",16,-1.0973,0.35,0.46,"No",0.8527,0.67,0.91,"Yes"
"11197","GO_BP","513837_GO_0060281_REGULATION_OF_OOCYTE_DEVELOPMENT",9,-1.0972,0.34,0.49,"No",-1.2224,0.24,0.88,"No"
"11198","REACTOME","576265_REACT_118744_PRE_NOTCH_EXPRESSION_AND_PROCESSING",45,-1.0972,0.32,0.53,"No",-1.0385,0.36,0.96,"No"
"11199","REACTOME","187205_REACT_23847_GP1B_IX_V_ACTIVATION_SIGNALLING",10,-1.097,0.34,0.53,"No",1.1629,0.28,0.49,"Yes"
"11200","C4_Cancer_modules","C4_CM_338_MODULE_403",46,-1.097,0.3,0.42,"No",1.1519,0.24,0.46,"Yes"
"11201","GO_BP","488973_GO_0003179_HEART_VALVE_MORPHOGENESIS",26,-1.097,0.35,0.49,"No",-1.0518,0.39,0.97,"No"
"11202","C3_TF_targets","C3_TFT_450_V_CREB_Q4_01",208,-1.0968,0.27,0.36,"No",-0.8016,0.95,1,"No"
"11203","C2_Chemical_and_genetic_perturbations","C2_CGP_2334_MATZUK_SPERMATOGONIA",22,-1.0968,0.31,0.42,"No",0.7716,0.8,1,"Yes"
"11204","C2_Chemical_and_genetic_perturbations","C2_CGP_2302_ZHANG_BREAST_CANCER_PROGENITORS_DN",145,-1.0967,0.29,0.42,"No",-0.6421,1,1,"No"
"11205","GO_CC","493471_GO_0009279_CELL_OUTER_MEMBRANE",5,-1.0965,0.37,0.59,"No",0.6948,0.82,0.99,"Yes"
"11206","C7_Immunologic_signatures","C7_ALL_1196_GSE27786_CD4_TCELL_VS_NKTCELL_DN",196,-1.0965,0.27,0.37,"No",0.8642,0.85,1,"Yes"
"11207","GO_BP","497922_GO_0019042_VIRAL_LATENCY",11,-1.0965,0.35,0.49,"No",0.8263,0.69,1,"Yes"
"11208","REACTOME","160988_REACT_15452_PEPTIDE_HORMONE_BIOSYNTHESIS",13,-1.0965,0.36,0.53,"No",-1.0079,0.45,0.99,"No"
"11209","GO_BP","518314_GO_0090174_ORGANELLE_MEMBRANE_FUSION",92,-1.0965,0.3,0.49,"No",0.9432,0.59,1,"Yes"
"11210","GO_MF","511628_GO_0050656_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING",6,-1.0965,0.38,0.53,"No",1.0109,0.47,0.87,"Yes"
"11211","KEGG_reaction","R08266_TAMOXIFEN_NADPH_OXYGEN_OXIDOREDUCTASE_N_OXIDE_FORMING_TAMOXIFEN_OXYGEN_NADPH_H_TAMOXIFEN_N_OXIDE_NADP_H2O",5,-1.0963,0.35,0.49,"No",0.6887,0.85,1,"Yes"
"11212","C7_Immunologic_signatures","C7_ALL_1335_GSE30083_SP3_VS_SP4_THYMOCYTE_UP",195,-1.0963,0.27,0.37,"No",-0.9672,0.55,1,"No"
"11213","C2_Chemical_and_genetic_perturbations","C2_CGP_3305_FORTSCHEGGER_PHF8_TARGETS_UP",270,-1.0963,0.26,0.42,"No",-0.861,0.88,1,"No"
"11214","C7_Immunologic_signatures","C7_ALL_19_GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP",200,-1.0963,0.28,0.37,"No",0.6314,1,1,"Yes"
"11215","C2_Chemical_and_genetic_perturbations","C2_CGP_3331_PECE_MAMMARY_STEM_CELL_UP",144,-1.0962,0.28,0.42,"No",2.8899,0,0,"Yes"
"11216","GO_MF","492767_GO_0008483_TRANSAMINASE_ACTIVITY",20,-1.0962,0.34,0.53,"No",-0.9247,0.58,0.96,"No"
"11217","REACTOME","645303_REACT_121313_KERATAN_SULFATE_DEGRADATION",12,-1.0962,0.35,0.53,"No",-0.8678,0.64,1,"No"
"11218","GO_BP","518190_GO_0090049_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",16,-1.0961,0.34,0.49,"No",-1.1847,0.24,0.9,"No"
"11219","REACTOME","106501_REACT_15334_DARPP_32_EVENTS",27,-1.096,0.31,0.53,"No",1.1029,0.31,0.58,"Yes"
"11220","C2_Chemical_and_genetic_perturbations","C2_CGP_172_WANG_LMO4_TARGETS_UP",366,-1.0959,0.24,0.42,"No",1.2726,0.021,0.42,"Yes"
"11221","C2_Chemical_and_genetic_perturbations","C2_CGP_2052_LEIN_MIDBRAIN_MARKERS",77,-1.0957,0.3,0.42,"No",0.9602,0.53,0.85,"Yes"
"11222","GO_BP","488347_GO_0002474_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I",107,-1.0957,0.28,0.49,"No",1.8581,0,0.059,"Yes"
"11223","C3_TF_targets","C3_TFT_363_V_E4F1_Q6",282,-1.0956,0.23,0.36,"No",-0.7576,0.99,1,"No"
"11224","GO_BP","498561_GO_0019748_SECONDARY_METABOLIC_PROCESS",47,-1.0955,0.31,0.49,"No",-0.9476,0.55,1,"No"
"11225","KEGG_enzyme","1.14.13.8_FLAVIN_CONTAINING_MONOOXYGENASE_DIMETHYLANILINE_OXIDASE_DIMETHYLANILINE_N_OXIDASE_FAD_CONTAINING_MONOOXYGENASE_N_N_DIMETHYLANILINE_MONOOXYGENASE_DMA_OXIDASE_FLAVIN_MIXED_FUNCTION_OXIDASE_ZIEGLER_S_ENZYME_MIXED_FUNCTION_AMINE_OXIDASE_FMO_FMO_I_FMO_II_FMO1_FMO2_FMO3_FMO4_FMO5_FLAVIN_MONOOXYGENASE_METHYLPHENYLTETRAHYDROPYRIDINE_N_MONOOXYGENASE_1_METHYL_4_PHENYL_1_2_3_6_TETRAHYDROPYRIDINE_OXYGEN_N_OXIDOREDUCTASE_DIMETHYLANILINE_MONOOXYGENASE_N_OXIDE_FORMING_",5,-1.0955,0.37,0.54,"No",0.6904,0.83,1,"Yes"
"11226","C7_Immunologic_signatures","C7_ALL_1683_GSE3982_BCELL_VS_TH1_UP",197,-1.0955,0.27,0.37,"No",0.7597,0.98,1,"Yes"
"11227","WikiPathways","198773_WP43_CYTOCHROME_P450",61,-1.0955,0.31,0.44,"No",0.9572,0.54,1,"Yes"
"11228","GO_BP","505594_GO_0042455_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS",125,-1.0953,0.29,0.49,"No",1.1109,0.23,0.89,"Yes"
"11229","OMIM_gene","OMIM603444_FAR_UPSTREAM_ELEMENT_BINDING_PROTEIN_1_FUBP1",5,-1.0953,0.38,0.81,"No",0.8771,0.59,1,"Yes"
"11230","GO_BP","496950_GO_0017156_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",30,-1.0949,0.31,0.49,"No",0.6889,0.95,1,"Yes"
"11231","GO_BP","512833_GO_0051983_REGULATION_OF_CHROMOSOME_SEGREGATION",67,-1.0948,0.31,0.49,"No",0.9538,0.54,1,"Yes"
"11232","GO_BP","491424_GO_0006528_ASPARAGINE_METABOLIC_PROCESS",5,-1.0945,0.38,0.49,"No",-0.586,0.92,1,"No"
"11233","C7_Immunologic_signatures","C7_ALL_488_GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_DN",195,-1.0944,0.29,0.37,"No",1.17,0.13,0.28,"Yes"
"11234","C7_Immunologic_signatures","C7_ALL_1448_GSE360_L_DONOVANI_VS_T_GONDII_DC_DN",194,-1.0944,0.28,0.37,"No",-1.0498,0.33,1,"No"
"11235","REACTOME","106409_REACT_7956_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION",6,-1.0943,0.38,0.53,"No",1.1719,0.29,0.48,"Yes"
"11236","GO_BP","487491_GO_0001553_LUTEINIZATION",8,-1.0943,0.35,0.49,"No",0.9251,0.52,1,"Yes"
"11237","REACTOME","1127628_REACT_264581_S33_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.0942,0.33,0.53,"No",0.6797,0.91,1,"Yes"
"11238","C0_Hallmark","H_ALL_9_HALLMARK_G2M_CHECKPOINT",200,-1.0942,0.29,0.32,"No",0.9026,0.73,0.92,"Yes"
"11239","GO_MF","496643_GO_0016723_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR",12,-1.0942,0.37,0.53,"No",0.7753,0.76,1,"Yes"
"11240","C6_Oncogenic_signatures","C6_ALL_53_BCAT_BILD_ET_AL_DN",44,-1.0941,0.34,0.34,"No",-0.8624,0.7,0.96,"No"
"11241","GO_BP","491781_GO_0006930_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION",7,-1.0941,0.36,0.49,"No",0.7242,0.82,1,"Yes"
"11242","C1_Positional","C1_ALL_283_CHRXQ26",52,-1.094,0.3,0.86,"No",1.457,0.03,0.31,"Yes"
"11243","GO_BP","499323_GO_0022405_HAIR_CYCLE_PROCESS",73,-1.094,0.3,0.49,"No",0.8161,0.82,1,"Yes"
"11244","GO_BP","489136_GO_0003344_PERICARDIUM_MORPHOGENESIS",5,-1.094,0.38,0.49,"No",-0.8177,0.71,1,"No"
"11245","GO_CC","507401_GO_0044453_NUCLEAR_MEMBRANE_PART",14,-1.094,0.34,0.6,"No",-0.8121,0.7,1,"No"
"11246","REACTOME","645294_REACT_120726_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_",16,-1.0938,0.35,0.53,"No",1.2354,0.18,0.41,"Yes"
"11247","GO_BP","495817_GO_0015682_FERRIC_IRON_TRANSPORT",37,-1.0938,0.32,0.49,"No",0.9033,0.65,1,"Yes"
"11248","GO_MF","495444_GO_0015172_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.0938,0.35,0.53,"No",0.9831,0.46,0.89,"Yes"
"11249","C2_Chemical_and_genetic_perturbations","C2_CGP_1845_CHANG_IMMORTALIZED_BY_HPV31_UP",82,-1.0937,0.29,0.42,"No",-1.2043,0.16,0.8,"No"
"11250","C2_Chemical_and_genetic_perturbations","C2_CGP_2300_IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN",106,-1.0937,0.29,0.42,"No",-0.9735,0.5,1,"No"
"11251","GO_BP","499490_GO_0030031_CELL_PROJECTION_ASSEMBLY",231,-1.0935,0.29,0.49,"No",0.6806,1,1,"Yes"
"11252","C2_BioCarta_Pathways","C2_CP_BIOCARTA_214_BIOCARTA_VEGF_PATHWAY",29,-1.0935,0.33,0.46,"No",1.1627,0.24,0.68,"Yes"
"11253","GO_CC","486695_GO_0000164_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX",8,-1.0935,0.38,0.6,"No",-0.8995,0.58,0.96,"No"
"11254","OMIM_gene","OMIM607751_TASTE_RECEPTOR_TYPE_2_MEMBER_38_TAS2R38",5,-1.0934,0.4,0.79,"No",0.9362,0.53,1,"Yes"
"11255","C2_Chemical_and_genetic_perturbations","C2_CGP_3146_MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP",7,-1.0934,0.36,0.42,"No",1.2837,0.2,0.41,"Yes"
"11256","C3_TF_targets","C3_TFT_339_V_HOXA4_Q2",257,-1.0933,0.25,0.37,"No",0.9386,0.64,1,"Yes"
"11257","C2_Chemical_and_genetic_perturbations","C2_CGP_2057_LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES",37,-1.0933,0.31,0.42,"No",1.1754,0.21,0.53,"Yes"
"11258","GO_MF","490222_GO_0004931_EXTRACELLULAR_ATP_GATED_CATION_CHANNEL_ACTIVITY",7,-1.0931,0.36,0.53,"No",-0.8062,0.69,1,"No"
"11259","GO_BP","487958_GO_0002068_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT",16,-1.093,0.34,0.49,"No",-1.2599,0.16,0.91,"No"
"11260","REACTOME","1127626_REACT_264127_T41_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.0928,0.36,0.53,"No",0.6899,0.87,1,"Yes"
"11261","GO_BP","506972_GO_0043954_CELLULAR_COMPONENT_MAINTENANCE",23,-1.0928,0.32,0.49,"No",-1.2275,0.2,0.88,"No"
"11262","GO_BP","515247_GO_0070314_G1_TO_G0_TRANSITION",7,-1.0927,0.34,0.49,"No",-0.5988,0.94,1,"No"
"11263","KEGG_compound","C00097_L_CYSTEINE_L_2_AMINO_3_MERCAPTOPROPIONIC_ACID",14,-1.0927,0.35,0.51,"No",0.8663,0.63,1,"Yes"
"11264","C2_Chemical_and_genetic_perturbations","C2_CGP_1063_FRIDMAN_IMMORTALIZATION_DN",33,-1.0927,0.32,0.42,"No",0.7986,0.8,0.99,"Yes"
"11265","GO_MF","500295_GO_0031005_FILAMIN_BINDING",8,-1.0927,0.35,0.53,"No",-1.0353,0.42,0.88,"No"
"11266","GO_MF","504171_GO_0034979_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY",17,-1.0926,0.37,0.53,"No",-1.4007,0.091,0.62,"No"
"11267","C7_Immunologic_signatures","C7_ALL_647_GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_UP",199,-1.0926,0.28,0.38,"No",1.4921,0.0022,0.014,"Yes"
"11268","GO_BP","491637_GO_0006760_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS",25,-1.0926,0.35,0.49,"No",-0.8993,0.62,1,"No"
"11269","C3_MicroRNA_targets","C3_MIR_130_GACAGGG_MIR_339",67,-1.0925,0.31,0.46,"No",-0.8634,0.75,1,"No"
"11270","GO_BP","487739_GO_0001843_NEURAL_TUBE_CLOSURE",79,-1.0924,0.31,0.49,"No",-0.7399,0.95,1,"No"
"11271","C7_Immunologic_signatures","C7_ALL_678_GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_DN",200,-1.0923,0.29,0.38,"No",0.9705,0.52,0.83,"Yes"
"11272","GO_BP","496305_GO_0016239_POSITIVE_REGULATION_OF_MACROAUTOPHAGY",16,-1.0923,0.36,0.49,"No",0.7934,0.77,1,"Yes"
"11273","C2_Chemical_and_genetic_perturbations","C2_CGP_2311_BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP",22,-1.0923,0.33,0.42,"No",0.6376,0.95,1,"Yes"
"11274","C2_Chemical_and_genetic_perturbations","C2_CGP_191_GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP",117,-1.0922,0.29,0.42,"No",1.2657,0.073,0.42,"Yes"
"11275","C7_Immunologic_signatures","C7_ALL_970_GSE22886_NEUTROPHIL_VS_MONOCYTE_DN",200,-1.0922,0.27,0.38,"No",2.164,0,0,"Yes"
"11276","C3_TF_targets","C3_TFT_261_V_AR_Q2",123,-1.0922,0.3,0.37,"No",-0.7304,0.97,1,"No"
"11277","C2_Chemical_and_genetic_perturbations","C2_CGP_2543_RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN",16,-1.0921,0.33,0.42,"No",1.4243,0.085,0.28,"Yes"
"11278","C2_Chemical_and_genetic_perturbations","C2_CGP_453_GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP",38,-1.0921,0.31,0.42,"No",-0.9631,0.51,1,"No"
"11279","GO_BP","492670_GO_0008361_REGULATION_OF_CELL_SIZE",105,-1.092,0.3,0.49,"No",-0.8634,0.76,1,"No"
"11280","C2_Chemical_and_genetic_perturbations","C2_CGP_1627_SU_PANCREAS",49,-1.092,0.32,0.42,"No",-0.8247,0.79,1,"No"
"11281","C7_Immunologic_signatures","C7_ALL_521_GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_UP",200,-1.0918,0.29,0.38,"No",1.4986,0.0047,0.013,"Yes"
"11282","C3_TF_targets","C3_TFT_406_V_COUP_DR1_Q6",239,-1.0917,0.28,0.37,"No",-0.9788,0.5,0.81,"No"
"11283","C4_Cancer_modules","C4_CM_19_MODULE_20",79,-1.0917,0.3,0.43,"No",0.7616,0.92,0.99,"Yes"
"11284","GO_BP","513980_GO_0060425_LUNG_MORPHOGENESIS",45,-1.0917,0.32,0.49,"No",1.1153,0.24,0.88,"Yes"
"11285","GO_BP","514130_GO_0060575_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION",18,-1.0916,0.35,0.49,"No",0.9889,0.47,0.99,"Yes"
"11286","C7_Immunologic_signatures","C7_ALL_506_GSE17721_CTRL_VS_CPG_8H_BMDM_DN",198,-1.0916,0.28,0.38,"No",0.8946,0.75,1,"Yes"
"11287","GO_MF","511751_GO_0050780_DOPAMINE_RECEPTOR_BINDING",13,-1.0916,0.37,0.53,"No",-1.138,0.27,0.8,"No"
"11288","C4_Cancer_gene_neighborhoods","C4_CGN_172_MORF_RBBP8",208,-1.0915,0.28,0.52,"No",-0.758,0.99,1,"No"
"11289","GO_MF","490039_GO_0004725_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY",100,-1.0914,0.3,0.53,"No",1.1417,0.21,0.75,"Yes"
"11290","GO_BP","493577_GO_0009404_TOXIN_METABOLIC_PROCESS",13,-1.0913,0.36,0.5,"No",-0.9018,0.58,1,"No"
"11291","GO_BP","511977_GO_0051052_REGULATION_OF_DNA_METABOLIC_PROCESS",275,-1.0913,0.27,0.5,"No",0.7765,0.99,1,"Yes"
"11292","GO_BP","491074_GO_0006091_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY",374,-1.0913,0.25,0.5,"No",1.6435,0,0.25,"Yes"
"11293","GO_BP","512125_GO_0051231_SPINDLE_ELONGATION",8,-1.0912,0.37,0.5,"No",0.6976,0.85,1,"Yes"
"11294","GO_MF","494022_GO_0009931_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",9,-1.0911,0.36,0.53,"No",-1.0998,0.35,0.83,"No"
"11295","REACTOME","1127624_REACT_263863_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX",15,-1.0911,0.37,0.53,"No",0.6967,0.89,1,"Yes"
"11296","C7_Immunologic_signatures","C7_ALL_1458_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN",196,-1.0909,0.29,0.38,"No",1.0059,0.44,0.72,"Yes"
"11297","GO_BP","1039897_GO_0090596_SENSORY_ORGAN_MORPHOGENESIS",243,-1.0905,0.26,0.5,"No",-0.8976,0.77,1,"No"
"11298","C2_Chemical_and_genetic_perturbations","C2_CGP_358_HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP",176,-1.0905,0.29,0.42,"No",1.7156,0,0.074,"Yes"
"11299","C2_BioCarta_Pathways","C2_CP_BIOCARTA_11_BIOCARTA_AKT_PATHWAY",22,-1.0905,0.33,0.46,"No",0.9561,0.5,0.84,"Yes"
"11300","GO_BP","512516_GO_0051640_ORGANELLE_LOCALIZATION",362,-1.0905,0.24,0.5,"No",1.1903,0.05,0.8,"Yes"
"11301","C2_Chemical_and_genetic_perturbations","C2_CGP_885_KIM_MYCN_AMPLIFICATION_TARGETS_UP",91,-1.0904,0.3,0.42,"No",-1.0566,0.33,0.97,"No"
"11302","GO_MF","490218_GO_0042813_WNT_ACTIVATED_RECEPTOR_ACTIVITY",20,-1.0904,0.35,0.53,"No",-1.1821,0.26,0.78,"No"
"11303","GO_BP","493411_GO_0009215_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",11,-1.0904,0.37,0.5,"No",0.8784,0.64,1,"Yes"
"11304","GO_BP","503517_GO_0034314_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION",18,-1.0903,0.34,0.5,"No",0.8958,0.62,1,"Yes"
"11305","C2_Chemical_and_genetic_perturbations","C2_CGP_1417_IIZUKA_LIVER_CANCER_EARLY_RECURRENCE",11,-1.0901,0.35,0.42,"No",0.7176,0.85,1,"Yes"
"11306","GO_BP","487738_GO_0001842_NEURAL_FOLD_FORMATION",7,-1.09,0.36,0.5,"No",-0.7029,0.83,1,"No"
"11307","C2_Chemical_and_genetic_perturbations","C2_CGP_469_BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP",31,-1.09,0.34,0.42,"No",1.4302,0.054,0.27,"Yes"
"11308","REACTOME","187099_REACT_25039_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10",12,-1.0898,0.36,0.53,"No",0.7191,0.84,1,"Yes"
"11309","C7_Immunologic_signatures","C7_ALL_323_GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP",193,-1.0896,0.28,0.38,"No",1.091,0.21,0.47,"Yes"
"11310","GO_BP","501764_GO_0032534_REGULATION_OF_MICROVILLUS_ASSEMBLY",5,-1.0896,0.39,0.5,"No",-0.6313,0.88,1,"No"
"11311","GO_BP","492245_GO_0007492_ENDODERM_DEVELOPMENT",75,-1.0894,0.32,0.5,"No",-0.9959,0.47,0.99,"No"
"11312","C2_Chemical_and_genetic_perturbations","C2_CGP_901_SEMBA_FHIT_TARGETS_DN",10,-1.0892,0.36,0.43,"No",0.7566,0.78,1,"Yes"
"11313","C7_Immunologic_signatures","C7_ALL_736_GSE17721_0_5H_VS_24H_PAM3CSK4_BMDM_DN",197,-1.0892,0.27,0.38,"No",1.2815,0.034,0.12,"Yes"
"11314","GO_BP","514584_GO_0061036_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT",27,-1.0891,0.33,0.5,"No",-1.1111,0.3,0.94,"No"
"11315","C7_Immunologic_signatures","C7_ALL_475_GSE17721_CTRL_VS_POLYIC_12H_BMDM_UP",199,-1.0891,0.26,0.38,"No",1.2801,0.036,0.12,"Yes"
"11316","C2_Chemical_and_genetic_perturbations","C2_CGP_1479_HOFMANN_CELL_LYMPHOMA_UP",50,-1.089,0.33,0.43,"No",-0.622,0.98,1,"No"
"11317","GO_BP","511865_GO_0050930_INDUCTION_OF_POSITIVE_CHEMOTAXIS",13,-1.0889,0.36,0.5,"No",-0.8643,0.64,1,"No"
"11318","C6_Oncogenic_signatures","C6_ALL_64_CAMP_UP_V1_UP",197,-1.0889,0.29,0.35,"No",1.5769,0.0023,0.096,"Yes"
"11319","C2_BioCarta_Pathways","C2_CP_BIOCARTA_87_BIOCARTA_HCMV_PATHWAY",17,-1.0888,0.36,0.46,"No",0.7183,0.85,1,"Yes"
"11320","REACTOME","106049_REACT_1178_DISINHIBITION_OF_SNARE_FORMATION",5,-1.0888,0.37,0.53,"No",-0.7044,0.84,1,"No"
"11321","GO_BP","752390_GO_0086019_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION",19,-1.0887,0.35,0.5,"No",0.7676,0.81,1,"Yes"
"11322","GO_BP","1129496_GO_1903670_REGULATION_OF_SPROUTING_ANGIOGENESIS",19,-1.0886,0.35,0.5,"No",-1.2734,0.16,0.89,"No"
"11323","C2_Chemical_and_genetic_perturbations","C2_CGP_1082_KOYAMA_SEMA3B_TARGETS_UP",280,-1.0886,0.26,0.43,"No",0.8827,0.84,0.94,"Yes"
"11324","GO_BP","517312_GO_0072396_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING",5,-1.0886,0.39,0.5,"No",-0.9391,0.55,1,"No"
"11325","C2_Chemical_and_genetic_perturbations","C2_CGP_1040_RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP",5,-1.0885,0.37,0.43,"No",-0.8399,0.63,1,"No"
"11326","REACTOME","187173_REACT_24941_CIRCADIAN_CLOCK",62,-1.0883,0.32,0.53,"No",0.8196,0.84,0.99,"Yes"
"11327","C4_Cancer_gene_neighborhoods","C4_CGN_184_MORF_TNFRSF6",160,-1.0883,0.28,0.52,"No",-1.0724,0.3,0.75,"No"
"11328","C4_Cancer_gene_neighborhoods","C4_CGN_4_MORF_BNIP1",184,-1.0882,0.29,0.52,"No",-1.1061,0.23,0.72,"No"
"11329","C3_MicroRNA_targets","C3_MIR_27_GTATGAT_MIR_154_MIR_487",68,-1.0882,0.32,0.47,"No",0.7705,0.88,1,"Yes"
"11330","GO_BP","492778_GO_0017121_PHOSPHOLIPID_SCRAMBLING",11,-1.0881,0.34,0.5,"No",0.7393,0.78,1,"Yes"
"11331","C6_Oncogenic_signatures","C6_ALL_67_MEK_UP_V1_DN",191,-1.088,0.28,0.35,"No",1.1198,0.2,0.5,"Yes"
"11332","GO_BP","501668_GO_0032436_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",58,-1.088,0.32,0.5,"No",0.8231,0.81,1,"Yes"
"11333","GO_BP","518269_GO_0090129_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION",10,-1.088,0.36,0.5,"No",-1.0576,0.41,0.96,"No"
"11334","C2_Chemical_and_genetic_perturbations","C2_CGP_2726_CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN",51,-1.0879,0.32,0.43,"No",-1.089,0.3,0.93,"No"
"11335","GO_BP","507469_GO_0045069_REGULATION_OF_VIRAL_GENOME_REPLICATION",68,-1.0878,0.33,0.5,"No",1.5573,0.012,0.33,"Yes"
"11336","C2_Chemical_and_genetic_perturbations","C2_CGP_1678_RODWELL_AGING_KIDNEY_NO_BLOOD_DN",148,-1.0877,0.28,0.43,"No",1.5957,0.0024,0.14,"Yes"
"11337","C2_Chemical_and_genetic_perturbations","C2_CGP_1825_BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP",27,-1.0877,0.34,0.43,"No",-0.6785,0.92,1,"No"
"11338","C4_Cancer_modules","C4_CM_387_MODULE_486",100,-1.0876,0.32,0.44,"No",-1.6489,0.0018,0.19,"No"
"11339","C7_Immunologic_signatures","C7_ALL_1624_GSE3982_MAST_CELL_VS_TH1_DN",196,-1.0876,0.28,0.39,"No",1.0344,0.33,0.63,"Yes"
"11340","C7_Immunologic_signatures","C7_ALL_329_GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP",187,-1.0875,0.29,0.39,"No",1.0294,0.35,0.65,"Yes"
"11341","KEGG_compound","C01194_1_PHOSPHATIDYL_D_MYO_INOSITOL_1_PHOSPHATIDYL_1D_MYO_INOSITOL_1_PHOSPHATIDYL_MYO_INOSITOL_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATIDYL_1_D_INOSITOL_1_2_DIACYL_SN_GLYCERO_3_PHOSPHOINOSITOL_PHOSPHATIDYLINOSITOL",22,-1.0874,0.35,0.52,"No",0.8605,0.68,1,"Yes"
"11342","GO_BP","500127_GO_0030828_POSITIVE_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS",17,-1.0872,0.34,0.5,"No",-1.0025,0.45,0.99,"No"
"11343","C2_Chemical_and_genetic_perturbations","C2_CGP_3020_WHITFIELD_CELL_CYCLE_S",161,-1.0872,0.3,0.43,"No",-0.7305,0.98,1,"No"
"11344","GO_BP","488426_GO_0002553_HISTAMINE_SECRETION_BY_MAST_CELL",5,-1.0871,0.39,0.5,"No",0.904,0.59,1,"Yes"
"11345","C2_Chemical_and_genetic_perturbations","C2_CGP_681_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8",12,-1.087,0.35,0.43,"No",-0.6934,0.87,1,"No"
"11346","GO_MF","492506_GO_0008157_PROTEIN_PHOSPHATASE_1_BINDING",13,-1.087,0.34,0.54,"No",-0.645,0.91,1,"No"
"11347","C7_Immunologic_signatures","C7_ALL_1805_GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP",198,-1.0869,0.3,0.39,"No",1.1128,0.19,0.41,"Yes"
"11348","REACTOME","1127532_REACT_263982_CA2_PATHWAY",60,-1.0869,0.32,0.54,"No",-0.9922,0.46,0.99,"No"
"11349","C2_Chemical_and_genetic_perturbations","C2_CGP_297_SABATES_COLORECTAL_ADENOMA_SIZE_DN",12,-1.0868,0.36,0.43,"No",1.1199,0.32,0.6,"Yes"
"11350","REACTOME","1127685_REACT_263961_HDMS_DEMETHYLATE_HISTONES",45,-1.0868,0.35,0.54,"No",-1.8619,0,0.059,"No"
"11351","GO_BP","502846_GO_0033630_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN",17,-1.0868,0.36,0.5,"No",0.8283,0.72,1,"Yes"
"11352","WikiPathways","198820_WP528_ACETYLCHOLINE_SYNTHESIS",7,-1.0866,0.37,0.45,"No",1.1143,0.34,0.97,"Yes"
"11353","C7_Immunologic_signatures","C7_ALL_473_GSE17721_CTRL_VS_POLYIC_8H_BMDM_UP",198,-1.0866,0.29,0.39,"No",1.6488,0,0.0013,"Yes"
"11354","REACTOME","187092_REACT_25195_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING",13,-1.0866,0.38,0.54,"No",1.4513,0.086,0.18,"Yes"
"11355","C3_TF_targets","C3_TFT_576_TGATTTRY_V_GFI1_01",280,-1.0865,0.28,0.38,"No",1.1976,0.072,0.71,"Yes"
"11356","C4_Cancer_modules","C4_CM_366_MODULE_447",38,-1.0865,0.33,0.44,"No",1.6102,0.0086,0.072,"Yes"
"11357","C7_Immunologic_signatures","C7_ALL_1627_GSE3982_DC_VS_MAC_UP",189,-1.0864,0.29,0.39,"No",0.7099,1,1,"Yes"
"11358","GO_BP","1129370_GO_1903543_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION",12,-1.0864,0.35,0.5,"No",1.2582,0.18,0.72,"Yes"
"11359","GO_BP","507567_GO_0045185_MAINTENANCE_OF_PROTEIN_LOCATION",114,-1.0864,0.32,0.5,"No",0.7723,0.95,1,"Yes"
"11360","REACTOME","1127686_REACT_268728_PKMTS_METHYLATE_HISTONE_LYSINES",61,-1.0864,0.33,0.54,"No",-1.6056,0.0038,0.33,"No"
"11361","C2_Chemical_and_genetic_perturbations","C2_CGP_451_GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP",167,-1.0863,0.29,0.43,"No",-0.8564,0.84,1,"No"
"11362","C2_Chemical_and_genetic_perturbations","C2_CGP_1242_ONDER_CDH1_TARGETS_3_UP",17,-1.0863,0.33,0.43,"No",0.6865,0.88,1,"Yes"
"11363","GO_BP","493319_GO_0009120_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS",7,-1.0861,0.36,0.5,"No",0.7351,0.81,1,"Yes"
"11364","C1_Positional","C1_ALL_209_CHR11Q23",127,-1.0861,0.31,0.88,"No",1.0151,0.41,0.75,"Yes"
"11365","GO_BP","508227_GO_0045920_NEGATIVE_REGULATION_OF_EXOCYTOSIS",22,-1.0861,0.34,0.5,"No",1.3994,0.077,0.55,"Yes"
"11366","GO_BP","507106_GO_0044091_MEMBRANE_BIOGENESIS",25,-1.0861,0.34,0.5,"No",0.9596,0.52,1,"Yes"
"11367","GO_BP","495133_GO_0014061_REGULATION_OF_NOREPINEPHRINE_SECRETION",13,-1.0861,0.35,0.5,"No",1.1641,0.25,0.82,"Yes"
"11368","REACTOME","833811_REACT_163942_SYNDECAN_INTERACTIONS",20,-1.0861,0.35,0.53,"No",1.1949,0.21,0.45,"Yes"
"11369","C2_Chemical_and_genetic_perturbations","C2_CGP_2198_CHENG_IMPRINTED_BY_ESTRADIOL",110,-1.086,0.29,0.43,"No",0.71,0.99,1,"Yes"
"11370","GO_BP","511817_GO_0050879_MULTICELLULAR_ORGANISMAL_MOVEMENT",35,-1.0859,0.34,0.5,"No",-1.2784,0.12,0.89,"No"
"11371","GO_BP","499324_GO_0022406_MEMBRANE_DOCKING",76,-1.0857,0.32,0.5,"No",-0.8404,0.79,1,"No"
"11372","C2_Chemical_and_genetic_perturbations","C2_CGP_2933_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7",75,-1.0854,0.32,0.43,"No",1.1986,0.17,0.49,"Yes"
"11373","REACTOME","105801_REACT_2203_G2_M_TRANSITION",114,-1.0854,0.31,0.54,"No",-0.5884,1,1,"No"
"11374","REACTOME","187178_REACT_25199_GABA_RECEPTOR_ACTIVATION",52,-1.0854,0.33,0.53,"No",-1.1608,0.24,0.85,"No"
"11375","GO_BP","506646_GO_0043615_ASTROCYTE_CELL_MIGRATION",6,-1.0854,0.39,0.5,"No",1.3985,0.12,0.55,"Yes"
"11376","KEGG_reaction","R05795_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_ADP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_BISPHOSPHATE",7,-1.0853,0.38,0.5,"No",-0.7116,0.82,1,"No"
"11377","GO_BP","499307_GO_0022028_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB",8,-1.0853,0.36,0.5,"No",-1.6034,0.034,0.7,"No"
"11378","GO_BP","493300_GO_0009100_GLYCOPROTEIN_METABOLIC_PROCESS",389,-1.0853,0.27,0.5,"No",0.8522,0.96,1,"Yes"
"11379","GO_CC","500199_GO_0030904_RETROMER_COMPLEX",22,-1.0852,0.34,0.62,"No",0.7764,0.78,0.97,"Yes"
"11380","C2_Chemical_and_genetic_perturbations","C2_CGP_1964_SASSON_FSH_RESPONSE",9,-1.0849,0.35,0.43,"No",0.9857,0.49,0.81,"Yes"
"11381","KEGG_compound","C05139_16ALPHA_HYDROXYDEHYDROEPIANDROSTERONE_5_ANDROSTENE_3BETA_16ALPHA_DIOL_17_ONE",9,-1.0848,0.36,0.52,"No",0.8056,0.71,1,"Yes"
"11382","GO_MF","489649_GO_0004198_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",19,-1.0848,0.35,0.54,"No",-0.9501,0.52,0.95,"No"
"11383","GO_BP","488351_GO_0002478_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN",168,-1.0847,0.31,0.5,"No",1.65,0,0.25,"Yes"
"11384","GO_MF","499430_GO_0030594_NEUROTRANSMITTER_RECEPTOR_ACTIVITY",74,-1.0845,0.33,0.54,"No",-1.1531,0.21,0.81,"No"
"11385","KEGG_pathway","HSA05221_ACUTE_MYELOID_LEUKEMIA",57,-1.0845,0.32,0.39,"No",0.538,1,1,"Yes"
"11386","GO_BP","752620_GO_0097119_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING",6,-1.0845,0.37,0.5,"No",-1.3887,0.12,1,"No"
"11387","GO_BP","502302_GO_0033081_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS",23,-1.0844,0.36,0.5,"No",-1.1207,0.3,0.94,"No"
"11388","GO_BP","492346_GO_0007605_SENSORY_PERCEPTION_OF_SOUND",137,-1.0839,0.31,0.51,"No",0.9677,0.55,1,"Yes"
"11389","KEGG_pathway","HSA05016_HUNTINGTON_S_DISEASE",183,-1.0838,0.31,0.39,"No",1.9344,0,0.0042,"Yes"
"11390","C2_Chemical_and_genetic_perturbations","C2_CGP_1083_KOYAMA_SEMA3B_TARGETS_DN",400,-1.0836,0.28,0.43,"No",-0.8739,0.88,1,"No"
"11391","C2_Chemical_and_genetic_perturbations","C2_CGP_2449_SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP",13,-1.0836,0.37,0.43,"No",-1.4452,0.081,0.53,"No"
"11392","C2_Chemical_and_genetic_perturbations","C2_CGP_2807_FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP",71,-1.0836,0.32,0.43,"No",-1.1129,0.28,0.9,"No"
"11393","GO_BP","488800_GO_0003002_REGIONALIZATION",330,-1.083,0.27,0.51,"No",-1.0736,0.26,0.96,"No"
"11394","REACTOME","1183595_REACT_355021_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS",9,-1.0828,0.36,0.54,"No",-0.6827,0.86,1,"No"
"11395","GO_MF","492460_GO_0008093_CYTOSKELETAL_ADAPTOR_ACTIVITY",12,-1.0828,0.39,0.54,"No",-0.9061,0.59,0.98,"No"
"11396","GO_BP","512694_GO_0051823_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY",8,-1.0828,0.37,0.51,"No",0.7037,0.84,1,"Yes"
"11397","GO_BP","514936_GO_0065005_PROTEIN_LIPID_COMPLEX_ASSEMBLY",19,-1.0827,0.37,0.51,"No",-1.0055,0.47,0.98,"No"
"11398","C7_Immunologic_signatures","C7_ALL_1022_GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN",199,-1.0826,0.31,0.4,"No",1.4764,0.0024,0.016,"Yes"
"11399","GO_BP","511932_GO_0050999_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY",40,-1.0826,0.35,0.51,"No",0.9183,0.59,1,"Yes"
"11400","GO_BP","753110_GO_1900115_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION",18,-1.0824,0.35,0.51,"No",1.1392,0.26,0.85,"Yes"
"11401","GO_MF","489643_GO_0004177_AMINOPEPTIDASE_ACTIVITY",41,-1.0824,0.34,0.54,"No",-0.857,0.68,1,"No"
"11402","GO_CC","487087_GO_0000796_CONDENSIN_COMPLEX",6,-1.0824,0.38,0.62,"No",0.4723,1,1,"Yes"
"11403","C7_Immunologic_signatures","C7_ALL_371_GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP",186,-1.0823,0.3,0.4,"No",1.141,0.16,0.34,"Yes"
"11404","GO_MF","498632_GO_0019841_RETINOL_BINDING",12,-1.0823,0.35,0.54,"No",-0.9823,0.47,0.93,"No"
"11405","C3_MicroRNA_targets","C3_MIR_41_ATGCTGC_MIR_103_MIR_107",220,-1.0823,0.29,0.48,"No",0.8927,0.77,1,"Yes"
"11406","C7_Immunologic_signatures","C7_ALL_565_GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_UP",193,-1.0823,0.28,0.4,"No",1.1493,0.14,0.32,"Yes"
"11407","GO_BP","512112_GO_0051216_CARTILAGE_DEVELOPMENT",150,-1.0822,0.32,0.51,"No",-1.136,0.19,0.93,"No"
"11408","GO_BP","492621_GO_0008300_ISOPRENOID_CATABOLIC_PROCESS",7,-1.0821,0.39,0.51,"No",-1.3262,0.16,0.89,"No"
"11409","GO_BP","750959_GO_0036037_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",8,-1.082,0.37,0.51,"No",0.686,0.86,1,"Yes"
"11410","GO_BP","488314_GO_0002441_HISTAMINE_SECRETION_INVOLVED_IN_INFLAMMATORY_RESPONSE",5,-1.082,0.38,0.51,"No",0.8962,0.59,1,"Yes"
"11411","GO_CC","515748_GO_0070820_TERTIARY_GRANULE",6,-1.0818,0.38,0.62,"No",-0.8125,0.69,1,"No"
"11412","GO_BP","507078_GO_0044062_REGULATION_OF_EXCRETION",25,-1.0818,0.34,0.51,"No",1.6115,0.019,0.28,"Yes"
"11413","C3_TF_targets","C3_TFT_46_V_GATA1_01",236,-1.0817,0.28,0.39,"No",-0.829,0.9,1,"No"
"11414","C2_Chemical_and_genetic_perturbations","C2_CGP_105_HOOI_ST7_TARGETS_DN",120,-1.0816,0.31,0.44,"No",-1.0308,0.38,0.97,"No"
"11415","GO_BP","518381_GO_0090241_NEGATIVE_REGULATION_OF_HISTONE_H4_ACETYLATION",5,-1.0816,0.41,0.51,"No",0.572,0.96,1,"Yes"
"11416","GO_BP","754831_GO_1901880_NEGATIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION",59,-1.0816,0.35,0.51,"No",-0.9369,0.56,1,"No"
"11417","C2_Chemical_and_genetic_perturbations","C2_CGP_2106_JEPSEN_SMRT_TARGETS",32,-1.0815,0.34,0.44,"No",0.9545,0.51,0.86,"Yes"
"11418","REACTOME","106510_REACT_11045_SIGNALING_BY_WNT",322,-1.0814,0.29,0.54,"No",-0.8149,0.96,1,"No"
"11419","GO_MF","495357_GO_0046935_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY",6,-1.0813,0.35,0.54,"No",-0.7978,0.73,1,"No"
"11420","C2_Chemical_and_genetic_perturbations","C2_CGP_865_JAZAG_TGFB1_SIGNALING_UP",106,-1.0813,0.32,0.44,"No",-0.6807,0.99,1,"No"
"11421","WikiPathways","698758_WP2276_GLIAL_CELL_DIFFERENTIATION",7,-1.0811,0.36,0.46,"No",0.7187,0.82,1,"Yes"
"11422","C7_Immunologic_signatures","C7_ALL_556_GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_DN",199,-1.0809,0.3,0.4,"No",1.4294,0.0046,0.029,"Yes"
"11423","GO_BP","491762_GO_0006904_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS",47,-1.0809,0.35,0.51,"No",0.9389,0.57,1,"Yes"
"11424","C7_Immunologic_signatures","C7_ALL_1089_GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP",194,-1.0807,0.29,0.4,"No",0.9371,0.63,0.94,"Yes"
"11425","C2_Chemical_and_genetic_perturbations","C2_CGP_174_WANG_CLIM2_TARGETS_UP",259,-1.0807,0.29,0.44,"No",-0.9194,0.7,1,"No"
"11426","C3_TF_targets","C3_TFT_428_V_USF_Q6_01",236,-1.0806,0.3,0.4,"No",1.0048,0.42,1,"Yes"
"11427","GO_BP","492018_GO_0007220_NOTCH_RECEPTOR_PROCESSING",22,-1.0806,0.35,0.51,"No",0.8566,0.69,1,"Yes"
"11428","REACTOME","119551_REACT_19333_G_ALPHA_Z_SIGNALLING_EVENTS",45,-1.0805,0.35,0.54,"No",-0.9609,0.52,1,"No"
"11429","REACTOME","905990_REACT_169208_GLYCOGEN_SYNTHESIS",15,-1.0804,0.35,0.54,"No",1.407,0.078,0.22,"Yes"
"11430","GO_BP","1051069_GO_1903429_REGULATION_OF_CELL_MATURATION",13,-1.0803,0.37,0.51,"No",-0.9882,0.46,1,"No"
"11431","C3_MicroRNA_targets","C3_MIR_56_AGTCAGC_MIR_345",59,-1.0803,0.31,0.48,"No",-0.9296,0.57,1,"No"
"11432","GO_BP","508735_GO_0046475_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS",9,-1.0802,0.38,0.51,"No",-0.4975,0.98,1,"No"
"11433","GO_BP","501343_GO_0032106_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS",22,-1.0801,0.37,0.51,"No",-0.8347,0.72,1,"No"
"11434","GO_BP","513581_GO_0060023_SOFT_PALATE_DEVELOPMENT",5,-1.08,0.4,0.51,"No",-0.7384,0.77,1,"No"
"11435","KEGG_compound","C03227_3_HYDROXY_L_KYNURENINE",5,-1.08,0.38,0.53,"No",-1.2973,0.19,0.63,"No"
"11436","WikiPathways","705377_WP2371_PARKINSONS_DISEASE_PATHWAY",39,-1.0799,0.33,0.46,"No",-0.5726,1,1,"No"
"11437","GO_BP","496149_GO_0016050_VESICLE_ORGANIZATION",232,-1.0799,0.29,0.51,"No",1.3824,0.0047,0.57,"Yes"
"11438","KEGG_enzyme","2.3.1.51_1_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_1_ACYL_SN_GLYCERO_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCERO_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCEROLPHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCEROPHOSPHATE_ACYLTRANSFERASE_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE",9,-1.0798,0.38,0.52,"No",-0.7653,0.75,0.93,"No"
"11439","C2_Chemical_and_genetic_perturbations","C2_CGP_3376_GHANDHI_BYSTANDER_IRRADIATION_DN",12,-1.0797,0.35,0.44,"No",-1.3971,0.096,0.59,"No"
"11440","GO_BP","514989_GO_0070050_NEURON_CELLULAR_HOMEOSTASIS",7,-1.0796,0.37,0.51,"No",1.0244,0.41,0.97,"Yes"
"11441","GO_MF","750781_GO_0038036_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY",5,-1.0794,0.4,0.55,"No",0.7157,0.8,1,"Yes"
"11442","GO_BP","752651_GO_0097150_NEURONAL_STEM_CELL_MAINTENANCE",18,-1.0793,0.38,0.51,"No",-0.5694,0.97,1,"No"
"11443","GO_BP","510584_GO_0048512_CIRCADIAN_BEHAVIOR",15,-1.0793,0.35,0.51,"No",-0.8892,0.63,1,"No"
"11444","C2_Chemical_and_genetic_perturbations","C2_CGP_1013_RAHMAN_TP53_TARGETS_PHOSPHORYLATED",21,-1.0792,0.37,0.44,"No",1.7836,0.002,0.048,"Yes"
"11445","GO_BP","499515_GO_0030073_INSULIN_SECRETION",38,-1.0792,0.31,0.51,"No",1.2391,0.14,0.75,"Yes"
"11446","C3_TF_targets","C3_TFT_102_V_PAX5_01",150,-1.0791,0.31,0.4,"No",-0.9582,0.53,0.85,"No"
"11447","C3_TF_targets","C3_TFT_194_CCANNAGRKGGC_UNKNOWN",115,-1.079,0.33,0.4,"No",1.0757,0.29,1,"Yes"
"11448","C7_Immunologic_signatures","C7_ALL_490_GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_DN",199,-1.079,0.3,0.4,"No",-0.6805,1,1,"No"
"11449","C7_Immunologic_signatures","C7_ALL_143_GSE13229_MATURE_VS_INTMATURE_NKCELL_UP",191,-1.0789,0.31,0.4,"No",-1.1032,0.22,1,"No"
"11450","REACTOME","119531_REACT_19230_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING",9,-1.0789,0.38,0.54,"No",-0.976,0.48,1,"No"
"11451","GO_BP","488222_GO_0002349_HISTAMINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",5,-1.0789,0.4,0.51,"No",0.8933,0.58,1,"Yes"
"11452","REACTOME","1127520_REACT_264532_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS",7,-1.0789,0.38,0.54,"No",0.5203,0.97,1,"Yes"
"11453","GO_CC","948516_GO_1902710_GABA_RECEPTOR_COMPLEX",5,-1.0788,0.41,0.63,"No",0.7663,0.75,0.97,"Yes"
"11454","C1_Positional","C1_ALL_160_CHR5Q",6,-1.0788,0.36,0.9,"No",-0.802,0.72,0.97,"No"
"11455","C2_Chemical_and_genetic_perturbations","C2_CGP_1485_ASTIER_INTEGRIN_SIGNALING",59,-1.0788,0.33,0.44,"No",-1.0353,0.4,0.98,"No"
"11456","GO_BP","488958_GO_0003164_HIS_PURKINJE_SYSTEM_DEVELOPMENT",5,-1.0787,0.41,0.51,"No",-1.5303,0.043,0.76,"No"
"11457","REACTOME","576273_REACT_118862_SIGNALING_BY_NOTCH3",11,-1.0787,0.37,0.54,"No",-0.9513,0.53,1,"No"
"11458","C3_MicroRNA_targets","C3_MIR_216_CCACACA_MIR_147",62,-1.0786,0.34,0.48,"No",-0.4985,1,1,"No"
"11459","C7_Immunologic_signatures","C7_ALL_326_GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN",199,-1.0784,0.3,0.41,"No",1.3397,0.017,0.07,"Yes"
"11460","REACTOME","106538_REACT_18422_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS",16,-1.0783,0.37,0.54,"No",-1.4145,0.059,0.5,"No"
"11461","C2_Chemical_and_genetic_perturbations","C2_CGP_1809_YIH_RESPONSE_TO_ARSENITE_C4",18,-1.0782,0.34,0.44,"No",-0.7168,0.86,1,"No"
"11462","KEGG_pathway","HSA04350_TGF_BETA_SIGNALING_PATHWAY",80,-1.0781,0.33,0.4,"No",-1.0021,0.44,0.87,"No"
"11463","C7_Immunologic_signatures","C7_ALL_592_GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_DN",198,-1.078,0.3,0.41,"No",-0.7423,0.99,1,"No"
"11464","C7_Immunologic_signatures","C7_ALL_1618_GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN",192,-1.078,0.31,0.41,"No",-1.0899,0.26,1,"No"
"11465","WikiPathways","672464_WP1991_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION",13,-1.078,0.36,0.46,"No",-1.2711,0.18,0.95,"No"
"11466","GO_BP","513847_GO_0060291_LONG_TERM_SYNAPTIC_POTENTIATION",31,-1.078,0.34,0.51,"No",-1.1765,0.22,0.9,"No"
"11467","REACTOME","119529_REACT_19342_INACTIVATION_OF_CDC42_AND_RAC",9,-1.0778,0.36,0.54,"No",-1.2284,0.24,0.79,"No"
"11468","GO_BP","511934_GO_0051001_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY",8,-1.0778,0.39,0.51,"No",-0.9963,0.46,0.99,"No"
"11469","C2_Chemical_and_genetic_perturbations","C2_CGP_1700_RAMASWAMY_METASTASIS_DN",58,-1.0778,0.34,0.44,"No",0.9404,0.57,0.88,"Yes"
"11470","GO_MF","504436_GO_0035252_UDP_XYLOSYLTRANSFERASE_ACTIVITY",5,-1.0778,0.39,0.55,"No",0.7477,0.78,1,"Yes"
"11471","REACTOME","161002_REACT_22228_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING",10,-1.0777,0.37,0.54,"No",-1.2925,0.15,0.66,"No"
"11472","C7_Immunologic_signatures","C7_ALL_129_GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP",193,-1.0776,0.31,0.41,"No",1.4169,0.005,0.033,"Yes"
"11473","C2_Chemical_and_genetic_perturbations","C2_CGP_2566_WALLACE_JAK2_TARGETS_UP",26,-1.0776,0.37,0.44,"No",0.909,0.6,0.91,"Yes"
"11474","WikiPathways","672453_WP2197_ENDOTHELIN",33,-1.0776,0.36,0.45,"No",0.8912,0.66,1,"Yes"
"11475","C7_Immunologic_signatures","C7_ALL_1005_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP",200,-1.0776,0.3,0.41,"No",0.7749,0.98,1,"Yes"
"11476","GO_CC","513635_GO_0060077_INHIBITORY_SYNAPSE",9,-1.0773,0.38,0.63,"No",-0.8782,0.61,0.96,"No"
"11477","C7_Immunologic_signatures","C7_ALL_720_GSE17721_0_5H_VS_4H_POLYIC_BMDM_DN",199,-1.0772,0.3,0.41,"No",1.2326,0.067,0.18,"Yes"
"11478","GO_BP","488922_GO_0003128_HEART_FIELD_SPECIFICATION",8,-1.0772,0.37,0.52,"No",-0.7699,0.76,1,"No"
"11479","C3_TF_targets","C3_TFT_529_TTANWNANTGGM_UNKNOWN",59,-1.0771,0.35,0.4,"No",0.9094,0.61,1,"Yes"
"11480","C2_Chemical_and_genetic_perturbations","C2_CGP_2980_ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE",18,-1.0771,0.37,0.44,"No",-0.8673,0.62,1,"No"
"11481","C4_Cancer_modules","C4_CM_384_MODULE_481",86,-1.077,0.32,0.46,"No",1.0133,0.41,0.71,"Yes"
"11482","C1_Positional","C1_ALL_16_CHR1P11",8,-1.0769,0.37,0.89,"No",1.0604,0.4,0.67,"Yes"
"11483","REACTOME","161035_REACT_20593_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS",37,-1.0769,0.36,0.54,"No",0.8306,0.78,0.97,"Yes"
"11484","KEGG_compound","C01180_4_METHYLTHIO_2_OXOBUTANOIC_ACID_4_METHYLTHIO_2_OXOBUTANOATE_2_KETO_4_METHYLTHIOBUTYRIC_ACID_2_OXO_4_METHYLTHIOBUTANOATE_2_OXO_4_METHYLTHIOBUTANOIC_ACID",5,-1.0768,0.4,0.53,"No",-1.0325,0.46,1,"No"
"11485","GO_BP","495076_GO_0014003_OLIGODENDROCYTE_DEVELOPMENT",32,-1.0767,0.36,0.52,"No",0.9971,0.44,0.98,"Yes"
"11486","C2_Chemical_and_genetic_perturbations","C2_CGP_2446_GRESHOCK_CANCER_COPY_NUMBER_UP",319,-1.0767,0.3,0.45,"No",0.6935,1,1,"Yes"
"11487","C3_TF_targets","C3_TFT_422_V_HNF3_Q6",181,-1.0765,0.32,0.4,"No",-0.9071,0.69,0.95,"No"
"11488","C4_Cancer_gene_neighborhoods","C4_CGN_133_MORF_MYL3",69,-1.0765,0.33,0.55,"No",-1.3801,0.06,0.46,"No"
"11489","GO_BP","516484_GO_0071560_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",168,-1.0763,0.33,0.52,"No",-0.7697,0.97,1,"No"
"11490","C6_Oncogenic_signatures","C6_ALL_165_TBK1_DN_48HRS_UP",50,-1.0763,0.34,0.37,"No",0.929,0.58,0.9,"Yes"
"11491","C3_MicroRNA_targets","C3_MIR_39_GACTGTT_MIR_212_MIR_132",161,-1.0762,0.32,0.48,"No",0.8582,0.85,1,"Yes"
"11492","GO_BP","486573_GO_0000022_MITOTIC_SPINDLE_ELONGATION",8,-1.0762,0.38,0.52,"No",0.6964,0.86,1,"Yes"
"11493","GO_BP","492562_GO_0019835_CYTOLYSIS",23,-1.0762,0.36,0.52,"No",0.8311,0.72,1,"Yes"
"11494","KEGG_pathway","HSA05213_ENDOMETRIAL_CANCER",52,-1.0761,0.35,0.4,"No",0.5618,1,1,"Yes"
"11495","C2_Chemical_and_genetic_perturbations","C2_CGP_689_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12",11,-1.0759,0.36,0.45,"No",-0.7989,0.73,1,"No"
"11496","C6_Oncogenic_signatures","C6_ALL_93_ESC_J1_UP_EARLY_V1_DN",154,-1.0756,0.31,0.37,"No",-0.9264,0.65,0.86,"No"
"11497","KEGG_pathway","HSA05168_HERPES_SIMPLEX_INFECTION",176,-1.0756,0.33,0.4,"No",0.8297,0.91,1,"Yes"
"11498","GO_MF","517265_GO_0072349_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,-1.0754,0.38,0.55,"No",-1.4199,0.086,0.67,"No"
"11499","C3_TF_targets","C3_TFT_331_V_EFC_Q6",259,-1.0754,0.29,0.4,"No",-0.9302,0.66,0.91,"No"
"11500","GO_BP","849923_GO_1902222_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",9,-1.0754,0.38,0.52,"No",-0.8266,0.68,1,"No"
"11501","C2_Chemical_and_genetic_perturbations","C2_CGP_2818_WEBER_METHYLATED_ICP_IN_SPERM_DN",13,-1.0753,0.36,0.45,"No",1.1014,0.33,0.63,"Yes"
"11502","C2_Chemical_and_genetic_perturbations","C2_CGP_1434_GOLDRATH_IMMUNE_MEMORY",65,-1.0752,0.32,0.45,"No",-0.7577,0.89,1,"No"
"11503","GO_BP","492152_GO_0007389_PATTERN_SPECIFICATION_PROCESS",424,-1.0751,0.28,0.52,"No",-1.026,0.37,0.98,"No"
"11504","C7_Immunologic_signatures","C7_ALL_1529_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP",188,-1.075,0.29,0.41,"No",1.0778,0.26,0.51,"Yes"
"11505","C2_BioCarta_Pathways","C2_CP_BIOCARTA_111_BIOCARTA_LECTIN_PATHWAY",11,-1.075,0.38,0.48,"No",-1.1122,0.31,1,"No"
"11506","C7_Immunologic_signatures","C7_ALL_702_GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_DN",196,-1.0749,0.29,0.41,"No",1.5975,0,0.0032,"Yes"
"11507","C2_Chemical_and_genetic_perturbations","C2_CGP_2442_WANG_TUMOR_INVASIVENESS_UP",374,-1.0748,0.29,0.45,"No",2.0409,0,0.0039,"Yes"
"11508","GO_BP","519038_GO_2000398_REGULATION_OF_THYMOCYTE_AGGREGATION",23,-1.0748,0.37,0.52,"No",-1.1308,0.28,0.93,"No"
"11509","C3_TF_targets","C3_TFT_160_V_STAT1_01",67,-1.0747,0.33,0.41,"No",-0.7275,0.94,1,"No"
"11510","GO_BP","491379_GO_0006477_PROTEIN_SULFATION",6,-1.0747,0.39,0.52,"No",-0.4535,0.99,1,"No"
"11511","C2_Chemical_and_genetic_perturbations","C2_CGP_387_LAU_APOPTOSIS_CDKN2A_UP",55,-1.0747,0.33,0.45,"No",1.1475,0.22,0.56,"Yes"
"11512","C2_Chemical_and_genetic_perturbations","C2_CGP_245_MULLIGHAN_MLL_SIGNATURE_2_DN",279,-1.0745,0.31,0.45,"No",1.1267,0.15,0.59,"Yes"
"11513","C4_Cancer_modules","C4_CM_293_MODULE_334",163,-1.0744,0.32,0.46,"No",1.276,0.049,0.3,"Yes"
"11514","C3_TF_targets","C3_TFT_243_V_MEIS1BHOXA9_01",133,-1.0743,0.34,0.41,"No",1.074,0.27,1,"Yes"
"11515","GO_BP","488195_GO_0002322_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE",5,-1.0743,0.42,0.52,"No",-0.8867,0.61,1,"No"
"11516","GO_BP","752768_GO_0097267_OMEGA_HYDROXYLASE_P450_PATHWAY",9,-1.0741,0.38,0.52,"No",-1.0254,0.43,0.97,"No"
"11517","GO_BP","512746_GO_0051891_POSITIVE_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION",5,-1.074,0.39,0.52,"No",-1.0367,0.43,0.98,"No"
"11518","C2_Chemical_and_genetic_perturbations","C2_CGP_149_BORCZUK_MALIGNANT_MESOTHELIOMA_UP",305,-1.0737,0.3,0.45,"No",1.8804,0,0.023,"Yes"
"11519","C2_Chemical_and_genetic_perturbations","C2_CGP_1505_YU_MYC_TARGETS_DN",55,-1.0736,0.36,0.45,"No",-0.8659,0.7,1,"No"
"11520","GO_CC","486824_GO_0000307_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX",20,-1.0736,0.39,0.64,"No",-0.5778,0.98,1,"No"
"11521","GO_BP","509050_GO_0046827_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS",14,-1.0735,0.37,0.52,"No",-0.7248,0.83,1,"No"
"11522","GO_MF","500655_GO_0031404_CHLORIDE_ION_BINDING",5,-1.0734,0.41,0.56,"No",0.9908,0.48,0.89,"Yes"
"11523","C7_Immunologic_signatures","C7_ALL_933_GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP",190,-1.0732,0.3,0.42,"No",1.657,0,0.0012,"Yes"
"11524","C7_Immunologic_signatures","C7_ALL_1475_GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP",190,-1.0731,0.3,0.42,"No",1.3929,0.012,0.04,"Yes"
"11525","C7_Immunologic_signatures","C7_ALL_443_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP",196,-1.0731,0.31,0.42,"No",0.6668,1,1,"Yes"
"11526","GO_BP","501567_GO_0032332_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION",18,-1.073,0.39,0.52,"No",-0.992,0.47,1,"No"
"11527","C4_Cancer_gene_neighborhoods","C4_CGN_69_MORF_CASP10",113,-1.073,0.32,0.55,"No",-0.976,0.49,0.86,"No"
"11528","C2_Chemical_and_genetic_perturbations","C2_CGP_744_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",33,-1.0729,0.38,0.45,"No",1.4579,0.038,0.25,"Yes"
"11529","C3_TF_targets","C3_TFT_463_V_SP1_Q6_01",242,-1.0727,0.31,0.41,"No",-1.4664,0.0035,0.13,"No"
"11530","C2_Chemical_and_genetic_perturbations","C2_CGP_1637_LU_AGING_BRAIN_DN",153,-1.0727,0.32,0.45,"No",0.9553,0.55,0.86,"Yes"
"11531","C2_Chemical_and_genetic_perturbations","C2_CGP_2782_KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN",7,-1.0727,0.36,0.45,"No",0.8969,0.58,0.93,"Yes"
"11532","REACTOME","161033_REACT_20563_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS",41,-1.0727,0.36,0.55,"No",-0.8006,0.8,1,"No"
"11533","GO_BP","511900_GO_0050966_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN",9,-1.0727,0.38,0.52,"No",-1.1644,0.26,0.91,"No"
"11534","C7_Immunologic_signatures","C7_ALL_1250_GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN",181,-1.0726,0.31,0.42,"No",1.0726,0.23,0.52,"Yes"
"11535","GO_BP","494678_GO_0010614_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY",10,-1.0726,0.38,0.52,"No",-0.6552,0.92,1,"No"
"11536","GO_BP","497181_GO_0018210_PEPTIDYL_THREONINE_MODIFICATION",49,-1.0724,0.34,0.52,"No",-0.6182,0.99,1,"No"
"11537","GO_BP","513514_GO_0055081_ANION_HOMEOSTASIS",41,-1.0723,0.36,0.52,"No",-1.0758,0.34,0.95,"No"
"11538","REACTOME","105926_REACT_9480_GAP_JUNCTION_TRAFFICKING_AND_REGULATION",29,-1.0722,0.36,0.55,"No",-0.9117,0.59,1,"No"
"11539","GO_BP","505557_GO_0042416_DOPAMINE_BIOSYNTHETIC_PROCESS",10,-1.0721,0.38,0.52,"No",-1.0206,0.43,0.97,"No"
"11540","C3_TF_targets","C3_TFT_540_YAATNRNNNYNATT_UNKNOWN",101,-1.0721,0.35,0.41,"No",0.8505,0.81,1,"Yes"
"11541","GO_BP","752934_GO_0097435_FIBRIL_ORGANIZATION",16,-1.072,0.38,0.52,"No",0.5566,0.97,1,"Yes"
"11542","C7_Immunologic_signatures","C7_ALL_1845_GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP",200,-1.0719,0.32,0.42,"No",1.4569,0.0025,0.02,"Yes"
"11543","GO_BP","511663_GO_0050691_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST",30,-1.0719,0.38,0.52,"No",-1.0858,0.35,0.96,"No"
"11544","C2_Chemical_and_genetic_perturbations","C2_CGP_3102_GABRIELY_MIR21_TARGETS",289,-1.0719,0.31,0.45,"No",0.9529,0.63,0.86,"Yes"
"11545","C2_Chemical_and_genetic_perturbations","C2_CGP_2831_SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",82,-1.0718,0.34,0.45,"No",1.4279,0.024,0.28,"Yes"
"11546","C2_Chemical_and_genetic_perturbations","C2_CGP_1062_FRIDMAN_SENESCENCE_DN",12,-1.0718,0.39,0.45,"No",-1.1138,0.32,0.9,"No"
"11547","GO_BP","516483_GO_0071559_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA",168,-1.0717,0.32,0.52,"No",-0.7738,0.97,1,"No"
"11548","C7_Immunologic_signatures","C7_ALL_346_GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN",194,-1.0716,0.32,0.42,"No",0.7225,0.99,1,"Yes"
"11549","C7_Immunologic_signatures","C7_ALL_838_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN",182,-1.0716,0.32,0.42,"No",0.8109,0.92,1,"Yes"
"11550","GO_BP","501346_GO_0032109_POSITIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS",22,-1.0716,0.35,0.52,"No",-0.8499,0.66,1,"No"
"11551","GO_MF","493113_GO_0008889_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY",7,-1.0716,0.37,0.56,"No",1.2805,0.18,0.63,"Yes"
"11552","GO_BP","491155_GO_0006183_GTP_BIOSYNTHETIC_PROCESS",10,-1.0715,0.38,0.52,"No",-0.9088,0.57,1,"No"
"11553","C2_Chemical_and_genetic_perturbations","C2_CGP_3248_KOHOUTEK_CCNT2_TARGETS",57,-1.0713,0.34,0.45,"No",1.2394,0.14,0.45,"Yes"
"11554","GO_BP","496207_GO_0016114_TERPENOID_BIOSYNTHETIC_PROCESS",11,-1.0713,0.39,0.53,"No",-0.9422,0.54,1,"No"
"11555","C7_Immunologic_signatures","C7_ALL_313_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP",198,-1.0713,0.32,0.42,"No",1.0354,0.36,0.63,"Yes"
"11556","C7_Immunologic_signatures","C7_ALL_1093_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP",195,-1.0712,0.31,0.42,"No",1.4927,0,0.014,"Yes"
"11557","GO_BP","501760_GO_0032530_REGULATION_OF_MICROVILLUS_ORGANIZATION",6,-1.0711,0.42,0.53,"No",-0.6417,0.91,1,"No"
"11558","C2_BioCarta_Pathways","C2_CP_BIOCARTA_137_BIOCARTA_PLCE_PATHWAY",12,-1.071,0.39,0.49,"No",-0.879,0.62,1,"No"
"11559","GO_BP","513870_GO_0060314_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",27,-1.071,0.37,0.53,"No",1.3256,0.11,0.64,"Yes"
"11560","GO_BP","516391_GO_0071467_CELLULAR_RESPONSE_TO_PH",16,-1.0708,0.38,0.53,"No",-1.4986,0.064,0.81,"No"
"11561","GO_BP","510277_GO_0048147_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION",28,-1.0707,0.37,0.53,"No",0.9373,0.56,1,"Yes"
"11562","GO_BP","503843_GO_0034643_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED",9,-1.0707,0.4,0.53,"No",-0.9451,0.53,1,"No"
"11563","GO_MF","503391_GO_0034185_APOLIPOPROTEIN_BINDING",16,-1.0707,0.37,0.56,"No",0.8857,0.59,0.99,"Yes"
"11564","C7_Immunologic_signatures","C7_ALL_690_GSE17721_LPS_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-1.0706,0.33,0.42,"No",0.8711,0.84,1,"Yes"
"11565","WikiPathways","920968_WP2112_IL17_SIGNALING_PATHWAY",29,-1.0706,0.36,0.46,"No",-0.5032,1,1,"No"
"11566","GO_MF","499678_GO_0030274_LIM_DOMAIN_BINDING",7,-1.0705,0.39,0.56,"No",-0.8368,0.67,1,"No"
"11567","GO_BP","513454_GO_0055021_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH",36,-1.0705,0.36,0.53,"No",0.7334,0.9,1,"Yes"
"11568","GO_BP","492655_GO_0008344_ADULT_LOCOMOTORY_BEHAVIOR",78,-1.0705,0.35,0.53,"No",-1.0098,0.43,0.98,"No"
"11569","GO_CC","502487_GO_0033268_NODE_OF_RANVIER",16,-1.0704,0.37,0.64,"No",-1.2935,0.15,0.67,"No"
"11570","GO_CC","925891_GO_0098562_CYTOPLASMIC_SIDE_OF_MEMBRANE",66,-1.0702,0.34,0.64,"No",0.8348,0.8,0.93,"Yes"
"11571","GO_BP","504741_GO_0035561_REGULATION_OF_CHROMATIN_BINDING",9,-1.0702,0.37,0.53,"No",-1.2774,0.2,0.89,"No"
"11572","GO_BP","494903_GO_0010839_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION",12,-1.0701,0.36,0.53,"No",-1.2374,0.21,0.9,"No"
"11573","C6_Oncogenic_signatures","C6_ALL_81_BRCA1_DN_V1_DN",133,-1.0699,0.34,0.38,"No",-1.3039,0.041,0.36,"No"
"11574","C2_Chemical_and_genetic_perturbations","C2_CGP_1722_JI_RESPONSE_TO_FSH_DN",58,-1.0699,0.37,0.46,"No",1.3883,0.048,0.3,"Yes"
"11575","REACTOME","730306_REACT_150180_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES",54,-1.0698,0.35,0.55,"No",-1.2944,0.082,0.67,"No"
"11576","C2_Chemical_and_genetic_perturbations","C2_CGP_3089_FIGUEROA_AML_METHYLATION_CLUSTER_6_DN",35,-1.0698,0.36,0.46,"No",1.0934,0.31,0.64,"Yes"
"11577","GO_BP","515355_GO_0070423_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY",29,-1.0698,0.35,0.53,"No",0.8442,0.72,1,"Yes"
"11578","GO_BP","488699_GO_0002826_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE",6,-1.0696,0.37,0.53,"No",0.9141,0.57,1,"Yes"
"11579","GO_CC","487078_GO_0000785_CHROMATIN",414,-1.0695,0.29,0.64,"No",-1.2579,0.016,0.68,"No"
"11580","GO_BP","494933_GO_0010869_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS",20,-1.0694,0.37,0.53,"No",1.3583,0.089,0.6,"Yes"
"11581","GO_BP","503536_GO_0034333_ADHERENS_JUNCTION_ASSEMBLY",32,-1.0693,0.38,0.53,"No",-1.3895,0.084,1,"No"
"11582","GO_BP","501899_GO_0032673_REGULATION_OF_INTERLEUKIN_4_PRODUCTION",26,-1.0692,0.37,0.53,"No",0.9337,0.57,1,"Yes"
"11583","GO_MF","504439_GO_0035255_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING",19,-1.0692,0.38,0.56,"No",-1.274,0.17,0.82,"No"
"11584","C7_Immunologic_signatures","C7_ALL_1177_GSE27786_BCELL_VS_CD4_TCELL_UP",200,-1.0692,0.32,0.42,"No",0.7988,0.96,1,"Yes"
"11585","C1_Positional","C1_ALL_106_CHR5Q31",199,-1.0692,0.35,0.91,"No",1.2429,0.041,0.58,"Yes"
"11586","GO_BP","504780_GO_0035601_PROTEIN_DEACYLATION",46,-1.0692,0.35,0.53,"No",-1.143,0.24,0.93,"No"
"11587","C1_Positional","C1_ALL_214_CHR2Q33",93,-1.0692,0.34,0.9,"No",1.0125,0.42,0.74,"Yes"
"11588","GO_MF","492677_GO_0008374_O_ACYLTRANSFERASE_ACTIVITY",38,-1.0691,0.37,0.56,"No",-0.9562,0.52,0.95,"No"
"11589","C2_Chemical_and_genetic_perturbations","C2_CGP_2027_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4",297,-1.069,0.3,0.46,"No",1.0585,0.3,0.7,"Yes"
"11590","C1_Positional","C1_ALL_246_CHR13Q33",18,-1.0689,0.37,0.89,"No",-1.5246,0.026,0.53,"No"
"11591","GO_BP","503788_GO_0034587_PIRNA_METABOLIC_PROCESS",27,-1.0689,0.38,0.53,"No",1.175,0.25,0.81,"Yes"
"11592","GO_BP","486906_GO_0000413_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION",41,-1.0689,0.38,0.53,"No",1.2894,0.095,0.69,"Yes"
"11593","C7_Immunologic_signatures","C7_ALL_373_GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP",186,-1.0689,0.32,0.43,"No",0.9917,0.49,0.76,"Yes"
"11594","GO_BP","514156_GO_0060601_LATERAL_SPROUTING_FROM_AN_EPITHELIUM",7,-1.0688,0.36,0.53,"No",1.276,0.21,0.7,"Yes"
"11595","C3_TF_targets","C3_TFT_227_CCCNNNNNNAAGWT_UNKNOWN",102,-1.0688,0.35,0.42,"No",1.1844,0.14,0.74,"Yes"
"11596","C3_TF_targets","C3_TFT_501_MYAATNNNNNNNGGC_UNKNOWN",108,-1.0687,0.34,0.42,"No",-0.8006,0.89,1,"No"
"11597","C7_Immunologic_signatures","C7_ALL_422_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN",199,-1.0686,0.33,0.43,"No",1.0921,0.23,0.47,"Yes"
"11598","REACTOME","161015_REACT_22387_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS",52,-1.0686,0.36,0.56,"No",-0.5699,0.98,1,"No"
"11599","GO_BP","518301_GO_0090161_GOLGI_RIBBON_FORMATION",9,-1.0685,0.38,0.53,"No",0.7522,0.78,1,"Yes"
"11600","GO_BP","515914_GO_0070988_DEMETHYLATION",62,-1.0684,0.36,0.53,"No",-1.3626,0.047,0.97,"No"
"11601","GO_BP","496270_GO_0016188_SYNAPTIC_VESICLE_MATURATION",8,-1.0684,0.37,0.53,"No",-1.108,0.36,0.94,"No"
"11602","GO_BP","487791_GO_0001895_RETINA_HOMEOSTASIS",60,-1.0684,0.37,0.53,"No",1.3443,0.048,0.61,"Yes"
"11603","C2_Chemical_and_genetic_perturbations","C2_CGP_3234_SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP",25,-1.0684,0.39,0.46,"No",-0.7736,0.8,1,"No"
"11604","GO_BP","489115_GO_0003323_TYPE_B_PANCREATIC_CELL_DEVELOPMENT",11,-1.0683,0.37,0.53,"No",0.9702,0.49,1,"Yes"
"11605","C2_Chemical_and_genetic_perturbations","C2_CGP_310_KIM_WT1_TARGETS_12HR_DN",209,-1.0681,0.33,0.46,"No",1.3978,0.0093,0.29,"Yes"
"11606","C2_Chemical_and_genetic_perturbations","C2_CGP_3391_ZWANG_EGF_PERSISTENTLY_DN",61,-1.0681,0.35,0.46,"No",-0.9352,0.57,1,"No"
"11607","GO_BP","491260_GO_0006301_POSTREPLICATION_REPAIR",24,-1.068,0.36,0.53,"No",-0.7027,0.9,1,"No"
"11608","C2_Chemical_and_genetic_perturbations","C2_CGP_3152_KIM_PTEN_TARGETS_UP",18,-1.0677,0.36,0.46,"No",1.3761,0.1,0.31,"Yes"
"11609","C2_Chemical_and_genetic_perturbations","C2_CGP_3332_PECE_MAMMARY_STEM_CELL_DN",156,-1.0676,0.33,0.46,"No",0.9061,0.73,0.92,"Yes"
"11610","C1_Positional","C1_ALL_305_CHR18P11",72,-1.0676,0.36,0.89,"No",0.9845,0.52,0.78,"Yes"
"11611","GO_BP","500485_GO_0031223_AUDITORY_BEHAVIOR",8,-1.0675,0.39,0.53,"No",-0.99,0.46,1,"No"
"11612","GO_MF","511653_GO_0050681_ANDROGEN_RECEPTOR_BINDING",39,-1.0675,0.37,0.57,"No",0.6783,0.96,1,"Yes"
"11613","GO_BP","491719_GO_0006851_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT",9,-1.0674,0.38,0.53,"No",1.0161,0.44,0.97,"Yes"
"11614","C2_Chemical_and_genetic_perturbations","C2_CGP_2921_MIKKELSEN_NPC_ICP_WITH_H3K4ME3",442,-1.0673,0.31,0.46,"No",0.86,0.94,0.96,"Yes"
"11615","GO_MF","499699_GO_0030296_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY",14,-1.0673,0.38,0.57,"No",-0.9304,0.56,0.97,"No"
"11616","GO_BP","494724_GO_0010661_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS",14,-1.0673,0.37,0.53,"No",0.7911,0.74,1,"Yes"
"11617","C3_TF_targets","C3_TFT_493_GTTGNYNNRGNAAC_UNKNOWN",106,-1.0673,0.34,0.42,"No",0.9341,0.62,1,"Yes"
"11618","C2_Chemical_and_genetic_perturbations","C2_CGP_450_GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN",8,-1.0673,0.37,0.46,"No",1.3532,0.13,0.34,"Yes"
"11619","KEGG_compound","C00129_ISOPENTENYL_DIPHOSPHATE_DELTA3_ISOPENTENYL_DIPHOSPHATE_DELTA3_METHYL_3_BUTENYL_DIPHOSPHATE",9,-1.0671,0.4,0.54,"No",-0.7199,0.86,1,"No"
"11620","GO_MF","496633_GO_0016712_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",30,-1.0671,0.35,0.57,"No",-1.4928,0.029,0.58,"No"
"11621","REACTOME","833814_REACT_163699_SCAVENGING_BY_CLASS_A_RECEPTORS",19,-1.067,0.35,0.56,"No",0.9438,0.52,0.84,"Yes"
"11622","C2_Chemical_and_genetic_perturbations","C2_CGP_796_KANG_GIST_WITH_PDGFRA_UP",50,-1.0669,0.36,0.46,"No",0.7442,0.9,1,"Yes"
"11623","C6_Oncogenic_signatures","C6_ALL_187_KRAS_PROSTATE_UP_V1_UP",128,-1.0669,0.34,0.38,"No",-1.1003,0.24,0.57,"No"
"11624","GO_BP","491455_GO_0006559_L_PHENYLALANINE_CATABOLIC_PROCESS",9,-1.0669,0.39,0.53,"No",-0.8227,0.72,1,"No"
"11625","KEGG_compound","C04253_ELECTRON_TRANSFERRING_FLAVOPROTEIN_ELECTRON_TRANSFER_FLAVOPROTEIN",5,-1.0669,0.42,0.54,"No",0.6448,0.86,1,"Yes"
"11626","C2_Chemical_and_genetic_perturbations","C2_CGP_4_WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN",20,-1.0668,0.38,0.46,"No",-1.2575,0.16,0.74,"No"
"11627","GO_BP","983711_GO_1902992_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",8,-1.0668,0.39,0.53,"No",-0.7435,0.79,1,"No"
"11628","C7_Immunologic_signatures","C7_ALL_1750_GSE6269_FLU_VS_E_COLI_INF_PBMC_DN",151,-1.0668,0.31,0.43,"No",1.9371,0,0,"Yes"
"11629","C7_Immunologic_signatures","C7_ALL_1096_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN",199,-1.0667,0.32,0.43,"No",-0.6833,1,1,"No"
"11630","GO_CC","499808_GO_0030430_HOST_CELL_CYTOPLASM",5,-1.0662,0.41,0.65,"No",-1.0618,0.39,0.82,"No"
"11631","GO_BP","507472_GO_0045072_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS",16,-1.066,0.38,0.53,"No",-0.613,0.94,1,"No"
"11632","KEGG_pathway","HSA05220_CHRONIC_MYELOID_LEUKEMIA",73,-1.066,0.35,0.41,"No",-0.6089,1,1,"No"
"11633","GO_BP","517126_GO_0072210_METANEPHRIC_NEPHRON_DEVELOPMENT",34,-1.066,0.36,0.53,"No",0.8322,0.73,1,"Yes"
"11634","GO_CC","488067_GO_0002178_PALMITOYLTRANSFERASE_COMPLEX",8,-1.066,0.39,0.65,"No",-0.9435,0.53,0.9,"No"
"11635","C2_Chemical_and_genetic_perturbations","C2_CGP_2440_ZHOU_PANCREATIC_BETA_CELL",10,-1.0659,0.4,0.46,"No",0.9348,0.52,0.89,"Yes"
"11636","C1_Positional","C1_ALL_274_CHR1Q22",76,-1.0659,0.34,0.88,"No",-1.0887,0.28,1,"No"
"11637","C7_Immunologic_signatures","C7_ALL_1729_GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP",200,-1.0658,0.32,0.43,"No",0.7067,1,1,"Yes"
"11638","KEGG_pathway","HSA00860_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM",42,-1.0657,0.36,0.41,"No",1.8469,0,0.0087,"Yes"
"11639","C3_TF_targets","C3_TFT_307_V_STAT5A_04",207,-1.0657,0.33,0.42,"No",0.878,0.79,1,"Yes"
"11640","C7_Immunologic_signatures","C7_ALL_711_GSE17721_0_5H_VS_8H_LPS_BMDM_UP",197,-1.0656,0.32,0.43,"No",1.2652,0.047,0.14,"Yes"
"11641","REACTOME","106325_REACT_9431_METABOLISM_OF_PORPHYRINS",17,-1.0653,0.39,0.56,"No",0.9369,0.54,0.85,"Yes"
"11642","C7_Immunologic_signatures","C7_ALL_1429_GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP",198,-1.065,0.35,0.43,"No",1.4089,0.005,0.035,"Yes"
"11643","C7_Immunologic_signatures","C7_ALL_872_GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN",197,-1.065,0.33,0.43,"No",1.4107,0,0.034,"Yes"
"11644","GO_BP","515997_GO_0071071_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS",11,-1.065,0.38,0.53,"No",0.8305,0.64,1,"Yes"
"11645","GO_MF","487204_GO_0000980_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING",57,-1.0649,0.36,0.57,"No",-1.2709,0.12,0.82,"No"
"11646","GO_BP","510766_GO_0048711_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION",10,-1.0649,0.4,0.53,"No",-1.1967,0.25,0.89,"No"
"11647","GO_CC","513634_GO_0060076_EXCITATORY_SYNAPSE",22,-1.0649,0.38,0.65,"No",-1.3237,0.13,0.65,"No"
"11648","KEGG_compound","C04570_REDUCED_ELECTRON_TRANSFERRING_FLAVOPROTEIN_REDUCED_ELECTRON_TRANSFER_FLAVOPROTEIN",5,-1.0648,0.41,0.54,"No",0.6764,0.85,1,"Yes"
"11649","C3_TF_targets","C3_TFT_464_V_SP1_Q4_01",256,-1.0647,0.34,0.42,"No",-1.3772,0.015,0.19,"No"
"11650","OMIM_gene","OMIM602621_COXSACKIEVIRUS_AND_ADENOVIRUS_RECEPTOR_CXADR",6,-1.0647,0.39,0.83,"No",-1.0454,0.42,0.76,"No"
"11651","GO_BP","494866_GO_0010801_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION",13,-1.0646,0.39,0.53,"No",1.1918,0.24,0.79,"Yes"
"11652","C4_Cancer_gene_neighborhoods","C4_CGN_279_CAR_MYST2",26,-1.0645,0.37,0.57,"No",-1.1806,0.23,0.69,"No"
"11653","GO_BP","518470_GO_0090330_REGULATION_OF_PLATELET_AGGREGATION",12,-1.0644,0.4,0.53,"No",1.2828,0.17,0.7,"Yes"
"11654","C2_Chemical_and_genetic_perturbations","C2_CGP_915_FURUKAWA_DUSP6_TARGETS_PCI35_UP",72,-1.0644,0.36,0.46,"No",0.9931,0.43,0.81,"Yes"
"11655","GO_BP","504928_GO_0035751_REGULATION_OF_LYSOSOMAL_LUMEN_PH",5,-1.0644,0.42,0.53,"No",-0.5898,0.93,1,"No"
"11656","GO_BP","503962_GO_0034763_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT",62,-1.0643,0.35,0.53,"No",1.0747,0.33,0.93,"Yes"
"11657","GO_MF","754628_GO_1901677_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",24,-1.0641,0.36,0.57,"No",-0.8241,0.74,1,"No"
"11658","GO_BP","1129564_GO_1903749_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",92,-1.0641,0.37,0.53,"No",1.24,0.11,0.75,"Yes"
"11659","GO_CC","492610_GO_0008287_PROTEIN_SERINE_THREONINE_PHOSPHATASE_COMPLEX",45,-1.0641,0.37,0.65,"No",-0.7856,0.83,1,"No"
"11660","C1_Positional","C1_ALL_89_CHR14Q23",47,-1.064,0.36,0.88,"No",0.7579,0.87,0.98,"Yes"
"11661","GO_BP","488703_GO_0002830_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE",12,-1.064,0.38,0.54,"No",0.9332,0.53,1,"Yes"
"11662","GO_MF","487449_GO_0004197_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",102,-1.0639,0.34,0.57,"No",-0.7741,0.92,1,"No"
"11663","C3_TF_targets","C3_TFT_491_GTCNYYATGR_UNKNOWN",111,-1.0639,0.34,0.43,"No",-0.9901,0.48,0.78,"No"
"11664","C2_Chemical_and_genetic_perturbations","C2_CGP_908_KREPPEL_CD99_TARGETS_DN",8,-1.0639,0.39,0.47,"No",-0.5918,0.93,1,"No"
"11665","REACTOME","530745_REACT_115828_DOWNREGULATION_OF_ERBB4_SIGNALING",8,-1.0638,0.38,0.56,"No",1.5016,0.057,0.14,"Yes"
"11666","C2_Chemical_and_genetic_perturbations","C2_CGP_1396_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN",21,-1.0637,0.36,0.47,"No",1.4119,0.089,0.29,"Yes"
"11667","GO_BP","494886_GO_0010822_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION",136,-1.0637,0.35,0.54,"No",1.2799,0.051,0.7,"Yes"
"11668","C1_Positional","C1_ALL_186_CHR4P15",47,-1.0634,0.36,0.87,"No",0.8136,0.77,0.93,"Yes"
"11669","GO_MF","489282_GO_0003755_PEPTIDYL_PROLYL_CIS_TRANS_ISOMERASE_ACTIVITY",41,-1.0634,0.37,0.57,"No",1.3064,0.09,0.6,"Yes"
"11670","C4_Cancer_modules","C4_CM_137_MODULE_145",108,-1.0633,0.34,0.48,"No",0.9299,0.64,0.8,"Yes"
"11671","GO_BP","495191_GO_0014743_REGULATION_OF_MUSCLE_HYPERTROPHY",30,-1.0633,0.38,0.54,"No",-0.6677,0.93,1,"No"
"11672","C2_Chemical_and_genetic_perturbations","C2_CGP_194_OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN",267,-1.0632,0.33,0.47,"No",1.2434,0.042,0.45,"Yes"
"11673","GO_MF","490375_GO_0005109_FRIZZLED_BINDING",37,-1.0632,0.38,0.57,"No",-1.4007,0.058,0.63,"No"
"11674","GO_MF","490288_GO_0005001_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY",17,-1.0631,0.38,0.57,"No",1.4346,0.062,0.45,"Yes"
"11675","C1_Positional","C1_ALL_116_CHR13Q34",37,-1.0631,0.36,0.87,"No",-1.1937,0.2,1,"No"
"11676","GO_MF","501684_GO_0032452_HISTONE_DEMETHYLASE_ACTIVITY",33,-1.0628,0.36,0.57,"No",-1.6181,0.015,0.45,"No"
"11677","C2_Chemical_and_genetic_perturbations","C2_CGP_1489_BROWN_MYELOID_CELL_DEVELOPMENT_DN",129,-1.0626,0.35,0.47,"No",1.0638,0.29,0.69,"Yes"
"11678","OMIM_gene","OMIM103220_SOLUTE_CARRIER_FAMILY_25_MITOCHONDRIAL_CARRIER_ADENINE_NUCLEOTIDE_TRANSLOCATOR_MEMBER_4_SLC25A4",5,-1.0625,0.42,0.81,"No",-0.7545,0.75,1,"No"
"11679","GO_BP","946557_GO_0098900_REGULATION_OF_ACTION_POTENTIAL",30,-1.0625,0.39,0.54,"No",-1.2332,0.14,0.9,"No"
"11680","GO_MF","496624_GO_0016702_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN_INCORPORATION_OF_TWO_ATOMS_OF_OXYGEN",25,-1.0625,0.36,0.57,"No",-0.8256,0.74,1,"No"
"11681","C2_Chemical_and_genetic_perturbations","C2_CGP_2639_MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED",23,-1.0625,0.38,0.47,"No",-1.1864,0.21,0.81,"No"
"11682","C7_Immunologic_signatures","C7_ALL_476_GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN",198,-1.0624,0.31,0.44,"No",0.7867,0.98,1,"Yes"
"11683","GO_BP","488951_GO_0003157_ENDOCARDIUM_DEVELOPMENT",11,-1.0624,0.4,0.54,"No",-0.7311,0.81,1,"No"
"11684","GO_BP","491991_GO_0007191_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",11,-1.0623,0.39,0.54,"No",1.3347,0.15,0.62,"Yes"
"11685","GO_CC","496436_GO_0016459_MYOSIN_COMPLEX",62,-1.0623,0.36,0.65,"No",-1.0746,0.34,0.81,"No"
"11686","C2_Chemical_and_genetic_perturbations","C2_CGP_2405_KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION",32,-1.0623,0.37,0.47,"No",0.9283,0.57,0.89,"Yes"
"11687","GO_BP","498079_GO_0019227_NEURONAL_ACTION_POTENTIAL_PROPAGATION",8,-1.0623,0.39,0.54,"No",-0.7336,0.82,1,"No"
"11688","GO_BP","492888_GO_0008645_HEXOSE_TRANSPORT",72,-1.0623,0.38,0.54,"No",0.9207,0.62,1,"Yes"
"11689","C3_TF_targets","C3_TFT_172_CATRRAGC_UNKNOWN",133,-1.0622,0.37,0.43,"No",0.9946,0.5,1,"Yes"
"11690","C3_TF_targets","C3_TFT_280_V_AP2GAMMA_01",248,-1.062,0.31,0.43,"No",-1.2605,0.047,0.26,"No"
"11691","GO_BP","492267_GO_0048535_LYMPH_NODE_DEVELOPMENT",17,-1.0619,0.37,0.54,"No",0.6584,0.92,1,"Yes"
"11692","C1_Positional","C1_ALL_137_CHR13Q22",16,-1.0619,0.37,0.86,"No",-0.8909,0.61,1,"No"
"11693","GO_MF","504438_GO_0035254_GLUTAMATE_RECEPTOR_BINDING",31,-1.0619,0.36,0.57,"No",-1.3576,0.081,0.69,"No"
"11694","KEGG_pathway","HSA05210_COLORECTAL_CANCER",62,-1.0619,0.36,0.42,"No",-0.8035,0.85,0.99,"No"
"11695","C4_Cancer_gene_neighborhoods","C4_CGN_159_MORF_PTPN9",58,-1.0618,0.35,0.58,"No",-0.8414,0.74,1,"No"
"11696","C4_Cancer_gene_neighborhoods","C4_CGN_226_GCM_DLG1",77,-1.0617,0.37,0.57,"No",0.7324,0.96,1,"Yes"
"11697","GO_BP","492035_GO_0007256_ACTIVATION_OF_JNKK_ACTIVITY",6,-1.0617,0.41,0.54,"No",-0.892,0.59,1,"No"
"11698","GO_MF","490520_GO_0005313_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.0617,0.38,0.57,"No",0.9664,0.47,0.91,"Yes"
"11699","GO_CC","503566_GO_0034364_HIGH_DENSITY_LIPOPROTEIN_PARTICLE",25,-1.0616,0.35,0.65,"No",0.9658,0.51,0.83,"Yes"
"11700","C2_Chemical_and_genetic_perturbations","C2_CGP_2035_LOPES_METHYLATED_IN_COLON_CANCER_DN",28,-1.0616,0.38,0.47,"No",0.9366,0.52,0.88,"Yes"
"11701","REACTOME","161061_REACT_19140_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1",24,-1.0616,0.38,0.57,"No",0.7713,0.84,1,"Yes"
"11702","C3_MicroRNA_targets","C3_MIR_190_CAGTCAC_MIR_134",52,-1.0616,0.35,0.52,"No",0.6372,0.97,1,"Yes"
"11703","C2_Chemical_and_genetic_perturbations","C2_CGP_82_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP",43,-1.0615,0.36,0.47,"No",0.6967,0.95,1,"Yes"
"11704","GO_BP","491515_GO_0006622_PROTEIN_TARGETING_TO_LYSOSOME",13,-1.0615,0.39,0.54,"No",0.7813,0.78,1,"Yes"
"11705","KEGG_pathway","HSA00532_GLYCOSAMINOGLYCAN_BIOSYNTHESIS",20,-1.0614,0.35,0.42,"No",0.4552,1,1,"Yes"
"11706","C2_Chemical_and_genetic_perturbations","C2_CGP_739_AIYAR_COBRA1_TARGETS_DN",28,-1.0614,0.37,0.47,"No",0.9465,0.52,0.87,"Yes"
"11707","C2_Chemical_and_genetic_perturbations","C2_CGP_2967_MURAKAMI_UV_RESPONSE_1HR_UP",15,-1.0614,0.38,0.47,"No",1.6139,0.02,0.13,"Yes"
"11708","GO_BP","487981_GO_0002092_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION",20,-1.0613,0.38,0.54,"No",-0.6726,0.91,1,"No"
"11709","C7_Immunologic_signatures","C7_ALL_511_GSE17721_CTRL_VS_GARDIQUIMOD_0_5H_BMDM_UP",200,-1.061,0.33,0.44,"No",1.0706,0.25,0.52,"Yes"
"11710","GO_BP","507418_GO_0045008_DEPYRIMIDINATION",5,-1.061,0.43,0.54,"No",1.3812,0.13,0.57,"Yes"
"11711","GO_BP","491954_GO_0007141_MALE_MEIOSIS_I",16,-1.0607,0.38,0.54,"No",-0.757,0.8,1,"No"
"11712","GO_BP","499620_GO_0030210_HEPARIN_BIOSYNTHETIC_PROCESS",8,-1.0606,0.38,0.54,"No",0.8056,0.72,1,"Yes"
"11713","GO_MF","496868_GO_0017046_PEPTIDE_HORMONE_BINDING",35,-1.0604,0.37,0.57,"No",1.5603,0.028,0.33,"Yes"
"11714","C1_Positional","C1_ALL_44_CHR3P14",41,-1.0604,0.37,0.86,"No",1.2979,0.087,0.53,"Yes"
"11715","C2_Chemical_and_genetic_perturbations","C2_CGP_1924_NIELSEN_LEIOMYOSARCOMA_CNN1_UP",19,-1.0601,0.37,0.47,"No",-0.8852,0.61,1,"No"
"11716","C3_MicroRNA_targets","C3_MIR_124_GCAAGAC_MIR_431",45,-1.06,0.36,0.52,"No",0.7629,0.88,1,"Yes"
"11717","C4_Cancer_gene_neighborhoods","C4_CGN_144_MORF_PML",140,-1.0599,0.35,0.57,"No",-0.9875,0.51,0.87,"No"
"11718","C2_Chemical_and_genetic_perturbations","C2_CGP_2196_OSADA_ASCL1_TARGETS_UP",43,-1.0598,0.36,0.47,"No",-0.781,0.84,1,"No"
"11719","C2_Chemical_and_genetic_perturbations","C2_CGP_2127_KONDO_EZH2_TARGETS",239,-1.0598,0.33,0.47,"No",1.1649,0.11,0.53,"Yes"
"11720","GO_CC","502240_GO_0033018_SARCOPLASMIC_RETICULUM_LUMEN",8,-1.0598,0.38,0.65,"No",-0.8317,0.69,0.99,"No"
"11721","REACTOME","645327_REACT_121280_SYNTHESIS_OF_PG",8,-1.0597,0.38,0.57,"No",0.8025,0.73,1,"Yes"
"11722","C7_Immunologic_signatures","C7_ALL_455_GSE17721_CTRL_VS_LPS_6H_BMDM_UP",200,-1.0595,0.35,0.45,"No",1.1107,0.18,0.42,"Yes"
"11723","C2_Chemical_and_genetic_perturbations","C2_CGP_2493_JU_AGING_TERC_TARGETS_UP",9,-1.0595,0.4,0.47,"No",0.9214,0.54,0.9,"Yes"
"11724","GO_BP","753037_GO_1900040_REGULATION_OF_INTERLEUKIN_2_SECRETION",7,-1.0595,0.4,0.54,"No",-0.9476,0.53,1,"No"
"11725","C4_Cancer_modules","C4_CM_57_MODULE_61",50,-1.0593,0.35,0.49,"No",1.2374,0.13,0.34,"Yes"
"11726","GO_BP","496864_GO_0046886_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS",9,-1.0591,0.38,0.54,"No",1.0941,0.35,0.91,"Yes"
"11727","C2_Chemical_and_genetic_perturbations","C2_CGP_1145_AMIT_SERUM_RESPONSE_20_MCF10A",21,-1.0589,0.37,0.47,"No",1.1543,0.22,0.55,"Yes"
"11728","GO_CC","501370_GO_0032133_CHROMOSOME_PASSENGER_COMPLEX",5,-1.0589,0.41,0.65,"No",-1.0007,0.49,0.87,"No"
"11729","C7_Immunologic_signatures","C7_ALL_1738_GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN",197,-1.0589,0.34,0.45,"No",1.8129,0,2.9e-05,"Yes"
"11730","GO_BP","491687_GO_0006818_HYDROGEN_TRANSPORT",119,-1.0588,0.35,0.54,"No",1.7812,0,0.12,"Yes"
"11731","C7_Immunologic_signatures","C7_ALL_1589_GSE3982_EOSINOPHIL_VS_MAC_UP",193,-1.0587,0.35,0.45,"No",-0.7768,0.97,1,"No"
"11732","C4_Cancer_modules","C4_CM_44_MODULE_48",317,-1.0585,0.34,0.49,"No",-0.9344,0.65,0.88,"No"
"11733","GO_MF","492536_GO_0008194_UDP_GLYCOSYLTRANSFERASE_ACTIVITY",133,-1.0585,0.35,0.57,"No",1.1568,0.14,0.74,"Yes"
"11734","C7_Immunologic_signatures","C7_ALL_633_GSE17721_POLYIC_VS_CPG_24H_BMDM_UP",194,-1.0584,0.36,0.45,"No",1.3894,0.012,0.041,"Yes"
"11735","C2_Chemical_and_genetic_perturbations","C2_CGP_1989_SUZUKI_RESPONSE_TO_TSA",21,-1.0584,0.41,0.47,"No",0.6851,0.9,1,"Yes"
"11736","GO_CC","486679_GO_0000145_EXOCYST",17,-1.0583,0.39,0.65,"No",-0.8926,0.63,0.95,"No"
"11737","GO_BP","1129254_GO_0089711_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT",13,-1.0583,0.4,0.54,"No",0.9759,0.46,1,"Yes"
"11738","GO_MF","500947_GO_0031701_ANGIOTENSIN_RECEPTOR_BINDING",11,-1.0582,0.41,0.57,"No",1.4035,0.091,0.47,"Yes"
"11739","C7_Immunologic_signatures","C7_ALL_414_GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN",196,-1.0581,0.34,0.45,"No",1.1501,0.14,0.32,"Yes"
"11740","C1_Positional","C1_ALL_280_CHR8Q11",22,-1.0581,0.37,0.86,"No",0.7581,0.85,0.98,"Yes"
"11741","GO_BP","489306_GO_0030042_ACTIN_FILAMENT_DEPOLYMERIZATION",8,-1.058,0.4,0.54,"No",-1.0876,0.36,0.95,"No"
"11742","C3_TF_targets","C3_TFT_211_V_ZF5_B",233,-1.0579,0.34,0.44,"No",-1.1692,0.13,0.41,"No"
"11743","GO_BP","505330_GO_0042168_HEME_METABOLIC_PROCESS",30,-1.0579,0.39,0.54,"No",1.0745,0.36,0.93,"Yes"
"11744","GO_BP","493568_GO_0009395_PHOSPHOLIPID_CATABOLIC_PROCESS",25,-1.0578,0.38,0.54,"No",-0.6312,0.95,1,"No"
"11745","C2_Chemical_and_genetic_perturbations","C2_CGP_697_LUI_THYROID_CANCER_CLUSTER_1",51,-1.0578,0.37,0.48,"No",-1.1727,0.21,0.82,"No"
"11746","C7_Immunologic_signatures","C7_ALL_524_GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_DN",192,-1.0578,0.34,0.45,"No",1.1936,0.095,0.24,"Yes"
"11747","C2_Chemical_and_genetic_perturbations","C2_CGP_1511_WANG_TARGETS_OF_MLL_CBP_FUSION_DN",45,-1.0578,0.36,0.47,"No",1.1402,0.26,0.57,"Yes"
"11748","C2_Chemical_and_genetic_perturbations","C2_CGP_1894_BURTON_ADIPOGENESIS_11",57,-1.0575,0.36,0.48,"No",0.839,0.77,0.98,"Yes"
"11749","C3_TF_targets","C3_TFT_469_GGCNNMSMYNTTG_UNKNOWN",75,-1.0575,0.37,0.44,"No",1.3486,0.042,0.4,"Yes"
"11750","GO_MF","492492_GO_0008138_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",42,-1.0574,0.36,0.57,"No",0.8186,0.77,1,"Yes"
"11751","GO_MF","509161_GO_0046970_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H4_K16_SPECIFIC_",12,-1.0574,0.4,0.57,"No",-1.1912,0.27,0.79,"No"
"11752","C7_Immunologic_signatures","C7_ALL_778_GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN",199,-1.0573,0.36,0.45,"No",-1.0277,0.39,1,"No"
"11753","GO_BP","499239_GO_0021960_ANTERIOR_COMMISSURE_MORPHOGENESIS",6,-1.0573,0.41,0.55,"No",1.0017,0.45,0.98,"Yes"
"11754","GO_BP","487613_GO_0001710_MESODERMAL_CELL_FATE_COMMITMENT",13,-1.0573,0.4,0.55,"No",1.3568,0.11,0.6,"Yes"
"11755","GO_BP","491265_GO_0006306_DNA_METHYLATION",71,-1.0572,0.36,0.55,"No",-1.714,0,0.72,"No"
"11756","C1_Positional","C1_ALL_310_CHR6P",8,-1.0572,0.39,0.85,"No",-1.5383,0.045,0.59,"No"
"11757","C7_Immunologic_signatures","C7_ALL_411_GSE15930_STIM_VS_STIM_AND_IL_12_24H_CD8_T_CELL_UP",198,-1.0572,0.36,0.45,"No",1.7088,0,0.00056,"Yes"
"11758","C3_TF_targets","C3_TFT_357_V_TEL2_Q6",233,-1.057,0.34,0.44,"No",0.8065,0.97,1,"Yes"
"11759","GO_BP","502835_GO_0033619_MEMBRANE_PROTEIN_PROTEOLYSIS",34,-1.057,0.38,0.55,"No",0.5907,0.99,1,"Yes"
"11760","C2_Chemical_and_genetic_perturbations","C2_CGP_622_BAKER_HEMATOPOIESIS_STAT3_TARGETS",16,-1.057,0.39,0.48,"No",1.3396,0.13,0.35,"Yes"
"11761","GO_MF","490465_GO_0005223_INTRACELLULAR_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY",7,-1.0567,0.4,0.57,"No",0.6895,0.85,1,"Yes"
"11762","GO_MF","500669_GO_0031418_L_ASCORBIC_ACID_BINDING",21,-1.0564,0.38,0.57,"No",-1.0652,0.39,0.86,"No"
"11763","GO_BP","508440_GO_0051197_POSITIVE_REGULATION_OF_COENZYME_METABOLIC_PROCESS",13,-1.0564,0.38,0.55,"No",1.2097,0.22,0.78,"Yes"
"11764","KEGG_reaction","R00089_ATP_DIPHOSPHATE_LYASE_CYCLIZING_3_5_CYCLIC_AMP_FORMING_ATP_3_5_CYCLIC_AMP_DIPHOSPHATE",10,-1.0563,0.4,0.54,"No",-1.0947,0.35,0.68,"No"
"11765","C2_Chemical_and_genetic_perturbations","C2_CGP_1456_VERNELL_RETINOBLASTOMA_PATHWAY_DN",22,-1.0562,0.38,0.48,"No",-0.6123,0.95,1,"No"
"11766","OMIM_gene","OMIM600538_PEROXIREDOXIN_2_PRDX2",5,-1.0561,0.43,0.79,"No",1.3339,0.15,0.84,"Yes"
"11767","C2_Chemical_and_genetic_perturbations","C2_CGP_2195_FUJII_YBX1_TARGETS_DN",201,-1.0561,0.36,0.48,"No",1.1001,0.19,0.63,"Yes"
"11768","C2_Chemical_and_genetic_perturbations","C2_CGP_1604_BROWNE_HCMV_INFECTION_20HR_UP",240,-1.0561,0.34,0.48,"No",-1.0569,0.3,0.97,"No"
"11769","C6_Oncogenic_signatures","C6_ALL_95_ESC_J1_UP_LATE_V1_DN",174,-1.056,0.34,0.41,"No",-0.9107,0.68,0.87,"No"
"11770","C2_Chemical_and_genetic_perturbations","C2_CGP_2492_LUDWICZEK_TREATING_IRON_OVERLOAD",7,-1.0559,0.42,0.48,"No",1.1834,0.27,0.51,"Yes"
"11771","C7_Immunologic_signatures","C7_ALL_1243_GSE2826_XID_VS_BTK_KO_BCELL_UP",196,-1.0558,0.38,0.45,"No",1.509,0.0072,0.011,"Yes"
"11772","GO_BP","518410_GO_0090270_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION",5,-1.0557,0.43,0.55,"No",-1.0489,0.39,0.97,"No"
"11773","GO_BP","509093_GO_0046880_REGULATION_OF_FOLLICLE_STIMULATING_HORMONE_SECRETION",5,-1.0556,0.42,0.55,"No",0.8903,0.57,1,"Yes"
"11774","C7_Immunologic_signatures","C7_ALL_714_GSE17721_0_5H_VS_24H_LPS_BMDM_DN",199,-1.0554,0.33,0.45,"No",0.906,0.73,1,"Yes"
"11775","C2_Chemical_and_genetic_perturbations","C2_CGP_2330_MATZUK_EARLY_ANTRAL_FOLLICLE",13,-1.0554,0.41,0.48,"No",1.0405,0.42,0.73,"Yes"
"11776","WikiPathways","198858_WP1602_NICOTINE_ACTIVITY_ON_DOPAMINERGIC_NEURONS",21,-1.0552,0.38,0.49,"No",-0.8872,0.64,1,"No"
"11777","KEGG_compound","C16608_DEMETHYLCITALOPRAM",5,-1.0551,0.41,0.56,"No",-0.9719,0.5,1,"No"
"11778","C3_MicroRNA_targets","C3_MIR_210_TGCAAAC_MIR_452",106,-1.0551,0.36,0.53,"No",-0.9071,0.67,1,"No"
"11779","GO_BP","499629_GO_0030219_MEGAKARYOCYTE_DIFFERENTIATION",21,-1.055,0.4,0.55,"No",0.9875,0.47,0.99,"Yes"
"11780","GO_BP","509676_GO_0047497_MITOCHONDRION_TRANSPORT_ALONG_MICROTUBULE",9,-1.055,0.39,0.55,"No",-0.9283,0.54,1,"No"
"11781","GO_BP","504215_GO_0035025_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION",11,-1.0549,0.41,0.55,"No",0.724,0.82,1,"Yes"
"11782","GO_MF","490460_GO_0005218_INTRACELLULAR_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY",10,-1.0548,0.4,0.58,"No",-0.9224,0.54,0.96,"No"
"11783","C2_Chemical_and_genetic_perturbations","C2_CGP_2206_DAIRKEE_CANCER_PRONE_RESPONSE_E2",28,-1.0547,0.41,0.48,"No",-0.8527,0.71,1,"No"
"11784","GO_BP","516987_GO_0072070_LOOP_OF_HENLE_DEVELOPMENT",10,-1.0547,0.38,0.55,"No",-1.3101,0.16,0.87,"No"
"11785","GO_BP","518364_GO_0090224_REGULATION_OF_SPINDLE_ORGANIZATION",24,-1.0546,0.37,0.55,"No",1.0897,0.34,0.92,"Yes"
"11786","C7_Immunologic_signatures","C7_ALL_1042_GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN",197,-1.0545,0.35,0.46,"No",1.4859,0,0.015,"Yes"
"11787","GO_BP","494936_GO_0010872_REGULATION_OF_CHOLESTEROL_ESTERIFICATION",10,-1.0545,0.41,0.55,"No",0.9,0.57,1,"Yes"
"11788","REACTOME","106540_REACT_7970_TELOMERE_MAINTENANCE",78,-1.0545,0.36,0.58,"No",-1.0494,0.36,0.94,"No"
"11789","KEGG_pathway","HSA00310_LYSINE_DEGRADATION",52,-1.0544,0.38,0.43,"No",-1.387,0.05,0.36,"No"
"11790","GO_BP","499853_GO_0030514_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY",42,-1.0544,0.38,0.55,"No",0.7232,0.93,1,"Yes"
"11791","C2_Chemical_and_genetic_perturbations","C2_CGP_3124_BHAT_ESR1_TARGETS_VIA_AKT1_UP",276,-1.0543,0.35,0.48,"No",-1.3113,0.018,0.69,"No"
"11792","GO_BP","493348_GO_0009151_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",16,-1.0543,0.4,0.55,"No",0.827,0.72,1,"Yes"
"11793","GO_MF","496670_GO_0016757_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS",269,-1.0542,0.34,0.58,"No",1.1301,0.14,0.75,"Yes"
"11794","C2_Chemical_and_genetic_perturbations","C2_CGP_2348_GRADE_COLON_VS_RECTAL_CANCER_DN",55,-1.0541,0.36,0.48,"No",-0.9592,0.52,1,"No"
"11795","GO_BP","508144_GO_0045821_POSITIVE_REGULATION_OF_GLYCOLYTIC_PROCESS",13,-1.0541,0.42,0.55,"No",1.1653,0.26,0.82,"Yes"
"11796","REACTOME","106056_REACT_15381_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS",15,-1.0541,0.41,0.58,"No",1.853,0.0021,0.013,"Yes"
"11797","GO_CC","506357_GO_0043296_APICAL_JUNCTION_COMPLEX",123,-1.0538,0.37,0.66,"No",-0.9982,0.45,0.86,"No"
"11798","C7_Immunologic_signatures","C7_ALL_1314_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN",197,-1.0538,0.35,0.46,"No",-0.8964,0.75,1,"No"
"11799","GO_BP","491378_GO_0006476_PROTEIN_DEACETYLATION",43,-1.0537,0.39,0.55,"No",-1.2722,0.13,0.89,"No"
"11800","C2_Chemical_and_genetic_perturbations","C2_CGP_2360_NAKAMURA_METASTASIS_MODEL_UP",42,-1.0536,0.37,0.48,"No",0.9575,0.53,0.86,"Yes"
"11801","KEGG_reaction","R08391_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_5_6_EPOXYRETINOIC_ACID_NADP_H2O",5,-1.0536,0.41,0.54,"No",-1.3437,0.13,0.35,"No"
"11802","REACTOME","1183569_REACT_355227_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING",28,-1.0536,0.39,0.58,"No",0.7612,0.84,1,"Yes"
"11803","GO_CC","1025426_GO_1903293_PHOSPHATASE_COMPLEX",45,-1.0536,0.39,0.66,"No",-0.7883,0.82,1,"No"
"11804","REACTOME","1183518_REACT_355457_DISEASES_OF_SIGNAL_TRANSDUCTION",259,-1.0535,0.34,0.58,"No",0.9235,0.72,0.87,"Yes"
"11805","GO_BP","512097_GO_0051194_POSITIVE_REGULATION_OF_COFACTOR_METABOLIC_PROCESS",13,-1.0535,0.4,0.55,"No",1.2085,0.23,0.78,"Yes"
"11806","GO_CC","507223_GO_0044216_OTHER_ORGANISM_CELL",11,-1.0534,0.4,0.66,"No",-1.3285,0.14,0.65,"No"
"11807","C1_Positional","C1_ALL_149_CHRXQ23",15,-1.0534,0.4,0.86,"No",-1.5026,0.046,0.52,"No"
"11808","GO_MF","492489_GO_0008134_TRANSCRIPTION_FACTOR_BINDING",472,-1.0534,0.33,0.58,"No",0.7055,1,1,"Yes"
"11809","GO_CC","516471_GO_0071547_PIP_BODY",5,-1.0533,0.44,0.66,"No",-0.4887,0.99,1,"No"
"11810","C7_Immunologic_signatures","C7_ALL_53_GSE10325_MYELOID_VS_LUPUS_MYELOID_UP",188,-1.0532,0.36,0.46,"No",-1.0154,0.41,1,"No"
"11811","C7_Immunologic_signatures","C7_ALL_206_GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN",152,-1.0532,0.37,0.46,"No",-1.1997,0.11,0.81,"No"
"11812","GO_BP","496350_GO_0045744_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",71,-1.0531,0.37,0.55,"No",0.8738,0.74,1,"Yes"
"11813","GO_BP","513775_GO_0060219_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION",15,-1.0529,0.39,0.55,"No",-0.8975,0.6,1,"No"
"11814","C7_Immunologic_signatures","C7_ALL_181_GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP",199,-1.0528,0.37,0.46,"No",1.0086,0.42,0.71,"Yes"
"11815","GO_BP","487833_GO_0001942_HAIR_FOLLICLE_DEVELOPMENT",72,-1.0527,0.38,0.55,"No",0.835,0.77,1,"Yes"
"11816","C2_Chemical_and_genetic_perturbations","C2_CGP_1099_HE_PTEN_TARGETS_UP",15,-1.0526,0.37,0.48,"No",0.8036,0.76,0.99,"Yes"
"11817","C1_Positional","C1_ALL_161_CHR21Q21",17,-1.0526,0.39,0.85,"No",-0.9235,0.57,1,"No"
"11818","C2_Chemical_and_genetic_perturbations","C2_CGP_1815_EHRLICH_ICF_SYNDROM_DN",14,-1.0525,0.39,0.48,"No",-1.2599,0.18,0.74,"No"
"11819","GO_MF","495791_GO_0015651_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-1.0525,0.4,0.58,"No",-1.0301,0.4,0.88,"No"
"11820","REACTOME","106041_REACT_18407_G_ALPHA_12_13_SIGNALLING_EVENTS",75,-1.0525,0.37,0.58,"No",-0.9316,0.59,1,"No"
"11821","C2_Chemical_and_genetic_perturbations","C2_CGP_3067_GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB",142,-1.0522,0.36,0.48,"No",1.2537,0.065,0.43,"Yes"
"11822","GO_BP","492609_GO_0008286_INSULIN_RECEPTOR_SIGNALING_PATHWAY",141,-1.0522,0.36,0.55,"No",-0.7795,0.96,1,"No"
"11823","C3_TF_targets","C3_TFT_537_WWTAAGGC_UNKNOWN",137,-1.0521,0.35,0.45,"No",0.7829,0.96,1,"Yes"
"11824","C2_Chemical_and_genetic_perturbations","C2_CGP_1846_MODY_HIPPOCAMPUS_PRENATAL",42,-1.052,0.37,0.48,"No",2.1218,0,0.0016,"Yes"
"11825","C4_Cancer_modules","C4_CM_133_MODULE_138",85,-1.052,0.38,0.5,"No",0.8715,0.74,0.89,"Yes"
"11826","GO_BP","513809_GO_0060253_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION",9,-1.052,0.42,0.55,"No",-0.4403,1,1,"No"
"11827","GO_MF","492439_GO_0008066_GLUTAMATE_RECEPTOR_ACTIVITY",27,-1.052,0.39,0.58,"No",1.2093,0.2,0.7,"Yes"
"11828","REACTOME","106499_REACT_15312_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY",10,-1.052,0.41,0.58,"No",-1.1222,0.31,0.89,"No"
"11829","GO_BP","492322_GO_0048102_AUTOPHAGIC_CELL_DEATH",6,-1.0519,0.41,0.55,"No",-0.6327,0.91,1,"No"
"11830","GO_BP","514199_GO_0060644_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION",16,-1.0519,0.39,0.55,"No",0.8228,0.73,1,"Yes"
"11831","GO_BP","517571_GO_0072668_TUBULIN_COMPLEX_BIOGENESIS",8,-1.0519,0.41,0.55,"No",-0.9034,0.6,1,"No"
"11832","GO_BP","506531_GO_0043500_MUSCLE_ADAPTATION",29,-1.0518,0.38,0.55,"No",-1.1849,0.22,0.91,"No"
"11833","GO_MF","499654_GO_0030249_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY",7,-1.0515,0.4,0.58,"No",-0.8108,0.71,1,"No"
"11834","C1_Positional","C1_ALL_98_CHR6P21",353,-1.0515,0.35,0.85,"No",-1.3323,0.01,0.89,"No"
"11835","C7_Immunologic_signatures","C7_ALL_1563_GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP",196,-1.0515,0.34,0.46,"No",1.4055,0.0096,0.035,"Yes"
"11836","KEGG_pathway","HSA00330_ARGININE_AND_PROLINE_METABOLISM",58,-1.0515,0.38,0.43,"No",-1.0707,0.33,0.72,"No"
"11837","GO_BP","494540_GO_0010470_REGULATION_OF_GASTRULATION",31,-1.0514,0.39,0.55,"No",-1.1272,0.27,0.94,"No"
"11838","C2_Chemical_and_genetic_perturbations","C2_CGP_59_GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN",483,-1.0514,0.32,0.48,"No",1.0593,0.25,0.7,"Yes"
"11839","GO_BP","498795_GO_0021511_SPINAL_CORD_PATTERNING",24,-1.0512,0.39,0.55,"No",-1.4427,0.066,0.91,"No"
"11840","GO_BP","493329_GO_0009132_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",35,-1.0512,0.39,0.55,"No",0.7079,0.92,1,"Yes"
"11841","GO_BP","493321_GO_0009124_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",87,-1.051,0.38,0.55,"No",1.4169,0.022,0.53,"Yes"
"11842","GO_BP","494527_GO_0010457_CENTRIOLE_CENTRIOLE_COHESION",6,-1.051,0.4,0.55,"No",-1.2771,0.19,0.89,"No"
"11843","REACTOME","106351_REACT_9413_FGFR2C_LIGAND_BINDING_AND_ACTIVATION",10,-1.051,0.39,0.58,"No",-1.3182,0.14,0.62,"No"
"11844","GO_BP","499841_GO_0030500_REGULATION_OF_BONE_MINERALIZATION",64,-1.051,0.36,0.55,"No",-1.2691,0.095,0.89,"No"
"11845","C2_Chemical_and_genetic_perturbations","C2_CGP_2200_DE_YY1_TARGETS_DN",92,-1.051,0.38,0.49,"No",1.336,0.038,0.35,"Yes"
"11846","GO_BP","499657_GO_0030252_GROWTH_HORMONE_SECRETION",8,-1.0509,0.41,0.55,"No",-0.9355,0.54,1,"No"
"11847","C7_Immunologic_signatures","C7_ALL_1495_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP",196,-1.0509,0.37,0.46,"No",1.0093,0.39,0.71,"Yes"
"11848","C7_Immunologic_signatures","C7_ALL_1869_GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP",199,-1.0507,0.37,0.46,"No",1.0823,0.24,0.49,"Yes"
"11849","GO_BP","496101_GO_0015992_PROTON_TRANSPORT",117,-1.0506,0.37,0.56,"No",1.7873,0,0.11,"Yes"
"11850","GO_BP","513684_GO_0060126_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION",5,-1.0506,0.44,0.56,"No",-1.1144,0.36,0.93,"No"
"11851","C7_Immunologic_signatures","C7_ALL_1048_GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN",199,-1.0506,0.36,0.46,"No",1.4109,0.0048,0.035,"Yes"
"11852","C4_Cancer_gene_neighborhoods","C4_CGN_53_MORF_MYC",78,-1.0506,0.37,0.6,"No",0.7629,0.92,1,"Yes"
"11853","GO_BP","494808_GO_0010743_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION",27,-1.0504,0.39,0.56,"No",1.551,0.029,0.34,"Yes"
"11854","REACTOME","106246_REACT_17050_FOLDING_OF_ACTIN_BY_CCT_TRIC",9,-1.0504,0.4,0.58,"No",1.5644,0.029,0.11,"Yes"
"11855","C4_Cancer_modules","C4_CM_260_MODULE_295",20,-1.0503,0.37,0.5,"No",1.2798,0.12,0.3,"Yes"
"11856","C4_Cancer_modules","C4_CM_365_MODULE_445",14,-1.0503,0.39,0.5,"No",-1.2313,0.2,0.61,"No"
"11857","GO_BP","507573_GO_0045191_REGULATION_OF_ISOTYPE_SWITCHING",22,-1.0502,0.38,0.56,"No",-1.2608,0.16,0.91,"No"
"11858","C7_Immunologic_signatures","C7_ALL_1145_GSE27786_LSK_VS_BCELL_UP",198,-1.0501,0.35,0.47,"No",0.6502,1,1,"Yes"
"11859","KEGG_compound","C20879_VERY_LONG_CHAIN_TRANS_2_3_DEHYDROACYL_COA",5,-1.05,0.42,0.57,"No",1.2614,0.23,0.78,"Yes"
"11860","WikiPathways","920978_WP1528_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART",24,-1.0499,0.39,0.5,"No",0.7531,0.83,1,"Yes"
"11861","C3_TF_targets","C3_TFT_550_YRCCAKNNGNCGC_UNKNOWN",65,-1.0499,0.37,0.46,"No",-0.8756,0.72,0.98,"No"
"11862","GO_BP","492331_GO_0007589_BODY_FLUID_SECRETION",68,-1.0497,0.39,0.56,"No",0.8699,0.72,1,"Yes"
"11863","GO_CC","490827_GO_0030126_COPI_VESICLE_COAT",14,-1.0497,0.41,0.66,"No",1.4255,0.075,0.27,"Yes"
"11864","C2_Chemical_and_genetic_perturbations","C2_CGP_1105_BENPORATH_ES_1",374,-1.0497,0.37,0.49,"No",1.0197,0.36,0.77,"Yes"
"11865","C2_Chemical_and_genetic_perturbations","C2_CGP_628_NAKAMURA_LUNG_CANCER",8,-1.0496,0.41,0.49,"No",-1.2464,0.19,0.75,"No"
"11866","C2_Chemical_and_genetic_perturbations","C2_CGP_2851_PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN",23,-1.0494,0.37,0.49,"No",1.7942,0.0065,0.045,"Yes"
"11867","REACTOME","1127620_REACT_264030_AXIN_MISSENSE_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0494,0.41,0.58,"No",0.6532,0.92,1,"Yes"
"11868","GO_BP","513880_GO_0060324_FACE_DEVELOPMENT",46,-1.0494,0.39,0.56,"No",-0.7367,0.9,1,"No"
"11869","C2_BioCarta_Pathways","C2_CP_BIOCARTA_170_BIOCARTA_MITOCHONDRIA_PATHWAY",21,-1.0494,0.38,0.52,"No",-0.4797,1,1,"No"
"11870","C2_Chemical_and_genetic_perturbations","C2_CGP_1300_SMITH_TERT_TARGETS_UP",144,-1.0492,0.38,0.49,"No",1.3602,0.023,0.33,"Yes"
"11871","C7_Immunologic_signatures","C7_ALL_1467_GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP",193,-1.0492,0.35,0.47,"No",-1.0013,0.46,1,"No"
"11872","C2_Chemical_and_genetic_perturbations","C2_CGP_2945_YIH_RESPONSE_TO_ARSENITE_C5",10,-1.0492,0.4,0.49,"No",1.0973,0.34,0.64,"Yes"
"11873","C2_Chemical_and_genetic_perturbations","C2_CGP_452_GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN",19,-1.0491,0.38,0.49,"No",-1.2054,0.23,0.8,"No"
"11874","C2_Chemical_and_genetic_perturbations","C2_CGP_1276_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3",8,-1.0491,0.4,0.49,"No",-1.3718,0.12,0.63,"No"
"11875","GO_BP","512147_GO_0051256_MITOTIC_SPINDLE_MIDZONE_ASSEMBLY",7,-1.0491,0.42,0.56,"No",0.9462,0.52,1,"Yes"
"11876","GO_MF","509157_GO_0046965_RETINOID_X_RECEPTOR_BINDING",16,-1.0491,0.41,0.59,"No",0.8511,0.66,1,"Yes"
"11877","GO_BP","499063_GO_0021783_PREGANGLIONIC_PARASYMPATHETIC_FIBER_DEVELOPMENT",16,-1.049,0.39,0.56,"No",-0.8242,0.68,1,"No"
"11878","GO_BP","505717_GO_0042590_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I",79,-1.0488,0.39,0.56,"No",1.9827,0,0.015,"Yes"
"11879","GO_BP","492338_GO_0007597_BLOOD_COAGULATION_INTRINSIC_PATHWAY",18,-1.0488,0.4,0.56,"No",-1.1018,0.31,0.94,"No"
"11880","GO_BP","491979_GO_0007179_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",133,-1.0488,0.37,0.56,"No",0.7986,0.91,1,"Yes"
"11881","C7_Immunologic_signatures","C7_ALL_107_GSE12366_GC_BCELL_VS_PLASMA_CELL_UP",197,-1.0487,0.36,0.47,"No",1.0585,0.32,0.56,"Yes"
"11882","GO_BP","493460_GO_0009267_CELLULAR_RESPONSE_TO_STARVATION",136,-1.0486,0.38,0.56,"No",0.6762,1,1,"Yes"
"11883","GO_BP","499278_GO_0021999_NEURAL_PLATE_ANTERIOR_POSTERIOR_REGIONALIZATION",5,-1.0484,0.44,0.56,"No",-0.7608,0.8,1,"No"
"11884","GO_BP","504514_GO_0035330_REGULATION_OF_HIPPO_SIGNALING",8,-1.0483,0.4,0.56,"No",-0.9483,0.52,1,"No"
"11885","GO_BP","491490_GO_0006595_POLYAMINE_METABOLIC_PROCESS",21,-1.0483,0.4,0.56,"No",-0.7547,0.84,1,"No"
"11886","GO_MF","490363_GO_0005095_GTPASE_INHIBITOR_ACTIVITY",14,-1.0481,0.4,0.59,"No",-1.1282,0.3,0.81,"No"
"11887","KEGG_compound","C07572_CITALOPRAM",5,-1.0479,0.42,0.57,"No",-0.9428,0.54,1,"No"
"11888","REACTOME","106223_REACT_12389_ENOS_ACTIVATION_AND_REGULATION",20,-1.0479,0.4,0.59,"No",0.7588,0.81,1,"Yes"
"11889","GO_BP","494078_GO_0009994_OOCYTE_DIFFERENTIATION",33,-1.0478,0.38,0.56,"No",-1.3979,0.06,1,"No"
"11890","WikiPathways","198806_WP138_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",86,-1.0477,0.39,0.5,"No",0.809,0.88,1,"Yes"
"11891","C3_TF_targets","C3_TFT_76_V_TAXCREB_02",25,-1.0476,0.39,0.46,"No",0.8472,0.71,1,"Yes"
"11892","GO_CC","503476_GO_0034273_ATG1_UKL1_SIGNALING_COMPLEX",5,-1.0476,0.44,0.67,"No",0.5442,0.95,1,"Yes"
"11893","C0_Hallmark","H_ALL_6_HALLMARK_TGF_BETA_SIGNALING",54,-1.0476,0.39,0.41,"No",-0.5839,1,1,"No"
"11894","REACTOME","1183600_REACT_355604_VESICLE_MEDIATED_TRANSPORT",237,-1.0474,0.35,0.59,"No",1.4019,0,0.22,"Yes"
"11895","KEGG_compound","C00229_ACYL_CARRIER_PROTEIN_ACP_ACYL_CARRIER_PROTEIN_HOLO_ACYL_CARRIER_PROTEIN_",19,-1.0474,0.39,0.57,"No",-0.6072,0.96,1,"No"
"11896","C4_Cancer_modules","C4_CM_274_MODULE_313",17,-1.0473,0.39,0.51,"No",0.8782,0.66,0.88,"Yes"
"11897","REACTOME","187102_REACT_25271_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING",33,-1.0473,0.39,0.59,"No",1.6754,0.013,0.058,"Yes"
"11898","GO_BP","501954_GO_0032728_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION",25,-1.0471,0.39,0.56,"No",-0.6727,0.93,1,"No"
"11899","C7_Immunologic_signatures","C7_ALL_142_GSE13229_IMM_VS_INTMATURE_NKCELL_DN",199,-1.0471,0.37,0.47,"No",0.8904,0.8,1,"Yes"
"11900","GO_BP","514594_GO_0061046_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS",6,-1.047,0.42,0.56,"No",-1.3716,0.12,0.98,"No"
"11901","GO_BP","502119_GO_0032897_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION",25,-1.0469,0.4,0.56,"No",0.9966,0.43,0.98,"Yes"
"11902","REACTOME","119522_REACT_19277_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE",24,-1.0469,0.41,0.59,"No",-0.922,0.59,1,"No"
"11903","GO_BP","504596_GO_0035412_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS",23,-1.0468,0.42,0.56,"No",-0.7834,0.78,1,"No"
"11904","GO_BP","502146_GO_0032924_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",20,-1.0468,0.4,0.56,"No",-0.8703,0.65,1,"No"
"11905","C7_Immunologic_signatures","C7_ALL_367_GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP",190,-1.0467,0.36,0.47,"No",-0.9019,0.75,1,"No"
"11906","C7_Immunologic_signatures","C7_ALL_1887_GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP",200,-1.0465,0.37,0.47,"No",1.6861,0,0.00081,"Yes"
"11907","GO_BP","493455_GO_0009262_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",35,-1.0465,0.39,0.56,"No",1.4821,0.029,0.44,"Yes"
"11908","C7_Immunologic_signatures","C7_ALL_1013_GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP",195,-1.0464,0.37,0.47,"No",0.9708,0.54,0.83,"Yes"
"11909","KEGG_compound","C00143_5_10_METHYLENETETRAHYDROFOLATE_6R_5_10_METHYLENETETRAHYDROFOLATE_5_10_METHYLENE_THF",11,-1.0463,0.41,0.57,"No",-0.6113,0.94,1,"No"
"11910","C2_Chemical_and_genetic_perturbations","C2_CGP_511_LUI_THYROID_CANCER_PAX8_PPARG_DN",45,-1.0461,0.39,0.49,"No",2.0861,0,0.0023,"Yes"
"11911","C7_Immunologic_signatures","C7_ALL_1533_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP",186,-1.046,0.36,0.47,"No",1.0335,0.35,0.64,"Yes"
"11912","C7_Immunologic_signatures","C7_ALL_1161_GSE27786_LIN_NEG_VS_BCELL_UP",199,-1.046,0.36,0.47,"No",1.1637,0.089,0.29,"Yes"
"11913","GO_CC","502870_GO_0033655_HOST_CELL_CYTOPLASM_PART",5,-1.0459,0.42,0.67,"No",-1.0806,0.37,0.81,"No"
"11914","C1_Positional","C1_ALL_291_CHR2Q35",53,-1.0459,0.37,0.86,"No",-0.8129,0.82,0.99,"No"
"11915","KEGG_compound","C05378_BETA_D_FRUCTOSE_1_6_BISPHOSPHATE",8,-1.0458,0.42,0.57,"No",-0.5641,0.97,1,"No"
"11916","GO_BP","491572_GO_0006684_SPHINGOMYELIN_METABOLIC_PROCESS",13,-1.0458,0.4,0.56,"No",0.6698,0.91,1,"Yes"
"11917","C4_Cancer_modules","C4_CM_279_MODULE_320",20,-1.0458,0.39,0.51,"No",0.7271,0.87,1,"Yes"
"11918","C2_Chemical_and_genetic_perturbations","C2_CGP_2791_SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP",67,-1.0457,0.39,0.49,"No",1.2591,0.11,0.43,"Yes"
"11919","C2_Chemical_and_genetic_perturbations","C2_CGP_2928_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2",82,-1.0457,0.38,0.49,"No",-1.041,0.38,0.97,"No"
"11920","GO_MF","492646_GO_0008331_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",11,-1.0455,0.39,0.59,"No",-1.2764,0.17,0.81,"No"
"11921","C1_Positional","C1_ALL_323_CHR4Q32",35,-1.0455,0.38,0.85,"No",1.6965,0.0042,0.16,"Yes"
"11922","GO_BP","510614_GO_0048546_DIGESTIVE_TRACT_MORPHOGENESIS",51,-1.0455,0.41,0.56,"No",0.9701,0.52,1,"Yes"
"11923","GO_BP","504803_GO_0035624_RECEPTOR_TRANSACTIVATION",5,-1.0453,0.44,0.56,"No",-1.089,0.39,0.95,"No"
"11924","GO_BP","1184587_GO_1904063_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT",44,-1.0452,0.39,0.56,"No",-0.7408,0.9,1,"No"
"11925","C7_Immunologic_signatures","C7_ALL_671_GSE17721_POLYIC_VS_GARDIQUIMOD_0_5H_BMDM_UP",191,-1.0452,0.37,0.48,"No",1.0894,0.23,0.47,"Yes"
"11926","C4_Cancer_gene_neighborhoods","C4_CGN_111_MORF_IFNA1",196,-1.0451,0.37,0.61,"No",-0.9904,0.46,0.87,"No"
"11927","C2_Chemical_and_genetic_perturbations","C2_CGP_449_GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP",26,-1.045,0.39,0.5,"No",0.8692,0.64,0.95,"Yes"
"11928","REACTOME","119565_REACT_19275_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS",5,-1.0448,0.43,0.59,"No",-0.9496,0.55,1,"No"
"11929","C7_Immunologic_signatures","C7_ALL_1734_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN",196,-1.0447,0.37,0.48,"No",1.4481,0.0024,0.023,"Yes"
"11930","OMIM_gene","OMIM188830_PROTEIN_KINASE_CAMP_DEPENDENT_REGULATORY_TYPE_I_ALPHA_PRKAR1A",6,-1.0447,0.44,0.79,"No",-1.0577,0.4,0.81,"No"
"11931","C7_Immunologic_signatures","C7_ALL_680_GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDM_DN",198,-1.0447,0.38,0.48,"No",1.0965,0.23,0.45,"Yes"
"11932","OMIM_gene","OMIM603881_NUCLEAR_RECEPTOR_SUBFAMILY_1_GROUP_I_MEMBER_3_NR1I3",6,-1.0445,0.42,0.77,"No",-1.0568,0.4,0.78,"No"
"11933","C2_Chemical_and_genetic_perturbations","C2_CGP_3120_PILON_KLF1_TARGETS_UP",494,-1.0444,0.36,0.5,"No",1.3256,0.0056,0.37,"Yes"
"11934","GO_BP","510842_GO_0048791_CALCIUM_ION_DEPENDENT_EXOCYTOSIS_OF_NEUROTRANSMITTER",33,-1.0443,0.39,0.56,"No",0.9802,0.48,1,"Yes"
"11935","REACTOME","105656_REACT_964_INTRINSIC_PATHWAY_FOR_APOPTOSIS",38,-1.0443,0.39,0.59,"No",0.8632,0.68,0.94,"Yes"
"11936","KEGG_compound","C16680_ALL_TRANS_5_6_EPOXYRETINOIC_ACID_ALL_TRANS_5_6_EPOXY_5_6_DIHYDRORETINOIC_ACID",5,-1.0442,0.44,0.57,"No",-1.3711,0.12,0.51,"No"
"11937","C6_Oncogenic_signatures","C6_ALL_120_NRL_DN_V1_UP",127,-1.0442,0.38,0.43,"No",-1.2972,0.059,0.37,"No"
"11938","GO_CC","501223_GO_0031985_GOLGI_CISTERNA",92,-1.0441,0.37,0.67,"No",0.8664,0.77,0.91,"Yes"
"11939","GO_BP","506410_GO_0043371_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",9,-1.0439,0.42,0.57,"No",-1.0394,0.4,0.98,"No"
"11940","C1_Positional","C1_ALL_105_CHR5P14",15,-1.0438,0.39,0.85,"No",-0.8829,0.61,1,"No"
"11941","GO_BP","517280_GO_0072364_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS_BY_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",7,-1.0438,0.42,0.57,"No",-0.93,0.56,1,"No"
"11942","C7_Immunologic_signatures","C7_ALL_168_GSE13411_NAIVE_VS_MEMORY_BCELL_DN",197,-1.0437,0.37,0.48,"No",1.309,0.026,0.094,"Yes"
"11943","GO_BP","493397_GO_0009201_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",70,-1.0437,0.4,0.57,"No",1.1897,0.16,0.79,"Yes"
"11944","GO_BP","486799_GO_0000281_MITOTIC_CYTOKINESIS",28,-1.0436,0.41,0.57,"No",0.7722,0.81,1,"Yes"
"11945","OMIM_gene","OMIM602783_SPG7_GENE_SPG7",6,-1.0436,0.44,0.75,"No",-1.0763,0.37,0.86,"No"
"11946","REACTOME","1127615_REACT_264621_TRUNCATED_APC_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0435,0.41,0.59,"No",0.6543,0.92,1,"Yes"
"11947","C2_Chemical_and_genetic_perturbations","C2_CGP_494_ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP",59,-1.0435,0.4,0.5,"No",-0.9542,0.56,1,"No"
"11948","WikiPathways","198876_WP404_NUCLEOTIDE_METABOLISM",20,-1.0434,0.39,0.5,"No",0.9174,0.57,1,"Yes"
"11949","GO_BP","489285_GO_0006334_NUCLEOSOME_ASSEMBLY",129,-1.0433,0.39,0.57,"No",-1.169,0.15,0.91,"No"
"11950","GO_BP","496016_GO_0015893_DRUG_TRANSPORT",24,-1.0433,0.41,0.57,"No",-1.2507,0.18,0.91,"No"
"11951","GO_BP","504224_GO_0035036_SPERM_EGG_RECOGNITION",43,-1.0433,0.39,0.57,"No",-0.9682,0.52,1,"No"
"11952","C2_Chemical_and_genetic_perturbations","C2_CGP_1050_FUJIWARA_PARK2_IN_LIVER_CANCER_DN",5,-1.0432,0.43,0.5,"No",-1.59,0.032,0.43,"No"
"11953","C4_Cancer_gene_neighborhoods","C4_CGN_141_MORF_PDCD1",69,-1.0431,0.39,0.61,"No",1.0455,0.37,0.47,"Yes"
"11954","GO_BP","492366_GO_0007625_GROOMING_BEHAVIOR",13,-1.0431,0.42,0.57,"No",0.8572,0.67,1,"Yes"
"11955","KEGG_compound","C00036_OXALOACETATE_OXALACETIC_ACID_OXALOACETIC_ACID_2_OXOBUTANEDIOIC_ACID_2_OXOSUCCINIC_ACID_KETO_OXALOACETATE",12,-1.0431,0.43,0.57,"No",0.8336,0.71,1,"Yes"
"11956","GO_BP","494676_GO_0010612_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION",5,-1.043,0.44,0.57,"No",-1.1166,0.35,0.94,"No"
"11957","REACTOME","1183565_REACT_355069_FRS_MEDIATED_FGFR2_SIGNALING",32,-1.043,0.39,0.59,"No",-0.752,0.85,1,"No"
"11958","GO_BP","494939_GO_0010875_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX",13,-1.043,0.43,0.57,"No",0.7407,0.83,1,"Yes"
"11959","C1_Positional","C1_ALL_167_CHR15Q22",81,-1.043,0.4,0.84,"No",1.045,0.35,0.7,"Yes"
"11960","GO_BP","518559_GO_0097009_ENERGY_HOMEOSTASIS",8,-1.0429,0.4,0.57,"No",-0.6986,0.86,1,"No"
"11961","C7_Immunologic_signatures","C7_ALL_33_GSE10239_NAIVE_VS_DAY4_5_EFF_CD8_TCELL_UP",199,-1.0428,0.37,0.48,"No",1.4314,0,0.028,"Yes"
"11962","C4_Cancer_modules","C4_CM_131_MODULE_136",483,-1.0427,0.36,0.51,"No",0.8886,0.91,0.87,"Yes"
"11963","GO_BP","488933_GO_0003139_SECONDARY_HEART_FIELD_SPECIFICATION",8,-1.0427,0.4,0.57,"No",-0.7752,0.76,1,"No"
"11964","C7_Immunologic_signatures","C7_ALL_1898_GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN",200,-1.0425,0.36,0.48,"No",1.2863,0.057,0.11,"Yes"
"11965","C7_Immunologic_signatures","C7_ALL_675_GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDM_UP",199,-1.0425,0.39,0.48,"No",1.0774,0.27,0.51,"Yes"
"11966","C7_Immunologic_signatures","C7_ALL_370_GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN",195,-1.0425,0.38,0.48,"No",0.9372,0.66,0.94,"Yes"
"11967","C7_Immunologic_signatures","C7_ALL_134_GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN",200,-1.0424,0.37,0.48,"No",1.8071,0,2.8e-05,"Yes"
"11968","GO_BP","511980_GO_0051055_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS",41,-1.0424,0.39,0.57,"No",0.835,0.74,1,"Yes"
"11969","GO_MF","495507_GO_0015245_FATTY_ACID_TRANSPORTER_ACTIVITY",8,-1.0422,0.42,0.6,"No",1.0566,0.38,0.83,"Yes"
"11970","C7_Immunologic_signatures","C7_ALL_632_GSE17721_POLYIC_VS_CPG_16H_BMDM_DN",199,-1.0421,0.39,0.48,"No",1.4607,0.0023,0.02,"Yes"
"11971","C3_TF_targets","C3_TFT_5_V_CMYB_01",247,-1.042,0.39,0.47,"No",-1.051,0.3,0.64,"No"
"11972","REACTOME","106372_REACT_18302_LEUKOTRIENE_RECEPTORS",5,-1.0419,0.44,0.59,"No",-0.7506,0.77,1,"No"
"11973","C2_Chemical_and_genetic_perturbations","C2_CGP_1425_COLLER_MYC_TARGETS_DN",9,-1.0419,0.42,0.5,"No",-0.7694,0.8,1,"No"
"11974","GO_BP","518667_GO_2000018_REGULATION_OF_MALE_GONAD_DEVELOPMENT",10,-1.0418,0.43,0.57,"No",-1.2774,0.2,0.89,"No"
"11975","C3_MicroRNA_targets","C3_MIR_13_CTCTAGA_MIR_526C_MIR_518F_MIR_526A",58,-1.0417,0.4,0.56,"No",-0.8181,0.8,1,"No"
"11976","C4_Cancer_modules","C4_CM_249_MODULE_281",28,-1.0417,0.41,0.51,"No",1.3986,0.064,0.19,"Yes"
"11977","GO_MF","498672_GO_0019894_KINESIN_BINDING",32,-1.0415,0.4,0.6,"No",-1.5299,0.027,0.53,"No"
"11978","C2_Chemical_and_genetic_perturbations","C2_CGP_1001_FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN",95,-1.0415,0.39,0.5,"No",0.8126,0.89,0.98,"Yes"
"11979","C2_Chemical_and_genetic_perturbations","C2_CGP_1323_WILLERT_WNT_SIGNALING",21,-1.0414,0.39,0.5,"No",1.419,0.066,0.28,"Yes"
"11980","KEGG_module","HSA_M00104_BILE_ACID_BIOSYNTHESIS_CHOLESTEROL_CHOLATE_CHENODEOXYCHOLATE",12,-1.0414,0.4,0.75,"No",0.9451,0.51,0.91,"Yes"
"11981","C2_Chemical_and_genetic_perturbations","C2_CGP_1245_ZEILSTRA_CD44_TARGETS_UP",7,-1.0414,0.42,0.5,"No",1.3338,0.15,0.36,"Yes"
"11982","REACTOME","576275_REACT_118607_SIGNALING_BY_HIPPO",20,-1.0412,0.38,0.59,"No",0.681,0.91,1,"Yes"
"11983","C7_Immunologic_signatures","C7_ALL_1258_GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN",182,-1.0411,0.38,0.48,"No",1.0684,0.28,0.53,"Yes"
"11984","GO_MF","496671_GO_0016758_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS",196,-1.041,0.36,0.6,"No",1.1787,0.11,0.73,"Yes"
"11985","C7_Immunologic_signatures","C7_ALL_1047_GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP",198,-1.0409,0.39,0.48,"No",1.2475,0.057,0.16,"Yes"
"11986","GO_BP","492014_GO_0007216_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",13,-1.0409,0.41,0.57,"No",-1.0136,0.43,0.98,"No"
"11987","KEGG_module","HSA_M00688_MAPK_JNK_SIGNALING",21,-1.0407,0.41,0.73,"No",-1.4827,0.062,0.68,"No"
"11988","C7_Immunologic_signatures","C7_ALL_1629_GSE3982_DC_VS_NEUTROPHIL_UP",200,-1.0407,0.39,0.48,"No",1.4714,0.0024,0.017,"Yes"
"11989","GO_BP","514577_GO_0061029_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE",11,-1.0406,0.4,0.57,"No",0.9064,0.59,1,"Yes"
"11990","GO_BP","512438_GO_0051560_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS",15,-1.0405,0.41,0.57,"No",0.7567,0.81,1,"Yes"
"11991","KEGG_enzyme","1.14.14.1_UNSPECIFIC_MONOOXYGENASE_MICROSOMAL_MONOOXYGENASE_XENOBIOTIC_MONOOXYGENASE_ARYL_4_MONOOXYGENASE_ARYL_HYDROCARBON_HYDROXYLASE_MICROSOMAL_P_450_FLAVOPROTEIN_LINKED_MONOOXYGENASE_FLAVOPROTEIN_MONOOXYGENASE",21,-1.0404,0.4,0.54,"No",-1.6818,0.0077,0.068,"No"
"11992","GO_BP","492264_GO_0007512_ADULT_HEART_DEVELOPMENT",15,-1.0404,0.41,0.57,"No",-1.7505,0.011,0.58,"No"
"11993","C2_Chemical_and_genetic_perturbations","C2_CGP_1234_TCGA_GLIOBLASTOMA_COPY_NUMBER_DN",29,-1.0404,0.38,0.5,"No",-0.527,0.99,1,"No"
"11994","GO_BP","512015_GO_0051101_REGULATION_OF_DNA_BINDING",81,-1.0403,0.39,0.57,"No",1.5526,0.0066,0.34,"Yes"
"11995","GO_BP","513692_GO_0060134_PREPULSE_INHIBITION",12,-1.0402,0.43,0.57,"No",1.3873,0.11,0.57,"Yes"
"11996","GO_BP","505688_GO_0042558_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",32,-1.0402,0.4,0.57,"No",0.703,0.93,1,"Yes"
"11997","GO_BP","491106_GO_0045454_CELL_REDOX_HOMEOSTASIS",61,-1.0401,0.4,0.57,"No",1.1196,0.25,0.88,"Yes"
"11998","C7_Immunologic_signatures","C7_ALL_1626_GSE3982_MAST_CELL_VS_TH2_DN",198,-1.0401,0.36,0.48,"No",1.1136,0.21,0.41,"Yes"
"11999","GO_BP","492885_GO_0008637_APOPTOTIC_MITOCHONDRIAL_CHANGES",62,-1.0401,0.4,0.57,"No",1.2509,0.13,0.73,"Yes"
"12000","C4_Cancer_modules","C4_CM_418_MODULE_544",85,-1.0399,0.39,0.52,"No",1.0249,0.39,0.68,"Yes"
"12001","GO_MF","489766_GO_0004407_HISTONE_DEACETYLASE_ACTIVITY",25,-1.0399,0.42,0.6,"No",-1.2816,0.15,0.8,"No"
"12002","GO_BP","519067_GO_2000427_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE",7,-1.0398,0.44,0.57,"No",-1.196,0.26,0.89,"No"
"12003","GO_BP","510658_GO_0048599_OOCYTE_DEVELOPMENT",31,-1.0397,0.4,0.57,"No",-1.3899,0.062,1,"No"
"12004","C2_Chemical_and_genetic_perturbations","C2_CGP_1224_NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER",92,-1.0397,0.39,0.5,"No",-1.0498,0.36,0.97,"No"
"12005","GO_BP","517098_GO_0072182_REGULATION_OF_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION",14,-1.0396,0.43,0.57,"No",-0.7666,0.78,1,"No"
"12006","GO_BP","499605_GO_0030195_NEGATIVE_REGULATION_OF_BLOOD_COAGULATION",43,-1.0395,0.4,0.57,"No",1.329,0.067,0.63,"Yes"
"12007","GO_BP","502341_GO_0033120_POSITIVE_REGULATION_OF_RNA_SPLICING",25,-1.0395,0.4,0.57,"No",-0.8703,0.67,1,"No"
"12008","REACTOME","771602_REACT_160205_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS",21,-1.0394,0.4,0.6,"No",0.8939,0.61,0.91,"Yes"
"12009","GO_BP","507971_GO_0045623_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION",9,-1.0393,0.42,0.57,"No",-1.0258,0.43,0.97,"No"
"12010","GO_BP","514034_GO_0060479_LUNG_CELL_DIFFERENTIATION",27,-1.0392,0.4,0.57,"No",0.9205,0.58,1,"Yes"
"12011","C2_Chemical_and_genetic_perturbations","C2_CGP_323_MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN",12,-1.0391,0.4,0.51,"No",-0.8395,0.66,1,"No"
"12012","GO_BP","488565_GO_0002692_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION",5,-1.0391,0.41,0.57,"No",-1.2252,0.25,0.88,"No"
"12013","REACTOME","106222_REACT_12508_METABOLISM_OF_NITRIC_OXIDE",20,-1.0389,0.39,0.6,"No",0.7637,0.81,1,"Yes"
"12014","GO_BP","982482_GO_1902914_REGULATION_OF_PROTEIN_POLYUBIQUITINATION",8,-1.0388,0.43,0.57,"No",-0.6123,0.93,1,"No"
"12015","OMIM_gene","OMIM604896_MKKS_GENE_MKKS",5,-1.0388,0.44,0.74,"No",0.7182,0.82,1,"Yes"
"12016","GO_MF","495320_GO_0015020_GLUCURONOSYLTRANSFERASE_ACTIVITY",34,-1.0387,0.41,0.6,"No",1.4041,0.058,0.49,"Yes"
"12017","REACTOME","1127621_REACT_264511_AMER1_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0387,0.4,0.6,"No",0.6567,0.91,1,"Yes"
"12018","GO_BP","495144_GO_0014072_RESPONSE_TO_ISOQUINOLINE_ALKALOID",30,-1.0387,0.42,0.57,"No",-0.9896,0.48,1,"No"
"12019","C2_Chemical_and_genetic_perturbations","C2_CGP_2963_GERHOLD_RESPONSE_TO_TZD_UP",6,-1.0385,0.43,0.51,"No",-1.0826,0.37,0.94,"No"
"12020","C2_Chemical_and_genetic_perturbations","C2_CGP_852_DAIRKEE_TERT_TARGETS_UP",374,-1.0384,0.39,0.51,"No",1.6369,0,0.12,"Yes"
"12021","C7_Immunologic_signatures","C7_ALL_1797_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP",191,-1.0383,0.4,0.49,"No",-0.9474,0.59,1,"No"
"12022","GO_BP","493569_GO_0009396_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",10,-1.0383,0.42,0.57,"No",-0.6823,0.86,1,"No"
"12023","GO_BP","488119_GO_0002246_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE",6,-1.0383,0.46,0.57,"No",0.845,0.63,1,"Yes"
"12024","C2_Chemical_and_genetic_perturbations","C2_CGP_1507_ZHAN_MULTIPLE_MYELOMA_UP",64,-1.0381,0.4,0.51,"No",0.8254,0.81,0.98,"Yes"
"12025","GO_MF","494921_GO_0010857_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY",10,-1.0381,0.43,0.6,"No",-1.0434,0.41,0.87,"No"
"12026","C1_Positional","C1_ALL_143_CHR6Q",5,-1.0379,0.43,0.85,"No",1.4974,0.061,0.28,"Yes"
"12027","GO_BP","499624_GO_0030214_HYALURONAN_CATABOLIC_PROCESS",15,-1.0379,0.4,0.57,"No",-1.1681,0.26,0.91,"No"
"12028","C7_Immunologic_signatures","C7_ALL_610_GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_DN",197,-1.0378,0.4,0.49,"No",1.6871,0,8e-04,"Yes"
"12029","GO_BP","517432_GO_0072527_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",76,-1.0378,0.39,0.57,"No",0.9403,0.59,1,"Yes"
"12030","C2_Chemical_and_genetic_perturbations","C2_CGP_621_BAKER_HEMATOPOESIS_STAT1_TARGETS",10,-1.0377,0.42,0.51,"No",0.815,0.73,0.98,"Yes"
"12031","GO_BP","519335_GO_2000696_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",16,-1.0375,0.43,0.57,"No",-0.749,0.82,1,"No"
"12032","WikiPathways","198857_WP205_IL_7_SIGNALING_PATHWAY",44,-1.0375,0.41,0.51,"No",0.7114,0.93,1,"Yes"
"12033","GO_MF","501683_GO_0032451_DEMETHYLASE_ACTIVITY",41,-1.0375,0.41,0.6,"No",-1.403,0.044,0.64,"No"
"12034","GO_BP","498804_GO_0021520_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION",11,-1.0375,0.42,0.57,"No",0.9904,0.5,0.99,"Yes"
"12035","C3_MicroRNA_targets","C3_MIR_92_AGGCACT_MIR_515_3P",88,-1.0374,0.4,0.57,"No",-0.7454,0.94,1,"No"
"12036","GO_BP","1133934_GO_0098773_SKIN_EPIDERMIS_DEVELOPMENT",73,-1.0373,0.38,0.57,"No",0.8453,0.82,1,"Yes"
"12037","GO_BP","511886_GO_0050951_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS",17,-1.0372,0.42,0.57,"No",-1.2287,0.21,0.89,"No"
"12038","GO_CC","499690_GO_0030286_DYNEIN_COMPLEX",40,-1.0372,0.4,0.69,"No",-1.1632,0.22,0.68,"No"
"12039","GO_BP","750987_GO_0036065_FUCOSYLATION",25,-1.0371,0.4,0.57,"No",0.7056,0.89,1,"Yes"
"12040","C2_Chemical_and_genetic_perturbations","C2_CGP_2271_SMID_BREAST_CANCER_ERBB2_DN",5,-1.0371,0.45,0.51,"No",0.9666,0.5,0.84,"Yes"
"12041","REACTOME","1127617_REACT_263992_APC_TRUNCATION_MUTANTS_HAVE_IMPAIRED_AXIN_BINDING",14,-1.0369,0.41,0.6,"No",0.6593,0.91,1,"Yes"
"12042","GO_BP","506316_GO_0043249_ERYTHROCYTE_MATURATION",12,-1.0369,0.42,0.57,"No",0.9102,0.57,1,"Yes"
"12043","GO_BP","501262_GO_0032025_RESPONSE_TO_COBALT_ION",6,-1.0368,0.43,0.57,"No",0.7043,0.85,1,"Yes"
"12044","C2_Chemical_and_genetic_perturbations","C2_CGP_1480_GUO_HEX_TARGETS_DN",63,-1.0368,0.41,0.51,"No",1.7322,0.0046,0.067,"Yes"
"12045","C2_Chemical_and_genetic_perturbations","C2_CGP_1887_DAZARD_RESPONSE_TO_UV_NHEK_DN",317,-1.0367,0.39,0.51,"No",-0.6102,1,1,"No"
"12046","C2_Chemical_and_genetic_perturbations","C2_CGP_200_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN",25,-1.0363,0.41,0.51,"No",1.2589,0.15,0.43,"Yes"
"12047","GO_BP","488739_GO_0002866_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",7,-1.0362,0.44,0.58,"No",-0.6646,0.87,1,"No"
"12048","GO_BP","505024_GO_0035855_MEGAKARYOCYTE_DEVELOPMENT",15,-1.0362,0.4,0.58,"No",0.9613,0.49,1,"Yes"
"12049","GO_BP","513872_GO_0060316_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",10,-1.0361,0.42,0.58,"No",0.8996,0.59,1,"Yes"
"12050","GO_BP","499612_GO_0030202_HEPARIN_METABOLIC_PROCESS",8,-1.0361,0.45,0.58,"No",0.8134,0.69,1,"Yes"
"12051","C2_Chemical_and_genetic_perturbations","C2_CGP_3191_BILANGES_RAPAMYCIN_SENSITIVE_GENES",39,-1.0361,0.4,0.51,"No",1.9047,0,0.019,"Yes"
"12052","GO_BP","494934_GO_0010870_POSITIVE_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS",11,-1.036,0.41,0.58,"No",0.6357,0.91,1,"Yes"
"12053","C4_Cancer_modules","C4_CM_25_MODULE_26",202,-1.036,0.39,0.52,"No",-0.7113,1,1,"No"
"12054","C2_Chemical_and_genetic_perturbations","C2_CGP_1992_BILD_MYC_ONCOGENIC_SIGNATURE",204,-1.0359,0.4,0.51,"No",-1.157,0.12,0.84,"No"
"12055","GO_BP","492118_GO_0009880_EMBRYONIC_PATTERN_SPECIFICATION",66,-1.0359,0.4,0.58,"No",-0.7751,0.88,1,"No"
"12056","C7_Immunologic_signatures","C7_ALL_936_GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN",198,-1.0359,0.4,0.5,"No",1.3617,0.0071,0.056,"Yes"
"12057","GO_BP","500157_GO_0030859_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION",9,-1.0358,0.42,0.58,"No",0.6228,0.92,1,"Yes"
"12058","C7_Immunologic_signatures","C7_ALL_1179_GSE27786_BCELL_VS_CD8_TCELL_UP",199,-1.0358,0.38,0.5,"No",-0.7659,0.98,1,"No"
"12059","GO_BP","508030_GO_0045685_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION",51,-1.0357,0.41,0.58,"No",0.7905,0.86,1,"Yes"
"12060","GO_BP","508157_GO_0045836_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION",13,-1.0356,0.42,0.58,"No",1.048,0.4,0.95,"Yes"
"12061","GO_BP","491871_GO_0007044_CELL_SUBSTRATE_JUNCTION_ASSEMBLY",39,-1.0356,0.4,0.58,"No",-0.7579,0.85,1,"No"
"12062","C7_Immunologic_signatures","C7_ALL_1342_GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN",199,-1.0356,0.39,0.5,"No",1.4903,0.0026,0.014,"Yes"
"12063","C2_Chemical_and_genetic_perturbations","C2_CGP_638_SEIDEN_ONCOGENESIS_BY_MET",88,-1.0356,0.41,0.51,"No",1.9634,0,0.01,"Yes"
"12064","GO_BP","505649_GO_0042518_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",5,-1.0356,0.45,0.58,"No",-0.6079,0.91,1,"No"
"12065","GO_BP","491649_GO_0006776_VITAMIN_A_METABOLIC_PROCESS",8,-1.0355,0.43,0.58,"No",1.1726,0.26,0.81,"Yes"
"12066","C7_Immunologic_signatures","C7_ALL_1363_GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP",191,-1.0353,0.39,0.5,"No",-1.0798,0.28,1,"No"
"12067","C3_TF_targets","C3_TFT_31_V_NMYC_01",269,-1.0353,0.39,0.49,"No",1.0555,0.3,1,"Yes"
"12068","GO_MF","490036_GO_0004722_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",53,-1.0353,0.41,0.61,"No",0.942,0.54,0.94,"Yes"
"12069","C3_TF_targets","C3_TFT_181_V_TATA_01",234,-1.0352,0.37,0.49,"No",-1.0476,0.32,0.65,"No"
"12070","C2_Chemical_and_genetic_perturbations","C2_CGP_1216_NIKOLSKY_BREAST_CANCER_19P13_AMPLICON",5,-1.0351,0.44,0.51,"No",-0.8176,0.69,1,"No"
"12071","C6_Oncogenic_signatures","C6_ALL_131_RPS14_DN_V1_DN",183,-1.035,0.38,0.45,"No",-0.828,0.89,0.96,"No"
"12072","GO_CC","505714_GO_0042587_GLYCOGEN_GRANULE",6,-1.0349,0.43,0.69,"No",0.9199,0.55,0.87,"Yes"
"12073","C1_Positional","C1_ALL_35_CHR12Q14",41,-1.0349,0.41,0.85,"No",0.9163,0.64,0.84,"Yes"
"12074","GO_BP","506285_GO_0043217_MYELIN_MAINTENANCE",12,-1.0349,0.44,0.58,"No",0.7373,0.81,1,"Yes"
"12075","GO_BP","487857_GO_0001967_SUCKLING_BEHAVIOR",14,-1.0348,0.42,0.58,"No",-0.7402,0.81,1,"No"
"12076","C7_Immunologic_signatures","C7_ALL_1570_GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN",194,-1.0348,0.39,0.5,"No",-1.0859,0.24,1,"No"
"12077","GO_CC","849733_GO_0036379_MYOFILAMENT",25,-1.0347,0.4,0.69,"No",-1.2786,0.12,0.66,"No"
"12078","C1_Positional","C1_ALL_290_CHR7Q34",50,-1.0347,0.4,0.85,"No",-0.9013,0.64,1,"No"
"12079","GO_BP","517007_GO_0072091_REGULATION_OF_STEM_CELL_PROLIFERATION",89,-1.0346,0.39,0.58,"No",1.0056,0.45,0.98,"Yes"
"12080","C7_Immunologic_signatures","C7_ALL_652_GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDM_DN",196,-1.0346,0.38,0.5,"No",1.1866,0.1,0.25,"Yes"
"12081","GO_MF","495399_GO_0015125_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",9,-1.0346,0.41,0.61,"No",-1.8607,0.0038,0.15,"No"
"12082","GO_MF","495543_GO_0015299_SOLUTE_PROTON_ANTIPORTER_ACTIVITY",16,-1.0345,0.42,0.61,"No",-0.9202,0.55,0.96,"No"
"12083","GO_MF","486607_GO_0000062_FATTY_ACYL_COA_BINDING",18,-1.0341,0.43,0.61,"No",0.6427,0.94,1,"Yes"
"12084","C7_Immunologic_signatures","C7_ALL_1908_GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN",198,-1.0341,0.4,0.5,"No",1.0377,0.33,0.62,"Yes"
"12085","REACTOME","119554_REACT_19358_CD28_DEPENDENT_PI3K_AKT_SIGNALING",21,-1.034,0.4,0.6,"No",0.6072,0.99,1,"Yes"
"12086","GO_BP","502235_GO_0033013_TETRAPYRROLE_METABOLIC_PROCESS",59,-1.0339,0.43,0.58,"No",1.3414,0.074,0.62,"Yes"
"12087","C2_Chemical_and_genetic_perturbations","C2_CGP_1883_WHITESIDE_CISPLATIN_RESISTANCE_DN",12,-1.0339,0.44,0.51,"No",1.9074,0.002,0.018,"Yes"
"12088","GO_BP","492547_GO_0008206_BILE_ACID_METABOLIC_PROCESS",38,-1.0338,0.4,0.58,"No",1.1086,0.3,0.89,"Yes"
"12089","GO_MF","511930_GO_0050997_QUATERNARY_AMMONIUM_GROUP_BINDING",34,-1.0337,0.41,0.61,"No",-1.7598,0.0054,0.23,"No"
"12090","C7_Immunologic_signatures","C7_ALL_563_GSE17721_PAM3CSK4_VS_CPG_0_5H_BMDM_UP",199,-1.0337,0.41,0.5,"No",-0.9441,0.59,1,"No"
"12091","GO_MF","498053_GO_0019198_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY",17,-1.0335,0.44,0.61,"No",1.423,0.062,0.47,"Yes"
"12092","GO_CC","490818_GO_0005790_SMOOTH_ENDOPLASMIC_RETICULUM",30,-1.0335,0.41,0.69,"No",1.0466,0.37,0.72,"Yes"
"12093","C7_Immunologic_signatures","C7_ALL_541_GSE17721_LPS_VS_POLYIC_16H_BMDM_UP",198,-1.0335,0.41,0.5,"No",1.525,0,0.0089,"Yes"
"12094","REACTOME","106055_REACT_15443_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS",15,-1.0334,0.42,0.6,"No",1.8767,0,0.01,"Yes"
"12095","REACTOME","771575_REACT_160111_UBIQUINOL_BIOSYNTHESIS",7,-1.0334,0.43,0.6,"No",-0.7468,0.75,1,"No"
"12096","GO_BP","515356_GO_0070424_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY",6,-1.0332,0.42,0.58,"No",0.4763,0.99,1,"Yes"
"12097","GO_BP","508114_GO_0045777_POSITIVE_REGULATION_OF_BLOOD_PRESSURE",37,-1.0332,0.41,0.58,"No",1.3506,0.092,0.61,"Yes"
"12098","GO_MF","496609_GO_0016679_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS",9,-1.0332,0.41,0.61,"No",1.2639,0.18,0.65,"Yes"
"12099","C1_Positional","C1_ALL_77_CHR3Q24",17,-1.0332,0.43,0.85,"No",0.9588,0.51,0.81,"Yes"
"12100","GO_BP","507939_GO_0045591_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION",6,-1.0331,0.45,0.58,"No",-0.743,0.81,1,"No"
"12101","C7_Immunologic_signatures","C7_ALL_1369_GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP",198,-1.0331,0.39,0.5,"No",1.0407,0.35,0.61,"Yes"
"12102","REACTOME","1127618_REACT_264496_AXIN_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX_ACTIVATING_WNT_SIGNALING",14,-1.0331,0.42,0.6,"No",0.6412,0.91,1,"Yes"
"12103","C4_Cancer_gene_neighborhoods","C4_CGN_119_MORF_JAK3",93,-1.033,0.4,0.63,"No",-1.0404,0.37,0.81,"No"
"12104","C2_Chemical_and_genetic_perturbations","C2_CGP_42_FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN",6,-1.033,0.41,0.52,"No",-0.5122,0.98,1,"No"
"12105","GO_CC","506286_GO_0043218_COMPACT_MYELIN",16,-1.033,0.42,0.69,"No",0.9659,0.48,0.83,"Yes"
"12106","C2_Chemical_and_genetic_perturbations","C2_CGP_3320_FOSTER_KDM1A_TARGETS_DN",209,-1.0329,0.4,0.52,"No",-0.8696,0.81,1,"No"
"12107","C0_Hallmark","H_ALL_47_HALLMARK_SPERMATOGENESIS",132,-1.0328,0.41,0.43,"No",-1.072,0.32,0.86,"No"
"12108","GO_MF","512115_GO_0051219_PHOSPHOPROTEIN_BINDING",50,-1.0327,0.42,0.61,"No",1.2277,0.14,0.7,"Yes"
"12109","GO_BP","513737_GO_0060180_FEMALE_MATING_BEHAVIOR",9,-1.0326,0.43,0.58,"No",0.6659,0.9,1,"Yes"
"12110","GO_BP","515187_GO_0070252_ACTIN_MEDIATED_CELL_CONTRACTION",46,-1.0325,0.4,0.58,"No",-1.025,0.42,0.97,"No"
"12111","GO_BP","512226_GO_0051342_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",8,-1.0325,0.44,0.58,"No",1.0318,0.43,0.97,"Yes"
"12112","GO_BP","487508_GO_0001570_VASCULOGENESIS",64,-1.0324,0.43,0.58,"No",0.821,0.84,1,"Yes"
"12113","REACTOME","1127518_REACT_264034_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE",31,-1.0324,0.42,0.6,"No",-0.4851,1,1,"No"
"12114","C7_Immunologic_signatures","C7_ALL_887_GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP",192,-1.0323,0.4,0.5,"No",-1.3407,0.025,0.37,"No"
"12115","C2_Chemical_and_genetic_perturbations","C2_CGP_1188_COLLIS_PRKDC_SUBSTRATES",19,-1.0322,0.42,0.52,"No",-0.8767,0.63,1,"No"
"12116","C2_Chemical_and_genetic_perturbations","C2_CGP_691_MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA",16,-1.0322,0.41,0.52,"No",0.3584,1,1,"Yes"
"12117","GO_MF","492488_GO_0008131_PRIMARY_AMINE_OXIDASE_ACTIVITY",6,-1.0322,0.46,0.61,"No",-1.2036,0.28,0.81,"No"
"12118","GO_CC","507222_GO_0044215_OTHER_ORGANISM",12,-1.0321,0.45,0.69,"No",-1.3746,0.11,0.62,"No"
"12119","GO_BP","1184426_GO_1903900_REGULATION_OF_VIRAL_LIFE_CYCLE",175,-1.0321,0.39,0.58,"No",1.688,0,0.21,"Yes"
"12120","GO_BP","495880_GO_0015749_MONOSACCHARIDE_TRANSPORT",74,-1.032,0.4,0.58,"No",0.8737,0.75,1,"Yes"
"12121","C2_Chemical_and_genetic_perturbations","C2_CGP_428_GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN",229,-1.032,0.4,0.52,"No",-0.9706,0.55,1,"No"
"12122","GO_CC","515022_GO_0070083_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE_MEMBRANE",5,-1.0319,0.48,0.69,"No",-0.7036,0.83,1,"No"
"12123","GO_MF","496676_GO_0016763_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS",50,-1.0318,0.41,0.61,"No",-0.604,0.99,1,"No"
"12124","REACTOME","1127623_REACT_263893_TRUNCATIONS_OF_AMER1_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0318,0.45,0.6,"No",0.6496,0.91,1,"Yes"
"12125","C2_BioCarta_Pathways","C2_CP_BIOCARTA_186_BIOCARTA_SPRY_PATHWAY",18,-1.0317,0.42,0.55,"No",-0.9272,0.56,1,"No"
"12126","C7_Immunologic_signatures","C7_ALL_756_GSE17721_0_5H_VS_4H_GARDIQUIMOD_BMDM_DN",198,-1.0316,0.41,0.5,"No",1.0774,0.25,0.51,"Yes"
"12127","GO_BP","494289_GO_0010212_RESPONSE_TO_IONIZING_RADIATION",125,-1.0316,0.4,0.58,"No",0.9119,0.63,1,"Yes"
"12128","GO_BP","488880_GO_0003084_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",15,-1.0316,0.42,0.58,"No",1.0386,0.39,0.96,"Yes"
"12129","KEGG_compound","C00067_FORMALDEHYDE_METHANAL_OXOMETHANE_OXOMETHYLENE_METHYLENE_OXIDE_FORMALIN",12,-1.0316,0.44,0.59,"No",-1.2192,0.22,0.76,"No"
"12130","C2_Chemical_and_genetic_perturbations","C2_CGP_2452_BEIER_GLIOMA_STEM_CELL_UP",37,-1.0316,0.42,0.52,"No",0.7458,0.88,1,"Yes"
"12131","GO_BP","488955_GO_0003161_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT",14,-1.0315,0.42,0.58,"No",0.7143,0.86,1,"Yes"
"12132","GO_CC","499594_GO_0030176_INTEGRAL_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",113,-1.0313,0.41,0.69,"No",0.886,0.75,0.91,"Yes"
"12133","C1_Positional","C1_ALL_308_CHR6Q12",16,-1.0313,0.43,0.84,"No",-0.7692,0.78,0.96,"No"
"12134","GO_BP","1184543_GO_1904019_EPITHELIAL_CELL_APOPTOTIC_PROCESS",22,-1.0313,0.41,0.58,"No",1.0213,0.44,0.97,"Yes"
"12135","GO_BP","777516_GO_0044772_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",295,-1.0312,0.39,0.58,"No",1.1156,0.13,0.88,"Yes"
"12136","C2_Chemical_and_genetic_perturbations","C2_CGP_2852_CAIRO_HEPATOBLASTOMA_UP",207,-1.0311,0.41,0.52,"No",1.1199,0.18,0.6,"Yes"
"12137","C7_Immunologic_signatures","C7_ALL_110_GSE12366_GC_VS_NAIVE_BCELL_DN",196,-1.031,0.4,0.5,"No",0.8938,0.78,1,"Yes"
"12138","C1_Positional","C1_ALL_129_CHR7P14",47,-1.031,0.42,0.84,"No",0.9752,0.51,0.79,"Yes"
"12139","C3_TF_targets","C3_TFT_578_RGTTAMWNATT_V_HNF1_01",70,-1.0309,0.42,0.5,"No",0.9624,0.53,1,"Yes"
"12140","C2_Chemical_and_genetic_perturbations","C2_CGP_2227_MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP",18,-1.0308,0.43,0.52,"No",1.5382,0.039,0.18,"Yes"
"12141","GO_CC","487104_GO_0000813_ESCRT_I_COMPLEX",9,-1.0308,0.42,0.69,"No",1.1384,0.3,0.6,"Yes"
"12142","KEGG_module","HSA_M00095_C5_ISOPRENOID_BIOSYNTHESIS_MEVALONATE_PATHWAY",10,-1.0307,0.43,0.73,"No",-0.9281,0.54,1,"No"
"12143","REACTOME","106044_REACT_2202_EFFECTS_OF_PIP2_HYDROLYSIS",25,-1.0307,0.41,0.61,"No",-1.5953,0.019,0.33,"No"
"12144","REACTOME","119544_REACT_19241_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_ALPHA_PPARALPHA_",114,-1.0305,0.41,0.6,"No",-0.7112,0.98,1,"No"
"12145","C4_Cancer_modules","C4_CM_371_MODULE_455",37,-1.0303,0.42,0.53,"No",0.7135,0.92,1,"Yes"
"12146","KEGG_compound","C00026_2_OXOGLUTARATE_OXOGLUTARIC_ACID_2_KETOGLUTARIC_ACID_ALPHA_KETOGLUTARIC_ACID",42,-1.0303,0.41,0.59,"No",-0.9347,0.56,1,"No"
"12147","GO_BP","494592_GO_0010523_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",9,-1.0302,0.43,0.58,"No",-1.2401,0.19,0.91,"No"
"12148","GO_BP","506942_GO_0043922_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION",13,-1.0301,0.43,0.58,"No",0.7852,0.75,1,"Yes"
"12149","GO_MF","507697_GO_0045340_MERCURY_ION_BINDING",5,-1.0301,0.44,0.61,"No",1.1652,0.32,0.73,"Yes"
"12150","KEGG_compound","C00631_2_PHOSPHO_D_GLYCERATE_D_GLYCERATE_2_PHOSPHATE_2_PHOSPHO_R_GLYCERATE",8,-1.03,0.43,0.58,"No",-0.759,0.77,1,"No"
"12151","C3_TF_targets","C3_TFT_157_V_SREBP1_02",87,-1.03,0.42,0.5,"No",-0.8774,0.72,0.98,"No"
"12152","C2_BioCarta_Pathways","C2_CP_BIOCARTA_12_BIOCARTA_ALK_PATHWAY",36,-1.03,0.43,0.55,"No",-0.8923,0.65,1,"No"
"12153","GO_BP","494885_GO_0010821_REGULATION_OF_MITOCHONDRION_ORGANIZATION",302,-1.0298,0.41,0.58,"No",1.2041,0.043,0.78,"Yes"
"12154","C3_TF_targets","C3_TFT_85_V_PBX1_02",125,-1.0298,0.42,0.5,"No",0.7679,0.96,1,"Yes"
"12155","C2_Chemical_and_genetic_perturbations","C2_CGP_2673_ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN",15,-1.0296,0.43,0.52,"No",0.731,0.85,1,"Yes"
"12156","C2_Chemical_and_genetic_perturbations","C2_CGP_806_DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN",483,-1.0295,0.4,0.52,"No",-0.5747,1,1,"No"
"12157","C4_Cancer_modules","C4_CM_421_MODULE_552",18,-1.0295,0.44,0.53,"No",-0.7339,0.84,1,"No"
"12158","C4_Cancer_modules","C4_CM_307_MODULE_356",146,-1.0294,0.4,0.53,"No",0.9149,0.73,0.82,"Yes"
"12159","GO_BP","754133_GO_1901166_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT",5,-1.0294,0.46,0.59,"No",1.3653,0.15,0.6,"Yes"
"12160","C4_Cancer_modules","C4_CM_374_MODULE_458",36,-1.0292,0.42,0.53,"No",-1.2015,0.17,0.62,"No"
"12161","C2_Chemical_and_genetic_perturbations","C2_CGP_2821_PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP",56,-1.0291,0.43,0.52,"No",1.2513,0.12,0.44,"Yes"
"12162","GO_BP","492016_GO_0007218_NEUROPEPTIDE_SIGNALING_PATHWAY",80,-1.0291,0.42,0.59,"No",-0.9895,0.48,1,"No"
"12163","GO_BP","754301_GO_1901339_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",6,-1.0291,0.44,0.59,"No",-0.6785,0.85,1,"No"
"12164","C4_Cancer_modules","C4_CM_68_MODULE_72",306,-1.0288,0.41,0.53,"No",1.202,0.064,0.39,"Yes"
"12165","GO_BP","491432_GO_0006536_GLUTAMATE_METABOLIC_PROCESS",21,-1.0287,0.41,0.59,"No",0.7572,0.83,1,"Yes"
"12166","GO_BP","510872_GO_0048821_ERYTHROCYTE_DEVELOPMENT",27,-1.0287,0.43,0.59,"No",1.396,0.086,0.56,"Yes"
"12167","C4_Cancer_gene_neighborhoods","C4_CGN_243_GCM_MSN",28,-1.0285,0.43,0.64,"No",1.5112,0.021,0.029,"Yes"
"12168","GO_BP","499135_GO_0021855_HYPOTHALAMUS_CELL_MIGRATION",5,-1.0284,0.45,0.59,"No",1.3311,0.17,0.63,"Yes"
"12169","KEGG_compound","C01134_PANTETHEINE_4_PHOSPHATE_4_PHOSPHOPANTETHEINE_PHOSPHOPANTETHEINE_D_PANTETHEINE_4_PHOSPHATE",9,-1.0283,0.41,0.59,"No",-0.597,0.93,1,"No"
"12170","C3_MicroRNA_targets","C3_MIR_113_AATGGAG_MIR_136",79,-1.0282,0.42,0.59,"No",0.7775,0.9,1,"Yes"
"12171","C6_Oncogenic_signatures","C6_ALL_186_KRAS_PROSTATE_UP_V1_DN",134,-1.0281,0.42,0.46,"No",1.1785,0.13,0.42,"Yes"
"12172","REACTOME","1127533_REACT_267785_SIGNALING_BY_RETINOIC_ACID",40,-1.028,0.4,0.61,"No",-1.328,0.081,0.61,"No"
"12173","KEGG_compound","C00670_SN_GLYCERO_3_PHOSPHOCHOLINE_GLYCEROPHOSPHOCHOLINE",8,-1.0278,0.42,0.59,"No",-0.889,0.59,1,"No"
"12174","C2_Chemical_and_genetic_perturbations","C2_CGP_896_WANG_RESPONSE_TO_BEXAROTENE_UP",33,-1.0278,0.42,0.52,"No",1.1759,0.24,0.53,"Yes"
"12175","C7_Immunologic_signatures","C7_ALL_820_GSE17974_0_5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN",198,-1.0277,0.41,0.51,"No",0.9339,0.65,0.94,"Yes"
"12176","REACTOME","530749_REACT_116145_PPARA_ACTIVATES_GENE_EXPRESSION",111,-1.0277,0.4,0.61,"No",-0.6628,0.99,1,"No"
"12177","C2_Chemical_and_genetic_perturbations","C2_CGP_3343_HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP",38,-1.0275,0.42,0.52,"No",0.7366,0.91,1,"Yes"
"12178","C7_Immunologic_signatures","C7_ALL_552_GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_DN",198,-1.0274,0.43,0.51,"No",0.9377,0.63,0.94,"Yes"
"12179","GO_MF","489888_GO_0004551_NUCLEOTIDE_DIPHOSPHATASE_ACTIVITY",9,-1.0274,0.42,0.62,"No",1.0852,0.35,0.81,"Yes"
"12180","GO_BP","777514_GO_0044770_CELL_CYCLE_PHASE_TRANSITION",300,-1.0274,0.42,0.59,"No",1.1198,0.15,0.88,"Yes"
"12181","C7_Immunologic_signatures","C7_ALL_959_GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP",200,-1.0274,0.41,0.51,"No",1.7437,0,0.00034,"Yes"
"12182","C3_TF_targets","C3_TFT_474_V_PR_01",140,-1.0273,0.41,0.51,"No",0.948,0.57,1,"Yes"
"12183","GO_BP","755365_GO_2001259_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY",31,-1.0273,0.42,0.59,"No",-0.6516,0.94,1,"No"
"12184","GO_BP","491727_GO_0006862_NUCLEOTIDE_TRANSPORT",21,-1.0272,0.43,0.59,"No",-0.8599,0.69,1,"No"
"12185","GO_BP","510889_GO_0048839_INNER_EAR_DEVELOPMENT",172,-1.0272,0.4,0.59,"No",1.0107,0.39,0.98,"Yes"
"12186","C2_Chemical_and_genetic_perturbations","C2_CGP_707_SCHLOSSER_SERUM_RESPONSE_UP",131,-1.0272,0.41,0.52,"No",-1.275,0.068,0.71,"No"
"12187","REACTOME","576269_REACT_118859_SIGNALING_BY_NOTCH1",73,-1.027,0.42,0.61,"No",-0.7173,0.96,1,"No"
"12188","GO_CC","504863_GO_0035686_SPERM_FIBROUS_SHEATH",10,-1.0269,0.44,0.7,"No",-1.4746,0.076,0.61,"No"
"12189","GO_BP","499860_GO_0030521_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",41,-1.0269,0.42,0.59,"No",-0.9769,0.48,1,"No"
"12190","GO_BP","491057_GO_0006072_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS",6,-1.0267,0.42,0.59,"No",1.3295,0.14,0.63,"Yes"
"12191","REACTOME","106446_REACT_13526_NADE_MODULATES_DEATH_SIGNALLING",6,-1.0266,0.45,0.61,"No",0.5025,0.98,1,"Yes"
"12192","C7_Immunologic_signatures","C7_ALL_724_GSE17721_0_5H_VS_24H_POLYIC_BMDM_DN",196,-1.0266,0.42,0.52,"No",0.8008,0.95,1,"Yes"
"12193","C7_Immunologic_signatures","C7_ALL_30_GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN",200,-1.0265,0.4,0.51,"No",1.1376,0.14,0.34,"Yes"
"12194","C2_Chemical_and_genetic_perturbations","C2_CGP_2293_WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN",37,-1.0265,0.43,0.53,"No",-1.4406,0.061,0.53,"No"
"12195","GO_BP","519375_GO_2000736_REGULATION_OF_STEM_CELL_DIFFERENTIATION",100,-1.0262,0.42,0.59,"No",-0.9823,0.5,1,"No"
"12196","GO_MF","511311_GO_0050321_TAU_PROTEIN_KINASE_ACTIVITY",12,-1.0262,0.42,0.62,"No",-0.9528,0.51,0.95,"No"
"12197","GO_MF","489895_GO_0004559_ALPHA_MANNOSIDASE_ACTIVITY",14,-1.0262,0.41,0.62,"No",-0.3804,1,1,"No"
"12198","C7_Immunologic_signatures","C7_ALL_428_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN",195,-1.0262,0.41,0.52,"No",1.4081,0.0047,0.035,"Yes"
"12199","GO_BP","493339_GO_0009142_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",81,-1.0262,0.41,0.59,"No",1.1586,0.19,0.83,"Yes"
"12200","C7_Immunologic_signatures","C7_ALL_667_GSE17721_LPS_VS_CPG_16H_BMDM_UP",195,-1.0259,0.42,0.52,"No",0.9458,0.59,0.91,"Yes"
"12201","GO_BP","488775_GO_0002902_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS",18,-1.0258,0.44,0.59,"No",0.4903,1,1,"Yes"
"12202","C3_TF_targets","C3_TFT_303_V_STAT1_03",244,-1.0258,0.4,0.51,"No",-0.8942,0.78,0.97,"No"
"12203","GO_BP","500260_GO_0030968_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",100,-1.0258,0.41,0.59,"No",0.7085,0.97,1,"Yes"
"12204","GO_BP","518696_GO_2000047_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN",10,-1.0257,0.43,0.59,"No",1.3572,0.16,0.6,"Yes"
"12205","C2_Chemical_and_genetic_perturbations","C2_CGP_875_CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN",38,-1.0256,0.41,0.53,"No",0.8896,0.63,0.94,"Yes"
"12206","GO_BP","488313_GO_0002440_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",64,-1.0256,0.42,0.59,"No",0.65,1,1,"Yes"
"12207","C2_Chemical_and_genetic_perturbations","C2_CGP_695_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5",5,-1.0256,0.43,0.53,"No",-1.034,0.44,0.97,"No"
"12208","C2_Chemical_and_genetic_perturbations","C2_CGP_2986_NIELSEN_GIST",96,-1.0255,0.41,0.53,"No",-0.7861,0.92,1,"No"
"12209","C7_Immunologic_signatures","C7_ALL_272_GSE14308_INDUCED_VS_NATURAL_TREG_DN",199,-1.0255,0.41,0.52,"No",0.9628,0.6,0.86,"Yes"
"12210","C2_Chemical_and_genetic_perturbations","C2_CGP_264_PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN",43,-1.0255,0.43,0.53,"No",-0.9957,0.45,1,"No"
"12211","GO_BP","512647_GO_0051775_RESPONSE_TO_REDOX_STATE",11,-1.0254,0.44,0.59,"No",0.8019,0.71,1,"Yes"
"12212","C2_Chemical_and_genetic_perturbations","C2_CGP_2989_NIELSEN_SYNOVIAL_SARCOMA_UP",18,-1.0253,0.44,0.53,"No",-0.7327,0.84,1,"No"
"12213","C7_Immunologic_signatures","C7_ALL_145_GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP",200,-1.0251,0.4,0.52,"No",0.9634,0.52,0.86,"Yes"
"12214","C7_Immunologic_signatures","C7_ALL_423_GSE15930_STIM_VS_STIM_AND_IL_12_72H_CD8_T_CELL_UP",197,-1.0251,0.41,0.52,"No",1.1478,0.15,0.32,"Yes"
"12215","GO_BP","491196_GO_0006228_UTP_BIOSYNTHETIC_PROCESS",11,-1.025,0.42,0.59,"No",-0.8476,0.67,1,"No"
"12216","C2_Chemical_and_genetic_perturbations","C2_CGP_3122_BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP",207,-1.025,0.42,0.53,"No",-1.1026,0.22,0.92,"No"
"12217","C7_Immunologic_signatures","C7_ALL_1186_GSE27786_BCELL_VS_ERYTHROBLAST_DN",191,-1.0249,0.41,0.52,"No",-0.9823,0.5,1,"No"
"12218","GO_BP","516284_GO_0071360_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA",8,-1.0248,0.43,0.59,"No",1.5643,0.025,0.34,"Yes"
"12219","GO_MF","492681_GO_0008378_GALACTOSYLTRANSFERASE_ACTIVITY",33,-1.0247,0.43,0.62,"No",1.048,0.39,0.83,"Yes"
"12220","GO_BP","505491_GO_0042347_NEGATIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS",15,-1.0247,0.44,0.59,"No",1.0443,0.39,0.95,"Yes"
"12221","REACTOME","106059_REACT_326_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION",22,-1.0247,0.43,0.61,"No",-1.0889,0.32,0.9,"No"
"12222","GO_MF","495464_GO_0015197_PEPTIDE_TRANSPORTER_ACTIVITY",8,-1.0247,0.45,0.62,"No",-1.4108,0.11,0.67,"No"
"12223","GO_CC","750978_GO_0036056_FILTRATION_DIAPHRAGM",8,-1.0244,0.44,0.7,"No",-1.4035,0.11,0.65,"No"
"12224","WikiPathways","198905_WP229_IRINOTECAN_PATHWAY",13,-1.0241,0.44,0.53,"No",0.5541,0.97,1,"Yes"
"12225","GO_BP","487494_GO_0001556_OOCYTE_MATURATION",17,-1.024,0.41,0.59,"No",-1.3004,0.15,0.89,"No"
"12226","C7_Immunologic_signatures","C7_ALL_1839_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP",198,-1.0237,0.43,0.52,"No",2.0961,0,0,"Yes"
"12227","REACTOME","106456_REACT_11064_ACTIVATION_OF_TRKA_RECEPTORS",6,-1.0237,0.47,0.61,"No",-0.9684,0.51,1,"No"
"12228","GO_MF","490319_GO_0005035_DEATH_RECEPTOR_ACTIVITY",11,-1.0232,0.44,0.62,"No",0.8071,0.73,1,"Yes"
"12229","GO_BP","494759_GO_0010694_POSITIVE_REGULATION_OF_ALKALINE_PHOSPHATASE_ACTIVITY",6,-1.0231,0.44,0.6,"No",-0.7475,0.78,1,"No"
"12230","GO_CC","501653_GO_0032421_STEREOCILIUM_BUNDLE",38,-1.023,0.42,0.7,"No",-1.5396,0.021,0.6,"No"
"12231","C1_Positional","C1_ALL_237_CHRXQ13",67,-1.0229,0.44,0.86,"No",0.9486,0.56,0.82,"Yes"
"12232","GO_BP","1025334_GO_0090594_INFLAMMATORY_RESPONSE_TO_WOUNDING",6,-1.0229,0.45,0.6,"No",0.836,0.66,1,"Yes"
"12233","GO_BP","510726_GO_0048671_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING",7,-1.0228,0.44,0.6,"No",0.5877,0.94,1,"Yes"
"12234","C2_BioCarta_Pathways","C2_CP_BIOCARTA_101_BIOCARTA_IL7_PATHWAY",17,-1.0227,0.43,0.55,"No",1.0262,0.42,0.83,"Yes"
"12235","C2_Chemical_and_genetic_perturbations","C2_CGP_1611_MCCLUNG_DELTA_FOSB_TARGETS_8WK",46,-1.0227,0.45,0.53,"No",0.6258,0.98,1,"Yes"
"12236","KEGG_enzyme","2.4.1.175_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_N_ACETYLGALACTOSAMINYLTRANSFERASE_II_UDP_N_ACETYL_D_GALACTOSAMINE_D_GLUCURONYL_N_ACETYL_1_3_BETA_D_GALACTOSAMINYLPROTEOGLYCAN_BETA_1_4_N_ACETYLGALACTOSAMINYLTRANSFERASE_CHONDROITIN_SYNTHASE_GLUCURONYL_N_ACETYLGALACTOSAMINYLPROTEOGLYCAN_BETA_1_4_N_ACETYLGALACTOSAMINYLTRANSFERASE_URIDINE_DIPHOSPHOACETYLGALACTOSAMINE_CHONDROITIN_ACETYLGALACTOSAMINYLTRANSFERASE_II_UDP_N_ACETYL_D_GALACTOSAMINE_BETA_D_GLUCURONOSYL_1_3_N_ACETYL_BETA_D_GALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE",5,-1.0226,0.45,0.53,"No",0.7204,0.82,1,"Yes"
"12237","GO_CC","499714_GO_0030314_JUNCTIONAL_MEMBRANE_COMPLEX",7,-1.0225,0.44,0.7,"No",0.993,0.46,0.8,"Yes"
"12238","C2_Chemical_and_genetic_perturbations","C2_CGP_2077_ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP",12,-1.0224,0.45,0.53,"No",0.8161,0.71,0.98,"Yes"
"12239","C3_MicroRNA_targets","C3_MIR_154_TACAATC_MIR_508",65,-1.0224,0.43,0.6,"No",1.0124,0.41,1,"Yes"
"12240","REACTOME","645281_REACT_120863_ACTIVATED_POINT_MUTANTS_OF_FGFR2",11,-1.0223,0.44,0.62,"No",-1.43,0.085,0.5,"No"
"12241","C2_Chemical_and_genetic_perturbations","C2_CGP_1411_WONG_IFNA2_RESISTANCE_DN",33,-1.0223,0.4,0.53,"No",1.328,0.092,0.36,"Yes"
"12242","C3_TF_targets","C3_TFT_82_V_USF_02",267,-1.0223,0.4,0.52,"No",1.109,0.18,1,"Yes"
"12243","C7_Immunologic_signatures","C7_ALL_1065_GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP",200,-1.0223,0.42,0.52,"No",1.2928,0.021,0.11,"Yes"
"12244","GO_MF","496936_GO_0017136_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY",16,-1.0222,0.44,0.62,"No",-1.2588,0.19,0.83,"No"
"12245","KEGG_pathway","HSA00250_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM",34,-1.0222,0.43,0.48,"No",-1.2054,0.19,0.52,"No"
"12246","GO_BP","515164_GO_0070229_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS",30,-1.0222,0.43,0.6,"No",0.9023,0.61,1,"Yes"
"12247","C7_Immunologic_signatures","C7_ALL_1306_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN",198,-1.0222,0.42,0.52,"No",1.0679,0.27,0.53,"Yes"
"12248","GO_BP","497073_GO_0018095_PROTEIN_POLYGLUTAMYLATION",9,-1.0222,0.42,0.6,"No",0.8544,0.66,1,"Yes"
"12249","KEGG_module","HSA_M00141_C1_UNIT_INTERCONVERSION_EUKARYOTES",6,-1.0221,0.45,0.74,"No",-0.5373,0.97,1,"No"
"12250","GO_MF","506876_GO_0043855_CYCLIC_NUCLEOTIDE_GATED_ION_CHANNEL_ACTIVITY",11,-1.022,0.45,0.62,"No",0.8799,0.6,1,"Yes"
"12251","C2_Chemical_and_genetic_perturbations","C2_CGP_2987_NIELSEN_LEIOMYOSARCOMA_CNN1_DN",20,-1.0219,0.45,0.53,"No",-0.6567,0.92,1,"No"
"12252","GO_BP","755135_GO_2001029_REGULATION_OF_CELLULAR_GLUCURONIDATION",9,-1.0219,0.44,0.6,"No",0.7104,0.85,1,"Yes"
"12253","C2_Chemical_and_genetic_perturbations","C2_CGP_2276_KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP",9,-1.0218,0.44,0.53,"No",1.1172,0.31,0.6,"Yes"
"12254","C4_Cancer_modules","C4_CM_431_MODULE_576",106,-1.0218,0.42,0.54,"No",0.9475,0.58,0.78,"Yes"
"12255","C1_Positional","C1_ALL_120_CHR6P23",17,-1.0218,0.42,0.85,"No",0.6038,0.97,1,"Yes"
"12256","GO_BP","948084_GO_0061591_CALCIUM_ACTIVATED_GALACTOSYLCERAMIDE_SCRAMBLING",5,-1.0218,0.46,0.6,"No",1.1538,0.32,0.83,"Yes"
"12257","C2_Chemical_and_genetic_perturbations","C2_CGP_1684_NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP",18,-1.0216,0.41,0.53,"No",1.305,0.15,0.39,"Yes"
"12258","C2_Chemical_and_genetic_perturbations","C2_CGP_2439_ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR",11,-1.0216,0.46,0.53,"No",0.8494,0.65,0.97,"Yes"
"12259","C4_Cancer_modules","C4_CM_119_MODULE_124",96,-1.0215,0.4,0.54,"No",1.2704,0.073,0.3,"Yes"
"12260","C3_MicroRNA_targets","C3_MIR_64_GTTTGTT_MIR_495",256,-1.0214,0.43,0.6,"No",1.042,0.29,1,"Yes"
"12261","C3_TF_targets","C3_TFT_323_V_MYCMAX_03",252,-1.0214,0.43,0.52,"No",1.0109,0.43,1,"Yes"
"12262","KEGG_pathway","HSA05223_NON_SMALL_CELL_LUNG_CANCER",56,-1.0213,0.42,0.48,"No",-0.8091,0.8,1,"No"
"12263","C3_MicroRNA_targets","C3_MIR_112_ATATGCA_MIR_448",210,-1.0213,0.42,0.6,"No",0.7566,0.99,1,"Yes"
"12264","C3_TF_targets","C3_TFT_503_RACTNNRTTTNC_UNKNOWN",120,-1.0212,0.43,0.52,"No",-0.6723,1,1,"No"
"12265","C3_MicroRNA_targets","C3_MIR_187_GGCACTT_MIR_519E",120,-1.0211,0.44,0.6,"No",0.7245,0.98,1,"Yes"
"12266","C2_Chemical_and_genetic_perturbations","C2_CGP_810_HEIDENBLAD_AMPLICON_8Q24_DN",46,-1.021,0.41,0.53,"No",0.5332,1,1,"Yes"
"12267","GO_BP","510294_GO_0048169_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY",28,-1.021,0.43,0.6,"No",-0.8986,0.61,1,"No"
"12268","C2_Chemical_and_genetic_perturbations","C2_CGP_2045_HILLION_HMGA1_TARGETS",87,-1.021,0.43,0.53,"No",1.8651,0,0.026,"Yes"
"12269","GO_BP","493419_GO_0009223_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS",9,-1.0209,0.44,0.6,"No",1.4974,0.054,0.41,"Yes"
"12270","KEGG_compound","C00448_TRANS_TRANS_FARNESYL_DIPHOSPHATE_FARNESYL_DIPHOSPHATE_FARNESYL_PYROPHOSPHATE_2_TRANS_6_TRANS_FARNESYL_DIPHOSPHATE_2E_6E_FARNESYL_DIPHOSPHATE",10,-1.0209,0.44,0.6,"No",0.762,0.79,1,"Yes"
"12271","C2_Chemical_and_genetic_perturbations","C2_CGP_177_VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN",131,-1.0209,0.42,0.53,"No",-0.7786,0.94,1,"No"
"12272","GO_BP","510295_GO_0048170_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY",7,-1.0209,0.46,0.6,"No",-1.3915,0.1,1,"No"
"12273","GO_BP","510720_GO_0048665_NEURON_FATE_SPECIFICATION",27,-1.0208,0.44,0.6,"No",1.6313,0.011,0.26,"Yes"
"12274","GO_CC","500560_GO_0031301_INTEGRAL_COMPONENT_OF_ORGANELLE_MEMBRANE",234,-1.0207,0.43,0.7,"No",0.8836,0.84,0.9,"Yes"
"12275","GO_BP","502545_GO_0033327_LEYDIG_CELL_DIFFERENTIATION",12,-1.0207,0.44,0.6,"No",-0.8881,0.61,1,"No"
"12276","GO_BP","518341_GO_0090201_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",18,-1.0206,0.42,0.6,"No",1.3474,0.1,0.61,"Yes"
"12277","GO_BP","492177_GO_0007416_SYNAPSE_ASSEMBLY",56,-1.0205,0.42,0.6,"No",-0.8942,0.64,1,"No"
"12278","C7_Immunologic_signatures","C7_ALL_1098_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN",198,-1.0205,0.41,0.53,"No",1.41,0.0026,0.035,"Yes"
"12279","C2_Chemical_and_genetic_perturbations","C2_CGP_2776_MIKKELSEN_IPS_ICP_WITH_H3K27ME3",51,-1.0204,0.43,0.54,"No",-1.155,0.21,0.84,"No"
"12280","REACTOME","366222_REACT_75896_CA2_ACTIVATED_K_CHANNELS",9,-1.0204,0.43,0.62,"No",0.8224,0.71,0.98,"Yes"
"12281","C3_TF_targets","C3_TFT_49_V_EVI1_01",16,-1.0204,0.45,0.52,"No",0.9631,0.51,1,"Yes"
"12282","C7_Immunologic_signatures","C7_ALL_1367_GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP",198,-1.0204,0.43,0.53,"No",1.134,0.15,0.35,"Yes"
"12283","C7_Immunologic_signatures","C7_ALL_357_GSE15659_TREG_VS_TCONV_UP",183,-1.0204,0.44,0.53,"No",-0.9757,0.5,1,"No"
"12284","C2_Chemical_and_genetic_perturbations","C2_CGP_11_NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP",280,-1.0203,0.45,0.54,"No",1.2984,0.02,0.39,"Yes"
"12285","C3_MicroRNA_targets","C3_MIR_19_AAGTCCA_MIR_422B_MIR_422A",70,-1.0203,0.4,0.59,"No",-0.9177,0.63,1,"No"
"12286","GO_BP","501642_GO_0032410_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY",47,-1.0199,0.41,0.6,"No",1.0309,0.38,0.97,"Yes"
"12287","C3_MicroRNA_targets","C3_MIR_81_GGTGAAG_MIR_412",60,-1.0197,0.42,0.59,"No",-0.8314,0.79,1,"No"
"12288","REACTOME","187181_REACT_25330_ACTIVATION_OF_GABAB_RECEPTORS",38,-1.0196,0.46,0.62,"No",-0.9149,0.58,1,"No"
"12289","C7_Immunologic_signatures","C7_ALL_1185_GSE27786_BCELL_VS_ERYTHROBLAST_UP",198,-1.0196,0.44,0.53,"No",1.0475,0.33,0.6,"Yes"
"12290","KEGG_pathway","HSA00270_CYSTEINE_AND_METHIONINE_METABOLISM",36,-1.0195,0.43,0.48,"No",0.9641,0.51,0.95,"Yes"
"12291","C1_Positional","C1_ALL_213_CHR7Q",9,-1.0195,0.43,0.85,"No",1.2013,0.25,0.64,"Yes"
"12292","GO_CC","501222_GO_0031984_ORGANELLE_SUBCOMPARTMENT",280,-1.0193,0.42,0.7,"No",1.0099,0.41,0.77,"Yes"
"12293","C2_Chemical_and_genetic_perturbations","C2_CGP_1029_GOUYER_TATI_TARGETS_DN",17,-1.0193,0.45,0.54,"No",-1.5367,0.046,0.43,"No"
"12294","GO_BP","501822_GO_0032596_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT",6,-1.0192,0.47,0.6,"No",-0.7837,0.74,1,"No"
"12295","C6_Oncogenic_signatures","C6_ALL_124_RB_P107_DN_V1_UP",131,-1.0191,0.44,0.48,"No",0.9416,0.62,0.93,"Yes"
"12296","GO_CC","515020_GO_0070081_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE",5,-1.0191,0.46,0.7,"No",-0.6987,0.81,1,"No"
"12297","C7_Immunologic_signatures","C7_ALL_1403_GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP",197,-1.019,0.44,0.53,"No",2.3086,0,0,"Yes"
"12298","GO_CC","500488_GO_0031227_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",118,-1.0188,0.43,0.7,"No",0.8566,0.82,0.92,"Yes"
"12299","C7_Immunologic_signatures","C7_ALL_1792_GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN",194,-1.0188,0.45,0.53,"No",-0.914,0.69,1,"No"
"12300","C2_Chemical_and_genetic_perturbations","C2_CGP_377_CHOW_RASSF1_TARGETS_UP",27,-1.0188,0.42,0.54,"No",1.4441,0.053,0.26,"Yes"
"12301","REACTOME","645280_REACT_121155_FGFR2_MUTANT_RECEPTOR_ACTIVATION",11,-1.0187,0.44,0.62,"No",-1.4221,0.085,0.49,"No"
"12302","C4_Cancer_modules","C4_CM_219_MODULE_240",18,-1.0182,0.43,0.55,"No",0.8673,0.64,0.89,"Yes"
"12303","C7_Immunologic_signatures","C7_ALL_1565_GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP",193,-1.0182,0.42,0.53,"No",1.6016,0.0023,0.003,"Yes"
"12304","C2_Chemical_and_genetic_perturbations","C2_CGP_2794_NAKAYAMA_FGF2_TARGETS",29,-1.0182,0.44,0.54,"No",1.6561,0.015,0.11,"Yes"
"12305","GO_BP","499727_GO_0030326_EMBRYONIC_LIMB_MORPHOGENESIS",126,-1.018,0.42,0.6,"No",-0.93,0.63,1,"No"
"12306","C7_Immunologic_signatures","C7_ALL_684_GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDM_DN",199,-1.018,0.43,0.53,"No",1.4988,0,0.013,"Yes"
"12307","GO_BP","491867_GO_0007040_LYSOSOME_ORGANIZATION",46,-1.018,0.42,0.6,"No",0.7053,0.94,1,"Yes"
"12308","C2_Chemical_and_genetic_perturbations","C2_CGP_1970_MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN",271,-1.018,0.42,0.54,"No",1.4454,0,0.26,"Yes"
"12309","REACTOME","106151_REACT_11038_PREGNENOLONE_BIOSYNTHESIS",9,-1.018,0.44,0.62,"No",-1.0309,0.42,0.97,"No"
"12310","GO_BP","503239_GO_0034030_RIBONUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",17,-1.0179,0.44,0.6,"No",-0.9243,0.54,1,"No"
"12311","KEGG_module","HSA_M00676_PI3K_AKT_SIGNALING",15,-1.0177,0.43,0.73,"No",0.7875,0.75,0.92,"Yes"
"12312","GO_BP","514593_GO_0061045_NEGATIVE_REGULATION_OF_WOUND_HEALING",51,-1.0177,0.45,0.6,"No",1.2071,0.16,0.78,"Yes"
"12313","C2_Chemical_and_genetic_perturbations","C2_CGP_2043_HOWLIN_CITED1_TARGETS_2_UP",17,-1.0176,0.43,0.54,"No",0.8728,0.64,0.95,"Yes"
"12314","C7_Immunologic_signatures","C7_ALL_561_GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_UP",200,-1.0175,0.43,0.53,"No",1.0351,0.38,0.63,"Yes"
"12315","REACTOME","187212_REACT_25325_AUF1_HNRNP_D0_DESTABILIZES_MRNA",55,-1.0175,0.42,0.62,"No",1.8182,0,0.018,"Yes"
"12316","GO_BP","491264_GO_0006305_DNA_ALKYLATION",73,-1.0175,0.44,0.6,"No",-1.7023,0,0.68,"No"
"12317","C7_Immunologic_signatures","C7_ALL_580_GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_DN",198,-1.0175,0.43,0.53,"No",1.0452,0.33,0.6,"Yes"
"12318","C3_TF_targets","C3_TFT_238_CCGNMNNTNACG_UNKNOWN",77,-1.0174,0.44,0.53,"No",0.898,0.66,1,"Yes"
"12319","C7_Immunologic_signatures","C7_ALL_497_GSE17721_CTRL_VS_CPG_1H_BMDM_UP",198,-1.0174,0.43,0.53,"No",1.1943,0.11,0.24,"Yes"
"12320","C4_Cancer_modules","C4_CM_192_MODULE_205",297,-1.0173,0.45,0.55,"No",-0.9425,0.64,0.89,"No"
"12321","WikiPathways","219802_WP1982_SREBP_SIGNALLING",60,-1.0171,0.42,0.54,"No",0.8677,0.74,1,"Yes"
"12322","C2_Chemical_and_genetic_perturbations","C2_CGP_2512_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN",39,-1.017,0.44,0.54,"No",0.9274,0.58,0.89,"Yes"
"12323","C2_Chemical_and_genetic_perturbations","C2_CGP_145_WANG_RESPONSE_TO_FORSKOLIN_DN",9,-1.017,0.44,0.54,"No",0.689,0.87,1,"Yes"
"12324","C2_Chemical_and_genetic_perturbations","C2_CGP_473_BARIS_THYROID_CANCER_UP",23,-1.0169,0.43,0.54,"No",0.8956,0.6,0.93,"Yes"
"12325","GO_BP","518095_GO_0080171_LYTIC_VACUOLE_ORGANIZATION",46,-1.0169,0.43,0.61,"No",0.6903,0.94,1,"Yes"
"12326","WikiPathways","920977_WP2446_RB_IN_CANCER",87,-1.0166,0.45,0.54,"No",0.9444,0.58,1,"Yes"
"12327","GO_MF","492840_GO_0016887_ATPASE_ACTIVITY",386,-1.0166,0.43,0.63,"No",-0.8637,0.91,1,"No"
"12328","C2_BioCarta_Pathways","C2_CP_BIOCARTA_216_BIOCARTA_WNT_PATHWAY",26,-1.0165,0.44,0.56,"No",0.6341,0.96,1,"Yes"
"12329","GO_BP","495989_GO_0015865_PURINE_NUCLEOTIDE_TRANSPORT",9,-1.0164,0.44,0.61,"No",-0.6798,0.86,1,"No"
"12330","C3_MicroRNA_targets","C3_MIR_82_AGGGCCA_MIR_328",79,-1.0164,0.43,0.6,"No",-0.8117,0.84,1,"No"
"12331","C2_Chemical_and_genetic_perturbations","C2_CGP_1723_WESTON_VEGFA_TARGETS_12HR",32,-1.0164,0.43,0.54,"No",1.0634,0.32,0.69,"Yes"
"12332","C7_Immunologic_signatures","C7_ALL_1638_GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN",197,-1.0163,0.45,0.54,"No",1.1052,0.2,0.43,"Yes"
"12333","GO_BP","503572_GO_0034370_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING",9,-1.0163,0.44,0.61,"No",-1.3214,0.13,0.89,"No"
"12334","GO_BP","750874_GO_0035947_REGULATION_OF_GLUCONEOGENESIS_BY_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",5,-1.0163,0.46,0.61,"No",-0.776,0.75,1,"No"
"12335","GO_BP","487982_GO_0002093_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS",12,-1.0163,0.43,0.61,"No",0.6613,0.87,1,"Yes"
"12336","GO_CC","506287_GO_0043219_LATERAL_LOOP",5,-1.0162,0.45,0.71,"No",0.7431,0.79,0.98,"Yes"
"12337","C3_TF_targets","C3_TFT_12_V_ATF_01",253,-1.0161,0.44,0.53,"No",-0.79,0.97,1,"No"
"12338","GO_BP","948081_GO_0061588_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING",5,-1.0161,0.48,0.61,"No",1.1419,0.32,0.85,"Yes"
"12339","GO_BP","752706_GO_0097205_RENAL_FILTRATION",10,-1.0161,0.45,0.61,"No",-0.6092,0.95,1,"No"
"12340","REACTOME","105807_REACT_15479_CENTROSOME_MATURATION",72,-1.016,0.44,0.62,"No",-0.8813,0.7,1,"No"
"12341","GO_CC","490734_GO_0005680_ANAPHASE_PROMOTING_COMPLEX",21,-1.0159,0.43,0.71,"No",0.997,0.47,0.79,"Yes"
"12342","GO_BP","505381_GO_0042220_RESPONSE_TO_COCAINE",35,-1.0159,0.45,0.61,"No",-0.8549,0.69,1,"No"
"12343","C2_Chemical_and_genetic_perturbations","C2_CGP_3235_SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN",8,-1.0158,0.44,0.54,"No",1.341,0.12,0.35,"Yes"
"12344","C2_Chemical_and_genetic_perturbations","C2_CGP_2123_KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3",88,-1.0157,0.43,0.54,"No",1.0121,0.44,0.78,"Yes"
"12345","GO_BP","488640_GO_0002767_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",5,-1.0157,0.47,0.61,"No",0.8439,0.66,1,"Yes"
"12346","C3_TF_targets","C3_TFT_321_V_HTF_01",71,-1.0156,0.43,0.53,"No",-0.7075,0.96,1,"No"
"12347","KEGG_compound","C00245_TAURINE_2_AMINOETHANESULFONIC_ACID_AMINOETHYLSULFONIC_ACID",7,-1.0155,0.45,0.6,"No",0.7587,0.78,1,"Yes"
"12348","GO_BP","491144_GO_0006172_ADP_BIOSYNTHETIC_PROCESS",5,-1.0153,0.44,0.61,"No",-0.7835,0.73,1,"No"
"12349","C2_Chemical_and_genetic_perturbations","C2_CGP_3300_FU_INTERACT_WITH_ALKBH8",13,-1.0153,0.45,0.54,"No",1.8422,0.004,0.03,"Yes"
"12350","C3_TF_targets","C3_TFT_516_SYATTGTG_UNKNOWN",228,-1.0152,0.44,0.53,"No",-1.2033,0.082,0.35,"No"
"12351","GO_CC","750979_GO_0036057_SLIT_DIAPHRAGM",8,-1.0152,0.45,0.71,"No",-1.4185,0.084,0.67,"No"
"12352","C7_Immunologic_signatures","C7_ALL_127_GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP",197,-1.0151,0.45,0.54,"No",1.9588,0,0,"Yes"
"12353","C7_Immunologic_signatures","C7_ALL_1318_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN",198,-1.015,0.45,0.54,"No",1.7611,0,0.00026,"Yes"
"12354","GO_BP","752679_GO_0097178_RUFFLE_ASSEMBLY",9,-1.0149,0.45,0.61,"No",-0.8103,0.7,1,"No"
"12355","GO_BP","491778_GO_0006927_TRANSFORMED_CELL_APOPTOTIC_PROCESS",7,-1.0147,0.45,0.61,"No",-0.8511,0.67,1,"No"
"12356","KEGG_module","HSA_M00679_BMP_SIGNALING",22,-1.0146,0.46,0.72,"No",-0.9703,0.49,1,"No"
"12357","GO_BP","753043_GO_1900047_NEGATIVE_REGULATION_OF_HEMOSTASIS",43,-1.0146,0.44,0.61,"No",1.3216,0.093,0.64,"Yes"
"12358","REACTOME","106334_REACT_12472_REGULATORY_RNA_PATHWAYS",128,-1.0145,0.43,0.62,"No",-1.1282,0.2,0.89,"No"
"12359","C2_BioCarta_Pathways","C2_CP_BIOCARTA_5_BIOCARTA_AMI_PATHWAY",20,-1.0145,0.44,0.56,"No",1.4603,0.073,0.43,"Yes"
"12360","GO_BP","506170_GO_0043090_AMINO_ACID_IMPORT",14,-1.0144,0.44,0.61,"No",-0.8417,0.64,1,"No"
"12361","GO_BP","514523_GO_0060968_REGULATION_OF_GENE_SILENCING",37,-1.0143,0.45,0.61,"No",-1.351,0.092,0.93,"No"
"12362","GO_CC","490920_GO_0005921_GAP_JUNCTION",28,-1.0143,0.45,0.71,"No",-1.2632,0.15,0.67,"No"
"12363","GO_BP","512132_GO_0051238_SEQUESTERING_OF_METAL_ION",11,-1.0143,0.44,0.61,"No",1.4252,0.088,0.53,"Yes"
"12364","GO_BP","491149_GO_0006177_GMP_BIOSYNTHETIC_PROCESS",5,-1.0142,0.47,0.61,"No",-0.627,0.89,1,"No"
"12365","C2_Chemical_and_genetic_perturbations","C2_CGP_312_ELVIDGE_HYPOXIA_DN",146,-1.0142,0.44,0.55,"No",1.033,0.35,0.75,"Yes"
"12366","GO_CC","496388_GO_0016363_NUCLEAR_MATRIX",93,-1.0142,0.44,0.7,"No",0.6173,1,0.99,"Yes"
"12367","REACTOME","106054_REACT_15523_INTEGRIN_ALPHAIIB_BETA3_SIGNALING",27,-1.0142,0.43,0.62,"No",1.4107,0.081,0.21,"Yes"
"12368","GO_BP","493443_GO_0009250_GLUCAN_BIOSYNTHETIC_PROCESS",27,-1.0142,0.44,0.61,"No",0.8932,0.62,1,"Yes"
"12369","GO_BP","849794_GO_0061549_SYMPATHETIC_GANGLION_DEVELOPMENT",9,-1.0141,0.46,0.61,"No",0.8661,0.61,1,"Yes"
"12370","C4_Cancer_modules","C4_CM_428_MODULE_571",15,-1.0141,0.45,0.55,"No",-0.9309,0.53,0.87,"No"
"12371","C7_Immunologic_signatures","C7_ALL_1566_GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN",193,-1.014,0.43,0.54,"No",1.1399,0.16,0.34,"Yes"
"12372","C2_Chemical_and_genetic_perturbations","C2_CGP_3380_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR",85,-1.014,0.43,0.55,"No",0.9934,0.45,0.81,"Yes"
"12373","GO_MF","490477_GO_0005243_GAP_JUNCTION_CHANNEL_ACTIVITY",13,-1.0139,0.42,0.64,"No",-1.1394,0.31,0.82,"No"
"12374","GO_BP","511743_GO_0050772_POSITIVE_REGULATION_OF_AXONOGENESIS",56,-1.0138,0.45,0.61,"No",-0.8069,0.82,1,"No"
"12375","C2_Chemical_and_genetic_perturbations","C2_CGP_698_LUI_THYROID_CANCER_CLUSTER_2",42,-1.0138,0.44,0.55,"No",-1.249,0.15,0.74,"No"
"12376","GO_BP","508289_GO_0045989_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION",10,-1.0138,0.45,0.61,"No",-0.9819,0.49,1,"No"
"12377","GO_MF","490037_GO_0004723_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",6,-1.0133,0.47,0.64,"No",-0.5741,0.95,1,"No"
"12378","C2_Chemical_and_genetic_perturbations","C2_CGP_1163_SUNG_METASTASIS_STROMA_DN",53,-1.0132,0.44,0.55,"No",1.2251,0.13,0.46,"Yes"
"12379","GO_BP","514554_GO_0060999_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT",20,-1.013,0.45,0.61,"No",-1.2367,0.18,0.9,"No"
"12380","GO_CC","507224_GO_0044217_OTHER_ORGANISM_PART",12,-1.013,0.45,0.7,"No",-1.3879,0.093,0.65,"No"
"12381","GO_BP","491289_GO_0006346_METHYLATION_DEPENDENT_CHROMATIN_SILENCING",6,-1.0129,0.46,0.61,"No",-1.4642,0.077,0.87,"No"
"12382","GO_MF","508596_GO_0046332_SMAD_BINDING",67,-1.0129,0.45,0.64,"No",-0.648,0.99,1,"No"
"12383","GO_CC","490922_GO_0005923_TIGHT_JUNCTION",107,-1.0129,0.45,0.7,"No",-1.0324,0.39,0.84,"No"
"12384","REACTOME","161066_REACT_20547_METAL_ION_SLC_TRANSPORTERS",24,-1.0128,0.43,0.63,"No",-0.7924,0.78,1,"No"
"12385","GO_BP","505465_GO_0042321_NEGATIVE_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP",5,-1.0127,0.46,0.61,"No",-1.0876,0.39,0.95,"No"
"12386","C2_Chemical_and_genetic_perturbations","C2_CGP_2634_MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3",12,-1.0127,0.43,0.55,"No",-1.3059,0.16,0.69,"No"
"12387","GO_MF","492622_GO_0008301_DNA_BINDING_BENDING",18,-1.0126,0.44,0.64,"No",1.0054,0.44,0.87,"Yes"
"12388","C2_Chemical_and_genetic_perturbations","C2_CGP_938_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP",478,-1.0126,0.45,0.55,"No",1.4739,0,0.23,"Yes"
"12389","GO_BP","501738_GO_0032507_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL",107,-1.0125,0.42,0.61,"No",0.7064,0.97,1,"Yes"
"12390","GO_MF","504509_GO_0035325_TOLL_LIKE_RECEPTOR_BINDING",6,-1.0124,0.46,0.64,"No",0.69,0.85,1,"Yes"
"12391","GO_MF","490463_GO_0005221_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_ACTIVITY",11,-1.0124,0.45,0.64,"No",0.8882,0.6,0.99,"Yes"
"12392","GO_BP","501566_GO_0032331_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION",16,-1.012,0.46,0.61,"No",-1.5548,0.034,0.72,"No"
"12393","C2_Chemical_and_genetic_perturbations","C2_CGP_2738_KAPOSI_LIVER_CANCER_MET_DN",5,-1.012,0.49,0.55,"No",0.8359,0.65,0.98,"Yes"
"12394","REACTOME","187180_REACT_25031_GABA_B_RECEPTOR_ACTIVATION",38,-1.0119,0.46,0.63,"No",-0.9217,0.57,1,"No"
"12395","GO_MF","490615_GO_0005506_IRON_ION_BINDING",166,-1.0118,0.45,0.64,"No",1.2184,0.097,0.7,"Yes"
"12396","GO_MF","490443_GO_0005179_HORMONE_ACTIVITY",103,-1.0118,0.44,0.64,"No",-1.6783,0,0.37,"No"
"12397","C7_Immunologic_signatures","C7_ALL_219_GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP",185,-1.0118,0.45,0.55,"No",-0.846,0.89,1,"No"
"12398","C2_Chemical_and_genetic_perturbations","C2_CGP_1263_SWEET_KRAS_TARGETS_DN",63,-1.0117,0.44,0.55,"No",1.5851,0.0091,0.15,"Yes"
"12399","REACTOME","105808_REACT_15296_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES",72,-1.0117,0.43,0.63,"No",-0.873,0.72,1,"No"
"12400","C1_Positional","C1_ALL_118_CHR4Q22",30,-1.0117,0.45,0.87,"No",1.15,0.25,0.63,"Yes"
"12401","GO_CC","507310_GO_0044304_MAIN_AXON",54,-1.0116,0.44,0.7,"No",-1.47,0.03,0.59,"No"
"12402","GO_CC","506312_GO_0043245_EXTRAORGANISMAL_SPACE",12,-1.0113,0.42,0.7,"No",-1.397,0.098,0.64,"No"
"12403","C7_Immunologic_signatures","C7_ALL_284_GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN",199,-1.0113,0.44,0.55,"No",1.1539,0.12,0.31,"Yes"
"12404","C7_Immunologic_signatures","C7_ALL_1080_GSE25087_FETAL_VS_ADULT_TREG_DN",191,-1.0113,0.46,0.55,"No",-0.9491,0.58,1,"No"
"12405","C7_Immunologic_signatures","C7_ALL_119_GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP",195,-1.0112,0.44,0.55,"No",-0.853,0.85,1,"No"
"12406","KEGG_compound","C00681_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_LYSOPHOSPHATIDATE_LYSOPHOSPHATIDATE_LYSOPHOSPHATIDIC_ACID",14,-1.0112,0.43,0.61,"No",0.754,0.81,1,"Yes"
"12407","GO_BP","500352_GO_0031062_POSITIVE_REGULATION_OF_HISTONE_METHYLATION",27,-1.011,0.43,0.61,"No",-0.6743,0.93,1,"No"
"12408","GO_BP","752606_GO_0097105_PRESYNAPTIC_MEMBRANE_ASSEMBLY",9,-1.011,0.46,0.61,"No",1.0791,0.34,0.93,"Yes"
"12409","C2_Chemical_and_genetic_perturbations","C2_CGP_2380_YAGUE_PRETUMOR_DRUG_RESISTANCE_DN",13,-1.011,0.44,0.55,"No",1.0609,0.39,0.69,"Yes"
"12410","C2_Chemical_and_genetic_perturbations","C2_CGP_2179_OUILLETTE_CLL_13Q14_DELETION_DN",58,-1.0109,0.44,0.55,"No",-1.0934,0.3,0.93,"No"
"12411","C2_Chemical_and_genetic_perturbations","C2_CGP_2391_CHEN_HOXA5_TARGETS_9HR_UP",222,-1.0109,0.44,0.55,"No",-0.9343,0.65,1,"No"
"12412","GO_BP","513597_GO_0060039_PERICARDIUM_DEVELOPMENT",17,-1.0109,0.45,0.61,"No",-0.9243,0.56,1,"No"
"12413","GO_BP","507569_GO_0045187_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP",17,-1.0109,0.46,0.61,"No",-0.9173,0.57,1,"No"
"12414","C7_Immunologic_signatures","C7_ALL_1169_GSE27786_LIN_NEG_VS_NKTCELL_UP",197,-1.0109,0.45,0.55,"No",1.0346,0.33,0.63,"Yes"
"12415","C2_Chemical_and_genetic_perturbations","C2_CGP_1159_JEON_SMAD6_TARGETS_UP",24,-1.0108,0.43,0.55,"No",-0.8563,0.67,1,"No"
"12416","GO_MF","496914_GO_0017112_RAB_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",30,-1.0107,0.44,0.64,"No",-0.8176,0.77,1,"No"
"12417","GO_CC","490702_GO_0005635_NUCLEAR_ENVELOPE",376,-1.0104,0.45,0.7,"No",0.9926,0.47,0.79,"Yes"
"12418","C7_Immunologic_signatures","C7_ALL_365_GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP",189,-1.0104,0.45,0.55,"No",0.9677,0.57,0.84,"Yes"
"12419","GO_BP","491006_GO_0006020_INOSITOL_METABOLIC_PROCESS",11,-1.0102,0.45,0.62,"No",-1.4989,0.042,0.82,"No"
"12420","GO_BP","516996_GO_0072079_NEPHRON_TUBULE_FORMATION",17,-1.0101,0.45,0.62,"No",0.6594,0.92,1,"Yes"
"12421","C2_Chemical_and_genetic_perturbations","C2_CGP_563_MOTAMED_RESPONSE_TO_ANDROGEN_DN",6,-1.0101,0.49,0.55,"No",-1.0187,0.46,0.98,"No"
"12422","GO_BP","500398_GO_0031111_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",32,-1.0101,0.44,0.62,"No",-0.8433,0.72,1,"No"
"12423","GO_BP","500879_GO_0031629_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_MEMBRANE",12,-1.0098,0.46,0.62,"No",0.555,0.98,1,"Yes"
"12424","GO_MF","500878_GO_0031628_OPIOID_RECEPTOR_BINDING",6,-1.0097,0.48,0.64,"No",-0.5882,0.94,1,"No"
"12425","C3_TF_targets","C3_TFT_279_V_AP2ALPHA_01",239,-1.0096,0.44,0.54,"No",-1.1772,0.11,0.39,"No"
"12426","REACTOME","106169_REACT_13_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES",189,-1.0096,0.45,0.63,"No",1.1202,0.16,0.56,"Yes"
"12427","C2_Chemical_and_genetic_perturbations","C2_CGP_1484_MUNSHI_MULTIPLE_MYELOMA_DN",11,-1.0095,0.44,0.55,"No",0.9484,0.52,0.87,"Yes"
"12428","GO_CC","752698_GO_0097197_TETRASPANIN_ENRICHED_MICRODOMAIN",7,-1.0095,0.47,0.7,"No",-0.4713,0.99,1,"No"
"12429","GO_BP","505851_GO_0042745_CIRCADIAN_SLEEP_WAKE_CYCLE",7,-1.0093,0.47,0.62,"No",-0.6509,0.89,1,"No"
"12430","C3_TF_targets","C3_TFT_382_V_SF1_Q6",253,-1.0092,0.46,0.54,"No",-0.8006,0.96,1,"No"
"12431","C2_Chemical_and_genetic_perturbations","C2_CGP_109_PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN",144,-1.0091,0.44,0.55,"No",1.7181,0.0023,0.073,"Yes"
"12432","GO_BP","505078_GO_0035909_AORTA_MORPHOGENESIS",23,-1.009,0.45,0.62,"No",-0.9714,0.48,1,"No"
"12433","GO_BP","755392_GO_2001286_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS",5,-1.009,0.47,0.62,"No",0.9537,0.52,1,"Yes"
"12434","KEGG_compound","C00212_ADENOSINE",16,-1.0087,0.45,0.61,"No",-0.7813,0.78,1,"No"
"12435","GO_BP","491984_GO_0007184_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS",8,-1.0085,0.46,0.62,"No",-1.4715,0.051,0.85,"No"
"12436","C4_Cancer_modules","C4_CM_148_MODULE_156",20,-1.0085,0.46,0.56,"No",0.9044,0.6,0.84,"Yes"
"12437","GO_BP","754939_GO_2000833_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION",11,-1.0085,0.46,0.62,"No",1.5389,0.045,0.36,"Yes"
"12438","C3_MicroRNA_targets","C3_MIR_47_GGCCAGT_MIR_193A_MIR_193B",87,-1.0084,0.46,0.61,"No",-0.8467,0.78,1,"No"
"12439","GO_BP","496523_GO_0016575_HISTONE_DEACETYLATION",41,-1.0083,0.46,0.62,"No",-1.115,0.27,0.94,"No"
"12440","C2_Chemical_and_genetic_perturbations","C2_CGP_1231_GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11",62,-1.0083,0.44,0.55,"No",0.7853,0.86,1,"Yes"
"12441","GO_BP","512803_GO_0051953_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT",30,-1.0083,0.45,0.62,"No",-1.1853,0.2,0.91,"No"
"12442","GO_BP","494958_GO_0010894_NEGATIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS",20,-1.0082,0.43,0.62,"No",-0.9346,0.56,1,"No"
"12443","REACTOME","645304_REACT_121314_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM",52,-1.0082,0.45,0.63,"No",1.4275,0.034,0.2,"Yes"
"12444","GO_MF","496342_GO_0016289_COA_HYDROLASE_ACTIVITY",18,-1.0081,0.46,0.64,"No",-1.062,0.38,0.86,"No"
"12445","GO_BP","503407_GO_0034201_RESPONSE_TO_OLEIC_ACID",6,-1.0081,0.48,0.62,"No",-1.351,0.13,0.93,"No"
"12446","GO_BP","492017_GO_0007219_NOTCH_SIGNALING_PATHWAY",132,-1.0079,0.45,0.62,"No",-0.8029,0.9,1,"No"
"12447","GO_BP","491695_GO_0006828_MANGANESE_ION_TRANSPORT",13,-1.0077,0.46,0.62,"No",-1.2287,0.2,0.89,"No"
"12448","C7_Immunologic_signatures","C7_ALL_244_GSE14308_TH2_VS_TH1_DN",198,-1.0076,0.44,0.56,"No",0.7393,0.99,1,"Yes"
"12449","GO_BP","508245_GO_0045939_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS",22,-1.0076,0.45,0.62,"No",-0.8526,0.68,1,"No"
"12450","GO_BP","752821_GO_0097320_MEMBRANE_TUBULATION",11,-1.0075,0.44,0.62,"No",0.8098,0.73,1,"Yes"
"12451","C3_MicroRNA_targets","C3_MIR_121_CCATCCA_MIR_432",56,-1.0075,0.43,0.61,"No",-0.957,0.53,1,"No"
"12452","GO_CC","490937_GO_0005942_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX",18,-1.0075,0.45,0.71,"No",0.9529,0.5,0.83,"Yes"
"12453","KEGG_compound","C03069_3_METHYLCROTONYL_COA_3_METHYLBUT_2_ENOYL_COA_3_METHYLCROTONOYL_COA_DIMETHYLACRYLOYL_COA",7,-1.0075,0.47,0.61,"No",1.2011,0.26,0.85,"Yes"
"12454","GO_BP","501711_GO_0032479_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION",111,-1.0074,0.43,0.62,"No",1.034,0.38,0.96,"Yes"
"12455","C3_MicroRNA_targets","C3_MIR_191_TCCAGAG_MIR_518C",148,-1.0074,0.45,0.61,"No",-0.9481,0.57,1,"No"
"12456","GO_BP","493269_GO_0009068_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",17,-1.0073,0.43,0.62,"No",1.0349,0.43,0.96,"Yes"
"12457","GO_BP","512045_GO_0051135_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION",5,-1.0073,0.47,0.62,"No",-1.2214,0.26,0.88,"No"
"12458","GO_MF","489485_GO_0004016_ADENYLATE_CYCLASE_ACTIVITY",11,-1.0071,0.45,0.64,"No",-1.0096,0.43,0.89,"No"
"12459","GO_BP","495889_GO_0015758_GLUCOSE_TRANSPORT",71,-1.0071,0.45,0.62,"No",0.9213,0.63,1,"Yes"
"12460","GO_BP","504298_GO_0035113_EMBRYONIC_APPENDAGE_MORPHOGENESIS",129,-1.007,0.45,0.62,"No",-0.9145,0.67,1,"No"
"12461","C3_TF_targets","C3_TFT_561_TGACGTCA_V_ATF3_Q6",228,-1.007,0.45,0.55,"No",0.8051,0.96,1,"Yes"
"12462","C7_Immunologic_signatures","C7_ALL_243_GSE14308_TH2_VS_TH1_UP",199,-1.0069,0.45,0.56,"No",1.2077,0.07,0.21,"Yes"
"12463","C3_TF_targets","C3_TFT_606_TGACCTTG_V_SF1_Q6",244,-1.0068,0.46,0.55,"No",1.0615,0.28,1,"Yes"
"12464","GO_CC","506288_GO_0043220_SCHMIDT_LANTERMAN_INCISURE",12,-1.0067,0.45,0.71,"No",0.5398,0.98,1,"Yes"
"12465","REACTOME","105934_REACT_11049_FORMATION_OF_ANNULAR_GAP_JUNCTIONS",9,-1.0066,0.44,0.63,"No",1.1933,0.27,0.45,"Yes"
"12466","GO_BP","754000_GO_1901030_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",33,-1.0066,0.45,0.62,"No",0.5743,0.98,1,"Yes"
"12467","OMIM_gene","OMIM602880_GROWTH_DIFFERENTIATION_FACTOR_1_GDF1",5,-1.0066,0.48,0.78,"No",-1.3396,0.15,0.82,"No"
"12468","GO_BP","516696_GO_0071773_CELLULAR_RESPONSE_TO_BMP_STIMULUS",20,-1.0065,0.43,0.62,"No",-0.9578,0.53,1,"No"
"12469","C2_Chemical_and_genetic_perturbations","C2_CGP_734_HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2",18,-1.0064,0.45,0.56,"No",0.7737,0.78,1,"Yes"
"12470","GO_BP","753120_GO_1900125_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS",6,-1.0064,0.47,0.62,"No",0.6228,0.9,1,"Yes"
"12471","C3_TF_targets","C3_TFT_51_ACAWNRNSRCGG_UNKNOWN",63,-1.0064,0.45,0.55,"No",-0.7389,0.92,1,"No"
"12472","C3_MicroRNA_targets","C3_MIR_109_TATCTGG_MIR_488",62,-1.0064,0.45,0.61,"No",0.62,0.99,1,"Yes"
"12473","GO_BP","506547_GO_0043516_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",27,-1.0062,0.46,0.62,"No",0.8867,0.66,1,"Yes"
"12474","GO_CC","925888_GO_0097546_CILIARY_BASE",21,-1.0062,0.46,0.71,"No",1.1501,0.28,0.59,"Yes"
"12475","GO_BP","513587_GO_0060029_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS",6,-1.0062,0.48,0.62,"No",1.4205,0.082,0.53,"Yes"
"12476","C7_Immunologic_signatures","C7_ALL_467_GSE17721_CTRL_VS_POLYIC_2H_BMDM_UP",197,-1.006,0.44,0.56,"No",1.1541,0.14,0.31,"Yes"
"12477","C7_Immunologic_signatures","C7_ALL_1164_GSE27786_LIN_NEG_VS_CD4_TCELL_DN",198,-1.0059,0.47,0.56,"No",0.7779,0.98,1,"Yes"
"12478","GO_BP","495243_GO_0014848_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION",9,-1.0059,0.47,0.62,"No",-0.695,0.84,1,"No"
"12479","GO_BP","514620_GO_0061072_IRIS_MORPHOGENESIS",7,-1.0057,0.47,0.62,"No",-0.8028,0.71,1,"No"
"12480","GO_BP","517266_GO_0072350_TRICARBOXYLIC_ACID_METABOLIC_PROCESS",37,-1.0057,0.45,0.62,"No",1.5244,0.029,0.37,"Yes"
"12481","GO_BP","491899_GO_0007076_MITOTIC_CHROMOSOME_CONDENSATION",13,-1.0056,0.44,0.62,"No",-1.0102,0.42,0.98,"No"
"12482","GO_BP","486996_GO_0000578_EMBRYONIC_AXIS_SPECIFICATION",37,-1.0054,0.45,0.62,"No",-0.9928,0.44,1,"No"
"12483","C2_Chemical_and_genetic_perturbations","C2_CGP_913_CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP",5,-1.0054,0.47,0.56,"No",0.8149,0.69,0.98,"Yes"
"12484","GO_MF","509792_GO_0047617_ACYL_COA_HYDROLASE_ACTIVITY",14,-1.0053,0.46,0.65,"No",-1.1137,0.32,0.82,"No"
"12485","KEGG_pathway","HSA00430_TAURINE_AND_HYPOTAURINE_METABOLISM",10,-1.0052,0.45,0.51,"No",0.9062,0.57,1,"Yes"
"12486","C4_Cancer_modules","C4_CM_330_MODULE_392",18,-1.005,0.44,0.57,"No",1.1255,0.32,0.49,"Yes"
"12487","GO_BP","489113_GO_0003321_POSITIVE_REGULATION_OF_BLOOD_PRESSURE_BY_EPINEPHRINE_NOREPINEPHRINE",7,-1.0049,0.47,0.62,"No",1.2964,0.19,0.67,"Yes"
"12488","GO_MF","512029_GO_0051117_ATPASE_BINDING",45,-1.0049,0.44,0.65,"No",-0.7036,0.94,1,"No"
"12489","C3_TF_targets","C3_TFT_9_V_ELK1_01",266,-1.0047,0.47,0.55,"No",1.4187,0.0025,0.29,"Yes"
"12490","C3_TF_targets","C3_TFT_289_V_AR_01",153,-1.0047,0.45,0.55,"No",-0.6876,0.99,1,"No"
"12491","GO_BP","752765_GO_0097264_SELF_PROTEOLYSIS",5,-1.0047,0.48,0.62,"No",0.989,0.47,0.99,"Yes"
"12492","GO_BP","510857_GO_0048806_GENITALIA_DEVELOPMENT",44,-1.0047,0.45,0.62,"No",0.914,0.59,1,"Yes"
"12493","C1_Positional","C1_ALL_1_CHR5Q23",57,-1.0046,0.44,0.88,"No",1.3297,0.049,0.5,"Yes"
"12494","C7_Immunologic_signatures","C7_ALL_1456_GSE360_L_MAJOR_VS_T_GONDII_DC_DN",193,-1.0046,0.46,0.56,"No",-1.0871,0.27,1,"No"
"12495","GO_MF","489648_GO_0004190_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY",23,-1.0045,0.46,0.65,"No",0.8865,0.64,0.99,"Yes"
"12496","REACTOME","1127515_REACT_264567_REPRESSION_OF_WNT_TARGET_GENES",13,-1.0045,0.46,0.64,"No",-0.6815,0.89,1,"No"
"12497","KEGG_compound","C00327_L_CITRULLINE_2_AMINO_5_UREIDOVALERIC_ACID_CITRULLINE",5,-1.0045,0.46,0.61,"No",-1.105,0.36,0.92,"No"
"12498","C2_Chemical_and_genetic_perturbations","C2_CGP_1410_REN_BOUND_BY_E2F",61,-1.0044,0.44,0.56,"No",1.0394,0.37,0.73,"Yes"
"12499","C2_Chemical_and_genetic_perturbations","C2_CGP_980_GROSS_HIF1A_TARGETS_UP",8,-1.0043,0.46,0.56,"No",0.9271,0.55,0.9,"Yes"
"12500","REACTOME","1183549_REACT_355405_C_TYPE_LECTIN_RECEPTORS_CLRS_",124,-1.0043,0.45,0.64,"No",1.5171,0.0047,0.14,"Yes"
"12501","GO_MF","499765_GO_0030374_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_TRANSCRIPTION_COACTIVATOR_ACTIVITY",50,-1.0043,0.46,0.65,"No",-0.809,0.81,1,"No"
"12502","C7_Immunologic_signatures","C7_ALL_630_GSE17721_POLYIC_VS_CPG_12H_BMDM_DN",195,-1.0042,0.46,0.56,"No",1.2098,0.063,0.21,"Yes"
"12503","GO_BP","514585_GO_0061037_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT",22,-1.0041,0.44,0.62,"No",-1.6259,0.024,0.7,"No"
"12504","C6_Oncogenic_signatures","C6_ALL_91_DCA_UP_V1_DN",174,-1.0038,0.47,0.51,"No",-1.1481,0.18,0.48,"No"
"12505","GO_BP","1025320_GO_0044854_PLASMA_MEMBRANE_RAFT_ASSEMBLY",5,-1.0036,0.47,0.62,"No",-0.6576,0.88,1,"No"
"12506","KEGG_module","HSA_M00077_CHONDROITIN_SULFATE_DEGRADATION",8,-1.0036,0.46,0.73,"No",-0.8316,0.66,1,"No"
"12507","KEGG_compound","C05689_SE_METHYL_L_SELENOCYSTEINE",5,-1.0035,0.47,0.61,"No",-0.8747,0.63,1,"No"
"12508","GO_BP","494822_GO_0010757_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION",5,-1.0035,0.49,0.62,"No",-0.814,0.68,1,"No"
"12509","C7_Immunologic_signatures","C7_ALL_1125_GSE2706_R848_VS_LPS_2H_STIM_DC_UP",171,-1.0035,0.46,0.56,"No",-0.8319,0.9,1,"No"
"12510","C4_Cancer_modules","C4_CM_398_MODULE_505",15,-1.0034,0.45,0.57,"No",1.351,0.11,0.23,"Yes"
"12511","C1_Positional","C1_ALL_31_CHR2Q22",17,-1.0034,0.47,0.88,"No",0.7209,0.88,0.99,"Yes"
"12512","GO_MF","504435_GO_0035251_UDP_GLUCOSYLTRANSFERASE_ACTIVITY",9,-1.0033,0.45,0.65,"No",0.9341,0.52,0.94,"Yes"
"12513","GO_BP","513999_GO_0060444_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS",23,-1.0033,0.44,0.62,"No",-0.7296,0.86,1,"No"
"12514","C3_TF_targets","C3_TFT_364_V_ETF_Q6",114,-1.0033,0.47,0.55,"No",1.0229,0.39,1,"Yes"
"12515","C2_Chemical_and_genetic_perturbations","C2_CGP_1331_BECKER_TAMOXIFEN_RESISTANCE_UP",49,-1.0033,0.47,0.56,"No",-0.8473,0.74,1,"No"
"12516","C2_Chemical_and_genetic_perturbations","C2_CGP_339_WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN",196,-1.0032,0.47,0.56,"No",1.3125,0.027,0.38,"Yes"
"12517","C7_Immunologic_signatures","C7_ALL_67_GSE11057_CD4_EFF_MEM_VS_PBMC_UP",197,-1.0032,0.46,0.57,"No",0.9197,0.72,0.98,"Yes"
"12518","GO_BP","506407_GO_0043368_POSITIVE_T_CELL_SELECTION",19,-1.0031,0.45,0.63,"No",-1.343,0.11,0.92,"No"
"12519","C2_Chemical_and_genetic_perturbations","C2_CGP_2702_DING_LUNG_CANCER_BY_MUTATION_RATE",20,-1.0031,0.46,0.56,"No",-0.8414,0.71,1,"No"
"12520","C7_Immunologic_signatures","C7_ALL_1307_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP",192,-1.003,0.48,0.57,"No",0.8011,0.93,1,"Yes"
"12521","GO_BP","488133_GO_0002260_LYMPHOCYTE_HOMEOSTASIS",52,-1.003,0.43,0.63,"No",0.9146,0.62,1,"Yes"
"12522","C4_Cancer_gene_neighborhoods","C4_CGN_280_CAR_TNFRSF25",29,-1.003,0.45,0.71,"No",-0.897,0.63,1,"No"
"12523","C3_MicroRNA_targets","C3_MIR_153_TCTGATA_MIR_361",91,-1.0027,0.48,0.61,"No",1.0349,0.37,1,"Yes"
"12524","GO_BP","512185_GO_0051301_CELL_DIVISION",459,-1.0027,0.48,0.63,"No",1.0417,0.32,0.96,"Yes"
"12525","GO_BP","505859_GO_0042753_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM",16,-1.0027,0.46,0.63,"No",1.3096,0.15,0.66,"Yes"
"12526","GO_BP","492005_GO_0007207_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY",6,-1.0027,0.49,0.63,"No",0.9152,0.54,1,"Yes"
"12527","C2_Chemical_and_genetic_perturbations","C2_CGP_2910_MIKKELSEN_ES_HCP_WITH_H3K27ME3",40,-1.0026,0.45,0.56,"No",1.4169,0.043,0.28,"Yes"
"12528","C7_Immunologic_signatures","C7_ALL_902_GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN",199,-1.0025,0.48,0.57,"No",1.4618,0.0069,0.019,"Yes"
"12529","REACTOME","187228_REACT_23832_NEPHRIN_INTERACTIONS",22,-1.0024,0.45,0.64,"No",-1.0118,0.45,0.99,"No"
"12530","GO_BP","501341_GO_0032104_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS",64,-1.0022,0.47,0.63,"No",-0.7174,0.94,1,"No"
"12531","GO_BP","487140_GO_0000910_CYTOKINESIS",96,-1.0022,0.46,0.63,"No",0.9993,0.44,0.98,"Yes"
"12532","C2_Chemical_and_genetic_perturbations","C2_CGP_2631_SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL",65,-1.0021,0.46,0.57,"No",-0.6047,0.99,1,"No"
"12533","C7_Immunologic_signatures","C7_ALL_247_GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP",198,-1.002,0.48,0.57,"No",1.1707,0.096,0.28,"Yes"
"12534","GO_BP","505484_GO_0042340_KERATAN_SULFATE_CATABOLIC_PROCESS",12,-1.0019,0.45,0.63,"No",0.6455,0.92,1,"Yes"
"12535","GO_CC","501205_GO_0031965_NUCLEAR_MEMBRANE",256,-1.0019,0.48,0.72,"No",0.9701,0.51,0.82,"Yes"
"12536","C3_MicroRNA_targets","C3_MIR_101_CCCACAT_MIR_299_3P",54,-1.0018,0.47,0.61,"No",0.9168,0.64,1,"Yes"
"12537","C2_Chemical_and_genetic_perturbations","C2_CGP_899_REN_MIF_TARGETS_DN",5,-1.0017,0.48,0.57,"No",0.6212,0.9,1,"Yes"
"12538","C2_Chemical_and_genetic_perturbations","C2_CGP_3140_CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY",38,-1.0017,0.46,0.57,"No",-0.9414,0.52,1,"No"
"12539","GO_BP","518421_GO_0090281_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT",5,-1.0016,0.47,0.63,"No",0.9681,0.5,1,"Yes"
"12540","C2_Chemical_and_genetic_perturbations","C2_CGP_1259_CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN",21,-1.0015,0.46,0.57,"No",1.1133,0.3,0.61,"Yes"
"12541","GO_MF","490481_GO_0005247_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY",9,-1.0015,0.47,0.65,"No",-1.1648,0.28,0.8,"No"
"12542","GO_BP","512330_GO_0051452_INTRACELLULAR_PH_REDUCTION",24,-1.0014,0.48,0.63,"No",-0.6147,0.96,1,"No"
"12543","GO_BP","505750_GO_0042636_NEGATIVE_REGULATION_OF_HAIR_CYCLE",5,-1.0014,0.47,0.63,"No",-0.7034,0.81,1,"No"
"12544","C2_Chemical_and_genetic_perturbations","C2_CGP_204_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN",10,-1.0014,0.47,0.57,"No",1.188,0.25,0.51,"Yes"
"12545","GO_BP","495061_GO_0010996_RESPONSE_TO_AUDITORY_STIMULUS",15,-1.0012,0.46,0.63,"No",-0.7905,0.76,1,"No"
"12546","GO_CC","490806_GO_0005776_AUTOPHAGIC_VACUOLE",53,-1.0012,0.46,0.72,"No",-0.552,1,1,"No"
"12547","GO_BP","494624_GO_0010559_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",29,-1.0011,0.44,0.63,"No",-0.7402,0.85,1,"No"
"12548","KEGG_pathway","HSA00630_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM",28,-1.0011,0.47,0.52,"No",0.9025,0.61,1,"Yes"
"12549","C4_Cancer_modules","C4_CM_177_MODULE_189",23,-1.0011,0.46,0.57,"No",0.9321,0.57,0.81,"Yes"
"12550","REACTOME","477122_REACT_111119_ANTIGEN_PROCESSING_CROSS_PRESENTATION",81,-1.001,0.46,0.64,"No",1.8816,0,0.0099,"Yes"
"12551","GO_MF","492725_GO_0008430_SELENIUM_BINDING",14,-1.001,0.47,0.65,"No",1.0592,0.37,0.83,"Yes"
"12552","GO_BP","1022088_GO_0044851_HAIR_CYCLE_PHASE",14,-1.0009,0.46,0.63,"No",-1.3794,0.11,0.99,"No"
"12553","GO_MF","515499_GO_0070569_URIDYLYLTRANSFERASE_ACTIVITY",7,-1.0007,0.47,0.65,"No",-1.0711,0.36,0.86,"No"
"12554","GO_BP","515764_GO_0070836_CAVEOLA_ASSEMBLY",5,-1.0007,0.48,0.63,"No",-0.6825,0.83,1,"No"
"12555","C1_Positional","C1_ALL_255_CHR2P25",54,-1.0006,0.47,0.88,"No",1.4663,0.019,0.3,"Yes"
"12556","C3_TF_targets","C3_TFT_125_V_CREB_Q4",264,-1.0006,0.47,0.56,"No",-0.9104,0.76,0.95,"No"
"12557","GO_BP","494119_GO_0010039_RESPONSE_TO_IRON_ION",24,-1.0005,0.46,0.63,"No",1.1798,0.19,0.8,"Yes"
"12558","GO_BP","491466_GO_0006570_TYROSINE_METABOLIC_PROCESS",9,-1.0005,0.48,0.63,"No",-0.9513,0.52,1,"No"
"12559","GO_BP","487512_GO_0001574_GANGLIOSIDE_BIOSYNTHETIC_PROCESS",7,-1.0005,0.48,0.63,"No",0.6179,0.93,1,"Yes"
"12560","C2_Chemical_and_genetic_perturbations","C2_CGP_731_LA_MEN1_TARGETS",22,-1.0005,0.44,0.57,"No",-0.7714,0.79,1,"No"
"12561","C7_Immunologic_signatures","C7_ALL_1154_GSE27786_LSK_VS_NKTCELL_DN",199,-1.0004,0.48,0.57,"No",1.139,0.15,0.34,"Yes"
"12562","C2_Chemical_and_genetic_perturbations","C2_CGP_2970_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN",46,-1.0003,0.45,0.57,"No",1.3326,0.067,0.36,"Yes"
"12563","GO_BP","508364_GO_0046068_CGMP_METABOLIC_PROCESS",23,-1.0003,0.47,0.63,"No",-1.003,0.45,0.99,"No"
"12564","GO_BP","1144982_GO_1903844_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",101,-1.0002,0.45,0.63,"No",0.9958,0.47,0.98,"Yes"
"12565","GO_BP","513602_GO_0060044_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION",8,-1.0002,0.47,0.63,"No",0.97,0.51,1,"Yes"
"12566","OMIM_gene","OMIM158343_ATP_BINDING_CASSETTE_SUBFAMILY_C_MEMBER_1_ABCC1",5,-1.0001,0.48,0.77,"No",-1.0965,0.39,1,"No"
"12567","GO_BP","501874_GO_0032648_REGULATION_OF_INTERFERON_BETA_PRODUCTION",37,-1.0001,0.46,0.63,"No",-0.7393,0.88,1,"No"
"12568","C7_Immunologic_signatures","C7_ALL_571_GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_UP",200,-1.0001,0.47,0.57,"No",0.9746,0.51,0.82,"Yes"
"12569","GO_BP","754262_GO_1901298_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH",6,-1.0001,0.48,0.63,"No",1.757,0.004,0.13,"Yes"
"12570","GO_BP","506274_GO_0043206_EXTRACELLULAR_FIBRIL_ORGANIZATION",12,-0.9997,0.46,0.63,"No",0.6415,0.9,1,"Yes"
"12571","C1_Positional","C1_ALL_204_CHR8Q23",23,-0.9997,0.47,0.88,"No",1.3586,0.084,0.46,"Yes"
"12572","C2_Chemical_and_genetic_perturbations","C2_CGP_536_NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP",29,-0.9996,0.47,0.57,"No",-0.8123,0.73,1,"No"
"12573","GO_BP","488456_GO_0002583_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN",7,-0.9995,0.48,0.63,"No",-1.4951,0.056,0.81,"No"
"12574","GO_MF","495529_GO_0015278_CALCIUM_RELEASE_CHANNEL_ACTIVITY",15,-0.9995,0.46,0.65,"No",-1.2173,0.22,0.83,"No"
"12575","C2_Chemical_and_genetic_perturbations","C2_CGP_933_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN",45,-0.9993,0.47,0.57,"No",1.2044,0.19,0.49,"Yes"
"12576","GO_BP","503576_GO_0034374_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",10,-0.9992,0.48,0.63,"No",0.9053,0.57,1,"Yes"
"12577","GO_BP","495217_GO_0014821_PHASIC_SMOOTH_MUSCLE_CONTRACTION",16,-0.9991,0.47,0.63,"No",-1.0004,0.44,0.99,"No"
"12578","GO_MF","498730_GO_0019966_INTERLEUKIN_1_BINDING",7,-0.999,0.45,0.65,"No",0.6706,0.88,1,"Yes"
"12579","C4_Cancer_modules","C4_CM_397_MODULE_503",108,-0.9989,0.45,0.58,"No",0.9496,0.58,0.78,"Yes"
"12580","C7_Immunologic_signatures","C7_ALL_1356_GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN",199,-0.9989,0.47,0.57,"No",1.232,0.073,0.18,"Yes"
"12581","GO_BP","492342_GO_0007601_VISUAL_PERCEPTION",195,-0.9988,0.47,0.63,"No",-1.3952,0.018,1,"No"
"12582","C2_Chemical_and_genetic_perturbations","C2_CGP_2995_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN",9,-0.9988,0.47,0.57,"No",0.8266,0.69,0.98,"Yes"
"12583","GO_MF","500684_GO_0031433_TELETHONIN_BINDING",5,-0.9987,0.48,0.65,"No",-1.7665,0.0019,0.23,"No"
"12584","C2_Chemical_and_genetic_perturbations","C2_CGP_2498_PALOMERO_GSI_SENSITIVITY_DN",6,-0.9986,0.49,0.57,"No",0.5667,0.95,1,"Yes"
"12585","GO_BP","516466_GO_0071542_DOPAMINERGIC_NEURON_DIFFERENTIATION",12,-0.9985,0.44,0.63,"No",1.0244,0.42,0.97,"Yes"
"12586","GO_BP","506427_GO_0043388_POSITIVE_REGULATION_OF_DNA_BINDING",35,-0.9985,0.48,0.63,"No",1.3755,0.086,0.58,"Yes"
"12587","C2_Chemical_and_genetic_perturbations","C2_CGP_2866_HAHTOLA_CTCL_CUTANEOUS",25,-0.9984,0.46,0.57,"No",1.5505,0.045,0.17,"Yes"
"12588","C3_TF_targets","C3_TFT_322_V_ARNT_02",247,-0.9984,0.48,0.56,"No",0.9629,0.55,1,"Yes"
"12589","GO_BP","503075_GO_0033866_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",17,-0.9984,0.48,0.63,"No",-0.9401,0.55,1,"No"
"12590","GO_BP","494381_GO_0010310_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS",11,-0.9983,0.46,0.63,"No",-0.5961,0.94,1,"No"
"12591","GO_CC","515097_GO_0070160_OCCLUDING_JUNCTION",108,-0.9983,0.49,0.72,"No",-1.0364,0.37,0.84,"No"
"12592","KEGG_pathway","HSA04744_PHOTOTRANSDUCTION",26,-0.9982,0.48,0.52,"No",-1.4664,0.045,0.42,"No"
"12593","C3_MicroRNA_targets","C3_MIR_128_CTACTAG_MIR_325",18,-0.998,0.45,0.62,"No",-1.006,0.44,1,"No"
"12594","C4_Cancer_gene_neighborhoods","C4_CGN_235_GCM_IL6ST",54,-0.9979,0.46,0.72,"No",1.4149,0.027,0.056,"Yes"
"12595","GO_BP","487517_GO_0001578_MICROTUBULE_BUNDLE_FORMATION",41,-0.9978,0.48,0.63,"No",1.0752,0.32,0.93,"Yes"
"12596","GO_BP","510386_GO_0048278_VESICLE_DOCKING",64,-0.9978,0.48,0.63,"No",-0.8715,0.71,1,"No"
"12597","GO_MF","496393_GO_0016405_COA_LIGASE_ACTIVITY",8,-0.9977,0.49,0.65,"No",-1.1283,0.32,0.82,"No"
"12598","C2_BioCarta_Pathways","C2_CP_BIOCARTA_197_BIOCARTA_41BB_PATHWAY",17,-0.9975,0.46,0.59,"No",-1.0636,0.37,1,"No"
"12599","GO_CC","750791_GO_0002199_ZONA_PELLUCIDA_RECEPTOR_COMPLEX",10,-0.9975,0.48,0.72,"No",1.1104,0.32,0.63,"Yes"
"12600","C7_Immunologic_signatures","C7_ALL_426_GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN",200,-0.9972,0.46,0.58,"No",1.4077,0.0052,0.035,"Yes"
"12601","REACTOME","119575_REACT_19188_INOSITOL_TRANSPORTERS",7,-0.997,0.45,0.65,"No",-1.1852,0.27,0.85,"No"
"12602","GO_BP","501344_GO_0032107_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS",64,-0.997,0.46,0.63,"No",-0.7122,0.95,1,"No"
"12603","C4_Cancer_modules","C4_CM_318_MODULE_372",24,-0.9968,0.47,0.58,"No",-0.9674,0.53,0.85,"No"
"12604","GO_BP","505546_GO_0042403_THYROID_HORMONE_METABOLIC_PROCESS",14,-0.9968,0.49,0.63,"No",1.013,0.42,0.97,"Yes"
"12605","GO_MF","496949_GO_0017154_SEMAPHORIN_RECEPTOR_ACTIVITY",10,-0.9967,0.46,0.65,"No",-1.1273,0.28,0.81,"No"
"12606","GO_BP","514042_GO_0060487_LUNG_EPITHELIAL_CELL_DIFFERENTIATION",26,-0.9967,0.47,0.63,"No",0.9538,0.53,1,"Yes"
"12607","GO_BP","948897_GO_1902742_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT",22,-0.9967,0.47,0.63,"No",-1.2253,0.2,0.88,"No"
"12608","GO_MF","496046_GO_0015924_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY",10,-0.9966,0.48,0.65,"No",-0.7922,0.75,1,"No"
"12609","C2_Chemical_and_genetic_perturbations","C2_CGP_818_FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES",7,-0.9966,0.49,0.57,"No",0.9665,0.48,0.84,"Yes"
"12610","GO_BP","504817_GO_0035640_EXPLORATION_BEHAVIOR",19,-0.9966,0.47,0.63,"No",0.7319,0.88,1,"Yes"
"12611","C3_MicroRNA_targets","C3_MIR_221_GTAGGCA_MIR_189",28,-0.9965,0.47,0.62,"No",-0.6729,0.95,1,"No"
"12612","GO_BP","506322_GO_0043255_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS",84,-0.9963,0.47,0.63,"No",0.816,0.84,1,"Yes"
"12613","C7_Immunologic_signatures","C7_ALL_600_GSE17721_LPS_VS_PAM3CSK4_0_5H_BMDM_DN",196,-0.9963,0.48,0.58,"No",1.0472,0.35,0.6,"Yes"
"12614","GO_BP","519015_GO_2000369_REGULATION_OF_CLATHRIN_MEDIATED_ENDOCYTOSIS",11,-0.9962,0.47,0.63,"No",0.4948,0.99,1,"Yes"
"12615","C2_Chemical_and_genetic_perturbations","C2_CGP_1475_WANG_TARGETS_OF_MLL_CBP_FUSION_UP",44,-0.9959,0.48,0.58,"No",1.2251,0.17,0.46,"Yes"
"12616","GO_CC","500375_GO_0031088_PLATELET_DENSE_GRANULE_MEMBRANE",5,-0.9959,0.49,0.72,"No",0.5231,0.98,1,"Yes"
"12617","GO_BP","753074_GO_1900078_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",15,-0.9957,0.48,0.63,"No",0.6681,0.91,1,"Yes"
"12618","GO_BP","781976_GO_1901987_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION",347,-0.9957,0.51,0.63,"No",1.2676,0.029,0.71,"Yes"
"12619","GO_BP","514633_GO_0061085_REGULATION_OF_HISTONE_H3_K27_METHYLATION",9,-0.9957,0.48,0.63,"No",-0.866,0.62,1,"No"
"12620","C2_Chemical_and_genetic_perturbations","C2_CGP_1644_HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR",37,-0.9957,0.46,0.58,"No",0.8233,0.78,0.98,"Yes"
"12621","C4_Cancer_gene_neighborhoods","C4_CGN_82_MORF_DAP",78,-0.9954,0.49,0.72,"No",2.1005,0,0.00013,"Yes"
"12622","GO_BP","519424_GO_2000785_REGULATION_OF_AUTOPHAGIC_VACUOLE_ASSEMBLY",15,-0.9954,0.47,0.64,"No",1.1177,0.29,0.88,"Yes"
"12623","GO_BP","512293_GO_0051414_RESPONSE_TO_CORTISOL",6,-0.9954,0.5,0.63,"No",-1.0227,0.44,0.97,"No"
"12624","GO_BP","504674_GO_0035493_SNARE_COMPLEX_ASSEMBLY",7,-0.9953,0.49,0.63,"No",0.8126,0.71,1,"Yes"
"12625","C2_Chemical_and_genetic_perturbations","C2_CGP_1819_BROWNE_HCMV_INFECTION_18HR_UP",178,-0.9952,0.49,0.58,"No",-0.7626,0.97,1,"No"
"12626","C7_Immunologic_signatures","C7_ALL_1312_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN",200,-0.9951,0.49,0.58,"No",1.0088,0.41,0.71,"Yes"
"12627","GO_BP","518241_GO_0090101_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",109,-0.9946,0.46,0.64,"No",0.9815,0.52,1,"Yes"
"12628","GO_BP","492142_GO_0007379_SEGMENT_SPECIFICATION",16,-0.9945,0.45,0.64,"No",0.8272,0.69,1,"Yes"
"12629","GO_BP","753710_GO_1900739_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",26,-0.9944,0.45,0.64,"No",0.5858,0.98,1,"Yes"
"12630","C2_Chemical_and_genetic_perturbations","C2_CGP_2396_CADWELL_ATG16L1_TARGETS_DN",67,-0.9943,0.48,0.58,"No",-0.6138,0.99,1,"No"
"12631","GO_BP","750894_GO_0035967_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN",111,-0.9943,0.48,0.64,"No",0.6306,1,1,"Yes"
"12632","C7_Immunologic_signatures","C7_ALL_653_GSE17721_LPS_VS_CPG_0_5H_BMDM_UP",197,-0.9942,0.47,0.59,"No",0.8854,0.8,1,"Yes"
"12633","GO_BP","505320_GO_0042157_LIPOPROTEIN_METABOLIC_PROCESS",120,-0.994,0.48,0.64,"No",-0.9459,0.57,1,"No"
"12634","GO_BP","488875_GO_0035813_REGULATION_OF_RENAL_SODIUM_EXCRETION",22,-0.9939,0.47,0.64,"No",1.7563,0.0086,0.13,"Yes"
"12635","GO_BP","495087_GO_0014014_NEGATIVE_REGULATION_OF_GLIOGENESIS",34,-0.9939,0.45,0.64,"No",-1.0317,0.4,0.98,"No"
"12636","GO_BP","502163_GO_0032941_SECRETION_BY_TISSUE",62,-0.9938,0.48,0.64,"No",0.928,0.59,1,"Yes"
"12637","C4_Cancer_modules","C4_CM_145_MODULE_153",29,-0.9937,0.48,0.58,"No",1.208,0.18,0.39,"Yes"
"12638","KEGG_module","HSA_M00076_DERMATAN_SULFATE_DEGRADATION",9,-0.9937,0.48,0.73,"No",-0.843,0.65,1,"No"
"12639","GO_BP","501499_GO_0032264_IMP_SALVAGE",5,-0.9936,0.48,0.64,"No",-0.8061,0.72,1,"No"
"12640","REACTOME","576266_REACT_118568_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION",29,-0.9935,0.47,0.66,"No",-1.423,0.06,0.5,"No"
"12641","GO_BP","487942_GO_0002052_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION",19,-0.9934,0.46,0.64,"No",0.9942,0.46,0.99,"Yes"
"12642","GO_CC","499968_GO_0030663_COPI_COATED_VESICLE_MEMBRANE",16,-0.9933,0.47,0.73,"No",1.5265,0.048,0.18,"Yes"
"12643","GO_BP","948083_GO_0061590_CALCIUM_ACTIVATED_PHOSPHATIDYLCHOLINE_SCRAMBLING",5,-0.9933,0.5,0.64,"No",1.1446,0.31,0.84,"Yes"
"12644","C3_TF_targets","C3_TFT_21_V_CREB_01",260,-0.9932,0.51,0.58,"No",0.8217,0.96,1,"Yes"
"12645","KEGG_pathway","HSA05212_PANCREATIC_CANCER",66,-0.9931,0.49,0.53,"No",0.7169,0.97,1,"Yes"
"12646","GO_BP","512481_GO_0051604_PROTEIN_MATURATION",27,-0.9931,0.48,0.64,"No",0.7426,0.85,1,"Yes"
"12647","C4_Cancer_gene_neighborhoods","C4_CGN_194_GCM_ATM",26,-0.9931,0.45,0.73,"No",-0.6408,0.96,1,"No"
"12648","GO_BP","500894_GO_0031645_NEGATIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS",12,-0.9929,0.46,0.64,"No",0.7405,0.82,1,"Yes"
"12649","C7_Immunologic_signatures","C7_ALL_359_GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP",182,-0.9927,0.49,0.59,"No",0.9632,0.54,0.86,"Yes"
"12650","C2_Chemical_and_genetic_perturbations","C2_CGP_165_NOJIMA_SFRP2_TARGETS_DN",25,-0.9927,0.47,0.58,"No",1.5036,0.021,0.21,"Yes"
"12651","GO_BP","754751_GO_1901800_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",63,-0.9924,0.48,0.64,"No",0.8619,0.74,1,"Yes"
"12652","C2_Chemical_and_genetic_perturbations","C2_CGP_800_DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP",27,-0.9923,0.45,0.58,"No",-0.7455,0.85,1,"No"
"12653","GO_MF","501197_GO_0031957_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY",8,-0.9922,0.48,0.66,"No",0.8128,0.68,1,"Yes"
"12654","C2_Chemical_and_genetic_perturbations","C2_CGP_2959_BAUS_TFF2_TARGETS_UP",29,-0.9922,0.47,0.58,"No",1.1469,0.24,0.56,"Yes"
"12655","C7_Immunologic_signatures","C7_ALL_762_GSE17721_4_VS_24H_GARDIQUIMOD_BMDM_DN",200,-0.9922,0.48,0.59,"No",1.2897,0.036,0.11,"Yes"
"12656","GO_BP","777529_GO_1901977_NEGATIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT",5,-0.9921,0.49,0.64,"No",-1.3023,0.17,0.89,"No"
"12657","GO_BP","518957_GO_2000311_REGULATION_OF_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",19,-0.9918,0.49,0.64,"No",-1.1428,0.27,0.93,"No"
"12658","C1_Positional","C1_ALL_115_CHR6P25",38,-0.9918,0.48,0.89,"No",0.5312,1,1,"Yes"
"12659","C7_Immunologic_signatures","C7_ALL_1615_GSE3982_MAST_CELL_VS_BASOPHIL_UP",195,-0.9918,0.49,0.59,"No",1.1495,0.13,0.32,"Yes"
"12660","C3_MicroRNA_targets","C3_MIR_49_TCTGATC_MIR_383",48,-0.9917,0.46,0.63,"No",-0.9223,0.59,1,"No"
"12661","GO_BP","504168_GO_0034976_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",167,-0.9917,0.48,0.64,"No",0.7588,0.98,1,"Yes"
"12662","GO_BP","503242_GO_0034033_PURINE_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",17,-0.9916,0.46,0.64,"No",-0.9231,0.58,1,"No"
"12663","C7_Immunologic_signatures","C7_ALL_369_GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP",185,-0.9916,0.49,0.59,"No",1.186,0.11,0.25,"Yes"
"12664","C7_Immunologic_signatures","C7_ALL_88_GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",189,-0.9914,0.49,0.59,"No",1.2182,0.073,0.2,"Yes"
"12665","GO_BP","512479_GO_0051601_EXOCYST_LOCALIZATION",6,-0.9914,0.48,0.64,"No",-0.7695,0.76,1,"No"
"12666","WikiPathways","198844_WP673_ERBB_SIGNALING_PATHWAY",54,-0.9913,0.46,0.59,"No",0.7014,0.96,1,"Yes"
"12667","C1_Positional","C1_ALL_169_CHR1Q31",42,-0.9912,0.48,0.89,"No",1.4943,0.021,0.27,"Yes"
"12668","C2_Chemical_and_genetic_perturbations","C2_CGP_2291_WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN",5,-0.9912,0.52,0.58,"No",0.8369,0.64,0.97,"Yes"
"12669","GO_BP","1133967_GO_1903792_NEGATIVE_REGULATION_OF_ANION_TRANSPORT",30,-0.9911,0.47,0.64,"No",1.0124,0.42,0.97,"Yes"
"12670","GO_BP","1025323_GO_0044857_PLASMA_MEMBRANE_RAFT_ORGANIZATION",5,-0.9911,0.5,0.64,"No",-0.6661,0.87,1,"No"
"12671","C6_Oncogenic_signatures","C6_ALL_76_PRC2_EZH2_UP_V1_UP",188,-0.9911,0.5,0.54,"No",1.0071,0.46,0.79,"Yes"
"12672","C7_Immunologic_signatures","C7_ALL_638_GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_DN",199,-0.9909,0.48,0.59,"No",1.6064,0,0.0027,"Yes"
"12673","C7_Immunologic_signatures","C7_ALL_263_GSE14308_TH17_VS_INDUCED_TREG_UP",199,-0.9908,0.49,0.59,"No",1.0538,0.29,0.58,"Yes"
"12674","C2_Chemical_and_genetic_perturbations","C2_CGP_1064_SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP",172,-0.9908,0.48,0.58,"No",1.4729,0,0.23,"Yes"
"12675","GO_CC","499976_GO_0030673_AXOLEMMA",13,-0.9908,0.48,0.73,"No",-1.3212,0.15,0.64,"No"
"12676","C2_Chemical_and_genetic_perturbations","C2_CGP_2694_VALK_AML_WITH_EVI1",23,-0.9907,0.49,0.58,"No",0.5489,0.98,1,"Yes"
"12677","C2_Chemical_and_genetic_perturbations","C2_CGP_2453_BEIER_GLIOMA_STEM_CELL_DN",65,-0.9907,0.47,0.58,"No",0.8285,0.82,0.98,"Yes"
"12678","C7_Immunologic_signatures","C7_ALL_409_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP",197,-0.9906,0.5,0.59,"No",0.7607,0.99,1,"Yes"
"12679","C3_MicroRNA_targets","C3_MIR_26_TCTATGA_MIR_376A_MIR_376B",83,-0.9904,0.49,0.63,"No",1.0502,0.33,1,"Yes"
"12680","KEGG_compound","C01185_NICOTINATE_D_RIBONUCLEOTIDE_BETA_NICOTINATE_D_RIBONUCLEOTIDE_NICOTINATE_RIBONUCLEOTIDE_NICOTINIC_ACID_RIBONUCLEOTIDE",19,-0.9903,0.46,0.64,"No",0.8728,0.64,1,"Yes"
"12681","C4_Cancer_gene_neighborhoods","C4_CGN_357_GNF2_HLA_C",47,-0.9903,0.48,0.73,"No",1.1922,0.19,0.23,"Yes"
"12682","C2_Chemical_and_genetic_perturbations","C2_CGP_2193_RIZKI_TUMOR_INVASIVENESS_2D_DN",62,-0.9903,0.49,0.59,"No",1.3436,0.07,0.35,"Yes"
"12683","REACTOME","1127548_REACT_263908_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA",15,-0.9903,0.49,0.66,"No",0.5634,0.99,1,"Yes"
"12684","C2_Chemical_and_genetic_perturbations","C2_CGP_2256_SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP",38,-0.9901,0.49,0.59,"No",1.2195,0.18,0.47,"Yes"
"12685","GO_BP","518302_GO_0090162_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY",16,-0.9899,0.48,0.64,"No",1.1842,0.22,0.8,"Yes"
"12686","GO_MF","489329_GO_0003828_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY",5,-0.9899,0.48,0.67,"No",0.7618,0.77,1,"Yes"
"12687","C1_Positional","C1_ALL_193_CHR3P21",229,-0.9899,0.5,0.88,"No",0.9299,0.7,0.83,"Yes"
"12688","C4_Cancer_modules","C4_CM_311_MODULE_361",144,-0.9898,0.5,0.59,"No",1.3245,0.049,0.25,"Yes"
"12689","GO_BP","492034_GO_0007254_JNK_CASCADE",83,-0.9898,0.48,0.64,"No",0.7157,0.97,1,"Yes"
"12690","GO_BP","509060_GO_0046838_PHOSPHORYLATED_CARBOHYDRATE_DEPHOSPHORYLATION",11,-0.9898,0.46,0.64,"No",0.5721,0.97,1,"Yes"
"12691","GO_BP","508291_GO_0045991_CARBON_CATABOLITE_ACTIVATION_OF_TRANSCRIPTION",5,-0.9898,0.51,0.64,"No",-0.9241,0.56,1,"No"
"12692","GO_CC","501143_GO_0031902_LATE_ENDOSOME_MEMBRANE",100,-0.9897,0.47,0.73,"No",1.6482,0,0.087,"Yes"
"12693","GO_BP","501526_GO_0032291_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM",15,-0.9895,0.47,0.64,"No",-0.7652,0.79,1,"No"
"12694","REACTOME","187097_REACT_25359_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS",76,-0.9894,0.48,0.66,"No",1.1114,0.23,0.56,"Yes"
"12695","REACTOME","1183573_REACT_355514_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR3",44,-0.9894,0.48,0.66,"No",-1.1685,0.2,0.85,"No"
"12696","GO_CC","496487_GO_0016528_SARCOPLASM",64,-0.9892,0.48,0.73,"No",-1.3683,0.057,0.61,"No"
"12697","GO_MF","490006_GO_0004683_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",30,-0.989,0.5,0.67,"No",-1.0925,0.3,0.84,"No"
"12698","GO_BP","488705_GO_0002832_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS",27,-0.9889,0.48,0.64,"No",1.1867,0.22,0.8,"Yes"
"12699","GO_BP","513562_GO_0060004_REFLEX",19,-0.9889,0.48,0.64,"No",0.9448,0.54,1,"Yes"
"12700","C2_Chemical_and_genetic_perturbations","C2_CGP_1756_RODWELL_AGING_KIDNEY_DN",143,-0.9889,0.48,0.59,"No",1.5706,0.0023,0.16,"Yes"
"12701","GO_BP","491853_GO_0007023_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY",5,-0.9889,0.5,0.64,"No",-0.7603,0.75,1,"No"
"12702","GO_BP","496219_GO_0016126_STEROL_BIOSYNTHETIC_PROCESS",41,-0.9888,0.47,0.64,"No",0.8613,0.7,1,"Yes"
"12703","C6_Oncogenic_signatures","C6_ALL_32_PIGF_UP_V1_UP",189,-0.9887,0.5,0.54,"No",1.0746,0.27,0.6,"Yes"
"12704","GO_BP","489126_GO_0003334_KERATINOCYTE_DEVELOPMENT",9,-0.9887,0.48,0.64,"No",-0.514,0.98,1,"No"
"12705","GO_BP","492419_GO_0030534_ADULT_BEHAVIOR",130,-0.9886,0.49,0.64,"No",-1.3437,0.029,0.92,"No"
"12706","C4_Cancer_modules","C4_CM_389_MODULE_489",30,-0.9885,0.48,0.59,"No",-1.1206,0.29,0.66,"No"
"12707","GO_CC","1184380_GO_0098791_GOLGI_SUBCOMPARTMENT",273,-0.9885,0.52,0.73,"No",1.0216,0.36,0.75,"Yes"
"12708","C2_Chemical_and_genetic_perturbations","C2_CGP_2289_MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER",41,-0.9884,0.49,0.59,"No",-1.1819,0.2,0.82,"No"
"12709","GO_BP","516695_GO_0071772_RESPONSE_TO_BMP",20,-0.9884,0.47,0.64,"No",-0.9509,0.53,1,"No"
"12710","C7_Immunologic_signatures","C7_ALL_1329_GSE30083_SP1_VS_SP4_THYMOCYTE_UP",196,-0.9884,0.51,0.6,"No",0.7185,1,1,"Yes"
"12711","GO_BP","496847_GO_0017015_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",101,-0.9883,0.5,0.64,"No",1.0118,0.44,0.97,"Yes"
"12712","GO_BP","516746_GO_0071824_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION",201,-0.9882,0.51,0.64,"No",-1.1529,0.14,0.92,"No"
"12713","C7_Immunologic_signatures","C7_ALL_1105_GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP",191,-0.9882,0.51,0.6,"No",1.0247,0.39,0.66,"Yes"
"12714","C7_Immunologic_signatures","C7_ALL_752_GSE17721_12H_VS_24H_CPG_BMDM_DN",197,-0.9882,0.51,0.6,"No",1.5974,0,0.0031,"Yes"
"12715","REACTOME","530753_REACT_115639_SULFUR_AMINO_ACID_METABOLISM",22,-0.9881,0.47,0.66,"No",0.4288,1,1,"Yes"
"12716","KEGG_compound","C16681_9_CIS_RETINAL",9,-0.988,0.48,0.64,"No",0.9554,0.5,1,"Yes"
"12717","GO_BP","504541_GO_0035357_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY",6,-0.9878,0.51,0.65,"No",0.95,0.51,1,"Yes"
"12718","C1_Positional","C1_ALL_23_CHRYP11",6,-0.9877,0.49,0.88,"No",-0.7527,0.77,0.97,"No"
"12719","C7_Immunologic_signatures","C7_ALL_297_GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP",198,-0.9877,0.52,0.6,"No",1.351,0.0024,0.061,"Yes"
"12720","GO_BP","496063_GO_0015942_FORMATE_METABOLIC_PROCESS",6,-0.9877,0.49,0.65,"No",0.7696,0.76,1,"Yes"
"12721","C1_Positional","C1_ALL_271_CHR20Q11",109,-0.9876,0.5,0.88,"No",0.8561,0.82,0.9,"Yes"
"12722","REACTOME","771587_REACT_160214_SIGNALING_BY_NOTCH1_IN_CANCER",57,-0.9876,0.49,0.67,"No",-0.6809,0.97,1,"No"
"12723","C3_TF_targets","C3_TFT_128_ATCMNTCCGY_UNKNOWN",51,-0.9875,0.48,0.59,"No",-0.7904,0.84,1,"No"
"12724","KEGG_compound","C05703_METHANESELENOL_METHYLSELENOL",6,-0.9875,0.52,0.64,"No",0.7508,0.75,1,"Yes"
"12725","C2_Chemical_and_genetic_perturbations","C2_CGP_917_WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP",13,-0.9875,0.45,0.59,"No",0.7819,0.77,1,"Yes"
"12726","GO_BP","509152_GO_0046958_NONASSOCIATIVE_LEARNING",5,-0.9873,0.5,0.65,"No",1.0694,0.37,0.93,"Yes"
"12727","GO_BP","514127_GO_0060572_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD",8,-0.9873,0.48,0.65,"No",-0.9547,0.51,1,"No"
"12728","C1_Positional","C1_ALL_175_CHR1P34",162,-0.9873,0.52,0.87,"No",-0.9628,0.54,1,"No"
"12729","GO_CC","752726_GO_0097225_SPERM_MIDPIECE",10,-0.9873,0.47,0.73,"No",-1.2902,0.17,0.67,"No"
"12730","C2_Chemical_and_genetic_perturbations","C2_CGP_1150_AMIT_SERUM_RESPONSE_480_MCF10A",37,-0.9871,0.48,0.59,"No",1.4475,0.039,0.26,"Yes"
"12731","GO_BP","511888_GO_0050953_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS",199,-0.987,0.48,0.65,"No",-1.3504,0.014,0.93,"No"
"12732","C3_TF_targets","C3_TFT_337_CYTAGCAAY_UNKNOWN",147,-0.9869,0.49,0.59,"No",-0.8584,0.8,1,"No"
"12733","GO_MF","490059_GO_0004745_RETINOL_DEHYDROGENASE_ACTIVITY",16,-0.9868,0.49,0.67,"No",1.1587,0.25,0.74,"Yes"
"12734","GO_CC","982479_GO_1902911_PROTEIN_KINASE_COMPLEX",87,-0.9867,0.48,0.73,"No",0.8243,0.86,0.94,"Yes"
"12735","C2_Chemical_and_genetic_perturbations","C2_CGP_2202_MCCABE_BOUND_BY_HOXC6",423,-0.9866,0.52,0.59,"No",1.0421,0.31,0.73,"Yes"
"12736","C7_Immunologic_signatures","C7_ALL_1735_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP",197,-0.9864,0.51,0.6,"No",1.0718,0.28,0.52,"Yes"
"12737","GO_BP","503954_GO_0034755_IRON_ION_TRANSMEMBRANE_TRANSPORT",5,-0.9864,0.49,0.65,"No",0.9875,0.49,0.99,"Yes"
"12738","REACTOME","106458_REACT_11046_NGF_INDEPENDANT_TRKA_ACTIVATION",5,-0.9863,0.51,0.67,"No",-0.8969,0.57,1,"No"
"12739","GO_BP","494042_GO_0009953_DORSAL_VENTRAL_PATTERN_FORMATION",94,-0.9863,0.5,0.65,"No",-1.2613,0.085,0.91,"No"
"12740","C2_Chemical_and_genetic_perturbations","C2_CGP_738_AIYAR_COBRA1_TARGETS_UP",39,-0.9862,0.49,0.59,"No",1.161,0.21,0.54,"Yes"
"12741","KEGG_pathway","HSA05033_NICOTINE_ADDICTION",38,-0.9862,0.49,0.54,"No",1.1545,0.24,0.66,"Yes"
"12742","GO_BP","519248_GO_2000609_REGULATION_OF_THYROID_HORMONE_GENERATION",5,-0.9862,0.51,0.65,"No",-1.1675,0.3,0.91,"No"
"12743","C6_Oncogenic_signatures","C6_ALL_147_SIRNA_EIF4GI_DN",96,-0.9861,0.5,0.54,"No",1.2418,0.11,0.35,"Yes"
"12744","KEGG_reaction","R01280_PALMITATE_COA_LIGASE_AMP_FORMING_ATP_HEXADECANOIC_ACID_COA_AMP_PALMITOYL_COA_DIPHOSPHATE",7,-0.9861,0.48,0.64,"No",0.5822,0.96,1,"Yes"
"12745","GO_BP","508348_GO_0046051_UTP_METABOLIC_PROCESS",12,-0.9859,0.48,0.65,"No",-0.845,0.67,1,"No"
"12746","C3_MicroRNA_targets","C3_MIR_86_GCTCTTG_MIR_335",86,-0.9859,0.48,0.63,"No",0.8055,0.91,1,"Yes"
"12747","C2_Chemical_and_genetic_perturbations","C2_CGP_296_SABATES_COLORECTAL_ADENOMA_SIZE_UP",23,-0.9859,0.49,0.59,"No",-1.5195,0.047,0.44,"No"
"12748","C2_Chemical_and_genetic_perturbations","C2_CGP_92_CHANDRAN_METASTASIS_TOP50_UP",38,-0.9858,0.49,0.59,"No",0.8794,0.67,0.94,"Yes"
"12749","WikiPathways","198854_WP136_PHASE_I_NON_P450",6,-0.9858,0.49,0.6,"No",1.7057,0.023,0.11,"Yes"
"12750","GO_MF","757162_GO_0044769_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_ROTATIONAL_MECHANISM",25,-0.9856,0.49,0.67,"No",1.7998,0.0041,0.079,"Yes"
"12751","GO_MF","492537_GO_0008195_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY",11,-0.9856,0.48,0.67,"No",0.7997,0.72,1,"Yes"
"12752","GO_BP","516427_GO_0071503_RESPONSE_TO_HEPARIN",6,-0.9855,0.48,0.65,"No",-1.9435,0.002,0.33,"No"
"12753","GO_CC","490835_GO_0030667_SECRETORY_GRANULE_MEMBRANE",71,-0.9854,0.49,0.73,"No",1.3975,0.032,0.3,"Yes"
"12754","KEGG_compound","C00407_L_ISOLEUCINE_2_AMINO_3_METHYLVALERIC_ACID",5,-0.9853,0.5,0.64,"No",0.7605,0.77,1,"Yes"
"12755","GO_BP","506943_GO_0043923_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION",12,-0.9853,0.49,0.65,"No",0.8911,0.58,1,"Yes"
"12756","C4_Cancer_modules","C4_CM_178_MODULE_190",11,-0.9853,0.49,0.6,"No",1.3393,0.14,0.24,"Yes"
"12757","C2_Chemical_and_genetic_perturbations","C2_CGP_129_LIU_TARGETS_OF_VMYB_VS_CMYB_UP",19,-0.9852,0.5,0.59,"No",-0.9996,0.45,1,"No"
"12758","OMIM_gene","OMIM608160_SRY_BOX_9_SOX9",5,-0.9852,0.49,0.78,"No",-1.488,0.063,1,"No"
"12759","C2_Chemical_and_genetic_perturbations","C2_CGP_3365_LIM_MAMMARY_LUMINAL_MATURE_UP",115,-0.9851,0.5,0.59,"No",-0.8313,0.84,1,"No"
"12760","GO_BP","499856_GO_0030517_NEGATIVE_REGULATION_OF_AXON_EXTENSION",23,-0.985,0.47,0.65,"No",-1.0541,0.39,0.97,"No"
"12761","GO_BP","781979_GO_1901990_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",214,-0.9848,0.52,0.65,"No",1.4199,0.0023,0.53,"Yes"
"12762","C2_Chemical_and_genetic_perturbations","C2_CGP_706_LUI_TARGETS_OF_PAX8_PPARG_FUSION",34,-0.9848,0.48,0.59,"No",2.0994,0,0.0019,"Yes"
"12763","GO_CC","500777_GO_0031526_BRUSH_BORDER_MEMBRANE",45,-0.9848,0.51,0.73,"No",-0.7321,0.91,1,"No"
"12764","GO_BP","515040_GO_0070102_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY",8,-0.9847,0.47,0.65,"No",0.5868,0.95,1,"Yes"
"12765","C4_Cancer_gene_neighborhoods","C4_CGN_274_GCM_VAV1",47,-0.9844,0.49,0.74,"No",-0.6102,0.99,1,"No"
"12766","GO_MF","490380_GO_0005114_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING",7,-0.9844,0.5,0.67,"No",-1.2597,0.21,0.84,"No"
"12767","C2_Chemical_and_genetic_perturbations","C2_CGP_834_MANN_RESPONSE_TO_AMIFOSTINE_DN",10,-0.9844,0.45,0.59,"No",1.9201,0.0039,0.016,"Yes"
"12768","GO_MF","492713_GO_0008417_FUCOSYLTRANSFERASE_ACTIVITY",14,-0.9844,0.5,0.67,"No",0.6706,0.89,1,"Yes"
"12769","C2_Chemical_and_genetic_perturbations","C2_CGP_3210_YUAN_ZNF143_PARTNERS",21,-0.9843,0.47,0.59,"No",0.5941,0.98,1,"Yes"
"12770","GO_BP","751870_GO_0044728_DNA_METHYLATION_OR_DEMETHYLATION",87,-0.9843,0.5,0.65,"No",-1.481,0.0072,0.84,"No"
"12771","GO_BP","754152_GO_1901185_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY",44,-0.9842,0.48,0.65,"No",1.221,0.14,0.77,"Yes"
"12772","GO_BP","494981_GO_0010917_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL",5,-0.9842,0.52,0.65,"No",0.8519,0.64,1,"Yes"
"12773","C2_Chemical_and_genetic_perturbations","C2_CGP_1724_KRASNOSELSKAYA_ILF3_TARGETS_UP",38,-0.9839,0.48,0.6,"No",1.6464,0.009,0.11,"Yes"
"12774","C2_Chemical_and_genetic_perturbations","C2_CGP_2626_ELLWOOD_MYC_TARGETS_DN",40,-0.9839,0.49,0.6,"No",1.627,0.016,0.12,"Yes"
"12775","GO_BP","516654_GO_0071731_RESPONSE_TO_NITRIC_OXIDE",12,-0.9837,0.48,0.65,"No",0.774,0.78,1,"Yes"
"12776","GO_BP","518817_GO_2000169_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION",5,-0.9837,0.51,0.65,"No",0.74,0.8,1,"Yes"
"12777","GO_BP","495284_GO_0014891_STRIATED_MUSCLE_ATROPHY",6,-0.9833,0.5,0.65,"No",0.9227,0.56,1,"Yes"
"12778","C3_TF_targets","C3_TFT_453_V_E2F_Q6_01",239,-0.983,0.53,0.6,"No",-0.7602,0.98,1,"No"
"12779","GO_BP","490966_GO_0005978_GLYCOGEN_BIOSYNTHETIC_PROCESS",27,-0.983,0.48,0.65,"No",0.9135,0.58,1,"Yes"
"12780","GO_BP","492369_GO_0007628_ADULT_WALKING_BEHAVIOR",34,-0.9829,0.49,0.65,"No",-1.2257,0.17,0.88,"No"
"12781","C2_BioCarta_Pathways","C2_CP_BIOCARTA_165_BIOCARTA_CARDIACEGF_PATHWAY",18,-0.9829,0.48,0.61,"No",1.1651,0.24,0.69,"Yes"
"12782","GO_CC","490887_GO_0005881_CYTOPLASMIC_MICROTUBULE",54,-0.9827,0.5,0.73,"No",0.569,1,1,"Yes"
"12783","GO_BP","488982_GO_0003188_HEART_VALVE_FORMATION",12,-0.9826,0.47,0.65,"No",0.7231,0.84,1,"Yes"
"12784","C7_Immunologic_signatures","C7_ALL_436_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN",198,-0.9824,0.52,0.61,"No",1.1643,0.12,0.29,"Yes"
"12785","GO_BP","503820_GO_0034620_CELLULAR_RESPONSE_TO_UNFOLDED_PROTEIN",103,-0.9824,0.51,0.65,"No",0.6615,1,1,"Yes"
"12786","REACTOME","771593_REACT_160243_CONSTITUTIVE_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS",57,-0.9824,0.5,0.67,"No",-0.6844,0.95,1,"No"
"12787","GO_BP","946575_GO_1902600_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORT",96,-0.9823,0.51,0.65,"No",2.0275,0,0.0094,"Yes"
"12788","C2_Chemical_and_genetic_perturbations","C2_CGP_1615_IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS",10,-0.9823,0.49,0.6,"No",0.7949,0.72,0.99,"Yes"
"12789","GO_BP","493422_GO_0009226_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS",16,-0.9823,0.5,0.65,"No",-0.7651,0.77,1,"No"
"12790","C2_Chemical_and_genetic_perturbations","C2_CGP_1206_NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON",151,-0.9821,0.5,0.6,"No",-1.0856,0.27,0.94,"No"
"12791","GO_BP","491239_GO_0006275_REGULATION_OF_DNA_REPLICATION",116,-0.982,0.51,0.65,"No",0.7173,0.98,1,"Yes"
"12792","GO_MF","489678_GO_0004312_FATTY_ACID_SYNTHASE_ACTIVITY",7,-0.9819,0.5,0.68,"No",-0.9362,0.53,0.96,"No"
"12793","KEGG_compound","C00483_TYRAMINE_2_P_HYDROXYPHENYL_ETHYLAMINE",6,-0.9817,0.51,0.64,"No",-1.2178,0.25,0.75,"No"
"12794","GO_CC","487094_GO_0000803_SEX_CHROMOSOME",25,-0.9816,0.49,0.74,"No",-1.018,0.41,0.84,"No"
"12795","GO_BP","505081_GO_0035912_DORSAL_AORTA_MORPHOGENESIS",5,-0.9814,0.5,0.66,"No",-1.008,0.47,0.98,"No"
"12796","C3_TF_targets","C3_TFT_183_CCAATNNSNNNGCG_UNKNOWN",56,-0.9813,0.5,0.61,"No",1.1018,0.28,1,"Yes"
"12797","C2_BioCarta_Pathways","C2_CP_BIOCARTA_114_BIOCARTA_MAPK_PATHWAY",87,-0.9813,0.49,0.61,"No",-1.2688,0.1,1,"No"
"12798","C2_Chemical_and_genetic_perturbations","C2_CGP_1549_ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN",19,-0.9813,0.51,0.6,"No",0.5205,0.99,1,"Yes"
"12799","C2_Chemical_and_genetic_perturbations","C2_CGP_3025_KARLSSON_TGFB1_TARGETS_UP",126,-0.9813,0.49,0.6,"No",1.798,0,0.044,"Yes"
"12800","GO_BP","515425_GO_0070493_THROMBIN_RECEPTOR_SIGNALING_PATHWAY",9,-0.9812,0.48,0.66,"No",1.6107,0.033,0.28,"Yes"
"12801","GO_BP","519377_GO_2000738_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION",45,-0.9811,0.5,0.66,"No",-1.1908,0.2,0.9,"No"
"12802","GO_MF","496726_GO_0016829_LYASE_ACTIVITY",170,-0.981,0.51,0.68,"No",1.349,0.018,0.52,"Yes"
"12803","C3_TF_targets","C3_TFT_251_V_E2F1_Q3",243,-0.981,0.53,0.6,"No",0.8765,0.83,1,"Yes"
"12804","GO_BP","494783_GO_0010718_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",29,-0.9808,0.51,0.66,"No",-1.1366,0.26,0.93,"No"
"12805","C4_Cancer_modules","C4_CM_182_MODULE_195",143,-0.9807,0.5,0.61,"No",0.9934,0.44,0.72,"Yes"
"12806","C3_TF_targets","C3_TFT_452_V_E2F_Q4_01",237,-0.9807,0.54,0.6,"No",-0.726,1,1,"No"
"12807","GO_BP","491374_GO_0006471_PROTEIN_ADP_RIBOSYLATION",19,-0.9805,0.48,0.66,"No",-1.3878,0.084,1,"No"
"12808","C2_Chemical_and_genetic_perturbations","C2_CGP_2175_WALLACE_PROSTATE_CANCER_RACE_DN",84,-0.9804,0.5,0.6,"No",0.8133,0.87,0.98,"Yes"
"12809","C4_Cancer_modules","C4_CM_115_MODULE_120",70,-0.9803,0.49,0.6,"No",0.9188,0.61,0.81,"Yes"
"12810","C4_Cancer_modules","C4_CM_149_MODULE_157",105,-0.9803,0.51,0.6,"No",-0.9017,0.69,0.87,"No"
"12811","GO_CC","512172_GO_0051286_CELL_TIP",7,-0.9801,0.48,0.74,"No",1.052,0.38,0.71,"Yes"
"12812","GO_BP","498072_GO_0019217_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS",77,-0.98,0.49,0.66,"No",1.0619,0.32,0.94,"Yes"
"12813","GO_BP","496952_GO_0017158_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",55,-0.9799,0.52,0.66,"No",-1.0822,0.32,0.95,"No"
"12814","GO_BP","518640_GO_0097090_PRESYNAPTIC_MEMBRANE_ORGANIZATION",11,-0.9799,0.51,0.66,"No",-0.9571,0.51,1,"No"
"12815","C1_Positional","C1_ALL_203_CHR4P13",14,-0.9798,0.47,0.89,"No",-0.7279,0.83,0.98,"No"
"12816","C7_Immunologic_signatures","C7_ALL_266_GSE14308_TH17_VS_NATURAL_TREG_DN",196,-0.9798,0.51,0.62,"No",-0.9856,0.5,1,"No"
"12817","WikiPathways","219801_WP1984_INTEGRATED_BREAST_CANCER_PATHWAY",151,-0.9798,0.51,0.6,"No",0.5251,1,0.99,"Yes"
"12818","GO_BP","508585_GO_0046320_REGULATION_OF_FATTY_ACID_OXIDATION",24,-0.9797,0.49,0.66,"No",0.8997,0.6,1,"Yes"
"12819","GO_BP","752205_GO_0061462_PROTEIN_LOCALIZATION_TO_LYSOSOME",16,-0.9797,0.48,0.66,"No",0.8957,0.59,1,"Yes"
"12820","GO_MF","514942_GO_0070001_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY",25,-0.9796,0.51,0.68,"No",0.7383,0.86,1,"Yes"
"12821","GO_BP","502155_GO_0032933_SREBP_SIGNALING_PATHWAY",7,-0.9795,0.49,0.66,"No",-0.961,0.51,1,"No"
"12822","C2_Chemical_and_genetic_perturbations","C2_CGP_1537_VERNELL_RETINOBLASTOMA_PATHWAY_UP",70,-0.9795,0.48,0.6,"No",1.0623,0.36,0.69,"Yes"
"12823","C3_TF_targets","C3_TFT_497_KMCATNNWGGA_UNKNOWN",88,-0.9794,0.51,0.61,"No",-0.9819,0.47,0.8,"No"
"12824","GO_BP","499843_GO_0030502_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION",15,-0.9793,0.5,0.66,"No",1.1045,0.3,0.9,"Yes"
"12825","GO_BP","752605_GO_0097104_POSTSYNAPTIC_MEMBRANE_ASSEMBLY",6,-0.9792,0.51,0.66,"No",-0.8832,0.62,1,"No"
"12826","C2_Chemical_and_genetic_perturbations","C2_CGP_1898_RAMASWAMY_METASTASIS_UP",66,-0.9787,0.49,0.6,"No",0.7617,0.88,1,"Yes"
"12827","GO_BP","517560_GO_0072657_PROTEIN_LOCALIZATION_TO_MEMBRANE",349,-0.9785,0.56,0.66,"No",2.6912,0,0,"Yes"
"12828","GO_BP","494713_GO_0010649_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING",13,-0.9785,0.49,0.66,"No",1.3175,0.14,0.65,"Yes"
"12829","GO_BP","495282_GO_0014889_MUSCLE_ATROPHY",7,-0.9784,0.47,0.66,"No",0.8947,0.61,1,"Yes"
"12830","C2_Chemical_and_genetic_perturbations","C2_CGP_3129_JOHNSTONE_PARVB_TARGETS_2_DN",332,-0.9782,0.56,0.61,"No",1.5457,0,0.17,"Yes"
"12831","C3_MicroRNA_targets","C3_MIR_30_TAGGTCA_MIR_192_MIR_215",46,-0.9782,0.49,0.65,"No",0.9749,0.5,1,"Yes"
"12832","C2_Chemical_and_genetic_perturbations","C2_CGP_2085_YEGNASUBRAMANIAN_PROSTATE_CANCER",116,-0.9781,0.48,0.61,"No",1.2027,0.13,0.48,"Yes"
"12833","C2_Chemical_and_genetic_perturbations","C2_CGP_816_FUNG_IL2_SIGNALING_1",11,-0.9781,0.49,0.6,"No",0.9037,0.6,0.92,"Yes"
"12834","C2_Chemical_and_genetic_perturbations","C2_CGP_604_DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP",26,-0.9779,0.5,0.61,"No",-1.0311,0.4,0.98,"No"
"12835","GO_BP","508759_GO_0046500_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS",14,-0.9779,0.5,0.66,"No",-1.3285,0.13,0.89,"No"
"12836","GO_BP","506413_GO_0043374_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",7,-0.9779,0.49,0.66,"No",0.7206,0.82,1,"Yes"
"12837","C3_MicroRNA_targets","C3_MIR_151_AAAGACA_MIR_511",199,-0.9776,0.54,0.65,"No",0.9509,0.59,1,"Yes"
"12838","REACTOME","105933_REACT_11035_GAP_JUNCTION_DEGRADATION",10,-0.9775,0.5,0.68,"No",1.0758,0.37,0.62,"Yes"
"12839","C2_Chemical_and_genetic_perturbations","C2_CGP_2056_LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES",17,-0.9775,0.5,0.61,"No",-1.1433,0.28,0.86,"No"
"12840","GO_BP","502305_GO_0033084_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION_IN_THYMUS",7,-0.9774,0.5,0.66,"No",0.7225,0.8,1,"Yes"
"12841","C3_TF_targets","C3_TFT_254_V_TITF1_Q3",230,-0.9773,0.55,0.61,"No",-1.0334,0.35,0.69,"No"
"12842","GO_BP","518330_GO_0090190_POSITIVE_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS",19,-0.9771,0.49,0.66,"No",1.2577,0.17,0.72,"Yes"
"12843","C2_Chemical_and_genetic_perturbations","C2_CGP_3160_CHANGOLKAR_H2AFY_TARGETS_DN",40,-0.9771,0.51,0.61,"No",1.0379,0.41,0.74,"Yes"
"12844","GO_BP","753711_GO_1900740_POSITIVE_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",26,-0.9771,0.49,0.66,"No",0.5828,0.99,1,"Yes"
"12845","OMIM_gene","OMIM604891_NCK_ASSOCIATED_PROTEIN_1_NCKAP1",8,-0.977,0.48,0.77,"No",0.6113,0.93,1,"Yes"
"12846","REACTOME","771592_REACT_160301_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER",57,-0.9769,0.52,0.68,"No",-0.6725,0.97,1,"No"
"12847","C1_Positional","C1_ALL_46_CHR15Q24",75,-0.9768,0.5,0.89,"No",-1,0.45,1,"No"
"12848","C2_Chemical_and_genetic_perturbations","C2_CGP_364_PROVENZANI_METASTASIS_UP",194,-0.9768,0.53,0.61,"No",1.6551,0,0.11,"Yes"
"12849","GO_BP","494867_GO_0010803_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY",16,-0.9767,0.53,0.66,"No",-0.4451,1,1,"No"
"12850","C2_Chemical_and_genetic_perturbations","C2_CGP_1949_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP",18,-0.9766,0.49,0.61,"No",-0.9552,0.51,1,"No"
"12851","GO_BP","512166_GO_0051280_NEGATIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",5,-0.9764,0.52,0.66,"No",-0.7576,0.75,1,"No"
"12852","C2_Chemical_and_genetic_perturbations","C2_CGP_2908_CHANDRAN_METASTASIS_UP",214,-0.9757,0.55,0.61,"No",-0.9293,0.67,1,"No"
"12853","GO_BP","491491_GO_0006596_POLYAMINE_BIOSYNTHETIC_PROCESS",13,-0.9757,0.49,0.66,"No",-0.7171,0.83,1,"No"
"12854","C7_Immunologic_signatures","C7_ALL_1490_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN",197,-0.9756,0.51,0.63,"No",1.0022,0.45,0.73,"Yes"
"12855","C4_Cancer_gene_neighborhoods","C4_CGN_8_MORF_BRCA1",258,-0.9753,0.54,0.76,"No",-1.0888,0.23,0.75,"No"
"12856","GO_BP","504275_GO_0035090_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY",7,-0.9752,0.47,0.66,"No",1.2274,0.21,0.76,"Yes"
"12857","KEGG_module","HSA_M00683_HIPPO_SIGNALING",15,-0.9752,0.47,0.76,"No",-0.6281,0.95,1,"No"
"12858","C3_TF_targets","C3_TFT_127_V_MYB_Q6",248,-0.9751,0.55,0.62,"No",-0.8558,0.88,1,"No"
"12859","GO_BP","491857_GO_0007029_ENDOPLASMIC_RETICULUM_ORGANIZATION",40,-0.975,0.52,0.66,"No",0.594,0.99,1,"Yes"
"12860","GO_BP","517200_GO_0072284_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS",5,-0.975,0.5,0.66,"No",1.1017,0.37,0.9,"Yes"
"12861","GO_BP","505055_GO_0035886_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",12,-0.975,0.48,0.66,"No",-0.7331,0.82,1,"No"
"12862","C7_Immunologic_signatures","C7_ALL_926_GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN",200,-0.9748,0.55,0.63,"No",1.648,0,0.0013,"Yes"
"12863","GO_BP","499595_GO_0030177_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY",158,-0.9747,0.53,0.67,"No",1.2018,0.078,0.78,"Yes"
"12864","GO_BP","510800_GO_0048747_MUSCLE_FIBER_DEVELOPMENT",42,-0.9745,0.5,0.67,"No",-1.2976,0.1,0.89,"No"
"12865","C7_Immunologic_signatures","C7_ALL_1094_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN",199,-0.9745,0.54,0.63,"No",0.8868,0.78,1,"Yes"
"12866","C2_Chemical_and_genetic_perturbations","C2_CGP_2044_HOWLIN_CITED1_TARGETS_2_DN",17,-0.9744,0.51,0.61,"No",-0.5789,0.97,1,"No"
"12867","C7_Immunologic_signatures","C7_ALL_1871_GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP",197,-0.9743,0.53,0.63,"No",1.3702,0.017,0.051,"Yes"
"12868","GO_MF","496740_GO_0016846_CARBON_SULFUR_LYASE_ACTIVITY",11,-0.9743,0.5,0.69,"No",0.9689,0.49,0.91,"Yes"
"12869","GO_BP","494803_GO_0010738_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING",17,-0.9743,0.5,0.67,"No",0.9569,0.51,1,"Yes"
"12870","GO_BP","496276_GO_0016202_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",96,-0.9742,0.52,0.67,"No",-0.8356,0.81,1,"No"
"12871","C2_BioCarta_Pathways","C2_CP_BIOCARTA_144_BIOCARTA_AKAPCENTROSOME_PATHWAY",15,-0.9742,0.5,0.62,"No",1.1972,0.21,0.68,"Yes"
"12872","GO_MF","496944_GO_0017147_WNT_PROTEIN_BINDING",27,-0.974,0.49,0.69,"No",-0.9183,0.6,0.97,"No"
"12873","C2_Chemical_and_genetic_perturbations","C2_CGP_927_SCHMAHL_PDGF_SIGNALING",9,-0.974,0.5,0.61,"No",0.5771,0.96,1,"Yes"
"12874","GO_BP","510425_GO_0048318_AXIAL_MESODERM_DEVELOPMENT",8,-0.9739,0.49,0.67,"No",-0.8852,0.6,1,"No"
"12875","GO_BP","518178_GO_0090031_POSITIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",6,-0.9739,0.49,0.67,"No",0.7923,0.69,1,"Yes"
"12876","GO_BP","494926_GO_0010862_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",45,-0.9739,0.5,0.67,"No",0.8895,0.64,1,"Yes"
"12877","GO_MF","506340_GO_0043274_PHOSPHOLIPASE_BINDING",16,-0.9739,0.49,0.69,"No",0.9512,0.52,0.93,"Yes"
"12878","GO_BP","754630_GO_1901679_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT",12,-0.9739,0.48,0.67,"No",-1.0367,0.41,0.98,"No"
"12879","C7_Immunologic_signatures","C7_ALL_1759_GSE6269_STREP_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP",177,-0.9738,0.52,0.63,"No",1.0437,0.37,0.61,"Yes"
"12880","C2_Chemical_and_genetic_perturbations","C2_CGP_272_ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN",44,-0.9737,0.5,0.61,"No",-0.6361,0.98,1,"No"
"12881","C4_Cancer_gene_neighborhoods","C4_CGN_231_GCM_FCGR2B",37,-0.9737,0.51,0.76,"No",-0.7346,0.89,1,"No"
"12882","C2_Chemical_and_genetic_perturbations","C2_CGP_2055_LEIN_CEREBELLUM_MARKERS",82,-0.9735,0.51,0.61,"No",-0.809,0.85,1,"No"
"12883","GO_CC","490832_GO_0030133_TRANSPORT_VESICLE",164,-0.9733,0.52,0.75,"No",1.19,0.093,0.55,"Yes"
"12884","GO_BP","503582_GO_0034380_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY",8,-0.9732,0.49,0.67,"No",-1.1355,0.3,0.93,"No"
"12885","C4_Cancer_modules","C4_CM_324_MODULE_381",12,-0.9732,0.49,0.62,"No",-1.2847,0.18,0.53,"No"
"12886","GO_BP","513645_GO_0060087_RELAXATION_OF_VASCULAR_SMOOTH_MUSCLE",7,-0.9732,0.5,0.67,"No",1.2019,0.25,0.78,"Yes"
"12887","GO_BP","781992_GO_1902003_REGULATION_OF_BETA_AMYLOID_FORMATION",10,-0.9731,0.48,0.67,"No",1.0282,0.43,0.97,"Yes"
"12888","KEGG_compound","C00343_THIOREDOXIN_DISULFIDE_OXIDIZED_THIOREDOXIN_THIOREDOXIN_SULFIDE",7,-0.9731,0.51,0.66,"No",1.0626,0.4,1,"Yes"
"12889","GO_BP","1129562_GO_1903747_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",99,-0.9731,0.53,0.67,"No",1.2648,0.087,0.71,"Yes"
"12890","GO_BP","752655_GO_0097154_GABAERGIC_NEURON_DIFFERENTIATION",9,-0.9731,0.48,0.67,"No",-1.7037,0.012,0.7,"No"
"12891","C7_Immunologic_signatures","C7_ALL_1865_GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP",197,-0.973,0.54,0.64,"No",0.8254,0.93,1,"Yes"
"12892","C2_Chemical_and_genetic_perturbations","C2_CGP_388_LAU_APOPTOSIS_CDKN2A_DN",5,-0.9729,0.53,0.61,"No",0.5017,0.98,1,"Yes"
"12893","GO_BP","494529_GO_0010459_NEGATIVE_REGULATION_OF_HEART_RATE",10,-0.9729,0.51,0.67,"No",1.3867,0.1,0.57,"Yes"
"12894","C2_Chemical_and_genetic_perturbations","C2_CGP_1982_TSENG_ADIPOGENIC_POTENTIAL_UP",30,-0.9728,0.5,0.61,"No",-0.9742,0.49,1,"No"
"12895","C2_Chemical_and_genetic_perturbations","C2_CGP_644_ROVERSI_GLIOMA_COPY_NUMBER_UP",99,-0.9728,0.53,0.61,"No",0.5655,1,1,"Yes"
"12896","GO_BP","505875_GO_0042769_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE",9,-0.9728,0.5,0.67,"No",-0.697,0.85,1,"No"
"12897","GO_BP","491760_GO_0006900_MEMBRANE_BUDDING",68,-0.9726,0.5,0.67,"No",1.8279,0,0.077,"Yes"
"12898","GO_BP","516205_GO_0071281_CELLULAR_RESPONSE_TO_IRON_ION",6,-0.9725,0.5,0.67,"No",1.2908,0.17,0.69,"Yes"
"12899","C2_Chemical_and_genetic_perturbations","C2_CGP_314_ELVIDGE_HYPOXIA_BY_DMOG_DN",59,-0.9725,0.51,0.61,"No",0.8957,0.7,0.93,"Yes"
"12900","GO_BP","505683_GO_0042552_MYELINATION",85,-0.9723,0.54,0.67,"No",0.7347,0.96,1,"Yes"
"12901","GO_BP","492045_GO_0007266_RHO_PROTEIN_SIGNAL_TRANSDUCTION",49,-0.9723,0.51,0.67,"No",0.969,0.52,1,"Yes"
"12902","C2_Chemical_and_genetic_perturbations","C2_CGP_1277_GOLUB_ALL_VS_AML_UP",24,-0.9722,0.49,0.61,"No",0.6196,0.98,1,"Yes"
"12903","C1_Positional","C1_ALL_158_CHR14Q32",127,-0.9722,0.54,0.89,"No",-0.9239,0.62,1,"No"
"12904","GO_BP","510491_GO_0048384_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",18,-0.9722,0.51,0.67,"No",0.7391,0.85,1,"Yes"
"12905","REACTOME","771594_REACT_160248_SIGNALING_BY_NOTCH1_HD_PEST_DOMAIN_MUTANTS_IN_CANCER",57,-0.9722,0.5,0.69,"No",-0.6686,0.97,1,"No"
"12906","GO_BP","519412_GO_2000773_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE",10,-0.972,0.51,0.67,"No",-0.7293,0.82,1,"No"
"12907","KEGG_compound","C00149__S_MALATE_L_MALATE_L_APPLE_ACID_L_MALIC_ACID_L_2_HYDROXYBUTANEDIOIC_ACID_MALATE_MALIC_ACID",6,-0.972,0.52,0.66,"No",1.1159,0.35,1,"Yes"
"12908","KEGG_module","HSA_M00086_BETA_OXIDATION_ACYL_COA_SYNTHESIS",7,-0.972,0.5,0.75,"No",0.5724,0.96,0.99,"Yes"
"12909","C2_Chemical_and_genetic_perturbations","C2_CGP_2046_HILLION_HMGA1B_TARGETS",89,-0.972,0.52,0.61,"No",1.9845,0,0.0075,"Yes"
"12910","OMIM_gene","OMIM603819_STEROID_RECEPTOR_RNA_ACTIVATOR_1_SRA1",5,-0.9717,0.52,0.76,"No",-1.4811,0.045,0.8,"No"
"12911","C1_Positional","C1_ALL_226_CHR6Q25",56,-0.9717,0.5,0.89,"No",-0.9354,0.59,1,"No"
"12912","KEGG_compound","C00135_L_HISTIDINE_S_ALPHA_AMINO_1H_IMIDAZOLE_4_PROPIONIC_ACID",8,-0.9714,0.49,0.66,"No",-0.6957,0.85,1,"No"
"12913","GO_BP","488185_GO_0002312_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",33,-0.9714,0.5,0.67,"No",0.7456,0.86,1,"Yes"
"12914","REACTOME","771595_REACT_160254_CONSTITUTIVE_SIGNALING_BY_NOTCH1_HD_PEST_DOMAIN_MUTANTS",57,-0.9714,0.51,0.69,"No",-0.6665,0.98,1,"No"
"12915","REACTOME","645314_REACT_120906_SYNTHESIS_OF_PA",26,-0.9714,0.51,0.69,"No",1.0667,0.36,0.63,"Yes"
"12916","GO_BP","497078_GO_0018103_PROTEIN_C_LINKED_GLYCOSYLATION",5,-0.9713,0.52,0.67,"No",0.7393,0.78,1,"Yes"
"12917","GO_CC","752600_GO_0090543_FLEMMING_BODY",8,-0.9713,0.49,0.75,"No",1.2931,0.17,0.41,"Yes"
"12918","KEGG_reaction","R00434_GTP_DIPHOSPHATE_LYASE_CYCLIZING_3_5_CYCLIC_GMP_FORMING_GTP_3_5_CYCLIC_GMP_DIPHOSPHATE",18,-0.9711,0.48,0.66,"No",-0.7695,0.81,1,"No"
"12919","KEGG_compound","C00455_NICOTINAMIDE_D_RIBONUCLEOTIDE_NMN_NICOTINAMIDE_MONONUCLEOTIDE_NICOTINAMIDE_RIBONUCLEOTIDE_NICOTINAMIDE_NUCLEOTIDE_BETA_NICOTINAMIDE_D_RIBONUCLEOTIDE_BETA_NICOTINAMIDE_RIBONUCLEOTIDE_BETA_NICOTINAMIDE_MONONUCLEOTIDE",19,-0.9709,0.51,0.65,"No",0.8176,0.73,1,"Yes"
"12920","GO_BP","518482_GO_0090342_REGULATION_OF_CELL_AGING",31,-0.9708,0.49,0.67,"No",-0.8722,0.67,1,"No"
"12921","GO_BP","509075_GO_0046855_INOSITOL_PHOSPHATE_DEPHOSPHORYLATION",10,-0.9705,0.48,0.67,"No",-0.5021,0.98,1,"No"
"12922","C1_Positional","C1_ALL_254_CHR4Q27",12,-0.9704,0.49,0.89,"No",0.7614,0.77,0.99,"Yes"
"12923","REACTOME","106249_REACT_11193_METABOLISM_OF_VITAMINS_AND_COFACTORS",86,-0.9704,0.51,0.69,"No",0.8308,0.83,0.97,"Yes"
"12924","GO_MF","492434_GO_0008061_CHITIN_BINDING",8,-0.9703,0.5,0.7,"No",1.7334,0.012,0.12,"Yes"
"12925","GO_CC","490656_GO_0005583_FIBRILLAR_COLLAGEN_TRIMER",13,-0.9703,0.51,0.76,"No",-1.1457,0.26,0.7,"No"
"12926","REACTOME","1183555_REACT_355503_CD209_DC_SIGN_SIGNALING",21,-0.9702,0.51,0.69,"No",0.9905,0.43,0.77,"Yes"
"12927","GO_CC","850020_GO_1990111_SPERMATOPROTEASOME_COMPLEX",5,-0.97,0.52,0.75,"No",0.6761,0.85,0.98,"Yes"
"12928","KEGG_compound","C00342_THIOREDOXIN_REDUCED_THIOREDOXIN",7,-0.97,0.5,0.65,"No",1.0439,0.4,1,"Yes"
"12929","C2_Chemical_and_genetic_perturbations","C2_CGP_1996_BILD_CTNNB1_ONCOGENIC_SIGNATURE",81,-0.9699,0.53,0.62,"No",-0.8044,0.87,1,"No"
"12930","GO_BP","753990_GO_1901020_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",20,-0.9697,0.51,0.67,"No",0.8181,0.73,1,"Yes"
"12931","C7_Immunologic_signatures","C7_ALL_28_GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN",200,-0.9697,0.54,0.65,"No",1.04,0.36,0.62,"Yes"
"12932","GO_BP","501995_GO_0032769_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY",12,-0.9696,0.5,0.67,"No",-0.9807,0.49,1,"No"
"12933","REACTOME","106480_REACT_12435_RETROGRADE_NEUROTROPHIN_SIGNALLING",13,-0.9696,0.5,0.69,"No",0.6411,0.92,1,"Yes"
"12934","REACTOME","187192_REACT_25283_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING",28,-0.9695,0.49,0.69,"No",0.8634,0.65,0.95,"Yes"
"12935","C2_Chemical_and_genetic_perturbations","C2_CGP_2960_BAUS_TFF2_TARGETS_DN",10,-0.9695,0.5,0.62,"No",0.7679,0.77,1,"Yes"
"12936","C7_Immunologic_signatures","C7_ALL_380_GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN",200,-0.9694,0.54,0.65,"No",1.1397,0.15,0.34,"Yes"
"12937","C3_MicroRNA_targets","C3_MIR_185_CCAGGGG_MIR_331",96,-0.9692,0.52,0.67,"No",-1.7022,0,0.08,"No"
"12938","GO_BP","518191_GO_0090050_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",7,-0.9692,0.5,0.67,"No",-0.6947,0.84,1,"No"
"12939","GO_BP","502417_GO_0033197_RESPONSE_TO_VITAMIN_E",12,-0.9691,0.52,0.67,"No",1.0158,0.42,0.97,"Yes"
"12940","GO_BP","491070_GO_0006085_ACETYL_COA_BIOSYNTHETIC_PROCESS",5,-0.9691,0.52,0.67,"No",0.7072,0.83,1,"Yes"
"12941","GO_MF","492627_GO_0008307_STRUCTURAL_CONSTITUENT_OF_MUSCLE",39,-0.9689,0.51,0.7,"No",-1.2294,0.15,0.84,"No"
"12942","C2_Chemical_and_genetic_perturbations","C2_CGP_2645_WENDT_COHESIN_TARGETS_UP",33,-0.9688,0.51,0.62,"No",0.9566,0.54,0.86,"Yes"
"12943","GO_BP","489174_GO_0003382_EPITHELIAL_CELL_MORPHOGENESIS",45,-0.9685,0.51,0.67,"No",-1.3712,0.063,0.98,"No"
"12944","C2_Chemical_and_genetic_perturbations","C2_CGP_3233_LIU_TOPBP1_TARGETS",16,-0.9684,0.52,0.62,"No",1.2436,0.17,0.45,"Yes"
"12945","REACTOME","106100_REACT_1525_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS",5,-0.9683,0.5,0.69,"No",1.4326,0.085,0.2,"Yes"
"12946","GO_BP","510760_GO_0048705_SKELETAL_SYSTEM_MORPHOGENESIS",206,-0.9683,0.54,0.67,"No",-1.3524,0.017,0.95,"No"
"12947","KEGG_compound","C00643_5_HYDROXY_L_TRYPTOPHAN_OXITRIPTAN",5,-0.9681,0.55,0.66,"No",-1.2706,0.17,0.68,"No"
"12948","C2_Chemical_and_genetic_perturbations","C2_CGP_417_CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP",33,-0.968,0.51,0.62,"No",-0.4191,1,1,"No"
"12949","REACTOME","730337_REACT_150201_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES",6,-0.9678,0.51,0.69,"No",0.8893,0.62,0.91,"Yes"
"12950","GO_MF","489905_GO_0004571_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY",8,-0.9678,0.5,0.7,"No",-0.7173,0.82,1,"No"
"12951","C7_Immunologic_signatures","C7_ALL_931_GSE22886_NAIVE_VS_MEMORY_TCELL_UP",195,-0.9675,0.55,0.65,"No",-1.0266,0.38,1,"No"
"12952","C2_Chemical_and_genetic_perturbations","C2_CGP_2451_MIKI_COEXPRESSED_WITH_CYP19A1",7,-0.9675,0.5,0.62,"No",0.6991,0.83,1,"Yes"
"12953","KEGG_module","HSA_M00691_DNA_DAMAGE_INDUCED_CELL_CYCLE_CHECKPOINTS",7,-0.9675,0.51,0.74,"No",-0.6373,0.91,1,"No"
"12954","C6_Oncogenic_signatures","C6_ALL_129_CAHOY_NEURONAL",99,-0.9674,0.54,0.58,"No",1.1572,0.2,0.42,"Yes"
"12955","C1_Positional","C1_ALL_100_CHR5Q15",20,-0.9672,0.49,0.89,"No",-0.9846,0.48,0.99,"No"
"12956","C3_MicroRNA_targets","C3_MIR_202_ATCATGA_MIR_433",115,-0.9672,0.54,0.67,"No",0.9119,0.66,1,"Yes"
"12957","C2_Chemical_and_genetic_perturbations","C2_CGP_198_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN",54,-0.9671,0.52,0.62,"No",0.7672,0.88,1,"Yes"
"12958","WikiPathways","198834_WP422_MAPK_CASCADE",29,-0.967,0.52,0.62,"No",-0.6977,0.91,1,"No"
"12959","WikiPathways","198884_WP231_TNF_ALPHA_NF_KB_SIGNALING_PATHWAY",190,-0.967,0.56,0.62,"No",1.1622,0.11,0.9,"Yes"
"12960","C2_Chemical_and_genetic_perturbations","C2_CGP_2469_BOYLAN_MULTIPLE_MYELOMA_D_UP",87,-0.9669,0.54,0.62,"No",0.7405,0.95,1,"Yes"
"12961","GO_BP","519287_GO_2000648_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION",65,-0.9668,0.52,0.68,"No",1.1385,0.23,0.85,"Yes"
"12962","C2_Chemical_and_genetic_perturbations","C2_CGP_2593_LEE_SP4_THYMOCYTE",14,-0.9667,0.51,0.62,"No",1.2356,0.19,0.45,"Yes"
"12963","C2_Chemical_and_genetic_perturbations","C2_CGP_1428_FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN",25,-0.9666,0.52,0.62,"No",0.9045,0.6,0.92,"Yes"
"12964","C2_Chemical_and_genetic_perturbations","C2_CGP_617_APPIERTO_RESPONSE_TO_FENRETINIDE_DN",51,-0.9665,0.52,0.62,"No",1.4118,0.043,0.29,"Yes"
"12965","C2_Chemical_and_genetic_perturbations","C2_CGP_1751_MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP",81,-0.9665,0.53,0.62,"No",-0.6878,0.97,1,"No"
"12966","REACTOME","105906_REACT_18368_IRE1ALPHA_ACTIVATES_CHAPERONES",59,-0.9665,0.51,0.7,"No",0.757,0.92,1,"Yes"
"12967","GO_BP","491651_GO_0006778_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS",39,-0.9665,0.51,0.68,"No",1.1574,0.22,0.83,"Yes"
"12968","GO_BP","511761_GO_0050792_REGULATION_OF_VIRAL_PROCESS",185,-0.9664,0.54,0.68,"No",1.6884,0,0.21,"Yes"
"12969","GO_BP","982499_GO_1902931_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS",15,-0.9662,0.53,0.68,"No",-1.1197,0.3,0.94,"No"
"12970","C0_Hallmark","H_ALL_24_HALLMARK_UNFOLDED_PROTEIN_RESPONSE",112,-0.9661,0.54,0.57,"No",1.3482,0.026,0.074,"Yes"
"12971","KEGG_module","HSA_M00089_TRIACYLGLYCEROL_BIOSYNTHESIS",16,-0.9661,0.53,0.73,"No",0.7661,0.78,0.91,"Yes"
"12972","GO_BP","516473_GO_0071549_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS",18,-0.966,0.51,0.68,"No",1.3449,0.13,0.61,"Yes"
"12973","GO_BP","508001_GO_0045653_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION",17,-0.966,0.5,0.68,"No",-1.2681,0.18,0.89,"No"
"12974","REACTOME","187202_REACT_23905_PLATELET_CALCIUM_HOMEOSTASIS",19,-0.9659,0.5,0.7,"No",-1.3421,0.1,0.6,"No"
"12975","C2_Chemical_and_genetic_perturbations","C2_CGP_2704_CHEN_LIVER_METABOLISM_QTL_CIS",92,-0.9659,0.53,0.62,"No",0.9552,0.56,0.86,"Yes"
"12976","GO_BP","517155_GO_0072239_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT",7,-0.9659,0.51,0.68,"No",-0.6584,0.87,1,"No"
"12977","C3_TF_targets","C3_TFT_95_ACTWSNACTNY_UNKNOWN",103,-0.9658,0.53,0.64,"No",-0.712,0.98,1,"No"
"12978","GO_BP","514089_GO_0060534_TRACHEA_CARTILAGE_DEVELOPMENT",6,-0.9657,0.51,0.68,"No",-0.8988,0.59,1,"No"
"12979","C4_Cancer_modules","C4_CM_135_MODULE_141",15,-0.9656,0.52,0.63,"No",-1.2443,0.19,0.58,"No"
"12980","GO_BP","493365_GO_0009169_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",381,-0.9655,0.58,0.68,"No",-0.8437,0.94,1,"No"
"12981","C7_Immunologic_signatures","C7_ALL_760_GSE17721_0_5H_VS_24H_GARDIQUIMOD_BMDM_DN",199,-0.9652,0.55,0.66,"No",1.1558,0.13,0.31,"Yes"
"12982","C1_Positional","C1_ALL_230_CHR9Q21",53,-0.9652,0.51,0.89,"No",1.0352,0.38,0.72,"Yes"
"12983","C2_Chemical_and_genetic_perturbations","C2_CGP_1960_BROWNE_HCMV_INFECTION_6HR_DN",160,-0.9649,0.56,0.63,"No",1.0141,0.44,0.78,"Yes"
"12984","C4_Cancer_modules","C4_CM_222_MODULE_243",80,-0.9647,0.54,0.63,"No",1.5414,0.0022,0.096,"Yes"
"12985","GO_BP","751435_GO_0039528_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY_IN_RESPONSE_TO_VIRUS",6,-0.9646,0.51,0.68,"No",1.2017,0.26,0.78,"Yes"
"12986","GO_BP","501688_GO_0032456_ENDOCYTIC_RECYCLING",18,-0.9646,0.5,0.68,"No",0.5903,0.97,1,"Yes"
"12987","GO_BP","505877_GO_0042771_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR",30,-0.9646,0.53,0.68,"No",-0.7121,0.9,1,"No"
"12988","GO_BP","501496_GO_0032261_PURINE_NUCLEOTIDE_SALVAGE",8,-0.9646,0.5,0.68,"No",0.6952,0.83,1,"Yes"
"12989","GO_MF","494915_GO_0010851_CYCLASE_REGULATOR_ACTIVITY",8,-0.9646,0.53,0.71,"No",-0.8562,0.63,1,"No"
"12990","GO_BP","506245_GO_0043173_NUCLEOTIDE_SALVAGE",14,-0.9645,0.53,0.68,"No",-0.6806,0.9,1,"No"
"12991","GO_MF","490354_GO_0005086_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",18,-0.9645,0.51,0.71,"No",-1.0037,0.43,0.9,"No"
"12992","GO_BP","515023_GO_0070085_GLYCOSYLATION",300,-0.9645,0.58,0.68,"No",0.9392,0.69,1,"Yes"
"12993","GO_BP","518890_GO_2000243_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS",122,-0.9644,0.54,0.68,"No",1.4286,0.0024,0.52,"Yes"
"12994","C3_TF_targets","C3_TFT_57_V_ZID_01",253,-0.9644,0.57,0.64,"No",-1.0575,0.3,0.64,"No"
"12995","C2_Chemical_and_genetic_perturbations","C2_CGP_3108_CHYLA_CBFA2T3_TARGETS_DN",236,-0.9644,0.54,0.63,"No",0.9941,0.48,0.81,"Yes"
"12996","C4_Cancer_modules","C4_CM_218_MODULE_239",120,-0.9644,0.55,0.63,"No",1.5326,0.0091,0.1,"Yes"
"12997","GO_BP","518620_GO_0097070_DUCTUS_ARTERIOSUS_CLOSURE",5,-0.9642,0.52,0.68,"No",1.5821,0.031,0.31,"Yes"
"12998","C1_Positional","C1_ALL_236_CHR12Q23",69,-0.9642,0.53,0.88,"No",1.0965,0.27,0.64,"Yes"
"12999","GO_BP","1022157_GO_1903170_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT",20,-0.9642,0.51,0.68,"No",0.8207,0.7,1,"Yes"
"13000","GO_BP","497182_GO_0018211_PEPTIDYL_TRYPTOPHAN_MODIFICATION",5,-0.9642,0.54,0.68,"No",0.7501,0.75,1,"Yes"
"13001","C3_TF_targets","C3_TFT_265_V_NKX3A_01",225,-0.9641,0.56,0.64,"No",1.1227,0.17,0.97,"Yes"
"13002","C7_Immunologic_signatures","C7_ALL_1515_GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP",200,-0.9641,0.56,0.66,"No",-0.843,0.87,1,"No"
"13003","C2_Chemical_and_genetic_perturbations","C2_CGP_2871_KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN",220,-0.964,0.56,0.63,"No",1.2743,0.036,0.42,"Yes"
"13004","C2_Chemical_and_genetic_perturbations","C2_CGP_3110_CARD_MIR302A_TARGETS",77,-0.964,0.52,0.63,"No",-0.6406,0.99,1,"No"
"13005","C3_TF_targets","C3_TFT_23_V_CREBP1CJUN_01",256,-0.9639,0.56,0.64,"No",0.7683,1,1,"Yes"
"13006","GO_MF","490539_GO_0005346_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.9638,0.53,0.71,"No",-0.8311,0.68,1,"No"
"13007","GO_BP","488763_GO_0002890_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",10,-0.9635,0.5,0.68,"No",-0.7609,0.77,1,"No"
"13008","GO_BP","510447_GO_0048340_PARAXIAL_MESODERM_MORPHOGENESIS",9,-0.9634,0.5,0.68,"No",0.8068,0.73,1,"Yes"
"13009","GO_BP","751886_GO_0044744_PROTEIN_TARGETING_TO_NUCLEUS",96,-0.9634,0.54,0.68,"No",0.7225,0.98,1,"Yes"
"13010","GO_BP","849867_GO_1902165_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR",15,-0.9634,0.52,0.68,"No",-0.7907,0.75,1,"No"
"13011","C2_Chemical_and_genetic_perturbations","C2_CGP_1209_NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON",14,-0.9633,0.5,0.63,"No",-0.6923,0.87,1,"No"
"13012","GO_BP","495031_GO_0010966_REGULATION_OF_PHOSPHATE_TRANSPORT",5,-0.9629,0.53,0.68,"No",-1.2425,0.23,0.91,"No"
"13013","C2_Chemical_and_genetic_perturbations","C2_CGP_1938_NIELSEN_LEIOMYOSARCOMA_UP",17,-0.9629,0.52,0.63,"No",-0.7598,0.8,1,"No"
"13014","C7_Immunologic_signatures","C7_ALL_1658_GSE3982_MAC_VS_TH1_DN",196,-0.9629,0.57,0.66,"No",0.9677,0.55,0.84,"Yes"
"13015","C2_Chemical_and_genetic_perturbations","C2_CGP_2730_CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN",192,-0.9629,0.55,0.63,"No",2.401,0,0,"Yes"
"13016","C2_Chemical_and_genetic_perturbations","C2_CGP_2604_BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS",8,-0.9629,0.52,0.63,"No",-0.9956,0.49,1,"No"
"13017","GO_BP","516549_GO_0071625_VOCALIZATION_BEHAVIOR",13,-0.9628,0.52,0.68,"No",-0.9845,0.49,1,"No"
"13018","C2_BioCarta_Pathways","C2_CP_BIOCARTA_120_BIOCARTA_IGF1R_PATHWAY",23,-0.9624,0.51,0.63,"No",1.1412,0.29,0.66,"Yes"
"13019","C7_Immunologic_signatures","C7_ALL_1692_GSE3982_BASOPHIL_VS_NKCELL_DN",192,-0.9624,0.58,0.66,"No",0.7949,0.96,1,"Yes"
"13020","C7_Immunologic_signatures","C7_ALL_1771_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP",199,-0.9623,0.57,0.66,"No",1.3803,0.0093,0.045,"Yes"
"13021","C4_Cancer_gene_neighborhoods","C4_CGN_240_GCM_MAPK10",77,-0.9623,0.55,0.79,"No",-0.8601,0.75,1,"No"
"13022","KEGG_compound","C01227_DEHYDROEPIANDROSTERONE_3BETA_HYDROXYANDROST_5_EN_17_ONE_DEHYDROISOANDROSTERONE_DHA_DHEA",13,-0.9623,0.51,0.66,"No",0.9997,0.44,1,"Yes"
"13023","C2_Chemical_and_genetic_perturbations","C2_CGP_566_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP",6,-0.9623,0.51,0.63,"No",-1.049,0.4,0.97,"No"
"13024","C2_Chemical_and_genetic_perturbations","C2_CGP_629_GALLUZZI_PERMEABILIZE_MITOCHONDRIA",42,-0.962,0.53,0.63,"No",0.7537,0.86,1,"Yes"
"13025","GO_MF","498601_GO_0019798_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY",7,-0.962,0.53,0.71,"No",-0.97,0.5,0.94,"No"
"13026","GO_MF","498090_GO_0019239_DEAMINASE_ACTIVITY",29,-0.9619,0.52,0.71,"No",-0.5825,0.99,1,"No"
"13027","C7_Immunologic_signatures","C7_ALL_1133_GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP",172,-0.9618,0.56,0.66,"No",-1.2408,0.079,0.65,"No"
"13028","GO_BP","510758_GO_0048703_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS",9,-0.9618,0.51,0.68,"No",-0.7749,0.73,1,"No"
"13029","GO_BP","489199_GO_0003407_NEURAL_RETINA_DEVELOPMENT",44,-0.9618,0.52,0.68,"No",-0.8929,0.65,1,"No"
"13030","REACTOME","160989_REACT_15398_GLYCOPROTEIN_HORMONES",11,-0.9618,0.51,0.7,"No",-0.8903,0.59,1,"No"
"13031","C4_Cancer_gene_neighborhoods","C4_CGN_269_GCM_TEC",31,-0.9618,0.53,0.79,"No",-0.8098,0.77,1,"No"
"13032","C2_Chemical_and_genetic_perturbations","C2_CGP_479_WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP",26,-0.9618,0.52,0.63,"No",0.7714,0.81,1,"Yes"
"13033","GO_MF","486812_GO_0000295_ADENINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.9617,0.52,0.71,"No",-0.832,0.65,1,"No"
"13034","GO_BP","493325_GO_0009128_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",382,-0.9617,0.6,0.68,"No",-0.8476,0.94,1,"No"
"13035","GO_MF","489271_GO_0003727_SINGLE_STRANDED_RNA_BINDING",58,-0.9616,0.51,0.71,"No",0.6593,0.99,1,"Yes"
"13036","C4_Cancer_gene_neighborhoods","C4_CGN_371_GNF2_LYN",27,-0.9616,0.51,0.78,"No",1.0377,0.37,0.48,"Yes"
"13037","C7_Immunologic_signatures","C7_ALL_660_GSE17721_LPS_VS_CPG_4H_BMDM_DN",200,-0.9616,0.57,0.66,"No",1.3956,0.0044,0.039,"Yes"
"13038","C4_Cancer_gene_neighborhoods","C4_CGN_316_GNF2_SMC4L1",84,-0.9616,0.53,0.78,"No",1.5336,0.0087,0.024,"Yes"
"13039","GO_MF","983700_GO_0098639_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION",5,-0.9615,0.55,0.71,"No",-1.1026,0.38,0.84,"No"
"13040","GO_BP","754615_GO_1901663_QUINONE_BIOSYNTHETIC_PROCESS",14,-0.9614,0.51,0.68,"No",0.8964,0.61,1,"Yes"
"13041","GO_BP","492892_GO_0045987_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION",23,-0.9613,0.52,0.68,"No",-0.83,0.72,1,"No"
"13042","REACTOME","106250_REACT_11238_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS",86,-0.9611,0.53,0.7,"No",0.8263,0.84,0.98,"Yes"
"13043","GO_BP","506548_GO_0043517_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",13,-0.9611,0.5,0.68,"No",0.6112,0.96,1,"Yes"
"13044","GO_BP","510361_GO_0048246_MACROPHAGE_CHEMOTAXIS",13,-0.961,0.51,0.68,"No",1.4046,0.1,0.55,"Yes"
"13045","C4_Cancer_modules","C4_CM_109_MODULE_114",338,-0.9609,0.59,0.63,"No",3.2044,0,0,"Yes"
"13046","GO_BP","513905_GO_0060349_BONE_MORPHOGENESIS",87,-0.9609,0.54,0.68,"No",-1.3767,0.028,0.99,"No"
"13047","C7_Immunologic_signatures","C7_ALL_317_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP",199,-0.9608,0.57,0.67,"No",1.8351,0,0,"Yes"
"13048","C7_Immunologic_signatures","C7_ALL_1562_GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN",187,-0.9607,0.56,0.66,"No",0.9504,0.6,0.89,"Yes"
"13049","GO_BP","497341_GO_0018406_PROTEIN_C_LINKED_GLYCOSYLATION_VIA_2_ALPHA_MANNOSYL_L_TRYPTOPHAN",5,-0.9605,0.52,0.69,"No",0.7473,0.78,1,"Yes"
"13050","GO_BP","492376_GO_0007635_CHEMOSENSORY_BEHAVIOR",11,-0.9603,0.52,0.69,"No",-1.2454,0.21,0.91,"No"
"13051","C7_Immunologic_signatures","C7_ALL_599_GSE17721_LPS_VS_PAM3CSK4_0_5H_BMDM_UP",192,-0.9603,0.57,0.67,"No",1.2275,0.061,0.18,"Yes"
"13052","C2_Chemical_and_genetic_perturbations","C2_CGP_1184_MORI_PLASMA_CELL_UP",51,-0.9602,0.53,0.63,"No",1.348,0.069,0.35,"Yes"
"13053","C2_Chemical_and_genetic_perturbations","C2_CGP_1575_IGLESIAS_E2F_TARGETS_DN",14,-0.9602,0.52,0.63,"No",1.277,0.18,0.42,"Yes"
"13054","C2_Chemical_and_genetic_perturbations","C2_CGP_2290_WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP",21,-0.96,0.52,0.63,"No",0.6469,0.95,1,"Yes"
"13055","GO_BP","1129405_GO_1903579_NEGATIVE_REGULATION_OF_ATP_METABOLIC_PROCESS",13,-0.96,0.54,0.69,"No",-0.9378,0.54,1,"No"
"13056","C2_Chemical_and_genetic_perturbations","C2_CGP_1679_INGRAM_SHH_TARGETS",7,-0.96,0.5,0.63,"No",0.9815,0.49,0.81,"Yes"
"13057","C7_Immunologic_signatures","C7_ALL_728_GSE17721_12H_VS_24H_POLYIC_BMDM_DN",199,-0.96,0.56,0.67,"No",1.2556,0.024,0.15,"Yes"
"13058","GO_BP","498636_GO_0046929_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION",7,-0.9599,0.53,0.69,"No",0.9479,0.51,1,"Yes"
"13059","GO_CC","507387_GO_0044438_MICROBODY_PART",80,-0.9598,0.56,0.78,"No",0.9581,0.54,0.83,"Yes"
"13060","C2_Chemical_and_genetic_perturbations","C2_CGP_2076_ZHENG_FOXP3_TARGETS_IN_THYMUS_DN",12,-0.9596,0.52,0.63,"No",1.5484,0.037,0.17,"Yes"
"13061","GO_BP","507588_GO_0045214_SARCOMERE_ORGANIZATION",27,-0.9593,0.53,0.69,"No",-1.3546,0.088,0.96,"No"
"13062","GO_MF","498682_GO_0019905_SYNTAXIN_BINDING",86,-0.9593,0.52,0.71,"No",0.9548,0.55,0.92,"Yes"
"13063","GO_BP","487845_GO_0001955_BLOOD_VESSEL_MATURATION",8,-0.9592,0.53,0.69,"No",1.1513,0.3,0.84,"Yes"
"13064","GO_BP","511819_GO_0050881_MUSCULOSKELETAL_MOVEMENT",34,-0.9592,0.51,0.69,"No",-1.3411,0.096,0.91,"No"
"13065","KEGG_compound","C01353_CARBONIC_ACID_DIHYDROGEN_CARBONATE_H2CO3",11,-0.9591,0.51,0.67,"No",-0.9911,0.47,1,"No"
"13066","GO_BP","514316_GO_0060761_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS",38,-0.959,0.55,0.69,"No",-0.7846,0.82,1,"No"
"13067","GO_BP","510347_GO_0048227_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT",8,-0.959,0.51,0.69,"No",1.0661,0.37,0.94,"Yes"
"13068","GO_BP","487854_GO_0001964_STARTLE_RESPONSE",23,-0.9589,0.52,0.69,"No",1.4687,0.038,0.47,"Yes"
"13069","GO_BP","500346_GO_0031056_REGULATION_OF_HISTONE_MODIFICATION",108,-0.9589,0.55,0.69,"No",-0.8013,0.88,1,"No"
"13070","GO_MF","506215_GO_0043142_SINGLE_STRANDED_DNA_DEPENDENT_ATPASE_ACTIVITY",5,-0.9589,0.52,0.71,"No",-0.7407,0.77,1,"No"
"13071","GO_CC","490831_GO_0005802_TRANS_GOLGI_NETWORK",166,-0.9588,0.57,0.78,"No",0.8115,0.93,0.95,"Yes"
"13072","C2_Chemical_and_genetic_perturbations","C2_CGP_1091_RICKMAN_HEAD_AND_NECK_CANCER_F",49,-0.9588,0.53,0.63,"No",-1.0018,0.44,1,"No"
"13073","C1_Positional","C1_ALL_187_CHR12P11",42,-0.9587,0.51,0.89,"No",0.7978,0.8,0.95,"Yes"
"13074","GO_BP","512448_GO_0051570_REGULATION_OF_HISTONE_H3_K9_METHYLATION",11,-0.9586,0.55,0.69,"No",0.3973,1,1,"Yes"
"13075","C7_Immunologic_signatures","C7_ALL_1645_GSE3982_MAC_VS_NEUTROPHIL_UP",198,-0.9585,0.57,0.67,"No",1.6406,0,0.0014,"Yes"
"13076","GO_BP","515785_GO_0070857_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS",7,-0.9584,0.52,0.69,"No",-0.7636,0.78,1,"No"
"13077","C7_Immunologic_signatures","C7_ALL_520_GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_DN",196,-0.9583,0.56,0.67,"No",1.443,0.0025,0.024,"Yes"
"13078","GO_BP","507570_GO_0045188_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP",7,-0.9582,0.51,0.69,"No",-1.101,0.34,0.94,"No"
"13079","GO_BP","493584_GO_0009411_RESPONSE_TO_UV",119,-0.9582,0.54,0.69,"No",0.8109,0.9,1,"Yes"
"13080","GO_CC","500379_GO_0031092_PLATELET_ALPHA_GRANULE_MEMBRANE",8,-0.958,0.52,0.78,"No",1.6387,0.024,0.092,"Yes"
"13081","C7_Immunologic_signatures","C7_ALL_1732_GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN",198,-0.958,0.58,0.67,"No",-0.8362,0.87,1,"No"
"13082","C7_Immunologic_signatures","C7_ALL_898_GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN",198,-0.958,0.57,0.67,"No",0.8106,0.94,1,"Yes"
"13083","GO_BP","499644_GO_0030238_MALE_SEX_DETERMINATION",13,-0.958,0.53,0.69,"No",-1.5977,0.022,0.68,"No"
"13084","GO_BP","508427_GO_0046131_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS",34,-0.958,0.53,0.69,"No",0.5603,0.99,1,"Yes"
"13085","C2_Chemical_and_genetic_perturbations","C2_CGP_884_KIM_MYC_AMPLIFICATION_TARGETS_DN",95,-0.9579,0.55,0.64,"No",0.9353,0.6,0.89,"Yes"
"13086","C6_Oncogenic_signatures","C6_ALL_74_PRC2_EDD_UP_V1_UP",191,-0.9579,0.57,0.6,"No",-1.295,0.03,0.33,"No"
"13087","C3_MicroRNA_targets","C3_MIR_79_TGAGATT_MIR_216",106,-0.9579,0.57,0.69,"No",0.8008,0.91,1,"Yes"
"13088","REACTOME","105865_REACT_1924_ATM_MEDIATED_PHOSPHORYLATION_OF_REPAIR_PROTEINS",5,-0.9576,0.53,0.71,"No",-0.9498,0.55,1,"No"
"13089","C7_Immunologic_signatures","C7_ALL_445_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP",200,-0.9576,0.59,0.67,"No",-0.9782,0.52,1,"No"
"13090","KEGG_compound","C04598_2_ACETYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE_PLATELET_ACTIVATING_FACTOR_PAF",10,-0.9574,0.52,0.67,"No",1.1072,0.32,1,"Yes"
"13091","C2_Chemical_and_genetic_perturbations","C2_CGP_684_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2",5,-0.9571,0.55,0.64,"No",-0.677,0.87,1,"No"
"13092","GO_CC","496437_GO_0016460_MYOSIN_II_COMPLEX",25,-0.9571,0.54,0.78,"No",-1.0753,0.36,0.82,"No"
"13093","C2_BioCarta_Pathways","C2_CP_BIOCARTA_129_BIOCARTA_RARRXR_PATHWAY",15,-0.957,0.51,0.64,"No",0.7072,0.88,1,"Yes"
"13094","GO_MF","490535_GO_0005338_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-0.9569,0.52,0.71,"No",-0.8343,0.67,1,"No"
"13095","GO_MF","495479_GO_0015215_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",17,-0.9568,0.54,0.71,"No",-0.8369,0.68,1,"No"
"13096","GO_BP","488451_GO_0002578_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION",5,-0.9568,0.52,0.69,"No",-0.5671,0.96,1,"No"
"13097","C7_Immunologic_signatures","C7_ALL_84_GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN",193,-0.9568,0.57,0.67,"No",1.4088,0.0068,0.035,"Yes"
"13098","REACTOME","119541_REACT_19145_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA",19,-0.9567,0.52,0.71,"No",-0.9086,0.58,1,"No"
"13099","GO_BP","493355_GO_0009158_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",381,-0.9566,0.61,0.69,"No",-0.8395,0.95,1,"No"
"13100","C7_Immunologic_signatures","C7_ALL_363_GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP",188,-0.9565,0.58,0.67,"No",1.268,0.037,0.13,"Yes"
"13101","GO_BP","502372_GO_0033151_V_D_J_RECOMBINATION",17,-0.9565,0.52,0.69,"No",0.8266,0.72,1,"Yes"
"13102","C2_Chemical_and_genetic_perturbations","C2_CGP_891_YANG_BREAST_CANCER_ESR1_DN",25,-0.9564,0.54,0.64,"No",0.9173,0.6,0.9,"Yes"
"13103","C4_Cancer_gene_neighborhoods","C4_CGN_173_MORF_RBM8A",83,-0.9563,0.56,0.79,"No",-0.7836,0.89,1,"No"
"13104","GO_BP","491905_GO_0007084_MITOTIC_NUCLEAR_ENVELOPE_REASSEMBLY",10,-0.9562,0.54,0.69,"No",1.014,0.39,0.97,"Yes"
"13105","GO_BP","489286_GO_0034728_NUCLEOSOME_ORGANIZATION",155,-0.9559,0.57,0.69,"No",-1.1615,0.14,0.92,"No"
"13106","C7_Immunologic_signatures","C7_ALL_23_GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP",200,-0.9557,0.59,0.67,"No",1.2762,0.05,0.12,"Yes"
"13107","KEGG_reaction","R00132_CARBONATE_HYDRO_LYASE_CARBON_DIOXIDE_FORMING_CARBONIC_ACID_HYDRO_LYASE_CARBONIC_ACID_CO2_H2O",11,-0.9557,0.53,0.68,"No",-1.0084,0.44,0.78,"No"
"13108","C3_MicroRNA_targets","C3_MIR_122_CATGTAA_MIR_496",173,-0.9555,0.59,0.69,"No",1.1915,0.1,1,"Yes"
"13109","GO_BP","493322_GO_0009125_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",384,-0.9555,0.61,0.69,"No",-0.8453,0.95,1,"No"
"13110","KEGG_module","HSA_M00158_F_TYPE_ATPASE_EUKARYOTES",15,-0.9554,0.5,0.74,"No",2.1928,0,0,"Yes"
"13111","GO_BP","754189_GO_1901222_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING",29,-0.9554,0.52,0.69,"No",1.4114,0.071,0.54,"Yes"
"13112","C2_Chemical_and_genetic_perturbations","C2_CGP_1975_BROWNE_HCMV_INFECTION_12HR_DN",101,-0.9553,0.55,0.64,"No",1.0552,0.32,0.7,"Yes"
"13113","C7_Immunologic_signatures","C7_ALL_1010_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN",200,-0.9553,0.58,0.67,"No",1.4733,0.0023,0.017,"Yes"
"13114","GO_BP","496271_GO_0016197_ENDOSOMAL_TRANSPORT",216,-0.9552,0.58,0.69,"No",1.0391,0.35,0.96,"Yes"
"13115","GO_BP","516524_GO_0071600_OTIC_VESICLE_MORPHOGENESIS",10,-0.9551,0.53,0.69,"No",-1.0817,0.35,0.95,"No"
"13116","GO_BP","506129_GO_0043043_PEPTIDE_BIOSYNTHETIC_PROCESS",24,-0.955,0.53,0.69,"No",0.915,0.59,1,"Yes"
"13117","C2_Chemical_and_genetic_perturbations","C2_CGP_506_VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",16,-0.9549,0.54,0.64,"No",-0.848,0.66,1,"No"
"13118","GO_CC","501392_GO_0032156_SEPTIN_CYTOSKELETON",12,-0.9549,0.51,0.78,"No",-1.1657,0.27,0.68,"No"
"13119","C7_Immunologic_signatures","C7_ALL_285_GSE14350_TREG_VS_TEFF_UP",200,-0.9545,0.6,0.68,"No",0.6379,1,1,"Yes"
"13120","C4_Cancer_gene_neighborhoods","C4_CGN_296_GNF2_FEN1",56,-0.9545,0.53,0.79,"No",1.5253,0.02,0.026,"Yes"
"13121","C7_Immunologic_signatures","C7_ALL_545_GSE17721_POLYIC_VS_PAM3CSK4_0_5H_BMDM_UP",191,-0.9544,0.57,0.68,"No",1.1603,0.11,0.3,"Yes"
"13122","GO_BP","501650_GO_0032418_LYSOSOME_LOCALIZATION",25,-0.9543,0.54,0.69,"No",1.0733,0.33,0.93,"Yes"
"13123","REACTOME","645262_REACT_120916_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA",18,-0.9543,0.52,0.72,"No",1.6147,0.018,0.088,"Yes"
"13124","C2_Chemical_and_genetic_perturbations","C2_CGP_3286_ROLEF_GLIS3_TARGETS",31,-0.9543,0.54,0.64,"No",-0.9787,0.46,1,"No"
"13125","REACTOME","833822_REACT_163773_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION",13,-0.9542,0.48,0.71,"No",0.7531,0.81,1,"Yes"
"13126","GO_BP","1026072_GO_1903300_NEGATIVE_REGULATION_OF_HEXOKINASE_ACTIVITY",6,-0.9542,0.51,0.69,"No",-0.8536,0.62,1,"No"
"13127","GO_BP","491211_GO_0006244_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS",10,-0.9539,0.54,0.69,"No",1.4817,0.08,0.44,"Yes"
"13128","C7_Immunologic_signatures","C7_ALL_1221_GSE27786_NKTCELL_VS_ERYTHROBLAST_UP",199,-0.9537,0.58,0.68,"No",0.9851,0.51,0.79,"Yes"
"13129","GO_CC","490890_GO_0005885_ARP2_3_PROTEIN_COMPLEX",12,-0.9537,0.53,0.78,"No",1.0352,0.39,0.73,"Yes"
"13130","REACTOME","576276_REACT_118713_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION",29,-0.9537,0.54,0.71,"No",-0.8155,0.77,1,"No"
"13131","C6_Oncogenic_signatures","C6_ALL_78_PRC2_SUZ12_UP_V1_UP",176,-0.9532,0.59,0.61,"No",-1.0417,0.35,0.58,"No"
"13132","C7_Immunologic_signatures","C7_ALL_1108_GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN",180,-0.9532,0.57,0.68,"No",0.941,0.62,0.93,"Yes"
"13133","GO_BP","508139_GO_0045814_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC",109,-0.9531,0.55,0.7,"No",-1.2132,0.13,0.88,"No"
"13134","GO_BP","511416_GO_0050433_REGULATION_OF_CATECHOLAMINE_SECRETION",36,-0.953,0.53,0.7,"No",1.2762,0.12,0.7,"Yes"
"13135","GO_MF","498060_GO_0019205_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY",48,-0.9529,0.56,0.72,"No",-0.9571,0.53,0.95,"No"
"13136","C2_Chemical_and_genetic_perturbations","C2_CGP_2116_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS",33,-0.9529,0.52,0.65,"No",0.8271,0.76,0.98,"Yes"
"13137","C2_Chemical_and_genetic_perturbations","C2_CGP_2976_ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE",17,-0.9528,0.52,0.65,"No",-0.6594,0.91,1,"No"
"13138","KEGG_compound","C00119_5_PHOSPHO_ALPHA_D_RIBOSE_1_DIPHOSPHATE_5_PHOSPHORIBOSYL_DIPHOSPHATE_5_PHOSPHORIBOSYL_1_PYROPHOSPHATE_PRPP",11,-0.9528,0.52,0.67,"No",1.4388,0.11,0.42,"Yes"
"13139","C3_MicroRNA_targets","C3_MIR_162_AGTCTAG_MIR_151",24,-0.9526,0.52,0.69,"No",0.5951,0.98,1,"Yes"
"13140","GO_MF","490441_GO_0042043_NEUREXIN_FAMILY_PROTEIN_BINDING",13,-0.9526,0.5,0.72,"No",-1.0218,0.45,0.89,"No"
"13141","GO_BP","506084_GO_0042992_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS",35,-0.9526,0.52,0.7,"No",0.6707,0.94,1,"Yes"
"13142","KEGG_compound","C00270_N_ACETYLNEURAMINATE_N_ACETYLNEURAMINIC_ACID_5_ACETAMIDO_3_5_DIDEOXY_D_GLYCERO_D_GALACTO_2_NONULOSONIC_ACID_NEU5AC",7,-0.9525,0.53,0.67,"No",0.8752,0.64,1,"Yes"
"13143","KEGG_compound","C00311_ISOCITRATE_ISOCITRIC_ACID_1_HYDROXYTRICARBALLYLIC_ACID_1_HYDROXYPROPANE_1_2_3_TRICARBOXYLIC_ACID",7,-0.9524,0.54,0.67,"No",0.9612,0.5,1,"Yes"
"13144","C2_Chemical_and_genetic_perturbations","C2_CGP_2188_CAMPS_COLON_CANCER_COPY_NUMBER_UP",87,-0.9523,0.56,0.65,"No",-1.2119,0.15,0.8,"No"
"13145","KEGG_compound","C00009_ORTHOPHOSPHATE_PHOSPHATE_PHOSPHORIC_ACID_ORTHOPHOSPHORIC_ACID",140,-0.9521,0.57,0.67,"No",0.8679,0.79,1,"Yes"
"13146","GO_CC","486739_GO_0016469_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX",46,-0.9521,0.54,0.78,"No",1.9431,0,0.0063,"Yes"
"13147","GO_MF","515445_GO_0070513_DEATH_DOMAIN_BINDING",8,-0.9518,0.53,0.72,"No",0.6757,0.86,1,"Yes"
"13148","C2_Chemical_and_genetic_perturbations","C2_CGP_156_NEWMAN_ERCC6_TARGETS_DN",35,-0.9516,0.53,0.65,"No",-0.987,0.47,1,"No"
"13149","REACTOME","1127531_REACT_264533_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2",13,-0.9516,0.53,0.72,"No",0.9103,0.57,0.89,"Yes"
"13150","C2_Chemical_and_genetic_perturbations","C2_CGP_3002_WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53",12,-0.9515,0.54,0.65,"No",-1.1483,0.27,0.85,"No"
"13151","KEGG_compound","C00037_GLYCINE_AMINOACETIC_ACID_GLY",23,-0.9515,0.53,0.67,"No",0.8618,0.69,1,"Yes"
"13152","GO_BP","493267_GO_0009066_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",49,-0.9515,0.54,0.7,"No",-0.7324,0.93,1,"No"
"13153","C2_Chemical_and_genetic_perturbations","C2_CGP_2675_ROME_INSULIN_TARGETS_IN_MUSCLE_UP",441,-0.9514,0.61,0.65,"No",2.286,0,0.00018,"Yes"
"13154","C2_Chemical_and_genetic_perturbations","C2_CGP_2459_LEE_LIVER_CANCER_SURVIVAL_DN",172,-0.9514,0.59,0.65,"No",2.1075,0,0.0018,"Yes"
"13155","C2_Chemical_and_genetic_perturbations","C2_CGP_591_LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP",176,-0.9514,0.59,0.65,"No",0.7972,0.94,0.99,"Yes"
"13156","C4_Cancer_modules","C4_CM_392_MODULE_493",68,-0.9514,0.57,0.65,"No",-0.9576,0.55,0.86,"No"
"13157","C2_Chemical_and_genetic_perturbations","C2_CGP_1562_ZHAN_MULTIPLE_MYELOMA_HP_UP",48,-0.9513,0.55,0.65,"No",1.7513,0.0043,0.06,"Yes"
"13158","KEGG_module","HSA_M00075_N_GLYCAN_BIOSYNTHESIS_COMPLEX_TYPE",16,-0.9513,0.53,0.73,"No",-0.5094,0.98,1,"No"
"13159","GO_MF","490293_GO_0005007_FIBROBLAST_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",5,-0.9512,0.55,0.72,"No",-1.3671,0.14,0.69,"No"
"13160","KEGG_compound","C00014_AMMONIA_NH3",47,-0.9511,0.53,0.67,"No",-0.8717,0.7,1,"No"
"13161","KEGG_pathway","HSA00360_PHENYLALANINE_METABOLISM",18,-0.951,0.53,0.61,"No",-1.2755,0.16,0.45,"No"
"13162","C3_TF_targets","C3_TFT_195_V_RFX1_02",272,-0.951,0.61,0.67,"No",-1.0751,0.26,0.61,"No"
"13163","GO_BP","501586_GO_0032351_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS",9,-0.951,0.53,0.7,"No",-0.8793,0.62,1,"No"
"13164","GO_BP","515166_GO_0070231_T_CELL_APOPTOTIC_PROCESS",15,-0.9507,0.54,0.7,"No",1.2689,0.17,0.71,"Yes"
"13165","GO_BP","515860_GO_0070933_HISTONE_H4_DEACETYLATION",17,-0.9506,0.54,0.7,"No",-1.0311,0.4,0.98,"No"
"13166","C4_Cancer_modules","C4_CM_215_MODULE_236",18,-0.9505,0.52,0.65,"No",-0.8865,0.64,0.91,"No"
"13167","GO_BP","508032_GO_0045687_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION",25,-0.9505,0.53,0.7,"No",1.0661,0.35,0.93,"Yes"
"13168","C3_MicroRNA_targets","C3_MIR_211_CAGCCTC_MIR_485_5P",143,-0.9504,0.59,0.69,"No",-1.0106,0.43,1,"No"
"13169","GO_BP","495944_GO_0015816_GLYCINE_TRANSPORT",9,-0.9504,0.53,0.7,"No",0.6299,0.9,1,"Yes"
"13170","C7_Immunologic_signatures","C7_ALL_669_GSE17721_LPS_VS_CPG_24H_BMDM_UP",192,-0.9504,0.58,0.69,"No",-0.8122,0.94,1,"No"
"13171","GO_BP","506451_GO_0043413_MACROMOLECULE_GLYCOSYLATION",290,-0.9503,0.6,0.7,"No",0.9105,0.75,1,"Yes"
"13172","GO_BP","499667_GO_0030262_APOPTOTIC_NUCLEAR_CHANGES",30,-0.9502,0.54,0.7,"No",-0.6475,0.95,1,"No"
"13173","GO_CC","490810_GO_0044439_PEROXISOMAL_PART",79,-0.9501,0.54,0.79,"No",1.0238,0.4,0.75,"Yes"
"13174","C2_Chemical_and_genetic_perturbations","C2_CGP_577_ABDULRAHMAN_KIDNEY_CANCER_VHL_UP",5,-0.95,0.53,0.65,"No",-1.1989,0.25,0.79,"No"
"13175","GO_BP","491387_GO_0006486_PROTEIN_GLYCOSYLATION",289,-0.95,0.61,0.7,"No",0.9114,0.74,1,"Yes"
"13176","GO_BP","494625_GO_0010560_POSITIVE_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",12,-0.95,0.52,0.7,"No",-0.8167,0.71,1,"No"
"13177","GO_BP","491875_GO_0007050_CELL_CYCLE_ARREST",140,-0.9499,0.56,0.7,"No",-0.761,0.96,1,"No"
"13178","GO_BP","510392_GO_0048284_ORGANELLE_FUSION",110,-0.9495,0.58,0.7,"No",1.1795,0.14,0.8,"Yes"
"13179","GO_BP","491263_GO_0006304_DNA_MODIFICATION",103,-0.9495,0.56,0.7,"No",-1.2441,0.11,0.91,"No"
"13180","C2_Chemical_and_genetic_perturbations","C2_CGP_2930_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4",15,-0.9493,0.53,0.65,"No",0.8612,0.67,0.96,"Yes"
"13181","GO_BP","518754_GO_2000105_POSITIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION",13,-0.9493,0.53,0.7,"No",-0.7357,0.84,1,"No"
"13182","C4_Cancer_gene_neighborhoods","C4_CGN_364_GNF2_INPP5D",43,-0.9493,0.54,0.8,"No",1.387,0.057,0.066,"Yes"
"13183","REACTOME","645259_REACT_121311_CELLULAR_RESPONSE_TO_HYPOXIA",25,-0.9493,0.53,0.72,"No",1.4425,0.05,0.19,"Yes"
"13184","C7_Immunologic_signatures","C7_ALL_526_GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_DN",196,-0.9492,0.58,0.69,"No",1.3371,0.031,0.071,"Yes"
"13185","C4_Cancer_gene_neighborhoods","C4_CGN_309_GNF2_RFC3",41,-0.9492,0.54,0.8,"No",1.5068,0.027,0.029,"Yes"
"13186","REACTOME","771585_REACT_160156_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION_",22,-0.9491,0.53,0.72,"No",1.1098,0.31,0.56,"Yes"
"13187","C2_Chemical_and_genetic_perturbations","C2_CGP_3326_BOUDOUKHA_BOUND_BY_IGF2BP2",107,-0.9491,0.57,0.65,"No",1.7214,0,0.071,"Yes"
"13188","GO_BP","502532_GO_0033314_MITOTIC_DNA_REPLICATION_CHECKPOINT",5,-0.9491,0.54,0.7,"No",1.1671,0.29,0.82,"Yes"
"13189","GO_CC","502399_GO_0033179_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN",10,-0.9491,0.53,0.79,"No",-0.7476,0.79,1,"No"
"13190","GO_BP","505609_GO_0042472_INNER_EAR_MORPHOGENESIS",96,-0.9491,0.58,0.7,"No",0.8287,0.83,1,"Yes"
"13191","C2_Chemical_and_genetic_perturbations","C2_CGP_2329_MATZUK_EMBRYONIC_GERM_CELL",18,-0.9489,0.54,0.65,"No",-1.1869,0.21,0.81,"No"
"13192","GO_BP","518790_GO_2000142_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION",23,-0.9488,0.55,0.7,"No",0.7903,0.79,1,"Yes"
"13193","KEGG_pathway","HSA05012_PARKINSON_S_DISEASE",126,-0.9486,0.59,0.61,"No",2.4353,0,0,"Yes"
"13194","GO_BP","493312_GO_0009113_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS",12,-0.9486,0.52,0.7,"No",0.93,0.54,1,"Yes"
"13195","GO_BP","499289_GO_0022010_CENTRAL_NERVOUS_SYSTEM_MYELINATION",14,-0.9486,0.54,0.7,"No",-0.7486,0.8,1,"No"
"13196","GO_BP","498364_GO_0019530_TAURINE_METABOLIC_PROCESS",7,-0.9485,0.53,0.7,"No",0.9385,0.55,1,"Yes"
"13197","GO_BP","518447_GO_0090307_MITOTIC_SPINDLE_ASSEMBLY",29,-0.9484,0.55,0.7,"No",0.7933,0.78,1,"Yes"
"13198","GO_BP","516472_GO_0071548_RESPONSE_TO_DEXAMETHASONE",21,-0.9483,0.51,0.7,"No",1.2413,0.18,0.75,"Yes"
"13199","GO_MF","504424_GO_0035240_DOPAMINE_BINDING",10,-0.9482,0.52,0.73,"No",1.2206,0.22,0.7,"Yes"
"13200","GO_BP","497279_GO_0018317_PROTEIN_C_LINKED_GLYCOSYLATION_VIA_TRYPTOPHAN",5,-0.9482,0.56,0.7,"No",0.7474,0.8,1,"Yes"
"13201","GO_BP","500908_GO_0031659_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",7,-0.948,0.53,0.7,"No",-0.8342,0.67,1,"No"
"13202","C3_TF_targets","C3_TFT_83_V_MYCMAX_02",262,-0.948,0.61,0.68,"No",1.2008,0.075,0.73,"Yes"
"13203","C2_Chemical_and_genetic_perturbations","C2_CGP_582_EGUCHI_CELL_CYCLE_RB1_TARGETS",23,-0.948,0.52,0.65,"No",1.502,0.039,0.21,"Yes"
"13204","C2_Chemical_and_genetic_perturbations","C2_CGP_1965_CHEN_ETV5_TARGETS_TESTIS",20,-0.948,0.53,0.65,"No",-0.61,0.96,1,"No"
"13205","GO_BP","488250_GO_0002377_IMMUNOGLOBULIN_PRODUCTION",43,-0.9478,0.54,0.7,"No",0.5894,0.99,1,"Yes"
"13206","C2_BioCarta_Pathways","C2_CP_BIOCARTA_168_BIOCARTA_MAL_PATHWAY",19,-0.9478,0.54,0.65,"No",0.456,1,1,"Yes"
"13207","C1_Positional","C1_ALL_289_CHR1Q44",71,-0.9476,0.58,0.92,"No",1.3801,0.036,0.43,"Yes"
"13208","GO_BP","519433_GO_2000794_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS",7,-0.9476,0.54,0.7,"No",-0.8179,0.71,1,"No"
"13209","C7_Immunologic_signatures","C7_ALL_1586_GSE3982_EOSINOPHIL_VS_MAST_CELL_DN",197,-0.9474,0.58,0.69,"No",1.7555,0,3e-04,"Yes"
"13210","GO_BP","486638_GO_0000096_SULFUR_AMINO_ACID_METABOLIC_PROCESS",44,-0.9472,0.56,0.7,"No",-0.7441,0.87,1,"No"
"13211","GO_BP","505845_GO_0042738_EXOGENOUS_DRUG_CATABOLIC_PROCESS",21,-0.9472,0.53,0.7,"No",-1.8023,0.0057,0.45,"No"
"13212","C2_Chemical_and_genetic_perturbations","C2_CGP_142_DOANE_BREAST_CANCER_ESR1_DN",46,-0.9471,0.56,0.65,"No",0.8659,0.71,0.96,"Yes"
"13213","GO_BP","513450_GO_0055017_CARDIAC_MUSCLE_TISSUE_GROWTH",22,-0.9471,0.54,0.7,"No",1.0616,0.38,0.94,"Yes"
"13214","KEGG_reaction","R04404_PHOSPHATIDYL_MYO_INOSITOL_4_5_BISPHOSPHATE_4_PHOSPHOHYDROLASE_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_H2O_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_ORTHOPHOSPHATE",5,-0.9471,0.53,0.69,"No",-0.9985,0.47,0.79,"No"
"13215","C2_Chemical_and_genetic_perturbations","C2_CGP_808_DIRMEIER_LMP1_RESPONSE_LATE_DN",31,-0.947,0.55,0.65,"No",1.8992,0,0.02,"Yes"
"13216","GO_BP","946566_GO_0098909_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION",12,-0.947,0.53,0.7,"No",0.8385,0.67,1,"Yes"
"13217","GO_BP","513774_GO_0060218_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION",12,-0.9469,0.54,0.7,"No",-0.8768,0.61,1,"No"
"13218","GO_BP","508859_GO_0046605_REGULATION_OF_CENTROSOME_CYCLE",37,-0.9469,0.54,0.7,"No",-0.7821,0.82,1,"No"
"13219","GO_BP","500897_GO_0031648_PROTEIN_DESTABILIZATION",27,-0.9469,0.56,0.7,"No",0.7885,0.79,1,"Yes"
"13220","C7_Immunologic_signatures","C7_ALL_1353_GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP",200,-0.9468,0.6,0.69,"No",-0.6728,1,1,"No"
"13221","GO_BP","513975_GO_0060419_HEART_GROWTH",23,-0.9467,0.51,0.7,"No",1.1558,0.24,0.83,"Yes"
"13222","C7_Immunologic_signatures","C7_ALL_1228_GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN",199,-0.9464,0.6,0.69,"No",-0.7831,0.95,1,"No"
"13223","C2_Chemical_and_genetic_perturbations","C2_CGP_1041_RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN",8,-0.9464,0.54,0.65,"No",0.8421,0.66,0.97,"Yes"
"13224","GO_BP","493747_GO_0009629_RESPONSE_TO_GRAVITY",8,-0.9462,0.53,0.7,"No",0.8102,0.69,1,"Yes"
"13225","GO_BP","515439_GO_0070507_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION",115,-0.9461,0.58,0.7,"No",0.793,0.93,1,"Yes"
"13226","C3_TF_targets","C3_TFT_527_TNCATNTCCYR_UNKNOWN",131,-0.9461,0.57,0.68,"No",0.7103,0.99,1,"Yes"
"13227","GO_BP","519364_GO_2000725_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",18,-0.946,0.52,0.7,"No",-0.766,0.82,1,"No"
"13228","C2_Chemical_and_genetic_perturbations","C2_CGP_2186_IWANAGA_CARCINOGENESIS_BY_KRAS_DN",119,-0.946,0.58,0.65,"No",0.7468,0.95,1,"Yes"
"13229","GO_BP","505701_GO_0042573_RETINOIC_ACID_METABOLIC_PROCESS",20,-0.9459,0.54,0.7,"No",-1.3101,0.12,0.87,"No"
"13230","REACTOME","833821_REACT_163743_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION",5,-0.9457,0.55,0.73,"No",0.59,0.93,1,"Yes"
"13231","REACTOME","645260_REACT_120815_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN",25,-0.9456,0.56,0.73,"No",1.4572,0.059,0.18,"Yes"
"13232","C2_Chemical_and_genetic_perturbations","C2_CGP_605_DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN",88,-0.9455,0.57,0.66,"No",-1.0529,0.35,0.97,"No"
"13233","C7_Immunologic_signatures","C7_ALL_462_GSE17721_CTRL_VS_LPS_24H_BMDM_DN",200,-0.9454,0.62,0.7,"No",1.1854,0.11,0.25,"Yes"
"13234","C1_Positional","C1_ALL_302_CHR6Q22",63,-0.9454,0.55,0.92,"No",0.9287,0.61,0.82,"Yes"
"13235","C2_Chemical_and_genetic_perturbations","C2_CGP_1928_JIANG_HYPOXIA_CANCER",82,-0.9453,0.55,0.66,"No",1.3785,0.04,0.31,"Yes"
"13236","GO_BP","491728_GO_0006863_PURINE_NUCLEOBASE_TRANSPORT",5,-0.9453,0.55,0.71,"No",-0.6886,0.82,1,"No"
"13237","GO_BP","504499_GO_0035315_HAIR_CELL_DIFFERENTIATION",36,-0.9452,0.54,0.71,"No",0.48,1,1,"Yes"
"13238","C1_Positional","C1_ALL_65_CHR18Q21",73,-0.9452,0.57,0.91,"No",0.9364,0.58,0.83,"Yes"
"13239","C2_Chemical_and_genetic_perturbations","C2_CGP_3334_MIZUSHIMA_AUTOPHAGOSOME_FORMATION",19,-0.9451,0.54,0.66,"No",-0.6791,0.89,1,"No"
"13240","GO_BP","491724_GO_0006858_EXTRACELLULAR_TRANSPORT",6,-0.9448,0.53,0.71,"No",1.2044,0.25,0.78,"Yes"
"13241","GO_BP","489284_GO_0006333_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY",163,-0.9447,0.59,0.71,"No",-1.1627,0.14,0.92,"No"
"13242","C7_Immunologic_signatures","C7_ALL_249_GSE14308_TH2_VS_INDUCED_TREG_UP",195,-0.9445,0.6,0.7,"No",1.063,0.29,0.55,"Yes"
"13243","REACTOME","106525_REACT_15309_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE",17,-0.9444,0.54,0.73,"No",-1.2205,0.21,0.79,"No"
"13244","GO_BP","507577_GO_0045199_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY",6,-0.9444,0.54,0.71,"No",1.3701,0.13,0.59,"Yes"
"13245","GO_BP","1129368_GO_1903541_REGULATION_OF_EXOSOMAL_SECRETION",15,-0.9444,0.54,0.71,"No",1.3025,0.13,0.66,"Yes"
"13246","GO_MF","489355_GO_0003854_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY",5,-0.9444,0.54,0.74,"No",-0.8279,0.67,1,"No"
"13247","KEGG_compound","C00412_STEAROYL_COA_STEARYL_COA_STEARYL_COENZYME_A",8,-0.9444,0.55,0.68,"No",-0.6383,0.9,1,"No"
"13248","C2_Chemical_and_genetic_perturbations","C2_CGP_472_BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN",12,-0.9443,0.55,0.66,"No",-1.249,0.19,0.75,"No"
"13249","GO_MF","503938_GO_0034739_HISTONE_DEACETYLASE_ACTIVITY_H4_K16_SPECIFIC_",13,-0.9443,0.54,0.73,"No",-1.2521,0.18,0.83,"No"
"13250","GO_BP","868042_GO_0044801_SINGLE_ORGANISM_MEMBRANE_FUSION",120,-0.9443,0.58,0.71,"No",1.1985,0.12,0.78,"Yes"
"13251","WikiPathways","198769_WP12_OSTEOCLAST_SIGNALING",16,-0.9442,0.56,0.66,"No",1.2931,0.16,0.67,"Yes"
"13252","C4_Cancer_modules","C4_CM_153_MODULE_162",18,-0.9441,0.54,0.66,"No",-1.832,0.0038,0.086,"No"
"13253","C4_Cancer_modules","C4_CM_139_MODULE_147",106,-0.9441,0.61,0.66,"No",0.9841,0.49,0.73,"Yes"
"13254","REACTOME","106284_REACT_655_PYRIMIDINE_SALVAGE_REACTIONS",9,-0.9441,0.54,0.73,"No",-0.7463,0.79,1,"No"
"13255","C7_Immunologic_signatures","C7_ALL_76_GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN",193,-0.944,0.59,0.7,"No",0.8589,0.87,1,"Yes"
"13256","GO_BP","491823_GO_0006987_ACTIVATION_OF_SIGNALING_PROTEIN_ACTIVITY_INVOLVED_IN_UNFOLDED_PROTEIN_RESPONSE",70,-0.944,0.58,0.71,"No",0.6159,1,1,"Yes"
"13257","GO_BP","512529_GO_0051653_SPINDLE_LOCALIZATION",31,-0.944,0.55,0.71,"No",0.7037,0.93,1,"Yes"
"13258","C7_Immunologic_signatures","C7_ALL_716_GSE17721_12H_VS_24H_LPS_BMDM_DN",197,-0.9439,0.61,0.7,"No",1.2477,0.055,0.16,"Yes"
"13259","C7_Immunologic_signatures","C7_ALL_1707_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP",191,-0.9439,0.61,0.7,"No",0.8212,0.91,1,"Yes"
"13260","C2_Chemical_and_genetic_perturbations","C2_CGP_949_PUJANA_BRCA2_PCC_NETWORK",422,-0.9438,0.65,0.66,"No",1.2664,0.026,0.42,"Yes"
"13261","GO_MF","490243_GO_0004952_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY",6,-0.9438,0.53,0.73,"No",1.1503,0.3,0.74,"Yes"
"13262","GO_BP","502409_GO_0033189_RESPONSE_TO_VITAMIN_A",14,-0.9438,0.55,0.71,"No",0.9945,0.44,0.98,"Yes"
"13263","C4_Cancer_modules","C4_CM_287_MODULE_328",14,-0.9437,0.53,0.66,"No",-1.8174,0.0078,0.076,"No"
"13264","C7_Immunologic_signatures","C7_ALL_1315_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP",192,-0.9437,0.6,0.7,"No",1.0024,0.44,0.73,"Yes"
"13265","WikiPathways","198868_WP1403_AMPK_SIGNALING",68,-0.9436,0.58,0.66,"No",0.7029,0.97,1,"Yes"
"13266","GO_CC","752939_GO_0097440_APICAL_DENDRITE",7,-0.9436,0.54,0.8,"No",-0.8751,0.59,0.95,"No"
"13267","C3_TF_targets","C3_TFT_193_V_RFX1_01",252,-0.9435,0.61,0.69,"No",0.9156,0.72,1,"Yes"
"13268","C7_Immunologic_signatures","C7_ALL_265_GSE14308_TH17_VS_NATURAL_TREG_UP",199,-0.9434,0.6,0.7,"No",1.3694,0.012,0.051,"Yes"
"13269","C2_Chemical_and_genetic_perturbations","C2_CGP_2213_OUYANG_PROSTATE_CANCER_MARKERS",19,-0.9434,0.55,0.66,"No",1.1606,0.25,0.54,"Yes"
"13270","GO_BP","495976_GO_0015851_NUCLEOBASE_TRANSPORT",7,-0.9434,0.54,0.71,"No",-0.9346,0.53,1,"No"
"13271","REACTOME","366230_REACT_75770_VOLTAGE_GATED_POTASSIUM_CHANNELS",43,-0.9432,0.55,0.73,"No",-1.337,0.086,0.6,"No"
"13272","C4_Cancer_modules","C4_CM_326_MODULE_385",27,-0.9431,0.56,0.66,"No",1.2008,0.19,0.39,"Yes"
"13273","C7_Immunologic_signatures","C7_ALL_1358_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN",200,-0.9431,0.62,0.7,"No",0.774,0.98,1,"Yes"
"13274","GO_CC","500559_GO_0031300_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE",255,-0.943,0.61,0.8,"No",0.9222,0.71,0.87,"Yes"
"13275","GO_BP","516144_GO_0071218_CELLULAR_RESPONSE_TO_MISFOLDED_PROTEIN",9,-0.943,0.55,0.71,"No",0.5366,0.97,1,"Yes"
"13276","REACTOME","1127637_REACT_267615_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES",6,-0.943,0.52,0.73,"No",-0.6025,0.92,1,"No"
"13277","GO_BP","495116_GO_0014044_SCHWANN_CELL_DEVELOPMENT",25,-0.9428,0.55,0.71,"No",-0.7919,0.79,1,"No"
"13278","GO_BP","519141_GO_2000501_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS",9,-0.9427,0.53,0.71,"No",1.2218,0.23,0.76,"Yes"
"13279","C2_Chemical_and_genetic_perturbations","C2_CGP_2445_JIANG_TIP30_TARGETS_DN",24,-0.9426,0.55,0.66,"No",-0.9492,0.52,1,"No"
"13280","GO_BP","493383_GO_0009187_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",56,-0.9425,0.56,0.71,"No",-1.2816,0.092,0.89,"No"
"13281","GO_BP","500748_GO_0031497_CHROMATIN_ASSEMBLY",143,-0.9425,0.59,0.71,"No",-1.1236,0.21,0.94,"No"
"13282","KEGG_compound","C04742__15S_15_HYDROXY_5_8_11_CIS_13_TRANS_EICOSATETRAENOATE_15S_15_HYDROXY_5_8_11_CIS_13_TRANS_ICOSATETRAENOATE_5Z_8Z_11Z_13E_15S_15_HYDROXYICOSA_5_8_11_13_TETRAENOIC_ACID_15_S_HETE",6,-0.9424,0.53,0.68,"No",0.5362,0.98,1,"Yes"
"13283","GO_BP","491186_GO_0006216_CYTIDINE_CATABOLIC_PROCESS",9,-0.9421,0.51,0.71,"No",0.786,0.75,1,"Yes"
"13284","C7_Immunologic_signatures","C7_ALL_1372_GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN",195,-0.942,0.61,0.7,"No",1.2023,0.089,0.22,"Yes"
"13285","GO_CC","500591_GO_0031332_RNAI_EFFECTOR_COMPLEX",11,-0.942,0.55,0.8,"No",-0.8608,0.61,0.96,"No"
"13286","C2_BioCarta_Pathways","C2_CP_BIOCARTA_204_BIOCARTA_TNFR1_PATHWAY",29,-0.942,0.56,0.66,"No",-0.7989,0.78,1,"No"
"13287","GO_BP","514344_GO_0060789_HAIR_FOLLICLE_PLACODE_FORMATION",6,-0.9418,0.56,0.71,"No",1.0805,0.38,0.92,"Yes"
"13288","GO_CC","505738_GO_0042622_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE",15,-0.9416,0.54,0.8,"No",-1.2825,0.15,0.66,"No"
"13289","KEGG_module","HSA_M00337_IMMUNOPROTEASOME",17,-0.9416,0.55,0.73,"No",1.7689,0.0079,0.051,"Yes"
"13290","GO_BP","494061_GO_0009972_CYTIDINE_DEAMINATION",9,-0.9416,0.52,0.71,"No",0.8074,0.72,1,"Yes"
"13291","GO_BP","491943_GO_0007130_SYNAPTONEMAL_COMPLEX_ASSEMBLY",17,-0.9416,0.53,0.71,"No",-0.702,0.87,1,"No"
"13292","C7_Immunologic_signatures","C7_ALL_1422_GSE360_CTRL_VS_L_MAJOR_MAC_DN",196,-0.9413,0.63,0.7,"No",-0.9175,0.7,1,"No"
"13293","REACTOME","730307_REACT_150268_ANCHORING_FIBRIL_FORMATION",7,-0.9412,0.55,0.73,"No",-0.4759,0.99,1,"No"
"13294","GO_BP","497923_GO_0019043_ESTABLISHMENT_OF_VIRAL_LATENCY",10,-0.9411,0.57,0.71,"No",1.0593,0.38,0.94,"Yes"
"13295","C7_Immunologic_signatures","C7_ALL_1014_GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN",200,-0.941,0.59,0.7,"No",1.5123,0,0.01,"Yes"
"13296","C7_Immunologic_signatures","C7_ALL_195_GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP",193,-0.941,0.6,0.7,"No",-0.6978,1,1,"No"
"13297","GO_BP","491583_GO_0006695_CHOLESTEROL_BIOSYNTHETIC_PROCESS",36,-0.9409,0.55,0.71,"No",-0.7719,0.84,1,"No"
"13298","C1_Positional","C1_ALL_127_CHR12P12",59,-0.9409,0.55,0.92,"No",1.0149,0.42,0.74,"Yes"
"13299","GO_MF","490471_GO_0005230_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",72,-0.9408,0.59,0.74,"No",-1.3564,0.048,0.69,"No"
"13300","REACTOME","1183559_REACT_110235_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1",44,-0.9407,0.57,0.73,"No",-0.8978,0.65,1,"No"
"13301","C7_Immunologic_signatures","C7_ALL_199_GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP",162,-0.9407,0.6,0.7,"No",-1.2543,0.072,0.61,"No"
"13302","C1_Positional","C1_ALL_313_CHR9P24",46,-0.9406,0.56,0.91,"No",1.1591,0.22,0.62,"Yes"
"13303","C3_TF_targets","C3_TFT_419_V_AHR_Q5",213,-0.9404,0.63,0.7,"No",-0.6859,1,1,"No"
"13304","GO_BP","488626_GO_0002753_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY",35,-0.9403,0.57,0.71,"No",1.0602,0.36,0.94,"Yes"
"13305","GO_BP","506516_GO_0043484_REGULATION_OF_RNA_SPLICING",87,-0.9403,0.59,0.71,"No",-0.8051,0.84,1,"No"
"13306","GO_BP","487866_GO_0001976_NEUROLOGICAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",18,-0.9402,0.53,0.71,"No",-1.1014,0.32,0.94,"No"
"13307","C7_Immunologic_signatures","C7_ALL_1581_GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP",197,-0.9402,0.63,0.7,"No",1.7898,0,0.00017,"Yes"
"13308","C4_Cancer_modules","C4_CM_294_MODULE_335",14,-0.9401,0.52,0.67,"No",0.7661,0.79,0.99,"Yes"
"13309","C2_Chemical_and_genetic_perturbations","C2_CGP_287_TIEN_INTESTINE_PROBIOTICS_6HR_UP",55,-0.9401,0.54,0.67,"No",2.826,0,0,"Yes"
"13310","C1_Positional","C1_ALL_322_CHR17P12",26,-0.9399,0.55,0.91,"No",1.0075,0.42,0.74,"Yes"
"13311","C4_Cancer_gene_neighborhoods","C4_CGN_263_GCM_RING1",104,-0.9399,0.59,0.82,"No",0.8067,0.89,0.98,"Yes"
"13312","GO_BP","506715_GO_0043687_POST_TRANSLATIONAL_PROTEIN_MODIFICATION",256,-0.9399,0.63,0.71,"No",1.0134,0.41,0.97,"Yes"
"13313","GO_CC","498651_GO_0019867_OUTER_MEMBRANE",173,-0.9396,0.62,0.8,"No",1.4093,0.0071,0.29,"Yes"
"13314","KEGG_reaction","R07035_GLUTATHIONE_15_HPETE_OXIDOREDUCTASE_2_GLUTATHIONE_15_S_HPETE_GLUTATHIONE_DISULFIDE_15S_15_HYDROXY_5_8_11_CIS_13_TRANS_EICOSATETRAENOATE_H2O",6,-0.9396,0.57,0.7,"No",0.5396,0.98,1,"Yes"
"13315","C7_Immunologic_signatures","C7_ALL_512_GSE17721_CTRL_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-0.9396,0.64,0.71,"No",0.9802,0.51,0.8,"Yes"
"13316","GO_BP","491389_GO_0006488_DOLICHOL_LINKED_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS",67,-0.9396,0.59,0.71,"No",0.8897,0.67,1,"Yes"
"13317","C2_Chemical_and_genetic_perturbations","C2_CGP_2347_GRADE_COLON_VS_RECTAL_CANCER_UP",37,-0.9395,0.59,0.67,"No",1.0012,0.45,0.8,"Yes"
"13318","C3_TF_targets","C3_TFT_429_V_HIF1_Q3",223,-0.9395,0.63,0.7,"No",0.8445,0.91,1,"Yes"
"13319","GO_BP","911331_GO_0097503_SIALYLATION",20,-0.9394,0.57,0.71,"No",0.5674,0.98,1,"Yes"
"13320","C2_Chemical_and_genetic_perturbations","C2_CGP_2059_GAVIN_FOXP3_TARGETS_CLUSTER_T7",98,-0.9394,0.59,0.67,"No",2.0746,0,0.0026,"Yes"
"13321","GO_BP","925942_GO_1902593_SINGLE_ORGANISM_NUCLEAR_IMPORT",98,-0.9394,0.59,0.71,"No",0.7105,0.99,1,"Yes"
"13322","REACTOME","105864_REACT_204_ATM_MEDIATED_RESPONSE_TO_DNA_DOUBLE_STRAND_BREAK",5,-0.9393,0.55,0.73,"No",-0.95,0.5,1,"No"
"13323","C7_Immunologic_signatures","C7_ALL_1538_GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN",160,-0.9393,0.63,0.71,"No",-0.8896,0.75,1,"No"
"13324","C4_Cancer_modules","C4_CM_232_MODULE_256",61,-0.9392,0.57,0.67,"No",1.0554,0.35,0.62,"Yes"
"13325","C4_Cancer_gene_neighborhoods","C4_CGN_62_MORF_ARAF1",78,-0.9391,0.59,0.81,"No",-0.717,0.95,1,"No"
"13326","GO_BP","488586_GO_0002713_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY",10,-0.9391,0.54,0.71,"No",-0.7679,0.77,1,"No"
"13327","REACTOME","187229_REACT_25299_DSCAM_INTERACTIONS",11,-0.9391,0.53,0.73,"No",-1.266,0.19,0.71,"No"
"13328","C2_Chemical_and_genetic_perturbations","C2_CGP_1995_BILD_SRC_ONCOGENIC_SIGNATURE",61,-0.939,0.57,0.67,"No",-0.7144,0.96,1,"No"
"13329","GO_BP","516469_GO_0071545_INOSITOL_PHOSPHATE_CATABOLIC_PROCESS",11,-0.939,0.51,0.71,"No",0.547,0.98,1,"Yes"
"13330","GO_BP","489090_GO_0003298_PHYSIOLOGICAL_MUSCLE_HYPERTROPHY",6,-0.9387,0.55,0.71,"No",1.6066,0.02,0.28,"Yes"
"13331","C7_Immunologic_signatures","C7_ALL_1578_GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN",191,-0.9387,0.62,0.71,"No",0.7143,1,1,"Yes"
"13332","REACTOME","730335_REACT_150209_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS",6,-0.9386,0.54,0.73,"No",0.8451,0.66,0.96,"Yes"
"13333","GO_BP","494080_GO_0009996_NEGATIVE_REGULATION_OF_CELL_FATE_SPECIFICATION",7,-0.9385,0.53,0.71,"No",-0.83,0.66,1,"No"
"13334","C4_Cancer_modules","C4_CM_247_MODULE_279",138,-0.9385,0.61,0.66,"No",1.2772,0.044,0.3,"Yes"
"13335","GO_MF","754633_GO_1901682_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",25,-0.9383,0.57,0.74,"No",0.6492,0.96,1,"Yes"
"13336","REACTOME","730349_REACT_150238_SIGNALING_BY_ACTIVIN",13,-0.9382,0.55,0.73,"No",-0.5184,0.99,1,"No"
"13337","C2_Chemical_and_genetic_perturbations","C2_CGP_1617_BURTON_ADIPOGENESIS_10",30,-0.9381,0.53,0.67,"No",1.0929,0.33,0.64,"Yes"
"13338","C2_Chemical_and_genetic_perturbations","C2_CGP_1650_WESTON_VEGFA_TARGETS_6HR",55,-0.9381,0.57,0.67,"No",1.0045,0.45,0.79,"Yes"
"13339","C7_Immunologic_signatures","C7_ALL_1021_GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP",197,-0.9381,0.61,0.71,"No",0.9142,0.72,0.99,"Yes"
"13340","GO_MF","516809_GO_0071889_14_3_3_PROTEIN_BINDING",18,-0.938,0.56,0.74,"No",-1.3016,0.14,0.77,"No"
"13341","KEGG_compound","C16265_N_ACETYLGALACTOSAMINE_4_SULFATE",5,-0.938,0.55,0.68,"No",0.7404,0.77,1,"Yes"
"13342","C2_Chemical_and_genetic_perturbations","C2_CGP_1914_MURAKAMI_UV_RESPONSE_24HR",19,-0.9378,0.57,0.67,"No",0.7768,0.78,1,"Yes"
"13343","C2_Chemical_and_genetic_perturbations","C2_CGP_1008_LIU_BREAST_CANCER",26,-0.9377,0.55,0.67,"No",0.7602,0.84,1,"Yes"
"13344","C2_Chemical_and_genetic_perturbations","C2_CGP_1424_PENG_RAPAMYCIN_RESPONSE_DN",243,-0.9375,0.63,0.67,"No",1.8001,0,0.044,"Yes"
"13345","C7_Immunologic_signatures","C7_ALL_1252_GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN",180,-0.9374,0.61,0.71,"No",1.1669,0.11,0.29,"Yes"
"13346","GO_MF","495361_GO_0015078_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",92,-0.9374,0.61,0.74,"No",1.9844,0,0.013,"Yes"
"13347","REACTOME","105832_REACT_6820_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B",21,-0.9373,0.57,0.73,"No",1.267,0.16,0.36,"Yes"
"13348","GO_BP","501225_GO_0031987_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR",6,-0.9372,0.56,0.72,"No",-0.4205,1,1,"No"
"13349","C3_TF_targets","C3_TFT_161_CAGNYGKNAAA_UNKNOWN",72,-0.937,0.56,0.7,"No",1.3196,0.059,0.49,"Yes"
"13350","GO_BP","514573_GO_0061025_MEMBRANE_FUSION",156,-0.937,0.62,0.72,"No",1.4054,0.02,0.55,"Yes"
"13351","KEGG_reaction","R07825_G12336_H2O_DWA_2_N_ACETYLGALACTOSAMINE_4_SULFATE",5,-0.9369,0.55,0.69,"No",0.74,0.79,1,"Yes"
"13352","REACTOME","105652_REACT_1432_TNF_SIGNALING",14,-0.9368,0.57,0.73,"No",-0.9075,0.57,1,"No"
"13353","C3_TF_targets","C3_TFT_507_RRAGTTGT_UNKNOWN",246,-0.9366,0.63,0.7,"No",0.881,0.82,1,"Yes"
"13354","GO_CC","506266_GO_0043198_DENDRITIC_SHAFT",35,-0.9366,0.58,0.8,"No",-1.0858,0.33,0.81,"No"
"13355","GO_BP","519283_GO_2000644_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS",7,-0.9365,0.54,0.72,"No",-0.8885,0.6,1,"No"
"13356","C7_Immunologic_signatures","C7_ALL_1302_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN",184,-0.9363,0.63,0.71,"No",-0.9,0.74,1,"No"
"13357","C2_Chemical_and_genetic_perturbations","C2_CGP_2825_SYED_ESTRADIOL_RESPONSE",19,-0.9361,0.55,0.67,"No",1.0482,0.37,0.72,"Yes"
"13358","GO_BP","489003_GO_0003209_CARDIAC_ATRIUM_MORPHOGENESIS",27,-0.936,0.55,0.72,"No",1.0099,0.44,0.98,"Yes"
"13359","REACTOME","161014_REACT_22433_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN",67,-0.9359,0.58,0.73,"No",0.8461,0.75,0.96,"Yes"
"13360","REACTOME","105799_REACT_1915_G2_PHASE",5,-0.9359,0.57,0.73,"No",0.6851,0.85,1,"Yes"
"13361","GO_BP","515105_GO_0070168_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT",17,-0.9359,0.55,0.72,"No",0.9417,0.53,1,"Yes"
"13362","C2_Chemical_and_genetic_perturbations","C2_CGP_101_ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN",374,-0.9359,0.67,0.67,"No",1.1181,0.17,0.6,"Yes"
"13363","REACTOME","1127513_REACT_263991_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY",28,-0.9357,0.56,0.73,"No",0.564,0.98,1,"Yes"
"13364","GO_BP","502353_GO_0033132_NEGATIVE_REGULATION_OF_GLUCOKINASE_ACTIVITY",6,-0.9355,0.55,0.72,"No",-0.8442,0.67,1,"No"
"13365","GO_BP","516326_GO_0071402_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS",5,-0.9354,0.56,0.72,"No",1.0175,0.46,0.97,"Yes"
"13366","GO_BP","516629_GO_0071705_NITROGEN_COMPOUND_TRANSPORT",471,-0.9353,0.67,0.72,"No",0.8448,0.98,1,"Yes"
"13367","KEGG_pathway","HSA04110_CELL_CYCLE",124,-0.9352,0.61,0.63,"No",1.1058,0.24,0.78,"Yes"
"13368","GO_BP","509091_GO_0046877_REGULATION_OF_SALIVA_SECRETION",6,-0.9352,0.58,0.72,"No",-1.2067,0.28,0.89,"No"
"13369","REACTOME","187219_REACT_25091_ER_QUALITY_CONTROL_COMPARTMENT_ERQC_",6,-0.9352,0.56,0.73,"No",-0.713,0.8,1,"No"
"13370","C7_Immunologic_signatures","C7_ALL_1664_GSE3982_NEUTROPHIL_VS_BASOPHIL_DN",198,-0.9351,0.62,0.71,"No",1.8372,0,0,"Yes"
"13371","GO_BP","517425_GO_0072520_SEMINIFEROUS_TUBULE_DEVELOPMENT",9,-0.935,0.55,0.72,"No",0.8161,0.7,1,"Yes"
"13372","C7_Immunologic_signatures","C7_ALL_539_GSE17721_LPS_VS_POLYIC_12H_BMDM_UP",199,-0.9349,0.64,0.71,"No",0.9072,0.73,1,"Yes"
"13373","GO_MF","489898_GO_0004563_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY",5,-0.9349,0.56,0.75,"No",-0.848,0.64,1,"No"
"13374","C3_MicroRNA_targets","C3_MIR_214_TAATAAT_MIR_126",218,-0.9349,0.64,0.73,"No",1.1817,0.094,1,"Yes"
"13375","GO_BP","512533_GO_0051657_MAINTENANCE_OF_ORGANELLE_LOCATION",8,-0.9349,0.57,0.72,"No",0.7476,0.82,1,"Yes"
"13376","KEGG_module","HSA_M00682_NOTCH_SIGNALING",16,-0.9348,0.53,0.73,"No",-1.1347,0.31,1,"No"
"13377","GO_BP","781990_GO_1902001_FATTY_ACID_TRANSMEMBRANE_TRANSPORT",11,-0.9347,0.55,0.72,"No",-0.8927,0.59,1,"No"
"13378","KEGG_compound","C00301_ADP_RIBOSE_ADP_D_RIBOSE_ADENOSINE_DIPHOSPHATE_RIBOSE",5,-0.9344,0.56,0.69,"No",0.9384,0.53,1,"Yes"
"13379","C7_Immunologic_signatures","C7_ALL_755_GSE17721_0_5H_VS_4H_GARDIQUIMOD_BMDM_UP",199,-0.9343,0.62,0.72,"No",1.4591,0,0.02,"Yes"
"13380","C2_BioCarta_Pathways","C2_CP_BIOCARTA_132_BIOCARTA_P38MAPK_PATHWAY",40,-0.9343,0.55,0.67,"No",-1.0843,0.33,1,"No"
"13381","C2_Chemical_and_genetic_perturbations","C2_CGP_1225_WHITEHURST_PACLITAXEL_SENSITIVITY",36,-0.9343,0.56,0.67,"No",0.763,0.86,1,"Yes"
"13382","GO_BP","500403_GO_0031116_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION",11,-0.9343,0.56,0.72,"No",-0.4042,1,1,"No"
"13383","OMIM_gene","OMIM107773_NUCLEAR_RECEPTOR_SUBFAMILY_2_GROUP_F_MEMBER_2_NR2F2",6,-0.9343,0.57,0.81,"No",-1.2248,0.23,1,"No"
"13384","GO_BP","509110_GO_0046902_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY",29,-0.9343,0.57,0.72,"No",1.2048,0.19,0.78,"Yes"
"13385","C3_MicroRNA_targets","C3_MIR_207_CGTCTTA_MIR_208",8,-0.9342,0.55,0.73,"No",-0.8781,0.6,1,"No"
"13386","C3_MicroRNA_targets","C3_MIR_213_GGTAACC_MIR_409_5P",33,-0.9342,0.54,0.72,"No",-1.1842,0.21,1,"No"
"13387","C4_Cancer_gene_neighborhoods","C4_CGN_229_GCM_FANCC",119,-0.9341,0.6,0.82,"No",0.7405,0.98,1,"Yes"
"13388","GO_BP","492675_GO_0008366_AXON_ENSHEATHMENT",89,-0.9341,0.59,0.72,"No",-0.7823,0.91,1,"No"
"13389","KEGG_pathway","HSA00061_FATTY_ACID_BIOSYNTHESIS",13,-0.9338,0.55,0.63,"No",-0.4711,1,1,"No"
"13390","GO_MF","486683_GO_0000149_SNARE_BINDING",116,-0.9336,0.6,0.75,"No",0.8519,0.83,1,"Yes"
"13391","C2_Chemical_and_genetic_perturbations","C2_CGP_545_DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN",170,-0.9336,0.63,0.68,"No",-0.8272,0.88,1,"No"
"13392","GO_BP","489093_GO_0003301_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY",6,-0.9336,0.56,0.72,"No",1.6221,0.025,0.27,"Yes"
"13393","GO_CC","496425_GO_0016442_RISC_COMPLEX",11,-0.9336,0.54,0.81,"No",-0.8596,0.66,0.95,"No"
"13394","C1_Positional","C1_ALL_321_CHR11P13",39,-0.9334,0.55,0.92,"No",0.737,0.9,0.99,"Yes"
"13395","GO_BP","505632_GO_0042501_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN",5,-0.9333,0.57,0.72,"No",-1.1391,0.35,0.93,"No"
"13396","GO_BP","507429_GO_0045022_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT",20,-0.9333,0.56,0.72,"No",-0.6321,0.94,1,"No"
"13397","C3_TF_targets","C3_TFT_37_V_IRF2_01",123,-0.9332,0.62,0.71,"No",0.7871,0.94,1,"Yes"
"13398","GO_BP","494571_GO_0010501_RNA_SECONDARY_STRUCTURE_UNWINDING",7,-0.9332,0.56,0.72,"No",-1.2836,0.17,0.89,"No"
"13399","C2_Chemical_and_genetic_perturbations","C2_CGP_578_ABDULRAHMAN_KIDNEY_CANCER_VHL_DN",14,-0.9332,0.56,0.68,"No",0.968,0.49,0.84,"Yes"
"13400","GO_BP","498515_GO_0019692_DEOXYRIBOSE_PHOSPHATE_METABOLIC_PROCESS",32,-0.9332,0.57,0.72,"No",1.4078,0.073,0.55,"Yes"
"13401","GO_BP","494864_GO_0010799_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION",29,-0.9331,0.58,0.72,"No",1.4314,0.042,0.52,"Yes"
"13402","C7_Immunologic_signatures","C7_ALL_259_GSE14308_TH1_VS_NATURAL_TREG_UP",191,-0.933,0.64,0.72,"No",1.2339,0.06,0.18,"Yes"
"13403","C6_Oncogenic_signatures","C6_ALL_5_EGFR_UP_V1_DN",191,-0.933,0.62,0.65,"No",0.8273,0.91,1,"Yes"
"13404","C2_Chemical_and_genetic_perturbations","C2_CGP_2134_KANG_CISPLATIN_RESISTANCE_DN",8,-0.9329,0.55,0.68,"No",1.3811,0.12,0.31,"Yes"
"13405","GO_BP","492330_GO_0007588_EXCRETION",48,-0.9329,0.58,0.72,"No",-1.2942,0.11,0.88,"No"
"13406","GO_BP","502757_GO_0033539_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE",6,-0.9328,0.58,0.72,"No",0.9113,0.57,1,"Yes"
"13407","GO_BP","489411_GO_0006606_PROTEIN_IMPORT_INTO_NUCLEUS",94,-0.9328,0.61,0.72,"No",0.7724,0.94,1,"Yes"
"13408","GO_BP","500401_GO_0031114_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION",25,-0.9327,0.54,0.72,"No",0.8829,0.65,1,"Yes"
"13409","GO_CC","515314_GO_0070382_EXOCYTIC_VESICLE",10,-0.9326,0.52,0.81,"No",1.0098,0.45,0.77,"Yes"
"13410","C2_Chemical_and_genetic_perturbations","C2_CGP_2712_BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN",19,-0.9326,0.58,0.68,"No",1.0745,0.34,0.67,"Yes"
"13411","C2_Chemical_and_genetic_perturbations","C2_CGP_3115_WIERENGA_PML_INTERACTOME",41,-0.9326,0.57,0.68,"No",1.8627,0,0.026,"Yes"
"13412","C2_Chemical_and_genetic_perturbations","C2_CGP_2975_ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN",17,-0.9325,0.55,0.68,"No",-0.66,0.93,1,"No"
"13413","C2_Chemical_and_genetic_perturbations","C2_CGP_2335_MATZUK_SPERMATOCYTE",69,-0.9324,0.58,0.68,"No",-1.2696,0.097,0.71,"No"
"13414","KEGG_compound","C01074_N_ACETYLGALACTOSAMINE_N_ACETYLCHONDROSAMINE_2_ACETAMIDO_2_DEOXYGALACTOSE_GALNAC",5,-0.9324,0.58,0.69,"No",0.7344,0.81,1,"Yes"
"13415","GO_BP","516926_GO_0072007_MESANGIAL_CELL_DIFFERENTIATION",6,-0.9324,0.56,0.72,"No",0.5145,0.98,1,"Yes"
"13416","GO_BP","505174_GO_0040016_EMBRYONIC_CLEAVAGE",7,-0.9323,0.53,0.72,"No",0.9451,0.53,1,"Yes"
"13417","C7_Immunologic_signatures","C7_ALL_1162_GSE27786_LIN_NEG_VS_BCELL_DN",197,-0.9323,0.65,0.72,"No",1.1345,0.16,0.35,"Yes"
"13418","REACTOME","1183594_REACT_355252_RHO_GTPASES_ACTIVATE_FORMINS",114,-0.9322,0.61,0.74,"No",1.1221,0.2,0.55,"Yes"
"13419","GO_BP","1184481_GO_1903955_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION",66,-0.9322,0.6,0.72,"No",1.4145,0.043,0.54,"Yes"
"13420","GO_MF","496797_GO_0016917_GABA_RECEPTOR_ACTIVITY",20,-0.932,0.57,0.75,"No",-1.3141,0.12,0.74,"No"
"13421","GO_MF","496689_GO_0016780_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS",17,-0.932,0.56,0.75,"No",0.8538,0.67,1,"Yes"
"13422","C2_BioCarta_Pathways","C2_CP_BIOCARTA_155_BIOCARTA_EIF4_PATHWAY",24,-0.932,0.58,0.67,"No",0.8693,0.65,0.92,"Yes"
"13423","C2_Chemical_and_genetic_perturbations","C2_CGP_1895_BROWNE_HCMV_INFECTION_12HR_UP",108,-0.932,0.59,0.68,"No",-0.6491,1,1,"No"
"13424","GO_BP","982420_GO_1902850_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS",34,-0.9316,0.58,0.72,"No",1.037,0.36,0.96,"Yes"
"13425","C7_Immunologic_signatures","C7_ALL_257_GSE14308_TH1_VS_INDUCED_TREG_UP",195,-0.9315,0.63,0.72,"No",1.199,0.1,0.23,"Yes"
"13426","GO_MF","506385_GO_0043325_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING",21,-0.9315,0.57,0.75,"No",-0.8222,0.73,1,"No"
"13427","GO_BP","499168_GO_0021889_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION",14,-0.9314,0.56,0.72,"No",1.0696,0.38,0.93,"Yes"
"13428","GO_CC","490876_GO_0005865_STRIATED_MUSCLE_THIN_FILAMENT",22,-0.9312,0.56,0.81,"No",-1.193,0.23,0.68,"No"
"13429","GO_BP","516573_GO_0071649_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION",6,-0.9312,0.54,0.73,"No",-0.5738,0.94,1,"No"
"13430","C1_Positional","C1_ALL_317_CHR8P22",35,-0.9309,0.55,0.92,"No",1.5385,0.022,0.29,"Yes"
"13431","KEGG_compound","C00091_SUCCINYL_COA_SUCCINYL_COENZYME_A",15,-0.9309,0.55,0.69,"No",1.0919,0.34,1,"Yes"
"13432","GO_BP","516807_GO_0071887_LEUKOCYTE_APOPTOTIC_PROCESS",24,-0.9308,0.56,0.73,"No",1.2311,0.19,0.75,"Yes"
"13433","C7_Immunologic_signatures","C7_ALL_344_GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN",198,-0.9308,0.62,0.72,"No",0.9233,0.67,0.97,"Yes"
"13434","C2_Chemical_and_genetic_perturbations","C2_CGP_2125_KONDO_COLON_CANCER_HCP_WITH_H3K27ME1",25,-0.9307,0.56,0.68,"No",-0.8136,0.73,1,"No"
"13435","GO_BP","519280_GO_2000641_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT",12,-0.9307,0.56,0.73,"No",0.7743,0.78,1,"Yes"
"13436","GO_BP","510796_GO_0048742_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT",11,-0.9307,0.56,0.73,"No",0.9364,0.53,1,"Yes"
"13437","GO_BP","492041_GO_0007262_STAT_PROTEIN_IMPORT_INTO_NUCLEUS",5,-0.9306,0.57,0.73,"No",1.1882,0.26,0.79,"Yes"
"13438","C2_Chemical_and_genetic_perturbations","C2_CGP_1710_JIANG_VHL_TARGETS",138,-0.9306,0.6,0.68,"No",1.5829,0,0.15,"Yes"
"13439","GO_BP","488638_GO_0002765_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION",6,-0.9306,0.56,0.73,"No",-0.9251,0.57,1,"No"
"13440","KEGG_compound","C00015_UDP_URIDINE_5_DIPHOSPHATE",62,-0.9305,0.58,0.69,"No",1.207,0.16,0.86,"Yes"
"13441","GO_BP","496945_GO_0017148_NEGATIVE_REGULATION_OF_TRANSLATION",76,-0.9305,0.6,0.73,"No",1.0016,0.43,0.98,"Yes"
"13442","GO_BP","514287_GO_0060732_POSITIVE_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS",9,-0.9305,0.55,0.73,"No",1.6267,0.021,0.26,"Yes"
"13443","C7_Immunologic_signatures","C7_ALL_822_GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN",199,-0.9303,0.63,0.72,"No",1.0905,0.22,0.47,"Yes"
"13444","C7_Immunologic_signatures","C7_ALL_303_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP",200,-0.9302,0.61,0.72,"No",1.8324,0,0,"Yes"
"13445","C3_TF_targets","C3_TFT_247_V_E2F_Q3",226,-0.9302,0.65,0.72,"No",0.705,1,1,"Yes"
"13446","GO_BP","497859_GO_0018963_PHTHALATE_METABOLIC_PROCESS",6,-0.9301,0.57,0.73,"No",1.3938,0.1,0.56,"Yes"
"13447","C3_MicroRNA_targets","C3_MIR_145_CTCCAAG_MIR_432",83,-0.9301,0.6,0.73,"No",-1.0102,0.42,1,"No"
"13448","GO_MF","492676_GO_0008373_SIALYLTRANSFERASE_ACTIVITY",20,-0.9299,0.56,0.76,"No",0.5774,0.99,1,"Yes"
"13449","C7_Immunologic_signatures","C7_ALL_636_GSE17721_PAM3CSK4_VS_GADIQUIMOD_0_5H_BMDM_DN",198,-0.9299,0.63,0.72,"No",0.967,0.54,0.84,"Yes"
"13450","GO_BP","491437_GO_0006541_GLUTAMINE_METABOLIC_PROCESS",23,-0.9299,0.57,0.73,"No",-1.3536,0.11,0.95,"No"
"13451","REACTOME","1127503_REACT_267965_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE",89,-0.9298,0.59,0.74,"No",-0.8813,0.73,1,"No"
"13452","C2_Chemical_and_genetic_perturbations","C2_CGP_866_JAZAG_TGFB1_SIGNALING_DN",34,-0.9298,0.57,0.68,"No",0.8701,0.7,0.96,"Yes"
"13453","C2_Chemical_and_genetic_perturbations","C2_CGP_1338_PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP",19,-0.9297,0.56,0.68,"No",1.4545,0.072,0.25,"Yes"
"13454","GO_CC","505893_GO_0042788_POLYSOMAL_RIBOSOME",6,-0.9297,0.56,0.81,"No",0.8698,0.59,0.91,"Yes"
"13455","GO_BP","497169_GO_0018198_PEPTIDYL_CYSTEINE_MODIFICATION",17,-0.9296,0.56,0.73,"No",1.2456,0.18,0.74,"Yes"
"13456","C4_Cancer_gene_neighborhoods","C4_CGN_17_MORF_FDXR",220,-0.9295,0.64,0.83,"No",-0.8586,0.85,1,"No"
"13457","GO_MF","1039900_GO_0090599_ALPHA_GLUCOSIDASE_ACTIVITY",6,-0.9295,0.54,0.76,"No",-0.5886,0.94,1,"No"
"13458","GO_BP","514597_GO_0061049_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT",6,-0.9294,0.55,0.73,"No",1.6377,0.014,0.25,"Yes"
"13459","WikiPathways","198774_WP366_TGF_BETA_RECEPTOR_SIGNALING_PATHWAY",154,-0.9293,0.63,0.68,"No",1.0529,0.3,1,"Yes"
"13460","C2_Chemical_and_genetic_perturbations","C2_CGP_463_CAIRO_PML_TARGETS_BOUND_BY_MYC_UP",23,-0.9293,0.58,0.68,"No",1.1492,0.27,0.56,"Yes"
"13461","C3_MicroRNA_targets","C3_MIR_80_GTCAACC_MIR_380_5P",22,-0.9293,0.57,0.73,"No",-0.6901,0.91,1,"No"
"13462","GO_BP","499592_GO_0030174_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION_INITIATION",6,-0.9293,0.56,0.73,"No",0.6168,0.92,1,"Yes"
"13463","C2_Chemical_and_genetic_perturbations","C2_CGP_1045_WOTTON_RUNX_TARGETS_UP",21,-0.9292,0.58,0.68,"No",1.126,0.31,0.59,"Yes"
"13464","REACTOME","833797_REACT_163914_FERTILIZATION",22,-0.9289,0.56,0.74,"No",-1.0904,0.33,0.9,"No"
"13465","C2_BioCarta_Pathways","C2_CP_BIOCARTA_105_BIOCARTA_GLEEVEC_PATHWAY",23,-0.9289,0.58,0.67,"No",0.6691,0.92,1,"Yes"
"13466","C2_Chemical_and_genetic_perturbations","C2_CGP_3335_KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES",267,-0.9286,0.65,0.68,"No",1.2573,0.03,0.43,"Yes"
"13467","C7_Immunologic_signatures","C7_ALL_528_GSE17721_LPS_VS_POLYIC_0_5H_BMDM_DN",190,-0.9285,0.63,0.73,"No",0.9267,0.68,0.96,"Yes"
"13468","C2_Chemical_and_genetic_perturbations","C2_CGP_1896_NIELSEN_SCHWANNOMA_UP",18,-0.9284,0.55,0.68,"No",-1.05,0.4,0.97,"No"
"13469","C2_Chemical_and_genetic_perturbations","C2_CGP_880_WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP",72,-0.9284,0.58,0.68,"No",-0.9177,0.63,1,"No"
"13470","OMIM_gene","OMIM605631_NAPSIN_A_NAPSA",9,-0.9283,0.56,0.8,"No",0.597,0.95,1,"Yes"
"13471","C2_Chemical_and_genetic_perturbations","C2_CGP_1494_HALMOS_CEBPA_TARGETS_DN",46,-0.9282,0.58,0.68,"No",1.1451,0.24,0.56,"Yes"
"13472","GO_BP","516428_GO_0071504_CELLULAR_RESPONSE_TO_HEPARIN",5,-0.9279,0.59,0.73,"No",-1.8373,0,0.43,"No"
"13473","C7_Immunologic_signatures","C7_ALL_1703_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP",194,-0.9278,0.64,0.73,"No",-0.9728,0.52,1,"No"
"13474","C2_Chemical_and_genetic_perturbations","C2_CGP_352_RODRIGUES_THYROID_CARCINOMA_UP",16,-0.9277,0.57,0.68,"No",1.1301,0.28,0.58,"Yes"
"13475","KEGG_compound","C05356_5_S_HPETE_5_S_HYDROPEROXY_6_TRANS_8_11_14_CIS_EICOSATETRAENOIC_ACID_6E_8Z_11Z_14Z_5S_5_HYDROPEROXYEICOSA_6_8_11_14_TETRAENOATE_6E_8Z_11Z_14Z_5S_5_HYDROPEROXYEICOSA_6_8_11_14_TETRAENOIC_ACID_5S_6E_8Z_11Z_14Z_5_HYDROPEROXYICOSA_6_8_11_14_TETRAENOATE",7,-0.9276,0.54,0.69,"No",0.5822,0.94,1,"Yes"
"13476","GO_BP","518189_GO_0090045_POSITIVE_REGULATION_OF_DEACETYLASE_ACTIVITY",6,-0.9275,0.56,0.73,"No",-0.8408,0.65,1,"No"
"13477","GO_BP","513445_GO_0055012_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",20,-0.9275,0.57,0.73,"No",-1.0423,0.4,0.98,"No"
"13478","C7_Immunologic_signatures","C7_ALL_1445_GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP",198,-0.9273,0.63,0.73,"No",1.0075,0.44,0.71,"Yes"
"13479","GO_BP","982256_GO_0044843_CELL_CYCLE_G1_S_PHASE_TRANSITION",170,-0.9271,0.64,0.73,"No",1.5907,0,0.3,"Yes"
"13480","GO_CC","490334_GO_0005778_PEROXISOMAL_MEMBRANE",54,-0.927,0.59,0.82,"No",0.9483,0.57,0.83,"Yes"
"13481","GO_CC","516489_GO_0071565_NBAF_COMPLEX",13,-0.9269,0.56,0.81,"No",-1.2294,0.21,0.64,"No"
"13482","C2_Chemical_and_genetic_perturbations","C2_CGP_454_GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN",9,-0.9268,0.55,0.68,"No",0.6455,0.91,1,"Yes"
"13483","C7_Immunologic_signatures","C7_ALL_1537_GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP",182,-0.9268,0.64,0.73,"No",-1.0666,0.3,1,"No"
"13484","GO_BP","488507_GO_0002634_REGULATION_OF_GERMINAL_CENTER_FORMATION",9,-0.9268,0.55,0.73,"No",-1.6455,0.029,0.7,"No"
"13485","GO_BP","486605_GO_0000060_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION",24,-0.9266,0.56,0.73,"No",-1.2099,0.21,0.88,"No"
"13486","GO_MF","515233_GO_0070300_PHOSPHATIDIC_ACID_BINDING",10,-0.9266,0.56,0.76,"No",-0.5905,0.93,1,"No"
"13487","KEGG_compound","C01120_SPHINGANINE_1_PHOSPHATE_DIHYDROSPHINGOSINE_1_PHOSPHATE",8,-0.9266,0.57,0.69,"No",0.8927,0.6,1,"Yes"
"13488","C3_MicroRNA_targets","C3_MIR_45_ACACTGG_MIR_199A_MIR_199B",157,-0.9265,0.62,0.73,"No",0.774,0.96,1,"Yes"
"13489","C7_Immunologic_signatures","C7_ALL_177_GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP",198,-0.9265,0.64,0.73,"No",-0.6678,1,1,"No"
"13490","KEGG_reaction","R07034_GLUTATHIONE_5_HPETE_OXIDOREDUCTASE_2_GLUTATHIONE_5_S_HPETE_GLUTATHIONE_DISULFIDE_5_S_HETE_H2O",6,-0.9264,0.57,0.71,"No",0.5318,0.98,0.99,"Yes"
"13491","GO_MF","496584_GO_0016645_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS",25,-0.9263,0.57,0.76,"No",-0.7461,0.86,1,"No"
"13492","GO_MF","502484_GO_0033265_CHOLINE_BINDING",5,-0.9262,0.6,0.76,"No",-1.1579,0.33,0.81,"No"
"13493","GO_CC","486748_GO_0000228_NUCLEAR_CHROMOSOME",426,-0.9261,0.7,0.81,"No",-1.1576,0.092,0.68,"No"
"13494","REACTOME","833796_REACT_163848_REPRODUCTION",22,-0.926,0.57,0.75,"No",-1.0955,0.34,0.91,"No"
"13495","GO_BP","516406_GO_0071482_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS",92,-0.9259,0.61,0.73,"No",-0.6414,0.99,1,"No"
"13496","C2_Chemical_and_genetic_perturbations","C2_CGP_3336_KUMAR_AUTOPHAGY_NETWORK",71,-0.9258,0.6,0.69,"No",0.9176,0.65,0.9,"Yes"
"13497","GO_BP","508244_GO_0045938_POSITIVE_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP",6,-0.9257,0.56,0.73,"No",1.351,0.12,0.61,"Yes"
"13498","GO_BP","492357_GO_0007616_LONG_TERM_MEMORY",27,-0.9255,0.57,0.73,"No",-1.3233,0.1,0.88,"No"
"13499","C2_Chemical_and_genetic_perturbations","C2_CGP_2761_YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN",62,-0.9255,0.6,0.69,"No",-0.8861,0.68,1,"No"
"13500","C4_Cancer_gene_neighborhoods","C4_CGN_166_MORF_RAB6A",68,-0.9254,0.6,0.84,"No",1.6724,0,0.008,"Yes"
"13501","C2_BioCarta_Pathways","C2_CP_BIOCARTA_90_BIOCARTA_IGF1_PATHWAY",21,-0.9252,0.55,0.67,"No",0.7937,0.75,0.98,"Yes"
"13502","C1_Positional","C1_ALL_238_CHR1P36",362,-0.9251,0.7,0.93,"No",-0.8777,0.86,1,"No"
"13503","GO_CC","507402_GO_0044454_NUCLEAR_CHROMOSOME_PART",375,-0.9249,0.7,0.81,"No",-1.1958,0.056,0.7,"No"
"13504","GO_BP","500476_GO_0031214_BIOMINERAL_TISSUE_DEVELOPMENT",67,-0.9249,0.61,0.73,"No",-1.0119,0.42,0.98,"No"
"13505","GO_BP","486622_GO_0000082_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",169,-0.9246,0.63,0.74,"No",1.6013,0,0.29,"Yes"
"13506","C2_Chemical_and_genetic_perturbations","C2_CGP_1704_VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP",15,-0.9246,0.56,0.69,"No",0.7613,0.81,1,"Yes"
"13507","GO_MF","492628_GO_0008308_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY",15,-0.9244,0.57,0.76,"No",-0.6773,0.89,1,"No"
"13508","C2_Chemical_and_genetic_perturbations","C2_CGP_3060_CHICAS_RB1_TARGETS_LOW_SERUM",96,-0.9241,0.6,0.69,"No",1.9891,0,0.0073,"Yes"
"13509","GO_BP","510608_GO_0048539_BONE_MARROW_DEVELOPMENT",6,-0.924,0.57,0.74,"No",0.7124,0.83,1,"Yes"
"13510","C2_Chemical_and_genetic_perturbations","C2_CGP_2393_LIN_NPAS4_TARGETS_UP",160,-0.9239,0.63,0.69,"No",1.4044,0.0071,0.29,"Yes"
"13511","GO_BP","502365_GO_0033144_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",32,-0.9238,0.58,0.74,"No",-0.8403,0.72,1,"No"
"13512","GO_CC","501808_GO_0032580_GOLGI_CISTERNA_MEMBRANE",74,-0.9238,0.6,0.82,"No",0.869,0.74,0.91,"Yes"
"13513","GO_BP","514532_GO_0060977_CORONARY_VASCULATURE_MORPHOGENESIS",10,-0.9238,0.56,0.74,"No",-0.6355,0.93,1,"No"
"13514","GO_BP","499866_GO_0030539_MALE_GENITALIA_DEVELOPMENT",20,-0.9238,0.56,0.74,"No",0.83,0.71,1,"Yes"
"13515","GO_BP","493309_GO_0009110_VITAMIN_BIOSYNTHETIC_PROCESS",23,-0.9237,0.56,0.74,"No",0.8581,0.67,1,"Yes"
"13516","C2_Chemical_and_genetic_perturbations","C2_CGP_1531_STAEGE_EWING_FAMILY_TUMOR",32,-0.9233,0.58,0.69,"No",-0.6928,0.92,1,"No"
"13517","C2_Chemical_and_genetic_perturbations","C2_CGP_587_RIZ_ERYTHROID_DIFFERENTIATION",77,-0.9233,0.62,0.69,"No",1.0439,0.36,0.73,"Yes"
"13518","GO_BP","861516_GO_1902373_NEGATIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS",5,-0.9232,0.56,0.74,"No",0.4686,0.99,1,"Yes"
"13519","GO_BP","753146_GO_1900151_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY",14,-0.9232,0.58,0.74,"No",-0.8453,0.65,1,"No"
"13520","C7_Immunologic_signatures","C7_ALL_1852_GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN",186,-0.9232,0.64,0.74,"No",1.1624,0.11,0.3,"Yes"
"13521","C1_Positional","C1_ALL_132_CHR15Q13",46,-0.9231,0.58,0.93,"No",-1.0277,0.4,1,"No"
"13522","KEGG_compound","C00526_DEOXYURIDINE_2_DEOXYURIDINE_2_DEOXYURIDINE",17,-0.923,0.58,0.7,"No",-0.4983,0.99,1,"No"
"13523","C2_Chemical_and_genetic_perturbations","C2_CGP_1958_LEE_CALORIE_RESTRICTION_MUSCLE_DN",49,-0.9229,0.6,0.69,"No",0.9784,0.51,0.82,"Yes"
"13524","GO_BP","498774_GO_0020027_HEMOGLOBIN_METABOLIC_PROCESS",12,-0.9229,0.55,0.74,"No",1.612,0.028,0.28,"Yes"
"13525","GO_BP","500245_GO_0030952_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY",5,-0.9228,0.55,0.74,"No",-0.6084,0.92,1,"No"
"13526","KEGG_reaction","R03362_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_D_MYO_INOSITOL_ADP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATE",5,-0.9226,0.58,0.71,"No",-0.7963,0.71,1,"No"
"13527","C2_Chemical_and_genetic_perturbations","C2_CGP_3032_NOUSHMEHR_GBM_SOMATIC_MUTATED",9,-0.9225,0.58,0.69,"No",-0.7314,0.8,1,"No"
"13528","GO_BP","499707_GO_0030307_POSITIVE_REGULATION_OF_CELL_GROWTH",112,-0.9225,0.64,0.74,"No",0.6984,1,1,"Yes"
"13529","GO_BP","750919_GO_0035994_RESPONSE_TO_MUSCLE_STRETCH",10,-0.9225,0.54,0.74,"No",-1.3801,0.096,1,"No"
"13530","KEGG_reaction","R07824_G13043_H2O_DWA_2_N_ACETYLGALACTOSAMINE",5,-0.9223,0.59,0.7,"No",0.7394,0.78,1,"Yes"
"13531","C7_Immunologic_signatures","C7_ALL_311_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP",200,-0.9222,0.66,0.74,"No",1.2319,0.065,0.18,"Yes"
"13532","GO_BP","494938_GO_0010874_REGULATION_OF_CHOLESTEROL_EFFLUX",18,-0.922,0.59,0.74,"No",1.1775,0.23,0.81,"Yes"
"13533","REACTOME","187216_REACT_25218_HUR_STABILIZES_MRNA",8,-0.9219,0.56,0.75,"No",-0.8832,0.59,1,"No"
"13534","GO_MF","509664_GO_0047485_PROTEIN_N_TERMINUS_BINDING",93,-0.9218,0.61,0.77,"No",1.3871,0.023,0.48,"Yes"
"13535","KEGG_compound","C00002_ATP_ADENOSINE_5_TRIPHOSPHATE",292,-0.9218,0.7,0.7,"No",-0.6324,1,1,"No"
"13536","GO_BP","508383_GO_0046087_CYTIDINE_METABOLIC_PROCESS",9,-0.9218,0.58,0.74,"No",0.8101,0.69,1,"Yes"
"13537","GO_BP","494730_GO_0010667_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS",8,-0.9217,0.54,0.74,"No",-0.8666,0.62,1,"No"
"13538","REACTOME","119546_REACT_19400_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS",54,-0.9215,0.58,0.75,"No",1.1697,0.21,0.48,"Yes"
"13539","GO_BP","508074_GO_0045732_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS",216,-0.9215,0.67,0.74,"No",1.3212,0.0048,0.64,"Yes"
"13540","REACTOME","1127614_REACT_264125_SIGNALING_BY_WNT_IN_CANCER",34,-0.9215,0.59,0.75,"No",-0.8314,0.76,1,"No"
"13541","C2_Chemical_and_genetic_perturbations","C2_CGP_2984_RUAN_RESPONSE_TO_TROGLITAZONE_DN",18,-0.9214,0.56,0.69,"No",1.2497,0.21,0.44,"Yes"
"13542","GO_BP","491473_GO_0006577_AMINO_ACID_BETAINE_METABOLIC_PROCESS",17,-0.9213,0.56,0.74,"No",-1.0663,0.37,0.96,"No"
"13543","C2_Chemical_and_genetic_perturbations","C2_CGP_1754_DAZARD_RESPONSE_TO_UV_SCC_DN",123,-0.9213,0.59,0.69,"No",1.0313,0.38,0.75,"Yes"
"13544","C7_Immunologic_signatures","C7_ALL_1063_GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP",200,-0.9212,0.66,0.74,"No",1.3429,0.019,0.067,"Yes"
"13545","C2_Chemical_and_genetic_perturbations","C2_CGP_300_SCIBETTA_KDM5B_TARGETS_UP",19,-0.9212,0.58,0.69,"No",-0.7899,0.75,1,"No"
"13546","GO_MF","490464_GO_0005222_INTRACELLULAR_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY",8,-0.9211,0.57,0.77,"No",1.1997,0.23,0.7,"Yes"
"13547","KEGG_reaction","R00274_GLUTATHIONE_HYDROGEN_PEROXIDE_OXIDOREDUCTASE_HYDROGEN_PEROXIDE_2_GLUTATHIONE_GLUTATHIONE_DISULFIDE_2_H2O",6,-0.921,0.59,0.69,"No",0.5311,0.97,0.99,"Yes"
"13548","C1_Positional","C1_ALL_78_CHR22Q11",148,-0.9208,0.64,0.93,"No",-1.0918,0.26,1,"No"
"13549","GO_BP","501849_GO_0032623_INTERLEUKIN_2_PRODUCTION",7,-0.9208,0.54,0.74,"No",0.7791,0.74,1,"Yes"
"13550","C7_Immunologic_signatures","C7_ALL_1235_GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP",192,-0.9206,0.66,0.74,"No",0.9759,0.49,0.82,"Yes"
"13551","C2_Chemical_and_genetic_perturbations","C2_CGP_1830_KANG_DOXORUBICIN_RESISTANCE_DN",19,-0.9206,0.57,0.69,"No",0.7633,0.8,1,"Yes"
"13552","C2_Chemical_and_genetic_perturbations","C2_CGP_2719_BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP",45,-0.9205,0.59,0.69,"No",1.1452,0.24,0.56,"Yes"
"13553","GO_MF","500670_GO_0031419_COBALAMIN_BINDING",9,-0.9203,0.58,0.77,"No",0.6885,0.88,1,"Yes"
"13554","GO_MF","490009_GO_0004689_PHOSPHORYLASE_KINASE_ACTIVITY",5,-0.9202,0.57,0.77,"No",-1.2833,0.16,0.81,"No"
"13555","GO_BP","510627_GO_0048562_EMBRYONIC_ORGAN_MORPHOGENESIS",277,-0.9201,0.69,0.74,"No",-0.9054,0.78,1,"No"
"13556","GO_BP","501523_GO_0032288_MYELIN_ASSEMBLY",19,-0.9201,0.59,0.74,"No",-0.521,0.99,1,"No"
"13557","KEGG_module","HSA_M00010_CITRATE_CYCLE_FIRST_CARBON_OXIDATION_OXALOACETATE_2_OXOGLUTARATE",8,-0.9201,0.57,0.75,"No",0.9438,0.54,0.89,"Yes"
"13558","GO_MF","499878_GO_0030552_CAMP_BINDING",24,-0.9198,0.59,0.77,"No",1.1845,0.21,0.73,"Yes"
"13559","C2_Chemical_and_genetic_perturbations","C2_CGP_1516_ZHAN_MULTIPLE_MYELOMA_CD2_UP",45,-0.9198,0.6,0.69,"No",1.1578,0.22,0.54,"Yes"
"13560","C2_Chemical_and_genetic_perturbations","C2_CGP_1416_GRANDVAUX_IRF3_TARGETS_DN",18,-0.9197,0.58,0.69,"No",0.9562,0.54,0.86,"Yes"
"13561","C7_Immunologic_signatures","C7_ALL_212_GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN",196,-0.9196,0.66,0.75,"No",1.6674,0,0.00097,"Yes"
"13562","REACTOME","106377_REACT_18426_OPSINS",8,-0.9196,0.6,0.76,"No",-1.5082,0.063,0.44,"No"
"13563","GO_BP","512205_GO_0051321_MEIOTIC_CELL_CYCLE",161,-0.9195,0.65,0.74,"No",-0.7963,0.94,1,"No"
"13564","GO_BP","752173_GO_0061430_BONE_TRABECULA_MORPHOGENESIS",11,-0.9195,0.56,0.74,"No",-1.0435,0.39,0.98,"No"
"13565","GO_CC","499552_GO_0030120_VESICLE_COAT",47,-0.9193,0.6,0.82,"No",1.1999,0.17,0.53,"Yes"
"13566","GO_MF","512109_GO_0051213_DIOXYGENASE_ACTIVITY",87,-0.9193,0.64,0.77,"No",-0.7154,0.97,1,"No"
"13567","C2_Chemical_and_genetic_perturbations","C2_CGP_3275_PLASARI_TGFB1_TARGETS_1HR_DN",6,-0.9192,0.57,0.7,"No",1.3174,0.16,0.38,"Yes"
"13568","GO_BP","505503_GO_0042359_VITAMIN_D_METABOLIC_PROCESS",11,-0.9189,0.56,0.74,"No",-1.1485,0.3,0.93,"No"
"13569","C2_Chemical_and_genetic_perturbations","C2_CGP_812_HEIDENBLAD_AMPLICON_12P11_12_DN",30,-0.9189,0.6,0.7,"No",-0.601,0.98,1,"No"
"13570","GO_BP","494987_GO_0010923_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY",65,-0.9189,0.61,0.74,"No",-0.8984,0.65,1,"No"
"13571","WikiPathways","198764_WP1531_VITAMIN_D_SYNTHESIS",7,-0.9188,0.57,0.7,"No",-0.6087,0.92,1,"No"
"13572","C2_BioCarta_Pathways","C2_CP_BIOCARTA_104_BIOCARTA_RACCYCD_PATHWAY",26,-0.9187,0.58,0.68,"No",0.6127,0.98,1,"Yes"
"13573","GO_BP","503518_GO_0034315_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION",15,-0.9186,0.56,0.74,"No",0.7353,0.84,1,"Yes"
"13574","C7_Immunologic_signatures","C7_ALL_321_GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP",198,-0.9186,0.67,0.75,"No",-1.1345,0.18,1,"No"
"13575","C3_TF_targets","C3_TFT_499_KTGGYRSGAA_UNKNOWN",75,-0.9185,0.6,0.74,"No",-0.6215,1,1,"No"
"13576","REACTOME","685552_REACT_147904_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP_",41,-0.9185,0.6,0.76,"No",-0.6152,0.99,1,"No"
"13577","GO_CC","488005_GO_0002116_SEMAPHORIN_RECEPTOR_COMPLEX",7,-0.9184,0.59,0.82,"No",-1.4205,0.096,0.68,"No"
"13578","C4_Cancer_gene_neighborhoods","C4_CGN_157_MORF_PTEN",82,-0.9184,0.62,0.85,"No",0.6494,0.99,1,"Yes"
"13579","C3_TF_targets","C3_TFT_299_V_STAT1_02",250,-0.9181,0.66,0.74,"No",0.9562,0.59,1,"Yes"
"13580","GO_BP","511908_GO_0050974_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",26,-0.9181,0.58,0.74,"No",-1.1366,0.25,0.93,"No"
"13581","C4_Cancer_gene_neighborhoods","C4_CGN_169_MORF_RAGE",141,-0.9181,0.63,0.85,"No",-1,0.43,0.86,"No"
"13582","C7_Immunologic_signatures","C7_ALL_1007_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP",200,-0.918,0.66,0.75,"No",0.8407,0.88,1,"Yes"
"13583","KEGG_module","HSA_M00029_UREA_CYCLE",6,-0.918,0.61,0.74,"No",-0.6516,0.86,1,"No"
"13584","GO_BP","499150_GO_0021871_FOREBRAIN_REGIONALIZATION",23,-0.9179,0.57,0.74,"No",0.7243,0.87,1,"Yes"
"13585","GO_BP","517264_GO_0072348_SULFUR_COMPOUND_TRANSPORT",30,-0.9179,0.57,0.74,"No",-0.6425,0.96,1,"No"
"13586","C3_TF_targets","C3_TFT_508_RRCCGTTA_UNKNOWN",85,-0.9179,0.63,0.74,"No",-0.7327,0.94,1,"No"
"13587","C4_Cancer_gene_neighborhoods","C4_CGN_19_MORF_GPX4",55,-0.9179,0.61,0.84,"No",2.1162,0,0.00011,"Yes"
"13588","C4_Cancer_modules","C4_CM_151_MODULE_159",81,-0.9179,0.61,0.71,"No",2.1855,0,0.00021,"Yes"
"13589","GO_MF","496585_GO_0016646_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",18,-0.9178,0.57,0.77,"No",0.6991,0.89,1,"Yes"
"13590","GO_MF","495381_GO_0015106_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-0.9178,0.56,0.77,"No",-0.7568,0.78,1,"No"
"13591","C3_TF_targets","C3_TFT_389_V_E2F4DP1_01",237,-0.9177,0.67,0.74,"No",-0.902,0.75,0.96,"No"
"13592","KEGG_compound","C05332_PHENETHYLAMINE_2_PHENYLETHYLAMINE_BETA_PHENYLETHYLAMINE_PHENYLETHYLAMINE",5,-0.9177,0.58,0.7,"No",-1.2548,0.24,0.7,"No"
"13593","GO_BP","511639_GO_0050667_HOMOCYSTEINE_METABOLIC_PROCESS",8,-0.9176,0.57,0.75,"No",0.7697,0.76,1,"Yes"
"13594","GO_MF","496781_GO_0016894_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS",17,-0.9174,0.56,0.77,"No",1.5583,0.034,0.32,"Yes"
"13595","REACTOME","1127516_REACT_264596_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT",226,-0.9172,0.66,0.76,"No",0.8663,0.86,0.94,"Yes"
"13596","GO_MF","510561_GO_0048487_BETA_TUBULIN_BINDING",35,-0.9171,0.59,0.77,"No",1.1716,0.21,0.73,"Yes"
"13597","GO_BP","491493_GO_0006598_POLYAMINE_CATABOLIC_PROCESS",5,-0.9168,0.59,0.75,"No",-1.0301,0.44,0.98,"No"
"13598","C7_Immunologic_signatures","C7_ALL_1163_GSE27786_LIN_NEG_VS_CD4_TCELL_UP",197,-0.9167,0.68,0.75,"No",1.1763,0.11,0.27,"Yes"
"13599","GO_BP","491550_GO_0006662_GLYCEROL_ETHER_METABOLIC_PROCESS",13,-0.9166,0.6,0.75,"No",0.8516,0.68,1,"Yes"
"13600","C2_Chemical_and_genetic_perturbations","C2_CGP_2388_LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK",17,-0.9166,0.6,0.7,"No",1.1918,0.22,0.5,"Yes"
"13601","C4_Cancer_gene_neighborhoods","C4_CGN_139_MORF_PAPSS1",103,-0.9165,0.65,0.84,"No",1.9042,0,0.00079,"Yes"
"13602","KEGG_enzyme","1.11.1.9_GLUTATHIONE_PEROXIDASE_GSH_PEROXIDASE_SELENIUM_GLUTATHIONE_PEROXIDASE_REDUCED_GLUTATHIONE_PEROXIDASE",6,-0.9165,0.59,0.66,"No",0.54,0.96,0.97,"Yes"
"13603","GO_BP","500397_GO_0031110_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",53,-0.9164,0.59,0.75,"No",0.7218,0.93,1,"Yes"
"13604","C7_Immunologic_signatures","C7_ALL_1783_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP",200,-0.9163,0.68,0.75,"No",0.8594,0.89,1,"Yes"
"13605","C2_Chemical_and_genetic_perturbations","C2_CGP_2230_MCCABE_HOXC6_TARGETS_UP",9,-0.9163,0.58,0.7,"No",-0.8346,0.69,1,"No"
"13606","GO_BP","510756_GO_0048701_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS",42,-0.9158,0.59,0.75,"No",-1.0216,0.44,0.97,"No"
"13607","GO_BP","1129476_GO_1903650_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT",85,-0.9158,0.63,0.75,"No",-0.6708,0.99,1,"No"
"13608","REACTOME","106104_REACT_2122_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION",8,-0.9157,0.58,0.76,"No",0.6683,0.88,1,"Yes"
"13609","C7_Immunologic_signatures","C7_ALL_275_GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP",197,-0.9157,0.68,0.75,"No",0.8214,0.95,1,"Yes"
"13610","GO_BP","498797_GO_0021513_SPINAL_CORD_DORSAL_VENTRAL_PATTERNING",22,-0.9157,0.59,0.75,"No",-1.1581,0.28,0.92,"No"
"13611","GO_BP","488971_GO_0003177_PULMONARY_VALVE_DEVELOPMENT",9,-0.9155,0.58,0.75,"No",-0.8598,0.62,1,"No"
"13612","GO_BP","754937_GO_2000831_REGULATION_OF_STEROID_HORMONE_SECRETION",16,-0.9154,0.58,0.75,"No",1.2987,0.15,0.67,"Yes"
"13613","C3_MicroRNA_targets","C3_MIR_217_TAATGTG_MIR_323",159,-0.9153,0.68,0.75,"No",0.6613,1,1,"Yes"
"13614","KEGG_reaction","R10905_HYALURONIC_ACID_H2O_HYALURONIC_ACID_G00526",5,-0.9153,0.6,0.7,"No",0.7563,0.74,1,"Yes"
"13615","GO_MF","503654_GO_0034452_DYNACTIN_BINDING",8,-0.9151,0.56,0.77,"No",-1.2399,0.21,0.85,"No"
"13616","GO_BP","490969_GO_0005981_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS",6,-0.9149,0.57,0.75,"No",-1.1417,0.31,0.93,"No"
"13617","KEGG_compound","C00422_TRIACYLGLYCEROL_TRIGLYCERIDE",11,-0.9148,0.55,0.71,"No",-0.9995,0.46,1,"No"
"13618","GO_BP","512146_GO_0051255_SPINDLE_MIDZONE_ASSEMBLY",9,-0.9147,0.59,0.75,"No",0.6528,0.9,1,"Yes"
"13619","GO_MF","489689_GO_0005381_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.9146,0.58,0.77,"No",1.0514,0.41,0.83,"Yes"
"13620","KEGG_compound","C00473_RETINOL_ALL_TRANS_RETINOL_VITAMIN_A_VITAMIN_A1",23,-0.9146,0.58,0.7,"No",1.4575,0.052,0.39,"Yes"
"13621","OMIM_gene","OMIM179605_PERIPHERIN_2_MOUSE_HOMOLOG_OF_PRPH2",5,-0.9144,0.57,0.8,"No",-0.8635,0.64,0.94,"No"
"13622","GO_BP","501176_GO_0031936_NEGATIVE_REGULATION_OF_CHROMATIN_SILENCING",9,-0.9144,0.59,0.75,"No",0.7445,0.8,1,"Yes"
"13623","GO_BP","488978_GO_0003184_PULMONARY_VALVE_MORPHOGENESIS",9,-0.9144,0.57,0.75,"No",-0.8518,0.65,1,"No"
"13624","GO_BP","491543_GO_0006655_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS",13,-0.9144,0.59,0.75,"No",0.5979,0.95,1,"Yes"
"13625","GO_BP","491940_GO_0007127_MEIOSIS_I",74,-0.9143,0.62,0.75,"No",-0.8188,0.82,1,"No"
"13626","GO_MF","751042_GO_0036122_BMP_BINDING",6,-0.914,0.58,0.77,"No",0.9574,0.53,0.92,"Yes"
"13627","C1_Positional","C1_ALL_275_CHR6Q26",11,-0.914,0.58,0.94,"No",0.9133,0.57,0.84,"Yes"
"13628","GO_CC","494439_GO_0010369_CHROMOCENTER",12,-0.9139,0.59,0.83,"No",-0.9839,0.47,0.86,"No"
"13629","C4_Cancer_modules","C4_CM_227_MODULE_249",21,-0.9139,0.6,0.71,"No",0.931,0.58,0.8,"Yes"
"13630","GO_BP","499681_GO_0030277_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM",15,-0.9139,0.58,0.75,"No",1.0097,0.43,0.98,"Yes"
"13631","KEGG_pathway","HSA05216_THYROID_CANCER",29,-0.9139,0.6,0.67,"No",1.0646,0.35,0.86,"Yes"
"13632","C2_Chemical_and_genetic_perturbations","C2_CGP_1527_JAIN_NFKB_SIGNALING",75,-0.9139,0.63,0.71,"No",1.0015,0.46,0.8,"Yes"
"13633","C7_Immunologic_signatures","C7_ALL_1346_GSE31082_DN_VS_DP_THYMOCYTE_DN",200,-0.9139,0.69,0.76,"No",-0.8643,0.81,1,"No"
"13634","GO_BP","492051_GO_0007272_ENSHEATHMENT_OF_NEURONS",90,-0.9138,0.63,0.75,"No",-0.7807,0.91,1,"No"
"13635","C3_TF_targets","C3_TFT_554_YTTCCNNNGGAMR_UNKNOWN",50,-0.9136,0.61,0.75,"No",0.8812,0.67,1,"Yes"
"13636","GO_BP","490618_GO_0005513_DETECTION_OF_CALCIUM_ION",14,-0.9136,0.57,0.75,"No",0.8765,0.63,1,"Yes"
"13637","GO_MF","496767_GO_0016878_ACID_THIOL_LIGASE_ACTIVITY",20,-0.9136,0.57,0.77,"No",0.7715,0.82,1,"Yes"
"13638","REACTOME","730311_REACT_150331_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES",30,-0.9134,0.58,0.76,"No",-1.1337,0.28,0.9,"No"
"13639","GO_CC","490840_GO_0005814_CENTRIOLE",91,-0.9134,0.61,0.83,"No",-1.1923,0.13,0.67,"No"
"13640","WikiPathways","198878_WP732_SEROTONIN_RECEPTOR_2_AND_ELK_SRF_GATA4_SIGNALING",17,-0.9132,0.59,0.71,"No",-0.7699,0.8,1,"No"
"13641","C7_Immunologic_signatures","C7_ALL_123_GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP",194,-0.913,0.67,0.76,"No",1.1998,0.083,0.23,"Yes"
"13642","GO_MF","490270_GO_0004983_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY",8,-0.9128,0.59,0.77,"No",-1.2495,0.21,0.83,"No"
"13643","GO_BP","753148_GO_1900153_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY",14,-0.9126,0.58,0.75,"No",-0.8535,0.65,1,"No"
"13644","KEGG_compound","C00376_RETINAL_VITAMIN_A_ALDEHYDE_RETINENE_ALL_TRANS_RETINAL_ALL_TRANS_VITAMIN_A_ALDEHYDE_ALL_TRANS_RETINENE",22,-0.9125,0.59,0.71,"No",1.5422,0.039,0.25,"Yes"
"13645","C4_Cancer_gene_neighborhoods","C4_CGN_344_GNF2_DDX5",63,-0.9121,0.62,0.85,"No",-0.6028,0.99,1,"No"
"13646","GO_BP","487911_GO_0002021_RESPONSE_TO_DIETARY_EXCESS",16,-0.9121,0.6,0.75,"No",0.9479,0.53,1,"Yes"
"13647","C6_Oncogenic_signatures","C6_ALL_169_JAK2_DN_V1_UP",163,-0.9121,0.66,0.7,"No",-1.1021,0.25,0.58,"No"
"13648","GO_BP","492887_GO_0008643_CARBOHYDRATE_TRANSPORT",111,-0.912,0.64,0.75,"No",0.7834,0.93,1,"Yes"
"13649","REACTOME","905995_REACT_169121_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF_",16,-0.9118,0.6,0.77,"No",1.1838,0.26,0.46,"Yes"
"13650","C2_Chemical_and_genetic_perturbations","C2_CGP_790_SCHRAMM_INHBA_TARGETS_UP",6,-0.9118,0.57,0.71,"No",0.6825,0.85,1,"Yes"
"13651","GO_BP","505244_GO_0042059_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",43,-0.9118,0.6,0.75,"No",1.3156,0.1,0.65,"Yes"
"13652","REACTOME","530768_REACT_115871_SIGNALING_BY_EGFR_IN_CANCER",19,-0.9117,0.58,0.77,"No",1.3688,0.11,0.25,"Yes"
"13653","GO_BP","517159_GO_0072243_METANEPHRIC_NEPHRON_EPITHELIUM_DEVELOPMENT",18,-0.9117,0.58,0.75,"No",0.735,0.85,1,"Yes"
"13654","REACTOME","1183580_REACT_355216_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4",44,-0.9116,0.61,0.76,"No",-1.3281,0.092,0.61,"No"
"13655","C2_Chemical_and_genetic_perturbations","C2_CGP_136_CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN",50,-0.9115,0.6,0.71,"No",-0.9406,0.57,1,"No"
"13656","GO_BP","513881_GO_0060325_FACE_MORPHOGENESIS",35,-0.9114,0.6,0.75,"No",0.7846,0.81,1,"Yes"
"13657","C2_Chemical_and_genetic_perturbations","C2_CGP_1314_IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP",27,-0.9114,0.6,0.71,"No",1.2513,0.16,0.44,"Yes"
"13658","GO_MF","509806_GO_0047631_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY",5,-0.9113,0.6,0.78,"No",-0.7066,0.82,1,"No"
"13659","GO_BP","849976_GO_1902275_REGULATION_OF_CHROMATIN_ORGANIZATION",128,-0.9111,0.65,0.75,"No",0.6325,1,1,"Yes"
"13660","GO_BP","505033_GO_0035864_RESPONSE_TO_POTASSIUM_ION",9,-0.9109,0.58,0.75,"No",-0.916,0.55,1,"No"
"13661","C2_Chemical_and_genetic_perturbations","C2_CGP_2089_STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP",31,-0.9109,0.6,0.71,"No",0.7799,0.85,1,"Yes"
"13662","C7_Immunologic_signatures","C7_ALL_1855_GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP",199,-0.9108,0.67,0.76,"No",0.8852,0.8,1,"Yes"
"13663","GO_BP","507558_GO_0045176_APICAL_PROTEIN_LOCALIZATION",11,-0.9107,0.57,0.75,"No",1.3187,0.14,0.65,"Yes"
"13664","GO_BP","502453_GO_0033233_REGULATION_OF_PROTEIN_SUMOYLATION",17,-0.9106,0.58,0.75,"No",0.6962,0.88,1,"Yes"
"13665","C2_BioCarta_Pathways","C2_CP_BIOCARTA_8_BIOCARTA_ARAP_PATHWAY",17,-0.9103,0.58,0.69,"No",0.598,0.97,1,"Yes"
"13666","GO_BP","751600_GO_0044387_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION",6,-0.9102,0.58,0.76,"No",0.926,0.56,1,"Yes"
"13667","C2_Chemical_and_genetic_perturbations","C2_CGP_2715_BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP",52,-0.91,0.62,0.71,"No",1.2518,0.11,0.44,"Yes"
"13668","C7_Immunologic_signatures","C7_ALL_1103_GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP",189,-0.91,0.68,0.77,"No",-1.004,0.43,1,"No"
"13669","C7_Immunologic_signatures","C7_ALL_254_GSE14308_TH1_VS_TH17_DN",199,-0.9099,0.7,0.77,"No",1.0851,0.22,0.48,"Yes"
"13670","GO_CC","490946_GO_0005952_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX",9,-0.9098,0.58,0.84,"No",0.9556,0.49,0.83,"Yes"
"13671","REACTOME","1127576_REACT_268006_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_VARIANTS_IN_CANCER",19,-0.9096,0.58,0.77,"No",1.3464,0.12,0.27,"Yes"
"13672","GO_BP","501939_GO_0032713_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION",6,-0.9096,0.58,0.76,"No",0.9611,0.5,1,"Yes"
"13673","REACTOME","161036_REACT_20568_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS",29,-0.9095,0.61,0.77,"No",0.7944,0.82,1,"Yes"
"13674","C3_TF_targets","C3_TFT_449_V_CREB_Q2_01",218,-0.9095,0.7,0.76,"No",-0.8436,0.9,1,"No"
"13675","C2_Chemical_and_genetic_perturbations","C2_CGP_1849_IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR",148,-0.9094,0.68,0.71,"No",1.7273,0,0.068,"Yes"
"13676","GO_BP","495952_GO_0015824_PROLINE_TRANSPORT",9,-0.9094,0.58,0.76,"No",0.6502,0.89,1,"Yes"
"13677","REACTOME","685554_REACT_147867_TRANSLOCATION_OF_GLUT4_TO_THE_PLASMA_MEMBRANE",62,-0.9092,0.62,0.77,"No",1.1228,0.24,0.55,"Yes"
"13678","GO_MF","489792_GO_0004438_PHOSPHATIDYLINOSITOL_3_PHOSPHATASE_ACTIVITY",8,-0.9092,0.58,0.78,"No",0.5592,0.96,1,"Yes"
"13679","C2_Chemical_and_genetic_perturbations","C2_CGP_845_OXFORD_RALA_OR_RALB_TARGETS_DN",24,-0.9091,0.6,0.71,"No",-1.2213,0.17,0.78,"No"
"13680","GO_MF","487327_GO_0001104_RNA_POLYMERASE_II_TRANSCRIPTION_COFACTOR_ACTIVITY",82,-0.9089,0.66,0.78,"No",-0.8928,0.67,1,"No"
"13681","GO_BP","510769_GO_0048714_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION",11,-0.9089,0.58,0.76,"No",1.6562,0.024,0.24,"Yes"
"13682","C4_Cancer_modules","C4_CM_380_MODULE_471",9,-0.9087,0.56,0.72,"No",0.5233,0.98,1,"Yes"
"13683","GO_MF","490625_GO_0005523_TROPOMYOSIN_BINDING",13,-0.9084,0.59,0.78,"No",-0.9675,0.47,0.94,"No"
"13684","C4_Cancer_modules","C4_CM_408_MODULE_525",65,-0.9083,0.63,0.72,"No",0.8257,0.77,0.94,"Yes"
"13685","C4_Cancer_modules","C4_CM_143_MODULE_151",318,-0.9082,0.75,0.72,"No",3.2789,0,0,"Yes"
"13686","GO_BP","504489_GO_0035305_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION",71,-0.908,0.65,0.76,"No",0.7924,0.9,1,"Yes"
"13687","GO_BP","508788_GO_0046530_PHOTORECEPTOR_CELL_DIFFERENTIATION",50,-0.908,0.62,0.76,"No",-1.3391,0.091,0.91,"No"
"13688","GO_BP","499809_GO_0030431_SLEEP",13,-0.908,0.6,0.76,"No",-0.7532,0.8,1,"No"
"13689","C7_Immunologic_signatures","C7_ALL_325_GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP",186,-0.9079,0.71,0.77,"No",0.8744,0.8,1,"Yes"
"13690","C3_TF_targets","C3_TFT_391_V_E2F1DP1RB_01",229,-0.9078,0.69,0.76,"No",-0.9052,0.76,0.95,"No"
"13691","GO_BP","495290_GO_0014898_CARDIAC_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS",11,-0.9076,0.59,0.76,"No",-1.1575,0.28,0.92,"No"
"13692","GO_BP","503586_GO_0034384_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE",6,-0.9075,0.58,0.76,"No",-0.924,0.58,1,"No"
"13693","C4_Cancer_gene_neighborhoods","C4_CGN_129_MORF_MAP3K14",113,-0.9075,0.67,0.85,"No",0.9025,0.7,0.83,"Yes"
"13694","C3_TF_targets","C3_TFT_255_V_HMX1_01",43,-0.9073,0.61,0.76,"No",-1.0065,0.45,0.75,"No"
"13695","C2_Chemical_and_genetic_perturbations","C2_CGP_3149_STEGER_ADIPOGENESIS_DN",24,-0.9073,0.6,0.72,"No",1.2221,0.19,0.46,"Yes"
"13696","C3_MicroRNA_targets","C3_MIR_35_ACTACCT_MIR_196A_MIR_196B",145,-0.9072,0.69,0.77,"No",0.878,0.78,1,"Yes"
"13697","GO_MF","506562_GO_0043531_ADP_BINDING",30,-0.9071,0.61,0.78,"No",-0.7946,0.79,1,"No"
"13698","C4_Cancer_modules","C4_CM_122_MODULE_127",26,-0.9071,0.6,0.72,"No",0.8959,0.62,0.86,"Yes"
"13699","C2_Chemical_and_genetic_perturbations","C2_CGP_836_DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP",6,-0.9069,0.59,0.72,"No",-0.5976,0.93,1,"No"
"13700","GO_BP","499077_GO_0021797_FOREBRAIN_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION",5,-0.9069,0.61,0.76,"No",-0.8683,0.6,1,"No"
"13701","GO_BP","510560_GO_0048486_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT",19,-0.9068,0.57,0.76,"No",-0.654,0.92,1,"No"
"13702","REACTOME","106205_REACT_2071_PYRUVATE_METABOLISM",22,-0.9067,0.59,0.77,"No",1.2235,0.19,0.42,"Yes"
"13703","GO_BP","515802_GO_0070874_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS",9,-0.9067,0.6,0.76,"No",0.5793,0.95,1,"Yes"
"13704","GO_BP","505624_GO_0042491_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION",30,-0.9066,0.61,0.76,"No",-0.4853,1,1,"No"
"13705","C7_Immunologic_signatures","C7_ALL_1600_GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN",196,-0.9065,0.69,0.77,"No",1.6023,0,0.0029,"Yes"
"13706","C2_Chemical_and_genetic_perturbations","C2_CGP_2471_BOYLAN_MULTIPLE_MYELOMA_C_D_UP",138,-0.9064,0.67,0.72,"No",1.0112,0.43,0.78,"Yes"
"13707","GO_BP","512178_GO_0051293_ESTABLISHMENT_OF_SPINDLE_LOCALIZATION",28,-0.9063,0.61,0.76,"No",0.6455,0.96,1,"Yes"
"13708","C7_Immunologic_signatures","C7_ALL_378_GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN",193,-0.9063,0.67,0.77,"No",1.0184,0.39,0.69,"Yes"
"13709","C3_TF_targets","C3_TFT_513_RYTGCNWTGGNR_UNKNOWN",116,-0.9061,0.66,0.76,"No",-0.8604,0.8,1,"No"
"13710","C2_Chemical_and_genetic_perturbations","C2_CGP_2402_CONRAD_GERMLINE_STEM_CELL",11,-0.906,0.6,0.72,"No",0.9347,0.54,0.88,"Yes"
"13711","C7_Immunologic_signatures","C7_ALL_721_GSE17721_0_5H_VS_8H_POLYIC_BMDM_UP",194,-0.9059,0.69,0.77,"No",1.4476,0.0024,0.023,"Yes"
"13712","REACTOME","1127554_REACT_264071_HSF1_ACTIVATION",12,-0.9059,0.58,0.77,"No",1.5062,0.047,0.14,"Yes"
"13713","GO_BP","510400_GO_0048293_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES",7,-0.9056,0.6,0.76,"No",-1.1097,0.34,0.94,"No"
"13714","GO_BP","506614_GO_0043583_EAR_DEVELOPMENT",196,-0.9056,0.67,0.76,"No",1.0466,0.34,0.95,"Yes"
"13715","C2_Chemical_and_genetic_perturbations","C2_CGP_529_STREICHER_LSM1_TARGETS_DN",19,-0.9055,0.6,0.72,"No",-0.7836,0.75,1,"No"
"13716","C2_Chemical_and_genetic_perturbations","C2_CGP_925_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6",45,-0.9053,0.61,0.72,"No",-0.9729,0.5,1,"No"
"13717","GO_BP","517059_GO_0072143_MESANGIAL_CELL_DEVELOPMENT",5,-0.9053,0.59,0.76,"No",0.5829,0.94,1,"Yes"
"13718","GO_BP","490219_GO_0016055_WNT_SIGNALING_PATHWAY",237,-0.9049,0.72,0.76,"No",0.8102,0.96,1,"Yes"
"13719","C2_Chemical_and_genetic_perturbations","C2_CGP_3219_PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN",177,-0.9047,0.69,0.72,"No",0.9557,0.59,0.86,"Yes"
"13720","C7_Immunologic_signatures","C7_ALL_975_GSE22886_NAIVE_TCELL_VS_DC_UP",196,-0.9047,0.69,0.78,"No",2.6709,0,0,"Yes"
"13721","GO_BP","504818_GO_0035641_LOCOMOTORY_EXPLORATION_BEHAVIOR",9,-0.9046,0.59,0.76,"No",-1.3658,0.1,0.99,"No"
"13722","GO_BP","502367_GO_0033146_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",26,-0.9046,0.59,0.76,"No",1.0574,0.37,0.94,"Yes"
"13723","GO_BP","491862_GO_0007035_VACUOLAR_ACIDIFICATION",13,-0.9045,0.58,0.76,"No",-0.6796,0.87,1,"No"
"13724","C7_Immunologic_signatures","C7_ALL_99_GSE11924_TFH_VS_TH17_CD4_TCELL_UP",197,-0.9045,0.69,0.78,"No",-0.9593,0.56,1,"No"
"13725","C2_Chemical_and_genetic_perturbations","C2_CGP_1476_STONER_ESOPHAGEAL_CARCINOGENESIS_UP",39,-0.9043,0.61,0.72,"No",1.2308,0.16,0.46,"Yes"
"13726","GO_BP","517121_GO_0072205_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT",8,-0.9041,0.58,0.76,"No",-0.8896,0.58,1,"No"
"13727","GO_MF","750817_GO_0052744_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY",8,-0.904,0.58,0.79,"No",0.5509,0.96,1,"Yes"
"13728","C2_Chemical_and_genetic_perturbations","C2_CGP_1747_KAYO_AGING_MUSCLE_DN",120,-0.904,0.68,0.72,"No",1.9595,0,0.011,"Yes"
"13729","C7_Immunologic_signatures","C7_ALL_214_GSE13493_DP_VS_CD8POS_THYMOCYTE_DN",197,-0.9039,0.68,0.78,"No",1.1013,0.21,0.44,"Yes"
"13730","GO_MF","490340_GO_0005068_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY",9,-0.9037,0.6,0.79,"No",1.5412,0.053,0.34,"Yes"
"13731","GO_BP","505580_GO_0042440_PIGMENT_METABOLIC_PROCESS",64,-0.9035,0.64,0.77,"No",1.0126,0.43,0.97,"Yes"
"13732","GO_BP","518839_GO_2000192_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT",8,-0.9035,0.61,0.77,"No",0.9665,0.49,1,"Yes"
"13733","GO_BP","507478_GO_0045078_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS",12,-0.9032,0.59,0.77,"No",-0.5402,0.98,1,"No"
"13734","C3_TF_targets","C3_TFT_282_CTCNANGTGNY_UNKNOWN",84,-0.9031,0.63,0.77,"No",-1.0884,0.29,0.57,"No"
"13735","GO_BP","518428_GO_0090288_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS",102,-0.9031,0.66,0.77,"No",1.0839,0.27,0.92,"Yes"
"13736","GO_BP","501459_GO_0032224_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC",6,-0.903,0.58,0.77,"No",0.9368,0.52,1,"Yes"
"13737","GO_BP","512522_GO_0051646_MITOCHONDRION_LOCALIZATION",27,-0.903,0.6,0.77,"No",-0.9325,0.55,1,"No"
"13738","C7_Immunologic_signatures","C7_ALL_1301_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP",194,-0.903,0.7,0.78,"No",1.2753,0.048,0.12,"Yes"
"13739","C7_Immunologic_signatures","C7_ALL_361_GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP",189,-0.9029,0.69,0.78,"No",0.9098,0.71,1,"Yes"
"13740","C2_Chemical_and_genetic_perturbations","C2_CGP_597_RIZ_ERYTHROID_DIFFERENTIATION_12HR",42,-0.9024,0.63,0.72,"No",-0.6764,0.94,1,"No"
"13741","GO_BP","849930_GO_1902229_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",34,-0.9021,0.61,0.77,"No",0.9921,0.48,0.99,"Yes"
"13742","GO_BP","946568_GO_0098911_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",8,-0.9021,0.58,0.77,"No",0.8595,0.62,1,"Yes"
"13743","GO_BP","491858_GO_0007030_GOLGI_ORGANIZATION",76,-0.902,0.64,0.77,"No",-0.5956,1,1,"No"
"13744","GO_BP","517577_GO_0072674_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION",5,-0.9019,0.62,0.77,"No",0.9664,0.52,1,"Yes"
"13745","C3_TF_targets","C3_TFT_80_V_MAX_01",257,-0.9018,0.71,0.77,"No",1.0465,0.31,1,"Yes"
"13746","C2_Chemical_and_genetic_perturbations","C2_CGP_1726_KEEN_RESPONSE_TO_ROSIGLITAZONE_UP",37,-0.9015,0.61,0.73,"No",0.9486,0.55,0.87,"Yes"
"13747","C4_Cancer_gene_neighborhoods","C4_CGN_331_GNF2_CD48",32,-0.9015,0.63,0.87,"No",1.3026,0.12,0.12,"Yes"
"13748","KEGG_module","HSA_M00687_MAPK_ERK1_2_SIGNALING",8,-0.9015,0.61,0.75,"No",-0.7842,0.74,1,"No"
"13749","GO_BP","751213_GO_0036295_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS",9,-0.9014,0.56,0.77,"No",0.8854,0.62,1,"Yes"
"13750","C2_Chemical_and_genetic_perturbations","C2_CGP_343_MAYBURD_RESPONSE_TO_L663536_DN",55,-0.9013,0.64,0.73,"No",1.4474,0.023,0.26,"Yes"
"13751","C2_Chemical_and_genetic_perturbations","C2_CGP_1252_LANDEMAINE_LUNG_METASTASIS",21,-0.9013,0.61,0.73,"No",0.8246,0.72,0.98,"Yes"
"13752","GO_BP","505855_GO_0042749_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE",18,-0.9012,0.61,0.77,"No",-0.8455,0.67,1,"No"
"13753","C4_Cancer_modules","C4_CM_329_MODULE_389",210,-0.9012,0.7,0.73,"No",-1.0018,0.44,0.79,"No"
"13754","GO_BP","496174_GO_0016081_SYNAPTIC_VESICLE_DOCKING",8,-0.9011,0.6,0.77,"No",-0.745,0.81,1,"No"
"13755","GO_BP","514665_GO_0061117_NEGATIVE_REGULATION_OF_HEART_GROWTH",11,-0.9011,0.61,0.77,"No",0.9467,0.5,1,"Yes"
"13756","KEGG_pathway","HSA00260_GLYCINE_SERINE_AND_THREONINE_METABOLISM",38,-0.9008,0.62,0.69,"No",-0.99,0.48,0.89,"No"
"13757","KEGG_compound","C04805_5_S_HETE_5_HYDROXYEICOSATETRAENOATE_5_HETE_6E_8Z_11Z_14Z_5S_5_HYDROXYICOSA_6_8_11_14_TETRAENOIC_ACID",6,-0.9008,0.61,0.72,"No",0.5406,0.96,1,"Yes"
"13758","C7_Immunologic_signatures","C7_ALL_586_GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_DN",200,-0.9007,0.71,0.78,"No",1.6335,0,0.0016,"Yes"
"13759","GO_BP","754747_GO_1901796_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",48,-0.9007,0.62,0.77,"No",-0.8617,0.69,1,"No"
"13760","GO_CC","487646_GO_0001750_PHOTORECEPTOR_OUTER_SEGMENT",56,-0.9005,0.64,0.86,"No",-0.9295,0.58,0.92,"No"
"13761","KEGG_enzyme","2.7.4.6_NUCLEOSIDE_DIPHOSPHATE_KINASE_NUCLEOSIDE_5_DIPHOSPHATE_KINASE_NUCLEOSIDE_DIPHOSPHATE_UDP_KINASE_NUCLEOSIDE_DIPHOSPHOKINASE_NUCLEOTIDE_PHOSPHATE_KINASE_UDP_KINASE_URIDINE_DIPHOSPHATE_KINASE",8,-0.9005,0.6,0.64,"No",-0.6937,0.84,0.91,"No"
"13762","GO_MF","490623_GO_0005520_INSULIN_LIKE_GROWTH_FACTOR_BINDING",24,-0.9004,0.62,0.79,"No",0.7278,0.88,1,"Yes"
"13763","GO_CC","502396_GO_0033176_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX",22,-0.9003,0.62,0.85,"No",0.7628,0.81,0.98,"Yes"
"13764","GO_BP","508231_GO_0045924_REGULATION_OF_FEMALE_RECEPTIVITY",8,-0.9003,0.56,0.77,"No",0.679,0.87,1,"Yes"
"13765","GO_BP","752130_GO_0061387_REGULATION_OF_EXTENT_OF_CELL_GROWTH",71,-0.9003,0.67,0.77,"No",-0.9308,0.6,1,"No"
"13766","C3_TF_targets","C3_TFT_219_V_PAX3_01",21,-0.9002,0.61,0.77,"No",-1.3614,0.11,0.19,"No"
"13767","GO_CC","501296_GO_0032059_BLEB",7,-0.9,0.6,0.85,"No",0.5807,0.95,1,"Yes"
"13768","C2_Chemical_and_genetic_perturbations","C2_CGP_1598_GENTILE_UV_RESPONSE_CLUSTER_D9",28,-0.9,0.61,0.73,"No",1.2433,0.16,0.44,"Yes"
"13769","GO_MF","496927_GO_0017127_CHOLESTEROL_TRANSPORTER_ACTIVITY",18,-0.8999,0.59,0.79,"No",-1.139,0.28,0.81,"No"
"13770","C7_Immunologic_signatures","C7_ALL_953_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP",197,-0.8998,0.72,0.79,"No",1.0879,0.23,0.47,"Yes"
"13771","C2_Chemical_and_genetic_perturbations","C2_CGP_2295_WEBER_METHYLATED_HCP_IN_SPERM_UP",19,-0.8998,0.58,0.73,"No",-1.6586,0.019,0.37,"No"
"13772","GO_BP","514601_GO_0061053_SOMITE_DEVELOPMENT",73,-0.8997,0.66,0.77,"No",-0.9454,0.56,1,"No"
"13773","GO_BP","499258_GO_0021979_HYPOTHALAMUS_CELL_DIFFERENTIATION",8,-0.8997,0.59,0.77,"No",-1.0582,0.39,0.96,"No"
"13774","C2_Chemical_and_genetic_perturbations","C2_CGP_1990_BURTON_ADIPOGENESIS_PEAK_AT_16HR",40,-0.8995,0.63,0.73,"No",1.2895,0.1,0.4,"Yes"
"13775","C2_Chemical_and_genetic_perturbations","C2_CGP_1613_BROWNE_HCMV_INFECTION_16HR_UP",224,-0.8995,0.71,0.73,"No",0.9199,0.73,0.9,"Yes"
"13776","C4_Cancer_modules","C4_CM_246_MODULE_278",34,-0.8995,0.62,0.73,"No",-0.6169,0.96,1,"No"
"13777","GO_BP","507103_GO_0044088_REGULATION_OF_VACUOLE_ORGANIZATION",18,-0.8994,0.6,0.77,"No",0.8483,0.67,1,"Yes"
"13778","C1_Positional","C1_ALL_285_CHR3P23",13,-0.8992,0.59,0.97,"No",-0.9886,0.48,1,"No"
"13779","C1_Positional","C1_ALL_101_CHR2Q13",32,-0.8988,0.62,0.97,"No",0.7536,0.87,0.98,"Yes"
"13780","C3_TF_targets","C3_TFT_314_V_E2F_03",245,-0.8988,0.72,0.77,"No",0.9548,0.57,1,"Yes"
"13781","GO_MF","490040_GO_0004726_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY",7,-0.8986,0.6,0.79,"No",1.0476,0.41,0.83,"Yes"
"13782","REACTOME","160134_REACT_21281_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX",26,-0.8986,0.61,0.78,"No",0.7017,0.9,1,"Yes"
"13783","C7_Immunologic_signatures","C7_ALL_261_GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP",200,-0.8986,0.72,0.79,"No",1.2136,0.089,0.2,"Yes"
"13784","C7_Immunologic_signatures","C7_ALL_794_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN",198,-0.8985,0.7,0.79,"No",0.8245,0.91,1,"Yes"
"13785","GO_CC","752729_GO_0097228_SPERM_PRINCIPAL_PIECE",16,-0.8984,0.58,0.85,"No",-1.6408,0.02,0.33,"No"
"13786","GO_BP","754041_GO_1901072_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",8,-0.8983,0.61,0.77,"No",1.591,0.032,0.3,"Yes"
"13787","GO_BP","511846_GO_0050910_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND",14,-0.8983,0.61,0.77,"No",0.6638,0.91,1,"Yes"
"13788","C1_Positional","C1_ALL_36_CHR2Q36",40,-0.8983,0.65,0.96,"No",-1.1937,0.2,1,"No"
"13789","KEGG_compound","C20878_VERY_LONG_CHAIN_3R_3_HYDROXYACYL_COA",5,-0.8982,0.61,0.73,"No",1.0263,0.45,1,"Yes"
"13790","GO_MF","495389_GO_0015114_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-0.8982,0.62,0.79,"No",-0.9281,0.55,0.97,"No"
"13791","REACTOME","730310_REACT_150366_ELASTIC_FIBRE_FORMATION",41,-0.8979,0.64,0.78,"No",-0.9249,0.61,1,"No"
"13792","GO_MF","503396_GO_0034190_APOLIPOPROTEIN_RECEPTOR_BINDING",6,-0.8977,0.58,0.79,"No",0.756,0.77,1,"Yes"
"13793","GO_BP","508234_GO_0045927_POSITIVE_REGULATION_OF_GROWTH",191,-0.8976,0.69,0.77,"No",0.8449,0.92,1,"Yes"
"13794","GO_BP","491276_GO_0006323_DNA_PACKAGING",177,-0.8976,0.7,0.77,"No",-1.1418,0.18,0.93,"No"
"13795","GO_BP","515999_GO_0071073_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS",7,-0.8976,0.59,0.77,"No",0.6062,0.93,1,"Yes"
"13796","C2_Chemical_and_genetic_perturbations","C2_CGP_2118_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS",12,-0.8976,0.61,0.73,"No",1.1351,0.28,0.57,"Yes"
"13797","GO_BP","502815_GO_0033599_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",16,-0.8975,0.6,0.77,"No",-0.8874,0.62,1,"No"
"13798","GO_CC","490678_GO_0005606_LAMININ_1_COMPLEX",7,-0.8971,0.6,0.86,"No",1.1363,0.31,0.6,"Yes"
"13799","C7_Immunologic_signatures","C7_ALL_362_GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN",190,-0.8971,0.7,0.79,"No",-0.7535,0.98,1,"No"
"13800","GO_MF","499567_GO_0030145_MANGANESE_ION_BINDING",48,-0.8969,0.64,0.79,"No",0.8762,0.7,1,"Yes"
"13801","GO_BP","508877_GO_0046629_GAMMA_DELTA_T_CELL_ACTIVATION",5,-0.8966,0.63,0.77,"No",-1.496,0.053,0.81,"No"
"13802","C2_Chemical_and_genetic_perturbations","C2_CGP_934_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP",38,-0.8965,0.64,0.73,"No",1.1668,0.21,0.53,"Yes"
"13803","C2_Chemical_and_genetic_perturbations","C2_CGP_3347_HOLLEMAN_DAUNORUBICIN_B_ALL_UP",10,-0.8965,0.59,0.73,"No",-1.3352,0.15,0.69,"No"
"13804","GO_BP","504466_GO_0035282_SEGMENTATION",96,-0.8964,0.67,0.78,"No",0.8119,0.85,1,"Yes"
"13805","C7_Immunologic_signatures","C7_ALL_1156_GSE27786_LSK_VS_ERYTHROBLAST_DN",193,-0.8963,0.7,0.79,"No",1.1603,0.12,0.3,"Yes"
"13806","REACTOME","771591_REACT_160089_CONSTITUTIVE_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS",15,-0.8962,0.64,0.79,"No",0.9028,0.61,0.9,"Yes"
"13807","C4_Cancer_modules","C4_CM_416_MODULE_540",10,-0.896,0.6,0.73,"No",1.1922,0.25,0.4,"Yes"
"13808","GO_MF","490166_GO_0004865_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY",6,-0.896,0.61,0.8,"No",0.9614,0.5,0.91,"Yes"
"13809","GO_BP","492059_GO_0007281_GERM_CELL_DEVELOPMENT",185,-0.8954,0.71,0.78,"No",-1.0791,0.3,0.95,"No"
"13810","C2_Chemical_and_genetic_perturbations","C2_CGP_1770_GENTILE_UV_RESPONSE_CLUSTER_D5",39,-0.8954,0.63,0.73,"No",-0.7213,0.9,1,"No"
"13811","GO_BP","504621_GO_0035437_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM",10,-0.8952,0.59,0.78,"No",0.7704,0.77,1,"Yes"
"13812","OMIM_gene","OMIM176801_PROSAPOSIN_PSAP_SAPOSIN_A_INCLUDED_SAPA_INCLUDED",5,-0.8951,0.62,0.81,"No",-1.0245,0.46,0.74,"No"
"13813","GO_BP","511802_GO_0050859_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY",5,-0.8951,0.62,0.78,"No",-0.8323,0.68,1,"No"
"13814","GO_BP","501740_GO_0032509_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY",6,-0.895,0.6,0.78,"No",1.1824,0.26,0.8,"Yes"
"13815","C2_Chemical_and_genetic_perturbations","C2_CGP_2418_MALONEY_RESPONSE_TO_17AAG_DN",78,-0.8949,0.66,0.74,"No",2.2634,0,0.00025,"Yes"
"13816","C7_Immunologic_signatures","C7_ALL_327_GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP",194,-0.8948,0.71,0.8,"No",1.2025,0.07,0.22,"Yes"
"13817","REACTOME","106349_REACT_9390_FGFR2_LIGAND_BINDING_AND_ACTIVATION",14,-0.8948,0.62,0.79,"No",-1.0805,0.35,0.91,"No"
"13818","C7_Immunologic_signatures","C7_ALL_289_GSE14350_IL2RB_KO_VS_WT_TREG_UP",198,-0.8947,0.74,0.79,"No",0.9351,0.69,0.94,"Yes"
"13819","C2_Chemical_and_genetic_perturbations","C2_CGP_1771_BRACHAT_RESPONSE_TO_METHOTREXATE_UP",26,-0.8947,0.62,0.74,"No",0.704,0.9,1,"Yes"
"13820","C7_Immunologic_signatures","C7_ALL_554_GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDM_DN",196,-0.8947,0.7,0.79,"No",1.5978,0,0.0031,"Yes"
"13821","KEGG_compound","C16162__9Z_12Z_15Z_OCTADECATRIENOYL_COA_ALPHA_LINOLENOYL_COA",5,-0.8947,0.58,0.73,"No",-0.631,0.91,1,"No"
"13822","GO_BP","514531_GO_0060976_CORONARY_VASCULATURE_DEVELOPMENT",15,-0.8945,0.61,0.78,"No",0.638,0.94,1,"Yes"
"13823","GO_BP","499867_GO_0030540_FEMALE_GENITALIA_DEVELOPMENT",16,-0.8944,0.63,0.78,"No",-0.902,0.6,1,"No"
"13824","GO_CC","501208_GO_0031968_ORGANELLE_OUTER_MEMBRANE",166,-0.8944,0.71,0.86,"No",1.448,0,0.25,"Yes"
"13825","KEGG_compound","C00234_10_FORMYLTETRAHYDROFOLATE_10_FORMYL_THF",9,-0.8943,0.59,0.73,"No",0.5594,0.97,1,"Yes"
"13826","C2_Chemical_and_genetic_perturbations","C2_CGP_3311_PHONG_TNF_TARGETS_DN",8,-0.8942,0.62,0.74,"No",-0.645,0.89,1,"No"
"13827","GO_MF","505909_GO_0042806_FUCOSE_BINDING",6,-0.8941,0.6,0.8,"No",0.7757,0.74,1,"Yes"
"13828","C2_Chemical_and_genetic_perturbations","C2_CGP_3267_IM_SREBF1A_TARGETS",5,-0.8938,0.61,0.74,"No",-1.1296,0.33,0.88,"No"
"13829","GO_BP","753174_GO_1900181_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS",61,-0.8938,0.64,0.78,"No",-0.7971,0.85,1,"No"
"13830","GO_BP","495999_GO_0051181_COFACTOR_TRANSPORT",24,-0.8937,0.63,0.78,"No",-1.1727,0.23,0.91,"No"
"13831","GO_CC","501144_GO_0031903_MICROBODY_MEMBRANE",55,-0.8937,0.65,0.86,"No",0.9628,0.52,0.82,"Yes"
"13832","C7_Immunologic_signatures","C7_ALL_1296_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN",195,-0.8932,0.72,0.8,"No",0.7871,0.98,1,"Yes"
"13833","GO_BP","510381_GO_0048268_CLATHRIN_COAT_ASSEMBLY",13,-0.8931,0.59,0.78,"No",1.2738,0.18,0.71,"Yes"
"13834","C2_Chemical_and_genetic_perturbations","C2_CGP_517_HUMMERICH_BENIGN_SKIN_TUMOR_DN",18,-0.8931,0.61,0.74,"No",-1.1812,0.24,0.82,"No"
"13835","GO_BP","508428_GO_0046132_PYRIMIDINE_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS",23,-0.8929,0.62,0.78,"No",-0.5872,0.96,1,"No"
"13836","GO_CC","487084_GO_0000791_EUCHROMATIN",29,-0.8929,0.61,0.86,"No",-0.8111,0.77,1,"No"
"13837","C2_BioCarta_Pathways","C2_CP_BIOCARTA_215_BIOCARTA_VITCB_PATHWAY",11,-0.8927,0.62,0.71,"No",-1.1568,0.27,1,"No"
"13838","C7_Immunologic_signatures","C7_ALL_351_GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP",198,-0.8926,0.72,0.8,"No",-1.1473,0.17,1,"No"
"13839","GO_BP","502103_GO_0032881_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS",43,-0.8925,0.65,0.78,"No",-0.5493,1,1,"No"
"13840","REACTOME","1127632_REACT_264378_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION",8,-0.8924,0.62,0.79,"No",-0.9832,0.47,1,"No"
"13841","C7_Immunologic_signatures","C7_ALL_288_GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN",191,-0.8921,0.72,0.8,"No",-0.8182,0.93,1,"No"
"13842","REACTOME","106231_REACT_1069_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION",36,-0.8921,0.62,0.79,"No",0.7332,0.89,1,"Yes"
"13843","GO_BP","504747_GO_0035567_NON_CANONICAL_WNT_SIGNALING_PATHWAY",35,-0.8921,0.64,0.78,"No",-0.9351,0.55,1,"No"
"13844","GO_BP","510799_GO_0048745_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT",20,-0.892,0.64,0.78,"No",-1.2618,0.16,0.91,"No"
"13845","C2_Chemical_and_genetic_perturbations","C2_CGP_3214_TERAO_AOX4_TARGETS_HG_UP",28,-0.892,0.62,0.74,"No",0.6461,0.95,1,"Yes"
"13846","C2_Chemical_and_genetic_perturbations","C2_CGP_402_CASTELLANO_NRAS_TARGETS_DN",14,-0.8919,0.6,0.74,"No",0.5792,0.97,1,"Yes"
"13847","C7_Immunologic_signatures","C7_ALL_187_GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP",199,-0.8919,0.72,0.8,"No",1.6881,0,0.00079,"Yes"
"13848","C2_Chemical_and_genetic_perturbations","C2_CGP_2501_SEKI_INFLAMMATORY_RESPONSE_LPS_DN",22,-0.8917,0.64,0.74,"No",-1.1119,0.3,0.9,"No"
"13849","C7_Immunologic_signatures","C7_ALL_833_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP",164,-0.8915,0.71,0.8,"No",1.3782,0.0084,0.046,"Yes"
"13850","GO_BP","496100_GO_0015980_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS",308,-0.8914,0.76,0.78,"No",1.7657,0,0.13,"Yes"
"13851","GO_BP","514935_GO_0065004_PROTEIN_DNA_COMPLEX_ASSEMBLY",153,-0.8913,0.71,0.78,"No",-1.0653,0.29,0.96,"No"
"13852","GO_MF","487325_GO_0001102_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING",36,-0.8913,0.64,0.8,"No",-1.1536,0.24,0.81,"No"
"13853","GO_BP","498211_GO_0019368_FATTY_ACID_ELONGATION_UNSATURATED_FATTY_ACID",5,-0.8913,0.6,0.78,"No",-0.9662,0.52,1,"No"
"13854","C2_Chemical_and_genetic_perturbations","C2_CGP_1130_PETRETTO_HEART_MASS_QTL_CIS_DN",24,-0.8912,0.62,0.74,"No",1.1798,0.22,0.52,"Yes"
"13855","KEGG_compound","C16217_3_HYDROXYOCTADECANOYL_COA_3_HYDROXYSTEAROYL_COA_BETA_HYDROXYSTEAROYL_COA",5,-0.8911,0.64,0.73,"No",1.0435,0.42,1,"Yes"
"13856","GO_BP","492348_GO_0050909_SENSORY_PERCEPTION_OF_TASTE",60,-0.891,0.65,0.78,"No",-0.8781,0.7,1,"No"
"13857","GO_MF","490472_GO_0005231_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",49,-0.891,0.65,0.8,"No",-1.3688,0.063,0.69,"No"
"13858","WikiPathways","198887_WP299_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY",33,-0.891,0.63,0.74,"No",-0.9353,0.55,1,"No"
"13859","GO_BP","491939_GO_0007126_MEIOTIC_NUCLEAR_DIVISION",121,-0.8909,0.7,0.78,"No",-0.9933,0.48,1,"No"
"13860","C3_MicroRNA_targets","C3_MIR_62_GTGCCAT_MIR_183",170,-0.8907,0.73,0.8,"No",1.591,0,0.54,"Yes"
"13861","GO_BP","492898_GO_0008652_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS",91,-0.8907,0.68,0.78,"No",-0.7461,0.95,1,"No"
"13862","GO_BP","508726_GO_0046465_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS",5,-0.8906,0.6,0.78,"No",-1.3478,0.15,0.92,"No"
"13863","C2_Chemical_and_genetic_perturbations","C2_CGP_2020_MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP",393,-0.8904,0.76,0.74,"No",1.078,0.22,0.67,"Yes"
"13864","GO_MF","511721_GO_0050750_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING",15,-0.8904,0.61,0.8,"No",-1.3246,0.13,0.73,"No"
"13865","GO_BP","514091_GO_0060536_CARTILAGE_MORPHOGENESIS",12,-0.8901,0.61,0.78,"No",-0.9766,0.49,1,"No"
"13866","KEGG_pathway","HSA04130_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT",34,-0.89,0.63,0.71,"No",1.1941,0.18,0.55,"Yes"
"13867","GO_BP","514724_GO_0061179_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",6,-0.8898,0.61,0.78,"No",0.5313,0.99,1,"Yes"
"13868","C2_Chemical_and_genetic_perturbations","C2_CGP_159_GAL_LEUKEMIC_STEM_CELL_UP",130,-0.8898,0.7,0.74,"No",0.9857,0.49,0.81,"Yes"
"13869","GO_MF","496756_GO_0016864_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_S_S_BONDS",22,-0.8898,0.6,0.8,"No",-0.7463,0.86,1,"No"
"13870","C3_MicroRNA_targets","C3_MIR_172_CGCAAAA_MIR_450",9,-0.8898,0.61,0.8,"No",-1.0626,0.38,1,"No"
"13871","GO_BP","491752_GO_0006892_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT",102,-0.8897,0.7,0.78,"No",1.041,0.36,0.96,"Yes"
"13872","GO_MF","502908_GO_0033691_SIALIC_ACID_BINDING",9,-0.8896,0.62,0.8,"No",-0.6706,0.88,1,"No"
"13873","WikiPathways","198798_WP1423_GANGLIO_SPHINGOLIPID_METABOLISM",11,-0.8896,0.6,0.74,"No",1.0507,0.39,1,"Yes"
"13874","GO_CC","490724_GO_0005667_TRANSCRIPTION_FACTOR_COMPLEX",285,-0.8895,0.75,0.86,"No",0.7449,1,0.98,"Yes"
"13875","C7_Immunologic_signatures","C7_ALL_1147_GSE27786_LSK_VS_CD4_TCELL_UP",198,-0.8895,0.74,0.8,"No",1.0332,0.31,0.64,"Yes"
"13876","REACTOME","106350_REACT_9416_FGFR2B_LIGAND_BINDING_AND_ACTIVATION",6,-0.8894,0.61,0.8,"No",0.6931,0.84,1,"Yes"
"13877","REACTOME","106450_REACT_13696_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL",13,-0.8893,0.62,0.8,"No",1.0608,0.39,0.65,"Yes"
"13878","C2_Chemical_and_genetic_perturbations","C2_CGP_1945_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP",22,-0.8893,0.64,0.74,"No",1.195,0.19,0.49,"Yes"
"13879","C2_Chemical_and_genetic_perturbations","C2_CGP_1075_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN",32,-0.8892,0.63,0.74,"No",-0.8106,0.8,1,"No"
"13880","GO_MF","515035_GO_0070097_DELTA_CATENIN_BINDING",7,-0.8892,0.61,0.8,"No",-1.704,0.0039,0.31,"No"
"13881","GO_BP","921147_GO_1902548_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS",5,-0.8892,0.64,0.79,"No",-0.695,0.86,1,"No"
"13882","GO_BP","516242_GO_0071318_CELLULAR_RESPONSE_TO_ATP",10,-0.8891,0.61,0.79,"No",0.8892,0.59,1,"Yes"
"13883","GO_BP","982377_GO_1902807_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION",103,-0.8889,0.69,0.79,"No",1.4803,0.009,0.44,"Yes"
"13884","REACTOME","106138_REACT_17017_BETA_OXIDATION_OF_PRISTANOYL_COA",8,-0.8888,0.61,0.8,"No",1.1786,0.26,0.47,"Yes"
"13885","GO_BP","808770_GO_1902099_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",49,-0.8888,0.64,0.79,"No",0.8475,0.76,1,"Yes"
"13886","REACTOME","105927_REACT_9411_GAP_JUNCTION_TRAFFICKING",27,-0.8887,0.62,0.79,"No",-1.0056,0.42,0.98,"No"
"13887","C7_Immunologic_signatures","C7_ALL_1721_GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP",198,-0.8886,0.73,0.81,"No",1.2254,0.064,0.19,"Yes"
"13888","C7_Immunologic_signatures","C7_ALL_615_GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_UP",200,-0.8886,0.71,0.81,"No",0.9278,0.67,0.96,"Yes"
"13889","GO_BP","504279_GO_0035094_RESPONSE_TO_NICOTINE",38,-0.8885,0.64,0.79,"No",-1.1047,0.3,0.94,"No"
"13890","C2_Chemical_and_genetic_perturbations","C2_CGP_837_DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN",29,-0.8885,0.6,0.74,"No",-1.2154,0.2,0.8,"No"
"13891","C7_Immunologic_signatures","C7_ALL_246_GSE14308_TH2_VS_TH17_DN",199,-0.8885,0.74,0.8,"No",-0.8162,0.92,1,"No"
"13892","REACTOME","106053_REACT_278_PLATELET_AGGREGATION_PLUG_FORMATION_",37,-0.8883,0.64,0.79,"No",1.1972,0.19,0.45,"Yes"
"13893","GO_BP","486798_GO_0000280_NUCLEAR_DIVISION",439,-0.8882,0.79,0.79,"No",1.1592,0.071,0.83,"Yes"
"13894","C2_Chemical_and_genetic_perturbations","C2_CGP_420_NADERI_BREAST_CANCER_PROGNOSIS_DN",18,-0.8882,0.61,0.75,"No",1.3038,0.12,0.39,"Yes"
"13895","GO_MF","489287_GO_0042393_HISTONE_BINDING",163,-0.8881,0.73,0.8,"No",-1.2157,0.087,0.82,"No"
"13896","C2_Chemical_and_genetic_perturbations","C2_CGP_1923_DAZARD_UV_RESPONSE_CLUSTER_G6",152,-0.888,0.72,0.75,"No",0.9531,0.59,0.86,"Yes"
"13897","C7_Immunologic_signatures","C7_ALL_286_GSE14350_TREG_VS_TEFF_DN",187,-0.8879,0.72,0.81,"No",-0.8949,0.73,1,"No"
"13898","GO_BP","491176_GO_0006206_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS",33,-0.8876,0.64,0.79,"No",0.9575,0.54,1,"Yes"
"13899","C1_Positional","C1_ALL_171_CHR13Q14",84,-0.8875,0.67,0.98,"No",-0.914,0.63,1,"No"
"13900","C7_Immunologic_signatures","C7_ALL_1428_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN",196,-0.8873,0.75,0.81,"No",1.0296,0.39,0.65,"Yes"
"13901","GO_BP","516478_GO_0071554_CELL_WALL_ORGANIZATION_OR_BIOGENESIS",9,-0.8872,0.61,0.79,"No",-1.1997,0.24,0.9,"No"
"13902","GO_BP","516219_GO_0071295_CELLULAR_RESPONSE_TO_VITAMIN",42,-0.8872,0.65,0.79,"No",0.7576,0.88,1,"Yes"
"13903","GO_BP","517489_GO_0072584_CAVEOLIN_MEDIATED_ENDOCYTOSIS",5,-0.8872,0.6,0.79,"No",-0.4736,0.99,1,"No"
"13904","GO_BP","518426_GO_0090286_CYTOSKELETAL_ANCHORING_AT_NUCLEAR_MEMBRANE",7,-0.8872,0.62,0.79,"No",-1.097,0.35,0.95,"No"
"13905","GO_CC","499550_GO_0030117_MEMBRANE_COAT",87,-0.8871,0.69,0.87,"No",1.2785,0.072,0.43,"Yes"
"13906","C1_Positional","C1_ALL_306_CHR17Q11",108,-0.887,0.7,0.98,"No",0.9166,0.66,0.84,"Yes"
"13907","C0_Hallmark","H_ALL_41_HALLMARK_HEME_METABOLISM",198,-0.8869,0.73,0.73,"No",1.8367,0,0.0014,"Yes"
"13908","GO_MF","516869_GO_0071949_FAD_BINDING",10,-0.8869,0.61,0.81,"No",0.7531,0.79,1,"Yes"
"13909","GO_MF","492781_GO_0016595_GLUTAMATE_BINDING",9,-0.8868,0.63,0.81,"No",1.2451,0.21,0.69,"Yes"
"13910","C3_MicroRNA_targets","C3_MIR_184_GGGATGC_MIR_324_5P",48,-0.8865,0.65,0.8,"No",-0.9839,0.48,1,"No"
"13911","C2_Chemical_and_genetic_perturbations","C2_CGP_2763_MEISSNER_BRAIN_HCP_WITH_H3K4ME2",17,-0.8865,0.62,0.75,"No",-1.0559,0.4,0.96,"No"
"13912","C7_Immunologic_signatures","C7_ALL_1904_GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN",200,-0.8865,0.75,0.81,"No",1.3107,0.033,0.092,"Yes"
"13913","REACTOME","530771_REACT_18273_XBP1_S_ACTIVATES_CHAPERONE_GENES",57,-0.8865,0.66,0.8,"No",0.8248,0.78,0.98,"Yes"
"13914","GO_BP","751350_GO_0038092_NODAL_SIGNALING_PATHWAY",9,-0.8864,0.62,0.79,"No",-1.43,0.086,0.92,"No"
"13915","GO_BP","993420_GO_1903078_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",28,-0.8863,0.63,0.79,"No",-0.6924,0.92,1,"No"
"13916","GO_BP","506118_GO_0043029_T_CELL_HOMEOSTASIS",33,-0.886,0.64,0.79,"No",1.0516,0.35,0.95,"Yes"
"13917","GO_BP","504971_GO_0035794_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY",15,-0.8859,0.61,0.79,"No",0.8928,0.62,1,"Yes"
"13918","GO_MF","490165_GO_0004864_PROTEIN_PHOSPHATASE_INHIBITOR_ACTIVITY",33,-0.8858,0.63,0.81,"No",-1.0305,0.41,0.88,"No"
"13919","C2_Chemical_and_genetic_perturbations","C2_CGP_876_INAMURA_LUNG_CANCER_SCC_UP",13,-0.8857,0.62,0.75,"No",-0.6051,0.95,1,"No"
"13920","GO_BP","508194_GO_0045880_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY",26,-0.8857,0.61,0.79,"No",0.8196,0.74,1,"Yes"
"13921","GO_BP","491154_GO_0006182_CGMP_BIOSYNTHETIC_PROCESS",15,-0.8854,0.64,0.79,"No",-0.9788,0.5,1,"No"
"13922","REACTOME","1127527_REACT_264224_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING",143,-0.8853,0.71,0.8,"No",1.1905,0.11,0.45,"Yes"
"13923","C3_MicroRNA_targets","C3_MIR_33_TGCACGA_MIR_517A_MIR_517C",17,-0.8853,0.63,0.8,"No",-0.9893,0.46,1,"No"
"13924","KEGG_module","HSA_M00034_METHIONINE_SALVAGE_PATHWAY",11,-0.8853,0.6,0.77,"No",0.715,0.82,0.94,"Yes"
"13925","GO_BP","518937_GO_2000291_REGULATION_OF_MYOBLAST_PROLIFERATION",8,-0.8853,0.62,0.79,"No",-0.7288,0.81,1,"No"
"13926","GO_CC","503601_GO_0034399_NUCLEAR_PERIPHERY",111,-0.8852,0.7,0.87,"No",-0.7358,0.96,1,"No"
"13927","C2_Chemical_and_genetic_perturbations","C2_CGP_478_TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN",29,-0.885,0.62,0.75,"No",1.4389,0.064,0.26,"Yes"
"13928","GO_BP","751078_GO_0036158_OUTER_DYNEIN_ARM_ASSEMBLY",8,-0.885,0.64,0.79,"No",-1.374,0.12,0.99,"No"
"13929","C2_Chemical_and_genetic_perturbations","C2_CGP_3261_PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP",13,-0.8848,0.62,0.75,"No",0.6534,0.91,1,"Yes"
"13930","GO_BP","751347_GO_0038089_POSITIVE_REGULATION_OF_CELL_MIGRATION_BY_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY",5,-0.8848,0.63,0.79,"No",-1.1099,0.36,0.94,"No"
"13931","GO_BP","489133_GO_0003341_CILIUM_MOVEMENT",31,-0.8847,0.62,0.79,"No",-1.6809,0.0075,0.59,"No"
"13932","GO_CC","501814_GO_0032588_TRANS_GOLGI_NETWORK_MEMBRANE",41,-0.8846,0.65,0.87,"No",0.7014,0.94,0.99,"Yes"
"13933","C7_Immunologic_signatures","C7_ALL_1354_GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN",199,-0.8845,0.75,0.81,"No",0.7025,1,1,"Yes"
"13934","C7_Immunologic_signatures","C7_ALL_621_GSE17721_POLYIC_VS_CPG_2H_BMDM_UP",199,-0.8845,0.73,0.81,"No",1.2891,0.016,0.11,"Yes"
"13935","REACTOME","530769_REACT_115852_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS",19,-0.8845,0.64,0.8,"No",1.3459,0.11,0.27,"Yes"
"13936","KEGG_pathway","HSA00750_VITAMIN_B6_METABOLISM",6,-0.8844,0.64,0.72,"No",0.9662,0.51,0.96,"Yes"
"13937","GO_MF","515645_GO_0070717_POLY_PURINE_TRACT_BINDING",16,-0.8844,0.62,0.81,"No",0.6947,0.89,1,"Yes"
"13938","C7_Immunologic_signatures","C7_ALL_643_GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_UP",200,-0.8842,0.73,0.81,"No",1.0714,0.27,0.52,"Yes"
"13939","GO_BP","502016_GO_0032793_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY",14,-0.8842,0.61,0.79,"No",-1.1776,0.25,0.9,"No"
"13940","GO_MF","496687_GO_0016778_DIPHOSPHOTRANSFERASE_ACTIVITY",6,-0.8842,0.6,0.81,"No",0.8108,0.69,1,"Yes"
"13941","C7_Immunologic_signatures","C7_ALL_1858_GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN",199,-0.8842,0.75,0.81,"No",1.1272,0.15,0.37,"Yes"
"13942","GO_CC","499689_GO_0030285_INTEGRAL_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE",7,-0.884,0.61,0.87,"No",-1.5179,0.05,0.63,"No"
"13943","GO_BP","491307_GO_0006379_MRNA_CLEAVAGE",19,-0.8839,0.63,0.79,"No",-0.972,0.47,1,"No"
"13944","GO_MF","511931_GO_0050998_NITRIC_OXIDE_SYNTHASE_BINDING",16,-0.8838,0.64,0.81,"No",0.8928,0.59,0.99,"Yes"
"13945","GO_BP","752687_GO_0097186_AMELOGENESIS",15,-0.8838,0.62,0.79,"No",-1.2437,0.2,0.91,"No"
"13946","GO_MF","496902_GO_0017091_AU_RICH_ELEMENT_BINDING",18,-0.8836,0.63,0.81,"No",0.7878,0.77,1,"Yes"
"13947","GO_MF","495594_GO_0015370_SOLUTE_SODIUM_SYMPORTER_ACTIVITY",51,-0.8831,0.65,0.81,"No",-1.647,0.0056,0.4,"No"
"13948","GO_CC","490839_GO_0005813_CENTROSOME",450,-0.8831,0.82,0.87,"No",0.6952,1,0.99,"Yes"
"13949","C2_Chemical_and_genetic_perturbations","C2_CGP_315_ELVIDGE_HIF1A_TARGETS_UP",67,-0.883,0.68,0.75,"No",1.1015,0.27,0.63,"Yes"
"13950","KEGG_module","HSA_M00058_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE_BACKBONE",6,-0.883,0.61,0.76,"No",0.7732,0.74,0.92,"Yes"
"13951","GO_BP","495030_GO_0010965_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION",45,-0.8829,0.65,0.79,"No",0.9416,0.56,1,"Yes"
"13952","GO_MF","911269_GO_0036442_HYDROGEN_EXPORTING_ATPASE_ACTIVITY",26,-0.8828,0.63,0.81,"No",1.5673,0.019,0.32,"Yes"
"13953","GO_BP","492557_GO_0008216_SPERMIDINE_METABOLIC_PROCESS",7,-0.8827,0.61,0.79,"No",-1.1428,0.28,0.93,"No"
"13954","GO_BP","512475_GO_0051597_RESPONSE_TO_METHYLMERCURY",8,-0.8826,0.63,0.79,"No",1.4587,0.084,0.48,"Yes"
"13955","C7_Immunologic_signatures","C7_ALL_1253_GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP",185,-0.8826,0.75,0.81,"No",1.596,0,0.0032,"Yes"
"13956","GO_BP","509059_GO_0046836_GLYCOLIPID_TRANSPORT",7,-0.8824,0.58,0.79,"No",0.6594,0.89,1,"Yes"
"13957","C4_Cancer_modules","C4_CM_180_MODULE_192",109,-0.8823,0.72,0.76,"No",1.2641,0.072,0.31,"Yes"
"13958","GO_MF","501233_GO_0031995_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING",7,-0.8823,0.62,0.81,"No",0.8395,0.68,1,"Yes"
"13959","C2_Chemical_and_genetic_perturbations","C2_CGP_2112_KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION",87,-0.8822,0.67,0.75,"No",-0.746,0.94,1,"No"
"13960","GO_BP","510695_GO_0048639_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH",117,-0.8822,0.69,0.79,"No",-0.6814,1,1,"No"
"13961","REACTOME","187198_REACT_23876_PLATELET_HOMEOSTASIS",77,-0.8822,0.68,0.8,"No",-0.8487,0.76,1,"No"
"13962","GO_BP","516827_GO_0071907_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY",7,-0.8821,0.62,0.79,"No",-1.4293,0.098,0.92,"No"
"13963","C4_Cancer_gene_neighborhoods","C4_CGN_142_MORF_PDPK1",74,-0.8821,0.68,0.91,"No",0.5545,1,1,"Yes"
"13964","C3_MicroRNA_targets","C3_MIR_69_CTACTGT_MIR_199A",182,-0.882,0.73,0.8,"No",-0.8729,0.8,1,"No"
"13965","GO_BP","499177_GO_0021898_COMMITMENT_OF_MULTIPOTENT_STEM_CELLS_TO_NEURONAL_LINEAGE_IN_FOREBRAIN",5,-0.8818,0.64,0.8,"No",-0.862,0.6,1,"No"
"13966","GO_BP","1026080_GO_1903308_REGULATION_OF_CHROMATIN_MODIFICATION",121,-0.8817,0.73,0.8,"No",-0.7184,0.98,1,"No"
"13967","REACTOME","1127669_REACT_268530_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS",100,-0.8813,0.71,0.8,"No",-1.1216,0.23,0.88,"No"
"13968","GO_BP","502187_GO_0032965_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS",28,-0.8813,0.64,0.8,"No",1.0172,0.42,0.97,"Yes"
"13969","GO_BP","508429_GO_0046133_PYRIMIDINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS",10,-0.8812,0.62,0.8,"No",0.8414,0.66,1,"Yes"
"13970","C1_Positional","C1_ALL_58_CHR5Q21",26,-0.8812,0.66,0.99,"No",-0.5267,1,1,"No"
"13971","C4_Cancer_gene_neighborhoods","C4_CGN_292_GNF2_CCNA1",66,-0.8811,0.7,0.91,"No",-1.2656,0.1,0.53,"No"
"13972","REACTOME","1127497_REACT_264212_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS",42,-0.8811,0.64,0.8,"No",0.816,0.77,0.99,"Yes"
"13973","REACTOME","576256_REACT_118764_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS",26,-0.881,0.66,0.8,"No",0.8107,0.77,0.99,"Yes"
"13974","GO_MF","496489_GO_0016530_METALLOCHAPERONE_ACTIVITY",5,-0.8806,0.64,0.81,"No",1.1271,0.35,0.75,"Yes"
"13975","GO_CC","925892_GO_0098563_INTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE",7,-0.8804,0.63,0.87,"No",-1.4988,0.058,0.59,"No"
"13976","GO_BP","751847_GO_0044704_SINGLE_ORGANISM_REPRODUCTIVE_BEHAVIOR",52,-0.8804,0.68,0.8,"No",-0.8713,0.71,1,"No"
"13977","GO_CC","487969_GO_0002080_ACROSOMAL_MEMBRANE",20,-0.8803,0.64,0.87,"No",0.7196,0.87,0.99,"Yes"
"13978","GO_BP","501645_GO_0032413_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",39,-0.8801,0.69,0.8,"No",-0.7708,0.86,1,"No"
"13979","KEGG_module","HSA_M00385_CUL4_DDB1_DDB2_COMPLEX",5,-0.88,0.64,0.75,"No",0.7289,0.8,0.94,"Yes"
"13980","C2_BioCarta_Pathways","C2_CP_BIOCARTA_134_BIOCARTA_PDGF_PATHWAY",32,-0.88,0.65,0.73,"No",0.7639,0.84,1,"Yes"
"13981","GO_BP","505506_GO_0042362_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS",12,-0.8799,0.63,0.8,"No",1.0307,0.39,0.97,"Yes"
"13982","C7_Immunologic_signatures","C7_ALL_549_GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_UP",199,-0.8797,0.74,0.82,"No",0.6651,1,1,"Yes"
"13983","GO_BP","510725_GO_0048670_REGULATION_OF_COLLATERAL_SPROUTING",14,-0.8796,0.63,0.8,"No",0.6597,0.91,1,"Yes"
"13984","C2_BioCarta_Pathways","C2_CP_BIOCARTA_19_BIOCARTA_ATM_PATHWAY",20,-0.8795,0.63,0.73,"No",-0.837,0.71,1,"No"
"13985","C7_Immunologic_signatures","C7_ALL_591_GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_UP",198,-0.8794,0.75,0.82,"No",1.1847,0.088,0.25,"Yes"
"13986","GO_BP","512080_GO_0051170_NUCLEAR_IMPORT",102,-0.8792,0.69,0.8,"No",0.8124,0.9,1,"Yes"
"13987","GO_BP","505337_GO_0042176_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS",375,-0.8792,0.8,0.8,"No",1.1673,0.071,0.82,"Yes"
"13988","GO_BP","491433_GO_0006537_GLUTAMATE_BIOSYNTHETIC_PROCESS",5,-0.8791,0.63,0.8,"No",-1.1872,0.27,0.9,"No"
"13989","GO_MF","493053_GO_0008823_CUPRIC_REDUCTASE_ACTIVITY",5,-0.8791,0.62,0.81,"No",1.2963,0.17,0.62,"Yes"
"13990","C2_Chemical_and_genetic_perturbations","C2_CGP_1972_URS_ADIPOCYTE_DIFFERENTIATION_DN",29,-0.8791,0.65,0.76,"No",1.5023,0.029,0.21,"Yes"
"13991","GO_CC","503568_GO_0034366_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE",7,-0.879,0.63,0.87,"No",0.9293,0.53,0.86,"Yes"
"13992","C2_Chemical_and_genetic_perturbations","C2_CGP_3041_STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP",48,-0.8789,0.65,0.76,"No",-0.852,0.73,1,"No"
"13993","C7_Immunologic_signatures","C7_ALL_1723_GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP",198,-0.8789,0.76,0.82,"No",1.5196,0.0024,0.0094,"Yes"
"13994","C7_Immunologic_signatures","C7_ALL_267_GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP",198,-0.8789,0.75,0.82,"No",0.7642,0.99,1,"Yes"
"13995","GO_BP","504589_GO_0035405_HISTONE_THREONINE_PHOSPHORYLATION",7,-0.8788,0.6,0.8,"No",0.9151,0.55,1,"Yes"
"13996","GO_BP","499105_GO_0021825_SUBSTRATE_DEPENDENT_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION",5,-0.8787,0.62,0.8,"No",0.6763,0.86,1,"Yes"
"13997","GO_BP","507525_GO_0045136_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS",11,-0.8787,0.64,0.8,"No",1.0813,0.36,0.92,"Yes"
"13998","GO_BP","494831_GO_0010766_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT",10,-0.8786,0.62,0.8,"No",0.9283,0.56,1,"Yes"
"13999","GO_BP","500350_GO_0031060_REGULATION_OF_HISTONE_METHYLATION",43,-0.8786,0.66,0.8,"No",-0.5973,0.99,1,"No"
"14000","C2_Chemical_and_genetic_perturbations","C2_CGP_1014_WEI_MIR34A_TARGETS",146,-0.8785,0.73,0.76,"No",1.2141,0.087,0.47,"Yes"
"14001","GO_MF","489283_GO_0003756_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY",22,-0.8784,0.64,0.81,"No",-0.7578,0.81,1,"No"
"14002","GO_BP","488356_GO_0002483_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN",11,-0.8783,0.63,0.8,"No",1.1714,0.25,0.81,"Yes"
"14003","GO_BP","755364_GO_2001258_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY",22,-0.8782,0.64,0.8,"No",-0.8124,0.73,1,"No"
"14004","GO_MF","504369_GO_0035184_HISTONE_THREONINE_KINASE_ACTIVITY",7,-0.878,0.62,0.81,"No",0.928,0.53,0.95,"Yes"
"14005","GO_BP","493333_GO_0009136_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-0.8779,0.65,0.8,"No",-0.4959,0.99,1,"No"
"14006","GO_MF","496409_GO_0016421_COA_CARBOXYLASE_ACTIVITY",6,-0.8777,0.63,0.81,"No",0.5849,0.95,1,"Yes"
"14007","C6_Oncogenic_signatures","C6_ALL_54_BCAT_BILD_ET_AL_UP",45,-0.8777,0.68,0.77,"No",1.09,0.3,0.56,"Yes"
"14008","GO_CC","507845_GO_0045495_POLE_PLASM",13,-0.8776,0.66,0.87,"No",-0.7058,0.85,1,"No"
"14009","REACTOME","161016_REACT_22230_SYNTHESIS_OF_DOLICHYL_PHOSPHATE",5,-0.8775,0.63,0.81,"No",-1.3403,0.15,0.6,"No"
"14010","GO_BP","499634_GO_0030224_MONOCYTE_DIFFERENTIATION",16,-0.8774,0.65,0.8,"No",-0.8394,0.68,1,"No"
"14011","GO_BP","491890_GO_0007067_MITOTIC_NUCLEAR_DIVISION",338,-0.8774,0.8,0.8,"No",1.3358,0,0.62,"Yes"
"14012","C1_Positional","C1_ALL_32_CHR9Q33",63,-0.8774,0.68,0.99,"No",0.8688,0.72,0.89,"Yes"
"14013","C1_Positional","C1_ALL_196_CHR10Q26",102,-0.8773,0.72,0.98,"No",-0.8687,0.77,0.98,"No"
"14014","GO_BP","490991_GO_0006003_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS",5,-0.8773,0.64,0.8,"No",-0.603,0.93,1,"No"
"14015","C7_Immunologic_signatures","C7_ALL_352_GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN",198,-0.8772,0.75,0.82,"No",1.023,0.39,0.67,"Yes"
"14016","C2_Chemical_and_genetic_perturbations","C2_CGP_648_RASHI_RESPONSE_TO_IONIZING_RADIATION_4",61,-0.8772,0.69,0.76,"No",1.0577,0.35,0.7,"Yes"
"14017","C4_Cancer_modules","C4_CM_413_MODULE_534",18,-0.8772,0.64,0.77,"No",0.7273,0.85,1,"Yes"
"14018","REACTOME","105752_REACT_407_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX",12,-0.877,0.61,0.81,"No",0.8895,0.58,0.91,"Yes"
"14019","GO_MF","490378_GO_0005112_NOTCH_BINDING",15,-0.8769,0.61,0.81,"No",-1.2121,0.22,0.82,"No"
"14020","GO_BP","509048_GO_0046825_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS",28,-0.8769,0.65,0.8,"No",-0.818,0.77,1,"No"
"14021","C7_Immunologic_signatures","C7_ALL_1859_GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP",199,-0.8769,0.75,0.82,"No",1.009,0.4,0.71,"Yes"
"14022","GO_BP","499545_GO_0030111_REGULATION_OF_WNT_SIGNALING_PATHWAY",287,-0.8769,0.78,0.8,"No",1.1628,0.085,0.82,"Yes"
"14023","C1_Positional","C1_ALL_52_CHR11Q22",52,-0.8769,0.68,0.98,"No",0.7277,0.92,0.99,"Yes"
"14024","C2_Chemical_and_genetic_perturbations","C2_CGP_2082_SANSOM_APC_MYC_TARGETS",215,-0.8768,0.77,0.76,"No",-0.7942,0.97,1,"No"
"14025","C4_Cancer_modules","C4_CM_193_MODULE_206",152,-0.8766,0.75,0.77,"No",-0.8313,0.86,0.96,"No"
"14026","C1_Positional","C1_ALL_220_CHR11Q25",19,-0.8765,0.64,0.97,"No",-1.0073,0.44,1,"No"
"14027","C4_Cancer_gene_neighborhoods","C4_CGN_41_MORF_RFC5",76,-0.8765,0.69,0.91,"No",1.036,0.37,0.49,"Yes"
"14028","C7_Immunologic_signatures","C7_ALL_268_GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN",200,-0.8765,0.78,0.83,"No",1.2517,0.041,0.15,"Yes"
"14029","GO_BP","517253_GO_0072337_MODIFIED_AMINO_ACID_TRANSPORT",23,-0.8765,0.64,0.8,"No",-1.3489,0.11,0.93,"No"
"14030","GO_BP","498666_GO_0019883_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN",13,-0.8765,0.61,0.8,"No",1.0822,0.34,0.92,"Yes"
"14031","GO_CC","500165_GO_0030867_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE",17,-0.8765,0.62,0.87,"No",1.0292,0.44,0.74,"Yes"
"14032","GO_BP","514082_GO_0060527_PROSTATE_EPITHELIAL_CORD_ARBORIZATION_INVOLVED_IN_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS",7,-0.8764,0.62,0.8,"No",1.1294,0.3,0.87,"Yes"
"14033","GO_BP","511750_GO_0050779_RNA_DESTABILIZATION",10,-0.8764,0.64,0.8,"No",-0.5102,0.98,1,"No"
"14034","KEGG_compound","C00049_L_ASPARTATE_L_ASPARTIC_ACID_2_AMINOSUCCINIC_ACID_L_ASP",15,-0.8762,0.66,0.75,"No",-1.0936,0.34,0.93,"No"
"14035","GO_BP","507052_GO_0044036_CELL_WALL_MACROMOLECULE_METABOLIC_PROCESS",9,-0.876,0.63,0.8,"No",-1.2229,0.24,0.88,"No"
"14036","GO_CC","490803_GO_0005771_MULTIVESICULAR_BODY",31,-0.8759,0.65,0.87,"No",1.5257,0.043,0.18,"Yes"
"14037","GO_MF","489797_GO_0004445_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY",6,-0.8759,0.63,0.81,"No",-1.1929,0.25,0.8,"No"
"14038","C7_Immunologic_signatures","C7_ALL_1478_GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN",198,-0.8758,0.74,0.83,"No",0.8085,0.95,1,"Yes"
"14039","C1_Positional","C1_ALL_166_CHR17P11",84,-0.8757,0.71,0.97,"No",-0.9435,0.56,1,"No"
"14040","REACTOME","106327_REACT_1046_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE",43,-0.8755,0.67,0.81,"No",1.5744,0.022,0.11,"Yes"
"14041","GO_BP","505598_GO_0042461_PHOTORECEPTOR_CELL_DEVELOPMENT",39,-0.8754,0.66,0.8,"No",-1.0373,0.38,0.98,"No"
"14042","GO_BP","502701_GO_0033483_GAS_HOMEOSTASIS",9,-0.8753,0.62,0.8,"No",1.3457,0.14,0.62,"Yes"
"14043","C1_Positional","C1_ALL_245_CHR17Q21",271,-0.8753,0.8,0.96,"No",-1.1572,0.097,1,"No"
"14044","GO_MF","495599_GO_0015377_CATION_CHLORIDE_SYMPORTER_ACTIVITY",8,-0.8752,0.62,0.81,"No",-1.221,0.21,0.85,"No"
"14045","REACTOME","771590_REACT_160133_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER",15,-0.8751,0.67,0.81,"No",0.8713,0.65,0.94,"Yes"
"14046","GO_BP","750997_GO_0036075_REPLACEMENT_OSSIFICATION",29,-0.875,0.66,0.8,"No",-1.355,0.055,0.96,"No"
"14047","C2_Chemical_and_genetic_perturbations","C2_CGP_317_ELVIDGE_HIF2A_TARGETS_UP",6,-0.875,0.63,0.77,"No",0.5825,0.94,1,"Yes"
"14048","GO_CC","513849_GO_0060293_GERM_PLASM",13,-0.875,0.65,0.87,"No",-0.6831,0.89,1,"No"
"14049","GO_BP","513455_GO_0055022_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH",11,-0.8748,0.64,0.8,"No",0.9362,0.53,1,"Yes"
"14050","GO_BP","514081_GO_0060526_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS",7,-0.8746,0.65,0.8,"No",1.1488,0.27,0.84,"Yes"
"14051","GO_BP","517088_GO_0072172_MESONEPHRIC_TUBULE_FORMATION",9,-0.8745,0.63,0.8,"No",1.3199,0.16,0.64,"Yes"
"14052","GO_BP","487583_GO_0001672_REGULATION_OF_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY",7,-0.8745,0.63,0.8,"No",1.1582,0.3,0.83,"Yes"
"14053","C7_Immunologic_signatures","C7_ALL_1222_GSE27786_NKTCELL_VS_ERYTHROBLAST_DN",196,-0.8745,0.75,0.83,"No",-1.0326,0.38,1,"No"
"14054","GO_MF","490355_GO_0005087_RAN_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",6,-0.8745,0.62,0.81,"No",-1.1269,0.32,0.81,"No"
"14055","GO_BP","492901_GO_0008655_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE",10,-0.8744,0.63,0.8,"No",-0.7828,0.76,1,"No"
"14056","KEGG_reaction","R02326_ATP_DCDP_PHOSPHOTRANSFERASE_ATP_DCDP_ADP_DCTP",8,-0.8743,0.64,0.76,"No",-0.6862,0.87,1,"No"
"14057","C2_Chemical_and_genetic_perturbations","C2_CGP_2189_CAMPS_COLON_CANCER_COPY_NUMBER_DN",65,-0.8743,0.69,0.77,"No",-0.9936,0.45,1,"No"
"14058","C3_TF_targets","C3_TFT_388_V_E2F1DP2_01",234,-0.8743,0.78,0.83,"No",-0.8467,0.89,1,"No"
"14059","GO_MF","516853_GO_0071933_ARP2_3_COMPLEX_BINDING",8,-0.8742,0.62,0.81,"No",1.3998,0.1,0.48,"Yes"
"14060","GO_BP","519376_GO_2000737_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION",39,-0.8741,0.67,0.8,"No",-0.7637,0.85,1,"No"
"14061","GO_BP","505455_GO_0042308_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS",55,-0.874,0.69,0.8,"No",-0.7857,0.85,1,"No"
"14062","KEGG_compound","C00996_FERRICYTOCHROME_B5",7,-0.874,0.62,0.76,"No",-0.6611,0.87,1,"No"
"14063","REACTOME","106273_REACT_1923_PURINE_SALVAGE",13,-0.874,0.63,0.81,"No",0.6635,0.92,1,"Yes"
"14064","GO_MF","489289_GO_0042623_ATPASE_ACTIVITY_COUPLED",274,-0.874,0.78,0.81,"No",-0.785,0.98,1,"No"
"14065","GO_BP","502188_GO_0032966_NEGATIVE_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS",5,-0.8738,0.66,0.8,"No",0.9455,0.54,1,"Yes"
"14066","GO_CC","506258_GO_0043186_P_GRANULE",13,-0.8736,0.63,0.87,"No",-0.6836,0.9,1,"No"
"14067","GO_CC","752912_GO_0097413_LEWY_BODY",5,-0.8736,0.61,0.87,"No",-0.9954,0.45,0.85,"No"
"14068","C2_Chemical_and_genetic_perturbations","C2_CGP_1705_CHUANG_OXIDATIVE_STRESS_RESPONSE_DN",11,-0.8736,0.61,0.77,"No",-0.93,0.54,1,"No"
"14069","GO_BP","493271_GO_0009070_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS",13,-0.8734,0.64,0.8,"No",0.8219,0.72,1,"Yes"
"14070","GO_BP","502436_GO_0033216_FERRIC_IRON_IMPORT",5,-0.8734,0.64,0.8,"No",1.3081,0.18,0.66,"Yes"
"14071","REACTOME","1127517_REACT_264384_WNT_MEDIATED_ACTIVATION_OF_DVL",8,-0.8734,0.62,0.81,"No",0.9434,0.53,0.84,"Yes"
"14072","GO_BP","494952_GO_0010888_NEGATIVE_REGULATION_OF_LIPID_STORAGE",16,-0.8734,0.62,0.8,"No",0.7962,0.74,1,"Yes"
"14073","KEGG_reaction","R00156_ATP_UDP_PHOSPHOTRANSFERASE_ATP_UDP_ADP_UTP",8,-0.8733,0.63,0.75,"No",-0.678,0.87,1,"No"
"14074","GO_MF","498063_GO_0019208_PHOSPHATASE_REGULATOR_ACTIVITY",80,-0.8733,0.71,0.81,"No",1.1273,0.24,0.75,"Yes"
"14075","GO_BP","491686_GO_0006817_PHOSPHATE_ION_TRANSPORT",14,-0.8733,0.62,0.8,"No",-0.8078,0.74,1,"No"
"14076","KEGG_compound","C02050_LINOLEOYL_COA_9Z_12Z_OCTADECADIENOYL_COA",5,-0.8733,0.62,0.75,"No",-0.6196,0.9,1,"No"
"14077","GO_BP","496308_GO_0016242_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY",12,-0.8732,0.65,0.8,"No",0.6247,0.91,1,"Yes"
"14078","GO_CC","925903_GO_1902554_SERINE_THREONINE_PROTEIN_KINASE_COMPLEX",68,-0.8732,0.69,0.87,"No",0.9322,0.6,0.86,"Yes"
"14079","GO_BP","505338_GO_0042177_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS",108,-0.8732,0.72,0.8,"No",1.041,0.37,0.96,"Yes"
"14080","C2_Chemical_and_genetic_perturbations","C2_CGP_369_COLDREN_GEFITINIB_RESISTANCE_UP",85,-0.8732,0.71,0.77,"No",-0.6227,1,1,"No"
"14081","GO_CC","517273_GO_0072357_PTW_PP1_PHOSPHATASE_COMPLEX",7,-0.8729,0.63,0.87,"No",0.8266,0.69,0.94,"Yes"
"14082","C2_Chemical_and_genetic_perturbations","C2_CGP_763_AGARWAL_AKT_PATHWAY_TARGETS",9,-0.8728,0.62,0.77,"No",1.0711,0.36,0.68,"Yes"
"14083","GO_BP","510757_GO_0048702_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS",5,-0.8726,0.62,0.81,"No",0.8363,0.67,1,"Yes"
"14084","C6_Oncogenic_signatures","C6_ALL_140_PDGF_ERK_DN_V1_UP",136,-0.8725,0.76,0.77,"No",1.148,0.18,0.43,"Yes"
"14085","GO_BP","754130_GO_1901163_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION",7,-0.8724,0.62,0.81,"No",1.4299,0.1,0.52,"Yes"
"14086","C2_Chemical_and_genetic_perturbations","C2_CGP_1220_NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON",31,-0.8724,0.68,0.77,"No",-0.7485,0.84,1,"No"
"14087","GO_BP","750924_GO_0035999_TETRAHYDROFOLATE_INTERCONVERSION",7,-0.8723,0.65,0.81,"No",-0.6263,0.91,1,"No"
"14088","GO_BP","491390_GO_0006489_DOLICHYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",5,-0.8723,0.64,0.81,"No",-1.3538,0.15,0.95,"No"
"14089","C7_Immunologic_signatures","C7_ALL_1760_GSE6269_STREP_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN",179,-0.8721,0.76,0.83,"No",0.9018,0.74,1,"Yes"
"14090","GO_BP","510896_GO_0048846_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",7,-0.8721,0.62,0.81,"No",-1.0124,0.45,0.98,"No"
"14091","C7_Immunologic_signatures","C7_ALL_1101_GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP",188,-0.872,0.76,0.83,"No",0.7896,0.95,1,"Yes"
"14092","C1_Positional","C1_ALL_54_CHR16Q22",144,-0.872,0.73,0.97,"No",1.1184,0.21,0.62,"Yes"
"14093","GO_MF","500743_GO_0031492_NUCLEOSOMAL_DNA_BINDING",30,-0.8719,0.67,0.82,"No",-0.942,0.56,0.95,"No"
"14094","C2_BioCarta_Pathways","C2_CP_BIOCARTA_142_BIOCARTA_PS1_PATHWAY",14,-0.8719,0.62,0.74,"No",-0.7941,0.73,1,"No"
"14095","GO_BP","500889_GO_0031640_KILLING_OF_CELLS_OF_OTHER_ORGANISM",20,-0.8718,0.64,0.81,"No",1.693,0.014,0.2,"Yes"
"14096","GO_BP","508158_GO_0045837_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL",13,-0.8718,0.64,0.81,"No",-0.8462,0.66,1,"No"
"14097","GO_BP","505234_GO_0042045_EPITHELIAL_FLUID_TRANSPORT",5,-0.8716,0.64,0.81,"No",0.9255,0.56,1,"Yes"
"14098","C3_TF_targets","C3_TFT_387_V_E2F1DP1_01",234,-0.8714,0.81,0.83,"No",-0.8282,0.92,1,"No"
"14099","C7_Immunologic_signatures","C7_ALL_1256_GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN",164,-0.8714,0.74,0.83,"No",-1.1145,0.21,1,"No"
"14100","GO_BP","751577_GO_0044364_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM",20,-0.8713,0.64,0.81,"No",1.7284,0.01,0.16,"Yes"
"14101","GO_BP","517123_GO_0072207_METANEPHRIC_EPITHELIUM_DEVELOPMENT",22,-0.8712,0.66,0.81,"No",0.9383,0.51,1,"Yes"
"14102","GO_BP","516402_GO_0071478_CELLULAR_RESPONSE_TO_RADIATION",133,-0.8712,0.76,0.81,"No",0.8859,0.74,1,"Yes"
"14103","C1_Positional","C1_ALL_185_CHR8Q21",51,-0.8711,0.68,0.96,"No",1.1961,0.15,0.63,"Yes"
"14104","GO_MF","500303_GO_0031013_TROPONIN_I_BINDING",6,-0.8709,0.62,0.82,"No",-0.7183,0.83,1,"No"
"14105","GO_BP","509046_GO_0046823_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT",64,-0.8709,0.69,0.81,"No",0.6041,1,1,"Yes"
"14106","C2_BioCarta_Pathways","C2_CP_BIOCARTA_174_BIOCARTA_RANMS_PATHWAY",10,-0.8709,0.64,0.73,"No",-1.1595,0.28,1,"No"
"14107","REACTOME","106435_REACT_6836_RELEASE_OF_EIF4E",8,-0.8708,0.63,0.81,"No",-0.7828,0.75,1,"No"
"14108","KEGG_reaction","R03530_ATP_DIDP_PHOSPHOTRANSFERASE_ATP_DIDP_ADP_DITP",8,-0.8707,0.64,0.75,"No",-0.6798,0.87,1,"No"
"14109","C7_Immunologic_signatures","C7_ALL_1018_GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN",199,-0.8705,0.79,0.84,"No",0.9708,0.54,0.83,"Yes"
"14110","C4_Cancer_gene_neighborhoods","C4_CGN_86_MORF_DDX11",153,-0.8705,0.78,0.92,"No",0.7203,0.99,1,"Yes"
"14111","GO_BP","491956_GO_0007143_FEMALE_MEIOTIC_DIVISION",19,-0.8703,0.64,0.81,"No",-0.7925,0.77,1,"No"
"14112","C7_Immunologic_signatures","C7_ALL_1867_GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP",199,-0.8701,0.77,0.84,"No",0.8909,0.78,1,"Yes"
"14113","GO_MF","498670_GO_0019888_PROTEIN_PHOSPHATASE_REGULATOR_ACTIVITY",71,-0.8701,0.7,0.82,"No",1.0424,0.37,0.83,"Yes"
"14114","GO_BP","513902_GO_0060346_BONE_TRABECULA_FORMATION",8,-0.8701,0.65,0.81,"No",-0.8387,0.67,1,"No"
"14115","C3_MicroRNA_targets","C3_MIR_206_ATTACAT_MIR_380_3P",101,-0.87,0.73,0.83,"No",1.1109,0.24,1,"Yes"
"14116","C2_Chemical_and_genetic_perturbations","C2_CGP_93_CHANDRAN_METASTASIS_TOP50_DN",45,-0.87,0.67,0.77,"No",1.2999,0.093,0.39,"Yes"
"14117","KEGG_reaction","R02093_ATP_DTDP_PHOSPHOTRANSFERASE_ATP_DTDP_ADP_DTTP",8,-0.87,0.62,0.74,"No",-0.694,0.86,1,"No"
"14118","GO_BP","490595_GO_0007033_VACUOLE_ORGANIZATION",100,-0.87,0.73,0.81,"No",1.0081,0.45,0.98,"Yes"
"14119","GO_BP","505073_GO_0035904_AORTA_DEVELOPMENT",26,-0.8698,0.66,0.81,"No",-0.7314,0.87,1,"No"
"14120","GO_BP","506177_GO_0043097_PYRIMIDINE_NUCLEOSIDE_SALVAGE",10,-0.8695,0.64,0.81,"No",-0.7658,0.78,1,"No"
"14121","GO_BP","511854_GO_0050919_NEGATIVE_CHEMOTAXIS",19,-0.8694,0.65,0.81,"No",1.3455,0.13,0.62,"Yes"
"14122","GO_BP","515249_GO_0070316_REGULATION_OF_G0_TO_G1_TRANSITION",7,-0.8694,0.63,0.81,"No",-1.1225,0.32,0.93,"No"
"14123","GO_BP","506172_GO_0043092_L_AMINO_ACID_IMPORT",12,-0.8691,0.64,0.81,"No",-0.7329,0.82,1,"No"
"14124","GO_MF","496736_GO_0016841_AMMONIA_LYASE_ACTIVITY",5,-0.8689,0.62,0.82,"No",1.4681,0.058,0.4,"Yes"
"14125","C3_TF_targets","C3_TFT_390_V_E2F4DP2_01",234,-0.8689,0.78,0.84,"No",-0.8419,0.91,1,"No"
"14126","GO_BP","853112_GO_1902337_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS",10,-0.8688,0.62,0.81,"No",0.7825,0.76,1,"Yes"
"14127","GO_BP","501718_GO_0032486_RAP_PROTEIN_SIGNAL_TRANSDUCTION",10,-0.8686,0.62,0.81,"No",0.8213,0.67,1,"Yes"
"14128","C3_TF_targets","C3_TFT_167_V_ARNT_01",258,-0.8685,0.77,0.84,"No",1.0227,0.36,1,"Yes"
"14129","C4_Cancer_gene_neighborhoods","C4_CGN_112_MORF_IKBKG",134,-0.8685,0.75,0.92,"No",-0.585,1,1,"No"
"14130","GO_MF","490314_GO_0005031_TUMOR_NECROSIS_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",9,-0.8684,0.64,0.82,"No",1.0399,0.42,0.83,"Yes"
"14131","KEGG_compound","C03035_GAMMA_LINOLENOYL_COA",5,-0.8684,0.63,0.76,"No",-0.6278,0.89,1,"No"
"14132","C2_Chemical_and_genetic_perturbations","C2_CGP_2481_GU_PDEF_TARGETS_DN",35,-0.8683,0.65,0.78,"No",-1.0032,0.44,1,"No"
"14133","GO_BP","506599_GO_0043568_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",13,-0.8681,0.65,0.81,"No",-0.9664,0.49,1,"No"
"14134","C7_Immunologic_signatures","C7_ALL_116_GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN",197,-0.8681,0.77,0.84,"No",0.9855,0.52,0.79,"Yes"
"14135","C2_BioCarta_Pathways","C2_CP_BIOCARTA_122_BIOCARTA_NGF_PATHWAY",18,-0.8673,0.65,0.74,"No",0.7932,0.75,0.97,"Yes"
"14136","GO_BP","501701_GO_0032469_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS",20,-0.8673,0.67,0.81,"No",-0.8407,0.71,1,"No"
"14137","C3_TF_targets","C3_TFT_374_V_PAX8_01",36,-0.8671,0.67,0.84,"No",-1.0973,0.32,0.56,"No"
"14138","GO_BP","488182_GO_0002309_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE",6,-0.8671,0.65,0.81,"No",1.2528,0.22,0.73,"Yes"
"14139","C4_Cancer_modules","C4_CM_363_MODULE_440",19,-0.867,0.66,0.78,"No",-0.8149,0.73,0.96,"No"
"14140","GO_BP","849889_GO_1902187_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL",18,-0.8669,0.65,0.81,"No",0.7454,0.82,1,"Yes"
"14141","GO_BP","514271_GO_0060716_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT",20,-0.8669,0.65,0.81,"No",-0.8778,0.63,1,"No"
"14142","C7_Immunologic_signatures","C7_ALL_1001_GSE22886_IL2_VS_IL15_STIM_NKCELL_UP",185,-0.8669,0.77,0.84,"No",-1.1007,0.23,1,"No"
"14143","GO_CC","486793_GO_0000275_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_CATALYTIC_CORE_F_1_",5,-0.8667,0.64,0.88,"No",1.3937,0.11,0.3,"Yes"
"14144","GO_BP","487828_GO_0001937_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION",29,-0.8667,0.67,0.81,"No",1.1753,0.23,0.81,"Yes"
"14145","KEGG_compound","C00197_3_PHOSPHO_D_GLYCERATE_D_GLYCERATE_3_PHOSPHATE_3_PHOSPHO_R_GLYCERATE_3_PHOSPHOGLYCERATE",11,-0.8666,0.66,0.76,"No",-0.7116,0.84,1,"No"
"14146","KEGG_compound","C00606_3_SULFINO_L_ALANINE_L_CYSTEINESULFINIC_ACID_3_SULPHINO_L_ALANINE_3_SULFINOALANINE",6,-0.8666,0.64,0.76,"No",1.1473,0.32,0.96,"Yes"
"14147","KEGG_compound","C00999_FERROCYTOCHROME_B5",7,-0.8665,0.65,0.76,"No",-0.6697,0.88,1,"No"
"14148","C7_Immunologic_signatures","C7_ALL_940_GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN",191,-0.8665,0.77,0.84,"No",-0.8781,0.78,1,"No"
"14149","GO_MF","489259_GO_0003714_TRANSCRIPTION_COREPRESSOR_ACTIVITY",204,-0.8664,0.75,0.82,"No",-0.7537,0.99,1,"No"
"14150","GO_BP","754180_GO_1901213_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_HEART_DEVELOPMENT",13,-0.8663,0.68,0.81,"No",-0.6143,0.94,1,"No"
"14151","GO_BP","498625_GO_0019827_STEM_CELL_MAINTENANCE",132,-0.866,0.75,0.81,"No",-0.7907,0.94,1,"No"
"14152","C7_Immunologic_signatures","C7_ALL_383_GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP",199,-0.8658,0.76,0.84,"No",1.2493,0.043,0.15,"Yes"
"14153","GO_BP","505861_GO_0042755_EATING_BEHAVIOR",21,-0.8656,0.67,0.81,"No",0.944,0.53,1,"Yes"
"14154","C2_Chemical_and_genetic_perturbations","C2_CGP_183_SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN",5,-0.8652,0.65,0.78,"No",0.9265,0.55,0.89,"Yes"
"14155","GO_BP","492455_GO_0008088_AXON_CARGO_TRANSPORT",39,-0.8652,0.66,0.81,"No",0.9411,0.51,1,"Yes"
"14156","GO_BP","487848_GO_0001958_ENDOCHONDRAL_OSSIFICATION",29,-0.8651,0.69,0.81,"No",-1.3649,0.093,0.98,"No"
"14157","C2_Chemical_and_genetic_perturbations","C2_CGP_531_BUSA_SAM68_TARGETS_DN",6,-0.865,0.64,0.78,"No",1.3434,0.15,0.35,"Yes"
"14158","REACTOME","106473_REACT_15408_CAM_PDE_1_ACTIVATION",6,-0.865,0.65,0.82,"No",0.9692,0.49,0.8,"Yes"
"14159","C7_Immunologic_signatures","C7_ALL_1198_GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN",192,-0.8647,0.77,0.85,"No",-0.9104,0.7,1,"No"
"14160","GO_BP","493446_GO_0009253_PEPTIDOGLYCAN_CATABOLIC_PROCESS",5,-0.8646,0.65,0.81,"No",-0.6845,0.86,1,"No"
"14161","KEGG_reaction","R02331_ATP_DUDP_PHOSPHOTRANSFERASE_ATP_DUDP_ADP_DUTP",8,-0.8645,0.66,0.75,"No",-0.6954,0.86,1,"No"
"14162","KEGG_module","HSA_M00409_ESCRT_I_COMPLEX",8,-0.8645,0.66,0.76,"No",1.1086,0.34,0.68,"Yes"
"14163","GO_BP","514568_GO_0061014_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS",18,-0.8644,0.65,0.82,"No",-0.7538,0.81,1,"No"
"14164","GO_BP","508321_GO_0046021_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_MITOTIC",6,-0.8644,0.64,0.81,"No",-1.124,0.32,0.94,"No"
"14165","C2_Chemical_and_genetic_perturbations","C2_CGP_292_ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN",278,-0.8643,0.79,0.78,"No",-0.8532,0.88,1,"No"
"14166","GO_BP","488168_GO_0002295_T_HELPER_CELL_LINEAGE_COMMITMENT",6,-0.8642,0.65,0.82,"No",-1.0359,0.42,0.98,"No"
"14167","GO_MF","495510_GO_0015248_STEROL_TRANSPORTER_ACTIVITY",19,-0.8641,0.66,0.82,"No",-1.1453,0.28,0.81,"No"
"14168","KEGG_pathway","HSA00020_CITRATE_CYCLE_TCA_CYCLE_",30,-0.864,0.66,0.76,"No",1.6999,0.0063,0.031,"Yes"
"14169","KEGG_reaction","R00330_ATP_GDP_PHOSPHOTRANSFERASE_ATP_GDP_ADP_GTP",8,-0.864,0.63,0.74,"No",-0.6701,0.89,0.99,"No"
"14170","GO_BP","751011_GO_0036089_CLEAVAGE_FURROW_FORMATION",7,-0.864,0.66,0.82,"No",0.9837,0.45,1,"Yes"
"14171","C2_Chemical_and_genetic_perturbations","C2_CGP_336_BIDUS_METASTASIS_UP",213,-0.8639,0.82,0.78,"No",1.3646,0.012,0.33,"Yes"
"14172","GO_BP","486789_GO_0000270_PEPTIDOGLYCAN_METABOLIC_PROCESS",5,-0.8638,0.64,0.82,"No",-0.6907,0.84,1,"No"
"14173","GO_MF","495755_GO_0015605_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",18,-0.8638,0.66,0.82,"No",-0.8328,0.68,1,"No"
"14174","GO_BP","493416_GO_0009220_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",24,-0.8637,0.68,0.82,"No",-0.5343,0.99,1,"No"
"14175","GO_BP","491087_GO_0006102_ISOCITRATE_METABOLIC_PROCESS",5,-0.8636,0.64,0.82,"No",0.932,0.55,1,"Yes"
"14176","C2_Chemical_and_genetic_perturbations","C2_CGP_2014_CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP",20,-0.8635,0.68,0.79,"No",0.7189,0.9,1,"Yes"
"14177","GO_CC","486750_GO_0000794_CONDENSED_NUCLEAR_CHROMOSOME",75,-0.8634,0.71,0.88,"No",-1.0718,0.33,0.81,"No"
"14178","REACTOME","906013_REACT_169238_DEFECTS_IN_BIOTIN_BTN_METABOLISM",7,-0.8634,0.63,0.83,"No",-0.6893,0.86,1,"No"
"14179","GO_BP","502431_GO_0033211_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY",6,-0.8633,0.63,0.82,"No",1.127,0.33,0.87,"Yes"
"14180","C2_BioCarta_Pathways","C2_CP_BIOCARTA_1_BIOCARTA_RELA_PATHWAY",16,-0.8632,0.66,0.74,"No",-0.726,0.82,1,"No"
"14181","C2_Chemical_and_genetic_perturbations","C2_CGP_2819_WEBER_METHYLATED_LCP_IN_SPERM_UP",14,-0.8632,0.66,0.79,"No",-1.6629,0.019,0.39,"No"
"14182","C3_MicroRNA_targets","C3_MIR_129_CCTGAGT_MIR_510",42,-0.8631,0.69,0.84,"No",0.8988,0.64,1,"Yes"
"14183","C2_Chemical_and_genetic_perturbations","C2_CGP_946_PUJANA_BREAST_CANCER_LIT_INT_NETWORK",101,-0.8631,0.73,0.79,"No",0.8251,0.87,0.98,"Yes"
"14184","GO_BP","514707_GO_0061162_ESTABLISHMENT_OF_MONOPOLAR_CELL_POLARITY",11,-0.8629,0.65,0.82,"No",-0.9254,0.55,1,"No"
"14185","GO_MF","752045_GO_0052851_FERRIC_CHELATE_REDUCTASE_NADPH_ACTIVITY",5,-0.8627,0.66,0.83,"No",1.2819,0.18,0.64,"Yes"
"14186","GO_BP","507951_GO_0045603_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION",10,-0.8623,0.64,0.82,"No",0.6905,0.86,1,"Yes"
"14187","GO_MF","498067_GO_0019212_PHOSPHATASE_INHIBITOR_ACTIVITY",35,-0.8622,0.68,0.83,"No",-0.9738,0.48,0.94,"No"
"14188","GO_BP","515841_GO_0070914_UV_DAMAGE_EXCISION_REPAIR",9,-0.8617,0.65,0.82,"No",-0.9501,0.51,1,"No"
"14189","GO_BP","491367_GO_0051131_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY",13,-0.8617,0.66,0.82,"No",1.3068,0.13,0.66,"Yes"
"14190","C7_Immunologic_signatures","C7_ALL_537_GSE17721_LPS_VS_POLYIC_8H_BMDM_UP",200,-0.8615,0.78,0.85,"No",1.6562,0,0.0012,"Yes"
"14191","GO_BP","513595_GO_0060037_PHARYNGEAL_SYSTEM_DEVELOPMENT",16,-0.8614,0.64,0.82,"No",-1.1757,0.23,0.9,"No"
"14192","GO_MF","496773_GO_0016885_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS",7,-0.8613,0.64,0.83,"No",-0.6882,0.86,1,"No"
"14193","C1_Positional","C1_ALL_25_CHR11Q",7,-0.8611,0.65,0.98,"No",-0.9956,0.48,1,"No"
"14194","REACTOME","1127681_REACT_264155_CHROMATIN_ORGANIZATION",250,-0.861,0.8,0.83,"No",-1.3627,0.012,0.56,"No"
"14195","KEGG_module","HSA_M00428_EIF4F_COMPLEX",8,-0.861,0.64,0.76,"No",0.6645,0.86,0.97,"Yes"
"14196","GO_MF","492507_GO_0008158_HEDGEHOG_RECEPTOR_ACTIVITY",10,-0.8609,0.66,0.83,"No",-1.1018,0.33,0.83,"No"
"14197","WikiPathways","672452_WP2036_TWEAK_SIGNALING_PATHWAY",41,-0.8608,0.68,0.79,"No",-0.6342,0.96,1,"No"
"14198","GO_MF","498723_GO_0019957_C_C_CHEMOKINE_BINDING",6,-0.8608,0.66,0.83,"No",1.3417,0.15,0.53,"Yes"
"14199","WikiPathways","198866_WP496_STEROID_BIOSYNTHESIS",10,-0.8607,0.66,0.79,"No",1.1179,0.32,0.99,"Yes"
"14200","C2_Chemical_and_genetic_perturbations","C2_CGP_2115_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD",30,-0.8607,0.69,0.79,"No",0.9034,0.63,0.92,"Yes"
"14201","GO_BP","493364_GO_0009168_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",59,-0.8607,0.7,0.82,"No",1.3956,0.043,0.56,"Yes"
"14202","GO_BP","501698_GO_0032466_NEGATIVE_REGULATION_OF_CYTOKINESIS",7,-0.8604,0.63,0.82,"No",-0.6683,0.88,1,"No"
"14203","GO_BP","518792_GO_2000144_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION",17,-0.8604,0.68,0.82,"No",-0.9303,0.55,1,"No"
"14204","GO_MF","487299_GO_0001076_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",121,-0.8604,0.75,0.83,"No",-0.927,0.65,0.97,"No"
"14205","C7_Immunologic_signatures","C7_ALL_792_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN",196,-0.8604,0.8,0.85,"No",0.8416,0.91,1,"Yes"
"14206","C7_Immunologic_signatures","C7_ALL_451_GSE17721_CTRL_VS_LPS_2H_BMDM_UP",198,-0.8603,0.8,0.85,"No",1.4172,0.007,0.033,"Yes"
"14207","C2_Chemical_and_genetic_perturbations","C2_CGP_2441_ISHIKAWA_STING_SIGNALING",8,-0.8602,0.66,0.79,"No",0.6205,0.93,1,"Yes"
"14208","C2_Chemical_and_genetic_perturbations","C2_CGP_1512_HADDAD_B_LYMPHOCYTE_PROGENITOR",285,-0.86,0.83,0.79,"No",-0.7642,0.99,1,"No"
"14209","GO_MF","504204_GO_0035014_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY",8,-0.8599,0.64,0.83,"No",-0.7786,0.71,1,"No"
"14210","GO_BP","505456_GO_0042310_VASOCONSTRICTION",30,-0.8598,0.68,0.82,"No",1.3782,0.084,0.58,"Yes"
"14211","GO_BP","503271_GO_0034063_STRESS_GRANULE_ASSEMBLY",9,-0.8598,0.64,0.82,"No",-1.033,0.43,0.98,"No"
"14212","KEGG_reaction","R03408_DEHYDROEPIANDROSTERONE_H_OXYGEN_NADPH_16ALPHA_HYDROXYDEHYDROEPIANDROSTERONE_NADP_H2O",7,-0.8595,0.65,0.74,"No",0.9517,0.52,1,"Yes"
"14213","GO_BP","492372_GO_0007631_FEEDING_BEHAVIOR",77,-0.8595,0.73,0.82,"No",-1.1154,0.25,0.94,"No"
"14214","C2_Chemical_and_genetic_perturbations","C2_CGP_2524_NICK_RESPONSE_TO_PROC_TREATMENT_DN",27,-0.8594,0.69,0.79,"No",1.2186,0.19,0.47,"Yes"
"14215","GO_MF","496750_GO_0016857_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES",9,-0.8594,0.64,0.83,"No",-0.802,0.71,1,"No"
"14216","C2_Chemical_and_genetic_perturbations","C2_CGP_595_RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2",25,-0.8592,0.67,0.79,"No",-0.7215,0.88,1,"No"
"14217","REACTOME","106536_REACT_18347_GLUTAMATE_BINDING_ACTIVATION_OF_AMPA_RECEPTORS_AND_SYNAPTIC_PLASTICITY",30,-0.8592,0.67,0.83,"No",-1.3702,0.075,0.56,"No"
"14218","C2_Chemical_and_genetic_perturbations","C2_CGP_104_HOOI_ST7_TARGETS_UP",92,-0.8591,0.75,0.79,"No",1.0275,0.39,0.76,"Yes"
"14219","KEGG_pathway","HSA00790_FOLATE_BIOSYNTHESIS",14,-0.8591,0.66,0.76,"No",1.0536,0.38,0.82,"Yes"
"14220","GO_BP","488984_GO_0003190_ATRIOVENTRICULAR_VALVE_FORMATION",7,-0.859,0.66,0.82,"No",1.1957,0.26,0.79,"Yes"
"14221","REACTOME","161008_REACT_22312_NEUROFASCIN_INTERACTIONS",6,-0.859,0.64,0.83,"No",-1.0628,0.4,0.92,"No"
"14222","C2_Chemical_and_genetic_perturbations","C2_CGP_3278_PLASARI_NFIC_TARGETS_BASAL_UP",27,-0.859,0.68,0.79,"No",1.5947,0.012,0.14,"Yes"
"14223","GO_MF","515627_GO_0070697_ACTIVIN_RECEPTOR_BINDING",5,-0.8588,0.66,0.83,"No",-0.9002,0.59,0.99,"No"
"14224","C7_Immunologic_signatures","C7_ALL_144_GSE13229_MATURE_VS_INTMATURE_NKCELL_DN",199,-0.8586,0.79,0.86,"No",0.9576,0.54,0.88,"Yes"
"14225","C7_Immunologic_signatures","C7_ALL_1050_GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN",200,-0.8584,0.81,0.86,"No",1.5841,0.0024,0.0039,"Yes"
"14226","KEGG_module","HSA_M00160_V_TYPE_ATPASE_EUKARYOTES",23,-0.8583,0.67,0.75,"No",0.8759,0.6,0.9,"Yes"
"14227","GO_BP","755330_GO_2001224_POSITIVE_REGULATION_OF_NEURON_MIGRATION",7,-0.8582,0.64,0.82,"No",-0.9478,0.52,1,"No"
"14228","KEGG_reaction","R01137_ATP_DADP_PHOSPHOTRANSFERASE_ATP_DADP_ADP_DATP",8,-0.8581,0.66,0.74,"No",-0.6817,0.85,1,"No"
"14229","GO_BP","501755_GO_0032525_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION",11,-0.858,0.67,0.82,"No",-1.3447,0.12,0.93,"No"
"14230","GO_BP","514884_GO_0061339_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY",11,-0.858,0.65,0.82,"No",-0.9369,0.54,1,"No"
"14231","KEGG_compound","C01345_DITP_2_DEOXYINOSINE_5_TRIPHOSPHATE_2_DEOXYINOSINE_5_TRIPHOSPHATE",9,-0.858,0.66,0.77,"No",-0.6041,0.94,1,"No"
"14232","GO_BP","491080_GO_0006101_CITRATE_METABOLIC_PROCESS",33,-0.858,0.67,0.82,"No",1.8468,0.002,0.064,"Yes"
"14233","GO_BP","507973_GO_0045625_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION",8,-0.8579,0.66,0.82,"No",0.5756,0.96,1,"Yes"
"14234","GO_MF","504678_GO_0035497_CAMP_RESPONSE_ELEMENT_BINDING",12,-0.8579,0.66,0.83,"No",-0.8834,0.62,1,"No"
"14235","GO_BP","500834_GO_0031584_ACTIVATION_OF_PHOSPHOLIPASE_D_ACTIVITY",5,-0.8576,0.66,0.82,"No",1.1301,0.34,0.87,"Yes"
"14236","C7_Immunologic_signatures","C7_ALL_103_GSE11924_TH1_VS_TH17_CD4_TCELL_UP",193,-0.8576,0.8,0.86,"No",-0.9349,0.63,1,"No"
"14237","GO_BP","499666_GO_0030261_CHROMOSOME_CONDENSATION",28,-0.8576,0.67,0.82,"No",-0.9417,0.5,1,"No"
"14238","C7_Immunologic_signatures","C7_ALL_1237_GSE28237_EARLY_VS_LATE_GC_BCELL_UP",195,-0.8576,0.8,0.86,"No",-0.8507,0.88,1,"No"
"14239","C3_TF_targets","C3_TFT_253_V_E2F1_Q6",232,-0.8575,0.83,0.86,"No",0.8124,0.96,1,"Yes"
"14240","GO_BP","492036_GO_0007257_ACTIVATION_OF_JUN_KINASE_ACTIVITY",35,-0.8575,0.7,0.82,"No",-0.7332,0.92,1,"No"
"14241","GO_BP","491083_GO_0006105_SUCCINATE_METABOLIC_PROCESS",10,-0.8574,0.66,0.82,"No",1.4396,0.082,0.51,"Yes"
"14242","GO_MF","494608_GO_0051787_MISFOLDED_PROTEIN_BINDING",11,-0.8573,0.66,0.83,"No",0.7291,0.85,1,"Yes"
"14243","REACTOME","1127682_REACT_264165_CHROMATIN_MODIFYING_ENZYMES",250,-0.8573,0.81,0.83,"No",-1.3665,0.0052,0.56,"No"
"14244","GO_BP","517117_GO_0072201_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION",6,-0.8572,0.65,0.82,"No",0.8048,0.71,1,"Yes"
"14245","REACTOME","106438_REACT_1109_INSULIN_RECEPTOR_RECYCLING",24,-0.857,0.67,0.83,"No",0.834,0.7,0.97,"Yes"
"14246","C2_Chemical_and_genetic_perturbations","C2_CGP_1667_MURAKAMI_UV_RESPONSE_6HR_DN",19,-0.857,0.67,0.79,"No",-0.9347,0.54,1,"No"
"14247","GO_BP","518457_GO_0090317_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT",75,-0.8568,0.72,0.82,"No",-0.6159,0.99,1,"No"
"14248","GO_BP","505415_GO_0042256_MATURE_RIBOSOME_ASSEMBLY",6,-0.8568,0.67,0.82,"No",1.3281,0.17,0.63,"Yes"
"14249","WikiPathways","198893_WP400_P38_MAPK_SIGNALING_PATHWAY",34,-0.8567,0.68,0.79,"No",-1.0718,0.33,0.94,"No"
"14250","C2_Chemical_and_genetic_perturbations","C2_CGP_1430_PENG_GLUTAMINE_DEPRIVATION_DN",334,-0.8566,0.83,0.8,"No",1.4444,0.0026,0.26,"Yes"
"14251","WikiPathways","672461_WP2007_IRON_METABOLISM_IN_PLACENTA",12,-0.8566,0.64,0.79,"No",1.2399,0.22,0.79,"Yes"
"14252","REACTOME","730314_REACT_150182_MASTL_FACILITATES_MITOTIC_PROGRESSION",10,-0.8564,0.66,0.83,"No",0.577,0.96,1,"Yes"
"14253","C2_Chemical_and_genetic_perturbations","C2_CGP_2499_SOUCEK_MYC_TARGETS",8,-0.8564,0.65,0.8,"No",1.4796,0.08,0.23,"Yes"
"14254","GO_BP","517498_GO_0072595_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE",25,-0.8563,0.68,0.82,"No",0.5556,0.99,1,"Yes"
"14255","C7_Immunologic_signatures","C7_ALL_1508_GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN",199,-0.8563,0.8,0.86,"No",1.0096,0.39,0.72,"Yes"
"14256","GO_BP","493567_GO_0009394_2_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",30,-0.8562,0.69,0.82,"No",1.4564,0.035,0.48,"Yes"
"14257","GO_MF","496263_GO_0016174_NAD_P_H_OXIDASE_ACTIVITY",6,-0.8562,0.66,0.83,"No",-0.8094,0.68,1,"No"
"14258","GO_BP","754191_GO_1901224_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING",23,-0.8562,0.68,0.82,"No",1.4561,0.054,0.48,"Yes"
"14259","GO_MF","502017_GO_0032794_GTPASE_ACTIVATING_PROTEIN_BINDING",12,-0.856,0.65,0.83,"No",-0.852,0.67,1,"No"
"14260","REACTOME","1127577_REACT_268269_SIGNALING_BY_EGFRVIII_IN_CANCER",15,-0.856,0.68,0.83,"No",0.9348,0.54,0.85,"Yes"
"14261","GO_BP","491841_GO_0007006_MITOCHONDRIAL_MEMBRANE_ORGANIZATION",50,-0.8559,0.73,0.83,"No",1.526,0.015,0.37,"Yes"
"14262","KEGG_reaction","R00722_ATP_IDP_PHOSPHOTRANSFERASE_ATP_IDP_ADP_ITP",8,-0.8559,0.65,0.73,"No",-0.6886,0.85,1,"No"
"14263","GO_BP","513717_GO_0060159_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",6,-0.8558,0.66,0.83,"No",-0.8321,0.68,1,"No"
"14264","C7_Immunologic_signatures","C7_ALL_1247_GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP",168,-0.8557,0.81,0.86,"No",1.1166,0.18,0.4,"Yes"
"14265","GO_BP","849764_GO_0044788_MODULATION_BY_HOST_OF_VIRAL_PROCESS",12,-0.8556,0.66,0.83,"No",0.8864,0.63,1,"Yes"
"14266","C2_Chemical_and_genetic_perturbations","C2_CGP_733_LUND_SILENCED_BY_METHYLATION",16,-0.8555,0.66,0.8,"No",0.7356,0.84,1,"Yes"
"14267","C2_Chemical_and_genetic_perturbations","C2_CGP_3318_ZHANG_ADIPOGENESIS_BY_BMP7",14,-0.8555,0.65,0.8,"No",0.6529,0.92,1,"Yes"
"14268","GO_BP","752960_GO_0097461_FERRIC_IRON_IMPORT_INTO_CELL",5,-0.8555,0.67,0.83,"No",1.2935,0.17,0.68,"Yes"
"14269","GO_BP","504492_GO_0035308_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION",6,-0.8554,0.66,0.83,"No",1.02,0.46,0.97,"Yes"
"14270","C2_Chemical_and_genetic_perturbations","C2_CGP_665_NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA",7,-0.8552,0.63,0.8,"No",-1.3952,0.11,0.59,"No"
"14271","C2_Chemical_and_genetic_perturbations","C2_CGP_3157_LINSLEY_MIR16_TARGETS",206,-0.8552,0.8,0.8,"No",0.8493,0.88,0.97,"Yes"
"14272","KEGG_compound","C01344_DIDP_2_DEOXYINOSINE_5_DIPHOSPHATE_2_DEOXYINOSINE_5_DIPHOSPHATE",9,-0.855,0.65,0.77,"No",-0.6969,0.86,1,"No"
"14273","GO_CC","490786_GO_0005753_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX",21,-0.8549,0.69,0.9,"No",2.1627,0.002,0.00034,"Yes"
"14274","REACTOME","119538_REACT_19189_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN",15,-0.8549,0.68,0.83,"No",0.7961,0.77,0.99,"Yes"
"14275","C1_Positional","C1_ALL_55_CHR11Q24",70,-0.8549,0.72,0.99,"No",1.1229,0.24,0.63,"Yes"
"14276","GO_MF","502829_GO_0033613_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING",55,-0.8548,0.72,0.83,"No",-0.9944,0.46,0.91,"No"
"14277","GO_BP","502266_GO_0033045_REGULATION_OF_SISTER_CHROMATID_SEGREGATION",46,-0.8548,0.69,0.83,"No",1.0251,0.39,0.97,"Yes"
"14278","REACTOME","576248_REACT_118773_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR_",189,-0.8547,0.8,0.83,"No",1.1146,0.19,0.56,"Yes"
"14279","GO_BP","506412_GO_0043373_CD4_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT",7,-0.8546,0.65,0.83,"No",-1.17,0.3,0.91,"No"
"14280","GO_BP","500364_GO_0031076_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT",38,-0.8546,0.68,0.83,"No",1.0012,0.46,0.98,"Yes"
"14281","C7_Immunologic_signatures","C7_ALL_567_GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_UP",195,-0.8546,0.8,0.86,"No",-0.9163,0.7,1,"No"
"14282","GO_BP","754955_GO_2000849_REGULATION_OF_GLUCOCORTICOID_SECRETION",9,-0.8545,0.65,0.83,"No",0.7983,0.72,1,"Yes"
"14283","C2_Chemical_and_genetic_perturbations","C2_CGP_2216_GAUTSCHI_SRC_SIGNALING",8,-0.8544,0.67,0.8,"No",-1.202,0.24,0.8,"No"
"14284","GO_BP","513815_GO_0060259_REGULATION_OF_FEEDING_BEHAVIOR",14,-0.8544,0.68,0.83,"No",1.0458,0.39,0.95,"Yes"
"14285","C2_Chemical_and_genetic_perturbations","C2_CGP_2815_WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN",8,-0.8544,0.68,0.8,"No",-1.0416,0.42,0.98,"No"
"14286","C3_TF_targets","C3_TFT_156_V_SREBP1_01",166,-0.8543,0.79,0.86,"No",1.2899,0.039,0.5,"Yes"
"14287","GO_BP","508307_GO_0046007_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION",8,-0.8543,0.64,0.83,"No",0.7372,0.81,1,"Yes"
"14288","C2_Chemical_and_genetic_perturbations","C2_CGP_429_VANHARANTA_UTERINE_FIBROID_UP",43,-0.8542,0.71,0.8,"No",0.8134,0.8,0.98,"Yes"
"14289","GO_BP","513604_GO_0060046_REGULATION_OF_ACROSOME_REACTION",11,-0.8542,0.67,0.83,"No",-1.0041,0.46,0.99,"No"
"14290","GO_BP","493376_GO_0009180_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-0.8541,0.66,0.83,"No",-0.4945,0.98,1,"No"
"14291","GO_BP","512656_GO_0051784_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION",57,-0.854,0.72,0.83,"No",0.603,1,1,"Yes"
"14292","GO_BP","496510_GO_0016559_PEROXISOME_FISSION",10,-0.8539,0.65,0.83,"No",0.8111,0.69,1,"Yes"
"14293","KEGG_compound","C01243_1D_MYO_INOSITOL_1_3_4_TRISPHOSPHATE_D_MYO_INOSITOL_1_3_4_TRISPHOSPHATE_INOSITOL_1_3_4_TRISPHOSPHATE",5,-0.8537,0.66,0.77,"No",-0.6016,0.91,1,"No"
"14294","GO_MF","492983_GO_0016651_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H",94,-0.8537,0.75,0.83,"No",1.6817,0,0.17,"Yes"
"14295","GO_BP","505587_GO_0042447_HORMONE_CATABOLIC_PROCESS",8,-0.8536,0.65,0.83,"No",1.5604,0.044,0.33,"Yes"
"14296","WikiPathways","920974_WP1533_VITAMIN_B12_METABOLISM",18,-0.8534,0.67,0.79,"No",1.4183,0.06,0.43,"Yes"
"14297","C4_Cancer_gene_neighborhoods","C4_CGN_306_GNF2_PRDX2",30,-0.8532,0.68,0.95,"No",1.6861,0.01,0.0071,"Yes"
"14298","C2_Chemical_and_genetic_perturbations","C2_CGP_585_IVANOV_MUTATED_IN_COLON_CANCER",13,-0.8531,0.67,0.8,"No",0.5582,0.97,1,"Yes"
"14299","GO_BP","510493_GO_0048386_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",5,-0.8531,0.68,0.83,"No",-1.5612,0.035,0.71,"No"
"14300","KEGG_compound","C00942_3_5_CYCLIC_GMP_GUANOSINE_3_5_CYCLIC_MONOPHOSPHATE_GUANOSINE_3_5_CYCLIC_PHOSPHATE_CYCLIC_GMP_CGMP",34,-0.8529,0.7,0.77,"No",-0.8506,0.72,1,"No"
"14301","REACTOME","106537_REACT_18307_TRAFFICKING_OF_AMPA_RECEPTORS",30,-0.8527,0.69,0.84,"No",-1.3638,0.09,0.57,"No"
"14302","C4_Cancer_modules","C4_CM_409_MODULE_528",10,-0.8527,0.65,0.81,"No",0.5077,0.99,1,"Yes"
"14303","C2_Chemical_and_genetic_perturbations","C2_CGP_1625_WEBER_METHYLATED_IN_COLON_CANCER",17,-0.8527,0.66,0.8,"No",-1.3291,0.11,0.69,"No"
"14304","GO_CC","490823_GO_0005795_GOLGI_STACK",124,-0.8526,0.77,0.9,"No",1.0011,0.46,0.79,"Yes"
"14305","REACTOME","1127526_REACT_264276_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS",5,-0.8526,0.66,0.83,"No",-1.0679,0.41,0.91,"No"
"14306","GO_BP","516283_GO_0071359_CELLULAR_RESPONSE_TO_DSRNA",31,-0.8526,0.68,0.83,"No",1.0852,0.33,0.92,"Yes"
"14307","C2_Chemical_and_genetic_perturbations","C2_CGP_1528_ROETH_TERT_TARGETS_UP",14,-0.8524,0.67,0.8,"No",2.025,0,0.0047,"Yes"
"14308","C3_MicroRNA_targets","C3_MIR_53_GGATCCG_MIR_127",11,-0.8522,0.67,0.85,"No",1.1425,0.28,1,"Yes"
"14309","C6_Oncogenic_signatures","C6_ALL_89_PTEN_DN_V2_DN",137,-0.8521,0.81,0.81,"No",-0.9255,0.63,0.85,"No"
"14310","C7_Immunologic_signatures","C7_ALL_242_GSE14026_TH1_VS_TH17_DN",194,-0.8521,0.79,0.87,"No",1.1026,0.19,0.44,"Yes"
"14311","GO_BP","489076_GO_0003283_ATRIAL_SEPTUM_DEVELOPMENT",17,-0.852,0.66,0.83,"No",-1.151,0.27,0.93,"No"
"14312","GO_BP","911463_GO_1902475_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT",23,-0.852,0.67,0.83,"No",0.9268,0.57,1,"Yes"
"14313","C1_Positional","C1_ALL_72_CHR2Q24",43,-0.852,0.71,0.99,"No",0.8268,0.78,0.92,"Yes"
"14314","GO_BP","503965_GO_0034766_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT",54,-0.8517,0.73,0.83,"No",0.9841,0.46,1,"Yes"
"14315","GO_BP","494829_GO_0010764_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION",6,-0.8515,0.67,0.83,"No",-0.662,0.87,1,"No"
"14316","GO_BP","491696_GO_0006829_ZINC_II_ION_TRANSPORT",25,-0.8515,0.69,0.83,"No",0.9392,0.56,1,"Yes"
"14317","GO_MF","489800_GO_0004448_ISOCITRATE_DEHYDROGENASE_ACTIVITY",5,-0.8515,0.66,0.83,"No",0.94,0.54,0.94,"Yes"
"14318","C7_Immunologic_signatures","C7_ALL_1207_GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP",200,-0.8514,0.81,0.87,"No",-0.7887,0.95,1,"No"
"14319","C3_TF_targets","C3_TFT_589_RYTGCNNRGNAAC_V_MIF1_01",85,-0.8513,0.73,0.87,"No",-0.9786,0.49,0.8,"No"
"14320","GO_BP","754917_GO_2000811_NEGATIVE_REGULATION_OF_ANOIKIS",16,-0.8513,0.67,0.83,"No",1.0239,0.42,0.97,"Yes"
"14321","C3_MicroRNA_targets","C3_MIR_91_GGCAGAC_MIR_346",41,-0.8511,0.71,0.85,"No",-1.0839,0.3,1,"No"
"14322","C1_Positional","C1_ALL_99_CHR17Q",9,-0.8511,0.66,0.99,"No",-1.0224,0.42,1,"No"
"14323","GO_BP","501703_GO_0032471_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION",8,-0.8511,0.64,0.83,"No",-0.4691,0.99,1,"No"
"14324","REACTOME","771589_REACT_160106_CONSTITUTIVE_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT",7,-0.851,0.68,0.84,"No",-1.176,0.31,0.86,"No"
"14325","GO_BP","491856_GO_0007028_CYTOPLASM_ORGANIZATION",8,-0.8509,0.66,0.83,"No",-0.8544,0.63,1,"No"
"14326","C7_Immunologic_signatures","C7_ALL_1753_GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP",169,-0.8509,0.8,0.87,"No",1.2447,0.051,0.16,"Yes"
"14327","REACTOME","906014_REACT_169312_DEFECTIVE_HLCS_CAUSES_MULTIPLE_CARBOXYLASE_DEFICIENCY",7,-0.8509,0.69,0.84,"No",-0.6797,0.87,1,"No"
"14328","C2_Chemical_and_genetic_perturbations","C2_CGP_1880_SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN",29,-0.8509,0.71,0.8,"No",-0.8861,0.66,1,"No"
"14329","C2_Chemical_and_genetic_perturbations","C2_CGP_1326_KENNY_CTNNB1_TARGETS_DN",52,-0.8508,0.73,0.8,"No",1.0728,0.32,0.67,"Yes"
"14330","GO_BP","512034_GO_0051123_RNA_POLYMERASE_II_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY",5,-0.8508,0.66,0.83,"No",1.0775,0.38,0.93,"Yes"
"14331","GO_CC","496477_GO_0016514_SWI_SNF_COMPLEX",14,-0.8507,0.66,0.9,"No",-0.9109,0.57,0.96,"No"
"14332","REACTOME","106224_REACT_12477_ENOS_ACTIVATION",10,-0.8505,0.64,0.84,"No",0.8127,0.72,0.99,"Yes"
"14333","KEGG_reaction","R00124_ATP_ADP_PHOSPHATRANSFERASE_ATP_ADP_ADP_ATP",8,-0.8504,0.67,0.74,"No",-0.6816,0.88,1,"No"
"14334","C4_Cancer_modules","C4_CM_21_MODULE_22",45,-0.8501,0.73,0.81,"No",2.2153,0,0.00027,"Yes"
"14335","C2_Chemical_and_genetic_perturbations","C2_CGP_3014_BROWNE_HCMV_INFECTION_1HR_DN",220,-0.85,0.83,0.8,"No",-0.823,0.93,1,"No"
"14336","C2_Chemical_and_genetic_perturbations","C2_CGP_2939_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13",172,-0.8498,0.82,0.8,"No",2.4382,0,0,"Yes"
"14337","OMIM_gene","OMIM163970_SOLUTE_CARRIER_FAMILY_6_NEUROTRANSMITTER_TRANSPORTER_NORADRENALINE_MEMBER_2_SLC6A2",8,-0.8497,0.65,0.87,"No",0.8052,0.73,1,"Yes"
"14338","C2_Chemical_and_genetic_perturbations","C2_CGP_3164_BAKKER_FOXO3_TARGETS_DN",182,-0.8496,0.82,0.8,"No",0.9895,0.46,0.81,"Yes"
"14339","C7_Immunologic_signatures","C7_ALL_581_GSE17721_CPG_VS_GARDIQUIMOD_0_5H_BMDM_UP",193,-0.8496,0.82,0.87,"No",1.2282,0.061,0.18,"Yes"
"14340","GO_BP","492061_GO_0007283_SPERMATOGENESIS",422,-0.8494,0.87,0.83,"No",-1.0722,0.25,0.96,"No"
"14341","C2_Chemical_and_genetic_perturbations","C2_CGP_206_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN",25,-0.8493,0.67,0.8,"No",-1.1187,0.29,0.89,"No"
"14342","GO_BP","502268_GO_0033047_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION",46,-0.8491,0.71,0.83,"No",1.009,0.44,0.98,"Yes"
"14343","GO_BP","491627_GO_0006744_UBIQUINONE_BIOSYNTHETIC_PROCESS",12,-0.8491,0.66,0.83,"No",0.9242,0.54,1,"Yes"
"14344","GO_MF","492785_GO_0008504_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-0.8491,0.65,0.84,"No",-0.8926,0.6,1,"No"
"14345","GO_BP","512439_GO_0051561_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION",9,-0.8491,0.67,0.83,"No",0.6573,0.89,1,"Yes"
"14346","GO_BP","508204_GO_0045896_REGULATION_OF_TRANSCRIPTION_DURING_MITOSIS",7,-0.8491,0.66,0.83,"No",-1.0532,0.39,0.97,"No"
"14347","GO_BP","506549_GO_0043518_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",12,-0.8491,0.68,0.83,"No",0.8354,0.68,1,"Yes"
"14348","GO_CC","507239_GO_0044232_ORGANELLE_MEMBRANE_CONTACT_SITE",11,-0.8491,0.67,0.9,"No",0.7924,0.73,0.96,"Yes"
"14349","GO_BP","752538_GO_0090481_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT",5,-0.849,0.65,0.83,"No",-1.0348,0.44,0.98,"No"
"14350","GO_BP","506922_GO_0043902_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS",144,-0.8489,0.79,0.83,"No",1.5205,0,0.38,"Yes"
"14351","GO_MF","496759_GO_0016868_INTRAMOLECULAR_TRANSFERASE_ACTIVITY_PHOSPHOTRANSFERASES",11,-0.8489,0.65,0.84,"No",-0.8731,0.65,1,"No"
"14352","GO_BP","502107_GO_0032885_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS",36,-0.8489,0.71,0.83,"No",-0.4266,1,1,"No"
"14353","REACTOME","1183529_REACT_355208_DISEASES_OF_METABOLISM",35,-0.8488,0.73,0.84,"No",1.2019,0.19,0.44,"Yes"
"14354","GO_BP","755350_GO_2001244_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",53,-0.8486,0.72,0.83,"No",0.9578,0.56,1,"Yes"
"14355","GO_MF","496611_GO_0016681_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS_CYTOCHROME_AS_ACCEPTOR",8,-0.8485,0.69,0.84,"No",1.5254,0.041,0.36,"Yes"
"14356","C2_Chemical_and_genetic_perturbations","C2_CGP_1499_GALE_APL_WITH_FLT3_MUTATED_DN",17,-0.8484,0.66,0.8,"No",1.0916,0.33,0.64,"Yes"
"14357","GO_BP","498953_GO_0021670_LATERAL_VENTRICLE_DEVELOPMENT",12,-0.8484,0.68,0.83,"No",0.5574,0.97,1,"Yes"
"14358","C7_Immunologic_signatures","C7_ALL_203_GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP",184,-0.8484,0.81,0.87,"No",1.6975,0,0.00069,"Yes"
"14359","C7_Immunologic_signatures","C7_ALL_560_GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_DN",199,-0.8482,0.79,0.87,"No",1.6553,0,0.0012,"Yes"
"14360","C2_Chemical_and_genetic_perturbations","C2_CGP_743_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",7,-0.8482,0.66,0.8,"No",0.911,0.56,0.91,"Yes"
"14361","GO_BP","495050_GO_0010985_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE",7,-0.8481,0.66,0.83,"No",-1.4481,0.077,0.9,"No"
"14362","GO_BP","849793_GO_0061548_GANGLION_DEVELOPMENT",13,-0.8481,0.68,0.83,"No",0.6562,0.91,1,"Yes"
"14363","REACTOME","1127578_REACT_267817_CONSTITUTIVE_SIGNALING_BY_EGFRVIII",15,-0.8481,0.67,0.84,"No",0.9498,0.5,0.83,"Yes"
"14364","C7_Immunologic_signatures","C7_ALL_154_GSE13306_TREG_VS_TCONV_DN",200,-0.848,0.83,0.87,"No",1.1798,0.088,0.26,"Yes"
"14365","C4_Cancer_modules","C4_CM_420_MODULE_547",14,-0.8479,0.66,0.81,"No",0.6378,0.92,1,"Yes"
"14366","GO_BP","511656_GO_0050684_REGULATION_OF_MRNA_PROCESSING",93,-0.8478,0.77,0.83,"No",-1.0481,0.36,0.97,"No"
"14367","GO_BP","519289_GO_2000650_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-0.8478,0.64,0.83,"No",1.0962,0.37,0.91,"Yes"
"14368","GO_BP","982373_GO_1902803_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT",25,-0.8478,0.7,0.83,"No",0.7876,0.83,1,"Yes"
"14369","KEGG_reaction","R00570_ATP_CDP_PHOSPHOTRANSFERASE_ATP_CDP_ADP_CTP",8,-0.8477,0.69,0.73,"No",-0.6623,0.89,0.99,"No"
"14370","C2_Chemical_and_genetic_perturbations","C2_CGP_1436_ROSS_AML_WITH_AML1_ETO_FUSION",76,-0.8476,0.74,0.81,"No",-0.671,0.98,1,"No"
"14371","C4_Cancer_modules","C4_CM_358_MODULE_432",15,-0.8475,0.68,0.81,"No",-0.6326,0.94,1,"No"
"14372","GO_BP","750994_GO_0036072_DIRECT_OSSIFICATION",6,-0.8474,0.67,0.83,"No",-0.9649,0.52,1,"No"
"14373","GO_BP","948905_GO_1902750_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION",10,-0.8474,0.67,0.83,"No",1.3294,0.14,0.63,"Yes"
"14374","C1_Positional","C1_ALL_247_CHR11P15",290,-0.8474,0.85,0.99,"No",1.0966,0.19,0.65,"Yes"
"14375","GO_MF","492394_GO_0008020_G_PROTEIN_COUPLED_PHOTORECEPTOR_ACTIVITY",7,-0.8474,0.66,0.84,"No",-1.477,0.056,0.58,"No"
"14376","C3_TF_targets","C3_TFT_40_AAGWWRNYGGC_UNKNOWN",120,-0.8473,0.77,0.87,"No",-0.8763,0.75,0.98,"No"
"14377","GO_BP","502108_GO_0032886_REGULATION_OF_MICROTUBULE_BASED_PROCESS",139,-0.8473,0.8,0.83,"No",0.8271,0.9,1,"Yes"
"14378","GO_BP","510349_GO_0048232_MALE_GAMETE_GENERATION",423,-0.8473,0.86,0.83,"No",-1.0601,0.3,0.96,"No"
"14379","GO_MF","496704_GO_0016799_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS",21,-0.8472,0.69,0.84,"No",1.389,0.084,0.48,"Yes"
"14380","GO_BP","987845_GO_1903044_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT",7,-0.847,0.68,0.83,"No",-0.7238,0.81,1,"No"
"14381","GO_BP","518946_GO_2000300_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS",18,-0.847,0.68,0.83,"No",-0.7323,0.85,1,"No"
"14382","REACTOME","1183598_REACT_355048_TRANSCRIPTIONAL_REGULATION_BY_TP53",64,-0.8467,0.73,0.84,"No",1.3575,0.039,0.26,"Yes"
"14383","C2_Chemical_and_genetic_perturbations","C2_CGP_1834_CHEN_PDGF_TARGETS",19,-0.8465,0.66,0.81,"No",-1.0643,0.39,0.96,"No"
"14384","GO_BP","495131_GO_0014059_REGULATION_OF_DOPAMINE_SECRETION",19,-0.8464,0.7,0.83,"No",1.1182,0.31,0.88,"Yes"
"14385","GO_BP","515169_GO_0070234_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS",14,-0.8463,0.68,0.83,"No",-0.6159,0.94,1,"No"
"14386","C2_Chemical_and_genetic_perturbations","C2_CGP_3116_ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP",84,-0.8462,0.75,0.81,"No",-0.7977,0.88,1,"No"
"14387","C7_Immunologic_signatures","C7_ALL_1008_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN",200,-0.8461,0.82,0.88,"No",1.8464,0,0,"Yes"
"14388","GO_BP","754676_GO_1901725_REGULATION_OF_HISTONE_DEACETYLASE_ACTIVITY",5,-0.8461,0.67,0.83,"No",-0.7415,0.79,1,"No"
"14389","GO_BP","495225_GO_0014829_VASCULAR_SMOOTH_MUSCLE_CONTRACTION",13,-0.8459,0.7,0.83,"No",1.5573,0.035,0.34,"Yes"
"14390","KEGG_compound","C00288_HCO3_BICARBONATE_HYDROGEN_CARBONATE_ACID_CARBONATE",21,-0.8457,0.72,0.78,"No",-0.8406,0.71,1,"No"
"14391","GO_MF","500686_GO_0031435_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING",22,-0.8457,0.69,0.84,"No",-0.8835,0.64,1,"No"
"14392","GO_BP","508237_GO_0045930_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE",221,-0.8455,0.82,0.84,"No",1.3231,0.014,0.64,"Yes"
"14393","GO_BP","493414_GO_0009218_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS",26,-0.8454,0.69,0.84,"No",-0.5103,1,1,"No"
"14394","C2_Chemical_and_genetic_perturbations","C2_CGP_456_GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN",22,-0.8454,0.71,0.81,"No",0.8651,0.65,0.96,"Yes"
"14395","C7_Immunologic_signatures","C7_ALL_1725_GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP",198,-0.8453,0.81,0.88,"No",1.0511,0.31,0.59,"Yes"
"14396","REACTOME","1183551_REACT_188329_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION",13,-0.8453,0.66,0.84,"No",0.5214,0.99,1,"Yes"
"14397","GO_BP","505617_GO_0042481_REGULATION_OF_ODONTOGENESIS",25,-0.845,0.69,0.84,"No",-0.7596,0.82,1,"No"
"14398","KEGG_compound","C01233_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_GLYCEROPHOSPHOETHANOLAMINE",7,-0.8449,0.66,0.78,"No",-0.7592,0.74,1,"No"
"14399","REACTOME","119562_REACT_19314_SODIUM_PROTON_EXCHANGERS",9,-0.8445,0.67,0.84,"No",-0.8212,0.7,1,"No"
"14400","C7_Immunologic_signatures","C7_ALL_394_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN",199,-0.8445,0.83,0.88,"No",1.8144,0,3e-05,"Yes"
"14401","GO_BP","987847_GO_1903046_MEIOTIC_CELL_CYCLE_PROCESS",95,-0.8444,0.78,0.84,"No",-0.731,0.94,1,"No"
"14402","GO_BP","515859_GO_0070932_HISTONE_H3_DEACETYLATION",22,-0.8441,0.68,0.84,"No",-0.9711,0.49,1,"No"
"14403","GO_MF","490027_GO_0004711_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY",7,-0.8439,0.68,0.84,"No",-0.5073,0.98,1,"No"
"14404","GO_CC","502239_GO_0033017_SARCOPLASMIC_RETICULUM_MEMBRANE",36,-0.8439,0.72,0.91,"No",-0.7778,0.83,1,"No"
"14405","C2_Chemical_and_genetic_perturbations","C2_CGP_3040_STAMBOLSKY_BOUND_BY_MUTATED_TP53",18,-0.8437,0.69,0.81,"No",0.7635,0.82,1,"Yes"
"14406","C7_Immunologic_signatures","C7_ALL_534_GSE17721_LPS_VS_POLYIC_4H_BMDM_DN",199,-0.8435,0.84,0.88,"No",1.5712,0,0.0047,"Yes"
"14407","C3_MicroRNA_targets","C3_MIR_138_GTCGATC_MIR_369_5P",5,-0.8435,0.66,0.86,"No",-1.468,0.076,0.54,"No"
"14408","GO_BP","513646_GO_0060088_AUDITORY_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION",9,-0.8434,0.67,0.84,"No",-0.3965,1,1,"No"
"14409","GO_MF","495786_GO_0015645_FATTY_ACID_LIGASE_ACTIVITY",15,-0.8433,0.69,0.84,"No",0.8837,0.61,1,"Yes"
"14410","GO_BP","501599_GO_0032364_OXYGEN_HOMEOSTASIS",6,-0.8432,0.67,0.84,"No",1.537,0.049,0.36,"Yes"
"14411","REACTOME","106476_REACT_12442_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS",9,-0.843,0.66,0.84,"No",-1.1847,0.25,0.85,"No"
"14412","C2_Chemical_and_genetic_perturbations","C2_CGP_2870_KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP",92,-0.8429,0.77,0.81,"No",1.5101,0.013,0.2,"Yes"
"14413","C2_Chemical_and_genetic_perturbations","C2_CGP_1108_BENPORATH_OCT4_TARGETS",289,-0.8427,0.86,0.81,"No",1.2072,0.059,0.48,"Yes"
"14414","GO_BP","518783_GO_2000134_NEGATIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",101,-0.8425,0.77,0.84,"No",1.5809,0.0023,0.31,"Yes"
"14415","C2_Chemical_and_genetic_perturbations","C2_CGP_2209_YAMASHITA_SILENCED_BY_METHYLATION",6,-0.8425,0.68,0.81,"No",0.7121,0.83,1,"Yes"
"14416","GO_BP","513906_GO_0060350_ENDOCHONDRAL_BONE_MORPHOGENESIS",54,-0.8424,0.71,0.84,"No",-1.4967,0.013,0.81,"No"
"14417","KEGG_module","HSA_M00044_TYROSINE_DEGRADATION_TYROSINE_HOMOGENTISATE",5,-0.8424,0.7,0.76,"No",-1.3894,0.095,0.79,"No"
"14418","C1_Positional","C1_ALL_201_CHR20P11",48,-0.8423,0.75,0.99,"No",1.5307,0.013,0.27,"Yes"
"14419","GO_MF","496602_GO_0016670_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",6,-0.8423,0.65,0.84,"No",-0.649,0.89,1,"No"
"14420","C4_Cancer_modules","C4_CM_4_MODULE_4",21,-0.8422,0.7,0.82,"No",0.9482,0.52,0.78,"Yes"
"14421","GO_MF","495470_GO_0015205_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.8422,0.68,0.84,"No",-1.2471,0.22,0.83,"No"
"14422","GO_BP","518291_GO_0090151_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE",8,-0.8421,0.68,0.84,"No",1.2736,0.2,0.71,"Yes"
"14423","GO_BP","491440_GO_0006544_GLYCINE_METABOLIC_PROCESS",15,-0.842,0.69,0.84,"No",0.4959,0.99,1,"Yes"
"14424","GO_CC","500172_GO_0030877_BETA_CATENIN_DESTRUCTION_COMPLEX",10,-0.8419,0.67,0.91,"No",-0.4764,0.99,1,"No"
"14425","GO_BP","518371_GO_0090231_REGULATION_OF_SPINDLE_CHECKPOINT",16,-0.8416,0.7,0.84,"No",0.7556,0.8,1,"Yes"
"14426","C4_Cancer_modules","C4_CM_216_MODULE_237",58,-0.8414,0.76,0.81,"No",0.8813,0.69,0.89,"Yes"
"14427","C1_Positional","C1_ALL_134_CHR6Q15",19,-0.8414,0.69,0.99,"No",-0.871,0.65,1,"No"
"14428","GO_BP","501746_GO_0032515_NEGATIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",10,-0.8414,0.69,0.84,"No",0.717,0.85,1,"Yes"
"14429","GO_BP","511746_GO_0050775_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS",24,-0.8413,0.68,0.84,"No",-1.4283,0.076,0.93,"No"
"14430","GO_BP","513448_GO_0055015_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT",13,-0.8413,0.68,0.84,"No",-1.1469,0.27,0.93,"No"
"14431","GO_BP","495037_GO_0010972_NEGATIVE_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",9,-0.841,0.67,0.84,"No",1.2312,0.2,0.75,"Yes"
"14432","C6_Oncogenic_signatures","C6_ALL_35_BCAT_GDS748_DN",43,-0.841,0.73,0.83,"No",-0.835,0.74,0.97,"No"
"14433","REACTOME","730346_REACT_150210_IGF1R_SIGNALING_CASCADE",86,-0.8409,0.78,0.85,"No",0.7572,0.94,1,"Yes"
"14434","REACTOME","730345_REACT_150359_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R_",86,-0.8408,0.77,0.84,"No",0.7534,0.95,1,"Yes"
"14435","GO_MF","495605_GO_0015385_SODIUM_PROTON_ANTIPORTER_ACTIVITY",9,-0.8408,0.66,0.84,"No",-0.8078,0.72,1,"No"
"14436","C7_Immunologic_signatures","C7_ALL_38_GSE10325_CD4_TCELL_VS_BCELL_DN",185,-0.8408,0.81,0.88,"No",-0.7551,0.99,1,"No"
"14437","REACTOME","1183599_REACT_355377_TP53_REGULATES_METABOLIC_GENES",64,-0.8407,0.74,0.84,"No",1.3294,0.068,0.29,"Yes"
"14438","GO_BP","514427_GO_0060872_SEMICIRCULAR_CANAL_DEVELOPMENT",8,-0.8405,0.66,0.84,"No",0.7017,0.85,1,"Yes"
"14439","C3_TF_targets","C3_TFT_26_V_E2F_02",234,-0.8404,0.84,0.89,"No",-0.8387,0.9,1,"No"
"14440","KEGG_pathway","HSA04140_REGULATION_OF_AUTOPHAGY",34,-0.8402,0.72,0.79,"No",0.636,0.97,1,"Yes"
"14441","GO_BP","491953_GO_0007140_MALE_MEIOSIS",35,-0.8402,0.72,0.84,"No",-0.9809,0.47,1,"No"
"14442","C2_BioCarta_Pathways","C2_CP_BIOCARTA_173_BIOCARTA_CDC42RAC_PATHWAY",16,-0.8402,0.68,0.77,"No",1.8636,0.0042,0.092,"Yes"
"14443","C2_Chemical_and_genetic_perturbations","C2_CGP_862_MAINA_VHL_TARGETS_DN",17,-0.8401,0.69,0.82,"No",0.6013,0.96,1,"Yes"
"14444","GO_MF","495455_GO_0015186_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.84,0.69,0.84,"No",-0.877,0.62,1,"No"
"14445","REACTOME","187211_REACT_24994_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS",87,-0.84,0.77,0.84,"No",1.8175,0,0.018,"Yes"
"14446","GO_MF","752871_GO_0097372_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K18_SPECIFIC_",12,-0.8397,0.66,0.84,"No",-1.2655,0.17,0.83,"No"
"14447","GO_BP","515801_GO_0070873_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS",35,-0.8397,0.73,0.84,"No",-0.6558,0.96,1,"No"
"14448","GO_BP","514321_GO_0060766_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",14,-0.8396,0.69,0.84,"No",-1.0248,0.41,0.97,"No"
"14449","KEGG_compound","C00134_PUTRESCINE_1_4_BUTANEDIAMINE_1_4_DIAMINOBUTANE_TETRAMETHYLENEDIAMINE_BUTANE_1_4_DIAMINE",7,-0.8396,0.67,0.79,"No",-0.9783,0.49,1,"No"
"14450","GO_MF","496889_GO_0017075_SYNTAXIN_1_BINDING",18,-0.8395,0.7,0.84,"No",-1.0106,0.43,0.89,"No"
"14451","C2_Chemical_and_genetic_perturbations","C2_CGP_2943_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17",180,-0.8395,0.82,0.82,"No",2.1603,0,0.0011,"Yes"
"14452","KEGG_compound","C02843_LONG_CHAIN_ACYL_COA",7,-0.8394,0.68,0.79,"No",0.5632,0.95,1,"Yes"
"14453","C7_Immunologic_signatures","C7_ALL_1110_GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN",190,-0.8393,0.85,0.89,"No",0.883,0.79,1,"Yes"
"14454","C1_Positional","C1_ALL_96_CHR4Q24",17,-0.8392,0.7,0.99,"No",1.4566,0.055,0.3,"Yes"
"14455","GO_CC","500496_GO_0031235_INTRINSIC_COMPONENT_OF_THE_CYTOPLASMIC_SIDE_OF_THE_PLASMA_MEMBRANE",14,-0.8391,0.69,0.92,"No",-0.7948,0.76,1,"No"
"14456","C7_Immunologic_signatures","C7_ALL_1241_GSE2826_WT_VS_BTK_KO_BCELL_UP",199,-0.8391,0.83,0.89,"No",0.845,0.89,1,"Yes"
"14457","GO_BP","501737_GO_0032506_CYTOKINETIC_PROCESS",13,-0.8391,0.71,0.84,"No",0.7545,0.82,1,"Yes"
"14458","GO_MF","492857_GO_0008601_PROTEIN_PHOSPHATASE_TYPE_2A_REGULATOR_ACTIVITY",20,-0.8391,0.7,0.84,"No",1.0764,0.34,0.82,"Yes"
"14459","GO_BP","506408_GO_0043369_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT",8,-0.8391,0.67,0.84,"No",-1.2921,0.17,0.88,"No"
"14460","REACTOME","1183583_REACT_355588_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING",27,-0.8388,0.7,0.84,"No",-0.7907,0.79,1,"No"
"14461","GO_MF","487130_GO_0000900_TRANSLATION_REPRESSOR_ACTIVITY_NUCLEIC_ACID_BINDING",9,-0.8386,0.68,0.84,"No",-1.2089,0.25,0.81,"No"
"14462","C7_Immunologic_signatures","C7_ALL_855_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP",160,-0.8386,0.8,0.89,"No",-1.4194,0.014,0.19,"No"
"14463","GO_BP","491569_GO_0006681_GALACTOSYLCERAMIDE_METABOLIC_PROCESS",5,-0.8386,0.68,0.84,"No",0.9498,0.52,1,"Yes"
"14464","GO_BP","487678_GO_0001782_B_CELL_HOMEOSTASIS",24,-0.8382,0.72,0.84,"No",0.5972,0.97,1,"Yes"
"14465","C3_TF_targets","C3_TFT_467_V_E2F1_Q3_01",237,-0.8382,0.86,0.89,"No",-0.8975,0.75,0.96,"No"
"14466","REACTOME","1183597_REACT_355072_TNFR1_MEDIATED_PROAPOPTOTIC_SIGNALING",12,-0.8382,0.68,0.85,"No",-0.9993,0.44,0.98,"No"
"14467","C2_BioCarta_Pathways","C2_CP_BIOCARTA_205_BIOCARTA_TNFR2_PATHWAY",18,-0.8382,0.69,0.77,"No",-0.6485,0.93,1,"No"
"14468","GO_BP","493902_GO_0009798_AXIS_SPECIFICATION",85,-0.8381,0.78,0.84,"No",-1.374,0.038,0.99,"No"
"14469","GO_BP","514397_GO_0060842_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION",5,-0.8381,0.68,0.84,"No",1.0393,0.42,0.96,"Yes"
"14470","GO_BP","508064_GO_0045719_NEGATIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS",8,-0.838,0.68,0.84,"No",0.5545,0.97,1,"Yes"
"14471","C2_Chemical_and_genetic_perturbations","C2_CGP_2623_MIKKELSEN_DEDIFFERENTIATED_STATE_DN",7,-0.838,0.66,0.82,"No",-1.0572,0.38,0.97,"No"
"14472","GO_MF","514947_GO_0070006_METALLOAMINOPEPTIDASE_ACTIVITY",5,-0.8378,0.65,0.84,"No",1.3015,0.17,0.61,"Yes"
"14473","C2_Chemical_and_genetic_perturbations","C2_CGP_809_HEIDENBLAD_AMPLICON_8Q24_UP",40,-0.8377,0.72,0.82,"No",-0.8143,0.79,1,"No"
"14474","GO_BP","509061_GO_0046839_PHOSPHOLIPID_DEPHOSPHORYLATION",22,-0.8377,0.71,0.84,"No",-0.9797,0.5,1,"No"
"14475","C2_Chemical_and_genetic_perturbations","C2_CGP_3240_JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP",114,-0.8376,0.79,0.82,"No",1.2198,0.093,0.47,"Yes"
"14476","C7_Immunologic_signatures","C7_ALL_1362_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN",200,-0.8373,0.86,0.89,"No",1.0825,0.23,0.49,"Yes"
"14477","C2_Chemical_and_genetic_perturbations","C2_CGP_425_CHIN_BREAST_CANCER_COPY_NUMBER_UP",25,-0.8373,0.71,0.82,"No",-0.9955,0.44,1,"No"
"14478","KEGG_compound","C00158_CITRATE_CITRIC_ACID_2_HYDROXY_1_2_3_PROPANETRICARBOXYLIC_ACID_2_HYDROXYTRICARBALLYLIC_ACID",5,-0.8371,0.68,0.79,"No",-0.5113,0.98,1,"No"
"14479","GO_BP","508288_GO_0045988_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION",6,-0.837,0.68,0.85,"No",0.8352,0.65,1,"Yes"
"14480","GO_BP","1026083_GO_1903311_REGULATION_OF_MRNA_METABOLIC_PROCESS",104,-0.837,0.8,0.85,"No",-0.9706,0.48,1,"No"
"14481","REACTOME","105923_REACT_18339_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION",27,-0.837,0.72,0.85,"No",-0.681,0.92,1,"No"
"14482","GO_BP","781977_GO_1901988_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION",286,-0.837,0.86,0.85,"No",1.3476,0.016,0.61,"Yes"
"14483","REACTOME","106160_REACT_11123_MEMBRANE_TRAFFICKING",199,-0.8369,0.84,0.85,"No",1.4174,0,0.21,"Yes"
"14484","C2_Chemical_and_genetic_perturbations","C2_CGP_975_WILLIAMS_ESR2_TARGETS_DN",11,-0.8369,0.68,0.82,"No",0.9879,0.47,0.81,"Yes"
"14485","GO_BP","492666_GO_0008356_ASYMMETRIC_CELL_DIVISION",5,-0.8369,0.66,0.85,"No",0.842,0.67,1,"Yes"
"14486","KEGG_reaction","R01857_ATP_DGDP_PHOSPHOTRANSFERASE_ATP_DGDP_ADP_DGTP",8,-0.8368,0.69,0.74,"No",-0.6711,0.9,1,"No"
"14487","GO_BP","512381_GO_0051503_ADENINE_NUCLEOTIDE_TRANSPORT",8,-0.8367,0.68,0.85,"No",-0.7067,0.84,1,"No"
"14488","GO_BP","1026092_GO_1903320_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL",240,-0.8367,0.85,0.85,"No",1.3731,0.0022,0.58,"Yes"
"14489","REACTOME","771588_REACT_160082_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT",7,-0.8365,0.68,0.84,"No",-1.1628,0.3,0.85,"No"
"14490","GO_BP","493856_GO_0009744_RESPONSE_TO_SUCROSE",6,-0.8364,0.68,0.85,"No",1.2663,0.22,0.71,"Yes"
"14491","C2_Chemical_and_genetic_perturbations","C2_CGP_2260_SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP",18,-0.8363,0.68,0.82,"No",0.8647,0.65,0.96,"Yes"
"14492","GO_BP","492104_GO_0007340_ACROSOME_REACTION",14,-0.836,0.72,0.85,"No",-0.7973,0.75,1,"No"
"14493","C2_BioCarta_Pathways","C2_CP_BIOCARTA_182_BIOCARTA_IGF1MTOR_PATHWAY",20,-0.8357,0.72,0.77,"No",1.5083,0.038,0.39,"Yes"
"14494","C2_Chemical_and_genetic_perturbations","C2_CGP_3393_CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN",19,-0.8356,0.7,0.82,"No",0.8297,0.72,0.98,"Yes"
"14495","GO_MF","489652_GO_0008234_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY",152,-0.8356,0.82,0.85,"No",0.7082,0.98,1,"Yes"
"14496","C2_Chemical_and_genetic_perturbations","C2_CGP_1308_WELCH_GATA1_TARGETS",21,-0.8352,0.71,0.82,"No",1.1344,0.28,0.57,"Yes"
"14497","C7_Immunologic_signatures","C7_ALL_764_GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_DN",199,-0.8352,0.84,0.89,"No",1.4779,0.0071,0.016,"Yes"
"14498","C7_Immunologic_signatures","C7_ALL_645_GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_UP",198,-0.8351,0.83,0.89,"No",1.2808,0.033,0.12,"Yes"
"14499","C2_Chemical_and_genetic_perturbations","C2_CGP_1852_CHIBA_RESPONSE_TO_TSA_DN",23,-0.8349,0.71,0.82,"No",0.8972,0.61,0.93,"Yes"
"14500","GO_MF","496660_GO_0016747_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS",194,-0.8349,0.84,0.85,"No",-0.8835,0.77,1,"No"
"14501","C2_Chemical_and_genetic_perturbations","C2_CGP_647_RASHI_RESPONSE_TO_IONIZING_RADIATION_3",48,-0.8348,0.72,0.82,"No",-1.0339,0.4,0.97,"No"
"14502","C2_Chemical_and_genetic_perturbations","C2_CGP_1205_NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON",8,-0.8347,0.69,0.82,"No",1.108,0.33,0.62,"Yes"
"14503","C2_Chemical_and_genetic_perturbations","C2_CGP_1151_GEORGES_CELL_CYCLE_MIR192_TARGETS",62,-0.8342,0.76,0.82,"No",0.9965,0.48,0.8,"Yes"
"14504","GO_BP","504744_GO_0035564_REGULATION_OF_KIDNEY_SIZE",5,-0.8342,0.67,0.85,"No",1.3638,0.12,0.6,"Yes"
"14505","GO_CC","510549_GO_0048475_COATED_MEMBRANE",93,-0.8341,0.78,0.92,"No",1.2788,0.064,0.43,"Yes"
"14506","GO_BP","487850_GO_0001960_NEGATIVE_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",34,-0.8339,0.73,0.85,"No",-0.7302,0.9,1,"No"
"14507","GO_BP","755128_GO_2001022_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS",56,-0.8337,0.75,0.85,"No",0.8019,0.84,1,"Yes"
"14508","GO_BP","488599_GO_0002726_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION",10,-0.8337,0.69,0.85,"No",-1.1319,0.29,0.93,"No"
"14509","GO_CC","495149_GO_0014701_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE",10,-0.8337,0.71,0.92,"No",1.2268,0.21,0.49,"Yes"
"14510","C4_Cancer_gene_neighborhoods","C4_CGN_134_MORF_MYST2",68,-0.8337,0.78,0.99,"No",0.7264,0.94,1,"Yes"
"14511","GO_CC","499712_GO_0030312_EXTERNAL_ENCAPSULATING_STRUCTURE",18,-0.8333,0.71,0.92,"No",1.0667,0.35,0.69,"Yes"
"14512","C2_BioCarta_Pathways","C2_CP_BIOCARTA_151_BIOCARTA_CHREBP2_PATHWAY",42,-0.833,0.74,0.77,"No",1.2443,0.13,0.67,"Yes"
"14513","GO_BP","502364_GO_0033143_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",59,-0.8329,0.77,0.85,"No",0.8821,0.7,1,"Yes"
"14514","GO_MF","492531_GO_0008188_NEUROPEPTIDE_RECEPTOR_ACTIVITY",41,-0.8327,0.73,0.85,"No",1.1614,0.24,0.74,"Yes"
"14515","GO_BP","499170_GO_0021891_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT",9,-0.8327,0.68,0.85,"No",-0.6897,0.85,1,"No"
"14516","C2_Chemical_and_genetic_perturbations","C2_CGP_831_LI_WILMS_TUMOR_ANAPLASTIC_DN",5,-0.8327,0.7,0.83,"No",-1.1934,0.25,0.81,"No"
"14517","GO_BP","508206_GO_0045898_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY",6,-0.8327,0.69,0.85,"No",0.9539,0.52,1,"Yes"
"14518","C2_Chemical_and_genetic_perturbations","C2_CGP_2972_ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL",16,-0.8325,0.72,0.83,"No",-0.9933,0.47,1,"No"
"14519","GO_BP","504515_GO_0035331_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING",5,-0.8324,0.69,0.85,"No",-1.3263,0.15,0.89,"No"
"14520","GO_BP","500432_GO_0031145_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",83,-0.8324,0.79,0.85,"No",1.7583,0,0.13,"Yes"
"14521","GO_BP","497166_GO_0018195_PEPTIDYL_ARGININE_MODIFICATION",16,-0.8322,0.7,0.85,"No",-0.6907,0.87,1,"No"
"14522","GO_BP","494576_GO_0010507_NEGATIVE_REGULATION_OF_AUTOPHAGY",30,-0.8322,0.71,0.85,"No",0.5418,0.99,1,"Yes"
"14523","REACTOME","106419_REACT_498_SIGNALING_BY_INSULIN_RECEPTOR",108,-0.8322,0.81,0.85,"No",0.7961,0.89,1,"Yes"
"14524","C7_Immunologic_signatures","C7_ALL_686_GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_DN",200,-0.8322,0.84,0.9,"No",1.4995,0.0046,0.013,"Yes"
"14525","GO_BP","503574_GO_0034372_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",7,-0.8321,0.67,0.85,"No",-1,0.43,0.99,"No"
"14526","GO_BP","491820_GO_0006983_ER_OVERLOAD_RESPONSE",10,-0.832,0.7,0.85,"No",-1.0768,0.36,0.95,"No"
"14527","KEGG_pathway","HSA00230_PURINE_METABOLISM",171,-0.8317,0.83,0.81,"No",0.8937,0.74,1,"Yes"
"14528","C2_Chemical_and_genetic_perturbations","C2_CGP_3027_WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP",22,-0.8317,0.71,0.83,"No",1.3396,0.11,0.35,"Yes"
"14529","GO_BP","491085_GO_0006107_OXALOACETATE_METABOLIC_PROCESS",11,-0.8317,0.71,0.85,"No",0.9844,0.46,1,"Yes"
"14530","GO_BP","494779_GO_0010714_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS",25,-0.8315,0.7,0.85,"No",-0.9876,0.5,1,"No"
"14531","C2_Chemical_and_genetic_perturbations","C2_CGP_2603_BRUNEAU_SEPTATION_VENTRICULAR",10,-0.8313,0.68,0.83,"No",-1.0729,0.38,0.95,"No"
"14532","C7_Immunologic_signatures","C7_ALL_1248_GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN",168,-0.8309,0.83,0.9,"No",-1.0702,0.27,1,"No"
"14533","C2_Chemical_and_genetic_perturbations","C2_CGP_892_YANG_BREAST_CANCER_ESR1_LASER_UP",34,-0.8309,0.73,0.83,"No",-0.6661,0.94,1,"No"
"14534","OMIM_gene","OMIM603817_DEVELOPMENT_AND_DIFFERENTIATION_ENHANCING_FACTOR_2_DDEF2",6,-0.8309,0.67,0.88,"No",0.9707,0.47,1,"Yes"
"14535","C2_BioCarta_Pathways","C2_CP_BIOCARTA_60_BIOCARTA_EGF_PATHWAY",31,-0.8309,0.71,0.77,"No",0.8275,0.75,0.95,"Yes"
"14536","C7_Immunologic_signatures","C7_ALL_1548_GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN",199,-0.8307,0.86,0.9,"No",1.2564,0.045,0.15,"Yes"
"14537","KEGG_compound","C00705_DCDP_2_DEOXYCYTIDINE_DIPHOSPHATE_2_DEOXYCYTIDINE_5_DIPHOSPHATE",17,-0.8307,0.68,0.8,"No",1.04,0.4,1,"Yes"
"14538","GO_BP","513879_GO_0060323_HEAD_MORPHOGENESIS",40,-0.8305,0.72,0.85,"No",0.7291,0.91,1,"Yes"
"14539","REACTOME","576274_REACT_118636_SIGNALING_BY_NOTCH4",11,-0.8305,0.69,0.85,"No",-0.9334,0.55,1,"No"
"14540","GO_BP","510761_GO_0048706_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT",124,-0.8305,0.81,0.85,"No",-0.9231,0.65,1,"No"
"14541","GO_BP","512335_GO_0051457_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS",15,-0.8305,0.7,0.85,"No",-0.6669,0.89,1,"No"
"14542","GO_BP","502180_GO_0032958_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS",6,-0.8303,0.68,0.85,"No",0.6703,0.84,1,"Yes"
"14543","C7_Immunologic_signatures","C7_ALL_1514_GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN",198,-0.8302,0.87,0.9,"No",1.7021,0,0.00061,"Yes"
"14544","GO_BP","491995_GO_0007195_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",5,-0.8302,0.7,0.85,"No",-0.606,0.92,1,"No"
"14545","GO_MF","517447_GO_0072542_PROTEIN_PHOSPHATASE_ACTIVATOR_ACTIVITY",8,-0.8298,0.72,0.85,"No",1.2121,0.23,0.7,"Yes"
"14546","GO_BP","514305_GO_0060750_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_ELONGATION",5,-0.8298,0.71,0.85,"No",1.1382,0.33,0.85,"Yes"
"14547","GO_BP","491626_GO_0006743_UBIQUINONE_METABOLIC_PROCESS",13,-0.8297,0.69,0.85,"No",0.9403,0.55,1,"Yes"
"14548","GO_MF","489472_GO_0004000_ADENOSINE_DEAMINASE_ACTIVITY",11,-0.8297,0.71,0.85,"No",-0.7981,0.74,1,"No"
"14549","C2_Chemical_and_genetic_perturbations","C2_CGP_1355_CHESLER_BRAIN_HIGHEST_EXPRESSION",40,-0.8296,0.74,0.83,"No",1.403,0.053,0.29,"Yes"
"14550","REACTOME","1127535_REACT_264508_SIGNALING_BY_HEDGEHOG",135,-0.8295,0.82,0.85,"No",1.4745,0.0093,0.16,"Yes"
"14551","GO_BP","489210_GO_0003418_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION",5,-0.8292,0.71,0.85,"No",-1.5139,0.051,0.81,"No"
"14552","GO_CC","490761_GO_0005719_NUCLEAR_EUCHROMATIN",23,-0.829,0.73,0.93,"No",-0.6925,0.9,1,"No"
"14553","GO_BP","491861_GO_0007034_VACUOLAR_TRANSPORT",76,-0.829,0.79,0.85,"No",0.8267,0.82,1,"Yes"
"14554","C2_Chemical_and_genetic_perturbations","C2_CGP_2400_BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN",38,-0.8287,0.75,0.83,"No",-0.9576,0.51,1,"No"
"14555","GO_MF","489945_GO_0004614_PHOSPHOGLUCOMUTASE_ACTIVITY",5,-0.8287,0.68,0.85,"No",-0.8024,0.71,1,"No"
"14556","REACTOME","530770_REACT_18423_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES",10,-0.8287,0.72,0.85,"No",-0.6647,0.9,1,"No"
"14557","C2_Chemical_and_genetic_perturbations","C2_CGP_1861_WENG_POR_TARGETS_GLOBAL_UP",19,-0.8285,0.71,0.83,"No",-0.71,0.86,1,"No"
"14558","GO_CC","500466_GO_0031201_SNARE_COMPLEX",49,-0.8284,0.73,0.93,"No",1.0385,0.39,0.73,"Yes"
"14559","KEGG_pathway","HSA00510_N_GLYCAN_BIOSYNTHESIS",49,-0.8283,0.75,0.81,"No",0.8566,0.72,1,"Yes"
"14560","REACTOME","645263_REACT_121092_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR",9,-0.8282,0.67,0.85,"No",0.7095,0.84,1,"Yes"
"14561","GO_BP","495189_GO_0014741_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY",12,-0.8281,0.68,0.86,"No",-0.9026,0.57,1,"No"
"14562","C7_Immunologic_signatures","C7_ALL_1652_GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN",190,-0.828,0.85,0.9,"No",1.0832,0.24,0.49,"Yes"
"14563","GO_CC","507398_GO_0044450_MICROTUBULE_ORGANIZING_CENTER_PART",129,-0.8279,0.81,0.93,"No",-1.0396,0.36,0.84,"No"
"14564","GO_BP","507685_GO_0045329_CARNITINE_BIOSYNTHETIC_PROCESS",5,-0.8278,0.69,0.86,"No",0.7019,0.81,1,"Yes"
"14565","GO_BP","506092_GO_0043001_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT",26,-0.8278,0.75,0.86,"No",0.8674,0.68,1,"Yes"
"14566","GO_CC","501210_GO_0031970_ORGANELLE_ENVELOPE_LUMEN",79,-0.8278,0.8,0.92,"No",1.7935,0,0.029,"Yes"
"14567","GO_BP","495013_GO_0010948_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS",335,-0.8278,0.9,0.86,"No",1.3398,0,0.62,"Yes"
"14568","GO_BP","501461_GO_0032226_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC",7,-0.8278,0.68,0.86,"No",-1.1817,0.26,0.91,"No"
"14569","GO_BP","491178_GO_0006220_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS",43,-0.8278,0.76,0.86,"No",1.1119,0.29,0.89,"Yes"
"14570","GO_BP","508430_GO_0046134_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS",32,-0.8277,0.74,0.86,"No",-0.6006,0.98,1,"No"
"14571","C7_Immunologic_signatures","C7_ALL_449_GSE17721_CTRL_VS_LPS_1H_BMDM_UP",196,-0.8276,0.85,0.9,"No",1.0202,0.4,0.68,"Yes"
"14572","C7_Immunologic_signatures","C7_ALL_324_GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN",199,-0.8275,0.86,0.9,"No",1.932,0,0,"Yes"
"14573","GO_BP","509133_GO_0046928_REGULATION_OF_NEUROTRANSMITTER_SECRETION",47,-0.8275,0.74,0.86,"No",0.9059,0.62,1,"Yes"
"14574","GO_BP","494460_GO_0010390_HISTONE_MONOUBIQUITINATION",23,-0.8273,0.73,0.86,"No",0.579,0.98,1,"Yes"
"14575","GO_BP","495245_GO_0014850_RESPONSE_TO_MUSCLE_ACTIVITY",13,-0.8273,0.71,0.86,"No",0.9973,0.47,0.98,"Yes"
"14576","C2_BioCarta_Pathways","C2_CP_BIOCARTA_136_BIOCARTA_PTDINS_PATHWAY",23,-0.8271,0.72,0.77,"No",-1.1037,0.3,1,"No"
"14577","GO_BP","491732_GO_0006868_GLUTAMINE_TRANSPORT",5,-0.827,0.68,0.86,"No",-0.8678,0.62,1,"No"
"14578","GO_BP","491514_GO_0006621_PROTEIN_RETENTION_IN_ER_LUMEN",9,-0.8268,0.7,0.86,"No",0.8095,0.71,1,"Yes"
"14579","GO_MF","487329_GO_0001106_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_ACTIVITY",25,-0.8268,0.75,0.86,"No",1.0574,0.36,0.83,"Yes"
"14580","C7_Immunologic_signatures","C7_ALL_1842_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN",191,-0.8266,0.86,0.9,"No",-1.0528,0.33,1,"No"
"14581","C7_Immunologic_signatures","C7_ALL_1205_GSE27786_CD8_TCELL_VS_NKTCELL_UP",195,-0.8266,0.86,0.9,"No",0.9555,0.58,0.88,"Yes"
"14582","OMIM_gene","OMIM605553_POLY_A_POLYMERASE_ALPHA_PAPOLA",6,-0.8263,0.67,0.87,"No",0.9499,0.55,1,"Yes"
"14583","GO_BP","498217_GO_0019374_GALACTOLIPID_METABOLIC_PROCESS",5,-0.8262,0.71,0.86,"No",0.9448,0.53,1,"Yes"
"14584","GO_BP","517223_GO_0072307_REGULATION_OF_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION",8,-0.8261,0.69,0.86,"No",-0.78,0.76,1,"No"
"14585","REACTOME","1183527_REACT_355468_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER",24,-0.8261,0.71,0.86,"No",-1.0784,0.35,0.91,"No"
"14586","C2_Chemical_and_genetic_perturbations","C2_CGP_1016_LIAO_HAVE_SOX4_BINDING_SITES",40,-0.8261,0.76,0.83,"No",-0.6377,0.97,1,"No"
"14587","C7_Immunologic_signatures","C7_ALL_216_GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN",195,-0.826,0.86,0.9,"No",-0.9603,0.56,1,"No"
"14588","GO_BP","491656_GO_0006783_HEME_BIOSYNTHETIC_PROCESS",21,-0.826,0.72,0.86,"No",1.1985,0.23,0.78,"Yes"
"14589","C1_Positional","C1_ALL_150_CHR2P15",14,-0.8256,0.71,1,"No",-0.8429,0.69,0.96,"No"
"14590","C2_Chemical_and_genetic_perturbations","C2_CGP_228_BILBAN_B_CLL_LPL_UP",62,-0.8255,0.77,0.83,"No",0.8387,0.82,0.98,"Yes"
"14591","C2_Chemical_and_genetic_perturbations","C2_CGP_1874_HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2",163,-0.8254,0.84,0.83,"No",1.3767,0.0094,0.31,"Yes"
"14592","C2_Chemical_and_genetic_perturbations","C2_CGP_1566_XU_CREBBP_TARGETS_UP",25,-0.8254,0.74,0.83,"No",0.7101,0.89,1,"Yes"
"14593","GO_BP","510759_GO_0048704_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS",94,-0.8254,0.8,0.86,"No",0.8685,0.74,1,"Yes"
"14594","GO_BP","513694_GO_0060136_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY",6,-0.8253,0.68,0.86,"No",-0.5669,0.94,1,"No"
"14595","C4_Cancer_modules","C4_CM_235_MODULE_261",99,-0.8251,0.8,0.84,"No",0.7175,0.97,1,"Yes"
"14596","GO_BP","508446_GO_0046148_PIGMENT_BIOSYNTHETIC_PROCESS",49,-0.8249,0.76,0.86,"No",1.0295,0.39,0.97,"Yes"
"14597","GO_BP","499855_GO_0030516_REGULATION_OF_AXON_EXTENSION",60,-0.8245,0.81,0.86,"No",-0.9439,0.56,1,"No"
"14598","REACTOME","1127683_REACT_264245_HATS_ACETYLATE_HISTONES",140,-0.8245,0.82,0.86,"No",-1.1748,0.14,0.86,"No"
"14599","C2_Chemical_and_genetic_perturbations","C2_CGP_409_LINDGREN_BLADDER_CANCER_CLUSTER_1_UP",118,-0.8244,0.82,0.84,"No",1.8379,0,0.031,"Yes"
"14600","C2_Chemical_and_genetic_perturbations","C2_CGP_2917_MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3",6,-0.8243,0.71,0.84,"No",-1.3149,0.18,0.7,"No"
"14601","C3_TF_targets","C3_TFT_325_V_ALX4_01",16,-0.8242,0.72,0.91,"No",0.703,0.89,1,"Yes"
"14602","GO_BP","514511_GO_0060956_ENDOCARDIAL_CELL_DIFFERENTIATION",6,-0.8238,0.71,0.86,"No",-0.8941,0.59,1,"No"
"14603","C7_Immunologic_signatures","C7_ALL_875_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP",198,-0.8238,0.86,0.91,"No",-0.7066,1,1,"No"
"14604","GO_CC","486658_GO_0000118_HISTONE_DEACETYLASE_COMPLEX",55,-0.8236,0.77,0.93,"No",-0.8873,0.66,0.96,"No"
"14605","GO_BP","512466_GO_0051588_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT",65,-0.8236,0.77,0.86,"No",0.8381,0.79,1,"Yes"
"14606","C4_Cancer_modules","C4_CM_316_MODULE_368",18,-0.8235,0.71,0.84,"No",-1.3701,0.1,0.52,"No"
"14607","GO_BP","492848_GO_0008588_RELEASE_OF_CYTOPLASMIC_SEQUESTERED_NF_KAPPAB",5,-0.8234,0.69,0.86,"No",0.6244,0.91,1,"Yes"
"14608","GO_BP","492337_GO_0007595_LACTATION",39,-0.8233,0.75,0.86,"No",1.2048,0.18,0.78,"Yes"
"14609","KEGG_compound","C14819_FE3_FE_III_FERRIC_ION_IRON_3_",5,-0.8233,0.69,0.8,"No",1.0577,0.39,1,"Yes"
"14610","GO_BP","514647_GO_0061099_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY",17,-0.8233,0.73,0.86,"No",-0.6586,0.91,1,"No"
"14611","GO_MF","504440_GO_0035256_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING",6,-0.8232,0.68,0.86,"No",-1.2009,0.26,0.81,"No"
"14612","C7_Immunologic_signatures","C7_ALL_13_GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP",199,-0.8232,0.87,0.91,"No",0.7739,0.99,1,"Yes"
"14613","C2_Chemical_and_genetic_perturbations","C2_CGP_2567_AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP",292,-0.8232,0.89,0.84,"No",1.1296,0.12,0.58,"Yes"
"14614","GO_MF","503796_GO_0034595_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY",11,-0.8231,0.73,0.86,"No",-0.5891,0.96,1,"No"
"14615","C2_Chemical_and_genetic_perturbations","C2_CGP_791_SCHRAMM_INHBA_TARGETS_DN",23,-0.8231,0.74,0.84,"No",0.7603,0.83,1,"Yes"
"14616","C4_Cancer_modules","C4_CM_157_MODULE_166",54,-0.823,0.8,0.84,"No",1.0096,0.43,0.7,"Yes"
"14617","GO_BP","488236_GO_0002363_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT",8,-0.8229,0.71,0.86,"No",-1.2718,0.19,0.89,"No"
"14618","C2_Chemical_and_genetic_perturbations","C2_CGP_2102_TESAR_JAK_TARGETS_MOUSE_ES_D3_DN",8,-0.8229,0.71,0.84,"No",-1.6444,0.018,0.36,"No"
"14619","WikiPathways","198756_WP241_ONE_CARBON_METABOLISM",29,-0.8228,0.75,0.84,"No",-0.9001,0.63,1,"No"
"14620","GO_BP","750897_GO_0035970_PEPTIDYL_THREONINE_DEPHOSPHORYLATION",9,-0.8228,0.69,0.86,"No",0.392,1,1,"Yes"
"14621","C2_Chemical_and_genetic_perturbations","C2_CGP_2494_JU_AGING_TERC_TARGETS_DN",5,-0.8227,0.71,0.84,"No",1.5373,0.029,0.18,"Yes"
"14622","GO_CC","505548_GO_0042405_NUCLEAR_INCLUSION_BODY",10,-0.8227,0.69,0.93,"No",-0.9611,0.5,0.89,"No"
"14623","C2_Chemical_and_genetic_perturbations","C2_CGP_2625_ELLWOOD_MYC_TARGETS_UP",12,-0.8227,0.69,0.84,"No",0.6382,0.92,1,"Yes"
"14624","GO_CC","501142_GO_0031901_EARLY_ENDOSOME_MEMBRANE",101,-0.8227,0.81,0.93,"No",0.8351,0.85,0.93,"Yes"
"14625","GO_BP","492515_GO_0019079_VIRAL_GENOME_REPLICATION",20,-0.8226,0.72,0.86,"No",0.98,0.47,1,"Yes"
"14626","GO_MF","500742_GO_0031491_NUCLEOSOME_BINDING",43,-0.8225,0.76,0.86,"No",-0.9252,0.58,0.96,"No"
"14627","GO_BP","495281_GO_0014888_STRIATED_MUSCLE_ADAPTATION",24,-0.8225,0.73,0.86,"No",-1.0978,0.31,0.95,"No"
"14628","C2_Chemical_and_genetic_perturbations","C2_CGP_2327_MATZUK_MEIOTIC_AND_DNA_REPAIR",38,-0.8224,0.75,0.84,"No",-1.3177,0.1,0.7,"No"
"14629","C1_Positional","C1_ALL_22_CHR14Q11",132,-0.8223,0.83,1,"No",-1.1598,0.16,1,"No"
"14630","REACTOME","1183579_REACT_355580_FRS2_MEDIATED_FGFR4_SIGNALING",31,-0.8222,0.73,0.86,"No",-0.8377,0.74,1,"No"
"14631","KEGG_reaction","R02241_ACYL_COA_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_O_ACYLTRANSFERASE_PHOSPHATIDATE_COA_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYL_COA",8,-0.822,0.72,0.76,"No",0.7167,0.83,1,"Yes"
"14632","C2_Chemical_and_genetic_perturbations","C2_CGP_1171_SHIN_B_CELL_LYMPHOMA_CLUSTER_9",19,-0.822,0.73,0.84,"No",0.7683,0.8,1,"Yes"
"14633","C7_Immunologic_signatures","C7_ALL_97_GSE11924_TFH_VS_TH2_CD4_TCELL_UP",199,-0.8219,0.87,0.91,"No",-0.9684,0.53,1,"No"
"14634","GO_CC","502397_GO_0033177_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN",21,-0.8219,0.74,0.93,"No",1.4701,0.057,0.23,"Yes"
"14635","GO_CC","490776_GO_0005741_MITOCHONDRIAL_OUTER_MEMBRANE",140,-0.8219,0.85,0.93,"No",1.4288,0.018,0.28,"Yes"
"14636","GO_BP","499513_GO_0030071_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION",47,-0.8217,0.78,0.86,"No",0.8537,0.73,1,"Yes"
"14637","GO_BP","510360_GO_0048245_EOSINOPHIL_CHEMOTAXIS",7,-0.8217,0.7,0.86,"No",1.5841,0.038,0.31,"Yes"
"14638","GO_BP","989120_GO_1903055_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION",9,-0.8215,0.71,0.86,"No",-0.7377,0.79,1,"No"
"14639","GO_BP","491915_GO_0007096_REGULATION_OF_EXIT_FROM_MITOSIS",12,-0.8214,0.69,0.86,"No",0.8622,0.66,1,"Yes"
"14640","GO_BP","511954_GO_0051029_RRNA_TRANSPORT",5,-0.8214,0.69,0.86,"No",1.278,0.21,0.7,"Yes"
"14641","C1_Positional","C1_ALL_148_CHR8P23",70,-0.8213,0.79,1,"No",0.9375,0.55,0.84,"Yes"
"14642","C7_Immunologic_signatures","C7_ALL_227_GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP",172,-0.8213,0.86,0.91,"No",-0.7003,0.99,1,"No"
"14643","REACTOME","730348_REACT_150203_IRS_RELATED_EVENTS_TRIGGERED_BY_IGF1R",83,-0.8212,0.79,0.86,"No",0.8025,0.85,1,"Yes"
"14644","REACTOME","1127524_REACT_264580_REGULATION_OF_FZD_BY_UBIQUITINATION",20,-0.8211,0.73,0.86,"No",0.7031,0.9,1,"Yes"
"14645","C2_BioCarta_Pathways","C2_CP_BIOCARTA_150_BIOCARTA_RB_PATHWAY",13,-0.821,0.71,0.78,"No",-0.7539,0.8,1,"No"
"14646","GO_BP","754193_GO_1901228_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_HEART_DEVELOPMENT",5,-0.8206,0.7,0.86,"No",0.8601,0.62,1,"Yes"
"14647","GO_BP","505289_GO_0042117_MONOCYTE_ACTIVATION",8,-0.8205,0.69,0.86,"No",-0.721,0.82,1,"No"
"14648","GO_MF","496934_GO_0017134_FIBROBLAST_GROWTH_FACTOR_BINDING",20,-0.8204,0.73,0.86,"No",1.012,0.43,0.87,"Yes"
"14649","C2_Chemical_and_genetic_perturbations","C2_CGP_2411_QI_PLASMACYTOMA_DN",97,-0.8204,0.81,0.84,"No",1.3828,0.023,0.31,"Yes"
"14650","GO_BP","514383_GO_0060828_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY",220,-0.8204,0.87,0.86,"No",1.1495,0.13,0.84,"Yes"
"14651","C7_Immunologic_signatures","C7_ALL_1486_GSE360_L_MAJOR_VS_T_GONDII_MAC_DN",196,-0.8204,0.87,0.91,"No",0.9662,0.55,0.85,"Yes"
"14652","GO_CC","752880_GO_0097381_PHOTORECEPTOR_DISC_MEMBRANE",13,-0.82,0.69,0.93,"No",-1.8152,0.0038,0.27,"No"
"14653","C2_Chemical_and_genetic_perturbations","C2_CGP_2208_DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2",117,-0.8197,0.82,0.84,"No",1.425,0.0095,0.28,"Yes"
"14654","C2_Chemical_and_genetic_perturbations","C2_CGP_233_PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN",21,-0.8197,0.74,0.84,"No",1.2349,0.2,0.45,"Yes"
"14655","C4_Cancer_gene_neighborhoods","C4_CGN_66_MORF_BMPR2",50,-0.8197,0.76,1,"No",-0.7587,0.85,1,"No"
"14656","GO_MF","496954_GO_0017160_RAL_GTPASE_BINDING",13,-0.8197,0.73,0.87,"No",-1.2349,0.21,0.84,"No"
"14657","C2_Chemical_and_genetic_perturbations","C2_CGP_2401_CONRAD_STEM_CELL",38,-0.8194,0.74,0.84,"No",0.7793,0.83,1,"Yes"
"14658","C2_Chemical_and_genetic_perturbations","C2_CGP_1948_SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN",21,-0.8194,0.75,0.84,"No",-0.8157,0.73,1,"No"
"14659","WikiPathways","198776_WP666_HYPOTHETICAL_NETWORK_FOR_DRUG_ADDICTION",32,-0.8192,0.75,0.84,"No",-0.9276,0.59,1,"No"
"14660","C4_Cancer_modules","C4_CM_9_MODULE_9",119,-0.8191,0.81,0.84,"No",-0.8698,0.76,0.93,"No"
"14661","C3_MicroRNA_targets","C3_MIR_192_CACCAGC_MIR_138",224,-0.8191,0.9,0.9,"No",-0.686,1,1,"No"
"14662","GO_BP","506343_GO_0043278_RESPONSE_TO_MORPHINE",25,-0.819,0.76,0.87,"No",-0.7903,0.79,1,"No"
"14663","WikiPathways","198831_WP1604_CODEINE_AND_MORPHINE_METABOLISM",8,-0.8189,0.69,0.84,"No",0.7911,0.71,1,"Yes"
"14664","C7_Immunologic_signatures","C7_ALL_1841_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP",198,-0.8188,0.85,0.91,"No",1.6569,0,0.0012,"Yes"
"14665","C4_Cancer_gene_neighborhoods","C4_CGN_65_MORF_BMI1",81,-0.8188,0.79,1,"No",1.409,0.018,0.058,"Yes"
"14666","C2_BioCarta_Pathways","C2_CP_BIOCARTA_39_BIOCARTA_CERAMIDE_PATHWAY",22,-0.8188,0.74,0.78,"No",0.7122,0.9,1,"Yes"
"14667","C2_Chemical_and_genetic_perturbations","C2_CGP_1194_KAUFFMANN_DNA_REPLICATION_GENES",146,-0.8186,0.84,0.84,"No",1.1965,0.12,0.49,"Yes"
"14668","C2_BioCarta_Pathways","C2_CP_BIOCARTA_46_BIOCARTA_CTCF_PATHWAY",23,-0.8186,0.74,0.77,"No",1.3666,0.089,0.51,"Yes"
"14669","GO_BP","510765_GO_0048710_REGULATION_OF_ASTROCYTE_DIFFERENTIATION",25,-0.8186,0.73,0.87,"No",-1.5644,0.022,0.72,"No"
"14670","C2_Chemical_and_genetic_perturbations","C2_CGP_180_BARRIER_COLON_CANCER_RECURRENCE_UP",41,-0.8185,0.78,0.84,"No",1.8711,0.0021,0.025,"Yes"
"14671","REACTOME","1183576_REACT_355144_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING",27,-0.8184,0.75,0.86,"No",0.8165,0.75,0.99,"Yes"
"14672","GO_BP","512102_GO_0051205_PROTEIN_INSERTION_INTO_MEMBRANE",14,-0.8184,0.72,0.87,"No",1.1343,0.28,0.86,"Yes"
"14673","C2_Chemical_and_genetic_perturbations","C2_CGP_1736_MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN",52,-0.8182,0.77,0.84,"No",-1.0219,0.41,0.98,"No"
"14674","GO_BP","504452_GO_0035268_PROTEIN_MANNOSYLATION",18,-0.8181,0.72,0.87,"No",-0.5548,0.98,1,"No"
"14675","GO_BP","487441_GO_0001502_CARTILAGE_CONDENSATION",22,-0.8179,0.74,0.87,"No",-1.439,0.059,0.91,"No"
"14676","REACTOME","530763_REACT_115697_PROLACTIN_RECEPTOR_SIGNALING",14,-0.8177,0.73,0.86,"No",0.8507,0.68,0.96,"Yes"
"14677","OMIM_gene","OMIM167805_REGENERATING_ISLET_DERIVED_3_ALPHA_REG3A",6,-0.8175,0.7,0.86,"No",0.9629,0.51,1,"Yes"
"14678","WikiPathways","698759_WP2290_RALA_DOWNSTREAM_REGULATED_GENES",9,-0.8174,0.71,0.83,"No",1.2209,0.21,0.83,"Yes"
"14679","GO_BP","487847_GO_0001957_INTRAMEMBRANOUS_OSSIFICATION",6,-0.8174,0.71,0.87,"No",-0.9607,0.52,1,"No"
"14680","REACTOME","1127495_REACT_264351_MITOCHONDRIAL_BIOGENESIS",51,-0.8173,0.8,0.86,"No",0.8394,0.76,0.96,"Yes"
"14681","REACTOME","1127582_REACT_264430_MYOCLONIC_EPILEPSY_OF_LAFORA",10,-0.8173,0.7,0.86,"No",1.3271,0.15,0.29,"Yes"
"14682","REACTOME","366224_REACT_75918_INWARDLY_RECTIFYING_K_CHANNELS",30,-0.8173,0.74,0.86,"No",0.8604,0.71,0.94,"Yes"
"14683","C7_Immunologic_signatures","C7_ALL_1295_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP",187,-0.8172,0.86,0.92,"No",0.8947,0.78,1,"Yes"
"14684","GO_BP","1025350_GO_1903214_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION",73,-0.8172,0.79,0.87,"No",1.3755,0.036,0.58,"Yes"
"14685","GO_BP","512543_GO_0051668_LOCALIZATION_WITHIN_MEMBRANE",42,-0.817,0.76,0.87,"No",1.7576,0,0.13,"Yes"
"14686","KEGG_compound","C00093_SN_GLYCEROL_3_PHOSPHATE_GLYCEROPHOSPHORIC_ACID_D_GLYCEROL_1_PHOSPHATE",12,-0.8168,0.73,0.81,"No",1.669,0.024,0.1,"Yes"
"14687","GO_BP","513816_GO_0060260_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER",15,-0.8166,0.72,0.87,"No",0.722,0.88,1,"Yes"
"14688","C7_Immunologic_signatures","C7_ALL_1246_GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN",174,-0.8164,0.86,0.92,"No",0.922,0.68,0.97,"Yes"
"14689","GO_BP","499262_GO_0021983_PITUITARY_GLAND_DEVELOPMENT",43,-0.8162,0.78,0.87,"No",-1.1291,0.28,0.94,"No"
"14690","WikiPathways","198839_WP501_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE",15,-0.8161,0.71,0.83,"No",0.9531,0.54,1,"Yes"
"14691","REACTOME","106369_REACT_16942_HORMONE_LIGAND_BINDING_RECEPTORS",11,-0.816,0.7,0.86,"No",-1.3711,0.1,0.57,"No"
"14692","GO_BP","516349_GO_0071425_HEMATOPOIETIC_STEM_CELL_PROLIFERATION",13,-0.8159,0.71,0.87,"No",0.9061,0.58,1,"Yes"
"14693","GO_BP","1053350_GO_0098743_CELL_AGGREGATION",22,-0.8156,0.72,0.87,"No",-1.4055,0.067,0.98,"No"
"14694","GO_BP","754303_GO_1901341_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",5,-0.8156,0.71,0.87,"No",0.7167,0.81,1,"Yes"
"14695","GO_MF","492403_GO_0050811_GABA_RECEPTOR_BINDING",13,-0.8156,0.73,0.87,"No",1.0169,0.41,0.87,"Yes"
"14696","GO_BP","491268_GO_0006309_APOPTOTIC_DNA_FRAGMENTATION",17,-0.8155,0.7,0.87,"No",0.973,0.49,1,"Yes"
"14697","REACTOME","160948_REACT_21352_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION",143,-0.8153,0.84,0.86,"No",-1.1984,0.13,0.83,"No"
"14698","C4_Cancer_gene_neighborhoods","C4_CGN_238_GCM_MAP1B",65,-0.8151,0.79,1,"No",-0.7596,0.89,1,"No"
"14699","GO_BP","503488_GO_0034285_RESPONSE_TO_DISACCHARIDE",7,-0.815,0.68,0.87,"No",1.0106,0.42,0.98,"Yes"
"14700","REACTOME","1183530_REACT_355504_DISEASES_OF_CARBOHYDRATE_METABOLISM",10,-0.815,0.7,0.86,"No",1.3456,0.13,0.27,"Yes"
"14701","GO_BP","516655_GO_0071732_CELLULAR_RESPONSE_TO_NITRIC_OXIDE",10,-0.8145,0.69,0.87,"No",0.883,0.62,1,"Yes"
"14702","GO_BP","514039_GO_0060484_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT",9,-0.8145,0.72,0.87,"No",-0.8402,0.67,1,"No"
"14703","GO_BP","495260_GO_0014866_SKELETAL_MYOFIBRIL_ASSEMBLY",7,-0.8145,0.69,0.87,"No",-1.7001,0.013,0.64,"No"
"14704","GO_BP","505195_GO_0040037_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",14,-0.8144,0.73,0.87,"No",0.9988,0.44,0.98,"Yes"
"14705","GO_MF","515496_GO_0070566_ADENYLYLTRANSFERASE_ACTIVITY",24,-0.8144,0.76,0.87,"No",1.3201,0.11,0.58,"Yes"
"14706","GO_MF","506276_GO_0043208_GLYCOSPHINGOLIPID_BINDING",8,-0.8144,0.71,0.87,"No",1.0147,0.45,0.87,"Yes"
"14707","GO_BP","512187_GO_0051303_ESTABLISHMENT_OF_CHROMOSOME_LOCALIZATION",51,-0.8143,0.78,0.87,"No",1.467,0.022,0.47,"Yes"
"14708","C3_TF_targets","C3_TFT_494_GTTNYYNNGGTNA_UNKNOWN",86,-0.8142,0.82,0.93,"No",-1.0679,0.33,0.62,"No"
"14709","C1_Positional","C1_ALL_294_CHR18Q11",30,-0.8142,0.74,1,"No",-0.6142,0.96,0.99,"No"
"14710","GO_MF","501234_GO_0031996_THIOESTERASE_BINDING",14,-0.8139,0.71,0.87,"No",0.7856,0.76,1,"Yes"
"14711","REACTOME","833795_REACT_163919_INACTIVATION_RECOVERY_AND_REGULATION_OF_THE_PHOTOTRANSDUCTION_CASCADE",30,-0.8139,0.74,0.86,"No",-1.0804,0.35,0.91,"No"
"14712","C1_Positional","C1_ALL_19_CHR7P13",40,-0.8137,0.77,1,"No",-0.793,0.81,0.96,"No"
"14713","GO_BP","515030_GO_0070092_REGULATION_OF_GLUCAGON_SECRETION",5,-0.8137,0.72,0.87,"No",-1.1805,0.29,0.91,"No"
"14714","GO_BP","504488_GO_0035304_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION",25,-0.8135,0.76,0.87,"No",1.0687,0.34,0.93,"Yes"
"14715","GO_BP","505866_GO_0042760_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS",5,-0.8131,0.71,0.87,"No",0.9823,0.47,1,"Yes"
"14716","GO_MF","496731_GO_0016835_CARBON_OXYGEN_LYASE_ACTIVITY",66,-0.813,0.81,0.87,"No",1.5212,0.011,0.37,"Yes"
"14717","GO_BP","495009_GO_0010944_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING",10,-0.8127,0.7,0.87,"No",-1.2903,0.15,0.88,"No"
"14718","C1_Positional","C1_ALL_278_CHR1Q41",35,-0.8127,0.76,1,"No",0.8744,0.67,0.89,"Yes"
"14719","GO_BP","513769_GO_0060213_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING",11,-0.8126,0.7,0.87,"No",-0.7823,0.77,1,"No"
"14720","GO_BP","491370_GO_0006465_SIGNAL_PEPTIDE_PROCESSING",8,-0.8125,0.69,0.87,"No",1.413,0.092,0.54,"Yes"
"14721","C1_Positional","C1_ALL_184_CHR20P13",70,-0.8121,0.81,1,"No",-0.7139,0.95,0.98,"No"
"14722","KEGG_compound","C00012_PEPTIDE",7,-0.8119,0.71,0.82,"No",1.0301,0.42,1,"Yes"
"14723","GO_BP","505047_GO_0035878_NAIL_DEVELOPMENT",8,-0.8117,0.72,0.87,"No",0.6836,0.88,1,"Yes"
"14724","C7_Immunologic_signatures","C7_ALL_1598_GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN",197,-0.8116,0.86,0.92,"No",1.6811,0,0.00084,"Yes"
"14725","GO_BP","501472_GO_0032237_ACTIVATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",5,-0.8116,0.7,0.87,"No",0.7246,0.78,1,"Yes"
"14726","C2_Chemical_and_genetic_perturbations","C2_CGP_2946_MOOTHA_PYR",8,-0.8115,0.71,0.85,"No",1.412,0.092,0.29,"Yes"
"14727","C4_Cancer_gene_neighborhoods","C4_CGN_253_GCM_PRKAG1",48,-0.8114,0.78,1,"No",0.8528,0.75,0.92,"Yes"
"14728","REACTOME","1127538_REACT_268323_HEDGEHOG_OFF_STATE",100,-0.8114,0.83,0.87,"No",1.7006,0,0.048,"Yes"
"14729","GO_BP","515178_GO_0070243_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS",14,-0.8113,0.73,0.87,"No",0.7523,0.81,1,"Yes"
"14730","C3_TF_targets","C3_TFT_425_GGAMTNNNNNTCCY_UNKNOWN",115,-0.8113,0.84,0.93,"No",-0.832,0.84,1,"No"
"14731","GO_BP","514854_GO_0061309_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS",6,-0.8112,0.7,0.87,"No",0.593,0.94,1,"Yes"
"14732","C2_Chemical_and_genetic_perturbations","C2_CGP_1483_ZHAN_MULTIPLE_MYELOMA_SPIKED",22,-0.8112,0.75,0.85,"No",1.1129,0.32,0.61,"Yes"
"14733","GO_BP","487846_GO_0001956_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION",11,-0.811,0.73,0.87,"No",0.8538,0.66,1,"Yes"
"14734","GO_BP","508031_GO_0045686_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION",23,-0.8109,0.71,0.87,"No",-1.1032,0.33,0.94,"No"
"14735","C2_Chemical_and_genetic_perturbations","C2_CGP_1817_GENTILE_UV_RESPONSE_CLUSTER_D6",37,-0.8108,0.79,0.85,"No",1.081,0.33,0.66,"Yes"
"14736","C2_Chemical_and_genetic_perturbations","C2_CGP_1698_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8",15,-0.8108,0.73,0.85,"No",0.5095,0.99,1,"Yes"
"14737","GO_BP","502494_GO_0033275_ACTIN_MYOSIN_FILAMENT_SLIDING",37,-0.8107,0.76,0.87,"No",1.0755,0.31,0.93,"Yes"
"14738","KEGG_pathway","HSA00400_PHENYLALANINE_TYROSINE_AND_TRYPTOPHAN_BIOSYNTHESIS",5,-0.8107,0.73,0.83,"No",0.6696,0.85,1,"Yes"
"14739","C2_Chemical_and_genetic_perturbations","C2_CGP_2282_BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP",31,-0.8107,0.76,0.85,"No",1.0214,0.42,0.77,"Yes"
"14740","C7_Immunologic_signatures","C7_ALL_1351_GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP",199,-0.8106,0.87,0.92,"No",1.2526,0.032,0.15,"Yes"
"14741","C2_Chemical_and_genetic_perturbations","C2_CGP_3019_WHITFIELD_CELL_CYCLE_G1_S",143,-0.8106,0.84,0.85,"No",0.685,1,1,"Yes"
"14742","C2_Chemical_and_genetic_perturbations","C2_CGP_2711_BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP",65,-0.8105,0.8,0.85,"No",1.0706,0.32,0.68,"Yes"
"14743","GO_BP","515162_GO_0070227_LYMPHOCYTE_APOPTOTIC_PROCESS",19,-0.8104,0.73,0.87,"No",1.4309,0.08,0.52,"Yes"
"14744","C7_Immunologic_signatures","C7_ALL_390_GSE15767_MED_VS_SCS_MAC_LN_DN",199,-0.8104,0.87,0.92,"No",1.1358,0.16,0.35,"Yes"
"14745","GO_BP","507432_GO_0045026_PLASMA_MEMBRANE_FUSION",12,-0.8103,0.71,0.87,"No",0.864,0.63,1,"Yes"
"14746","REACTOME","1183572_REACT_355212_FRS_MEDIATED_FGFR3_SIGNALING",31,-0.81,0.76,0.87,"No",-0.6581,0.95,1,"No"
"14747","GO_MF","489517_GO_0017110_NUCLEOSIDE_DIPHOSPHATASE_ACTIVITY",12,-0.8099,0.72,0.88,"No",0.5949,0.93,1,"Yes"
"14748","GO_BP","492456_GO_0008089_ANTEROGRADE_AXON_CARGO_TRANSPORT",24,-0.8099,0.74,0.87,"No",1.236,0.16,0.75,"Yes"
"14749","WikiPathways","198903_WP383_STRIATED_MUSCLE_CONTRACTION",37,-0.8098,0.76,0.84,"No",1.1788,0.21,0.93,"Yes"
"14750","GO_BP","499500_GO_0030049_MUSCLE_FILAMENT_SLIDING",37,-0.8097,0.76,0.87,"No",1.0466,0.36,0.95,"Yes"
"14751","C7_Immunologic_signatures","C7_ALL_1696_GSE3982_BASOPHIL_VS_TH2_DN",195,-0.8096,0.88,0.93,"No",1.2573,0.043,0.15,"Yes"
"14752","GO_BP","500208_GO_0030913_PARANODAL_JUNCTION_ASSEMBLY",7,-0.8096,0.7,0.87,"No",-0.5132,0.98,1,"No"
"14753","GO_BP","516204_GO_0071280_CELLULAR_RESPONSE_TO_COPPER_ION",6,-0.8096,0.71,0.87,"No",0.8175,0.69,1,"Yes"
"14754","GO_BP","489140_GO_0003348_CARDIAC_ENDOTHELIAL_CELL_DIFFERENTIATION",6,-0.8096,0.72,0.87,"No",-0.8833,0.59,1,"No"
"14755","C2_Chemical_and_genetic_perturbations","C2_CGP_1084_COURTOIS_SENESCENCE_TRIGGERS",6,-0.8095,0.73,0.85,"No",-0.7198,0.81,1,"No"
"14756","GO_MF","492788_GO_0008508_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY",6,-0.8095,0.7,0.88,"No",-1.6575,0.0083,0.4,"No"
"14757","C7_Immunologic_signatures","C7_ALL_1051_GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP",199,-0.8093,0.88,0.93,"No",-0.6773,1,1,"No"
"14758","C7_Immunologic_signatures","C7_ALL_1215_GSE27786_NKCELL_VS_ERYTHROBLAST_UP",200,-0.8091,0.89,0.93,"No",1.0769,0.26,0.51,"Yes"
"14759","GO_CC","490907_GO_0030119_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX",40,-0.8091,0.75,0.94,"No",0.982,0.46,0.81,"Yes"
"14760","C7_Immunologic_signatures","C7_ALL_293_GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP",195,-0.8088,0.88,0.93,"No",1.0632,0.3,0.55,"Yes"
"14761","GO_BP","516321_GO_0071397_CELLULAR_RESPONSE_TO_CHOLESTEROL",13,-0.8088,0.74,0.88,"No",-0.5659,0.97,1,"No"
"14762","GO_BP","501460_GO_0032225_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC",16,-0.8088,0.73,0.88,"No",-0.984,0.49,1,"No"
"14763","KEGG_compound","C00369_STARCH",10,-0.8085,0.71,0.82,"No",-1.0214,0.42,1,"No"
"14764","GO_BP","494892_GO_0010828_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT",31,-0.8085,0.75,0.88,"No",1.122,0.26,0.88,"Yes"
"14765","C7_Immunologic_signatures","C7_ALL_831_GSE18148_CBFB_KO_VS_WT_TREG_UP",179,-0.8085,0.88,0.93,"No",0.9316,0.64,0.95,"Yes"
"14766","GO_BP","505858_GO_0042752_REGULATION_OF_CIRCADIAN_RHYTHM",89,-0.8085,0.82,0.88,"No",-0.9776,0.49,1,"No"
"14767","GO_BP","516264_GO_0071340_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING",7,-0.8085,0.69,0.88,"No",-0.9567,0.52,1,"No"
"14768","KEGG_reaction","R10092_CARBONATE_HYDRO_LYASE_CARBON_DIOXIDE_FORMING_HCO3_H_CO2_H2O",13,-0.8083,0.72,0.77,"No",0.7981,0.76,1,"Yes"
"14769","GO_BP","491957_GO_0007144_FEMALE_MEIOSIS_I",6,-0.8081,0.72,0.88,"No",-0.9661,0.49,1,"No"
"14770","GO_BP","516285_GO_0071361_CELLULAR_RESPONSE_TO_ETHANOL",8,-0.8078,0.72,0.88,"No",1.0177,0.46,0.97,"Yes"
"14771","GO_BP","504448_GO_0035264_MULTICELLULAR_ORGANISM_GROWTH",76,-0.8077,0.83,0.88,"No",-0.9054,0.65,1,"No"
"14772","GO_CC","506262_GO_0043194_AXON_INITIAL_SEGMENT",10,-0.8076,0.7,0.94,"No",-1.4517,0.091,0.62,"No"
"14773","C2_Chemical_and_genetic_perturbations","C2_CGP_840_OXFORD_RALB_TARGETS_DN",9,-0.8076,0.71,0.86,"No",0.9933,0.45,0.81,"Yes"
"14774","GO_MF","987827_GO_0061631_UBIQUITIN_CONJUGATING_ENZYME_ACTIVITY",19,-0.8073,0.74,0.88,"No",0.7836,0.78,1,"Yes"
"14775","C2_Chemical_and_genetic_perturbations","C2_CGP_1283_CHESLER_BRAIN_QTL_CIS",74,-0.8072,0.81,0.86,"No",1.2549,0.11,0.43,"Yes"
"14776","C1_Positional","C1_ALL_165_CHR10Q22",98,-0.8071,0.83,1,"No",0.7921,0.89,0.95,"Yes"
"14777","C6_Oncogenic_signatures","C6_ALL_145_YAP1_DN",42,-0.807,0.76,0.88,"No",-1.0264,0.39,0.62,"No"
"14778","GO_BP","508890_GO_0046642_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION",6,-0.8068,0.7,0.88,"No",1.2514,0.21,0.73,"Yes"
"14779","C2_Chemical_and_genetic_perturbations","C2_CGP_1052_GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN",171,-0.8068,0.89,0.86,"No",1.5691,0,0.16,"Yes"
"14780","C3_TF_targets","C3_TFT_381_GCGNNANTTCC_UNKNOWN",123,-0.8068,0.83,0.94,"No",1.0462,0.35,1,"Yes"
"14781","GO_BP","501756_GO_0032526_RESPONSE_TO_RETINOIC_ACID",108,-0.8067,0.84,0.88,"No",1.1971,0.12,0.78,"Yes"
"14782","C1_Positional","C1_ALL_45_CHR22Q",6,-0.8067,0.73,1,"No",0.6969,0.84,1,"Yes"
"14783","C3_TF_targets","C3_TFT_165_V_MEF2_04",24,-0.8064,0.76,0.94,"No",0.5516,0.99,1,"Yes"
"14784","GO_BP","506620_GO_0043589_SKIN_MORPHOGENESIS",9,-0.8063,0.75,0.88,"No",-0.9555,0.53,1,"No"
"14785","GO_BP","518319_GO_0090179_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE",13,-0.806,0.72,0.88,"No",1.1647,0.26,0.82,"Yes"
"14786","REACTOME","1127581_REACT_264090_GLYCOGEN_STORAGE_DISEASES",10,-0.8059,0.72,0.87,"No",1.3011,0.15,0.32,"Yes"
"14787","C3_MicroRNA_targets","C3_MIR_208_ATCTTGC_MIR_31",77,-0.8058,0.82,0.92,"No",0.7732,0.91,1,"Yes"
"14788","GO_BP","496435_GO_0016458_GENE_SILENCING",121,-0.8058,0.84,0.88,"No",-1.2818,0.061,0.89,"No"
"14789","GO_BP","510991_GO_0050000_CHROMOSOME_LOCALIZATION",51,-0.8057,0.79,0.88,"No",1.4628,0.024,0.48,"Yes"
"14790","C1_Positional","C1_ALL_288_CHR2P12",24,-0.8057,0.77,1,"No",1.3712,0.1,0.44,"Yes"
"14791","GO_BP","488340_GO_0002467_GERMINAL_CENTER_FORMATION",8,-0.8056,0.71,0.88,"No",-1.1761,0.26,0.9,"No"
"14792","GO_MF","495531_GO_0015280_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY",8,-0.8056,0.71,0.88,"No",-1.2008,0.26,0.81,"No"
"14793","GO_BP","486613_GO_0000070_MITOTIC_SISTER_CHROMATID_SEGREGATION",77,-0.8055,0.81,0.88,"No",1.0269,0.39,0.97,"Yes"
"14794","C7_Immunologic_signatures","C7_ALL_1016_GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN",200,-0.8054,0.89,0.93,"No",1.8154,0,3.1e-05,"Yes"
"14795","GO_BP","513997_GO_0060442_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS",11,-0.8052,0.72,0.88,"No",1.0926,0.35,0.91,"Yes"
"14796","C2_Chemical_and_genetic_perturbations","C2_CGP_1847_BURTON_ADIPOGENESIS_4",46,-0.805,0.77,0.86,"No",1.1876,0.18,0.51,"Yes"
"14797","C2_Chemical_and_genetic_perturbations","C2_CGP_1080_SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP",20,-0.8048,0.75,0.86,"No",0.8868,0.61,0.94,"Yes"
"14798","C4_Cancer_gene_neighborhoods","C4_CGN_201_GCM_HDAC1",38,-0.8048,0.78,1,"No",1.4456,0.037,0.045,"Yes"
"14799","C2_Chemical_and_genetic_perturbations","C2_CGP_1359_ZUCCHI_METASTASIS_UP",42,-0.8047,0.79,0.86,"No",1.3621,0.076,0.33,"Yes"
"14800","GO_BP","514300_GO_0060745_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY",5,-0.8047,0.71,0.88,"No",-0.8623,0.63,1,"No"
"14801","C1_Positional","C1_ALL_221_CHR5Q11",39,-0.8047,0.79,1,"No",0.8658,0.7,0.89,"Yes"
"14802","GO_BP","518403_GO_0090263_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY",127,-0.8047,0.87,0.88,"No",1.2501,0.072,0.73,"Yes"
"14803","GO_CC","499551_GO_0030118_CLATHRIN_COAT",45,-0.8047,0.76,0.95,"No",1.0869,0.3,0.67,"Yes"
"14804","GO_BP","495228_GO_0014832_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION",7,-0.8045,0.74,0.88,"No",0.7197,0.82,1,"Yes"
"14805","C2_Chemical_and_genetic_perturbations","C2_CGP_2269_SMID_BREAST_CANCER_LUMINAL_A_DN",18,-0.8045,0.74,0.86,"No",1.078,0.34,0.66,"Yes"
"14806","C2_Chemical_and_genetic_perturbations","C2_CGP_3265_LOPEZ_TRANSLATION_VIA_FN1_SIGNALING",35,-0.8045,0.77,0.86,"No",1.3415,0.099,0.35,"Yes"
"14807","C2_Chemical_and_genetic_perturbations","C2_CGP_2336_MATZUK_SPERMATID_DIFFERENTIATION",36,-0.8044,0.76,0.86,"No",1.152,0.22,0.55,"Yes"
"14808","REACTOME","576250_REACT_118638_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR_",161,-0.8044,0.88,0.88,"No",1.2028,0.083,0.44,"Yes"
"14809","C2_Chemical_and_genetic_perturbations","C2_CGP_682_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23",19,-0.8039,0.73,0.86,"No",-0.9315,0.55,1,"No"
"14810","GO_BP","514853_GO_0061308_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_HEART_DEVELOPMENT",6,-0.8038,0.73,0.88,"No",0.5873,0.95,1,"Yes"
"14811","GO_CC","502398_GO_0033178_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN",17,-0.8038,0.74,0.95,"No",1.859,0.004,0.016,"Yes"
"14812","REACTOME","105781_REACT_1321_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION",10,-0.8037,0.72,0.88,"No",0.7771,0.76,1,"Yes"
"14813","GO_BP","519411_GO_2000772_REGULATION_OF_CELLULAR_SENESCENCE",23,-0.8033,0.76,0.88,"No",-0.8922,0.64,1,"No"
"14814","GO_CC","507611_GO_0045239_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX",11,-0.803,0.75,0.95,"No",0.8749,0.61,0.92,"Yes"
"14815","REACTOME","105765_REACT_152_CELL_CYCLE_MITOTIC",475,-0.8027,0.95,0.88,"No",1.215,0.042,0.43,"Yes"
"14816","C4_Cancer_gene_neighborhoods","C4_CGN_283_GNF2_BNIP2",34,-0.8027,0.78,1,"No",1.7175,0.0022,0.0054,"Yes"
"14817","GO_BP","491982_GO_0007182_COMMON_PARTNER_SMAD_PROTEIN_PHOSPHORYLATION",6,-0.8026,0.73,0.88,"No",-0.9029,0.58,1,"No"
"14818","GO_BP","514004_GO_0060449_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING",5,-0.8025,0.7,0.88,"No",-1.0712,0.41,0.96,"No"
"14819","GO_BP","508290_GO_0045990_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION",7,-0.8025,0.72,0.88,"No",-0.6061,0.93,1,"No"
"14820","C4_Cancer_modules","C4_CM_32_MODULE_36",160,-0.8024,0.88,0.87,"No",1.2797,0.053,0.3,"Yes"
"14821","GO_MF","505926_GO_0042826_HISTONE_DEACETYLASE_BINDING",79,-0.8023,0.82,0.88,"No",0.6296,1,1,"Yes"
"14822","C7_Immunologic_signatures","C7_ALL_1656_GSE3982_MAC_VS_NKCELL_DN",191,-0.8023,0.9,0.93,"No",0.9134,0.71,0.99,"Yes"
"14823","GO_BP","491281_GO_0006337_NUCLEOSOME_DISASSEMBLY",17,-0.8022,0.72,0.88,"No",0.843,0.69,1,"Yes"
"14824","GO_BP","494041_GO_0009952_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION",195,-0.8021,0.9,0.88,"No",1.0507,0.33,0.95,"Yes"
"14825","C1_Positional","C1_ALL_97_CHR7Q31",85,-0.8018,0.82,1,"No",-1.0556,0.37,1,"No"
"14826","GO_MF","489273_GO_0003730_MRNA_3_UTR_BINDING",36,-0.8017,0.78,0.88,"No",-0.8516,0.73,1,"No"
"14827","GO_BP","494891_GO_0010827_REGULATION_OF_GLUCOSE_TRANSPORT",86,-0.8016,0.86,0.88,"No",0.9394,0.59,1,"Yes"
"14828","C2_Chemical_and_genetic_perturbations","C2_CGP_1877_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP",15,-0.8016,0.75,0.86,"No",0.9836,0.47,0.81,"Yes"
"14829","C1_Positional","C1_ALL_34_CHR3Q28",21,-0.8015,0.76,0.99,"No",1.1705,0.25,0.61,"Yes"
"14830","GO_BP","505034_GO_0035865_CELLULAR_RESPONSE_TO_POTASSIUM_ION",7,-0.8013,0.73,0.88,"No",-0.698,0.85,1,"No"
"14831","KEGG_compound","C00117_D_RIBOSE_5_PHOSPHATE_RIBOSE_5_PHOSPHATE",13,-0.8013,0.72,0.83,"No",1.4479,0.071,0.4,"Yes"
"14832","GO_BP","512116_GO_0051220_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN",32,-0.8012,0.77,0.88,"No",0.844,0.72,1,"Yes"
"14833","C7_Immunologic_signatures","C7_ALL_315_GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP",190,-0.8011,0.9,0.94,"No",-0.5886,1,1,"No"
"14834","REACTOME","161038_REACT_20510_RSK_ACTIVATION",6,-0.8009,0.72,0.88,"No",-0.7019,0.84,1,"No"
"14835","C3_MicroRNA_targets","C3_MIR_141_CTGTTAC_MIR_194",106,-0.8008,0.83,0.92,"No",0.7423,0.97,1,"Yes"
"14836","C2_BioCarta_Pathways","C2_CP_BIOCARTA_26_BIOCARTA_RANKL_PATHWAY",14,-0.8008,0.73,0.79,"No",0.8677,0.63,0.91,"Yes"
"14837","GO_BP","494660_GO_0010596_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION",33,-0.8005,0.77,0.88,"No",-0.7213,0.89,1,"No"
"14838","C1_Positional","C1_ALL_61_CHR1P35",98,-0.8005,0.84,0.99,"No",-1.1339,0.2,1,"No"
"14839","GO_MF","490454_GO_0005212_STRUCTURAL_CONSTITUENT_OF_EYE_LENS",19,-0.7995,0.76,0.89,"No",1.1286,0.29,0.75,"Yes"
"14840","C1_Positional","C1_ALL_229_CHRXP11",140,-0.7995,0.88,0.98,"No",-1.1779,0.15,1,"No"
"14841","C2_Chemical_and_genetic_perturbations","C2_CGP_2622_MIKKELSEN_DEDIFFERENTIATED_STATE_UP",8,-0.7995,0.72,0.87,"No",-1.1751,0.26,0.83,"No"
"14842","GO_BP","504700_GO_0035519_PROTEIN_K29_LINKED_UBIQUITINATION",5,-0.7993,0.72,0.89,"No",0.6263,0.91,1,"Yes"
"14843","GO_BP","518177_GO_0090030_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",13,-0.7992,0.73,0.89,"No",1.0305,0.41,0.97,"Yes"
"14844","C2_Chemical_and_genetic_perturbations","C2_CGP_2114_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS",40,-0.7992,0.76,0.87,"No",0.8872,0.66,0.94,"Yes"
"14845","GO_BP","499630_GO_0030220_PLATELET_FORMATION",16,-0.7992,0.76,0.89,"No",1.0641,0.35,0.94,"Yes"
"14846","C2_Chemical_and_genetic_perturbations","C2_CGP_1051_GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP",57,-0.7989,0.82,0.87,"No",-1.2839,0.09,0.7,"No"
"14847","GO_BP","499318_GO_0022400_REGULATION_OF_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY",31,-0.7989,0.78,0.89,"No",-1.0896,0.32,0.95,"No"
"14848","GO_BP","946558_GO_0098901_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",17,-0.7986,0.76,0.89,"No",0.6831,0.89,1,"Yes"
"14849","GO_BP","492773_GO_0046058_CAMP_METABOLIC_PROCESS",34,-0.7984,0.78,0.89,"No",-1.1008,0.34,0.94,"No"
"14850","GO_CC","518588_GO_0097038_PERINUCLEAR_ENDOPLASMIC_RETICULUM",11,-0.798,0.73,0.95,"No",-0.6087,0.95,1,"No"
"14851","GO_BP","487906_GO_0002016_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN",10,-0.7979,0.73,0.89,"No",1.281,0.18,0.7,"Yes"
"14852","GO_BP","500749_GO_0031498_CHROMATIN_DISASSEMBLY",17,-0.7976,0.73,0.89,"No",0.8376,0.72,1,"Yes"
"14853","C7_Immunologic_signatures","C7_ALL_955_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP",198,-0.7976,0.9,0.94,"No",1.335,0.018,0.073,"Yes"
"14854","GO_MF","750757_GO_0001205_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",23,-0.7976,0.75,0.89,"No",-0.5794,0.97,1,"No"
"14855","C2_Chemical_and_genetic_perturbations","C2_CGP_1007_LIU_LIVER_CANCER",37,-0.7976,0.78,0.87,"No",1.0965,0.3,0.64,"Yes"
"14856","GO_BP","502208_GO_0032986_PROTEIN_DNA_COMPLEX_DISASSEMBLY",17,-0.7974,0.75,0.89,"No",0.8389,0.69,1,"Yes"
"14857","GO_BP","513792_GO_0060236_REGULATION_OF_MITOTIC_SPINDLE_ORGANIZATION",20,-0.7974,0.76,0.89,"No",1.2618,0.16,0.72,"Yes"
"14858","REACTOME","1127542_REACT_268718_HEDGEHOG_ON_STATE",84,-0.7972,0.86,0.88,"No",1.6748,0,0.058,"Yes"
"14859","GO_BP","516961_GO_0072044_COLLECTING_DUCT_DEVELOPMENT",12,-0.7972,0.75,0.89,"No",-1.2672,0.17,0.89,"No"
"14860","GO_BP","506015_GO_0042921_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY",8,-0.7971,0.73,0.89,"No",-0.6759,0.88,1,"No"
"14861","C2_Chemical_and_genetic_perturbations","C2_CGP_1173_ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN",103,-0.7969,0.84,0.87,"No",0.7261,0.98,1,"Yes"
"14862","GO_BP","515190_GO_0070255_REGULATION_OF_MUCUS_SECRETION",11,-0.7969,0.73,0.89,"No",1.4372,0.08,0.51,"Yes"
"14863","C2_Chemical_and_genetic_perturbations","C2_CGP_3109_FUKUSHIMA_TNFSF11_TARGETS",16,-0.7965,0.75,0.87,"No",-0.9713,0.52,1,"No"
"14864","C7_Immunologic_signatures","C7_ALL_63_GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP",197,-0.7964,0.92,0.94,"No",0.8581,0.88,1,"Yes"
"14865","C7_Immunologic_signatures","C7_ALL_564_GSE17721_PAM3CSK4_VS_CPG_0_5H_BMDM_DN",196,-0.7964,0.9,0.94,"No",1.6551,0,0.0012,"Yes"
"14866","C3_MicroRNA_targets","C3_MIR_44_GCGCCTT_MIR_525_MIR_524",15,-0.7961,0.75,0.92,"No",1.1275,0.3,1,"Yes"
"14867","GO_BP","515824_GO_0070897_DNA_TEMPLATED_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY",7,-0.7961,0.73,0.89,"No",1.0878,0.37,0.92,"Yes"
"14868","GO_BP","510634_GO_0048569_POST_EMBRYONIC_ORGAN_DEVELOPMENT",12,-0.7961,0.75,0.89,"No",-0.7229,0.83,1,"No"
"14869","C2_Chemical_and_genetic_perturbations","C2_CGP_24_KORKOLA_SEMINOMA_DN",11,-0.7959,0.73,0.87,"No",-1.0783,0.38,0.95,"No"
"14870","GO_CC","500778_GO_0031527_FILOPODIUM_MEMBRANE",17,-0.7958,0.75,0.95,"No",0.704,0.86,0.99,"Yes"
"14871","GO_BP","494459_GO_0010389_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",37,-0.7958,0.79,0.89,"No",1.2248,0.16,0.76,"Yes"
"14872","GO_MF","496627_GO_0016706_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_2_OXOGLUTARATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_EACH_OF_OXYGEN_INTO_BOTH_DONORS",48,-0.7956,0.79,0.89,"No",-0.7436,0.9,1,"No"
"14873","REACTOME","1127528_REACT_264199_PCP_CE_PATHWAY",91,-0.7954,0.86,0.88,"No",1.5531,0.0044,0.12,"Yes"
"14874","C2_Chemical_and_genetic_perturbations","C2_CGP_2287_GALI_TP53_TARGETS_APOPTOTIC_DN",6,-0.7953,0.73,0.87,"No",-0.5322,0.97,1,"No"
"14875","C2_Chemical_and_genetic_perturbations","C2_CGP_3294_MALIK_REPRESSED_BY_ESTROGEN",12,-0.795,0.75,0.87,"No",-1.0007,0.45,1,"No"
"14876","GO_MF","496636_GO_0016715_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",5,-0.7949,0.73,0.89,"No",-0.6955,0.86,1,"No"
"14877","GO_BP","501238_GO_0032000_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION",8,-0.7949,0.75,0.89,"No",0.796,0.72,1,"Yes"
"14878","GO_BP","492103_GO_0007339_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA",31,-0.7946,0.8,0.89,"No",0.9612,0.5,1,"Yes"
"14879","C2_BioCarta_Pathways","C2_CP_BIOCARTA_208_BIOCARTA_CREB_PATHWAY",27,-0.7945,0.77,0.8,"No",1.1976,0.21,0.7,"Yes"
"14880","GO_BP","495049_GO_0010984_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE",12,-0.7944,0.74,0.89,"No",-1.3306,0.14,0.9,"No"
"14881","REACTOME","106239_REACT_1830_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR",7,-0.7944,0.73,0.89,"No",-0.7919,0.73,1,"No"
"14882","GO_BP","754493_GO_1901533_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",22,-0.7943,0.76,0.89,"No",-1.3906,0.077,1,"No"
"14883","REACTOME","187201_REACT_23767_CGMP_EFFECTS",18,-0.7939,0.73,0.88,"No",0.7731,0.78,1,"Yes"
"14884","GO_BP","513617_GO_0060059_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",8,-0.7936,0.74,0.89,"No",0.9488,0.52,1,"Yes"
"14885","GO_CC","497910_GO_0019028_VIRAL_CAPSID",6,-0.7935,0.78,0.96,"No",-0.9971,0.49,0.86,"No"
"14886","GO_BP","504597_GO_0035413_POSITIVE_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS",11,-0.7934,0.74,0.89,"No",0.9611,0.51,1,"Yes"
"14887","GO_MF","493074_GO_0019104_DNA_N_GLYCOSYLASE_ACTIVITY",13,-0.7934,0.74,0.89,"No",1.5157,0.055,0.37,"Yes"
"14888","C2_Chemical_and_genetic_perturbations","C2_CGP_2848_HOSHIDA_LIVER_CANCER_SUBCLASS_S2",115,-0.7933,0.88,0.87,"No",1.6011,0,0.14,"Yes"
"14889","GO_BP","497013_GO_0018027_PEPTIDYL_LYSINE_DIMETHYLATION",9,-0.7933,0.73,0.89,"No",-0.7831,0.73,1,"No"
"14890","GO_CC","496873_GO_0017053_TRANSCRIPTIONAL_REPRESSOR_COMPLEX",71,-0.7932,0.83,0.95,"No",1.0305,0.42,0.74,"Yes"
"14891","GO_BP","1022150_GO_1903146_REGULATION_OF_MITOCHONDRION_DEGRADATION",140,-0.7926,0.89,0.89,"No",1.1349,0.17,0.86,"Yes"
"14892","GO_BP","501285_GO_0032048_CARDIOLIPIN_METABOLIC_PROCESS",13,-0.7925,0.75,0.89,"No",-0.9582,0.53,1,"No"
"14893","REACTOME","1127587_REACT_268749_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE",18,-0.7922,0.76,0.89,"No",1.4156,0.082,0.21,"Yes"
"14894","WikiPathways","698755_WP2289_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY",17,-0.7922,0.74,0.86,"No",-1.0082,0.44,1,"No"
"14895","C2_Chemical_and_genetic_perturbations","C2_CGP_1500_ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP",89,-0.7921,0.87,0.87,"No",0.6883,0.98,1,"Yes"
"14896","GO_MF","506256_GO_0043184_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING",6,-0.792,0.75,0.89,"No",1.4043,0.081,0.49,"Yes"
"14897","GO_BP","514598_GO_0061050_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT",6,-0.7919,0.73,0.89,"No",0.6711,0.85,1,"Yes"
"14898","C1_Positional","C1_ALL_293_CHR16P13",264,-0.7919,0.93,0.99,"No",-1.0842,0.24,1,"No"
"14899","GO_BP","754347_GO_1901385_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",19,-0.7918,0.75,0.89,"No",-1.1085,0.31,0.94,"No"
"14900","GO_BP","1144983_GO_1903845_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",72,-0.7915,0.84,0.89,"No",1.0194,0.4,0.97,"Yes"
"14901","GO_CC","751046_GO_0036126_SPERM_FLAGELLUM",40,-0.7915,0.8,0.96,"No",-1.3654,0.082,0.61,"No"
"14902","GO_BP","491532_GO_0006642_TRIGLYCERIDE_MOBILIZATION",5,-0.7913,0.71,0.89,"No",0.5026,0.99,1,"Yes"
"14903","REACTOME","105928_REACT_9509_GAP_JUNCTION_ASSEMBLY",18,-0.7913,0.77,0.89,"No",-1.3198,0.13,0.62,"No"
"14904","C4_Cancer_gene_neighborhoods","C4_CGN_171_MORF_RAP1A",137,-0.7912,0.9,1,"No",0.7214,0.99,1,"Yes"
"14905","C1_Positional","C1_ALL_21_CHR8Q22",72,-0.7912,0.86,0.99,"No",1.564,0.0021,0.27,"Yes"
"14906","GO_BP","491393_GO_0006493_PROTEIN_O_LINKED_GLYCOSYLATION",97,-0.7909,0.87,0.89,"No",0.6553,1,1,"Yes"
"14907","GO_BP","513767_GO_0060211_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING",11,-0.7906,0.74,0.89,"No",-0.7943,0.73,1,"No"
"14908","GO_MF","496581_GO_0016641_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",15,-0.7905,0.77,0.9,"No",-1.3409,0.13,0.7,"No"
"14909","C7_Immunologic_signatures","C7_ALL_1823_GSE7852_THYMUS_VS_FAT_TCONV_UP",199,-0.7905,0.92,0.95,"No",1.3031,0.019,0.099,"Yes"
"14910","REACTOME","161069_REACT_20603_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY",10,-0.7904,0.75,0.89,"No",-0.9104,0.57,1,"No"
"14911","GO_BP","513949_GO_0060393_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",57,-0.7903,0.83,0.89,"No",1.0947,0.29,0.91,"Yes"
"14912","GO_BP","494626_GO_0010561_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",10,-0.7903,0.75,0.89,"No",-0.6585,0.88,1,"No"
"14913","GO_BP","491854_GO_0007026_NEGATIVE_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION",23,-0.7903,0.78,0.89,"No",0.9518,0.52,1,"Yes"
"14914","GO_MF","500948_GO_0031702_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING",10,-0.7901,0.76,0.9,"No",1.5057,0.06,0.38,"Yes"
"14915","GO_MF","506463_GO_0043425_BHLH_TRANSCRIPTION_FACTOR_BINDING",27,-0.7901,0.81,0.9,"No",-0.6818,0.91,1,"No"
"14916","GO_BP","489130_GO_0003338_METANEPHROS_MORPHOGENESIS",26,-0.79,0.77,0.89,"No",0.8959,0.63,1,"Yes"
"14917","GO_BP","499851_GO_0030512_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",72,-0.7899,0.84,0.89,"No",0.9981,0.49,0.98,"Yes"
"14918","C4_Cancer_gene_neighborhoods","C4_CGN_1_MORF_ATRX",210,-0.7897,0.93,1,"No",-0.7557,0.98,1,"No"
"14919","GO_BP","503895_GO_0034695_RESPONSE_TO_PROSTAGLANDIN_E",15,-0.7895,0.76,0.89,"No",0.9987,0.45,0.98,"Yes"
"14920","C2_Chemical_and_genetic_perturbations","C2_CGP_1292_GOLDRATH_HOMEOSTATIC_PROLIFERATION",170,-0.7891,0.89,0.88,"No",2.0465,0,0.0038,"Yes"
"14921","C1_Positional","C1_ALL_234_CHR8P12",36,-0.7891,0.77,0.99,"No",-0.9467,0.55,1,"No"
"14922","REACTOME","1127588_REACT_268678_DEFECTIVE_B3GAT3_CAUSES_JDSSDHD",18,-0.7887,0.74,0.89,"No",1.403,0.087,0.22,"Yes"
"14923","GO_BP","508900_GO_0046654_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS",5,-0.7887,0.75,0.9,"No",-0.8499,0.66,1,"No"
"14924","KEGG_compound","C00155_L_HOMOCYSTEINE_L_2_AMINO_4_MERCAPTOBUTYRIC_ACID_HOMOCYSTEINE",5,-0.7884,0.74,0.85,"No",-1.2229,0.23,0.77,"No"
"14925","GO_BP","499037_GO_0021756_STRIATUM_DEVELOPMENT",15,-0.7883,0.75,0.9,"No",-0.9789,0.49,1,"No"
"14926","C2_Chemical_and_genetic_perturbations","C2_CGP_2602_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5",69,-0.788,0.84,0.88,"No",-1.307,0.074,0.69,"No"
"14927","REACTOME","833793_REACT_163722_THE_PHOTOTRANSDUCTION_CASCADE",31,-0.7879,0.79,0.89,"No",-1.0386,0.39,0.96,"No"
"14928","C4_Cancer_gene_neighborhoods","C4_CGN_281_CAR_WBSCR22",35,-0.7875,0.81,1,"No",-1.1748,0.21,0.69,"No"
"14929","KEGG_compound","C00035_GDP_GUANOSINE_5_DIPHOSPHATE_GUANOSINE_DIPHOSPHATE",36,-0.7875,0.81,0.85,"No",0.8931,0.63,1,"Yes"
"14930","GO_BP","507084_GO_0044068_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS",14,-0.7875,0.77,0.9,"No",0.8068,0.74,1,"Yes"
"14931","GO_BP","512659_GO_0051788_RESPONSE_TO_MISFOLDED_PROTEIN",11,-0.7874,0.75,0.9,"No",0.6533,0.89,1,"Yes"
"14932","GO_BP","517189_GO_0072273_METANEPHRIC_NEPHRON_MORPHOGENESIS",21,-0.7873,0.77,0.9,"No",-0.781,0.79,1,"No"
"14933","C7_Immunologic_signatures","C7_ALL_479_GSE17721_CTRL_VS_PAM3CSK4_0_5H_BMDM_UP",198,-0.7872,0.91,0.95,"No",1.4054,0.0048,0.035,"Yes"
"14934","GO_BP","518276_GO_0090136_EPITHELIAL_CELL_CELL_ADHESION",14,-0.7871,0.76,0.9,"No",-1.6427,0.012,0.7,"No"
"14935","C7_Immunologic_signatures","C7_ALL_252_GSE14308_TH2_VS_NATURAL_TREG_DN",195,-0.787,0.92,0.95,"No",-0.9512,0.58,1,"No"
"14936","C3_TF_targets","C3_TFT_458_GGCNKCCATNK_UNKNOWN",119,-0.7867,0.88,0.96,"No",1.3585,0.022,0.41,"Yes"
"14937","GO_BP","501588_GO_0032353_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS",8,-0.7866,0.74,0.9,"No",-0.951,0.51,1,"No"
"14938","C7_Immunologic_signatures","C7_ALL_100_GSE11924_TFH_VS_TH17_CD4_TCELL_DN",199,-0.7866,0.91,0.95,"No",1.3275,0.026,0.079,"Yes"
"14939","GO_MF","499679_GO_0030275_LRR_DOMAIN_BINDING",17,-0.7865,0.75,0.9,"No",-1.0542,0.39,0.87,"No"
"14940","C4_Cancer_modules","C4_CM_58_MODULE_62",89,-0.7863,0.89,0.89,"No",2.5549,0,0,"Yes"
"14941","GO_MF","496635_GO_0016714_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",7,-0.7862,0.74,0.9,"No",1.2831,0.18,0.64,"Yes"
"14942","GO_BP","500647_GO_0031396_REGULATION_OF_PROTEIN_UBIQUITINATION",221,-0.7862,0.92,0.9,"No",1.4457,0.0047,0.5,"Yes"
"14943","OMIM_gene","OMIM611409_OCA2_GENE",7,-0.7862,0.77,0.89,"No",0.7308,0.79,1,"Yes"
"14944","C1_Positional","C1_ALL_140_CHR17Q12",80,-0.7861,0.85,0.99,"No",1.3056,0.073,0.52,"Yes"
"14945","C7_Immunologic_signatures","C7_ALL_1310_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN",199,-0.7857,0.92,0.95,"No",1.2801,0.033,0.12,"Yes"
"14946","GO_BP","492019_GO_0007221_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET",5,-0.7857,0.73,0.9,"No",-0.9021,0.58,1,"No"
"14947","REACTOME","105922_REACT_6759_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING",16,-0.7856,0.76,0.89,"No",2.2325,0,5.9e-05,"Yes"
"14948","GO_BP","494302_GO_0010225_RESPONSE_TO_UV_C",11,-0.7855,0.77,0.9,"No",-0.8289,0.69,1,"No"
"14949","C3_TF_targets","C3_TFT_17_V_CETS1P54_01",259,-0.7854,0.93,0.96,"No",1.2097,0.047,0.74,"Yes"
"14950","GO_BP","491768_GO_0006914_AUTOPHAGY",139,-0.7854,0.89,0.9,"No",1.3472,0.028,0.61,"Yes"
"14951","GO_MF","508873_GO_0046625_SPHINGOLIPID_BINDING",13,-0.785,0.76,0.9,"No",0.9335,0.53,0.94,"Yes"
"14952","GO_BP","496315_GO_0016255_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN",7,-0.785,0.75,0.9,"No",-0.7727,0.74,1,"No"
"14953","KEGG_compound","C00360_DAMP_2_DEOXYADENOSINE_5_PHOSPHATE_2_DEOXYADENOSINE_5_MONOPHOSPHATE_DEOXYADENYLIC_ACID_DEOXYADENOSINE_MONOPHOSPHATE",17,-0.785,0.74,0.85,"No",-0.8509,0.68,1,"No"
"14954","GO_BP","500355_GO_0031065_POSITIVE_REGULATION_OF_HISTONE_DEACETYLATION",13,-0.7848,0.76,0.9,"No",-1.4314,0.093,0.93,"No"
"14955","GO_BP","513853_GO_0060297_REGULATION_OF_SARCOMERE_ORGANIZATION",7,-0.7845,0.74,0.9,"No",-0.9939,0.47,0.99,"No"
"14956","GO_BP","500719_GO_0031468_NUCLEAR_ENVELOPE_REASSEMBLY",13,-0.7844,0.75,0.9,"No",1.2228,0.22,0.76,"Yes"
"14957","GO_BP","499183_GO_0021904_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",21,-0.7842,0.77,0.9,"No",0.7793,0.77,1,"Yes"
"14958","GO_BP","750843_GO_0036342_POST_ANAL_TAIL_MORPHOGENESIS",18,-0.7842,0.78,0.9,"No",1.1598,0.24,0.83,"Yes"
"14959","GO_BP","495035_GO_0010970_MICROTUBULE_BASED_TRANSPORT",96,-0.7837,0.86,0.9,"No",0.964,0.54,1,"Yes"
"14960","GO_BP","491090_GO_0006111_REGULATION_OF_GLUCONEOGENESIS",36,-0.7834,0.82,0.9,"No",0.8356,0.71,1,"Yes"
"14961","GO_BP","488934_GO_0003140_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM",5,-0.7832,0.75,0.9,"No",-0.938,0.54,1,"No"
"14962","C2_Chemical_and_genetic_perturbations","C2_CGP_1734_SIMBULAN_PARP1_TARGETS_UP",31,-0.7832,0.79,0.89,"No",1.0026,0.44,0.8,"Yes"
"14963","GO_BP","507545_GO_0045162_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS",7,-0.7832,0.76,0.9,"No",-1.1294,0.3,0.94,"No"
"14964","C4_Cancer_gene_neighborhoods","C4_CGN_234_GCM_HMGA2",115,-0.7829,0.87,1,"No",0.7736,0.96,1,"Yes"
"14965","C3_TF_targets","C3_TFT_277_V_ROAZ_01",10,-0.7829,0.76,0.97,"No",0.6643,0.9,1,"Yes"
"14966","GO_BP","495912_GO_0015781_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSPORT",6,-0.7827,0.73,0.9,"No",-1.0161,0.45,0.98,"No"
"14967","C7_Immunologic_signatures","C7_ALL_1583_GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP",198,-0.7825,0.93,0.96,"No",1.8597,0,0,"Yes"
"14968","GO_BP","504463_GO_0035279_MRNA_CLEAVAGE_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",5,-0.7825,0.77,0.9,"No",-1.1183,0.38,0.94,"No"
"14969","GO_BP","508110_GO_0045773_POSITIVE_REGULATION_OF_AXON_EXTENSION",31,-0.7824,0.79,0.9,"No",-0.9602,0.52,1,"No"
"14970","GO_MF","496753_GO_0016861_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES",11,-0.7815,0.76,0.9,"No",0.8347,0.66,1,"Yes"
"14971","C2_Chemical_and_genetic_perturbations","C2_CGP_2568_AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN",234,-0.7814,0.92,0.89,"No",1.396,0.013,0.3,"Yes"
"14972","GO_MF","498724_GO_0019958_C_X_C_CHEMOKINE_BINDING",5,-0.7813,0.76,0.9,"No",1.1365,0.34,0.75,"Yes"
"14973","GO_BP","486570_GO_0000018_REGULATION_OF_DNA_RECOMBINATION",55,-0.7813,0.83,0.9,"No",-0.7157,0.94,1,"No"
"14974","KEGG_compound","C00112_CDP_CYTIDINE_5_DIPHOSPHATE_CYTIDINE_DIPHOSPHATE",20,-0.781,0.77,0.85,"No",0.9937,0.46,1,"Yes"
"14975","C2_Chemical_and_genetic_perturbations","C2_CGP_2392_CHEN_HOXA5_TARGETS_9HR_DN",41,-0.7809,0.83,0.89,"No",0.9012,0.62,0.92,"Yes"
"14976","GO_BP","510189_GO_0048025_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME",18,-0.7809,0.76,0.9,"No",-1.2072,0.22,0.89,"No"
"14977","C2_BioCarta_Pathways","C2_CP_BIOCARTA_158_BIOCARTA_PGC1A_PATHWAY",23,-0.7809,0.78,0.81,"No",0.6097,0.96,1,"Yes"
"14978","REACTOME","161012_REACT_22161_POST_TRANSLATIONAL_PROTEIN_MODIFICATION",347,-0.7809,0.97,0.9,"No",1.0326,0.32,0.69,"Yes"
"14979","REACTOME","645278_REACT_121141_SIGNALING_BY_FGFR1_FUSION_MUTANTS",19,-0.7808,0.78,0.9,"No",0.8552,0.67,0.95,"Yes"
"14980","GO_MF","987826_GO_0061630_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY",72,-0.7807,0.88,0.9,"No",0.9899,0.47,0.88,"Yes"
"14981","REACTOME","187101_REACT_24969_TRAF6_MEDIATED_NF_KB_ACTIVATION",24,-0.7807,0.8,0.9,"No",0.8748,0.64,0.93,"Yes"
"14982","GO_CC","502400_GO_0033180_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN",9,-0.7804,0.77,0.97,"No",1.3931,0.13,0.3,"Yes"
"14983","GO_MF","489697_GO_0004331_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY",5,-0.7803,0.74,0.9,"No",0.5337,0.97,1,"Yes"
"14984","C2_Chemical_and_genetic_perturbations","C2_CGP_1709_HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR",55,-0.7802,0.81,0.89,"No",1.7564,0.0023,0.058,"Yes"
"14985","C3_TF_targets","C3_TFT_14_V_E2F_01",67,-0.78,0.87,0.97,"No",-1.0346,0.39,0.68,"No"
"14986","C7_Immunologic_signatures","C7_ALL_682_GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_DN",200,-0.7798,0.93,0.96,"No",1.0648,0.29,0.54,"Yes"
"14987","GO_BP","861512_GO_1902369_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS",7,-0.7797,0.74,0.9,"No",0.9574,0.54,1,"Yes"
"14988","REACTOME","105905_REACT_18348_ATF6_ALPHA_ACTIVATES_CHAPERONES",12,-0.7795,0.77,0.9,"No",-0.7149,0.86,1,"No"
"14989","C6_Oncogenic_signatures","C6_ALL_114_EIF4E_UP",96,-0.7795,0.87,0.92,"No",1.1133,0.23,0.5,"Yes"
"14990","C2_Chemical_and_genetic_perturbations","C2_CGP_3137_BRUINS_UVC_RESPONSE_EARLY_LATE",315,-0.7794,0.95,0.89,"No",1.1634,0.09,0.54,"Yes"
"14991","C2_Chemical_and_genetic_perturbations","C2_CGP_1207_NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON",45,-0.7792,0.82,0.89,"No",-0.9327,0.57,1,"No"
"14992","REACTOME","106420_REACT_1195_INSULIN_RECEPTOR_SIGNALLING_CASCADE",85,-0.779,0.86,0.9,"No",0.7621,0.93,1,"Yes"
"14993","C4_Cancer_gene_neighborhoods","C4_CGN_200_GCM_GSTA4",66,-0.779,0.84,1,"No",-1.0245,0.39,0.82,"No"
"14994","GO_BP","781980_GO_1901991_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",145,-0.7789,0.9,0.91,"No",1.5905,0,0.3,"Yes"
"14995","GO_BP","849960_GO_1902259_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",10,-0.7788,0.75,0.91,"No",-1.1825,0.26,0.91,"No"
"14996","GO_BP","494725_GO_0010662_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS",18,-0.7788,0.77,0.91,"No",1.0445,0.38,0.95,"Yes"
"14997","GO_BP","491248_GO_0006285_BASE_EXCISION_REPAIR_AP_SITE_FORMATION",8,-0.7787,0.77,0.91,"No",1.083,0.35,0.92,"Yes"
"14998","GO_BP","508408_GO_0046112_NUCLEOBASE_BIOSYNTHETIC_PROCESS",16,-0.7787,0.77,0.91,"No",1.3347,0.14,0.62,"Yes"
"14999","GO_BP","488807_GO_0003009_SKELETAL_MUSCLE_CONTRACTION",23,-0.7785,0.78,0.91,"No",-1.4727,0.05,0.85,"No"
"15000","GO_MF","487383_GO_0001161_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",6,-0.7783,0.74,0.91,"No",-0.6569,0.88,1,"No"
"15001","WikiPathways","198907_WP1541_ENERGY_METABOLISM",48,-0.7783,0.82,0.88,"No",0.6229,0.99,1,"Yes"
"15002","C7_Immunologic_signatures","C7_ALL_1327_GSE30083_SP1_VS_SP3_THYMOCYTE_UP",196,-0.7782,0.91,0.96,"No",1.2343,0.063,0.18,"Yes"
"15003","GO_BP","499718_GO_0030318_MELANOCYTE_DIFFERENTIATION",21,-0.7782,0.8,0.91,"No",1.4294,0.083,0.52,"Yes"
"15004","C7_Immunologic_signatures","C7_ALL_1654_GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN",193,-0.7782,0.94,0.96,"No",0.9854,0.49,0.79,"Yes"
"15005","REACTOME","576258_REACT_118563_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1",21,-0.7781,0.78,0.9,"No",0.8683,0.66,0.94,"Yes"
"15006","GO_BP","492893_GO_0046878_POSITIVE_REGULATION_OF_SALIVA_SECRETION",5,-0.7781,0.76,0.91,"No",-1.0562,0.41,0.97,"No"
"15007","GO_BP","512768_GO_0051918_NEGATIVE_REGULATION_OF_FIBRINOLYSIS",10,-0.778,0.77,0.91,"No",0.8545,0.61,1,"Yes"
"15008","GO_BP","497928_GO_0019048_MODULATION_BY_VIRUS_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY",22,-0.7779,0.79,0.91,"No",0.8788,0.63,1,"Yes"
"15009","GO_BP","911418_GO_1902430_NEGATIVE_REGULATION_OF_BETA_AMYLOID_FORMATION",6,-0.7778,0.76,0.91,"No",-0.772,0.74,1,"No"
"15010","C2_Chemical_and_genetic_perturbations","C2_CGP_1074_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP",10,-0.7777,0.76,0.89,"No",0.72,0.85,1,"Yes"
"15011","GO_MF","507220_GO_0044213_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",6,-0.7776,0.74,0.91,"No",-0.657,0.89,1,"No"
"15012","GO_BP","495139_GO_0014067_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",11,-0.7775,0.77,0.91,"No",0.6593,0.89,1,"Yes"
"15013","C3_TF_targets","C3_TFT_468_V_E2F1_Q4_01",228,-0.7773,0.94,0.97,"No",-0.7541,0.99,1,"No"
"15014","C7_Immunologic_signatures","C7_ALL_788_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN",198,-0.7772,0.93,0.96,"No",1.445,0.0023,0.023,"Yes"
"15015","GO_BP","489264_GO_0042994_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR",18,-0.777,0.77,0.91,"No",0.8336,0.7,1,"Yes"
"15016","GO_MF","515670_GO_0070742_C2H2_ZINC_FINGER_DOMAIN_BINDING",16,-0.777,0.8,0.91,"No",0.6777,0.9,1,"Yes"
"15017","GO_BP","505672_GO_0042541_HEMOGLOBIN_BIOSYNTHETIC_PROCESS",6,-0.7769,0.73,0.91,"No",1.2305,0.22,0.75,"Yes"
"15018","C1_Positional","C1_ALL_188_CHR9P13",62,-0.7767,0.84,1,"No",0.9499,0.53,0.82,"Yes"
"15019","GO_MF","751944_GO_0052743_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY",5,-0.7766,0.77,0.91,"No",-0.6337,0.88,1,"No"
"15020","C2_Chemical_and_genetic_perturbations","C2_CGP_2298_TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C",452,-0.7766,0.97,0.89,"No",0.9211,0.8,0.9,"Yes"
"15021","GO_BP","494888_GO_0010824_REGULATION_OF_CENTROSOME_DUPLICATION",33,-0.7766,0.83,0.91,"No",0.6738,0.94,1,"Yes"
"15022","C7_Immunologic_signatures","C7_ALL_1146_GSE27786_LSK_VS_BCELL_DN",199,-0.7765,0.93,0.96,"No",1.1245,0.18,0.38,"Yes"
"15023","C2_Chemical_and_genetic_perturbations","C2_CGP_1451_ZHAN_MULTIPLE_MYELOMA_SUBGROUPS",30,-0.7762,0.81,0.89,"No",1.7611,0.0062,0.057,"Yes"
"15024","REACTOME","187200_REACT_23862_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE",24,-0.776,0.8,0.9,"No",0.8349,0.71,0.97,"Yes"
"15025","C2_Chemical_and_genetic_perturbations","C2_CGP_1203_NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON",126,-0.776,0.89,0.89,"No",1.3956,0.016,0.3,"Yes"
"15026","GO_MF","489688_GO_0004322_FERROXIDASE_ACTIVITY",6,-0.7759,0.75,0.91,"No",0.8826,0.6,1,"Yes"
"15027","KEGG_compound","C00130_IMP_INOSINIC_ACID_INOSINE_MONOPHOSPHATE_INOSINE_5_MONOPHOSPHATE_INOSINE_5_PHOSPHATE_5_INOSINATE_5_INOSINIC_ACID_5_INOSINE_MONOPHOSPHATE_5_IMP",28,-0.7757,0.8,0.86,"No",-0.5438,1,1,"No"
"15028","GO_CC","752921_GO_0097422_TUBULAR_ENDOSOME",5,-0.7757,0.74,0.98,"No",1.2997,0.17,0.4,"Yes"
"15029","GO_BP","494699_GO_0010635_REGULATION_OF_MITOCHONDRIAL_FUSION",6,-0.7756,0.78,0.91,"No",0.6762,0.86,1,"Yes"
"15030","C2_Chemical_and_genetic_perturbations","C2_CGP_2495_ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS",14,-0.7756,0.76,0.89,"No",-0.7822,0.78,1,"No"
"15031","C2_Chemical_and_genetic_perturbations","C2_CGP_673_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15",10,-0.7753,0.76,0.89,"No",-0.7131,0.83,1,"No"
"15032","GO_BP","514537_GO_0060982_CORONARY_ARTERY_MORPHOGENESIS",6,-0.7753,0.78,0.91,"No",-0.7596,0.76,1,"No"
"15033","C7_Immunologic_signatures","C7_ALL_1882_GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN",200,-0.7751,0.93,0.96,"No",1.929,0,0,"Yes"
"15034","C7_Immunologic_signatures","C7_ALL_1254_GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN",178,-0.7751,0.92,0.96,"No",0.7401,0.99,1,"Yes"
"15035","GO_BP","507976_GO_0045628_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION",9,-0.775,0.76,0.91,"No",-1.1099,0.33,0.94,"No"
"15036","C4_Cancer_gene_neighborhoods","C4_CGN_155_MORF_PRKAR1A",144,-0.775,0.91,1,"No",2.1888,0,2.1e-05,"Yes"
"15037","GO_MF","500366_GO_0031078_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC_",12,-0.7748,0.75,0.91,"No",-1.1804,0.24,0.78,"No"
"15038","GO_BP","751293_GO_0038030_NON_CANONICAL_WNT_SIGNALING_PATHWAY_VIA_MAPK_CASCADE",6,-0.7745,0.76,0.91,"No",-1.084,0.37,0.96,"No"
"15039","GO_BP","488453_GO_0002580_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II",5,-0.7745,0.76,0.91,"No",-0.9802,0.5,1,"No"
"15040","GO_BP","513522_GO_0055089_FATTY_ACID_HOMEOSTASIS",11,-0.7745,0.76,0.91,"No",0.7178,0.81,1,"Yes"
"15041","C3_MicroRNA_targets","C3_MIR_36_TTGGAGA_MIR_515_5P_MIR_519E",146,-0.774,0.91,0.95,"No",-0.7034,0.99,1,"No"
"15042","GO_BP","493285_GO_0009084_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS",19,-0.7739,0.78,0.91,"No",-0.8343,0.7,1,"No"
"15043","GO_BP","493310_GO_0009111_VITAMIN_CATABOLIC_PROCESS",10,-0.7738,0.78,0.91,"No",-1.3369,0.15,0.9,"No"
"15044","GO_MF","492806_GO_0008527_TASTE_RECEPTOR_ACTIVITY",31,-0.7737,0.81,0.91,"No",0.7787,0.82,1,"Yes"
"15045","GO_BP","491069_GO_0006084_ACETYL_COA_METABOLIC_PROCESS",19,-0.7736,0.78,0.91,"No",-0.9371,0.52,1,"No"
"15046","KEGG_pathway","HSA00910_NITROGEN_METABOLISM",17,-0.7734,0.77,0.89,"No",-0.7417,0.85,1,"No"
"15047","GO_BP","492447_GO_0008078_MESODERMAL_CELL_MIGRATION",6,-0.7734,0.77,0.91,"No",-0.9753,0.5,1,"No"
"15048","GO_BP","496326_GO_0016266_O_GLYCAN_PROCESSING",56,-0.7731,0.84,0.91,"No",0.8541,0.73,1,"Yes"
"15049","GO_BP","491427_GO_0006531_ASPARTATE_METABOLIC_PROCESS",7,-0.773,0.78,0.91,"No",1.2022,0.24,0.78,"Yes"
"15050","C1_Positional","C1_ALL_307_CHRXQ24",29,-0.7728,0.82,1,"No",-0.6182,0.97,1,"No"
"15051","GO_CC","490712_GO_0005652_NUCLEAR_LAMINA",8,-0.7726,0.78,0.98,"No",-1.2527,0.21,0.67,"No"
"15052","C2_Chemical_and_genetic_perturbations","C2_CGP_2915_MIKKELSEN_ES_LCP_WITH_H3K27ME3",12,-0.7723,0.76,0.9,"No",0.9681,0.5,0.84,"Yes"
"15053","GO_BP","514065_GO_0060510_TYPE_II_PNEUMOCYTE_DIFFERENTIATION",5,-0.7722,0.76,0.91,"No",1.5179,0.058,0.38,"Yes"
"15054","C7_Immunologic_signatures","C7_ALL_101_GSE11924_TH1_VS_TH2_CD4_TCELL_UP",197,-0.7722,0.93,0.97,"No",0.7959,0.95,1,"Yes"
"15055","GO_BP","514320_GO_0060765_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",23,-0.7721,0.79,0.91,"No",-0.5869,0.98,1,"No"
"15056","GO_BP","514469_GO_0060914_HEART_FORMATION",11,-0.7721,0.76,0.91,"No",-1.0839,0.35,0.95,"No"
"15057","KEGG_compound","C00356__S_3_HYDROXY_3_METHYLGLUTARYL_COA_HYDROXYMETHYLGLUTARYL_COA_HYDROXYMETHYLGLUTAROYL_COENZYME_A_HMG_COA_3_HYDROXY_3_METHYLGLUTARYL_COA",6,-0.7719,0.77,0.86,"No",0.8567,0.63,1,"Yes"
"15058","GO_BP","491421_GO_0006525_ARGININE_METABOLIC_PROCESS",16,-0.7717,0.77,0.91,"No",-1.2511,0.18,0.91,"No"
"15059","GO_BP","496183_GO_0046326_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT",28,-0.7717,0.81,0.91,"No",1.0012,0.44,0.98,"Yes"
"15060","GO_BP","492661_GO_0051013_MICROTUBULE_SEVERING",8,-0.7715,0.77,0.91,"No",-0.7162,0.85,1,"No"
"15061","C4_Cancer_modules","C4_CM_305_MODULE_354",17,-0.7714,0.79,0.91,"No",1.4266,0.075,0.17,"Yes"
"15062","GO_MF","486641_GO_0000099_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-0.7714,0.76,0.91,"No",-0.7872,0.73,1,"No"
"15063","C7_Immunologic_signatures","C7_ALL_209_GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP",184,-0.7714,0.93,0.97,"No",1.6703,0,0.00097,"Yes"
"15064","C2_BioCarta_Pathways","C2_CP_BIOCARTA_113_BIOCARTA_EGFR_SMRTE_PATHWAY",11,-0.7713,0.78,0.82,"No",0.6135,0.94,1,"Yes"
"15065","REACTOME","645305_REACT_121408_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS",25,-0.7712,0.82,0.9,"No",1.3425,0.11,0.27,"Yes"
"15066","C2_Chemical_and_genetic_perturbations","C2_CGP_967_OZEN_MIR125B1_TARGETS",25,-0.7711,0.8,0.9,"No",-0.6534,0.93,1,"No"
"15067","GO_BP","502186_GO_0032964_COLLAGEN_BIOSYNTHETIC_PROCESS",6,-0.7709,0.77,0.91,"No",-1.2129,0.24,0.88,"No"
"15068","GO_BP","516211_GO_0071287_CELLULAR_RESPONSE_TO_MANGANESE_ION",5,-0.7709,0.76,0.91,"No",0.5497,0.95,1,"Yes"
"15069","C7_Immunologic_signatures","C7_ALL_1144_GSE27786_LSK_VS_LIN_NEG_CELL_DN",197,-0.7707,0.93,0.97,"No",1.3745,0.0069,0.048,"Yes"
"15070","C7_Immunologic_signatures","C7_ALL_928_GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN",199,-0.7706,0.94,0.97,"No",1.9869,0,0,"Yes"
"15071","GO_BP","510418_GO_0048311_MITOCHONDRION_DISTRIBUTION",9,-0.7706,0.75,0.91,"No",-1.3186,0.14,0.89,"No"
"15072","GO_BP","488874_GO_0035811_NEGATIVE_REGULATION_OF_URINE_VOLUME",5,-0.7706,0.73,0.91,"No",1.1809,0.27,0.8,"Yes"
"15073","C7_Immunologic_signatures","C7_ALL_958_GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN",200,-0.7705,0.93,0.97,"No",1.743,0,0.00033,"Yes"
"15074","GO_MF","501278_GO_0032041_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC_",12,-0.7704,0.77,0.91,"No",-1.1933,0.24,0.8,"No"
"15075","GO_BP","751294_GO_0038031_NON_CANONICAL_WNT_SIGNALING_PATHWAY_VIA_JNK_CASCADE",5,-0.7703,0.76,0.91,"No",0.9315,0.55,1,"Yes"
"15076","GO_MF","495438_GO_0015165_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.7703,0.75,0.91,"No",-1.0145,0.46,0.89,"No"
"15077","GO_BP","517309_GO_0072393_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER",6,-0.7702,0.76,0.91,"No",-0.9557,0.51,1,"No"
"15078","GO_BP","515192_GO_0070257_POSITIVE_REGULATION_OF_MUCUS_SECRETION",8,-0.7696,0.75,0.91,"No",1.2813,0.18,0.7,"Yes"
"15079","C4_Cancer_gene_neighborhoods","C4_CGN_76_MORF_CDK2",72,-0.7695,0.88,1,"No",1.3991,0.041,0.062,"Yes"
"15080","C2_Chemical_and_genetic_perturbations","C2_CGP_1006_GOUYER_TUMOR_INVASIVENESS",9,-0.7693,0.76,0.9,"No",0.9735,0.49,0.83,"Yes"
"15081","GO_BP","502265_GO_0033044_REGULATION_OF_CHROMOSOME_ORGANIZATION",196,-0.7692,0.92,0.91,"No",0.8761,0.82,1,"Yes"
"15082","C3_TF_targets","C3_TFT_615_GCCATNTTG_V_YY1_Q6",429,-0.7691,0.97,0.98,"No",0.9816,0.52,1,"Yes"
"15083","GO_BP","502024_GO_0032801_RECEPTOR_CATABOLIC_PROCESS",12,-0.7687,0.77,0.91,"No",-1.4446,0.078,0.91,"No"
"15084","GO_MF","490425_GO_0005160_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING",47,-0.7685,0.83,0.91,"No",0.896,0.65,0.98,"Yes"
"15085","GO_BP","496860_GO_0017038_PROTEIN_IMPORT",129,-0.7682,0.91,0.91,"No",1.0892,0.28,0.92,"Yes"
"15086","C2_Chemical_and_genetic_perturbations","C2_CGP_3078_FIGUEROA_AML_METHYLATION_CLUSTER_1_UP",120,-0.7682,0.89,0.9,"No",1.1089,0.23,0.62,"Yes"
"15087","C4_Cancer_gene_neighborhoods","C4_CGN_327_GNF2_CBFB",30,-0.7682,0.81,1,"No",1.3526,0.11,0.084,"Yes"
"15088","C4_Cancer_gene_neighborhoods","C4_CGN_9_MORF_BUB1",52,-0.768,0.86,1,"No",1.8792,0,0.001,"Yes"
"15089","GO_BP","493742_GO_0009624_RESPONSE_TO_NEMATODE",5,-0.7679,0.78,0.91,"No",-0.6668,0.87,1,"No"
"15090","C2_Chemical_and_genetic_perturbations","C2_CGP_1329_CHESLER_BRAIN_QTL_TRANS",6,-0.7678,0.77,0.9,"No",0.9181,0.54,0.9,"Yes"
"15091","GO_MF","489430_GO_0003950_NAD_ADP_RIBOSYLTRANSFERASE_ACTIVITY",25,-0.7677,0.81,0.91,"No",-0.8927,0.6,1,"No"
"15092","GO_MF","490379_GO_0005113_PATCHED_BINDING",7,-0.7675,0.78,0.91,"No",-0.811,0.72,1,"No"
"15093","C7_Immunologic_signatures","C7_ALL_957_GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP",194,-0.7674,0.94,0.97,"No",1.1682,0.11,0.28,"Yes"
"15094","GO_BP","501713_GO_0032481_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION",77,-0.7673,0.86,0.91,"No",1.0397,0.36,0.96,"Yes"
"15095","REACTOME","105658_REACT_697_ACTIVATION_OF_BH3_ONLY_PROTEINS",25,-0.7673,0.82,0.91,"No",0.5535,0.99,1,"Yes"
"15096","GO_BP","989117_GO_1903052_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",146,-0.7672,0.93,0.91,"No",1.5907,0,0.3,"Yes"
"15097","GO_MF","1129219_GO_0061650_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY",20,-0.7672,0.8,0.91,"No",0.7925,0.75,1,"Yes"
"15098","C6_Oncogenic_signatures","C6_ALL_168_JAK2_DN_V1_DN",147,-0.767,0.93,0.93,"No",-1.2576,0.076,0.37,"No"
"15099","GO_MF","496644_GO_0016724_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS_OXYGEN_AS_ACCEPTOR",6,-0.7669,0.78,0.91,"No",0.9046,0.58,0.98,"Yes"
"15100","GO_BP","515862_GO_0070935_3_UTR_MEDIATED_MRNA_STABILIZATION",11,-0.7669,0.76,0.91,"No",0.6824,0.89,1,"Yes"
"15101","GO_BP","516966_GO_0072049_COMMA_SHAPED_BODY_MORPHOGENESIS",5,-0.7667,0.79,0.92,"No",-0.6931,0.84,1,"No"
"15102","GO_BP","751260_GO_0036344_PLATELET_MORPHOGENESIS",17,-0.7666,0.8,0.91,"No",1.0284,0.42,0.97,"Yes"
"15103","C3_TF_targets","C3_TFT_252_V_E2F1_Q4",243,-0.7665,0.94,0.98,"No",0.8889,0.84,1,"Yes"
"15104","GO_BP","500892_GO_0031643_POSITIVE_REGULATION_OF_MYELINATION",8,-0.7665,0.76,0.91,"No",0.9327,0.55,1,"Yes"
"15105","GO_CC","507625_GO_0045259_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX",22,-0.7664,0.81,0.99,"No",2.2136,0,0.00022,"Yes"
"15106","C7_Immunologic_signatures","C7_ALL_1308_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN",197,-0.7664,0.96,0.97,"No",0.7294,0.99,1,"Yes"
"15107","C2_Chemical_and_genetic_perturbations","C2_CGP_2371_CLIMENT_BREAST_CANCER_COPY_NUMBER_UP",22,-0.7662,0.81,0.9,"No",-1.077,0.35,0.95,"No"
"15108","REACTOME","106193_REACT_14820_METABOLISM_OF_POLYAMINES",15,-0.7661,0.77,0.91,"No",-0.7529,0.8,1,"No"
"15109","C3_TF_targets","C3_TFT_532_WCAANNNYCAG_UNKNOWN",250,-0.766,0.95,0.98,"No",0.7748,0.99,1,"Yes"
"15110","GO_BP","492033_GO_0007253_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB",6,-0.7659,0.75,0.92,"No",1.2626,0.17,0.72,"Yes"
"15111","C2_Chemical_and_genetic_perturbations","C2_CGP_717_FARMER_BREAST_CANCER_CLUSTER_8",7,-0.7657,0.77,0.9,"No",-0.5992,0.94,1,"No"
"15112","C1_Positional","C1_ALL_6_CHR10Q23",94,-0.7657,0.88,1,"No",1.1002,0.27,0.65,"Yes"
"15113","GO_BP","1039918_GO_1903364_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS",151,-0.7657,0.92,0.92,"No",1.5348,0,0.36,"Yes"
"15114","GO_BP","513945_GO_0060389_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",12,-0.7654,0.77,0.92,"No",0.6267,0.92,1,"Yes"
"15115","C2_Chemical_and_genetic_perturbations","C2_CGP_658_IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM",6,-0.7654,0.78,0.9,"No",-1.0446,0.42,0.97,"No"
"15116","C2_Chemical_and_genetic_perturbations","C2_CGP_2968_MURAKAMI_UV_RESPONSE_1HR_DN",10,-0.7653,0.77,0.9,"No",-0.8683,0.6,1,"No"
"15117","GO_BP","491190_GO_0006221_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",30,-0.7652,0.83,0.92,"No",0.6756,0.93,1,"Yes"
"15118","GO_BP","503710_GO_0034508_CENTROMERE_COMPLEX_ASSEMBLY",48,-0.7652,0.86,0.92,"No",-0.954,0.52,1,"No"
"15119","GO_BP","494250_GO_0010171_BODY_MORPHOGENESIS",51,-0.7651,0.85,0.92,"No",0.7893,0.86,1,"Yes"
"15120","C1_Positional","C1_ALL_10_CHRXP21",26,-0.7651,0.81,1,"No",1.8326,0,0.098,"Yes"
"15121","GO_MF","496775_GO_0016888_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",14,-0.7647,0.79,0.91,"No",-0.8072,0.73,1,"No"
"15122","GO_MF","489557_GO_0004089_CARBONATE_DEHYDRATASE_ACTIVITY",15,-0.7647,0.79,0.91,"No",0.7419,0.82,1,"Yes"
"15123","GO_BP","491501_GO_0006607_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS",14,-0.7646,0.78,0.92,"No",-0.4601,1,1,"No"
"15124","C7_Immunologic_signatures","C7_ALL_1219_GSE27786_NKCELL_VS_MONO_MAC_UP",200,-0.7646,0.94,0.97,"No",1.4211,0.0091,0.031,"Yes"
"15125","GO_BP","508083_GO_0045743_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",7,-0.7644,0.77,0.92,"No",0.6571,0.9,1,"Yes"
"15126","C7_Immunologic_signatures","C7_ALL_155_GSE13306_RA_VS_UNTREATED_TREG_UP",197,-0.7642,0.95,0.97,"No",1.2469,0.051,0.16,"Yes"
"15127","GO_MF","494064_GO_0009975_CYCLASE_ACTIVITY",22,-0.7639,0.8,0.91,"No",0.7312,0.87,1,"Yes"
"15128","GO_BP","510224_GO_0048069_EYE_PIGMENTATION",7,-0.7639,0.79,0.92,"No",0.8299,0.7,1,"Yes"
"15129","C1_Positional","C1_ALL_202_CHR5Q22",22,-0.7636,0.8,1,"No",1.1289,0.27,0.63,"Yes"
"15130","GO_BP","514022_GO_0060467_NEGATIVE_REGULATION_OF_FERTILIZATION",6,-0.7636,0.78,0.92,"No",-1.1688,0.28,0.91,"No"
"15131","GO_BP","493353_GO_0009156_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",73,-0.763,0.89,0.92,"No",1.4642,0.018,0.48,"Yes"
"15132","GO_MF","489235_GO_0003682_CHROMATIN_BINDING",444,-0.763,0.99,0.91,"No",-0.7044,1,1,"No"
"15133","C2_Chemical_and_genetic_perturbations","C2_CGP_554_CORRADETTI_MTOR_PATHWAY_REGULATORS_DN",6,-0.763,0.77,0.91,"No",-0.6417,0.88,1,"No"
"15134","GO_BP","489198_GO_0003406_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT",6,-0.7628,0.8,0.92,"No",-1.4153,0.094,0.95,"No"
"15135","GO_BP","517247_GO_0072331_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",129,-0.7628,0.91,0.92,"No",1.5283,0,0.37,"Yes"
"15136","GO_BP","507320_GO_0044314_PROTEIN_K27_LINKED_UBIQUITINATION",5,-0.7626,0.78,0.92,"No",0.6731,0.87,1,"Yes"
"15137","REACTOME","105809_REACT_15510_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES",11,-0.7625,0.77,0.91,"No",0.5007,0.99,1,"Yes"
"15138","C1_Positional","C1_ALL_130_CHR6Q21",56,-0.7624,0.86,0.99,"No",1.1976,0.18,0.64,"Yes"
"15139","GO_BP","499581_GO_0030163_PROTEIN_CATABOLIC_PROCESS",481,-0.7622,0.98,0.92,"No",1.3351,0.0055,0.62,"Yes"
"15140","GO_BP","812233_GO_1902110_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS",12,-0.762,0.76,0.92,"No",1.2716,0.2,0.71,"Yes"
"15141","GO_BP","487109_GO_0000819_SISTER_CHROMATID_SEGREGATION",84,-0.762,0.88,0.92,"No",1.0192,0.41,0.97,"Yes"
"15142","C7_Immunologic_signatures","C7_ALL_1262_GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN",196,-0.762,0.95,0.97,"No",2.1424,0,0,"Yes"
"15143","GO_BP","512266_GO_0051382_KINETOCHORE_ASSEMBLY",10,-0.7616,0.77,0.92,"No",-0.9322,0.52,1,"No"
"15144","C2_Chemical_and_genetic_perturbations","C2_CGP_877_INAMURA_LUNG_CANCER_SCC_DN",14,-0.7616,0.78,0.91,"No",-1.0749,0.35,0.96,"No"
"15145","C3_TF_targets","C3_TFT_451_V_E2F_Q3_01",235,-0.7615,0.94,0.98,"No",-0.6902,1,1,"No"
"15146","C2_Chemical_and_genetic_perturbations","C2_CGP_584_MARKS_ACETYLATED_NON_HISTONE_PROTEINS",15,-0.7611,0.8,0.91,"No",0.6774,0.89,1,"Yes"
"15147","GO_BP","489024_GO_0003230_CARDIAC_ATRIUM_DEVELOPMENT",30,-0.7611,0.83,0.92,"No",-0.9663,0.5,1,"No"
"15148","GO_MF","498368_GO_0019534_TOXIN_TRANSPORTER_ACTIVITY",9,-0.761,0.77,0.91,"No",-1.1918,0.24,0.79,"No"
"15149","GO_BP","505187_GO_0040029_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC",234,-0.7609,0.96,0.92,"No",-1.0277,0.37,0.97,"No"
"15150","C3_TF_targets","C3_TFT_79_V_MYCMAX_01",251,-0.7609,0.97,0.98,"No",0.8535,0.89,1,"Yes"
"15151","GO_CC","496488_GO_0016529_SARCOPLASMIC_RETICULUM",57,-0.7608,0.86,0.99,"No",-1.3176,0.076,0.64,"No"
"15152","REACTOME","105763_REACT_1041_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS",18,-0.7607,0.81,0.92,"No",1.2154,0.23,0.43,"Yes"
"15153","C3_MicroRNA_targets","C3_MIR_107_TCCGTCC_MIR_184",13,-0.7603,0.77,0.96,"No",-1.1648,0.26,1,"No"
"15154","C7_Immunologic_signatures","C7_ALL_1690_GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN",196,-0.7602,0.95,0.97,"No",0.8183,0.94,1,"Yes"
"15155","C2_Chemical_and_genetic_perturbations","C2_CGP_632_MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER",53,-0.7601,0.88,0.91,"No",1.4832,0.029,0.23,"Yes"
"15156","GO_BP","487652_GO_0001756_SOMITOGENESIS",62,-0.7601,0.87,0.92,"No",0.8688,0.75,1,"Yes"
"15157","KEGG_compound","C00061_FMN_RIBOFLAVIN_5_PHOSPHATE_FLAVIN_MONONUCLEOTIDE",8,-0.76,0.75,0.88,"No",1.2514,0.21,0.79,"Yes"
"15158","GO_BP","518483_GO_0090343_POSITIVE_REGULATION_OF_CELL_AGING",6,-0.76,0.77,0.92,"No",-1.02,0.43,0.97,"No"
"15159","C3_TF_targets","C3_TFT_168_V_AHRARNT_02",15,-0.7599,0.8,0.98,"No",0.8371,0.67,1,"Yes"
"15160","GO_BP","850007_GO_1902306_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",8,-0.7598,0.79,0.92,"No",1.0578,0.39,0.94,"Yes"
"15161","KEGG_compound","C06800_AFLATOXIN_B1",5,-0.7595,0.78,0.87,"No",-0.838,0.67,1,"No"
"15162","REACTOME","1127525_REACT_264383_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS",15,-0.7593,0.8,0.92,"No",-0.9722,0.49,1,"No"
"15163","GO_MF","489258_GO_0003713_TRANSCRIPTION_COACTIVATOR_ACTIVITY",289,-0.7593,0.96,0.92,"No",0.7308,1,1,"Yes"
"15164","GO_BP","494672_GO_0010608_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION",477,-0.7591,0.98,0.92,"No",1.3518,0.0024,0.61,"Yes"
"15165","GO_BP","754563_GO_1901607_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS",80,-0.759,0.89,0.92,"No",-0.715,0.96,1,"No"
"15166","GO_BP","491642_GO_0006768_BIOTIN_METABOLIC_PROCESS",11,-0.7589,0.8,0.92,"No",0.7441,0.8,1,"Yes"
"15167","GO_BP","509049_GO_0046826_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS",7,-0.7588,0.77,0.92,"No",1.0744,0.38,0.93,"Yes"
"15168","C1_Positional","C1_ALL_112_CHR5Q14",42,-0.7587,0.82,0.99,"No",1.5178,0.018,0.28,"Yes"
"15169","GO_BP","754127_GO_1901160_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS",13,-0.7587,0.79,0.92,"No",-1.066,0.36,0.96,"No"
"15170","C2_Chemical_and_genetic_perturbations","C2_CGP_3325_VANOEVELEN_MYOGENESIS_SIN3A_TARGETS",220,-0.7579,0.96,0.91,"No",1.5284,0,0.18,"Yes"
"15171","C4_Cancer_gene_neighborhoods","C4_CGN_266_GCM_SMO",59,-0.7578,0.88,1,"No",-1.2864,0.091,0.54,"No"
"15172","C1_Positional","C1_ALL_173_CHR14Q12",24,-0.7578,0.82,0.99,"No",0.5718,0.97,1,"Yes"
"15173","GO_MF","506553_GO_0043522_LEUCINE_ZIPPER_DOMAIN_BINDING",11,-0.7576,0.78,0.92,"No",-1.2853,0.18,0.82,"No"
"15174","OMIM_gene","OMIM605143_ACTIN_RELATED_PROTEIN_1A_ACTR1A",5,-0.7575,0.76,0.92,"No",-1.1523,0.31,1,"No"
"15175","REACTOME","106257_REACT_11153_BIOTIN_TRANSPORT_AND_METABOLISM",11,-0.7575,0.77,0.92,"No",0.7392,0.8,1,"Yes"
"15176","C2_Chemical_and_genetic_perturbations","C2_CGP_1383_DER_IFN_GAMMA_RESPONSE_DN",11,-0.7574,0.81,0.91,"No",0.9357,0.53,0.89,"Yes"
"15177","GO_CC","490872_GO_0005859_MUSCLE_MYOSIN_COMPLEX",18,-0.7573,0.81,1,"No",-1.1371,0.28,0.72,"No"
"15178","KEGG_compound","C00105_UMP_URIDYLIC_ACID_URIDINE_MONOPHOSPHATE_URIDINE_5_MONOPHOSPHATE_5_URIDYLIC_ACID",27,-0.7572,0.83,0.88,"No",0.9816,0.46,1,"Yes"
"15179","GO_BP","513459_GO_0055026_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",16,-0.7572,0.8,0.92,"No",0.8022,0.75,1,"Yes"
"15180","GO_BP","492020_GO_0007224_SMOOTHENED_SIGNALING_PATHWAY",73,-0.757,0.9,0.92,"No",-1.1597,0.2,0.92,"No"
"15181","GO_BP","508799_GO_0046543_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS",9,-0.757,0.79,0.92,"No",1.1585,0.3,0.83,"Yes"
"15182","REACTOME","1127507_REACT_268425_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM",5,-0.757,0.78,0.92,"No",-0.6787,0.85,1,"No"
"15183","GO_CC","505731_GO_0042611_MHC_PROTEIN_COMPLEX",35,-0.7568,0.84,0.99,"No",0.5874,0.99,1,"Yes"
"15184","C1_Positional","C1_ALL_75_CHR1Q43",15,-0.7566,0.82,0.99,"No",0.9759,0.49,0.8,"Yes"
"15185","GO_MF","496768_GO_0016879_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS",57,-0.7566,0.87,0.92,"No",-0.6454,0.98,1,"No"
"15186","REACTOME","160941_REACT_21267_MITOTIC_G1_G1_S_PHASES",135,-0.7563,0.93,0.92,"No",1.8774,0,0.01,"Yes"
"15187","GO_CC","490732_GO_0005677_CHROMATIN_SILENCING_COMPLEX",8,-0.7562,0.79,0.99,"No",0.5666,0.95,1,"Yes"
"15188","KEGG_reaction","R09408_AFLATOXIN_B1_OXYGEN_NADPH_H_AFLATOXIN_B1_EXO_8_9_EPOXIDE_H2O_NADP_",5,-0.7562,0.77,0.84,"No",-0.8132,0.72,1,"No"
"15189","GO_BP","493384_GO_0009188_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",7,-0.7561,0.79,0.92,"No",0.7702,0.74,1,"Yes"
"15190","GO_BP","512183_GO_0051298_CENTROSOME_DUPLICATION",23,-0.756,0.83,0.92,"No",-1.2415,0.17,0.91,"No"
"15191","GO_BP","502189_GO_0032967_POSITIVE_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS",23,-0.7556,0.85,0.92,"No",-1.0275,0.43,0.97,"No"
"15192","GO_BP","512787_GO_0051937_CATECHOLAMINE_TRANSPORT",14,-0.7556,0.78,0.92,"No",1.0134,0.43,0.97,"Yes"
"15193","GO_BP","510242_GO_0048087_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION",9,-0.7555,0.78,0.92,"No",1.1007,0.31,0.9,"Yes"
"15194","REACTOME","105764_REACT_1072_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX",18,-0.7553,0.81,0.92,"No",1.2103,0.21,0.43,"Yes"
"15195","GO_BP","492556_GO_0008215_SPERMINE_METABOLIC_PROCESS",5,-0.7552,0.77,0.92,"No",-1.0679,0.4,0.96,"No"
"15196","GO_BP","490967_GO_0005979_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS",28,-0.7551,0.83,0.92,"No",-0.3794,1,1,"No"
"15197","GO_BP","517064_GO_0072148_EPITHELIAL_CELL_FATE_COMMITMENT",15,-0.7549,0.81,0.92,"No",0.6992,0.87,1,"Yes"
"15198","REACTOME","833800_REACT_163933_INTERACTION_WITH_THE_ZONA_PELLUCIDA",8,-0.7547,0.77,0.92,"No",-0.6481,0.93,1,"No"
"15199","GO_BP","505076_GO_0035907_DORSAL_AORTA_DEVELOPMENT",6,-0.7543,0.8,0.92,"No",-0.7976,0.71,1,"No"
"15200","GO_BP","512367_GO_0051489_REGULATION_OF_FILOPODIUM_ASSEMBLY",36,-0.754,0.83,0.92,"No",0.7919,0.83,1,"Yes"
"15201","C2_Chemical_and_genetic_perturbations","C2_CGP_1030_CAFFAREL_RESPONSE_TO_THC_UP",33,-0.7538,0.86,0.92,"No",0.6865,0.94,1,"Yes"
"15202","GO_BP","491302_GO_0006367_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER",189,-0.7534,0.95,0.93,"No",0.8063,0.95,1,"Yes"
"15203","GO_BP","506601_GO_0043570_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS",5,-0.7531,0.78,0.93,"No",-1.1695,0.31,0.91,"No"
"15204","GO_BP","500888_GO_0031639_PLASMINOGEN_ACTIVATION",7,-0.7527,0.79,0.93,"No",-1.2965,0.18,0.88,"No"
"15205","C4_Cancer_modules","C4_CM_82_MODULE_87",44,-0.7526,0.87,0.93,"No",1.8564,0.0022,0.013,"Yes"
"15206","REACTOME","106332_REACT_13819_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS",17,-0.7524,0.84,0.92,"No",-0.9912,0.48,0.99,"No"
"15207","GO_BP","505669_GO_0042538_HYPEROSMOTIC_SALINITY_RESPONSE",8,-0.7523,0.78,0.93,"No",1.5077,0.052,0.4,"Yes"
"15208","C3_TF_targets","C3_TFT_510_RYAAAKNNNNNNTTGW_UNKNOWN",80,-0.7523,0.9,0.98,"No",0.8205,0.84,1,"Yes"
"15209","GO_MF","499978_GO_0030676_RAC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",13,-0.7522,0.8,0.92,"No",-0.916,0.55,0.97,"No"
"15210","C1_Positional","C1_ALL_146_CHR16P12",88,-0.752,0.9,0.99,"No",-0.6982,0.97,0.98,"No"
"15211","GO_CC","505711_GO_0042584_CHROMAFFIN_GRANULE_MEMBRANE",6,-0.752,0.78,1,"No",0.9685,0.51,0.83,"Yes"
"15212","C4_Cancer_gene_neighborhoods","C4_CGN_2_MORF_ATOX1",80,-0.7519,0.9,1,"No",2.0299,0,0.00024,"Yes"
"15213","C2_Chemical_and_genetic_perturbations","C2_CGP_1346_CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE",35,-0.7519,0.85,0.92,"No",1.2252,0.19,0.47,"Yes"
"15214","C2_Chemical_and_genetic_perturbations","C2_CGP_3257_WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR",29,-0.7519,0.82,0.92,"No",0.8892,0.64,0.93,"Yes"
"15215","C2_Chemical_and_genetic_perturbations","C2_CGP_787_TERAMOTO_OPN_TARGETS_CLUSTER_6",27,-0.7519,0.82,0.92,"No",-1.4735,0.048,0.5,"No"
"15216","GO_BP","515791_GO_0070863_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM",5,-0.7516,0.79,0.93,"No",1.2987,0.19,0.67,"Yes"
"15217","C2_Chemical_and_genetic_perturbations","C2_CGP_1204_NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON",152,-0.7515,0.95,0.92,"No",1.0617,0.29,0.69,"Yes"
"15218","GO_CC","486686_GO_0000152_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX",38,-0.7512,0.85,1,"No",1.0565,0.36,0.71,"Yes"
"15219","C7_Immunologic_signatures","C7_ALL_1739_GSE5960_TH1_VS_ANERGIC_TH1_UP",197,-0.7512,0.96,0.98,"No",1.778,0,0.00021,"Yes"
"15220","C2_Chemical_and_genetic_perturbations","C2_CGP_652_IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM",31,-0.7511,0.84,0.92,"No",1.1708,0.24,0.53,"Yes"
"15221","GO_BP","518151_GO_0090004_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",26,-0.7511,0.83,0.93,"No",0.8037,0.77,1,"Yes"
"15222","GO_BP","506174_GO_0043094_CELLULAR_METABOLIC_COMPOUND_SALVAGE",37,-0.751,0.86,0.93,"No",-0.738,0.87,1,"No"
"15223","REACTOME","106328_REACT_13698_REGULATION_OF_BETA_CELL_DEVELOPMENT",26,-0.7508,0.84,0.92,"No",-0.9463,0.54,1,"No"
"15224","GO_BP","504619_GO_0035435_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT",12,-0.7508,0.8,0.93,"No",-0.582,0.96,1,"No"
"15225","GO_BP","491284_GO_0048096_CHROMATIN_MEDIATED_MAINTENANCE_OF_TRANSCRIPTION",7,-0.7508,0.79,0.93,"No",-0.7194,0.82,1,"No"
"15226","GO_BP","516425_GO_0071501_CELLULAR_RESPONSE_TO_STEROL_DEPLETION",9,-0.7507,0.8,0.93,"No",-0.8501,0.66,1,"No"
"15227","C1_Positional","C1_ALL_199_CHR2P21",41,-0.7504,0.88,0.98,"No",-1.0688,0.35,1,"No"
"15228","GO_BP","495288_GO_0014896_MUSCLE_HYPERTROPHY",24,-0.7503,0.82,0.93,"No",-0.7614,0.83,1,"No"
"15229","GO_CC","507409_GO_0044462_EXTERNAL_ENCAPSULATING_STRUCTURE_PART",14,-0.7503,0.79,1,"No",1.2333,0.17,0.48,"Yes"
"15230","GO_BP","782528_GO_1902017_REGULATION_OF_CILIUM_ASSEMBLY",40,-0.7502,0.85,0.93,"No",-0.6111,0.98,1,"No"
"15231","WikiPathways","198846_WP28_SELENIUM_METABOLISM_AND_SELENOPROTEINS",40,-0.7498,0.87,0.91,"No",0.9564,0.53,1,"Yes"
"15232","GO_BP","493382_GO_0009186_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",9,-0.7498,0.82,0.93,"No",1.2179,0.22,0.76,"Yes"
"15233","C1_Positional","C1_ALL_3_CHR8Q24",154,-0.7498,0.93,0.98,"No",-0.7784,0.96,0.97,"No"
"15234","GO_MF","489467_GO_0003995_ACYL_COA_DEHYDROGENASE_ACTIVITY",15,-0.7496,0.82,0.93,"No",0.625,0.92,1,"Yes"
"15235","C7_Immunologic_signatures","C7_ALL_772_GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN",199,-0.7495,0.96,0.98,"No",1.0091,0.42,0.71,"Yes"
"15236","GO_BP","948271_GO_1902686_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_PROGRAMMED_CELL_DEATH",12,-0.7494,0.82,0.93,"No",1.3029,0.15,0.66,"Yes"
"15237","GO_BP","514567_GO_0061013_REGULATION_OF_MRNA_CATABOLIC_PROCESS",21,-0.7489,0.8,0.93,"No",-0.807,0.75,1,"No"
"15238","C2_Chemical_and_genetic_perturbations","C2_CGP_1185_MORI_PLASMA_CELL_DN",33,-0.7488,0.84,0.92,"No",1.1733,0.23,0.53,"Yes"
"15239","GO_BP","497802_GO_0018904_ETHER_METABOLIC_PROCESS",24,-0.7488,0.83,0.93,"No",1.0434,0.38,0.95,"Yes"
"15240","KEGG_compound","C00044_GTP_GUANOSINE_5_TRIPHOSPHATE",81,-0.7488,0.91,0.88,"No",0.6633,1,1,"Yes"
"15241","C7_Immunologic_signatures","C7_ALL_1677_GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP",193,-0.7488,0.95,0.98,"No",1.0772,0.25,0.51,"Yes"
"15242","C7_Immunologic_signatures","C7_ALL_1539_GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP",195,-0.7486,0.96,0.98,"No",1.394,0.0024,0.039,"Yes"
"15243","GO_CC","487164_GO_0000940_CONDENSED_CHROMOSOME_OUTER_KINETOCHORE",13,-0.7482,0.8,1,"No",1.0415,0.38,0.72,"Yes"
"15244","C2_Chemical_and_genetic_perturbations","C2_CGP_2936_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10",69,-0.7481,0.89,0.92,"No",1.989,0,0.0072,"Yes"
"15245","GO_BP","505868_GO_0042762_REGULATION_OF_SULFUR_METABOLIC_PROCESS",18,-0.748,0.83,0.93,"No",1.1829,0.24,0.8,"Yes"
"15246","GO_BP","513675_GO_0060117_AUDITORY_RECEPTOR_CELL_DEVELOPMENT",16,-0.7479,0.82,0.93,"No",0.5099,1,1,"Yes"
"15247","GO_BP","493903_GO_0009799_SPECIFICATION_OF_SYMMETRY",100,-0.7478,0.92,0.93,"No",-1.0317,0.39,0.98,"No"
"15248","C4_Cancer_gene_neighborhoods","C4_CGN_264_GCM_SMARCC1",37,-0.7476,0.86,1,"No",1.19,0.21,0.23,"Yes"
"15249","GO_MF","490264_GO_0004977_MELANOCORTIN_RECEPTOR_ACTIVITY",6,-0.7476,0.8,0.93,"No",-0.8662,0.62,1,"No"
"15250","C7_Immunologic_signatures","C7_ALL_726_GSE17721_4H_VS_24H_POLYIC_BMDM_DN",200,-0.7476,0.96,0.98,"No",1.1981,0.07,0.23,"Yes"
"15251","C7_Immunologic_signatures","C7_ALL_515_GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_UP",195,-0.7475,0.96,0.98,"No",1.3342,0.024,0.073,"Yes"
"15252","C2_Chemical_and_genetic_perturbations","C2_CGP_1032_CAFFAREL_RESPONSE_TO_THC_8HR_5_UP",16,-0.7474,0.83,0.92,"No",0.8222,0.71,0.98,"Yes"
"15253","GO_BP","498168_GO_0019323_PENTOSE_CATABOLIC_PROCESS",5,-0.7473,0.77,0.93,"No",0.805,0.7,1,"Yes"
"15254","C7_Immunologic_signatures","C7_ALL_1604_GSE3982_EOSINOPHIL_VS_TH1_DN",198,-0.7471,0.95,0.98,"No",1.6458,0,0.0013,"Yes"
"15255","GO_BP","508901_GO_0046655_FOLIC_ACID_METABOLIC_PROCESS",10,-0.747,0.8,0.93,"No",-0.7828,0.75,1,"No"
"15256","GO_BP","507327_GO_0044321_RESPONSE_TO_LEPTIN",13,-0.7469,0.81,0.93,"No",1.0288,0.43,0.97,"Yes"
"15257","C7_Immunologic_signatures","C7_ALL_256_GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN",194,-0.7468,0.96,0.98,"No",0.6877,1,1,"Yes"
"15258","C2_Chemical_and_genetic_perturbations","C2_CGP_2902_WONG_EMBRYONIC_STEM_CELL_CORE",335,-0.7468,0.98,0.92,"No",2.2548,0,0.00039,"Yes"
"15259","GO_BP","504645_GO_0035461_VITAMIN_TRANSMEMBRANE_TRANSPORT",8,-0.7468,0.79,0.93,"No",-1.0458,0.39,0.97,"No"
"15260","GO_MF","490013_GO_0004693_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",32,-0.7468,0.87,0.93,"No",-0.9523,0.52,0.95,"No"
"15261","GO_BP","948904_GO_1902749_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION",39,-0.7465,0.87,0.93,"No",1.2677,0.12,0.71,"Yes"
"15262","GO_BP","492319_GO_0007569_CELL_AGING",61,-0.7462,0.89,0.93,"No",-0.6129,0.99,1,"No"
"15263","GO_CC","505927_GO_0042827_PLATELET_DENSE_GRANULE",6,-0.7461,0.79,1,"No",0.7217,0.82,0.99,"Yes"
"15264","C2_Chemical_and_genetic_perturbations","C2_CGP_1297_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS",65,-0.746,0.9,0.92,"No",1.3933,0.03,0.3,"Yes"
"15265","C7_Immunologic_signatures","C7_ALL_78_GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN",196,-0.7459,0.95,0.98,"No",1.2204,0.076,0.19,"Yes"
"15266","GO_CC","493534_GO_0045240_DIHYDROLIPOYL_DEHYDROGENASE_COMPLEX",8,-0.7459,0.79,1,"No",0.6064,0.92,0.99,"Yes"
"15267","C2_Chemical_and_genetic_perturbations","C2_CGP_798_MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP",19,-0.7458,0.83,0.92,"No",1.4468,0.063,0.26,"Yes"
"15268","KEGG_compound","C00025_L_GLUTAMATE_L_GLUTAMIC_ACID_L_GLUTAMINIC_ACID_GLUTAMATE",53,-0.7457,0.87,0.89,"No",-0.8232,0.8,1,"No"
"15269","REACTOME","685551_REACT_147797_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF_",54,-0.7454,0.9,0.93,"No",-0.3886,1,1,"No"
"15270","GO_CC","498582_GO_0019773_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",8,-0.7454,0.79,0.99,"No",1.5085,0.059,0.19,"Yes"
"15271","GO_BP","503454_GO_0034249_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS",7,-0.7452,0.78,0.93,"No",-0.7233,0.81,1,"No"
"15272","C2_Chemical_and_genetic_perturbations","C2_CGP_2751_YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN",9,-0.7452,0.8,0.92,"No",0.6314,0.9,1,"Yes"
"15273","KEGG_pathway","HSA01210_2_OXOCARBOXYLIC_ACID_METABOLISM",17,-0.745,0.82,0.92,"No",0.7434,0.82,1,"Yes"
"15274","GO_CC","507627_GO_0045261_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_CATALYTIC_CORE_F_1_",6,-0.745,0.8,0.99,"No",1.5247,0.047,0.18,"Yes"
"15275","GO_CC","490762_GO_0005720_NUCLEAR_HETEROCHROMATIN",33,-0.7449,0.85,0.99,"No",-0.7767,0.81,1,"No"
"15276","GO_BP","498707_GO_0019934_CGMP_MEDIATED_SIGNALING",9,-0.7444,0.82,0.93,"No",1.3755,0.12,0.58,"Yes"
"15277","GO_MF","489332_GO_0003831_BETA_N_ACETYLGLUCOSAMINYLGLYCOPEPTIDE_BETA_1_4_GALACTOSYLTRANSFERASE_ACTIVITY",5,-0.7443,0.8,0.93,"No",-0.6046,0.93,1,"No"
"15278","GO_BP","506679_GO_0043649_DICARBOXYLIC_ACID_CATABOLIC_PROCESS",14,-0.744,0.81,0.93,"No",1.4611,0.083,0.48,"Yes"
"15279","C2_Chemical_and_genetic_perturbations","C2_CGP_1319_CHANG_POU5F1_TARGETS_UP",15,-0.7439,0.79,0.92,"No",-1.4434,0.054,0.53,"No"
"15280","GO_MF","496125_GO_0016015_MORPHOGEN_ACTIVITY",5,-0.7439,0.79,0.93,"No",-1.0196,0.44,0.89,"No"
"15281","GO_CC","752948_GO_0097449_ASTROCYTE_PROJECTION",7,-0.7435,0.78,0.99,"No",-1.0619,0.38,0.82,"No"
"15282","GO_BP","489205_GO_0003413_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS",8,-0.7435,0.8,0.93,"No",-1.6004,0.035,0.68,"No"
"15283","C7_Immunologic_signatures","C7_ALL_1234_GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN",198,-0.7433,0.97,0.98,"No",1.646,0,0.0013,"Yes"
"15284","C2_Chemical_and_genetic_perturbations","C2_CGP_727_HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER",6,-0.7432,0.77,0.92,"No",0.8813,0.6,0.94,"Yes"
"15285","REACTOME","106016_REACT_9406_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION",5,-0.743,0.79,0.93,"No",1.286,0.2,0.34,"Yes"
"15286","GO_BP","508586_GO_0046321_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION",12,-0.7428,0.8,0.93,"No",1.1286,0.31,0.87,"Yes"
"15287","C2_Chemical_and_genetic_perturbations","C2_CGP_561_SHIRAISHI_PLZF_TARGETS_DN",8,-0.7426,0.81,0.92,"No",1.2088,0.21,0.48,"Yes"
"15288","REACTOME","105751_REACT_897_G2_M_DNA_DAMAGE_CHECKPOINT",16,-0.7424,0.82,0.93,"No",0.4985,0.99,1,"Yes"
"15289","GO_BP","497263_GO_0018298_PROTEIN_CHROMOPHORE_LINKAGE",11,-0.7423,0.81,0.93,"No",-1.4445,0.09,0.91,"No"
"15290","KEGG_pathway","HSA04710_CIRCADIAN_RHYTHM",30,-0.7422,0.85,0.92,"No",0.535,0.99,1,"Yes"
"15291","GO_MF","494259_GO_0010181_FMN_BINDING",15,-0.7421,0.8,0.93,"No",-0.9708,0.51,0.94,"No"
"15292","GO_BP","501695_GO_0032463_NEGATIVE_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION",6,-0.742,0.79,0.93,"No",1.0637,0.41,0.94,"Yes"
"15293","GO_BP","505092_GO_0038003_OPIOID_RECEPTOR_SIGNALING_PATHWAY",8,-0.7419,0.81,0.93,"No",0.634,0.91,1,"Yes"
"15294","GO_BP","849872_GO_1902170_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES",13,-0.7415,0.81,0.93,"No",0.6495,0.9,1,"Yes"
"15295","GO_CC","499509_GO_0030061_MITOCHONDRIAL_CRISTA",7,-0.7415,0.79,0.99,"No",0.6159,0.92,0.99,"Yes"
"15296","GO_BP","494634_GO_0010569_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION",15,-0.7415,0.81,0.93,"No",1.0734,0.37,0.93,"Yes"
"15297","GO_BP","516994_GO_0072077_RENAL_VESICLE_MORPHOGENESIS",12,-0.7415,0.83,0.93,"No",-0.9958,0.46,0.99,"No"
"15298","C4_Cancer_modules","C4_CM_423_MODULE_560",12,-0.7414,0.78,0.94,"No",0.5063,0.99,1,"Yes"
"15299","GO_BP","488233_GO_0002360_T_CELL_LINEAGE_COMMITMENT",12,-0.7414,0.81,0.93,"No",-1.392,0.082,1,"No"
"15300","C2_Chemical_and_genetic_perturbations","C2_CGP_1956_GENTILE_RESPONSE_CLUSTER_D3",61,-0.7411,0.9,0.93,"No",1.2199,0.14,0.47,"Yes"
"15301","GO_BP","494360_GO_0010288_RESPONSE_TO_LEAD_ION",12,-0.7409,0.82,0.93,"No",1.1234,0.29,0.88,"Yes"
"15302","C2_Chemical_and_genetic_perturbations","C2_CGP_1211_NIKOLSKY_BREAST_CANCER_16P13_AMPLICON",114,-0.7409,0.93,0.93,"No",-0.9872,0.47,1,"No"
"15303","C2_Chemical_and_genetic_perturbations","C2_CGP_1477_STONER_ESOPHAGEAL_CARCINOGENESIS_DN",7,-0.7409,0.79,0.93,"No",-0.5748,0.96,1,"No"
"15304","C2_Chemical_and_genetic_perturbations","C2_CGP_2379_YAGUE_PRETUMOR_DRUG_RESISTANCE_UP",8,-0.7408,0.81,0.92,"No",-0.5206,0.97,1,"No"
"15305","REACTOME","106424_REACT_762_IRS_RELATED_EVENTS",81,-0.7408,0.91,0.93,"No",0.8015,0.87,0.99,"Yes"
"15306","GO_BP","509012_GO_0046785_MICROTUBULE_POLYMERIZATION",21,-0.7407,0.86,0.93,"No",0.5632,0.98,1,"Yes"
"15307","GO_BP","514306_GO_0060751_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING",6,-0.7407,0.8,0.93,"No",0.9437,0.51,1,"Yes"
"15308","GO_MF","492858_GO_0008603_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY",9,-0.7407,0.82,0.93,"No",0.7998,0.72,1,"Yes"
"15309","GO_BP","487500_GO_0001561_FATTY_ACID_ALPHA_OXIDATION",6,-0.7407,0.81,0.93,"No",1.4261,0.092,0.52,"Yes"
"15310","GO_CC","501818_GO_0032592_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE",39,-0.7407,0.88,0.99,"No",0.9374,0.55,0.85,"Yes"
"15311","C3_MicroRNA_targets","C3_MIR_48_CGCTGCT_MIR_503",24,-0.7406,0.82,0.98,"No",-0.8275,0.73,1,"No"
"15312","GO_CC","500493_GO_0031232_EXTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",7,-0.7405,0.8,0.99,"No",-1.2477,0.21,0.64,"No"
"15313","KEGG_pathway","HSA00534_GLYCOSAMINOGLYCAN_BIOSYNTHESIS",24,-0.7403,0.84,0.92,"No",1.3527,0.12,0.27,"Yes"
"15314","GO_BP","493587_GO_0009414_RESPONSE_TO_WATER_DEPRIVATION",5,-0.7403,0.8,0.93,"No",0.7693,0.77,1,"Yes"
"15315","KEGG_pathway","HSA04966_COLLECTING_DUCT_ACID_SECRETION",26,-0.7402,0.85,0.92,"No",1.0787,0.35,0.82,"Yes"
"15316","C2_Chemical_and_genetic_perturbations","C2_CGP_560_SHIRAISHI_PLZF_TARGETS_UP",10,-0.7399,0.81,0.93,"No",-0.719,0.84,1,"No"
"15317","C2_Chemical_and_genetic_perturbations","C2_CGP_432_VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN",36,-0.7396,0.86,0.93,"No",0.6598,0.95,1,"Yes"
"15318","GO_BP","491177_GO_0006213_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS",51,-0.7395,0.9,0.94,"No",0.7124,0.94,1,"Yes"
"15319","GO_BP","518602_GO_0097052_L_KYNURENINE_METABOLIC_PROCESS",5,-0.7395,0.82,0.94,"No",0.7603,0.77,1,"Yes"
"15320","C2_Chemical_and_genetic_perturbations","C2_CGP_2304_BERNARD_PPAPDC1B_TARGETS_UP",40,-0.7392,0.88,0.93,"No",1.169,0.23,0.53,"Yes"
"15321","C2_Chemical_and_genetic_perturbations","C2_CGP_1288_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS",184,-0.7391,0.96,0.93,"No",1.3308,0.023,0.36,"Yes"
"15322","C7_Immunologic_signatures","C7_ALL_348_GSE15215_CD2_POS_VS_NEG_PDC_DN",200,-0.739,0.97,0.99,"No",1.3552,0.016,0.059,"Yes"
"15323","GO_BP","514649_GO_0061101_NEUROENDOCRINE_CELL_DIFFERENTIATION",7,-0.7385,0.81,0.94,"No",-1.2003,0.27,0.9,"No"
"15324","GO_BP","500693_GO_0031442_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING",16,-0.7383,0.82,0.94,"No",-0.8932,0.6,1,"No"
"15325","C7_Immunologic_signatures","C7_ALL_1321_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP",198,-0.7383,0.97,0.99,"No",0.8818,0.8,1,"Yes"
"15326","GO_BP","753236_GO_1900246_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY",6,-0.7383,0.78,0.94,"No",0.8228,0.69,1,"Yes"
"15327","REACTOME","105834_REACT_6867_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE",17,-0.738,0.82,0.93,"No",1.0452,0.38,0.67,"Yes"
"15328","GO_MF","490272_GO_0004985_OPIOID_RECEPTOR_ACTIVITY",8,-0.7373,0.81,0.93,"No",0.6382,0.9,1,"Yes"
"15329","C4_Cancer_gene_neighborhoods","C4_CGN_43_MORF_RPA2",193,-0.7372,0.96,1,"No",1.3469,0.022,0.087,"Yes"
"15330","GO_MF","777519_GO_0097472_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",32,-0.737,0.84,0.93,"No",-0.9537,0.54,0.95,"No"
"15331","REACTOME","105866_REACT_97_RECRUITMENT_OF_REPAIR_AND_SIGNALING_PROTEINS_TO_DOUBLE_STRAND_BREAKS",8,-0.737,0.8,0.93,"No",-0.9099,0.56,1,"No"
"15332","GO_BP","1039915_GO_1903361_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE",5,-0.7366,0.78,0.94,"No",1.4078,0.1,0.55,"Yes"
"15333","GO_CC","486900_GO_0000407_PRE_AUTOPHAGOSOMAL_STRUCTURE",35,-0.7366,0.86,0.99,"No",0.7853,0.81,0.96,"Yes"
"15334","GO_BP","491753_GO_0006893_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT",38,-0.7365,0.87,0.94,"No",0.7451,0.9,1,"Yes"
"15335","GO_BP","493396_GO_0009200_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",18,-0.7365,0.83,0.94,"No",1.0029,0.45,0.98,"Yes"
"15336","GO_BP","519313_GO_2000674_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS",9,-0.7365,0.81,0.94,"No",1.0206,0.4,0.97,"Yes"
"15337","C2_Chemical_and_genetic_perturbations","C2_CGP_1089_RICKMAN_HEAD_AND_NECK_CANCER_D",30,-0.7364,0.86,0.93,"No",1.126,0.26,0.59,"Yes"
"15338","GO_BP","515814_GO_0070886_POSITIVE_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE",5,-0.7361,0.82,0.94,"No",-0.8029,0.73,1,"No"
"15339","GO_MF","486775_GO_0005283_SODIUM_AMINO_ACID_SYMPORTER_ACTIVITY",9,-0.7361,0.8,0.93,"No",-1.3226,0.15,0.72,"No"
"15340","C7_Immunologic_signatures","C7_ALL_1644_GSE3982_DC_VS_TH2_DN",198,-0.7361,0.97,0.99,"No",1.2391,0.041,0.17,"Yes"
"15341","C2_Chemical_and_genetic_perturbations","C2_CGP_1079_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN",5,-0.7359,0.79,0.93,"No",-1.015,0.46,0.99,"No"
"15342","GO_CC","496438_GO_0016461_UNCONVENTIONAL_MYOSIN_COMPLEX",8,-0.7357,0.81,0.99,"No",-0.5992,0.92,1,"No"
"15343","GO_BP","495992_GO_0015868_PURINE_RIBONUCLEOTIDE_TRANSPORT",7,-0.7356,0.8,0.94,"No",-0.8055,0.72,1,"No"
"15344","REACTOME","1127521_REACT_264178_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX",42,-0.7356,0.89,0.93,"No",0.7482,0.89,1,"Yes"
"15345","GO_BP","503703_GO_0034501_PROTEIN_LOCALIZATION_TO_KINETOCHORE",10,-0.7349,0.84,0.94,"No",0.7436,0.8,1,"Yes"
"15346","GO_MF","492663_GO_0008353_RNA_POLYMERASE_II_CARBOXY_TERMINAL_DOMAIN_KINASE_ACTIVITY",17,-0.7349,0.82,0.94,"No",0.5899,0.97,1,"Yes"
"15347","GO_MF","499847_GO_0030507_SPECTRIN_BINDING",25,-0.7348,0.85,0.93,"No",0.7819,0.81,1,"Yes"
"15348","C3_TF_targets","C3_TFT_250_V_E2F_Q6",232,-0.7346,0.97,1,"No",0.7738,0.98,1,"Yes"
"15349","C2_Chemical_and_genetic_perturbations","C2_CGP_3034_NOUSHMEHR_GBM_SILENCED_BY_METHYLATION",50,-0.7346,0.88,0.93,"No",0.9433,0.58,0.87,"Yes"
"15350","REACTOME","106281_REACT_957_PYRIMIDINE_METABOLISM",24,-0.7345,0.84,0.93,"No",0.4611,1,1,"Yes"
"15351","C7_Immunologic_signatures","C7_ALL_398_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN",200,-0.7345,0.97,0.99,"No",2.1568,0,0,"Yes"
"15352","GO_BP","500692_GO_0031441_NEGATIVE_REGULATION_OF_MRNA_3_END_PROCESSING",10,-0.7344,0.81,0.94,"No",0.8403,0.68,1,"Yes"
"15353","C2_BioCarta_Pathways","C2_CP_BIOCARTA_209_BIOCARTA_CARM1_PATHWAY",13,-0.7344,0.82,0.87,"No",1.1662,0.26,0.72,"Yes"
"15354","GO_BP","754954_GO_2000848_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION",7,-0.7341,0.81,0.94,"No",1.7709,0.006,0.12,"Yes"
"15355","REACTOME","160979_REACT_993_PROPIONYL_COA_CATABOLISM",5,-0.7341,0.81,0.93,"No",0.9519,0.54,0.83,"Yes"
"15356","GO_MF","1129228_GO_0061659_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY",75,-0.734,0.9,0.93,"No",0.9749,0.52,0.9,"Yes"
"15357","GO_BP","514304_GO_0060749_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT",20,-0.7339,0.84,0.94,"No",1.221,0.19,0.77,"Yes"
"15358","C7_Immunologic_signatures","C7_ALL_339_GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP",200,-0.7339,0.97,0.99,"No",1.5519,0.0023,0.0061,"Yes"
"15359","GO_MF","506460_GO_0043422_PROTEIN_KINASE_B_BINDING",11,-0.7338,0.81,0.93,"No",-0.5393,0.98,1,"No"
"15360","GO_BP","494333_GO_0010259_MULTICELLULAR_ORGANISMAL_AGING",26,-0.7332,0.85,0.94,"No",-0.944,0.56,1,"No"
"15361","C2_Chemical_and_genetic_perturbations","C2_CGP_2467_BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP",26,-0.732,0.87,0.93,"No",-0.7465,0.84,1,"No"
"15362","C3_TF_targets","C3_TFT_81_V_USF_01",256,-0.7319,0.98,1,"No",1.2779,0.014,0.49,"Yes"
"15363","C7_Immunologic_signatures","C7_ALL_1857_GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP",197,-0.7318,0.97,0.99,"No",1.2588,0.057,0.14,"Yes"
"15364","GO_BP","516438_GO_0071514_GENETIC_IMPRINTING",24,-0.7316,0.85,0.94,"No",-1.4328,0.063,0.92,"No"
"15365","C7_Immunologic_signatures","C7_ALL_796_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN",198,-0.7314,0.96,0.99,"No",1.4599,0.0095,0.02,"Yes"
"15366","GO_MF","750743_GO_0001191_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",36,-0.7314,0.89,0.94,"No",1.0521,0.37,0.83,"Yes"
"15367","GO_BP","488352_GO_0002479_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_TAP_DEPENDENT",75,-0.7313,0.93,0.94,"No",2.0237,0,0.0095,"Yes"
"15368","GO_BP","502390_GO_0033169_HISTONE_H3_K9_DEMETHYLATION",8,-0.7309,0.81,0.94,"No",-1.1702,0.27,0.91,"No"
"15369","GO_BP","495280_GO_0014887_CARDIAC_MUSCLE_ADAPTATION",12,-0.7308,0.83,0.94,"No",-1.2973,0.15,0.88,"No"
"15370","GO_BP","513695_GO_0060137_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION",7,-0.7307,0.78,0.94,"No",0.9913,0.48,0.99,"Yes"
"15371","GO_BP","514635_GO_0061087_POSITIVE_REGULATION_OF_HISTONE_H3_K27_METHYLATION",6,-0.7307,0.8,0.94,"No",-1.2477,0.21,0.91,"No"
"15372","GO_BP","513843_GO_0060287_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY",8,-0.7305,0.78,0.94,"No",-1.5289,0.049,0.77,"No"
"15373","C4_Cancer_gene_neighborhoods","C4_CGN_250_GCM_PFN1",51,-0.7303,0.9,1,"No",2.3514,0,0,"Yes"
"15374","GO_BP","504491_GO_0035307_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION",21,-0.7299,0.83,0.94,"No",0.8191,0.74,1,"Yes"
"15375","GO_MF","492727_GO_0008432_JUN_KINASE_BINDING",6,-0.7298,0.8,0.94,"No",-0.8903,0.59,1,"No"
"15376","C2_Chemical_and_genetic_perturbations","C2_CGP_3178_AZARE_STAT3_TARGETS",24,-0.7297,0.85,0.93,"No",1.0384,0.41,0.74,"Yes"
"15377","GO_BP","516967_GO_0072050_S_SHAPED_BODY_MORPHOGENESIS",7,-0.7297,0.8,0.94,"No",0.4307,1,1,"Yes"
"15378","GO_BP","507576_GO_0045198_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY",6,-0.729,0.81,0.94,"No",0.7763,0.76,1,"Yes"
"15379","C2_Chemical_and_genetic_perturbations","C2_CGP_2820_WEBER_METHYLATED_LCP_IN_SPERM_DN",6,-0.7285,0.81,0.93,"No",1.2858,0.2,0.41,"Yes"
"15380","GO_MF","491308_GO_0008143_POLY_A_BINDING",13,-0.7282,0.83,0.94,"No",0.6503,0.91,1,"Yes"
"15381","GO_BP","505507_GO_0042363_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS",9,-0.728,0.82,0.94,"No",-1.3858,0.12,0.99,"No"
"15382","GO_BP","500648_GO_0031397_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION",115,-0.7279,0.95,0.94,"No",1.7296,0,0.16,"Yes"
"15383","GO_BP","502340_GO_0033119_NEGATIVE_REGULATION_OF_RNA_SPLICING",21,-0.7278,0.86,0.94,"No",-1.0037,0.43,0.99,"No"
"15384","C3_TF_targets","C3_TFT_74_V_CREB_02",249,-0.7278,0.98,1,"No",0.8872,0.83,1,"Yes"
"15385","GO_BP","498846_GO_0021562_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT",7,-0.7275,0.82,0.94,"No",0.9628,0.49,1,"Yes"
"15386","C1_Positional","C1_ALL_136_CHR3Q12",35,-0.7273,0.9,1,"No",1.0971,0.3,0.65,"Yes"
"15387","GO_BP","505623_GO_0042490_MECHANORECEPTOR_DIFFERENTIATION",56,-0.7271,0.9,0.95,"No",-0.7325,0.93,1,"No"
"15388","GO_BP","496181_GO_0045727_POSITIVE_REGULATION_OF_TRANSLATION",71,-0.7268,0.93,0.95,"No",1.4608,0.013,0.48,"Yes"
"15389","C2_Chemical_and_genetic_perturbations","C2_CGP_2874_KYNG_WERNER_SYNDROM_UP",19,-0.7268,0.85,0.94,"No",1.4048,0.084,0.29,"Yes"
"15390","KEGG_compound","C00096_GDP_MANNOSE_GDP_D_MANNOSE_GDP_ALPHA_D_MANNOSE",6,-0.7267,0.84,0.91,"No",-0.9209,0.57,1,"No"
"15391","GO_BP","494811_GO_0010746_REGULATION_OF_PLASMA_MEMBRANE_LONG_CHAIN_FATTY_ACID_TRANSPORT",5,-0.7266,0.8,0.95,"No",0.9445,0.55,1,"Yes"
"15392","GO_BP","495053_GO_0010988_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE",6,-0.7265,0.81,0.95,"No",-1.2992,0.18,0.89,"No"
"15393","REACTOME","645351_REACT_121388_ABACAVIR_METABOLISM",5,-0.7264,0.8,0.94,"No",0.6995,0.85,1,"Yes"
"15394","C2_Chemical_and_genetic_perturbations","C2_CGP_1789_MA_PITUITARY_FETAL_VS_ADULT_UP",28,-0.7263,0.88,0.94,"No",0.9606,0.51,0.85,"Yes"
"15395","C4_Cancer_modules","C4_CM_77_MODULE_82",24,-0.7262,0.86,0.95,"No",1.2539,0.15,0.32,"Yes"
"15396","GO_BP","925940_GO_1902591_SINGLE_ORGANISM_MEMBRANE_BUDDING",34,-0.7261,0.86,0.95,"No",1.6863,0.0042,0.21,"Yes"
"15397","GO_BP","512360_GO_0051482_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION_INVOLVED_IN_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_SIGNALING_PATHWAY",15,-0.726,0.83,0.95,"No",1.1512,0.29,0.84,"Yes"
"15398","GO_BP","493957_GO_0009855_DETERMINATION_OF_BILATERAL_SYMMETRY",95,-0.7257,0.94,0.95,"No",-0.9432,0.61,1,"No"
"15399","GO_BP","849868_GO_1902166_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR",13,-0.7257,0.81,0.95,"No",-0.7996,0.71,1,"No"
"15400","GO_BP","515852_GO_0070925_ORGANELLE_ASSEMBLY",384,-0.7254,0.99,0.95,"No",0.9153,0.79,1,"Yes"
"15401","GO_MF","509125_GO_0046920_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY",8,-0.7252,0.81,0.94,"No",0.6176,0.92,1,"Yes"
"15402","GO_MF","492736_GO_0008443_PHOSPHOFRUCTOKINASE_ACTIVITY",7,-0.7252,0.8,0.94,"No",0.5931,0.94,1,"Yes"
"15403","GO_CC","487639_GO_0001741_XY_BODY",14,-0.7251,0.84,1,"No",-0.9545,0.52,0.88,"No"
"15404","GO_BP","489091_GO_0003299_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS",12,-0.7251,0.82,0.95,"No",-1.2794,0.18,0.89,"No"
"15405","GO_BP","514299_GO_0060744_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_THELARCHE",6,-0.725,0.81,0.95,"No",1.2259,0.23,0.76,"Yes"
"15406","REACTOME","161037_REACT_20546_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR",19,-0.725,0.85,0.94,"No",0.9137,0.55,0.89,"Yes"
"15407","C1_Positional","C1_ALL_287_CHR9Q31",57,-0.7249,0.91,1,"No",1.3444,0.055,0.47,"Yes"
"15408","C4_Cancer_gene_neighborhoods","C4_CGN_100_MORF_FANCG",164,-0.7247,0.97,1,"No",0.7542,0.99,1,"Yes"
"15409","GO_BP","948858_GO_0097576_VACUOLE_FUSION",9,-0.7246,0.84,0.95,"No",1.2154,0.24,0.77,"Yes"
"15410","GO_BP","502280_GO_0033059_CELLULAR_PIGMENTATION",48,-0.7245,0.92,0.95,"No",1.2357,0.14,0.75,"Yes"
"15411","GO_BP","505508_GO_0042364_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS",11,-0.7242,0.82,0.95,"No",0.4779,1,1,"Yes"
"15412","C2_Chemical_and_genetic_perturbations","C2_CGP_267_UDAYAKUMAR_MED1_TARGETS_UP",134,-0.7241,0.95,0.94,"No",1.0084,0.44,0.79,"Yes"
"15413","GO_BP","489016_GO_0003222_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS",11,-0.7235,0.83,0.95,"No",-0.7807,0.77,1,"No"
"15414","GO_MF","513538_GO_0055106_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY",7,-0.7232,0.81,0.94,"No",0.7567,0.78,1,"Yes"
"15415","C2_Chemical_and_genetic_perturbations","C2_CGP_257_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN",16,-0.723,0.84,0.94,"No",1.6362,0.012,0.12,"Yes"
"15416","C1_Positional","C1_ALL_135_CHR4Q31",70,-0.7228,0.92,1,"No",1.1899,0.15,0.6,"Yes"
"15417","GO_BP","513951_GO_0060395_SMAD_PROTEIN_SIGNAL_TRANSDUCTION",49,-0.7227,0.91,0.95,"No",0.9085,0.62,1,"Yes"
"15418","GO_BP","508160_GO_0045839_NEGATIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION",48,-0.7222,0.91,0.95,"No",0.7778,0.88,1,"Yes"
"15419","KEGG_compound","C16682_9_CIS_RETINOL",6,-0.7219,0.82,0.91,"No",-0.6766,0.84,1,"No"
"15420","GO_BP","502778_GO_0033561_REGULATION_OF_WATER_LOSS_VIA_SKIN",20,-0.7219,0.86,0.95,"No",1.704,0.019,0.19,"Yes"
"15421","C4_Cancer_modules","C4_CM_45_MODULE_49",284,-0.7214,0.99,0.95,"No",-0.9052,0.77,0.88,"No"
"15422","GO_BP","1039912_GO_1903358_REGULATION_OF_GOLGI_ORGANIZATION",9,-0.7214,0.82,0.95,"No",-0.4279,1,1,"No"
"15423","C7_Immunologic_signatures","C7_ALL_481_GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_UP",200,-0.7212,0.98,0.99,"No",1.2645,0.045,0.14,"Yes"
"15424","GO_MF","492483_GO_0008121_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY",7,-0.7212,0.79,0.94,"No",1.4589,0.096,0.41,"Yes"
"15425","GO_BP","514559_GO_0061004_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",8,-0.7212,0.79,0.95,"No",-1.0691,0.35,0.96,"No"
"15426","WikiPathways","198875_WP531_MISMATCH_REPAIR",9,-0.7211,0.82,0.94,"No",0.6731,0.87,1,"Yes"
"15427","GO_MF","498652_GO_0019869_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY",9,-0.7211,0.84,0.94,"No",0.6711,0.88,1,"Yes"
"15428","GO_BP","502821_GO_0033605_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION",10,-0.7209,0.83,0.95,"No",1.0861,0.36,0.92,"Yes"
"15429","GO_BP","512661_GO_0051790_SHORT_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS",7,-0.7209,0.83,0.95,"No",0.6606,0.9,1,"Yes"
"15430","C1_Positional","C1_ALL_232_CHR1P32",80,-0.7209,0.93,1,"No",-0.66,0.98,1,"No"
"15431","GO_BP","512267_GO_0051383_KINETOCHORE_ORGANIZATION",12,-0.7208,0.82,0.95,"No",-0.8068,0.72,1,"No"
"15432","GO_BP","754129_GO_1901162_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS",5,-0.7208,0.83,0.95,"No",-1.1074,0.36,0.94,"No"
"15433","C2_Chemical_and_genetic_perturbations","C2_CGP_3340_ROESSLER_LIVER_CANCER_METASTASIS_DN",51,-0.7208,0.9,0.94,"No",0.8114,0.8,0.98,"Yes"
"15434","C7_Immunologic_signatures","C7_ALL_128_GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN",195,-0.7206,0.98,0.99,"No",-0.864,0.83,1,"No"
"15435","GO_BP","509076_GO_0046856_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION",17,-0.7206,0.84,0.95,"No",-1.0876,0.33,0.95,"No"
"15436","REACTOME","1127631_REACT_264594_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING",6,-0.7206,0.83,0.94,"No",-0.6699,0.88,1,"No"
"15437","GO_BP","501527_GO_0032292_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT",22,-0.7206,0.87,0.95,"No",-0.8544,0.67,1,"No"
"15438","REACTOME","105849_REACT_1064_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1",9,-0.7206,0.83,0.94,"No",1.2261,0.21,0.42,"Yes"
"15439","GO_BP","499290_GO_0022011_MYELINATION_IN_PERIPHERAL_NERVOUS_SYSTEM",22,-0.7205,0.86,0.95,"No",-0.8405,0.71,1,"No"
"15440","GO_BP","501184_GO_0031944_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS",5,-0.7205,0.81,0.95,"No",1.1834,0.29,0.8,"Yes"
"15441","GO_CC","499510_GO_0030062_MITOCHONDRIAL_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX",6,-0.7203,0.83,1,"No",0.9147,0.57,0.86,"Yes"
"15442","GO_BP","519120_GO_2000480_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY",8,-0.7202,0.84,0.95,"No",1.3108,0.16,0.66,"Yes"
"15443","C7_Immunologic_signatures","C7_ALL_173_GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP",199,-0.7202,0.99,0.99,"No",0.8263,0.92,1,"Yes"
"15444","GO_CC","513727_GO_0060170_CILIARY_MEMBRANE",69,-0.72,0.93,1,"No",-1.2535,0.11,0.68,"No"
"15445","GO_MF","492530_GO_0008187_POLY_PYRIMIDINE_TRACT_BINDING",15,-0.7198,0.84,0.94,"No",-0.8369,0.73,1,"No"
"15446","C4_Cancer_modules","C4_CM_302_MODULE_349",17,-0.7197,0.85,0.95,"No",-0.8301,0.69,0.96,"No"
"15447","GO_MF","506652_GO_0043621_PROTEIN_SELF_ASSOCIATION",39,-0.7195,0.9,0.94,"No",-0.851,0.72,1,"No"
"15448","GO_MF","515119_GO_0070182_DNA_POLYMERASE_BINDING",8,-0.7194,0.81,0.94,"No",-1.0734,0.35,0.86,"No"
"15449","GO_BP","508140_GO_0045815_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC",19,-0.7194,0.85,0.95,"No",0.7358,0.85,1,"Yes"
"15450","GO_BP","486611_GO_0007059_CHROMOSOME_SEGREGATION",202,-0.7192,0.98,0.95,"No",1.0243,0.39,0.97,"Yes"
"15451","GO_MF","496054_GO_0015932_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",32,-0.7192,0.88,0.94,"No",-0.9496,0.52,0.95,"No"
"15452","GO_BP","494070_GO_0046033_AMP_METABOLIC_PROCESS",13,-0.7192,0.83,0.95,"No",0.7321,0.83,1,"Yes"
"15453","KEGG_module","HSA_M00386_CUL4_DDB1_CSA_COMPLEX",5,-0.7189,0.81,0.93,"No",0.6289,0.9,0.99,"Yes"
"15454","GO_BP","517568_GO_0072665_PROTEIN_LOCALIZATION_TO_VACUOLE",30,-0.7189,0.88,0.95,"No",0.9788,0.48,1,"Yes"
"15455","GO_MF","994740_GO_0097617_ANNEALING_ACTIVITY",8,-0.7185,0.84,0.94,"No",-1.2508,0.21,0.83,"No"
"15456","C4_Cancer_modules","C4_CM_73_MODULE_78",20,-0.7185,0.86,0.95,"No",-0.8288,0.72,0.95,"No"
"15457","GO_BP","505804_GO_0042695_THELARCHE",6,-0.7181,0.83,0.95,"No",1.2319,0.24,0.76,"Yes"
"15458","GO_CC","515508_GO_0070578_RISC_LOADING_COMPLEX",6,-0.718,0.81,1,"No",-1.1324,0.34,0.72,"No"
"15459","GO_BP","514922_GO_0061377_MAMMARY_GLAND_LOBULE_DEVELOPMENT",20,-0.7178,0.86,0.95,"No",1.2199,0.21,0.77,"Yes"
"15460","GO_BP","517401_GO_0072488_AMMONIUM_TRANSMEMBRANE_TRANSPORT",23,-0.7177,0.86,0.95,"No",-0.6986,0.89,1,"No"
"15461","C1_Positional","C1_ALL_56_CHR5Q12",37,-0.7174,0.88,1,"No",1.1847,0.19,0.6,"Yes"
"15462","GO_MF","496798_GO_0016922_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING",19,-0.7172,0.86,0.94,"No",1.2311,0.2,0.7,"Yes"
"15463","GO_BP","512788_GO_0051938_L_GLUTAMATE_IMPORT",7,-0.7172,0.82,0.95,"No",0.4676,0.99,1,"Yes"
"15464","GO_BP","487971_GO_0002082_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION",10,-0.7171,0.84,0.95,"No",1.385,0.093,0.57,"Yes"
"15465","C4_Cancer_modules","C4_CM_335_MODULE_400",16,-0.7169,0.85,0.95,"No",1.1364,0.28,0.48,"Yes"
"15466","C2_Chemical_and_genetic_perturbations","C2_CGP_1576_HOEGERKORP_CD44_TARGETS_TEMPORAL_UP",12,-0.7168,0.83,0.94,"No",-0.5449,0.97,1,"No"
"15467","GO_BP","777518_GO_0044774_MITOTIC_DNA_INTEGRITY_CHECKPOINT",107,-0.7168,0.95,0.95,"No",1.5609,0.0022,0.34,"Yes"
"15468","GO_BP","504209_GO_0035019_SOMATIC_STEM_CELL_MAINTENANCE",69,-0.7168,0.92,0.95,"No",0.9383,0.56,1,"Yes"
"15469","GO_BP","489098_GO_0003306_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",7,-0.7158,0.85,0.95,"No",1.3426,0.14,0.62,"Yes"
"15470","GO_BP","491634_GO_0006754_ATP_BIOSYNTHETIC_PROCESS",34,-0.7157,0.89,0.95,"No",1.6798,0.01,0.21,"Yes"
"15471","GO_MF","517951_GO_0080025_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING",19,-0.7156,0.83,0.94,"No",-0.8587,0.66,1,"No"
"15472","C1_Positional","C1_ALL_14_CHR18Q23",18,-0.7156,0.86,0.99,"No",0.8313,0.7,0.92,"Yes"
"15473","C2_Chemical_and_genetic_perturbations","C2_CGP_318_ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP",41,-0.7155,0.91,0.95,"No",1.1961,0.18,0.49,"Yes"
"15474","C2_Chemical_and_genetic_perturbations","C2_CGP_1019_TONG_INTERACT_WITH_PTTG1",57,-0.7152,0.91,0.95,"No",1.7109,0,0.076,"Yes"
"15475","GO_BP","501187_GO_0031947_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS",5,-0.7152,0.82,0.95,"No",1.153,0.3,0.83,"Yes"
"15476","REACTOME","530740_REACT_115662_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING",13,-0.7148,0.82,0.95,"No",0.9914,0.43,0.76,"Yes"
"15477","REACTOME","106362_REACT_16973_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS",7,-0.7146,0.85,0.95,"No",-0.797,0.73,1,"No"
"15478","C2_Chemical_and_genetic_perturbations","C2_CGP_3322_RAO_BOUND_BY_SALL4_ISOFORM_A",173,-0.7144,0.98,0.95,"No",1.2685,0.047,0.42,"Yes"
"15479","GO_BP","487943_GO_0002053_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION",35,-0.7141,0.89,0.95,"No",1.3832,0.048,0.57,"Yes"
"15480","C7_Immunologic_signatures","C7_ALL_1230_GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN",199,-0.7141,0.97,1,"No",1.1802,0.078,0.26,"Yes"
"15481","GO_BP","493608_GO_0009437_CARNITINE_METABOLIC_PROCESS",12,-0.714,0.84,0.95,"No",0.5304,0.98,1,"Yes"
"15482","C2_Chemical_and_genetic_perturbations","C2_CGP_552_OZANNE_AP1_TARGETS_DN",5,-0.7139,0.82,0.95,"No",0.9954,0.48,0.81,"Yes"
"15483","GO_MF","506464_GO_0043426_MRF_BINDING",5,-0.7139,0.84,0.94,"No",0.9314,0.54,0.94,"Yes"
"15484","C1_Positional","C1_ALL_73_CHR22Q13",181,-0.7139,0.97,0.99,"No",0.8075,0.93,0.94,"Yes"
"15485","GO_BP","503706_GO_0034504_PROTEIN_LOCALIZATION_TO_NUCLEUS",140,-0.7136,0.97,0.95,"No",0.8577,0.82,1,"Yes"
"15486","GO_BP","513985_GO_0060430_LUNG_SACCULE_DEVELOPMENT",7,-0.7133,0.82,0.95,"No",-1.5884,0.028,0.72,"No"
"15487","C7_Immunologic_signatures","C7_ALL_226_GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN",190,-0.7132,0.99,1,"No",2.0113,0,0,"Yes"
"15488","C4_Cancer_gene_neighborhoods","C4_CGN_127_MORF_MAP2K2",132,-0.7129,0.97,1,"No",2.1201,0,0.00011,"Yes"
"15489","C4_Cancer_gene_neighborhoods","C4_CGN_418_GNF2_TM4SF2",26,-0.7127,0.9,1,"No",-1.3232,0.13,0.51,"No"
"15490","GO_BP","494580_GO_0010511_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS",6,-0.7126,0.84,0.95,"No",0.8852,0.58,1,"Yes"
"15491","GO_BP","489129_GO_0003337_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS",9,-0.7124,0.82,0.95,"No",1.0898,0.36,0.92,"Yes"
"15492","C7_Immunologic_signatures","C7_ALL_273_GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP",189,-0.7122,0.98,1,"No",-0.7453,0.98,1,"No"
"15493","REACTOME","161048_REACT_22172_CHROMOSOME_MAINTENANCE",106,-0.712,0.97,0.95,"No",-0.8908,0.69,1,"No"
"15494","GO_BP","502455_GO_0033235_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION",12,-0.7119,0.86,0.95,"No",-0.538,0.98,1,"No"
"15495","GO_MF","489932_GO_0016018_CYCLOSPORIN_A_BINDING",7,-0.7119,0.83,0.94,"No",1.2296,0.21,0.7,"Yes"
"15496","GO_CC","500571_GO_0031312_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE",19,-0.7117,0.86,1,"No",-0.7824,0.76,1,"No"
"15497","C2_Chemical_and_genetic_perturbations","C2_CGP_2157_LIN_MELANOMA_COPY_NUMBER_UP",70,-0.7116,0.94,0.95,"No",0.9378,0.59,0.88,"Yes"
"15498","C7_Immunologic_signatures","C7_ALL_604_GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_DN",194,-0.7116,0.98,1,"No",0.9841,0.5,0.79,"Yes"
"15499","GO_BP","516965_GO_0072048_RENAL_SYSTEM_PATTERN_SPECIFICATION",8,-0.7115,0.82,0.95,"No",-1.0563,0.4,0.97,"No"
"15500","C7_Immunologic_signatures","C7_ALL_856_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN",177,-0.7113,0.98,1,"No",-1.3592,0.025,0.34,"No"
"15501","GO_BP","491912_GO_0007093_MITOTIC_CELL_CYCLE_CHECKPOINT",165,-0.7113,0.98,0.95,"No",1.3749,0.014,0.58,"Yes"
"15502","GO_MF","515334_GO_0070402_NADPH_BINDING",11,-0.7112,0.86,0.94,"No",0.7886,0.75,1,"Yes"
"15503","GO_BP","1026093_GO_1903321_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL",120,-0.7111,0.95,0.95,"No",1.7029,0,0.19,"Yes"
"15504","C2_Chemical_and_genetic_perturbations","C2_CGP_936_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP",14,-0.711,0.86,0.95,"No",1.3227,0.14,0.37,"Yes"
"15505","GO_MF","511298_GO_0050308_SUGAR_PHOSPHATASE_ACTIVITY",10,-0.7109,0.86,0.94,"No",1.015,0.42,0.87,"Yes"
"15506","GO_BP","516481_GO_0071557_HISTONE_H3_K27_DEMETHYLATION",5,-0.7109,0.83,0.95,"No",-1.0822,0.41,0.95,"No"
"15507","GO_BP","808771_GO_1902100_NEGATIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",40,-0.7107,0.92,0.95,"No",0.9319,0.59,1,"Yes"
"15508","C7_Immunologic_signatures","C7_ALL_918_GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN",198,-0.7107,0.99,1,"No",1.0113,0.42,0.71,"Yes"
"15509","GO_BP","493901_GO_0009794_REGULATION_OF_MITOTIC_CELL_CYCLE_EMBRYONIC",5,-0.7107,0.81,0.95,"No",-0.8591,0.62,1,"No"
"15510","GO_BP","501257_GO_0032020_ISG15_PROTEIN_CONJUGATION",6,-0.7102,0.83,0.95,"No",1.0079,0.44,0.98,"Yes"
"15511","GO_MF","496591_GO_0016655_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR",53,-0.7101,0.93,0.94,"No",1.9967,0,0.013,"Yes"
"15512","C7_Immunologic_signatures","C7_ALL_1304_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN",192,-0.7099,0.98,1,"No",1.3533,0.016,0.06,"Yes"
"15513","C4_Cancer_modules","C4_CM_210_MODULE_227",15,-0.7094,0.88,0.95,"No",1.5323,0.04,0.098,"Yes"
"15514","GO_MF","513535_GO_0055103_LIGASE_REGULATOR_ACTIVITY",8,-0.709,0.83,0.94,"No",0.67,0.88,1,"Yes"
"15515","GO_BP","849954_GO_1902253_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR",21,-0.7081,0.88,0.96,"No",0.6378,0.96,1,"Yes"
"15516","C2_Chemical_and_genetic_perturbations","C2_CGP_2701_DING_LUNG_CANCER_MUTATED_RECURRENTLY",6,-0.7075,0.82,0.95,"No",-0.6226,0.88,1,"No"
"15517","GO_BP","517569_GO_0072666_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE",27,-0.7074,0.87,0.96,"No",0.9304,0.55,1,"Yes"
"15518","C3_TF_targets","C3_TFT_248_V_E2F_Q4",234,-0.7074,0.99,1,"No",0.8182,0.95,1,"Yes"
"15519","GO_MF","495488_GO_0051184_COFACTOR_TRANSPORTER_ACTIVITY",20,-0.707,0.88,0.95,"No",-1.4924,0.051,0.58,"No"
"15520","GO_BP","495911_GO_0015780_NUCLEOTIDE_SUGAR_TRANSPORT",7,-0.7067,0.84,0.96,"No",-0.9681,0.49,1,"No"
"15521","GO_MF","750729_GO_0036310_ANNEALING_HELICASE_ACTIVITY",8,-0.7067,0.85,0.95,"No",-1.2388,0.22,0.84,"No"
"15522","GO_BP","500399_GO_0031112_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",17,-0.7065,0.85,0.96,"No",0.6686,0.91,1,"Yes"
"15523","C4_Cancer_gene_neighborhoods","C4_CGN_74_MORF_CDC2L5",138,-0.7064,0.98,1,"No",-0.9481,0.57,0.91,"No"
"15524","GO_BP","494667_GO_0010603_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY",8,-0.7063,0.85,0.96,"No",0.5331,0.98,1,"Yes"
"15525","GO_MF","505912_GO_0042809_VITAMIN_D_RECEPTOR_BINDING",15,-0.7061,0.87,0.95,"No",0.6916,0.9,1,"Yes"
"15526","GO_BP","517483_GO_0072578_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING",8,-0.7056,0.84,0.96,"No",0.6694,0.87,1,"Yes"
"15527","C4_Cancer_modules","C4_CM_354_MODULE_427",114,-0.7055,0.96,0.95,"No",1.262,0.078,0.31,"Yes"
"15528","GO_BP","511658_GO_0050686_NEGATIVE_REGULATION_OF_MRNA_PROCESSING",29,-0.7055,0.91,0.96,"No",-0.9757,0.5,1,"No"
"15529","GO_BP","516988_GO_0072071_KIDNEY_INTERSTITIAL_FIBROBLAST_DIFFERENTIATION",7,-0.7053,0.85,0.96,"No",-0.6203,0.92,1,"No"
"15530","REACTOME","530747_REACT_115606_O_LINKED_GLYCOSYLATION_OF_MUCINS",63,-0.7052,0.94,0.96,"No",-0.66,0.98,1,"No"
"15531","GO_BP","849931_GO_1902230_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",27,-0.7051,0.89,0.96,"No",1.1397,0.24,0.85,"Yes"
"15532","GO_BP","499236_GO_0021957_CORTICOSPINAL_TRACT_MORPHOGENESIS",7,-0.705,0.82,0.96,"No",-0.4454,1,1,"No"
"15533","C2_Chemical_and_genetic_perturbations","C2_CGP_958_KHETCHOUMIAN_TRIM24_TARGETS_DN",7,-0.705,0.86,0.95,"No",-1.522,0.044,0.45,"No"
"15534","C4_Cancer_gene_neighborhoods","C4_CGN_257_GCM_PTPRU",52,-0.7049,0.93,1,"No",0.7496,0.9,1,"Yes"
"15535","REACTOME","771573_REACT_160113_NUCLEAR_ENVELOPE_REASSEMBLY",13,-0.7048,0.86,0.95,"No",1.1953,0.25,0.45,"Yes"
"15536","GO_MF","515343_GO_0070411_I_SMAD_BINDING",11,-0.7044,0.84,0.95,"No",-0.6017,0.94,1,"No"
"15537","GO_BP","493370_GO_0009174_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",11,-0.7043,0.85,0.96,"No",0.9322,0.55,1,"Yes"
"15538","GO_BP","508854_GO_0046600_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION",6,-0.7042,0.86,0.96,"No",-0.6386,0.89,1,"No"
"15539","C2_Chemical_and_genetic_perturbations","C2_CGP_1689_VIETOR_IFRD1_TARGETS",23,-0.7041,0.88,0.95,"No",0.8089,0.77,0.98,"Yes"
"15540","GO_BP","494935_GO_0010871_NEGATIVE_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS",6,-0.704,0.84,0.96,"No",1.2267,0.25,0.76,"Yes"
"15541","GO_BP","496303_GO_0016236_MACROAUTOPHAGY",61,-0.7037,0.94,0.96,"No",1.0629,0.33,0.94,"Yes"
"15542","C6_Oncogenic_signatures","C6_ALL_2_GLI1_UP_V1_UP",27,-0.7036,0.89,0.98,"No",1.2429,0.18,0.37,"Yes"
"15543","GO_BP","491486_GO_0006590_THYROID_HORMONE_GENERATION",10,-0.7036,0.84,0.96,"No",0.9675,0.47,1,"Yes"
"15544","GO_BP","504691_GO_0035510_DNA_DEALKYLATION",18,-0.7035,0.87,0.96,"No",0.9621,0.51,1,"Yes"
"15545","GO_MF","495579_GO_0015347_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.7031,0.85,0.95,"No",1.0632,0.39,0.83,"Yes"
"15546","GO_MF","495475_GO_0015211_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-0.7029,0.83,0.95,"No",-0.751,0.78,1,"No"
"15547","GO_BP","491191_GO_0006222_UMP_BIOSYNTHETIC_PROCESS",11,-0.7027,0.85,0.96,"No",0.9315,0.54,1,"Yes"
"15548","C2_Chemical_and_genetic_perturbations","C2_CGP_926_LIEN_BREAST_CARCINOMA_METAPLASTIC",35,-0.7023,0.91,0.95,"No",1.2703,0.11,0.42,"Yes"
"15549","C6_Oncogenic_signatures","C6_ALL_60_SRC_UP_V1_UP",161,-0.7022,0.98,0.97,"No",-1.3863,0.022,0.38,"No"
"15550","GO_BP","513575_GO_0060017_PARATHYROID_GLAND_DEVELOPMENT",7,-0.7019,0.86,0.96,"No",1.2159,0.24,0.76,"Yes"
"15551","GO_BP","513600_GO_0060042_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",48,-0.7017,0.92,0.96,"No",0.9978,0.44,0.98,"Yes"
"15552","C7_Immunologic_signatures","C7_ALL_601_GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_UP",198,-0.7017,0.99,1,"No",1.4903,0,0.014,"Yes"
"15553","C7_Immunologic_signatures","C7_ALL_1197_GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP",200,-0.7014,0.98,1,"No",1.0188,0.37,0.68,"Yes"
"15554","C1_Positional","C1_ALL_242_CHR2Q",5,-0.7013,0.85,1,"No",1.0673,0.41,0.66,"Yes"
"15555","GO_BP","512369_GO_0051491_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY",24,-0.7012,0.9,0.96,"No",-0.8849,0.66,1,"No"
"15556","GO_BP","506077_GO_0042984_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS",7,-0.7012,0.85,0.96,"No",-0.9472,0.51,1,"No"
"15557","GO_BP","754228_GO_1901264_CARBOHYDRATE_DERIVATIVE_TRANSPORT",42,-0.7012,0.9,0.96,"No",0.7551,0.88,1,"Yes"
"15558","GO_BP","508789_GO_0046532_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION",5,-0.7011,0.84,0.96,"No",-1.0614,0.41,0.96,"No"
"15559","GO_MF","750758_GO_0001206_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",6,-0.7011,0.81,0.95,"No",0.4642,0.99,1,"Yes"
"15560","REACTOME","106472_REACT_15502_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB",5,-0.701,0.87,0.96,"No",1.0789,0.4,0.62,"Yes"
"15561","C2_Chemical_and_genetic_perturbations","C2_CGP_2713_BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP",39,-0.7007,0.91,0.95,"No",0.7741,0.87,1,"Yes"
"15562","C2_Chemical_and_genetic_perturbations","C2_CGP_789_TERAMOTO_OPN_TARGETS_CLUSTER_8",8,-0.7007,0.85,0.95,"No",-1.1238,0.33,0.89,"No"
"15563","C1_Positional","C1_ALL_252_CHR14Q22",63,-0.7005,0.94,0.99,"No",-0.8125,0.82,0.97,"No"
"15564","C7_Immunologic_signatures","C7_ALL_264_GSE14308_TH17_VS_INDUCED_TREG_DN",199,-0.7003,0.99,1,"No",1.1488,0.13,0.32,"Yes"
"15565","GO_BP","755118_GO_2001012_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_RENAL_SYSTEM_DEVELOPMENT",8,-0.7001,0.87,0.96,"No",-1.3496,0.14,0.93,"No"
"15566","C2_Chemical_and_genetic_perturbations","C2_CGP_720_FARMER_BREAST_CANCER_CLUSTER_5",19,-0.6999,0.88,0.95,"No",0.8473,0.67,0.97,"Yes"
"15567","GO_MF","516482_GO_0071558_HISTONE_DEMETHYLASE_ACTIVITY_H3_K27_SPECIFIC_",5,-0.6999,0.85,0.95,"No",-1.1033,0.36,0.84,"No"
"15568","GO_CC","500335_GO_0031045_DENSE_CORE_GRANULE",12,-0.6997,0.85,1,"No",-0.8694,0.63,0.95,"No"
"15569","C1_Positional","C1_ALL_170_CHR10Q24",104,-0.6996,0.98,0.99,"No",1.1289,0.22,0.62,"Yes"
"15570","GO_MF","505436_GO_0042285_XYLOSYLTRANSFERASE_ACTIVITY",7,-0.6995,0.84,0.95,"No",0.7532,0.79,1,"Yes"
"15571","C2_Chemical_and_genetic_perturbations","C2_CGP_2345_GRADE_COLON_AND_RECTAL_CANCER_UP",285,-0.6993,1,0.96,"No",2.0376,0,0.004,"Yes"
"15572","GO_BP","488254_GO_0002381_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",26,-0.699,0.88,0.96,"No",-0.5793,0.98,1,"No"
"15573","GO_MF","490566_GO_0005388_CALCIUM_TRANSPORTING_ATPASE_ACTIVITY",9,-0.6989,0.85,0.95,"No",-1.0307,0.43,0.88,"No"
"15574","GO_BP","510188_GO_0048024_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME",57,-0.6988,0.94,0.96,"No",-0.8888,0.68,1,"No"
"15575","GO_BP","493369_GO_0009173_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS",11,-0.6987,0.85,0.96,"No",0.9226,0.54,1,"Yes"
"15576","GO_BP","518179_GO_0090032_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",6,-0.6986,0.87,0.96,"No",0.9268,0.54,1,"Yes"
"15577","GO_BP","493764_GO_0009649_ENTRAINMENT_OF_CIRCADIAN_CLOCK",24,-0.6983,0.91,0.96,"No",0.806,0.77,1,"Yes"
"15578","C2_Chemical_and_genetic_perturbations","C2_CGP_1867_LIANG_SILENCED_BY_METHYLATION_DN",11,-0.6981,0.86,0.96,"No",1.7408,0.01,0.063,"Yes"
"15579","GO_MF","490227_GO_0004936_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY",6,-0.6981,0.83,0.95,"No",-1.1696,0.29,0.79,"No"
"15580","C2_Chemical_and_genetic_perturbations","C2_CGP_2705_BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP",113,-0.6981,0.97,0.96,"No",-0.8259,0.85,1,"No"
"15581","GO_MF","496045_GO_0015923_MANNOSIDASE_ACTIVITY",15,-0.698,0.86,0.95,"No",0.4508,0.99,1,"Yes"
"15582","GO_BP","491441_GO_0006545_GLYCINE_BIOSYNTHETIC_PROCESS",6,-0.6979,0.85,0.96,"No",0.8523,0.66,1,"Yes"
"15583","C2_Chemical_and_genetic_perturbations","C2_CGP_1588_XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN",15,-0.6977,0.88,0.96,"No",1.4002,0.11,0.29,"Yes"
"15584","GO_BP","508346_GO_0046049_UMP_METABOLIC_PROCESS",11,-0.6976,0.87,0.96,"No",0.9438,0.5,1,"Yes"
"15585","GO_BP","513680_GO_0060122_INNER_EAR_RECEPTOR_STEREOCILIUM_ORGANIZATION",18,-0.6974,0.86,0.96,"No",0.4965,1,1,"Yes"
"15586","GO_MF","487207_GO_0000983_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",11,-0.6971,0.88,0.95,"No",-0.6513,0.91,1,"No"
"15587","C2_Chemical_and_genetic_perturbations","C2_CGP_22_KORKOLA_CHORIOCARCINOMA_DN",11,-0.697,0.85,0.96,"No",-0.815,0.71,1,"No"
"15588","GO_CC","757166_GO_0090544_BAF_TYPE_COMPLEX",19,-0.6969,0.89,1,"No",-1.1619,0.27,0.68,"No"
"15589","GO_BP","510870_GO_0048819_REGULATION_OF_HAIR_FOLLICLE_MATURATION",5,-0.6968,0.82,0.96,"No",-0.7152,0.83,1,"No"
"15590","GO_CC","507389_GO_0044441_CILIARY_PART",288,-0.6966,1,1,"No",-1.1823,0.093,0.69,"No"
"15591","C1_Positional","C1_ALL_87_CHR2Q34",16,-0.6966,0.88,0.99,"No",-1.0409,0.41,1,"No"
"15592","GO_BP","494631_GO_0010566_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS",7,-0.6962,0.84,0.96,"No",0.9237,0.57,1,"Yes"
"15593","REACTOME","366245_REACT_75881_METHIONINE_SALVAGE_PATHWAY",6,-0.696,0.83,0.96,"No",-0.4812,0.99,1,"No"
"15594","KEGG_compound","C00536_TRIPHOSPHATE_TRIPHOSPHORIC_ACID_TRIPOLYPHOSPHATE_INORGANIC_TRIPHOSPHATE",5,-0.6957,0.85,0.94,"No",1.3781,0.13,0.55,"Yes"
"15595","C4_Cancer_gene_neighborhoods","C4_CGN_361_GNF2_IGF1",26,-0.6953,0.89,1,"No",1.193,0.22,0.23,"Yes"
"15596","C3_TF_targets","C3_TFT_359_GATGKMRGCG_UNKNOWN",66,-0.6952,0.95,1,"No",0.7771,0.88,1,"Yes"
"15597","GO_BP","491652_GO_0006779_PORPHYRIN_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",27,-0.6951,0.89,0.96,"No",1.1935,0.2,0.79,"Yes"
"15598","C2_Chemical_and_genetic_perturbations","C2_CGP_3225_WACKER_HYPOXIA_TARGETS_OF_VHL",13,-0.695,0.87,0.96,"No",-0.6317,0.92,1,"No"
"15599","GO_BP","781993_GO_1902004_POSITIVE_REGULATION_OF_BETA_AMYLOID_FORMATION",5,-0.6948,0.85,0.96,"No",1.3888,0.11,0.57,"Yes"
"15600","GO_BP","498603_GO_0019800_PEPTIDE_CROSS_LINKING_VIA_CHONDROITIN_4_SULFATE_GLYCOSAMINOGLYCAN",6,-0.6948,0.85,0.96,"No",-1.5922,0.031,0.71,"No"
"15601","GO_BP","492619_GO_0008298_INTRACELLULAR_MRNA_LOCALIZATION",9,-0.6947,0.84,0.96,"No",-0.7181,0.86,1,"No"
"15602","REACTOME","160136_REACT_21368_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1",16,-0.6946,0.87,0.96,"No",-0.5403,0.98,1,"No"
"15603","GO_BP","487736_GO_0001840_NEURAL_PLATE_DEVELOPMENT",13,-0.6946,0.87,0.96,"No",-1.0761,0.36,0.95,"No"
"15604","REACTOME","1127551_REACT_8017_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A",23,-0.6946,0.89,0.96,"No",1.4415,0.061,0.19,"Yes"
"15605","GO_BP","489092_GO_0003300_CARDIAC_MUSCLE_HYPERTROPHY",20,-0.6945,0.87,0.96,"No",-0.811,0.73,1,"No"
"15606","GO_BP","500827_GO_0031577_SPINDLE_CHECKPOINT",40,-0.6944,0.91,0.96,"No",1.1085,0.29,0.89,"Yes"
"15607","GO_BP","501183_GO_0031943_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS",9,-0.6943,0.85,0.96,"No",0.7992,0.73,1,"Yes"
"15608","GO_BP","513896_GO_0060340_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY",8,-0.6942,0.87,0.96,"No",1.013,0.45,0.97,"Yes"
"15609","C2_Chemical_and_genetic_perturbations","C2_CGP_841_OXFORD_RALB_TARGETS_UP",8,-0.6941,0.87,0.96,"No",1.0561,0.41,0.7,"Yes"
"15610","KEGG_compound","C00110_DOLICHYL_PHOSPHATE_DOLICHOL_PHOSPHATE",7,-0.6939,0.86,0.94,"No",-0.7804,0.73,1,"No"
"15611","GO_CC","508835_GO_0046581_INTERCELLULAR_CANALICULUS",7,-0.6936,0.86,1,"No",1.6626,0.01,0.081,"Yes"
"15612","C3_TF_targets","C3_TFT_566_SGCGSSAAA_V_E2F1DP2_01",167,-0.6932,0.98,1,"No",0.7655,0.96,1,"Yes"
"15613","GO_MF","496852_GO_0017022_MYOSIN_BINDING",51,-0.693,0.93,0.95,"No",1.1606,0.22,0.74,"Yes"
"15614","GO_BP","495113_GO_0014041_REGULATION_OF_NEURON_MATURATION",7,-0.693,0.83,0.96,"No",1.0262,0.45,0.97,"Yes"
"15615","C4_Cancer_modules","C4_CM_383_MODULE_480",96,-0.6928,0.96,0.96,"No",1.2004,0.11,0.39,"Yes"
"15616","GO_MF","495661_GO_0015464_ACETYLCHOLINE_RECEPTOR_ACTIVITY",19,-0.6928,0.9,0.95,"No",-1.5121,0.048,0.55,"No"
"15617","C3_TF_targets","C3_TFT_348_GAANYNYGACNY_UNKNOWN",74,-0.6928,0.94,1,"No",0.6574,0.99,1,"Yes"
"15618","GO_BP","504322_GO_0035137_HINDLIMB_MORPHOGENESIS",37,-0.6927,0.93,0.96,"No",-1.0191,0.43,0.97,"No"
"15619","GO_BP","516991_GO_0072074_KIDNEY_MESENCHYME_DEVELOPMENT",17,-0.6927,0.88,0.96,"No",-1.1292,0.29,0.94,"No"
"15620","GO_BP","517077_GO_0072161_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",8,-0.6925,0.86,0.96,"No",-1.3508,0.14,0.93,"No"
"15621","C2_Chemical_and_genetic_perturbations","C2_CGP_2994_DASU_IL6_SIGNALING_DN",7,-0.6924,0.86,0.96,"No",-0.7404,0.8,1,"No"
"15622","C1_Positional","C1_ALL_107_CHR2P24",49,-0.692,0.94,0.99,"No",1.0791,0.33,0.65,"Yes"
"15623","C2_Chemical_and_genetic_perturbations","C2_CGP_1631_JIANG_AGING_CEREBRAL_CORTEX_UP",36,-0.6919,0.92,0.96,"No",1.2672,0.12,0.42,"Yes"
"15624","KEGG_reaction","R00328_GDP_PHOSPHOHYDROLASE_GDP_H2O_GMP_ORTHOPHOSPHATE",6,-0.6919,0.85,0.91,"No",0.7417,0.78,1,"Yes"
"15625","C1_Positional","C1_ALL_68_CHR17Q22",27,-0.6915,0.89,0.98,"No",-0.988,0.47,1,"No"
"15626","GO_BP","495027_GO_0010962_REGULATION_OF_GLUCAN_BIOSYNTHETIC_PROCESS",30,-0.6911,0.91,0.96,"No",-0.4344,1,1,"No"
"15627","C2_Chemical_and_genetic_perturbations","C2_CGP_3262_PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN",6,-0.691,0.85,0.96,"No",1.2973,0.15,0.39,"Yes"
"15628","C2_Chemical_and_genetic_perturbations","C2_CGP_2951_LY_AGING_OLD_UP",6,-0.6908,0.83,0.96,"No",-1.0733,0.38,0.95,"No"
"15629","C7_Immunologic_signatures","C7_ALL_1685_GSE3982_BCELL_VS_TH2_UP",196,-0.6908,0.99,1,"No",-0.7226,0.99,1,"No"
"15630","C4_Cancer_modules","C4_CM_346_MODULE_415",13,-0.6907,0.88,0.96,"No",-1.97,0,0.051,"No"
"15631","C2_Chemical_and_genetic_perturbations","C2_CGP_2886_ZHAN_MULTIPLE_MYELOMA_PR_DN",44,-0.6906,0.93,0.96,"No",0.8237,0.78,0.98,"Yes"
"15632","GO_BP","508059_GO_0045714_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BIOSYNTHETIC_PROCESS",7,-0.6906,0.86,0.96,"No",0.9446,0.53,1,"Yes"
"15633","C3_MicroRNA_targets","C3_MIR_199_CTCTATG_MIR_368",40,-0.6905,0.9,1,"No",1.2338,0.15,1,"Yes"
"15634","C2_Chemical_and_genetic_perturbations","C2_CGP_2158_LIN_MELANOMA_COPY_NUMBER_DN",41,-0.6904,0.93,0.96,"No",1.5382,0.031,0.18,"Yes"
"15635","KEGG_reaction","R00155_UDP_PHOSPHOHYDROLASE_UDP_H2O_UMP_ORTHOPHOSPHATE",6,-0.6902,0.85,0.9,"No",0.7511,0.78,1,"Yes"
"15636","REACTOME","771574_REACT_160242_INITIATION_OF_NUCLEAR_ENVELOPE_REFORMATION",13,-0.69,0.89,0.96,"No",1.2007,0.23,0.44,"Yes"
"15637","WikiPathways","198859_WP325_TRIACYLGLYCERIDE_SYNTHESIS",23,-0.69,0.9,0.97,"No",1.1293,0.3,0.97,"Yes"
"15638","C2_Chemical_and_genetic_perturbations","C2_CGP_699_LUI_THYROID_CANCER_CLUSTER_3",28,-0.6898,0.89,0.96,"No",2.4313,0,0,"Yes"
"15639","C7_Immunologic_signatures","C7_ALL_381_GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP",200,-0.6897,1,1,"No",1.0067,0.43,0.72,"Yes"
"15640","GO_MF","504654_GO_0035473_LIPASE_BINDING",6,-0.6893,0.84,0.95,"No",0.9565,0.49,0.92,"Yes"
"15641","REACTOME","106573_REACT_15480_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT",43,-0.6893,0.93,0.96,"No",-1.0418,0.37,0.95,"No"
"15642","C7_Immunologic_signatures","C7_ALL_776_GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN",198,-0.6892,0.99,1,"No",1.0816,0.23,0.49,"Yes"
"15643","GO_BP","849879_GO_1902177_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",6,-0.6891,0.85,0.97,"No",-1.178,0.27,0.91,"No"
"15644","C2_Chemical_and_genetic_perturbations","C2_CGP_1161_WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT",63,-0.6889,0.95,0.96,"No",1.2268,0.14,0.46,"Yes"
"15645","GO_BP","519181_GO_2000542_NEGATIVE_REGULATION_OF_GASTRULATION",7,-0.6888,0.85,0.97,"No",-0.9405,0.55,1,"No"
"15646","KEGG_compound","C00272_TETRAHYDROBIOPTERIN_5_6_7_8_TETRAHYDROBIOPTERIN_2_AMINO_6_1_2_DIHYDROXYPROPYL_5_6_7_8_TETRAHYDORO_4_1H_PTERIDINONE_L_ERYTHRO_TETRAHYDROBIOPTERIN",6,-0.6883,0.86,0.94,"No",0.9591,0.51,1,"Yes"
"15647","GO_BP","505445_GO_0042297_VOCAL_LEARNING",5,-0.6878,0.85,0.97,"No",-1.0946,0.38,0.95,"No"
"15648","GO_BP","514861_GO_0061316_CANONICAL_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",5,-0.6871,0.85,0.97,"No",-0.7179,0.8,1,"No"
"15649","GO_BP","504650_GO_0035469_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY",5,-0.6869,0.85,0.97,"No",-1.3527,0.12,0.95,"No"
"15650","GO_BP","982302_GO_0098597_OBSERVATIONAL_LEARNING",5,-0.6868,0.86,0.97,"No",-1.0784,0.38,0.95,"No"
"15651","GO_BP","491079_GO_0006099_TRICARBOXYLIC_ACID_CYCLE",29,-0.6867,0.91,0.97,"No",1.9319,0.0021,0.028,"Yes"
"15652","GO_BP","514742_GO_0061197_FUNGIFORM_PAPILLA_MORPHOGENESIS",5,-0.6865,0.85,0.97,"No",-1.046,0.42,0.97,"No"
"15653","GO_BP","514558_GO_0061003_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS",9,-0.6865,0.86,0.97,"No",-1.2973,0.17,0.89,"No"
"15654","GO_BP","512738_GO_0051883_KILLING_OF_CELLS_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",10,-0.6861,0.87,0.97,"No",1.4982,0.069,0.41,"Yes"
"15655","GO_BP","491827_GO_0006991_RESPONSE_TO_STEROL_DEPLETION",10,-0.6859,0.88,0.97,"No",-0.7621,0.76,1,"No"
"15656","C1_Positional","C1_ALL_138_CHR15Q15",76,-0.6859,0.97,0.98,"No",-0.9236,0.6,1,"No"
"15657","KEGG_compound","C00546_METHYLGLYOXAL_PYRUVALDEHYDE_PYRUVIC_ALDEHYDE_2_KETOPROPIONALDEHYDE_2_OXOPROPANAL",8,-0.6857,0.85,0.95,"No",-0.9044,0.58,1,"No"
"15658","KEGG_module","HSA_M00152_CYTOCHROME_BC1_COMPLEX",10,-0.6855,0.86,0.95,"No",1.5656,0.035,0.13,"Yes"
"15659","C2_Chemical_and_genetic_perturbations","C2_CGP_1595_FAELT_B_CLL_WITH_VH3_21_UP",44,-0.6853,0.93,0.96,"No",-0.5499,1,1,"No"
"15660","C3_MicroRNA_targets","C3_MIR_203_CAGCAGG_MIR_370",153,-0.685,0.98,1,"No",-1.416,0.0086,0.56,"No"
"15661","REACTOME","105825_REACT_6828_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS",83,-0.6849,0.97,0.97,"No",1.8999,0,0.0081,"Yes"
"15662","C7_Immunologic_signatures","C7_ALL_864_GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN",200,-0.6849,0.99,1,"No",0.9936,0.47,0.76,"Yes"
"15663","GO_BP","501186_GO_0031946_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS",7,-0.6848,0.87,0.97,"No",0.8247,0.69,1,"Yes"
"15664","C7_Immunologic_signatures","C7_ALL_1227_GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP",193,-0.6847,0.99,1,"No",1.2323,0.069,0.18,"Yes"
"15665","GO_BP","507348_GO_0044342_TYPE_B_PANCREATIC_CELL_PROLIFERATION",8,-0.6846,0.86,0.97,"No",-0.8611,0.63,1,"No"
"15666","GO_BP","752621_GO_0097120_RECEPTOR_LOCALIZATION_TO_SYNAPSE",8,-0.6846,0.87,0.97,"No",-0.7028,0.84,1,"No"
"15667","GO_BP","512689_GO_0051818_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",10,-0.6845,0.86,0.97,"No",1.4713,0.095,0.46,"Yes"
"15668","REACTOME","160944_REACT_21279_REGULATION_OF_MITOTIC_CELL_CYCLE",83,-0.6843,0.96,0.97,"No",1.8717,0,0.011,"Yes"
"15669","KEGG_reaction","R08379_RETINOL_NADP_OXIDOREDUCTASE_RETINOL_NADP_RETINAL_NADPH_H_",7,-0.6842,0.88,0.9,"No",0.7662,0.73,1,"Yes"
"15670","GO_CC","925902_GO_0098573_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE",41,-0.6842,0.94,1,"No",1.0002,0.45,0.79,"Yes"
"15671","GO_BP","1022195_GO_1903209_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH",8,-0.6842,0.86,0.97,"No",-1.2064,0.23,0.88,"No"
"15672","GO_BP","501666_GO_0032434_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",128,-0.6839,0.98,0.97,"No",1.1049,0.23,0.9,"Yes"
"15673","GO_BP","510369_GO_0048255_MRNA_STABILIZATION",28,-0.6836,0.9,0.97,"No",1.0053,0.43,0.98,"Yes"
"15674","GO_BP","491468_GO_0006572_TYROSINE_CATABOLIC_PROCESS",5,-0.6836,0.84,0.97,"No",-1.2523,0.22,0.91,"No"
"15675","GO_CC","490834_GO_0030658_TRANSPORT_VESICLE_MEMBRANE",82,-0.6835,0.96,1,"No",1.063,0.32,0.7,"Yes"
"15676","GO_BP","517433_GO_0072528_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",38,-0.6831,0.92,0.97,"No",0.6333,0.98,1,"Yes"
"15677","C3_TF_targets","C3_TFT_553_YTCCCRNNAGGY_UNKNOWN",72,-0.683,0.95,1,"No",-0.9329,0.59,0.9,"No"
"15678","C4_Cancer_gene_neighborhoods","C4_CGN_90_MORF_EI24",143,-0.6829,0.98,1,"No",2.1263,0,0.00012,"Yes"
"15679","C2_Chemical_and_genetic_perturbations","C2_CGP_2610_ZHANG_TLX_TARGETS_UP",89,-0.6825,0.98,0.96,"No",1.0044,0.44,0.79,"Yes"
"15680","GO_BP","519022_GO_2000382_POSITIVE_REGULATION_OF_MESODERM_DEVELOPMENT",5,-0.6823,0.88,0.97,"No",0.5771,0.94,1,"Yes"
"15681","GO_CC","507372_GO_0044423_VIRION_PART",11,-0.6822,0.88,1,"No",-0.8468,0.68,0.97,"No"
"15682","REACTOME","105734_REACT_11184_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS",10,-0.6821,0.89,0.97,"No",-1.3507,0.12,0.59,"No"
"15683","GO_BP","983712_GO_1902993_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",5,-0.6812,0.89,0.97,"No",1.3458,0.13,0.62,"Yes"
"15684","C2_Chemical_and_genetic_perturbations","C2_CGP_3216_TERAO_AOX4_TARGETS_SKIN_UP",38,-0.6809,0.93,0.96,"No",-0.8759,0.67,1,"No"
"15685","C7_Immunologic_signatures","C7_ALL_1229_GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP",193,-0.6806,0.99,1,"No",0.7205,1,1,"Yes"
"15686","GO_MF","500193_GO_0030898_ACTIN_DEPENDENT_ATPASE_ACTIVITY",12,-0.6805,0.87,0.96,"No",-0.6394,0.93,1,"No"
"15687","GO_BP","506399_GO_0043353_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION",8,-0.6802,0.87,0.97,"No",-0.5191,0.98,1,"No"
"15688","GO_BP","491811_GO_0006972_HYPEROSMOTIC_RESPONSE",23,-0.6801,0.9,0.97,"No",1.0973,0.29,0.9,"Yes"
"15689","GO_BP","487030_GO_0000733_DNA_STRAND_RENATURATION",9,-0.6801,0.85,0.97,"No",-1.197,0.26,0.9,"No"
"15690","GO_BP","493941_GO_0009838_ABSCISSION",6,-0.68,0.86,0.97,"No",0.973,0.49,1,"Yes"
"15691","GO_BP","505290_GO_0042118_ENDOTHELIAL_CELL_ACTIVATION",9,-0.6797,0.9,0.97,"No",0.5998,0.93,1,"Yes"
"15692","GO_CC","1051067_GO_0097651_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I",5,-0.6797,0.84,1,"No",1.3847,0.12,0.3,"Yes"
"15693","GO_MF","505904_GO_0042800_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K4_SPECIFIC_",17,-0.6795,0.9,0.96,"No",-0.7194,0.86,1,"No"
"15694","GO_BP","518744_GO_2000095_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY",13,-0.6795,0.86,0.97,"No",0.7232,0.84,1,"Yes"
"15695","GO_CC","499560_GO_0030131_CLATHRIN_ADAPTOR_COMPLEX",32,-0.6792,0.92,1,"No",0.9845,0.49,0.81,"Yes"
"15696","C2_Chemical_and_genetic_perturbations","C2_CGP_704_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13",6,-0.6791,0.86,0.96,"No",-0.8824,0.6,1,"No"
"15697","GO_MF","503618_GO_0034416_BISPHOSPHOGLYCERATE_PHOSPHATASE_ACTIVITY",5,-0.6789,0.86,0.96,"No",-0.8359,0.66,1,"No"
"15698","C4_Cancer_modules","C4_CM_258_MODULE_293",11,-0.6787,0.88,0.96,"No",0.717,0.85,1,"Yes"
"15699","GO_BP","982303_GO_0098598_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING",5,-0.6783,0.83,0.97,"No",-1.0665,0.42,0.96,"No"
"15700","GO_BP","492653_GO_0048148_BEHAVIORAL_RESPONSE_TO_COCAINE",12,-0.6782,0.87,0.97,"No",-1.2178,0.21,0.88,"No"
"15701","C1_Positional","C1_ALL_211_CHR9Q34",229,-0.6781,1,0.99,"No",-1.059,0.3,1,"No"
"15702","GO_MF","752539_GO_0090482_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.678,0.86,0.96,"No",-1.0634,0.4,0.86,"No"
"15703","REACTOME","106108_REACT_11082_IMPORT_OF_PALMITOYL_COA_INTO_THE_MITOCHONDRIAL_MATRIX",11,-0.6779,0.88,0.97,"No",-0.7984,0.75,1,"No"
"15704","GO_BP","505862_GO_0042756_DRINKING_BEHAVIOR",8,-0.6779,0.86,0.97,"No",1.0722,0.36,0.93,"Yes"
"15705","GO_BP","512430_GO_0051552_FLAVONE_METABOLIC_PROCESS",6,-0.6773,0.89,0.97,"No",0.979,0.49,1,"Yes"
"15706","GO_BP","784757_GO_1902033_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION",5,-0.6773,0.85,0.97,"No",1.1144,0.34,0.88,"Yes"
"15707","C2_Chemical_and_genetic_perturbations","C2_CGP_18_KORKOLA_EMBRYONAL_CARCINOMA_DN",12,-0.6772,0.88,0.97,"No",-0.8979,0.59,1,"No"
"15708","C3_MicroRNA_targets","C3_MIR_57_ACACTCC_MIR_122A",75,-0.6771,0.97,1,"No",0.7236,0.95,1,"Yes"
"15709","GO_BP","510190_GO_0048026_POSITIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME",16,-0.677,0.9,0.97,"No",-0.7296,0.83,1,"No"
"15710","OMIM_gene","OMIM611756_ROPN1_LIKE_PROTEIN_ROPN1L",7,-0.6769,0.89,1,"No",-0.6174,0.91,0.94,"No"
"15711","C2_Chemical_and_genetic_perturbations","C2_CGP_3000_JIANG_HYPOXIA_VIA_VHL",34,-0.6767,0.92,0.97,"No",1.477,0.032,0.23,"Yes"
"15712","C4_Cancer_modules","C4_CM_248_MODULE_280",44,-0.6767,0.94,0.96,"No",1.3615,0.093,0.22,"Yes"
"15713","GO_BP","514011_GO_0060456_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS",10,-0.6764,0.88,0.97,"No",0.7505,0.82,1,"Yes"
"15714","C1_Positional","C1_ALL_192_CHR13Q12",81,-0.6764,0.96,0.98,"No",1.6294,0,0.22,"Yes"
"15715","GO_BP","509009_GO_0046782_REGULATION_OF_VIRAL_TRANSCRIPTION",80,-0.6761,0.97,0.97,"No",1.3617,0.032,0.6,"Yes"
"15716","C7_Immunologic_signatures","C7_ALL_1733_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP",200,-0.6761,0.99,1,"No",1.0888,0.25,0.47,"Yes"
"15717","C7_Immunologic_signatures","C7_ALL_1853_GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP",200,-0.676,0.99,1,"No",0.9479,0.64,0.9,"Yes"
"15718","C2_Chemical_and_genetic_perturbations","C2_CGP_63_GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN",66,-0.6759,0.96,0.97,"No",1.5499,0.0067,0.17,"Yes"
"15719","GO_BP","494868_GO_0010804_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY",10,-0.6758,0.88,0.97,"No",-0.5973,0.92,1,"No"
"15720","GO_CC","504437_GO_0035253_CILIARY_ROOTLET",9,-0.6757,0.89,1,"No",-0.7186,0.84,1,"No"
"15721","GO_BP","752469_GO_0086103_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS",6,-0.6756,0.89,0.97,"No",0.7766,0.75,1,"Yes"
"15722","GO_BP","514741_GO_0061196_FUNGIFORM_PAPILLA_DEVELOPMENT",6,-0.6748,0.86,0.97,"No",-0.9677,0.48,1,"No"
"15723","GO_BP","506568_GO_0043537_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",21,-0.6747,0.91,0.97,"No",-0.6805,0.91,1,"No"
"15724","GO_BP","982301_GO_0098596_IMITATIVE_LEARNING",5,-0.6747,0.88,0.97,"No",-1.0517,0.4,0.97,"No"
"15725","GO_BP","1022085_GO_0044848_BIOLOGICAL_PHASE",362,-0.6746,1,0.97,"No",1.4941,0,0.42,"Yes"
"15726","GO_CC","501811_GO_0032585_MULTIVESICULAR_BODY_MEMBRANE",7,-0.6741,0.87,1,"No",1.1247,0.33,0.61,"Yes"
"15727","GO_BP","755244_GO_2001138_REGULATION_OF_PHOSPHOLIPID_TRANSPORT",7,-0.674,0.86,0.97,"No",-0.8889,0.59,1,"No"
"15728","GO_BP","495940_GO_0015809_ARGININE_TRANSPORT",6,-0.6737,0.86,0.97,"No",1.0046,0.45,0.98,"Yes"
"15729","C7_Immunologic_signatures","C7_ALL_499_GSE17721_CTRL_VS_CPG_2H_BMDM_UP",197,-0.6735,1,1,"No",1.0877,0.25,0.47,"Yes"
"15730","GO_MF","515811_GO_0070883_PRE_MIRNA_BINDING",7,-0.6733,0.87,0.96,"No",-1.1247,0.33,0.81,"No"
"15731","REACTOME","106475_REACT_12564_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL",13,-0.6733,0.89,0.97,"No",-0.7981,0.73,1,"No"
"15732","KEGG_reaction","R08383_9_CIS_RETINOL_NADP_9_CIS_RETINAL_NADPH_H_",5,-0.6732,0.87,0.9,"No",-0.6152,0.91,0.99,"No"
"15733","C2_Chemical_and_genetic_perturbations","C2_CGP_1730_WU_HBX_TARGETS_3_UP",18,-0.6732,0.9,0.97,"No",1.5574,0.021,0.17,"Yes"
"15734","GO_BP","488357_GO_0002484_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_VIA_ER_PATHWAY",5,-0.6731,0.87,0.97,"No",1.1336,0.33,0.86,"Yes"
"15735","GO_MF","498722_GO_0019956_CHEMOKINE_BINDING",13,-0.6731,0.88,0.96,"No",1.7068,0.0099,0.15,"Yes"
"15736","GO_MF","515342_GO_0070410_CO_SMAD_BINDING",12,-0.673,0.89,0.96,"No",-0.8607,0.65,1,"No"
"15737","C2_Chemical_and_genetic_perturbations","C2_CGP_3217_TERAO_AOX4_TARGETS_SKIN_DN",27,-0.673,0.92,0.97,"No",0.924,0.57,0.9,"Yes"
"15738","KEGG_enzyme","2.4.2.30_NAD_ADP_RIBOSYLTRANSFERASE_POLY_ADP_RIBOSE_SYNTHASE_ADP_RIBOSYLTRANSFERASE_POLYMERIZING_NAD_ADP_RIBOSYLTRANSFERASE_PARP_PARP_1_NAD_POLY_ADENINE_DIPHOSPHATE_D_RIBOSYL_ACCEPTOR_ADP_D_RIBOSYL_TRANSFERASE_INCORRECT_NAD_POLY_ADENOSINE_DIPHOSPHATE_D_RIBOSYL_ACCEPTOR_ADP_D_RIBOSYL_TRANSFERASE",17,-0.6729,0.89,0.88,"No",0.6822,0.9,0.99,"Yes"
"15739","GO_BP","518318_GO_0090178_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE",14,-0.6729,0.9,0.97,"No",1.1647,0.25,0.82,"Yes"
"15740","KEGG_pathway","HSA00670_ONE_CARBON_POOL_BY_FOLATE",20,-0.6727,0.9,0.97,"No",0.7656,0.78,1,"Yes"
"15741","GO_BP","512468_GO_0051590_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT",16,-0.6725,0.89,0.97,"No",-0.6904,0.86,1,"No"
"15742","GO_BP","506615_GO_0043584_NOSE_DEVELOPMENT",16,-0.6722,0.9,0.97,"No",-0.8412,0.67,1,"No"
"15743","GO_BP","492133_GO_0007368_DETERMINATION_OF_LEFT_RIGHT_SYMMETRY",89,-0.6716,0.97,0.97,"No",-1.0689,0.32,0.96,"No"
"15744","GO_CC","500566_GO_0031307_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE",17,-0.6714,0.88,1,"No",-0.6981,0.88,1,"No"
"15745","GO_BP","519148_GO_2000508_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS",5,-0.6713,0.88,0.97,"No",0.7069,0.84,1,"Yes"
"15746","GO_CC","497895_GO_0019012_VIRION",11,-0.6712,0.89,1,"No",-0.8664,0.63,0.95,"No"
"15747","C2_Chemical_and_genetic_perturbations","C2_CGP_1011_LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER",214,-0.6711,0.99,0.97,"No",1.3001,0.012,0.39,"Yes"
"15748","C2_Chemical_and_genetic_perturbations","C2_CGP_625_AUNG_GASTRIC_CANCER",52,-0.671,0.96,0.97,"No",0.8169,0.83,0.98,"Yes"
"15749","GO_BP","501914_GO_0032688_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION",9,-0.6709,0.88,0.97,"No",-0.8429,0.67,1,"No"
"15750","C3_TF_targets","C3_TFT_407_V_LXR_DR4_Q3",91,-0.6708,0.98,1,"No",-1.1261,0.23,0.49,"No"
"15751","GO_BP","491972_GO_0007168_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY",11,-0.6708,0.89,0.97,"No",-1.2135,0.22,0.88,"No"
"15752","GO_BP","492664_GO_0008354_GERM_CELL_MIGRATION",11,-0.6708,0.9,0.97,"No",0.7418,0.81,1,"Yes"
"15753","REACTOME","106063_REACT_12621_TIE2_SIGNALING",18,-0.6708,0.9,0.97,"No",0.9248,0.55,0.87,"Yes"
"15754","GO_BP","502306_GO_0033085_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS",8,-0.6705,0.87,0.97,"No",-1.4809,0.086,0.83,"No"
"15755","GO_BP","491412_GO_0006515_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEIN_CATABOLIC_PROCESS",13,-0.6704,0.88,0.97,"No",0.8039,0.75,1,"Yes"
"15756","C3_MicroRNA_targets","C3_MIR_96_CGGTGTG_MIR_220",6,-0.6704,0.87,1,"No",0.6328,0.92,1,"Yes"
"15757","C2_Chemical_and_genetic_perturbations","C2_CGP_1633_HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC",50,-0.6702,0.95,0.97,"No",1.4918,0.03,0.22,"Yes"
"15758","C1_Positional","C1_ALL_2_CHR16Q24",86,-0.67,0.98,0.98,"No",0.6492,0.99,1,"Yes"
"15759","C4_Cancer_gene_neighborhoods","C4_CGN_215_GCM_CDH5",33,-0.6699,0.93,1,"No",-0.8589,0.7,1,"No"
"15760","GO_BP","516383_GO_0071459_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION",12,-0.6699,0.89,0.97,"No",0.5886,0.94,1,"Yes"
"15761","GO_BP","755246_GO_2001140_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSPORT",7,-0.6697,0.86,0.97,"No",-0.8641,0.64,1,"No"
"15762","GO_CC","799471_GO_1990075_PERICILIARY_MEMBRANE_COMPARTMENT",6,-0.6693,0.87,1,"No",-0.5369,0.97,1,"No"
"15763","GO_BP","514701_GO_0061156_PULMONARY_ARTERY_MORPHOGENESIS",5,-0.669,0.84,0.97,"No",-0.972,0.5,1,"No"
"15764","GO_MF","496766_GO_0016877_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS",40,-0.6689,0.96,0.96,"No",0.9651,0.54,0.91,"Yes"
"15765","REACTOME","106426_REACT_332_IRS_MEDIATED_SIGNALLING",79,-0.6689,0.97,0.97,"No",0.8176,0.86,0.99,"Yes"
"15766","GO_BP","503171_GO_0033962_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY",9,-0.6688,0.89,0.97,"No",-0.704,0.85,1,"No"
"15767","GO_BP","499058_GO_0021778_OLIGODENDROCYTE_CELL_FATE_SPECIFICATION",5,-0.6686,0.87,0.97,"No",0.8785,0.61,1,"Yes"
"15768","GO_BP","502900_GO_0033683_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION",8,-0.6683,0.88,0.97,"No",0.9243,0.55,1,"Yes"
"15769","GO_BP","505578_GO_0042438_MELANIN_BIOSYNTHETIC_PROCESS",13,-0.6682,0.89,0.97,"No",-0.751,0.83,1,"No"
"15770","GO_BP","507252_GO_0044245_POLYSACCHARIDE_DIGESTION",5,-0.6681,0.87,0.97,"No",0.9512,0.51,1,"Yes"
"15771","GO_BP","777517_GO_0044773_MITOTIC_DNA_DAMAGE_CHECKPOINT",101,-0.668,0.98,0.97,"No",1.5108,0.0066,0.39,"Yes"
"15772","GO_CC","492625_GO_0016281_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX",9,-0.6676,0.88,1,"No",1.4212,0.074,0.28,"Yes"
"15773","GO_BP","519365_GO_2000726_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",6,-0.6672,0.87,0.97,"No",0.7315,0.8,1,"Yes"
"15774","GO_CC","490928_GO_0005929_CILIUM",431,-0.6671,1,1,"No",-1.1326,0.12,0.73,"No"
"15775","GO_BP","1129216_GO_0061647_HISTONE_H3_K9_MODIFICATION",27,-0.6668,0.95,0.97,"No",-1.3031,0.13,0.89,"No"
"15776","GO_BP","490999_GO_0006013_MANNOSE_METABOLIC_PROCESS",7,-0.6665,0.9,0.97,"No",0.5967,0.93,1,"Yes"
"15777","GO_BP","502097_GO_0032875_REGULATION_OF_DNA_ENDOREDUPLICATION",8,-0.6664,0.9,0.97,"No",1.0468,0.41,0.95,"Yes"
"15778","GO_BP","510569_GO_0048496_MAINTENANCE_OF_ORGAN_IDENTITY",5,-0.6663,0.87,0.97,"No",0.7815,0.73,1,"Yes"
"15779","C2_Chemical_and_genetic_perturbations","C2_CGP_1257_BYSTRYKH_SCP2_QTL",6,-0.6663,0.87,0.97,"No",0.4116,1,1,"Yes"
"15780","GO_CC","498683_GO_0019907_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVATING_KINASE_HOLOENZYME_COMPLEX",6,-0.6661,0.88,1,"No",0.7071,0.82,0.99,"Yes"
"15781","C2_Chemical_and_genetic_perturbations","C2_CGP_1129_PETRETTO_HEART_MASS_QTL_CIS_UP",28,-0.666,0.93,0.97,"No",0.8636,0.66,0.96,"Yes"
"15782","WikiPathways","920989_WP1530_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE",9,-0.666,0.89,0.98,"No",0.5654,0.96,1,"Yes"
"15783","C2_Chemical_and_genetic_perturbations","C2_CGP_521_HUMMERICH_MALIGNANT_SKIN_TUMOR_DN",18,-0.6658,0.9,0.97,"No",-0.79,0.76,1,"No"
"15784","GO_BP","754039_GO_1901070_GUANOSINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",17,-0.6658,0.89,0.97,"No",-0.7591,0.82,1,"No"
"15785","REACTOME","106329_REACT_13778_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS",5,-0.6656,0.88,0.97,"No",0.859,0.65,0.95,"Yes"
"15786","GO_BP","519039_GO_2000399_NEGATIVE_REGULATION_OF_THYMOCYTE_AGGREGATION",8,-0.6654,0.88,0.97,"No",-1.5102,0.073,0.81,"No"
"15787","GO_BP","492652_GO_0008340_DETERMINATION_OF_ADULT_LIFESPAN",11,-0.6651,0.89,0.97,"No",-1.0591,0.37,0.96,"No"
"15788","C3_MicroRNA_targets","C3_MIR_16_AGCGCTT_MIR_518F_MIR_518E_MIR_518A",18,-0.6649,0.89,1,"No",0.8281,0.68,1,"Yes"
"15789","GO_MF","496600_GO_0016668_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR",9,-0.6648,0.87,0.96,"No",1.0933,0.35,0.8,"Yes"
"15790","GO_CC","486685_GO_0000151_UBIQUITIN_LIGASE_COMPLEX",188,-0.6647,1,1,"No",1.1005,0.23,0.64,"Yes"
"15791","REACTOME","106477_REACT_12447_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK",8,-0.6645,0.88,0.97,"No",-0.5738,0.96,1,"No"
"15792","C1_Positional","C1_ALL_86_CHR2P11",53,-0.6643,0.97,0.98,"No",1.0695,0.33,0.66,"Yes"
"15793","C3_TF_targets","C3_TFT_470_V_E2F1_Q6_01",236,-0.664,1,1,"No",-0.7661,0.99,1,"No"
"15794","GO_MF","496770_GO_0016881_ACID_AMINO_ACID_LIGASE_ACTIVITY",21,-0.6636,0.93,0.96,"No",-0.6944,0.88,1,"No"
"15795","GO_BP","507264_GO_0044257_CELLULAR_PROTEIN_CATABOLIC_PROCESS",444,-0.6636,1,0.97,"No",1.3572,0,0.6,"Yes"
"15796","GO_BP","506246_GO_0043174_NUCLEOSIDE_SALVAGE",15,-0.6633,0.9,0.97,"No",0.5829,0.96,1,"Yes"
"15797","GO_BP","486616_GO_0000075_CELL_CYCLE_CHECKPOINT",249,-0.6633,1,0.97,"No",1.3844,0.0048,0.57,"Yes"
"15798","C7_Immunologic_signatures","C7_ALL_1009_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP",199,-0.6632,1,1,"No",-0.7469,0.99,1,"No"
"15799","GO_BP","496208_GO_0016115_TERPENOID_CATABOLIC_PROCESS",5,-0.6628,0.87,0.97,"No",-0.9643,0.53,1,"No"
"15800","C7_Immunologic_signatures","C7_ALL_260_GSE14308_TH1_VS_NATURAL_TREG_DN",198,-0.6626,1,1,"No",0.7356,0.99,1,"Yes"
"15801","C2_Chemical_and_genetic_perturbations","C2_CGP_2211_OUYANG_PROSTATE_CANCER_PROGRESSION_UP",19,-0.6623,0.9,0.97,"No",-0.7752,0.81,1,"No"
"15802","WikiPathways","198818_WP561_HEME_BIOSYNTHESIS",9,-0.6618,0.9,0.98,"No",1.0266,0.43,1,"Yes"
"15803","GO_CC","500715_GO_0031464_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX",9,-0.6618,0.89,1,"No",1.1349,0.28,0.59,"Yes"
"15804","C2_Chemical_and_genetic_perturbations","C2_CGP_382_ENK_UV_RESPONSE_KERATINOCYTE_DN",485,-0.6617,1,0.97,"No",1.4747,0,0.23,"Yes"
"15805","GO_CC","983679_GO_0090575_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_COMPLEX",82,-0.6615,0.97,1,"No",0.9817,0.5,0.81,"Yes"
"15806","C2_Chemical_and_genetic_perturbations","C2_CGP_1745_BURTON_ADIPOGENESIS_12",36,-0.6613,0.94,0.97,"No",1.1833,0.24,0.51,"Yes"
"15807","GO_BP","506226_GO_0043153_ENTRAINMENT_OF_CIRCADIAN_CLOCK_BY_PHOTOPERIOD",20,-0.661,0.91,0.97,"No",0.8827,0.63,1,"Yes"
"15808","KEGG_compound","C00269_CDP_DIACYLGLYCEROL_CDP_1_2_DIACYLGLYCEROL_1_2_DIACYL_SN_GLYCERO_3_CYTIDINE_5_DIPHOSPHATE",5,-0.6609,0.89,0.97,"No",0.9256,0.54,1,"Yes"
"15809","GO_BP","518540_GO_0090400_STRESS_INDUCED_PREMATURE_SENESCENCE",8,-0.6608,0.91,0.97,"No",-1.2027,0.24,0.89,"No"
"15810","C7_Immunologic_signatures","C7_ALL_224_GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN",190,-0.6608,1,1,"No",2.5522,0,0,"Yes"
"15811","REACTOME","1183585_REACT_355192_RHO_GTPASES_ACTIVATE_ROCKS",17,-0.6607,0.91,0.98,"No",0.9443,0.53,0.84,"Yes"
"15812","GO_BP","498816_GO_0021532_NEURAL_TUBE_PATTERNING",36,-0.6606,0.94,0.97,"No",-0.8936,0.63,1,"No"
"15813","GO_BP","493415_GO_0009219_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",14,-0.6606,0.91,0.97,"No",1.6148,0.019,0.28,"Yes"
"15814","GO_BP","491408_GO_0051603_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",429,-0.6603,1,0.97,"No",1.3394,0.0052,0.62,"Yes"
"15815","GO_BP","518254_GO_0090114_COPII_COATED_VESICLE_BUDDING",19,-0.66,0.92,0.97,"No",1.4521,0.075,0.49,"Yes"
"15816","GO_BP","491872_GO_0007045_CELL_SUBSTRATE_ADHERENS_JUNCTION_ASSEMBLY",23,-0.66,0.91,0.97,"No",-0.8858,0.65,1,"No"
"15817","GO_BP","518125_GO_0085020_PROTEIN_K6_LINKED_UBIQUITINATION",8,-0.6599,0.88,0.97,"No",0.9394,0.55,1,"Yes"
"15818","GO_BP","487962_GO_0002072_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT",8,-0.6599,0.9,0.97,"No",1.0663,0.39,0.94,"Yes"
"15819","GO_CC","505871_GO_0042765_GPI_ANCHOR_TRANSAMIDASE_COMPLEX",5,-0.6598,0.88,1,"No",-0.6953,0.83,1,"No"
"15820","GO_BP","513846_GO_0060290_TRANSDIFFERENTIATION",5,-0.6595,0.88,0.97,"No",0.8468,0.64,1,"Yes"
"15821","C4_Cancer_gene_neighborhoods","C4_CGN_143_MORF_PHB",124,-0.6587,0.99,1,"No",1.0413,0.36,0.48,"Yes"
"15822","GO_BP","518968_GO_2000322_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY",7,-0.6585,0.89,0.98,"No",-0.9511,0.51,1,"No"
"15823","GO_BP","495995_GO_0015871_CHOLINE_TRANSPORT",5,-0.6584,0.89,0.97,"No",-0.7618,0.79,1,"No"
"15824","GO_MF","489590_GO_0004126_CYTIDINE_DEAMINASE_ACTIVITY",8,-0.6583,0.9,0.97,"No",0.7844,0.72,1,"Yes"
"15825","C7_Immunologic_signatures","C7_ALL_193_GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP",180,-0.6583,1,1,"No",2.2225,0,0,"Yes"
"15826","C4_Cancer_gene_neighborhoods","C4_CGN_188_MORF_UBE2A",50,-0.6582,0.97,1,"No",1.3891,0.048,0.065,"Yes"
"15827","C2_Chemical_and_genetic_perturbations","C2_CGP_3215_TERAO_AOX4_TARGETS_HG_DN",6,-0.6582,0.87,0.97,"No",-0.9135,0.56,1,"No"
"15828","C2_Chemical_and_genetic_perturbations","C2_CGP_676_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16",9,-0.6577,0.88,0.97,"No",0.6738,0.88,1,"Yes"
"15829","C2_Chemical_and_genetic_perturbations","C2_CGP_2136_STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP",125,-0.6576,0.98,0.97,"No",1.364,0.02,0.33,"Yes"
"15830","GO_BP","493327_GO_0009130_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",13,-0.6574,0.91,0.98,"No",0.9021,0.59,1,"Yes"
"15831","GO_MF","490063_GO_0004749_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY",5,-0.6573,0.89,0.97,"No",0.8453,0.62,1,"Yes"
"15832","GO_BP","517057_GO_0072141_RENAL_INTERSTITIAL_FIBROBLAST_DEVELOPMENT",6,-0.6573,0.88,0.98,"No",-0.7012,0.82,1,"No"
"15833","C2_BioCarta_Pathways","C2_CP_BIOCARTA_119_BIOCARTA_MTOR_PATHWAY",23,-0.6566,0.94,0.95,"No",1.4164,0.068,0.48,"Yes"
"15834","C2_Chemical_and_genetic_perturbations","C2_CGP_883_KIM_MYC_AMPLIFICATION_TARGETS_UP",198,-0.6564,1,0.97,"No",1.8115,0,0.04,"Yes"
"15835","GO_CC","507306_GO_0044300_CEREBELLAR_MOSSY_FIBER",7,-0.6564,0.9,1,"No",-1.0446,0.39,0.84,"No"
"15836","GO_BP","487492_GO_0001554_LUTEOLYSIS",5,-0.6564,0.88,0.98,"No",1.0391,0.43,0.96,"Yes"
"15837","GO_BP","502791_GO_0033574_RESPONSE_TO_TESTOSTERONE",28,-0.6564,0.93,0.98,"No",0.8537,0.71,1,"Yes"
"15838","GO_BP","498706_GO_0019933_CAMP_MEDIATED_SIGNALING",23,-0.6562,0.94,0.98,"No",0.9854,0.47,1,"Yes"
"15839","C2_BioCarta_Pathways","C2_CP_BIOCARTA_16_BIOCARTA_DNAFRAGMENT_PATHWAY",10,-0.6561,0.9,0.94,"No",1.1757,0.25,0.71,"Yes"
"15840","C1_Positional","C1_ALL_62_CHR3P12",14,-0.6559,0.91,0.98,"No",0.9478,0.56,0.82,"Yes"
"15841","C7_Immunologic_signatures","C7_ALL_719_GSE17721_0_5H_VS_4H_POLYIC_BMDM_UP",195,-0.6559,1,1,"No",1.4161,0.0049,0.033,"Yes"
"15842","GO_BP","504464_GO_0035280_MIRNA_LOADING_ONTO_RISC_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",7,-0.6553,0.9,0.98,"No",-0.9044,0.57,1,"No"
"15843","GO_BP","499059_GO_0021779_OLIGODENDROCYTE_CELL_FATE_COMMITMENT",5,-0.6552,0.9,0.98,"No",0.8591,0.61,1,"Yes"
"15844","KEGG_pathway","HSA00190_OXIDATIVE_PHOSPHORYLATION",116,-0.6551,0.99,0.98,"No",2.5837,0,0,"Yes"
"15845","GO_BP","498668_GO_0019885_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I",9,-0.655,0.9,0.98,"No",1.405,0.11,0.55,"Yes"
"15846","GO_BP","499060_GO_0021780_GLIAL_CELL_FATE_SPECIFICATION",5,-0.655,0.88,0.98,"No",0.8575,0.65,1,"Yes"
"15847","GO_BP","496531_GO_0016584_NUCLEOSOME_POSITIONING",8,-0.6548,0.9,0.98,"No",1.1894,0.26,0.79,"Yes"
"15848","C2_Chemical_and_genetic_perturbations","C2_CGP_127_LIU_CMYB_TARGETS_DN",7,-0.6545,0.89,0.97,"No",1.2676,0.21,0.42,"Yes"
"15849","GO_CC","516705_GO_0071782_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK",9,-0.6545,0.91,1,"No",0.8769,0.63,0.91,"Yes"
"15850","GO_BP","752402_GO_0086036_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL",8,-0.6545,0.91,0.98,"No",-1.466,0.07,0.87,"No"
"15851","GO_BP","511933_GO_0051000_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY",18,-0.6543,0.9,0.98,"No",1.0451,0.39,0.95,"Yes"
"15852","GO_BP","510205_GO_0048041_FOCAL_ADHESION_ASSEMBLY",23,-0.6542,0.92,0.98,"No",-0.8998,0.61,1,"No"
"15853","REACTOME","105812_REACT_910_M_PHASE",296,-0.654,1,0.98,"No",1.2787,0.021,0.35,"Yes"
"15854","GO_BP","517199_GO_0072283_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS",11,-0.6539,0.9,0.98,"No",1.0971,0.33,0.9,"Yes"
"15855","C3_MicroRNA_targets","C3_MIR_114_CCTGTGA_MIR_513",123,-0.6538,0.99,1,"No",-0.7903,0.89,1,"No"
"15856","GO_BP","921133_GO_1902534_SINGLE_ORGANISM_MEMBRANE_INVAGINATION",15,-0.6537,0.92,0.98,"No",0.9839,0.48,1,"Yes"
"15857","REACTOME","106445_REACT_13643_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS",15,-0.6536,0.9,0.98,"No",1.1923,0.22,0.45,"Yes"
"15858","GO_BP","516100_GO_0071174_MITOTIC_SPINDLE_CHECKPOINT",35,-0.6533,0.93,0.98,"No",1.0371,0.39,0.96,"Yes"
"15859","KEGG_reaction","R02124_RETINOL_NAD_OXIDOREDUCTASE_RETINOL_NAD_RETINAL_NADH_H_",11,-0.6533,0.91,0.92,"No",1.6657,0.012,0.08,"Yes"
"15860","GO_BP","487725_GO_0001829_TROPHECTODERMAL_CELL_DIFFERENTIATION",18,-0.6529,0.91,0.98,"No",-0.7118,0.88,1,"No"
"15861","GO_MF","489408_GO_0003923_GPI_ANCHOR_TRANSAMIDASE_ACTIVITY",5,-0.6528,0.88,0.97,"No",-0.6891,0.86,1,"No"
"15862","GO_BP","505420_GO_0042268_REGULATION_OF_CYTOLYSIS",8,-0.6525,0.89,0.98,"No",1.1877,0.29,0.79,"Yes"
"15863","GO_MF","496747_GO_0016854_RACEMASE_AND_EPIMERASE_ACTIVITY",15,-0.6517,0.91,0.97,"No",0.8058,0.73,1,"Yes"
"15864","GO_BP","519150_GO_2000510_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS",5,-0.6517,0.89,0.98,"No",0.7171,0.8,1,"Yes"
"15865","GO_BP","513598_GO_0060040_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION",5,-0.6515,0.88,0.98,"No",0.9731,0.51,1,"Yes"
"15866","C7_Immunologic_signatures","C7_ALL_201_GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP",188,-0.6515,1,1,"No",-1.0834,0.26,1,"No"
"15867","KEGG_compound","C00021_S_ADENOSYL_L_HOMOCYSTEINE_S_ADENOSYLHOMOCYSTEINE",56,-0.6514,0.97,0.97,"No",-0.9716,0.49,1,"No"
"15868","GO_BP","506075_GO_0042982_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS",11,-0.6513,0.91,0.98,"No",0.5367,0.98,1,"Yes"
"15869","GO_BP","503920_GO_0034720_HISTONE_H3_K4_DEMETHYLATION",6,-0.6508,0.9,0.98,"No",-0.6141,0.91,1,"No"
"15870","GO_BP","487978_GO_0002089_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",22,-0.6503,0.93,0.98,"No",1.086,0.32,0.92,"Yes"
"15871","REACTOME","645334_REACT_120836_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE",18,-0.6502,0.92,0.98,"No",0.4701,1,1,"Yes"
"15872","GO_BP","505876_GO_0042770_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE",104,-0.6497,0.99,0.98,"No",1.5994,0.0045,0.29,"Yes"
"15873","C4_Cancer_gene_neighborhoods","C4_CGN_260_GCM_RAN",196,-0.6494,1,1,"No",0.8986,0.78,0.83,"Yes"
"15874","GO_CC","925884_GO_0097542_CILIARY_TIP",43,-0.6491,0.96,1,"No",0.9175,0.58,0.87,"Yes"
"15875","C2_Chemical_and_genetic_perturbations","C2_CGP_49_KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN",13,-0.6491,0.91,0.98,"No",-0.8862,0.62,1,"No"
"15876","KEGG_module","HSA_M00430_EXON_JUNCTION_COMPLEX_EJC_",18,-0.6489,0.91,0.98,"No",-0.6095,0.96,1,"No"
"15877","GO_MF","497980_GO_0019103_PYRIMIDINE_NUCLEOTIDE_BINDING",6,-0.6485,0.89,0.97,"No",1.1509,0.31,0.74,"Yes"
"15878","GO_BP","508162_GO_0045841_NEGATIVE_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION",37,-0.6484,0.96,0.98,"No",0.9553,0.56,1,"Yes"
"15879","GO_BP","505313_GO_0042147_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI",67,-0.6484,0.98,0.98,"No",0.7185,0.95,1,"Yes"
"15880","REACTOME","1127541_REACT_268156_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",60,-0.6479,0.97,0.98,"No",2.1267,0,0.00045,"Yes"
"15881","GO_BP","752356_GO_0075713_ESTABLISHMENT_OF_INTEGRATED_PROVIRAL_LATENCY",8,-0.6478,0.9,0.98,"No",1.364,0.12,0.6,"Yes"
"15882","GO_MF","492643_GO_0008327_METHYL_CPG_BINDING",11,-0.6477,0.9,0.97,"No",-0.9607,0.53,0.95,"No"
"15883","GO_BP","493757_GO_0009642_RESPONSE_TO_LIGHT_INTENSITY",9,-0.6474,0.91,0.98,"No",-1.5715,0.04,0.72,"No"
"15884","GO_MF","510191_GO_0048027_MRNA_5_UTR_BINDING",7,-0.6473,0.88,0.97,"No",1.1951,0.26,0.71,"Yes"
"15885","GO_BP","508920_GO_0046676_NEGATIVE_REGULATION_OF_INSULIN_SECRETION",31,-0.6471,0.93,0.98,"No",-0.872,0.66,1,"No"
"15886","GO_BP","494992_GO_0010927_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS",216,-0.6469,1,0.98,"No",-0.9918,0.47,1,"No"
"15887","C1_Positional","C1_ALL_316_CHR16Q11",7,-0.6465,0.88,0.98,"No",0.5046,0.99,1,"Yes"
"15888","C2_Chemical_and_genetic_perturbations","C2_CGP_971_KAUFFMANN_MELANOMA_RELAPSE_DN",6,-0.646,0.87,0.98,"No",-0.5523,0.96,1,"No"
"15889","C2_Chemical_and_genetic_perturbations","C2_CGP_1457_HASLINGER_B_CLL_WITH_MUTATED_VH_GENES",18,-0.6458,0.91,0.98,"No",1.1654,0.27,0.53,"Yes"
"15890","GO_BP","491245_GO_0006282_REGULATION_OF_DNA_REPAIR",61,-0.6458,0.97,0.98,"No",0.8312,0.78,1,"Yes"
"15891","GO_BP","516224_GO_0071300_CELLULAR_RESPONSE_TO_RETINOIC_ACID",61,-0.6457,0.98,0.98,"No",1.1128,0.24,0.89,"Yes"
"15892","C3_MicroRNA_targets","C3_MIR_89_ATAACCT_MIR_154",60,-0.6455,0.98,1,"No",0.7513,0.89,1,"Yes"
"15893","GO_BP","491478_GO_0006582_MELANIN_METABOLIC_PROCESS",14,-0.6453,0.9,0.98,"No",-0.8563,0.63,1,"No"
"15894","C3_TF_targets","C3_TFT_349_V_NRF1_Q6",254,-0.6453,1,1,"No",-0.9635,0.56,0.84,"No"
"15895","GO_BP","512824_GO_0051974_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY",8,-0.6452,0.9,0.98,"No",0.732,0.8,1,"Yes"
"15896","C4_Cancer_gene_neighborhoods","C4_CGN_268_GCM_SUPT4H1",56,-0.6451,0.97,1,"No",0.5605,1,1,"Yes"
"15897","GO_CC","507240_GO_0044233_ER_MITOCHONDRION_MEMBRANE_CONTACT_SITE",7,-0.6449,0.9,1,"No",1.3907,0.11,0.3,"Yes"
"15898","C7_Immunologic_signatures","C7_ALL_532_GSE17721_LPS_VS_POLYIC_2H_BMDM_DN",200,-0.6449,1,1,"No",1.6254,0,0.0019,"Yes"
"15899","GO_BP","518949_GO_2000303_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS",5,-0.6446,0.89,0.98,"No",-1.0784,0.38,0.95,"No"
"15900","REACTOME","576271_REACT_118780_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION",47,-0.6446,0.96,0.98,"No",0.7332,0.94,1,"Yes"
"15901","C4_Cancer_gene_neighborhoods","C4_CGN_39_MORF_RFC1",109,-0.6445,0.99,1,"No",0.9928,0.5,0.6,"Yes"
"15902","REACTOME","366161_REACT_75820_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION",255,-0.6442,1,0.98,"No",1.5948,0,0.096,"Yes"
"15903","GO_BP","495299_GO_0014909_SMOOTH_MUSCLE_CELL_MIGRATION",7,-0.6441,0.9,0.98,"No",1.24,0.21,0.75,"Yes"
"15904","GO_CC","504330_GO_0035145_EXON_EXON_JUNCTION_COMPLEX",21,-0.6439,0.94,1,"No",-0.7134,0.87,1,"No"
"15905","GO_MF","489592_GO_0004128_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H",7,-0.6438,0.9,0.97,"No",-0.6346,0.91,1,"No"
"15906","GO_BP","812239_GO_1902116_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY",15,-0.6438,0.91,0.98,"No",-0.5031,0.99,1,"No"
"15907","GO_BP","515913_GO_0070986_LEFT_RIGHT_AXIS_SPECIFICATION",14,-0.6437,0.89,0.98,"No",-1.7882,0.0075,0.48,"No"
"15908","GO_BP","491434_GO_0006538_GLUTAMATE_CATABOLIC_PROCESS",6,-0.6435,0.9,0.98,"No",1.0229,0.45,0.97,"Yes"
"15909","C1_Positional","C1_ALL_217_CHR6P12",52,-0.6434,0.96,0.98,"No",1.1799,0.2,0.59,"Yes"
"15910","GO_BP","513527_GO_0055094_RESPONSE_TO_LIPOPROTEIN_PARTICLE",11,-0.6434,0.91,0.98,"No",1.083,0.37,0.92,"Yes"
"15911","C3_TF_targets","C3_TFT_152_V_SEF1_C",5,-0.6431,0.88,1,"No",-0.6655,0.85,1,"No"
"15912","KEGG_reaction","R00961_IDP_PHOSPHOHYDROLASE_INOSINE_DIPHOSPHATE_PHOSPHATASE_IDP_H2O_IMP_ORTHOPHOSPHATE",7,-0.6431,0.89,0.92,"No",0.6091,0.92,1,"Yes"
"15913","KEGG_compound","C00460_DUTP_2_DEOXYURIDINE_5_TRIPHOSPHATE",13,-0.6431,0.91,0.98,"No",-0.6881,0.87,1,"No"
"15914","GO_MF","494917_GO_0010853_CYCLASE_ACTIVATOR_ACTIVITY",6,-0.643,0.9,0.97,"No",-1.0034,0.47,0.9,"No"
"15915","C2_BioCarta_Pathways","C2_CP_BIOCARTA_148_BIOCARTA_RAS_PATHWAY",23,-0.6425,0.94,0.95,"No",1.2603,0.14,0.65,"Yes"
"15916","GO_BP","1039916_GO_1903362_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS",270,-0.6425,1,0.98,"No",1.3354,0.015,0.62,"Yes"
"15917","C2_Chemical_and_genetic_perturbations","C2_CGP_1968_DASU_IL6_SIGNALING_SCAR_DN",15,-0.6418,0.94,0.98,"No",1.0785,0.35,0.67,"Yes"
"15918","GO_MF","500685_GO_0031434_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING",17,-0.6412,0.93,0.97,"No",-0.8335,0.7,1,"No"
"15919","GO_BP","513586_GO_0060028_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION",5,-0.6411,0.9,0.98,"No",-0.8407,0.68,1,"No"
"15920","WikiPathways","198786_WP183_PROTEASOME_DEGRADATION",65,-0.641,0.99,0.99,"No",1.871,0,0.027,"Yes"
"15921","C2_Chemical_and_genetic_perturbations","C2_CGP_1286_IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN",11,-0.641,0.91,0.98,"No",1.0108,0.45,0.78,"Yes"
"15922","OMIM_gene","OMIM602322_TELOMERASE_RNA_COMPONENT_TERC",6,-0.641,0.9,1,"No",0.8869,0.6,1,"Yes"
"15923","C4_Cancer_gene_neighborhoods","C4_CGN_163_MORF_RAB1A",195,-0.6406,1,1,"No",2.0507,0,0.00018,"Yes"
"15924","GO_BP","754922_GO_2000816_NEGATIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION",37,-0.6404,0.95,0.98,"No",0.9704,0.49,1,"Yes"
"15925","GO_BP","497934_GO_0019054_MODULATION_BY_VIRUS_OF_HOST_PROCESS",11,-0.6404,0.91,0.98,"No",0.9306,0.54,1,"Yes"
"15926","C2_BioCarta_Pathways","C2_CP_BIOCARTA_198_BIOCARTA_KREB_PATHWAY",8,-0.6402,0.89,0.95,"No",1.0181,0.42,0.83,"Yes"
"15927","REACTOME","477130_REACT_111057_SIGNALING_BY_NODAL",18,-0.64,0.94,0.98,"No",-0.4086,1,1,"No"
"15928","C4_Cancer_gene_neighborhoods","C4_CGN_78_MORF_CSNK1D",70,-0.6399,0.99,1,"No",0.8237,0.82,0.97,"Yes"
"15929","GO_MF","501685_GO_0032453_HISTONE_DEMETHYLASE_ACTIVITY_H3_K4_SPECIFIC_",6,-0.6392,0.89,0.97,"No",-0.6319,0.91,1,"No"
"15930","GO_CC","505710_GO_0042583_CHROMAFFIN_GRANULE",7,-0.6391,0.91,1,"No",1.2102,0.24,0.51,"Yes"
"15931","GO_BP","493326_GO_0009129_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS",14,-0.6387,0.91,0.98,"No",0.8206,0.69,1,"Yes"
"15932","GO_BP","514350_GO_0060795_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER",25,-0.6384,0.94,0.98,"No",1.2014,0.22,0.78,"Yes"
"15933","C3_MicroRNA_targets","C3_MIR_70_CAAGGAT_MIR_362",66,-0.6383,0.97,0.99,"No",0.712,0.95,1,"Yes"
"15934","GO_BP","503551_GO_0034349_GLIAL_CELL_APOPTOTIC_PROCESS",6,-0.6382,0.89,0.98,"No",0.9399,0.52,1,"Yes"
"15935","GO_BP","502269_GO_0033048_NEGATIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION",37,-0.638,0.96,0.98,"No",0.9782,0.49,1,"Yes"
"15936","C2_Chemical_and_genetic_perturbations","C2_CGP_1904_MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5",23,-0.6379,0.96,0.98,"No",1.007,0.46,0.79,"Yes"
"15937","GO_BP","498456_GO_0019627_UREA_METABOLIC_PROCESS",13,-0.6376,0.91,0.98,"No",-0.8909,0.59,1,"No"
"15938","GO_BP","486598_GO_0000050_UREA_CYCLE",12,-0.6371,0.92,0.98,"No",-0.8512,0.67,1,"No"
"15939","KEGG_module","HSA_M00694_CGMP_SIGNALING",10,-0.637,0.91,0.97,"No",0.8637,0.64,0.91,"Yes"
"15940","REACTOME","1127502_REACT_268265_ASSEMBLY_OF_THE_PRIMARY_CILIUM",179,-0.6364,1,0.98,"No",-0.6535,1,1,"No"
"15941","GO_BP","489208_GO_0003416_ENDOCHONDRAL_BONE_GROWTH",18,-0.636,0.93,0.98,"No",-1.3431,0.082,0.92,"No"
"15942","REACTOME","105659_REACT_549_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA",15,-0.6358,0.94,0.98,"No",0.6074,0.96,1,"Yes"
"15943","REACTOME","106336_REACT_12034_SIGNALING_BY_BMP",22,-0.6357,0.93,0.98,"No",-0.8064,0.77,1,"No"
"15944","C2_Chemical_and_genetic_perturbations","C2_CGP_3104_THILLAINADESAN_ZNF217_TARGETS_DN",9,-0.6356,0.92,0.98,"No",1.1748,0.25,0.52,"Yes"
"15945","C7_Immunologic_signatures","C7_ALL_1183_GSE27786_BCELL_VS_NKTCELL_UP",200,-0.6356,1,1,"No",1.0278,0.35,0.65,"Yes"
"15946","GO_BP","486617_GO_0000076_DNA_REPLICATION_CHECKPOINT",12,-0.6354,0.91,0.98,"No",1.1058,0.32,0.89,"Yes"
"15947","KEGG_module","HSA_M00180_RNA_POLYMERASE_II_EUKARYOTES",14,-0.6354,0.93,0.96,"No",0.9671,0.48,0.92,"Yes"
"15948","GO_BP","504252_GO_0035067_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION",14,-0.6352,0.92,0.98,"No",1.2822,0.17,0.7,"Yes"
"15949","GO_BP","519042_GO_2000402_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION",7,-0.6351,0.91,0.98,"No",1.0383,0.42,0.96,"Yes"
"15950","GO_MF","510282_GO_0048156_TAU_PROTEIN_BINDING",9,-0.6349,0.93,0.98,"No",0.9979,0.45,0.88,"Yes"
"15951","GO_MF","494410_GO_0010340_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY",5,-0.6347,0.9,0.97,"No",0.8622,0.61,1,"Yes"
"15952","GO_BP","508329_GO_0046031_ADP_METABOLIC_PROCESS",9,-0.6346,0.91,0.98,"No",-0.957,0.54,1,"No"
"15953","GO_BP","946578_GO_1902603_CARNITINE_TRANSMEMBRANE_TRANSPORT",12,-0.6341,0.92,0.98,"No",-0.6849,0.86,1,"No"
"15954","GO_BP","487960_GO_0002070_EPITHELIAL_CELL_MATURATION",16,-0.6339,0.92,0.98,"No",1.079,0.36,0.93,"Yes"
"15955","C3_TF_targets","C3_TFT_432_V_CREB_Q3",250,-0.6339,1,1,"No",1.1156,0.17,1,"Yes"
"15956","REACTOME","105769_REACT_1783_G1_S_TRANSITION",109,-0.6338,0.99,0.98,"No",1.9559,0,0.0043,"Yes"
"15957","GO_MF","496048_GO_0015926_GLUCOSIDASE_ACTIVITY",10,-0.6337,0.91,0.97,"No",-0.9403,0.55,0.96,"No"
"15958","KEGG_compound","C00559_DEOXYADENOSINE_2_DEOXYADENOSINE",11,-0.6337,0.92,0.99,"No",0.5024,0.99,1,"Yes"
"15959","GO_BP","491544_GO_0006656_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS",25,-0.6335,0.94,0.98,"No",-0.7281,0.88,1,"No"
"15960","GO_BP","502369_GO_0033148_POSITIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",7,-0.6333,0.89,0.98,"No",0.8196,0.7,1,"Yes"
"15961","GO_BP","508798_GO_0046541_SALIVA_SECRETION",6,-0.6332,0.91,0.98,"No",1.0515,0.41,0.95,"Yes"
"15962","GO_BP","507454_GO_0045053_PROTEIN_RETENTION_IN_GOLGI_APPARATUS",5,-0.6331,0.92,0.98,"No",-0.8497,0.65,1,"No"
"15963","GO_BP","516830_GO_0071910_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY",6,-0.6329,0.9,0.98,"No",-1.3654,0.12,0.99,"No"
"15964","REACTOME","730342_REACT_150237_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS",6,-0.6327,0.91,0.98,"No",0.9241,0.54,0.87,"Yes"
"15965","GO_MF","496855_GO_0017025_TBP_CLASS_PROTEIN_BINDING",17,-0.6324,0.92,0.97,"No",1.2287,0.19,0.7,"Yes"
"15966","GO_BP","506618_GO_0043587_TONGUE_MORPHOGENESIS",8,-0.6324,0.91,0.98,"No",-0.6664,0.87,1,"No"
"15967","GO_CC","502805_GO_0033588_ELONGATOR_HOLOENZYME_COMPLEX",6,-0.6322,0.93,1,"No",1.0711,0.36,0.69,"Yes"
"15968","GO_BP","494524_GO_0010454_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT",11,-0.6322,0.93,0.98,"No",-1.124,0.32,0.94,"No"
"15969","GO_MF","495487_GO_0051183_VITAMIN_TRANSPORTER_ACTIVITY",18,-0.6317,0.93,0.97,"No",-1.4704,0.055,0.6,"No"
"15970","C4_Cancer_gene_neighborhoods","C4_CGN_217_GCM_CRKL",64,-0.6316,0.98,1,"No",0.8533,0.76,0.92,"Yes"
"15971","C2_Chemical_and_genetic_perturbations","C2_CGP_823_TSUNODA_CISPLATIN_RESISTANCE_UP",14,-0.6314,0.91,0.98,"No",-1.1219,0.31,0.89,"No"
"15972","GO_BP","502267_GO_0033046_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_SEGREGATION",37,-0.6314,0.95,0.98,"No",0.9666,0.51,1,"Yes"
"15973","KEGG_compound","C01346_DUDP_2_DEOXYURIDINE_5_DIPHOSPHATE",12,-0.6312,0.94,0.99,"No",-0.6769,0.9,1,"No"
"15974","C2_Chemical_and_genetic_perturbations","C2_CGP_1291_IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN",25,-0.6312,0.94,0.98,"No",0.7144,0.86,1,"Yes"
"15975","OMIM_gene","OMIM600287_GLYCYL_TRNA_SYNTHETASE_GARS",5,-0.631,0.91,1,"No",0.8429,0.65,1,"Yes"
"15976","GO_MF","512848_GO_0051998_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY",5,-0.631,0.91,0.97,"No",0.869,0.62,1,"Yes"
"15977","GO_BP","496517_GO_0016569_COVALENT_CHROMATIN_MODIFICATION",322,-0.6307,1,0.98,"No",-0.9159,0.74,1,"No"
"15978","GO_BP","506520_GO_0043489_RNA_STABILIZATION",29,-0.6306,0.95,0.98,"No",0.9984,0.44,0.98,"Yes"
"15979","GO_BP","506518_GO_0043487_REGULATION_OF_RNA_STABILITY",53,-0.6303,0.98,0.98,"No",0.9594,0.55,1,"Yes"
"15980","KEGG_compound","C00294_INOSINE",11,-0.6301,0.92,0.98,"No",0.4995,0.98,1,"Yes"
"15981","GO_MF","499655_GO_0030250_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY",6,-0.6301,0.91,0.97,"No",-1.0146,0.46,0.89,"No"
"15982","GO_BP","519317_GO_2000678_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",16,-0.6299,0.92,0.98,"No",1.533,0.046,0.36,"Yes"
"15983","GO_BP","518538_GO_0090398_CELLULAR_SENESCENCE",28,-0.6298,0.95,0.98,"No",-1.064,0.38,0.96,"No"
"15984","GO_BP","496518_GO_0016570_HISTONE_MODIFICATION",317,-0.6293,1,0.98,"No",-0.8841,0.84,1,"No"
"15985","GO_BP","502130_GO_0032908_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION",7,-0.6292,0.91,0.98,"No",1.3065,0.13,0.66,"Yes"
"15986","GO_BP","507459_GO_0045059_POSITIVE_THYMIC_T_CELL_SELECTION",8,-0.6291,0.92,0.98,"No",-0.886,0.6,1,"No"
"15987","GO_BP","493330_GO_0009133_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",9,-0.6291,0.9,0.98,"No",0.7833,0.74,1,"Yes"
"15988","GO_BP","499099_GO_0021819_LAYER_FORMATION_IN_CEREBRAL_CORTEX",12,-0.6288,0.93,0.98,"No",-0.7659,0.78,1,"No"
"15989","GO_CC","490894_GO_0005892_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX",18,-0.6284,0.95,1,"No",-2.0223,0,0.04,"No"
"15990","C2_Chemical_and_genetic_perturbations","C2_CGP_2146_WONG_MITOCHONDRIA_GENE_MODULE",216,-0.6283,1,0.98,"No",2.3739,0,0,"Yes"
"15991","GO_BP","494865_GO_0010800_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION",19,-0.6276,0.94,0.98,"No",1.4075,0.08,0.55,"Yes"
"15992","GO_BP","518035_GO_0080111_DNA_DEMETHYLATION",15,-0.6272,0.93,0.98,"No",0.9822,0.46,1,"Yes"
"15993","GO_BP","491983_GO_0007183_SMAD_PROTEIN_COMPLEX_ASSEMBLY",8,-0.6271,0.91,0.98,"No",-0.671,0.87,1,"No"
"15994","C1_Positional","C1_ALL_42_CHR2Q32",42,-0.626,0.97,0.99,"No",1.0343,0.4,0.71,"Yes"
"15995","GO_BP","516403_GO_0071479_CELLULAR_RESPONSE_TO_IONIZING_RADIATION",47,-0.6259,0.97,0.98,"No",1.1585,0.21,0.83,"Yes"
"15996","C3_TF_targets","C3_TFT_473_V_AR_02",39,-0.6259,0.97,1,"No",0.8456,0.76,1,"Yes"
"15997","GO_CC","994746_GO_0036464_CYTOPLASMIC_RIBONUCLEOPROTEIN_GRANULE",121,-0.6258,1,1,"No",1.2865,0.058,0.42,"Yes"
"15998","GO_CC","492398_GO_0008024_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX_B",5,-0.6257,0.9,1,"No",1.2121,0.24,0.51,"Yes"
"15999","REACTOME","645319_REACT_121238_SYNTHESIS_OF_PC",19,-0.6252,0.93,0.99,"No",-0.515,0.98,1,"No"
"16000","GO_BP","512835_GO_0051985_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION",40,-0.6251,0.97,0.98,"No",1.0418,0.38,0.96,"Yes"
"16001","GO_BP","491462_GO_0006566_THREONINE_METABOLIC_PROCESS",6,-0.625,0.92,0.98,"No",1.3665,0.12,0.59,"Yes"
"16002","GO_BP","493763_GO_0009648_PHOTOPERIODISM",23,-0.625,0.94,0.98,"No",-0.8889,0.64,1,"No"
"16003","GO_MF","490603_GO_0005484_SNAP_RECEPTOR_ACTIVITY",37,-0.6248,0.96,0.98,"No",1.1937,0.17,0.71,"Yes"
"16004","C4_Cancer_modules","C4_CM_61_MODULE_65",10,-0.6248,0.93,0.99,"No",1.0102,0.43,0.7,"Yes"
"16005","C2_Chemical_and_genetic_perturbations","C2_CGP_1336_TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN",38,-0.6247,0.97,0.98,"No",1.0233,0.42,0.77,"Yes"
"16006","GO_BP","518969_GO_2000323_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY",6,-0.6245,0.91,0.98,"No",-0.9121,0.56,1,"No"
"16007","GO_MF","496959_GO_0017169_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY",8,-0.6243,0.93,0.98,"No",-0.5335,0.98,1,"No"
"16008","KEGG_module","HSA_M00009_CITRATE_CYCLE_TCA_CYCLE_KREBS_CYCLE_",22,-0.6232,0.95,0.96,"No",1.6208,0.021,0.12,"Yes"
"16009","KEGG_reaction","R01234_GUANOSINE_3_5_CYCLIC_PHOSPHATE_5_NUCLEOTIDOHYDROLASE_3_5_CYCLIC_GMP_H2O_GMP",16,-0.6232,0.95,0.93,"No",-0.7634,0.81,1,"No"
"16010","C1_Positional","C1_ALL_66_CHR1P33",41,-0.6231,0.98,0.98,"No",-1.2183,0.16,1,"No"
"16011","C2_Chemical_and_genetic_perturbations","C2_CGP_1200_NIKOLSKY_BREAST_CANCER_7P15_AMPLICON",10,-0.6226,0.93,0.98,"No",1.6593,0.018,0.11,"Yes"
"16012","WikiPathways","198758_WP497_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS",20,-0.6221,0.95,0.99,"No",-0.6603,0.93,1,"No"
"16013","GO_CC","504947_GO_0035770_RIBONUCLEOPROTEIN_GRANULE",121,-0.6219,1,1,"No",1.3016,0.042,0.4,"Yes"
"16014","C2_Chemical_and_genetic_perturbations","C2_CGP_754_XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP",14,-0.6219,0.93,0.98,"No",-0.7852,0.75,1,"No"
"16015","GO_BP","1026094_GO_1903322_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL",171,-0.6218,1,0.98,"No",1.5669,0,0.33,"Yes"
"16016","KEGG_compound","C00226_PRIMARY_ALCOHOL_1_ALCOHOL",9,-0.6215,0.93,0.99,"No",-0.9578,0.52,1,"No"
"16017","GO_BP","508944_GO_0046716_MUSCLE_CELL_CELLULAR_HOMEOSTASIS",18,-0.6214,0.95,0.98,"No",-0.6726,0.9,1,"No"
"16018","GO_BP","508853_GO_0046599_REGULATION_OF_CENTRIOLE_REPLICATION",13,-0.6212,0.94,0.98,"No",0.7732,0.76,1,"Yes"
"16019","GO_BP","513584_GO_0060026_CONVERGENT_EXTENSION",14,-0.6203,0.94,0.98,"No",0.9346,0.53,1,"Yes"
"16020","GO_BP","486618_GO_0000077_DNA_DAMAGE_CHECKPOINT",144,-0.6192,1,0.98,"No",1.3485,0.013,0.61,"Yes"
"16021","C7_Immunologic_signatures","C7_ALL_692_GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_DN",197,-0.6192,1,1,"No",1.5906,0,0.0036,"Yes"
"16022","GO_CC","489322_GO_0042612_MHC_CLASS_I_PROTEIN_COMPLEX",11,-0.6191,0.93,1,"No",1.0856,0.35,0.67,"Yes"
"16023","GO_BP","512227_GO_0051343_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",5,-0.6187,0.9,0.98,"No",1.0518,0.42,0.95,"Yes"
"16024","GO_BP","515849_GO_0070922_SMALL_RNA_LOADING_ONTO_RISC",8,-0.6181,0.93,0.98,"No",-0.8743,0.61,1,"No"
"16025","GO_BP","486807_GO_0000290_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA",7,-0.6179,0.92,0.98,"No",0.8252,0.67,1,"Yes"
"16026","GO_BP","492596_GO_0008272_SULFATE_TRANSPORT",13,-0.6178,0.93,0.98,"No",1.0568,0.38,0.94,"Yes"
"16027","GO_BP","754848_GO_1901897_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE",6,-0.6178,0.93,0.98,"No",-0.936,0.57,1,"No"
"16028","GO_MF","489677_GO_0004311_FARNESYLTRANSTRANSFERASE_ACTIVITY",5,-0.6173,0.9,0.98,"No",0.5966,0.93,1,"Yes"
"16029","C2_Chemical_and_genetic_perturbations","C2_CGP_782_HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER",31,-0.6169,0.98,0.99,"No",0.7587,0.85,1,"Yes"
"16030","GO_BP","513671_GO_0060113_INNER_EAR_RECEPTOR_CELL_DIFFERENTIATION",51,-0.6162,0.97,0.98,"No",-0.7122,0.95,1,"No"
"16031","C2_Chemical_and_genetic_perturbations","C2_CGP_2703_TCGA_GLIOBLASTOMA_MUTATED",8,-0.6156,0.91,0.99,"No",1.2352,0.21,0.45,"Yes"
"16032","KEGG_compound","C00575_3_5_CYCLIC_AMP_CYCLIC_ADENYLIC_ACID_CYCLIC_AMP_ADENOSINE_3_5_PHOSPHATE_ADENOSINE_3_5_CYCLIC_PHOSPHATE_CAMP",26,-0.6156,0.95,0.99,"No",-1.2632,0.14,0.69,"No"
"16033","GO_BP","493375_GO_0009179_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",14,-0.615,0.95,0.98,"No",0.4842,1,1,"Yes"
"16034","C2_Chemical_and_genetic_perturbations","C2_CGP_2822_PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN",9,-0.6149,0.94,0.99,"No",-0.6318,0.93,1,"No"
"16035","GO_BP","503856_GO_0034656_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS",6,-0.6143,0.9,0.99,"No",0.9297,0.5,1,"Yes"
"16036","GO_MF","487278_GO_0001055_RNA_POLYMERASE_II_ACTIVITY",9,-0.6142,0.94,0.98,"No",0.7488,0.78,1,"Yes"
"16037","C0_Hallmark","H_ALL_34_HALLMARK_OXIDATIVE_PHOSPHORYLATION",200,-0.6135,1,1,"No",2.7033,0,0,"Yes"
"16038","C2_Chemical_and_genetic_perturbations","C2_CGP_2376_TSUDA_ALVEOLAR_SOFT_PART_SARCOMA",10,-0.6133,0.94,0.99,"No",1.1649,0.25,0.53,"Yes"
"16039","GO_BP","516621_GO_0071697_ECTODERMAL_PLACODE_MORPHOGENESIS",22,-0.6133,0.96,0.99,"No",0.7611,0.82,1,"Yes"
"16040","GO_MF","510602_GO_0048531_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY",9,-0.6122,0.93,0.98,"No",1.3493,0.14,0.53,"Yes"
"16041","GO_BP","754046_GO_1901077_REGULATION_OF_RELAXATION_OF_MUSCLE",7,-0.6122,0.93,0.99,"No",-0.6517,0.87,1,"No"
"16042","C3_TF_targets","C3_TFT_84_ACTAYRNNNCCCR_UNKNOWN",447,-0.6119,1,1,"No",0.8624,0.96,1,"Yes"
"16043","C2_Chemical_and_genetic_perturbations","C2_CGP_1139_AMIT_EGF_RESPONSE_20_MCF10A",14,-0.6117,0.93,0.99,"No",1.53,0.038,0.18,"Yes"
"16044","C2_Chemical_and_genetic_perturbations","C2_CGP_175_WANG_CLIM2_TARGETS_DN",184,-0.6117,1,0.99,"No",1.6298,0,0.12,"Yes"
"16045","GO_BP","493332_GO_0009135_PURINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",14,-0.6116,0.94,0.99,"No",0.4735,0.99,1,"Yes"
"16046","GO_BP","516620_GO_0071696_ECTODERMAL_PLACODE_DEVELOPMENT",22,-0.6115,0.94,0.99,"No",0.7617,0.82,1,"Yes"
"16047","C2_Chemical_and_genetic_perturbations","C2_CGP_3097_LI_DCP2_BOUND_MRNA",89,-0.6115,0.99,0.99,"No",1.5954,0.0046,0.14,"Yes"
"16048","GO_BP","515136_GO_0070199_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME",6,-0.6113,0.93,0.99,"No",0.8725,0.61,1,"Yes"
"16049","C2_Chemical_and_genetic_perturbations","C2_CGP_2372_CLIMENT_BREAST_CANCER_COPY_NUMBER_DN",8,-0.6111,0.94,0.99,"No",0.499,0.98,1,"Yes"
"16050","GO_MF","489793_GO_0004439_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY",7,-0.6109,0.93,0.98,"No",-0.473,0.99,1,"No"
"16051","GO_BP","752179_GO_0061436_ESTABLISHMENT_OF_SKIN_BARRIER",17,-0.6107,0.95,0.99,"No",1.8178,0.0064,0.085,"Yes"
"16052","C2_Chemical_and_genetic_perturbations","C2_CGP_762_WAESCH_ANAPHASE_PROMOTING_COMPLEX",12,-0.61,0.94,0.99,"No",-0.7658,0.77,1,"No"
"16053","GO_CC","925869_GO_0038201_TOR_COMPLEX",11,-0.6099,0.95,1,"No",0.6905,0.86,0.99,"Yes"
"16054","GO_CC","486760_GO_0000242_PERICENTRIOLAR_MATERIAL",17,-0.6097,0.94,1,"No",0.7774,0.79,0.97,"Yes"
"16055","GO_BP","493381_GO_0009185_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",17,-0.609,0.95,0.99,"No",0.6363,0.93,1,"Yes"
"16056","GO_BP","502838_GO_0033622_INTEGRIN_ACTIVATION",6,-0.609,0.93,0.99,"No",-1.1713,0.29,0.91,"No"
"16057","C2_Chemical_and_genetic_perturbations","C2_CGP_1352_DISTECHE_ESCAPED_FROM_X_INACTIVATION",13,-0.609,0.96,0.99,"No",1.2066,0.22,0.48,"Yes"
"16058","GO_BP","516304_GO_0071380_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS",9,-0.6081,0.95,0.99,"No",1.0135,0.43,0.97,"Yes"
"16059","GO_MF","500740_GO_0031489_MYOSIN_V_BINDING",17,-0.608,0.96,0.98,"No",1.0462,0.39,0.83,"Yes"
"16060","GO_BP","518418_GO_0090278_NEGATIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION",36,-0.607,0.98,0.99,"No",-0.9178,0.6,1,"No"
"16061","C2_Chemical_and_genetic_perturbations","C2_CGP_555_HU_ANGIOGENESIS_UP",19,-0.6062,0.95,0.99,"No",0.805,0.75,0.99,"Yes"
"16062","GO_BP","518471_GO_0090331_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION",7,-0.6061,0.94,0.99,"No",1.3863,0.13,0.57,"Yes"
"16063","WikiPathways","739008_WP2333_TRANS_SULFURATION_PATHWAY",9,-0.6061,0.92,1,"No",-0.6559,0.88,1,"No"
"16064","GO_BP","989115_GO_1903050_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",260,-0.606,1,0.99,"No",1.3753,0,0.58,"Yes"
"16065","GO_BP","488860_GO_0003062_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL",7,-0.606,0.94,0.99,"No",1.2492,0.22,0.73,"Yes"
"16066","KEGG_compound","C14770_11_12_EET_5Z_8Z_14Z_11_12_EPOXYEICOSA_5_8_14_TRIENOIC_ACID_5Z_8Z_14Z_11_12_EPOXYICOSA_5_8_14_TRIENOIC_ACID",5,-0.606,0.93,0.99,"No",-1.2036,0.28,0.77,"No"
"16067","C2_Chemical_and_genetic_perturbations","C2_CGP_1144_AMIT_EGF_RESPONSE_480_MCF10A",43,-0.6059,0.98,0.99,"No",0.8199,0.79,0.98,"Yes"
"16068","C4_Cancer_gene_neighborhoods","C4_CGN_197_GCM_BCL2L1",35,-0.6056,0.97,1,"No",0.7163,0.91,1,"Yes"
"16069","GO_BP","486594_GO_0000046_AUTOPHAGIC_VACUOLE_FUSION",8,-0.6054,0.94,0.99,"No",1.24,0.21,0.75,"Yes"
"16070","REACTOME","105904_REACT_18356_UNFOLDED_PROTEIN_RESPONSE_UPR_",89,-0.6043,0.99,0.99,"No",1.0478,0.35,0.67,"Yes"
"16071","GO_BP","754952_GO_2000846_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION",11,-0.6043,0.94,0.99,"No",1.3419,0.12,0.62,"Yes"
"16072","GO_BP","500691_GO_0031440_REGULATION_OF_MRNA_3_END_PROCESSING",26,-0.6043,0.97,0.99,"No",-0.6284,0.96,1,"No"
"16073","REACTOME","160139_REACT_21326_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS",10,-0.6037,0.93,0.99,"No",-1.3,0.15,0.67,"No"
"16074","GO_CC","516129_GO_0071203_WASH_COMPLEX",11,-0.6036,0.95,1,"No",1.2215,0.22,0.5,"Yes"
"16075","GO_BP","495289_GO_0014897_STRIATED_MUSCLE_HYPERTROPHY",22,-0.6027,0.96,0.99,"No",-0.9037,0.61,1,"No"
"16076","REACTOME","106342_REACT_12484_EGFR_DOWNREGULATION",26,-0.602,0.97,0.99,"No",1.4142,0.075,0.21,"Yes"
"16077","KEGG_compound","C02188_PROTEIN_LYSINE_PEPTIDYL_L_LYSINE",30,-0.6019,0.97,0.99,"No",-1.4292,0.064,0.41,"No"
"16078","GO_BP","516095_GO_0071169_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN",6,-0.6019,0.93,0.99,"No",0.8634,0.64,1,"Yes"
"16079","GO_BP","507046_GO_0044030_REGULATION_OF_DNA_METHYLATION",14,-0.6015,0.95,0.99,"No",1.0183,0.4,0.97,"Yes"
"16080","C4_Cancer_modules","C4_CM_292_MODULE_333",28,-0.6009,0.97,0.99,"No",1.1518,0.24,0.45,"Yes"
"16081","GO_MF","489491_GO_0004022_ALCOHOL_DEHYDROGENASE_NAD_ACTIVITY",8,-0.6007,0.93,0.98,"No",1.5433,0.041,0.34,"Yes"
"16082","C4_Cancer_modules","C4_CM_402_MODULE_514",10,-0.6007,0.94,0.99,"No",-1.2583,0.21,0.58,"No"
"16083","C2_Chemical_and_genetic_perturbations","C2_CGP_1778_GAJATE_RESPONSE_TO_TRABECTEDIN_DN",19,-0.6005,0.97,0.99,"No",-1.0695,0.36,0.96,"No"
"16084","GO_BP","487853_GO_0001963_SYNAPTIC_TRANSMISSION_DOPAMINERGIC",14,-0.6004,0.97,0.99,"No",1.4619,0.068,0.48,"Yes"
"16085","C4_Cancer_gene_neighborhoods","C4_CGN_199_GCM_ERBB2IP",64,-0.6004,0.99,1,"No",0.843,0.75,0.94,"Yes"
"16086","C4_Cancer_gene_neighborhoods","C4_CGN_28_MORF_PRDX3",85,-0.6001,1,1,"No",2.5075,0,0,"Yes"
"16087","KEGG_module","HSA_M00681_ACTIVIN_SIGNALING",10,-0.6,0.93,0.96,"No",-0.6919,0.85,1,"No"
"16088","C2_Chemical_and_genetic_perturbations","C2_CGP_161_CHOI_ATL_CHRONIC_VS_ACUTE_DN",18,-0.5998,0.95,0.99,"No",1.8542,0,0.028,"Yes"
"16089","C4_Cancer_gene_neighborhoods","C4_CGN_16_MORF_ESPL1",61,-0.5992,0.99,1,"No",1.627,0.0043,0.012,"Yes"
"16090","GO_BP","491017_GO_0006032_CHITIN_CATABOLIC_PROCESS",7,-0.5988,0.94,0.99,"No",1.6499,0.015,0.25,"Yes"
"16091","GO_BP","489209_GO_0003417_GROWTH_PLATE_CARTILAGE_DEVELOPMENT",12,-0.5984,0.94,0.99,"No",-1.3164,0.14,0.89,"No"
"16092","GO_BP","515514_GO_0070584_MITOCHONDRION_MORPHOGENESIS",19,-0.598,0.96,0.99,"No",1.1801,0.24,0.8,"Yes"
"16093","WikiPathways","198783_WP106_ALANINE_AND_ASPARTATE_METABOLISM",11,-0.5978,0.95,0.99,"No",1.4978,0.057,0.34,"Yes"
"16094","C2_BioCarta_Pathways","C2_CP_BIOCARTA_161_BIOCARTA_LEPTIN_PATHWAY",11,-0.5967,0.95,0.97,"No",0.9212,0.54,0.91,"Yes"
"16095","GO_BP","492814_GO_0061136_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",191,-0.5966,1,0.99,"No",1.0796,0.25,0.93,"Yes"
"16096","GO_BP","508171_GO_0045852_PH_ELEVATION",5,-0.5964,0.93,0.99,"No",0.6558,0.87,1,"Yes"
"16097","C3_TF_targets","C3_TFT_42_V_YY1_02",243,-0.5963,1,1,"No",0.743,1,1,"Yes"
"16098","GO_BP","516029_GO_0071103_DNA_CONFORMATION_CHANGE",235,-0.5959,1,0.99,"No",-0.9538,0.58,1,"No"
"16099","GO_MF","509223_GO_0047035_TESTOSTERONE_DEHYDROGENASE_NAD_ACTIVITY",6,-0.5958,0.93,0.98,"No",1.5866,0.044,0.31,"Yes"
"16100","GO_BP","491015_GO_0006030_CHITIN_METABOLIC_PROCESS",7,-0.5955,0.94,0.99,"No",1.6928,0.014,0.2,"Yes"
"16101","GO_MF","489903_GO_0004568_CHITINASE_ACTIVITY",7,-0.5955,0.92,0.98,"No",1.6405,0.012,0.22,"Yes"
"16102","GO_BP","1047421_GO_1903421_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING",6,-0.5947,0.93,0.99,"No",0.906,0.58,1,"Yes"
"16103","GO_BP","493616_GO_0009445_PUTRESCINE_METABOLIC_PROCESS",5,-0.5945,0.95,0.99,"No",-0.9437,0.54,1,"No"
"16104","GO_BP","510317_GO_0048194_GOLGI_VESICLE_BUDDING",16,-0.594,0.95,0.99,"No",1.5608,0.029,0.34,"Yes"
"16105","GO_BP","513677_GO_0060119_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT",32,-0.5939,0.98,0.99,"No",-0.5969,0.97,1,"No"
"16106","KEGG_compound","C00250_PYRIDOXAL",5,-0.5935,0.93,1,"No",0.934,0.54,1,"Yes"
"16107","GO_BP","494039_GO_0009950_DORSAL_VENTRAL_AXIS_SPECIFICATION",16,-0.5934,0.95,0.99,"No",-1.374,0.093,0.99,"No"
"16108","KEGG_compound","C00131_DATP_2_DEOXYADENOSINE_5_TRIPHOSPHATE_DEOXYADENOSINE_5_TRIPHOSPHATE_DEOXYADENOSINE_TRIPHOSPHATE",25,-0.5929,0.96,1,"No",0.5775,0.98,1,"Yes"
"16109","GO_BP","755362_GO_2001256_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY",8,-0.5918,0.96,0.99,"No",-1.0545,0.37,0.97,"No"
"16110","GO_BP","755126_GO_2001020_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS",131,-0.5915,1,0.99,"No",1.1492,0.17,0.84,"Yes"
"16111","GO_MF","509731_GO_0047555_3_5_CYCLIC_GMP_PHOSPHODIESTERASE_ACTIVITY",11,-0.5909,0.95,0.99,"No",-1.0669,0.38,0.86,"No"
"16112","C3_TF_targets","C3_TFT_545_YGCGYRCGC_UNKNOWN",318,-0.5908,1,1,"No",-0.7573,0.99,1,"No"
"16113","KEGG_compound","C00510_OLEOYL_COA_9Z_OCTADECENOYL_COA",6,-0.5907,0.94,0.99,"No",-0.7261,0.81,1,"No"
"16114","GO_BP","754809_GO_1901858_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS",6,-0.5904,0.94,0.99,"No",-0.5276,0.97,1,"No"
"16115","C4_Cancer_gene_neighborhoods","C4_CGN_15_MORF_ERCC2",101,-0.5904,1,1,"No",0.5694,1,1,"Yes"
"16116","GO_BP","512332_GO_0051454_INTRACELLULAR_PH_ELEVATION",5,-0.5897,0.94,0.99,"No",0.6402,0.87,1,"Yes"
"16117","GO_BP","1026084_GO_1903312_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS",34,-0.5894,0.97,0.99,"No",-0.8775,0.63,1,"No"
"16118","GO_BP","517003_GO_0072087_RENAL_VESICLE_DEVELOPMENT",13,-0.5894,0.96,0.99,"No",-1.0207,0.43,0.97,"No"
"16119","KEGG_compound","C00286_DGTP_2_DEOXYGUANOSINE_5_TRIPHOSPHATE_DEOXYGUANOSINE_5_TRIPHOSPHATE_DEOXYGUANOSINE_TRIPHOSPHATE",26,-0.5894,0.97,0.99,"No",0.6098,0.96,1,"Yes"
"16120","C3_TF_targets","C3_TFT_496_KCCGNSWTTT_UNKNOWN",104,-0.5892,1,1,"No",-0.655,1,1,"No"
"16121","C2_Chemical_and_genetic_perturbations","C2_CGP_2814_WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP",12,-0.5886,0.96,0.99,"No",-1.5959,0.025,0.42,"No"
"16122","GO_BP","500821_GO_0031570_DNA_INTEGRITY_CHECKPOINT",155,-0.5884,1,0.99,"No",1.4063,0.0024,0.55,"Yes"
"16123","GO_BP","508601_GO_0046337_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS",15,-0.5882,0.96,0.99,"No",0.5797,0.97,1,"Yes"
"16124","C2_BioCarta_Pathways","C2_CP_BIOCARTA_106_BIOCARTA_INSULIN_PATHWAY",21,-0.588,0.97,0.97,"No",-0.697,0.89,1,"No"
"16125","C4_Cancer_gene_neighborhoods","C4_CGN_267_GCM_SUFU",77,-0.588,0.99,1,"No",-0.5703,1,1,"No"
"16126","GO_BP","494568_GO_0010498_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",272,-0.5878,1,0.99,"No",1.387,0.0046,0.57,"Yes"
"16127","GO_BP","519396_GO_2000757_NEGATIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION",15,-0.5876,0.96,0.99,"No",1.2231,0.21,0.76,"Yes"
"16128","GO_MF","515626_GO_0070696_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING",13,-0.5876,0.96,0.99,"No",0.6164,0.95,1,"Yes"
"16129","GO_MF","487308_GO_0001085_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING",92,-0.5875,1,0.98,"No",0.6966,0.98,1,"Yes"
"16130","OMIM_gene","OMIM609901_ANKYRIN_REPEAT_AND_STERILE_ALPHA_MOTIF_DOMAINS_CONTAINING_PROTEIN_4B_ANKS4B",5,-0.5874,0.94,1,"No",-1.1838,0.28,1,"No"
"16131","GO_BP","497012_GO_0018026_PEPTIDYL_LYSINE_MONOMETHYLATION",6,-0.587,0.95,0.99,"No",-0.6286,0.89,1,"No"
"16132","GO_BP","487959_GO_0002069_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION",6,-0.5869,0.93,0.99,"No",0.6738,0.85,1,"Yes"
"16133","GO_BP","515219_GO_0070286_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY",15,-0.5868,0.97,0.99,"No",-1.4595,0.075,0.88,"No"
"16134","GO_CC","489480_GO_0043190_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX",8,-0.5866,0.95,1,"No",-1.505,0.048,0.62,"No"
"16135","GO_BP","491411_GO_0006513_PROTEIN_MONOUBIQUITINATION",46,-0.5863,0.99,0.99,"No",0.8322,0.78,1,"Yes"
"16136","C2_Chemical_and_genetic_perturbations","C2_CGP_878_INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP",14,-0.5863,0.96,0.99,"No",1.0115,0.45,0.78,"Yes"
"16137","KEGG_compound","C14771_14_15_EET_5Z_8Z_11Z_14_15_EPOXYEICOSA_5_8_11_TRIENOIC_ACID_5Z_8Z_11Z_14_15_EPOXYICOSA_5_8_11_TRIENOIC_ACID",5,-0.5862,0.95,0.99,"No",-1.2254,0.25,0.78,"No"
"16138","GO_BP","494598_GO_0010529_NEGATIVE_REGULATION_OF_TRANSPOSITION",9,-0.5862,0.96,0.99,"No",0.9373,0.56,1,"Yes"
"16139","GO_BP","494597_GO_0010528_REGULATION_OF_TRANSPOSITION",9,-0.5861,0.95,0.99,"No",0.9511,0.5,1,"Yes"
"16140","REACTOME","106326_REACT_9465_HEME_BIOSYNTHESIS",11,-0.5857,0.96,1,"No",1.0851,0.35,0.61,"Yes"
"16141","REACTOME","477137_REACT_111083_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT",135,-0.5855,1,1,"No",2.6442,0,0,"Yes"
"16142","KEGG_compound","C00019_S_ADENOSYL_L_METHIONINE_S_ADENOSYLMETHIONINE_ADOMET_SAM",59,-0.5848,0.99,0.99,"No",-0.727,0.94,1,"No"
"16143","GO_BP","510492_GO_0048385_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",22,-0.5841,0.97,0.99,"No",-1.0602,0.35,0.96,"No"
"16144","C4_Cancer_gene_neighborhoods","C4_CGN_198_GCM_BECN1",68,-0.5841,1,1,"No",1.4844,0.017,0.035,"Yes"
"16145","C2_Chemical_and_genetic_perturbations","C2_CGP_612_TURJANSKI_MAPK14_TARGETS",10,-0.5839,0.93,0.99,"No",-0.9053,0.59,1,"No"
"16146","REACTOME","366163_REACT_75795_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC",24,-0.5833,0.97,1,"No",1.242,0.16,0.4,"Yes"
"16147","C2_Chemical_and_genetic_perturbations","C2_CGP_708_SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC",107,-0.5831,1,0.99,"No",1.1493,0.17,0.56,"Yes"
"16148","GO_CC","500565_GO_0031306_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE",18,-0.5822,0.97,1,"No",-0.6166,0.96,1,"No"
"16149","GO_CC","516739_GO_0071817_MMXD_COMPLEX",5,-0.5814,0.93,1,"No",0.9701,0.47,0.83,"Yes"
"16150","GO_CC","501276_GO_0032039_INTEGRATOR_COMPLEX",13,-0.581,0.96,1,"No",-0.6401,0.9,1,"No"
"16151","GO_BP","488665_GO_0002792_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION",37,-0.5807,0.98,0.99,"No",-0.9021,0.62,1,"No"
"16152","REACTOME","106455_REACT_13443_REGULATED_PROTEOLYSIS_OF_P75NTR",10,-0.5802,0.96,1,"No",0.6167,0.93,1,"Yes"
"16153","GO_CC","490731_GO_0005675_HOLO_TFIIH_COMPLEX",12,-0.5801,0.97,1,"No",0.7376,0.82,0.98,"Yes"
"16154","OMIM_gene","OMIM606622_SWI_SNF_RELATED_MATRIX_ASSOCIATED_ACTIN_DEPENDENT_REGULATOR_OF_CHROMATIN_SUBFAMILY_A_LIKE_PROTEIN_1_SMARCAL1",5,-0.5795,0.93,1,"No",-1.1944,0.26,1,"No"
"16155","C2_Chemical_and_genetic_perturbations","C2_CGP_68_IGARASHI_ATF4_TARGETS_UP",6,-0.5794,0.94,0.99,"No",-1.2667,0.19,0.72,"No"
"16156","GO_BP","518230_GO_0090090_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY",152,-0.579,1,0.99,"No",1.4866,0.0047,0.43,"Yes"
"16157","OMIM_gene","OMIM606157_PANTOTHENATE_KINASE_2_PANK2",5,-0.5789,0.95,1,"No",-1.1839,0.28,1,"No"
"16158","REACTOME","1127546_REACT_268444_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS",18,-0.5787,0.97,1,"No",0.9457,0.52,0.84,"Yes"
"16159","GO_BP","486731_GO_0019941_MODIFICATION_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",399,-0.5785,1,0.99,"No",1.3117,0.0027,0.66,"Yes"
"16160","GO_BP","518451_GO_0090311_REGULATION_OF_PROTEIN_DEACETYLATION",32,-0.5781,0.99,0.99,"No",-1.1223,0.27,0.93,"No"
"16161","REACTOME","106504_REACT_6844_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX",72,-0.5776,1,1,"No",1.1119,0.26,0.56,"Yes"
"16162","C2_Chemical_and_genetic_perturbations","C2_CGP_47_FRASOR_TAMOXIFEN_RESPONSE_DN",11,-0.5775,0.96,0.99,"No",-0.6616,0.9,1,"No"
"16163","KEGG_compound","C00363_DTDP_DEOXYTHYMIDINE_5_DIPHOSPHATE",14,-0.5772,0.96,0.99,"No",-0.5008,0.99,1,"No"
"16164","GO_BP","505840_GO_0042733_EMBRYONIC_DIGIT_MORPHOGENESIS",60,-0.5771,0.99,0.99,"No",0.9107,0.62,1,"Yes"
"16165","REACTOME","106544_REACT_7993_TELOMERE_C_STRAND_SYNTHESIS_INITIATION",6,-0.5768,0.95,1,"No",-0.5976,0.93,1,"No"
"16166","WikiPathways","198767_WP288_NLR_PROTEINS",8,-0.5766,0.96,1,"No",-0.5072,0.99,1,"No"
"16167","GO_BP","506235_GO_0043162_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY",18,-0.5766,0.98,0.99,"No",1.6508,0.012,0.25,"Yes"
"16168","REACTOME","106247_REACT_16907_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS",29,-0.5762,0.98,0.99,"No",1.1604,0.25,0.49,"Yes"
"16169","C2_Chemical_and_genetic_perturbations","C2_CGP_2953_NAKAMURA_ADIPOGENESIS_EARLY_DN",37,-0.576,0.98,0.99,"No",1.4066,0.062,0.29,"Yes"
"16170","GO_BP","512558_GO_0051683_ESTABLISHMENT_OF_GOLGI_LOCALIZATION",6,-0.5758,0.95,0.99,"No",1.4827,0.069,0.44,"Yes"
"16171","GO_BP","519418_GO_2000779_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR",27,-0.5752,0.98,0.99,"No",0.741,0.86,1,"Yes"
"16172","REACTOME","105785_REACT_2244_DNA_REPLICATION_INITIATION",6,-0.5749,0.94,0.99,"No",-0.603,0.93,1,"No"
"16173","GO_BP","496300_GO_0016233_TELOMERE_CAPPING",5,-0.5748,0.95,0.99,"No",0.6609,0.89,1,"Yes"
"16174","GO_BP","508080_GO_0045739_POSITIVE_REGULATION_OF_DNA_REPAIR",28,-0.5745,0.98,0.99,"No",0.6873,0.93,1,"Yes"
"16175","C2_Chemical_and_genetic_perturbations","C2_CGP_1070_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP",15,-0.5744,0.98,0.99,"No",-0.9959,0.48,1,"No"
"16176","GO_BP","504297_GO_0035112_GENITALIA_MORPHOGENESIS",10,-0.5728,0.96,0.99,"No",-0.5486,0.96,1,"No"
"16177","GO_MF","507678_GO_0045322_UNMETHYLATED_CPG_BINDING",5,-0.5725,0.95,0.99,"No",-1.3867,0.12,0.66,"No"
"16178","C4_Cancer_gene_neighborhoods","C4_CGN_61_MORF_AP3D1",130,-0.5716,1,1,"No",2.166,0,2e-05,"Yes"
"16179","C2_Chemical_and_genetic_perturbations","C2_CGP_2671_ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN",30,-0.5713,0.98,0.99,"No",1.8802,0.0043,0.023,"Yes"
"16180","C2_Chemical_and_genetic_perturbations","C2_CGP_839_OXFORD_RALA_TARGETS_DN",10,-0.5709,0.95,0.99,"No",0.7162,0.81,1,"Yes"
"16181","REACTOME","106109_REACT_12528_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX",14,-0.5706,0.95,0.99,"No",1.0778,0.35,0.62,"Yes"
"16182","C4_Cancer_modules","C4_CM_204_MODULE_219",27,-0.5678,0.98,1,"No",1.3782,0.072,0.2,"Yes"
"16183","GO_BP","500353_GO_0031063_REGULATION_OF_HISTONE_DEACETYLATION",24,-0.5672,0.98,0.99,"No",-1.2511,0.17,0.91,"No"
"16184","GO_BP","506234_GO_0043161_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",265,-0.5671,1,0.99,"No",1.3595,0.012,0.6,"Yes"
"16185","OMIM_gene","OMIM607211_CASPASE_RECRUITMENT_DOMAIN_CONTAINING_PROTEIN_14_CARD14",6,-0.5659,0.96,0.99,"No",1.0597,0.39,1,"Yes"
"16186","GO_CC","496535_GO_0016589_NURF_COMPLEX",6,-0.5659,0.95,1,"No",-1.0298,0.43,0.83,"No"
"16187","GO_BP","497199_GO_0018231_PEPTIDYL_S_DIACYLGLYCEROL_L_CYSTEINE_BIOSYNTHETIC_PROCESS_FROM_PEPTIDYL_CYSTEINE",5,-0.5655,0.96,0.99,"No",0.7052,0.83,1,"Yes"
"16188","KEGG_compound","C00082_L_TYROSINE_S_3_P_HYDROXYPHENYL_ALANINE_S_2_AMINO_3_P_HYDROXYPHENYL_PROPIONIC_ACID_TYROSINE",11,-0.5655,0.96,1,"No",0.9075,0.58,1,"Yes"
"16189","C3_TF_targets","C3_TFT_392_GCGSCMNTTT_UNKNOWN",68,-0.5653,0.99,1,"No",-0.5949,1,1,"No"
"16190","C2_Chemical_and_genetic_perturbations","C2_CGP_525_ZIRN_TRETINOIN_RESPONSE_WT1_DN",6,-0.5644,0.97,0.99,"No",0.6424,0.89,1,"Yes"
"16191","REACTOME","106197_REACT_9472_DIGESTION_OF_DIETARY_CARBOHYDRATE",8,-0.5642,0.96,1,"No",-0.6496,0.9,1,"No"
"16192","GO_BP","490990_GO_0006002_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS",6,-0.5642,0.96,0.99,"No",-0.9617,0.5,1,"No"
"16193","C2_Chemical_and_genetic_perturbations","C2_CGP_2585_HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP",10,-0.5635,0.96,0.99,"No",-1.121,0.32,0.89,"No"
"16194","GO_BP","512451_GO_0051573_NEGATIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION",6,-0.5628,0.95,0.99,"No",-0.8723,0.6,1,"No"
"16195","GO_MF","489279_GO_0003747_TRANSLATION_RELEASE_FACTOR_ACTIVITY",6,-0.5627,0.96,0.99,"No",0.9668,0.53,0.91,"Yes"
"16196","GO_BP","499811_GO_0030433_ER_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",43,-0.5627,0.99,0.99,"No",0.9962,0.47,0.98,"Yes"
"16197","GO_MF","492448_GO_0008079_TRANSLATION_TERMINATION_FACTOR_ACTIVITY",6,-0.5617,0.94,0.99,"No",0.9347,0.55,0.94,"Yes"
"16198","GO_CC","493535_GO_0045254_PYRUVATE_DEHYDROGENASE_COMPLEX",5,-0.5617,0.95,1,"No",1.1092,0.36,0.63,"Yes"
"16199","REACTOME","1183590_REACT_355321_RHO_GTPASES_ACTIVATE_KTN1",11,-0.5615,0.95,1,"No",0.6698,0.92,1,"Yes"
"16200","REACTOME","161017_REACT_22394_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE",5,-0.5614,0.97,0.99,"No",-1.0767,0.39,0.9,"No"
"16201","GO_BP","491033_GO_0006048_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS",5,-0.5613,0.96,0.99,"No",-1.0552,0.42,0.97,"No"
"16202","GO_MF","487277_GO_0001054_RNA_POLYMERASE_I_ACTIVITY",12,-0.5607,0.98,0.99,"No",0.909,0.61,0.98,"Yes"
"16203","GO_BP","849888_GO_1902186_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL",31,-0.5604,0.98,0.99,"No",1.2597,0.16,0.72,"Yes"
"16204","REACTOME","530748_REACT_115835_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS",25,-0.5595,0.98,0.99,"No",-0.9084,0.59,1,"No"
"16205","GO_BP","497198_GO_0018230_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION",5,-0.559,0.96,0.99,"No",0.7015,0.82,1,"Yes"
"16206","C4_Cancer_modules","C4_CM_136_MODULE_143",13,-0.5589,0.98,0.99,"No",-0.5827,0.96,1,"No"
"16207","GO_BP","500678_GO_0031427_RESPONSE_TO_METHOTREXATE",5,-0.5577,0.96,1,"No",-1.0747,0.4,0.96,"No"
"16208","C2_Chemical_and_genetic_perturbations","C2_CGP_397_CASTELLANO_HRAS_TARGETS_UP",5,-0.5574,0.96,0.99,"No",1.293,0.18,0.4,"Yes"
"16209","KEGG_module","HSA_M00182_RNA_POLYMERASE_I_EUKARYOTES",12,-0.5572,0.96,0.97,"No",0.9051,0.55,0.92,"Yes"
"16210","GO_BP","491410_GO_0006511_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",391,-0.5571,1,1,"No",1.3134,0.0024,0.66,"Yes"
"16211","GO_BP","754629_GO_1901678_IRON_COORDINATION_ENTITY_TRANSPORT",12,-0.5566,0.97,1,"No",-1.1573,0.3,0.92,"No"
"16212","GO_BP","493456_GO_0009263_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",12,-0.5565,0.97,1,"No",1.111,0.33,0.89,"Yes"
"16213","GO_BP","494251_GO_0010172_EMBRYONIC_BODY_MORPHOGENESIS",10,-0.5563,0.96,0.99,"No",-0.6635,0.9,1,"No"
"16214","C4_Cancer_gene_neighborhoods","C4_CGN_167_MORF_RAC1",213,-0.5559,1,1,"No",1.9454,0,0.00053,"Yes"
"16215","GO_CC","487085_GO_0000792_HETEROCHROMATIN",74,-0.5558,1,1,"No",-0.5559,1,1,"No"
"16216","C1_Positional","C1_ALL_259_CHR8Q13",42,-0.5557,0.99,1,"No",0.8857,0.66,0.89,"Yes"
"16217","GO_BP","510415_GO_0048308_ORGANELLE_INHERITANCE",10,-0.555,0.97,1,"No",0.686,0.87,1,"Yes"
"16218","GO_BP","496058_GO_0015937_COENZYME_A_BIOSYNTHETIC_PROCESS",11,-0.5546,0.96,1,"No",-0.7002,0.89,1,"No"
"16219","GO_BP","504742_GO_0035562_NEGATIVE_REGULATION_OF_CHROMATIN_BINDING",5,-0.5544,0.95,0.99,"No",-0.953,0.54,1,"No"
"16220","GO_CC","492458_GO_0008091_SPECTRIN",9,-0.5542,0.96,1,"No",-1.385,0.12,0.64,"No"
"16221","KEGG_compound","C00018_PYRIDOXAL_PHOSPHATE_PYRIDOXAL_5_PHOSPHATE_PYRIDOXAL_5_PHOSPHATE_PLP",5,-0.5541,0.96,1,"No",0.8669,0.62,1,"Yes"
"16222","REACTOME","105900_REACT_1181_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX",15,-0.5524,0.98,0.99,"No",1.4114,0.083,0.21,"Yes"
"16223","C2_Chemical_and_genetic_perturbations","C2_CGP_9_PYEON_HPV_POSITIVE_TUMORS_UP",96,-0.552,1,0.99,"No",-0.8059,0.85,1,"No"
"16224","GO_MF","514944_GO_0070003_THREONINE_TYPE_PEPTIDASE_ACTIVITY",21,-0.5516,0.98,0.99,"No",1.5386,0.029,0.34,"Yes"
"16225","GO_BP","506132_GO_0043046_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION",15,-0.5515,0.98,1,"No",-0.7618,0.8,1,"No"
"16226","C2_Chemical_and_genetic_perturbations","C2_CGP_1888_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP",18,-0.5514,0.98,0.99,"No",-0.7133,0.86,1,"No"
"16227","GO_MF","510370_GO_0048256_FLAP_ENDONUCLEASE_ACTIVITY",7,-0.5514,0.97,0.99,"No",0.7227,0.81,1,"Yes"
"16228","GO_BP","493261_GO_0009060_AEROBIC_RESPIRATION",48,-0.5488,0.99,1,"No",1.5851,0.0042,0.31,"Yes"
"16229","GO_BP","492068_GO_0007290_SPERMATID_NUCLEUS_ELONGATION",5,-0.5468,0.97,1,"No",0.5163,0.99,1,"Yes"
"16230","KEGG_compound","C00346_ETHANOLAMINE_PHOSPHATE_O_PHOSPHORYLETHANOLAMINE_PHOSPHOETHANOLAMINE_O_PHOSPHOETHANOLAMINE",8,-0.5463,0.97,1,"No",0.4899,0.99,1,"Yes"
"16231","C1_Positional","C1_ALL_219_CHR16Q23",30,-0.5463,0.99,1,"No",1.4523,0.056,0.3,"Yes"
"16232","GO_BP","491072_GO_0006089_LACTATE_METABOLIC_PROCESS",7,-0.546,0.99,1,"No",1.4053,0.092,0.55,"Yes"
"16233","GO_BP","491513_GO_0006620_POSTTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",6,-0.546,0.98,1,"No",0.812,0.7,1,"Yes"
"16234","C3_MicroRNA_targets","C3_MIR_12_TACGGGT_MIR_99A_MIR_100_MIR_99B",23,-0.5449,0.99,1,"No",0.8353,0.7,1,"Yes"
"16235","GO_CC","490859_GO_0005839_PROTEASOME_CORE_COMPLEX",20,-0.5434,0.98,1,"No",1.5788,0.029,0.13,"Yes"
"16236","GO_BP","489008_GO_0003214_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS",13,-0.5422,0.98,1,"No",0.5209,0.99,1,"Yes"
"16237","GO_CC","502029_GO_0032806_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX",21,-0.542,0.98,1,"No",1.1616,0.25,0.57,"Yes"
"16238","GO_MF","515630_GO_0070700_BMP_RECEPTOR_BINDING",8,-0.5413,0.97,1,"No",0.8701,0.63,1,"Yes"
"16239","GO_CC","911504_GO_1990204_OXIDOREDUCTASE_COMPLEX",85,-0.5412,1,1,"No",2.2752,0,0,"Yes"
"16240","GO_MF","489665_GO_0004298_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY",21,-0.5405,0.99,0.99,"No",1.4942,0.056,0.39,"Yes"
"16241","GO_BP","510767_GO_0048712_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION",13,-0.5405,0.98,1,"No",-1.3138,0.15,0.87,"No"
"16242","GO_MF","495728_GO_0015556_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.5402,0.98,0.99,"No",-1.2202,0.23,0.84,"No"
"16243","GO_BP","506519_GO_0043488_REGULATION_OF_MRNA_STABILITY",49,-0.5397,1,1,"No",0.9844,0.5,1,"Yes"
"16244","C4_Cancer_gene_neighborhoods","C4_CGN_223_GCM_DEAF1",28,-0.5383,0.99,1,"No",0.7242,0.91,1,"Yes"
"16245","C4_Cancer_modules","C4_CM_98_MODULE_103",12,-0.5383,0.98,1,"No",1.8215,0.0039,0.019,"Yes"
"16246","C4_Cancer_modules","C4_CM_76_MODULE_81",20,-0.5376,0.98,0.99,"No",2.0475,0,0.0019,"Yes"
"16247","GO_BP","491851_GO_0007020_MICROTUBULE_NUCLEATION",16,-0.5371,0.98,1,"No",-0.5163,0.99,1,"No"
"16248","GO_CC","507553_GO_0045171_INTERCELLULAR_BRIDGE",42,-0.5357,0.99,1,"No",0.4925,1,1,"Yes"
"16249","GO_BP","517435_GO_0072530_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT",6,-0.5356,0.97,1,"No",-0.9358,0.52,1,"No"
"16250","GO_BP","516398_GO_0071474_CELLULAR_HYPEROSMOTIC_RESPONSE",8,-0.5346,0.97,1,"No",-0.6668,0.89,1,"No"
"16251","REACTOME","645266_REACT_121111_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY",23,-0.5336,0.99,1,"No",1.0479,0.37,0.67,"Yes"
"16252","GO_BP","491361_GO_0006449_REGULATION_OF_TRANSLATIONAL_TERMINATION",8,-0.5335,0.97,1,"No",0.6992,0.86,1,"Yes"
"16253","GO_MF","495449_GO_0015180_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.5334,0.97,0.99,"No",-0.5406,0.97,1,"No"
"16254","C2_Chemical_and_genetic_perturbations","C2_CGP_633_GILMORE_CORE_NFKB_PATHWAY",14,-0.5329,0.99,1,"No",-0.9465,0.53,1,"No"
"16255","GO_BP","493377_GO_0009181_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",5,-0.5329,0.97,1,"No",0.7508,0.79,1,"Yes"
"16256","GO_MF","490390_GO_0005127_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING",5,-0.5328,0.97,0.99,"No",-1.1136,0.35,0.82,"No"
"16257","GO_BP","506662_GO_0043632_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS",412,-0.5325,1,1,"No",1.3715,0.0025,0.58,"Yes"
"16258","GO_BP","502352_GO_0033131_REGULATION_OF_GLUCOKINASE_ACTIVITY",10,-0.532,0.97,1,"No",0.7012,0.84,1,"Yes"
"16259","GO_CC","490774_GO_0005736_DNA_DIRECTED_RNA_POLYMERASE_I_COMPLEX",13,-0.5315,0.98,1,"No",0.8859,0.63,0.91,"Yes"
"16260","REACTOME","105683_REACT_13462_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR",13,-0.5311,0.99,1,"No",1.3794,0.081,0.24,"Yes"
"16261","GO_BP","777641_GO_1901984_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION",16,-0.5305,0.98,1,"No",1.4989,0.047,0.41,"Yes"
"16262","GO_BP","496057_GO_0015936_COENZYME_A_METABOLIC_PROCESS",18,-0.5304,0.98,1,"No",0.8784,0.62,1,"Yes"
"16263","REACTOME","105682_REACT_1213_APOPTOSIS_INDUCED_DNA_FRAGMENTATION",13,-0.5295,0.97,1,"No",1.3944,0.1,0.23,"Yes"
"16264","C2_Chemical_and_genetic_perturbations","C2_CGP_1212_NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON",52,-0.5294,1,1,"No",-0.8165,0.8,1,"No"
"16265","GO_MF","499397_GO_0022858_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.5283,0.97,0.99,"No",-0.5604,0.95,1,"No"
"16266","C3_TF_targets","C3_TFT_260_CGGAARNGGCNG_UNKNOWN",50,-0.5268,1,1,"No",1.1441,0.23,0.9,"Yes"
"16267","GO_BP","516936_GO_0072017_DISTAL_TUBULE_DEVELOPMENT",11,-0.526,0.98,1,"No",-0.8077,0.72,1,"No"
"16268","GO_BP","493334_GO_0009137_PURINE_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",5,-0.5257,0.98,1,"No",0.7442,0.78,1,"Yes"
"16269","GO_BP","492301_GO_0007549_DOSAGE_COMPENSATION",8,-0.5255,0.98,1,"No",1.2018,0.24,0.78,"Yes"
"16270","GO_MF","492591_GO_0008266_POLY_U_RNA_BINDING",13,-0.5249,0.98,0.99,"No",-0.5861,0.96,1,"No"
"16271","GO_CC","757167_GO_0090545_CHD_TYPE_COMPLEX",18,-0.5248,0.99,1,"No",-1.0148,0.44,0.84,"No"
"16272","GO_BP","1026071_GO_1903299_REGULATION_OF_HEXOKINASE_ACTIVITY",10,-0.5247,0.98,1,"No",0.6898,0.85,1,"Yes"
"16273","GO_BP","510420_GO_0048313_GOLGI_INHERITANCE",9,-0.5242,0.99,1,"No",0.694,0.85,1,"Yes"
"16274","GO_BP","755079_GO_2000973_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION",5,-0.5241,0.97,1,"No",-1.0909,0.38,0.95,"No"
"16275","GO_MF","490200_GO_0004904_INTERFERON_RECEPTOR_ACTIVITY",5,-0.5241,0.97,0.99,"No",1.2209,0.24,0.71,"Yes"
"16276","GO_BP","504453_GO_0035269_PROTEIN_O_LINKED_MANNOSYLATION",14,-0.522,0.98,1,"No",-0.6593,0.89,1,"No"
"16277","C2_Chemical_and_genetic_perturbations","C2_CGP_2233_BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1",12,-0.5205,0.98,1,"No",1.7133,0.016,0.075,"Yes"
"16278","GO_BP","516094_GO_0071168_PROTEIN_LOCALIZATION_TO_CHROMATIN",11,-0.5203,0.98,1,"No",1.1117,0.32,0.89,"Yes"
"16279","C2_Chemical_and_genetic_perturbations","C2_CGP_1189_COLLIS_PRKDC_REGULATORS",15,-0.5201,0.98,1,"No",1.6498,0.03,0.11,"Yes"
"16280","GO_BP","491099_GO_0022904_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN",107,-0.5197,1,1,"No",2.6379,0,0,"Yes"
"16281","GO_BP","754624_GO_1901673_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY",13,-0.5192,0.98,1,"No",1.1144,0.31,0.88,"Yes"
"16282","GO_BP","495984_GO_0015860_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT",6,-0.5192,0.96,1,"No",-0.9109,0.56,1,"No"
"16283","C2_Chemical_and_genetic_perturbations","C2_CGP_609_TURJANSKI_MAPK8_AND_MAPK9_TARGETS",8,-0.5189,0.98,1,"No",-1.2365,0.22,0.76,"No"
"16284","GO_CC","496529_GO_0016581_NURD_COMPLEX",18,-0.5181,0.99,1,"No",-1.0173,0.43,0.84,"No"
"16285","GO_BP","493387_GO_0009191_RIBONUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",7,-0.5172,0.97,1,"No",0.6515,0.89,1,"Yes"
"16286","GO_CC","503253_GO_0034045_PRE_AUTOPHAGOSOMAL_STRUCTURE_MEMBRANE",15,-0.5171,0.99,1,"No",0.8748,0.63,0.91,"Yes"
"16287","C4_Cancer_gene_neighborhoods","C4_CGN_108_MORF_GNB1",305,-0.5167,1,1,"No",2.1057,0,0.00013,"Yes"
"16288","GO_BP","751442_GO_0039535_REGULATION_OF_RIG_I_SIGNALING_PATHWAY",10,-0.5153,0.98,1,"No",0.8516,0.66,1,"Yes"
"16289","GO_BP","501175_GO_0031935_REGULATION_OF_CHROMATIN_SILENCING",15,-0.5149,0.99,1,"No",0.7859,0.78,1,"Yes"
"16290","REACTOME","477131_REACT_111059_REGULATION_OF_SIGNALING_BY_NODAL",8,-0.514,0.98,1,"No",-0.7525,0.77,1,"No"
"16291","GO_CC","498684_GO_0019908_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX",9,-0.5136,0.97,1,"No",0.7004,0.83,0.99,"Yes"
"16292","GO_MF","489749_GO_0004383_GUANYLATE_CYCLASE_ACTIVITY",8,-0.5133,0.98,1,"No",1.0995,0.33,0.79,"Yes"
"16293","KEGG_pathway","HSA03450_NON_HOMOLOGOUS_END_JOINING",13,-0.5133,0.99,1,"No",1.2523,0.16,0.48,"Yes"
"16294","KEGG_compound","C01179_3_4_HYDROXYPHENYL_PYRUVATE_4_HYDROXYPHENYLPYRUVATE_P_HYDROXYPHENYLPYRUVIC_ACID",6,-0.5128,0.98,1,"No",-0.9759,0.48,1,"No"
"16295","KEGG_compound","C00166_PHENYLPYRUVATE_PHENYLPYRUVIC_ACID_ALPHA_KETOHYDROCINNAMIC_ACID_KETO_PHENYLPYRUVATE_3_PHENYL_2_OXOPROPANOATE_2_OXO_3_PHENYLPROPANOATE",6,-0.5126,0.97,1,"No",-0.9484,0.54,1,"No"
"16296","KEGG_compound","C00104_IDP_INOSINE_5_DIPHOSPHATE_INOSINE_DIPHOSPHATE",26,-0.5125,0.99,1,"No",0.525,1,1,"Yes"
"16297","C4_Cancer_gene_neighborhoods","C4_CGN_79_MORF_CSNK2B",288,-0.5123,1,1,"No",2.3606,0,0,"Yes"
"16298","GO_BP","516686_GO_0071763_NUCLEAR_MEMBRANE_ORGANIZATION",6,-0.5119,0.98,1,"No",0.4087,1,1,"Yes"
"16299","GO_CC","490854_GO_0005832_CHAPERONIN_CONTAINING_T_COMPLEX",9,-0.5117,0.98,1,"No",1.7651,0.017,0.035,"Yes"
"16300","GO_BP","507690_GO_0045333_CELLULAR_RESPIRATION",154,-0.5113,1,1,"No",2.4407,0,0,"Yes"
"16301","C4_Cancer_gene_neighborhoods","C4_CGN_170_MORF_RAN",269,-0.5111,1,1,"No",2.849,0,0,"Yes"
"16302","WikiPathways","198870_WP623_OXIDATIVE_PHOSPHORYLATION",53,-0.5105,1,1,"No",2.617,0,0,"Yes"
"16303","GO_CC","490852_GO_0005828_KINETOCHORE_MICROTUBULE",6,-0.5102,0.98,1,"No",-0.5044,0.98,1,"No"
"16304","GO_BP","518699_GO_2000050_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY",15,-0.51,0.99,1,"No",0.6594,0.91,1,"Yes"
"16305","GO_BP","514857_GO_0061312_BMP_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",5,-0.5098,0.99,1,"No",-0.647,0.87,1,"No"
"16306","GO_BP","512446_GO_0051568_HISTONE_H3_K4_METHYLATION",28,-0.5081,1,1,"No",0.5587,0.99,1,"Yes"
"16307","C2_Chemical_and_genetic_perturbations","C2_CGP_688_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6",5,-0.5075,0.98,1,"No",-0.5929,0.93,1,"No"
"16308","GO_BP","514099_GO_0060544_REGULATION_OF_NECROPTOTIC_PROCESS",12,-0.5071,0.99,1,"No",-0.7793,0.76,1,"No"
"16309","GO_BP","499731_GO_0030330_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",89,-0.507,1,1,"No",1.6476,0.0023,0.24,"Yes"
"16310","GO_CC","862183_GO_0044798_NUCLEAR_TRANSCRIPTION_FACTOR_COMPLEX",104,-0.5066,1,1,"No",0.9556,0.55,0.83,"Yes"
"16311","GO_BP","494522_GO_0010452_HISTONE_H3_K36_METHYLATION",6,-0.505,0.99,1,"No",-0.6575,0.87,1,"No"
"16312","GO_BP","491459_GO_0006563_L_SERINE_METABOLIC_PROCESS",8,-0.5048,0.99,1,"No",0.8619,0.64,1,"Yes"
"16313","GO_CC","490704_GO_0005638_LAMIN_FILAMENT",5,-0.5047,0.98,1,"No",-1.0225,0.45,0.84,"No"
"16314","GO_BP","491761_GO_0006901_VESICLE_COATING",39,-0.5045,1,1,"No",1.739,0.002,0.15,"Yes"
"16315","GO_BP","519316_GO_2000677_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",26,-0.5041,1,1,"No",1.4801,0.048,0.44,"Yes"
"16316","GO_BP","486593_GO_0000045_AUTOPHAGIC_VACUOLE_ASSEMBLY",45,-0.504,1,1,"No",1.0618,0.34,0.94,"Yes"
"16317","GO_BP","491505_GO_0006611_PROTEIN_EXPORT_FROM_NUCLEUS",27,-0.5038,1,1,"No",0.6974,0.91,1,"Yes"
"16318","C4_Cancer_gene_neighborhoods","C4_CGN_214_GCM_CBFB",70,-0.5037,1,1,"No",1.9218,0,0.00068,"Yes"
"16319","GO_BP","491139_GO_0006167_AMP_BIOSYNTHETIC_PROCESS",6,-0.5033,0.98,1,"No",1.0084,0.45,0.98,"Yes"
"16320","GO_BP","493331_GO_0009134_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",8,-0.503,0.98,1,"No",0.8509,0.63,1,"Yes"
"16321","GO_CC","500564_GO_0031305_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE",15,-0.5025,0.99,1,"No",1.1769,0.24,0.55,"Yes"
"16322","GO_BP","495939_GO_0015808_L_ALANINE_TRANSPORT",7,-0.5006,0.99,1,"No",-0.4752,1,1,"No"
"16323","GO_BP","514007_GO_0060452_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION",7,-0.5002,0.99,1,"No",-0.9188,0.56,1,"No"
"16324","GO_BP","491107_GO_0022900_ELECTRON_TRANSPORT_CHAIN",109,-0.4999,1,1,"No",2.6387,0,0,"Yes"
"16325","GO_BP","1022189_GO_1903203_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH",9,-0.4994,0.99,1,"No",1.6624,0.02,0.23,"Yes"
"16326","GO_BP","489099_GO_0003307_REGULATION_OF_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",8,-0.4983,0.99,1,"No",-0.7048,0.81,1,"No"
"16327","GO_MF","512307_GO_0051429_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING",5,-0.498,0.98,1,"No",-1.3446,0.13,0.7,"No"
"16328","GO_BP","512814_GO_0051964_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY",5,-0.4976,0.97,1,"No",0.9119,0.58,1,"Yes"
"16329","KEGG_compound","C01042_N_ACETYL_L_ASPARTATE_N_ACETYL_L_ASPARTIC_ACID",5,-0.4972,0.99,1,"No",-0.8847,0.61,1,"No"
"16330","GO_BP","497954_GO_0019076_VIRAL_RELEASE_FROM_HOST_CELL",6,-0.4963,0.99,1,"No",1.3876,0.15,0.57,"Yes"
"16331","GO_CC","515008_GO_0070069_CYTOCHROME_COMPLEX",13,-0.4945,0.99,1,"No",1.6188,0.025,0.1,"Yes"
"16332","REACTOME","106330_REACT_13673_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS",5,-0.4944,0.98,1,"No",-0.5485,0.95,1,"No"
"16333","GO_BP","498710_GO_0048016_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING",13,-0.4934,0.99,1,"No",-0.9575,0.5,1,"No"
"16334","GO_BP","946559_GO_0098902_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL",5,-0.4932,0.99,1,"No",0.8904,0.6,1,"Yes"
"16335","REACTOME","106260_REACT_11167_METABOLISM_OF_FOLATE_AND_PTERINES",9,-0.4925,0.98,1,"No",-0.7843,0.73,1,"No"
"16336","GO_BP","499646_GO_0030240_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY",5,-0.4917,0.99,1,"No",-1.3977,0.09,1,"No"
"16337","KEGG_pathway","HSA00604_GLYCOSPHINGOLIPID_BIOSYNTHESIS",15,-0.4907,0.99,1,"No",0.6591,0.91,1,"Yes"
"16338","C1_Positional","C1_ALL_60_CHRXQ12",15,-0.4896,0.99,1,"No",-0.971,0.48,1,"No"
"16339","GO_CC","500563_GO_0031304_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE",16,-0.4889,0.99,1,"No",1.149,0.27,0.59,"Yes"
"16340","REACTOME","105991_REACT_6918_INTEGRATION_OF_PROVIRUS",9,-0.4885,1,1,"No",1.242,0.22,0.4,"Yes"
"16341","KEGG_compound","C00144_GMP_GUANOSINE_5_PHOSPHATE_GUANOSINE_MONOPHOSPHATE_GUANOSINE_5_MONOPHOSPHATE_GUANYLIC_ACID",40,-0.4812,1,1,"No",0.8055,0.81,1,"Yes"
"16342","GO_BP","494244_GO_0010165_RESPONSE_TO_X_RAY",25,-0.4799,0.99,1,"No",0.703,0.9,1,"Yes"
"16343","GO_BP","517311_GO_0072395_SIGNAL_TRANSDUCTION_INVOLVED_IN_CELL_CYCLE_CHECKPOINT",71,-0.4797,1,1,"No",1.6876,0.0044,0.21,"Yes"
"16344","GO_BP","751220_GO_0036302_ATRIOVENTRICULAR_CANAL_DEVELOPMENT",7,-0.4796,0.99,1,"No",0.9436,0.5,1,"Yes"
"16345","GO_BP","505464_GO_0042320_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_REM_SLEEP",6,-0.4795,0.99,1,"No",1.7678,0.0084,0.13,"Yes"
"16346","GO_BP","487782_GO_0001886_ENDOTHELIAL_CELL_MORPHOGENESIS",11,-0.4793,1,1,"No",-1.2958,0.16,0.88,"No"
"16347","REACTOME","105993_REACT_9058_2_LTR_CIRCLE_FORMATION",7,-0.4783,0.99,1,"No",1.225,0.24,0.42,"Yes"
"16348","KEGG_compound","C00387_GUANOSINE",10,-0.4777,1,1,"No",0.4823,1,1,"Yes"
"16349","GO_MF","512415_GO_0051537_2_IRON_2_SULFUR_CLUSTER_BINDING",19,-0.4775,1,1,"No",2.0766,0,0.0064,"Yes"
"16350","C2_Chemical_and_genetic_perturbations","C2_CGP_1418_RADAEVA_RESPONSE_TO_IFNA1_DN",10,-0.4771,0.99,1,"No",1.0323,0.39,0.75,"Yes"
"16351","GO_MF","496590_GO_0016653_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR",12,-0.4764,0.99,1,"No",-0.9818,0.47,0.93,"No"
"16352","OMIM_gene","OMIM605734_TRANSMEMBRANE_PROTEIN_WITH_EGF_LIKE_AND_2_FOLLISTATIN_LIKE_DOMAINS_2_TMEFF2",7,-0.4739,0.98,1,"No",1.3334,0.12,0.77,"Yes"
"16353","GO_BP","492031_GO_0007250_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY",19,-0.4734,0.99,1,"No",1.6397,0.016,0.25,"Yes"
"16354","C2_Chemical_and_genetic_perturbations","C2_CGP_71_ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN",70,-0.4724,1,1,"No",1.3425,0.068,0.35,"Yes"
"16355","GO_BP","506683_GO_0043653_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS",9,-0.4717,0.99,1,"No",-0.5025,1,1,"No"
"16356","KEGG_compound","C00235_DIMETHYLALLYL_DIPHOSPHATE_2_ISOPENTENYL_DIPHOSPHATE_DELTA2_ISOPENTENYL_DIPHOSPHATE_DIMETHYLALLYL_PYROPHOSPHATE_DMAPP_MONOPRENYL_DIPHOSPHATE_PRENYL_DIPHOSPHATE",5,-0.4707,0.99,1,"No",0.8953,0.59,1,"Yes"
"16357","KEGG_compound","C01762_XANTHOSINE",10,-0.4705,1,1,"No",0.4806,1,1,"Yes"
"16358","GO_BP","512521_GO_0051645_GOLGI_LOCALIZATION",11,-0.4703,0.99,1,"No",0.8632,0.63,1,"Yes"
"16359","GO_BP","1129419_GO_1903593_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL",6,-0.4672,0.99,1,"No",1.6496,0.0083,0.25,"Yes"
"16360","GO_BP","488900_GO_0003105_NEGATIVE_REGULATION_OF_GLOMERULAR_FILTRATION",6,-0.4662,0.99,1,"No",1.6035,0.035,0.29,"Yes"
"16361","GO_BP","508331_GO_0046034_ATP_METABOLIC_PROCESS",108,-0.4662,1,1,"No",2.1522,0,0.0015,"Yes"
"16362","REACTOME","106266_REACT_1776_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS",11,-0.4652,1,1,"No",0.6779,0.89,1,"Yes"
"16363","GO_BP","508337_GO_0046040_IMP_METABOLIC_PROCESS",14,-0.4626,0.99,1,"No",0.7305,0.83,1,"Yes"
"16364","KEGG_compound","C00214_THYMIDINE_DEOXYTHYMIDINE",12,-0.4624,1,1,"No",-0.4728,0.99,1,"No"
"16365","GO_CC","496443_GO_0016471_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX",11,-0.4621,1,1,"No",-0.756,0.8,1,"No"
"16366","GO_BP","508315_GO_0046015_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE",6,-0.462,0.99,1,"No",-0.59,0.93,1,"No"
"16367","C2_BioCarta_Pathways","C2_CP_BIOCARTA_61_BIOCARTA_ETC_PATHWAY",11,-0.461,1,1,"No",1.3205,0.16,0.55,"Yes"
"16368","GO_BP","518309_GO_0090169_REGULATION_OF_SPINDLE_ASSEMBLY",15,-0.4594,0.99,1,"No",1.2843,0.17,0.7,"Yes"
"16369","C2_Chemical_and_genetic_perturbations","C2_CGP_2716_BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN",10,-0.4574,1,1,"No",-1.0448,0.39,0.97,"No"
"16370","C4_Cancer_gene_neighborhoods","C4_CGN_148_MORF_PPP2R4",51,-0.4569,1,1,"No",1.9632,0,5e-04,"Yes"
"16371","GO_MF","496799_GO_0046966_THYROID_HORMONE_RECEPTOR_BINDING",27,-0.4558,1,1,"No",0.8419,0.72,1,"Yes"
"16372","GO_BP","496428_GO_0016445_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS",28,-0.4479,1,1,"No",0.8467,0.73,1,"Yes"
"16373","WikiPathways","198863_WP712_ESTROGEN_SIGNALING_PATHWAY",19,-0.4459,1,1,"No",-0.8347,0.7,1,"No"
"16374","GO_MF","490020_GO_0004704_NF_KAPPAB_INDUCING_KINASE_ACTIVITY",6,-0.4453,1,1,"No",-0.6689,0.85,1,"No"
"16375","GO_BP","502366_GO_0033145_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",11,-0.4451,1,1,"No",1.1846,0.25,0.8,"Yes"
"16376","GO_CC","510311_GO_0048188_SET1C_COMPASS_COMPLEX",9,-0.4442,1,1,"No",0.6288,0.91,0.99,"Yes"
"16377","GO_CC","502282_GO_0033061_DNA_RECOMBINASE_MEDIATOR_COMPLEX",7,-0.4432,0.99,1,"No",-0.67,0.88,1,"No"
"16378","KEGG_compound","C03150_NICOTINAMIDE_BETA_RIBOSIDE_N_RIBOSYLNICOTINAMIDE_1_BETA_D_RIBOFURANOSYL_NICOTINAMIDE",12,-0.4349,1,1,"No",0.6677,0.91,1,"Yes"
"16379","GO_CC","515750_GO_0070822_SIN3_TYPE_COMPLEX",15,-0.4294,1,1,"No",-0.6752,0.91,1,"No"
"16380","REACTOME","105819_REACT_1932_MITOTIC_TELOPHASE_CYTOKINESIS",14,-0.4261,1,1,"No",1.0778,0.33,0.62,"Yes"
"16381","KEGG_compound","C05841_NICOTINATE_D_RIBONUCLEOSIDE_BETA_D_RIBOSYLNICOTINATE",12,-0.4237,1,1,"No",0.6754,0.91,1,"Yes"
"16382","GO_CC","515351_GO_0070419_NONHOMOLOGOUS_END_JOINING_COMPLEX",7,-0.4214,1,1,"No",1.0427,0.41,0.72,"Yes"
"16383","GO_BP","486732_GO_0042787_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",58,-0.4168,1,1,"No",-0.8893,0.69,1,"No"
"16384","C4_Cancer_gene_neighborhoods","C4_CGN_302_GNF2_TDG",35,-0.4156,1,1,"No",0.9373,0.57,0.74,"Yes"
"16385","GO_BP","519254_GO_2000615_REGULATION_OF_HISTONE_H3_K9_ACETYLATION",7,-0.4127,1,1,"No",-1.0598,0.4,0.96,"No"
"16386","GO_MF","489883_GO_0004535_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY",11,-0.4078,1,1,"No",0.797,0.73,1,"Yes"
"16387","GO_BP","496800_GO_0016925_PROTEIN_SUMOYLATION",27,-0.4043,1,1,"No",1.0942,0.32,0.91,"Yes"
"16388","GO_MF","496776_GO_0016889_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS",9,-0.4042,1,1,"No",1.2223,0.21,0.71,"Yes"
"16389","KEGG_compound","C00081_ITP_INOSINE_5_TRIPHOSPHATE_INOSINE_TRIPHOSPHATE_INOSINE_TRIPOLYPHOSPHATE",22,-0.4041,1,1,"No",0.7419,0.83,1,"Yes"
"16390","WikiPathways","198895_WP438_NON_HOMOLOGOUS_END_JOINING",6,-0.4023,1,1,"No",1.1635,0.28,0.93,"Yes"
"16391","GO_BP","513817_GO_0060261_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER",10,-0.3997,1,1,"No",-0.758,0.76,1,"No"
"16392","GO_BP","516396_GO_0071472_CELLULAR_RESPONSE_TO_SALT_STRESS",5,-0.3959,1,1,"No",0.997,0.46,0.98,"Yes"
"16393","GO_BP","496180_GO_0045722_POSITIVE_REGULATION_OF_GLUCONEOGENESIS",12,-0.3899,1,1,"No",0.7296,0.83,1,"Yes"
"16394","GO_CC","983705_GO_0098644_COMPLEX_OF_COLLAGEN_TRIMERS",11,-0.3822,1,1,"No",-0.9045,0.59,0.96,"No"
"16395","OMIM_gene","OMIM601592_RECEPTOR_ASSOCIATED_PROTEIN_OF_THE_SYNAPSE_43_KD_RAPSN",5,-0.377,1,1,"No",-0.7231,0.8,0.95,"No"
"16396","C3_MicroRNA_targets","C3_MIR_115_AACGGTT_MIR_451",12,-0.3231,1,1,"No",-0.669,0.9,1,"No"
"16397","C2_BioCarta_Pathways","C2_CP_BIOCARTA_195_BIOCARTA_TGFB_PATHWAY",19,0.3898,1,1,"Yes",-0.8012,0.75,1,"No"
"16398","GO_MF","489577_GO_0004112_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",25,0.4161,1,1,"Yes",-1.2359,0.17,0.84,"No"
"16399","GO_CC","516720_GO_0071797_LUBAC_COMPLEX",5,0.4189,0.99,1,"Yes",-0.7483,0.77,1,"No"
"16400","GO_CC","490868_GO_0005852_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX",16,0.4213,1,1,"Yes",2.1047,0,0.00054,"Yes"
"16401","GO_BP","512823_GO_0051973_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY",7,0.4257,1,1,"Yes",-0.834,0.64,1,"No"
"16402","GO_BP","508613_GO_0046349_AMINO_SUGAR_BIOSYNTHETIC_PROCESS",7,0.4258,1,1,"Yes",-0.9997,0.45,0.99,"No"
"16403","GO_BP","502069_GO_0032847_REGULATION_OF_CELLULAR_PH_REDUCTION",6,0.4261,1,1,"Yes",-0.6912,0.83,1,"No"
"16404","C2_Chemical_and_genetic_perturbations","C2_CGP_1672_SESTO_RESPONSE_TO_UV_C4",19,0.4268,1,1,"Yes",0.7723,0.79,1,"Yes"
"16405","GO_BP","491750_GO_0006890_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ER",33,0.4331,1,1,"Yes",0.9307,0.57,1,"Yes"
"16406","GO_BP","496430_GO_0016447_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS",23,0.4475,1,1,"Yes",0.7454,0.84,1,"Yes"
"16407","GO_BP","515103_GO_0070166_ENAMEL_MINERALIZATION",7,0.4542,1,1,"Yes",-1.0343,0.42,0.98,"No"
"16408","GO_BP","493482_GO_0009298_GDP_MANNOSE_BIOSYNTHETIC_PROCESS",5,0.4543,0.99,1,"Yes",1.1059,0.33,0.9,"Yes"
"16409","REACTOME","161018_REACT_22423_SYNTHESIS_OF_GDP_MANNOSE",5,0.4579,1,1,"Yes",1.1177,0.35,0.56,"Yes"
"16410","C2_Chemical_and_genetic_perturbations","C2_CGP_1374_KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP",12,0.4586,0.99,1,"Yes",1.249,0.21,0.44,"Yes"
"16411","KEGG_compound","C00881_DEOXYCYTIDINE_2_DEOXYCYTIDINE",12,0.4604,0.99,1,"Yes",0.6169,0.94,1,"Yes"
"16412","GO_BP","491757_GO_0006896_GOLGI_TO_VACUOLE_TRANSPORT",8,0.462,1,1,"Yes",0.9477,0.53,1,"Yes"
"16413","GO_MF","510202_GO_0048038_QUINONE_BINDING",17,0.4622,1,1,"Yes",0.8004,0.73,1,"Yes"
"16414","GO_MF","489579_GO_0004114_3_5_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",24,0.4668,1,1,"Yes",-1.1391,0.28,0.81,"No"
"16415","C4_Cancer_gene_neighborhoods","C4_CGN_259_GCM_RAF1",43,0.4698,1,1,"Yes",1.0739,0.33,0.42,"Yes"
"16416","C4_Cancer_modules","C4_CM_141_MODULE_149",37,0.4719,1,1,"Yes",2.4203,0,0,"Yes"
"16417","GO_BP","487629_GO_0001731_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX",18,0.4771,0.99,1,"Yes",2.1557,0,0.0014,"Yes"
"16418","GO_BP","491266_GO_0006307_DNA_DEALKYLATION_INVOLVED_IN_DNA_REPAIR",7,0.4771,0.99,1,"Yes",1.1012,0.34,0.9,"Yes"
"16419","C2_Chemical_and_genetic_perturbations","C2_CGP_725_JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER",40,0.4773,1,1,"Yes",1.2925,0.11,0.4,"Yes"
"16420","GO_BP","512447_GO_0051569_REGULATION_OF_HISTONE_H3_K4_METHYLATION",21,0.4777,1,1,"Yes",0.7856,0.76,1,"Yes"
"16421","GO_MF","515025_GO_0070087_CHROMO_SHADOW_DOMAIN_BINDING",6,0.4818,0.99,1,"Yes",-0.6495,0.88,1,"No"
"16422","GO_MF","489474_GO_0004003_ATP_DEPENDENT_DNA_HELICASE_ACTIVITY",33,0.4822,1,1,"Yes",-0.6325,0.97,1,"No"
"16423","REACTOME","105692_REACT_962_MEK_ACTIVATION",7,0.4856,0.99,1,"Yes",1.1679,0.28,0.48,"Yes"
"16424","GO_CC","496528_GO_0016580_SIN3_COMPLEX",13,0.4951,0.99,1,"Yes",0.4779,1,1,"Yes"
"16425","GO_BP","515770_GO_0070842_AGGRESOME_ASSEMBLY",5,0.4975,0.99,1,"Yes",-0.7188,0.79,1,"No"
"16426","WikiPathways","198761_WP1434_OSTEOPONTIN_SIGNALING",11,0.498,1,1,"Yes",0.5954,0.95,1,"Yes"
"16427","GO_BP","505775_GO_0042661_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION",7,0.5004,0.99,1,"Yes",0.8403,0.68,1,"Yes"
"16428","GO_CC","494564_GO_0010494_CYTOPLASMIC_STRESS_GRANULE",31,0.5006,1,1,"Yes",1.2555,0.14,0.45,"Yes"
"16429","C4_Cancer_gene_neighborhoods","C4_CGN_7_MORF_BECN1",102,0.502,1,1,"Yes",1.7806,0,0.0029,"Yes"
"16430","GO_BP","511661_GO_0050689_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST",5,0.5031,0.99,1,"Yes",0.963,0.5,1,"Yes"
"16431","GO_BP","512412_GO_0051534_NEGATIVE_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS",5,0.5037,0.98,1,"Yes",-0.9127,0.59,1,"No"
"16432","REACTOME","105693_REACT_614_RAF_PHOSPHORYLATES_MEK",7,0.5043,0.98,1,"Yes",1.145,0.3,0.52,"Yes"
"16433","KEGG_compound","C04352__R_4_PHOSPHOPANTOTHENOYL_L_CYSTEINE_N_R_4_PHOSPHOPANTOTHENOYL_L_CYSTEINE",6,0.5047,0.99,1,"Yes",-0.676,0.87,1,"No"
"16434","REACTOME","106008_REACT_6818_ASSEMBLY_OF_THE_HIV_VIRION",13,0.5058,0.99,1,"Yes",1.7328,0.0041,0.037,"Yes"
"16435","C2_Chemical_and_genetic_perturbations","C2_CGP_2458_MOOTHA_TCA",16,0.508,1,1,"Yes",1.6576,0.024,0.11,"Yes"
"16436","REACTOME","106163_REACT_11208_GOLGI_TO_ER_RETROGRADE_TRANSPORT",11,0.5093,0.99,1,"Yes",1.2301,0.21,0.42,"Yes"
"16437","GO_BP","515769_GO_0070841_INCLUSION_BODY_ASSEMBLY",6,0.5145,0.99,1,"Yes",0.6668,0.87,1,"Yes"
"16438","GO_BP","508365_GO_0046069_CGMP_CATABOLIC_PROCESS",6,0.5151,0.98,1,"Yes",-0.9835,0.47,1,"No"
"16439","GO_BP","488855_GO_0003057_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL",7,0.5159,1,1,"Yes",-0.5732,0.96,1,"No"
"16440","GO_BP","492864_GO_0008611_ETHER_LIPID_BIOSYNTHETIC_PROCESS",5,0.5165,0.98,1,"Yes",0.9672,0.53,1,"Yes"
"16441","REACTOME","106164_REACT_11096_COPI_MEDIATED_TRANSPORT",11,0.5177,0.99,1,"Yes",1.2017,0.26,0.44,"Yes"
"16442","REACTOME","771597_REACT_160305_LOSS_OF_FUNCTION_OF_FBXW7_IN_CANCER_AND_NOTCH1_SIGNALING",5,0.518,0.98,1,"Yes",0.623,0.92,1,"Yes"
"16443","GO_BP","494879_GO_0010815_BRADYKININ_CATABOLIC_PROCESS",5,0.5188,0.97,1,"Yes",-0.6701,0.88,1,"No"
"16444","GO_BP","486915_GO_0000422_MITOCHONDRION_DEGRADATION",36,0.5201,1,1,"Yes",1.3048,0.1,0.66,"Yes"
"16445","GO_MF","503913_GO_0034713_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING",9,0.5206,0.99,1,"Yes",-0.7601,0.77,1,"No"
"16446","GO_BP","487868_GO_0001978_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CAROTID_SINUS_BARORECEPTOR_FEEDBACK",6,0.522,0.98,1,"Yes",-1.2781,0.21,0.89,"No"
"16447","WikiPathways","198890_WP186_HOMOLOGOUS_RECOMBINATION",14,0.5228,0.99,1,"Yes",0.6119,0.93,1,"Yes"
"16448","GO_BP","494218_GO_0010138_PYRIMIDINE_RIBONUCLEOTIDE_SALVAGE",5,0.5232,0.97,1,"Yes",-0.6951,0.85,1,"No"
"16449","GO_BP","752883_GO_0097384_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS",5,0.5236,0.98,1,"Yes",1.0033,0.45,0.98,"Yes"
"16450","GO_CC","501282_GO_0032045_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX",7,0.5243,0.98,1,"Yes",0.9993,0.46,0.79,"Yes"
"16451","C4_Cancer_modules","C4_CM_110_MODULE_115",27,0.5246,1,1,"Yes",2.2927,0,0,"Yes"
"16452","GO_BP","491831_GO_0006995_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION",19,0.5247,1,1,"Yes",0.8933,0.62,1,"Yes"
"16453","REACTOME","771596_REACT_160099_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER",5,0.5254,0.97,1,"Yes",0.6286,0.91,1,"Yes"
"16454","GO_BP","501497_GO_0032262_PYRIMIDINE_NUCLEOTIDE_SALVAGE",5,0.5265,0.99,1,"Yes",-0.6919,0.85,1,"No"
"16455","GO_BP","754463_GO_1901503_ETHER_BIOSYNTHETIC_PROCESS",5,0.5272,0.99,1,"Yes",0.9992,0.44,0.98,"Yes"
"16456","OMIM_gene","OMIM300205_EMOPAMIL_BINDING_PROTEIN_EBP",5,0.5275,0.97,0.97,"Yes",-0.5741,0.95,0.94,"No"
"16457","GO_BP","502816_GO_0033600_NEGATIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",5,0.5278,0.97,1,"Yes",0.7544,0.77,1,"Yes"
"16458","GO_MF","486580_GO_0000030_MANNOSYLTRANSFERASE_ACTIVITY",22,0.5293,1,1,"Yes",1.1359,0.28,0.75,"Yes"
"16459","GO_BP","508763_GO_0046504_GLYCEROL_ETHER_BIOSYNTHETIC_PROCESS",5,0.5312,0.97,1,"Yes",1.0002,0.45,0.98,"Yes"
"16460","GO_MF","518219_GO_0090079_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING",17,0.5319,0.99,1,"Yes",-1.0183,0.42,0.89,"No"
"16461","GO_BP","507214_GO_0044206_UMP_SALVAGE",5,0.5327,0.96,1,"Yes",-0.6927,0.84,1,"No"
"16462","C1_Positional","C1_ALL_82_CHR12P",5,0.533,0.97,0.99,"Yes",-1.4987,0.034,0.46,"No"
"16463","C2_Chemical_and_genetic_perturbations","C2_CGP_608_TURJANSKI_MAPK1_AND_MAPK2_TARGETS",12,0.5338,0.98,1,"Yes",-0.4537,1,1,"No"
"16464","KEGG_compound","C16633_5_FLUOROURIDINE",5,0.534,0.95,1,"Yes",-0.6915,0.83,1,"No"
"16465","OMIM_gene","OMIM605590_SPLICING_FACTOR_3B_SUBUNIT_1_SF3B1",5,0.5349,0.97,0.99,"Yes",-1.0787,0.4,0.9,"No"
"16466","GO_BP","519105_GO_2000465_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY",8,0.535,0.98,1,"Yes",-1.2087,0.23,0.88,"No"
"16467","GO_BP","515238_GO_0070305_RESPONSE_TO_CGMP",7,0.536,0.96,1,"Yes",-0.6528,0.87,1,"No"
"16468","C2_Chemical_and_genetic_perturbations","C2_CGP_1058_RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN",15,0.5361,0.99,1,"Yes",-0.8276,0.71,1,"No"
"16469","REACTOME","1183550_REACT_188323_CLEC7A_DECTIN_1_SIGNALING",100,0.5372,1,1,"Yes",1.72,0,0.041,"Yes"
"16470","GO_BP","517078_GO_0072162_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION",5,0.5376,0.98,1,"Yes",-1.5314,0.046,0.76,"No"
"16471","GO_CC","501172_GO_0031932_TORC2_COMPLEX",8,0.5392,0.99,1,"Yes",1.0567,0.4,0.71,"Yes"
"16472","GO_BP","868064_GO_1902402_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_DNA_DAMAGE_CHECKPOINT",68,0.5409,1,1,"Yes",1.6514,0,0.25,"Yes"
"16473","GO_BP","501579_GO_0032344_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS",6,0.5417,0.97,1,"Yes",0.9793,0.47,1,"Yes"
"16474","GO_MF","515558_GO_0070628_PROTEASOME_BINDING",10,0.5419,0.98,1,"Yes",1.5343,0.051,0.35,"Yes"
"16475","GO_BP","493354_GO_0009157_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",6,0.542,0.98,1,"Yes",0.9026,0.58,1,"Yes"
"16476","C4_Cancer_gene_neighborhoods","C4_CGN_145_MORF_PPP1CA",169,0.5425,1,1,"Yes",2.7316,0,0,"Yes"
"16477","OMIM_gene","OMIM612990_ADDITIONAL_SEX_COMBS_LIKE_1_ASXL1",5,0.543,0.96,1,"Yes",-1.0444,0.43,0.73,"No"
"16478","GO_BP","1039930_GO_1903376_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",7,0.543,0.98,1,"Yes",1.411,0.1,0.54,"Yes"
"16479","GO_BP","515863_GO_0070936_PROTEIN_K48_LINKED_UBIQUITINATION",45,0.544,1,1,"Yes",1.0147,0.43,0.97,"Yes"
"16480","GO_BP","506593_GO_0043562_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS",19,0.5446,0.99,1,"Yes",0.8739,0.62,1,"Yes"
"16481","REACTOME","645264_REACT_121061_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER",43,0.5446,1,1,"Yes",0.8205,0.8,0.99,"Yes"
"16482","GO_BP","513947_GO_0060391_POSITIVE_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS",11,0.5447,0.99,1,"Yes",-1.1378,0.3,0.93,"No"
"16483","OMIM_gene","OMIM612839_TET_ONCOGENE_FAMILY_MEMBER_2_TET2",5,0.5456,0.96,1,"Yes",-1.0897,0.35,1,"No"
"16484","GO_BP","504787_GO_0035608_PROTEIN_DEGLUTAMYLATION",6,0.5461,0.98,1,"Yes",-1.0245,0.42,0.97,"No"
"16485","C2_Chemical_and_genetic_perturbations","C2_CGP_705_GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION",14,0.5463,0.99,1,"Yes",-0.5455,0.98,1,"No"
"16486","C2_Chemical_and_genetic_perturbations","C2_CGP_634_SCHEIDEREIT_IKK_TARGETS",18,0.5477,0.99,1,"Yes",0.6005,0.96,1,"Yes"
"16487","GO_BP","501582_GO_0032347_REGULATION_OF_ALDOSTERONE_BIOSYNTHETIC_PROCESS",6,0.5489,0.97,1,"Yes",1.0132,0.45,0.97,"Yes"
"16488","GO_CC","989110_GO_0098651_BASEMENT_MEMBRANE_COLLAGEN_TRIMER",8,0.549,0.98,1,"Yes",0.8979,0.6,0.9,"Yes"
"16489","GO_BP","754787_GO_1901836_REGULATION_OF_TRANSCRIPTION_OF_NUCLEAR_LARGE_RRNA_TRANSCRIPT_FROM_RNA_POLYMERASE_I_PROMOTER",5,0.5497,0.95,1,"Yes",1.1084,0.37,0.89,"Yes"
"16490","OMIM_gene","OMIM605066_TYROSINE_3_MONOOXYGENASE_TRYPTOPHAN_5_MONOOXYGENASE_ACTIVATION_PROTEIN_EPSILON_ISOFORM_YWHAE",5,0.5498,0.96,1,"Yes",-1.0787,0.38,0.96,"No"
"16491","GO_BP","517329_GO_0072413_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_CELL_CYCLE_CHECKPOINT",68,0.5505,1,1,"Yes",1.6482,0.0021,0.24,"Yes"
"16492","GO_BP","502190_GO_0032968_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",14,0.5508,0.99,1,"Yes",1.3168,0.15,0.65,"Yes"
"16493","C2_Chemical_and_genetic_perturbations","C2_CGP_168_RODRIGUES_DCC_TARGETS_UP",5,0.5508,0.97,1,"Yes",0.5982,0.93,1,"Yes"
"16494","GO_BP","868065_GO_1902403_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_DNA_INTEGRITY_CHECKPOINT",68,0.5512,1,1,"Yes",1.6346,0.0021,0.25,"Yes"
"16495","GO_BP","517090_GO_0072174_METANEPHRIC_TUBULE_FORMATION",6,0.5516,0.95,1,"Yes",-1.3732,0.1,0.98,"No"
"16496","GO_MF","495523_GO_0015271_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",10,0.5518,0.98,1,"Yes",-0.9635,0.5,0.95,"No"
"16497","GO_CC","501171_GO_0031931_TORC1_COMPLEX",6,0.5528,0.97,1,"Yes",-1.271,0.21,0.66,"No"
"16498","C2_Chemical_and_genetic_perturbations","C2_CGP_2424_ALONSO_METASTASIS_EMT_DN",5,0.5539,0.95,1,"Yes",0.7901,0.72,1,"Yes"
"16499","KEGG_compound","C05544_PROTEIN_N6_METHYL_L_LYSINE",25,0.5543,1,1,"Yes",-1.4221,0.047,0.41,"No"
"16500","GO_BP","505256_GO_0042074_CELL_MIGRATION_INVOLVED_IN_GASTRULATION",12,0.5544,0.99,1,"Yes",-1.4198,0.11,0.94,"No"
"16501","OMIM_gene","OMIM100725_CHOLINERGIC_RECEPTOR_NICOTINIC_EPSILON_POLYPEPTIDE_CHRNE",5,0.5547,0.95,1,"Yes",-1.465,0.07,0.67,"No"
"16502","GO_MF","495308_GO_0015002_HEME_COPPER_TERMINAL_OXIDASE_ACTIVITY",21,0.5557,0.99,1,"Yes",2.0529,0,0.0082,"Yes"
"16503","GO_BP","512009_GO_0051095_REGULATION_OF_HELICASE_ACTIVITY",9,0.556,0.98,1,"Yes",1.3586,0.12,0.6,"Yes"
"16504","GO_BP","500343_GO_0031053_PRIMARY_MIRNA_PROCESSING",6,0.5562,0.97,1,"Yes",-0.6479,0.88,1,"No"
"16505","GO_CC","502721_GO_0033503_HULC_COMPLEX",5,0.5564,0.96,1,"Yes",1.1699,0.31,0.56,"Yes"
"16506","KEGG_pathway","HSA03015_MRNA_SURVEILLANCE_PATHWAY",86,0.5567,1,0.99,"Yes",0.9312,0.61,1,"Yes"
"16507","C2_Chemical_and_genetic_perturbations","C2_CGP_786_TERAMOTO_OPN_TARGETS_CLUSTER_5",7,0.557,0.97,1,"Yes",0.5305,0.98,1,"Yes"
"16508","REACTOME","160963_REACT_6341_MITOCHONDRIAL_UNCOUPLING_PROTEINS",5,0.5571,0.94,1,"Yes",-0.9545,0.53,1,"No"
"16509","GO_BP","948906_GO_1902751_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION",16,0.5575,0.99,1,"Yes",0.7638,0.79,1,"Yes"
"16510","C4_Cancer_gene_neighborhoods","C4_CGN_21_MORF_HDAC1",255,0.558,1,1,"Yes",2.4419,0,0,"Yes"
"16511","GO_BP","498498_GO_0019673_GDP_MANNOSE_METABOLIC_PROCESS",9,0.5584,0.97,1,"Yes",0.839,0.69,1,"Yes"
"16512","GO_BP","499350_GO_0022615_PROTEIN_TO_MEMBRANE_DOCKING",7,0.5586,0.96,1,"Yes",0.8549,0.66,1,"Yes"
"16513","GO_MF","500927_GO_0031681_G_PROTEIN_BETA_SUBUNIT_BINDING",9,0.5621,0.96,1,"Yes",1.3773,0.11,0.49,"Yes"
"16514","GO_BP","510331_GO_0048208_COPII_VESICLE_COATING",15,0.5629,0.97,1,"Yes",1.351,0.12,0.61,"Yes"
"16515","GO_MF","504221_GO_0035033_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY",5,0.5633,0.95,1,"Yes",-1.1524,0.31,0.8,"No"
"16516","REACTOME","160965_REACT_6196_THE_PROTON_BUFFERING_MODEL",5,0.5638,0.95,1,"Yes",-0.9488,0.52,1,"No"
"16517","KEGG_compound","C05546_PROTEIN_N6_N6_N6_TRIMETHYL_L_LYSINE",25,0.5638,0.99,1,"Yes",-1.4212,0.059,0.41,"No"
"16518","GO_BP","502098_GO_0032876_NEGATIVE_REGULATION_OF_DNA_ENDOREDUPLICATION",5,0.564,0.94,1,"Yes",0.7485,0.78,1,"Yes"
"16519","GO_BP","512821_GO_0051971_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE",5,0.5649,0.95,1,"Yes",-1.3421,0.16,0.92,"No"
"16520","KEGG_reaction","R03875_PROTEIN_LYSINE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_METHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE",25,0.5649,1,0.97,"Yes",-1.4268,0.067,0.26,"No"
"16521","GO_BP","517347_GO_0072431_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_G1_DNA_DAMAGE_CHECKPOINT",67,0.5652,1,1,"Yes",1.6802,0.0022,0.21,"Yes"
"16522","GO_BP","495036_GO_0010971_POSITIVE_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",16,0.5656,0.99,1,"Yes",0.7345,0.86,1,"Yes"
"16523","GO_MF","496607_GO_0016676_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",21,0.5663,0.99,1,"Yes",2.0303,0,0.0097,"Yes"
"16524","KEGG_compound","C03492_D_4_PHOSPHOPANTOTHENATE_R_4_PHOSPHOPANTOTHENATE",5,0.5712,0.97,1,"Yes",-0.8099,0.72,1,"No"
"16525","GO_MF","489593_GO_0004129_CYTOCHROME_C_OXIDASE_ACTIVITY",21,0.5716,0.98,1,"Yes",1.9999,0,0.013,"Yes"
"16526","GO_CC","496920_GO_0017119_GOLGI_TRANSPORT_COMPLEX",11,0.5722,0.97,1,"Yes",-0.7786,0.75,1,"No"
"16527","GO_BP","515315_GO_0070383_DNA_CYTOSINE_DEAMINATION",5,0.5723,0.95,1,"Yes",0.4635,0.99,1,"Yes"
"16528","GO_MF","515460_GO_0070530_K63_LINKED_POLYUBIQUITIN_BINDING",15,0.5727,0.98,1,"Yes",-1.178,0.25,0.78,"No"
"16529","GO_CC","507640_GO_0045275_RESPIRATORY_CHAIN_COMPLEX_III",6,0.5728,0.95,1,"Yes",1.3043,0.19,0.4,"Yes"
"16530","KEGG_reaction","R04867_S_ADENOSYL_L_METHIONINE_CYTOCHROME_C_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_N6_DIMETHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_PROTEIN_N6_N6_N6_TRIMETHYL_L_LYSINE",25,0.5731,0.99,0.98,"Yes",-1.433,0.059,0.26,"No"
"16531","KEGG_reaction","R04866_S_ADENOSYL_L_METHIONINE_CYTOCHROME_C_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_METHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_PROTEIN_N6_N6_DIMETHYL_L_LYSINE",25,0.5732,0.98,0.99,"Yes",-1.4196,0.053,0.25,"No"
"16532","GO_BP","510330_GO_0048207_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI",15,0.5735,0.98,1,"Yes",1.3585,0.13,0.6,"Yes"
"16533","C1_Positional","C1_ALL_71_CHR14Q13",26,0.5736,0.99,1,"Yes",0.9562,0.52,0.81,"Yes"
"16534","KEGG_enzyme","1.6.2.2_CYTOCHROME_B5_REDUCTASE_CYTOCHROME_B5_REDUCTASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_CYTOCHROME_B5_REDUCTASE_REDUCED_NICOTINAMIDE_ADENINEDINUCLEOTIDE_CYTOCHROME_B5_REDUCTASE_NADH_FERRICYTOCHROME_B5_OXIDOREDUCTASE_NADH_CYTOCHROME_B5_REDUCTASE_NADH_5ALPHA_REDUCTASE_NADH_CYTOCHROME_B5_REDUCTASE",5,0.574,0.94,0.95,"Yes",0.7395,0.78,1,"Yes"
"16535","GO_MF","512417_GO_0051539_4_IRON_4_SULFUR_CLUSTER_BINDING",38,0.5746,0.99,1,"Yes",1.0838,0.32,0.81,"Yes"
"16536","GO_CC","497913_GO_0019031_VIRAL_ENVELOPE",5,0.5747,0.95,1,"Yes",-1.1798,0.29,0.68,"No"
"16537","GO_CC","490784_GO_0005750_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III",6,0.5757,0.94,1,"Yes",1.3302,0.14,0.37,"Yes"
"16538","GO_BP","494636_GO_0010571_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION",5,0.5765,0.95,1,"Yes",-1.0633,0.41,0.96,"No"
"16539","GO_BP","519145_GO_2000505_REGULATION_OF_ENERGY_HOMEOSTASIS",11,0.5767,0.97,1,"Yes",1.4251,0.078,0.52,"Yes"
"16540","GO_BP","868062_GO_1902400_INTRACELLULAR_SIGNAL_TRANSDUCTION_INVOLVED_IN_G1_DNA_DAMAGE_CHECKPOINT",67,0.5769,1,1,"Yes",1.6739,0.0045,0.22,"Yes"
"16541","GO_CC","751255_GO_0036338_VIRAL_MEMBRANE",5,0.5774,0.97,1,"Yes",-1.1698,0.29,0.69,"No"
"16542","GO_BP","510322_GO_0048199_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI",28,0.578,0.99,1,"Yes",1.6298,0.017,0.26,"Yes"
"16543","REACTOME","105903_REACT_15550_INSULIN_PROCESSING",25,0.5789,0.98,1,"Yes",-0.7173,0.87,1,"No"
"16544","GO_MF","492494_GO_0008140_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING",11,0.5789,0.95,1,"Yes",-0.6647,0.88,1,"No"
"16545","REACTOME","160964_REACT_6258_THE_FATTY_ACID_CYCLING_MODEL",5,0.5792,0.95,1,"Yes",-0.9375,0.55,1,"No"
"16546","REACTOME","106511_REACT_11063_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX",81,0.5794,1,1,"Yes",1.9122,0,0.0072,"Yes"
"16547","REACTOME","730325_REACT_150188_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL",10,0.5804,0.96,1,"Yes",0.4676,1,1,"Yes"
"16548","GO_BP","1133954_GO_1903779_REGULATION_OF_CARDIAC_CONDUCTION",16,0.5812,0.98,1,"Yes",1.8468,0.0022,0.065,"Yes"
"16549","GO_BP","493253_GO_0009048_DOSAGE_COMPENSATION_BY_INACTIVATION_OF_X_CHROMOSOME",6,0.5812,0.95,1,"Yes",0.988,0.47,0.99,"Yes"
"16550","GO_CC","500210_GO_0030915_SMC5_SMC6_COMPLEX",7,0.5813,0.95,1,"Yes",1.2154,0.25,0.51,"Yes"
"16551","GO_MF","489869_GO_0004520_ENDODEOXYRIBONUCLEASE_ACTIVITY",45,0.5823,0.99,1,"Yes",1.134,0.26,0.75,"Yes"
"16552","KEGG_compound","C00079_L_PHENYLALANINE_S_ALPHA_AMINO_BETA_PHENYLPROPIONIC_ACID",10,0.5827,0.95,1,"Yes",0.842,0.65,1,"Yes"
"16553","KEGG_reaction","R00100_NADH_FERRICYTOCHROME_B5_OXIDOREDUCTASE_NADH_2_FERRICYTOCHROME_B5_NAD_2_FERROCYTOCHROME_B5_H_",5,0.5833,0.94,1,"Yes",0.7527,0.78,1,"Yes"
"16554","KEGG_module","HSA_M00154_CYTOCHROME_C_OXIDASE",18,0.5836,0.98,0.96,"Yes",1.9614,0.0021,0.007,"Yes"
"16555","C1_Positional","C1_ALL_131_CHRYQ11",14,0.5847,0.97,1,"Yes",0.867,0.62,0.89,"Yes"
"16556","GO_BP","491815_GO_0006977_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST",66,0.5851,1,1,"Yes",1.6607,0.0066,0.24,"Yes"
"16557","C2_Chemical_and_genetic_perturbations","C2_CGP_671_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7",7,0.5854,0.93,1,"Yes",0.9544,0.53,0.86,"Yes"
"16558","OMIM_gene","OMIM606406_NUCLEAR_PORE_COMPLEX_INTERACTING_PROTEIN_NPIP",7,0.5878,0.95,1,"Yes",-1.5414,0.034,1,"No"
"16559","KEGG_compound","C15602_QUINONE",6,0.5879,0.93,1,"Yes",1.2738,0.2,0.78,"Yes"
"16560","GO_BP","497959_GO_0019082_VIRAL_PROTEIN_PROCESSING",12,0.5883,0.95,1,"Yes",1.7783,0.0063,0.12,"Yes"
"16561","REACTOME","105823_REACT_1707_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX",11,0.5886,0.97,1,"Yes",0.8506,0.67,0.96,"Yes"
"16562","C2_Chemical_and_genetic_perturbations","C2_CGP_213_RUNNE_GENDER_EFFECT_UP",9,0.5894,0.94,1,"Yes",-0.7393,0.78,1,"No"
"16563","KEGG_compound","C01528_HYDROGEN_SELENIDE_SELENIDE",6,0.5894,0.94,1,"Yes",1.0395,0.42,1,"Yes"
"16564","GO_MF","490186_GO_0004889_ACETYLCHOLINE_ACTIVATED_CATION_SELECTIVE_CHANNEL_ACTIVITY",17,0.5894,0.96,1,"Yes",-1.9519,0.0019,0.18,"No"
"16565","C1_Positional","C1_ALL_200_CHR19Q12",12,0.5902,0.95,1,"Yes",1.1463,0.27,0.63,"Yes"
"16566","GO_BP","501563_GO_0032328_ALANINE_TRANSPORT",9,0.5908,0.94,1,"Yes",0.94,0.52,1,"Yes"
"16567","REACTOME","106171_REACT_847_UREA_CYCLE",9,0.5913,0.95,1,"Yes",-0.7027,0.86,1,"No"
"16568","C3_MicroRNA_targets","C3_MIR_168_AGCGCAG_MIR_191",13,0.5915,0.95,0.99,"Yes",1.0715,0.36,1,"Yes"
"16569","REACTOME","530766_REACT_115893_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS",11,0.5915,0.96,1,"Yes",1.6594,0.023,0.065,"Yes"
"16570","GO_MF","496606_GO_0016675_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS",23,0.5918,0.98,1,"Yes",2.0188,0,0.011,"Yes"
"16571","GO_BP","853113_GO_1902338_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS",6,0.5925,0.93,1,"Yes",1.3693,0.14,0.59,"Yes"
"16572","GO_BP","508774_GO_0046516_HYPUSINE_METABOLIC_PROCESS",5,0.5942,0.94,1,"Yes",1.1672,0.31,0.82,"Yes"
"16573","C4_Cancer_gene_neighborhoods","C4_CGN_106_MORF_G22P1",172,0.5947,1,1,"Yes",2.6099,0,0,"Yes"
"16574","GO_BP","496429_GO_0016446_SOMATIC_HYPERMUTATION_OF_IMMUNOGLOBULIN_GENES",11,0.595,0.96,1,"Yes",0.579,0.97,1,"Yes"
"16575","GO_CC","516905_GO_0071986_RAGULATOR_COMPLEX",6,0.5953,0.92,1,"Yes",1.3972,0.11,0.3,"Yes"
"16576","GO_MF","499381_GO_0022835_TRANSMITTER_GATED_CHANNEL_ACTIVITY",9,0.5961,0.95,1,"Yes",-1.3475,0.15,0.7,"No"
"16577","REACTOME","1127572_REACT_263857_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_F_BONT_F_",5,0.5965,0.92,1,"Yes",-1.0195,0.46,0.98,"No"
"16578","GO_BP","512819_GO_0051969_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE",10,0.5971,0.95,1,"Yes",-1.0035,0.47,0.99,"No"
"16579","GO_CC","517933_GO_0080008_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX",23,0.5979,0.99,1,"Yes",1.1013,0.31,0.64,"Yes"
"16580","GO_CC","487460_GO_0001520_OUTER_DENSE_FIBER",8,0.6005,0.93,1,"Yes",-1.7916,0.0038,0.21,"No"
"16581","C2_Chemical_and_genetic_perturbations","C2_CGP_493_SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN",17,0.6007,0.96,1,"Yes",-0.8228,0.7,1,"No"
"16582","GO_MF","511984_GO_0051059_NF_KAPPAB_BINDING",29,0.6007,0.98,1,"Yes",1.0085,0.44,0.87,"Yes"
"16583","GO_BP","511418_GO_0050435_BETA_AMYLOID_METABOLIC_PROCESS",13,0.6014,0.96,1,"Yes",1.0362,0.37,0.96,"Yes"
"16584","GO_CC","496943_GO_0017146_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX",11,0.6014,0.95,1,"Yes",0.9198,0.55,0.87,"Yes"
"16585","GO_BP","494971_GO_0010907_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS",32,0.6015,0.99,1,"Yes",0.5717,0.99,1,"Yes"
"16586","REACTOME","1127558_REACT_115860_SYNTHESIS_AND_PROCESSING_OF_GAG_GAGPOL_POLYPROTEINS",11,0.6027,0.95,1,"Yes",1.6356,0.023,0.076,"Yes"
"16587","C2_Chemical_and_genetic_perturbations","C2_CGP_624_SEIDEN_MET_SIGNALING",19,0.6034,0.97,1,"Yes",1.575,0.017,0.16,"Yes"
"16588","GO_MF","489401_GO_0003916_DNA_TOPOISOMERASE_ACTIVITY",6,0.6036,0.92,1,"Yes",0.7415,0.79,1,"Yes"
"16589","GO_BP","488083_GO_0002204_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENES_INVOLVED_IN_IMMUNE_RESPONSE",18,0.6037,0.96,1,"Yes",0.9731,0.49,1,"Yes"
"16590","GO_BP","518713_GO_2000064_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS",5,0.6038,0.91,1,"Yes",0.7839,0.76,1,"Yes"
"16591","C2_Chemical_and_genetic_perturbations","C2_CGP_2863_GUTIERREZ_MULTIPLE_MYELOMA_DN",35,0.6041,0.98,1,"Yes",2.0934,0,0.002,"Yes"
"16592","GO_BP","508334_GO_0046037_GMP_METABOLIC_PROCESS",9,0.6045,0.93,1,"Yes",-0.5273,0.98,1,"No"
"16593","REACTOME","1127571_REACT_263924_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D_",5,0.6053,0.91,1,"Yes",-1.026,0.44,0.98,"No"
"16594","GO_BP","503969_GO_0034770_HISTONE_H4_K20_METHYLATION",7,0.6073,0.93,1,"Yes",-0.8491,0.64,1,"No"
"16595","C2_Chemical_and_genetic_perturbations","C2_CGP_2957_VERRECCHIA_RESPONSE_TO_TGFB1_C6",5,0.6079,0.92,1,"Yes",0.6147,0.93,1,"Yes"
"16596","C2_Chemical_and_genetic_perturbations","C2_CGP_2313_JONES_TCOF1_TARGETS",5,0.6084,0.9,1,"Yes",1.1471,0.31,0.56,"Yes"
"16597","GO_BP","517338_GO_0072422_SIGNAL_TRANSDUCTION_INVOLVED_IN_DNA_DAMAGE_CHECKPOINT",70,0.6084,1,1,"Yes",1.6879,0,0.21,"Yes"
"16598","GO_BP","488087_GO_0002208_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS_INVOLVED_IN_IMMUNE_RESPONSE",18,0.6101,0.94,1,"Yes",0.9908,0.45,0.99,"Yes"
"16599","GO_BP","504789_GO_0035610_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION",5,0.6106,0.91,1,"Yes",-0.8094,0.69,1,"No"
"16600","GO_BP","512449_GO_0051571_POSITIVE_REGULATION_OF_HISTONE_H3_K4_METHYLATION",12,0.6107,0.94,1,"Yes",0.6167,0.93,1,"Yes"
"16601","C4_Cancer_gene_neighborhoods","C4_CGN_179_MORF_SS18",62,0.6112,1,1,"Yes",0.7107,0.95,1,"Yes"
"16602","GO_BP","507491_GO_0045091_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE",8,0.6113,0.94,1,"Yes",0.5375,0.97,1,"Yes"
"16603","GO_BP","493358_GO_0009162_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS",9,0.6118,0.94,1,"Yes",0.9807,0.49,1,"Yes"
"16604","GO_BP","517317_GO_0072401_SIGNAL_TRANSDUCTION_INVOLVED_IN_DNA_INTEGRITY_CHECKPOINT",70,0.6119,1,1,"Yes",1.68,0,0.21,"Yes"
"16605","C4_Cancer_modules","C4_CM_20_MODULE_21",10,0.6122,0.95,1,"Yes",0.6456,0.93,1,"Yes"
"16606","KEGG_compound","C15603_HYDROQUINONE_P_HYDROQUINONE_QUINOL_REDUCED_QUINONE",6,0.6125,0.91,1,"Yes",1.2713,0.18,0.77,"Yes"
"16607","GO_MF","486893_GO_0000400_FOUR_WAY_JUNCTION_DNA_BINDING",9,0.6132,0.95,1,"Yes",-0.8182,0.71,1,"No"
"16608","REACTOME","906027_REACT_169263_TGFBR1_KD_MUTANTS_IN_CANCER",7,0.6134,0.93,1,"Yes",-0.7415,0.77,1,"No"
"16609","GO_BP","515756_GO_0070828_HETEROCHROMATIN_ORGANIZATION",12,0.614,0.94,1,"Yes",0.7158,0.85,1,"Yes"
"16610","GO_BP","487636_GO_0001738_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM",23,0.6145,0.97,1,"Yes",1.2385,0.17,0.75,"Yes"
"16611","GO_CC","487637_GO_0001739_SEX_CHROMATIN",7,0.6146,0.92,1,"Yes",0.5307,0.98,1,"Yes"
"16612","GO_BP","500433_GO_0031146_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",21,0.6147,0.98,1,"Yes",0.6969,0.9,1,"Yes"
"16613","C2_Chemical_and_genetic_perturbations","C2_CGP_1881_DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4",11,0.6149,0.94,1,"Yes",-0.8659,0.62,1,"No"
"16614","GO_MF","498058_GO_0019203_CARBOHYDRATE_PHOSPHATASE_ACTIVITY",11,0.615,0.94,1,"Yes",1.1294,0.3,0.75,"Yes"
"16615","GO_BP","507572_GO_0045190_ISOTYPE_SWITCHING",18,0.6155,0.96,1,"Yes",0.9811,0.45,1,"Yes"
"16616","REACTOME","106089_REACT_6323_HOST_INTERACTIONS_WITH_INFLUENZA_FACTORS",5,0.6157,0.91,1,"Yes",-0.8163,0.68,1,"No"
"16617","C2_Chemical_and_genetic_perturbations","C2_CGP_777_KORKOLA_EMBRYONAL_CARCINOMA",13,0.6161,0.95,1,"Yes",0.8626,0.63,0.96,"Yes"
"16618","OMIM_gene","OMIM606186_CALCYCLIN_BINDING_PROTEIN_CACYBP",5,0.6161,0.9,1,"Yes",-0.6881,0.83,0.92,"No"
"16619","GO_MF","499688_GO_0030284_ESTROGEN_RECEPTOR_ACTIVITY",5,0.6166,0.9,1,"Yes",0.7875,0.73,1,"Yes"
"16620","OMIM_gene","OMIM602487_HEAT_RESPONSIVE_PROTEIN_12_HRSP12",5,0.6167,0.9,1,"Yes",0.6827,0.85,1,"Yes"
"16621","GO_BP","504430_GO_0035246_PEPTIDYL_ARGININE_N_METHYLATION",9,0.6172,0.9,1,"Yes",-0.7226,0.83,1,"No"
"16622","REACTOME","161028_REACT_22336_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",13,0.6183,0.93,1,"Yes",-1.7925,0.012,0.085,"No"
"16623","OMIM_gene","OMIM612409_RNA_BINDING_MOTIF_PROTEIN_14_RBM14",5,0.6183,0.9,1,"Yes",-0.6691,0.86,0.91,"No"
"16624","REACTOME","906025_REACT_169311_LOSS_OF_FUNCTION_OF_TGFBR1_IN_CANCER",7,0.6202,0.92,1,"Yes",-0.7486,0.78,1,"No"
"16625","GO_BP","502147_GO_0032925_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",21,0.6208,0.97,1,"Yes",-0.9134,0.56,1,"No"
"16626","GO_BP","502148_GO_0032926_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",9,0.6208,0.91,1,"Yes",-1.2825,0.17,0.89,"No"
"16627","GO_BP","487776_GO_0001880_MULLERIAN_DUCT_REGRESSION",5,0.6212,0.91,1,"Yes",-1.1986,0.29,0.9,"No"
"16628","GO_BP","516245_GO_0071321_CELLULAR_RESPONSE_TO_CGMP",6,0.6212,0.93,1,"Yes",-0.675,0.85,1,"No"
"16629","GO_CC","486932_GO_0000439_CORE_TFIIH_COMPLEX",8,0.6214,0.9,1,"Yes",1.3024,0.16,0.4,"Yes"
"16630","GO_BP","517092_GO_0072176_NEPHRIC_DUCT_DEVELOPMENT",12,0.6217,0.94,1,"Yes",-0.818,0.7,1,"No"
"16631","GO_BP","512822_GO_0051972_REGULATION_OF_TELOMERASE_ACTIVITY",14,0.6219,0.95,1,"Yes",0.5393,0.99,1,"Yes"
"16632","KEGG_pathway","HSA04120_UBIQUITIN_MEDIATED_PROTEOLYSIS",137,0.6225,1,1,"Yes",0.9463,0.58,0.99,"Yes"
"16633","C2_Chemical_and_genetic_perturbations","C2_CGP_2019_YANG_MUC2_TARGETS_COLON_3MO_DN",5,0.6228,0.91,1,"Yes",-0.5192,0.97,1,"No"
"16634","REACTOME","161022_REACT_21314_RELAXIN_RECEPTORS",7,0.623,0.91,1,"Yes",-1.1481,0.29,0.86,"No"
"16635","KEGG_reaction","R00191_ADENOSINE_3_5_PHOSPHATE_5_NUCLEOTIDOHYDROLASE_3_5_CYCLIC_AMP_H2O_AMP",16,0.6238,0.96,0.99,"Yes",-1.0654,0.38,0.71,"No"
"16636","REACTOME","106103_REACT_705_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS",7,0.624,0.91,1,"Yes",1.0603,0.4,0.65,"Yes"
"16637","GO_BP","511417_GO_0050434_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION",57,0.6248,0.98,1,"Yes",1.4442,0.015,0.5,"Yes"
"16638","GO_BP","750914_GO_0035989_TENDON_DEVELOPMENT",6,0.6249,0.91,1,"Yes",-1.7826,0.0039,0.47,"No"
"16639","GO_BP","519020_GO_2000380_REGULATION_OF_MESODERM_DEVELOPMENT",13,0.626,0.93,1,"Yes",0.7868,0.76,1,"Yes"
"16640","GO_BP","518634_GO_0097084_VASCULAR_SMOOTH_MUSCLE_CELL_DEVELOPMENT",6,0.6261,0.91,1,"Yes",0.5939,0.94,1,"Yes"
"16641","C2_Chemical_and_genetic_perturbations","C2_CGP_2887_DANG_REGULATED_BY_MYC_UP",70,0.6263,1,1,"Yes",-0.73,0.92,1,"No"
"16642","GO_BP","516084_GO_0071158_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST",86,0.6266,1,1,"Yes",1.5918,0.0022,0.3,"Yes"
"16643","GO_BP","1129616_GO_1990542_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT",44,0.6271,0.99,1,"Yes",1.9539,0,0.021,"Yes"
"16644","GO_BP","487720_GO_0001824_BLASTOCYST_DEVELOPMENT",68,0.6277,1,1,"Yes",1.0221,0.39,0.97,"Yes"
"16645","GO_BP","508745_GO_0046485_ETHER_LIPID_METABOLIC_PROCESS",8,0.6278,0.93,1,"Yes",0.8564,0.62,1,"Yes"
"16646","C2_Chemical_and_genetic_perturbations","C2_CGP_1036_CAFFAREL_RESPONSE_TO_THC_24HR_3_UP",7,0.6287,0.92,1,"Yes",1.2709,0.21,0.42,"Yes"
"16647","C2_Chemical_and_genetic_perturbations","C2_CGP_1327_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP",10,0.6288,0.93,1,"Yes",1.5071,0.07,0.21,"Yes"
"16648","C2_Chemical_and_genetic_perturbations","C2_CGP_1687_GEISS_RESPONSE_TO_DSRNA_DN",16,0.6289,0.93,1,"Yes",1.0657,0.34,0.68,"Yes"
"16649","GO_BP","751319_GO_0038061_NIK_NF_KAPPAB_SIGNALING",31,0.6292,0.98,1,"Yes",1.196,0.2,0.79,"Yes"
"16650","REACTOME","645292_REACT_120850_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS",32,0.6295,0.98,1,"Yes",1.3135,0.13,0.31,"Yes"
"16651","KEGG_reaction","R06075_GDP_L_FUCOSE_SIALYL_3_PARAGLOBOSIDE_GDP_IV3NEUAC_III3FUC_NLC4CER",5,0.6301,0.92,1,"Yes",-0.6926,0.82,1,"No"
"16652","GO_BP","487777_GO_0001881_RECEPTOR_RECYCLING",8,0.6309,0.92,1,"Yes",0.6654,0.88,1,"Yes"
"16653","GO_MF","754434_GO_1901474_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,0.6311,0.91,1,"Yes",0.5139,0.97,1,"Yes"
"16654","GO_MF","496334_GO_0016274_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY",9,0.6312,0.92,1,"Yes",-0.7196,0.82,1,"No"
"16655","GO_BP","496522_GO_0016574_HISTONE_UBIQUITINATION",36,0.6316,0.99,1,"Yes",0.7909,0.82,1,"Yes"
"16656","KEGG_module","HSA_M00290_HOLO_TFIIH_COMPLEX",11,0.6318,0.92,0.94,"Yes",1.1799,0.25,0.55,"Yes"
"16657","C2_Chemical_and_genetic_perturbations","C2_CGP_2008_LI_CYTIDINE_ANALOGS_CYCTOTOXICITY",15,0.6319,0.96,1,"Yes",1.1456,0.27,0.56,"Yes"
"16658","C4_Cancer_gene_neighborhoods","C4_CGN_11_MORF_CTBP1",169,0.632,1,1,"Yes",2.3985,0,0,"Yes"
"16659","GO_BP","504692_GO_0035511_OXIDATIVE_DNA_DEMETHYLATION",7,0.6322,0.91,1,"Yes",0.927,0.53,1,"Yes"
"16660","GO_BP","751438_GO_0039531_REGULATION_OF_VIRAL_INDUCED_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY",11,0.6331,0.94,1,"Yes",1.0885,0.36,0.92,"Yes"
"16661","C2_Chemical_and_genetic_perturbations","C2_CGP_148_LAIHO_COLORECTAL_CANCER_SERRATED_DN",84,0.6339,1,1,"Yes",-1.1536,0.22,0.85,"No"
"16662","GO_MF","496333_GO_0016273_ARGININE_N_METHYLTRANSFERASE_ACTIVITY",9,0.6339,0.91,1,"Yes",-0.7218,0.82,1,"No"
"16663","GO_MF","489820_GO_0004468_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR",5,0.634,0.88,1,"Yes",-1.2162,0.25,0.83,"No"
"16664","REACTOME","106161_REACT_11203_ER_TO_GOLGI_TRANSPORT",9,0.635,0.93,1,"Yes",0.6703,0.89,1,"Yes"
"16665","GO_BP","868044_GO_0044803_MULTI_ORGANISM_MEMBRANE_ORGANIZATION",19,0.6357,0.94,1,"Yes",1.2302,0.19,0.75,"Yes"
"16666","GO_BP","491969_GO_0007164_ESTABLISHMENT_OF_TISSUE_POLARITY",15,0.636,0.94,1,"Yes",1.0838,0.36,0.92,"Yes"
"16667","GO_BP","868045_GO_0044804_NUCLEOPHAGY",25,0.6368,0.96,1,"Yes",1.1694,0.22,0.81,"Yes"
"16668","WikiPathways","755437_WP2113_TYPE_III_INTERFERON_SIGNALING",10,0.6371,0.92,1,"Yes",-0.5556,0.97,1,"No"
"16669","GO_BP","503704_GO_0034502_PROTEIN_LOCALIZATION_TO_CHROMOSOME",31,0.6378,0.98,1,"Yes",1.0766,0.34,0.93,"Yes"
"16670","REACTOME","105921_REACT_6305_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_",96,0.6381,1,1,"Yes",2.7197,0,0,"Yes"
"16671","GO_MF","506212_GO_0043139_5_3_DNA_HELICASE_ACTIVITY",7,0.6384,0.89,1,"Yes",0.5532,0.96,1,"Yes"
"16672","GO_BP","514519_GO_0060964_REGULATION_OF_GENE_SILENCING_BY_MIRNA",9,0.6397,0.93,1,"Yes",-1.2477,0.21,0.91,"No"
"16673","OMIM_gene","OMIM172480_PHOSPHOSERINE_PHOSPHATASE_PSPH",5,0.64,0.88,1,"Yes",0.6918,0.86,1,"Yes"
"16674","GO_BP","487034_GO_0000737_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC",59,0.6402,0.99,1,"Yes",1.1724,0.19,0.81,"Yes"
"16675","REACTOME","106535_REACT_15461_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS",15,0.6403,0.95,1,"Yes",-1.8224,0.0042,0.071,"No"
"16676","GO_MF","487122_GO_0000832_INOSITOL_HEXAKISPHOSPHATE_5_KINASE_ACTIVITY",5,0.6407,0.89,1,"Yes",-0.4693,1,1,"No"
"16677","C2_Chemical_and_genetic_perturbations","C2_CGP_1210_NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON",21,0.6413,0.95,1,"Yes",0.646,0.96,1,"Yes"
"16678","REACTOME","106162_REACT_12507_COPII_COAT_PROTEIN_2_MEDIATED_VESICLE_TRANSPORT",9,0.6418,0.9,1,"Yes",0.6775,0.87,1,"Yes"
"16679","C3_TF_targets","C3_TFT_424_V_YY1_Q6",246,0.642,1,0.99,"Yes",1.0434,0.33,1,"Yes"
"16680","GO_BP","495316_GO_0015015_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION",5,0.6426,0.89,1,"Yes",1.5919,0.022,0.31,"Yes"
"16681","C4_Cancer_gene_neighborhoods","C4_CGN_97_MORF_ERH",115,0.644,1,1,"Yes",2.6514,0,0,"Yes"
"16682","GO_MF","507510_GO_0045118_AZOLE_TRANSPORTER_ACTIVITY",6,0.6448,0.9,1,"Yes",0.5071,0.98,1,"Yes"
"16683","GO_BP","512462_GO_0051584_REGULATION_OF_DOPAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION",9,0.6451,0.89,1,"Yes",1.0213,0.43,0.97,"Yes"
"16684","GO_MF","492519_GO_0008171_O_METHYLTRANSFERASE_ACTIVITY",16,0.6452,0.93,1,"Yes",1.136,0.29,0.75,"Yes"
"16685","KEGG_enzyme","2.7.4.21_INOSITOL_HEXAKISPHOSPHATE_KINASE_ATP_1D_MYO_INOSITOL_HEXAKISPHOSPHATE_PHOSPHOTRANSFERASE_IP6K",5,0.6453,0.88,0.97,"Yes",-0.4594,0.99,0.99,"No"
"16686","C2_Chemical_and_genetic_perturbations","C2_CGP_2473_BOYLAN_MULTIPLE_MYELOMA_C_UP",47,0.6453,0.99,1,"Yes",1.1383,0.23,0.57,"Yes"
"16687","GO_BP","518293_GO_0090153_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS",7,0.6458,0.89,1,"Yes",-0.7515,0.78,1,"No"
"16688","GO_BP","503700_GO_0034498_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT",10,0.6459,0.93,1,"Yes",1.0978,0.34,0.9,"Yes"
"16689","C4_Cancer_modules","C4_CM_52_MODULE_56",12,0.6468,0.92,1,"Yes",0.9622,0.5,0.76,"Yes"
"16690","GO_BP","493410_GO_0009214_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS",17,0.6474,0.94,1,"Yes",-1.1073,0.31,0.94,"No"
"16691","GO_CC","515461_GO_0070531_BRCA1_A_COMPLEX",7,0.6475,0.89,1,"Yes",1.1637,0.28,0.57,"Yes"
"16692","GO_BP","1039917_GO_1903363_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS",74,0.6482,1,1,"Yes",1.1899,0.15,0.79,"Yes"
"16693","GO_BP","494890_GO_0010826_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION",10,0.6487,0.89,1,"Yes",1.0746,0.35,0.93,"Yes"
"16694","GO_BP","500324_GO_0031034_MYOSIN_FILAMENT_ASSEMBLY",5,0.6488,0.88,1,"Yes",-1.5468,0.032,0.75,"No"
"16695","REACTOME","161029_REACT_22352_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS",10,0.649,0.89,1,"Yes",-1.7809,0.0058,0.091,"No"
"16696","REACTOME","161027_REACT_22126_ACTIVATION_OF_NICOTINIC_ACETYLCHOLINE_RECEPTORS",15,0.6491,0.92,1,"Yes",-1.8715,0.006,0.058,"No"
"16697","GO_BP","514702_GO_0061157_MRNA_DESTABILIZATION",7,0.6492,0.89,1,"Yes",0.6467,0.9,1,"Yes"
"16698","GO_MF","515498_GO_0070568_GUANYLYLTRANSFERASE_ACTIVITY",5,0.6495,0.89,1,"Yes",0.6888,0.84,1,"Yes"
"16699","GO_CC","911279_GO_0036452_ESCRT_COMPLEX",21,0.6497,0.95,1,"Yes",1.4161,0.072,0.28,"Yes"
"16700","C2_Chemical_and_genetic_perturbations","C2_CGP_3171_VANDESLUIS_NORMAL_EMBRYOS_UP",5,0.6502,0.9,1,"Yes",1.2894,0.21,0.4,"Yes"
"16701","GO_CC","501626_GO_0032391_PHOTORECEPTOR_CONNECTING_CILIUM",31,0.6505,0.98,1,"Yes",-0.7628,0.85,1,"No"
"16702","GO_CC","983672_GO_0090568_NUCLEAR_TRANSCRIPTIONAL_REPRESSOR_COMPLEX",20,0.6507,0.93,1,"Yes",-0.7069,0.87,1,"No"
"16703","GO_CC","496547_GO_0016605_PML_BODY",92,0.6513,1,1,"Yes",1.198,0.14,0.53,"Yes"
"16704","GO_BP","511852_GO_0050917_SENSORY_PERCEPTION_OF_UMAMI_TASTE",6,0.6514,0.9,1,"Yes",-1.3289,0.16,0.89,"No"
"16705","GO_BP","494579_GO_0010510_REGULATION_OF_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE",12,0.6518,0.92,1,"Yes",1.2166,0.21,0.77,"Yes"
"16706","GO_BP","753211_GO_1900221_REGULATION_OF_BETA_AMYLOID_CLEARANCE",6,0.6518,0.9,1,"Yes",-1.0675,0.4,0.96,"No"
"16707","REACTOME","833808_REACT_163812_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1_",5,0.652,0.89,1,"Yes",1.6231,0.018,0.083,"Yes"
"16708","GO_BP","512790_GO_0051940_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION",9,0.6537,0.88,1,"Yes",1.0067,0.45,0.98,"Yes"
"16709","GO_BP","514187_GO_0060632_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT",15,0.6538,0.94,1,"Yes",0.7712,0.77,1,"Yes"
"16710","GO_MF","487118_GO_0000828_INOSITOL_HEXAKISPHOSPHATE_KINASE_ACTIVITY",5,0.654,0.86,1,"Yes",-0.4559,0.99,1,"No"
"16711","GO_BP","513946_GO_0060390_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS",14,0.6541,0.94,1,"Yes",-1.0521,0.38,0.97,"No"
"16712","GO_MF","751938_GO_0052723_INOSITOL_HEXAKISPHOSPHATE_1_KINASE_ACTIVITY",5,0.6547,0.85,1,"Yes",-0.4614,1,1,"No"
"16713","GO_BP","982452_GO_1902884_POSITIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS",10,0.6549,0.91,1,"Yes",0.9828,0.48,1,"Yes"
"16714","GO_BP","500323_GO_0031033_MYOSIN_FILAMENT_ORGANIZATION",5,0.6568,0.87,1,"Yes",-1.5066,0.046,0.82,"No"
"16715","REACTOME","771586_REACT_160083_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION_",6,0.657,0.89,1,"Yes",1.2582,0.19,0.37,"Yes"
"16716","C3_MicroRNA_targets","C3_MIR_90_TCTAGAG_MIR_517",45,0.6581,0.97,1,"Yes",0.8131,0.8,1,"Yes"
"16717","GO_BP","499171_GO_0021892_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION",8,0.6582,0.91,1,"Yes",-1.5315,0.05,0.77,"No"
"16718","REACTOME","161032_REACT_22303_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",12,0.6588,0.91,1,"Yes",-1.747,0.0058,0.12,"No"
"16719","REACTOME","105740_REACT_2254_G1_S_DNA_DAMAGE_CHECKPOINTS",60,0.659,0.96,1,"Yes",1.804,0,0.02,"Yes"
"16720","GO_BP","503924_GO_0034724_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION",53,0.6592,0.99,1,"Yes",-0.9086,0.62,1,"No"
"16721","GO_MF","492779_GO_0008499_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY",7,0.6594,0.88,1,"Yes",1.3787,0.13,0.49,"Yes"
"16722","GO_MF","751939_GO_0052724_INOSITOL_HEXAKISPHOSPHATE_3_KINASE_ACTIVITY",5,0.6597,0.85,1,"Yes",-0.4566,1,1,"No"
"16723","OMIM_gene","OMIM604061_SEPTIN_9_SEPT9",5,0.6601,0.86,1,"Yes",-0.8102,0.68,1,"No"
"16724","REACTOME","106366_REACT_16968_DOPAMINE_RECEPTORS",5,0.6604,0.86,1,"Yes",1.2165,0.28,0.43,"Yes"
"16725","C3_TF_targets","C3_TFT_520_TCCCRNNRTGC_UNKNOWN",211,0.6609,1,1,"Yes",0.9775,0.52,1,"Yes"
"16726","GO_BP","508069_GO_0045725_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS",14,0.661,0.9,1,"Yes",-0.6062,0.95,1,"No"
"16727","GO_BP","502354_GO_0033133_POSITIVE_REGULATION_OF_GLUCOKINASE_ACTIVITY",5,0.6617,0.89,1,"Yes",1.0112,0.46,0.98,"Yes"
"16728","REACTOME","105770_REACT_1574_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION",65,0.6626,1,1,"Yes",2.1437,0,0.00036,"Yes"
"16729","GO_BP","504431_GO_0035247_PEPTIDYL_ARGININE_OMEGA_N_METHYLATION",8,0.6632,0.91,1,"Yes",-0.7575,0.78,1,"No"
"16730","GO_BP","849955_GO_1902254_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR",16,0.6637,0.91,1,"Yes",-0.7342,0.83,1,"No"
"16731","GO_MF","496337_GO_0016278_LYSINE_N_METHYLTRANSFERASE_ACTIVITY",47,0.664,0.99,1,"Yes",-1.0603,0.34,0.86,"No"
"16732","REACTOME","730313_REACT_150266_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION",11,0.664,0.9,1,"Yes",1.2226,0.23,0.42,"Yes"
"16733","REACTOME","105863_REACT_1587_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS",17,0.6642,0.93,1,"Yes",-0.7045,0.87,1,"No"
"16734","C4_Cancer_gene_neighborhoods","C4_CGN_34_MORF_RAD21",182,0.6643,1,1,"Yes",2.3566,0,0,"Yes"
"16735","GO_BP","487614_GO_0001711_ENDODERMAL_CELL_FATE_COMMITMENT",13,0.6653,0.9,1,"Yes",0.7483,0.81,1,"Yes"
"16736","GO_BP","495991_GO_0015867_ATP_TRANSPORT",6,0.6659,0.87,1,"Yes",0.8535,0.66,1,"Yes"
"16737","OMIM_gene","OMIM606382_MEMBRANE_ASSOCIATED_GUANYLATE_KINASE_WW_AND_PDZ_DOMAINS_CONTAINING_2_MAGI2",6,0.6666,0.87,1,"Yes",0.6311,0.9,1,"Yes"
"16738","GO_BP","753393_GO_1900409_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",10,0.6668,0.92,1,"Yes",1.0131,0.43,0.97,"Yes"
"16739","REACTOME","105862_REACT_1874_HOMOLOGOUS_RECOMBINATION_REPAIR",17,0.6669,0.93,1,"Yes",-0.7085,0.88,1,"No"
"16740","KEGG_compound","C00330_DEOXYGUANOSINE_2_DEOXYGUANOSINE",11,0.6672,0.91,1,"Yes",0.8788,0.6,1,"Yes"
"16741","C1_Positional","C1_ALL_172_CHR11P",5,0.6673,0.87,0.99,"Yes",1.5934,0.016,0.23,"Yes"
"16742","GO_BP","497177_GO_0018206_PEPTIDYL_METHIONINE_MODIFICATION",10,0.6675,0.89,1,"Yes",1.0983,0.34,0.91,"Yes"
"16743","C4_Cancer_gene_neighborhoods","C4_CGN_44_MORF_RRM1",102,0.6676,1,1,"Yes",1.8426,0,0.0014,"Yes"
"16744","C2_Chemical_and_genetic_perturbations","C2_CGP_3356_HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN",25,0.668,0.94,1,"Yes",1.6302,0.019,0.12,"Yes"
"16745","KEGG_compound","C00299_URIDINE",15,0.668,0.92,1,"Yes",0.5409,0.99,1,"Yes"
"16746","GO_CC","500382_GO_0031095_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE",9,0.6681,0.9,1,"Yes",-1.2574,0.19,0.67,"No"
"16747","GO_BP","912528_GO_0044819_MITOTIC_G1_S_TRANSITION_CHECKPOINT",77,0.6683,1,1,"Yes",1.6106,0.011,0.28,"Yes"
"16748","C4_Cancer_gene_neighborhoods","C4_CGN_12_MORF_CCNF",78,0.6684,1,1,"Yes",0.8927,0.67,0.84,"Yes"
"16749","GO_BP","508860_GO_0046606_NEGATIVE_REGULATION_OF_CENTROSOME_CYCLE",10,0.6687,0.89,1,"Yes",1.0727,0.37,0.93,"Yes"
"16750","GO_MF","489774_GO_0004415_HYALURONONGLUCOSAMINIDASE_ACTIVITY",8,0.6687,0.88,1,"Yes",0.6816,0.87,1,"Yes"
"16751","GO_CC","490749_GO_0005697_TELOMERASE_HOLOENZYME_COMPLEX",6,0.6687,0.86,1,"Yes",-0.688,0.83,1,"No"
"16752","GO_BP","755127_GO_2001021_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS",45,0.6689,0.98,1,"Yes",1.1754,0.21,0.81,"Yes"
"16753","GO_BP","1051070_GO_1903430_NEGATIVE_REGULATION_OF_CELL_MATURATION",7,0.6694,0.88,1,"Yes",0.9639,0.5,1,"Yes"
"16754","GO_BP","849925_GO_1902224_KETONE_BODY_METABOLIC_PROCESS",9,0.6697,0.89,1,"Yes",1.2019,0.25,0.78,"Yes"
"16755","GO_MF","500843_GO_0031593_POLYUBIQUITIN_BINDING",36,0.6698,0.94,1,"Yes",-0.935,0.56,0.96,"No"
"16756","GO_MF","496556_GO_0016615_MALATE_DEHYDROGENASE_ACTIVITY",7,0.6699,0.86,1,"Yes",1.2267,0.21,0.7,"Yes"
"16757","GO_BP","519378_GO_2000739_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION",6,0.6699,0.86,1,"Yes",0.8544,0.65,1,"Yes"
"16758","C2_Chemical_and_genetic_perturbations","C2_CGP_2362_GRATIAS_RETINOBLASTOMA_16Q24",17,0.6706,0.91,1,"Yes",1.0468,0.4,0.72,"Yes"
"16759","GO_BP","503288_GO_0034080_CENP_A_CONTAINING_NUCLEOSOME_ASSEMBLY",42,0.6707,0.97,1,"Yes",-0.9525,0.53,1,"No"
"16760","REACTOME","1127496_REACT_264544_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION",10,0.6708,0.89,1,"Yes",0.847,0.63,0.96,"Yes"
"16761","GO_CC","487156_GO_0000932_CYTOPLASMIC_MRNA_PROCESSING_BODY",62,0.6709,1,1,"Yes",0.7692,0.92,0.97,"Yes"
"16762","GO_MF","492579_GO_0008252_NUCLEOTIDASE_ACTIVITY",15,0.6712,0.91,1,"Yes",0.5383,0.98,1,"Yes"
"16763","GO_BP","1039895_GO_0061641_CENP_A_CONTAINING_CHROMATIN_ORGANIZATION",42,0.6714,0.96,1,"Yes",-0.9588,0.52,1,"No"
"16764","GO_BP","514524_GO_0060969_NEGATIVE_REGULATION_OF_GENE_SILENCING",15,0.6718,0.91,1,"Yes",0.5982,0.95,1,"Yes"
"16765","GO_BP","493385_GO_0009189_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",5,0.6719,0.84,1,"Yes",0.9428,0.52,1,"Yes"
"16766","GO_CC","490763_GO_0005721_PERICENTRIC_HETEROCHROMATIN",14,0.672,0.91,1,"Yes",0.5157,0.99,1,"Yes"
"16767","GO_BP","491280_GO_0006336_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ASSEMBLY",53,0.6723,0.98,1,"Yes",-0.8969,0.68,1,"No"
"16768","C4_Cancer_gene_neighborhoods","C4_CGN_286_GNF2_BUB3",28,0.6723,0.94,1,"Yes",1.8394,0.0022,0.0015,"Yes"
"16769","GO_MF","496338_GO_0016279_PROTEIN_LYSINE_N_METHYLTRANSFERASE_ACTIVITY",47,0.6723,0.96,1,"Yes",-1.0763,0.32,0.86,"No"
"16770","GO_MF","492755_GO_0008469_HISTONE_ARGININE_N_METHYLTRANSFERASE_ACTIVITY",8,0.6727,0.88,1,"Yes",-0.7587,0.78,1,"No"
"16771","C3_TF_targets","C3_TFT_488_GGGNRMNNYCAT_UNKNOWN",79,0.6731,1,1,"Yes",0.9214,0.61,1,"Yes"
"16772","GO_MF","498066_GO_0019211_PHOSPHATASE_ACTIVATOR_ACTIVITY",11,0.6733,0.88,1,"Yes",1.4485,0.064,0.43,"Yes"
"16773","C4_Cancer_modules","C4_CM_24_MODULE_25",13,0.6734,0.91,1,"Yes",1.9301,0,0.0064,"Yes"
"16774","OMIM_gene","OMIM609205_DAB2_INTERACTING_PROTEIN_DAB2IP",6,0.6744,0.87,1,"Yes",0.6518,0.88,1,"Yes"
"16775","REACTOME","161031_REACT_22149_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",15,0.6746,0.91,1,"Yes",-1.8389,0.0061,0.067,"No"
"16776","GO_BP","494293_GO_0010216_MAINTENANCE_OF_DNA_METHYLATION",5,0.6753,0.84,1,"Yes",-0.7721,0.72,1,"No"
"16777","GO_CC","515401_GO_0070469_RESPIRATORY_CHAIN",69,0.6755,0.99,1,"Yes",2.6263,0,0,"Yes"
"16778","REACTOME","105783_REACT_9029_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY",66,0.6761,0.99,1,"Yes",2.1546,0,0.00026,"Yes"
"16779","GO_BP","1026073_GO_1903301_POSITIVE_REGULATION_OF_HEXOKINASE_ACTIVITY",5,0.6761,0.84,1,"Yes",1.0219,0.44,0.97,"Yes"
"16780","C2_Chemical_and_genetic_perturbations","C2_CGP_1087_RICKMAN_HEAD_AND_NECK_CANCER_B",43,0.6764,0.96,1,"Yes",1.0204,0.41,0.77,"Yes"
"16781","C2_Chemical_and_genetic_perturbations","C2_CGP_1807_IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM",31,0.6764,0.95,1,"Yes",1.1365,0.24,0.57,"Yes"
"16782","GO_BP","500552_GO_0031293_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS",17,0.6764,0.94,1,"Yes",0.7678,0.82,1,"Yes"
"16783","GO_BP","492254_GO_0007501_MESODERMAL_CELL_FATE_SPECIFICATION",6,0.6765,0.84,1,"Yes",1.5108,0.058,0.39,"Yes"
"16784","GO_BP","491619_GO_0006734_NADH_METABOLIC_PROCESS",9,0.6767,0.87,1,"Yes",0.7776,0.76,1,"Yes"
"16785","OMIM_gene","OMIM606235_THIOREDOXIN_REDUCTASE_3_TXNRD3",6,0.6775,0.87,1,"Yes",0.6658,0.87,1,"Yes"
"16786","GO_CC","516465_GO_0071541_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M",7,0.6777,0.88,1,"Yes",1.931,0,0.0071,"Yes"
"16787","C2_Chemical_and_genetic_perturbations","C2_CGP_1123_STARK_HYPPOCAMPUS_22Q11_DELETION_DN",19,0.6785,0.92,1,"Yes",-0.5528,0.98,1,"No"
"16788","GO_MF","489465_GO_0003993_ACID_PHOSPHATASE_ACTIVITY",11,0.6795,0.87,1,"Yes",1.379,0.11,0.49,"Yes"
"16789","WikiPathways","198787_WP78_TCA_CYCLE",17,0.6816,0.89,1,"Yes",1.676,0.014,0.11,"Yes"
"16790","GO_MF","492580_GO_0008253_5_NUCLEOTIDASE_ACTIVITY",13,0.6818,0.89,1,"Yes",0.5188,0.99,1,"Yes"
"16791","GO_BP","518469_GO_0090329_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION",35,0.6818,0.95,1,"Yes",0.7151,0.91,1,"Yes"
"16792","GO_MF","495391_GO_0015116_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,0.6819,0.88,1,"Yes",1.144,0.29,0.76,"Yes"
"16793","C2_Chemical_and_genetic_perturbations","C2_CGP_2998_HOFFMAN_CLOCK_TARGETS_DN",10,0.682,0.86,1,"Yes",1.4733,0.07,0.23,"Yes"
"16794","GO_BP","512458_GO_0051580_REGULATION_OF_NEUROTRANSMITTER_UPTAKE",13,0.6824,0.89,1,"Yes",-1.2239,0.21,0.88,"No"
"16795","REACTOME","105881_REACT_1022_NONHOMOLOGOUS_END_JOINING_NHEJ_",6,0.6826,0.87,1,"Yes",1.2461,0.2,0.4,"Yes"
"16796","KEGG_module","HSA_M00382_SCF_FBS_COMPLEX",5,0.6826,0.81,0.91,"Yes",0.8532,0.65,0.92,"Yes"
"16797","GO_BP","518452_GO_0090312_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION",17,0.6829,0.92,1,"Yes",-1.1521,0.29,0.92,"No"
"16798","GO_BP","491086_GO_0006108_MALATE_METABOLIC_PROCESS",7,0.683,0.87,1,"Yes",1.2113,0.24,0.78,"Yes"
"16799","GO_MF","497010_GO_0018024_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY",40,0.6833,0.96,1,"Yes",-0.9579,0.5,0.95,"No"
"16800","REACTOME","106432_REACT_6964_MTORC1_MEDIATED_SIGNALLING",13,0.6834,0.9,1,"Yes",1.1308,0.3,0.54,"Yes"
"16801","GO_BP","911330_GO_0097502_MANNOSYLATION",30,0.6841,0.96,1,"Yes",1.153,0.24,0.83,"Yes"
"16802","C2_Chemical_and_genetic_perturbations","C2_CGP_3341_HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP",22,0.6852,0.92,1,"Yes",1.2126,0.2,0.48,"Yes"
"16803","GO_BP","506131_GO_0043045_DNA_METHYLATION_INVOLVED_IN_EMBRYO_DEVELOPMENT",6,0.6857,0.86,1,"Yes",-1.1058,0.36,0.94,"No"
"16804","GO_MF","504249_GO_0035064_METHYLATED_HISTONE_BINDING",50,0.6861,0.97,1,"Yes",-0.9812,0.49,0.92,"No"
"16805","GO_BP","491169_GO_0006198_CAMP_CATABOLIC_PROCESS",15,0.6866,0.89,1,"Yes",-1.0298,0.43,0.98,"No"
"16806","GO_CC","515533_GO_0070603_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX",68,0.6867,0.99,1,"Yes",-0.9955,0.46,0.85,"No"
"16807","C2_Chemical_and_genetic_perturbations","C2_CGP_2746_WANG_RECURRENT_LIVER_CANCER_UP",20,0.6868,0.92,1,"Yes",1.342,0.096,0.35,"Yes"
"16808","OMIM_gene","OMIM612294_DEP_DOMAIN_CONTAINING_PROTEIN_7_DEPDC7",6,0.6876,0.82,1,"Yes",0.65,0.87,1,"Yes"
"16809","REACTOME","1127539_REACT_268366_GLI3_IS_PROCESSED_TO_GLI3R_BY_THE_PROTEASOME",59,0.6877,0.98,1,"Yes",2.1091,0,5e-04,"Yes"
"16810","GO_BP","808750_GO_0044783_G1_DNA_DAMAGE_CHECKPOINT",77,0.6882,0.98,1,"Yes",1.6491,0.0023,0.24,"Yes"
"16811","GO_CC","516488_GO_0071564_NPBAF_COMPLEX",12,0.6884,0.87,1,"Yes",0.6329,0.94,1,"Yes"
"16812","C2_Chemical_and_genetic_perturbations","C2_CGP_40_DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN",20,0.6887,0.92,1,"Yes",-0.9193,0.57,1,"No"
"16813","GO_BP","504212_GO_0035022_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION",5,0.6902,0.83,1,"Yes",0.821,0.69,1,"Yes"
"16814","GO_BP","517093_GO_0072177_MESONEPHRIC_DUCT_DEVELOPMENT",9,0.6905,0.89,1,"Yes",1.1366,0.3,0.85,"Yes"
"16815","OMIM_gene","OMIM608074_PROGRAMMED_CELL_DEATH_6_INTERACTING_PROTEIN_PDCD6IP",6,0.6906,0.85,1,"Yes",0.6316,0.92,1,"Yes"
"16816","REACTOME","833809_REACT_163646_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9_",6,0.6906,0.86,1,"Yes",1.6208,0.019,0.084,"Yes"
"16817","GO_BP","1026104_GO_1903332_REGULATION_OF_PROTEIN_FOLDING",5,0.6909,0.8,1,"Yes",1.4201,0.11,0.53,"Yes"
"16818","C2_Chemical_and_genetic_perturbations","C2_CGP_2224_WORSCHECH_TUMOR_REJECTION_DN",10,0.691,0.88,1,"Yes",1.2008,0.24,0.49,"Yes"
"16819","GO_MF","499762_GO_0030371_TRANSLATION_REPRESSOR_ACTIVITY",18,0.692,0.9,1,"Yes",0.8081,0.76,1,"Yes"
"16820","C2_Chemical_and_genetic_perturbations","C2_CGP_760_SHI_SPARC_TARGETS_UP",24,0.6924,0.93,1,"Yes",0.8606,0.69,0.96,"Yes"
"16821","OMIM_gene","OMIM602746_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_MEMBER_14_TNFRSF14",6,0.6925,0.83,1,"Yes",0.6438,0.9,1,"Yes"
"16822","GO_BP","498694_GO_0019919_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE",7,0.6927,0.82,1,"Yes",-0.5207,0.97,1,"No"
"16823","C4_Cancer_gene_neighborhoods","C4_CGN_398_GNF2_RAB3A",37,0.6941,0.97,1,"Yes",-1.3259,0.093,0.53,"No"
"16824","REACTOME","106558_REACT_975_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE",27,0.6942,0.92,1,"Yes",1.365,0.091,0.26,"Yes"
"16825","C3_MicroRNA_targets","C3_MIR_119_TCTGGAC_MIR_198",83,0.6948,0.99,1,"Yes",0.8351,0.8,1,"Yes"
"16826","GO_CC","500666_GO_0031415_NATA_COMPLEX",5,0.695,0.81,1,"Yes",-0.8094,0.69,1,"No"
"16827","C1_Positional","C1_ALL_241_CHR3P13",9,0.695,0.84,0.99,"Yes",1.0168,0.46,0.75,"Yes"
"16828","GO_BP","499442_GO_0023021_TERMINATION_OF_SIGNAL_TRANSDUCTION",42,0.695,0.97,1,"Yes",1.0172,0.4,0.97,"Yes"
"16829","GO_MF","492600_GO_0008276_PROTEIN_METHYLTRANSFERASE_ACTIVITY",72,0.6951,0.98,1,"Yes",-0.698,0.97,1,"No"
"16830","REACTOME","161034_REACT_20594_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION",17,0.6952,0.91,1,"Yes",0.8756,0.61,0.93,"Yes"
"16831","GO_BP","491291_GO_0006349_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING",18,0.6953,0.88,1,"Yes",-1.3377,0.12,0.91,"No"
"16832","WikiPathways","198860_WP111_ELECTRON_TRANSPORT_CHAIN",92,0.6959,1,1,"Yes",2.7023,0,0,"Yes"
"16833","GO_BP","488439_GO_0002566_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION",12,0.696,0.88,1,"Yes",0.7582,0.78,1,"Yes"
"16834","C2_Chemical_and_genetic_perturbations","C2_CGP_1740_KANG_FLUOROURACIL_RESISTANCE_UP",22,0.6962,0.92,1,"Yes",1.2009,0.21,0.49,"Yes"
"16835","C1_Positional","C1_ALL_153_CHR14Q",7,0.6963,0.86,1,"Yes",1.3068,0.18,0.53,"Yes"
"16836","GO_BP","507416_GO_0045006_DNA_DEAMINATION",9,0.6966,0.85,1,"Yes",1.1173,0.29,0.88,"Yes"
"16837","GO_BP","491457_GO_0006561_PROLINE_BIOSYNTHETIC_PROCESS",7,0.6967,0.82,1,"Yes",1.0829,0.37,0.92,"Yes"
"16838","GO_MF","504426_GO_0035242_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY",7,0.6969,0.86,1,"Yes",-0.5268,0.98,1,"No"
"16839","GO_MF","505241_GO_0042054_HISTONE_METHYLTRANSFERASE_ACTIVITY",51,0.6969,0.97,1,"Yes",-0.8796,0.66,1,"No"
"16840","C4_Cancer_gene_neighborhoods","C4_CGN_203_GCM_RAD21",37,0.6973,0.97,1,"Yes",1.7868,0.0022,0.0026,"Yes"
"16841","REACTOME","161041_REACT_20661_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKK",6,0.6973,0.84,1,"Yes",1.0363,0.39,0.69,"Yes"
"16842","GO_BP","491535_GO_0006646_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS",14,0.6976,0.86,1,"Yes",0.5619,0.97,1,"Yes"
"16843","GO_BP","515068_GO_0070131_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION",6,0.6979,0.82,1,"Yes",1.0755,0.36,0.93,"Yes"
"16844","KEGG_compound","C00268_DIHYDROBIOPTERIN_6_7_DIHYDROBIOPTERIN_QUINOID_DIHYDROBIOPTERIN_6R_6_L_ERYTHRO_1_2_DIHYDROXYPROPYL_7_8_DIHYDRO_6H_PTERIN",7,0.698,0.82,1,"Yes",1.3285,0.15,0.68,"Yes"
"16845","GO_BP","519182_GO_2000543_POSITIVE_REGULATION_OF_GASTRULATION",9,0.698,0.86,1,"Yes",0.899,0.58,1,"Yes"
"16846","GO_BP","491910_GO_0007091_METAPHASE_ANAPHASE_TRANSITION_OF_MITOTIC_CELL_CYCLE",7,0.6981,0.82,1,"Yes",1.0114,0.44,0.98,"Yes"
"16847","GO_MF","511670_GO_0050699_WW_DOMAIN_BINDING",22,0.6982,0.91,1,"Yes",1.0738,0.34,0.82,"Yes"
"16848","C2_Chemical_and_genetic_perturbations","C2_CGP_618_NAGY_TFTC_COMPONENTS_HUMAN",19,0.6986,0.89,1,"Yes",-0.8178,0.73,1,"No"
"16849","GO_BP","495832_GO_0015697_QUATERNARY_AMMONIUM_GROUP_TRANSPORT",18,0.6989,0.88,1,"Yes",-1.1146,0.3,0.94,"No"
"16850","GO_CC","490779_GO_0005744_MITOCHONDRIAL_INNER_MEMBRANE_PRESEQUENCE_TRANSLOCASE_COMPLEX",8,0.6991,0.85,1,"Yes",1.0787,0.34,0.67,"Yes"
"16851","C4_Cancer_modules","C4_CM_317_MODULE_371",26,0.6993,0.91,1,"Yes",1.5951,0.013,0.074,"Yes"
"16852","REACTOME","160974_REACT_21393_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK",13,0.6994,0.87,1,"Yes",0.6873,0.89,1,"Yes"
"16853","GO_BP","512767_GO_0051917_REGULATION_OF_FIBRINOLYSIS",14,0.6994,0.9,1,"Yes",-1.0632,0.39,0.96,"No"
"16854","REACTOME","833828_REACT_163994_FCERI_MEDIATED_NF_KB_ACTIVATION",23,0.6995,0.9,1,"Yes",-0.623,0.95,1,"No"
"16855","GO_MF","490097_GO_0004791_THIOREDOXIN_DISULFIDE_REDUCTASE_ACTIVITY",5,0.6996,0.84,1,"Yes",-0.6093,0.93,1,"No"
"16856","GO_BP","492436_GO_0008063_TOLL_SIGNALING_PATHWAY",5,0.7003,0.83,1,"Yes",0.8445,0.66,1,"Yes"
"16857","GO_CC","487126_GO_0000836_HRD1P_UBIQUITIN_LIGASE_COMPLEX",5,0.7005,0.8,1,"Yes",1.1837,0.29,0.54,"Yes"
"16858","C2_Chemical_and_genetic_perturbations","C2_CGP_1536_FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN",48,0.7005,0.96,1,"Yes",1.921,0,0.016,"Yes"
"16859","GO_BP","504160_GO_0034968_HISTONE_LYSINE_METHYLATION",57,0.7008,0.96,1,"Yes",-0.6782,0.98,1,"No"
"16860","REACTOME","530761_REACT_115831_ISG15_ANTIVIRAL_MECHANISM",72,0.7008,0.99,1,"Yes",1.4515,0.014,0.18,"Yes"
"16861","GO_BP","490600_GO_0006903_VESICLE_TARGETING",39,0.7011,0.95,1,"Yes",1.6719,0.013,0.22,"Yes"
"16862","REACTOME","105919_REACT_1785_CITRIC_ACID_CYCLE_TCA_CYCLE_",19,0.7016,0.93,1,"Yes",1.7313,0.0065,0.038,"Yes"
"16863","GO_BP","512235_GO_0051351_POSITIVE_REGULATION_OF_LIGASE_ACTIVITY",93,0.7016,0.99,1,"Yes",1.8873,0,0.043,"Yes"
"16864","GO_MF","492595_GO_0008271_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,0.7017,0.84,1,"Yes",1.1327,0.26,0.75,"Yes"
"16865","GO_BP","505860_GO_0042754_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM",13,0.7019,0.87,1,"Yes",-1.2328,0.21,0.9,"No"
"16866","REACTOME","106142_REACT_9405_CHOLESTEROL_BIOSYNTHESIS",23,0.702,0.92,1,"Yes",0.9064,0.61,0.9,"Yes"
"16867","GO_BP","496003_GO_0015879_CARNITINE_TRANSPORT",13,0.7025,0.87,1,"Yes",-0.8189,0.71,1,"No"
"16868","REACTOME","160962_REACT_22393_RESPIRATORY_ELECTRON_TRANSPORT",75,0.7027,1,1,"Yes",2.58,0,0,"Yes"
"16869","REACTOME","105891_REACT_1941_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX",29,0.703,0.93,1,"Yes",1.3758,0.075,0.24,"Yes"
"16870","GO_CC","487125_GO_0000835_ER_UBIQUITIN_LIGASE_COMPLEX",5,0.7032,0.83,1,"Yes",1.187,0.3,0.54,"Yes"
"16871","GO_BP","491282_GO_0006338_CHROMATIN_REMODELING",157,0.7034,0.99,1,"Yes",-0.8926,0.75,1,"No"
"16872","C2_Chemical_and_genetic_perturbations","C2_CGP_2325_MATZUK_POST_IMPLANTATION_AND_POST_PARTUM",13,0.7039,0.88,1,"Yes",1.2904,0.13,0.4,"Yes"
"16873","GO_CC","500300_GO_0031010_ISWI_TYPE_COMPLEX",10,0.7041,0.84,1,"Yes",-0.8859,0.61,0.96,"No"
"16874","GO_BP","497008_GO_0018022_PEPTIDYL_LYSINE_METHYLATION",64,0.7041,0.98,1,"Yes",-0.8131,0.82,1,"No"
"16875","GO_BP","518384_GO_0090244_WNT_SIGNALING_PATHWAY_INVOLVED_IN_SOMITOGENESIS",7,0.7042,0.79,1,"Yes",-1.0575,0.38,0.96,"No"
"16876","C4_Cancer_gene_neighborhoods","C4_CGN_207_GCM_AIP",40,0.7045,0.95,1,"Yes",0.7955,0.82,0.99,"Yes"
"16877","GO_BP","505878_GO_0042772_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION",15,0.7047,0.88,1,"Yes",0.7681,0.81,1,"Yes"
"16878","REACTOME","105673_REACT_666_SMAC_MEDIATED_APOPTOTIC_RESPONSE",5,0.7048,0.82,1,"Yes",1.3927,0.14,0.23,"Yes"
"16879","GO_MF","506112_GO_0043022_RIBOSOME_BINDING",31,0.7048,0.94,1,"Yes",1.7787,0.0022,0.094,"Yes"
"16880","GO_MF","515507_GO_0070577_LYSINE_ACETYLATED_HISTONE_BINDING",17,0.7049,0.91,1,"Yes",-0.7675,0.81,1,"No"
"16881","GO_BP","489100_GO_0003308_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",5,0.7051,0.82,1,"Yes",0.898,0.57,1,"Yes"
"16882","C2_Chemical_and_genetic_perturbations","C2_CGP_2147_WONG_PROTEASOME_GENE_MODULE",49,0.7056,0.95,1,"Yes",1.5736,0.013,0.16,"Yes"
"16883","KEGG_compound","C00655_XANTHOSINE_5_PHOSPHATE_XANTHYLIC_ACID_XMP_9_D_RIBOSYLXANTHINE_5_PHOSPHATE",15,0.7057,0.85,1,"Yes",0.6904,0.9,1,"Yes"
"16884","C2_Chemical_and_genetic_perturbations","C2_CGP_2753_MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN",10,0.7063,0.83,1,"Yes",1.4638,0.087,0.24,"Yes"
"16885","GO_BP","504912_GO_0035735_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_MORPHOGENESIS",6,0.7069,0.81,1,"Yes",0.7202,0.81,1,"Yes"
"16886","GO_MF","504434_GO_0035250_UDP_GALACTOSYLTRANSFERASE_ACTIVITY",19,0.7073,0.89,1,"Yes",1.1653,0.23,0.74,"Yes"
"16887","GO_BP","502845_GO_0033629_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN",11,0.7077,0.85,1,"Yes",0.7877,0.75,1,"Yes"
"16888","GO_BP","495964_GO_0015838_AMINO_ACID_BETAINE_TRANSPORT",13,0.7079,0.86,1,"Yes",-0.8219,0.72,1,"No"
"16889","GO_BP","808751_GO_0044784_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",7,0.7084,0.82,1,"Yes",1.0078,0.45,0.98,"Yes"
"16890","GO_MF","489872_GO_0004523_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY",6,0.7086,0.8,1,"Yes",1.5149,0.038,0.37,"Yes"
"16891","GO_BP","500822_GO_0031571_MITOTIC_G1_DNA_DAMAGE_CHECKPOINT",76,0.7091,0.98,1,"Yes",1.6703,0.0021,0.22,"Yes"
"16892","C4_Cancer_gene_neighborhoods","C4_CGN_29_MORF_PCNA",83,0.7095,0.98,1,"Yes",2.2343,0,0,"Yes"
"16893","KEGG_module","HSA_M00380_SCF_BTRC_COMPLEX",5,0.7097,0.81,0.9,"Yes",0.9239,0.54,0.9,"Yes"
"16894","REACTOME","105675_REACT_1767_SMAC_MEDIATED_DISSOCIATION_OF_IAP_CASPASE_COMPLEXES",5,0.7098,0.79,1,"Yes",1.3936,0.14,0.23,"Yes"
"16895","REACTOME","106000_REACT_6237_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE",27,0.7108,0.93,1,"Yes",1.3434,0.087,0.27,"Yes"
"16896","KEGG_compound","C05284_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_ANDROST_4_ENE_3_17_DIONE_11BETA_OL_4_ANDROSTEN_11BETA_OL_3_17_DIONE",9,0.7112,0.85,1,"Yes",1.243,0.22,0.81,"Yes"
"16897","GO_MF","501417_GO_0032182_UBIQUITIN_LIKE_PROTEIN_BINDING",95,0.7116,0.98,1,"Yes",0.6765,0.99,1,"Yes"
"16898","GO_MF","506203_GO_0043130_UBIQUITIN_BINDING",84,0.7123,0.98,1,"Yes",0.7436,0.96,1,"Yes"
"16899","GO_CC","515582_GO_0070652_HAUS_COMPLEX",8,0.7126,0.82,1,"Yes",1.3221,0.15,0.38,"Yes"
"16900","GO_BP","512010_GO_0051096_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY",6,0.7127,0.8,1,"Yes",0.9998,0.44,0.98,"Yes"
"16901","GO_BP","491381_GO_0006479_PROTEIN_METHYLATION",102,0.7139,0.99,1,"Yes",-0.593,1,1,"No"
"16902","REACTOME","105674_REACT_2190_SMAC_BINDS_TO_IAPS",5,0.7144,0.83,1,"Yes",1.3521,0.14,0.26,"Yes"
"16903","GO_BP","510564_GO_0048490_ANTEROGRADE_SYNAPTIC_VESICLE_TRANSPORT",15,0.7146,0.89,1,"Yes",1.4411,0.081,0.51,"Yes"
"16904","C2_Chemical_and_genetic_perturbations","C2_CGP_1020_SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP",9,0.7147,0.82,1,"Yes",-0.706,0.85,1,"No"
"16905","C1_Positional","C1_ALL_239_CHR2P23",80,0.7148,0.99,0.99,"Yes",0.6429,0.99,1,"Yes"
"16906","C2_BioCarta_Pathways","C2_CP_BIOCARTA_69_BIOCARTA_EIF_PATHWAY",16,0.7149,0.85,0.93,"Yes",1.3878,0.1,0.53,"Yes"
"16907","REACTOME","106047_REACT_162_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS",9,0.7155,0.83,1,"Yes",-0.9625,0.49,1,"No"
"16908","GO_BP","513442_GO_0055009_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS",6,0.7157,0.77,1,"Yes",0.9151,0.57,1,"Yes"
"16909","KEGG_compound","C06124_SPHINGOSINE_1_PHOSPHATE_SPHING_4_ENINE_1_PHOSPHATE_S1P",6,0.716,0.81,1,"Yes",1.0157,0.46,1,"Yes"
"16910","REACTOME","530760_REACT_115676_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES",72,0.7163,0.99,1,"Yes",1.4351,0.036,0.19,"Yes"
"16911","GO_CC","490720_GO_0005662_DNA_REPLICATION_FACTOR_A_COMPLEX",14,0.7164,0.87,1,"Yes",1.2011,0.22,0.53,"Yes"
"16912","GO_MF","490429_GO_0005165_NEUROTROPHIN_RECEPTOR_BINDING",9,0.7167,0.82,1,"Yes",0.9316,0.52,0.94,"Yes"
"16913","GO_MF","507564_GO_0045182_TRANSLATION_REGULATOR_ACTIVITY",34,0.7176,0.93,1,"Yes",1.2198,0.16,0.7,"Yes"
"16914","REACTOME","1127504_REACT_267624_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE",51,0.7177,0.96,1,"Yes",0.7994,0.81,1,"Yes"
"16915","GO_BP","501522_GO_0032287_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE",7,0.7179,0.82,1,"Yes",0.7868,0.73,1,"Yes"
"16916","GO_CC","500168_GO_0030870_MRE11_COMPLEX",6,0.7181,0.8,1,"Yes",0.8223,0.66,0.94,"Yes"
"16917","GO_BP","505050_GO_0035881_AMACRINE_CELL_DIFFERENTIATION",5,0.7185,0.81,1,"Yes",-0.6883,0.84,1,"No"
"16918","GO_MF","757231_GO_1990050_PHOSPHATIDIC_ACID_TRANSPORTER_ACTIVITY",5,0.7192,0.82,1,"Yes",1.1012,0.37,0.79,"Yes"
"16919","GO_BP","516861_GO_0071941_NITROGEN_CYCLE_METABOLIC_PROCESS",14,0.7194,0.87,1,"Yes",-0.6616,0.91,1,"No"
"16920","C2_Chemical_and_genetic_perturbations","C2_CGP_2896_DORN_ADENOVIRUS_INFECTION_32HR_UP",11,0.7211,0.83,1,"Yes",1.0922,0.33,0.64,"Yes"
"16921","GO_BP","486643_GO_0000101_SULFUR_AMINO_ACID_TRANSPORT",6,0.7214,0.8,1,"Yes",-0.7687,0.75,1,"No"
"16922","C3_MicroRNA_targets","C3_MIR_183_TAGAACC_MIR_182",38,0.7216,0.9,1,"Yes",-0.7649,0.86,1,"No"
"16923","GO_MF","509068_GO_0046848_HYDROXYAPATITE_BINDING",5,0.7219,0.81,1,"Yes",-1.2117,0.23,0.81,"No"
"16924","KEGG_module","HSA_M00404_COPII_COMPLEX",11,0.7223,0.82,0.9,"Yes",0.8377,0.68,0.93,"Yes"
"16925","REACTOME","105861_REACT_2054_DOUBLE_STRAND_BREAK_REPAIR",23,0.7232,0.86,1,"Yes",0.9155,0.57,0.89,"Yes"
"16926","GO_BP","519107_GO_2000467_POSITIVE_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY",5,0.7233,0.78,1,"Yes",-1.3465,0.15,0.92,"No"
"16927","C2_Chemical_and_genetic_perturbations","C2_CGP_2508_FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP",23,0.7234,0.86,1,"Yes",0.8526,0.66,0.97,"Yes"
"16928","C2_Chemical_and_genetic_perturbations","C2_CGP_3044_STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN",22,0.7235,0.88,1,"Yes",1.0248,0.39,0.76,"Yes"
"16929","GO_BP","508257_GO_0045955_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",8,0.7235,0.81,1,"Yes",1.2047,0.25,0.78,"Yes"
"16930","GO_BP","489022_GO_0003228_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",6,0.7236,0.81,1,"Yes",0.9177,0.56,1,"Yes"
"16931","GO_BP","501692_GO_0032460_NEGATIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION",10,0.7239,0.84,1,"Yes",0.9214,0.54,1,"Yes"
"16932","C2_Chemical_and_genetic_perturbations","C2_CGP_1132_PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN",7,0.7247,0.82,1,"Yes",1.3201,0.16,0.37,"Yes"
"16933","GO_BP","1129425_GO_1903599_POSITIVE_REGULATION_OF_MITOCHONDRION_DEGRADATION",8,0.7248,0.8,1,"Yes",1.1927,0.26,0.79,"Yes"
"16934","C4_Cancer_gene_neighborhoods","C4_CGN_146_MORF_PPP1CC",165,0.725,1,1,"Yes",1.8482,0,0.0014,"Yes"
"16935","GO_BP","504301_GO_0035116_EMBRYONIC_HINDLIMB_MORPHOGENESIS",30,0.7255,0.92,1,"Yes",-1.04,0.38,0.98,"No"
"16936","GO_CC","502061_GO_0032838_CELL_PROJECTION_CYTOPLASM",109,0.7256,0.99,1,"Yes",-1.0532,0.34,0.83,"No"
"16937","GO_CC","490873_GO_0005861_TROPONIN_COMPLEX",8,0.7256,0.83,1,"Yes",0.918,0.54,0.87,"Yes"
"16938","GO_BP","487634_GO_0001736_ESTABLISHMENT_OF_PLANAR_POLARITY",14,0.7257,0.83,1,"Yes",1.1655,0.26,0.82,"Yes"
"16939","GO_BP","488954_GO_0003160_ENDOCARDIUM_MORPHOGENESIS",6,0.7271,0.79,1,"Yes",-0.6113,0.91,1,"No"
"16940","GO_BP","518700_GO_2000051_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY",6,0.7272,0.77,1,"Yes",-0.8724,0.59,1,"No"
"16941","KEGG_module","HSA_M00307_PYRUVATE_OXIDATION_PYRUVATE_ACETYL_COA",5,0.7279,0.79,0.91,"Yes",1.5964,0.017,0.12,"Yes"
"16942","GO_CC","500191_GO_0030896_CHECKPOINT_CLAMP_COMPLEX",5,0.728,0.79,1,"Yes",-1.1665,0.31,0.69,"No"
"16943","GO_BP","510225_GO_0048070_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION",17,0.7283,0.88,1,"Yes",1.4074,0.083,0.55,"Yes"
"16944","C4_Cancer_gene_neighborhoods","C4_CGN_85_MORF_DDB1",244,0.7287,1,1,"Yes",1.3587,0.0071,0.081,"Yes"
"16945","GO_BP","506130_GO_0043044_ATP_DEPENDENT_CHROMATIN_REMODELING",72,0.7288,0.97,1,"Yes",-1.156,0.19,0.92,"No"
"16946","C2_BioCarta_Pathways","C2_CP_BIOCARTA_33_BIOCARTA_CD40_PATHWAY",15,0.7295,0.84,0.96,"Yes",0.8945,0.6,0.91,"Yes"
"16947","GO_CC","490788_GO_0045263_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_COUPLING_FACTOR_F_O_",11,0.7297,0.83,1,"Yes",1.9103,0.002,0.0093,"Yes"
"16948","REACTOME","105892_REACT_2222_DUAL_INCISION_REACTION_IN_TC_NER",29,0.7298,0.88,1,"Yes",1.3874,0.063,0.23,"Yes"
"16949","REACTOME","119563_REACT_19315_CATION_COUPLED_CHLORIDE_COTRANSPORTERS",7,0.7298,0.8,1,"Yes",-1.1036,0.33,0.9,"No"
"16950","C4_Cancer_modules","C4_CM_245_MODULE_277",54,0.7301,0.92,1,"Yes",0.9871,0.45,0.72,"Yes"
"16951","KEGG_compound","C00364_DTMP_THYMIDINE_5_PHOSPHATE_DEOXYTHYMIDINE_5_PHOSPHATE_THYMIDYLIC_ACID_5_THYMIDYLIC_ACID_THYMIDINE_MONOPHOSPHATE_DEOXYTHYMIDYLIC_ACID_THYMIDYLATE",15,0.7303,0.86,1,"Yes",-0.486,0.99,1,"No"
"16952","GO_BP","500345_GO_0031055_CHROMATIN_REMODELING_AT_CENTROMERE",44,0.7303,0.94,1,"Yes",-0.8876,0.66,1,"No"
"16953","GO_BP","508760_GO_0046501_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS",11,0.7305,0.83,1,"Yes",1.3065,0.14,0.66,"Yes"
"16954","GO_MF","504381_GO_0035197_SIRNA_BINDING",6,0.7305,0.78,1,"Yes",-1.4277,0.082,0.65,"No"
"16955","KEGG_compound","C00065_L_SERINE_L_2_AMINO_3_HYDROXYPROPIONIC_ACID_L_3_HYDROXY_ALANINE_SERINE",14,0.7306,0.84,1,"Yes",0.9829,0.46,1,"Yes"
"16956","GO_BP","516992_GO_0072075_METANEPHRIC_MESENCHYME_DEVELOPMENT",13,0.7309,0.84,1,"Yes",-1.2375,0.21,0.9,"No"
"16957","GO_MF","515497_GO_0070567_CYTIDYLYLTRANSFERASE_ACTIVITY",8,0.7309,0.79,1,"Yes",1.2597,0.2,0.65,"Yes"
"16958","GO_CC","983703_GO_0098642_NETWORK_FORMING_COLLAGEN_TRIMER",7,0.731,0.78,1,"Yes",-0.8734,0.6,0.94,"No"
"16959","C2_Chemical_and_genetic_perturbations","C2_CGP_2092_STEIN_ESRRA_TARGETS_DN",104,0.7312,0.99,1,"Yes",1.2213,0.1,0.47,"Yes"
"16960","GO_CC","983706_GO_0098645_COLLAGEN_NETWORK",7,0.7312,0.79,1,"Yes",-0.8542,0.64,0.96,"No"
"16961","GO_BP","503591_GO_0034389_LIPID_PARTICLE_ORGANIZATION",15,0.7315,0.85,1,"Yes",0.7514,0.81,1,"Yes"
"16962","GO_BP","507326_GO_0044320_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS",10,0.732,0.8,1,"Yes",1.3634,0.12,0.6,"Yes"
"16963","GO_CC","503653_GO_0034451_CENTRIOLAR_SATELLITE",18,0.7325,0.83,1,"Yes",-1.0326,0.39,0.85,"No"
"16964","C2_Chemical_and_genetic_perturbations","C2_CGP_3344_HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN",15,0.7327,0.82,1,"Yes",2.1908,0,0.00059,"Yes"
"16965","GO_BP","500344_GO_0031054_PRE_MIRNA_PROCESSING",12,0.7327,0.82,1,"Yes",-0.7999,0.74,1,"No"
"16966","REACTOME","645265_REACT_120734_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION",31,0.7328,0.92,1,"Yes",1.0197,0.39,0.72,"Yes"
"16967","GO_BP","514239_GO_0060684_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING",6,0.733,0.78,1,"Yes",1.1373,0.33,0.85,"Yes"
"16968","GO_MF","496735_GO_0016840_CARBON_NITROGEN_LYASE_ACTIVITY",9,0.7334,0.8,1,"Yes",1.2374,0.21,0.69,"Yes"
"16969","REACTOME","833794_REACT_163932_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE",10,0.7334,0.8,1,"Yes",-1.5723,0.036,0.37,"No"
"16970","C4_Cancer_gene_neighborhoods","C4_CGN_48_MORF_SOD1",278,0.734,1,1,"Yes",2.5289,0,0,"Yes"
"16971","GO_BP","502149_GO_0032927_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",8,0.7341,0.8,1,"Yes",0.5348,0.97,1,"Yes"
"16972","C1_Positional","C1_ALL_26_CHR4P14",26,0.7342,0.89,0.99,"Yes",0.9991,0.46,0.76,"Yes"
"16973","GO_MF","512453_GO_0051575_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY",5,0.7348,0.8,1,"Yes",1.4836,0.051,0.39,"Yes"
"16974","GO_BP","493417_GO_0009221_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",6,0.7348,0.79,1,"Yes",1.049,0.42,0.95,"Yes"
"16975","C2_Chemical_and_genetic_perturbations","C2_CGP_670_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25",8,0.7348,0.8,1,"Yes",1.3417,0.13,0.35,"Yes"
"16976","GO_MF","498596_GO_0019787_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY",310,0.735,1,1,"Yes",1.1732,0.081,0.74,"Yes"
"16977","GO_MF","496859_GO_0017034_RAP_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",5,0.7352,0.76,1,"Yes",0.7354,0.78,1,"Yes"
"16978","GO_BP","516034_GO_0071108_PROTEIN_K48_LINKED_DEUBIQUITINATION",18,0.7353,0.87,1,"Yes",-0.6974,0.9,1,"No"
"16979","GO_BP","514343_GO_0060788_ECTODERMAL_PLACODE_FORMATION",18,0.7354,0.86,1,"Yes",0.873,0.66,1,"Yes"
"16980","GO_BP","497344_GO_0018410_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION",38,0.736,0.91,1,"Yes",0.9336,0.54,1,"Yes"
"16981","C2_Chemical_and_genetic_perturbations","C2_CGP_1071_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN",10,0.7363,0.86,1,"Yes",1.1731,0.26,0.53,"Yes"
"16982","C2_Chemical_and_genetic_perturbations","C2_CGP_2894_DORN_ADENOVIRUS_INFECTION_24HR_UP",11,0.7366,0.86,1,"Yes",0.4478,0.99,1,"Yes"
"16983","C4_Cancer_gene_neighborhoods","C4_CGN_202_GCM_PSME1",85,0.7371,0.97,1,"Yes",2.6928,0,0,"Yes"
"16984","GO_BP","514685_GO_0061140_LUNG_SECRETORY_CELL_DIFFERENTIATION",10,0.7371,0.85,1,"Yes",1.6453,0.019,0.25,"Yes"
"16985","GO_BP","504167_GO_0034975_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM",9,0.7375,0.8,1,"Yes",1.1309,0.3,0.87,"Yes"
"16986","C4_Cancer_modules","C4_CM_332_MODULE_396",10,0.7376,0.81,1,"Yes",-0.662,0.88,1,"No"
"16987","GO_BP","491456_GO_0006560_PROLINE_METABOLIC_PROCESS",8,0.7379,0.8,1,"Yes",1.1238,0.33,0.88,"Yes"
"16988","C2_Chemical_and_genetic_perturbations","C2_CGP_1513_PARK_HSC_AND_MULTIPOTENT_PROGENITORS",49,0.7384,0.92,1,"Yes",1.5651,0.0041,0.16,"Yes"
"16989","KEGG_compound","C00064_L_GLUTAMINE_L_2_AMINOGLUTARAMIC_ACID",17,0.7385,0.85,1,"Yes",-1.0601,0.36,0.99,"No"
"16990","GO_BP","491310_GO_0006384_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_III_PROMOTER",7,0.7396,0.77,1,"Yes",-0.5082,0.98,1,"No"
"16991","C4_Cancer_gene_neighborhoods","C4_CGN_321_GNF2_ANP32B",37,0.74,0.89,1,"Yes",1.7118,0.011,0.0056,"Yes"
"16992","REACTOME","771576_REACT_160176_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY",13,0.74,0.82,1,"Yes",1.1129,0.31,0.56,"Yes"
"16993","C7_Immunologic_signatures","C7_ALL_345_GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP",199,0.7401,1,1,"Yes",1.2934,0.024,0.11,"Yes"
"16994","GO_BP","515789_GO_0070861_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM",6,0.7406,0.78,1,"Yes",1.3784,0.11,0.58,"Yes"
"16995","C2_Chemical_and_genetic_perturbations","C2_CGP_58_GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP",25,0.7406,0.89,1,"Yes",1.0012,0.46,0.8,"Yes"
"16996","C2_Chemical_and_genetic_perturbations","C2_CGP_2105_GAZIN_EPIGENETIC_SILENCING_BY_KRAS",25,0.7409,0.91,1,"Yes",-0.8444,0.7,1,"No"
"16997","GO_MF","489438_GO_0003958_NADPH_HEMOPROTEIN_REDUCTASE_ACTIVITY",7,0.741,0.78,1,"Yes",-0.8265,0.69,1,"No"
"16998","C2_Chemical_and_genetic_perturbations","C2_CGP_3029_WANG_METASTASIS_OF_BREAST_CANCER",15,0.7415,0.84,1,"Yes",1.17,0.25,0.53,"Yes"
"16999","GO_BP","861238_GO_1902358_SULFATE_TRANSMEMBRANE_TRANSPORT",11,0.7415,0.79,1,"Yes",1.2348,0.21,0.75,"Yes"
"17000","C3_TF_targets","C3_TFT_515_SNACANNNYSYAGA_UNKNOWN",88,0.7417,0.99,1,"Yes",-0.677,0.98,1,"No"
"17001","GO_BP","989116_GO_1903051_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",69,0.7419,0.95,1,"Yes",1.201,0.13,0.78,"Yes"
"17002","GO_MF","490164_GO_0004862_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY",8,0.7419,0.8,1,"Yes",1.442,0.086,0.44,"Yes"
"17003","C2_Chemical_and_genetic_perturbations","C2_CGP_3086_FIGUEROA_AML_METHYLATION_CLUSTER_5_UP",12,0.7423,0.82,1,"Yes",-0.5878,0.96,1,"No"
"17004","KEGG_compound","C00365_DUMP_DEOXYURIDYLIC_ACID_DEOXYURIDINE_MONOPHOSPHATE_DEOXYURIDINE_5_PHOSPHATE_2_DEOXYURIDINE_5_PHOSPHATE",16,0.7425,0.86,1,"Yes",0.5741,0.98,1,"Yes"
"17005","GO_BP","487721_GO_0001825_BLASTOCYST_FORMATION",29,0.743,0.89,1,"Yes",0.9735,0.49,1,"Yes"
"17006","C2_Chemical_and_genetic_perturbations","C2_CGP_2009_LI_CYTIDINE_ANALOG_PATHWAY",17,0.7435,0.84,1,"Yes",1.0798,0.35,0.67,"Yes"
"17007","GO_BP","491039_GO_0006054_N_ACETYLNEURAMINATE_METABOLIC_PROCESS",9,0.7436,0.81,1,"Yes",0.5552,0.97,1,"Yes"
"17008","REACTOME","906016_REACT_169122_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER",8,0.7436,0.8,1,"Yes",-0.6675,0.86,1,"No"
"17009","GO_CC","490791_GO_0005758_MITOCHONDRIAL_INTERMEMBRANE_SPACE",69,0.7438,0.96,1,"Yes",1.7817,0,0.032,"Yes"
"17010","GO_BP","751075_GO_0036155_ACYLGLYCEROL_ACYL_CHAIN_REMODELING",5,0.7438,0.78,1,"Yes",0.9212,0.56,1,"Yes"
"17011","GO_MF","503685_GO_0034483_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY",13,0.7441,0.79,1,"Yes",1.9846,0,0.014,"Yes"
"17012","GO_BP","501286_GO_0032049_CARDIOLIPIN_BIOSYNTHETIC_PROCESS",7,0.7442,0.77,1,"Yes",-0.5464,0.96,1,"No"
"17013","C1_Positional","C1_ALL_257_CHR1P",7,0.7442,0.78,0.99,"Yes",1.0936,0.36,0.63,"Yes"
"17014","GO_BP","497946_GO_0019068_VIRION_ASSEMBLY",36,0.7445,0.93,1,"Yes",1.602,0.015,0.29,"Yes"
"17015","GO_BP","510727_GO_0048672_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING",7,0.7445,0.81,1,"Yes",0.6415,0.9,1,"Yes"
"17016","C2_Chemical_and_genetic_perturbations","C2_CGP_2187_DER_IFN_ALPHA_RESPONSE_DN",6,0.7446,0.78,1,"Yes",1.2788,0.2,0.42,"Yes"
"17017","GO_BP","751295_GO_0038032_TERMINATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",39,0.7453,0.89,1,"Yes",1.0499,0.35,0.95,"Yes"
"17018","GO_CC","946556_GO_0098576_LUMENAL_SIDE_OF_MEMBRANE",26,0.7453,0.9,1,"Yes",0.7786,0.8,0.97,"Yes"
"17019","GO_CC","516382_GO_0071458_INTEGRAL_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",6,0.7454,0.77,1,"Yes",0.705,0.83,0.99,"Yes"
"17020","GO_BP","488079_GO_0002200_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS",47,0.7454,0.93,1,"Yes",1.0559,0.35,0.94,"Yes"
"17021","OMIM_gene","OMIM607075_PDGFA_ASSOCIATED_PROTEIN_1_PDAP1",9,0.7457,0.78,1,"Yes",0.9951,0.43,1,"Yes"
"17022","GO_MF","498598_GO_0019789_SUMO_TRANSFERASE_ACTIVITY",10,0.746,0.8,1,"Yes",1.1883,0.25,0.72,"Yes"
"17023","GO_CC","500629_GO_0031371_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX",10,0.7462,0.78,1,"Yes",1.1682,0.28,0.56,"Yes"
"17024","GO_CC","921101_GO_0098553_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",26,0.7462,0.87,1,"Yes",0.7983,0.76,0.96,"Yes"
"17025","KEGG_module","HSA_M00120_COENZYME_A_BIOSYNTHESIS_PANTOTHENATE_COA",7,0.7473,0.79,0.9,"Yes",-0.5463,0.97,1,"No"
"17026","C4_Cancer_gene_neighborhoods","C4_CGN_151_MORF_PPP5C",91,0.7473,0.96,1,"Yes",-0.5931,1,1,"No"
"17027","GO_CC","490722_GO_0005665_DNA_DIRECTED_RNA_POLYMERASE_II_CORE_COMPLEX",16,0.7474,0.8,1,"Yes",1.2018,0.21,0.53,"Yes"
"17028","GO_BP","498674_GO_0019896_AXON_TRANSPORT_OF_MITOCHONDRION",5,0.7476,0.74,1,"Yes",-0.6272,0.9,1,"No"
"17029","GO_MF","501637_GO_0032405_MUTLALPHA_COMPLEX_BINDING",6,0.748,0.77,1,"Yes",0.4928,0.99,1,"Yes"
"17030","C2_Chemical_and_genetic_perturbations","C2_CGP_2624_MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY",10,0.7485,0.82,1,"Yes",0.9993,0.46,0.8,"Yes"
"17031","GO_BP","508124_GO_0045793_POSITIVE_REGULATION_OF_CELL_SIZE",9,0.7488,0.8,1,"Yes",0.986,0.48,1,"Yes"
"17032","GO_BP","491913_GO_0007094_MITOTIC_SPINDLE_ASSEMBLY_CHECKPOINT",32,0.7489,0.87,1,"Yes",0.9176,0.6,1,"Yes"
"17033","GO_CC","501658_GO_0032426_STEREOCILIUM_BUNDLE_TIP",8,0.749,0.79,1,"Yes",-1.2785,0.21,0.66,"No"
"17034","REACTOME","187086_REACT_25380_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX",10,0.7491,0.78,1,"Yes",1.4459,0.093,0.19,"Yes"
"17035","REACTOME","645315_REACT_121122_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG",5,0.7495,0.75,1,"Yes",0.9218,0.54,0.87,"Yes"
"17036","REACTOME","160972_REACT_21387_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK",19,0.7501,0.86,1,"Yes",0.7919,0.76,1,"Yes"
"17037","GO_BP","510788_GO_0048733_SEBACEOUS_GLAND_DEVELOPMENT",7,0.7502,0.77,1,"Yes",-0.5433,0.96,1,"No"
"17038","GO_CC","516480_GO_0071556_INTEGRAL_COMPONENT_OF_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",26,0.751,0.87,1,"Yes",0.787,0.78,0.96,"Yes"
"17039","KEGG_module","HSA_M00072_N_GLYCOSYLATION_BY_OLIGOSACCHARYLTRANSFERASE",7,0.7513,0.78,0.91,"Yes",0.9489,0.55,0.92,"Yes"
"17040","C2_Chemical_and_genetic_perturbations","C2_CGP_1202_NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON",54,0.7517,0.91,1,"Yes",0.8072,0.82,0.98,"Yes"
"17041","KEGG_compound","C00062_L_ARGININE_S_2_AMINO_5_GUANIDINOVALERIC_ACID_L_ARG",11,0.7521,0.8,1,"Yes",-1.1755,0.27,0.82,"No"
"17042","GO_BP","488435_GO_0002562_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_GERMLINE_RECOMBINATION_WITHIN_A_SINGLE_LOCUS",39,0.7525,0.91,1,"Yes",0.971,0.5,1,"Yes"
"17043","C2_Chemical_and_genetic_perturbations","C2_CGP_1344_CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP",13,0.7533,0.81,1,"Yes",-1.1525,0.28,0.85,"No"
"17044","C4_Cancer_gene_neighborhoods","C4_CGN_208_GCM_ANP32B",36,0.7533,0.9,1,"Yes",2.1245,0,0.00012,"Yes"
"17045","GO_BP","499074_GO_0021794_THALAMUS_DEVELOPMENT",11,0.7534,0.8,1,"Yes",0.7045,0.85,1,"Yes"
"17046","C4_Cancer_gene_neighborhoods","C4_CGN_254_GCM_PRKCG",59,0.7534,0.94,1,"Yes",-0.7766,0.86,1,"No"
"17047","C4_Cancer_gene_neighborhoods","C4_CGN_135_MORF_NME2",155,0.7536,0.99,1,"Yes",3.2607,0,0,"Yes"
"17048","REACTOME","105741_REACT_85_P53_DEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT",57,0.7537,0.93,1,"Yes",1.8377,0,0.015,"Yes"
"17049","GO_BP","505191_GO_0040033_NEGATIVE_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED",9,0.7541,0.82,1,"Yes",-1.3292,0.16,0.9,"No"
"17050","C2_Chemical_and_genetic_perturbations","C2_CGP_196_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN",23,0.7541,0.9,1,"Yes",-0.6982,0.88,1,"No"
"17051","KEGG_module","HSA_M00340_PROTEASOME_20S_CORE_PARTICLE",15,0.7542,0.81,0.93,"Yes",1.6693,0.022,0.084,"Yes"
"17052","GO_BP","486628_GO_0000088_MITOTIC_PROPHASE",76,0.7544,0.93,1,"Yes",0.7019,0.97,1,"Yes"
"17053","GO_BP","496427_GO_0016444_SOMATIC_CELL_DNA_RECOMBINATION",39,0.7548,0.91,1,"Yes",0.9683,0.5,1,"Yes"
"17054","GO_BP","506087_GO_0042996_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT",8,0.7551,0.78,1,"Yes",0.7254,0.8,1,"Yes"
"17055","GO_BP","500205_GO_0030910_OLFACTORY_PLACODE_FORMATION",6,0.7551,0.78,1,"Yes",0.7843,0.76,1,"Yes"
"17056","C4_Cancer_gene_neighborhoods","C4_CGN_228_GCM_ERCC4",26,0.7551,0.86,1,"Yes",0.6841,0.92,1,"Yes"
"17057","GO_CC","500282_GO_0030992_INTRACILIARY_TRANSPORT_PARTICLE_B",18,0.7554,0.84,1,"Yes",0.6401,0.93,0.99,"Yes"
"17058","GO_BP","514101_GO_0060546_NEGATIVE_REGULATION_OF_NECROPTOTIC_PROCESS",9,0.7557,0.78,1,"Yes",-0.7749,0.76,1,"No"
"17059","GO_BP","496060_GO_0015939_PANTOTHENATE_METABOLIC_PROCESS",12,0.7558,0.81,1,"Yes",1.2794,0.19,0.7,"Yes"
"17060","GO_BP","911315_GO_0039702_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX",12,0.7559,0.81,1,"Yes",1.3348,0.13,0.62,"Yes"
"17061","GO_MF","502828_GO_0033612_RECEPTOR_SERINE_THREONINE_KINASE_BINDING",14,0.7559,0.8,1,"Yes",-0.5747,0.97,1,"No"
"17062","GO_BP","492554_GO_0008213_PROTEIN_ALKYLATION",104,0.756,0.97,1,"Yes",-0.5586,1,1,"No"
"17063","C7_Immunologic_signatures","C7_ALL_1199_GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP",199,0.7564,1,1,"Yes",0.9924,0.5,0.76,"Yes"
"17064","GO_CC","487077_GO_0000784_NUCLEAR_CHROMOSOME_TELOMERIC_REGION",25,0.7566,0.85,1,"Yes",0.8361,0.73,0.93,"Yes"
"17065","GO_BP","491886_GO_0007063_REGULATION_OF_SISTER_CHROMATID_COHESION",11,0.7567,0.81,1,"Yes",0.7379,0.82,1,"Yes"
"17066","GO_BP","751292_GO_0038027_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY",5,0.7569,0.72,1,"Yes",1.0584,0.36,0.94,"Yes"
"17067","C2_Chemical_and_genetic_perturbations","C2_CGP_1381_MOOTHA_VOXPHOS",88,0.7575,0.95,1,"Yes",2.5084,0,0,"Yes"
"17068","GO_CC","507403_GO_0044455_MITOCHONDRIAL_MEMBRANE_PART",158,0.7575,0.99,1,"Yes",2.524,0,0,"Yes"
"17069","GO_BP","491447_GO_0006551_LEUCINE_METABOLIC_PROCESS",7,0.7576,0.74,1,"Yes",1.3415,0.15,0.62,"Yes"
"17070","GO_MF","486566_GO_0000014_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY",7,0.7576,0.79,1,"Yes",0.8045,0.71,1,"Yes"
"17071","C3_MicroRNA_targets","C3_MIR_166_ACCATTT_MIR_522",156,0.7583,0.98,1,"Yes",0.7725,0.97,1,"Yes"
"17072","GO_BP","487148_GO_0000920_CELL_SEPARATION_AFTER_CYTOKINESIS",18,0.7594,0.79,1,"Yes",1.3557,0.1,0.6,"Yes"
"17073","GO_BP","510797_GO_0048743_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT",6,0.7596,0.74,1,"Yes",1.0548,0.4,0.94,"Yes"
"17074","GO_MF","490262_GO_0004972_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",8,0.7599,0.78,1,"Yes",0.923,0.55,0.95,"Yes"
"17075","GO_BP","487735_GO_0001839_NEURAL_PLATE_MORPHOGENESIS",10,0.7614,0.75,1,"Yes",-0.9513,0.51,1,"No"
"17076","C2_Chemical_and_genetic_perturbations","C2_CGP_3145_KIM_GLIS2_TARGETS_DN",6,0.7614,0.74,1,"Yes",1.2079,0.27,0.48,"Yes"
"17077","GO_BP","514455_GO_0060900_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION",12,0.7618,0.79,1,"Yes",1.7152,0.016,0.18,"Yes"
"17078","GO_BP","504267_GO_0035082_AXONEME_ASSEMBLY",20,0.7621,0.85,1,"Yes",1.2619,0.16,0.72,"Yes"
"17079","GO_BP","518455_GO_0090315_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE",6,0.7623,0.75,1,"Yes",0.6248,0.9,1,"Yes"
"17080","GO_BP","849796_GO_0061551_TRIGEMINAL_GANGLION_DEVELOPMENT",5,0.7623,0.71,1,"Yes",-0.8519,0.65,1,"No"
"17081","REACTOME","106158_REACT_13621_HDL_MEDIATED_LIPID_TRANSPORT",15,0.7624,0.79,1,"Yes",-1.4872,0.065,0.46,"No"
"17082","GO_BP","508275_GO_0045974_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED",9,0.7624,0.77,1,"Yes",-1.3543,0.11,0.95,"No"
"17083","C2_Chemical_and_genetic_perturbations","C2_CGP_2296_BASSO_HAIRY_CELL_LEUKEMIA_UP",5,0.7627,0.75,1,"Yes",0.7222,0.81,1,"Yes"
"17084","KEGG_module","HSA_M00011_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2_OXOGLUTARATE_OXALOACETATE",14,0.763,0.8,0.93,"Yes",1.6704,0.023,0.089,"Yes"
"17085","GO_MF","495497_GO_0015232_HEME_TRANSPORTER_ACTIVITY",8,0.7631,0.76,1,"Yes",-1.442,0.079,0.62,"No"
"17086","GO_CC","517288_GO_0072372_PRIMARY_CILIUM",181,0.7633,0.99,1,"Yes",-0.8954,0.76,0.95,"No"
"17087","GO_BP","495933_GO_0015802_BASIC_AMINO_ACID_TRANSPORT",11,0.764,0.78,1,"Yes",1.1349,0.3,0.86,"Yes"
"17088","REACTOME","105743_REACT_1625_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE",57,0.7641,0.93,1,"Yes",1.829,0,0.017,"Yes"
"17089","GO_BP","777528_GO_1901976_REGULATION_OF_CELL_CYCLE_CHECKPOINT",30,0.7642,0.86,1,"Yes",1.0415,0.39,0.96,"Yes"
"17090","C4_Cancer_gene_neighborhoods","C4_CGN_211_GCM_BMPR2",83,0.7643,0.96,1,"Yes",1.1655,0.21,0.26,"Yes"
"17091","GO_CC","486794_GO_0000276_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_COUPLING_FACTOR_F_O_",6,0.7648,0.77,1,"Yes",1.6014,0.027,0.12,"Yes"
"17092","GO_BP","500649_GO_0031398_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION",155,0.765,0.98,1,"Yes",1.6392,0,0.25,"Yes"
"17093","KEGG_compound","C05545_PROTEIN_N6_N6_DIMETHYL_L_LYSINE",27,0.7653,0.85,1,"Yes",-1.3661,0.079,0.51,"No"
"17094","GO_BP","498832_GO_0021548_PONS_DEVELOPMENT",13,0.7654,0.8,1,"Yes",-1.1586,0.27,0.92,"No"
"17095","GO_MF","487322_GO_0001099_BASAL_RNA_POLYMERASE_II_TRANSCRIPTION_MACHINERY_BINDING",22,0.7658,0.81,1,"Yes",-0.645,0.92,1,"No"
"17096","KEGG_compound","C00459_DTTP_DEOXYTHYMIDINE_TRIPHOSPHATE_DEOXYTHYMIDINE_5_TRIPHOSPHATE_TTP",25,0.7658,0.84,1,"Yes",0.781,0.79,1,"Yes"
"17097","REACTOME","187084_REACT_25018_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION",10,0.7659,0.78,1,"Yes",1.4464,0.089,0.19,"Yes"
"17098","REACTOME","105794_REACT_1385_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND",16,0.7661,0.8,1,"Yes",1.3719,0.087,0.25,"Yes"
"17099","KEGG_compound","C01885_1_ACYLGLYCEROL_GLYCERIDE_MONOGLYCERIDE_MONOACYLGLYCEROL_1_MONOACYLGLYCEROL",12,0.7661,0.78,1,"Yes",-0.8383,0.7,1,"No"
"17100","GO_CC","500713_GO_0031462_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX",7,0.7667,0.75,1,"Yes",1.3468,0.14,0.35,"Yes"
"17101","GO_MF","501686_GO_0032454_HISTONE_DEMETHYLASE_ACTIVITY_H3_K9_SPECIFIC_",6,0.7671,0.72,1,"Yes",-1.1144,0.35,0.82,"No"
"17102","GO_BP","516082_GO_0071156_REGULATION_OF_CELL_CYCLE_ARREST",106,0.7675,0.97,1,"Yes",1.6576,0,0.24,"Yes"
"17103","GO_BP","849795_GO_0061550_CRANIAL_GANGLION_DEVELOPMENT",5,0.768,0.71,1,"Yes",-0.8398,0.65,1,"No"
"17104","GO_BP","487605_GO_0001702_GASTRULATION_WITH_MOUTH_FORMING_SECOND",30,0.7684,0.85,1,"Yes",1.1039,0.3,0.9,"Yes"
"17105","GO_BP","488823_GO_0003025_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_BARORECEPTOR_FEEDBACK",7,0.7689,0.76,1,"Yes",-1.1364,0.3,0.93,"No"
"17106","KEGG_pathway","HSA00130_UBIQUINONE_AND_OTHER_TERPENOID_QUINONE_BIOSYNTHESIS",11,0.769,0.76,0.96,"Yes",-1.3912,0.092,0.37,"No"
"17107","GO_BP","514317_GO_0060762_REGULATION_OF_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS",6,0.7703,0.75,1,"Yes",1.0228,0.45,0.97,"Yes"
"17108","C2_Chemical_and_genetic_perturbations","C2_CGP_1034_CAFFAREL_RESPONSE_TO_THC_8HR_3_UP",5,0.7705,0.72,1,"Yes",1.2191,0.27,0.47,"Yes"
"17109","C4_Cancer_gene_neighborhoods","C4_CGN_246_GCM_NCAM1",128,0.7706,0.97,1,"Yes",-0.8034,0.89,1,"No"
"17110","GO_BP","505663_GO_0042532_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",7,0.7709,0.75,1,"Yes",0.6409,0.91,1,"Yes"
"17111","C2_Chemical_and_genetic_perturbations","C2_CGP_1268_PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN",18,0.7715,0.82,1,"Yes",1.8056,0.0065,0.041,"Yes"
"17112","GO_BP","491655_GO_0006782_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS",9,0.7717,0.77,1,"Yes",1.0234,0.39,0.97,"Yes"
"17113","C2_Chemical_and_genetic_perturbations","C2_CGP_2885_ZHAN_MULTIPLE_MYELOMA_MS_DN",46,0.7719,0.91,1,"Yes",1.2963,0.098,0.4,"Yes"
"17114","GO_MF","489913_GO_0004579_DOLICHYL_DIPHOSPHOOLIGOSACCHARIDE_PROTEIN_GLYCOTRANSFERASE_ACTIVITY",8,0.7723,0.75,1,"Yes",1.148,0.29,0.75,"Yes"
"17115","GO_MF","492461_GO_0008094_DNA_DEPENDENT_ATPASE_ACTIVITY",79,0.7726,0.95,1,"Yes",-0.5923,1,1,"No"
"17116","GO_BP","504462_GO_0035278_NEGATIVE_REGULATION_OF_TRANSLATION_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",9,0.7728,0.76,1,"Yes",-1.3511,0.14,0.94,"No"
"17117","GO_MF","490144_GO_0004842_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",296,0.773,1,1,"Yes",1.1154,0.16,0.77,"Yes"
"17118","GO_BP","491516_GO_0006623_PROTEIN_TARGETING_TO_VACUOLE",26,0.773,0.82,1,"Yes",0.9697,0.52,1,"Yes"
"17119","REACTOME","576257_REACT_118811_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN",6,0.7735,0.72,1,"Yes",0.6343,0.9,1,"Yes"
"17120","GO_BP","505252_GO_0042069_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS",16,0.7735,0.78,1,"Yes",1.3903,0.082,0.57,"Yes"
"17121","REACTOME","1183602_REACT_355390_FRUCTOSE_METABOLISM",5,0.7737,0.74,1,"Yes",-0.8961,0.61,1,"No"
"17122","GO_BP","754748_GO_1901797_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",25,0.7738,0.84,1,"Yes",0.8083,0.78,1,"Yes"
"17123","GO_BP","491100_GO_0006119_OXIDATIVE_PHOSPHORYLATION",62,0.774,0.93,1,"Yes",2.4326,0,0,"Yes"
"17124","GO_BP","516623_GO_0071699_OLFACTORY_PLACODE_MORPHOGENESIS",6,0.7749,0.73,1,"Yes",0.7705,0.75,1,"Yes"
"17125","GO_BP","519318_GO_2000679_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",9,0.7751,0.75,1,"Yes",1.0306,0.4,0.97,"Yes"
"17126","C1_Positional","C1_ALL_125_CHR3P24",39,0.7754,0.89,0.96,"Yes",-0.6486,0.98,1,"No"
"17127","GO_MF","487321_GO_0001098_BASAL_TRANSCRIPTION_MACHINERY_BINDING",22,0.776,0.81,1,"Yes",-0.6473,0.94,1,"No"
"17128","C1_Positional","C1_ALL_28_CHR12Q15",25,0.7761,0.84,0.97,"Yes",0.76,0.83,0.99,"Yes"
"17129","GO_MF","490019_GO_0004703_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY",7,0.7762,0.75,1,"Yes",-1.083,0.37,0.85,"No"
"17130","GO_CC","500280_GO_0030990_INTRACILIARY_TRANSPORT_PARTICLE",29,0.7762,0.85,1,"Yes",0.8414,0.74,0.92,"Yes"
"17131","GO_BP","515177_GO_0070242_THYMOCYTE_APOPTOTIC_PROCESS",5,0.7764,0.74,1,"Yes",0.8366,0.66,1,"Yes"
"17132","GO_BP","491253_GO_0006290_PYRIMIDINE_DIMER_REPAIR",8,0.7765,0.74,1,"Yes",-0.581,0.95,1,"No"
"17133","GO_CC","500714_GO_0031463_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX",24,0.7773,0.82,1,"Yes",0.7509,0.85,0.98,"Yes"
"17134","GO_CC","500381_GO_0031094_PLATELET_DENSE_TUBULAR_NETWORK",11,0.7774,0.75,1,"Yes",-0.9943,0.46,0.84,"No"
"17135","C2_Chemical_and_genetic_perturbations","C2_CGP_1018_HASEGAWA_TUMORIGENESIS_BY_RET_C634R",11,0.7774,0.76,1,"Yes",1.3786,0.11,0.31,"Yes"
"17136","GO_BP","512208_GO_0051324_PROPHASE",80,0.7775,0.93,1,"Yes",0.6582,0.99,1,"Yes"
"17137","GO_BP","506491_GO_0043457_REGULATION_OF_CELLULAR_RESPIRATION",13,0.7776,0.77,1,"Yes",1.4439,0.071,0.5,"Yes"
"17138","GO_BP","488199_GO_0002326_B_CELL_LINEAGE_COMMITMENT",5,0.7776,0.7,1,"Yes",-1.1604,0.31,0.92,"No"
"17139","GO_BP","1022123_GO_0098722_ASYMMETRIC_STEM_CELL_DIVISION",6,0.778,0.72,1,"Yes",-0.6173,0.92,1,"No"
"17140","GO_BP","1184371_GO_0098779_ACTIVATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION",7,0.7783,0.73,1,"Yes",0.701,0.83,1,"Yes"
"17141","GO_BP","777530_GO_1901978_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT",9,0.7786,0.73,1,"Yes",1.2193,0.23,0.77,"Yes"
"17142","GO_CC","487091_GO_0000800_LATERAL_ELEMENT",11,0.7798,0.79,1,"Yes",-0.936,0.53,0.91,"No"
"17143","GO_MF","493214_GO_0009008_DNA_METHYLTRANSFERASE_ACTIVITY",5,0.7801,0.72,1,"Yes",-1.0844,0.37,0.85,"No"
"17144","GO_BP","983727_GO_1903008_ORGANELLE_DISASSEMBLY",50,0.7802,0.87,1,"Yes",1.3846,0.051,0.57,"Yes"
"17145","GO_BP","512209_GO_0051325_INTERPHASE",148,0.7809,0.98,1,"Yes",1.8444,0,0.066,"Yes"
"17146","C2_Chemical_and_genetic_perturbations","C2_CGP_1106_BENPORATH_ES_2",40,0.7813,0.87,1,"Yes",-1.0157,0.41,0.99,"No"
"17147","C7_Immunologic_signatures","C7_ALL_851_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP",198,0.7814,0.98,1,"Yes",1.5085,0,0.011,"Yes"
"17148","GO_BP","495220_GO_0014824_ARTERY_SMOOTH_MUSCLE_CONTRACTION",8,0.7816,0.76,1,"Yes",1.4183,0.11,0.53,"Yes"
"17149","WikiPathways","198809_WP197_CHOLESTEROL_BIOSYNTHESIS",17,0.7817,0.78,1,"Yes",0.5982,0.96,1,"Yes"
"17150","GO_BP","754795_GO_1901844_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION",9,0.7822,0.73,1,"Yes",1.3915,0.13,0.57,"Yes"
"17151","GO_MF","488051_GO_0002162_DYSTROGLYCAN_BINDING",6,0.7822,0.72,1,"Yes",1.2737,0.2,0.63,"Yes"
"17152","KEGG_compound","C05752_OCTANOYL_ACP_OCTANOYL_ACYL_CARRIER_PROTEIN_",5,0.7822,0.7,1,"Yes",-0.5873,0.93,1,"No"
"17153","GO_BP","513682_GO_0060124_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION",7,0.7823,0.75,1,"Yes",0.6813,0.86,1,"Yes"
"17154","GO_MF","516777_GO_0071855_NEUROPEPTIDE_RECEPTOR_BINDING",26,0.7824,0.84,1,"Yes",-1.9752,0,0.26,"No"
"17155","C4_Cancer_gene_neighborhoods","C4_CGN_252_GCM_PPP1CC",56,0.7826,0.91,1,"Yes",2.3093,0,0,"Yes"
"17156","C2_Chemical_and_genetic_perturbations","C2_CGP_3345_HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP",26,0.7828,0.82,1,"Yes",3.0219,0,0,"Yes"
"17157","GO_BP","491756_GO_0006895_GOLGI_TO_ENDOSOME_TRANSPORT",18,0.7832,0.77,1,"Yes",0.5452,0.97,1,"Yes"
"17158","REACTOME","477112_REACT_111158_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS",17,0.7835,0.75,0.99,"Yes",-1.1709,0.24,0.86,"No"
"17159","C4_Cancer_gene_neighborhoods","C4_CGN_46_MORF_SMC1L1",62,0.7835,0.93,1,"Yes",1.3926,0.039,0.064,"Yes"
"17160","C4_Cancer_gene_neighborhoods","C4_CGN_47_MORF_SP3",80,0.7837,0.94,1,"Yes",2.0657,0,0.00017,"Yes"
"17161","GO_BP","505240_GO_0042053_REGULATION_OF_DOPAMINE_METABOLIC_PROCESS",15,0.7837,0.77,1,"Yes",1.2574,0.2,0.72,"Yes"
"17162","C2_Chemical_and_genetic_perturbations","C2_CGP_1124_STARK_BRAIN_22Q11_DELETION",13,0.7837,0.75,1,"Yes",0.7986,0.74,0.99,"Yes"
"17163","GO_BP","494728_GO_0010665_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS",15,0.7839,0.75,1,"Yes",0.7492,0.81,1,"Yes"
"17164","GO_BP","512224_GO_0051340_REGULATION_OF_LIGASE_ACTIVITY",110,0.784,0.93,1,"Yes",1.9261,0,0.029,"Yes"
"17165","C7_Immunologic_signatures","C7_ALL_1201_GSE27786_CD4_TCELL_VS_MONO_MAC_UP",200,0.7846,0.98,1,"Yes",0.6865,1,1,"Yes"
"17166","GO_BP","1026081_GO_1903309_NEGATIVE_REGULATION_OF_CHROMATIN_MODIFICATION",43,0.7851,0.85,1,"Yes",1.0182,0.42,0.97,"Yes"
"17167","GO_BP","515466_GO_0070536_PROTEIN_K63_LINKED_DEUBIQUITINATION",20,0.7851,0.79,1,"Yes",0.8041,0.77,1,"Yes"
"17168","KEGG_compound","C00242_GUANINE_2_AMINO_6_HYDROXYPURINE",6,0.7856,0.71,1,"Yes",0.955,0.53,1,"Yes"
"17169","GO_BP","753347_GO_1900363_REGULATION_OF_MRNA_POLYADENYLATION",9,0.7859,0.74,1,"Yes",0.6996,0.83,1,"Yes"
"17170","GO_MF","754465_GO_1901505_CARBOHYDRATE_DERIVATIVE_TRANSPORTER_ACTIVITY",31,0.7865,0.82,1,"Yes",-0.6109,0.97,1,"No"
"17171","GO_CC","496339_GO_0016282_EUKARYOTIC_43S_PREINITIATION_COMPLEX",15,0.7866,0.79,1,"Yes",2.1297,0,0.00041,"Yes"
"17172","C6_Oncogenic_signatures","C6_ALL_162_TBK1_DF_DN",283,0.7869,1,0.95,"Yes",1.2699,0.022,0.42,"Yes"
"17173","GO_CC","490660_GO_0005587_COLLAGEN_TYPE_IV_TRIMER",6,0.7872,0.72,1,"Yes",-0.8048,0.7,1,"No"
"17174","GO_CC","502508_GO_0033290_EUKARYOTIC_48S_PREINITIATION_COMPLEX",15,0.7876,0.78,1,"Yes",2.29,0,0,"Yes"
"17175","C7_Immunologic_signatures","C7_ALL_157_GSE13306_RA_VS_UNTREATED_TCONV_UP",196,0.7877,0.98,1,"Yes",-0.6564,1,1,"No"
"17176","KEGG_pathway","HSA04742_TASTE_TRANSDUCTION",48,0.7878,0.88,0.97,"Yes",-1.0558,0.38,0.74,"No"
"17177","GO_BP","491448_GO_0006552_LEUCINE_CATABOLIC_PROCESS",5,0.7882,0.69,1,"Yes",1.1806,0.28,0.8,"Yes"
"17178","GO_BP","512582_GO_0051709_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM",7,0.7884,0.72,1,"Yes",-0.6301,0.93,1,"No"
"17179","GO_BP","514183_GO_0060628_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT",12,0.7886,0.74,1,"Yes",1.2197,0.22,0.77,"Yes"
"17180","GO_BP","493398_GO_0009202_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",6,0.7888,0.71,1,"Yes",-0.5131,0.98,1,"No"
"17181","GO_BP","751562_GO_0044349_DNA_EXCISION",22,0.7889,0.8,1,"Yes",1.3628,0.091,0.6,"Yes"
"17182","GO_BP","494741_GO_0010676_POSITIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",59,0.789,0.91,1,"Yes",1.1053,0.28,0.9,"Yes"
"17183","GO_BP","516622_GO_0071698_OLFACTORY_PLACODE_DEVELOPMENT",6,0.7892,0.74,1,"Yes",0.7906,0.74,1,"Yes"
"17184","GO_BP","494670_GO_0010606_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY",5,0.7894,0.7,1,"Yes",0.8396,0.66,1,"Yes"
"17185","C2_Chemical_and_genetic_perturbations","C2_CGP_1387_SCHUHMACHER_MYC_TARGETS_UP",80,0.7894,0.94,1,"Yes",1.1895,0.16,0.5,"Yes"
"17186","C4_Cancer_gene_neighborhoods","C4_CGN_154_MORF_PRKAG1",222,0.7894,0.98,1,"Yes",1.5408,0,0.023,"Yes"
"17187","GO_MF","496462_GO_0016494_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY",8,0.7895,0.72,1,"Yes",1.6553,0.021,0.19,"Yes"
"17188","C7_Immunologic_signatures","C7_ALL_136_GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN",200,0.7896,0.99,1,"Yes",1.6644,0,0.001,"Yes"
"17189","C3_MicroRNA_targets","C3_MIR_77_GTGGTGA_MIR_197",71,0.7896,0.91,1,"Yes",-0.7926,0.89,1,"No"
"17190","GO_BP","506269_GO_0043201_RESPONSE_TO_LEUCINE",6,0.7904,0.74,1,"Yes",0.7612,0.76,1,"Yes"
"17191","GO_MF","487929_GO_0002039_P53_BINDING",57,0.7905,0.87,1,"Yes",0.626,0.99,1,"Yes"
"17192","GO_BP","514008_GO_0060453_REGULATION_OF_GASTRIC_ACID_SECRETION",5,0.7907,0.68,1,"Yes",0.5883,0.94,1,"Yes"
"17193","GO_BP","518707_GO_2000058_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",96,0.791,0.93,1,"Yes",1.6801,0,0.21,"Yes"
"17194","GO_BP","486883_GO_0000381_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME",29,0.7911,0.82,1,"Yes",-1.1283,0.29,0.93,"No"
"17195","GO_BP","512048_GO_0051138_POSITIVE_REGULATION_OF_NK_T_CELL_DIFFERENTIATION",5,0.7916,0.72,1,"Yes",0.9672,0.52,1,"Yes"
"17196","GO_BP","512569_GO_0051694_POINTED_END_ACTIN_FILAMENT_CAPPING",7,0.7921,0.73,1,"Yes",-1.2205,0.24,0.88,"No"
"17197","C4_Cancer_gene_neighborhoods","C4_CGN_212_GCM_CALM1",108,0.7926,0.96,1,"Yes",-0.6819,0.99,1,"No"
"17198","GO_BP","751908_GO_0044766_MULTI_ORGANISM_TRANSPORT",36,0.7926,0.83,1,"Yes",1.5696,0.017,0.33,"Yes"
"17199","GO_CC","487106_GO_0000815_ESCRT_III_COMPLEX",10,0.7927,0.7,1,"Yes",1.0579,0.4,0.71,"Yes"
"17200","GO_BP","494272_GO_0035196_PRODUCTION_OF_MIRNAS_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",19,0.7932,0.77,1,"Yes",-0.6467,0.95,1,"No"
"17201","C7_Immunologic_signatures","C7_ALL_1831_GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP",194,0.7937,1,1,"Yes",1.2959,0.014,0.11,"Yes"
"17202","GO_MF","506597_GO_0043566_STRUCTURE_SPECIFIC_DNA_BINDING",247,0.7937,1,1,"Yes",1.2005,0.08,0.7,"Yes"
"17203","GO_MF","490349_GO_0005078_MAP_KINASE_SCAFFOLD_ACTIVITY",7,0.7937,0.71,1,"Yes",-1.106,0.33,0.84,"No"
"17204","C2_Chemical_and_genetic_perturbations","C2_CGP_1232_CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS",49,0.7938,0.87,1,"Yes",1.0326,0.39,0.75,"Yes"
"17205","C2_Chemical_and_genetic_perturbations","C2_CGP_1233_TCGA_GLIOBLASTOMA_COPY_NUMBER_UP",73,0.794,0.93,1,"Yes",0.9764,0.5,0.82,"Yes"
"17206","REACTOME","105830_REACT_6904_PHOSPHORYLATION_OF_THE_APC_C",17,0.7948,0.79,0.97,"Yes",1.0963,0.31,0.59,"Yes"
"17207","GO_MF","512594_GO_0051721_PROTEIN_PHOSPHATASE_2A_BINDING",19,0.7951,0.76,1,"Yes",0.8062,0.76,1,"Yes"
"17208","GO_BP","512046_GO_0051136_REGULATION_OF_NK_T_CELL_DIFFERENTIATION",5,0.7952,0.71,1,"Yes",0.9722,0.52,1,"Yes"
"17209","REACTOME","1127688_REACT_264442_MISMATCH_REPAIR",16,0.7952,0.77,0.97,"Yes",0.9184,0.54,0.88,"Yes"
"17210","GO_BP","516099_GO_0071173_SPINDLE_ASSEMBLY_CHECKPOINT",33,0.7953,0.84,1,"Yes",0.8974,0.63,1,"Yes"
"17211","GO_BP","491903_GO_0007080_MITOTIC_METAPHASE_PLATE_CONGRESSION",35,0.7957,0.82,1,"Yes",1.6021,0.015,0.29,"Yes"
"17212","C7_Immunologic_signatures","C7_ALL_1283_GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP",185,0.7961,0.97,1,"Yes",1.0528,0.29,0.58,"Yes"
"17213","C4_Cancer_modules","C4_CM_291_MODULE_332",45,0.7961,0.85,0.97,"Yes",-0.7481,0.91,1,"No"
"17214","C3_TF_targets","C3_TFT_447_GGCKCATGS_UNKNOWN",65,0.7962,0.88,1,"Yes",0.7367,0.94,1,"Yes"
"17215","GO_BP","491720_GO_0006853_CARNITINE_SHUTTLE",9,0.7969,0.72,1,"Yes",-0.8114,0.69,1,"No"
"17216","GO_MF","489910_GO_0004576_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY",9,0.7971,0.74,1,"Yes",1.3131,0.15,0.59,"Yes"
"17217","GO_MF","498687_GO_0019911_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH",5,0.7973,0.7,1,"Yes",0.9939,0.48,0.88,"Yes"
"17218","GO_BP","491267_GO_0006308_DNA_CATABOLIC_PROCESS",72,0.7973,0.9,1,"Yes",1.2342,0.12,0.75,"Yes"
"17219","C7_Immunologic_signatures","C7_ALL_248_GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN",195,0.7974,0.98,1,"Yes",0.6822,1,1,"Yes"
"17220","C2_Chemical_and_genetic_perturbations","C2_CGP_842_OXFORD_RALA_AND_RALB_TARGETS_UP",10,0.7975,0.73,1,"Yes",-1.1055,0.34,0.92,"No"
"17221","C2_Chemical_and_genetic_perturbations","C2_CGP_784_TERAMOTO_OPN_TARGETS_CLUSTER_3",5,0.7976,0.7,1,"Yes",0.6728,0.88,1,"Yes"
"17222","C4_Cancer_modules","C4_CM_426_MODULE_567",98,0.7977,0.89,0.99,"Yes",1.3305,0.05,0.24,"Yes"
"17223","C1_Positional","C1_ALL_47_CHR2P",9,0.7983,0.69,0.95,"Yes",1.2815,0.18,0.54,"Yes"
"17224","GO_MF","490346_GO_0030618_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_PATHWAY_SPECIFIC_CYTOPLASMIC_MEDIATOR_ACTIVITY",5,0.7983,0.69,1,"Yes",-0.4177,1,1,"No"
"17225","C4_Cancer_modules","C4_CM_46_MODULE_50",13,0.7986,0.73,1,"Yes",1.8928,0.0043,0.0087,"Yes"
"17226","GO_MF","511704_GO_0050733_RS_DOMAIN_BINDING",8,0.7986,0.72,1,"Yes",-1.2149,0.21,0.82,"No"
"17227","GO_BP","493282_GO_0009081_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS",23,0.7987,0.79,1,"Yes",1.2393,0.18,0.75,"Yes"
"17228","GO_BP","518407_GO_0090267_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT",6,0.799,0.69,1,"Yes",1.0098,0.46,0.98,"Yes"
"17229","GO_MF","492518_GO_0008170_N_METHYLTRANSFERASE_ACTIVITY",72,0.7993,0.9,1,"Yes",-0.8145,0.82,1,"No"
"17230","GO_MF","506106_GO_0043015_GAMMA_TUBULIN_BINDING",20,0.7994,0.75,1,"Yes",0.5869,0.97,1,"Yes"
"17231","REACTOME","1127697_REACT_264617_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION",22,0.8007,0.77,0.97,"Yes",1.4182,0.058,0.21,"Yes"
"17232","C7_Immunologic_signatures","C7_ALL_1751_GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_UP",170,0.8007,0.99,1,"Yes",1.0059,0.44,0.72,"Yes"
"17233","GO_MF","506247_GO_0043175_RNA_POLYMERASE_CORE_ENZYME_BINDING",22,0.8008,0.75,1,"Yes",-0.6554,0.94,1,"No"
"17234","GO_BP","508250_GO_0045945_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",11,0.8018,0.74,1,"Yes",-0.5862,0.95,1,"No"
"17235","C2_Chemical_and_genetic_perturbations","C2_CGP_3143_IVANOVSKA_MIR106B_TARGETS",90,0.8018,0.88,1,"Yes",0.7741,0.92,1,"Yes"
"17236","OMIM_gene","OMIM164360_ATP_SYNTHASE_H_TRANSPORTING_MITOCHONDRIAL_F1_COMPLEX_ALPHA_SUBUNIT_1_ATP5A1",5,0.8021,0.71,1,"Yes",1.7895,0.002,0.23,"Yes"
"17237","GO_BP","499080_GO_0021800_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION",8,0.8022,0.71,1,"Yes",0.7992,0.72,1,"Yes"
"17238","GO_MF","501371_GO_0032135_DNA_INSERTION_OR_DELETION_BINDING",6,0.8023,0.7,1,"Yes",-0.5942,0.93,1,"No"
"17239","GO_BP","518753_GO_2000104_NEGATIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION",15,0.8024,0.72,1,"Yes",-0.6378,0.92,1,"No"
"17240","C2_BioCarta_Pathways","C2_CP_BIOCARTA_29_BIOCARTA_CARM_ER_PATHWAY",34,0.8026,0.81,0.9,"Yes",-0.7363,0.89,1,"No"
"17241","GO_BP","518534_GO_0090394_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",6,0.803,0.7,1,"Yes",-1.1376,0.31,0.93,"No"
"17242","REACTOME","645276_REACT_120999_FGFR1_MUTANT_RECEPTOR_ACTIVATION",28,0.8031,0.77,0.97,"Yes",0.685,0.95,1,"Yes"
"17243","C2_Chemical_and_genetic_perturbations","C2_CGP_2850_PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP",188,0.8031,0.97,1,"Yes",0.7996,0.96,0.99,"Yes"
"17244","C3_MicroRNA_targets","C3_MIR_111_ACGCACA_MIR_210",8,0.8033,0.71,1,"Yes",-0.7611,0.78,1,"No"
"17245","C1_Positional","C1_ALL_267_CHR7Q35",40,0.8036,0.8,0.95,"Yes",-0.9177,0.6,1,"No"
"17246","GO_BP","487015_GO_0000718_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_REMOVAL",22,0.8041,0.77,1,"Yes",1.3579,0.084,0.6,"Yes"
"17247","GO_BP","507123_GO_0044108_CELLULAR_ALCOHOL_BIOSYNTHETIC_PROCESS",5,0.8042,0.69,1,"Yes",-1.0024,0.47,0.99,"No"
"17248","GO_BP","496010_GO_0015886_HEME_TRANSPORT",9,0.8043,0.73,1,"Yes",-1.2142,0.22,0.88,"No"
"17249","GO_BP","507122_GO_0044107_CELLULAR_ALCOHOL_METABOLIC_PROCESS",5,0.8048,0.68,1,"Yes",-1.013,0.44,0.98,"No"
"17250","GO_BP","491996_GO_0007196_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",7,0.8053,0.71,1,"Yes",1.4436,0.08,0.5,"Yes"
"17251","KEGG_reaction","R02088_2_DEOXYADENOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DAMP_H2O_DEOXYADENOSINE_ORTHOPHOSPHATE",9,0.8054,0.69,0.79,"Yes",0.5571,0.95,1,"Yes"
"17252","C2_Chemical_and_genetic_perturbations","C2_CGP_2898_DORN_ADENOVIRUS_INFECTION_48HR_UP",14,0.8054,0.72,1,"Yes",0.9257,0.55,0.89,"Yes"
"17253","C3_TF_targets","C3_TFT_205_CCAWNWWNNNGGC_UNKNOWN",81,0.8059,0.87,1,"Yes",1.2017,0.13,0.76,"Yes"
"17254","REACTOME","1127540_REACT_267700_DEGRADATION_OF_GLI2_BY_THE_PROTEASOME",59,0.8062,0.85,0.96,"Yes",2.1547,0,0.00026,"Yes"
"17255","GO_BP","511978_GO_0051053_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS",85,0.8063,0.89,1,"Yes",0.8337,0.82,1,"Yes"
"17256","REACTOME","645274_REACT_120736_SIGNALING_BY_FGFR_IN_DISEASE",39,0.8064,0.8,0.96,"Yes",-0.7686,0.82,1,"No"
"17257","GO_BP","507978_GO_0045630_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION",6,0.8066,0.65,1,"Yes",-0.8569,0.65,1,"No"
"17258","GO_BP","755357_GO_2001251_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION",92,0.8068,0.9,1,"Yes",1.129,0.2,0.87,"Yes"
"17259","GO_CC","507395_GO_0044447_AXONEME_PART",29,0.8069,0.79,0.99,"Yes",-1.6631,0.0071,0.32,"No"
"17260","GO_BP","505882_GO_0042776_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_PROTON_TRANSPORT",17,0.8071,0.74,1,"Yes",2.2246,0,0.00048,"Yes"
"17261","C4_Cancer_gene_neighborhoods","C4_CGN_101_MORF_FBL",140,0.8074,0.94,1,"Yes",2.5073,0,0,"Yes"
"17262","GO_CC","490921_GO_0005922_CONNEXON_COMPLEX",19,0.8076,0.72,0.99,"Yes",-1.4436,0.064,0.63,"No"
"17263","GO_MF","493050_GO_0008821_CROSSOVER_JUNCTION_ENDODEOXYRIBONUCLEASE_ACTIVITY",6,0.8078,0.68,1,"Yes",1.0675,0.41,0.82,"Yes"
"17264","GO_BP","511659_GO_0050687_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS",17,0.808,0.74,1,"Yes",1.4084,0.08,0.55,"Yes"
"17265","GO_MF","492532_GO_0008190_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING",7,0.808,0.7,1,"Yes",0.7135,0.82,1,"Yes"
"17266","REACTOME","1127696_REACT_263856_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS",33,0.8081,0.82,0.96,"Yes",1.2779,0.12,0.35,"Yes"
"17267","GO_BP","506315_GO_0043248_PROTEASOME_ASSEMBLY",9,0.8081,0.72,1,"Yes",1.5343,0.042,0.36,"Yes"
"17268","C1_Positional","C1_ALL_284_CHR3Q23",23,0.8084,0.76,0.96,"Yes",1.5981,0.021,0.24,"Yes"
"17269","GO_BP","494951_GO_0010887_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE",6,0.8084,0.7,1,"Yes",1.3243,0.17,0.64,"Yes"
"17270","GO_BP","487728_GO_0001832_BLASTOCYST_GROWTH",19,0.8086,0.78,1,"Yes",0.8464,0.7,1,"Yes"
"17271","GO_MF","496791_GO_0016907_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY",5,0.8095,0.69,1,"Yes",0.8706,0.62,1,"Yes"
"17272","REACTOME","1127529_REACT_264478_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS",63,0.8098,0.89,0.96,"Yes",1.8134,0,0.019,"Yes"
"17273","GO_BP","491816_GO_0006978_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR",14,0.81,0.75,1,"Yes",0.7969,0.75,1,"Yes"
"17274","GO_BP","517151_GO_0072235_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT",6,0.8102,0.67,1,"Yes",1.0743,0.37,0.93,"Yes"
"17275","GO_BP","505315_GO_0042149_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION",27,0.8103,0.77,1,"Yes",0.5642,0.99,1,"Yes"
"17276","GO_BP","491160_GO_0006188_IMP_BIOSYNTHETIC_PROCESS",11,0.8106,0.72,1,"Yes",0.5593,0.96,1,"Yes"
"17277","REACTOME","1127509_REACT_268024_INTRAFLAGELLAR_TRANSPORT",41,0.8108,0.82,0.96,"Yes",0.772,0.88,1,"Yes"
"17278","GO_BP","493458_GO_0009265_2_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",9,0.8114,0.68,1,"Yes",0.9494,0.54,1,"Yes"
"17279","C3_MicroRNA_targets","C3_MIR_152_ATAAGCT_MIR_21",113,0.8115,0.91,1,"Yes",1.0588,0.31,1,"Yes"
"17280","GO_BP","488269_GO_0002396_MHC_PROTEIN_COMPLEX_ASSEMBLY",6,0.812,0.68,1,"Yes",-0.9337,0.55,1,"No"
"17281","GO_CC","490781_GO_0005746_MITOCHONDRIAL_RESPIRATORY_CHAIN",62,0.8122,0.88,0.99,"Yes",2.5853,0,0,"Yes"
"17282","KEGG_compound","C00630_2_METHYLPROPANOYL_COA_2_METHYLPROPIONYL_COA_ISOBUTYRYL_COA",5,0.8123,0.65,1,"Yes",1.2024,0.25,0.87,"Yes"
"17283","GO_BP","500212_GO_0030917_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT",6,0.813,0.69,1,"Yes",-1.0324,0.44,0.98,"No"
"17284","C1_Positional","C1_ALL_154_CHR11P14",26,0.8134,0.78,0.96,"Yes",0.8375,0.75,0.92,"Yes"
"17285","GO_BP","925928_GO_1902579_MULTI_ORGANISM_LOCALIZATION",36,0.8135,0.8,1,"Yes",1.5416,0.028,0.36,"Yes"
"17286","GO_BP","512317_GO_0051439_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_MITOTIC_CELL_CYCLE",78,0.8146,0.9,1,"Yes",1.987,0,0.015,"Yes"
"17287","C2_Chemical_and_genetic_perturbations","C2_CGP_3348_HOLLEMAN_DAUNORUBICIN_B_ALL_DN",12,0.8146,0.68,1,"Yes",1.4722,0.081,0.23,"Yes"
"17288","GO_CC","515919_GO_0070993_TRANSLATION_PREINITIATION_COMPLEX",16,0.8148,0.73,0.99,"Yes",2.2729,0,0,"Yes"
"17289","GO_MF","489669_GO_0004303_ESTRADIOL_17_BETA_DEHYDROGENASE_ACTIVITY",9,0.8148,0.68,1,"Yes",1.8955,0,0.033,"Yes"
"17290","C2_Chemical_and_genetic_perturbations","C2_CGP_2033_PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",49,0.8153,0.84,1,"Yes",2.1488,0,0.0012,"Yes"
"17291","GO_BP","752386_GO_0086014_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",8,0.816,0.69,1,"Yes",0.7816,0.73,1,"Yes"
"17292","REACTOME","771572_REACT_160251_CLEARANCE_OF_NUCLEAR_ENVELOPE_MEMBRANES_FROM_CHROMATIN",7,0.8164,0.69,0.96,"Yes",1.435,0.074,0.19,"Yes"
"17293","GO_BP","496519_GO_0016571_HISTONE_METHYLATION",73,0.8164,0.89,1,"Yes",-0.601,0.99,1,"No"
"17294","GO_BP","495208_GO_0014812_MUSCLE_CELL_MIGRATION",16,0.8165,0.71,1,"Yes",1.4626,0.048,0.48,"Yes"
"17295","REACTOME","160983_REACT_15513_AMINE_DERIVED_HORMONES",15,0.8166,0.73,0.96,"Yes",0.8833,0.63,0.92,"Yes"
"17296","GO_BP","515915_GO_0070989_OXIDATIVE_DEMETHYLATION",15,0.8168,0.71,1,"Yes",0.682,0.92,1,"Yes"
"17297","GO_BP","514102_GO_0060547_NEGATIVE_REGULATION_OF_NECROTIC_CELL_DEATH",11,0.8175,0.7,1,"Yes",-0.9625,0.53,1,"No"
"17298","KEGG_enzyme","2.7.7.7_DNA_DIRECTED_DNA_POLYMERASE_DNA_POLYMERASE_I_DNA_POLYMERASE_II_DNA_POLYMERASE_III_DNA_POLYMERASE_ALPHA_DNA_POLYMERASE_BETA_DNA_POLYMERASE_GAMMA_DNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DEOXYRIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_DEOXYNUCLEATE_POLYMERASE_DEOXYRIBONUCLEIC_ACID_DUPLICASE_DEOXYRIBONUCLEIC_ACID_POLYMERASE_DEOXYRIBONUCLEIC_DUPLICASE_DEOXYRIBONUCLEIC_POLYMERASE_DEOXYRIBONUCLEIC_POLYMERASE_I_DNA_DUPLICASE_DNA_NUCLEOTIDYLTRANSFERASE_DNA_POLYMERASE_DNA_REPLICASE_DNA_DEPENDENT_DNA_POLYMERASE_DUPLICASE_KLENOW_FRAGMENT_SEQUENASE_TAQ_DNA_POLYMERASE_TAQ_POL_I_TCA_DNA_POLYMERASE",17,0.8177,0.73,0.79,"Yes",-1.157,0.28,0.69,"No"
"17299","GO_BP","512194_GO_0051310_METAPHASE_PLATE_CONGRESSION",41,0.818,0.81,1,"Yes",1.4747,0.027,0.45,"Yes"
"17300","GO_BP","493407_GO_0009211_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",5,0.8181,0.67,1,"Yes",0.7862,0.72,1,"Yes"
"17301","GO_MF","496948_GO_0017153_SODIUM_DICARBOXYLATE_SYMPORTER_ACTIVITY",10,0.8187,0.69,1,"Yes",-0.9316,0.55,0.97,"No"
"17302","REACTOME","106546_REACT_8027_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE",12,0.8188,0.71,0.96,"Yes",1.2638,0.18,0.37,"Yes"
"17303","C7_Immunologic_signatures","C7_ALL_688_GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_DN",197,0.8188,0.96,1,"Yes",1.3847,0.016,0.043,"Yes"
"17304","C2_Chemical_and_genetic_perturbations","C2_CGP_2652_MILI_PSEUDOPODIA_CHEMOTAXIS_UP",74,0.8188,0.87,1,"Yes",1.3137,0.063,0.38,"Yes"
"17305","KEGG_reaction","R01664_2_DEOXYCYTIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DCMP_H2O_DEOXYCYTIDINE_ORTHOPHOSPHATE",9,0.8189,0.68,0.78,"Yes",0.5631,0.96,1,"Yes"
"17306","GO_CC","500717_GO_0031466_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX",6,0.8189,0.68,0.98,"Yes",1.557,0.017,0.15,"Yes"
"17307","GO_BP","505528_GO_0042384_CILIUM_ASSEMBLY",137,0.8194,0.91,1,"Yes",-0.7773,0.95,1,"No"
"17308","REACTOME","105852_REACT_2174_DNA_DAMAGE_BYPASS",46,0.8194,0.83,0.96,"Yes",1.5394,0.019,0.13,"Yes"
"17309","KEGG_reaction","R02323_NICOTINAMIDE_RIBONUCLEOTIDE_PHOSPHOHYDROLASE_NICOTINAMIDE_D_RIBONUCLEOTIDE_H2O_NICOTINAMIDE_BETA_RIBOSIDE_ORTHOPHOSPHATE",9,0.8194,0.69,0.8,"Yes",0.5624,0.97,1,"Yes"
"17310","GO_BP","517094_GO_0072178_NEPHRIC_DUCT_MORPHOGENESIS",9,0.8196,0.67,1,"Yes",1.0485,0.36,0.95,"Yes"
"17311","REACTOME","161074_REACT_22310_ORGANIC_ANION_TRANSPORT",5,0.8197,0.64,0.96,"Yes",1.7288,0.0021,0.038,"Yes"
"17312","GO_CC","500712_GO_0031461_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX",105,0.8199,0.91,0.99,"Yes",1.257,0.1,0.45,"Yes"
"17313","KEGG_reaction","R02719_XANTHOSINE_5_PHOSPHATE_PHOSPHOHYDROLASE_XANTHOSINE_5_PHOSPHATE_H2O_XANTHOSINE_ORTHOPHOSPHATE",9,0.8199,0.72,0.81,"Yes",0.5647,0.96,1,"Yes"
"17314","C7_Immunologic_signatures","C7_ALL_251_GSE14308_TH2_VS_NATURAL_TREG_UP",194,0.8201,0.97,1,"Yes",1.1426,0.17,0.34,"Yes"
"17315","C7_Immunologic_signatures","C7_ALL_106_GSE11924_TH2_VS_TH17_CD4_TCELL_DN",199,0.8202,0.98,1,"Yes",0.9285,0.67,0.96,"Yes"
"17316","GO_MF","489884_GO_0004536_DEOXYRIBONUCLEASE_ACTIVITY",59,0.8203,0.83,1,"Yes",1.2199,0.15,0.7,"Yes"
"17317","GO_BP","489288_GO_0043486_HISTONE_EXCHANGE",51,0.8204,0.82,1,"Yes",-0.9776,0.5,1,"No"
"17318","GO_BP","496310_GO_0016246_RNA_INTERFERENCE",10,0.8208,0.69,1,"Yes",-0.6945,0.86,1,"No"
"17319","C2_Chemical_and_genetic_perturbations","C2_CGP_611_TURJANSKI_MAPK11_TARGETS",5,0.8208,0.66,1,"Yes",-0.9263,0.56,1,"No"
"17320","REACTOME","105795_REACT_70_REMOVAL_OF_THE_FLAP_INTERMEDIATE",14,0.8209,0.73,0.96,"Yes",1.4175,0.075,0.21,"Yes"
"17321","C1_Positional","C1_ALL_295_CHR3Q27",56,0.821,0.81,0.96,"Yes",1.1947,0.16,0.62,"Yes"
"17322","C2_Chemical_and_genetic_perturbations","C2_CGP_2456_MOOTHA_HUMAN_MITODB_6_2002",430,0.821,1,1,"Yes",2.1894,0,0.00061,"Yes"
"17323","GO_BP","502236_GO_0033014_TETRAPYRROLE_BIOSYNTHETIC_PROCESS",30,0.822,0.79,1,"Yes",1.1985,0.19,0.78,"Yes"
"17324","GO_MF","490343_GO_0005072_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_CYTOPLASMIC_MEDIATOR_ACTIVITY",10,0.8224,0.68,1,"Yes",-0.5014,0.99,1,"No"
"17325","REACTOME","1183546_REACT_355196_IKBKG_DEFICIENCY_CAUSES_ANHIDROTIC_ECTODERMAL_DYSPLASIA_WITH_IMMUNODEFICIENCY_EDA_ID_VIA_TLR_",8,0.8227,0.68,0.96,"Yes",-0.5078,0.99,1,"No"
"17326","GO_BP","489144_GO_0003352_REGULATION_OF_CILIUM_MOVEMENT",9,0.8233,0.68,1,"Yes",-0.5979,0.93,1,"No"
"17327","REACTOME","1127690_REACT_264347_MISMATCH_REPAIR_MMR_DIRECTED_BY_MSH2_MSH3_MUTSBETA_",15,0.8233,0.72,0.96,"Yes",0.9349,0.54,0.86,"Yes"
"17328","C4_Cancer_modules","C4_CM_67_MODULE_71",22,0.824,0.78,0.99,"Yes",-0.8193,0.74,0.95,"No"
"17329","GO_BP","500340_GO_0031050_DSRNA_FRAGMENTATION",20,0.8241,0.73,1,"Yes",-0.6072,0.96,1,"No"
"17330","C4_Cancer_modules","C4_CM_303_MODULE_350",58,0.8252,0.83,1,"Yes",1.5051,0.021,0.11,"Yes"
"17331","KEGG_module","HSA_M00383_ECV_COMPLEX",5,0.8254,0.65,0.85,"Yes",1.4647,0.063,0.21,"Yes"
"17332","KEGG_reaction","R03346_NICOTINATE_D_RIBONUCLEOTIDE_PHOSPHOHYDROLASE_NICOTINATE_D_RIBONUCLEOTIDE_H2O_NICOTINATE_D_RIBONUCLEOSIDE_ORTHOPHOSPHATE",9,0.8256,0.69,0.82,"Yes",0.5692,0.97,1,"Yes"
"17333","GO_BP","515135_GO_0070198_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION",6,0.8256,0.68,1,"Yes",0.7989,0.7,1,"Yes"
"17334","KEGG_reaction","R01126_INOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_IMP_H2O_INOSINE_ORTHOPHOSPHATE",9,0.8261,0.67,0.83,"Yes",0.5663,0.95,1,"Yes"
"17335","GO_BP","491885_GO_0007062_SISTER_CHROMATID_COHESION",27,0.8269,0.75,1,"Yes",-0.6037,0.97,1,"No"
"17336","GO_BP","1133947_GO_1903772_REGULATION_OF_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX",5,0.8269,0.64,1,"Yes",1.3047,0.17,0.66,"Yes"
"17337","REACTOME","645307_REACT_120752_HS_GAG_DEGRADATION",21,0.8269,0.73,0.96,"Yes",1.0684,0.35,0.63,"Yes"
"17338","REACTOME","105815_REACT_682_MITOTIC_PROMETAPHASE",109,0.8277,0.9,0.96,"Yes",1.499,0.0044,0.15,"Yes"
"17339","GO_CC","499476_GO_0030008_TRAPP_COMPLEX",5,0.8279,0.68,0.97,"Yes",0.9832,0.47,0.81,"Yes"
"17340","GO_BP","491413_GO_0006516_GLYCOPROTEIN_CATABOLIC_PROCESS",12,0.8282,0.69,1,"Yes",0.9686,0.5,1,"Yes"
"17341","GO_MF","752541_GO_0090484_DRUG_TRANSPORTER_ACTIVITY",20,0.8285,0.7,1,"Yes",-1.0119,0.43,0.89,"No"
"17342","C2_Chemical_and_genetic_perturbations","C2_CGP_2178_OUILLETTE_CLL_13Q14_DELETION_UP",73,0.8286,0.84,1,"Yes",0.9045,0.67,0.92,"Yes"
"17343","GO_CC","492602_GO_0008278_COHESIN_COMPLEX",12,0.8287,0.69,0.98,"Yes",-0.6791,0.88,1,"No"
"17344","C2_Chemical_and_genetic_perturbations","C2_CGP_2832_LOPEZ_EPITHELIOID_MESOTHELIOMA",16,0.8288,0.71,1,"Yes",-1.4526,0.081,0.53,"No"
"17345","GO_BP","508679_GO_0046416_D_AMINO_ACID_METABOLIC_PROCESS",5,0.8289,0.61,1,"Yes",1.6381,0.0062,0.25,"Yes"
"17346","GO_BP","488070_GO_0002181_CYTOPLASMIC_TRANSLATION",16,0.829,0.7,1,"Yes",1.7614,0.0064,0.13,"Yes"
"17347","KEGG_reaction","R01569_THYMIDYLATE_5_PHOSPHOHYDROLASE_DTMP_H2O_THYMIDINE_ORTHOPHOSPHATE",9,0.829,0.69,0.84,"Yes",0.5796,0.96,1,"Yes"
"17348","C1_Positional","C1_ALL_292_CHR6Q14",35,0.8291,0.76,0.96,"Yes",0.9621,0.5,0.81,"Yes"
"17349","GO_BP","754498_GO_1901538_CHANGES_TO_DNA_METHYLATION_INVOLVED_IN_EMBRYO_DEVELOPMENT",7,0.8293,0.69,1,"Yes",-1.2645,0.19,0.9,"No"
"17350","GO_BP","512321_GO_0051443_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",88,0.8293,0.88,1,"Yes",1.9598,0,0.02,"Yes"
"17351","C2_Chemical_and_genetic_perturbations","C2_CGP_1967_WELCSH_BRCA1_TARGETS_DN",141,0.8294,0.91,1,"Yes",0.7567,0.97,1,"Yes"
"17352","KEGG_reaction","R01968_2_DEOXYGUANOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DGMP_H2O_DEOXYGUANOSINE_ORTHOPHOSPHATE",9,0.8294,0.66,0.86,"Yes",0.545,0.97,1,"Yes"
"17353","GO_MF","496394_GO_0016406_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY",6,0.8294,0.63,1,"Yes",-0.8017,0.7,1,"No"
"17354","C7_Immunologic_signatures","C7_ALL_628_GSE17721_POLYIC_VS_CPG_8H_BMDM_DN",199,0.8294,0.94,1,"Yes",1.61,0,0.0025,"Yes"
"17355","GO_BP","496154_GO_0016056_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY",36,0.8294,0.77,1,"Yes",-1.1161,0.28,0.94,"No"
"17356","C4_Cancer_gene_neighborhoods","C4_CGN_35_MORF_RAD23A",347,0.8297,0.98,1,"Yes",2.3717,0,0,"Yes"
"17357","REACTOME","160973_REACT_21285_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1",17,0.8297,0.69,0.96,"Yes",0.9687,0.49,0.8,"Yes"
"17358","GO_BP","486806_GO_0000289_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING",25,0.8299,0.73,1,"Yes",0.9381,0.54,1,"Yes"
"17359","GO_BP","516386_GO_0071462_CELLULAR_RESPONSE_TO_WATER_STIMULUS",6,0.8302,0.63,1,"Yes",-0.557,0.96,1,"No"
"17360","KEGG_reaction","R02102_2_DEOXYURIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DUMP_H2O_DEOXYURIDINE_ORTHOPHOSPHATE",9,0.8305,0.68,0.88,"Yes",0.5709,0.96,1,"Yes"
"17361","GO_BP","508220_GO_0045913_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS",66,0.8309,0.83,1,"Yes",1.2013,0.15,0.78,"Yes"
"17362","C2_Chemical_and_genetic_perturbations","C2_CGP_2606_ZHANG_TLX_TARGETS_36HR_DN",185,0.8309,0.94,1,"Yes",1.3628,0.012,0.33,"Yes"
"17363","GO_MF","489992_GO_0004663_RAB_GERANYLGERANYLTRANSFERASE_ACTIVITY",5,0.8317,0.61,1,"Yes",0.6565,0.88,1,"Yes"
"17364","GO_MF","489580_GO_0004115_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY",11,0.8317,0.69,1,"Yes",-1.1779,0.26,0.78,"No"
"17365","KEGG_reaction","R00963_URIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_UMP_H2O_URIDINE_ORTHOPHOSPHATE",9,0.8317,0.65,0.89,"Yes",0.5652,0.96,1,"Yes"
"17366","KEGG_reaction","R00511_CYTIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_CMP_H2O_CYTIDINE_ORTHOPHOSPHATE",9,0.8318,0.67,0.91,"Yes",0.556,0.98,1,"Yes"
"17367","GO_MF","487556_GO_0001640_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY",7,0.8326,0.67,1,"Yes",1.427,0.12,0.47,"Yes"
"17368","GO_BP","515845_GO_0070918_PRODUCTION_OF_SMALL_RNA_INVOLVED_IN_GENE_SILENCING_BY_RNA",20,0.8329,0.74,1,"Yes",-0.6053,0.97,1,"No"
"17369","C3_TF_targets","C3_TFT_29_AACYNNNNTTCCS_UNKNOWN",93,0.833,0.88,1,"Yes",0.874,0.74,1,"Yes"
"17370","GO_BP","508252_GO_0045948_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION",15,0.8333,0.69,1,"Yes",-0.9452,0.53,1,"No"
"17371","GO_MF","492705_GO_0008409_5_3_EXONUCLEASE_ACTIVITY",11,0.8339,0.67,1,"Yes",1.4967,0.054,0.39,"Yes"
"17372","GO_CC","499693_GO_0030289_PROTEIN_PHOSPHATASE_4_COMPLEX",5,0.8341,0.65,0.97,"Yes",0.7516,0.77,0.98,"Yes"
"17373","REACTOME","105853_REACT_2198_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE",37,0.8342,0.77,0.95,"Yes",1.3595,0.087,0.26,"Yes"
"17374","GO_BP","500337_GO_0031047_GENE_SILENCING_BY_RNA",57,0.8343,0.8,1,"Yes",0.507,1,1,"Yes"
"17375","KEGG_enzyme","2.1.1.43_HISTONE_LYSINE_N_METHYLTRANSFERASE_PROTEIN_METHYLASE_III_PROTEIN_METHYLASE_3_PROTEIN_LYSINE_METHYLTRANSFERASE_PROTEIN_METHYLTRANSFERASE_II_PROTEIN_LYSINE_N_METHYLTRANSFERASE_HISTONE_H1_SPECIFIC_S_ADENOSYLMETHIONINE_PROTEIN_LYSINE_N_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_6_N_METHYLTRANSFERASE",27,0.8344,0.74,0.83,"Yes",-1.2617,0.17,0.55,"No"
"17376","KEGG_reaction","R01227_GUANOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_GMP_H2O_GUANOSINE_ORTHOPHOSPHATE",9,0.8344,0.65,0.93,"Yes",0.5751,0.94,1,"Yes"
"17377","KEGG_reaction","R00183_ADENOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_AMP_H2O_ADENOSINE_ORTHOPHOSPHATE",9,0.8345,0.66,0.95,"Yes",0.5595,0.96,1,"Yes"
"17378","GO_BP","1129498_GO_1903672_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS",9,0.8348,0.67,1,"Yes",0.7941,0.7,1,"Yes"
"17379","GO_MF","489388_GO_0003887_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY",29,0.8348,0.75,1,"Yes",-1.1218,0.29,0.81,"No"
"17380","REACTOME","1183548_REACT_355226_IKBA_VARIANT_LEADS_TO_EDA_ID",7,0.835,0.68,0.95,"Yes",-0.4869,0.99,1,"No"
"17381","GO_BP","755160_GO_2001054_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS",9,0.8352,0.67,1,"Yes",1.6351,0.016,0.25,"Yes"
"17382","GO_MF","503442_GO_0034237_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING",10,0.8354,0.68,1,"Yes",0.8309,0.69,1,"Yes"
"17383","C2_Chemical_and_genetic_perturbations","C2_CGP_3105_PHESSE_TARGETS_OF_APC_AND_MBD2_UP",19,0.8359,0.73,1,"Yes",0.6886,0.87,1,"Yes"
"17384","GO_BP","506080_GO_0042987_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",8,0.8363,0.66,1,"Yes",0.8875,0.6,1,"Yes"
"17385","C2_Chemical_and_genetic_perturbations","C2_CGP_2969_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP",40,0.8363,0.77,1,"Yes",1.2439,0.14,0.45,"Yes"
"17386","GO_BP","491860_GO_0007032_ENDOSOME_ORGANIZATION",36,0.8364,0.75,1,"Yes",1.0267,0.39,0.97,"Yes"
"17387","C2_Chemical_and_genetic_perturbations","C2_CGP_2647_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP",5,0.8365,0.63,1,"Yes",-0.8188,0.7,1,"No"
"17388","GO_CC","505030_GO_0035861_SITE_OF_DOUBLE_STRAND_BREAK",21,0.8367,0.71,0.97,"Yes",0.9155,0.57,0.87,"Yes"
"17389","GO_BP","489152_GO_0003360_BRAINSTEM_DEVELOPMENT",6,0.8367,0.63,1,"Yes",-0.6735,0.86,1,"No"
"17390","GO_BP","502581_GO_0033363_SECRETORY_GRANULE_ORGANIZATION",28,0.8368,0.78,1,"Yes",1.1432,0.26,0.84,"Yes"
"17391","GO_BP","515143_GO_0070208_PROTEIN_HETEROTRIMERIZATION",11,0.8369,0.68,1,"Yes",-1.0679,0.39,0.96,"No"
"17392","KEGG_compound","C16677_ALL_TRANS_4_HYDROXYRETINOIC_ACID",15,0.8371,0.71,1,"Yes",-1.003,0.48,1,"No"
"17393","C2_BioCarta_Pathways","C2_CP_BIOCARTA_147_BIOCARTA_RAC1_PATHWAY",22,0.8372,0.72,0.89,"Yes",1.0194,0.43,0.84,"Yes"
"17394","C2_Chemical_and_genetic_perturbations","C2_CGP_982_GROSS_HYPOXIA_VIA_HIF1A_UP",77,0.8376,0.85,1,"Yes",1.2816,0.089,0.41,"Yes"
"17395","REACTOME","106553_REACT_953_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION",47,0.8376,0.8,0.95,"Yes",0.7486,0.88,1,"Yes"
"17396","C7_Immunologic_signatures","C7_ALL_1082_GSE25087_FETAL_VS_ADULT_TCONV_DN",189,0.8377,0.96,1,"Yes",-0.8583,0.84,1,"No"
"17397","GO_BP","491997_GO_0007197_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY",5,0.8379,0.64,1,"Yes",0.8836,0.61,1,"Yes"
"17398","C1_Positional","C1_ALL_190_CHR3Q29",54,0.8379,0.78,0.95,"Yes",-1.0982,0.27,1,"No"
"17399","GO_BP","510328_GO_0048205_COPI_COATING_OF_GOLGI_VESICLE",13,0.838,0.68,1,"Yes",1.6016,0.033,0.29,"Yes"
"17400","GO_CC","500665_GO_0031414_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX",10,0.8381,0.68,0.97,"Yes",-0.8502,0.65,0.97,"No"
"17401","GO_BP","499441_GO_0023019_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION",21,0.8381,0.7,1,"Yes",1.0509,0.39,0.95,"Yes"
"17402","GO_BP","494701_GO_0010637_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION",5,0.8383,0.66,1,"Yes",1.0273,0.46,0.97,"Yes"
"17403","C7_Immunologic_signatures","C7_ALL_1743_GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP",171,0.8383,0.94,1,"Yes",-1.5185,0.0017,0.054,"No"
"17404","REACTOME","576278_REACT_118699_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS",7,0.8385,0.65,0.95,"Yes",-1.2822,0.17,0.67,"No"
"17405","C2_Chemical_and_genetic_perturbations","C2_CGP_3138_BRUINS_UVC_RESPONSE_MIDDLE",97,0.8387,0.86,1,"Yes",-0.8413,0.82,1,"No"
"17406","C2_Chemical_and_genetic_perturbations","C2_CGP_190_GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN",330,0.8388,0.94,1,"Yes",-1.6351,0,0.37,"No"
"17407","GO_BP","516950_GO_0072033_RENAL_VESICLE_FORMATION",5,0.8388,0.62,1,"Yes",0.7612,0.74,1,"Yes"
"17408","GO_MF","496912_GO_0017108_5_FLAP_ENDONUCLEASE_ACTIVITY",5,0.8389,0.64,1,"Yes",0.838,0.64,1,"Yes"
"17409","GO_BP","504699_GO_0035518_HISTONE_H2A_MONOUBIQUITINATION",12,0.8392,0.68,1,"Yes",0.8132,0.73,1,"Yes"
"17410","C7_Immunologic_signatures","C7_ALL_641_GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_UP",199,0.8398,0.96,1,"Yes",1.0992,0.21,0.45,"Yes"
"17411","GO_MF","492827_GO_0008553_HYDROGEN_EXPORTING_ATPASE_ACTIVITY_PHOSPHORYLATIVE_MECHANISM",7,0.8398,0.66,1,"Yes",1.2165,0.25,0.7,"Yes"
"17412","KEGG_pathway","HSA00100_STEROID_BIOSYNTHESIS",20,0.84,0.68,0.91,"Yes",-0.7032,0.88,1,"No"
"17413","GO_BP","510475_GO_0048368_LATERAL_MESODERM_DEVELOPMENT",11,0.8401,0.66,1,"Yes",-1.0355,0.42,0.98,"No"
"17414","REACTOME","730315_REACT_150425_RESOLUTION_OF_SISTER_CHROMATID_COHESION",101,0.8403,0.9,0.95,"Yes",1.424,0.016,0.2,"Yes"
"17415","GO_MF","492638_GO_0008318_PROTEIN_PRENYLTRANSFERASE_ACTIVITY",9,0.8405,0.66,1,"Yes",0.9203,0.57,0.96,"Yes"
"17416","C7_Immunologic_signatures","C7_ALL_262_GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN",195,0.8413,0.92,1,"Yes",-0.7497,0.97,1,"No"
"17417","REACTOME","106433_REACT_6754_S6K1_MEDIATED_SIGNALLING",11,0.8414,0.67,0.95,"Yes",1.2049,0.22,0.44,"Yes"
"17418","GO_BP","504238_GO_0035050_EMBRYONIC_HEART_TUBE_DEVELOPMENT",72,0.8414,0.84,1,"Yes",-0.823,0.81,1,"No"
"17419","GO_BP","493284_GO_0009083_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS",19,0.8418,0.73,1,"Yes",1.156,0.24,0.83,"Yes"
"17420","KEGG_reaction","R00376_DEOXYGUANOSINE_5_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DGTP_DNA_DIPHOSPHATE_DNA",12,0.8418,0.67,0.96,"Yes",0.8332,0.68,1,"Yes"
"17421","GO_BP","494301_GO_0010224_RESPONSE_TO_UV_B",17,0.8419,0.69,1,"Yes",-1.0298,0.42,0.97,"No"
"17422","C2_Chemical_and_genetic_perturbations","C2_CGP_879_INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN",5,0.8419,0.62,1,"Yes",-0.7256,0.81,1,"No"
"17423","REACTOME","1183616_REACT_355250_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS",30,0.8423,0.7,0.95,"Yes",1.5918,0.015,0.097,"Yes"
"17424","GO_BP","498824_GO_0021540_CORPUS_CALLOSUM_MORPHOGENESIS",5,0.8424,0.62,1,"Yes",-0.4245,1,1,"No"
"17425","GO_BP","491705_GO_0006839_MITOCHONDRIAL_TRANSPORT",143,0.8427,0.94,1,"Yes",1.8722,0,0.052,"Yes"
"17426","C6_Oncogenic_signatures","C6_ALL_16_HINATA_NFKB_MATRIX",8,0.8436,0.65,0.98,"Yes",0.8077,0.71,0.98,"Yes"
"17427","GO_BP","504300_GO_0035115_EMBRYONIC_FORELIMB_MORPHOGENESIS",30,0.8441,0.75,1,"Yes",-1.1155,0.3,0.94,"No"
"17428","REACTOME","160994_REACT_20514_DEADENYLATION_OF_MRNA",23,0.8442,0.73,0.95,"Yes",0.9651,0.49,0.8,"Yes"
"17429","REACTOME","105829_REACT_6954_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS",73,0.8442,0.82,0.95,"Yes",2.0697,0,0.00092,"Yes"
"17430","GO_BP","491025_GO_0006040_AMINO_SUGAR_METABOLIC_PROCESS",38,0.8442,0.74,1,"Yes",1.0053,0.44,0.98,"Yes"
"17431","C2_Chemical_and_genetic_perturbations","C2_CGP_1073_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN",7,0.8444,0.64,1,"Yes",0.527,0.99,1,"Yes"
"17432","C4_Cancer_modules","C4_CM_97_MODULE_102",19,0.8445,0.69,0.99,"Yes",1.1291,0.3,0.49,"Yes"
"17433","C2_Chemical_and_genetic_perturbations","C2_CGP_1086_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3",5,0.8446,0.64,1,"Yes",1.2207,0.24,0.47,"Yes"
"17434","C4_Cancer_gene_neighborhoods","C4_CGN_174_MORF_REV3L",58,0.8447,0.8,1,"Yes",0.7596,0.9,1,"Yes"
"17435","C2_BioCarta_Pathways","C2_CP_BIOCARTA_56_BIOCARTA_RNA_PATHWAY",10,0.8447,0.68,0.94,"Yes",1.1995,0.25,0.72,"Yes"
"17436","REACTOME","106335_REACT_12417_MICRORNA_MIRNA_BIOGENESIS",23,0.8449,0.71,0.95,"Yes",0.7976,0.76,1,"Yes"
"17437","GO_BP","754792_GO_1901841_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",7,0.8452,0.64,1,"Yes",1.4057,0.12,0.55,"Yes"
"17438","GO_BP","492066_GO_0007288_SPERM_AXONEME_ASSEMBLY",7,0.8456,0.63,1,"Yes",-0.6746,0.88,1,"No"
"17439","REACTOME","105886_REACT_257_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER",21,0.8457,0.7,0.95,"Yes",1.5198,0.037,0.14,"Yes"
"17440","GO_BP","508649_GO_0046385_DEOXYRIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS",9,0.8458,0.63,1,"Yes",0.9656,0.48,1,"Yes"
"17441","GO_BP","750891_GO_0035964_COPI_COATED_VESICLE_BUDDING",13,0.8473,0.68,1,"Yes",1.5897,0.02,0.3,"Yes"
"17442","GO_BP","498708_GO_0019935_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING",31,0.8474,0.71,1,"Yes",1.2561,0.15,0.73,"Yes"
"17443","KEGG_compound","C00077_L_ORNITHINE_S_2_5_DIAMINOVALERIC_ACID_S_2_5_DIAMINOPENTANOIC_ACID_S_2_5_DIAMINOPENTANOATE",7,0.8475,0.63,1,"Yes",-0.7409,0.8,1,"No"
"17444","GO_BP","518242_GO_0090102_COCHLEA_DEVELOPMENT",38,0.848,0.75,1,"Yes",1.3573,0.091,0.6,"Yes"
"17445","GO_BP","491293_GO_0006352_DNA_TEMPLATED_TRANSCRIPTION_INITIATION",224,0.8481,0.91,1,"Yes",0.8582,0.87,1,"Yes"
"17446","C2_Chemical_and_genetic_perturbations","C2_CGP_2533_WU_ALZHEIMER_DISEASE_UP",13,0.8483,0.65,1,"Yes",-0.6728,0.87,1,"No"
"17447","GO_BP","517089_GO_0072173_METANEPHRIC_TUBULE_MORPHOGENESIS",11,0.8484,0.67,1,"Yes",-1.0165,0.44,0.98,"No"
"17448","GO_CC","505826_GO_0042719_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX",5,0.8484,0.62,0.95,"Yes",1.3135,0.19,0.39,"Yes"
"17449","GO_MF","500683_GO_0031432_TITIN_BINDING",13,0.8487,0.68,1,"Yes",-0.6229,0.93,1,"No"
"17450","GO_MF","496638_GO_0016717_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER",6,0.8488,0.62,1,"Yes",-0.8516,0.64,1,"No"
"17451","GO_CC","486663_GO_0000124_SAGA_COMPLEX",8,0.8491,0.62,0.95,"Yes",0.8514,0.65,0.91,"Yes"
"17452","REACTOME","105896_REACT_18265_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY",10,0.8495,0.62,0.95,"Yes",1.3704,0.14,0.25,"Yes"
"17453","GO_CC","490807_GO_0005779_INTEGRAL_COMPONENT_OF_PEROXISOMAL_MEMBRANE",14,0.8497,0.65,0.96,"Yes",1.4068,0.075,0.29,"Yes"
"17454","C4_Cancer_gene_neighborhoods","C4_CGN_67_MORF_BUB1B",66,0.85,0.78,0.99,"Yes",1.464,0.03,0.04,"Yes"
"17455","GO_BP","491306_GO_0006378_MRNA_POLYADENYLATION",28,0.8503,0.75,1,"Yes",0.9386,0.57,1,"Yes"
"17456","GO_BP","750796_GO_0002931_RESPONSE_TO_ISCHEMIA",21,0.8503,0.72,1,"Yes",-0.7143,0.88,1,"No"
"17457","REACTOME","105887_REACT_311_DUAL_INCISION_REACTION_IN_GG_NER",21,0.8506,0.73,0.95,"Yes",1.5499,0.032,0.12,"Yes"
"17458","GO_MF","492493_GO_0008139_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING",8,0.8507,0.66,1,"Yes",0.7768,0.74,1,"Yes"
"17459","C4_Cancer_modules","C4_CM_92_MODULE_97",97,0.8509,0.82,1,"Yes",0.7905,0.9,0.98,"Yes"
"17460","C4_Cancer_gene_neighborhoods","C4_CGN_83_MORF_DAP3",195,0.8511,0.98,0.99,"Yes",2.4942,0,0,"Yes"
"17461","GO_BP","517105_GO_0072189_URETER_DEVELOPMENT",13,0.8514,0.64,1,"Yes",0.8615,0.63,1,"Yes"
"17462","GO_BP","517237_GO_0072321_CHAPERONE_MEDIATED_PROTEIN_TRANSPORT",8,0.8515,0.65,1,"Yes",1.1534,0.29,0.83,"Yes"
"17463","C4_Cancer_gene_neighborhoods","C4_CGN_132_MORF_MTA1",102,0.8516,0.89,1,"Yes",2.0531,0,0.00019,"Yes"
"17464","GO_BP","489066_GO_0003272_ENDOCARDIAL_CUSHION_FORMATION",12,0.8527,0.64,1,"Yes",-0.8154,0.71,1,"No"
"17465","C2_Chemical_and_genetic_perturbations","C2_CGP_2801_TSAI_DNAJB4_TARGETS_DN",6,0.8527,0.62,1,"Yes",1.552,0.024,0.17,"Yes"
"17466","GO_BP","488776_GO_0002903_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS",11,0.8532,0.64,1,"Yes",0.5456,0.97,1,"Yes"
"17467","GO_MF","495373_GO_0015095_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,0.8534,0.68,1,"Yes",0.7258,0.83,1,"Yes"
"17468","GO_BP","489193_GO_0003401_AXIS_ELONGATION",25,0.8535,0.71,1,"Yes",-0.8817,0.63,1,"No"
"17469","REACTOME","106010_REACT_6288_HOST_INTERACTIONS_OF_HIV_FACTORS",127,0.8537,0.91,0.94,"Yes",2.0908,0,0.00071,"Yes"
"17470","KEGG_compound","C00475_CYTIDINE",13,0.8539,0.67,1,"Yes",0.526,0.98,1,"Yes"
"17471","GO_BP","494534_GO_0010464_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION",41,0.8545,0.72,1,"Yes",1.3578,0.063,0.6,"Yes"
"17472","REACTOME","105731_REACT_6933_CONJUGATION_OF_BENZOATE_WITH_GLYCINE",6,0.8546,0.61,0.95,"Yes",-1.8018,0.002,0.08,"No"
"17473","REACTOME","119535_REACT_19373_TIGHT_JUNCTION_INTERACTIONS",29,0.855,0.73,0.95,"Yes",-1.0011,0.44,0.99,"No"
"17474","REACTOME","1183558_REACT_355584_FRS_MEDIATED_FGFR1_SIGNALING",31,0.855,0.69,0.95,"Yes",0.852,0.71,0.96,"Yes"
"17475","GO_MF","509163_GO_0046974_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K9_SPECIFIC_",6,0.8551,0.59,1,"Yes",-1.0147,0.46,0.89,"No"
"17476","C4_Cancer_modules","C4_CM_72_MODULE_77",28,0.8551,0.68,1,"Yes",2.1313,0,0.00065,"Yes"
"17477","GO_BP","510316_GO_0048193_GOLGI_VESICLE_TRANSPORT",234,0.8553,0.92,1,"Yes",1.2988,0.029,0.67,"Yes"
"17478","C7_Immunologic_signatures","C7_ALL_694_GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_DN",200,0.8559,0.94,1,"Yes",1.9086,0,0,"Yes"
"17479","KEGG_reaction","R00378_DEOXYTHYMIDINE_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DTTP_DNA_DIPHOSPHATE_DNA",12,0.856,0.66,0.95,"Yes",0.8571,0.67,1,"Yes"
"17480","GO_BP","510323_GO_0048200_GOLGI_TRANSPORT_VESICLE_COATING",13,0.8562,0.66,1,"Yes",1.6104,0.023,0.28,"Yes"
"17481","GO_BP","506985_GO_0043967_HISTONE_H4_ACETYLATION",49,0.8567,0.73,1,"Yes",0.5103,1,1,"Yes"
"17482","GO_BP","501345_GO_0032108_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS",27,0.8567,0.71,1,"Yes",0.676,0.93,1,"Yes"
"17483","C1_Positional","C1_ALL_183_CHR3P25",75,0.857,0.81,0.92,"Yes",-0.8464,0.78,0.97,"No"
"17484","C2_Chemical_and_genetic_perturbations","C2_CGP_3352_HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN",19,0.857,0.7,1,"Yes",2.2703,0,0.00021,"Yes"
"17485","GO_BP","849962_GO_1902261_POSITIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",5,0.8571,0.64,1,"Yes",-0.9422,0.54,1,"No"
"17486","GO_BP","507844_GO_0045494_PHOTORECEPTOR_CELL_MAINTENANCE",31,0.8573,0.68,1,"Yes",1.0703,0.34,0.93,"Yes"
"17487","KEGG_compound","C00122_FUMARATE_FUMARIC_ACID_TRANS_BUTENEDIOIC_ACID",9,0.8575,0.62,1,"Yes",1.2696,0.2,0.77,"Yes"
"17488","C4_Cancer_modules","C4_CM_228_MODULE_252",236,0.8576,0.93,1,"Yes",1.5455,0,0.095,"Yes"
"17489","GO_MF","502259_GO_0033038_BITTER_TASTE_RECEPTOR_ACTIVITY",20,0.8577,0.69,1,"Yes",-0.871,0.65,1,"No"
"17490","C4_Cancer_gene_neighborhoods","C4_CGN_265_GCM_SMARCD1",101,0.8577,0.84,0.99,"Yes",0.8615,0.76,0.91,"Yes"
"17491","C6_Oncogenic_signatures","C6_ALL_4_E2F1_UP_V1_UP",180,0.858,0.91,1,"Yes",0.8965,0.75,0.95,"Yes"
"17492","REACTOME","161040_REACT_20642_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII",17,0.8582,0.7,0.95,"Yes",1.1486,0.26,0.51,"Yes"
"17493","GO_BP","1022190_GO_1903204_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH",7,0.8583,0.64,1,"Yes",1.6562,0.014,0.24,"Yes"
"17494","GO_BP","502131_GO_0032909_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION",8,0.8585,0.63,1,"Yes",0.6883,0.85,1,"Yes"
"17495","GO_BP","518917_GO_2000270_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS",8,0.8586,0.64,1,"Yes",-0.771,0.76,1,"No"
"17496","C2_Chemical_and_genetic_perturbations","C2_CGP_1229_TESAR_ALK_TARGETS_HUMAN_ES_5D_DN",7,0.8587,0.64,1,"Yes",-1.0021,0.46,1,"No"
"17497","GO_BP","499321_GO_0022403_CELL_CYCLE_PHASE",336,0.8588,0.94,1,"Yes",1.6165,0,0.28,"Yes"
"17498","GO_BP","1133993_GO_1903818_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY",5,0.8588,0.62,1,"Yes",-0.9466,0.55,1,"No"
"17499","GO_BP","495873_GO_0015740_C4_DICARBOXYLATE_TRANSPORT",8,0.8592,0.63,1,"Yes",-0.661,0.88,1,"No"
"17500","C2_Chemical_and_genetic_perturbations","C2_CGP_2172_WALLACE_PROSTATE_CANCER_UP",20,0.8595,0.68,1,"Yes",1.2599,0.17,0.43,"Yes"
"17501","KEGG_compound","C04895_7_8_DIHYDRONEOPTERIN_3_TRIPHOSPHATE_2_AMINO_4_HYDROXY_6_ERYTHRO_1_2_3_TRIHYDROXYPROPYL_DIHYDROPTERIDINE_TRIPHOSPHATE_6_L_ERYTHRO_1_2_DIHYDROXYPROPYL_3_TRIPHOSPHATE_7_8_DIHYDROPTERIN_6_1S_2R_1_2_DIHYDROXY_3_TRIPHOSPHOOXYPROPYL_7_8_DIHYDROPTERIN",6,0.8596,0.61,1,"Yes",1.253,0.22,0.8,"Yes"
"17502","KEGG_module","HSA_M00424_SHELTERIN_COMPLEX",6,0.8598,0.6,0.8,"Yes",0.4954,0.99,0.99,"Yes"
"17503","GO_BP","501691_GO_0032459_REGULATION_OF_PROTEIN_OLIGOMERIZATION",31,0.8599,0.72,1,"Yes",1.2198,0.16,0.77,"Yes"
"17504","GO_MF","509166_GO_0046977_TAP_BINDING",7,0.8601,0.61,1,"Yes",1.1842,0.26,0.73,"Yes"
"17505","C2_Chemical_and_genetic_perturbations","C2_CGP_2839_KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN",24,0.8602,0.7,1,"Yes",-0.9886,0.48,1,"No"
"17506","C2_Chemical_and_genetic_perturbations","C2_CGP_2294_WEBER_METHYLATED_HCP_IN_SPERM_DN",24,0.8604,0.68,1,"Yes",-1.0792,0.34,0.95,"No"
"17507","GO_CC","486862_GO_0000346_TRANSCRIPTION_EXPORT_COMPLEX",13,0.8605,0.65,0.94,"Yes",-0.7373,0.82,1,"No"
"17508","GO_BP","752854_GO_0097354_PRENYLATION",10,0.8606,0.62,1,"Yes",0.9484,0.53,1,"Yes"
"17509","C4_Cancer_modules","C4_CM_355_MODULE_429",14,0.8609,0.65,1,"Yes",2.11,0,0.00092,"Yes"
"17510","GO_BP","517580_GO_0072677_EOSINOPHIL_MIGRATION",8,0.861,0.64,1,"Yes",1.5599,0.036,0.33,"Yes"
"17511","C2_Chemical_and_genetic_perturbations","C2_CGP_1713_EHRLICH_ICF_SYNDROM_UP",11,0.8613,0.63,1,"Yes",1.339,0.14,0.35,"Yes"
"17512","OMIM_gene","OMIM613591_BUTYROPHILIN_SUBFAMILY_2_MEMBER_A2_BTN2A2",5,0.8614,0.61,1,"Yes",0.9429,0.55,1,"Yes"
"17513","REACTOME","645352_REACT_121123_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE",12,0.8616,0.62,0.94,"Yes",0.8429,0.68,0.96,"Yes"
"17514","GO_CC","507511_GO_0045120_PRONUCLEUS",17,0.862,0.67,0.94,"Yes",-0.8265,0.72,1,"No"
"17515","GO_BP","491399_GO_0006501_C_TERMINAL_PROTEIN_LIPIDATION",32,0.862,0.69,1,"Yes",0.8351,0.72,1,"Yes"
"17516","GO_MF","490436_GO_0005172_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING",8,0.8622,0.64,1,"Yes",1.437,0.085,0.45,"Yes"
"17517","GO_BP","518372_GO_0090232_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT",7,0.8623,0.64,1,"Yes",1.0222,0.42,0.97,"Yes"
"17518","GO_MF","496397_GO_0016409_PALMITOYLTRANSFERASE_ACTIVITY",35,0.8626,0.73,1,"Yes",-1.2027,0.17,0.81,"No"
"17519","REACTOME","106364_REACT_16943_MUSCARINIC_ACETYLCHOLINE_RECEPTORS",5,0.8628,0.62,0.94,"Yes",0.9073,0.57,0.9,"Yes"
"17520","GO_MF","489642_GO_0004176_ATP_DEPENDENT_PEPTIDASE_ACTIVITY",7,0.8628,0.59,1,"Yes",0.5618,0.95,1,"Yes"
"17521","GO_BP","498807_GO_0021523_SOMATIC_MOTOR_NEURON_DIFFERENTIATION",6,0.8628,0.62,1,"Yes",-1.0922,0.36,0.95,"No"
"17522","GO_BP","501342_GO_0032105_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS",27,0.8632,0.7,1,"Yes",0.669,0.96,1,"Yes"
"17523","GO_BP","513713_GO_0060155_PLATELET_DENSE_GRANULE_ORGANIZATION",8,0.8634,0.62,1,"Yes",1.4569,0.1,0.48,"Yes"
"17524","GO_BP","518349_GO_0090209_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS",7,0.8636,0.66,1,"Yes",1.3032,0.17,0.67,"Yes"
"17525","GO_BP","754750_GO_1901799_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",62,0.8638,0.79,1,"Yes",1.2948,0.095,0.68,"Yes"
"17526","GO_BP","752361_GO_0080182_HISTONE_H3_K4_TRIMETHYLATION",10,0.8638,0.65,1,"Yes",0.5453,0.97,1,"Yes"
"17527","GO_BP","499596_GO_0030178_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY",183,0.8639,0.94,1,"Yes",1.432,0.012,0.52,"Yes"
"17528","GO_CC","492577_GO_0008250_OLIGOSACCHARYLTRANSFERASE_COMPLEX",10,0.8639,0.65,0.94,"Yes",1.3544,0.12,0.34,"Yes"
"17529","GO_BP","514478_GO_0060923_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT",6,0.8639,0.63,1,"Yes",-0.7847,0.71,1,"No"
"17530","GO_MF","752658_GO_0097157_PRE_MRNA_INTRONIC_BINDING",5,0.8643,0.63,1,"Yes",-1.2631,0.2,0.83,"No"
"17531","KEGG_reaction","R08392_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_4_HYDROXYRETINOIC_ACID_NADP_H2O",15,0.8643,0.66,0.96,"Yes",-0.9969,0.48,0.77,"No"
"17532","C2_Chemical_and_genetic_perturbations","C2_CGP_2461_MOOTHA_MITOCHONDRIA",446,0.865,1,1,"Yes",2.1258,0,0.0015,"Yes"
"17533","GO_BP","782514_GO_0044782_CILIUM_ORGANIZATION",155,0.8652,0.88,1,"Yes",-0.8047,0.92,1,"No"
"17534","GO_BP","503420_GO_0034214_PROTEIN_HEXAMERIZATION",7,0.8653,0.6,1,"Yes",0.5697,0.95,1,"Yes"
"17535","REACTOME","1127689_REACT_264501_MISMATCH_REPAIR_MMR_DIRECTED_BY_MSH2_MSH6_MUTSALPHA_",15,0.8653,0.65,0.94,"Yes",1.0092,0.43,0.74,"Yes"
"17536","GO_MF","498727_GO_0019961_INTERFERON_BINDING",6,0.8654,0.59,1,"Yes",1.2868,0.18,0.63,"Yes"
"17537","C2_Chemical_and_genetic_perturbations","C2_CGP_2025_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2",451,0.8654,1,1,"Yes",-1.2001,0.048,0.79,"No"
"17538","REACTOME","105835_REACT_6761_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1",69,0.8655,0.75,0.94,"Yes",1.949,0,0.0045,"Yes"
"17539","C2_Chemical_and_genetic_perturbations","C2_CGP_2922_MIKKELSEN_NPC_WITH_LCP_H3K27ME3",6,0.8658,0.58,1,"Yes",0.8227,0.7,0.98,"Yes"
"17540","GO_BP","496266_GO_0016180_SNRNA_PROCESSING",16,0.8659,0.68,1,"Yes",-0.6398,0.95,1,"No"
"17541","GO_BP","491576_GO_0006688_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS",16,0.8661,0.64,1,"Yes",0.8705,0.64,1,"Yes"
"17542","KEGG_reaction","R00377_DEOXYCYTIDINE_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DCTP_DNA_DIPHOSPHATE_DNA",12,0.8662,0.65,0.98,"Yes",0.8546,0.66,1,"Yes"
"17543","C7_Immunologic_signatures","C7_ALL_1002_GSE22886_IL2_VS_IL15_STIM_NKCELL_DN",193,0.8667,0.91,0.99,"Yes",1.7391,0,0.00037,"Yes"
"17544","GO_BP","513556_GO_0055129_L_PROLINE_BIOSYNTHETIC_PROCESS",5,0.8672,0.6,1,"Yes",1.2406,0.24,0.75,"Yes"
"17545","C3_TF_targets","C3_TFT_517_TAANNYSGCG_UNKNOWN",77,0.8673,0.76,1,"Yes",1.2844,0.072,0.49,"Yes"
"17546","GO_BP","501440_GO_0032205_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE",10,0.8677,0.62,1,"Yes",0.5299,0.98,1,"Yes"
"17547","REACTOME","1183586_REACT_355347_RHO_GTPASES_ACTIVATE_PAKS",23,0.8683,0.66,0.94,"Yes",1.334,0.11,0.28,"Yes"
"17548","GO_BP","516817_GO_0071897_DNA_BIOSYNTHETIC_PROCESS",53,0.8687,0.74,1,"Yes",-1.1422,0.23,0.93,"No"
"17549","GO_BP","507470_GO_0045070_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION",26,0.8691,0.69,1,"Yes",1.4071,0.067,0.55,"Yes"
"17550","C2_BioCarta_Pathways","C2_CP_BIOCARTA_94_BIOCARTA_IL4_PATHWAY",11,0.8692,0.64,0.96,"Yes",0.6948,0.88,1,"Yes"
"17551","GO_MF","489240_GO_0003690_DOUBLE_STRANDED_DNA_BINDING",110,0.8692,0.81,1,"Yes",1.1183,0.2,0.76,"Yes"
"17552","GO_BP","752615_GO_0097114_N_METHYL_D_ASPARTATE_RECEPTOR_CLUSTERING",5,0.8695,0.61,1,"Yes",1.1471,0.34,0.84,"Yes"
"17553","C2_Chemical_and_genetic_perturbations","C2_CGP_2030_MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN",8,0.8704,0.63,1,"Yes",1.1846,0.27,0.51,"Yes"
"17554","GO_BP","487925_GO_0002035_BRAIN_RENIN_ANGIOTENSIN_SYSTEM",5,0.8705,0.62,1,"Yes",1.1231,0.35,0.88,"Yes"
"17555","C2_Chemical_and_genetic_perturbations","C2_CGP_2032_PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",64,0.8706,0.73,1,"Yes",1.7594,0,0.058,"Yes"
"17556","GO_CC","486649_GO_0000109_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX",13,0.8708,0.64,0.93,"Yes",0.9151,0.59,0.87,"Yes"
"17557","C2_Chemical_and_genetic_perturbations","C2_CGP_712_SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP",47,0.8711,0.73,1,"Yes",0.7062,0.96,1,"Yes"
"17558","C2_BioCarta_Pathways","C2_CP_BIOCARTA_212_BIOCARTA_ARF_PATHWAY",17,0.8711,0.66,1,"Yes",1.3211,0.12,0.57,"Yes"
"17559","GO_CC","487154_GO_0000930_GAMMA_TUBULIN_COMPLEX",15,0.8712,0.64,0.93,"Yes",0.7985,0.76,0.96,"Yes"
"17560","C4_Cancer_gene_neighborhoods","C4_CGN_130_MORF_MBD4",86,0.8714,0.8,0.96,"Yes",2.5007,0,0,"Yes"
"17561","GO_BP","501600_GO_0032365_INTRACELLULAR_LIPID_TRANSPORT",19,0.8719,0.64,1,"Yes",0.7262,0.87,1,"Yes"
"17562","C3_MicroRNA_targets","C3_MIR_127_GTCTACC_MIR_379",22,0.872,0.66,1,"Yes",1.4143,0.056,0.59,"Yes"
"17563","GO_MF","487217_GO_0000993_RNA_POLYMERASE_II_CORE_BINDING",19,0.8722,0.67,1,"Yes",-0.709,0.88,1,"No"
"17564","GO_BP","487882_GO_0001992_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN",5,0.8723,0.62,1,"Yes",0.6427,0.89,1,"Yes"
"17565","GO_MF","490431_GO_0005167_NEUROTROPHIN_TRK_RECEPTOR_BINDING",6,0.8723,0.61,1,"Yes",1.0783,0.38,0.82,"Yes"
"17566","GO_CC","515898_GO_0070971_ENDOPLASMIC_RETICULUM_EXIT_SITE",11,0.8725,0.61,0.93,"Yes",1.428,0.081,0.27,"Yes"
"17567","C7_Immunologic_signatures","C7_ALL_1167_GSE27786_LIN_NEG_VS_NKCELL_UP",198,0.8728,0.85,0.98,"Yes",1.2727,0.039,0.13,"Yes"
"17568","KEGG_reaction","R00375_DEOXYADENOSINE_5_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DATP_DNA_DIPHOSPHATE_DNA",12,0.8729,0.6,0.99,"Yes",0.8498,0.65,1,"Yes"
"17569","GO_MF","490397_GO_0005134_INTERLEUKIN_2_RECEPTOR_BINDING",5,0.8734,0.59,1,"Yes",0.4349,0.99,1,"Yes"
"17570","C2_Chemical_and_genetic_perturbations","C2_CGP_2879_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS",25,0.8737,0.67,1,"Yes",1.2815,0.12,0.41,"Yes"
"17571","C3_TF_targets","C3_TFT_347_V_NFMUE1_Q6",246,0.8739,0.89,1,"Yes",1.1597,0.11,0.85,"Yes"
"17572","GO_BP","752396_GO_0086026_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_SIGNALING",9,0.8739,0.62,1,"Yes",0.9912,0.46,0.99,"Yes"
"17573","GO_CC","500492_GO_0031231_INTRINSIC_COMPONENT_OF_PEROXISOMAL_MEMBRANE",14,0.874,0.61,0.93,"Yes",1.3958,0.11,0.3,"Yes"
"17574","REACTOME","477126_REACT_111056_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES_",49,0.8742,0.73,0.93,"Yes",1.9799,0,0.0031,"Yes"
"17575","GO_BP","501457_GO_0032222_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC",11,0.8745,0.63,1,"Yes",-1.1497,0.3,0.93,"No"
"17576","REACTOME","105899_REACT_829_REGULATION_OF_DNA_REPLICATION",75,0.8746,0.78,0.93,"Yes",2.0202,0,0.0017,"Yes"
"17577","OMIM_gene","OMIM612869_ATTRACTIN_LIKE_1_ATRNL1",7,0.8747,0.6,1,"Yes",1.5185,0.049,1,"Yes"
"17578","GO_BP","497300_GO_0018345_PROTEIN_PALMITOYLATION",24,0.8747,0.64,1,"Yes",-0.9388,0.56,1,"No"
"17579","GO_MF","489532_GO_0004064_ARYLESTERASE_ACTIVITY",5,0.8747,0.6,1,"Yes",1.2817,0.19,0.63,"Yes"
"17580","GO_BP","504280_GO_0035095_BEHAVIORAL_RESPONSE_TO_NICOTINE",7,0.875,0.6,1,"Yes",-1.4593,0.079,0.88,"No"
"17581","GO_CC","487092_GO_0000801_CENTRAL_ELEMENT",6,0.8754,0.6,0.93,"Yes",1.1625,0.3,0.57,"Yes"
"17582","REACTOME","906020_REACT_169103_SMAD2_3_PHOSPHORYLATION_MOTIF_MUTANTS_IN_CANCER",6,0.8756,0.58,0.93,"Yes",-0.7942,0.76,1,"No"
"17583","REACTOME","1127593_REACT_268786_DEFECTIVE_CHST6_CAUSES_MCDC1",7,0.8756,0.62,0.93,"Yes",0.9257,0.56,0.87,"Yes"
"17584","GO_BP","499182_GO_0021903_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING",11,0.876,0.65,1,"Yes",-0.7955,0.77,1,"No"
"17585","GO_MF","503269_GO_0034061_DNA_POLYMERASE_ACTIVITY",33,0.8761,0.67,1,"Yes",-0.9314,0.56,0.96,"No"
"17586","GO_BP","518321_GO_0090181_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS",19,0.8762,0.64,1,"Yes",1.0775,0.34,0.93,"Yes"
"17587","GO_CC","492685_GO_0008385_IKAPPAB_KINASE_COMPLEX",11,0.8763,0.64,0.94,"Yes",-0.6407,0.91,1,"No"
"17588","GO_BP","496103_GO_0015986_ATP_SYNTHESIS_COUPLED_PROTON_TRANSPORT",24,0.8764,0.64,1,"Yes",1.9211,0.0022,0.03,"Yes"
"17589","GO_BP","501601_GO_0032366_INTRACELLULAR_STEROL_TRANSPORT",8,0.877,0.6,1,"Yes",1.2622,0.2,0.72,"Yes"
"17590","C1_Positional","C1_ALL_79_CHR7P11",18,0.8771,0.64,0.89,"Yes",1.3161,0.13,0.53,"Yes"
"17591","GO_BP","517254_GO_0072338_CELLULAR_LACTAM_METABOLIC_PROCESS",5,0.8775,0.58,1,"Yes",1.2855,0.18,0.7,"Yes"
"17592","GO_BP","499668_GO_0030263_APOPTOTIC_CHROMOSOME_CONDENSATION",5,0.8782,0.6,1,"Yes",-0.647,0.88,1,"No"
"17593","C7_Immunologic_signatures","C7_ALL_1171_GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP",200,0.8782,0.91,0.97,"Yes",1.2232,0.067,0.19,"Yes"
"17594","GO_BP","486889_GO_0000394_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION",11,0.8784,0.59,1,"Yes",1.6135,0.011,0.28,"Yes"
"17595","REACTOME","105831_REACT_6781_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS",72,0.8784,0.73,0.93,"Yes",2.091,0,0.00072,"Yes"
"17596","GO_MF","496395_GO_0016407_ACETYLTRANSFERASE_ACTIVITY",97,0.8786,0.75,1,"Yes",0.8669,0.76,1,"Yes"
"17597","GO_CC","486687_GO_0000153_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX",10,0.8788,0.59,0.94,"Yes",1.6763,0.022,0.075,"Yes"
"17598","C2_Chemical_and_genetic_perturbations","C2_CGP_940_HUI_MAPK14_TARGETS_UP",20,0.8789,0.67,1,"Yes",-0.7243,0.84,1,"No"
"17599","GO_BP","515803_GO_0070875_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS",17,0.879,0.62,1,"Yes",-0.6712,0.91,1,"No"
"17600","GO_BP","755379_GO_2001273_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS",11,0.879,0.63,1,"Yes",-1.0615,0.37,0.96,"No"
"17601","REACTOME","119564_REACT_19357_MULTIFUNCTIONAL_ANION_EXCHANGERS",6,0.8793,0.59,0.93,"Yes",0.9021,0.56,0.9,"Yes"
"17602","GO_BP","506661_GO_0043631_RNA_POLYADENYLATION",30,0.8796,0.71,1,"Yes",0.8893,0.63,1,"Yes"
"17603","REACTOME","106255_REACT_11218_COENZYME_A_BIOSYNTHESIS",8,0.8798,0.59,0.93,"Yes",0.6877,0.88,1,"Yes"
"17604","GO_BP","503753_GO_0034551_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY",5,0.8803,0.56,1,"Yes",0.6579,0.88,1,"Yes"
"17605","KEGG_reaction","R03938_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_HISTONE_N6_METHYL_L_LYSINE",26,0.8803,0.63,1,"Yes",-1.2808,0.14,0.44,"No"
"17606","C1_Positional","C1_ALL_90_CHR5Q33",57,0.8805,0.7,0.9,"Yes",1.1179,0.28,0.62,"Yes"
"17607","GO_MF","496468_GO_0016500_PROTEIN_HORMONE_RECEPTOR_ACTIVITY",10,0.8806,0.6,1,"Yes",-0.8774,0.59,1,"No"
"17608","GO_BP","515180_GO_0070245_POSITIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS",6,0.8806,0.6,1,"Yes",-0.7374,0.8,1,"No"
"17609","C2_Chemical_and_genetic_perturbations","C2_CGP_2365_WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP",21,0.8807,0.65,1,"Yes",0.8337,0.71,0.98,"Yes"
"17610","C7_Immunologic_signatures","C7_ALL_400_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN",200,0.8808,0.88,0.97,"Yes",1.9575,0,0,"Yes"
"17611","C4_Cancer_modules","C4_CM_78_MODULE_83",318,0.8808,0.99,1,"Yes",3.4374,0,0,"Yes"
"17612","C1_Positional","C1_ALL_12_CHR6Q13",15,0.8808,0.63,0.91,"Yes",1.1086,0.32,0.64,"Yes"
"17613","GO_MF","512418_GO_0051540_METAL_CLUSTER_BINDING",64,0.8808,0.73,1,"Yes",1.7545,0,0.11,"Yes"
"17614","GO_BP","487021_GO_0000724_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION",70,0.8809,0.74,1,"Yes",0.6713,0.99,1,"Yes"
"17615","KEGG_compound","C03702_HISTONE_N6_METHYL_L_LYSINE",26,0.8811,0.68,1,"Yes",-1.3131,0.12,0.6,"No"
"17616","GO_BP","501441_GO_0032206_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE",7,0.8813,0.6,1,"Yes",0.5043,0.98,1,"Yes"
"17617","C2_BioCarta_Pathways","C2_CP_BIOCARTA_34_BIOCARTA_MCM_PATHWAY",18,0.8815,0.63,1,"Yes",1.371,0.099,0.55,"Yes"
"17618","C2_Chemical_and_genetic_perturbations","C2_CGP_1670_MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7",18,0.8816,0.62,1,"Yes",1.2425,0.16,0.45,"Yes"
"17619","C2_Chemical_and_genetic_perturbations","C2_CGP_1226_STEGMEIER_PRE_MITOTIC_CELL_CYCLE_REGULATORS",11,0.8816,0.61,1,"Yes",0.8317,0.66,0.98,"Yes"
"17620","GO_BP","510446_GO_0048339_PARAXIAL_MESODERM_DEVELOPMENT",15,0.8817,0.59,1,"Yes",-0.6197,0.94,1,"No"
"17621","C7_Immunologic_signatures","C7_ALL_1660_GSE3982_MAC_VS_TH2_DN",199,0.8819,0.88,0.97,"Yes",1.0508,0.31,0.59,"Yes"
"17622","GO_CC","504283_GO_0035098_ESC_E_Z_COMPLEX",16,0.8828,0.65,0.93,"Yes",-0.5043,0.99,1,"No"
"17623","GO_CC","487103_GO_0000812_SWR1_COMPLEX",9,0.8829,0.59,0.94,"Yes",0.7674,0.75,0.97,"Yes"
"17624","C1_Positional","C1_ALL_114_CHR1Q42",95,0.883,0.77,0.92,"Yes",0.9852,0.47,0.79,"Yes"
"17625","C1_Positional","C1_ALL_240_CHR2Q31",76,0.883,0.74,0.93,"Yes",1.745,0.0022,0.14,"Yes"
"17626","GO_MF","490432_GO_0005168_NEUROTROPHIN_TRKA_RECEPTOR_BINDING",5,0.8832,0.58,1,"Yes",1.0623,0.41,0.83,"Yes"
"17627","GO_MF","495501_GO_0015238_DRUG_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",16,0.8832,0.64,1,"Yes",-0.8005,0.74,1,"No"
"17628","GO_BP","515474_GO_0070544_HISTONE_H3_K36_DEMETHYLATION",7,0.8833,0.59,1,"Yes",-0.8352,0.66,1,"No"
"17629","C7_Immunologic_signatures","C7_ALL_606_GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_DN",199,0.8833,0.85,0.97,"Yes",1.2779,0.037,0.12,"Yes"
"17630","C1_Positional","C1_ALL_109_CHR4Q26",22,0.8834,0.64,0.95,"Yes",0.6175,0.96,1,"Yes"
"17631","OMIM_gene","OMIM605889_PDZ_AND_LIM_DOMAIN_PROTEIN_3_PDLIM3",7,0.8837,0.58,1,"Yes",1.4955,0.069,0.91,"Yes"
"17632","GO_BP","504598_GO_0035414_NEGATIVE_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS",9,0.8838,0.62,1,"Yes",-0.9142,0.56,1,"No"
"17633","GO_BP","500354_GO_0031064_NEGATIVE_REGULATION_OF_HISTONE_DEACETYLATION",5,0.8841,0.58,1,"Yes",-0.8383,0.68,1,"No"
"17634","GO_CC","500166_GO_0030868_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE",6,0.8842,0.59,0.94,"Yes",1.059,0.39,0.71,"Yes"
"17635","GO_BP","487443_GO_0001504_NEUROTRANSMITTER_UPTAKE",14,0.8842,0.6,1,"Yes",1.0303,0.43,0.97,"Yes"
"17636","GO_BP","516379_GO_0071455_CELLULAR_RESPONSE_TO_HYPEROXIA",7,0.8844,0.57,1,"Yes",0.8956,0.59,1,"Yes"
"17637","KEGG_module","HSA_M00052_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHESIS_UMP_UDP_UTP_CDP_CTP",12,0.8846,0.6,0.77,"Yes",0.8238,0.71,0.93,"Yes"
"17638","GO_BP","501667_GO_0032435_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",58,0.8846,0.69,1,"Yes",1.3676,0.043,0.59,"Yes"
"17639","C1_Positional","C1_ALL_256_CHR6P24",28,0.8848,0.67,0.96,"Yes",1.2781,0.16,0.53,"Yes"
"17640","GO_MF","512414_GO_0051536_IRON_SULFUR_CLUSTER_BINDING",64,0.8854,0.7,1,"Yes",1.7842,0,0.092,"Yes"
"17641","GO_BP","508066_GO_0045721_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS",11,0.8854,0.6,1,"Yes",0.6394,0.92,1,"Yes"
"17642","GO_MF","489988_GO_0004659_PRENYLTRANSFERASE_ACTIVITY",15,0.8855,0.61,1,"Yes",1.2325,0.2,0.7,"Yes"
"17643","REACTOME","106547_REACT_7999_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND",10,0.8857,0.6,0.92,"Yes",1.413,0.091,0.21,"Yes"
"17644","C1_Positional","C1_ALL_318_CHR14Q24",101,0.8866,0.73,0.97,"Yes",0.7932,0.88,0.95,"Yes"
"17645","C7_Immunologic_signatures","C7_ALL_1203_GSE27786_CD8_TCELL_VS_NKCELL_UP",198,0.8868,0.82,0.97,"Yes",1.1869,0.1,0.25,"Yes"
"17646","GO_BP","501602_GO_0032367_INTRACELLULAR_CHOLESTEROL_TRANSPORT",8,0.8869,0.6,1,"Yes",1.2731,0.18,0.71,"Yes"
"17647","GO_BP","505881_GO_0042775_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT",52,0.887,0.71,1,"Yes",2.37,0,4.6e-05,"Yes"
"17648","C2_Chemical_and_genetic_perturbations","C2_CGP_1227_TESAR_ALK_TARGETS_HUMAN_ES_4D_DN",6,0.8871,0.58,1,"Yes",-0.9089,0.58,1,"No"
"17649","GO_MF","506248_GO_0043176_AMINE_BINDING",9,0.8871,0.61,1,"Yes",1.2164,0.23,0.69,"Yes"
"17650","REACTOME","1127592_REACT_268431_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D_",7,0.8872,0.58,0.92,"Yes",0.9135,0.56,0.89,"Yes"
"17651","REACTOME","105945_REACT_1470_MRNA_CAPPING",29,0.8874,0.65,0.92,"Yes",1.3789,0.052,0.24,"Yes"
"17652","GO_BP","502402_GO_0033182_REGULATION_OF_HISTONE_UBIQUITINATION",8,0.8876,0.6,1,"Yes",0.6233,0.93,1,"Yes"
"17653","KEGG_compound","C00255_RIBOFLAVIN_LACTOFLAVIN_7_8_DIMETHYL_10_RIBITYLISOALLOXAZINE_VITAMIN_B2",6,0.8878,0.56,1,"Yes",0.9701,0.49,1,"Yes"
"17654","GO_BP","495095_GO_0014022_NEURAL_PLATE_ELONGATION",5,0.8879,0.59,1,"Yes",0.8632,0.64,1,"Yes"
"17655","C2_Chemical_and_genetic_perturbations","C2_CGP_619_NAGY_STAGA_COMPONENTS_HUMAN",15,0.888,0.59,1,"Yes",-0.7145,0.85,1,"No"
"17656","GO_MF","496578_GO_0016638_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS",19,0.8882,0.62,1,"Yes",-1.4786,0.055,0.59,"No"
"17657","GO_BP","496102_GO_0015985_ENERGY_COUPLED_PROTON_TRANSPORT_DOWN_ELECTROCHEMICAL_GRADIENT",24,0.8883,0.65,1,"Yes",1.9171,0.0022,0.032,"Yes"
"17658","GO_BP","515464_GO_0070534_PROTEIN_K63_LINKED_UBIQUITINATION",36,0.8892,0.63,1,"Yes",1.1873,0.19,0.8,"Yes"
"17659","GO_BP","496882_GO_0017062_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY",5,0.8894,0.6,1,"Yes",0.6751,0.85,1,"Yes"
"17660","GO_MF","493977_GO_0009881_PHOTORECEPTOR_ACTIVITY",15,0.8902,0.57,1,"Yes",-1.5942,0.025,0.48,"No"
"17661","GO_BP","491859_GO_0007031_PEROXISOME_ORGANIZATION",36,0.8903,0.66,1,"Yes",1.1182,0.27,0.88,"Yes"
"17662","OMIM_gene","OMIM148041_KERATIN_6A_KRT6A",5,0.8903,0.59,1,"Yes",1.0486,0.41,1,"Yes"
"17663","KEGG_pathway","HSA00450_SELENOCOMPOUND_METABOLISM",17,0.8905,0.6,0.83,"Yes",1.1953,0.22,0.57,"Yes"
"17664","C2_Chemical_and_genetic_perturbations","C2_CGP_2238_ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP",169,0.8905,0.79,1,"Yes",1.8888,0,0.022,"Yes"
"17665","KEGG_module","HSA_M00101_CHOLESTEROL_BIOSYNTHESIS_SQUALENE_2_3_EPOXIDE_CHOLESTEROL",11,0.8906,0.6,0.78,"Yes",0.9886,0.49,0.9,"Yes"
"17666","GO_BP","510595_GO_0048524_POSITIVE_REGULATION_OF_VIRAL_PROCESS",102,0.8911,0.75,1,"Yes",1.7528,0,0.14,"Yes"
"17667","GO_BP","513629_GO_0060071_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY",21,0.8911,0.61,1,"Yes",0.9029,0.62,1,"Yes"
"17668","GO_BP","497176_GO_0018205_PEPTIDYL_LYSINE_MODIFICATION",211,0.8915,0.8,1,"Yes",-0.65,1,1,"No"
"17669","C2_Chemical_and_genetic_perturbations","C2_CGP_3090_FIGUEROA_AML_METHYLATION_CLUSTER_7_UP",115,0.8916,0.77,1,"Yes",1.1601,0.15,0.54,"Yes"
"17670","OMIM_gene","OMIM601597_B_CELL_TRANSLOCATION_GENE_2_BTG2",5,0.892,0.56,1,"Yes",1.0465,0.4,1,"Yes"
"17671","REACTOME","106447_REACT_13695_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1",6,0.8921,0.56,0.91,"Yes",0.5933,0.93,1,"Yes"
"17672","C4_Cancer_gene_neighborhoods","C4_CGN_272_GCM_UBE2N",155,0.8922,0.82,0.91,"Yes",0.6264,1,1,"Yes"
"17673","REACTOME","105771_REACT_9003_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21",56,0.8922,0.7,0.91,"Yes",2.1805,0,0.00019,"Yes"
"17674","GO_BP","487022_GO_0000725_RECOMBINATIONAL_REPAIR",71,0.8928,0.69,1,"Yes",0.7872,0.89,1,"Yes"
"17675","C2_Chemical_and_genetic_perturbations","C2_CGP_2633_MEISSNER_ES_ICP_WITH_H3K4ME3",32,0.893,0.64,1,"Yes",-0.8091,0.78,1,"No"
"17676","C2_Chemical_and_genetic_perturbations","C2_CGP_947_PUJANA_XPRSS_INT_NETWORK",168,0.8931,0.82,1,"Yes",1.4336,0.0095,0.27,"Yes"
"17677","GO_BP","1129266_GO_0090611_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY",5,0.8935,0.56,1,"Yes",1.3879,0.13,0.57,"Yes"
"17678","KEGG_compound","C02415_HISTONE_L_LYSINE",26,0.894,0.64,1,"Yes",-1.3121,0.13,0.6,"No"
"17679","REACTOME","119530_REACT_19226_ACTIVATION_OF_RAC",13,0.894,0.61,0.91,"Yes",0.9858,0.49,0.77,"Yes"
"17680","GO_BP","518583_GO_0097033_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III_BIOGENESIS",5,0.8942,0.56,1,"Yes",0.6775,0.86,1,"Yes"
"17681","GO_BP","501446_GO_0032211_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE",6,0.8944,0.56,1,"Yes",-1.0263,0.45,0.98,"No"
"17682","GO_BP","515861_GO_0070934_CRD_MEDIATED_MRNA_STABILIZATION",5,0.8944,0.54,1,"Yes",1.0363,0.43,0.96,"Yes"
"17683","REACTOME","105755_REACT_2137_MITOTIC_SPINDLE_CHECKPOINT",19,0.8944,0.61,0.91,"Yes",1.2743,0.14,0.35,"Yes"
"17684","GO_BP","513827_GO_0060271_CILIUM_MORPHOGENESIS",168,0.8951,0.84,1,"Yes",-0.7951,0.92,1,"No"
"17685","C7_Immunologic_signatures","C7_ALL_1579_GSE3982_DC_VS_MAC_LPS_STIM_UP",195,0.8964,0.78,0.95,"Yes",1.389,0,0.041,"Yes"
"17686","C3_MicroRNA_targets","C3_MIR_108_CACGTTT_MIR_302A",30,0.8966,0.62,1,"Yes",0.6807,0.94,1,"Yes"
"17687","GO_BP","491138_GO_0006166_PURINE_RIBONUCLEOSIDE_SALVAGE",5,0.8971,0.57,1,"Yes",1.091,0.38,0.92,"Yes"
"17688","OMIM_gene","OMIM609221_N_ACETYLTRANSFERASE_10_NAT10",7,0.8974,0.58,1,"Yes",1.5323,0.055,1,"Yes"
"17689","C7_Immunologic_signatures","C7_ALL_114_GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN",197,0.8974,0.84,0.95,"Yes",1.2978,0.038,0.11,"Yes"
"17690","GO_MF","512722_GO_0051864_HISTONE_DEMETHYLASE_ACTIVITY_H3_K36_SPECIFIC_",7,0.8975,0.59,1,"Yes",-0.8309,0.67,1,"No"
"17691","GO_BP","494613_GO_0010544_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION",15,0.8976,0.57,1,"Yes",1.0404,0.4,0.96,"Yes"
"17692","GO_BP","512179_GO_0051294_ESTABLISHMENT_OF_SPINDLE_ORIENTATION",21,0.8983,0.6,1,"Yes",0.732,0.86,1,"Yes"
"17693","GO_BP","487611_GO_0001708_CELL_FATE_SPECIFICATION",61,0.8985,0.67,1,"Yes",1.5217,0.0044,0.38,"Yes"
"17694","C2_Chemical_and_genetic_perturbations","C2_CGP_2017_YANG_MUC2_TARGETS_DUODENUM_6MO_UP",6,0.8987,0.55,1,"Yes",0.6993,0.83,1,"Yes"
"17695","GO_BP","504556_GO_0035372_PROTEIN_LOCALIZATION_TO_MICROTUBULE",8,0.8987,0.55,1,"Yes",1.0782,0.34,0.93,"Yes"
"17696","GO_BP","491400_GO_0018342_PROTEIN_PRENYLATION",10,0.8993,0.57,1,"Yes",0.9573,0.48,1,"Yes"
"17697","C2_Chemical_and_genetic_perturbations","C2_CGP_1223_NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON",17,0.8993,0.61,1,"Yes",-1.2887,0.15,0.7,"No"
"17698","GO_BP","493405_GO_0009209_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",16,0.8994,0.56,1,"Yes",-0.7306,0.83,1,"No"
"17699","C7_Immunologic_signatures","C7_ALL_1193_GSE27786_CD4_TCELL_VS_NKCELL_UP",197,0.8995,0.85,0.95,"Yes",1.1036,0.21,0.43,"Yes"
"17700","GO_MF","492834_GO_0008565_PROTEIN_TRANSPORTER_ACTIVITY",81,0.8997,0.7,1,"Yes",1.8208,0,0.064,"Yes"
"17701","GO_MF","496656_GO_0016742_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY",8,0.9001,0.58,1,"Yes",0.8277,0.67,1,"Yes"
"17702","C2_BioCarta_Pathways","C2_CP_BIOCARTA_130_BIOCARTA_NUCLEARRS_PATHWAY",14,0.9003,0.6,1,"Yes",0.9554,0.5,0.83,"Yes"
"17703","C2_Chemical_and_genetic_perturbations","C2_CGP_3084_FIGUEROA_AML_METHYLATION_CLUSTER_4_UP",110,0.9004,0.73,1,"Yes",1.0823,0.28,0.66,"Yes"
"17704","KEGG_compound","C00239_DCMP_DEOXYCYTIDYLIC_ACID_DEOXYCYTIDINE_MONOPHOSPHATE_DEOXYCYTIDYLATE_2_DEOXYCYTIDINE_5_MONOPHOSPHATE",14,0.9004,0.58,1,"Yes",1.2781,0.16,0.79,"Yes"
"17705","C1_Positional","C1_ALL_320_CHR15Q21",88,0.9005,0.7,0.95,"Yes",0.879,0.73,0.89,"Yes"
"17706","C7_Immunologic_signatures","C7_ALL_132_GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN",199,0.9005,0.85,0.95,"Yes",0.9649,0.56,0.85,"Yes"
"17707","C7_Immunologic_signatures","C7_ALL_98_GSE11924_TFH_VS_TH2_CD4_TCELL_DN",198,0.9006,0.84,0.95,"Yes",1.44,0.0047,0.025,"Yes"
"17708","GO_BP","508587_GO_0046322_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION",7,0.9013,0.59,1,"Yes",0.8815,0.62,1,"Yes"
"17709","GO_BP","495181_GO_0014733_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION",6,0.9013,0.57,1,"Yes",-0.7747,0.76,1,"No"
"17710","GO_BP","493404_GO_0009208_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",17,0.9015,0.57,1,"Yes",-0.7292,0.86,1,"No"
"17711","C4_Cancer_modules","C4_CM_172_MODULE_182",99,0.9015,0.72,1,"Yes",0.779,0.92,0.98,"Yes"
"17712","C2_Chemical_and_genetic_perturbations","C2_CGP_2482_TOOKER_GEMCITABINE_RESISTANCE_UP",79,0.9017,0.73,1,"Yes",1.6877,0.0044,0.09,"Yes"
"17713","GO_MF","499373_GO_0022824_TRANSMITTER_GATED_ION_CHANNEL_ACTIVITY",8,0.9019,0.58,1,"Yes",-1.1637,0.27,0.8,"No"
"17714","C7_Immunologic_signatures","C7_ALL_176_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN",198,0.9019,0.78,0.95,"Yes",1.8548,0,0,"Yes"
"17715","GO_MF","511127_GO_0050136_NADH_DEHYDROGENASE_QUINONE_ACTIVITY",39,0.9022,0.6,1,"Yes",2.3412,0,0.00018,"Yes"
"17716","C3_MicroRNA_targets","C3_MIR_215_ATGCACG_MIR_517B",20,0.9023,0.6,1,"Yes",-0.5727,0.99,1,"No"
"17717","GO_CC","752924_GO_0097425_SMOOTH_ENDOPLASMIC_RETICULUM_PART",6,0.903,0.58,0.89,"Yes",1.0449,0.41,0.72,"Yes"
"17718","C2_Chemical_and_genetic_perturbations","C2_CGP_764_NEBEN_AML_WITH_FLT3_OR_NRAS_UP",8,0.903,0.57,1,"Yes",1.1877,0.25,0.51,"Yes"
"17719","GO_BP","517048_GO_0072132_MESENCHYME_MORPHOGENESIS",28,0.9032,0.62,1,"Yes",0.9029,0.61,1,"Yes"
"17720","GO_BP","512337_GO_0051459_REGULATION_OF_CORTICOTROPIN_SECRETION",5,0.9039,0.58,1,"Yes",-0.7122,0.82,1,"No"
"17721","GO_BP","487810_GO_0001919_REGULATION_OF_RECEPTOR_RECYCLING",18,0.9042,0.56,1,"Yes",1.2189,0.19,0.77,"Yes"
"17722","OMIM_gene","OMIM601184_DNAJ_HSP40_HOMOLOG_SUBFAMILY_C_MEMBER_3_DNAJC3",5,0.9042,0.53,1,"Yes",1.2934,0.18,0.74,"Yes"
"17723","GO_BP","752432_GO_0086066_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION",9,0.9061,0.57,1,"Yes",0.9796,0.49,1,"Yes"
"17724","GO_BP","1129331_GO_1903504_REGULATION_OF_MITOTIC_SPINDLE_CHECKPOINT",11,0.9062,0.59,1,"Yes",1.0581,0.37,0.94,"Yes"
"17725","GO_BP","487837_GO_0001947_HEART_LOOPING",52,0.9063,0.67,1,"Yes",-0.86,0.71,1,"No"
"17726","GO_BP","487020_GO_0000723_TELOMERE_MAINTENANCE",75,0.9064,0.7,1,"Yes",0.9579,0.54,1,"Yes"
"17727","GO_BP","488997_GO_0003203_ENDOCARDIAL_CUSHION_MORPHOGENESIS",17,0.9066,0.59,1,"Yes",0.6628,0.92,1,"Yes"
"17728","C4_Cancer_gene_neighborhoods","C4_CGN_393_GNF2_PPP6C",39,0.9066,0.64,0.87,"Yes",2.2053,0,2.2e-05,"Yes"
"17729","REACTOME","105664_REACT_330_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS",8,0.907,0.56,0.88,"Yes",0.9004,0.58,0.91,"Yes"
"17730","KEGG_compound","C00042_SUCCINATE_SUCCINIC_ACID_BUTANEDIONIC_ACID_ETHYLENESUCCINIC_ACID",20,0.9077,0.58,1,"Yes",0.8326,0.69,1,"Yes"
"17731","GO_BP","947904_GO_0098586_CELLULAR_RESPONSE_TO_VIRUS",10,0.9079,0.6,1,"Yes",1.5798,0.041,0.31,"Yes"
"17732","GO_BP","491422_GO_0006526_ARGININE_BIOSYNTHETIC_PROCESS",6,0.908,0.54,1,"Yes",-0.8197,0.68,1,"No"
"17733","C2_Chemical_and_genetic_perturbations","C2_CGP_719_FARMER_BREAST_CANCER_CLUSTER_6",16,0.908,0.59,1,"Yes",-0.7445,0.84,1,"No"
"17734","GO_BP","518709_GO_2000060_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",87,0.9081,0.7,1,"Yes",1.8643,0,0.056,"Yes"
"17735","C7_Immunologic_signatures","C7_ALL_1894_GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN",176,0.9081,0.77,0.94,"Yes",1.2592,0.063,0.14,"Yes"
"17736","GO_BP","518406_GO_0090266_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT",11,0.9081,0.58,1,"Yes",1.0601,0.39,0.94,"Yes"
"17737","GO_BP","486754_GO_0000236_MITOTIC_PROMETAPHASE",101,0.9084,0.71,1,"Yes",1.4887,0.0096,0.43,"Yes"
"17738","C6_Oncogenic_signatures","C6_ALL_37_BCAT_100_UP_V1_DN",39,0.9089,0.66,1,"Yes",-1.3045,0.1,0.39,"No"
"17739","GO_BP","508605_GO_0046341_CDP_DIACYLGLYCEROL_METABOLIC_PROCESS",14,0.9093,0.58,1,"Yes",1.2134,0.23,0.77,"Yes"
"17740","C4_Cancer_gene_neighborhoods","C4_CGN_107_MORF_GMPS",53,0.9094,0.62,0.87,"Yes",2.0793,0,0.00016,"Yes"
"17741","C7_Immunologic_signatures","C7_ALL_916_GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN",199,0.9095,0.79,0.94,"Yes",0.805,0.97,1,"Yes"
"17742","GO_CC","500189_GO_0030894_REPLISOME",29,0.9095,0.6,0.88,"Yes",1.2378,0.16,0.48,"Yes"
"17743","GO_BP","513707_GO_0060149_NEGATIVE_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING",6,0.9097,0.53,1,"Yes",-0.7842,0.72,1,"No"
"17744","GO_BP","499076_GO_0021796_CEREBRAL_CORTEX_REGIONALIZATION",7,0.9097,0.57,1,"Yes",-0.6418,0.91,1,"No"
"17745","GO_BP","501604_GO_0032369_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT",25,0.9098,0.61,1,"Yes",1.2793,0.14,0.7,"Yes"
"17746","C2_Chemical_and_genetic_perturbations","C2_CGP_2961_KAMMINGA_SENESCENCE",39,0.9098,0.59,1,"Yes",-0.9949,0.46,1,"No"
"17747","GO_BP","508333_GO_0046036_CTP_METABOLIC_PROCESS",15,0.91,0.58,1,"Yes",-0.7157,0.86,1,"No"
"17748","GO_CC","507636_GO_0045271_RESPIRATORY_CHAIN_COMPLEX_I",41,0.9101,0.61,0.89,"Yes",2.4512,0,0,"Yes"
"17749","GO_CC","500188_GO_0030893_MEIOTIC_COHESIN_COMPLEX",7,0.9101,0.53,0.89,"Yes",0.6823,0.84,0.98,"Yes"
"17750","GO_BP","486565_GO_0000012_SINGLE_STRAND_BREAK_REPAIR",8,0.9102,0.54,1,"Yes",1.1169,0.33,0.88,"Yes"
"17751","GO_CC","490861_GO_0005845_MRNA_CAP_BINDING_COMPLEX",12,0.9112,0.57,0.89,"Yes",1.0302,0.39,0.74,"Yes"
"17752","C3_TF_targets","C3_TFT_533_WCTCNATGGY_UNKNOWN",82,0.9116,0.65,1,"Yes",1.3005,0.063,0.49,"Yes"
"17753","GO_CC","506632_GO_0043601_NUCLEAR_REPLISOME",29,0.9118,0.6,0.89,"Yes",1.2587,0.13,0.45,"Yes"
"17754","GO_BP","488374_GO_0002501_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX",5,0.9121,0.55,1,"Yes",-1.1543,0.3,0.92,"No"
"17755","KEGG_module","HSA_M00065_GPI_ANCHOR_BIOSYNTHESIS_CORE_OLIGOSACCHARIDE",8,0.9134,0.55,0.76,"Yes",0.8353,0.66,0.92,"Yes"
"17756","REACTOME","105845_REACT_2156_CLEAVAGE_OF_THE_DAMAGED_PYRIMIDINE",8,0.9136,0.56,0.87,"Yes",1.1507,0.29,0.51,"Yes"
"17757","GO_BP","491242_GO_0006278_RNA_DEPENDENT_DNA_REPLICATION",14,0.9141,0.55,1,"Yes",1.1153,0.32,0.88,"Yes"
"17758","C2_Chemical_and_genetic_perturbations","C2_CGP_2283_BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN",22,0.9144,0.58,1,"Yes",-0.7203,0.86,1,"No"
"17759","GO_BP","509011_GO_0046784_VIRAL_MRNA_EXPORT_FROM_HOST_CELL_NUCLEUS",8,0.9145,0.54,1,"Yes",0.9077,0.57,1,"Yes"
"17760","GO_BP","513705_GO_0060147_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING",12,0.9146,0.59,1,"Yes",-1.0585,0.38,0.96,"No"
"17761","C1_Positional","C1_ALL_260_CHR2P16",36,0.9147,0.62,0.92,"Yes",0.4597,1,1,"Yes"
"17762","KEGG_compound","C05335_L_SELENOMETHIONINE",7,0.9148,0.57,1,"Yes",0.8548,0.64,1,"Yes"
"17763","REACTOME","1183562_REACT_355218_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING",27,0.9149,0.58,0.87,"Yes",1.1828,0.2,0.46,"Yes"
"17764","C2_Chemical_and_genetic_perturbations","C2_CGP_943_BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION",13,0.915,0.58,1,"Yes",-0.5861,0.97,1,"No"
"17765","GO_BP","517086_GO_0072170_METANEPHRIC_TUBULE_DEVELOPMENT",18,0.9152,0.56,1,"Yes",-0.8648,0.65,1,"No"
"17766","C2_Chemical_and_genetic_perturbations","C2_CGP_3349_HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP",19,0.9153,0.57,1,"Yes",1.2577,0.18,0.43,"Yes"
"17767","GO_BP","510605_GO_0048536_SPLEEN_DEVELOPMENT",35,0.9157,0.61,1,"Yes",0.875,0.66,1,"Yes"
"17768","GO_BP","812231_GO_1902108_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS",18,0.9158,0.59,1,"Yes",1.4232,0.076,0.53,"Yes"
"17769","C7_Immunologic_signatures","C7_ALL_1232_GSE27786_NEUTROPHIL_VS_MONO_MAC_DN",198,0.916,0.77,0.92,"Yes",1.5268,0,0.0086,"Yes"
"17770","GO_BP","491948_GO_0007135_MEIOSIS_II",5,0.916,0.54,1,"Yes",-0.679,0.85,1,"No"
"17771","REACTOME","161009_REACT_22329_NRCAM_INTERACTIONS",7,0.916,0.55,0.87,"Yes",-1.0675,0.37,0.91,"No"
"17772","C7_Immunologic_signatures","C7_ALL_1370_GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN",199,0.9162,0.74,0.92,"Yes",1.031,0.33,0.64,"Yes"
"17773","GO_BP","512316_GO_0051438_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",104,0.9163,0.7,1,"Yes",1.9677,0,0.018,"Yes"
"17774","C7_Immunologic_signatures","C7_ALL_1741_GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP",168,0.9164,0.74,0.93,"Yes",1.8211,0,3.2e-05,"Yes"
"17775","GO_BP","507544_GO_0045161_NEURONAL_ION_CHANNEL_CLUSTERING",12,0.9164,0.56,1,"Yes",-1.3011,0.16,0.89,"No"
"17776","GO_BP","505569_GO_0042428_SEROTONIN_METABOLIC_PROCESS",11,0.9165,0.54,1,"Yes",-0.8847,0.6,1,"No"
"17777","KEGG_enzyme","2.3.1.48_HISTONE_ACETYLTRANSFERASE_NUCLEOSOME_HISTONE_ACETYLTRANSFERASE_HISTONE_ACETOKINASE_HISTONE_ACETYLASE_HISTONE_TRANSACETYLASE",18,0.9165,0.56,0.75,"Yes",0.7143,0.86,1,"Yes"
"17778","GO_MF","492520_GO_0008172_S_METHYLTRANSFERASE_ACTIVITY",7,0.9167,0.53,1,"Yes",-0.7976,0.71,1,"No"
"17779","GO_CC","490860_GO_0005844_POLYSOME",33,0.9167,0.6,0.89,"Yes",1.2613,0.13,0.45,"Yes"
"17780","GO_MF","492813_GO_0061133_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY",5,0.9168,0.52,1,"Yes",1.4041,0.11,0.48,"Yes"
"17781","GO_BP","501439_GO_0032204_REGULATION_OF_TELOMERE_MAINTENANCE",16,0.917,0.58,1,"Yes",0.5703,0.96,1,"Yes"
"17782","C7_Immunologic_signatures","C7_ALL_1155_GSE27786_LSK_VS_ERYTHROBLAST_UP",200,0.917,0.81,0.93,"Yes",1.3256,0.015,0.08,"Yes"
"17783","GO_CC","500257_GO_0030964_NADH_DEHYDROGENASE_COMPLEX",41,0.9172,0.6,0.89,"Yes",2.5509,0,0,"Yes"
"17784","GO_BP","500347_GO_0031057_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION",34,0.9176,0.61,1,"Yes",1.0212,0.41,0.97,"Yes"
"17785","C2_Chemical_and_genetic_perturbations","C2_CGP_894_YANG_BREAST_CANCER_ESR1_BULK_UP",27,0.9178,0.57,1,"Yes",1.0146,0.4,0.78,"Yes"
"17786","GO_CC","503720_GO_0034518_RNA_CAP_BINDING_COMPLEX",12,0.918,0.55,0.89,"Yes",1.0188,0.43,0.75,"Yes"
"17787","GO_BP","500351_GO_0031061_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION",13,0.9183,0.56,1,"Yes",-0.6364,0.95,1,"No"
"17788","GO_CC","490782_GO_0005747_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I",41,0.9183,0.58,0.9,"Yes",2.5413,0,0,"Yes"
"17789","C7_Immunologic_signatures","C7_ALL_392_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN",199,0.9189,0.79,0.93,"Yes",1.8801,0,0,"Yes"
"17790","C2_Chemical_and_genetic_perturbations","C2_CGP_1281_SCHUHMACHER_MYC_TARGETS_DN",7,0.9191,0.51,1,"Yes",1.1263,0.31,0.59,"Yes"
"17791","C2_Chemical_and_genetic_perturbations","C2_CGP_2100_TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN",6,0.9191,0.53,1,"Yes",-1.1418,0.32,0.86,"No"
"17792","GO_BP","505879_GO_0042773_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT",52,0.9192,0.61,1,"Yes",2.4193,0,0,"Yes"
"17793","KEGG_module","HSA_M00680_TGF_BETA_SIGNALING",8,0.9192,0.56,0.76,"Yes",-0.6815,0.88,1,"No"
"17794","GO_BP","491336_GO_0006417_REGULATION_OF_TRANSLATION",272,0.9192,0.75,1,"Yes",1.5135,0,0.39,"Yes"
"17795","C2_Chemical_and_genetic_perturbations","C2_CGP_2526_NUTT_GBM_VS_AO_GLIOMA_DN",45,0.9197,0.61,1,"Yes",2.1547,0,0.0011,"Yes"
"17796","OMIM_gene","OMIM176820_KALLIKREIN_RELATED_PEPTIDASE_3_KLK3",7,0.9197,0.53,1,"Yes",1.0945,0.35,1,"Yes"
"17797","REACTOME","833819_REACT_163993_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN",14,0.9201,0.56,0.86,"Yes",0.9653,0.52,0.8,"Yes"
"17798","GO_BP","492404_GO_0050812_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS",13,0.9203,0.55,1,"Yes",1.4227,0.093,0.53,"Yes"
"17799","GO_BP","494037_GO_0009948_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION",45,0.9204,0.63,1,"Yes",-1.1467,0.22,0.93,"No"
"17800","GO_BP","491712_GO_0015810_ASPARTATE_TRANSPORT",7,0.9205,0.54,1,"Yes",-0.6893,0.85,1,"No"
"17801","GO_BP","513631_GO_0060073_MICTURITION",7,0.9208,0.53,1,"Yes",0.8134,0.7,1,"Yes"
"17802","GO_MF","512262_GO_0051378_SEROTONIN_BINDING",8,0.9208,0.55,1,"Yes",1.0568,0.4,0.83,"Yes"
"17803","GO_BP","492349_GO_0050912_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE",42,0.9211,0.6,1,"Yes",0.862,0.69,1,"Yes"
"17804","KEGG_compound","C00164_ACETOACETATE_3_OXOBUTANOIC_ACID_BETA_KETOBUTYRIC_ACID_ACETOACETIC_ACID",8,0.9211,0.55,1,"Yes",0.7885,0.73,1,"Yes"
"17805","KEGG_module","HSA_M00057_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE",5,0.9215,0.55,0.78,"Yes",-0.3998,1,1,"No"
"17806","GO_BP","495358_GO_0015074_DNA_INTEGRATION",10,0.9222,0.55,1,"Yes",0.8066,0.72,1,"Yes"
"17807","GO_BP","501435_GO_0032200_TELOMERE_ORGANIZATION",76,0.9222,0.63,1,"Yes",0.9281,0.61,1,"Yes"
"17808","GO_BP","509020_GO_0046794_TRANSPORT_OF_VIRUS",35,0.9224,0.59,1,"Yes",1.5785,0.015,0.32,"Yes"
"17809","C1_Positional","C1_ALL_266_CHR2Q14",42,0.9228,0.62,0.91,"Yes",1.4853,0.037,0.28,"Yes"
"17810","GO_BP","505176_GO_0040018_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH",32,0.9229,0.61,1,"Yes",1.1542,0.24,0.83,"Yes"
"17811","GO_MF","503418_GO_0034212_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY",9,0.9233,0.54,1,"Yes",0.7177,0.86,1,"Yes"
"17812","GO_BP","491305_GO_0006376_MRNA_SPLICE_SITE_SELECTION",27,0.9235,0.58,1,"Yes",-0.8714,0.64,1,"No"
"17813","C4_Cancer_gene_neighborhoods","C4_CGN_10_MORF_BUB3",277,0.9236,0.8,0.83,"Yes",2.395,0,0,"Yes"
"17814","GO_BP","506586_GO_0043555_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS",16,0.9238,0.56,1,"Yes",0.9827,0.46,1,"Yes"
"17815","GO_CC","505716_GO_0042589_ZYMOGEN_GRANULE_MEMBRANE",9,0.9239,0.54,0.89,"Yes",1.7118,0.019,0.056,"Yes"
"17816","C7_Immunologic_signatures","C7_ALL_618_GSE17721_POLYIC_VS_CPG_0_5H_BMDM_DN",199,0.9239,0.69,0.91,"Yes",1.2799,0.032,0.12,"Yes"
"17817","C2_Chemical_and_genetic_perturbations","C2_CGP_1561_NOUZOVA_METHYLATED_IN_APL",65,0.9242,0.62,1,"Yes",0.9992,0.47,0.8,"Yes"
"17818","C4_Cancer_gene_neighborhoods","C4_CGN_222_GCM_DDX5",65,0.9244,0.63,0.84,"Yes",1.6268,0.0022,0.012,"Yes"
"17819","GO_BP","487617_GO_0001714_ENDODERMAL_CELL_FATE_SPECIFICATION",6,0.9245,0.54,1,"Yes",0.7754,0.74,1,"Yes"
"17820","C7_Immunologic_signatures","C7_ALL_1821_GSE7852_LN_VS_FAT_TCONV_UP",200,0.9245,0.72,0.92,"Yes",1.0084,0.42,0.71,"Yes"
"17821","GO_BP","505802_GO_0042693_MUSCLE_CELL_FATE_COMMITMENT",13,0.9251,0.54,1,"Yes",-0.7719,0.75,1,"No"
"17822","GO_BP","512523_GO_0051647_NUCLEUS_LOCALIZATION",22,0.9252,0.56,1,"Yes",-0.9939,0.46,1,"No"
"17823","GO_BP","492115_GO_0007350_BLASTODERM_SEGMENTATION",21,0.9255,0.57,1,"Yes",0.8301,0.73,1,"Yes"
"17824","GO_CC","504253_GO_0035068_MICRO_RIBONUCLEOPROTEIN_COMPLEX",7,0.9255,0.56,0.89,"Yes",-1.0497,0.41,0.83,"No"
"17825","C2_Chemical_and_genetic_perturbations","C2_CGP_2875_KYNG_WERNER_SYNDROM_DN",29,0.9259,0.56,1,"Yes",-0.7455,0.87,1,"No"
"17826","GO_MF","492491_GO_0008137_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY",39,0.9259,0.58,1,"Yes",2.4018,0,0.00027,"Yes"
"17827","GO_BP","506452_GO_0043414_MACROMOLECULE_METHYLATION",206,0.9259,0.76,1,"Yes",-0.9224,0.68,1,"No"
"17828","GO_BP","516772_GO_0071850_MITOTIC_CELL_CYCLE_ARREST",14,0.926,0.57,1,"Yes",1.0156,0.46,0.97,"Yes"
"17829","C7_Immunologic_signatures","C7_ALL_1606_GSE3982_EOSINOPHIL_VS_TH2_DN",197,0.9262,0.76,0.92,"Yes",1.6556,0,0.0012,"Yes"
"17830","C4_Cancer_gene_neighborhoods","C4_CGN_18_MORF_FEN1",65,0.9265,0.6,0.84,"Yes",2.0573,0,0.00017,"Yes"
"17831","GO_BP","510619_GO_0048552_REGULATION_OF_METALLOENZYME_ACTIVITY",12,0.9266,0.55,1,"Yes",1.0834,0.35,0.92,"Yes"
"17832","C3_TF_targets","C3_TFT_480_GGCNRNWCTTYS_UNKNOWN",82,0.9268,0.61,1,"Yes",1.0476,0.36,1,"Yes"
"17833","GO_MF","491837_GO_0019237_CENTROMERIC_DNA_BINDING",7,0.9269,0.54,1,"Yes",0.9618,0.5,0.92,"Yes"
"17834","C7_Immunologic_signatures","C7_ALL_18_GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN",200,0.927,0.67,0.92,"Yes",1.647,0,0.0013,"Yes"
"17835","GO_BP","487729_GO_0001833_INNER_CELL_MASS_CELL_PROLIFERATION",15,0.9273,0.52,1,"Yes",0.9262,0.57,1,"Yes"
"17836","C2_Chemical_and_genetic_perturbations","C2_CGP_1663_BROWNE_HCMV_INFECTION_10HR_DN",56,0.928,0.58,1,"Yes",1.0823,0.31,0.66,"Yes"
"17837","GO_BP","514522_GO_0060967_NEGATIVE_REGULATION_OF_GENE_SILENCING_BY_RNA",6,0.9283,0.52,1,"Yes",-0.7966,0.72,1,"No"
"17838","REACTOME","105777_REACT_1095_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX",30,0.9285,0.55,0.84,"Yes",1.4933,0.027,0.15,"Yes"
"17839","REACTOME","645341_REACT_120918_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE",10,0.9288,0.54,0.85,"Yes",0.7694,0.75,1,"Yes"
"17840","GO_BP","488004_GO_0002115_STORE_OPERATED_CALCIUM_ENTRY",5,0.9296,0.54,1,"Yes",0.9188,0.57,1,"Yes"
"17841","GO_MF","515118_GO_0070181_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING",5,0.9297,0.51,1,"Yes",1.5825,0.031,0.3,"Yes"
"17842","REACTOME","187207_REACT_25073_MOLYBDENUM_COFACTOR_BIOSYNTHESIS",6,0.9297,0.53,0.85,"Yes",0.7627,0.76,1,"Yes"
"17843","GO_MF","501418_GO_0032183_SUMO_BINDING",12,0.9297,0.52,1,"Yes",-0.5779,0.96,1,"No"
"17844","GO_BP","750988_GO_0036066_PROTEIN_O_LINKED_FUCOSYLATION",12,0.9298,0.54,1,"Yes",0.7601,0.79,1,"Yes"
"17845","GO_CC","490863_GO_0005847_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX",10,0.9301,0.53,0.88,"Yes",1.3445,0.13,0.35,"Yes"
"17846","C7_Immunologic_signatures","C7_ALL_819_GSE17974_0_5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP",193,0.9302,0.68,0.91,"Yes",0.9738,0.53,0.82,"Yes"
"17847","C2_Chemical_and_genetic_perturbations","C2_CGP_431_VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP",66,0.9304,0.64,1,"Yes",-1.0116,0.41,0.99,"No"
"17848","GO_BP","486627_GO_0000087_MITOTIC_M_PHASE",235,0.9306,0.77,1,"Yes",1.6683,0,0.23,"Yes"
"17849","GO_MF","983686_GO_0097602_CULLIN_FAMILY_PROTEIN_BINDING",5,0.9307,0.51,1,"Yes",1.0723,0.39,0.82,"Yes"
"17850","C3_TF_targets","C3_TFT_71_V_NRF2_01",270,0.931,0.81,1,"Yes",1.5667,0,0.1,"Yes"
"17851","GO_BP","510903_GO_0048853_FOREBRAIN_MORPHOGENESIS",18,0.9311,0.57,1,"Yes",1.0216,0.41,0.97,"Yes"
"17852","GO_BP","491403_GO_0006505_GPI_ANCHOR_METABOLIC_PROCESS",34,0.9313,0.58,1,"Yes",0.9994,0.44,0.98,"Yes"
"17853","GO_BP","491209_GO_0006241_CTP_BIOSYNTHETIC_PROCESS",15,0.9313,0.54,1,"Yes",-0.7151,0.85,1,"No"
"17854","GO_BP","501474_GO_0032239_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT",12,0.9315,0.52,1,"Yes",1.1177,0.32,0.88,"Yes"
"17855","C7_Immunologic_signatures","C7_ALL_333_GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP",199,0.9317,0.74,0.91,"Yes",1.627,0,0.0018,"Yes"
"17856","REACTOME","106179_REACT_197_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM",17,0.9319,0.53,0.84,"Yes",1.2955,0.15,0.33,"Yes"
"17857","GO_MF","486713_GO_0000182_RDNA_BINDING",7,0.932,0.53,1,"Yes",-0.7183,0.81,1,"No"
"17858","GO_MF","489434_GO_0003954_NADH_DEHYDROGENASE_ACTIVITY",39,0.9321,0.58,1,"Yes",2.3436,0,0.00021,"Yes"
"17859","C2_Chemical_and_genetic_perturbations","C2_CGP_3051_KIM_ALL_DISORDERS_DURATION_CORR_UP",9,0.9324,0.53,1,"Yes",-1.3396,0.15,0.71,"No"
"17860","C2_Chemical_and_genetic_perturbations","C2_CGP_482_KERLEY_RESPONSE_TO_CISPLATIN_DN",5,0.9324,0.52,1,"Yes",-1.2055,0.26,0.8,"No"
"17861","GO_CC","504287_GO_0035102_PRC1_COMPLEX",13,0.9324,0.54,0.88,"Yes",0.6871,0.88,0.99,"Yes"
"17862","REACTOME","1127536_REACT_264605_HEDGEHOG_LIGAND_BIOGENESIS",63,0.9325,0.6,0.84,"Yes",2.0159,0,0.0018,"Yes"
"17863","C2_Chemical_and_genetic_perturbations","C2_CGP_952_PUJANA_BRCA_CENTERED_NETWORK",117,0.9328,0.68,1,"Yes",1.5281,0.0065,0.18,"Yes"
"17864","GO_MF","492836_GO_0008568_MICROTUBULE_SEVERING_ATPASE_ACTIVITY",10,0.933,0.54,1,"Yes",1.294,0.15,0.62,"Yes"
"17865","GO_CC","499556_GO_0030127_COPII_VESICLE_COAT",10,0.9335,0.55,0.88,"Yes",1.0816,0.35,0.67,"Yes"
"17866","GO_BP","511717_GO_0050746_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS",10,0.9335,0.56,1,"Yes",1.1559,0.27,0.83,"Yes"
"17867","GO_CC","500764_GO_0031513_NONMOTILE_PRIMARY_CILIUM",116,0.9341,0.69,0.88,"Yes",-0.895,0.7,0.95,"No"
"17868","GO_BP","514521_GO_0060966_REGULATION_OF_GENE_SILENCING_BY_RNA",12,0.9343,0.55,1,"Yes",-1.0624,0.37,0.96,"No"
"17869","GO_MF","506069_GO_0042975_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING",10,0.935,0.56,1,"Yes",-1.0579,0.37,0.87,"No"
"17870","C2_Chemical_and_genetic_perturbations","C2_CGP_530_BUSA_SAM68_TARGETS_UP",7,0.9352,0.52,1,"Yes",-0.7823,0.73,1,"No"
"17871","C1_Positional","C1_ALL_218_CHR7Q21",80,0.9354,0.56,0.89,"Yes",0.8419,0.81,0.93,"Yes"
"17872","C7_Immunologic_signatures","C7_ALL_1298_GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN",200,0.9354,0.66,0.9,"Yes",1.3534,0.02,0.06,"Yes"
"17873","OMIM_gene","OMIM609017_ERYTHROBLAST_MEMBRANE_ASSOCIATED_PROTEIN_ERMAP",5,0.9356,0.51,1,"Yes",0.8593,0.64,1,"Yes"
"17874","KEGG_compound","C00013_DIPHOSPHATE_DIPHOSPHORIC_ACID_PYROPHOSPHATE_PYROPHOSPHORIC_ACID_PPI",182,0.9356,0.68,1,"Yes",1.1561,0.13,0.95,"Yes"
"17875","C2_Chemical_and_genetic_perturbations","C2_CGP_1027_SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN",17,0.9359,0.53,1,"Yes",-0.704,0.88,1,"No"
"17876","C7_Immunologic_signatures","C7_ALL_584_GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDM_DN",197,0.936,0.73,0.9,"Yes",1.5664,0,0.005,"Yes"
"17877","GO_BP","518856_GO_2000209_REGULATION_OF_ANOIKIS",22,0.9362,0.53,1,"Yes",1.1276,0.29,0.87,"Yes"
"17878","GO_BP","514916_GO_0061371_DETERMINATION_OF_HEART_LEFT_RIGHT_ASYMMETRY",55,0.9363,0.61,1,"Yes",-1.0298,0.4,0.97,"No"
"17879","C4_Cancer_gene_neighborhoods","C4_CGN_30_MORF_PSMC1",191,0.9369,0.7,0.81,"Yes",2.5286,0,0,"Yes"
"17880","C7_Immunologic_signatures","C7_ALL_1223_GSE27786_NKTCELL_VS_NEUTROPHIL_UP",199,0.937,0.67,0.9,"Yes",1.1011,0.22,0.44,"Yes"
"17881","GO_MF","515257_GO_0070324_THYROID_HORMONE_BINDING",6,0.937,0.51,1,"Yes",-1.0201,0.44,0.89,"No"
"17882","C4_Cancer_modules","C4_CM_38_MODULE_42",25,0.9373,0.53,0.92,"Yes",2.1782,0,0.00019,"Yes"
"17883","C7_Immunologic_signatures","C7_ALL_1129_GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP",185,0.9376,0.73,0.91,"Yes",-1.1831,0.13,0.88,"No"
"17884","GO_BP","491646_GO_0009235_COBALAMIN_METABOLIC_PROCESS",19,0.9377,0.51,1,"Yes",1.1075,0.32,0.89,"Yes"
"17885","C4_Cancer_gene_neighborhoods","C4_CGN_206_GCM_ACTG1",124,0.9377,0.64,0.81,"Yes",2.9803,0,0,"Yes"
"17886","GO_BP","486797_GO_0000279_M_PHASE",239,0.9378,0.68,1,"Yes",1.6394,0,0.25,"Yes"
"17887","GO_BP","493345_GO_0009148_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",20,0.9378,0.52,1,"Yes",-0.7372,0.84,1,"No"
"17888","C4_Cancer_modules","C4_CM_175_MODULE_186",20,0.9379,0.52,0.95,"Yes",-1.0239,0.42,0.78,"No"
"17889","GO_BP","517198_GO_0072282_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS",8,0.9382,0.52,1,"Yes",-1.2512,0.21,0.91,"No"
"17890","GO_BP","751695_GO_0044550_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS",17,0.9383,0.51,1,"Yes",0.6442,0.93,1,"Yes"
"17891","GO_BP","513887_GO_0060331_NEGATIVE_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA",5,0.9386,0.52,1,"Yes",1.2873,0.19,0.69,"Yes"
"17892","C1_Positional","C1_ALL_279_CHR15Q14",43,0.9393,0.59,0.9,"Yes",0.9628,0.52,0.81,"Yes"
"17893","C7_Immunologic_signatures","C7_ALL_171_GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP",197,0.9397,0.73,0.9,"Yes",1.1994,0.1,0.23,"Yes"
"17894","GO_BP","753026_GO_1900029_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY",6,0.9399,0.5,1,"Yes",0.8585,0.64,1,"Yes"
"17895","GO_BP","1184428_GO_1903902_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE",97,0.9406,0.61,1,"Yes",1.7616,0,0.13,"Yes"
"17896","GO_MF","498061_GO_0019206_NUCLEOSIDE_KINASE_ACTIVITY",11,0.9409,0.53,1,"Yes",1.1392,0.29,0.76,"Yes"
"17897","C2_Chemical_and_genetic_perturbations","C2_CGP_1010_LIU_COMMON_CANCER_GENES",77,0.9409,0.61,1,"Yes",0.8189,0.84,0.98,"Yes"
"17898","GO_BP","506528_GO_0043497_REGULATION_OF_PROTEIN_HETERODIMERIZATION_ACTIVITY",8,0.9409,0.5,1,"Yes",0.7825,0.74,1,"Yes"
"17899","GO_MF","512638_GO_0051766_INOSITOL_TRISPHOSPHATE_KINASE_ACTIVITY",8,0.9411,0.49,1,"Yes",0.9971,0.45,0.88,"Yes"
"17900","GO_CC","507419_GO_0045009_CHITOSOME",8,0.9415,0.5,0.87,"Yes",0.8891,0.59,0.91,"Yes"
"17901","GO_MF","486787_GO_0000268_PEROXISOME_TARGETING_SEQUENCE_BINDING",5,0.9417,0.52,1,"Yes",-0.7739,0.74,1,"No"
"17902","GO_MF","491838_GO_0042162_TELOMERIC_DNA_BINDING",16,0.9419,0.53,1,"Yes",0.6732,0.9,1,"Yes"
"17903","GO_BP","912525_GO_0039703_RNA_REPLICATION",6,0.9423,0.51,1,"Yes",-0.5392,0.97,1,"No"
"17904","GO_BP","515406_GO_0070474_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION",8,0.9424,0.51,1,"Yes",-0.9548,0.52,1,"No"
"17905","C2_Chemical_and_genetic_perturbations","C2_CGP_1053_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP",233,0.9425,0.7,1,"Yes",0.9094,0.75,0.91,"Yes"
"17906","GO_BP","518156_GO_0090009_PRIMITIVE_STREAK_FORMATION",10,0.9429,0.51,1,"Yes",0.8778,0.59,1,"Yes"
"17907","GO_BP","493344_GO_0009147_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",22,0.9432,0.51,1,"Yes",-0.7468,0.83,1,"No"
"17908","C7_Immunologic_signatures","C7_ALL_1360_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN",198,0.9437,0.65,0.89,"Yes",0.9744,0.52,0.82,"Yes"
"17909","GO_BP","513892_GO_0060336_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY",5,0.9441,0.5,1,"Yes",1.2815,0.18,0.7,"Yes"
"17910","C7_Immunologic_signatures","C7_ALL_396_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN",199,0.9443,0.73,0.89,"Yes",1.8289,0,0,"Yes"
"17911","C4_Cancer_gene_neighborhoods","C4_CGN_397_GNF2_PTX3",36,0.9443,0.54,0.79,"Yes",0.9014,0.62,0.83,"Yes"
"17912","C7_Immunologic_signatures","C7_ALL_258_GSE14308_TH1_VS_INDUCED_TREG_DN",196,0.9446,0.67,0.9,"Yes",1.1877,0.095,0.25,"Yes"
"17913","GO_BP","494726_GO_0010663_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS",7,0.9446,0.52,1,"Yes",1.2273,0.23,0.76,"Yes"
"17914","KEGG_reaction","R08945_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NAD_17_OXIDOREDUCTASE_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NAD_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_NADH_H_",6,0.9451,0.51,0.87,"Yes",1.5067,0.065,0.22,"Yes"
"17915","C4_Cancer_gene_neighborhoods","C4_CGN_185_MORF_TPR",145,0.9451,0.63,0.8,"Yes",1.1063,0.2,0.36,"Yes"
"17916","GO_BP","513791_GO_0060235_LENS_INDUCTION_IN_CAMERA_TYPE_EYE",7,0.9457,0.5,1,"Yes",0.7011,0.82,1,"Yes"
"17917","GO_BP","509147_GO_0046950_CELLULAR_KETONE_BODY_METABOLIC_PROCESS",8,0.9458,0.5,1,"Yes",1.0365,0.43,0.96,"Yes"
"17918","GO_BP","497187_GO_0018216_PEPTIDYL_ARGININE_METHYLATION",11,0.9459,0.51,1,"Yes",0.4895,0.99,1,"Yes"
"17919","WikiPathways","198842_WP322_OSTEOBLAST_SIGNALING",13,0.946,0.5,0.87,"Yes",1.3143,0.15,0.62,"Yes"
"17920","GO_MF","496659_GO_0016746_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS",233,0.9462,0.67,1,"Yes",-0.8244,0.91,1,"No"
"17921","GO_BP","493440_GO_0009247_GLYCOLIPID_BIOSYNTHETIC_PROCESS",50,0.9464,0.53,1,"Yes",1.0368,0.38,0.96,"Yes"
"17922","GO_BP","505160_GO_0040001_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION",20,0.9466,0.52,1,"Yes",0.7607,0.82,1,"Yes"
"17923","C7_Immunologic_signatures","C7_ALL_1217_GSE27786_NKCELL_VS_NEUTROPHIL_UP",200,0.9469,0.67,0.89,"Yes",1.4882,0.0048,0.014,"Yes"
"17924","C4_Cancer_gene_neighborhoods","C4_CGN_55_MORF_XRCC5",235,0.9472,0.72,0.8,"Yes",2.2114,0,2.2e-05,"Yes"
"17925","GO_BP","488814_GO_0003016_RESPIRATORY_SYSTEM_PROCESS",11,0.9475,0.51,1,"Yes",0.996,0.45,0.98,"Yes"
"17926","C4_Cancer_gene_neighborhoods","C4_CGN_311_GNF2_RPA1",28,0.9478,0.54,0.8,"Yes",1.4788,0.043,0.036,"Yes"
"17927","GO_CC","515703_GO_0070775_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX",7,0.9481,0.47,0.85,"Yes",-0.8931,0.61,0.95,"No"
"17928","C1_Positional","C1_ALL_324_CHR4Q11",14,0.9483,0.52,0.88,"Yes",1.8247,0.0041,0.081,"Yes"
"17929","C7_Immunologic_signatures","C7_ALL_1189_GSE27786_BCELL_VS_MONO_MAC_UP",199,0.9485,0.62,0.89,"Yes",0.9515,0.63,0.89,"Yes"
"17930","REACTOME","833804_REACT_163862_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM",20,0.9486,0.5,0.8,"Yes",1.0463,0.38,0.67,"Yes"
"17931","C4_Cancer_modules","C4_CM_309_MODULE_358",79,0.9486,0.58,0.95,"Yes",0.8323,0.84,0.93,"Yes"
"17932","C2_Chemical_and_genetic_perturbations","C2_CGP_573_CHOI_ATL_STAGE_PREDICTOR",44,0.949,0.53,1,"Yes",2.0117,0,0.0054,"Yes"
"17933","GO_BP","513571_GO_0060013_RIGHTING_REFLEX",7,0.9493,0.52,1,"Yes",-1.1428,0.3,0.93,"No"
"17934","GO_BP","494729_GO_0010666_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS",7,0.9494,0.5,1,"Yes",1.2292,0.22,0.76,"Yes"
"17935","C2_BioCarta_Pathways","C2_CP_BIOCARTA_163_BIOCARTA_AKAP13_PATHWAY",12,0.95,0.49,1,"Yes",1.7002,0.008,0.25,"Yes"
"17936","C2_Chemical_and_genetic_perturbations","C2_CGP_2554_CHANG_CORE_SERUM_RESPONSE_UP",212,0.95,0.61,1,"Yes",1.8553,0,0.028,"Yes"
"17937","KEGG_compound","C00458_DCTP_DEOXYCYTIDINE_5_TRIPHOSPHATE_DEOXYCYTIDINE_TRIPHOSPHATE_2_DEOXYCYTIDINE_5_TRIPHOSPHATE",24,0.9501,0.55,1,"Yes",0.7832,0.81,1,"Yes"
"17938","C2_Chemical_and_genetic_perturbations","C2_CGP_262_LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN",7,0.9503,0.49,1,"Yes",1.2705,0.19,0.42,"Yes"
"17939","GO_BP","494906_GO_0010842_RETINA_LAYER_FORMATION",19,0.9506,0.54,1,"Yes",-1.1544,0.27,0.92,"No"
"17940","KEGG_module","HSA_M00412_ESCRT_III_COMPLEX",13,0.9506,0.51,0.74,"Yes",1.2714,0.19,0.43,"Yes"
"17941","GO_MF","490076_GO_0004767_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY",7,0.9508,0.49,1,"Yes",1.0019,0.45,0.87,"Yes"
"17942","KEGG_compound","C00165_DIACYLGLYCEROL_DIGLYCERIDE",7,0.9509,0.49,1,"Yes",0.8025,0.71,1,"Yes"
"17943","GO_BP","507822_GO_0045472_RESPONSE_TO_ETHER",5,0.951,0.52,1,"Yes",1.1582,0.32,0.83,"Yes"
"17944","GO_CC","496539_GO_0016593_CDC73_PAF1_COMPLEX",7,0.9511,0.51,0.85,"Yes",1.0715,0.38,0.69,"Yes"
"17945","GO_BP","515404_GO_0070472_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION",10,0.9511,0.53,1,"Yes",-0.8222,0.68,1,"No"
"17946","KEGG_reaction","R06520_3_SN_PHOSPHATIDATE_PHOSPHOHYDROLASE_SPHINGANINE_1_PHOSPHATE_H2O_SPHINGANINE_ORTHOPHOSPHATE",5,0.9513,0.52,0.88,"Yes",1.2094,0.26,0.87,"Yes"
"17947","C7_Immunologic_signatures","C7_ALL_1632_GSE3982_DC_VS_BCELL_DN",190,0.9514,0.64,0.88,"Yes",0.9739,0.53,0.82,"Yes"
"17948","C4_Cancer_gene_neighborhoods","C4_CGN_117_MORF_ITGA2",52,0.9515,0.53,0.79,"Yes",1.4324,0.03,0.05,"Yes"
"17949","REACTOME","105826_REACT_6837_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE",77,0.9516,0.55,0.8,"Yes",2.0349,0,0.0015,"Yes"
"17950","C2_Chemical_and_genetic_perturbations","C2_CGP_1686_HEDENFALK_BREAST_CANCER_BRACX_UP",20,0.9516,0.55,1,"Yes",2.0957,0,0.0019,"Yes"
"17951","GO_BP","755381_GO_2001275_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS",6,0.9516,0.5,1,"Yes",-0.5465,0.96,1,"No"
"17952","GO_BP","487403_GO_0001302_REPLICATIVE_CELL_AGING",8,0.9518,0.49,1,"Yes",0.6844,0.87,1,"Yes"
"17953","REACTOME","187087_REACT_24918_IRAK1_RECRUITS_IKK_COMPLEX",11,0.9518,0.51,0.8,"Yes",1.0109,0.43,0.73,"Yes"
"17954","C7_Immunologic_signatures","C7_ALL_1747_GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_UP",185,0.9519,0.61,0.89,"Yes",-0.5949,1,1,"No"
"17955","REACTOME","730308_REACT_150206_CROSSLINKING_OF_COLLAGEN_FIBRILS",9,0.952,0.48,0.8,"Yes",-1.006,0.44,0.98,"No"
"17956","GO_BP","491262_GO_0006303_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING",21,0.9525,0.53,1,"Yes",0.6844,0.9,1,"Yes"
"17957","GO_BP","495216_GO_0014820_TONIC_SMOOTH_MUSCLE_CONTRACTION",9,0.953,0.51,1,"Yes",1.4596,0.071,0.48,"Yes"
"17958","REACTOME","106554_REACT_1913_RNA_POLYMERASE_I_PROMOTER_ESCAPE",30,0.9533,0.54,0.8,"Yes",1.1949,0.19,0.45,"Yes"
"17959","REACTOME","161030_REACT_22223_HIGHLY_SODIUM_PERMEABLE_ACETYLCHOLINE_NICOTINIC_RECEPTORS",8,0.9533,0.51,0.81,"Yes",-1.4369,0.077,0.51,"No"
"17960","GO_BP","491963_GO_0007158_NEURON_CELL_CELL_ADHESION",15,0.9534,0.5,1,"Yes",-1.0801,0.35,0.95,"No"
"17961","KEGG_module","HSA_M00403_HRD1_SEL1_ERAD_COMPLEX",13,0.9534,0.48,0.76,"Yes",1.3263,0.14,0.36,"Yes"
"17962","C4_Cancer_gene_neighborhoods","C4_CGN_104_MORF_FRK",105,0.9535,0.62,0.79,"Yes",0.9068,0.68,0.82,"Yes"
"17963","C2_Chemical_and_genetic_perturbations","C2_CGP_3264_YANG_BCL3_TARGETS_DN",8,0.9535,0.48,1,"Yes",-1.1387,0.3,0.87,"No"
"17964","KEGG_module","HSA_M00406_TREX_COMPLEX",8,0.9541,0.49,0.78,"Yes",0.8931,0.59,0.92,"Yes"
"17965","GO_BP","511848_GO_0050913_SENSORY_PERCEPTION_OF_BITTER_TASTE",35,0.9541,0.53,1,"Yes",-0.9858,0.49,1,"No"
"17966","KEGG_compound","C01157_HYDROXYPROLINE_L_HYDROXYPROLINE_TRANS_4_HYDROXY_L_PROLINE",6,0.9544,0.48,1,"Yes",0.7905,0.72,1,"Yes"
"17967","REACTOME","161067_REACT_20530_ZINC_TRANSPORTERS",16,0.9546,0.5,0.81,"Yes",-0.8705,0.64,1,"No"
"17968","GO_MF","487457_GO_0001517_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY",5,0.9547,0.49,1,"Yes",1.0542,0.41,0.83,"Yes"
"17969","C2_Chemical_and_genetic_perturbations","C2_CGP_1328_WONG_IFNA2_RESISTANCE_UP",16,0.9553,0.53,1,"Yes",0.6794,0.91,1,"Yes"
"17970","REACTOME","106026_REACT_9031_VPU_MEDIATED_DEGRADATION_OF_CD4",51,0.9553,0.57,0.81,"Yes",2.2251,0,5.8e-05,"Yes"
"17971","GO_CC","515704_GO_0070776_MOZ_MORF_HISTONE_ACETYLTRANSFERASE_COMPLEX",7,0.9555,0.5,0.84,"Yes",-0.8928,0.61,0.95,"No"
"17972","REACTOME","105844_REACT_702_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PYRIMIDINE",8,0.9556,0.49,0.81,"Yes",1.1792,0.26,0.47,"Yes"
"17973","GO_CC","502383_GO_0033162_MELANOSOME_MEMBRANE",8,0.956,0.49,0.85,"Yes",0.8635,0.65,0.91,"Yes"
"17974","GO_BP","515906_GO_0070979_PROTEIN_K11_LINKED_UBIQUITINATION",27,0.9564,0.54,1,"Yes",1.4245,0.063,0.52,"Yes"
"17975","C1_Positional","C1_ALL_157_CHR20Q12",36,0.9565,0.52,0.87,"Yes",1.1512,0.23,0.64,"Yes"
"17976","GO_BP","503448_GO_0034243_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",23,0.9574,0.5,1,"Yes",1.2606,0.16,0.72,"Yes"
"17977","GO_BP","495996_GO_0015872_DOPAMINE_TRANSPORT",9,0.9578,0.48,1,"Yes",1.1826,0.28,0.8,"Yes"
"17978","GO_BP","491573_GO_0006685_SPHINGOMYELIN_CATABOLIC_PROCESS",6,0.958,0.48,1,"Yes",1.0734,0.38,0.93,"Yes"
"17979","GO_CC","504182_GO_0034991_NUCLEAR_MEIOTIC_COHESIN_COMPLEX",6,0.9581,0.51,0.85,"Yes",0.7574,0.76,0.98,"Yes"
"17980","REACTOME","187083_REACT_25354_IRAK1_RECRUITS_IKK_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION",11,0.9582,0.49,0.8,"Yes",0.9876,0.47,0.77,"Yes"
"17981","C4_Cancer_gene_neighborhoods","C4_CGN_95_MORF_EPHA7",132,0.9583,0.59,0.78,"Yes",-0.8317,0.87,1,"No"
"17982","WikiPathways","198757_WP391_MITOCHONDRIAL_GENE_EXPRESSION",12,0.9586,0.51,0.92,"Yes",0.8351,0.71,1,"Yes"
"17983","GO_BP","492008_GO_0007210_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY",17,0.9586,0.5,1,"Yes",1.4004,0.079,0.55,"Yes"
"17984","C4_Cancer_modules","C4_CM_201_MODULE_214",26,0.9587,0.49,0.94,"Yes",-1.1966,0.22,0.62,"No"
"17985","GO_MF","489929_GO_0004596_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY",8,0.9587,0.51,1,"Yes",0.9784,0.47,0.9,"Yes"
"17986","C7_Immunologic_signatures","C7_ALL_96_GSE11924_TFH_VS_TH1_CD4_TCELL_DN",194,0.959,0.54,0.86,"Yes",1.6523,0,0.0012,"Yes"
"17987","OMIM_gene","OMIM162150_PROPROTEIN_CONVERTASE_SUBTILISIN_KEXIN_TYPE_1_PCSK1",6,0.9593,0.51,1,"Yes",1.0662,0.39,1,"Yes"
"17988","GO_CC","499478_GO_0030014_CCR4_NOT_COMPLEX",15,0.9599,0.48,0.85,"Yes",0.9237,0.57,0.86,"Yes"
"17989","C2_Chemical_and_genetic_perturbations","C2_CGP_709_SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY",32,0.9601,0.51,1,"Yes",1.5279,0.038,0.18,"Yes"
"17990","GO_BP","512585_GO_0051712_POSITIVE_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM",6,0.9608,0.47,0.99,"Yes",0.5972,0.96,1,"Yes"
"17991","KEGG_pathway","HSA03050_PROTEASOME",44,0.9608,0.52,0.67,"Yes",2.1078,0,0.00054,"Yes"
"17992","C7_Immunologic_signatures","C7_ALL_271_GSE14308_INDUCED_VS_NATURAL_TREG_UP",198,0.9609,0.56,0.85,"Yes",1.3542,0.022,0.059,"Yes"
"17993","C2_Chemical_and_genetic_perturbations","C2_CGP_1267_LEI_HOXC8_TARGETS_UP",12,0.9612,0.49,1,"Yes",1.7631,0.0041,0.056,"Yes"
"17994","GO_BP","494826_GO_0010761_FIBROBLAST_MIGRATION",8,0.9614,0.47,0.99,"Yes",-0.5105,0.97,1,"No"
"17995","C7_Immunologic_signatures","C7_ALL_133_GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP",196,0.9614,0.59,0.85,"Yes",1.3389,0.012,0.07,"Yes"
"17996","GO_BP","493810_GO_0009698_PHENYLPROPANOID_METABOLIC_PROCESS",9,0.9617,0.49,0.99,"Yes",-1.3296,0.15,0.9,"No"
"17997","GO_BP","506088_GO_0042997_NEGATIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT",5,0.9618,0.48,1,"Yes",-0.8421,0.64,1,"No"
"17998","GO_BP","1129320_GO_0098763_MITOTIC_CELL_CYCLE_PHASE",308,0.9618,0.6,1,"Yes",1.7237,0,0.17,"Yes"
"17999","GO_CC","493942_GO_0019005_SCF_UBIQUITIN_LIGASE_COMPLEX",30,0.9618,0.5,0.85,"Yes",1.0974,0.3,0.65,"Yes"
"18000","KEGG_reaction","R02353_ESTRADIOL_17BETA_NADP_17_OXIDOREDUCTASE_ESTRADIOL_17BETA_NADP_ESTRONE_NADPH_H_",6,0.962,0.49,0.88,"Yes",1.5254,0.049,0.22,"Yes"
"18001","GO_BP","491360_GO_0006448_REGULATION_OF_TRANSLATIONAL_ELONGATION",23,0.9621,0.5,1,"Yes",1.5821,0.02,0.31,"Yes"
"18002","GO_MF","490280_GO_0004993_SEROTONIN_RECEPTOR_ACTIVITY",17,0.9623,0.51,1,"Yes",1.3607,0.11,0.51,"Yes"
"18003","GO_BP","502741_GO_0033523_HISTONE_H2B_UBIQUITINATION",9,0.9624,0.5,1,"Yes",-0.6179,0.94,1,"No"
"18004","GO_CC","502609_GO_0033391_CHROMATOID_BODY",12,0.9628,0.48,0.85,"Yes",-1.1692,0.27,0.69,"No"
"18005","KEGG_pathway","HSA02010_ABC_TRANSPORTERS",43,0.963,0.52,0.69,"Yes",-1.0952,0.31,0.72,"No"
"18006","KEGG_compound","C00140_N_ACETYL_D_GLUCOSAMINE_N_ACETYLCHITOSAMINE_2_ACETAMIDO_2_DEOXY_D_GLUCOSE_GLCNAC",7,0.9632,0.49,1,"Yes",0.8248,0.68,1,"Yes"
"18007","GO_CC","515625_GO_0070695_FHF_COMPLEX",5,0.9632,0.5,0.85,"Yes",-0.8411,0.68,0.98,"No"
"18008","GO_CC","504282_GO_0035097_HISTONE_METHYLTRANSFERASE_COMPLEX",67,0.9633,0.5,0.86,"Yes",0.6327,0.99,0.99,"Yes"
"18009","C7_Immunologic_signatures","C7_ALL_1294_GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN",195,0.9639,0.59,0.85,"Yes",1.1742,0.088,0.27,"Yes"
"18010","GO_BP","752614_GO_0097113_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_CLUSTERING",5,0.964,0.5,0.99,"Yes",-0.747,0.78,1,"No"
"18011","C2_Chemical_and_genetic_perturbations","C2_CGP_811_HEIDENBLAD_AMPLICON_12P11_12_UP",33,0.9643,0.5,1,"Yes",1.2648,0.12,0.42,"Yes"
"18012","REACTOME","161054_REACT_6344_TAT_MEDIATED_HIV_ELONGATION_ARREST_AND_RECOVERY",30,0.9651,0.51,0.79,"Yes",1.5362,0.016,0.13,"Yes"
"18013","GO_BP","499896_GO_0030575_NUCLEAR_BODY_ORGANIZATION",7,0.9654,0.5,0.99,"Yes",1.0655,0.38,0.94,"Yes"
"18014","C2_Chemical_and_genetic_perturbations","C2_CGP_3088_FIGUEROA_AML_METHYLATION_CLUSTER_6_UP",138,0.9656,0.56,1,"Yes",0.9877,0.47,0.81,"Yes"
"18015","C4_Cancer_modules","C4_CM_63_MODULE_67",218,0.9659,0.57,0.95,"Yes",0.9923,0.49,0.72,"Yes"
"18016","GO_BP","491404_GO_0006506_GPI_ANCHOR_BIOSYNTHETIC_PROCESS",32,0.9659,0.49,0.99,"Yes",1.0783,0.33,0.93,"Yes"
"18017","C2_Chemical_and_genetic_perturbations","C2_CGP_2432_MUELLER_PLURINET",298,0.9659,0.6,1,"Yes",1.3695,0.008,0.32,"Yes"
"18018","GO_CC","518564_GO_0097014_CILIARY_CYTOPLASM",91,0.9663,0.58,0.85,"Yes",-1.1933,0.13,0.69,"No"
"18019","C2_Chemical_and_genetic_perturbations","C2_CGP_189_GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP",77,0.9664,0.51,1,"Yes",1.1026,0.25,0.63,"Yes"
"18020","GO_CC","487074_GO_0000781_CHROMOSOME_TELOMERIC_REGION",57,0.9666,0.54,0.86,"Yes",0.7704,0.88,0.97,"Yes"
"18021","C4_Cancer_gene_neighborhoods","C4_CGN_423_GNF2_TTN",25,0.9666,0.51,0.76,"Yes",0.9604,0.48,0.68,"Yes"
"18022","GO_BP","911307_GO_0039694_VIRAL_RNA_GENOME_REPLICATION",6,0.9667,0.47,0.99,"Yes",-0.5336,0.96,1,"No"
"18023","GO_BP","512213_GO_0051329_MITOTIC_INTERPHASE",131,0.9667,0.54,0.99,"Yes",2.0215,0,0.0097,"Yes"
"18024","C2_Chemical_and_genetic_perturbations","C2_CGP_785_TERAMOTO_OPN_TARGETS_CLUSTER_4",12,0.9668,0.48,1,"Yes",0.9627,0.52,0.85,"Yes"
"18025","C2_Chemical_and_genetic_perturbations","C2_CGP_440_ODONNELL_METASTASIS_DN",23,0.9668,0.48,1,"Yes",1.2716,0.16,0.42,"Yes"
"18026","C7_Immunologic_signatures","C7_ALL_1611_GSE3982_MAST_CELL_VS_NEUTROPHIL_UP",199,0.967,0.56,0.84,"Yes",1.7882,0,0.00017,"Yes"
"18027","C1_Positional","C1_ALL_119_CHR7Q22",114,0.967,0.58,0.86,"Yes",-0.813,0.88,1,"No"
"18028","KEGG_compound","C18075_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_11BETA_HYDROXYTESTOSTERONE",6,0.967,0.48,1,"Yes",1.5112,0.051,0.3,"Yes"
"18029","GO_BP","496424_GO_0016441_POSTTRANSCRIPTIONAL_GENE_SILENCING",36,0.9673,0.51,0.99,"Yes",-0.8568,0.69,1,"No"
"18030","GO_CC","500838_GO_0031588_AMP_ACTIVATED_PROTEIN_KINASE_COMPLEX",12,0.9673,0.48,0.86,"Yes",0.9098,0.58,0.87,"Yes"
"18031","GO_BP","925932_GO_1902583_MULTI_ORGANISM_INTRACELLULAR_TRANSPORT",32,0.9675,0.52,0.99,"Yes",1.6794,0.01,0.21,"Yes"
"18032","KEGG_enzyme","2.3.1.225_PROTEIN_S_ACYLTRANSFERASE_DHHC_PALMITOYL_TRANSFERASE_S_PROTEIN_ACYLTRANSFERASE_G_PROTEIN_PALMITOYLTRANSFERASE",23,0.9675,0.48,0.73,"Yes",-0.9043,0.61,0.9,"No"
"18033","REACTOME","1127583_REACT_268324_DISEASES_OF_GLYCOSYLATION",25,0.9678,0.51,0.78,"Yes",1.2981,0.14,0.32,"Yes"
"18034","C1_Positional","C1_ALL_182_CHR2Q21",52,0.9679,0.54,0.87,"Yes",1.2162,0.14,0.61,"Yes"
"18035","GO_MF","515003_GO_0070064_PROLINE_RICH_REGION_BINDING",19,0.968,0.48,1,"Yes",-0.7371,0.82,1,"No"
"18036","GO_CC","994751_GO_0098687_CHROMOSOMAL_REGION",225,0.9683,0.54,0.86,"Yes",1.142,0.13,0.6,"Yes"
"18037","C7_Immunologic_signatures","C7_ALL_547_GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_UP",199,0.9684,0.55,0.83,"Yes",1.3084,0.0094,0.094,"Yes"
"18038","C4_Cancer_modules","C4_CM_185_MODULE_198",301,0.9691,0.57,0.97,"Yes",1.4495,0,0.15,"Yes"
"18039","GO_MF","490475_GO_0005237_INHIBITORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",5,0.9693,0.5,1,"Yes",-1.8583,0.0021,0.14,"No"
"18040","GO_BP","512315_GO_0051437_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_REGULATION_OF_MITOTIC_CELL_CYCLE_TRANSITION",72,0.9695,0.54,0.99,"Yes",2.0668,0,0.0054,"Yes"
"18041","GO_MF","492856_GO_0008599_PROTEIN_PHOSPHATASE_TYPE_1_REGULATOR_ACTIVITY",12,0.9704,0.49,1,"Yes",1.0113,0.46,0.87,"Yes"
"18042","KEGG_reaction","R04682_ESTRIOL_NADP_17_OXIDOREDUCTASE_ESTRIOL_NADP_16ALPHA_HYDROXYESTRONE_NADPH_H_",6,0.9706,0.49,0.89,"Yes",1.4945,0.067,0.23,"Yes"
"18043","GO_BP","514157_GO_0060602_BRANCH_ELONGATION_OF_AN_EPITHELIUM",15,0.9708,0.49,0.98,"Yes",0.9034,0.61,1,"Yes"
"18044","C2_Chemical_and_genetic_perturbations","C2_CGP_1208_NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON",15,0.9708,0.5,1,"Yes",-1.1649,0.25,0.83,"No"
"18045","GO_BP","491296_GO_0006356_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER",21,0.971,0.52,0.99,"Yes",0.9281,0.58,1,"Yes"
"18046","C7_Immunologic_signatures","C7_ALL_469_GSE17721_CTRL_VS_POLYIC_4H_BMDM_UP",198,0.9713,0.51,0.82,"Yes",1.5278,0.0025,0.0085,"Yes"
"18047","GO_BP","752359_GO_0075733_INTRACELLULAR_TRANSPORT_OF_VIRUS",32,0.9715,0.49,0.99,"Yes",1.6492,0.0061,0.25,"Yes"
"18048","C7_Immunologic_signatures","C7_ALL_337_GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP",200,0.9716,0.59,0.83,"Yes",1.522,0,0.0092,"Yes"
"18049","GO_BP","1184365_GO_0097688_GLUTAMATE_RECEPTOR_CLUSTERING",5,0.9717,0.46,0.99,"Yes",-0.7356,0.81,1,"No"
"18050","GO_CC","513649_GO_0060091_KINOCILIUM",5,0.9719,0.46,0.86,"Yes",-0.7595,0.77,1,"No"
"18051","C4_Cancer_gene_neighborhoods","C4_CGN_196_GCM_BAG5",38,0.972,0.47,0.75,"Yes",1.3075,0.1,0.11,"Yes"
"18052","C2_Chemical_and_genetic_perturbations","C2_CGP_2487_FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN",29,0.972,0.49,1,"Yes",0.8096,0.77,0.98,"Yes"
"18053","REACTOME","106003_REACT_6162_TAT_MEDIATED_ELONGATION_OF_THE_HIV_1_TRANSCRIPT",42,0.972,0.51,0.78,"Yes",1.5537,0.0091,0.12,"Yes"
"18054","KEGG_reaction","R04681_ESTRIOL_NAD_17_OXIDOREDUCTASE_ESTRIOL_NAD_16ALPHA_HYDROXYESTRONE_NADH_H_",6,0.972,0.47,0.92,"Yes",1.512,0.046,0.22,"Yes"
"18055","REACTOME","105843_REACT_1405_DEPYRIMIDINATION",8,0.9721,0.46,0.78,"Yes",1.1569,0.29,0.5,"Yes"
"18056","C2_Chemical_and_genetic_perturbations","C2_CGP_930_TOMLINS_METASTASIS_UP",13,0.9722,0.5,1,"Yes",-0.9377,0.56,1,"No"
"18057","C2_Chemical_and_genetic_perturbations","C2_CGP_87_TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN",7,0.9727,0.45,1,"Yes",-0.9363,0.51,1,"No"
"18058","GO_BP","516523_GO_0071599_OTIC_VESICLE_DEVELOPMENT",15,0.9732,0.51,0.98,"Yes",-0.9473,0.51,1,"No"
"18059","C2_Chemical_and_genetic_perturbations","C2_CGP_208_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN",60,0.9736,0.56,1,"Yes",1.048,0.36,0.72,"Yes"
"18060","GO_MF","509128_GO_0046923_ER_RETENTION_SEQUENCE_BINDING",5,0.9739,0.48,1,"Yes",-0.9639,0.52,0.95,"No"
"18061","C2_Chemical_and_genetic_perturbations","C2_CGP_3354_HOLLEMAN_DAUNORUBICIN_ALL_DN",8,0.974,0.48,1,"Yes",1.4526,0.082,0.25,"Yes"
"18062","GO_BP","491230_GO_0006266_DNA_LIGATION",11,0.9741,0.47,0.98,"Yes",1.3876,0.12,0.57,"Yes"
"18063","C2_Chemical_and_genetic_perturbations","C2_CGP_361_HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN",116,0.9743,0.53,1,"Yes",1.871,0,0.024,"Yes"
"18064","REACTOME","105730_REACT_6889_CONJUGATION_OF_CARBOXYLIC_ACIDS",9,0.9744,0.45,0.77,"Yes",-1.5004,0.049,0.45,"No"
"18065","GO_BP","499570_GO_0030150_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX",5,0.9746,0.47,0.98,"Yes",1.1903,0.29,0.79,"Yes"
"18066","KEGG_module","HSA_M00092_PHOSPHATIDYLETHANOLAMINE_PE_BIOSYNTHESIS_ETHANOLAMINE_PE",7,0.9746,0.48,0.76,"Yes",0.6957,0.82,0.95,"Yes"
"18067","REACTOME","833806_REACT_163793_PROCESSING_AND_ACTIVATION_OF_SUMO",9,0.9746,0.48,0.78,"Yes",1.5053,0.063,0.14,"Yes"
"18068","REACTOME","161055_REACT_6143_PAUSING_AND_RECOVERY_OF_TAT_MEDIATED_HIV_ELONGATION",30,0.9751,0.49,0.78,"Yes",1.534,0.02,0.13,"Yes"
"18069","REACTOME","1127584_REACT_268624_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM",25,0.9752,0.47,0.78,"Yes",1.3041,0.12,0.32,"Yes"
"18070","C4_Cancer_gene_neighborhoods","C4_CGN_275_GCM_ZNF198",118,0.9756,0.5,0.74,"Yes",-0.5547,1,1,"No"
"18071","C2_Chemical_and_genetic_perturbations","C2_CGP_630_HAEGERSTRAND_RESPONSE_TO_IMATINIB",9,0.9756,0.49,1,"Yes",1.0031,0.45,0.79,"Yes"
"18072","GO_CC","489295_GO_0005930_AXONEME",80,0.9758,0.52,0.85,"Yes",-1.1915,0.16,0.67,"No"
"18073","GO_BP","501610_GO_0032375_NEGATIVE_REGULATION_OF_CHOLESTEROL_TRANSPORT",11,0.9761,0.43,0.98,"Yes",0.8909,0.6,1,"Yes"
"18074","C4_Cancer_modules","C4_CM_282_MODULE_323",61,0.9762,0.5,0.98,"Yes",1.4707,0.021,0.14,"Yes"
"18075","REACTOME","645306_REACT_121248_HS_GAG_BIOSYNTHESIS",30,0.9763,0.5,0.78,"Yes",1.7938,0.0062,0.022,"Yes"
"18076","GO_MF","490565_GO_0005385_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",15,0.9765,0.48,1,"Yes",-0.8618,0.64,1,"No"
"18077","GO_BP","510587_GO_0048515_SPERMATID_DIFFERENTIATION",107,0.9766,0.5,0.98,"Yes",-0.9467,0.59,1,"No"
"18078","KEGG_enzyme","1.6.5.3_NADH_UBIQUINONE_REDUCTASE_H_TRANSLOCATING_UBIQUINONE_REDUCTASE_TYPE_1_DEHYDROGENASE_COMPLEX_1_DEHYDROGENASE_COENZYME_Q_REDUCTASE_COMPLEX_I_ELECTRON_TRANSPORT_CHAIN_COMPLEX_I_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_I_NADH_Q1_OXIDOREDUCTASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_COENZYME_Q_REDUCTASE_DPNH_COENZYME_Q_REDUCTASE_DPNH_UBIQUINONE_REDUCTASE_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_1_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_I_NADH_COENZYME_Q1_REDUCTASE_NADH_COENZYME_Q_OXIDOREDUCTASE_NADH_COENZYME_Q_REDUCTASE_NADH_COQ_OXIDOREDUCTASE_NADH_COQ_REDUCTASE_NADH_UBIQUINONE_REDUCTASE_NADH_UBIQUINONE_OXIDOREDUCTASE_NADH_UBIQUINONE_1_REDUCTASE_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_COENZYME_Q_REDUCTASE_NADH_UBIQUINONE_OXIDOREDUCTASE_COMPLEX_NADH_Q6_OXIDOREDUCTASE_ELECTRON_TRANSFER_COMPLEX_I_NADH2_DEHYDROGENASE_UBIQUINONE_",7,0.9772,0.45,0.79,"Yes",1.5,0.063,0.3,"Yes"
"18079","GO_BP","753034_GO_1900037_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA",7,0.9773,0.46,0.98,"Yes",0.5348,0.98,1,"Yes"
"18080","GO_CC","487089_GO_0000798_NUCLEAR_COHESIN_COMPLEX",6,0.9774,0.47,0.85,"Yes",0.7345,0.77,0.99,"Yes"
"18081","GO_BP","487763_GO_0001867_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY",6,0.9775,0.49,0.98,"Yes",1.3419,0.13,0.62,"Yes"
"18082","C2_Chemical_and_genetic_perturbations","C2_CGP_1400_POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN",43,0.9777,0.49,1,"Yes",2.2748,0,0.00017,"Yes"
"18083","GO_BP","487007_GO_0000710_MEIOTIC_MISMATCH_REPAIR",5,0.9779,0.45,0.98,"Yes",-1.2173,0.25,0.88,"No"
"18084","C4_Cancer_gene_neighborhoods","C4_CGN_177_MORF_SKP1A",204,0.978,0.51,0.74,"Yes",2.6506,0,0,"Yes"
"18085","GO_MF","506113_GO_0043023_RIBOSOMAL_LARGE_SUBUNIT_BINDING",7,0.9781,0.46,1,"Yes",1.4984,0.065,0.39,"Yes"
"18086","GO_CC","752847_GO_0097346_INO80_TYPE_COMPLEX",21,0.9781,0.47,0.85,"Yes",0.9035,0.61,0.89,"Yes"
"18087","GO_MF","489246_GO_0003696_SATELLITE_DNA_BINDING",7,0.9782,0.46,1,"Yes",1.0572,0.38,0.83,"Yes"
"18088","C2_Chemical_and_genetic_perturbations","C2_CGP_2081_SANSOM_APC_TARGETS",204,0.9782,0.58,1,"Yes",0.8337,0.91,0.98,"Yes"
"18089","KEGG_reaction","R06227_GDP_L_FUCOSE_G00081_GDP_G00082",5,0.9787,0.48,0.93,"Yes",1.1148,0.35,0.91,"Yes"
"18090","REACTOME","105750_REACT_828_G2_M_CHECKPOINTS",51,0.9787,0.43,0.78,"Yes",1.3568,0.067,0.26,"Yes"
"18091","GO_BP","491101_GO_0006120_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE",39,0.9788,0.47,0.98,"Yes",2.4596,0,0,"Yes"
"18092","REACTOME","1127549_REACT_267701_APC_CDC20_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS_PRIOR_TO_SATISFATION_OF_THE_CELL_CYCLE_CHECKPOINT",70,0.9791,0.51,0.78,"Yes",2.1418,0,0.00035,"Yes"
"18093","GO_BP","500261_GO_0030970_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL",5,0.9792,0.47,0.98,"Yes",1.2978,0.19,0.67,"Yes"
"18094","OMIM_gene","OMIM603026_PLEOMORPHIC_ADENOMA_GENE_1_PLAG1_PLAG1_CTNNB1_FUSION_GENE_INCLUDED",5,0.9792,0.45,1,"Yes",1.3751,0.11,0.94,"Yes"
"18095","REACTOME","105839_REACT_804_BASE_EXCISION_REPAIR_AP_SITE_FORMATION",10,0.9792,0.43,0.78,"Yes",1.2382,0.21,0.41,"Yes"
"18096","GO_CC","506627_GO_0043596_NUCLEAR_REPLICATION_FORK",39,0.9795,0.47,0.86,"Yes",1.1714,0.21,0.56,"Yes"
"18097","GO_BP","501694_GO_0032462_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION",15,0.9797,0.47,0.98,"Yes",1.3403,0.13,0.62,"Yes"
"18098","REACTOME","105739_REACT_1538_CELL_CYCLE_CHECKPOINTS",125,0.9799,0.49,0.78,"Yes",1.8934,0,0.0087,"Yes"
"18099","GO_MF","515423_GO_0070491_REPRESSING_TRANSCRIPTION_FACTOR_BINDING",53,0.98,0.46,1,"Yes",0.8094,0.82,1,"Yes"
"18100","REACTOME","106102_REACT_1988_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY",5,0.98,0.46,0.78,"Yes",0.9931,0.5,0.76,"Yes"
"18101","GO_BP","519267_GO_2000628_REGULATION_OF_MIRNA_METABOLIC_PROCESS",7,0.9803,0.45,0.98,"Yes",0.8485,0.62,1,"Yes"
"18102","C6_Oncogenic_signatures","C6_ALL_21_CSR_EARLY_UP_V1_DN",122,0.9804,0.52,0.85,"Yes",-0.8,0.89,0.99,"No"
"18103","C2_Chemical_and_genetic_perturbations","C2_CGP_3355_HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP",22,0.9813,0.49,1,"Yes",2.1932,0,0.00057,"Yes"
"18104","C2_Chemical_and_genetic_perturbations","C2_CGP_2608_ZHANG_TLX_TARGETS_60HR_DN",277,0.9818,0.57,1,"Yes",1.4653,0,0.24,"Yes"
"18105","REACTOME","105729_REACT_6971_AMINO_ACID_CONJUGATION",9,0.9819,0.43,0.78,"Yes",-1.4981,0.067,0.45,"No"
"18106","REACTOME","106381_REACT_18319_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS_",36,0.9822,0.47,0.78,"Yes",0.6775,0.95,1,"Yes"
"18107","GO_BP","506576_GO_0043545_MOLYBDOPTERIN_COFACTOR_METABOLIC_PROCESS",7,0.9827,0.49,0.97,"Yes",0.917,0.56,1,"Yes"
"18108","GO_BP","516501_GO_0071577_ZINC_II_ION_TRANSMEMBRANE_TRANSPORT",15,0.9827,0.46,0.97,"Yes",-0.8614,0.66,1,"No"
"18109","REACTOME","105901_REACT_207_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS",72,0.9829,0.47,0.79,"Yes",2.0743,0,0.00087,"Yes"
"18110","GO_BP","505040_GO_0035871_PROTEIN_K11_LINKED_DEUBIQUITINATION",10,0.9833,0.47,0.97,"Yes",0.7472,0.79,1,"Yes"
"18111","REACTOME","576255_REACT_118823_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA",67,0.9836,0.47,0.79,"Yes",1.2108,0.13,0.43,"Yes"
"18112","C2_Chemical_and_genetic_perturbations","C2_CGP_2996_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP",9,0.9839,0.47,1,"Yes",0.6646,0.87,1,"Yes"
"18113","KEGG_pathway","HSA00240_PYRIMIDINE_METABOLISM",102,0.984,0.47,0.66,"Yes",1.0585,0.33,0.83,"Yes"
"18114","C1_Positional","C1_ALL_94_CHR5P12",14,0.9843,0.47,0.83,"Yes",-1.0062,0.42,1,"No"
"18115","GO_BP","493272_GO_0009071_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",10,0.9843,0.48,0.97,"Yes",1.2302,0.2,0.75,"Yes"
"18116","GO_BP","501607_GO_0032372_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT",11,0.9844,0.43,0.97,"Yes",0.891,0.6,1,"Yes"
"18117","GO_BP","487519_GO_0001580_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_BITTER_TASTE",31,0.9846,0.47,0.97,"Yes",-0.8134,0.78,1,"No"
"18118","GO_CC","750986_GO_0036064_CILIARY_BASAL_BODY",84,0.9847,0.52,0.85,"Yes",-0.6051,1,1,"No"
"18119","GO_BP","512445_GO_0051567_HISTONE_H3_K9_METHYLATION",12,0.9849,0.48,0.97,"Yes",-0.8691,0.59,1,"No"
"18120","GO_MF","496763_GO_0016874_LIGASE_ACTIVITY",425,0.9849,0.63,1,"Yes",1.0215,0.36,0.86,"Yes"
"18121","GO_MF","496688_GO_0016779_NUCLEOTIDYLTRANSFERASE_ACTIVITY",123,0.9852,0.51,1,"Yes",1.0421,0.35,0.83,"Yes"
"18122","GO_MF","487862_GO_0001972_RETINOIC_ACID_BINDING",22,0.9854,0.46,1,"Yes",1.0487,0.41,0.83,"Yes"
"18123","C2_Chemical_and_genetic_perturbations","C2_CGP_2486_FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP",53,0.9855,0.49,1,"Yes",2.6461,0,0,"Yes"
"18124","GO_BP","488072_GO_0002183_CYTOPLASMIC_TRANSLATIONAL_INITIATION",8,0.9857,0.46,0.97,"Yes",1.4339,0.11,0.52,"Yes"
"18125","C7_Immunologic_signatures","C7_ALL_416_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN",199,0.9859,0.55,0.76,"Yes",1.4207,0,0.031,"Yes"
"18126","GO_BP","500241_GO_0030948_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",7,0.9859,0.48,0.97,"Yes",-0.6823,0.83,1,"No"
"18127","GO_BP","492149_GO_0007386_COMPARTMENT_PATTERN_SPECIFICATION",5,0.9864,0.48,0.97,"Yes",-0.7818,0.73,1,"No"
"18128","GO_BP","512578_GO_0051703_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS",42,0.9865,0.48,0.97,"Yes",0.7536,0.89,1,"Yes"
"18129","KEGG_reaction","R02352_ESTRADIOL_17BETA_NAD_17_OXIDOREDUCTASE_ESTRADIOL_17BETA_NAD_ESTRONE_NADH_H_",6,0.9865,0.46,0.94,"Yes",1.5336,0.058,0.22,"Yes"
"18130","C7_Immunologic_signatures","C7_ALL_138_GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN",198,0.9867,0.46,0.76,"Yes",1.7846,0,0.00017,"Yes"
"18131","REACTOME","106001_REACT_6274_HIV_TRANSCRIPTION_ELONGATION",42,0.9868,0.47,0.78,"Yes",1.5344,0.022,0.13,"Yes"
"18132","GO_BP","506034_GO_0042940_D_AMINO_ACID_TRANSPORT",5,0.9869,0.44,0.97,"Yes",0.6591,0.89,1,"Yes"
"18133","REACTOME","106004_REACT_6346_FORMATION_OF_HIV_1_ELONGATION_COMPLEX_CONTAINING_HIV_1_TAT",42,0.9875,0.46,0.78,"Yes",1.5607,0.024,0.12,"Yes"
"18134","GO_BP","505961_GO_0042866_PYRUVATE_BIOSYNTHETIC_PROCESS",5,0.9878,0.46,0.97,"Yes",1.3391,0.16,0.62,"Yes"
"18135","GO_CC","516067_GO_0071141_SMAD_PROTEIN_COMPLEX",5,0.9879,0.44,0.84,"Yes",0.8377,0.66,0.93,"Yes"
"18136","C7_Immunologic_signatures","C7_ALL_21_GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP",200,0.9882,0.52,0.75,"Yes",1.2814,0.031,0.12,"Yes"
"18137","GO_MF","495446_GO_0015174_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",9,0.9883,0.43,1,"Yes",1.1733,0.27,0.74,"Yes"
"18138","REACTOME","161056_REACT_21376_PYRIMIDINE_BIOSYNTHESIS",6,0.9885,0.46,0.78,"Yes",1.1912,0.27,0.45,"Yes"
"18139","C4_Cancer_gene_neighborhoods","C4_CGN_218_GCM_CSNK1A1",36,0.9889,0.47,0.7,"Yes",1.4933,0.019,0.033,"Yes"
"18140","KEGG_reaction","R06025_GDP_L_FUCOSE_PARAGLOBOSIDE_GDP_III3FUC_NLC4CER",5,0.9891,0.47,0.97,"Yes",1.1404,0.32,1,"Yes"
"18141","GO_BP","518685_GO_2000036_REGULATION_OF_STEM_CELL_MAINTENANCE",17,0.9891,0.47,0.97,"Yes",1.0496,0.39,0.95,"Yes"
"18142","C2_Chemical_and_genetic_perturbations","C2_CGP_2651_MILI_PSEUDOPODIA",43,0.9893,0.46,1,"Yes",1.4136,0.038,0.28,"Yes"
"18143","C7_Immunologic_signatures","C7_ALL_165_GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP",194,0.9897,0.52,0.75,"Yes",0.8868,0.78,1,"Yes"
"18144","GO_BP","491887_GO_0007064_MITOTIC_SISTER_CHROMATID_COHESION",12,0.9897,0.44,0.97,"Yes",-0.4527,1,1,"No"
"18145","GO_BP","491617_GO_0051189_PROSTHETIC_GROUP_METABOLIC_PROCESS",7,0.9899,0.46,0.97,"Yes",0.9077,0.55,1,"Yes"
"18146","GO_BP","499219_GO_0021940_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION",7,0.9901,0.44,0.97,"Yes",1.4332,0.08,0.52,"Yes"
"18147","REACTOME","106236_REACT_1853_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS",25,0.9903,0.46,0.78,"Yes",1.0023,0.45,0.75,"Yes"
"18148","C7_Immunologic_signatures","C7_ALL_825_GSE17974_0_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP",197,0.9909,0.46,0.75,"Yes",1.4014,0,0.037,"Yes"
"18149","GO_BP","491650_GO_0006777_MO_MOLYBDOPTERIN_COFACTOR_BIOSYNTHETIC_PROCESS",7,0.9913,0.45,0.97,"Yes",0.9152,0.56,1,"Yes"
"18150","REACTOME","645316_REACT_120919_SYNTHESIS_OF_PE",12,0.9913,0.46,0.78,"Yes",0.5611,0.98,1,"Yes"
"18151","C1_Positional","C1_ALL_296_CHR7Q11",115,0.9915,0.45,0.83,"Yes",-0.7227,0.97,0.98,"No"
"18152","C7_Immunologic_signatures","C7_ALL_331_GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP",192,0.9917,0.45,0.75,"Yes",0.858,0.85,1,"Yes"
"18153","C4_Cancer_modules","C4_CM_93_MODULE_98",391,0.9918,0.46,0.96,"Yes",1.6384,0,0.065,"Yes"
"18154","GO_CC","502422_GO_0033202_DNA_HELICASE_COMPLEX",14,0.9918,0.45,0.84,"Yes",0.8086,0.73,0.95,"Yes"
"18155","REACTOME","730319_REACT_150421_COHESIN_LOADING_ONTO_CHROMATIN",10,0.9919,0.46,0.78,"Yes",1.102,0.31,0.58,"Yes"
"18156","REACTOME","105748_REACT_2160_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE",52,0.9919,0.48,0.79,"Yes",2.1185,0,0.00047,"Yes"
"18157","C2_Chemical_and_genetic_perturbations","C2_CGP_3165_BERGER_MBD2_TARGETS",5,0.992,0.45,1,"Yes",0.7018,0.81,1,"Yes"
"18158","GO_BP","486639_GO_0000097_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS",20,0.9923,0.45,0.97,"Yes",0.6896,0.9,1,"Yes"
"18159","GO_BP","498344_GO_0019509_L_METHIONINE_BIOSYNTHETIC_PROCESS_FROM_METHYLTHIOADENOSINE",9,0.9924,0.43,0.97,"Yes",0.6566,0.87,1,"Yes"
"18160","GO_BP","508982_GO_0046755_VIRAL_BUDDING",16,0.9926,0.43,0.97,"Yes",1.5332,0.029,0.36,"Yes"
"18161","GO_MF","499873_GO_0030547_RECEPTOR_INHIBITOR_ACTIVITY",11,0.9926,0.46,1,"Yes",-0.9253,0.58,0.97,"No"
"18162","REACTOME","105822_REACT_567_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION",6,0.993,0.45,0.79,"Yes",1.0216,0.44,0.71,"Yes"
"18163","GO_BP","513996_GO_0060441_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS",28,0.9935,0.45,0.97,"Yes",1.3453,0.098,0.61,"Yes"
"18164","GO_BP","517150_GO_0072234_METANEPHRIC_NEPHRON_TUBULE_DEVELOPMENT",15,0.9935,0.46,0.97,"Yes",-0.833,0.7,1,"No"
"18165","GO_BP","491298_GO_0006359_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",22,0.9936,0.48,0.97,"Yes",-0.552,0.98,1,"No"
"18166","GO_BP","498862_GO_0021578_HINDBRAIN_MATURATION",6,0.9939,0.45,0.97,"Yes",-0.8446,0.63,1,"No"
"18167","C7_Immunologic_signatures","C7_ALL_1271_GSE29618_BCELL_VS_PDC_UP",188,0.9943,0.49,0.74,"Yes",1.1852,0.11,0.25,"Yes"
"18168","C7_Immunologic_signatures","C7_ALL_1151_GSE27786_LSK_VS_NKCELL_UP",200,0.9944,0.45,0.75,"Yes",0.8069,0.97,1,"Yes"
"18169","GO_BP","925941_GO_1902592_MULTI_ORGANISM_MEMBRANE_BUDDING",16,0.9949,0.47,0.97,"Yes",1.5745,0.042,0.32,"Yes"
"18170","C7_Immunologic_signatures","C7_ALL_1681_GSE3982_BCELL_VS_NKCELL_UP",191,0.9949,0.48,0.75,"Yes",1.2152,0.073,0.2,"Yes"
"18171","KEGG_reaction","R08980_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NADP_17_OXIDOREDUCTASE_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NADP_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_NADPH_H_",6,0.9951,0.47,0.98,"Yes",1.5189,0.044,0.22,"Yes"
"18172","GO_CC","487068_GO_0000775_CHROMOSOME_CENTROMERIC_REGION",168,0.9953,0.47,0.83,"Yes",1.2412,0.062,0.47,"Yes"
"18173","C2_Chemical_and_genetic_perturbations","C2_CGP_564_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP",7,0.9954,0.44,1,"Yes",0.7606,0.78,1,"Yes"
"18174","KEGG_compound","C00362_DGMP_2_DEOXYGUANOSINE_5_MONOPHOSPHATE_2_DEOXYGUANOSINE_5_PHOSPHATE_DEOXYGUANYLIC_ACID_DEOXYGUANOSINE_MONOPHOSPHATE",12,0.9955,0.44,1,"Yes",1.1235,0.3,1,"Yes"
"18175","C1_Positional","C1_ALL_273_CHR5P15",72,0.9957,0.47,0.83,"Yes",0.9705,0.5,0.79,"Yes"
"18176","REACTOME","530772_REACT_18355_ATF4_ACTIVATES_GENES",24,0.9957,0.45,0.78,"Yes",1.1318,0.28,0.54,"Yes"
"18177","OMIM_gene","OMIM603453_RECEPTOR_INTERACTING_SERINE_THREONINE_KINASE_1_RIPK1",5,0.9959,0.43,1,"Yes",1.3078,0.17,0.74,"Yes"
"18178","C4_Cancer_gene_neighborhoods","C4_CGN_164_MORF_RAB3A",84,0.9962,0.46,0.68,"Yes",0.8993,0.67,0.83,"Yes"
"18179","C7_Immunologic_signatures","C7_ALL_1531_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP",191,0.9963,0.45,0.75,"Yes",1.0557,0.31,0.57,"Yes"
"18180","C3_MicroRNA_targets","C3_MIR_8_GCGCTTT_MIR_518B_MIR_518C_MIR_518D",20,0.9963,0.46,1,"Yes",1.4869,0.043,0.67,"Yes"
"18181","GO_BP","488937_GO_0003143_EMBRYONIC_HEART_TUBE_MORPHOGENESIS",58,0.9964,0.51,0.97,"Yes",0.834,0.78,1,"Yes"
"18182","GO_BP","491545_GO_0006657_CDP_CHOLINE_PATHWAY",7,0.9966,0.42,0.97,"Yes",0.7109,0.82,1,"Yes"
"18183","GO_BP","518315_GO_0090175_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY",22,0.9967,0.43,0.97,"Yes",0.8698,0.64,1,"Yes"
"18184","KEGG_reaction","R06095_GDP_L_FUCOSE_IV2FUC_NLC4CER_GDP_III3_IV2FUC_NLC4CER",5,0.9968,0.45,1,"Yes",1.119,0.36,0.92,"Yes"
"18185","C4_Cancer_gene_neighborhoods","C4_CGN_191_MORF_USP5",52,0.997,0.44,0.69,"Yes",1.4618,0.026,0.04,"Yes"
"18186","GO_BP","505608_GO_0042471_EAR_MORPHOGENESIS",116,0.9971,0.44,0.97,"Yes",1.0719,0.31,0.93,"Yes"
"18187","GO_MF","486896_GO_0000403_Y_FORM_DNA_BINDING",5,0.9976,0.45,1,"Yes",-0.8348,0.64,1,"No"
"18188","GO_BP","507002_GO_0043984_HISTONE_H4_K16_ACETYLATION",19,0.9976,0.44,0.97,"Yes",-0.9053,0.57,1,"No"
"18189","C4_Cancer_gene_neighborhoods","C4_CGN_54_MORF_XPC",62,0.9976,0.48,0.69,"Yes",1.8997,0,8e-04,"Yes"
"18190","GO_BP","510719_GO_0048664_NEURON_FATE_DETERMINATION",7,0.9977,0.43,0.97,"Yes",-0.6748,0.86,1,"No"
"18191","GO_BP","494650_GO_0010586_MIRNA_METABOLIC_PROCESS",9,0.9979,0.44,0.97,"Yes",-0.7124,0.82,1,"No"
"18192","KEGG_pathway","HSA00072_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES",10,0.998,0.45,0.65,"Yes",0.7249,0.83,1,"Yes"
"18193","REACTOME","645293_REACT_120727_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING",26,0.9981,0.45,0.78,"Yes",1.3425,0.1,0.27,"Yes"
"18194","GO_BP","505833_GO_0042726_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS",5,0.9987,0.45,0.97,"Yes",0.662,0.87,1,"Yes"
"18195","C4_Cancer_gene_neighborhoods","C4_CGN_109_MORF_GSPT1",49,0.9991,0.48,0.69,"Yes",2.1812,0,2e-05,"Yes"
"18196","GO_BP","501559_GO_0032324_MOLYBDOPTERIN_COFACTOR_BIOSYNTHETIC_PROCESS",7,0.9994,0.47,0.97,"Yes",0.905,0.56,1,"Yes"
"18197","KEGG_reaction","R06230_GDP_L_FUCOSE_NLC6CER_GDP_III3FUC_NLC6CER",5,0.9994,0.45,1,"Yes",1.1237,0.33,0.95,"Yes"
"18198","GO_BP","494688_GO_0010624_REGULATION_OF_SCHWANN_CELL_PROLIFERATION",5,0.9995,0.45,0.97,"Yes",-0.7045,0.84,1,"No"
"18199","GO_BP","498909_GO_0021626_CENTRAL_NERVOUS_SYSTEM_MATURATION",6,0.9999,0.43,0.97,"Yes",-0.8563,0.64,1,"No"
"18200","C2_Chemical_and_genetic_perturbations","C2_CGP_2641_MEISSNER_BRAIN_ICP_WITH_H3K4ME3",29,1.0003,0.45,1,"Yes",-0.6213,0.97,1,"No"
"18201","C2_Chemical_and_genetic_perturbations","C2_CGP_416_KOINUMA_COLON_CANCER_MSI_DN",8,1.0003,0.42,1,"Yes",1.4045,0.099,0.29,"Yes"
"18202","GO_CC","504451_GO_0035267_NUA4_HISTONE_ACETYLTRANSFERASE_COMPLEX",15,1.0004,0.43,0.82,"Yes",1.1346,0.28,0.59,"Yes"
"18203","GO_BP","504161_GO_0034969_HISTONE_ARGININE_METHYLATION",10,1.0007,0.44,0.97,"Yes",0.4627,0.99,1,"Yes"
"18204","C4_Cancer_gene_neighborhoods","C4_CGN_59_MORF_ANP32B",198,1.001,0.47,0.69,"Yes",2.9241,0,0,"Yes"
"18205","C2_Chemical_and_genetic_perturbations","C2_CGP_663_LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q",116,1.0014,0.43,1,"Yes",1.3909,0.018,0.3,"Yes"
"18206","C2_Chemical_and_genetic_perturbations","C2_CGP_3333_ABRAMSON_INTERACT_WITH_AIRE",45,1.0016,0.47,1,"Yes",0.9398,0.57,0.88,"Yes"
"18207","GO_BP","504380_GO_0035195_GENE_SILENCING_BY_MIRNA",32,1.0017,0.42,0.97,"Yes",-0.8122,0.76,1,"No"
"18208","GO_BP","502906_GO_0033689_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION",8,1.0018,0.46,0.97,"Yes",-1.0696,0.39,0.96,"No"
"18209","GO_BP","508164_GO_0045843_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",33,1.0024,0.45,0.97,"Yes",0.8095,0.82,1,"Yes"
"18210","GO_CC","505703_GO_0042575_DNA_POLYMERASE_COMPLEX",14,1.0025,0.45,0.82,"Yes",-0.7896,0.75,1,"No"
"18211","REACTOME","905998_REACT_169385_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM",18,1.0026,0.45,0.77,"Yes",0.8821,0.62,0.92,"Yes"
"18212","GO_MF","510183_GO_0048019_RECEPTOR_ANTAGONIST_ACTIVITY",10,1.0026,0.42,1,"Yes",0.8947,0.6,0.99,"Yes"
"18213","C1_Positional","C1_ALL_11_CHR4Q12",33,1.003,0.43,0.82,"Yes",1.1947,0.19,0.61,"Yes"
"18214","GO_BP","503577_GO_0034375_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",15,1.0031,0.45,0.97,"Yes",-0.6528,0.9,1,"No"
"18215","C2_Chemical_and_genetic_perturbations","C2_CGP_2698_JISON_SICKLE_CELL_DISEASE_DN",178,1.0032,0.46,1,"Yes",2.3723,0,0,"Yes"
"18216","KEGG_module","HSA_M00036_LEUCINE_DEGRADATION_LEUCINE_ACETOACETATE_ACETYL_COA",13,1.0034,0.44,0.72,"Yes",1.5954,0.015,0.12,"Yes"
"18217","C4_Cancer_gene_neighborhoods","C4_CGN_232_GCM_GSPT1",168,1.0035,0.43,0.69,"Yes",0.5835,1,1,"Yes"
"18218","C2_Chemical_and_genetic_perturbations","C2_CGP_3271_LE_NEURONAL_DIFFERENTIATION_UP",18,1.0036,0.42,1,"Yes",-0.9737,0.47,1,"No"
"18219","GO_BP","519419_GO_2000780_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR",8,1.0037,0.44,0.97,"Yes",0.6785,0.87,1,"Yes"
"18220","KEGG_enzyme","1.1.1.62_17BETA_ESTRADIOL_17_DEHYDROGENASE_20ALPHA_HYDROXYSTEROID_DEHYDROGENASE_17BETA_20ALPHA_HYDROXYSTEROID_DEHYDROGENASE_17BETA_ESTRADIOL_DEHYDROGENASE_ESTRADIOL_DEHYDROGENASE_ESTROGEN_17_OXIDOREDUCTASE_17BETA_HSD_HSD17B7",6,1.0037,0.44,0.83,"Yes",1.5322,0.049,0.36,"Yes"
"18221","KEGG_reaction","R06222_GDP_L_FUCOSE_G00084_GDP_G00085",5,1.0037,0.44,1,"Yes",1.1346,0.32,1,"Yes"
"18222","KEGG_compound","C00188_L_THREONINE_2_AMINO_3_HYDROXYBUTYRIC_ACID",5,1.0039,0.44,1,"Yes",1.0502,0.41,1,"Yes"
"18223","KEGG_enzyme","1.6.99.3_NADH_DEHYDROGENASE_CYTOCHROME_C_REDUCTASE_TYPE_1_DEHYDROGENASE_BETA_NADH_DEHYDROGENASE_DINUCLEOTIDE_DIAPHORASE_DIHYDROCODEHYDROGENASE_I_DEHYDROGENASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_DEHYDROGENASE_DIPHOSPHOPYRIDINE_DIAPHORASE_DPNH_DIAPHORASE_NADH_DIAPHORASE_NADH_HYDROGENASE_NADH_OXIDOREDUCTASE_NADH_MENADIONE_OXIDOREDUCTASE_REDUCED_DIPHOSPHOPYRIDINE_NUCLEOTIDE_DIAPHORASE_NADH_CYTOCHROME_C_OXIDOREDUCTASE_NADH2_DEHYDROGENASE_NADH_ACCEPTOR_OXIDOREDUCTASE",7,1.0039,0.45,0.95,"Yes",1.4792,0.075,0.25,"Yes"
"18224","C4_Cancer_gene_neighborhoods","C4_CGN_314_GNF2_SMC1L1",27,1.0042,0.45,0.69,"Yes",1.3945,0.073,0.064,"Yes"
"18225","GO_BP","503655_GO_0034453_MICROTUBULE_ANCHORING",29,1.0044,0.43,0.97,"Yes",-0.7503,0.87,1,"No"
"18226","GO_BP","504361_GO_0035176_SOCIAL_BEHAVIOR",41,1.0046,0.44,0.97,"Yes",0.7694,0.84,1,"Yes"
"18227","GO_BP","925939_GO_1902590_MULTI_ORGANISM_ORGANELLE_ORGANIZATION",16,1.0046,0.41,0.97,"Yes",1.6085,0.016,0.28,"Yes"
"18228","GO_CC","496121_GO_0016011_DYSTROGLYCAN_COMPLEX",6,1.0046,0.46,0.82,"Yes",0.6414,0.9,1,"Yes"
"18229","C1_Positional","C1_ALL_41_CHR12Q24",219,1.0047,0.45,0.84,"Yes",-0.7353,0.99,0.98,"No"
"18230","GO_MF","492886_GO_0008641_SMALL_PROTEIN_ACTIVATING_ENZYME_ACTIVITY",10,1.005,0.45,1,"Yes",1.2414,0.2,0.7,"Yes"
"18231","C4_Cancer_gene_neighborhoods","C4_CGN_192_MORF_WNT1",101,1.0057,0.44,0.69,"Yes",-1.0029,0.43,0.88,"No"
"18232","GO_MF","503441_GO_0034236_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING",12,1.0058,0.46,1,"Yes",1.2981,0.14,0.61,"Yes"
"18233","GO_MF","509165_GO_0046976_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K27_SPECIFIC_",5,1.0061,0.44,1,"Yes",-1.108,0.37,0.83,"No"
"18234","GO_BP","498542_GO_0019720_MO_MOLYBDOPTERIN_COFACTOR_METABOLIC_PROCESS",7,1.0062,0.44,0.97,"Yes",0.9119,0.53,1,"Yes"
"18235","GO_CC","500301_GO_0031011_INO80_COMPLEX",14,1.0062,0.44,0.82,"Yes",0.8153,0.75,0.94,"Yes"
"18236","KEGG_reaction","R06224_GDP_L_FUCOSE_G00085_GDP_G00086",5,1.0064,0.45,1,"Yes",1.1072,0.35,0.91,"Yes"
"18237","GO_MF","496250_GO_0016160_AMYLASE_ACTIVITY",5,1.0068,0.45,1,"Yes",0.6068,0.91,1,"Yes"
"18238","GO_MF","750927_GO_0036002_PRE_MRNA_BINDING",14,1.0068,0.42,1,"Yes",-0.5208,0.99,1,"No"
"18239","GO_BP","502740_GO_0033522_HISTONE_H2A_UBIQUITINATION",16,1.0069,0.42,0.97,"Yes",0.6768,0.9,1,"Yes"
"18240","C7_Immunologic_signatures","C7_ALL_1609_GSE3982_MAST_CELL_VS_MAC_UP",197,1.007,0.4,0.69,"Yes",1.559,0,0.0054,"Yes"
"18241","C2_Chemical_and_genetic_perturbations","C2_CGP_2636_MEISSNER_NPC_ICP_WITH_H3K4ME3",19,1.0078,0.43,1,"Yes",0.8468,0.68,0.97,"Yes"
"18242","C2_Chemical_and_genetic_perturbations","C2_CGP_173_WANG_LMO4_TARGETS_DN",345,1.0081,0.42,1,"Yes",1.542,0,0.17,"Yes"
"18243","KEGG_compound","C00148_L_PROLINE_2_PYRROLIDINECARBOXYLIC_ACID",9,1.0081,0.42,1,"Yes",0.8663,0.63,1,"Yes"
"18244","KEGG_reaction","R06039_GDP_L_FUCOSE_NLC8CER_GDP_G00084",5,1.0082,0.46,1,"Yes",1.135,0.35,1,"Yes"
"18245","C7_Immunologic_signatures","C7_ALL_879_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP",199,1.0085,0.43,0.69,"Yes",-0.62,1,1,"No"
"18246","C4_Cancer_modules","C4_CM_240_MODULE_267",15,1.0087,0.43,0.93,"Yes",-1.6878,0.015,0.16,"No"
"18247","GO_BP","506532_GO_0043501_SKELETAL_MUSCLE_ADAPTATION",8,1.0088,0.44,0.96,"Yes",-1.2701,0.2,0.89,"No"
"18248","KEGG_module","HSA_M00284_ORIGIN_RECOGNITION_COMPLEX",6,1.0089,0.43,0.73,"Yes",1.0408,0.39,0.8,"Yes"
"18249","GO_BP","511951_GO_0051026_CHIASMA_ASSEMBLY",6,1.0091,0.42,0.96,"Yes",0.5947,0.94,1,"Yes"
"18250","C7_Immunologic_signatures","C7_ALL_1893_GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP",165,1.0092,0.43,0.69,"Yes",-1.0014,0.46,1,"No"
"18251","OMIM_gene","OMIM606793_AMINOPEPTIDASE_PUROMYCIN_SENSITIVE_NPEPPS",5,1.0101,0.44,1,"Yes",1.3747,0.12,0.84,"Yes"
"18252","GO_BP","505550_GO_0042407_CRISTAE_FORMATION",5,1.0102,0.42,0.96,"Yes",0.8942,0.57,1,"Yes"
"18253","KEGG_pathway","HSA00514_OTHER_TYPES_OF_O_GLYCAN_BIOSYNTHESIS",31,1.0106,0.46,0.64,"Yes",1.0078,0.47,0.88,"Yes"
"18254","C2_Chemical_and_genetic_perturbations","C2_CGP_2978_ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE",16,1.0108,0.41,1,"Yes",0.7817,0.77,1,"Yes"
"18255","GO_MF","504382_GO_0035198_MIRNA_BINDING",14,1.0109,0.4,1,"Yes",-1.1254,0.31,0.81,"No"
"18256","C2_Chemical_and_genetic_perturbations","C2_CGP_2802_ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN",44,1.0109,0.43,1,"Yes",1.1786,0.18,0.52,"Yes"
"18257","KEGG_module","HSA_M00098_ACYLGLYCEROL_DEGRADATION",9,1.011,0.42,0.75,"Yes",1.0787,0.37,0.73,"Yes"
"18258","GO_BP","488511_GO_0002638_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION",5,1.0111,0.43,0.96,"Yes",0.7557,0.78,1,"Yes"
"18259","C7_Immunologic_signatures","C7_ALL_1512_GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN",199,1.0113,0.41,0.69,"Yes",1.1501,0.13,0.32,"Yes"
"18260","GO_CC","498650_GO_0019866_ORGANELLE_INNER_MEMBRANE",486,1.0113,0.33,0.81,"Yes",2.345,0,0,"Yes"
"18261","GO_BP","514094_GO_0060539_DIAPHRAGM_DEVELOPMENT",9,1.0116,0.41,0.96,"Yes",-0.594,0.94,1,"No"
"18262","GO_BP","508079_GO_0045738_NEGATIVE_REGULATION_OF_DNA_REPAIR",9,1.0117,0.41,0.96,"Yes",1.2899,0.17,0.69,"Yes"
"18263","GO_CC","502476_GO_0033256_I_KAPPAB_NF_KAPPAB_COMPLEX",8,1.0126,0.42,0.81,"Yes",-0.6572,0.88,1,"No"
"18264","REACTOME","106009_REACT_6359_BUDDING_AND_MATURATION_OF_HIV_VIRION",26,1.013,0.42,0.74,"Yes",1.8833,0,0.0098,"Yes"
"18265","REACTOME","105749_REACT_1614_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A",52,1.0131,0.42,0.75,"Yes",2.134,0.0022,0.00038,"Yes"
"18266","KEGG_reaction","R06221_GDP_L_FUCOSE_V3FUC_NLC6CER_GDP_V3FUC_III3FUC_NLC6CER",5,1.0133,0.47,1,"Yes",1.119,0.36,0.94,"Yes"
"18267","C7_Immunologic_signatures","C7_ALL_368_GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN",193,1.0137,0.37,0.68,"Yes",0.7122,1,1,"Yes"
"18268","GO_MF","498653_GO_0019870_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY",8,1.0144,0.44,1,"Yes",1.073,0.39,0.82,"Yes"
"18269","GO_BP","1184485_GO_1903959_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT",26,1.0145,0.42,0.95,"Yes",0.9671,0.5,1,"Yes"
"18270","C4_Cancer_gene_neighborhoods","C4_CGN_116_MORF_IL9",90,1.0147,0.39,0.66,"Yes",1.017,0.39,0.53,"Yes"
"18271","C7_Immunologic_signatures","C7_ALL_1214_GSE27786_NKCELL_VS_NKTCELL_DN",197,1.0147,0.34,0.68,"Yes",1.0711,0.26,0.52,"Yes"
"18272","C2_Chemical_and_genetic_perturbations","C2_CGP_1903_ABE_INNER_EAR",48,1.0152,0.43,1,"Yes",2.2204,0,0.00045,"Yes"
"18273","KEGG_compound","C03402_L_ASPARAGINYL_TRNA_ASN_ASN_TRNA_ASN_ASPARAGINYL_TRNA_ASN_",5,1.0153,0.44,1,"Yes",0.9056,0.58,1,"Yes"
"18274","GO_BP","750913_GO_0035988_CHONDROCYTE_PROLIFERATION",8,1.0153,0.44,0.95,"Yes",-1.0767,0.37,0.95,"No"
"18275","GO_BP","500409_GO_0031122_CYTOPLASMIC_MICROTUBULE_ORGANIZATION",34,1.0155,0.43,0.95,"Yes",1.0714,0.35,0.93,"Yes"
"18276","C4_Cancer_modules","C4_CM_304_MODULE_352",17,1.016,0.44,0.94,"Yes",1.0745,0.38,0.58,"Yes"
"18277","C1_Positional","C1_ALL_4_CHR13Q11",13,1.016,0.42,0.81,"Yes",0.6526,0.91,1,"Yes"
"18278","GO_BP","508185_GO_0045869_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE",6,1.0164,0.43,0.95,"Yes",0.7478,0.78,1,"Yes"
"18279","GO_BP","491234_GO_0006270_DNA_REPLICATION_INITIATION",25,1.0165,0.41,0.95,"Yes",1.152,0.26,0.83,"Yes"
"18280","REACTOME","105907_REACT_18277_PERK_REGULATES_GENE_EXPRESSION",27,1.0166,0.43,0.74,"Yes",1.2689,0.14,0.36,"Yes"
"18281","C2_Chemical_and_genetic_perturbations","C2_CGP_1197_NIKOLSKY_BREAST_CANCER_5P15_AMPLICON",25,1.0178,0.42,1,"Yes",0.4439,1,1,"Yes"
"18282","GO_BP","513607_GO_0060049_REGULATION_OF_PROTEIN_GLYCOSYLATION",11,1.018,0.44,0.95,"Yes",1.1019,0.33,0.9,"Yes"
"18283","C7_Immunologic_signatures","C7_ALL_861_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP",198,1.0181,0.4,0.67,"Yes",1.4085,0,0.035,"Yes"
"18284","C7_Immunologic_signatures","C7_ALL_238_GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN",199,1.019,0.39,0.67,"Yes",0.8119,0.93,1,"Yes"
"18285","C4_Cancer_gene_neighborhoods","C4_CGN_416_GNF2_TAL1",72,1.0192,0.42,0.65,"Yes",2.0079,0,0.00031,"Yes"
"18286","GO_BP","494271_GO_0010193_RESPONSE_TO_OZONE",5,1.0201,0.42,0.95,"Yes",-1.1337,0.34,0.93,"No"
"18287","KEGG_reaction","R06076_GDP_L_FUCOSE_VI2FUC_NLC6_GDP_G00081",5,1.0204,0.41,1,"Yes",1.1282,0.34,0.97,"Yes"
"18288","GO_BP","486882_GO_0000380_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME",11,1.0205,0.43,0.95,"Yes",-0.9001,0.59,1,"No"
"18289","WikiPathways","760637_WP2363_GASTRIC_CANCER_NETWORK_2",33,1.021,0.4,0.82,"Yes",1.5432,0.03,0.28,"Yes"
"18290","REACTOME","906019_REACT_169398_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER",7,1.0213,0.43,0.73,"Yes",-0.6863,0.85,1,"No"
"18291","GO_BP","492861_GO_0008608_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE",12,1.0218,0.42,0.94,"Yes",0.8429,0.7,1,"Yes"
"18292","REACTOME","105828_REACT_6821_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1",54,1.022,0.39,0.73,"Yes",2.0333,0,0.0015,"Yes"
"18293","C2_Chemical_and_genetic_perturbations","C2_CGP_400_CASTELLANO_HRAS_AND_NRAS_TARGETS_DN",7,1.0222,0.41,1,"Yes",1.4588,0.086,0.25,"Yes"
"18294","C7_Immunologic_signatures","C7_ALL_696_GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_DN",199,1.0222,0.36,0.65,"Yes",1.3173,0.009,0.088,"Yes"
"18295","C7_Immunologic_signatures","C7_ALL_801_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0_5H_ACT_CD4_TCELL_UP",176,1.0222,0.42,0.66,"Yes",1.8937,0,0,"Yes"
"18296","C7_Immunologic_signatures","C7_ALL_868_GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN",198,1.0229,0.42,0.66,"Yes",1.3066,0.015,0.096,"Yes"
"18297","KEGG_reaction","R06038_GDP_L_FUCOSE_NLC6CER_GDP_V3FUC_NLC6CER",5,1.0231,0.42,1,"Yes",1.1301,0.33,0.99,"Yes"
"18298","C2_Chemical_and_genetic_perturbations","C2_CGP_1000_FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP",166,1.0231,0.37,1,"Yes",1.3488,0.014,0.34,"Yes"
"18299","C2_Chemical_and_genetic_perturbations","C2_CGP_1824_MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP",23,1.0233,0.4,1,"Yes",1.8178,0.0021,0.038,"Yes"
"18300","GO_BP","510904_GO_0048854_BRAIN_MORPHOGENESIS",32,1.0234,0.41,0.94,"Yes",1.0401,0.36,0.96,"Yes"
"18301","GO_BP","491300_GO_0006362_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_I_PROMOTER",31,1.0235,0.41,0.94,"Yes",1.1612,0.23,0.82,"Yes"
"18302","GO_BP","491449_GO_0006553_LYSINE_METABOLIC_PROCESS",9,1.0243,0.41,0.94,"Yes",-1.1938,0.25,0.9,"No"
"18303","C2_Chemical_and_genetic_perturbations","C2_CGP_620_NAGY_PCAF_COMPONENTS_HUMAN",9,1.0246,0.39,1,"Yes",-0.6406,0.9,1,"No"
"18304","GO_BP","491451_GO_0006555_METHIONINE_METABOLIC_PROCESS",19,1.0247,0.39,0.94,"Yes",-0.5897,0.96,1,"No"
"18305","GO_BP","497173_GO_0018202_PEPTIDYL_HISTIDINE_MODIFICATION",16,1.0248,0.39,0.94,"Yes",0.6278,0.94,1,"Yes"
"18306","REACTOME","833807_REACT_163725_SUMO_IS_PROTEOLYTICALLY_PROCESSED",6,1.0249,0.41,0.72,"Yes",1.4885,0.066,0.15,"Yes"
"18307","GO_BP","504898_GO_0035721_INTRACILIARY_RETROGRADE_TRANSPORT",7,1.0251,0.43,0.94,"Yes",-0.9761,0.47,1,"No"
"18308","C7_Immunologic_signatures","C7_ALL_483_GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_UP",200,1.0255,0.32,0.65,"Yes",1.1698,0.086,0.28,"Yes"
"18309","C2_Chemical_and_genetic_perturbations","C2_CGP_1186_MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP",109,1.0255,0.35,1,"Yes",0.9199,0.68,0.9,"Yes"
"18310","REACTOME","105747_REACT_1208_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT",52,1.0258,0.4,0.72,"Yes",2.1102,0,0.00052,"Yes"
"18311","GO_CC","496122_GO_0016012_SARCOGLYCAN_COMPLEX",5,1.026,0.42,0.78,"Yes",0.6867,0.86,0.99,"Yes"
"18312","C2_BioCarta_Pathways","C2_CP_BIOCARTA_172_BIOCARTA_PARKIN_PATHWAY",12,1.026,0.42,0.96,"Yes",1.187,0.24,0.7,"Yes"
"18313","REACTOME","106002_REACT_6319_FORMATION_OF_THE_HIV_1_EARLY_ELONGATION_COMPLEX",33,1.026,0.39,0.73,"Yes",1.4375,0.042,0.19,"Yes"
"18314","REACTOME","187183_REACT_25004_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS",24,1.0265,0.4,0.73,"Yes",0.7778,0.79,1,"Yes"
"18315","GO_BP","505844_GO_0042737_DRUG_CATABOLIC_PROCESS",23,1.0266,0.44,0.94,"Yes",-1.7861,0.0096,0.47,"No"
"18316","C2_Chemical_and_genetic_perturbations","C2_CGP_696_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18",5,1.0267,0.42,1,"Yes",0.6421,0.89,1,"Yes"
"18317","GO_BP","501739_GO_0032508_DNA_DUPLEX_UNWINDING",55,1.0273,0.41,0.94,"Yes",0.8432,0.74,1,"Yes"
"18318","OMIM_gene","OMIM601895_TNF_RECEPTOR_ASSOCIATED_FACTOR_2_TRAF2",6,1.0273,0.41,1,"Yes",1.103,0.34,1,"Yes"
"18319","GO_BP","492098_GO_0007320_INSEMINATION",14,1.0274,0.39,0.94,"Yes",1.0576,0.39,0.94,"Yes"
"18320","C7_Immunologic_signatures","C7_ALL_1225_GSE27786_NKTCELL_VS_MONO_MAC_UP",200,1.0274,0.37,0.65,"Yes",1.2721,0.027,0.13,"Yes"
"18321","GO_MF","496783_GO_0016896_EXORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",29,1.0278,0.4,0.97,"Yes",1.3403,0.086,0.53,"Yes"
"18322","C2_BioCarta_Pathways","C2_CP_BIOCARTA_154_BIOCARTA_EIF2_PATHWAY",11,1.028,0.42,1,"Yes",1.1329,0.27,0.66,"Yes"
"18323","OMIM_gene","OMIM312610_RETINITIS_PIGMENTOSA_GTPASE_REGULATOR_RPGR",5,1.028,0.44,1,"Yes",1.1286,0.35,1,"Yes"
"18324","GO_BP","517411_GO_0072498_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT",16,1.0287,0.39,0.94,"Yes",-1.2719,0.16,0.89,"No"
"18325","GO_BP","754813_GO_1901862_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT",33,1.0289,0.39,0.94,"Yes",0.7887,0.82,1,"Yes"
"18326","GO_BP","515078_GO_0070141_RESPONSE_TO_UV_A",6,1.0291,0.4,0.94,"Yes",0.6513,0.91,1,"Yes"
"18327","C1_Positional","C1_ALL_181_CHR18Q22",26,1.0296,0.42,0.79,"Yes",1.1817,0.23,0.6,"Yes"
"18328","KEGG_compound","C00588_CHOLINE_PHOSPHATE_PHOSPHORYLCHOLINE_PHOSPHOCHOLINE_O_PHOSPHOCHOLINE",10,1.0296,0.41,1,"Yes",0.7563,0.8,1,"Yes"
"18329","C4_Cancer_gene_neighborhoods","C4_CGN_320_GNF2_ANK1",73,1.0301,0.39,0.62,"Yes",1.9252,0,0.00064,"Yes"
"18330","C7_Immunologic_signatures","C7_ALL_1675_GSE3982_BCELL_VS_BASOPHIL_UP",193,1.0305,0.34,0.64,"Yes",0.8251,0.91,1,"Yes"
"18331","GO_CC","515864_GO_0070937_CRD_MEDIATED_MRNA_STABILITY_COMPLEX",6,1.0307,0.39,0.77,"Yes",1.3914,0.12,0.3,"Yes"
"18332","GO_BP","487023_GO_0000726_NON_RECOMBINATIONAL_REPAIR",25,1.0307,0.4,0.94,"Yes",0.6009,0.96,1,"Yes"
"18333","GO_BP","505611_GO_0042474_MIDDLE_EAR_MORPHOGENESIS",23,1.0314,0.38,0.94,"Yes",1.0991,0.3,0.9,"Yes"
"18334","GO_BP","491985_GO_0007185_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY",6,1.0314,0.39,0.94,"Yes",1.8316,0,0.074,"Yes"
"18335","GO_BP","492505_GO_0008156_NEGATIVE_REGULATION_OF_DNA_REPLICATION",42,1.0317,0.4,0.94,"Yes",-0.5319,1,1,"No"
"18336","GO_MF","486738_GO_0000217_DNA_SECONDARY_STRUCTURE_BINDING",18,1.0318,0.41,0.96,"Yes",-0.6047,0.95,1,"No"
"18337","GO_BP","504379_GO_0035194_POSTTRANSCRIPTIONAL_GENE_SILENCING_BY_RNA",35,1.032,0.35,0.94,"Yes",-0.7657,0.85,1,"No"
"18338","REACTOME","1183520_REACT_355221_SIGNALING_BY_FGFR1_MUTANTS",34,1.0324,0.37,0.72,"Yes",0.8632,0.7,0.95,"Yes"
"18339","C4_Cancer_gene_neighborhoods","C4_CGN_251_GCM_PPM1D",26,1.0326,0.39,0.62,"Yes",-0.6565,0.95,1,"No"
"18340","GO_BP","486669_GO_0000132_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION",18,1.0331,0.42,0.94,"Yes",0.7875,0.77,1,"Yes"
"18341","C4_Cancer_gene_neighborhoods","C4_CGN_50_MORF_TERF2IP",114,1.0331,0.35,0.62,"Yes",1.5758,0.0022,0.018,"Yes"
"18342","C4_Cancer_modules","C4_CM_278_MODULE_318",28,1.0332,0.37,0.91,"Yes",-0.8811,0.64,0.91,"No"
"18343","GO_MF","507012_GO_0043995_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K5_SPECIFIC_",9,1.0333,0.41,0.96,"Yes",-0.5779,0.95,1,"No"
"18344","KEGG_reaction","R02250_TRIACYLGLYCEROL_ACYLHYDROLASE_TRIACYLGLYCEROL_H2O_1_2_DIACYL_SN_GLYCEROL_FATTY_ACID",8,1.0335,0.42,1,"Yes",0.7193,0.81,1,"Yes"
"18345","GO_BP","502820_GO_0033604_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION",13,1.0339,0.39,0.94,"Yes",1.0776,0.36,0.93,"Yes"
"18346","GO_BP","495025_GO_0010960_MAGNESIUM_ION_HOMEOSTASIS",11,1.034,0.38,0.94,"Yes",0.9964,0.46,0.98,"Yes"
"18347","C4_Cancer_gene_neighborhoods","C4_CGN_308_GNF2_RAD23A",69,1.0342,0.4,0.63,"Yes",1.9887,0,0.00035,"Yes"
"18348","KEGG_module","HSA_M00295_BRCA1_ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX_BASC_",16,1.0349,0.37,0.72,"Yes",1.2907,0.14,0.41,"Yes"
"18349","REACTOME","906021_REACT_169165_SMAD2_3_MH2_DOMAIN_MUTANTS_IN_CANCER",7,1.035,0.42,0.71,"Yes",-0.6927,0.87,1,"No"
"18350","GO_CC","492397_GO_0008023_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX",42,1.0351,0.33,0.76,"Yes",1.0519,0.34,0.71,"Yes"
"18351","OMIM_gene","OMIM176873_CYCLIN_DEPENDENT_KINASE_11B_CDK11B",7,1.0352,0.41,1,"Yes",0.9801,0.46,1,"Yes"
"18352","GO_BP","518345_GO_0090205_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS",5,1.036,0.42,0.93,"Yes",0.7123,0.79,1,"Yes"
"18353","GO_MF","489393_GO_0003906_DNA_APURINIC_OR_APYRIMIDINIC_SITE_LYASE_ACTIVITY",13,1.037,0.37,0.96,"Yes",1.6721,0.018,0.17,"Yes"
"18354","GO_BP","496169_GO_0016075_RRNA_CATABOLIC_PROCESS",11,1.0371,0.39,0.93,"Yes",0.8653,0.62,1,"Yes"
"18355","GO_BP","1129550_GO_1903726_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS",7,1.0373,0.4,0.93,"Yes",1.2772,0.21,0.7,"Yes"
"18356","C4_Cancer_gene_neighborhoods","C4_CGN_310_GNF2_RFC4",60,1.0374,0.4,0.62,"Yes",1.4718,0.026,0.038,"Yes"
"18357","REACTOME","1127550_REACT_6850_CDC20_PHOSPHO_APC_C_MEDIATED_DEGRADATION_OF_CYCLIN_A",69,1.0374,0.4,0.71,"Yes",2.1367,0,0.00039,"Yes"
"18358","REACTOME","833823_REACT_163977_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA",16,1.0374,0.39,0.71,"Yes",1.5019,0.062,0.15,"Yes"
"18359","GO_MF","509162_GO_0046972_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K16_SPECIFIC_",9,1.0374,0.42,0.96,"Yes",-0.5926,0.96,1,"No"
"18360","C1_Positional","C1_ALL_17_CHR9P12",18,1.0375,0.39,0.78,"Yes",-0.9505,0.54,1,"No"
"18361","GO_MF","515002_GO_0070063_RNA_POLYMERASE_BINDING",35,1.0375,0.36,0.97,"Yes",0.8791,0.66,1,"Yes"
"18362","GO_BP","491450_GO_0006554_LYSINE_CATABOLIC_PROCESS",9,1.0377,0.4,0.93,"Yes",-1.181,0.24,0.91,"No"
"18363","C2_Chemical_and_genetic_perturbations","C2_CGP_1821_ZHANG_RESPONSE_TO_CANTHARIDIN_DN",68,1.0378,0.33,0.98,"Yes",2.2872,0,0.00019,"Yes"
"18364","GO_BP","501940_GO_0032714_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION",6,1.0379,0.4,0.93,"Yes",1.3505,0.16,0.61,"Yes"
"18365","C1_Positional","C1_ALL_13_CHR2P22",41,1.0387,0.36,0.79,"Yes",1.2846,0.11,0.54,"Yes"
"18366","C2_Chemical_and_genetic_perturbations","C2_CGP_3082_FIGUEROA_AML_METHYLATION_CLUSTER_3_UP",167,1.0387,0.33,0.98,"Yes",1.3341,0.032,0.36,"Yes"
"18367","GO_BP","507532_GO_0045143_HOMOLOGOUS_CHROMOSOME_SEGREGATION",36,1.039,0.37,0.93,"Yes",-0.7422,0.87,1,"No"
"18368","KEGG_compound","C00073_L_METHIONINE_METHIONINE_L_2_AMINO_4METHYLTHIOBUTYRIC_ACID",13,1.0393,0.39,1,"Yes",-0.8313,0.68,1,"No"
"18369","C4_Cancer_gene_neighborhoods","C4_CGN_413_GNF2_SPTB",73,1.0395,0.35,0.62,"Yes",1.9302,0,0.00063,"Yes"
"18370","C7_Immunologic_signatures","C7_ALL_889_GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP",194,1.0397,0.26,0.59,"Yes",1.221,0.078,0.19,"Yes"
"18371","KEGG_reaction","R02541_SPHINGOMYELIN_CHOLINEPHOSPHOHYDROLASE_SPHINGOMYELIN_H2O_N_ACYLSPHINGOSINE_CHOLINE_PHOSPHATE",5,1.0401,0.42,1,"Yes",1.0455,0.44,0.91,"Yes"
"18372","REACTOME","187189_REACT_24023_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS",42,1.0406,0.38,0.71,"Yes",0.84,0.74,0.96,"Yes"
"18373","C4_Cancer_gene_neighborhoods","C4_CGN_195_GCM_BNIP1",74,1.0409,0.35,0.62,"Yes",1.2176,0.12,0.2,"Yes"
"18374","GO_BP","755159_GO_2001053_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS",11,1.0409,0.39,0.93,"Yes",1.7237,0.01,0.17,"Yes"
"18375","GO_CC","487086_GO_0000795_SYNAPTONEMAL_COMPLEX",29,1.0413,0.39,0.75,"Yes",-0.7273,0.88,1,"No"
"18376","REACTOME","366226_REACT_75831_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS",24,1.0413,0.36,0.71,"Yes",0.7692,0.8,1,"Yes"
"18377","REACTOME","161053_REACT_6244_PAUSING_AND_RECOVERY_OF_HIV_ELONGATION",31,1.0418,0.37,0.71,"Yes",1.5479,0.015,0.12,"Yes"
"18378","KEGG_compound","C07047_IFOSFAMIDE_ISOPHOSPHAMIDE",5,1.0419,0.4,1,"Yes",-0.9386,0.52,1,"No"
"18379","GO_MF","496782_GO_0016895_EXODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",15,1.042,0.39,0.96,"Yes",1.2075,0.2,0.69,"Yes"
"18380","GO_CC","504511_GO_0035327_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN",18,1.0431,0.38,0.75,"Yes",0.747,0.84,0.98,"Yes"
"18381","REACTOME","366225_REACT_75780_G_PROTEIN_GATED_POTASSIUM_CHANNELS",24,1.0431,0.41,0.71,"Yes",0.7929,0.77,1,"Yes"
"18382","C7_Immunologic_signatures","C7_ALL_1339_GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP",199,1.0431,0.32,0.58,"Yes",1.6934,0,0.00074,"Yes"
"18383","GO_MF","507013_GO_0043996_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K8_SPECIFIC_",9,1.0436,0.4,0.96,"Yes",-0.5875,0.96,1,"No"
"18384","GO_BP","491834_GO_0006998_NUCLEAR_ENVELOPE_ORGANIZATION",70,1.044,0.36,0.92,"Yes",1.2361,0.13,0.75,"Yes"
"18385","C2_BioCarta_Pathways","C2_CP_BIOCARTA_141_BIOCARTA_PLATELETAPP_PATHWAY",14,1.0441,0.38,1,"Yes",-0.7809,0.76,1,"No"
"18386","GO_BP","509148_GO_0046951_KETONE_BODY_BIOSYNTHETIC_PROCESS",6,1.0442,0.38,0.92,"Yes",0.8424,0.65,1,"Yes"
"18387","KEGG_reaction","R02687_1_2_DIACYL_SN_GLYCEROL_ACYLHYDROLASE_1_2_DIACYL_SN_GLYCEROL_H2O_1_ACYLGLYCEROL_FATTY_ACID",8,1.0442,0.38,1,"Yes",0.709,0.84,1,"Yes"
"18388","REACTOME","1183519_REACT_355059_SIGNALING_BY_FGFR1_IN_DISEASE",34,1.045,0.37,0.71,"Yes",0.8821,0.66,0.92,"Yes"
"18389","GO_CC","496538_GO_0016592_MEDIATOR_COMPLEX",36,1.0456,0.37,0.75,"Yes",-0.589,0.99,1,"No"
"18390","C2_Chemical_and_genetic_perturbations","C2_CGP_2122_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN",20,1.0457,0.37,0.96,"Yes",0.932,0.56,0.89,"Yes"
"18391","C4_Cancer_gene_neighborhoods","C4_CGN_284_GNF2_BNIP3L",68,1.0457,0.34,0.61,"Yes",2.009,0,0.00031,"Yes"
"18392","C7_Immunologic_signatures","C7_ALL_1614_GSE3982_MAST_CELL_VS_BCELL_DN",194,1.0459,0.25,0.57,"Yes",-0.7664,0.97,1,"No"
"18393","C6_Oncogenic_signatures","C6_ALL_146_YAP1_UP",47,1.0462,0.32,0.66,"Yes",1.4201,0.031,0.22,"Yes"
"18394","REACTOME","105820_REACT_1725_M_G1_TRANSITION",82,1.0468,0.36,0.7,"Yes",2.0838,0,0.00075,"Yes"
"18395","REACTOME","187187_REACT_23887_AQUAPORIN_MEDIATED_TRANSPORT",49,1.0469,0.34,0.71,"Yes",0.7429,0.9,1,"Yes"
"18396","GO_MF","503652_GO_0034450_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY",10,1.047,0.39,0.96,"Yes",1.3861,0.095,0.48,"Yes"
"18397","GO_BP","500824_GO_0031573_INTRA_S_DNA_DAMAGE_CHECKPOINT",11,1.0473,0.4,0.91,"Yes",-0.4921,0.99,1,"No"
"18398","GO_CC","496120_GO_0016010_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX",19,1.0477,0.4,0.75,"Yes",-0.8213,0.73,1,"No"
"18399","C7_Immunologic_signatures","C7_ALL_1266_GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN",187,1.0479,0.36,0.57,"Yes",1.4496,0.0045,0.022,"Yes"
"18400","C4_Cancer_gene_neighborhoods","C4_CGN_42_MORF_RPA1",61,1.0483,0.33,0.61,"Yes",1.6759,0.0067,0.0078,"Yes"
"18401","C2_Chemical_and_genetic_perturbations","C2_CGP_80_TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP",67,1.0484,0.34,0.96,"Yes",-0.8968,0.67,1,"No"
"18402","REACTOME","105949_REACT_846_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX",33,1.0486,0.36,0.71,"Yes",1.4757,0.049,0.16,"Yes"
"18403","GO_BP","488007_GO_0002118_AGGRESSIVE_BEHAVIOR",10,1.0487,0.38,0.91,"Yes",1.1343,0.3,0.86,"Yes"
"18404","C2_Chemical_and_genetic_perturbations","C2_CGP_3273_STEINER_ERYTHROCYTE_MEMBRANE_GENES",15,1.0488,0.37,0.96,"Yes",1.6682,0.028,0.1,"Yes"
"18405","C2_Chemical_and_genetic_perturbations","C2_CGP_1634_DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP",312,1.0488,0.26,0.97,"Yes",1.7088,0,0.078,"Yes"
"18406","C2_Chemical_and_genetic_perturbations","C2_CGP_2117_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD",24,1.0494,0.36,0.98,"Yes",1.2761,0.16,0.42,"Yes"
"18407","C7_Immunologic_signatures","C7_ALL_921_GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP",198,1.0499,0.3,0.56,"Yes",1.7685,0,0.00021,"Yes"
"18408","GO_MF","496788_GO_0016901_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR",5,1.0499,0.39,0.96,"Yes",0.5855,0.93,1,"Yes"
"18409","C1_Positional","C1_ALL_30_CHR9Q12",13,1.05,0.39,0.78,"Yes",0.9339,0.54,0.83,"Yes"
"18410","GO_BP","515777_GO_0070849_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR",26,1.0501,0.34,0.9,"Yes",0.9107,0.61,1,"Yes"
"18411","GO_BP","512723_GO_0051865_PROTEIN_AUTOUBIQUITINATION",45,1.0502,0.35,0.91,"Yes",1.3123,0.088,0.66,"Yes"
"18412","REACTOME","105948_REACT_833_RNA_POLYMERASE_II_TRANSCRIPTION_ELONGATION",43,1.051,0.35,0.7,"Yes",1.5911,0.004,0.097,"Yes"
"18413","GO_BP","496815_GO_0016973_POLY_A_MRNA_EXPORT_FROM_NUCLEUS",10,1.051,0.37,0.9,"Yes",-1.1197,0.31,0.94,"No"
"18414","GO_BP","512329_GO_0051451_MYOBLAST_MIGRATION",8,1.0513,0.36,0.91,"Yes",-0.7534,0.78,1,"No"
"18415","GO_CC","486751_GO_0000793_CONDENSED_CHROMOSOME",187,1.0516,0.27,0.74,"Yes",1.2651,0.053,0.45,"Yes"
"18416","C1_Positional","C1_ALL_312_CHRXQ22",78,1.0517,0.32,0.79,"Yes",1.6197,0.0023,0.22,"Yes"
"18417","GO_BP","492201_GO_0007440_FOREGUT_MORPHOGENESIS",11,1.0518,0.36,0.91,"Yes",-0.9335,0.54,1,"No"
"18418","C1_Positional","C1_ALL_37_CHR9Q22",94,1.0522,0.33,0.81,"Yes",0.9354,0.58,0.83,"Yes"
"18419","GO_BP","750782_GO_0002190_CAP_INDEPENDENT_TRANSLATIONAL_INITIATION",5,1.0533,0.4,0.9,"Yes",0.8194,0.66,1,"Yes"
"18420","C7_Immunologic_signatures","C7_ALL_619_GSE17721_POLYIC_VS_CPG_1H_BMDM_UP",199,1.0535,0.27,0.55,"Yes",1.3587,0.0096,0.057,"Yes"
"18421","GO_CC","487808_GO_0001917_PHOTORECEPTOR_INNER_SEGMENT",28,1.0537,0.35,0.74,"Yes",-1.2372,0.17,0.64,"No"
"18422","REACTOME","161052_REACT_22201_FORMATION_OF_HIV_ELONGATION_COMPLEX_IN_THE_ABSENCE_OF_HIV_TAT",43,1.0537,0.34,0.7,"Yes",1.5747,0.022,0.11,"Yes"
"18423","C2_Chemical_and_genetic_perturbations","C2_CGP_2955_NAKAMURA_ADIPOGENESIS_LATE_DN",37,1.0543,0.35,0.96,"Yes",1.2907,0.12,0.4,"Yes"
"18424","C2_Chemical_and_genetic_perturbations","C2_CGP_1264_SHEPARD_CRUSH_AND_BURN_MUTANT_UP",194,1.0546,0.3,0.97,"Yes",1.3065,0.029,0.39,"Yes"
"18425","GO_BP","501236_GO_0031998_REGULATION_OF_FATTY_ACID_BETA_OXIDATION",13,1.055,0.38,0.9,"Yes",1.0378,0.39,0.96,"Yes"
"18426","GO_BP","499174_GO_0021895_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION",19,1.0551,0.34,0.9,"Yes",-0.8817,0.61,1,"No"
"18427","KEGG_compound","C00721_DEXTRIN",6,1.0554,0.38,1,"Yes",0.646,0.89,1,"Yes"
"18428","GO_CC","492871_GO_0008622_EPSILON_DNA_POLYMERASE_COMPLEX",5,1.0556,0.39,0.74,"Yes",0.8117,0.7,0.95,"Yes"
"18429","GO_MF","486855_GO_0000339_RNA_CAP_BINDING",12,1.0559,0.35,0.94,"Yes",1.038,0.42,0.83,"Yes"
"18430","GO_CC","490877_GO_0005869_DYNACTIN_COMPLEX",8,1.056,0.38,0.75,"Yes",1.4977,0.067,0.2,"Yes"
"18431","GO_BP","487035_GO_0000738_DNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC",16,1.056,0.37,0.9,"Yes",1.3102,0.12,0.66,"Yes"
"18432","C7_Immunologic_signatures","C7_ALL_1209_GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP",199,1.0574,0.29,0.53,"Yes",1.3779,0.012,0.046,"Yes"
"18433","C1_Positional","C1_ALL_93_CHR10Q11",74,1.0574,0.33,0.81,"Yes",1.264,0.089,0.55,"Yes"
"18434","GO_BP","510803_GO_0048752_SEMICIRCULAR_CANAL_MORPHOGENESIS",6,1.0576,0.38,0.9,"Yes",1.0875,0.36,0.92,"Yes"
"18435","REACTOME","106360_REACT_16963_TACHYKININ_RECEPTORS_BIND_TACHYKININS",5,1.0577,0.39,0.69,"Yes",-1.1566,0.31,0.85,"No"
"18436","GO_BP","497318_GO_0018377_PROTEIN_MYRISTOYLATION",5,1.0586,0.38,0.89,"Yes",1.0046,0.46,0.98,"Yes"
"18437","KEGG_compound","C05300_16ALPHA_HYDROXYESTRONE",8,1.0588,0.36,1,"Yes",1.3826,0.11,0.55,"Yes"
"18438","GO_BP","492064_GO_0007286_SPERMATID_DEVELOPMENT",102,1.0589,0.33,0.89,"Yes",-0.8481,0.79,1,"No"
"18439","GO_BP","510794_GO_0048739_CARDIAC_MUSCLE_FIBER_DEVELOPMENT",8,1.059,0.36,0.9,"Yes",-1.1679,0.29,0.91,"No"
"18440","KEGG_compound","C00075_UTP_URIDINE_5_TRIPHOSPHATE_URIDINE_TRIPHOSPHATE",55,1.0598,0.33,1,"Yes",0.7619,0.91,1,"Yes"
"18441","C4_Cancer_gene_neighborhoods","C4_CGN_220_GCM_CSNK2B",99,1.0599,0.31,0.57,"Yes",2.8125,0,0,"Yes"
"18442","GO_CC","487072_GO_0000779_CONDENSED_CHROMOSOME_CENTROMERIC_REGION",100,1.0605,0.31,0.74,"Yes",1.4121,0.015,0.29,"Yes"
"18443","C7_Immunologic_signatures","C7_ALL_1594_GSE3982_EOSINOPHIL_VS_BCELL_DN",193,1.0607,0.26,0.52,"Yes",1.7272,0,0.00043,"Yes"
"18444","GO_BP","752712_GO_0097211_CELLULAR_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE",6,1.0607,0.37,0.89,"Yes",-1.4347,0.091,0.93,"No"
"18445","C2_Chemical_and_genetic_perturbations","C2_CGP_970_KAUFFMANN_MELANOMA_RELAPSE_UP",61,1.0615,0.32,0.95,"Yes",1.3985,0.052,0.3,"Yes"
"18446","GO_BP","504277_GO_0035092_SPERM_CHROMATIN_CONDENSATION",8,1.0619,0.38,0.89,"Yes",-0.8705,0.61,1,"No"
"18447","C2_Chemical_and_genetic_perturbations","C2_CGP_1285_IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP",16,1.0624,0.33,0.95,"Yes",1.4202,0.065,0.28,"Yes"
"18448","GO_BP","504321_GO_0035136_FORELIMB_MORPHOGENESIS",36,1.0628,0.33,0.89,"Yes",-0.9593,0.53,1,"No"
"18449","GO_BP","518243_GO_0090103_COCHLEA_MORPHOGENESIS",22,1.0629,0.35,0.89,"Yes",1.4499,0.057,0.49,"Yes"
"18450","C4_Cancer_gene_neighborhoods","C4_CGN_22_MORF_HDAC2",279,1.063,0.19,0.57,"Yes",2.2572,0,0,"Yes"
"18451","REACTOME","106176_REACT_13565_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC_",50,1.0631,0.33,0.68,"Yes",2.0307,0,0.0015,"Yes"
"18452","C4_Cancer_gene_neighborhoods","C4_CGN_262_GCM_RBM8A",81,1.0637,0.31,0.57,"Yes",0.6983,0.97,1,"Yes"
"18453","GO_BP","496128_GO_0016024_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS",13,1.0638,0.35,0.89,"Yes",1.2333,0.21,0.75,"Yes"
"18454","KEGG_compound","C00020_AMP_ADENOSINE_5_MONOPHOSPHATE_ADENYLIC_ACID_ADENYLATE_5_AMP_5_ADENYLIC_ACID_5_ADENOSINE_MONOPHOSPHATE_ADENOSINE_5_PHOSPHATE",132,1.0639,0.26,1,"Yes",0.7881,0.93,1,"Yes"
"18455","C4_Cancer_modules","C4_CM_86_MODULE_91",37,1.0641,0.33,0.83,"Yes",2.1807,0,2e-04,"Yes"
"18456","C7_Immunologic_signatures","C7_ALL_1113_GSE2706_UNSTIM_VS_2H_R848_DC_UP",188,1.0644,0.26,0.51,"Yes",0.9712,0.55,0.83,"Yes"
"18457","GO_BP","492361_GO_0007620_COPULATION",18,1.0645,0.37,0.89,"Yes",1.4264,0.06,0.52,"Yes"
"18458","REACTOME","105744_REACT_309_STABILIZATION_OF_P53",52,1.0647,0.32,0.68,"Yes",2.1447,0,0.00036,"Yes"
"18459","REACTOME","105898_REACT_734_DNA_REPLICATION_PRE_INITIATION",82,1.0648,0.29,0.68,"Yes",2.0565,0,0.0012,"Yes"
"18460","C4_Cancer_gene_neighborhoods","C4_CGN_13_MORF_CCNI",88,1.0649,0.31,0.57,"Yes",2.7369,0,0,"Yes"
"18461","GO_MF","489765_GO_0004402_HISTONE_ACETYLTRANSFERASE_ACTIVITY",55,1.0652,0.35,0.92,"Yes",0.7825,0.87,1,"Yes"
"18462","C4_Cancer_gene_neighborhoods","C4_CGN_122_MORF_LCAT",126,1.0653,0.27,0.58,"Yes",-0.98,0.52,0.86,"No"
"18463","GO_BP","489261_GO_0006363_TERMINATION_OF_RNA_POLYMERASE_I_TRANSCRIPTION",31,1.0654,0.33,0.89,"Yes",1.1409,0.27,0.85,"Yes"
"18464","GO_BP","752711_GO_0097210_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE",6,1.0654,0.4,0.89,"Yes",-1.4404,0.08,0.91,"No"
"18465","C2_Chemical_and_genetic_perturbations","C2_CGP_1779_LEE_AGING_MUSCLE_DN",46,1.0657,0.32,0.95,"Yes",1.3423,0.075,0.35,"Yes"
"18466","REACTOME","161051_REACT_6259_HIV_ELONGATION_ARREST_AND_RECOVERY",31,1.0659,0.35,0.68,"Yes",1.519,0.039,0.14,"Yes"
"18467","GO_BP","501445_GO_0032210_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE",8,1.0665,0.36,0.89,"Yes",-0.5279,0.98,1,"No"
"18468","GO_BP","506574_GO_0043543_PROTEIN_ACYLATION",159,1.0666,0.25,0.89,"Yes",-0.7738,0.97,1,"No"
"18469","GO_BP","751215_GO_0036297_INTERSTRAND_CROSS_LINK_REPAIR",8,1.0666,0.36,0.89,"Yes",-0.8584,0.63,1,"No"
"18470","C2_Chemical_and_genetic_perturbations","C2_CGP_1201_NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON",73,1.0668,0.31,0.95,"Yes",0.9305,0.62,0.89,"Yes"
"18471","C4_Cancer_gene_neighborhoods","C4_CGN_165_MORF_RAB5A",97,1.0672,0.28,0.58,"Yes",2.2018,0,2.1e-05,"Yes"
"18472","C2_Chemical_and_genetic_perturbations","C2_CGP_2816_WEBER_METHYLATED_ICP_IN_FIBROBLAST",21,1.0675,0.31,0.96,"Yes",1.2648,0.17,0.42,"Yes"
"18473","GO_BP","507890_GO_0045540_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS",11,1.0676,0.34,0.89,"Yes",1.0231,0.41,0.97,"Yes"
"18474","REACTOME","105690_REACT_2077_RAF_ACTIVATION",5,1.0676,0.36,0.68,"Yes",1.2741,0.2,0.35,"Yes"
"18475","C4_Cancer_gene_neighborhoods","C4_CGN_244_GCM_MYCL1",23,1.0678,0.35,0.58,"Yes",1.0424,0.38,0.48,"Yes"
"18476","GO_BP","751440_GO_0039533_REGULATION_OF_MDA_5_SIGNALING_PATHWAY",5,1.0679,0.39,0.89,"Yes",1.2916,0.19,0.68,"Yes"
"18477","GO_MF","492733_GO_0008440_INOSITOL_1_4_5_TRISPHOSPHATE_3_KINASE_ACTIVITY",7,1.068,0.37,0.92,"Yes",1.0204,0.45,0.86,"Yes"
"18478","C4_Cancer_gene_neighborhoods","C4_CGN_110_MORF_HEAB",81,1.0682,0.31,0.59,"Yes",0.8101,0.88,0.98,"Yes"
"18479","C4_Cancer_modules","C4_CM_211_MODULE_229",31,1.0683,0.36,0.85,"Yes",0.8191,0.77,0.95,"Yes"
"18480","GO_BP","491299_GO_0006361_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_I_PROMOTER",34,1.0685,0.32,0.89,"Yes",1.2198,0.16,0.77,"Yes"
"18481","REACTOME","105788_REACT_1221_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6",50,1.0687,0.34,0.68,"Yes",2.1964,0,0.00017,"Yes"
"18482","REACTOME","161075_REACT_22285_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES",37,1.0687,0.33,0.68,"Yes",-0.921,0.6,1,"No"
"18483","C7_Immunologic_signatures","C7_ALL_857_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP",193,1.0688,0.21,0.49,"Yes",1.0887,0.24,0.47,"Yes"
"18484","REACTOME","106428_REACT_456_PKB_MEDIATED_EVENTS",30,1.069,0.32,0.68,"Yes",1.2902,0.12,0.33,"Yes"
"18485","GO_MF","496772_GO_0016884_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR",12,1.0692,0.35,0.92,"Yes",0.451,0.99,1,"Yes"
"18486","GO_BP","505321_GO_0042158_LIPOPROTEIN_BIOSYNTHETIC_PROCESS",83,1.0699,0.33,0.89,"Yes",0.7941,0.91,1,"Yes"
"18487","C7_Immunologic_signatures","C7_ALL_1181_GSE27786_BCELL_VS_NKCELL_UP",199,1.07,0.25,0.49,"Yes",1.071,0.27,0.52,"Yes"
"18488","GO_BP","491395_GO_0006497_PROTEIN_LIPIDATION",78,1.0705,0.27,0.89,"Yes",0.8657,0.75,1,"Yes"
"18489","GO_BP","491237_GO_0006273_LAGGING_STRAND_ELONGATION",6,1.0707,0.36,0.89,"Yes",0.6571,0.88,1,"Yes"
"18490","C4_Cancer_gene_neighborhoods","C4_CGN_92_MORF_EIF3S6",122,1.0713,0.27,0.58,"Yes",3.1073,0,0,"Yes"
"18491","C6_Oncogenic_signatures","C6_ALL_10_GCNP_SHH_UP_EARLY_V1_UP",158,1.0714,0.27,0.67,"Yes",1.2141,0.076,0.39,"Yes"
"18492","REACTOME","105833_REACT_6871_APC_C_CDC20_MEDIATED_DEGRADATION_OF_SECURIN",64,1.0717,0.31,0.68,"Yes",2.1308,0,0.00041,"Yes"
"18493","GO_CC","487069_GO_0000776_KINETOCHORE",117,1.0728,0.23,0.71,"Yes",1.3708,0.021,0.32,"Yes"
"18494","C2_BioCarta_Pathways","C2_CP_BIOCARTA_27_BIOCARTA_CACAM_PATHWAY",13,1.0734,0.36,1,"Yes",1.1228,0.3,0.68,"Yes"
"18495","C4_Cancer_gene_neighborhoods","C4_CGN_158_MORF_PTPN11",108,1.0735,0.27,0.58,"Yes",2.0464,0.0024,0.00021,"Yes"
"18496","C7_Immunologic_signatures","C7_ALL_1233_GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP",196,1.0736,0.23,0.48,"Yes",0.8744,0.82,1,"Yes"
"18497","REACTOME","106262_REACT_16969_STRIATED_MUSCLE_CONTRACTION",30,1.0739,0.37,0.68,"Yes",1.1165,0.28,0.56,"Yes"
"18498","C7_Immunologic_signatures","C7_ALL_82_GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",191,1.0742,0.24,0.48,"Yes",1.6398,0,0.0014,"Yes"
"18499","C4_Cancer_gene_neighborhoods","C4_CGN_336_GNF2_CDH11",25,1.0745,0.33,0.59,"Yes",-0.9563,0.52,0.89,"No"
"18500","C4_Cancer_gene_neighborhoods","C4_CGN_91_MORF_EIF3S2",246,1.0751,0.25,0.59,"Yes",2.5227,0,0,"Yes"
"18501","C3_MicroRNA_targets","C3_MIR_175_AGGAGTG_MIR_483",64,1.0752,0.29,1,"Yes",-0.923,0.59,1,"No"
"18502","GO_BP","751609_GO_0044458_MOTILE_CILIUM_ASSEMBLY",8,1.076,0.36,0.87,"Yes",0.934,0.53,1,"Yes"
"18503","GO_CC","490865_GO_0005849_MRNA_CLEAVAGE_FACTOR_COMPLEX",15,1.0761,0.33,0.71,"Yes",1.2275,0.2,0.49,"Yes"
"18504","GO_CC","492815_GO_0008540_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",5,1.0764,0.38,0.71,"Yes",1.3166,0.16,0.39,"Yes"
"18505","GO_MF","492679_GO_0008376_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY",36,1.0772,0.31,0.9,"Yes",-0.8369,0.75,1,"No"
"18506","GO_BP","510621_GO_0048554_POSITIVE_REGULATION_OF_METALLOENZYME_ACTIVITY",6,1.0776,0.35,0.87,"Yes",0.9096,0.57,1,"Yes"
"18507","C4_Cancer_gene_neighborhoods","C4_CGN_88_MORF_DEK",264,1.0782,0.2,0.59,"Yes",2.6083,0,0,"Yes"
"18508","C1_Positional","C1_ALL_251_CHR5P13",48,1.0784,0.32,0.76,"Yes",1.5335,0.017,0.28,"Yes"
"18509","C4_Cancer_modules","C4_CM_295_MODULE_337",62,1.0784,0.28,0.86,"Yes",0.6401,0.98,1,"Yes"
"18510","GO_CC","492598_GO_0008274_GAMMA_TUBULIN_RING_COMPLEX",7,1.0785,0.35,0.71,"Yes",1.1312,0.31,0.6,"Yes"
"18511","REACTOME","685548_REACT_147841_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES",17,1.0786,0.33,0.67,"Yes",0.9959,0.45,0.76,"Yes"
"18512","REACTOME","105857_REACT_127_DNA_DAMAGE_REVERSAL",6,1.0788,0.37,0.67,"Yes",1.3963,0.091,0.23,"Yes"
"18513","GO_MF","489232_GO_0003678_DNA_HELICASE_ACTIVITY",50,1.0793,0.29,0.9,"Yes",0.7862,0.83,1,"Yes"
"18514","GO_MF","510510_GO_0048407_PLATELET_DERIVED_GROWTH_FACTOR_BINDING",11,1.0793,0.35,0.91,"Yes",0.5568,0.97,1,"Yes"
"18515","GO_MF","489877_GO_0004529_EXODEOXYRIBONUCLEASE_ACTIVITY",15,1.0797,0.35,0.92,"Yes",1.1717,0.24,0.73,"Yes"
"18516","C4_Cancer_gene_neighborhoods","C4_CGN_219_GCM_CSNK1D",32,1.0798,0.3,0.59,"Yes",1.2072,0.17,0.21,"Yes"
"18517","REACTOME","106494_REACT_15457_G_PROTEIN_ACTIVATION",27,1.0799,0.31,0.67,"Yes",-0.9897,0.48,0.99,"No"
"18518","GO_BP","491376_GO_0006474_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION",13,1.0805,0.36,0.86,"Yes",0.7319,0.84,1,"Yes"
"18519","C3_TF_targets","C3_TFT_182_V_NRSF_01",92,1.0807,0.28,0.56,"Yes",-1.2315,0.1,0.3,"No"
"18520","C4_Cancer_gene_neighborhoods","C4_CGN_270_GCM_TPR",32,1.0808,0.33,0.59,"Yes",1.4739,0.041,0.038,"Yes"
"18521","GO_CC","502495_GO_0033276_TRANSCRIPTION_FACTOR_TFTC_COMPLEX",14,1.0811,0.36,0.71,"Yes",-0.6514,0.9,1,"No"
"18522","C7_Immunologic_signatures","C7_ALL_307_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP",197,1.0827,0.2,0.44,"Yes",1.2249,0.083,0.19,"Yes"
"18523","C7_Immunologic_signatures","C7_ALL_770_GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN",198,1.0828,0.24,0.45,"Yes",1.0313,0.35,0.64,"Yes"
"18524","GO_MF","1039896_GO_0090595_ACETYL_COA_L_LYSINE_N6_ACETYLTRANSFERASE",55,1.0831,0.27,0.91,"Yes",0.7726,0.91,1,"Yes"
"18525","C2_Chemical_and_genetic_perturbations","C2_CGP_2940_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14",142,1.0832,0.26,0.9,"Yes",1.4709,0.0046,0.24,"Yes"
"18526","GO_CC","486784_GO_0005834_HETEROTRIMERIC_G_PROTEIN_COMPLEX",34,1.0833,0.33,0.71,"Yes",1.0478,0.38,0.72,"Yes"
"18527","GO_BP","496377_GO_0016338_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES",20,1.0841,0.34,0.85,"Yes",-1.2174,0.2,0.88,"No"
"18528","C4_Cancer_gene_neighborhoods","C4_CGN_120_MORF_JUND",64,1.085,0.28,0.58,"Yes",3.0901,0,0,"Yes"
"18529","GO_MF","494385_GO_0010314_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING",10,1.0854,0.33,0.91,"Yes",-0.7116,0.85,1,"No"
"18530","C7_Immunologic_signatures","C7_ALL_985_GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP",199,1.0861,0.17,0.44,"Yes",2.0601,0,0,"Yes"
"18531","REACTOME","106556_REACT_1074_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION",31,1.0861,0.29,0.66,"Yes",1.156,0.23,0.5,"Yes"
"18532","C7_Immunologic_signatures","C7_ALL_228_GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN",193,1.087,0.21,0.44,"Yes",2.0494,0,0,"Yes"
"18533","REACTOME","105950_REACT_1845_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX",43,1.087,0.32,0.66,"Yes",1.5434,0.025,0.12,"Yes"
"18534","C7_Immunologic_signatures","C7_ALL_847_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP",197,1.0875,0.2,0.44,"Yes",1.4227,0.0024,0.031,"Yes"
"18535","GO_CC","490778_GO_0005743_MITOCHONDRIAL_INNER_MEMBRANE",442,1.0877,0.21,0.7,"Yes",2.4499,0,0,"Yes"
"18536","C2_Chemical_and_genetic_perturbations","C2_CGP_1890_KALMA_E2F1_TARGETS",11,1.0877,0.35,0.89,"Yes",1.7401,0.016,0.063,"Yes"
"18537","GO_BP","1039931_GO_1903377_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",5,1.0878,0.38,0.84,"Yes",1.4445,0.06,0.5,"Yes"
"18538","REACTOME","160954_REACT_1096_PROCESSING_OF_INTRONLESS_PRE_MRNAS",14,1.0881,0.33,0.66,"Yes",1.0689,0.36,0.63,"Yes"
"18539","GO_MF","501501_GO_0032266_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING",26,1.0881,0.3,0.91,"Yes",0.5169,1,1,"Yes"
"18540","GO_BP","754168_GO_1901201_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY",6,1.0887,0.35,0.84,"Yes",0.7093,0.82,1,"Yes"
"18541","C7_Immunologic_signatures","C7_ALL_1591_GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP",198,1.0887,0.21,0.44,"Yes",1.6043,0.0046,0.0028,"Yes"
"18542","GO_BP","849890_GO_1902188_POSITIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL",14,1.0892,0.33,0.84,"Yes",1.3426,0.13,0.62,"Yes"
"18543","C2_BioCarta_Pathways","C2_CP_BIOCARTA_164_BIOCARTA_ATRBRCA_PATHWAY",21,1.0893,0.33,1,"Yes",-0.555,0.99,1,"No"
"18544","GO_CC","487155_GO_0000931_GAMMA_TUBULIN_LARGE_COMPLEX",7,1.0893,0.37,0.7,"Yes",1.1461,0.29,0.59,"Yes"
"18545","GO_BP","518539_GO_0090399_REPLICATIVE_SENESCENCE",11,1.0894,0.34,0.84,"Yes",-0.9029,0.61,1,"No"
"18546","GO_BP","508028_GO_0045683_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT",15,1.0895,0.32,0.84,"Yes",-0.6519,0.92,1,"No"
"18547","GO_BP","505610_GO_0042473_OUTER_EAR_MORPHOGENESIS",8,1.0898,0.35,0.84,"Yes",1.3031,0.17,0.67,"Yes"
"18548","C7_Immunologic_signatures","C7_ALL_1268_GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN",176,1.09,0.23,0.44,"Yes",-0.911,0.71,1,"No"
"18549","C1_Positional","C1_ALL_210_CHR10P14",21,1.0906,0.32,0.74,"Yes",1.3124,0.13,0.53,"Yes"
"18550","C2_Chemical_and_genetic_perturbations","C2_CGP_45_NAM_FXYD5_TARGETS_DN",18,1.0912,0.34,0.88,"Yes",1.8143,0.0064,0.039,"Yes"
"18551","C6_Oncogenic_signatures","C6_ALL_151_SINGH_KRAS_DEPENDENCY_SIGNATURE_",20,1.0914,0.33,0.76,"Yes",-0.6446,0.93,1,"No"
"18552","C4_Cancer_modules","C4_CM_202_MODULE_215",15,1.0914,0.32,0.85,"Yes",-1.302,0.14,0.51,"No"
"18553","GO_BP","507704_GO_0045347_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS",6,1.0918,0.35,0.84,"Yes",1.3741,0.14,0.58,"Yes"
"18554","GO_CC","515393_GO_0070461_SAGA_TYPE_COMPLEX",30,1.0921,0.33,0.7,"Yes",0.8021,0.79,0.96,"Yes"
"18555","C7_Immunologic_signatures","C7_ALL_402_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN",200,1.0921,0.21,0.44,"Yes",2.1684,0,0,"Yes"
"18556","GO_BP","518857_GO_2000210_POSITIVE_REGULATION_OF_ANOIKIS",6,1.0922,0.36,0.84,"Yes",1.0034,0.44,0.98,"Yes"
"18557","GO_BP","782516_GO_0061512_PROTEIN_LOCALIZATION_TO_CILIUM",15,1.0922,0.34,0.84,"Yes",0.8138,0.74,1,"Yes"
"18558","GO_MF","496398_GO_0016410_N_ACYLTRANSFERASE_ACTIVITY",97,1.0927,0.25,0.9,"Yes",-0.6412,1,1,"No"
"18559","GO_BP","750784_GO_0002192_IRES_DEPENDENT_TRANSLATIONAL_INITIATION",5,1.0931,0.34,0.84,"Yes",0.8326,0.66,1,"Yes"
"18560","C3_TF_targets","C3_TFT_215_V_GABP_B",259,1.0933,0.15,0.56,"Yes",1.4712,0.0048,0.2,"Yes"
"18561","GO_BP","507521_GO_0045132_MEIOTIC_CHROMOSOME_SEGREGATION",53,1.0936,0.28,0.84,"Yes",0.7021,0.96,1,"Yes"
"18562","C7_Immunologic_signatures","C7_ALL_1192_GSE27786_CD4_VS_CD8_TCELL_DN",198,1.0937,0.21,0.43,"Yes",1.4437,0.0048,0.024,"Yes"
"18563","C7_Immunologic_signatures","C7_ALL_1672_GSE3982_NEUTROPHIL_VS_TH1_DN",200,1.0948,0.2,0.43,"Yes",1.6799,0,0.00085,"Yes"
"18564","KEGG_compound","C16679_ALL_TRANS_18_HYDROXYRETINOIC_ACID",14,1.0955,0.33,1,"Yes",-0.9931,0.46,1,"No"
"18565","C2_Chemical_and_genetic_perturbations","C2_CGP_664_NAKAMURA_ALVEOLAR_EPITHELIUM",5,1.0961,0.36,0.87,"Yes",0.4595,0.99,1,"Yes"
"18566","REACTOME","771600_REACT_160163_SCAVENGING_OF_HEME_FROM_PLASMA",12,1.0963,0.31,0.64,"Yes",1.2887,0.17,0.34,"Yes"
"18567","C2_Chemical_and_genetic_perturbations","C2_CGP_3292_KRIEG_KDM3A_TARGETS_NOT_HYPOXIA",198,1.0965,0.18,0.88,"Yes",1.5532,0,0.17,"Yes"
"18568","GO_BP","503861_GO_0034661_NCRNA_CATABOLIC_PROCESS",16,1.0965,0.32,0.83,"Yes",0.7457,0.8,1,"Yes"
"18569","REACTOME","106430_REACT_6838_MTOR_SIGNALLING",29,1.0969,0.33,0.64,"Yes",1.2846,0.15,0.34,"Yes"
"18570","GO_MF","487558_GO_0001642_GROUP_III_METABOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY",5,1.0973,0.35,0.89,"Yes",1.3866,0.11,0.48,"Yes"
"18571","C4_Cancer_gene_neighborhoods","C4_CGN_20_MORF_HAT1",175,1.0975,0.19,0.55,"Yes",2.5896,0,0,"Yes"
"18572","C7_Immunologic_signatures","C7_ALL_1216_GSE27786_NKCELL_VS_ERYTHROBLAST_DN",196,1.0977,0.21,0.42,"Yes",1.0676,0.29,0.53,"Yes"
"18573","C2_Chemical_and_genetic_perturbations","C2_CGP_3169_VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP",18,1.0979,0.31,0.88,"Yes",1.4089,0.086,0.29,"Yes"
"18574","GO_BP","500173_GO_0030878_THYROID_GLAND_DEVELOPMENT",16,1.098,0.31,0.83,"Yes",-0.8554,0.67,1,"No"
"18575","C4_Cancer_gene_neighborhoods","C4_CGN_36_MORF_RAD23B",179,1.0981,0.24,0.55,"Yes",2.4172,0,0,"Yes"
"18576","GO_BP","493908_GO_0009804_COUMARIN_METABOLIC_PROCESS",8,1.0982,0.31,0.83,"Yes",-1.3319,0.17,0.91,"No"
"18577","C7_Immunologic_signatures","C7_ALL_58_GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN",188,1.0983,0.15,0.43,"Yes",1.6442,0,0.0013,"Yes"
"18578","C1_Positional","C1_ALL_20_CHR4P16",114,1.0985,0.21,0.73,"Yes",0.6772,1,1,"Yes"
"18579","C2_Chemical_and_genetic_perturbations","C2_CGP_2403_THUM_MIR21_TARGETS_HEART_DISEASE_UP",16,1.0988,0.34,0.89,"Yes",1.1428,0.26,0.56,"Yes"
"18580","GO_BP","493496_GO_0009312_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS",14,1.0991,0.31,0.83,"Yes",0.9225,0.56,1,"Yes"
"18581","GO_BP","486610_GO_0006260_DNA_REPLICATION",207,1.0994,0.21,0.83,"Yes",1.1514,0.12,0.84,"Yes"
"18582","KEGG_reaction","R05916_UDP_N_ACETYL_D_GLUCOSAMINE_1_PHOSPHATIDYL_D_MYO_INOSITOL_UDP_G00143",7,1.0997,0.32,1,"Yes",1.1419,0.29,1,"Yes"
"18583","C4_Cancer_gene_neighborhoods","C4_CGN_152_MORF_PPP6C",103,1.1006,0.24,0.55,"Yes",2.1893,0,2.1e-05,"Yes"
"18584","KEGG_reaction","R08390_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_18_HYDROXYRETINOIC_ACID_NADP_H2O",14,1.1017,0.32,1,"Yes",-0.9847,0.47,0.78,"No"
"18585","C7_Immunologic_signatures","C7_ALL_126_GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN",199,1.1027,0.17,0.41,"Yes",1.2888,0.028,0.11,"Yes"
"18586","GO_MF","486778_GO_0005337_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,1.1027,0.31,0.88,"Yes",0.6229,0.93,1,"Yes"
"18587","REACTOME","160939_REACT_20549_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1",51,1.103,0.26,0.63,"Yes",2.145,0,0.00037,"Yes"
"18588","C2_Chemical_and_genetic_perturbations","C2_CGP_1674_SU_TESTIS",72,1.1037,0.24,0.87,"Yes",-1.0744,0.31,0.95,"No"
"18589","C2_Chemical_and_genetic_perturbations","C2_CGP_2435_FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION",9,1.1038,0.33,0.88,"Yes",1.0637,0.37,0.69,"Yes"
"18590","GO_CC","500209_GO_0030914_STAGA_COMPLEX",13,1.1052,0.32,0.67,"Yes",-0.7026,0.86,1,"No"
"18591","C1_Positional","C1_ALL_244_CHR3P11",5,1.1055,0.32,0.73,"Yes",1.1282,0.34,0.62,"Yes"
"18592","REACTOME","1183574_REACT_355197_SHC_MEDIATED_CASCADE_FGFR3",16,1.1058,0.31,0.62,"Yes",-1.0734,0.35,0.9,"No"
"18593","GO_CC","500281_GO_0030991_INTRACILIARY_TRANSPORT_PARTICLE_A",7,1.1063,0.33,0.68,"Yes",-0.6407,0.9,1,"No"
"18594","GO_MF","505327_GO_0042165_NEUROTRANSMITTER_BINDING",17,1.1069,0.29,0.88,"Yes",-1.7107,0.015,0.3,"No"
"18595","GO_MF","488050_GO_0002161_AMINOACYL_TRNA_EDITING_ACTIVITY",12,1.1073,0.3,0.88,"Yes",0.8231,0.71,1,"Yes"
"18596","C2_Chemical_and_genetic_perturbations","C2_CGP_1316_KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN",57,1.108,0.25,0.87,"Yes",0.8563,0.78,0.96,"Yes"
"18597","C2_Chemical_and_genetic_perturbations","C2_CGP_2620_MIKKELSEN_PLURIPOTENT_STATE_UP",10,1.1081,0.27,0.88,"Yes",-1.3579,0.12,0.66,"No"
"18598","GO_MF","499706_GO_0030306_ADP_RIBOSYLATION_FACTOR_BINDING",7,1.1081,0.33,0.89,"Yes",-0.8268,0.69,1,"No"
"18599","GO_MF","490005_GO_0004679_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY",7,1.1087,0.33,0.89,"Yes",1.2747,0.19,0.64,"Yes"
"18600","C4_Cancer_gene_neighborhoods","C4_CGN_150_MORF_PPP2R5E",83,1.1089,0.2,0.53,"Yes",1.6038,0.0046,0.014,"Yes"
"18601","GO_BP","492050_GO_0007271_SYNAPTIC_TRANSMISSION_CHOLINERGIC",20,1.109,0.31,0.8,"Yes",-1.6213,0.019,0.7,"No"
"18602","GO_BP","491942_GO_0007129_SYNAPSIS",34,1.1092,0.26,0.8,"Yes",-0.8404,0.73,1,"No"
"18603","GO_BP","491358_GO_0006446_REGULATION_OF_TRANSLATIONAL_INITIATION",71,1.1093,0.22,0.81,"Yes",1.8387,0,0.069,"Yes"
"18604","REACTOME","106567_REACT_63_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION",23,1.1094,0.32,0.62,"Yes",0.9706,0.48,0.8,"Yes"
"18605","GO_BP","518280_GO_0090140_REGULATION_OF_MITOCHONDRIAL_FISSION",13,1.1098,0.28,0.81,"Yes",0.8606,0.67,1,"Yes"
"18606","C2_Chemical_and_genetic_perturbations","C2_CGP_657_LASTOWSKA_COAMPLIFIED_WITH_MYCN",40,1.1098,0.25,0.88,"Yes",1.3823,0.056,0.31,"Yes"
"18607","GO_BP","507759_GO_0045402_REGULATION_OF_INTERLEUKIN_4_BIOSYNTHETIC_PROCESS",5,1.1102,0.35,0.81,"Yes",1.1216,0.33,0.88,"Yes"
"18608","C4_Cancer_gene_neighborhoods","C4_CGN_40_MORF_RFC4",151,1.1109,0.24,0.53,"Yes",2.0894,0,0.00013,"Yes"
"18609","C2_Chemical_and_genetic_perturbations","C2_CGP_2374_SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP",24,1.1113,0.29,0.89,"Yes",1.8496,0.0041,0.028,"Yes"
"18610","GO_BP","491229_GO_0006265_DNA_TOPOLOGICAL_CHANGE",9,1.1118,0.3,0.8,"Yes",1.2557,0.2,0.73,"Yes"
"18611","C1_Positional","C1_ALL_15_CHR8P11",42,1.1118,0.23,0.73,"Yes",0.8709,0.68,0.89,"Yes"
"18612","GO_MF","495785_GO_0015643_TOXIC_SUBSTANCE_BINDING",11,1.1123,0.32,0.89,"Yes",0.933,0.54,0.94,"Yes"
"18613","REACTOME","106353_REACT_9508_FGFR3B_LIGAND_BINDING_AND_ACTIVATION",6,1.1126,0.31,0.61,"Yes",-1.5502,0.029,0.39,"No"
"18614","GO_BP","492247_GO_0007494_MIDGUT_DEVELOPMENT",12,1.1135,0.29,0.8,"Yes",1.7065,0.019,0.19,"Yes"
"18615","GO_BP","500758_GO_0031507_HETEROCHROMATIN_ASSEMBLY",8,1.1138,0.33,0.8,"Yes",0.8403,0.65,1,"Yes"
"18616","C7_Immunologic_signatures","C7_ALL_1774_GSE7460_CD8_TCELL_VS_TREG_ACT_DN",199,1.1147,0.15,0.37,"Yes",1.5389,0,0.0073,"Yes"
"18617","C2_Chemical_and_genetic_perturbations","C2_CGP_1811_MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4",21,1.1157,0.31,0.88,"Yes",1.077,0.37,0.67,"Yes"
"18618","C7_Immunologic_signatures","C7_ALL_1648_GSE3982_MAC_VS_BCELL_DN",192,1.1157,0.13,0.37,"Yes",0.9533,0.61,0.89,"Yes"
"18619","C7_Immunologic_signatures","C7_ALL_1668_GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN",197,1.116,0.14,0.37,"Yes",1.7281,0,0.00041,"Yes"
"18620","REACTOME","106427_REACT_976_PI3K_CASCADE",63,1.116,0.26,0.61,"Yes",0.9635,0.52,0.8,"Yes"
"18621","REACTOME","105786_REACT_2148_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE",70,1.1161,0.24,0.61,"Yes",2.0803,0,0.00083,"Yes"
"18622","GO_CC","505526_GO_0042382_PARASPECKLES",6,1.1162,0.34,0.66,"Yes",0.6678,0.85,0.99,"Yes"
"18623","GO_CC","754890_GO_1990023_MITOTIC_SPINDLE_MIDZONE",7,1.1162,0.33,0.66,"Yes",0.8287,0.69,0.93,"Yes"
"18624","KEGG_module","HSA_M00143_NADH_DEHYDROGENASE_UBIQUINONE_FE_S_PROTEIN_FLAVOPROTEIN_COMPLEX_MITOCHONDRIA",11,1.1164,0.3,0.58,"Yes",1.7617,0.0063,0.05,"Yes"
"18625","KEGG_compound","C00870_4_NITROPHENOL_P_NITROPHENOL_PNP_NIPHEN_4_HYDROXYNITROBENZENE",6,1.1164,0.32,1,"Yes",1.6479,0.018,0.12,"Yes"
"18626","GO_CC","925911_GO_1902562_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX",16,1.1164,0.29,0.67,"Yes",1.1362,0.27,0.59,"Yes"
"18627","GO_BP","510676_GO_0048617_EMBRYONIC_FOREGUT_MORPHOGENESIS",10,1.1167,0.3,0.79,"Yes",-0.8167,0.67,1,"No"
"18628","C4_Cancer_gene_neighborhoods","C4_CGN_354_GNF2_G22P1",36,1.1171,0.28,0.52,"Yes",1.7194,0.0086,0.0053,"Yes"
"18629","GO_BP","506719_GO_0043691_REVERSE_CHOLESTEROL_TRANSPORT",17,1.1172,0.29,0.79,"Yes",-0.6507,0.93,1,"No"
"18630","C4_Cancer_gene_neighborhoods","C4_CGN_318_GNF2_XRCC5",75,1.1178,0.23,0.52,"Yes",2.1377,0,7.9e-05,"Yes"
"18631","C4_Cancer_gene_neighborhoods","C4_CGN_87_MORF_DEAF1",57,1.1182,0.24,0.53,"Yes",2.3049,0,0,"Yes"
"18632","GO_BP","502817_GO_0033601_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",6,1.1186,0.33,0.79,"Yes",-1.2033,0.29,0.89,"No"
"18633","KEGG_module","HSA_M00405_THC_COMPLEX",5,1.1187,0.31,0.59,"Yes",0.904,0.57,0.91,"Yes"
"18634","GO_BP","496041_GO_0015919_PEROXISOMAL_MEMBRANE_TRANSPORT",7,1.119,0.32,0.79,"Yes",1.387,0.12,0.57,"Yes"
"18635","C1_Positional","C1_ALL_177_CHR6Q16",23,1.1191,0.25,0.73,"Yes",1.2663,0.15,0.56,"Yes"
"18636","C1_Positional","C1_ALL_83_CHR2Q11",63,1.1192,0.21,0.76,"Yes",1.0344,0.39,0.72,"Yes"
"18637","GO_BP","495055_GO_0010990_REGULATION_OF_SMAD_PROTEIN_COMPLEX_ASSEMBLY",5,1.12,0.33,0.79,"Yes",-0.6672,0.87,1,"No"
"18638","C2_Chemical_and_genetic_perturbations","C2_CGP_3018_BROWNE_HCMV_INFECTION_4HR_DN",252,1.1201,0.08,0.87,"Yes",1.0257,0.37,0.76,"Yes"
"18639","C4_Cancer_gene_neighborhoods","C4_CGN_345_GNF2_DEK",58,1.121,0.26,0.52,"Yes",1.9261,0,0.00062,"Yes"
"18640","REACTOME","105925_REACT_18274_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION",39,1.1212,0.27,0.6,"Yes",1.1268,0.26,0.55,"Yes"
"18641","GO_BP","491775_GO_0006924_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS",6,1.1216,0.33,0.79,"Yes",1.4452,0.082,0.5,"Yes"
"18642","C4_Cancer_gene_neighborhoods","C4_CGN_38_MORF_RAD54L",105,1.1218,0.2,0.53,"Yes",1.5513,0.0047,0.022,"Yes"
"18643","GO_MF","752251_GO_0097371_MDM2_MDM4_FAMILY_PROTEIN_BINDING",6,1.1219,0.33,0.87,"Yes",0.7763,0.74,1,"Yes"
"18644","GO_BP","508248_GO_0045943_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER",12,1.1219,0.28,0.79,"Yes",0.5694,0.96,1,"Yes"
"18645","GO_BP","506194_GO_0043117_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY",9,1.122,0.32,0.79,"Yes",0.8401,0.68,1,"Yes"
"18646","C4_Cancer_gene_neighborhoods","C4_CGN_300_GNF2_HAT1",50,1.1223,0.23,0.53,"Yes",2.3039,0,0,"Yes"
"18647","C1_Positional","C1_ALL_50_CHR12Q22",31,1.1224,0.27,0.77,"Yes",1.0244,0.42,0.73,"Yes"
"18648","C4_Cancer_gene_neighborhoods","C4_CGN_221_GCM_DDX11",44,1.1225,0.25,0.54,"Yes",-0.9067,0.62,1,"No"
"18649","REACTOME","105851_REACT_2192_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR",7,1.1228,0.31,0.6,"Yes",1.0771,0.36,0.62,"Yes"
"18650","C4_Cancer_modules","C4_CM_373_MODULE_457",10,1.123,0.27,0.78,"Yes",1.6311,0.028,0.064,"Yes"
"18651","REACTOME","366162_REACT_75842_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",211,1.1232,0.12,0.6,"Yes",1.6778,0,0.057,"Yes"
"18652","GO_CC","505685_GO_0042555_MCM_COMPLEX",11,1.1232,0.32,0.65,"Yes",1.355,0.12,0.34,"Yes"
"18653","REACTOME","106198_REACT_9441_HEXOSE_TRANSPORT",46,1.1233,0.25,0.6,"Yes",0.7971,0.83,1,"Yes"
"18654","C7_Immunologic_signatures","C7_ALL_217_GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP",191,1.1233,0.15,0.35,"Yes",-0.695,1,1,"No"
"18655","C2_Chemical_and_genetic_perturbations","C2_CGP_2844_BOYLAN_MULTIPLE_MYELOMA_PCA1_DN",8,1.1234,0.33,0.86,"Yes",1.0664,0.39,0.68,"Yes"
"18656","GO_BP","752560_GO_0090503_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC",30,1.1239,0.28,0.79,"Yes",1.3014,0.13,0.67,"Yes"
"18657","GO_MF","496668_GO_0016755_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS",21,1.1239,0.28,0.87,"Yes",1.0799,0.35,0.82,"Yes"
"18658","REACTOME","576251_REACT_118656_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS",66,1.1241,0.21,0.6,"Yes",2.0356,0,0.0015,"Yes"
"18659","REACTOME","105787_REACT_1156_ORC1_REMOVAL_FROM_CHROMATIN",70,1.1243,0.21,0.61,"Yes",2.1072,0,0.00049,"Yes"
"18660","GO_BP","515129_GO_0070192_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOSIS",39,1.1246,0.26,0.79,"Yes",-0.8133,0.77,1,"No"
"18661","GO_CC","490666_GO_0005593_FACIT_COLLAGEN_TRIMER",7,1.1247,0.3,0.66,"Yes",-1.0742,0.38,0.8,"No"
"18662","C2_Chemical_and_genetic_perturbations","C2_CGP_769_SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS",36,1.1248,0.25,0.86,"Yes",0.684,0.94,1,"Yes"
"18663","C2_Chemical_and_genetic_perturbations","C2_CGP_3126_JOHNSTONE_PARVB_TARGETS_1_UP",7,1.1254,0.29,0.87,"Yes",0.8224,0.69,0.98,"Yes"
"18664","GO_BP","513950_GO_0060394_NEGATIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",11,1.1258,0.28,0.78,"Yes",1.0675,0.38,0.93,"Yes"
"18665","C3_TF_targets","C3_TFT_192_V_MIF1_01",180,1.1262,0.12,0.48,"Yes",-0.795,0.94,1,"No"
"18666","C4_Cancer_gene_neighborhoods","C4_CGN_245_GCM_MYST2",173,1.1266,0.12,0.53,"Yes",0.7895,0.96,1,"Yes"
"18667","GO_MF","490329_GO_0005048_SIGNAL_SEQUENCE_BINDING",23,1.1269,0.25,0.87,"Yes",0.9021,0.57,0.98,"Yes"
"18668","C7_Immunologic_signatures","C7_ALL_1844_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN",193,1.1272,0.056,0.34,"Yes",0.9822,0.53,0.8,"Yes"
"18669","C0_Hallmark","H_ALL_8_HALLMARK_DNA_REPAIR",150,1.1276,0.16,0.19,"Yes",1.757,0,0.0024,"Yes"
"18670","GO_MF","499835_GO_0030492_HEMOGLOBIN_BINDING",5,1.1277,0.32,0.87,"Yes",1.8972,0,0.033,"Yes"
"18671","C7_Immunologic_signatures","C7_ALL_1173_GSE27786_LIN_NEG_VS_NEUTROPHIL_UP",199,1.128,0.1,0.34,"Yes",1.3123,0.028,0.091,"Yes"
"18672","GO_BP","495237_GO_0014842_REGULATION_OF_SATELLITE_CELL_PROLIFERATION",8,1.1283,0.3,0.78,"Yes",0.5917,0.94,1,"Yes"
"18673","C4_Cancer_gene_neighborhoods","C4_CGN_372_GNF2_MAP2K3",75,1.1284,0.22,0.53,"Yes",2.0335,0,0.00023,"Yes"
"18674","GO_MF","489272_GO_0003729_MRNA_BINDING",120,1.1285,0.19,0.88,"Yes",1.3445,0.035,0.53,"Yes"
"18675","C4_Cancer_gene_neighborhoods","C4_CGN_178_MORF_SNRP70",62,1.1293,0.19,0.54,"Yes",1.634,0.0043,0.011,"Yes"
"18676","GO_BP","518220_GO_0090080_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",5,1.1296,0.32,0.78,"Yes",-1.1508,0.31,0.92,"No"
"18677","C7_Immunologic_signatures","C7_ALL_382_GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN",191,1.1298,0.1,0.34,"Yes",1.1464,0.16,0.33,"Yes"
"18678","GO_BP","494858_GO_0010793_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS",6,1.1298,0.32,0.78,"Yes",1.028,0.41,0.97,"Yes"
"18679","GO_CC","501514_GO_0032279_ASYMMETRIC_SYNAPSE",6,1.13,0.32,0.65,"Yes",1.3701,0.15,0.32,"Yes"
"18680","REACTOME","161068_REACT_20582_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY",6,1.1302,0.3,0.6,"Yes",0.781,0.74,1,"Yes"
"18681","C2_BioCarta_Pathways","C2_CP_BIOCARTA_143_BIOCARTA_PROTEASOME_PATHWAY",28,1.1306,0.25,1,"Yes",2.1296,0,0.0046,"Yes"
"18682","GO_BP","501627_GO_0032392_DNA_GEOMETRIC_CHANGE",57,1.1308,0.23,0.78,"Yes",0.9017,0.69,1,"Yes"
"18683","C7_Immunologic_signatures","C7_ALL_1211_GSE27786_CD8_TCELL_VS_MONO_MAC_UP",198,1.1308,0.11,0.34,"Yes",1.3144,0.026,0.089,"Yes"
"18684","GO_BP","507415_GO_0045005_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY",20,1.131,0.26,0.78,"Yes",-0.5139,0.99,1,"No"
"18685","GO_MF","489867_GO_0004518_NUCLEASE_ACTIVITY",179,1.1311,0.14,0.88,"Yes",1.444,0.0095,0.44,"Yes"
"18686","KEGG_pathway","HSA04950_MATURITY_ONSET_DIABETES_OF_THE_YOUNG",21,1.1311,0.26,0.36,"Yes",-1.0069,0.43,0.86,"No"
"18687","GO_BP","514012_GO_0060457_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS",8,1.1315,0.31,0.78,"Yes",-0.8182,0.7,1,"No"
"18688","GO_BP","510210_GO_0048048_EMBRYONIC_EYE_MORPHOGENESIS",31,1.132,0.27,0.78,"Yes",1.2165,0.19,0.76,"Yes"
"18689","GO_CC","506261_GO_0043189_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX",16,1.1322,0.27,0.65,"Yes",1.1801,0.22,0.55,"Yes"
"18690","C1_Positional","C1_ALL_314_CHR11P11",60,1.1325,0.24,0.76,"Yes",0.6673,0.98,1,"Yes"
"18691","GO_BP","501332_GO_0032095_REGULATION_OF_RESPONSE_TO_FOOD",19,1.1329,0.25,0.78,"Yes",-1.1338,0.29,0.93,"No"
"18692","GO_CC","496549_GO_0016607_NUCLEAR_SPECK",179,1.1331,0.14,0.65,"Yes",0.7941,0.97,0.96,"Yes"
"18693","GO_MF","489868_GO_0004519_ENDONUCLEASE_ACTIVITY",108,1.1334,0.16,0.88,"Yes",1.3705,0.026,0.5,"Yes"
"18694","GO_MF","490651_GO_0017069_SNRNA_BINDING",22,1.1343,0.26,0.88,"Yes",1.1202,0.29,0.77,"Yes"
"18695","GO_BP","491749_GO_0006888_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT",68,1.135,0.21,0.77,"Yes",1.8506,0,0.063,"Yes"
"18696","REACTOME","771570_REACT_160255_NUCLEAR_ENVELOPE_BREAKDOWN",50,1.1353,0.22,0.59,"Yes",1.3649,0.055,0.25,"Yes"
"18697","GO_CC","495179_GO_0014731_SPECTRIN_ASSOCIATED_CYTOSKELETON",8,1.1354,0.3,0.65,"Yes",1.3125,0.17,0.39,"Yes"
"18698","GO_MF","489278_GO_0003746_TRANSLATION_ELONGATION_FACTOR_ACTIVITY",18,1.1355,0.28,0.89,"Yes",1.8917,0,0.033,"Yes"
"18699","GO_MF","486898_GO_0000405_BUBBLE_DNA_BINDING",6,1.1356,0.29,0.89,"Yes",0.9867,0.46,0.89,"Yes"
"18700","C7_Immunologic_signatures","C7_ALL_1263_GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP",187,1.1359,0.087,0.32,"Yes",0.7678,0.98,1,"Yes"
"18701","REACTOME","106254_REACT_11172_VITAMIN_B5_PANTOTHENATE_METABOLISM",12,1.136,0.31,0.59,"Yes",1.2296,0.21,0.42,"Yes"
"18702","C1_Positional","C1_ALL_48_CHR13Q31",11,1.1362,0.28,0.78,"Yes",1.2065,0.24,0.63,"Yes"
"18703","GO_CC","486995_GO_0000506_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX",8,1.1364,0.3,0.65,"Yes",1.1659,0.3,0.57,"Yes"
"18704","C2_Chemical_and_genetic_perturbations","C2_CGP_3227_IKEDA_MIR1_TARGETS_DN",7,1.1367,0.32,0.84,"Yes",1.1966,0.26,0.49,"Yes"
"18705","GO_BP","519021_GO_2000381_NEGATIVE_REGULATION_OF_MESODERM_DEVELOPMENT",6,1.1375,0.32,0.77,"Yes",1.0557,0.4,0.94,"Yes"
"18706","REACTOME","105818_REACT_1275_MITOTIC_ANAPHASE",173,1.1377,0.12,0.59,"Yes",2.037,0,0.0015,"Yes"
"18707","GO_MF","486706_GO_0000175_3_5_EXORIBONUCLEASE_ACTIVITY",27,1.1377,0.26,0.89,"Yes",1.2717,0.13,0.64,"Yes"
"18708","GO_BP","509663_GO_0047484_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS",8,1.1391,0.31,0.76,"Yes",1.1395,0.3,0.85,"Yes"
"18709","REACTOME","106097_REACT_1665_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION",32,1.1397,0.26,0.58,"Yes",1.0148,0.43,0.73,"Yes"
"18710","GO_BP","492067_GO_0007289_SPERMATID_NUCLEUS_DIFFERENTIATION",20,1.1398,0.25,0.76,"Yes",1.2013,0.19,0.78,"Yes"
"18711","C2_Chemical_and_genetic_perturbations","C2_CGP_286_TIEN_INTESTINE_PROBIOTICS_2HR_DN",88,1.1405,0.2,0.83,"Yes",1.3107,0.068,0.38,"Yes"
"18712","REACTOME","477124_REACT_111178_ER_PHAGOSOME_PATHWAY",64,1.1407,0.2,0.58,"Yes",2.2708,0,7.1e-05,"Yes"
"18713","C2_Chemical_and_genetic_perturbations","C2_CGP_2212_OUYANG_PROSTATE_CANCER_PROGRESSION_DN",20,1.1408,0.25,0.84,"Yes",-1.0416,0.4,0.97,"No"
"18714","C4_Cancer_modules","C4_CM_142_MODULE_150",15,1.1409,0.26,0.75,"Yes",2.1931,0,0.00025,"Yes"
"18715","C7_Immunologic_signatures","C7_ALL_202_GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN",193,1.1412,0.1,0.31,"Yes",2.4233,0,0,"Yes"
"18716","GO_BP","491767_GO_0006913_NUCLEOCYTOPLASMIC_TRANSPORT",230,1.1412,0.089,0.76,"Yes",1.0599,0.29,0.94,"Yes"
"18717","GO_BP","753348_GO_1900364_NEGATIVE_REGULATION_OF_MRNA_POLYADENYLATION",8,1.1413,0.29,0.76,"Yes",0.8089,0.69,1,"Yes"
"18718","GO_BP","510692_GO_0048635_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT",35,1.1416,0.25,0.76,"Yes",0.8403,0.74,1,"Yes"
"18719","KEGG_reaction","R02239_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHATE_PHOSPHOHYDROLASE_PHOSPHATIDATE_H2O_1_2_DIACYL_SN_GLYCEROL_ORTHOPHOSPHATE",6,1.1418,0.29,1,"Yes",1.345,0.15,0.53,"Yes"
"18720","C7_Immunologic_signatures","C7_ALL_1006_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN",199,1.1426,0.14,0.31,"Yes",1.6661,0,0.001,"Yes"
"18721","KEGG_module","HSA_M00389_APC_C_COMPLEX",14,1.143,0.27,0.57,"Yes",1.3749,0.11,0.31,"Yes"
"18722","GO_MF","495654_GO_0015450_P_P_BOND_HYDROLYSIS_DRIVEN_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,1.1432,0.29,0.88,"Yes",1.3901,0.1,0.48,"Yes"
"18723","C4_Cancer_modules","C4_CM_253_MODULE_287",49,1.1437,0.17,0.79,"Yes",1.0834,0.31,0.57,"Yes"
"18724","GO_MF","496757_GO_0016866_INTRAMOLECULAR_TRANSFERASE_ACTIVITY",27,1.1443,0.23,0.89,"Yes",1.0658,0.37,0.82,"Yes"
"18725","C2_Chemical_and_genetic_perturbations","C2_CGP_2937_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11",103,1.1446,0.16,0.83,"Yes",1.6824,0,0.093,"Yes"
"18726","REACTOME","1183613_REACT_355480_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX",28,1.1446,0.24,0.58,"Yes",1.8065,0,0.02,"Yes"
"18727","GO_BP","493268_GO_0009067_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS",22,1.1446,0.25,0.76,"Yes",0.7548,0.85,1,"Yes"
"18728","REACTOME","105884_REACT_2253_GLOBAL_GENOMIC_NER_GG_NER_",35,1.1447,0.23,0.58,"Yes",1.5081,0.032,0.14,"Yes"
"18729","GO_CC","490792_GO_0005759_MITOCHONDRIAL_MATRIX",340,1.1452,0.074,0.64,"Yes",1.7809,0,0.031,"Yes"
"18730","GO_BP","501693_GO_0032461_POSITIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION",20,1.1458,0.24,0.75,"Yes",1.2785,0.16,0.7,"Yes"
"18731","REACTOME","730317_REACT_150314_MITOTIC_METAPHASE_AND_ANAPHASE",174,1.1471,0.099,0.58,"Yes",2.0049,0,0.0021,"Yes"
"18732","GO_BP","492116_GO_0007351_TRIPARTITE_REGIONAL_SUBDIVISION",15,1.1472,0.27,0.75,"Yes",-0.7759,0.77,1,"No"
"18733","GO_MF","489990_GO_0004661_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY",6,1.1473,0.28,0.89,"Yes",1.0404,0.42,0.83,"Yes"
"18734","REACTOME","105897_REACT_383_DNA_REPLICATION",105,1.1476,0.18,0.58,"Yes",2.0336,0,0.0015,"Yes"
"18735","C7_Immunologic_signatures","C7_ALL_1674_GSE3982_NEUTROPHIL_VS_TH2_DN",197,1.1479,0.1,0.29,"Yes",1.4614,0.0022,0.02,"Yes"
"18736","GO_BP","487019_GO_0000722_TELOMERE_MAINTENANCE_VIA_RECOMBINATION",27,1.1482,0.25,0.75,"Yes",1.3245,0.11,0.64,"Yes"
"18737","GO_BP","495535_GO_0046931_PORE_COMPLEX_ASSEMBLY",13,1.1485,0.28,0.75,"Yes",1.4382,0.074,0.51,"Yes"
"18738","REACTOME","105792_REACT_1792_POLYMERASE_SWITCHING",14,1.1485,0.27,0.58,"Yes",1.3529,0.11,0.26,"Yes"
"18739","GO_BP","491402_GO_0018344_PROTEIN_GERANYLGERANYLATION",6,1.1486,0.28,0.75,"Yes",1.0449,0.41,0.95,"Yes"
"18740","GO_BP","503699_GO_0034497_PROTEIN_LOCALIZATION_TO_PRE_AUTOPHAGOSOMAL_STRUCTURE",9,1.1488,0.29,0.75,"Yes",0.635,0.91,1,"Yes"
"18741","C2_Chemical_and_genetic_perturbations","C2_CGP_1540_HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP",65,1.149,0.21,0.82,"Yes",1.236,0.14,0.45,"Yes"
"18742","REACTOME","105782_REACT_899_S_PHASE",124,1.1494,0.14,0.58,"Yes",2.0443,0,0.0014,"Yes"
"18743","GO_BP","502482_GO_0033262_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION",11,1.1503,0.31,0.75,"Yes",-0.7177,0.84,1,"No"
"18744","GO_CC","487584_GO_0001673_MALE_GERM_CELL_NUCLEUS",17,1.1507,0.26,0.63,"Yes",-1.0843,0.35,0.81,"No"
"18745","GO_CC","487075_GO_0000782_TELOMERE_CAP_COMPLEX",12,1.1507,0.28,0.63,"Yes",0.8807,0.62,0.91,"Yes"
"18746","C7_Immunologic_signatures","C7_ALL_269_GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP",196,1.151,0.11,0.29,"Yes",1.2623,0.051,0.14,"Yes"
"18747","GO_BP","495056_GO_0010991_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_COMPLEX_ASSEMBLY",5,1.1517,0.31,0.75,"Yes",-0.6588,0.87,1,"No"
"18748","GO_BP","513895_GO_0060339_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY",5,1.1518,0.29,0.75,"Yes",0.8595,0.63,1,"Yes"
"18749","GO_BP","491377_GO_0006475_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION",111,1.1519,0.17,0.75,"Yes",-0.5689,1,1,"No"
"18750","GO_CC","490716_GO_0005657_REPLICATION_FORK",62,1.1523,0.17,0.64,"Yes",1.184,0.17,0.55,"Yes"
"18751","GO_BP","499257_GO_0021978_TELENCEPHALON_REGIONALIZATION",12,1.1527,0.25,0.75,"Yes",0.9007,0.58,1,"Yes"
"18752","GO_MF","489237_GO_0003684_DAMAGED_DNA_BINDING",57,1.1528,0.22,0.88,"Yes",1.3945,0.031,0.48,"Yes"
"18753","KEGG_compound","C00039_DNA_DNAN_DNAN_1_DEOXYRIBONUCLEOTIDE_N_DEOXYRIBONUCLEOTIDE_M_DEOXYRIBONUCLEOTIDE_N_M_DEOXYRIBONUCLEIC_ACID",15,1.1529,0.27,1,"Yes",0.6973,0.89,1,"Yes"
"18754","GO_BP","494458_GO_0010388_CULLIN_DENEDDYLATION",9,1.1529,0.29,0.75,"Yes",1.6079,0.037,0.28,"Yes"
"18755","GO_BP","491271_GO_0006312_MITOTIC_RECOMBINATION",34,1.1532,0.21,0.75,"Yes",1.2618,0.14,0.72,"Yes"
"18756","C7_Immunologic_signatures","C7_ALL_790_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN",199,1.1533,0.077,0.28,"Yes",1.0982,0.23,0.45,"Yes"
"18757","C4_Cancer_gene_neighborhoods","C4_CGN_224_GCM_DENR",49,1.1537,0.2,0.47,"Yes",1.5426,0.015,0.023,"Yes"
"18758","GO_MF","492539_GO_0008198_FERROUS_IRON_BINDING",15,1.1539,0.24,0.88,"Yes",1.8621,0.002,0.044,"Yes"
"18759","GO_BP","509054_GO_0046831_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS",10,1.154,0.27,0.75,"Yes",0.9444,0.55,1,"Yes"
"18760","C4_Cancer_gene_neighborhoods","C4_CGN_81_MORF_CUL1",73,1.1544,0.17,0.48,"Yes",1.8341,0,0.0016,"Yes"
"18761","GO_BP","500415_GO_0031128_DEVELOPMENTAL_INDUCTION",30,1.1546,0.25,0.75,"Yes",-1.0312,0.41,0.98,"No"
"18762","C7_Immunologic_signatures","C7_ALL_949_GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP",198,1.1546,0.1,0.28,"Yes",0.9066,0.78,1,"Yes"
"18763","C7_Immunologic_signatures","C7_ALL_1803_GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP",199,1.1551,0.089,0.29,"Yes",1.3876,0.0076,0.042,"Yes"
"18764","C2_Chemical_and_genetic_perturbations","C2_CGP_3098_WAGSCHAL_EHMT2_TARGETS_UP",11,1.1558,0.26,0.81,"Yes",1.8525,0.0039,0.028,"Yes"
"18765","GO_BP","501696_GO_0032464_POSITIVE_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION",9,1.1558,0.28,0.75,"Yes",1.4169,0.089,0.53,"Yes"
"18766","GO_BP","510628_GO_0048563_POST_EMBRYONIC_ORGAN_MORPHOGENESIS",6,1.156,0.28,0.75,"Yes",1.0722,0.38,0.93,"Yes"
"18767","GO_BP","754040_GO_1901071_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",25,1.1562,0.24,0.75,"Yes",1.0582,0.36,0.94,"Yes"
"18768","GO_MF","490189_GO_0032395_MHC_CLASS_II_RECEPTOR_ACTIVITY",10,1.1564,0.28,0.88,"Yes",0.7357,0.79,1,"Yes"
"18769","WikiPathways","198803_WP107_TRANSLATION_FACTORS",55,1.1566,0.16,0.52,"Yes",2.3132,0,0,"Yes"
"18770","REACTOME","730318_REACT_150471_SEPARATION_OF_SISTER_CHROMATIDS",162,1.1569,0.14,0.57,"Yes",2.0404,0,0.0014,"Yes"
"18771","REACTOME","771582_REACT_160130_RETINOID_CYCLE_DISEASE_EVENTS",9,1.1571,0.25,0.57,"Yes",0.9217,0.53,0.87,"Yes"
"18772","C2_Chemical_and_genetic_perturbations","C2_CGP_2004_GHO_ATF5_TARGETS_UP",13,1.1572,0.24,0.81,"Yes",1.2403,0.18,0.45,"Yes"
"18773","C4_Cancer_gene_neighborhoods","C4_CGN_25_MORF_MSH2",61,1.1585,0.16,0.47,"Yes",1.7713,0.0044,0.003,"Yes"
"18774","GO_MF","494555_GO_0010485_H4_HISTONE_ACETYLTRANSFERASE_ACTIVITY",16,1.1585,0.25,0.88,"Yes",0.7247,0.81,1,"Yes"
"18775","C4_Cancer_gene_neighborhoods","C4_CGN_52_MORF_UNG",76,1.1586,0.18,0.48,"Yes",2.4278,0,0,"Yes"
"18776","C2_Chemical_and_genetic_perturbations","C2_CGP_1694_HEDENFALK_BREAST_CANCER_BRACX_DN",20,1.1587,0.23,0.81,"Yes",1.0489,0.37,0.72,"Yes"
"18777","GO_BP","510388_GO_0048280_VESICLE_FUSION_WITH_GOLGI_APPARATUS",9,1.1591,0.28,0.75,"Yes",1.2493,0.22,0.73,"Yes"
"18778","GO_BP","512314_GO_0051436_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_MITOTIC_CELL_CYCLE",67,1.1592,0.18,0.75,"Yes",2.2275,0,0.00047,"Yes"
"18779","C4_Cancer_gene_neighborhoods","C4_CGN_161_MORF_PTPRR",96,1.1594,0.16,0.48,"Yes",1.2443,0.099,0.17,"Yes"
"18780","REACTOME","161062_REACT_20647_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR",22,1.1599,0.23,0.57,"Yes",1.0316,0.4,0.69,"Yes"
"18781","C2_Chemical_and_genetic_perturbations","C2_CGP_2207_DAIRKEE_CANCER_PRONE_RESPONSE_BPA",51,1.1605,0.21,0.81,"Yes",1.5743,0.016,0.16,"Yes"
"18782","C4_Cancer_gene_neighborhoods","C4_CGN_84_MORF_DCC",105,1.1608,0.16,0.48,"Yes",-0.6743,0.99,1,"No"
"18783","C4_Cancer_gene_neighborhoods","C4_CGN_305_GNF2_MSH6",31,1.162,0.22,0.49,"Yes",1.6881,0.01,0.0071,"Yes"
"18784","C7_Immunologic_signatures","C7_ALL_1836_GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN",200,1.1622,0.078,0.27,"Yes",1.2912,0.032,0.11,"Yes"
"18785","GO_BP","512204_GO_0051320_S_PHASE",123,1.1624,0.14,0.74,"Yes",2.0146,0,0.01,"Yes"
"18786","GO_CC","516606_GO_0071682_ENDOCYTIC_VESICLE_LUMEN",17,1.1626,0.23,0.62,"Yes",1.6468,0.015,0.087,"Yes"
"18787","C7_Immunologic_signatures","C7_ALL_821_GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP",197,1.1627,0.076,0.27,"Yes",1.4657,0.0072,0.019,"Yes"
"18788","C2_Chemical_and_genetic_perturbations","C2_CGP_1221_NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON",143,1.1628,0.12,0.81,"Yes",1.0261,0.38,0.76,"Yes"
"18789","GO_BP","504994_GO_0035825_RECIPROCAL_DNA_RECOMBINATION",34,1.1632,0.22,0.74,"Yes",0.7731,0.84,1,"Yes"
"18790","GO_BP","519269_GO_2000630_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS",5,1.1634,0.31,0.74,"Yes",1.1917,0.28,0.79,"Yes"
"18791","GO_BP","489060_GO_0003266_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION",9,1.1635,0.26,0.74,"Yes",-1.3268,0.15,0.9,"No"
"18792","REACTOME","187108_REACT_23898_RAP1_SIGNALLING",16,1.1636,0.24,0.56,"Yes",1.3647,0.11,0.25,"Yes"
"18793","GO_CC","502489_GO_0033270_PARANODE_REGION_OF_AXON",12,1.1644,0.26,0.62,"Yes",-0.7574,0.81,1,"No"
"18794","GO_CC","487076_GO_0000783_NUCLEAR_TELOMERE_CAP_COMPLEX",12,1.1651,0.27,0.62,"Yes",0.8899,0.61,0.91,"Yes"
"18795","GO_MF","987849_GO_1990381_UBIQUITIN_SPECIFIC_PROTEASE_BINDING",7,1.1656,0.28,0.87,"Yes",0.9648,0.5,0.91,"Yes"
"18796","GO_MF","496701_GO_0016796_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS",44,1.1668,0.19,0.88,"Yes",1.4747,0.031,0.4,"Yes"
"18797","C4_Cancer_modules","C4_CM_415_MODULE_539",16,1.1669,0.25,0.76,"Yes",1.7387,0.013,0.037,"Yes"
"18798","GO_BP","497329_GO_0018394_PEPTIDYL_LYSINE_ACETYLATION",107,1.1669,0.16,0.73,"Yes",0.5876,1,1,"Yes"
"18799","GO_BP","515303_GO_0070371_ERK1_AND_ERK2_CASCADE",16,1.167,0.25,0.74,"Yes",0.8959,0.61,1,"Yes"
"18800","C7_Immunologic_signatures","C7_ALL_196_GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN",158,1.1674,0.091,0.26,"Yes",1.3395,0.02,0.07,"Yes"
"18801","C7_Immunologic_signatures","C7_ALL_827_GSE17974_1_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP",197,1.1676,0.082,0.26,"Yes",1.5379,0.0023,0.0074,"Yes"
"18802","GO_BP","491304_GO_0006370_7_METHYLGUANOSINE_MRNA_CAPPING",32,1.1677,0.23,0.74,"Yes",1.528,0.019,0.37,"Yes"
"18803","REACTOME","105791_REACT_1838_LEADING_STRAND_SYNTHESIS",14,1.1681,0.25,0.55,"Yes",1.3292,0.14,0.29,"Yes"
"18804","GO_BP","488950_GO_0003156_REGULATION_OF_ORGAN_FORMATION",28,1.1683,0.24,0.74,"Yes",0.8063,0.8,1,"Yes"
"18805","C2_Chemical_and_genetic_perturbations","C2_CGP_1153_SHEN_SMARCA2_TARGETS_UP",424,1.1694,0.022,0.8,"Yes",2.0811,0,0.0024,"Yes"
"18806","GO_MF","492775_GO_0008494_TRANSLATION_ACTIVATOR_ACTIVITY",7,1.1696,0.27,0.87,"Yes",0.7715,0.76,1,"Yes"
"18807","REACTOME","1183535_REACT_355497_INFECTIOUS_DISEASE",372,1.1702,0.057,0.55,"Yes",2.8058,0,0,"Yes"
"18808","REACTOME","1127595_REACT_267741_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2",12,1.1713,0.24,0.55,"Yes",1.501,0.048,0.14,"Yes"
"18809","C4_Cancer_modules","C4_CM_120_MODULE_125",44,1.1713,0.18,0.8,"Yes",1.7017,0.0045,0.045,"Yes"
"18810","GO_BP","518290_GO_0090150_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE",239,1.172,0.067,0.73,"Yes",3.1155,0,0,"Yes"
"18811","C7_Immunologic_signatures","C7_ALL_849_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP",199,1.172,0.097,0.25,"Yes",1.4992,0.0024,0.013,"Yes"
"18812","GO_BP","755120_GO_2001014_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION",15,1.1724,0.24,0.73,"Yes",0.5642,0.98,1,"Yes"
"18813","GO_BP","488896_GO_0003100_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN",5,1.1726,0.27,0.73,"Yes",-1.1712,0.31,0.91,"No"
"18814","GO_BP","497050_GO_0018065_PROTEIN_COFACTOR_LINKAGE",9,1.173,0.26,0.73,"Yes",1.2097,0.22,0.77,"Yes"
"18815","REACTOME","105890_REACT_1628_TRANSCRIPTION_COUPLED_NER_TC_NER_",46,1.1739,0.18,0.55,"Yes",1.5918,0.011,0.097,"Yes"
"18816","GO_MF","492989_GO_0008757_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY",116,1.1743,0.16,0.87,"Yes",-0.8223,0.88,1,"No"
"18817","GO_BP","497009_GO_0018023_PEPTIDYL_LYSINE_TRIMETHYLATION",20,1.1756,0.24,0.72,"Yes",0.5589,0.99,1,"Yes"
"18818","REACTOME","105837_REACT_216_DNA_REPAIR",144,1.1759,0.12,0.55,"Yes",1.5816,0,0.1,"Yes"
"18819","REACTOME","105821_REACT_2243_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX",67,1.1768,0.16,0.55,"Yes",2.1098,0,0.00051,"Yes"
"18820","GO_BP","492427_GO_0008053_MITOCHONDRIAL_FUSION",15,1.1769,0.25,0.72,"Yes",1.4797,0.06,0.44,"Yes"
"18821","C2_Chemical_and_genetic_perturbations","C2_CGP_3073_DEMAGALHAES_AGING_DN",15,1.1773,0.25,0.78,"Yes",1.6793,0.0084,0.094,"Yes"
"18822","C2_Chemical_and_genetic_perturbations","C2_CGP_3096_TSUTSUMI_FBXW8_TARGETS",8,1.1775,0.26,0.79,"Yes",0.9637,0.5,0.85,"Yes"
"18823","KEGG_pathway","HSA00563_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS",25,1.1781,0.2,0.29,"Yes",1.0418,0.39,0.84,"Yes"
"18824","GO_BP","510655_GO_0048596_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS",27,1.1781,0.21,0.72,"Yes",1.4827,0.039,0.44,"Yes"
"18825","GO_MF","500627_GO_0031369_TRANSLATION_INITIATION_FACTOR_BINDING",24,1.1785,0.23,0.86,"Yes",1.3252,0.12,0.57,"Yes"
"18826","GO_BP","495251_GO_0014857_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION",8,1.1788,0.24,0.72,"Yes",0.6068,0.94,1,"Yes"
"18827","GO_MF","489875_GO_0004527_EXONUCLEASE_ACTIVITY",72,1.179,0.17,0.87,"Yes",1.3444,0.051,0.53,"Yes"
"18828","GO_BP","513907_GO_0060351_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS",22,1.179,0.2,0.72,"Yes",-1.2385,0.16,0.91,"No"
"18829","C2_Chemical_and_genetic_perturbations","C2_CGP_2023_MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN",7,1.1791,0.24,0.79,"Yes",0.9627,0.49,0.85,"Yes"
"18830","GO_BP","495982_GO_0015858_NUCLEOSIDE_TRANSPORT",15,1.1794,0.23,0.72,"Yes",0.6918,0.89,1,"Yes"
"18831","REACTOME","106545_REACT_7987_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE",14,1.1795,0.23,0.54,"Yes",1.3601,0.099,0.26,"Yes"
"18832","C4_Cancer_gene_neighborhoods","C4_CGN_56_MORF_AATF",207,1.1796,0.096,0.44,"Yes",2.0524,0,0.00018,"Yes"
"18833","GO_BP","516493_GO_0071569_PROTEIN_UFMYLATION",6,1.1796,0.27,0.72,"Yes",1.4031,0.09,0.55,"Yes"
"18834","C4_Cancer_gene_neighborhoods","C4_CGN_187_MORF_TTN",48,1.1799,0.16,0.45,"Yes",1.4048,0.046,0.06,"Yes"
"18835","GO_BP","487679_GO_0001783_B_CELL_APOPTOTIC_PROCESS",6,1.181,0.25,0.72,"Yes",1.3124,0.16,0.66,"Yes"
"18836","GO_BP","486728_GO_0000209_PROTEIN_POLYUBIQUITINATION",191,1.1817,0.053,0.72,"Yes",1.8999,0,0.039,"Yes"
"18837","GO_BP","493487_GO_0009303_RRNA_TRANSCRIPTION",20,1.1829,0.21,0.72,"Yes",1.4432,0.054,0.5,"Yes"
"18838","C1_Positional","C1_ALL_191_CHR16P",5,1.183,0.27,0.64,"Yes",1.4111,0.093,0.36,"Yes"
"18839","GO_MF","498528_GO_0019706_PROTEIN_CYSTEINE_S_PALMITOYLTRANSFERASE_ACTIVITY",25,1.183,0.23,0.87,"Yes",-0.8386,0.71,1,"No"
"18840","GO_BP","499215_GO_0021936_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION",9,1.1831,0.24,0.72,"Yes",1.3299,0.14,0.63,"Yes"
"18841","REACTOME","106187_REACT_1298_LYSINE_CATABOLISM",8,1.1843,0.26,0.54,"Yes",-1.007,0.44,0.98,"No"
"18842","C4_Cancer_gene_neighborhoods","C4_CGN_400_GNF2_RAN",86,1.1845,0.13,0.44,"Yes",2.4979,0,0,"Yes"
"18843","GO_BP","498715_GO_0045116_PROTEIN_NEDDYLATION",8,1.1854,0.25,0.72,"Yes",1.5905,0.024,0.3,"Yes"
"18844","C7_Immunologic_signatures","C7_ALL_991_GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP",200,1.1854,0.05,0.22,"Yes",1.8781,0,0,"Yes"
"18845","GO_BP","505850_GO_0042744_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS",21,1.1859,0.23,0.72,"Yes",1.3957,0.081,0.56,"Yes"
"18846","KEGG_module","HSA_M00055_N_GLYCAN_PRECURSOR_BIOSYNTHESIS",14,1.1863,0.24,0.51,"Yes",1.3591,0.13,0.33,"Yes"
"18847","C2_Chemical_and_genetic_perturbations","C2_CGP_1199_NIKOLSKY_BREAST_CANCER_7P22_AMPLICON",37,1.1866,0.19,0.77,"Yes",0.8295,0.74,0.98,"Yes"
"18848","GO_BP","501463_GO_0032228_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC",32,1.1866,0.22,0.72,"Yes",-1.0921,0.33,0.95,"No"
"18849","GO_BP","514481_GO_0060926_CARDIAC_PACEMAKER_CELL_DEVELOPMENT",5,1.1869,0.26,0.72,"Yes",-0.8489,0.66,1,"No"
"18850","REACTOME","187195_REACT_25387_LIGAND_GATED_ION_CHANNEL_TRANSPORT",24,1.1873,0.21,0.53,"Yes",-1.1386,0.28,0.89,"No"
"18851","KEGG_module","HSA_M00090_PHOSPHATIDYLCHOLINE_PC_BIOSYNTHESIS_CHOLINE_PC",6,1.1877,0.25,0.53,"Yes",0.7917,0.72,0.94,"Yes"
"18852","GO_MF","503270_GO_0034062_RNA_POLYMERASE_ACTIVITY",44,1.1877,0.19,0.86,"Yes",0.8934,0.66,0.99,"Yes"
"18853","GO_BP","512079_GO_0051169_NUCLEAR_TRANSPORT",235,1.189,0.055,0.71,"Yes",1.0913,0.19,0.91,"Yes"
"18854","GO_BP","501292_GO_0032055_NEGATIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS",7,1.1892,0.27,0.71,"Yes",-0.7451,0.77,1,"No"
"18855","C7_Immunologic_signatures","C7_ALL_31_GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP",199,1.1893,0.073,0.21,"Yes",1.2217,0.067,0.19,"Yes"
"18856","KEGG_compound","C00101_TETRAHYDROFOLATE_5_6_7_8_TETRAHYDROFOLATE_TETRAHYDROFOLIC_ACID_THF_6S_TETRAHYDROFOLATE_6S_TETRAHYDROFOLIC_ACID_6S_THFA",20,1.1894,0.2,1,"Yes",0.8717,0.64,1,"Yes"
"18857","GO_BP","755122_GO_2001016_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION",5,1.1894,0.26,0.72,"Yes",-0.9413,0.54,1,"No"
"18858","C1_Positional","C1_ALL_303_CHR7Q32",50,1.1895,0.2,0.64,"Yes",0.8228,0.79,0.93,"Yes"
"18859","REACTOME","1183615_REACT_355324_TRANSLESION_SYNTHESIS_BY_POLI",17,1.1907,0.2,0.53,"Yes",1.8265,0.0021,0.017,"Yes"
"18860","GO_CC","497896_GO_0019013_VIRAL_NUCLEOCAPSID",5,1.1912,0.28,0.57,"Yes",1.0221,0.45,0.75,"Yes"
"18861","GO_BP","511997_GO_0051081_NUCLEAR_ENVELOPE_DISASSEMBLY",44,1.1915,0.2,0.71,"Yes",1.2393,0.13,0.75,"Yes"
"18862","GO_BP","511719_GO_0050748_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS",6,1.1917,0.25,0.71,"Yes",0.888,0.57,1,"Yes"
"18863","C7_Immunologic_signatures","C7_ALL_1666_GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN",195,1.1919,0.052,0.21,"Yes",1.4784,0.0049,0.016,"Yes"
"18864","C4_Cancer_gene_neighborhoods","C4_CGN_33_MORF_PRKDC",191,1.1919,0.088,0.43,"Yes",1.9893,0,0.00035,"Yes"
"18865","GO_MF","496965_GO_0017176_PHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY",5,1.1923,0.28,0.86,"Yes",1.3134,0.17,0.59,"Yes"
"18866","GO_BP","491246_GO_0006283_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR",49,1.1924,0.18,0.71,"Yes",1.584,0.01,0.31,"Yes"
"18867","REACTOME","106200_REACT_212_GLUCOSE_TRANSPORT",40,1.1928,0.19,0.53,"Yes",0.8686,0.69,0.94,"Yes"
"18868","GO_BP","487586_GO_0001675_ACROSOME_ASSEMBLY",12,1.1929,0.25,0.71,"Yes",0.8809,0.62,1,"Yes"
"18869","GO_CC","490830_GO_0005801_CIS_GOLGI_NETWORK",36,1.1939,0.2,0.56,"Yes",0.9742,0.49,0.82,"Yes"
"18870","C2_Chemical_and_genetic_perturbations","C2_CGP_3297_LIU_IL13_MEMORY_MODEL_DN",5,1.1939,0.3,0.76,"Yes",1.1814,0.29,0.51,"Yes"
"18871","C2_Chemical_and_genetic_perturbations","C2_CGP_1856_SONG_TARGETS_OF_IE86_CMV_PROTEIN",60,1.194,0.16,0.76,"Yes",1.4143,0.032,0.28,"Yes"
"18872","GO_BP","505014_GO_0035845_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION",6,1.1942,0.23,0.71,"Yes",0.7381,0.8,1,"Yes"
"18873","GO_MF","492449_GO_0008080_N_ACETYLTRANSFERASE_ACTIVITY",82,1.1947,0.15,0.86,"Yes",0.7329,0.96,1,"Yes"
"18874","REACTOME","1183560_REACT_355194_SHC_MEDIATED_CASCADE_FGFR1",16,1.1948,0.22,0.53,"Yes",0.7437,0.82,1,"Yes"
"18875","GO_BP","491944_GO_0007131_RECIPROCAL_MEIOTIC_RECOMBINATION",34,1.1956,0.15,0.71,"Yes",0.7487,0.86,1,"Yes"
"18876","REACTOME","1183525_REACT_355283_SIGNALING_BY_FGFR4_IN_DISEASE",22,1.1957,0.18,0.53,"Yes",-1.0057,0.43,0.98,"No"
"18877","GO_MF","515206_GO_0070273_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING",16,1.1959,0.23,0.86,"Yes",-0.5511,0.97,1,"No"
"18878","C4_Cancer_gene_neighborhoods","C4_CGN_168_MORF_RAF1",112,1.196,0.11,0.43,"Yes",1.8092,0,0.002,"Yes"
"18879","GO_BP","515662_GO_0070734_HISTONE_H3_K27_METHYLATION",6,1.1963,0.27,0.71,"Yes",-1.0688,0.38,0.96,"No"
"18880","C1_Positional","C1_ALL_301_CHR3Q11",13,1.1963,0.22,0.65,"Yes",0.6261,0.93,1,"Yes"
"18881","KEGG_pathway","HSA03420_NUCLEOTIDE_EXCISION_REPAIR",46,1.197,0.17,0.27,"Yes",1.4991,0.026,0.1,"Yes"
"18882","C2_Chemical_and_genetic_perturbations","C2_CGP_2920_MIKKELSEN_NPC_ICP_WITH_H3K27ME3",12,1.1981,0.23,0.76,"Yes",0.9357,0.56,0.88,"Yes"
"18883","GO_BP","515065_GO_0070127_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION",5,1.1983,0.3,0.71,"Yes",-1.2171,0.26,0.88,"No"
"18884","GO_BP","507965_GO_0045617_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION",7,1.1989,0.23,0.71,"Yes",-1.4924,0.062,0.82,"No"
"18885","C2_Chemical_and_genetic_perturbations","C2_CGP_2648_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN",25,1.199,0.19,0.77,"Yes",0.9908,0.46,0.81,"Yes"
"18886","C4_Cancer_gene_neighborhoods","C4_CGN_378_GNF2_MCM5",61,1.1994,0.14,0.42,"Yes",1.603,0.0086,0.014,"Yes"
"18887","GO_CC","516130_GO_0071204_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX",6,1.1997,0.24,0.56,"Yes",1.4485,0.073,0.25,"Yes"
"18888","C7_Immunologic_signatures","C7_ALL_1567_GSE3982_CTRL_VS_LPS_4H_MAC_UP",197,1.1999,0.048,0.19,"Yes",1.4109,0.0094,0.034,"Yes"
"18889","REACTOME","730343_REACT_150353_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS",9,1.2001,0.25,0.52,"Yes",0.8948,0.6,0.91,"Yes"
"18890","KEGG_reaction","R00443_UTP_RNA_URIDYLYLTRANSFERASE_UTP_RNA_DIPHOSPHATE_RNA",31,1.2004,0.19,1,"Yes",0.8239,0.75,1,"Yes"
"18891","GO_CC","486938_GO_0000445_THO_COMPLEX_PART_OF_TRANSCRIPTION_EXPORT_COMPLEX",6,1.2013,0.27,0.56,"Yes",1.1873,0.27,0.55,"Yes"
"18892","GO_BP","514466_GO_0060911_CARDIAC_CELL_FATE_COMMITMENT",11,1.2013,0.23,0.7,"Yes",-0.8082,0.7,1,"No"
"18893","C2_Chemical_and_genetic_perturbations","C2_CGP_2564_VANTVEER_BREAST_CANCER_BRCA1_UP",35,1.2025,0.17,0.76,"Yes",0.9113,0.65,0.91,"Yes"
"18894","GO_BP","493287_GO_0009086_METHIONINE_BIOSYNTHETIC_PROCESS",16,1.2032,0.2,0.7,"Yes",-0.6191,0.94,1,"No"
"18895","GO_MF","515344_GO_0070412_R_SMAD_BINDING",22,1.2032,0.2,0.85,"Yes",-0.8832,0.66,1,"No"
"18896","GO_BP","515970_GO_0071044_HISTONE_MRNA_CATABOLIC_PROCESS",14,1.2036,0.21,0.7,"Yes",1.1324,0.29,0.86,"Yes"
"18897","REACTOME","105883_REACT_1826_NUCLEOTIDE_EXCISION_REPAIR",51,1.2037,0.14,0.51,"Yes",1.6464,0.0084,0.071,"Yes"
"18898","C4_Cancer_gene_neighborhoods","C4_CGN_147_MORF_PPP2CA",129,1.2039,0.069,0.42,"Yes",2.2595,0,0,"Yes"
"18899","GO_BP","486630_GO_0000090_MITOTIC_ANAPHASE",162,1.2039,0.056,0.7,"Yes",2.0174,0,0.0099,"Yes"
"18900","GO_BP","515515_GO_0070585_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",65,1.2041,0.13,0.7,"Yes",1.8108,0,0.091,"Yes"
"18901","KEGG_module","HSA_M00037_MELATONIN_BIOSYNTHESIS_TRYPTOPHAN_SEROTONIN_MELATONIN",5,1.2046,0.29,0.52,"Yes",-0.8999,0.58,1,"No"
"18902","GO_MF","492618_GO_0008297_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY",5,1.2054,0.25,0.85,"Yes",0.8373,0.67,1,"Yes"
"18903","C2_Chemical_and_genetic_perturbations","C2_CGP_184_SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP",81,1.2054,0.11,0.76,"Yes",1.2711,0.088,0.42,"Yes"
"18904","GO_BP","754594_GO_1901642_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT",11,1.2064,0.21,0.7,"Yes",-0.7565,0.79,1,"No"
"18905","KEGG_pathway","HSA03020_RNA_POLYMERASE",31,1.2076,0.17,0.27,"Yes",0.8258,0.76,1,"Yes"
"18906","GO_CC","486994_GO_0000502_PROTEASOME_COMPLEX",66,1.2079,0.15,0.55,"Yes",2.109,0,0.00056,"Yes"
"18907","GO_MF","490350_GO_0051018_PROTEIN_KINASE_A_BINDING",36,1.2087,0.18,0.85,"Yes",0.9026,0.64,0.98,"Yes"
"18908","GO_BP","507550_GO_0045168_CELL_CELL_SIGNALING_INVOLVED_IN_CELL_FATE_COMMITMENT",32,1.209,0.17,0.69,"Yes",-0.9842,0.48,1,"No"
"18909","C2_Chemical_and_genetic_perturbations","C2_CGP_2491_SPIRA_SMOKERS_LUNG_CANCER_DN",22,1.2093,0.18,0.76,"Yes",1.1093,0.29,0.62,"Yes"
"18910","GO_BP","507651_GO_0045292_MRNA_CIS_SPLICING_VIA_SPLICEOSOME",12,1.2096,0.22,0.69,"Yes",-0.8084,0.71,1,"No"
"18911","GO_BP","499784_GO_0030397_MEMBRANE_DISASSEMBLY",44,1.21,0.15,0.69,"Yes",1.2326,0.14,0.75,"Yes"
"18912","KEGG_reaction","R00441_GTP_RNA_GUANYLYLTRANSFERASE_DNA_DIRECTED_GTP_RNA_GUANYLYLTRANSFERASE_RNA_DIRECTED_GTP_RNA_DIPHOSPHATE_RNA",31,1.2102,0.15,1,"Yes",0.8295,0.72,1,"Yes"
"18913","GO_BP","500412_GO_0031125_RRNA_3_END_PROCESSING",6,1.2104,0.27,0.69,"Yes",1.4375,0.077,0.51,"Yes"
"18914","GO_BP","489058_GO_0003264_REGULATION_OF_CARDIOBLAST_PROLIFERATION",9,1.2105,0.24,0.69,"Yes",-1.3339,0.14,0.92,"No"
"18915","C4_Cancer_modules","C4_CM_150_MODULE_158",43,1.2109,0.14,0.72,"Yes",1.6485,0.0066,0.061,"Yes"
"18916","GO_BP","518445_GO_0090305_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS",210,1.2116,0.039,0.69,"Yes",1.3943,0.0073,0.56,"Yes"
"18917","GO_BP","487812_GO_0001921_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING",10,1.2116,0.23,0.7,"Yes",1.3307,0.15,0.63,"Yes"
"18918","C7_Immunologic_signatures","C7_ALL_240_GSE14000_4H_VS_16H_LPS_DC_DN",199,1.2118,0.048,0.17,"Yes",1.2226,0.062,0.19,"Yes"
"18919","C2_Chemical_and_genetic_perturbations","C2_CGP_2739_YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP",53,1.212,0.15,0.76,"Yes",2.7196,0,0,"Yes"
"18920","OMIM_gene","OMIM611258_TUDOR_DOMAIN_CONTAINING_PROTEIN_7_TDRD7",6,1.2129,0.26,1,"Yes",1.1271,0.33,1,"Yes"
"18921","GO_MF","489390_GO_0003899_DNA_DIRECTED_RNA_POLYMERASE_ACTIVITY",43,1.2129,0.12,0.85,"Yes",0.8649,0.72,1,"Yes"
"18922","REACTOME","161063_REACT_21384_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS_",31,1.2133,0.15,0.5,"Yes",1.0375,0.38,0.69,"Yes"
"18923","GO_BP","497122_GO_0018149_PEPTIDE_CROSS_LINKING",27,1.2137,0.19,0.69,"Yes",-1.0767,0.34,0.95,"No"
"18924","REACTOME","106238_REACT_952_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_",16,1.2139,0.22,0.5,"Yes",1.1325,0.28,0.54,"Yes"
"18925","C0_Hallmark","H_ALL_28_HALLMARK_MYC_TARGETS_V1",200,1.2142,0.046,0.14,"Yes",2.6757,0,0,"Yes"
"18926","KEGG_reaction","R00442_CTP_RNA_CYTIDYLYLTRANSFERASE_DNA_DIRECTED_CTP_RNA_CYTIDYLYLTRANSFERASE_RNA_DIRECTED_CTP_RNA_DIPHOSPHATE_RNA",31,1.2149,0.16,1,"Yes",0.8245,0.75,1,"Yes"
"18927","C7_Immunologic_signatures","C7_ALL_938_GSE22886_TCELL_VS_BCELL_NAIVE_DN",193,1.2151,0.039,0.17,"Yes",0.6511,1,1,"Yes"
"18928","GO_BP","515951_GO_0071025_RNA_SURVEILLANCE",9,1.2153,0.22,0.69,"Yes",1.2246,0.23,0.76,"Yes"
"18929","GO_BP","499263_GO_0021984_ADENOHYPOPHYSIS_DEVELOPMENT",14,1.2153,0.21,0.69,"Yes",0.832,0.71,1,"Yes"
"18930","C4_Cancer_gene_neighborhoods","C4_CGN_412_GNF2_SPTA1",80,1.2154,0.094,0.4,"Yes",2.0123,0,0.00027,"Yes"
"18931","GO_BP","501465_GO_0032230_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC",13,1.2156,0.21,0.69,"Yes",-1.386,0.12,0.99,"No"
"18932","KEGG_reaction","R00435_ATP_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ATP_RNA_ADENYLYLTRANSFERASE_ATP_RNA_DIPHOSPHATE_RNA",31,1.2159,0.15,1,"Yes",0.8074,0.76,1,"Yes"
"18933","REACTOME","1183567_REACT_355225_SHC_MEDIATED_CASCADE_FGFR2",20,1.2162,0.18,0.5,"Yes",-0.8197,0.76,1,"No"
"18934","REACTOME","105870_REACT_1763_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE",7,1.2163,0.23,0.5,"Yes",1.2254,0.22,0.42,"Yes"
"18935","C2_Chemical_and_genetic_perturbations","C2_CGP_2204_POS_RESPONSE_TO_HISTAMINE_DN",11,1.2165,0.2,0.75,"Yes",0.6796,0.88,1,"Yes"
"18936","GO_BP","491252_GO_0006289_NUCLEOTIDE_EXCISION_REPAIR",82,1.2168,0.091,0.69,"Yes",1.6278,0,0.26,"Yes"
"18937","GO_BP","517934_GO_0080009_MRNA_METHYLATION",5,1.2168,0.27,0.69,"Yes",1.083,0.37,0.92,"Yes"
"18938","GO_BP","754380_GO_1901419_REGULATION_OF_RESPONSE_TO_ALCOHOL",8,1.2182,0.21,0.69,"Yes",1.0853,0.33,0.92,"Yes"
"18939","REACTOME","1183526_REACT_355202_SIGNALING_BY_FGFR4_MUTANTS",22,1.2185,0.15,0.5,"Yes",-0.9953,0.46,0.99,"No"
"18940","GO_BP","507001_GO_0043983_HISTONE_H4_K12_ACETYLATION",8,1.2185,0.23,0.69,"Yes",-0.7494,0.79,1,"No"
"18941","REACTOME","1183522_REACT_355511_SIGNALING_BY_FGFR2_MUTANTS",21,1.2185,0.19,0.5,"Yes",-0.8956,0.62,1,"No"
"18942","C4_Cancer_gene_neighborhoods","C4_CGN_31_MORF_PSMC2",117,1.2186,0.074,0.4,"Yes",2.3823,0,0,"Yes"
"18943","GO_CC","487070_GO_0000777_CONDENSED_CHROMOSOME_KINETOCHORE",93,1.2191,0.093,0.53,"Yes",1.5048,0.0048,0.19,"Yes"
"18944","C7_Immunologic_signatures","C7_ALL_1815_GSE7852_LN_VS_FAT_TREG_UP",200,1.2196,0.024,0.16,"Yes",1.367,0.0091,0.052,"Yes"
"18945","GO_BP","513962_GO_0060406_POSITIVE_REGULATION_OF_PENILE_ERECTION",5,1.2197,0.26,0.69,"Yes",1.5065,0.054,0.4,"Yes"
"18946","REACTOME","645349_REACT_121189_ABACAVIR_TRANSPORT_AND_METABOLISM",10,1.22,0.21,0.5,"Yes",-0.7772,0.76,1,"No"
"18947","GO_BP","491261_GO_0006302_DOUBLE_STRAND_BREAK_REPAIR",129,1.2203,0.079,0.69,"Yes",1.0958,0.25,0.91,"Yes"
"18948","GO_BP","513681_GO_0060123_REGULATION_OF_GROWTH_HORMONE_SECRETION",10,1.2205,0.22,0.69,"Yes",0.9764,0.48,1,"Yes"
"18949","REACTOME","105824_REACT_1949_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX",58,1.2206,0.13,0.5,"Yes",2.1078,0,0.00049,"Yes"
"18950","C7_Immunologic_signatures","C7_ALL_774_GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN",200,1.2206,0.034,0.16,"Yes",1.5982,0,0.0032,"Yes"
"18951","C4_Cancer_gene_neighborhoods","C4_CGN_5_MORF_BAG5",57,1.2208,0.13,0.4,"Yes",2.495,0,0,"Yes"
"18952","GO_CC","500370_GO_0031083_BLOC_1_COMPLEX",14,1.2217,0.19,0.53,"Yes",1.4489,0.067,0.25,"Yes"
"18953","KEGG_module","HSA_M00397_LSM_1_7_COMPLEX",7,1.2221,0.23,0.51,"Yes",1.5301,0.054,0.16,"Yes"
"18954","GO_BP","512759_GO_0051905_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION",25,1.2225,0.18,0.69,"Yes",1.1374,0.28,0.85,"Yes"
"18955","C2_Chemical_and_genetic_perturbations","C2_CGP_953_SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER",24,1.2228,0.19,0.74,"Yes",1.4494,0.054,0.26,"Yes"
"18956","REACTOME","1127594_REACT_267942_DEFECTIVE_EXT1_CAUSES_EXOSTOSES_1_TRPS2_AND_CHDS",12,1.223,0.2,0.5,"Yes",1.5072,0.062,0.14,"Yes"
"18957","GO_BP","495836_GO_0015701_BICARBONATE_TRANSPORT",33,1.2236,0.17,0.69,"Yes",1.2056,0.19,0.78,"Yes"
"18958","REACTOME","576277_REACT_118560_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS",9,1.2237,0.21,0.5,"Yes",0.6761,0.88,1,"Yes"
"18959","GO_BP","512206_GO_0051322_ANAPHASE",162,1.2238,0.065,0.69,"Yes",2.0393,0,0.0079,"Yes"
"18960","REACTOME","106080_REACT_6296_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS",31,1.2243,0.16,0.5,"Yes",0.9693,0.51,0.8,"Yes"
"18961","GO_MF","498529_GO_0019707_PROTEIN_CYSTEINE_S_ACYLTRANSFERASE_ACTIVITY",25,1.2244,0.15,0.82,"Yes",-0.8485,0.65,1,"No"
"18962","GO_BP","486592_GO_0000042_PROTEIN_TARGETING_TO_GOLGI",18,1.225,0.19,0.69,"Yes",0.6204,0.94,1,"Yes"
"18963","GO_BP","491029_GO_0006044_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS",16,1.2252,0.2,0.69,"Yes",0.57,0.98,1,"Yes"
"18964","C1_Positional","C1_ALL_297_CHR3Q21",108,1.2254,0.089,0.58,"Yes",1.0654,0.31,0.66,"Yes"
"18965","GO_CC","486863_GO_0000347_THO_COMPLEX",6,1.2255,0.23,0.52,"Yes",1.1873,0.26,0.55,"Yes"
"18966","C7_Immunologic_signatures","C7_ALL_655_GSE17721_LPS_VS_CPG_1H_BMDM_UP",198,1.2258,0.025,0.15,"Yes",1.8075,0,2.9e-05,"Yes"
"18967","GO_BP","515107_GO_0070170_REGULATION_OF_TOOTH_MINERALIZATION",7,1.2268,0.23,0.69,"Yes",0.7453,0.81,1,"Yes"
"18968","REACTOME","105944_REACT_2089_RNA_POLYMERASE_II_PROMOTER_ESCAPE",45,1.228,0.19,0.5,"Yes",1.601,0.0087,0.092,"Yes"
"18969","REACTOME","105685_REACT_13648_REGULATION_OF_APOPTOSIS",50,1.2281,0.13,0.5,"Yes",2.2483,0,6.2e-05,"Yes"
"18970","GO_BP","487461_GO_0001522_PSEUDOURIDINE_SYNTHESIS",17,1.2286,0.2,0.68,"Yes",1.2596,0.17,0.72,"Yes"
"18971","C4_Cancer_gene_neighborhoods","C4_CGN_189_MORF_UBE2I",239,1.2287,0.019,0.38,"Yes",2.9221,0,0,"Yes"
"18972","C2_Chemical_and_genetic_perturbations","C2_CGP_2301_ZHANG_BREAST_CANCER_PROGENITORS_UP",425,1.2288,0.02,0.73,"Yes",1.7314,0,0.067,"Yes"
"18973","GO_CC","499989_GO_0030687_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR",5,1.2294,0.26,0.52,"Yes",1.0446,0.42,0.72,"Yes"
"18974","C4_Cancer_gene_neighborhoods","C4_CGN_273_GCM_USP6",70,1.2305,0.12,0.39,"Yes",-0.7888,0.88,1,"No"
"18975","GO_BP","494810_GO_0010745_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION",13,1.2308,0.22,0.68,"Yes",1.451,0.078,0.49,"Yes"
"18976","C2_BioCarta_Pathways","C2_CP_BIOCARTA_193_BIOCARTA_TALL1_PATHWAY",15,1.231,0.21,1,"Yes",-1.3045,0.16,1,"No"
"18977","REACTOME","105854_REACT_8_TRANSLESION_SYNTHESIS_BY_REV1",16,1.2314,0.21,0.5,"Yes",1.8164,0.0086,0.018,"Yes"
"18978","C2_Chemical_and_genetic_perturbations","C2_CGP_466_OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN",11,1.2318,0.22,0.73,"Yes",1.2187,0.21,0.47,"Yes"
"18979","C4_Cancer_gene_neighborhoods","C4_CGN_236_GCM_ING1",66,1.2321,0.097,0.39,"Yes",-0.7095,0.95,1,"No"
"18980","GO_MF","506114_GO_0043024_RIBOSOMAL_SMALL_SUBUNIT_BINDING",10,1.2325,0.17,0.81,"Yes",0.826,0.7,1,"Yes"
"18981","GO_BP","496504_GO_0016553_BASE_CONVERSION_OR_SUBSTITUTION_EDITING",7,1.2326,0.21,0.68,"Yes",0.5069,0.98,1,"Yes"
"18982","C3_TF_targets","C3_TFT_15_V_ELK1_02",249,1.2328,0.011,0.22,"Yes",1.7057,0,0.035,"Yes"
"18983","C2_Chemical_and_genetic_perturbations","C2_CGP_1517_HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY",24,1.2328,0.15,0.74,"Yes",1.0868,0.31,0.65,"Yes"
"18984","REACTOME","771581_REACT_160102_DISEASES_ASSOCIATED_WITH_VISUAL_TRANSDUCTION",9,1.233,0.2,0.5,"Yes",0.8917,0.6,0.91,"Yes"
"18985","GO_BP","512340_GO_0051462_REGULATION_OF_CORTISOL_SECRETION",5,1.2331,0.23,0.68,"Yes",1.3912,0.11,0.57,"Yes"
"18986","KEGG_module","HSA_M00414_BLOOM_S_SYNDROME_COMPLEX",5,1.2332,0.26,0.51,"Yes",1.3459,0.14,0.34,"Yes"
"18987","REACTOME","1183614_REACT_355158_TRANSLESION_SYNTHESIS_BY_POLK",17,1.2332,0.19,0.5,"Yes",1.806,0.0021,0.02,"Yes"
"18988","GO_BP","496521_GO_0016573_HISTONE_ACETYLATION",100,1.2334,0.082,0.68,"Yes",0.6588,1,1,"Yes"
"18989","C2_Chemical_and_genetic_perturbations","C2_CGP_686_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30",5,1.2335,0.25,0.74,"Yes",1.1074,0.38,0.62,"Yes"
"18990","C2_Chemical_and_genetic_perturbations","C2_CGP_188_OSMAN_BLADDER_CANCER_DN",397,1.2345,0,0.75,"Yes",2.2289,0,0.00038,"Yes"
"18991","GO_BP","501494_GO_0032259_METHYLATION",296,1.2357,0.014,0.67,"Yes",-0.8729,0.86,1,"No"
"18992","C7_Immunologic_signatures","C7_ALL_36_GSE10239_MEMORY_VS_DAY4_5_EFF_CD8_TCELL_DN",199,1.236,0.041,0.14,"Yes",1.9318,0,0,"Yes"
"18993","GO_BP","508947_GO_0046719_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL",11,1.2364,0.24,0.67,"Yes",1.5717,0.048,0.33,"Yes"
"18994","REACTOME","105943_REACT_1851_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION",45,1.2368,0.12,0.49,"Yes",1.6122,0.011,0.088,"Yes"
"18995","REACTOME","1127494_REACT_264135_ORGANELLE_BIOGENESIS_AND_MAINTENANCE",320,1.237,0.029,0.5,"Yes",1.5215,0,0.14,"Yes"
"18996","C1_Positional","C1_ALL_7_CHR13Q13",28,1.2377,0.18,0.57,"Yes",1.147,0.24,0.63,"Yes"
"18997","C2_Chemical_and_genetic_perturbations","C2_CGP_1077_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN",8,1.2378,0.2,0.75,"Yes",0.8121,0.7,0.98,"Yes"
"18998","GO_BP","508512_GO_0046219_INDOLALKYLAMINE_BIOSYNTHETIC_PROCESS",5,1.2386,0.26,0.67,"Yes",-0.8934,0.58,1,"No"
"18999","GO_MF","499483_GO_0030020_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH",6,1.2389,0.25,0.79,"Yes",-1.537,0.058,0.54,"No"
"19000","C7_Immunologic_signatures","C7_ALL_1208_GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN",193,1.239,0.055,0.13,"Yes",1.4242,0.0047,0.031,"Yes"
"19001","REACTOME","105942_REACT_834_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION_AND_PROMOTER_CLEARANCE",45,1.2391,0.097,0.5,"Yes",1.603,0.0043,0.092,"Yes"
"19002","GO_MF","505328_GO_0042166_ACETYLCHOLINE_BINDING",12,1.2391,0.2,0.8,"Yes",-1.8351,0,0.12,"No"
"19003","GO_BP","516301_GO_0071377_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS",37,1.2397,0.14,0.67,"Yes",1.1123,0.27,0.89,"Yes"
"19004","KEGG_enzyme","2.7.7.6_DNA_DIRECTED_RNA_POLYMERASE_RNA_POLYMERASE_RNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_RNA_POLYMERASE_I_RNA_POLYMERASE_II_RNA_POLYMERASE_III_C_RNA_FORMATION_FACTORS_DEOXYRIBONUCLEIC_ACID_DEPENDENT_RIBONUCLEIC_ACID_POLYMERASE_DNA_DEPENDENT_RIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_DNA_DEPENDENT_RNA_NUCLEOTIDYLTRANSFERASE_DNA_DEPENDENT_RNA_POLYMERASE_RIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_RIBONUCLEATE_POLYMERASE_C_RIBONUCLEIC_ACID_FORMATION_FACTORS_RIBONUCLEIC_ACID_NUCLEOTIDYLTRANSFERASE_RIBONUCLEIC_ACID_POLYMERASE_RIBONUCLEIC_ACID_TRANSCRIPTASE_RIBONUCLEIC_POLYMERASE_RIBONUCLEIC_TRANSCRIPTASE_RNA_NUCLEOTIDYLTRANSFERASE_RNA_TRANSCRIPTASE_TRANSCRIPTASE_RNA_NUCLEOTIDYLTRANSFERASE_I",7,1.2398,0.23,0.55,"Yes",-0.8921,0.6,0.85,"No"
"19005","C1_Positional","C1_ALL_59_CHR14Q21",40,1.2402,0.13,0.59,"Yes",1.2268,0.16,0.59,"Yes"
"19006","GO_BP","508217_GO_0045910_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION",15,1.2404,0.18,0.67,"Yes",-0.7088,0.86,1,"No"
"19007","GO_BP","515010_GO_0070071_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY",9,1.2404,0.19,0.67,"Yes",0.5893,0.95,1,"Yes"
"19008","REACTOME","106543_REACT_7961_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS",23,1.2406,0.18,0.5,"Yes",1.4696,0.038,0.17,"Yes"
"19009","WikiPathways","198917_WP405_EUKARYOTIC_TRANSCRIPTION_INITIATION",41,1.2414,0.13,0.41,"Yes",1.2452,0.13,0.81,"Yes"
"19010","REACTOME","105941_REACT_1655_RNA_POLYMERASE_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING",45,1.242,0.14,0.5,"Yes",1.6113,0.01,0.088,"Yes"
"19011","C2_Chemical_and_genetic_perturbations","C2_CGP_210_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN",11,1.2422,0.2,0.75,"Yes",1.3734,0.1,0.32,"Yes"
"19012","GO_CC","490686_GO_0005614_INTERSTITIAL_MATRIX",15,1.2427,0.17,0.5,"Yes",0.8731,0.63,0.91,"Yes"
"19013","KEGG_module","HSA_M00296_BER_COMPLEX",10,1.2428,0.2,0.52,"Yes",1.2605,0.19,0.44,"Yes"
"19014","GO_BP","489249_GO_0006360_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER",37,1.2435,0.17,0.66,"Yes",1.297,0.097,0.67,"Yes"
"19015","C2_Chemical_and_genetic_perturbations","C2_CGP_2386_LU_TUMOR_ENDOTHELIAL_MARKERS_DN",5,1.2444,0.23,0.75,"Yes",-1.0404,0.44,0.97,"No"
"19016","REACTOME","105998_REACT_6332_HIV_TRANSCRIPTION_INITIATION",45,1.245,0.12,0.49,"Yes",1.6077,0.0022,0.089,"Yes"
"19017","GO_CC","490727_GO_0005671_ADA2_GCN5_ADA3_TRANSCRIPTION_ACTIVATOR_COMPLEX",16,1.246,0.18,0.5,"Yes",0.983,0.44,0.81,"Yes"
"19018","GO_BP","506984_GO_0043966_HISTONE_H3_ACETYLATION",48,1.246,0.095,0.66,"Yes",0.6505,0.98,1,"Yes"
"19019","GO_BP","491228_GO_0006264_MITOCHONDRIAL_DNA_REPLICATION",12,1.2466,0.18,0.66,"Yes",1.0061,0.44,0.98,"Yes"
"19020","GO_CC","500765_GO_0031514_MOTILE_CILIUM",90,1.2471,0.064,0.5,"Yes",-1.3806,0.029,0.63,"No"
"19021","GO_BP","510902_GO_0048852_DIENCEPHALON_MORPHOGENESIS",6,1.2473,0.23,0.66,"Yes",1.312,0.21,0.66,"Yes"
"19022","KEGG_module","HSA_M00395_DECAPPING_COMPLEX",6,1.2477,0.2,0.54,"Yes",1.2046,0.25,0.53,"Yes"
"19023","GO_CC","505759_GO_0042645_MITOCHONDRIAL_NUCLEOID",41,1.2477,0.12,0.5,"Yes",1.4607,0.028,0.24,"Yes"
"19024","GO_CC","490829_GO_0030134_ER_TO_GOLGI_TRANSPORT_VESICLE",51,1.2482,0.11,0.51,"Yes",1.4275,0.05,0.27,"Yes"
"19025","GO_BP","516288_GO_0071364_CELLULAR_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR_STIMULUS",22,1.2486,0.16,0.66,"Yes",0.9661,0.52,1,"Yes"
"19026","C4_Cancer_gene_neighborhoods","C4_CGN_58_MORF_ACTG1",138,1.2493,0.078,0.36,"Yes",3.6144,0,0,"Yes"
"19027","GO_MF","487326_GO_0001103_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING",27,1.2496,0.14,0.78,"Yes",0.905,0.64,0.98,"Yes"
"19028","REACTOME","105999_REACT_6253_RNA_POLYMERASE_II_HIV_PROMOTER_ESCAPE",45,1.2496,0.13,0.49,"Yes",1.6013,0.016,0.093,"Yes"
"19029","GO_BP","515953_GO_0071027_NUCLEAR_RNA_SURVEILLANCE",7,1.2496,0.19,0.66,"Yes",1.1732,0.25,0.81,"Yes"
"19030","GO_BP","501335_GO_0032098_REGULATION_OF_APPETITE",21,1.25,0.17,0.66,"Yes",-1.3737,0.079,0.99,"No"
"19031","C2_Chemical_and_genetic_perturbations","C2_CGP_1273_SHIPP_DLBCL_CURED_VS_FATAL_DN",43,1.252,0.12,0.73,"Yes",1.5312,0.017,0.18,"Yes"
"19032","GO_MF","490145_GO_0004843_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY",77,1.2521,0.073,0.78,"Yes",1.0392,0.36,0.83,"Yes"
"19033","GO_BP","514475_GO_0060920_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION",6,1.2522,0.2,0.65,"Yes",-0.6944,0.82,1,"No"
"19034","C2_Chemical_and_genetic_perturbations","C2_CGP_654_SUZUKI_AMPLIFIED_IN_ORAL_CANCER",14,1.2525,0.16,0.74,"Yes",-1.1452,0.29,0.85,"No"
"19035","C7_Immunologic_signatures","C7_ALL_943_GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP",193,1.2526,0.043,0.11,"Yes",-0.67,1,1,"No"
"19036","C1_Positional","C1_ALL_263_CHR20Q13",179,1.2528,0.048,0.58,"Yes",0.9014,0.76,0.85,"Yes"
"19037","C6_Oncogenic_signatures","C6_ALL_7_ERB2_UP_V1_DN",196,1.2531,0.043,0.27,"Yes",1.5533,0,0.081,"Yes"
"19038","GO_BP","496527_GO_0016579_PROTEIN_DEUBIQUITINATION",86,1.2533,0.083,0.65,"Yes",0.9628,0.54,1,"Yes"
"19039","C3_TF_targets","C3_TFT_150_CAGNWMCNNNGAC_UNKNOWN",81,1.2535,0.09,0.22,"Yes",1.253,0.095,0.55,"Yes"
"19040","REACTOME","105793_REACT_312_LAGGING_STRAND_SYNTHESIS",21,1.2537,0.16,0.48,"Yes",1.6366,0.014,0.076,"Yes"
"19041","GO_CC","500770_GO_0031519_PCG_PROTEIN_COMPLEX",44,1.2538,0.13,0.5,"Yes",0.6417,0.97,1,"Yes"
"19042","GO_BP","518612_GO_0097062_DENDRITIC_SPINE_MAINTENANCE",7,1.254,0.21,0.65,"Yes",0.8014,0.71,1,"Yes"
"19043","GO_BP","491269_GO_0006310_DNA_RECOMBINATION",201,1.2542,0.027,0.65,"Yes",1.2497,0.046,0.73,"Yes"
"19044","GO_BP","486886_GO_0000389_MRNA_3_SPLICE_SITE_RECOGNITION",5,1.2542,0.23,0.66,"Yes",1.4347,0.08,0.51,"Yes"
"19045","GO_BP","516904_GO_0071985_MULTIVESICULAR_BODY_SORTING_PATHWAY",7,1.2543,0.2,0.66,"Yes",1.5416,0.04,0.36,"Yes"
"19046","OMIM_gene","OMIM604311_MEDIATOR_COMPLEX_SUBUNIT_1_MED1",6,1.2544,0.23,1,"Yes",1.3371,0.16,0.91,"Yes"
"19047","GO_BP","491320_GO_0006398_HISTONE_MRNA_3_END_PROCESSING",5,1.2549,0.24,0.66,"Yes",1.1935,0.28,0.79,"Yes"
"19048","C7_Immunologic_signatures","C7_ALL_1349_GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP",200,1.2553,0.016,0.11,"Yes",1.718,0,0.00045,"Yes"
"19049","GO_BP","505575_GO_0042435_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",5,1.2556,0.21,0.66,"Yes",-0.8838,0.61,1,"No"
"19050","KEGG_compound","C01272_1D_MYO_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_D_MYO_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE",8,1.2556,0.19,1,"Yes",0.7874,0.73,1,"Yes"
"19051","GO_BP","1129636_GO_1990564_PROTEIN_POLYUFMYLATION",5,1.2561,0.23,0.66,"Yes",1.4394,0.081,0.51,"Yes"
"19052","GO_BP","491244_GO_0006281_DNA_REPAIR",416,1.2566,0.029,0.66,"Yes",1.3758,0,0.58,"Yes"
"19053","GO_BP","487028_GO_0000731_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR",13,1.2568,0.17,0.66,"Yes",-1.0235,0.43,0.97,"No"
"19054","GO_CC","486937_GO_0000444_MIS12_MIND_TYPE_COMPLEX",5,1.2568,0.24,0.5,"Yes",1.2132,0.24,0.51,"Yes"
"19055","GO_BP","849938_GO_1902237_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",8,1.257,0.19,0.66,"Yes",1.0699,0.38,0.93,"Yes"
"19056","C2_Chemical_and_genetic_perturbations","C2_CGP_3246_MADAN_DPPA4_TARGETS",44,1.2573,0.13,0.74,"Yes",0.9269,0.57,0.89,"Yes"
"19057","C1_Positional","C1_ALL_180_CHR15Q25",56,1.258,0.11,0.6,"Yes",0.9104,0.63,0.84,"Yes"
"19058","C4_Cancer_gene_neighborhoods","C4_CGN_209_GCM_APEX1",114,1.2584,0.072,0.34,"Yes",2.8081,0,0,"Yes"
"19059","C7_Immunologic_signatures","C7_ALL_1055_GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP",199,1.2586,0,0.11,"Yes",1.2721,0.049,0.13,"Yes"
"19060","OMIM_gene","OMIM300017_FILAMIN_A_FLNA",5,1.2586,0.24,1,"Yes",0.8574,0.64,1,"Yes"
"19061","C2_Chemical_and_genetic_perturbations","C2_CGP_3024_RAGHAVACHARI_PLATELET_SPECIFIC_GENES",70,1.2589,0.094,0.75,"Yes",2.3499,0,7.1e-05,"Yes"
"19062","GO_CC","911394_GO_0098536_DEUTEROSOME",5,1.2594,0.21,0.5,"Yes",-0.7666,0.74,1,"No"
"19063","GO_BP","518225_GO_0090085_REGULATION_OF_PROTEIN_DEUBIQUITINATION",6,1.26,0.24,0.66,"Yes",1.3911,0.11,0.57,"Yes"
"19064","GO_MF","492490_GO_0008135_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING",84,1.2602,0.076,0.77,"Yes",2.3083,0,0.00015,"Yes"
"19065","GO_BP","488876_GO_0035815_POSITIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION",13,1.2605,0.16,0.66,"Yes",1.8396,0.0042,0.069,"Yes"
"19066","C7_Immunologic_signatures","C7_ALL_250_GSE14308_TH2_VS_INDUCED_TREG_DN",199,1.2606,0.017,0.11,"Yes",1.2235,0.057,0.19,"Yes"
"19067","C7_Immunologic_signatures","C7_ALL_942_GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN",191,1.261,0.023,0.11,"Yes",0.6305,1,1,"Yes"
"19068","C2_Chemical_and_genetic_perturbations","C2_CGP_1589_NOUZOVA_TRETINOIN_AND_H4_ACETYLATION",143,1.2613,0.037,0.75,"Yes",1.7544,0,0.058,"Yes"
"19069","GO_BP","501436_GO_0032201_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION",23,1.2616,0.14,0.66,"Yes",1.4568,0.044,0.48,"Yes"
"19070","KEGG_enzyme","2.3.1.88_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_BETA_ENDORPHIN_ACETYLTRANSFERASE_PEPTIDE_ACETYLTRANSFERASE_PROTEIN_N_TERMINAL_ACETYLTRANSFERASE_NAT_NALPHA_ACETYLTRANSFERASE_AMINO_TERMINAL_AMINO_ACID_ACETYLATING_ENZYME_ACETYL_COA_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE",5,1.2621,0.21,0.61,"Yes",0.8098,0.68,1,"Yes"
"19071","GO_CC","500227_GO_0030934_ANCHORING_COLLAGEN_COMPLEX",6,1.2631,0.19,0.49,"Yes",-1.1588,0.29,0.68,"No"
"19072","GO_BP","496314_GO_0016254_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE",16,1.2633,0.14,0.66,"Yes",1.117,0.32,0.88,"Yes"
"19073","REACTOME","106345_REACT_9483_FGFR1_LIGAND_BINDING_AND_ACTIVATION",11,1.2636,0.16,0.46,"Yes",-0.6086,0.94,1,"No"
"19074","GO_BP","486624_GO_0000084_MITOTIC_S_PHASE",117,1.2636,0.026,0.66,"Yes",2.1236,0,0.0025,"Yes"
"19075","REACTOME","1183521_REACT_355533_SIGNALING_BY_FGFR2_IN_DISEASE",21,1.2639,0.14,0.47,"Yes",-0.9038,0.59,1,"No"
"19076","C7_Immunologic_signatures","C7_ALL_859_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP",198,1.2645,0.034,0.11,"Yes",1.4365,0.0048,0.026,"Yes"
"19077","C2_Chemical_and_genetic_perturbations","C2_CGP_3046_KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN",32,1.2647,0.14,0.75,"Yes",-1.0756,0.34,0.95,"No"
"19078","REACTOME","106005_REACT_6261_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT",23,1.266,0.16,0.46,"Yes",1.4392,0.062,0.19,"Yes"
"19079","C2_Chemical_and_genetic_perturbations","C2_CGP_1193_KAUFFMANN_DNA_REPAIR_GENES",228,1.2663,0.01,0.76,"Yes",1.2037,0.063,0.48,"Yes"
"19080","GO_BP","515954_GO_0071028_NUCLEAR_MRNA_SURVEILLANCE",7,1.2668,0.21,0.65,"Yes",1.1555,0.28,0.83,"Yes"
"19081","GO_BP","751044_GO_0036124_HISTONE_H3_K9_TRIMETHYLATION",5,1.2671,0.22,0.65,"Yes",-0.5869,0.91,1,"No"
"19082","GO_BP","497328_GO_0018393_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION",105,1.2675,0.071,0.65,"Yes",0.5693,1,1,"Yes"
"19083","GO_MF","490445_GO_0005184_NEUROPEPTIDE_HORMONE_ACTIVITY",23,1.2681,0.17,0.75,"Yes",-1.7456,0.011,0.24,"No"
"19084","GO_BP","488992_GO_0003198_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION",9,1.2685,0.2,0.65,"Yes",0.7236,0.84,1,"Yes"
"19085","C2_Chemical_and_genetic_perturbations","C2_CGP_562_MOTAMED_RESPONSE_TO_ANDROGEN_UP",5,1.2688,0.22,0.76,"Yes",0.8701,0.61,0.96,"Yes"
"19086","REACTOME","160987_REACT_15439_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS",5,1.269,0.22,0.46,"Yes",-0.9078,0.57,1,"No"
"19087","GO_BP","501294_GO_0032057_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS",5,1.269,0.21,0.65,"Yes",0.8216,0.68,1,"Yes"
"19088","GO_BP","512322_GO_0051444_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",74,1.2693,0.081,0.65,"Yes",2.2382,0,0.00039,"Yes"
"19089","GO_BP","502358_GO_0033137_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION",20,1.2693,0.15,0.66,"Yes",1.3787,0.087,0.58,"Yes"
"19090","GO_BP","499123_GO_0021843_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_INTERNEURON_MIGRATION",9,1.2694,0.19,0.66,"Yes",-1.8679,0.0039,0.41,"No"
"19091","GO_BP","491487_GO_0006591_ORNITHINE_METABOLIC_PROCESS",6,1.2699,0.19,0.66,"Yes",0.9442,0.54,1,"Yes"
"19092","C1_Positional","C1_ALL_133_CHR3Q22",40,1.2714,0.094,0.59,"Yes",0.8833,0.68,0.89,"Yes"
"19093","REACTOME","645283_REACT_121249_FGFR3_MUTANT_RECEPTOR_ACTIVATION",10,1.2728,0.19,0.46,"Yes",-1.3874,0.091,0.54,"No"
"19094","GO_BP","753255_GO_1900271_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION",5,1.2733,0.22,0.65,"Yes",0.8382,0.67,1,"Yes"
"19095","KEGG_pathway","HSA03440_HOMOLOGOUS_RECOMBINATION",28,1.2734,0.14,0.2,"Yes",1.1812,0.22,0.58,"Yes"
"19096","GO_BP","754932_GO_2000826_REGULATION_OF_HEART_MORPHOGENESIS",24,1.2735,0.14,0.65,"Yes",0.6964,0.91,1,"Yes"
"19097","C7_Immunologic_signatures","C7_ALL_1345_GSE31082_DN_VS_DP_THYMOCYTE_UP",200,1.2735,0.0089,0.097,"Yes",2.044,0,0,"Yes"
"19098","GO_BP","496526_GO_0016578_HISTONE_DEUBIQUITINATION",20,1.274,0.13,0.65,"Yes",-0.6925,0.91,1,"No"
"19099","REACTOME","161060_REACT_20653_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12",21,1.2753,0.14,0.46,"Yes",0.8927,0.61,0.91,"Yes"
"19100","GO_BP","512017_GO_0051103_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR",7,1.2754,0.2,0.65,"Yes",1.0925,0.35,0.91,"Yes"
"19101","REACTOME","105983_REACT_6185_HIV_INFECTION",221,1.2763,0.0099,0.46,"Yes",2.286,0,3.8e-05,"Yes"
"19102","GO_BP","501336_GO_0032099_NEGATIVE_REGULATION_OF_APPETITE",11,1.2767,0.19,0.65,"Yes",-0.7393,0.8,1,"No"
"19103","GO_BP","499902_GO_0030581_SYMBIONT_INTRACELLULAR_PROTEIN_TRANSPORT_IN_HOST",5,1.2767,0.21,0.65,"Yes",1.5622,0.028,0.34,"Yes"
"19104","C2_Chemical_and_genetic_perturbations","C2_CGP_3004_ONGUSAHA_BRCA1_TARGETS_DN",13,1.2771,0.15,0.74,"Yes",1.6124,0.03,0.13,"Yes"
"19105","GO_BP","497937_GO_0019058_VIRAL_LIFE_CYCLE",243,1.2772,0,0.65,"Yes",3.0604,0,0,"Yes"
"19106","REACTOME","105957_REACT_1849_MRNA_3_END_PROCESSING",34,1.2786,0.12,0.45,"Yes",0.7654,0.84,1,"Yes"
"19107","GO_BP","511851_GO_0050916_SENSORY_PERCEPTION_OF_SWEET_TASTE",6,1.2795,0.23,0.65,"Yes",-0.9418,0.53,1,"No"
"19108","C7_Immunologic_signatures","C7_ALL_1662_GSE3982_NEUTROPHIL_VS_BCELL_DN",198,1.2796,0.032,0.092,"Yes",1.67,0,0.00096,"Yes"
"19109","GO_BP","502973_GO_0033762_RESPONSE_TO_GLUCAGON",48,1.28,0.064,0.65,"Yes",1.0794,0.3,0.93,"Yes"
"19110","GO_BP","753102_GO_1900107_REGULATION_OF_NODAL_SIGNALING_PATHWAY",6,1.2818,0.18,0.65,"Yes",-1.1848,0.27,0.9,"No"
"19111","GO_BP","503584_GO_0034382_CHYLOMICRON_REMNANT_CLEARANCE",6,1.2826,0.21,0.65,"Yes",0.7452,0.77,1,"Yes"
"19112","GO_MF","489247_GO_0003697_SINGLE_STRANDED_DNA_BINDING",79,1.2826,0.067,0.72,"Yes",1.7505,0,0.11,"Yes"
"19113","GO_BP","492854_GO_0008595_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION_EMBRYO",14,1.2834,0.16,0.65,"Yes",-0.8394,0.68,1,"No"
"19114","OMIM_gene","OMIM604591_PHOSPHATIDYLETHANOLAMINE_BINDING_PROTEIN_1_PEBP1",5,1.2841,0.2,1,"Yes",1.4183,0.087,0.99,"Yes"
"19115","GO_BP","491375_GO_0006473_PROTEIN_ACETYLATION",124,1.2841,0.037,0.65,"Yes",0.6962,1,1,"Yes"
"19116","GO_MF","925868_GO_0036459_UBIQUITINYL_HYDROLASE_ACTIVITY",83,1.2843,0.059,0.72,"Yes",1.0784,0.3,0.82,"Yes"
"19117","GO_BP","506986_GO_0043968_HISTONE_H2A_ACETYLATION",12,1.2843,0.15,0.65,"Yes",1.0474,0.38,0.95,"Yes"
"19118","C3_TF_targets","C3_TFT_311_V_PPARG_01",43,1.2848,0.1,0.21,"Yes",1.2259,0.16,0.67,"Yes"
"19119","REACTOME","106542_REACT_7974_TELOMERE_EXTENSION_BY_TELOMERASE",6,1.2855,0.18,0.44,"Yes",1.2649,0.21,0.37,"Yes"
"19120","KEGG_compound","C00055_CMP_CYTIDINE_5_MONOPHOSPHATE_CYTIDYLIC_ACID",24,1.2863,0.12,1,"Yes",1.4915,0.034,0.33,"Yes"
"19121","REACTOME","576261_REACT_118595_MITOCHONDRIAL_PROTEIN_IMPORT",54,1.2867,0.097,0.44,"Yes",2.0897,0,7e-04,"Yes"
"19122","C7_Immunologic_signatures","C7_ALL_973_GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP",200,1.2872,0.0083,0.086,"Yes",2.5077,0,0,"Yes"
"19123","C2_Chemical_and_genetic_perturbations","C2_CGP_666_NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS",13,1.2873,0.18,0.72,"Yes",-1.035,0.41,0.97,"No"
"19124","C2_Chemical_and_genetic_perturbations","C2_CGP_1035_CAFFAREL_RESPONSE_TO_THC_8HR_3_DN",10,1.2873,0.17,0.73,"Yes",1.0487,0.39,0.72,"Yes"
"19125","C2_Chemical_and_genetic_perturbations","C2_CGP_3386_ZWANG_DOWN_BY_2ND_EGF_PULSE",273,1.2881,0,0.74,"Yes",-1.0914,0.23,0.93,"No"
"19126","C4_Cancer_gene_neighborhoods","C4_CGN_335_GNF2_CDC27",60,1.2883,0.086,0.28,"Yes",2.0835,0,0.00014,"Yes"
"19127","GO_BP","491918_GO_0007099_CENTRIOLE_REPLICATION",11,1.2885,0.18,0.64,"Yes",-0.8108,0.72,1,"No"
"19128","GO_BP","489263_GO_0006386_TERMINATION_OF_RNA_POLYMERASE_III_TRANSCRIPTION",18,1.2891,0.16,0.64,"Yes",0.8528,0.68,1,"Yes"
"19129","REACTOME","106352_REACT_9439_FGFR3_LIGAND_BINDING_AND_ACTIVATION",10,1.2897,0.16,0.44,"Yes",-1.3744,0.12,0.57,"No"
"19130","GO_BP","512090_GO_0051182_COENZYME_TRANSPORT",5,1.2897,0.21,0.64,"Yes",0.7566,0.75,1,"Yes"
"19131","C1_Positional","C1_ALL_126_CHR7Q33",18,1.2903,0.14,0.57,"Yes",0.8385,0.7,0.92,"Yes"
"19132","GO_BP","491842_GO_0007007_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION",11,1.291,0.19,0.64,"Yes",1.1391,0.3,0.85,"Yes"
"19133","GO_BP","501333_GO_0032096_NEGATIVE_REGULATION_OF_RESPONSE_TO_FOOD",12,1.2917,0.16,0.64,"Yes",-0.7667,0.75,1,"No"
"19134","C4_Cancer_gene_neighborhoods","C4_CGN_388_GNF2_NS",40,1.2918,0.093,0.28,"Yes",2.3664,0,0,"Yes"
"19135","GO_BP","502015_GO_0032792_NEGATIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY",5,1.2921,0.2,0.64,"Yes",-0.7002,0.84,1,"No"
"19136","GO_MF","499417_GO_0022884_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",20,1.2922,0.14,0.71,"Yes",1.5745,0.03,0.31,"Yes"
"19137","C2_Chemical_and_genetic_perturbations","C2_CGP_602_WAKASUGI_HAVE_ZNF143_BINDING_SITES",58,1.2923,0.084,0.74,"Yes",0.6349,0.99,1,"Yes"
"19138","WikiPathways","198771_WP466_DNA_REPLICATION",42,1.2927,0.1,0.38,"Yes",1.7052,0.0022,0.094,"Yes"
"19139","GO_BP","501279_GO_0032042_MITOCHONDRIAL_DNA_METABOLIC_PROCESS",16,1.2928,0.13,0.64,"Yes",0.9064,0.56,1,"Yes"
"19140","GO_BP","508222_GO_0045915_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS",5,1.2936,0.2,0.64,"Yes",1.3491,0.13,0.61,"Yes"
"19141","GO_CC","493479_GO_0009295_NUCLEOID",43,1.294,0.1,0.44,"Yes",1.4448,0.028,0.25,"Yes"
"19142","GO_BP","491751_GO_0006891_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT",43,1.2942,0.098,0.64,"Yes",0.8627,0.71,1,"Yes"
"19143","GO_BP","513828_GO_0060272_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS",13,1.2945,0.13,0.64,"Yes",-0.793,0.73,1,"No"
"19144","GO_BP","491833_GO_0006997_NUCLEUS_ORGANIZATION",127,1.2946,0.047,0.65,"Yes",1.5615,0.0046,0.34,"Yes"
"19145","GO_BP","512236_GO_0051352_NEGATIVE_REGULATION_OF_LIGASE_ACTIVITY",74,1.2947,0.066,0.65,"Yes",2.2605,0,0.00023,"Yes"
"19146","REACTOME","106354_REACT_9510_FGFR3C_LIGAND_BINDING_AND_ACTIVATION",10,1.2953,0.17,0.43,"Yes",-1.4232,0.083,0.51,"No"
"19147","KEGG_compound","C00046_RNA_RNAN_RNAN_1_RNA_LINEAR_RIBONUCLEOTIDE_N_RIBONUCLEOTIDE_M_RIBONUCLEOTIDE_N_M_RIBONUCLEIC_ACID",32,1.2955,0.085,1,"Yes",0.9201,0.59,1,"Yes"
"19148","GO_BP","501633_GO_0032401_ESTABLISHMENT_OF_MELANOSOME_LOCALIZATION",24,1.2956,0.14,0.65,"Yes",1.1337,0.27,0.86,"Yes"
"19149","GO_BP","505255_GO_0042073_INTRACILIARY_TRANSPORT",28,1.2964,0.12,0.65,"Yes",-0.6914,0.94,1,"No"
"19150","GO_BP","500556_GO_0031297_REPLICATION_FORK_PROCESSING",15,1.2965,0.14,0.65,"Yes",0.6335,0.94,1,"Yes"
"19151","GO_BP","507000_GO_0043982_HISTONE_H4_K8_ACETYLATION",15,1.2971,0.13,0.65,"Yes",0.4107,1,1,"Yes"
"19152","GO_BP","508251_GO_0045947_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION",19,1.2979,0.13,0.65,"Yes",1.5554,0.035,0.33,"Yes"
"19153","C7_Immunologic_signatures","C7_ALL_945_GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP",192,1.2986,0.023,0.075,"Yes",-0.8822,0.78,1,"No"
"19154","GO_BP","492015_GO_0007217_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY",8,1.299,0.15,0.65,"Yes",-1.111,0.34,0.94,"No"
"19155","GO_BP","491232_GO_0006268_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION",10,1.3,0.17,0.65,"Yes",1.0468,0.39,0.95,"Yes"
"19156","C2_Chemical_and_genetic_perturbations","C2_CGP_3080_FIGUEROA_AML_METHYLATION_CLUSTER_2_UP",53,1.3,0.073,0.73,"Yes",1.2256,0.15,0.47,"Yes"
"19157","C7_Immunologic_signatures","C7_ALL_1187_GSE27786_BCELL_VS_NEUTROPHIL_UP",200,1.3002,0.0088,0.075,"Yes",1.0237,0.41,0.67,"Yes"
"19158","GO_BP","516083_GO_0071157_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST",15,1.3002,0.12,0.65,"Yes",1.3301,0.13,0.63,"Yes"
"19159","GO_BP","512581_GO_0051708_INTRACELLULAR_PROTEIN_TRANSPORT_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",5,1.3011,0.19,0.65,"Yes",1.5236,0.045,0.37,"Yes"
"19160","REACTOME","187185_REACT_23892_TRANSPORT_OF_FATTY_ACIDS",7,1.3013,0.17,0.43,"Yes",-1.1317,0.32,0.9,"No"
"19161","GO_MF","489981_GO_0004652_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ACTIVITY",8,1.3013,0.17,0.69,"Yes",1.0039,0.44,0.87,"Yes"
"19162","C1_Positional","C1_ALL_57_CHR10P11",31,1.302,0.13,0.57,"Yes",0.8785,0.65,0.89,"Yes"
"19163","REACTOME","105858_REACT_2020_REVERSAL_OF_ALKYLATION_DAMAGE_BY_DNA_DIOXYGENASES",5,1.3022,0.19,0.43,"Yes",1.3239,0.15,0.29,"Yes"
"19164","GO_BP","491900_GO_0007077_MITOTIC_NUCLEAR_ENVELOPE_DISASSEMBLY",42,1.3022,0.1,0.65,"Yes",1.2691,0.11,0.71,"Yes"
"19165","REACTOME","105686_REACT_13464_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION",49,1.3023,0.082,0.43,"Yes",2.2762,0,3.7e-05,"Yes"
"19166","C2_Chemical_and_genetic_perturbations","C2_CGP_192_GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN",175,1.3035,0.019,0.73,"Yes",-0.906,0.7,1,"No"
"19167","REACTOME","645284_REACT_121337_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR3",10,1.3044,0.14,0.43,"Yes",-1.3963,0.094,0.53,"No"
"19168","C4_Cancer_gene_neighborhoods","C4_CGN_425_GNF2_UBE2I",44,1.3044,0.096,0.27,"Yes",2.5239,0,0,"Yes"
"19169","GO_CC","490718_GO_0005663_DNA_REPLICATION_FACTOR_C_COMPLEX",6,1.3045,0.19,0.42,"Yes",1.5184,0.047,0.18,"Yes"
"19170","GO_BP","497939_GO_0019060_INTRACELLULAR_TRANSPORT_OF_VIRAL_PROTEIN_IN_HOST_CELL",5,1.3046,0.18,0.65,"Yes",1.5497,0.04,0.34,"Yes"
"19171","GO_MF","509933_GO_0047760_BUTYRATE_COA_LIGASE_ACTIVITY",8,1.3049,0.14,0.69,"Yes",-1.0112,0.45,0.89,"No"
"19172","GO_BP","504243_GO_0035058_NONMOTILE_PRIMARY_CILIUM_ASSEMBLY",14,1.3051,0.14,0.65,"Yes",0.6361,0.93,1,"Yes"
"19173","GO_CC","496546_GO_0016604_NUCLEAR_BODY",332,1.3053,0.015,0.42,"Yes",1.2767,0.0071,0.43,"Yes"
"19174","GO_MF","501636_GO_0032404_MISMATCH_REPAIR_COMPLEX_BINDING",12,1.3061,0.15,0.69,"Yes",0.7235,0.84,1,"Yes"
"19175","GO_BP","487027_GO_0000730_DNA_RECOMBINASE_ASSEMBLY",5,1.3067,0.2,0.65,"Yes",1.1807,0.29,0.8,"Yes"
"19176","REACTOME","105784_REACT_2014_SYNTHESIS_OF_DNA",97,1.3077,0.065,0.43,"Yes",2.1469,0,0.00035,"Yes"
"19177","GO_BP","496836_GO_0017004_CYTOCHROME_COMPLEX_ASSEMBLY",19,1.3081,0.15,0.64,"Yes",1.1556,0.25,0.83,"Yes"
"19178","C7_Immunologic_signatures","C7_ALL_233_GSE14000_UNSTIM_VS_4H_LPS_DC_UP",197,1.3082,0.017,0.069,"Yes",1.0555,0.3,0.57,"Yes"
"19179","KEGG_module","HSA_M00128_UBIQUINONE_BIOSYNTHESIS_EUKARYOTES_4_HYDROXYBENZOATE_UBIQUINONE",5,1.3084,0.19,0.44,"Yes",0.8912,0.6,0.9,"Yes"
"19180","GO_BP","506589_GO_0043558_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS",11,1.3085,0.16,0.64,"Yes",1.2814,0.16,0.7,"Yes"
"19181","C4_Cancer_gene_neighborhoods","C4_CGN_14_MORF_DNMT1",118,1.3092,0.027,0.26,"Yes",1.9458,0,0.00053,"Yes"
"19182","WikiPathways","198768_WP311_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES",5,1.3093,0.18,0.43,"Yes",0.5593,0.96,1,"Yes"
"19183","GO_BP","518281_GO_0090141_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION",10,1.3095,0.16,0.64,"Yes",1.0012,0.44,0.98,"Yes"
"19184","GO_MF","495530_GO_0015279_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",11,1.3095,0.17,0.69,"Yes",0.7393,0.82,1,"Yes"
"19185","GO_BP","498886_GO_0021603_CRANIAL_NERVE_FORMATION",5,1.3099,0.18,0.65,"Yes",0.6607,0.85,1,"Yes"
"19186","GO_MF","496405_GO_0016417_S_ACYLTRANSFERASE_ACTIVITY",29,1.3101,0.096,0.7,"Yes",0.8445,0.72,1,"Yes"
"19187","GO_BP","486818_GO_0000301_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI",19,1.3104,0.12,0.65,"Yes",0.6638,0.93,1,"Yes"
"19188","C2_Chemical_and_genetic_perturbations","C2_CGP_631_MATHEW_FANCONI_ANEMIA_GENES",11,1.3106,0.13,0.72,"Yes",0.9291,0.54,0.89,"Yes"
"19189","KEGG_module","HSA_M00146_NADH_DEHYDROGENASE_UBIQUINONE_1_ALPHA_SUBCOMPLEX",15,1.3118,0.14,0.46,"Yes",1.6992,0.016,0.074,"Yes"
"19190","KEGG_pathway","HSA00512_MUCIN_TYPE_O_GLYCAN_BIOSYNTHESIS",31,1.3125,0.095,0.17,"Yes",0.9104,0.58,1,"Yes"
"19191","GO_BP","948072_GO_0044827_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION",7,1.3127,0.18,0.64,"Yes",1.418,0.11,0.53,"Yes"
"19192","GO_BP","491500_GO_0006605_PROTEIN_TARGETING",396,1.3136,0,0.64,"Yes",2.6196,0,0,"Yes"
"19193","GO_BP","499106_GO_0021826_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION",9,1.3137,0.17,0.65,"Yes",-1.8567,0.0038,0.43,"No"
"19194","C4_Cancer_modules","C4_CM_281_MODULE_322",57,1.3138,0.067,0.47,"Yes",1.604,0.011,0.073,"Yes"
"19195","C4_Cancer_gene_neighborhoods","C4_CGN_230_GCM_FANCL",24,1.3138,0.095,0.26,"Yes",-0.826,0.75,1,"No"
"19196","GO_CC","496537_GO_0016591_DNA_DIRECTED_RNA_POLYMERASE_II_HOLOENZYME",92,1.3145,0.048,0.41,"Yes",1.4119,0.021,0.29,"Yes"
"19197","GO_BP","506999_GO_0043981_HISTONE_H4_K5_ACETYLATION",15,1.3154,0.13,0.64,"Yes",0.3984,1,1,"Yes"
"19198","C2_Chemical_and_genetic_perturbations","C2_CGP_1131_PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP",6,1.3155,0.19,0.71,"Yes",1.3655,0.11,0.33,"Yes"
"19199","GO_BP","516752_GO_0071830_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE",6,1.3157,0.18,0.64,"Yes",0.7671,0.75,1,"Yes"
"19200","REACTOME","106227_REACT_12541_NOSTRIN_MEDIATED_ENOS_TRAFFICKING",5,1.3162,0.18,0.41,"Yes",-1.0256,0.45,0.97,"No"
"19201","C2_Chemical_and_genetic_perturbations","C2_CGP_16_LU_TUMOR_VASCULATURE_DN",11,1.3163,0.15,0.73,"Yes",1.453,0.08,0.25,"Yes"
"19202","GO_BP","491311_GO_0006385_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_III_PROMOTER",18,1.3171,0.12,0.64,"Yes",0.8578,0.65,1,"Yes"
"19203","GO_CC","489323_GO_0042613_MHC_CLASS_II_PROTEIN_COMPLEX",14,1.3174,0.15,0.41,"Yes",0.6861,0.88,0.98,"Yes"
"19204","GO_MF","493230_GO_0016783_SULFURTRANSFERASE_ACTIVITY",8,1.3176,0.15,0.69,"Yes",1.2693,0.2,0.64,"Yes"
"19205","C2_Chemical_and_genetic_perturbations","C2_CGP_675_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9",8,1.3181,0.14,0.74,"Yes",1.0693,0.39,0.68,"Yes"
"19206","REACTOME","1127635_REACT_264623_HH_MUTANTS_ABROGATE_LIGAND_SECRETION",54,1.3182,0.08,0.41,"Yes",2.2606,0,6.7e-05,"Yes"
"19207","C7_Immunologic_signatures","C7_ALL_854_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN",182,1.3184,0,0.061,"Yes",1.391,0.0023,0.041,"Yes"
"19208","GO_BP","507413_GO_0045003_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING",5,1.319,0.18,0.64,"Yes",1.2251,0.26,0.76,"Yes"
"19209","C2_Chemical_and_genetic_perturbations","C2_CGP_2132_MCGOWAN_RSP6_TARGETS_DN",5,1.3191,0.2,0.75,"Yes",1.1234,0.35,0.6,"Yes"
"19210","REACTOME","905999_REACT_169429_DEFECTS_IN_COBALAMIN_B12_METABOLISM",11,1.3205,0.14,0.41,"Yes",0.9053,0.57,0.9,"Yes"
"19211","GO_MF","751603_GO_0044390_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING",14,1.321,0.13,0.69,"Yes",0.9856,0.47,0.89,"Yes"
"19212","REACTOME","105873_REACT_2141_ASSEMBLY_OF_THE_RAD51_SSDNA_NUCLEOPROTEIN_COMPLEX",5,1.3215,0.16,0.41,"Yes",1.1926,0.27,0.45,"Yes"
"19213","REACTOME","105855_REACT_1287_TRANSLESION_SYNTHESIS_BY_POLH",19,1.3216,0.11,0.42,"Yes",1.7812,0.0061,0.024,"Yes"
"19214","GO_BP","516405_GO_0071481_CELLULAR_RESPONSE_TO_X_RAY",5,1.3219,0.2,0.63,"Yes",0.9129,0.56,1,"Yes"
"19215","REACTOME","106566_REACT_756_RNA_POLYMERASE_III_CHAIN_ELONGATION",18,1.3237,0.11,0.41,"Yes",0.848,0.7,0.96,"Yes"
"19216","REACTOME","106017_REACT_9453_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G",53,1.324,0.064,0.42,"Yes",2.3632,0,0,"Yes"
"19217","REACTOME","187215_REACT_25042_KSRP_DESTABILIZES_MRNA",17,1.324,0.14,0.42,"Yes",1.5288,0.04,0.13,"Yes"
"19218","C7_Immunologic_signatures","C7_ALL_829_GSE17974_2_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP",197,1.3245,0,0.058,"Yes",1.3316,0.016,0.075,"Yes"
"19219","C2_Chemical_and_genetic_perturbations","C2_CGP_1814_GENTILE_UV_RESPONSE_CLUSTER_D7",40,1.3245,0.05,0.75,"Yes",1.8834,0,0.023,"Yes"
"19220","C4_Cancer_gene_neighborhoods","C4_CGN_193_MORF_ZNF10",53,1.3253,0.045,0.25,"Yes",0.684,0.96,1,"Yes"
"19221","GO_MF","487279_GO_0001056_RNA_POLYMERASE_III_ACTIVITY",18,1.3253,0.1,0.69,"Yes",0.8662,0.64,1,"Yes"
"19222","REACTOME","1127522_REACT_264438_DEGRADATION_OF_DVL",56,1.3254,0.075,0.42,"Yes",2.2377,0,6.1e-05,"Yes"
"19223","GO_BP","515009_GO_0070070_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY",6,1.3256,0.18,0.63,"Yes",-0.7891,0.72,1,"No"
"19224","GO_CC","490723_GO_0005666_DNA_DIRECTED_RNA_POLYMERASE_III_COMPLEX",18,1.3258,0.11,0.4,"Yes",0.8544,0.66,0.92,"Yes"
"19225","GO_BP","512758_GO_0051904_PIGMENT_GRANULE_TRANSPORT",24,1.326,0.13,0.63,"Yes",1.321,0.11,0.64,"Yes"
"19226","GO_BP","494006_GO_0009912_AUDITORY_RECEPTOR_CELL_FATE_COMMITMENT",6,1.3274,0.17,0.63,"Yes",-0.63,0.88,1,"No"
"19227","KEGG_enzyme","2.7.7.19_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_NTP_POLYMERASE_RNA_ADENYLATING_ENZYME_AMP_POLYNUCLEOTIDYLEXOTRANSFERASE_ATP_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ATP_POLYNUCLEOTIDYLEXOTRANSFERASE_POLY_A_POLYMERASE_POLY_A_SYNTHETASE_POLYADENYLATE_NUCLEOTIDYLTRANSFERASE_POLYADENYLATE_POLYMERASE_POLYADENYLATE_SYNTHETASE_POLYADENYLIC_ACID_POLYMERASE_POLYADENYLIC_POLYMERASE_TERMINAL_RIBOADENYLATE_TRANSFERASE_POLY_A_HYDROLASE_RNA_FORMATION_FACTORS_PF1_ADENOSINE_TRIPHOSPHATE_RIBONUCLEIC_ACID_ADENYLYLTRANSFERASE",8,1.3275,0.15,0.58,"Yes",1.023,0.4,0.98,"Yes"
"19228","GO_CC","501665_GO_0032433_FILOPODIUM_TIP",9,1.3288,0.16,0.4,"Yes",0.5262,0.98,1,"Yes"
"19229","GO_BP","486762_GO_0000244_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY",11,1.3298,0.13,0.62,"Yes",-0.8428,0.64,1,"No"
"19230","GO_CC","993456_GO_1990391_DNA_REPAIR_COMPLEX",35,1.3308,0.1,0.4,"Yes",0.7508,0.87,0.98,"Yes"
"19231","GO_MF","489277_GO_0003743_TRANSLATION_INITIATION_FACTOR_ACTIVITY",51,1.3309,0.056,0.68,"Yes",2.2705,0,0.00038,"Yes"
"19232","REACTOME","106132_REACT_1861_KETONE_BODY_METABOLISM",5,1.3311,0.17,0.41,"Yes",0.549,0.96,1,"Yes"
"19233","GO_MF","506213_GO_0043140_ATP_DEPENDENT_3_5_DNA_HELICASE_ACTIVITY",5,1.3314,0.2,0.69,"Yes",0.8074,0.66,1,"Yes"
"19234","REACTOME","105754_REACT_6769_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS",37,1.3318,0.085,0.42,"Yes",1.4909,0.034,0.15,"Yes"
"19235","C1_Positional","C1_ALL_248_CHR1P21",33,1.332,0.11,0.52,"Yes",1.0124,0.43,0.74,"Yes"
"19236","REACTOME","1127636_REACT_263883_HH_MUTANTS_THAT_DON_T_UNDERGO_AUTOCATALYTIC_PROCESSING_ARE_DEGRADED_BY_ERAD",54,1.3324,0.053,0.42,"Yes",2.2691,0,6.9e-05,"Yes"
"19237","GO_BP","513524_GO_0055091_PHOSPHOLIPID_HOMEOSTASIS",10,1.3329,0.14,0.62,"Yes",0.8099,0.7,1,"Yes"
"19238","GO_MF","512735_GO_0051880_G_QUADRUPLEX_DNA_BINDING",5,1.3336,0.17,0.69,"Yes",1.2392,0.25,0.69,"Yes"
"19239","GO_BP","1184486_GO_1903960_NEGATIVE_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT",6,1.3353,0.18,0.61,"Yes",0.9354,0.53,1,"Yes"
"19240","GO_BP","507003_GO_0043985_HISTONE_H4_R3_METHYLATION",6,1.336,0.15,0.61,"Yes",-0.9142,0.58,1,"No"
"19241","C7_Immunologic_signatures","C7_ALL_1670_GSE3982_NEUTROPHIL_VS_NKCELL_DN",194,1.3368,0.0084,0.05,"Yes",1.6036,0.0025,0.0028,"Yes"
"19242","C4_Cancer_gene_neighborhoods","C4_CGN_380_GNF2_MLF1",84,1.3379,0.029,0.23,"Yes",-1.0014,0.43,0.87,"No"
"19243","GO_BP","515011_GO_0070072_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY",6,1.3395,0.16,0.6,"Yes",-0.7964,0.72,1,"No"
"19244","KEGG_pathway","HSA03022_BASAL_TRANSCRIPTION_FACTORS",44,1.3398,0.062,0.15,"Yes",1.4721,0.025,0.12,"Yes"
"19245","GO_CC","495069_GO_0012507_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE",41,1.3398,0.046,0.39,"Yes",1.2274,0.16,0.49,"Yes"
"19246","GO_MF","496418_GO_0016433_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY",6,1.34,0.17,0.68,"Yes",0.7505,0.75,1,"Yes"
"19247","GO_MF","501639_GO_0032407_MUTSALPHA_COMPLEX_BINDING",5,1.3411,0.16,0.69,"Yes",0.9919,0.47,0.89,"Yes"
"19248","GO_CC","504220_GO_0035032_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III",5,1.3411,0.19,0.39,"Yes",1.1205,0.34,0.61,"Yes"
"19249","KEGG_module","HSA_M00285_MCM_COMPLEX",6,1.3416,0.15,0.43,"Yes",1.4947,0.067,0.18,"Yes"
"19250","OMIM_gene","OMIM108345_N_ACETYLTRANSFERASE_1_NAT1",5,1.342,0.17,1,"Yes",-0.7056,0.83,0.94,"No"
"19251","REACTOME","106355_REACT_9452_FGFR4_LIGAND_BINDING_AND_ACTIVATION",10,1.3427,0.15,0.4,"Yes",-1.7346,0.013,0.13,"No"
"19252","GO_BP","517503_GO_0072600_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_GOLGI",20,1.3436,0.11,0.6,"Yes",0.7036,0.89,1,"Yes"
"19253","GO_BP","487722_GO_0001826_INNER_CELL_MASS_CELL_DIFFERENTIATION",5,1.3436,0.13,0.6,"Yes",1.194,0.27,0.79,"Yes"
"19254","KEGG_pathway","HSA03430_MISMATCH_REPAIR",23,1.3455,0.12,0.16,"Yes",1.5209,0.037,0.096,"Yes"
"19255","GO_BP","498435_GO_0019605_BUTYRATE_METABOLIC_PROCESS",6,1.3461,0.17,0.59,"Yes",0.3291,1,1,"Yes"
"19256","C1_Positional","C1_ALL_268_CHR5Q13",64,1.3469,0.024,0.51,"Yes",1.6454,0,0.22,"Yes"
"19257","GO_MF","500874_GO_0031624_UBIQUITIN_CONJUGATING_ENZYME_BINDING",13,1.3486,0.12,0.68,"Yes",0.6494,0.91,1,"Yes"
"19258","GO_MF","489241_GO_0003691_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING",5,1.3488,0.16,0.69,"Yes",1.0965,0.35,0.79,"Yes"
"19259","GO_CC","490777_GO_0005742_MITOCHONDRIAL_OUTER_MEMBRANE_TRANSLOCASE_COMPLEX",8,1.3495,0.16,0.38,"Yes",2.0043,0,0.0033,"Yes"
"19260","GO_MF","506111_GO_0043021_RIBONUCLEOPROTEIN_COMPLEX_BINDING",70,1.3498,0.027,0.7,"Yes",1.9381,0,0.022,"Yes"
"19261","GO_BP","503707_GO_0034505_TOOTH_MINERALIZATION",10,1.3507,0.13,0.58,"Yes",0.8671,0.62,1,"Yes"
"19262","GO_CC","500369_GO_0031082_BLOC_COMPLEX",19,1.3526,0.093,0.38,"Yes",1.5633,0.029,0.15,"Yes"
"19263","REACTOME","106264_REACT_1206_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE",7,1.3533,0.16,0.38,"Yes",0.7722,0.77,1,"Yes"
"19264","GO_BP","515492_GO_0070562_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY",6,1.3551,0.15,0.57,"Yes",1.0193,0.44,0.97,"Yes"
"19265","GO_BP","510697_GO_0048641_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",43,1.3553,0.052,0.58,"Yes",0.8843,0.68,1,"Yes"
"19266","GO_BP","516933_GO_0072014_PROXIMAL_TUBULE_DEVELOPMENT",6,1.3557,0.15,0.58,"Yes",-1.0826,0.36,0.96,"No"
"19267","GO_MF","489493_GO_0004024_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT",5,1.3562,0.15,0.69,"Yes",-1.8714,0,0.15,"No"
"19268","GO_BP","512731_GO_0051875_PIGMENT_GRANULE_LOCALIZATION",28,1.3563,0.084,0.58,"Yes",1.4009,0.08,0.55,"Yes"
"19269","GO_CC","503908_GO_0034708_METHYLTRANSFERASE_COMPLEX",83,1.3563,0.032,0.38,"Yes",1.1577,0.19,0.57,"Yes"
"19270","REACTOME","106434_REACT_6772_S6K1_SIGNALLING",5,1.3565,0.14,0.38,"Yes",1.5106,0.045,0.14,"Yes"
"19271","REACTOME","105981_REACT_15306_CYTOSOLIC_TRNA_AMINOACYLATION",24,1.3571,0.085,0.38,"Yes",1.9746,0,0.0033,"Yes"
"19272","GO_BP","808753_GO_0044786_CELL_CYCLE_DNA_REPLICATION",28,1.3571,0.086,0.58,"Yes",1.5633,0.013,0.34,"Yes"
"19273","GO_BP","502480_GO_0033260_NUCLEAR_DNA_REPLICATION",27,1.358,0.085,0.58,"Yes",1.603,0.014,0.29,"Yes"
"19274","GO_MF","489885_GO_0004540_RIBONUCLEASE_ACTIVITY",82,1.358,0.036,0.7,"Yes",1.7348,0.0023,0.12,"Yes"
"19275","GO_BP","517558_GO_0072655_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",59,1.3584,0.073,0.58,"Yes",1.9236,0,0.03,"Yes"
"19276","C2_Chemical_and_genetic_perturbations","C2_CGP_3172_VANDESLUIS_NORMAL_EMBRYOS_DN",24,1.3594,0.073,0.64,"Yes",1.6956,0.0061,0.086,"Yes"
"19277","REACTOME","106380_REACT_18377_GLUCAGON_TYPE_LIGAND_RECEPTORS",27,1.3597,0.095,0.38,"Yes",0.867,0.67,0.94,"Yes"
"19278","REACTOME","187199_REACT_23946_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR",18,1.3606,0.089,0.38,"Yes",0.7801,0.79,1,"Yes"
"19279","GO_BP","487655_GO_0001759_ORGAN_INDUCTION",16,1.3606,0.11,0.58,"Yes",0.8208,0.73,1,"Yes"
"19280","GO_BP","500411_GO_0031124_MRNA_3_END_PROCESSING",87,1.3609,0.025,0.58,"Yes",1.1569,0.17,0.83,"Yes"
"19281","GO_BP","506605_GO_0043574_PEROXISOMAL_TRANSPORT",19,1.361,0.11,0.58,"Yes",1.2319,0.18,0.75,"Yes"
"19282","GO_BP","506182_GO_0043102_AMINO_ACID_SALVAGE",11,1.3613,0.13,0.58,"Yes",-0.7239,0.82,1,"No"
"19283","GO_BP","513678_GO_0060120_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT",6,1.3618,0.14,0.58,"Yes",-0.6084,0.92,1,"No"
"19284","GO_BP","491258_GO_0006297_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING",20,1.3619,0.11,0.59,"Yes",1.3814,0.099,0.57,"Yes"
"19285","GO_CC","487099_GO_0000808_ORIGIN_RECOGNITION_COMPLEX",9,1.3638,0.13,0.37,"Yes",1.3041,0.16,0.4,"Yes"
"19286","GO_BP","493982_GO_0009886_POST_EMBRYONIC_MORPHOGENESIS",12,1.3642,0.12,0.58,"Yes",0.98,0.48,1,"Yes"
"19287","C1_Positional","C1_ALL_309_CHR3Q",6,1.3643,0.15,0.5,"Yes",-1.0349,0.43,1,"No"
"19288","REACTOME","1127523_REACT_263873_DEGRADATION_OF_AXIN",54,1.3661,0.058,0.38,"Yes",2.1336,0,0.00037,"Yes"
"19289","GO_BP","493623_GO_0009452_7_METHYLGUANOSINE_RNA_CAPPING",35,1.3665,0.062,0.58,"Yes",1.6665,0.0022,0.23,"Yes"
"19290","GO_MF","492639_GO_0008320_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",14,1.3666,0.12,0.68,"Yes",1.623,0.029,0.24,"Yes"
"19291","C4_Cancer_gene_neighborhoods","C4_CGN_249_GCM_NUMA1",56,1.3668,0.04,0.2,"Yes",0.486,1,1,"Yes"
"19292","GO_BP","518784_GO_2000136_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS",16,1.3678,0.12,0.58,"Yes",-0.9533,0.5,1,"No"
"19293","GO_CC","490654_GO_0005579_MEMBRANE_ATTACK_COMPLEX",7,1.3682,0.16,0.36,"Yes",1.1015,0.36,0.64,"Yes"
"19294","GO_BP","501632_GO_0032400_MELANOSOME_LOCALIZATION",27,1.3683,0.072,0.58,"Yes",1.4329,0.05,0.52,"Yes"
"19295","KEGG_pathway","HSA03410_BASE_EXCISION_REPAIR",33,1.3685,0.059,0.15,"Yes",1.5204,0.025,0.092,"Yes"
"19296","GO_MF","500273_GO_0030983_MISMATCHED_DNA_BINDING",12,1.3686,0.12,0.69,"Yes",-0.5221,0.98,1,"No"
"19297","GO_BP","513961_GO_0060405_REGULATION_OF_PENILE_ERECTION",7,1.3693,0.13,0.58,"Yes",1.7097,0.008,0.18,"Yes"
"19298","GO_BP","751180_GO_0036260_RNA_CAPPING",35,1.3698,0.056,0.58,"Yes",1.6378,0.0083,0.25,"Yes"
"19299","GO_BP","501634_GO_0032402_MELANOSOME_TRANSPORT",23,1.3703,0.092,0.58,"Yes",1.3045,0.13,0.66,"Yes"
"19300","GO_BP","503449_GO_0034244_NEGATIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",9,1.3707,0.13,0.58,"Yes",1.1484,0.27,0.84,"Yes"
"19301","C2_Chemical_and_genetic_perturbations","C2_CGP_2431_KRISHNAN_FURIN_TARGETS_DN",13,1.3734,0.13,0.6,"Yes",-0.8134,0.74,1,"No"
"19302","REACTOME","105797_REACT_4_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1",50,1.3737,0.039,0.37,"Yes",2.255,0,6.4e-05,"Yes"
"19303","GO_BP","492654_GO_0008343_ADULT_FEEDING_BEHAVIOR",10,1.3741,0.11,0.58,"Yes",-1.1484,0.3,0.93,"No"
"19304","GO_BP","491362_GO_0006450_REGULATION_OF_TRANSLATIONAL_FIDELITY",16,1.3756,0.098,0.58,"Yes",1.5442,0.032,0.35,"Yes"
"19305","GO_MF","489880_GO_0004532_EXORIBONUCLEASE_ACTIVITY",33,1.3758,0.073,0.68,"Yes",1.4191,0.056,0.47,"Yes"
"19306","REACTOME","106347_REACT_9515_FGFR1C_LIGAND_BINDING_AND_ACTIVATION",10,1.3758,0.15,0.37,"Yes",-0.6864,0.87,1,"No"
"19307","GO_CC","490726_GO_0005669_TRANSCRIPTION_FACTOR_TFIID_COMPLEX",23,1.376,0.07,0.35,"Yes",1.3185,0.1,0.39,"Yes"
"19308","C2_Chemical_and_genetic_perturbations","C2_CGP_2684_VALK_AML_CLUSTER_8",26,1.3761,0.09,0.61,"Yes",1.7553,0.006,0.058,"Yes"
"19309","C2_Chemical_and_genetic_perturbations","C2_CGP_2412_TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA",75,1.3766,0.039,0.62,"Yes",1.5615,0.022,0.16,"Yes"
"19310","GO_MF","498592_GO_0019783_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY",85,1.3767,0.034,0.69,"Yes",1.1258,0.22,0.75,"Yes"
"19311","GO_MF","492704_GO_0008408_3_5_EXONUCLEASE_ACTIVITY",44,1.3777,0.063,0.7,"Yes",1.2194,0.17,0.7,"Yes"
"19312","C4_Cancer_gene_neighborhoods","C4_CGN_213_GCM_CASP2",27,1.3782,0.065,0.18,"Yes",-0.5632,0.98,1,"No"
"19313","KEGG_module","HSA_M00181_RNA_POLYMERASE_III_EUKARYOTES",17,1.3787,0.092,0.39,"Yes",0.7997,0.77,0.94,"Yes"
"19314","REACTOME","105796_REACT_938_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D",50,1.3789,0.046,0.36,"Yes",2.2552,0,6.6e-05,"Yes"
"19315","GO_CC","490721_GO_0005664_NUCLEAR_ORIGIN_OF_REPLICATION_RECOGNITION_COMPLEX",9,1.379,0.12,0.35,"Yes",1.3358,0.15,0.37,"Yes"
"19316","C4_Cancer_gene_neighborhoods","C4_CGN_233_GCM_HBP1",69,1.3794,0.03,0.19,"Yes",1.5354,0.01,0.024,"Yes"
"19317","GO_BP","491259_GO_0006298_MISMATCH_REPAIR",30,1.3796,0.085,0.57,"Yes",0.9038,0.6,1,"Yes"
"19318","C4_Cancer_gene_neighborhoods","C4_CGN_227_GCM_DPF2",32,1.3802,0.062,0.19,"Yes",1.2359,0.17,0.18,"Yes"
"19319","C4_Cancer_gene_neighborhoods","C4_CGN_73_MORF_CDC16",74,1.3803,0.017,0.2,"Yes",1.6079,0.0089,0.014,"Yes"
"19320","REACTOME","105951_REACT_1735_MRNA_SPLICING",114,1.3815,0.016,0.36,"Yes",1.8029,0,0.02,"Yes"
"19321","REACTOME","1183611_REACT_355367_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY",7,1.3819,0.14,0.37,"Yes",-0.7176,0.83,1,"No"
"19322","GO_BP","491314_GO_0006390_TRANSCRIPTION_FROM_MITOCHONDRIAL_PROMOTER",10,1.3824,0.12,0.56,"Yes",1.4037,0.095,0.55,"Yes"
"19323","C7_Immunologic_signatures","C7_ALL_335_GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP",200,1.3826,0,0.026,"Yes",1.3609,0.011,0.056,"Yes"
"19324","GO_MF","492617_GO_0008296_3_5_EXODEOXYRIBONUCLEASE_ACTIVITY",8,1.383,0.13,0.69,"Yes",1.1789,0.27,0.73,"Yes"
"19325","GO_BP","494827_GO_0010762_REGULATION_OF_FIBROBLAST_MIGRATION",19,1.3851,0.1,0.56,"Yes",0.7552,0.83,1,"Yes"
"19326","GO_BP","505901_GO_0042796_SNRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",5,1.3852,0.12,0.56,"Yes",0.5222,0.97,1,"Yes"
"19327","GO_BP","510890_GO_0048840_OTOLITH_DEVELOPMENT",5,1.3864,0.16,0.56,"Yes",1.1855,0.29,0.8,"Yes"
"19328","REACTOME","1183524_REACT_355313_SIGNALING_BY_FGFR3_MUTANTS",20,1.3868,0.075,0.36,"Yes",-0.8403,0.69,1,"No"
"19329","KEGG_pathway","HSA03018_RNA_DEGRADATION",74,1.3869,0.046,0.15,"Yes",1.5531,0.0066,0.086,"Yes"
"19330","REACTOME","105871_REACT_408_PRESYNAPTIC_PHASE_OF_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE",6,1.3869,0.13,0.36,"Yes",1.2109,0.26,0.44,"Yes"
"19331","C4_Cancer_gene_neighborhoods","C4_CGN_389_GNF2_PA2G4",79,1.3871,0.016,0.19,"Yes",2.392,0,0,"Yes"
"19332","GO_BP","487574_GO_0001661_CONDITIONED_TASTE_AVERSION",5,1.3892,0.13,0.55,"Yes",-1.2551,0.22,0.91,"No"
"19333","C2_Chemical_and_genetic_perturbations","C2_CGP_2708_BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP",188,1.3908,0.014,0.59,"Yes",2.2073,0,0.00057,"Yes"
"19334","GO_BP","503275_GO_0034067_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS",32,1.3908,0.06,0.55,"Yes",0.8117,0.79,1,"Yes"
"19335","GO_BP","516189_GO_0071265_L_METHIONINE_BIOSYNTHETIC_PROCESS",11,1.3909,0.11,0.56,"Yes",-0.7163,0.84,1,"No"
"19336","C7_Immunologic_signatures","C7_ALL_80_GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN",193,1.3916,0.016,0.023,"Yes",1.3588,0.012,0.057,"Yes"
"19337","C4_Cancer_gene_neighborhoods","C4_CGN_176_MORF_SART1",63,1.3919,0.037,0.19,"Yes",2.6636,0,0,"Yes"
"19338","GO_BP","515066_GO_0070129_REGULATION_OF_MITOCHONDRIAL_TRANSLATION",10,1.3944,0.11,0.55,"Yes",1.1711,0.28,0.81,"Yes"
"19339","GO_MF","492529_GO_0008186_RNA_DEPENDENT_ATPASE_ACTIVITY",39,1.3949,0.05,0.67,"Yes",0.7722,0.85,1,"Yes"
"19340","GO_CC","490737_GO_0005683_U7_SNRNP",7,1.396,0.11,0.33,"Yes",1.6582,0.011,0.083,"Yes"
"19341","GO_MF","489475_GO_0004004_ATP_DEPENDENT_RNA_HELICASE_ACTIVITY",38,1.3963,0.047,0.68,"Yes",0.7996,0.8,1,"Yes"
"19342","GO_BP","516191_GO_0071267_L_METHIONINE_SALVAGE",11,1.3964,0.085,0.55,"Yes",-0.731,0.8,1,"No"
"19343","C3_TF_targets","C3_TFT_526_TMTCGCGANR_UNKNOWN",160,1.3966,0.012,0.11,"Yes",1.3862,0.0045,0.35,"Yes"
"19344","GO_BP","518786_GO_2000138_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS",5,1.3977,0.12,0.55,"Yes",0.9835,0.46,1,"Yes"
"19345","C2_Chemical_and_genetic_perturbations","C2_CGP_1313_DER_IFN_BETA_RESPONSE_DN",7,1.3983,0.11,0.58,"Yes",0.7729,0.76,1,"Yes"
"19346","C7_Immunologic_signatures","C7_ALL_951_GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP",200,1.3985,0,0.022,"Yes",1.4082,0.0096,0.035,"Yes"
"19347","C4_Cancer_gene_neighborhoods","C4_CGN_241_GCM_MAX",30,1.3997,0.056,0.19,"Yes",1.5376,0.017,0.024,"Yes"
"19348","C2_Chemical_and_genetic_perturbations","C2_CGP_2450_SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN",8,1.3997,0.11,0.6,"Yes",0.9806,0.46,0.81,"Yes"
"19349","GO_BP","510577_GO_0048505_REGULATION_OF_TIMING_OF_CELL_DIFFERENTIATION",11,1.4,0.089,0.54,"Yes",-0.7933,0.72,1,"No"
"19350","GO_BP","491839_GO_0007004_TELOMERE_MAINTENANCE_VIA_TELOMERASE",11,1.4,0.11,0.54,"Yes",1.3317,0.13,0.63,"Yes"
"19351","REACTOME","105836_REACT_6785_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C",60,1.4014,0.047,0.34,"Yes",2.3699,0,0,"Yes"
"19352","KEGG_compound","C00063_CTP_CYTIDINE_5_TRIPHOSPHATE_CYTIDINE_TRIPHOSPHATE",55,1.4014,0.052,0.75,"Yes",0.8574,0.73,1,"Yes"
"19353","GO_BP","514933_GO_0065002_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT",37,1.4017,0.079,0.54,"Yes",1.5118,0.033,0.39,"Yes"
"19354","C2_Chemical_and_genetic_perturbations","C2_CGP_918_WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN",5,1.4019,0.12,0.61,"Yes",1.209,0.25,0.48,"Yes"
"19355","C4_Cancer_gene_neighborhoods","C4_CGN_72_MORF_CDC10",145,1.4027,0.0059,0.19,"Yes",1.827,0,0.0016,"Yes"
"19356","REACTOME","1183523_REACT_355310_SIGNALING_BY_FGFR3_IN_DISEASE",20,1.4032,0.086,0.34,"Yes",-0.8196,0.72,1,"No"
"19357","C4_Cancer_gene_neighborhoods","C4_CGN_375_GNF2_MBD4",25,1.4042,0.071,0.19,"Yes",2.3921,0,0,"Yes"
"19358","REACTOME","1183612_REACT_355510_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR",19,1.4048,0.088,0.34,"Yes",1.5174,0.043,0.14,"Yes"
"19359","KEGG_module","HSA_M00048_INOSINE_MONOPHOSPHATE_BIOSYNTHESIS_PRPP_GLUTAMINE_IMP",6,1.4048,0.12,0.37,"Yes",0.9856,0.46,0.89,"Yes"
"19360","GO_MF","489238_GO_0003688_DNA_REPLICATION_ORIGIN_BINDING",7,1.4053,0.13,0.66,"Yes",1.5557,0.053,0.32,"Yes"
"19361","C7_Immunologic_signatures","C7_ALL_189_GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP",197,1.4055,0,0.02,"Yes",1.9579,0,0,"Yes"
"19362","REACTOME","1183552_REACT_188330_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING",59,1.4068,0.043,0.34,"Yes",2.179,0,0.00019,"Yes"
"19363","GO_BP","516404_GO_0071480_CELLULAR_RESPONSE_TO_GAMMA_RADIATION",15,1.4073,0.083,0.53,"Yes",1.0873,0.34,0.92,"Yes"
"19364","C4_Cancer_gene_neighborhoods","C4_CGN_301_GNF2_HDAC1",110,1.4076,0.0059,0.19,"Yes",1.9356,0,0.00058,"Yes"
"19365","GO_BP","518916_GO_2000269_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS",16,1.4095,0.085,0.53,"Yes",1.024,0.42,0.97,"Yes"
"19366","GO_BP","518918_GO_2000271_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS",6,1.4095,0.12,0.53,"Yes",0.8582,0.61,1,"Yes"
"19367","GO_BP","948074_GO_0044829_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION",5,1.4099,0.11,0.53,"Yes",1.3447,0.14,0.61,"Yes"
"19368","C7_Immunologic_signatures","C7_ALL_117_GSE12366_NAIVE_VS_MEMORY_BCELL_UP",190,1.4108,0,0.019,"Yes",0.6062,1,1,"Yes"
"19369","C2_Chemical_and_genetic_perturbations","C2_CGP_945_JIANG_CORE_DUPLICON_GENES",11,1.4117,0.1,0.59,"Yes",-1.0392,0.4,0.97,"No"
"19370","REACTOME","205244_REACT_27258_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT_",29,1.4123,0.063,0.33,"Yes",2.0255,0,0.0016,"Yes"
"19371","GO_BP","499110_GO_0021830_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX",5,1.4124,0.13,0.53,"Yes",-1.6143,0.018,0.7,"No"
"19372","GO_CC","490741_GO_0005687_U4_SNRNP",9,1.4132,0.089,0.31,"Yes",1.6952,0.0082,0.064,"Yes"
"19373","GO_CC","487830_GO_0001939_FEMALE_PRONUCLEUS",8,1.4133,0.096,0.31,"Yes",0.7246,0.82,0.99,"Yes"
"19374","REACTOME","105952_REACT_467_MRNA_SPLICING_MAJOR_PATHWAY",114,1.4154,0.031,0.33,"Yes",1.8193,0,0.018,"Yes"
"19375","C7_Immunologic_signatures","C7_ALL_229_GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP",199,1.4157,0.008,0.019,"Yes",1.5779,0,0.0043,"Yes"
"19376","GO_MF","492405_GO_0008026_ATP_DEPENDENT_HELICASE_ACTIVITY",73,1.4159,0.027,0.64,"Yes",0.8141,0.85,1,"Yes"
"19377","C2_Chemical_and_genetic_perturbations","C2_CGP_3195_BILANGES_SERUM_RESPONSE_TRANSLATION",35,1.416,0.049,0.59,"Yes",2.8296,0,0,"Yes"
"19378","GO_BP","751885_GO_0044743_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_IMPORT",31,1.4161,0.04,0.52,"Yes",1.57,0.028,0.33,"Yes"
"19379","GO_BP","486553_GO_0000002_MITOCHONDRIAL_GENOME_MAINTENANCE",25,1.4167,0.061,0.52,"Yes",0.8185,0.76,1,"Yes"
"19380","GO_BP","486854_GO_0000338_PROTEIN_DENEDDYLATION",12,1.4171,0.093,0.52,"Yes",1.6572,0.019,0.24,"Yes"
"19381","C4_Cancer_modules","C4_CM_290_MODULE_331",74,1.4178,0.027,0.29,"Yes",1.2789,0.098,0.3,"Yes"
"19382","GO_BP","491161_GO_0006189_DE_NOVO_IMP_BIOSYNTHETIC_PROCESS",6,1.4194,0.12,0.52,"Yes",0.9819,0.49,1,"Yes"
"19383","GO_BP","505902_GO_0042797_TRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",6,1.4203,0.11,0.52,"Yes",1.2991,0.17,0.67,"Yes"
"19384","REACTOME","106565_REACT_571_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER",28,1.4207,0.046,0.33,"Yes",0.7363,0.89,1,"Yes"
"19385","KEGG_pathway","HSA04122_SULFUR_RELAY_SYSTEM",10,1.4225,0.11,0.13,"Yes",1.0996,0.31,0.78,"Yes"
"19386","C2_Chemical_and_genetic_perturbations","C2_CGP_1761_MA_PITUITARY_FETAL_VS_ADULT_DN",18,1.4233,0.093,0.59,"Yes",1.1695,0.22,0.53,"Yes"
"19387","GO_CC","486664_GO_0000125_PCAF_COMPLEX",6,1.4235,0.13,0.3,"Yes",0.964,0.5,0.82,"Yes"
"19388","GO_BP","515455_GO_0070525_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS",5,1.4243,0.11,0.51,"Yes",0.855,0.64,1,"Yes"
"19389","GO_MF","506526_GO_0043495_PROTEIN_ANCHOR",8,1.4253,0.11,0.62,"Yes",0.8569,0.66,1,"Yes"
"19390","GO_BP","492508_GO_0032786_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",24,1.4255,0.064,0.51,"Yes",1.3939,0.074,0.56,"Yes"
"19391","GO_BP","911392_GO_0098534_CENTRIOLE_ASSEMBLY",14,1.4258,0.093,0.51,"Yes",-0.789,0.76,1,"No"
"19392","C2_Chemical_and_genetic_perturbations","C2_CGP_2414_CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN",28,1.4278,0.08,0.59,"Yes",1.653,0.011,0.11,"Yes"
"19393","GO_CC","490814_GO_0005786_SIGNAL_RECOGNITION_PARTICLE_ENDOPLASMIC_RETICULUM_TARGETING",6,1.4281,0.087,0.29,"Yes",1.8163,0.0043,0.023,"Yes"
"19394","GO_BP","510844_GO_0048793_PRONEPHROS_DEVELOPMENT",9,1.4292,0.098,0.51,"Yes",-0.7077,0.86,1,"No"
"19395","GO_CC","490740_GO_0005686_U2_SNRNP",6,1.4293,0.11,0.3,"Yes",1.6645,0.016,0.081,"Yes"
"19396","GO_BP","510699_GO_0048643_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",17,1.4298,0.072,0.51,"Yes",0.906,0.62,1,"Yes"
"19397","GO_BP","510494_GO_0048387_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",16,1.4301,0.064,0.51,"Yes",-0.8667,0.67,1,"No"
"19398","GO_BP","505896_GO_0042791_5S_CLASS_RRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_TYPE_1_PROMOTER",6,1.4307,0.094,0.51,"Yes",1.3228,0.16,0.64,"Yes"
"19399","GO_BP","512270_GO_0051386_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY",7,1.4307,0.098,0.51,"Yes",1.5695,0.034,0.33,"Yes"
"19400","REACTOME","1127506_REACT_267948_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM",23,1.4318,0.057,0.31,"Yes",1.2885,0.14,0.34,"Yes"
"19401","GO_BP","507447_GO_0045046_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE",6,1.4319,0.13,0.51,"Yes",1.4792,0.073,0.44,"Yes"
"19402","GO_BP","492811_GO_0008535_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY",14,1.4327,0.087,0.51,"Yes",1.1242,0.31,0.88,"Yes"
"19403","GO_BP","496168_GO_0016074_SNORNA_METABOLIC_PROCESS",5,1.4338,0.11,0.51,"Yes",1.3471,0.15,0.61,"Yes"
"19404","C7_Immunologic_signatures","C7_ALL_1347_GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP",200,1.4371,0.008,0.014,"Yes",1.8971,0,0,"Yes"
"19405","GO_CC","983680_GO_0090576_RNA_POLYMERASE_III_TRANSCRIPTION_FACTOR_COMPLEX",7,1.4407,0.1,0.28,"Yes",1.2404,0.21,0.47,"Yes"
"19406","C1_Positional","C1_ALL_174_CHR4Q",5,1.4426,0.1,0.35,"Yes",1.3446,0.17,0.48,"Yes"
"19407","GO_MF","490604_GO_0005487_NUCLEOCYTOPLASMIC_TRANSPORTER_ACTIVITY",14,1.4433,0.078,0.58,"Yes",-0.7259,0.81,1,"No"
"19408","GO_BP","491518_GO_0006626_PROTEIN_TARGETING_TO_MITOCHONDRION",56,1.4445,0.025,0.49,"Yes",1.9316,0,0.028,"Yes"
"19409","GO_CC","486666_GO_0000127_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX",6,1.4455,0.1,0.28,"Yes",1.3173,0.16,0.39,"Yes"
"19410","KEGG_module","HSA_M00413_FA_CORE_COMPLEX",10,1.4457,0.077,0.32,"Yes",0.7189,0.84,0.94,"Yes"
"19411","KEGG_compound","C02189__PROTEIN_L_SERINE_PROTEIN_SERINE_PROTEIN_L_SERINE",31,1.4471,0.031,0.66,"Yes",-0.8063,0.75,1,"No"
"19412","GO_CC","510573_GO_0048500_SIGNAL_RECOGNITION_PARTICLE",6,1.4471,0.12,0.28,"Yes",1.7994,0.0061,0.027,"Yes"
"19413","GO_CC","500679_GO_0031428_BOX_C_D_SNORNP_COMPLEX",5,1.4472,0.095,0.28,"Yes",1.5357,0.036,0.17,"Yes"
"19414","C7_Immunologic_signatures","C7_ALL_1175_GSE27786_LIN_NEG_VS_MONO_MAC_UP",198,1.4479,0,0.012,"Yes",1.1889,0.072,0.25,"Yes"
"19415","C2_Chemical_and_genetic_perturbations","C2_CGP_1532_GALE_APL_WITH_FLT3_MUTATED_UP",56,1.4491,0.021,0.54,"Yes",1.2553,0.12,0.43,"Yes"
"19416","C4_Cancer_gene_neighborhoods","C4_CGN_137_MORF_NPM1",162,1.4502,0,0.15,"Yes",3.7332,0,0,"Yes"
"19417","C1_Positional","C1_ALL_43_CHR4Q35",37,1.4516,0.043,0.36,"Yes",1.1878,0.2,0.6,"Yes"
"19418","C4_Cancer_gene_neighborhoods","C4_CGN_94_MORF_EIF4E",85,1.4519,0.023,0.15,"Yes",1.5453,0.0045,0.023,"Yes"
"19419","REACTOME","187213_REACT_24915_BUTYRATE_RESPONSE_FACTOR_1_BRF1_DESTABILIZES_MRNA",17,1.4524,0.056,0.28,"Yes",1.5445,0.036,0.12,"Yes"
"19420","WikiPathways","198775_WP1559_TFS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY",9,1.4541,0.093,0.27,"Yes",-0.7685,0.76,1,"No"
"19421","KEGG_module","HSA_M00396_LSM_2_8_COMPLEX",7,1.4544,0.087,0.33,"Yes",1.4098,0.085,0.27,"Yes"
"19422","GO_MF","495347_GO_0015057_THROMBIN_RECEPTOR_ACTIVITY",5,1.4552,0.087,0.56,"Yes",1.5821,0.02,0.3,"Yes"
"19423","C4_Cancer_gene_neighborhoods","C4_CGN_49_MORF_TERF1",66,1.4554,0.015,0.15,"Yes",1.2282,0.14,0.19,"Yes"
"19424","C2_Chemical_and_genetic_perturbations","C2_CGP_2083_SANSOM_APC_TARGETS_REQUIRE_MYC",207,1.456,0,0.54,"Yes",0.8652,0.87,0.96,"Yes"
"19425","GO_BP","492877_GO_0008628_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY",5,1.4563,0.099,0.46,"Yes",-1.1972,0.27,0.9,"No"
"19426","GO_BP","502210_GO_0032988_RIBONUCLEOPROTEIN_COMPLEX_DISASSEMBLY",10,1.4565,0.091,0.46,"Yes",1.4294,0.074,0.52,"Yes"
"19427","C2_Chemical_and_genetic_perturbations","C2_CGP_2292_WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP",6,1.4567,0.096,0.56,"Yes",-1.1236,0.32,0.89,"No"
"19428","REACTOME","106361_REACT_17041_VASOPRESSIN_LIKE_RECEPTORS",6,1.457,0.1,0.28,"Yes",-0.6646,0.9,1,"No"
"19429","GO_MF","501419_GO_0032184_SUMO_POLYMER_BINDING",5,1.4574,0.1,0.56,"Yes",0.866,0.65,1,"Yes"
"19430","GO_BP","502964_GO_0033753_ESTABLISHMENT_OF_RIBOSOME_LOCALIZATION",6,1.4593,0.081,0.46,"Yes",1.5581,0.037,0.34,"Yes"
"19431","REACTOME","106541_REACT_8030_EXTENSION_OF_TELOMERES",29,1.4612,0.038,0.27,"Yes",1.6145,0.015,0.087,"Yes"
"19432","GO_BP","493488_GO_0009304_TRNA_TRANSCRIPTION",7,1.4616,0.093,0.46,"Yes",1.2547,0.2,0.73,"Yes"
"19433","GO_BP","502013_GO_0032790_RIBOSOME_DISASSEMBLY",7,1.4629,0.081,0.46,"Yes",1.5782,0.034,0.31,"Yes"
"19434","REACTOME","106561_REACT_1371_RNA_POLYMERASE_III_TRANSCRIPTION",40,1.4629,0.024,0.27,"Yes",1.0299,0.4,0.69,"Yes"
"19435","C2_Chemical_and_genetic_perturbations","C2_CGP_1059_RICKMAN_METASTASIS_UP",340,1.4636,0,0.55,"Yes",1.358,0.0073,0.33,"Yes"
"19436","GO_MF","490710_GO_0008536_RAN_GTPASE_BINDING",26,1.465,0.044,0.56,"Yes",1.104,0.3,0.78,"Yes"
"19437","REACTOME","160947_REACT_22107_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS",64,1.4662,0.0041,0.27,"Yes",1.7184,0.002,0.041,"Yes"
"19438","GO_BP","486601_GO_0000054_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS",6,1.4664,0.088,0.45,"Yes",1.5559,0.028,0.33,"Yes"
"19439","GO_CC","490773_GO_0005732_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX",15,1.4666,0.046,0.26,"Yes",1.6558,0.024,0.083,"Yes"
"19440","GO_BP","518213_GO_0090073_POSITIVE_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY",7,1.4668,0.061,0.45,"Yes",1.2701,0.19,0.71,"Yes"
"19441","GO_BP","496509_GO_0016558_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX",13,1.467,0.066,0.45,"Yes",0.9491,0.53,1,"Yes"
"19442","GO_BP","502430_GO_0033210_LEPTIN_MEDIATED_SIGNALING_PATHWAY",6,1.4672,0.086,0.46,"Yes",1.3087,0.17,0.66,"Yes"
"19443","REACTOME","833803_REACT_163931_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY",33,1.4672,0.038,0.27,"Yes",1.2263,0.19,0.42,"Yes"
"19444","REACTOME","576252_REACT_118778_ACTIVATION_OF_RAS_IN_B_CELLS",5,1.4676,0.075,0.28,"Yes",1.5483,0.053,0.12,"Yes"
"19445","GO_CC","490738_GO_0005684_U2_TYPE_SPLICEOSOMAL_COMPLEX",7,1.4676,0.076,0.26,"Yes",1.4861,0.069,0.21,"Yes"
"19446","REACTOME","105996_REACT_6233_TRANSCRIPTION_OF_THE_HIV_GENOME",66,1.4686,0.018,0.28,"Yes",1.7401,0.0021,0.035,"Yes"
"19447","GO_CC","486708_GO_0000177_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX_",9,1.4692,0.071,0.26,"Yes",0.7381,0.8,0.99,"Yes"
"19448","REACTOME","106411_REACT_8028_TERMINAL_PATHWAY_OF_COMPLEMENT",7,1.4695,0.12,0.28,"Yes",1.1013,0.34,0.58,"Yes"
"19449","GO_BP","496972_GO_0017183_PEPTIDYL_DIPHTHAMIDE_BIOSYNTHETIC_PROCESS_FROM_PEPTIDYL_HISTIDINE",8,1.4697,0.073,0.45,"Yes",0.9995,0.46,0.98,"Yes"
"19450","GO_BP","502961_GO_0033750_RIBOSOME_LOCALIZATION",6,1.4701,0.11,0.45,"Yes",1.5205,0.056,0.38,"Yes"
"19451","C4_Cancer_modules","C4_CM_27_MODULE_28",32,1.4702,0.045,0.24,"Yes",2.2994,0,0,"Yes"
"19452","GO_CC","500192_GO_0030897_HOPS_COMPLEX",12,1.4703,0.073,0.26,"Yes",1.087,0.33,0.67,"Yes"
"19453","C1_Positional","C1_ALL_189_CHR2Q37",117,1.4724,0.012,0.35,"Yes",1.2932,0.037,0.53,"Yes"
"19454","REACTOME","105708_REACT_13450_VITAMINS",6,1.4739,0.088,0.28,"Yes",-0.9794,0.48,1,"No"
"19455","C4_Cancer_gene_neighborhoods","C4_CGN_247_GCM_NF2",302,1.474,0,0.13,"Yes",1.0962,0.19,0.38,"Yes"
"19456","GO_BP","516729_GO_0071806_PROTEIN_TRANSMEMBRANE_TRANSPORT",47,1.4759,0.03,0.44,"Yes",1.7268,0.0045,0.16,"Yes"
"19457","KEGG_module","HSA_M00289_RF_C_COMPLEX",5,1.4778,0.072,0.32,"Yes",1.5194,0.049,0.16,"Yes"
"19458","GO_BP","752558_GO_0090501_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS",85,1.4779,0.019,0.44,"Yes",1.7935,0,0.11,"Yes"
"19459","GO_BP","500450_GO_0031163_METALLO_SULFUR_CLUSTER_ASSEMBLY",18,1.48,0.056,0.44,"Yes",1.7081,0.021,0.19,"Yes"
"19460","C7_Immunologic_signatures","C7_ALL_1285_GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP",183,1.48,0.007,0.0071,"Yes",0.9905,0.5,0.77,"Yes"
"19461","C1_Positional","C1_ALL_250_CHR3Q13",81,1.4807,0.0041,0.37,"Yes",1.5453,0,0.29,"Yes"
"19462","GO_BP","496971_GO_0017182_PEPTIDYL_DIPHTHAMIDE_METABOLIC_PROCESS",8,1.4813,0.077,0.44,"Yes",1.0326,0.39,0.96,"Yes"
"19463","KEGG_enzyme","2.3.2.13_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_TRANSGLUTAMINASE_FACTOR_XIIIA_FIBRINOLIGASE_FIBRIN_STABILIZING_FACTOR_GLUTAMINYLPEPTIDE_GAMMA_GLUTAMYLTRANSFERASE_POLYAMINE_TRANSGLUTAMINASE_TISSUE_TRANSGLUTAMINASE_R_GLUTAMINYL_PEPTIDE_AMINE_GAMMA_GLUTAMYL_TRANSFERASE",8,1.4818,0.071,0.37,"Yes",0.9108,0.58,1,"Yes"
"19464","C7_Immunologic_signatures","C7_ALL_1159_GSE27786_LSK_VS_MONO_MAC_UP",198,1.4821,0,0.0072,"Yes",1.1862,0.092,0.25,"Yes"
"19465","REACTOME","160949_REACT_22339_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION",40,1.4834,0.027,0.26,"Yes",1.0337,0.38,0.69,"Yes"
"19466","REACTOME","105895_REACT_18410_FANCONI_ANEMIA_PATHWAY",24,1.4862,0.046,0.26,"Yes",1.407,0.076,0.22,"Yes"
"19467","REACTOME","160951_REACT_1768_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA",23,1.4865,0.058,0.27,"Yes",1.5071,0.047,0.14,"Yes"
"19468","GO_BP","515170_GO_0070235_REGULATION_OF_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS",5,1.4872,0.081,0.43,"Yes",1.1293,0.31,0.87,"Yes"
"19469","GO_CC","513461_GO_0055029_NUCLEAR_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX",115,1.4884,0.0056,0.24,"Yes",1.325,0.036,0.38,"Yes"
"19470","C2_Chemical_and_genetic_perturbations","C2_CGP_2872_KYNG_NORMAL_AGING_UP",18,1.4887,0.061,0.49,"Yes",1.1415,0.27,0.56,"Yes"
"19471","GO_BP","490809_GO_0006625_PROTEIN_TARGETING_TO_PEROXISOME",17,1.4889,0.065,0.42,"Yes",1.243,0.19,0.74,"Yes"
"19472","GO_BP","517566_GO_0072663_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME",18,1.4896,0.061,0.43,"Yes",1.2679,0.18,0.71,"Yes"
"19473","GO_BP","491247_GO_0006284_BASE_EXCISION_REPAIR",44,1.4897,0.039,0.43,"Yes",1.6904,0.0042,0.21,"Yes"
"19474","C1_Positional","C1_ALL_159_CHR7P22",77,1.4898,0.0087,0.39,"Yes",1.1335,0.21,0.62,"Yes"
"19475","GO_BP","518584_GO_0097034_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_IV_BIOGENESIS",7,1.4906,0.078,0.43,"Yes",0.7216,0.83,1,"Yes"
"19476","GO_CC","487831_GO_0001940_MALE_PRONUCLEUS",6,1.4915,0.089,0.24,"Yes",1.1374,0.32,0.6,"Yes"
"19477","GO_BP","487026_GO_0000729_DNA_DOUBLE_STRAND_BREAK_PROCESSING",10,1.4919,0.075,0.43,"Yes",1.0091,0.43,0.98,"Yes"
"19478","KEGG_reaction","R08281_ALCOPHOSPHAMIDE_NAD_OXIDOREDUCTASE_ALDOPHOSPHAMIDE_NADH_H_ALCOPHOSPHAMIDE_NAD_",7,1.4937,0.066,0.45,"Yes",1.0947,0.33,0.9,"Yes"
"19479","GO_BP","487987_GO_0002098_TRNA_WOBBLE_URIDINE_MODIFICATION",7,1.4948,0.069,0.42,"Yes",1.5392,0.043,0.36,"Yes"
"19480","GO_BP","499306_GO_0022027_INTERKINETIC_NUCLEAR_MIGRATION",9,1.4958,0.063,0.42,"Yes",0.6526,0.9,1,"Yes"
"19481","GO_BP","496295_GO_0016226_IRON_SULFUR_CLUSTER_ASSEMBLY",18,1.4969,0.034,0.42,"Yes",1.6991,0.0043,0.19,"Yes"
"19482","C4_Cancer_gene_neighborhoods","C4_CGN_350_GNF2_ELAC2",46,1.497,0.032,0.12,"Yes",1.0626,0.34,0.44,"Yes"
"19483","GO_BP","493442_GO_0009249_PROTEIN_LIPOYLATION",5,1.4977,0.058,0.42,"Yes",0.917,0.55,1,"Yes"
"19484","C7_Immunologic_signatures","C7_ALL_1157_GSE27786_LSK_VS_NEUTROPHIL_UP",199,1.4978,0,0.0059,"Yes",1.3063,0.017,0.096,"Yes"
"19485","GO_CC","490743_GO_0005689_U12_TYPE_SPLICEOSOMAL_COMPLEX",24,1.498,0.046,0.24,"Yes",2.0635,0.0021,0.0015,"Yes"
"19486","KEGG_compound","C00469_ETHANOL_ETHYL_ALCOHOL_METHYLCARBINOL",8,1.4982,0.078,0.56,"Yes",1.0344,0.43,1,"Yes"
"19487","GO_BP","515576_GO_0070646_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL",102,1.499,0.0055,0.42,"Yes",1.3152,0.043,0.65,"Yes"
"19488","REACTOME","160985_REACT_15292_THYROXINE_BIOSYNTHESIS",7,1.499,0.082,0.25,"Yes",1.1126,0.33,0.56,"Yes"
"19489","C2_Chemical_and_genetic_perturbations","C2_CGP_2496_WAGNER_APO2_SENSITIVITY",25,1.4994,0.056,0.48,"Yes",0.8379,0.74,0.98,"Yes"
"19490","KEGG_enzyme","1.1.1.1_ALCOHOL_DEHYDROGENASE_ALDEHYDE_REDUCTASE_ADH_ALCOHOL_DEHYDROGENASE_NAD_ALIPHATIC_ALCOHOL_DEHYDROGENASE_ETHANOL_DEHYDROGENASE_NAD_DEPENDENT_ALCOHOL_DEHYDROGENASE_NAD_SPECIFIC_AROMATIC_ALCOHOL_DEHYDROGENASE_NADH_ALCOHOL_DEHYDROGENASE_NADH_ALDEHYDE_DEHYDROGENASE_PRIMARY_ALCOHOL_DEHYDROGENASE_YEAST_ALCOHOL_DEHYDROGENASE",7,1.5009,0.068,0.49,"Yes",1.0857,0.37,0.96,"Yes"
"19491","GO_MF","489504_GO_0004035_ALKALINE_PHOSPHATASE_ACTIVITY",6,1.5011,0.089,0.47,"Yes",1.621,0.023,0.24,"Yes"
"19492","GO_BP","489262_GO_0006369_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION",48,1.5015,0.02,0.42,"Yes",1.2736,0.12,0.71,"Yes"
"19493","REACTOME","105893_REACT_74_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC_NER",17,1.5017,0.053,0.25,"Yes",1.3441,0.085,0.27,"Yes"
"19494","REACTOME","160995_REACT_20619_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE",11,1.5025,0.06,0.25,"Yes",1.6561,0.02,0.067,"Yes"
"19495","KEGG_compound","C16586_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE",7,1.5026,0.076,0.63,"Yes",1.0721,0.38,1,"Yes"
"19496","C4_Cancer_modules","C4_CM_29_MODULE_32",241,1.5032,0,0.22,"Yes",3.0837,0,0,"Yes"
"19497","GO_BP","486956_GO_0000463_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",5,1.5038,0.093,0.42,"Yes",0.937,0.52,1,"Yes"
"19498","GO_BP","505821_GO_0042713_SPERM_EJACULATION",6,1.5043,0.074,0.42,"Yes",0.8521,0.63,1,"Yes"
"19499","GO_BP","486805_GO_0000288_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY",55,1.5048,0.027,0.42,"Yes",1.5225,0.017,0.38,"Yes"
"19500","GO_BP","502833_GO_0033617_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY",7,1.5059,0.067,0.42,"Yes",0.7211,0.83,1,"Yes"
"19501","GO_BP","505192_GO_0040034_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC",12,1.507,0.077,0.42,"Yes",-0.6676,0.89,1,"No"
"19502","GO_BP","516350_GO_0071426_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS",6,1.5074,0.067,0.42,"Yes",1.5516,0.057,0.34,"Yes"
"19503","C2_Chemical_and_genetic_perturbations","C2_CGP_3301_SUZUKI_CTCFL_TARGETS_UP",12,1.508,0.054,0.48,"Yes",0.7538,0.82,1,"Yes"
"19504","REACTOME","187214_REACT_25064_TRISTETRAPROLIN_TTP_DESTABILIZES_MRNA",17,1.5084,0.03,0.25,"Yes",1.6364,0.016,0.076,"Yes"
"19505","C4_Cancer_gene_neighborhoods","C4_CGN_216_GCM_CHUK",72,1.5088,0.0041,0.11,"Yes",1.1657,0.19,0.26,"Yes"
"19506","KEGG_pathway","HSA03030_DNA_REPLICATION",36,1.5099,0.032,0.082,"Yes",1.9856,0,0.0025,"Yes"
"19507","GO_BP","491313_GO_0006388_TRNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION",10,1.5109,0.068,0.42,"Yes",1.7789,0.0021,0.12,"Yes"
"19508","KEGG_reaction","R08306_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE_NAD_OXIDOREDUCTASE_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE_NAD_3_CARBAMOYL_2_PHENYLPROPIONALDEHYDE_NADH_H_",7,1.511,0.073,0.46,"Yes",1.0914,0.35,0.87,"Yes"
"19509","GO_CC","503666_GO_0034464_BBSOME",10,1.5112,0.056,0.22,"Yes",0.8206,0.69,0.94,"Yes"
"19510","GO_CC","517451_GO_0072546_ER_MEMBRANE_PROTEIN_COMPLEX",10,1.5116,0.075,0.23,"Yes",1.593,0.019,0.12,"Yes"
"19511","KEGG_compound","C16551_ALCOPHOSPHAMIDE",7,1.512,0.075,0.7,"Yes",1.079,0.37,1,"Yes"
"19512","GO_BP","491363_GO_0006451_TRANSLATIONAL_READTHROUGH",6,1.512,0.065,0.42,"Yes",-0.7016,0.83,1,"No"
"19513","C3_TF_targets","C3_TFT_414_GGAANCGGAANY_UNKNOWN",105,1.5126,0.0055,0.063,"Yes",2.091,0,0.00062,"Yes"
"19514","C7_Immunologic_signatures","C7_ALL_981_GSE22886_NAIVE_BCELL_VS_DC_UP",192,1.5138,0,0.0048,"Yes",1.5431,0,0.0068,"Yes"
"19515","GO_BP","496167_GO_0016073_SNRNA_METABOLIC_PROCESS",28,1.5153,0.037,0.41,"Yes",-0.7228,0.9,1,"No"
"19516","GO_BP","782530_GO_1902019_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY",6,1.5155,0.06,0.42,"Yes",0.7703,0.77,1,"Yes"
"19517","REACTOME","1183581_REACT_355159_SHC_MEDIATED_CASCADE_FGFR4",19,1.5156,0.036,0.24,"Yes",-0.9538,0.52,1,"No"
"19518","GO_BP","491303_GO_0006368_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",72,1.5163,0.019,0.42,"Yes",1.803,0,0.097,"Yes"
"19519","C4_Cancer_gene_neighborhoods","C4_CGN_242_GCM_MLL",174,1.5169,0,0.11,"Yes",-0.5828,1,1,"No"
"19520","GO_BP","518650_GO_2000001_REGULATION_OF_DNA_DAMAGE_CHECKPOINT",12,1.5172,0.068,0.42,"Yes",1.0859,0.34,0.92,"Yes"
"19521","C1_Positional","C1_ALL_277_CHR11Q21",42,1.5174,0.01,0.38,"Yes",-1.0281,0.44,1,"No"
"19522","C7_Immunologic_signatures","C7_ALL_1057_GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP",200,1.518,0,0.0048,"Yes",1.9819,0,0,"Yes"
"19523","GO_BP","518453_GO_0090313_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE",25,1.5181,0.037,0.42,"Yes",1.1965,0.22,0.79,"Yes"
"19524","GO_BP","516352_GO_0071428_RRNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS",6,1.52,0.081,0.42,"Yes",1.5691,0.031,0.33,"Yes"
"19525","GO_BP","504701_GO_0035520_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION",9,1.5203,0.063,0.42,"Yes",1.1691,0.25,0.81,"Yes"
"19526","GO_BP","492500_GO_0032785_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",10,1.5211,0.082,0.42,"Yes",1.0833,0.33,0.92,"Yes"
"19527","GO_MF","492894_GO_0008649_RRNA_METHYLTRANSFERASE_ACTIVITY",11,1.5215,0.067,0.42,"Yes",1.1025,0.31,0.79,"Yes"
"19528","REACTOME","105889_REACT_378_REPAIR_SYNTHESIS_OF_PATCH_27_30_BASES_LONG_BY_DNA_POLYMERASE",15,1.5223,0.067,0.23,"Yes",1.4736,0.069,0.16,"Yes"
"19529","C2_Chemical_and_genetic_perturbations","C2_CGP_99_GARY_CD5_TARGETS_DN",430,1.5224,0,0.45,"Yes",2.0192,0,0.005,"Yes"
"19530","KEGG_compound","C16596_5_PHENYL_1_3_OXAZINANE_2_4_DIONE",7,1.5233,0.069,0.78,"Yes",1.0577,0.38,1,"Yes"
"19531","REACTOME","105838_REACT_1104_BASE_EXCISION_REPAIR",35,1.5235,0.022,0.23,"Yes",1.4406,0.047,0.19,"Yes"
"19532","GO_BP","518581_GO_0097031_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_BIOGENESIS",17,1.5236,0.054,0.42,"Yes",1.505,0.038,0.4,"Yes"
"19533","GO_BP","494897_GO_0010833_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING",37,1.5247,0.0066,0.42,"Yes",1.4448,0.047,0.5,"Yes"
"19534","GO_BP","487190_GO_0000966_RNA_5_END_PROCESSING",5,1.5248,0.06,0.42,"Yes",1.0341,0.43,0.96,"Yes"
"19535","KEGG_module","HSA_M00056_O_GLYCAN_BIOSYNTHESIS_MUCIN_TYPE_CORE",27,1.525,0.022,0.27,"Yes",0.7656,0.83,0.9,"Yes"
"19536","GO_BP","486785_GO_0000266_MITOCHONDRIAL_FISSION",20,1.5263,0.042,0.42,"Yes",-0.8113,0.74,1,"No"
"19537","REACTOME","105846_REACT_1893_RESOLUTION_OF_ABASIC_SITES_AP_SITES_",35,1.5264,0.027,0.23,"Yes",1.4648,0.031,0.17,"Yes"
"19538","GO_CC","503915_GO_0034715_PICLN_SM_PROTEIN_COMPLEX",6,1.5264,0.055,0.21,"Yes",1.8761,0,0.013,"Yes"
"19539","C7_Immunologic_signatures","C7_ALL_41_GSE10325_BCELL_VS_MYELOID_UP",188,1.5266,0,0.0041,"Yes",1.1405,0.16,0.34,"Yes"
"19540","GO_BP","489256_GO_0032784_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",42,1.5275,0.023,0.42,"Yes",1.5361,0.019,0.36,"Yes"
"19541","C2_Chemical_and_genetic_perturbations","C2_CGP_2154_LEE_METASTASIS_AND_RNA_PROCESSING_UP",17,1.5284,0.044,0.46,"Yes",1.5327,0.045,0.18,"Yes"
"19542","REACTOME","105974_REACT_1815_RECYCLING_OF_EIF2_GDP",8,1.5291,0.056,0.23,"Yes",1.2431,0.2,0.4,"Yes"
"19543","GO_BP","507680_GO_0045324_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT",7,1.5294,0.064,0.42,"Yes",1.3646,0.12,0.6,"Yes"
"19544","GO_CC","506307_GO_0043240_FANCONI_ANAEMIA_NUCLEAR_COMPLEX",14,1.5295,0.038,0.21,"Yes",0.7159,0.85,0.99,"Yes"
"19545","C7_Immunologic_signatures","C7_ALL_1817_GSE7852_THYMUS_VS_FAT_TREG_UP",200,1.5295,0,0.0042,"Yes",1.8702,0,0,"Yes"
"19546","GO_BP","487454_GO_0001514_SELENOCYSTEINE_INCORPORATION",6,1.5296,0.065,0.42,"Yes",-0.7144,0.82,1,"No"
"19547","KEGG_reaction","R00623_PRIMARY_ALCOHOL_NAD_OXIDOREDUCTASE_PRIMARY_ALCOHOL_NAD_ALDEHYDE_NADH_H_",7,1.5306,0.068,0.46,"Yes",1.0931,0.35,0.88,"Yes"
"19548","GO_CC","486921_GO_0000428_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX",115,1.5311,0,0.21,"Yes",1.3297,0.03,0.37,"Yes"
"19549","GO_BP","849769_GO_0044794_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS",7,1.5317,0.071,0.42,"Yes",0.899,0.59,1,"Yes"
"19550","GO_BP","515259_GO_0070327_THYROID_HORMONE_TRANSPORT",5,1.5318,0.064,0.42,"Yes",0.9716,0.51,1,"Yes"
"19551","GO_BP","498088_GO_0019236_RESPONSE_TO_PHEROMONE",5,1.5324,0.054,0.42,"Yes",0.6801,0.85,1,"Yes"
"19552","C4_Cancer_gene_neighborhoods","C4_CGN_303_GNF2_MLH1",42,1.5326,0.017,0.099,"Yes",1.8432,0.0043,0.0014,"Yes"
"19553","REACTOME","105850_REACT_1128_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY",22,1.5326,0.03,0.23,"Yes",1.4952,0.052,0.15,"Yes"
"19554","GO_BP","486963_GO_0000470_MATURATION_OF_LSU_RRNA",6,1.5338,0.054,0.42,"Yes",1.1151,0.35,0.88,"Yes"
"19555","GO_BP","513852_GO_0060296_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY",6,1.5349,0.062,0.42,"Yes",0.7886,0.71,1,"Yes"
"19556","C2_Chemical_and_genetic_perturbations","C2_CGP_2667_IRITANI_MAD1_TARGETS_DN",47,1.5349,0.0076,0.46,"Yes",2.4207,0,0,"Yes"
"19557","REACTOME","105888_REACT_1998_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER",17,1.5359,0.039,0.23,"Yes",1.341,0.12,0.27,"Yes"
"19558","REACTOME","160956_REACT_13523_VITAMIN_D_CALCIFEROL_METABOLISM",6,1.5362,0.066,0.23,"Yes",-1.0508,0.41,0.95,"No"
"19559","KEGG_reaction","R00754_ETHANOL_NAD_OXIDOREDUCTASE_ETHANOL_NAD_ACETALDEHYDE_NADH_H_",7,1.5364,0.066,0.52,"Yes",1.105,0.33,0.89,"Yes"
"19560","GO_MF","489268_GO_0003724_RNA_HELICASE_ACTIVITY",44,1.537,0.018,0.4,"Yes",1.0782,0.29,0.82,"Yes"
"19561","REACTOME","105894_REACT_1993_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POLYMERASE_IN_TC_NER",15,1.5372,0.028,0.23,"Yes",1.4479,0.073,0.19,"Yes"
"19562","GO_BP","502203_GO_0032981_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_ASSEMBLY",17,1.5374,0.046,0.42,"Yes",1.5213,0.048,0.38,"Yes"
"19563","REACTOME","1127678_REACT_268628_SYNTHESIS_OF_DIPHTHAMIDE_EEF2",8,1.5381,0.06,0.23,"Yes",1.0258,0.43,0.7,"Yes"
"19564","KEGG_reaction","R07105_TRICHLOROETHANOL_NAD_OXIDOREDUCTASE_CHLORAL_HYDRATE_NADH_H_TRICHLOROETHANOL_NAD_H2O",7,1.5398,0.063,0.62,"Yes",1.0846,0.37,0.87,"Yes"
"19565","GO_MF","490130_GO_0004826_PHENYLALANINE_TRNA_LIGASE_ACTIVITY",5,1.5415,0.043,0.39,"Yes",1.4821,0.057,0.39,"Yes"
"19566","KEGG_reaction","R04880_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL_NAD_OXIDOREDUCTASE_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL_NAD_3_4_DIHYDROXYMANDELALDEHYDE_NADH_H_",7,1.5419,0.057,0.76,"Yes",1.0832,0.37,0.85,"Yes"
"19567","GO_CC","516263_GO_0071339_MLL1_COMPLEX",27,1.5425,0.041,0.2,"Yes",0.9504,0.51,0.83,"Yes"
"19568","GO_BP","500624_GO_0031365_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION",24,1.5433,0.036,0.41,"Yes",1.151,0.25,0.83,"Yes"
"19569","GO_MF","490287_GO_0005000_VASOPRESSIN_RECEPTOR_ACTIVITY",7,1.5436,0.054,0.4,"Yes",-0.635,0.91,1,"No"
"19570","C2_Chemical_and_genetic_perturbations","C2_CGP_710_SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM",159,1.5456,0,0.45,"Yes",2.551,0,0,"Yes"
"19571","C2_Chemical_and_genetic_perturbations","C2_CGP_1669_RAMALHO_STEMNESS_UP",206,1.546,0,0.47,"Yes",2.0546,0,0.0034,"Yes"
"19572","GO_CC","500175_GO_0030880_RNA_POLYMERASE_COMPLEX",117,1.5466,0,0.2,"Yes",1.3618,0.023,0.33,"Yes"
"19573","GO_BP","1184373_GO_0098781_NCRNA_TRANSCRIPTION",30,1.5476,0.022,0.4,"Yes",1.2111,0.18,0.78,"Yes"
"19574","GO_BP","508804_GO_0046548_RETINAL_ROD_CELL_DEVELOPMENT",9,1.5483,0.046,0.4,"Yes",0.8913,0.61,1,"Yes"
"19575","GO_CC","496332_GO_0016272_PREFOLDIN_COMPLEX",7,1.5498,0.057,0.2,"Yes",1.398,0.097,0.3,"Yes"
"19576","GO_BP","494331_GO_0010257_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY",17,1.5501,0.036,0.4,"Yes",1.5117,0.043,0.39,"Yes"
"19577","C1_Positional","C1_ALL_178_CHR16Q21",21,1.5506,0.03,0.36,"Yes",-0.903,0.6,1,"No"
"19578","C2_Chemical_and_genetic_perturbations","C2_CGP_2817_WEBER_METHYLATED_ICP_IN_SPERM_UP",8,1.5507,0.059,0.49,"Yes",1.1039,0.33,0.62,"Yes"
"19579","GO_BP","513851_GO_0060295_REGULATION_OF_CILIUM_MOVEMENT_INVOLVED_IN_CELL_MOTILITY",6,1.5546,0.054,0.39,"Yes",0.7936,0.72,1,"Yes"
"19580","C2_Chemical_and_genetic_perturbations","C2_CGP_1651_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP",14,1.5548,0.049,0.5,"Yes",1.3047,0.15,0.39,"Yes"
"19581","GO_BP","506663_GO_0043633_POLYADENYLATION_DEPENDENT_RNA_CATABOLIC_PROCESS",5,1.5549,0.04,0.4,"Yes",1.2991,0.19,0.67,"Yes"
"19582","GO_BP","506002_GO_0042908_XENOBIOTIC_TRANSPORT",5,1.5552,0.037,0.4,"Yes",-0.7948,0.72,1,"No"
"19583","KEGG_compound","C16595_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE",7,1.5556,0.051,0.8,"Yes",1.0888,0.36,1,"Yes"
"19584","GO_BP","506658_GO_0043628_NCRNA_3_END_PROCESSING",14,1.5586,0.043,0.4,"Yes",1.8881,0.0044,0.043,"Yes"
"19585","C4_Cancer_gene_neighborhoods","C4_CGN_162_MORF_RAB11A",60,1.5592,0.0077,0.085,"Yes",1.7594,0,0.0035,"Yes"
"19586","REACTOME","106559_REACT_894_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION",43,1.5618,0.02,0.2,"Yes",1.2303,0.15,0.42,"Yes"
"19587","GO_MF","489870_GO_0004521_ENDORIBONUCLEASE_ACTIVITY",42,1.5625,0.014,0.37,"Yes",1.5186,0.024,0.37,"Yes"
"19588","GO_BP","500454_GO_0031167_RRNA_METHYLATION",12,1.5639,0.03,0.39,"Yes",1.0926,0.31,0.91,"Yes"
"19589","GO_BP","496507_GO_0016556_MRNA_MODIFICATION",12,1.5649,0.038,0.39,"Yes",1.1865,0.25,0.8,"Yes"
"19590","REACTOME","160996_REACT_20518_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE",15,1.5665,0.029,0.2,"Yes",1.5001,0.047,0.15,"Yes"
"19591","C4_Cancer_gene_neighborhoods","C4_CGN_248_GCM_NPM1",116,1.5682,0,0.083,"Yes",3.4414,0,0,"Yes"
"19592","GO_BP","500410_GO_0031123_RNA_3_END_PROCESSING",107,1.569,0,0.38,"Yes",1.4033,0.022,0.55,"Yes"
"19593","C4_Cancer_gene_neighborhoods","C4_CGN_93_MORF_EIF4A2",137,1.5737,0,0.082,"Yes",3.1623,0,0,"Yes"
"19594","KEGG_reaction","R08310_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE_NAD_OXIDOREDUCTASE_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE_NAD_5_PHENYL_1_3_OXAZINANE_2_4_DIONE_NADH_H_",7,1.5741,0.051,0.83,"Yes",1.0793,0.37,0.84,"Yes"
"19595","GO_MF","496655_GO_0016741_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS",216,1.5764,0,0.34,"Yes",0.8001,0.96,1,"Yes"
"19596","REACTOME","106560_REACT_387_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION",43,1.5766,0.016,0.19,"Yes",1.2144,0.15,0.43,"Yes"
"19597","GO_CC","505038_GO_0035869_CILIARY_TRANSITION_ZONE",25,1.5767,0.015,0.17,"Yes",0.5375,0.99,1,"Yes"
"19598","C4_Cancer_gene_neighborhoods","C4_CGN_57_MORF_ACP1",211,1.5782,0,0.083,"Yes",2.6894,0,0,"Yes"
"19599","GO_MF","506211_GO_0043138_3_5_DNA_HELICASE_ACTIVITY",7,1.5784,0.035,0.35,"Yes",1.0055,0.45,0.87,"Yes"
"19600","GO_MF","496887_GO_0017070_U6_SNRNA_BINDING",8,1.5787,0.049,0.36,"Yes",1.0866,0.35,0.81,"Yes"
"19601","C2_Chemical_and_genetic_perturbations","C2_CGP_1237_DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER",100,1.5821,0,0.45,"Yes",1.8541,0,0.027,"Yes"
"19602","GO_BP","517565_GO_0072662_PROTEIN_LOCALIZATION_TO_PEROXISOME",19,1.5835,0.028,0.35,"Yes",1.2218,0.19,0.76,"Yes"
"19603","C2_BioCarta_Pathways","C2_CP_BIOCARTA_82_BIOCARTA_AHSP_PATHWAY",13,1.5858,0.04,0.55,"Yes",1.7984,0.0041,0.14,"Yes"
"19604","GO_MF","492632_GO_0008312_7S_RNA_BINDING",7,1.5868,0.039,0.35,"Yes",1.7562,0.0042,0.11,"Yes"
"19605","GO_BP","514564_GO_0061009_COMMON_BILE_DUCT_DEVELOPMENT",5,1.5903,0.037,0.34,"Yes",-1.0852,0.38,0.96,"No"
"19606","C2_Chemical_and_genetic_perturbations","C2_CGP_2683_VALK_AML_CLUSTER_7",27,1.5904,0.019,0.45,"Yes",1.5568,0.025,0.17,"Yes"
"19607","REACTOME","645279_REACT_121153_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1",9,1.592,0.033,0.17,"Yes",-0.6641,0.87,1,"No"
"19608","GO_CC","515689_GO_0070761_PRE_SNORNP_COMPLEX",6,1.592,0.034,0.16,"Yes",1.2837,0.18,0.42,"Yes"
"19609","C1_Positional","C1_ALL_215_CHR8Q",7,1.5926,0.042,0.32,"Yes",0.9279,0.56,0.82,"Yes"
"19610","GO_MF","492522_GO_0008174_MRNA_METHYLTRANSFERASE_ACTIVITY",5,1.5931,0.035,0.35,"Yes",1.377,0.12,0.49,"Yes"
"19611","GO_CC","503909_GO_0034709_METHYLOSOME",10,1.5933,0.041,0.16,"Yes",1.8306,0.0022,0.02,"Yes"
"19612","KEGG_pathway","HSA03040_SPLICEOSOME",132,1.594,0,0.051,"Yes",1.69,0.0023,0.031,"Yes"
"19613","GO_BP","517497_GO_0072594_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE",343,1.5945,0,0.33,"Yes",2.8289,0,0,"Yes"
"19614","GO_BP","507979_GO_0045631_REGULATION_OF_MECHANORECEPTOR_DIFFERENTIATION",5,1.5967,0.029,0.33,"Yes",0.4545,0.99,1,"Yes"
"19615","GO_CC","911481_GO_1902493_ACETYLTRANSFERASE_COMPLEX",93,1.5972,0.0051,0.16,"Yes",0.9554,0.57,0.83,"Yes"
"19616","GO_BP","491840_GO_0007005_MITOCHONDRION_ORGANIZATION",398,1.5975,0,0.33,"Yes",2.0529,0,0.0066,"Yes"
"19617","GO_BP","755086_GO_2000980_REGULATION_OF_INNER_EAR_RECEPTOR_CELL_DIFFERENTIATION",5,1.5977,0.038,0.33,"Yes",0.4617,1,1,"Yes"
"19618","C2_Chemical_and_genetic_perturbations","C2_CGP_2438_ZHOU_PANCREATIC_EXOCRINE_PROGENITOR",11,1.5995,0.036,0.45,"Yes",1.1708,0.27,0.53,"Yes"
"19619","C4_Cancer_modules","C4_CM_152_MODULE_160",15,1.5998,0.03,0.14,"Yes",1.5483,0.025,0.095,"Yes"
"19620","GO_BP","487986_GO_0002097_TRNA_WOBBLE_BASE_MODIFICATION",8,1.6022,0.038,0.33,"Yes",1.5078,0.048,0.4,"Yes"
"19621","GO_BP","512191_GO_0051307_MEIOTIC_CHROMOSOME_SEPARATION",11,1.6051,0.027,0.32,"Yes",1.2005,0.24,0.78,"Yes"
"19622","C4_Cancer_modules","C4_CM_128_MODULE_133",15,1.6054,0.031,0.16,"Yes",1.6998,0.019,0.045,"Yes"
"19623","REACTOME","105789_REACT_932_DNA_STRAND_ELONGATION",32,1.6069,0.019,0.16,"Yes",1.8113,0.0021,0.019,"Yes"
"19624","GO_CC","486662_GO_0000123_HISTONE_ACETYLTRANSFERASE_COMPLEX",83,1.6105,0.0044,0.15,"Yes",1.0064,0.42,0.77,"Yes"
"19625","C2_Chemical_and_genetic_perturbations","C2_CGP_711_SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN",47,1.6117,0.0074,0.45,"Yes",1.8488,0,0.028,"Yes"
"19626","GO_BP","494828_GO_0010763_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION",8,1.6137,0.029,0.31,"Yes",1.1816,0.28,0.8,"Yes"
"19627","GO_BP","504174_GO_0034982_MITOCHONDRIAL_PROTEIN_PROCESSING",6,1.6163,0.041,0.31,"Yes",0.7001,0.83,1,"Yes"
"19628","GO_BP","493485_GO_0009301_SNRNA_TRANSCRIPTION",10,1.6189,0.02,0.3,"Yes",0.6632,0.89,1,"Yes"
"19629","GO_MF","492516_GO_0008168_METHYLTRANSFERASE_ACTIVITY",203,1.6197,0,0.3,"Yes",0.7945,0.95,1,"Yes"
"19630","OMIM_gene","OMIM600190_TRANSDUCIN_LIKE_ENHANCER_OF_SPLIT_3_TLE3",5,1.6206,0.022,1,"Yes",0.9909,0.48,1,"Yes"
"19631","GO_BP","512177_GO_0051292_NUCLEAR_PORE_COMPLEX_ASSEMBLY",9,1.6209,0.028,0.3,"Yes",1.5346,0.039,0.36,"Yes"
"19632","GO_CC","499990_GO_0030688_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR",6,1.621,0.028,0.14,"Yes",0.8541,0.65,0.92,"Yes"
"19633","GO_BP","505900_GO_0042795_SNRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",7,1.6213,0.03,0.3,"Yes",0.5836,0.95,1,"Yes"
"19634","GO_CC","500507_GO_0031248_PROTEIN_ACETYLTRANSFERASE_COMPLEX",93,1.6228,0,0.14,"Yes",0.9346,0.6,0.86,"Yes"
"19635","REACTOME","105953_REACT_1753_MRNA_SPLICING_MINOR_PATHWAY",42,1.6252,0.018,0.14,"Yes",1.8351,0,0.016,"Yes"
"19636","GO_CC","751809_GO_0044665_MLL1_2_COMPLEX",28,1.6273,0.0061,0.14,"Yes",1.0142,0.44,0.76,"Yes"
"19637","REACTOME","160993_REACT_20639_DEADENYLATION_DEPENDENT_MRNA_DECAY",49,1.6284,0.0035,0.14,"Yes",1.6783,0.0022,0.057,"Yes"
"19638","GO_BP","491227_GO_0006261_DNA_DEPENDENT_DNA_REPLICATION",93,1.6286,0,0.29,"Yes",1.1422,0.19,0.85,"Yes"
"19639","KEGG_module","HSA_M00351_SPLICEOSOME_U1_SNRNP",10,1.6293,0.037,0.16,"Yes",1.9443,0,0.0081,"Yes"
"19640","C7_Immunologic_signatures","C7_ALL_1745_GSE6269_HEALTHY_VS_STREP_AUREUS_INF_PBMC_UP",179,1.6312,0,0.00074,"Yes",-0.9185,0.68,1,"No"
"19641","GO_BP","496053_GO_0015931_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT",176,1.6344,0,0.28,"Yes",1.1719,0.12,0.81,"Yes"
"19642","C4_Cancer_gene_neighborhoods","C4_CGN_186_MORF_TPT1",102,1.6357,0,0.052,"Yes",3.6649,0,0,"Yes"
"19643","GO_CC","503590_GO_0034388_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME",7,1.6367,0.039,0.13,"Yes",1.2625,0.2,0.45,"Yes"
"19644","GO_BP","491396_GO_0006498_N_TERMINAL_PROTEIN_LIPIDATION",5,1.6372,0.029,0.28,"Yes",0.9909,0.48,0.99,"Yes"
"19645","GO_MF","496411_GO_0016423_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY",5,1.6379,0.017,0.27,"Yes",1.2017,0.28,0.7,"Yes"
"19646","GO_BP","753113_GO_1900118_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS",8,1.6387,0.037,0.28,"Yes",1.3316,0.13,0.63,"Yes"
"19647","C1_Positional","C1_ALL_91_CHR6Q27",36,1.6396,0.0066,0.29,"Yes",-0.8541,0.71,0.98,"No"
"19648","GO_CC","490867_GO_0005851_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX",6,1.6404,0.029,0.13,"Yes",1.114,0.35,0.62,"Yes"
"19649","C2_Chemical_and_genetic_perturbations","C2_CGP_2168_FINETTI_BREAST_CANCERS_KINOME_GRAY",15,1.6411,0.025,0.4,"Yes",1.6703,0.017,0.1,"Yes"
"19650","C4_Cancer_gene_neighborhoods","C4_CGN_225_GCM_DFFA",129,1.6458,0,0.051,"Yes",1.1779,0.13,0.24,"Yes"
"19651","REACTOME","106562_REACT_281_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION",35,1.6474,0.01,0.13,"Yes",0.9474,0.52,0.84,"Yes"
"19652","GO_BP","491506_GO_0006612_PROTEIN_TARGETING_TO_MEMBRANE",160,1.6485,0,0.26,"Yes",3.5723,0,0,"Yes"
"19653","KEGG_pathway","HSA03460_FANCONI_ANEMIA_PATHWAY",52,1.6486,0.004,0.038,"Yes",1.251,0.11,0.47,"Yes"
"19654","REACTOME","106557_REACT_1366_RNA_POLYMERASE_II_TRANSCRIPTION",107,1.6499,0,0.13,"Yes",1.6544,0,0.067,"Yes"
"19655","C7_Immunologic_signatures","C7_ALL_223_GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP",200,1.6501,0,5e-04,"Yes",1.8385,0,0,"Yes"
"19656","GO_BP","502329_GO_0033108_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY",28,1.6505,0.016,0.26,"Yes",1.5853,0.022,0.31,"Yes"
"19657","C7_Immunologic_signatures","C7_ALL_823_GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP",197,1.6516,0,0.00048,"Yes",1.4051,0.0024,0.035,"Yes"
"19658","GO_BP","488957_GO_0003163_SINOATRIAL_NODE_DEVELOPMENT",5,1.652,0.019,0.26,"Yes",1.064,0.4,0.94,"Yes"
"19659","GO_MF","490370_GO_0005104_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING",17,1.6529,0.039,0.25,"Yes",-1.174,0.24,0.78,"No"
"19660","GO_BP","512188_GO_0051304_CHROMOSOME_SEPARATION",16,1.658,0.0083,0.25,"Yes",0.8806,0.64,1,"Yes"
"19661","GO_CC","495534_GO_0046930_PORE_COMPLEX",86,1.6584,0,0.12,"Yes",1.5959,0.0046,0.12,"Yes"
"19662","GO_MF","489239_GO_0003689_DNA_CLAMP_LOADER_ACTIVITY",6,1.6589,0.031,0.25,"Yes",1.1437,0.32,0.75,"Yes"
"19663","C7_Immunologic_signatures","C7_ALL_983_GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP",187,1.6608,0,0.00041,"Yes",-0.6894,1,1,"No"
"19664","C2_Chemical_and_genetic_perturbations","C2_CGP_202_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN",12,1.662,0.017,0.38,"Yes",1.6362,0.017,0.12,"Yes"
"19665","GO_MF","495513_GO_0015252_HYDROGEN_ION_CHANNEL_ACTIVITY",5,1.6627,0.023,0.26,"Yes",-1.1833,0.28,0.78,"No"
"19666","REACTOME","1183517_REACT_355174_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS",74,1.6636,0,0.12,"Yes",1.5515,0.0088,0.12,"Yes"
"19667","KEGG_module","HSA_M00398_SM_CORE_COMPLEX",7,1.6638,0.031,0.14,"Yes",1.8536,0,0.024,"Yes"
"19668","GO_MF","489982_GO_0004653_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY",21,1.6674,0.0084,0.26,"Yes",-0.7064,0.89,1,"No"
"19669","C1_Positional","C1_ALL_85_CHR4Q33",5,1.6681,0.014,0.31,"Yes",1.1068,0.35,0.64,"Yes"
"19670","REACTOME","106564_REACT_1036_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER",26,1.6683,0.021,0.12,"Yes",1.0942,0.31,0.59,"Yes"
"19671","REACTOME","1183516_REACT_355247_SUMO_E3_LIGASES_SUMOYLATE_TARGET_PROTEINS",74,1.6708,0,0.12,"Yes",1.5405,0.0088,0.13,"Yes"
"19672","C1_Positional","C1_ALL_40_CHR6P11",7,1.6718,0.031,0.46,"Yes",0.8362,0.69,0.92,"Yes"
"19673","GO_BP","500155_GO_0030857_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION",32,1.672,0.009,0.23,"Yes",-0.7409,0.88,1,"No"
"19674","GO_BP","518454_GO_0090314_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE",19,1.6729,0.017,0.23,"Yes",1.1754,0.24,0.81,"Yes"
"19675","REACTOME","105790_REACT_6776_UNWINDING_OF_DNA",11,1.6745,0.02,0.12,"Yes",1.5035,0.049,0.15,"Yes"
"19676","GO_MF","502391_GO_0033170_PROTEIN_DNA_LOADING_ATPASE_ACTIVITY",6,1.6751,0.019,0.25,"Yes",1.1728,0.28,0.73,"Yes"
"19677","GO_BP","489255_GO_0006383_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",43,1.6759,0.0038,0.23,"Yes",1.0732,0.34,0.93,"Yes"
"19678","GO_MF","489320_GO_0003810_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY",9,1.6768,0.036,0.26,"Yes",1.2114,0.23,0.7,"Yes"
"19679","GO_BP","487009_GO_0000712_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES",10,1.6791,0.018,0.23,"Yes",1.2875,0.19,0.69,"Yes"
"19680","GO_MF","492780_GO_0016594_GLYCINE_BINDING",14,1.6791,0.016,0.27,"Yes",1.1778,0.25,0.73,"Yes"
"19681","REACTOME","106563_REACT_347_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER",27,1.6797,0.012,0.11,"Yes",1.209,0.19,0.44,"Yes"
"19682","GO_CC","490858_GO_0005838_PROTEASOME_REGULATORY_PARTICLE",17,1.6798,0.031,0.1,"Yes",1.9546,0.0021,0.0053,"Yes"
"19683","C4_Cancer_gene_neighborhoods","C4_CGN_391_GNF2_PCAF",36,1.68,0.0071,0.04,"Yes",2.1716,0,2e-05,"Yes"
"19684","GO_MF","494069_GO_0009982_PSEUDOURIDINE_SYNTHASE_ACTIVITY",13,1.6805,0.011,0.27,"Yes",1.2962,0.16,0.61,"Yes"
"19685","GO_BP","516092_GO_0071166_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION",8,1.6846,0.023,0.22,"Yes",1.731,0.0061,0.16,"Yes"
"19686","KEGG_module","HSA_M00341_PROTEASOME_19S_REGULATORY_PARTICLE_PA700_",18,1.6864,0.011,0.13,"Yes",2.0366,0.002,0.0029,"Yes"
"19687","C4_Cancer_gene_neighborhoods","C4_CGN_190_MORF_UBE2N",95,1.6882,0,0.039,"Yes",2.2417,0,0,"Yes"
"19688","GO_BP","491323_GO_0006401_RNA_CATABOLIC_PROCESS",218,1.6883,0,0.22,"Yes",3.2904,0,0,"Yes"
"19689","KEGG_module","HSA_M00359_AMINOACYL_TRNA_BIOSYNTHESIS_EUKARYOTES",38,1.6893,0.01,0.15,"Yes",1.1864,0.2,0.55,"Yes"
"19690","KEGG_pathway","HSA03060_PROTEIN_EXPORT",23,1.6949,0.009,0.033,"Yes",1.9027,0.0021,0.0049,"Yes"
"19691","C7_Immunologic_signatures","C7_ALL_1763_GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP",200,1.6958,0,0.00015,"Yes",2.4806,0,0,"Yes"
"19692","GO_CC","504809_GO_0035631_CD40_RECEPTOR_COMPLEX",11,1.6962,0.011,0.093,"Yes",-0.563,0.96,1,"No"
"19693","GO_BP","491836_GO_0007000_NUCLEOLUS_ORGANIZATION",5,1.6967,0.021,0.21,"Yes",1.6178,0.029,0.28,"Yes"
"19694","REACTOME","160950_REACT_125_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA",145,1.698,0,0.1,"Yes",1.7886,0,0.023,"Yes"
"19695","GO_BP","486971_GO_0000478_ENDONUCLEOLYTIC_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING",7,1.7015,0.015,0.2,"Yes",1.5161,0.048,0.38,"Yes"
"19696","GO_CC","500367_GO_0031080_NUCLEAR_PORE_OUTER_RING",10,1.7022,0.022,0.091,"Yes",1.3155,0.14,0.39,"Yes"
"19697","GO_CC","750960_GO_0036038_TCTN_B9D_COMPLEX",13,1.7071,0.019,0.089,"Yes",-0.5438,0.97,1,"No"
"19698","REACTOME","105984_REACT_6256_HIV_LIFE_CYCLE",140,1.7077,0,0.096,"Yes",2.0844,0,0.00076,"Yes"
"19699","GO_CC","490795_GO_0005762_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT",22,1.7097,0.019,0.089,"Yes",2.0287,0,0.0025,"Yes"
"19700","C2_Chemical_and_genetic_perturbations","C2_CGP_3190_BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES",68,1.7108,0,0.28,"Yes",3.5347,0,0,"Yes"
"19701","KEGG_enzyme","2.4.1.41_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_PROTEIN_UDP_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_GALNAC_POLYPEPTIDE_N_ACETYLGALACTOSAMINYL_TRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_KAPPA_CASEIN_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_URIDINE_DIPHOSPHOACETYLGALACTOSAMINE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_POLYPEPTIDE_N_ACETYLGALACTOSAMINE_TRANSFERASE_UDP_ACETYLGALACTOSAMINE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_ACETYLGALACTOSAMINE_PEPTIDE_N_GALACTOSAMINYLTRANSFERASE_UDP_GALNAC_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYL_ALPHA_D_GALACTOSAMINE_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_GLYCOPROTEIN_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_PROTEIN_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_PROTEIN_N_ACETYLGALACTOSAMINYL_TRANSFERASE_PPGALNAC_T",21,1.7111,0.019,0.2,"Yes",-0.7417,0.87,0.9,"No"
"19702","GO_MF","495327_GO_0019825_OXYGEN_BINDING",48,1.7114,0,0.23,"Yes",1.4122,0.053,0.48,"Yes"
"19703","GO_CC","507393_GO_0044445_CYTOSOLIC_PART",202,1.7124,0,0.089,"Yes",3.2843,0,0,"Yes"
"19704","GO_CC","517572_GO_0072669_TRNA_SPLICING_LIGASE_COMPLEX",7,1.7167,0.026,0.089,"Yes",1.7158,0.013,0.055,"Yes"
"19705","GO_BP","487187_GO_0000963_MITOCHONDRIAL_RNA_PROCESSING",6,1.7182,0.018,0.18,"Yes",1.3628,0.15,0.6,"Yes"
"19706","C6_Oncogenic_signatures","C6_ALL_58_MYC_UP_V1_UP",169,1.7194,0,0.013,"Yes",1.1919,0.11,0.44,"Yes"
"19707","C2_Chemical_and_genetic_perturbations","C2_CGP_368_LIU_CDX2_TARGETS_DN",5,1.7234,0.0067,0.29,"Yes",1.4966,0.055,0.21,"Yes"
"19708","GO_BP","512078_GO_0051168_NUCLEAR_EXPORT",111,1.7242,0,0.17,"Yes",1.2334,0.11,0.75,"Yes"
"19709","GO_BP","491325_GO_0006403_RNA_LOCALIZATION",156,1.7261,0,0.17,"Yes",1.2149,0.079,0.77,"Yes"
"19710","GO_BP","491294_GO_0006354_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",99,1.7274,0,0.17,"Yes",1.6271,0,0.26,"Yes"
"19711","KEGG_reaction","R05907_UDP_N_ACETYL_D_GALACTOSAMINE_PROTEIN_L_SERINE_UDP_TN_ANTIGEN",21,1.7277,0.009,0.38,"Yes",-0.7406,0.85,1,"No"
"19712","C2_Chemical_and_genetic_perturbations","C2_CGP_1354_MANALO_HYPOXIA_DN",289,1.7297,0,0.31,"Yes",1.6797,0,0.095,"Yes"
"19713","GO_BP","491235_GO_0006271_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION",34,1.7319,0.0035,0.17,"Yes",1.852,0.0022,0.063,"Yes"
"19714","REACTOME","106203_REACT_6804_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN",29,1.7325,0.0066,0.08,"Yes",1.4772,0.059,0.16,"Yes"
"19715","REACTOME","833805_REACT_163823_SUMOYLATION",79,1.7336,0,0.081,"Yes",1.5589,0.0022,0.12,"Yes"
"19716","C4_Cancer_gene_neighborhoods","C4_CGN_258_GCM_RAB10",176,1.7353,0,0.027,"Yes",1.523,0.0024,0.026,"Yes"
"19717","GO_BP","752559_GO_0090502_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC",48,1.7401,0,0.16,"Yes",1.6408,0.0021,0.25,"Yes"
"19718","GO_BP","486972_GO_0000479_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",7,1.7404,0.012,0.16,"Yes",1.5279,0.052,0.37,"Yes"
"19719","GO_BP","487183_GO_0000959_MITOCHONDRIAL_RNA_METABOLIC_PROCESS",21,1.744,0.0028,0.16,"Yes",1.2535,0.17,0.73,"Yes"
"19720","C7_Immunologic_signatures","C7_ALL_843_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP",198,1.7444,0,0,"Yes",1.7539,0,3e-04,"Yes"
"19721","GO_CC","486832_GO_0000315_ORGANELLAR_LARGE_RIBOSOMAL_SUBUNIT",22,1.7448,0,0.073,"Yes",1.9941,0.002,0.0035,"Yes"
"19722","GO_MF","496774_GO_0016886_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS",6,1.7467,0.014,0.18,"Yes",1.0357,0.41,0.83,"Yes"
"19723","GO_MF","489755_GO_0004386_HELICASE_ACTIVITY",153,1.7489,0,0.18,"Yes",1.0733,0.29,0.82,"Yes"
"19724","REACTOME","645350_REACT_120801_ABACAVIR_TRANSMEMBRANE_TRANSPORT",5,1.7505,0.0071,0.072,"Yes",-0.9994,0.48,0.98,"No"
"19725","KEGG_module","HSA_M00391_EXOSOME_EUKARYOTES",10,1.7518,0.018,0.11,"Yes",1.5856,0.031,0.12,"Yes"
"19726","REACTOME","106076_REACT_6354_VIRAL_MESSENGER_RNA_SYNTHESIS",41,1.7532,0,0.071,"Yes",1.6519,0.0069,0.068,"Yes"
"19727","C7_Immunologic_signatures","C7_ALL_1121_GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP",191,1.7559,0,0,"Yes",1.0536,0.29,0.58,"Yes"
"19728","GO_MF","498634_GO_0019843_RRNA_BINDING",39,1.7583,0.0035,0.18,"Yes",2.545,0,0,"Yes"
"19729","GO_BP","489260_GO_0006353_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION",92,1.7589,0,0.14,"Yes",1.362,0.028,0.6,"Yes"
"19730","GO_BP","499351_GO_0022616_DNA_STRAND_ELONGATION",36,1.7598,0.006,0.14,"Yes",1.7763,0,0.12,"Yes"
"19731","C7_Immunologic_signatures","C7_ALL_1117_GSE2706_UNSTIM_VS_2H_LPS_DC_UP",186,1.7607,0,0,"Yes",0.8647,0.83,1,"Yes"
"19732","GO_MF","499684_GO_0030280_STRUCTURAL_CONSTITUENT_OF_EPIDERMIS",6,1.7608,0.012,0.19,"Yes",1.0479,0.41,0.83,"Yes"
"19733","GO_BP","505414_GO_0042255_RIBOSOME_ASSEMBLY",28,1.7608,0.0029,0.14,"Yes",2.3165,0,0.00011,"Yes"
"19734","GO_MF","496780_GO_0016893_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS",35,1.7624,0,0.2,"Yes",1.156,0.24,0.74,"Yes"
"19735","C7_Immunologic_signatures","C7_ALL_839_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP",199,1.7627,0,0,"Yes",1.5569,0,0.0056,"Yes"
"19736","C2_Chemical_and_genetic_perturbations","C2_CGP_2861_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP",9,1.7636,0.013,0.27,"Yes",1.1979,0.24,0.49,"Yes"
"19737","REACTOME","105964_REACT_1835_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT",35,1.7656,0.0037,0.066,"Yes",1.3785,0.068,0.24,"Yes"
"19738","REACTOME","160990_REACT_16925_GLYOXYLATE_METABOLISM",5,1.7672,0.0072,0.066,"Yes",1.39,0.096,0.23,"Yes"
"19739","GO_CC","499359_GO_0022624_PROTEASOME_ACCESSORY_COMPLEX",24,1.7687,0,0.061,"Yes",2.0921,0,0.00085,"Yes"
"19740","GO_BP","492649_GO_0008334_HISTONE_MRNA_METABOLIC_PROCESS",28,1.7711,0.0062,0.13,"Yes",1.8962,0.0021,0.04,"Yes"
"19741","WikiPathways","198843_WP411_MRNA_PROCESSING",132,1.7751,0,0.04,"Yes",1.3389,0.021,0.61,"Yes"
"19742","GO_MF","499854_GO_0030515_SNORNA_BINDING",26,1.7784,0.0029,0.18,"Yes",1.8628,0.0021,0.045,"Yes"
"19743","C2_Chemical_and_genetic_perturbations","C2_CGP_123_CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN",9,1.7836,0.017,0.26,"Yes",1.9557,0.0021,0.011,"Yes"
"19744","GO_CC","486707_GO_0000176_NUCLEAR_EXOSOME_RNASE_COMPLEX_",10,1.784,0.02,0.054,"Yes",1.431,0.089,0.27,"Yes"
"19745","GO_MF","514974_GO_0070035_PURINE_NTP_DEPENDENT_HELICASE_ACTIVITY",113,1.7877,0,0.18,"Yes",1.1371,0.19,0.76,"Yes"
"19746","REACTOME","106011_REACT_6757_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS",34,1.7877,0.0064,0.057,"Yes",1.4824,0.047,0.16,"Yes"
"19747","GO_BP","512130_GO_0051236_ESTABLISHMENT_OF_RNA_LOCALIZATION",146,1.7921,0,0.11,"Yes",1.2317,0.086,0.75,"Yes"
"19748","C0_Hallmark","H_ALL_29_HALLMARK_MYC_TARGETS_V2",58,1.7941,0,0.0018,"Yes",1.6165,0.011,0.0094,"Yes"
"19749","GO_BP","486688_GO_0000154_RRNA_MODIFICATION",16,1.7954,0.0083,0.11,"Yes",1.3649,0.099,0.6,"Yes"
"19750","GO_BP","511630_GO_0050658_RNA_TRANSPORT",146,1.7968,0,0.11,"Yes",1.2381,0.077,0.75,"Yes"
"19751","C4_Cancer_modules","C4_CM_173_MODULE_183",65,1.7988,0,0.046,"Yes",1.8107,0,0.02,"Yes"
"19752","GO_CC","490739_GO_0005685_U1_SNRNP",15,1.8016,0.0079,0.048,"Yes",1.8909,0.0019,0.011,"Yes"
"19753","GO_BP","486763_GO_0000245_SPLICEOSOMAL_COMPLEX_ASSEMBLY",51,1.802,0,0.11,"Yes",1.2828,0.1,0.7,"Yes"
"19754","GO_BP","486959_GO_0000466_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",12,1.8039,0.0054,0.11,"Yes",1.5498,0.04,0.34,"Yes"
"19755","GO_CC","501535_GO_0032300_MISMATCH_REPAIR_COMPLEX",13,1.8059,0.0027,0.048,"Yes",-0.6035,0.94,1,"No"
"19756","REACTOME","106015_REACT_9395_NUCLEAR_IMPORT_OF_REV_PROTEIN",31,1.8063,0,0.049,"Yes",1.4208,0.052,0.21,"Yes"
"19757","KEGG_module","HSA_M00352_SPLICEOSOME_U2_SNRNP",20,1.8097,0.0092,0.074,"Yes",2.2446,0,0,"Yes"
"19758","GO_BP","510698_GO_0048642_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",12,1.8116,0.013,0.1,"Yes",1.1281,0.3,0.87,"Yes"
"19759","GO_MF","496876_GO_0017056_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE",10,1.8149,0.0053,0.15,"Yes",1.5584,0.045,0.32,"Yes"
"19760","C7_Immunologic_signatures","C7_ALL_1281_GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP",185,1.821,0,0,"Yes",1.484,0.0024,0.015,"Yes"
"19761","GO_CC","508797_GO_0046540_U4_U6_X_U5_TRI_SNRNP_COMPLEX",13,1.822,0.016,0.042,"Yes",1.7732,0.008,0.033,"Yes"
"19762","C4_Cancer_gene_neighborhoods","C4_CGN_205_GCM_TINF2",40,1.825,0,0.013,"Yes",1.0735,0.33,0.42,"Yes"
"19763","KEGG_compound","C03201_1_ALKYL_2_ACYLGLYCEROL_2_ACYL_1_ALKYL_SN_GLYCEROL",7,1.8274,0.0077,0.12,"Yes",1.5249,0.053,0.28,"Yes"
"19764","C4_Cancer_modules","C4_CM_105_MODULE_110",16,1.8305,0.011,0.045,"Yes",1.5595,0.037,0.091,"Yes"
"19765","GO_BP","511629_GO_0050657_NUCLEIC_ACID_TRANSPORT",147,1.8306,0,0.085,"Yes",1.2508,0.059,0.73,"Yes"
"19766","REACTOME","105980_REACT_15482_TRNA_AMINOACYLATION",42,1.8327,0.0035,0.04,"Yes",1.5533,0.013,0.12,"Yes"
"19767","C4_Cancer_gene_neighborhoods","C4_CGN_369_GNF2_KPNB1",73,1.8328,0,0.013,"Yes",1.889,0,0.00094,"Yes"
"19768","GO_CC","911353_GO_0097526_SPLICEOSOMAL_TRI_SNRNP_COMPLEX",13,1.8353,0.0079,0.037,"Yes",1.8021,0.0088,0.027,"Yes"
"19769","GO_BP","506124_GO_0043038_AMINO_ACID_ACTIVATION",52,1.8358,0,0.082,"Yes",1.3357,0.057,0.62,"Yes"
"19770","C4_Cancer_modules","C4_CM_31_MODULE_35",16,1.8365,0.0079,0.056,"Yes",1.3661,0.11,0.22,"Yes"
"19771","REACTOME","160953_REACT_185_SLBP_INDEPENDENT_PROCESSING_OF_HISTONE_PRE_MRNAS",10,1.8395,0.013,0.039,"Yes",1.5986,0.033,0.093,"Yes"
"19772","C7_Immunologic_signatures","C7_ALL_841_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP",199,1.8399,0,0,"Yes",1.5982,0,0.0032,"Yes"
"19773","GO_BP","491324_GO_0006402_MRNA_CATABOLIC_PROCESS",193,1.8436,0,0.078,"Yes",3.3408,0,0,"Yes"
"19774","REACTOME","105970_REACT_1258_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S",56,1.8458,0,0.037,"Yes",3.3339,0,0,"Yes"
"19775","GO_MF","496765_GO_0016876_LIGASE_ACTIVITY_FORMING_AMINOACYL_TRNA_AND_RELATED_COMPOUNDS",44,1.8486,0,0.12,"Yes",1.3839,0.04,0.48,"Yes"
"19776","REACTOME","105972_REACT_931_RIBOSOMAL_SCANNING_AND_START_CODON_RECOGNITION",55,1.8535,0.0038,0.036,"Yes",3.3883,0,0,"Yes"
"19777","GO_BP","491835_GO_0006999_NUCLEAR_PORE_ORGANIZATION",11,1.8544,0,0.071,"Yes",1.684,0.022,0.21,"Yes"
"19778","C4_Cancer_gene_neighborhoods","C4_CGN_304_GNF2_MSH2",28,1.858,0,0.011,"Yes",1.9518,0.0022,0.00051,"Yes"
"19779","GO_BP","506125_GO_0043039_TRNA_AMINOACYLATION",50,1.8619,0,0.067,"Yes",1.526,0.016,0.37,"Yes"
"19780","REACTOME","105961_REACT_338_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS",36,1.8698,0.0033,0.031,"Yes",1.394,0.072,0.23,"Yes"
"19781","GO_BP","511953_GO_0051028_MRNA_TRANSPORT",126,1.8705,0,0.062,"Yes",1.2471,0.058,0.73,"Yes"
"19782","REACTOME","105959_REACT_1281_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM",55,1.872,0,0.031,"Yes",1.1347,0.25,0.54,"Yes"
"19783","C2_Chemical_and_genetic_perturbations","C2_CGP_2413_CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP",52,1.8745,0,0.14,"Yes",3.3645,0,0,"Yes"
"19784","GO_CC","490736_GO_0005682_U5_SNRNP",9,1.8755,0.0052,0.027,"Yes",1.4771,0.06,0.22,"Yes"
"19785","REACTOME","105982_REACT_15302_MITOCHONDRIAL_TRNA_AMINOACYLATION",21,1.876,0,0.031,"Yes",0.8534,0.69,0.96,"Yes"
"19786","REACTOME","105995_REACT_6361_LATE_PHASE_OF_HIV_LIFE_CYCLE",127,1.8805,0,0.031,"Yes",2.0731,0,0.00089,"Yes"
"19787","GO_BP","506946_GO_0043928_EXONUCLEOLYTIC_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_INVOLVED_IN_DEADENYLATION_DEPENDENT_DECAY",29,1.8812,0,0.057,"Yes",1.9327,0,0.028,"Yes"
"19788","C7_Immunologic_signatures","C7_ALL_1405_GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP",180,1.8816,0,0,"Yes",1.9693,0,0,"Yes"
"19789","GO_BP","507953_GO_0045605_NEGATIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION",11,1.886,0,0.055,"Yes",-0.8304,0.7,1,"No"
"19790","GO_MF","496764_GO_0016875_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS",44,1.8891,0,0.091,"Yes",1.3945,0.042,0.48,"Yes"
"19791","GO_BP","486962_GO_0000469_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING",11,1.8895,0.0048,0.054,"Yes",1.6913,0.016,0.2,"Yes"
"19792","GO_MF","489886_GO_0004549_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY",13,1.8904,0.0054,0.1,"Yes",1.5655,0.026,0.32,"Yes"
"19793","REACTOME","105971_REACT_1979_TRANSLATION_INITIATION_COMPLEX_FORMATION",55,1.8915,0,0.029,"Yes",3.3615,0,0,"Yes"
"19794","KEGG_reaction","R01176_BUTANOATE_COA_LIGASE_AMP_FORMING_ATP_BUTANOIC_ACID_COA_AMP_DIPHOSPHATE_BUTANOYL_COA",6,1.8927,0.0026,0.14,"Yes",-0.7759,0.74,1,"No"
"19795","C2_Chemical_and_genetic_perturbations","C2_CGP_10_PYEON_HPV_POSITIVE_TUMORS_DN",6,1.8954,0,0.14,"Yes",1.1659,0.27,0.53,"Yes"
"19796","GO_MF","490116_GO_0004812_AMINOACYL_TRNA_LIGASE_ACTIVITY",44,1.8958,0,0.11,"Yes",1.3955,0.048,0.48,"Yes"
"19797","GO_BP","491319_GO_0006397_MRNA_PROCESSING",423,1.8963,0,0.052,"Yes",1.6831,0,0.21,"Yes"
"19798","KEGG_compound","C00246_BUTANOIC_ACID_BUTANOATE_BUTYRATE_BUTYRIC_ACID",6,1.8983,0,0.09,"Yes",-0.7813,0.73,1,"No"
"19799","GO_BP","491337_GO_0006418_TRNA_AMINOACYLATION_FOR_PROTEIN_TRANSLATION",47,1.9012,0.0039,0.05,"Yes",1.4715,0.025,0.46,"Yes"
"19800","C7_Immunologic_signatures","C7_ALL_1273_GSE29618_BCELL_VS_MDC_UP",184,1.9019,0,0,"Yes",1.404,0.014,0.036,"Yes"
"19801","REACTOME","106013_REACT_7991_VPR_MEDIATED_NUCLEAR_IMPORT_OF_PICS",31,1.9034,0,0.026,"Yes",1.5801,0.03,0.1,"Yes"
"19802","C4_Cancer_gene_neighborhoods","C4_CGN_346_GNF2_DENR",51,1.9034,0,0.0059,"Yes",1.9286,0,0.00063,"Yes"
"19803","GO_CC","490709_GO_0005643_NUCLEAR_PORE",70,1.9054,0,0.02,"Yes",1.5641,0.0088,0.15,"Yes"
"19804","GO_CC","490728_GO_0005672_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX",6,1.9117,0,0.02,"Yes",1.5368,0.04,0.17,"Yes"
"19805","REACTOME","160952_REACT_1364_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS",11,1.9121,0.0082,0.025,"Yes",1.6517,0.0081,0.068,"Yes"
"19806","REACTOME","105963_REACT_424_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA",32,1.9144,0,0.025,"Yes",1.3644,0.068,0.25,"Yes"
"19807","REACTOME","106014_REACT_6916_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS",34,1.9158,0,0.025,"Yes",1.5196,0.024,0.14,"Yes"
"19808","REACTOME","106068_REACT_6145_INFLUENZA_LIFE_CYCLE",136,1.918,0,0.026,"Yes",3.4816,0,0,"Yes"
"19809","GO_BP","486808_GO_0000291_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC",31,1.9181,0,0.042,"Yes",1.8708,0,0.052,"Yes"
"19810","GO_CC","486830_GO_0000313_ORGANELLAR_RIBOSOME",63,1.9193,0,0.019,"Yes",2.4026,0,0,"Yes"
"19811","GO_BP","491328_GO_0006406_MRNA_EXPORT_FROM_NUCLEUS",70,1.9208,0,0.042,"Yes",0.9256,0.6,1,"Yes"
"19812","REACTOME","106067_REACT_6167_INFLUENZA_INFECTION",141,1.9231,0,0.025,"Yes",3.447,0,0,"Yes"
"19813","GO_MF","486597_GO_0000049_TRNA_BINDING",41,1.9247,0.0037,0.089,"Yes",1.7015,0.0043,0.15,"Yes"
"19814","C7_Immunologic_signatures","C7_ALL_845_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP",199,1.927,0,0,"Yes",1.6857,0,8e-04,"Yes"
"19815","GO_BP","492576_GO_0008380_RNA_SPLICING",340,1.9344,0,0.036,"Yes",1.8724,0,0.052,"Yes"
"19816","REACTOME","106073_REACT_6248_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS",29,1.9348,0,0.022,"Yes",1.5349,0.034,0.13,"Yes"
"19817","GO_BP","486953_GO_0000460_MATURATION_OF_5_8S_RRNA",18,1.9362,0.0028,0.036,"Yes",1.7898,0.0084,0.11,"Yes"
"19818","GO_CC","502020_GO_0032797_SMN_COMPLEX",12,1.9366,0,0.016,"Yes",1.8385,0.0063,0.019,"Yes"
"19819","GO_MF","489874_GO_0004526_RIBONUCLEASE_P_ACTIVITY",10,1.9389,0.0047,0.091,"Yes",1.3672,0.13,0.5,"Yes"
"19820","REACTOME","105960_REACT_1597_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON_CONTAINING_TRANSCRIPT",51,1.9397,0,0.021,"Yes",1.0814,0.3,0.62,"Yes"
"19821","REACTOME","105969_REACT_1079_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX",48,1.9439,0,0.022,"Yes",3.2982,0,0,"Yes"
"19822","GO_BP","486579_GO_0000028_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY",11,1.9451,0,0.034,"Yes",2.2264,0,0.00046,"Yes"
"19823","GO_BP","486891_GO_0000398_MRNA_SPLICING_VIA_SPLICEOSOME",226,1.946,0,0.034,"Yes",1.7854,0,0.11,"Yes"
"19824","REACTOME","106007_REACT_6190_REV_MEDIATED_NUCLEAR_EXPORT_OF_HIV_RNA",32,1.9462,0,0.022,"Yes",1.4575,0.047,0.18,"Yes"
"19825","C4_Cancer_modules","C4_CM_328_MODULE_388",17,1.9471,0.0027,0.033,"Yes",2.1911,0,0.00023,"Yes"
"19826","REACTOME","105962_REACT_405_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA",33,1.9515,0,0.021,"Yes",1.3909,0.076,0.23,"Yes"
"19827","GO_CC","911332_GO_0097504_GEMINI_OF_COILED_BODIES",11,1.9539,0,0.014,"Yes",1.6319,0.021,0.094,"Yes"
"19828","KEGG_pathway","HSA03013_RNA_TRANSPORT",166,1.9542,0,0.0034,"Yes",1.9248,0,0.004,"Yes"
"19829","GO_BP","506308_GO_0043241_PROTEIN_COMPLEX_DISASSEMBLY",219,1.9621,0,0.029,"Yes",3.46,0,0,"Yes"
"19830","GO_BP","486879_GO_0000377_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS_WITH_BULGED_ADENOSINE_AS_NUCLEOPHILE",227,1.9723,0,0.026,"Yes",1.7678,0,0.13,"Yes"
"19831","KEGG_compound","C00048_GLYOXYLATE_GLYOXALATE_GLYOXYLIC_ACID",7,1.9729,0.0024,0.075,"Yes",1.7293,0.01,0.062,"Yes"
"19832","GO_BP","495806_GO_0015669_GAS_TRANSPORT",20,1.974,0.0028,0.026,"Yes",1.9818,0,0.016,"Yes"
"19833","GO_BP","499832_GO_0030488_TRNA_METHYLATION",15,1.9828,0.0028,0.024,"Yes",1.562,0.036,0.34,"Yes"
"19834","GO_CC","490794_GO_0005761_MITOCHONDRIAL_RIBOSOME",61,1.9831,0,0.011,"Yes",2.4113,0,0,"Yes"
"19835","GO_CC","499983_GO_0030681_MULTIMERIC_RIBONUCLEASE_P_COMPLEX",7,1.988,0,0.011,"Yes",1.5554,0.032,0.15,"Yes"
"19836","GO_CC","490796_GO_0005763_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT",22,1.9919,0,0.011,"Yes",1.9766,0,0.0042,"Yes"
"19837","GO_CC","486709_GO_0000178_EXOSOME_RNASE_COMPLEX_",21,1.9974,0,0.011,"Yes",1.6342,0.01,0.093,"Yes"
"19838","GO_BP","486877_GO_0000375_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS",230,1.9975,0,0.021,"Yes",1.7938,0,0.11,"Yes"
"19839","GO_CC","486831_GO_0000314_ORGANELLAR_SMALL_RIBOSOMAL_SUBUNIT",22,1.9983,0,0.011,"Yes",1.9732,0,0.0043,"Yes"
"19840","GO_CC","515939_GO_0071013_CATALYTIC_STEP_2_SPLICEOSOME",83,1.9991,0,0.012,"Yes",1.9733,0,0.0044,"Yes"
"19841","C7_Immunologic_signatures","C7_ALL_979_GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP",196,1.9992,0,0,"Yes",2.6033,0,0,"Yes"
"19842","GO_CC","499979_GO_0030677_RIBONUCLEASE_P_COMPLEX",7,2.0035,0.0025,0.011,"Yes",1.561,0.049,0.15,"Yes"
"19843","GO_BP","502206_GO_0032984_MACROMOLECULAR_COMPLEX_DISASSEMBLY",228,2.0035,0,0.02,"Yes",3.4477,0,0,"Yes"
"19844","GO_BP","487450_GO_0001510_RNA_METHYLATION",42,2.0091,0,0.019,"Yes",1.5348,0.023,0.36,"Yes"
"19845","REACTOME","106082_REACT_6179_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY",29,2.0109,0.0031,0.012,"Yes",1.6081,0.011,0.09,"Yes"
"19846","GO_MF","492523_GO_0008175_TRNA_METHYLTRANSFERASE_ACTIVITY",15,2.0197,0,0.043,"Yes",1.5837,0.028,0.3,"Yes"
"19847","C4_Cancer_gene_neighborhoods","C4_CGN_322_GNF2_APEX1",92,2.0241,0,0.0027,"Yes",2.0934,0,0.00013,"Yes"
"19848","C2_Chemical_and_genetic_perturbations","C2_CGP_1468_MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN",73,2.0251,0,0.048,"Yes",2.1461,0,0.0012,"Yes"
"19849","GO_CC","490714_GO_0005655_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX",7,2.0285,0,0.0086,"Yes",1.5621,0.06,0.15,"Yes"
"19850","GO_BP","491327_GO_0006405_RNA_EXPORT_FROM_NUCLEUS",78,2.0313,0,0.015,"Yes",1.187,0.16,0.8,"Yes"
"19851","C7_Immunologic_signatures","C7_ALL_837_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP",195,2.0323,0,0,"Yes",1.815,0,3.1e-05,"Yes"
"19852","GO_MF","496778_GO_0016891_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",24,2.0376,0,0.043,"Yes",1.4643,0.046,0.41,"Yes"
"19853","KEGG_module","HSA_M00426_SURVIVAL_MOTOR_NEURON_SMN_COMPLEX",10,2.0409,0,0.0071,"Yes",1.7616,0.011,0.046,"Yes"
"19854","KEGG_pathway","HSA00970_AMINOACYL_TRNA_BIOSYNTHESIS",65,2.0443,0,0.00096,"Yes",1.5885,0.0043,0.072,"Yes"
"19855","GO_BP","515899_GO_0070972_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM",134,2.0774,0,0.0079,"Yes",3.6582,0,0,"Yes"
"19856","GO_BP","499353_GO_0022618_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY",151,2.0796,0,0.0079,"Yes",2.1797,0,0.0011,"Yes"
"19857","C4_Cancer_gene_neighborhoods","C4_CGN_343_GNF2_DAP3",119,2.0813,0,0.0017,"Yes",3.3727,0,0,"Yes"
"19858","GO_BP","495808_GO_0015671_OXYGEN_TRANSPORT",15,2.0819,0,0.0079,"Yes",1.9856,0,0.015,"Yes"
"19859","GO_CC","490735_GO_0005681_SPLICEOSOMAL_COMPLEX",160,2.0847,0,0.0041,"Yes",2.0038,0,0.0033,"Yes"
"19860","C1_Positional","C1_ALL_205_CHR19P12",40,2.0863,0,0.017,"Yes",2.0242,0,0.013,"Yes"
"19861","C4_Cancer_modules","C4_CM_28_MODULE_29",28,2.0879,0,0.012,"Yes",2.9633,0,0,"Yes"
"19862","C4_Cancer_gene_neighborhoods","C4_CGN_271_GCM_TPT1",70,2.0887,0,0.0017,"Yes",3.6265,0,0,"Yes"
"19863","C7_Immunologic_signatures","C7_ALL_1269_GSE29618_BCELL_VS_MONOCYTE_UP",182,2.0916,0,0,"Yes",1.5168,0.0048,0.0097,"Yes"
"19864","C4_Cancer_gene_neighborhoods","C4_CGN_402_GNF2_RBBP6",70,2.0966,0,0.002,"Yes",2.3078,0,0,"Yes"
"19865","REACTOME","645346_REACT_120969_O2_CO2_EXCHANGE_IN_ERYTHROCYTES",9,2.1001,0,0.0039,"Yes",2.0747,0,0.00088,"Yes"
"19866","C7_Immunologic_signatures","C7_ALL_835_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP",187,2.104,0,0,"Yes",1.7482,0,0.00032,"Yes"
"19867","REACTOME","645347_REACT_121329_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN",9,2.1174,0,0.0032,"Yes",2.0533,0,0.0013,"Yes"
"19868","GO_MF","487463_GO_0005344_OXYGEN_TRANSPORTER_ACTIVITY",13,2.118,0.0027,0.02,"Yes",2.1744,0,0.0016,"Yes"
"19869","REACTOME","645348_REACT_121380_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE",9,2.1217,0,0.0032,"Yes",2.0877,0,0.00072,"Yes"
"19870","GO_BP","516748_GO_0071826_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION",163,2.1302,0,0.0042,"Yes",2.237,0,0.00042,"Yes"
"19871","GO_CC","486712_GO_0022627_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT",41,2.1345,0,0.0022,"Yes",3.1713,0,0,"Yes"
"19872","C2_Chemical_and_genetic_perturbations","C2_CGP_1572_MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN",171,2.162,0,0.012,"Yes",2.293,0,0.00013,"Yes"
"19873","C7_Immunologic_signatures","C7_ALL_47_GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP",188,2.1624,0,0,"Yes",1.5378,0,0.0073,"Yes"
"19874","GO_BP","506655_GO_0043624_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY",200,2.1626,0,0.0028,"Yes",3.549,0,0,"Yes"
"19875","C7_Immunologic_signatures","C7_ALL_225_GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP",199,2.1745,0,0,"Yes",1.9687,0,0,"Yes"
"19876","GO_BP","487180_GO_0000956_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS",181,2.1755,0,0.0024,"Yes",3.4965,0,0,"Yes"
"19877","KEGG_module","HSA_M00427_NUCLEAR_PORE_COMPLEX",46,2.1906,0,0.0029,"Yes",1.5451,0.0084,0.15,"Yes"
"19878","GO_BP","486884_GO_0000387_SPLICEOSOMAL_SNRNP_ASSEMBLY",38,2.202,0,0.0016,"Yes",1.9707,0,0.018,"Yes"
"19879","GO_CC","503919_GO_0034719_SMN_SM_PROTEIN_COMPLEX",17,2.2139,0,0.00059,"Yes",2.2741,0,0,"Yes"
"19880","GO_MF","492521_GO_0008173_RNA_METHYLTRANSFERASE_ACTIVITY",39,2.2226,0,0.0079,"Yes",1.5912,0.017,0.3,"Yes"
"19881","GO_BP","486715_GO_0000184_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY",115,2.2432,0,0.00081,"Yes",3.7356,0,0,"Yes"
"19882","GO_CC","495325_GO_0015030_CAJAL_BODY",50,2.2447,0,0.00039,"Yes",1.8876,0,0.011,"Yes"
"19883","REACTOME","106074_REACT_6152_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION",127,2.2486,0,0.00068,"Yes",3.6624,0,0,"Yes"
"19884","GO_CC","911352_GO_0097525_SPLICEOSOMAL_SNRNP_COMPLEX",37,2.2494,0,0.00042,"Yes",2.0426,0,0.002,"Yes"
"19885","REACTOME","1127501_REACT_268261_MITOCHONDRIAL_TRANSLATION_TERMINATION",84,2.2495,0,0.00071,"Yes",2.5893,0,0,"Yes"
"19886","GO_BP","505425_GO_0042273_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS",21,2.2541,0,0.00074,"Yes",2.4332,0,0,"Yes"
"19887","GO_BP","515062_GO_0070124_MITOCHONDRIAL_TRANSLATIONAL_INITIATION",84,2.2552,0,0.00077,"Yes",2.6207,0,0,"Yes"
"19888","KEGG_module","HSA_M00354_SPLICEOSOME_U4_U6_U5_TRI_SNRNP",30,2.2588,0,0.0033,"Yes",2.1657,0,0,"Yes"
"19889","REACTOME","366241_REACT_75822_NONSENSE_MEDIATED_DECAY_NMD_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX_EJC_",106,2.2638,0,7e-04,"Yes",3.779,0,0,"Yes"
"19890","REACTOME","366240_REACT_75886_NONSENSE_MEDIATED_DECAY_NMD_",106,2.2733,0,0.00068,"Yes",3.7522,0,0,"Yes"
"19891","GO_CC","507400_GO_0044452_NUCLEOLAR_PART",56,2.288,0,0.00028,"Yes",2.0064,0,0.0032,"Yes"
"19892","REACTOME","1127500_REACT_268133_MITOCHONDRIAL_TRANSLATION_ELONGATION",84,2.2969,0,0.00047,"Yes",2.6143,0,0,"Yes"
"19893","GO_BP","515064_GO_0070126_MITOCHONDRIAL_TRANSLATIONAL_TERMINATION",84,2.3028,0,0.00039,"Yes",2.6433,0,0,"Yes"
"19894","REACTOME","1127498_REACT_268551_MITOCHONDRIAL_TRANSLATION",90,2.303,0,0.00044,"Yes",2.6424,0,0,"Yes"
"19895","GO_BP","515063_GO_0070125_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION",85,2.3127,0,0.00034,"Yes",2.6303,0,0,"Yes"
"19896","GO_CC","490855_GO_0005833_HEMOGLOBIN_COMPLEX",11,2.3334,0,1e-04,"Yes",2.3738,0,0,"Yes"
"19897","GO_BP","517502_GO_0072599_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM",115,2.3353,0,0.00022,"Yes",3.7526,0,0,"Yes"
"19898","GO_CC","489275_GO_0030532_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX",45,2.3378,0,0.00011,"Yes",2.1343,0,0.00042,"Yes"
"19899","C4_Cancer_gene_neighborhoods","C4_CGN_349_GNF2_EIF3S6",121,2.3384,0,0,"Yes",3.7789,0,0,"Yes"
"19900","REACTOME","1127499_REACT_267634_MITOCHONDRIAL_TRANSLATION_INITIATION",84,2.3394,0,0.00027,"Yes",2.6723,0,0,"Yes"
"19901","GO_BP","493622_GO_0009451_RNA_MODIFICATION",96,2.3447,0,0.00021,"Yes",1.7415,0.0023,0.15,"Yes"
"19902","GO_CC","486711_GO_0022625_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT",50,2.3461,0,0.00012,"Yes",3.5386,0,0,"Yes"
"19903","REACTOME","105965_REACT_1014_TRANSLATION",145,2.3483,0,0.00022,"Yes",3.8312,0,0,"Yes"
"19904","GO_CC","496056_GO_0015935_SMALL_RIBOSOMAL_SUBUNIT",65,2.3556,0,0.00014,"Yes",3.2575,0,0,"Yes"
"19905","GO_BP","486955_GO_0000462_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",28,2.3605,0,0.00015,"Yes",2.1016,0,0.0035,"Yes"
"19906","REACTOME","105967_REACT_2099_CAP_DEPENDENT_TRANSLATION_INITIATION",112,2.387,0,7.4e-05,"Yes",3.8617,0,0,"Yes"
"19907","REACTOME","160955_REACT_79_L13A_MEDIATED_TRANSLATIONAL_SILENCING_OF_CERULOPLASMIN_EXPRESSION",104,2.3978,0,8.1e-05,"Yes",3.895,0,0,"Yes"
"19908","GO_BP","507448_GO_0045047_PROTEIN_TARGETING_TO_ER",111,2.4013,0,7.6e-05,"Yes",3.7493,0,0,"Yes"
"19909","GO_BP","501773_GO_0032543_MITOCHONDRIAL_TRANSLATION",102,2.4036,0,8e-05,"Yes",2.5717,0,0,"Yes"
"19910","REACTOME","105968_REACT_1797_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS",94,2.408,0,8.8e-05,"Yes",3.9416,0,0,"Yes"
"19911","REACTOME","105973_REACT_2085_GTP_HYDROLYSIS_AND_JOINING_OF_THE_60S_RIBOSOMAL_SUBUNIT",105,2.4097,0,9.7e-05,"Yes",3.8417,0,0,"Yes"
"19912","GO_CC","499988_GO_0030686_90S_PRERIBOSOME",25,2.4105,0,0.00016,"Yes",1.8774,0,0.013,"Yes"
"19913","C4_Cancer_gene_neighborhoods","C4_CGN_387_GNF2_NPM1",72,2.4133,0,0,"Yes",2.9936,0,0,"Yes"
"19914","REACTOME","106228_REACT_11052_METABOLISM_OF_NON_CODING_RNA",50,2.4208,0,0.00011,"Yes",2.1137,0,5e-04,"Yes"
"19915","GO_CC","496055_GO_0015934_LARGE_RIBOSOMAL_SUBUNIT",78,2.4257,0,0,"Yes",3.3914,0,0,"Yes"
"19916","KEGG_pathway","HSA03008_RIBOSOME_BIOGENESIS_IN_EUKARYOTES",81,2.437,0,0,"Yes",2.0718,0,0.0011,"Yes"
"19917","GO_BP","491332_GO_0006412_TRANSLATION",365,2.4377,0,5.5e-05,"Yes",3.3523,0,0,"Yes"
"19918","C4_Cancer_gene_neighborhoods","C4_CGN_421_GNF2_TPT1",38,2.4422,0,0,"Yes",3.4211,0,0,"Yes"
"19919","C3_TF_targets","C3_TFT_490_GKCGCNNNNNNNTGAYG_UNKNOWN",58,2.4474,0,0,"Yes",1.9616,0,0.0027,"Yes"
"19920","C4_Cancer_gene_neighborhoods","C4_CGN_414_GNF2_ST13",64,2.4474,0,0,"Yes",3.6571,0,0,"Yes"
"19921","GO_BP","491507_GO_0006613_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",109,2.4484,0,2.9e-05,"Yes",3.7592,0,0,"Yes"
"19922","REACTOME","106229_REACT_11066_SNRNP_ASSEMBLY",50,2.4531,0,0.00012,"Yes",2.1258,0,0.00046,"Yes"
"19923","C2_Chemical_and_genetic_perturbations","C2_CGP_1217_NIKOLSKY_BREAST_CANCER_19Q13_1_AMPLICON",22,2.4592,0,0,"Yes",1.7863,0.0043,0.047,"Yes"
"19924","GO_BP","491508_GO_0006614_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",107,2.4608,0,0,"Yes",3.779,0,0,"Yes"
"19925","C4_Cancer_gene_neighborhoods","C4_CGN_355_GNF2_GLTSCR2",31,2.4623,0,0,"Yes",3.0862,0,0,"Yes"
"19926","REACTOME","105966_REACT_2159_EUKARYOTIC_TRANSLATION_INITIATION",112,2.4629,0,0.00014,"Yes",3.8457,0,0,"Yes"
"19927","GO_BP","491322_GO_0006400_TRNA_MODIFICATION",40,2.4684,0,0,"Yes",1.7174,0.0043,0.17,"Yes"
"19928","GO_BP","491333_GO_0006413_TRANSLATIONAL_INITIATION",221,2.4845,0,0,"Yes",3.6733,0,0,"Yes"
"19929","REACTOME","105978_REACT_1986_EUKARYOTIC_TRANSLATION_TERMINATION",84,2.5116,0,0,"Yes",3.8178,0,0,"Yes"
"19930","WikiPathways","198853_WP477_CYTOPLASMIC_RIBOSOMAL_PROTEINS",104,2.5143,0,0,"Yes",3.8574,0,0,"Yes"
"19931","REACTOME","106077_REACT_9491_VIRAL_MRNA_TRANSLATION",84,2.5268,0,0,"Yes",3.8386,0,0,"Yes"
"19932","REACTOME","530746_REACT_115902_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",107,2.5289,0,0,"Yes",3.8309,0,0,"Yes"
"19933","GO_BP","499833_GO_0030490_MATURATION_OF_SSU_RRNA",37,2.5421,0,0,"Yes",2.2796,0,0.00015,"Yes"
"19934","GO_CC","501277_GO_0032040_SMALL_SUBUNIT_PROCESSOME",32,2.5576,0,0,"Yes",2.0745,0,0.0012,"Yes"
"19935","GO_MF","489276_GO_0003735_STRUCTURAL_CONSTITUENT_OF_RIBOSOME",149,2.5609,0,0,"Yes",3.6602,0,0,"Yes"
"19936","GO_BP","507049_GO_0044033_MULTI_ORGANISM_METABOLIC_PROCESS",126,2.5638,0,0,"Yes",3.687,0,0,"Yes"
"19937","GO_CC","499360_GO_0022626_CYTOSOLIC_RIBOSOME",99,2.5726,0,0,"Yes",3.8345,0,0,"Yes"
"19938","REACTOME","105976_REACT_1477_EUKARYOTIC_TRANSLATION_ELONGATION",88,2.5789,0,0,"Yes",3.8591,0,0,"Yes"
"19939","KEGG_pathway","HSA03010_RIBOSOME",133,2.5792,0,0,"Yes",3.7522,0,0,"Yes"
"19940","GO_BP","497957_GO_0019080_VIRAL_GENE_EXPRESSION",120,2.5793,0,0,"Yes",3.6938,0,0,"Yes"
"19941","REACTOME","366242_REACT_75768_NONSENSE_MEDIATED_DECAY_NMD_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX_EJC_",89,2.5896,0,0,"Yes",3.8068,0,0,"Yes"
"19942","GO_CC","490649_GO_0005840_RIBOSOME",212,2.5913,0,0,"Yes",3.5712,0,0,"Yes"
"19943","C4_Cancer_gene_neighborhoods","C4_CGN_351_GNF2_FBL",146,2.5925,0,0,"Yes",3.4581,0,0,"Yes"
"19944","KEGG_module","HSA_M00177_RIBOSOME_EUKARYOTES",88,2.6154,0,0,"Yes",3.8616,0,0,"Yes"
"19945","GO_BP","492410_GO_0008033_TRNA_PROCESSING",98,2.6224,0,0,"Yes",1.9635,0,0.019,"Yes"
"19946","GO_BP","505426_GO_0042274_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS",48,2.6511,0,0,"Yes",2.5196,0,0,"Yes"
"19947","GO_BP","491321_GO_0006399_TRNA_METABOLIC_PROCESS",149,2.6538,0,0,"Yes",2.0249,0,0.0096,"Yes"
"19948","GO_BP","491335_GO_0006415_TRANSLATIONAL_TERMINATION",170,2.6804,0,0,"Yes",3.7048,0,0,"Yes"
"19949","REACTOME","105977_REACT_1404_PEPTIDE_CHAIN_ELONGATION",84,2.7036,0,0,"Yes",3.9023,0,0,"Yes"
"19950","GO_BP","499348_GO_0022613_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS",314,2.704,0,0,"Yes",2.6368,0,0,"Yes"
"19951","GO_BP","503860_GO_0034660_NCRNA_METABOLIC_PROCESS",398,2.707,0,0,"Yes",2.3909,0,2.4e-05,"Yes"
"19952","GO_CC","751604_GO_0044391_RIBOSOMAL_SUBUNIT",142,2.7129,0,0,"Yes",3.7272,0,0,"Yes"
"19953","GO_BP","497960_GO_0019083_VIRAL_TRANSCRIPTION",110,2.7153,0,0,"Yes",3.7253,0,0,"Yes"
"19954","GO_BP","491334_GO_0006414_TRANSLATIONAL_ELONGATION",186,2.7339,0,0,"Yes",3.6665,0,0,"Yes"
"19955","GO_CC","499986_GO_0030684_PRERIBOSOME",45,2.7765,0,0,"Yes",2.1707,0,0.00036,"Yes"
"19956","GO_BP","496166_GO_0016072_RRNA_METABOLIC_PROCESS",144,2.82,0,0,"Yes",2.592,0,0,"Yes"
"19957","GO_BP","503672_GO_0034470_NCRNA_PROCESSING",264,2.8349,0,0,"Yes",2.4068,0,2.4e-05,"Yes"
"19958","GO_BP","491301_GO_0006364_RRNA_PROCESSING",139,2.8386,0,0,"Yes",2.562,0,0,"Yes"
"19959","GO_BP","486555_GO_0042254_RIBOSOME_BIOGENESIS",188,2.9023,0,0,"Yes",2.71,0,0,"Yes"
